id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
30967378|NCT01393405|59037350|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
30967379|NCT01393405|59037351|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
30967380|NCT01393405|59037352|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
30967381|NCT01393405|59037350|FG000|Induction Period (week1-16)|Adverse Event|16|||
30967382|NCT01393405|59037351|FG001|Induction Period (week1-16)|Adverse Event|0|||
30967383|NCT01393405|59037352|FG002|Induction Period (week1-16)|Adverse Event|0|||
30967384|NCT01393405|59037350|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
30967385|NCT01393405|59037351|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
30967386|NCT01393405|59037352|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
30967387|NCT01393405|59037350|FG000|Maintenance Period Week|Lack of Efficacy|0|||
30967388|NCT01393405|59037351|FG001|Maintenance Period Week|Lack of Efficacy|22|||
30967389|NCT01393405|59037352|FG002|Maintenance Period Week|Lack of Efficacy|22|||
30967390|NCT01393405|59037350|FG000|Maintenance Period Week|Adverse Event|0|||
30787677|NCT00104104|58800959|FG000|Overall Study|Adverse Event|8|||
30787678|NCT00104104|58800960|FG001|Overall Study|Adverse Event|8|||
30787679|NCT00104104|58800959|FG000|Overall Study|Abnormal laboratory value(s)|20|||
30787680|NCT00104104|58800960|FG001|Overall Study|Abnormal laboratory value(s)|14|||
30787681|NCT00104104|58800959|FG000|Overall Study|Lack of Efficacy|0|||
30787682|NCT00104104|58800960|FG001|Overall Study|Lack of Efficacy|3|||
30877602|NCT01958164|58909104|FG000|Overall Study|Adverse Event|0|||
30877603|NCT01958164|58909105|FG001|Overall Study|Adverse Event|2|||
30877604|NCT01958164|58909104|FG000|Overall Study|Lost to Follow-up|2|||
30877605|NCT01958164|58909105|FG001|Overall Study|Lost to Follow-up|3|||
30877606|NCT01976104|58909115|FG000|Overall Study|Adverse Event|0|||
30877607|NCT01976104|58909116|FG001|Overall Study|Adverse Event|0|||
30877608|NCT01976104|58909117|FG002|Overall Study|Adverse Event|1|||
30967391|NCT01393405|59037351|FG001|Maintenance Period Week|Adverse Event|5|||
30967392|NCT01393405|59037352|FG002|Maintenance Period Week|Adverse Event|2|||
30967393|NCT01393405|59037350|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
30967394|NCT01393405|59037351|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
30967395|NCT01393405|59037352|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
30967396|NCT01393405|59037350|FG000|Maintenance Period Week|Lost to Follow-up|0|||
30967397|NCT01393405|59037351|FG001|Maintenance Period Week|Lost to Follow-up|1|||
30967398|NCT01393405|59037352|FG002|Maintenance Period Week|Lost to Follow-up|0|||
30967399|NCT01419197|59037364|FG000|Overall Study|Death|247|||
30967400|NCT01419197|59037365|FG001|Overall Study|Death|122|||
30967401|NCT01419197|59037364|FG000|Overall Study|Physician Decision|4|||
30967402|NCT01419197|59037365|FG001|Overall Study|Physician Decision|4|||
30967403|NCT01419197|59037364|FG000|Overall Study|Non-compliance|3|||
30967404|NCT01419197|59037365|FG001|Overall Study|Non-compliance|1|||
30967405|NCT01419197|59037364|FG000|Overall Study|Withdrawal by Subject|33|||
30967406|NCT01419197|59037365|FG001|Overall Study|Withdrawal by Subject|32|||
30787683|NCT00104104|58800959|FG000|Overall Study|Condition no longer requires study drug|7|||
30787684|NCT00104104|58800960|FG001|Overall Study|Condition no longer requires study drug|4|||
30787685|NCT00104104|58800959|FG000|Overall Study|Protocol Violation|5|||
30787686|NCT00104104|58800960|FG001|Overall Study|Protocol Violation|2|||
30877609|NCT01976104|58909118|FG003|Overall Study|Adverse Event|0|||
30967407|NCT01419197|59037364|FG000|Overall Study|Study Completed by Sponsor|103|||
30967408|NCT01419197|59037365|FG001|Overall Study|Study Completed by Sponsor|34|||
30967409|NCT01419197|59037364|FG000|Overall Study|Reason Not Specified|0|||
30967410|NCT01419197|59037365|FG001|Overall Study|Reason Not Specified|1|||
30967411|NCT01419197|59037364|FG000|Overall Study|Lost to Follow-up|14|||
30967412|NCT01419197|59037365|FG001|Overall Study|Lost to Follow-up|4|||
30967413|NCT01414075|59037376|FG000|Overall Study|Adverse Event|1|||
30967414|NCT01414075|59037377|FG001|Overall Study|Adverse Event|0|||
30967415|NCT01414075|59037378|FG002|Overall Study|Adverse Event|1|||
30967416|NCT01414075|59037379|FG003|Overall Study|Adverse Event|0|||
30967417|NCT01414075|59037376|FG000|Overall Study|Death|1|||
30967418|NCT01414075|59037377|FG001|Overall Study|Death|0|||
30967419|NCT01414075|59037378|FG002|Overall Study|Death|0|||
30967420|NCT01414075|59037379|FG003|Overall Study|Death|1|||
30967421|NCT01414075|59037376|FG000|Overall Study|Withdrawal by Subject|0|||
30967422|NCT01414075|59037377|FG001|Overall Study|Withdrawal by Subject|0|||
30967423|NCT01414075|59037378|FG002|Overall Study|Withdrawal by Subject|0|||
30967424|NCT01414075|59037379|FG003|Overall Study|Withdrawal by Subject|1|||
30967425|NCT01414075|59037376|FG000|Overall Study|Other than specified|1|||
30967426|NCT01414075|59037377|FG001|Overall Study|Other than specified|0|||
30877610|NCT01976104|58909115|FG000|Overall Study|Lost to Follow-up|3|||
30967427|NCT01414075|59037378|FG002|Overall Study|Other than specified|1|||
30967428|NCT01414075|59037379|FG003|Overall Study|Other than specified|0|||
30967429|NCT01434823|59037391|FG000|Overall Study|Incomplete data in medical record|4|||
30787687|NCT00104104|58800959|FG000|Overall Study|Withdrawal by Subject|11|||
30787688|NCT00104104|58800960|FG001|Overall Study|Withdrawal by Subject|15|||
30877611|NCT01976104|58909116|FG001|Overall Study|Lost to Follow-up|0|||
30877612|NCT01976104|58909117|FG002|Overall Study|Lost to Follow-up|1|||
30967430|NCT01434823|59037392|FG001|Overall Study|Incomplete data in medical record|7|||
30967431|NCT01513460|59037402|FG000|Overall Study|Death|0|||
30787689|NCT00104104|58800959|FG000|Overall Study|Lost to Follow-up|3|||
30787690|NCT00104104|58800960|FG001|Overall Study|Lost to Follow-up|7|||
30787691|NCT00104104|58800959|FG000|Overall Study|Administrative problems|12|||
30787692|NCT00104104|58800960|FG001|Overall Study|Administrative problems|13|||
30787693|NCT00104104|58800959|FG000|Overall Study|Death|9|||
30787694|NCT00104104|58800960|FG001|Overall Study|Death|6|||
30787695|NCT03557151|58800968|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
30787696|NCT03557151|58800969|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
30787697|NCT03557151|58800968|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
30787698|NCT03557151|58800969|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
30787699|NCT03557151|58800968|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
30787700|NCT03557151|58800969|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
30787701|NCT00115739|58800977|FG000|Overall Study|Lost to Follow-up|3|||
30787702|NCT01347086|58800993|FG000|Overall Study|failed screening visit|0|||
30787703|NCT01347086|58800994|FG001|Overall Study|failed screening visit|0|||
30787704|NCT01347086|58800995|FG002|Overall Study|failed screening visit|1|||
30787705|NCT01347086|58800996|FG003|Overall Study|failed screening visit|0|||
30787706|NCT01347086|58800997|FG004|Overall Study|failed screening visit|0|||
30787707|NCT01347086|58800998|FG005|Overall Study|failed screening visit|0|||
30787708|NCT01347086|58800999|FG006|Overall Study|failed screening visit|1|||
30787709|NCT01347086|58801000|FG007|Overall Study|failed screening visit|1|||
30787710|NCT01347086|58801001|FG008|Overall Study|failed screening visit|0|||
30787711|NCT01347086|58801002|FG009|Overall Study|failed screening visit|1|||
30787712|NCT03605745|58801034|FG000|Overall Study|Study was terminated for business reasons|47|||
30787713|NCT03246152|58801038|FG000|Overall Study|Lost to Follow-up|2|||
30787714|NCT03246152|58801038|FG000|Overall Study|Protocol Violation|1|||
30787715|NCT03571581|58801042|FG000|Overall Study|Death|2|||
30787716|NCT03571581|58801042|FG000|Overall Study|Withdrawal by Subject|2|||
30787717|NCT00115349|58801051|FG000|Overall Study|Study closed due to low enrollment.|11|||
30787718|NCT00115349|58801052|FG001|Overall Study|Study closed due to low enrollment.|9|||
30787719|NCT00115037|58801060|FG000|Phase1|Lost to Follow-up|16|||
30787720|NCT00115037|58801061|FG001|Phase1|Lost to Follow-up|23|||
30787721|NCT00115037|58801062|FG002|Phase1|Lost to Follow-up|0|||
30787722|NCT00115037|58801063|FG003|Phase1|Lost to Follow-up|0|||
30787723|NCT00115037|58801064|FG004|Phase1|Lost to Follow-up|0|||
30787724|NCT00115037|58801065|FG005|Phase1|Lost to Follow-up|0|||
30787725|NCT00115037|58801060|FG000|Phase1|Withdrawal by Subject|9|||
30787726|NCT00115037|58801061|FG001|Phase1|Withdrawal by Subject|4|||
30787727|NCT00115037|58801062|FG002|Phase1|Withdrawal by Subject|0|||
30787728|NCT00115037|58801063|FG003|Phase1|Withdrawal by Subject|0|||
30787729|NCT00115037|58801064|FG004|Phase1|Withdrawal by Subject|0|||
30787730|NCT00115037|58801065|FG005|Phase1|Withdrawal by Subject|0|||
30787731|NCT00115037|58801060|FG000|Phase2|Death|0|||
30787732|NCT00115037|58801061|FG001|Phase2|Death|0|||
30787733|NCT00115037|58801062|FG002|Phase2|Death|1|||
30787734|NCT00115037|58801063|FG003|Phase2|Death|0|||
30787735|NCT00115037|58801064|FG004|Phase2|Death|0|||
30787736|NCT00115037|58801065|FG005|Phase2|Death|1|||
30787737|NCT00115037|58801060|FG000|Phase2|Withdrawal by Subject|0|||
30877613|NCT01976104|58909118|FG003|Overall Study|Lost to Follow-up|1|||
30877614|NCT01976104|58909115|FG000|Overall Study|Subject Choice|0|||
30877615|NCT01976104|58909116|FG001|Overall Study|Subject Choice|1|||
30877616|NCT01976104|58909117|FG002|Overall Study|Subject Choice|0|||
30877617|NCT01976104|58909118|FG003|Overall Study|Subject Choice|1|||
30877618|NCT01976104|58909115|FG000|Overall Study|Withdrawal by Subject|3|||
30877619|NCT01976104|58909116|FG001|Overall Study|Withdrawal by Subject|0|||
30877620|NCT01976104|58909117|FG002|Overall Study|Withdrawal by Subject|0|||
30877621|NCT01976104|58909118|FG003|Overall Study|Withdrawal by Subject|1|||
30877622|NCT01976104|58909115|FG000|Overall Study|Other|0|||
30877623|NCT01976104|58909116|FG001|Overall Study|Other|1|||
30877624|NCT01976104|58909117|FG002|Overall Study|Other|0|||
30877625|NCT01976104|58909118|FG003|Overall Study|Other|0|||
30877626|NCT01372501|58909129|FG000|Overall Study|Adverse Event|4|||
30787738|NCT00115037|58801061|FG001|Phase2|Withdrawal by Subject|0|||
30787739|NCT00115037|58801062|FG002|Phase2|Withdrawal by Subject|2|||
30787740|NCT00115037|58801063|FG003|Phase2|Withdrawal by Subject|1|||
30787741|NCT00115037|58801064|FG004|Phase2|Withdrawal by Subject|2|||
30787742|NCT00115037|58801065|FG005|Phase2|Withdrawal by Subject|1|||
30787743|NCT00115037|58801060|FG000|Phase2|Lost to Follow-up|0|||
30787744|NCT00115037|58801061|FG001|Phase2|Lost to Follow-up|0|||
30787745|NCT00115037|58801062|FG002|Phase2|Lost to Follow-up|12|||
30787746|NCT00115037|58801063|FG003|Phase2|Lost to Follow-up|14|||
30787747|NCT00115037|58801064|FG004|Phase2|Lost to Follow-up|4|||
30787748|NCT00115037|58801065|FG005|Phase2|Lost to Follow-up|10|||
30787749|NCT03214640|58801083|FG000|Overall Study|Protocol Violation|1|||
30787750|NCT03214640|58801084|FG001|Overall Study|Protocol Violation|2|||
30787751|NCT03214640|58801085|FG002|Overall Study|Protocol Violation|1|||
30877627|NCT01372501|58909129|FG000|Overall Study|Device migration|1|||
30877628|NCT01958008|58909138|FG000|Overall Study|Worsening of disease under study|0|||
30877629|NCT01958008|58909139|FG001|Overall Study|Worsening of disease under study|0|||
30787752|NCT03214640|58801086|FG003|Overall Study|Protocol Violation|4|||
30787753|NCT03214406|58801098|FG000|Overall Study|did not meet enrollment criteria|9|||
30787754|NCT03214406|58801099|FG001|Overall Study|did not meet enrollment criteria|13|||
30787755|NCT03214406|58801098|FG000|Overall Study|Withdrawal by Subject|1|||
30787756|NCT03214406|58801099|FG001|Overall Study|Withdrawal by Subject|0|||
30787757|NCT03214406|58801098|FG000|Overall Study|Lost to Follow-up|0|||
30787758|NCT03214406|58801099|FG001|Overall Study|Lost to Follow-up|2|||
30787759|NCT03213938|58801107|FG000|Overall Study|Lost to Follow-up|4|||
30787760|NCT03213938|58801108|FG001|Overall Study|Lost to Follow-up|3|||
30787761|NCT03213938|58801107|FG000|Overall Study|Lack of Efficacy|1|||
30787762|NCT03213938|58801108|FG001|Overall Study|Lack of Efficacy|0|||
30787763|NCT03213938|58801107|FG000|Overall Study|Decline to participate|5|||
30787764|NCT03213938|58801108|FG001|Overall Study|Decline to participate|4|||
30787765|NCT03213938|58801107|FG000|Overall Study|Without reason|4|||
30787766|NCT03213938|58801108|FG001|Overall Study|Without reason|5|||
30787767|NCT03604497|58801114|FG000|Overall Study|Protocol Violation|52|||
30787768|NCT03213626|58801122|FG000|Overall Study|Adverse Event|1|||
30787769|NCT03213626|58801122|FG000|Overall Study|Progressive Disease|6|||
30787770|NCT03604341|58801128|FG000|Overall Study|Withdrawal by Subject|1|||
30787771|NCT03604341|58801129|FG001|Overall Study|Withdrawal by Subject|1|||
30787772|NCT03604341|58801128|FG000|Overall Study|Adverse Event|1|||
30787773|NCT03604341|58801129|FG001|Overall Study|Adverse Event|0|||
30787774|NCT03604341|58801128|FG000|Overall Study|Protocol Violation|0|||
30787775|NCT03604341|58801129|FG001|Overall Study|Protocol Violation|1|||
30787776|NCT03603639|58801135|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
30787777|NCT03603639|58801136|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
30787778|NCT03603639|58801137|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
30787779|NCT03603639|58801138|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
30787780|NCT03603639|58801139|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
30787781|NCT03603639|58801140|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
30787782|NCT03603639|58801135|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
30787783|NCT03603639|58801136|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
30787784|NCT03603639|58801137|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
30787785|NCT03603639|58801138|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
30787786|NCT03603639|58801139|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
30787787|NCT03603639|58801140|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
30787788|NCT00114959|58801150|FG000|Overall Study|Lack of Efficacy|6|||
30787789|NCT00114959|58801150|FG000|Overall Study|Physician Decision|1|||
30787790|NCT00114959|58801150|FG000|Overall Study|Death|1|||
30787791|NCT02778100|58801156|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
30787792|NCT02778100|58801157|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
30787793|NCT00118157|58801165|FG000|Overall Study|Adverse Event|2|||
30787794|NCT00118157|58801165|FG000|Overall Study|Death|8|||
30787795|NCT00118157|58801165|FG000|Overall Study|Withdrawal by Subject|2|||
30787796|NCT02762500|58801172|FG000|Overall Study|Lack of Efficacy|1|||
30787797|NCT02762500|58801173|FG001|Overall Study|Lack of Efficacy|0|||
30787798|NCT02762500|58801172|FG000|Overall Study|Withdrawal by Subject|1|||
30787799|NCT02762500|58801173|FG001|Overall Study|Withdrawal by Subject|1|||
30787800|NCT02762500|58801172|FG000|Overall Study|Adverse Event|0|||
30787801|NCT02762500|58801173|FG001|Overall Study|Adverse Event|2|||
30787802|NCT03552549|58801181|FG000|Overall Study|Disease progression|25|||
30787803|NCT03552549|58801182|FG001|Overall Study|Disease progression|17|||
30787804|NCT03552549|58801181|FG000|Overall Study|Adverse event in first 12 months|12|||
30787805|NCT03552549|58801182|FG001|Overall Study|Adverse event in first 12 months|8|||
30877630|NCT01958008|58909140|FG002|Overall Study|Worsening of disease under study|1|||
30877631|NCT01958008|58909141|FG003|Overall Study|Worsening of disease under study|0|||
30877632|NCT01958008|58909138|FG000|Overall Study|Other adverse event|1|||
30877633|NCT01958008|58909139|FG001|Overall Study|Other adverse event|0|||
30877634|NCT01958008|58909140|FG002|Overall Study|Other adverse event|0|||
30877635|NCT01958008|58909141|FG003|Overall Study|Other adverse event|0|||
30877636|NCT01998880|58909169|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
30877637|NCT01998880|58909170|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
30877638|NCT01998880|58909169|FG000|Overall Study|Disease Progression|1|||
30877639|NCT01998880|58909170|FG001|Overall Study|Disease Progression|8|||
30877640|NCT01998880|58909169|FG000|Overall Study|Withdrew Consent|2|||
30877641|NCT01998880|58909170|FG001|Overall Study|Withdrew Consent|1|||
30787806|NCT03552549|58801181|FG000|Overall Study|Withdrawal by Subject|7|||
30787807|NCT03552549|58801182|FG001|Overall Study|Withdrawal by Subject|7|||
30787808|NCT03552549|58801181|FG000|Overall Study|Unknown (no reason provided)|4|||
30787809|NCT03552549|58801182|FG001|Overall Study|Unknown (no reason provided)|2|||
30877642|NCT01998880|58909169|FG000|Overall Study|Death|3|||
30877643|NCT01998880|58909170|FG001|Overall Study|Death|6|||
30967432|NCT01513460|59037403|FG001|Overall Study|Death|0|||
30787810|NCT03552549|58801181|FG000|Overall Study|Not in participant's best interest|2|||
30787811|NCT03552549|58801182|FG001|Overall Study|Not in participant's best interest|1|||
30787812|NCT03552549|58801181|FG000|Overall Study|Did not complete study treatment|2|||
30787813|NCT03552549|58801182|FG001|Overall Study|Did not complete study treatment|3|||
30787814|NCT03552549|58801181|FG000|Overall Study|Did not meet eligibility criteria|1|||
30787815|NCT03552549|58801182|FG001|Overall Study|Did not meet eligibility criteria|0|||
30787816|NCT03552549|58801181|FG000|Overall Study|Administrative|0|||
30787817|NCT03552549|58801182|FG001|Overall Study|Administrative|14|||
30787818|NCT00117845|58801188|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
30787819|NCT02761642|58801192|FG000|Overall Study|Did not Receive Study Treatment|3|||
30787820|NCT02761642|58801192|FG000|Overall Study|Adverse Event|13|||
30787821|NCT02761642|58801192|FG000|Overall Study|Withdrawal by Subject|2|||
30787822|NCT02761642|58801192|FG000|Overall Study|Non-compliant|7|||
30787823|NCT02761642|58801192|FG000|Overall Study|Death|3|||
30787824|NCT02761642|58801192|FG000|Overall Study|Lack of Efficacy|20|||
30787825|NCT02761642|58801192|FG000|Overall Study|Physician Decision|1|||
30697583|NCT00768989|58711899|FG000|Prior to Week 24|Withdrawal by Subject|1|||
30697584|NCT00768989|58711900|FG001|Prior to Week 24|Withdrawal by Subject|0|||
30697585|NCT00768989|58711899|FG000|Prior to Week 24|Adverse Event|3|||
30697586|NCT00768989|58711900|FG001|Prior to Week 24|Adverse Event|0|||
30697587|NCT00768989|58711899|FG000|Prior to Week 24|Lost to Follow-up|0|||
30697588|NCT00768989|58711900|FG001|Prior to Week 24|Lost to Follow-up|1|||
30697589|NCT00768989|58711899|FG000|Prior to Week 24|Protocol Violation|0|||
30697590|NCT00768989|58711900|FG001|Prior to Week 24|Protocol Violation|2|||
30697591|NCT00768989|58711899|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
30697592|NCT00768989|58711900|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
30697593|NCT00768989|58711899|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
30697594|NCT00768989|58711900|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
30787826|NCT02761642|58801192|FG000|Overall Study|Reason Unspecified|21|||
30787827|NCT00113555|58801196|FG000|Overall Study|Baseline Failure|59|||
30787828|NCT00113555|58801196|FG000|Overall Study|Permanently Explanted|7|||
30787829|NCT00113555|58801196|FG000|Overall Study|Death|1|||
30787830|NCT00113555|58801196|FG000|Overall Study|Missed Followup|4|||
30787831|NCT00113555|58801196|FG000|Overall Study|Lost to Follow-up|8|||
30787832|NCT03189524|58801204|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
30787833|NCT03189524|58801205|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
30787834|NCT03189524|58801206|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
30787835|NCT03189524|58801204|FG000|Overall Study|Death|2|||
30787836|NCT03189524|58801205|FG001|Overall Study|Death|2|||
30787837|NCT03189524|58801206|FG002|Overall Study|Death|1|||
30787838|NCT03189524|58801204|FG000|Overall Study|Lost to Follow-up|1|||
30787839|NCT03189524|58801205|FG001|Overall Study|Lost to Follow-up|0|||
30787840|NCT03189524|58801206|FG002|Overall Study|Lost to Follow-up|8|||
30787841|NCT03189524|58801204|FG000|Overall Study|Withdrawal by Subject|1|||
30787842|NCT03189524|58801205|FG001|Overall Study|Withdrawal by Subject|1|||
30787843|NCT03189524|58801206|FG002|Overall Study|Withdrawal by Subject|3|||
30787844|NCT03189524|58801204|FG000|Overall Study|Progressive Disease|0|||
30787845|NCT03189524|58801205|FG001|Overall Study|Progressive Disease|2|||
30787846|NCT03189524|58801206|FG002|Overall Study|Progressive Disease|0|||
30787847|NCT03600909|58801221|FG000|Overall Study|Not treated|0|||
30787848|NCT03600909|58801222|FG001|Overall Study|Not treated|3|||
30787849|NCT03600909|58801223|FG002|Overall Study|Not treated|0|||
30787850|NCT03189446|58801231|FG000|Overall Study|Adverse Event|2|||
30787851|NCT03189446|58801231|FG000|Overall Study|Withdrawal by Subject|2|||
30787852|NCT03189446|58801231|FG000|Overall Study|Physician Decision|1|||
30787853|NCT03212690|58801235|FG000|Overall Study|Protocol Violation|1|||
30787854|NCT03568461|58801239|FG000|Overall Study|Death|7|||
30787855|NCT03568461|58801239|FG000|Overall Study|Physician Decision|5|||
30787856|NCT03568461|58801239|FG000|Overall Study|Subject decision|5|||
30787857|NCT03568461|58801239|FG000|Overall Study|Lost to Follow-up|1|||
30787858|NCT03188120|58801243|FG000|Overall Study|Adverse Event|4|||
30787859|NCT03188120|58801243|FG000|Overall Study|Insufficient Effectiveness|8|||
30787860|NCT03188120|58801243|FG000|Overall Study|Improved|12|||
30787861|NCT03188120|58801243|FG000|Overall Study|Lost to Follow-up|7|||
30787862|NCT03188120|58801243|FG000|Overall Study|Other than specified|3|||
30787863|NCT03188120|58801243|FG000|Overall Study|No visit after the first visit|13|||
30787864|NCT02895945|58801249|FG000|Overall Study|Physician Decision|2|||
30787865|NCT02895945|58801250|FG001|Overall Study|Physician Decision|1|||
30787866|NCT02777554|58801258|FG000|Overall Study|Adverse Event|4|||
30787867|NCT02777554|58801259|FG001|Overall Study|Adverse Event|4|||
30787868|NCT02777554|58801260|FG002|Overall Study|Adverse Event|0|||
30787869|NCT02777554|58801261|FG003|Overall Study|Adverse Event|1|||
30787870|NCT02777554|58801262|FG004|Overall Study|Adverse Event|0|||
30967433|NCT01513460|59037404|FG002|Overall Study|Death|1|||
30697595|NCT00768989|58711899|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
30787871|NCT02777554|58801263|FG005|Overall Study|Adverse Event|0|||
30787872|NCT02777554|58801258|FG000|Overall Study|Withdrawal by Subject|3|||
30787873|NCT02777554|58801259|FG001|Overall Study|Withdrawal by Subject|1|||
30967434|NCT01513460|59037402|FG000|Overall Study|Lost to Follow-up|0|||
30787874|NCT02777554|58801260|FG002|Overall Study|Withdrawal by Subject|1|||
30787875|NCT02777554|58801261|FG003|Overall Study|Withdrawal by Subject|0|||
30787876|NCT02777554|58801262|FG004|Overall Study|Withdrawal by Subject|0|||
30787877|NCT02777554|58801263|FG005|Overall Study|Withdrawal by Subject|0|||
30787878|NCT02777554|58801258|FG000|Overall Study|Discharged early due to hurricane|22|||
30787879|NCT02777554|58801259|FG001|Overall Study|Discharged early due to hurricane|20|||
30877644|NCT01998880|58909169|FG000|Overall Study|Insufficient Therapeutic Response|1|||
30877645|NCT01998880|58909170|FG001|Overall Study|Insufficient Therapeutic Response|5|||
30877646|NCT01998880|58909169|FG000|Overall Study|Administrative/Other|1|||
30877647|NCT01998880|58909170|FG001|Overall Study|Administrative/Other|1|||
30877648|NCT01998880|58909169|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
30877649|NCT01998880|58909170|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
30877650|NCT01998880|58909169|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
30877651|NCT01998880|58909170|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
30877652|NCT01998880|58909169|FG000|Overall Study|Did Not Receive Treatment|3|||
30877653|NCT01998880|58909170|FG001|Overall Study|Did Not Receive Treatment|2|||
30877654|NCT01975948|58909180|FG000|Overall Study|Withdrawal by Subject|17|||
30877655|NCT01975948|58909181|FG001|Overall Study|Withdrawal by Subject|21|||
30877656|NCT01975948|58909182|FG002|Overall Study|Withdrawal by Subject|7|||
30877657|NCT01975948|58909183|FG003|Overall Study|Withdrawal by Subject|6|||
30877658|NCT01975246|58909195|FG000|Overall Study|Adverse Event|2|||
30877659|NCT01975246|58909196|FG001|Overall Study|Adverse Event|1|||
30787880|NCT02777554|58801260|FG002|Overall Study|Discharged early due to hurricane|0|||
30787881|NCT02777554|58801261|FG003|Overall Study|Discharged early due to hurricane|0|||
30787882|NCT02777554|58801262|FG004|Overall Study|Discharged early due to hurricane|0|||
30787883|NCT02777554|58801263|FG005|Overall Study|Discharged early due to hurricane|0|||
30787884|NCT02777554|58801258|FG000|Overall Study|Other - Miscellaneous|1|||
30787885|NCT02777554|58801259|FG001|Overall Study|Other - Miscellaneous|0|||
30787886|NCT02777554|58801260|FG002|Overall Study|Other - Miscellaneous|0|||
30787887|NCT02777554|58801261|FG003|Overall Study|Other - Miscellaneous|0|||
30787888|NCT02777554|58801262|FG004|Overall Study|Other - Miscellaneous|0|||
30787889|NCT02777554|58801263|FG005|Overall Study|Other - Miscellaneous|0|||
30877660|NCT01975246|58909195|FG000|Overall Study|Lack of Efficacy|1|||
30877661|NCT01975246|58909196|FG001|Overall Study|Lack of Efficacy|0|||
30877662|NCT01975246|58909195|FG000|Overall Study|Protocol Violation|1|||
30877663|NCT01975246|58909196|FG001|Overall Study|Protocol Violation|0|||
30877664|NCT01975246|58909195|FG000|Overall Study|Other than stated|0|||
30877665|NCT01975246|58909196|FG001|Overall Study|Other than stated|1|||
30877666|NCT01621126|58909202|FG000|Overall Study|Physician Decision|6|||
30877667|NCT01973998|58909208|FG000|Overall Study|Death|2|||
30877668|NCT01973998|58909209|FG001|Overall Study|Death|2|||
30877669|NCT02664415|58909217|FG000|Overall Study|Adverse Event|1|||
30877670|NCT02664415|58909218|FG001|Overall Study|Adverse Event|0|||
30877671|NCT02661061|58909226|FG000|Overall Study|Lack of Efficacy|1|||
30877672|NCT02661061|58909227|FG001|Overall Study|Lack of Efficacy|1|||
30877673|NCT02661061|58909226|FG000|Overall Study|Withdrawal by Subject|1|||
30877674|NCT02661061|58909227|FG001|Overall Study|Withdrawal by Subject|1|||
30787890|NCT03550209|58801287|FG000|Overall Study|Lost to Follow-up|1|||
30787891|NCT03550209|58801288|FG001|Overall Study|Lost to Follow-up|0|||
30787892|NCT03550209|58801289|FG002|Overall Study|Lost to Follow-up|1|||
30787893|NCT03550209|58801290|FG003|Overall Study|Lost to Follow-up|0|||
30787894|NCT03550209|58801287|FG000|Overall Study|Withdrawal by Subject|0|||
30787895|NCT03550209|58801288|FG001|Overall Study|Withdrawal by Subject|3|||
30787896|NCT03550209|58801289|FG002|Overall Study|Withdrawal by Subject|1|||
30787897|NCT03550209|58801290|FG003|Overall Study|Withdrawal by Subject|2|||
30787898|NCT03550209|58801287|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
30787899|NCT03550209|58801288|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
30877675|NCT01995838|58909240|FG000|Overall Study|Lost to Follow-up|0|||
30877676|NCT01995838|58909241|FG001|Overall Study|Lost to Follow-up|1|||
30877677|NCT01995838|58909242|FG002|Overall Study|Lost to Follow-up|0|||
30877678|NCT01995838|58909243|FG003|Overall Study|Lost to Follow-up|0|||
30967435|NCT01513460|59037403|FG001|Overall Study|Lost to Follow-up|0|||
30787900|NCT03550209|58801289|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
30787901|NCT03550209|58801290|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
30787902|NCT03032510|58801302|FG000|Overall Study|Adverse Event|5|||
30787903|NCT03032510|58801303|FG001|Overall Study|Adverse Event|2|||
30787904|NCT03032510|58801302|FG000|Overall Study|Lost to Follow-up|8|||
30787905|NCT03032510|58801303|FG001|Overall Study|Lost to Follow-up|7|||
30787906|NCT03032510|58801302|FG000|Overall Study|Withdrawal by Subject|8|||
30787907|NCT03032510|58801303|FG001|Overall Study|Withdrawal by Subject|7|||
30877679|NCT01995838|58909244|FG004|Overall Study|Lost to Follow-up|0|||
30877680|NCT01995838|58909245|FG005|Overall Study|Lost to Follow-up|0|||
30877681|NCT01995838|58909246|FG006|Overall Study|Lost to Follow-up|1|||
30877682|NCT01995838|58909240|FG000|Overall Study|Participant choice|2|||
30877683|NCT01995838|58909241|FG001|Overall Study|Participant choice|0|||
30877684|NCT01995838|58909242|FG002|Overall Study|Participant choice|0|||
30877685|NCT01995838|58909243|FG003|Overall Study|Participant choice|0|||
30967436|NCT01513460|59037404|FG002|Overall Study|Lost to Follow-up|2|||
30967437|NCT01513460|59037402|FG000|Overall Study|Abnormal laboratory value|1|||
30967438|NCT01513460|59037403|FG001|Overall Study|Abnormal laboratory value|0|||
30967439|NCT01513460|59037404|FG002|Overall Study|Abnormal laboratory value|1|||
30967440|NCT01513460|59037402|FG000|Overall Study|Lack of Efficacy|1|||
30967441|NCT01513460|59037403|FG001|Overall Study|Lack of Efficacy|2|||
30967442|NCT01513460|59037404|FG002|Overall Study|Lack of Efficacy|5|||
30967443|NCT01513460|59037402|FG000|Overall Study|Protocol deviations|3|||
30967444|NCT01513460|59037403|FG001|Overall Study|Protocol deviations|4|||
30967445|NCT01513460|59037404|FG002|Overall Study|Protocol deviations|3|||
30967446|NCT01513460|59037402|FG000|Overall Study|Withdrawal by Subject|7|||
30967447|NCT01513460|59037403|FG001|Overall Study|Withdrawal by Subject|8|||
30967448|NCT01513460|59037404|FG002|Overall Study|Withdrawal by Subject|21|||
30967449|NCT01513460|59037402|FG000|Overall Study|Adverse Event|16|||
30967450|NCT01513460|59037403|FG001|Overall Study|Adverse Event|18|||
30967451|NCT01513460|59037404|FG002|Overall Study|Adverse Event|23|||
30967452|NCT01513460|59037402|FG000|Overall Study|Abnormal test procedure|1|||
30967453|NCT01513460|59037403|FG001|Overall Study|Abnormal test procedure|0|||
30967454|NCT01513460|59037404|FG002|Overall Study|Abnormal test procedure|0|||
30967455|NCT01392547|59037414|FG000|Overall Study|Adverse Event|2|||
30967456|NCT01392547|59037414|FG000|Overall Study|Non-compliance|2|||
30967457|NCT01392547|59037414|FG000|Overall Study|Withdrawal criteria|3|||
30967458|NCT01392547|59037414|FG000|Overall Study|Unclassified|1|||
30967459|NCT01435655|59037420|FG000|Overall Study|Death|2|||
30967460|NCT01435655|59037420|FG000|Overall Study|Other|1|||
30967461|NCT01434667|59037426|FG000|Overall Study|Lost to Follow-up|5|||
30967462|NCT01434667|59037427|FG001|Overall Study|Lost to Follow-up|10|||
30967463|NCT01513148|59037435|FG000|Overall Study|Protocol Violation|2|||
30967464|NCT01513148|59037436|FG001|Overall Study|Protocol Violation|2|||
30967465|NCT01418339|59037484|FG000|Overall Study|Adverse Event|5|||
30967466|NCT01418339|59037485|FG001|Overall Study|Adverse Event|2|||
30967467|NCT01418339|59037484|FG000|Overall Study|Subject Withdrew Consent|1|||
30967468|NCT01418339|59037485|FG001|Overall Study|Subject Withdrew Consent|2|||
30967469|NCT01418339|59037484|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
30967470|NCT01418339|59037485|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
30967471|NCT01512368|59037491|FG000|Overall Study|Protocol Violation|3|||
30967472|NCT01412983|59037495|FG000|1st Period|Ineligible|0|||
30967473|NCT01412983|59037496|FG001|1st Period|Ineligible|1|||
30967474|NCT01412983|59037495|FG000|1st Period|Positive slit lamp finding|0|||
30967475|NCT01412983|59037496|FG001|1st Period|Positive slit lamp finding|1|||
30967476|NCT01412983|59037495|FG000|1st Period|Unacceptable lens movement|0|||
30967477|NCT01412983|59037496|FG001|1st Period|Unacceptable lens movement|1|||
30967478|NCT01412983|59037495|FG000|1st Period|Inability to maintain wear|0|||
30967479|NCT01412983|59037496|FG001|1st Period|Inability to maintain wear|1|||
30967480|NCT01417481|59037505|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
30967481|NCT01417481|59037506|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
30967482|NCT01392469|59037512|FG000|Overall Study|Adverse Event|2|||
30967483|NCT01392469|59037512|FG000|Overall Study|Withdrawal by Subject|1|||
30967484|NCT01392469|59037512|FG000|Overall Study|Protocol Violation|1|||
30967485|NCT01435577|59037529|FG000|Overall Study|Adverse Event|10|||
30967486|NCT01435577|59037530|FG001|Overall Study|Adverse Event|0|||
30967487|NCT01435577|59037529|FG000|Overall Study|Lack of Efficacy|7|||
30967488|NCT01435577|59037530|FG001|Overall Study|Lack of Efficacy|51|||
30967489|NCT01435577|59037529|FG000|Overall Study|Alternative treatment started|0|||
30967490|NCT01435577|59037530|FG001|Overall Study|Alternative treatment started|1|||
30877686|NCT01995838|58909244|FG004|Overall Study|Participant choice|0|||
30877687|NCT01995838|58909245|FG005|Overall Study|Participant choice|1|||
30877688|NCT01995838|58909246|FG006|Overall Study|Participant choice|1|||
30877689|NCT01995838|58909240|FG000|Overall Study|Adverse Event|0|||
30877690|NCT01995838|58909241|FG001|Overall Study|Adverse Event|0|||
30877691|NCT01995838|58909242|FG002|Overall Study|Adverse Event|0|||
30877692|NCT01995838|58909243|FG003|Overall Study|Adverse Event|0|||
30877693|NCT01995838|58909244|FG004|Overall Study|Adverse Event|0|||
30967491|NCT01411891|59037542|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
30967492|NCT01411891|59037543|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
30967493|NCT01416389|59037551|FG000|Overall Study|Lost to Follow-up|1|||
30967494|NCT01416389|59037552|FG001|Overall Study|Lost to Follow-up|0|||
30967495|NCT01416389|59037551|FG000|Overall Study|Started New Therapy|2|||
30967496|NCT01416389|59037552|FG001|Overall Study|Started New Therapy|0|||
30877694|NCT01995838|58909245|FG005|Overall Study|Adverse Event|0|||
30877695|NCT01995838|58909246|FG006|Overall Study|Adverse Event|1|||
30877696|NCT01995838|58909240|FG000|Overall Study|Withdrawal by Subject|0|||
30967497|NCT01544348|59037568|FG000|Overall Study|Lost to Follow-up|1|||
30967498|NCT01544348|59037569|FG001|Overall Study|Lost to Follow-up|0|||
30967499|NCT01544348|59037570|FG002|Overall Study|Lost to Follow-up|0|||
30967500|NCT01544348|59037571|FG003|Overall Study|Lost to Follow-up|0|||
30967501|NCT01544348|59037572|FG004|Overall Study|Lost to Follow-up|0|||
30967502|NCT01544348|59037573|FG005|Overall Study|Lost to Follow-up|0|||
30967503|NCT01544348|59037574|FG006|Overall Study|Lost to Follow-up|1|||
30967504|NCT01544348|59037575|FG007|Overall Study|Lost to Follow-up|0|||
30967505|NCT01544348|59037568|FG000|Overall Study|Withdrawal by Subject|1|||
30967506|NCT01544348|59037569|FG001|Overall Study|Withdrawal by Subject|0|||
30967507|NCT01544348|59037570|FG002|Overall Study|Withdrawal by Subject|0|||
30967508|NCT01544348|59037571|FG003|Overall Study|Withdrawal by Subject|0|||
30967509|NCT01544348|59037572|FG004|Overall Study|Withdrawal by Subject|1|||
30967510|NCT01544348|59037573|FG005|Overall Study|Withdrawal by Subject|2|||
30967511|NCT01544348|59037574|FG006|Overall Study|Withdrawal by Subject|1|||
30967512|NCT01544348|59037575|FG007|Overall Study|Withdrawal by Subject|0|||
30967513|NCT01544348|59037568|FG000|Overall Study|Physician Decision|0|||
30967514|NCT01544348|59037569|FG001|Overall Study|Physician Decision|0|||
30967515|NCT01544348|59037570|FG002|Overall Study|Physician Decision|0|||
30967516|NCT01544348|59037571|FG003|Overall Study|Physician Decision|0|||
30967517|NCT01544348|59037572|FG004|Overall Study|Physician Decision|0|||
30967518|NCT01544348|59037573|FG005|Overall Study|Physician Decision|1|||
30967519|NCT01544348|59037574|FG006|Overall Study|Physician Decision|0|||
30967520|NCT01544348|59037575|FG007|Overall Study|Physician Decision|0|||
30967521|NCT01416155|59037600|FG000|Overall Study|Adverse Event|8|||
30967522|NCT01416155|59037600|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
30967523|NCT01416155|59037600|FG000|Overall Study|Withdrawal by Subject|33|||
30967524|NCT01416155|59037600|FG000|Overall Study|Investigator decision|8|||
30967525|NCT01416155|59037600|FG000|Overall Study|Other|7|||
30967526|NCT01415921|59037606|FG000|Overall Study|Adverse Event|0|||
30967527|NCT01415921|59037607|FG001|Overall Study|Adverse Event|1|||
30967528|NCT01415921|59037606|FG000|Overall Study|Physician Decision|1|||
30967529|NCT01415921|59037607|FG001|Overall Study|Physician Decision|1|||
30967530|NCT01415921|59037606|FG000|Overall Study|Withdrawal by Subject|0|||
30967531|NCT01415921|59037607|FG001|Overall Study|Withdrawal by Subject|1|||
30967532|NCT01415921|59037606|FG000|Overall Study|Other|2|||
30967533|NCT01415921|59037607|FG001|Overall Study|Other|0|||
30967534|NCT01415531|59037615|FG000|Overall Study|Adverse Event|7|||
30967535|NCT01415531|59037616|FG001|Overall Study|Adverse Event|10|||
30967536|NCT01415531|59037615|FG000|Overall Study|Lack of Efficacy|3|||
30967537|NCT01415531|59037616|FG001|Overall Study|Lack of Efficacy|2|||
30967538|NCT01415531|59037615|FG000|Overall Study|Protocol Violation|0|||
30967539|NCT01415531|59037616|FG001|Overall Study|Protocol Violation|1|||
30967540|NCT01415531|59037615|FG000|Overall Study|Withdrawal by Subject|5|||
30967541|NCT01415531|59037616|FG001|Overall Study|Withdrawal by Subject|4|||
30967542|NCT01415531|59037615|FG000|Overall Study|Lost to Follow-up|6|||
30967543|NCT01415531|59037616|FG001|Overall Study|Lost to Follow-up|14|||
30967544|NCT01415531|59037615|FG000|Overall Study|Lack of Compliance|1|||
30967545|NCT01415531|59037616|FG001|Overall Study|Lack of Compliance|4|||
30967546|NCT01415531|59037615|FG000|Overall Study|Other Reasons|3|||
30967547|NCT01415531|59037616|FG001|Overall Study|Other Reasons|2|||
30967548|NCT01544114|59037625|FG000|Overall Study|Withdrawal by Subject|0|||
30967549|NCT01544114|59037626|FG001|Overall Study|Withdrawal by Subject|0|||
30967550|NCT01544114|59037627|FG002|Overall Study|Withdrawal by Subject|3|||
30967551|NCT01544114|59037625|FG000|Overall Study|Lost to Follow-up|0|||
30760585|NCT03381274|58769074|FG004|Overall Study|Death|3|||
30787908|NCT03032510|58801302|FG000|Overall Study|Subject noncompliance|4|||
30787909|NCT03032510|58801303|FG001|Overall Study|Subject noncompliance|2|||
30787910|NCT03032510|58801302|FG000|Overall Study|Physician Decision|2|||
30787911|NCT03032510|58801303|FG001|Overall Study|Physician Decision|0|||
30787912|NCT03599349|58801313|FG000|Overall Study|Lost to Follow-up|1|||
30787913|NCT03599193|58801323|FG000|Overall Study|Adverse Event|0|||
30787914|NCT03599193|58801324|FG001|Overall Study|Adverse Event|2|||
30787915|NCT03599193|58801323|FG000|Overall Study|Withdrawal by Subject|1|||
30787916|NCT03599193|58801324|FG001|Overall Study|Withdrawal by Subject|0|||
30787917|NCT03599193|58801323|FG000|Overall Study|Protocol Violation|1|||
30787918|NCT03599193|58801324|FG001|Overall Study|Protocol Violation|0|||
30787919|NCT03599193|58801323|FG000|Overall Study|Lost to Follow-up|0|||
30787920|NCT03599193|58801324|FG001|Overall Study|Lost to Follow-up|1|||
30787921|NCT03166124|58801333|FG000|Treatment Period 1|Adverse Event|0|||
30967552|NCT01544114|59037626|FG001|Overall Study|Lost to Follow-up|2|||
30967553|NCT01544114|59037627|FG002|Overall Study|Lost to Follow-up|0|||
30967554|NCT01544114|59037625|FG000|Overall Study|Adverse Event|1|||
30967555|NCT01544114|59037626|FG001|Overall Study|Adverse Event|1|||
30967556|NCT01544114|59037627|FG002|Overall Study|Adverse Event|2|||
30967557|NCT01544114|59037625|FG000|Overall Study|Protocol Violation|0|||
30967558|NCT01544114|59037626|FG001|Overall Study|Protocol Violation|1|||
30967559|NCT01544114|59037627|FG002|Overall Study|Protocol Violation|0|||
30967560|NCT01435265|59037639|FG000|Overall Study|Lost to Follow-up|0|||
30967561|NCT01435265|59037640|FG001|Overall Study|Lost to Follow-up|1|||
30967562|NCT01433263|59037648|FG000|Overall Study|Adverse Event|3|||
30967563|NCT01433263|59037649|FG001|Overall Study|Adverse Event|1|||
30787922|NCT03166124|58801334|FG001|Treatment Period 1|Adverse Event|0|||
30787923|NCT03166124|58801335|FG002|Treatment Period 1|Adverse Event|1|||
30967564|NCT01433263|59037648|FG000|Overall Study|Death|5|||
30967565|NCT01433263|59037649|FG001|Overall Study|Death|3|||
30967566|NCT01433263|59037648|FG000|Overall Study|Lost to Follow-up|0|||
30967567|NCT01433263|59037649|FG001|Overall Study|Lost to Follow-up|1|||
30967568|NCT01433263|59037648|FG000|Overall Study|Protocol Deviation|1|||
30967569|NCT01433263|59037649|FG001|Overall Study|Protocol Deviation|0|||
30967570|NCT01433263|59037648|FG000|Overall Study|Withdrawal by Subject|10|||
30967571|NCT01433263|59037649|FG001|Overall Study|Withdrawal by Subject|7|||
30967572|NCT01432951|59037658|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
30967573|NCT01432327|59037667|FG000|Posttest 3 Months|depression|3|||
30967574|NCT01432327|59037668|FG001|Posttest 3 Months|depression|0|||
30967575|NCT01432327|59037669|FG002|Posttest 3 Months|depression|0|||
30967576|NCT01432327|59037670|FG003|Posttest 3 Months|depression|0|||
30967577|NCT01432327|59037667|FG000|Posttest 3 Months|Lost to Follow-up|1|||
30967578|NCT01432327|59037668|FG001|Posttest 3 Months|Lost to Follow-up|0|||
30967579|NCT01432327|59037669|FG002|Posttest 3 Months|Lost to Follow-up|2|||
30967580|NCT01432327|59037670|FG003|Posttest 3 Months|Lost to Follow-up|1|||
30967581|NCT01432327|59037667|FG000|Posttest 3 Months|Allergic reaction|0|||
30967582|NCT01432327|59037668|FG001|Posttest 3 Months|Allergic reaction|2|||
30967583|NCT01432327|59037669|FG002|Posttest 3 Months|Allergic reaction|0|||
30967584|NCT01432327|59037670|FG003|Posttest 3 Months|Allergic reaction|0|||
30967585|NCT01432327|59037667|FG000|Posttest 6 Months|Lost to Follow-up|0|||
30967586|NCT01432327|59037668|FG001|Posttest 6 Months|Lost to Follow-up|0|||
30967587|NCT01432327|59037669|FG002|Posttest 6 Months|Lost to Follow-up|3|||
30967588|NCT01432327|59037670|FG003|Posttest 6 Months|Lost to Follow-up|2|||
30967589|NCT01432327|59037667|FG000|Posttest 6 Months|Allergic reaction|0|||
30967590|NCT01432327|59037668|FG001|Posttest 6 Months|Allergic reaction|0|||
30967591|NCT01432327|59037669|FG002|Posttest 6 Months|Allergic reaction|1|||
30967592|NCT01432327|59037670|FG003|Posttest 6 Months|Allergic reaction|0|||
30967593|NCT01432327|59037667|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
30967594|NCT01432327|59037668|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
30967595|NCT01432327|59037669|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
30967596|NCT01432327|59037670|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
30967597|NCT01432327|59037667|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
30967598|NCT01432327|59037668|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
30967599|NCT01432327|59037669|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
30967600|NCT01432327|59037670|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
30967601|NCT01432327|59037667|FG000|Posttest 1 Year|Lost to Follow-up|0|||
30967602|NCT01432327|59037668|FG001|Posttest 1 Year|Lost to Follow-up|0|||
30967603|NCT01432327|59037669|FG002|Posttest 1 Year|Lost to Follow-up|4|||
30967604|NCT01432327|59037670|FG003|Posttest 1 Year|Lost to Follow-up|2|||
30967605|NCT01432327|59037667|FG000|Posttest 1 Year|Allergic reaction|0|||
30967606|NCT01432327|59037668|FG001|Posttest 1 Year|Allergic reaction|0|||
30967607|NCT01432327|59037669|FG002|Posttest 1 Year|Allergic reaction|1|||
30967608|NCT01432327|59037670|FG003|Posttest 1 Year|Allergic reaction|1|||
30967609|NCT01410799|59037680|FG000|Overall Study|PI decision|13|||
30967610|NCT01432171|59037686|FG000|Overall Study|Death|1|||
30967611|NCT01432171|59037687|FG001|Overall Study|Death|2|||
30967612|NCT01432171|59037686|FG000|Overall Study|Lost to Follow-up|6|||
30967613|NCT01432171|59037687|FG001|Overall Study|Lost to Follow-up|5|||
30967614|NCT01432171|59037686|FG000|Overall Study|Withdrawal by Subject|3|||
30967615|NCT01432171|59037687|FG001|Overall Study|Withdrawal by Subject|1|||
30967616|NCT01432171|59037686|FG000|Overall Study|Noncompliance|2|||
30967617|NCT01432171|59037687|FG001|Overall Study|Noncompliance|3|||
30967618|NCT01432171|59037686|FG000|Overall Study|Insurance denial trial coverage|1|||
30967619|NCT01432171|59037687|FG001|Overall Study|Insurance denial trial coverage|0|||
30967620|NCT01432171|59037686|FG000|Overall Study|Patient moved to palliative care|1|||
30967621|NCT01432171|59037687|FG001|Overall Study|Patient moved to palliative care|0|||
30967622|NCT01435031|59037697|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
30967623|NCT01435031|59037697|FG000|ITT at 1 Month|Death|1|||
30967624|NCT01435031|59037697|FG000|ITT at 1 Month|Lost to Follow-up|4|||
30967625|NCT01435031|59037697|FG000|ITT at 6 Months|Death|2|||
30948400|NCT01729819|58994257|FG001|Overall Study|Lost to Follow-up|0|||
30967626|NCT01435031|59037697|FG000|ITT at 6 Months|Lost to Follow-up|3|||
30967627|NCT01435031|59037697|FG000|ITT at 1 Year|Death|1|||
30967628|NCT01435031|59037697|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
30967629|NCT01435031|59037697|FG000|ITT at 1 Year|Lost to Follow-up|6|||
30967630|NCT01435031|59037697|FG000|ITT at 2 Years|Death|7|||
30967631|NCT01435031|59037697|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
30967632|NCT01435031|59037697|FG000|ITT at 2 Years|Lost to Follow-up|4|||
30967633|NCT01435031|59037697|FG000|ITT at 3 Years|Death|5|||
30967634|NCT01435031|59037697|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
30967635|NCT01435031|59037697|FG000|ITT at 3 Years|Lost to Follow-up|4|||
30967636|NCT01435031|59037697|FG000|ITT at 4 Years|Death|4|||
30967637|NCT01435031|59037697|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
30967638|NCT01435031|59037697|FG000|ITT at 4 Years|Lost to Follow-up|1|||
30967639|NCT01433549|59037701|FG000|Phase 2: Second Study Product|Adverse Event|0|||
30967640|NCT01433549|59037702|FG001|Phase 2: Second Study Product|Adverse Event|1|||
30967641|NCT01414205|59037710|FG000|Overall Study|Death|5|||
30967642|NCT01414205|59037711|FG001|Overall Study|Death|1|||
30967643|NCT01414205|59037710|FG000|Overall Study|Lost to Follow-up|1|||
30967644|NCT01414205|59037711|FG001|Overall Study|Lost to Follow-up|4|||
30967645|NCT01414205|59037710|FG000|Overall Study|Physician Decision|0|||
30967646|NCT01414205|59037711|FG001|Overall Study|Physician Decision|1|||
30967647|NCT01414205|59037710|FG000|Overall Study|Randomized but not Treated|1|||
30967648|NCT01414205|59037711|FG001|Overall Study|Randomized but not Treated|1|||
30608000|NCT01290692|58618682|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
30608001|NCT00700882|58618718|FG000|Overall Study|Never received treatment|6|||
30608002|NCT00700882|58618718|FG000|Overall Study|Ineligible|2|||
30608003|NCT00700882|58618718|FG000|Overall Study|No KIT mutation|51|||
30608004|NCT00666835|58618756|FG000|Overall Study|Withdrawal by Subject|5|||
30608005|NCT00666835|58618757|FG001|Overall Study|Withdrawal by Subject|2|||
30608006|NCT00666835|58618756|FG000|Overall Study|Lack of Efficacy|0|||
30608007|NCT00666835|58618757|FG001|Overall Study|Lack of Efficacy|1|||
30608008|NCT00666835|58618756|FG000|Overall Study|Incl./excl. not fulfilled|7|||
30608009|NCT00666835|58618757|FG001|Overall Study|Incl./excl. not fulfilled|2|||
30608010|NCT00666835|58618756|FG000|Overall Study|Adverse Event|7|||
30608011|NCT00666835|58618757|FG001|Overall Study|Adverse Event|6|||
30608012|NCT00666835|58618756|FG000|Overall Study|Protocol Violation|2|||
30608013|NCT00666835|58618757|FG001|Overall Study|Protocol Violation|0|||
30608014|NCT00666835|58618756|FG000|Overall Study|Death|15|||
30608015|NCT00666835|58618757|FG001|Overall Study|Death|4|||
30608016|NCT00666835|58618756|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
30608017|NCT00666835|58618757|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
30608018|NCT00666835|58618756|FG000|Overall Study|Hemoglobulin concentration|4|||
30608019|NCT00666835|58618757|FG001|Overall Study|Hemoglobulin concentration|3|||
30608020|NCT00666835|58618756|FG000|Overall Study|Planned operation|2|||
30608021|NCT00666835|58618757|FG001|Overall Study|Planned operation|0|||
30608022|NCT00666835|58618756|FG000|Overall Study|Physician Decision|1|||
30608023|NCT00666835|58618757|FG001|Overall Study|Physician Decision|2|||
30608024|NCT00551759|58618764|FG000|Overall Study|Adverse Event|7|||
30608025|NCT00551759|58618764|FG000|Overall Study|Death|5|||
30608026|NCT00551759|58618764|FG000|Overall Study|Ineligible|1|||
30608027|NCT00335140|58618768|FG000|Overall Study|Ineligible|1|||
30608028|NCT00304239|58618774|FG000|Overall Study|Protocol Deviations/Violations|15|||
30608029|NCT00304239|58618775|FG001|Overall Study|Protocol Deviations/Violations|0|||
30608030|NCT00304239|58618774|FG000|Overall Study|Adverse Event|2|||
30608031|NCT00304239|58618775|FG001|Overall Study|Adverse Event|0|||
30608032|NCT00101283|58618783|FG000|Overall Study|Withdrawal by Subject|0|||
30608033|NCT00101283|58618784|FG001|Overall Study|Withdrawal by Subject|1|||
30608034|NCT00101283|58618783|FG000|Overall Study|Insurance Refusal|0|||
30608035|NCT00101283|58618784|FG001|Overall Study|Insurance Refusal|1|||
30608036|NCT00101283|58618783|FG000|Overall Study|Prostate Cancer Recurrence|0|||
30608037|NCT00101283|58618784|FG001|Overall Study|Prostate Cancer Recurrence|1|||
30608038|NCT01302041|58618790|FG000|Overall Study|Death|5|||
30608039|NCT01302041|58618790|FG000|Overall Study|Withdrawal by Subject|4|||
30608040|NCT01302041|58618790|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
30608041|NCT01302041|58618790|FG000|Overall Study|Other-Miscellaneous Reason|2|||
30608042|NCT01301729|58618795|FG000|Overall Study|Withdrawal by Subject|2|||
30608043|NCT01301729|58618795|FG000|Overall Study|Participant did not Return for Treatment|1|||
30608044|NCT01301729|58618795|FG000|Overall Study|Violated Selection Criteria|1|||
30608045|NCT01187043|58618805|FG000|Overall Study|Adverse Event|0|||
30608046|NCT01187043|58618806|FG001|Overall Study|Adverse Event|0|||
30608047|NCT01187043|58618807|FG002|Overall Study|Adverse Event|0|||
30608048|NCT01187043|58618808|FG003|Overall Study|Adverse Event|0|||
30608049|NCT01187043|58618809|FG004|Overall Study|Adverse Event|1|||
30608050|NCT01187043|58618805|FG000|Overall Study|Unable to make scheduled visits|1|||
30608051|NCT01187043|58618806|FG001|Overall Study|Unable to make scheduled visits|0|||
30608052|NCT01187043|58618807|FG002|Overall Study|Unable to make scheduled visits|4|||
30608053|NCT01187043|58618808|FG003|Overall Study|Unable to make scheduled visits|0|||
30608054|NCT01187043|58618809|FG004|Overall Study|Unable to make scheduled visits|1|||
30697596|NCT00768989|58711900|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
30697597|NCT00768989|58711899|FG000|On or After Week 36|Lack of Efficacy|1|||
30967649|NCT01433471|59037719|FG000|Overall Study|Withdrawal by Subject|0|||
30608055|NCT01186809|58618821|FG000|Overall Study|Death|30|||
30608056|NCT01186419|58618827|FG000|Overall Study|Withdrawal by Subject|5|||
30608057|NCT01186419|58618828|FG001|Overall Study|Withdrawal by Subject|3|||
30608058|NCT01186419|58618827|FG000|Overall Study|Adverse Event|1|||
30608059|NCT01186419|58618828|FG001|Overall Study|Adverse Event|2|||
30608060|NCT01186419|58618827|FG000|Overall Study|Physician Decision|0|||
30608061|NCT01186419|58618828|FG001|Overall Study|Physician Decision|3|||
30608062|NCT01186419|58618827|FG000|Overall Study|Other|1|||
30608063|NCT01186419|58618828|FG001|Overall Study|Other|1|||
30608064|NCT01301027|58618835|FG000|Overall Study|Physician Decision|2|||
30608065|NCT01301027|58618836|FG001|Overall Study|Physician Decision|0|||
30967650|NCT01433471|59037720|FG001|Overall Study|Withdrawal by Subject|1|||
30967651|NCT01433159|59037730|FG000|Overall Study|Adverse Event|1|||
30608066|NCT01301027|58618835|FG000|Overall Study|Withdrawal by Subject|2|||
30608067|NCT01301027|58618836|FG001|Overall Study|Withdrawal by Subject|3|||
30608068|NCT01301027|58618835|FG000|Overall Study|Adverse Event|0|||
30608069|NCT01301027|58618836|FG001|Overall Study|Adverse Event|2|||
30608070|NCT01301027|58618835|FG000|Overall Study|Fracture|1|||
30608071|NCT01301027|58618836|FG001|Overall Study|Fracture|3|||
30608072|NCT01301027|58618835|FG000|Overall Study|Transplant|0|||
30608073|NCT01301027|58618836|FG001|Overall Study|Transplant|2|||
30608074|NCT01301027|58618835|FG000|Overall Study|Volume Overload|3|||
30608075|NCT01301027|58618836|FG001|Overall Study|Volume Overload|0|||
30608076|NCT01185639|58618842|FG000|Overall Study|Progressed and didn't receive therapy|2|||
30608077|NCT01185561|58618848|FG000|Overall Study|Lost to Follow-up|0|||
30608078|NCT01185561|58618849|FG001|Overall Study|Lost to Follow-up|4|||
30608079|NCT01185561|58618848|FG000|Overall Study|Withdrawal by Subject|2|||
30697598|NCT00768989|58711900|FG001|On or After Week 36|Lack of Efficacy|0|||
30697599|NCT00768989|58711899|FG000|On or After Week 36|Adverse Event|0|||
30697600|NCT00768989|58711900|FG001|On or After Week 36|Adverse Event|1|||
30697601|NCT00768989|58711899|FG000|On or After Week 36|Lost to Follow-up|1|||
30697602|NCT00768989|58711900|FG001|On or After Week 36|Lost to Follow-up|0|||
30697603|NCT00768989|58711899|FG000|On or After Week 36|Poor Compliance|1|||
30697604|NCT00768989|58711900|FG001|On or After Week 36|Poor Compliance|0|||
30697605|NCT00768989|58711899|FG000|On or After Week 36|Protocol Violation|1|||
30697606|NCT00768989|58711900|FG001|On or After Week 36|Protocol Violation|0|||
30697607|NCT00768989|58711899|FG000|On or After Week 36|Did not attend termination visit|2|||
30697608|NCT00768989|58711900|FG001|On or After Week 36|Did not attend termination visit|0|||
30697609|NCT00768989|58711899|FG000|On or After Week 36|Sponsor Termination|45|||
30697610|NCT00768989|58711900|FG001|On or After Week 36|Sponsor Termination|26|||
30697611|NCT00305773|58711910|FG000|Overall Study|Death|3|||
30697612|NCT00305773|58711911|FG001|Overall Study|Death|2|||
30697613|NCT00305773|58711910|FG000|Overall Study|Adverse Event|1|||
30697614|NCT00305773|58711911|FG001|Overall Study|Adverse Event|2|||
30697615|NCT00305773|58711910|FG000|Overall Study|Alternative Treatment|4|||
30697616|NCT00305773|58711911|FG001|Overall Study|Alternative Treatment|4|||
30697617|NCT00305773|58711910|FG000|Overall Study|Physician Decision|1|||
30697618|NCT00305773|58711911|FG001|Overall Study|Physician Decision|1|||
30697619|NCT00305773|58711910|FG000|Overall Study|Withdrawal by Subject|1|||
30697620|NCT00305773|58711911|FG001|Overall Study|Withdrawal by Subject|4|||
30697621|NCT00305773|58711910|FG000|Overall Study|Disease Progression|1|||
30697622|NCT00305773|58711911|FG001|Overall Study|Disease Progression|3|||
30697623|NCT00305773|58711910|FG000|Overall Study|All other reasons|3|||
30697624|NCT00305773|58711911|FG001|Overall Study|All other reasons|2|||
30697625|NCT00305695|58711919|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
30697626|NCT00305695|58711920|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
30697627|NCT00305695|58711919|FG000|Overall Study|Did not have baseline scan|1|||
30697628|NCT00305695|58711920|FG001|Overall Study|Did not have baseline scan|1|||
30697629|NCT00647556|58711928|FG000|Overall Study|Adverse Event|0|||
30697630|NCT00647556|58711929|FG001|Overall Study|Adverse Event|1|||
30697631|NCT00647556|58711928|FG000|Overall Study|Lost to Follow-up|1|||
30697632|NCT00647556|58711929|FG001|Overall Study|Lost to Follow-up|0|||
30697633|NCT00647556|58711928|FG000|Overall Study|Protocol Violation|0|||
30697634|NCT00647556|58711929|FG001|Overall Study|Protocol Violation|1|||
30697635|NCT00647556|58711928|FG000|Overall Study|Withdrawal by Subject|1|||
30697636|NCT00647556|58711929|FG001|Overall Study|Withdrawal by Subject|0|||
30697637|NCT00647556|58711928|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
30697638|NCT00647556|58711929|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
30697639|NCT00320593|58711937|FG000|Overall Study|Lost to Follow-up|3|||
30697640|NCT00320593|58711938|FG001|Overall Study|Lost to Follow-up|0|||
30697641|NCT00320593|58711937|FG000|Overall Study|Moved to another state|1|||
30697642|NCT00320593|58711938|FG001|Overall Study|Moved to another state|0|||
30697643|NCT00320593|58711937|FG000|Overall Study|Withdrawal by Subject|2|||
30697644|NCT00320593|58711938|FG001|Overall Study|Withdrawal by Subject|1|||
30697645|NCT00320593|58711937|FG000|Overall Study|Withdrawal by clinical center|1|||
30697646|NCT00320593|58711938|FG001|Overall Study|Withdrawal by clinical center|0|||
30697647|NCT00320515|58711944|FG000|Overall Study|Death|33|||
30697648|NCT00320515|58711944|FG000|Overall Study|Lost to Follow-up|6|||
30697649|NCT00320515|58711944|FG000|Overall Study|Physician Decision|2|||
30697650|NCT00320515|58711944|FG000|Overall Study|Withdrawal by Subject|8|||
30697651|NCT00662012|58711948|FG000|Overall Study|Lost to Follow-up|85|||
30697652|NCT00662012|58711948|FG000|Overall Study|Death|1|||
30697653|NCT00662012|58711948|FG000|Overall Study|Withdrawal by Subject|1|||
30697654|NCT00661778|58711952|FG000|Overall Study|Disease Progression|23|||
30697655|NCT00661778|58711952|FG000|Overall Study|Adverse Event|18|||
30697656|NCT00661778|58711952|FG000|Overall Study|Reason not Specified|6|||
30697657|NCT00661778|58711952|FG000|Overall Study|Protocol Violation|2|||
30697658|NCT00661778|58711952|FG000|Overall Study|Withdrawal of Consent|1|||
30608080|NCT01185561|58618849|FG001|Overall Study|Withdrawal by Subject|8|||
30608081|NCT01185249|58618855|FG000|Overall Study|Patients discharged or change in status|42|||
30697659|NCT00319735|58711956|FG000|Overall Study|Death|2|||
30697660|NCT00653328|58711961|FG000|Overall Study|Withdrawal by Subject|1|||
30697661|NCT00653328|58711961|FG000|Overall Study|Adverse Event|2|||
30697662|NCT00653328|58711961|FG000|Overall Study|Disease progression|10|||
30697663|NCT00653328|58711961|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
30697664|NCT00642642|58711974|FG000|Treatment & Follow Up|Adverse Event|2|||
30697665|NCT00642642|58711974|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
30697666|NCT00642642|58711974|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
30697667|NCT00534352|58711984|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
30697668|NCT00534352|58711984|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
30697669|NCT00534352|58711984|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
30697670|NCT00534352|58711984|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
30697671|NCT00534352|58711984|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
30697672|NCT00534352|58711984|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
30697673|NCT00642174|58711999|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
30697674|NCT00642174|58712000|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
30697675|NCT00665366|58712008|FG000|Overall Study|Lack of Efficacy|11|||
30697676|NCT00665366|58712009|FG001|Overall Study|Lack of Efficacy|10|||
30697677|NCT00665366|58712008|FG000|Overall Study|Adverse Event|25|||
30697678|NCT00665366|58712009|FG001|Overall Study|Adverse Event|23|||
30697679|NCT00665366|58712008|FG000|Overall Study|Withdrawal by Subject|11|||
30697680|NCT00665366|58712009|FG001|Overall Study|Withdrawal by Subject|14|||
30697681|NCT00665366|58712008|FG000|Overall Study|Lost to Follow-up|3|||
30697682|NCT00665366|58712009|FG001|Overall Study|Lost to Follow-up|5|||
30697683|NCT00665366|58712008|FG000|Overall Study|Poor compliance/noncompliance|3|||
30697684|NCT00665366|58712009|FG001|Overall Study|Poor compliance/noncompliance|5|||
30697685|NCT00665366|58712008|FG000|Overall Study|Pregnancy|1|||
30697686|NCT00665366|58712009|FG001|Overall Study|Pregnancy|0|||
30697687|NCT00665366|58712008|FG000|Overall Study|No longer meets study criteria|0|||
30697688|NCT00665366|58712009|FG001|Overall Study|No longer meets study criteria|1|||
30697689|NCT00665366|58712008|FG000|Overall Study|Other reasons|4|||
30697690|NCT00665366|58712009|FG001|Overall Study|Other reasons|1|||
30697691|NCT00642018|58712039|FG000|Overall Study|Adverse Event|11|||
30697692|NCT00642018|58712040|FG001|Overall Study|Adverse Event|36|||
30697693|NCT00642018|58712039|FG000|Overall Study|Withdrawal by Subject|4|||
30697694|NCT00642018|58712040|FG001|Overall Study|Withdrawal by Subject|10|||
30697695|NCT00642018|58712039|FG000|Overall Study|Progressive Disease|13|||
30697696|NCT00642018|58712040|FG001|Overall Study|Progressive Disease|18|||
30697697|NCT00642018|58712039|FG000|Overall Study|Physician Decision|0|||
30697698|NCT00642018|58712040|FG001|Overall Study|Physician Decision|10|||
30697699|NCT00642018|58712039|FG000|Overall Study|Protocol Violation|0|||
30697700|NCT00642018|58712040|FG001|Overall Study|Protocol Violation|1|||
30697701|NCT00642018|58712039|FG000|Overall Study|Death|0|||
30697702|NCT00642018|58712040|FG001|Overall Study|Death|3|||
30697703|NCT00642018|58712039|FG000|Overall Study|Entry Criteria Not Met|0|||
30697704|NCT00642018|58712040|FG001|Overall Study|Entry Criteria Not Met|1|||
30697705|NCT00532948|58712050|FG000|Overall Study|Protocol Violation|1|||
30697706|NCT00532948|58712051|FG001|Overall Study|Protocol Violation|0|||
30697707|NCT00532948|58712052|FG002|Overall Study|Protocol Violation|0|||
30697708|NCT00532948|58712050|FG000|Overall Study|Death|3|||
30697709|NCT00532948|58712051|FG001|Overall Study|Death|3|||
30697710|NCT00532948|58712052|FG002|Overall Study|Death|4|||
30697711|NCT00532948|58712050|FG000|Overall Study|Violation of selection criteria at entry|0|||
30697712|NCT00532948|58712051|FG001|Overall Study|Violation of selection criteria at entry|1|||
30697713|NCT00532948|58712052|FG002|Overall Study|Violation of selection criteria at entry|0|||
30697714|NCT00532948|58712050|FG000|Overall Study|Failure to return|0|||
30697715|NCT00532948|58712051|FG001|Overall Study|Failure to return|1|||
30697716|NCT00532948|58712052|FG002|Overall Study|Failure to return|0|||
30697717|NCT00641706|58712066|FG000|Overall Study|Adverse Event|2|||
30697718|NCT00641706|58712067|FG001|Overall Study|Adverse Event|1|||
30697719|NCT00641706|58712066|FG000|Overall Study|Withdrawal by Subject|6|||
30697720|NCT00641706|58712067|FG001|Overall Study|Withdrawal by Subject|1|||
30697721|NCT00641706|58712066|FG000|Overall Study|Clinical Decline|1|||
30697722|NCT00641706|58712067|FG001|Overall Study|Clinical Decline|0|||
30697723|NCT00641706|58712066|FG000|Overall Study|Lead Investigator Decision|0|||
30697724|NCT00641706|58712067|FG001|Overall Study|Lead Investigator Decision|1|||
30697725|NCT00644358|58712073|FG000|Overall Study|Adverse Event|124|||
30697726|NCT00644358|58712073|FG000|Overall Study|Lost to Follow-up|105|||
30697727|NCT00644358|58712073|FG000|Overall Study|Consent Withdrawal|64|||
30697728|NCT00644358|58712073|FG000|Overall Study|Lack of Effectiveness|39|||
30697729|NCT00644358|58712073|FG000|Overall Study|Protocol Violation|5|||
30697730|NCT00644358|58712073|FG000|Overall Study|Noncompliance|14|||
30697731|NCT00644358|58712073|FG000|Overall Study|Other Unspecified|11|||
30697732|NCT00640926|58712080|FG000|Overall Study|Adverse Event|2|||
30697733|NCT00640926|58712081|FG001|Overall Study|Adverse Event|3|||
30697734|NCT00640926|58712082|FG002|Overall Study|Adverse Event|2|||
30697735|NCT00640926|58712080|FG000|Overall Study|Lack of Efficacy|0|||
30697736|NCT00640926|58712081|FG001|Overall Study|Lack of Efficacy|2|||
30697737|NCT00640926|58712082|FG002|Overall Study|Lack of Efficacy|1|||
30697738|NCT00640926|58712080|FG000|Overall Study|Protocol Violation|2|||
30697739|NCT00640926|58712081|FG001|Overall Study|Protocol Violation|0|||
30697740|NCT00640926|58712082|FG002|Overall Study|Protocol Violation|2|||
30697741|NCT00640926|58712080|FG000|Overall Study|Lost to Follow-up|3|||
30697742|NCT00640926|58712081|FG001|Overall Study|Lost to Follow-up|1|||
30697743|NCT00640926|58712082|FG002|Overall Study|Lost to Follow-up|2|||
30697744|NCT00640926|58712080|FG000|Overall Study|Withdrawal by Subject|1|||
30697745|NCT00640926|58712081|FG001|Overall Study|Withdrawal by Subject|0|||
30697746|NCT00640926|58712082|FG002|Overall Study|Withdrawal by Subject|1|||
30697747|NCT03892564|58712090|FG000|Overall Study|Withdrawal by Subject|2|||
30697748|NCT03891862|58712097|FG000|Open-label Period|Adverse Event|2|||
30697749|NCT03891862|58712098|FG001|Open-label Period|Adverse Event|0|||
30697750|NCT03891862|58712099|FG002|Open-label Period|Adverse Event|0|||
30697751|NCT03891862|58712097|FG000|Open-label Period|Protocol Violation|5|||
30697752|NCT03891862|58712098|FG001|Open-label Period|Protocol Violation|0|||
30697753|NCT03891862|58712099|FG002|Open-label Period|Protocol Violation|0|||
30697754|NCT03891862|58712097|FG000|Open-label Period|Withdrawal by Subject|6|||
30697755|NCT03891862|58712098|FG001|Open-label Period|Withdrawal by Subject|0|||
30697756|NCT03891862|58712099|FG002|Open-label Period|Withdrawal by Subject|0|||
30697757|NCT03891862|58712097|FG000|Open-label Period|Death|1|||
30697758|NCT03891862|58712098|FG001|Open-label Period|Death|0|||
30697759|NCT03891862|58712099|FG002|Open-label Period|Death|0|||
30697760|NCT03891862|58712097|FG000|Open-label Period|Lost to Follow-up|2|||
30697761|NCT03891862|58712098|FG001|Open-label Period|Lost to Follow-up|0|||
30697762|NCT03891862|58712099|FG002|Open-label Period|Lost to Follow-up|0|||
30697763|NCT03891862|58712097|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
30697764|NCT03891862|58712098|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
30697765|NCT03891862|58712099|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
30697766|NCT03891862|58712097|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
30697767|NCT03891862|58712098|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
30697768|NCT03891862|58712099|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
30697769|NCT03891862|58712097|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
30697770|NCT03891862|58712098|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
30697771|NCT03891862|58712099|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
30697772|NCT03891862|58712097|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
30697773|NCT03891862|58712098|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
30697774|NCT03891862|58712099|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
30697775|NCT00640614|58712108|FG000|Overall Study|Lost to Follow-up|1|||
30697776|NCT00640614|58712109|FG001|Overall Study|Lost to Follow-up|0|||
30697777|NCT00761657|58712147|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
30697778|NCT00761657|58712148|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
30697779|NCT00761657|58712149|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
30697780|NCT00761657|58712150|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
30697781|NCT00761657|58712151|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
30697782|NCT00761657|58712152|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
30697783|NCT00761657|58712153|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
30697784|NCT00761657|58712154|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
30697785|NCT00761657|58712155|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
30697786|NCT00761657|58712147|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
30697787|NCT00761657|58712148|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
30697788|NCT00761657|58712149|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
30697789|NCT00761657|58712150|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
30697790|NCT00761657|58712151|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
30697791|NCT00761657|58712152|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
30697792|NCT00761657|58712153|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
30697793|NCT00761657|58712154|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
30697794|NCT00761657|58712155|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
30697795|NCT00761657|58712147|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
30697796|NCT00761657|58712148|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
30697797|NCT00761657|58712149|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
30697798|NCT00761657|58712150|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
30697799|NCT00761657|58712151|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
30697800|NCT00761657|58712152|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
30697801|NCT00761657|58712153|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
30697802|NCT00761657|58712154|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
30697803|NCT00761657|58712155|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
30697804|NCT00761657|58712147|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
30697805|NCT00761657|58712148|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
30697806|NCT00761657|58712149|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
30697807|NCT00761657|58712150|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
30787924|NCT03166124|58801336|FG003|Treatment Period 1|Adverse Event|0|||
30787925|NCT03166124|58801333|FG000|Wash-out Period|Withdrawal by Subject|0|||
30697808|NCT00761657|58712151|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
30697809|NCT00761657|58712152|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
30697810|NCT00761657|58712153|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
30697811|NCT00761657|58712154|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
30697812|NCT00761657|58712155|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
30697813|NCT00319501|58712187|FG000|Double-blind Period|Withdrawal by Subject|0|||
30697814|NCT00319501|58712188|FG001|Double-blind Period|Withdrawal by Subject|3|||
30697815|NCT00319501|58712187|FG000|Double-blind Period|Sponsor Request|1|||
30697816|NCT00319501|58712188|FG001|Double-blind Period|Sponsor Request|0|||
30697817|NCT00319501|58712187|FG000|Double-blind Period|Did not receive treatment|42|||
30697818|NCT00319501|58712188|FG001|Double-blind Period|Did not receive treatment|29|||
30697819|NCT00319501|58712187|FG000|Open-label Period|Adverse Event|5|||
30697820|NCT00319501|58712188|FG001|Open-label Period|Adverse Event|0|||
30697821|NCT00319501|58712187|FG000|Open-label Period|Protocol Violation|6|||
30697822|NCT00319501|58712188|FG001|Open-label Period|Protocol Violation|0|||
30697823|NCT00319501|58712187|FG000|Open-label Period|Withdrawal by Subject|38|||
30697824|NCT00319501|58712188|FG001|Open-label Period|Withdrawal by Subject|0|||
30697825|NCT00319501|58712187|FG000|Open-label Period|Principal Investigator decision|6|||
30697826|NCT00319501|58712188|FG001|Open-label Period|Principal Investigator decision|0|||
30697827|NCT00319501|58712187|FG000|Open-label Period|Sponsor request|12|||
30697828|NCT00319501|58712188|FG001|Open-label Period|Sponsor request|0|||
30697829|NCT00319501|58712187|FG000|Open-label Period|Lost to Follow-up|5|||
30697830|NCT00319501|58712188|FG001|Open-label Period|Lost to Follow-up|0|||
30697831|NCT00319501|58712187|FG000|Open-label Period|Did not receive treatment|33|||
30697832|NCT00319501|58712188|FG001|Open-label Period|Did not receive treatment|0|||
30697833|NCT00319501|58712187|FG000|Open-label Period|Other|11|||
30697834|NCT00319501|58712188|FG001|Open-label Period|Other|0|||
30697835|NCT00319501|58712187|FG000|Open-label Extension Period|Adverse Event|2|||
30697836|NCT00319501|58712188|FG001|Open-label Extension Period|Adverse Event|0|||
30697837|NCT00319501|58712187|FG000|Open-label Extension Period|Did not receive treatment|18|||
30697838|NCT00319501|58712188|FG001|Open-label Extension Period|Did not receive treatment|0|||
30697839|NCT00319501|58712187|FG000|Open-label Extension Period|Other|1|||
30697840|NCT00319501|58712188|FG001|Open-label Extension Period|Other|0|||
30697841|NCT00319501|58712187|FG000|Open-label Extension Period|Principal investigator decision|2|||
30697842|NCT00319501|58712188|FG001|Open-label Extension Period|Principal investigator decision|0|||
30697843|NCT00319501|58712187|FG000|Open-label Extension Period|Sponsor request|26|||
30697844|NCT00319501|58712188|FG001|Open-label Extension Period|Sponsor request|0|||
30697845|NCT00319501|58712187|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
30697846|NCT00319501|58712188|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
30697847|NCT00761579|58712199|FG000|Overall Study|Adverse Event|10|||
30697848|NCT00761579|58712199|FG000|Overall Study|Death|2|||
30697849|NCT00761579|58712199|FG000|Overall Study|Lack of Efficacy|21|||
30787926|NCT03166124|58801334|FG001|Wash-out Period|Withdrawal by Subject|1|||
30787927|NCT03166124|58801335|FG002|Wash-out Period|Withdrawal by Subject|0|||
30787928|NCT03166124|58801336|FG003|Wash-out Period|Withdrawal by Subject|1|||
30787929|NCT03166124|58801333|FG000|Wash-out Period|Adverse Event|0|||
30787930|NCT03166124|58801334|FG001|Wash-out Period|Adverse Event|1|||
30787931|NCT03166124|58801335|FG002|Wash-out Period|Adverse Event|1|||
30787932|NCT03166124|58801336|FG003|Wash-out Period|Adverse Event|0|||
30787933|NCT03567291|58801347|FG000|Period I|Adverse Event|14|||
30787934|NCT03567291|58801348|FG001|Period I|Adverse Event|0|||
30787935|NCT03567291|58801349|FG002|Period I|Adverse Event|0|||
30787936|NCT03567291|58801350|FG003|Period I|Adverse Event|0|||
30787937|NCT03567291|58801347|FG000|Period I|Protocol Violation|1|||
30787938|NCT03567291|58801348|FG001|Period I|Protocol Violation|0|||
30787939|NCT03567291|58801349|FG002|Period I|Protocol Violation|0|||
30787940|NCT03567291|58801350|FG003|Period I|Protocol Violation|0|||
30787941|NCT03567291|58801347|FG000|Period I|Withdrawal by Subject|23|||
30787942|NCT03567291|58801348|FG001|Period I|Withdrawal by Subject|0|||
30787943|NCT03567291|58801349|FG002|Period I|Withdrawal by Subject|0|||
30787944|NCT03567291|58801350|FG003|Period I|Withdrawal by Subject|0|||
30787945|NCT03567291|58801347|FG000|Period I|Lost to Follow-up|2|||
30787946|NCT03567291|58801348|FG001|Period I|Lost to Follow-up|0|||
30787947|NCT03567291|58801349|FG002|Period I|Lost to Follow-up|0|||
30787948|NCT03567291|58801350|FG003|Period I|Lost to Follow-up|0|||
30787949|NCT03567291|58801347|FG000|Period I|Terminated by sponsor|44|||
30787950|NCT03567291|58801348|FG001|Period I|Terminated by sponsor|0|||
30787951|NCT03567291|58801349|FG002|Period I|Terminated by sponsor|0|||
30787952|NCT03567291|58801350|FG003|Period I|Terminated by sponsor|0|||
30787953|NCT03567291|58801347|FG000|Period I|Missing or unknown|7|||
30787954|NCT03567291|58801348|FG001|Period I|Missing or unknown|0|||
30787955|NCT03567291|58801349|FG002|Period I|Missing or unknown|0|||
30787956|NCT03567291|58801350|FG003|Period I|Missing or unknown|0|||
30787957|NCT03567291|58801347|FG000|Period II|Adverse Event|0|||
30787958|NCT03567291|58801348|FG001|Period II|Adverse Event|1|||
30787959|NCT03567291|58801349|FG002|Period II|Adverse Event|0|||
30787960|NCT03567291|58801350|FG003|Period II|Adverse Event|0|||
30787961|NCT03567291|58801347|FG000|Period II|Missing or unknown|0|||
30787962|NCT03567291|58801348|FG001|Period II|Missing or unknown|2|||
30787963|NCT03567291|58801349|FG002|Period II|Missing or unknown|1|||
30787964|NCT03567291|58801350|FG003|Period II|Missing or unknown|0|||
30787965|NCT03567291|58801347|FG000|Period III|Adverse Event|0|||
30787966|NCT03567291|58801348|FG001|Period III|Adverse Event|0|||
30787967|NCT03567291|58801349|FG002|Period III|Adverse Event|0|||
30787968|NCT03567291|58801350|FG003|Period III|Adverse Event|4|||
30787969|NCT03567291|58801347|FG000|Period III|Withdrawal by Subject|0|||
30787970|NCT03567291|58801348|FG001|Period III|Withdrawal by Subject|0|||
30787971|NCT03567291|58801349|FG002|Period III|Withdrawal by Subject|0|||
30787972|NCT03567291|58801350|FG003|Period III|Withdrawal by Subject|4|||
30787973|NCT03567291|58801347|FG000|Period III|Lost to Follow-up|0|||
30787974|NCT03567291|58801348|FG001|Period III|Lost to Follow-up|0|||
30787975|NCT03567291|58801349|FG002|Period III|Lost to Follow-up|0|||
30787976|NCT03567291|58801350|FG003|Period III|Lost to Follow-up|1|||
30787977|NCT03567291|58801347|FG000|Period III|Terminated by sponsor|0|||
30787978|NCT03567291|58801348|FG001|Period III|Terminated by sponsor|0|||
30787979|NCT03567291|58801349|FG002|Period III|Terminated by sponsor|0|||
30787980|NCT03567291|58801350|FG003|Period III|Terminated by sponsor|68|||
30787981|NCT03567291|58801347|FG000|Period III|Missing or unknown|0|||
30787982|NCT03567291|58801348|FG001|Period III|Missing or unknown|0|||
30787983|NCT03567291|58801349|FG002|Period III|Missing or unknown|0|||
30787984|NCT03567291|58801350|FG003|Period III|Missing or unknown|8|||
30787985|NCT02777242|58801356|FG000|Overall Study|Other|2|||
30787986|NCT02777242|58801356|FG000|Overall Study|Lost to Follow-up|1|||
30787987|NCT02777242|58801356|FG000|Overall Study|Multiple|1|||
30787988|NCT02777242|58801356|FG000|Overall Study|Sponsor's request|1|||
30787989|NCT02777242|58801356|FG000|Overall Study|Withdrawal by Subject|1|||
30787990|NCT03212144|58801362|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
30787991|NCT03212144|58801363|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
30787992|NCT03212144|58801362|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
30787993|NCT03212144|58801363|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
30787994|NCT03566979|58801373|FG000|Overall Study|Withdrawal by Subject|2|||
30787995|NCT03566979|58801374|FG001|Overall Study|Withdrawal by Subject|0|||
30787996|NCT03566979|58801375|FG002|Overall Study|Withdrawal by Subject|1|||
30787997|NCT03566979|58801376|FG003|Overall Study|Withdrawal by Subject|1|||
30787998|NCT03566979|58801373|FG000|Overall Study|Lost to Follow-up|2|||
30787999|NCT03566979|58801374|FG001|Overall Study|Lost to Follow-up|7|||
30788000|NCT03566979|58801375|FG002|Overall Study|Lost to Follow-up|9|||
30788001|NCT03566979|58801376|FG003|Overall Study|Lost to Follow-up|5|||
30788002|NCT03566979|58801373|FG000|Overall Study|Adverse Event|1|||
30697850|NCT00761579|58712199|FG000|Overall Study|Lost to Follow-up|16|||
30697851|NCT00761579|58712199|FG000|Overall Study|Pregnancy|1|||
30697852|NCT00761579|58712199|FG000|Overall Study|Withdrawal by Subject|34|||
30697853|NCT00761579|58712199|FG000|Overall Study|Lack of compliance|2|||
30697854|NCT00761579|58712199|FG000|Overall Study|Protocol deviation|1|||
30697855|NCT00761579|58712199|FG000|Overall Study|Drug overdose|1|||
30697856|NCT00761579|58712199|FG000|Overall Study|Aggravation of depression|1|||
30697857|NCT00761579|58712199|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
30697858|NCT00761579|58712199|FG000|Overall Study|Lost survey form|1|||
30788003|NCT03566979|58801374|FG001|Overall Study|Adverse Event|0|||
30788004|NCT03566979|58801375|FG002|Overall Study|Adverse Event|0|||
30788005|NCT03566979|58801376|FG003|Overall Study|Adverse Event|0|||
30788006|NCT00116831|58801388|FG000|Overall Study|Adverse Event|14|||
30788007|NCT00116831|58801389|FG001|Overall Study|Adverse Event|16|||
30788008|NCT00116831|58801388|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
30788009|NCT00116831|58801389|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
30788010|NCT00116831|58801388|FG000|Overall Study|Lost to Follow-up|8|||
30788011|NCT00116831|58801389|FG001|Overall Study|Lost to Follow-up|6|||
30788012|NCT00116831|58801388|FG000|Overall Study|Protocol Violation|3|||
30788013|NCT00116831|58801389|FG001|Overall Study|Protocol Violation|6|||
30788014|NCT00116831|58801388|FG000|Overall Study|Hypoglycaemic events|1|||
30788015|NCT00116831|58801389|FG001|Overall Study|Hypoglycaemic events|0|||
30788016|NCT00116831|58801388|FG000|Overall Study|Low haemoglobin on screening|1|||
30788017|NCT00116831|58801389|FG001|Overall Study|Low haemoglobin on screening|0|||
30788018|NCT00116831|58801388|FG000|Overall Study|Withdrawn investigational product|1|||
30788019|NCT00116831|58801389|FG001|Overall Study|Withdrawn investigational product|0|||
30788020|NCT00116831|58801388|FG000|Overall Study|Withdrawal by Subject|32|||
30788021|NCT00116831|58801389|FG001|Overall Study|Withdrawal by Subject|32|||
30788022|NCT00116831|58801388|FG000|Overall Study|Insufficient therapeutic effect|0|||
30788023|NCT00116831|58801389|FG001|Overall Study|Insufficient therapeutic effect|1|||
30788024|NCT00116831|58801388|FG000|Overall Study|Missing data for participant|1|||
30788025|NCT00116831|58801389|FG001|Overall Study|Missing data for participant|0|||
30788026|NCT02777086|58801397|FG000|Overall Study|Lost to Follow-up|96|||
30697859|NCT00761579|58712199|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
30788027|NCT02777086|58801398|FG001|Overall Study|Lost to Follow-up|99|||
30788028|NCT03549429|58801406|FG000|Overall Study|Protocol Violation|5|||
30788029|NCT03549429|58801407|FG001|Overall Study|Protocol Violation|3|||
30788030|NCT02784704|58801417|FG000|Overall Study|Adverse Event|4|||
30788031|NCT02784704|58801418|FG001|Overall Study|Adverse Event|2|||
30788032|NCT02784704|58801417|FG000|Overall Study|Lost to Follow-up|6|||
30788033|NCT02784704|58801418|FG001|Overall Study|Lost to Follow-up|4|||
30788034|NCT02784704|58801417|FG000|Overall Study|Withdrawal by Subject|1|||
30788035|NCT02784704|58801418|FG001|Overall Study|Withdrawal by Subject|3|||
30788036|NCT02784704|58801417|FG000|Overall Study|Subject Non Compliance|2|||
30788037|NCT02784704|58801418|FG001|Overall Study|Subject Non Compliance|0|||
30788038|NCT03566823|58801429|FG000|Overall Study|Lack of Efficacy|0|||
30788039|NCT03566823|58801430|FG001|Overall Study|Lack of Efficacy|1|||
30788040|NCT03566823|58801431|FG002|Overall Study|Lack of Efficacy|0|||
30788041|NCT03566823|58801429|FG000|Overall Study|Withdrawal by Subject|1|||
30788042|NCT03566823|58801430|FG001|Overall Study|Withdrawal by Subject|2|||
30788043|NCT03566823|58801431|FG002|Overall Study|Withdrawal by Subject|0|||
30788044|NCT03566823|58801429|FG000|Overall Study|Adverse Event|1|||
30788045|NCT03566823|58801430|FG001|Overall Study|Adverse Event|0|||
30788046|NCT03566823|58801431|FG002|Overall Study|Adverse Event|2|||
30788047|NCT03549117|58801441|FG000|Overall Study|Withdrawal by Subject|1|||
30788048|NCT03549117|58801442|FG001|Overall Study|Withdrawal by Subject|0|||
30788049|NCT03183908|58801450|FG000|Overall Study|Missing Symptom Diary Data|0|||
30877697|NCT01995838|58909241|FG001|Overall Study|Withdrawal by Subject|0|||
30877698|NCT01995838|58909242|FG002|Overall Study|Withdrawal by Subject|0|||
30877699|NCT01995838|58909243|FG003|Overall Study|Withdrawal by Subject|0|||
30877700|NCT01995838|58909244|FG004|Overall Study|Withdrawal by Subject|1|||
30877701|NCT01995838|58909245|FG005|Overall Study|Withdrawal by Subject|0|||
30877702|NCT01995838|58909246|FG006|Overall Study|Withdrawal by Subject|0|||
30877703|NCT01995838|58909240|FG000|Overall Study|Other|3|||
30877704|NCT01995838|58909241|FG001|Overall Study|Other|1|||
30877705|NCT01995838|58909242|FG002|Overall Study|Other|0|||
30877706|NCT01995838|58909243|FG003|Overall Study|Other|2|||
30877707|NCT01995838|58909244|FG004|Overall Study|Other|1|||
30877708|NCT01995838|58909245|FG005|Overall Study|Other|1|||
30877709|NCT01995838|58909246|FG006|Overall Study|Other|2|||
30877710|NCT01957462|58909267|FG000|Test Period 1|Withdrawal by Subject|1|||
30877711|NCT01957462|58909268|FG001|Test Period 1|Withdrawal by Subject|0|||
30877712|NCT01957462|58909267|FG000|Test Period 1|Adverse Event|1|||
30877713|NCT01957462|58909268|FG001|Test Period 1|Adverse Event|0|||
30877714|NCT01957150|58909276|FG000|Overall Study|Adverse Event|23|||
30877715|NCT01957150|58909277|FG001|Overall Study|Adverse Event|20|||
30877716|NCT01957150|58909276|FG000|Overall Study|Withdrawal by Subject|13|||
30877717|NCT01957150|58909277|FG001|Overall Study|Withdrawal by Subject|17|||
30877718|NCT01957150|58909276|FG000|Overall Study|Physician Decision|3|||
30877719|NCT01957150|58909277|FG001|Overall Study|Physician Decision|6|||
30877720|NCT01957150|58909276|FG000|Overall Study|Lost to Follow-up|4|||
30877721|NCT01957150|58909277|FG001|Overall Study|Lost to Follow-up|4|||
30877722|NCT01957150|58909276|FG000|Overall Study|Protocol Violation|1|||
30877723|NCT01957150|58909277|FG001|Overall Study|Protocol Violation|0|||
30877724|NCT01957150|58909276|FG000|Overall Study|Lack of Efficacy|11|||
30877725|NCT01957150|58909277|FG001|Overall Study|Lack of Efficacy|11|||
30877726|NCT01955122|58909285|FG000|Overall Study|Physician Decision|5|||
30877727|NCT01955122|58909286|FG001|Overall Study|Physician Decision|5|||
30877728|NCT01995526|58909298|FG000|Overall Study|Physician Decision|1|||
30877729|NCT01955044|58909305|FG000|Overall Study|Death|1|||
30877730|NCT01955044|58909306|FG001|Overall Study|Death|1|||
30877731|NCT01955044|58909307|FG002|Overall Study|Death|0|||
30877732|NCT01973218|58909317|FG000|Overall Study|Adverse Event|1|||
30877733|NCT01973218|58909318|FG001|Overall Study|Adverse Event|0|||
30877734|NCT01973218|58909317|FG000|Overall Study|Withdrawal by Subject|1|||
30877735|NCT01973218|58909318|FG001|Overall Study|Withdrawal by Subject|0|||
30877736|NCT01954342|58909330|FG000|Overall Study|Missing data from 13-16week study visit|0|||
30877737|NCT01954342|58909331|FG001|Overall Study|Missing data from 13-16week study visit|0|||
30877738|NCT01954342|58909332|FG002|Overall Study|Missing data from 13-16week study visit|0|||
30877739|NCT01954342|58909333|FG003|Overall Study|Missing data from 13-16week study visit|1|||
30877740|NCT01954342|58909330|FG000|Overall Study|Miscarriage|0|||
30877741|NCT01954342|58909331|FG001|Overall Study|Miscarriage|0|||
30877742|NCT01954342|58909332|FG002|Overall Study|Miscarriage|0|||
30877743|NCT01954342|58909333|FG003|Overall Study|Miscarriage|3|||
30877744|NCT01954342|58909330|FG000|Overall Study|Lost to Follow-up|0|||
30697860|NCT00627042|58712205|FG000|Overall Study|Withdrawal by Subject|2|||
30877745|NCT01954342|58909331|FG001|Overall Study|Lost to Follow-up|0|||
30877746|NCT01954342|58909332|FG002|Overall Study|Lost to Follow-up|0|||
30877747|NCT01954342|58909333|FG003|Overall Study|Lost to Follow-up|5|||
30877748|NCT01954342|58909330|FG000|Overall Study|Preterm delivery|0|||
30877749|NCT01954342|58909331|FG001|Overall Study|Preterm delivery|0|||
30877750|NCT01954342|58909332|FG002|Overall Study|Preterm delivery|0|||
30877751|NCT01954342|58909333|FG003|Overall Study|Preterm delivery|3|||
30877752|NCT01954342|58909330|FG000|Overall Study|Pre-eclampsia|0|||
30877753|NCT01954342|58909331|FG001|Overall Study|Pre-eclampsia|0|||
30877754|NCT01954342|58909332|FG002|Overall Study|Pre-eclampsia|0|||
30877755|NCT01954342|58909333|FG003|Overall Study|Pre-eclampsia|4|||
30877756|NCT01954342|58909330|FG000|Overall Study|Unreliable Data|0|||
30877757|NCT01954342|58909331|FG001|Overall Study|Unreliable Data|0|||
30877758|NCT01954342|58909332|FG002|Overall Study|Unreliable Data|0|||
30877759|NCT01954342|58909333|FG003|Overall Study|Unreliable Data|2|||
30877760|NCT01972438|58909345|FG000|Baseline-Month 3 Crossover Period|Death|1|||
30877761|NCT01972438|58909346|FG001|Baseline-Month 3 Crossover Period|Death|0|||
30877762|NCT01972438|58909345|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
30697861|NCT00319111|58712209|FG000|Overall Study|Adverse Event|20|||
30697862|NCT00319111|58712209|FG000|Overall Study|Withdrawal of consent|11|||
30697863|NCT00319111|58712209|FG000|Overall Study|Death|9|||
30697864|NCT00319111|58712209|FG000|Overall Study|Lack of clinical improvement|4|||
30697865|NCT00319111|58712209|FG000|Overall Study|Administrative|2|||
30697866|NCT00319111|58712209|FG000|Overall Study|Treatment failure|1|||
30697867|NCT00640224|58712217|FG000|Overall Study|Lost to Follow-up|5|||
30697868|NCT00640224|58712218|FG001|Overall Study|Lost to Follow-up|2|||
30697869|NCT00640224|58712219|FG002|Overall Study|Lost to Follow-up|0|||
30697870|NCT00640224|58712220|FG003|Overall Study|Lost to Follow-up|0|||
30697871|NCT00640224|58712217|FG000|Overall Study|Withdrawal by Subject|1|||
30697872|NCT00640224|58712218|FG001|Overall Study|Withdrawal by Subject|0|||
30697873|NCT00640224|58712219|FG002|Overall Study|Withdrawal by Subject|0|||
30697874|NCT00640224|58712220|FG003|Overall Study|Withdrawal by Subject|0|||
30697875|NCT00640224|58712217|FG000|Overall Study|Headaches|0|||
30697876|NCT00640224|58712218|FG001|Overall Study|Headaches|1|||
30697877|NCT00640224|58712219|FG002|Overall Study|Headaches|0|||
30697878|NCT00640224|58712220|FG003|Overall Study|Headaches|0|||
30697879|NCT00318643|58712235|FG000|Overall Study|Adverse Event|0|||
30697880|NCT00318643|58712236|FG001|Overall Study|Adverse Event|0|||
30697881|NCT00318643|58712237|FG002|Overall Study|Adverse Event|0|||
30697882|NCT00318643|58712238|FG003|Overall Study|Adverse Event|0|||
30697883|NCT00318643|58712239|FG004|Overall Study|Adverse Event|1|||
30697884|NCT00318643|58712235|FG000|Overall Study|Participant's Decision|0|||
30697885|NCT00318643|58712236|FG001|Overall Study|Participant's Decision|0|||
30697886|NCT00318643|58712237|FG002|Overall Study|Participant's Decision|0|||
30697887|NCT00318643|58712238|FG003|Overall Study|Participant's Decision|0|||
30697888|NCT00318643|58712239|FG004|Overall Study|Participant's Decision|1|||
30697889|NCT00318643|58712235|FG000|Overall Study|Investigator's Decision|0|||
30697890|NCT00318643|58712236|FG001|Overall Study|Investigator's Decision|0|||
30697891|NCT00318643|58712237|FG002|Overall Study|Investigator's Decision|0|||
30697892|NCT00318643|58712238|FG003|Overall Study|Investigator's Decision|0|||
30697893|NCT00318643|58712239|FG004|Overall Study|Investigator's Decision|1|||
30697894|NCT00318565|58712252|FG000|Overall Study|Excluded per protocol|24|||
30697895|NCT00304915|58712258|FG000|Overall Study|Lost to Follow-up|11|||
30697896|NCT00304915|58712259|FG001|Overall Study|Lost to Follow-up|11|||
30697897|NCT00304915|58712258|FG000|Overall Study|Death|4|||
30697898|NCT00304915|58712259|FG001|Overall Study|Death|5|||
30697899|NCT00304915|58712258|FG000|Overall Study|Withdrawal by Subject|3|||
30697900|NCT00304915|58712259|FG001|Overall Study|Withdrawal by Subject|0|||
30697901|NCT03687970|58712267|FG000|Overall Study|visit scheduling conflicts|2|||
30697902|NCT03687970|58712268|FG001|Overall Study|visit scheduling conflicts|0|||
30697903|NCT00530920|58712279|FG000|Overall Study|Randomized but not treated|0|||
30697904|NCT00530920|58712280|FG001|Overall Study|Randomized but not treated|2|||
30697905|NCT00530920|58712281|FG002|Overall Study|Randomized but not treated|0|||
30697906|NCT00530920|58712279|FG000|Overall Study|Adverse Event|0|||
30697907|NCT00530920|58712280|FG001|Overall Study|Adverse Event|0|||
30697908|NCT00530920|58712281|FG002|Overall Study|Adverse Event|3|||
30697909|NCT00530920|58712279|FG000|Overall Study|Withdrawal by Subject|0|||
30877763|NCT01972438|58909346|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
30877764|NCT01972438|58909345|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
30877765|NCT01972438|58909346|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
30877766|NCT01972438|58909345|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
30877767|NCT01972438|58909346|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
30877768|NCT01972438|58909345|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
30877769|NCT01972438|58909346|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
30877770|NCT01972438|58909345|FG000|Months 6-12 Study Period|Death|1|||
30877771|NCT01972438|58909346|FG001|Months 6-12 Study Period|Death|0|||
30877772|NCT01972438|58909345|FG000|Months 6-12 Study Period|Early Study Closure|2|||
30877773|NCT01972438|58909346|FG001|Months 6-12 Study Period|Early Study Closure|2|||
30877774|NCT01972438|58909345|FG000|Post Month 12 Study Period|Early Study Closure|3|||
30877775|NCT01972438|58909346|FG001|Post Month 12 Study Period|Early Study Closure|4|||
30877776|NCT01946152|58909358|FG000|Overall Study|Adverse Event|1|||
30877777|NCT01946152|58909359|FG001|Overall Study|Adverse Event|0|||
30877778|NCT01946152|58909360|FG002|Overall Study|Adverse Event|0|||
30877779|NCT01946152|58909361|FG003|Overall Study|Adverse Event|0|||
30877780|NCT01946152|58909358|FG000|Overall Study|Withdrawal by Subject|0|||
30697910|NCT00530920|58712280|FG001|Overall Study|Withdrawal by Subject|0|||
30697911|NCT00530920|58712281|FG002|Overall Study|Withdrawal by Subject|1|||
30697912|NCT03878758|58712290|FG000|Overall Study|Withdrawal by Subject|1|||
30697913|NCT03878758|58712290|FG000|Overall Study|Protocol defined|2|||
30697914|NCT03878758|58712290|FG000|Overall Study|Improper consent documentation|1|||
30697915|NCT03878602|58712305|FG000|Overall Study|cord blood donation|7|||
30697916|NCT03878602|58712306|FG001|Overall Study|cord blood donation|1|||
30697917|NCT03878602|58712305|FG000|Overall Study|incomplete data collection|2|||
30697918|NCT03878602|58712306|FG001|Overall Study|incomplete data collection|0|||
30697919|NCT00768755|58712318|FG000|Phase 1|Death|6|||
30697920|NCT00768755|58712319|FG001|Phase 1|Death|0|||
30697921|NCT00768755|58712320|FG002|Phase 1|Death|0|||
30697922|NCT00768755|58712321|FG003|Phase 1|Death|0|||
30697923|NCT00768755|58712318|FG000|Phase 1|Other|4|||
30697924|NCT00768755|58712319|FG001|Phase 1|Other|0|||
30697925|NCT00768755|58712320|FG002|Phase 1|Other|0|||
30697926|NCT00768755|58712321|FG003|Phase 1|Other|0|||
30697927|NCT00768755|58712318|FG000|Phase 2|Death|0|||
30697928|NCT00768755|58712319|FG001|Phase 2|Death|37|||
30697929|NCT00768755|58712320|FG002|Phase 2|Death|48|||
30697930|NCT00768755|58712321|FG003|Phase 2|Death|31|||
30697931|NCT00768755|58712318|FG000|Phase 2|Protocol Violation|0|||
30697932|NCT00768755|58712319|FG001|Phase 2|Protocol Violation|2|||
30697933|NCT00768755|58712320|FG002|Phase 2|Protocol Violation|0|||
30697934|NCT00768755|58712321|FG003|Phase 2|Protocol Violation|1|||
30697935|NCT00768755|58712318|FG000|Phase 2|Lost to Follow-up|0|||
30697936|NCT00768755|58712319|FG001|Phase 2|Lost to Follow-up|1|||
30697937|NCT00768755|58712320|FG002|Phase 2|Lost to Follow-up|1|||
30697938|NCT00768755|58712321|FG003|Phase 2|Lost to Follow-up|4|||
30697939|NCT00768755|58712318|FG000|Phase 2|Withdrawal by Subject|0|||
30697940|NCT00768755|58712319|FG001|Phase 2|Withdrawal by Subject|1|||
30697941|NCT00768755|58712320|FG002|Phase 2|Withdrawal by Subject|0|||
30697942|NCT00768755|58712321|FG003|Phase 2|Withdrawal by Subject|1|||
30697943|NCT00768755|58712318|FG000|Phase 2|Other|0|||
30697944|NCT00768755|58712319|FG001|Phase 2|Other|1|||
30697945|NCT00768755|58712320|FG002|Phase 2|Other|2|||
30697946|NCT00768755|58712321|FG003|Phase 2|Other|4|||
30697947|NCT00768755|58712318|FG000|Phase 2|Study Terminated by Sponsor|0|||
30697948|NCT00768755|58712319|FG001|Phase 2|Study Terminated by Sponsor|13|||
30697949|NCT00768755|58712320|FG002|Phase 2|Study Terminated by Sponsor|7|||
30697950|NCT00768755|58712321|FG003|Phase 2|Study Terminated by Sponsor|14|||
30697951|NCT00768755|58712318|FG000|Phase 2|Randomized but not treated|0|||
30697952|NCT00768755|58712319|FG001|Phase 2|Randomized but not treated|0|||
30697953|NCT00768755|58712320|FG002|Phase 2|Randomized but not treated|0|||
30697954|NCT00768755|58712321|FG003|Phase 2|Randomized but not treated|2|||
30697955|NCT00530842|58712332|FG000|Overall Study|Adverse Event|10|||
30697956|NCT00530842|58712333|FG001|Overall Study|Adverse Event|6|||
30697957|NCT00530842|58712332|FG000|Overall Study|Lack of Efficacy|2|||
30697958|NCT00530842|58712333|FG001|Overall Study|Lack of Efficacy|1|||
30697959|NCT00530842|58712332|FG000|Overall Study|Lost to Follow-up|0|||
30697960|NCT00530842|58712333|FG001|Overall Study|Lost to Follow-up|4|||
30697961|NCT00530842|58712332|FG000|Overall Study|Protocol Violation|3|||
30697962|NCT00530842|58712333|FG001|Overall Study|Protocol Violation|2|||
30697963|NCT00530842|58712332|FG000|Overall Study|Withdrawal by Subject|4|||
30697964|NCT00530842|58712333|FG001|Overall Study|Withdrawal by Subject|5|||
30697965|NCT00530842|58712332|FG000|Overall Study|Individual different reasons|4|||
30697966|NCT00530842|58712333|FG001|Overall Study|Individual different reasons|3|||
30697967|NCT00530842|58712332|FG000|Period 1|Adverse Event|7|||
30697968|NCT00530842|58712333|FG001|Period 1|Adverse Event|3|||
30697969|NCT00530842|58712332|FG000|Period 1|Lack of Efficacy|1|||
30697970|NCT00530842|58712333|FG001|Period 1|Lack of Efficacy|1|||
30697971|NCT00530842|58712332|FG000|Period 1|Protocol Violation|2|||
30697972|NCT00530842|58712333|FG001|Period 1|Protocol Violation|1|||
30697973|NCT00530842|58712332|FG000|Period 1|Withdrawal by Subject|2|||
30697974|NCT00530842|58712333|FG001|Period 1|Withdrawal by Subject|3|||
30697975|NCT00530842|58712332|FG000|Period 1|Individual different reasons|2|||
30697976|NCT00530842|58712333|FG001|Period 1|Individual different reasons|3|||
30697977|NCT00530842|58712332|FG000|Period 2|Adverse Event|3|||
30697978|NCT00530842|58712333|FG001|Period 2|Adverse Event|3|||
30697979|NCT00530842|58712332|FG000|Period 2|Lack of Efficacy|1|||
30697980|NCT00530842|58712333|FG001|Period 2|Lack of Efficacy|0|||
30697981|NCT00530842|58712332|FG000|Period 2|Lost to Follow-up|0|||
30697982|NCT00530842|58712333|FG001|Period 2|Lost to Follow-up|4|||
30697983|NCT00530842|58712332|FG000|Period 2|Protocol Violation|1|||
30697984|NCT00530842|58712333|FG001|Period 2|Protocol Violation|0|||
30697985|NCT00530842|58712332|FG000|Period 2|Withdrawal by Subject|1|||
30697986|NCT00530842|58712333|FG001|Period 2|Withdrawal by Subject|2|||
30697987|NCT00530842|58712332|FG000|Period 2|Individual different reasons|2|||
30697988|NCT00530842|58712333|FG001|Period 2|Individual different reasons|0|||
30697989|NCT03882424|58712344|FG000|Overall Study|Lost to Follow-up|3|||
30697990|NCT03882424|58712345|FG001|Overall Study|Lost to Follow-up|0|||
30697991|NCT03882424|58712346|FG002|Overall Study|Lost to Follow-up|0|||
30697992|NCT03882424|58712344|FG000|Overall Study|schedule conflict|1|||
30697993|NCT03882424|58712345|FG001|Overall Study|schedule conflict|0|||
30697994|NCT03882424|58712346|FG002|Overall Study|schedule conflict|0|||
30697995|NCT03879772|58712359|FG000|Overall Study|Adverse Event|2|||
30697996|NCT03879772|58712360|FG001|Overall Study|Adverse Event|2|||
30697997|NCT03879772|58712361|FG002|Overall Study|Adverse Event|3|||
30697998|NCT03879772|58712362|FG003|Overall Study|Adverse Event|4|||
30697999|NCT03879772|58712363|FG004|Overall Study|Adverse Event|3|||
30698000|NCT03879772|58712359|FG000|Overall Study|Treatment Failure|1|||
30698001|NCT03879772|58712360|FG001|Overall Study|Treatment Failure|0|||
30698002|NCT03879772|58712361|FG002|Overall Study|Treatment Failure|0|||
30698003|NCT03879772|58712362|FG003|Overall Study|Treatment Failure|2|||
30698004|NCT03879772|58712363|FG004|Overall Study|Treatment Failure|1|||
30698005|NCT03879772|58712359|FG000|Overall Study|Lost to Follow-up|0|||
30698006|NCT03879772|58712360|FG001|Overall Study|Lost to Follow-up|0|||
30698007|NCT03879772|58712361|FG002|Overall Study|Lost to Follow-up|0|||
30698008|NCT03879772|58712362|FG003|Overall Study|Lost to Follow-up|0|||
30698009|NCT03879772|58712363|FG004|Overall Study|Lost to Follow-up|1|||
30698010|NCT03879772|58712359|FG000|Overall Study|Withdrawal by Subject|0|||
30698011|NCT03879772|58712360|FG001|Overall Study|Withdrawal by Subject|1|||
30698012|NCT03879772|58712361|FG002|Overall Study|Withdrawal by Subject|3|||
30698013|NCT03879772|58712362|FG003|Overall Study|Withdrawal by Subject|1|||
30698014|NCT03879772|58712363|FG004|Overall Study|Withdrawal by Subject|1|||
30698015|NCT03879772|58712359|FG000|Overall Study|Protocol Violation|0|||
30698016|NCT03879772|58712360|FG001|Overall Study|Protocol Violation|0|||
30698017|NCT03879772|58712361|FG002|Overall Study|Protocol Violation|3|||
30698018|NCT03879772|58712362|FG003|Overall Study|Protocol Violation|1|||
30698019|NCT03879772|58712363|FG004|Overall Study|Protocol Violation|2|||
30698020|NCT03879772|58712359|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
30698021|NCT03879772|58712360|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
30698022|NCT03879772|58712361|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
30698023|NCT03879772|58712362|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
30698024|NCT03879772|58712363|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
30698025|NCT00642954|58712380|FG000|Overall Study|Progressive Disease|3|||
30877781|NCT01946152|58909359|FG001|Overall Study|Withdrawal by Subject|2|||
30877782|NCT01946152|58909360|FG002|Overall Study|Withdrawal by Subject|0|||
30877783|NCT01946152|58909361|FG003|Overall Study|Withdrawal by Subject|0|||
30877784|NCT01946152|58909358|FG000|Overall Study|Progression|0|||
30877785|NCT01946152|58909359|FG001|Overall Study|Progression|1|||
30877786|NCT01946152|58909360|FG002|Overall Study|Progression|4|||
30877787|NCT01946152|58909361|FG003|Overall Study|Progression|7|||
30877788|NCT01946152|58909358|FG000|Overall Study|Physician Decision|0|||
30877789|NCT01946152|58909359|FG001|Overall Study|Physician Decision|0|||
30877790|NCT01946152|58909360|FG002|Overall Study|Physician Decision|1|||
30877791|NCT01946152|58909361|FG003|Overall Study|Physician Decision|0|||
30877792|NCT01946152|58909358|FG000|Overall Study|Second malignancy|0|||
30877793|NCT01946152|58909359|FG001|Overall Study|Second malignancy|0|||
30877794|NCT01946152|58909360|FG002|Overall Study|Second malignancy|1|||
30877795|NCT01946152|58909361|FG003|Overall Study|Second malignancy|0|||
30877796|NCT01946152|58909358|FG000|Overall Study|Adverse Event|0|||
30877797|NCT01946152|58909359|FG001|Overall Study|Adverse Event|0|||
30877798|NCT01946152|58909360|FG002|Overall Study|Adverse Event|0|||
30877799|NCT01946152|58909361|FG003|Overall Study|Adverse Event|1|||
30877800|NCT01945996|58909375|FG000|Overall Study|Lost to Follow-up|3|||
30877801|NCT01945996|58909376|FG001|Overall Study|Lost to Follow-up|5|||
30877802|NCT01971346|58909384|FG000|Overall Study|Protocol Violation|3|||
30877803|NCT01971346|58909384|FG000|Overall Study|Lost to Follow-up|2|||
30877804|NCT01971346|58909384|FG000|Overall Study|Withdrawal by Subject|2|||
30877805|NCT01971346|58909384|FG000|Overall Study|Physician Decision|1|||
30877806|NCT01945216|58909399|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
30877807|NCT01945216|58909399|FG000|Overall Study|Protocol Violation|42|||
30877808|NCT01945216|58909399|FG000|Overall Study|CRF not assured by investigators|5|||
30877809|NCT02641379|58909418|FG000|Overall Study|Exclusion criterion during screening|1|||
30877810|NCT02641379|58909419|FG001|Overall Study|Exclusion criterion during screening|0|||
30877811|NCT02641379|58909420|FG002|Overall Study|Exclusion criterion during screening|0|||
30877812|NCT02641379|58909421|FG003|Overall Study|Exclusion criterion during screening|1|||
30877813|NCT02641379|58909422|FG004|Overall Study|Exclusion criterion during screening|2|||
30877814|NCT02641379|58909423|FG005|Overall Study|Exclusion criterion during screening|0|||
30877815|NCT02641379|58909424|FG006|Overall Study|Exclusion criterion during screening|0|||
30877816|NCT02641379|58909425|FG007|Overall Study|Exclusion criterion during screening|0|||
30877817|NCT02641379|58909426|FG008|Overall Study|Exclusion criterion during screening|0|||
30877818|NCT02641379|58909427|FG009|Overall Study|Exclusion criterion during screening|0|||
30877819|NCT02641379|58909428|FG010|Overall Study|Exclusion criterion during screening|0|||
30877820|NCT02641379|58909418|FG000|Overall Study|Withdrawal of informed consent|0|||
30877821|NCT02641379|58909419|FG001|Overall Study|Withdrawal of informed consent|1|||
30877822|NCT02641379|58909420|FG002|Overall Study|Withdrawal of informed consent|0|||
30698026|NCT00642954|58712381|FG001|Overall Study|Progressive Disease|3|||
30698027|NCT00642954|58712382|FG002|Overall Study|Progressive Disease|3|||
30698028|NCT00642954|58712383|FG003|Overall Study|Progressive Disease|3|||
30948401|NCT01729819|58994256|FG000|Overall Study|Other reason|1|||
30877823|NCT02641379|58909421|FG003|Overall Study|Withdrawal of informed consent|0|||
30877824|NCT02641379|58909422|FG004|Overall Study|Withdrawal of informed consent|0|||
30877825|NCT02641379|58909423|FG005|Overall Study|Withdrawal of informed consent|0|||
30877826|NCT02641379|58909424|FG006|Overall Study|Withdrawal of informed consent|0|||
30877827|NCT02641379|58909425|FG007|Overall Study|Withdrawal of informed consent|1|||
30877828|NCT02641379|58909426|FG008|Overall Study|Withdrawal of informed consent|0|||
30877829|NCT02641379|58909427|FG009|Overall Study|Withdrawal of informed consent|0|||
30877830|NCT02641379|58909428|FG010|Overall Study|Withdrawal of informed consent|0|||
30877831|NCT02641379|58909418|FG000|Overall Study|Adverse Event|7|||
30877832|NCT02641379|58909419|FG001|Overall Study|Adverse Event|8|||
30877833|NCT02641379|58909420|FG002|Overall Study|Adverse Event|2|||
30877834|NCT02641379|58909421|FG003|Overall Study|Adverse Event|2|||
30877835|NCT02641379|58909422|FG004|Overall Study|Adverse Event|5|||
30877836|NCT02641379|58909423|FG005|Overall Study|Adverse Event|1|||
30877837|NCT02641379|58909424|FG006|Overall Study|Adverse Event|5|||
30877838|NCT02641379|58909425|FG007|Overall Study|Adverse Event|0|||
30877839|NCT02641379|58909426|FG008|Overall Study|Adverse Event|1|||
30877840|NCT02641379|58909427|FG009|Overall Study|Adverse Event|1|||
30877841|NCT02641379|58909428|FG010|Overall Study|Adverse Event|5|||
30877842|NCT02641379|58909418|FG000|Overall Study|Lack of Efficacy|0|||
30877843|NCT02641379|58909419|FG001|Overall Study|Lack of Efficacy|0|||
30877844|NCT02641379|58909420|FG002|Overall Study|Lack of Efficacy|2|||
30877845|NCT02641379|58909421|FG003|Overall Study|Lack of Efficacy|0|||
30877846|NCT02641379|58909422|FG004|Overall Study|Lack of Efficacy|0|||
30877847|NCT02641379|58909423|FG005|Overall Study|Lack of Efficacy|2|||
30877848|NCT02641379|58909424|FG006|Overall Study|Lack of Efficacy|0|||
30877849|NCT02641379|58909425|FG007|Overall Study|Lack of Efficacy|5|||
30877850|NCT02641379|58909426|FG008|Overall Study|Lack of Efficacy|0|||
30877851|NCT02641379|58909427|FG009|Overall Study|Lack of Efficacy|0|||
30877852|NCT02641379|58909428|FG010|Overall Study|Lack of Efficacy|0|||
30877853|NCT02641379|58909418|FG000|Overall Study|Participant unable to attend study visit|4|||
30877854|NCT02641379|58909419|FG001|Overall Study|Participant unable to attend study visit|10|||
30877855|NCT02641379|58909420|FG002|Overall Study|Participant unable to attend study visit|1|||
30877856|NCT02641379|58909421|FG003|Overall Study|Participant unable to attend study visit|2|||
30877857|NCT02641379|58909422|FG004|Overall Study|Participant unable to attend study visit|5|||
30877858|NCT02641379|58909423|FG005|Overall Study|Participant unable to attend study visit|1|||
30877859|NCT02641379|58909424|FG006|Overall Study|Participant unable to attend study visit|1|||
30877860|NCT02641379|58909425|FG007|Overall Study|Participant unable to attend study visit|1|||
30877861|NCT02641379|58909426|FG008|Overall Study|Participant unable to attend study visit|0|||
30877862|NCT02641379|58909427|FG009|Overall Study|Participant unable to attend study visit|2|||
30877863|NCT02641379|58909428|FG010|Overall Study|Participant unable to attend study visit|0|||
30877864|NCT02641379|58909418|FG000|Overall Study|Participant's compliance|0|||
30877865|NCT02641379|58909419|FG001|Overall Study|Participant's compliance|1|||
30877866|NCT02641379|58909420|FG002|Overall Study|Participant's compliance|0|||
30877867|NCT02641379|58909421|FG003|Overall Study|Participant's compliance|1|||
30877868|NCT02641379|58909422|FG004|Overall Study|Participant's compliance|0|||
30877869|NCT02641379|58909423|FG005|Overall Study|Participant's compliance|2|||
30877870|NCT02641379|58909424|FG006|Overall Study|Participant's compliance|0|||
30877871|NCT02641379|58909425|FG007|Overall Study|Participant's compliance|0|||
30877872|NCT02641379|58909426|FG008|Overall Study|Participant's compliance|1|||
30877873|NCT02641379|58909427|FG009|Overall Study|Participant's compliance|1|||
30877874|NCT02641379|58909428|FG010|Overall Study|Participant's compliance|1|||
30877875|NCT02641379|58909418|FG000|Overall Study|Participant cannot be reached|4|||
30877876|NCT02641379|58909419|FG001|Overall Study|Participant cannot be reached|4|||
30877877|NCT02641379|58909420|FG002|Overall Study|Participant cannot be reached|0|||
30877878|NCT02641379|58909421|FG003|Overall Study|Participant cannot be reached|8|||
30877879|NCT02641379|58909422|FG004|Overall Study|Participant cannot be reached|2|||
30877880|NCT02641379|58909423|FG005|Overall Study|Participant cannot be reached|1|||
30877881|NCT02641379|58909424|FG006|Overall Study|Participant cannot be reached|0|||
30877882|NCT02641379|58909425|FG007|Overall Study|Participant cannot be reached|1|||
30877883|NCT02641379|58909426|FG008|Overall Study|Participant cannot be reached|0|||
30877884|NCT02641379|58909427|FG009|Overall Study|Participant cannot be reached|2|||
30877885|NCT02641379|58909428|FG010|Overall Study|Participant cannot be reached|1|||
30877886|NCT02641379|58909418|FG000|Overall Study|PCR positive at Week 24|15|||
30877887|NCT02641379|58909419|FG001|Overall Study|PCR positive at Week 24|21|||
30877888|NCT02641379|58909420|FG002|Overall Study|PCR positive at Week 24|62|||
30877889|NCT02641379|58909421|FG003|Overall Study|PCR positive at Week 24|0|||
30877890|NCT02641379|58909422|FG004|Overall Study|PCR positive at Week 24|0|||
30877891|NCT02641379|58909423|FG005|Overall Study|PCR positive at Week 24|6|||
30877892|NCT02641379|58909424|FG006|Overall Study|PCR positive at Week 24|3|||
30877893|NCT02641379|58909425|FG007|Overall Study|PCR positive at Week 24|8|||
30877894|NCT02641379|58909426|FG008|Overall Study|PCR positive at Week 24|0|||
30877895|NCT02641379|58909427|FG009|Overall Study|PCR positive at Week 24|1|||
30967652|NCT01433159|59037731|FG001|Overall Study|Adverse Event|0|||
30877896|NCT02641379|58909428|FG010|Overall Study|PCR positive at Week 24|0|||
30877897|NCT02641379|58909418|FG000|Overall Study|PCR positive at follow up 2|1|||
30877898|NCT02641379|58909419|FG001|Overall Study|PCR positive at follow up 2|0|||
30877899|NCT02641379|58909420|FG002|Overall Study|PCR positive at follow up 2|0|||
30877900|NCT02641379|58909421|FG003|Overall Study|PCR positive at follow up 2|0|||
30877901|NCT02641379|58909422|FG004|Overall Study|PCR positive at follow up 2|0|||
30877902|NCT02641379|58909423|FG005|Overall Study|PCR positive at follow up 2|0|||
30877903|NCT02641379|58909424|FG006|Overall Study|PCR positive at follow up 2|0|||
30877904|NCT02641379|58909425|FG007|Overall Study|PCR positive at follow up 2|0|||
30877905|NCT02641379|58909426|FG008|Overall Study|PCR positive at follow up 2|0|||
30877906|NCT02641379|58909427|FG009|Overall Study|PCR positive at follow up 2|0|||
30877907|NCT02641379|58909428|FG010|Overall Study|PCR positive at follow up 2|0|||
30877908|NCT02641379|58909418|FG000|Overall Study|Participant showed relapse|1|||
30877909|NCT02641379|58909419|FG001|Overall Study|Participant showed relapse|0|||
30877910|NCT02641379|58909420|FG002|Overall Study|Participant showed relapse|0|||
30877911|NCT02641379|58909421|FG003|Overall Study|Participant showed relapse|0|||
30877912|NCT02641379|58909422|FG004|Overall Study|Participant showed relapse|0|||
30877913|NCT02641379|58909423|FG005|Overall Study|Participant showed relapse|0|||
30877914|NCT02641379|58909424|FG006|Overall Study|Participant showed relapse|1|||
30877915|NCT02641379|58909425|FG007|Overall Study|Participant showed relapse|0|||
30877916|NCT02641379|58909426|FG008|Overall Study|Participant showed relapse|0|||
30877917|NCT02641379|58909427|FG009|Overall Study|Participant showed relapse|0|||
30877918|NCT02641379|58909428|FG010|Overall Study|Participant showed relapse|0|||
30877919|NCT02641379|58909418|FG000|Overall Study|Participant stopped study/treatment|1|||
30877920|NCT02641379|58909419|FG001|Overall Study|Participant stopped study/treatment|3|||
30877921|NCT02641379|58909420|FG002|Overall Study|Participant stopped study/treatment|1|||
30877922|NCT02641379|58909421|FG003|Overall Study|Participant stopped study/treatment|0|||
30877923|NCT02641379|58909422|FG004|Overall Study|Participant stopped study/treatment|0|||
30877924|NCT02641379|58909423|FG005|Overall Study|Participant stopped study/treatment|1|||
30877925|NCT02641379|58909424|FG006|Overall Study|Participant stopped study/treatment|2|||
30877926|NCT02641379|58909425|FG007|Overall Study|Participant stopped study/treatment|0|||
30877927|NCT02641379|58909426|FG008|Overall Study|Participant stopped study/treatment|1|||
30877928|NCT02641379|58909427|FG009|Overall Study|Participant stopped study/treatment|0|||
30877929|NCT02641379|58909428|FG010|Overall Study|Participant stopped study/treatment|0|||
30877930|NCT02641379|58909418|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
30877931|NCT02641379|58909419|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
30877932|NCT02641379|58909420|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
30877933|NCT02641379|58909421|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
30877934|NCT02641379|58909422|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
30877935|NCT02641379|58909423|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
30877936|NCT02641379|58909424|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
30877937|NCT02641379|58909425|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
30877938|NCT02641379|58909426|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
30877939|NCT02641379|58909427|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
30877940|NCT02641379|58909428|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
30877941|NCT02641379|58909418|FG000|Overall Study|Financial problems|0|||
30877942|NCT02641379|58909419|FG001|Overall Study|Financial problems|1|||
30877943|NCT02641379|58909420|FG002|Overall Study|Financial problems|0|||
30877944|NCT02641379|58909421|FG003|Overall Study|Financial problems|0|||
30877945|NCT02641379|58909422|FG004|Overall Study|Financial problems|0|||
30877946|NCT02641379|58909423|FG005|Overall Study|Financial problems|0|||
30877947|NCT02641379|58909424|FG006|Overall Study|Financial problems|0|||
30877948|NCT02641379|58909425|FG007|Overall Study|Financial problems|0|||
30877949|NCT02641379|58909426|FG008|Overall Study|Financial problems|0|||
30877950|NCT02641379|58909427|FG009|Overall Study|Financial problems|0|||
30877951|NCT02641379|58909428|FG010|Overall Study|Financial problems|0|||
30877952|NCT02641379|58909418|FG000|Overall Study|PCR positive at Week 68|0|||
30877953|NCT02641379|58909419|FG001|Overall Study|PCR positive at Week 68|1|||
30877954|NCT02641379|58909420|FG002|Overall Study|PCR positive at Week 68|0|||
30877955|NCT02641379|58909421|FG003|Overall Study|PCR positive at Week 68|0|||
30877956|NCT02641379|58909422|FG004|Overall Study|PCR positive at Week 68|0|||
30877957|NCT02641379|58909423|FG005|Overall Study|PCR positive at Week 68|0|||
30877958|NCT02641379|58909424|FG006|Overall Study|PCR positive at Week 68|0|||
30877959|NCT02641379|58909425|FG007|Overall Study|PCR positive at Week 68|0|||
30877960|NCT02641379|58909426|FG008|Overall Study|PCR positive at Week 68|0|||
30877961|NCT02641379|58909427|FG009|Overall Study|PCR positive at Week 68|0|||
30877962|NCT02641379|58909428|FG010|Overall Study|PCR positive at Week 68|0|||
30877963|NCT02641379|58909418|FG000|Overall Study|PCR positive at Week 48|0|||
30877964|NCT02641379|58909419|FG001|Overall Study|PCR positive at Week 48|1|||
30877965|NCT02641379|58909420|FG002|Overall Study|PCR positive at Week 48|0|||
30877966|NCT02641379|58909421|FG003|Overall Study|PCR positive at Week 48|0|||
30877967|NCT02641379|58909422|FG004|Overall Study|PCR positive at Week 48|0|||
30877968|NCT02641379|58909423|FG005|Overall Study|PCR positive at Week 48|0|||
30877969|NCT02641379|58909424|FG006|Overall Study|PCR positive at Week 48|0|||
30877970|NCT02641379|58909425|FG007|Overall Study|PCR positive at Week 48|0|||
30877971|NCT02641379|58909426|FG008|Overall Study|PCR positive at Week 48|0|||
30877972|NCT02641379|58909427|FG009|Overall Study|PCR positive at Week 48|0|||
30877973|NCT02641379|58909428|FG010|Overall Study|PCR positive at Week 48|0|||
30877974|NCT02641379|58909418|FG000|Overall Study|PCR not performed at Week 12|0|||
30877975|NCT02641379|58909419|FG001|Overall Study|PCR not performed at Week 12|0|||
30877976|NCT02641379|58909420|FG002|Overall Study|PCR not performed at Week 12|1|||
30877977|NCT02641379|58909421|FG003|Overall Study|PCR not performed at Week 12|0|||
30877978|NCT02641379|58909422|FG004|Overall Study|PCR not performed at Week 12|0|||
30877979|NCT02641379|58909423|FG005|Overall Study|PCR not performed at Week 12|0|||
30877980|NCT02641379|58909424|FG006|Overall Study|PCR not performed at Week 12|0|||
30877981|NCT02641379|58909425|FG007|Overall Study|PCR not performed at Week 12|0|||
30877982|NCT02641379|58909426|FG008|Overall Study|PCR not performed at Week 12|0|||
30877983|NCT02641379|58909427|FG009|Overall Study|PCR not performed at Week 12|0|||
30877984|NCT02641379|58909428|FG010|Overall Study|PCR not performed at Week 12|0|||
30877985|NCT02641379|58909418|FG000|Overall Study|No PCR at baseline|0|||
30877986|NCT02641379|58909419|FG001|Overall Study|No PCR at baseline|0|||
30877987|NCT02641379|58909420|FG002|Overall Study|No PCR at baseline|1|||
30877988|NCT02641379|58909421|FG003|Overall Study|No PCR at baseline|0|||
30877989|NCT02641379|58909422|FG004|Overall Study|No PCR at baseline|0|||
30877990|NCT02641379|58909423|FG005|Overall Study|No PCR at baseline|0|||
30877991|NCT02641379|58909424|FG006|Overall Study|No PCR at baseline|0|||
30877992|NCT02641379|58909425|FG007|Overall Study|No PCR at baseline|0|||
30877993|NCT02641379|58909426|FG008|Overall Study|No PCR at baseline|0|||
30877994|NCT02641379|58909427|FG009|Overall Study|No PCR at baseline|0|||
30877995|NCT02641379|58909428|FG010|Overall Study|No PCR at baseline|0|||
30877996|NCT02641379|58909418|FG000|Overall Study|PCR positive at Week 28|0|||
30877997|NCT02641379|58909419|FG001|Overall Study|PCR positive at Week 28|0|||
30877998|NCT02641379|58909420|FG002|Overall Study|PCR positive at Week 28|1|||
30877999|NCT02641379|58909421|FG003|Overall Study|PCR positive at Week 28|0|||
30878000|NCT02641379|58909422|FG004|Overall Study|PCR positive at Week 28|0|||
30878001|NCT02641379|58909423|FG005|Overall Study|PCR positive at Week 28|0|||
30878002|NCT02641379|58909424|FG006|Overall Study|PCR positive at Week 28|0|||
30878003|NCT02641379|58909425|FG007|Overall Study|PCR positive at Week 28|0|||
30878004|NCT02641379|58909426|FG008|Overall Study|PCR positive at Week 28|0|||
30878005|NCT02641379|58909427|FG009|Overall Study|PCR positive at Week 28|0|||
30878006|NCT02641379|58909428|FG010|Overall Study|PCR positive at Week 28|0|||
30878007|NCT02641379|58909418|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
30878008|NCT02641379|58909419|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
30878009|NCT02641379|58909420|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
30878010|NCT02641379|58909421|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
30878011|NCT02641379|58909422|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
30878012|NCT02641379|58909423|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
30878013|NCT02641379|58909424|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
30878014|NCT02641379|58909425|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
30878015|NCT02641379|58909426|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
30878016|NCT02641379|58909427|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
30878017|NCT02641379|58909428|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
30878018|NCT02641379|58909418|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
30878019|NCT02641379|58909419|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
30878020|NCT02641379|58909420|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
30878021|NCT02641379|58909421|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
30878022|NCT02641379|58909422|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
30878023|NCT02641379|58909423|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
30878024|NCT02641379|58909424|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
30878025|NCT02641379|58909425|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
30878026|NCT02641379|58909426|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
30878027|NCT02641379|58909427|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
30878028|NCT02641379|58909428|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
30878029|NCT02641379|58909418|FG000|Overall Study|Baseline viral load unavailable|0|||
30878030|NCT02641379|58909419|FG001|Overall Study|Baseline viral load unavailable|0|||
30878031|NCT02641379|58909420|FG002|Overall Study|Baseline viral load unavailable|0|||
30878032|NCT02641379|58909421|FG003|Overall Study|Baseline viral load unavailable|1|||
30878033|NCT02641379|58909422|FG004|Overall Study|Baseline viral load unavailable|0|||
30878034|NCT02641379|58909423|FG005|Overall Study|Baseline viral load unavailable|0|||
30878035|NCT02641379|58909424|FG006|Overall Study|Baseline viral load unavailable|0|||
30698029|NCT00642954|58712384|FG004|Overall Study|Progressive Disease|9|||
30878036|NCT02641379|58909425|FG007|Overall Study|Baseline viral load unavailable|0|||
30878037|NCT02641379|58909426|FG008|Overall Study|Baseline viral load unavailable|0|||
30878038|NCT02641379|58909427|FG009|Overall Study|Baseline viral load unavailable|0|||
30878039|NCT02641379|58909428|FG010|Overall Study|Baseline viral load unavailable|0|||
30878040|NCT02641379|58909418|FG000|Overall Study|Blood could not be drawn|0|||
30698030|NCT00642954|58712380|FG000|Overall Study|Withdrawal by Subject|0|||
30878041|NCT02641379|58909419|FG001|Overall Study|Blood could not be drawn|0|||
30878042|NCT02641379|58909420|FG002|Overall Study|Blood could not be drawn|0|||
30878043|NCT02641379|58909421|FG003|Overall Study|Blood could not be drawn|0|||
30878044|NCT02641379|58909422|FG004|Overall Study|Blood could not be drawn|1|||
30878045|NCT02641379|58909423|FG005|Overall Study|Blood could not be drawn|0|||
30878046|NCT02641379|58909424|FG006|Overall Study|Blood could not be drawn|0|||
30878047|NCT02641379|58909425|FG007|Overall Study|Blood could not be drawn|0|||
30878048|NCT02641379|58909426|FG008|Overall Study|Blood could not be drawn|0|||
30878049|NCT02641379|58909427|FG009|Overall Study|Blood could not be drawn|0|||
30878050|NCT02641379|58909428|FG010|Overall Study|Blood could not be drawn|0|||
30878051|NCT02641379|58909418|FG000|Overall Study|Protocol Violation|0|||
30878052|NCT02641379|58909419|FG001|Overall Study|Protocol Violation|0|||
30878053|NCT02641379|58909420|FG002|Overall Study|Protocol Violation|0|||
30878054|NCT02641379|58909421|FG003|Overall Study|Protocol Violation|0|||
30878055|NCT02641379|58909422|FG004|Overall Study|Protocol Violation|2|||
30878056|NCT02641379|58909423|FG005|Overall Study|Protocol Violation|0|||
30878057|NCT02641379|58909424|FG006|Overall Study|Protocol Violation|0|||
30878058|NCT02641379|58909425|FG007|Overall Study|Protocol Violation|0|||
30878059|NCT02641379|58909426|FG008|Overall Study|Protocol Violation|1|||
30878060|NCT02641379|58909427|FG009|Overall Study|Protocol Violation|0|||
30878061|NCT02641379|58909428|FG010|Overall Study|Protocol Violation|0|||
30878062|NCT02641379|58909418|FG000|Overall Study|Participation in sili rescue study|0|||
30878063|NCT02641379|58909419|FG001|Overall Study|Participation in sili rescue study|0|||
30878064|NCT02641379|58909420|FG002|Overall Study|Participation in sili rescue study|0|||
30878065|NCT02641379|58909421|FG003|Overall Study|Participation in sili rescue study|0|||
30878066|NCT02641379|58909422|FG004|Overall Study|Participation in sili rescue study|0|||
30878067|NCT02641379|58909423|FG005|Overall Study|Participation in sili rescue study|1|||
30878068|NCT02641379|58909424|FG006|Overall Study|Participation in sili rescue study|0|||
30878069|NCT02641379|58909425|FG007|Overall Study|Participation in sili rescue study|0|||
30878070|NCT02641379|58909426|FG008|Overall Study|Participation in sili rescue study|0|||
30878071|NCT02641379|58909427|FG009|Overall Study|Participation in sili rescue study|0|||
30878072|NCT02641379|58909428|FG010|Overall Study|Participation in sili rescue study|0|||
30878073|NCT02641379|58909418|FG000|Overall Study|Lost to Follow-up|0|||
30878074|NCT02641379|58909419|FG001|Overall Study|Lost to Follow-up|0|||
30878075|NCT02641379|58909420|FG002|Overall Study|Lost to Follow-up|0|||
30878076|NCT02641379|58909421|FG003|Overall Study|Lost to Follow-up|0|||
30878077|NCT02641379|58909422|FG004|Overall Study|Lost to Follow-up|0|||
30878078|NCT02641379|58909423|FG005|Overall Study|Lost to Follow-up|0|||
30878079|NCT02641379|58909424|FG006|Overall Study|Lost to Follow-up|0|||
30878080|NCT02641379|58909425|FG007|Overall Study|Lost to Follow-up|0|||
30878081|NCT02641379|58909426|FG008|Overall Study|Lost to Follow-up|1|||
30878082|NCT02641379|58909427|FG009|Overall Study|Lost to Follow-up|0|||
30878083|NCT02641379|58909428|FG010|Overall Study|Lost to Follow-up|0|||
30878084|NCT02641379|58909418|FG000|Overall Study|Source data not found|0|||
30878085|NCT02641379|58909419|FG001|Overall Study|Source data not found|0|||
30878086|NCT02641379|58909420|FG002|Overall Study|Source data not found|0|||
30878087|NCT02641379|58909421|FG003|Overall Study|Source data not found|0|||
30878088|NCT02641379|58909422|FG004|Overall Study|Source data not found|0|||
30878089|NCT02641379|58909423|FG005|Overall Study|Source data not found|1|||
30878090|NCT02641379|58909424|FG006|Overall Study|Source data not found|0|||
30878091|NCT02641379|58909425|FG007|Overall Study|Source data not found|0|||
30878092|NCT02641379|58909426|FG008|Overall Study|Source data not found|0|||
30878093|NCT02641379|58909427|FG009|Overall Study|Source data not found|0|||
30878094|NCT02641379|58909428|FG010|Overall Study|Source data not found|0|||
30878095|NCT02641379|58909418|FG000|Overall Study|Participant showed weight reduction|0|||
30878096|NCT02641379|58909419|FG001|Overall Study|Participant showed weight reduction|0|||
30878097|NCT02641379|58909420|FG002|Overall Study|Participant showed weight reduction|0|||
30878098|NCT02641379|58909421|FG003|Overall Study|Participant showed weight reduction|0|||
30878099|NCT02641379|58909422|FG004|Overall Study|Participant showed weight reduction|0|||
30878100|NCT02641379|58909423|FG005|Overall Study|Participant showed weight reduction|0|||
30878101|NCT02641379|58909424|FG006|Overall Study|Participant showed weight reduction|0|||
30878102|NCT02641379|58909425|FG007|Overall Study|Participant showed weight reduction|1|||
30878103|NCT02641379|58909426|FG008|Overall Study|Participant showed weight reduction|0|||
30878104|NCT02641379|58909427|FG009|Overall Study|Participant showed weight reduction|0|||
30878105|NCT02641379|58909428|FG010|Overall Study|Participant showed weight reduction|0|||
30878106|NCT02641379|58909418|FG000|Overall Study|Non-response Week 12|0|||
30878107|NCT02641379|58909419|FG001|Overall Study|Non-response Week 12|0|||
30878108|NCT02641379|58909420|FG002|Overall Study|Non-response Week 12|0|||
30878109|NCT02641379|58909421|FG003|Overall Study|Non-response Week 12|0|||
30878110|NCT02641379|58909422|FG004|Overall Study|Non-response Week 12|0|||
30878111|NCT02641379|58909423|FG005|Overall Study|Non-response Week 12|0|||
30878112|NCT02641379|58909424|FG006|Overall Study|Non-response Week 12|0|||
30878113|NCT02641379|58909425|FG007|Overall Study|Non-response Week 12|1|||
30878114|NCT02641379|58909426|FG008|Overall Study|Non-response Week 12|0|||
30878115|NCT02641379|58909427|FG009|Overall Study|Non-response Week 12|0|||
30878116|NCT02641379|58909428|FG010|Overall Study|Non-response Week 12|0|||
30878117|NCT02641379|58909418|FG000|Overall Study|No 2 Log drop at Week 12|0|||
30878118|NCT02641379|58909419|FG001|Overall Study|No 2 Log drop at Week 12|0|||
30878119|NCT02641379|58909420|FG002|Overall Study|No 2 Log drop at Week 12|0|||
30878120|NCT02641379|58909421|FG003|Overall Study|No 2 Log drop at Week 12|0|||
30878121|NCT02641379|58909422|FG004|Overall Study|No 2 Log drop at Week 12|0|||
30878122|NCT02641379|58909423|FG005|Overall Study|No 2 Log drop at Week 12|0|||
30878123|NCT02641379|58909424|FG006|Overall Study|No 2 Log drop at Week 12|0|||
30878124|NCT02641379|58909425|FG007|Overall Study|No 2 Log drop at Week 12|0|||
30878125|NCT02641379|58909426|FG008|Overall Study|No 2 Log drop at Week 12|0|||
30878126|NCT02641379|58909427|FG009|Overall Study|No 2 Log drop at Week 12|0|||
30878127|NCT02641379|58909428|FG010|Overall Study|No 2 Log drop at Week 12|1|||
30878128|NCT02641379|58909418|FG000|Overall Study|Negative PCR result|0|||
30878129|NCT02641379|58909419|FG001|Overall Study|Negative PCR result|0|||
30878130|NCT02641379|58909420|FG002|Overall Study|Negative PCR result|0|||
30878131|NCT02641379|58909421|FG003|Overall Study|Negative PCR result|0|||
30878132|NCT02641379|58909422|FG004|Overall Study|Negative PCR result|0|||
30878133|NCT02641379|58909423|FG005|Overall Study|Negative PCR result|0|||
30878134|NCT02641379|58909424|FG006|Overall Study|Negative PCR result|0|||
30878135|NCT02641379|58909425|FG007|Overall Study|Negative PCR result|0|||
30878136|NCT02641379|58909426|FG008|Overall Study|Negative PCR result|0|||
30878137|NCT02641379|58909427|FG009|Overall Study|Negative PCR result|1|||
30878138|NCT02641379|58909428|FG010|Overall Study|Negative PCR result|0|||
30878139|NCT02641379|58909418|FG000|Overall Study|Participant's PCR high|0|||
30878140|NCT02641379|58909419|FG001|Overall Study|Participant's PCR high|0|||
30878141|NCT02641379|58909420|FG002|Overall Study|Participant's PCR high|0|||
30878142|NCT02641379|58909421|FG003|Overall Study|Participant's PCR high|0|||
30878143|NCT02641379|58909422|FG004|Overall Study|Participant's PCR high|0|||
30878144|NCT02641379|58909423|FG005|Overall Study|Participant's PCR high|0|||
30878145|NCT02641379|58909424|FG006|Overall Study|Participant's PCR high|0|||
30878146|NCT02641379|58909425|FG007|Overall Study|Participant's PCR high|1|||
30878147|NCT02641379|58909426|FG008|Overall Study|Participant's PCR high|0|||
30878148|NCT02641379|58909427|FG009|Overall Study|Participant's PCR high|0|||
30878149|NCT02641379|58909428|FG010|Overall Study|Participant's PCR high|0|||
30878150|NCT02641379|58909418|FG000|Overall Study|Participant treated after Week 24|0|||
30878151|NCT02641379|58909419|FG001|Overall Study|Participant treated after Week 24|0|||
30878152|NCT02641379|58909420|FG002|Overall Study|Participant treated after Week 24|0|||
30878153|NCT02641379|58909421|FG003|Overall Study|Participant treated after Week 24|0|||
30878154|NCT02641379|58909422|FG004|Overall Study|Participant treated after Week 24|0|||
30878155|NCT02641379|58909423|FG005|Overall Study|Participant treated after Week 24|0|||
30878156|NCT02641379|58909424|FG006|Overall Study|Participant treated after Week 24|0|||
30878157|NCT02641379|58909425|FG007|Overall Study|Participant treated after Week 24|0|||
30878158|NCT02641379|58909426|FG008|Overall Study|Participant treated after Week 24|1|||
30878159|NCT02641379|58909427|FG009|Overall Study|Participant treated after Week 24|0|||
30878160|NCT02641379|58909428|FG010|Overall Study|Participant treated after Week 24|0|||
30878161|NCT02641379|58909418|FG000|Overall Study|Missing PCR result at Week 8|0|||
30878162|NCT02641379|58909419|FG001|Overall Study|Missing PCR result at Week 8|0|||
30878163|NCT02641379|58909420|FG002|Overall Study|Missing PCR result at Week 8|0|||
30878164|NCT02641379|58909421|FG003|Overall Study|Missing PCR result at Week 8|0|||
30878165|NCT02641379|58909422|FG004|Overall Study|Missing PCR result at Week 8|0|||
30878166|NCT02641379|58909423|FG005|Overall Study|Missing PCR result at Week 8|0|||
30878167|NCT02641379|58909424|FG006|Overall Study|Missing PCR result at Week 8|0|||
30878168|NCT02641379|58909425|FG007|Overall Study|Missing PCR result at Week 8|0|||
30878169|NCT02641379|58909426|FG008|Overall Study|Missing PCR result at Week 8|0|||
30878170|NCT02641379|58909427|FG009|Overall Study|Missing PCR result at Week 8|1|||
30878171|NCT02641379|58909428|FG010|Overall Study|Missing PCR result at Week 8|0|||
30878172|NCT02641379|58909418|FG000|Overall Study|PCR positive|0|||
30878173|NCT02641379|58909419|FG001|Overall Study|PCR positive|0|||
30878174|NCT02641379|58909420|FG002|Overall Study|PCR positive|0|||
30878175|NCT02641379|58909421|FG003|Overall Study|PCR positive|0|||
30878176|NCT02641379|58909422|FG004|Overall Study|PCR positive|0|||
30878177|NCT02641379|58909423|FG005|Overall Study|PCR positive|0|||
30878178|NCT02641379|58909424|FG006|Overall Study|PCR positive|1|||
30878179|NCT02641379|58909425|FG007|Overall Study|PCR positive|0|||
30878180|NCT02641379|58909426|FG008|Overall Study|PCR positive|0|||
30878181|NCT02641379|58909427|FG009|Overall Study|PCR positive|0|||
30878182|NCT02641379|58909428|FG010|Overall Study|PCR positive|0|||
30878183|NCT02660983|58909459|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
30878184|NCT02660983|58909460|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
30878185|NCT02660983|58909459|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
30878186|NCT02660983|58909460|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
30878187|NCT02660983|58909459|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
30878188|NCT02660983|58909460|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
30878189|NCT02660983|58909459|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
30878190|NCT02660983|58909460|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
30878191|NCT02660983|58909459|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
30878192|NCT02660983|58909460|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
30878193|NCT02660983|58909459|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
30878194|NCT02660983|58909460|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
30878195|NCT02660983|58909459|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
30878196|NCT02660983|58909460|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
30878197|NCT01953328|58909475|FG000|Overall Study|Withdrawal by Subject|0|||
30878198|NCT01953328|58909476|FG001|Overall Study|Withdrawal by Subject|0|||
30878199|NCT01953328|58909477|FG002|Overall Study|Withdrawal by Subject|0|||
30878200|NCT01953328|58909478|FG003|Overall Study|Withdrawal by Subject|0|||
30878201|NCT01953328|58909479|FG004|Overall Study|Withdrawal by Subject|1|||
30878202|NCT01953328|58909480|FG005|Overall Study|Withdrawal by Subject|0|||
30878203|NCT01953328|58909481|FG006|Overall Study|Withdrawal by Subject|0|||
30878204|NCT01953328|58909482|FG007|Overall Study|Withdrawal by Subject|0|||
30878205|NCT01953328|58909475|FG000|Overall Study|Lost to Follow-up|0|||
30878206|NCT01953328|58909476|FG001|Overall Study|Lost to Follow-up|0|||
30878207|NCT01953328|58909477|FG002|Overall Study|Lost to Follow-up|0|||
30878208|NCT01953328|58909478|FG003|Overall Study|Lost to Follow-up|0|||
30878209|NCT01953328|58909479|FG004|Overall Study|Lost to Follow-up|1|||
30878210|NCT01953328|58909480|FG005|Overall Study|Lost to Follow-up|0|||
30878211|NCT01953328|58909481|FG006|Overall Study|Lost to Follow-up|0|||
30878212|NCT01953328|58909482|FG007|Overall Study|Lost to Follow-up|0|||
30878213|NCT02640755|58909502|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
30878214|NCT02640755|58909503|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
30878215|NCT02640755|58909502|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
30878216|NCT02640755|58909503|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
30878217|NCT02640755|58909502|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
30878218|NCT02640755|58909503|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
30878219|NCT02640677|58909510|FG000|Overall Study|Lost to Follow-up|1|||
30878220|NCT02640677|58909510|FG000|Overall Study|Withdrawal by Subject|1|||
30878221|NCT02643251|58909527|FG000|Overall Study|Adverse Event|3|||
30878222|NCT02643251|58909528|FG001|Overall Study|Adverse Event|1|||
30878223|NCT02643251|58909527|FG000|Overall Study|Withdrawal by Subject|2|||
30878224|NCT02643251|58909528|FG001|Overall Study|Withdrawal by Subject|0|||
30878225|NCT02643251|58909527|FG000|Overall Study|Lost to Follow-up|4|||
30878226|NCT02643251|58909528|FG001|Overall Study|Lost to Follow-up|1|||
30878227|NCT02643251|58909527|FG000|Overall Study|Protocol Violation|1|||
30878228|NCT02643251|58909528|FG001|Overall Study|Protocol Violation|0|||
30878229|NCT02643251|58909527|FG000|Overall Study|PI Decision to terminate patient|1|||
30878230|NCT02643251|58909528|FG001|Overall Study|PI Decision to terminate patient|0|||
30878231|NCT01970878|58909538|FG000|Overall Study|Withdrawal by Subject|11|||
30878232|NCT01970878|58909539|FG001|Overall Study|Withdrawal by Subject|10|||
30878233|NCT01970878|58909540|FG002|Overall Study|Withdrawal by Subject|14|||
30878234|NCT01970878|58909541|FG003|Overall Study|Withdrawal by Subject|7|||
30878235|NCT01970878|58909538|FG000|Overall Study|Lost to Follow-up|1|||
30878236|NCT01970878|58909539|FG001|Overall Study|Lost to Follow-up|3|||
30878237|NCT01970878|58909540|FG002|Overall Study|Lost to Follow-up|2|||
30878238|NCT01970878|58909541|FG003|Overall Study|Lost to Follow-up|4|||
30878239|NCT01970878|58909538|FG000|Overall Study|Administrative Reasons|1|||
30878240|NCT01970878|58909539|FG001|Overall Study|Administrative Reasons|0|||
30878241|NCT01970878|58909540|FG002|Overall Study|Administrative Reasons|0|||
30878242|NCT01970878|58909541|FG003|Overall Study|Administrative Reasons|4|||
30878243|NCT01970878|58909538|FG000|Overall Study|Lack of Efficacy|2|||
30878244|NCT01970878|58909539|FG001|Overall Study|Lack of Efficacy|1|||
30878245|NCT01970878|58909540|FG002|Overall Study|Lack of Efficacy|2|||
30878246|NCT01970878|58909541|FG003|Overall Study|Lack of Efficacy|0|||
30878247|NCT01970878|58909538|FG000|Overall Study|Adverse Event|12|||
30878248|NCT01970878|58909539|FG001|Overall Study|Adverse Event|7|||
30878249|NCT01970878|58909540|FG002|Overall Study|Adverse Event|4|||
30878250|NCT01970878|58909541|FG003|Overall Study|Adverse Event|3|||
30878251|NCT01970878|58909538|FG000|Overall Study|Protocol Specified Criteria|10|||
30878252|NCT01970878|58909539|FG001|Overall Study|Protocol Specified Criteria|4|||
30878253|NCT01970878|58909540|FG002|Overall Study|Protocol Specified Criteria|3|||
30878254|NCT01970878|58909541|FG003|Overall Study|Protocol Specified Criteria|6|||
30878255|NCT01970878|58909538|FG000|Overall Study|Physician Decision|0|||
30878256|NCT01970878|58909539|FG001|Overall Study|Physician Decision|1|||
30878257|NCT01970878|58909540|FG002|Overall Study|Physician Decision|1|||
30878258|NCT01970878|58909541|FG003|Overall Study|Physician Decision|0|||
30878259|NCT01970878|58909538|FG000|Overall Study|No Completion Status|0|||
30878260|NCT01970878|58909539|FG001|Overall Study|No Completion Status|1|||
30878261|NCT01970878|58909540|FG002|Overall Study|No Completion Status|0|||
30698031|NCT00642954|58712381|FG001|Overall Study|Withdrawal by Subject|0|||
30878262|NCT01970878|58909541|FG003|Overall Study|No Completion Status|0|||
30878263|NCT01970488|58909553|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
30878264|NCT01970488|58909554|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
30878265|NCT01970488|58909555|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
30878266|NCT01970488|58909556|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
30878267|NCT01970488|58909557|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
30878268|NCT01970488|58909553|FG000|Part 1: Through Week 16|Protocol Violation|1|||
30878269|NCT01970488|58909554|FG001|Part 1: Through Week 16|Protocol Violation|2|||
30878270|NCT01970488|58909555|FG002|Part 1: Through Week 16|Protocol Violation|0|||
30878271|NCT01970488|58909556|FG003|Part 1: Through Week 16|Protocol Violation|0|||
30878272|NCT01970488|58909557|FG004|Part 1: Through Week 16|Protocol Violation|0|||
30878273|NCT01970488|58909553|FG000|Part 1: Through Week 16|Adverse Event|6|||
30878274|NCT01970488|58909554|FG001|Part 1: Through Week 16|Adverse Event|5|||
30878275|NCT01970488|58909555|FG002|Part 1: Through Week 16|Adverse Event|0|||
30878276|NCT01970488|58909556|FG003|Part 1: Through Week 16|Adverse Event|0|||
30878277|NCT01970488|58909557|FG004|Part 1: Through Week 16|Adverse Event|0|||
30878278|NCT01970488|58909553|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
30878279|NCT01970488|58909554|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
30878280|NCT01970488|58909555|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
30878281|NCT01970488|58909556|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
30878282|NCT01970488|58909557|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
30878283|NCT01970488|58909553|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
30878284|NCT01970488|58909554|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
30878285|NCT01970488|58909555|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
30878286|NCT01970488|58909556|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
30878287|NCT01970488|58909557|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
30878288|NCT01970488|58909553|FG000|Part 2: Post Week 16|Physician Decision|0|||
30878289|NCT01970488|58909554|FG001|Part 2: Post Week 16|Physician Decision|0|||
30878290|NCT01970488|58909555|FG002|Part 2: Post Week 16|Physician Decision|0|||
30878291|NCT01970488|58909556|FG003|Part 2: Post Week 16|Physician Decision|0|||
30878292|NCT01970488|58909557|FG004|Part 2: Post Week 16|Physician Decision|1|||
30878293|NCT01970488|58909553|FG000|Part 2: Post Week 16|Non-compliance|0|||
30878294|NCT01970488|58909554|FG001|Part 2: Post Week 16|Non-compliance|0|||
30878295|NCT01970488|58909555|FG002|Part 2: Post Week 16|Non-compliance|1|||
30878296|NCT01970488|58909556|FG003|Part 2: Post Week 16|Non-compliance|0|||
30878297|NCT01970488|58909557|FG004|Part 2: Post Week 16|Non-compliance|0|||
30878298|NCT01970488|58909553|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
30878299|NCT01970488|58909554|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
30878300|NCT01970488|58909555|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
30878301|NCT01970488|58909556|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
30878302|NCT01970488|58909557|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
30878303|NCT01970488|58909553|FG000|Part 2: Post Week 16|Adverse Event|0|||
30878304|NCT01970488|58909554|FG001|Part 2: Post Week 16|Adverse Event|0|||
30878305|NCT01970488|58909555|FG002|Part 2: Post Week 16|Adverse Event|5|||
30878306|NCT01970488|58909556|FG003|Part 2: Post Week 16|Adverse Event|1|||
30878307|NCT01970488|58909557|FG004|Part 2: Post Week 16|Adverse Event|1|||
30878308|NCT01970488|58909553|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
30878309|NCT01970488|58909554|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
30878310|NCT01970488|58909555|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
30878311|NCT01970488|58909556|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
30878312|NCT01970488|58909557|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
30878313|NCT01970488|58909553|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
30878314|NCT01970488|58909554|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
30878315|NCT01970488|58909555|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
30878316|NCT01970488|58909556|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
30878317|NCT01970488|58909557|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
30878318|NCT02661217|58909574|FG000|Overall Study|Physician Decision|12|||
30878319|NCT02661217|58909575|FG001|Overall Study|Physician Decision|15|||
30878320|NCT02661217|58909574|FG000|Overall Study|Lost to Follow-up|1|||
30878321|NCT02661217|58909575|FG001|Overall Study|Lost to Follow-up|4|||
30878322|NCT02661217|58909574|FG000|Overall Study|Protocol Deviation|0|||
30878323|NCT02661217|58909575|FG001|Overall Study|Protocol Deviation|4|||
30878324|NCT02661217|58909574|FG000|Overall Study|Non-compliance with study treatment|5|||
30878325|NCT02661217|58909575|FG001|Overall Study|Non-compliance with study treatment|5|||
30878326|NCT02661217|58909574|FG000|Overall Study|Death|21|||
30878327|NCT02661217|58909575|FG001|Overall Study|Death|15|||
30698032|NCT00642954|58712382|FG002|Overall Study|Withdrawal by Subject|0|||
30878328|NCT02661217|58909574|FG000|Overall Study|Adverse Event|10|||
30878329|NCT02661217|58909575|FG001|Overall Study|Adverse Event|8|||
30878330|NCT02661217|58909574|FG000|Overall Study|Withdrawal by Subject|15|||
30878331|NCT02661217|58909575|FG001|Overall Study|Withdrawal by Subject|19|||
30878332|NCT02661217|58909574|FG000|Overall Study|Did not enter follow-up epoch|7|||
30878333|NCT02661217|58909575|FG001|Overall Study|Did not enter follow-up epoch|10|||
30878334|NCT02661217|58909574|FG000|Overall Study|Death - no study drug received|1|||
30878335|NCT02661217|58909575|FG001|Overall Study|Death - no study drug received|2|||
30878336|NCT02661217|58909574|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
30878337|NCT02661217|58909575|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
30878338|NCT01952080|58909586|FG000|Overall Study|Withdrawal by Subject|0|||
30878339|NCT01952080|58909587|FG001|Overall Study|Withdrawal by Subject|0|||
30878340|NCT01952080|58909588|FG002|Overall Study|Withdrawal by Subject|0|||
30878341|NCT01952080|58909589|FG003|Overall Study|Withdrawal by Subject|1|||
30878342|NCT01952080|58909586|FG000|Overall Study|Protocol Non-compliance|0|||
30878343|NCT01952080|58909587|FG001|Overall Study|Protocol Non-compliance|1|||
30878344|NCT01952080|58909588|FG002|Overall Study|Protocol Non-compliance|0|||
30878345|NCT01952080|58909589|FG003|Overall Study|Protocol Non-compliance|0|||
30878346|NCT01951378|58909601|FG000|Overall Study|Study Terminated-Not completed|23|||
30878347|NCT01951378|58909602|FG001|Overall Study|Study Terminated-Not completed|17|||
30878348|NCT01944670|58909608|FG000|Overall Study|Lost to Follow-up|2|||
30878349|NCT01361009|58909612|FG000|Overall Study|Protocol Violation|116|||
30878350|NCT01944046|58909618|FG000|Randomized to DB|Adverse Event|5|||
30878351|NCT01944046|58909619|FG001|Randomized to DB|Adverse Event|2|||
30878352|NCT01944046|58909618|FG000|Randomized to DB|Clinical Worsening|3|||
30878353|NCT01944046|58909619|FG001|Randomized to DB|Clinical Worsening|2|||
30878354|NCT01944046|58909618|FG000|Randomized to DB|Lost to Follow-up|3|||
30878355|NCT01944046|58909619|FG001|Randomized to DB|Lost to Follow-up|3|||
30878356|NCT01944046|58909618|FG000|Randomized to DB|Withdrawal by Subject|2|||
30878357|NCT01944046|58909619|FG001|Randomized to DB|Withdrawal by Subject|4|||
30878358|NCT01944046|58909618|FG000|Randomized to DB|Physician Decision|1|||
30878359|NCT01944046|58909619|FG001|Randomized to DB|Physician Decision|2|||
30878360|NCT01944046|58909618|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
30878361|NCT01944046|58909619|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
30878362|NCT01944046|58909618|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
30878363|NCT01944046|58909619|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
30878364|NCT01944046|58909618|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
30878365|NCT01944046|58909619|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
30878366|NCT01944046|58909618|FG000|Open Label Eligible and Consented|Adverse Event|6|||
30878367|NCT01944046|58909619|FG001|Open Label Eligible and Consented|Adverse Event|1|||
30878368|NCT01944046|58909618|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
30878369|NCT01944046|58909619|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
30878370|NCT01944046|58909618|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
30878371|NCT01944046|58909619|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
30878372|NCT01969084|58909631|FG000|Overall Study|Adverse Event|0|||
30878373|NCT01969084|58909632|FG001|Overall Study|Adverse Event|1|||
30878374|NCT01942486|58909642|FG000|Overall Study|Lost to Follow-up|27|||
30878375|NCT01941940|58909646|FG000|Overall Study|Adverse Event|11|||
30878376|NCT01941940|58909646|FG000|Overall Study|Lost to Follow-up|2|||
30878377|NCT01941940|58909646|FG000|Overall Study|Physician Decision|2|||
30878378|NCT01941940|58909646|FG000|Overall Study|Withdrawal by Subject|15|||
30878379|NCT01941940|58909646|FG000|Overall Study|Death|1|||
30878380|NCT01941940|58909646|FG000|Overall Study|Other|1|||
30878381|NCT01941940|58909646|FG000|Overall Study|Other|1|||
30878382|NCT01968694|58909652|FG000|Washout (1 Month)|Lost to Follow-up|0|||
30878383|NCT01968694|58909653|FG001|Washout (1 Month)|Lost to Follow-up|1|||
30878384|NCT01968226|58909661|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
30878385|NCT02640053|58909667|FG000|Overall Study|Withdrawal by Subject|2|||
30878386|NCT02640053|58909668|FG001|Overall Study|Withdrawal by Subject|1|||
30878387|NCT02640053|58909667|FG000|Overall Study|Adverse Event|1|||
30878388|NCT02640053|58909668|FG001|Overall Study|Adverse Event|1|||
30878389|NCT02640053|58909667|FG000|Overall Study|Alternative Therapy|1|||
30878390|NCT02640053|58909668|FG001|Overall Study|Alternative Therapy|1|||
30878391|NCT02640053|58909667|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
30878392|NCT02640053|58909668|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
30878393|NCT01950364|58909676|FG000|Overall Study|Adverse Event|3|||
30878394|NCT01950364|58909677|FG001|Overall Study|Adverse Event|0|||
30878395|NCT01950364|58909676|FG000|Overall Study|Stem Cell Transplant|2|||
30878396|NCT01950364|58909677|FG001|Overall Study|Stem Cell Transplant|6|||
30878397|NCT01950364|58909676|FG000|Overall Study|Disease Progression|5|||
30878398|NCT01950364|58909677|FG001|Overall Study|Disease Progression|2|||
30878399|NCT01950364|58909676|FG000|Overall Study|Withdrawal by Subject|0|||
30878400|NCT01950364|58909677|FG001|Overall Study|Withdrawal by Subject|1|||
30878401|NCT01950364|58909676|FG000|Overall Study|Protocol Violation|0|||
30878402|NCT01950364|58909677|FG001|Overall Study|Protocol Violation|1|||
30878403|NCT01968070|58909701|FG000|Period 1|Withdrawal by Subject|0|||
30878404|NCT01968070|58909702|FG001|Period 1|Withdrawal by Subject|1|||
30878405|NCT01968070|58909703|FG002|Period 1|Withdrawal by Subject|0|||
30878406|NCT01968070|58909704|FG003|Period 1|Withdrawal by Subject|0|||
30878407|NCT01968070|58909705|FG004|Period 1|Withdrawal by Subject|0|||
30878408|NCT01968070|58909706|FG005|Period 1|Withdrawal by Subject|0|||
30878409|NCT01968070|58909707|FG006|Period 1|Withdrawal by Subject|1|||
30878410|NCT01968070|58909708|FG007|Period 1|Withdrawal by Subject|0|||
30878411|NCT01968070|58909709|FG008|Period 1|Withdrawal by Subject|0|||
30878412|NCT01968070|58909710|FG009|Period 1|Withdrawal by Subject|0|||
30878413|NCT01968070|58909711|FG010|Period 1|Withdrawal by Subject|0|||
30878414|NCT01968070|58909712|FG011|Period 1|Withdrawal by Subject|0|||
30878415|NCT01968070|58909713|FG012|Period 1|Withdrawal by Subject|0|||
30878416|NCT01968070|58909714|FG013|Period 1|Withdrawal by Subject|0|||
30878417|NCT01968070|58909715|FG014|Period 1|Withdrawal by Subject|0|||
30878418|NCT01968070|58909716|FG015|Period 1|Withdrawal by Subject|1|||
30878419|NCT01968070|58909717|FG016|Period 1|Withdrawal by Subject|0|||
30878420|NCT01968070|58909718|FG017|Period 1|Withdrawal by Subject|0|||
30878421|NCT01968070|58909701|FG000|Period 1|Protocol Violation|0|||
30878422|NCT01968070|58909702|FG001|Period 1|Protocol Violation|0|||
30878423|NCT01968070|58909703|FG002|Period 1|Protocol Violation|0|||
30878424|NCT01968070|58909704|FG003|Period 1|Protocol Violation|1|||
30878425|NCT01968070|58909705|FG004|Period 1|Protocol Violation|1|||
30878426|NCT01968070|58909706|FG005|Period 1|Protocol Violation|0|||
30878427|NCT01968070|58909707|FG006|Period 1|Protocol Violation|0|||
30878428|NCT01968070|58909708|FG007|Period 1|Protocol Violation|0|||
30878429|NCT01968070|58909709|FG008|Period 1|Protocol Violation|0|||
30878430|NCT01968070|58909710|FG009|Period 1|Protocol Violation|0|||
30878431|NCT01968070|58909711|FG010|Period 1|Protocol Violation|0|||
30878432|NCT01968070|58909712|FG011|Period 1|Protocol Violation|0|||
30878433|NCT01968070|58909713|FG012|Period 1|Protocol Violation|0|||
30878434|NCT01968070|58909714|FG013|Period 1|Protocol Violation|0|||
30878435|NCT01968070|58909715|FG014|Period 1|Protocol Violation|0|||
30878436|NCT01968070|58909716|FG015|Period 1|Protocol Violation|0|||
30878437|NCT01968070|58909717|FG016|Period 1|Protocol Violation|0|||
30878438|NCT01968070|58909718|FG017|Period 1|Protocol Violation|0|||
30878439|NCT01968070|58909701|FG000|Period 1|Lost to Follow-up|0|||
30878440|NCT01968070|58909702|FG001|Period 1|Lost to Follow-up|0|||
30878441|NCT01968070|58909703|FG002|Period 1|Lost to Follow-up|0|||
30878442|NCT01968070|58909704|FG003|Period 1|Lost to Follow-up|1|||
30878443|NCT01968070|58909705|FG004|Period 1|Lost to Follow-up|0|||
30878444|NCT01968070|58909706|FG005|Period 1|Lost to Follow-up|0|||
30878445|NCT01968070|58909707|FG006|Period 1|Lost to Follow-up|0|||
30878446|NCT01968070|58909708|FG007|Period 1|Lost to Follow-up|0|||
30878447|NCT01968070|58909709|FG008|Period 1|Lost to Follow-up|0|||
30878448|NCT01968070|58909710|FG009|Period 1|Lost to Follow-up|0|||
30878449|NCT01968070|58909711|FG010|Period 1|Lost to Follow-up|0|||
30878450|NCT01968070|58909712|FG011|Period 1|Lost to Follow-up|0|||
30878451|NCT01968070|58909713|FG012|Period 1|Lost to Follow-up|0|||
30878452|NCT01968070|58909714|FG013|Period 1|Lost to Follow-up|0|||
30878453|NCT01968070|58909715|FG014|Period 1|Lost to Follow-up|0|||
30878454|NCT01968070|58909716|FG015|Period 1|Lost to Follow-up|0|||
30878455|NCT01968070|58909717|FG016|Period 1|Lost to Follow-up|0|||
30878456|NCT01968070|58909718|FG017|Period 1|Lost to Follow-up|0|||
30878457|NCT01968070|58909701|FG000|Period 1|Adverse Event|0|||
30878458|NCT01968070|58909702|FG001|Period 1|Adverse Event|0|||
30878459|NCT01968070|58909703|FG002|Period 1|Adverse Event|0|||
30878460|NCT01968070|58909704|FG003|Period 1|Adverse Event|0|||
30878461|NCT01968070|58909705|FG004|Period 1|Adverse Event|0|||
30878462|NCT01968070|58909706|FG005|Period 1|Adverse Event|0|||
30878463|NCT01968070|58909707|FG006|Period 1|Adverse Event|1|||
30878464|NCT01968070|58909708|FG007|Period 1|Adverse Event|0|||
30878465|NCT01968070|58909709|FG008|Period 1|Adverse Event|0|||
30878466|NCT01968070|58909710|FG009|Period 1|Adverse Event|0|||
30878467|NCT01968070|58909711|FG010|Period 1|Adverse Event|0|||
30878468|NCT01968070|58909712|FG011|Period 1|Adverse Event|0|||
30878469|NCT01968070|58909713|FG012|Period 1|Adverse Event|0|||
30878470|NCT01968070|58909714|FG013|Period 1|Adverse Event|0|||
30878471|NCT01968070|58909715|FG014|Period 1|Adverse Event|0|||
30878472|NCT01968070|58909716|FG015|Period 1|Adverse Event|0|||
30878473|NCT01968070|58909717|FG016|Period 1|Adverse Event|0|||
30878474|NCT01968070|58909718|FG017|Period 1|Adverse Event|0|||
30878475|NCT01968070|58909701|FG000|Period 1|Physician Decision|0|||
30878476|NCT01968070|58909702|FG001|Period 1|Physician Decision|0|||
30878477|NCT01968070|58909703|FG002|Period 1|Physician Decision|0|||
30878478|NCT01968070|58909704|FG003|Period 1|Physician Decision|0|||
30878479|NCT01968070|58909705|FG004|Period 1|Physician Decision|0|||
30878480|NCT01968070|58909706|FG005|Period 1|Physician Decision|0|||
30878481|NCT01968070|58909707|FG006|Period 1|Physician Decision|0|||
30878482|NCT01968070|58909708|FG007|Period 1|Physician Decision|0|||
30967653|NCT01433159|59037730|FG000|Overall Study|Physician Decision|1|||
30878483|NCT01968070|58909709|FG008|Period 1|Physician Decision|0|||
30878484|NCT01968070|58909710|FG009|Period 1|Physician Decision|0|||
30878485|NCT01968070|58909711|FG010|Period 1|Physician Decision|0|||
30878486|NCT01968070|58909712|FG011|Period 1|Physician Decision|1|||
30878487|NCT01968070|58909713|FG012|Period 1|Physician Decision|0|||
30878488|NCT01968070|58909714|FG013|Period 1|Physician Decision|0|||
30878489|NCT01968070|58909715|FG014|Period 1|Physician Decision|0|||
30878490|NCT01968070|58909716|FG015|Period 1|Physician Decision|0|||
30878491|NCT01968070|58909717|FG016|Period 1|Physician Decision|0|||
30878492|NCT01968070|58909718|FG017|Period 1|Physician Decision|0|||
30878493|NCT01968070|58909701|FG000|Period 2|Withdrawal by Subject|0|||
30878494|NCT01968070|58909702|FG001|Period 2|Withdrawal by Subject|0|||
30878495|NCT01968070|58909703|FG002|Period 2|Withdrawal by Subject|0|||
30878496|NCT01968070|58909704|FG003|Period 2|Withdrawal by Subject|0|||
30878497|NCT01968070|58909705|FG004|Period 2|Withdrawal by Subject|1|||
30878498|NCT01968070|58909706|FG005|Period 2|Withdrawal by Subject|0|||
30878499|NCT01968070|58909707|FG006|Period 2|Withdrawal by Subject|0|||
30878500|NCT01968070|58909708|FG007|Period 2|Withdrawal by Subject|0|||
30878501|NCT01968070|58909709|FG008|Period 2|Withdrawal by Subject|0|||
30878502|NCT01968070|58909710|FG009|Period 2|Withdrawal by Subject|0|||
30878503|NCT01968070|58909711|FG010|Period 2|Withdrawal by Subject|0|||
30878504|NCT01968070|58909712|FG011|Period 2|Withdrawal by Subject|0|||
30878505|NCT01968070|58909713|FG012|Period 2|Withdrawal by Subject|0|||
30878506|NCT01968070|58909714|FG013|Period 2|Withdrawal by Subject|0|||
30878507|NCT01968070|58909715|FG014|Period 2|Withdrawal by Subject|0|||
30878508|NCT01968070|58909716|FG015|Period 2|Withdrawal by Subject|0|||
30878509|NCT01968070|58909717|FG016|Period 2|Withdrawal by Subject|0|||
30878510|NCT01968070|58909718|FG017|Period 2|Withdrawal by Subject|0|||
30878511|NCT01918774|58909756|FG000|Overall Study|Lost prior to first CBTw session|4|||
30878512|NCT01918774|58909756|FG000|Overall Study|Lost to Follow-up|1|||
30878513|NCT01949116|58909762|FG000|Overall Study|Death|2|||
30878514|NCT01949116|58909763|FG001|Overall Study|Death|0|||
30878515|NCT01949116|58909762|FG000|Overall Study|Lost to Follow-up|1|||
30878516|NCT01949116|58909763|FG001|Overall Study|Lost to Follow-up|3|||
30878517|NCT01949116|58909762|FG000|Overall Study|Withdrawal by Subject|5|||
30878518|NCT01949116|58909763|FG001|Overall Study|Withdrawal by Subject|3|||
30878519|NCT01673009|58909773|FG000|Overall Study|Physician Decision|5|||
30878520|NCT01673009|58909773|FG000|Overall Study|Withdrawal by Subject|8|||
30878521|NCT01939366|58909782|FG000|Overall Study|Adverse Event|8|||
30878522|NCT01939366|58909783|FG001|Overall Study|Adverse Event|17|||
30878523|NCT01939366|58909784|FG002|Overall Study|Adverse Event|30|||
30878524|NCT01939366|58909785|FG003|Overall Study|Adverse Event|8|||
30967654|NCT01433159|59037731|FG001|Overall Study|Physician Decision|0|||
30967655|NCT01433159|59037730|FG000|Overall Study|Protocol Violation|0|||
30967656|NCT01433159|59037731|FG001|Overall Study|Protocol Violation|1|||
30967657|NCT01413503|59037746|FG000|Overall Study|Lost to Follow-up|1|||
30967658|NCT01413191|59037750|FG000|Overall Study|Lost to Follow-up|5|||
30967659|NCT01413191|59037750|FG000|Overall Study|Disease Progression|5|||
30967660|NCT01413191|59037750|FG000|Overall Study|Death|1|||
30967661|NCT02036970|59037764|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
30967662|NCT02036970|59037765|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
30967663|NCT02036970|59037766|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
30967664|NCT02036970|59037767|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
30967665|NCT02036970|59037768|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
30967666|NCT02036970|59037769|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
30967667|NCT02036970|59037770|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
30967668|NCT02036970|59037771|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
30967669|NCT02036970|59037772|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
30967670|NCT02036970|59037773|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
30967671|NCT02036970|59037764|FG000|Part 1: Day 1 Through Week 16|Death|0|||
30967672|NCT02036970|59037765|FG001|Part 1: Day 1 Through Week 16|Death|0|||
30967673|NCT02036970|59037766|FG002|Part 1: Day 1 Through Week 16|Death|0|||
30967674|NCT02036970|59037767|FG003|Part 1: Day 1 Through Week 16|Death|0|||
30967675|NCT02036970|59037768|FG004|Part 1: Day 1 Through Week 16|Death|0|||
30967676|NCT02036970|59037769|FG005|Part 1: Day 1 Through Week 16|Death|0|||
30967677|NCT02036970|59037770|FG006|Part 1: Day 1 Through Week 16|Death|0|||
30967678|NCT02036970|59037771|FG007|Part 1: Day 1 Through Week 16|Death|0|||
30967679|NCT02036970|59037772|FG008|Part 1: Day 1 Through Week 16|Death|1|||
30967680|NCT02036970|59037773|FG009|Part 1: Day 1 Through Week 16|Death|0|||
30967681|NCT02036970|59037764|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
30967682|NCT02036970|59037765|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
30967683|NCT02036970|59037766|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
30967684|NCT02036970|59037767|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
30967685|NCT02036970|59037768|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
30967686|NCT02036970|59037769|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
30967687|NCT02036970|59037770|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
30967688|NCT02036970|59037771|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
30967689|NCT02036970|59037772|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
30698033|NCT00642954|58712383|FG003|Overall Study|Withdrawal by Subject|0|||
30967690|NCT02036970|59037773|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
30967691|NCT02036970|59037764|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
30967692|NCT02036970|59037765|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
30967693|NCT02036970|59037766|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
30878525|NCT01939366|58909786|FG004|Overall Study|Adverse Event|5|||
30878526|NCT01939366|58909782|FG000|Overall Study|Lack of Efficacy|2|||
30878527|NCT01939366|58909783|FG001|Overall Study|Lack of Efficacy|1|||
30878528|NCT01939366|58909784|FG002|Overall Study|Lack of Efficacy|1|||
30878529|NCT01939366|58909785|FG003|Overall Study|Lack of Efficacy|1|||
30967694|NCT02036970|59037767|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
30967695|NCT02036970|59037768|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
30967696|NCT02036970|59037769|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
30967697|NCT02036970|59037770|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
30967698|NCT02036970|59037771|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
30967699|NCT02036970|59037772|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
30967700|NCT02036970|59037773|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
30967701|NCT02036970|59037764|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
30967702|NCT02036970|59037765|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
30967703|NCT02036970|59037766|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
30967704|NCT02036970|59037767|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
30967705|NCT02036970|59037768|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
30967706|NCT02036970|59037769|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
30967707|NCT02036970|59037770|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
30967708|NCT02036970|59037771|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
30967709|NCT02036970|59037772|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
30967710|NCT02036970|59037773|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
30967711|NCT02036970|59037764|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
30967712|NCT02036970|59037765|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
30967713|NCT02036970|59037766|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
30967714|NCT02036970|59037767|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
30967715|NCT02036970|59037768|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
30967716|NCT02036970|59037769|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
30967717|NCT02036970|59037770|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
30967718|NCT02036970|59037771|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
30967719|NCT02036970|59037772|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
30967720|NCT02036970|59037773|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
30967721|NCT02036970|59037764|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
30967722|NCT02036970|59037765|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
30967723|NCT02036970|59037766|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
30967724|NCT02036970|59037767|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
30967725|NCT02036970|59037768|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
30967726|NCT02036970|59037769|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
30967727|NCT02036970|59037770|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
30967728|NCT02036970|59037771|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
30967729|NCT02036970|59037772|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
30967730|NCT02036970|59037773|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
30967731|NCT02036970|59037764|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
30967732|NCT02036970|59037765|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
30967733|NCT02036970|59037766|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
30967734|NCT02036970|59037767|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
30967735|NCT02036970|59037768|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
30967736|NCT02036970|59037769|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
30967737|NCT02036970|59037770|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
30967738|NCT02036970|59037771|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
30967739|NCT02036970|59037772|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
30967740|NCT02036970|59037773|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
30967741|NCT02036970|59037764|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
30967742|NCT02036970|59037765|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
30967743|NCT02036970|59037766|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
30967744|NCT02036970|59037767|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
30967745|NCT02036970|59037768|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
30967746|NCT02036970|59037769|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
30967747|NCT02036970|59037770|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
30967748|NCT02036970|59037771|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
30967749|NCT02036970|59037772|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
30967750|NCT02036970|59037773|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
30967751|NCT01412957|59037807|FG000|Overall Study|Withdrawal by Subject|6|||
30967752|NCT01412957|59037808|FG001|Overall Study|Withdrawal by Subject|22|||
30967753|NCT01412957|59037807|FG000|Overall Study|Lost to Follow-up|7|||
30967754|NCT01412957|59037808|FG001|Overall Study|Lost to Follow-up|2|||
30967755|NCT01412957|59037807|FG000|Overall Study|Death|136|||
30967756|NCT01412957|59037808|FG001|Overall Study|Death|133|||
30967757|NCT01432457|59037821|FG000|Overall Study|Adverse Event|7|||
30967758|NCT01432457|59037822|FG001|Overall Study|Adverse Event|10|||
30967759|NCT01432457|59037823|FG002|Overall Study|Adverse Event|16|||
30967760|NCT01432457|59037821|FG000|Overall Study|Lack of Efficacy|2|||
30967761|NCT01432457|59037822|FG001|Overall Study|Lack of Efficacy|1|||
30967762|NCT01432457|59037823|FG002|Overall Study|Lack of Efficacy|1|||
30967763|NCT01432457|59037821|FG000|Overall Study|Lost to Follow-up|11|||
30967764|NCT01432457|59037822|FG001|Overall Study|Lost to Follow-up|15|||
30967765|NCT01432457|59037823|FG002|Overall Study|Lost to Follow-up|20|||
30967766|NCT01432457|59037821|FG000|Overall Study|Protocol Violation|3|||
30967767|NCT01432457|59037822|FG001|Overall Study|Protocol Violation|2|||
30967768|NCT01432457|59037823|FG002|Overall Study|Protocol Violation|6|||
30967769|NCT01432457|59037821|FG000|Overall Study|Withdrawal by Subject|6|||
30967770|NCT01432457|59037822|FG001|Overall Study|Withdrawal by Subject|11|||
30967771|NCT01432457|59037823|FG002|Overall Study|Withdrawal by Subject|9|||
30967772|NCT01432457|59037821|FG000|Overall Study|Reasons not defined|2|||
30967773|NCT01432457|59037822|FG001|Overall Study|Reasons not defined|3|||
30967774|NCT01432457|59037823|FG002|Overall Study|Reasons not defined|4|||
30967775|NCT01432457|59037821|FG000|Overall Study|Did not take study drug|6|||
30967776|NCT01432457|59037822|FG001|Overall Study|Did not take study drug|6|||
30967777|NCT01432457|59037823|FG002|Overall Study|Did not take study drug|3|||
30967778|NCT01390441|59037845|FG000|Treatment Period|Protocol Violation|0|||
30967779|NCT01390441|59037846|FG001|Treatment Period|Protocol Violation|1|||
30967780|NCT01390441|59037847|FG002|Treatment Period|Protocol Violation|0|||
30967781|NCT01390441|59037848|FG003|Treatment Period|Protocol Violation|0|||
30967782|NCT01390441|59037849|FG004|Treatment Period|Protocol Violation|0|||
30967783|NCT01390441|59037845|FG000|Treatment Period|Physician Decision|0|||
30967784|NCT01390441|59037846|FG001|Treatment Period|Physician Decision|0|||
30967785|NCT01390441|59037847|FG002|Treatment Period|Physician Decision|0|||
30967786|NCT01390441|59037848|FG003|Treatment Period|Physician Decision|1|||
30967787|NCT01390441|59037849|FG004|Treatment Period|Physician Decision|0|||
30967788|NCT01390441|59037845|FG000|Treatment Period|Lack of Efficacy|0|||
30967789|NCT01390441|59037846|FG001|Treatment Period|Lack of Efficacy|0|||
30967790|NCT01390441|59037847|FG002|Treatment Period|Lack of Efficacy|0|||
30967791|NCT01390441|59037848|FG003|Treatment Period|Lack of Efficacy|0|||
30967792|NCT01390441|59037849|FG004|Treatment Period|Lack of Efficacy|1|||
30967793|NCT01390441|59037845|FG000|Treatment Period|Unknown due to early stopping of study|0|||
30967794|NCT01390441|59037846|FG001|Treatment Period|Unknown due to early stopping of study|0|||
30967795|NCT01390441|59037847|FG002|Treatment Period|Unknown due to early stopping of study|8|||
30967796|NCT01390441|59037848|FG003|Treatment Period|Unknown due to early stopping of study|11|||
30967797|NCT01390441|59037849|FG004|Treatment Period|Unknown due to early stopping of study|7|||
30967798|NCT01390441|59037845|FG000|Treatment Period|Adverse Event|0|||
30967799|NCT01390441|59037846|FG001|Treatment Period|Adverse Event|0|||
30967800|NCT01390441|59037847|FG002|Treatment Period|Adverse Event|1|||
30967801|NCT01390441|59037848|FG003|Treatment Period|Adverse Event|1|||
30967802|NCT01390441|59037849|FG004|Treatment Period|Adverse Event|2|||
30967803|NCT01390441|59037845|FG000|Treatment Period|Withdrawal by Subject|0|||
30967804|NCT01390441|59037846|FG001|Treatment Period|Withdrawal by Subject|0|||
30967805|NCT01390441|59037847|FG002|Treatment Period|Withdrawal by Subject|1|||
30967806|NCT01390441|59037848|FG003|Treatment Period|Withdrawal by Subject|0|||
30967807|NCT01390441|59037849|FG004|Treatment Period|Withdrawal by Subject|1|||
30967808|NCT01390441|59037845|FG000|Treatment Period|Lost to Follow-up|1|||
30967809|NCT01390441|59037846|FG001|Treatment Period|Lost to Follow-up|0|||
30967810|NCT01390441|59037847|FG002|Treatment Period|Lost to Follow-up|0|||
30967811|NCT01390441|59037848|FG003|Treatment Period|Lost to Follow-up|0|||
30967812|NCT01390441|59037849|FG004|Treatment Period|Lost to Follow-up|0|||
30967813|NCT01390441|59037845|FG000|Extension Period|Protocol Violation|3|||
30967814|NCT01390441|59037846|FG001|Extension Period|Protocol Violation|1|||
30967815|NCT01390441|59037847|FG002|Extension Period|Protocol Violation|0|||
30967816|NCT01390441|59037848|FG003|Extension Period|Protocol Violation|1|||
30967817|NCT01390441|59037849|FG004|Extension Period|Protocol Violation|0|||
30967818|NCT01412879|59037898|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
30967819|NCT01412879|59037899|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
30967820|NCT01412879|59037900|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
30967821|NCT01412879|59037898|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
30967822|NCT01412879|59037899|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
30967823|NCT01412879|59037900|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
30967824|NCT01412879|59037898|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
30967825|NCT01412879|59037899|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
30967826|NCT01412879|59037900|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
30967827|NCT01412879|59037898|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
30967828|NCT01412879|59037899|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
30967829|NCT01412879|59037900|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
30967830|NCT01412879|59037898|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
30967831|NCT01412879|59037899|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
30967832|NCT01412879|59037900|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
30967833|NCT01431079|59037912|FG000|Overall Study|Lost to Follow-up|35|||
30967834|NCT01431079|59037913|FG001|Overall Study|Lost to Follow-up|39|||
30967835|NCT01430611|59037945|FG000|Overall Study|Adverse Event|0|||
30967836|NCT01430611|59037946|FG001|Overall Study|Adverse Event|1|||
30967837|NCT01430611|59037945|FG000|Overall Study|Protocol Violation|1|||
30967838|NCT01430611|59037946|FG001|Overall Study|Protocol Violation|0|||
30967839|NCT01430611|59037945|FG000|Overall Study|Lost to Follow-up|1|||
30967840|NCT01430611|59037946|FG001|Overall Study|Lost to Follow-up|0|||
30967841|NCT01430611|59037945|FG000|Overall Study|Withdrawal by Subject|15|||
30967842|NCT01430611|59037946|FG001|Overall Study|Withdrawal by Subject|14|||
30967843|NCT01409707|59037955|FG000|Overall Study|Withdrawal by Subject|5|||
30967844|NCT01409707|59037956|FG001|Overall Study|Withdrawal by Subject|17|||
30967845|NCT01409707|59037957|FG002|Overall Study|Withdrawal by Subject|16|||
30967846|NCT01389973|59037964|FG000|Overall Study|Lost to Follow-up|1|||
30967847|NCT01389973|59037964|FG000|Overall Study|Trial Stopped by Sponsor|9|||
30967848|NCT01389973|59037964|FG000|Overall Study|Other|10|||
30967849|NCT01389817|59037984|FG000|Overall Study|Physician Decision|1|||
30967850|NCT01389817|59037985|FG001|Overall Study|Physician Decision|0|||
30967851|NCT01389817|59037984|FG000|Overall Study|Lost to Follow-up|1|||
30967852|NCT01389817|59037985|FG001|Overall Study|Lost to Follow-up|0|||
30967853|NCT01389817|59037984|FG000|Overall Study|Withdrawal by Subject|2|||
30967854|NCT01389817|59037985|FG001|Overall Study|Withdrawal by Subject|0|||
30967855|NCT01430455|59038000|FG000|Overall Study|Withdrawal by Subject|1|||
30967856|NCT01430455|59038000|FG000|Overall Study|Switched to follow-up phase|1|||
30967857|NCT01429441|59038028|FG000|Overall Study|Adverse Event|5|||
30967858|NCT01429441|59038029|FG001|Overall Study|Adverse Event|1|||
30967859|NCT01429441|59038028|FG000|Overall Study|Death|0|||
30967860|NCT01429441|59038029|FG001|Overall Study|Death|2|||
30967861|NCT01429441|59038028|FG000|Overall Study|Lost to Follow-up|5|||
30967862|NCT01429441|59038029|FG001|Overall Study|Lost to Follow-up|2|||
30967863|NCT01429441|59038028|FG000|Overall Study|Physician Decision|1|||
30967864|NCT01429441|59038029|FG001|Overall Study|Physician Decision|0|||
30967865|NCT01429441|59038028|FG000|Overall Study|Withdrawal by Subject|27|||
30967866|NCT01429441|59038029|FG001|Overall Study|Withdrawal by Subject|18|||
30967867|NCT01429285|59038064|FG000|Overall Study|Protocol Violation|9|||
30967868|NCT01429285|59038065|FG001|Overall Study|Protocol Violation|4|||
30967869|NCT01429285|59038064|FG000|Overall Study|Missing Data|5|||
30967870|NCT01429285|59038065|FG001|Overall Study|Missing Data|3|||
30967871|NCT01429285|59038064|FG000|Overall Study|Erroneously Enrolled Twice|8|||
30967872|NCT01429285|59038065|FG001|Overall Study|Erroneously Enrolled Twice|2|||
30967873|NCT01429051|59038142|FG000|Titration Phase|Death|1|||
30967874|NCT01429051|59038142|FG000|Titration Phase|Withdrawal by Subject|7|||
30967875|NCT01429051|59038142|FG000|Titration Phase|Physician Decision|1|||
30967876|NCT01429051|59038142|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
30967877|NCT01429051|59038142|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
30967878|NCT01429051|59038142|FG000|Efficacy Phase|Adverse Event|1|||
30967879|NCT01429051|59038142|FG000|Efficacy Phase|Death|1|||
30967880|NCT01429051|59038142|FG000|Tolerability Phase|Death|5|||
30967881|NCT01429051|59038142|FG000|Tolerability Phase|Adverse Event|2|||
30967882|NCT01429051|59038142|FG000|Tolerability Phase|Withdrawal by Subject|5|||
30967883|NCT01429051|59038142|FG000|Tolerability Phase|Physician Decision|1|||
30967884|NCT01429051|59038142|FG000|Tolerability Phase|Other|2|||
30967885|NCT01428661|59038175|FG000|Double-Masked Phase|Protocol Violation|9|||
30967886|NCT01428661|59038176|FG001|Double-Masked Phase|Protocol Violation|4|||
30967887|NCT01428661|59038177|FG002|Double-Masked Phase|Protocol Violation|0|||
30967888|NCT01428661|59038175|FG000|Double-Masked Phase|Adverse Event|13|||
30967889|NCT01428661|59038176|FG001|Double-Masked Phase|Adverse Event|4|||
30967890|NCT01428661|59038177|FG002|Double-Masked Phase|Adverse Event|0|||
30967891|NCT01428661|59038175|FG000|Double-Masked Phase|Lost to Follow-up|14|||
30967892|NCT01428661|59038176|FG001|Double-Masked Phase|Lost to Follow-up|14|||
30967893|NCT01428661|59038177|FG002|Double-Masked Phase|Lost to Follow-up|0|||
30967894|NCT01428661|59038175|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
30967895|NCT01428661|59038176|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
30967896|NCT01428661|59038177|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
30967897|NCT01428661|59038175|FG000|Double-Masked Phase|Lack of Efficacy|2|||
30967898|NCT01428661|59038176|FG001|Double-Masked Phase|Lack of Efficacy|1|||
30967899|NCT01428661|59038177|FG002|Double-Masked Phase|Lack of Efficacy|0|||
30967900|NCT01428661|59038175|FG000|Double-Masked Phase|*Various|1|||
30967901|NCT01428661|59038176|FG001|Double-Masked Phase|*Various|6|||
30967902|NCT01428661|59038177|FG002|Double-Masked Phase|*Various|0|||
30967903|NCT01428661|59038175|FG000|Open Label Extension|Protocol Violation|0|||
30967904|NCT01428661|59038176|FG001|Open Label Extension|Protocol Violation|0|||
30698034|NCT00642954|58712384|FG004|Overall Study|Withdrawal by Subject|1|||
30698035|NCT00642954|58712380|FG000|Overall Study|Adverse Event|1|||
30967905|NCT01428661|59038177|FG002|Open Label Extension|Protocol Violation|9|||
30967906|NCT01428661|59038175|FG000|Open Label Extension|Adverse Event|0|||
30967907|NCT01428661|59038176|FG001|Open Label Extension|Adverse Event|0|||
30967908|NCT01428661|59038177|FG002|Open Label Extension|Adverse Event|15|||
30967909|NCT01428661|59038175|FG000|Open Label Extension|Lost to Follow-up|0|||
30967910|NCT01428661|59038176|FG001|Open Label Extension|Lost to Follow-up|0|||
30967911|NCT01428661|59038177|FG002|Open Label Extension|Lost to Follow-up|38|||
30967912|NCT01428661|59038175|FG000|Open Label Extension|Withdrawal by Subject|0|||
30967913|NCT01428661|59038176|FG001|Open Label Extension|Withdrawal by Subject|0|||
30967914|NCT01428661|59038177|FG002|Open Label Extension|Withdrawal by Subject|49|||
30967915|NCT01428661|59038175|FG000|Open Label Extension|Lack of Efficacy|0|||
30967916|NCT01428661|59038176|FG001|Open Label Extension|Lack of Efficacy|0|||
30967917|NCT01428661|59038177|FG002|Open Label Extension|Lack of Efficacy|24|||
30967918|NCT01428661|59038175|FG000|Open Label Extension|**Various|0|||
30967919|NCT01428661|59038176|FG001|Open Label Extension|**Various|0|||
30967920|NCT01428661|59038177|FG002|Open Label Extension|**Various|185|||
30967921|NCT01428583|59038185|FG000|Overall Study|Adverse Event|75|||
30967922|NCT01428583|59038185|FG000|Overall Study|Withdrawal by Subject|51|||
30967923|NCT01428583|59038185|FG000|Overall Study|Lack of Efficacy|37|||
30967924|NCT01428583|59038185|FG000|Overall Study|Lost to Follow-up|17|||
30967925|NCT01428583|59038185|FG000|Overall Study|Death|1|||
30967926|NCT01428583|59038185|FG000|Overall Study|Pregnancy|1|||
30967927|NCT01428583|59038185|FG000|Overall Study|Protocol Violation|1|||
30967928|NCT01428583|59038185|FG000|Overall Study|Physician Decision|12|||
30967929|NCT01428583|59038185|FG000|Overall Study|Non-compliant|25|||
30967930|NCT01428583|59038185|FG000|Overall Study|Confirmed positive urine drug test|8|||
30967931|NCT01428583|59038185|FG000|Overall Study|Sponsor's request|3|||
30967932|NCT01428583|59038185|FG000|Overall Study|Other|6|||
30967933|NCT01428193|59038202|FG000|Overall Study|Physician Decision|1|||
30967934|NCT01428193|59038202|FG000|Overall Study|Elevated screening liver enzymes|1|||
30967935|NCT01428115|59038206|FG000|Overall Study|Lack of Efficacy|3|||
30967936|NCT01428115|59038206|FG000|Overall Study|Lost to Follow-up|10|||
30967937|NCT01428115|59038206|FG000|Overall Study|Pregnancy|1|||
30967938|NCT01428115|59038206|FG000|Overall Study|Protocol Violation|3|||
30967939|NCT01428115|59038206|FG000|Overall Study|Withdrawal by Subject|4|||
30967940|NCT01427803|59038213|FG000|Overall Study|Lost to Follow-up|32|||
30967941|NCT01427803|59038214|FG001|Overall Study|Lost to Follow-up|26|||
30967942|NCT01427803|59038213|FG000|Overall Study|Withdrawal by Subject|20|||
30967943|NCT01427803|59038214|FG001|Overall Study|Withdrawal by Subject|0|||
30967944|NCT01427803|59038213|FG000|Overall Study|Unable to complete full treatment period|6|||
30967945|NCT01427803|59038214|FG001|Overall Study|Unable to complete full treatment period|0|||
30967946|NCT01427803|59038213|FG000|Overall Study|Protocol Violation|1|||
30967947|NCT01427803|59038214|FG001|Overall Study|Protocol Violation|0|||
30967948|NCT01427803|59038213|FG000|Overall Study|Physician Decision|3|||
30967949|NCT01427803|59038214|FG001|Overall Study|Physician Decision|0|||
30967950|NCT01427803|59038213|FG000|Overall Study|did not take product|1|||
30967951|NCT01427803|59038214|FG001|Overall Study|did not take product|0|||
30967952|NCT01408537|59038218|FG000|Overall Study|Withdrawal by Subject|2|||
30967953|NCT01408537|59038218|FG000|Overall Study|Protocol Violation|3|||
30967954|NCT01408537|59038218|FG000|Overall Study|Lost to Follow-up|3|||
30967955|NCT01408459|59038251|FG000|Overall Study|Withdrawal by Subject|1|||
30967956|NCT01408459|59038252|FG001|Overall Study|Withdrawal by Subject|1|||
30967957|NCT01408303|59038271|FG000|Overall Study|Adverse Event|3|||
30967958|NCT01408303|59038272|FG001|Overall Study|Adverse Event|7|||
30967959|NCT01408303|59038273|FG002|Overall Study|Adverse Event|2|||
30967960|NCT01408303|59038271|FG000|Overall Study|Lost to Follow-up|0|||
30967961|NCT01408303|59038272|FG001|Overall Study|Lost to Follow-up|1|||
30967962|NCT01408303|59038273|FG002|Overall Study|Lost to Follow-up|2|||
30967963|NCT01408303|59038271|FG000|Overall Study|Withdrawal by Subject|2|||
30967964|NCT01408303|59038272|FG001|Overall Study|Withdrawal by Subject|3|||
30967965|NCT01408303|59038273|FG002|Overall Study|Withdrawal by Subject|1|||
30967966|NCT01408303|59038271|FG000|Overall Study|Protocol Violation|0|||
30967967|NCT01408303|59038272|FG001|Overall Study|Protocol Violation|1|||
30967968|NCT01408303|59038273|FG002|Overall Study|Protocol Violation|0|||
30967969|NCT01408303|59038271|FG000|Overall Study|Noncompliance|1|||
30967970|NCT01408303|59038272|FG001|Overall Study|Noncompliance|0|||
30967971|NCT01408303|59038273|FG002|Overall Study|Noncompliance|1|||
30967972|NCT01408147|59038294|FG000|Overall Study|Withdrawal by Subject|0|||
30967973|NCT01408147|59038295|FG001|Overall Study|Withdrawal by Subject|1|||
30967974|NCT01407367|59038303|FG000|Overall Study|Death|24|||
30967975|NCT01407367|59038304|FG001|Overall Study|Death|32|||
30967976|NCT01407367|59038303|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
30967977|NCT01407367|59038304|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
30967978|NCT01407367|59038303|FG000|Overall Study|Withdrawal by Subject|4|||
30967979|NCT01407367|59038304|FG001|Overall Study|Withdrawal by Subject|15|||
30967980|NCT01407367|59038303|FG000|Overall Study|Lost to Follow-up|0|||
30967981|NCT01407367|59038304|FG001|Overall Study|Lost to Follow-up|2|||
30967982|NCT01405027|59038340|FG000|Overall Study|Withdrawn consent|3|||
30967983|NCT01405027|59038341|FG001|Overall Study|Withdrawn consent|0|||
30967984|NCT01405027|59038340|FG000|Overall Study|Lost to Follow-up|16|||
30967985|NCT01405027|59038341|FG001|Overall Study|Lost to Follow-up|24|||
30967986|NCT01405027|59038340|FG000|Overall Study|Investigator judgement|0|||
30967987|NCT01405027|59038341|FG001|Overall Study|Investigator judgement|2|||
30967988|NCT01405027|59038340|FG000|Overall Study|Death|1|||
30967989|NCT01405027|59038341|FG001|Overall Study|Death|0|||
30967990|NCT01405027|59038340|FG000|Overall Study|Other or Unknown|12|||
30967991|NCT01405027|59038341|FG001|Overall Study|Other or Unknown|25|||
30967992|NCT01412801|59038362|FG000|Overall Study|Death|0|||
30967993|NCT01412801|59038363|FG001|Overall Study|Death|1|||
30967994|NCT01412801|59038364|FG002|Overall Study|Death|0|||
30967995|NCT01412801|59038365|FG003|Overall Study|Death|4|||
30967996|NCT01412801|59038366|FG004|Overall Study|Death|2|||
30967997|NCT01412801|59038367|FG005|Overall Study|Death|2|||
30967998|NCT01412801|59038362|FG000|Overall Study|Lost to Follow-up|1|||
30967999|NCT01412801|59038363|FG001|Overall Study|Lost to Follow-up|2|||
30968000|NCT01412801|59038364|FG002|Overall Study|Lost to Follow-up|4|||
30968001|NCT01412801|59038365|FG003|Overall Study|Lost to Follow-up|0|||
30968002|NCT01412801|59038366|FG004|Overall Study|Lost to Follow-up|1|||
30968003|NCT01412801|59038367|FG005|Overall Study|Lost to Follow-up|1|||
30968004|NCT01412801|59038362|FG000|Overall Study|Withdrawal by Subject|3|||
30968005|NCT01412801|59038363|FG001|Overall Study|Withdrawal by Subject|2|||
30968006|NCT01412801|59038364|FG002|Overall Study|Withdrawal by Subject|1|||
30968007|NCT01412801|59038365|FG003|Overall Study|Withdrawal by Subject|0|||
30968008|NCT01412801|59038366|FG004|Overall Study|Withdrawal by Subject|0|||
30968009|NCT01412801|59038367|FG005|Overall Study|Withdrawal by Subject|0|||
30968010|NCT01412801|59038362|FG000|Overall Study|Relocated to another area|0|||
30968011|NCT01412801|59038363|FG001|Overall Study|Relocated to another area|0|||
30968012|NCT01412801|59038364|FG002|Overall Study|Relocated to another area|2|||
30968013|NCT01412801|59038365|FG003|Overall Study|Relocated to another area|0|||
30968014|NCT01412801|59038366|FG004|Overall Study|Relocated to another area|0|||
30968015|NCT01412801|59038367|FG005|Overall Study|Relocated to another area|0|||
30968016|NCT01525628|59038415|FG000|Overall Study|Adverse Event|1|||
30968017|NCT01525628|59038416|FG001|Overall Study|Adverse Event|1|||
30968018|NCT01525628|59038417|FG002|Overall Study|Adverse Event|2|||
30968019|NCT01525628|59038418|FG003|Overall Study|Adverse Event|0|||
30968020|NCT01525628|59038419|FG004|Overall Study|Adverse Event|1|||
30968021|NCT01525628|59038415|FG000|Overall Study|Lack of Efficacy|0|||
30968022|NCT01525628|59038416|FG001|Overall Study|Lack of Efficacy|2|||
30968023|NCT01525628|59038417|FG002|Overall Study|Lack of Efficacy|2|||
30968024|NCT01525628|59038418|FG003|Overall Study|Lack of Efficacy|1|||
30968025|NCT01525628|59038419|FG004|Overall Study|Lack of Efficacy|2|||
30968026|NCT01525628|59038415|FG000|Overall Study|Protocol Violation|0|||
30968027|NCT01525628|59038416|FG001|Overall Study|Protocol Violation|0|||
30968028|NCT01525628|59038417|FG002|Overall Study|Protocol Violation|1|||
30968029|NCT01525628|59038418|FG003|Overall Study|Protocol Violation|0|||
30968030|NCT01525628|59038419|FG004|Overall Study|Protocol Violation|0|||
30968031|NCT01525628|59038415|FG000|Overall Study|Lost to Follow-up|1|||
30968032|NCT01525628|59038416|FG001|Overall Study|Lost to Follow-up|1|||
30968033|NCT01525628|59038417|FG002|Overall Study|Lost to Follow-up|0|||
30968034|NCT01525628|59038418|FG003|Overall Study|Lost to Follow-up|0|||
30968035|NCT01525628|59038419|FG004|Overall Study|Lost to Follow-up|0|||
30968036|NCT01525628|59038415|FG000|Overall Study|Withdrawal by Subject|0|||
30968037|NCT01525628|59038416|FG001|Overall Study|Withdrawal by Subject|1|||
30968038|NCT01525628|59038417|FG002|Overall Study|Withdrawal by Subject|0|||
30968039|NCT01525628|59038418|FG003|Overall Study|Withdrawal by Subject|0|||
30968040|NCT01525628|59038419|FG004|Overall Study|Withdrawal by Subject|0|||
30968041|NCT01525628|59038415|FG000|Overall Study|Other reason not defined above|0|||
30968042|NCT01525628|59038416|FG001|Overall Study|Other reason not defined above|0|||
30968043|NCT01525628|59038417|FG002|Overall Study|Other reason not defined above|0|||
30968044|NCT01525628|59038418|FG003|Overall Study|Other reason not defined above|3|||
30968045|NCT01525628|59038419|FG004|Overall Study|Other reason not defined above|0|||
30968046|NCT01412021|59038437|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
30968047|NCT01412021|59038437|FG000|Overall Study|Treatment Prior to Approval|3|||
30968048|NCT01412021|59038437|FG000|Overall Study|Transferred to Other Hospital|9|||
30968049|NCT01426789|59038443|FG000|Part 1|Protocol deviation|0|||
30968050|NCT01426789|59038444|FG001|Part 1|Protocol deviation|1|||
30968051|NCT01426789|59038445|FG002|Part 1|Protocol deviation|0|||
30968052|NCT01426789|59038446|FG003|Part 1|Protocol deviation|0|||
30968053|NCT01426789|59038447|FG004|Part 1|Protocol deviation|0|||
30968054|NCT01426789|59038448|FG005|Part 1|Protocol deviation|0|||
30968055|NCT01426789|59038443|FG000|Part 1|Lost to Follow-up|1|||
30968056|NCT01426789|59038444|FG001|Part 1|Lost to Follow-up|2|||
30968057|NCT01426789|59038445|FG002|Part 1|Lost to Follow-up|0|||
30968058|NCT01426789|59038446|FG003|Part 1|Lost to Follow-up|0|||
30968059|NCT01426789|59038447|FG004|Part 1|Lost to Follow-up|0|||
30968060|NCT01426789|59038448|FG005|Part 1|Lost to Follow-up|0|||
30968061|NCT01426789|59038443|FG000|Part 1|Lack of Efficacy|2|||
30968062|NCT01426789|59038444|FG001|Part 1|Lack of Efficacy|1|||
30968063|NCT01426789|59038445|FG002|Part 1|Lack of Efficacy|0|||
30968064|NCT01426789|59038446|FG003|Part 1|Lack of Efficacy|0|||
30968065|NCT01426789|59038447|FG004|Part 1|Lack of Efficacy|0|||
30968066|NCT01426789|59038448|FG005|Part 1|Lack of Efficacy|0|||
30968067|NCT01426789|59038443|FG000|Part 1|Adverse Event|3|||
30968068|NCT01426789|59038444|FG001|Part 1|Adverse Event|0|||
30968069|NCT01426789|59038445|FG002|Part 1|Adverse Event|0|||
30968070|NCT01426789|59038446|FG003|Part 1|Adverse Event|0|||
30968071|NCT01426789|59038447|FG004|Part 1|Adverse Event|0|||
30968072|NCT01426789|59038448|FG005|Part 1|Adverse Event|0|||
30968073|NCT01426789|59038443|FG000|Part 2|Protocol deviation|0|||
30968074|NCT01426789|59038444|FG001|Part 2|Protocol deviation|0|||
30968075|NCT01426789|59038445|FG002|Part 2|Protocol deviation|1|||
30968076|NCT01426789|59038446|FG003|Part 2|Protocol deviation|0|||
30968077|NCT01426789|59038447|FG004|Part 2|Protocol deviation|0|||
30968078|NCT01426789|59038448|FG005|Part 2|Protocol deviation|0|||
30968079|NCT01426789|59038443|FG000|Part 2|Death|0|||
30968080|NCT01426789|59038444|FG001|Part 2|Death|0|||
30968081|NCT01426789|59038445|FG002|Part 2|Death|1|||
30968082|NCT01426789|59038446|FG003|Part 2|Death|0|||
30968083|NCT01426789|59038447|FG004|Part 2|Death|1|||
30968084|NCT01426789|59038448|FG005|Part 2|Death|0|||
30968085|NCT01426789|59038443|FG000|Part 2|Administrative problems|0|||
30968086|NCT01426789|59038444|FG001|Part 2|Administrative problems|0|||
30968087|NCT01426789|59038445|FG002|Part 2|Administrative problems|2|||
30968088|NCT01426789|59038446|FG003|Part 2|Administrative problems|0|||
30968089|NCT01426789|59038447|FG004|Part 2|Administrative problems|1|||
30968090|NCT01426789|59038448|FG005|Part 2|Administrative problems|0|||
30968091|NCT01426789|59038443|FG000|Part 2|Lost to Follow-up|0|||
30968092|NCT01426789|59038444|FG001|Part 2|Lost to Follow-up|0|||
30968093|NCT01426789|59038445|FG002|Part 2|Lost to Follow-up|4|||
30968094|NCT01426789|59038446|FG003|Part 2|Lost to Follow-up|0|||
30968095|NCT01426789|59038447|FG004|Part 2|Lost to Follow-up|1|||
30968096|NCT01426789|59038448|FG005|Part 2|Lost to Follow-up|0|||
30968097|NCT01426789|59038443|FG000|Part 2|Withdrawal by Subject|0|||
30968098|NCT01426789|59038444|FG001|Part 2|Withdrawal by Subject|0|||
30968099|NCT01426789|59038445|FG002|Part 2|Withdrawal by Subject|0|||
30968100|NCT01426789|59038446|FG003|Part 2|Withdrawal by Subject|1|||
30968101|NCT01426789|59038447|FG004|Part 2|Withdrawal by Subject|2|||
30968102|NCT01426789|59038448|FG005|Part 2|Withdrawal by Subject|0|||
30968103|NCT01426789|59038443|FG000|Part 2|Lack of Efficacy|0|||
30968104|NCT01426789|59038444|FG001|Part 2|Lack of Efficacy|0|||
30968105|NCT01426789|59038445|FG002|Part 2|Lack of Efficacy|5|||
30968106|NCT01426789|59038446|FG003|Part 2|Lack of Efficacy|0|||
30968107|NCT01426789|59038447|FG004|Part 2|Lack of Efficacy|2|||
30968108|NCT01426789|59038448|FG005|Part 2|Lack of Efficacy|0|||
30968109|NCT01426789|59038443|FG000|Part 2|Adverse Event|0|||
30968110|NCT01426789|59038444|FG001|Part 2|Adverse Event|0|||
30968111|NCT01426789|59038445|FG002|Part 2|Adverse Event|2|||
30968112|NCT01426789|59038446|FG003|Part 2|Adverse Event|0|||
30968113|NCT01426789|59038447|FG004|Part 2|Adverse Event|1|||
30968114|NCT01426789|59038448|FG005|Part 2|Adverse Event|0|||
30968115|NCT01426009|59038469|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
30968116|NCT01426009|59038469|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
30968117|NCT01426009|59038469|FG000|Washout 1|Withdrawal by Subject|1|||
30968118|NCT01426009|59038469|FG000|Washout 1|Personal Reasons|1|||
30968119|NCT01426009|59038469|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
30968120|NCT01426009|59038469|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
30968121|NCT01426009|59038469|FG000|Washout 2|electrive surgery|1|||
30968122|NCT01426009|59038469|FG000|Washout 3|personal reasons|1|||
30968123|NCT01426009|59038469|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
30968124|NCT01426009|59038469|FG000|Washout 4|Lost to Follow-up|1|||
30968125|NCT01411319|59038498|FG000|Overall Study|Lost to Follow-up|1|||
30968126|NCT01543958|59038502|FG000|Overall Study|Loss to follow-up|3|||
30968127|NCT01543958|59038502|FG000|Overall Study|ART initiation|1|||
30968128|NCT01411085|59038506|FG000|Overall Study|Physician Decision|1|||
30968129|NCT01411085|59038506|FG000|Overall Study|Protocol Violation|1|||
30968130|NCT01411085|59038506|FG000|Overall Study|Adverse Event|1|||
30968131|NCT01543490|59038512|FG000|Overall Study|Adverse Event|4|||
30968132|NCT01543490|59038513|FG001|Overall Study|Adverse Event|0|||
30968133|NCT01543490|59038512|FG000|Overall Study|Physician Decision|1|||
30968134|NCT01543490|59038513|FG001|Overall Study|Physician Decision|0|||
30968135|NCT01543490|59038512|FG000|Overall Study|Lack of Efficacy|3|||
30968136|NCT01543490|59038513|FG001|Overall Study|Lack of Efficacy|3|||
30968137|NCT01543490|59038512|FG000|Overall Study|Lost to Follow-up|5|||
30968138|NCT01543490|59038513|FG001|Overall Study|Lost to Follow-up|0|||
30968139|NCT01543490|59038512|FG000|Overall Study|Withdrawal by Subject|2|||
30968140|NCT01543490|59038513|FG001|Overall Study|Withdrawal by Subject|0|||
30968141|NCT01543490|59038512|FG000|Overall Study|Other-Various Administrative Reasons|1|||
30968142|NCT01543490|59038513|FG001|Overall Study|Other-Various Administrative Reasons|2|||
30968143|NCT01404949|59038519|FG000|Overall Study|Not Treated|1|||
30968144|NCT01431521|59038527|FG000|Overall Study|Withdrawal by Subject|0|||
30968145|NCT01431521|59038528|FG001|Overall Study|Withdrawal by Subject|0|||
30968146|NCT01431521|59038529|FG002|Overall Study|Withdrawal by Subject|1|||
30968147|NCT01431521|59038530|FG003|Overall Study|Withdrawal by Subject|0|||
30968148|NCT01404325|59038615|FG000|Overall Study|Lost to Follow-up|1|||
30968149|NCT01404325|59038616|FG001|Overall Study|Lost to Follow-up|0|||
30968150|NCT01404325|59038615|FG000|Overall Study|Death|2|||
30968151|NCT01404325|59038616|FG001|Overall Study|Death|0|||
30968152|NCT01404325|59038615|FG000|Overall Study|Graft loss/Retransplantation|1|||
30968153|NCT01404325|59038616|FG001|Overall Study|Graft loss/Retransplantation|0|||
30968154|NCT01404325|59038615|FG000|Overall Study|non-specified reason|0|||
30968155|NCT01404325|59038616|FG001|Overall Study|non-specified reason|2|||
30968156|NCT01425463|59038637|FG000|Overall Study|Adverse Event|5|||
30968157|NCT01425463|59038638|FG001|Overall Study|Adverse Event|7|||
30968158|NCT01425463|59038637|FG000|Overall Study|Lack of Efficacy|1|||
30968159|NCT01425463|59038638|FG001|Overall Study|Lack of Efficacy|1|||
30968160|NCT01425463|59038637|FG000|Overall Study|Protocol Violation|2|||
30968161|NCT01425463|59038638|FG001|Overall Study|Protocol Violation|2|||
30968162|NCT01425463|59038637|FG000|Overall Study|Lost to Follow-up|5|||
30968163|NCT01425463|59038638|FG001|Overall Study|Lost to Follow-up|2|||
30968164|NCT01425463|59038637|FG000|Overall Study|Withdrawal by Subject|7|||
30968165|NCT01425463|59038638|FG001|Overall Study|Withdrawal by Subject|5|||
30968166|NCT01425463|59038637|FG000|Overall Study|Unknown Reason|4|||
30968167|NCT01425463|59038638|FG001|Overall Study|Unknown Reason|7|||
30968168|NCT04655586|59038660|FG000|Overall Study|Physician Decision|1|||
30968169|NCT04655586|59038661|FG001|Overall Study|Physician Decision|3|||
30968170|NCT04655586|59038662|FG002|Overall Study|Physician Decision|4|||
30968171|NCT04655586|59038660|FG000|Overall Study|Withdrawal by Subject|1|||
30968172|NCT04655586|59038661|FG001|Overall Study|Withdrawal by Subject|3|||
30968173|NCT04655586|59038662|FG002|Overall Study|Withdrawal by Subject|1|||
30968174|NCT01388647|59038685|FG000|Overall Study|Adverse Event|1|||
30968175|NCT01388647|59038686|FG001|Overall Study|Adverse Event|2|||
30968176|NCT01402063|59038761|FG000|Overall Study|Withdrawal by Subject|3|||
30968177|NCT01402063|59038762|FG001|Overall Study|Withdrawal by Subject|3|||
30968178|NCT01796301|59038770|FG000|Overall Study|Withdrawal by Subject|15|||
30968179|NCT01796301|59038771|FG001|Overall Study|Withdrawal by Subject|15|||
30968180|NCT01796301|59038770|FG000|Overall Study|Lost to Follow-up|3|||
30968181|NCT01796301|59038771|FG001|Overall Study|Lost to Follow-up|3|||
30968182|NCT01796301|59038770|FG000|Overall Study|Death|0|||
30968183|NCT01796301|59038771|FG001|Overall Study|Death|1|||
30968184|NCT01796301|59038770|FG000|Overall Study|Decision by Sponsor|0|||
30968185|NCT01796301|59038771|FG001|Overall Study|Decision by Sponsor|1|||
30968186|NCT01388335|59038790|FG000|Period 1|Progressive Disease|1|||
30968187|NCT01388335|59038790|FG000|Period 2|Progressive Disease|2|||
30968188|NCT01388335|59038790|FG000|Period 2|Sponsor Decision|1|||
30968189|NCT01388335|59038790|FG000|Safety Extension|Progressive Disease|7|||
30968190|NCT01401361|59038837|FG000|Overall Study|Withdrawal by Subject|16|||
30968191|NCT01401361|59038837|FG000|Overall Study|Lack of Efficacy|6|||
30968192|NCT01401361|59038837|FG000|Overall Study|Physician Decision|1|||
30968193|NCT01401361|59038837|FG000|Overall Study|Lost to Follow-up|3|||
30968194|NCT01401361|59038837|FG000|Overall Study|Subject/family decision post procedure|2|||
30968195|NCT01401283|59038843|FG000|Overall Study|surgery cancelled|5|||
30968196|NCT01401283|59038844|FG001|Overall Study|surgery cancelled|8|||
30968197|NCT01401283|59038843|FG000|Overall Study|preoperative arrhythmia|5|||
30968198|NCT01401283|59038844|FG001|Overall Study|preoperative arrhythmia|0|||
30968199|NCT01401283|59038843|FG000|Overall Study|no central venous access|0|||
30968200|NCT01401283|59038844|FG001|Overall Study|no central venous access|1|||
30968201|NCT01401283|59038843|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
30968202|NCT01401283|59038844|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
30968203|NCT01422889|59038867|FG000|Overall Study|No Data Entered for Study Stent|9|||
30968204|NCT01400971|59038871|FG000|Overall Study|Death|82|||
30968205|NCT01400971|59038871|FG000|Overall Study|Lost to Follow-up|196|||
30968206|NCT01400971|59038871|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
30968207|NCT01400971|59038871|FG000|Overall Study|Physician Decision|57|||
30968208|NCT01400971|59038871|FG000|Overall Study|Withdrawal by Subject|158|||
30968209|NCT01400971|59038871|FG000|Overall Study|Other|422|||
30968210|NCT01387789|59038875|FG000|Overall Study|Adverse Event|5|||
30968211|NCT01387789|59038875|FG000|Overall Study|Lack of Efficacy|2|||
30968212|NCT01387789|59038875|FG000|Overall Study|Lost to Follow-up|1|||
30968213|NCT01400893|59038886|FG000|Overall Study|Death|27|||
30968214|NCT01400893|59038887|FG001|Overall Study|Death|21|||
30968215|NCT01400893|59038886|FG000|Overall Study|Lost to Follow-up|0|||
30968216|NCT01400893|59038887|FG001|Overall Study|Lost to Follow-up|6|||
30968217|NCT01400815|59038927|FG000|Overall Study|Adverse Event|3|||
30968218|NCT01400815|59038928|FG001|Overall Study|Adverse Event|0|||
30968219|NCT01400815|59038927|FG000|Overall Study|Death|0|||
30968220|NCT01400815|59038928|FG001|Overall Study|Death|1|||
30968221|NCT01400815|59038927|FG000|Overall Study|Lost to Follow-up|18|||
30968222|NCT01400815|59038928|FG001|Overall Study|Lost to Follow-up|11|||
30968223|NCT01400815|59038927|FG000|Overall Study|Protocol Violation|0|||
30968224|NCT01400815|59038928|FG001|Overall Study|Protocol Violation|1|||
30968225|NCT01400815|59038927|FG000|Overall Study|Physician Decision|1|||
30968226|NCT01400815|59038928|FG001|Overall Study|Physician Decision|0|||
30968227|NCT01400815|59038927|FG000|Overall Study|Withdrawal by Subject|15|||
30968228|NCT01400815|59038928|FG001|Overall Study|Withdrawal by Subject|8|||
30968229|NCT01400815|59038927|FG000|Overall Study|Subject in jail|1|||
30968230|NCT01400815|59038928|FG001|Overall Study|Subject in jail|0|||
30968231|NCT01400503|59038982|FG000|Overall Study|Withdrawal by Subject|1|||
30968232|NCT01400503|59038982|FG000|Overall Study|Study Terminated by Sponsor|58|||
30968233|NCT01400503|59038982|FG000|Overall Study|Other|1|||
30968234|NCT01400425|59038998|FG000|Overall Study|Withdrawal by Subject|10|||
30968235|NCT01421719|59039004|FG000|Overall Study|Withdrawal by Subject|4|||
30968236|NCT01421641|59039011|FG000|Overall Study|Protocol Violation|2|||
30968237|NCT01421641|59039012|FG001|Overall Study|Protocol Violation|2|||
30968238|NCT01385995|59039020|FG000|Period 1, 2 Months|Physician Decision|1|||
30968239|NCT01385995|59039021|FG001|Period 1, 2 Months|Physician Decision|0|||
30968240|NCT01421017|59039032|FG000|Overall Study|Withdrawal by Subject|2|||
30968241|NCT01421017|59039033|FG001|Overall Study|Withdrawal by Subject|0|||
30968242|NCT01421017|59039034|FG002|Overall Study|Withdrawal by Subject|0|||
30968243|NCT01421017|59039032|FG000|Overall Study|POD|0|||
30968244|NCT01421017|59039033|FG001|Overall Study|POD|6|||
30968245|NCT01421017|59039034|FG002|Overall Study|POD|3|||
30968246|NCT01420627|59039081|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
30968247|NCT01400113|59039091|FG000|Overall Study|Withdrawal by Subject|1|||
30968248|NCT01400113|59039092|FG001|Overall Study|Withdrawal by Subject|1|||
30968249|NCT01399723|59039100|FG000|Overall Study|Lost to Follow-up|0|||
30968250|NCT01399723|59039101|FG001|Overall Study|Lost to Follow-up|1|||
30968251|NCT01385371|59039110|FG000|Overall Study|Adverse Event|54|||
30968252|NCT01385371|59039111|FG001|Overall Study|Adverse Event|19|||
30968253|NCT01385371|59039110|FG000|Overall Study|Lost to Follow-up|16|||
30968254|NCT01385371|59039111|FG001|Overall Study|Lost to Follow-up|16|||
30968255|NCT01385371|59039110|FG000|Overall Study|Withdrawal by Subject|52|||
30968256|NCT01385371|59039111|FG001|Overall Study|Withdrawal by Subject|39|||
30968257|NCT01385371|59039110|FG000|Overall Study|Protocol Violation|25|||
30968258|NCT01385371|59039111|FG001|Overall Study|Protocol Violation|21|||
30968259|NCT01385371|59039110|FG000|Overall Study|Administrative|2|||
30968260|NCT01385371|59039111|FG001|Overall Study|Administrative|2|||
30968261|NCT01399099|59039117|FG000|Overall Study|Lost to Follow-up|11|||
30968262|NCT01399099|59039117|FG000|Overall Study|Physician Decision|1|||
30968263|NCT01399099|59039117|FG000|Overall Study|Protocol Violation|1|||
30968264|NCT01399099|59039117|FG000|Overall Study|Skin Irritation|13|||
30968265|NCT01399099|59039117|FG000|Overall Study|Infection|1|||
30968266|NCT01399099|59039117|FG000|Overall Study|Miscellaneous|4|||
30968267|NCT01398787|59039122|FG000|Overall Study|Adverse Event|1|||
30968268|NCT01383499|59039128|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
30968269|NCT01383499|59039129|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
30968270|NCT01383499|59039130|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
30968271|NCT01383499|59039131|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
30968272|NCT01397461|59039147|FG000|Overall Study|Withdrawal by Subject|2|||
30968273|NCT01397461|59039148|FG001|Overall Study|Withdrawal by Subject|1|||
30968274|NCT01397461|59039149|FG002|Overall Study|Withdrawal by Subject|0|||
30968275|NCT01397461|59039147|FG000|Overall Study|Lost to Follow-up|0|||
30968276|NCT01397461|59039148|FG001|Overall Study|Lost to Follow-up|2|||
30968277|NCT01397461|59039149|FG002|Overall Study|Lost to Follow-up|1|||
30968278|NCT01397461|59039147|FG000|Overall Study|Lack of Efficacy|0|||
30968279|NCT01397461|59039148|FG001|Overall Study|Lack of Efficacy|3|||
30968280|NCT01397461|59039149|FG002|Overall Study|Lack of Efficacy|0|||
30968281|NCT01397461|59039147|FG000|Overall Study|Not treated|0|||
30968282|NCT01397461|59039148|FG001|Overall Study|Not treated|0|||
30968283|NCT01397461|59039149|FG002|Overall Study|Not treated|1|||
30968284|NCT01382251|59039159|FG000|Overall Study|Surgeries cancelled or delayed|16|||
30968285|NCT01382251|59039160|FG001|Overall Study|Surgeries cancelled or delayed|16|||
30968286|NCT01382251|59039159|FG000|Overall Study|Lost to Follow-up|4|||
30968287|NCT01382251|59039160|FG001|Overall Study|Lost to Follow-up|4|||
30968288|NCT01382251|59039159|FG000|Overall Study|Contacted after study closed|1|||
30968289|NCT01382251|59039160|FG001|Overall Study|Contacted after study closed|1|||
30968290|NCT01396525|59039165|FG000|Overall Study|Withdrawal by Subject|8|||
30968291|NCT01396525|59039165|FG000|Overall Study|Death|14|||
30968292|NCT01396525|59039165|FG000|Overall Study|Lost to Follow-up|4|||
30968293|NCT02849652|59039177|FG000|Overall Study|Lost to Follow-up|104|||
30968294|NCT02849652|59039178|FG001|Overall Study|Lost to Follow-up|35|||
30968295|NCT02849652|59039179|FG002|Overall Study|Lost to Follow-up|116|||
30968296|NCT02849652|59039180|FG003|Overall Study|Lost to Follow-up|22|||
30968297|NCT02849652|59039177|FG000|Overall Study|Withdrawal by Subject|10|||
30968298|NCT02849652|59039178|FG001|Overall Study|Withdrawal by Subject|2|||
30968299|NCT02849652|59039179|FG002|Overall Study|Withdrawal by Subject|8|||
30968300|NCT02849652|59039180|FG003|Overall Study|Withdrawal by Subject|4|||
30968301|NCT01396447|59039192|FG000|Overall Study|Did Not Receive Treatment|3|||
30698036|NCT00642954|58712381|FG001|Overall Study|Adverse Event|1|||
30968302|NCT01396447|59039193|FG001|Overall Study|Did Not Receive Treatment|2|||
30968303|NCT01396447|59039194|FG002|Overall Study|Did Not Receive Treatment|1|||
30968304|NCT01396447|59039195|FG003|Overall Study|Did Not Receive Treatment|0|||
30968305|NCT01396447|59039192|FG000|Overall Study|Adverse Event|15|||
30968306|NCT01396447|59039193|FG001|Overall Study|Adverse Event|12|||
30968307|NCT01396447|59039194|FG002|Overall Study|Adverse Event|12|||
30968308|NCT01396447|59039195|FG003|Overall Study|Adverse Event|17|||
30968309|NCT01396447|59039192|FG000|Overall Study|Insufficient Therapeutic Response|5|||
30968310|NCT01396447|59039193|FG001|Overall Study|Insufficient Therapeutic Response|5|||
30968311|NCT01396447|59039194|FG002|Overall Study|Insufficient Therapeutic Response|2|||
30968312|NCT01396447|59039195|FG003|Overall Study|Insufficient Therapeutic Response|4|||
30968313|NCT01396447|59039192|FG000|Overall Study|Protocol Violation|5|||
30968314|NCT01396447|59039193|FG001|Overall Study|Protocol Violation|2|||
30968315|NCT01396447|59039194|FG002|Overall Study|Protocol Violation|3|||
30968316|NCT01396447|59039195|FG003|Overall Study|Protocol Violation|7|||
30968317|NCT01396447|59039192|FG000|Overall Study|Withdrawal of Consent|11|||
30968318|NCT01396447|59039193|FG001|Overall Study|Withdrawal of Consent|9|||
30968319|NCT01396447|59039194|FG002|Overall Study|Withdrawal of Consent|4|||
30968320|NCT01396447|59039195|FG003|Overall Study|Withdrawal of Consent|15|||
30968321|NCT01396447|59039192|FG000|Overall Study|Lost to Follow-up|4|||
30968322|NCT01396447|59039193|FG001|Overall Study|Lost to Follow-up|8|||
30968323|NCT01396447|59039194|FG002|Overall Study|Lost to Follow-up|7|||
30968324|NCT01396447|59039195|FG003|Overall Study|Lost to Follow-up|9|||
30968325|NCT01396447|59039192|FG000|Overall Study|Other Miscellaneous Reasons|0|||
30968326|NCT01396447|59039193|FG001|Overall Study|Other Miscellaneous Reasons|2|||
30968327|NCT01396447|59039194|FG002|Overall Study|Other Miscellaneous Reasons|1|||
30968328|NCT01396447|59039195|FG003|Overall Study|Other Miscellaneous Reasons|0|||
30968329|NCT01678560|59039268|FG000|Overall Study|Physician Decision|4|||
30968330|NCT01678560|59039269|FG001|Overall Study|Physician Decision|4|||
30968331|NCT01678560|59039268|FG000|Overall Study|Death|0|||
30968332|NCT01678560|59039269|FG001|Overall Study|Death|1|||
30968333|NCT01678560|59039268|FG000|Overall Study|Withdrawal by Subject|0|||
30968334|NCT01678560|59039269|FG001|Overall Study|Withdrawal by Subject|1|||
30968335|NCT01381549|59039308|FG000|Overall Study|Ineligible: No organisms isolated|0|||
30968336|NCT01381549|59039309|FG001|Overall Study|Ineligible: No organisms isolated|0|||
30968337|NCT01381549|59039310|FG002|Overall Study|Ineligible: No organisms isolated|1|||
30968338|NCT00159432|59039319|FG000|Overall Study|Adverse Event|1|||
30968339|NCT00159432|59039319|FG000|Overall Study|Death|1|||
30968340|NCT00159432|59039319|FG000|Overall Study|Lack of Efficacy|8|||
30968341|NCT01396057|59039325|FG000|Overall Study|Adverse Event|2|||
30968342|NCT01396057|59039326|FG001|Overall Study|Adverse Event|6|||
30968343|NCT01396057|59039325|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30968344|NCT01396057|59039326|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
30968345|NCT01396057|59039325|FG000|Overall Study|Protocol deviation|4|||
30968346|NCT01396057|59039326|FG001|Overall Study|Protocol deviation|4|||
30968347|NCT01396057|59039325|FG000|Overall Study|Consent withdrawn|3|||
30968348|NCT01396057|59039326|FG001|Overall Study|Consent withdrawn|2|||
30968349|NCT01380769|59039343|FG000|Overall Study|Withdrawal by Subject|7|||
30968350|NCT01380769|59039344|FG001|Overall Study|Withdrawal by Subject|11|||
30968351|NCT01380769|59039343|FG000|Overall Study|Physician Decision|1|||
30968352|NCT01380769|59039344|FG001|Overall Study|Physician Decision|1|||
30968353|NCT01380769|59039343|FG000|Overall Study|Adverse Event|1|||
30968354|NCT01380769|59039344|FG001|Overall Study|Adverse Event|1|||
30968355|NCT01380769|59039343|FG000|Overall Study|Protocol Violation|0|||
30968356|NCT01380769|59039344|FG001|Overall Study|Protocol Violation|1|||
30968357|NCT01395901|59039352|FG000|Overall Study|Lost to Follow-up|4|||
30968358|NCT01395901|59039353|FG001|Overall Study|Lost to Follow-up|0|||
30968359|NCT01395901|59039352|FG000|Overall Study|Randomized but not received study drug|5|||
30968360|NCT01395901|59039353|FG001|Overall Study|Randomized but not received study drug|4|||
30968361|NCT01395901|59039352|FG000|Overall Study|Adverse Event|0|||
30968362|NCT01395901|59039353|FG001|Overall Study|Adverse Event|1|||
30968363|NCT01395901|59039352|FG000|Overall Study|Withdrawal of consent|1|||
30968364|NCT01395901|59039353|FG001|Overall Study|Withdrawal of consent|0|||
30968365|NCT01395823|59039361|FG000|Overall Study|Death|4|||
30968366|NCT01395823|59039362|FG001|Overall Study|Death|4|||
30968367|NCT01395823|59039361|FG000|Overall Study|Physician Decision|3|||
30968368|NCT01395823|59039362|FG001|Overall Study|Physician Decision|1|||
30968369|NCT01395823|59039361|FG000|Overall Study|Lost to Follow-up|1|||
30968370|NCT01395823|59039362|FG001|Overall Study|Lost to Follow-up|0|||
30968371|NCT01395823|59039361|FG000|Overall Study|Transplant|1|||
30968372|NCT01395823|59039362|FG001|Overall Study|Transplant|0|||
30968373|NCT01395823|59039361|FG000|Overall Study|GI symptoms|1|||
30968374|NCT01395823|59039362|FG001|Overall Study|GI symptoms|0|||
30968375|NCT01395823|59039361|FG000|Overall Study|Withdrawal by Subject|5|||
30968376|NCT01395823|59039362|FG001|Overall Study|Withdrawal by Subject|4|||
30968377|NCT00158184|59039370|FG000|Overall Study|personal issues|3|||
30968378|NCT00158184|59039371|FG001|Overall Study|personal issues|1|||
30968379|NCT00158184|59039370|FG000|Overall Study|failed for follow unit/study rules|2|||
30968380|NCT00158184|59039371|FG001|Overall Study|failed for follow unit/study rules|0|||
30968381|NCT00158184|59039370|FG000|Overall Study|Adverse Event|1|||
30968382|NCT00158184|59039371|FG001|Overall Study|Adverse Event|1|||
30968383|NCT01380691|59039379|FG000|Washout (7 Days)|Protocol Violation|0|||
30968384|NCT01380691|59039380|FG001|Washout (7 Days)|Protocol Violation|0|||
30968385|NCT01380691|59039381|FG002|Washout (7 Days)|Protocol Violation|0|||
30968386|NCT01380691|59039382|FG003|Washout (7 Days)|Protocol Violation|1|||
30968387|NCT01380691|59039379|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
30968388|NCT01380691|59039380|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
30968389|NCT01380691|59039381|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
30968390|NCT01380691|59039382|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
30968391|NCT01380535|59039408|FG000|Overall Study|Adverse Event|3|||
30968392|NCT01380535|59039409|FG001|Overall Study|Adverse Event|3|||
30968393|NCT01380535|59039408|FG000|Overall Study|Death|3|||
30968394|NCT01380535|59039409|FG001|Overall Study|Death|0|||
30968395|NCT01380535|59039408|FG000|Overall Study|Study site closed|0|||
30968396|NCT01380535|59039409|FG001|Overall Study|Study site closed|5|||
30968397|NCT01380535|59039408|FG000|Overall Study|Withdrawal by Subject|1|||
30968398|NCT01380535|59039409|FG001|Overall Study|Withdrawal by Subject|2|||
30968399|NCT01380535|59039408|FG000|Overall Study|Protocol Violation|0|||
30968400|NCT01380535|59039409|FG001|Overall Study|Protocol Violation|2|||
30968401|NCT01380535|59039408|FG000|Overall Study|Lack of Efficacy|0|||
30968402|NCT01380535|59039409|FG001|Overall Study|Lack of Efficacy|3|||
30968403|NCT01380379|59039419|FG000|Overall Study|Pregnancy|1|||
30968404|NCT01380145|59039423|FG000|Overall Study|Progressive disease|4|||
30968405|NCT03420222|59039449|FG000|Overall Study|Withdrawal by Subject|5|||
30968406|NCT03420222|59039450|FG001|Overall Study|Withdrawal by Subject|0|||
30968407|NCT03420222|59039449|FG000|Overall Study|Physician Decision|0|||
30968408|NCT03420222|59039450|FG001|Overall Study|Physician Decision|1|||
30968409|NCT01394185|59039456|FG000|Overall Study|Withdrawal by Subject|2|||
30968410|NCT01394185|59039457|FG001|Overall Study|Withdrawal by Subject|0|||
30968411|NCT01394185|59039458|FG002|Overall Study|Withdrawal by Subject|0|||
30968412|NCT01394185|59039459|FG003|Overall Study|Withdrawal by Subject|0|||
30968413|NCT01394185|59039460|FG004|Overall Study|Withdrawal by Subject|1|||
30968414|NCT01394185|59039461|FG005|Overall Study|Withdrawal by Subject|0|||
30968415|NCT01394185|59039456|FG000|Overall Study|Change in protocol|3|||
30968416|NCT01394185|59039457|FG001|Overall Study|Change in protocol|0|||
30968417|NCT01394185|59039458|FG002|Overall Study|Change in protocol|0|||
30968418|NCT01394185|59039459|FG003|Overall Study|Change in protocol|0|||
30968419|NCT01394185|59039460|FG004|Overall Study|Change in protocol|3|||
30968420|NCT01394185|59039461|FG005|Overall Study|Change in protocol|0|||
30968421|NCT01394185|59039456|FG000|Overall Study|Protocol Violation|1|||
30968422|NCT01394185|59039457|FG001|Overall Study|Protocol Violation|0|||
30968423|NCT01394185|59039458|FG002|Overall Study|Protocol Violation|0|||
30968424|NCT01394185|59039459|FG003|Overall Study|Protocol Violation|1|||
30968425|NCT01394185|59039460|FG004|Overall Study|Protocol Violation|0|||
30968426|NCT01394185|59039461|FG005|Overall Study|Protocol Violation|1|||
30968427|NCT01677936|59039494|FG000|Overall Study|Lost to Follow-up|4|||
30968428|NCT01677936|59039495|FG001|Overall Study|Lost to Follow-up|1|||
30968429|NCT01677936|59039494|FG000|Overall Study|Protocol Violation|3|||
30968430|NCT01677936|59039495|FG001|Overall Study|Protocol Violation|0|||
30968431|NCT01677936|59039494|FG000|Overall Study|Adverse Event|1|||
30968432|NCT01677936|59039495|FG001|Overall Study|Adverse Event|0|||
30968433|NCT01677936|59039494|FG000|Overall Study|Lost to Follow-up|1|||
30968434|NCT01677936|59039495|FG001|Overall Study|Lost to Follow-up|0|||
30968435|NCT01677936|59039494|FG000|Overall Study|Protocol Violation|0|||
30968436|NCT01677936|59039495|FG001|Overall Study|Protocol Violation|4|||
30968437|NCT01525550|59039526|FG000|Overall Study|Lost to Follow-up|8|||
30968438|NCT01525550|59039527|FG001|Overall Study|Lost to Follow-up|2|||
30968439|NCT01525550|59039526|FG000|Overall Study|Death|19|||
30968440|NCT01525550|59039527|FG001|Overall Study|Death|28|||
30968441|NCT01525550|59039526|FG000|Overall Study|Other|0|||
30968442|NCT01525550|59039527|FG001|Overall Study|Other|4|||
30968443|NCT01525550|59039526|FG000|Overall Study|Sponsor's Decision|30|||
30968444|NCT01525550|59039527|FG001|Overall Study|Sponsor's Decision|11|||
30968445|NCT01525550|59039526|FG000|Overall Study|Withdrawal by Subject|4|||
30968446|NCT01525550|59039527|FG001|Overall Study|Withdrawal by Subject|0|||
30968447|NCT00211237|59039548|FG000|Baseline|Withdrew|1|||
30968448|NCT00211237|59039549|FG001|Baseline|Withdrew|3|||
30968449|NCT00211237|59039550|FG002|Baseline|Withdrew|0|||
30968450|NCT00211237|59039548|FG000|Baseline|Refused random assignment|1|||
30968451|NCT00211237|59039549|FG001|Baseline|Refused random assignment|0|||
30968452|NCT00211237|59039550|FG002|Baseline|Refused random assignment|0|||
30968453|NCT00211237|59039548|FG000|1 Month|Death|2|||
30968454|NCT00211237|59039549|FG001|1 Month|Death|1|||
30968455|NCT00211237|59039550|FG002|1 Month|Death|0|||
30968456|NCT00211237|59039548|FG000|1 Month|Lost to Follow-up|0|||
30968457|NCT00211237|59039549|FG001|1 Month|Lost to Follow-up|2|||
30968458|NCT00211237|59039550|FG002|1 Month|Lost to Follow-up|0|||
30968459|NCT00211237|59039548|FG000|1 Month|Withdrew|0|||
30968460|NCT00211237|59039549|FG001|1 Month|Withdrew|4|||
30968461|NCT00211237|59039550|FG002|1 Month|Withdrew|0|||
30968462|NCT00211237|59039548|FG000|1 Month|Additional surgery needed|1|||
30968463|NCT00211237|59039549|FG001|1 Month|Additional surgery needed|0|||
30968464|NCT00211237|59039550|FG002|1 Month|Additional surgery needed|0|||
30968465|NCT00211237|59039548|FG000|1 Month|Non-medical problem|0|||
30968466|NCT00211237|59039549|FG001|1 Month|Non-medical problem|2|||
30968467|NCT00211237|59039550|FG002|1 Month|Non-medical problem|0|||
30968468|NCT00211237|59039548|FG000|3 Months|Death|7|||
30968469|NCT00211237|59039549|FG001|3 Months|Death|3|||
30968470|NCT00211237|59039550|FG002|3 Months|Death|0|||
30968471|NCT00211237|59039548|FG000|3 Months|Could not comply with protocol|1|||
30968472|NCT00211237|59039549|FG001|3 Months|Could not comply with protocol|0|||
30968473|NCT00211237|59039550|FG002|3 Months|Could not comply with protocol|0|||
30968474|NCT00211237|59039548|FG000|3 Months|Withdrew|0|||
30968475|NCT00211237|59039549|FG001|3 Months|Withdrew|1|||
30968476|NCT00211237|59039550|FG002|3 Months|Withdrew|0|||
30968477|NCT00211237|59039548|FG000|3 Months|Non-medical problem|0|||
30968478|NCT00211237|59039549|FG001|3 Months|Non-medical problem|0|||
30968479|NCT00211237|59039550|FG002|3 Months|Non-medical problem|1|||
30968480|NCT00211237|59039548|FG000|6 Months|Death|6|||
30968481|NCT00211237|59039549|FG001|6 Months|Death|0|||
30968482|NCT00211237|59039550|FG002|6 Months|Death|3|||
30968483|NCT00211237|59039548|FG000|6 Months|Lost to Follow-up|2|||
30968484|NCT00211237|59039549|FG001|6 Months|Lost to Follow-up|0|||
30968485|NCT00211237|59039550|FG002|6 Months|Lost to Follow-up|0|||
30968486|NCT00211237|59039548|FG000|6 Months|Could not comply with protocol|0|||
30968487|NCT00211237|59039549|FG001|6 Months|Could not comply with protocol|2|||
30968488|NCT00211237|59039550|FG002|6 Months|Could not comply with protocol|0|||
30968489|NCT00211237|59039548|FG000|12 Months|Death|8|||
30968490|NCT00211237|59039549|FG001|12 Months|Death|2|||
30968491|NCT00211237|59039550|FG002|12 Months|Death|3|||
30968492|NCT00211237|59039548|FG000|12 Months|Lost to Follow-up|1|||
30968493|NCT00211237|59039549|FG001|12 Months|Lost to Follow-up|0|||
30968494|NCT00211237|59039550|FG002|12 Months|Lost to Follow-up|1|||
30968495|NCT00211237|59039548|FG000|12 Months|Withdrew|0|||
30968496|NCT00211237|59039549|FG001|12 Months|Withdrew|0|||
30968497|NCT00211237|59039550|FG002|12 Months|Withdrew|1|||
30968498|NCT00211237|59039548|FG000|12 Months|unrelated medical problem|0|||
30968499|NCT00211237|59039549|FG001|12 Months|unrelated medical problem|0|||
30968500|NCT00211237|59039550|FG002|12 Months|unrelated medical problem|1|||
30968501|NCT01489358|59039570|FG000|Overall Study|Lost to Follow-up|0|||
30968502|NCT01489358|59039571|FG001|Overall Study|Lost to Follow-up|0|||
30968503|NCT01489358|59039572|FG002|Overall Study|Lost to Follow-up|2|||
30968504|NCT01525238|59039583|FG000|Overall Study|Withdrawal by Subject|1|||
30968505|NCT01525238|59039584|FG001|Overall Study|Withdrawal by Subject|0|||
30968506|NCT01525238|59039585|FG002|Overall Study|Withdrawal by Subject|0|||
30968507|NCT01525082|59039606|FG000|Overall Study|Death|1|||
30968508|NCT01488578|59039613|FG000|Overall Study|Protocol Violation|1836|||
30968509|NCT01524770|59039654|FG000|First Intervention|Withdrawal by Subject|1|||
30968510|NCT01524770|59039655|FG001|First Intervention|Withdrawal by Subject|0|||
30968511|NCT01524770|59039654|FG000|First Intervention|Adverse Event|1|||
30968512|NCT01524770|59039655|FG001|First Intervention|Adverse Event|1|||
30968513|NCT01524770|59039654|FG000|First Intervention|Protocol Violation|1|||
30968514|NCT01524770|59039655|FG001|First Intervention|Protocol Violation|0|||
30968515|NCT01524692|59039661|FG000|Overall Study|Withdrawal by Subject|3|||
30968516|NCT01431287|59039680|FG000|Overall Study|not treated|0|||
30968517|NCT01431287|59039681|FG001|Overall Study|not treated|0|||
30968518|NCT01431287|59039682|FG002|Overall Study|not treated|1|||
30968519|NCT01431287|59039683|FG003|Overall Study|not treated|0|||
30968520|NCT01431287|59039684|FG004|Overall Study|not treated|0|||
30968521|NCT01431287|59039680|FG000|Overall Study|Adverse Event|59|||
30968522|NCT01431287|59039681|FG001|Overall Study|Adverse Event|57|||
30968523|NCT01431287|59039682|FG002|Overall Study|Adverse Event|53|||
30968524|NCT01431287|59039683|FG003|Overall Study|Adverse Event|33|||
30968525|NCT01431287|59039684|FG004|Overall Study|Adverse Event|41|||
30968526|NCT01431287|59039680|FG000|Overall Study|Non compliant with protocol|6|||
30968527|NCT01431287|59039681|FG001|Overall Study|Non compliant with protocol|6|||
30968528|NCT01431287|59039682|FG002|Overall Study|Non compliant with protocol|5|||
30968529|NCT01431287|59039683|FG003|Overall Study|Non compliant with protocol|6|||
30968530|NCT01431287|59039684|FG004|Overall Study|Non compliant with protocol|5|||
30968531|NCT01431287|59039680|FG000|Overall Study|Lost to Follow-up|0|||
30968532|NCT01431287|59039681|FG001|Overall Study|Lost to Follow-up|3|||
30968533|NCT01431287|59039682|FG002|Overall Study|Lost to Follow-up|2|||
30968534|NCT01431287|59039683|FG003|Overall Study|Lost to Follow-up|3|||
30968535|NCT01431287|59039684|FG004|Overall Study|Lost to Follow-up|1|||
30968536|NCT01431287|59039680|FG000|Overall Study|Consent withdrawn not due to AE|29|||
30968537|NCT01431287|59039681|FG001|Overall Study|Consent withdrawn not due to AE|30|||
30968538|NCT01431287|59039682|FG002|Overall Study|Consent withdrawn not due to AE|34|||
30968539|NCT01431287|59039683|FG003|Overall Study|Consent withdrawn not due to AE|19|||
30968540|NCT01431287|59039684|FG004|Overall Study|Consent withdrawn not due to AE|29|||
30968541|NCT01431287|59039680|FG000|Overall Study|not stated above|4|||
30968542|NCT01431287|59039681|FG001|Overall Study|not stated above|2|||
30968543|NCT01431287|59039682|FG002|Overall Study|not stated above|2|||
30968544|NCT01431287|59039683|FG003|Overall Study|not stated above|2|||
30968545|NCT01431287|59039684|FG004|Overall Study|not stated above|1|||
30968546|NCT01274715|59039730|FG000|Overall Study|Lost to Follow-up|1|||
30968547|NCT01274715|59039730|FG000|Overall Study|After consent, met exclusion criteria.|1|||
30968548|NCT01274715|59039730|FG000|Overall Study|After consent, met exclusion criteria.|1|||
30968549|NCT01274715|59039730|FG000|Overall Study|After consent, met exclusion criteria.|1|||
30968550|NCT01410227|59039734|FG000|Overall Study|Adverse Event|1|||
30968551|NCT01410227|59039735|FG001|Overall Study|Adverse Event|0|||
30968552|NCT01410227|59039736|FG002|Overall Study|Adverse Event|0|||
30968553|NCT01410227|59039737|FG003|Overall Study|Adverse Event|0|||
30968554|NCT01410227|59039734|FG000|Overall Study|Withdrawal by Subject|3|||
30968555|NCT01410227|59039735|FG001|Overall Study|Withdrawal by Subject|0|||
30968556|NCT01410227|59039736|FG002|Overall Study|Withdrawal by Subject|1|||
30968557|NCT01410227|59039737|FG003|Overall Study|Withdrawal by Subject|0|||
30968558|NCT01410227|59039734|FG000|Overall Study|Pregnancy|0|||
30968559|NCT01410227|59039735|FG001|Overall Study|Pregnancy|0|||
30968560|NCT01410227|59039736|FG002|Overall Study|Pregnancy|0|||
30968561|NCT01410227|59039737|FG003|Overall Study|Pregnancy|1|||
30968562|NCT01410227|59039734|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
30968563|NCT01410227|59039735|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
30968564|NCT01410227|59039736|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
30968565|NCT01410227|59039737|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
30968566|NCT01274559|59039749|FG000|Overall Study|Adverse Event|57|||
30968567|NCT01274559|59039750|FG001|Overall Study|Adverse Event|13|||
30968568|NCT01274559|59039749|FG000|Overall Study|Death|1|||
30968569|NCT01274559|59039750|FG001|Overall Study|Death|1|||
30968570|NCT01274559|59039749|FG000|Overall Study|Lost to Follow-up|3|||
30968571|NCT01274559|59039750|FG001|Overall Study|Lost to Follow-up|3|||
30968572|NCT01274559|59039749|FG000|Overall Study|Non-compliance with Study Drug|2|||
30968573|NCT01274559|59039750|FG001|Overall Study|Non-compliance with Study Drug|4|||
30968574|NCT01274559|59039749|FG000|Overall Study|Physician Decision|2|||
30968575|NCT01274559|59039750|FG001|Overall Study|Physician Decision|1|||
30968576|NCT01274559|59039749|FG000|Overall Study|Protocol Violation|28|||
30968577|NCT01274559|59039750|FG001|Overall Study|Protocol Violation|23|||
30968578|NCT01274559|59039749|FG000|Overall Study|Study Terminated by Sponsor|79|||
30968579|NCT01274559|59039750|FG001|Overall Study|Study Terminated by Sponsor|87|||
30968580|NCT01274559|59039749|FG000|Overall Study|Withdrawal by Subject|25|||
30968581|NCT01274559|59039750|FG001|Overall Study|Withdrawal by Subject|13|||
30968582|NCT01409993|59039758|FG000|Overall Study|Adverse Event|4|||
30968583|NCT01409993|59039759|FG001|Overall Study|Adverse Event|4|||
30968584|NCT01409993|59039760|FG002|Overall Study|Adverse Event|3|||
30968585|NCT01409993|59039761|FG003|Overall Study|Adverse Event|1|||
30968586|NCT01409993|59039758|FG000|Overall Study|Withdrawal by Subject|0|||
30968587|NCT01409993|59039759|FG001|Overall Study|Withdrawal by Subject|0|||
30968588|NCT01409993|59039760|FG002|Overall Study|Withdrawal by Subject|0|||
30968589|NCT01409993|59039761|FG003|Overall Study|Withdrawal by Subject|4|||
30968590|NCT01409993|59039758|FG000|Overall Study|Lost to Follow-up|0|||
30968591|NCT01409993|59039759|FG001|Overall Study|Lost to Follow-up|1|||
30968592|NCT01409993|59039760|FG002|Overall Study|Lost to Follow-up|0|||
30968593|NCT01409993|59039761|FG003|Overall Study|Lost to Follow-up|0|||
30968594|NCT01273623|59039775|FG000|Overall Study|did not meet IVUS criteria|29|||
30968595|NCT01409915|59039783|FG000|Overall Study|Adverse Event|0|||
30968596|NCT01409915|59039784|FG001|Overall Study|Adverse Event|2|||
30968597|NCT01409915|59039783|FG000|Overall Study|Withdrawal by Subject|0|||
30968598|NCT01409915|59039784|FG001|Overall Study|Withdrawal by Subject|1|||
30968599|NCT01409915|59039783|FG000|Overall Study|Protocol Violation|1|||
30968600|NCT01409915|59039784|FG001|Overall Study|Protocol Violation|0|||
30968601|NCT01272921|59039792|FG000|Overall Study|Protocol Violation|2|||
30968602|NCT01272921|59039793|FG001|Overall Study|Protocol Violation|1|||
30968603|NCT01409837|59039803|FG000|Overall Study|Withdrawal by Subject|2|||
30968604|NCT01409837|59039804|FG001|Overall Study|Withdrawal by Subject|1|||
30968605|NCT01409837|59039803|FG000|Overall Study|Lost to Follow-up|1|||
30968606|NCT01409837|59039804|FG001|Overall Study|Lost to Follow-up|0|||
30968607|NCT01409837|59039803|FG000|Overall Study|Physician Decision|0|||
30968608|NCT01409837|59039804|FG001|Overall Study|Physician Decision|1|||
30968609|NCT01430585|59039823|FG000|Overall Study|Death|1|||
30968610|NCT01430585|59039823|FG000|Overall Study|Objective Progression or Relapse|3|||
30968611|NCT01430585|59039823|FG000|Overall Study|Study Terminated by Sponsor|3|||
30968612|NCT01430585|59039823|FG000|Overall Study|Other|7|||
30968613|NCT01408901|59039846|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
30968614|NCT01408901|59039847|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
30968615|NCT01408901|59039848|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
30968616|NCT01408901|59039849|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
30968617|NCT01408901|59039846|FG000|6-Week Follow-Up|Death|1|||
30968618|NCT01408901|59039847|FG001|6-Week Follow-Up|Death|0|||
30968619|NCT01408901|59039848|FG002|6-Week Follow-Up|Death|0|||
30968620|NCT01408901|59039849|FG003|6-Week Follow-Up|Death|0|||
30968621|NCT01408901|59039846|FG000|6-Week Follow-Up|Cancelled visit|0|||
30968622|NCT01408901|59039847|FG001|6-Week Follow-Up|Cancelled visit|1|||
30968623|NCT01408901|59039848|FG002|6-Week Follow-Up|Cancelled visit|0|||
30968624|NCT01408901|59039849|FG003|6-Week Follow-Up|Cancelled visit|2|||
30968625|NCT01408901|59039846|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
30968626|NCT01408901|59039847|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
30968627|NCT01408901|59039848|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
30968628|NCT01408901|59039849|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
30968629|NCT01408901|59039846|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
30968630|NCT01408901|59039847|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
30968631|NCT01408901|59039848|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
30968632|NCT01408901|59039849|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
30968633|NCT01408901|59039846|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
30968634|NCT01408901|59039847|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
30968635|NCT01408901|59039848|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
30968636|NCT01408901|59039849|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
30968637|NCT01408901|59039846|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
30968638|NCT01408901|59039847|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
30968639|NCT01408901|59039848|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
30968640|NCT01408901|59039849|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
30968641|NCT01408901|59039846|FG000|26-Week Follow-Up|Death|0|||
30968642|NCT01408901|59039847|FG001|26-Week Follow-Up|Death|1|||
30968643|NCT01408901|59039848|FG002|26-Week Follow-Up|Death|0|||
30968644|NCT01408901|59039849|FG003|26-Week Follow-Up|Death|0|||
30968645|NCT01428713|59039865|FG000|Overall Study|Non-compliance|2|||
30968646|NCT01428713|59039866|FG001|Overall Study|Non-compliance|2|||
30968647|NCT01428713|59039865|FG000|Overall Study|Withdrawal by Subject|1|||
30968648|NCT01428713|59039866|FG001|Overall Study|Withdrawal by Subject|1|||
30968649|NCT01428713|59039865|FG000|Overall Study|Adverse Event|0|||
30968650|NCT01428713|59039866|FG001|Overall Study|Adverse Event|2|||
30968651|NCT01408277|59039874|FG000|Overall Study|Adverse Event|3|||
30968652|NCT01408277|59039875|FG001|Overall Study|Adverse Event|4|||
30968653|NCT01408277|59039874|FG000|Overall Study|Lost to Follow-up|1|||
30968654|NCT01408277|59039875|FG001|Overall Study|Lost to Follow-up|0|||
30968655|NCT01408277|59039874|FG000|Overall Study|Withdrawal by Subject|2|||
30968656|NCT01408277|59039875|FG001|Overall Study|Withdrawal by Subject|0|||
30968657|NCT01408277|59039874|FG000|Overall Study|Protocol Violation|2|||
30968658|NCT01408277|59039875|FG001|Overall Study|Protocol Violation|0|||
30968659|NCT01408043|59039881|FG000|Overall Study|unable to collect cells|1|||
30968660|NCT01524224|59039893|FG000|Overall Study|Progressive Disease|1|||
30968661|NCT01524224|59039894|FG001|Overall Study|Progressive Disease|0|||
30968662|NCT01524224|59039895|FG002|Overall Study|Progressive Disease|2|||
30968663|NCT01524224|59039896|FG003|Overall Study|Progressive Disease|1|||
30968664|NCT01524224|59039897|FG004|Overall Study|Progressive Disease|2|||
30968665|NCT01524224|59039898|FG005|Overall Study|Progressive Disease|1|||
30968666|NCT01524224|59039899|FG006|Overall Study|Progressive Disease|1|||
30968667|NCT01524224|59039900|FG007|Overall Study|Progressive Disease|5|||
30968668|NCT01524224|59039893|FG000|Overall Study|Withdrawal by Subject|2|||
30968669|NCT01524224|59039894|FG001|Overall Study|Withdrawal by Subject|0|||
30968670|NCT01524224|59039895|FG002|Overall Study|Withdrawal by Subject|0|||
30968671|NCT01524224|59039896|FG003|Overall Study|Withdrawal by Subject|0|||
30968672|NCT01524224|59039897|FG004|Overall Study|Withdrawal by Subject|0|||
30968673|NCT01524224|59039898|FG005|Overall Study|Withdrawal by Subject|0|||
30968674|NCT01524224|59039899|FG006|Overall Study|Withdrawal by Subject|2|||
30968675|NCT01524224|59039900|FG007|Overall Study|Withdrawal by Subject|0|||
30968676|NCT01524224|59039893|FG000|Overall Study|Adverse Event|0|||
30968677|NCT01524224|59039894|FG001|Overall Study|Adverse Event|1|||
30968678|NCT01524224|59039895|FG002|Overall Study|Adverse Event|0|||
30968679|NCT01524224|59039896|FG003|Overall Study|Adverse Event|0|||
30968680|NCT01524224|59039897|FG004|Overall Study|Adverse Event|0|||
30968681|NCT01524224|59039898|FG005|Overall Study|Adverse Event|1|||
30968682|NCT01524224|59039899|FG006|Overall Study|Adverse Event|0|||
30968683|NCT01524224|59039900|FG007|Overall Study|Adverse Event|0|||
30968684|NCT01524224|59039893|FG000|Overall Study|Physician Decision|0|||
30968685|NCT01524224|59039894|FG001|Overall Study|Physician Decision|0|||
30968686|NCT01524224|59039895|FG002|Overall Study|Physician Decision|0|||
30968687|NCT01524224|59039896|FG003|Overall Study|Physician Decision|1|||
30968688|NCT01524224|59039897|FG004|Overall Study|Physician Decision|1|||
30968689|NCT01524224|59039898|FG005|Overall Study|Physician Decision|0|||
30968690|NCT01524224|59039899|FG006|Overall Study|Physician Decision|0|||
30968691|NCT01524224|59039900|FG007|Overall Study|Physician Decision|1|||
30968692|NCT01524224|59039893|FG000|Overall Study|Sponsor Decision|0|||
30968693|NCT01524224|59039894|FG001|Overall Study|Sponsor Decision|0|||
30968694|NCT01524224|59039895|FG002|Overall Study|Sponsor Decision|0|||
30968695|NCT01524224|59039896|FG003|Overall Study|Sponsor Decision|0|||
30968696|NCT01524224|59039897|FG004|Overall Study|Sponsor Decision|1|||
30968697|NCT01524224|59039898|FG005|Overall Study|Sponsor Decision|0|||
30968698|NCT01524224|59039899|FG006|Overall Study|Sponsor Decision|0|||
30968699|NCT01524224|59039900|FG007|Overall Study|Sponsor Decision|0|||
30968700|NCT00219349|59039918|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
30968701|NCT00219349|59039918|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
30968702|NCT00219349|59039918|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
30968703|NCT00219349|59039918|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
30968704|NCT01523756|59039922|FG000|Baseline Period|Adverse Event|0|||
30968705|NCT01523756|59039923|FG001|Baseline Period|Adverse Event|1|||
30968706|NCT01523756|59039922|FG000|Test Period 1|Adverse Event|1|||
30968707|NCT01523756|59039923|FG001|Test Period 1|Adverse Event|0|||
30968708|NCT01523756|59039922|FG000|Test Period 2|Withdrawal by Subject|0|||
30968709|NCT01523756|59039923|FG001|Test Period 2|Withdrawal by Subject|1|||
30968710|NCT00218257|59039931|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
30968711|NCT00218257|59039932|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
30968712|NCT01523366|59039943|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30968713|NCT01523366|59039944|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30968714|NCT01523366|59039943|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
30968715|NCT01523366|59039944|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
30968716|NCT01427933|59039954|FG000|Overall Study|Withdrawal by Subject|5|||
30968717|NCT01427933|59039955|FG001|Overall Study|Withdrawal by Subject|8|||
30968718|NCT01427933|59039954|FG000|Overall Study|Lost to Follow-up|1|||
30968719|NCT01427933|59039955|FG001|Overall Study|Lost to Follow-up|5|||
30968720|NCT01427933|59039954|FG000|Overall Study|Other|1|||
30968721|NCT01427933|59039955|FG001|Overall Study|Other|0|||
30968722|NCT01427933|59039954|FG000|Overall Study|Investigator's Decision|1|||
30968723|NCT01427933|59039955|FG001|Overall Study|Investigator's Decision|0|||
30968724|NCT00217087|59039964|FG000|Overall Study|decided to have esophagectomy|1|||
30968725|NCT00217087|59039965|FG001|Overall Study|decided to have esophagectomy|2|||
30968726|NCT00217087|59039964|FG000|Overall Study|completed less than 12 months return|10|||
30968727|NCT00217087|59039965|FG001|Overall Study|completed less than 12 months return|18|||
30968728|NCT01406873|59039979|FG000|Overall Study|Withdrawal by Subject|1|||
30968729|NCT01406873|59039980|FG001|Overall Study|Withdrawal by Subject|1|||
30968730|NCT01406795|59039996|FG000|Overall Study|Withdrawal by Subject|1|||
30968731|NCT01406717|59040002|FG000|Overall Study|Subject non-compliance|4|||
30968732|NCT01406717|59040003|FG001|Overall Study|Subject non-compliance|3|||
30968733|NCT01406717|59040002|FG000|Overall Study|Protocol Violation|5|||
30968734|NCT01406717|59040003|FG001|Overall Study|Protocol Violation|1|||
30968735|NCT01406717|59040002|FG000|Overall Study|Lost to Follow-up|14|||
30968736|NCT01406717|59040003|FG001|Overall Study|Lost to Follow-up|8|||
30968737|NCT01406717|59040002|FG000|Overall Study|Withdrawal by Subject|19|||
30968738|NCT01406717|59040003|FG001|Overall Study|Withdrawal by Subject|15|||
30968739|NCT01406717|59040002|FG000|Overall Study|Adverse Event|1|||
30968740|NCT01406717|59040003|FG001|Overall Study|Adverse Event|2|||
30968741|NCT01406717|59040002|FG000|Overall Study|Lack of Efficacy|0|||
30968742|NCT01406717|59040003|FG001|Overall Study|Lack of Efficacy|1|||
30968743|NCT01406717|59040002|FG000|Overall Study|Non-completion of visit activity|0|||
30968744|NCT01406717|59040003|FG001|Overall Study|Non-completion of visit activity|1|||
30968745|NCT01406015|59040021|FG000|Overall Study|Withdrawal by Subject|3|||
30968746|NCT01406015|59040022|FG001|Overall Study|Withdrawal by Subject|3|||
30968747|NCT00215683|59040031|FG000|Overall Study|Adverse Event|15|||
30968748|NCT00215683|59040032|FG001|Overall Study|Adverse Event|16|||
30968749|NCT00215683|59040033|FG002|Overall Study|Adverse Event|15|||
30968750|NCT00215683|59040031|FG000|Overall Study|Lack of Efficacy|5|||
30968751|NCT00215683|59040032|FG001|Overall Study|Lack of Efficacy|1|||
30968752|NCT00215683|59040033|FG002|Overall Study|Lack of Efficacy|2|||
30968753|NCT00215683|59040031|FG000|Overall Study|Lost to Follow-up|0|||
30968754|NCT00215683|59040032|FG001|Overall Study|Lost to Follow-up|2|||
30968755|NCT00215683|59040033|FG002|Overall Study|Lost to Follow-up|1|||
30968756|NCT00215683|59040031|FG000|Overall Study|Withdrawal by Subject|9|||
30968757|NCT00215683|59040032|FG001|Overall Study|Withdrawal by Subject|4|||
30968758|NCT00215683|59040033|FG002|Overall Study|Withdrawal by Subject|13|||
30968759|NCT00215683|59040031|FG000|Overall Study|Physician Decision|0|||
30968760|NCT00215683|59040032|FG001|Overall Study|Physician Decision|0|||
30968761|NCT00215683|59040033|FG002|Overall Study|Physician Decision|1|||
30968762|NCT00215683|59040031|FG000|Overall Study|Difficult to attend visits|0|||
30968763|NCT00215683|59040032|FG001|Overall Study|Difficult to attend visits|1|||
30968764|NCT00215683|59040033|FG002|Overall Study|Difficult to attend visits|0|||
30968765|NCT00215683|59040031|FG000|Overall Study|No study drug available|0|||
30968766|NCT00215683|59040032|FG001|Overall Study|No study drug available|1|||
30968767|NCT00215683|59040033|FG002|Overall Study|No study drug available|0|||
30968768|NCT00215683|59040031|FG000|Overall Study|Intermittent therapy required|0|||
30968769|NCT00215683|59040032|FG001|Overall Study|Intermittent therapy required|1|||
30968770|NCT00215683|59040033|FG002|Overall Study|Intermittent therapy required|0|||
30968771|NCT00215137|59040041|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
30968772|NCT00215137|59040042|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
30968773|NCT00215137|59040043|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
30968774|NCT00215137|59040041|FG000|Randomization Period|Lost to Follow-up|0|||
30968775|NCT00215137|59040042|FG001|Randomization Period|Lost to Follow-up|1|||
30968776|NCT00215137|59040043|FG002|Randomization Period|Lost to Follow-up|0|||
30968777|NCT00215137|59040041|FG000|Randomization Period|Withdrawal by Subject|0|||
30968778|NCT00215137|59040042|FG001|Randomization Period|Withdrawal by Subject|1|||
30968779|NCT00215137|59040043|FG002|Randomization Period|Withdrawal by Subject|0|||
30968780|NCT00214201|59040053|FG000|Overall Study|Withdrawal by Subject|2|||
30968781|NCT00214201|59040054|FG001|Overall Study|Withdrawal by Subject|0|||
30968782|NCT00214201|59040053|FG000|Overall Study|Death|0|||
30968783|NCT00214201|59040054|FG001|Overall Study|Death|2|||
30968784|NCT01486784|59040067|FG000|Overall Study|Withdrawal by Subject|0|||
30968785|NCT01486784|59040068|FG001|Overall Study|Withdrawal by Subject|0|||
30968786|NCT01486784|59040069|FG002|Overall Study|Withdrawal by Subject|1|||
30968787|NCT01486784|59040070|FG003|Overall Study|Withdrawal by Subject|0|||
30968788|NCT01486784|59040071|FG004|Overall Study|Withdrawal by Subject|1|||
30968789|NCT01486784|59040072|FG005|Overall Study|Withdrawal by Subject|2|||
30968790|NCT01486784|59040067|FG000|Overall Study|Subject did not meet entry criteria|0|||
30968791|NCT01486784|59040068|FG001|Overall Study|Subject did not meet entry criteria|0|||
30968792|NCT01486784|59040069|FG002|Overall Study|Subject did not meet entry criteria|0|||
30968793|NCT01486784|59040070|FG003|Overall Study|Subject did not meet entry criteria|0|||
30968794|NCT01486784|59040071|FG004|Overall Study|Subject did not meet entry criteria|1|||
30968795|NCT01486784|59040072|FG005|Overall Study|Subject did not meet entry criteria|0|||
30968796|NCT01486784|59040067|FG000|Overall Study|Death|0|||
30968797|NCT01486784|59040068|FG001|Overall Study|Death|0|||
30968798|NCT01486784|59040069|FG002|Overall Study|Death|0|||
30968799|NCT01486784|59040070|FG003|Overall Study|Death|0|||
30968800|NCT01486784|59040071|FG004|Overall Study|Death|0|||
30968801|NCT01486784|59040072|FG005|Overall Study|Death|1|||
30968802|NCT01521884|59040086|FG000|Overall Study|Non Responders|10|||
30968803|NCT01521884|59040086|FG000|Overall Study|Adverse Event|5|||
30698037|NCT00642954|58712382|FG002|Overall Study|Adverse Event|0|||
30698038|NCT00642954|58712383|FG003|Overall Study|Adverse Event|0|||
30698039|NCT00642954|58712384|FG004|Overall Study|Adverse Event|6|||
30698040|NCT00640146|58712398|FG000|Overall Study|Adverse Event|2|||
30698041|NCT00640146|58712399|FG001|Overall Study|Adverse Event|0|||
30698042|NCT00640146|58712398|FG000|Overall Study|Lost to Follow-up|0|||
30698043|NCT00640146|58712399|FG001|Overall Study|Lost to Follow-up|1|||
30698044|NCT00640146|58712398|FG000|Overall Study|Lack of Efficacy|0|||
30698045|NCT00640146|58712399|FG001|Overall Study|Lack of Efficacy|1|||
30698046|NCT00640146|58712398|FG000|Overall Study|Withdrawal by Subject|1|||
30698047|NCT00640146|58712399|FG001|Overall Study|Withdrawal by Subject|1|||
30698048|NCT00640146|58712398|FG000|Overall Study|Randomized but not treated|1|||
30698049|NCT00640146|58712399|FG001|Overall Study|Randomized but not treated|3|||
30698050|NCT00317473|58712411|FG000|Overall Study|Withdrawal by Subject|2|||
30968804|NCT01521884|59040086|FG000|Overall Study|Pregnancy|1|||
30968805|NCT01521884|59040086|FG000|Overall Study|Withdrawal by Subject|1|||
30968806|NCT01521884|59040086|FG000|Overall Study|Physician Decision|2|||
30968807|NCT01521884|59040086|FG000|Overall Study|Protocol Violation|3|||
30968808|NCT01521884|59040086|FG000|Overall Study|Participant non-eligible|1|||
30968809|NCT01521884|59040086|FG000|Overall Study|Lost to Follow-up|4|||
30968810|NCT01677858|59040095|FG000|Overall Study|Adverse Event|0|||
30968811|NCT01677858|59040096|FG001|Overall Study|Adverse Event|0|||
30968812|NCT01677858|59040097|FG002|Overall Study|Adverse Event|2|||
30968813|NCT01677858|59040098|FG003|Overall Study|Adverse Event|3|||
30968814|NCT01677858|59040099|FG004|Overall Study|Adverse Event|13|||
30968815|NCT01677858|59040095|FG000|Overall Study|Death|0|||
30968816|NCT01677858|59040096|FG001|Overall Study|Death|0|||
30968817|NCT01677858|59040097|FG002|Overall Study|Death|0|||
30968818|NCT01677858|59040098|FG003|Overall Study|Death|0|||
30968819|NCT01677858|59040099|FG004|Overall Study|Death|1|||
30968820|NCT01677858|59040095|FG000|Overall Study|Physician Decision|1|||
30968821|NCT01677858|59040096|FG001|Overall Study|Physician Decision|0|||
30968822|NCT01677858|59040097|FG002|Overall Study|Physician Decision|2|||
30968823|NCT01677858|59040098|FG003|Overall Study|Physician Decision|0|||
30968824|NCT01677858|59040099|FG004|Overall Study|Physician Decision|12|||
30968825|NCT01677858|59040095|FG000|Overall Study|Progressive Disease|2|||
30968826|NCT01677858|59040096|FG001|Overall Study|Progressive Disease|1|||
30968827|NCT01677858|59040097|FG002|Overall Study|Progressive Disease|9|||
30968828|NCT01677858|59040098|FG003|Overall Study|Progressive Disease|3|||
30968829|NCT01677858|59040099|FG004|Overall Study|Progressive Disease|43|||
30968830|NCT01677858|59040095|FG000|Overall Study|Withdrawal by Subject|0|||
30968831|NCT01677858|59040096|FG001|Overall Study|Withdrawal by Subject|1|||
30968832|NCT01677858|59040097|FG002|Overall Study|Withdrawal by Subject|1|||
30968833|NCT01677858|59040098|FG003|Overall Study|Withdrawal by Subject|0|||
30968834|NCT01677858|59040099|FG004|Overall Study|Withdrawal by Subject|15|||
30968835|NCT01677858|59040095|FG000|Overall Study|Lost to Follow-up|0|||
30968836|NCT01677858|59040096|FG001|Overall Study|Lost to Follow-up|0|||
30968837|NCT01677858|59040097|FG002|Overall Study|Lost to Follow-up|0|||
30968838|NCT01677858|59040098|FG003|Overall Study|Lost to Follow-up|0|||
30968839|NCT01677858|59040099|FG004|Overall Study|Lost to Follow-up|1|||
30968840|NCT01486316|59040119|FG000|Overall Study|Device explanted with/without re-implant|3|||
30968841|NCT01486316|59040120|FG001|Overall Study|Device explanted with/without re-implant|2|||
30968842|NCT01486316|59040121|FG002|Overall Study|Device explanted with/without re-implant|0|||
30968843|NCT01486316|59040122|FG003|Overall Study|Device explanted with/without re-implant|2|||
30968844|NCT01486316|59040119|FG000|Overall Study|Not meeting eligibility criteria|0|||
30968845|NCT01486316|59040120|FG001|Overall Study|Not meeting eligibility criteria|0|||
30968846|NCT01486316|59040121|FG002|Overall Study|Not meeting eligibility criteria|1|||
30698051|NCT00317473|58712412|FG001|Overall Study|Withdrawal by Subject|1|||
30698052|NCT00317473|58712413|FG002|Overall Study|Withdrawal by Subject|2|||
30968847|NCT01486316|59040122|FG003|Overall Study|Not meeting eligibility criteria|0|||
30968848|NCT01486316|59040119|FG000|Overall Study|Withdrawal by Subject|1|||
30968849|NCT01486316|59040120|FG001|Overall Study|Withdrawal by Subject|0|||
30968850|NCT01486316|59040121|FG002|Overall Study|Withdrawal by Subject|3|||
30968851|NCT01486316|59040122|FG003|Overall Study|Withdrawal by Subject|0|||
30968852|NCT01486316|59040119|FG000|Overall Study|Physician Decision|0|||
30968853|NCT01486316|59040120|FG001|Overall Study|Physician Decision|0|||
30968854|NCT01486316|59040121|FG002|Overall Study|Physician Decision|1|||
30968855|NCT01486316|59040122|FG003|Overall Study|Physician Decision|0|||
30968856|NCT01486316|59040119|FG000|Overall Study|Death|0|||
30968857|NCT01486316|59040120|FG001|Overall Study|Death|1|||
30968858|NCT01486316|59040121|FG002|Overall Study|Death|0|||
30968859|NCT01486316|59040122|FG003|Overall Study|Death|0|||
30968860|NCT01486238|59040133|FG000|Overall Study|Death|0|||
30968861|NCT01486238|59040134|FG001|Overall Study|Death|2|||
30968862|NCT01486238|59040133|FG000|Overall Study|Withdrawal by Subject|2|||
30968863|NCT01486238|59040134|FG001|Overall Study|Withdrawal by Subject|1|||
30968864|NCT01486238|59040133|FG000|Overall Study|Lost to Follow-up|0|||
30968865|NCT01486238|59040134|FG001|Overall Study|Lost to Follow-up|3|||
30968866|NCT01602744|59040142|FG000|Overall Study|Death|17|||
30968867|NCT01602744|59040143|FG001|Overall Study|Death|15|||
30968868|NCT01602744|59040142|FG000|Overall Study|Lost to Follow-up|13|||
30968869|NCT01602744|59040143|FG001|Overall Study|Lost to Follow-up|8|||
30968870|NCT03598777|59040154|FG000|Overall Study|Study Terminated by Sponsor|3|||
30968871|NCT03598777|59040155|FG001|Overall Study|Study Terminated by Sponsor|0|||
30968872|NCT03598777|59040156|FG002|Overall Study|Study Terminated by Sponsor|0|||
30968873|NCT03598777|59040157|FG003|Overall Study|Study Terminated by Sponsor|0|||
30968874|NCT03598777|59040158|FG004|Overall Study|Study Terminated by Sponsor|15|||
30968875|NCT03598777|59040154|FG000|Overall Study|Withdrawal by Subject|1|||
30968876|NCT03598777|59040155|FG001|Overall Study|Withdrawal by Subject|1|||
30968877|NCT03598777|59040156|FG002|Overall Study|Withdrawal by Subject|0|||
30968878|NCT03598777|59040157|FG003|Overall Study|Withdrawal by Subject|0|||
30968879|NCT03598777|59040158|FG004|Overall Study|Withdrawal by Subject|0|||
30968880|NCT03598777|59040154|FG000|Overall Study|Adverse Event|1|||
30968881|NCT03598777|59040155|FG001|Overall Study|Adverse Event|0|||
30968882|NCT03598777|59040156|FG002|Overall Study|Adverse Event|0|||
30968883|NCT03598777|59040157|FG003|Overall Study|Adverse Event|0|||
30968884|NCT03598777|59040158|FG004|Overall Study|Adverse Event|0|||
30968885|NCT03598777|59040154|FG000|Overall Study|Lost to Follow-up|1|||
30968886|NCT03598777|59040155|FG001|Overall Study|Lost to Follow-up|0|||
30968887|NCT03598777|59040156|FG002|Overall Study|Lost to Follow-up|0|||
30968888|NCT03598777|59040157|FG003|Overall Study|Lost to Follow-up|0|||
30968889|NCT03598777|59040158|FG004|Overall Study|Lost to Follow-up|0|||
30968890|NCT04348591|59040213|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
30968891|NCT04348591|59040214|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
30968892|NCT04348591|59040213|FG000|Imaging Session (120 Min)|Physician Decision|0|||
30968893|NCT04348591|59040214|FG001|Imaging Session (120 Min)|Physician Decision|1|||
30968894|NCT04348591|59040213|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
30968895|NCT04348591|59040214|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
30968896|NCT04059484|59040222|FG000|Overall Study|Adverse Event|2|||
30968897|NCT04059484|59040223|FG001|Overall Study|Adverse Event|5|||
30968898|NCT04059484|59040222|FG000|Overall Study|Withdrawal by Subject|5|||
30968899|NCT04059484|59040223|FG001|Overall Study|Withdrawal by Subject|3|||
30968900|NCT04059484|59040222|FG000|Overall Study|Progressive disease|112|||
30968901|NCT04059484|59040223|FG001|Overall Study|Progressive disease|112|||
30968902|NCT04059484|59040222|FG000|Overall Study|Other|8|||
30968903|NCT04059484|59040223|FG001|Overall Study|Other|3|||
30968904|NCT04059484|59040222|FG000|Overall Study|Ongoing|20|||
30968905|NCT04059484|59040223|FG001|Overall Study|Ongoing|20|||
30968906|NCT04046250|59040245|FG000|Overall Study|Death|0|||
30968907|NCT04046250|59040246|FG001|Overall Study|Death|1|||
30968908|NCT04046250|59040245|FG000|Overall Study|Withdrawal by Subject|3|||
30968909|NCT04046250|59040246|FG001|Overall Study|Withdrawal by Subject|3|||
30968910|NCT03841526|59040254|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
30968911|NCT03841526|59040255|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
30968912|NCT03841526|59040256|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
30968913|NCT03841526|59040257|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
30968914|NCT03841526|59040258|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
30968915|NCT03841526|59040259|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
30968916|NCT03841526|59040254|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
30968917|NCT03841526|59040255|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
30968918|NCT03841526|59040256|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
30968919|NCT03841526|59040257|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
30968920|NCT03841526|59040258|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
30968921|NCT03841526|59040259|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
30968922|NCT03841526|59040254|FG000|Outpatient Phase Treatment|Physician Decision|0|||
30968923|NCT03841526|59040255|FG001|Outpatient Phase Treatment|Physician Decision|1|||
30968924|NCT03841526|59040256|FG002|Outpatient Phase Treatment|Physician Decision|0|||
30968925|NCT03841526|59040257|FG003|Outpatient Phase Treatment|Physician Decision|0|||
30968926|NCT03841526|59040258|FG004|Outpatient Phase Treatment|Physician Decision|0|||
30968927|NCT03841526|59040259|FG005|Outpatient Phase Treatment|Physician Decision|0|||
30968928|NCT03841526|59040254|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
30968929|NCT03841526|59040255|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
30968930|NCT03841526|59040256|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
30968931|NCT03841526|59040257|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
30968932|NCT03841526|59040258|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
30968933|NCT03841526|59040259|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
30968934|NCT03834506|59040282|FG000|Overall Study|Death|268|||
30968935|NCT03834506|59040283|FG001|Overall Study|Death|285|||
30968936|NCT03834506|59040282|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
30968937|NCT03834506|59040283|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
30968938|NCT03834506|59040282|FG000|Overall Study|Withdrawal by Subject|12|||
30968939|NCT03834506|59040283|FG001|Overall Study|Withdrawal by Subject|8|||
30968940|NCT03834506|59040282|FG000|Overall Study|Participants ongoing in the study|234|||
30968941|NCT03834506|59040283|FG001|Overall Study|Participants ongoing in the study|221|||
30968942|NCT03734016|59040300|FG000|Overall Study|Participants Remaining in the Study|260|||
30968943|NCT03734016|59040301|FG001|Overall Study|Participants Remaining in the Study|240|||
30968944|NCT03734016|59040300|FG000|Overall Study|Death|48|||
30968945|NCT03734016|59040301|FG001|Overall Study|Death|60|||
30968946|NCT03734016|59040300|FG000|Overall Study|Withdrawal by Subject|14|||
30968947|NCT03734016|59040301|FG001|Overall Study|Withdrawal by Subject|16|||
30968948|NCT03734016|59040300|FG000|Overall Study|Physician Decision|0|||
30968949|NCT03734016|59040301|FG001|Overall Study|Physician Decision|7|||
30968950|NCT03734016|59040300|FG000|Overall Study|Lost to Follow-up|3|||
30968951|NCT03734016|59040301|FG001|Overall Study|Lost to Follow-up|1|||
30968952|NCT03734016|59040300|FG000|Overall Study|Adverse Event|2|||
30968953|NCT03734016|59040301|FG001|Overall Study|Adverse Event|1|||
30968954|NCT03535740|59040308|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
30968955|NCT03535740|59040308|FG000|Overall Study|Death|34|||
30968956|NCT03535740|59040308|FG000|Overall Study|Lost to Follow-up|1|||
30968957|NCT03535740|59040308|FG000|Overall Study|Withdrawal by Subject|13|||
30968958|NCT03351049|59040319|FG000|Overall Study|Withdrawal|26|||
30968959|NCT03351049|59040320|FG001|Overall Study|Withdrawal|22|||
30968960|NCT03288506|59040341|FG000|Overall Study|Withdrawal by Subject|52|||
30968961|NCT03191786|59040349|FG000|Overall Study|Death|236|||
30968962|NCT03191786|59040350|FG001|Overall Study|Death|127|||
30968963|NCT03191786|59040349|FG000|Overall Study|Lost to Follow-up|9|||
30968964|NCT03191786|59040350|FG001|Overall Study|Lost to Follow-up|3|||
30968965|NCT03191786|59040349|FG000|Overall Study|Physician Decision|1|||
30968966|NCT03191786|59040350|FG001|Overall Study|Physician Decision|0|||
30968967|NCT03191786|59040349|FG000|Overall Study|Study Terminated By Sponsor|15|||
30968968|NCT03191786|59040350|FG001|Overall Study|Study Terminated By Sponsor|5|||
30968969|NCT03191786|59040349|FG000|Overall Study|Withdrawal by Subject|26|||
30968970|NCT03191786|59040350|FG001|Overall Study|Withdrawal by Subject|16|||
30968971|NCT03180684|59040358|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
30968972|NCT03180684|59040359|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
30968973|NCT03180684|59040358|FG000|Overall Study|Physician Decision|1|||
30968974|NCT03180684|59040359|FG001|Overall Study|Physician Decision|0|||
30968975|NCT03180684|59040358|FG000|Overall Study|Lost to Follow-up|1|||
30968976|NCT03180684|59040359|FG001|Overall Study|Lost to Follow-up|0|||
30968977|NCT03180684|59040358|FG000|Overall Study|Progressive Disease|1|||
30968978|NCT03180684|59040359|FG001|Overall Study|Progressive Disease|0|||
30968979|NCT02747927|59040407|FG000|Overall Study|Adverse Event|5|||
30968980|NCT02747927|59040408|FG001|Overall Study|Adverse Event|14|||
30968981|NCT02747927|59040407|FG000|Overall Study|Lost to Follow-up|22|||
30968982|NCT02747927|59040408|FG001|Overall Study|Lost to Follow-up|43|||
30968983|NCT02747927|59040407|FG000|Overall Study|Pregnancy|34|||
30968984|NCT02747927|59040408|FG001|Overall Study|Pregnancy|66|||
30968985|NCT02747927|59040407|FG000|Overall Study|Protocol Violation|2|||
30968986|NCT02747927|59040408|FG001|Overall Study|Protocol Violation|4|||
30968987|NCT02747927|59040407|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
30968988|NCT02747927|59040408|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
30968989|NCT02747927|59040407|FG000|Overall Study|Reason not Specified|11|||
30968990|NCT02747927|59040408|FG001|Overall Study|Reason not Specified|27|||
30968991|NCT02515227|59040420|FG000|Overall Study|Adverse Event|0|||
30968992|NCT02515227|59040421|FG001|Overall Study|Adverse Event|2|||
30968993|NCT02515227|59040420|FG000|Overall Study|Progressive disease|2|||
30968994|NCT02515227|59040421|FG001|Overall Study|Progressive disease|9|||
30968995|NCT02369458|59040431|FG000|Overall Study|Determined to be not eligible|1|||
30968996|NCT02369458|59040432|FG001|Overall Study|Determined to be not eligible|0|||
30968997|NCT02294461|59040440|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
30968998|NCT02294461|59040441|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
30698053|NCT00317473|58712414|FG003|Overall Study|Withdrawal by Subject|1|||
30760586|NCT03381274|58769070|FG000|Overall Study|Lost to Follow-up|0|||
30968999|NCT02294461|59040440|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
30969000|NCT02294461|59040441|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
30969001|NCT02294461|59040440|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
30969002|NCT02294461|59040441|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
30969003|NCT02294461|59040440|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
30969004|NCT02294461|59040441|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
30969005|NCT02294461|59040440|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
30969006|NCT02294461|59040441|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
30969007|NCT02294461|59040440|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
30969008|NCT02294461|59040441|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
30969009|NCT02294461|59040440|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
30969010|NCT02294461|59040441|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
30969011|NCT02294461|59040440|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
30969012|NCT02294461|59040441|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
30969013|NCT02294461|59040440|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
30969014|NCT02294461|59040441|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
30969015|NCT02294461|59040440|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
30969016|NCT02294461|59040441|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
30969017|NCT02294461|59040440|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
30969018|NCT02294461|59040441|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
30969019|NCT02294461|59040440|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
30969020|NCT02294461|59040441|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
30969021|NCT02294461|59040440|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
30969022|NCT02294461|59040441|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
30969023|NCT02294461|59040440|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
30969024|NCT02294461|59040441|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
30969025|NCT02294461|59040440|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
30969026|NCT02294461|59040441|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
30969027|NCT01930539|59040461|FG000|Overall Study|Withdrawal by Subject|2|||
30969028|NCT01930539|59040462|FG001|Overall Study|Withdrawal by Subject|2|||
30969029|NCT01266642|59040474|FG000|Overall Study|Protocol Violation|0|||
30969030|NCT01266642|59040475|FG001|Overall Study|Protocol Violation|1|||
30969031|NCT00792948|59040481|FG000|Overall Study|Adverse Event|6|||
30969032|NCT00792948|59040481|FG000|Overall Study|Death|4|||
30969033|NCT00792948|59040481|FG000|Overall Study|Withdrawal by Subject|3|||
30969034|NCT00792948|59040481|FG000|Overall Study|Ineligible|2|||
30969035|NCT00792948|59040481|FG000|Overall Study|Insurance denial - not treated|1|||
30969036|NCT00792948|59040481|FG000|Overall Study|Physician Decision|11|||
30969037|NCT00792948|59040481|FG000|Overall Study|Protocol Violation|1|||
30969038|NCT00602641|59040501|FG000|Overall Study|Never started protocol therapy|6|||
30969039|NCT00602641|59040502|FG001|Overall Study|Never started protocol therapy|2|||
30969040|NCT00602641|59040501|FG000|Overall Study|Still on treatment at time of analysis|8|||
30969041|NCT00602641|59040502|FG001|Overall Study|Still on treatment at time of analysis|15|||
30969042|NCT00602641|59040501|FG000|Overall Study|Adverse Event|62|||
30969043|NCT00602641|59040502|FG001|Overall Study|Adverse Event|53|||
30969044|NCT00602641|59040501|FG000|Overall Study|Disease progression|38|||
30969045|NCT00602641|59040502|FG001|Overall Study|Disease progression|55|||
30969046|NCT00602641|59040501|FG000|Overall Study|Death|6|||
30969047|NCT00602641|59040502|FG001|Overall Study|Death|5|||
30969048|NCT00602641|59040501|FG000|Overall Study|Withdrawal by Subject|15|||
30969049|NCT00602641|59040502|FG001|Overall Study|Withdrawal by Subject|12|||
30969050|NCT00602641|59040501|FG000|Overall Study|Alternative therapy|5|||
30969051|NCT00602641|59040502|FG001|Overall Study|Alternative therapy|2|||
30969052|NCT00602641|59040501|FG000|Overall Study|Other Complicating Disease|5|||
30969053|NCT00602641|59040502|FG001|Overall Study|Other Complicating Disease|2|||
30969054|NCT00602641|59040501|FG000|Overall Study|Physician Decision|5|||
30969055|NCT00602641|59040502|FG001|Overall Study|Physician Decision|4|||
30969056|NCT00602641|59040501|FG000|Overall Study|Administrative Closure|1|||
30969057|NCT00602641|59040502|FG001|Overall Study|Administrative Closure|1|||
30969058|NCT00602641|59040501|FG000|Overall Study|Other|3|||
30969059|NCT00602641|59040502|FG001|Overall Study|Other|1|||
30969060|NCT00070499|59040531|FG000|Overall Study|Adverse Event|6|||
30969061|NCT00070499|59040532|FG001|Overall Study|Adverse Event|6|||
30969062|NCT00070499|59040533|FG002|Overall Study|Adverse Event|19|||
30969063|NCT00070499|59040534|FG003|Overall Study|Adverse Event|15|||
30969064|NCT00070499|59040531|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
30969065|NCT00070499|59040532|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
30969066|NCT00070499|59040533|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
30969067|NCT00070499|59040534|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
30698054|NCT00317473|58712415|FG004|Overall Study|Withdrawal by Subject|3|||
30698055|NCT00317473|58712416|FG005|Overall Study|Withdrawal by Subject|1|||
30698056|NCT00317473|58712411|FG000|Overall Study|Relocation|1|||
30969068|NCT00070499|59040531|FG000|Overall Study|Progression/relapse|4|||
30969069|NCT00070499|59040532|FG001|Overall Study|Progression/relapse|2|||
30969070|NCT00070499|59040533|FG002|Overall Study|Progression/relapse|1|||
30969071|NCT00070499|59040534|FG003|Overall Study|Progression/relapse|4|||
30969072|NCT00070499|59040531|FG000|Overall Study|Death|1|||
30969073|NCT00070499|59040532|FG001|Overall Study|Death|1|||
30969074|NCT00070499|59040533|FG002|Overall Study|Death|1|||
30969075|NCT00070499|59040534|FG003|Overall Study|Death|2|||
30969076|NCT00070499|59040531|FG000|Overall Study|Other - not protocol specified|7|||
30969077|NCT00070499|59040532|FG001|Overall Study|Other - not protocol specified|3|||
30969078|NCT00070499|59040533|FG002|Overall Study|Other - not protocol specified|12|||
30969079|NCT00070499|59040534|FG003|Overall Study|Other - not protocol specified|20|||
30698057|NCT00317473|58712412|FG001|Overall Study|Relocation|0|||
30608082|NCT01184859|58618865|FG000|Period 1: Single Dose|Insufficient urine production|0|||
30608083|NCT01184859|58618866|FG001|Period 1: Single Dose|Insufficient urine production|1|||
30608084|NCT01184859|58618867|FG002|Period 1: Single Dose|Insufficient urine production|0|||
30608085|NCT01184859|58618868|FG003|Period 1: Single Dose|Insufficient urine production|0|||
30608086|NCT01184859|58618869|FG004|Period 1: Single Dose|Insufficient urine production|0|||
30608087|NCT01184859|58618865|FG000|Period 1: Single Dose|Protocol Violation|0|||
30608088|NCT01184859|58618866|FG001|Period 1: Single Dose|Protocol Violation|1|||
30608089|NCT01184859|58618867|FG002|Period 1: Single Dose|Protocol Violation|0|||
30608090|NCT01184859|58618868|FG003|Period 1: Single Dose|Protocol Violation|0|||
30608091|NCT01184859|58618869|FG004|Period 1: Single Dose|Protocol Violation|0|||
30608092|NCT01184859|58618865|FG000|Period 1: Single Dose|Adverse Event|0|||
30608093|NCT01184859|58618866|FG001|Period 1: Single Dose|Adverse Event|0|||
30608094|NCT01184859|58618867|FG002|Period 1: Single Dose|Adverse Event|0|||
30608095|NCT01184859|58618868|FG003|Period 1: Single Dose|Adverse Event|0|||
30608096|NCT01184859|58618869|FG004|Period 1: Single Dose|Adverse Event|1|||
30608097|NCT01184859|58618865|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
30608098|NCT01184859|58618866|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
30608099|NCT01184859|58618867|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
30608100|NCT01184859|58618868|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
30608101|NCT01184859|58618869|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
30608102|NCT01184859|58618865|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
30608103|NCT01184859|58618866|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
30608104|NCT01184859|58618867|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
30608105|NCT01184859|58618868|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
30608106|NCT01184859|58618869|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
30608107|NCT01184079|58618888|FG000|Overall Study|Lost to Follow-up|14|||
30608108|NCT01184079|58618889|FG001|Overall Study|Lost to Follow-up|2|||
30608109|NCT01190865|58618897|FG000|Overall Study|Withdrawal by Subject|1|||
30608110|NCT01190865|58618897|FG000|Overall Study|Non-compliance|2|||
30608111|NCT01190475|58618904|FG000|Overall Study|Withdrawal by Subject|0|||
30608112|NCT01190475|58618905|FG001|Overall Study|Withdrawal by Subject|0|||
30608113|NCT01190475|58618906|FG002|Overall Study|Withdrawal by Subject|1|||
30608114|NCT01289990|58618929|FG000|Overall Study|Death|0|||
30608115|NCT01289990|58618930|FG001|Overall Study|Death|0|||
30608116|NCT01289990|58618931|FG002|Overall Study|Death|0|||
30608117|NCT01289990|58618932|FG003|Overall Study|Death|1|||
30608118|NCT01289990|58618933|FG004|Overall Study|Death|2|||
30608119|NCT01289990|58618934|FG005|Overall Study|Death|1|||
30608120|NCT01289990|58618935|FG006|Overall Study|Death|0|||
30608121|NCT01289990|58618936|FG007|Overall Study|Death|0|||
30608122|NCT01289990|58618937|FG008|Overall Study|Death|0|||
30608123|NCT01289990|58618938|FG009|Overall Study|Death|0|||
30608124|NCT01289990|58618939|FG010|Overall Study|Death|0|||
30608125|NCT01289990|58618940|FG011|Overall Study|Death|1|||
30608126|NCT01289990|58618941|FG012|Overall Study|Death|0|||
30608127|NCT01289990|58618929|FG000|Overall Study|Lost to Follow-up|3|||
30608128|NCT01289990|58618930|FG001|Overall Study|Lost to Follow-up|2|||
30608129|NCT01289990|58618931|FG002|Overall Study|Lost to Follow-up|5|||
30608130|NCT01289990|58618932|FG003|Overall Study|Lost to Follow-up|5|||
30608131|NCT01289990|58618933|FG004|Overall Study|Lost to Follow-up|3|||
30608132|NCT01289990|58618934|FG005|Overall Study|Lost to Follow-up|4|||
30608133|NCT01289990|58618935|FG006|Overall Study|Lost to Follow-up|2|||
30608134|NCT01289990|58618936|FG007|Overall Study|Lost to Follow-up|2|||
30608135|NCT01289990|58618937|FG008|Overall Study|Lost to Follow-up|1|||
30608136|NCT01289990|58618938|FG009|Overall Study|Lost to Follow-up|4|||
30608137|NCT01289990|58618939|FG010|Overall Study|Lost to Follow-up|2|||
30608138|NCT01289990|58618940|FG011|Overall Study|Lost to Follow-up|1|||
30608139|NCT01289990|58618941|FG012|Overall Study|Lost to Follow-up|2|||
30608140|NCT01289990|58618929|FG000|Overall Study|Withdrawal by Subject|15|||
30608141|NCT01289990|58618930|FG001|Overall Study|Withdrawal by Subject|14|||
30608142|NCT01289990|58618931|FG002|Overall Study|Withdrawal by Subject|12|||
30608143|NCT01289990|58618932|FG003|Overall Study|Withdrawal by Subject|13|||
30608144|NCT01289990|58618933|FG004|Overall Study|Withdrawal by Subject|8|||
30608145|NCT01289990|58618934|FG005|Overall Study|Withdrawal by Subject|7|||
30608146|NCT01289990|58618935|FG006|Overall Study|Withdrawal by Subject|13|||
30608147|NCT01289990|58618936|FG007|Overall Study|Withdrawal by Subject|9|||
30608148|NCT01289990|58618937|FG008|Overall Study|Withdrawal by Subject|12|||
30608149|NCT01289990|58618938|FG009|Overall Study|Withdrawal by Subject|13|||
30608150|NCT01289990|58618939|FG010|Overall Study|Withdrawal by Subject|11|||
30608151|NCT01289990|58618940|FG011|Overall Study|Withdrawal by Subject|13|||
30608152|NCT01289990|58618941|FG012|Overall Study|Withdrawal by Subject|16|||
30608153|NCT01289990|58618929|FG000|Overall Study|discontinued in preceding trial|18|||
30608154|NCT01289990|58618930|FG001|Overall Study|discontinued in preceding trial|20|||
30608155|NCT01289990|58618931|FG002|Overall Study|discontinued in preceding trial|41|||
30608156|NCT01289990|58618932|FG003|Overall Study|discontinued in preceding trial|17|||
30608157|NCT01289990|58618933|FG004|Overall Study|discontinued in preceding trial|11|||
30608158|NCT01289990|58618934|FG005|Overall Study|discontinued in preceding trial|12|||
30608159|NCT01289990|58618935|FG006|Overall Study|discontinued in preceding trial|18|||
30608160|NCT01289990|58618936|FG007|Overall Study|discontinued in preceding trial|8|||
30608161|NCT01289990|58618937|FG008|Overall Study|discontinued in preceding trial|17|||
30608162|NCT01289990|58618938|FG009|Overall Study|discontinued in preceding trial|21|||
30608163|NCT01289990|58618939|FG010|Overall Study|discontinued in preceding trial|17|||
30608164|NCT01289990|58618940|FG011|Overall Study|discontinued in preceding trial|17|||
30608165|NCT01289990|58618941|FG012|Overall Study|discontinued in preceding trial|24|||
30608166|NCT01289990|58618929|FG000|Overall Study|did not continue in extension|41|||
30608167|NCT01289990|58618930|FG001|Overall Study|did not continue in extension|45|||
30608168|NCT01289990|58618931|FG002|Overall Study|did not continue in extension|51|||
30608169|NCT01289990|58618932|FG003|Overall Study|did not continue in extension|51|||
30608170|NCT01289990|58618933|FG004|Overall Study|did not continue in extension|48|||
30608171|NCT01289990|58618934|FG005|Overall Study|did not continue in extension|50|||
30608172|NCT01289990|58618935|FG006|Overall Study|did not continue in extension|54|||
30608173|NCT01289990|58618936|FG007|Overall Study|did not continue in extension|36|||
30608174|NCT01289990|58618937|FG008|Overall Study|did not continue in extension|44|||
30608175|NCT01289990|58618938|FG009|Overall Study|did not continue in extension|48|||
30608176|NCT01289990|58618939|FG010|Overall Study|did not continue in extension|45|||
30608177|NCT01289990|58618940|FG011|Overall Study|did not continue in extension|34|||
30608178|NCT01289990|58618941|FG012|Overall Study|did not continue in extension|56|||
30608179|NCT01289990|58618929|FG000|Overall Study|Not treated|0|||
30608180|NCT01289990|58618930|FG001|Overall Study|Not treated|0|||
30608181|NCT01289990|58618931|FG002|Overall Study|Not treated|0|||
30608182|NCT01289990|58618932|FG003|Overall Study|Not treated|0|||
30608183|NCT01289990|58618933|FG004|Overall Study|Not treated|0|||
30608184|NCT01289990|58618934|FG005|Overall Study|Not treated|0|||
30608185|NCT01289990|58618935|FG006|Overall Study|Not treated|1|||
30608186|NCT01289990|58618936|FG007|Overall Study|Not treated|0|||
30608187|NCT01289990|58618937|FG008|Overall Study|Not treated|1|||
30608188|NCT01289990|58618938|FG009|Overall Study|Not treated|0|||
30608189|NCT01289990|58618939|FG010|Overall Study|Not treated|1|||
30608190|NCT01289990|58618940|FG011|Overall Study|Not treated|2|||
30608191|NCT01289990|58618941|FG012|Overall Study|Not treated|0|||
30608192|NCT01190007|58618969|FG000|Overall Study|Withdrawal by Subject|4|||
30608193|NCT01190007|58618969|FG000|Overall Study|Adverse Event|8|||
30608194|NCT01190007|58618969|FG000|Overall Study|Difficulty of visit for complications|1|||
30608195|NCT01190007|58618969|FG000|Overall Study|Participant was arrested|1|||
30608196|NCT01189461|58618973|FG000|Overall Study|Lack of Efficacy|13|||
30608197|NCT01189461|58618973|FG000|Overall Study|Lost to Follow-up|1|||
30608198|NCT01189461|58618973|FG000|Overall Study|Withdrawal by Subject|6|||
30608199|NCT01189461|58618973|FG000|Overall Study|Protocol Violation|1|||
30608200|NCT01189461|58618973|FG000|Overall Study|Adverse Event|2|||
30608201|NCT01189461|58618973|FG000|Overall Study|Did not meet entrance criteria|3|||
30608202|NCT01189461|58618973|FG000|Overall Study|Other|8|||
30608203|NCT01189227|58618979|FG000|Overall Study|Study terminated due to low accrual|6|||
30608204|NCT01189227|58618980|FG001|Overall Study|Study terminated due to low accrual|3|||
30608205|NCT01300247|58618988|FG000|Overall Study|Death|1|||
30608206|NCT01300247|58618989|FG001|Overall Study|Death|1|||
30608207|NCT01300247|58618988|FG000|Overall Study|Lost to Follow-up|2|||
30608208|NCT01300247|58618989|FG001|Overall Study|Lost to Follow-up|0|||
30608209|NCT01300247|58618988|FG000|Overall Study|Withdrawal by Subject|1|||
30608210|NCT01300247|58618989|FG001|Overall Study|Withdrawal by Subject|0|||
30608211|NCT01300247|58618988|FG000|Overall Study|Non-Compliance|0|||
30608212|NCT01300247|58618989|FG001|Overall Study|Non-Compliance|1|||
30608213|NCT01289678|58618995|FG000|Overall Study|Physician Decision|6|||
30608214|NCT01289210|58618999|FG000|Overall Study|Adverse Event|1|||
30608215|NCT01183221|58619005|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
30608216|NCT01183221|58619006|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
30608217|NCT01183143|58619012|FG000|Overall Study|Protocol Violation|115|||
30608218|NCT01183143|58619012|FG000|Overall Study|Withdrawal by Subject|19|||
30608219|NCT01183143|58619012|FG000|Overall Study|Subject Questionnaires not returned|5|||
30608220|NCT01183143|58619012|FG000|Overall Study|Subjects enrolled, but not treated|11|||
30608221|NCT01183065|58619016|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
30608222|NCT01182441|58619022|FG000|Overall Study|Patient Still in Follow-up|152|||
30608223|NCT01182441|58619023|FG001|Overall Study|Patient Still in Follow-up|72|||
30608224|NCT01182441|58619022|FG000|Overall Study|Death|37|||
30608225|NCT01182441|58619023|FG001|Overall Study|Death|25|||
30608226|NCT01182441|58619022|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
30608227|NCT01182441|58619023|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
30608228|NCT01182441|58619022|FG000|Overall Study|Lost to Follow-up|5|||
30608229|NCT01182441|58619023|FG001|Overall Study|Lost to Follow-up|8|||
30608230|NCT01182441|58619022|FG000|Overall Study|Withdrawal by Subject|6|||
30608231|NCT01182441|58619023|FG001|Overall Study|Withdrawal by Subject|13|||
30608232|NCT01182441|58619022|FG000|Overall Study|Implant Not Attempted|4|||
30608233|NCT01182441|58619023|FG001|Overall Study|Implant Not Attempted|0|||
30608234|NCT01182441|58619022|FG000|Overall Study|Adverse Event|2|||
30608235|NCT01182441|58619023|FG001|Overall Study|Adverse Event|0|||
30608236|NCT01182441|58619022|FG000|Overall Study|Physician Decision|1|||
30608237|NCT01182441|58619023|FG001|Overall Study|Physician Decision|1|||
30608238|NCT01182285|58619029|FG000|First Intervention Week 1-10|Disease progression|1|||
30608239|NCT01182285|58619030|FG001|First Intervention Week 1-10|Disease progression|0|||
30608240|NCT01182285|58619031|FG002|First Intervention Week 1-10|Disease progression|0|||
30608241|NCT01182285|58619029|FG000|First Intervention Week 1-10|Adverse Event|1|||
30608242|NCT01182285|58619030|FG001|First Intervention Week 1-10|Adverse Event|0|||
30608243|NCT01182285|58619031|FG002|First Intervention Week 1-10|Adverse Event|0|||
30608244|NCT01182285|58619029|FG000|First Intervention Week 1-10|Non-compliance|1|||
30608245|NCT01182285|58619030|FG001|First Intervention Week 1-10|Non-compliance|0|||
30608246|NCT01182285|58619031|FG002|First Intervention Week 1-10|Non-compliance|0|||
30608247|NCT01182285|58619029|FG000|Third Intervention Week 11-52|Disease Progression|0|||
30608248|NCT01182285|58619030|FG001|Third Intervention Week 11-52|Disease Progression|0|||
30608249|NCT01182285|58619031|FG002|Third Intervention Week 11-52|Disease Progression|6|||
30608250|NCT01182285|58619029|FG000|Third Intervention Week 11-52|Other|0|||
30608251|NCT01182285|58619030|FG001|Third Intervention Week 11-52|Other|0|||
30608252|NCT01182285|58619031|FG002|Third Intervention Week 11-52|Other|2|||
30608253|NCT01182207|58619040|FG000|First Intervention|Positive Hepatitis Results|0|||
30608254|NCT01182207|58619041|FG001|First Intervention|Positive Hepatitis Results|1|||
30608255|NCT01182207|58619040|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
30608256|NCT01182207|58619041|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
30608257|NCT01181895|58619050|FG000|Overall Study|Adverse Event|3|||
30608258|NCT01181895|58619051|FG001|Overall Study|Adverse Event|1|||
30608259|NCT01181895|58619052|FG002|Overall Study|Adverse Event|1|||
30608260|NCT01181895|58619050|FG000|Overall Study|Lack of Efficacy|8|||
30608261|NCT01181895|58619051|FG001|Overall Study|Lack of Efficacy|9|||
30608262|NCT01181895|58619052|FG002|Overall Study|Lack of Efficacy|9|||
30608263|NCT01181895|58619050|FG000|Overall Study|Protocol Violation|2|||
30608264|NCT01181895|58619051|FG001|Overall Study|Protocol Violation|1|||
30608265|NCT01181895|58619052|FG002|Overall Study|Protocol Violation|0|||
30608266|NCT01181895|58619050|FG000|Overall Study|Lost to Follow-up|0|||
30608267|NCT01181895|58619051|FG001|Overall Study|Lost to Follow-up|1|||
30608268|NCT01181895|58619052|FG002|Overall Study|Lost to Follow-up|2|||
30608269|NCT01181895|58619050|FG000|Overall Study|Investigator Discretion|1|||
30608270|NCT01181895|58619051|FG001|Overall Study|Investigator Discretion|2|||
30608271|NCT01181895|58619052|FG002|Overall Study|Investigator Discretion|1|||
30608272|NCT01181895|58619050|FG000|Overall Study|Withdrawal by Subject|3|||
30608273|NCT01181895|58619051|FG001|Overall Study|Withdrawal by Subject|0|||
30608274|NCT01181895|58619052|FG002|Overall Study|Withdrawal by Subject|5|||
30608275|NCT01181271|58619060|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
30608276|NCT01181271|58619060|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
30608277|NCT01181271|58619060|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
30608278|NCT01181271|58619060|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
30608279|NCT01180647|58619066|FG000|Overall Study|Lost to Follow-up|5|||
30608280|NCT01180647|58619067|FG001|Overall Study|Lost to Follow-up|6|||
30608281|NCT00969553|58619082|FG000|Overall Study|Progressive disease (PD)|2|||
30608282|NCT00969553|58619083|FG001|Overall Study|Progressive disease (PD)|2|||
30608283|NCT00969553|58619084|FG002|Overall Study|Progressive disease (PD)|6|||
30608284|NCT00969553|58619085|FG003|Overall Study|Progressive disease (PD)|9|||
30608285|NCT00969553|58619086|FG004|Overall Study|Progressive disease (PD)|2|||
30608286|NCT00969553|58619087|FG005|Overall Study|Progressive disease (PD)|4|||
30608287|NCT00969553|58619088|FG006|Overall Study|Progressive disease (PD)|2|||
30608288|NCT00969553|58619089|FG007|Overall Study|Progressive disease (PD)|12|||
30608289|NCT00969553|58619090|FG008|Overall Study|Progressive disease (PD)|3|||
30608290|NCT00969553|58619082|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
30608291|NCT00969553|58619083|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
30608292|NCT00969553|58619084|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
30608293|NCT00969553|58619085|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
30608294|NCT00969553|58619086|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
30608295|NCT00969553|58619087|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
30608296|NCT00969553|58619088|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
30608297|NCT00969553|58619089|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
30608298|NCT00969553|58619090|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
30608299|NCT00969553|58619082|FG000|Overall Study|Other Adverse Event|0|||
30608300|NCT00969553|58619083|FG001|Overall Study|Other Adverse Event|0|||
30608301|NCT00969553|58619084|FG002|Overall Study|Other Adverse Event|0|||
30608302|NCT00969553|58619085|FG003|Overall Study|Other Adverse Event|1|||
30608303|NCT00969553|58619086|FG004|Overall Study|Other Adverse Event|0|||
30608304|NCT00969553|58619087|FG005|Overall Study|Other Adverse Event|0|||
30608305|NCT00969553|58619088|FG006|Overall Study|Other Adverse Event|1|||
30608306|NCT00969553|58619089|FG007|Overall Study|Other Adverse Event|0|||
30608307|NCT00969553|58619090|FG008|Overall Study|Other Adverse Event|0|||
30608308|NCT00969553|58619082|FG000|Overall Study|Refused cont. medication|1|||
30608309|NCT00969553|58619083|FG001|Overall Study|Refused cont. medication|1|||
30608310|NCT00969553|58619084|FG002|Overall Study|Refused cont. medication|0|||
30608311|NCT00969553|58619085|FG003|Overall Study|Refused cont. medication|2|||
30608312|NCT00969553|58619086|FG004|Overall Study|Refused cont. medication|0|||
30608313|NCT00969553|58619087|FG005|Overall Study|Refused cont. medication|0|||
30608314|NCT00969553|58619088|FG006|Overall Study|Refused cont. medication|0|||
30608315|NCT00969553|58619089|FG007|Overall Study|Refused cont. medication|1|||
30608316|NCT00969553|58619090|FG008|Overall Study|Refused cont. medication|0|||
30608317|NCT00969553|58619082|FG000|Overall Study|Not specified above|0|||
30608318|NCT00969553|58619083|FG001|Overall Study|Not specified above|0|||
30608319|NCT00969553|58619084|FG002|Overall Study|Not specified above|0|||
30608320|NCT00969553|58619085|FG003|Overall Study|Not specified above|4|||
30608321|NCT00969553|58619086|FG004|Overall Study|Not specified above|0|||
30608322|NCT00969553|58619087|FG005|Overall Study|Not specified above|0|||
30608323|NCT00969553|58619088|FG006|Overall Study|Not specified above|1|||
30608324|NCT00969553|58619089|FG007|Overall Study|Not specified above|1|||
30608325|NCT00969553|58619090|FG008|Overall Study|Not specified above|0|||
30608326|NCT01179477|58619118|FG000|Overall Study|Death|542|||
30608327|NCT01179477|58619118|FG000|Overall Study|Unsuccessful implant|80|||
30608328|NCT01179477|58619118|FG000|Overall Study|Non-death withdrawal|438|||
30608329|NCT01179477|58619118|FG000|Overall Study|Did not complete final visit|27|||
30608330|NCT01179399|58619122|FG000|Overall Study|Adverse Event|1|||
30608331|NCT01179399|58619122|FG000|Overall Study|Lack of Efficacy|30|||
30608332|NCT01179399|58619122|FG000|Overall Study|Withdrawal by Subject|1|||
30608333|NCT01178853|58619128|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
30608334|NCT01178853|58619129|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
30608335|NCT01178853|58619128|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
30608336|NCT01178853|58619129|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
30608337|NCT01178853|58619128|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
30608338|NCT01178853|58619129|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
30608339|NCT01178853|58619128|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
30608340|NCT01178853|58619129|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
30608341|NCT01178853|58619128|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
30608342|NCT01178853|58619129|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
30608343|NCT01178385|58619137|FG000|Overall Study|Withdrawal by Subject|2|||
30608344|NCT01178385|58619138|FG001|Overall Study|Withdrawal by Subject|0|||
30608345|NCT01288976|58619147|FG000|Overall Study|Withdrawal by Subject|58|||
30608346|NCT01288976|58619148|FG001|Overall Study|Withdrawal by Subject|12|||
30608347|NCT01288976|58619149|FG002|Overall Study|Withdrawal by Subject|9|||
30608348|NCT01288976|58619147|FG000|Overall Study|Death|98|||
30608349|NCT01288976|58619148|FG001|Overall Study|Death|6|||
30608350|NCT01288976|58619149|FG002|Overall Study|Death|4|||
30608351|NCT01288976|58619147|FG000|Overall Study|Data unavailable|22|||
30608352|NCT01288976|58619148|FG001|Overall Study|Data unavailable|9|||
30608353|NCT01288976|58619149|FG002|Overall Study|Data unavailable|7|||
30608354|NCT00970489|58619157|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
30608355|NCT00970489|58619158|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
30608356|NCT00968617|58619164|FG000|Overall Study|Study terminated by sponsor|6|||
30608357|NCT00968539|58619170|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
30608358|NCT00968539|58619171|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
30608359|NCT00976573|58619180|FG000|Overall Study|Ineligible|0|||
30608360|NCT00976573|58619181|FG001|Overall Study|Ineligible|1|||
30608361|NCT00976573|58619180|FG000|Overall Study|Cancel prior to receiving treatment|4|||
30608362|NCT00976573|58619181|FG001|Overall Study|Cancel prior to receiving treatment|2|||
30608363|NCT03661723|58619189|FG000|Overall Study|Disease Progression|4|||
30608364|NCT03661723|58619190|FG001|Overall Study|Disease Progression|24|||
30608365|NCT03661723|58619191|FG002|Overall Study|Disease Progression|4|||
30608366|NCT03661723|58619192|FG003|Overall Study|Disease Progression|19|||
30608367|NCT03661723|58619189|FG000|Overall Study|Withdrawal by Subject|1|||
30608368|NCT03661723|58619190|FG001|Overall Study|Withdrawal by Subject|0|||
30608369|NCT03661723|58619191|FG002|Overall Study|Withdrawal by Subject|2|||
30608370|NCT03661723|58619192|FG003|Overall Study|Withdrawal by Subject|4|||
30608371|NCT03661723|58619189|FG000|Overall Study|Physician Decision|1|||
30608372|NCT03661723|58619190|FG001|Overall Study|Physician Decision|0|||
30608373|NCT03661723|58619191|FG002|Overall Study|Physician Decision|0|||
30608374|NCT03661723|58619192|FG003|Overall Study|Physician Decision|0|||
30608375|NCT03661723|58619189|FG000|Overall Study|Clinical Deterioration|0|||
30608376|NCT03661723|58619190|FG001|Overall Study|Clinical Deterioration|0|||
30608377|NCT03661723|58619191|FG002|Overall Study|Clinical Deterioration|0|||
30608378|NCT03661723|58619192|FG003|Overall Study|Clinical Deterioration|1|||
30608379|NCT00976495|58619201|FG000|Overall Study|Withdrawal by Subject|0|||
30608380|NCT00976495|58619202|FG001|Overall Study|Withdrawal by Subject|1|||
30608381|NCT00976495|58619203|FG002|Overall Study|Withdrawal by Subject|0|||
30608382|NCT01288430|58619221|FG000|Part 1|Progressive disease|2|||
30608383|NCT01288430|58619222|FG001|Part 1|Progressive disease|1|||
30608384|NCT01288430|58619223|FG002|Part 1|Progressive disease|1|||
30608385|NCT01288430|58619224|FG003|Part 1|Progressive disease|6|||
30608386|NCT01288430|58619225|FG004|Part 1|Progressive disease|2|||
30608387|NCT01288430|58619226|FG005|Part 1|Progressive disease|4|||
30608388|NCT01288430|58619227|FG006|Part 1|Progressive disease|2|||
30608389|NCT01288430|58619228|FG007|Part 1|Progressive disease|0|||
30608390|NCT01288430|58619229|FG008|Part 1|Progressive disease|0|||
30608391|NCT01288430|58619230|FG009|Part 1|Progressive disease|0|||
30608392|NCT01288430|58619221|FG000|Part 1|Clinical disease progression|0|||
30608393|NCT01288430|58619222|FG001|Part 1|Clinical disease progression|0|||
30608394|NCT01288430|58619223|FG002|Part 1|Clinical disease progression|1|||
30608395|NCT01288430|58619224|FG003|Part 1|Clinical disease progression|0|||
30608396|NCT01288430|58619225|FG004|Part 1|Clinical disease progression|0|||
30698058|NCT00317473|58712413|FG002|Overall Study|Relocation|1|||
30698059|NCT00317473|58712414|FG003|Overall Study|Relocation|1|||
30698060|NCT00317473|58712415|FG004|Overall Study|Relocation|5|||
30698061|NCT00317473|58712416|FG005|Overall Study|Relocation|2|||
30698062|NCT00317473|58712411|FG000|Overall Study|Death|1|||
30698063|NCT00317473|58712412|FG001|Overall Study|Death|0|||
30698064|NCT00317473|58712413|FG002|Overall Study|Death|0|||
30698065|NCT00317473|58712414|FG003|Overall Study|Death|0|||
30698066|NCT00317473|58712415|FG004|Overall Study|Death|0|||
30698067|NCT00317473|58712416|FG005|Overall Study|Death|0|||
30698068|NCT00317473|58712411|FG000|Overall Study|Other|0|||
30698069|NCT00317473|58712412|FG001|Overall Study|Other|2|||
30698070|NCT00317473|58712413|FG002|Overall Study|Other|0|||
30698071|NCT00317473|58712414|FG003|Overall Study|Other|0|||
30698072|NCT00317473|58712415|FG004|Overall Study|Other|0|||
30698073|NCT00317473|58712416|FG005|Overall Study|Other|0|||
30698074|NCT00530218|58712440|FG000|Overall Study|CMV Not Detected|13|||
30698075|NCT00530218|58712440|FG000|Overall Study|Death|12|||
30698076|NCT00761267|58712450|FG000|Overall Study|Death|1|||
30698077|NCT00761267|58712451|FG001|Overall Study|Death|2|||
30698078|NCT00761267|58712452|FG002|Overall Study|Death|5|||
30698079|NCT00761267|58712450|FG000|Overall Study|Lost to Follow-up|0|||
30698080|NCT00761267|58712451|FG001|Overall Study|Lost to Follow-up|0|||
30698081|NCT00761267|58712452|FG002|Overall Study|Lost to Follow-up|1|||
30698082|NCT00761267|58712450|FG000|Overall Study|Randomized but not treated|1|||
30698083|NCT00761267|58712451|FG001|Overall Study|Randomized but not treated|1|||
30698084|NCT00761267|58712452|FG002|Overall Study|Randomized but not treated|0|||
30698085|NCT00761267|58712450|FG000|Overall Study|Withdrawal by Subject|0|||
30698086|NCT00761267|58712451|FG001|Overall Study|Withdrawal by Subject|1|||
30698087|NCT00761267|58712452|FG002|Overall Study|Withdrawal by Subject|0|||
30698088|NCT00303667|58712473|FG000|Overall Study|Death|0|||
30698089|NCT00303667|58712474|FG001|Overall Study|Death|4|||
30698090|NCT00761189|58712480|FG000|Overall Study|Adverse Event|42|||
30698091|NCT00761189|58712480|FG000|Overall Study|Lack of Efficacy|45|||
30698092|NCT00761189|58712480|FG000|Overall Study|Lost to Follow-up|36|||
30698093|NCT00761189|58712480|FG000|Overall Study|Withdrawal by Subject|49|||
30698094|NCT00761189|58712480|FG000|Overall Study|Other|13|||
30698095|NCT00529516|58712487|FG000|Overall Study|Adverse Event|2|||
30698096|NCT00529516|58712488|FG001|Overall Study|Adverse Event|1|||
30698097|NCT00529516|58712489|FG002|Overall Study|Adverse Event|0|||
30698098|NCT00529516|58712487|FG000|Overall Study|Withdrawal by Subject|1|||
30698099|NCT00529516|58712488|FG001|Overall Study|Withdrawal by Subject|1|||
30698100|NCT00529516|58712489|FG002|Overall Study|Withdrawal by Subject|0|||
30698101|NCT00529516|58712487|FG000|Overall Study|Lost to Follow-up|0|||
30698102|NCT00529516|58712488|FG001|Overall Study|Lost to Follow-up|0|||
30698103|NCT00529516|58712489|FG002|Overall Study|Lost to Follow-up|1|||
30698104|NCT00316693|58712499|FG000|Overall Study|Adverse Event|6|||
30698105|NCT00316693|58712500|FG001|Overall Study|Adverse Event|1|||
30698106|NCT00316693|58712499|FG000|Overall Study|Protocol Violation|1|||
30698107|NCT00316693|58712500|FG001|Overall Study|Protocol Violation|0|||
30698108|NCT00316693|58712499|FG000|Overall Study|Withdrawal by Subject|6|||
30698109|NCT00316693|58712500|FG001|Overall Study|Withdrawal by Subject|6|||
30698110|NCT00316693|58712499|FG000|Overall Study|Lost to Follow-up|26|||
30698111|NCT00316693|58712500|FG001|Overall Study|Lost to Follow-up|34|||
30698112|NCT00316693|58712499|FG000|Overall Study|Other|38|||
30698113|NCT00316693|58712500|FG001|Overall Study|Other|44|||
30698114|NCT00316303|58712508|FG000|Overall Study|Lost to Follow-up|11|||
30698115|NCT00316303|58712509|FG001|Overall Study|Lost to Follow-up|16|||
30698116|NCT00760877|58712520|FG000|Overall Study|Protocol Violation|1|||
30698117|NCT00760877|58712521|FG001|Overall Study|Protocol Violation|0|||
30698118|NCT00760877|58712520|FG000|Overall Study|Non-compliance with protocol treatment|2|||
30698119|NCT00760877|58712521|FG001|Overall Study|Non-compliance with protocol treatment|1|||
30698120|NCT00760877|58712520|FG000|Overall Study|Pregnancy|1|||
30698121|NCT00760877|58712521|FG001|Overall Study|Pregnancy|4|||
30698122|NCT00760877|58712520|FG000|Overall Study|Death|2|||
30698123|NCT00760877|58712521|FG001|Overall Study|Death|1|||
30698124|NCT00760877|58712520|FG000|Overall Study|Withdrawal by Subject|7|||
30698125|NCT00760877|58712521|FG001|Overall Study|Withdrawal by Subject|3|||
30698126|NCT00760877|58712520|FG000|Overall Study|Adverse Event|19|||
30698127|NCT00760877|58712521|FG001|Overall Study|Adverse Event|12|||
30698128|NCT00760877|58712520|FG000|Overall Study|Participant diagnosed with AML|0|||
30698129|NCT00760877|58712521|FG001|Overall Study|Participant diagnosed with AML|1|||
30698130|NCT00760877|58712520|FG000|Overall Study|Participant not eligible to cross-over|0|||
30698131|NCT00760877|58712521|FG001|Overall Study|Participant not eligible to cross-over|1|||
30698132|NCT00760877|58712520|FG000|Overall Study|Physician Decision|1|||
30698133|NCT00760877|58712521|FG001|Overall Study|Physician Decision|2|||
30698134|NCT00760877|58712520|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
30698135|NCT00760877|58712521|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
30698136|NCT00760877|58712520|FG000|Overall Study|Treatment failure|1|||
30698137|NCT00760877|58712521|FG001|Overall Study|Treatment failure|0|||
30698138|NCT00302731|58712532|FG000|Overall Study|Lost to Follow-up|1|||
30698139|NCT00302731|58712533|FG001|Overall Study|Lost to Follow-up|2|||
30698140|NCT00302731|58712534|FG002|Overall Study|Lost to Follow-up|0|||
30698141|NCT00302731|58712535|FG003|Overall Study|Lost to Follow-up|0|||
30698142|NCT00302731|58712532|FG000|Overall Study|Adverse Event|0|||
30698143|NCT00302731|58712533|FG001|Overall Study|Adverse Event|2|||
30698144|NCT00302731|58712534|FG002|Overall Study|Adverse Event|2|||
30698145|NCT00302731|58712535|FG003|Overall Study|Adverse Event|0|||
30698146|NCT00302731|58712532|FG000|Overall Study|Withdrawal by Subject|1|||
30698147|NCT00302731|58712533|FG001|Overall Study|Withdrawal by Subject|1|||
30698148|NCT00302731|58712534|FG002|Overall Study|Withdrawal by Subject|0|||
30698149|NCT00302731|58712535|FG003|Overall Study|Withdrawal by Subject|0|||
30698150|NCT00302731|58712532|FG000|Overall Study|Protocol Violation|1|||
30698151|NCT00302731|58712533|FG001|Overall Study|Protocol Violation|0|||
30698152|NCT00302731|58712534|FG002|Overall Study|Protocol Violation|0|||
30698153|NCT00302731|58712535|FG003|Overall Study|Protocol Violation|0|||
30698154|NCT00302731|58712532|FG000|Overall Study|cancer unrelated to study discovered|1|||
30698155|NCT00302731|58712533|FG001|Overall Study|cancer unrelated to study discovered|0|||
30698156|NCT00302731|58712534|FG002|Overall Study|cancer unrelated to study discovered|1|||
30698157|NCT00302731|58712535|FG003|Overall Study|cancer unrelated to study discovered|0|||
30698158|NCT00780143|58712545|FG000|Overall Study|Progressive disease|1|||
30698159|NCT00780143|58712545|FG000|Overall Study|Toxicity|1|||
30698160|NCT00780143|58712545|FG000|Overall Study|Adverse Event|1|||
30698161|NCT00779909|58712553|FG000|Overall Study|Lost to Follow-up|1|||
30698162|NCT00779909|58712554|FG001|Overall Study|Lost to Follow-up|0|||
30698163|NCT00779909|58712555|FG002|Overall Study|Lost to Follow-up|0|||
30698164|NCT00779909|58712556|FG003|Overall Study|Lost to Follow-up|1|||
30698165|NCT00779909|58712553|FG000|Overall Study|Withdrawal by Subject|0|||
30698166|NCT00779909|58712554|FG001|Overall Study|Withdrawal by Subject|1|||
30698167|NCT00779909|58712555|FG002|Overall Study|Withdrawal by Subject|0|||
30698168|NCT00779909|58712556|FG003|Overall Study|Withdrawal by Subject|0|||
30698169|NCT00302107|58712575|FG000|Overall Study|Lost to Follow-up|6|||
30698170|NCT00302107|58712576|FG001|Overall Study|Lost to Follow-up|5|||
30698171|NCT00302107|58712575|FG000|Overall Study|Protocol Violation|1|||
30698172|NCT00302107|58712576|FG001|Overall Study|Protocol Violation|0|||
30698173|NCT00302107|58712575|FG000|Overall Study|Relocation|0|||
30698174|NCT00302107|58712576|FG001|Overall Study|Relocation|1|||
30698175|NCT00302107|58712575|FG000|Overall Study|Withdrawal by Subject|0|||
30698176|NCT00302107|58712576|FG001|Overall Study|Withdrawal by Subject|3|||
30698177|NCT00302107|58712575|FG000|Overall Study|Adverse Event|1|||
30698178|NCT00302107|58712576|FG001|Overall Study|Adverse Event|0|||
30698179|NCT00760487|58712582|FG000|Overall Study|Unilateral implantation|3|||
30698180|NCT00316225|58712586|FG000|Overall Study|Adverse Event|2|||
30698181|NCT00316225|58712586|FG000|Overall Study|Physician Decision|3|||
30698182|NCT00316225|58712586|FG000|Overall Study|Progressive Disease|15|||
30698183|NCT00316225|58712586|FG000|Overall Study|Withdrawal by Subject|3|||
30698184|NCT00316225|58712586|FG000|Overall Study|Death|2|||
30698185|NCT00586703|58712590|FG000|Overall Study|Death|12|||
30698186|NCT00586625|58712596|FG000|Overall Study|Adverse Event|6|||
30698187|NCT00586625|58712597|FG001|Overall Study|Adverse Event|6|||
30698188|NCT00586625|58712596|FG000|Overall Study|Protocol Violation|3|||
30698189|NCT00586625|58712597|FG001|Overall Study|Protocol Violation|0|||
30698190|NCT00586625|58712596|FG000|Overall Study|Withdrawal by Subject|32|||
30698191|NCT00586625|58712597|FG001|Overall Study|Withdrawal by Subject|10|||
30698192|NCT00586625|58712596|FG000|Overall Study|Subject non-compliance|0|||
30698193|NCT00586625|58712597|FG001|Overall Study|Subject non-compliance|1|||
30698194|NCT00586625|58712596|FG000|Overall Study|Subject unable to return for visit|2|||
30698195|NCT00586625|58712597|FG001|Overall Study|Subject unable to return for visit|0|||
30698196|NCT00636168|58712605|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
30698197|NCT00636168|58712606|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
30698198|NCT00636168|58712605|FG000|Randomized to Study Drug|Adverse Event|1|||
30698199|NCT00636168|58712606|FG001|Randomized to Study Drug|Adverse Event|0|||
30698200|NCT00636168|58712605|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
30698201|NCT00636168|58712606|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
30698202|NCT00636168|58712605|FG000|Treated With Study Drug|Recurrence of disease|135|||
30698203|NCT00636168|58712606|FG001|Treated With Study Drug|Recurrence of disease|282|||
30698204|NCT00636168|58712605|FG000|Treated With Study Drug|Adverse Event|250|||
30698205|NCT00636168|58712606|FG001|Treated With Study Drug|Adverse Event|22|||
30698206|NCT00636168|58712605|FG000|Treated With Study Drug|Participant withdrew consent|16|||
30698207|NCT00636168|58712606|FG001|Treated With Study Drug|Participant withdrew consent|21|||
30698208|NCT00636168|58712605|FG000|Treated With Study Drug|Poor/non-compliance|1|||
30698209|NCT00636168|58712606|FG001|Treated With Study Drug|Poor/non-compliance|3|||
30698210|NCT00636168|58712605|FG000|Treated With Study Drug|Death|3|||
30698211|NCT00636168|58712606|FG001|Treated With Study Drug|Death|0|||
30698212|NCT00636168|58712605|FG000|Treated With Study Drug|Pregnancy|1|||
30698213|NCT00636168|58712606|FG001|Treated With Study Drug|Pregnancy|0|||
30698214|NCT00636168|58712605|FG000|Treated With Study Drug|No longer meets study criteria|1|||
30760587|NCT03381274|58769071|FG001|Overall Study|Lost to Follow-up|0|||
30698215|NCT00636168|58712606|FG001|Treated With Study Drug|No longer meets study criteria|0|||
30698216|NCT00636168|58712605|FG000|Treated With Study Drug|Other reason|1|||
30698217|NCT00636168|58712606|FG001|Treated With Study Drug|Other reason|3|||
30698218|NCT00636168|58712605|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
30698219|NCT00636168|58712606|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
30698220|NCT00636168|58712605|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
30698221|NCT00636168|58712606|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
30698222|NCT00636168|58712605|FG000|Long Term Follow-Up|Death|8|||
30698223|NCT00636168|58712606|FG001|Long Term Follow-Up|Death|9|||
30698224|NCT00759941|58712614|FG000|Overall Study|Use of medication|1|||
30698225|NCT00759941|58712615|FG001|Overall Study|Use of medication|0|||
30698226|NCT00759941|58712614|FG000|Overall Study|Adverse Event|1|||
30698227|NCT00759941|58712615|FG001|Overall Study|Adverse Event|0|||
30698228|NCT00759941|58712614|FG000|Overall Study|Exited in error by site|1|||
30698229|NCT00759941|58712615|FG001|Overall Study|Exited in error by site|1|||
30698230|NCT00528424|58712621|FG000|Overall Study|Lost to Follow-up|13|||
30698231|NCT00528424|58712621|FG000|Overall Study|Withdrew consent|2|||
30698232|NCT00528424|58712621|FG000|Overall Study|Administrative reason|2|||
30698233|NCT00528424|58712621|FG000|Overall Study|Other|12|||
30698234|NCT00315445|58712628|FG000|Overall Study|Adverse Event|7|||
30698235|NCT00315445|58712629|FG001|Overall Study|Adverse Event|12|||
30698236|NCT00315445|58712630|FG002|Overall Study|Adverse Event|15|||
30698237|NCT00315445|58712628|FG000|Overall Study|Lack of Efficacy|16|||
30698238|NCT00315445|58712629|FG001|Overall Study|Lack of Efficacy|1|||
30698239|NCT00315445|58712630|FG002|Overall Study|Lack of Efficacy|7|||
30698240|NCT00315445|58712628|FG000|Overall Study|Lost to Follow-up|1|||
30698241|NCT00315445|58712629|FG001|Overall Study|Lost to Follow-up|0|||
30698242|NCT00315445|58712630|FG002|Overall Study|Lost to Follow-up|1|||
30698243|NCT00315445|58712628|FG000|Overall Study|Protocol Violation|2|||
30698244|NCT00315445|58712629|FG001|Overall Study|Protocol Violation|0|||
30698245|NCT00315445|58712630|FG002|Overall Study|Protocol Violation|1|||
30698246|NCT00315445|58712628|FG000|Overall Study|Other|1|||
30698247|NCT00315445|58712629|FG001|Overall Study|Other|3|||
30698248|NCT00315445|58712630|FG002|Overall Study|Other|0|||
30698249|NCT03687736|58712638|FG000|Overall Study|Lost to Follow-up|7|||
30698250|NCT03687736|58712638|FG000|Overall Study|Withdrawal by Subject|3|||
30698251|NCT00779675|58712644|FG000|Treatment Period|Adverse Event|87|||
30698252|NCT00779675|58712644|FG000|Treatment Period|Treatment Failure|80|||
30698253|NCT00779675|58712644|FG000|Treatment Period|Transferred to Another Study|38|||
30698254|NCT00779675|58712644|FG000|Treatment Period|Lost to Follow-up|23|||
30698255|NCT00779675|58712644|FG000|Treatment Period|Withdrawal by Subject|46|||
30698256|NCT00779675|58712644|FG000|Treatment Period|Protocol Violation|54|||
30698257|NCT00779675|58712644|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
30698258|NCT00779675|58712644|FG000|Treatment Period|Administrative|3|||
30698259|NCT00779675|58712644|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
30698260|NCT00779675|58712644|FG000|Extended Treatment Period|Protocol Violation|13|||
30698261|NCT00779675|58712644|FG000|Extended Treatment Period|Adverse Event|6|||
30698262|NCT00779675|58712644|FG000|Extended Treatment Period|Treatment Failure|11|||
30698263|NCT00779675|58712644|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
30698264|NCT00779675|58712644|FG000|Extended Treatment Period|Lost to Follow-up|6|||
30698265|NCT00759863|58712654|FG000|Overall Study|Death, moved, or lost contact|20|||
30698266|NCT00759863|58712655|FG001|Overall Study|Death, moved, or lost contact|18|||
30698267|NCT00759785|58712663|FG000|Overall Study|Participant sample not evaluable|11|||
30698268|NCT00759785|58712664|FG001|Overall Study|Participant sample not evaluable|2|||
30698269|NCT00759785|58712663|FG000|Overall Study|Participant sample lost|0|||
30698270|NCT00759785|58712664|FG001|Overall Study|Participant sample lost|1|||
30698271|NCT00759785|58712663|FG000|Overall Study|Protocol Violation|1|||
30698272|NCT00759785|58712664|FG001|Overall Study|Protocol Violation|0|||
30698273|NCT00759785|58712663|FG000|Overall Study|Physician Decision|0|||
30698274|NCT00759785|58712664|FG001|Overall Study|Physician Decision|1|||
30698275|NCT00759785|58712663|FG000|Overall Study|Withdrawal by Subject|0|||
30698276|NCT00759785|58712664|FG001|Overall Study|Withdrawal by Subject|1|||
30698277|NCT00300781|58712672|FG000|Overall Study|Disease Progression|55|||
30698278|NCT00300781|58712673|FG001|Overall Study|Disease Progression|52|||
30698279|NCT00300781|58712672|FG000|Overall Study|Adverse Event|5|||
30698280|NCT00300781|58712673|FG001|Overall Study|Adverse Event|6|||
30698281|NCT00300781|58712672|FG000|Overall Study|Withdrawal by Subject|1|||
30698282|NCT00300781|58712673|FG001|Overall Study|Withdrawal by Subject|2|||
30698283|NCT00300781|58712672|FG000|Overall Study|Physician Decision|1|||
30698284|NCT00300781|58712673|FG001|Overall Study|Physician Decision|0|||
30698285|NCT00300781|58712672|FG000|Overall Study|Not Recorded|0|||
30698286|NCT00300781|58712673|FG001|Overall Study|Not Recorded|1|||
30698287|NCT00300781|58712672|FG000|Overall Study|Symptomatic Deterioration|1|||
30698288|NCT00300781|58712673|FG001|Overall Study|Symptomatic Deterioration|0|||
30698289|NCT00300781|58712672|FG000|Overall Study|Lost to Follow-up|0|||
30698290|NCT00300781|58712673|FG001|Overall Study|Lost to Follow-up|1|||
30698291|NCT00315055|58712681|FG000|Overall Study|Protocol Violation|2|||
30698292|NCT00315055|58712682|FG001|Overall Study|Protocol Violation|4|||
30698293|NCT00315055|58712681|FG000|Overall Study|Lost to Follow-up|1|||
30698294|NCT00315055|58712682|FG001|Overall Study|Lost to Follow-up|1|||
30698295|NCT00528970|58712694|FG000|Overall Study|Adverse Event|6|||
30698296|NCT00528970|58712695|FG001|Overall Study|Adverse Event|8|||
30698297|NCT00528970|58712696|FG002|Overall Study|Adverse Event|5|||
30698298|NCT00528970|58712694|FG000|Overall Study|Lost to Follow-up|0|||
30698299|NCT00528970|58712695|FG001|Overall Study|Lost to Follow-up|0|||
30698300|NCT00528970|58712696|FG002|Overall Study|Lost to Follow-up|1|||
30698301|NCT00528970|58712694|FG000|Overall Study|Other than specified|2|||
30698302|NCT00528970|58712695|FG001|Overall Study|Other than specified|3|||
30698303|NCT00528970|58712696|FG002|Overall Study|Other than specified|3|||
30698304|NCT00528970|58712694|FG000|Overall Study|Protocol Violation|2|||
30698305|NCT00528970|58712695|FG001|Overall Study|Protocol Violation|1|||
30698306|NCT00528970|58712696|FG002|Overall Study|Protocol Violation|4|||
30698307|NCT00528970|58712694|FG000|Overall Study|Lack of Efficacy|0|||
30698308|NCT00528970|58712695|FG001|Overall Study|Lack of Efficacy|0|||
30698309|NCT00528970|58712696|FG002|Overall Study|Lack of Efficacy|1|||
30698310|NCT00528970|58712694|FG000|Overall Study|Withdrawal by Subject|4|||
30698311|NCT00528970|58712695|FG001|Overall Study|Withdrawal by Subject|3|||
30698312|NCT00528970|58712696|FG002|Overall Study|Withdrawal by Subject|5|||
30698313|NCT00528970|58712694|FG000|Overall Study|Randomized but not treated|0|||
30698314|NCT00528970|58712695|FG001|Overall Study|Randomized but not treated|0|||
30698315|NCT00528970|58712696|FG002|Overall Study|Randomized but not treated|1|||
30698316|NCT00759395|58712706|FG000|Overall Study|Adverse Event|1|||
30698317|NCT00759395|58712707|FG001|Overall Study|Adverse Event|0|||
30698318|NCT00759395|58712706|FG000|Overall Study|Withdrawal by Subject|1|||
30698319|NCT00759395|58712707|FG001|Overall Study|Withdrawal by Subject|0|||
30698320|NCT00759395|58712706|FG000|Overall Study|Lack of Efficacy|0|||
30698321|NCT00759395|58712707|FG001|Overall Study|Lack of Efficacy|2|||
30698322|NCT00293293|58712715|FG000|Overall Study|Withdrawal by Subject|1|||
30698323|NCT00293293|58712716|FG001|Overall Study|Withdrawal by Subject|1|||
30698324|NCT00293293|58712715|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
30698325|NCT00293293|58712716|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
30698326|NCT00293293|58712715|FG000|Overall Study|Patient discontinued chemotherapy|0|||
30698327|NCT00293293|58712716|FG001|Overall Study|Patient discontinued chemotherapy|1|||
30698328|NCT04864639|58712723|FG000|Overall Study|Death|1|||
30698329|NCT04864639|58712723|FG000|Overall Study|Lost to Follow-up|1|||
30698330|NCT04245449|58712749|FG000|Overall Study|COVID shutdown|7|||
30698331|NCT03887221|58712759|FG000|Overall Study|Protocol Violation|1|||
30698332|NCT03887221|58712760|FG001|Overall Study|Protocol Violation|0|||
30698333|NCT02782741|58712780|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
30698334|NCT02782741|58712781|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
30698335|NCT02782741|58712780|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
30698336|NCT02782741|58712781|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
30698337|NCT02782741|58712780|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2|||
30698338|NCT02782741|58712781|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1|||
30698339|NCT02782741|58712780|FG000|Open-label Long-term: Week 50 to 145|Other|1|||
30698340|NCT02782741|58712781|FG001|Open-label Long-term: Week 50 to 145|Other|0|||
30698341|NCT02782741|58712780|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48|||
30698342|NCT02782741|58712781|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43|||
30698343|NCT02771626|58712797|FG000|Overall Study|Adverse Event|1|||
30698344|NCT02771626|58712798|FG001|Overall Study|Adverse Event|5|||
30698345|NCT02771626|58712799|FG002|Overall Study|Adverse Event|3|||
30698346|NCT02771626|58712800|FG003|Overall Study|Adverse Event|0|||
30698347|NCT02771626|58712801|FG004|Overall Study|Adverse Event|1|||
30698348|NCT02771626|58712802|FG005|Overall Study|Adverse Event|1|||
30698349|NCT02771626|58712797|FG000|Overall Study|Radiologic Disease Progression|6|||
30698350|NCT02771626|58712798|FG001|Overall Study|Radiologic Disease Progression|13|||
30698351|NCT02771626|58712799|FG002|Overall Study|Radiologic Disease Progression|10|||
30698352|NCT02771626|58712800|FG003|Overall Study|Radiologic Disease Progression|7|||
30698353|NCT02771626|58712801|FG004|Overall Study|Radiologic Disease Progression|28|||
30698354|NCT02771626|58712802|FG005|Overall Study|Radiologic Disease Progression|15|||
30698355|NCT02771626|58712797|FG000|Overall Study|Symptomatic Deterioration|0|||
30698356|NCT02771626|58712798|FG001|Overall Study|Symptomatic Deterioration|4|||
30698357|NCT02771626|58712799|FG002|Overall Study|Symptomatic Deterioration|2|||
30698358|NCT02771626|58712800|FG003|Overall Study|Symptomatic Deterioration|0|||
30698359|NCT02771626|58712801|FG004|Overall Study|Symptomatic Deterioration|5|||
30698360|NCT02771626|58712802|FG005|Overall Study|Symptomatic Deterioration|2|||
30698361|NCT02771626|58712797|FG000|Overall Study|Participant Request|0|||
30698362|NCT02771626|58712798|FG001|Overall Study|Participant Request|1|||
30698363|NCT02771626|58712799|FG002|Overall Study|Participant Request|0|||
30698364|NCT02771626|58712800|FG003|Overall Study|Participant Request|2|||
30698365|NCT02771626|58712801|FG004|Overall Study|Participant Request|0|||
30698366|NCT02771626|58712802|FG005|Overall Study|Participant Request|1|||
30969080|NCT00070499|59040531|FG000|Overall Study|Still on protocol treatment|10|||
30698367|NCT02771626|58712797|FG000|Overall Study|Investigator Decision|0|||
30698368|NCT02771626|58712798|FG001|Overall Study|Investigator Decision|1|||
30698369|NCT02771626|58712799|FG002|Overall Study|Investigator Decision|0|||
30698370|NCT02771626|58712800|FG003|Overall Study|Investigator Decision|0|||
30698371|NCT02771626|58712801|FG004|Overall Study|Investigator Decision|1|||
30698372|NCT02771626|58712802|FG005|Overall Study|Investigator Decision|0|||
30698373|NCT02771626|58712797|FG000|Overall Study|Study Termination by Sponsor|0|||
30698374|NCT02771626|58712798|FG001|Overall Study|Study Termination by Sponsor|2|||
30698375|NCT02771626|58712799|FG002|Overall Study|Study Termination by Sponsor|1|||
30698376|NCT02771626|58712800|FG003|Overall Study|Study Termination by Sponsor|0|||
30698377|NCT02771626|58712801|FG004|Overall Study|Study Termination by Sponsor|1|||
30698378|NCT02771626|58712802|FG005|Overall Study|Study Termination by Sponsor|0|||
30698379|NCT02771626|58712797|FG000|Overall Study|Informed Consent Withdrawn|0|||
30698380|NCT02771626|58712798|FG001|Overall Study|Informed Consent Withdrawn|0|||
30698381|NCT02771626|58712799|FG002|Overall Study|Informed Consent Withdrawn|1|||
30698382|NCT02771626|58712800|FG003|Overall Study|Informed Consent Withdrawn|0|||
30698383|NCT02771626|58712801|FG004|Overall Study|Informed Consent Withdrawn|1|||
30698384|NCT02771626|58712802|FG005|Overall Study|Informed Consent Withdrawn|1|||
30698385|NCT02771626|58712797|FG000|Overall Study|Other, Not Specified|1|||
30698386|NCT02771626|58712798|FG001|Overall Study|Other, Not Specified|0|||
30698387|NCT02771626|58712799|FG002|Overall Study|Other, Not Specified|0|||
30698388|NCT02771626|58712800|FG003|Overall Study|Other, Not Specified|0|||
30698389|NCT02771626|58712801|FG004|Overall Study|Other, Not Specified|0|||
30698390|NCT02771626|58712802|FG005|Overall Study|Other, Not Specified|1|||
30698391|NCT02272790|58712822|FG000|Overall Study|Physician Decision|0|||
30698392|NCT02272790|58712823|FG001|Overall Study|Physician Decision|1|||
30698393|NCT02272790|58712824|FG002|Overall Study|Physician Decision|0|||
30698394|NCT02272790|58712825|FG003|Overall Study|Physician Decision|0|||
30698395|NCT02272790|58712826|FG004|Overall Study|Physician Decision|0|||
30698396|NCT02272790|58712827|FG005|Overall Study|Physician Decision|0|||
30698397|NCT01464164|58712854|FG000|Overall Study|Screen failure|0|||
30698398|NCT01464164|58712855|FG001|Overall Study|Screen failure|1|||
30698399|NCT01464164|58712856|FG002|Overall Study|Screen failure|2|||
30698400|NCT01464164|58712857|FG003|Overall Study|Screen failure|0|||
30698401|NCT01464164|58712858|FG004|Overall Study|Screen failure|0|||
30698402|NCT01464164|58712859|FG005|Overall Study|Screen failure|0|||
30698403|NCT01464164|58712860|FG006|Overall Study|Screen failure|0|||
30698404|NCT01464164|58712854|FG000|Overall Study|Physician Decision|0|||
30698405|NCT01464164|58712855|FG001|Overall Study|Physician Decision|1|||
30698406|NCT01464164|58712856|FG002|Overall Study|Physician Decision|0|||
30698407|NCT01464164|58712857|FG003|Overall Study|Physician Decision|0|||
30698408|NCT01464164|58712858|FG004|Overall Study|Physician Decision|0|||
30698409|NCT01464164|58712859|FG005|Overall Study|Physician Decision|0|||
30698410|NCT01464164|58712860|FG006|Overall Study|Physician Decision|2|||
30698411|NCT01377389|58712876|FG000|Overall Study|Withdrawal by Subject|1|||
30698412|NCT01377389|58712876|FG000|Overall Study|Screen failure|2|||
30698413|NCT01194271|58712880|FG000|Overall Study|Withdrawal by Subject|1|||
30698414|NCT01194271|58712880|FG000|Overall Study|Ineligible, Screen Failure|1|||
30698415|NCT01194271|58712880|FG000|Overall Study|Death|1|||
30698416|NCT01119508|58712884|FG000|Overall Study|Adverse Event|56|||
30698417|NCT01119508|58712884|FG000|Overall Study|Withdrawal by Subject|2|||
30698418|NCT01119508|58712884|FG000|Overall Study|Died before tumor response evaluation|1|||
30698419|NCT00568776|58712915|FG000|Overall Study|Adverse Event|8|||
30698420|NCT00568776|58712916|FG001|Overall Study|Adverse Event|8|||
30698421|NCT00568776|58712917|FG002|Overall Study|Adverse Event|10|||
30698422|NCT00568776|58712918|FG003|Overall Study|Adverse Event|8|||
30698423|NCT00568776|58712915|FG000|Overall Study|Death|0|||
30698424|NCT00568776|58712916|FG001|Overall Study|Death|1|||
30698425|NCT00568776|58712917|FG002|Overall Study|Death|4|||
30698426|NCT00568776|58712918|FG003|Overall Study|Death|3|||
30698427|NCT00568776|58712915|FG000|Overall Study|Physician Decision|0|||
30698428|NCT00568776|58712916|FG001|Overall Study|Physician Decision|2|||
30698429|NCT00568776|58712917|FG002|Overall Study|Physician Decision|0|||
30698430|NCT00568776|58712918|FG003|Overall Study|Physician Decision|0|||
30698431|NCT00568776|58712915|FG000|Overall Study|Lack of Efficacy|2|||
30698432|NCT00568776|58712916|FG001|Overall Study|Lack of Efficacy|2|||
30698433|NCT00568776|58712917|FG002|Overall Study|Lack of Efficacy|2|||
30698434|NCT00568776|58712918|FG003|Overall Study|Lack of Efficacy|4|||
30698435|NCT00568776|58712915|FG000|Overall Study|Lost to Follow-up|1|||
30698436|NCT00568776|58712916|FG001|Overall Study|Lost to Follow-up|1|||
30698437|NCT00568776|58712917|FG002|Overall Study|Lost to Follow-up|1|||
30698438|NCT00568776|58712918|FG003|Overall Study|Lost to Follow-up|1|||
30698439|NCT00568776|58712915|FG000|Overall Study|Protocol Violation|1|||
30698440|NCT00568776|58712916|FG001|Overall Study|Protocol Violation|0|||
30698441|NCT00568776|58712917|FG002|Overall Study|Protocol Violation|1|||
30698442|NCT00568776|58712918|FG003|Overall Study|Protocol Violation|1|||
30698443|NCT00568776|58712915|FG000|Overall Study|Withdrawal by Subject|13|||
30698444|NCT00568776|58712916|FG001|Overall Study|Withdrawal by Subject|15|||
30698445|NCT00568776|58712917|FG002|Overall Study|Withdrawal by Subject|13|||
30698446|NCT00568776|58712918|FG003|Overall Study|Withdrawal by Subject|7|||
30698447|NCT00568776|58712915|FG000|Overall Study|Loss of Caregiver|0|||
30698448|NCT00568776|58712916|FG001|Overall Study|Loss of Caregiver|2|||
30698449|NCT00568776|58712917|FG002|Overall Study|Loss of Caregiver|1|||
30698450|NCT00568776|58712918|FG003|Overall Study|Loss of Caregiver|2|||
30698451|NCT00568776|58712915|FG000|Overall Study|Sponsor Decision|2|||
30698452|NCT00568776|58712916|FG001|Overall Study|Sponsor Decision|2|||
30698453|NCT00568776|58712917|FG002|Overall Study|Sponsor Decision|41|||
30698454|NCT00568776|58712918|FG003|Overall Study|Sponsor Decision|42|||
30698455|NCT00568776|58712915|FG000|Overall Study|Miscellaeneous|3|||
30698456|NCT00568776|58712916|FG001|Overall Study|Miscellaeneous|3|||
30698457|NCT00568776|58712917|FG002|Overall Study|Miscellaeneous|1|||
30698458|NCT00568776|58712918|FG003|Overall Study|Miscellaeneous|4|||
30698459|NCT00758771|58712930|FG000|Overall Study|Withdrawal by Subject|1|||
30698460|NCT00758771|58712931|FG001|Overall Study|Withdrawal by Subject|1|||
30698461|NCT00758771|58712930|FG000|Overall Study|Did not meet eligibility criteria|2|||
30698462|NCT00758771|58712931|FG001|Overall Study|Did not meet eligibility criteria|4|||
30698463|NCT00635154|58712937|FG000|Overall Study|Alternative Treatment|8|||
30698464|NCT00635154|58712937|FG000|Overall Study|Other|4|||
30698465|NCT00635154|58712937|FG000|Overall Study|Still on treatment|21|||
30698466|NCT00778895|58712946|FG000|Active Phase|Adverse Event|3|||
30698467|NCT00778895|58712947|FG001|Active Phase|Adverse Event|1|||
30698468|NCT00778895|58712948|FG002|Active Phase|Adverse Event|0|||
30698469|NCT00778895|58712946|FG000|Active Phase|Withdrawal by Subject|1|||
30698470|NCT00778895|58712947|FG001|Active Phase|Withdrawal by Subject|4|||
30698471|NCT00778895|58712948|FG002|Active Phase|Withdrawal by Subject|0|||
30698472|NCT00778895|58712946|FG000|Active Phase|Lost to Follow-up|1|||
30698473|NCT00778895|58712947|FG001|Active Phase|Lost to Follow-up|1|||
30698474|NCT00778895|58712948|FG002|Active Phase|Lost to Follow-up|0|||
30698475|NCT00778895|58712946|FG000|Active Phase|Other|2|||
30698476|NCT00778895|58712947|FG001|Active Phase|Other|0|||
30698477|NCT00778895|58712948|FG002|Active Phase|Other|0|||
30698478|NCT00778895|58712946|FG000|ESFU Phase|Adverse Event|2|||
30698479|NCT00778895|58712947|FG001|ESFU Phase|Adverse Event|1|||
30698480|NCT00778895|58712948|FG002|ESFU Phase|Adverse Event|0|||
30698481|NCT00778895|58712946|FG000|ESFU Phase|Withdrawal by Subject|1|||
30698482|NCT00778895|58712947|FG001|ESFU Phase|Withdrawal by Subject|4|||
30698483|NCT00778895|58712948|FG002|ESFU Phase|Withdrawal by Subject|0|||
30698484|NCT00778895|58712946|FG000|ESFU Phase|Lost to Follow-up|6|||
30698485|NCT00778895|58712947|FG001|ESFU Phase|Lost to Follow-up|7|||
30698486|NCT00778895|58712948|FG002|ESFU Phase|Lost to Follow-up|2|||
30698487|NCT00778895|58712946|FG000|ESFU Phase|Other|2|||
30698488|NCT00778895|58712947|FG001|ESFU Phase|Other|0|||
30698489|NCT00778895|58712948|FG002|ESFU Phase|Other|0|||
30698490|NCT00293215|58712959|FG000|Overall Study|Progressive disease|3|||
30698491|NCT00293215|58712960|FG001|Overall Study|Progressive disease|1|||
30698492|NCT00293215|58712959|FG000|Overall Study|Adverse Event|2|||
30698493|NCT00293215|58712960|FG001|Overall Study|Adverse Event|2|||
30698494|NCT00778817|58712966|FG000|Overall Study|Adverse Event|2|||
30698495|NCT00778817|58712966|FG000|Overall Study|Withdrawal by Subject|2|||
30698496|NCT00293059|58712972|FG000|Overall Study|Adverse Event|12|||
30698497|NCT00293059|58712973|FG001|Overall Study|Adverse Event|4|||
30698498|NCT00293059|58712972|FG000|Overall Study|Lack of Efficacy|2|||
30698499|NCT00293059|58712973|FG001|Overall Study|Lack of Efficacy|0|||
30698500|NCT00293059|58712972|FG000|Overall Study|Lost to Follow-up|2|||
30698501|NCT00293059|58712973|FG001|Overall Study|Lost to Follow-up|3|||
30698502|NCT00293059|58712972|FG000|Overall Study|Pregnancy|1|||
30698503|NCT00293059|58712973|FG001|Overall Study|Pregnancy|1|||
30698504|NCT00293059|58712972|FG000|Overall Study|Protocol Violation|2|||
30698505|NCT00293059|58712973|FG001|Overall Study|Protocol Violation|0|||
30698506|NCT00293059|58712972|FG000|Overall Study|Withdrawal by Subject|11|||
30698507|NCT00293059|58712973|FG001|Overall Study|Withdrawal by Subject|5|||
30698508|NCT00293059|58712972|FG000|Overall Study|Participant moved out of state|1|||
30698509|NCT00293059|58712973|FG001|Overall Study|Participant moved out of state|0|||
30698510|NCT00293059|58712972|FG000|Overall Study|Participant stopped study drug|1|||
30698511|NCT00293059|58712973|FG001|Overall Study|Participant stopped study drug|0|||
30698512|NCT00293059|58712972|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
30698513|NCT00293059|58712973|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
30698514|NCT00293059|58712972|FG000|Overall Study|missing|3|||
30698515|NCT00293059|58712973|FG001|Overall Study|missing|5|||
30698516|NCT00756275|58712981|FG000|Overall Study|Lost to Follow-up|25|||
30698517|NCT00756275|58712982|FG001|Overall Study|Lost to Follow-up|21|||
30698518|NCT00756275|58712981|FG000|Overall Study|Withdrawal by Subject|4|||
30698519|NCT00756275|58712982|FG001|Overall Study|Withdrawal by Subject|7|||
30698520|NCT00758459|58712990|FG000|Overall Study|Adverse Event|3|||
30698521|NCT00758459|58712991|FG001|Overall Study|Adverse Event|2|||
30698522|NCT00758459|58712990|FG000|Overall Study|Protocol Violation|0|||
30698523|NCT00758459|58712991|FG001|Overall Study|Protocol Violation|1|||
30698524|NCT00758459|58712990|FG000|Overall Study|Withdrawal by Subject|0|||
30698525|NCT00758459|58712991|FG001|Overall Study|Withdrawal by Subject|1|||
30698526|NCT00298831|58712997|FG000|Overall Study|Adverse Event|1|||
30698527|NCT00298831|58712997|FG000|Overall Study|Lost to Follow-up|3|||
30698528|NCT00298831|58712997|FG000|Overall Study|Withdrawal by Subject|1|||
30698529|NCT00298831|58712997|FG000|Overall Study|Participants did not receive treatment|27|||
30698530|NCT00758069|58713004|FG000|Overall Study|Lack of Efficacy|0|||
30698531|NCT00758069|58713005|FG001|Overall Study|Lack of Efficacy|0|||
30698532|NCT00758069|58713006|FG002|Overall Study|Lack of Efficacy|1|||
30698533|NCT00758069|58713004|FG000|Overall Study|Incorrect Study Drug|1|||
30698534|NCT00758069|58713005|FG001|Overall Study|Incorrect Study Drug|0|||
30698535|NCT00758069|58713006|FG002|Overall Study|Incorrect Study Drug|0|||
30698536|NCT00311623|58713017|FG000|Overall Study|Physician Decision|0|||
30698537|NCT00311623|58713018|FG001|Overall Study|Physician Decision|0|||
30698538|NCT00311623|58713019|FG002|Overall Study|Physician Decision|2|||
30698539|NCT00528112|58713030|FG000|Treatment up to 3 Years|Adverse Event|313|||
30698540|NCT00528112|58713031|FG001|Treatment up to 3 Years|Adverse Event|278|||
30698541|NCT00528112|58713030|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
30698542|NCT00528112|58713031|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
30698543|NCT00528112|58713030|FG000|Treatment up to 3 Years|Protocol Violation|16|||
30698544|NCT00528112|58713031|FG001|Treatment up to 3 Years|Protocol Violation|16|||
30698545|NCT00528112|58713030|FG000|Treatment up to 3 Years|Death|0|||
30698546|NCT00528112|58713031|FG001|Treatment up to 3 Years|Death|1|||
30698547|NCT00528112|58713030|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
30698548|NCT00528112|58713031|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
30698549|NCT00528112|58713030|FG000|Treatment up to 3 Years|Pregnancy|9|||
30698550|NCT00528112|58713031|FG001|Treatment up to 3 Years|Pregnancy|10|||
30698551|NCT00528112|58713030|FG000|Treatment up to 3 Years|Other reasons|186|||
30698552|NCT00528112|58713031|FG001|Treatment up to 3 Years|Other reasons|186|||
30698553|NCT00528112|58713030|FG000|Extension Phase|Withdrawal by Subject|0|||
30698554|NCT00528112|58713031|FG001|Extension Phase|Withdrawal by Subject|3|||
30698555|NCT00528112|58713030|FG000|Extension Phase|Other reasons|0|||
30698556|NCT00528112|58713031|FG001|Extension Phase|Other reasons|100|||
30698557|NCT00528112|58713030|FG000|Extension Phase|Pregnancy|0|||
30698558|NCT00528112|58713031|FG001|Extension Phase|Pregnancy|3|||
30698559|NCT00528112|58713030|FG000|Extension Phase|Lost to Follow-up|0|||
30698560|NCT00528112|58713031|FG001|Extension Phase|Lost to Follow-up|12|||
30698561|NCT00528112|58713030|FG000|Extension Phase|Death|0|||
30698562|NCT00528112|58713031|FG001|Extension Phase|Death|1|||
30698563|NCT00528112|58713030|FG000|Extension Phase|Adverse Event|0|||
30698564|NCT00528112|58713031|FG001|Extension Phase|Adverse Event|36|||
30698565|NCT00528112|58713030|FG000|Extension Phase|Protocol Violation|0|||
30698566|NCT00528112|58713031|FG001|Extension Phase|Protocol Violation|2|||
30698567|NCT00633594|58713042|FG000|Overall Study|Adverse Event|0|||
30698568|NCT00633594|58713043|FG001|Overall Study|Adverse Event|4|||
30698569|NCT00633594|58713044|FG002|Overall Study|Adverse Event|7|||
30698570|NCT00633594|58713042|FG000|Overall Study|Death|0|||
30698571|NCT00633594|58713043|FG001|Overall Study|Death|1|||
30698572|NCT00633594|58713044|FG002|Overall Study|Death|2|||
30698573|NCT00633594|58713042|FG000|Overall Study|Disease Progression|0|||
30698574|NCT00633594|58713043|FG001|Overall Study|Disease Progression|0|||
30698575|NCT00633594|58713044|FG002|Overall Study|Disease Progression|1|||
30698576|NCT00755807|58713057|FG000|Acute Phase|Adverse Event|16|||
30698577|NCT00755807|58713058|FG001|Acute Phase|Adverse Event|5|||
30698578|NCT00755807|58713057|FG000|Acute Phase|Protocol Violation|1|||
30698579|NCT00755807|58713058|FG001|Acute Phase|Protocol Violation|3|||
30698580|NCT00755807|58713057|FG000|Acute Phase|Withdrawal by Subject|1|||
30698581|NCT00755807|58713058|FG001|Acute Phase|Withdrawal by Subject|2|||
30698582|NCT00755807|58713057|FG000|Acute Phase|Lack of Efficacy|0|||
30698583|NCT00755807|58713058|FG001|Acute Phase|Lack of Efficacy|1|||
30698584|NCT00755807|58713057|FG000|Acute Phase|Physician Decision|0|||
30698585|NCT00755807|58713058|FG001|Acute Phase|Physician Decision|1|||
30698586|NCT00755807|58713057|FG000|Open-label Extension Phase|Adverse Event|7|||
30698587|NCT00755807|58713058|FG001|Open-label Extension Phase|Adverse Event|7|||
30698588|NCT00755807|58713057|FG000|Open-label Extension Phase|Protocol Violation|5|||
30698589|NCT00755807|58713058|FG001|Open-label Extension Phase|Protocol Violation|2|||
30698590|NCT00755807|58713057|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
30698591|NCT00755807|58713058|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
30698592|NCT00755807|58713057|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
30698593|NCT00755807|58713058|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
30698594|NCT00755807|58713057|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
30698595|NCT00755807|58713058|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
30698596|NCT00755807|58713057|FG000|Open-label Extension Phase|Sponsor Decision|0|||
30698597|NCT00755807|58713058|FG001|Open-label Extension Phase|Sponsor Decision|1|||
30698598|NCT00631410|58713070|FG000|Overall Study|Adverse Event|1|||
30698599|NCT00631410|58713071|FG001|Overall Study|Adverse Event|3|||
30698600|NCT00631410|58713070|FG000|Overall Study|Objective Progression or Relapse|4|||
30698601|NCT00631410|58713071|FG001|Overall Study|Objective Progression or Relapse|3|||
30698602|NCT00631410|58713070|FG000|Overall Study|Surgery|1|||
30698603|NCT00631410|58713071|FG001|Overall Study|Surgery|0|||
30698604|NCT03686176|58713083|FG000|Overall Study|Procedure cancelled|1|||
30698605|NCT03686176|58713084|FG001|Overall Study|Procedure cancelled|0|||
30698606|NCT03686176|58713085|FG002|Overall Study|Procedure cancelled|0|||
30698607|NCT03686176|58713083|FG000|Overall Study|VR Malfunction|1|||
30698608|NCT03686176|58713084|FG001|Overall Study|VR Malfunction|0|||
30698609|NCT03686176|58713085|FG002|Overall Study|VR Malfunction|0|||
30698610|NCT00755417|58713096|FG000|Overall Study|Adverse Event|28|||
30698611|NCT00755417|58713097|FG001|Overall Study|Adverse Event|20|||
30698612|NCT00755417|58713098|FG002|Overall Study|Adverse Event|7|||
30698613|NCT00755417|58713096|FG000|Overall Study|Lack of Efficacy|8|||
30698614|NCT00755417|58713097|FG001|Overall Study|Lack of Efficacy|4|||
30698615|NCT00755417|58713098|FG002|Overall Study|Lack of Efficacy|9|||
30698616|NCT00755417|58713096|FG000|Overall Study|Protocol Violation|2|||
30698617|NCT00755417|58713097|FG001|Overall Study|Protocol Violation|1|||
30698618|NCT00755417|58713098|FG002|Overall Study|Protocol Violation|1|||
30698619|NCT00755417|58713096|FG000|Overall Study|Lost to Follow-up|3|||
30698620|NCT00755417|58713097|FG001|Overall Study|Lost to Follow-up|0|||
30698621|NCT00755417|58713098|FG002|Overall Study|Lost to Follow-up|1|||
30698622|NCT00755417|58713096|FG000|Overall Study|Withdrawal by Subject|12|||
30698623|NCT00755417|58713097|FG001|Overall Study|Withdrawal by Subject|12|||
30698624|NCT00755417|58713098|FG002|Overall Study|Withdrawal by Subject|12|||
30698625|NCT00755417|58713096|FG000|Overall Study|Not specified or missing data|9|||
30698626|NCT00755417|58713097|FG001|Overall Study|Not specified or missing data|18|||
30698627|NCT00755417|58713098|FG002|Overall Study|Not specified or missing data|12|||
30698628|NCT03685708|58713109|FG000|Overall Study|Withdrawal by Subject|0|||
30698629|NCT03685708|58713110|FG001|Overall Study|Withdrawal by Subject|0|||
30698630|NCT03685708|58713111|FG002|Overall Study|Withdrawal by Subject|1|||
30698631|NCT03685708|58713109|FG000|Overall Study|Screen Fail|0|||
30698632|NCT03685708|58713110|FG001|Overall Study|Screen Fail|1|||
30698633|NCT03685708|58713111|FG002|Overall Study|Screen Fail|1|||
30698634|NCT03685708|58713109|FG000|Overall Study|COVID 19 Pandemic|1|||
30698635|NCT03685708|58713110|FG001|Overall Study|COVID 19 Pandemic|1|||
30698636|NCT03685708|58713111|FG002|Overall Study|COVID 19 Pandemic|6|||
30698637|NCT03685708|58713109|FG000|Overall Study|Disease Progression|0|||
30698638|NCT03685708|58713110|FG001|Overall Study|Disease Progression|0|||
30698639|NCT03685708|58713111|FG002|Overall Study|Disease Progression|1|||
30698640|NCT03684928|58713119|FG000|First Intervention|Lost to Follow-up|0|||
30698641|NCT03684928|58713120|FG001|First Intervention|Lost to Follow-up|1|||
30698642|NCT03684928|58713119|FG000|First Intervention|Withdrawal by Subject|0|||
30788050|NCT03183908|58801451|FG001|Overall Study|Missing Symptom Diary Data|2|||
30788051|NCT03565887|58801463|FG000|Overall Study|Adverse Event|1|||
30788052|NCT03565887|58801464|FG001|Overall Study|Adverse Event|0|||
30788053|NCT03565887|58801463|FG000|Overall Study|Withdrawal by Subject|0|||
30788054|NCT03565887|58801464|FG001|Overall Study|Withdrawal by Subject|2|||
30788055|NCT03183518|58801470|FG000|Overall Study|Other (Not specified)|2|||
30788056|NCT03183518|58801470|FG000|Overall Study|Other (Withdrawal of consent)|1|||
30788057|NCT00116753|58801478|FG000|Overall Study|Adverse Event|16|||
30788058|NCT00116753|58801479|FG001|Overall Study|Adverse Event|10|||
30788059|NCT00116753|58801480|FG002|Overall Study|Adverse Event|7|||
30788060|NCT00116753|58801478|FG000|Overall Study|Withdrawal by Subject|11|||
30788061|NCT00116753|58801479|FG001|Overall Study|Withdrawal by Subject|12|||
30788062|NCT00116753|58801480|FG002|Overall Study|Withdrawal by Subject|8|||
30788063|NCT00116753|58801478|FG000|Overall Study|Lost to Follow-up|0|||
30788064|NCT00116753|58801479|FG001|Overall Study|Lost to Follow-up|2|||
30788065|NCT00116753|58801480|FG002|Overall Study|Lost to Follow-up|1|||
30788066|NCT00116753|58801478|FG000|Overall Study|Protocol Violation|0|||
30788067|NCT00116753|58801479|FG001|Overall Study|Protocol Violation|0|||
30788068|NCT00116753|58801480|FG002|Overall Study|Protocol Violation|1|||
30788069|NCT00116753|58801478|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
30788070|NCT00116753|58801479|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
30788071|NCT00116753|58801480|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
30788072|NCT00116753|58801478|FG000|Overall Study|Disease Progression|3|||
30788073|NCT00116753|58801479|FG001|Overall Study|Disease Progression|4|||
30788074|NCT00116753|58801480|FG002|Overall Study|Disease Progression|3|||
30788075|NCT00116753|58801478|FG000|Overall Study|Abnormal Echocardiogram|0|||
30788076|NCT00116753|58801479|FG001|Overall Study|Abnormal Echocardiogram|0|||
30788077|NCT00116753|58801480|FG002|Overall Study|Abnormal Echocardiogram|1|||
30788078|NCT00116753|58801478|FG000|Overall Study|Progressive Parkinson's Disease|1|||
30788079|NCT00116753|58801479|FG001|Overall Study|Progressive Parkinson's Disease|0|||
30788080|NCT00116753|58801480|FG002|Overall Study|Progressive Parkinson's Disease|0|||
30788081|NCT00116753|58801478|FG000|Overall Study|Dosing Error|0|||
30788082|NCT00116753|58801479|FG001|Overall Study|Dosing Error|1|||
30788083|NCT00116753|58801480|FG002|Overall Study|Dosing Error|0|||
30788084|NCT00113399|58801499|FG000|Overall Study|Death|1|||
30788085|NCT00113399|58801500|FG001|Overall Study|Death|1|||
30698643|NCT03684928|58713120|FG001|First Intervention|Withdrawal by Subject|2|||
30698644|NCT03684928|58713119|FG000|Second Intervention|Soft Tissue Injury|1|||
30788086|NCT00113399|58801499|FG000|Overall Study|Withdrawal by Subject|1|||
30788087|NCT00113399|58801500|FG001|Overall Study|Withdrawal by Subject|2|||
30788088|NCT00113399|58801499|FG000|Overall Study|Complete Response|0|||
30788089|NCT00113399|58801500|FG001|Overall Study|Complete Response|1|||
30788090|NCT00113399|58801499|FG000|Overall Study|Other|0|||
30788091|NCT00113399|58801500|FG001|Overall Study|Other|1|||
30788092|NCT00113087|58801508|FG000|Overall Study|Death or Transplant|14|||
30788093|NCT00113087|58801509|FG001|Overall Study|Death or Transplant|16|||
30788094|NCT00113087|58801508|FG000|Overall Study|Family or MD withdrew subject|10|||
30788095|NCT00113087|58801509|FG001|Overall Study|Family or MD withdrew subject|5|||
30788096|NCT00112463|58801515|FG000|Overall Study|Physician Decision|1|||
30788097|NCT00112463|58801515|FG000|Overall Study|Progression|30|||
30788098|NCT00112463|58801515|FG000|Overall Study|Second Primary|1|||
30788099|NCT00112463|58801515|FG000|Overall Study|Toxicity|3|||
30788100|NCT00112463|58801515|FG000|Overall Study|Withdrawal by Subject|2|||
30788101|NCT00112463|58801515|FG000|Overall Study|Never started treatment|2|||
30788102|NCT03548415|58801525|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
30788103|NCT03548415|58801526|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
30788104|NCT03548415|58801527|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
30788105|NCT03548415|58801528|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
30788106|NCT03548415|58801529|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
30788107|NCT00112385|58801545|FG000|Overall Study|Lost to Follow-up|1|||
30788108|NCT00112385|58801546|FG001|Overall Study|Lost to Follow-up|0|||
30788109|NCT00112385|58801545|FG000|Overall Study|Withdrawal by Subject|0|||
30788110|NCT00112385|58801546|FG001|Overall Study|Withdrawal by Subject|1|||
30788111|NCT03548337|58801554|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
30788112|NCT03548337|58801555|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
30788113|NCT03548337|58801554|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
30788114|NCT03548337|58801555|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
30788115|NCT03548337|58801554|FG000|Infant Series|Lost to Follow-up|2|||
30788116|NCT03548337|58801555|FG001|Infant Series|Lost to Follow-up|1|||
30788117|NCT03548337|58801554|FG000|Infant Series|Adverse Event|0|||
30788118|NCT03548337|58801555|FG001|Infant Series|Adverse Event|2|||
30788119|NCT03548337|58801554|FG000|Infant Series|Randomized but Not Vaccinated|1|||
30788120|NCT03548337|58801555|FG001|Infant Series|Randomized but Not Vaccinated|0|||
30788121|NCT03548337|58801554|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
30788122|NCT03548337|58801555|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
30788123|NCT03596151|58801567|FG000|Overall Study|Withdrawal by Subject|1|||
30788124|NCT03547635|58801574|FG000|Overall Study|Adverse Event|5|||
30788125|NCT03547635|58801575|FG001|Overall Study|Adverse Event|2|||
30788126|NCT03547635|58801576|FG002|Overall Study|Adverse Event|3|||
30788127|NCT03547635|58801574|FG000|Overall Study|Lost to Follow-up|1|||
30788128|NCT03547635|58801575|FG001|Overall Study|Lost to Follow-up|3|||
30788129|NCT03547635|58801576|FG002|Overall Study|Lost to Follow-up|4|||
30788130|NCT03547635|58801574|FG000|Overall Study|Withdrawal by Subject|1|||
30788131|NCT03547635|58801575|FG001|Overall Study|Withdrawal by Subject|0|||
30788132|NCT03547635|58801576|FG002|Overall Study|Withdrawal by Subject|0|||
30788133|NCT03547635|58801574|FG000|Overall Study|Withdrawal By PI|0|||
30788134|NCT03547635|58801575|FG001|Overall Study|Withdrawal By PI|1|||
30788135|NCT03547635|58801576|FG002|Overall Study|Withdrawal By PI|0|||
30788136|NCT03547635|58801574|FG000|Overall Study|Withdrawal by Sponsor|0|||
30788137|NCT03547635|58801575|FG001|Overall Study|Withdrawal by Sponsor|0|||
30788138|NCT03547635|58801576|FG002|Overall Study|Withdrawal by Sponsor|1|||
30788139|NCT03547635|58801574|FG000|Overall Study|Errant Randomization before Treatment|0|||
30788140|NCT03547635|58801575|FG001|Overall Study|Errant Randomization before Treatment|1|||
30788141|NCT03547635|58801576|FG002|Overall Study|Errant Randomization before Treatment|0|||
30788142|NCT03547635|58801574|FG000|Overall Study|Withdrawal by Subject|1|||
30788143|NCT03547635|58801575|FG001|Overall Study|Withdrawal by Subject|0|||
30788144|NCT03547635|58801576|FG002|Overall Study|Withdrawal by Subject|0|||
30788145|NCT03182738|58801630|FG000|Overall Study|Lost to Follow-up|9|||
30788146|NCT03182738|58801631|FG001|Overall Study|Lost to Follow-up|3|||
30788147|NCT03182738|58801630|FG000|Overall Study|Pregnancy|0|||
30788148|NCT03182738|58801631|FG001|Overall Study|Pregnancy|1|||
30788149|NCT03182738|58801630|FG000|Overall Study|Withdrawal by Subject|0|||
30788150|NCT03182738|58801631|FG001|Overall Study|Withdrawal by Subject|1|||
30788151|NCT03547167|58801639|FG000|Overall Study|Withdrawal by Subject|34|||
30788152|NCT03547167|58801640|FG001|Overall Study|Withdrawal by Subject|12|||
30788153|NCT03547167|58801639|FG000|Overall Study|Screen Failure|0|||
30788154|NCT03547167|58801640|FG001|Overall Study|Screen Failure|1|||
30788155|NCT03547167|58801639|FG000|Overall Study|Lost to Follow-up|59|||
30788156|NCT03547167|58801640|FG001|Overall Study|Lost to Follow-up|15|||
30788157|NCT03547167|58801639|FG000|Overall Study|Death|4|||
30788158|NCT03547167|58801640|FG001|Overall Study|Death|2|||
30788159|NCT03560739|58801654|FG000|Overall Study|Adverse Event|0|||
30788160|NCT03560739|58801655|FG001|Overall Study|Adverse Event|1|||
30788161|NCT03560739|58801656|FG002|Overall Study|Adverse Event|0|||
30788162|NCT03560739|58801657|FG003|Overall Study|Adverse Event|0|||
30788163|NCT00101686|58801677|FG000|Overall Study|Progressive Disease|37|||
30788164|NCT00101686|58801678|FG001|Overall Study|Progressive Disease|28|||
30788165|NCT00101686|58801679|FG002|Overall Study|Progressive Disease|37|||
30788166|NCT00101686|58801680|FG003|Overall Study|Progressive Disease|38|||
30788167|NCT00101686|58801681|FG004|Overall Study|Progressive Disease|28|||
30788168|NCT00101686|58801682|FG005|Overall Study|Progressive Disease|25|||
30788169|NCT00101686|58801683|FG006|Overall Study|Progressive Disease|5|||
30788170|NCT00101686|58801684|FG007|Overall Study|Progressive Disease|7|||
30788171|NCT00101686|58801685|FG008|Overall Study|Progressive Disease|10|||
30788172|NCT00101686|58801686|FG009|Overall Study|Progressive Disease|8|||
30788173|NCT00101686|58801677|FG000|Overall Study|initiation other anti-cancer treatment|4|||
30788174|NCT00101686|58801678|FG001|Overall Study|initiation other anti-cancer treatment|3|||
30788175|NCT00101686|58801679|FG002|Overall Study|initiation other anti-cancer treatment|4|||
30788176|NCT00101686|58801680|FG003|Overall Study|initiation other anti-cancer treatment|3|||
30788177|NCT00101686|58801681|FG004|Overall Study|initiation other anti-cancer treatment|1|||
30788178|NCT00101686|58801682|FG005|Overall Study|initiation other anti-cancer treatment|1|||
30788179|NCT00101686|58801683|FG006|Overall Study|initiation other anti-cancer treatment|2|||
30788180|NCT00101686|58801684|FG007|Overall Study|initiation other anti-cancer treatment|2|||
30788181|NCT00101686|58801685|FG008|Overall Study|initiation other anti-cancer treatment|3|||
30788182|NCT00101686|58801686|FG009|Overall Study|initiation other anti-cancer treatment|3|||
30788183|NCT00101686|58801677|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
30788184|NCT00101686|58801678|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
30788185|NCT00101686|58801679|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
30788186|NCT00101686|58801680|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
30788187|NCT00101686|58801681|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
30788188|NCT00101686|58801682|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
30788189|NCT00101686|58801683|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
30788190|NCT00101686|58801684|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
30788191|NCT00101686|58801685|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
30788192|NCT00101686|58801686|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
30788193|NCT00101686|58801677|FG000|Overall Study|unacceptable toxicity|3|||
30788194|NCT00101686|58801678|FG001|Overall Study|unacceptable toxicity|9|||
30788195|NCT00101686|58801679|FG002|Overall Study|unacceptable toxicity|10|||
30788196|NCT00101686|58801680|FG003|Overall Study|unacceptable toxicity|6|||
30788197|NCT00101686|58801681|FG004|Overall Study|unacceptable toxicity|16|||
30788198|NCT00101686|58801682|FG005|Overall Study|unacceptable toxicity|10|||
30788199|NCT00101686|58801683|FG006|Overall Study|unacceptable toxicity|4|||
30788200|NCT00101686|58801684|FG007|Overall Study|unacceptable toxicity|2|||
30788201|NCT00101686|58801685|FG008|Overall Study|unacceptable toxicity|1|||
30788202|NCT00101686|58801686|FG009|Overall Study|unacceptable toxicity|4|||
30788203|NCT00101686|58801677|FG000|Overall Study|Randomized but did not receive treament|1|||
30788204|NCT00101686|58801678|FG001|Overall Study|Randomized but did not receive treament|6|||
30788205|NCT00101686|58801679|FG002|Overall Study|Randomized but did not receive treament|2|||
30788206|NCT00101686|58801680|FG003|Overall Study|Randomized but did not receive treament|2|||
30788207|NCT00101686|58801681|FG004|Overall Study|Randomized but did not receive treament|2|||
30788208|NCT00101686|58801682|FG005|Overall Study|Randomized but did not receive treament|2|||
30788209|NCT00101686|58801683|FG006|Overall Study|Randomized but did not receive treament|0|||
30788210|NCT00101686|58801684|FG007|Overall Study|Randomized but did not receive treament|1|||
30788211|NCT00101686|58801685|FG008|Overall Study|Randomized but did not receive treament|0|||
30788212|NCT00101686|58801686|FG009|Overall Study|Randomized but did not receive treament|1|||
30788213|NCT00101686|58801677|FG000|Overall Study|intercurrent non-cancer related illness|0|||
30788214|NCT00101686|58801678|FG001|Overall Study|intercurrent non-cancer related illness|0|||
30788215|NCT00101686|58801679|FG002|Overall Study|intercurrent non-cancer related illness|2|||
30788216|NCT00101686|58801680|FG003|Overall Study|intercurrent non-cancer related illness|0|||
30788217|NCT00101686|58801681|FG004|Overall Study|intercurrent non-cancer related illness|1|||
30788218|NCT00101686|58801682|FG005|Overall Study|intercurrent non-cancer related illness|3|||
30788219|NCT00101686|58801683|FG006|Overall Study|intercurrent non-cancer related illness|1|||
30788220|NCT00101686|58801684|FG007|Overall Study|intercurrent non-cancer related illness|0|||
30788221|NCT00101686|58801685|FG008|Overall Study|intercurrent non-cancer related illness|1|||
30788222|NCT00101686|58801686|FG009|Overall Study|intercurrent non-cancer related illness|1|||
30788223|NCT00101686|58801677|FG000|Overall Study|Physician Decision|10|||
30788224|NCT00101686|58801678|FG001|Overall Study|Physician Decision|13|||
30788225|NCT00101686|58801679|FG002|Overall Study|Physician Decision|6|||
30788226|NCT00101686|58801680|FG003|Overall Study|Physician Decision|7|||
30788227|NCT00101686|58801681|FG004|Overall Study|Physician Decision|8|||
30788228|NCT00101686|58801682|FG005|Overall Study|Physician Decision|9|||
30788229|NCT00101686|58801683|FG006|Overall Study|Physician Decision|5|||
30788230|NCT00101686|58801684|FG007|Overall Study|Physician Decision|5|||
30788231|NCT00101686|58801685|FG008|Overall Study|Physician Decision|1|||
30788232|NCT00101686|58801686|FG009|Overall Study|Physician Decision|1|||
30788233|NCT00101686|58801677|FG000|Overall Study|Other|1|||
30788234|NCT00101686|58801678|FG001|Overall Study|Other|4|||
30788235|NCT00101686|58801679|FG002|Overall Study|Other|1|||
30788236|NCT00101686|58801680|FG003|Overall Study|Other|6|||
30788237|NCT00101686|58801681|FG004|Overall Study|Other|2|||
30788238|NCT00101686|58801682|FG005|Overall Study|Other|12|||
30788239|NCT00101686|58801683|FG006|Overall Study|Other|1|||
30788240|NCT00101686|58801684|FG007|Overall Study|Other|5|||
30788241|NCT00101686|58801685|FG008|Overall Study|Other|3|||
30788242|NCT00101686|58801686|FG009|Overall Study|Other|3|||
30788243|NCT00101686|58801677|FG000|Overall Study|Withdrawal by Subject|9|||
30788244|NCT00101686|58801678|FG001|Overall Study|Withdrawal by Subject|8|||
30788245|NCT00101686|58801679|FG002|Overall Study|Withdrawal by Subject|6|||
30788246|NCT00101686|58801680|FG003|Overall Study|Withdrawal by Subject|8|||
30788247|NCT00101686|58801681|FG004|Overall Study|Withdrawal by Subject|8|||
30788248|NCT00101686|58801682|FG005|Overall Study|Withdrawal by Subject|7|||
30788249|NCT00101686|58801683|FG006|Overall Study|Withdrawal by Subject|7|||
30788250|NCT00101686|58801684|FG007|Overall Study|Withdrawal by Subject|7|||
30788251|NCT00101686|58801685|FG008|Overall Study|Withdrawal by Subject|8|||
30788252|NCT00101686|58801686|FG009|Overall Study|Withdrawal by Subject|9|||
30788253|NCT00101452|58801706|FG000|Overall Study|Adverse Event|2|||
30788254|NCT00101452|58801707|FG001|Overall Study|Adverse Event|0|||
30788255|NCT00101452|58801708|FG002|Overall Study|Adverse Event|1|||
30788256|NCT00101452|58801706|FG000|Overall Study|Lost to Follow-up|13|||
30788257|NCT00101452|58801707|FG001|Overall Study|Lost to Follow-up|8|||
30788258|NCT00101452|58801708|FG002|Overall Study|Lost to Follow-up|14|||
30788259|NCT00101452|58801706|FG000|Overall Study|Withdrawal by Subject|10|||
30788260|NCT00101452|58801707|FG001|Overall Study|Withdrawal by Subject|14|||
30788261|NCT00101452|58801708|FG002|Overall Study|Withdrawal by Subject|9|||
30788262|NCT00101452|58801706|FG000|Overall Study|Baseline Fail|2|||
30788263|NCT00101452|58801707|FG001|Overall Study|Baseline Fail|1|||
30788264|NCT00101452|58801708|FG002|Overall Study|Baseline Fail|2|||
30788265|NCT00101452|58801706|FG000|Overall Study|Physician Decision|0|||
30788266|NCT00101452|58801707|FG001|Overall Study|Physician Decision|3|||
30788267|NCT00101452|58801708|FG002|Overall Study|Physician Decision|2|||
30788268|NCT00101452|58801706|FG000|Overall Study|Protocol Violation|2|||
30788269|NCT00101452|58801707|FG001|Overall Study|Protocol Violation|1|||
30788270|NCT00101452|58801708|FG002|Overall Study|Protocol Violation|3|||
30788271|NCT00101452|58801706|FG000|Overall Study|Other|15|||
30788272|NCT00101452|58801707|FG001|Overall Study|Other|16|||
30788273|NCT00101452|58801708|FG002|Overall Study|Other|12|||
30788274|NCT03546621|58801724|FG000|Overall Study|Withdrawal by Subject|0|||
30788275|NCT03546621|58801725|FG001|Overall Study|Withdrawal by Subject|1|||
30788276|NCT03546621|58801726|FG002|Overall Study|Withdrawal by Subject|2|||
30788277|NCT03546621|58801727|FG003|Overall Study|Withdrawal by Subject|1|||
30788278|NCT03546621|58801724|FG000|Overall Study|Lost to Follow-up|0|||
30788279|NCT03546621|58801725|FG001|Overall Study|Lost to Follow-up|1|||
30788280|NCT03546621|58801726|FG002|Overall Study|Lost to Follow-up|0|||
30788281|NCT03546621|58801727|FG003|Overall Study|Lost to Follow-up|0|||
30788282|NCT03546621|58801724|FG000|Overall Study|Adverse Event|0|||
30788283|NCT03546621|58801725|FG001|Overall Study|Adverse Event|1|||
30788284|NCT03546621|58801726|FG002|Overall Study|Adverse Event|0|||
30788285|NCT03546621|58801727|FG003|Overall Study|Adverse Event|1|||
30788286|NCT03546621|58801724|FG000|Overall Study|Progressive disease|0|||
30788287|NCT03546621|58801725|FG001|Overall Study|Progressive disease|0|||
30788288|NCT03546621|58801726|FG002|Overall Study|Progressive disease|0|||
30788289|NCT03546621|58801727|FG003|Overall Study|Progressive disease|1|||
30788290|NCT02761330|58801737|FG000|Treatment Week 1|Withdrawal by Subject|0|||
30788291|NCT02761330|58801738|FG001|Treatment Week 1|Withdrawal by Subject|0|||
30788292|NCT02761330|58801739|FG002|Treatment Week 1|Withdrawal by Subject|0|||
30788293|NCT02761330|58801740|FG003|Treatment Week 1|Withdrawal by Subject|1|||
30788294|NCT02761330|58801741|FG004|Treatment Week 1|Withdrawal by Subject|0|||
30788295|NCT02761330|58801742|FG005|Treatment Week 1|Withdrawal by Subject|1|||
30788296|NCT03559257|58801758|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
30788297|NCT03559257|58801759|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
30788298|NCT03559257|58801758|FG000|Double Blind Treatment Period|Protocol Violation|1|||
30788299|NCT03559257|58801759|FG001|Double Blind Treatment Period|Protocol Violation|4|||
30788300|NCT03559257|58801758|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
30788301|NCT03559257|58801759|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
30788302|NCT03559257|58801758|FG000|Double Blind Treatment Period|Adverse Event|0|||
30788303|NCT03559257|58801759|FG001|Double Blind Treatment Period|Adverse Event|1|||
30788304|NCT03559257|58801758|FG000|Double Blind Treatment Period|Screen Failure|0|||
30788305|NCT03559257|58801759|FG001|Double Blind Treatment Period|Screen Failure|1|||
30788306|NCT03559257|58801758|FG000|Open-label Treatment Period|Adverse Event|1|||
30788307|NCT03559257|58801759|FG001|Open-label Treatment Period|Adverse Event|4|||
30788308|NCT03559257|58801758|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
30788309|NCT03559257|58801759|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
30788310|NCT03559257|58801758|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
30788311|NCT03559257|58801759|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
30788312|NCT03559257|58801758|FG000|Open-label Treatment Period|Protocol Violation|2|||
30788313|NCT03559257|58801759|FG001|Open-label Treatment Period|Protocol Violation|0|||
30788314|NCT03559257|58801758|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
30788315|NCT03559257|58801759|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
30788316|NCT03559257|58801758|FG000|Open-label Treatment Period|Physician Decision|0|||
30788317|NCT03559257|58801759|FG001|Open-label Treatment Period|Physician Decision|1|||
30788318|NCT02892513|58801770|FG000|Overall Study|Withdrawal by Subject|0|||
30788319|NCT02892513|58801771|FG001|Overall Study|Withdrawal by Subject|1|||
30788320|NCT03558555|58801779|FG000|Overall Study|Lost to Follow-up|2|||
30788321|NCT03558555|58801780|FG001|Overall Study|Lost to Follow-up|1|||
30788322|NCT03541317|58801788|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
30788323|NCT03541317|58801789|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
30788324|NCT03541317|58801790|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
30788325|NCT03541317|58801791|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
30788326|NCT03541317|58801792|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
30788327|NCT03541317|58801793|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
30788328|NCT03590613|58801805|FG000|Period 2, 4 Days|Physician Decision|0|||
30788329|NCT03590613|58801806|FG001|Period 2, 4 Days|Physician Decision|0|||
30788330|NCT03590613|58801807|FG002|Period 2, 4 Days|Physician Decision|0|||
30788331|NCT03590613|58801808|FG003|Period 2, 4 Days|Physician Decision|1|||
30788332|NCT03557931|58801824|FG000|Overall Study|Adverse Event|4|||
30788333|NCT03557931|58801825|FG001|Overall Study|Adverse Event|6|||
30788334|NCT03557931|58801826|FG002|Overall Study|Adverse Event|1|||
30788335|NCT03557931|58801824|FG000|Overall Study|Lost to Follow-up|4|||
30788336|NCT03557931|58801825|FG001|Overall Study|Lost to Follow-up|4|||
30788337|NCT03557931|58801826|FG002|Overall Study|Lost to Follow-up|1|||
30788338|NCT03557931|58801824|FG000|Overall Study|Protocol Violation|1|||
30788339|NCT03557931|58801825|FG001|Overall Study|Protocol Violation|4|||
30788340|NCT03557931|58801826|FG002|Overall Study|Protocol Violation|1|||
30788341|NCT03557931|58801824|FG000|Overall Study|Withdrawal by Subject|14|||
30788342|NCT03557931|58801825|FG001|Overall Study|Withdrawal by Subject|0|||
30788343|NCT03557931|58801826|FG002|Overall Study|Withdrawal by Subject|7|||
30788344|NCT03557931|58801824|FG000|Overall Study|Miscellaneous|8|||
30788345|NCT03557931|58801825|FG001|Overall Study|Miscellaneous|5|||
30788346|NCT03557931|58801826|FG002|Overall Study|Miscellaneous|3|||
30788347|NCT03522675|58801836|FG000|Overall Study|Screen fail|1|||
30788348|NCT03522675|58801836|FG000|Overall Study|Non-reactive to histamine|1|||
30788349|NCT00294047|58801846|FG000|Month 48|Adverse Event|28|||
30788350|NCT00294047|58801847|FG001|Month 48|Adverse Event|13|||
30788351|NCT00294047|58801846|FG000|Month 48|Protocol Violation|4|||
30788352|NCT00294047|58801847|FG001|Month 48|Protocol Violation|4|||
30788353|NCT00294047|58801846|FG000|Month 48|Withdrawal by Subject|111|||
30788354|NCT00294047|58801847|FG001|Month 48|Withdrawal by Subject|115|||
30788355|NCT00294047|58801846|FG000|Month 48|Lost to Follow-up|272|||
30788356|NCT00294047|58801847|FG001|Month 48|Lost to Follow-up|287|||
30788357|NCT00294047|58801846|FG000|Month 48|Other|10|||
30788358|NCT00294047|58801847|FG001|Month 48|Other|14|||
30788359|NCT00294047|58801846|FG000|Month 84|Adverse Event|4|||
30788360|NCT00294047|58801847|FG001|Month 84|Adverse Event|2|||
30788361|NCT00294047|58801846|FG000|Month 84|Protocol Violation|1|||
30788362|NCT00294047|58801847|FG001|Month 84|Protocol Violation|1|||
30788363|NCT00294047|58801846|FG000|Month 84|Withdrawal by Subject|33|||
30788364|NCT00294047|58801847|FG001|Month 84|Withdrawal by Subject|31|||
30788365|NCT00294047|58801846|FG000|Month 84|Lost to Follow-up|187|||
30788366|NCT00294047|58801847|FG001|Month 84|Lost to Follow-up|190|||
30788367|NCT00294047|58801846|FG000|Month 84|Absent Cervix|2|||
30788368|NCT00294047|58801847|FG001|Month 84|Absent Cervix|0|||
30788369|NCT00294047|58801846|FG000|Month 84|Work related reasons|4|||
30788370|NCT00294047|58801847|FG001|Month 84|Work related reasons|2|||
30788371|NCT00294047|58801846|FG000|Month 84|Center closed, subject did not transfer|1|||
30788372|NCT00294047|58801847|FG001|Month 84|Center closed, subject did not transfer|0|||
30788373|NCT00294047|58801846|FG000|Month 84|Family problems|2|||
30788374|NCT00294047|58801847|FG001|Month 84|Family problems|2|||
30788375|NCT00294047|58801846|FG000|Month 84|Lack of time|3|||
30788376|NCT00294047|58801847|FG001|Month 84|Lack of time|1|||
30788377|NCT00294047|58801846|FG000|Month 84|Personal reason|2|||
30788378|NCT00294047|58801847|FG001|Month 84|Personal reason|4|||
30788379|NCT00294047|58801846|FG000|Month 84|Subject does not want male physician|1|||
30788380|NCT00294047|58801847|FG001|Month 84|Subject does not want male physician|0|||
30788381|NCT00294047|58801846|FG000|Month 84|Transport reimbursement delayed|0|||
30788382|NCT00294047|58801847|FG001|Month 84|Transport reimbursement delayed|1|||
30788383|NCT00294047|58801846|FG000|Month 84|Unable to reach study site|1|||
30788384|NCT00294047|58801847|FG001|Month 84|Unable to reach study site|0|||
30788385|NCT00294047|58801846|FG000|Month 84|Under investigation locally|1|||
30788386|NCT00294047|58801847|FG001|Month 84|Under investigation locally|0|||
30788387|NCT00294047|58801846|FG000|Month 84|Visit missed|0|||
30788388|NCT00294047|58801847|FG001|Month 84|Visit missed|1|||
30788389|NCT00294047|58801846|FG000|Month 84|No consent for Month 84 Follow-up|731|||
30788390|NCT00294047|58801847|FG001|Month 84|No consent for Month 84 Follow-up|754|||
30788391|NCT00293813|58801857|FG000|Overall Study|Physician Decision|0|||
30788392|NCT00293813|58801858|FG001|Overall Study|Physician Decision|1|||
30788393|NCT00293813|58801859|FG002|Overall Study|Physician Decision|0|||
30788394|NCT00293813|58801857|FG000|Overall Study|Adverse Event|3|||
30788395|NCT00293813|58801858|FG001|Overall Study|Adverse Event|1|||
30788396|NCT00293813|58801859|FG002|Overall Study|Adverse Event|1|||
30788397|NCT00293813|58801857|FG000|Overall Study|Withdrawal by Subject|7|||
30788398|NCT00293813|58801858|FG001|Overall Study|Withdrawal by Subject|4|||
30788399|NCT00293813|58801859|FG002|Overall Study|Withdrawal by Subject|4|||
30788400|NCT00293813|58801857|FG000|Overall Study|Lost to Follow-up|3|||
30788401|NCT00293813|58801858|FG001|Overall Study|Lost to Follow-up|2|||
30788402|NCT00293813|58801859|FG002|Overall Study|Lost to Follow-up|3|||
30788403|NCT00293813|58801857|FG000|Overall Study|Noncompliance|0|||
30788404|NCT00293813|58801858|FG001|Overall Study|Noncompliance|1|||
30788405|NCT00293813|58801859|FG002|Overall Study|Noncompliance|0|||
30788406|NCT00293579|58801867|FG000|Overall Study|Withdrawal by Subject|1|||
30788407|NCT00293423|58801874|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
30788408|NCT00293423|58801875|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
30788409|NCT00293423|58801874|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
30788410|NCT00293423|58801875|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
30788411|NCT00293423|58801874|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
30788412|NCT00293423|58801875|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
30788413|NCT00293423|58801874|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
30788414|NCT00293423|58801875|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
30788415|NCT00293423|58801874|FG000|Surgical Resection|processing error during surgical resection|1|||
30788416|NCT00293423|58801875|FG001|Surgical Resection|processing error during surgical resection|0|||
30788417|NCT00293423|58801874|FG000|Surgical Resection|Withdrawal by Subject|4|||
30788418|NCT00293423|58801875|FG001|Surgical Resection|Withdrawal by Subject|0|||
30788419|NCT00293423|58801874|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
30788420|NCT00293423|58801875|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
30788421|NCT03538743|58801890|FG000|Overall Study|Adverse Event|0|||
30788422|NCT03538743|58801891|FG001|Overall Study|Adverse Event|0|||
30788423|NCT03538743|58801892|FG002|Overall Study|Adverse Event|1|||
30788424|NCT03538743|58801893|FG003|Overall Study|Adverse Event|1|||
30788425|NCT03538743|58801894|FG004|Overall Study|Adverse Event|0|||
30788426|NCT03538743|58801895|FG005|Overall Study|Adverse Event|0|||
30788427|NCT03538743|58801896|FG006|Overall Study|Adverse Event|0|||
30788428|NCT03538743|58801897|FG007|Overall Study|Adverse Event|0|||
30788429|NCT03538743|58801898|FG008|Overall Study|Adverse Event|0|||
30788430|NCT03538743|58801890|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
30788431|NCT03538743|58801891|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
30788432|NCT03538743|58801892|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
30788433|NCT03538743|58801893|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
30788434|NCT03538743|58801894|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
30788435|NCT03538743|58801895|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
30788436|NCT03538743|58801896|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
30788437|NCT03538743|58801897|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
30788438|NCT03538743|58801898|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
30788439|NCT03538743|58801890|FG000|Overall Study|Withdrawal by Subject|0|||
30788440|NCT03538743|58801891|FG001|Overall Study|Withdrawal by Subject|0|||
30788441|NCT03538743|58801892|FG002|Overall Study|Withdrawal by Subject|0|||
30788442|NCT03538743|58801893|FG003|Overall Study|Withdrawal by Subject|1|||
30788443|NCT03538743|58801894|FG004|Overall Study|Withdrawal by Subject|0|||
30788444|NCT03538743|58801895|FG005|Overall Study|Withdrawal by Subject|0|||
30788445|NCT03538743|58801896|FG006|Overall Study|Withdrawal by Subject|0|||
30788446|NCT03538743|58801897|FG007|Overall Study|Withdrawal by Subject|0|||
30788447|NCT03538743|58801898|FG008|Overall Study|Withdrawal by Subject|0|||
30788448|NCT03521817|58801928|FG000|Overall Study|Protocol Violation|0|||
30788449|NCT03521817|58801929|FG001|Overall Study|Protocol Violation|1|||
30788450|NCT03538431|58801935|FG000|Overall Study|Physician Decision|0|||
30788451|NCT03538431|58801936|FG001|Overall Study|Physician Decision|1|||
30788452|NCT03538431|58801935|FG000|Overall Study|Withdrawal by Subject|1|||
30788453|NCT03538431|58801936|FG001|Overall Study|Withdrawal by Subject|0|||
30788454|NCT03521193|58801946|FG000|Overall Study|Withdrawal by Subject|8|||
30788455|NCT03521193|58801947|FG001|Overall Study|Withdrawal by Subject|0|||
30788456|NCT03521193|58801946|FG000|Overall Study|non compliant to ASA treatment|8|||
30788457|NCT03521193|58801947|FG001|Overall Study|non compliant to ASA treatment|0|||
30788458|NCT00293267|58801956|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
30788459|NCT00293267|58801957|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
30788460|NCT00293267|58801956|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
30788461|NCT00293267|58801957|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
30788462|NCT00293267|58801956|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
30788463|NCT00293267|58801957|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
30788464|NCT00293267|58801956|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
30788465|NCT00293267|58801957|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
30788466|NCT00293267|58801956|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
30788467|NCT00293267|58801957|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
30788468|NCT00293267|58801956|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
30788469|NCT00293267|58801957|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
30788470|NCT00293267|58801956|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
30788471|NCT00293267|58801957|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
30788472|NCT00293267|58801956|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
30788473|NCT00293267|58801957|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
30788474|NCT00293267|58801956|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
30788475|NCT00293267|58801957|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
30788476|NCT00293267|58801956|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
30788477|NCT00293267|58801957|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
30788478|NCT00293267|58801956|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
30788479|NCT00293267|58801957|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
30788480|NCT00293267|58801956|FG000|Extension - Double-Blind Week 49-156|Death|3|||
30788481|NCT00293267|58801957|FG001|Extension - Double-Blind Week 49-156|Death|0|||
30788482|NCT00293267|58801956|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
30788483|NCT00293267|58801957|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
30788484|NCT00293267|58801956|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
30788485|NCT00293267|58801957|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
30788486|NCT00293267|58801956|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
30788487|NCT00293267|58801957|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
30788488|NCT00293267|58801956|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
30788489|NCT00293267|58801957|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
30788490|NCT00293267|58801956|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
30788491|NCT00293267|58801957|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
30788492|NCT00293267|58801956|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
30788493|NCT00293267|58801957|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
30788494|NCT00293267|58801956|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
30788495|NCT00293267|58801957|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
30788496|NCT00293267|58801956|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
30788497|NCT00293267|58801957|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
30788498|NCT00293267|58801956|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
30788499|NCT00293267|58801957|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
30788500|NCT00293267|58801956|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
30788501|NCT00293267|58801957|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
30788502|NCT00293267|58801956|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
30788503|NCT00293267|58801957|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
30788504|NCT00293267|58801956|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
30788505|NCT00293267|58801957|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
30788506|NCT00293267|58801956|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
30788507|NCT00293267|58801957|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
30788508|NCT00293267|58801956|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
30788509|NCT00293267|58801957|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
30788510|NCT00293267|58801956|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
30788511|NCT00293267|58801957|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
30788512|NCT00293267|58801956|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
30788513|NCT00293267|58801957|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
30788514|NCT03520959|58801967|FG000|Overall Study|Study terminated by Sponsor|0|||
30788515|NCT03520959|58801968|FG001|Overall Study|Study terminated by Sponsor|1|||
30788516|NCT03537261|58801976|FG000|Overall Study|Lost to Follow-up|4|||
30788517|NCT03537261|58801977|FG001|Overall Study|Lost to Follow-up|5|||
30788518|NCT03537261|58801976|FG000|Overall Study|Withdrawal by Subject|4|||
30788519|NCT03537261|58801977|FG001|Overall Study|Withdrawal by Subject|6|||
30788520|NCT03537261|58801976|FG000|Overall Study|Did not return study questionnaires|0|||
30788521|NCT03537261|58801977|FG001|Overall Study|Did not return study questionnaires|1|||
30788522|NCT03536949|58801985|FG000|Overall Study|Adverse Event|4|||
30788523|NCT03536949|58801986|FG001|Overall Study|Adverse Event|0|||
30788524|NCT03536949|58801985|FG000|Overall Study|Lost to Follow-up|2|||
30788525|NCT03536949|58801986|FG001|Overall Study|Lost to Follow-up|1|||
30788526|NCT03536949|58801985|FG000|Overall Study|Withdrawal by Subject|6|||
30788527|NCT03536949|58801986|FG001|Overall Study|Withdrawal by Subject|0|||
30788528|NCT03536949|58801985|FG000|Overall Study|Non-compliance|2|||
30788529|NCT03536949|58801986|FG001|Overall Study|Non-compliance|1|||
30788530|NCT03588741|58801992|FG000|Overall Study|Withdrawal by Subject|1|||
30788531|NCT00111917|58801998|FG000|Overall Study|Withdrawal by Subject|1|||
30788532|NCT00111917|58801999|FG001|Overall Study|Withdrawal by Subject|1|||
30788533|NCT03520569|58802009|FG000|Overall Study|Withdrawal by Subject|1|||
30788534|NCT00111839|58802022|FG000|Overall Study|Disease Progression|30|||
30788535|NCT00111839|58802023|FG001|Overall Study|Disease Progression|33|||
30788536|NCT00111839|58802024|FG002|Overall Study|Disease Progression|33|||
30788537|NCT00111839|58802022|FG000|Overall Study|Adverse Event|5|||
30788538|NCT00111839|58802023|FG001|Overall Study|Adverse Event|3|||
30788539|NCT00111839|58802024|FG002|Overall Study|Adverse Event|1|||
30788540|NCT00111839|58802022|FG000|Overall Study|Protocol Violation|2|||
30788541|NCT00111839|58802023|FG001|Overall Study|Protocol Violation|4|||
30788542|NCT00111839|58802024|FG002|Overall Study|Protocol Violation|2|||
30788543|NCT00111839|58802022|FG000|Overall Study|Death|1|||
30788544|NCT00111839|58802023|FG001|Overall Study|Death|1|||
30788545|NCT00111839|58802024|FG002|Overall Study|Death|6|||
30788546|NCT00111839|58802022|FG000|Overall Study|Withdrawal by Subject|2|||
30788547|NCT00111839|58802023|FG001|Overall Study|Withdrawal by Subject|2|||
30788548|NCT00111839|58802024|FG002|Overall Study|Withdrawal by Subject|2|||
30788549|NCT00111839|58802022|FG000|Overall Study|Lost to Follow-up|1|||
30788550|NCT00111839|58802023|FG001|Overall Study|Lost to Follow-up|0|||
30788551|NCT00111839|58802024|FG002|Overall Study|Lost to Follow-up|0|||
30788552|NCT00111839|58802022|FG000|Overall Study|Logistical Constraint|1|||
30788553|NCT00111839|58802023|FG001|Overall Study|Logistical Constraint|0|||
30788554|NCT00111839|58802024|FG002|Overall Study|Logistical Constraint|0|||
30788555|NCT00111839|58802022|FG000|Overall Study|Other|6|||
30788556|NCT00111839|58802023|FG001|Overall Study|Other|3|||
30788557|NCT00111839|58802024|FG002|Overall Study|Other|3|||
30788558|NCT00111839|58802022|FG000|Overall Study|Randomized but Not Treated|0|||
30788559|NCT00111839|58802023|FG001|Overall Study|Randomized but Not Treated|0|||
30788560|NCT00111839|58802024|FG002|Overall Study|Randomized but Not Treated|2|||
30788561|NCT00111761|58802034|FG000|Part 1|Physician Decision|0|||
30788562|NCT00111761|58802035|FG001|Part 1|Physician Decision|1|||
30788563|NCT00111761|58802034|FG000|Part 1|Death|0|||
30788564|NCT00111761|58802035|FG001|Part 1|Death|2|||
30788565|NCT00111761|58802034|FG000|Part 1|Other|0|||
30788566|NCT00111761|58802035|FG001|Part 1|Other|1|||
30788567|NCT00111761|58802034|FG000|Part 1|Withdrawal by Subject|0|||
30788568|NCT00111761|58802035|FG001|Part 1|Withdrawal by Subject|1|||
30788569|NCT00111761|58802034|FG000|Part 2|Adverse Event|1|||
30788570|NCT00111761|58802035|FG001|Part 2|Adverse Event|0|||
30788571|NCT00111761|58802034|FG000|Part 2|Physician Decision|1|||
30788572|NCT00111761|58802035|FG001|Part 2|Physician Decision|0|||
30788573|NCT00111761|58802034|FG000|Part 2|Death|1|||
30788574|NCT00111761|58802035|FG001|Part 2|Death|0|||
30788575|NCT00111761|58802034|FG000|Part 2|Disease progression|3|||
30788576|NCT00111761|58802035|FG001|Part 2|Disease progression|0|||
30788577|NCT00111761|58802034|FG000|Part 2|Protocol-specified criteria|1|||
30788578|NCT00111761|58802035|FG001|Part 2|Protocol-specified criteria|0|||
30788579|NCT00111761|58802034|FG000|Part 2|Other|1|||
30788580|NCT00111761|58802035|FG001|Part 2|Other|0|||
30788581|NCT03519867|58802051|FG000|Overall Study|Adverse Event|1|||
30788582|NCT03519867|58802052|FG001|Overall Study|Adverse Event|1|||
30788583|NCT03519867|58802053|FG002|Overall Study|Adverse Event|0|||
30788584|NCT03519867|58802054|FG003|Overall Study|Adverse Event|0|||
30788585|NCT03519867|58802055|FG004|Overall Study|Adverse Event|0|||
30788586|NCT03519867|58802056|FG005|Overall Study|Adverse Event|0|||
30788587|NCT03519867|58802057|FG006|Overall Study|Adverse Event|0|||
30788588|NCT03519867|58802058|FG007|Overall Study|Adverse Event|0|||
30788589|NCT03519867|58802059|FG008|Overall Study|Adverse Event|0|||
30788590|NCT03519867|58802060|FG009|Overall Study|Adverse Event|0|||
30788591|NCT03519867|58802051|FG000|Overall Study|Protocol Violation|0|||
30788592|NCT03519867|58802052|FG001|Overall Study|Protocol Violation|0|||
30788593|NCT03519867|58802053|FG002|Overall Study|Protocol Violation|0|||
30788594|NCT03519867|58802054|FG003|Overall Study|Protocol Violation|0|||
30788595|NCT03519867|58802055|FG004|Overall Study|Protocol Violation|0|||
30788596|NCT03519867|58802056|FG005|Overall Study|Protocol Violation|1|||
30788597|NCT03519867|58802057|FG006|Overall Study|Protocol Violation|0|||
30788598|NCT03519867|58802058|FG007|Overall Study|Protocol Violation|0|||
30788599|NCT03519867|58802059|FG008|Overall Study|Protocol Violation|0|||
30788600|NCT03519867|58802060|FG009|Overall Study|Protocol Violation|0|||
30788601|NCT03519867|58802051|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
30788602|NCT03519867|58802052|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
30788603|NCT03519867|58802053|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
30788604|NCT03519867|58802054|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
30788605|NCT03519867|58802055|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
30843487|NCT02306161|58869582|FG000|Overall Study|Physician Decision|30|||
30788606|NCT03519867|58802056|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
30788607|NCT03519867|58802057|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
30788608|NCT03519867|58802058|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
30788609|NCT03519867|58802059|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
30788610|NCT03519867|58802060|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
30788611|NCT03519867|58802051|FG000|Overall Study|Admin. of other reversal agent|1|||
30788612|NCT03519867|58802052|FG001|Overall Study|Admin. of other reversal agent|1|||
30788613|NCT03519867|58802053|FG002|Overall Study|Admin. of other reversal agent|0|||
30788614|NCT03519867|58802054|FG003|Overall Study|Admin. of other reversal agent|0|||
30788615|NCT03519867|58802055|FG004|Overall Study|Admin. of other reversal agent|0|||
30788616|NCT03519867|58802056|FG005|Overall Study|Admin. of other reversal agent|1|||
30788617|NCT03519867|58802057|FG006|Overall Study|Admin. of other reversal agent|0|||
30788618|NCT03519867|58802058|FG007|Overall Study|Admin. of other reversal agent|0|||
30788619|NCT03519867|58802059|FG008|Overall Study|Admin. of other reversal agent|0|||
30788620|NCT03519867|58802060|FG009|Overall Study|Admin. of other reversal agent|0|||
30788621|NCT03519867|58802051|FG000|Overall Study|Reason not provided|1|||
30788622|NCT03519867|58802052|FG001|Overall Study|Reason not provided|1|||
30788623|NCT03519867|58802053|FG002|Overall Study|Reason not provided|1|||
30788624|NCT03519867|58802054|FG003|Overall Study|Reason not provided|1|||
30788625|NCT03519867|58802055|FG004|Overall Study|Reason not provided|0|||
30788626|NCT03519867|58802056|FG005|Overall Study|Reason not provided|1|||
30788627|NCT03519867|58802057|FG006|Overall Study|Reason not provided|0|||
30788628|NCT03519867|58802058|FG007|Overall Study|Reason not provided|1|||
30788629|NCT03519867|58802059|FG008|Overall Study|Reason not provided|1|||
30788630|NCT03519867|58802060|FG009|Overall Study|Reason not provided|0|||
30788631|NCT03519087|58802084|FG000|Clinic Evaluation|Physician Decision|15|||
30788632|NCT03519087|58802085|FG001|Clinic Evaluation|Physician Decision|18|||
30788633|NCT03519087|58802086|FG002|Clinic Evaluation|Physician Decision|0|||
30788634|NCT03519087|58802087|FG003|Clinic Evaluation|Physician Decision|0|||
30788635|NCT03519087|58802088|FG004|Clinic Evaluation|Physician Decision|0|||
30788636|NCT03519087|58802084|FG000|Clinic Evaluation|Protocol Violation|1|||
30788637|NCT03519087|58802085|FG001|Clinic Evaluation|Protocol Violation|0|||
30788638|NCT03519087|58802086|FG002|Clinic Evaluation|Protocol Violation|0|||
30788639|NCT03519087|58802087|FG003|Clinic Evaluation|Protocol Violation|0|||
30788640|NCT03519087|58802088|FG004|Clinic Evaluation|Protocol Violation|0|||
30788641|NCT03519087|58802084|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
30788642|NCT03519087|58802085|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
30788643|NCT03519087|58802086|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
30788644|NCT03519087|58802087|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
30788645|NCT03519087|58802088|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
30788646|NCT03519087|58802084|FG000|Re-randomization for Treatment|Not appropriate|2|||
30788647|NCT03519087|58802085|FG001|Re-randomization for Treatment|Not appropriate|3|||
30788648|NCT03519087|58802086|FG002|Re-randomization for Treatment|Not appropriate|0|||
30788649|NCT03519087|58802087|FG003|Re-randomization for Treatment|Not appropriate|0|||
30788650|NCT03519087|58802088|FG004|Re-randomization for Treatment|Not appropriate|0|||
30788651|NCT03519087|58802084|FG000|Laboratory Testing|Lost to Follow-up|0|||
30788652|NCT03519087|58802085|FG001|Laboratory Testing|Lost to Follow-up|0|||
30788653|NCT03519087|58802086|FG002|Laboratory Testing|Lost to Follow-up|2|||
30788654|NCT03519087|58802087|FG003|Laboratory Testing|Lost to Follow-up|3|||
30788655|NCT03519087|58802088|FG004|Laboratory Testing|Lost to Follow-up|6|||
30788656|NCT03519087|58802084|FG000|Laboratory Testing|Protocol Violation|0|||
30788657|NCT03519087|58802085|FG001|Laboratory Testing|Protocol Violation|0|||
30788658|NCT03519087|58802086|FG002|Laboratory Testing|Protocol Violation|0|||
30788659|NCT03519087|58802087|FG003|Laboratory Testing|Protocol Violation|1|||
30788660|NCT03519087|58802088|FG004|Laboratory Testing|Protocol Violation|0|||
30788661|NCT02763046|58802107|FG000|Overall Study|Adverse Event|5|||
30788662|NCT02763046|58802108|FG001|Overall Study|Adverse Event|4|||
30788663|NCT02763046|58802109|FG002|Overall Study|Adverse Event|0|||
30788664|NCT02763046|58802107|FG000|Overall Study|Lack of Efficacy|1|||
30788665|NCT02763046|58802108|FG001|Overall Study|Lack of Efficacy|1|||
30788666|NCT02763046|58802109|FG002|Overall Study|Lack of Efficacy|3|||
30788667|NCT02763046|58802107|FG000|Overall Study|Physician Decision|1|||
30788668|NCT02763046|58802108|FG001|Overall Study|Physician Decision|0|||
30788669|NCT02763046|58802109|FG002|Overall Study|Physician Decision|1|||
30788670|NCT02763046|58802107|FG000|Overall Study|Subject/guardian decision|2|||
30788671|NCT02763046|58802108|FG001|Overall Study|Subject/guardian decision|0|||
30788672|NCT02763046|58802109|FG002|Overall Study|Subject/guardian decision|4|||
30788673|NCT03518073|58802126|FG000|Overall Study|Adverse Event|2|||
30788674|NCT03518073|58802127|FG001|Overall Study|Adverse Event|4|||
30788675|NCT03518073|58802128|FG002|Overall Study|Adverse Event|2|||
30788676|NCT03518073|58802126|FG000|Overall Study|Death|2|||
30788677|NCT03518073|58802127|FG001|Overall Study|Death|1|||
30788678|NCT03518073|58802128|FG002|Overall Study|Death|3|||
30788679|NCT03518073|58802126|FG000|Overall Study|Lost to Follow-up|1|||
30788680|NCT03518073|58802127|FG001|Overall Study|Lost to Follow-up|0|||
30788681|NCT03518073|58802128|FG002|Overall Study|Lost to Follow-up|1|||
30788682|NCT03518073|58802126|FG000|Overall Study|Physician Decision|5|||
30788683|NCT03518073|58802127|FG001|Overall Study|Physician Decision|0|||
30788684|NCT03518073|58802128|FG002|Overall Study|Physician Decision|2|||
30788685|NCT03518073|58802126|FG000|Overall Study|Progressive disease|1|||
30788686|NCT03518073|58802127|FG001|Overall Study|Progressive disease|1|||
30788687|NCT03518073|58802128|FG002|Overall Study|Progressive disease|1|||
30788688|NCT03518073|58802126|FG000|Overall Study|Protocol Violation|1|||
30788689|NCT03518073|58802127|FG001|Overall Study|Protocol Violation|0|||
30788690|NCT03518073|58802128|FG002|Overall Study|Protocol Violation|0|||
30788691|NCT03518073|58802126|FG000|Overall Study|Withdrawal by Subject|30|||
30788692|NCT03518073|58802127|FG001|Overall Study|Withdrawal by Subject|34|||
30788693|NCT03518073|58802128|FG002|Overall Study|Withdrawal by Subject|29|||
30788694|NCT03518073|58802126|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
30788695|NCT03518073|58802127|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
30788696|NCT03518073|58802128|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
30788697|NCT03518073|58802126|FG000|Overall Study|Covid-19|1|||
30788698|NCT03518073|58802127|FG001|Overall Study|Covid-19|2|||
30788699|NCT03518073|58802128|FG002|Overall Study|Covid-19|1|||
30788700|NCT02759692|58802138|FG000|Period 1|Test article no longer available|1|||
30788701|NCT02759692|58802139|FG001|Period 1|Test article no longer available|1|||
30788702|NCT02759692|58802138|FG000|Period 1|No longer meets eligibility criteria.|1|||
30788703|NCT02759692|58802139|FG001|Period 1|No longer meets eligibility criteria.|0|||
30788704|NCT02759692|58802138|FG000|Period 1|Miss-Randomized|1|||
30788705|NCT02759692|58802139|FG001|Period 1|Miss-Randomized|1|||
30788706|NCT02759692|58802138|FG000|Period 2|Lost to Follow-up|1|||
30788707|NCT02759692|58802139|FG001|Period 2|Lost to Follow-up|0|||
30788708|NCT02759692|58802138|FG000|Period 2|Test article no longer available|0|||
30788709|NCT02759692|58802139|FG001|Period 2|Test article no longer available|1|||
30788710|NCT03586167|58802147|FG000|Overall Study|Other|1|||
30788711|NCT03586167|58802148|FG001|Overall Study|Other|0|||
30788712|NCT02762578|58802156|FG000|Overall Study|Adverse Event|1|||
30788713|NCT02762578|58802157|FG001|Overall Study|Adverse Event|6|||
30788714|NCT02762578|58802156|FG000|Overall Study|Protocol Violation|4|||
30788715|NCT02762578|58802157|FG001|Overall Study|Protocol Violation|2|||
30788716|NCT02762578|58802156|FG000|Overall Study|Withdrawal by Subject|4|||
30788717|NCT02762578|58802157|FG001|Overall Study|Withdrawal by Subject|2|||
30788718|NCT02762578|58802156|FG000|Overall Study|Unclassified|6|||
30788719|NCT02762578|58802157|FG001|Overall Study|Unclassified|0|||
30788720|NCT03514641|58802167|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
30788721|NCT03514641|58802168|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
30788722|NCT03514641|58802169|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
30788723|NCT03514641|58802170|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
30788724|NCT03514641|58802167|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
30788725|NCT03514641|58802168|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
30788726|NCT03514641|58802169|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
30788727|NCT03514641|58802170|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
30788728|NCT03514641|58802167|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
30788729|NCT03514641|58802168|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
30788730|NCT03514641|58802169|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
30788731|NCT03514641|58802170|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
30788732|NCT03514641|58802167|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
30788733|NCT03514641|58802168|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
30788734|NCT03514641|58802169|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
30788735|NCT03514641|58802170|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
30788736|NCT03514641|58802167|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
30788737|NCT03514641|58802168|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
30788738|NCT03514641|58802169|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
30788739|NCT03514641|58802170|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
30788740|NCT03514641|58802167|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
30788741|NCT03514641|58802168|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
30788742|NCT03514641|58802169|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
30788743|NCT03514641|58802170|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
30788744|NCT03514641|58802167|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
30788745|NCT03514641|58802168|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
30788746|NCT03514641|58802169|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
30788747|NCT03514641|58802170|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
30788748|NCT03514641|58802167|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
30788749|NCT03514641|58802168|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
30788750|NCT03514641|58802169|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
30788751|NCT03514641|58802170|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
30788752|NCT03514641|58802167|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
30788753|NCT03514641|58802168|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
30843488|NCT02306161|58869583|FG001|Overall Study|Physician Decision|18|||
30788754|NCT03514641|58802169|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
30788755|NCT03514641|58802170|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
30788756|NCT03514641|58802167|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
30788757|NCT03514641|58802168|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
30788758|NCT03514641|58802169|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
30788759|NCT03514641|58802170|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
30788760|NCT03514641|58802167|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
30788761|NCT03514641|58802168|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
30788762|NCT03514641|58802169|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
30788763|NCT03514641|58802170|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
30788764|NCT03514641|58802167|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
30788765|NCT03514641|58802168|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
30788766|NCT03514641|58802169|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
30788767|NCT03514641|58802170|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
30788768|NCT00100828|58802182|FG000|Overall Study|Physician Decision|6|||
30788769|NCT00100048|58802191|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
30788770|NCT00100048|58802192|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
30788771|NCT00100048|58802193|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
30788772|NCT00100048|58802194|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
30788773|NCT00100048|58802195|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
30788774|NCT00100048|58802196|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
30788775|NCT00100048|58802191|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
30788776|NCT00100048|58802192|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
30788777|NCT00100048|58802193|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
30788778|NCT00100048|58802194|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
30788779|NCT00100048|58802195|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
30788780|NCT00100048|58802196|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
30788781|NCT00100048|58802191|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
30788782|NCT00100048|58802192|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
30788783|NCT00100048|58802193|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
30788784|NCT00100048|58802194|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
30788785|NCT00100048|58802195|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
30788786|NCT00100048|58802196|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
30788787|NCT00100048|58802191|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
30788788|NCT00100048|58802192|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
30788789|NCT00100048|58802193|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
30788790|NCT00100048|58802194|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
30788791|NCT00100048|58802195|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
30788792|NCT00100048|58802196|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
30788793|NCT00100048|58802191|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
30788794|NCT00100048|58802192|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
30788795|NCT00100048|58802193|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
30788796|NCT00100048|58802194|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
30788797|NCT00100048|58802195|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
30788798|NCT00100048|58802196|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
30788799|NCT00100048|58802191|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
30788800|NCT00100048|58802192|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
30788801|NCT00100048|58802193|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
30788802|NCT00100048|58802194|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
30788803|NCT00100048|58802195|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
30788804|NCT00100048|58802196|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
30788805|NCT00100048|58802191|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
30788806|NCT00100048|58802192|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
30788807|NCT00100048|58802193|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
30788808|NCT00100048|58802194|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
30788809|NCT00100048|58802195|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
30788810|NCT00100048|58802196|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
30788811|NCT00100048|58802191|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
30788812|NCT00100048|58802192|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
30788813|NCT00100048|58802193|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
30788814|NCT00100048|58802194|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
30788815|NCT00100048|58802195|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
30788816|NCT00100048|58802196|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
30788817|NCT02757430|58802221|FG000|Overall Study|Physician Decision|6|||
30788818|NCT02757430|58802221|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
30788819|NCT02757430|58802221|FG000|Overall Study|No informed consent|1|||
30788820|NCT02757430|58802221|FG000|Overall Study|No procedure performed|2|||
30788821|NCT02757352|58802237|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
30788822|NCT02757352|58802238|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
30788823|NCT02757352|58802239|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
30788824|NCT02757352|58802240|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
30788825|NCT02757352|58802241|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
30788826|NCT02757352|58802242|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
30788827|NCT02757352|58802243|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
30788828|NCT02757352|58802244|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
30788829|NCT02757352|58802245|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
30788830|NCT02757352|58802246|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
30788831|NCT02757352|58802237|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
30788832|NCT02757352|58802238|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
30788833|NCT02757352|58802239|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
30788834|NCT02757352|58802240|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
30788835|NCT02757352|58802241|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
30788836|NCT02757352|58802242|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
30788837|NCT02757352|58802243|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
30788838|NCT02757352|58802244|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
30788839|NCT02757352|58802245|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
30788840|NCT02757352|58802246|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
30788841|NCT02757352|58802237|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
30788842|NCT02757352|58802238|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
30788843|NCT02757352|58802239|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
30788844|NCT02757352|58802240|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
30788845|NCT02757352|58802241|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
30788846|NCT02757352|58802242|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
30788847|NCT02757352|58802243|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
30788848|NCT02757352|58802244|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
30788849|NCT02757352|58802245|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
30788850|NCT02757352|58802246|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
30788851|NCT02757352|58802237|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
30788852|NCT02757352|58802238|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
30788853|NCT02757352|58802239|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
30788854|NCT02757352|58802240|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
30788855|NCT02757352|58802241|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
30788856|NCT02757352|58802242|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
30788857|NCT02757352|58802243|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
30788858|NCT02757352|58802244|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
30788859|NCT02757352|58802245|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
30788860|NCT02757352|58802246|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
30788861|NCT02757352|58802237|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788862|NCT02757352|58802238|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
30788863|NCT02757352|58802239|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788864|NCT02757352|58802240|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788865|NCT02757352|58802241|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788866|NCT02757352|58802242|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788867|NCT02757352|58802243|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788868|NCT02757352|58802244|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788869|NCT02757352|58802245|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788870|NCT02757352|58802246|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788871|NCT02757352|58802237|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
30788872|NCT02757352|58802238|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
30788873|NCT02757352|58802239|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
30788874|NCT02757352|58802240|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788875|NCT02757352|58802241|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788876|NCT02757352|58802242|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788877|NCT02757352|58802243|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788878|NCT02757352|58802244|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788879|NCT02757352|58802245|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788880|NCT02757352|58802246|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788881|NCT02757352|58802237|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
30788882|NCT02757352|58802238|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
30788883|NCT02757352|58802239|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
30788884|NCT02757352|58802240|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
30788885|NCT02757352|58802241|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
30788886|NCT02757352|58802242|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
30788887|NCT02757352|58802243|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
30788888|NCT02757352|58802244|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
30788889|NCT02757352|58802245|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
30788890|NCT02757352|58802246|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
30788891|NCT02757352|58802237|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
30788892|NCT02757352|58802238|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
30788893|NCT02757352|58802239|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
30788894|NCT02757352|58802240|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
30788895|NCT02757352|58802241|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
30788896|NCT02757352|58802242|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
30788897|NCT02757352|58802243|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
30788898|NCT02757352|58802244|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
30788899|NCT02757352|58802245|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
30788900|NCT02757352|58802246|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
30788901|NCT02757352|58802237|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788902|NCT02757352|58802238|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788903|NCT02757352|58802239|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788904|NCT02757352|58802240|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
30788905|NCT02757352|58802241|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
30788906|NCT02757352|58802242|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
30788907|NCT02757352|58802243|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788908|NCT02757352|58802244|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788909|NCT02757352|58802245|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788910|NCT02757352|58802246|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
30788911|NCT02757352|58802237|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
30788912|NCT02757352|58802238|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
30788913|NCT02757352|58802239|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
30788914|NCT02757352|58802240|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
30788915|NCT02757352|58802241|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
30788916|NCT02757352|58802242|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
30788917|NCT02757352|58802243|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
30788918|NCT02757352|58802244|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
30788919|NCT02757352|58802245|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
30788920|NCT02757352|58802246|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
30788921|NCT02757352|58802237|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
30788922|NCT02757352|58802238|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
30788923|NCT02757352|58802239|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
30788924|NCT02757352|58802240|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
30788925|NCT02757352|58802241|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
30788926|NCT02757352|58802242|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
30788927|NCT02757352|58802243|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
30788928|NCT02757352|58802244|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
30788929|NCT02757352|58802245|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
30788930|NCT02757352|58802246|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
30788931|NCT02757352|58802237|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788932|NCT02757352|58802238|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788933|NCT02757352|58802239|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788934|NCT02757352|58802240|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
30788935|NCT02757352|58802241|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
30788936|NCT02757352|58802242|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
30788937|NCT02757352|58802243|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788938|NCT02757352|58802244|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788939|NCT02757352|58802245|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788940|NCT02757352|58802246|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
30788941|NCT02757352|58802237|FG000|Follow-Up Period|Adverse Event|0|||
30788942|NCT02757352|58802238|FG001|Follow-Up Period|Adverse Event|0|||
30788943|NCT02757352|58802239|FG002|Follow-Up Period|Adverse Event|0|||
30788944|NCT02757352|58802240|FG003|Follow-Up Period|Adverse Event|0|||
30788945|NCT02757352|58802241|FG004|Follow-Up Period|Adverse Event|0|||
30788946|NCT02757352|58802242|FG005|Follow-Up Period|Adverse Event|0|||
30788947|NCT02757352|58802243|FG006|Follow-Up Period|Adverse Event|1|||
30788948|NCT02757352|58802244|FG007|Follow-Up Period|Adverse Event|0|||
30788949|NCT02757352|58802245|FG008|Follow-Up Period|Adverse Event|2|||
30788950|NCT02757352|58802246|FG009|Follow-Up Period|Adverse Event|0|||
30788951|NCT02757352|58802237|FG000|Follow-Up Period|Lost to Follow-up|0|||
30788952|NCT02757352|58802238|FG001|Follow-Up Period|Lost to Follow-up|0|||
30788953|NCT02757352|58802239|FG002|Follow-Up Period|Lost to Follow-up|0|||
30788954|NCT02757352|58802240|FG003|Follow-Up Period|Lost to Follow-up|0|||
30788955|NCT02757352|58802241|FG004|Follow-Up Period|Lost to Follow-up|0|||
30788956|NCT02757352|58802242|FG005|Follow-Up Period|Lost to Follow-up|0|||
30788957|NCT02757352|58802243|FG006|Follow-Up Period|Lost to Follow-up|0|||
30788958|NCT02757352|58802244|FG007|Follow-Up Period|Lost to Follow-up|0|||
30788959|NCT02757352|58802245|FG008|Follow-Up Period|Lost to Follow-up|1|||
30788960|NCT02757352|58802246|FG009|Follow-Up Period|Lost to Follow-up|0|||
30788961|NCT02757352|58802237|FG000|Follow-Up Period|Lack of Efficacy|0|||
30788962|NCT02757352|58802238|FG001|Follow-Up Period|Lack of Efficacy|0|||
30788963|NCT02757352|58802239|FG002|Follow-Up Period|Lack of Efficacy|0|||
30788964|NCT02757352|58802240|FG003|Follow-Up Period|Lack of Efficacy|0|||
30788965|NCT02757352|58802241|FG004|Follow-Up Period|Lack of Efficacy|0|||
30788966|NCT02757352|58802242|FG005|Follow-Up Period|Lack of Efficacy|0|||
30788967|NCT02757352|58802243|FG006|Follow-Up Period|Lack of Efficacy|0|||
30788968|NCT02757352|58802244|FG007|Follow-Up Period|Lack of Efficacy|0|||
30788969|NCT02757352|58802245|FG008|Follow-Up Period|Lack of Efficacy|1|||
30788970|NCT02757352|58802246|FG009|Follow-Up Period|Lack of Efficacy|1|||
30788971|NCT02757352|58802237|FG000|Follow-Up Period|Withdrawal by Subject|0|||
30788972|NCT02757352|58802238|FG001|Follow-Up Period|Withdrawal by Subject|0|||
30788973|NCT02757352|58802239|FG002|Follow-Up Period|Withdrawal by Subject|0|||
30788974|NCT02757352|58802240|FG003|Follow-Up Period|Withdrawal by Subject|0|||
30788975|NCT02757352|58802241|FG004|Follow-Up Period|Withdrawal by Subject|0|||
30788976|NCT02757352|58802242|FG005|Follow-Up Period|Withdrawal by Subject|0|||
30788977|NCT02757352|58802243|FG006|Follow-Up Period|Withdrawal by Subject|0|||
30788978|NCT02757352|58802244|FG007|Follow-Up Period|Withdrawal by Subject|1|||
30788979|NCT02757352|58802245|FG008|Follow-Up Period|Withdrawal by Subject|6|||
30788980|NCT02757352|58802246|FG009|Follow-Up Period|Withdrawal by Subject|2|||
30788981|NCT04588480|58802279|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
30788982|NCT04588480|58802280|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
30788983|NCT04588480|58802281|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
30788984|NCT04588480|58802279|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
30788985|NCT04588480|58802280|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
30788986|NCT04588480|58802281|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
30788987|NCT02756650|58802288|FG000|Overall Study|Physician Decision|1|||
30788988|NCT02756650|58802288|FG000|Overall Study|Adverse Event|1|||
30788989|NCT00110357|58802294|FG000|Overall Study|Deterioration without progression|2|||
30788990|NCT00110357|58802295|FG001|Overall Study|Deterioration without progression|0|||
30788991|NCT00110357|58802294|FG000|Overall Study|Disease progression/relapse|20|||
30788992|NCT00110357|58802295|FG001|Overall Study|Disease progression/relapse|15|||
30788993|NCT00110357|58802294|FG000|Overall Study|Study Closure|1|||
30788994|NCT00110357|58802295|FG001|Overall Study|Study Closure|0|||
30788995|NCT00110357|58802294|FG000|Overall Study|Study Drug Toxicity|1|||
30788996|NCT00110357|58802295|FG001|Overall Study|Study Drug Toxicity|3|||
30788997|NCT00110357|58802294|FG000|Overall Study|Withdrawal by Subject|3|||
30788998|NCT00110357|58802295|FG001|Overall Study|Withdrawal by Subject|1|||
30788999|NCT02752906|58802330|FG000|Overall Study|Protocol Violation|2|||
30789000|NCT02752906|58802331|FG001|Overall Study|Protocol Violation|1|||
30789001|NCT02752906|58802330|FG000|Overall Study|Withdrawal by Subject|2|||
30789002|NCT02752906|58802331|FG001|Overall Study|Withdrawal by Subject|2|||
30789003|NCT02752906|58802330|FG000|Overall Study|Lost to Follow-up|3|||
30789004|NCT02752906|58802331|FG001|Overall Study|Lost to Follow-up|2|||
30789005|NCT02756338|58802337|FG000|Overall Study|Withdrawn by Investigator|1|||
30789006|NCT02756338|58802337|FG000|Overall Study|Device Replaced with Pacemaker|4|||
30789007|NCT00293033|58802341|FG000|Open-label Titration Period|Adverse Event|10|||
30789008|NCT00293033|58802341|FG000|Open-label Titration Period|Death|3|||
30789009|NCT00293033|58802341|FG000|Open-label Titration Period|Lack of Efficacy|5|||
30789010|NCT00293033|58802341|FG000|Open-label Titration Period|Protocol Violation|2|||
30789011|NCT00293033|58802341|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
30789012|NCT00293033|58802341|FG000|Open-label Titration Period|Noncompliance and other|27|||
30789013|NCT00293033|58802341|FG000|Double-blind Treatment Period|Adverse Event|3|||
30789014|NCT00293033|58802341|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
30789015|NCT00293033|58802341|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
30789016|NCT00293033|58802341|FG000|Double-blind Treatment Period|Noncompliance|4|||
30789017|NCT02756182|58802349|FG000|Overall Study|StudyTechnical Difficulties|4|||
30789018|NCT03823703|58802358|FG000|Overall Study|Sponsor request|0|||
30789019|NCT03823703|58802359|FG001|Overall Study|Sponsor request|3|||
30789020|NCT03823703|58802360|FG002|Overall Study|Sponsor request|4|||
30789021|NCT03823703|58802358|FG000|Overall Study|Adverse Event|3|||
30789022|NCT03823703|58802359|FG001|Overall Study|Adverse Event|1|||
30789023|NCT03823703|58802360|FG002|Overall Study|Adverse Event|0|||
30789024|NCT03823703|58802358|FG000|Overall Study|Withdrawal by Subject|0|||
30789025|NCT03823703|58802359|FG001|Overall Study|Withdrawal by Subject|1|||
30789026|NCT03823703|58802360|FG002|Overall Study|Withdrawal by Subject|0|||
30789027|NCT00109577|58802370|FG000|Overall Study|Withdrawal by Subject|3|||
30789028|NCT00109577|58802371|FG001|Overall Study|Withdrawal by Subject|3|||
30789029|NCT02755090|58802379|FG000|Overall Study|equipment malfunction|1|||
30789030|NCT02755090|58802380|FG001|Overall Study|equipment malfunction|0|||
30789031|NCT00109343|58802389|FG000|Overall Study|Adverse Event|1|||
30789032|NCT00109343|58802390|FG001|Overall Study|Adverse Event|0|||
30789033|NCT00109343|58802391|FG002|Overall Study|Adverse Event|2|||
30789034|NCT00109343|58802389|FG000|Overall Study|Lack of Efficacy|1|||
30789035|NCT00109343|58802390|FG001|Overall Study|Lack of Efficacy|0|||
30789036|NCT00109343|58802391|FG002|Overall Study|Lack of Efficacy|0|||
30789037|NCT00109343|58802389|FG000|Overall Study|Lost to Follow-up|35|||
30789038|NCT00109343|58802390|FG001|Overall Study|Lost to Follow-up|20|||
30789039|NCT00109343|58802391|FG002|Overall Study|Lost to Follow-up|14|||
30789040|NCT00109343|58802389|FG000|Overall Study|Protocol Violation|1|||
30789041|NCT00109343|58802390|FG001|Overall Study|Protocol Violation|2|||
30789042|NCT00109343|58802391|FG002|Overall Study|Protocol Violation|2|||
30789043|NCT00109343|58802389|FG000|Overall Study|Withdrawal by Subject|15|||
30789044|NCT00109343|58802390|FG001|Overall Study|Withdrawal by Subject|11|||
30789045|NCT00109343|58802391|FG002|Overall Study|Withdrawal by Subject|10|||
30789046|NCT00109343|58802389|FG000|Overall Study|Subject Moved|6|||
30789047|NCT00109343|58802390|FG001|Overall Study|Subject Moved|2|||
30789048|NCT00109343|58802391|FG002|Overall Study|Subject Moved|1|||
30789049|NCT00109343|58802389|FG000|Overall Study|Other|5|||
30789050|NCT00109343|58802390|FG001|Overall Study|Other|2|||
30789051|NCT00109343|58802391|FG002|Overall Study|Other|1|||
30789052|NCT00108485|58802401|FG000|Overall Study|Withdrawal by Subject|3|||
30789053|NCT00108485|58802402|FG001|Overall Study|Withdrawal by Subject|0|||
30789054|NCT00108485|58802401|FG000|Overall Study|Lost to Follow-up|0|||
30789055|NCT00108485|58802402|FG001|Overall Study|Lost to Follow-up|2|||
30789056|NCT00107783|58802410|FG000|Overall Study|Adverse Event|0|||
30789057|NCT00107783|58802411|FG001|Overall Study|Adverse Event|2|||
30789058|NCT00107783|58802410|FG000|Overall Study|Death|0|||
30789059|NCT00107783|58802411|FG001|Overall Study|Death|1|||
30789060|NCT00107783|58802410|FG000|Overall Study|Withdrawal by Subject|2|||
30789061|NCT00107783|58802411|FG001|Overall Study|Withdrawal by Subject|0|||
30789062|NCT00107783|58802410|FG000|Overall Study|Second hip replacement|1|||
30789063|NCT00107783|58802411|FG001|Overall Study|Second hip replacement|1|||
30789064|NCT00095303|58802419|FG000|Main Study|Lost to Follow-up|91|||
30789065|NCT00095303|58802420|FG001|Main Study|Lost to Follow-up|87|||
30789066|NCT00095303|58802419|FG000|Follow Up Study|Lost to Follow-up|59|||
30789067|NCT00095303|58802420|FG001|Follow Up Study|Lost to Follow-up|58|||
30789068|NCT00105521|58802430|FG000|Overall Study|Other|1|||
30789069|NCT00105521|58802431|FG001|Overall Study|Other|1|||
30789070|NCT00105521|58802432|FG002|Overall Study|Other|2|||
30789071|NCT00105521|58802433|FG003|Overall Study|Other|0|||
30789072|NCT00105521|58802430|FG000|Overall Study|Adverse Event|10|||
30789073|NCT00105521|58802431|FG001|Overall Study|Adverse Event|4|||
30789074|NCT00105521|58802432|FG002|Overall Study|Adverse Event|10|||
30789075|NCT00105521|58802433|FG003|Overall Study|Adverse Event|8|||
30789076|NCT00105521|58802430|FG000|Overall Study|Withdrawal by Subject|1|||
30789077|NCT00105521|58802431|FG001|Overall Study|Withdrawal by Subject|0|||
30789078|NCT00105521|58802432|FG002|Overall Study|Withdrawal by Subject|1|||
30789079|NCT00105521|58802433|FG003|Overall Study|Withdrawal by Subject|4|||
30789080|NCT00105521|58802430|FG000|Overall Study|Lack of Efficacy|0|||
30789081|NCT00105521|58802431|FG001|Overall Study|Lack of Efficacy|0|||
30789082|NCT00105521|58802432|FG002|Overall Study|Lack of Efficacy|0|||
30789083|NCT00105521|58802433|FG003|Overall Study|Lack of Efficacy|1|||
30789084|NCT00105521|58802430|FG000|Overall Study|Protocol Violation|3|||
30789085|NCT00105521|58802431|FG001|Overall Study|Protocol Violation|5|||
30789086|NCT00105521|58802432|FG002|Overall Study|Protocol Violation|4|||
30789087|NCT00105521|58802433|FG003|Overall Study|Protocol Violation|4|||
30789088|NCT00105521|58802430|FG000|Overall Study|Lost to Follow-up|0|||
30789089|NCT00105521|58802431|FG001|Overall Study|Lost to Follow-up|1|||
30789090|NCT00105521|58802432|FG002|Overall Study|Lost to Follow-up|0|||
30789091|NCT00105521|58802433|FG003|Overall Study|Lost to Follow-up|0|||
30789092|NCT00291551|58802443|FG000|Overall Study|Death|7|||
30789093|NCT00291551|58802443|FG000|Overall Study|Withdrawal by Subject|6|||
30789094|NCT02752048|58802472|FG000|Overall Study|Withdrawal by Subject|0|||
30789095|NCT02752048|58802473|FG001|Overall Study|Withdrawal by Subject|0|||
30789096|NCT02752048|58802474|FG002|Overall Study|Withdrawal by Subject|3|||
30789097|NCT00095147|58802489|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
30789098|NCT00095147|58802490|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
30789099|NCT00095147|58802491|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
30789100|NCT00095147|58802492|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
30789101|NCT00095147|58802493|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
30789102|NCT00095147|58802489|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
30789103|NCT00095147|58802490|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
30789104|NCT00095147|58802491|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
30789105|NCT00095147|58802492|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
30789106|NCT00095147|58802493|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
30789107|NCT00095147|58802489|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
30789108|NCT00095147|58802490|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
30789109|NCT00095147|58802491|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
30789110|NCT00095147|58802492|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
30789111|NCT00095147|58802493|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
30789112|NCT00095147|58802489|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
30789113|NCT00095147|58802490|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
30789114|NCT00095147|58802491|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
30789115|NCT00095147|58802492|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
30789116|NCT00095147|58802493|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
30789117|NCT00095147|58802489|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
30789118|NCT00095147|58802490|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
30789119|NCT00095147|58802491|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
30789120|NCT00095147|58802492|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
30789121|NCT00095147|58802493|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
30789122|NCT00095147|58802489|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
30789123|NCT00095147|58802490|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
30789124|NCT00095147|58802491|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
30789125|NCT00095147|58802492|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
30789126|NCT00095147|58802493|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
30789127|NCT00095147|58802489|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
30789128|NCT00095147|58802490|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
30789129|NCT00095147|58802491|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
30789130|NCT00095147|58802492|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
30789131|NCT00095147|58802493|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
30789132|NCT00095147|58802489|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
30789133|NCT00095147|58802490|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
30789134|NCT00095147|58802491|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
30789135|NCT00095147|58802492|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
30789136|NCT00095147|58802493|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
30789137|NCT00095147|58802489|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
30789138|NCT00095147|58802490|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
30789139|NCT00095147|58802491|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
30789140|NCT00095147|58802492|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
30789141|NCT00095147|58802493|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
30789142|NCT00095147|58802489|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
30789143|NCT00095147|58802490|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
30789144|NCT00095147|58802491|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
30789145|NCT00095147|58802492|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
30789146|NCT00095147|58802493|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
30789147|NCT00095147|58802489|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
30789148|NCT00095147|58802490|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
30789149|NCT00095147|58802491|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
30789150|NCT00095147|58802492|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
30789151|NCT00095147|58802493|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
30789152|NCT00095147|58802489|FG000|Long-term Extension Period|Death|0|||
30789153|NCT00095147|58802490|FG001|Long-term Extension Period|Death|0|||
30789154|NCT00095147|58802491|FG002|Long-term Extension Period|Death|0|||
30789155|NCT00095147|58802492|FG003|Long-term Extension Period|Death|0|||
30789156|NCT00095147|58802493|FG004|Long-term Extension Period|Death|3|||
30789157|NCT00095147|58802489|FG000|Long-term Extension Period|Adverse Event|0|||
30789158|NCT00095147|58802490|FG001|Long-term Extension Period|Adverse Event|0|||
30789159|NCT00095147|58802491|FG002|Long-term Extension Period|Adverse Event|0|||
30789160|NCT00095147|58802492|FG003|Long-term Extension Period|Adverse Event|0|||
30789161|NCT00095147|58802493|FG004|Long-term Extension Period|Adverse Event|11|||
30789162|NCT00095147|58802489|FG000|Long-term Extension Period|Lack of Efficacy|0|||
30789163|NCT00095147|58802490|FG001|Long-term Extension Period|Lack of Efficacy|0|||
30789164|NCT00095147|58802491|FG002|Long-term Extension Period|Lack of Efficacy|0|||
30789165|NCT00095147|58802492|FG003|Long-term Extension Period|Lack of Efficacy|0|||
30789166|NCT00095147|58802493|FG004|Long-term Extension Period|Lack of Efficacy|9|||
30789167|NCT00095147|58802489|FG000|Long-term Extension Period|Lost to Follow-up|0|||
30789168|NCT00095147|58802490|FG001|Long-term Extension Period|Lost to Follow-up|0|||
30789169|NCT00095147|58802491|FG002|Long-term Extension Period|Lost to Follow-up|0|||
30789170|NCT00095147|58802492|FG003|Long-term Extension Period|Lost to Follow-up|0|||
30789171|NCT00095147|58802493|FG004|Long-term Extension Period|Lost to Follow-up|6|||
30789172|NCT00095147|58802489|FG000|Long-term Extension Period|Withdrawal of consent|0|||
30789173|NCT00095147|58802490|FG001|Long-term Extension Period|Withdrawal of consent|0|||
30789174|NCT00095147|58802491|FG002|Long-term Extension Period|Withdrawal of consent|0|||
30789175|NCT00095147|58802492|FG003|Long-term Extension Period|Withdrawal of consent|0|||
30789176|NCT00095147|58802493|FG004|Long-term Extension Period|Withdrawal of consent|12|||
30789177|NCT00095147|58802489|FG000|Long-term Extension Period|Pregnancy|0|||
30789178|NCT00095147|58802490|FG001|Long-term Extension Period|Pregnancy|0|||
30789179|NCT00095147|58802491|FG002|Long-term Extension Period|Pregnancy|0|||
30789180|NCT00095147|58802492|FG003|Long-term Extension Period|Pregnancy|0|||
30789181|NCT00095147|58802493|FG004|Long-term Extension Period|Pregnancy|1|||
30789182|NCT00095147|58802489|FG000|Long-term Extension Period|No longer meets study criteria|0|||
30789183|NCT00095147|58802490|FG001|Long-term Extension Period|No longer meets study criteria|0|||
30789184|NCT00095147|58802491|FG002|Long-term Extension Period|No longer meets study criteria|0|||
30789185|NCT00095147|58802492|FG003|Long-term Extension Period|No longer meets study criteria|0|||
30789186|NCT00095147|58802493|FG004|Long-term Extension Period|No longer meets study criteria|1|||
30789187|NCT00095147|58802489|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
30789188|NCT00095147|58802490|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
30789189|NCT00095147|58802491|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
30789190|NCT00095147|58802492|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
30789191|NCT00095147|58802493|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
30789192|NCT00095147|58802489|FG000|Long-term Extension Period|Leaving country|0|||
30789193|NCT00095147|58802490|FG001|Long-term Extension Period|Leaving country|0|||
30789194|NCT00095147|58802491|FG002|Long-term Extension Period|Leaving country|0|||
30789195|NCT00095147|58802492|FG003|Long-term Extension Period|Leaving country|0|||
30789196|NCT00095147|58802493|FG004|Long-term Extension Period|Leaving country|1|||
30789197|NCT02751580|58802511|FG000|Overall Study|Lost to Follow-up|4|||
30789198|NCT02751580|58802511|FG000|Overall Study|Death|2|||
30789199|NCT02751502|58802515|FG000|Overall Study|Lack of funding|4|||
30789200|NCT02257918|58802522|FG000|Overall Study|Lost to Follow-up|4|||
30789201|NCT02257918|58802523|FG001|Overall Study|Lost to Follow-up|1|||
30789202|NCT02257918|58802524|FG002|Overall Study|Lost to Follow-up|0|||
30789203|NCT02257918|58802522|FG000|Overall Study|Withdrawal by Subject|0|||
30789204|NCT02257918|58802523|FG001|Overall Study|Withdrawal by Subject|0|||
30789205|NCT02257918|58802524|FG002|Overall Study|Withdrawal by Subject|1|||
30789206|NCT02257918|58802522|FG000|Overall Study|Pregnancy|0|||
30789207|NCT02257918|58802523|FG001|Overall Study|Pregnancy|0|||
30789208|NCT02257918|58802524|FG002|Overall Study|Pregnancy|1|||
30789209|NCT02751424|58802541|FG000|Part 2|Adverse Event|0|||
30789210|NCT02751424|58802542|FG001|Part 2|Adverse Event|0|||
30789211|NCT02751424|58802543|FG002|Part 2|Adverse Event|0|||
30789212|NCT02751424|58802544|FG003|Part 2|Adverse Event|0|||
30789213|NCT02751424|58802545|FG004|Part 2|Adverse Event|0|||
30789214|NCT02751424|58802546|FG005|Part 2|Adverse Event|0|||
30789215|NCT02751424|58802547|FG006|Part 2|Adverse Event|0|||
30789216|NCT02751424|58802548|FG007|Part 2|Adverse Event|5|||
30789217|NCT02751424|58802549|FG008|Part 2|Adverse Event|0|||
30789218|NCT00094835|58802579|FG000|Overall Study|Physician Decision|1|||
30789219|NCT00094835|58802580|FG001|Overall Study|Physician Decision|0|||
30789220|NCT00094835|58802581|FG002|Overall Study|Physician Decision|0|||
30789221|NCT00094835|58802582|FG003|Overall Study|Physician Decision|0|||
30789222|NCT00094835|58802583|FG004|Overall Study|Physician Decision|0|||
30789223|NCT00094835|58802584|FG005|Overall Study|Physician Decision|1|||
30789224|NCT00094835|58802585|FG006|Overall Study|Physician Decision|0|||
30789225|NCT00094835|58802579|FG000|Overall Study|Withdrawal by Subject|0|||
30789226|NCT00094835|58802580|FG001|Overall Study|Withdrawal by Subject|0|||
30789227|NCT00094835|58802581|FG002|Overall Study|Withdrawal by Subject|0|||
30789228|NCT00094835|58802582|FG003|Overall Study|Withdrawal by Subject|0|||
30789229|NCT00094835|58802583|FG004|Overall Study|Withdrawal by Subject|0|||
30789230|NCT00094835|58802584|FG005|Overall Study|Withdrawal by Subject|0|||
30789231|NCT00094835|58802585|FG006|Overall Study|Withdrawal by Subject|1|||
30789232|NCT00094835|58802579|FG000|Overall Study|Lost to Follow-up|0|||
30789233|NCT00094835|58802580|FG001|Overall Study|Lost to Follow-up|0|||
30789234|NCT00094835|58802581|FG002|Overall Study|Lost to Follow-up|0|||
30789235|NCT00094835|58802582|FG003|Overall Study|Lost to Follow-up|0|||
30789236|NCT00094835|58802583|FG004|Overall Study|Lost to Follow-up|1|||
30789237|NCT00094835|58802584|FG005|Overall Study|Lost to Follow-up|0|||
30789238|NCT00094835|58802585|FG006|Overall Study|Lost to Follow-up|0|||
30789239|NCT00094835|58802579|FG000|Overall Study|Death|1|||
30789240|NCT00094835|58802580|FG001|Overall Study|Death|0|||
30789241|NCT00094835|58802581|FG002|Overall Study|Death|0|||
30789242|NCT00094835|58802582|FG003|Overall Study|Death|0|||
30789243|NCT00094835|58802583|FG004|Overall Study|Death|1|||
30789244|NCT00094835|58802584|FG005|Overall Study|Death|0|||
30789245|NCT00094835|58802585|FG006|Overall Study|Death|0|||
30789246|NCT00094835|58802579|FG000|Overall Study|Non-compliance|1|||
30789247|NCT00094835|58802580|FG001|Overall Study|Non-compliance|2|||
30789248|NCT00094835|58802581|FG002|Overall Study|Non-compliance|2|||
30789249|NCT00094835|58802582|FG003|Overall Study|Non-compliance|0|||
30789250|NCT00094835|58802583|FG004|Overall Study|Non-compliance|2|||
30789251|NCT00094835|58802584|FG005|Overall Study|Non-compliance|2|||
30789252|NCT00094835|58802585|FG006|Overall Study|Non-compliance|1|||
30789253|NCT00094835|58802579|FG000|Overall Study|Other|1|||
30789254|NCT00094835|58802580|FG001|Overall Study|Other|1|||
30789255|NCT00094835|58802581|FG002|Overall Study|Other|1|||
30789256|NCT00094835|58802582|FG003|Overall Study|Other|1|||
30789257|NCT00094835|58802583|FG004|Overall Study|Other|0|||
30789258|NCT00094835|58802584|FG005|Overall Study|Other|0|||
30789259|NCT00094835|58802585|FG006|Overall Study|Other|0|||
30789260|NCT00094757|58802609|FG000|Overall Study|Adverse Event|11|||
30789261|NCT00094757|58802610|FG001|Overall Study|Adverse Event|9|||
30789262|NCT00094757|58802611|FG002|Overall Study|Adverse Event|6|||
30789263|NCT00094757|58802609|FG000|Overall Study|Lack of Efficacy|11|||
30789264|NCT00094757|58802610|FG001|Overall Study|Lack of Efficacy|15|||
30789265|NCT00094757|58802611|FG002|Overall Study|Lack of Efficacy|8|||
30789266|NCT00094757|58802609|FG000|Overall Study|Lost to Follow-up|3|||
30789267|NCT00094757|58802610|FG001|Overall Study|Lost to Follow-up|5|||
30789268|NCT00094757|58802611|FG002|Overall Study|Lost to Follow-up|6|||
30789269|NCT00094757|58802609|FG000|Overall Study|Patient Moved|2|||
30789270|NCT00094757|58802610|FG001|Overall Study|Patient Moved|1|||
30789271|NCT00094757|58802611|FG002|Overall Study|Patient Moved|1|||
30789272|NCT00094757|58802609|FG000|Overall Study|Protocol Violation|8|||
30789273|NCT00094757|58802610|FG001|Overall Study|Protocol Violation|5|||
30789274|NCT00094757|58802611|FG002|Overall Study|Protocol Violation|3|||
30789275|NCT00094757|58802609|FG000|Overall Study|Withdrawal by Subject|14|||
30789276|NCT00094757|58802610|FG001|Overall Study|Withdrawal by Subject|21|||
30789277|NCT00094757|58802611|FG002|Overall Study|Withdrawal by Subject|5|||
30789278|NCT00094757|58802609|FG000|Overall Study|Other|3|||
30789279|NCT00094757|58802610|FG001|Overall Study|Other|3|||
30789280|NCT00094757|58802611|FG002|Overall Study|Other|1|||
30789281|NCT00094757|58802609|FG000|Overall Study|Protocol specified discontinuation|1|||
30789282|NCT00094757|58802610|FG001|Overall Study|Protocol specified discontinuation|3|||
30789283|NCT00094757|58802611|FG002|Overall Study|Protocol specified discontinuation|0|||
30789284|NCT00082433|58802621|FG000|Overall Study|Adverse Event|12|||
30789285|NCT00082433|58802622|FG001|Overall Study|Adverse Event|17|||
30789286|NCT00082433|58802621|FG000|Overall Study|Death|8|||
30789287|NCT00082433|58802622|FG001|Overall Study|Death|18|||
30789288|NCT00082433|58802621|FG000|Overall Study|Disease Progression/Relapse|270|||
30789289|NCT00082433|58802622|FG001|Overall Study|Disease Progression/Relapse|388|||
30789290|NCT00082433|58802621|FG000|Overall Study|Physician Decision|50|||
30789291|NCT00082433|58802622|FG001|Overall Study|Physician Decision|61|||
30789292|NCT00082433|58802621|FG000|Overall Study|Lost to Follow-up|1|||
30789293|NCT00082433|58802622|FG001|Overall Study|Lost to Follow-up|2|||
30789294|NCT00082433|58802621|FG000|Overall Study|Study Drug Toxicity|179|||
30789295|NCT00082433|58802622|FG001|Overall Study|Study Drug Toxicity|66|||
30789296|NCT00082433|58802621|FG000|Overall Study|Withdrawal by Subject|55|||
30789297|NCT00082433|58802622|FG001|Overall Study|Withdrawal by Subject|30|||
30789298|NCT00082433|58802621|FG000|Overall Study|Still On Treatment|2|||
30789299|NCT00082433|58802622|FG001|Overall Study|Still On Treatment|1|||
30789300|NCT00082433|58802621|FG000|Overall Study|Not Treated|12|||
30789301|NCT00082433|58802622|FG001|Overall Study|Not Treated|11|||
30789302|NCT00082433|58802621|FG000|Overall Study|Ineligible|2|||
30789303|NCT00082433|58802622|FG001|Overall Study|Ineligible|1|||
30789304|NCT00082433|58802621|FG000|Overall Study|Noncompliance|2|||
30789305|NCT00082433|58802622|FG001|Overall Study|Noncompliance|1|||
30789306|NCT00082433|58802621|FG000|Overall Study|New primary cancer|1|||
30789307|NCT00082433|58802622|FG001|Overall Study|New primary cancer|0|||
30789308|NCT00082433|58802621|FG000|Overall Study|Impending surgery|0|||
30789309|NCT00082433|58802622|FG001|Overall Study|Impending surgery|1|||
30789310|NCT00094445|58802628|FG000|Overall Study|Withdrawal by Subject|3|||
30789311|NCT00094445|58802628|FG000|Overall Study|Lost to Follow-up|1|||
30789312|NCT00094445|58802628|FG000|Overall Study|Progressive Disease|2|||
30789313|NCT00082355|58802632|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
30789314|NCT00082355|58802632|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
30789315|NCT00082355|58802632|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
30789316|NCT00094055|58802636|FG000|Overall Study|Adverse Event|11|||
30789317|NCT00094055|58802636|FG000|Overall Study|Death|4|||
30789318|NCT00094055|58802636|FG000|Overall Study|Lack of Efficacy|17|||
30789319|NCT00094055|58802636|FG000|Overall Study|Lost to Follow-up|2|||
30789320|NCT00094055|58802636|FG000|Overall Study|progressive disease|2|||
30789321|NCT00094055|58802636|FG000|Overall Study|clinical progression|1|||
30789322|NCT00094055|58802636|FG000|Overall Study|roll-over to another study|14|||
30789323|NCT00094055|58802636|FG000|Overall Study|Withdrawal by Subject|9|||
30789324|NCT00099983|58802642|FG000|Overall Study|Lost to Follow-up|2|||
30789325|NCT00099983|58802643|FG001|Overall Study|Lost to Follow-up|3|||
30789326|NCT00099983|58802642|FG000|Overall Study|Missing Source Documents|14|||
30789327|NCT00099983|58802643|FG001|Overall Study|Missing Source Documents|15|||
30789328|NCT00099983|58802642|FG000|Overall Study|Withdrawal by Subject|3|||
30789329|NCT00099983|58802643|FG001|Overall Study|Withdrawal by Subject|2|||
30789330|NCT00099983|58802642|FG000|Overall Study|Adverse Event|1|||
30789331|NCT00099983|58802643|FG001|Overall Study|Adverse Event|1|||
30789332|NCT00099983|58802642|FG000|Overall Study|Lack of Efficacy|0|||
30789333|NCT00099983|58802643|FG001|Overall Study|Lack of Efficacy|1|||
30789334|NCT00099983|58802642|FG000|Overall Study|Unable to return for appointments|1|||
30789335|NCT00099983|58802643|FG001|Overall Study|Unable to return for appointments|1|||
30789336|NCT00099983|58802642|FG000|Overall Study|Moved|1|||
30789337|NCT00099983|58802643|FG001|Overall Study|Moved|0|||
30789338|NCT00099983|58802642|FG000|Overall Study|Other psychiatric problem|1|||
30789339|NCT00099983|58802643|FG001|Overall Study|Other psychiatric problem|0|||
30789340|NCT00099983|58802642|FG000|Overall Study|Incarcerated|0|||
30789341|NCT00099983|58802643|FG001|Overall Study|Incarcerated|1|||
30789342|NCT00099983|58802642|FG000|Overall Study|Intolerant of burden of visits|0|||
30789343|NCT00099983|58802643|FG001|Overall Study|Intolerant of burden of visits|1|||
30789344|NCT00099983|58802642|FG000|Overall Study|Other issue|1|||
30789345|NCT00099983|58802643|FG001|Overall Study|Other issue|0|||
30789346|NCT00099359|58802652|FG000|Overall Study|Death|11|||
30789347|NCT00099359|58802653|FG001|Overall Study|Death|15|||
30789348|NCT00099359|58802654|FG002|Overall Study|Death|17|||
30789349|NCT00099359|58802652|FG000|Overall Study|Withdrawal by Subject|19|||
30789350|NCT00099359|58802653|FG001|Overall Study|Withdrawal by Subject|19|||
30789351|NCT00099359|58802654|FG002|Overall Study|Withdrawal by Subject|23|||
30789352|NCT00099359|58802652|FG000|Overall Study|Lost to Follow-up|15|||
30789353|NCT00099359|58802653|FG001|Overall Study|Lost to Follow-up|24|||
30789354|NCT00099359|58802654|FG002|Overall Study|Lost to Follow-up|24|||
30789355|NCT00099359|58802652|FG000|Overall Study|moved out of area|9|||
30789356|NCT00099359|58802653|FG001|Overall Study|moved out of area|7|||
30789357|NCT00099359|58802654|FG002|Overall Study|moved out of area|4|||
30789358|NCT00092495|58802676|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
30789359|NCT00092495|58802677|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
30789360|NCT00092495|58802678|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
30789361|NCT00092495|58802679|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
30789362|NCT00092495|58802680|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
30789363|NCT00092495|58802676|FG000|Base Study Vaccination Period|Extended|0|||
30789364|NCT00092495|58802677|FG001|Base Study Vaccination Period|Extended|0|||
30789365|NCT00092495|58802678|FG002|Base Study Vaccination Period|Extended|0|||
30789366|NCT00092495|58802679|FG003|Base Study Vaccination Period|Extended|1|||
30789367|NCT00092495|58802680|FG004|Base Study Vaccination Period|Extended|0|||
30789368|NCT00092495|58802676|FG000|Base Study Vaccination Period|*Clinical AE|1|||
30789369|NCT00092495|58802677|FG001|Base Study Vaccination Period|*Clinical AE|0|||
30789370|NCT00092495|58802678|FG002|Base Study Vaccination Period|*Clinical AE|1|||
30789371|NCT00092495|58802679|FG003|Base Study Vaccination Period|*Clinical AE|2|||
30789372|NCT00092495|58802680|FG004|Base Study Vaccination Period|*Clinical AE|0|||
30789373|NCT00092495|58802676|FG000|Base Study Vaccination Period|*Other reasons|1|||
30789374|NCT00092495|58802677|FG001|Base Study Vaccination Period|*Other reasons|0|||
30789375|NCT00092495|58802678|FG002|Base Study Vaccination Period|*Other reasons|0|||
30789376|NCT00092495|58802679|FG003|Base Study Vaccination Period|*Other reasons|1|||
30789377|NCT00092495|58802680|FG004|Base Study Vaccination Period|*Other reasons|0|||
30789378|NCT00092495|58802676|FG000|Base Study Vaccination Period|*Pregnancy|0|||
30789379|NCT00092495|58802677|FG001|Base Study Vaccination Period|*Pregnancy|2|||
30789380|NCT00092495|58802678|FG002|Base Study Vaccination Period|*Pregnancy|5|||
30789381|NCT00092495|58802679|FG003|Base Study Vaccination Period|*Pregnancy|7|||
30789382|NCT00092495|58802680|FG004|Base Study Vaccination Period|*Pregnancy|0|||
30789383|NCT00092495|58802676|FG000|Base Study Vaccination Period|Adverse Event|1|||
30789384|NCT00092495|58802677|FG001|Base Study Vaccination Period|Adverse Event|0|||
30789385|NCT00092495|58802678|FG002|Base Study Vaccination Period|Adverse Event|0|||
30789386|NCT00092495|58802679|FG003|Base Study Vaccination Period|Adverse Event|3|||
30789387|NCT00092495|58802680|FG004|Base Study Vaccination Period|Adverse Event|0|||
30789388|NCT00092495|58802676|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
30789389|NCT00092495|58802677|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
30789390|NCT00092495|58802678|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
30789391|NCT00092495|58802679|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
30789392|NCT00092495|58802680|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
30789393|NCT00092495|58802676|FG000|Base Study Vaccination Period|Moved|3|||
30789394|NCT00092495|58802677|FG001|Base Study Vaccination Period|Moved|1|||
30789395|NCT00092495|58802678|FG002|Base Study Vaccination Period|Moved|2|||
30789396|NCT00092495|58802679|FG003|Base Study Vaccination Period|Moved|2|||
30789397|NCT00092495|58802680|FG004|Base Study Vaccination Period|Moved|0|||
30789398|NCT00092495|58802676|FG000|Base Study Vaccination Period|Other|1|||
30789399|NCT00092495|58802677|FG001|Base Study Vaccination Period|Other|1|||
30789400|NCT00092495|58802678|FG002|Base Study Vaccination Period|Other|0|||
30789401|NCT00092495|58802679|FG003|Base Study Vaccination Period|Other|2|||
30789402|NCT00092495|58802680|FG004|Base Study Vaccination Period|Other|0|||
30789403|NCT00092495|58802676|FG000|Base Study Vaccination Period|Pregnancy|2|||
30789404|NCT00092495|58802677|FG001|Base Study Vaccination Period|Pregnancy|0|||
30789405|NCT00092495|58802678|FG002|Base Study Vaccination Period|Pregnancy|0|||
30789406|NCT00092495|58802679|FG003|Base Study Vaccination Period|Pregnancy|0|||
30789407|NCT00092495|58802680|FG004|Base Study Vaccination Period|Pregnancy|0|||
30789408|NCT00092495|58802676|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
30789409|NCT00092495|58802677|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
30789410|NCT00092495|58802678|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
30789411|NCT00092495|58802679|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
30789412|NCT00092495|58802680|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
30789413|NCT00092495|58802676|FG000|Base Study Vaccination Period|Protocol Violation|1|||
30789414|NCT00092495|58802677|FG001|Base Study Vaccination Period|Protocol Violation|0|||
30789415|NCT00092495|58802678|FG002|Base Study Vaccination Period|Protocol Violation|0|||
30789416|NCT00092495|58802679|FG003|Base Study Vaccination Period|Protocol Violation|0|||
30789417|NCT00092495|58802680|FG004|Base Study Vaccination Period|Protocol Violation|0|||
30789418|NCT00092495|58802676|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
30789419|NCT00092495|58802677|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
30789420|NCT00092495|58802678|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
30789421|NCT00092495|58802679|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
30789422|NCT00092495|58802680|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
30789423|NCT00092495|58802676|FG000|Base Study Follow-up Period|Extended|0|||
30789424|NCT00092495|58802677|FG001|Base Study Follow-up Period|Extended|0|||
30789425|NCT00092495|58802678|FG002|Base Study Follow-up Period|Extended|1|||
30789426|NCT00092495|58802679|FG003|Base Study Follow-up Period|Extended|2|||
30789427|NCT00092495|58802680|FG004|Base Study Follow-up Period|Extended|0|||
30789428|NCT00092495|58802676|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
30789429|NCT00092495|58802677|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
30789430|NCT00092495|58802678|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
30789431|NCT00092495|58802679|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
30789432|NCT00092495|58802680|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
30789433|NCT00092495|58802676|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
30789434|NCT00092495|58802677|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
30789435|NCT00092495|58802678|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
30789436|NCT00092495|58802679|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
30789437|NCT00092495|58802680|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
30789438|NCT00092417|58802695|FG000|Overall Study|Lost to Follow-up|2|||
30789439|NCT00092417|58802696|FG001|Overall Study|Lost to Follow-up|0|||
30789440|NCT00092417|58802695|FG000|Overall Study|Withdrawal by Subject|2|||
30789441|NCT00092417|58802696|FG001|Overall Study|Withdrawal by Subject|1|||
30789442|NCT00092417|58802695|FG000|Overall Study|Other|1|||
30789443|NCT00092417|58802696|FG001|Overall Study|Other|0|||
30789444|NCT00091949|58802704|FG000|Overall Study|Withdrawal by Subject|117|||
30789445|NCT00091949|58802705|FG001|Overall Study|Withdrawal by Subject|110|||
30789446|NCT00091949|58802704|FG000|Overall Study|Lost to Follow-up|58|||
30789447|NCT00091949|58802705|FG001|Overall Study|Lost to Follow-up|41|||
30789448|NCT02258542|58802715|FG000|Overall Study|eg. not made to the visit|7|||
30789449|NCT02258542|58802716|FG001|Overall Study|eg. not made to the visit|4|||
30789450|NCT02258542|58802717|FG002|Overall Study|eg. not made to the visit|0|||
30789451|NCT02258542|58802718|FG003|Overall Study|eg. not made to the visit|1|||
30789452|NCT02258542|58802715|FG000|Overall Study|study specific discount. criteria|1|||
30789453|NCT02258542|58802716|FG001|Overall Study|study specific discount. criteria|1|||
30789454|NCT02258542|58802717|FG002|Overall Study|study specific discount. criteria|0|||
30789455|NCT02258542|58802718|FG003|Overall Study|study specific discount. criteria|0|||
30789456|NCT02258542|58802715|FG000|Overall Study|Withdrawal by Subject|20|||
30789457|NCT02258542|58802716|FG001|Overall Study|Withdrawal by Subject|20|||
30789458|NCT02258542|58802717|FG002|Overall Study|Withdrawal by Subject|7|||
30789459|NCT02258542|58802718|FG003|Overall Study|Withdrawal by Subject|1|||
30789460|NCT02258542|58802715|FG000|Overall Study|Lost to Follow-up|5|||
30789461|NCT02258542|58802716|FG001|Overall Study|Lost to Follow-up|12|||
30789462|NCT02258542|58802717|FG002|Overall Study|Lost to Follow-up|1|||
30789463|NCT02258542|58802718|FG003|Overall Study|Lost to Follow-up|2|||
30789464|NCT02258542|58802715|FG000|Overall Study|Death|5|||
30789465|NCT02258542|58802716|FG001|Overall Study|Death|4|||
30789466|NCT02258542|58802717|FG002|Overall Study|Death|0|||
30789467|NCT02258542|58802718|FG003|Overall Study|Death|1|||
30789468|NCT02258542|58802715|FG000|Overall Study|Adverse Event|3|||
30789469|NCT02258542|58802716|FG001|Overall Study|Adverse Event|4|||
30789470|NCT02258542|58802717|FG002|Overall Study|Adverse Event|0|||
30789471|NCT02258542|58802718|FG003|Overall Study|Adverse Event|0|||
30789472|NCT02258542|58802715|FG000|Overall Study|Protocol Violation|1|||
30789473|NCT02258542|58802716|FG001|Overall Study|Protocol Violation|2|||
30789474|NCT02258542|58802717|FG002|Overall Study|Protocol Violation|0|||
30789475|NCT02258542|58802718|FG003|Overall Study|Protocol Violation|0|||
30789476|NCT02258542|58802715|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30789477|NCT02258542|58802716|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
30789478|NCT02258542|58802717|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
30789479|NCT02258542|58802718|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
30789480|NCT00091793|58802748|FG000|Overall Study|Adverse Event|1|||
30789481|NCT00091793|58802749|FG001|Overall Study|Adverse Event|2|||
30789482|NCT00091793|58802748|FG000|Overall Study|Withdrawal by Subject|10|||
30789483|NCT00091793|58802749|FG001|Overall Study|Withdrawal by Subject|15|||
30789484|NCT00091793|58802748|FG000|Overall Study|Ineligibility determined|2|||
30789485|NCT00091793|58802749|FG001|Overall Study|Ineligibility determined|0|||
30789486|NCT00091793|58802748|FG000|Overall Study|Lost to Follow-up|7|||
30789487|NCT00091793|58802749|FG001|Overall Study|Lost to Follow-up|5|||
30789488|NCT00091793|58802748|FG000|Overall Study|Noncompliance|2|||
30789489|NCT00091793|58802749|FG001|Overall Study|Noncompliance|0|||
30789490|NCT00091793|58802748|FG000|Overall Study|Other|2|||
30789491|NCT00091793|58802749|FG001|Overall Study|Other|0|||
30789492|NCT00098813|58802755|FG000|Overall Study|Death|8|||
30789493|NCT00098813|58802755|FG000|Overall Study|Protocol Violation|1|||
30789494|NCT00098813|58802755|FG000|Overall Study|Withdrawal by Subject|7|||
30789495|NCT00098813|58802755|FG000|Overall Study|Progression of Disease|1|||
30789496|NCT00098813|58802755|FG000|Overall Study|Other complicating disease|1|||
30789497|NCT00098813|58802755|FG000|Overall Study|Reversal of RAI resistance|1|||
30789498|NCT00090857|58802761|FG000|Overall Study|Lost to Follow-up|0|||
30789499|NCT00090857|58802762|FG001|Overall Study|Lost to Follow-up|1|||
30789500|NCT00090857|58802761|FG000|Overall Study|Withdrawal by Subject|2|||
30789501|NCT00090857|58802762|FG001|Overall Study|Withdrawal by Subject|0|||
30789502|NCT00090857|58802761|FG000|Overall Study|Adverse Event|2|||
30789503|NCT00090857|58802762|FG001|Overall Study|Adverse Event|2|||
30789504|NCT00090779|58802774|FG000|Step 1|Withdrawal by Subject|4|||
30789505|NCT00090779|58802775|FG001|Step 1|Withdrawal by Subject|2|||
30789506|NCT00090779|58802774|FG000|Step 1|Lost to Follow-up|3|||
30789507|NCT00090779|58802775|FG001|Step 1|Lost to Follow-up|2|||
30789508|NCT00090779|58802774|FG000|Step 1|Death|0|||
30789509|NCT00090779|58802775|FG001|Step 1|Death|2|||
30789510|NCT00090779|58802774|FG000|Step 1|Physician Decision|1|||
30789511|NCT00090779|58802775|FG001|Step 1|Physician Decision|0|||
30789512|NCT00090779|58802774|FG000|Step 1|Pregnancy|1|||
30789513|NCT00090779|58802775|FG001|Step 1|Pregnancy|0|||
30789514|NCT00090779|58802774|FG000|Step 1|Non-compliance to study requirements|0|||
30789515|NCT00090779|58802775|FG001|Step 1|Non-compliance to study requirements|1|||
30789516|NCT00090779|58802774|FG000|Step 1|Subject relocated|2|||
30789517|NCT00090779|58802775|FG001|Step 1|Subject relocated|8|||
30789518|NCT00090779|58802774|FG000|Step 2|Off study per study closure|6|||
30789519|NCT00090779|58802775|FG001|Step 2|Off study per study closure|16|||
30789520|NCT00090779|58802774|FG000|Step 2|Subject relocated|0|||
30789521|NCT00090779|58802775|FG001|Step 2|Subject relocated|1|||
30789522|NCT00090779|58802774|FG000|Step 2|Non-compliance to study requirements|0|||
30789523|NCT00090779|58802775|FG001|Step 2|Non-compliance to study requirements|1|||
30789524|NCT00090779|58802774|FG000|Step 3|Initiation of ART and off extended study|3|||
30789525|NCT00090779|58802775|FG001|Step 3|Initiation of ART and off extended study|2|||
30789526|NCT00090779|58802774|FG000|Step 3|Off extended study due to study closure|4|||
30789527|NCT00090779|58802775|FG001|Step 3|Off extended study due to study closure|3|||
30789528|NCT00098345|58802781|FG000|Overall Study|Adverse Event|7|||
30789529|NCT00098345|58802781|FG000|Overall Study|Withdrawal by Subject|2|||
30789530|NCT00098345|58802781|FG000|Overall Study|progression|4|||
30789531|NCT02224456|58802785|FG000|Overall Study|Lack of Efficacy|1|||
30789532|NCT02224456|58802785|FG000|Overall Study|Lost to Follow-up|15|||
30789533|NCT02224456|58802785|FG000|Overall Study|Withdrawal by Subject|9|||
30789534|NCT02224456|58802785|FG000|Overall Study|Physician Decision|3|||
30789535|NCT02224456|58802785|FG000|Overall Study|Death|2|||
30789536|NCT02224456|58802785|FG000|Overall Study|Pregnancy|4|||
30789537|NCT02224456|58802785|FG000|Overall Study|Protocol Violation|1|||
30789538|NCT02224456|58802785|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
30789539|NCT00097721|58802791|FG000|Overall Study|Adverse Event|8|||
30789540|NCT00097721|58802792|FG001|Overall Study|Adverse Event|1|||
30789541|NCT00097721|58802791|FG000|Overall Study|Withdrawal by Subject|6|||
30789542|NCT00097721|58802792|FG001|Overall Study|Withdrawal by Subject|1|||
30789543|NCT00097721|58802791|FG000|Overall Study|Progressive Disease|55|||
30789544|NCT00097721|58802792|FG001|Overall Study|Progressive Disease|27|||
30789545|NCT00097721|58802791|FG000|Overall Study|Physician Decision|1|||
30789546|NCT00097721|58802792|FG001|Overall Study|Physician Decision|3|||
30789547|NCT00097721|58802791|FG000|Overall Study|Reason not given|1|||
30789548|NCT00097721|58802792|FG001|Overall Study|Reason not given|1|||
30789549|NCT03553498|58802800|FG000|Overall Study|Missing primary outcome|1|||
30789550|NCT03553498|58802801|FG001|Overall Study|Missing primary outcome|2|||
30789551|NCT00096941|58802807|FG000|Overall Study|disease progression|3|||
30789552|NCT00096785|58802813|FG000|Overall Study|Lost to Follow-up|1|||
30789553|NCT00096785|58802814|FG001|Overall Study|Lost to Follow-up|0|||
30789554|NCT00096785|58802813|FG000|Overall Study|Withdrawal by Subject|0|||
30789555|NCT00096785|58802814|FG001|Overall Study|Withdrawal by Subject|1|||
30789556|NCT00096785|58802813|FG000|Overall Study|Relocated|1|||
30789557|NCT00096785|58802814|FG001|Overall Study|Relocated|0|||
30789558|NCT03285178|58802849|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
30789559|NCT03285178|58802850|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
30789560|NCT03285178|58802851|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
30789561|NCT03285178|58802852|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
30789562|NCT03285178|58802853|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
30789563|NCT03285178|58802854|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
30789564|NCT03285178|58802855|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
30789565|NCT03285178|58802849|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
30789566|NCT03285178|58802850|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
30789567|NCT03285178|58802851|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
30789568|NCT03285178|58802852|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
30789569|NCT03285178|58802853|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
30789570|NCT03285178|58802854|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
30789571|NCT03285178|58802855|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
30789572|NCT03285178|58802849|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
30789573|NCT03285178|58802850|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
30789574|NCT03285178|58802851|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
30789575|NCT03285178|58802852|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
30789576|NCT03285178|58802853|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
30789577|NCT03285178|58802854|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
30789578|NCT03285178|58802855|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
30789579|NCT03285178|58802849|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
30789580|NCT03285178|58802850|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
30789581|NCT03285178|58802851|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
30789582|NCT03285178|58802852|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
30789583|NCT03285178|58802853|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
30789584|NCT03285178|58802854|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
30789585|NCT03285178|58802855|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
30789586|NCT03285178|58802849|FG000|Single-Blind Run-In Period|Physician Decision|2|||
30789587|NCT03285178|58802850|FG001|Single-Blind Run-In Period|Physician Decision|0|||
30789588|NCT03285178|58802851|FG002|Single-Blind Run-In Period|Physician Decision|0|||
30789589|NCT03285178|58802852|FG003|Single-Blind Run-In Period|Physician Decision|0|||
30789590|NCT03285178|58802853|FG004|Single-Blind Run-In Period|Physician Decision|0|||
30789591|NCT03285178|58802854|FG005|Single-Blind Run-In Period|Physician Decision|0|||
30789592|NCT03285178|58802855|FG006|Single-Blind Run-In Period|Physician Decision|0|||
30789593|NCT03285178|58802849|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
30789594|NCT03285178|58802850|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
30789595|NCT03285178|58802851|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
30789596|NCT03285178|58802852|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
30789597|NCT03285178|58802853|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
30789598|NCT03285178|58802854|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
30789599|NCT03285178|58802855|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
30789600|NCT03285178|58802849|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30789601|NCT03285178|58802850|FG001|Double-Blind Treatment Period|Adverse Event|0|||
30789602|NCT03285178|58802851|FG002|Double-Blind Treatment Period|Adverse Event|0|||
30789603|NCT03285178|58802852|FG003|Double-Blind Treatment Period|Adverse Event|0|||
30789604|NCT03285178|58802853|FG004|Double-Blind Treatment Period|Adverse Event|0|||
30789605|NCT03285178|58802854|FG005|Double-Blind Treatment Period|Adverse Event|0|||
30789606|NCT03285178|58802855|FG006|Double-Blind Treatment Period|Adverse Event|2|||
30789607|NCT03285178|58802849|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
30789608|NCT03285178|58802850|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
30789609|NCT03285178|58802851|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
30789610|NCT03285178|58802852|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
30789611|NCT03285178|58802853|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
30878530|NCT01939366|58909786|FG004|Overall Study|Lack of Efficacy|3|||
30969081|NCT00070499|59040532|FG001|Overall Study|Still on protocol treatment|4|||
30789612|NCT03285178|58802854|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
30789613|NCT03285178|58802855|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
30789614|NCT03285178|58802849|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30789615|NCT03285178|58802850|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30789616|NCT03285178|58802851|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
30789617|NCT03285178|58802852|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
30789618|NCT03285178|58802853|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30789619|NCT03285178|58802854|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
30789620|NCT03285178|58802855|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
30789621|NCT03285178|58802849|FG000|Double-Blind Treatment Period|COVID-19|0|||
30789622|NCT03285178|58802850|FG001|Double-Blind Treatment Period|COVID-19|0|||
30789623|NCT03285178|58802851|FG002|Double-Blind Treatment Period|COVID-19|1|||
30789624|NCT03285178|58802852|FG003|Double-Blind Treatment Period|COVID-19|0|||
30789625|NCT03285178|58802853|FG004|Double-Blind Treatment Period|COVID-19|0|||
30789626|NCT03285178|58802854|FG005|Double-Blind Treatment Period|COVID-19|0|||
30789627|NCT03285178|58802855|FG006|Double-Blind Treatment Period|COVID-19|0|||
30789628|NCT00090545|58802879|FG000|Overall Study|Disease progression on study|21|||
30789629|NCT00090545|58802880|FG001|Overall Study|Disease progression on study|17|||
30789630|NCT00090545|58802879|FG000|Overall Study|Refused further treatment|1|||
30789631|NCT00090545|58802880|FG001|Overall Study|Refused further treatment|4|||
30789632|NCT00090545|58802879|FG000|Overall Study|Death|0|||
30789633|NCT00090545|58802880|FG001|Overall Study|Death|1|||
30789634|NCT00090545|58802879|FG000|Overall Study|Adverse Event|0|||
30789635|NCT00090545|58802880|FG001|Overall Study|Adverse Event|2|||
30789636|NCT03249376|58802890|FG000|Overall Study|Adverse Event|11|||
30789637|NCT03249376|58802891|FG001|Overall Study|Adverse Event|5|||
30789638|NCT03249376|58802890|FG000|Overall Study|Lack of Efficacy|2|||
30789639|NCT03249376|58802891|FG001|Overall Study|Lack of Efficacy|4|||
30789640|NCT03249376|58802890|FG000|Overall Study|Protocol Violation|3|||
30789641|NCT03249376|58802891|FG001|Overall Study|Protocol Violation|2|||
30789642|NCT03249376|58802890|FG000|Overall Study|Physician Decision|0|||
30789643|NCT03249376|58802891|FG001|Overall Study|Physician Decision|2|||
30789644|NCT03249376|58802890|FG000|Overall Study|Withdrawal by Subject|3|||
30789645|NCT03249376|58802891|FG001|Overall Study|Withdrawal by Subject|9|||
30789646|NCT03249376|58802890|FG000|Overall Study|LTFU|2|||
30789647|NCT03249376|58802891|FG001|Overall Study|LTFU|1|||
30789648|NCT00070109|58802902|FG000|Overall Study|Death|1|||
30789649|NCT00070109|58802903|FG001|Overall Study|Death|1|||
30789650|NCT00070109|58802904|FG002|Overall Study|Death|0|||
30789651|NCT00070109|58802905|FG003|Overall Study|Death|0|||
30789652|NCT00070109|58802906|FG004|Overall Study|Death|1|||
30789653|NCT00070109|58802902|FG000|Overall Study|Lack of Efficacy|6|||
30789654|NCT00070109|58802903|FG001|Overall Study|Lack of Efficacy|4|||
30789655|NCT00070109|58802904|FG002|Overall Study|Lack of Efficacy|5|||
30789656|NCT00070109|58802905|FG003|Overall Study|Lack of Efficacy|15|||
30789657|NCT00070109|58802906|FG004|Overall Study|Lack of Efficacy|5|||
30789658|NCT00070109|58802902|FG000|Overall Study|Physician Decision|1|||
30789659|NCT00070109|58802903|FG001|Overall Study|Physician Decision|0|||
30789660|NCT00070109|58802904|FG002|Overall Study|Physician Decision|0|||
30789661|NCT00070109|58802905|FG003|Overall Study|Physician Decision|0|||
30789662|NCT00070109|58802906|FG004|Overall Study|Physician Decision|0|||
30789663|NCT00070109|58802902|FG000|Overall Study|Withdrawal by Subject|0|||
30789664|NCT00070109|58802903|FG001|Overall Study|Withdrawal by Subject|1|||
30789665|NCT00070109|58802904|FG002|Overall Study|Withdrawal by Subject|1|||
30789666|NCT00070109|58802905|FG003|Overall Study|Withdrawal by Subject|0|||
30789667|NCT00070109|58802906|FG004|Overall Study|Withdrawal by Subject|0|||
30789668|NCT00070109|58802902|FG000|Overall Study|Adverse Event|0|||
30789669|NCT00070109|58802903|FG001|Overall Study|Adverse Event|0|||
30789670|NCT00070109|58802904|FG002|Overall Study|Adverse Event|2|||
30789671|NCT00070109|58802905|FG003|Overall Study|Adverse Event|4|||
30789672|NCT00070109|58802906|FG004|Overall Study|Adverse Event|2|||
30789673|NCT00070109|58802902|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
30789674|NCT00070109|58802903|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
30789675|NCT00070109|58802904|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
30789676|NCT00070109|58802905|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
30789677|NCT00070109|58802906|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
30789678|NCT00090233|58802927|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
30789679|NCT00090233|58802928|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
30789680|NCT00090233|58802927|FG000|Overall Study|Adverse Event|214|||
30789681|NCT00090233|58802928|FG001|Overall Study|Adverse Event|198|||
30789682|NCT00090233|58802927|FG000|Overall Study|Lost to Follow-up|68|||
30789683|NCT00090233|58802928|FG001|Overall Study|Lost to Follow-up|95|||
30789684|NCT00090233|58802927|FG000|Overall Study|Protocol Violation|960|||
30789685|NCT00090233|58802928|FG001|Overall Study|Protocol Violation|1022|||
30789686|NCT00090233|58802927|FG000|Overall Study|Withdrawal by Subject|182|||
30789687|NCT00090233|58802928|FG001|Overall Study|Withdrawal by Subject|211|||
30789688|NCT00090233|58802927|FG000|Overall Study|Moved|203|||
30789689|NCT00090233|58802928|FG001|Overall Study|Moved|189|||
30789690|NCT00090233|58802927|FG000|Overall Study|Other|1211|||
30789691|NCT00090233|58802928|FG001|Overall Study|Other|1160|||
30789692|NCT00090233|58802927|FG000|Overall Study|Data not available at data cut-off point|1552|||
30789693|NCT00090233|58802928|FG001|Overall Study|Data not available at data cut-off point|1563|||
30789694|NCT00069953|58802938|FG000|Overall Study|Protocol Violation|2|||
30789695|NCT02750800|58802948|FG000|Overall Study|Adverse Event|18|||
30789696|NCT02750800|58802948|FG000|Overall Study|Lost to Follow-up|12|||
30789697|NCT02750800|58802948|FG000|Overall Study|Investigator decision|53|||
30789698|NCT02750800|58802948|FG000|Overall Study|Patient request|12|||
30789699|NCT02750800|58802948|FG000|Overall Study|Other, not specified|3|||
30789700|NCT01329562|58802968|FG000|Overall Study|Protocol Violation|5|||
30789701|NCT01329562|58802969|FG001|Overall Study|Protocol Violation|3|||
30789702|NCT01329562|58802968|FG000|Overall Study|Lost to Follow-up|1|||
30789703|NCT01329562|58802969|FG001|Overall Study|Lost to Follow-up|1|||
30789704|NCT01329562|58802968|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
30789705|NCT01329562|58802969|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
30789706|NCT01329562|58802968|FG000|Overall Study|Physician Decision|0|||
30789707|NCT01329562|58802969|FG001|Overall Study|Physician Decision|1|||
30789708|NCT00069641|58802980|FG000|Overall Study|Death|1|||
30789709|NCT00069641|58802981|FG001|Overall Study|Death|0|||
30789710|NCT00069641|58802982|FG002|Overall Study|Death|1|||
30789711|NCT03653026|58802993|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
30789712|NCT03653026|58802994|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
30789713|NCT03653026|58802995|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
30789714|NCT03653026|58802996|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
30789715|NCT03653026|58802993|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
30789716|NCT03653026|58802994|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
30789717|NCT03653026|58802995|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
30789718|NCT03653026|58802996|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
30789719|NCT03653026|58802993|FG000|Part 1: Placebo-controlled Period|Other|0|||
30789720|NCT03653026|58802994|FG001|Part 1: Placebo-controlled Period|Other|3|||
30789721|NCT03653026|58802995|FG002|Part 1: Placebo-controlled Period|Other|0|||
30789722|NCT03653026|58802996|FG003|Part 1: Placebo-controlled Period|Other|0|||
30789723|NCT03653026|58802993|FG000|Part 2: Open-label Extension|Adverse Event|0|||
30789724|NCT03653026|58802994|FG001|Part 2: Open-label Extension|Adverse Event|0|||
30789725|NCT03653026|58802995|FG002|Part 2: Open-label Extension|Adverse Event|1|||
30789726|NCT03653026|58802996|FG003|Part 2: Open-label Extension|Adverse Event|1|||
30789727|NCT03653026|58802993|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
30789728|NCT03653026|58802994|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
30789729|NCT03653026|58802995|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
30789730|NCT03653026|58802996|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
30789731|NCT03653026|58802993|FG000|Part 2: Open-label Extension|Other|0|||
30789732|NCT03653026|58802994|FG001|Part 2: Open-label Extension|Other|0|||
30789733|NCT03653026|58802995|FG002|Part 2: Open-label Extension|Other|1|||
30789734|NCT03653026|58802996|FG003|Part 2: Open-label Extension|Other|2|||
30789735|NCT01329328|58803007|FG000|Overall Study|Withdrawal by Subject|2|||
30789736|NCT01329328|58803008|FG001|Overall Study|Withdrawal by Subject|4|||
30789737|NCT01329328|58803009|FG002|Overall Study|Withdrawal by Subject|3|||
30789738|NCT01337986|58803019|FG000|Overall Study|Adverse Event|2|||
30789739|NCT01337986|58803020|FG001|Overall Study|Adverse Event|2|||
30789740|NCT01337986|58803019|FG000|Overall Study|Lost to Follow-up|1|||
30789741|NCT01337986|58803020|FG001|Overall Study|Lost to Follow-up|0|||
30789742|NCT01337986|58803019|FG000|Overall Study|Protocol Violation|0|||
30789743|NCT01337986|58803020|FG001|Overall Study|Protocol Violation|3|||
30789744|NCT01337674|58803044|FG000|Treatment Period 1|Adverse Event|0|||
30789745|NCT01337674|58803045|FG001|Treatment Period 1|Adverse Event|1|||
30789746|NCT01337674|58803046|FG002|Treatment Period 1|Adverse Event|0|||
30789747|NCT01337674|58803047|FG003|Treatment Period 1|Adverse Event|0|||
30789748|NCT01337674|58803044|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
30789749|NCT01337674|58803045|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
30789750|NCT01337674|58803046|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
30789751|NCT01337674|58803047|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
30789752|NCT01337674|58803044|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30789753|NCT01337674|58803045|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30789754|NCT01337674|58803046|FG002|Treatment Period 2|Withdrawal by Subject|1|||
30789755|NCT01337674|58803047|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30789756|NCT02750410|58803062|FG000|Double-Blind Treatment Period|Adverse Event|2|||
30760588|NCT03381274|58769072|FG002|Overall Study|Lost to Follow-up|0|||
30789757|NCT02750410|58803063|FG001|Double-Blind Treatment Period|Adverse Event|2|||
30789758|NCT02750410|58803062|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30789759|NCT02750410|58803063|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
30789760|NCT02750410|58803062|FG000|Open-Label Extension Period|Adverse Event|5|||
30789761|NCT02750410|58803063|FG001|Open-Label Extension Period|Adverse Event|3|||
30789762|NCT02750410|58803062|FG000|Open-Label Extension Period|Protocol Violation|0|||
30789763|NCT02750410|58803063|FG001|Open-Label Extension Period|Protocol Violation|1|||
30789764|NCT02750410|58803062|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
30789765|NCT02750410|58803063|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
30789766|NCT02750332|58803073|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30789767|NCT02750332|58803074|FG001|Treatment Period 1|Withdrawal by Subject|1|||
30789768|NCT01337596|58803089|FG000|Overall Study|Withdrawal by Subject|0|||
30789769|NCT01337596|58803090|FG001|Overall Study|Withdrawal by Subject|0|||
30789770|NCT01337596|58803091|FG002|Overall Study|Withdrawal by Subject|0|||
30789771|NCT01337596|58803092|FG003|Overall Study|Withdrawal by Subject|0|||
30789772|NCT01337596|58803093|FG004|Overall Study|Withdrawal by Subject|2|||
30789773|NCT01337596|58803094|FG005|Overall Study|Withdrawal by Subject|0|||
30789774|NCT01337596|58803095|FG006|Overall Study|Withdrawal by Subject|0|||
30789775|NCT01337596|58803096|FG007|Overall Study|Withdrawal by Subject|0|||
30789776|NCT01337596|58803097|FG008|Overall Study|Withdrawal by Subject|0|||
30789777|NCT00069095|58803126|FG000|Primary Treatment Phase|Ongoing|0|||
30789778|NCT00069095|58803127|FG001|Primary Treatment Phase|Ongoing|0|||
30789779|NCT00069095|58803128|FG002|Primary Treatment Phase|Ongoing|5|||
30789780|NCT00069095|58803129|FG003|Primary Treatment Phase|Ongoing|7|||
30789781|NCT00069095|58803130|FG004|Primary Treatment Phase|Ongoing|7|||
30789782|NCT00069095|58803131|FG005|Primary Treatment Phase|Ongoing|4|||
30789783|NCT00069095|58803126|FG000|Primary Treatment Phase|Admin/Other|29|||
30789784|NCT00069095|58803127|FG001|Primary Treatment Phase|Admin/Other|38|||
30789785|NCT00069095|58803128|FG002|Primary Treatment Phase|Admin/Other|31|||
30789786|NCT00069095|58803129|FG003|Primary Treatment Phase|Admin/Other|45|||
30789787|NCT00069095|58803130|FG004|Primary Treatment Phase|Admin/Other|48|||
30789788|NCT00069095|58803131|FG005|Primary Treatment Phase|Admin/Other|42|||
30789789|NCT00069095|58803126|FG000|Primary Treatment Phase|Adverse Event|99|||
30789790|NCT00069095|58803127|FG001|Primary Treatment Phase|Adverse Event|92|||
30789791|NCT00069095|58803128|FG002|Primary Treatment Phase|Adverse Event|71|||
30789792|NCT00069095|58803129|FG003|Primary Treatment Phase|Adverse Event|72|||
30789793|NCT00069095|58803130|FG004|Primary Treatment Phase|Adverse Event|109|||
30789794|NCT00069095|58803131|FG005|Primary Treatment Phase|Adverse Event|101|||
30789795|NCT00069095|58803126|FG000|Primary Treatment Phase|Death|14|||
30789796|NCT00069095|58803127|FG001|Primary Treatment Phase|Death|8|||
30789797|NCT00069095|58803128|FG002|Primary Treatment Phase|Death|2|||
30789798|NCT00069095|58803129|FG003|Primary Treatment Phase|Death|5|||
30789799|NCT00069095|58803130|FG004|Primary Treatment Phase|Death|8|||
30789800|NCT00069095|58803131|FG005|Primary Treatment Phase|Death|8|||
30789801|NCT00069095|58803126|FG000|Primary Treatment Phase|Failure to return|5|||
30789802|NCT00069095|58803127|FG001|Primary Treatment Phase|Failure to return|5|||
30789803|NCT00069095|58803128|FG002|Primary Treatment Phase|Failure to return|0|||
30789804|NCT00069095|58803129|FG003|Primary Treatment Phase|Failure to return|0|||
30789805|NCT00069095|58803130|FG004|Primary Treatment Phase|Failure to return|0|||
30789806|NCT00069095|58803131|FG005|Primary Treatment Phase|Failure to return|2|||
30789807|NCT00069095|58803126|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
30789808|NCT00069095|58803127|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
30789809|NCT00069095|58803128|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
30789810|NCT00069095|58803129|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
30789811|NCT00069095|58803130|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
30789812|NCT00069095|58803131|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
30789813|NCT00069095|58803126|FG000|Primary Treatment Phase|Refused treatment|15|||
30789814|NCT00069095|58803127|FG001|Primary Treatment Phase|Refused treatment|26|||
30789815|NCT00069095|58803128|FG002|Primary Treatment Phase|Refused treatment|17|||
30789816|NCT00069095|58803129|FG003|Primary Treatment Phase|Refused treatment|31|||
30789817|NCT00069095|58803130|FG004|Primary Treatment Phase|Refused treatment|24|||
30789818|NCT00069095|58803131|FG005|Primary Treatment Phase|Refused treatment|27|||
30789819|NCT00069095|58803126|FG000|Primary Treatment Phase|Withdrew|2|||
30789820|NCT00069095|58803127|FG001|Primary Treatment Phase|Withdrew|3|||
30789821|NCT00069095|58803128|FG002|Primary Treatment Phase|Withdrew|8|||
30789822|NCT00069095|58803129|FG003|Primary Treatment Phase|Withdrew|2|||
30789823|NCT00069095|58803130|FG004|Primary Treatment Phase|Withdrew|4|||
30789824|NCT00069095|58803131|FG005|Primary Treatment Phase|Withdrew|9|||
30789825|NCT00069095|58803126|FG000|Primary Treatment Phase|Other Violation|0|||
30789826|NCT00069095|58803127|FG001|Primary Treatment Phase|Other Violation|1|||
30789827|NCT00069095|58803128|FG002|Primary Treatment Phase|Other Violation|1|||
30789828|NCT00069095|58803129|FG003|Primary Treatment Phase|Other Violation|1|||
30789829|NCT00069095|58803130|FG004|Primary Treatment Phase|Other Violation|0|||
30789830|NCT00069095|58803131|FG005|Primary Treatment Phase|Other Violation|1|||
30789831|NCT00069095|58803126|FG000|Primary Treatment Phase|Violation criteria|0|||
30789832|NCT00069095|58803127|FG001|Primary Treatment Phase|Violation criteria|2|||
30789833|NCT00069095|58803128|FG002|Primary Treatment Phase|Violation criteria|4|||
30789834|NCT00069095|58803129|FG003|Primary Treatment Phase|Violation criteria|3|||
30789835|NCT00069095|58803130|FG004|Primary Treatment Phase|Violation criteria|1|||
30789836|NCT00069095|58803131|FG005|Primary Treatment Phase|Violation criteria|5|||
30789837|NCT00069095|58803126|FG000|Post-study Treatment Phase|Missing reason|1|||
30789838|NCT00069095|58803127|FG001|Post-study Treatment Phase|Missing reason|3|||
30789839|NCT00069095|58803128|FG002|Post-study Treatment Phase|Missing reason|12|||
30789840|NCT00069095|58803129|FG003|Post-study Treatment Phase|Missing reason|8|||
30789841|NCT00069095|58803130|FG004|Post-study Treatment Phase|Missing reason|18|||
30789842|NCT00069095|58803131|FG005|Post-study Treatment Phase|Missing reason|17|||
30789843|NCT00069095|58803126|FG000|Post-study Treatment Phase|Adverse Event|2|||
30789844|NCT00069095|58803127|FG001|Post-study Treatment Phase|Adverse Event|3|||
30789845|NCT00069095|58803128|FG002|Post-study Treatment Phase|Adverse Event|1|||
30789846|NCT00069095|58803129|FG003|Post-study Treatment Phase|Adverse Event|0|||
30789847|NCT00069095|58803130|FG004|Post-study Treatment Phase|Adverse Event|5|||
30789848|NCT00069095|58803131|FG005|Post-study Treatment Phase|Adverse Event|1|||
30789849|NCT00069095|58803126|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
30789850|NCT00069095|58803127|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
30789851|NCT00069095|58803128|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
30789852|NCT00069095|58803129|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
30789853|NCT00069095|58803130|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
30789854|NCT00069095|58803131|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
30789855|NCT00069095|58803126|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
30789856|NCT00069095|58803127|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
30789857|NCT00069095|58803128|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
30789858|NCT00069095|58803129|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
30789859|NCT00069095|58803130|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
30789860|NCT00069095|58803131|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
30789861|NCT00069095|58803126|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
30789862|NCT00069095|58803127|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
30789863|NCT00069095|58803128|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
30789864|NCT00069095|58803129|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
30789865|NCT00069095|58803130|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
30789866|NCT00069095|58803131|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
30789867|NCT00069095|58803126|FG000|Post-study Treatment Phase|Participant had complete response|1|||
30789868|NCT00069095|58803127|FG001|Post-study Treatment Phase|Participant had complete response|1|||
30789869|NCT00069095|58803128|FG002|Post-study Treatment Phase|Participant had complete response|0|||
30789870|NCT00069095|58803129|FG003|Post-study Treatment Phase|Participant had complete response|0|||
30789871|NCT00069095|58803130|FG004|Post-study Treatment Phase|Participant had complete response|0|||
30789872|NCT00069095|58803131|FG005|Post-study Treatment Phase|Participant had complete response|0|||
30789873|NCT00069095|58803126|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
30789874|NCT00069095|58803127|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
30789875|NCT00069095|58803128|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
30789876|NCT00069095|58803129|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
30789877|NCT00069095|58803130|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
30789878|NCT00069095|58803131|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
30789879|NCT00069095|58803126|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
30789880|NCT00069095|58803127|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
30789881|NCT00069095|58803128|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
30789882|NCT00069095|58803129|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
30789883|NCT00069095|58803130|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
30789884|NCT00069095|58803131|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
30789885|NCT00069095|58803126|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
30789886|NCT00069095|58803127|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
30789887|NCT00069095|58803128|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
30789888|NCT00069095|58803129|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
30789889|NCT00069095|58803130|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
30789890|NCT00069095|58803131|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
30789891|NCT00069095|58803126|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
30789892|NCT00069095|58803127|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
30789893|NCT00069095|58803128|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
30789894|NCT00069095|58803129|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
30789895|NCT00069095|58803130|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
30789896|NCT00069095|58803131|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
30789897|NCT00069095|58803126|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
30789898|NCT00069095|58803127|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
30789899|NCT00069095|58803128|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
30969082|NCT00070499|59040533|FG002|Overall Study|Still on protocol treatment|79|||
30789900|NCT00069095|58803129|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
30789901|NCT00069095|58803130|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
30789902|NCT00069095|58803131|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
30789903|NCT00069095|58803126|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
30789904|NCT00069095|58803127|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
30789905|NCT00069095|58803128|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
30789906|NCT00069095|58803129|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
30789907|NCT00069095|58803130|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
30789908|NCT00069095|58803131|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
30789909|NCT00069095|58803126|FG000|Post-study Treatment Phase|Surgery|0|||
30789910|NCT00069095|58803127|FG001|Post-study Treatment Phase|Surgery|0|||
30789911|NCT00069095|58803128|FG002|Post-study Treatment Phase|Surgery|0|||
30789912|NCT00069095|58803129|FG003|Post-study Treatment Phase|Surgery|1|||
30789913|NCT00069095|58803130|FG004|Post-study Treatment Phase|Surgery|1|||
30789914|NCT00069095|58803131|FG005|Post-study Treatment Phase|Surgery|0|||
30789915|NCT00069095|58803126|FG000|Post-study Treatment Phase|Death|0|||
30789916|NCT00069095|58803127|FG001|Post-study Treatment Phase|Death|0|||
30789917|NCT00069095|58803128|FG002|Post-study Treatment Phase|Death|0|||
30789918|NCT00069095|58803129|FG003|Post-study Treatment Phase|Death|0|||
30789919|NCT00069095|58803130|FG004|Post-study Treatment Phase|Death|1|||
30789920|NCT00069095|58803131|FG005|Post-study Treatment Phase|Death|0|||
30789921|NCT00069095|58803126|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
30789922|NCT00069095|58803127|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
30789923|NCT00069095|58803128|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
30789924|NCT00069095|58803129|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
30789925|NCT00069095|58803130|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
30789926|NCT00069095|58803131|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
30789927|NCT00069095|58803126|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
30789928|NCT00069095|58803127|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
30789929|NCT00069095|58803128|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
30789930|NCT00069095|58803129|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
30789931|NCT00069095|58803130|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
30789932|NCT00069095|58803131|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
30789933|NCT00069095|58803126|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
30789934|NCT00069095|58803127|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
30789935|NCT00069095|58803128|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
30789936|NCT00069095|58803129|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
30789937|NCT00069095|58803130|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
30789938|NCT00069095|58803131|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
30789939|NCT00069095|58803126|FG000|Post-study Treatment Phase|Investigator decision|0|||
30789940|NCT00069095|58803127|FG001|Post-study Treatment Phase|Investigator decision|0|||
30789941|NCT00069095|58803128|FG002|Post-study Treatment Phase|Investigator decision|0|||
30789942|NCT00069095|58803129|FG003|Post-study Treatment Phase|Investigator decision|0|||
30789943|NCT00069095|58803130|FG004|Post-study Treatment Phase|Investigator decision|0|||
30789944|NCT00069095|58803131|FG005|Post-study Treatment Phase|Investigator decision|1|||
30789945|NCT00069095|58803126|FG000|Follow-up Phase|Death|174|||
30789946|NCT00069095|58803127|FG001|Follow-up Phase|Death|206|||
30789947|NCT00069095|58803128|FG002|Follow-up Phase|Death|120|||
30789948|NCT00069095|58803129|FG003|Follow-up Phase|Death|112|||
30789949|NCT00069095|58803130|FG004|Follow-up Phase|Death|92|||
30789950|NCT00069095|58803131|FG005|Follow-up Phase|Death|101|||
30789951|NCT00086411|58803147|FG000|Overall Study|Lost to Follow-up|11|||
30789952|NCT00086411|58803148|FG001|Overall Study|Lost to Follow-up|11|||
30789953|NCT00086411|58803149|FG002|Overall Study|Lost to Follow-up|13|||
30789954|NCT00086411|58803150|FG003|Overall Study|Lost to Follow-up|12|||
30789955|NCT00068237|58803161|FG000|Overall Study|Ineligible|3|||
30789956|NCT00068237|58803161|FG000|Overall Study|No protocol treatment received|2|||
30789957|NCT00055601|58803167|FG000|Overall Study|Protocol Violation|1|||
30789958|NCT00055601|58803168|FG001|Overall Study|Protocol Violation|1|||
30789959|NCT00055601|58803167|FG000|Overall Study|No protocol treatment received|1|||
30789960|NCT00055601|58803168|FG001|Overall Study|No protocol treatment received|1|||
30789961|NCT03806231|58803176|FG000|Overall Study|Physician Decision|1|||
30789962|NCT03806231|58803177|FG001|Overall Study|Physician Decision|0|||
30789963|NCT03806231|58803176|FG000|Overall Study|Withdrawal by Subject|1|||
30789964|NCT03806231|58803177|FG001|Overall Study|Withdrawal by Subject|0|||
30789965|NCT00054275|58803183|FG000|Overall Study|Withdrawal by Subject|4|||
30789966|NCT00054275|58803183|FG000|Overall Study|Adverse Event|5|||
30789967|NCT00054275|58803183|FG000|Overall Study|Progressive disease in cycle 1|1|||
30789968|NCT00054275|58803183|FG000|Overall Study|Physician Decision|1|||
30789969|NCT00053417|58803191|FG000|Overall Study|Adverse Event|1|||
30789970|NCT00053417|58803192|FG001|Overall Study|Adverse Event|0|||
30789971|NCT00053417|58803193|FG002|Overall Study|Adverse Event|1|||
30789972|NCT00053417|58803194|FG003|Overall Study|Adverse Event|5|||
30789973|NCT00053417|58803191|FG000|Overall Study|Non-Compliance|0|||
30789974|NCT00053417|58803192|FG001|Overall Study|Non-Compliance|0|||
30789975|NCT00053417|58803193|FG002|Overall Study|Non-Compliance|0|||
30789976|NCT00053417|58803194|FG003|Overall Study|Non-Compliance|1|||
30789977|NCT00053417|58803191|FG000|Overall Study|Withdrawal by Subject|0|||
30789978|NCT00053417|58803192|FG001|Overall Study|Withdrawal by Subject|1|||
30789979|NCT00053417|58803193|FG002|Overall Study|Withdrawal by Subject|0|||
30789980|NCT00053417|58803194|FG003|Overall Study|Withdrawal by Subject|0|||
30789981|NCT00053417|58803191|FG000|Overall Study|Lost to Follow-up|1|||
30789982|NCT00053417|58803192|FG001|Overall Study|Lost to Follow-up|1|||
30789983|NCT00053417|58803193|FG002|Overall Study|Lost to Follow-up|0|||
30789984|NCT00053417|58803194|FG003|Overall Study|Lost to Follow-up|0|||
30789985|NCT00052715|58803204|FG000|Overall Study|wrong histology|1|||
30789986|NCT00051311|58803210|FG000|Overall Study|Starting new study|0|||
30789987|NCT00051311|58803211|FG001|Overall Study|Starting new study|1|||
30789988|NCT00051311|58803210|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
30789989|NCT00051311|58803211|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
30789990|NCT00051311|58803210|FG000|Overall Study|Death of recipient|8|||
30789991|NCT00051311|58803211|FG001|Overall Study|Death of recipient|8|||
30789992|NCT00051311|58803210|FG000|Overall Study|Recipient taken off study|4|||
30789993|NCT00051311|58803211|FG001|Overall Study|Recipient taken off study|4|||
30789994|NCT00049673|58803217|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
30789995|NCT00049673|58803218|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
30789996|NCT00049127|58803229|FG000|Overall Study|Withdrawal by Subject|0|||
30789997|NCT00049127|58803230|FG001|Overall Study|Withdrawal by Subject|0|||
30789998|NCT00049127|58803231|FG002|Overall Study|Withdrawal by Subject|1|||
30789999|NCT00049127|58803232|FG003|Overall Study|Withdrawal by Subject|0|||
30790000|NCT00049127|58803233|FG004|Overall Study|Withdrawal by Subject|0|||
30790001|NCT00066365|58803247|FG000|Overall Study|Adverse Event|1|||
30790002|NCT00066365|58803248|FG001|Overall Study|Adverse Event|0|||
30790003|NCT00066365|58803247|FG000|Overall Study|Lack of Efficacy|15|||
30790004|NCT00066365|58803248|FG001|Overall Study|Lack of Efficacy|12|||
30790005|NCT00066365|58803247|FG000|Overall Study|Physician Decision|1|||
30878531|NCT01939366|58909782|FG000|Overall Study|Lost to Follow-up|1|||
30878532|NCT01939366|58909783|FG001|Overall Study|Lost to Follow-up|1|||
30878533|NCT01939366|58909784|FG002|Overall Study|Lost to Follow-up|0|||
30878534|NCT01939366|58909785|FG003|Overall Study|Lost to Follow-up|0|||
30878535|NCT01939366|58909786|FG004|Overall Study|Lost to Follow-up|0|||
30878536|NCT01939366|58909782|FG000|Overall Study|Withdrawal by Subject|1|||
30878537|NCT01939366|58909783|FG001|Overall Study|Withdrawal by Subject|0|||
30878538|NCT01939366|58909784|FG002|Overall Study|Withdrawal by Subject|2|||
30878539|NCT01939366|58909785|FG003|Overall Study|Withdrawal by Subject|2|||
30878540|NCT01939366|58909786|FG004|Overall Study|Withdrawal by Subject|3|||
30878541|NCT01939366|58909782|FG000|Overall Study|Inclusion criteria not met|0|||
30878542|NCT01939366|58909783|FG001|Overall Study|Inclusion criteria not met|1|||
30878543|NCT01939366|58909784|FG002|Overall Study|Inclusion criteria not met|1|||
30878544|NCT01939366|58909785|FG003|Overall Study|Inclusion criteria not met|0|||
30878545|NCT01939366|58909786|FG004|Overall Study|Inclusion criteria not met|1|||
30878546|NCT01939366|58909782|FG000|Overall Study|Other|0|||
30878547|NCT01939366|58909783|FG001|Overall Study|Other|0|||
30878548|NCT01939366|58909784|FG002|Overall Study|Other|2|||
30878549|NCT01939366|58909785|FG003|Overall Study|Other|2|||
30878550|NCT01939366|58909786|FG004|Overall Study|Other|1|||
30878551|NCT01939366|58909782|FG000|Overall Study|Protocol Violation|0|||
30878552|NCT01939366|58909783|FG001|Overall Study|Protocol Violation|0|||
30878553|NCT01939366|58909784|FG002|Overall Study|Protocol Violation|0|||
30878554|NCT01939366|58909785|FG003|Overall Study|Protocol Violation|1|||
30878555|NCT01939366|58909786|FG004|Overall Study|Protocol Violation|0|||
30878556|NCT01939366|58909782|FG000|Overall Study|Sponsor decision|0|||
30878557|NCT01939366|58909783|FG001|Overall Study|Sponsor decision|0|||
30878558|NCT01939366|58909784|FG002|Overall Study|Sponsor decision|0|||
30878559|NCT01939366|58909785|FG003|Overall Study|Sponsor decision|0|||
30878560|NCT01939366|58909786|FG004|Overall Study|Sponsor decision|2|||
30878561|NCT01939366|58909782|FG000|Overall Study|GCP non-compliance at site|2|||
30878562|NCT01939366|58909783|FG001|Overall Study|GCP non-compliance at site|3|||
30878563|NCT01939366|58909784|FG002|Overall Study|GCP non-compliance at site|2|||
30878564|NCT01939366|58909785|FG003|Overall Study|GCP non-compliance at site|3|||
30878565|NCT01939366|58909786|FG004|Overall Study|GCP non-compliance at site|3|||
30878566|NCT01918306|58909800|FG000|Overall Study|progresive disease|4|||
30790006|NCT00066365|58803248|FG001|Overall Study|Physician Decision|0|||
30790007|NCT00066365|58803247|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
30790008|NCT00066365|58803248|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
30790009|NCT00066365|58803247|FG000|Overall Study|Ineligible|4|||
30878567|NCT01918306|58909801|FG001|Overall Study|progresive disease|0|||
30878568|NCT01918306|58909802|FG002|Overall Study|progresive disease|1|||
30878569|NCT01918306|58909803|FG003|Overall Study|progresive disease|1|||
30878570|NCT01918306|58909800|FG000|Overall Study|Withdrawal by Subject|0|||
30878571|NCT01918306|58909801|FG001|Overall Study|Withdrawal by Subject|0|||
30878572|NCT01918306|58909802|FG002|Overall Study|Withdrawal by Subject|0|||
30878573|NCT01918306|58909803|FG003|Overall Study|Withdrawal by Subject|2|||
30878574|NCT01918306|58909800|FG000|Overall Study|neutropenia|1|||
30878575|NCT01918306|58909801|FG001|Overall Study|neutropenia|0|||
30878576|NCT01918306|58909802|FG002|Overall Study|neutropenia|0|||
30878577|NCT01918306|58909803|FG003|Overall Study|neutropenia|0|||
30878578|NCT01918306|58909800|FG000|Overall Study|Lack of Efficacy|1|||
30878579|NCT01918306|58909801|FG001|Overall Study|Lack of Efficacy|0|||
30878580|NCT01918306|58909802|FG002|Overall Study|Lack of Efficacy|0|||
30878581|NCT01918306|58909803|FG003|Overall Study|Lack of Efficacy|0|||
30878582|NCT01918306|58909800|FG000|Overall Study|progress disease, crossover|0|||
30878583|NCT01918306|58909801|FG001|Overall Study|progress disease, crossover|0|||
30878584|NCT01918306|58909802|FG002|Overall Study|progress disease, crossover|1|||
30878585|NCT01918306|58909803|FG003|Overall Study|progress disease, crossover|0|||
30878586|NCT01917526|58909825|FG000|Overall Study|Protocol Violation|1|||
30878587|NCT01917526|58909826|FG001|Overall Study|Protocol Violation|1|||
30878588|NCT01948258|58909832|FG000|Overall Study|Pregnancy|41|||
30878589|NCT01948258|58909832|FG000|Overall Study|Did not complete by cut-off date|35|||
30878590|NCT01948258|58909832|FG000|Overall Study|Lost to Follow-up|27|||
30878591|NCT01948258|58909832|FG000|Overall Study|Withdrawal by SPD|8|||
30878592|NCT01948258|58909832|FG000|Overall Study|Withdrawal by Subject|6|||
30878593|NCT01948258|58909832|FG000|Overall Study|Health Care Professional|43|||
30878594|NCT01948258|58909832|FG000|Overall Study|Removed from statistical analysis|2|||
30878595|NCT01916980|58909838|FG000|Overall Study|Adverse Event|4|||
30878596|NCT01916980|58909839|FG001|Overall Study|Adverse Event|2|||
30878597|NCT01916980|58909838|FG000|Overall Study|Lack of Efficacy|2|||
30878598|NCT01916980|58909839|FG001|Overall Study|Lack of Efficacy|2|||
30878599|NCT01916980|58909838|FG000|Overall Study|Withdrawal by Subject|1|||
30878600|NCT01916980|58909839|FG001|Overall Study|Withdrawal by Subject|0|||
30878601|NCT05940077|58909845|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
30878602|NCT05011513|58909859|FG000|Overall Study|Death|0|||
30878603|NCT05011513|58909860|FG001|Overall Study|Death|1|||
30878604|NCT05011513|58909859|FG000|Overall Study|Lost to Follow-up|4|||
30878605|NCT05011513|58909860|FG001|Overall Study|Lost to Follow-up|0|||
30878606|NCT05011513|58909859|FG000|Overall Study|Withdrawal by Subject|18|||
30878607|NCT05011513|58909860|FG001|Overall Study|Withdrawal by Subject|17|||
30878608|NCT05011513|58909859|FG000|Overall Study|Other|4|||
30878609|NCT05011513|58909860|FG001|Overall Study|Other|2|||
30878610|NCT04750239|58909866|FG000|Overall Study|Withdrawal by Subject|2|||
30878611|NCT04750239|58909866|FG000|Overall Study|Trial terminated by sponsor|1|||
30878612|NCT04668209|58909873|FG000|Overall Study|Withdrawal by Subject|2|||
30878613|NCT04668209|58909874|FG001|Overall Study|Withdrawal by Subject|2|||
30878614|NCT04668209|58909873|FG000|Overall Study|Lost to Follow-up|3|||
30878615|NCT04668209|58909874|FG001|Overall Study|Lost to Follow-up|4|||
30878616|NCT04668209|58909873|FG000|Overall Study|Subject Expired|2|||
30878617|NCT04668209|58909874|FG001|Overall Study|Subject Expired|0|||
30878618|NCT04668209|58909873|FG000|Overall Study|Withdrawn from study|0|||
30878619|NCT04668209|58909874|FG001|Overall Study|Withdrawn from study|1|||
30878620|NCT04668209|58909873|FG000|Overall Study|Adverse Event|0|||
30878621|NCT04668209|58909874|FG001|Overall Study|Adverse Event|1|||
30878622|NCT04590248|58909880|FG000|Overall Study|Lost to Follow-up|1|||
30878623|NCT04590248|58909880|FG000|Overall Study|Withdrawal by Subject|16|||
30878624|NCT04590248|58909880|FG000|Overall Study|Other|2|||
30878625|NCT04560816|58909884|FG000|Overall Study|Withdrawal by Subject|1|||
30878626|NCT04560816|58909885|FG001|Overall Study|Withdrawal by Subject|1|||
30878627|NCT04560816|58909886|FG002|Overall Study|Withdrawal by Subject|1|||
30878628|NCT04560816|58909887|FG003|Overall Study|Withdrawal by Subject|0|||
30878629|NCT04560816|58909888|FG004|Overall Study|Withdrawal by Subject|3|||
30878630|NCT04560816|58909889|FG005|Overall Study|Withdrawal by Subject|0|||
30878631|NCT04560816|58909884|FG000|Overall Study|Lost to Follow-up|1|||
30878632|NCT04560816|58909885|FG001|Overall Study|Lost to Follow-up|0|||
30878633|NCT04560816|58909886|FG002|Overall Study|Lost to Follow-up|0|||
30878634|NCT04560816|58909887|FG003|Overall Study|Lost to Follow-up|0|||
30878635|NCT04560816|58909888|FG004|Overall Study|Lost to Follow-up|0|||
30878636|NCT04560816|58909889|FG005|Overall Study|Lost to Follow-up|0|||
30878637|NCT04560816|58909884|FG000|Overall Study|Protocol Violation|1|||
30878638|NCT04560816|58909885|FG001|Overall Study|Protocol Violation|0|||
30878639|NCT04560816|58909886|FG002|Overall Study|Protocol Violation|0|||
30878640|NCT04560816|58909887|FG003|Overall Study|Protocol Violation|0|||
30878641|NCT04560816|58909888|FG004|Overall Study|Protocol Violation|0|||
30878642|NCT04560816|58909889|FG005|Overall Study|Protocol Violation|0|||
30878643|NCT04092582|58909903|FG000|Overall Study|Death|1|||
30878644|NCT04092582|58909904|FG001|Overall Study|Death|1|||
30878645|NCT04092582|58909903|FG000|Overall Study|Withdrawal by Subject|4|||
30878646|NCT04092582|58909904|FG001|Overall Study|Withdrawal by Subject|1|||
30948402|NCT01729819|58994257|FG001|Overall Study|Other reason|0|||
30608397|NCT01288430|58619226|FG005|Part 1|Clinical disease progression|2|||
30878647|NCT04092582|58909903|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
30878648|NCT04092582|58909904|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
30878649|NCT03636256|58909953|FG000|Overall Study|Lost to Follow-up|3|||
30878650|NCT03636256|58909954|FG001|Overall Study|Lost to Follow-up|0|||
30878651|NCT03636256|58909955|FG002|Overall Study|Lost to Follow-up|2|||
30878652|NCT03636256|58909956|FG003|Overall Study|Lost to Follow-up|1|||
30878653|NCT03636256|58909957|FG004|Overall Study|Lost to Follow-up|0|||
30878654|NCT03636256|58909958|FG005|Overall Study|Lost to Follow-up|4|||
30878655|NCT03636256|58909959|FG006|Overall Study|Lost to Follow-up|2|||
30878656|NCT03636256|58909960|FG007|Overall Study|Lost to Follow-up|0|||
30878657|NCT03636256|58909961|FG008|Overall Study|Lost to Follow-up|4|||
30878658|NCT03636256|58909953|FG000|Overall Study|Withdrawal by Subject|0|||
30878659|NCT03636256|58909954|FG001|Overall Study|Withdrawal by Subject|0|||
30878660|NCT03636256|58909955|FG002|Overall Study|Withdrawal by Subject|0|||
30878661|NCT03636256|58909956|FG003|Overall Study|Withdrawal by Subject|0|||
30878662|NCT03636256|58909957|FG004|Overall Study|Withdrawal by Subject|0|||
30878663|NCT03636256|58909958|FG005|Overall Study|Withdrawal by Subject|0|||
30878664|NCT03636256|58909959|FG006|Overall Study|Withdrawal by Subject|0|||
30878665|NCT03636256|58909960|FG007|Overall Study|Withdrawal by Subject|0|||
30878666|NCT03636256|58909961|FG008|Overall Study|Withdrawal by Subject|1|||
30878667|NCT03614676|58909992|FG000|Overall Study|Delivery before planned visit|2|||
30878668|NCT03614676|58909993|FG001|Overall Study|Delivery before planned visit|0|||
30878669|NCT03614676|58909992|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
30878670|NCT03614676|58909993|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
30878671|NCT03614676|58909992|FG000|Overall Study|Migrated / moved from the study area|30|||
30878672|NCT03614676|58909993|FG001|Overall Study|Migrated / moved from the study area|22|||
30878673|NCT03614676|58909992|FG000|Overall Study|Lost to Follow-up|17|||
30878674|NCT03614676|58909993|FG001|Overall Study|Lost to Follow-up|42|||
30878675|NCT03614676|58909992|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
30878676|NCT03614676|58909993|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
30878677|NCT03614676|58909992|FG000|Overall Study|Other|16|||
30878678|NCT03614676|58909993|FG001|Overall Study|Other|47|||
30878679|NCT03614676|58909992|FG000|Overall Study|Protocol Violation|0|||
30878680|NCT03614676|58909993|FG001|Overall Study|Protocol Violation|2|||
30878681|NCT03614676|58909992|FG000|Overall Study|Neonatal event of interest|0|||
30878682|NCT03614676|58909993|FG001|Overall Study|Neonatal event of interest|6|||
30878683|NCT03614676|58909992|FG000|Overall Study|Death in infant greater than 28 days old|0|||
30878684|NCT03614676|58909993|FG001|Overall Study|Death in infant greater than 28 days old|12|||
30878685|NCT03614676|58909992|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
30878686|NCT03614676|58909993|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
30878687|NCT02937818|58910007|FG000|Overall Study|Participants decision|1|||
30878688|NCT02937818|58910008|FG001|Overall Study|Participants decision|0|||
30878689|NCT02937818|58910009|FG002|Overall Study|Participants decision|1|||
30878690|NCT02937818|58910010|FG003|Overall Study|Participants decision|1|||
30878691|NCT02937818|58910007|FG000|Overall Study|Adverse Event|2|||
30878692|NCT02937818|58910008|FG001|Overall Study|Adverse Event|4|||
30878693|NCT02937818|58910009|FG002|Overall Study|Adverse Event|1|||
30878694|NCT02937818|58910010|FG003|Overall Study|Adverse Event|1|||
30878695|NCT02937818|58910007|FG000|Overall Study|Disease progression|17|||
30878696|NCT02937818|58910008|FG001|Overall Study|Disease progression|14|||
30878697|NCT02937818|58910009|FG002|Overall Study|Disease progression|7|||
30878698|NCT02937818|58910010|FG003|Overall Study|Disease progression|18|||
30878699|NCT02937818|58910007|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1|||
30878700|NCT02937818|58910008|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2|||
30878701|NCT02937818|58910009|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
30878702|NCT02937818|58910010|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
30878703|NCT02937818|58910007|FG000|Overall Study|Condition under investigation worsened|0|||
30878704|NCT02937818|58910008|FG001|Overall Study|Condition under investigation worsened|0|||
30878705|NCT02937818|58910009|FG002|Overall Study|Condition under investigation worsened|1|||
30878706|NCT02937818|58910010|FG003|Overall Study|Condition under investigation worsened|0|||
30878707|NCT02937818|58910007|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
30878708|NCT02937818|58910008|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
30878709|NCT02937818|58910009|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
30878710|NCT02937818|58910010|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1|||
30878711|NCT02727478|58910025|FG000|Overall Study|Withdrawal by Subject|8|||
30878712|NCT02727478|58910026|FG001|Overall Study|Withdrawal by Subject|10|||
30878713|NCT02614794|58910034|FG000|Overall Study|Death|258|||
30878714|NCT02614794|58910035|FG001|Overall Study|Death|151|||
30760589|NCT03381274|58769073|FG003|Overall Study|Lost to Follow-up|1|||
30878715|NCT02614794|58910034|FG000|Overall Study|Study closure by Sponsor|119|||
30878716|NCT02614794|58910035|FG001|Overall Study|Study closure by Sponsor|45|||
30878717|NCT02614794|58910034|FG000|Overall Study|Withdrawal by Subject|24|||
30878718|NCT02614794|58910035|FG001|Overall Study|Withdrawal by Subject|5|||
30878719|NCT02614794|58910034|FG000|Overall Study|Lost to Follow-up|7|||
30878720|NCT02614794|58910035|FG001|Overall Study|Lost to Follow-up|0|||
30878721|NCT02614794|58910034|FG000|Overall Study|Physician Decision|1|||
30878722|NCT02614794|58910035|FG001|Overall Study|Physician Decision|1|||
30878723|NCT02614794|58910034|FG000|Overall Study|Hospital closure|1|||
30878724|NCT02614794|58910035|FG001|Overall Study|Hospital closure|0|||
30878725|NCT02361944|58910043|FG000|Overall Study|surgery cancellation|0|||
30878726|NCT02361944|58910044|FG001|Overall Study|surgery cancellation|1|||
30878727|NCT01649232|58910057|FG000|Overall Study|Physician Decision|2|||
30878728|NCT01649232|58910058|FG001|Overall Study|Physician Decision|0|||
30878729|NCT00955968|58910072|FG000|Overall Study|Death|2|||
30878730|NCT00955968|58910073|FG001|Overall Study|Death|4|||
30878731|NCT00955968|58910072|FG000|Overall Study|Withdrawal by Subject|35|||
30878732|NCT00955968|58910073|FG001|Overall Study|Withdrawal by Subject|31|||
30878733|NCT00955968|58910072|FG000|Overall Study|Lost to Follow-up|45|||
30878734|NCT00955968|58910073|FG001|Overall Study|Lost to Follow-up|39|||
30878735|NCT00955968|58910072|FG000|Overall Study|Site closed|55|||
30878736|NCT00955968|58910073|FG001|Overall Study|Site closed|52|||
30878737|NCT05062759|58910097|FG000|Overall Study|Death|0|||
30878738|NCT05062759|58910098|FG001|Overall Study|Death|1|||
30878739|NCT05062759|58910097|FG000|Overall Study|Lost to Follow-up|1|||
30878740|NCT05062759|58910098|FG001|Overall Study|Lost to Follow-up|0|||
30878741|NCT05033262|58910117|FG000|Overall Study|Lost to Follow-up|1|||
30878742|NCT05033262|58910118|FG001|Overall Study|Lost to Follow-up|0|||
30878743|NCT05033262|58910119|FG002|Overall Study|Lost to Follow-up|0|||
30878744|NCT05033262|58910120|FG003|Overall Study|Lost to Follow-up|1|||
30878745|NCT04963062|58910134|FG000|Overall Study|withdrew by the study team|4|||
30878746|NCT04963062|58910135|FG001|Overall Study|withdrew by the study team|2|||
30878747|NCT04900220|58910147|FG000|Overall Study|Lost to Follow-up|1|||
30878748|NCT04900220|58910148|FG001|Overall Study|Lost to Follow-up|1|||
30878749|NCT04599062|58910160|FG000|Overall Study|Physician Decision|1|||
30878750|NCT04599062|58910161|FG001|Overall Study|Physician Decision|0|||
30878751|NCT04585815|58910169|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
30878752|NCT04585815|58910170|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
30878753|NCT04585815|58910169|FG000|Sub-study A- Treatment Phase|Death|0|||
30878754|NCT04585815|58910170|FG001|Sub-study A- Treatment Phase|Death|1|||
30878755|NCT04585815|58910169|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
30878756|NCT04585815|58910170|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
30878757|NCT04585815|58910169|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
30878758|NCT04585815|58910170|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
30878759|NCT04585815|58910169|FG000|Sub-study A- Treatment Phase|Other|1|||
30878760|NCT04585815|58910170|FG001|Sub-study A- Treatment Phase|Other|0|||
30878761|NCT04585815|58910169|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
30878762|NCT04585815|58910170|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
30878763|NCT04585815|58910169|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
30878764|NCT04585815|58910170|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
30878765|NCT04537208|58910189|FG000|Overall Study|Adverse Event|0|||
30878766|NCT04537208|58910190|FG001|Overall Study|Adverse Event|0|||
30878767|NCT04537208|58910191|FG002|Overall Study|Adverse Event|0|||
30878768|NCT04537208|58910192|FG003|Overall Study|Adverse Event|0|||
30878769|NCT04537208|58910193|FG004|Overall Study|Adverse Event|0|||
30878770|NCT04537208|58910194|FG005|Overall Study|Adverse Event|0|||
30878771|NCT04537208|58910195|FG006|Overall Study|Adverse Event|0|||
30878772|NCT04537208|58910196|FG007|Overall Study|Adverse Event|0|||
30878773|NCT04537208|58910197|FG008|Overall Study|Adverse Event|1|||
30878774|NCT04537208|58910198|FG009|Overall Study|Adverse Event|0|||
30878775|NCT04537208|58910199|FG010|Overall Study|Adverse Event|0|||
30878776|NCT04537208|58910189|FG000|Overall Study|Protocol deviation|0|||
30878777|NCT04537208|58910190|FG001|Overall Study|Protocol deviation|0|||
30878778|NCT04537208|58910191|FG002|Overall Study|Protocol deviation|2|||
30878779|NCT04537208|58910192|FG003|Overall Study|Protocol deviation|0|||
30878780|NCT04537208|58910193|FG004|Overall Study|Protocol deviation|0|||
30878781|NCT04537208|58910194|FG005|Overall Study|Protocol deviation|2|||
30878782|NCT04537208|58910195|FG006|Overall Study|Protocol deviation|4|||
30878783|NCT04537208|58910196|FG007|Overall Study|Protocol deviation|0|||
30878784|NCT04537208|58910197|FG008|Overall Study|Protocol deviation|1|||
30878785|NCT04537208|58910198|FG009|Overall Study|Protocol deviation|0|||
30878786|NCT04537208|58910199|FG010|Overall Study|Protocol deviation|2|||
30878787|NCT04537208|58910189|FG000|Overall Study|Withdrawal by Subject|4|||
30878788|NCT04537208|58910190|FG001|Overall Study|Withdrawal by Subject|2|||
30878789|NCT04537208|58910191|FG002|Overall Study|Withdrawal by Subject|1|||
30878790|NCT04537208|58910192|FG003|Overall Study|Withdrawal by Subject|3|||
30878791|NCT04537208|58910193|FG004|Overall Study|Withdrawal by Subject|5|||
30878792|NCT04537208|58910194|FG005|Overall Study|Withdrawal by Subject|1|||
30878793|NCT04537208|58910195|FG006|Overall Study|Withdrawal by Subject|6|||
30878794|NCT04537208|58910196|FG007|Overall Study|Withdrawal by Subject|1|||
30878795|NCT04537208|58910197|FG008|Overall Study|Withdrawal by Subject|7|||
30878796|NCT04537208|58910198|FG009|Overall Study|Withdrawal by Subject|2|||
30878797|NCT04537208|58910199|FG010|Overall Study|Withdrawal by Subject|4|||
30878798|NCT04537208|58910189|FG000|Overall Study|Lost to Follow-up|4|||
30878799|NCT04537208|58910190|FG001|Overall Study|Lost to Follow-up|1|||
30878800|NCT04537208|58910191|FG002|Overall Study|Lost to Follow-up|3|||
30878801|NCT04537208|58910192|FG003|Overall Study|Lost to Follow-up|4|||
30878802|NCT04537208|58910193|FG004|Overall Study|Lost to Follow-up|3|||
30878803|NCT04537208|58910194|FG005|Overall Study|Lost to Follow-up|2|||
30878804|NCT04537208|58910195|FG006|Overall Study|Lost to Follow-up|3|||
30878805|NCT04537208|58910196|FG007|Overall Study|Lost to Follow-up|2|||
30878806|NCT04537208|58910197|FG008|Overall Study|Lost to Follow-up|7|||
30878807|NCT04537208|58910198|FG009|Overall Study|Lost to Follow-up|2|||
30878808|NCT04537208|58910199|FG010|Overall Study|Lost to Follow-up|2|||
30878809|NCT04502433|58910228|FG000|Overall Study|Death|2|||
30878810|NCT04502433|58910229|FG001|Overall Study|Death|4|||
30878811|NCT04502433|58910228|FG000|Overall Study|Lost to Follow-up|1|||
30878812|NCT04502433|58910229|FG001|Overall Study|Lost to Follow-up|0|||
30878813|NCT04502433|58910228|FG000|Overall Study|Physician Decision|0|||
30878814|NCT04502433|58910229|FG001|Overall Study|Physician Decision|1|||
30878815|NCT04442503|58910237|FG000|Overall Study|Adverse Event|1|||
30878816|NCT04442503|58910238|FG001|Overall Study|Adverse Event|1|||
30878817|NCT04442503|58910237|FG000|Overall Study|Lost to Follow-up|8|||
30878818|NCT04442503|58910238|FG001|Overall Study|Lost to Follow-up|6|||
30878819|NCT04442503|58910237|FG000|Overall Study|Physician Decision|0|||
30878820|NCT04442503|58910238|FG001|Overall Study|Physician Decision|2|||
30878821|NCT04442503|58910237|FG000|Overall Study|Withdrawal by Subject|3|||
30878822|NCT04442503|58910238|FG001|Overall Study|Withdrawal by Subject|4|||
30878823|NCT04442503|58910237|FG000|Overall Study|Reason not Specified|0|||
30878824|NCT04442503|58910238|FG001|Overall Study|Reason not Specified|1|||
30878825|NCT04442503|58910237|FG000|Overall Study|Randomized but not Treated|3|||
30878826|NCT04442503|58910238|FG001|Overall Study|Randomized but not Treated|1|||
30878827|NCT04411914|58910246|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
30878828|NCT04411914|58910247|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
30878829|NCT04389671|58910266|FG000|Overall Study|Death|7|||
30878830|NCT04381494|58910270|FG000|Overall Study|Early termination of trial|19|||
30878831|NCT04381494|58910270|FG000|Overall Study|Investigator's discretion|1|||
30878832|NCT04381494|58910270|FG000|Overall Study|Withdrawal by Subject|9|||
30878833|NCT04381494|58910270|FG000|Overall Study|NSCLC disease progression|4|||
30878834|NCT04381494|58910270|FG000|Overall Study|Device-Related Adverse Event|2|||
30878835|NCT04094584|58910325|FG000|Overall Study|No interest in study|88|||
30878836|NCT04094584|58910325|FG000|Overall Study|Unwilling to undergo screening tests|36|||
30878837|NCT04094584|58910325|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
30878838|NCT04094584|58910325|FG000|Overall Study|Opioid use|7|||
30878839|NCT04094584|58910325|FG000|Overall Study|Need for major surgery in study period|4|||
30878840|NCT04094584|58910325|FG000|Overall Study|eligible but declined enrollment|4|||
30878841|NCT04094584|58910325|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
30878842|NCT04094584|58910325|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
30878843|NCT04094584|58910325|FG000|Overall Study|Lost to Follow-up|3|||
30878844|NCT04094584|58910325|FG000|Overall Study|Withdrawal by Subject|2|||
30878845|NCT04021290|58910340|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
30878846|NCT04021290|58910341|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
30878847|NCT04021290|58910342|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
30878848|NCT04021290|58910340|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
30878849|NCT04021290|58910341|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
30878850|NCT04021290|58910342|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
30878851|NCT04021290|58910340|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
30878852|NCT04021290|58910341|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
30878853|NCT04021290|58910342|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
30878854|NCT04021290|58910340|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
30878855|NCT04021290|58910341|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
30878856|NCT04021290|58910342|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
30878857|NCT04021290|58910340|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
30878858|NCT04021290|58910341|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
30878859|NCT04021290|58910342|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
30878860|NCT04021290|58910340|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
30878861|NCT04021290|58910341|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
30878862|NCT04021290|58910342|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
30878863|NCT04021290|58910340|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
30878864|NCT04021290|58910341|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
30878865|NCT04021290|58910342|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
30948403|NCT01729819|58994256|FG000|Overall Study|Protocol Violation|0|||
30878866|NCT04021290|58910340|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
30878867|NCT04021290|58910341|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
30878868|NCT04021290|58910342|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
30878869|NCT04021290|58910340|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
30878870|NCT04021290|58910341|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
30878871|NCT04021290|58910342|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
30878872|NCT04021290|58910340|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
30878873|NCT04021290|58910341|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
30878874|NCT04021290|58910342|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
30878875|NCT04021290|58910340|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
30878876|NCT04021290|58910341|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
30878877|NCT04021290|58910342|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
30878878|NCT04021290|58910340|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
30878879|NCT04021290|58910341|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
30878880|NCT04021290|58910342|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
30878881|NCT04020341|58910352|FG000|Overall Study|Adverse Event|8|||
30878882|NCT04020341|58910353|FG001|Overall Study|Adverse Event|6|||
30878883|NCT04020341|58910352|FG000|Overall Study|Lost to Follow-up|8|||
30878884|NCT04020341|58910353|FG001|Overall Study|Lost to Follow-up|2|||
30878885|NCT04020341|58910352|FG000|Overall Study|Withdrawal by Subject|16|||
30878886|NCT04020341|58910353|FG001|Overall Study|Withdrawal by Subject|16|||
30878887|NCT04020341|58910352|FG000|Overall Study|Participant not able to swallow the tablet|1|||
30878888|NCT04020341|58910353|FG001|Overall Study|Participant not able to swallow the tablet|0|||
30878889|NCT04020341|58910352|FG000|Overall Study|Physician Decision|0|||
30878890|NCT04020341|58910353|FG001|Overall Study|Physician Decision|2|||
30878891|NCT04020341|58910352|FG000|Overall Study|Protocol Deviation|0|||
30878892|NCT04020341|58910353|FG001|Overall Study|Protocol Deviation|2|||
30878893|NCT03868891|58910375|FG000|Overall Study|Adverse Event|1|||
30878894|NCT03868891|58910376|FG001|Overall Study|Adverse Event|0|||
30878895|NCT03868891|58910375|FG000|Overall Study|Lost to Follow-up|2|||
30878896|NCT03868891|58910376|FG001|Overall Study|Lost to Follow-up|1|||
30878897|NCT03868891|58910375|FG000|Overall Study|COVID-19 Restrictions|1|||
30878898|NCT03868891|58910376|FG001|Overall Study|COVID-19 Restrictions|2|||
30878899|NCT03827655|58910421|FG000|Overall Study|Death|0|||
30878900|NCT03827655|58910422|FG001|Overall Study|Death|0|||
30878901|NCT03827655|58910423|FG002|Overall Study|Death|0|||
30878902|NCT03827655|58910424|FG003|Overall Study|Death|0|||
30878903|NCT03827655|58910425|FG004|Overall Study|Death|1|||
30878904|NCT03827655|58910421|FG000|Overall Study|Protocol Deviation|1|||
30878905|NCT03827655|58910422|FG001|Overall Study|Protocol Deviation|0|||
30878906|NCT03827655|58910423|FG002|Overall Study|Protocol Deviation|1|||
30878907|NCT03827655|58910424|FG003|Overall Study|Protocol Deviation|1|||
30878908|NCT03827655|58910425|FG004|Overall Study|Protocol Deviation|0|||
30878909|NCT03827655|58910421|FG000|Overall Study|Withdrawal by Subject|3|||
30878910|NCT03827655|58910422|FG001|Overall Study|Withdrawal by Subject|2|||
30878911|NCT03827655|58910423|FG002|Overall Study|Withdrawal by Subject|2|||
30878912|NCT03827655|58910424|FG003|Overall Study|Withdrawal by Subject|0|||
30878913|NCT03827655|58910425|FG004|Overall Study|Withdrawal by Subject|1|||
30878914|NCT03827655|58910421|FG000|Overall Study|Reason not Specified|3|||
30878915|NCT03827655|58910422|FG001|Overall Study|Reason not Specified|1|||
30878916|NCT03827655|58910423|FG002|Overall Study|Reason not Specified|1|||
30878917|NCT03827655|58910424|FG003|Overall Study|Reason not Specified|1|||
30878918|NCT03827655|58910425|FG004|Overall Study|Reason not Specified|1|||
30878919|NCT03782064|58910460|FG000|Overall Study|Lack of Efficacy|2|||
30878920|NCT03782064|58910460|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
30878921|NCT03772522|58910466|FG000|Pre-intervention|Withdrawal by Subject|3|||
30878922|NCT03772522|58910467|FG001|Pre-intervention|Withdrawal by Subject|4|||
30878923|NCT03772522|58910466|FG000|Intervention|Withdrawal by Subject|1|||
30878924|NCT03772522|58910467|FG001|Intervention|Withdrawal by Subject|0|||
30878925|NCT03772522|58910466|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
30878926|NCT03772522|58910467|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
30878927|NCT03755518|58910477|FG000|Overall Study|Adverse Event|6|||
30878928|NCT03755518|58910477|FG000|Overall Study|Lack of Efficacy|6|||
30878929|NCT03755518|58910477|FG000|Overall Study|Bone Marrow Transplant|4|||
30878930|NCT03755518|58910477|FG000|Overall Study|Withdrawal by participant|4|||
30878931|NCT03755518|58910477|FG000|Overall Study|Progressive Disease|2|||
30878932|NCT03755518|58910477|FG000|Overall Study|Death|1|||
30878933|NCT03755518|58910477|FG000|Overall Study|Physician Decision|1|||
30878934|NCT03755518|58910477|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
30878935|NCT03739112|58910483|FG000|Overall Study|Adverse Event|2|||
30878936|NCT03739112|58910484|FG001|Overall Study|Adverse Event|2|||
30878937|NCT03739112|58910483|FG000|Overall Study|Withdrawal by Subject|38|||
30878938|NCT03739112|58910484|FG001|Overall Study|Withdrawal by Subject|19|||
30878939|NCT03739112|58910483|FG000|Overall Study|Lost to Follow-up|31|||
30878940|NCT03739112|58910484|FG001|Overall Study|Lost to Follow-up|33|||
30878941|NCT03739112|58910483|FG000|Overall Study|Protocol Deviation|12|||
30878942|NCT03739112|58910484|FG001|Overall Study|Protocol Deviation|9|||
30878943|NCT03739112|58910483|FG000|Overall Study|Physician Decision|1|||
30878944|NCT03739112|58910484|FG001|Overall Study|Physician Decision|0|||
30878945|NCT03739112|58910483|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
30878946|NCT03739112|58910484|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
30878947|NCT03739112|58910483|FG000|Overall Study|Site went on hold|65|||
30878948|NCT03739112|58910484|FG001|Overall Study|Site went on hold|67|||
30878949|NCT03739112|58910483|FG000|Overall Study|Other than specified|8|||
30878950|NCT03739112|58910484|FG001|Overall Study|Other than specified|5|||
30878951|NCT03739112|58910483|FG000|Overall Study|Randomized but not vaccinated|31|||
30878952|NCT03739112|58910484|FG001|Overall Study|Randomized but not vaccinated|25|||
30878953|NCT03622593|58910493|FG000|Overall Study|Withdrawal by Subject|11|||
30878954|NCT03622593|58910494|FG001|Overall Study|Withdrawal by Subject|9|||
30878955|NCT03622593|58910495|FG002|Overall Study|Withdrawal by Subject|13|||
30878956|NCT03622593|58910493|FG000|Overall Study|Death|12|||
30878957|NCT03622593|58910494|FG001|Overall Study|Death|9|||
30878958|NCT03622593|58910495|FG002|Overall Study|Death|10|||
30878959|NCT03622593|58910493|FG000|Overall Study|Lost to Follow-up|11|||
30878960|NCT03622593|58910494|FG001|Overall Study|Lost to Follow-up|5|||
30878961|NCT03622593|58910495|FG002|Overall Study|Lost to Follow-up|8|||
30878962|NCT03622593|58910493|FG000|Overall Study|Adverse Event|4|||
30878963|NCT03622593|58910494|FG001|Overall Study|Adverse Event|5|||
30878964|NCT03622593|58910495|FG002|Overall Study|Adverse Event|6|||
30878965|NCT03622593|58910493|FG000|Overall Study|Physician Decision|2|||
30878966|NCT03622593|58910494|FG001|Overall Study|Physician Decision|1|||
30878967|NCT03622593|58910495|FG002|Overall Study|Physician Decision|6|||
30878968|NCT03622593|58910493|FG000|Overall Study|Other|2|||
30878969|NCT03622593|58910494|FG001|Overall Study|Other|2|||
30878970|NCT03622593|58910495|FG002|Overall Study|Other|3|||
30878971|NCT03622593|58910493|FG000|Overall Study|Protocol Violation|0|||
30878972|NCT03622593|58910494|FG001|Overall Study|Protocol Violation|0|||
30878973|NCT03622593|58910495|FG002|Overall Study|Protocol Violation|1|||
30878974|NCT03622593|58910493|FG000|Overall Study|Pregnancy|0|||
30878975|NCT03622593|58910494|FG001|Overall Study|Pregnancy|0|||
30878976|NCT03622593|58910495|FG002|Overall Study|Pregnancy|1|||
30878977|NCT03593655|58910506|FG000|First Product Use Period|Withdrawal by Subject|1|||
30878978|NCT03593655|58910507|FG001|First Product Use Period|Withdrawal by Subject|1|||
30878979|NCT03593655|58910506|FG000|First Product Use Period|Lost to Follow-up|1|||
30878980|NCT03593655|58910507|FG001|First Product Use Period|Lost to Follow-up|3|||
30878981|NCT03593655|58910506|FG000|Second Product Use Period|Withdrawal by Subject|1|||
30878982|NCT03593655|58910507|FG001|Second Product Use Period|Withdrawal by Subject|1|||
30878983|NCT03593655|58910506|FG000|Second Product Use Period|Lost to Follow-up|1|||
30878984|NCT03593655|58910507|FG001|Second Product Use Period|Lost to Follow-up|0|||
30878985|NCT03593655|58910506|FG000|Third Product Use Period|Lost to Follow-up|1|||
30878986|NCT03593655|58910507|FG001|Third Product Use Period|Lost to Follow-up|2|||
30878987|NCT03593655|58910506|FG000|Third Product Use Period|Physician Decision|0|||
30878988|NCT03593655|58910507|FG001|Third Product Use Period|Physician Decision|1|||
30878989|NCT03593655|58910506|FG000|Third Product Use Period|Withdrawal by Subject|0|||
30878990|NCT03593655|58910507|FG001|Third Product Use Period|Withdrawal by Subject|1|||
30878991|NCT03577106|58910516|FG000|Overall Study|Withdrawal by Subject|3|||
30878992|NCT03534180|58910520|FG000|Overall Study|Withdrawal by Subject|1|||
30878993|NCT03364231|58910530|FG000|Overall Study|Adverse Event|1|||
30878994|NCT03364231|58910531|FG001|Overall Study|Adverse Event|4|||
30878995|NCT03364231|58910530|FG000|Overall Study|Death|1|||
30878996|NCT03364231|58910531|FG001|Overall Study|Death|0|||
30878997|NCT03364231|58910530|FG000|Overall Study|Investigator Decision|2|||
30878998|NCT03364231|58910531|FG001|Overall Study|Investigator Decision|2|||
30878999|NCT03364231|58910530|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
30879000|NCT03364231|58910531|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
30879001|NCT03364231|58910530|FG000|Overall Study|Withdrawal of Subject Consent|1|||
30879002|NCT03364231|58910531|FG001|Overall Study|Withdrawal of Subject Consent|0|||
30879003|NCT03364231|58910530|FG000|Overall Study|Reason Not Specified|1|||
30879004|NCT03364231|58910531|FG001|Overall Study|Reason Not Specified|0|||
30879005|NCT03364231|58910530|FG000|Overall Study|Disease Progression|0|||
30879006|NCT03364231|58910531|FG001|Overall Study|Disease Progression|6|||
30879007|NCT03303625|58910542|FG000|Overall Study|Withdrawal by Subject|2|||
30879008|NCT03303625|58910543|FG001|Overall Study|Withdrawal by Subject|0|||
30879009|NCT03303625|58910544|FG002|Overall Study|Withdrawal by Subject|0|||
30879010|NCT03303625|58910545|FG003|Overall Study|Withdrawal by Subject|0|||
30879011|NCT03299816|58910557|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
30879012|NCT03299816|58910558|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
30879013|NCT03299816|58910557|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
30879014|NCT03299816|58910558|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
30879015|NCT03299816|58910557|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
30879016|NCT03299816|58910558|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
30879017|NCT03291431|58910566|FG000|Overall Study|Protocol Violation|2|||
30879018|NCT03291431|58910567|FG001|Overall Study|Protocol Violation|1|||
30879019|NCT03291431|58910566|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
30879020|NCT03291431|58910567|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
30879021|NCT03291431|58910566|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
30879022|NCT03291431|58910567|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
30879023|NCT03288493|58910580|FG000|Overall Study|Withdrawal by Subject|4|||
30879024|NCT03288493|58910581|FG001|Overall Study|Withdrawal by Subject|0|||
30879025|NCT03288493|58910582|FG002|Overall Study|Withdrawal by Subject|0|||
30879026|NCT03288493|58910583|FG003|Overall Study|Withdrawal by Subject|0|||
30879027|NCT03288493|58910584|FG004|Overall Study|Withdrawal by Subject|0|||
30879028|NCT03288493|58910585|FG005|Overall Study|Withdrawal by Subject|2|||
30879029|NCT03288493|58910586|FG006|Overall Study|Withdrawal by Subject|0|||
30879030|NCT03288493|58910580|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
30879031|NCT03288493|58910581|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
30879032|NCT03288493|58910582|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
30879033|NCT03288493|58910583|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
30879034|NCT03288493|58910584|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
30879035|NCT03288493|58910585|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
30879036|NCT03288493|58910586|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
30879037|NCT03288493|58910580|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
30879038|NCT03288493|58910581|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
30879039|NCT03288493|58910582|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
30879040|NCT03288493|58910583|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
30879041|NCT03288493|58910584|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
30879042|NCT03288493|58910585|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
30879043|NCT03288493|58910586|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
30879044|NCT03288493|58910580|FG000|Overall Study|Death|2|||
30879045|NCT03288493|58910581|FG001|Overall Study|Death|0|||
30879046|NCT03288493|58910582|FG002|Overall Study|Death|0|||
30879047|NCT03288493|58910583|FG003|Overall Study|Death|0|||
30879048|NCT03288493|58910584|FG004|Overall Study|Death|0|||
30879049|NCT03288493|58910585|FG005|Overall Study|Death|0|||
30879050|NCT03288493|58910586|FG006|Overall Study|Death|0|||
30879051|NCT03288493|58910580|FG000|Overall Study|other reason not listed above|2|||
30879052|NCT03288493|58910581|FG001|Overall Study|other reason not listed above|0|||
30879053|NCT03288493|58910582|FG002|Overall Study|other reason not listed above|0|||
30879054|NCT03288493|58910583|FG003|Overall Study|other reason not listed above|0|||
30879055|NCT03288493|58910584|FG004|Overall Study|other reason not listed above|0|||
30879056|NCT03288493|58910585|FG005|Overall Study|other reason not listed above|0|||
30879057|NCT03288493|58910586|FG006|Overall Study|other reason not listed above|0|||
30879058|NCT03238300|58910606|FG000|Baseline (Before Intervention)|Physician Decision|0|||
30879059|NCT03238300|58910607|FG001|Baseline (Before Intervention)|Physician Decision|1|||
30879060|NCT03238300|58910606|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
30879061|NCT03238300|58910607|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
30879062|NCT03238300|58910606|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
30879063|NCT03238300|58910607|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
30879064|NCT03238300|58910606|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
30879065|NCT03238300|58910607|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
30879066|NCT03235544|58910621|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
30879067|NCT03235544|58910622|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
30879068|NCT03235544|58910623|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
30879069|NCT03235544|58910624|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
30879070|NCT03235544|58910621|FG000|Overall Study|Death|11|||
30879071|NCT03235544|58910622|FG001|Overall Study|Death|23|||
30879072|NCT03235544|58910623|FG002|Overall Study|Death|11|||
30879073|NCT03235544|58910624|FG003|Overall Study|Death|20|||
30879074|NCT03235544|58910621|FG000|Overall Study|Lost to Follow-up|0|||
30879075|NCT03235544|58910622|FG001|Overall Study|Lost to Follow-up|1|||
30879076|NCT03235544|58910623|FG002|Overall Study|Lost to Follow-up|0|||
30608398|NCT01288430|58619227|FG006|Part 1|Clinical disease progression|2|||
30879077|NCT03235544|58910624|FG003|Overall Study|Lost to Follow-up|1|||
30879078|NCT03235544|58910621|FG000|Overall Study|Withdrawal by Participant|0|||
30879079|NCT03235544|58910622|FG001|Overall Study|Withdrawal by Participant|0|||
30879080|NCT03235544|58910623|FG002|Overall Study|Withdrawal by Participant|1|||
30879081|NCT03235544|58910624|FG003|Overall Study|Withdrawal by Participant|0|||
30879082|NCT03235544|58910621|FG000|Overall Study|Reason not Specified|0|||
30879083|NCT03235544|58910622|FG001|Overall Study|Reason not Specified|4|||
30879084|NCT03235544|58910623|FG002|Overall Study|Reason not Specified|0|||
30879085|NCT03235544|58910624|FG003|Overall Study|Reason not Specified|1|||
30879086|NCT03178045|58910637|FG000|Overall Study|Withdrawal by Subject|5|||
30879087|NCT03178045|58910638|FG001|Overall Study|Withdrawal by Subject|7|||
30879088|NCT03178045|58910637|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
30879089|NCT03178045|58910638|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
30879090|NCT03178045|58910637|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
30879091|NCT03178045|58910638|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
30879092|NCT03113500|58910662|FG000|Overall Study|Withdrawal by Subject|1|||
30879093|NCT02927301|58910681|FG000|Overall Study|Adverse Event|7|||
30879094|NCT02927301|58910681|FG000|Overall Study|Withdrawal by Subject|1|||
30879095|NCT02927301|58910681|FG000|Overall Study|Physician Decision|2|||
30879096|NCT02924727|58910687|FG000|Overall Study|Withdrawal by Subject|2|||
30879097|NCT02924727|58910688|FG001|Overall Study|Withdrawal by Subject|4|||
30879098|NCT02924727|58910687|FG000|Overall Study|Lost to Follow-up|2|||
30879099|NCT02924727|58910688|FG001|Overall Study|Lost to Follow-up|5|||
30879100|NCT02924727|58910687|FG000|Overall Study|Death|221|||
30879101|NCT02924727|58910688|FG001|Overall Study|Death|247|||
30879102|NCT02924727|58910687|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
30879103|NCT02924727|58910688|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
30879104|NCT02901626|58910698|FG000|Overall Study|Lost to Follow-up|1|||
30879105|NCT02901626|58910699|FG001|Overall Study|Lost to Follow-up|1|||
30879106|NCT02720692|58910738|FG000|Overall Study|Withdrawal by Subject|3|||
30879107|NCT02720692|58910739|FG001|Overall Study|Withdrawal by Subject|0|||
30879108|NCT02720692|58910738|FG000|Overall Study|Physician Decision|1|||
30879109|NCT02720692|58910739|FG001|Overall Study|Physician Decision|0|||
30879110|NCT02720692|58910738|FG000|Overall Study|Lost to Follow-up|8|||
30879111|NCT02720692|58910739|FG001|Overall Study|Lost to Follow-up|3|||
30879112|NCT02720692|58910738|FG000|Overall Study|Subject unable to return for visit|1|||
30879113|NCT02720692|58910739|FG001|Overall Study|Subject unable to return for visit|0|||
30879114|NCT02656303|58910748|FG000|Overall Study|Adverse Event|3|||
30879115|NCT02656303|58910749|FG001|Overall Study|Adverse Event|2|||
30879116|NCT02656303|58910750|FG002|Overall Study|Adverse Event|0|||
30879117|NCT02656303|58910748|FG000|Overall Study|Death|12|||
30879118|NCT02656303|58910749|FG001|Overall Study|Death|4|||
30879119|NCT02656303|58910750|FG002|Overall Study|Death|1|||
30879120|NCT02656303|58910748|FG000|Overall Study|Lack of Efficacy|1|||
30879121|NCT02656303|58910749|FG001|Overall Study|Lack of Efficacy|0|||
30879122|NCT02656303|58910750|FG002|Overall Study|Lack of Efficacy|0|||
30879123|NCT02656303|58910748|FG000|Overall Study|Non-Compliance with Study|1|||
30879124|NCT02656303|58910749|FG001|Overall Study|Non-Compliance with Study|1|||
30879125|NCT02656303|58910750|FG002|Overall Study|Non-Compliance with Study|0|||
30879126|NCT02656303|58910748|FG000|Overall Study|Investigator Decision|2|||
30879127|NCT02656303|58910749|FG001|Overall Study|Investigator Decision|1|||
30879128|NCT02656303|58910750|FG002|Overall Study|Investigator Decision|0|||
30879129|NCT02656303|58910748|FG000|Overall Study|Progressive Disease|25|||
30879130|NCT02656303|58910749|FG001|Overall Study|Progressive Disease|14|||
30879131|NCT02656303|58910750|FG002|Overall Study|Progressive Disease|10|||
30879132|NCT02656303|58910748|FG000|Overall Study|Study Terminated by Sponsor|20|||
30879133|NCT02656303|58910749|FG001|Overall Study|Study Terminated by Sponsor|7|||
30879134|NCT02656303|58910750|FG002|Overall Study|Study Terminated by Sponsor|5|||
30879135|NCT02656303|58910748|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
30879136|NCT02656303|58910749|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
30879137|NCT02656303|58910750|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
30879138|NCT02656303|58910748|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
30879139|NCT02656303|58910749|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
30879140|NCT02656303|58910750|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
30879141|NCT02656303|58910748|FG000|Overall Study|Reason not Specified|1|||
30879142|NCT02656303|58910749|FG001|Overall Study|Reason not Specified|1|||
30879143|NCT02656303|58910750|FG002|Overall Study|Reason not Specified|2|||
30879144|NCT02628626|58910760|FG000|Overall Study|Withdrawal by Subject|2|||
30879145|NCT02628626|58910761|FG001|Overall Study|Withdrawal by Subject|2|||
30879146|NCT02527707|58910793|FG000|Overall Study|Adverse Event|1|||
30879147|NCT02527707|58910793|FG000|Overall Study|Adverse Event|1|||
30879148|NCT02453191|58910804|FG000|Overall Study|Withdrawal by Subject|1|||
30879149|NCT02352090|58910812|FG000|Overall Study|general malaise|1|||
30879150|NCT02352090|58910813|FG001|Overall Study|general malaise|0|||
30879151|NCT02352090|58910814|FG002|Overall Study|general malaise|0|||
30948404|NCT01729819|58994257|FG001|Overall Study|Protocol Violation|1|||
30879152|NCT02352090|58910812|FG000|Overall Study|non-specified mild side-effects|0|||
30879153|NCT02352090|58910813|FG001|Overall Study|non-specified mild side-effects|0|||
30879154|NCT02352090|58910814|FG002|Overall Study|non-specified mild side-effects|2|||
30879155|NCT02135107|58910824|FG000|Treatment Period|Withdrawal by Subject|11|||
30879156|NCT02135107|58910825|FG001|Treatment Period|Withdrawal by Subject|0|||
30879157|NCT02135107|58910826|FG002|Treatment Period|Withdrawal by Subject|0|||
30879158|NCT02135107|58910827|FG003|Treatment Period|Withdrawal by Subject|0|||
30879159|NCT02135107|58910824|FG000|Treatment Period|Adverse Event|5|||
30879160|NCT02135107|58910825|FG001|Treatment Period|Adverse Event|2|||
30879161|NCT02135107|58910826|FG002|Treatment Period|Adverse Event|0|||
30879162|NCT02135107|58910827|FG003|Treatment Period|Adverse Event|0|||
30879163|NCT02135107|58910824|FG000|Treatment Period|Pregnancy|1|||
30879164|NCT02135107|58910825|FG001|Treatment Period|Pregnancy|0|||
30879165|NCT02135107|58910826|FG002|Treatment Period|Pregnancy|0|||
30879166|NCT02135107|58910827|FG003|Treatment Period|Pregnancy|0|||
30879167|NCT02135107|58910824|FG000|Treatment Period|Other|115|||
30879168|NCT02135107|58910825|FG001|Treatment Period|Other|24|||
30879169|NCT02135107|58910826|FG002|Treatment Period|Other|0|||
30879170|NCT02135107|58910827|FG003|Treatment Period|Other|0|||
30879171|NCT02135107|58910824|FG000|Maintenance Therapy Period|Adverse Event|0|||
30879172|NCT02135107|58910825|FG001|Maintenance Therapy Period|Adverse Event|0|||
30879173|NCT02135107|58910826|FG002|Maintenance Therapy Period|Adverse Event|3|||
30879174|NCT02135107|58910827|FG003|Maintenance Therapy Period|Adverse Event|7|||
30879175|NCT02135107|58910824|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
30879176|NCT02135107|58910825|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
30879177|NCT02135107|58910826|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
30879178|NCT02135107|58910827|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
30879179|NCT02135107|58910824|FG000|Maintenance Therapy Period|Pregnancy|0|||
30879180|NCT02135107|58910825|FG001|Maintenance Therapy Period|Pregnancy|0|||
30879181|NCT02135107|58910826|FG002|Maintenance Therapy Period|Pregnancy|0|||
30879182|NCT02135107|58910827|FG003|Maintenance Therapy Period|Pregnancy|1|||
30879183|NCT02135107|58910824|FG000|Maintenance Therapy Period|Other|0|||
30879184|NCT02135107|58910825|FG001|Maintenance Therapy Period|Other|0|||
30879185|NCT02135107|58910826|FG002|Maintenance Therapy Period|Other|7|||
30879186|NCT02135107|58910827|FG003|Maintenance Therapy Period|Other|8|||
30879187|NCT02030847|58910839|FG000|Overall Study|Death|10|||
30879188|NCT02030847|58910839|FG000|Overall Study|Disease Progression|15|||
30879189|NCT02030847|58910839|FG000|Overall Study|New Cancer Therapy|8|||
30879190|NCT02030847|58910839|FG000|Overall Study|Physician Decision|3|||
30879191|NCT02030847|58910839|FG000|Overall Study|Withdrawal by Subject|1|||
30879192|NCT02030834|58910847|FG000|Overall Study|Death|4|||
30879193|NCT02030834|58910848|FG001|Overall Study|Death|0|||
30879194|NCT02030834|58910849|FG002|Overall Study|Death|0|||
30879195|NCT02030834|58910847|FG000|Overall Study|Manufacturing failure|2|||
30879196|NCT02030834|58910848|FG001|Overall Study|Manufacturing failure|0|||
30879197|NCT02030834|58910849|FG002|Overall Study|Manufacturing failure|1|||
30879198|NCT02030834|58910847|FG000|Overall Study|Disease progression|2|||
30879199|NCT02030834|58910848|FG001|Overall Study|Disease progression|0|||
30879200|NCT02030834|58910849|FG002|Overall Study|Disease progression|2|||
30879201|NCT02030834|58910847|FG000|Overall Study|Lost to Follow-up|1|||
30879202|NCT02030834|58910848|FG001|Overall Study|Lost to Follow-up|0|||
30879203|NCT02030834|58910849|FG002|Overall Study|Lost to Follow-up|0|||
30879204|NCT02030834|58910847|FG000|Overall Study|Withdrawal by Subject|1|||
30879205|NCT02030834|58910848|FG001|Overall Study|Withdrawal by Subject|0|||
30879206|NCT02030834|58910849|FG002|Overall Study|Withdrawal by Subject|0|||
30879207|NCT02030834|58910847|FG000|Overall Study|Lack of funding|1|||
30879208|NCT02030834|58910848|FG001|Overall Study|Lack of funding|0|||
30879209|NCT02030834|58910849|FG002|Overall Study|Lack of funding|0|||
30879210|NCT02025010|58910857|FG000|Overall Study|Symptomatic or radiographic progression|36|||
30879211|NCT02025010|58910857|FG000|Overall Study|Adverse Event|6|||
30879212|NCT02025010|58910857|FG000|Overall Study|Physician Decision|7|||
30879213|NCT02025010|58910857|FG000|Overall Study|Withdrawal by Subject|3|||
30879214|NCT02025010|58910857|FG000|Overall Study|Intercurrent illness|3|||
30879215|NCT02025010|58910857|FG000|Overall Study|Patients still on treatment|3|||
30879216|NCT02025010|58910857|FG000|Overall Study|Never initiate the treatment|2|||
30879217|NCT01982448|58910865|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
30879218|NCT01982448|58910866|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
30879219|NCT01982448|58910865|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
30879220|NCT01982448|58910866|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
30879221|NCT01982448|58910865|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
30879222|NCT01982448|58910866|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
30879223|NCT01982448|58910865|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
30879224|NCT01982448|58910866|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
30879225|NCT01844986|58910878|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
30879226|NCT01844986|58910879|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
30879227|NCT01844986|58910878|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
30879228|NCT01844986|58910879|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
30879229|NCT01844986|58910878|FG000|Overall Study (Global Cohort)|Death|55|||
30879230|NCT01844986|58910879|FG001|Overall Study (Global Cohort)|Death|26|||
30879231|NCT01844986|58910878|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
30879232|NCT01844986|58910879|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
30879233|NCT01844986|58910878|FG000|Overall Study (China Cohort)|Death|10|||
30879234|NCT01844986|58910879|FG001|Overall Study (China Cohort)|Death|6|||
30879235|NCT01773421|58910893|FG000|Treatment Phase|Other|0|||
30879236|NCT01773421|58910894|FG001|Treatment Phase|Other|0|||
30879237|NCT01773421|58910895|FG002|Treatment Phase|Other|2|||
30879238|NCT01773421|58910896|FG003|Treatment Phase|Other|0|||
30879239|NCT01773421|58910897|FG004|Treatment Phase|Other|0|||
30879240|NCT01773421|58910898|FG005|Treatment Phase|Other|0|||
30879241|NCT01773421|58910899|FG006|Treatment Phase|Other|0|||
30879242|NCT01773421|58910893|FG000|Treatment Phase|Adverse Event|0|||
30879243|NCT01773421|58910894|FG001|Treatment Phase|Adverse Event|0|||
30879244|NCT01773421|58910895|FG002|Treatment Phase|Adverse Event|3|||
30879245|NCT01773421|58910896|FG003|Treatment Phase|Adverse Event|1|||
30879246|NCT01773421|58910897|FG004|Treatment Phase|Adverse Event|0|||
30879247|NCT01773421|58910898|FG005|Treatment Phase|Adverse Event|0|||
30879248|NCT01773421|58910899|FG006|Treatment Phase|Adverse Event|0|||
30879249|NCT01773421|58910893|FG000|Treatment Phase|Withdrawal by Subject|0|||
30879250|NCT01773421|58910894|FG001|Treatment Phase|Withdrawal by Subject|0|||
30879251|NCT01773421|58910895|FG002|Treatment Phase|Withdrawal by Subject|1|||
30879252|NCT01773421|58910896|FG003|Treatment Phase|Withdrawal by Subject|1|||
30879253|NCT01773421|58910897|FG004|Treatment Phase|Withdrawal by Subject|0|||
30879254|NCT01773421|58910898|FG005|Treatment Phase|Withdrawal by Subject|0|||
30879255|NCT01773421|58910899|FG006|Treatment Phase|Withdrawal by Subject|0|||
30879256|NCT01773421|58910893|FG000|Extension Phase|Other|0|||
30879257|NCT01773421|58910894|FG001|Extension Phase|Other|0|||
30879258|NCT01773421|58910895|FG002|Extension Phase|Other|0|||
30879259|NCT01773421|58910896|FG003|Extension Phase|Other|0|||
30879260|NCT01773421|58910897|FG004|Extension Phase|Other|1|||
30879261|NCT01773421|58910898|FG005|Extension Phase|Other|2|||
30879262|NCT01773421|58910899|FG006|Extension Phase|Other|0|||
30879263|NCT01773421|58910893|FG000|Extension Phase|Adverse Event|0|||
30879264|NCT01773421|58910894|FG001|Extension Phase|Adverse Event|0|||
30879265|NCT01773421|58910895|FG002|Extension Phase|Adverse Event|0|||
30879266|NCT01773421|58910896|FG003|Extension Phase|Adverse Event|0|||
30879267|NCT01773421|58910897|FG004|Extension Phase|Adverse Event|2|||
30879268|NCT01773421|58910898|FG005|Extension Phase|Adverse Event|0|||
30879269|NCT01773421|58910899|FG006|Extension Phase|Adverse Event|0|||
30879270|NCT01747486|58910917|FG000|Stage 1|Physician Decision|3|||
30879271|NCT01747486|58910918|FG001|Stage 1|Physician Decision|0|||
30879272|NCT01747486|58910917|FG000|Stage 1|Withdrawal by Subject|4|||
30879273|NCT01747486|58910918|FG001|Stage 1|Withdrawal by Subject|3|||
30879274|NCT01747486|58910917|FG000|Stage 1|Disease progression|4|||
30879275|NCT01747486|58910918|FG001|Stage 1|Disease progression|9|||
30879276|NCT01747486|58910917|FG000|Stage 1|Death|1|||
30879277|NCT01747486|58910918|FG001|Stage 1|Death|1|||
30879278|NCT01747486|58910917|FG000|Stage 2|Physician Decision|2|||
30879279|NCT01747486|58910918|FG001|Stage 2|Physician Decision|0|||
30879280|NCT01747486|58910917|FG000|Stage 2|Withdrawal by Subject|1|||
30879281|NCT01747486|58910918|FG001|Stage 2|Withdrawal by Subject|0|||
30879282|NCT01747486|58910917|FG000|Stage 2|New Cancer Therapy|3|||
30879283|NCT01747486|58910918|FG001|Stage 2|New Cancer Therapy|0|||
30879284|NCT01747486|58910917|FG000|Stage 2|Disease Progression|3|||
30879285|NCT01747486|58910918|FG001|Stage 2|Disease Progression|0|||
30879286|NCT01659151|58910928|FG000|Overall Study|Inadequate TIL growth|1|||
30879287|NCT01593254|58910934|FG000|Overall Study|Disease progression|2|||
30879288|NCT01593254|58910935|FG001|Overall Study|Disease progression|7|||
30879289|NCT01593254|58910934|FG000|Overall Study|Study drug toxicity|6|||
30879290|NCT01593254|58910935|FG001|Overall Study|Study drug toxicity|20|||
30879291|NCT01593254|58910934|FG000|Overall Study|Death|3|||
30879292|NCT01593254|58910935|FG001|Overall Study|Death|3|||
30879293|NCT01593254|58910934|FG000|Overall Study|AE unrelated to study drug|0|||
30879294|NCT01593254|58910935|FG001|Overall Study|AE unrelated to study drug|1|||
30879295|NCT01593254|58910934|FG000|Overall Study|participant request to discontinue study treatment|1|||
30879296|NCT01593254|58910935|FG001|Overall Study|participant request to discontinue study treatment|3|||
30879297|NCT01593254|58910934|FG000|Overall Study|participant withdrew consent|0|||
30879298|NCT01593254|58910935|FG001|Overall Study|participant withdrew consent|9|||
30879299|NCT01593254|58910934|FG000|Overall Study|lost to follow up|1|||
30879300|NCT01593254|58910935|FG001|Overall Study|lost to follow up|6|||
30879301|NCT01593254|58910934|FG000|Overall Study|maximum clinical benefit|1|||
30879302|NCT01593254|58910935|FG001|Overall Study|maximum clinical benefit|2|||
30879303|NCT01593254|58910934|FG000|Overall Study|Poor/non compliance|1|||
30879304|NCT01593254|58910935|FG001|Overall Study|Poor/non compliance|1|||
30879305|NCT01593254|58910934|FG000|Overall Study|Pregnancy|0|||
30879306|NCT01593254|58910935|FG001|Overall Study|Pregnancy|3|||
30879307|NCT01593254|58910934|FG000|Overall Study|participant no longer meets study criteria|1|||
30879308|NCT01593254|58910935|FG001|Overall Study|participant no longer meets study criteria|1|||
30879309|NCT01593254|58910934|FG000|Overall Study|Admin reason by sponsor|7|||
30879310|NCT01593254|58910935|FG001|Overall Study|Admin reason by sponsor|3|||
30879311|NCT01593254|58910934|FG000|Overall Study|Imatinib treatment failure|2|||
30879312|NCT01593254|58910935|FG001|Overall Study|Imatinib treatment failure|0|||
30879313|NCT01593254|58910934|FG000|Overall Study|Other Reasons|61|||
30879314|NCT01593254|58910935|FG001|Overall Study|Other Reasons|115|||
30879315|NCT01559818|58910942|FG000|Overall Study|Physician Decision|1|||
30879316|NCT01559818|58910942|FG000|Overall Study|Pregnancy|1|||
30879317|NCT01559818|58910942|FG000|Overall Study|Study terminated by Sponsor|4|||
30879318|NCT01559818|58910942|FG000|Overall Study|Withdrawal by Subject|1|||
30879319|NCT01454934|58910949|FG000|Overall Study|Clinical progression|28|||
30879320|NCT01454934|58910950|FG001|Overall Study|Clinical progression|25|||
30879321|NCT01454934|58910949|FG000|Overall Study|Other|6|||
30879322|NCT01454934|58910950|FG001|Overall Study|Other|17|||
30879323|NCT01454934|58910949|FG000|Overall Study|Adverse Event|28|||
30879324|NCT01454934|58910950|FG001|Overall Study|Adverse Event|24|||
30879325|NCT01454934|58910949|FG000|Overall Study|Withdrawn consent|2|||
30879326|NCT01454934|58910950|FG001|Overall Study|Withdrawn consent|5|||
30879327|NCT01454934|58910949|FG000|Overall Study|Withdrawal by Subject|11|||
30879328|NCT01454934|58910950|FG001|Overall Study|Withdrawal by Subject|15|||
30879329|NCT01454934|58910949|FG000|Overall Study|Disease progression|194|||
30879330|NCT01454934|58910950|FG001|Overall Study|Disease progression|181|||
30879331|NCT01454934|58910949|FG000|Overall Study|Lost to Follow-up|0|||
30879332|NCT01454934|58910950|FG001|Overall Study|Lost to Follow-up|1|||
30879333|NCT01454934|58910949|FG000|Overall Study|Not treated|1|||
30879334|NCT01454934|58910950|FG001|Overall Study|Not treated|2|||
30879335|NCT01439282|58910958|FG000|Overall Study|Adverse Event|5|||
30879336|NCT01439282|58910959|FG001|Overall Study|Adverse Event|0|||
30879337|NCT01439282|58910958|FG000|Overall Study|Withdrawal by Subject|2|||
30879338|NCT01439282|58910959|FG001|Overall Study|Withdrawal by Subject|0|||
30879339|NCT01439282|58910958|FG000|Overall Study|Other|1|||
30879340|NCT01439282|58910959|FG001|Overall Study|Other|1|||
30879341|NCT01326312|58910969|FG000|Overall Study|Adverse Event|11|||
30879342|NCT01326312|58910970|FG001|Overall Study|Adverse Event|11|||
30879343|NCT01326312|58910971|FG002|Overall Study|Adverse Event|1|||
30879344|NCT01326312|58910969|FG000|Overall Study|Withdrawal by Subject|1|||
30879345|NCT01326312|58910970|FG001|Overall Study|Withdrawal by Subject|2|||
30879346|NCT01326312|58910971|FG002|Overall Study|Withdrawal by Subject|1|||
30879347|NCT01326312|58910969|FG000|Overall Study|Protocol Violation|0|||
30879348|NCT01326312|58910970|FG001|Overall Study|Protocol Violation|1|||
30879349|NCT01326312|58910971|FG002|Overall Study|Protocol Violation|0|||
30879350|NCT01326312|58910969|FG000|Overall Study|Lack of Efficacy|13|||
30879351|NCT01326312|58910970|FG001|Overall Study|Lack of Efficacy|7|||
30879352|NCT01326312|58910971|FG002|Overall Study|Lack of Efficacy|1|||
30879353|NCT01326312|58910969|FG000|Overall Study|Death|1|||
30879354|NCT01326312|58910970|FG001|Overall Study|Death|0|||
30879355|NCT01326312|58910971|FG002|Overall Study|Death|1|||
30879356|NCT01326312|58910969|FG000|Overall Study|progressive disease|0|||
30879357|NCT01326312|58910970|FG001|Overall Study|progressive disease|1|||
30879358|NCT01326312|58910971|FG002|Overall Study|progressive disease|1|||
30879359|NCT01326312|58910969|FG000|Overall Study|Study terminated by Sponsor|8|||
30879360|NCT01326312|58910970|FG001|Overall Study|Study terminated by Sponsor|32|||
30879361|NCT01326312|58910971|FG002|Overall Study|Study terminated by Sponsor|46|||
30879362|NCT01326312|58910969|FG000|Overall Study|Treatment arm terminated|19|||
30879363|NCT01326312|58910970|FG001|Overall Study|Treatment arm terminated|0|||
30879364|NCT01326312|58910971|FG002|Overall Study|Treatment arm terminated|0|||
30879365|NCT01326312|58910969|FG000|Overall Study|QTc > 500|0|||
30879366|NCT01326312|58910970|FG001|Overall Study|QTc > 500|1|||
30879367|NCT01326312|58910971|FG002|Overall Study|QTc > 500|0|||
30879368|NCT01269346|58910993|FG000|Treatment Phase|Disease progression|3|||
30879369|NCT01269346|58910993|FG000|Treatment Phase|Adverse Event|3|||
30879370|NCT01269346|58910993|FG000|Treatment Phase|Withdrawal by Subject|1|||
30879371|NCT01269346|58910993|FG000|Treatment Phase|Other|2|||
30879372|NCT01269346|58910993|FG000|Extension Phase|Adverse Event|6|||
30879373|NCT01269346|58910993|FG000|Extension Phase|Withdrawal by Subject|4|||
30879374|NCT01269346|58910993|FG000|Extension Phase|Disease progression|22|||
30879375|NCT01269346|58910993|FG000|Extension Phase|Physician decision or participant choice|9|||
30879376|NCT01269346|58910993|FG000|Extension Phase|Clinical progression|1|||
30879377|NCT01269346|58910993|FG000|Extension Phase|Started a prohibited con med|1|||
30879378|NCT01268293|58910998|FG000|Overall Study|Disease progression|7|||
30879379|NCT01268293|58910998|FG000|Overall Study|Adverse Event|1|||
30879380|NCT01268293|58910998|FG000|Overall Study|Subject choice|1|||
30879381|NCT01268150|58911002|FG000|Treatment Phase|Progression of disease|18|||
30879382|NCT01268150|58911002|FG000|Treatment Phase|Adverse Event|3|||
30879383|NCT01268150|58911002|FG000|Treatment Phase|Withdrawal by Subject|3|||
30879384|NCT01268150|58911002|FG000|Treatment Phase|Other|4|||
30879385|NCT01268150|58911002|FG000|Extension Phase|Adverse Event|3|||
30879386|NCT01268150|58911002|FG000|Extension Phase|Disease progression|18|||
30879387|NCT01268150|58911002|FG000|Extension Phase|Other|6|||
30879388|NCT01267175|58911006|FG000|Overall Study|Withdrawal by Subject|1|||
30879389|NCT01267175|58911006|FG000|Overall Study|Lost to Follow-up|1|||
30879390|NCT01133756|58911017|FG000|Overall Study|Adverse Event|1|||
30879391|NCT01133756|58911018|FG001|Overall Study|Adverse Event|2|||
30879392|NCT01133756|58911019|FG002|Overall Study|Adverse Event|1|||
30879393|NCT01133756|58911017|FG000|Overall Study|Investigator Decision|1|||
30879394|NCT01133756|58911018|FG001|Overall Study|Investigator Decision|0|||
30879395|NCT01133756|58911019|FG002|Overall Study|Investigator Decision|0|||
30879396|NCT01133756|58911017|FG000|Overall Study|Withdrawal by Subject|0|||
30879397|NCT01133756|58911018|FG001|Overall Study|Withdrawal by Subject|1|||
30879398|NCT01133756|58911019|FG002|Overall Study|Withdrawal by Subject|0|||
30879399|NCT01133756|58911017|FG000|Overall Study|Progression of Disease|0|||
30879400|NCT01133756|58911018|FG001|Overall Study|Progression of Disease|0|||
30879401|NCT01133756|58911019|FG002|Overall Study|Progression of Disease|1|||
30879402|NCT01126736|58911032|FG000|Overall Study|Death|2|||
30879403|NCT01126736|58911033|FG001|Overall Study|Death|2|||
30879404|NCT01126736|58911034|FG002|Overall Study|Death|1|||
30879405|NCT01126736|58911035|FG003|Overall Study|Death|19|||
30879406|NCT01126736|58911036|FG004|Overall Study|Death|19|||
30879407|NCT01126736|58911032|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
30879408|NCT01126736|58911033|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
30879409|NCT01126736|58911034|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
30879410|NCT01126736|58911035|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
30879411|NCT01126736|58911036|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
30879412|NCT01126736|58911032|FG000|Overall Study|Lost to Follow-up|0|||
30879413|NCT01126736|58911033|FG001|Overall Study|Lost to Follow-up|0|||
30879414|NCT01126736|58911034|FG002|Overall Study|Lost to Follow-up|0|||
30879415|NCT01126736|58911035|FG003|Overall Study|Lost to Follow-up|1|||
30879416|NCT01126736|58911036|FG004|Overall Study|Lost to Follow-up|1|||
30879417|NCT01126736|58911032|FG000|Overall Study|Administrative reasons|0|||
30879418|NCT01126736|58911033|FG001|Overall Study|Administrative reasons|0|||
30879419|NCT01126736|58911034|FG002|Overall Study|Administrative reasons|0|||
30879420|NCT01126736|58911035|FG003|Overall Study|Administrative reasons|0|||
30879421|NCT01126736|58911036|FG004|Overall Study|Administrative reasons|1|||
30879422|NCT01126736|58911032|FG000|Overall Study|Progressive disease|0|||
30879423|NCT01126736|58911033|FG001|Overall Study|Progressive disease|0|||
30879424|NCT01126736|58911034|FG002|Overall Study|Progressive disease|0|||
30879425|NCT01126736|58911035|FG003|Overall Study|Progressive disease|2|||
30879426|NCT01126736|58911036|FG004|Overall Study|Progressive disease|1|||
30879427|NCT01126736|58911032|FG000|Overall Study|Withdrawal by Subject|0|||
30879428|NCT01126736|58911033|FG001|Overall Study|Withdrawal by Subject|0|||
30879429|NCT01126736|58911034|FG002|Overall Study|Withdrawal by Subject|0|||
30879430|NCT01126736|58911035|FG003|Overall Study|Withdrawal by Subject|1|||
30879431|NCT01126736|58911036|FG004|Overall Study|Withdrawal by Subject|1|||
30879432|NCT01126736|58911032|FG000|Overall Study|Other|2|||
30879433|NCT01126736|58911033|FG001|Overall Study|Other|4|||
30879434|NCT01126736|58911034|FG002|Overall Study|Other|4|||
30879435|NCT01126736|58911035|FG003|Overall Study|Other|16|||
30879436|NCT01126736|58911036|FG004|Overall Study|Other|15|||
30879437|NCT01111461|58911048|FG000|Overall Study|Adverse Event|32|||
30879438|NCT01111461|58911048|FG000|Overall Study|Participant choice|11|||
30879439|NCT01111461|58911048|FG000|Overall Study|Lost to Follow-up|1|||
30879440|NCT01111461|58911048|FG000|Overall Study|Withdrawal by Subject|1|||
30879441|NCT01111461|58911048|FG000|Overall Study|Other|6|||
30879442|NCT01104155|58911054|FG000|Overall Study|Adverse Event|15|||
30879443|NCT01104155|58911055|FG001|Overall Study|Adverse Event|8|||
30879444|NCT01104155|58911054|FG000|Overall Study|Participant choice|6|||
30879445|NCT01104155|58911055|FG001|Overall Study|Participant choice|5|||
30879446|NCT01104155|58911054|FG000|Overall Study|Withdrawal of consent|1|||
30879447|NCT01104155|58911055|FG001|Overall Study|Withdrawal of consent|1|||
30879448|NCT01104155|58911054|FG000|Overall Study|Other|3|||
30879449|NCT01104155|58911055|FG001|Overall Study|Other|4|||
30879450|NCT01065597|58911061|FG000|Overall Study|Adverse Event|1|||
30879451|NCT01051856|58911067|FG000|Overall Study|Withdrawal by Subject|1|||
30879452|NCT01051856|58911068|FG001|Overall Study|Withdrawal by Subject|0|||
30879453|NCT01029366|58911076|FG000|Overall Study|Withdrawal by Subject|1|||
30879454|NCT01029366|58911077|FG001|Overall Study|Withdrawal by Subject|0|||
30879455|NCT01029366|58911076|FG000|Overall Study|Death|1|||
30879456|NCT01029366|58911077|FG001|Overall Study|Death|1|||
30879457|NCT01029366|58911076|FG000|Overall Study|disease progression|2|||
30879458|NCT01029366|58911077|FG001|Overall Study|disease progression|0|||
30879459|NCT01029366|58911076|FG000|Overall Study|manufacturing failure|0|||
30879460|NCT01029366|58911077|FG001|Overall Study|manufacturing failure|1|||
30879461|NCT01005745|58911084|FG000|Overall Study|No TIL growth|1|||
30879462|NCT01005745|58911084|FG000|Overall Study|Disease progressed during TIL growth|3|||
30879463|NCT01005745|58911084|FG000|Overall Study|Death prior to treatment|1|||
30879464|NCT01005745|58911084|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
30879465|NCT00879086|58911090|FG000|Overall Study|Adverse Event|3|||
30879466|NCT00879086|58911091|FG001|Overall Study|Adverse Event|15|||
30879467|NCT00879086|58911090|FG000|Overall Study|Participant choice|2|||
30879468|NCT00879086|58911091|FG001|Overall Study|Participant choice|2|||
30879469|NCT00879086|58911090|FG000|Overall Study|Progression of disease|40|||
30879470|NCT00879086|58911091|FG001|Overall Study|Progression of disease|26|||
30879471|NCT00879086|58911090|FG000|Overall Study|Withdrawal of consent|2|||
30879472|NCT00879086|58911091|FG001|Overall Study|Withdrawal of consent|1|||
30879473|NCT00879086|58911090|FG000|Overall Study|Other|4|||
30879474|NCT00879086|58911091|FG001|Overall Study|Other|6|||
30879475|NCT00879086|58911090|FG000|Overall Study|Death|1|||
30879476|NCT00879086|58911091|FG001|Overall Study|Death|2|||
30879477|NCT00244933|58911107|FG000|Overall Study|Not response evaluable|2|||
30879478|NCT02637557|58911188|FG000|Overall Study|Adverse Event|3|||
30879479|NCT02637557|58911189|FG001|Overall Study|Adverse Event|1|||
30879480|NCT02637557|58911190|FG002|Overall Study|Adverse Event|3|||
30879481|NCT02637557|58911191|FG003|Overall Study|Adverse Event|3|||
30879482|NCT02637557|58911188|FG000|Overall Study|Lost to Follow-up|1|||
30879483|NCT02637557|58911189|FG001|Overall Study|Lost to Follow-up|1|||
30879484|NCT02637557|58911190|FG002|Overall Study|Lost to Follow-up|0|||
30879485|NCT02637557|58911191|FG003|Overall Study|Lost to Follow-up|1|||
30879486|NCT02637557|58911188|FG000|Overall Study|Physician Decision|1|||
30879487|NCT02637557|58911189|FG001|Overall Study|Physician Decision|0|||
30879488|NCT02637557|58911190|FG002|Overall Study|Physician Decision|0|||
30879489|NCT02637557|58911191|FG003|Overall Study|Physician Decision|0|||
30879490|NCT02637557|58911188|FG000|Overall Study|Protocol Violation|2|||
30879491|NCT02637557|58911189|FG001|Overall Study|Protocol Violation|0|||
30879492|NCT02637557|58911190|FG002|Overall Study|Protocol Violation|2|||
30879493|NCT02637557|58911191|FG003|Overall Study|Protocol Violation|1|||
30879494|NCT02637557|58911188|FG000|Overall Study|Withdrawal by Subject|1|||
30879495|NCT02637557|58911189|FG001|Overall Study|Withdrawal by Subject|3|||
30879496|NCT02637557|58911190|FG002|Overall Study|Withdrawal by Subject|4|||
30879497|NCT02637557|58911191|FG003|Overall Study|Withdrawal by Subject|2|||
30879498|NCT02638493|58911204|FG000|Overall Study|Inability to provide semen samples|2|||
30879499|NCT02638493|58911205|FG001|Overall Study|Inability to provide semen samples|0|||
30879500|NCT02638493|58911206|FG002|Overall Study|Inability to provide semen samples|0|||
30879501|NCT02638337|58911216|FG000|Overall Study|Adverse Event|6|||
30879502|NCT02638337|58911217|FG001|Overall Study|Adverse Event|10|||
30879503|NCT02638337|58911216|FG000|Overall Study|Protocol Violation|3|||
30879504|NCT02638337|58911217|FG001|Overall Study|Protocol Violation|0|||
30879505|NCT02638337|58911216|FG000|Overall Study|Withdrawal by Subject|13|||
30879506|NCT02638337|58911217|FG001|Overall Study|Withdrawal by Subject|16|||
30879507|NCT02638337|58911216|FG000|Overall Study|Lost to Follow-up|7|||
30879508|NCT02638337|58911217|FG001|Overall Study|Lost to Follow-up|7|||
30879509|NCT02638337|58911216|FG000|Overall Study|Other - Miscellaneous|4|||
30879510|NCT02638337|58911217|FG001|Overall Study|Other - Miscellaneous|3|||
30879511|NCT02638259|58911225|FG000|Treatment Period 1|Adverse Event|1|||
30879512|NCT02638259|58911226|FG001|Treatment Period 1|Adverse Event|5|||
30879513|NCT02638259|58911225|FG000|Treatment Period 1|Death|0|||
30879514|NCT02638259|58911226|FG001|Treatment Period 1|Death|1|||
30879515|NCT02638259|58911225|FG000|Treatment Period 1|Lack of Efficacy|0|||
30879516|NCT02638259|58911226|FG001|Treatment Period 1|Lack of Efficacy|1|||
30879517|NCT02638259|58911225|FG000|Treatment Period 1|Protocol Violation|0|||
30879518|NCT02638259|58911226|FG001|Treatment Period 1|Protocol Violation|3|||
30879519|NCT02638259|58911225|FG000|Treatment Period 1|Withdrawal by Subject|4|||
30879520|NCT02638259|58911226|FG001|Treatment Period 1|Withdrawal by Subject|6|||
30879521|NCT02638259|58911225|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
30879522|NCT02638259|58911226|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
30879523|NCT02638259|58911225|FG000|Treatment Period 2|Adverse Event|5|||
30879524|NCT02638259|58911226|FG001|Treatment Period 2|Adverse Event|4|||
30879525|NCT02638259|58911225|FG000|Treatment Period 2|Withdrawal by Subject|1|||
30879526|NCT02638259|58911226|FG001|Treatment Period 2|Withdrawal by Subject|7|||
30879527|NCT02637323|58911238|FG000|Overall Study|Lost to Follow-up|2|||
30879528|NCT02637323|58911239|FG001|Overall Study|Lost to Follow-up|0|||
30879529|NCT02637323|58911238|FG000|Overall Study|Protocol Violation|0|||
30879530|NCT02637323|58911239|FG001|Overall Study|Protocol Violation|1|||
30879531|NCT03573817|58911248|FG000|Overall Study|Adverse Event|0|||
30879532|NCT03573817|58911249|FG001|Overall Study|Adverse Event|2|||
30879533|NCT03573817|58911248|FG000|Overall Study|Protocol Violation|0|||
30879534|NCT03573817|58911249|FG001|Overall Study|Protocol Violation|1|||
30879535|NCT03573817|58911248|FG000|Overall Study|Withdrawal by Subject|1|||
30879536|NCT03573817|58911249|FG001|Overall Study|Withdrawal by Subject|1|||
30879537|NCT02638103|58911264|FG000|Overall Study|Adverse Event|13|||
30879538|NCT02638103|58911265|FG001|Overall Study|Adverse Event|12|||
30879539|NCT02638103|58911266|FG002|Overall Study|Adverse Event|19|||
30879540|NCT02638103|58911267|FG003|Overall Study|Adverse Event|12|||
30879541|NCT02638103|58911264|FG000|Overall Study|Withdrawal by Subject|43|||
30879542|NCT02638103|58911265|FG001|Overall Study|Withdrawal by Subject|53|||
30879543|NCT02638103|58911266|FG002|Overall Study|Withdrawal by Subject|30|||
30879544|NCT02638103|58911267|FG003|Overall Study|Withdrawal by Subject|61|||
30879545|NCT02638103|58911264|FG000|Overall Study|Protocol Violation|1|||
30879546|NCT02638103|58911265|FG001|Overall Study|Protocol Violation|2|||
30879547|NCT02638103|58911266|FG002|Overall Study|Protocol Violation|1|||
30879548|NCT02638103|58911267|FG003|Overall Study|Protocol Violation|4|||
30879549|NCT02638103|58911264|FG000|Overall Study|Pregnancy|2|||
30879550|NCT02638103|58911265|FG001|Overall Study|Pregnancy|3|||
30879551|NCT02638103|58911266|FG002|Overall Study|Pregnancy|0|||
30879552|NCT02638103|58911267|FG003|Overall Study|Pregnancy|1|||
30879553|NCT02638103|58911264|FG000|Overall Study|Non-compliance to Study Procedures|2|||
30879554|NCT02638103|58911265|FG001|Overall Study|Non-compliance to Study Procedures|1|||
30879555|NCT02638103|58911266|FG002|Overall Study|Non-compliance to Study Procedures|1|||
30879556|NCT02638103|58911267|FG003|Overall Study|Non-compliance to Study Procedures|1|||
30879557|NCT02638103|58911264|FG000|Overall Study|Lost to Follow-up|26|||
30879558|NCT02638103|58911265|FG001|Overall Study|Lost to Follow-up|33|||
30879559|NCT02638103|58911266|FG002|Overall Study|Lost to Follow-up|20|||
30879560|NCT02638103|58911267|FG003|Overall Study|Lost to Follow-up|37|||
30879561|NCT02638103|58911264|FG000|Overall Study|Lack of Efficacy|14|||
30879562|NCT02638103|58911265|FG001|Overall Study|Lack of Efficacy|10|||
30879563|NCT02638103|58911266|FG002|Overall Study|Lack of Efficacy|12|||
30879564|NCT02638103|58911267|FG003|Overall Study|Lack of Efficacy|22|||
30879565|NCT02638103|58911264|FG000|Overall Study|Other than specified|5|||
30879566|NCT02638103|58911265|FG001|Overall Study|Other than specified|4|||
30879567|NCT02638103|58911266|FG002|Overall Study|Other than specified|2|||
30879568|NCT02638103|58911267|FG003|Overall Study|Other than specified|4|||
30879569|NCT03551743|58911289|FG000|Overall Study|Adverse Event|1|||
30879570|NCT03551743|58911290|FG001|Overall Study|Adverse Event|0|||
30879571|NCT03551743|58911291|FG002|Overall Study|Adverse Event|0|||
30879572|NCT03551743|58911292|FG003|Overall Study|Adverse Event|0|||
30879573|NCT03551743|58911289|FG000|Overall Study|Withdrawal by Subject|1|||
30879574|NCT03551743|58911290|FG001|Overall Study|Withdrawal by Subject|0|||
30879575|NCT03551743|58911291|FG002|Overall Study|Withdrawal by Subject|0|||
30879576|NCT03551743|58911292|FG003|Overall Study|Withdrawal by Subject|0|||
30879577|NCT02636699|58911304|FG000|Overall Study|Adverse Event|4|||
30879578|NCT02636699|58911305|FG001|Overall Study|Adverse Event|0|||
30879579|NCT02636699|58911304|FG000|Overall Study|Lost to Follow-up|3|||
30879580|NCT02636699|58911305|FG001|Overall Study|Lost to Follow-up|3|||
30879581|NCT02636699|58911304|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
30879582|NCT02636699|58911305|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
30879583|NCT02636699|58911304|FG000|Overall Study|Physician Decision|0|||
30879584|NCT02636699|58911305|FG001|Overall Study|Physician Decision|1|||
30879585|NCT02636699|58911304|FG000|Overall Study|Withdrawal by Subject|13|||
30879586|NCT02636699|58911305|FG001|Overall Study|Withdrawal by Subject|6|||
30879587|NCT02636699|58911304|FG000|Overall Study|Other|3|||
30879588|NCT02636699|58911305|FG001|Overall Study|Other|1|||
30879589|NCT02634983|58911311|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
30879590|NCT02634983|58911312|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
30879591|NCT02633501|58911324|FG000|Overall Study|Adverse Event|0|||
30879592|NCT02633501|58911325|FG001|Overall Study|Adverse Event|0|||
30879593|NCT02633501|58911326|FG002|Overall Study|Adverse Event|1|||
30879594|NCT02633501|58911327|FG003|Overall Study|Adverse Event|0|||
30879595|NCT02633501|58911328|FG004|Overall Study|Adverse Event|1|||
30879596|NCT02633501|58911329|FG005|Overall Study|Adverse Event|1|||
30879597|NCT02633501|58911324|FG000|Overall Study|Withdrawal by Subject|2|||
30879598|NCT02633501|58911325|FG001|Overall Study|Withdrawal by Subject|1|||
30879599|NCT02633501|58911326|FG002|Overall Study|Withdrawal by Subject|2|||
30879600|NCT02633501|58911327|FG003|Overall Study|Withdrawal by Subject|2|||
30879601|NCT02633501|58911328|FG004|Overall Study|Withdrawal by Subject|1|||
30879602|NCT02633501|58911329|FG005|Overall Study|Withdrawal by Subject|3|||
30879603|NCT02633501|58911324|FG000|Overall Study|Various other reasons|0|||
30879604|NCT02633501|58911325|FG001|Overall Study|Various other reasons|2|||
30879605|NCT02633501|58911326|FG002|Overall Study|Various other reasons|4|||
30879606|NCT02633501|58911327|FG003|Overall Study|Various other reasons|1|||
30879607|NCT02633501|58911328|FG004|Overall Study|Various other reasons|7|||
30879608|NCT02633501|58911329|FG005|Overall Study|Various other reasons|11|||
30879609|NCT02633501|58911324|FG000|Overall Study|Lost to Follow-up|0|||
30879610|NCT02633501|58911325|FG001|Overall Study|Lost to Follow-up|0|||
30879611|NCT02633501|58911326|FG002|Overall Study|Lost to Follow-up|0|||
30879612|NCT02633501|58911327|FG003|Overall Study|Lost to Follow-up|1|||
30879613|NCT02633501|58911328|FG004|Overall Study|Lost to Follow-up|2|||
30879614|NCT02633501|58911329|FG005|Overall Study|Lost to Follow-up|0|||
30879615|NCT03138499|58911350|FG000|Overall Study|Lost to Follow-up|1|||
30879616|NCT03138499|58911351|FG001|Overall Study|Lost to Follow-up|0|||
30879617|NCT03138499|58911350|FG000|Overall Study|Participants withdrew consent|1|||
30879618|NCT03138499|58911351|FG001|Overall Study|Participants withdrew consent|0|||
30879619|NCT03138499|58911350|FG000|Overall Study|Participant discontinued study before treatment|0|||
30879620|NCT03138499|58911351|FG001|Overall Study|Participant discontinued study before treatment|1|||
30879621|NCT03138499|58911350|FG000|Overall Study|Disease Progression|2|||
30879622|NCT03138499|58911351|FG001|Overall Study|Disease Progression|6|||
30879623|NCT03138499|58911350|FG000|Overall Study|Study drug toxicity|2|||
30879624|NCT03138499|58911351|FG001|Overall Study|Study drug toxicity|2|||
30879625|NCT03138499|58911350|FG000|Overall Study|Participant request to discontinue study treatment|1|||
30879626|NCT03138499|58911351|FG001|Overall Study|Participant request to discontinue study treatment|1|||
30879627|NCT03138499|58911350|FG000|Overall Study|Other reasons|2|||
30879628|NCT03138499|58911351|FG001|Overall Study|Other reasons|0|||
30879629|NCT04508621|58911360|FG000|Overall Study|Adverse Event|39|||
30879630|NCT04508621|58911361|FG001|Overall Study|Adverse Event|16|||
30879631|NCT04508621|58911360|FG000|Overall Study|Lack of Efficacy|2|||
30879632|NCT04508621|58911361|FG001|Overall Study|Lack of Efficacy|8|||
30879633|NCT04508621|58911360|FG000|Overall Study|Physician Decision|0|||
30879634|NCT04508621|58911361|FG001|Overall Study|Physician Decision|1|||
30879635|NCT04508621|58911360|FG000|Overall Study|Withdrawal by Subject|10|||
30879636|NCT04508621|58911361|FG001|Overall Study|Withdrawal by Subject|14|||
30879637|NCT04508621|58911360|FG000|Overall Study|Lost to Follow-up|12|||
30879638|NCT04508621|58911361|FG001|Overall Study|Lost to Follow-up|9|||
30879639|NCT04508621|58911360|FG000|Overall Study|COVID-19 related crisis|3|||
30879640|NCT04508621|58911361|FG001|Overall Study|COVID-19 related crisis|0|||
30879641|NCT04508621|58911360|FG000|Overall Study|Subject non-compliance|1|||
30879642|NCT04508621|58911361|FG001|Overall Study|Subject non-compliance|0|||
30879643|NCT03591107|58911369|FG000|Overall Study|Same patient in both arms|1|||
30879644|NCT03591107|58911370|FG001|Overall Study|Same patient in both arms|1|||
30879645|NCT03591107|58911369|FG000|Overall Study|Sought care at other clinics|0|||
30879646|NCT03591107|58911370|FG001|Overall Study|Sought care at other clinics|2|||
30879647|NCT03591107|58911369|FG000|Overall Study|Discharged from clinic|0|||
30879648|NCT03591107|58911370|FG001|Overall Study|Discharged from clinic|1|||
30879649|NCT03591107|58911369|FG000|Overall Study|Withdrawal by Subject|0|||
30879650|NCT03591107|58911370|FG001|Overall Study|Withdrawal by Subject|1|||
30879651|NCT02922023|58911383|FG000|Overall Study|Lost to Follow-up|2|||
30879652|NCT02922023|58911384|FG001|Overall Study|Lost to Follow-up|0|||
30879653|NCT01672853|58911393|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
30879654|NCT01672853|58911394|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
30879655|NCT01672853|58911395|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
30879656|NCT01672853|58911393|FG000|Overall Study|Pregnancy|0|||
30879657|NCT01672853|58911394|FG001|Overall Study|Pregnancy|1|||
30879658|NCT01672853|58911395|FG002|Overall Study|Pregnancy|0|||
30879659|NCT01672853|58911393|FG000|Overall Study|Investigator's Discretion|1|||
30879660|NCT01672853|58911394|FG001|Overall Study|Investigator's Discretion|0|||
30879661|NCT01672853|58911395|FG002|Overall Study|Investigator's Discretion|0|||
30879662|NCT01672853|58911393|FG000|Overall Study|Withdrew Consent|5|||
30879663|NCT01672853|58911394|FG001|Overall Study|Withdrew Consent|5|||
30879664|NCT01672853|58911395|FG002|Overall Study|Withdrew Consent|5|||
30879665|NCT01672853|58911393|FG000|Overall Study|Adverse Event|4|||
30879666|NCT01672853|58911394|FG001|Overall Study|Adverse Event|6|||
30879667|NCT01672853|58911395|FG002|Overall Study|Adverse Event|8|||
30879668|NCT01672853|58911393|FG000|Overall Study|Lost to Follow-up|0|||
30879669|NCT01672853|58911394|FG001|Overall Study|Lost to Follow-up|1|||
30879670|NCT01672853|58911395|FG002|Overall Study|Lost to Follow-up|0|||
30879671|NCT01672853|58911393|FG000|Overall Study|Randomized but Never Treated|0|||
30879672|NCT01672853|58911394|FG001|Overall Study|Randomized but Never Treated|0|||
30760590|NCT03381274|58769074|FG004|Overall Study|Lost to Follow-up|0|||
30879673|NCT01672853|58911395|FG002|Overall Study|Randomized but Never Treated|1|||
30879674|NCT01603459|58911403|FG000|Overall Study|Adverse Event|5|||
30879675|NCT01603459|58911403|FG000|Overall Study|Withdrawal by Subject|5|||
30879676|NCT01603459|58911403|FG000|Overall Study|Lost to Follow-up|3|||
30879677|NCT01603459|58911403|FG000|Overall Study|Predefined discontinuation criteria|3|||
30879678|NCT01603459|58911403|FG000|Overall Study|Non-compliance|1|||
30879679|NCT01603459|58911403|FG000|Overall Study|Administrative reason|1|||
30879680|NCT01678807|58911442|FG000|Overall Study|Adverse Event|4|||
30879681|NCT01678807|58911443|FG001|Overall Study|Adverse Event|4|||
30879682|NCT01678807|58911444|FG002|Overall Study|Adverse Event|0|||
30879683|NCT01678807|58911442|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
30879684|NCT01678807|58911443|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
30879685|NCT01678807|58911444|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
30879686|NCT03073525|58911455|FG000|Overall Study|Withdrawal by Subject|0|||
30879687|NCT03073525|58911456|FG001|Overall Study|Withdrawal by Subject|0|||
30879688|NCT03073525|58911457|FG002|Overall Study|Withdrawal by Subject|3|||
30879689|NCT02631551|58911478|FG000|Overall Study|Adverse Event|1|||
30879690|NCT02631551|58911479|FG001|Overall Study|Adverse Event|2|||
30879691|NCT02631551|58911480|FG002|Overall Study|Adverse Event|4|||
30879692|NCT02631551|58911481|FG003|Overall Study|Adverse Event|0|||
30879693|NCT02631551|58911478|FG000|Overall Study|Lack of Efficacy|0|||
30879694|NCT02631551|58911479|FG001|Overall Study|Lack of Efficacy|0|||
30879695|NCT02631551|58911480|FG002|Overall Study|Lack of Efficacy|1|||
30879696|NCT02631551|58911481|FG003|Overall Study|Lack of Efficacy|0|||
30879697|NCT02631551|58911478|FG000|Overall Study|Lost to Follow-up|1|||
30879698|NCT02631551|58911479|FG001|Overall Study|Lost to Follow-up|2|||
30879699|NCT02631551|58911480|FG002|Overall Study|Lost to Follow-up|0|||
30879700|NCT02631551|58911481|FG003|Overall Study|Lost to Follow-up|3|||
30879701|NCT02631551|58911478|FG000|Overall Study|Withdrawal by Subject|2|||
30879702|NCT02631551|58911479|FG001|Overall Study|Withdrawal by Subject|2|||
30879703|NCT02631551|58911480|FG002|Overall Study|Withdrawal by Subject|0|||
30879704|NCT02631551|58911481|FG003|Overall Study|Withdrawal by Subject|5|||
30879705|NCT02631551|58911478|FG000|Overall Study|Protocol deviation|3|||
30879706|NCT02631551|58911479|FG001|Overall Study|Protocol deviation|6|||
30879707|NCT02631551|58911480|FG002|Overall Study|Protocol deviation|3|||
30879708|NCT02631551|58911481|FG003|Overall Study|Protocol deviation|0|||
30879709|NCT02631551|58911478|FG000|Overall Study|Non-compliance with study procedures|0|||
30879710|NCT02631551|58911479|FG001|Overall Study|Non-compliance with study procedures|0|||
30879711|NCT02631551|58911480|FG002|Overall Study|Non-compliance with study procedures|1|||
30879712|NCT02631551|58911481|FG003|Overall Study|Non-compliance with study procedures|1|||
30879713|NCT02631551|58911478|FG000|Overall Study|Non-compliance with study drug|1|||
30879714|NCT02631551|58911479|FG001|Overall Study|Non-compliance with study drug|0|||
30879715|NCT02631551|58911480|FG002|Overall Study|Non-compliance with study drug|0|||
30879716|NCT02631551|58911481|FG003|Overall Study|Non-compliance with study drug|0|||
30879717|NCT02631551|58911478|FG000|Overall Study|Other, specific reasons not collected|5|||
30879718|NCT02631551|58911479|FG001|Overall Study|Other, specific reasons not collected|7|||
30879719|NCT02631551|58911480|FG002|Overall Study|Other, specific reasons not collected|2|||
30879720|NCT02631551|58911481|FG003|Overall Study|Other, specific reasons not collected|2|||
30879721|NCT01680991|58911494|FG000|Overall Study|Adverse Event|1|||
30879722|NCT01680991|58911495|FG001|Overall Study|Adverse Event|0|||
30879723|NCT01680991|58911496|FG002|Overall Study|Adverse Event|0|||
30879724|NCT01680991|58911494|FG000|Overall Study|Death|1|||
30879725|NCT01680991|58911495|FG001|Overall Study|Death|0|||
30879726|NCT01680991|58911496|FG002|Overall Study|Death|1|||
30879727|NCT01680991|58911494|FG000|Overall Study|Protocol Violation|0|||
30879728|NCT01680991|58911495|FG001|Overall Study|Protocol Violation|1|||
30879729|NCT01680991|58911496|FG002|Overall Study|Protocol Violation|0|||
30879730|NCT01680991|58911494|FG000|Overall Study|Withdrawal by Subject|5|||
30879731|NCT01680991|58911495|FG001|Overall Study|Withdrawal by Subject|1|||
30879732|NCT01680991|58911496|FG002|Overall Study|Withdrawal by Subject|0|||
30879733|NCT01680991|58911494|FG000|Overall Study|Progressive disease (PD)|0|||
30879734|NCT01680991|58911495|FG001|Overall Study|Progressive disease (PD)|10|||
30879735|NCT01680991|58911496|FG002|Overall Study|Progressive disease (PD)|0|||
30879736|NCT01680991|58911494|FG000|Overall Study|Physician Decision|0|||
30879737|NCT01680991|58911495|FG001|Overall Study|Physician Decision|7|||
30879738|NCT01680991|58911496|FG002|Overall Study|Physician Decision|2|||
30879739|NCT01680991|58911494|FG000|Overall Study|Bad physical condition|0|||
30879740|NCT01680991|58911495|FG001|Overall Study|Bad physical condition|0|||
30879741|NCT01680991|58911496|FG002|Overall Study|Bad physical condition|1|||
30879742|NCT01680991|58911494|FG000|Overall Study|PD confirmed in other hospital|1|||
30879743|NCT01680991|58911495|FG001|Overall Study|PD confirmed in other hospital|0|||
30879744|NCT01680991|58911496|FG002|Overall Study|PD confirmed in other hospital|0|||
30879745|NCT02819479|58911506|FG000|Overall Study|Adverse Event|2|||
30879746|NCT04064411|58911513|FG000|Overall Study|Adverse Event|29|||
30879747|NCT04064411|58911514|FG001|Overall Study|Adverse Event|19|||
30969083|NCT00070499|59040534|FG003|Overall Study|Still on protocol treatment|57|||
30879748|NCT04064411|58911513|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
30879749|NCT04064411|58911514|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
30879750|NCT04064411|58911513|FG000|Overall Study|Protocol Deviation|0|||
30879751|NCT04064411|58911514|FG001|Overall Study|Protocol Deviation|2|||
30879752|NCT04064411|58911513|FG000|Overall Study|Withdrawal by Subject|25|||
30879753|NCT04064411|58911514|FG001|Overall Study|Withdrawal by Subject|29|||
30879754|NCT04064411|58911513|FG000|Overall Study|Lost to Follow-up|5|||
30879755|NCT04064411|58911514|FG001|Overall Study|Lost to Follow-up|2|||
30879756|NCT04064411|58911513|FG000|Overall Study|Other than Specified|4|||
30879757|NCT04064411|58911514|FG001|Overall Study|Other than Specified|1|||
30879758|NCT04064411|58911513|FG000|Overall Study|Death|1|||
30879759|NCT04064411|58911514|FG001|Overall Study|Death|0|||
30879760|NCT02004691|58911522|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
30879761|NCT02004691|58911523|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
30879762|NCT02004691|58911522|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
30879763|NCT02004691|58911523|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
30879764|NCT02004691|58911522|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
30879765|NCT02004691|58911523|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
30879766|NCT02004691|58911522|FG000|ETP: Ongoing From Week 52|Other|0|||
30879767|NCT02004691|58911523|FG001|ETP: Ongoing From Week 52|Other|1|||
30879768|NCT02004691|58911522|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
30879769|NCT02004691|58911523|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
30879770|NCT02629133|58911531|FG000|Overall Study|Lost to Follow-up|3|||
30879771|NCT02629133|58911532|FG001|Overall Study|Lost to Follow-up|1|||
30879772|NCT02629133|58911531|FG000|Overall Study|Withdrawal by Subject|1|||
30879773|NCT02629133|58911532|FG001|Overall Study|Withdrawal by Subject|1|||
30879774|NCT02660359|58911541|FG000|Overall Study|Protocol Deviation|0|||
30879775|NCT02660359|58911542|FG001|Overall Study|Protocol Deviation|0|||
30879776|NCT02660359|58911543|FG002|Overall Study|Protocol Deviation|1|||
30879777|NCT02660359|58911541|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
30879778|NCT02660359|58911542|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
30879779|NCT02660359|58911543|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
30879780|NCT02660359|58911541|FG000|Overall Study|Lack of Efficacy|1|||
30879781|NCT02660359|58911542|FG001|Overall Study|Lack of Efficacy|1|||
30879782|NCT02660359|58911543|FG002|Overall Study|Lack of Efficacy|1|||
30879783|NCT02660359|58911541|FG000|Overall Study|Adverse Event|0|||
30879784|NCT02660359|58911542|FG001|Overall Study|Adverse Event|1|||
30879785|NCT02660359|58911543|FG002|Overall Study|Adverse Event|0|||
30879786|NCT02660359|58911541|FG000|Overall Study|Other|2|||
30879787|NCT02660359|58911542|FG001|Overall Study|Other|1|||
30879788|NCT02660359|58911543|FG002|Overall Study|Other|3|||
30879789|NCT02660359|58911541|FG000|Overall Study|Withdrawal by Subject|7|||
30879790|NCT02660359|58911542|FG001|Overall Study|Withdrawal by Subject|5|||
30879791|NCT02660359|58911543|FG002|Overall Study|Withdrawal by Subject|8|||
30879792|NCT02660359|58911541|FG000|Overall Study|Lost to Follow-up|3|||
30879793|NCT02660359|58911542|FG001|Overall Study|Lost to Follow-up|3|||
30879794|NCT02660359|58911543|FG002|Overall Study|Lost to Follow-up|0|||
30879795|NCT02628743|58911551|FG000|Overall Study|Other|3|||
30879796|NCT02628743|58911551|FG000|Overall Study|Withdrawal by Subject|50|||
30879797|NCT02628743|58911551|FG000|Overall Study|Study Terminated by Sponsor|76|||
30879798|NCT02628743|58911551|FG000|Overall Study|Physician Decision|2|||
30879799|NCT03839459|58911555|FG000|Overall Study|Withdrawal by Subject|2|||
30879800|NCT03839459|58911555|FG000|Overall Study|progression of disease|3|||
30879801|NCT02630693|58911561|FG000|Overall Study|No receive treatment|0|||
30879802|NCT02630693|58911562|FG001|Overall Study|No receive treatment|1|||
30879803|NCT05059301|58911571|FG000|Overall Study|Adverse Event|0|||
30879804|NCT05059301|58911572|FG001|Overall Study|Adverse Event|2|||
30879805|NCT05059301|58911573|FG002|Overall Study|Adverse Event|2|||
30879806|NCT05059301|58911571|FG000|Overall Study|Lost to Follow-up|2|||
30879807|NCT05059301|58911572|FG001|Overall Study|Lost to Follow-up|3|||
30879808|NCT05059301|58911573|FG002|Overall Study|Lost to Follow-up|3|||
30879809|NCT01938430|58911599|FG000|Overall Study|Randomized but Not Treated|0|||
30879810|NCT01938430|58911600|FG001|Overall Study|Randomized but Not Treated|0|||
30879811|NCT01938430|58911601|FG002|Overall Study|Randomized but Not Treated|0|||
30879812|NCT01938430|58911602|FG003|Overall Study|Randomized but Not Treated|0|||
30879813|NCT01938430|58911603|FG004|Overall Study|Randomized but Not Treated|0|||
30879814|NCT01938430|58911604|FG005|Overall Study|Randomized but Not Treated|0|||
30879815|NCT01938430|58911605|FG006|Overall Study|Randomized but Not Treated|0|||
30879816|NCT01938430|58911606|FG007|Overall Study|Randomized but Not Treated|0|||
30879817|NCT01938430|58911607|FG008|Overall Study|Randomized but Not Treated|0|||
30879818|NCT01938430|58911608|FG009|Overall Study|Randomized but Not Treated|0|||
30879819|NCT01938430|58911609|FG010|Overall Study|Randomized but Not Treated|1|||
30879820|NCT01938430|58911610|FG011|Overall Study|Randomized but Not Treated|0|||
30879821|NCT01938430|58911611|FG012|Overall Study|Randomized but Not Treated|0|||
30879822|NCT01938430|58911612|FG013|Overall Study|Randomized but Not Treated|1|||
30879823|NCT01938430|58911599|FG000|Overall Study|Adverse Event|0|||
30879824|NCT01938430|58911600|FG001|Overall Study|Adverse Event|0|||
30879825|NCT01938430|58911601|FG002|Overall Study|Adverse Event|0|||
30879826|NCT01938430|58911602|FG003|Overall Study|Adverse Event|0|||
30879827|NCT01938430|58911603|FG004|Overall Study|Adverse Event|0|||
30879828|NCT01938430|58911604|FG005|Overall Study|Adverse Event|0|||
30879829|NCT01938430|58911605|FG006|Overall Study|Adverse Event|1|||
30879830|NCT01938430|58911606|FG007|Overall Study|Adverse Event|0|||
30879831|NCT01938430|58911607|FG008|Overall Study|Adverse Event|0|||
30879832|NCT01938430|58911608|FG009|Overall Study|Adverse Event|0|||
30879833|NCT01938430|58911609|FG010|Overall Study|Adverse Event|0|||
30879834|NCT01938430|58911610|FG011|Overall Study|Adverse Event|0|||
30879835|NCT01938430|58911611|FG012|Overall Study|Adverse Event|0|||
30879836|NCT01938430|58911612|FG013|Overall Study|Adverse Event|0|||
30879837|NCT01938430|58911599|FG000|Overall Study|Death|1|||
30879838|NCT01938430|58911600|FG001|Overall Study|Death|2|||
30879839|NCT01938430|58911601|FG002|Overall Study|Death|2|||
30879840|NCT01938430|58911602|FG003|Overall Study|Death|1|||
30879841|NCT01938430|58911603|FG004|Overall Study|Death|0|||
30879842|NCT01938430|58911604|FG005|Overall Study|Death|0|||
30879843|NCT01938430|58911605|FG006|Overall Study|Death|1|||
30879844|NCT01938430|58911606|FG007|Overall Study|Death|1|||
30879845|NCT01938430|58911607|FG008|Overall Study|Death|2|||
30879846|NCT01938430|58911608|FG009|Overall Study|Death|3|||
30879847|NCT01938430|58911609|FG010|Overall Study|Death|0|||
30879848|NCT01938430|58911610|FG011|Overall Study|Death|0|||
30879849|NCT01938430|58911611|FG012|Overall Study|Death|0|||
30879850|NCT01938430|58911612|FG013|Overall Study|Death|0|||
30879851|NCT01938430|58911599|FG000|Overall Study|Investigator's Discretion|0|||
30879852|NCT01938430|58911600|FG001|Overall Study|Investigator's Discretion|0|||
30879853|NCT01938430|58911601|FG002|Overall Study|Investigator's Discretion|1|||
30879854|NCT01938430|58911602|FG003|Overall Study|Investigator's Discretion|0|||
30879855|NCT01938430|58911603|FG004|Overall Study|Investigator's Discretion|0|||
30879856|NCT01938430|58911604|FG005|Overall Study|Investigator's Discretion|0|||
30879857|NCT01938430|58911605|FG006|Overall Study|Investigator's Discretion|0|||
30879858|NCT01938430|58911606|FG007|Overall Study|Investigator's Discretion|0|||
30879859|NCT01938430|58911607|FG008|Overall Study|Investigator's Discretion|0|||
30879860|NCT01938430|58911608|FG009|Overall Study|Investigator's Discretion|0|||
30879861|NCT01938430|58911609|FG010|Overall Study|Investigator's Discretion|0|||
30879862|NCT01938430|58911610|FG011|Overall Study|Investigator's Discretion|0|||
30879863|NCT01938430|58911611|FG012|Overall Study|Investigator's Discretion|0|||
30879864|NCT01938430|58911612|FG013|Overall Study|Investigator's Discretion|0|||
30879865|NCT01938430|58911599|FG000|Overall Study|Lack of Efficacy|3|||
30879866|NCT01938430|58911600|FG001|Overall Study|Lack of Efficacy|1|||
30879867|NCT01938430|58911601|FG002|Overall Study|Lack of Efficacy|1|||
30879868|NCT01938430|58911602|FG003|Overall Study|Lack of Efficacy|1|||
30879869|NCT01938430|58911603|FG004|Overall Study|Lack of Efficacy|0|||
30879870|NCT01938430|58911604|FG005|Overall Study|Lack of Efficacy|0|||
30879871|NCT01938430|58911605|FG006|Overall Study|Lack of Efficacy|0|||
30879872|NCT01938430|58911606|FG007|Overall Study|Lack of Efficacy|0|||
30879873|NCT01938430|58911607|FG008|Overall Study|Lack of Efficacy|1|||
30879874|NCT01938430|58911608|FG009|Overall Study|Lack of Efficacy|0|||
30879875|NCT01938430|58911609|FG010|Overall Study|Lack of Efficacy|2|||
30879876|NCT01938430|58911610|FG011|Overall Study|Lack of Efficacy|1|||
30879877|NCT01938430|58911611|FG012|Overall Study|Lack of Efficacy|0|||
30879878|NCT01938430|58911612|FG013|Overall Study|Lack of Efficacy|0|||
30879879|NCT01938430|58911599|FG000|Overall Study|Lost to Follow-up|0|||
30879880|NCT01938430|58911600|FG001|Overall Study|Lost to Follow-up|0|||
30879881|NCT01938430|58911601|FG002|Overall Study|Lost to Follow-up|1|||
30879882|NCT01938430|58911602|FG003|Overall Study|Lost to Follow-up|0|||
30879883|NCT01938430|58911603|FG004|Overall Study|Lost to Follow-up|0|||
30879884|NCT01938430|58911604|FG005|Overall Study|Lost to Follow-up|1|||
30879885|NCT01938430|58911605|FG006|Overall Study|Lost to Follow-up|0|||
30879886|NCT01938430|58911606|FG007|Overall Study|Lost to Follow-up|0|||
30879887|NCT01938430|58911607|FG008|Overall Study|Lost to Follow-up|0|||
30879888|NCT01938430|58911608|FG009|Overall Study|Lost to Follow-up|0|||
30879889|NCT01938430|58911609|FG010|Overall Study|Lost to Follow-up|0|||
30879890|NCT01938430|58911610|FG011|Overall Study|Lost to Follow-up|0|||
30879891|NCT01938430|58911611|FG012|Overall Study|Lost to Follow-up|0|||
30879892|NCT01938430|58911612|FG013|Overall Study|Lost to Follow-up|0|||
30879893|NCT01938430|58911599|FG000|Overall Study|Withdrew Consent|0|||
30879894|NCT01938430|58911600|FG001|Overall Study|Withdrew Consent|0|||
30879895|NCT01938430|58911601|FG002|Overall Study|Withdrew Consent|0|||
30879896|NCT01938430|58911602|FG003|Overall Study|Withdrew Consent|0|||
30879897|NCT01938430|58911603|FG004|Overall Study|Withdrew Consent|0|||
30879898|NCT01938430|58911604|FG005|Overall Study|Withdrew Consent|0|||
30879899|NCT01938430|58911605|FG006|Overall Study|Withdrew Consent|0|||
30879900|NCT01938430|58911606|FG007|Overall Study|Withdrew Consent|0|||
30879901|NCT01938430|58911607|FG008|Overall Study|Withdrew Consent|1|||
30879902|NCT01938430|58911608|FG009|Overall Study|Withdrew Consent|0|||
30879903|NCT01938430|58911609|FG010|Overall Study|Withdrew Consent|0|||
30879904|NCT01938430|58911610|FG011|Overall Study|Withdrew Consent|0|||
30879905|NCT01938430|58911611|FG012|Overall Study|Withdrew Consent|0|||
30879906|NCT01938430|58911612|FG013|Overall Study|Withdrew Consent|0|||
30879907|NCT01937884|58911669|FG000|Overall Study|Withdrawal by Subject|1|||
30879908|NCT01937884|58911670|FG001|Overall Study|Withdrawal by Subject|0|||
30879909|NCT01916824|58911680|FG000|Overall Study|Lost to Follow-up|3|||
30879910|NCT01916824|58911681|FG001|Overall Study|Lost to Follow-up|6|||
30879911|NCT01916824|58911680|FG000|Overall Study|Physician Decision|2|||
30879912|NCT01916824|58911681|FG001|Overall Study|Physician Decision|0|||
30879913|NCT01916824|58911680|FG000|Overall Study|Withdrawal by Subject|2|||
30879914|NCT01916824|58911681|FG001|Overall Study|Withdrawal by Subject|3|||
30879915|NCT01915732|58911689|FG000|Overall Study|Withdrawal by Subject|18|||
30879916|NCT01915732|58911690|FG001|Overall Study|Withdrawal by Subject|18|||
30879917|NCT01915732|58911689|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
30879918|NCT01915732|58911690|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
30879919|NCT01915732|58911689|FG000|Overall Study|Adverse Event|12|||
30879920|NCT01915732|58911690|FG001|Overall Study|Adverse Event|4|||
30879921|NCT01915732|58911689|FG000|Overall Study|Protocol Violation|5|||
30879922|NCT01915732|58911690|FG001|Overall Study|Protocol Violation|5|||
30879923|NCT01915732|58911689|FG000|Overall Study|Lack of Efficacy|6|||
30879924|NCT01915732|58911690|FG001|Overall Study|Lack of Efficacy|11|||
30879925|NCT01915732|58911689|FG000|Overall Study|Lost to Follow-up|22|||
30879926|NCT01915732|58911690|FG001|Overall Study|Lost to Follow-up|26|||
30879927|NCT01915732|58911689|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
30879928|NCT01915732|58911690|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
30879929|NCT01915732|58911689|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
30879930|NCT01915732|58911690|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
30879931|NCT01915732|58911689|FG000|Overall Study|Drug Release Error|1|||
30879932|NCT01915732|58911690|FG001|Overall Study|Drug Release Error|0|||
30879933|NCT01915732|58911689|FG000|Overall Study|Recovered|1|||
30879934|NCT01915732|58911690|FG001|Overall Study|Recovered|0|||
30879935|NCT01915732|58911689|FG000|Overall Study|Pregnancy|1|||
30879936|NCT01915732|58911690|FG001|Overall Study|Pregnancy|0|||
30879937|NCT01915732|58911689|FG000|Overall Study|Poor Perceived Efficacy|1|||
30879938|NCT01915732|58911690|FG001|Overall Study|Poor Perceived Efficacy|0|||
30879939|NCT01915732|58911689|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
30879940|NCT01915732|58911690|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
30879941|NCT01915732|58911689|FG000|Overall Study|Got Well|0|||
30879942|NCT01915732|58911690|FG001|Overall Study|Got Well|1|||
30879943|NCT01915732|58911689|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
30879944|NCT01915732|58911690|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
30879945|NCT01915732|58911689|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
30879946|NCT01915732|58911690|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
30879947|NCT01915732|58911689|FG000|Overall Study|Job Transfer|0|||
30879948|NCT01915732|58911690|FG001|Overall Study|Job Transfer|1|||
30879949|NCT01915732|58911689|FG000|Overall Study|Improper Facial Procedure|0|||
30879950|NCT01915732|58911690|FG001|Overall Study|Improper Facial Procedure|1|||
30879951|NCT01915732|58911689|FG000|Overall Study|Poor Conscious Effect|0|||
30879952|NCT01915732|58911690|FG001|Overall Study|Poor Conscious Effect|1|||
30879953|NCT01936948|58911700|FG000|Overall Study|no 30-day follow-up data|0|||
30879954|NCT01936948|58911701|FG001|Overall Study|no 30-day follow-up data|3|||
30879955|NCT01936948|58911702|FG002|Overall Study|no 30-day follow-up data|3|||
30879956|NCT01936948|58911703|FG003|Overall Study|no 30-day follow-up data|3|||
30879957|NCT01936870|58911711|FG000|Overall Study|No Visit After Treatment|176|||
30879958|NCT01936870|58911711|FG000|Overall Study|Protocol Violation|12|||
30879959|NCT01936870|58911711|FG000|Overall Study|No Drug Administration|1|||
30879960|NCT01618864|58911715|FG000|Overall Study|Withdrawal by Subject|2|||
30879961|NCT01618864|58911715|FG000|Overall Study|Lost to Follow-up|2|||
30879962|NCT01618708|58911726|FG000|Overall Study|Adverse Event|10|||
30879963|NCT01618708|58911727|FG001|Overall Study|Adverse Event|10|||
30879964|NCT01618708|58911726|FG000|Overall Study|Lost to Follow-up|3|||
30879965|NCT01618708|58911727|FG001|Overall Study|Lost to Follow-up|3|||
30879966|NCT01618708|58911726|FG000|Overall Study|Withdrawal by Subject|17|||
30879967|NCT01618708|58911727|FG001|Overall Study|Withdrawal by Subject|22|||
30879968|NCT01618708|58911726|FG000|Overall Study|Lack of Efficacy|8|||
30879969|NCT01618708|58911727|FG001|Overall Study|Lack of Efficacy|8|||
30879970|NCT01618708|58911726|FG000|Overall Study|Technical problems|2|||
30879971|NCT01618708|58911727|FG001|Overall Study|Technical problems|0|||
30879972|NCT01618708|58911726|FG000|Overall Study|Other than specified above|1|||
30879973|NCT01618708|58911727|FG001|Overall Study|Other than specified above|1|||
30879974|NCT01618708|58911726|FG000|Overall Study|Randomized but not treated|3|||
30879975|NCT01618708|58911727|FG001|Overall Study|Randomized but not treated|2|||
30879976|NCT00790933|58911743|FG000|Overall Study|Adverse Event|94|||
30879977|NCT00790933|58911744|FG001|Overall Study|Adverse Event|119|||
30879978|NCT00790933|58911745|FG002|Overall Study|Adverse Event|65|||
30879979|NCT00790933|58911746|FG003|Overall Study|Adverse Event|5|||
30879980|NCT00790933|58911747|FG004|Overall Study|Adverse Event|69|||
30879981|NCT00790933|58911743|FG000|Overall Study|Protocol Violation(s)|8|||
30879982|NCT00790933|58911744|FG001|Overall Study|Protocol Violation(s)|18|||
30879983|NCT00790933|58911745|FG002|Overall Study|Protocol Violation(s)|7|||
30879984|NCT00790933|58911746|FG003|Overall Study|Protocol Violation(s)|0|||
30879985|NCT00790933|58911747|FG004|Overall Study|Protocol Violation(s)|12|||
30879986|NCT00790933|58911743|FG000|Overall Study|Lack of Efficacy|192|||
30879987|NCT00790933|58911744|FG001|Overall Study|Lack of Efficacy|176|||
30879988|NCT00790933|58911745|FG002|Overall Study|Lack of Efficacy|130|||
30879989|NCT00790933|58911746|FG003|Overall Study|Lack of Efficacy|1|||
30879990|NCT00790933|58911747|FG004|Overall Study|Lack of Efficacy|121|||
30879991|NCT00790933|58911743|FG000|Overall Study|Study Terminated by Sponsor|0|||
30879992|NCT00790933|58911744|FG001|Overall Study|Study Terminated by Sponsor|0|||
30879993|NCT00790933|58911745|FG002|Overall Study|Study Terminated by Sponsor|1|||
30879994|NCT00790933|58911746|FG003|Overall Study|Study Terminated by Sponsor|0|||
30879995|NCT00790933|58911747|FG004|Overall Study|Study Terminated by Sponsor|0|||
30879996|NCT00790933|58911743|FG000|Overall Study|Withdrawal by Subject|123|||
30879997|NCT00790933|58911744|FG001|Overall Study|Withdrawal by Subject|120|||
30879998|NCT00790933|58911745|FG002|Overall Study|Withdrawal by Subject|52|||
30879999|NCT00790933|58911746|FG003|Overall Study|Withdrawal by Subject|6|||
30880000|NCT00790933|58911747|FG004|Overall Study|Withdrawal by Subject|50|||
30880001|NCT00790933|58911743|FG000|Overall Study|Lost to Follow-up|13|||
30880002|NCT00790933|58911744|FG001|Overall Study|Lost to Follow-up|31|||
30880003|NCT00790933|58911745|FG002|Overall Study|Lost to Follow-up|10|||
30880004|NCT00790933|58911746|FG003|Overall Study|Lost to Follow-up|1|||
30880005|NCT00790933|58911747|FG004|Overall Study|Lost to Follow-up|15|||
30880006|NCT00790933|58911743|FG000|Overall Study|Reason Not Specified|8|||
30880007|NCT00790933|58911744|FG001|Overall Study|Reason Not Specified|16|||
30880008|NCT00790933|58911745|FG002|Overall Study|Reason Not Specified|4|||
30880009|NCT00790933|58911746|FG003|Overall Study|Reason Not Specified|1|||
30880010|NCT00790933|58911747|FG004|Overall Study|Reason Not Specified|9|||
30880011|NCT02161211|58911766|FG000|Overall Study|Lost to Follow-up|21|||
30880012|NCT02161211|58911767|FG001|Overall Study|Lost to Follow-up|27|||
30880013|NCT02161211|58911768|FG002|Overall Study|Lost to Follow-up|21|||
30880014|NCT02161211|58911766|FG000|Overall Study|Dropped|12|||
30880015|NCT02161211|58911767|FG001|Overall Study|Dropped|5|||
30880016|NCT02161211|58911768|FG002|Overall Study|Dropped|9|||
30880017|NCT01676701|58911778|FG000|Overall Study|Protocol Violation|1|||
30880018|NCT01676701|58911779|FG001|Overall Study|Protocol Violation|0|||
30880019|NCT01676701|58911778|FG000|Overall Study|Sponsor Decision|3|||
30880020|NCT01676701|58911779|FG001|Overall Study|Sponsor Decision|4|||
30880021|NCT01670279|58911790|FG000|Overall Study|Adverse Event|0|||
30880022|NCT01670279|58911791|FG001|Overall Study|Adverse Event|1|||
30880023|NCT01670279|58911792|FG002|Overall Study|Adverse Event|0|||
30880024|NCT01670279|58911793|FG003|Overall Study|Adverse Event|0|||
30880025|NCT01670279|58911790|FG000|Overall Study|Physician Decision|0|||
30880026|NCT01670279|58911791|FG001|Overall Study|Physician Decision|1|||
30880027|NCT01670279|58911792|FG002|Overall Study|Physician Decision|0|||
30880028|NCT01670279|58911793|FG003|Overall Study|Physician Decision|0|||
30880029|NCT01670279|58911790|FG000|Overall Study|Participant met withdrawal criteria|0|||
30880030|NCT01670279|58911791|FG001|Overall Study|Participant met withdrawal criteria|0|||
30880031|NCT01670279|58911792|FG002|Overall Study|Participant met withdrawal criteria|0|||
30880032|NCT01670279|58911793|FG003|Overall Study|Participant met withdrawal criteria|1|||
30880033|NCT02627495|58911801|FG000|Overall Study|Withdrawal by Subject|4|||
30880034|NCT01670045|58911805|FG000|Overall Study|Withdrawal by Subject|3|||
30880035|NCT01670045|58911805|FG000|Overall Study|Adverse Event|1|||
30880036|NCT01670045|58911805|FG000|Overall Study|Death|1|||
30880037|NCT01670045|58911805|FG000|Overall Study|Lost to Follow-up|11|||
30880038|NCT01669421|58911809|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
30880039|NCT01669421|58911809|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
30880040|NCT01671059|58911823|FG000|Overall Study|Adverse Event|4|||
30880041|NCT01671059|58911823|FG000|Overall Study|Lack of Efficacy|1|||
30880042|NCT01669811|58911839|FG000|Overall Study|Investigator decision|0|||
30880043|NCT01669811|58911840|FG001|Overall Study|Investigator decision|1|||
30880044|NCT01669811|58911839|FG000|Overall Study|Withdrawal by Subject|1|||
30880045|NCT01669811|58911840|FG001|Overall Study|Withdrawal by Subject|2|||
30880046|NCT01669811|58911839|FG000|Overall Study|Adverse Event|2|||
30880047|NCT01669811|58911840|FG001|Overall Study|Adverse Event|6|||
30880048|NCT01669811|58911839|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
30880049|NCT01669811|58911840|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
30880050|NCT01669577|58911846|FG000|Overall Study|Death|22|||
30880051|NCT01669577|58911846|FG000|Overall Study|Lost to Follow-up|78|||
30880052|NCT01669577|58911846|FG000|Overall Study|Physician Decision|34|||
30880053|NCT02658175|58911853|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
30880054|NCT02658175|58911854|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
30880055|NCT02658175|58911855|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
30880056|NCT02658175|58911853|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
30880057|NCT02658175|58911854|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
30880058|NCT02658175|58911855|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
30880059|NCT02658175|58911853|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
30880060|NCT02658175|58911854|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
30880061|NCT02658175|58911855|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
30880062|NCT02658175|58911853|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
30880063|NCT02658175|58911854|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
30880064|NCT02658175|58911855|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
30880065|NCT02658175|58911853|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
30880066|NCT02658175|58911854|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
30880067|NCT02658175|58911855|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
30880068|NCT02658175|58911853|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
30880069|NCT02658175|58911854|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
30880070|NCT02658175|58911855|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
30880071|NCT02658175|58911853|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
30880072|NCT02658175|58911854|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
30880073|NCT02658175|58911855|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
30880074|NCT02658175|58911853|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
30880075|NCT02658175|58911854|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
30880076|NCT02658175|58911855|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
30880077|NCT02658175|58911853|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
30880078|NCT02658175|58911854|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
30880079|NCT02658175|58911855|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
30880080|NCT02658175|58911853|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
30880081|NCT02658175|58911854|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
30880082|NCT02658175|58911855|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
30880083|NCT02625623|58911865|FG000|Overall Study|Participants randomized but not treated|9|||
30880084|NCT02625623|58911866|FG001|Overall Study|Participants randomized but not treated|1|||
30880085|NCT02658019|58911874|FG000|Overall Study|Adverse Event|1|||
30880086|NCT02624687|58911880|FG000|Overall Study|Withdrawal by Subject|1|||
30880087|NCT02624687|58911881|FG001|Overall Study|Withdrawal by Subject|1|||
30880088|NCT02624687|58911880|FG000|Overall Study|medical leave from work|0|||
30880089|NCT02624687|58911881|FG001|Overall Study|medical leave from work|1|||
30880090|NCT01675765|58911889|FG000|Overall Study|Progressive disease|4|||
30880091|NCT01675765|58911890|FG001|Overall Study|Progressive disease|4|||
30880092|NCT01675765|58911889|FG000|Overall Study|Adverse Event|1|||
30880093|NCT01675765|58911890|FG001|Overall Study|Adverse Event|2|||
30880094|NCT01675765|58911889|FG000|Overall Study|Withdrawal by Subject|2|||
30880095|NCT01675765|58911890|FG001|Overall Study|Withdrawal by Subject|0|||
30880096|NCT01675765|58911889|FG000|Overall Study|Death|1|||
30880097|NCT01675765|58911890|FG001|Overall Study|Death|0|||
30880098|NCT01675765|58911889|FG000|Overall Study|Clinical progression|3|||
30880099|NCT01675765|58911890|FG001|Overall Study|Clinical progression|2|||
30880100|NCT02625233|58911898|FG000|Overall Study|Adverse Event|2|||
30880101|NCT02625233|58911899|FG001|Overall Study|Adverse Event|0|||
30880102|NCT02656693|58911908|FG000|Overall Study|Pregnancy|1|||
30880103|NCT02656693|58911909|FG001|Overall Study|Pregnancy|1|||
30880104|NCT02656693|58911910|FG002|Overall Study|Pregnancy|1|||
30880105|NCT02656693|58911908|FG000|Overall Study|Bariatric surgery|0|||
30880106|NCT02656693|58911909|FG001|Overall Study|Bariatric surgery|1|||
30880107|NCT02656693|58911910|FG002|Overall Study|Bariatric surgery|2|||
30880108|NCT02633293|58911918|FG000|Overall Study|Death|56|||
30880109|NCT02633293|58911918|FG000|Overall Study|Progressive Disease|12|||
30880110|NCT02633293|58911918|FG000|Overall Study|Adverse Event|29|||
30880111|NCT02633293|58911918|FG000|Overall Study|Withdrawal by Subject|41|||
30880112|NCT02633293|58911918|FG000|Overall Study|Protocol Violation|1|||
30880113|NCT02633293|58911918|FG000|Overall Study|Lost to Follow-up|1|||
30880114|NCT02633293|58911918|FG000|Overall Study|Study Terminated by Sponsor|24|||
30880115|NCT02633293|58911918|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
30880116|NCT02633293|58911918|FG000|Overall Study|Lung Transplant|5|||
30880117|NCT02633293|58911918|FG000|Overall Study|Lack of Efficacy|2|||
30880118|NCT02633293|58911918|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
30880119|NCT02623829|58911924|FG000|Overall Study|Lost to Follow-up|1|||
30880120|NCT02623829|58911925|FG001|Overall Study|Lost to Follow-up|1|||
30880121|NCT02655679|58911936|FG000|Overall Study|Adverse Event|0|||
30880122|NCT02655679|58911937|FG001|Overall Study|Adverse Event|1|||
30880123|NCT02655679|58911938|FG002|Overall Study|Adverse Event|0|||
30880124|NCT02655679|58911939|FG003|Overall Study|Adverse Event|0|||
30880125|NCT02655679|58911940|FG004|Overall Study|Adverse Event|0|||
30880126|NCT02655679|58911936|FG000|Overall Study|Withdrawal by Subject|1|||
30880127|NCT02655679|58911937|FG001|Overall Study|Withdrawal by Subject|1|||
30880128|NCT02655679|58911938|FG002|Overall Study|Withdrawal by Subject|0|||
30880129|NCT02655679|58911939|FG003|Overall Study|Withdrawal by Subject|3|||
30880130|NCT02655679|58911940|FG004|Overall Study|Withdrawal by Subject|1|||
30880131|NCT02655679|58911936|FG000|Overall Study|Inability to Comply with the Protocol|1|||
30880132|NCT02655679|58911937|FG001|Overall Study|Inability to Comply with the Protocol|0|||
30880133|NCT02655679|58911938|FG002|Overall Study|Inability to Comply with the Protocol|0|||
30880134|NCT02655679|58911939|FG003|Overall Study|Inability to Comply with the Protocol|0|||
30880135|NCT02655679|58911940|FG004|Overall Study|Inability to Comply with the Protocol|0|||
30880136|NCT02655679|58911936|FG000|Overall Study|Lost to Follow-up|0|||
30880137|NCT02655679|58911937|FG001|Overall Study|Lost to Follow-up|1|||
30880138|NCT02655679|58911938|FG002|Overall Study|Lost to Follow-up|1|||
30880139|NCT02655679|58911939|FG003|Overall Study|Lost to Follow-up|1|||
30880140|NCT02655679|58911940|FG004|Overall Study|Lost to Follow-up|0|||
30880141|NCT02655679|58911936|FG000|Overall Study|Other Miscellaneous Reasons|1|||
30880142|NCT02655679|58911937|FG001|Overall Study|Other Miscellaneous Reasons|0|||
30880143|NCT02655679|58911938|FG002|Overall Study|Other Miscellaneous Reasons|0|||
30880144|NCT02655679|58911939|FG003|Overall Study|Other Miscellaneous Reasons|0|||
30880145|NCT02655679|58911940|FG004|Overall Study|Other Miscellaneous Reasons|0|||
30880146|NCT02623361|58911955|FG000|Overall Study|Protocol Violation|0|||
30880147|NCT02623361|58911956|FG001|Overall Study|Protocol Violation|1|||
30880148|NCT02623361|58911955|FG000|Overall Study|Withdrawal by Subject|0|||
30880149|NCT02623361|58911956|FG001|Overall Study|Withdrawal by Subject|1|||
30880150|NCT01675531|58911984|FG000|Overall Study|Adverse Event|9|||
30880151|NCT01675531|58911984|FG000|Overall Study|Withdrawal by Subject|7|||
30880152|NCT01675531|58911984|FG000|Overall Study|Lack of Efficacy|1|||
30880153|NCT01675531|58911984|FG000|Overall Study|Protocol Violation|8|||
30880154|NCT02532543|58911993|FG000|Overall Study|Lost to Follow-up|0|||
30880155|NCT02532543|58911994|FG001|Overall Study|Lost to Follow-up|0|||
30880156|NCT02532543|58911995|FG002|Overall Study|Lost to Follow-up|1|||
30880157|NCT02532543|58911996|FG003|Overall Study|Lost to Follow-up|0|||
30880158|NCT02532465|58912008|FG000|Overall Study|Protocol Violation|1|||
30880159|NCT02532465|58912009|FG001|Overall Study|Protocol Violation|0|||
30880160|NCT02532465|58912008|FG000|Overall Study|Lack of Efficacy|0|||
30880161|NCT02532465|58912009|FG001|Overall Study|Lack of Efficacy|1|||
30880162|NCT02528331|58912015|FG000|Overall Study|Withdrawal by Subject|2|||
30880163|NCT02654977|58912019|FG000|Overall Study|Death|1|||
30880164|NCT02654977|58912019|FG000|Overall Study|Lost to Follow-up|1|||
30880165|NCT02654977|58912019|FG000|Overall Study|Adverse Event|1|||
30880166|NCT02654977|58912019|FG000|Overall Study|Withdrawal by Subject|1|||
30880167|NCT02654977|58912019|FG000|Overall Study|Lack of Efficacy|3|||
30880168|NCT01362517|58912023|FG000|Overall Study|Protocol Violation|1|||
30880169|NCT01362517|58912023|FG000|Overall Study|Lost to Follow-up|1|||
30880170|NCT01362439|58912030|FG000|Overall Study|Adverse Event|1|||
30880171|NCT01362439|58912030|FG000|Overall Study|Lack of Efficacy|3|||
30880172|NCT01362439|58912030|FG000|Overall Study|Lost to Follow-up|2|||
30880173|NCT01362439|58912030|FG000|Overall Study|Study medication non-compliant|1|||
30880174|NCT01362439|58912030|FG000|Overall Study|Participant who withdrew consent|8|||
30880175|NCT02653495|58912037|FG000|Overall Study|Lost to Follow-up|2|||
30880176|NCT02653495|58912038|FG001|Overall Study|Lost to Follow-up|0|||
30880177|NCT02653495|58912037|FG000|Overall Study|Screening Failure|10|||
30880178|NCT02653495|58912038|FG001|Overall Study|Screening Failure|0|||
30880179|NCT01675141|58912044|FG000|Overall Study|Lenalidomide outside NIH|3|||
30880180|NCT01675141|58912044|FG000|Overall Study|Withdrawal by Subject|3|||
30880181|NCT01675141|58912044|FG000|Overall Study|Physician Decision|4|||
30880182|NCT01675141|58912044|FG000|Overall Study|No treatment, per protocol|1|||
30880183|NCT03367819|58912079|FG000|Overall Study|Adverse Event|4|||
30880184|NCT03367819|58912080|FG001|Overall Study|Adverse Event|4|||
30880185|NCT03367819|58912079|FG000|Overall Study|Progressive Disease|15|||
30880186|NCT03367819|58912080|FG001|Overall Study|Progressive Disease|13|||
30880187|NCT03367819|58912079|FG000|Overall Study|Withdrawal by Subject|1|||
30880188|NCT03367819|58912080|FG001|Overall Study|Withdrawal by Subject|0|||
30880189|NCT03367819|58912079|FG000|Overall Study|Other|4|||
30880190|NCT03367819|58912080|FG001|Overall Study|Other|2|||
30880191|NCT01597193|58912123|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
30880192|NCT01597193|58912124|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
30880193|NCT01597193|58912125|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
30880194|NCT01597193|58912126|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
30880195|NCT01597193|58912127|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
30880196|NCT01597193|58912128|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
30880197|NCT01597193|58912129|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
30880198|NCT01597193|58912123|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
30880199|NCT01597193|58912124|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
30880200|NCT01597193|58912125|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
30880201|NCT01597193|58912126|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
30880202|NCT01597193|58912127|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
30969084|NCT00070499|59040531|FG000|Overall Study|Did not start treatment|1|||
30969085|NCT00070499|59040532|FG001|Overall Study|Did not start treatment|0|||
30969086|NCT00070499|59040533|FG002|Overall Study|Did not start treatment|0|||
30969087|NCT00070499|59040534|FG003|Overall Study|Did not start treatment|2|||
30969088|NCT00070499|59040531|FG000|Overall Study|Not eligible|2|||
30969089|NCT00070499|59040532|FG001|Overall Study|Not eligible|5|||
30969090|NCT00070499|59040533|FG002|Overall Study|Not eligible|3|||
30969091|NCT00070499|59040534|FG003|Overall Study|Not eligible|2|||
30969092|NCT00066573|59040554|FG000|Overall Study|Did not received protocol treatment|28|||
30969093|NCT00066573|59040555|FG001|Overall Study|Did not received protocol treatment|28|||
30969094|NCT03594955|59040561|FG000|Overall Study|Adverse Event|1|||
30969095|NCT03594955|59040561|FG000|Overall Study|Progressive disease|5|||
30969096|NCT03594955|59040561|FG000|Overall Study|Sponsor's decision|1|||
30969097|NCT01677624|59040589|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
30969098|NCT01272219|59040610|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
30969099|NCT01272219|59040611|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
30969100|NCT01272219|59040612|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
30969101|NCT01272219|59040613|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
30969102|NCT01272219|59040614|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
30969103|NCT01272219|59040615|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
30969104|NCT01272219|59040610|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
30969105|NCT01272219|59040611|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
30969106|NCT01272219|59040612|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
30969107|NCT01272219|59040613|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
30969108|NCT01272219|59040614|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
30969109|NCT01272219|59040615|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
30969110|NCT01272219|59040610|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
30969111|NCT01272219|59040611|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
30969112|NCT01272219|59040612|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
30969113|NCT01272219|59040613|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
30969114|NCT01272219|59040614|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
30969115|NCT01272219|59040615|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
30969116|NCT01272219|59040610|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
30969117|NCT01272219|59040611|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
30969118|NCT01272219|59040612|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
30969119|NCT01272219|59040613|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
30969120|NCT01272219|59040614|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
30969121|NCT01272219|59040615|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
30969122|NCT01272219|59040610|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
30969123|NCT01272219|59040611|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
30969124|NCT01272219|59040612|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
30969125|NCT01272219|59040613|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
30969126|NCT01272219|59040614|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
30969127|NCT01272219|59040615|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
30969128|NCT01272219|59040610|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
30969129|NCT01272219|59040611|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
30969130|NCT01272219|59040612|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
30969131|NCT01272219|59040613|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
30969132|NCT01272219|59040614|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
30969133|NCT01272219|59040615|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
30969134|NCT01272219|59040610|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
30969135|NCT01272219|59040611|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
30969136|NCT01272219|59040612|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
30969137|NCT01272219|59040613|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
30969138|NCT01272219|59040614|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
30969139|NCT01272219|59040615|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
30969140|NCT01272219|59040610|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
30969141|NCT01272219|59040611|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
30969142|NCT01272219|59040612|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
30969143|NCT01272219|59040613|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
30969144|NCT01272219|59040614|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
30969145|NCT01272219|59040615|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
30969146|NCT01272219|59040610|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
30969147|NCT01272219|59040611|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
30969148|NCT01272219|59040612|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
30969149|NCT01272219|59040613|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
30969150|NCT01272219|59040614|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
30969151|NCT01272219|59040615|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
30969152|NCT01272219|59040610|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
30969153|NCT01272219|59040611|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
30969154|NCT01272219|59040612|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
30969155|NCT01272219|59040613|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
30969156|NCT01272219|59040614|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
30969157|NCT01272219|59040615|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
30969158|NCT01272219|59040610|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
30969159|NCT01272219|59040611|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
30969160|NCT01272219|59040612|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
30969161|NCT01272219|59040613|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
30969162|NCT01272219|59040614|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
30969163|NCT01272219|59040615|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
30790010|NCT00066365|58803248|FG001|Overall Study|Ineligible|2|||
30969164|NCT01272219|59040610|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
30969165|NCT01272219|59040611|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
30969166|NCT01272219|59040612|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
30969167|NCT01272219|59040613|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
30969168|NCT01272219|59040614|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
30969169|NCT01272219|59040615|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
30969170|NCT01272219|59040610|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
30969171|NCT01272219|59040611|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
30969172|NCT01272219|59040612|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
30969173|NCT01272219|59040613|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
30969174|NCT01272219|59040614|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
30969175|NCT01272219|59040615|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
30969176|NCT01272219|59040610|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
30969177|NCT01272219|59040611|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
30969178|NCT01272219|59040612|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
30969179|NCT01272219|59040613|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
30969180|NCT01272219|59040614|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
30969181|NCT01272219|59040615|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
30969182|NCT01272219|59040610|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
30969183|NCT01272219|59040611|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
30969184|NCT01272219|59040612|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
30969185|NCT01272219|59040613|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
30969186|NCT01272219|59040614|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
30969187|NCT01272219|59040615|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
30969188|NCT01272219|59040610|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
30969189|NCT01272219|59040611|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
30969190|NCT01272219|59040612|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
30969191|NCT01272219|59040613|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
30969192|NCT01272219|59040614|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
30969193|NCT01272219|59040615|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
30969194|NCT01510028|59040632|FG000|Overall Study|Lack of Efficacy|1|||
30969195|NCT01510028|59040633|FG001|Overall Study|Lack of Efficacy|0|||
30969196|NCT01510028|59040634|FG002|Overall Study|Lack of Efficacy|0|||
30969197|NCT01510028|59040635|FG003|Overall Study|Lack of Efficacy|0|||
30969198|NCT01521494|59040656|FG000|Overall Study|Adverse Event|1|||
30969199|NCT01521494|59040657|FG001|Overall Study|Adverse Event|2|||
30969200|NCT01521494|59040658|FG002|Overall Study|Adverse Event|9|||
30969201|NCT01521494|59040659|FG003|Overall Study|Adverse Event|6|||
30969202|NCT01521494|59040660|FG004|Overall Study|Adverse Event|2|||
30969203|NCT01521494|59040656|FG000|Overall Study|Lack of Efficacy|0|||
30969204|NCT01521494|59040657|FG001|Overall Study|Lack of Efficacy|0|||
30969205|NCT01521494|59040658|FG002|Overall Study|Lack of Efficacy|0|||
30969206|NCT01521494|59040659|FG003|Overall Study|Lack of Efficacy|0|||
30969207|NCT01521494|59040660|FG004|Overall Study|Lack of Efficacy|2|||
30969208|NCT01521494|59040656|FG000|Overall Study|Withdrawal by Subject|1|||
30969209|NCT01521494|59040657|FG001|Overall Study|Withdrawal by Subject|1|||
30969210|NCT01521494|59040658|FG002|Overall Study|Withdrawal by Subject|0|||
30969211|NCT01521494|59040659|FG003|Overall Study|Withdrawal by Subject|2|||
30969212|NCT01521494|59040660|FG004|Overall Study|Withdrawal by Subject|0|||
30969213|NCT01521494|59040656|FG000|Overall Study|Decrease in serum phosphate|0|||
30969214|NCT01521494|59040657|FG001|Overall Study|Decrease in serum phosphate|2|||
30969215|NCT01521494|59040658|FG002|Overall Study|Decrease in serum phosphate|3|||
30969216|NCT01521494|59040659|FG003|Overall Study|Decrease in serum phosphate|12|||
30969217|NCT01521494|59040660|FG004|Overall Study|Decrease in serum phosphate|0|||
30969218|NCT01521494|59040656|FG000|Overall Study|Decrease in serum calcium|0|||
30969219|NCT01521494|59040657|FG001|Overall Study|Decrease in serum calcium|0|||
30969220|NCT01521494|59040658|FG002|Overall Study|Decrease in serum calcium|0|||
30969221|NCT01521494|59040659|FG003|Overall Study|Decrease in serum calcium|1|||
30969222|NCT01521494|59040660|FG004|Overall Study|Decrease in serum calcium|1|||
30969223|NCT01521494|59040656|FG000|Overall Study|Physician Decision|0|||
30969224|NCT01521494|59040657|FG001|Overall Study|Physician Decision|0|||
30969225|NCT01521494|59040658|FG002|Overall Study|Physician Decision|0|||
30969226|NCT01521494|59040659|FG003|Overall Study|Physician Decision|0|||
30969227|NCT01521494|59040660|FG004|Overall Study|Physician Decision|2|||
30969228|NCT01270971|59040674|FG000|Overall Study|Withdrawal by Subject|24|||
30969229|NCT01270971|59040675|FG001|Overall Study|Withdrawal by Subject|11|||
30969230|NCT01270971|59040674|FG000|Overall Study|Lost to Follow-up|18|||
30969231|NCT01270971|59040675|FG001|Overall Study|Lost to Follow-up|5|||
30969232|NCT01270971|59040674|FG000|Overall Study|Adverse Event|1|||
30969233|NCT01270971|59040675|FG001|Overall Study|Adverse Event|2|||
30969234|NCT01270971|59040674|FG000|Overall Study|Non compliance|2|||
30969235|NCT01270971|59040675|FG001|Overall Study|Non compliance|2|||
30969236|NCT01270971|59040674|FG000|Overall Study|Non-specific|7|||
30969237|NCT01270971|59040675|FG001|Overall Study|Non-specific|3|||
30969238|NCT01270503|59040702|FG000|Overall Study|Lost to Follow-up|1|||
30969239|NCT01277211|59040719|FG000|Overall Study|Adverse Event|60|||
30969240|NCT01277211|59040720|FG001|Overall Study|Adverse Event|22|||
30969241|NCT01277211|59040719|FG000|Overall Study|Pregnancy|9|||
30969242|NCT01277211|59040720|FG001|Overall Study|Pregnancy|4|||
30969243|NCT01277211|59040719|FG000|Overall Study|Lost to Follow-up|14|||
30969244|NCT01277211|59040720|FG001|Overall Study|Lost to Follow-up|9|||
30969245|NCT01277211|59040719|FG000|Overall Study|Did not wish to continue|17|||
30969246|NCT01277211|59040720|FG001|Overall Study|Did not wish to continue|0|||
30969247|NCT01277211|59040719|FG000|Overall Study|Withdrew Consent|9|||
30969248|NCT01277211|59040720|FG001|Overall Study|Withdrew Consent|9|||
30969249|NCT01277211|59040719|FG000|Overall Study|Non-compliance with protocol|13|||
30969250|NCT01277211|59040720|FG001|Overall Study|Non-compliance with protocol|4|||
30969251|NCT01277211|59040719|FG000|Overall Study|Did not meet protocol eligibility|1|||
30969252|NCT01277211|59040720|FG001|Overall Study|Did not meet protocol eligibility|0|||
30969253|NCT01277211|59040719|FG000|Overall Study|Administrative|3|||
30969254|NCT01277211|59040720|FG001|Overall Study|Administrative|0|||
30969255|NCT01277211|59040719|FG000|Overall Study|Pregnancy wish|0|||
30969256|NCT01277211|59040720|FG001|Overall Study|Pregnancy wish|2|||
30969257|NCT01277211|59040719|FG000|Overall Study|Discontinued prior to treatment|24|||
30969258|NCT01277211|59040720|FG001|Overall Study|Discontinued prior to treatment|13|||
30969259|NCT01676220|59040728|FG000|Overall Study|Randomized But Not Treated|4|||
30969260|NCT01676220|59040729|FG001|Overall Study|Randomized But Not Treated|1|||
30969261|NCT01676220|59040728|FG000|Overall Study|Adverse Event|10|||
30969262|NCT01676220|59040729|FG001|Overall Study|Adverse Event|8|||
30969263|NCT01676220|59040728|FG000|Overall Study|Lack of Efficacy|2|||
30969264|NCT01676220|59040729|FG001|Overall Study|Lack of Efficacy|5|||
30969265|NCT01676220|59040728|FG000|Overall Study|Protocol Violation|11|||
30969266|NCT01676220|59040729|FG001|Overall Study|Protocol Violation|12|||
30969267|NCT01676220|59040728|FG000|Overall Study|Received Rescue Therapy|14|||
30969268|NCT01676220|59040729|FG001|Overall Study|Received Rescue Therapy|22|||
30969269|NCT01676220|59040728|FG000|Overall Study|Personal Reason|34|||
30969270|NCT01676220|59040729|FG001|Overall Study|Personal Reason|45|||
30969271|NCT01676220|59040728|FG000|Overall Study|Lost to Follow-up|11|||
30969272|NCT01676220|59040729|FG001|Overall Study|Lost to Follow-up|18|||
30969273|NCT01676220|59040728|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
30969274|NCT01676220|59040729|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
30969275|NCT01676220|59040728|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
30969276|NCT01676220|59040729|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
30969277|NCT01676220|59040728|FG000|Overall Study|Perceived Lack of Efficacy|3|||
30969278|NCT01676220|59040729|FG001|Overall Study|Perceived Lack of Efficacy|1|||
30969279|NCT01676220|59040728|FG000|Overall Study|Non Serious Hypoglycemia|2|||
30969280|NCT01676220|59040729|FG001|Overall Study|Non Serious Hypoglycemia|0|||
30969281|NCT01676220|59040728|FG000|Overall Study|No More Need of Insulin|1|||
30969282|NCT01676220|59040729|FG001|Overall Study|No More Need of Insulin|0|||
30969283|NCT01485614|59040759|FG000|Randomization|Not Treated|1|||
30969284|NCT01485614|59040760|FG001|Randomization|Not Treated|0|||
30969285|NCT01485614|59040761|FG002|Randomization|Not Treated|0|||
30969286|NCT01485614|59040762|FG003|Randomization|Not Treated|0|||
30969287|NCT01485614|59040759|FG000|Weeks 0-20|Lost to Follow-up|2|||
30969288|NCT01485614|59040760|FG001|Weeks 0-20|Lost to Follow-up|0|||
30969289|NCT01485614|59040761|FG002|Weeks 0-20|Lost to Follow-up|0|||
30969290|NCT01485614|59040762|FG003|Weeks 0-20|Lost to Follow-up|0|||
30969291|NCT01485614|59040759|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
30969292|NCT01485614|59040760|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
30969293|NCT01485614|59040761|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
30969294|NCT01485614|59040762|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
30969295|NCT01485614|59040759|FG000|Weeks 0-20|Withdrawal by Subject|3|||
30969296|NCT01485614|59040760|FG001|Weeks 0-20|Withdrawal by Subject|2|||
30969297|NCT01485614|59040761|FG002|Weeks 0-20|Withdrawal by Subject|1|||
30969298|NCT01485614|59040762|FG003|Weeks 0-20|Withdrawal by Subject|0|||
30969299|NCT01485614|59040759|FG000|Weeks 20-54|Lost to Follow-up|4|||
30969300|NCT01485614|59040760|FG001|Weeks 20-54|Lost to Follow-up|3|||
30969301|NCT01485614|59040761|FG002|Weeks 20-54|Lost to Follow-up|1|||
30969302|NCT01485614|59040762|FG003|Weeks 20-54|Lost to Follow-up|0|||
30969303|NCT01485614|59040759|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
30969304|NCT01485614|59040760|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
30969305|NCT01485614|59040761|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
30969306|NCT01485614|59040762|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
30969307|NCT01485614|59040759|FG000|Weeks 20-54|Withdrawal by Subject|5|||
30969308|NCT01485614|59040760|FG001|Weeks 20-54|Withdrawal by Subject|3|||
30969309|NCT01485614|59040761|FG002|Weeks 20-54|Withdrawal by Subject|0|||
30969310|NCT01485614|59040762|FG003|Weeks 20-54|Withdrawal by Subject|0|||
30969311|NCT01485536|59040812|FG000|Overall Study|Withdrawal by Subject|3|||
30969312|NCT01485536|59040812|FG000|Overall Study|Adverse Event|1|||
30969313|NCT02658630|59040816|FG000|Overall Study|Withdrawal by Subject|4|||
30969314|NCT01484912|59040822|FG000|Overall Study|Withdrawal by Subject|1|||
30969315|NCT01484912|59040823|FG001|Overall Study|Withdrawal by Subject|0|||
30969316|NCT01484912|59040822|FG000|Overall Study|Physician Decision|0|||
30969317|NCT01484912|59040823|FG001|Overall Study|Physician Decision|1|||
30969318|NCT01520870|59040829|FG000|Overall Study|Withdrawal by Subject|2|||
30969319|NCT01520714|59040835|FG000|Overall Study|Protocol Violation|0|||
30969320|NCT01520714|59040836|FG001|Overall Study|Protocol Violation|3|||
30969321|NCT01520714|59040835|FG000|Overall Study|Adverse Event|0|||
30969322|NCT01520714|59040836|FG001|Overall Study|Adverse Event|2|||
30969323|NCT01520714|59040835|FG000|Overall Study|Lack of Efficacy|0|||
30969324|NCT01520714|59040836|FG001|Overall Study|Lack of Efficacy|1|||
30969325|NCT02659098|59040855|FG000|Overall Study|Withdrawal by Subject|7|||
30969326|NCT01508936|59040866|FG000|Overall Study|Adverse Event|11|||
30969327|NCT01508936|59040867|FG001|Overall Study|Adverse Event|32|||
30969328|NCT01508936|59040866|FG000|Overall Study|Lack of Efficacy|0|||
30969329|NCT01508936|59040867|FG001|Overall Study|Lack of Efficacy|1|||
30969330|NCT01508936|59040866|FG000|Overall Study|Withdrawal by Subject|4|||
30969331|NCT01508936|59040867|FG001|Overall Study|Withdrawal by Subject|18|||
30969332|NCT01508936|59040866|FG000|Overall Study|Protocol Violation|2|||
30969333|NCT01508936|59040867|FG001|Overall Study|Protocol Violation|3|||
30969334|NCT01508936|59040866|FG000|Overall Study|Lost to Follow-up|2|||
30969335|NCT01508936|59040867|FG001|Overall Study|Lost to Follow-up|9|||
30969336|NCT01508936|59040866|FG000|Overall Study|Other|0|||
30969337|NCT01508936|59040867|FG001|Overall Study|Other|5|||
30969338|NCT01508936|59040866|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
30969339|NCT01508936|59040867|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
30969340|NCT01508702|59040888|FG000|Overall Study|Adverse Event|7|||
30969341|NCT01508702|59040889|FG001|Overall Study|Adverse Event|3|||
30969342|NCT01508702|59040888|FG000|Overall Study|Gout flare|2|||
30969343|NCT01508702|59040889|FG001|Overall Study|Gout flare|0|||
30969344|NCT01508702|59040888|FG000|Overall Study|Protocol Violation|2|||
30969345|NCT01508702|59040889|FG001|Overall Study|Protocol Violation|1|||
30969346|NCT01508702|59040888|FG000|Overall Study|Lost to Follow-up|1|||
30969347|NCT01508702|59040889|FG001|Overall Study|Lost to Follow-up|2|||
30969348|NCT01508702|59040888|FG000|Overall Study|Withdrawal by Subject|11|||
30969349|NCT01508702|59040889|FG001|Overall Study|Withdrawal by Subject|7|||
30969350|NCT01484834|59040903|FG000|Overall Study|Lost to Follow-up|5|||
30969351|NCT01484834|59040904|FG001|Overall Study|Lost to Follow-up|8|||
30969352|NCT01484834|59040905|FG002|Overall Study|Lost to Follow-up|1|||
30969353|NCT01484834|59040906|FG003|Overall Study|Lost to Follow-up|4|||
30969354|NCT01484132|59040916|FG000|Overall Study|Lost to Follow-up|8|||
30969355|NCT01484132|59040916|FG000|Overall Study|Difficulty with time commitment|2|||
30969356|NCT01484132|59040916|FG000|Overall Study|Ineligible|1|||
30969357|NCT01484132|59040916|FG000|Overall Study|No pre-treatment urine sample collected|1|||
30969358|NCT01484132|59040916|FG000|Overall Study|No post-treatment urine sample collected|10|||
30969359|NCT01276041|59040920|FG000|Overall Study|Adverse Event|2|||
30969360|NCT01276041|59040920|FG000|Overall Study|Protocol Violation|1|||
30969361|NCT01275339|59040928|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
30969362|NCT01275339|59040929|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
30969363|NCT01275339|59040930|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
30969364|NCT01275339|59040931|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
30969365|NCT01275339|59040928|FG000|Overall Study|Withdrawal by Subject|0|||
30969366|NCT01275339|59040929|FG001|Overall Study|Withdrawal by Subject|0|||
30969367|NCT01275339|59040930|FG002|Overall Study|Withdrawal by Subject|1|||
30969368|NCT01275339|59040931|FG003|Overall Study|Withdrawal by Subject|0|||
30969369|NCT01520402|59040941|FG000|Overall Study|Withdrawal by Subject|2|||
30969370|NCT01520402|59040941|FG000|Overall Study|Physician Decision|3|||
30969371|NCT01520324|59040956|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
30969372|NCT01519934|59040960|FG000|Overall Study|Lost to Follow-up|3|||
30969373|NCT01484054|59040964|FG000|Period 1|Withdrawal by Subject|0|||
30969374|NCT01484054|59040965|FG001|Period 1|Withdrawal by Subject|1|||
30969375|NCT01483820|59040972|FG000|Overall Study|Lack of Efficacy|6|||
30969376|NCT01483820|59040972|FG000|Overall Study|Adverse Event|1|||
30969377|NCT01483820|59040972|FG000|Overall Study|Death|1|||
30969378|NCT01507298|59040987|FG000|Overall Study|Protocol Violation|0|||
30969379|NCT01507298|59040988|FG001|Overall Study|Protocol Violation|6|||
30969380|NCT01483118|59040997|FG000|Overall Study|Lost to Follow-up|12|||
30969381|NCT01483118|59040998|FG001|Overall Study|Lost to Follow-up|16|||
30969382|NCT01506908|59041008|FG000|Overall Study|Adverse Event|1|||
30969383|NCT01506908|59041009|FG001|Overall Study|Adverse Event|0|||
30969384|NCT01519778|59041017|FG000|Overall Study|Withdrawal by Subject|3|||
30969385|NCT01519778|59041017|FG000|Overall Study|Lost to Follow-up|10|||
30969386|NCT01519778|59041017|FG000|Overall Study|Physician Decision|1|||
30969387|NCT01519700|59041025|FG000|Overall Study|Death|1|||
30969388|NCT01519700|59041026|FG001|Overall Study|Death|0|||
30969389|NCT01519700|59041027|FG002|Overall Study|Death|0|||
30969390|NCT01519700|59041028|FG003|Overall Study|Death|0|||
30969391|NCT01519700|59041025|FG000|Overall Study|Lost to Follow-up|0|||
30969392|NCT01519700|59041026|FG001|Overall Study|Lost to Follow-up|0|||
30969393|NCT01519700|59041027|FG002|Overall Study|Lost to Follow-up|1|||
30969394|NCT01519700|59041028|FG003|Overall Study|Lost to Follow-up|1|||
30969395|NCT01519700|59041025|FG000|Overall Study|Physician Decision|1|||
30969396|NCT01519700|59041026|FG001|Overall Study|Physician Decision|1|||
30969397|NCT01519700|59041027|FG002|Overall Study|Physician Decision|3|||
30969398|NCT01519700|59041028|FG003|Overall Study|Physician Decision|0|||
30969399|NCT01519700|59041025|FG000|Overall Study|Withdrawal by Subject|5|||
30969400|NCT01519700|59041026|FG001|Overall Study|Withdrawal by Subject|3|||
30969401|NCT01519700|59041027|FG002|Overall Study|Withdrawal by Subject|3|||
30969402|NCT01519700|59041028|FG003|Overall Study|Withdrawal by Subject|2|||
30969403|NCT01519700|59041025|FG000|Overall Study|Other Reason|2|||
30969404|NCT01519700|59041026|FG001|Overall Study|Other Reason|2|||
30969405|NCT01519700|59041027|FG002|Overall Study|Other Reason|0|||
30969406|NCT01519700|59041028|FG003|Overall Study|Other Reason|4|||
30969407|NCT02656680|59041046|FG000|Overall Study|Lost to Follow-up|0|||
30969408|NCT02656680|59041047|FG001|Overall Study|Lost to Follow-up|1|||
30969409|NCT02658084|59041083|FG000|Overall Study|Withdrawal by Subject|1|||
30969410|NCT02658084|59041084|FG001|Overall Study|Withdrawal by Subject|0|||
30969411|NCT02658084|59041083|FG000|Overall Study|Study Termination|1|||
30969412|NCT02658084|59041084|FG001|Overall Study|Study Termination|0|||
30969413|NCT01482962|59041100|FG000|Overall Study|Progressive Disease|65|||
30969414|NCT01482962|59041101|FG001|Overall Study|Progressive Disease|53|||
30969415|NCT01482962|59041100|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
30969416|NCT01482962|59041101|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
30969417|NCT01482962|59041100|FG000|Overall Study|Adverse Event|18|||
30969418|NCT01482962|59041101|FG001|Overall Study|Adverse Event|22|||
30969419|NCT01482962|59041100|FG000|Overall Study|Withdrawal by Participant|8|||
30969420|NCT01482962|59041101|FG001|Overall Study|Withdrawal by Participant|13|||
30969421|NCT01482962|59041100|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
30969422|NCT01482962|59041101|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
30969423|NCT01482962|59041100|FG000|Overall Study|Other Reason|1|||
30969424|NCT01482962|59041101|FG001|Overall Study|Other Reason|5|||
30969425|NCT01482962|59041100|FG000|Overall Study|Study Terminated by Sponsor|5|||
30969426|NCT01482962|59041101|FG001|Overall Study|Study Terminated by Sponsor|2|||
30969427|NCT01482962|59041100|FG000|Overall Study|Did not Receive Study Drug|1|||
30969428|NCT01482962|59041101|FG001|Overall Study|Did not Receive Study Drug|6|||
30969429|NCT02655666|59041109|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
30969430|NCT01506596|59041113|FG000|Overall Study|ineligible pathology|1|||
30969431|NCT01482884|59041132|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
30969432|NCT01482884|59041133|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
30969433|NCT01482884|59041132|FG000|Overall Study|Protocol Violation|1|||
30969434|NCT01482884|59041133|FG001|Overall Study|Protocol Violation|0|||
30969435|NCT01482884|59041132|FG000|Overall Study|Lost to Follow-up|2|||
30969436|NCT01482884|59041133|FG001|Overall Study|Lost to Follow-up|2|||
30969437|NCT01482884|59041132|FG000|Overall Study|Lack of Efficacy|0|||
30969438|NCT01482884|59041133|FG001|Overall Study|Lack of Efficacy|1|||
30969439|NCT01482884|59041132|FG000|Overall Study|Adverse Event|2|||
30969440|NCT01482884|59041133|FG001|Overall Study|Adverse Event|1|||
30969441|NCT01482884|59041132|FG000|Overall Study|Withdrawal by Subject|8|||
30969442|NCT01482884|59041133|FG001|Overall Study|Withdrawal by Subject|13|||
30969443|NCT01518374|59041139|FG000|Overall Study|Withdrawal by Subject|2|||
30969444|NCT01518374|59041139|FG000|Overall Study|Protocol Violation|3|||
30969445|NCT01518374|59041139|FG000|Overall Study|Lost to Follow-up|2|||
30969446|NCT01481324|59041146|FG000|Overall Study|Missing Data|0|||
30969447|NCT01481324|59041147|FG001|Overall Study|Missing Data|2|||
30969448|NCT01481324|59041148|FG002|Overall Study|Missing Data|2|||
30969449|NCT04591626|59041158|FG000|Overall Study|Adverse Event|4|||
30969450|NCT04591626|59041159|FG001|Overall Study|Adverse Event|0|||
30969451|NCT04591626|59041158|FG000|Overall Study|Withdrawal by Subject|5|||
30969452|NCT04591626|59041159|FG001|Overall Study|Withdrawal by Subject|3|||
30969453|NCT04591626|59041158|FG000|Overall Study|Physician Decision|0|||
30969454|NCT04591626|59041159|FG001|Overall Study|Physician Decision|1|||
30969455|NCT04591626|59041158|FG000|Overall Study|Death|0|||
30969456|NCT04591626|59041159|FG001|Overall Study|Death|1|||
30969457|NCT04591626|59041158|FG000|Overall Study|Non-Compliance with Study Drug|1|||
30969458|NCT04591626|59041159|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30969459|NCT03583333|59041167|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
30969460|NCT03583333|59041168|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
30969461|NCT03583333|59041167|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
30969462|NCT03583333|59041168|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
30969463|NCT03583333|59041167|FG000|Overall Study|Withdrawal by Subject|9|||
30969464|NCT03583333|59041168|FG001|Overall Study|Withdrawal by Subject|5|||
30969465|NCT03583333|59041167|FG000|Overall Study|Physician Decision|3|||
30969466|NCT03583333|59041168|FG001|Overall Study|Physician Decision|2|||
30969467|NCT03583333|59041167|FG000|Overall Study|Death|12|||
30969468|NCT03583333|59041168|FG001|Overall Study|Death|7|||
30969469|NCT01602510|59041174|FG000|Open Label Phase|Adverse Event|46|||
30969470|NCT01602510|59041175|FG001|Open Label Phase|Adverse Event|0|||
30969471|NCT01602510|59041176|FG002|Open Label Phase|Adverse Event|0|||
30969472|NCT01602510|59041174|FG000|Open Label Phase|Lack of Efficacy|22|||
30969473|NCT01602510|59041175|FG001|Open Label Phase|Lack of Efficacy|0|||
30969474|NCT01602510|59041176|FG002|Open Label Phase|Lack of Efficacy|0|||
30969475|NCT01602510|59041174|FG000|Open Label Phase|Protocol Violation|15|||
30969476|NCT01602510|59041175|FG001|Open Label Phase|Protocol Violation|0|||
30969477|NCT01602510|59041176|FG002|Open Label Phase|Protocol Violation|0|||
30969478|NCT01602510|59041174|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
30969479|NCT01602510|59041175|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
30969480|NCT01602510|59041176|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
30969481|NCT01602510|59041174|FG000|Open Label Phase|Lost to Follow-up|22|||
30969482|NCT01602510|59041175|FG001|Open Label Phase|Lost to Follow-up|0|||
30969483|NCT01602510|59041176|FG002|Open Label Phase|Lost to Follow-up|0|||
30969484|NCT01602510|59041174|FG000|Open Label Phase|Physician Decision|19|||
30969485|NCT01602510|59041175|FG001|Open Label Phase|Physician Decision|0|||
30969486|NCT01602510|59041176|FG002|Open Label Phase|Physician Decision|0|||
30969487|NCT01602510|59041174|FG000|Open Label Phase|Withdrawal by Subject|57|||
30969488|NCT01602510|59041175|FG001|Open Label Phase|Withdrawal by Subject|0|||
30969489|NCT01602510|59041176|FG002|Open Label Phase|Withdrawal by Subject|0|||
30969490|NCT01602510|59041174|FG000|Randomized Phase|Adverse Event|0|||
30969491|NCT01602510|59041175|FG001|Randomized Phase|Adverse Event|2|||
30969492|NCT01602510|59041176|FG002|Randomized Phase|Adverse Event|6|||
30969493|NCT01602510|59041174|FG000|Randomized Phase|Lack of Efficacy|0|||
30969494|NCT01602510|59041175|FG001|Randomized Phase|Lack of Efficacy|4|||
30969495|NCT01602510|59041176|FG002|Randomized Phase|Lack of Efficacy|4|||
30969496|NCT01602510|59041174|FG000|Randomized Phase|Protocol Violation|0|||
30969497|NCT01602510|59041175|FG001|Randomized Phase|Protocol Violation|3|||
30969498|NCT01602510|59041176|FG002|Randomized Phase|Protocol Violation|3|||
30969499|NCT01602510|59041174|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
30969500|NCT01602510|59041175|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
30969501|NCT01602510|59041176|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
30969502|NCT01602510|59041174|FG000|Randomized Phase|Lost to Follow-up|0|||
30969503|NCT01602510|59041175|FG001|Randomized Phase|Lost to Follow-up|1|||
30969504|NCT01602510|59041176|FG002|Randomized Phase|Lost to Follow-up|3|||
30969505|NCT01602510|59041174|FG000|Randomized Phase|Physician Decision|0|||
30969506|NCT01602510|59041175|FG001|Randomized Phase|Physician Decision|0|||
30969507|NCT01602510|59041176|FG002|Randomized Phase|Physician Decision|2|||
30969508|NCT01602510|59041174|FG000|Randomized Phase|Withdrawal by Subject|0|||
30969509|NCT01602510|59041175|FG001|Randomized Phase|Withdrawal by Subject|6|||
30969510|NCT01602510|59041176|FG002|Randomized Phase|Withdrawal by Subject|7|||
30969511|NCT01675596|59041191|FG000|Overall Study|Death|6|||
30969512|NCT01675596|59041191|FG000|Overall Study|Exit with other reason|1|||
30969513|NCT01675596|59041191|FG000|Overall Study|Missed Visit|1|||
30969514|NCT02653326|59041201|FG000|Overall Study|Lost to Follow-up|10|||
30969515|NCT02653326|59041202|FG001|Overall Study|Lost to Follow-up|7|||
30969516|NCT02653170|59041211|FG000|Overall Study|Withdrawal by Subject|3|||
30969517|NCT02653170|59041212|FG001|Overall Study|Withdrawal by Subject|8|||
30969518|NCT02653170|59041213|FG002|Overall Study|Withdrawal by Subject|3|||
30969519|NCT02653170|59041211|FG000|Overall Study|withdrawn by study team|2|||
30969520|NCT02653170|59041212|FG001|Overall Study|withdrawn by study team|4|||
30969521|NCT02653170|59041213|FG002|Overall Study|withdrawn by study team|5|||
30969522|NCT02653170|59041211|FG000|Overall Study|Lost to Follow-up|12|||
30969523|NCT02653170|59041212|FG001|Overall Study|Lost to Follow-up|4|||
30969524|NCT02653170|59041213|FG002|Overall Study|Lost to Follow-up|10|||
30969525|NCT01463696|59041233|FG000|Overall Study|Adverse Event|0|||
30969526|NCT01463696|59041234|FG001|Overall Study|Adverse Event|1|||
30969527|NCT01463696|59041235|FG002|Overall Study|Adverse Event|0|||
30969528|NCT01463696|59041236|FG003|Overall Study|Adverse Event|2|||
30969529|NCT01463696|59041237|FG004|Overall Study|Adverse Event|0|||
30969530|NCT01463696|59041238|FG005|Overall Study|Adverse Event|1|||
30969531|NCT01463696|59041239|FG006|Overall Study|Adverse Event|3|||
30969532|NCT01463696|59041240|FG007|Overall Study|Adverse Event|2|||
30969533|NCT01463696|59041233|FG000|Overall Study|Lost to Follow-up|0|||
30969534|NCT01463696|59041234|FG001|Overall Study|Lost to Follow-up|0|||
30969535|NCT01463696|59041235|FG002|Overall Study|Lost to Follow-up|1|||
30969536|NCT01463696|59041236|FG003|Overall Study|Lost to Follow-up|0|||
30969537|NCT01463696|59041237|FG004|Overall Study|Lost to Follow-up|0|||
30969538|NCT01463696|59041238|FG005|Overall Study|Lost to Follow-up|0|||
30969539|NCT01463696|59041239|FG006|Overall Study|Lost to Follow-up|0|||
30969540|NCT01463696|59041240|FG007|Overall Study|Lost to Follow-up|0|||
30969541|NCT01463696|59041233|FG000|Overall Study|Progressive Disease|0|||
30969542|NCT01463696|59041234|FG001|Overall Study|Progressive Disease|1|||
30969543|NCT01463696|59041235|FG002|Overall Study|Progressive Disease|0|||
30969544|NCT01463696|59041236|FG003|Overall Study|Progressive Disease|1|||
30969545|NCT01463696|59041237|FG004|Overall Study|Progressive Disease|0|||
30969546|NCT01463696|59041238|FG005|Overall Study|Progressive Disease|1|||
30969547|NCT01463696|59041239|FG006|Overall Study|Progressive Disease|4|||
30969548|NCT01463696|59041240|FG007|Overall Study|Progressive Disease|2|||
30969549|NCT01463696|59041233|FG000|Overall Study|Withdrawal by Subject|0|||
30969550|NCT01463696|59041234|FG001|Overall Study|Withdrawal by Subject|0|||
30969551|NCT01463696|59041235|FG002|Overall Study|Withdrawal by Subject|0|||
30969552|NCT01463696|59041236|FG003|Overall Study|Withdrawal by Subject|1|||
30969553|NCT01463696|59041237|FG004|Overall Study|Withdrawal by Subject|1|||
30969554|NCT01463696|59041238|FG005|Overall Study|Withdrawal by Subject|1|||
30969555|NCT01463696|59041239|FG006|Overall Study|Withdrawal by Subject|2|||
30969556|NCT01463696|59041240|FG007|Overall Study|Withdrawal by Subject|0|||
30969557|NCT01463696|59041233|FG000|Overall Study|Not Treated|0|||
30969558|NCT01463696|59041234|FG001|Overall Study|Not Treated|0|||
30969559|NCT01463696|59041235|FG002|Overall Study|Not Treated|0|||
30969560|NCT01463696|59041236|FG003|Overall Study|Not Treated|0|||
30969561|NCT01463696|59041237|FG004|Overall Study|Not Treated|0|||
30969562|NCT01463696|59041238|FG005|Overall Study|Not Treated|0|||
30969563|NCT01463696|59041239|FG006|Overall Study|Not Treated|1|||
30969564|NCT01463696|59041240|FG007|Overall Study|Not Treated|0|||
30969565|NCT02653482|59041264|FG000|Overall Study|Death|1|||
30969566|NCT02653482|59041265|FG001|Overall Study|Death|1|||
30969567|NCT01362348|59041271|FG000|Overall Study|Protocol-defined stopping criteria|9|||
30969568|NCT01362348|59041271|FG000|Overall Study|Study closed/terminated|5|||
30969569|NCT01675128|59041341|FG000|Overall Study|Disease progression on study|1|||
30969570|NCT01675128|59041342|FG001|Overall Study|Disease progression on study|1|||
30969571|NCT01675128|59041343|FG002|Overall Study|Disease progression on study|1|||
30969572|NCT01675128|59041341|FG000|Overall Study|Refused further treatment|1|||
30969573|NCT01675128|59041342|FG001|Overall Study|Refused further treatment|0|||
30969574|NCT01675128|59041343|FG002|Overall Study|Refused further treatment|0|||
30969575|NCT01675128|59041341|FG000|Overall Study|Pulmonary complication; off study|0|||
30969576|NCT01675128|59041342|FG001|Overall Study|Pulmonary complication; off study|1|||
30969577|NCT01675128|59041343|FG002|Overall Study|Pulmonary complication; off study|0|||
30969578|NCT01427309|59041389|FG000|Overall Study|Lost to Follow-up|130|||
30969579|NCT01427309|59041390|FG001|Overall Study|Lost to Follow-up|145|||
30969580|NCT01427309|59041391|FG002|Overall Study|Lost to Follow-up|122|||
30969581|NCT01427309|59041392|FG003|Overall Study|Lost to Follow-up|135|||
30969582|NCT01427309|59041389|FG000|Overall Study|Protocol Violation|42|||
30969583|NCT01427309|59041390|FG001|Overall Study|Protocol Violation|69|||
30969584|NCT01427309|59041391|FG002|Overall Study|Protocol Violation|125|||
30969585|NCT01427309|59041392|FG003|Overall Study|Protocol Violation|124|||
30969586|NCT01427309|59041389|FG000|Overall Study|Adverse Event|0|||
30969587|NCT01427309|59041390|FG001|Overall Study|Adverse Event|0|||
30969588|NCT01427309|59041391|FG002|Overall Study|Adverse Event|3|||
30969589|NCT01427309|59041392|FG003|Overall Study|Adverse Event|1|||
30969590|NCT01427309|59041389|FG000|Overall Study|Serious adverse event|52|||
30969591|NCT01427309|59041390|FG001|Overall Study|Serious adverse event|45|||
30969592|NCT01427309|59041391|FG002|Overall Study|Serious adverse event|50|||
30969593|NCT01427309|59041392|FG003|Overall Study|Serious adverse event|61|||
30969594|NCT01427309|59041389|FG000|Overall Study|Withdrawal by Subject|148|||
30969595|NCT01427309|59041390|FG001|Overall Study|Withdrawal by Subject|148|||
30969596|NCT01427309|59041391|FG002|Overall Study|Withdrawal by Subject|61|||
30969597|NCT01427309|59041392|FG003|Overall Study|Withdrawal by Subject|55|||
30969598|NCT01426373|59041402|FG000|Overall Study|Adverse Event|6|||
30969599|NCT01426373|59041402|FG000|Overall Study|Lost to Follow-up|14|||
30969600|NCT01426373|59041402|FG000|Overall Study|Participant Convenience|10|||
30969601|NCT01426373|59041402|FG000|Overall Study|Miscellaneous Reasons|4|||
30969602|NCT01426217|59041410|FG000|Overall Study|lost sample|8|||
30969603|NCT01426217|59041411|FG001|Overall Study|lost sample|14|||
30969604|NCT01425749|59041419|FG000|Overall Study|progression of melanoma|0|||
30969605|NCT01425749|59041420|FG001|Overall Study|progression of melanoma|1|||
30969606|NCT01403987|59041436|FG000|Overall Study|Residents forgot their secret PIN|18|||
30969607|NCT01403987|59041437|FG001|Overall Study|Residents forgot their secret PIN|17|||
30969608|NCT01403987|59041438|FG002|Overall Study|Residents forgot their secret PIN|18|||
30969609|NCT01425359|59041448|FG000|Overall Study|Randomized but Not Treated|2|||
30969610|NCT01425359|59041449|FG001|Overall Study|Randomized but Not Treated|3|||
30969611|NCT01425359|59041448|FG000|Overall Study|Adverse Event|9|||
30969612|NCT01425359|59041449|FG001|Overall Study|Adverse Event|8|||
30969613|NCT01425359|59041448|FG000|Overall Study|Revascularization|0|||
30969614|NCT01425359|59041449|FG001|Overall Study|Revascularization|1|||
30969615|NCT01425359|59041448|FG000|Overall Study|Death|0|||
30969616|NCT01425359|59041449|FG001|Overall Study|Death|1|||
30969617|NCT01425359|59041448|FG000|Overall Study|Unsatisfactory Response|1|||
30969618|NCT01425359|59041449|FG001|Overall Study|Unsatisfactory Response|0|||
30969619|NCT01425359|59041448|FG000|Overall Study|Protocol Violation|1|||
30969620|NCT01425359|59041449|FG001|Overall Study|Protocol Violation|2|||
30969621|NCT01425359|59041448|FG000|Overall Study|Subject Withdrew Consent|1|||
30969622|NCT01425359|59041449|FG001|Overall Study|Subject Withdrew Consent|2|||
30969623|NCT01425359|59041448|FG000|Overall Study|Investigator's Discretion|2|||
30969624|NCT01425359|59041449|FG001|Overall Study|Investigator's Discretion|0|||
30969625|NCT01425359|59041448|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
30969626|NCT01425359|59041449|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
30969627|NCT01403051|59041469|FG000|Overall Study|Protocol Violation|2|||
30969628|NCT01403051|59041470|FG001|Overall Study|Protocol Violation|0|||
30969629|NCT01403051|59041469|FG000|Overall Study|Death|1|||
30969630|NCT01403051|59041470|FG001|Overall Study|Death|0|||
30969631|NCT01403051|59041469|FG000|Overall Study|Withdrawal by Subject|2|||
30969632|NCT01403051|59041470|FG001|Overall Study|Withdrawal by Subject|1|||
30969633|NCT01403051|59041469|FG000|Overall Study|Lost to Follow-up|5|||
30969634|NCT01403051|59041470|FG001|Overall Study|Lost to Follow-up|5|||
30969635|NCT04115748|59041485|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
30969636|NCT04115748|59041486|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
30969637|NCT04115748|59041487|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
30969638|NCT04115748|59041488|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
30969639|NCT04115748|59041489|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
30969640|NCT04115748|59041490|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
30969641|NCT04115748|59041491|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
30969642|NCT04115748|59041492|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
30969643|NCT04115748|59041493|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
30969644|NCT04115748|59041494|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
30969645|NCT04115748|59041485|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
30969646|NCT04115748|59041486|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
30969647|NCT04115748|59041487|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
30969648|NCT04115748|59041488|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
30969649|NCT04115748|59041489|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
30969650|NCT04115748|59041490|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
30969651|NCT04115748|59041491|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
30969652|NCT04115748|59041492|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
30969653|NCT04115748|59041493|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
30969654|NCT04115748|59041494|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
30969655|NCT04115748|59041485|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
30969656|NCT04115748|59041486|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
30969657|NCT04115748|59041487|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
30969658|NCT04115748|59041488|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
30969659|NCT04115748|59041489|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
30969660|NCT04115748|59041490|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
30969661|NCT04115748|59041491|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
30969662|NCT04115748|59041492|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
30969663|NCT04115748|59041493|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
30969664|NCT04115748|59041494|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
30969665|NCT04115748|59041485|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
30969666|NCT04115748|59041486|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
30969667|NCT04115748|59041487|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
30969668|NCT04115748|59041488|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
30969669|NCT04115748|59041489|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
30969670|NCT04115748|59041490|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
30969671|NCT04115748|59041491|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
30969672|NCT04115748|59041492|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
30969673|NCT04115748|59041493|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
30969674|NCT04115748|59041494|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
30969675|NCT02652624|59041551|FG000|Randomized Phase|Pregnancy|3|||
30969676|NCT02652624|59041552|FG001|Randomized Phase|Pregnancy|1|||
30969677|NCT02652624|59041551|FG000|Randomized Phase|Investigator's Discretion|0|||
30969678|NCT02652624|59041552|FG001|Randomized Phase|Investigator's Discretion|2|||
30969679|NCT02652624|59041551|FG000|Randomized Phase|Death|0|||
30969680|NCT02652624|59041552|FG001|Randomized Phase|Death|1|||
30969681|NCT02652624|59041551|FG000|Randomized Phase|Lost to Follow-up|0|||
30969682|NCT02652624|59041552|FG001|Randomized Phase|Lost to Follow-up|1|||
30969683|NCT02652624|59041551|FG000|Extension Phase|Lost to Follow-up|3|||
30969684|NCT02652624|59041552|FG001|Extension Phase|Lost to Follow-up|1|||
30969685|NCT02652624|59041551|FG000|Extension Phase|Pregnancy|1|||
30969686|NCT02652624|59041552|FG001|Extension Phase|Pregnancy|1|||
30969687|NCT02652624|59041551|FG000|Extension Phase|Adverse Event|0|||
30969688|NCT02652624|59041552|FG001|Extension Phase|Adverse Event|1|||
30969689|NCT02652624|59041551|FG000|Extension Phase|Withdrew Consent|0|||
30969690|NCT02652624|59041552|FG001|Extension Phase|Withdrew Consent|1|||
30969691|NCT00249795|59041562|FG000|Overall Study|Not treated|16|||
30969692|NCT00249795|59041563|FG001|Overall Study|Not treated|14|||
30969693|NCT00249795|59041562|FG000|Overall Study|Symptomatic hypotension|127|||
30969694|NCT00249795|59041563|FG001|Overall Study|Symptomatic hypotension|64|||
30969695|NCT00249795|59041562|FG000|Overall Study|Other Serious Adverse Event|84|||
30969696|NCT00249795|59041563|FG001|Overall Study|Other Serious Adverse Event|93|||
30969697|NCT00249795|59041562|FG000|Overall Study|Qualifying condition not present|26|||
30969698|NCT00249795|59041563|FG001|Overall Study|Qualifying condition not present|29|||
30969699|NCT00249795|59041562|FG000|Overall Study|Withdrawal by Subject|678|||
30969700|NCT00249795|59041563|FG001|Overall Study|Withdrawal by Subject|742|||
30969701|NCT00249795|59041562|FG000|Overall Study|Thromboembolic / outcome event|39|||
30969702|NCT00249795|59041563|FG001|Overall Study|Thromboembolic / outcome event|45|||
30969703|NCT00249795|59041562|FG000|Overall Study|Oral anticoagulant required|2|||
30969704|NCT00249795|59041563|FG001|Overall Study|Oral anticoagulant required|0|||
30969705|NCT00249795|59041562|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
30969706|NCT00249795|59041563|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
30969707|NCT00249795|59041562|FG000|Overall Study|Non-compliance|71|||
30969708|NCT00249795|59041563|FG001|Overall Study|Non-compliance|69|||
30969709|NCT00249795|59041562|FG000|Overall Study|Study drug intolerance|3|||
30969710|NCT00249795|59041563|FG001|Overall Study|Study drug intolerance|3|||
30969711|NCT00249795|59041562|FG000|Overall Study|Other adverse events (non-serious)|188|||
30969712|NCT00249795|59041563|FG001|Overall Study|Other adverse events (non-serious)|159|||
30969713|NCT00249795|59041562|FG000|Overall Study|Physician withdrew consent|71|||
30969714|NCT00249795|59041563|FG001|Overall Study|Physician withdrew consent|63|||
30969715|NCT00249795|59041562|FG000|Overall Study|Surgery / procedure|4|||
30969716|NCT00249795|59041563|FG001|Overall Study|Surgery / procedure|5|||
30969717|NCT00249795|59041562|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
30969718|NCT00249795|59041563|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
30969719|NCT00249795|59041562|FG000|Overall Study|Lightheadedness / dizziness|15|||
30969720|NCT00249795|59041563|FG001|Overall Study|Lightheadedness / dizziness|11|||
30969721|NCT00249795|59041562|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
30969722|NCT00249795|59041563|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
30969723|NCT00249795|59041562|FG000|Overall Study|Other contraindicated medication|1|||
30969724|NCT00249795|59041563|FG001|Overall Study|Other contraindicated medication|1|||
30969725|NCT00249795|59041562|FG000|Overall Study|Event related to cardiac condition|17|||
30969726|NCT00249795|59041563|FG001|Overall Study|Event related to cardiac condition|16|||
30969727|NCT00249795|59041562|FG000|Overall Study|Patient not wish to continue after May08|4|||
30969728|NCT00249795|59041563|FG001|Overall Study|Patient not wish to continue after May08|6|||
30969729|NCT00249795|59041562|FG000|Overall Study|Site not agree to continue after May08|1|||
30969730|NCT00249795|59041563|FG001|Overall Study|Site not agree to continue after May08|1|||
30969731|NCT00249795|59041562|FG000|Overall Study|Lost to Follow-up|0|||
30969732|NCT00249795|59041563|FG001|Overall Study|Lost to Follow-up|2|||
30969733|NCT00249795|59041562|FG000|Overall Study|Missing|0|||
30969734|NCT00249795|59041563|FG001|Overall Study|Missing|1|||
30969735|NCT02651220|59041572|FG000|Overall Study|Adverse Event|1|||
30969736|NCT02651220|59041573|FG001|Overall Study|Adverse Event|5|||
30969737|NCT02651220|59041574|FG002|Overall Study|Adverse Event|1|||
30969738|NCT02651220|59041572|FG000|Overall Study|Lost to Follow-up|8|||
30969739|NCT02651220|59041573|FG001|Overall Study|Lost to Follow-up|14|||
30969740|NCT02651220|59041574|FG002|Overall Study|Lost to Follow-up|14|||
30969741|NCT02651220|59041572|FG000|Overall Study|Non-Compliance with Study Drug|4|||
30969742|NCT02651220|59041573|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30969743|NCT02651220|59041574|FG002|Overall Study|Non-Compliance with Study Drug|1|||
30969744|NCT02651220|59041572|FG000|Overall Study|Pregnancy|1|||
30969745|NCT02651220|59041573|FG001|Overall Study|Pregnancy|0|||
30969746|NCT02651220|59041574|FG002|Overall Study|Pregnancy|1|||
30969747|NCT02651220|59041572|FG000|Overall Study|Protocol Violation|0|||
30969748|NCT02651220|59041573|FG001|Overall Study|Protocol Violation|0|||
30969749|NCT02651220|59041574|FG002|Overall Study|Protocol Violation|1|||
30969750|NCT02651220|59041572|FG000|Overall Study|Withdrawal by Subject|5|||
30969751|NCT02651220|59041573|FG001|Overall Study|Withdrawal by Subject|6|||
30969752|NCT02651220|59041574|FG002|Overall Study|Withdrawal by Subject|8|||
30969753|NCT02651220|59041572|FG000|Overall Study|Miscellaneous|4|||
30969754|NCT02651220|59041573|FG001|Overall Study|Miscellaneous|1|||
30969755|NCT02651220|59041574|FG002|Overall Study|Miscellaneous|2|||
30969756|NCT02651220|59041572|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30969757|NCT02651220|59041573|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
30969758|NCT02651220|59041574|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
30969759|NCT00247611|59041622|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
30969760|NCT00247611|59041623|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
30969761|NCT00247611|59041622|FG000|Baselined|Completed baseline only|9|||
30969762|NCT00247611|59041623|FG001|Baselined|Completed baseline only|8|||
30969763|NCT00246753|59041646|FG000|Overall Study|Withdrawal by Subject|2|||
30969764|NCT00246753|59041646|FG000|Overall Study|Physician Decision|2|||
30969765|NCT00246753|59041646|FG000|Overall Study|Adverse Event|2|||
30969766|NCT00246753|59041646|FG000|Overall Study|Unacceptable toxicity|2|||
30969767|NCT00246129|59041663|FG000|Overall Study|Lost to Follow-up|1|||
30969768|NCT00246129|59041664|FG001|Overall Study|Lost to Follow-up|0|||
30969769|NCT00246129|59041663|FG000|Overall Study|Death|2|||
30969770|NCT00246129|59041664|FG001|Overall Study|Death|1|||
30969771|NCT00246129|59041663|FG000|Overall Study|suffered primary non-function|1|||
30969772|NCT00246129|59041664|FG001|Overall Study|suffered primary non-function|0|||
30969773|NCT00246129|59041663|FG000|Overall Study|grafts failed|3|||
30969774|NCT00246129|59041664|FG001|Overall Study|grafts failed|1|||
30969775|NCT03182868|59041687|FG000|Overall Study|Protocol Violation|3|||
30969776|NCT03182868|59041688|FG001|Overall Study|Protocol Violation|0|||
30969777|NCT03182868|59041689|FG002|Overall Study|Protocol Violation|4|||
30969778|NCT03182868|59041690|FG003|Overall Study|Protocol Violation|1|||
30969779|NCT03182868|59041691|FG004|Overall Study|Protocol Violation|8|||
30969780|NCT00245583|59041715|FG000|Overall Study|Lost to Follow-up|1|||
30969781|NCT00245583|59041716|FG001|Overall Study|Lost to Follow-up|5|||
30969782|NCT00245583|59041715|FG000|Overall Study|Adverse Event|2|||
30969783|NCT00245583|59041716|FG001|Overall Study|Adverse Event|1|||
30969784|NCT00245583|59041715|FG000|Overall Study|Lack of Efficacy|1|||
30969785|NCT00245583|59041716|FG001|Overall Study|Lack of Efficacy|0|||
30969786|NCT00245583|59041715|FG000|Overall Study|Withdrawal by Subject|2|||
30969787|NCT00245583|59041716|FG001|Overall Study|Withdrawal by Subject|3|||
30969788|NCT02652156|59041725|FG000|Overall Study|Physician Decision|1|||
30969789|NCT02652156|59041726|FG001|Overall Study|Physician Decision|0|||
30969790|NCT02652156|59041727|FG002|Overall Study|Physician Decision|0|||
30969791|NCT01675050|59041774|FG000|Period One Treatment|Withdrawal by Subject|1|||
30969792|NCT01675050|59041775|FG001|Period One Treatment|Withdrawal by Subject|0|||
30969793|NCT00244881|59041794|FG000|Overall Study|Withdrawal by Subject|3|||
30969794|NCT00244725|59041825|FG000|Overall Study|Lost to Follow-up|3|||
30969795|NCT00244725|59041826|FG001|Overall Study|Lost to Follow-up|4|||
30969796|NCT00244725|59041827|FG002|Overall Study|Lost to Follow-up|9|||
30969797|NCT00244725|59041828|FG003|Overall Study|Lost to Follow-up|2|||
30969798|NCT00244725|59041825|FG000|Overall Study|Withdrawal by Subject|9|||
30969799|NCT00244725|59041826|FG001|Overall Study|Withdrawal by Subject|7|||
30969800|NCT00244725|59041827|FG002|Overall Study|Withdrawal by Subject|7|||
30969801|NCT00244725|59041828|FG003|Overall Study|Withdrawal by Subject|8|||
30969802|NCT00244725|59041825|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
30969803|NCT00244725|59041826|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
30969804|NCT00244725|59041827|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
30969805|NCT00244725|59041828|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
30969806|NCT00244725|59041825|FG000|Overall Study|Physician Decision|3|||
30969807|NCT00244725|59041826|FG001|Overall Study|Physician Decision|0|||
30969808|NCT00244725|59041827|FG002|Overall Study|Physician Decision|1|||
30969809|NCT00244725|59041828|FG003|Overall Study|Physician Decision|2|||
30969810|NCT00244725|59041825|FG000|Overall Study|Adverse Events|3|||
30969811|NCT00244725|59041826|FG001|Overall Study|Adverse Events|1|||
30969812|NCT00244725|59041827|FG002|Overall Study|Adverse Events|4|||
30969813|NCT00244725|59041828|FG003|Overall Study|Adverse Events|4|||
30969814|NCT00244725|59041825|FG000|Overall Study|Withdrwal by participant|1|||
30969815|NCT00244725|59041826|FG001|Overall Study|Withdrwal by participant|0|||
30969816|NCT00244725|59041827|FG002|Overall Study|Withdrwal by participant|0|||
30969817|NCT00244725|59041828|FG003|Overall Study|Withdrwal by participant|1|||
30969818|NCT00244725|59041825|FG000|Overall Study|Liver function test abnormality|2|||
30969819|NCT00244725|59041826|FG001|Overall Study|Liver function test abnormality|0|||
30969820|NCT00244725|59041827|FG002|Overall Study|Liver function test abnormality|0|||
30969821|NCT00244725|59041828|FG003|Overall Study|Liver function test abnormality|1|||
30969822|NCT00244725|59041825|FG000|Overall Study|Sponsor withdrew the participant|1|||
30969823|NCT00244725|59041826|FG001|Overall Study|Sponsor withdrew the participant|0|||
30969824|NCT00244725|59041827|FG002|Overall Study|Sponsor withdrew the participant|0|||
30969825|NCT00244725|59041828|FG003|Overall Study|Sponsor withdrew the participant|1|||
30969826|NCT00244725|59041825|FG000|Overall Study|Mediciation Error|0|||
30969827|NCT00244725|59041826|FG001|Overall Study|Mediciation Error|1|||
30969828|NCT00244725|59041827|FG002|Overall Study|Mediciation Error|0|||
30969829|NCT00244725|59041828|FG003|Overall Study|Mediciation Error|0|||
30969830|NCT00244725|59041825|FG000|Overall Study|Rehab Refused to allow participantion|0|||
30969831|NCT00244725|59041826|FG001|Overall Study|Rehab Refused to allow participantion|1|||
30969832|NCT00244725|59041827|FG002|Overall Study|Rehab Refused to allow participantion|0|||
30969833|NCT00244725|59041828|FG003|Overall Study|Rehab Refused to allow participantion|0|||
30969834|NCT00244725|59041825|FG000|Overall Study|Headache|0|||
30969835|NCT00244725|59041826|FG001|Overall Study|Headache|1|||
30969836|NCT00244725|59041827|FG002|Overall Study|Headache|0|||
30969837|NCT00244725|59041828|FG003|Overall Study|Headache|0|||
30969838|NCT00244725|59041825|FG000|Overall Study|Received prohibited medication|0|||
30969839|NCT00244725|59041826|FG001|Overall Study|Received prohibited medication|1|||
30969840|NCT00244725|59041827|FG002|Overall Study|Received prohibited medication|0|||
30969841|NCT00244725|59041828|FG003|Overall Study|Received prohibited medication|1|||
30969842|NCT00244725|59041825|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
30969843|NCT00244725|59041826|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
30969844|NCT00244725|59041827|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
30969845|NCT00244725|59041828|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
30969846|NCT00244725|59041825|FG000|Overall Study|Administrative reason|0|||
30969847|NCT00244725|59041826|FG001|Overall Study|Administrative reason|0|||
30969848|NCT00244725|59041827|FG002|Overall Study|Administrative reason|1|||
30969849|NCT00244725|59041828|FG003|Overall Study|Administrative reason|0|||
30969850|NCT00244725|59041825|FG000|Overall Study|Vomit|0|||
30969851|NCT00244725|59041826|FG001|Overall Study|Vomit|0|||
30969852|NCT00244725|59041827|FG002|Overall Study|Vomit|1|||
30969853|NCT00244725|59041828|FG003|Overall Study|Vomit|0|||
30969854|NCT00244725|59041825|FG000|Overall Study|Failed to follow-up|0|||
30969855|NCT00244725|59041826|FG001|Overall Study|Failed to follow-up|0|||
30969856|NCT00244725|59041827|FG002|Overall Study|Failed to follow-up|1|||
30969857|NCT00244725|59041828|FG003|Overall Study|Failed to follow-up|1|||
30969858|NCT02649894|59041840|FG000|Overall Study|Adverse Event|1|||
30969859|NCT02649894|59041841|FG001|Overall Study|Adverse Event|0|||
30969860|NCT02649894|59041840|FG000|Overall Study|Physician Decision|0|||
30969861|NCT02649894|59041841|FG001|Overall Study|Physician Decision|1|||
30969862|NCT02649894|59041840|FG000|Overall Study|Withdrawal by Subject|5|||
30969863|NCT02649894|59041841|FG001|Overall Study|Withdrawal by Subject|2|||
30969864|NCT02649894|59041840|FG000|Overall Study|Lost to Follow-up|2|||
30969865|NCT02649894|59041841|FG001|Overall Study|Lost to Follow-up|1|||
30969866|NCT02649894|59041840|FG000|Overall Study|Death|30|||
30969867|NCT02649894|59041841|FG001|Overall Study|Death|7|||
30969868|NCT02649894|59041840|FG000|Overall Study|Other, not specified|6|||
30969869|NCT02649894|59041841|FG001|Overall Study|Other, not specified|0|||
30969870|NCT01278615|59041847|FG000|Overall Study|Withdrawal by Subject|2|||
30969871|NCT01505114|59041873|FG000|Overall Study|Withdrawal by Subject|5|||
30969872|NCT01505114|59041874|FG001|Overall Study|Withdrawal by Subject|4|||
30969873|NCT01505114|59041875|FG002|Overall Study|Withdrawal by Subject|4|||
30969874|NCT01505114|59041876|FG003|Overall Study|Withdrawal by Subject|7|||
30969875|NCT01505114|59041873|FG000|Overall Study|Death|1|||
30969876|NCT01505114|59041874|FG001|Overall Study|Death|0|||
30969877|NCT01505114|59041875|FG002|Overall Study|Death|0|||
30969878|NCT01505114|59041876|FG003|Overall Study|Death|1|||
30969879|NCT01505114|59041873|FG000|Overall Study|unable to adhere to visit schedule|3|||
30969880|NCT01505114|59041874|FG001|Overall Study|unable to adhere to visit schedule|2|||
30969881|NCT01505114|59041875|FG002|Overall Study|unable to adhere to visit schedule|3|||
30969882|NCT01505114|59041876|FG003|Overall Study|unable to adhere to visit schedule|3|||
30969883|NCT01505114|59041873|FG000|Overall Study|Lost to Follow-up|11|||
30969884|NCT01505114|59041874|FG001|Overall Study|Lost to Follow-up|5|||
30969885|NCT01505114|59041875|FG002|Overall Study|Lost to Follow-up|8|||
30969886|NCT01505114|59041876|FG003|Overall Study|Lost to Follow-up|7|||
30969887|NCT01505114|59041873|FG000|Overall Study|relocated|4|||
30969888|NCT01505114|59041874|FG001|Overall Study|relocated|2|||
30969889|NCT01505114|59041875|FG002|Overall Study|relocated|2|||
30969890|NCT01505114|59041876|FG003|Overall Study|relocated|3|||
30969891|NCT01505114|59041873|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
30969892|NCT01505114|59041874|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
30969893|NCT01505114|59041875|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
30969894|NCT01505114|59041876|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
30969895|NCT01505114|59041873|FG000|Overall Study|staff safety concerns|0|||
30969896|NCT01505114|59041874|FG001|Overall Study|staff safety concerns|0|||
30969897|NCT01505114|59041875|FG002|Overall Study|staff safety concerns|0|||
30969898|NCT01505114|59041876|FG003|Overall Study|staff safety concerns|1|||
30969899|NCT01505114|59041873|FG000|Overall Study|investigator decision|1|||
30969900|NCT01505114|59041874|FG001|Overall Study|investigator decision|0|||
30969901|NCT01505114|59041875|FG002|Overall Study|investigator decision|1|||
30969902|NCT01505114|59041876|FG003|Overall Study|investigator decision|0|||
30969903|NCT02651922|59041908|FG000|Overall Study|due to exclusion criteria|2|||
30969904|NCT01277757|59041912|FG000|Overall Study|Disease Progression|1|||
30969905|NCT01277757|59041912|FG000|Overall Study|Withdrawal by Subject|1|||
30969906|NCT01276821|59041918|FG000|Overall Study|Protocol Violation|0|||
30969907|NCT01276821|59041919|FG001|Overall Study|Protocol Violation|1|||
30969908|NCT00245037|59041925|FG000|Overall Study|Death|17|||
30969909|NCT00241839|59041931|FG000|Overall Study|Withdrawal by Subject|18|||
30969910|NCT00241839|59041932|FG001|Overall Study|Withdrawal by Subject|17|||
30969911|NCT00241839|59041931|FG000|Overall Study|Adverse Event|1|||
30969912|NCT00241839|59041932|FG001|Overall Study|Adverse Event|1|||
30969913|NCT02651688|59041941|FG000|Overall Study|Non-compliance|0|||
30969914|NCT02651688|59041942|FG001|Overall Study|Non-compliance|0|||
30969915|NCT02651688|59041943|FG002|Overall Study|Non-compliance|1|||
30969916|NCT02651688|59041941|FG000|Overall Study|Principal Investigator (PI) decision|0|||
30969917|NCT02651688|59041942|FG001|Overall Study|Principal Investigator (PI) decision|2|||
30969918|NCT02651688|59041943|FG002|Overall Study|Principal Investigator (PI) decision|0|||
30969919|NCT02651688|59041941|FG000|Overall Study|Lost to Follow-up|1|||
30969920|NCT02651688|59041942|FG001|Overall Study|Lost to Follow-up|3|||
30969921|NCT02651688|59041943|FG002|Overall Study|Lost to Follow-up|0|||
30969922|NCT02651688|59041941|FG000|Overall Study|Withdrawal by Subject|1|||
30969923|NCT02651688|59041942|FG001|Overall Study|Withdrawal by Subject|0|||
30969924|NCT02651688|59041943|FG002|Overall Study|Withdrawal by Subject|2|||
30969925|NCT01276353|59041953|FG000|Double-blind|Adverse Event|2|||
30969926|NCT01276353|59041954|FG001|Double-blind|Adverse Event|0|||
30969927|NCT01276353|59041953|FG000|Double-blind|Withdrawal by Subject|1|||
30969928|NCT01276353|59041954|FG001|Double-blind|Withdrawal by Subject|0|||
30969929|NCT01276353|59041953|FG000|Extension|Adverse Event|2|||
30969930|NCT01276353|59041954|FG001|Extension|Adverse Event|5|||
30969931|NCT01276353|59041953|FG000|Extension|Withdrawal by Subject|1|||
30969932|NCT01276353|59041954|FG001|Extension|Withdrawal by Subject|2|||
30969933|NCT01276353|59041953|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
30969934|NCT01276353|59041954|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
30969935|NCT01276353|59041953|FG000|Extension|Physician Decision|1|||
30969936|NCT01276353|59041954|FG001|Extension|Physician Decision|0|||
30969937|NCT01276353|59041953|FG000|Extension|Prohibited concomitant medications|0|||
30969938|NCT01276353|59041954|FG001|Extension|Prohibited concomitant medications|1|||
30969939|NCT02536794|59041989|FG000|Reached 1st Response Assessment|Adverse Event|2|||
30969940|NCT02536794|59041989|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
30969941|NCT02536794|59041989|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
30969942|NCT02536794|59041989|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
30969943|NCT02536794|59041989|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
30969944|NCT02536794|59041989|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
30969945|NCT01480076|59042068|FG000|Overall Study|Run-in Failure|52|||
30969946|NCT01480076|59042068|FG000|Overall Study|Adverse Event|39|||
30969947|NCT01480076|59042068|FG000|Overall Study|Death|2|||
30969948|NCT01480076|59042068|FG000|Overall Study|Disease Progression|5|||
30969949|NCT01480076|59042068|FG000|Overall Study|Non-compliance With Study Protocol|15|||
30969950|NCT01480076|59042068|FG000|Overall Study|Withdrawal by Subject|105|||
30969951|NCT01480076|59042068|FG000|Overall Study|Lost to Follow-up|7|||
30969952|NCT01480076|59042068|FG000|Overall Study|Investigator Decision|13|||
30969953|NCT01480076|59042068|FG000|Overall Study|Other|52|||
30969954|NCT02650128|59042156|FG000|Overall Study|Death|2|||
30969955|NCT01362270|59042171|FG000|Overall Study|Withdrawal by Subject|1|||
30969956|NCT01362270|59042172|FG001|Overall Study|Withdrawal by Subject|0|||
30969957|NCT01362270|59042171|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
30969958|NCT01362270|59042172|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
30969959|NCT01362270|59042171|FG000|Overall Study|Met excl. criteria before 1st session|1|||
30969960|NCT01362270|59042172|FG001|Overall Study|Met excl. criteria before 1st session|1|||
30969961|NCT00089479|59042193|FG000|Overall Study|Death|108|||
30969962|NCT00089479|59042194|FG001|Overall Study|Death|75|||
30969963|NCT00089479|59042193|FG000|Overall Study|Withdrawal by Subject|86|||
30969964|NCT00089479|59042194|FG001|Overall Study|Withdrawal by Subject|107|||
30969965|NCT00089479|59042193|FG000|Overall Study|Lost to Follow-up|137|||
30969966|NCT00089479|59042194|FG001|Overall Study|Lost to Follow-up|107|||
30969967|NCT01463306|59042203|FG000|Overall Study|Adverse Event|6|||
30969968|NCT01463306|59042204|FG001|Overall Study|Adverse Event|9|||
30969969|NCT01463306|59042205|FG002|Overall Study|Adverse Event|3|||
30969970|NCT01463306|59042203|FG000|Overall Study|Death|3|||
30969971|NCT01463306|59042204|FG001|Overall Study|Death|3|||
30969972|NCT01463306|59042205|FG002|Overall Study|Death|0|||
30969973|NCT01463306|59042203|FG000|Overall Study|Lack of Efficacy|22|||
30969974|NCT01463306|59042204|FG001|Overall Study|Lack of Efficacy|16|||
30969975|NCT01463306|59042205|FG002|Overall Study|Lack of Efficacy|1|||
30969976|NCT01463306|59042203|FG000|Overall Study|Lost to Follow-up|5|||
30969977|NCT01463306|59042204|FG001|Overall Study|Lost to Follow-up|2|||
30969978|NCT01463306|59042205|FG002|Overall Study|Lost to Follow-up|0|||
30969979|NCT01463306|59042203|FG000|Overall Study|Protocol Violation|4|||
30969980|NCT01463306|59042204|FG001|Overall Study|Protocol Violation|0|||
30969981|NCT01463306|59042205|FG002|Overall Study|Protocol Violation|0|||
30969982|NCT01463306|59042203|FG000|Overall Study|Withdrawal by Subject|19|||
30969983|NCT01463306|59042204|FG001|Overall Study|Withdrawal by Subject|9|||
30969984|NCT01463306|59042205|FG002|Overall Study|Withdrawal by Subject|1|||
30969985|NCT01463306|59042203|FG000|Overall Study|Other|26|||
30969986|NCT01463306|59042204|FG001|Overall Study|Other|13|||
30969987|NCT01463306|59042205|FG002|Overall Study|Other|0|||
30969988|NCT01463306|59042203|FG000|Overall Study|Approval expiry at site|1|||
30969989|NCT01463306|59042204|FG001|Overall Study|Approval expiry at site|0|||
30969990|NCT01463306|59042205|FG002|Overall Study|Approval expiry at site|0|||
30969991|NCT01504412|59042234|FG000|Overall Study|Adverse Event|1|||
30969992|NCT01504412|59042235|FG001|Overall Study|Adverse Event|8|||
30969993|NCT01504412|59042236|FG002|Overall Study|Adverse Event|1|||
30969994|NCT01504412|59042237|FG003|Overall Study|Adverse Event|7|||
30969995|NCT01504412|59042238|FG004|Overall Study|Adverse Event|10|||
30969996|NCT01504412|59042234|FG000|Overall Study|Withdrawal by Subject|2|||
30969997|NCT01504412|59042235|FG001|Overall Study|Withdrawal by Subject|1|||
30969998|NCT01504412|59042236|FG002|Overall Study|Withdrawal by Subject|1|||
30969999|NCT01504412|59042237|FG003|Overall Study|Withdrawal by Subject|5|||
30970000|NCT01504412|59042238|FG004|Overall Study|Withdrawal by Subject|1|||
30970001|NCT01504412|59042234|FG000|Overall Study|Other|2|||
30970002|NCT01504412|59042235|FG001|Overall Study|Other|1|||
30970003|NCT01504412|59042236|FG002|Overall Study|Other|1|||
30970004|NCT01504412|59042237|FG003|Overall Study|Other|6|||
30970005|NCT01504412|59042238|FG004|Overall Study|Other|1|||
30970006|NCT01504412|59042234|FG000|Overall Study|Lost to Follow-up|0|||
30970007|NCT01504412|59042235|FG001|Overall Study|Lost to Follow-up|2|||
30970008|NCT01504412|59042236|FG002|Overall Study|Lost to Follow-up|0|||
30970009|NCT01504412|59042237|FG003|Overall Study|Lost to Follow-up|0|||
30970010|NCT01504412|59042238|FG004|Overall Study|Lost to Follow-up|0|||
30970011|NCT01504412|59042234|FG000|Overall Study|Lack of Efficacy|0|||
30970012|NCT01504412|59042235|FG001|Overall Study|Lack of Efficacy|0|||
30970013|NCT01504412|59042236|FG002|Overall Study|Lack of Efficacy|1|||
30970014|NCT01504412|59042237|FG003|Overall Study|Lack of Efficacy|0|||
30970015|NCT01504412|59042238|FG004|Overall Study|Lack of Efficacy|1|||
30970016|NCT01504412|59042234|FG000|Overall Study|Death|0|||
30970017|NCT01504412|59042235|FG001|Overall Study|Death|0|||
30970018|NCT01504412|59042236|FG002|Overall Study|Death|0|||
30970019|NCT01504412|59042237|FG003|Overall Study|Death|1|||
30970020|NCT01504412|59042238|FG004|Overall Study|Death|0|||
30970021|NCT01503164|59042268|FG000|Overall Study|Withdrawal by Subject|2|||
30970022|NCT01503164|59042269|FG001|Overall Study|Withdrawal by Subject|1|||
30970023|NCT00088465|59042275|FG000|Overall Study|Withdrawal by Subject|290|||
30970024|NCT00088465|59042275|FG000|Overall Study|Adverse Event|77|||
30970025|NCT00088465|59042275|FG000|Overall Study|Lost to Follow-up|57|||
30970026|NCT00088465|59042275|FG000|Overall Study|Physician Decision|45|||
30970027|NCT00088465|59042275|FG000|Overall Study|Sponsor Decision|37|||
30970028|NCT00088465|59042275|FG000|Overall Study|Lack of Efficacy|27|||
30970029|NCT00088465|59042275|FG000|Overall Study|Protocol Violation|17|||
30970030|NCT00088465|59042275|FG000|Overall Study|Death|11|||
30970031|NCT00088153|59042303|FG000|Overall Study|Physician Decision|3|||
30970032|NCT00088153|59042304|FG001|Overall Study|Physician Decision|3|||
30970033|NCT00088153|59042303|FG000|Overall Study|Withdrawal by Subject|10|||
30970034|NCT00088153|59042304|FG001|Overall Study|Withdrawal by Subject|10|||
30970035|NCT00088153|59042303|FG000|Overall Study|Lost to Follow-up|11|||
30970036|NCT00088153|59042304|FG001|Overall Study|Lost to Follow-up|12|||
30970037|NCT00087685|59042323|FG000|Overall Study|Adverse Event|5|||
30970038|NCT00087685|59042323|FG000|Overall Study|Non-Compliance|1|||
30970039|NCT00087685|59042323|FG000|Overall Study|Progressive Disease|5|||
30970040|NCT00087685|59042323|FG000|Overall Study|Withdrawal by Subject|3|||
30970041|NCT01502228|59042327|FG000|Overall Study|Death|1|||
30970042|NCT01502072|59042334|FG000|Overall Study|Withdrawal by Subject|1|||
30970043|NCT01502072|59042335|FG001|Overall Study|Withdrawal by Subject|0|||
30970044|NCT01502072|59042336|FG002|Overall Study|Withdrawal by Subject|0|||
30970045|NCT01502072|59042334|FG000|Overall Study|Death|0|||
30970046|NCT01502072|59042335|FG001|Overall Study|Death|1|||
30970047|NCT01502072|59042336|FG002|Overall Study|Death|0|||
30970048|NCT01462370|59042344|FG000|Overall Study|Lack of Qualifying Event|1|||
30970049|NCT01462370|59042345|FG001|Overall Study|Lack of Qualifying Event|1|||
30970050|NCT01462370|59042344|FG000|Overall Study|Physician Decision|0|||
30970051|NCT01462370|59042345|FG001|Overall Study|Physician Decision|1|||
30970052|NCT01462370|59042344|FG000|Overall Study|Withdrawal by Subject|0|||
30970053|NCT01462370|59042345|FG001|Overall Study|Withdrawal by Subject|3|||
30970054|NCT01479764|59042353|FG000|Randomized|Adverse Event|1|||
30970055|NCT01479764|59042354|FG001|Randomized|Adverse Event|1|||
30970056|NCT01479764|59042353|FG000|Randomized|Withdrawal by Subject|1|||
30970057|NCT01479764|59042354|FG001|Randomized|Withdrawal by Subject|0|||
30970058|NCT01479764|59042353|FG000|Treated|Lost to Follow-up|0|||
30970059|NCT01479764|59042354|FG001|Treated|Lost to Follow-up|2|||
30970060|NCT01479530|59042362|FG000|Overall Study|Adverse Event|5|||
30970061|NCT01479530|59042363|FG001|Overall Study|Adverse Event|6|||
30970062|NCT01479530|59042362|FG000|Overall Study|Lack of Efficacy|0|||
30970063|NCT01479530|59042363|FG001|Overall Study|Lack of Efficacy|1|||
30970064|NCT01479530|59042362|FG000|Overall Study|Protocol Violation|2|||
30970065|NCT01479530|59042363|FG001|Overall Study|Protocol Violation|3|||
30970066|NCT01479530|59042362|FG000|Overall Study|Withdrawal of Consent|3|||
30970067|NCT01479530|59042363|FG001|Overall Study|Withdrawal of Consent|2|||
30970068|NCT01479374|59042372|FG000|Overall Study|Adverse Event|2|||
30970069|NCT01479374|59042373|FG001|Overall Study|Adverse Event|1|||
30970070|NCT01479374|59042374|FG002|Overall Study|Adverse Event|0|||
30970071|NCT01479374|59042372|FG000|Overall Study|Lost to Follow-up|1|||
30970072|NCT01479374|59042373|FG001|Overall Study|Lost to Follow-up|2|||
30970073|NCT01479374|59042374|FG002|Overall Study|Lost to Follow-up|0|||
30970074|NCT01479374|59042372|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
30970075|NCT01479374|59042373|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
30970076|NCT01479374|59042374|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
30970077|NCT01479374|59042372|FG000|Overall Study|Other|0|||
30970078|NCT01479374|59042373|FG001|Overall Study|Other|4|||
30970079|NCT01479374|59042374|FG002|Overall Study|Other|5|||
30970080|NCT00087529|59042384|FG000|Overall Study|Death|1|||
30970081|NCT00087529|59042385|FG001|Overall Study|Death|0|||
30970082|NCT00087529|59042384|FG000|Overall Study|Adverse Event|0|||
30970083|NCT00087529|59042385|FG001|Overall Study|Adverse Event|8|||
30970084|NCT00087529|59042384|FG000|Overall Study|Pregnancy|0|||
30970085|NCT00087529|59042385|FG001|Overall Study|Pregnancy|1|||
30970086|NCT00087529|59042384|FG000|Overall Study|Lost to Follow-up|2|||
30970087|NCT00087529|59042385|FG001|Overall Study|Lost to Follow-up|3|||
30970088|NCT00087529|59042384|FG000|Overall Study|Participant Decision|14|||
30970089|NCT00087529|59042385|FG001|Overall Study|Participant Decision|37|||
30970090|NCT00087529|59042384|FG000|Overall Study|Physician Decision|4|||
30970091|NCT00087529|59042385|FG001|Overall Study|Physician Decision|8|||
30970092|NCT00087529|59042384|FG000|Overall Study|Initiation of Excluded Therapy|0|||
30970093|NCT00087529|59042385|FG001|Overall Study|Initiation of Excluded Therapy|1|||
30970094|NCT00087529|59042384|FG000|Overall Study|Participant Noncompliance|0|||
30970095|NCT00087529|59042385|FG001|Overall Study|Participant Noncompliance|1|||
30970096|NCT00087529|59042384|FG000|Overall Study|Disease Progression|5|||
30970097|NCT00087529|59042385|FG001|Overall Study|Disease Progression|4|||
30970098|NCT00087529|59042384|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
30970099|NCT00087529|59042385|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
30970100|NCT01500434|59042408|FG000|Overall Study|Death|1|||
30970101|NCT01500434|59042408|FG000|Overall Study|Withdrawal by Subject|1|||
30970102|NCT01500434|59042408|FG000|Overall Study|Missed 12-month follow-up|5|||
30970103|NCT00087139|59042415|FG000|Overall Study|Adverse Event|18|||
30970104|NCT00087139|59042416|FG001|Overall Study|Adverse Event|17|||
30970105|NCT00087139|59042417|FG002|Overall Study|Adverse Event|13|||
30970106|NCT00087139|59042415|FG000|Overall Study|Death|2|||
30970107|NCT00087139|59042416|FG001|Overall Study|Death|1|||
30970108|NCT00087139|59042417|FG002|Overall Study|Death|0|||
30970109|NCT00087139|59042415|FG000|Overall Study|Withdrawal by Subject|3|||
30970110|NCT00087139|59042416|FG001|Overall Study|Withdrawal by Subject|2|||
30970111|NCT00087139|59042417|FG002|Overall Study|Withdrawal by Subject|2|||
30970112|NCT00087139|59042415|FG000|Overall Study|Physician Decision|1|||
30970113|NCT00087139|59042416|FG001|Overall Study|Physician Decision|1|||
30970114|NCT00087139|59042417|FG002|Overall Study|Physician Decision|1|||
30970115|NCT00087139|59042415|FG000|Overall Study|Disease progression|9|||
30970116|NCT00087139|59042416|FG001|Overall Study|Disease progression|19|||
30970117|NCT00087139|59042417|FG002|Overall Study|Disease progression|12|||
30970118|NCT00087139|59042415|FG000|Overall Study|Ineligible|4|||
30970119|NCT00087139|59042416|FG001|Overall Study|Ineligible|7|||
30970120|NCT00087139|59042417|FG002|Overall Study|Ineligible|4|||
30970121|NCT00087139|59042415|FG000|Overall Study|Symptomatic deterioration|1|||
30970122|NCT00087139|59042416|FG001|Overall Study|Symptomatic deterioration|1|||
30970123|NCT00087139|59042417|FG002|Overall Study|Symptomatic deterioration|3|||
30970124|NCT00087139|59042415|FG000|Overall Study|Use of coumadin|1|||
30970125|NCT00087139|59042416|FG001|Overall Study|Use of coumadin|0|||
30970126|NCT00087139|59042417|FG002|Overall Study|Use of coumadin|0|||
30970127|NCT00087139|59042415|FG000|Overall Study|Response achieved|0|||
30970128|NCT00087139|59042416|FG001|Overall Study|Response achieved|1|||
30970129|NCT00087139|59042417|FG002|Overall Study|Response achieved|0|||
30970130|NCT00087139|59042415|FG000|Overall Study|Extradural disease|0|||
30970131|NCT00087139|59042416|FG001|Overall Study|Extradural disease|0|||
30970132|NCT00087139|59042417|FG002|Overall Study|Extradural disease|1|||
30970133|NCT01500278|59042469|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
30970134|NCT01500278|59042470|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
30970135|NCT01500278|59042469|FG000|Week 0 - Week 12|Protocol Violation|10|||
30970136|NCT01500278|59042470|FG001|Week 0 - Week 12|Protocol Violation|16|||
30970137|NCT01500278|59042469|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
30970138|NCT01500278|59042470|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
30970139|NCT01500278|59042469|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
30970140|NCT01500278|59042470|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
30970141|NCT01500278|59042469|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
30970142|NCT01500278|59042470|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
30970143|NCT01500278|59042469|FG000|Week 0 - Week 12|Patient decision|1|||
30970144|NCT01500278|59042470|FG001|Week 0 - Week 12|Patient decision|0|||
30970145|NCT01500278|59042469|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
30970146|NCT01500278|59042470|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
30970147|NCT01500278|59042469|FG000|Week 0 - Week 12|Investigator decision|1|||
30970148|NCT01500278|59042470|FG001|Week 0 - Week 12|Investigator decision|0|||
30970149|NCT01500278|59042469|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
30970150|NCT01500278|59042470|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
30970151|NCT01500278|59042469|FG000|Week 0 - Week 12|Sponsor decision|1|||
30970152|NCT01500278|59042470|FG001|Week 0 - Week 12|Sponsor decision|0|||
30970153|NCT01500278|59042469|FG000|Week 0 - Week 12|Personal reason|0|||
30970154|NCT01500278|59042470|FG001|Week 0 - Week 12|Personal reason|1|||
30970155|NCT01500278|59042469|FG000|Week 0 - Week 12|Other serious disease|0|||
30970156|NCT01500278|59042470|FG001|Week 0 - Week 12|Other serious disease|1|||
30970157|NCT01500278|59042469|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
30970158|NCT01500278|59042470|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
30970159|NCT01500278|59042469|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
30970160|NCT01500278|59042470|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
30970161|NCT01500278|59042469|FG000|Week 13 - Week 104|Protocol Violation|6|||
30970162|NCT01500278|59042470|FG001|Week 13 - Week 104|Protocol Violation|6|||
30970163|NCT01500278|59042469|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
30970164|NCT01500278|59042470|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
30970165|NCT01500278|59042469|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
30970166|NCT01500278|59042470|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
30970167|NCT01500278|59042469|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
30970168|NCT01500278|59042470|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
30970169|NCT01500278|59042469|FG000|Week 13 - Week 104|Non/bad compliance|7|||
30970170|NCT01500278|59042470|FG001|Week 13 - Week 104|Non/bad compliance|5|||
30970171|NCT01500278|59042469|FG000|Week 13 - Week 104|Recurrent infections|1|||
30970172|NCT01500278|59042470|FG001|Week 13 - Week 104|Recurrent infections|0|||
30970173|NCT01500278|59042469|FG000|Week 13 - Week 104|False positive test|1|||
30970174|NCT01500278|59042470|FG001|Week 13 - Week 104|False positive test|2|||
30970175|NCT01500278|59042469|FG000|Week 13 - Week 104|Sponsor request|4|||
30970176|NCT01500278|59042470|FG001|Week 13 - Week 104|Sponsor request|0|||
30970177|NCT01500278|59042469|FG000|Week 13 - Week 104|Withdrawn in error|1|||
30970178|NCT01500278|59042470|FG001|Week 13 - Week 104|Withdrawn in error|0|||
30970179|NCT01500278|59042469|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
30970180|NCT01500278|59042470|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
30970181|NCT01500278|59042469|FG000|Week 13 - Week 104|Protocol deviation|1|||
30970182|NCT01500278|59042470|FG001|Week 13 - Week 104|Protocol deviation|0|||
30970183|NCT01500278|59042469|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
30970184|NCT01500278|59042470|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
30970185|NCT01500278|59042469|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
30970186|NCT01500278|59042470|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
30970187|NCT01500278|59042469|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
30970188|NCT01500278|59042470|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
30970189|NCT01500278|59042469|FG000|Week 13 - Week 104|Relocation|0|||
30970190|NCT01500278|59042470|FG001|Week 13 - Week 104|Relocation|1|||
30970191|NCT01500278|59042469|FG000|Week 13 - Week 104|Sponsor decision|0|||
30970192|NCT01500278|59042470|FG001|Week 13 - Week 104|Sponsor decision|2|||
30970193|NCT01500278|59042469|FG000|Week 13 - Week 104|Medical monitor decision|0|||
30970194|NCT01500278|59042470|FG001|Week 13 - Week 104|Medical monitor decision|2|||
30970195|NCT01500278|59042469|FG000|Week 13 - Week 104|Personal reason|0|||
30970196|NCT01500278|59042470|FG001|Week 13 - Week 104|Personal reason|1|||
30970197|NCT01500278|59042469|FG000|Week 13 - Week 104|Not completed|0|||
30970198|NCT01500278|59042470|FG001|Week 13 - Week 104|Not completed|1|||
30970199|NCT01500278|59042469|FG000|Week 13 - Week 104|Death|2|||
30970200|NCT01500278|59042470|FG001|Week 13 - Week 104|Death|4|||
30970201|NCT01500278|59042469|FG000|Week 13 - Week 104|Adverse Event|54|||
30970202|NCT01500278|59042470|FG001|Week 13 - Week 104|Adverse Event|54|||
30970203|NCT00086281|59042493|FG000|Phase 1|Adverse Event|0|||
30970204|NCT00086281|59042494|FG001|Phase 1|Adverse Event|0|||
30970205|NCT00086281|59042495|FG002|Phase 1|Adverse Event|0|||
30970206|NCT00086281|59042496|FG003|Phase 1|Adverse Event|0|||
30970207|NCT00086281|59042497|FG004|Phase 1|Adverse Event|0|||
30970208|NCT00086281|59042498|FG005|Phase 1|Adverse Event|0|||
30970209|NCT00086281|59042499|FG006|Phase 1|Adverse Event|0|||
30970210|NCT00086281|59042500|FG007|Phase 1|Adverse Event|0|||
30970211|NCT00086281|59042501|FG008|Phase 1|Adverse Event|0|||
30970212|NCT00086281|59042502|FG009|Phase 1|Adverse Event|1|||
30970213|NCT00086281|59042503|FG010|Phase 1|Adverse Event|2|||
30970214|NCT00086281|59042504|FG011|Phase 1|Adverse Event|1|||
30970215|NCT00086281|59042505|FG012|Phase 1|Adverse Event|1|||
30970216|NCT00086281|59042506|FG013|Phase 1|Adverse Event|1|||
30970217|NCT00086281|59042507|FG014|Phase 1|Adverse Event|2|||
30970218|NCT00086281|59042493|FG000|Phase 1|Protocol Violation|0|||
30970219|NCT00086281|59042494|FG001|Phase 1|Protocol Violation|0|||
30970220|NCT00086281|59042495|FG002|Phase 1|Protocol Violation|0|||
30970221|NCT00086281|59042496|FG003|Phase 1|Protocol Violation|0|||
30970222|NCT00086281|59042497|FG004|Phase 1|Protocol Violation|0|||
30970223|NCT00086281|59042498|FG005|Phase 1|Protocol Violation|0|||
30970224|NCT00086281|59042499|FG006|Phase 1|Protocol Violation|0|||
30970225|NCT00086281|59042500|FG007|Phase 1|Protocol Violation|0|||
30970226|NCT00086281|59042501|FG008|Phase 1|Protocol Violation|0|||
30970227|NCT00086281|59042502|FG009|Phase 1|Protocol Violation|0|||
30970228|NCT00086281|59042503|FG010|Phase 1|Protocol Violation|1|||
30970229|NCT00086281|59042504|FG011|Phase 1|Protocol Violation|0|||
30970230|NCT00086281|59042505|FG012|Phase 1|Protocol Violation|0|||
30970231|NCT00086281|59042506|FG013|Phase 1|Protocol Violation|0|||
30970232|NCT00086281|59042507|FG014|Phase 1|Protocol Violation|0|||
30970233|NCT00086281|59042493|FG000|Phase 1|Serious Adverse Event|0|||
30970234|NCT00086281|59042494|FG001|Phase 1|Serious Adverse Event|0|||
30970235|NCT00086281|59042495|FG002|Phase 1|Serious Adverse Event|0|||
30970236|NCT00086281|59042496|FG003|Phase 1|Serious Adverse Event|0|||
30970237|NCT00086281|59042497|FG004|Phase 1|Serious Adverse Event|0|||
30970238|NCT00086281|59042498|FG005|Phase 1|Serious Adverse Event|0|||
30970239|NCT00086281|59042499|FG006|Phase 1|Serious Adverse Event|0|||
30970240|NCT00086281|59042500|FG007|Phase 1|Serious Adverse Event|0|||
30970241|NCT00086281|59042501|FG008|Phase 1|Serious Adverse Event|0|||
30970242|NCT00086281|59042502|FG009|Phase 1|Serious Adverse Event|0|||
30970243|NCT00086281|59042503|FG010|Phase 1|Serious Adverse Event|0|||
30970244|NCT00086281|59042504|FG011|Phase 1|Serious Adverse Event|0|||
30970245|NCT00086281|59042505|FG012|Phase 1|Serious Adverse Event|0|||
30970246|NCT00086281|59042506|FG013|Phase 1|Serious Adverse Event|0|||
30970247|NCT00086281|59042507|FG014|Phase 1|Serious Adverse Event|1|||
30970248|NCT00086281|59042493|FG000|Phase 2|Adverse Event|0|||
30970249|NCT00086281|59042494|FG001|Phase 2|Adverse Event|0|||
30970250|NCT00086281|59042495|FG002|Phase 2|Adverse Event|0|||
30970251|NCT00086281|59042496|FG003|Phase 2|Adverse Event|0|||
30970252|NCT00086281|59042497|FG004|Phase 2|Adverse Event|0|||
30970253|NCT00086281|59042498|FG005|Phase 2|Adverse Event|0|||
30970254|NCT00086281|59042499|FG006|Phase 2|Adverse Event|0|||
30970255|NCT00086281|59042500|FG007|Phase 2|Adverse Event|0|||
30970256|NCT00086281|59042501|FG008|Phase 2|Adverse Event|0|||
30970257|NCT00086281|59042502|FG009|Phase 2|Adverse Event|0|||
30970258|NCT00086281|59042503|FG010|Phase 2|Adverse Event|0|||
30970259|NCT00086281|59042504|FG011|Phase 2|Adverse Event|0|||
30970260|NCT00086281|59042505|FG012|Phase 2|Adverse Event|1|||
30970261|NCT00086281|59042506|FG013|Phase 2|Adverse Event|1|||
30970262|NCT00086281|59042507|FG014|Phase 2|Adverse Event|0|||
30970263|NCT00086047|59042519|FG000|Overall Study|Lost to Follow-up|7|||
30970264|NCT00086047|59042520|FG001|Overall Study|Lost to Follow-up|6|||
30970265|NCT00086047|59042519|FG000|Overall Study|Physician Decision|0|||
30970266|NCT00086047|59042520|FG001|Overall Study|Physician Decision|1|||
30970267|NCT01478828|59042532|FG000|Overall Study|Adverse Event|1|||
30970268|NCT00085423|59042537|FG000|Overall Study|Withdrawal by Subject|1|||
30970269|NCT00085423|59042537|FG000|Overall Study|screen failure|1|||
30970270|NCT00084487|59042541|FG000|Overall Study|Death|1|||
30970271|NCT01425281|59042581|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
30970272|NCT01425281|59042582|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
30970273|NCT01425281|59042581|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
30970274|NCT01425281|59042582|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
30970275|NCT01425281|59042581|FG000|At 180-day Clinical Follow-up|Death|0|||
30970276|NCT01425281|59042582|FG001|At 180-day Clinical Follow-up|Death|1|||
30970277|NCT01425281|59042581|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
30970278|NCT01425281|59042582|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
30970279|NCT01425281|59042581|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
30970280|NCT01425281|59042582|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
30970281|NCT01425281|59042581|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
30970282|NCT01425281|59042582|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
30970283|NCT01425281|59042581|FG000|At 2-year Clinical Follow-up|Death|2|||
30970284|NCT01425281|59042582|FG001|At 2-year Clinical Follow-up|Death|0|||
30970285|NCT01425281|59042581|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
30970286|NCT01425281|59042582|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
30970287|NCT01425281|59042581|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
30970288|NCT01425281|59042582|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
30970289|NCT01425281|59042581|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
30970290|NCT01425281|59042582|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
30970291|NCT01425281|59042581|FG000|At 3-year Clinical Follow-up|Death|2|||
30970292|NCT01425281|59042582|FG001|At 3-year Clinical Follow-up|Death|3|||
30970293|NCT01425281|59042581|FG000|At 4-year Clinical Follow-up|Death|7|||
30970294|NCT01425281|59042582|FG001|At 4-year Clinical Follow-up|Death|3|||
30970295|NCT01425281|59042581|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
30970296|NCT01425281|59042582|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
30970297|NCT01425281|59042581|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
30970298|NCT01425281|59042582|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
30970299|NCT01425281|59042581|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
30970300|NCT01425281|59042582|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
30970301|NCT01425281|59042581|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
30970302|NCT01425281|59042582|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
30970303|NCT01425281|59042581|FG000|At 5-year Clinical Follow-up|Death|2|||
30970304|NCT01425281|59042582|FG001|At 5-year Clinical Follow-up|Death|0|||
30970305|NCT01425281|59042581|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
30970306|NCT01425281|59042582|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
30970307|NCT01425281|59042581|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
30970308|NCT01425281|59042582|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
30970309|NCT01425281|59042581|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
30970310|NCT01425281|59042582|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
30970311|NCT02648724|59042610|FG000|Overall Study|Withdrawal by Subject|0|||
30970312|NCT02648724|59042611|FG001|Overall Study|Withdrawal by Subject|1|||
30970313|NCT02648724|59042612|FG002|Overall Study|Withdrawal by Subject|1|||
30970314|NCT02648724|59042613|FG003|Overall Study|Withdrawal by Subject|0|||
30970315|NCT02648724|59042614|FG004|Overall Study|Withdrawal by Subject|1|||
30970316|NCT02648724|59042615|FG005|Overall Study|Withdrawal by Subject|0|||
30970317|NCT02648724|59042616|FG006|Overall Study|Withdrawal by Subject|0|||
30970318|NCT02648724|59042610|FG000|Overall Study|Progressive disease|2|||
30970319|NCT02648724|59042611|FG001|Overall Study|Progressive disease|2|||
30970320|NCT02648724|59042612|FG002|Overall Study|Progressive disease|2|||
30970321|NCT02648724|59042613|FG003|Overall Study|Progressive disease|3|||
30970322|NCT02648724|59042614|FG004|Overall Study|Progressive disease|22|||
30970323|NCT02648724|59042615|FG005|Overall Study|Progressive disease|7|||
30970324|NCT02648724|59042616|FG006|Overall Study|Progressive disease|8|||
30970325|NCT02648724|59042610|FG000|Overall Study|Other reason (unknown)|1|||
30970326|NCT02648724|59042611|FG001|Overall Study|Other reason (unknown)|0|||
30970327|NCT02648724|59042612|FG002|Overall Study|Other reason (unknown)|0|||
30970328|NCT02648724|59042613|FG003|Overall Study|Other reason (unknown)|0|||
30970329|NCT02648724|59042614|FG004|Overall Study|Other reason (unknown)|0|||
30970330|NCT02648724|59042615|FG005|Overall Study|Other reason (unknown)|0|||
30970331|NCT02648724|59042616|FG006|Overall Study|Other reason (unknown)|0|||
30970332|NCT02648724|59042610|FG000|Overall Study|Protocol Violation|0|||
30970333|NCT02648724|59042611|FG001|Overall Study|Protocol Violation|0|||
30970334|NCT02648724|59042612|FG002|Overall Study|Protocol Violation|0|||
30970335|NCT02648724|59042613|FG003|Overall Study|Protocol Violation|0|||
30970336|NCT02648724|59042614|FG004|Overall Study|Protocol Violation|1|||
30970337|NCT02648724|59042615|FG005|Overall Study|Protocol Violation|0|||
30970338|NCT02648724|59042616|FG006|Overall Study|Protocol Violation|0|||
30970339|NCT02648724|59042610|FG000|Overall Study|Death|0|||
30970340|NCT02648724|59042611|FG001|Overall Study|Death|0|||
30970341|NCT02648724|59042612|FG002|Overall Study|Death|0|||
30970342|NCT02648724|59042613|FG003|Overall Study|Death|0|||
30970343|NCT02648724|59042614|FG004|Overall Study|Death|0|||
30970344|NCT02648724|59042615|FG005|Overall Study|Death|0|||
30970345|NCT02648724|59042616|FG006|Overall Study|Death|3|||
30970346|NCT02648724|59042610|FG000|Overall Study|Physician Decision|0|||
30970347|NCT02648724|59042611|FG001|Overall Study|Physician Decision|0|||
30970348|NCT02648724|59042612|FG002|Overall Study|Physician Decision|0|||
30970349|NCT02648724|59042613|FG003|Overall Study|Physician Decision|0|||
30970350|NCT02648724|59042614|FG004|Overall Study|Physician Decision|1|||
30970351|NCT02648724|59042615|FG005|Overall Study|Physician Decision|0|||
30970352|NCT02648724|59042616|FG006|Overall Study|Physician Decision|1|||
30970353|NCT02648724|59042610|FG000|Overall Study|Transferred to named patient program|0|||
30970354|NCT02648724|59042611|FG001|Overall Study|Transferred to named patient program|0|||
30970355|NCT02648724|59042612|FG002|Overall Study|Transferred to named patient program|0|||
30970356|NCT02648724|59042613|FG003|Overall Study|Transferred to named patient program|0|||
30970357|NCT02648724|59042614|FG004|Overall Study|Transferred to named patient program|0|||
30970358|NCT02648724|59042615|FG005|Overall Study|Transferred to named patient program|1|||
30970359|NCT02648724|59042616|FG006|Overall Study|Transferred to named patient program|0|||
30970360|NCT01402817|59042648|FG000|Overall Study|Withdrawal by Subject|3|||
30970361|NCT01402817|59042648|FG000|Overall Study|Study Suspended by FDA|8|||
30970362|NCT01425203|59042655|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
30970363|NCT01425203|59042656|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
30970364|NCT01425203|59042657|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
30970365|NCT01425203|59042655|FG000|Treatment Phase|Failure at futility timepoint|8|||
30970366|NCT01425203|59042656|FG001|Treatment Phase|Failure at futility timepoint|27|||
30970367|NCT01425203|59042657|FG002|Treatment Phase|Failure at futility timepoint|0|||
30970368|NCT01425203|59042655|FG000|Treatment Phase|Other virologic failure criteria|5|||
30970369|NCT01425203|59042656|FG001|Treatment Phase|Other virologic failure criteria|3|||
30970370|NCT01425203|59042657|FG002|Treatment Phase|Other virologic failure criteria|0|||
30970371|NCT01425203|59042655|FG000|Treatment Phase|Unidentified reasons|11|||
30970372|NCT01425203|59042656|FG001|Treatment Phase|Unidentified reasons|5|||
30970373|NCT01425203|59042657|FG002|Treatment Phase|Unidentified reasons|0|||
30970374|NCT01425203|59042655|FG000|Treatment Phase|Did not receive treatment|0|||
30970375|NCT01425203|59042656|FG001|Treatment Phase|Did not receive treatment|1|||
30970376|NCT01425203|59042657|FG002|Treatment Phase|Did not receive treatment|0|||
30970377|NCT01425203|59042655|FG000|Crossover Phase|Failure at futility timepoint|0|||
30970378|NCT01425203|59042656|FG001|Crossover Phase|Failure at futility timepoint|0|||
30970379|NCT01425203|59042657|FG002|Crossover Phase|Failure at futility timepoint|3|||
30970380|NCT01425203|59042655|FG000|Crossover Phase|Other virologic failure criteria|0|||
30970381|NCT01425203|59042656|FG001|Crossover Phase|Other virologic failure criteria|0|||
30970382|NCT01425203|59042657|FG002|Crossover Phase|Other virologic failure criteria|3|||
30970383|NCT00081289|59042667|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
30970384|NCT00081289|59042668|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
30970385|NCT00081289|59042667|FG000|Overall Study|Ineligible / no protocol treatment|3|||
30970386|NCT00081289|59042668|FG001|Overall Study|Ineligible / no protocol treatment|4|||
30970387|NCT01478594|59042677|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
30970388|NCT01478594|59042678|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
30970389|NCT01478594|59042677|FG000|Overall Study|Death|45|||
30970390|NCT01478594|59042678|FG001|Overall Study|Death|18|||
30970391|NCT01478594|59042677|FG000|Overall Study|Lost to Follow-up|3|||
30970392|NCT01478594|59042678|FG001|Overall Study|Lost to Follow-up|1|||
30970393|NCT01478594|59042677|FG000|Overall Study|Withdrawal by Subject|9|||
30970394|NCT01478594|59042678|FG001|Overall Study|Withdrawal by Subject|3|||
30970395|NCT01478594|59042677|FG000|Overall Study|Study Closed by Sponsor|8|||
30970396|NCT01478594|59042678|FG001|Overall Study|Study Closed by Sponsor|5|||
30970397|NCT01424813|59042739|FG000|Overall Study|Withdrawal by Subject|3|||
30970398|NCT01424813|59042740|FG001|Overall Study|Withdrawal by Subject|0|||
30970399|NCT01424813|59042739|FG000|Overall Study|Protocol Violation|1|||
30970400|NCT01424813|59042740|FG001|Overall Study|Protocol Violation|0|||
30970401|NCT01424813|59042739|FG000|Overall Study|Other|1|||
30970402|NCT01424813|59042740|FG001|Overall Study|Other|2|||
30970403|NCT00080899|59042746|FG000|Overall Study|Adverse Event|1|||
30970404|NCT00089635|59042750|FG000|Overall Study|Adverse Event|2|||
30970405|NCT00089635|59042750|FG000|Overall Study|Death|17|||
30970406|NCT00089635|59042750|FG000|Overall Study|Disease Progression|12|||
30970407|NCT00089635|59042750|FG000|Overall Study|Lost to Follow-up|3|||
30970408|NCT00089635|59042750|FG000|Overall Study|Withdrawal by Subject|6|||
30970409|NCT00089635|59042750|FG000|Overall Study|Ineligibility determined|1|||
30970410|NCT00089635|59042750|FG000|Overall Study|Other|2|||
30970411|NCT01500200|59042764|FG000|Stage 1|Adverse Event|1|||
30970412|NCT01500200|59042765|FG001|Stage 1|Adverse Event|4|||
30970413|NCT01500200|59042766|FG002|Stage 1|Adverse Event|5|||
30970414|NCT01500200|59042767|FG003|Stage 1|Adverse Event|0|||
30970415|NCT01500200|59042768|FG004|Stage 1|Adverse Event|0|||
30970416|NCT01500200|59042769|FG005|Stage 1|Adverse Event|0|||
30970417|NCT01500200|59042764|FG000|Stage 1|Lost to Follow-up|2|||
30970418|NCT01500200|59042765|FG001|Stage 1|Lost to Follow-up|2|||
30970419|NCT01500200|59042766|FG002|Stage 1|Lost to Follow-up|1|||
30970420|NCT01500200|59042767|FG003|Stage 1|Lost to Follow-up|0|||
30970421|NCT01500200|59042768|FG004|Stage 1|Lost to Follow-up|0|||
30970422|NCT01500200|59042769|FG005|Stage 1|Lost to Follow-up|0|||
30970423|NCT01500200|59042764|FG000|Stage 1|Withdrawal by Subject|3|||
30970424|NCT01500200|59042765|FG001|Stage 1|Withdrawal by Subject|0|||
30970425|NCT01500200|59042766|FG002|Stage 1|Withdrawal by Subject|0|||
30970426|NCT01500200|59042767|FG003|Stage 1|Withdrawal by Subject|0|||
30970427|NCT01500200|59042768|FG004|Stage 1|Withdrawal by Subject|0|||
30970428|NCT01500200|59042769|FG005|Stage 1|Withdrawal by Subject|0|||
30970429|NCT01500200|59042764|FG000|Stage 1|Noncompliance with Study Drug|1|||
30970430|NCT01500200|59042765|FG001|Stage 1|Noncompliance with Study Drug|0|||
30970431|NCT01500200|59042766|FG002|Stage 1|Noncompliance with Study Drug|0|||
30970432|NCT01500200|59042767|FG003|Stage 1|Noncompliance with Study Drug|0|||
30970433|NCT01500200|59042768|FG004|Stage 1|Noncompliance with Study Drug|0|||
30970434|NCT01500200|59042769|FG005|Stage 1|Noncompliance with Study Drug|0|||
30970435|NCT01500200|59042764|FG000|Stage 1|Physician Decision|1|||
30970436|NCT01500200|59042765|FG001|Stage 1|Physician Decision|0|||
30970437|NCT01500200|59042766|FG002|Stage 1|Physician Decision|0|||
30970438|NCT01500200|59042767|FG003|Stage 1|Physician Decision|0|||
30970439|NCT01500200|59042768|FG004|Stage 1|Physician Decision|0|||
30970440|NCT01500200|59042769|FG005|Stage 1|Physician Decision|0|||
30970441|NCT01500200|59042764|FG000|Stage 2|Adverse Event|0|||
30970442|NCT01500200|59042765|FG001|Stage 2|Adverse Event|0|||
30970443|NCT01500200|59042766|FG002|Stage 2|Adverse Event|0|||
30970444|NCT01500200|59042767|FG003|Stage 2|Adverse Event|0|||
30970445|NCT01500200|59042768|FG004|Stage 2|Adverse Event|5|||
30970446|NCT01500200|59042769|FG005|Stage 2|Adverse Event|4|||
30970447|NCT01478360|59042785|FG000|Overall Study|Lost to Follow-up|1|||
30970448|NCT01478360|59042786|FG001|Overall Study|Lost to Follow-up|0|||
30970449|NCT01478360|59042785|FG000|Overall Study|Adverse Event|0|||
30970450|NCT01478360|59042786|FG001|Overall Study|Adverse Event|1|||
30970451|NCT01478360|59042785|FG000|Overall Study|Administrative problems|1|||
30970452|NCT01478360|59042786|FG001|Overall Study|Administrative problems|2|||
30970453|NCT01461980|59042804|FG000|Overall Study|Other|9|||
30970454|NCT01461980|59042805|FG001|Overall Study|Other|8|||
30970455|NCT01461980|59042806|FG002|Overall Study|Other|6|||
30970456|NCT01461980|59042804|FG000|Overall Study|Medication error|7|||
30970457|NCT01461980|59042805|FG001|Overall Study|Medication error|5|||
30970458|NCT01461980|59042806|FG002|Overall Study|Medication error|6|||
30970459|NCT01461980|59042804|FG000|Overall Study|Adverse Event|12|||
30970460|NCT01461980|59042805|FG001|Overall Study|Adverse Event|5|||
30970461|NCT01461980|59042806|FG002|Overall Study|Adverse Event|6|||
30970462|NCT01461980|59042804|FG000|Overall Study|Protocol Violation|12|||
30970463|NCT01461980|59042805|FG001|Overall Study|Protocol Violation|19|||
30970464|NCT01461980|59042806|FG002|Overall Study|Protocol Violation|16|||
30970465|NCT01461980|59042804|FG000|Overall Study|No longer meets eligibility criteria|18|||
30970466|NCT01461980|59042805|FG001|Overall Study|No longer meets eligibility criteria|9|||
30970467|NCT01461980|59042806|FG002|Overall Study|No longer meets eligibility criteria|19|||
30970468|NCT01461980|59042804|FG000|Overall Study|Lost to Follow-up|52|||
30970469|NCT01461980|59042805|FG001|Overall Study|Lost to Follow-up|53|||
30970470|NCT01461980|59042806|FG002|Overall Study|Lost to Follow-up|51|||
30970471|NCT01461980|59042804|FG000|Overall Study|No longer willing to participate|52|||
30970472|NCT01461980|59042805|FG001|Overall Study|No longer willing to participate|38|||
30970473|NCT01461980|59042806|FG002|Overall Study|No longer willing to participate|54|||
30970474|NCT01461980|59042804|FG000|Overall Study|Randomized but not vaccinated|4|||
30970475|NCT01461980|59042805|FG001|Overall Study|Randomized but not vaccinated|8|||
30970476|NCT01461980|59042806|FG002|Overall Study|Randomized but not vaccinated|7|||
30970477|NCT01424501|59042821|FG000|Overall Study|Withdrawal by Subject|1|||
30970478|NCT01424501|59042822|FG001|Overall Study|Withdrawal by Subject|0|||
30970479|NCT01424501|59042823|FG002|Overall Study|Withdrawal by Subject|1|||
30970480|NCT01424501|59042824|FG003|Overall Study|Withdrawal by Subject|0|||
30970481|NCT01424501|59042825|FG004|Overall Study|Withdrawal by Subject|0|||
30970482|NCT01424501|59042826|FG005|Overall Study|Withdrawal by Subject|0|||
30970483|NCT01424501|59042821|FG000|Overall Study|Lost to Follow-up|0|||
30970484|NCT01424501|59042822|FG001|Overall Study|Lost to Follow-up|1|||
30970485|NCT01424501|59042823|FG002|Overall Study|Lost to Follow-up|1|||
30970486|NCT01424501|59042824|FG003|Overall Study|Lost to Follow-up|0|||
30970487|NCT01424501|59042825|FG004|Overall Study|Lost to Follow-up|0|||
30970488|NCT01424501|59042826|FG005|Overall Study|Lost to Follow-up|0|||
30970489|NCT01401959|59042907|FG000|Enrolled|Withdrawal by Subject|1|||
30970490|NCT01401959|59042908|FG001|Enrolled|Withdrawal by Subject|0|||
30970491|NCT01401959|59042909|FG002|Enrolled|Withdrawal by Subject|0|||
30970492|NCT01401959|59042907|FG000|Treated|Disease Progression|2|||
30970493|NCT01401959|59042908|FG001|Treated|Disease Progression|2|||
30970494|NCT01401959|59042909|FG002|Treated|Disease Progression|1|||
30970495|NCT01401959|59042907|FG000|Treated|Adverse Event|4|||
30970496|NCT01401959|59042908|FG001|Treated|Adverse Event|3|||
30970497|NCT01401959|59042909|FG002|Treated|Adverse Event|2|||
30970498|NCT01401959|59042907|FG000|Treated|Withdrawal by Subject|1|||
30970499|NCT01401959|59042908|FG001|Treated|Withdrawal by Subject|2|||
30970500|NCT01401959|59042909|FG002|Treated|Withdrawal by Subject|2|||
30970501|NCT01401959|59042907|FG000|Treated|Protocol Violation|0|||
30970502|NCT01401959|59042908|FG001|Treated|Protocol Violation|1|||
30970503|NCT01401959|59042909|FG002|Treated|Protocol Violation|0|||
30970504|NCT01478048|59042939|FG000|Overall Study|Disease Progression|52|||
30970505|NCT01478048|59042940|FG001|Overall Study|Disease Progression|35|||
30970506|NCT01478048|59042939|FG000|Overall Study|study drug toxicity|11|||
30970507|NCT01478048|59042940|FG001|Overall Study|study drug toxicity|14|||
30970508|NCT01478048|59042939|FG000|Overall Study|Adverse Event|2|||
30970509|NCT01478048|59042940|FG001|Overall Study|Adverse Event|11|||
30970510|NCT01478048|59042939|FG000|Overall Study|subject request to discontinue treatment|3|||
30970511|NCT01478048|59042940|FG001|Overall Study|subject request to discontinue treatment|5|||
30970512|NCT01478048|59042939|FG000|Overall Study|Withdrawal by Subject|2|||
30970513|NCT01478048|59042940|FG001|Overall Study|Withdrawal by Subject|5|||
30970514|NCT01478048|59042939|FG000|Overall Study|non-specified|6|||
30970515|NCT01478048|59042940|FG001|Overall Study|non-specified|4|||
30970516|NCT01478048|59042939|FG000|Overall Study|poor/non-compliance|0|||
30970517|NCT01478048|59042940|FG001|Overall Study|poor/non-compliance|1|||
30970518|NCT01478048|59042939|FG000|Overall Study|no longer meets study criteria|1|||
30970519|NCT01478048|59042940|FG001|Overall Study|no longer meets study criteria|0|||
30970520|NCT01424189|59042948|FG000|Overall Study|Adverse Event|1|||
30970521|NCT01424189|59042949|FG001|Overall Study|Adverse Event|0|||
30970522|NCT01424189|59042948|FG000|Overall Study|Lost to Follow-up|4|||
30970523|NCT01424189|59042949|FG001|Overall Study|Lost to Follow-up|1|||
30970524|NCT01424189|59042948|FG000|Overall Study|Withdrawal by Subject|4|||
30970525|NCT01424189|59042949|FG001|Overall Study|Withdrawal by Subject|4|||
30970526|NCT01424189|59042948|FG000|Overall Study|Subject moved|1|||
30970527|NCT01424189|59042949|FG001|Overall Study|Subject moved|0|||
30970528|NCT01424189|59042948|FG000|Overall Study|Death|3|||
30970529|NCT01424189|59042949|FG001|Overall Study|Death|1|||
30970530|NCT01401647|59042962|FG000|Overall Study|Withdrawal by Subject|1|||
30970531|NCT01401647|59042963|FG001|Overall Study|Withdrawal by Subject|5|||
30970532|NCT01401647|59042964|FG002|Overall Study|Withdrawal by Subject|2|||
30970533|NCT01401647|59042962|FG000|Overall Study|Lost to Follow-up|3|||
30970534|NCT01401647|59042963|FG001|Overall Study|Lost to Follow-up|3|||
30970535|NCT01401647|59042964|FG002|Overall Study|Lost to Follow-up|1|||
30970536|NCT01499810|59042972|FG000|Overall Study|Lost to Follow-up|10|||
30970537|NCT01499810|59042972|FG000|Overall Study|Protocol Violation|1|||
30970538|NCT01499810|59042972|FG000|Overall Study|Withdrawal by Subject|1|||
30970539|NCT01423253|59042977|FG000|Overall Study|Adverse Event|2|||
30970540|NCT01423253|59042977|FG000|Overall Study|Lack of Efficacy|2|||
30970541|NCT01423253|59042977|FG000|Overall Study|Lost to Follow-up|1|||
30970542|NCT01423253|59042977|FG000|Overall Study|Protocol Violation|2|||
30970543|NCT01423253|59042977|FG000|Overall Study|Withdrawal by Subject|2|||
30970544|NCT01477892|59042983|FG000|Overall Study|Withdrawal by Subject|0|||
30970545|NCT01477892|59042984|FG001|Overall Study|Withdrawal by Subject|2|||
30970546|NCT01422239|59042997|FG000|Overall Study|Lost to Follow-up|4|||
30970547|NCT01422239|59042998|FG001|Overall Study|Lost to Follow-up|3|||
30970548|NCT01499576|59043004|FG000|Overall Study|Physician Decision|12|||
30970549|NCT01499576|59043004|FG000|Overall Study|Withdrawal by Subject|9|||
30970550|NCT01476722|59043018|FG000|Overall Study|Adverse Event|1|||
30970551|NCT01476644|59043031|FG000|Overall Study|Death|5|||
30970552|NCT01476644|59043031|FG000|Overall Study|moved to another state|2|||
30970553|NCT01476644|59043031|FG000|Overall Study|Lost to Follow-up|19|||
30970554|NCT01476644|59043031|FG000|Overall Study|Withdrawal by Subject|13|||
30970555|NCT01421459|59043055|FG000|Overall Study|Adverse Event|6|||
30970556|NCT01421459|59043056|FG001|Overall Study|Adverse Event|10|||
30970557|NCT01421459|59043055|FG000|Overall Study|Death|1|||
30970558|NCT01421459|59043056|FG001|Overall Study|Death|1|||
30970559|NCT01421459|59043055|FG000|Overall Study|Lack of Efficacy|1|||
30970560|NCT01421459|59043056|FG001|Overall Study|Lack of Efficacy|2|||
30970561|NCT01421459|59043055|FG000|Overall Study|Lost to Follow-up|8|||
30970562|NCT01421459|59043056|FG001|Overall Study|Lost to Follow-up|9|||
30970563|NCT01421459|59043055|FG000|Overall Study|Physician Decision|9|||
30970564|NCT01421459|59043056|FG001|Overall Study|Physician Decision|9|||
30970565|NCT01421459|59043055|FG000|Overall Study|Protocol Violation|8|||
30970566|NCT01421459|59043056|FG001|Overall Study|Protocol Violation|5|||
30970567|NCT01421459|59043055|FG000|Overall Study|Withdrawal by Subject|12|||
30970568|NCT01421459|59043056|FG001|Overall Study|Withdrawal by Subject|16|||
30970569|NCT01498952|59043064|FG000|Overall Study|Death|2|||
30970570|NCT01498952|59043065|FG001|Overall Study|Death|2|||
30970571|NCT01498952|59043066|FG002|Overall Study|Death|0|||
30970572|NCT01498952|59043067|FG003|Overall Study|Death|0|||
30970573|NCT01498952|59043068|FG004|Overall Study|Death|0|||
30970574|NCT01461044|59043100|FG000|Overall Study|Death|58|||
30970575|NCT01461044|59043101|FG001|Overall Study|Death|35|||
30970576|NCT01461044|59043100|FG000|Overall Study|Lost to Follow-up|12|||
30970577|NCT01461044|59043101|FG001|Overall Study|Lost to Follow-up|5|||
30970578|NCT01421303|59043134|FG000|Overall Study|Lost to Follow-up|13|||
30970579|NCT01421303|59043134|FG000|Overall Study|Non compliance with study procedure|1|||
30970580|NCT01421303|59043134|FG000|Overall Study|Other|7|||
30970581|NCT01421303|59043134|FG000|Overall Study|Withdrawal by Subject|1|||
30970582|NCT01475474|59043138|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
30970583|NCT01475474|59043138|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
30970584|NCT01400243|59043145|FG000|Overall Study|Protocol Violation|8|||
30970585|NCT01400243|59043146|FG001|Overall Study|Protocol Violation|11|||
30970586|NCT01475162|59043163|FG000|Overall Study|Physician Decision|1|||
30970587|NCT01475162|59043163|FG000|Overall Study|Death|10|||
30970588|NCT01475162|59043163|FG000|Overall Study|Study closed for safety|3|||
30970589|NCT01421225|59043170|FG000|Overall Study|Withdrawal by Subject|0|||
30970590|NCT01421225|59043171|FG001|Overall Study|Withdrawal by Subject|1|||
30970591|NCT01498640|59043187|FG000|Overall Study|Lost to Follow-up|1|||
30970592|NCT01498640|59043187|FG000|Overall Study|Death|1|||
30970593|NCT01498640|59043187|FG000|Overall Study|Other|3|||
30970594|NCT01498484|59043199|FG000|Overall Study|Death|6|||
30970595|NCT01498484|59043200|FG001|Overall Study|Death|3|||
30970596|NCT01498484|59043201|FG002|Overall Study|Death|1|||
30970597|NCT01498484|59043202|FG003|Overall Study|Death|1|||
30970598|NCT01498484|59043203|FG004|Overall Study|Death|0|||
30970599|NCT01498484|59043204|FG005|Overall Study|Death|0|||
30970600|NCT01498484|59043205|FG006|Overall Study|Death|10|||
30970601|NCT01498484|59043206|FG007|Overall Study|Death|1|||
30970602|NCT01498484|59043207|FG008|Overall Study|Death|0|||
30970603|NCT01498484|59043199|FG000|Overall Study|Physician Decision|3|||
30970604|NCT01498484|59043200|FG001|Overall Study|Physician Decision|2|||
30970605|NCT01498484|59043201|FG002|Overall Study|Physician Decision|1|||
30970606|NCT01498484|59043202|FG003|Overall Study|Physician Decision|1|||
30970607|NCT01498484|59043203|FG004|Overall Study|Physician Decision|0|||
30970608|NCT01498484|59043204|FG005|Overall Study|Physician Decision|0|||
30970609|NCT01498484|59043205|FG006|Overall Study|Physician Decision|8|||
30970610|NCT01498484|59043206|FG007|Overall Study|Physician Decision|13|||
30970611|NCT01498484|59043207|FG008|Overall Study|Physician Decision|1|||
30970612|NCT01498484|59043199|FG000|Overall Study|Adverse Event|0|||
30608399|NCT01288430|58619228|FG007|Part 1|Clinical disease progression|0|||
30608400|NCT01288430|58619229|FG008|Part 1|Clinical disease progression|0|||
30970613|NCT01498484|59043200|FG001|Overall Study|Adverse Event|0|||
30970614|NCT01498484|59043201|FG002|Overall Study|Adverse Event|0|||
30970615|NCT01498484|59043202|FG003|Overall Study|Adverse Event|0|||
30970616|NCT01498484|59043203|FG004|Overall Study|Adverse Event|0|||
30970617|NCT01498484|59043204|FG005|Overall Study|Adverse Event|1|||
30970618|NCT01498484|59043205|FG006|Overall Study|Adverse Event|0|||
30970619|NCT01498484|59043206|FG007|Overall Study|Adverse Event|0|||
30970620|NCT01498484|59043207|FG008|Overall Study|Adverse Event|0|||
30970621|NCT01498484|59043199|FG000|Overall Study|Withdrawal by Subject|0|||
30970622|NCT01498484|59043200|FG001|Overall Study|Withdrawal by Subject|0|||
30970623|NCT01498484|59043201|FG002|Overall Study|Withdrawal by Subject|0|||
30970624|NCT01498484|59043202|FG003|Overall Study|Withdrawal by Subject|1|||
30970625|NCT01498484|59043203|FG004|Overall Study|Withdrawal by Subject|0|||
30970626|NCT01498484|59043204|FG005|Overall Study|Withdrawal by Subject|0|||
30970627|NCT01498484|59043205|FG006|Overall Study|Withdrawal by Subject|1|||
30970628|NCT01498484|59043206|FG007|Overall Study|Withdrawal by Subject|0|||
30970629|NCT01498484|59043207|FG008|Overall Study|Withdrawal by Subject|0|||
30970630|NCT01498484|59043199|FG000|Overall Study|Other|5|||
30970631|NCT01498484|59043200|FG001|Overall Study|Other|2|||
30970632|NCT01498484|59043201|FG002|Overall Study|Other|0|||
30970633|NCT01498484|59043202|FG003|Overall Study|Other|0|||
30970634|NCT01498484|59043203|FG004|Overall Study|Other|1|||
30970635|NCT01498484|59043204|FG005|Overall Study|Other|0|||
30970636|NCT01498484|59043205|FG006|Overall Study|Other|3|||
30970637|NCT01498484|59043206|FG007|Overall Study|Other|0|||
30970638|NCT01498484|59043207|FG008|Overall Study|Other|1|||
30970639|NCT01474772|59043216|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
30970640|NCT01474772|59043217|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
30970641|NCT01474772|59043216|FG000|Period 1|AE not Related to Study Drug|1|||
30970642|NCT01474772|59043217|FG001|Period 1|AE not Related to Study Drug|0|||
30970643|NCT01474772|59043216|FG000|Period 1|Withdrawal by Subject|3|||
30970644|NCT01474772|59043217|FG001|Period 1|Withdrawal by Subject|1|||
30970645|NCT01474772|59043216|FG000|Period 1|Lost to Follow-up|1|||
30970646|NCT01474772|59043217|FG001|Period 1|Lost to Follow-up|0|||
30970647|NCT01474772|59043216|FG000|Period 1|Reason not Specified|1|||
30970648|NCT01474772|59043217|FG001|Period 1|Reason not Specified|1|||
30970649|NCT01474772|59043216|FG000|Washout|AE not Related to Study Drug|2|||
30970650|NCT01474772|59043217|FG001|Washout|AE not Related to Study Drug|0|||
30970651|NCT01474772|59043216|FG000|Washout|Withdrawal by Subject|1|||
30970652|NCT01474772|59043217|FG001|Washout|Withdrawal by Subject|0|||
30970653|NCT01474772|59043216|FG000|Washout|Lost to Follow-up|0|||
30970654|NCT01474772|59043217|FG001|Washout|Lost to Follow-up|1|||
30970655|NCT01474772|59043216|FG000|Washout|Reason not Specified|0|||
30970656|NCT01474772|59043217|FG001|Washout|Reason not Specified|1|||
30970657|NCT01474772|59043216|FG000|Period 2|Death|0|||
30970658|NCT01474772|59043217|FG001|Period 2|Death|1|||
30970659|NCT01474772|59043216|FG000|Period 2|AE Related to Study Drug|0|||
30970660|NCT01474772|59043217|FG001|Period 2|AE Related to Study Drug|1|||
30970661|NCT01474772|59043216|FG000|Period 2|AE not Related to Study Drug|4|||
30970662|NCT01474772|59043217|FG001|Period 2|AE not Related to Study Drug|1|||
30970663|NCT01474772|59043216|FG000|Period 2|Lack of Efficacy|1|||
30970664|NCT01474772|59043217|FG001|Period 2|Lack of Efficacy|0|||
30970665|NCT01474772|59043216|FG000|Period 2|Withdrawal by Subject|3|||
30970666|NCT01474772|59043217|FG001|Period 2|Withdrawal by Subject|4|||
30970667|NCT01474772|59043216|FG000|Period 2|Lost to Follow-up|1|||
30970668|NCT01474772|59043217|FG001|Period 2|Lost to Follow-up|1|||
30970669|NCT01474772|59043216|FG000|Period 2|Reason not Specified|0|||
30970670|NCT01474772|59043217|FG001|Period 2|Reason not Specified|2|||
30970671|NCT01474772|59043216|FG000|Follow-up|AE not Related to Study Drug|0|||
30970672|NCT01474772|59043217|FG001|Follow-up|AE not Related to Study Drug|1|||
30970673|NCT01421147|59043225|FG000|Treatment Period|Adverse Event|2|||
30970674|NCT01421147|59043226|FG001|Treatment Period|Adverse Event|3|||
30970675|NCT01421147|59043225|FG000|Treatment Period|Lost to Follow-up|2|||
30970676|NCT01421147|59043226|FG001|Treatment Period|Lost to Follow-up|1|||
30970677|NCT01421147|59043225|FG000|Treatment Period|Physician Decision|2|||
30970678|NCT01421147|59043226|FG001|Treatment Period|Physician Decision|2|||
30970679|NCT01421147|59043225|FG000|Treatment Period|Withdrawal by Subject|10|||
30970680|NCT01421147|59043226|FG001|Treatment Period|Withdrawal by Subject|5|||
30970681|NCT01421147|59043225|FG000|Extension Period|Adverse Event|0|||
30970682|NCT01421147|59043226|FG001|Extension Period|Adverse Event|2|||
30970683|NCT01421147|59043225|FG000|Extension Period|Death|0|||
30970684|NCT01421147|59043226|FG001|Extension Period|Death|1|||
30970685|NCT01421147|59043225|FG000|Extension Period|Lost to Follow-up|2|||
30970686|NCT01421147|59043226|FG001|Extension Period|Lost to Follow-up|5|||
30970687|NCT01421147|59043225|FG000|Extension Period|Physician Decision|1|||
30970688|NCT01421147|59043226|FG001|Extension Period|Physician Decision|0|||
30970689|NCT01421147|59043225|FG000|Extension Period|Withdrawal by Subject|5|||
30970690|NCT01421147|59043226|FG001|Extension Period|Withdrawal by Subject|3|||
30970691|NCT01497938|59043243|FG000|Overall Study|Adverse Event|0|||
30970692|NCT01497938|59043244|FG001|Overall Study|Adverse Event|1|||
30970693|NCT01497938|59043243|FG000|Overall Study|Physician Decision|0|||
30970694|NCT01497938|59043244|FG001|Overall Study|Physician Decision|1|||
30970695|NCT01497938|59043243|FG000|Overall Study|Withdrawal by Subject|4|||
30970696|NCT01497938|59043244|FG001|Overall Study|Withdrawal by Subject|0|||
30970697|NCT01497938|59043243|FG000|Overall Study|Device Violation|1|||
30970698|NCT01497938|59043244|FG001|Overall Study|Device Violation|0|||
30970699|NCT01460342|59043294|FG000|Overall Study|Adverse Event|5|||
30970700|NCT01460342|59043295|FG001|Overall Study|Adverse Event|4|||
30970701|NCT01460342|59043294|FG000|Overall Study|Lost to Follow-up|1|||
30970702|NCT01460342|59043295|FG001|Overall Study|Lost to Follow-up|2|||
30970703|NCT01460342|59043294|FG000|Overall Study|Protocol Violation|0|||
30970704|NCT01460342|59043295|FG001|Overall Study|Protocol Violation|1|||
30970705|NCT01460342|59043294|FG000|Overall Study|Withdrawal by Subject|3|||
30970706|NCT01460342|59043295|FG001|Overall Study|Withdrawal by Subject|4|||
30970707|NCT01460342|59043294|FG000|Overall Study|Physician Decision|1|||
30970708|NCT01460342|59043295|FG001|Overall Study|Physician Decision|3|||
30970709|NCT01460342|59043294|FG000|Overall Study|Lack of Efficacy|1|||
30970710|NCT01460342|59043295|FG001|Overall Study|Lack of Efficacy|0|||
30970711|NCT01459796|59043327|FG000|Overall Study|Non compliance with protocol|2|||
30970712|NCT01459796|59043328|FG001|Overall Study|Non compliance with protocol|4|||
30970713|NCT01459796|59043327|FG000|Overall Study|Adverse Event|5|||
30970714|NCT01459796|59043328|FG001|Overall Study|Adverse Event|5|||
30970715|NCT01459796|59043327|FG000|Overall Study|Withdrawal by Subject|6|||
30970716|NCT01459796|59043328|FG001|Overall Study|Withdrawal by Subject|3|||
30970717|NCT01459796|59043327|FG000|Overall Study|Lost to Follow-up|5|||
30970718|NCT01459796|59043328|FG001|Overall Study|Lost to Follow-up|4|||
30970719|NCT01459796|59043327|FG000|Overall Study|Reason unspecified|1|||
30970720|NCT01459796|59043328|FG001|Overall Study|Reason unspecified|2|||
30970721|NCT01459796|59043327|FG000|Overall Study|Decision by the sponsor|75|||
30970722|NCT01459796|59043328|FG001|Overall Study|Decision by the sponsor|108|||
30970723|NCT01459718|59043338|FG000|Overall Study|Physician Decision|1|||
30970724|NCT01459718|59043338|FG000|Overall Study|Lost to Follow-up|1|||
30970725|NCT01459718|59043338|FG000|Overall Study|Adverse Event|1|||
30970726|NCT02970318|59043348|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
30970727|NCT02970318|59043349|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
30970728|NCT02970318|59043350|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
30970729|NCT02970318|59043351|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
30970730|NCT02970318|59043348|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
30970731|NCT02970318|59043349|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
30970732|NCT02970318|59043350|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
30970733|NCT02970318|59043351|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
30970734|NCT02970318|59043348|FG000|Overall for Arm A & Main for Arm B|Death|41|||
30970735|NCT02970318|59043349|FG001|Overall for Arm A & Main for Arm B|Death|33|||
30970736|NCT02970318|59043350|FG002|Overall for Arm A & Main for Arm B|Death|0|||
30970737|NCT02970318|59043351|FG003|Overall for Arm A & Main for Arm B|Death|0|||
30880203|NCT01597193|58912128|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
30880204|NCT01597193|58912129|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
30880205|NCT01597193|58912123|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
30880206|NCT01597193|58912124|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
30880207|NCT01597193|58912125|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
30880208|NCT01597193|58912126|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
30880209|NCT01597193|58912127|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
30880210|NCT01597193|58912128|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
30880211|NCT01597193|58912129|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
30880212|NCT01597193|58912123|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
30880213|NCT01597193|58912124|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
30880214|NCT01597193|58912125|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
30880215|NCT01597193|58912126|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
30880216|NCT01597193|58912127|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
30880217|NCT01597193|58912128|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
30880218|NCT01597193|58912129|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
30880219|NCT01597193|58912123|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
30880220|NCT01597193|58912124|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
30880221|NCT01597193|58912125|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
30970738|NCT02970318|59043348|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
30970739|NCT02970318|59043349|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
30970740|NCT02970318|59043350|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
30970741|NCT02970318|59043351|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
30970742|NCT02970318|59043348|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
30970743|NCT02970318|59043349|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
30970744|NCT02970318|59043350|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
30970745|NCT02970318|59043351|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
30970746|NCT02970318|59043348|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
30970747|NCT02970318|59043349|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
30970748|NCT02970318|59043350|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
30970749|NCT02970318|59043351|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
30970750|NCT02970318|59043348|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
30970751|NCT02970318|59043349|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
30970752|NCT02970318|59043350|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
30970753|NCT02970318|59043351|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
30970754|NCT02900976|59043361|FG000|Overall Study|Adverse Event|0|||
30970755|NCT02900976|59043362|FG001|Overall Study|Adverse Event|1|||
30970756|NCT02900976|59043361|FG000|Overall Study|Physician Decision|0|||
30970757|NCT02900976|59043362|FG001|Overall Study|Physician Decision|2|||
30970758|NCT02900976|59043361|FG000|Overall Study|Progressive disease|0|||
30970759|NCT02900976|59043362|FG001|Overall Study|Progressive disease|6|||
30970760|NCT01474538|59043375|FG000|Treatment Period 1|Death|1|||
30970761|NCT01474538|59043376|FG001|Treatment Period 1|Death|0|||
30970762|NCT01474538|59043375|FG000|Treatment Period 1|Physician Decision|1|||
30970763|NCT01474538|59043376|FG001|Treatment Period 1|Physician Decision|0|||
30970764|NCT01474538|59043375|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30970765|NCT01474538|59043376|FG001|Treatment Period 1|Withdrawal by Subject|3|||
30970766|NCT01474538|59043375|FG000|Treatment Period 1|Protocol Violation|0|||
30970767|NCT01474538|59043376|FG001|Treatment Period 1|Protocol Violation|1|||
30970768|NCT01474538|59043375|FG000|Treatment Period 2|Death|1|||
30970769|NCT01474538|59043376|FG001|Treatment Period 2|Death|0|||
30970770|NCT01474538|59043375|FG000|Treatment Period 2|Adverse Event|1|||
30970771|NCT01474538|59043376|FG001|Treatment Period 2|Adverse Event|1|||
30970772|NCT01474538|59043375|FG000|Treatment Period 2|Withdrawal by Subject|2|||
30970773|NCT01474538|59043376|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30970774|NCT01474538|59043375|FG000|Treatment Period 2|Sponsor decision|1|||
30970775|NCT01474538|59043376|FG001|Treatment Period 2|Sponsor decision|0|||
30970776|NCT01474538|59043375|FG000|Treatment Period 2|Physician Decision|0|||
30970777|NCT01474538|59043376|FG001|Treatment Period 2|Physician Decision|1|||
30970778|NCT01474538|59043375|FG000|Treatment Period 2|Protocol Violation|1|||
30970779|NCT01474538|59043376|FG001|Treatment Period 2|Protocol Violation|0|||
30970780|NCT02647788|59043384|FG000|Overall Study|Lost to Follow-up|13|||
30970781|NCT02647788|59043385|FG001|Overall Study|Lost to Follow-up|11|||
30970782|NCT02647788|59043384|FG000|Overall Study|Did not want opiate|0|||
30970783|NCT02647788|59043385|FG001|Overall Study|Did not want opiate|1|||
30970784|NCT02647788|59043384|FG000|Overall Study|Withdrawal by Subject|1|||
30970785|NCT02647788|59043385|FG001|Overall Study|Withdrawal by Subject|0|||
30970786|NCT02647788|59043384|FG000|Overall Study|Felt itchy with assigned medication|1|||
30970787|NCT02647788|59043385|FG001|Overall Study|Felt itchy with assigned medication|0|||
30970788|NCT02647788|59043384|FG000|Overall Study|Felt nauseous with assigned medication|1|||
30970789|NCT02647788|59043385|FG001|Overall Study|Felt nauseous with assigned medication|1|||
30970790|NCT01459016|59043391|FG000|Overall Study|Withdrawal by Subject|11|||
30970791|NCT01459016|59043391|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
30970792|NCT01458392|59043433|FG000|Overall Study|Death|2|||
30970793|NCT01458392|59043434|FG001|Overall Study|Death|11|||
30970794|NCT01458392|59043435|FG002|Overall Study|Death|22|||
30970795|NCT01458392|59043433|FG000|Overall Study|At the discretion of the sponsor|0|||
30970796|NCT01458392|59043434|FG001|Overall Study|At the discretion of the sponsor|2|||
30970797|NCT01458392|59043435|FG002|Overall Study|At the discretion of the sponsor|7|||
30970798|NCT01458392|59043433|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
30970799|NCT01458392|59043434|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
30970800|NCT01458392|59043435|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
30970801|NCT01421069|59043447|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
30970802|NCT01421069|59043447|FG000|Parent Study|Failed to return|3|||
30970803|NCT01421069|59043447|FG000|Parent Study|Withdrawal by Subject|1|||
30970804|NCT01421069|59043447|FG000|Parent Study|Lost to Follow-up|2|||
30970805|NCT01421069|59043447|FG000|Parent Study|Lack of Efficacy|1|||
30970806|NCT01421069|59043447|FG000|Overall Period for Extension Study|Other|2|||
30970807|NCT01421069|59043447|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
30970808|NCT01421069|59043447|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
30970809|NCT01421069|59043447|FG000|Overall Period for Extension Study|Pregnancy|1|||
30970810|NCT01421069|59043447|FG000|Overall Period for Extension Study|Adverse Event|1|||
30970811|NCT01421069|59043447|FG000|Overall Period for Extension Study|Protocol Violation|1|||
30970812|NCT01421069|59043447|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
30970813|NCT01421069|59043447|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
30970814|NCT01421069|59043447|FG000|Active Treatment Period|Other|1|||
30970815|NCT01421069|59043447|FG000|Active Treatment Period|No longer willing to participate in study|8|||
30970816|NCT01421069|59043447|FG000|Active Treatment Period|Insufficient clinical response|1|||
30970817|NCT01421069|59043447|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
30970818|NCT01421069|59043447|FG000|Active Treatment Period|Pregnancy|1|||
30970819|NCT01421069|59043447|FG000|Active Treatment Period|Adverse Event|1|||
30970820|NCT01421069|59043447|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
30970821|NCT01421069|59043447|FG000|Active Treatment Period|Enrolled in observational period|29|||
30970822|NCT01421069|59043447|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
30970823|NCT01421069|59043447|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
30970824|NCT01421069|59043447|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
30970825|NCT01421069|59043447|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
30970826|NCT01421069|59043447|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
30970827|NCT01421069|59043447|FG000|2b. Retreatment Period|Protocol Violation|1|||
30970828|NCT01421069|59043447|FG000|Observational Period|Other|1|||
30970829|NCT01421069|59043447|FG000|Observational Period|No longer willing to participate in study|4|||
30970830|NCT01421069|59043447|FG000|Observational Period|Lost to Follow-up|3|||
30970831|NCT01473836|59043479|FG000|Overall Study|Adverse Event|4|||
30970832|NCT01473836|59043479|FG000|Overall Study|Lack of Efficacy|1|||
30970833|NCT01473836|59043479|FG000|Overall Study|Does not meet entrance criteria|1|||
30970834|NCT01473758|59043519|FG000|Cycle 1|Adverse Event|10|||
30970835|NCT01473758|59043520|FG001|Cycle 1|Adverse Event|2|||
30970836|NCT01473758|59043521|FG002|Cycle 1|Adverse Event|0|||
30970837|NCT01473758|59043522|FG003|Cycle 1|Adverse Event|0|||
30970838|NCT01473758|59043519|FG000|Cycle 1|Withdrawal by Subject|1|||
30970839|NCT01473758|59043520|FG001|Cycle 1|Withdrawal by Subject|1|||
30970840|NCT01473758|59043521|FG002|Cycle 1|Withdrawal by Subject|0|||
30970841|NCT01473758|59043522|FG003|Cycle 1|Withdrawal by Subject|0|||
30970842|NCT01473758|59043519|FG000|Cycle 2|Adverse Event|0|||
30970843|NCT01473758|59043520|FG001|Cycle 2|Adverse Event|0|||
30970844|NCT01473758|59043521|FG002|Cycle 2|Adverse Event|5|||
30970845|NCT01473758|59043522|FG003|Cycle 2|Adverse Event|0|||
30970846|NCT01420679|59043532|FG000|Overall Study|Disease Progression|3|||
30970847|NCT01420679|59043533|FG001|Overall Study|Disease Progression|2|||
30970848|NCT01420679|59043532|FG000|Overall Study|Adverse Event|4|||
30970849|NCT01420679|59043533|FG001|Overall Study|Adverse Event|0|||
30970850|NCT01420679|59043532|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
30970851|NCT01420679|59043533|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
30970852|NCT01420679|59043532|FG000|Overall Study|Patient Decision|1|||
30970853|NCT01420679|59043533|FG001|Overall Study|Patient Decision|0|||
30970854|NCT01420679|59043532|FG000|Overall Study|Investigator Decision|1|||
30970855|NCT01420679|59043533|FG001|Overall Study|Investigator Decision|2|||
30970856|NCT01420679|59043532|FG000|Overall Study|Sponsor Decision|3|||
30970857|NCT01420679|59043533|FG001|Overall Study|Sponsor Decision|3|||
30970858|NCT01420679|59043532|FG000|Overall Study|Other|1|||
30970859|NCT01420679|59043533|FG001|Overall Study|Other|0|||
30970860|NCT01496846|59043550|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
30880222|NCT01597193|58912126|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
30880223|NCT01597193|58912127|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
30880224|NCT01597193|58912128|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
30880225|NCT01597193|58912129|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
30880226|NCT02649439|58912152|FG000|Overall Study|Switched to alternative treatment|6|||
30880227|NCT02649439|58912153|FG001|Overall Study|Switched to alternative treatment|4|||
30880228|NCT02649439|58912152|FG000|Overall Study|Patient decision|1|||
30880229|NCT02649439|58912153|FG001|Overall Study|Patient decision|0|||
30880230|NCT02649439|58912152|FG000|Overall Study|Patient going out of country|1|||
30880231|NCT02649439|58912153|FG001|Overall Study|Patient going out of country|0|||
30880232|NCT02649439|58912152|FG000|Overall Study|To start finasteride|1|||
30880233|NCT02649439|58912153|FG001|Overall Study|To start finasteride|0|||
30880234|NCT02649439|58912152|FG000|Overall Study|Physician Decision|1|||
30880235|NCT02649439|58912153|FG001|Overall Study|Physician Decision|0|||
30880236|NCT02649439|58912152|FG000|Overall Study|Disease progression on study|12|||
30880237|NCT02649439|58912153|FG001|Overall Study|Disease progression on study|13|||
30880238|NCT02649439|58912152|FG000|Overall Study|Refused further treatment|1|||
30880239|NCT02649439|58912153|FG001|Overall Study|Refused further treatment|0|||
30880240|NCT02649439|58912152|FG000|Overall Study|Refused further follow up|2|||
30880241|NCT02649439|58912153|FG001|Overall Study|Refused further follow up|7|||
30880242|NCT02649439|58912152|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
30880243|NCT02649439|58912153|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
30880244|NCT02649439|58912152|FG000|Overall Study|No treatment, per protocol|1|||
30880245|NCT02649439|58912153|FG001|Overall Study|No treatment, per protocol|0|||
30970861|NCT01496846|59043551|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
30970862|NCT01496846|59043552|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
30970863|NCT01496846|59043553|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
30970864|NCT01496846|59043554|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
30970865|NCT01496846|59043555|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
30970866|NCT00964002|59043566|FG000|Overall Study|Protocol Violation|8|||
30970867|NCT01399697|59043578|FG000|Overall Study|Adverse Event|13|||
30970868|NCT01399697|59043579|FG001|Overall Study|Adverse Event|3|||
30970869|NCT01399697|59043580|FG002|Overall Study|Adverse Event|1|||
30970870|NCT01399697|59043578|FG000|Overall Study|Lost to Follow-up|2|||
30970871|NCT01399697|59043579|FG001|Overall Study|Lost to Follow-up|0|||
30970872|NCT01399697|59043580|FG002|Overall Study|Lost to Follow-up|0|||
30970873|NCT01399697|59043578|FG000|Overall Study|Withdrawal by Subject|8|||
30970874|NCT01399697|59043579|FG001|Overall Study|Withdrawal by Subject|0|||
30970875|NCT01399697|59043580|FG002|Overall Study|Withdrawal by Subject|0|||
30970876|NCT01399697|59043578|FG000|Overall Study|Investigator Decisión|1|||
30970877|NCT01399697|59043579|FG001|Overall Study|Investigator Decisión|0|||
30970878|NCT01399697|59043580|FG002|Overall Study|Investigator Decisión|2|||
30970879|NCT01399697|59043578|FG000|Overall Study|Lack of Efficacy|9|||
30970880|NCT01399697|59043579|FG001|Overall Study|Lack of Efficacy|0|||
30970881|NCT01399697|59043580|FG002|Overall Study|Lack of Efficacy|1|||
30970882|NCT01399697|59043578|FG000|Overall Study|Protocol Violation|2|||
30970883|NCT01399697|59043579|FG001|Overall Study|Protocol Violation|0|||
30970884|NCT01399697|59043580|FG002|Overall Study|Protocol Violation|0|||
30970885|NCT01399697|59043578|FG000|Overall Study|Non-Compliant|1|||
30970886|NCT01399697|59043579|FG001|Overall Study|Non-Compliant|0|||
30970887|NCT01399697|59043580|FG002|Overall Study|Non-Compliant|0|||
30970888|NCT01399697|59043578|FG000|Overall Study|Inclusion Error|2|||
30970889|NCT01399697|59043579|FG001|Overall Study|Inclusion Error|0|||
30970890|NCT01399697|59043580|FG002|Overall Study|Inclusion Error|0|||
30970891|NCT01399697|59043578|FG000|Overall Study|Positive result for hepatitis B|1|||
30970892|NCT01399697|59043579|FG001|Overall Study|Positive result for hepatitis B|0|||
30970893|NCT01399697|59043580|FG002|Overall Study|Positive result for hepatitis B|0|||
30970894|NCT01399697|59043578|FG000|Overall Study|Clinical RA remission|1|||
30970895|NCT01399697|59043579|FG001|Overall Study|Clinical RA remission|0|||
30970896|NCT01399697|59043580|FG002|Overall Study|Clinical RA remission|0|||
30970897|NCT01399697|59043578|FG000|Overall Study|Sponsor Decision|1|||
30970898|NCT01399697|59043579|FG001|Overall Study|Sponsor Decision|0|||
30970899|NCT01399697|59043580|FG002|Overall Study|Sponsor Decision|0|||
30970900|NCT01473602|59043614|FG000|Overall Study|Adverse Event|1|||
30970901|NCT01473602|59043615|FG001|Overall Study|Adverse Event|2|||
30970902|NCT01473602|59043614|FG000|Overall Study|Death|0|||
30970903|NCT01473602|59043615|FG001|Overall Study|Death|1|||
30970904|NCT01473602|59043614|FG000|Overall Study|Lost to Follow-up|1|||
30970905|NCT01473602|59043615|FG001|Overall Study|Lost to Follow-up|1|||
30970906|NCT01473602|59043614|FG000|Overall Study|Withdrawal by Subject|5|||
30970907|NCT01473602|59043615|FG001|Overall Study|Withdrawal by Subject|4|||
30970908|NCT01473602|59043614|FG000|Overall Study|Physician Decision|1|||
30970909|NCT01473602|59043615|FG001|Overall Study|Physician Decision|0|||
30970910|NCT01496612|59043623|FG000|1st Intervention|Adverse Event|1|||
30970911|NCT01496612|59043624|FG001|1st Intervention|Adverse Event|0|||
30970912|NCT01496612|59043623|FG000|1st Intervention|Withdrawal by Subject|1|||
30970913|NCT01496612|59043624|FG001|1st Intervention|Withdrawal by Subject|0|||
30970914|NCT00790218|59043641|FG000|Overall Study|Death|1|||
30970915|NCT00790218|59043642|FG001|Overall Study|Death|0|||
30970916|NCT00790218|59043643|FG002|Overall Study|Death|0|||
30970917|NCT01457924|59043669|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
30970918|NCT01457924|59043670|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
30970919|NCT01457924|59043671|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
30970920|NCT01457924|59043672|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
30970921|NCT01457924|59043673|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
30970922|NCT01457924|59043669|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
30970923|NCT01457924|59043670|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
30970924|NCT01457924|59043671|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
30970925|NCT01457924|59043672|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
30970926|NCT01457924|59043673|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
30970927|NCT01457924|59043669|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
30970928|NCT01457924|59043670|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
30970929|NCT01457924|59043671|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
30970930|NCT01457924|59043672|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
30970931|NCT01457924|59043673|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
30970932|NCT01457924|59043669|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
30790011|NCT00048581|58803258|FG000|Double-Blind Period|Adverse Event|9|||
30970933|NCT01457924|59043670|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
30970934|NCT01457924|59043671|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
30970935|NCT01457924|59043672|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
30970936|NCT01457924|59043673|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
30970937|NCT01457924|59043669|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
30970938|NCT01457924|59043670|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
30970939|NCT01457924|59043671|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
30970940|NCT01457924|59043672|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
30970941|NCT01457924|59043673|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
30970942|NCT01457924|59043669|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
30970943|NCT01457924|59043670|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
30970944|NCT01457924|59043671|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
30970945|NCT01457924|59043672|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
30970946|NCT01457924|59043673|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
30970947|NCT01457924|59043669|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
30970948|NCT01457924|59043670|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
30970949|NCT01457924|59043671|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
30970950|NCT01457924|59043672|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
30970951|NCT01457924|59043673|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
30970952|NCT01457924|59043669|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
30970953|NCT01457924|59043670|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
30970954|NCT01457924|59043671|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
30970955|NCT01457924|59043672|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
30970956|NCT01457924|59043673|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
30970957|NCT01457924|59043669|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
30970958|NCT01457924|59043670|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
30970959|NCT01457924|59043671|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
30970960|NCT01457924|59043672|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
30970961|NCT01457924|59043673|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
30970962|NCT01457924|59043669|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
30970963|NCT01457924|59043670|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
30970964|NCT01457924|59043671|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
30970965|NCT01457924|59043672|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
30970966|NCT01457924|59043673|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
30970967|NCT01457924|59043669|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
30970968|NCT01457924|59043670|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
30970969|NCT01457924|59043671|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
30970970|NCT01457924|59043672|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
30970971|NCT01457924|59043673|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
30970972|NCT01457924|59043669|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
30970973|NCT01457924|59043670|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
30970974|NCT01457924|59043671|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
30970975|NCT01457924|59043672|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
30970976|NCT01457924|59043673|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
30970977|NCT01457924|59043669|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
30970978|NCT01457924|59043670|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
30970979|NCT01457924|59043671|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
30970980|NCT01457924|59043672|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
30970981|NCT01457924|59043673|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
30970982|NCT01399619|59043694|FG000|Overall Study|Adverse Event|10|||
30970983|NCT01399619|59043695|FG001|Overall Study|Adverse Event|0|||
30970984|NCT01399619|59043696|FG002|Overall Study|Adverse Event|4|||
30970985|NCT01399619|59043697|FG003|Overall Study|Adverse Event|10|||
30970986|NCT01399619|59043694|FG000|Overall Study|Lack of Efficacy|9|||
30970987|NCT01399619|59043695|FG001|Overall Study|Lack of Efficacy|0|||
30970988|NCT01399619|59043696|FG002|Overall Study|Lack of Efficacy|5|||
30970989|NCT01399619|59043697|FG003|Overall Study|Lack of Efficacy|0|||
30970990|NCT01399619|59043694|FG000|Overall Study|Withdrawal by Subject|6|||
30970991|NCT01399619|59043695|FG001|Overall Study|Withdrawal by Subject|0|||
30970992|NCT01399619|59043696|FG002|Overall Study|Withdrawal by Subject|3|||
30970993|NCT01399619|59043697|FG003|Overall Study|Withdrawal by Subject|4|||
30970994|NCT01399619|59043694|FG000|Overall Study|Protocol Violation|0|||
30970995|NCT01399619|59043695|FG001|Overall Study|Protocol Violation|0|||
30970996|NCT01399619|59043696|FG002|Overall Study|Protocol Violation|0|||
30970997|NCT01399619|59043697|FG003|Overall Study|Protocol Violation|1|||
30970998|NCT01399619|59043694|FG000|Overall Study|Not treated|0|||
30970999|NCT01399619|59043695|FG001|Overall Study|Not treated|0|||
30971000|NCT01399619|59043696|FG002|Overall Study|Not treated|0|||
30971001|NCT01399619|59043697|FG003|Overall Study|Not treated|2|||
30971002|NCT01496456|59043712|FG000|Overall Study|Protocol Violation|1|||
30971003|NCT01496456|59043712|FG000|Overall Study|Lost to Follow-up|7|||
30971004|NCT04999111|59043875|FG000|Overall Study|Lost to Follow-up|0|||
30971005|NCT04999111|59043876|FG001|Overall Study|Lost to Follow-up|3|||
30971006|NCT04999111|59043877|FG002|Overall Study|Lost to Follow-up|1|||
30971007|NCT04999111|59043878|FG003|Overall Study|Lost to Follow-up|1|||
30971008|NCT04999111|59043879|FG004|Overall Study|Lost to Follow-up|1|||
30971009|NCT04999111|59043880|FG005|Overall Study|Lost to Follow-up|1|||
30971010|NCT04999111|59043875|FG000|Overall Study|Physician Decision|0|||
30971011|NCT04999111|59043876|FG001|Overall Study|Physician Decision|0|||
30971012|NCT04999111|59043877|FG002|Overall Study|Physician Decision|0|||
30971013|NCT04999111|59043878|FG003|Overall Study|Physician Decision|1|||
30971014|NCT04999111|59043879|FG004|Overall Study|Physician Decision|0|||
30971015|NCT04999111|59043880|FG005|Overall Study|Physician Decision|0|||
30971016|NCT04999111|59043875|FG000|Overall Study|Withdrawal by Subject|3|||
30971017|NCT04999111|59043876|FG001|Overall Study|Withdrawal by Subject|3|||
30971018|NCT04999111|59043877|FG002|Overall Study|Withdrawal by Subject|2|||
30971019|NCT04999111|59043878|FG003|Overall Study|Withdrawal by Subject|1|||
30971020|NCT04999111|59043879|FG004|Overall Study|Withdrawal by Subject|3|||
30971021|NCT04999111|59043880|FG005|Overall Study|Withdrawal by Subject|0|||
30971022|NCT04999111|59043875|FG000|Overall Study|Other|1|||
30971023|NCT04999111|59043876|FG001|Overall Study|Other|1|||
30971024|NCT04999111|59043877|FG002|Overall Study|Other|1|||
30971025|NCT04999111|59043878|FG003|Overall Study|Other|0|||
30971026|NCT04999111|59043879|FG004|Overall Study|Other|0|||
30971027|NCT04999111|59043880|FG005|Overall Study|Other|0|||
30971028|NCT04999111|59043875|FG000|Overall Study|Ongoing|326|||
30971029|NCT04999111|59043876|FG001|Overall Study|Ongoing|321|||
30971030|NCT04999111|59043877|FG002|Overall Study|Ongoing|112|||
30971031|NCT04999111|59043878|FG003|Overall Study|Ongoing|323|||
30971032|NCT04999111|59043879|FG004|Overall Study|Ongoing|322|||
30971033|NCT04999111|59043880|FG005|Overall Study|Ongoing|105|||
30971034|NCT04999111|59043875|FG000|Overall Study|Randomized but not vaccinated|1|||
30971035|NCT04999111|59043876|FG001|Overall Study|Randomized but not vaccinated|2|||
30971036|NCT04999111|59043877|FG002|Overall Study|Randomized but not vaccinated|0|||
30971037|NCT04999111|59043878|FG003|Overall Study|Randomized but not vaccinated|3|||
30971038|NCT04999111|59043879|FG004|Overall Study|Randomized but not vaccinated|3|||
30971039|NCT04999111|59043880|FG005|Overall Study|Randomized but not vaccinated|0|||
30971040|NCT01673646|59043941|FG000|Overall Study|Adverse Event|2|||
30971041|NCT01673646|59043942|FG001|Overall Study|Adverse Event|1|||
30971042|NCT01673646|59043943|FG002|Overall Study|Adverse Event|1|||
30971043|NCT01673646|59043941|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30971044|NCT01673646|59043942|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30971045|NCT01673646|59043943|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
30971046|NCT01673646|59043941|FG000|Overall Study|Condition no longer requires study drug|0|||
30971047|NCT01673646|59043942|FG001|Overall Study|Condition no longer requires study drug|1|||
30971048|NCT01673646|59043943|FG002|Overall Study|Condition no longer requires study drug|0|||
30971049|NCT01673646|59043941|FG000|Overall Study|Withdrawal by Subject|0|||
30971050|NCT01673646|59043942|FG001|Overall Study|Withdrawal by Subject|2|||
30971051|NCT01673646|59043943|FG002|Overall Study|Withdrawal by Subject|2|||
30971052|NCT01673646|59043941|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
30971053|NCT01673646|59043942|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
30971054|NCT01673646|59043943|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
30971055|NCT02647944|59043983|FG000|Overall Study|Withdrawal by Subject|0|||
30971056|NCT02647944|59043984|FG001|Overall Study|Withdrawal by Subject|3|||
30971057|NCT02647944|59043983|FG000|Overall Study|Adverse Event|2|||
30971058|NCT02647944|59043984|FG001|Overall Study|Adverse Event|0|||
30971059|NCT01397825|59044039|FG000|Overall Study|Progressive Disease|10|||
30971060|NCT01397825|59044040|FG001|Overall Study|Progressive Disease|3|||
30971061|NCT01397825|59044041|FG002|Overall Study|Progressive Disease|11|||
30971062|NCT01397825|59044042|FG003|Overall Study|Progressive Disease|1|||
30971063|NCT01397825|59044043|FG004|Overall Study|Progressive Disease|0|||
30971064|NCT01397825|59044039|FG000|Overall Study|Symptomatic Deterioration|2|||
30971065|NCT01397825|59044040|FG001|Overall Study|Symptomatic Deterioration|0|||
30971066|NCT01397825|59044041|FG002|Overall Study|Symptomatic Deterioration|4|||
30971067|NCT01397825|59044042|FG003|Overall Study|Symptomatic Deterioration|0|||
30971068|NCT01397825|59044043|FG004|Overall Study|Symptomatic Deterioration|0|||
30971069|NCT01397825|59044039|FG000|Overall Study|Adverse Event|0|||
30971070|NCT01397825|59044040|FG001|Overall Study|Adverse Event|1|||
30971071|NCT01397825|59044041|FG002|Overall Study|Adverse Event|5|||
30971072|NCT01397825|59044042|FG003|Overall Study|Adverse Event|1|||
30971073|NCT01397825|59044043|FG004|Overall Study|Adverse Event|0|||
30971074|NCT01397825|59044039|FG000|Overall Study|Withdrawal by Subject|1|||
30971075|NCT01397825|59044040|FG001|Overall Study|Withdrawal by Subject|0|||
30971076|NCT01397825|59044041|FG002|Overall Study|Withdrawal by Subject|5|||
30971077|NCT01397825|59044042|FG003|Overall Study|Withdrawal by Subject|1|||
30971078|NCT01397825|59044043|FG004|Overall Study|Withdrawal by Subject|0|||
30971079|NCT01397747|59044066|FG000|Overall Study|Multitarget DNA test excluded|689|||
30971080|NCT01397747|59044066|FG000|Overall Study|Colonoscopy excluded|304|||
30971081|NCT01397747|59044066|FG000|Overall Study|FIT excluded|34|||
30971082|NCT01397201|59044104|FG000|Overall Study|Not treated|0|||
30971083|NCT01397201|59044105|FG001|Overall Study|Not treated|0|||
30971084|NCT01397201|59044106|FG002|Overall Study|Not treated|1|||
30971085|NCT01397201|59044107|FG003|Overall Study|Not treated|0|||
30971086|NCT01397201|59044108|FG004|Overall Study|Not treated|0|||
30971087|NCT01397201|59044104|FG000|Overall Study|Not yet defined|3|||
30971088|NCT01397201|59044105|FG001|Overall Study|Not yet defined|6|||
30971089|NCT01397201|59044106|FG002|Overall Study|Not yet defined|5|||
30971090|NCT01397201|59044107|FG003|Overall Study|Not yet defined|5|||
30971091|NCT01397201|59044108|FG004|Overall Study|Not yet defined|4|||
30971092|NCT01397201|59044104|FG000|Overall Study|Adverse Event|2|||
30971093|NCT01397201|59044105|FG001|Overall Study|Adverse Event|0|||
30971094|NCT01397201|59044106|FG002|Overall Study|Adverse Event|0|||
30971095|NCT01397201|59044107|FG003|Overall Study|Adverse Event|0|||
30971096|NCT01397201|59044108|FG004|Overall Study|Adverse Event|0|||
30971097|NCT01393613|59044142|FG000|Overall Study|Adverse Event|11|||
30971098|NCT01393613|59044143|FG001|Overall Study|Adverse Event|11|||
30971099|NCT01393613|59044144|FG002|Overall Study|Adverse Event|13|||
30971100|NCT01393613|59044145|FG003|Overall Study|Adverse Event|22|||
30971101|NCT01393613|59044142|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
30971102|NCT01393613|59044143|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
30971103|NCT01393613|59044144|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
30971104|NCT01393613|59044145|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
30971105|NCT01393613|59044142|FG000|Overall Study|Physician Decision|2|||
30971106|NCT01393613|59044143|FG001|Overall Study|Physician Decision|0|||
30971107|NCT01393613|59044144|FG002|Overall Study|Physician Decision|0|||
30971108|NCT01393613|59044145|FG003|Overall Study|Physician Decision|1|||
30971109|NCT01393613|59044142|FG000|Overall Study|Withdrawal by Subject|15|||
30971110|NCT01393613|59044143|FG001|Overall Study|Withdrawal by Subject|25|||
30971111|NCT01393613|59044144|FG002|Overall Study|Withdrawal by Subject|23|||
30971112|NCT01393613|59044145|FG003|Overall Study|Withdrawal by Subject|21|||
30971113|NCT01393613|59044142|FG000|Overall Study|Protocol Deviation|2|||
30971114|NCT01393613|59044143|FG001|Overall Study|Protocol Deviation|1|||
30971115|NCT01393613|59044144|FG002|Overall Study|Protocol Deviation|0|||
30971116|NCT01393613|59044145|FG003|Overall Study|Protocol Deviation|0|||
30971117|NCT01393613|59044142|FG000|Overall Study|Lack of Efficacy|9|||
30971118|NCT01393613|59044143|FG001|Overall Study|Lack of Efficacy|20|||
30971119|NCT01393613|59044144|FG002|Overall Study|Lack of Efficacy|16|||
30971120|NCT01393613|59044145|FG003|Overall Study|Lack of Efficacy|21|||
30971121|NCT01396421|59044195|FG000|Overall Study|Lost to Follow-up|0|||
30971122|NCT01396421|59044196|FG001|Overall Study|Lost to Follow-up|0|||
30971123|NCT01396421|59044197|FG002|Overall Study|Lost to Follow-up|0|||
30971124|NCT01396421|59044198|FG003|Overall Study|Lost to Follow-up|1|||
30971125|NCT01396421|59044195|FG000|Overall Study|Adverse Event|17|||
30971126|NCT01396421|59044196|FG001|Overall Study|Adverse Event|15|||
30971127|NCT01396421|59044197|FG002|Overall Study|Adverse Event|12|||
30971128|NCT01396421|59044198|FG003|Overall Study|Adverse Event|32|||
30971129|NCT01396421|59044195|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
30971130|NCT01396421|59044196|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
30971131|NCT01396421|59044197|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
30971132|NCT01396421|59044198|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
30971133|NCT01396421|59044195|FG000|Overall Study|Physician Decision|1|||
30971134|NCT01396421|59044196|FG001|Overall Study|Physician Decision|1|||
30971135|NCT01396421|59044197|FG002|Overall Study|Physician Decision|0|||
30971136|NCT01396421|59044198|FG003|Overall Study|Physician Decision|3|||
30971137|NCT01396421|59044195|FG000|Overall Study|Withdrawal by Subject|31|||
30971138|NCT01396421|59044196|FG001|Overall Study|Withdrawal by Subject|24|||
30971139|NCT01396421|59044197|FG002|Overall Study|Withdrawal by Subject|13|||
30971140|NCT01396421|59044198|FG003|Overall Study|Withdrawal by Subject|21|||
30971141|NCT01396421|59044195|FG000|Overall Study|Protocol Deviation|2|||
30971142|NCT01396421|59044196|FG001|Overall Study|Protocol Deviation|1|||
30971143|NCT01396421|59044197|FG002|Overall Study|Protocol Deviation|1|||
30971144|NCT01396421|59044198|FG003|Overall Study|Protocol Deviation|0|||
30971145|NCT01396421|59044195|FG000|Overall Study|Lack of Efficacy|7|||
30971146|NCT01396421|59044196|FG001|Overall Study|Lack of Efficacy|17|||
30971147|NCT01396421|59044197|FG002|Overall Study|Lack of Efficacy|7|||
30971148|NCT01396421|59044198|FG003|Overall Study|Lack of Efficacy|18|||
30971149|NCT01396265|59044256|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
30971150|NCT02647866|59044301|FG000|Overall Study|Adverse Event|0|||
30971151|NCT02647866|59044302|FG001|Overall Study|Adverse Event|0|||
30971152|NCT02647866|59044303|FG002|Overall Study|Adverse Event|2|||
30971153|NCT02647866|59044304|FG003|Overall Study|Adverse Event|2|||
30971154|NCT02647866|59044305|FG004|Overall Study|Adverse Event|1|||
30971155|NCT02647866|59044301|FG000|Overall Study|Disease Worsening|3|||
30971156|NCT02647866|59044302|FG001|Overall Study|Disease Worsening|1|||
30971157|NCT02647866|59044303|FG002|Overall Study|Disease Worsening|0|||
30608401|NCT01288430|58619230|FG009|Part 1|Clinical disease progression|0|||
30608402|NCT01288430|58619221|FG000|Part 1|Death due to disease progression|0|||
30971158|NCT02647866|59044304|FG003|Overall Study|Disease Worsening|0|||
30971159|NCT02647866|59044305|FG004|Overall Study|Disease Worsening|1|||
30971160|NCT02647866|59044301|FG000|Overall Study|Withdrawal by Subject|1|||
30971161|NCT02647866|59044302|FG001|Overall Study|Withdrawal by Subject|1|||
30971162|NCT02647866|59044303|FG002|Overall Study|Withdrawal by Subject|2|||
30971163|NCT02647866|59044304|FG003|Overall Study|Withdrawal by Subject|4|||
30971164|NCT02647866|59044305|FG004|Overall Study|Withdrawal by Subject|4|||
30971165|NCT02647866|59044301|FG000|Overall Study|Physician Decision|0|||
30971166|NCT02647866|59044302|FG001|Overall Study|Physician Decision|1|||
30971167|NCT02647866|59044303|FG002|Overall Study|Physician Decision|1|||
30971168|NCT02647866|59044304|FG003|Overall Study|Physician Decision|0|||
30971169|NCT02647866|59044305|FG004|Overall Study|Physician Decision|2|||
30971170|NCT02647866|59044301|FG000|Overall Study|Death|0|||
30971171|NCT02647866|59044302|FG001|Overall Study|Death|1|||
30971172|NCT02647866|59044303|FG002|Overall Study|Death|0|||
30971173|NCT02647866|59044304|FG003|Overall Study|Death|0|||
30971174|NCT02647866|59044305|FG004|Overall Study|Death|0|||
30971175|NCT02647866|59044301|FG000|Overall Study|Subject moved to different country|1|||
30971176|NCT02647866|59044302|FG001|Overall Study|Subject moved to different country|0|||
30971177|NCT02647866|59044303|FG002|Overall Study|Subject moved to different country|0|||
30971178|NCT02647866|59044304|FG003|Overall Study|Subject moved to different country|0|||
30971179|NCT02647866|59044305|FG004|Overall Study|Subject moved to different country|0|||
30971180|NCT01396187|59044365|FG000|Overall Study|Adverse Event|0|||
30880246|NCT02649439|58912152|FG000|Overall Study|PSA DT makes ineligible|0|||
30880247|NCT02649439|58912153|FG001|Overall Study|PSA DT makes ineligible|1|||
30880248|NCT02649439|58912152|FG000|Overall Study|Rising PSA No Mets|0|||
30971181|NCT01396187|59044366|FG001|Overall Study|Adverse Event|1|||
30971182|NCT01396187|59044367|FG002|Overall Study|Adverse Event|0|||
30971183|NCT01396187|59044368|FG003|Overall Study|Adverse Event|0|||
30971184|NCT01396187|59044369|FG004|Overall Study|Adverse Event|0|||
30971185|NCT01396187|59044365|FG000|Overall Study|Withdrawal by Subject|0|||
30971186|NCT01396187|59044366|FG001|Overall Study|Withdrawal by Subject|1|||
30971187|NCT01396187|59044367|FG002|Overall Study|Withdrawal by Subject|1|||
30971188|NCT01396187|59044368|FG003|Overall Study|Withdrawal by Subject|0|||
30971189|NCT01396187|59044369|FG004|Overall Study|Withdrawal by Subject|0|||
30971190|NCT01396187|59044365|FG000|Overall Study|Other|1|||
30971191|NCT01396187|59044366|FG001|Overall Study|Other|1|||
30971192|NCT01396187|59044367|FG002|Overall Study|Other|0|||
30971193|NCT01396187|59044368|FG003|Overall Study|Other|0|||
30880249|NCT02649439|58912153|FG001|Overall Study|Rising PSA No Mets|1|||
30880250|NCT02649439|58912152|FG000|Overall Study|Rising PSA|0|||
30971194|NCT01396187|59044369|FG004|Overall Study|Other|1|||
30971195|NCT01392677|59044416|FG000|Overall Study|Adverse Event|3|||
30971196|NCT01392677|59044417|FG001|Overall Study|Adverse Event|1|||
30971197|NCT01392677|59044416|FG000|Overall Study|Withdrawal by Subject|0|||
30971198|NCT01392677|59044417|FG001|Overall Study|Withdrawal by Subject|2|||
30971199|NCT01392677|59044416|FG000|Overall Study|Incorrect enrollment|2|||
30971200|NCT01392677|59044417|FG001|Overall Study|Incorrect enrollment|3|||
30971201|NCT01392677|59044416|FG000|Overall Study|Other reason|3|||
30971202|NCT01392677|59044417|FG001|Overall Study|Other reason|2|||
30880251|NCT02649439|58912153|FG001|Overall Study|Rising PSA|1|||
30880252|NCT02649439|58912152|FG000|Overall Study|Signed follow up protocol|0|||
30880253|NCT02649439|58912153|FG001|Overall Study|Signed follow up protocol|1|||
30880254|NCT02622113|58912168|FG000|Overall Study|Adverse Event|4|||
30880255|NCT02622113|58912169|FG001|Overall Study|Adverse Event|4|||
30880256|NCT02622113|58912168|FG000|Overall Study|Physician Decision|0|||
30880257|NCT02622113|58912169|FG001|Overall Study|Physician Decision|1|||
30880258|NCT02622113|58912168|FG000|Overall Study|Withdrawal by Subject|0|||
30880259|NCT02622113|58912169|FG001|Overall Study|Withdrawal by Subject|2|||
30880260|NCT02622113|58912168|FG000|Overall Study|Stopping Criteria|1|||
30880261|NCT02622113|58912169|FG001|Overall Study|Stopping Criteria|3|||
30880262|NCT02651467|58912178|FG000|Overall Study|Withdrawal by Subject|0|||
30880263|NCT02651467|58912179|FG001|Overall Study|Withdrawal by Subject|0|||
30880264|NCT02651467|58912180|FG002|Overall Study|Withdrawal by Subject|2|||
30880265|NCT02651467|58912178|FG000|Overall Study|Other (Not specified)|1|||
30880266|NCT02651467|58912179|FG001|Overall Study|Other (Not specified)|0|||
30880267|NCT02651467|58912180|FG002|Overall Study|Other (Not specified)|2|||
30880268|NCT02620787|58912209|FG000|Overall Study|Adverse Event|1|||
30880269|NCT02620787|58912210|FG001|Overall Study|Adverse Event|0|||
30880270|NCT02620787|58912209|FG000|Overall Study|Eligibility Criteria Not Met|1|||
30880271|NCT02620787|58912210|FG001|Overall Study|Eligibility Criteria Not Met|0|||
30880272|NCT02651155|58912218|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
30880273|NCT02651155|58912219|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
30880274|NCT02651155|58912218|FG000|Overall Study|Voluntary Withdrawal|5|||
30880275|NCT02651155|58912219|FG001|Overall Study|Voluntary Withdrawal|0|||
30880276|NCT02619617|58912225|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
30880277|NCT02619617|58912226|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
30971203|NCT01392443|59044466|FG000|Overall Study|Disease progression|30|||
30971204|NCT01392443|59044466|FG000|Overall Study|Adverse Event|24|||
30971205|NCT01392443|59044466|FG000|Overall Study|Death|7|||
30971206|NCT01392443|59044466|FG000|Overall Study|Withdrawal by Subject|5|||
30971207|NCT01392443|59044466|FG000|Overall Study|Lost to Follow-up|1|||
30971208|NCT01392443|59044466|FG000|Overall Study|Protocol Violation|1|||
30971209|NCT01391819|59044470|FG000|Overall Study|Withdrawal by Subject|56|||
30971210|NCT01391819|59044470|FG000|Overall Study|Migrated/moved from study area|82|||
30971211|NCT01391819|59044470|FG000|Overall Study|Lost to Follow-up|252|||
30971212|NCT01391819|59044470|FG000|Overall Study|Death|3|||
30971213|NCT01391819|59044470|FG000|Overall Study|Other|9|||
30971214|NCT03845023|59044481|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
30971215|NCT03845023|59044482|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
30971216|NCT03845023|59044483|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
30971217|NCT03845023|59044484|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
30880278|NCT02619617|58912225|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
30880279|NCT02619617|58912226|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
30971218|NCT03845023|59044481|FG000|Follow-Up (14 Days)|Adverse Event|0|||
30880280|NCT02650921|58912247|FG000|Overall Study|Withdrawal by Subject|4|||
30880281|NCT02650921|58912247|FG000|Overall Study|Lost to Follow-up|2|||
30880282|NCT02650921|58912247|FG000|Overall Study|Adverse Event|1|||
30880283|NCT02650921|58912247|FG000|Overall Study|Due to Medical Condition|1|||
30880284|NCT01596335|58912255|FG000|Overall Study|exacerbation of primary disease|5|||
30880285|NCT01596335|58912256|FG001|Overall Study|exacerbation of primary disease|9|||
30880286|NCT02618759|58912264|FG000|Overall Study|Lost to Follow-up|0|||
30880287|NCT02618759|58912265|FG001|Overall Study|Lost to Follow-up|1|||
30880288|NCT02618759|58912264|FG000|Overall Study|Withdrawal by Subject|1|||
30880289|NCT02618759|58912265|FG001|Overall Study|Withdrawal by Subject|0|||
30971219|NCT03845023|59044482|FG001|Follow-Up (14 Days)|Adverse Event|0|||
30971220|NCT03845023|59044483|FG002|Follow-Up (14 Days)|Adverse Event|1|||
30971221|NCT03845023|59044484|FG003|Follow-Up (14 Days)|Adverse Event|1|||
30971222|NCT01395017|59044546|FG000|Overall Study|Lost to Follow-up|1|||
30971223|NCT01395017|59044547|FG001|Overall Study|Lost to Follow-up|0|||
30971224|NCT01395017|59044546|FG000|Overall Study|Adverse Event|26|||
30971225|NCT01395017|59044547|FG001|Overall Study|Adverse Event|12|||
30971226|NCT01395017|59044546|FG000|Overall Study|Physician Decision|11|||
30971227|NCT01395017|59044547|FG001|Overall Study|Physician Decision|15|||
30971228|NCT01395017|59044546|FG000|Overall Study|Withdrawal by Subject|14|||
30971229|NCT01395017|59044547|FG001|Overall Study|Withdrawal by Subject|8|||
30971230|NCT01395017|59044546|FG000|Overall Study|Protocol deviation|1|||
30971231|NCT01395017|59044547|FG001|Overall Study|Protocol deviation|2|||
30971232|NCT01395017|59044546|FG000|Overall Study|Death|4|||
30971233|NCT01395017|59044547|FG001|Overall Study|Death|3|||
30971234|NCT01395017|59044546|FG000|Overall Study|Disease progression|42|||
30971235|NCT01395017|59044547|FG001|Overall Study|Disease progression|58|||
30971236|NCT01395017|59044546|FG000|Overall Study|Sponsor discontinued study|1|||
30971237|NCT01395017|59044547|FG001|Overall Study|Sponsor discontinued study|4|||
30971238|NCT02647320|59044576|FG000|Overall Study|Adverse Event|0|||
30971239|NCT02647320|59044577|FG001|Overall Study|Adverse Event|1|||
30971240|NCT02647320|59044578|FG002|Overall Study|Adverse Event|3|||
30971241|NCT02647320|59044579|FG003|Overall Study|Adverse Event|2|||
30971242|NCT02647320|59044580|FG004|Overall Study|Adverse Event|1|||
30971243|NCT02647320|59044576|FG000|Overall Study|Protocol Violation|0|||
30971244|NCT02647320|59044577|FG001|Overall Study|Protocol Violation|0|||
30971245|NCT02647320|59044578|FG002|Overall Study|Protocol Violation|3|||
30971246|NCT02647320|59044579|FG003|Overall Study|Protocol Violation|0|||
30971247|NCT02647320|59044580|FG004|Overall Study|Protocol Violation|0|||
30971248|NCT02647320|59044576|FG000|Overall Study|Withdrawal by Subject|7|||
30971249|NCT02647320|59044577|FG001|Overall Study|Withdrawal by Subject|4|||
30971250|NCT02647320|59044578|FG002|Overall Study|Withdrawal by Subject|2|||
30971251|NCT02647320|59044579|FG003|Overall Study|Withdrawal by Subject|2|||
30971252|NCT02647320|59044580|FG004|Overall Study|Withdrawal by Subject|7|||
30971253|NCT02647320|59044576|FG000|Overall Study|Persistent hyperglycemia|0|||
30971254|NCT02647320|59044577|FG001|Overall Study|Persistent hyperglycemia|1|||
30971255|NCT02647320|59044578|FG002|Overall Study|Persistent hyperglycemia|1|||
30971256|NCT02647320|59044579|FG003|Overall Study|Persistent hyperglycemia|1|||
30971257|NCT02647320|59044580|FG004|Overall Study|Persistent hyperglycemia|1|||
30971258|NCT02647320|59044576|FG000|Overall Study|Study terminated by sponsor|1|||
30971259|NCT02647320|59044577|FG001|Overall Study|Study terminated by sponsor|1|||
30971260|NCT02647320|59044578|FG002|Overall Study|Study terminated by sponsor|1|||
30971261|NCT02647320|59044579|FG003|Overall Study|Study terminated by sponsor|1|||
30880290|NCT02618759|58912264|FG000|Overall Study|Other Reasons|1|||
30880291|NCT02618759|58912265|FG001|Overall Study|Other Reasons|4|||
30971262|NCT02647320|59044580|FG004|Overall Study|Study terminated by sponsor|2|||
30971263|NCT02647320|59044576|FG000|Overall Study|Reason not provided|0|||
30971264|NCT02647320|59044577|FG001|Overall Study|Reason not provided|0|||
30971265|NCT02647320|59044578|FG002|Overall Study|Reason not provided|1|||
30971266|NCT02647320|59044579|FG003|Overall Study|Reason not provided|0|||
30971267|NCT02647320|59044580|FG004|Overall Study|Reason not provided|2|||
30971268|NCT02647320|59044576|FG000|Overall Study|Lost to Follow-up|1|||
30880292|NCT02614079|58912280|FG000|Overall Study|Withdrawal by Subject|1|||
30971269|NCT02647320|59044577|FG001|Overall Study|Lost to Follow-up|1|||
30971270|NCT02647320|59044578|FG002|Overall Study|Lost to Follow-up|0|||
30971271|NCT02647320|59044579|FG003|Overall Study|Lost to Follow-up|0|||
30880293|NCT02616029|58912286|FG000|Overall Study|Adverse Event|1|||
30971272|NCT02647320|59044580|FG004|Overall Study|Lost to Follow-up|0|||
30971273|NCT02647320|59044576|FG000|Overall Study|Develop anemia|1|||
30971274|NCT02647320|59044577|FG001|Overall Study|Develop anemia|0|||
30971275|NCT02647320|59044578|FG002|Overall Study|Develop anemia|0|||
30880294|NCT02616029|58912287|FG001|Overall Study|Adverse Event|0|||
30880295|NCT02616029|58912286|FG000|Overall Study|Death|0|||
30880296|NCT02616029|58912287|FG001|Overall Study|Death|1|||
30880297|NCT02616029|58912286|FG000|Overall Study|Protocol Violation|1|||
30880298|NCT02616029|58912287|FG001|Overall Study|Protocol Violation|0|||
30880299|NCT02616029|58912286|FG000|Overall Study|Withdrew Consent|1|||
30971276|NCT02647320|59044579|FG003|Overall Study|Develop anemia|0|||
30971277|NCT02647320|59044580|FG004|Overall Study|Develop anemia|0|||
30971278|NCT02647320|59044576|FG000|Overall Study|Lack of Efficacy|0|||
30971279|NCT02647320|59044577|FG001|Overall Study|Lack of Efficacy|0|||
30971280|NCT02647320|59044578|FG002|Overall Study|Lack of Efficacy|0|||
30971281|NCT02647320|59044579|FG003|Overall Study|Lack of Efficacy|1|||
30880300|NCT02616029|58912287|FG001|Overall Study|Withdrew Consent|0|||
30880301|NCT02616029|58912286|FG000|Overall Study|Enrolled and Never Treated|1|||
30880302|NCT02616029|58912287|FG001|Overall Study|Enrolled and Never Treated|1|||
30880303|NCT02614859|58912295|FG000|Overall Study|Physician Decision|0|||
30880304|NCT02614859|58912296|FG001|Overall Study|Physician Decision|1|||
30880305|NCT02615249|58912304|FG000|Overall Study|Withdrawal by Subject|1|||
30880306|NCT02615171|58912311|FG000|Overall Study|Lost to Follow-up|2|||
30880307|NCT02615171|58912312|FG001|Overall Study|Lost to Follow-up|1|||
30880308|NCT02648347|58912320|FG000|Overall Study|Death|174|||
30880309|NCT02648347|58912321|FG001|Overall Study|Death|167|||
30880310|NCT02648347|58912320|FG000|Overall Study|Withdrawal by Subject|16|||
30880311|NCT02648347|58912321|FG001|Overall Study|Withdrawal by Subject|9|||
30880312|NCT02648347|58912320|FG000|Overall Study|Lost to Follow-up|18|||
30880313|NCT02648347|58912321|FG001|Overall Study|Lost to Follow-up|21|||
30971282|NCT02647320|59044580|FG004|Overall Study|Lack of Efficacy|0|||
30971283|NCT02647320|59044576|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
30971284|NCT02647320|59044577|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
30971285|NCT02647320|59044578|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
30971286|NCT02647320|59044579|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
30971287|NCT02647320|59044580|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
30880314|NCT02648347|58912320|FG000|Overall Study|Missing|1|||
30880315|NCT02648347|58912321|FG001|Overall Study|Missing|0|||
30880316|NCT02614703|58912329|FG000|Overall Study|Withdrawal by Subject|7|||
30971288|NCT03458325|59044603|FG000|Overall Study|Withdrawal by Subject|1|||
30971289|NCT02646618|59044612|FG000|Overall Study|Lost to Follow-up|10|||
30971290|NCT02646618|59044613|FG001|Overall Study|Lost to Follow-up|14|||
30971291|NCT02644122|59044649|FG000|Overall Study|Withdrawal by Subject|1|||
30971292|NCT01394939|59044675|FG000|Overall Study|Adverse Event|1|||
30880317|NCT02614703|58912330|FG001|Overall Study|Withdrawal by Subject|1|||
30880318|NCT01669343|58912336|FG000|Part A: All Patients|Withdrawal by Subject|7|||
30971293|NCT01394939|59044676|FG001|Overall Study|Adverse Event|3|||
30971294|NCT01394939|59044677|FG002|Overall Study|Adverse Event|0|||
30971295|NCT01394939|59044678|FG003|Overall Study|Adverse Event|2|||
30971296|NCT01394939|59044675|FG000|Overall Study|Death|0|||
30971297|NCT01394939|59044676|FG001|Overall Study|Death|2|||
30971298|NCT01394939|59044677|FG002|Overall Study|Death|0|||
30971299|NCT01394939|59044678|FG003|Overall Study|Death|0|||
30971300|NCT01394939|59044675|FG000|Overall Study|Physician Decision|0|||
30971301|NCT01394939|59044676|FG001|Overall Study|Physician Decision|1|||
30971302|NCT01394939|59044677|FG002|Overall Study|Physician Decision|0|||
30971303|NCT01394939|59044678|FG003|Overall Study|Physician Decision|0|||
30971304|NCT01394939|59044675|FG000|Overall Study|Withdrawal by Subject|0|||
30971305|NCT01394939|59044676|FG001|Overall Study|Withdrawal by Subject|2|||
30971306|NCT01394939|59044677|FG002|Overall Study|Withdrawal by Subject|0|||
30971307|NCT01394939|59044678|FG003|Overall Study|Withdrawal by Subject|2|||
30971308|NCT01394939|59044675|FG000|Overall Study|Others|0|||
30971309|NCT01394939|59044676|FG001|Overall Study|Others|2|||
30971310|NCT01394939|59044677|FG002|Overall Study|Others|0|||
30971311|NCT01394939|59044678|FG003|Overall Study|Others|3|||
30971312|NCT01394627|59044696|FG000|First Intervention (1 Day)|poor intravenous access|0|||
30971313|NCT01394627|59044697|FG001|First Intervention (1 Day)|poor intravenous access|1|||
30971314|NCT01394627|59044696|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
30880319|NCT01669343|58912336|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
30880320|NCT01669343|58912336|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
30971315|NCT01394627|59044697|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
30971316|NCT01391663|59044716|FG000|Overall Study|Withdrawal by Subject|0|||
30971317|NCT01391663|59044717|FG001|Overall Study|Withdrawal by Subject|0|||
30880321|NCT01669343|58912336|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
30880322|NCT01669343|58912336|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
30971318|NCT01391663|59044718|FG002|Overall Study|Withdrawal by Subject|1|||
30971319|NCT01391663|59044719|FG003|Overall Study|Withdrawal by Subject|0|||
30971320|NCT02641392|59044740|FG000|Overall Study|Lost to Follow-up|0|||
30971321|NCT02641392|59044741|FG001|Overall Study|Lost to Follow-up|0|||
30880323|NCT01594931|58912346|FG000|Overall Study|Adverse Event|3|||
30880324|NCT01594931|58912347|FG001|Overall Study|Adverse Event|1|||
30971322|NCT02641392|59044742|FG002|Overall Study|Lost to Follow-up|2|||
30971323|NCT02641392|59044740|FG000|Overall Study|Withdrawal by Subject|0|||
30971324|NCT02641392|59044741|FG001|Overall Study|Withdrawal by Subject|0|||
30971325|NCT02641392|59044742|FG002|Overall Study|Withdrawal by Subject|17|||
30971326|NCT02641392|59044740|FG000|Overall Study|Adverse Event|0|||
30971327|NCT02641392|59044741|FG001|Overall Study|Adverse Event|1|||
30971328|NCT02641392|59044742|FG002|Overall Study|Adverse Event|25|||
30971329|NCT02641392|59044740|FG000|Overall Study|Study Terminated by Sponsor|4|||
30971330|NCT02641392|59044741|FG001|Overall Study|Study Terminated by Sponsor|12|||
30971331|NCT02641392|59044742|FG002|Overall Study|Study Terminated by Sponsor|144|||
30971332|NCT02641392|59044740|FG000|Overall Study|Lack of Efficacy|0|||
30971333|NCT02641392|59044741|FG001|Overall Study|Lack of Efficacy|0|||
30971334|NCT02641392|59044742|FG002|Overall Study|Lack of Efficacy|101|||
30971335|NCT02641392|59044740|FG000|Overall Study|Miscellaneous|0|||
30971336|NCT02641392|59044741|FG001|Overall Study|Miscellaneous|0|||
30971337|NCT02641392|59044742|FG002|Overall Study|Miscellaneous|3|||
30971338|NCT02641392|59044740|FG000|Overall Study|Death|0|||
30971339|NCT02641392|59044741|FG001|Overall Study|Death|0|||
30971340|NCT02641392|59044742|FG002|Overall Study|Death|1|||
30971341|NCT04440007|59044752|FG000|Overall Study|Adverse Event|0|||
30971342|NCT04440007|59044753|FG001|Overall Study|Adverse Event|1|||
30971343|NCT04440007|59044752|FG000|Overall Study|Lost to Follow-up|1|||
30971344|NCT04440007|59044753|FG001|Overall Study|Lost to Follow-up|3|||
30971345|NCT04440007|59044752|FG000|Overall Study|Death|7|||
30971346|NCT04440007|59044753|FG001|Overall Study|Death|2|||
30971347|NCT04440007|59044752|FG000|Overall Study|Physician Decision|1|||
30971348|NCT04440007|59044753|FG001|Overall Study|Physician Decision|1|||
30971349|NCT04440007|59044752|FG000|Overall Study|Withdrawal by Subject|2|||
30971350|NCT04440007|59044753|FG001|Overall Study|Withdrawal by Subject|1|||
30971351|NCT04440007|59044752|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
30971352|NCT04440007|59044753|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
30971353|NCT04440007|59044752|FG000|Overall Study|Discontinued prior to dosing|0|||
30971354|NCT04440007|59044753|FG001|Overall Study|Discontinued prior to dosing|2|||
30971355|NCT01391507|59044772|FG000|Overall Study|Death|0|||
30971356|NCT01391507|59044773|FG001|Overall Study|Death|0|||
30971357|NCT01391507|59044774|FG002|Overall Study|Death|0|||
30971358|NCT01391507|59044775|FG003|Overall Study|Death|1|||
30971359|NCT01391507|59044772|FG000|Overall Study|Adverse Event|1|||
30971360|NCT01391507|59044773|FG001|Overall Study|Adverse Event|1|||
30971361|NCT01391507|59044774|FG002|Overall Study|Adverse Event|2|||
30971362|NCT01391507|59044775|FG003|Overall Study|Adverse Event|2|||
30971363|NCT01391507|59044772|FG000|Overall Study|Withdrawal by Subject|1|||
30971364|NCT01391507|59044773|FG001|Overall Study|Withdrawal by Subject|2|||
30971365|NCT01391507|59044774|FG002|Overall Study|Withdrawal by Subject|1|||
30971366|NCT01391507|59044775|FG003|Overall Study|Withdrawal by Subject|1|||
30971367|NCT01391507|59044772|FG000|Overall Study|Lack of Efficacy|0|||
30971368|NCT01391507|59044773|FG001|Overall Study|Lack of Efficacy|0|||
30971369|NCT01391507|59044774|FG002|Overall Study|Lack of Efficacy|0|||
30971370|NCT01391507|59044775|FG003|Overall Study|Lack of Efficacy|1|||
30971371|NCT01391507|59044772|FG000|Overall Study|Protocol Violation|2|||
30971372|NCT01391507|59044773|FG001|Overall Study|Protocol Violation|1|||
30971373|NCT01391507|59044774|FG002|Overall Study|Protocol Violation|1|||
30971374|NCT01391507|59044775|FG003|Overall Study|Protocol Violation|2|||
30971375|NCT01473524|59044797|FG000|DB Phase|Adverse Event|4|||
30971376|NCT01473524|59044798|FG001|DB Phase|Adverse Event|8|||
30971377|NCT01473524|59044799|FG002|DB Phase|Adverse Event|2|||
30971378|NCT01473524|59044800|FG003|DB Phase|Adverse Event|0|||
30971379|NCT01473524|59044801|FG004|DB Phase|Adverse Event|0|||
30971380|NCT01473524|59044802|FG005|DB Phase|Adverse Event|0|||
30971381|NCT01473524|59044797|FG000|DB Phase|Death|1|||
30971382|NCT01473524|59044798|FG001|DB Phase|Death|0|||
30971383|NCT01473524|59044799|FG002|DB Phase|Death|0|||
30971384|NCT01473524|59044800|FG003|DB Phase|Death|0|||
30971385|NCT01473524|59044801|FG004|DB Phase|Death|0|||
30971386|NCT01473524|59044802|FG005|DB Phase|Death|0|||
30971387|NCT01473524|59044797|FG000|DB Phase|Withdrawal by Subject|2|||
30971388|NCT01473524|59044798|FG001|DB Phase|Withdrawal by Subject|1|||
30971389|NCT01473524|59044799|FG002|DB Phase|Withdrawal by Subject|1|||
30971390|NCT01473524|59044800|FG003|DB Phase|Withdrawal by Subject|0|||
30971391|NCT01473524|59044801|FG004|DB Phase|Withdrawal by Subject|0|||
30971392|NCT01473524|59044802|FG005|DB Phase|Withdrawal by Subject|0|||
30971393|NCT01473524|59044797|FG000|LTSE Phase|Withdrawal by Subject|0|||
30971394|NCT01473524|59044798|FG001|LTSE Phase|Withdrawal by Subject|0|||
30971395|NCT01473524|59044799|FG002|LTSE Phase|Withdrawal by Subject|0|||
30971396|NCT01473524|59044800|FG003|LTSE Phase|Withdrawal by Subject|3|||
30971397|NCT01473524|59044801|FG004|LTSE Phase|Withdrawal by Subject|3|||
30971398|NCT01473524|59044802|FG005|LTSE Phase|Withdrawal by Subject|6|||
30971399|NCT01473524|59044797|FG000|LTSE Phase|Death|0|||
30971400|NCT01473524|59044798|FG001|LTSE Phase|Death|0|||
30971401|NCT01473524|59044799|FG002|LTSE Phase|Death|0|||
30971402|NCT01473524|59044800|FG003|LTSE Phase|Death|0|||
30971403|NCT01473524|59044801|FG004|LTSE Phase|Death|1|||
30971404|NCT01473524|59044802|FG005|LTSE Phase|Death|0|||
30971405|NCT01473524|59044797|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
30971406|NCT01473524|59044798|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
30971407|NCT01473524|59044799|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
30971408|NCT01473524|59044800|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
30971409|NCT01473524|59044801|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
30971410|NCT01473524|59044802|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
30971411|NCT01473524|59044797|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
30971412|NCT01473524|59044798|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
30971413|NCT01473524|59044799|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
30971414|NCT01473524|59044800|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
30971415|NCT01473524|59044801|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
30971416|NCT01473524|59044802|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
30971417|NCT01473524|59044797|FG000|LTSE Phase|Lost to Follow-up|0|||
30971418|NCT01473524|59044798|FG001|LTSE Phase|Lost to Follow-up|0|||
30971419|NCT01473524|59044799|FG002|LTSE Phase|Lost to Follow-up|0|||
30971420|NCT01473524|59044800|FG003|LTSE Phase|Lost to Follow-up|1|||
30971421|NCT01473524|59044801|FG004|LTSE Phase|Lost to Follow-up|3|||
30971422|NCT01473524|59044802|FG005|LTSE Phase|Lost to Follow-up|2|||
30971423|NCT01473524|59044797|FG000|LTSE Phase|Principal Investigator Decision|0|||
30971424|NCT01473524|59044798|FG001|LTSE Phase|Principal Investigator Decision|0|||
30971425|NCT01473524|59044799|FG002|LTSE Phase|Principal Investigator Decision|0|||
30971426|NCT01473524|59044800|FG003|LTSE Phase|Principal Investigator Decision|1|||
30971427|NCT01473524|59044801|FG004|LTSE Phase|Principal Investigator Decision|1|||
30971428|NCT01473524|59044802|FG005|LTSE Phase|Principal Investigator Decision|3|||
30971429|NCT01473524|59044797|FG000|LTSE Phase|Liver Transplantation|0|||
30971430|NCT01473524|59044798|FG001|LTSE Phase|Liver Transplantation|0|||
30971431|NCT01473524|59044799|FG002|LTSE Phase|Liver Transplantation|0|||
30971432|NCT01473524|59044800|FG003|LTSE Phase|Liver Transplantation|0|||
30971433|NCT01473524|59044801|FG004|LTSE Phase|Liver Transplantation|0|||
30971434|NCT01473524|59044802|FG005|LTSE Phase|Liver Transplantation|1|||
30971435|NCT01473524|59044797|FG000|LTSE Phase|Pregnancy|0|||
30971436|NCT01473524|59044798|FG001|LTSE Phase|Pregnancy|0|||
30971437|NCT01473524|59044799|FG002|LTSE Phase|Pregnancy|0|||
30971438|NCT01473524|59044800|FG003|LTSE Phase|Pregnancy|1|||
30971439|NCT01473524|59044801|FG004|LTSE Phase|Pregnancy|0|||
30971440|NCT01473524|59044802|FG005|LTSE Phase|Pregnancy|0|||
30971441|NCT01473524|59044797|FG000|LTSE Phase|Protocol Violation|0|||
30971442|NCT01473524|59044798|FG001|LTSE Phase|Protocol Violation|0|||
30971443|NCT01473524|59044799|FG002|LTSE Phase|Protocol Violation|0|||
30971444|NCT01473524|59044800|FG003|LTSE Phase|Protocol Violation|0|||
30971445|NCT01473524|59044801|FG004|LTSE Phase|Protocol Violation|0|||
30971446|NCT01473524|59044802|FG005|LTSE Phase|Protocol Violation|1|||
30971447|NCT01390649|59044833|FG000|Overall Study|Physician Decision|1|||
30971448|NCT01390181|59044837|FG000|Overall Study|Lost to Follow-up|1|||
30971449|NCT01390181|59044837|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
30971450|NCT02641080|59044843|FG000|Overall Study|Physician Decision|2|||
30971451|NCT02641080|59044844|FG001|Overall Study|Physician Decision|0|||
30971452|NCT02641080|59044843|FG000|Overall Study|Withdrawal by Subject|0|||
30971453|NCT02641080|59044844|FG001|Overall Study|Withdrawal by Subject|1|||
30971454|NCT02641080|59044843|FG000|Overall Study|Rehab Center denied use of pumps|0|||
30971455|NCT02641080|59044844|FG001|Overall Study|Rehab Center denied use of pumps|3|||
30971456|NCT02641080|59044843|FG000|Overall Study|Lost to Follow-up|0|||
30971457|NCT02641080|59044844|FG001|Overall Study|Lost to Follow-up|3|||
30971458|NCT01457846|59044852|FG000|Overall Study|Death before treatment|1|||
30971459|NCT01457846|59044853|FG001|Overall Study|Death before treatment|2|||
30971460|NCT01457846|59044852|FG000|Overall Study|Did not receive treatment|0|||
30971461|NCT01457846|59044853|FG001|Overall Study|Did not receive treatment|1|||
30971462|NCT01457846|59044852|FG000|Overall Study|Death|27|||
30971463|NCT01457846|59044853|FG001|Overall Study|Death|16|||
30971464|NCT01457846|59044852|FG000|Overall Study|Unclassified reason for not completed|11|||
30971465|NCT01457846|59044853|FG001|Overall Study|Unclassified reason for not completed|10|||
30971466|NCT01457846|59044852|FG000|Overall Study|Withdrawal by Subject|1|||
30971467|NCT01457846|59044853|FG001|Overall Study|Withdrawal by Subject|1|||
30971468|NCT01457846|59044852|FG000|Overall Study|Lost to Follow-up|1|||
30971469|NCT01457846|59044853|FG001|Overall Study|Lost to Follow-up|0|||
30608403|NCT01288430|58619222|FG001|Part 1|Death due to disease progression|0|||
30608404|NCT01288430|58619223|FG002|Part 1|Death due to disease progression|0|||
30971470|NCT01496066|59044865|FG000|Overall Study|Lost to Follow-up|8|||
30971471|NCT01496066|59044866|FG001|Overall Study|Lost to Follow-up|5|||
30971472|NCT01496066|59044865|FG000|Overall Study|Explant|3|||
30971473|NCT01496066|59044866|FG001|Overall Study|Explant|0|||
30971474|NCT01496066|59044865|FG000|Overall Study|Death|1|||
30971475|NCT01496066|59044866|FG001|Overall Study|Death|4|||
30971476|NCT01389323|59044879|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
30971477|NCT01389323|59044879|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
30971478|NCT01389323|59044879|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
30971479|NCT01389323|59044879|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
30971480|NCT01389323|59044879|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
30971481|NCT01389323|59044879|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
30971482|NCT01389323|59044879|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
30971483|NCT01389323|59044879|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
30971484|NCT01389323|59044879|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
30971485|NCT01389323|59044879|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
30971486|NCT01389323|59044879|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
30971487|NCT01389245|59044890|FG000|Overall Study|Protocol Violation|10|||
30971488|NCT01389245|59044890|FG000|Overall Study|Lost to Follow-up|3|||
30971489|NCT01389245|59044890|FG000|Overall Study|Withdrawal by Subject|2|||
30971490|NCT01494818|59044896|FG000|Overall Study|Relocation|1|||
30971491|NCT01494818|59044897|FG001|Overall Study|Relocation|2|||
30971492|NCT01494818|59044896|FG000|Overall Study|Lost to Follow-up|1|||
30971493|NCT01494818|59044897|FG001|Overall Study|Lost to Follow-up|0|||
30971494|NCT01494584|59044903|FG000|Overall Study|Study Closed/Terminated|1|||
30971495|NCT01388543|59044928|FG000|Day 14|Adverse Event|1|||
30971496|NCT01388543|59044929|FG001|Day 14|Adverse Event|4|||
30971497|NCT00512317|59044948|FG000|Overall Study|Insufficient clinical response|36|||
30971498|NCT00512317|59044948|FG000|Overall Study|Withdrawal by Subject|23|||
30971499|NCT00512317|59044948|FG000|Overall Study|Sponsor closure of study|21|||
30971500|NCT00512317|59044948|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
30971501|NCT00512317|59044948|FG000|Overall Study|Adverse Event|13|||
30971502|NCT00512317|59044948|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
30971503|NCT00512317|59044948|FG000|Overall Study|Lost to Follow-up|2|||
30971504|NCT00512317|59044948|FG000|Overall Study|Other|2|||
30971505|NCT01494506|59044964|FG000|Overall Study|Lack of Efficacy|77|||
30971506|NCT01494506|59044965|FG001|Overall Study|Lack of Efficacy|83|||
30971507|NCT01494506|59044966|FG002|Overall Study|Lack of Efficacy|57|||
30971508|NCT01494506|59044964|FG000|Overall Study|Adverse Event|17|||
30971509|NCT01494506|59044965|FG001|Overall Study|Adverse Event|10|||
30971510|NCT01494506|59044966|FG002|Overall Study|Adverse Event|11|||
30971511|NCT01494506|59044964|FG000|Overall Study|Death|9|||
30971512|NCT01494506|59044965|FG001|Overall Study|Death|5|||
30971513|NCT01494506|59044966|FG002|Overall Study|Death|2|||
30971514|NCT01494506|59044964|FG000|Overall Study|Physician Decision|7|||
30971515|NCT01494506|59044965|FG001|Overall Study|Physician Decision|5|||
30971516|NCT01494506|59044966|FG002|Overall Study|Physician Decision|4|||
30971517|NCT01494506|59044964|FG000|Overall Study|Withdrawal by Subject|17|||
30971518|NCT01494506|59044965|FG001|Overall Study|Withdrawal by Subject|20|||
30971519|NCT01494506|59044966|FG002|Overall Study|Withdrawal by Subject|14|||
30971520|NCT01494506|59044964|FG000|Overall Study|Clinical Deterioration|21|||
30971521|NCT01494506|59044965|FG001|Overall Study|Clinical Deterioration|17|||
30971522|NCT01494506|59044966|FG002|Overall Study|Clinical Deterioration|13|||
30971523|NCT01494506|59044964|FG000|Overall Study|Sponsor Decision|0|||
30971524|NCT01494506|59044965|FG001|Overall Study|Sponsor Decision|0|||
30971525|NCT01494506|59044966|FG002|Overall Study|Sponsor Decision|1|||
30971526|NCT01494506|59044964|FG000|Overall Study|Other|0|||
30971527|NCT01494506|59044965|FG001|Overall Study|Other|3|||
30971528|NCT01494506|59044966|FG002|Overall Study|Other|1|||
30971529|NCT02643420|59044978|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
30971530|NCT02643420|59044979|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
30971531|NCT02643420|59044978|FG000|Overall Study|Withdrawal by Subject|25|||
30971532|NCT02643420|59044979|FG001|Overall Study|Withdrawal by Subject|19|||
30971533|NCT02643420|59044978|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
30971534|NCT02643420|59044979|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
30971535|NCT02643420|59044978|FG000|Overall Study|Lost to Follow-up|6|||
30971536|NCT02643420|59044979|FG001|Overall Study|Lost to Follow-up|10|||
30971537|NCT02643420|59044978|FG000|Overall Study|Investigator Decision|2|||
30971538|NCT02643420|59044979|FG001|Overall Study|Investigator Decision|4|||
30971539|NCT02643420|59044978|FG000|Overall Study|Sponsor decision|1|||
30971540|NCT02643420|59044979|FG001|Overall Study|Sponsor decision|1|||
30971541|NCT02643420|59044978|FG000|Overall Study|Death|0|||
30971542|NCT02643420|59044979|FG001|Overall Study|Death|2|||
30971543|NCT02643420|59044978|FG000|Overall Study|Reason not Specified|8|||
30971544|NCT02643420|59044979|FG001|Overall Study|Reason not Specified|7|||
30971545|NCT01456130|59045002|FG000|Overall Study|Adverse Event|4|||
30971546|NCT01456130|59045002|FG000|Overall Study|Voluntary Withdrawal|1|||
30608405|NCT01288430|58619224|FG003|Part 1|Death due to disease progression|0|||
30971547|NCT01456130|59045002|FG000|Overall Study|Lack of Efficacy|4|||
30971548|NCT01456130|59045002|FG000|Overall Study|Other|1|||
30971549|NCT01456052|59045009|FG000|Overall Study|Adverse Event|1|||
30971550|NCT01456052|59045010|FG001|Overall Study|Adverse Event|1|||
30971551|NCT01456052|59045011|FG002|Overall Study|Adverse Event|2|||
30971552|NCT01456052|59045009|FG000|Overall Study|Consent withdrawn|0|||
30971553|NCT01456052|59045010|FG001|Overall Study|Consent withdrawn|2|||
30971554|NCT01456052|59045011|FG002|Overall Study|Consent withdrawn|1|||
30971555|NCT01456052|59045009|FG000|Overall Study|Protocol Violation|0|||
30971556|NCT01456052|59045010|FG001|Overall Study|Protocol Violation|1|||
30971557|NCT01456052|59045011|FG002|Overall Study|Protocol Violation|0|||
30971558|NCT01456052|59045009|FG000|Overall Study|Physician Decision|1|||
30971559|NCT01456052|59045010|FG001|Overall Study|Physician Decision|0|||
30971560|NCT01456052|59045011|FG002|Overall Study|Physician Decision|1|||
30971561|NCT01456052|59045009|FG000|Overall Study|Treatment Failure|0|||
30971562|NCT01456052|59045010|FG001|Overall Study|Treatment Failure|1|||
30971563|NCT01456052|59045011|FG002|Overall Study|Treatment Failure|1|||
30971564|NCT01387607|59045022|FG000|Overall Study|Adverse Event|23|||
30971565|NCT01387607|59045023|FG001|Overall Study|Adverse Event|11|||
30971566|NCT01387607|59045022|FG000|Overall Study|Lack of Efficacy|8|||
30971567|NCT01387607|59045023|FG001|Overall Study|Lack of Efficacy|6|||
30971568|NCT01387607|59045022|FG000|Overall Study|Lost to Follow-up|2|||
30971569|NCT01387607|59045023|FG001|Overall Study|Lost to Follow-up|1|||
30971570|NCT01387607|59045022|FG000|Overall Study|No longer meets eligibility criteria|0|||
30971571|NCT01387607|59045023|FG001|Overall Study|No longer meets eligibility criteria|1|||
30971572|NCT01387607|59045022|FG000|Overall Study|Protocol Violation|1|||
30971573|NCT01387607|59045023|FG001|Overall Study|Protocol Violation|5|||
30971574|NCT01387607|59045022|FG000|Overall Study|Withdrawal by Subject|13|||
30971575|NCT01387607|59045023|FG001|Overall Study|Withdrawal by Subject|14|||
30971576|NCT01387607|59045022|FG000|Overall Study|Other|1|||
30971577|NCT01387607|59045023|FG001|Overall Study|Other|1|||
30971578|NCT01387607|59045022|FG000|Overall Study|Randomized, not treated|3|||
30971579|NCT01387607|59045023|FG001|Overall Study|Randomized, not treated|6|||
30971580|NCT03451045|59045032|FG000|Overall Study|Lack of Efficacy|3|||
30971581|NCT03451045|59045033|FG001|Overall Study|Lack of Efficacy|2|||
30971582|NCT03451045|59045034|FG002|Overall Study|Lack of Efficacy|2|||
30971583|NCT03451045|59045032|FG000|Overall Study|Physician Decision|1|||
30971584|NCT03451045|59045033|FG001|Overall Study|Physician Decision|1|||
30971585|NCT03451045|59045034|FG002|Overall Study|Physician Decision|1|||
30971586|NCT03451045|59045032|FG000|Overall Study|Withdrawal by Subject|4|||
30971587|NCT03451045|59045033|FG001|Overall Study|Withdrawal by Subject|0|||
30971588|NCT03451045|59045034|FG002|Overall Study|Withdrawal by Subject|5|||
30971589|NCT03451045|59045032|FG000|Overall Study|Pregnancy|0|||
30971590|NCT03451045|59045033|FG001|Overall Study|Pregnancy|0|||
30971591|NCT03451045|59045034|FG002|Overall Study|Pregnancy|2|||
30971592|NCT03451045|59045032|FG000|Overall Study|Adverse Event|7|||
30971593|NCT03451045|59045033|FG001|Overall Study|Adverse Event|1|||
30971594|NCT03451045|59045034|FG002|Overall Study|Adverse Event|3|||
30971595|NCT03451045|59045032|FG000|Overall Study|Non-compliance with study|2|||
30971596|NCT03451045|59045033|FG001|Overall Study|Non-compliance with study|0|||
30971597|NCT03451045|59045034|FG002|Overall Study|Non-compliance with study|1|||
30971598|NCT03451045|59045032|FG000|Overall Study|any other reason|10|||
30971599|NCT03451045|59045033|FG001|Overall Study|any other reason|2|||
30971600|NCT03451045|59045034|FG002|Overall Study|any other reason|13|||
30971601|NCT03219567|59045045|FG000|Overall Study|Withdrawal by Subject|0|||
30971602|NCT03219567|59045046|FG001|Overall Study|Withdrawal by Subject|1|||
30971603|NCT01386125|59045055|FG000|Overall Study|Lost to Follow-up|3|||
30971604|NCT01386125|59045056|FG001|Overall Study|Lost to Follow-up|9|||
30971605|NCT01386125|59045055|FG000|Overall Study|Physician Decision|0|||
30971606|NCT01386125|59045056|FG001|Overall Study|Physician Decision|1|||
30971607|NCT01386125|59045055|FG000|Overall Study|Protocol Violation|5|||
30971608|NCT01386125|59045056|FG001|Overall Study|Protocol Violation|7|||
30971609|NCT01386125|59045055|FG000|Overall Study|Disease Progress|1|||
30971610|NCT01386125|59045056|FG001|Overall Study|Disease Progress|2|||
30971611|NCT01386125|59045055|FG000|Overall Study|Withdrawal by Subject|13|||
30971612|NCT01386125|59045056|FG001|Overall Study|Withdrawal by Subject|12|||
30971613|NCT01386125|59045055|FG000|Overall Study|Adverse Event|2|||
30971614|NCT01386125|59045056|FG001|Overall Study|Adverse Event|5|||
30971615|NCT01386125|59045055|FG000|Overall Study|Lack of Efficacy|0|||
30971616|NCT01386125|59045056|FG001|Overall Study|Lack of Efficacy|1|||
30971617|NCT01386125|59045055|FG000|Overall Study|Participant Leaving Country|1|||
30971618|NCT01386125|59045056|FG001|Overall Study|Participant Leaving Country|0|||
30971619|NCT01384877|59045064|FG000|Treatment 2|Lost to Follow-up|2|||
30971620|NCT01384877|59045065|FG001|Treatment 2|Lost to Follow-up|2|||
30971621|NCT00114517|59045075|FG000|Overall Study|Adverse Event|6|||
30971622|NCT00114517|59045076|FG001|Overall Study|Adverse Event|1|||
30971623|NCT00114517|59045077|FG002|Overall Study|Adverse Event|6|||
30971624|NCT00114517|59045078|FG003|Overall Study|Adverse Event|3|||
30971625|NCT00114517|59045075|FG000|Overall Study|Lost to Follow-up|2|||
30971626|NCT00114517|59045076|FG001|Overall Study|Lost to Follow-up|2|||
30971627|NCT00114517|59045077|FG002|Overall Study|Lost to Follow-up|2|||
30790012|NCT00048581|58803259|FG001|Double-Blind Period|Adverse Event|5|||
30971628|NCT00114517|59045078|FG003|Overall Study|Lost to Follow-up|1|||
30971629|NCT00114517|59045075|FG000|Overall Study|Too busy|3|||
30971630|NCT00114517|59045076|FG001|Overall Study|Too busy|1|||
30971631|NCT00114517|59045077|FG002|Overall Study|Too busy|1|||
30971632|NCT00114517|59045078|FG003|Overall Study|Too busy|2|||
30971633|NCT00114517|59045075|FG000|Overall Study|Moved from area|0|||
30971634|NCT00114517|59045076|FG001|Overall Study|Moved from area|3|||
30971635|NCT00114517|59045077|FG002|Overall Study|Moved from area|2|||
30971636|NCT00114517|59045078|FG003|Overall Study|Moved from area|1|||
30971637|NCT00114517|59045075|FG000|Overall Study|Did not want estradiol|1|||
30971638|NCT00114517|59045076|FG001|Overall Study|Did not want estradiol|1|||
30971639|NCT00114517|59045077|FG002|Overall Study|Did not want estradiol|0|||
30971640|NCT00114517|59045078|FG003|Overall Study|Did not want estradiol|0|||
30971641|NCT00114517|59045075|FG000|Overall Study|Armed-services duty|0|||
30971642|NCT00114517|59045076|FG001|Overall Study|Armed-services duty|1|||
30971643|NCT00114517|59045077|FG002|Overall Study|Armed-services duty|0|||
30971644|NCT00114517|59045078|FG003|Overall Study|Armed-services duty|1|||
30971645|NCT00114517|59045075|FG000|Overall Study|Competing family issue|0|||
30971646|NCT00114517|59045076|FG001|Overall Study|Competing family issue|1|||
30971647|NCT00114517|59045077|FG002|Overall Study|Competing family issue|0|||
30971648|NCT00114517|59045078|FG003|Overall Study|Competing family issue|1|||
30971649|NCT00114517|59045075|FG000|Overall Study|Physician Decision|0|||
30971650|NCT00114517|59045076|FG001|Overall Study|Physician Decision|1|||
30971651|NCT00114517|59045077|FG002|Overall Study|Physician Decision|0|||
30971652|NCT00114517|59045078|FG003|Overall Study|Physician Decision|0|||
30971653|NCT00114517|59045075|FG000|Overall Study|Lost interest|0|||
30971654|NCT00114517|59045076|FG001|Overall Study|Lost interest|0|||
30971655|NCT00114517|59045077|FG002|Overall Study|Lost interest|1|||
30971656|NCT00114517|59045078|FG003|Overall Study|Lost interest|0|||
30971657|NCT00114517|59045075|FG000|Overall Study|Weight increase|0|||
30971658|NCT00114517|59045076|FG001|Overall Study|Weight increase|0|||
30971659|NCT00114517|59045077|FG002|Overall Study|Weight increase|1|||
30971660|NCT00114517|59045078|FG003|Overall Study|Weight increase|0|||
30971661|NCT00114517|59045075|FG000|Overall Study|Concern about blood clots|0|||
30971662|NCT00114517|59045076|FG001|Overall Study|Concern about blood clots|0|||
30971663|NCT00114517|59045077|FG002|Overall Study|Concern about blood clots|1|||
30971664|NCT00114517|59045078|FG003|Overall Study|Concern about blood clots|0|||
30971665|NCT00114517|59045075|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
30971666|NCT00114517|59045076|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
30971667|NCT00114517|59045077|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
30971668|NCT00114517|59045078|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
30971669|NCT01384019|59045131|FG000|Overall Study|Withdrawal by Subject|3|||
30971670|NCT01384019|59045132|FG001|Overall Study|Withdrawal by Subject|0|||
30971671|NCT01384019|59045131|FG000|Overall Study|Death|1|||
30971672|NCT01384019|59045132|FG001|Overall Study|Death|0|||
30971673|NCT01384019|59045131|FG000|Overall Study|MRI refusal|6|||
30971674|NCT01384019|59045132|FG001|Overall Study|MRI refusal|6|||
30971675|NCT00033631|59045140|FG000|Overall Study|Protocol Violation|14|||
30971676|NCT00033631|59045141|FG001|Overall Study|Protocol Violation|11|||
30971677|NCT00033631|59045140|FG000|Overall Study|Withdrawal by Subject|4|||
30971678|NCT00033631|59045141|FG001|Overall Study|Withdrawal by Subject|4|||
30971679|NCT01471574|59045152|FG000|Treatment Period|Lack of Efficacy|12|||
30971680|NCT01471574|59045153|FG001|Treatment Period|Lack of Efficacy|4|||
30971681|NCT01471574|59045154|FG002|Treatment Period|Lack of Efficacy|14|||
30971682|NCT01471574|59045155|FG003|Treatment Period|Lack of Efficacy|1|||
30971683|NCT01471574|59045152|FG000|Treatment Period|Adverse Event|7|||
30971684|NCT01471574|59045153|FG001|Treatment Period|Adverse Event|3|||
30971685|NCT01471574|59045154|FG002|Treatment Period|Adverse Event|6|||
30971686|NCT01471574|59045155|FG003|Treatment Period|Adverse Event|1|||
30971687|NCT01471574|59045152|FG000|Treatment Period|Withdrawal by Subject|5|||
30971688|NCT01471574|59045153|FG001|Treatment Period|Withdrawal by Subject|1|||
30971689|NCT01471574|59045154|FG002|Treatment Period|Withdrawal by Subject|1|||
30971690|NCT01471574|59045155|FG003|Treatment Period|Withdrawal by Subject|0|||
30971691|NCT01471574|59045152|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
30971692|NCT01471574|59045153|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
30971693|NCT01471574|59045154|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
30971694|NCT01471574|59045155|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
30971695|NCT01471574|59045152|FG000|Treatment Period|Lost to Follow-up|1|||
30971696|NCT01471574|59045153|FG001|Treatment Period|Lost to Follow-up|2|||
30971697|NCT01471574|59045154|FG002|Treatment Period|Lost to Follow-up|2|||
30971698|NCT01471574|59045155|FG003|Treatment Period|Lost to Follow-up|0|||
30971699|NCT01471574|59045152|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
30971700|NCT01471574|59045153|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
30971701|NCT01471574|59045154|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
30971702|NCT01471574|59045155|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
30971703|NCT01471574|59045152|FG000|Treatment Period|Other|1|||
30971704|NCT01471574|59045153|FG001|Treatment Period|Other|0|||
30971705|NCT01471574|59045154|FG002|Treatment Period|Other|0|||
30971706|NCT01471574|59045155|FG003|Treatment Period|Other|0|||
30971707|NCT01471574|59045152|FG000|Follow-up Period|Withdrawal by Subject|3|||
30971708|NCT01471574|59045153|FG001|Follow-up Period|Withdrawal by Subject|0|||
30971709|NCT01471574|59045154|FG002|Follow-up Period|Withdrawal by Subject|3|||
30971710|NCT01471574|59045155|FG003|Follow-up Period|Withdrawal by Subject|1|||
30971711|NCT01471574|59045152|FG000|Follow-up Period|Lost to Follow-up|4|||
30971712|NCT01471574|59045153|FG001|Follow-up Period|Lost to Follow-up|1|||
30971713|NCT01471574|59045154|FG002|Follow-up Period|Lost to Follow-up|3|||
30971714|NCT01471574|59045155|FG003|Follow-up Period|Lost to Follow-up|2|||
30971715|NCT01471574|59045152|FG000|Follow-up Period|Death|0|||
30971716|NCT01471574|59045153|FG001|Follow-up Period|Death|0|||
30971717|NCT01471574|59045154|FG002|Follow-up Period|Death|1|||
30971718|NCT01471574|59045155|FG003|Follow-up Period|Death|0|||
30971719|NCT01471574|59045152|FG000|Follow-up Period|Follow-up no longer required|0|||
30971720|NCT01471574|59045153|FG001|Follow-up Period|Follow-up no longer required|1|||
30971721|NCT01471574|59045154|FG002|Follow-up Period|Follow-up no longer required|0|||
30971722|NCT01471574|59045155|FG003|Follow-up Period|Follow-up no longer required|0|||
30971723|NCT01383707|59045171|FG000|Overall Study|Consent withdrawal|6|||
30971724|NCT01383707|59045171|FG000|Overall Study|Death|19|||
30971725|NCT01383707|59045171|FG000|Overall Study|Other|8|||
30971726|NCT01383707|59045171|FG000|Overall Study|Sponsor's decision|2|||
30971727|NCT01383707|59045171|FG000|Overall Study|Adverse Event|14|||
30971728|NCT01383707|59045171|FG000|Overall Study|Progressive disease|23|||
30971729|NCT01383317|59045177|FG000|Overall Study|Lost to Follow-up|2|||
30971730|NCT01383317|59045178|FG001|Overall Study|Lost to Follow-up|1|||
30971731|NCT01383317|59045177|FG000|Overall Study|Death|1|||
30971732|NCT01383317|59045178|FG001|Overall Study|Death|0|||
30971733|NCT01383317|59045177|FG000|Overall Study|Adverse Event|0|||
30971734|NCT01383317|59045178|FG001|Overall Study|Adverse Event|1|||
30971735|NCT01455428|59045186|FG000|Overall Study|Protocol Violation|2|||
30971736|NCT01455428|59045187|FG001|Overall Study|Protocol Violation|1|||
30971737|NCT01455428|59045186|FG000|Overall Study|Adverse Event|6|||
30971738|NCT01455428|59045187|FG001|Overall Study|Adverse Event|2|||
30971739|NCT01455428|59045186|FG000|Overall Study|Lost to Follow-up|1|||
30971740|NCT01455428|59045187|FG001|Overall Study|Lost to Follow-up|1|||
30971741|NCT01455428|59045186|FG000|Overall Study|Withdrawal by Subject|2|||
30971742|NCT01455428|59045187|FG001|Overall Study|Withdrawal by Subject|5|||
30971743|NCT01455428|59045186|FG000|Overall Study|Did not meet entrance criteria|0|||
30971744|NCT01455428|59045187|FG001|Overall Study|Did not meet entrance criteria|2|||
30971745|NCT01455428|59045186|FG000|Overall Study|Insufficient clinical response|0|||
30971746|NCT01455428|59045187|FG001|Overall Study|Insufficient clinical response|2|||
30971747|NCT01455428|59045186|FG000|Overall Study|Did not receive treatment|1|||
30971748|NCT01455428|59045187|FG001|Overall Study|Did not receive treatment|1|||
30971749|NCT01455428|59045186|FG000|Overall Study|Other|2|||
30971750|NCT01455428|59045187|FG001|Overall Study|Other|4|||
30971751|NCT01383161|59045195|FG000|Overall Study|Adverse Event|5|||
30971752|NCT01383161|59045196|FG001|Overall Study|Adverse Event|1|||
30971753|NCT01383161|59045195|FG000|Overall Study|Withdrawal by Subject|0|||
30971754|NCT01383161|59045196|FG001|Overall Study|Withdrawal by Subject|2|||
30971755|NCT01383161|59045195|FG000|Overall Study|Lack of Efficacy|0|||
30971756|NCT01383161|59045196|FG001|Overall Study|Lack of Efficacy|1|||
30971757|NCT01382225|59045222|FG000|Overall Study|Adverse Event|3|||
30971758|NCT01382225|59045223|FG001|Overall Study|Adverse Event|2|||
30971759|NCT01382225|59045222|FG000|Overall Study|Protocol Violation|2|||
30971760|NCT01382225|59045223|FG001|Overall Study|Protocol Violation|1|||
30971761|NCT01382225|59045222|FG000|Overall Study|Subject Withdrew Consent|5|||
30971762|NCT01382225|59045223|FG001|Overall Study|Subject Withdrew Consent|2|||
30971763|NCT01382225|59045222|FG000|Overall Study|Other|4|||
30971764|NCT01382225|59045223|FG001|Overall Study|Other|2|||
30971765|NCT01381679|59045229|FG000|Overall Study|Adverse Event|3|||
30971766|NCT01381679|59045229|FG000|Overall Study|Lost to Follow-up|885|||
30971767|NCT01455194|59045236|FG000|Overall Study|Screen Failure|20|||
30971768|NCT01455194|59045237|FG001|Overall Study|Screen Failure|0|||
30971769|NCT01455194|59045238|FG002|Overall Study|Screen Failure|0|||
30971770|NCT01455194|59045239|FG003|Overall Study|Screen Failure|0|||
30971771|NCT01455194|59045236|FG000|Overall Study|Randomisation Failure|90|||
30971772|NCT01455194|59045237|FG001|Overall Study|Randomisation Failure|0|||
30971773|NCT01455194|59045238|FG002|Overall Study|Randomisation Failure|0|||
30608406|NCT01288430|58619225|FG004|Part 1|Death due to disease progression|1|||
30971774|NCT01455194|59045239|FG003|Overall Study|Randomisation Failure|0|||
30971775|NCT01455194|59045236|FG000|Overall Study|Deterioration in asthma|12|||
30971776|NCT01455194|59045237|FG001|Overall Study|Deterioration in asthma|6|||
30971777|NCT01455194|59045238|FG002|Overall Study|Deterioration in asthma|14|||
30971778|NCT01455194|59045239|FG003|Overall Study|Deterioration in asthma|9|||
30971779|NCT01455194|59045236|FG000|Overall Study|Adverse Event|1|||
30971780|NCT01455194|59045237|FG001|Overall Study|Adverse Event|1|||
30971781|NCT01455194|59045238|FG002|Overall Study|Adverse Event|1|||
30971782|NCT01455194|59045239|FG003|Overall Study|Adverse Event|3|||
30971783|NCT01455194|59045236|FG000|Overall Study|Withdrawal by Subject|21|||
30971784|NCT01455194|59045237|FG001|Overall Study|Withdrawal by Subject|16|||
30971785|NCT01455194|59045238|FG002|Overall Study|Withdrawal by Subject|12|||
30971786|NCT01455194|59045239|FG003|Overall Study|Withdrawal by Subject|9|||
30971787|NCT01455194|59045236|FG000|Overall Study|Lost to Follow-up|2|||
30971788|NCT01455194|59045237|FG001|Overall Study|Lost to Follow-up|0|||
30971789|NCT01455194|59045238|FG002|Overall Study|Lost to Follow-up|1|||
30971790|NCT01455194|59045239|FG003|Overall Study|Lost to Follow-up|1|||
30971791|NCT01455194|59045236|FG000|Overall Study|Pregnancy|0|||
30971792|NCT01455194|59045237|FG001|Overall Study|Pregnancy|1|||
30971793|NCT01455194|59045238|FG002|Overall Study|Pregnancy|1|||
30971794|NCT01455194|59045239|FG003|Overall Study|Pregnancy|0|||
30971795|NCT01455194|59045236|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
30971796|NCT01455194|59045237|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
30971797|NCT01455194|59045238|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
30971798|NCT01455194|59045239|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
30971799|NCT01455194|59045236|FG000|Overall Study|Miscellaneous|4|||
30971800|NCT01455194|59045237|FG001|Overall Study|Miscellaneous|5|||
30971801|NCT01455194|59045238|FG002|Overall Study|Miscellaneous|1|||
30971802|NCT01455194|59045239|FG003|Overall Study|Miscellaneous|4|||
30971803|NCT01454726|59045263|FG000|Overall Study|Withdrawal by Subject|0|||
30971804|NCT01454726|59045264|FG001|Overall Study|Withdrawal by Subject|1|||
30971805|NCT01361568|59045276|FG000|Overall Study|Adverse Event|0|||
30971806|NCT01361568|59045277|FG001|Overall Study|Adverse Event|0|||
30971807|NCT01361568|59045278|FG002|Overall Study|Adverse Event|0|||
30971808|NCT01361568|59045279|FG003|Overall Study|Adverse Event|0|||
30971809|NCT01361568|59045280|FG004|Overall Study|Adverse Event|1|||
30971810|NCT01361568|59045281|FG005|Overall Study|Adverse Event|0|||
30971811|NCT01361568|59045276|FG000|Overall Study|Physician Decision|0|||
30971812|NCT01361568|59045277|FG001|Overall Study|Physician Decision|0|||
30971813|NCT01361568|59045278|FG002|Overall Study|Physician Decision|0|||
30880325|NCT01594931|58912348|FG002|Overall Study|Adverse Event|1|||
30880326|NCT01594931|58912346|FG000|Overall Study|Withdrawal by Subject|2|||
30880327|NCT01594931|58912347|FG001|Overall Study|Withdrawal by Subject|1|||
30880328|NCT01594931|58912348|FG002|Overall Study|Withdrawal by Subject|1|||
30880329|NCT01594931|58912346|FG000|Overall Study|Lack of Efficacy|7|||
30880330|NCT01594931|58912347|FG001|Overall Study|Lack of Efficacy|2|||
30880331|NCT01594931|58912348|FG002|Overall Study|Lack of Efficacy|2|||
30880332|NCT01594931|58912346|FG000|Overall Study|Lost to Follow-up|4|||
30880333|NCT01594931|58912347|FG001|Overall Study|Lost to Follow-up|3|||
30880334|NCT01594931|58912348|FG002|Overall Study|Lost to Follow-up|3|||
30880335|NCT01594931|58912346|FG000|Overall Study|Protocol Violation|2|||
30880336|NCT01594931|58912347|FG001|Overall Study|Protocol Violation|1|||
30880337|NCT01594931|58912348|FG002|Overall Study|Protocol Violation|0|||
30880338|NCT01594931|58912346|FG000|Overall Study|No defiined|11|||
30880339|NCT01594931|58912347|FG001|Overall Study|No defiined|4|||
30880340|NCT01594931|58912348|FG002|Overall Study|No defiined|7|||
30880341|NCT01594853|58912358|FG000|Overall Study|Withdrawal by Subject|1|||
30880342|NCT01594853|58912359|FG001|Overall Study|Withdrawal by Subject|1|||
30880343|NCT01594853|58912358|FG000|Overall Study|Lost to Follow-up|1|||
30880344|NCT01594853|58912359|FG001|Overall Study|Lost to Follow-up|1|||
30880345|NCT01594853|58912358|FG000|Overall Study|noncompliance with exercise|0|||
30880346|NCT01594853|58912359|FG001|Overall Study|noncompliance with exercise|1|||
30880347|NCT01668797|58912376|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
30880348|NCT01668797|58912377|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
30880349|NCT01668797|58912378|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
30880350|NCT01668797|58912379|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
30880351|NCT01668797|58912376|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
30880352|NCT01668797|58912377|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
30880353|NCT01668797|58912378|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
30880354|NCT01668797|58912379|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
30880355|NCT01668797|58912376|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
30880356|NCT01668797|58912377|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
30880357|NCT01668797|58912378|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
30880358|NCT01668797|58912379|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
30880359|NCT01668797|58912376|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
30880360|NCT01668797|58912377|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
30880361|NCT01668797|58912378|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
30880362|NCT01668797|58912379|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
30880363|NCT01668797|58912376|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
30880364|NCT01668797|58912377|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
30880365|NCT01668797|58912378|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
30880366|NCT01668797|58912379|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
30971814|NCT01361568|59045279|FG003|Overall Study|Physician Decision|0|||
30971815|NCT01361568|59045280|FG004|Overall Study|Physician Decision|0|||
30971816|NCT01361568|59045281|FG005|Overall Study|Physician Decision|1|||
30971817|NCT01361568|59045276|FG000|Overall Study|Withdrawal by Subject|2|||
30971818|NCT01361568|59045277|FG001|Overall Study|Withdrawal by Subject|1|||
30971819|NCT01361568|59045278|FG002|Overall Study|Withdrawal by Subject|0|||
30971820|NCT01361568|59045279|FG003|Overall Study|Withdrawal by Subject|0|||
30971821|NCT01361568|59045280|FG004|Overall Study|Withdrawal by Subject|0|||
30971822|NCT01361568|59045281|FG005|Overall Study|Withdrawal by Subject|1|||
30971823|NCT03084367|59045296|FG000|Overall Study|Lost to Follow-up|32|||
30971824|NCT03084367|59045296|FG000|Overall Study|Withdrawal by Subject|4|||
30971825|NCT03084367|59045296|FG000|Overall Study|Other|1|||
30971826|NCT01454570|59045309|FG000|Overall Study|Withdrawal by Subject|2|||
30971827|NCT01454570|59045309|FG000|Overall Study|Screen Failure|7|||
30971828|NCT01494350|59045322|FG000|Overall Study|Worsening of lesion|1|||
30971829|NCT03281629|59045332|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
30971830|NCT03281629|59045333|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
30971831|NCT03281629|59045332|FG000|Overall Study|Death|0|||
30971832|NCT03281629|59045333|FG001|Overall Study|Death|1|||
30971833|NCT03281629|59045332|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
30971834|NCT03281629|59045333|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
30971835|NCT00218543|59045339|FG000|Overall Study|Lost to Follow-up|8|||
30971836|NCT00218543|59045339|FG000|Overall Study|relocated|1|||
30971837|NCT00218543|59045339|FG000|Overall Study|Withdrawal by Subject|1|||
30971838|NCT00218543|59045339|FG000|Overall Study|Physician Decision|3|||
30971839|NCT00218543|59045339|FG000|Overall Study|Adverse Event|2|||
30971840|NCT00216671|59045354|FG000|Overall Study|Adverse Event|4|||
30971841|NCT00216671|59045355|FG001|Overall Study|Adverse Event|9|||
30971842|NCT00216671|59045354|FG000|Overall Study|Pregnancy|0|||
30971843|NCT00216671|59045355|FG001|Overall Study|Pregnancy|1|||
30971844|NCT00216671|59045354|FG000|Overall Study|Withdrawal by Subject|4|||
30971845|NCT00216671|59045355|FG001|Overall Study|Withdrawal by Subject|2|||
30971846|NCT00216671|59045354|FG000|Overall Study|Refused Injections|3|||
30971847|NCT00216671|59045355|FG001|Overall Study|Refused Injections|13|||
30971848|NCT00216671|59045354|FG000|Overall Study|No Need to Continue Medication|1|||
30971849|NCT00216671|59045355|FG001|Overall Study|No Need to Continue Medication|1|||
30971850|NCT00216671|59045354|FG000|Overall Study|Insufficient Response|9|||
30971851|NCT00216671|59045355|FG001|Overall Study|Insufficient Response|4|||
30971852|NCT00216671|59045354|FG000|Overall Study|Lost to Follow-up|3|||
30971853|NCT00216671|59045355|FG001|Overall Study|Lost to Follow-up|5|||
30971854|NCT00216671|59045354|FG000|Overall Study|Non compliant|2|||
30971855|NCT00216671|59045355|FG001|Overall Study|Non compliant|2|||
30971856|NCT00216671|59045354|FG000|Overall Study|Ineligible|0|||
30971857|NCT00216671|59045355|FG001|Overall Study|Ineligible|2|||
30971858|NCT00216671|59045354|FG000|Overall Study|Physician Decision|1|||
30971859|NCT00216671|59045355|FG001|Overall Study|Physician Decision|1|||
30971860|NCT00216671|59045354|FG000|Overall Study|Protocol Violation|3|||
30971861|NCT00216671|59045355|FG001|Overall Study|Protocol Violation|5|||
30971862|NCT00216671|59045354|FG000|Overall Study|Relapse|1|||
30971863|NCT00216671|59045355|FG001|Overall Study|Relapse|0|||
30971864|NCT00216671|59045354|FG000|Overall Study|Investigator Illness|0|||
30971865|NCT00216671|59045355|FG001|Overall Study|Investigator Illness|1|||
30971866|NCT00216671|59045354|FG000|Overall Study|Patient Moved|0|||
30971867|NCT00216671|59045355|FG001|Overall Study|Patient Moved|1|||
30971868|NCT00216671|59045354|FG000|Overall Study|Ineligible, no efficacy data|2|||
30971869|NCT00216671|59045355|FG001|Overall Study|Ineligible, no efficacy data|2|||
30971870|NCT00216671|59045354|FG000|Overall Study|Insufficient Response Adverse Event|2|||
30971871|NCT00216671|59045355|FG001|Overall Study|Insufficient Response Adverse Event|1|||
30971872|NCT00216203|59045361|FG000|Overall Study|Withdrawal by Subject|2|||
30971873|NCT02644668|59045396|FG000|Overall Study|Adverse Event|2|||
30971874|NCT02644668|59045397|FG001|Overall Study|Adverse Event|0|||
30971875|NCT02644668|59045398|FG002|Overall Study|Adverse Event|1|||
30971876|NCT02644668|59045396|FG000|Overall Study|Protocol Violation|0|||
30971877|NCT02644668|59045397|FG001|Overall Study|Protocol Violation|0|||
30971878|NCT02644668|59045398|FG002|Overall Study|Protocol Violation|1|||
30971879|NCT02644668|59045396|FG000|Overall Study|Withdrawal by Subject|0|||
30971880|NCT02644668|59045397|FG001|Overall Study|Withdrawal by Subject|0|||
30971881|NCT02644668|59045398|FG002|Overall Study|Withdrawal by Subject|1|||
30971882|NCT02644356|59045417|FG000|Overall Study|Withdrawal by Subject|2|||
30971883|NCT01494038|59045458|FG000|Overall Study|Protocol Violation|1|||
30971884|NCT01494038|59045459|FG001|Overall Study|Protocol Violation|1|||
30971885|NCT01494038|59045458|FG000|Overall Study|Lost to Follow-up|18|||
30971886|NCT01494038|59045459|FG001|Overall Study|Lost to Follow-up|20|||
30971887|NCT01494038|59045458|FG000|Overall Study|Withdrawal by Subject|44|||
30971888|NCT01494038|59045459|FG001|Overall Study|Withdrawal by Subject|34|||
30880367|NCT01668797|58912376|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
30971889|NCT01494038|59045458|FG000|Overall Study|Not able to get to clinic|21|||
30971890|NCT01494038|59045459|FG001|Overall Study|Not able to get to clinic|15|||
30971891|NCT01494038|59045458|FG000|Overall Study|Not willing to adhere to reqs|2|||
30971892|NCT01494038|59045459|FG001|Overall Study|Not willing to adhere to reqs|9|||
30971893|NCT01494038|59045458|FG000|Overall Study|Death|2|||
30971894|NCT01494038|59045459|FG001|Overall Study|Death|4|||
30971895|NCT02640612|59045496|FG000|Overall Study|Adverse Event|6|||
30971896|NCT02640612|59045497|FG001|Overall Study|Adverse Event|7|||
30971897|NCT02640612|59045498|FG002|Overall Study|Adverse Event|2|||
30971898|NCT02640612|59045496|FG000|Overall Study|Death|1|||
30971899|NCT02640612|59045497|FG001|Overall Study|Death|0|||
30971900|NCT02640612|59045498|FG002|Overall Study|Death|0|||
30971901|NCT02640612|59045496|FG000|Overall Study|Withdrawal by Subject|10|||
30971902|NCT02640612|59045497|FG001|Overall Study|Withdrawal by Subject|3|||
30971903|NCT02640612|59045498|FG002|Overall Study|Withdrawal by Subject|3|||
30971904|NCT02640612|59045496|FG000|Overall Study|Lost to Follow-up|4|||
30971905|NCT02640612|59045497|FG001|Overall Study|Lost to Follow-up|1|||
30971906|NCT02640612|59045498|FG002|Overall Study|Lost to Follow-up|1|||
30971907|NCT02640612|59045496|FG000|Overall Study|Protocol Violation|0|||
30971908|NCT02640612|59045497|FG001|Overall Study|Protocol Violation|2|||
30971909|NCT02640612|59045498|FG002|Overall Study|Protocol Violation|0|||
30971910|NCT02640612|59045496|FG000|Overall Study|Lack of Efficacy|1|||
30971911|NCT02640612|59045497|FG001|Overall Study|Lack of Efficacy|1|||
30971912|NCT02640612|59045498|FG002|Overall Study|Lack of Efficacy|0|||
30971913|NCT00639769|59045506|FG000|Overall Study|Death|2|||
30971914|NCT00639769|59045506|FG000|Overall Study|Adverse Event|7|||
30971915|NCT00639769|59045506|FG000|Overall Study|Lack of Efficacy|1|||
30971916|NCT00639769|59045506|FG000|Overall Study|Disease progression|26|||
30971917|NCT00639769|59045506|FG000|Overall Study|Withdrawal by Subject|4|||
30971918|NCT00639457|59045512|FG000|Overall Study|Withdrawal by Subject|2|||
30971919|NCT00639457|59045513|FG001|Overall Study|Withdrawal by Subject|3|||
30971920|NCT00639379|59045519|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
30971921|NCT00639379|59045520|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
30971922|NCT00639379|59045519|FG000|Period 1 - 2 Weeks|lens issue|3|||
30971923|NCT00639379|59045520|FG001|Period 1 - 2 Weeks|lens issue|0|||
30971924|NCT00639223|59045528|FG000|Overall Study|Lost to Follow-up|0|||
30971925|NCT00639223|59045529|FG001|Overall Study|Lost to Follow-up|2|||
30971926|NCT00638989|59045538|FG000|Overall Study|Lost to Follow-up|0|||
30971927|NCT00638989|59045539|FG001|Overall Study|Lost to Follow-up|0|||
30971928|NCT00638989|59045540|FG002|Overall Study|Lost to Follow-up|1|||
30971929|NCT00637273|59045561|FG000|Overall Study|Adverse Event|11|||
30971930|NCT00637273|59045562|FG001|Overall Study|Adverse Event|5|||
30971931|NCT00637273|59045563|FG002|Overall Study|Adverse Event|7|||
30971932|NCT00637273|59045561|FG000|Overall Study|Lost to Follow-up|8|||
30971933|NCT00637273|59045562|FG001|Overall Study|Lost to Follow-up|9|||
30971934|NCT00637273|59045563|FG002|Overall Study|Lost to Follow-up|13|||
30971935|NCT00637273|59045561|FG000|Overall Study|Protocol Violation|2|||
30971936|NCT00637273|59045562|FG001|Overall Study|Protocol Violation|4|||
30971937|NCT00637273|59045563|FG002|Overall Study|Protocol Violation|1|||
30971938|NCT00637273|59045561|FG000|Overall Study|Withdrawal of Consent|18|||
30971939|NCT00637273|59045562|FG001|Overall Study|Withdrawal of Consent|6|||
30971940|NCT00637273|59045563|FG002|Overall Study|Withdrawal of Consent|18|||
30971941|NCT00637273|59045561|FG000|Overall Study|Investigator Decision|1|||
30971942|NCT00637273|59045562|FG001|Overall Study|Investigator Decision|3|||
30971943|NCT00637273|59045563|FG002|Overall Study|Investigator Decision|1|||
30971944|NCT00637273|59045561|FG000|Overall Study|Administrative|2|||
30971945|NCT00637273|59045562|FG001|Overall Study|Administrative|0|||
30971946|NCT00637273|59045563|FG002|Overall Study|Administrative|0|||
30971947|NCT00637273|59045561|FG000|Overall Study|Loss of Glucose Control|1|||
30971948|NCT00637273|59045562|FG001|Overall Study|Loss of Glucose Control|1|||
30971949|NCT00637273|59045563|FG002|Overall Study|Loss of Glucose Control|1|||
30971950|NCT00988351|59045573|FG000|Overall Study|Withdrawal by Subject|8|||
30971951|NCT00988351|59045574|FG001|Overall Study|Withdrawal by Subject|0|||
30971952|NCT00988351|59045573|FG000|Overall Study|Lost to Follow-up|6|||
30971953|NCT00988351|59045574|FG001|Overall Study|Lost to Follow-up|9|||
30971954|NCT00988351|59045573|FG000|Overall Study|not using CPAP|5|||
30971955|NCT00988351|59045574|FG001|Overall Study|not using CPAP|3|||
30971956|NCT00988117|59045580|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
30971957|NCT00988117|59045580|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
30971958|NCT00637195|59045587|FG000|Overall Study|Lost to Follow-up|1|||
30971959|NCT00637195|59045588|FG001|Overall Study|Lost to Follow-up|0|||
30971960|NCT00637195|59045587|FG000|Overall Study|Other|2|||
30971961|NCT00637195|59045588|FG001|Overall Study|Other|0|||
30971962|NCT00637195|59045587|FG000|Overall Study|Withdrawal by Subject|0|||
30971963|NCT00637195|59045588|FG001|Overall Study|Withdrawal by Subject|1|||
30971964|NCT00636961|59045606|FG000|Period 1|Administrative problems|1|||
30971965|NCT00636961|59045607|FG001|Period 1|Administrative problems|1|||
30971966|NCT00636961|59045606|FG000|Period 2|Adverse Event|1|||
30971967|NCT00636961|59045607|FG001|Period 2|Adverse Event|0|||
30971968|NCT00635089|59045622|FG000|Overall Study|Adverse Event|7|||
30971969|NCT00635089|59045622|FG000|Overall Study|Lack of Efficacy|28|||
30971970|NCT00635089|59045622|FG000|Overall Study|Protocol Deviation|4|||
30971971|NCT00635089|59045622|FG000|Overall Study|Lost to Follow-up|8|||
30971972|NCT00635089|59045622|FG000|Overall Study|Other|31|||
30971973|NCT01493414|59045639|FG000|Overall Study|Adverse Event|405|||
30971974|NCT01493414|59045639|FG000|Overall Study|Disease progression|204|||
30971975|NCT01493414|59045639|FG000|Overall Study|Death|101|||
30971976|NCT01493414|59045639|FG000|Overall Study|Physician Decision|93|||
30971977|NCT01493414|59045639|FG000|Overall Study|Withdrawal by Subject|79|||
30971978|NCT01493414|59045639|FG000|Overall Study|Protocol deviation|27|||
30971979|NCT01493414|59045639|FG000|Overall Study|Administrative problems|25|||
30971980|NCT01493414|59045639|FG000|Overall Study|Lost to Follow-up|16|||
30971981|NCT00634543|59045649|FG000|Overall Study|Other|1|||
30971982|NCT00634543|59045650|FG001|Overall Study|Other|2|||
30971983|NCT00634543|59045649|FG000|Overall Study|Protocol Violation|3|||
30971984|NCT00634543|59045650|FG001|Overall Study|Protocol Violation|3|||
30971985|NCT00634543|59045649|FG000|Overall Study|Adverse Event|11|||
30971986|NCT00634543|59045650|FG001|Overall Study|Adverse Event|11|||
30971987|NCT00634543|59045649|FG000|Overall Study|Withdrawal by Subject|4|||
30971988|NCT00634543|59045650|FG001|Overall Study|Withdrawal by Subject|4|||
30971989|NCT00634543|59045649|FG000|Overall Study|Lost to Follow-up|0|||
30971990|NCT00634543|59045650|FG001|Overall Study|Lost to Follow-up|1|||
30971991|NCT00985465|59045658|FG000|Overall Study|Withdrawal by Subject|1|||
30971992|NCT00985465|59045659|FG001|Overall Study|Withdrawal by Subject|2|||
30971993|NCT00985465|59045658|FG000|Overall Study|Considered to be part of the other group|0|||
30971994|NCT00985465|59045659|FG001|Overall Study|Considered to be part of the other group|1|||
30971995|NCT01049919|59045668|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
30971996|NCT01049919|59045669|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
30971997|NCT01049919|59045668|FG000|Overall Study|Withdrawal by Subject|5|||
30971998|NCT01049919|59045669|FG001|Overall Study|Withdrawal by Subject|0|||
30971999|NCT01049919|59045668|FG000|Overall Study|Lost to Follow-up|6|||
30972000|NCT01049919|59045669|FG001|Overall Study|Lost to Follow-up|1|||
30972001|NCT01049919|59045668|FG000|Overall Study|Physician Decision|2|||
30972002|NCT01049919|59045669|FG001|Overall Study|Physician Decision|0|||
30972003|NCT01049919|59045668|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
30972004|NCT01049919|59045669|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
30972005|NCT01049919|59045668|FG000|Overall Study|Early study termination by sponsor.|2|||
30972006|NCT01049919|59045669|FG001|Overall Study|Early study termination by sponsor.|0|||
30972007|NCT01049373|59045677|FG000|Overall Study|Protocol Violation|9|||
30972008|NCT01049373|59045678|FG001|Overall Study|Protocol Violation|9|||
30972009|NCT01049373|59045677|FG000|Overall Study|Withdrawal by Subject|8|||
30972010|NCT01049373|59045678|FG001|Overall Study|Withdrawal by Subject|5|||
30972011|NCT01049373|59045677|FG000|Overall Study|Adverse Event|3|||
30972012|NCT01049373|59045678|FG001|Overall Study|Adverse Event|3|||
30972013|NCT01049373|59045677|FG000|Overall Study|Lost to Follow-up|9|||
30972014|NCT01049373|59045678|FG001|Overall Study|Lost to Follow-up|4|||
30972015|NCT01049373|59045677|FG000|Overall Study|no evaluable study values|9|||
30972016|NCT01049373|59045678|FG001|Overall Study|no evaluable study values|21|||
30972017|NCT01049373|59045677|FG000|Overall Study|Other|1|||
30972018|NCT01049373|59045678|FG001|Overall Study|Other|1|||
30972019|NCT01049373|59045677|FG000|Overall Study|Non-cooperation|0|||
30972020|NCT01049373|59045678|FG001|Overall Study|Non-cooperation|1|||
30972021|NCT00985231|59045688|FG000|Overall Study|ineligible|1|||
30972022|NCT00985231|59045689|FG001|Overall Study|ineligible|0|||
30972023|NCT00985231|59045688|FG000|Overall Study|Protocol Violation|1|||
30972024|NCT00985231|59045689|FG001|Overall Study|Protocol Violation|0|||
30972025|NCT00985231|59045688|FG000|Overall Study|Withdrawal by Subject|1|||
30972026|NCT00985231|59045689|FG001|Overall Study|Withdrawal by Subject|0|||
30972027|NCT00985231|59045688|FG000|Overall Study|Lost to Follow-up|0|||
30972028|NCT00985231|59045689|FG001|Overall Study|Lost to Follow-up|1|||
30972029|NCT00985231|59045688|FG000|Overall Study|Study related symptoms & complaints|0|||
30972030|NCT00985231|59045689|FG001|Overall Study|Study related symptoms & complaints|2|||
30972031|NCT01048671|59045709|FG000|Overall Study|Protocol Violation|0|||
30972032|NCT01048671|59045710|FG001|Overall Study|Protocol Violation|1|||
30972033|NCT01048671|59045711|FG002|Overall Study|Protocol Violation|1|||
30972034|NCT01360866|59045723|FG000|Overall Study|Lost to Follow-up|11|||
30972035|NCT01360866|59045724|FG001|Overall Study|Lost to Follow-up|28|||
30972036|NCT01360866|59045725|FG002|Overall Study|Lost to Follow-up|41|||
30972037|NCT01360866|59045726|FG003|Overall Study|Lost to Follow-up|0|||
30972038|NCT01360866|59045723|FG000|Overall Study|Adverse Event|56|||
30972039|NCT01360866|59045724|FG001|Overall Study|Adverse Event|61|||
30972040|NCT01360866|59045725|FG002|Overall Study|Adverse Event|134|||
30972041|NCT01360866|59045726|FG003|Overall Study|Adverse Event|6|||
30972042|NCT01360866|59045723|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
30972043|NCT01360866|59045724|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
30972044|NCT01360866|59045725|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
30972045|NCT01360866|59045726|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
30972046|NCT01360866|59045723|FG000|Overall Study|Withdrawn by Investigator|9|||
30972047|NCT01360866|59045724|FG001|Overall Study|Withdrawn by Investigator|8|||
30972048|NCT01360866|59045725|FG002|Overall Study|Withdrawn by Investigator|31|||
30972049|NCT01360866|59045726|FG003|Overall Study|Withdrawn by Investigator|2|||
30972050|NCT01360866|59045723|FG000|Overall Study|Withdrawal by participant|79|||
30972051|NCT01360866|59045724|FG001|Overall Study|Withdrawal by participant|89|||
30972052|NCT01360866|59045725|FG002|Overall Study|Withdrawal by participant|168|||
30972053|NCT01360866|59045726|FG003|Overall Study|Withdrawal by participant|8|||
30972054|NCT01360866|59045723|FG000|Overall Study|Protocol Deviation|25|||
30972055|NCT01360866|59045724|FG001|Overall Study|Protocol Deviation|33|||
30972056|NCT01360866|59045725|FG002|Overall Study|Protocol Deviation|61|||
30972057|NCT01360866|59045726|FG003|Overall Study|Protocol Deviation|2|||
30972058|NCT01360866|59045723|FG000|Overall Study|Lack of Efficacy|30|||
30972059|NCT01360866|59045724|FG001|Overall Study|Lack of Efficacy|40|||
30972060|NCT01360866|59045725|FG002|Overall Study|Lack of Efficacy|30|||
30972061|NCT01360866|59045726|FG003|Overall Study|Lack of Efficacy|4|||
30972062|NCT00985153|59045740|FG000|Overall Study|Lost to Follow-up|16|||
30972063|NCT00985153|59045741|FG001|Overall Study|Lost to Follow-up|19|||
30972064|NCT00985153|59045742|FG002|Overall Study|Lost to Follow-up|17|||
30972065|NCT00985153|59045743|FG003|Overall Study|Lost to Follow-up|20|||
30972066|NCT00985153|59045740|FG000|Overall Study|Protocol Violation|3|||
30972067|NCT00985153|59045741|FG001|Overall Study|Protocol Violation|2|||
30972068|NCT00985153|59045742|FG002|Overall Study|Protocol Violation|4|||
30972069|NCT00985153|59045743|FG003|Overall Study|Protocol Violation|3|||
30972070|NCT00985153|59045740|FG000|Overall Study|Withdrawal by Subject|6|||
30972071|NCT00985153|59045741|FG001|Overall Study|Withdrawal by Subject|11|||
30972072|NCT00985153|59045742|FG002|Overall Study|Withdrawal by Subject|11|||
30972073|NCT00985153|59045743|FG003|Overall Study|Withdrawal by Subject|10|||
30972074|NCT00985153|59045740|FG000|Overall Study|Missed One or More Bleeds|7|||
30972075|NCT00985153|59045741|FG001|Overall Study|Missed One or More Bleeds|7|||
30972076|NCT00985153|59045742|FG002|Overall Study|Missed One or More Bleeds|8|||
30972077|NCT00985153|59045743|FG003|Overall Study|Missed One or More Bleeds|10|||
30972078|NCT00985153|59045740|FG000|Overall Study|Incomplete Safety Follow-up|3|||
30972079|NCT00985153|59045741|FG001|Overall Study|Incomplete Safety Follow-up|5|||
30972080|NCT00985153|59045742|FG002|Overall Study|Incomplete Safety Follow-up|4|||
30972081|NCT00985153|59045743|FG003|Overall Study|Incomplete Safety Follow-up|4|||
30972082|NCT01047345|59045755|FG000|Base Study|Adverse Event|3|||
30972083|NCT01047345|59045756|FG001|Base Study|Adverse Event|0|||
30972084|NCT01047345|59045757|FG002|Base Study|Adverse Event|0|||
30972085|NCT01047345|59045755|FG000|Base Study|Lost to Follow-up|4|||
30972086|NCT01047345|59045756|FG001|Base Study|Lost to Follow-up|1|||
30972087|NCT01047345|59045757|FG002|Base Study|Lost to Follow-up|0|||
30972088|NCT01047345|59045755|FG000|Base Study|Protocol Violation|3|||
30972089|NCT01047345|59045756|FG001|Base Study|Protocol Violation|1|||
30972090|NCT01047345|59045757|FG002|Base Study|Protocol Violation|0|||
30972091|NCT01047345|59045755|FG000|Base Study|Withdrawal by Subject|12|||
30972092|NCT01047345|59045756|FG001|Base Study|Withdrawal by Subject|4|||
30972093|NCT01047345|59045757|FG002|Base Study|Withdrawal by Subject|0|||
30972094|NCT01047345|59045755|FG000|Extension|Withdrawal by Subject|0|||
30972095|NCT01047345|59045756|FG001|Extension|Withdrawal by Subject|0|||
30972096|NCT01047345|59045757|FG002|Extension|Withdrawal by Subject|1|||
30972097|NCT01047345|59045755|FG000|Extension|Lost to Follow-up|0|||
30972098|NCT01047345|59045756|FG001|Extension|Lost to Follow-up|0|||
30972099|NCT01047345|59045757|FG002|Extension|Lost to Follow-up|5|||
30972100|NCT01046877|59045765|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
30972101|NCT01046877|59045765|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
30972102|NCT00984061|59045769|FG000|Clarithromycin Alone|Protocol Violation|1|||
30972103|NCT01046643|59045778|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
30972104|NCT01046643|59045779|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
30972105|NCT01046643|59045780|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
30972106|NCT01046643|59045781|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
30972107|NCT00983905|59045791|FG000|Theophylline Alone|Adverse Event|1|||
30972108|NCT00983905|59045791|FG000|Colchicine Alone|Adverse Event|2|||
30972109|NCT01046565|59045798|FG000|Overall Study|Adverse Event|2|||
30972110|NCT01046565|59045798|FG000|Overall Study|Withdrawal by Subject|7|||
30972111|NCT00983827|59045807|FG000|Overall Study|Withdrawal by Subject|1|||
30972112|NCT00983749|59045813|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
30972113|NCT00983749|59045814|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
30972114|NCT01046253|59045822|FG000|Second Intervention|Adverse Event|0|||
30972115|NCT01046253|59045823|FG001|Second Intervention|Adverse Event|1|||
30972116|NCT01046253|59045822|FG000|Second Intervention|Protocol Violation|0|||
30972117|NCT01046253|59045823|FG001|Second Intervention|Protocol Violation|1|||
30972118|NCT00983515|59045829|FG000|Ritonavir Alone|liver panel out of range|6|||
30972119|NCT00983515|59045829|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
30972120|NCT00982735|59045836|FG000|Overall Study|Lost to Follow-up|6|||
30972121|NCT00982735|59045836|FG000|Overall Study|Patient ineligible for trial|224|||
30972122|NCT01361178|59045842|FG000|Overall Study|Death|13|||
30972123|NCT01361178|59045843|FG001|Overall Study|Death|0|||
30972124|NCT00981799|59045853|FG000|Overall Study|Adverse Event|1|||
30972125|NCT00981799|59045854|FG001|Overall Study|Adverse Event|1|||
30972126|NCT00981799|59045855|FG002|Overall Study|Adverse Event|0|||
30972127|NCT00981799|59045856|FG003|Overall Study|Adverse Event|0|||
30972128|NCT00981175|59045870|FG000|Primary Dose Vaccination|Adverse Event|1|||
30972129|NCT00981175|59045871|FG001|Primary Dose Vaccination|Adverse Event|0|||
30972130|NCT00981175|59045870|FG000|Primary Dose Vaccination|Protocol Violation|0|||
30972131|NCT00981175|59045871|FG001|Primary Dose Vaccination|Protocol Violation|1|||
30972132|NCT00981175|59045870|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
30972133|NCT00981175|59045871|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
30972134|NCT00981175|59045870|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
30972135|NCT00981175|59045871|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
30972136|NCT00981019|59045884|FG000|Overall Study|Did not respond|65|||
30972137|NCT00981019|59045884|FG000|Overall Study|Did not match target population|94|||
30972138|NCT00981019|59045884|FG000|Overall Study|Inadvertent exclusion|239|||
30972139|NCT00981019|59045884|FG000|Overall Study|Hit the survey after closure|79|||
30972140|NCT01045161|59045891|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
30972141|NCT01045161|59045892|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
30972142|NCT01045161|59045893|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
30972143|NCT01045161|59045891|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
30972144|NCT01045161|59045892|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
30972145|NCT01045161|59045893|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
30972146|NCT01045161|59045891|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
30972147|NCT01045161|59045892|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
30972148|NCT01045161|59045893|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
30972149|NCT01045161|59045891|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
30972150|NCT01045161|59045892|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
30972151|NCT01045161|59045893|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
30972152|NCT01045161|59045891|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
30972153|NCT01045161|59045892|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
30972154|NCT01045161|59045893|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
30972155|NCT01045161|59045891|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
30972156|NCT01045161|59045892|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
30972157|NCT01045161|59045893|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
30972158|NCT01045161|59045891|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
30972159|NCT01045161|59045892|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
30972160|NCT01045161|59045893|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
30972161|NCT01045161|59045891|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
30972162|NCT01045161|59045892|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
30972163|NCT01045161|59045893|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
30972164|NCT01045161|59045891|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
30972165|NCT01045161|59045892|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
30972166|NCT01045161|59045893|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
30972167|NCT01045161|59045891|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
30972168|NCT01045161|59045892|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
30972169|NCT01045161|59045893|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
30972170|NCT01045161|59045891|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
30972171|NCT01045161|59045892|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
30972172|NCT01045161|59045893|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
30972173|NCT01045161|59045891|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
30972174|NCT01045161|59045892|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
30972175|NCT01045161|59045893|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
30972176|NCT01045161|59045891|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
30972177|NCT01045161|59045892|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
30972178|NCT01045161|59045893|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
30972179|NCT01045161|59045891|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
30972180|NCT01045161|59045892|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
30972181|NCT01045161|59045893|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
30972182|NCT00633217|59045912|FG000|Overall Study|Adverse Event|5|||
30972183|NCT00633217|59045913|FG001|Overall Study|Adverse Event|9|||
30972184|NCT00633217|59045912|FG000|Overall Study|Lack of Efficacy|0|||
30972185|NCT00633217|59045913|FG001|Overall Study|Lack of Efficacy|2|||
30972186|NCT00633217|59045912|FG000|Overall Study|Protocol Violation|3|||
30972187|NCT00633217|59045913|FG001|Overall Study|Protocol Violation|7|||
30972188|NCT00633217|59045912|FG000|Overall Study|Lost to Follow-up|2|||
30972189|NCT00633217|59045913|FG001|Overall Study|Lost to Follow-up|2|||
30972190|NCT00633217|59045912|FG000|Overall Study|Investigator Discretion|2|||
30972191|NCT00633217|59045913|FG001|Overall Study|Investigator Discretion|0|||
30972192|NCT00633217|59045912|FG000|Overall Study|Withdrew Consent|3|||
30972193|NCT00633217|59045913|FG001|Overall Study|Withdrew Consent|3|||
30972194|NCT01673490|59045919|FG000|Overall Study|Lost to Follow-up|1|||
30972195|NCT01673490|59045919|FG000|Overall Study|Adverse Event|3|||
30972196|NCT01673490|59045919|FG000|Overall Study|Withdrawal by Subject|3|||
30972197|NCT00215657|59045931|FG000|Overall Study|Adverse Event|5|||
30880368|NCT01668797|58912377|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
30972198|NCT00215657|59045932|FG001|Overall Study|Adverse Event|1|||
30972199|NCT00215657|59045933|FG002|Overall Study|Adverse Event|3|||
30972200|NCT00215657|59045934|FG003|Overall Study|Adverse Event|0|||
30972201|NCT00215657|59045935|FG004|Overall Study|Adverse Event|3|||
30972202|NCT00215657|59045936|FG005|Overall Study|Adverse Event|1|||
30972203|NCT00215657|59045937|FG006|Overall Study|Adverse Event|0|||
30972204|NCT00215657|59045938|FG007|Overall Study|Adverse Event|3|||
30972205|NCT00215657|59045931|FG000|Overall Study|Withdrawal by Subject|6|||
30972206|NCT00215657|59045932|FG001|Overall Study|Withdrawal by Subject|3|||
30972207|NCT00215657|59045933|FG002|Overall Study|Withdrawal by Subject|3|||
30972208|NCT00215657|59045934|FG003|Overall Study|Withdrawal by Subject|1|||
30972209|NCT00215657|59045935|FG004|Overall Study|Withdrawal by Subject|6|||
30972210|NCT00215657|59045936|FG005|Overall Study|Withdrawal by Subject|1|||
30972211|NCT00215657|59045937|FG006|Overall Study|Withdrawal by Subject|10|||
30972212|NCT00215657|59045938|FG007|Overall Study|Withdrawal by Subject|3|||
30972213|NCT00215657|59045931|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
30972214|NCT00215657|59045932|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
30972215|NCT00215657|59045933|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
30972216|NCT00215657|59045934|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
30972217|NCT00215657|59045935|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
30972218|NCT00215657|59045936|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
30972219|NCT00215657|59045937|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
30972220|NCT00215657|59045938|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
30972221|NCT00215657|59045931|FG000|Overall Study|Insufficient testosterone response|5|||
30972222|NCT00215657|59045932|FG001|Overall Study|Insufficient testosterone response|4|||
30972223|NCT00215657|59045933|FG002|Overall Study|Insufficient testosterone response|1|||
30972224|NCT00215657|59045934|FG003|Overall Study|Insufficient testosterone response|12|||
30972225|NCT00215657|59045935|FG004|Overall Study|Insufficient testosterone response|8|||
30972226|NCT00215657|59045936|FG005|Overall Study|Insufficient testosterone response|12|||
30972227|NCT00215657|59045937|FG006|Overall Study|Insufficient testosterone response|4|||
30972228|NCT00215657|59045938|FG007|Overall Study|Insufficient testosterone response|7|||
30972229|NCT00215657|59045931|FG000|Overall Study|Other|3|||
30972230|NCT00215657|59045932|FG001|Overall Study|Other|1|||
30972231|NCT00215657|59045933|FG002|Overall Study|Other|2|||
30972232|NCT00215657|59045934|FG003|Overall Study|Other|3|||
30972233|NCT00215657|59045935|FG004|Overall Study|Other|5|||
30972234|NCT00215657|59045936|FG005|Overall Study|Other|4|||
30972235|NCT00215657|59045937|FG006|Overall Study|Other|6|||
30972236|NCT00215657|59045938|FG007|Overall Study|Other|1|||
30972237|NCT00633061|59045958|FG000|Overall Study|Study closed|86|||
30972238|NCT00633061|59045959|FG001|Overall Study|Study closed|0|||
30972239|NCT00632827|59045967|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
30972240|NCT00632827|59045967|FG000|Overall Study|Death|2|||
30972241|NCT00632827|59045967|FG000|Overall Study|Adverse Event|5|||
30972242|NCT00632827|59045967|FG000|Overall Study|Lost to Follow-up|1|||
30972243|NCT00214019|59045972|FG000|Overall Study|Lost to Follow-up|11|||
30972244|NCT00214019|59045972|FG000|Overall Study|Withdrawal by Subject|2|||
30972245|NCT00214019|59045972|FG000|Overall Study|Screen Failed prior to randomization|17|||
30972246|NCT00210119|59045979|FG000|Overall Study|Protocol Violation|1|||
30972247|NCT00210119|59045979|FG000|Overall Study|Withdrawal by Subject|1|||
30972248|NCT01044459|59045985|FG000|Overall Study|Withdrawal by Subject|21|||
30972249|NCT01044459|59045986|FG001|Overall Study|Withdrawal by Subject|28|||
30972250|NCT01044459|59045985|FG000|Overall Study|Terminated by Sponsor|22|||
30972251|NCT01044459|59045986|FG001|Overall Study|Terminated by Sponsor|21|||
30972252|NCT01044459|59045985|FG000|Overall Study|Adverse Event|22|||
30972253|NCT01044459|59045986|FG001|Overall Study|Adverse Event|20|||
30972254|NCT01044459|59045985|FG000|Overall Study|Lack of Efficacy|23|||
30972255|NCT01044459|59045986|FG001|Overall Study|Lack of Efficacy|12|||
30972256|NCT01044459|59045985|FG000|Overall Study|Protocol Violation|11|||
30972257|NCT01044459|59045986|FG001|Overall Study|Protocol Violation|16|||
30972258|NCT01044459|59045985|FG000|Overall Study|Other Reason|7|||
30972259|NCT01044459|59045986|FG001|Overall Study|Other Reason|14|||
30972260|NCT01044459|59045985|FG000|Overall Study|COPD exacerbation|9|||
30972261|NCT01044459|59045986|FG001|Overall Study|COPD exacerbation|8|||
30972262|NCT01044459|59045985|FG000|Overall Study|Lost to Follow-up|18|||
30972263|NCT01044459|59045986|FG001|Overall Study|Lost to Follow-up|12|||
30972264|NCT00980005|59045994|FG000|Overall Study|Withdrawal by Subject|6|||
30972265|NCT00980005|59045995|FG001|Overall Study|Withdrawal by Subject|17|||
30972266|NCT00980005|59045994|FG000|Overall Study|Lost to Follow-up|37|||
30972267|NCT00980005|59045995|FG001|Overall Study|Lost to Follow-up|43|||
30972268|NCT00980005|59045994|FG000|Overall Study|Other|4|||
30972269|NCT00980005|59045995|FG001|Overall Study|Other|3|||
30972270|NCT01044303|59046005|FG000|Overall Study|Lost to Follow-up|2|||
30972271|NCT00983437|59046012|FG000|Overall Study|Adverse Event|9|||
30972272|NCT00983437|59046012|FG000|Overall Study|Lack of Efficacy|1|||
30972273|NCT00983437|59046012|FG000|Overall Study|Withdrawal by Subject|8|||
30972274|NCT00983437|59046012|FG000|Overall Study|Noncompliance to Study Procedures|1|||
30972275|NCT00983437|59046012|FG000|Overall Study|Lost to Follow-up|2|||
30972276|NCT00983437|59046012|FG000|Overall Study|Other Reason|26|||
30972277|NCT01042977|59046018|FG000|Overall Study|Adverse Event|4|||
30972278|NCT01042977|59046019|FG001|Overall Study|Adverse Event|12|||
30972279|NCT01042977|59046018|FG000|Overall Study|Death|2|||
30972280|NCT01042977|59046019|FG001|Overall Study|Death|1|||
30972281|NCT01042977|59046018|FG000|Overall Study|Withdrawal by Subject|8|||
30972282|NCT01042977|59046019|FG001|Overall Study|Withdrawal by Subject|16|||
30972283|NCT01042977|59046018|FG000|Overall Study|Lost to Follow-up|0|||
30972284|NCT01042977|59046019|FG001|Overall Study|Lost to Follow-up|2|||
30972285|NCT01042977|59046018|FG000|Overall Study|Poor/non-compliance|3|||
30972286|NCT01042977|59046019|FG001|Overall Study|Poor/non-compliance|4|||
30972287|NCT01042977|59046018|FG000|Overall Study|Subject no longer meets study criteria|15|||
30972288|NCT01042977|59046019|FG001|Overall Study|Subject no longer meets study criteria|13|||
30972289|NCT01042977|59046018|FG000|Overall Study|Incorrect enrollment|6|||
30972290|NCT01042977|59046019|FG001|Overall Study|Incorrect enrollment|4|||
30972291|NCT01042977|59046018|FG000|Overall Study|Safety|0|||
30972292|NCT01042977|59046019|FG001|Overall Study|Safety|2|||
30972293|NCT01042977|59046018|FG000|Overall Study|Administrative reason by sponsor|0|||
30972294|NCT01042977|59046019|FG001|Overall Study|Administrative reason by sponsor|1|||
30972295|NCT01042977|59046018|FG000|Overall Study|Various|3|||
30972296|NCT01042977|59046019|FG001|Overall Study|Various|0|||
30972297|NCT01041573|59046029|FG000|Overall Study|Withdrawal by Subject|2|||
30972298|NCT01041573|59046030|FG001|Overall Study|Withdrawal by Subject|5|||
30972299|NCT01041573|59046031|FG002|Overall Study|Withdrawal by Subject|2|||
30972300|NCT01041573|59046032|FG003|Overall Study|Withdrawal by Subject|0|||
30972301|NCT01041573|59046029|FG000|Overall Study|Death|1|||
30972302|NCT01041573|59046030|FG001|Overall Study|Death|0|||
30972303|NCT01041573|59046031|FG002|Overall Study|Death|0|||
30972304|NCT01041573|59046032|FG003|Overall Study|Death|0|||
30972305|NCT01041573|59046029|FG000|Overall Study|Lost to Follow-up|0|||
30972306|NCT01041573|59046030|FG001|Overall Study|Lost to Follow-up|1|||
30972307|NCT01041573|59046031|FG002|Overall Study|Lost to Follow-up|2|||
30972308|NCT01041573|59046032|FG003|Overall Study|Lost to Follow-up|1|||
30972309|NCT01041573|59046029|FG000|Overall Study|Adverse Event|0|||
30972310|NCT01041573|59046030|FG001|Overall Study|Adverse Event|2|||
30972311|NCT01041573|59046031|FG002|Overall Study|Adverse Event|0|||
30972312|NCT01041573|59046032|FG003|Overall Study|Adverse Event|0|||
30972313|NCT01041573|59046029|FG000|Overall Study|relocation|1|||
30972314|NCT01041573|59046030|FG001|Overall Study|relocation|4|||
30972315|NCT01041573|59046031|FG002|Overall Study|relocation|3|||
30972316|NCT01041573|59046032|FG003|Overall Study|relocation|1|||
30972317|NCT01041573|59046029|FG000|Overall Study|further blood extraction|0|||
30972318|NCT01041573|59046030|FG001|Overall Study|further blood extraction|1|||
30972319|NCT01041573|59046031|FG002|Overall Study|further blood extraction|0|||
30972320|NCT01041573|59046032|FG003|Overall Study|further blood extraction|0|||
30972321|NCT01041573|59046029|FG000|Overall Study|positive to anti-HCV|1|||
30972322|NCT01041573|59046030|FG001|Overall Study|positive to anti-HCV|0|||
30972323|NCT01041573|59046031|FG002|Overall Study|positive to anti-HCV|0|||
30972324|NCT01041573|59046032|FG003|Overall Study|positive to anti-HCV|0|||
30972325|NCT01041495|59046059|FG000|Overall Study|Withdrawal by Subject|2|||
30972326|NCT01041495|59046060|FG001|Overall Study|Withdrawal by Subject|5|||
30972327|NCT01041495|59046059|FG000|Overall Study|Adverse Event|2|||
30972328|NCT01041495|59046060|FG001|Overall Study|Adverse Event|1|||
30972329|NCT01041495|59046059|FG000|Overall Study|Lost to Follow-up|0|||
30972330|NCT01041495|59046060|FG001|Overall Study|Lost to Follow-up|1|||
30972331|NCT01041417|59046068|FG000|Overall Study|Adverse Event|5|||
30972332|NCT01041417|59046069|FG001|Overall Study|Adverse Event|2|||
30972333|NCT01041417|59046068|FG000|Overall Study|Lost to Follow-up|1|||
30972334|NCT01041417|59046069|FG001|Overall Study|Lost to Follow-up|1|||
30972335|NCT01041417|59046068|FG000|Overall Study|Death|1|||
30972336|NCT01041417|59046069|FG001|Overall Study|Death|0|||
30972337|NCT01040871|59046079|FG000|Overall Study|Adverse Event|6|||
30972338|NCT01040871|59046080|FG001|Overall Study|Adverse Event|2|||
30972339|NCT01040871|59046079|FG000|Overall Study|Withdrawal by Subject|2|||
30972340|NCT01040871|59046080|FG001|Overall Study|Withdrawal by Subject|0|||
30972341|NCT01040871|59046079|FG000|Overall Study|Death|1|||
30972342|NCT01040871|59046080|FG001|Overall Study|Death|3|||
30972343|NCT01040871|59046079|FG000|Overall Study|Lack of Efficacy|1|||
30972344|NCT01040871|59046080|FG001|Overall Study|Lack of Efficacy|1|||
30972345|NCT01040871|59046079|FG000|Overall Study|drug supply issue|1|||
30972346|NCT01040871|59046080|FG001|Overall Study|drug supply issue|0|||
30972347|NCT01040871|59046079|FG000|Overall Study|Randomized and Not Treated|2|||
30972348|NCT01040871|59046080|FG001|Overall Study|Randomized and Not Treated|1|||
30972349|NCT01040169|59046088|FG000|Overall Study|Lost to Follow-up|3|||
30972350|NCT01040169|59046089|FG001|Overall Study|Lost to Follow-up|8|||
30972351|NCT01673178|59046109|FG000|Overall Study|Lost to Follow-up|0|||
30972352|NCT01673178|59046110|FG001|Overall Study|Lost to Follow-up|1|||
30972353|NCT01673178|59046111|FG002|Overall Study|Lost to Follow-up|0|||
30972354|NCT01673178|59046112|FG003|Overall Study|Lost to Follow-up|0|||
30972355|NCT01673178|59046113|FG004|Overall Study|Lost to Follow-up|0|||
30972356|NCT01673178|59046109|FG000|Overall Study|Withdrawal by Subject|0|||
30972357|NCT01673178|59046110|FG001|Overall Study|Withdrawal by Subject|0|||
30972358|NCT01673178|59046111|FG002|Overall Study|Withdrawal by Subject|1|||
30972359|NCT01673178|59046112|FG003|Overall Study|Withdrawal by Subject|4|||
30972360|NCT01673178|59046113|FG004|Overall Study|Withdrawal by Subject|2|||
30972361|NCT01673178|59046109|FG000|Overall Study|Protocol Violation|1|||
30972362|NCT01673178|59046110|FG001|Overall Study|Protocol Violation|1|||
30972363|NCT01673178|59046111|FG002|Overall Study|Protocol Violation|0|||
30972364|NCT01673178|59046112|FG003|Overall Study|Protocol Violation|1|||
30972365|NCT01673178|59046113|FG004|Overall Study|Protocol Violation|0|||
30972366|NCT01673178|59046109|FG000|Overall Study|Adverse Event|1|||
30972367|NCT01673178|59046110|FG001|Overall Study|Adverse Event|0|||
30972368|NCT01673178|59046111|FG002|Overall Study|Adverse Event|0|||
30972369|NCT01673178|59046112|FG003|Overall Study|Adverse Event|2|||
30972370|NCT01673178|59046113|FG004|Overall Study|Adverse Event|0|||
30972371|NCT01673178|59046109|FG000|Overall Study|Other|1|||
30972372|NCT01673178|59046110|FG001|Overall Study|Other|0|||
30972373|NCT01673178|59046111|FG002|Overall Study|Other|2|||
30972374|NCT01673178|59046112|FG003|Overall Study|Other|1|||
30972375|NCT01673178|59046113|FG004|Overall Study|Other|0|||
30972376|NCT03593213|59046142|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
30972377|NCT03593213|59046143|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
30972378|NCT03593213|59046144|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
30972379|NCT03593213|59046145|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
30972380|NCT03593213|59046142|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
30972381|NCT03593213|59046143|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
30972382|NCT03593213|59046144|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
30972383|NCT03593213|59046145|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
30972384|NCT03593213|59046142|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
30972385|NCT03593213|59046143|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
30972386|NCT03593213|59046144|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
30972387|NCT03593213|59046145|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
30972388|NCT03593213|59046142|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
30972389|NCT03593213|59046143|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
30972390|NCT03593213|59046144|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
30972391|NCT03593213|59046145|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
30972392|NCT03593213|59046142|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
30972393|NCT03593213|59046143|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
30972394|NCT03593213|59046144|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
30972395|NCT03593213|59046145|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
30972396|NCT03593213|59046142|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
30972397|NCT03593213|59046143|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
30972398|NCT03593213|59046144|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
30972399|NCT03593213|59046145|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
30972400|NCT03593213|59046142|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
30972401|NCT03593213|59046143|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
30972402|NCT03593213|59046144|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
30972403|NCT03593213|59046145|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
30972404|NCT03593213|59046142|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
30972405|NCT03593213|59046143|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
30972406|NCT03593213|59046144|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
30972407|NCT03593213|59046145|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
30972408|NCT03593213|59046142|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
30972409|NCT03593213|59046143|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
30972410|NCT03593213|59046144|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
30972411|NCT03593213|59046145|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
30972412|NCT03593213|59046142|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
30972413|NCT03593213|59046143|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
30972414|NCT03593213|59046144|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
30972415|NCT03593213|59046145|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
30972416|NCT03593213|59046142|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
30972417|NCT03593213|59046143|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
30972418|NCT03593213|59046144|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
30880369|NCT01668797|58912378|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
30880370|NCT01668797|58912379|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
30972419|NCT03593213|59046145|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
30972420|NCT03593213|59046142|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
30972421|NCT03593213|59046143|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
30972422|NCT03593213|59046144|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
30972423|NCT03593213|59046145|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
30972424|NCT03593213|59046142|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
30972425|NCT03593213|59046143|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
30972426|NCT03593213|59046144|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
30972427|NCT03593213|59046145|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
30972428|NCT03593213|59046142|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
30972429|NCT03593213|59046143|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
30972430|NCT03593213|59046144|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
30972431|NCT03593213|59046145|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
30972432|NCT03593213|59046142|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
30972433|NCT03593213|59046143|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
30972434|NCT03593213|59046144|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
30972435|NCT03593213|59046145|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
30972436|NCT03593213|59046142|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
30972437|NCT03593213|59046143|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
30972438|NCT03593213|59046144|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
30972439|NCT03593213|59046145|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
30972440|NCT03593213|59046142|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
30972441|NCT03593213|59046143|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
30972442|NCT03593213|59046144|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
30972443|NCT03593213|59046145|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
30972444|NCT03593213|59046142|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
30972445|NCT03593213|59046143|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
30972446|NCT03593213|59046144|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
30972447|NCT03593213|59046145|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
30972448|NCT03593213|59046142|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
30972449|NCT03593213|59046143|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
30972450|NCT03593213|59046144|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
30972451|NCT03593213|59046145|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
30972452|NCT00013611|59046189|FG000|Overall Study|Lost to Follow-up|91|||
30972453|NCT00013611|59046190|FG001|Overall Study|Lost to Follow-up|100|||
30972454|NCT00010257|59046198|FG000|Overall Study|Withdrawal by Subject|1|||
30972455|NCT00010257|59046199|FG001|Overall Study|Withdrawal by Subject|0|||
30972456|NCT00211757|59046237|FG000|Overall Study|Withdrawal by Subject|1|||
30972457|NCT00211757|59046238|FG001|Overall Study|Withdrawal by Subject|1|||
30972458|NCT00211757|59046237|FG000|Overall Study|Lack of Efficacy|0|||
30972459|NCT00211757|59046238|FG001|Overall Study|Lack of Efficacy|1|||
30972460|NCT02639052|59046255|FG000|Overall Study|Lost to Follow-up|1|||
30972461|NCT02635776|59046362|FG000|Overall Study|Physician Decision|1|||
30972462|NCT02635776|59046363|FG001|Overall Study|Physician Decision|0|||
30972463|NCT02635776|59046362|FG000|Overall Study|Adverse Event|51|||
30972464|NCT02635776|59046363|FG001|Overall Study|Adverse Event|3|||
30972465|NCT02635776|59046362|FG000|Overall Study|Withdrawal by Subject|41|||
30972466|NCT02635776|59046363|FG001|Overall Study|Withdrawal by Subject|7|||
30972467|NCT02635776|59046362|FG000|Overall Study|Lost to Follow-up|4|||
30972468|NCT02635776|59046363|FG001|Overall Study|Lost to Follow-up|0|||
30972469|NCT02635776|59046362|FG000|Overall Study|Other reasons|5|||
30972470|NCT02635776|59046363|FG001|Overall Study|Other reasons|1|||
30972471|NCT02704403|59046377|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
30972472|NCT02704403|59046378|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
30972473|NCT02704403|59046377|FG000|Overall Study|Administrative reasons by sponsor|1251|||
30972474|NCT02704403|59046378|FG001|Overall Study|Administrative reasons by sponsor|616|||
30972475|NCT02704403|59046377|FG000|Overall Study|Death|4|||
30972476|NCT02704403|59046378|FG001|Overall Study|Death|3|||
30972477|NCT02704403|59046377|FG000|Overall Study|Endpoint event|52|||
30972478|NCT02704403|59046378|FG001|Overall Study|Endpoint event|24|||
30972479|NCT02704403|59046377|FG000|Overall Study|Lost to Follow-up|22|||
30972480|NCT02704403|59046378|FG001|Overall Study|Lost to Follow-up|11|||
30972481|NCT02704403|59046377|FG000|Overall Study|Protocol Violation|15|||
30972482|NCT02704403|59046378|FG001|Overall Study|Protocol Violation|15|||
30972483|NCT02704403|59046377|FG000|Overall Study|Adverse Event|2|||
30972484|NCT02704403|59046378|FG001|Overall Study|Adverse Event|0|||
30972485|NCT02704403|59046377|FG000|Overall Study|Withdrawal by Subject|85|||
30972486|NCT02704403|59046378|FG001|Overall Study|Withdrawal by Subject|45|||
30972487|NCT02704403|59046377|FG000|Overall Study|Investigator decision|1|||
30972488|NCT02704403|59046378|FG001|Overall Study|Investigator decision|1|||
30972489|NCT02704403|59046377|FG000|Overall Study|Follow-up not possible|1|||
30972490|NCT02704403|59046378|FG001|Overall Study|Follow-up not possible|2|||
30972491|NCT02636868|59046413|FG000|Overall Study|Death|0|||
30972492|NCT02636868|59046414|FG001|Overall Study|Death|1|||
30972493|NCT02636868|59046415|FG002|Overall Study|Death|2|||
30972494|NCT02635386|59046496|FG000|Overall Study|Pregnancy|2|||
30972495|NCT02635386|59046497|FG001|Overall Study|Pregnancy|0|||
30972496|NCT02635386|59046498|FG002|Overall Study|Pregnancy|0|||
30972497|NCT02635386|59046499|FG003|Overall Study|Pregnancy|0|||
30972498|NCT02635386|59046500|FG004|Overall Study|Pregnancy|2|||
30972499|NCT02635386|59046496|FG000|Overall Study|Withdrawal by Subject|1|||
30972500|NCT02635386|59046497|FG001|Overall Study|Withdrawal by Subject|1|||
30972501|NCT02635386|59046498|FG002|Overall Study|Withdrawal by Subject|0|||
30972502|NCT02635386|59046499|FG003|Overall Study|Withdrawal by Subject|1|||
30972503|NCT02635386|59046500|FG004|Overall Study|Withdrawal by Subject|0|||
30972504|NCT02635386|59046496|FG000|Overall Study|Physician Decision|0|||
30972505|NCT02635386|59046497|FG001|Overall Study|Physician Decision|1|||
30972506|NCT02635386|59046498|FG002|Overall Study|Physician Decision|0|||
30972507|NCT02635386|59046499|FG003|Overall Study|Physician Decision|0|||
30972508|NCT02635386|59046500|FG004|Overall Study|Physician Decision|0|||
30972509|NCT02635386|59046496|FG000|Overall Study|Moved Out of State|0|||
30972510|NCT02635386|59046497|FG001|Overall Study|Moved Out of State|1|||
30972511|NCT02635386|59046498|FG002|Overall Study|Moved Out of State|0|||
30972512|NCT02635386|59046499|FG003|Overall Study|Moved Out of State|0|||
30972513|NCT02635386|59046500|FG004|Overall Study|Moved Out of State|0|||
30972514|NCT02635386|59046496|FG000|Overall Study|Noncompliant|0|||
30972515|NCT02635386|59046497|FG001|Overall Study|Noncompliant|2|||
30972516|NCT02635386|59046498|FG002|Overall Study|Noncompliant|1|||
30972517|NCT02635386|59046499|FG003|Overall Study|Noncompliant|1|||
30972518|NCT02635386|59046500|FG004|Overall Study|Noncompliant|1|||
30972519|NCT02635386|59046496|FG000|Overall Study|side effects|0|||
30972520|NCT02635386|59046497|FG001|Overall Study|side effects|0|||
30972521|NCT02635386|59046498|FG002|Overall Study|side effects|1|||
30972522|NCT02635386|59046499|FG003|Overall Study|side effects|4|||
30972523|NCT02635386|59046500|FG004|Overall Study|side effects|6|||
30972524|NCT02635386|59046496|FG000|Overall Study|needed other major surgery|0|||
30972525|NCT02635386|59046497|FG001|Overall Study|needed other major surgery|1|||
30972526|NCT02635386|59046498|FG002|Overall Study|needed other major surgery|0|||
30972527|NCT02635386|59046499|FG003|Overall Study|needed other major surgery|0|||
30972528|NCT02635386|59046500|FG004|Overall Study|needed other major surgery|0|||
30972529|NCT02635386|59046496|FG000|Overall Study|Other medical problems not drug related|0|||
30972530|NCT02635386|59046497|FG001|Overall Study|Other medical problems not drug related|0|||
30972531|NCT02635386|59046498|FG002|Overall Study|Other medical problems not drug related|0|||
30972532|NCT02635386|59046499|FG003|Overall Study|Other medical problems not drug related|1|||
30972533|NCT02635386|59046500|FG004|Overall Study|Other medical problems not drug related|0|||
30972534|NCT02634606|59046607|FG000|Overall Study|unable to obtain the drug at start|13|||
30972535|NCT01672866|59046653|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
30972536|NCT01672866|59046654|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
30972537|NCT01672866|59046655|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
30972538|NCT01672866|59046653|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
30972539|NCT01672866|59046654|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
30972540|NCT01672866|59046655|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
30972541|NCT01672866|59046653|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
30972542|NCT01672866|59046654|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
30972543|NCT01672866|59046655|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
30972544|NCT01672866|59046653|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
30972545|NCT01672866|59046654|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
30972546|NCT01672866|59046655|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
30972547|NCT01672866|59046653|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
30972548|NCT01672866|59046654|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
30972549|NCT01672866|59046655|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
30972550|NCT01672866|59046653|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
30972551|NCT01672866|59046654|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
30972552|NCT01672866|59046655|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
30972553|NCT01672866|59046653|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
30972554|NCT01672866|59046654|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
30972555|NCT01672866|59046655|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
30972556|NCT01672866|59046653|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
30972557|NCT01672866|59046654|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
30972558|NCT01672866|59046655|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
30972559|NCT01672866|59046653|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
30972560|NCT01672866|59046654|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
30972561|NCT01672866|59046655|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
30972562|NCT01672866|59046653|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
30972563|NCT01672866|59046654|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
30972564|NCT01672866|59046655|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
30972565|NCT01672866|59046653|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
30972566|NCT01672866|59046654|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
30972567|NCT01672866|59046655|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
30972568|NCT01672866|59046653|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
30972569|NCT01672866|59046654|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
30972570|NCT01672866|59046655|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
30972571|NCT01672866|59046653|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
30972572|NCT01672866|59046654|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
30972573|NCT01672866|59046655|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
30972574|NCT04465877|59046881|FG000|Overall Study|Noncompliant with study requirements|0|||
30972575|NCT04465877|59046882|FG001|Overall Study|Noncompliant with study requirements|0|||
30972576|NCT04465877|59046883|FG002|Overall Study|Noncompliant with study requirements|1|||
30972577|NCT04465877|59046884|FG003|Overall Study|Noncompliant with study requirements|0|||
30972578|NCT04267133|59046941|FG000|Overall Study|Withdrawal by Subject|1|||
30972579|NCT04267133|59046941|FG000|Overall Study|Adverse Event|4|||
30972580|NCT02631876|59047072|FG000|Overall Study|Death|96|||
30972581|NCT02631876|59047073|FG001|Overall Study|Death|50|||
30972582|NCT02631876|59047072|FG000|Overall Study|Investigator's discretion|1|||
30972583|NCT02631876|59047073|FG001|Overall Study|Investigator's discretion|0|||
30972584|NCT02631876|59047072|FG000|Overall Study|Lost to Follow-up|2|||
30972585|NCT02631876|59047073|FG001|Overall Study|Lost to Follow-up|0|||
30972586|NCT02631876|59047072|FG000|Overall Study|Withdrawal by Subject|16|||
30972587|NCT02631876|59047073|FG001|Overall Study|Withdrawal by Subject|9|||
30972588|NCT02631876|59047072|FG000|Overall Study|Other than specified|4|||
30972589|NCT02631876|59047073|FG001|Overall Study|Other than specified|4|||
30972590|NCT02633046|59047102|FG000|Overall Study|Adverse Event|8|||
30972591|NCT02633046|59047102|FG000|Overall Study|Physician Decision|7|||
30972592|NCT02633046|59047102|FG000|Overall Study|Withdrawal by Subject|8|||
30972593|NCT02633046|59047102|FG000|Overall Study|Increased proteinuria|2|||
30972594|NCT02633046|59047102|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
30972595|NCT02633046|59047102|FG000|Overall Study|Mutual decision patient and physician|1|||
30972596|NCT01672788|59047161|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
30972597|NCT01672788|59047162|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
30972598|NCT01672788|59047163|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
30972599|NCT01672788|59047164|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
30972600|NCT02632110|59047179|FG000|Overall Study|Withdrawal by Subject|1|||
30972601|NCT02632110|59047180|FG001|Overall Study|Withdrawal by Subject|1|||
30972602|NCT02632110|59047181|FG002|Overall Study|Withdrawal by Subject|0|||
30972603|NCT02632110|59047182|FG003|Overall Study|Withdrawal by Subject|0|||
30972604|NCT02632110|59047183|FG004|Overall Study|Withdrawal by Subject|1|||
30972605|NCT02632110|59047184|FG005|Overall Study|Withdrawal by Subject|1|||
30972606|NCT02632110|59047185|FG006|Overall Study|Withdrawal by Subject|3|||
30972607|NCT02632110|59047186|FG007|Overall Study|Withdrawal by Subject|3|||
30972608|NCT02632110|59047187|FG008|Overall Study|Withdrawal by Subject|1|||
30972609|NCT02632110|59047188|FG009|Overall Study|Withdrawal by Subject|1|||
30972610|NCT01672710|59047430|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
30972611|NCT01672710|59047431|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
30972612|NCT01672710|59047430|FG000|3 Month Follow up|Lost to Follow-up|2|||
30972613|NCT01672710|59047431|FG001|3 Month Follow up|Lost to Follow-up|3|||
30972614|NCT01672710|59047430|FG000|3 Month Follow up|follow up due after termination date|4|||
30972615|NCT01672710|59047431|FG001|3 Month Follow up|follow up due after termination date|1|||
30880371|NCT01668797|58912376|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
30880372|NCT01668797|58912377|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
30880373|NCT01668797|58912378|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
30880374|NCT01668797|58912379|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
30880375|NCT01668797|58912376|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
30880376|NCT01668797|58912377|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
30880377|NCT01668797|58912378|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
30972616|NCT02630472|59047466|FG000|Overall Study|Physician Decision|10|||
30972617|NCT02630472|59047467|FG001|Overall Study|Physician Decision|0|||
30972618|NCT01670526|59047503|FG000|Overall Study|Withdrawal by Subject|3|||
30972619|NCT01670526|59047504|FG001|Overall Study|Withdrawal by Subject|1|||
30972620|NCT01670526|59047503|FG000|Overall Study|Lost to Follow-up|9|||
30972621|NCT01670526|59047504|FG001|Overall Study|Lost to Follow-up|5|||
30972622|NCT02630706|59047548|FG000|Overall Study|Adverse Event|2|||
30972623|NCT02630706|59047549|FG001|Overall Study|Adverse Event|1|||
30972624|NCT02630706|59047550|FG002|Overall Study|Adverse Event|1|||
30972625|NCT02630706|59047548|FG000|Overall Study|Lost to Follow-up|0|||
30972626|NCT02630706|59047549|FG001|Overall Study|Lost to Follow-up|1|||
30972627|NCT02630706|59047550|FG002|Overall Study|Lost to Follow-up|2|||
30972628|NCT02630706|59047548|FG000|Overall Study|Physician Decision|1|||
30972629|NCT02630706|59047549|FG001|Overall Study|Physician Decision|1|||
30972630|NCT02630706|59047550|FG002|Overall Study|Physician Decision|0|||
30972631|NCT02630706|59047548|FG000|Overall Study|Pregnancy|0|||
30972632|NCT02630706|59047549|FG001|Overall Study|Pregnancy|1|||
30972633|NCT02630706|59047550|FG002|Overall Study|Pregnancy|0|||
30972634|NCT02630706|59047548|FG000|Overall Study|Withdrawal by Subject|4|||
30972635|NCT02630706|59047549|FG001|Overall Study|Withdrawal by Subject|5|||
30972636|NCT02630706|59047550|FG002|Overall Study|Withdrawal by Subject|7|||
30972637|NCT02089997|59047727|FG000|Overall Study|Case report forms uncollected|99|||
30972638|NCT02089997|59047727|FG000|Overall Study|Protocol Violation|147|||
30972639|NCT01363661|59047733|FG000|Overall Study|Adverse Event|9|||
30972640|NCT01363661|59047734|FG001|Overall Study|Adverse Event|2|||
30972641|NCT01363661|59047733|FG000|Overall Study|Withdrawal by Subject|1|||
30972642|NCT01363661|59047734|FG001|Overall Study|Withdrawal by Subject|1|||
30972643|NCT01363661|59047733|FG000|Overall Study|Protocol Violation|1|||
30972644|NCT01363661|59047734|FG001|Overall Study|Protocol Violation|0|||
30972645|NCT01363661|59047733|FG000|Overall Study|Lost to Follow-up|3|||
30972646|NCT01363661|59047734|FG001|Overall Study|Lost to Follow-up|1|||
30972647|NCT02628600|59047742|FG000|Overall Study|Death|2|||
30972648|NCT02628600|59047743|FG001|Overall Study|Death|1|||
30972649|NCT02628600|59047742|FG000|Overall Study|Adverse Event|3|||
30972650|NCT02628600|59047743|FG001|Overall Study|Adverse Event|20|||
30972651|NCT02628600|59047742|FG000|Overall Study|Protocol Violation|0|||
30972652|NCT02628600|59047743|FG001|Overall Study|Protocol Violation|1|||
30972653|NCT02628600|59047742|FG000|Overall Study|Lack of Efficacy|2|||
30972654|NCT02628600|59047743|FG001|Overall Study|Lack of Efficacy|0|||
30972655|NCT02628600|59047742|FG000|Overall Study|Withdrawal by Subject|13|||
30972656|NCT02628600|59047743|FG001|Overall Study|Withdrawal by Subject|8|||
30972657|NCT02628600|59047742|FG000|Overall Study|Lost to Follow-up|1|||
30972658|NCT02628600|59047743|FG001|Overall Study|Lost to Follow-up|0|||
30972659|NCT02628600|59047742|FG000|Overall Study|Physician Decision|2|||
30972660|NCT02628600|59047743|FG001|Overall Study|Physician Decision|2|||
30972661|NCT02628600|59047742|FG000|Overall Study|Other not specified|1|||
30972662|NCT02628600|59047743|FG001|Overall Study|Other not specified|0|||
30972663|NCT00591318|59047760|FG000|Overall Study|Lack of Efficacy|2|||
30972664|NCT00591318|59047761|FG001|Overall Study|Lack of Efficacy|0|||
30972665|NCT00591318|59047760|FG000|Overall Study|Adverse Event|2|||
30972666|NCT00591318|59047761|FG001|Overall Study|Adverse Event|0|||
30972667|NCT01360632|59047774|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
30972668|NCT01360632|59047775|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
30972669|NCT01360632|59047776|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
30972670|NCT01360632|59047777|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
30972671|NCT01360632|59047778|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
30972672|NCT01360632|59047774|FG000|Phase A (8 Weeks)|Adverse Event|60|||
30972673|NCT01360632|59047775|FG001|Phase A (8 Weeks)|Adverse Event|0|||
30972674|NCT01360632|59047776|FG002|Phase A (8 Weeks)|Adverse Event|0|||
30972675|NCT01360632|59047777|FG003|Phase A (8 Weeks)|Adverse Event|0|||
30972676|NCT01360632|59047778|FG004|Phase A (8 Weeks)|Adverse Event|0|||
30972677|NCT01360632|59047774|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
30972678|NCT01360632|59047775|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
30972679|NCT01360632|59047776|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
30972680|NCT01360632|59047777|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
30972681|NCT01360632|59047778|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
30972682|NCT01360632|59047774|FG000|Phase A (8 Weeks)|Physician Decision|10|||
30972683|NCT01360632|59047775|FG001|Phase A (8 Weeks)|Physician Decision|0|||
30972684|NCT01360632|59047776|FG002|Phase A (8 Weeks)|Physician Decision|0|||
30972685|NCT01360632|59047777|FG003|Phase A (8 Weeks)|Physician Decision|0|||
30972686|NCT01360632|59047778|FG004|Phase A (8 Weeks)|Physician Decision|0|||
30972687|NCT01360632|59047774|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
30972688|NCT01360632|59047775|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
30972689|NCT01360632|59047776|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
30972690|NCT01360632|59047777|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
30972691|NCT01360632|59047778|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
30972692|NCT01360632|59047774|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
30608407|NCT01288430|58619226|FG005|Part 1|Death due to disease progression|0|||
30972693|NCT01360632|59047775|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
30972694|NCT01360632|59047776|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
30972695|NCT01360632|59047777|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
30972696|NCT01360632|59047778|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
30972697|NCT01360632|59047774|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
30972698|NCT01360632|59047775|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
30972699|NCT01360632|59047776|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
30972700|NCT01360632|59047777|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
30972701|NCT01360632|59047778|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
30972702|NCT01360632|59047774|FG000|Phase B (6 Weeks)|Adverse Event|0|||
30972703|NCT01360632|59047775|FG001|Phase B (6 Weeks)|Adverse Event|3|||
30972704|NCT01360632|59047776|FG002|Phase B (6 Weeks)|Adverse Event|9|||
30972705|NCT01360632|59047777|FG003|Phase B (6 Weeks)|Adverse Event|3|||
30972706|NCT01360632|59047778|FG004|Phase B (6 Weeks)|Adverse Event|0|||
30972707|NCT01360632|59047774|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
30972708|NCT01360632|59047775|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
30972709|NCT01360632|59047776|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
30972710|NCT01360632|59047777|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
30972711|NCT01360632|59047778|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
30972712|NCT01360632|59047774|FG000|Phase B (6 Weeks)|Physician Decision|0|||
30972713|NCT01360632|59047775|FG001|Phase B (6 Weeks)|Physician Decision|0|||
30972714|NCT01360632|59047776|FG002|Phase B (6 Weeks)|Physician Decision|0|||
30972715|NCT01360632|59047777|FG003|Phase B (6 Weeks)|Physician Decision|1|||
30972716|NCT01360632|59047778|FG004|Phase B (6 Weeks)|Physician Decision|0|||
30972717|NCT01360632|59047774|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
30972718|NCT01360632|59047775|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
30972719|NCT01360632|59047776|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
30972720|NCT01360632|59047777|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
30972721|NCT01360632|59047778|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
30972722|NCT01360632|59047774|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
30972723|NCT01360632|59047775|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
30972724|NCT01360632|59047776|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
30972725|NCT01360632|59047777|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
30972726|NCT01360632|59047778|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
30972727|NCT01360632|59047774|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
30972728|NCT01360632|59047775|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
30972729|NCT01360632|59047776|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
30972730|NCT01360632|59047777|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
30972731|NCT01360632|59047778|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
30972732|NCT01360632|59047774|FG000|Phase A+|Lost to Follow-up|0|||
30972733|NCT01360632|59047775|FG001|Phase A+|Lost to Follow-up|0|||
30972734|NCT01360632|59047776|FG002|Phase A+|Lost to Follow-up|0|||
30972735|NCT01360632|59047777|FG003|Phase A+|Lost to Follow-up|0|||
30972736|NCT01360632|59047778|FG004|Phase A+|Lost to Follow-up|2|||
30972737|NCT01360632|59047774|FG000|Phase A+|Adverse Event|0|||
30972738|NCT01360632|59047775|FG001|Phase A+|Adverse Event|0|||
30972739|NCT01360632|59047776|FG002|Phase A+|Adverse Event|0|||
30972740|NCT01360632|59047777|FG003|Phase A+|Adverse Event|0|||
30972741|NCT01360632|59047778|FG004|Phase A+|Adverse Event|2|||
30972742|NCT01360632|59047774|FG000|Phase A+|Met Withdrawal Criteria|0|||
30972743|NCT01360632|59047775|FG001|Phase A+|Met Withdrawal Criteria|0|||
30972744|NCT01360632|59047776|FG002|Phase A+|Met Withdrawal Criteria|0|||
30972745|NCT01360632|59047777|FG003|Phase A+|Met Withdrawal Criteria|0|||
30972746|NCT01360632|59047778|FG004|Phase A+|Met Withdrawal Criteria|7|||
30972747|NCT01360632|59047774|FG000|Phase A+|Physician Decision|0|||
30972748|NCT01360632|59047775|FG001|Phase A+|Physician Decision|0|||
30972749|NCT01360632|59047776|FG002|Phase A+|Physician Decision|0|||
30972750|NCT01360632|59047777|FG003|Phase A+|Physician Decision|0|||
30972751|NCT01360632|59047778|FG004|Phase A+|Physician Decision|3|||
30972752|NCT01360632|59047774|FG000|Phase A+|Withdrawal by Subject|0|||
30972753|NCT01360632|59047775|FG001|Phase A+|Withdrawal by Subject|0|||
30972754|NCT01360632|59047776|FG002|Phase A+|Withdrawal by Subject|0|||
30972755|NCT01360632|59047777|FG003|Phase A+|Withdrawal by Subject|0|||
30972756|NCT01360632|59047778|FG004|Phase A+|Withdrawal by Subject|8|||
30972757|NCT01360632|59047774|FG000|Phase A+|Protocol Deviation|0|||
30972758|NCT01360632|59047775|FG001|Phase A+|Protocol Deviation|0|||
30972759|NCT01360632|59047776|FG002|Phase A+|Protocol Deviation|0|||
30972760|NCT01360632|59047777|FG003|Phase A+|Protocol Deviation|0|||
30972761|NCT01360632|59047778|FG004|Phase A+|Protocol Deviation|3|||
30972762|NCT04157400|59047824|FG000|Overall Study|Withdrawal by Subject|1|||
30972763|NCT04157400|59047824|FG000|Overall Study|Lost to Follow-up|3|||
30972764|NCT02626182|59047898|FG000|Overall Study|Adverse Event|2|||
30972765|NCT02626182|59047899|FG001|Overall Study|Adverse Event|0|||
30608408|NCT01288430|58619227|FG006|Part 1|Death due to disease progression|0|||
30972766|NCT01669902|59048006|FG000|Overall Study|Adverse Event|11|||
30972767|NCT01669902|59048006|FG000|Overall Study|Lack of Efficacy|10|||
30972768|NCT01669902|59048006|FG000|Overall Study|Other|8|||
30972769|NCT01670292|59048039|FG000|Overall Study|Lost to Follow-up|14|||
30972770|NCT01360554|59048276|FG000|Overall Study|Death|359|||
30972771|NCT01360554|59048277|FG001|Overall Study|Death|371|||
30972772|NCT01360554|59048276|FG000|Overall Study|Lost to Follow-up|4|||
30972773|NCT01360554|59048277|FG001|Overall Study|Lost to Follow-up|4|||
30972774|NCT01360554|59048276|FG000|Overall Study|Withdrawal by Subject|23|||
30972775|NCT01360554|59048277|FG001|Overall Study|Withdrawal by Subject|24|||
30972776|NCT01360554|59048276|FG000|Overall Study|Study terminated by sponsor|49|||
30972777|NCT01360554|59048277|FG001|Overall Study|Study terminated by sponsor|37|||
30972778|NCT01360554|59048276|FG000|Overall Study|Other, not specified|1|||
30972779|NCT01360554|59048277|FG001|Overall Study|Other, not specified|0|||
30972780|NCT01360554|59048276|FG000|Overall Study|Randomized but not treated.|3|||
30972781|NCT01360554|59048277|FG001|Overall Study|Randomized but not treated.|3|||
30972782|NCT01360398|59048299|FG000|Overall Study|Withdrawal by Subject|14|||
30972783|NCT01360398|59048299|FG000|Overall Study|Other|7|||
30972784|NCT01360398|59048299|FG000|Overall Study|Migrated/moved from study area|1|||
30972785|NCT02626026|59048309|FG000|Overall Study|Randomized but Never Treated|0|||
30972786|NCT02626026|59048310|FG001|Overall Study|Randomized but Never Treated|0|||
30972787|NCT02626026|59048311|FG002|Overall Study|Randomized but Never Treated|0|||
30972788|NCT02626026|59048312|FG003|Overall Study|Randomized but Never Treated|0|||
30972789|NCT02626026|59048313|FG004|Overall Study|Randomized but Never Treated|1|||
30972790|NCT02626026|59048314|FG005|Overall Study|Randomized but Never Treated|0|||
30972791|NCT01765296|59048574|FG000|Overall Study|Protocol Violation|0|||
30972792|NCT01765296|59048575|FG001|Overall Study|Protocol Violation|5|||
30972793|NCT01765296|59048576|FG002|Overall Study|Protocol Violation|4|||
30972794|NCT01765296|59048574|FG000|Overall Study|Withdrawal by Subject|4|||
30972795|NCT01765296|59048575|FG001|Overall Study|Withdrawal by Subject|2|||
30972796|NCT01765296|59048576|FG002|Overall Study|Withdrawal by Subject|2|||
30972797|NCT01765296|59048574|FG000|Overall Study|Adverse Event|1|||
30972798|NCT01765296|59048575|FG001|Overall Study|Adverse Event|13|||
30972799|NCT01765296|59048576|FG002|Overall Study|Adverse Event|5|||
30972800|NCT01765296|59048574|FG000|Overall Study|Lack of Efficacy|0|||
30972801|NCT01765296|59048575|FG001|Overall Study|Lack of Efficacy|0|||
30972802|NCT01765296|59048576|FG002|Overall Study|Lack of Efficacy|2|||
30972803|NCT02089685|59048650|FG000|Overall Study|Adverse Event|1|||
30972804|NCT02089685|59048651|FG001|Overall Study|Adverse Event|0|||
30972805|NCT02089685|59048652|FG002|Overall Study|Adverse Event|0|||
30972806|NCT02089685|59048653|FG003|Overall Study|Adverse Event|0|||
30972807|NCT02089685|59048654|FG004|Overall Study|Adverse Event|1|||
30972808|NCT02089685|59048655|FG005|Overall Study|Adverse Event|0|||
30972809|NCT02089685|59048650|FG000|Overall Study|Clinical Progression|4|||
30972810|NCT02089685|59048651|FG001|Overall Study|Clinical Progression|0|||
30972811|NCT02089685|59048652|FG002|Overall Study|Clinical Progression|0|||
30972812|NCT02089685|59048653|FG003|Overall Study|Clinical Progression|5|||
30972813|NCT02089685|59048654|FG004|Overall Study|Clinical Progression|1|||
30972814|NCT02089685|59048655|FG005|Overall Study|Clinical Progression|2|||
30972815|NCT02089685|59048650|FG000|Overall Study|Excluded Medication|1|||
30972816|NCT02089685|59048651|FG001|Overall Study|Excluded Medication|0|||
30972817|NCT02089685|59048652|FG002|Overall Study|Excluded Medication|0|||
30972818|NCT02089685|59048653|FG003|Overall Study|Excluded Medication|11|||
30972819|NCT02089685|59048654|FG004|Overall Study|Excluded Medication|2|||
30972820|NCT02089685|59048655|FG005|Overall Study|Excluded Medication|1|||
30972821|NCT02089685|59048650|FG000|Overall Study|Progressive disease|13|||
30972822|NCT02089685|59048651|FG001|Overall Study|Progressive disease|10|||
30972823|NCT02089685|59048652|FG002|Overall Study|Progressive disease|3|||
30972824|NCT02089685|59048653|FG003|Overall Study|Progressive disease|51|||
30972825|NCT02089685|59048654|FG004|Overall Study|Progressive disease|17|||
30972826|NCT02089685|59048655|FG005|Overall Study|Progressive disease|12|||
30972827|NCT02089685|59048650|FG000|Overall Study|Follow up ended by sponsor|2|||
30972828|NCT02089685|59048651|FG001|Overall Study|Follow up ended by sponsor|2|||
30972829|NCT02089685|59048652|FG002|Overall Study|Follow up ended by sponsor|0|||
30972830|NCT02089685|59048653|FG003|Overall Study|Follow up ended by sponsor|70|||
30972831|NCT02089685|59048654|FG004|Overall Study|Follow up ended by sponsor|26|||
30972832|NCT02089685|59048655|FG005|Overall Study|Follow up ended by sponsor|26|||
30972833|NCT02089685|59048650|FG000|Overall Study|Withdrawal by Subject|0|||
30972834|NCT02089685|59048651|FG001|Overall Study|Withdrawal by Subject|2|||
30972835|NCT02089685|59048652|FG002|Overall Study|Withdrawal by Subject|0|||
30972836|NCT02089685|59048653|FG003|Overall Study|Withdrawal by Subject|8|||
30972837|NCT02089685|59048654|FG004|Overall Study|Withdrawal by Subject|1|||
30972838|NCT02089685|59048655|FG005|Overall Study|Withdrawal by Subject|1|||
30972839|NCT02089685|59048650|FG000|Overall Study|Status not recorded|1|||
30972840|NCT02089685|59048651|FG001|Overall Study|Status not recorded|0|||
30972841|NCT02089685|59048652|FG002|Overall Study|Status not recorded|0|||
30972842|NCT02089685|59048653|FG003|Overall Study|Status not recorded|0|||
30972843|NCT02089685|59048654|FG004|Overall Study|Status not recorded|1|||
30972844|NCT02089685|59048655|FG005|Overall Study|Status not recorded|0|||
30972845|NCT02089685|59048650|FG000|Overall Study|Death|0|||
30972846|NCT02089685|59048651|FG001|Overall Study|Death|0|||
30972847|NCT02089685|59048652|FG002|Overall Study|Death|0|||
30972848|NCT02089685|59048653|FG003|Overall Study|Death|7|||
30972849|NCT02089685|59048654|FG004|Overall Study|Death|2|||
30972850|NCT02089685|59048655|FG005|Overall Study|Death|5|||
30972851|NCT02089685|59048650|FG000|Overall Study|Lost to Follow-up|0|||
30972852|NCT02089685|59048651|FG001|Overall Study|Lost to Follow-up|0|||
30972853|NCT02089685|59048652|FG002|Overall Study|Lost to Follow-up|0|||
30972854|NCT02089685|59048653|FG003|Overall Study|Lost to Follow-up|1|||
30972855|NCT02089685|59048654|FG004|Overall Study|Lost to Follow-up|0|||
30972856|NCT02089685|59048655|FG005|Overall Study|Lost to Follow-up|0|||
30972857|NCT02089685|59048650|FG000|Overall Study|Physician Decision|0|||
30972858|NCT02089685|59048651|FG001|Overall Study|Physician Decision|0|||
30972859|NCT02089685|59048652|FG002|Overall Study|Physician Decision|0|||
30972860|NCT02089685|59048653|FG003|Overall Study|Physician Decision|0|||
30972861|NCT02089685|59048654|FG004|Overall Study|Physician Decision|0|||
30972862|NCT02089685|59048655|FG005|Overall Study|Physician Decision|4|||
30972863|NCT02089685|59048650|FG000|Overall Study|Screen failure|1|||
30972864|NCT02089685|59048651|FG001|Overall Study|Screen failure|0|||
30972865|NCT02089685|59048652|FG002|Overall Study|Screen failure|0|||
30972866|NCT02089685|59048653|FG003|Overall Study|Screen failure|0|||
30972867|NCT02089685|59048654|FG004|Overall Study|Screen failure|0|||
30972868|NCT02089685|59048655|FG005|Overall Study|Screen failure|0|||
30972869|NCT05282004|59048713|FG000|Overall Study|Adverse Event|2|||
30972870|NCT05004649|59048717|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
30972871|NCT05004649|59048717|FG000|Overall Study|Lost to Follow-up|1|||
30972872|NCT05004649|59048717|FG000|Overall Study|Withdrawal by Subject|2|||
30972873|NCT05004649|59048717|FG000|Overall Study|COVID-19|1|||
30972874|NCT04666298|59048727|FG000|Overall Study|Subject decision|1|||
30972875|NCT04666298|59048728|FG001|Overall Study|Subject decision|0|||
30972876|NCT04666298|59048729|FG002|Overall Study|Subject decision|0|||
30972877|NCT04666298|59048730|FG003|Overall Study|Subject decision|2|||
30972878|NCT04666298|59048727|FG000|Overall Study|Death|1|||
30972879|NCT04666298|59048728|FG001|Overall Study|Death|0|||
30972880|NCT04666298|59048729|FG002|Overall Study|Death|0|||
30972881|NCT04666298|59048730|FG003|Overall Study|Death|0|||
30972882|NCT04666298|59048727|FG000|Overall Study|Lost to Follow-up|0|||
30972883|NCT04666298|59048728|FG001|Overall Study|Lost to Follow-up|0|||
30972884|NCT04666298|59048729|FG002|Overall Study|Lost to Follow-up|0|||
30972885|NCT04666298|59048730|FG003|Overall Study|Lost to Follow-up|1|||
30972886|NCT04666298|59048727|FG000|Overall Study|Physician Decision|0|||
30972887|NCT04666298|59048728|FG001|Overall Study|Physician Decision|0|||
30972888|NCT04666298|59048729|FG002|Overall Study|Physician Decision|0|||
30972889|NCT04666298|59048730|FG003|Overall Study|Physician Decision|1|||
30972890|NCT04666298|59048727|FG000|Overall Study|Protocol deviation|0|||
30972891|NCT04666298|59048728|FG001|Overall Study|Protocol deviation|0|||
30972892|NCT04666298|59048729|FG002|Overall Study|Protocol deviation|1|||
30972893|NCT04666298|59048730|FG003|Overall Study|Protocol deviation|0|||
30972894|NCT04581200|59048742|FG000|Overall Study|Lost to Follow-up|6|||
30972895|NCT04581200|59048743|FG001|Overall Study|Lost to Follow-up|5|||
30972896|NCT04303780|59048778|FG000|Overall Study|Death|104|||
30972897|NCT04303780|59048779|FG001|Overall Study|Death|85|||
30972898|NCT04303780|59048778|FG000|Overall Study|Lost to Follow-up|5|||
30972899|NCT04303780|59048779|FG001|Overall Study|Lost to Follow-up|2|||
30972900|NCT04303780|59048778|FG000|Overall Study|Withdrawal by Subject|12|||
30972901|NCT04303780|59048779|FG001|Overall Study|Withdrawal by Subject|39|||
30972902|NCT04303780|59048778|FG000|Overall Study|Ongoing in study|50|||
30972903|NCT04303780|59048779|FG001|Overall Study|Ongoing in study|45|||
30972904|NCT04188301|59048789|FG000|Month 3|Lost to Follow-up|0|||
30972905|NCT04188301|59048790|FG001|Month 3|Lost to Follow-up|0|||
30972906|NCT04188301|59048791|FG002|Month 3|Lost to Follow-up|1|||
30972907|NCT04188301|59048789|FG000|Month 12|Lost to Follow-up|0|||
30972908|NCT04188301|59048790|FG001|Month 12|Lost to Follow-up|0|||
30972909|NCT04188301|59048791|FG002|Month 12|Lost to Follow-up|2|||
30972910|NCT04188301|59048789|FG000|Month 12|Death|1|||
30972911|NCT04188301|59048790|FG001|Month 12|Death|1|||
30972912|NCT04188301|59048791|FG002|Month 12|Death|0|||
30972913|NCT04188301|59048789|FG000|Month 18|Lost to Follow-up|6|||
30972914|NCT04188301|59048790|FG001|Month 18|Lost to Follow-up|0|||
30972915|NCT04188301|59048791|FG002|Month 18|Lost to Follow-up|0|||
30972916|NCT04006925|59048801|FG000|Overall Study|Side effects|2|||
30972917|NCT04006925|59048802|FG001|Overall Study|Side effects|0|||
30972918|NCT03599713|59048814|FG000|Overall Study|Death|26|||
30972919|NCT03599713|59048815|FG001|Overall Study|Death|3|||
30972920|NCT03599713|59048814|FG000|Overall Study|Withdrawal by Subject|6|||
30972921|NCT03599713|59048815|FG001|Overall Study|Withdrawal by Subject|0|||
30972922|NCT03599713|59048814|FG000|Overall Study|Ongoing|69|||
30972923|NCT03599713|59048815|FG001|Overall Study|Ongoing|3|||
30972924|NCT03597061|59048825|FG000|Overall Study|Lost to Follow-up|1|||
30972925|NCT03597061|59048826|FG001|Overall Study|Lost to Follow-up|0|||
30972926|NCT03597061|59048825|FG000|Overall Study|Protocol Violation|0|||
30972927|NCT03597061|59048826|FG001|Overall Study|Protocol Violation|1|||
30972928|NCT03148795|59048854|FG000|Overall Study|Death|6|||
30972929|NCT03148795|59048854|FG000|Overall Study|Adverse Event|5|||
30972930|NCT03148795|59048854|FG000|Overall Study|Other|15|||
30972931|NCT03148795|59048854|FG000|Overall Study|No Longer Clinically Benefitting|2|||
30972932|NCT03148795|59048854|FG000|Overall Study|Global Deterioration Of Health Status|6|||
30972933|NCT03148795|59048854|FG000|Overall Study|Withdrawal by Subject|2|||
30972934|NCT03148795|59048854|FG000|Overall Study|Progressive Disease|62|||
30972935|NCT03148795|59048854|FG000|Overall Study|Ongoing|30|||
30972936|NCT03146845|59048860|FG000|Overall Study|Reference ulcer healed|1|||
30972937|NCT03146845|59048861|FG001|Overall Study|Reference ulcer healed|0|||
30972938|NCT03146845|59048860|FG000|Overall Study|Physician Decision|1|||
30972939|NCT03146845|59048861|FG001|Overall Study|Physician Decision|0|||
30972940|NCT03146845|59048860|FG000|Overall Study|Adverse Event|1|||
30972941|NCT03146845|59048861|FG001|Overall Study|Adverse Event|0|||
30972942|NCT03146845|59048860|FG000|Overall Study|Withdrawal by Subject|2|||
30972943|NCT03146845|59048861|FG001|Overall Study|Withdrawal by Subject|0|||
30972944|NCT03146845|59048860|FG000|Overall Study|Noncompliance|0|||
30972945|NCT03146845|59048861|FG001|Overall Study|Noncompliance|1|||
30972946|NCT03146845|59048860|FG000|Overall Study|Protocol Violation|0|||
30972947|NCT03146845|59048861|FG001|Overall Study|Protocol Violation|2|||
30972948|NCT03146845|59048860|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
30972949|NCT03146845|59048861|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
30972950|NCT02975700|59048867|FG000|Overall Study|Adverse Event|1|||
30972951|NCT02975700|59048867|FG000|Overall Study|Progressive disease|3|||
30972952|NCT02975700|59048867|FG000|Overall Study|Failed screening criteria|2|||
30972953|NCT02895360|59048877|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
30972954|NCT02895360|59048878|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
30972955|NCT02895360|59048879|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
30972956|NCT02895360|59048880|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
30972957|NCT02895360|59048881|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
30972958|NCT02895360|59048882|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
30972959|NCT02895360|59048877|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
30972960|NCT02895360|59048878|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
30972961|NCT02895360|59048879|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
30972962|NCT02895360|59048880|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
30972963|NCT02895360|59048881|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
30972964|NCT02895360|59048882|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
30972965|NCT02895360|59048877|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
30972966|NCT02895360|59048878|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
30972967|NCT02895360|59048879|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
30972968|NCT02895360|59048880|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
30972969|NCT02895360|59048881|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
30972970|NCT02895360|59048882|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
30972971|NCT02895360|59048877|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
30972972|NCT02895360|59048878|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
30972973|NCT02895360|59048879|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
30972974|NCT02895360|59048880|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
30972975|NCT02895360|59048881|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
30972976|NCT02895360|59048882|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
30972977|NCT02895360|59048877|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
30972978|NCT02895360|59048878|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
30972979|NCT02895360|59048879|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
30972980|NCT02895360|59048880|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
30972981|NCT02895360|59048881|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
30972982|NCT02895360|59048882|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
30972983|NCT02895360|59048877|FG000|Phase 2a|Adverse Event|0|||
30972984|NCT02895360|59048878|FG001|Phase 2a|Adverse Event|0|||
30972985|NCT02895360|59048879|FG002|Phase 2a|Adverse Event|0|||
30972986|NCT02895360|59048880|FG003|Phase 2a|Adverse Event|0|||
30972987|NCT02895360|59048881|FG004|Phase 2a|Adverse Event|0|||
30972988|NCT02895360|59048882|FG005|Phase 2a|Adverse Event|1|||
30972989|NCT02895360|59048877|FG000|Phase 2a|Progressive disease|0|||
30972990|NCT02895360|59048878|FG001|Phase 2a|Progressive disease|0|||
30972991|NCT02895360|59048879|FG002|Phase 2a|Progressive disease|0|||
30972992|NCT02895360|59048880|FG003|Phase 2a|Progressive disease|0|||
30972993|NCT02895360|59048881|FG004|Phase 2a|Progressive disease|11|||
30972994|NCT02895360|59048882|FG005|Phase 2a|Progressive disease|11|||
30972995|NCT02863809|59048916|FG000|Overall Study|Adverse Event|8|||
30972996|NCT02863809|59048917|FG001|Overall Study|Adverse Event|8|||
30972997|NCT02863809|59048916|FG000|Overall Study|Withdrawal by Subject|0|||
30972998|NCT02863809|59048917|FG001|Overall Study|Withdrawal by Subject|1|||
30880378|NCT01668797|58912379|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
30880379|NCT01668797|58912376|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
30880380|NCT01668797|58912377|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
30880381|NCT01668797|58912378|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
30972999|NCT02863809|59048916|FG000|Overall Study|Lost to Follow-up|1|||
30973000|NCT02863809|59048917|FG001|Overall Study|Lost to Follow-up|1|||
30973001|NCT02863809|59048916|FG000|Overall Study|Death|1|||
30973002|NCT02863809|59048917|FG001|Overall Study|Death|0|||
30973003|NCT02829957|59048925|FG000|Overall Study|Lost to Follow-up|2|||
30973004|NCT02829957|59048926|FG001|Overall Study|Lost to Follow-up|1|||
30973005|NCT02753530|59048950|FG000|Overall Study|Adverse Event|7|||
30973006|NCT02753530|59048951|FG001|Overall Study|Adverse Event|1|||
30973007|NCT02753530|59048950|FG000|Overall Study|Death|0|||
30973008|NCT02753530|59048951|FG001|Overall Study|Death|1|||
30973009|NCT02753530|59048950|FG000|Overall Study|Physician Decision|0|||
30973010|NCT02753530|59048951|FG001|Overall Study|Physician Decision|1|||
30973011|NCT02753530|59048950|FG000|Overall Study|Protocol Violation|1|||
30973012|NCT02753530|59048951|FG001|Overall Study|Protocol Violation|0|||
30880382|NCT01668797|58912379|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
30880383|NCT01668797|58912376|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
30880384|NCT01668797|58912377|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
30880385|NCT01668797|58912378|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
30880386|NCT01668797|58912379|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
30880387|NCT01668797|58912376|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
30880388|NCT01668797|58912377|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
30880389|NCT01668797|58912378|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
30880390|NCT01668797|58912379|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
30880391|NCT01668797|58912376|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
30880392|NCT01668797|58912377|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
30880393|NCT01668797|58912378|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
30880394|NCT01668797|58912379|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
30880395|NCT01668797|58912376|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
30880396|NCT01668797|58912377|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
30880397|NCT01668797|58912378|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
30973013|NCT02753530|59048950|FG000|Overall Study|Withdrawal by Subject|4|||
30973014|NCT02753530|59048951|FG001|Overall Study|Withdrawal by Subject|3|||
30973015|NCT02289079|59048963|FG000|Overall Study|Physician Decision|2|||
30973016|NCT02289079|59048964|FG001|Overall Study|Physician Decision|0|||
30973017|NCT02289079|59048963|FG000|Overall Study|Lost to Follow-up|0|||
30973018|NCT02289079|59048964|FG001|Overall Study|Lost to Follow-up|1|||
30973019|NCT02095132|59049019|FG000|Overall Study|Adverse Event|0|||
30973020|NCT02095132|59049020|FG001|Overall Study|Adverse Event|0|||
30973021|NCT02095132|59049021|FG002|Overall Study|Adverse Event|0|||
30973022|NCT02095132|59049022|FG003|Overall Study|Adverse Event|0|||
30973023|NCT02095132|59049023|FG004|Overall Study|Adverse Event|1|||
30973024|NCT02095132|59049024|FG005|Overall Study|Adverse Event|0|||
30973025|NCT02095132|59049025|FG006|Overall Study|Adverse Event|1|||
30973026|NCT02095132|59049026|FG007|Overall Study|Adverse Event|0|||
30973027|NCT02095132|59049027|FG008|Overall Study|Adverse Event|0|||
30973028|NCT02095132|59049019|FG000|Overall Study|Death|0|||
30973029|NCT02095132|59049020|FG001|Overall Study|Death|0|||
30973030|NCT02095132|59049021|FG002|Overall Study|Death|0|||
30973031|NCT02095132|59049022|FG003|Overall Study|Death|0|||
30973032|NCT02095132|59049023|FG004|Overall Study|Death|0|||
30973033|NCT02095132|59049024|FG005|Overall Study|Death|0|||
30973034|NCT02095132|59049025|FG006|Overall Study|Death|1|||
30973035|NCT02095132|59049026|FG007|Overall Study|Death|0|||
30973036|NCT02095132|59049027|FG008|Overall Study|Death|0|||
30973037|NCT02095132|59049019|FG000|Overall Study|Lack of Efficacy|3|||
30973038|NCT02095132|59049020|FG001|Overall Study|Lack of Efficacy|5|||
30973039|NCT02095132|59049021|FG002|Overall Study|Lack of Efficacy|2|||
30973040|NCT02095132|59049022|FG003|Overall Study|Lack of Efficacy|8|||
30973041|NCT02095132|59049023|FG004|Overall Study|Lack of Efficacy|3|||
30973042|NCT02095132|59049024|FG005|Overall Study|Lack of Efficacy|6|||
30973043|NCT02095132|59049025|FG006|Overall Study|Lack of Efficacy|10|||
30973044|NCT02095132|59049026|FG007|Overall Study|Lack of Efficacy|9|||
30973045|NCT02095132|59049027|FG008|Overall Study|Lack of Efficacy|8|||
30973046|NCT02095132|59049019|FG000|Overall Study|Physician Decision|1|||
30973047|NCT02095132|59049020|FG001|Overall Study|Physician Decision|0|||
30973048|NCT02095132|59049021|FG002|Overall Study|Physician Decision|0|||
30973049|NCT02095132|59049022|FG003|Overall Study|Physician Decision|0|||
30973050|NCT02095132|59049023|FG004|Overall Study|Physician Decision|0|||
30973051|NCT02095132|59049024|FG005|Overall Study|Physician Decision|0|||
30973052|NCT02095132|59049025|FG006|Overall Study|Physician Decision|1|||
30973053|NCT02095132|59049026|FG007|Overall Study|Physician Decision|0|||
30973054|NCT02095132|59049027|FG008|Overall Study|Physician Decision|2|||
30973055|NCT02095132|59049019|FG000|Overall Study|Withdrawal by Subject|0|||
30973056|NCT02095132|59049020|FG001|Overall Study|Withdrawal by Subject|0|||
30973057|NCT02095132|59049021|FG002|Overall Study|Withdrawal by Subject|2|||
30973058|NCT02095132|59049022|FG003|Overall Study|Withdrawal by Subject|2|||
30973059|NCT02095132|59049023|FG004|Overall Study|Withdrawal by Subject|3|||
30973060|NCT02095132|59049024|FG005|Overall Study|Withdrawal by Subject|0|||
30880398|NCT01668797|58912379|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
30880399|NCT01668797|58912376|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
30973061|NCT02095132|59049025|FG006|Overall Study|Withdrawal by Subject|5|||
30973062|NCT02095132|59049026|FG007|Overall Study|Withdrawal by Subject|0|||
30973063|NCT02095132|59049027|FG008|Overall Study|Withdrawal by Subject|0|||
30973064|NCT00602667|59049087|FG000|Overall Study|Still on Therapy|0|||
30973065|NCT00602667|59049088|FG001|Overall Study|Still on Therapy|2|||
30973066|NCT00602667|59049089|FG002|Overall Study|Still on Therapy|2|||
30973067|NCT00602667|59049087|FG000|Overall Study|Death|0|||
30973068|NCT00602667|59049088|FG001|Overall Study|Death|1|||
30973069|NCT00602667|59049089|FG002|Overall Study|Death|1|||
30973070|NCT00602667|59049087|FG000|Overall Study|Family request|3|||
30973071|NCT00602667|59049088|FG001|Overall Study|Family request|25|||
30973072|NCT00602667|59049089|FG002|Overall Study|Family request|6|||
30973073|NCT00602667|59049087|FG000|Overall Study|Excessive toxicity|1|||
30973074|NCT00602667|59049088|FG001|Overall Study|Excessive toxicity|1|||
30973075|NCT00602667|59049089|FG002|Overall Study|Excessive toxicity|0|||
30973076|NCT00602667|59049087|FG000|Overall Study|Second malignancy|0|||
30973077|NCT00602667|59049088|FG001|Overall Study|Second malignancy|1|||
30973078|NCT00602667|59049089|FG002|Overall Study|Second malignancy|0|||
30973079|NCT00602667|59049087|FG000|Overall Study|Physician Decision|2|||
30973080|NCT00602667|59049088|FG001|Overall Study|Physician Decision|3|||
30973081|NCT00602667|59049089|FG002|Overall Study|Physician Decision|8|||
30973082|NCT00602667|59049087|FG000|Overall Study|Progressive disease|13|||
30973083|NCT00602667|59049088|FG001|Overall Study|Progressive disease|48|||
30973084|NCT00602667|59049089|FG002|Overall Study|Progressive disease|45|||
30973085|NCT00602667|59049087|FG000|Overall Study|Progressive disease prior to therapy|0|||
30973086|NCT00602667|59049088|FG001|Overall Study|Progressive disease prior to therapy|0|||
30973087|NCT00602667|59049089|FG002|Overall Study|Progressive disease prior to therapy|1|||
30973088|NCT02088905|59049132|FG000|Overall Study|Withdrawal by Subject|5|||
30973089|NCT02088905|59049133|FG001|Overall Study|Withdrawal by Subject|1|||
30973090|NCT02088047|59049141|FG000|Overall Study|Withdrawal by Subject|1|||
30973091|NCT02088047|59049142|FG001|Overall Study|Withdrawal by Subject|0|||
30973092|NCT02086565|59049168|FG000|Overall Study|Lost to Follow-up|9|||
30973093|NCT02086565|59049169|FG001|Overall Study|Lost to Follow-up|7|||
30973094|NCT02086565|59049168|FG000|Overall Study|Withdrawal by Subject|2|||
30973095|NCT02086565|59049169|FG001|Overall Study|Withdrawal by Subject|1|||
30973096|NCT02086565|59049168|FG000|Overall Study|Death|3|||
30973097|NCT02086565|59049169|FG001|Overall Study|Death|2|||
30973098|NCT02086565|59049168|FG000|Overall Study|withdrawn by research team|2|||
30973099|NCT02086565|59049169|FG001|Overall Study|withdrawn by research team|2|||
30973100|NCT02085941|59049177|FG000|Overall Study|Lack of Efficacy|1|||
30973101|NCT02085941|59049178|FG001|Overall Study|Lack of Efficacy|0|||
30973102|NCT02085941|59049177|FG000|Overall Study|Death|6|||
30973103|NCT02085941|59049178|FG001|Overall Study|Death|1|||
30973104|NCT02085941|59049177|FG000|Overall Study|Lost to Follow-up|1|||
30973105|NCT02085941|59049178|FG001|Overall Study|Lost to Follow-up|0|||
30973106|NCT02085941|59049177|FG000|Overall Study|Physician Decision|0|||
30973107|NCT02085941|59049178|FG001|Overall Study|Physician Decision|2|||
30973108|NCT02085785|59049186|FG000|Overall Study|Withdrawal by Subject|2|||
30973109|NCT02085785|59049187|FG001|Overall Study|Withdrawal by Subject|1|||
30973110|NCT02085785|59049186|FG000|Overall Study|Lost to Follow-up|0|||
30973111|NCT02085785|59049187|FG001|Overall Study|Lost to Follow-up|1|||
30973112|NCT02085161|59049215|FG000|Overall Study|Not Treated|1|||
30973113|NCT02085161|59049216|FG001|Overall Study|Not Treated|0|||
30973114|NCT02085161|59049217|FG002|Overall Study|Not Treated|0|||
30973115|NCT02085161|59049218|FG003|Overall Study|Not Treated|0|||
30973116|NCT02085161|59049215|FG000|Overall Study|Adverse Event|8|||
30973117|NCT02085161|59049216|FG001|Overall Study|Adverse Event|5|||
30973118|NCT02085161|59049217|FG002|Overall Study|Adverse Event|4|||
30973119|NCT02085161|59049218|FG003|Overall Study|Adverse Event|5|||
30973120|NCT02085161|59049215|FG000|Overall Study|Protocol Violation|0|||
30973121|NCT02085161|59049216|FG001|Overall Study|Protocol Violation|1|||
30973122|NCT02085161|59049217|FG002|Overall Study|Protocol Violation|0|||
30973123|NCT02085161|59049218|FG003|Overall Study|Protocol Violation|1|||
30973124|NCT02085161|59049215|FG000|Overall Study|Withdrawal by Subject|2|||
30973125|NCT02085161|59049216|FG001|Overall Study|Withdrawal by Subject|4|||
30973126|NCT02085161|59049217|FG002|Overall Study|Withdrawal by Subject|0|||
30973127|NCT02085161|59049218|FG003|Overall Study|Withdrawal by Subject|3|||
30973128|NCT02085161|59049215|FG000|Overall Study|Other Reason|1|||
30973129|NCT02085161|59049216|FG001|Overall Study|Other Reason|0|||
30973130|NCT02085161|59049217|FG002|Overall Study|Other Reason|1|||
30973131|NCT02085161|59049218|FG003|Overall Study|Other Reason|1|||
30973132|NCT02082977|59050101|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
30973133|NCT02082977|59050102|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
30973134|NCT02082977|59050103|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
30973135|NCT02082977|59050104|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
30973136|NCT02082977|59050105|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
30973137|NCT02082977|59050106|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
30973138|NCT02082977|59050107|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
30973139|NCT02082977|59050108|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
30973140|NCT02082977|59050109|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
30973141|NCT02082977|59050110|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
30973142|NCT02082977|59050101|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
30973143|NCT02082977|59050102|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
30973144|NCT02082977|59050103|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
30973145|NCT02082977|59050104|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
30973146|NCT02082977|59050105|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
30973147|NCT02082977|59050106|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
30973148|NCT02082977|59050107|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
30973149|NCT02082977|59050108|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
30973150|NCT02082977|59050109|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
30973151|NCT02082977|59050110|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
30973152|NCT02082977|59050101|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
30973153|NCT02082977|59050102|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
30973154|NCT02082977|59050103|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
30973155|NCT02082977|59050104|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
30973156|NCT02082977|59050105|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
30973157|NCT02082977|59050106|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
30973158|NCT02082977|59050107|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
30973159|NCT02082977|59050108|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
30973160|NCT02082977|59050109|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
30973161|NCT02082977|59050110|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
30973162|NCT02082977|59050101|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
30973163|NCT02082977|59050102|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
30973164|NCT02082977|59050103|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
30973165|NCT02082977|59050104|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
30973166|NCT02082977|59050105|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
30973167|NCT02082977|59050106|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
30973168|NCT02082977|59050107|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
30973169|NCT02082977|59050108|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
30973170|NCT02082977|59050109|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
30973171|NCT02082977|59050110|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
30973172|NCT02082977|59050101|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
30973173|NCT02082977|59050102|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
30973174|NCT02082977|59050103|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
30973175|NCT02082977|59050104|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
30973176|NCT02082977|59050105|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
30973177|NCT02082977|59050106|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
30973178|NCT02082977|59050107|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
30973179|NCT02082977|59050108|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
30973180|NCT02082977|59050109|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
30973181|NCT02082977|59050110|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
30973182|NCT01624259|59050144|FG000|Overall Study|Adverse Event|18|||
30973183|NCT01624259|59050145|FG001|Overall Study|Adverse Event|18|||
30973184|NCT01624259|59050144|FG000|Overall Study|Protocol Violation|1|||
30973185|NCT01624259|59050145|FG001|Overall Study|Protocol Violation|2|||
30973186|NCT01624259|59050144|FG000|Overall Study|Withdrawal by Subject|5|||
30973187|NCT01624259|59050145|FG001|Overall Study|Withdrawal by Subject|7|||
30973188|NCT01624259|59050144|FG000|Overall Study|Physician Decision|1|||
30973189|NCT01624259|59050145|FG001|Overall Study|Physician Decision|1|||
30973190|NCT01624259|59050144|FG000|Overall Study|Lost to Follow-up|2|||
30973191|NCT01624259|59050145|FG001|Overall Study|Lost to Follow-up|3|||
30973192|NCT01624259|59050144|FG000|Overall Study|Abnormal laboratory measure|3|||
30973193|NCT01624259|59050145|FG001|Overall Study|Abnormal laboratory measure|0|||
30973194|NCT02081417|59050155|FG000|Overall Study|Lost to Follow-up|26|||
30973195|NCT02081417|59050156|FG001|Overall Study|Lost to Follow-up|23|||
30973196|NCT02081417|59050155|FG000|Overall Study|Moved Away|1|||
30973197|NCT02081417|59050156|FG001|Overall Study|Moved Away|2|||
30973198|NCT02081417|59050155|FG000|Overall Study|Incarcerated|2|||
30973199|NCT02081417|59050156|FG001|Overall Study|Incarcerated|2|||
30973200|NCT02081417|59050155|FG000|Overall Study|Death|4|||
30973201|NCT02081417|59050156|FG001|Overall Study|Death|3|||
30973202|NCT02081417|59050155|FG000|Overall Study|Withdrawal by Subject|4|||
30973203|NCT02081417|59050156|FG001|Overall Study|Withdrawal by Subject|0|||
30973204|NCT02081417|59050155|FG000|Overall Study|Admitted to Residential Treatment|2|||
30973205|NCT02081417|59050156|FG001|Overall Study|Admitted to Residential Treatment|0|||
30973206|NCT02081417|59050155|FG000|Overall Study|Did not start treatment|17|||
30973207|NCT02081417|59050156|FG001|Overall Study|Did not start treatment|21|||
30973208|NCT02081183|59050164|FG000|Overall Study|Lost to Follow-up|0|||
30973209|NCT02081183|59050165|FG001|Overall Study|Lost to Follow-up|1|||
30973210|NCT02081183|59050164|FG000|Overall Study|Protocol Violation|1|||
30973211|NCT02081183|59050165|FG001|Overall Study|Protocol Violation|0|||
30973212|NCT02081183|59050164|FG000|Overall Study|Other|3|||
30973213|NCT02081183|59050165|FG001|Overall Study|Other|3|||
30973214|NCT02080871|59050171|FG000|Overall Study|Death|1|||
30973215|NCT02080871|59050171|FG000|Overall Study|Lost to Follow-up|1|||
30973216|NCT02080481|59050177|FG000|Overall Study|Never received a block.|1|||
30973217|NCT02080481|59050178|FG001|Overall Study|Never received a block.|0|||
30973218|NCT02080403|59050186|FG000|Overall Study|Adverse Event|5|||
30973219|NCT02080403|59050187|FG001|Overall Study|Adverse Event|1|||
30973220|NCT02080403|59050186|FG000|Overall Study|Death|0|||
30973221|NCT02080403|59050187|FG001|Overall Study|Death|2|||
30973222|NCT02080403|59050186|FG000|Overall Study|Lost to Follow-up|2|||
30608409|NCT01288430|58619228|FG007|Part 1|Death due to disease progression|0|||
30973223|NCT02080403|59050187|FG001|Overall Study|Lost to Follow-up|0|||
30973224|NCT02080403|59050186|FG000|Overall Study|Pregnancy|0|||
30973225|NCT02080403|59050187|FG001|Overall Study|Pregnancy|1|||
30973226|NCT02080403|59050186|FG000|Overall Study|Protocol Violation|3|||
30973227|NCT02080403|59050187|FG001|Overall Study|Protocol Violation|7|||
30973228|NCT02080403|59050186|FG000|Overall Study|Withdrawal by Subject|5|||
30973229|NCT02080403|59050187|FG001|Overall Study|Withdrawal by Subject|1|||
30973230|NCT02080091|59050193|FG000|Overall Study|Study Terminated|22|||
30973231|NCT02080091|59050193|FG000|Overall Study|Death|1|||
30973232|NCT02080091|59050193|FG000|Overall Study|Withdrawal by Subject|1|||
30973233|NCT02080091|59050193|FG000|Overall Study|Other|1|||
30973234|NCT02079077|59050199|FG000|Overall Study|Lost to Follow-up|5|||
30973235|NCT02079077|59050200|FG001|Overall Study|Lost to Follow-up|7|||
30973236|NCT02079077|59050199|FG000|Overall Study|Became STIs Positive|1|||
30973237|NCT02079077|59050200|FG001|Overall Study|Became STIs Positive|2|||
30973238|NCT02078219|59050228|FG000|Overall Study|Other|2|||
30973239|NCT02078219|59050229|FG001|Overall Study|Other|2|||
30973240|NCT02078219|59050230|FG002|Overall Study|Other|3|||
30973241|NCT02078219|59050231|FG003|Overall Study|Other|0|||
30973242|NCT02078219|59050232|FG004|Overall Study|Other|1|||
30973243|NCT02078219|59050228|FG000|Overall Study|Withdrawal by Subject|0|||
30973244|NCT02078219|59050229|FG001|Overall Study|Withdrawal by Subject|1|||
30973245|NCT02078219|59050230|FG002|Overall Study|Withdrawal by Subject|0|||
30973246|NCT02078219|59050231|FG003|Overall Study|Withdrawal by Subject|1|||
30973247|NCT02078219|59050232|FG004|Overall Study|Withdrawal by Subject|1|||
30973248|NCT02078219|59050228|FG000|Overall Study|Protocol Violation|0|||
30973249|NCT02078219|59050229|FG001|Overall Study|Protocol Violation|0|||
30973250|NCT02078219|59050230|FG002|Overall Study|Protocol Violation|0|||
30973251|NCT02078219|59050231|FG003|Overall Study|Protocol Violation|1|||
30973252|NCT02078219|59050232|FG004|Overall Study|Protocol Violation|0|||
30973253|NCT02078219|59050228|FG000|Overall Study|Death|0|||
30973254|NCT02078219|59050229|FG001|Overall Study|Death|0|||
30973255|NCT02078219|59050230|FG002|Overall Study|Death|0|||
30973256|NCT02078219|59050231|FG003|Overall Study|Death|1|||
30973257|NCT02078219|59050232|FG004|Overall Study|Death|0|||
30973258|NCT02078219|59050228|FG000|Overall Study|Adverse Event|1|||
30973259|NCT02078219|59050229|FG001|Overall Study|Adverse Event|1|||
30973260|NCT02078219|59050230|FG002|Overall Study|Adverse Event|3|||
30973261|NCT02078219|59050231|FG003|Overall Study|Adverse Event|1|||
30973262|NCT02078219|59050232|FG004|Overall Study|Adverse Event|0|||
30973263|NCT02076113|59050246|FG000|Overall Study|Lost to Follow-up|4|||
30973264|NCT02076113|59050247|FG001|Overall Study|Lost to Follow-up|1|||
30973265|NCT02076113|59050246|FG000|Overall Study|Withdrawal by Subject|2|||
30973266|NCT02076113|59050247|FG001|Overall Study|Withdrawal by Subject|3|||
30973267|NCT02076113|59050246|FG000|Overall Study|Death|1|||
30973268|NCT02076113|59050247|FG001|Overall Study|Death|3|||
30973269|NCT02075255|59050259|FG000|Overall Study|Study specific withdrawal criteria|0|||
30973270|NCT02075255|59050260|FG001|Overall Study|Study specific withdrawal criteria|1|||
30973271|NCT02075255|59050261|FG002|Overall Study|Study specific withdrawal criteria|1|||
30973272|NCT02075255|59050259|FG000|Overall Study|Withdrawal by Subject|4|||
30973273|NCT02075255|59050260|FG001|Overall Study|Withdrawal by Subject|1|||
30973274|NCT02075255|59050261|FG002|Overall Study|Withdrawal by Subject|0|||
30973275|NCT02075255|59050259|FG000|Overall Study|Lost to Follow-up|0|||
30973276|NCT02075255|59050260|FG001|Overall Study|Lost to Follow-up|0|||
30973277|NCT02075255|59050261|FG002|Overall Study|Lost to Follow-up|1|||
30973278|NCT02075255|59050259|FG000|Overall Study|Adverse Event|0|||
30973279|NCT02075255|59050260|FG001|Overall Study|Adverse Event|0|||
30973280|NCT02075255|59050261|FG002|Overall Study|Adverse Event|1|||
30973281|NCT02075255|59050259|FG000|Overall Study|Death|0|||
30973282|NCT02075255|59050260|FG001|Overall Study|Death|2|||
30973283|NCT02075255|59050261|FG002|Overall Study|Death|0|||
30973284|NCT02400671|59050432|FG000|Overall Study|Death|5|||
30973285|NCT02400671|59050433|FG001|Overall Study|Death|3|||
30973286|NCT02400671|59050434|FG002|Overall Study|Death|4|||
30973287|NCT02400671|59050432|FG000|Overall Study|Lost to Follow-up|20|||
30973288|NCT02400671|59050433|FG001|Overall Study|Lost to Follow-up|27|||
30973289|NCT02400671|59050434|FG002|Overall Study|Lost to Follow-up|24|||
30973290|NCT02400671|59050432|FG000|Overall Study|Withdrawal by Subject|2|||
30973291|NCT02400671|59050433|FG001|Overall Study|Withdrawal by Subject|2|||
30973292|NCT02400671|59050434|FG002|Overall Study|Withdrawal by Subject|0|||
30973293|NCT00089999|59050444|FG000|Overall Study|Adverse Event|4|||
30973294|NCT00089999|59050445|FG001|Overall Study|Adverse Event|7|||
30973295|NCT00089999|59050444|FG000|Overall Study|Withdrawal by Subject|0|||
30973296|NCT00089999|59050445|FG001|Overall Study|Withdrawal by Subject|4|||
30973297|NCT00089999|59050444|FG000|Overall Study|Lost to Follow-up|2|||
30973298|NCT00089999|59050445|FG001|Overall Study|Lost to Follow-up|1|||
30973299|NCT00089999|59050444|FG000|Overall Study|Radiological Progression of Cancer|52|||
30973300|NCT00089999|59050445|FG001|Overall Study|Radiological Progression of Cancer|44|||
30973301|NCT00089999|59050444|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
30973302|NCT00089999|59050445|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
30973303|NCT00089999|59050444|FG000|Overall Study|Death|3|||
30973304|NCT00089999|59050445|FG001|Overall Study|Death|3|||
30973305|NCT00089999|59050444|FG000|Overall Study|Poor General Condition|1|||
30973306|NCT00089999|59050445|FG001|Overall Study|Poor General Condition|0|||
30973307|NCT00089999|59050444|FG000|Overall Study|Clinical Progression|1|||
30973308|NCT00089999|59050445|FG001|Overall Study|Clinical Progression|2|||
30973309|NCT00089999|59050444|FG000|Overall Study|Physician Decision|2|||
30973310|NCT00089999|59050445|FG001|Overall Study|Physician Decision|2|||
30973311|NCT00089999|59050444|FG000|Overall Study|Patient Underwent Surgery|2|||
30973312|NCT00089999|59050445|FG001|Overall Study|Patient Underwent Surgery|0|||
30973313|NCT00089999|59050444|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
30973314|NCT00089999|59050445|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
30973315|NCT00089843|59050456|FG000|Overall Study|Withdrawal by Subject|1|||
30973316|NCT00089843|59050457|FG001|Overall Study|Withdrawal by Subject|4|||
30973317|NCT00089843|59050458|FG002|Overall Study|Withdrawal by Subject|5|||
30973318|NCT00089843|59050459|FG003|Overall Study|Withdrawal by Subject|6|||
30973319|NCT00089843|59050456|FG000|Overall Study|Physician Decision|1|||
30973320|NCT00089843|59050457|FG001|Overall Study|Physician Decision|0|||
30973321|NCT00089843|59050458|FG002|Overall Study|Physician Decision|0|||
30973322|NCT00089843|59050459|FG003|Overall Study|Physician Decision|1|||
30973323|NCT00089297|59050469|FG000|Overall Study|Adverse Event|9|||
30973324|NCT00089297|59050469|FG000|Overall Study|Death|1|||
30973325|NCT00089297|59050469|FG000|Overall Study|Withdrawal by Subject|12|||
30973326|NCT00089297|59050469|FG000|Overall Study|Disease progression|2|||
30973327|NCT00089297|59050469|FG000|Overall Study|Ineligible|11|||
30973328|NCT00089297|59050469|FG000|Overall Study|Secondary malignancy|1|||
30973329|NCT00089297|59050469|FG000|Overall Study|IRB approval not ready|1|||
30973330|NCT00089297|59050469|FG000|Overall Study|Non-compliance|1|||
30973331|NCT00088907|59050511|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
30973332|NCT00088907|59050512|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
30973333|NCT00088907|59050511|FG000|Randomized Study (Step 1)|Adverse Event|14|||
30973334|NCT00088907|59050512|FG001|Randomized Study (Step 1)|Adverse Event|19|||
30973335|NCT00088907|59050511|FG000|Randomized Study (Step 1)|Death|11|||
30973336|NCT00088907|59050512|FG001|Randomized Study (Step 1)|Death|12|||
30973337|NCT00088907|59050511|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
30973338|NCT00088907|59050512|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
30973339|NCT00088907|59050511|FG000|Randomized Study (Step 1)|complicating disease|3|||
30973340|NCT00088907|59050512|FG001|Randomized Study (Step 1)|complicating disease|1|||
30973341|NCT00088907|59050511|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
30973342|NCT00088907|59050512|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
30973343|NCT00088907|59050511|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
30973344|NCT00088907|59050512|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
30973345|NCT00088907|59050511|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
30973346|NCT00088907|59050512|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
30973347|NCT00088907|59050511|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
30973348|NCT00088907|59050512|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
30973349|NCT00088907|59050511|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
30973350|NCT00088907|59050512|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
30973351|NCT00088907|59050511|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
30973352|NCT00088907|59050512|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
30973353|NCT00088829|59050519|FG000|Overall Study|PI left institution and study was close|22|||
30973354|NCT00088595|59050523|FG000|Overall Study|Adverse Event|11|||
30973355|NCT00088595|59050523|FG000|Overall Study|Withdrawal by Subject|8|||
30973356|NCT00088595|59050523|FG000|Overall Study|Ongoing (After Core)|7|||
30973357|NCT00088595|59050523|FG000|Overall Study|New Cancer Therapy|2|||
30973358|NCT00088205|59050537|FG000|Overall Study|Adverse Event|4|||
30973359|NCT00088205|59050537|FG000|Overall Study|Progressive Disease|51|||
30973360|NCT00088205|59050537|FG000|Overall Study|Physician Decision|1|||
30973361|NCT00088205|59050537|FG000|Overall Study|Death Due to Study Disease|4|||
30973362|NCT00085709|59050631|FG000|Overall Study|Adverse Event|8|||
30880400|NCT01668797|58912377|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
30973363|NCT00085709|59050632|FG001|Overall Study|Adverse Event|0|||
30973364|NCT00085709|59050631|FG000|Overall Study|Death|8|||
30973365|NCT00085709|59050632|FG001|Overall Study|Death|2|||
30973366|NCT00085709|59050631|FG000|Overall Study|Refusal unrelated to adverse events|1|||
30973367|NCT00085709|59050632|FG001|Overall Study|Refusal unrelated to adverse events|2|||
30973368|NCT00085709|59050631|FG000|Overall Study|Progression|3|||
30973369|NCT00085709|59050632|FG001|Overall Study|Progression|4|||
30973370|NCT00085709|59050631|FG000|Overall Study|Not protocol specified|12|||
30973371|NCT00085709|59050632|FG001|Overall Study|Not protocol specified|22|||
30973372|NCT00085709|59050631|FG000|Overall Study|Not eligible|19|||
30973373|NCT00085709|59050632|FG001|Overall Study|Not eligible|19|||
30973374|NCT00085709|59050631|FG000|Overall Study|Withdrawal by Subject|2|||
30973375|NCT00085709|59050632|FG001|Overall Study|Withdrawal by Subject|1|||
30973376|NCT00085631|59050667|FG000|Overall Study|Missing Data|4|||
30973377|NCT00085631|59050668|FG001|Overall Study|Missing Data|11|||
30973378|NCT00085631|59050669|FG002|Overall Study|Missing Data|7|||
30973379|NCT00084929|59050685|FG000|Overall Study|ineligible - medical contraindication|1|||
30973380|NCT00084929|59050685|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
30973381|NCT00084929|59050685|FG000|Overall Study|Ineligible - Medical history|6|||
30973382|NCT00084929|59050685|FG000|Overall Study|Withdrawal by Subject|10|||
30973383|NCT00084929|59050685|FG000|Overall Study|Missing/incomplete CTC exam|9|||
30973384|NCT00084929|59050685|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
30973385|NCT00084617|59050743|FG000|Overall Study|Withdrawal by Subject|7|||
30973386|NCT00084617|59050743|FG000|Overall Study|Lack of Efficacy|1|||
30973387|NCT00084617|59050743|FG000|Overall Study|Protocol Violation|1|||
30973388|NCT00083915|59050857|FG000|Overall Study|Death|6|||
30973389|NCT00083915|59050858|FG001|Overall Study|Death|3|||
30973390|NCT00083915|59050857|FG000|Overall Study|Physician Decision|11|||
30973391|NCT00083915|59050858|FG001|Overall Study|Physician Decision|6|||
30973392|NCT00083915|59050857|FG000|Overall Study|Withdrawal by Subject|8|||
30973393|NCT00083915|59050858|FG001|Overall Study|Withdrawal by Subject|3|||
30973394|NCT00083915|59050857|FG000|Overall Study|disease progression|18|||
30973395|NCT00083915|59050858|FG001|Overall Study|disease progression|23|||
30973396|NCT00083915|59050857|FG000|Overall Study|Failure to collect|3|||
30973397|NCT00083915|59050858|FG001|Overall Study|Failure to collect|0|||
30973398|NCT00083915|59050857|FG000|Overall Study|No response|3|||
30973399|NCT00083915|59050858|FG001|Overall Study|No response|1|||
30973400|NCT00083915|59050857|FG000|Overall Study|Insurance issues|1|||
30973401|NCT00083915|59050858|FG001|Overall Study|Insurance issues|1|||
30973402|NCT04362761|59051520|FG000|Part A (48 Weeks)|Adverse Event|2|||
30973403|NCT04362761|59051520|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
30973404|NCT04362761|59051520|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
30973405|NCT04362761|59051520|FG000|Part A (48 Weeks)|Other|5|||
30973406|NCT04362761|59051520|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
30973407|NCT04362761|59051520|FG000|Part B (86 Weeks)|Other|4|||
30973408|NCT00632749|59051716|FG000|Overall Study|Progressive disease|3|||
30973409|NCT00632749|59051717|FG001|Overall Study|Progressive disease|2|||
30973410|NCT00632749|59051718|FG002|Overall Study|Progressive disease|2|||
30973411|NCT00632749|59051719|FG003|Overall Study|Progressive disease|2|||
30973412|NCT00632749|59051720|FG004|Overall Study|Progressive disease|4|||
30973413|NCT00632749|59051721|FG005|Overall Study|Progressive disease|4|||
30973414|NCT00632749|59051722|FG006|Overall Study|Progressive disease|3|||
30973415|NCT00632749|59051723|FG007|Overall Study|Progressive disease|2|||
30973416|NCT00632749|59051724|FG008|Overall Study|Progressive disease|3|||
30973417|NCT00632749|59051725|FG009|Overall Study|Progressive disease|2|||
30973418|NCT00632749|59051726|FG010|Overall Study|Progressive disease|4|||
30973419|NCT00632749|59051727|FG011|Overall Study|Progressive disease|3|||
30973420|NCT00632749|59051728|FG012|Overall Study|Progressive disease|2|||
30973421|NCT00632749|59051729|FG013|Overall Study|Progressive disease|4|||
30973422|NCT00632749|59051716|FG000|Overall Study|Other Adverse event|1|||
30973423|NCT00632749|59051717|FG001|Overall Study|Other Adverse event|1|||
30973424|NCT00632749|59051718|FG002|Overall Study|Other Adverse event|1|||
30973425|NCT00632749|59051719|FG003|Overall Study|Other Adverse event|1|||
30973426|NCT00632749|59051720|FG004|Overall Study|Other Adverse event|2|||
30973427|NCT00632749|59051721|FG005|Overall Study|Other Adverse event|4|||
30973428|NCT00632749|59051722|FG006|Overall Study|Other Adverse event|1|||
30973429|NCT00632749|59051723|FG007|Overall Study|Other Adverse event|2|||
30973430|NCT00632749|59051724|FG008|Overall Study|Other Adverse event|2|||
30973431|NCT00632749|59051725|FG009|Overall Study|Other Adverse event|0|||
30973432|NCT00632749|59051726|FG010|Overall Study|Other Adverse event|1|||
30973433|NCT00632749|59051727|FG011|Overall Study|Other Adverse event|0|||
30973434|NCT00632749|59051728|FG012|Overall Study|Other Adverse event|1|||
30973435|NCT00632749|59051729|FG013|Overall Study|Other Adverse event|0|||
30973436|NCT00632749|59051716|FG000|Overall Study|Refuse to continue medication|0|||
30973437|NCT00632749|59051717|FG001|Overall Study|Refuse to continue medication|0|||
30973438|NCT00632749|59051718|FG002|Overall Study|Refuse to continue medication|0|||
30973439|NCT00632749|59051719|FG003|Overall Study|Refuse to continue medication|1|||
30973440|NCT00632749|59051720|FG004|Overall Study|Refuse to continue medication|0|||
30973441|NCT00632749|59051721|FG005|Overall Study|Refuse to continue medication|0|||
30973442|NCT00632749|59051722|FG006|Overall Study|Refuse to continue medication|0|||
30973443|NCT00632749|59051723|FG007|Overall Study|Refuse to continue medication|0|||
30973444|NCT00632749|59051724|FG008|Overall Study|Refuse to continue medication|0|||
30973445|NCT00632749|59051725|FG009|Overall Study|Refuse to continue medication|1|||
30973446|NCT00632749|59051726|FG010|Overall Study|Refuse to continue medication|0|||
30973447|NCT00632749|59051727|FG011|Overall Study|Refuse to continue medication|0|||
30973448|NCT00632749|59051728|FG012|Overall Study|Refuse to continue medication|0|||
30973449|NCT00632749|59051729|FG013|Overall Study|Refuse to continue medication|0|||
30973450|NCT00632749|59051716|FG000|Overall Study|Reason other than those specified above|0|||
30973451|NCT00632749|59051717|FG001|Overall Study|Reason other than those specified above|2|||
30973452|NCT00632749|59051718|FG002|Overall Study|Reason other than those specified above|0|||
30973453|NCT00632749|59051719|FG003|Overall Study|Reason other than those specified above|0|||
30973454|NCT00632749|59051720|FG004|Overall Study|Reason other than those specified above|1|||
30973455|NCT00632749|59051721|FG005|Overall Study|Reason other than those specified above|0|||
30973456|NCT00632749|59051722|FG006|Overall Study|Reason other than those specified above|1|||
30973457|NCT00632749|59051723|FG007|Overall Study|Reason other than those specified above|0|||
30973458|NCT00632749|59051724|FG008|Overall Study|Reason other than those specified above|0|||
30973459|NCT00632749|59051725|FG009|Overall Study|Reason other than those specified above|0|||
30973460|NCT00632749|59051726|FG010|Overall Study|Reason other than those specified above|2|||
30973461|NCT00632749|59051727|FG011|Overall Study|Reason other than those specified above|1|||
30973462|NCT00632749|59051728|FG012|Overall Study|Reason other than those specified above|0|||
30973463|NCT00632749|59051729|FG013|Overall Study|Reason other than those specified above|2|||
30973464|NCT00632359|59051790|FG000|Overall Study|Withdrawal by Subject|2|||
30973465|NCT00632203|59051797|FG000|Overall Study|Did not start study treatment|1|||
30973466|NCT00632203|59051798|FG001|Overall Study|Did not start study treatment|0|||
30973467|NCT03830333|59051819|FG000|Overall Study|Death|0|||
30973468|NCT03830333|59051820|FG001|Overall Study|Death|1|||
30973469|NCT03830333|59051819|FG000|Overall Study|Withdrawal by Subject|5|||
30973470|NCT03830333|59051820|FG001|Overall Study|Withdrawal by Subject|1|||
30973471|NCT03830333|59051819|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
30973472|NCT03830333|59051820|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
30973473|NCT00631969|59051906|FG000|Overall Study|Adverse Event|3|||
30973474|NCT00631969|59051907|FG001|Overall Study|Adverse Event|1|||
30973475|NCT00631969|59051906|FG000|Overall Study|Lack of Efficacy|2|||
30973476|NCT00631969|59051907|FG001|Overall Study|Lack of Efficacy|8|||
30973477|NCT00631969|59051906|FG000|Overall Study|Lost to Follow-up|2|||
30973478|NCT00631969|59051907|FG001|Overall Study|Lost to Follow-up|1|||
30973479|NCT00631969|59051906|FG000|Overall Study|Protocol Violation|1|||
30973480|NCT00631969|59051907|FG001|Overall Study|Protocol Violation|1|||
30973481|NCT00631969|59051906|FG000|Overall Study|Consent Withdrawn|5|||
30973482|NCT00631969|59051907|FG001|Overall Study|Consent Withdrawn|7|||
30973483|NCT00631969|59051906|FG000|Overall Study|Noncompliant With Study Medication|0|||
30973484|NCT00631969|59051907|FG001|Overall Study|Noncompliant With Study Medication|1|||
30973485|NCT00631969|59051906|FG000|Overall Study|No Drug Exposure|2|||
30973486|NCT00631969|59051907|FG001|Overall Study|No Drug Exposure|2|||
30973487|NCT00631657|59051943|FG000|6-Month Treatment Period|Adverse Event|47|||
30973488|NCT00631657|59051944|FG001|6-Month Treatment Period|Adverse Event|0|||
30973489|NCT00631657|59051945|FG002|6-Month Treatment Period|Adverse Event|7|||
30973490|NCT00631657|59051943|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
30973491|NCT00631657|59051944|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
30973492|NCT00631657|59051945|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
30973493|NCT00631657|59051943|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
30973494|NCT00631657|59051944|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
30973495|NCT00631657|59051945|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
30973496|NCT00631657|59051943|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
30973497|NCT00631657|59051944|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
30973498|NCT00631657|59051945|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
30973499|NCT00631657|59051943|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
30973500|NCT00631657|59051944|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
30973501|NCT00631657|59051945|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
30973502|NCT00631657|59051943|FG000|6-Month Treatment Period|Other|16|||
30973503|NCT00631657|59051944|FG001|6-Month Treatment Period|Other|0|||
30973504|NCT00631657|59051945|FG002|6-Month Treatment Period|Other|4|||
30973505|NCT00631657|59051943|FG000|6-Month Treatment Period|Not Treated|2|||
30973506|NCT00631657|59051944|FG001|6-Month Treatment Period|Not Treated|0|||
30973507|NCT00631657|59051945|FG002|6-Month Treatment Period|Not Treated|1|||
30973508|NCT00631657|59051943|FG000|7-Day Discontinuation Period|Not Treated|1|||
30973509|NCT00631657|59051944|FG001|7-Day Discontinuation Period|Not Treated|1|||
30973510|NCT00631657|59051945|FG002|7-Day Discontinuation Period|Not Treated|1|||
30973511|NCT00631657|59051943|FG000|7-Day Discontinuation Period|Other|1|||
30973512|NCT00631657|59051944|FG001|7-Day Discontinuation Period|Other|0|||
30973513|NCT00631657|59051945|FG002|7-Day Discontinuation Period|Other|0|||
30973514|NCT00631189|59051983|FG000|Initial Phase|Protocol Violation|347|||
30973515|NCT00631189|59051984|FG001|Initial Phase|Protocol Violation|0|||
30973516|NCT00631189|59051985|FG002|Initial Phase|Protocol Violation|0|||
30973517|NCT00631189|59051986|FG003|Initial Phase|Protocol Violation|0|||
30973518|NCT00631189|59051983|FG000|Initial Phase|Withdrawal by Subject|4|||
30973519|NCT00631189|59051984|FG001|Initial Phase|Withdrawal by Subject|0|||
30973520|NCT00631189|59051985|FG002|Initial Phase|Withdrawal by Subject|0|||
30973521|NCT00631189|59051986|FG003|Initial Phase|Withdrawal by Subject|0|||
30973522|NCT00631189|59051983|FG000|Treatment Phase|Withdrawal by Subject|0|||
30973523|NCT00631189|59051984|FG001|Treatment Phase|Withdrawal by Subject|2|||
30973524|NCT00631189|59051985|FG002|Treatment Phase|Withdrawal by Subject|1|||
30973525|NCT00631189|59051986|FG003|Treatment Phase|Withdrawal by Subject|1|||
30973526|NCT00631189|59051983|FG000|Treatment Phase|Protocol Violation|0|||
30973527|NCT00631189|59051984|FG001|Treatment Phase|Protocol Violation|1|||
30973528|NCT00631189|59051985|FG002|Treatment Phase|Protocol Violation|6|||
30973529|NCT00631189|59051986|FG003|Treatment Phase|Protocol Violation|2|||
30973530|NCT00631189|59051983|FG000|Treatment Phase|Adverse Event|0|||
30973531|NCT00631189|59051984|FG001|Treatment Phase|Adverse Event|3|||
30973532|NCT00631189|59051985|FG002|Treatment Phase|Adverse Event|2|||
30973533|NCT00631189|59051986|FG003|Treatment Phase|Adverse Event|4|||
30973534|NCT00631189|59051983|FG000|Treatment Phase|Lost to Follow-up|0|||
30973535|NCT00631189|59051984|FG001|Treatment Phase|Lost to Follow-up|1|||
30973536|NCT00631189|59051985|FG002|Treatment Phase|Lost to Follow-up|0|||
30973537|NCT00631189|59051986|FG003|Treatment Phase|Lost to Follow-up|0|||
30973538|NCT00631189|59051983|FG000|Treatment Phase|Pregnancy|0|||
30973539|NCT00631189|59051984|FG001|Treatment Phase|Pregnancy|0|||
30973540|NCT00631189|59051985|FG002|Treatment Phase|Pregnancy|1|||
30973541|NCT00631189|59051986|FG003|Treatment Phase|Pregnancy|0|||
30973542|NCT00631189|59051983|FG000|Treatment Phase|patient did not take pravastatin|0|||
30973543|NCT00631189|59051984|FG001|Treatment Phase|patient did not take pravastatin|0|||
30973544|NCT00631189|59051985|FG002|Treatment Phase|patient did not take pravastatin|1|||
30973545|NCT00631189|59051986|FG003|Treatment Phase|patient did not take pravastatin|0|||
30973546|NCT00630877|59051999|FG000|Overall Study|Adverse Event|11|||
30973547|NCT00630877|59052000|FG001|Overall Study|Adverse Event|8|||
30973548|NCT00630877|59052001|FG002|Overall Study|Adverse Event|7|||
30973549|NCT00630877|59051999|FG000|Overall Study|Withdrawal by Subject|3|||
30973550|NCT00630877|59052000|FG001|Overall Study|Withdrawal by Subject|4|||
30973551|NCT00630877|59052001|FG002|Overall Study|Withdrawal by Subject|0|||
30973552|NCT00630877|59051999|FG000|Overall Study|Lost to Follow-up|2|||
30973553|NCT00630877|59052000|FG001|Overall Study|Lost to Follow-up|0|||
30973554|NCT00630877|59052001|FG002|Overall Study|Lost to Follow-up|0|||
30973555|NCT00630877|59051999|FG000|Overall Study|Noncompliance|2|||
30973556|NCT00630877|59052000|FG001|Overall Study|Noncompliance|3|||
30973557|NCT00630877|59052001|FG002|Overall Study|Noncompliance|1|||
30973558|NCT00630877|59051999|FG000|Overall Study|Protocol violation|1|||
30973559|NCT00630877|59052000|FG001|Overall Study|Protocol violation|0|||
30973560|NCT00630877|59052001|FG002|Overall Study|Protocol violation|1|||
30973561|NCT00630877|59051999|FG000|Overall Study|Personal reasons|0|||
30973562|NCT00630877|59052000|FG001|Overall Study|Personal reasons|0|||
30973563|NCT00630877|59052001|FG002|Overall Study|Personal reasons|1|||
30973564|NCT02915783|59052013|FG000|Overall Study|Death|21|||
30973565|NCT02915783|59052013|FG000|Overall Study|Lost to Follow-up|1|||
30973566|NCT02915783|59052013|FG000|Overall Study|Withdrawal by Subject|2|||
30973567|NCT00630331|59052028|FG000|Overall Study|Death|2|||
30973568|NCT00630331|59052029|FG001|Overall Study|Death|1|||
30973569|NCT00630331|59052030|FG002|Overall Study|Death|1|||
30973570|NCT00630331|59052028|FG000|Overall Study|Adverse Event|1|||
30973571|NCT00630331|59052029|FG001|Overall Study|Adverse Event|0|||
30973572|NCT00630331|59052030|FG002|Overall Study|Adverse Event|0|||
30973573|NCT00630331|59052028|FG000|Overall Study|Withdrawal by Subject|12|||
30973574|NCT00630331|59052029|FG001|Overall Study|Withdrawal by Subject|7|||
30973575|NCT00630331|59052030|FG002|Overall Study|Withdrawal by Subject|5|||
30973576|NCT00630331|59052028|FG000|Overall Study|Lost to Follow-up|175|||
30973577|NCT00630331|59052029|FG001|Overall Study|Lost to Follow-up|143|||
30973578|NCT00630331|59052030|FG002|Overall Study|Lost to Follow-up|170|||
30973579|NCT00630331|59052028|FG000|Overall Study|Inappropriate enrollment|3|||
30973580|NCT00630331|59052029|FG001|Overall Study|Inappropriate enrollment|6|||
30973581|NCT00630331|59052030|FG002|Overall Study|Inappropriate enrollment|3|||
30973582|NCT00630331|59052028|FG000|Overall Study|Unable to classify|9|||
30973583|NCT00630331|59052029|FG001|Overall Study|Unable to classify|4|||
30973584|NCT00630331|59052030|FG002|Overall Study|Unable to classify|3|||
30973585|NCT00630331|59052028|FG000|Overall Study|Protocol Violation|4|||
30973586|NCT00630331|59052029|FG001|Overall Study|Protocol Violation|5|||
30973587|NCT00630331|59052030|FG002|Overall Study|Protocol Violation|6|||
30973588|NCT00639509|59052082|FG000|Overall Study|Death|1|||
30973589|NCT00638963|59052088|FG000|Overall Study|Withdrawal by Subject|1|||
30973590|NCT00638963|59052089|FG001|Overall Study|Withdrawal by Subject|0|||
30973591|NCT00638183|59052095|FG000|Overall Study|Adverse Event|23|||
30973592|NCT00638183|59052095|FG000|Overall Study|Lack of Efficacy|14|||
30973593|NCT00638183|59052095|FG000|Overall Study|Physician Decision|9|||
30973594|NCT00638183|59052095|FG000|Overall Study|Lost to Follow-up|46|||
30973595|NCT00638183|59052095|FG000|Overall Study|Other reason not defined above|27|||
30973596|NCT00638027|59052101|FG000|Overall Study|Adverse Event|0|||
30973597|NCT00638027|59052102|FG001|Overall Study|Adverse Event|2|||
30973598|NCT00636155|59052108|FG000|Overall Study|Adverse Event|8|||
30973599|NCT00636155|59052108|FG000|Overall Study|Lack of Efficacy|1|||
30973600|NCT00636155|59052108|FG000|Overall Study|Withdrawal by Subject|3|||
30973601|NCT00636155|59052108|FG000|Overall Study|Stem cell transplant|1|||
30973602|NCT00636155|59052108|FG000|Overall Study|Physician Decision|5|||
30973603|NCT00634907|59052114|FG000|Overall Study|Withdrawal by Subject|3|||
30973604|NCT00634907|59052115|FG001|Overall Study|Withdrawal by Subject|0|||
30973605|NCT00634907|59052114|FG000|Overall Study|Physician Decision|3|||
30973606|NCT00634907|59052115|FG001|Overall Study|Physician Decision|9|||
30973607|NCT00634907|59052114|FG000|Overall Study|Withdrawal by Subject|11|||
30973608|NCT00634907|59052115|FG001|Overall Study|Withdrawal by Subject|8|||
30973609|NCT00634751|59052129|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
30973610|NCT00634751|59052130|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
30973611|NCT00634751|59052131|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
30973612|NCT00634751|59052132|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
30973613|NCT00634751|59052129|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
30973614|NCT00634751|59052130|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
30973615|NCT00634751|59052131|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
30973616|NCT00634751|59052132|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
30973617|NCT00634751|59052129|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
30973618|NCT00634751|59052130|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
30973619|NCT00634751|59052131|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
30973620|NCT00634751|59052132|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
30973621|NCT00634049|59052171|FG000|Overall Study|Never received study drug|1|||
30973622|NCT00634049|59052171|FG000|Overall Study|Died prior to receiving study drug|1|||
30973623|NCT00634049|59052171|FG000|Overall Study|Screening failure|1|||
30973624|NCT00632099|59052210|FG000|Overall Study|Lost to Follow-up|3|||
30973625|NCT00632099|59052211|FG001|Overall Study|Lost to Follow-up|3|||
30973626|NCT00632021|59052219|FG000|Overall Study|Withdrawal/death|4|||
30973627|NCT00632021|59052220|FG001|Overall Study|Withdrawal/death|7|||
30973628|NCT00631475|59052227|FG000|Overall Study|Death|18|||
30973629|NCT00631475|59052227|FG000|Overall Study|Adverse Event|14|||
30973630|NCT00631475|59052227|FG000|Overall Study|Withdrew consent|5|||
30973631|NCT00631475|59052227|FG000|Overall Study|Preparation for lung transplant|8|||
30973632|NCT00631163|59052248|FG000|Number of Participants in Year 1|Adverse Event|12|||
30973633|NCT00631163|59052248|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
30973634|NCT00631163|59052248|FG000|Number of Participants in Year 1|Death|6|||
30973635|NCT00631163|59052248|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
30973636|NCT00631163|59052248|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
30973637|NCT00631163|59052248|FG000|Number of Participants in Year 1|Administrative problems|6|||
30973638|NCT00631163|59052248|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
30973639|NCT00631163|59052248|FG000|Number of Participants in Year 2|Adverse Event|1|||
30973640|NCT00631163|59052248|FG000|Number of Participants in Year 2|Protocol Violation|1|||
30973641|NCT00631163|59052248|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
30973642|NCT00631007|59052265|FG000|Overall Study|Adverse Event|0|||
30973643|NCT00631007|59052266|FG001|Overall Study|Adverse Event|2|||
30973644|NCT00631007|59052267|FG002|Overall Study|Adverse Event|0|||
30973645|NCT00631007|59052268|FG003|Overall Study|Adverse Event|2|||
30973646|NCT00631007|59052269|FG004|Overall Study|Adverse Event|3|||
30973647|NCT00631007|59052270|FG005|Overall Study|Adverse Event|2|||
30973648|NCT00631007|59052265|FG000|Overall Study|Lost to Follow-up|2|||
30973649|NCT00631007|59052266|FG001|Overall Study|Lost to Follow-up|1|||
30973650|NCT00631007|59052267|FG002|Overall Study|Lost to Follow-up|2|||
30973651|NCT00631007|59052268|FG003|Overall Study|Lost to Follow-up|4|||
30973652|NCT00631007|59052269|FG004|Overall Study|Lost to Follow-up|5|||
30973653|NCT00631007|59052270|FG005|Overall Study|Lost to Follow-up|3|||
30973654|NCT00631007|59052265|FG000|Overall Study|Physician Decision|1|||
30973655|NCT00631007|59052266|FG001|Overall Study|Physician Decision|0|||
30973656|NCT00631007|59052267|FG002|Overall Study|Physician Decision|1|||
30973657|NCT00631007|59052268|FG003|Overall Study|Physician Decision|0|||
30973658|NCT00631007|59052269|FG004|Overall Study|Physician Decision|0|||
30973659|NCT00631007|59052270|FG005|Overall Study|Physician Decision|2|||
30973660|NCT00631007|59052265|FG000|Overall Study|Persistent Hyperglycemia|2|||
30973661|NCT00631007|59052266|FG001|Overall Study|Persistent Hyperglycemia|2|||
30973662|NCT00631007|59052267|FG002|Overall Study|Persistent Hyperglycemia|5|||
30973663|NCT00631007|59052268|FG003|Overall Study|Persistent Hyperglycemia|1|||
30973664|NCT00631007|59052269|FG004|Overall Study|Persistent Hyperglycemia|2|||
30973665|NCT00631007|59052270|FG005|Overall Study|Persistent Hyperglycemia|5|||
30973666|NCT00631007|59052265|FG000|Overall Study|Withdrawal by Subject|4|||
30973667|NCT00631007|59052266|FG001|Overall Study|Withdrawal by Subject|5|||
30973668|NCT00631007|59052267|FG002|Overall Study|Withdrawal by Subject|2|||
30973669|NCT00631007|59052268|FG003|Overall Study|Withdrawal by Subject|2|||
30973670|NCT00631007|59052269|FG004|Overall Study|Withdrawal by Subject|1|||
30973671|NCT00631007|59052270|FG005|Overall Study|Withdrawal by Subject|3|||
30973672|NCT00631007|59052265|FG000|Overall Study|Other|2|||
30973673|NCT00631007|59052266|FG001|Overall Study|Other|1|||
30973674|NCT00631007|59052267|FG002|Overall Study|Other|0|||
30973675|NCT00631007|59052268|FG003|Overall Study|Other|0|||
30973676|NCT00631007|59052269|FG004|Overall Study|Other|1|||
30973677|NCT00631007|59052270|FG005|Overall Study|Other|0|||
30973678|NCT00630539|59052297|FG000|Overall Study|Adverse Event|1|||
30973679|NCT00630539|59052298|FG001|Overall Study|Adverse Event|3|||
30973680|NCT00630539|59052299|FG002|Overall Study|Adverse Event|1|||
30973681|NCT00630539|59052300|FG003|Overall Study|Adverse Event|2|||
30973682|NCT00630539|59052297|FG000|Overall Study|Withdrawal by Subject|0|||
30973683|NCT00630539|59052298|FG001|Overall Study|Withdrawal by Subject|1|||
30973684|NCT00630539|59052299|FG002|Overall Study|Withdrawal by Subject|0|||
30973685|NCT00630539|59052300|FG003|Overall Study|Withdrawal by Subject|1|||
30973686|NCT00630305|59052378|FG000|Overall Study|Withdrawal by Subject|1|||
30973687|NCT00630305|59052378|FG000|Overall Study|Inability to insert contact lens|1|||
30973688|NCT01926197|59052604|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
30973689|NCT01926197|59052605|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
30973690|NCT01926197|59052604|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
30973691|NCT01926197|59052605|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
30973692|NCT00989963|59052630|FG000|Overall Study|Adverse Event|1|||
30973693|NCT00989963|59052631|FG001|Overall Study|Adverse Event|1|||
30973694|NCT00989963|59052632|FG002|Overall Study|Adverse Event|1|||
30973695|NCT00989573|59052670|FG000|Overall Study|Adverse Event|8|||
30973696|NCT00989573|59052671|FG001|Overall Study|Adverse Event|12|||
30973697|NCT00989573|59052672|FG002|Overall Study|Adverse Event|4|||
30973698|NCT00989573|59052670|FG000|Overall Study|Physician Decision|0|||
30973699|NCT00989573|59052671|FG001|Overall Study|Physician Decision|2|||
30973700|NCT00989573|59052672|FG002|Overall Study|Physician Decision|0|||
30973701|NCT00989573|59052670|FG000|Overall Study|Protocol Violation|1|||
30973702|NCT00989573|59052671|FG001|Overall Study|Protocol Violation|1|||
30973703|NCT00989573|59052672|FG002|Overall Study|Protocol Violation|1|||
30973704|NCT00989573|59052670|FG000|Overall Study|Withdrawal by Subject|4|||
30973705|NCT00989573|59052671|FG001|Overall Study|Withdrawal by Subject|7|||
30973706|NCT00989573|59052672|FG002|Overall Study|Withdrawal by Subject|3|||
30973707|NCT04126213|59052746|FG000|Overall Study|Lost to Follow-up|9|||
30973708|NCT04126213|59052747|FG001|Overall Study|Lost to Follow-up|1|||
30973709|NCT04126213|59052748|FG002|Overall Study|Lost to Follow-up|5|||
30973710|NCT04126213|59052749|FG003|Overall Study|Lost to Follow-up|10|||
30973711|NCT04126213|59052750|FG004|Overall Study|Lost to Follow-up|4|||
30973712|NCT04126213|59052751|FG005|Overall Study|Lost to Follow-up|7|||
30973713|NCT04126213|59052746|FG000|Overall Study|Withdrawal by Subject|3|||
30973714|NCT04126213|59052747|FG001|Overall Study|Withdrawal by Subject|2|||
30973715|NCT04126213|59052748|FG002|Overall Study|Withdrawal by Subject|1|||
30973716|NCT04126213|59052749|FG003|Overall Study|Withdrawal by Subject|1|||
30973717|NCT04126213|59052750|FG004|Overall Study|Withdrawal by Subject|1|||
30973718|NCT04126213|59052751|FG005|Overall Study|Withdrawal by Subject|1|||
30973719|NCT04126213|59052746|FG000|Overall Study|Other|0|||
30973720|NCT04126213|59052747|FG001|Overall Study|Other|0|||
30973721|NCT04126213|59052748|FG002|Overall Study|Other|2|||
30973722|NCT04126213|59052749|FG003|Overall Study|Other|2|||
30973723|NCT04126213|59052750|FG004|Overall Study|Other|0|||
30973724|NCT04126213|59052751|FG005|Overall Study|Other|1|||
30973725|NCT04126213|59052746|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30973726|NCT04126213|59052747|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
30973727|NCT04126213|59052748|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
30973728|NCT04126213|59052749|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30973729|NCT04126213|59052750|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
30973730|NCT04126213|59052751|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
30973731|NCT04128319|59052768|FG000|Overall Study|Death|3|||
30973732|NCT05038293|59052814|FG000|Overall Study|device was not operating properly for one subject.|1|||
30973733|NCT05038293|59052815|FG001|Overall Study|device was not operating properly for one subject.|0|||
30973734|NCT05038293|59052814|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
30973735|NCT05038293|59052815|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
30973736|NCT05013008|59052823|FG000|Overall Study|Exclusion from mBFAS|5|||
30973737|NCT05013008|59052824|FG001|Overall Study|Exclusion from mBFAS|25|||
30973738|NCT04753164|59052841|FG000|Overall Study|Adverse Event|0|||
30973739|NCT04753164|59052842|FG001|Overall Study|Adverse Event|2|||
30973740|NCT04753164|59052841|FG000|Overall Study|Withdrawal by Subject|9|||
30973741|NCT04753164|59052842|FG001|Overall Study|Withdrawal by Subject|7|||
30973742|NCT04753164|59052841|FG000|Overall Study|Lost to Follow-up|6|||
30973743|NCT04753164|59052842|FG001|Overall Study|Lost to Follow-up|6|||
30973744|NCT04753164|59052841|FG000|Overall Study|Other|12|||
30973745|NCT04753164|59052842|FG001|Overall Study|Other|5|||
30973746|NCT04729101|59052850|FG000|Overall Study|Adverse Event|1|||
30973747|NCT04729101|59052851|FG001|Overall Study|Adverse Event|0|||
30973748|NCT04729101|59052850|FG000|Overall Study|Physician Decision|1|||
30973749|NCT04729101|59052851|FG001|Overall Study|Physician Decision|0|||
30973750|NCT04729101|59052850|FG000|Overall Study|Withdrawal by Subject|1|||
30973751|NCT04729101|59052851|FG001|Overall Study|Withdrawal by Subject|0|||
30973752|NCT04569968|59052881|FG000|Overall Study|Lost to Follow-up|2|||
30973753|NCT04569968|59052882|FG001|Overall Study|Lost to Follow-up|5|||
30973754|NCT04569968|59052881|FG000|Overall Study|Story of head and/or neck surgery|2|||
30973755|NCT04569968|59052882|FG001|Overall Study|Story of head and/or neck surgery|2|||
30973756|NCT04569968|59052881|FG000|Overall Study|Time of stroke onset|8|||
30973757|NCT04569968|59052882|FG001|Overall Study|Time of stroke onset|7|||
30973758|NCT04569968|59052881|FG000|Overall Study|Type of strokr|12|||
30973759|NCT04569968|59052882|FG001|Overall Study|Type of strokr|8|||
30973760|NCT04569968|59052881|FG000|Overall Study|Cooperation|8|||
30973761|NCT04569968|59052882|FG001|Overall Study|Cooperation|8|||
30973762|NCT04569968|59052881|FG000|Overall Study|Age interval|17|||
30973763|NCT04569968|59052882|FG001|Overall Study|Age interval|6|||
30973764|NCT04569968|59052881|FG000|Overall Study|Denial of participation to the study|0|||
30973765|NCT04569968|59052882|FG001|Overall Study|Denial of participation to the study|3|||
30973766|NCT04569968|59052881|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
30973767|NCT04569968|59052882|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
30973768|NCT04569968|59052881|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
30973769|NCT04569968|59052882|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
30973770|NCT04569968|59052881|FG000|Overall Study|Quarantine|1|||
30973771|NCT04569968|59052882|FG001|Overall Study|Quarantine|0|||
30973772|NCT04569968|59052881|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
30973773|NCT04569968|59052882|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
30973774|NCT04569968|59052881|FG000|Overall Study|Repetitive stroke|8|||
30973775|NCT04569968|59052882|FG001|Overall Study|Repetitive stroke|0|||
30973776|NCT04569968|59052881|FG000|Overall Study|Insufficient mastication|1|||
30973777|NCT04569968|59052882|FG001|Overall Study|Insufficient mastication|0|||
30973778|NCT04569968|59052881|FG000|Overall Study|Infection|1|||
30973779|NCT04569968|59052882|FG001|Overall Study|Infection|0|||
30973780|NCT03385304|59052890|FG000|Overall Study|Death|19|||
30973781|NCT03385304|59052891|FG001|Overall Study|Death|7|||
30973782|NCT03385304|59052890|FG000|Overall Study|Lost to Follow-up|17|||
30973783|NCT03385304|59052891|FG001|Overall Study|Lost to Follow-up|14|||
30973784|NCT03385304|59052890|FG000|Overall Study|Withdrawal by Subject|3|||
30973785|NCT03385304|59052891|FG001|Overall Study|Withdrawal by Subject|2|||
30973786|NCT03385304|59052890|FG000|Overall Study|Incarceration|2|||
30973787|NCT03385304|59052891|FG001|Overall Study|Incarceration|3|||
30973788|NCT03325608|59052901|FG000|Overall Study|Lost to Follow-up|47|||
30973789|NCT03325608|59052902|FG001|Overall Study|Lost to Follow-up|47|||
30973790|NCT03325608|59052903|FG002|Overall Study|Lost to Follow-up|41|||
30973791|NCT03325608|59052904|FG003|Overall Study|Lost to Follow-up|41|||
30973792|NCT03325608|59052901|FG000|Overall Study|Death|44|||
30973793|NCT03325608|59052902|FG001|Overall Study|Death|0|||
30973794|NCT03325608|59052903|FG002|Overall Study|Death|41|||
30973795|NCT03325608|59052904|FG003|Overall Study|Death|0|||
30973796|NCT03325608|59052901|FG000|Overall Study|Death of Care Recipient|0|||
30973797|NCT03325608|59052902|FG001|Overall Study|Death of Care Recipient|44|||
30973798|NCT03325608|59052903|FG002|Overall Study|Death of Care Recipient|0|||
30973799|NCT03325608|59052904|FG003|Overall Study|Death of Care Recipient|41|||
30973800|NCT03325608|59052901|FG000|Overall Study|Withdrawal by Subject|44|||
30973801|NCT03325608|59052902|FG001|Overall Study|Withdrawal by Subject|44|||
30973802|NCT03325608|59052903|FG002|Overall Study|Withdrawal by Subject|30|||
30973803|NCT03325608|59052904|FG003|Overall Study|Withdrawal by Subject|30|||
30973804|NCT03183141|59052914|FG000|Overall Study|Withdrawal by Subject|2|||
30973805|NCT03183141|59052915|FG001|Overall Study|Withdrawal by Subject|4|||
30973806|NCT03183141|59052914|FG000|Overall Study|Death|0|||
30973807|NCT03183141|59052915|FG001|Overall Study|Death|8|||
30973808|NCT02957539|59052924|FG000|Baseline to Week 16|Lost to Follow-up|8|||
30973809|NCT02957539|59052925|FG001|Baseline to Week 16|Lost to Follow-up|10|||
30973810|NCT02957539|59052926|FG002|Baseline to Week 16|Lost to Follow-up|16|||
30973811|NCT02957539|59052924|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
30973812|NCT02957539|59052925|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
30973813|NCT02957539|59052926|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
30973814|NCT02957539|59052924|FG000|Week 16 to 32|Withdrawal by Subject|3|||
30973815|NCT02957539|59052925|FG001|Week 16 to 32|Withdrawal by Subject|3|||
30973816|NCT02957539|59052926|FG002|Week 16 to 32|Withdrawal by Subject|1|||
30973817|NCT02957539|59052924|FG000|Week 16 to 32|Lost to Follow-up|8|||
30973818|NCT02957539|59052925|FG001|Week 16 to 32|Lost to Follow-up|7|||
30973819|NCT02957539|59052926|FG002|Week 16 to 32|Lost to Follow-up|5|||
30973820|NCT02957539|59052924|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
30973821|NCT02957539|59052925|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
30973822|NCT02957539|59052926|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
30973823|NCT02957539|59052924|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
30973824|NCT02957539|59052925|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
30973825|NCT02957539|59052926|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
30973826|NCT02690077|59052939|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
30973827|NCT02690077|59052940|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
30973828|NCT02690077|59052939|FG000|Overall Study|Withdrawal by Subject|0|||
30973829|NCT02690077|59052940|FG001|Overall Study|Withdrawal by Subject|5|||
30973830|NCT02690077|59052939|FG000|Overall Study|Excluded by IRB|0|||
30973831|NCT02690077|59052940|FG001|Overall Study|Excluded by IRB|2|||
30973832|NCT02275780|59052948|FG000|Base Study: 96 Weeks|Adverse Event|6|||
30973833|NCT02275780|59052949|FG001|Base Study: 96 Weeks|Adverse Event|14|||
30973834|NCT02275780|59052948|FG000|Base Study: 96 Weeks|Death|3|||
30973835|NCT02275780|59052949|FG001|Base Study: 96 Weeks|Death|1|||
30973836|NCT02275780|59052948|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
30973837|NCT02275780|59052949|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
30973838|NCT02275780|59052948|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
30973839|NCT02275780|59052949|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
30973840|NCT02275780|59052948|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
30973841|NCT02275780|59052949|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
30973842|NCT02275780|59052948|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
30973843|NCT02275780|59052949|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
30973844|NCT02275780|59052948|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
30973845|NCT02275780|59052949|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
30973846|NCT02275780|59052948|FG000|Base Study: 96 Weeks|Physician Decision|2|||
30973847|NCT02275780|59052949|FG001|Base Study: 96 Weeks|Physician Decision|4|||
30973848|NCT02275780|59052948|FG000|Base Study: 96 Weeks|Pregnancy|2|||
30973849|NCT02275780|59052949|FG001|Base Study: 96 Weeks|Pregnancy|1|||
30973850|NCT02275780|59052948|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
30973851|NCT02275780|59052949|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
30973852|NCT02275780|59052948|FG000|Extension Study: up to 192 Weeks|Ongoing|260|||
30973853|NCT02275780|59052949|FG001|Extension Study: up to 192 Weeks|Ongoing|233|||
30973854|NCT02158091|59052958|FG000|Overall Study|DLT|2|||
30973855|NCT02158091|59052959|FG001|Overall Study|DLT|1|||
30973856|NCT02158091|59052960|FG002|Overall Study|DLT|0|||
30973857|NCT00545077|59052970|FG000|Overall Study|Treatment not received|5|||
30973858|NCT00545077|59052971|FG001|Overall Study|Treatment not received|1|||
30973859|NCT00545077|59052970|FG000|Overall Study|Disease Progression|131|||
30973860|NCT00545077|59052971|FG001|Overall Study|Disease Progression|98|||
30973861|NCT00545077|59052970|FG000|Overall Study|Withdrawal by Subject|3|||
30973862|NCT00545077|59052971|FG001|Overall Study|Withdrawal by Subject|14|||
30973863|NCT00545077|59052970|FG000|Overall Study|Physician Decision|6|||
30973864|NCT00545077|59052971|FG001|Overall Study|Physician Decision|3|||
30973865|NCT00545077|59052970|FG000|Overall Study|Lost to Follow-up|2|||
30973866|NCT00545077|59052971|FG001|Overall Study|Lost to Follow-up|0|||
30973867|NCT00545077|59052970|FG000|Overall Study|Protocol Violation|1|||
30973868|NCT00545077|59052971|FG001|Overall Study|Protocol Violation|0|||
30973869|NCT00545077|59052970|FG000|Overall Study|Adverse Event|0|||
30973870|NCT00545077|59052971|FG001|Overall Study|Adverse Event|31|||
30973871|NCT00545077|59052970|FG000|Overall Study|Death|0|||
30973872|NCT00545077|59052971|FG001|Overall Study|Death|8|||
30973873|NCT00130533|59052979|FG000|Overall Study|Withdrawal by Subject|33|||
30973874|NCT00130533|59052980|FG001|Overall Study|Withdrawal by Subject|6|||
30973875|NCT00130533|59052979|FG000|Overall Study|Adverse Event|34|||
30973876|NCT00130533|59052980|FG001|Overall Study|Adverse Event|1|||
30973877|NCT00130533|59052979|FG000|Overall Study|Disease relapse|9|||
30973878|NCT00130533|59052980|FG001|Overall Study|Disease relapse|13|||
30973879|NCT00130533|59052979|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
30973880|NCT00130533|59052980|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
30973881|NCT00130533|59052979|FG000|Overall Study|Death|4|||
30973882|NCT00130533|59052980|FG001|Overall Study|Death|2|||
30973883|NCT00130533|59052979|FG000|Overall Study|Protocol Violation|5|||
30973884|NCT00130533|59052980|FG001|Overall Study|Protocol Violation|1|||
30973885|NCT00130533|59052979|FG000|Overall Study|Lost to Follow-up|1|||
30973886|NCT00130533|59052980|FG001|Overall Study|Lost to Follow-up|1|||
30973887|NCT00130533|59052979|FG000|Overall Study|Sponsor´s decision|2|||
30973888|NCT00130533|59052980|FG001|Overall Study|Sponsor´s decision|0|||
30973889|NCT00130533|59052979|FG000|Overall Study|Second Primary Malignancy|0|||
30973890|NCT00130533|59052980|FG001|Overall Study|Second Primary Malignancy|1|||
30973891|NCT00130533|59052979|FG000|Overall Study|Other|12|||
30973892|NCT00130533|59052980|FG001|Overall Study|Other|5|||
30973893|NCT00129935|59052988|FG000|Overall Study|Adverse Event|18|||
30973894|NCT00129935|59052989|FG001|Overall Study|Adverse Event|56|||
30973895|NCT00129935|59052988|FG000|Overall Study|Death|1|||
30973896|NCT00129935|59052989|FG001|Overall Study|Death|1|||
30973897|NCT00129935|59052988|FG000|Overall Study|Withdrawal by Subject|7|||
30973898|NCT00129935|59052989|FG001|Overall Study|Withdrawal by Subject|20|||
30973899|NCT00129935|59052988|FG000|Overall Study|Protocol Violation|0|||
30973900|NCT00129935|59052989|FG001|Overall Study|Protocol Violation|4|||
30973901|NCT00129935|59052988|FG000|Overall Study|Physician Decision|3|||
30973902|NCT00129935|59052989|FG001|Overall Study|Physician Decision|4|||
30973903|NCT00129935|59052988|FG000|Overall Study|Recurrence|1|||
30973904|NCT00129935|59052989|FG001|Overall Study|Recurrence|3|||
30973905|NCT00129935|59052988|FG000|Overall Study|Second primary|0|||
30973906|NCT00129935|59052989|FG001|Overall Study|Second primary|1|||
30973907|NCT00129935|59052988|FG000|Overall Study|Other|3|||
30973908|NCT00129935|59052989|FG001|Overall Study|Other|2|||
30973909|NCT00129935|59052988|FG000|Overall Study|Crossed to the other arm|2|||
30973910|NCT00129935|59052989|FG001|Overall Study|Crossed to the other arm|1|||
30973911|NCT00129935|59052988|FG000|Overall Study|Incorrect study treatment|1|||
30973912|NCT00129935|59052989|FG001|Overall Study|Incorrect study treatment|0|||
30973913|NCT01647828|59053004|FG000|Overall Study|Death|3|||
30973914|NCT01647828|59053005|FG001|Overall Study|Death|4|||
30973915|NCT01647828|59053006|FG002|Overall Study|Death|4|||
30973916|NCT01647828|59053007|FG003|Overall Study|Death|5|||
30973917|NCT01647828|59053008|FG004|Overall Study|Death|6|||
30973918|NCT01647828|59053009|FG005|Overall Study|Death|3|||
30973919|NCT01647828|59053010|FG006|Overall Study|Death|10|||
30973920|NCT01647828|59053011|FG007|Overall Study|Death|60|||
30973921|NCT01647828|59053012|FG008|Overall Study|Death|71|||
30973922|NCT01647828|59053004|FG000|Overall Study|Withdrawal by Subject|2|||
30973923|NCT01647828|59053005|FG001|Overall Study|Withdrawal by Subject|0|||
30973924|NCT01647828|59053006|FG002|Overall Study|Withdrawal by Subject|0|||
30973925|NCT01647828|59053007|FG003|Overall Study|Withdrawal by Subject|1|||
30973926|NCT01647828|59053008|FG004|Overall Study|Withdrawal by Subject|0|||
30973927|NCT01647828|59053009|FG005|Overall Study|Withdrawal by Subject|0|||
30973928|NCT01647828|59053010|FG006|Overall Study|Withdrawal by Subject|1|||
30973929|NCT01647828|59053011|FG007|Overall Study|Withdrawal by Subject|0|||
30973930|NCT01647828|59053012|FG008|Overall Study|Withdrawal by Subject|2|||
30973931|NCT01647828|59053004|FG000|Overall Study|Study terminated by Sponsor|0|||
30973932|NCT01647828|59053005|FG001|Overall Study|Study terminated by Sponsor|0|||
30973933|NCT01647828|59053006|FG002|Overall Study|Study terminated by Sponsor|0|||
30973934|NCT01647828|59053007|FG003|Overall Study|Study terminated by Sponsor|0|||
30973935|NCT01647828|59053008|FG004|Overall Study|Study terminated by Sponsor|0|||
30973936|NCT01647828|59053009|FG005|Overall Study|Study terminated by Sponsor|0|||
30973937|NCT01647828|59053010|FG006|Overall Study|Study terminated by Sponsor|1|||
30973938|NCT01647828|59053011|FG007|Overall Study|Study terminated by Sponsor|26|||
30973939|NCT01647828|59053012|FG008|Overall Study|Study terminated by Sponsor|16|||
30973940|NCT01647828|59053004|FG000|Overall Study|Lost to Follow-up|0|||
30973941|NCT01647828|59053005|FG001|Overall Study|Lost to Follow-up|0|||
30973942|NCT01647828|59053006|FG002|Overall Study|Lost to Follow-up|0|||
30973943|NCT01647828|59053007|FG003|Overall Study|Lost to Follow-up|0|||
30973944|NCT01647828|59053008|FG004|Overall Study|Lost to Follow-up|0|||
30973945|NCT01647828|59053009|FG005|Overall Study|Lost to Follow-up|0|||
30973946|NCT01647828|59053010|FG006|Overall Study|Lost to Follow-up|0|||
30973947|NCT01647828|59053011|FG007|Overall Study|Lost to Follow-up|2|||
30973948|NCT01647828|59053012|FG008|Overall Study|Lost to Follow-up|0|||
30973949|NCT00989261|59053034|FG000|Overall Study|Still in follow up|12|||
30973950|NCT00989261|59053035|FG001|Overall Study|Still in follow up|21|||
30973951|NCT00989261|59053034|FG000|Overall Study|Withdrawal by Subject|0|||
30973952|NCT00989261|59053035|FG001|Overall Study|Withdrawal by Subject|1|||
30973953|NCT00989261|59053034|FG000|Overall Study|Lost to Follow-up|3|||
30973954|NCT00989261|59053035|FG001|Overall Study|Lost to Follow-up|0|||
30973955|NCT00988559|59053054|FG000|Overall Study|Withdrawal by Subject|1|||
30973956|NCT00988559|59053055|FG001|Overall Study|Withdrawal by Subject|1|||
30973957|NCT00988559|59053056|FG002|Overall Study|Withdrawal by Subject|0|||
30973958|NCT00988559|59053057|FG003|Overall Study|Withdrawal by Subject|1|||
30973959|NCT00988559|59053054|FG000|Overall Study|Pregnancy|0|||
30973960|NCT00988559|59053055|FG001|Overall Study|Pregnancy|1|||
30973961|NCT00988559|59053056|FG002|Overall Study|Pregnancy|1|||
30973962|NCT00988559|59053057|FG003|Overall Study|Pregnancy|0|||
30973963|NCT00988559|59053054|FG000|Overall Study|Lost to Follow-up|0|||
30973964|NCT00988559|59053055|FG001|Overall Study|Lost to Follow-up|0|||
30973965|NCT00988559|59053056|FG002|Overall Study|Lost to Follow-up|1|||
30973966|NCT00988559|59053057|FG003|Overall Study|Lost to Follow-up|0|||
30973967|NCT00988169|59053067|FG000|Overall Study|Withdrawal by Subject|1|||
30973968|NCT00988091|59053094|FG000|Double-blind Period|Withdrawal by Subject|15|||
30973969|NCT00988091|59053095|FG001|Double-blind Period|Withdrawal by Subject|13|||
30973970|NCT00988091|59053094|FG000|Double-blind Period|Lost to Follow-up|12|||
30973971|NCT00988091|59053095|FG001|Double-blind Period|Lost to Follow-up|14|||
30973972|NCT00988091|59053094|FG000|Double-blind Period|Other|8|||
30973973|NCT00988091|59053095|FG001|Double-blind Period|Other|8|||
30973974|NCT00988091|59053094|FG000|Double-blind Period|Adverse Event|6|||
30973975|NCT00988091|59053095|FG001|Double-blind Period|Adverse Event|9|||
30973976|NCT00988091|59053094|FG000|Double-blind Period|Use of exclusionary medication|2|||
30973977|NCT00988091|59053095|FG001|Double-blind Period|Use of exclusionary medication|3|||
30973978|NCT00988091|59053094|FG000|Open-label Period|Adverse Event|4|||
30973979|NCT00988091|59053095|FG001|Open-label Period|Adverse Event|7|||
30973980|NCT00988091|59053094|FG000|Open-label Period|Use of exclusionary medication|1|||
30973981|NCT00988091|59053095|FG001|Open-label Period|Use of exclusionary medication|1|||
30973982|NCT00988091|59053094|FG000|Open-label Period|Protocol Violation|1|||
30973983|NCT00988091|59053095|FG001|Open-label Period|Protocol Violation|1|||
30973984|NCT00988091|59053094|FG000|Open-label Period|Withdrawal by Subject|10|||
30973985|NCT00988091|59053095|FG001|Open-label Period|Withdrawal by Subject|16|||
30973986|NCT00988091|59053094|FG000|Open-label Period|Lost to Follow-up|3|||
30973987|NCT00988091|59053095|FG001|Open-label Period|Lost to Follow-up|5|||
30973988|NCT00988091|59053094|FG000|Open-label Period|Other|2|||
30973989|NCT00988091|59053095|FG001|Open-label Period|Other|3|||
30608410|NCT01288430|58619229|FG008|Part 1|Death due to disease progression|0|||
30973990|NCT02623218|59053385|FG000|Overall Study|Lost to Follow-up|0|||
30973991|NCT02623218|59053386|FG001|Overall Study|Lost to Follow-up|1|||
30973992|NCT02623218|59053387|FG002|Overall Study|Lost to Follow-up|0|||
30973993|NCT02623218|59053388|FG003|Overall Study|Lost to Follow-up|0|||
30973994|NCT02623218|59053389|FG004|Overall Study|Lost to Follow-up|0|||
30973995|NCT02622828|59053423|FG000|Overall Study|participant withdrew|3|||
30973996|NCT02621424|59053539|FG000|Overall Study|Withdrawal by Subject|1|||
30973997|NCT02621424|59053540|FG001|Overall Study|Withdrawal by Subject|2|||
30973998|NCT02621034|59053568|FG000|Overall Study|Lost to Follow-up|3|||
30973999|NCT02621034|59053569|FG001|Overall Study|Lost to Follow-up|2|||
30974000|NCT02621034|59053570|FG002|Overall Study|Lost to Follow-up|5|||
30974001|NCT02620020|59053643|FG000|Overall Study|Adverse Event|8|||
30974002|NCT02620020|59053644|FG001|Overall Study|Adverse Event|4|||
30974003|NCT02620020|59053645|FG002|Overall Study|Adverse Event|3|||
30974004|NCT02620020|59053646|FG003|Overall Study|Adverse Event|5|||
30974005|NCT02620020|59053643|FG000|Overall Study|Lost to Follow-up|4|||
30974006|NCT02620020|59053644|FG001|Overall Study|Lost to Follow-up|8|||
30974007|NCT02620020|59053645|FG002|Overall Study|Lost to Follow-up|1|||
30974008|NCT02620020|59053646|FG003|Overall Study|Lost to Follow-up|4|||
30974009|NCT02620020|59053643|FG000|Overall Study|Physician Decision|7|||
30974010|NCT02620020|59053644|FG001|Overall Study|Physician Decision|4|||
30974011|NCT02620020|59053645|FG002|Overall Study|Physician Decision|3|||
30974012|NCT02620020|59053646|FG003|Overall Study|Physician Decision|4|||
30974013|NCT02620020|59053643|FG000|Overall Study|Protocol Violation|5|||
30974014|NCT02620020|59053644|FG001|Overall Study|Protocol Violation|2|||
30974015|NCT02620020|59053645|FG002|Overall Study|Protocol Violation|1|||
30974016|NCT02620020|59053646|FG003|Overall Study|Protocol Violation|1|||
30974017|NCT02620020|59053643|FG000|Overall Study|Withdrawal by Subject|20|||
30974018|NCT02620020|59053644|FG001|Overall Study|Withdrawal by Subject|16|||
30974019|NCT02620020|59053645|FG002|Overall Study|Withdrawal by Subject|17|||
30974020|NCT02620020|59053646|FG003|Overall Study|Withdrawal by Subject|12|||
30974021|NCT02620020|59053643|FG000|Overall Study|Death|0|||
30974022|NCT02620020|59053644|FG001|Overall Study|Death|1|||
30974023|NCT02620020|59053645|FG002|Overall Study|Death|0|||
30974024|NCT02620020|59053646|FG003|Overall Study|Death|0|||
30974025|NCT02549989|59053656|FG000|Overall Study|Adverse Event|4|||
30974026|NCT02549989|59053656|FG000|Overall Study|Death|1|||
30974027|NCT02549989|59053656|FG000|Overall Study|Lack of Efficacy|19|||
30974028|NCT02549989|59053656|FG000|Overall Study|Withdrawal by Subject|3|||
30974029|NCT00987935|59053815|FG000|Overall Study|Progressive disease|3|||
30974030|NCT00987935|59053816|FG001|Overall Study|Progressive disease|2|||
30974031|NCT00987935|59053817|FG002|Overall Study|Progressive disease|3|||
30974032|NCT00987935|59053818|FG003|Overall Study|Progressive disease|2|||
30974033|NCT00987935|59053819|FG004|Overall Study|Progressive disease|5|||
30974034|NCT00987935|59053820|FG005|Overall Study|Progressive disease|3|||
30974035|NCT00987935|59053821|FG006|Overall Study|Progressive disease|9|||
30974036|NCT00987935|59053822|FG007|Overall Study|Progressive disease|48|||
30974037|NCT00987935|59053823|FG008|Overall Study|Progressive disease|23|||
30974038|NCT00987935|59053815|FG000|Overall Study|Adverse Event|0|||
30974039|NCT00987935|59053816|FG001|Overall Study|Adverse Event|1|||
30974040|NCT00987935|59053817|FG002|Overall Study|Adverse Event|0|||
30974041|NCT00987935|59053818|FG003|Overall Study|Adverse Event|1|||
30974042|NCT00987935|59053819|FG004|Overall Study|Adverse Event|1|||
30974043|NCT00987935|59053820|FG005|Overall Study|Adverse Event|0|||
30974044|NCT00987935|59053821|FG006|Overall Study|Adverse Event|2|||
30974045|NCT00987935|59053822|FG007|Overall Study|Adverse Event|10|||
30974046|NCT00987935|59053823|FG008|Overall Study|Adverse Event|6|||
30974047|NCT00987935|59053815|FG000|Overall Study|Refused to continue taking trial med.|1|||
30974048|NCT00987935|59053816|FG001|Overall Study|Refused to continue taking trial med.|0|||
30974049|NCT00987935|59053817|FG002|Overall Study|Refused to continue taking trial med.|0|||
30974050|NCT00987935|59053818|FG003|Overall Study|Refused to continue taking trial med.|0|||
30974051|NCT00987935|59053819|FG004|Overall Study|Refused to continue taking trial med.|1|||
30974052|NCT00987935|59053820|FG005|Overall Study|Refused to continue taking trial med.|0|||
30974053|NCT00987935|59053821|FG006|Overall Study|Refused to continue taking trial med.|4|||
30974054|NCT00987935|59053822|FG007|Overall Study|Refused to continue taking trial med.|4|||
30974055|NCT00987935|59053823|FG008|Overall Study|Refused to continue taking trial med.|2|||
30974056|NCT00987935|59053815|FG000|Overall Study|Reason other than those specified above|0|||
30974057|NCT00987935|59053816|FG001|Overall Study|Reason other than those specified above|0|||
30974058|NCT00987935|59053817|FG002|Overall Study|Reason other than those specified above|0|||
30974059|NCT00987935|59053818|FG003|Overall Study|Reason other than those specified above|0|||
30974060|NCT00987935|59053819|FG004|Overall Study|Reason other than those specified above|0|||
30974061|NCT00987935|59053820|FG005|Overall Study|Reason other than those specified above|0|||
30974062|NCT00987935|59053821|FG006|Overall Study|Reason other than those specified above|0|||
30974063|NCT00987935|59053822|FG007|Overall Study|Reason other than those specified above|0|||
30974064|NCT00987935|59053823|FG008|Overall Study|Reason other than those specified above|1|||
30974065|NCT01597050|59053851|FG000|Overall Study|Withdrawal by Subject|1|||
30974066|NCT01597050|59053852|FG001|Overall Study|Withdrawal by Subject|0|||
30974067|NCT00987623|59053869|FG000|Overall Study|Lost to Follow-up|2|||
30974068|NCT00987623|59053870|FG001|Overall Study|Lost to Follow-up|1|||
30974069|NCT00987623|59053869|FG000|Overall Study|Time/job conflict|2|||
30974070|NCT00987623|59053870|FG001|Overall Study|Time/job conflict|0|||
30974071|NCT00987623|59053869|FG000|Overall Study|Discomfort|1|||
30974072|NCT00987623|59053870|FG001|Overall Study|Discomfort|0|||
30974073|NCT00987623|59053869|FG000|Overall Study|Biomicroscopy|0|||
30974074|NCT00987623|59053870|FG001|Overall Study|Biomicroscopy|1|||
30974075|NCT00987623|59053869|FG000|Overall Study|Influenza|0|||
30974076|NCT00987623|59053870|FG001|Overall Study|Influenza|1|||
30974077|NCT00987467|59053876|FG000|Overall Study|Lost to Follow-up|2|||
30974078|NCT04990440|59053884|FG000|Overall Study|Sponsor's Decision|0|||
30974079|NCT04990440|59053885|FG001|Overall Study|Sponsor's Decision|0|||
30974080|NCT04990440|59053886|FG002|Overall Study|Sponsor's Decision|1|||
30974081|NCT04829747|59053894|FG000|Overall Study|Protocol Violation|1|||
30974082|NCT04408924|59053920|FG000|Overall Study|On Study Treatment|3|||
30974083|NCT04408924|59053920|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|14|||
30974084|NCT04408924|59053920|FG000|Overall Study|Lost to Follow-up|1|||
30974085|NCT04408924|59053920|FG000|Overall Study|Withdrawal by Subject|7|||
30974086|NCT04258423|59053936|FG000|Overall Study|Study Closure|2|||
30974087|NCT04258423|59053937|FG001|Overall Study|Study Closure|2|||
30974088|NCT04178967|59053945|FG000|Induction Period|Adverse Event|4|||
30974089|NCT04178967|59053946|FG001|Induction Period|Adverse Event|6|||
30974090|NCT04178967|59053947|FG002|Induction Period|Adverse Event|0|||
30974091|NCT04178967|59053948|FG003|Induction Period|Adverse Event|0|||
30974092|NCT04178967|59053949|FG004|Induction Period|Adverse Event|0|||
30974093|NCT04178967|59053950|FG005|Induction Period|Adverse Event|0|||
30974094|NCT04178967|59053951|FG006|Induction Period|Adverse Event|0|||
30974095|NCT04178967|59053952|FG007|Induction Period|Adverse Event|0|||
30974096|NCT04178967|59053953|FG008|Induction Period|Adverse Event|0|||
30974097|NCT04178967|59053954|FG009|Induction Period|Adverse Event|0|||
30974098|NCT04178967|59053955|FG010|Induction Period|Adverse Event|0|||
30974099|NCT04178967|59053945|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
30974100|NCT04178967|59053946|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
30974101|NCT04178967|59053947|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
30974102|NCT04178967|59053948|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
30974103|NCT04178967|59053949|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
30974104|NCT04178967|59053950|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
30974105|NCT04178967|59053951|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
30974106|NCT04178967|59053952|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
30974107|NCT04178967|59053953|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
30974108|NCT04178967|59053954|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
30974109|NCT04178967|59053955|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
30974110|NCT04178967|59053945|FG000|Induction Period|Lack of Efficacy|4|||
30974111|NCT04178967|59053946|FG001|Induction Period|Lack of Efficacy|1|||
30974112|NCT04178967|59053947|FG002|Induction Period|Lack of Efficacy|0|||
30974113|NCT04178967|59053948|FG003|Induction Period|Lack of Efficacy|0|||
30974114|NCT04178967|59053949|FG004|Induction Period|Lack of Efficacy|0|||
30974115|NCT04178967|59053950|FG005|Induction Period|Lack of Efficacy|0|||
30974116|NCT04178967|59053951|FG006|Induction Period|Lack of Efficacy|0|||
30974117|NCT04178967|59053952|FG007|Induction Period|Lack of Efficacy|0|||
30974118|NCT04178967|59053953|FG008|Induction Period|Lack of Efficacy|0|||
30974119|NCT04178967|59053954|FG009|Induction Period|Lack of Efficacy|0|||
30974120|NCT04178967|59053955|FG010|Induction Period|Lack of Efficacy|0|||
30974121|NCT04178967|59053945|FG000|Induction Period|Protocol Violation|0|||
30974122|NCT04178967|59053946|FG001|Induction Period|Protocol Violation|6|||
30974123|NCT04178967|59053947|FG002|Induction Period|Protocol Violation|0|||
30974124|NCT04178967|59053948|FG003|Induction Period|Protocol Violation|0|||
30974125|NCT04178967|59053949|FG004|Induction Period|Protocol Violation|0|||
30974126|NCT04178967|59053950|FG005|Induction Period|Protocol Violation|0|||
30974127|NCT04178967|59053951|FG006|Induction Period|Protocol Violation|0|||
30974128|NCT04178967|59053952|FG007|Induction Period|Protocol Violation|0|||
30974129|NCT04178967|59053953|FG008|Induction Period|Protocol Violation|0|||
30974130|NCT04178967|59053954|FG009|Induction Period|Protocol Violation|0|||
30974131|NCT04178967|59053955|FG010|Induction Period|Protocol Violation|0|||
30974132|NCT04178967|59053945|FG000|Induction Period|Withdrawal by Subject|6|||
30974133|NCT04178967|59053946|FG001|Induction Period|Withdrawal by Subject|4|||
30974134|NCT04178967|59053947|FG002|Induction Period|Withdrawal by Subject|0|||
30974135|NCT04178967|59053948|FG003|Induction Period|Withdrawal by Subject|0|||
30974136|NCT04178967|59053949|FG004|Induction Period|Withdrawal by Subject|0|||
30974137|NCT04178967|59053950|FG005|Induction Period|Withdrawal by Subject|0|||
30974138|NCT04178967|59053951|FG006|Induction Period|Withdrawal by Subject|0|||
30974139|NCT04178967|59053952|FG007|Induction Period|Withdrawal by Subject|0|||
30974140|NCT04178967|59053953|FG008|Induction Period|Withdrawal by Subject|0|||
30974141|NCT04178967|59053954|FG009|Induction Period|Withdrawal by Subject|0|||
30974142|NCT04178967|59053955|FG010|Induction Period|Withdrawal by Subject|0|||
30974143|NCT04178967|59053945|FG000|Induction Period|Lost to Follow-up|2|||
30974144|NCT04178967|59053946|FG001|Induction Period|Lost to Follow-up|0|||
30974145|NCT04178967|59053947|FG002|Induction Period|Lost to Follow-up|0|||
30974146|NCT04178967|59053948|FG003|Induction Period|Lost to Follow-up|0|||
30974147|NCT04178967|59053949|FG004|Induction Period|Lost to Follow-up|0|||
30974148|NCT04178967|59053950|FG005|Induction Period|Lost to Follow-up|0|||
30974149|NCT04178967|59053951|FG006|Induction Period|Lost to Follow-up|0|||
30974150|NCT04178967|59053952|FG007|Induction Period|Lost to Follow-up|0|||
30974151|NCT04178967|59053953|FG008|Induction Period|Lost to Follow-up|0|||
30974152|NCT04178967|59053954|FG009|Induction Period|Lost to Follow-up|0|||
30974153|NCT04178967|59053955|FG010|Induction Period|Lost to Follow-up|0|||
30974154|NCT04178967|59053945|FG000|Induction Period|Participant Missed Study Visits|0|||
30974155|NCT04178967|59053946|FG001|Induction Period|Participant Missed Study Visits|1|||
30974156|NCT04178967|59053947|FG002|Induction Period|Participant Missed Study Visits|0|||
30974157|NCT04178967|59053948|FG003|Induction Period|Participant Missed Study Visits|0|||
30974158|NCT04178967|59053949|FG004|Induction Period|Participant Missed Study Visits|0|||
30974159|NCT04178967|59053950|FG005|Induction Period|Participant Missed Study Visits|0|||
30974160|NCT04178967|59053951|FG006|Induction Period|Participant Missed Study Visits|0|||
30974161|NCT04178967|59053952|FG007|Induction Period|Participant Missed Study Visits|0|||
30974162|NCT04178967|59053953|FG008|Induction Period|Participant Missed Study Visits|0|||
30974163|NCT04178967|59053954|FG009|Induction Period|Participant Missed Study Visits|0|||
30974164|NCT04178967|59053955|FG010|Induction Period|Participant Missed Study Visits|0|||
30974165|NCT04178967|59053945|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
30974166|NCT04178967|59053946|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
30974167|NCT04178967|59053947|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
30974168|NCT04178967|59053948|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
30974169|NCT04178967|59053949|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
30974170|NCT04178967|59053950|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
30974171|NCT04178967|59053951|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
30974172|NCT04178967|59053952|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
30974173|NCT04178967|59053953|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
30974174|NCT04178967|59053954|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
30974175|NCT04178967|59053955|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
30974176|NCT04178967|59053945|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30974177|NCT04178967|59053946|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30974178|NCT04178967|59053947|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30974179|NCT04178967|59053948|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30974180|NCT04178967|59053949|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30974181|NCT04178967|59053950|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
30974182|NCT04178967|59053951|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30974183|NCT04178967|59053952|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30974184|NCT04178967|59053953|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30974185|NCT04178967|59053954|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30974186|NCT04178967|59053955|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30974187|NCT04178967|59053945|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30974188|NCT04178967|59053946|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30974189|NCT04178967|59053947|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30974190|NCT04178967|59053948|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
30974191|NCT04178967|59053949|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30974192|NCT04178967|59053950|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30974193|NCT04178967|59053951|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30974194|NCT04178967|59053952|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30974195|NCT04178967|59053953|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30974196|NCT04178967|59053954|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30974197|NCT04178967|59053955|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30974198|NCT04178967|59053945|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
30974199|NCT04178967|59053946|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
30974200|NCT04178967|59053947|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
30974201|NCT04178967|59053948|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
30974202|NCT04178967|59053949|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
30974203|NCT04178967|59053950|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
30880401|NCT01668797|58912378|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
30880402|NCT01668797|58912379|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
30974204|NCT04178967|59053951|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
30974205|NCT04178967|59053952|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
30974206|NCT04178967|59053953|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
30974207|NCT04178967|59053954|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
30974208|NCT04178967|59053955|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
30974209|NCT04178967|59053945|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30974210|NCT04178967|59053946|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30790013|NCT00048581|58803260|FG002|Double-Blind Period|Adverse Event|0|||
30974211|NCT04178967|59053947|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30974212|NCT04178967|59053948|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30974213|NCT04178967|59053949|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
30974214|NCT04178967|59053950|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
30974215|NCT04178967|59053951|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30974216|NCT04178967|59053952|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
30974217|NCT04178967|59053953|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30974218|NCT04178967|59053954|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30974219|NCT04178967|59053955|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30974220|NCT04178967|59053945|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
30974221|NCT04178967|59053946|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
30974222|NCT04178967|59053947|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
30974223|NCT04178967|59053948|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
30974224|NCT04178967|59053949|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
30974225|NCT04178967|59053950|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
30974226|NCT04178967|59053951|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
30974227|NCT04178967|59053952|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
30974228|NCT04178967|59053953|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
30974229|NCT04178967|59053954|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
30974230|NCT04178967|59053955|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
30974231|NCT04178967|59053945|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30974232|NCT04178967|59053946|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30974233|NCT04178967|59053947|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30974234|NCT04178967|59053948|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
30974235|NCT04178967|59053949|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30974236|NCT04178967|59053950|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
30974237|NCT04178967|59053951|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
30974238|NCT04178967|59053952|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
30974239|NCT04178967|59053953|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30974240|NCT04178967|59053954|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30974241|NCT04178967|59053955|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30974242|NCT04178967|59053945|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
30974243|NCT04178967|59053946|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
30974244|NCT04178967|59053947|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
30974245|NCT04178967|59053948|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
30974246|NCT04178967|59053949|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
30974247|NCT04178967|59053950|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
30974248|NCT04178967|59053951|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
30974249|NCT04178967|59053952|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
30974250|NCT04178967|59053953|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
30974251|NCT04178967|59053954|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
30974252|NCT04178967|59053955|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
30974253|NCT04178967|59053945|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30974254|NCT04178967|59053946|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30974255|NCT04178967|59053947|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30974256|NCT04178967|59053948|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30974257|NCT04178967|59053949|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30974258|NCT04178967|59053950|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30974259|NCT04178967|59053951|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30974260|NCT04178967|59053952|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30974261|NCT04178967|59053953|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
30974262|NCT04178967|59053954|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
30974263|NCT04178967|59053955|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
30974264|NCT04178967|59053945|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30974265|NCT04178967|59053946|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30974266|NCT04178967|59053947|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30974267|NCT04178967|59053948|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30974268|NCT04178967|59053949|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30974269|NCT04178967|59053950|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30974270|NCT04178967|59053951|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30974271|NCT04178967|59053952|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30974272|NCT04178967|59053953|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30974273|NCT04178967|59053954|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
30974274|NCT04178967|59053955|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30974275|NCT04178967|59053945|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30974276|NCT04178967|59053946|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30974277|NCT04178967|59053947|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30974278|NCT04178967|59053948|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30974279|NCT04178967|59053949|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30974280|NCT04178967|59053950|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30974281|NCT04178967|59053951|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30974282|NCT04178967|59053952|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30974283|NCT04178967|59053953|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
30974284|NCT04178967|59053954|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
30974285|NCT04178967|59053955|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
30974286|NCT04178967|59053945|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
30974287|NCT04178967|59053946|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
30974288|NCT04178967|59053947|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
30974289|NCT04178967|59053948|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
30974290|NCT04178967|59053949|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
30974291|NCT04178967|59053950|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
30974292|NCT04178967|59053951|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
30974293|NCT04178967|59053952|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
30974294|NCT04178967|59053953|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
30974295|NCT04178967|59053954|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
30974296|NCT04178967|59053955|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
30974297|NCT04178967|59053945|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
30974298|NCT04178967|59053946|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
30974299|NCT04178967|59053947|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
30974300|NCT04178967|59053948|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
30974301|NCT04178967|59053949|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
30974302|NCT04178967|59053950|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
30974303|NCT04178967|59053951|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
30974304|NCT04178967|59053952|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
30974305|NCT04178967|59053953|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
30974306|NCT04178967|59053954|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
30974307|NCT04178967|59053955|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
30974308|NCT04163900|59053977|FG000|Overall Study|Radiological disease progression|112|||
30974309|NCT04163900|59053978|FG001|Overall Study|Radiological disease progression|127|||
30974310|NCT04163900|59053977|FG000|Overall Study|Study closure|98|||
30974311|NCT04163900|59053978|FG001|Overall Study|Study closure|133|||
30974312|NCT04163900|59053977|FG000|Overall Study|Adverse Event|78|||
30974313|NCT04163900|59053978|FG001|Overall Study|Adverse Event|32|||
30974314|NCT04163900|59053977|FG000|Overall Study|Withdrawal by Subject|37|||
30974315|NCT04163900|59053978|FG001|Overall Study|Withdrawal by Subject|34|||
30974316|NCT04163900|59053977|FG000|Overall Study|Death|29|||
30974317|NCT04163900|59053978|FG001|Overall Study|Death|16|||
30974318|NCT04163900|59053977|FG000|Overall Study|Physician Decision|17|||
30974319|NCT04163900|59053978|FG001|Overall Study|Physician Decision|25|||
30974320|NCT04163900|59053977|FG000|Overall Study|Clinical disease progression|14|||
30974321|NCT04163900|59053978|FG001|Overall Study|Clinical disease progression|13|||
30974322|NCT04163900|59053977|FG000|Overall Study|Protocol Violation|3|||
30974323|NCT04163900|59053978|FG001|Overall Study|Protocol Violation|4|||
30974324|NCT04163900|59053977|FG000|Overall Study|Lost to Follow-up|0|||
30974325|NCT04163900|59053978|FG001|Overall Study|Lost to Follow-up|1|||
30974326|NCT04161495|59053986|FG000|Overall Study|Withdrawal by Subject|3|||
30974327|NCT04161495|59053987|FG001|Overall Study|Withdrawal by Subject|0|||
30974328|NCT04161495|59053986|FG000|Overall Study|Protocol Violation|1|||
30974329|NCT04161495|59053987|FG001|Overall Study|Protocol Violation|0|||
30974330|NCT04161495|59053986|FG000|Overall Study|Prohibited concomitant medication|3|||
30974331|NCT04161495|59053987|FG001|Overall Study|Prohibited concomitant medication|0|||
30974332|NCT04161495|59053986|FG000|Overall Study|Adverse Event|1|||
30974333|NCT04161495|59053987|FG001|Overall Study|Adverse Event|0|||
30974334|NCT04161495|59053986|FG000|Overall Study|Other - Unspecified|1|||
30974335|NCT04161495|59053987|FG001|Overall Study|Other - Unspecified|0|||
30974336|NCT04161495|59053986|FG000|Overall Study|Death|0|||
30974337|NCT04161495|59053987|FG001|Overall Study|Death|1|||
30974338|NCT04108000|59054016|FG000|Overall Study|Death of patient|1|||
30974339|NCT04108000|59054017|FG001|Overall Study|Death of patient|0|||
30974340|NCT04108000|59054018|FG002|Overall Study|Death of patient|1|||
30974341|NCT04108000|59054019|FG003|Overall Study|Death of patient|0|||
30974342|NCT04108000|59054016|FG000|Overall Study|Withdrawal by Subject|2|||
30974343|NCT04108000|59054017|FG001|Overall Study|Withdrawal by Subject|2|||
30974344|NCT04108000|59054018|FG002|Overall Study|Withdrawal by Subject|0|||
30974345|NCT04108000|59054019|FG003|Overall Study|Withdrawal by Subject|0|||
30974346|NCT04108000|59054016|FG000|Overall Study|Death of surrogate partner|0|||
30974347|NCT04108000|59054017|FG001|Overall Study|Death of surrogate partner|1|||
30974348|NCT04108000|59054018|FG002|Overall Study|Death of surrogate partner|0|||
30974349|NCT04108000|59054019|FG003|Overall Study|Death of surrogate partner|1|||
30974350|NCT04098068|59054033|FG000|Overall Study|Disease Progression|7|||
30974351|NCT04098068|59054033|FG000|Overall Study|Withdrawal by Subject|2|||
30974352|NCT04098068|59054033|FG000|Overall Study|New Cancer Diagnosis|1|||
30974353|NCT03945266|59054039|FG000|Overall Study|Withdrawal by Subject|1|||
30974354|NCT03945266|59054040|FG001|Overall Study|Withdrawal by Subject|0|||
30974355|NCT03945266|59054039|FG000|Overall Study|Miscarriage|0|||
30974356|NCT03945266|59054040|FG001|Overall Study|Miscarriage|2|||
30974357|NCT03945266|59054039|FG000|Overall Study|Lost to Follow-up|1|||
30974358|NCT03945266|59054040|FG001|Overall Study|Lost to Follow-up|0|||
30974359|NCT03916484|59054054|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
30974360|NCT03916484|59054055|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
30974361|NCT03916484|59054056|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
30974362|NCT03916484|59054057|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
30974363|NCT03916484|59054054|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
30974364|NCT03916484|59054055|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
30974365|NCT03916484|59054056|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
30974366|NCT03916484|59054057|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
30974367|NCT03769311|59054072|FG000|Overall Study|Withdrawal by Subject|1|||
30974368|NCT03738566|59054080|FG000|Initial Study Phase|Withdrawal by Subject|1|||
30974369|NCT03738566|59054081|FG001|Initial Study Phase|Withdrawal by Subject|1|||
30974370|NCT03738566|59054082|FG002|Initial Study Phase|Withdrawal by Subject|2|||
30974371|NCT03738566|59054083|FG003|Initial Study Phase|Withdrawal by Subject|0|||
30974372|NCT03738566|59054080|FG000|Initial Study Phase|Death|0|||
30974373|NCT03738566|59054081|FG001|Initial Study Phase|Death|1|||
30974374|NCT03738566|59054082|FG002|Initial Study Phase|Death|0|||
30974375|NCT03738566|59054083|FG003|Initial Study Phase|Death|0|||
30974376|NCT03738566|59054080|FG000|Initial Study Phase|Treatment failure|5|||
30974377|NCT03738566|59054081|FG001|Initial Study Phase|Treatment failure|0|||
30974378|NCT03738566|59054082|FG002|Initial Study Phase|Treatment failure|0|||
30974379|NCT03738566|59054083|FG003|Initial Study Phase|Treatment failure|0|||
30974380|NCT03738566|59054080|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
30974381|NCT03738566|59054081|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
30974382|NCT03738566|59054082|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
30974383|NCT03738566|59054083|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
30974384|NCT03692052|59054113|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
30974385|NCT03692052|59054113|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
30974386|NCT03692052|59054113|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
30974387|NCT03692052|59054113|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
30974388|NCT03533751|59054122|FG000|Overall Study|Withdrawal by Subject|12|||
30974389|NCT03533751|59054123|FG001|Overall Study|Withdrawal by Subject|6|||
30974390|NCT03533751|59054124|FG002|Overall Study|Withdrawal by Subject|11|||
30974391|NCT03533751|59054125|FG003|Overall Study|Withdrawal by Subject|9|||
30974392|NCT03533751|59054126|FG004|Overall Study|Withdrawal by Subject|10|||
30974393|NCT03533751|59054122|FG000|Overall Study|Adverse Event|4|||
30974394|NCT03533751|59054123|FG001|Overall Study|Adverse Event|7|||
30974395|NCT03533751|59054124|FG002|Overall Study|Adverse Event|2|||
30974396|NCT03533751|59054125|FG003|Overall Study|Adverse Event|4|||
30974397|NCT03533751|59054126|FG004|Overall Study|Adverse Event|5|||
30974398|NCT03533751|59054122|FG000|Overall Study|Physician Decision|0|||
30974399|NCT03533751|59054123|FG001|Overall Study|Physician Decision|2|||
30974400|NCT03533751|59054124|FG002|Overall Study|Physician Decision|1|||
30974401|NCT03533751|59054125|FG003|Overall Study|Physician Decision|2|||
30974402|NCT03533751|59054126|FG004|Overall Study|Physician Decision|1|||
30974403|NCT03533751|59054122|FG000|Overall Study|Sponsor Decision|0|||
30974404|NCT03533751|59054123|FG001|Overall Study|Sponsor Decision|0|||
30974405|NCT03533751|59054124|FG002|Overall Study|Sponsor Decision|1|||
30974406|NCT03533751|59054125|FG003|Overall Study|Sponsor Decision|1|||
30974407|NCT03533751|59054126|FG004|Overall Study|Sponsor Decision|0|||
30974408|NCT03533751|59054122|FG000|Overall Study|Lost to Follow-up|3|||
30974409|NCT03533751|59054123|FG001|Overall Study|Lost to Follow-up|7|||
30974410|NCT03533751|59054124|FG002|Overall Study|Lost to Follow-up|6|||
30974411|NCT03533751|59054125|FG003|Overall Study|Lost to Follow-up|4|||
30974412|NCT03533751|59054126|FG004|Overall Study|Lost to Follow-up|3|||
30974413|NCT03533751|59054122|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
30974414|NCT03533751|59054123|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
30974415|NCT03533751|59054124|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
30974416|NCT03533751|59054125|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
30974417|NCT03533751|59054126|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
30974418|NCT03533751|59054122|FG000|Overall Study|Other|0|||
30974419|NCT03533751|59054123|FG001|Overall Study|Other|2|||
30974420|NCT03533751|59054124|FG002|Overall Study|Other|1|||
30974421|NCT03533751|59054125|FG003|Overall Study|Other|0|||
30974422|NCT03533751|59054126|FG004|Overall Study|Other|3|||
30974423|NCT04856917|59054145|FG000|Overall Study|Withdrawal by Subject|4|||
30974424|NCT04856917|59054146|FG001|Overall Study|Withdrawal by Subject|3|||
30974425|NCT04856917|59054147|FG002|Overall Study|Withdrawal by Subject|1|||
30974426|NCT04856917|59054145|FG000|Overall Study|Lost to Follow-up|3|||
30974427|NCT04856917|59054146|FG001|Overall Study|Lost to Follow-up|1|||
30974428|NCT04856917|59054147|FG002|Overall Study|Lost to Follow-up|1|||
30974429|NCT04856917|59054145|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
30974430|NCT04856917|59054146|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
30974431|NCT04856917|59054147|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
30974432|NCT04856917|59054145|FG000|Overall Study|Other|1|||
30974433|NCT04856917|59054146|FG001|Overall Study|Other|1|||
30974434|NCT04856917|59054147|FG002|Overall Study|Other|0|||
30974435|NCT04615247|59054185|FG000|Overall Study|Adverse Event|0|||
30974436|NCT04615247|59054186|FG001|Overall Study|Adverse Event|2|||
30974437|NCT04615247|59054185|FG000|Overall Study|Withdrawal by Subject|1|||
30974438|NCT04615247|59054186|FG001|Overall Study|Withdrawal by Subject|1|||
30974439|NCT04552132|59054207|FG000|Overall Study|Lost to Follow-up|4|||
30974440|NCT04552132|59054208|FG001|Overall Study|Lost to Follow-up|3|||
30974441|NCT04552132|59054207|FG000|Overall Study|Protocol Violation|1|||
30974442|NCT04552132|59054208|FG001|Overall Study|Protocol Violation|0|||
30974443|NCT04421456|59054217|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
30974444|NCT04421456|59054218|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
30974445|NCT04421456|59054219|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
30974446|NCT04421456|59054217|FG000|Randomized Treatment Period|Adverse Event|0|||
30974447|NCT04421456|59054218|FG001|Randomized Treatment Period|Adverse Event|1|||
30974448|NCT04421456|59054219|FG002|Randomized Treatment Period|Adverse Event|0|||
30974449|NCT04421456|59054217|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
30974450|NCT04421456|59054218|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
30974451|NCT04421456|59054219|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
30974452|NCT04421456|59054217|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
30974453|NCT04421456|59054218|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
30974454|NCT04421456|59054219|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
30974455|NCT04421456|59054217|FG000|Randomized Treatment Period|Participant non-compliance|1|||
30974456|NCT04421456|59054218|FG001|Randomized Treatment Period|Participant non-compliance|1|||
30974457|NCT04421456|59054219|FG002|Randomized Treatment Period|Participant non-compliance|2|||
30974458|NCT04421456|59054217|FG000|Randomized Treatment Period|Other|0|||
30974459|NCT04421456|59054218|FG001|Randomized Treatment Period|Other|1|||
30974460|NCT04421456|59054219|FG002|Randomized Treatment Period|Other|3|||
30974461|NCT04341363|59054228|FG000|Overall Study|Adverse Event|1|||
30974462|NCT04341363|59054228|FG000|Overall Study|Withdrawal by Subject|1|||
30974463|NCT04268303|59054239|FG000|Overall Study|Lost to Follow-up|1|||
30974464|NCT04268303|59054240|FG001|Overall Study|Lost to Follow-up|1|||
30974465|NCT04268303|59054241|FG002|Overall Study|Lost to Follow-up|2|||
30974466|NCT04268303|59054239|FG000|Overall Study|Withdrawal by Subject|0|||
30974467|NCT04268303|59054240|FG001|Overall Study|Withdrawal by Subject|1|||
30880403|NCT01668797|58912376|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
30880404|NCT01668797|58912377|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
30974468|NCT04268303|59054241|FG002|Overall Study|Withdrawal by Subject|1|||
30974469|NCT04268303|59054239|FG000|Overall Study|Adverse Event|2|||
30974470|NCT04268303|59054240|FG001|Overall Study|Adverse Event|0|||
30974471|NCT04268303|59054241|FG002|Overall Study|Adverse Event|0|||
30974472|NCT04092452|59054285|FG000|Overall Study|Adverse Event|1|||
30974473|NCT04092452|59054286|FG001|Overall Study|Adverse Event|3|||
30974474|NCT04092452|59054287|FG002|Overall Study|Adverse Event|3|||
30974475|NCT04092452|59054288|FG003|Overall Study|Adverse Event|7|||
30974476|NCT04092452|59054285|FG000|Overall Study|Lack of Efficacy|1|||
30974477|NCT04092452|59054286|FG001|Overall Study|Lack of Efficacy|1|||
30974478|NCT04092452|59054287|FG002|Overall Study|Lack of Efficacy|1|||
30974479|NCT04092452|59054288|FG003|Overall Study|Lack of Efficacy|0|||
30974480|NCT04092452|59054285|FG000|Overall Study|Lost to Follow-up|4|||
30974481|NCT04092452|59054286|FG001|Overall Study|Lost to Follow-up|3|||
30974482|NCT04092452|59054287|FG002|Overall Study|Lost to Follow-up|5|||
30974483|NCT04092452|59054288|FG003|Overall Study|Lost to Follow-up|1|||
30974484|NCT04092452|59054285|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30974485|NCT04092452|59054286|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30974486|NCT04092452|59054287|FG002|Overall Study|Non-Compliance With Study Drug|1|||
30974487|NCT04092452|59054288|FG003|Overall Study|Non-Compliance With Study Drug|1|||
30974488|NCT04092452|59054285|FG000|Overall Study|Physician Decision|1|||
30974489|NCT04092452|59054286|FG001|Overall Study|Physician Decision|0|||
30974490|NCT04092452|59054287|FG002|Overall Study|Physician Decision|1|||
30974491|NCT04092452|59054288|FG003|Overall Study|Physician Decision|0|||
30974492|NCT04092452|59054285|FG000|Overall Study|Pregnancy|2|||
30974493|NCT04092452|59054286|FG001|Overall Study|Pregnancy|0|||
30974494|NCT04092452|59054287|FG002|Overall Study|Pregnancy|0|||
30974495|NCT04092452|59054288|FG003|Overall Study|Pregnancy|0|||
30974496|NCT04092452|59054285|FG000|Overall Study|Protocol Deviation|1|||
30974497|NCT04092452|59054286|FG001|Overall Study|Protocol Deviation|0|||
30974498|NCT04092452|59054287|FG002|Overall Study|Protocol Deviation|0|||
30974499|NCT04092452|59054288|FG003|Overall Study|Protocol Deviation|0|||
30974500|NCT04092452|59054285|FG000|Overall Study|Withdrawal by Subject|3|||
30974501|NCT04092452|59054286|FG001|Overall Study|Withdrawal by Subject|10|||
30974502|NCT04092452|59054287|FG002|Overall Study|Withdrawal by Subject|3|||
30974503|NCT04092452|59054288|FG003|Overall Study|Withdrawal by Subject|5|||
30974504|NCT04092452|59054285|FG000|Overall Study|Other|0|||
30974505|NCT04092452|59054286|FG001|Overall Study|Other|0|||
30974506|NCT04092452|59054287|FG002|Overall Study|Other|1|||
30974507|NCT04092452|59054288|FG003|Overall Study|Other|2|||
30974508|NCT04029116|59054303|FG000|Overall Study|Adverse Event|0|||
30974509|NCT04029116|59054304|FG001|Overall Study|Adverse Event|2|||
30974510|NCT04029116|59054303|FG000|Overall Study|Lost to Follow-up|3|||
30974511|NCT04029116|59054304|FG001|Overall Study|Lost to Follow-up|5|||
30974512|NCT04029116|59054303|FG000|Overall Study|Physician Decision|2|||
30974513|NCT04029116|59054304|FG001|Overall Study|Physician Decision|0|||
30974514|NCT04029116|59054303|FG000|Overall Study|Pregnancy|1|||
30974515|NCT04029116|59054304|FG001|Overall Study|Pregnancy|2|||
30974516|NCT04029116|59054303|FG000|Overall Study|Withdrawal by Subject|4|||
30974517|NCT04029116|59054304|FG001|Overall Study|Withdrawal by Subject|6|||
30974518|NCT04029116|59054303|FG000|Overall Study|Other|2|||
30974519|NCT04029116|59054304|FG001|Overall Study|Other|1|||
30974520|NCT03734029|59054335|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
30974521|NCT03734029|59054336|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
30974522|NCT03734029|59054335|FG000|Overall Study|Adverse Event|60|||
30974523|NCT03734029|59054336|FG001|Overall Study|Adverse Event|14|||
30974524|NCT03734029|59054335|FG000|Overall Study|Withdrawal by Subject|12|||
30974525|NCT03734029|59054336|FG001|Overall Study|Withdrawal by Subject|11|||
30974526|NCT03734029|59054335|FG000|Overall Study|Clinical progression by investigator|10|||
30974527|NCT03734029|59054336|FG001|Overall Study|Clinical progression by investigator|8|||
30974528|NCT03734029|59054335|FG000|Overall Study|Death|5|||
30974529|NCT03734029|59054336|FG001|Overall Study|Death|2|||
30974530|NCT03734029|59054335|FG000|Overall Study|Physician Decision|4|||
30974531|NCT03734029|59054336|FG001|Overall Study|Physician Decision|3|||
30974532|NCT03734029|59054335|FG000|Overall Study|Other|2|||
30974533|NCT03734029|59054336|FG001|Overall Study|Other|0|||
30974534|NCT03734029|59054335|FG000|Overall Study|Lost to Follow-up|0|||
30974535|NCT03734029|59054336|FG001|Overall Study|Lost to Follow-up|1|||
30974536|NCT03734029|59054335|FG000|Overall Study|Randomized, but not treated|2|||
30974537|NCT03734029|59054336|FG001|Overall Study|Randomized, but not treated|12|||
30974538|NCT03732820|59054344|FG000|Overall Study|Death|143|||
30974539|NCT03732820|59054345|FG001|Overall Study|Death|169|||
30974540|NCT03732820|59054344|FG000|Overall Study|Screen failure|0|||
30974541|NCT03732820|59054345|FG001|Overall Study|Screen failure|1|||
30974542|NCT03732820|59054344|FG000|Overall Study|Ongoing study at data cut off|239|||
30974543|NCT03732820|59054345|FG001|Overall Study|Ongoing study at data cut off|216|||
30974544|NCT03732820|59054344|FG000|Overall Study|Failure to meet randomisation criteria|1|||
30974545|NCT03732820|59054345|FG001|Overall Study|Failure to meet randomisation criteria|1|||
30974546|NCT03732820|59054344|FG000|Overall Study|Lost to Follow-up|1|||
30974547|NCT03732820|59054345|FG001|Overall Study|Lost to Follow-up|0|||
30974548|NCT03732820|59054344|FG000|Overall Study|Patient decision|13|||
30974549|NCT03732820|59054345|FG001|Overall Study|Patient decision|8|||
30974550|NCT03732820|59054344|FG000|Overall Study|Other|2|||
30974551|NCT03732820|59054345|FG001|Overall Study|Other|2|||
30974552|NCT03724032|59054354|FG000|Overall Study|Physician Decision|1|||
30974553|NCT03724032|59054355|FG001|Overall Study|Physician Decision|0|||
30974554|NCT03724032|59054356|FG002|Overall Study|Physician Decision|0|||
30974555|NCT03724032|59054354|FG000|Overall Study|Protocol Violation|2|||
30974556|NCT03724032|59054355|FG001|Overall Study|Protocol Violation|2|||
30974557|NCT03724032|59054356|FG002|Overall Study|Protocol Violation|1|||
30974558|NCT03657797|59054393|FG000|Overall Study|Lost to Follow-up|0|||
30974559|NCT03657797|59054394|FG001|Overall Study|Lost to Follow-up|1|||
30974560|NCT03657797|59054395|FG002|Overall Study|Lost to Follow-up|1|||
30974561|NCT03657797|59054396|FG003|Overall Study|Lost to Follow-up|0|||
30974562|NCT03657797|59054393|FG000|Overall Study|Physician Decision|0|||
30974563|NCT03657797|59054394|FG001|Overall Study|Physician Decision|1|||
30974564|NCT03657797|59054395|FG002|Overall Study|Physician Decision|0|||
30974565|NCT03657797|59054396|FG003|Overall Study|Physician Decision|0|||
30974566|NCT03657797|59054393|FG000|Overall Study|Withdrawal by Subject|0|||
30974567|NCT03657797|59054394|FG001|Overall Study|Withdrawal by Subject|1|||
30974568|NCT03657797|59054395|FG002|Overall Study|Withdrawal by Subject|2|||
30974569|NCT03657797|59054396|FG003|Overall Study|Withdrawal by Subject|0|||
30974570|NCT03657797|59054393|FG000|Overall Study|Adverse Event|0|||
30974571|NCT03657797|59054394|FG001|Overall Study|Adverse Event|0|||
30974572|NCT03657797|59054395|FG002|Overall Study|Adverse Event|2|||
30974573|NCT03657797|59054396|FG003|Overall Study|Adverse Event|0|||
30974574|NCT03551938|59054412|FG000|3-Month Follow Up|Lost to Follow-up|39|||
30974575|NCT03551938|59054413|FG001|3-Month Follow Up|Lost to Follow-up|38|||
30974576|NCT03551938|59054412|FG000|6-Month Follow Up|Lost to Follow-up|46|||
30974577|NCT03551938|59054413|FG001|6-Month Follow Up|Lost to Follow-up|42|||
30974578|NCT03551938|59054412|FG000|9-Month Follow Up|Lost to Follow-up|44|||
30974579|NCT03551938|59054413|FG001|9-Month Follow Up|Lost to Follow-up|43|||
30974580|NCT03525600|59054422|FG000|Overall Study|Adverse Event|9|||
30974581|NCT03525600|59054423|FG001|Overall Study|Adverse Event|6|||
30974582|NCT03525600|59054424|FG002|Overall Study|Adverse Event|5|||
30974583|NCT03525600|59054425|FG003|Overall Study|Adverse Event|3|||
30974584|NCT03525600|59054422|FG000|Overall Study|Lost to Follow-up|2|||
30974585|NCT03525600|59054423|FG001|Overall Study|Lost to Follow-up|4|||
30974586|NCT03525600|59054424|FG002|Overall Study|Lost to Follow-up|4|||
30974587|NCT03525600|59054425|FG003|Overall Study|Lost to Follow-up|0|||
30974588|NCT03525600|59054422|FG000|Overall Study|Physician Decision|1|||
30974589|NCT03525600|59054423|FG001|Overall Study|Physician Decision|0|||
30974590|NCT03525600|59054424|FG002|Overall Study|Physician Decision|2|||
30974591|NCT03525600|59054425|FG003|Overall Study|Physician Decision|0|||
30974592|NCT03525600|59054422|FG000|Overall Study|Consent withdrawal|36|||
30974593|NCT03525600|59054423|FG001|Overall Study|Consent withdrawal|20|||
30974594|NCT03525600|59054424|FG002|Overall Study|Consent withdrawal|6|||
30974595|NCT03525600|59054425|FG003|Overall Study|Consent withdrawal|13|||
30974596|NCT03525600|59054422|FG000|Overall Study|Death|7|||
30974597|NCT03525600|59054423|FG001|Overall Study|Death|6|||
30974598|NCT03525600|59054424|FG002|Overall Study|Death|4|||
30974599|NCT03525600|59054425|FG003|Overall Study|Death|3|||
30974600|NCT03525600|59054422|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
30974601|NCT03525600|59054423|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
30974602|NCT03525600|59054424|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
30974603|NCT03525600|59054425|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
30974604|NCT03525600|59054422|FG000|Overall Study|Other|0|||
30974605|NCT03525600|59054423|FG001|Overall Study|Other|1|||
30974606|NCT03525600|59054424|FG002|Overall Study|Other|0|||
30974607|NCT03525600|59054425|FG003|Overall Study|Other|0|||
30974608|NCT03472040|59054442|FG000|Overall Study|Physician Decision|0|||
30974609|NCT03472040|59054443|FG001|Overall Study|Physician Decision|3|||
30974610|NCT03472040|59054442|FG000|Overall Study|Withdrawal by Subject|10|||
30974611|NCT03472040|59054443|FG001|Overall Study|Withdrawal by Subject|23|||
30974612|NCT03472040|59054442|FG000|Overall Study|Perceived Lack of Efficacy|29|||
30974613|NCT03472040|59054443|FG001|Overall Study|Perceived Lack of Efficacy|30|||
30974614|NCT03472040|59054442|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
30974615|NCT03472040|59054443|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
30974616|NCT03472040|59054442|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
30974617|NCT03472040|59054443|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
30974618|NCT03472040|59054442|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
30974619|NCT03472040|59054443|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
30974620|NCT03472040|59054442|FG000|Overall Study|Subject Non-compliance|2|||
30974621|NCT03472040|59054443|FG001|Overall Study|Subject Non-compliance|5|||
30974622|NCT03472040|59054442|FG000|Overall Study|Discontinuation due to Rash|0|||
30974623|NCT03472040|59054443|FG001|Overall Study|Discontinuation due to Rash|1|||
30974624|NCT03472040|59054442|FG000|Overall Study|Subsequent Ineligibility|0|||
30974625|NCT03472040|59054443|FG001|Overall Study|Subsequent Ineligibility|2|||
30974626|NCT03472040|59054442|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
30974627|NCT03472040|59054443|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
30974628|NCT03323385|59054461|FG000|Overall Study|Withdrawal by Subject|1|||
30974629|NCT03323385|59054462|FG001|Overall Study|Withdrawal by Subject|2|||
30974630|NCT03323385|59054461|FG000|Overall Study|Noncompliance|0|||
30974631|NCT03323385|59054462|FG001|Overall Study|Noncompliance|1|||
30974632|NCT03298451|59054472|FG000|Overall Study|Death|275|||
30974633|NCT03298451|59054473|FG001|Overall Study|Death|260|||
30974634|NCT03298451|59054474|FG002|Overall Study|Death|122|||
30974635|NCT03298451|59054475|FG003|Overall Study|Death|280|||
30974636|NCT03298451|59054472|FG000|Overall Study|Lost to Follow-up|1|||
30974637|NCT03298451|59054473|FG001|Overall Study|Lost to Follow-up|1|||
30974638|NCT03298451|59054474|FG002|Overall Study|Lost to Follow-up|0|||
30974639|NCT03298451|59054475|FG003|Overall Study|Lost to Follow-up|7|||
30974640|NCT03298451|59054472|FG000|Overall Study|Withdrawal by Subject|9|||
30974641|NCT03298451|59054473|FG001|Overall Study|Withdrawal by Subject|7|||
30974642|NCT03298451|59054474|FG002|Overall Study|Withdrawal by Subject|1|||
30974643|NCT03298451|59054475|FG003|Overall Study|Withdrawal by Subject|20|||
30974644|NCT03164616|59054488|FG000|Overall Study|Death|250|||
30974645|NCT03164616|59054489|FG001|Overall Study|Death|264|||
30974646|NCT03164616|59054490|FG002|Overall Study|Death|279|||
30974647|NCT03164616|59054488|FG000|Overall Study|Lost to Follow-up|2|||
30974648|NCT03164616|59054489|FG001|Overall Study|Lost to Follow-up|2|||
30974649|NCT03164616|59054490|FG002|Overall Study|Lost to Follow-up|2|||
30974650|NCT03164616|59054488|FG000|Overall Study|Withdrawal by Subject|6|||
30974651|NCT03164616|59054489|FG001|Overall Study|Withdrawal by Subject|7|||
30974652|NCT03164616|59054490|FG002|Overall Study|Withdrawal by Subject|16|||
30974653|NCT03161483|59054504|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
30974654|NCT03161483|59054505|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
30974655|NCT03161483|59054506|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
30974656|NCT03161483|59054507|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
30974657|NCT03161483|59054504|FG000|Treatment Period|Death|1|||
30974658|NCT03161483|59054505|FG001|Treatment Period|Death|0|||
30974659|NCT03161483|59054506|FG002|Treatment Period|Death|0|||
30974660|NCT03161483|59054507|FG003|Treatment Period|Death|0|||
30974661|NCT03161483|59054504|FG000|Treatment Period|Adverse Event|5|||
30974662|NCT03161483|59054505|FG001|Treatment Period|Adverse Event|2|||
30974663|NCT03161483|59054506|FG002|Treatment Period|Adverse Event|1|||
30974664|NCT03161483|59054507|FG003|Treatment Period|Adverse Event|11|||
30974665|NCT03161483|59054504|FG000|Treatment Period|Pregnancy|1|||
30974666|NCT03161483|59054505|FG001|Treatment Period|Pregnancy|0|||
30974667|NCT03161483|59054506|FG002|Treatment Period|Pregnancy|0|||
30974668|NCT03161483|59054507|FG003|Treatment Period|Pregnancy|0|||
30974669|NCT03161483|59054504|FG000|Treatment Period|Lack of Efficacy|0|||
30974670|NCT03161483|59054505|FG001|Treatment Period|Lack of Efficacy|0|||
30974671|NCT03161483|59054506|FG002|Treatment Period|Lack of Efficacy|0|||
30974672|NCT03161483|59054507|FG003|Treatment Period|Lack of Efficacy|1|||
30974673|NCT03161483|59054504|FG000|Treatment Period|Withdrawal by Subject|2|||
30974674|NCT03161483|59054505|FG001|Treatment Period|Withdrawal by Subject|5|||
30974675|NCT03161483|59054506|FG002|Treatment Period|Withdrawal by Subject|2|||
30974676|NCT03161483|59054507|FG003|Treatment Period|Withdrawal by Subject|6|||
30974677|NCT03161483|59054504|FG000|Treatment Period|Lost to Follow-up|0|||
30974678|NCT03161483|59054505|FG001|Treatment Period|Lost to Follow-up|0|||
30974679|NCT03161483|59054506|FG002|Treatment Period|Lost to Follow-up|0|||
30974680|NCT03161483|59054507|FG003|Treatment Period|Lost to Follow-up|1|||
30974681|NCT03161483|59054504|FG000|Treatment Period|Protocol Violation|0|||
30974682|NCT03161483|59054505|FG001|Treatment Period|Protocol Violation|0|||
30974683|NCT03161483|59054506|FG002|Treatment Period|Protocol Violation|0|||
30974684|NCT03161483|59054507|FG003|Treatment Period|Protocol Violation|1|||
30974685|NCT03161483|59054504|FG000|Treatment Period|Other reasons|1|||
30974686|NCT03161483|59054505|FG001|Treatment Period|Other reasons|1|||
30974687|NCT03161483|59054506|FG002|Treatment Period|Other reasons|0|||
30974688|NCT03161483|59054507|FG003|Treatment Period|Other reasons|0|||
30974689|NCT03132636|59054521|FG000|Overall Study|Adverse Event|1|||
30974690|NCT03132636|59054522|FG001|Overall Study|Adverse Event|2|||
30974691|NCT03132636|59054521|FG000|Overall Study|Death|4|||
30974692|NCT03132636|59054522|FG001|Overall Study|Death|7|||
30974693|NCT03132636|59054521|FG000|Overall Study|Lost to Follow-up|2|||
30974694|NCT03132636|59054522|FG001|Overall Study|Lost to Follow-up|2|||
30974695|NCT03132636|59054521|FG000|Overall Study|Protocol Violation|1|||
30974696|NCT03132636|59054522|FG001|Overall Study|Protocol Violation|1|||
30974697|NCT03132636|59054521|FG000|Overall Study|Participant Decision|1|||
30974698|NCT03132636|59054522|FG001|Overall Study|Participant Decision|9|||
30974699|NCT03132636|59054521|FG000|Overall Study|Sponsor Decision|0|||
30974700|NCT03132636|59054522|FG001|Overall Study|Sponsor Decision|1|||
30974701|NCT03132636|59054521|FG000|Overall Study|Progressive disease|32|||
30974702|NCT03132636|59054522|FG001|Overall Study|Progressive disease|36|||
30974703|NCT03132636|59054521|FG000|Overall Study|Withdrawal of consent|2|||
30974704|NCT03132636|59054522|FG001|Overall Study|Withdrawal of consent|5|||
30974705|NCT03132636|59054521|FG000|Overall Study|Study ongoing|9|||
30974706|NCT03132636|59054522|FG001|Overall Study|Study ongoing|10|||
30974707|NCT03132636|59054521|FG000|Overall Study|Other|1|||
30974708|NCT03132636|59054522|FG001|Overall Study|Other|2|||
30974709|NCT02906202|59054528|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
30974710|NCT02869789|59054536|FG000|Overall Study|Disease progression|184|||
30974711|NCT02869789|59054537|FG001|Overall Study|Disease progression|109|||
30974712|NCT02869789|59054538|FG002|Overall Study|Disease progression|260|||
30974713|NCT02869789|59054539|FG003|Overall Study|Disease progression|19|||
30974714|NCT02869789|59054536|FG000|Overall Study|Study drug toxicity|90|||
30974715|NCT02869789|59054537|FG001|Overall Study|Study drug toxicity|32|||
30974716|NCT02869789|59054538|FG002|Overall Study|Study drug toxicity|55|||
30974717|NCT02869789|59054539|FG003|Overall Study|Study drug toxicity|14|||
30974718|NCT02869789|59054536|FG000|Overall Study|Death|7|||
30974719|NCT02869789|59054537|FG001|Overall Study|Death|3|||
30974720|NCT02869789|59054538|FG002|Overall Study|Death|5|||
30974721|NCT02869789|59054539|FG003|Overall Study|Death|1|||
30974722|NCT02869789|59054536|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
30974723|NCT02869789|59054537|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
30974724|NCT02869789|59054538|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
30974725|NCT02869789|59054539|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
30974726|NCT02869789|59054536|FG000|Overall Study|Participant request to discontinue study treatment|10|||
30974727|NCT02869789|59054537|FG001|Overall Study|Participant request to discontinue study treatment|5|||
30974728|NCT02869789|59054538|FG002|Overall Study|Participant request to discontinue study treatment|5|||
30974729|NCT02869789|59054539|FG003|Overall Study|Participant request to discontinue study treatment|3|||
30974730|NCT02869789|59054536|FG000|Overall Study|Withdrawal by Subject|5|||
30974731|NCT02869789|59054537|FG001|Overall Study|Withdrawal by Subject|2|||
30974732|NCT02869789|59054538|FG002|Overall Study|Withdrawal by Subject|7|||
30974733|NCT02869789|59054539|FG003|Overall Study|Withdrawal by Subject|2|||
30974734|NCT02869789|59054536|FG000|Overall Study|Lost to Follow-up|0|||
30974735|NCT02869789|59054537|FG001|Overall Study|Lost to Follow-up|0|||
30974736|NCT02869789|59054538|FG002|Overall Study|Lost to Follow-up|2|||
30974737|NCT02869789|59054539|FG003|Overall Study|Lost to Follow-up|0|||
30974738|NCT02869789|59054536|FG000|Overall Study|Maximum clinical benefit|5|||
30974739|NCT02869789|59054537|FG001|Overall Study|Maximum clinical benefit|2|||
30974740|NCT02869789|59054538|FG002|Overall Study|Maximum clinical benefit|1|||
30974741|NCT02869789|59054539|FG003|Overall Study|Maximum clinical benefit|0|||
30974742|NCT02869789|59054536|FG000|Overall Study|Poor/Non-compliance|0|||
30974743|NCT02869789|59054537|FG001|Overall Study|Poor/Non-compliance|2|||
30974744|NCT02869789|59054538|FG002|Overall Study|Poor/Non-compliance|1|||
30974745|NCT02869789|59054539|FG003|Overall Study|Poor/Non-compliance|0|||
30974746|NCT02869789|59054536|FG000|Overall Study|Participant no longer meets study criteria|0|||
30974747|NCT02869789|59054537|FG001|Overall Study|Participant no longer meets study criteria|1|||
30974748|NCT02869789|59054538|FG002|Overall Study|Participant no longer meets study criteria|1|||
30974749|NCT02869789|59054539|FG003|Overall Study|Participant no longer meets study criteria|0|||
30974750|NCT02869789|59054536|FG000|Overall Study|Administrative reason by sponsor|0|||
30974751|NCT02869789|59054537|FG001|Overall Study|Administrative reason by sponsor|0|||
30974752|NCT02869789|59054538|FG002|Overall Study|Administrative reason by sponsor|1|||
30974753|NCT02869789|59054539|FG003|Overall Study|Administrative reason by sponsor|0|||
30974754|NCT02869789|59054536|FG000|Overall Study|Other reasons|4|||
30974755|NCT02869789|59054537|FG001|Overall Study|Other reasons|8|||
30974756|NCT02869789|59054538|FG002|Overall Study|Other reasons|6|||
30974757|NCT02869789|59054539|FG003|Overall Study|Other reasons|0|||
30974758|NCT02760485|59054560|FG000|Phase 1|Death|3|||
30974759|NCT02760485|59054561|FG001|Phase 1|Death|6|||
30974760|NCT02760485|59054562|FG002|Phase 1|Death|0|||
30974761|NCT02760485|59054560|FG000|Phase 1|Withdrawal by Subject|2|||
30974762|NCT02760485|59054561|FG001|Phase 1|Withdrawal by Subject|0|||
30974763|NCT02760485|59054562|FG002|Phase 1|Withdrawal by Subject|0|||
30974764|NCT02760485|59054560|FG000|Phase 1|Progressive Disease|1|||
30974765|NCT02760485|59054561|FG001|Phase 1|Progressive Disease|0|||
30974766|NCT02760485|59054562|FG002|Phase 1|Progressive Disease|0|||
30974767|NCT02760485|59054560|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
30974768|NCT02760485|59054561|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
30974769|NCT02760485|59054562|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
30974770|NCT02760485|59054560|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
30974771|NCT02760485|59054561|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
30974772|NCT02760485|59054562|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
30974773|NCT02760485|59054560|FG000|Phase 2|Death|0|||
30974774|NCT02760485|59054561|FG001|Phase 2|Death|0|||
30974775|NCT02760485|59054562|FG002|Phase 2|Death|12|||
30974776|NCT02760485|59054560|FG000|Phase 2|Withdrawal by Subject|0|||
30974777|NCT02760485|59054561|FG001|Phase 2|Withdrawal by Subject|0|||
30974778|NCT02760485|59054562|FG002|Phase 2|Withdrawal by Subject|3|||
30974779|NCT02760485|59054560|FG000|Phase 2|Progressive Disease|0|||
30974780|NCT02760485|59054561|FG001|Phase 2|Progressive Disease|0|||
30974781|NCT02760485|59054562|FG002|Phase 2|Progressive Disease|1|||
30974782|NCT02760485|59054560|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
30974783|NCT02760485|59054561|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
30974784|NCT02760485|59054562|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
30974785|NCT02634333|59054597|FG000|Overall Study|Completed out of Window|3|||
30974786|NCT02634333|59054598|FG001|Overall Study|Completed out of Window|2|||
30974787|NCT02634333|59054597|FG000|Overall Study|Missed Visit|5|||
30974788|NCT02634333|59054598|FG001|Overall Study|Missed Visit|2|||
30974789|NCT02634333|59054597|FG000|Overall Study|Lost to Follow-up|12|||
30974790|NCT02634333|59054598|FG001|Overall Study|Lost to Follow-up|7|||
30974791|NCT02634333|59054597|FG000|Overall Study|Withdrawal by Subject|9|||
30974792|NCT02634333|59054598|FG001|Overall Study|Withdrawal by Subject|13|||
30608411|NCT01288430|58619230|FG009|Part 1|Death due to disease progression|0|||
30608412|NCT01288430|58619221|FG000|Part 1|Adverse Event|0|||
30608413|NCT01288430|58619222|FG001|Part 1|Adverse Event|0|||
30608414|NCT01288430|58619223|FG002|Part 1|Adverse Event|3|||
30608415|NCT01288430|58619224|FG003|Part 1|Adverse Event|1|||
30608416|NCT01288430|58619225|FG004|Part 1|Adverse Event|0|||
30608417|NCT01288430|58619226|FG005|Part 1|Adverse Event|0|||
30608418|NCT01288430|58619227|FG006|Part 1|Adverse Event|2|||
30608419|NCT01288430|58619228|FG007|Part 1|Adverse Event|0|||
30608420|NCT01288430|58619229|FG008|Part 1|Adverse Event|0|||
30608421|NCT01288430|58619230|FG009|Part 1|Adverse Event|0|||
30608422|NCT01288430|58619221|FG000|Part 1|Other|0|||
30608423|NCT01288430|58619222|FG001|Part 1|Other|2|||
30608424|NCT01288430|58619223|FG002|Part 1|Other|0|||
30608425|NCT01288430|58619224|FG003|Part 1|Other|0|||
30608426|NCT01288430|58619225|FG004|Part 1|Other|0|||
30608427|NCT01288430|58619226|FG005|Part 1|Other|0|||
30608428|NCT01288430|58619227|FG006|Part 1|Other|1|||
30608429|NCT01288430|58619228|FG007|Part 1|Other|0|||
30974793|NCT02634333|59054597|FG000|Overall Study|Death|11|||
30974794|NCT02634333|59054598|FG001|Overall Study|Death|8|||
30974795|NCT02515630|59054616|FG000|Overall Study|Withdrawal by Subject|5|||
30974796|NCT02515630|59054616|FG000|Overall Study|Adverse Event|4|||
30974797|NCT02515630|59054616|FG000|Overall Study|Physician Decision|4|||
30974798|NCT02515630|59054616|FG000|Overall Study|Death|2|||
30974799|NCT02515630|59054616|FG000|Overall Study|Disease Progression|1|||
30880405|NCT01668797|58912378|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
30880406|NCT01668797|58912379|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
30880407|NCT01668797|58912376|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
30974800|NCT02450331|59054625|FG000|Overall Study|Death|162|||
30974801|NCT02450331|59054626|FG001|Overall Study|Death|171|||
30974802|NCT02450331|59054625|FG000|Overall Study|Lost to Follow-up|14|||
30974803|NCT02450331|59054626|FG001|Overall Study|Lost to Follow-up|12|||
30974804|NCT02450331|59054625|FG000|Overall Study|Withdrawal by Subject|55|||
30974805|NCT02450331|59054626|FG001|Overall Study|Withdrawal by Subject|44|||
30608430|NCT01288430|58619229|FG008|Part 1|Other|0|||
30974806|NCT02450331|59054625|FG000|Overall Study|Non-specified other|1|||
30974807|NCT02450331|59054626|FG001|Overall Study|Non-specified other|1|||
30974808|NCT02335944|59054643|FG000|Treatment Phase|Progressive Disease|2|||
30974809|NCT02335944|59054644|FG001|Treatment Phase|Progressive Disease|5|||
30974810|NCT02335944|59054645|FG002|Treatment Phase|Progressive Disease|2|||
30974811|NCT02335944|59054646|FG003|Treatment Phase|Progressive Disease|11|||
30974812|NCT02335944|59054647|FG004|Treatment Phase|Progressive Disease|4|||
30974813|NCT02335944|59054648|FG005|Treatment Phase|Progressive Disease|25|||
30974814|NCT02335944|59054649|FG006|Treatment Phase|Progressive Disease|2|||
30974815|NCT02335944|59054650|FG007|Treatment Phase|Progressive Disease|30|||
30974816|NCT02335944|59054651|FG008|Treatment Phase|Progressive Disease|27|||
30974817|NCT02335944|59054652|FG009|Treatment Phase|Progressive Disease|0|||
30974818|NCT02335944|59054643|FG000|Treatment Phase|Adverse Event|2|||
30974819|NCT02335944|59054644|FG001|Treatment Phase|Adverse Event|0|||
30974820|NCT02335944|59054645|FG002|Treatment Phase|Adverse Event|0|||
30974821|NCT02335944|59054646|FG003|Treatment Phase|Adverse Event|2|||
30974822|NCT02335944|59054647|FG004|Treatment Phase|Adverse Event|1|||
30974823|NCT02335944|59054648|FG005|Treatment Phase|Adverse Event|15|||
30974824|NCT02335944|59054649|FG006|Treatment Phase|Adverse Event|0|||
30974825|NCT02335944|59054650|FG007|Treatment Phase|Adverse Event|5|||
30974826|NCT02335944|59054651|FG008|Treatment Phase|Adverse Event|7|||
30974827|NCT02335944|59054652|FG009|Treatment Phase|Adverse Event|0|||
30974828|NCT02335944|59054643|FG000|Treatment Phase|Physician Decision|0|||
30974829|NCT02335944|59054644|FG001|Treatment Phase|Physician Decision|0|||
30974830|NCT02335944|59054645|FG002|Treatment Phase|Physician Decision|0|||
30974831|NCT02335944|59054646|FG003|Treatment Phase|Physician Decision|1|||
30974832|NCT02335944|59054647|FG004|Treatment Phase|Physician Decision|0|||
30974833|NCT02335944|59054648|FG005|Treatment Phase|Physician Decision|6|||
30974834|NCT02335944|59054649|FG006|Treatment Phase|Physician Decision|1|||
30974835|NCT02335944|59054650|FG007|Treatment Phase|Physician Decision|2|||
30974836|NCT02335944|59054651|FG008|Treatment Phase|Physician Decision|1|||
30974837|NCT02335944|59054652|FG009|Treatment Phase|Physician Decision|0|||
30974838|NCT02335944|59054643|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
30974839|NCT02335944|59054644|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
30974840|NCT02335944|59054645|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
30974841|NCT02335944|59054646|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
30974842|NCT02335944|59054647|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
30974843|NCT02335944|59054648|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
30974844|NCT02335944|59054649|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
30974845|NCT02335944|59054650|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
30974846|NCT02335944|59054651|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
30974847|NCT02335944|59054652|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
30974848|NCT02335944|59054643|FG000|Treatment Phase|Subject/Guardian Decision|0|||
30974849|NCT02335944|59054644|FG001|Treatment Phase|Subject/Guardian Decision|0|||
30974850|NCT02335944|59054645|FG002|Treatment Phase|Subject/Guardian Decision|1|||
30974851|NCT02335944|59054646|FG003|Treatment Phase|Subject/Guardian Decision|0|||
30974852|NCT02335944|59054647|FG004|Treatment Phase|Subject/Guardian Decision|0|||
30974853|NCT02335944|59054648|FG005|Treatment Phase|Subject/Guardian Decision|1|||
30974854|NCT02335944|59054649|FG006|Treatment Phase|Subject/Guardian Decision|0|||
30974855|NCT02335944|59054650|FG007|Treatment Phase|Subject/Guardian Decision|4|||
30974856|NCT02335944|59054651|FG008|Treatment Phase|Subject/Guardian Decision|0|||
30974857|NCT02335944|59054652|FG009|Treatment Phase|Subject/Guardian Decision|0|||
30974858|NCT02335944|59054643|FG000|Post-treatment Follow-up|Progressive Disease|0|||
30974859|NCT02335944|59054644|FG001|Post-treatment Follow-up|Progressive Disease|0|||
30608431|NCT01288430|58619230|FG009|Part 1|Other|0|||
30974860|NCT02335944|59054645|FG002|Post-treatment Follow-up|Progressive Disease|0|||
30974861|NCT02335944|59054646|FG003|Post-treatment Follow-up|Progressive Disease|1|||
30974862|NCT02335944|59054647|FG004|Post-treatment Follow-up|Progressive Disease|0|||
30974863|NCT02335944|59054648|FG005|Post-treatment Follow-up|Progressive Disease|9|||
30974864|NCT02335944|59054649|FG006|Post-treatment Follow-up|Progressive Disease|0|||
30974865|NCT02335944|59054650|FG007|Post-treatment Follow-up|Progressive Disease|2|||
30974866|NCT02335944|59054651|FG008|Post-treatment Follow-up|Progressive Disease|3|||
30974867|NCT02335944|59054652|FG009|Post-treatment Follow-up|Progressive Disease|0|||
30974868|NCT02335944|59054643|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
30974869|NCT02335944|59054644|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
30974870|NCT02335944|59054645|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
30974871|NCT02335944|59054646|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
30974872|NCT02335944|59054647|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
30974873|NCT02335944|59054648|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
30974874|NCT02335944|59054649|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
30974875|NCT02335944|59054650|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
30974876|NCT02335944|59054651|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
30974877|NCT02335944|59054652|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
30974878|NCT02335944|59054643|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
30974879|NCT02335944|59054644|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
30974880|NCT02335944|59054645|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
30974881|NCT02335944|59054646|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
30974882|NCT02335944|59054647|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
30974883|NCT02335944|59054648|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
30974884|NCT02335944|59054649|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
30974885|NCT02335944|59054650|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
30974886|NCT02335944|59054651|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
30974887|NCT02335944|59054652|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
30974888|NCT02335944|59054643|FG000|Post-treatment Follow-up|Adverse Event|0|||
30974889|NCT02335944|59054644|FG001|Post-treatment Follow-up|Adverse Event|0|||
30974890|NCT02335944|59054645|FG002|Post-treatment Follow-up|Adverse Event|0|||
30974891|NCT02335944|59054646|FG003|Post-treatment Follow-up|Adverse Event|0|||
30974892|NCT02335944|59054647|FG004|Post-treatment Follow-up|Adverse Event|0|||
30974893|NCT02335944|59054648|FG005|Post-treatment Follow-up|Adverse Event|1|||
30974894|NCT02335944|59054649|FG006|Post-treatment Follow-up|Adverse Event|0|||
30974895|NCT02335944|59054650|FG007|Post-treatment Follow-up|Adverse Event|0|||
30974896|NCT02335944|59054651|FG008|Post-treatment Follow-up|Adverse Event|0|||
30974897|NCT02335944|59054652|FG009|Post-treatment Follow-up|Adverse Event|0|||
30974898|NCT02335944|59054643|FG000|Post-treatment Follow-up|Death|0|||
30974899|NCT02335944|59054644|FG001|Post-treatment Follow-up|Death|0|||
30974900|NCT02335944|59054645|FG002|Post-treatment Follow-up|Death|0|||
30974901|NCT02335944|59054646|FG003|Post-treatment Follow-up|Death|1|||
30974902|NCT02335944|59054647|FG004|Post-treatment Follow-up|Death|0|||
30974903|NCT02335944|59054648|FG005|Post-treatment Follow-up|Death|1|||
30974904|NCT02335944|59054649|FG006|Post-treatment Follow-up|Death|0|||
30974905|NCT02335944|59054650|FG007|Post-treatment Follow-up|Death|0|||
30974906|NCT02335944|59054651|FG008|Post-treatment Follow-up|Death|0|||
30974907|NCT02335944|59054652|FG009|Post-treatment Follow-up|Death|0|||
30974908|NCT02335944|59054643|FG000|Post-treatment Follow-up|Physician Decision|1|||
30974909|NCT02335944|59054644|FG001|Post-treatment Follow-up|Physician Decision|0|||
30974910|NCT02335944|59054645|FG002|Post-treatment Follow-up|Physician Decision|0|||
30974911|NCT02335944|59054646|FG003|Post-treatment Follow-up|Physician Decision|0|||
30974912|NCT02335944|59054647|FG004|Post-treatment Follow-up|Physician Decision|0|||
30974913|NCT02335944|59054648|FG005|Post-treatment Follow-up|Physician Decision|0|||
30974914|NCT02335944|59054649|FG006|Post-treatment Follow-up|Physician Decision|0|||
30974915|NCT02335944|59054650|FG007|Post-treatment Follow-up|Physician Decision|1|||
30974916|NCT02335944|59054651|FG008|Post-treatment Follow-up|Physician Decision|0|||
30974917|NCT02335944|59054652|FG009|Post-treatment Follow-up|Physician Decision|0|||
30974918|NCT02326974|59054690|FG000|Overall Study|Withdrawal by Subject|2|||
30974919|NCT02326974|59054690|FG000|Overall Study|failed heterogenity evaluation|5|||
30974920|NCT02246621|59054718|FG000|Overall Study|Withdrawal by Subject|28|||
30974921|NCT02246621|59054719|FG001|Overall Study|Withdrawal by Subject|16|||
30974922|NCT02246621|59054718|FG000|Overall Study|Lost to Follow-up|1|||
30974923|NCT02246621|59054719|FG001|Overall Study|Lost to Follow-up|0|||
30974924|NCT02246621|59054718|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
30974925|NCT02246621|59054719|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
30974926|NCT02200445|59054765|FG000|Overall Study|Lack of Efficacy|1|||
30974927|NCT02200445|59054766|FG001|Overall Study|Lack of Efficacy|2|||
30974928|NCT02200445|59054767|FG002|Overall Study|Lack of Efficacy|2|||
30974929|NCT02200445|59054765|FG000|Overall Study|Adverse Event|0|||
30974930|NCT02200445|59054766|FG001|Overall Study|Adverse Event|2|||
30974931|NCT02200445|59054767|FG002|Overall Study|Adverse Event|0|||
30974932|NCT02152982|59054777|FG000|Overall Study|Ineligible|4|||
30974933|NCT02152982|59054778|FG001|Overall Study|Ineligible|4|||
30974934|NCT02152982|59054777|FG000|Overall Study|Did not start treatment|12|||
30974935|NCT02152982|59054778|FG001|Overall Study|Did not start treatment|6|||
30974936|NCT02120352|59054790|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
30974937|NCT02120352|59054791|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
30974938|NCT02120352|59054792|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
30974939|NCT02120352|59054793|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
30974940|NCT02120352|59054790|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
30974941|NCT02120352|59054791|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
30974942|NCT02120352|59054792|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
30974943|NCT02120352|59054793|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
30974944|NCT02120352|59054790|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
30974945|NCT02120352|59054791|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
30974946|NCT02120352|59054792|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
30974947|NCT02120352|59054793|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
30974948|NCT02120352|59054790|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
30974949|NCT02120352|59054791|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
30974950|NCT02120352|59054792|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
30974951|NCT02120352|59054793|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
30974952|NCT02120352|59054790|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
30974953|NCT02120352|59054791|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
30880408|NCT01668797|58912377|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
30880409|NCT01668797|58912378|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
30880410|NCT01668797|58912379|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
30880411|NCT01668797|58912376|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
30880412|NCT01668797|58912377|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
30880413|NCT01668797|58912378|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
30880414|NCT01668797|58912379|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
30974954|NCT02120352|59054792|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
30974955|NCT02120352|59054793|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
30974956|NCT02120352|59054790|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
30974957|NCT02120352|59054791|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
30974958|NCT02120352|59054792|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
30974959|NCT02120352|59054793|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
30974960|NCT02120352|59054790|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
30974961|NCT02120352|59054791|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
30974962|NCT02120352|59054792|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
30974963|NCT02120352|59054793|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
30974964|NCT02120352|59054790|FG000|Maintenance Period (32 Weeks)|Adverse Event|0|||
30974965|NCT02120352|59054791|FG001|Maintenance Period (32 Weeks)|Adverse Event|0|||
30974966|NCT02120352|59054792|FG002|Maintenance Period (32 Weeks)|Adverse Event|6|||
30974967|NCT02120352|59054793|FG003|Maintenance Period (32 Weeks)|Adverse Event|1|||
30974968|NCT02120352|59054790|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
30974969|NCT02120352|59054791|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
30974970|NCT02120352|59054792|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
30974971|NCT02120352|59054793|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
30974972|NCT02120352|59054790|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0|||
30974973|NCT02120352|59054791|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0|||
30974974|NCT02120352|59054792|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2|||
30974975|NCT02120352|59054793|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0|||
30974976|NCT02120352|59054790|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
30974977|NCT02120352|59054791|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
30974978|NCT02120352|59054792|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
30974979|NCT02120352|59054793|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
30974980|NCT02120352|59054790|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
30974981|NCT02120352|59054791|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
30880415|NCT01668797|58912376|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
30880416|NCT01668797|58912377|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
30880417|NCT01668797|58912378|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
30880418|NCT01668797|58912379|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
30880419|NCT01668797|58912376|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
30880420|NCT01668797|58912377|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
30880421|NCT01668797|58912378|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
30880422|NCT01668797|58912379|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
30880423|NCT01668797|58912376|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
30880424|NCT01668797|58912377|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
30974982|NCT02120352|59054792|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
30974983|NCT02120352|59054793|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1|||
30974984|NCT02120352|59054790|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0|||
30974985|NCT02120352|59054791|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
30974986|NCT02120352|59054792|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1|||
30974987|NCT02120352|59054793|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
30974988|NCT02120352|59054790|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0|||
30974989|NCT02120352|59054791|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112|||
30974990|NCT02120352|59054792|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105|||
30974991|NCT02120352|59054793|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50|||
30974992|NCT02058693|59054809|FG000|Phase 1|Withdrawal by Subject|3|||
30974993|NCT02058693|59054810|FG001|Phase 1|Withdrawal by Subject|2|||
30974994|NCT02058693|59054809|FG000|Phase 1|Adverse Event|0|||
30974995|NCT02058693|59054810|FG001|Phase 1|Adverse Event|1|||
30974996|NCT02058693|59054809|FG000|Phase 1|Lack of Efficacy|1|||
30974997|NCT02058693|59054810|FG001|Phase 1|Lack of Efficacy|0|||
30974998|NCT02058693|59054809|FG000|Phase 1|Physician Decision|1|||
30974999|NCT02058693|59054810|FG001|Phase 1|Physician Decision|1|||
30975000|NCT02058693|59054809|FG000|Phase 2|Withdrawal by Subject|0|||
30975001|NCT02058693|59054810|FG001|Phase 2|Withdrawal by Subject|2|||
30975002|NCT02039856|59054820|FG000|Overall Study|Death|5|||
30975003|NCT02039856|59054821|FG001|Overall Study|Death|3|||
30975004|NCT02039856|59054820|FG000|Overall Study|Partial survey completion|61|||
30975005|NCT02039856|59054821|FG001|Overall Study|Partial survey completion|26|||
30975006|NCT02039856|59054820|FG000|Overall Study|Lost to Follow-up|388|||
30975007|NCT02039856|59054821|FG001|Overall Study|Lost to Follow-up|206|||
30975008|NCT02039856|59054820|FG000|Overall Study|Withdrawal by Subject|1573|||
30975009|NCT02039856|59054821|FG001|Overall Study|Withdrawal by Subject|618|||
30975010|NCT01796392|59054831|FG000|Overall Study|Withdrawal by Subject|2|||
30975011|NCT01796392|59054832|FG001|Overall Study|Withdrawal by Subject|0|||
30975012|NCT01796392|59054831|FG000|Overall Study|Death|5|||
30975013|NCT01796392|59054832|FG001|Overall Study|Death|1|||
30975014|NCT01796392|59054831|FG000|Overall Study|Excluded for medical reasons|1|||
30975015|NCT01796392|59054832|FG001|Overall Study|Excluded for medical reasons|2|||
30975016|NCT01796392|59054831|FG000|Overall Study|Lost to Follow-up|1|||
30975017|NCT01796392|59054832|FG001|Overall Study|Lost to Follow-up|0|||
30975018|NCT01571635|59054843|FG000|Overall Study|Adverse Event|3|||
30975019|NCT01571635|59054844|FG001|Overall Study|Adverse Event|0|||
30975020|NCT01571635|59054845|FG002|Overall Study|Adverse Event|2|||
30975021|NCT01571635|59054846|FG003|Overall Study|Adverse Event|3|||
30975022|NCT01571635|59054847|FG004|Overall Study|Adverse Event|5|||
30975023|NCT01571635|59054843|FG000|Overall Study|Other reasons|2|||
30975024|NCT01571635|59054844|FG001|Overall Study|Other reasons|1|||
30975025|NCT01571635|59054845|FG002|Overall Study|Other reasons|2|||
30975026|NCT01571635|59054846|FG003|Overall Study|Other reasons|2|||
30975027|NCT01571635|59054847|FG004|Overall Study|Other reasons|1|||
30975028|NCT01571635|59054843|FG000|Overall Study|Study terminated by sponsor|0|||
30975029|NCT01571635|59054844|FG001|Overall Study|Study terminated by sponsor|4|||
30975030|NCT01571635|59054845|FG002|Overall Study|Study terminated by sponsor|1|||
30975031|NCT01571635|59054846|FG003|Overall Study|Study terminated by sponsor|3|||
30975032|NCT01571635|59054847|FG004|Overall Study|Study terminated by sponsor|1|||
30975033|NCT01571635|59054843|FG000|Overall Study|Withdrew consent|1|||
30975034|NCT01571635|59054844|FG001|Overall Study|Withdrew consent|1|||
30975035|NCT01571635|59054845|FG002|Overall Study|Withdrew consent|2|||
30975036|NCT01571635|59054846|FG003|Overall Study|Withdrew consent|3|||
30975037|NCT01571635|59054847|FG004|Overall Study|Withdrew consent|0|||
30975038|NCT01571635|59054843|FG000|Overall Study|Lack of Efficacy|0|||
30975039|NCT01571635|59054844|FG001|Overall Study|Lack of Efficacy|2|||
30975040|NCT01571635|59054845|FG002|Overall Study|Lack of Efficacy|0|||
30975041|NCT01571635|59054846|FG003|Overall Study|Lack of Efficacy|1|||
30975042|NCT01571635|59054847|FG004|Overall Study|Lack of Efficacy|2|||
30975043|NCT01248715|59054865|FG000|Overall Study|Not influenza positive|501|||
30975044|NCT01248715|59054866|FG001|Overall Study|Not influenza positive|510|||
30975045|NCT00937937|59054889|FG000|Overall Study|Adverse Event|6|||
30975046|NCT00937937|59054889|FG000|Overall Study|Withdrawal by Subject|2|||
30975047|NCT00937937|59054889|FG000|Overall Study|Progression/relapse|61|||
30975048|NCT00937937|59054889|FG000|Overall Study|Death|1|||
30975049|NCT00937937|59054889|FG000|Overall Study|Other|2|||
30975050|NCT00812214|59054923|FG000|Overall Study|Lost to Follow-up|3|||
30975051|NCT00812214|59054924|FG001|Overall Study|Lost to Follow-up|1|||
30880425|NCT01668797|58912378|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
30975052|NCT00658814|59054933|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
30975053|NCT00658814|59054934|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
30975054|NCT00658814|59054933|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
30975055|NCT00658814|59054934|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
30975056|NCT00658814|59054933|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
30975057|NCT00658814|59054934|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
30975058|NCT00658814|59054933|FG000|Remission Induction Chemotherapy|Death|1|||
30975059|NCT00658814|59054934|FG001|Remission Induction Chemotherapy|Death|4|||
30975060|NCT00658814|59054933|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
30975061|NCT00658814|59054934|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
30975062|NCT00658814|59054933|FG000|Remission Induction Chemotherapy|Not eligible|1|||
30975063|NCT00658814|59054934|FG001|Remission Induction Chemotherapy|Not eligible|2|||
30975064|NCT00658814|59054933|FG000|Consolidation Therapy|Not protocol specified|0|||
30975065|NCT00658814|59054934|FG001|Consolidation Therapy|Not protocol specified|1|||
30975066|NCT00658814|59054933|FG000|Consolidation Therapy|Not eligible|2|||
30975067|NCT00658814|59054934|FG001|Consolidation Therapy|Not eligible|2|||
30975068|NCT00658814|59054933|FG000|Maintenance Therapy|Adverse Event|1|||
30975069|NCT00658814|59054934|FG001|Maintenance Therapy|Adverse Event|1|||
30975070|NCT00658814|59054933|FG000|Maintenance Therapy|Not protocol specified|1|||
30975071|NCT00658814|59054934|FG001|Maintenance Therapy|Not protocol specified|0|||
30975072|NCT00658814|59054933|FG000|Maintenance Therapy|Not eligible|1|||
30975073|NCT00658814|59054934|FG001|Maintenance Therapy|Not eligible|0|||
30975074|NCT00601900|59054946|FG000|Overall Study|Withdrawal by Subject|0|||
30975075|NCT00601900|59054947|FG001|Overall Study|Withdrawal by Subject|3|||
30975076|NCT00217425|59054953|FG000|Overall Study|Never started treatment|2|||
30975077|NCT00217425|59054953|FG000|Overall Study|Patient ineligible|5|||
30975078|NCT00217425|59054953|FG000|Overall Study|Lack of Efficacy|13|||
30975079|NCT00217425|59054953|FG000|Overall Study|Adverse Event|8|||
30975080|NCT00217425|59054953|FG000|Overall Study|Withdrawal by Subject|4|||
30975081|NCT00217425|59054953|FG000|Overall Study|Other complicating disease|1|||
30975082|NCT00217425|59054953|FG000|Overall Study|Other|4|||
30975083|NCT03208231|59054997|FG000|Overall Study|Death|1|||
30975084|NCT03208231|59054998|FG001|Overall Study|Death|2|||
30975085|NCT03208231|59054997|FG000|Overall Study|Moved and unable to get to clinic|1|||
30975086|NCT03208231|59054998|FG001|Overall Study|Moved and unable to get to clinic|0|||
30975087|NCT03208231|59054997|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
30975088|NCT03208231|59054998|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
30975089|NCT03102242|59055021|FG000|Overall Study|Adverse Event|2|||
30975090|NCT03097328|59055025|FG000|Overall Study|Still on Therapy|2|||
30975091|NCT03097328|59055025|FG000|Overall Study|Progressive Disease|29|||
30975092|NCT03097328|59055025|FG000|Overall Study|Adverse Event|4|||
30975093|NCT03097328|59055025|FG000|Overall Study|Withdrawal by Subject|1|||
30975094|NCT03097328|59055025|FG000|Overall Study|Physician Decision|1|||
30975095|NCT03097328|59055025|FG000|Overall Study|Patient Decision|1|||
30975096|NCT03097328|59055025|FG000|Overall Study|Ineligible for Study Drug|1|||
30975097|NCT03033602|59055031|FG000|Overall Study|Withdrawal by Subject|11|||
30975098|NCT03033602|59055032|FG001|Overall Study|Withdrawal by Subject|21|||
30975099|NCT03033602|59055031|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
30975100|NCT03033602|59055032|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
30975101|NCT02994784|59055043|FG000|6 Months Follow-up|Lost to Follow-up|3|||
30975102|NCT02948829|59055047|FG000|Overall Study|Lost to Follow-up|2|||
30975103|NCT02948829|59055047|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
30975104|NCT02948829|59055047|FG000|Overall Study|Pregnancy|1|||
30975105|NCT02948829|59055047|FG000|Overall Study|Other: Reason not Specified|8|||
30975106|NCT02617446|59055078|FG000|Overall Study|Withdrawal by Subject|0|||
30975107|NCT02617446|59055079|FG001|Overall Study|Withdrawal by Subject|2|||
30975108|NCT02617446|59055080|FG002|Overall Study|Withdrawal by Subject|0|||
30975109|NCT02617446|59055078|FG000|Overall Study|Adverse Event|1|||
30975110|NCT02617446|59055079|FG001|Overall Study|Adverse Event|0|||
30975111|NCT02617446|59055080|FG002|Overall Study|Adverse Event|5|||
30975112|NCT02617446|59055078|FG000|Overall Study|Lost to Follow-up|3|||
30975113|NCT02617446|59055079|FG001|Overall Study|Lost to Follow-up|0|||
30975114|NCT02617446|59055080|FG002|Overall Study|Lost to Follow-up|0|||
30975115|NCT02617446|59055078|FG000|Overall Study|Death|0|||
30975116|NCT02617446|59055079|FG001|Overall Study|Death|0|||
30975117|NCT02617446|59055080|FG002|Overall Study|Death|2|||
30975118|NCT02549170|59055094|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
30975119|NCT02549170|59055095|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
30975120|NCT02549170|59055096|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
30975121|NCT02549170|59055097|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
30975122|NCT02549170|59055098|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
30975123|NCT02549170|59055094|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
30975124|NCT02549170|59055095|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
30975125|NCT02549170|59055096|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
30975126|NCT02549170|59055097|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
30975127|NCT02549170|59055098|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
30975128|NCT02549170|59055094|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
30975129|NCT02549170|59055095|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
30975130|NCT02549170|59055096|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
30975131|NCT02549170|59055097|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
30975132|NCT02549170|59055098|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
30975133|NCT02476916|59055115|FG000|Core Period|Adverse Event|2|||
30975134|NCT02476916|59055116|FG001|Core Period|Adverse Event|2|||
30975135|NCT02476916|59055115|FG000|Core Period|Investigator decision|1|||
30975136|NCT02476916|59055116|FG001|Core Period|Investigator decision|1|||
30975137|NCT02476916|59055115|FG000|Core Period|Withdrawal by Subject|3|||
30975138|NCT02476916|59055116|FG001|Core Period|Withdrawal by Subject|0|||
30975139|NCT02476916|59055115|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
30975140|NCT02476916|59055116|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
30975141|NCT02476916|59055115|FG000|Extension Period|On Treatment|12|||
30975142|NCT02476916|59055116|FG001|Extension Period|On Treatment|17|||
30975143|NCT02410902|59055125|FG000|Overall Study|Adverse Event|2|||
30975144|NCT02410902|59055126|FG001|Overall Study|Adverse Event|3|||
30975145|NCT02410902|59055125|FG000|Overall Study|Lost to Follow-up|4|||
30975146|NCT02410902|59055126|FG001|Overall Study|Lost to Follow-up|1|||
30975147|NCT02410902|59055125|FG000|Overall Study|Protocol Violation|1|||
30975148|NCT02410902|59055126|FG001|Overall Study|Protocol Violation|4|||
30975149|NCT02410902|59055125|FG000|Overall Study|Withdrawal by Subject|6|||
30975150|NCT02410902|59055126|FG001|Overall Study|Withdrawal by Subject|8|||
30975151|NCT02410902|59055125|FG000|Overall Study|Non-Compliance|8|||
30975152|NCT02410902|59055126|FG001|Overall Study|Non-Compliance|2|||
30975153|NCT02101736|59055136|FG000|Overall Study|Protocol Violation|3|||
30975154|NCT02101736|59055137|FG001|Overall Study|Protocol Violation|0|||
30975155|NCT02101736|59055136|FG000|Overall Study|Withdrawal by Subject|1|||
30975156|NCT02101736|59055137|FG001|Overall Study|Withdrawal by Subject|1|||
30975157|NCT01918397|59055149|FG000|Overall Study|Never started treatment|2|||
30975158|NCT01918397|59055150|FG001|Overall Study|Never started treatment|1|||
30975159|NCT01918397|59055151|FG002|Overall Study|Never started treatment|0|||
30975160|NCT01918397|59055152|FG003|Overall Study|Never started treatment|0|||
30975161|NCT01918397|59055149|FG000|Overall Study|Adverse Event|1|||
30975162|NCT01918397|59055150|FG001|Overall Study|Adverse Event|1|||
30975163|NCT01918397|59055151|FG002|Overall Study|Adverse Event|1|||
30975164|NCT01918397|59055152|FG003|Overall Study|Adverse Event|0|||
30975165|NCT01918397|59055149|FG000|Overall Study|Lack of compliance|2|||
30975166|NCT01918397|59055150|FG001|Overall Study|Lack of compliance|2|||
30975167|NCT01918397|59055151|FG002|Overall Study|Lack of compliance|3|||
30975168|NCT01918397|59055152|FG003|Overall Study|Lack of compliance|0|||
30975169|NCT01918397|59055149|FG000|Overall Study|Pregnancy|0|||
30975170|NCT01918397|59055150|FG001|Overall Study|Pregnancy|1|||
30975171|NCT01918397|59055151|FG002|Overall Study|Pregnancy|0|||
30880426|NCT01668797|58912379|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
30880427|NCT01668797|58912376|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
30880428|NCT01668797|58912377|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
30880429|NCT01668797|58912378|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
30880430|NCT01668797|58912379|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
30880431|NCT01668797|58912376|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
30880432|NCT01668797|58912377|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
30880433|NCT01668797|58912378|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
30880434|NCT01668797|58912379|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
30880435|NCT01668797|58912376|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
30880436|NCT01668797|58912377|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
30880437|NCT01668797|58912378|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
30880438|NCT01668797|58912379|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
30880439|NCT01668797|58912376|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
30880440|NCT01668797|58912377|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
30880441|NCT01668797|58912378|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
30975172|NCT01918397|59055152|FG003|Overall Study|Pregnancy|0|||
30975173|NCT01918397|59055149|FG000|Overall Study|Rifampin susceptible|0|||
30975174|NCT01918397|59055150|FG001|Overall Study|Rifampin susceptible|0|||
30975175|NCT01918397|59055151|FG002|Overall Study|Rifampin susceptible|0|||
30975176|NCT01918397|59055152|FG003|Overall Study|Rifampin susceptible|2|||
30975177|NCT01918397|59055149|FG000|Overall Study|Treatment failure|0|||
30975178|NCT01918397|59055150|FG001|Overall Study|Treatment failure|0|||
30975179|NCT01918397|59055151|FG002|Overall Study|Treatment failure|0|||
30975180|NCT01918397|59055152|FG003|Overall Study|Treatment failure|1|||
30975181|NCT01918397|59055149|FG000|Overall Study|Withdrawal by Subject|3|||
30975182|NCT01918397|59055150|FG001|Overall Study|Withdrawal by Subject|2|||
30975183|NCT01918397|59055151|FG002|Overall Study|Withdrawal by Subject|1|||
30880442|NCT01668797|58912379|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
30880443|NCT01668797|58912376|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
30880444|NCT01668797|58912377|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
30880445|NCT01668797|58912378|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
30880446|NCT01668797|58912379|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
30880447|NCT02613221|58912386|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
30880448|NCT02613221|58912386|FG000|Overall Study|Adverse Event|2|||
30880449|NCT02613221|58912386|FG000|Overall Study|Voluntary Discontinuation|1|||
30880450|NCT02613221|58912386|FG000|Overall Study|Delayed Treatment|1|||
30880451|NCT02613221|58912386|FG000|Overall Study|Enrolled but Not Treated|1|||
30880452|NCT01362049|58912394|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
30880453|NCT01362049|58912395|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
30880454|NCT01362049|58912396|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
30880455|NCT01362049|58912397|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
30880456|NCT01362049|58912394|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
30880457|NCT01362049|58912395|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
30880458|NCT01362049|58912396|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
30975184|NCT01918397|59055152|FG003|Overall Study|Withdrawal by Subject|1|||
30975185|NCT01918397|59055149|FG000|Overall Study|XDR at baseline|0|||
30975186|NCT01918397|59055150|FG001|Overall Study|XDR at baseline|0|||
30975187|NCT01918397|59055151|FG002|Overall Study|XDR at baseline|1|||
30975188|NCT01918397|59055152|FG003|Overall Study|XDR at baseline|0|||
30975189|NCT01918397|59055149|FG000|Overall Study|Lost to Follow-up|2|||
30975190|NCT01918397|59055150|FG001|Overall Study|Lost to Follow-up|1|||
30975191|NCT01918397|59055151|FG002|Overall Study|Lost to Follow-up|1|||
30975192|NCT01918397|59055152|FG003|Overall Study|Lost to Follow-up|1|||
30975193|NCT01918397|59055149|FG000|Overall Study|Increased QTc|1|||
30975194|NCT01918397|59055150|FG001|Overall Study|Increased QTc|0|||
30975195|NCT01918397|59055151|FG002|Overall Study|Increased QTc|0|||
30975196|NCT01918397|59055152|FG003|Overall Study|Increased QTc|1|||
30975197|NCT01918397|59055149|FG000|Overall Study|Death|0|||
30975198|NCT01918397|59055150|FG001|Overall Study|Death|0|||
30975199|NCT01918397|59055151|FG002|Overall Study|Death|1|||
30975200|NCT01918397|59055152|FG003|Overall Study|Death|0|||
30975201|NCT01918397|59055149|FG000|Overall Study|Involved in another investigative trial|0|||
30975202|NCT01918397|59055150|FG001|Overall Study|Involved in another investigative trial|0|||
30975203|NCT01918397|59055151|FG002|Overall Study|Involved in another investigative trial|0|||
30975204|NCT01918397|59055152|FG003|Overall Study|Involved in another investigative trial|1|||
30975205|NCT00986921|59055186|FG000|Overall Study|Physician Decision|1|||
30975206|NCT00986921|59055187|FG001|Overall Study|Physician Decision|0|||
30975207|NCT01596972|59055198|FG000|Overall Study|Physician Decision|1|||
30975208|NCT01596972|59055199|FG001|Overall Study|Physician Decision|9|||
30975209|NCT01596972|59055198|FG000|Overall Study|Lost to Follow-up|0|||
30975210|NCT01596972|59055199|FG001|Overall Study|Lost to Follow-up|4|||
30975211|NCT01596972|59055198|FG000|Overall Study|Withdrawal by Subject|0|||
30975212|NCT01596972|59055199|FG001|Overall Study|Withdrawal by Subject|1|||
30975213|NCT00985751|59055300|FG000|Overall Study|Adverse Event|0|||
30975214|NCT00985751|59055301|FG001|Overall Study|Adverse Event|0|||
30975215|NCT00985751|59055302|FG002|Overall Study|Adverse Event|0|||
30975216|NCT00985751|59055303|FG003|Overall Study|Adverse Event|0|||
30975217|NCT00985751|59055304|FG004|Overall Study|Adverse Event|1|||
30975218|NCT01596582|59055349|FG000|Overall Study|Deemed ineligible after study visit|3|||
30975219|NCT01596582|59055350|FG001|Overall Study|Deemed ineligible after study visit|6|||
30975220|NCT01596582|59055349|FG000|Overall Study|Missing all outcome data|1|||
30975221|NCT01596582|59055350|FG001|Overall Study|Missing all outcome data|1|||
30975222|NCT01596504|59055366|FG000|Overall Study|Participant's Private Reason|0|||
30975223|NCT01596504|59055367|FG001|Overall Study|Participant's Private Reason|1|||
30975224|NCT01596504|59055368|FG002|Overall Study|Participant's Private Reason|0|||
30975225|NCT01596504|59055366|FG000|Overall Study|Adverse Event|1|||
30975226|NCT01596504|59055367|FG001|Overall Study|Adverse Event|2|||
30975227|NCT01596504|59055368|FG002|Overall Study|Adverse Event|1|||
30975228|NCT01596504|59055366|FG000|Overall Study|Withdrawal by Subject|1|||
30880459|NCT01362049|58912397|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
30880460|NCT02612909|58912429|FG000|Phase 2|Withdrawal by Subject|2|||
30880461|NCT02612909|58912430|FG001|Phase 2|Withdrawal by Subject|5|||
30880462|NCT02612909|58912431|FG002|Phase 2|Withdrawal by Subject|0|||
30880463|NCT02612909|58912432|FG003|Phase 2|Withdrawal by Subject|0|||
30880464|NCT02612909|58912433|FG004|Phase 2|Withdrawal by Subject|0|||
30880465|NCT02612909|58912429|FG000|Phase 2|Pregnancy|0|||
30880466|NCT02612909|58912430|FG001|Phase 2|Pregnancy|0|||
30975229|NCT01596504|59055367|FG001|Overall Study|Withdrawal by Subject|0|||
30975230|NCT01596504|59055368|FG002|Overall Study|Withdrawal by Subject|0|||
30975231|NCT02616900|59055423|FG000|Overall Study|Lack of Efficacy|7|||
30975232|NCT02616900|59055423|FG000|Overall Study|Lost to Follow-up|2|||
30975233|NCT02616900|59055423|FG000|Overall Study|Protocol Violation|5|||
30880467|NCT02612909|58912431|FG002|Phase 2|Pregnancy|1|||
30880468|NCT02612909|58912432|FG003|Phase 2|Pregnancy|0|||
30880469|NCT02612909|58912433|FG004|Phase 2|Pregnancy|0|||
30880470|NCT02612909|58912429|FG000|Phase 3|Withdrawal by Subject|0|||
30880471|NCT02612909|58912430|FG001|Phase 3|Withdrawal by Subject|0|||
30880472|NCT02612909|58912431|FG002|Phase 3|Withdrawal by Subject|0|||
30880473|NCT02612909|58912432|FG003|Phase 3|Withdrawal by Subject|1|||
30880474|NCT02612909|58912433|FG004|Phase 3|Withdrawal by Subject|0|||
30880475|NCT02612285|58912447|FG000|Overall Study|Withdrawal by Subject|1|||
30880476|NCT02609633|58912453|FG000|Overall Study|Consent Withdrawn|0|||
30880477|NCT02609633|58912454|FG001|Overall Study|Consent Withdrawn|1|||
30880478|NCT02609633|58912453|FG000|Overall Study|Protocol Deviation|1|||
30880479|NCT02609633|58912454|FG001|Overall Study|Protocol Deviation|0|||
30880480|NCT02609633|58912453|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
30880481|NCT02609633|58912454|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
30880482|NCT02609633|58912453|FG000|Overall Study|Reason not Specified|2|||
30880483|NCT02609633|58912454|FG001|Overall Study|Reason not Specified|1|||
30880484|NCT01371981|58912473|FG000|Overall Study|Adverse Event|12|||
30880485|NCT01371981|58912474|FG001|Overall Study|Adverse Event|17|||
30880486|NCT01371981|58912475|FG002|Overall Study|Adverse Event|0|||
30880487|NCT01371981|58912476|FG003|Overall Study|Adverse Event|4|||
30880488|NCT01371981|58912477|FG004|Overall Study|Adverse Event|1|||
30880489|NCT01371981|58912478|FG005|Overall Study|Adverse Event|0|||
30880490|NCT01371981|58912473|FG000|Overall Study|Death|22|||
30880491|NCT01371981|58912474|FG001|Overall Study|Death|16|||
30880492|NCT01371981|58912475|FG002|Overall Study|Death|0|||
30880493|NCT01371981|58912476|FG003|Overall Study|Death|0|||
30880494|NCT01371981|58912477|FG004|Overall Study|Death|2|||
30880495|NCT01371981|58912478|FG005|Overall Study|Death|2|||
30880496|NCT01371981|58912473|FG000|Overall Study|Lack of Efficacy|69|||
30880497|NCT01371981|58912474|FG001|Overall Study|Lack of Efficacy|61|||
30880498|NCT01371981|58912475|FG002|Overall Study|Lack of Efficacy|4|||
30880499|NCT01371981|58912476|FG003|Overall Study|Lack of Efficacy|8|||
30880500|NCT01371981|58912477|FG004|Overall Study|Lack of Efficacy|5|||
30880501|NCT01371981|58912478|FG005|Overall Study|Lack of Efficacy|0|||
30880502|NCT01371981|58912473|FG000|Overall Study|Physician Decision|48|||
30880503|NCT01371981|58912474|FG001|Overall Study|Physician Decision|63|||
30880504|NCT01371981|58912475|FG002|Overall Study|Physician Decision|1|||
30880505|NCT01371981|58912476|FG003|Overall Study|Physician Decision|7|||
30880506|NCT01371981|58912477|FG004|Overall Study|Physician Decision|14|||
30880507|NCT01371981|58912478|FG005|Overall Study|Physician Decision|3|||
30880508|NCT01371981|58912473|FG000|Overall Study|Withdrawal by Subject|12|||
30880509|NCT01371981|58912474|FG001|Overall Study|Withdrawal by Subject|19|||
30880510|NCT01371981|58912475|FG002|Overall Study|Withdrawal by Subject|1|||
30880511|NCT01371981|58912476|FG003|Overall Study|Withdrawal by Subject|2|||
30880512|NCT01371981|58912477|FG004|Overall Study|Withdrawal by Subject|10|||
30880513|NCT01371981|58912478|FG005|Overall Study|Withdrawal by Subject|3|||
30880514|NCT01371981|58912473|FG000|Overall Study|Ineligible|19|||
30880515|NCT01371981|58912474|FG001|Overall Study|Ineligible|13|||
30880516|NCT01371981|58912475|FG002|Overall Study|Ineligible|0|||
30880517|NCT01371981|58912476|FG003|Overall Study|Ineligible|0|||
30880518|NCT01371981|58912477|FG004|Overall Study|Ineligible|0|||
30880519|NCT01371981|58912478|FG005|Overall Study|Ineligible|4|||
30880520|NCT01371981|58912473|FG000|Overall Study|Did not start treatment|2|||
30880521|NCT01371981|58912474|FG001|Overall Study|Did not start treatment|3|||
30880522|NCT01371981|58912475|FG002|Overall Study|Did not start treatment|0|||
30880523|NCT01371981|58912476|FG003|Overall Study|Did not start treatment|0|||
30880524|NCT01371981|58912477|FG004|Overall Study|Did not start treatment|0|||
30880525|NCT01371981|58912478|FG005|Overall Study|Did not start treatment|2|||
30880526|NCT01597375|58912506|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
30880527|NCT01597375|58912507|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
30880528|NCT01597375|58912506|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
30880529|NCT01597375|58912507|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
30880530|NCT01597375|58912506|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
30880531|NCT01597375|58912507|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
30880532|NCT01597375|58912506|FG000|Washout (2 Weeks)|Adverse Event|1|||
30880533|NCT01597375|58912507|FG001|Washout (2 Weeks)|Adverse Event|0|||
30880534|NCT01597375|58912506|FG000|Second Intervention|Failed to react at both Aspirin|1|||
30880535|NCT01597375|58912507|FG001|Second Intervention|Failed to react at both Aspirin|1|||
30880536|NCT02527161|58912514|FG000|Overall Study|Failed MRI|52|||
30880537|NCT02527161|58912514|FG000|Overall Study|Withdrawal by Subject|19|||
30880538|NCT02527161|58912514|FG000|Overall Study|Delay in or unfit for surgery|16|||
30880539|NCT02527161|58912514|FG000|Overall Study|MRI contraindication|6|||
30880540|NCT02527161|58912514|FG000|Overall Study|Consent violation|4|||
30880541|NCT02527161|58912514|FG000|Overall Study|Only Recruited to Part A|27|||
30880542|NCT02527161|58912514|FG000|Overall Study|Physician Decision|1|||
30880543|NCT02527161|58912514|FG000|Overall Study|Adverse Event|1|||
30880544|NCT02527161|58912514|FG000|Overall Study|Lost to Follow-up|6|||
30880545|NCT02609399|58912521|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
30880546|NCT02609399|58912522|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
30880547|NCT02609399|58912521|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
30880548|NCT02609399|58912522|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
30880549|NCT02609399|58912521|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
30975234|NCT02616900|59055423|FG000|Overall Study|Withdrawal by Subject|3|||
30880550|NCT02609399|58912522|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
30880551|NCT02720185|58912530|FG000|Overall Study|Lost to Follow-up|1|||
30880552|NCT02526693|58912553|FG000|Overall Study|Physician Decision|3|||
30880553|NCT02526693|58912554|FG001|Overall Study|Physician Decision|1|||
30880554|NCT02710669|58912572|FG000|Overall Study|Physician Decision|2|||
30880555|NCT02710669|58912573|FG001|Overall Study|Physician Decision|1|||
30880556|NCT02710669|58912574|FG002|Overall Study|Physician Decision|0|||
30880557|NCT02710669|58912572|FG000|Overall Study|Institutional delays (including COVID)|2|||
30975235|NCT02616900|59055423|FG000|Overall Study|Incomplete data|6|||
30975236|NCT00985673|59055535|FG000|Overall Study|Lost to Follow-up|6|||
30975237|NCT00985673|59055536|FG001|Overall Study|Lost to Follow-up|7|||
30975238|NCT00985673|59055537|FG002|Overall Study|Lost to Follow-up|6|||
30975239|NCT00985673|59055538|FG003|Overall Study|Lost to Follow-up|10|||
30975240|NCT00985673|59055539|FG004|Overall Study|Lost to Follow-up|5|||
30880558|NCT02710669|58912573|FG001|Overall Study|Institutional delays (including COVID)|2|||
30880559|NCT02710669|58912574|FG002|Overall Study|Institutional delays (including COVID)|0|||
30880560|NCT02710669|58912572|FG000|Overall Study|arrived in afib/aflutter|10|||
30880561|NCT02710669|58912573|FG001|Overall Study|arrived in afib/aflutter|8|||
30880562|NCT02710669|58912574|FG002|Overall Study|arrived in afib/aflutter|2|||
30880563|NCT02610725|58912582|FG000|Overall Study|Lost to Follow-up|197|||
30880564|NCT02610725|58912582|FG000|Overall Study|self-reported contraindication|9|||
30880565|NCT02684461|58912589|FG000|Overall Study|Adverse Event|1|||
30880566|NCT02684461|58912590|FG001|Overall Study|Adverse Event|0|||
30880567|NCT02684461|58912591|FG002|Overall Study|Adverse Event|0|||
30880568|NCT02684461|58912589|FG000|Overall Study|Lack of Efficacy|1|||
30880569|NCT02684461|58912590|FG001|Overall Study|Lack of Efficacy|2|||
30880570|NCT02684461|58912591|FG002|Overall Study|Lack of Efficacy|0|||
30880571|NCT02647645|58912616|FG000|Overall Study|Lost to Follow-up|2|||
30880572|NCT02647645|58912617|FG001|Overall Study|Lost to Follow-up|1|||
30880573|NCT02531373|58912632|FG000|Overall Study|Lack of Efficacy|0|||
30880574|NCT02531373|58912633|FG001|Overall Study|Lack of Efficacy|0|||
30880575|NCT02531373|58912634|FG002|Overall Study|Lack of Efficacy|0|||
30880576|NCT02531373|58912635|FG003|Overall Study|Lack of Efficacy|0|||
30880577|NCT02531373|58912636|FG004|Overall Study|Lack of Efficacy|3|||
30880578|NCT02531373|58912637|FG005|Overall Study|Lack of Efficacy|2|||
30880579|NCT02531373|58912638|FG006|Overall Study|Lack of Efficacy|4|||
30880580|NCT02531373|58912639|FG007|Overall Study|Lack of Efficacy|8|||
30880581|NCT02531373|58912640|FG008|Overall Study|Lack of Efficacy|5|||
30880582|NCT02531373|58912632|FG000|Overall Study|Lost to Follow-up|0|||
30880583|NCT02531373|58912633|FG001|Overall Study|Lost to Follow-up|0|||
30880584|NCT02531373|58912634|FG002|Overall Study|Lost to Follow-up|0|||
30880585|NCT02531373|58912635|FG003|Overall Study|Lost to Follow-up|0|||
30880586|NCT02531373|58912636|FG004|Overall Study|Lost to Follow-up|0|||
30880587|NCT02531373|58912637|FG005|Overall Study|Lost to Follow-up|2|||
30880588|NCT02531373|58912638|FG006|Overall Study|Lost to Follow-up|2|||
30880589|NCT02531373|58912639|FG007|Overall Study|Lost to Follow-up|0|||
30880590|NCT02531373|58912640|FG008|Overall Study|Lost to Follow-up|0|||
30880591|NCT02531373|58912632|FG000|Overall Study|Physician Decision|0|||
30880592|NCT02531373|58912633|FG001|Overall Study|Physician Decision|0|||
30880593|NCT02531373|58912634|FG002|Overall Study|Physician Decision|0|||
30880594|NCT02531373|58912635|FG003|Overall Study|Physician Decision|0|||
30880595|NCT02531373|58912636|FG004|Overall Study|Physician Decision|2|||
30880596|NCT02531373|58912637|FG005|Overall Study|Physician Decision|1|||
30880597|NCT02531373|58912638|FG006|Overall Study|Physician Decision|0|||
30880598|NCT02531373|58912639|FG007|Overall Study|Physician Decision|0|||
30880599|NCT02531373|58912640|FG008|Overall Study|Physician Decision|0|||
30975241|NCT00985673|59055540|FG005|Overall Study|Lost to Follow-up|3|||
30975242|NCT00985673|59055535|FG000|Overall Study|Withdrawal by Subject|0|||
30975243|NCT00985673|59055536|FG001|Overall Study|Withdrawal by Subject|4|||
30975244|NCT00985673|59055537|FG002|Overall Study|Withdrawal by Subject|5|||
30975245|NCT00985673|59055538|FG003|Overall Study|Withdrawal by Subject|2|||
30880600|NCT02531373|58912632|FG000|Overall Study|Protocol Violation|0|||
30880601|NCT02531373|58912633|FG001|Overall Study|Protocol Violation|0|||
30880602|NCT02531373|58912634|FG002|Overall Study|Protocol Violation|0|||
30880603|NCT02531373|58912635|FG003|Overall Study|Protocol Violation|0|||
30880604|NCT02531373|58912636|FG004|Overall Study|Protocol Violation|0|||
30880605|NCT02531373|58912637|FG005|Overall Study|Protocol Violation|1|||
30880606|NCT02531373|58912638|FG006|Overall Study|Protocol Violation|1|||
30880607|NCT02531373|58912639|FG007|Overall Study|Protocol Violation|0|||
30880608|NCT02531373|58912640|FG008|Overall Study|Protocol Violation|1|||
30880609|NCT02531373|58912632|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30975246|NCT00985673|59055539|FG004|Overall Study|Withdrawal by Subject|2|||
30880610|NCT02531373|58912633|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
30880611|NCT02531373|58912634|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
30880612|NCT02531373|58912635|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
30880613|NCT02531373|58912636|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
30880614|NCT02531373|58912637|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
30880615|NCT02531373|58912638|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
30880616|NCT02531373|58912639|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
30880617|NCT02531373|58912640|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
30880618|NCT02531373|58912632|FG000|Overall Study|Withdrawal by Subject|0|||
30880619|NCT02531373|58912633|FG001|Overall Study|Withdrawal by Subject|0|||
30880620|NCT02531373|58912634|FG002|Overall Study|Withdrawal by Subject|0|||
30880621|NCT02531373|58912635|FG003|Overall Study|Withdrawal by Subject|0|||
30880622|NCT02531373|58912636|FG004|Overall Study|Withdrawal by Subject|3|||
30880623|NCT02531373|58912637|FG005|Overall Study|Withdrawal by Subject|0|||
30880624|NCT02531373|58912638|FG006|Overall Study|Withdrawal by Subject|0|||
30880625|NCT02531373|58912639|FG007|Overall Study|Withdrawal by Subject|0|||
30880626|NCT02531373|58912640|FG008|Overall Study|Withdrawal by Subject|0|||
30880627|NCT02606279|58912663|FG000|Overall Study|Lost to Follow-up|0|||
30880628|NCT02606279|58912664|FG001|Overall Study|Lost to Follow-up|1|||
30880629|NCT02643355|58912678|FG000|Overall Study|Withdrawal by Subject|1|||
30880630|NCT02643355|58912679|FG001|Overall Study|Withdrawal by Subject|3|||
30880631|NCT02643355|58912678|FG000|Overall Study|Protocol Violation|0|||
30880632|NCT02643355|58912679|FG001|Overall Study|Protocol Violation|2|||
30880633|NCT02604017|58912687|FG000|Overall Study|Withdrew Consent|0|||
30880634|NCT02604017|58912688|FG001|Overall Study|Withdrew Consent|2|||
30880635|NCT02604017|58912687|FG000|Overall Study|Lost to Follow-up|5|||
30880636|NCT02604017|58912688|FG001|Overall Study|Lost to Follow-up|6|||
30880637|NCT02604017|58912687|FG000|Overall Study|Other|1|||
30880638|NCT02604017|58912688|FG001|Overall Study|Other|0|||
30880639|NCT02640547|58912694|FG000|Overall Study|Failure to Return|1|||
30880640|NCT02640547|58912694|FG000|Overall Study|Withdrawal by Subject|1|||
30880641|NCT02640547|58912694|FG000|Overall Study|Death|6|||
30880642|NCT02640547|58912694|FG000|Overall Study|Miscellaneous|3|||
30880643|NCT02530905|58912708|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
30880644|NCT02530905|58912709|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
30880645|NCT02530905|58912710|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
30880646|NCT02530671|58912734|FG000|Overall Study|Lost to Follow-up|2|||
30880647|NCT02530671|58912735|FG001|Overall Study|Lost to Follow-up|0|||
30880648|NCT02530671|58912734|FG000|Overall Study|Withdrawal by Subject|1|||
30880649|NCT02530671|58912735|FG001|Overall Study|Withdrawal by Subject|0|||
30880650|NCT02603393|58912743|FG000|Overall Study|Patient/guardian decision|32|||
30880651|NCT02603393|58912744|FG001|Overall Study|Patient/guardian decision|18|||
30880652|NCT02603393|58912743|FG000|Overall Study|Adverse Event|17|||
30880653|NCT02603393|58912744|FG001|Overall Study|Adverse Event|15|||
30880654|NCT02603393|58912743|FG000|Overall Study|Technical problems|4|||
30880655|NCT02603393|58912744|FG001|Overall Study|Technical problems|7|||
30880656|NCT02603393|58912743|FG000|Overall Study|Lack of Efficacy|7|||
30880657|NCT02603393|58912744|FG001|Overall Study|Lack of Efficacy|2|||
30880658|NCT02603393|58912743|FG000|Overall Study|Death|3|||
30880659|NCT02603393|58912744|FG001|Overall Study|Death|4|||
30880660|NCT02603393|58912743|FG000|Overall Study|Physician Decision|3|||
30880661|NCT02603393|58912744|FG001|Overall Study|Physician Decision|3|||
30975247|NCT00985673|59055540|FG005|Overall Study|Withdrawal by Subject|3|||
30975248|NCT00985673|59055535|FG000|Overall Study|Other|1|||
30975249|NCT00985673|59055536|FG001|Overall Study|Other|0|||
30975250|NCT00985673|59055537|FG002|Overall Study|Other|1|||
30880662|NCT02603393|58912743|FG000|Overall Study|Protocol deviation|2|||
30880663|NCT02603393|58912744|FG001|Overall Study|Protocol deviation|3|||
30880664|NCT02603393|58912743|FG000|Overall Study|Lost to Follow-up|1|||
30880665|NCT02603393|58912744|FG001|Overall Study|Lost to Follow-up|2|||
30880666|NCT02603393|58912743|FG000|Overall Study|Non-compliance with study treatment|1|||
30880667|NCT02603393|58912744|FG001|Overall Study|Non-compliance with study treatment|0|||
30880668|NCT02603393|58912743|FG000|Overall Study|Sponsor decision|1|||
30880669|NCT02603393|58912744|FG001|Overall Study|Sponsor decision|0|||
30880670|NCT02642653|58912752|FG000|Overall Study|Adverse Event|2|||
30880671|NCT02642653|58912753|FG001|Overall Study|Adverse Event|0|||
30880672|NCT01659567|58912759|FG000|Overall Study|Lack of Efficacy|22|||
30880673|NCT01659567|58912759|FG000|Overall Study|Switched to Pegferon|6|||
30880674|NCT01659567|58912759|FG000|Overall Study|Adverse Event|12|||
30880675|NCT01659567|58912759|FG000|Overall Study|Good result at early stage of treatment|5|||
30880676|NCT01659567|58912759|FG000|Overall Study|Withdrawal by Subject|64|||
30880677|NCT01659567|58912759|FG000|Overall Study|Progression of the main disease|1|||
30880678|NCT01659567|58912759|FG000|Overall Study|Other|13|||
30880679|NCT02605967|58912775|FG000|Overall Study|subject / guardian decision|1|||
30975251|NCT00985673|59055538|FG003|Overall Study|Other|0|||
30880680|NCT02605967|58912776|FG001|Overall Study|subject / guardian decision|2|||
30880681|NCT02605967|58912775|FG000|Overall Study|Physician Decision|10|||
30880682|NCT02605967|58912776|FG001|Overall Study|Physician Decision|1|||
30975252|NCT00985673|59055539|FG004|Overall Study|Other|1|||
30880683|NCT02605967|58912775|FG000|Overall Study|Death|4|||
30880684|NCT02605967|58912776|FG001|Overall Study|Death|2|||
30880685|NCT02605967|58912775|FG000|Overall Study|Adverse Event|1|||
30880686|NCT02605967|58912776|FG001|Overall Study|Adverse Event|0|||
30880687|NCT02605967|58912775|FG000|Overall Study|progressive disease|66|||
30880688|NCT02605967|58912776|FG001|Overall Study|progressive disease|35|||
30880689|NCT01668173|58912786|FG000|Overall Study|Adverse Event|3|||
30880690|NCT01668173|58912786|FG000|Overall Study|Trial suspension|4|||
30880691|NCT02600351|58912803|FG000|Overall Study|Lack of Efficacy|3|||
30880692|NCT02600351|58912804|FG001|Overall Study|Lack of Efficacy|0|||
30880693|NCT02600351|58912805|FG002|Overall Study|Lack of Efficacy|5|||
30880694|NCT02600351|58912806|FG003|Overall Study|Lack of Efficacy|2|||
30880695|NCT02600351|58912803|FG000|Overall Study|Lost to Follow-up|1|||
30880696|NCT02600351|58912804|FG001|Overall Study|Lost to Follow-up|0|||
30880697|NCT02600351|58912805|FG002|Overall Study|Lost to Follow-up|0|||
30880698|NCT02600351|58912806|FG003|Overall Study|Lost to Follow-up|0|||
30880699|NCT02600351|58912803|FG000|Overall Study|Randomized but Not Treated|1|||
30880700|NCT02600351|58912804|FG001|Overall Study|Randomized but Not Treated|0|||
30880701|NCT02600351|58912805|FG002|Overall Study|Randomized but Not Treated|1|||
30880702|NCT02600351|58912806|FG003|Overall Study|Randomized but Not Treated|3|||
30880703|NCT02640235|58912820|FG000|Overall Study|Withdrawal by Subject|7|||
30975253|NCT00985673|59055540|FG005|Overall Study|Other|0|||
30975254|NCT00985439|59055586|FG000|Overall Study|Adverse Event|0|||
30975255|NCT00985439|59055587|FG001|Overall Study|Adverse Event|0|||
30975256|NCT00985439|59055588|FG002|Overall Study|Adverse Event|1|||
30975257|NCT00985439|59055589|FG003|Overall Study|Adverse Event|0|||
30880704|NCT02640235|58912821|FG001|Overall Study|Withdrawal by Subject|6|||
30975258|NCT02618928|59055599|FG000|Overall Study|Failure to Return|28|||
30975259|NCT02618928|59055599|FG000|Overall Study|Insufficient Virological Response|1|||
30975260|NCT02618928|59055599|FG000|Overall Study|Withdrawal by Subject|2|||
30975261|NCT02618928|59055599|FG000|Overall Study|Death|3|||
30975262|NCT02618928|59055599|FG000|Overall Study|Other|11|||
30975263|NCT02618928|59055599|FG000|Overall Study|Missing|6|||
30975264|NCT02618928|59055599|FG000|Overall Study|Treatment Never Started|7|||
30975265|NCT00983957|59055610|FG000|Overall Study|Adverse Event|1|||
30975266|NCT00983957|59055610|FG000|Overall Study|Personal Reasons|1|||
30975267|NCT00981149|59055664|FG000|Overall Study|Lost to Follow-up|1|||
30975268|NCT00981149|59055665|FG001|Overall Study|Lost to Follow-up|2|||
30975269|NCT00981149|59055664|FG000|Overall Study|Withdrawal by Subject|1|||
30975270|NCT00981149|59055665|FG001|Overall Study|Withdrawal by Subject|1|||
30975271|NCT01595646|59055723|FG000|Overall Study|Withdrawal by Subject|1|||
30975272|NCT01595646|59055724|FG001|Overall Study|Withdrawal by Subject|0|||
30975273|NCT01595646|59055725|FG002|Overall Study|Withdrawal by Subject|0|||
30975274|NCT00981461|59055753|FG000|Overall Study|Lost to Follow-up|5|||
30975275|NCT00981461|59055754|FG001|Overall Study|Lost to Follow-up|2|||
30975276|NCT02618616|59055771|FG000|Overall Study|Lack of Efficacy|4|||
30975277|NCT02618616|59055772|FG001|Overall Study|Lack of Efficacy|0|||
30975278|NCT02618616|59055771|FG000|Overall Study|Pregnancy|0|||
30975279|NCT02618616|59055772|FG001|Overall Study|Pregnancy|1|||
30975280|NCT02618616|59055771|FG000|Overall Study|Adverse Event|8|||
30975281|NCT02618616|59055772|FG001|Overall Study|Adverse Event|0|||
30975282|NCT02618616|59055771|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
30880705|NCT02640235|58912820|FG000|Overall Study|Lost to Follow-up|4|||
30880706|NCT02640235|58912821|FG001|Overall Study|Lost to Follow-up|3|||
30880707|NCT02640235|58912820|FG000|Overall Study|Death|2|||
30975283|NCT02618616|59055772|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
30975284|NCT02618616|59055771|FG000|Overall Study|Consent withdrawn by subject|8|||
30880708|NCT02640235|58912821|FG001|Overall Study|Death|3|||
30880709|NCT02640235|58912820|FG000|Overall Study|Other|1|||
30880710|NCT02640235|58912821|FG001|Overall Study|Other|2|||
30880711|NCT02599961|58912827|FG000|Overall Study|Withdrawal by Subject|1|||
30880712|NCT02599961|58912827|FG000|Overall Study|Subject Non-Compliance|2|||
30880713|NCT02599961|58912827|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
30880714|NCT02599961|58912827|FG000|Overall Study|Other, Not Specified|3|||
30880715|NCT02640157|58912852|FG000|Overall Study|Adverse Event|2|||
30880716|NCT02640157|58912853|FG001|Overall Study|Adverse Event|2|||
30975285|NCT02618616|59055772|FG001|Overall Study|Consent withdrawn by subject|5|||
30975286|NCT02618616|59055771|FG000|Overall Study|Lost to Follow-up|0|||
30975287|NCT02618616|59055772|FG001|Overall Study|Lost to Follow-up|1|||
30975288|NCT02618382|59055851|FG000|Overall Study|Physician Decision|1|||
30880717|NCT02640157|58912854|FG002|Overall Study|Adverse Event|1|||
30880718|NCT02640157|58912852|FG000|Overall Study|Withdrew consent|2|||
30880719|NCT02640157|58912853|FG001|Overall Study|Withdrew consent|0|||
30880720|NCT02640157|58912854|FG002|Overall Study|Withdrew consent|2|||
30880721|NCT02640157|58912852|FG000|Overall Study|Lost to Follow-up|9|||
30880722|NCT02640157|58912853|FG001|Overall Study|Lost to Follow-up|2|||
30880723|NCT02640157|58912854|FG002|Overall Study|Lost to Follow-up|7|||
30975289|NCT02618382|59055851|FG000|Overall Study|Withdrawal by Subject|1|||
30975290|NCT02618382|59055851|FG000|Overall Study|Protocol Violation|1|||
30975291|NCT00980057|59055895|FG000|Overall Study|Death|13|||
30880724|NCT02640157|58912852|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
30880725|NCT02640157|58912853|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
30880726|NCT02640157|58912854|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
30880727|NCT01673347|58912863|FG000|Overall Study|failure of allograft|7|||
30880728|NCT02528253|58912872|FG000|Overall Study|Adverse Event|3|||
30880729|NCT02528253|58912873|FG001|Overall Study|Adverse Event|4|||
30880730|NCT02528253|58912874|FG002|Overall Study|Adverse Event|4|||
30880731|NCT02528253|58912875|FG003|Overall Study|Adverse Event|8|||
30880732|NCT02528253|58912876|FG004|Overall Study|Adverse Event|18|||
30880733|NCT02528253|58912872|FG000|Overall Study|Death|2|||
30880734|NCT02528253|58912873|FG001|Overall Study|Death|2|||
30880735|NCT02528253|58912874|FG002|Overall Study|Death|1|||
30880736|NCT02528253|58912875|FG003|Overall Study|Death|0|||
30880737|NCT02528253|58912876|FG004|Overall Study|Death|1|||
30880738|NCT02528253|58912872|FG000|Overall Study|Insufficient clinical response|7|||
30880739|NCT02528253|58912873|FG001|Overall Study|Insufficient clinical response|10|||
30880740|NCT02528253|58912874|FG002|Overall Study|Insufficient clinical response|13|||
30880741|NCT02528253|58912875|FG003|Overall Study|Insufficient clinical response|12|||
30880742|NCT02528253|58912876|FG004|Overall Study|Insufficient clinical response|16|||
30880743|NCT02528253|58912872|FG000|Overall Study|Lost to Follow-up|16|||
30880744|NCT02528253|58912873|FG001|Overall Study|Lost to Follow-up|9|||
30880745|NCT02528253|58912874|FG002|Overall Study|Lost to Follow-up|31|||
30880746|NCT02528253|58912875|FG003|Overall Study|Lost to Follow-up|16|||
30880747|NCT02528253|58912876|FG004|Overall Study|Lost to Follow-up|34|||
30880748|NCT02528253|58912872|FG000|Overall Study|Other|21|||
30880749|NCT02528253|58912873|FG001|Overall Study|Other|22|||
30880750|NCT02528253|58912874|FG002|Overall Study|Other|58|||
30880751|NCT02528253|58912875|FG003|Overall Study|Other|52|||
30880752|NCT02528253|58912876|FG004|Overall Study|Other|76|||
30880753|NCT02528253|58912872|FG000|Overall Study|Withdrawal by Subject|25|||
30880754|NCT02528253|58912873|FG001|Overall Study|Withdrawal by Subject|20|||
30880755|NCT02528253|58912874|FG002|Overall Study|Withdrawal by Subject|29|||
30880756|NCT02528253|58912875|FG003|Overall Study|Withdrawal by Subject|48|||
30880757|NCT02528253|58912876|FG004|Overall Study|Withdrawal by Subject|73|||
30880758|NCT02528253|58912872|FG000|Overall Study|Protocol Violation|1|||
30880759|NCT02528253|58912873|FG001|Overall Study|Protocol Violation|2|||
30880760|NCT02528253|58912874|FG002|Overall Study|Protocol Violation|4|||
30880761|NCT02528253|58912875|FG003|Overall Study|Protocol Violation|0|||
30880762|NCT02528253|58912876|FG004|Overall Study|Protocol Violation|4|||
30880763|NCT02528253|58912872|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
30880764|NCT02528253|58912873|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
30880765|NCT02528253|58912874|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
30880766|NCT02528253|58912875|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
30880767|NCT02528253|58912876|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
30880768|NCT01672957|58912907|FG000|Overall Study|Protocol Violation|48|||
30880769|NCT01672957|58912907|FG000|Overall Study|Death|2|||
30880770|NCT01672957|58912907|FG000|Overall Study|ICF Signed After Transplantation|5|||
30880771|NCT02525133|58912913|FG000|Overall Study|Adverse Event|0|||
30880772|NCT02525133|58912914|FG001|Overall Study|Adverse Event|1|||
30880773|NCT02525133|58912913|FG000|Overall Study|Death|0|||
30880774|NCT02525133|58912914|FG001|Overall Study|Death|1|||
30880775|NCT02525133|58912913|FG000|Overall Study|did not meet randomization criteria|1|||
30880776|NCT02525133|58912914|FG001|Overall Study|did not meet randomization criteria|0|||
30880777|NCT02525133|58912913|FG000|Overall Study|Lost to Follow-up|5|||
30880778|NCT02525133|58912914|FG001|Overall Study|Lost to Follow-up|1|||
30880779|NCT02525133|58912913|FG000|Overall Study|randomized not enrolled|3|||
30880780|NCT02525133|58912914|FG001|Overall Study|randomized not enrolled|0|||
30880781|NCT02525133|58912913|FG000|Overall Study|Withdrawal by Subject|1|||
30880782|NCT02525133|58912914|FG001|Overall Study|Withdrawal by Subject|0|||
30880783|NCT01659255|58912941|FG000|Overall Study|Adverse Event|0|||
30880784|NCT01659255|58912942|FG001|Overall Study|Adverse Event|0|||
30880785|NCT01659255|58912943|FG002|Overall Study|Adverse Event|0|||
30880786|NCT01659255|58912944|FG003|Overall Study|Adverse Event|0|||
30880787|NCT01659255|58912945|FG004|Overall Study|Adverse Event|0|||
30975292|NCT00980057|59055896|FG001|Overall Study|Death|3|||
30975293|NCT00980057|59055895|FG000|Overall Study|Adverse Event|0|||
30975294|NCT00980057|59055896|FG001|Overall Study|Adverse Event|1|||
30880788|NCT01659255|58912946|FG005|Overall Study|Adverse Event|1|||
30880789|NCT01659255|58912947|FG006|Overall Study|Adverse Event|1|||
30880790|NCT01659255|58912948|FG007|Overall Study|Adverse Event|0|||
30880791|NCT01659255|58912949|FG008|Overall Study|Adverse Event|0|||
30880792|NCT01659255|58912950|FG009|Overall Study|Adverse Event|1|||
30880793|NCT01659255|58912951|FG010|Overall Study|Adverse Event|0|||
30880794|NCT01659255|58912952|FG011|Overall Study|Adverse Event|1|||
30880795|NCT01659255|58912953|FG012|Overall Study|Adverse Event|0|||
30880796|NCT01659255|58912954|FG013|Overall Study|Adverse Event|2|||
30880797|NCT01659255|58912955|FG014|Overall Study|Adverse Event|0|||
30880798|NCT01659255|58912956|FG015|Overall Study|Adverse Event|1|||
30880799|NCT01659255|58912957|FG016|Overall Study|Adverse Event|0|||
30975295|NCT00980057|59055895|FG000|Overall Study|Physician Decision|4|||
30975296|NCT00980057|59055896|FG001|Overall Study|Physician Decision|0|||
30975297|NCT00980057|59055895|FG000|Overall Study|Lost to Follow-up|1|||
30975298|NCT00980057|59055896|FG001|Overall Study|Lost to Follow-up|0|||
30975299|NCT00980057|59055895|FG000|Overall Study|Withdrawal by Subject|1|||
30975300|NCT00980057|59055896|FG001|Overall Study|Withdrawal by Subject|1|||
30975301|NCT04126733|59056008|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
30975302|NCT04126733|59056008|FG000|Treatment Period|Adverse Event|8|||
30975303|NCT04126733|59056008|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
30975304|NCT04126733|59056008|FG000|Treatment Period|Physician Decision|5|||
30975305|NCT04126733|59056008|FG000|Treatment Period|Death|1|||
30975306|NCT04126733|59056008|FG000|Treatment Period|Other Reasons|2|||
30975307|NCT04126733|59056008|FG000|Active Follow-up Period|Death|13|||
30975308|NCT04126733|59056008|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
30975309|NCT04126733|59056008|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
30975310|NCT04126733|59056008|FG000|Active Follow-up Period|Other Reasons|1|||
30975311|NCT04126733|59056008|FG000|Long-term Follow-up Period|Death|22|||
30975312|NCT04126733|59056008|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
30975313|NCT04126733|59056008|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
30975314|NCT00988247|59056043|FG000|Overall Study|Adverse Event|17|||
30975315|NCT00988247|59056044|FG001|Overall Study|Adverse Event|3|||
30975316|NCT00988247|59056043|FG000|Overall Study|Withdrawal by Subject|44|||
30975317|NCT00988247|59056044|FG001|Overall Study|Withdrawal by Subject|13|||
30975318|NCT00988247|59056043|FG000|Overall Study|Pregnancy|1|||
30880800|NCT01659255|58912941|FG000|Overall Study|Death|0|||
30880801|NCT01659255|58912942|FG001|Overall Study|Death|1|||
30880802|NCT01659255|58912943|FG002|Overall Study|Death|0|||
30880803|NCT01659255|58912944|FG003|Overall Study|Death|0|||
30880804|NCT01659255|58912945|FG004|Overall Study|Death|0|||
30880805|NCT01659255|58912946|FG005|Overall Study|Death|0|||
30880806|NCT01659255|58912947|FG006|Overall Study|Death|0|||
30880807|NCT01659255|58912948|FG007|Overall Study|Death|1|||
30880808|NCT01659255|58912949|FG008|Overall Study|Death|1|||
30880809|NCT01659255|58912950|FG009|Overall Study|Death|0|||
30880810|NCT01659255|58912951|FG010|Overall Study|Death|0|||
30880811|NCT01659255|58912952|FG011|Overall Study|Death|0|||
30880812|NCT01659255|58912953|FG012|Overall Study|Death|1|||
30880813|NCT01659255|58912954|FG013|Overall Study|Death|1|||
30880814|NCT01659255|58912955|FG014|Overall Study|Death|2|||
30880815|NCT01659255|58912956|FG015|Overall Study|Death|1|||
30880816|NCT01659255|58912957|FG016|Overall Study|Death|0|||
30880817|NCT01659255|58912941|FG000|Overall Study|Progressive Disease|2|||
30880818|NCT01659255|58912942|FG001|Overall Study|Progressive Disease|0|||
30880819|NCT01659255|58912943|FG002|Overall Study|Progressive Disease|0|||
30880820|NCT01659255|58912944|FG003|Overall Study|Progressive Disease|0|||
30975319|NCT00988247|59056044|FG001|Overall Study|Pregnancy|2|||
30975320|NCT00988247|59056043|FG000|Overall Study|Lost to Follow-up|11|||
30975321|NCT00988247|59056044|FG001|Overall Study|Lost to Follow-up|2|||
30975322|NCT00988247|59056043|FG000|Overall Study|Protocol Violation|4|||
30975323|NCT00988247|59056044|FG001|Overall Study|Protocol Violation|5|||
30975324|NCT00988247|59056043|FG000|Overall Study|Sponsor requested withdrawal|3|||
30975325|NCT00988247|59056044|FG001|Overall Study|Sponsor requested withdrawal|1|||
30975326|NCT00988247|59056043|FG000|Overall Study|Other|3|||
30975327|NCT00988247|59056044|FG001|Overall Study|Other|0|||
30975328|NCT00984659|59056054|FG000|2-week Run-in Period|Adverse Event|8|||
30975329|NCT00984659|59056055|FG001|2-week Run-in Period|Adverse Event|0|||
30975330|NCT00984659|59056056|FG002|2-week Run-in Period|Adverse Event|0|||
30975331|NCT00984659|59056057|FG003|2-week Run-in Period|Adverse Event|0|||
30975332|NCT00984659|59056054|FG000|2-week Run-in Period|Protocol Violation|5|||
30880821|NCT01659255|58912945|FG004|Overall Study|Progressive Disease|0|||
30880822|NCT01659255|58912946|FG005|Overall Study|Progressive Disease|0|||
30975333|NCT00984659|59056055|FG001|2-week Run-in Period|Protocol Violation|0|||
30975334|NCT00984659|59056056|FG002|2-week Run-in Period|Protocol Violation|0|||
30975335|NCT00984659|59056057|FG003|2-week Run-in Period|Protocol Violation|0|||
30975336|NCT00984659|59056054|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
30975337|NCT00984659|59056055|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
30975338|NCT00984659|59056056|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
30975339|NCT00984659|59056057|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
30975340|NCT00984659|59056054|FG000|2-week Run-in Period|Lost to Follow-up|3|||
30880823|NCT01659255|58912947|FG006|Overall Study|Progressive Disease|0|||
30880824|NCT01659255|58912948|FG007|Overall Study|Progressive Disease|1|||
30880825|NCT01659255|58912949|FG008|Overall Study|Progressive Disease|0|||
30880826|NCT01659255|58912950|FG009|Overall Study|Progressive Disease|2|||
30880827|NCT01659255|58912951|FG010|Overall Study|Progressive Disease|2|||
30880828|NCT01659255|58912952|FG011|Overall Study|Progressive Disease|3|||
30880829|NCT01659255|58912953|FG012|Overall Study|Progressive Disease|5|||
30880830|NCT01659255|58912954|FG013|Overall Study|Progressive Disease|13|||
30975341|NCT00984659|59056055|FG001|2-week Run-in Period|Lost to Follow-up|0|||
30975342|NCT00984659|59056056|FG002|2-week Run-in Period|Lost to Follow-up|0|||
30975343|NCT00984659|59056057|FG003|2-week Run-in Period|Lost to Follow-up|0|||
30975344|NCT00984659|59056054|FG000|2-week Run-in Period|Physician Decision|10|||
30975345|NCT00984659|59056055|FG001|2-week Run-in Period|Physician Decision|0|||
30975346|NCT00984659|59056056|FG002|2-week Run-in Period|Physician Decision|0|||
30975347|NCT00984659|59056057|FG003|2-week Run-in Period|Physician Decision|0|||
30975348|NCT00984659|59056054|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
30975349|NCT00984659|59056055|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
30975350|NCT00984659|59056056|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
30975351|NCT00984659|59056057|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
30975352|NCT00984659|59056054|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
30975353|NCT00984659|59056055|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
30975354|NCT00984659|59056056|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
30975355|NCT00984659|59056057|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
30975356|NCT00984659|59056054|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
30975357|NCT00984659|59056055|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
30975358|NCT00984659|59056056|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
30880831|NCT01659255|58912955|FG014|Overall Study|Progressive Disease|6|||
30880832|NCT01659255|58912956|FG015|Overall Study|Progressive Disease|2|||
30880833|NCT01659255|58912957|FG016|Overall Study|Progressive Disease|3|||
30880834|NCT01659255|58912941|FG000|Overall Study|Withdrew Consent|0|||
30880835|NCT01659255|58912942|FG001|Overall Study|Withdrew Consent|0|||
30880836|NCT01659255|58912943|FG002|Overall Study|Withdrew Consent|0|||
30880837|NCT01659255|58912944|FG003|Overall Study|Withdrew Consent|0|||
30880838|NCT01659255|58912945|FG004|Overall Study|Withdrew Consent|0|||
30880839|NCT01659255|58912946|FG005|Overall Study|Withdrew Consent|0|||
30880840|NCT01659255|58912947|FG006|Overall Study|Withdrew Consent|0|||
30880841|NCT01659255|58912948|FG007|Overall Study|Withdrew Consent|0|||
30880842|NCT01659255|58912949|FG008|Overall Study|Withdrew Consent|0|||
30880843|NCT01659255|58912950|FG009|Overall Study|Withdrew Consent|0|||
30880844|NCT01659255|58912951|FG010|Overall Study|Withdrew Consent|1|||
30880845|NCT01659255|58912952|FG011|Overall Study|Withdrew Consent|0|||
30880846|NCT01659255|58912953|FG012|Overall Study|Withdrew Consent|0|||
30880847|NCT01659255|58912954|FG013|Overall Study|Withdrew Consent|1|||
30880848|NCT01659255|58912955|FG014|Overall Study|Withdrew Consent|0|||
30880849|NCT01659255|58912956|FG015|Overall Study|Withdrew Consent|0|||
30880850|NCT01659255|58912957|FG016|Overall Study|Withdrew Consent|0|||
30880851|NCT01659255|58912941|FG000|Overall Study|Investigator Decision|0|||
30880852|NCT01659255|58912942|FG001|Overall Study|Investigator Decision|0|||
30880853|NCT01659255|58912943|FG002|Overall Study|Investigator Decision|0|||
30880854|NCT01659255|58912944|FG003|Overall Study|Investigator Decision|0|||
30880855|NCT01659255|58912945|FG004|Overall Study|Investigator Decision|0|||
30880856|NCT01659255|58912946|FG005|Overall Study|Investigator Decision|0|||
30880857|NCT01659255|58912947|FG006|Overall Study|Investigator Decision|0|||
30880858|NCT01659255|58912948|FG007|Overall Study|Investigator Decision|0|||
30880859|NCT01659255|58912949|FG008|Overall Study|Investigator Decision|0|||
30880860|NCT01659255|58912950|FG009|Overall Study|Investigator Decision|0|||
30880861|NCT01659255|58912951|FG010|Overall Study|Investigator Decision|0|||
30880862|NCT01659255|58912952|FG011|Overall Study|Investigator Decision|0|||
30880863|NCT01659255|58912953|FG012|Overall Study|Investigator Decision|1|||
30880864|NCT01659255|58912954|FG013|Overall Study|Investigator Decision|1|||
30975359|NCT00984659|59056057|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
30975360|NCT00984659|59056054|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
30975361|NCT00984659|59056055|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
30975362|NCT00984659|59056056|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
30975363|NCT00984659|59056057|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
30975364|NCT00984659|59056054|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
30975365|NCT00984659|59056055|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
30975366|NCT00984659|59056056|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
30975367|NCT00984659|59056057|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
30975368|NCT00984659|59056054|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
30975369|NCT00984659|59056055|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
30975370|NCT00984659|59056056|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
30975371|NCT00984659|59056057|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
30975372|NCT00984659|59056054|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
30975373|NCT00984659|59056055|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
30975374|NCT00984659|59056056|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
30880865|NCT01659255|58912955|FG014|Overall Study|Investigator Decision|0|||
30880866|NCT01659255|58912956|FG015|Overall Study|Investigator Decision|0|||
30880867|NCT01659255|58912957|FG016|Overall Study|Investigator Decision|0|||
30880868|NCT01659255|58912941|FG000|Overall Study|Sponsor's Decision|0|||
30880869|NCT01659255|58912942|FG001|Overall Study|Sponsor's Decision|0|||
30880870|NCT01659255|58912943|FG002|Overall Study|Sponsor's Decision|0|||
30880871|NCT01659255|58912944|FG003|Overall Study|Sponsor's Decision|0|||
30880872|NCT01659255|58912945|FG004|Overall Study|Sponsor's Decision|0|||
30880873|NCT01659255|58912946|FG005|Overall Study|Sponsor's Decision|0|||
30880874|NCT01659255|58912947|FG006|Overall Study|Sponsor's Decision|1|||
30880875|NCT01659255|58912948|FG007|Overall Study|Sponsor's Decision|0|||
30880876|NCT01659255|58912949|FG008|Overall Study|Sponsor's Decision|0|||
30880877|NCT01659255|58912950|FG009|Overall Study|Sponsor's Decision|0|||
30880878|NCT01659255|58912951|FG010|Overall Study|Sponsor's Decision|0|||
30880879|NCT01659255|58912952|FG011|Overall Study|Sponsor's Decision|0|||
30880880|NCT01659255|58912953|FG012|Overall Study|Sponsor's Decision|0|||
30880881|NCT01659255|58912954|FG013|Overall Study|Sponsor's Decision|0|||
30975375|NCT00984659|59056057|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
30975376|NCT00982319|59056066|FG000|Overall Study|Surgery date change|1|||
30975377|NCT00982319|59056067|FG001|Overall Study|Surgery date change|0|||
30975378|NCT00982319|59056066|FG000|Overall Study|Preop values out of acceptable range|1|||
30975379|NCT00982319|59056067|FG001|Overall Study|Preop values out of acceptable range|1|||
30975380|NCT00982319|59056066|FG000|Overall Study|Pregnancy|0|||
30975381|NCT00982319|59056067|FG001|Overall Study|Pregnancy|1|||
30975382|NCT02612064|59056079|FG000|Overall Study|Withdrawal by Subject|1|||
30975383|NCT02612064|59056080|FG001|Overall Study|Withdrawal by Subject|1|||
30975384|NCT02612064|59056079|FG000|Overall Study|Other|0|||
30975385|NCT02612064|59056080|FG001|Overall Study|Other|2|||
30975386|NCT02614560|59056099|FG000|Overall Study|Death|6|||
30975387|NCT02614560|59056100|FG001|Overall Study|Death|2|||
30975388|NCT01669122|59056117|FG000|Period I|Lost to Follow-up|1|||
30975389|NCT01669122|59056117|FG000|Washout Period II|Protocol Violation|2|||
30975390|NCT02611752|59056150|FG000|Overall Study|Adverse Event|0|||
30975391|NCT02611752|59056151|FG001|Overall Study|Adverse Event|1|||
30975392|NCT02611362|59056172|FG000|Overall Study|Withdrawal by Subject|7|||
30975393|NCT02611362|59056173|FG001|Overall Study|Withdrawal by Subject|2|||
30975394|NCT02611362|59056172|FG000|Overall Study|Lost to Follow-up|2|||
30975395|NCT02611362|59056173|FG001|Overall Study|Lost to Follow-up|4|||
30975396|NCT01594476|59056193|FG000|Overall Study|Protocol Violation|1|||
30975397|NCT01594476|59056194|FG001|Overall Study|Protocol Violation|3|||
30975398|NCT01668966|59056208|FG000|Overall Study|Withdrawal by Subject|1|||
30975399|NCT01668966|59056208|FG000|Overall Study|Death|1|||
30975400|NCT01668966|59056208|FG000|Overall Study|Not treated|2|||
30975401|NCT02609724|59056215|FG000|Overall Study|Death|2|||
30975402|NCT02609724|59056216|FG001|Overall Study|Death|0|||
30975403|NCT02609724|59056217|FG002|Overall Study|Death|1|||
30975404|NCT02609724|59056215|FG000|Overall Study|Withdrawal by Subject|1|||
30975405|NCT02609724|59056216|FG001|Overall Study|Withdrawal by Subject|2|||
30975406|NCT02609724|59056217|FG002|Overall Study|Withdrawal by Subject|3|||
30975407|NCT02609724|59056215|FG000|Overall Study|Illness|2|||
30975408|NCT02609724|59056216|FG001|Overall Study|Illness|1|||
30975409|NCT02609724|59056217|FG002|Overall Study|Illness|0|||
30975410|NCT02610816|59056250|FG000|Phase 1|Withdrawal by Subject|2|||
30975411|NCT02610816|59056251|FG001|Phase 1|Withdrawal by Subject|6|||
30975412|NCT02610816|59056252|FG002|Phase 1|Withdrawal by Subject|0|||
30975413|NCT02610816|59056253|FG003|Phase 1|Withdrawal by Subject|0|||
30975414|NCT02610816|59056250|FG000|Phase 1|Lost to Follow-up|2|||
30975415|NCT02610816|59056251|FG001|Phase 1|Lost to Follow-up|1|||
30975416|NCT02610816|59056252|FG002|Phase 1|Lost to Follow-up|0|||
30975417|NCT02610816|59056253|FG003|Phase 1|Lost to Follow-up|0|||
30975418|NCT02610816|59056250|FG000|Phase 1|Physician Decision|0|||
30975419|NCT02610816|59056251|FG001|Phase 1|Physician Decision|1|||
30975420|NCT02610816|59056252|FG002|Phase 1|Physician Decision|0|||
30975421|NCT02610816|59056253|FG003|Phase 1|Physician Decision|0|||
30975422|NCT02610816|59056250|FG000|Phase 2|Withdrawal by Subject|0|||
30975423|NCT02610816|59056251|FG001|Phase 2|Withdrawal by Subject|0|||
30975424|NCT02610816|59056252|FG002|Phase 2|Withdrawal by Subject|9|||
30975425|NCT02610816|59056253|FG003|Phase 2|Withdrawal by Subject|3|||
30975426|NCT02610816|59056250|FG000|Phase 2|Lost to Follow-up|0|||
30975427|NCT02610816|59056251|FG001|Phase 2|Lost to Follow-up|0|||
30975428|NCT02610816|59056252|FG002|Phase 2|Lost to Follow-up|2|||
30975429|NCT02610816|59056253|FG003|Phase 2|Lost to Follow-up|0|||
30880882|NCT01659255|58912955|FG014|Overall Study|Sponsor's Decision|0|||
30975430|NCT02610816|59056250|FG000|Phase 2|Physician Decision|0|||
30975431|NCT02610816|59056251|FG001|Phase 2|Physician Decision|0|||
30975432|NCT02610816|59056252|FG002|Phase 2|Physician Decision|0|||
30975433|NCT02610816|59056253|FG003|Phase 2|Physician Decision|2|||
30975434|NCT02610816|59056250|FG000|Phase 2|Pregnancy|0|||
30975435|NCT02610816|59056251|FG001|Phase 2|Pregnancy|0|||
30975436|NCT02610816|59056252|FG002|Phase 2|Pregnancy|0|||
30975437|NCT02610816|59056253|FG003|Phase 2|Pregnancy|1|||
30880883|NCT01659255|58912956|FG015|Overall Study|Sponsor's Decision|0|||
30975438|NCT02612610|59056349|FG000|Overall Study|Withdrawal by Subject|1|||
30975439|NCT02612610|59056350|FG001|Overall Study|Withdrawal by Subject|1|||
30975440|NCT02612610|59056351|FG002|Overall Study|Withdrawal by Subject|0|||
30975441|NCT02612610|59056352|FG003|Overall Study|Withdrawal by Subject|2|||
30975442|NCT02612610|59056349|FG000|Overall Study|Adverse Event|2|||
30975443|NCT02612610|59056350|FG001|Overall Study|Adverse Event|2|||
30975444|NCT02612610|59056351|FG002|Overall Study|Adverse Event|3|||
30880884|NCT01659255|58912957|FG016|Overall Study|Sponsor's Decision|0|||
30880885|NCT01659255|58912941|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880886|NCT01659255|58912942|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880887|NCT01659255|58912943|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880888|NCT01659255|58912944|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880889|NCT01659255|58912945|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880890|NCT01659255|58912946|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880891|NCT01659255|58912947|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880892|NCT01659255|58912948|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880893|NCT01659255|58912949|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880894|NCT01659255|58912950|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880895|NCT01659255|58912951|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880896|NCT01659255|58912952|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880897|NCT01659255|58912953|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880898|NCT01659255|58912954|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880899|NCT01659255|58912955|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880900|NCT01659255|58912956|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
30880901|NCT01659255|58912957|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
30880902|NCT01659255|58912941|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
30880903|NCT01659255|58912942|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
30880904|NCT01659255|58912943|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
30880905|NCT01659255|58912944|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
30880906|NCT01659255|58912945|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
30880907|NCT01659255|58912946|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
30880908|NCT01659255|58912947|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
30975445|NCT02612610|59056352|FG003|Overall Study|Adverse Event|10|||
30975446|NCT02612610|59056349|FG000|Overall Study|Lost to Follow-up|0|||
30975447|NCT02612610|59056350|FG001|Overall Study|Lost to Follow-up|1|||
30975448|NCT02612610|59056351|FG002|Overall Study|Lost to Follow-up|0|||
30975449|NCT02612610|59056352|FG003|Overall Study|Lost to Follow-up|0|||
30975450|NCT02612610|59056349|FG000|Overall Study|Protocol Violation|0|||
30975451|NCT02612610|59056350|FG001|Overall Study|Protocol Violation|1|||
30975452|NCT02612610|59056351|FG002|Overall Study|Protocol Violation|1|||
30975453|NCT02612610|59056352|FG003|Overall Study|Protocol Violation|0|||
30975454|NCT02612610|59056349|FG000|Overall Study|Lack of Efficacy|1|||
30975455|NCT02612610|59056350|FG001|Overall Study|Lack of Efficacy|2|||
30975456|NCT02612610|59056351|FG002|Overall Study|Lack of Efficacy|0|||
30975457|NCT02612610|59056352|FG003|Overall Study|Lack of Efficacy|1|||
30975458|NCT02612610|59056349|FG000|Overall Study|Physician Decision|0|||
30975459|NCT02612610|59056350|FG001|Overall Study|Physician Decision|1|||
30975460|NCT02612610|59056351|FG002|Overall Study|Physician Decision|0|||
30975461|NCT02612610|59056352|FG003|Overall Study|Physician Decision|0|||
30975462|NCT02612610|59056349|FG000|Overall Study|Noncompliance|1|||
30975463|NCT02612610|59056350|FG001|Overall Study|Noncompliance|0|||
30975464|NCT02612610|59056351|FG002|Overall Study|Noncompliance|0|||
30975465|NCT02612610|59056352|FG003|Overall Study|Noncompliance|0|||
30975466|NCT02612610|59056349|FG000|Overall Study|Cough Improvement|0|||
30975467|NCT02612610|59056350|FG001|Overall Study|Cough Improvement|0|||
30975468|NCT02612610|59056351|FG002|Overall Study|Cough Improvement|1|||
30975469|NCT02612610|59056352|FG003|Overall Study|Cough Improvement|0|||
30975470|NCT02610192|59056561|FG000|Overall Study|Received other treatment|8|||
30975471|NCT02610192|59056561|FG000|Overall Study|Physician Decision|1|||
30880909|NCT01659255|58912948|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
30880910|NCT01659255|58912949|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
30880911|NCT01659255|58912950|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
30880912|NCT01659255|58912951|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
30880913|NCT01659255|58912952|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
30880914|NCT01659255|58912953|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
30880915|NCT01659255|58912954|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
30880916|NCT01659255|58912955|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
30880917|NCT01659255|58912956|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
30880918|NCT01659255|58912957|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
30880919|NCT02637037|58912997|FG000|Overall Study|Positive drug screen at admission|1|||
30975472|NCT02609178|59056705|FG000|First Crown|Withdrawal by Subject|0|||
30975473|NCT02609178|59056706|FG001|First Crown|Withdrawal by Subject|0|||
30975474|NCT02609178|59056707|FG002|First Crown|Withdrawal by Subject|1|||
30975475|NCT02609178|59056708|FG003|First Crown|Withdrawal by Subject|1|||
30975476|NCT02609178|59056709|FG004|First Crown|Withdrawal by Subject|0|||
30975477|NCT02609178|59056710|FG005|First Crown|Withdrawal by Subject|0|||
30975478|NCT02607228|59056934|FG000|Overall Study|Progressive Disease|4|||
30975479|NCT02607228|59056935|FG001|Overall Study|Progressive Disease|3|||
30880920|NCT02637037|58912998|FG001|Overall Study|Positive drug screen at admission|0|||
30880921|NCT02637037|58912997|FG000|Overall Study|Withdrawal by Subject|2|||
30880922|NCT02637037|58912998|FG001|Overall Study|Withdrawal by Subject|1|||
30880923|NCT02637037|58912997|FG000|Overall Study|Adverse Event|1|||
30880924|NCT02637037|58912998|FG001|Overall Study|Adverse Event|0|||
30880925|NCT02637895|58913018|FG000|Overall Study|Lost to Follow-up|4|||
30880926|NCT02637895|58913019|FG001|Overall Study|Lost to Follow-up|0|||
30880927|NCT02637895|58913018|FG000|Overall Study|Protocol Violation|0|||
30880928|NCT02637895|58913019|FG001|Overall Study|Protocol Violation|1|||
30880929|NCT02637895|58913018|FG000|Overall Study|Lack of Efficacy|1|||
30880930|NCT02637895|58913019|FG001|Overall Study|Lack of Efficacy|0|||
30880931|NCT02637895|58913018|FG000|Overall Study|Withdrawal by Subject|1|||
30880932|NCT02637895|58913019|FG001|Overall Study|Withdrawal by Subject|1|||
30880933|NCT02637895|58913018|FG000|Overall Study|Abnormal baseline lab|0|||
30880934|NCT02637895|58913019|FG001|Overall Study|Abnormal baseline lab|1|||
30880935|NCT02522481|58913026|FG000|Overall Study|discontinued|1|||
30880936|NCT02522481|58913026|FG000|Overall Study|Not dosed|2|||
30880937|NCT02522403|58913039|FG000|Overall Study|Lost to Follow-up|2|||
30880938|NCT02522403|58913040|FG001|Overall Study|Lost to Follow-up|2|||
30880939|NCT02522403|58913039|FG000|Overall Study|Withdrawal by Subject|2|||
30880940|NCT02522403|58913040|FG001|Overall Study|Withdrawal by Subject|4|||
30880941|NCT02522325|58913046|FG000|Overall Study|Adverse Event|0|||
30880942|NCT02522325|58913047|FG001|Overall Study|Adverse Event|1|||
30880943|NCT01672879|58913056|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
30880944|NCT01672879|58913057|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
30880945|NCT01672879|58913058|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
30880946|NCT01672879|58913056|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
30880947|NCT01672879|58913057|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
30880948|NCT01672879|58913058|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
30880949|NCT01672879|58913056|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
30880950|NCT01672879|58913057|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
30880951|NCT01672879|58913058|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
30880952|NCT01672879|58913056|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
30880953|NCT01672879|58913057|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
30880954|NCT01672879|58913058|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
30880955|NCT01672879|58913056|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
30880956|NCT01672879|58913057|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
30880957|NCT01672879|58913058|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
30880958|NCT01672879|58913056|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
30880959|NCT01672879|58913057|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
30880960|NCT01672879|58913058|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
30880961|NCT01672879|58913056|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
30880962|NCT01672879|58913057|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
30880963|NCT01672879|58913058|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
30880964|NCT01672879|58913056|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
30880965|NCT01672879|58913057|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
30880966|NCT01672879|58913058|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
30880967|NCT01672879|58913056|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
30880968|NCT01672879|58913057|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
30880969|NCT01672879|58913058|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
30880970|NCT01672879|58913056|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
30880971|NCT01672879|58913057|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
30880972|NCT01672879|58913058|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
30975480|NCT02607228|59056936|FG002|Overall Study|Progressive Disease|1|||
30880973|NCT01672879|58913056|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
30880974|NCT01672879|58913057|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
30880975|NCT01672879|58913058|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
30880976|NCT01672879|58913056|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
30880977|NCT01672879|58913057|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
30880978|NCT01672879|58913058|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
30880979|NCT01672879|58913056|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
30880980|NCT01672879|58913057|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
30880981|NCT01672879|58913058|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
30880982|NCT02601209|58913074|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
30880983|NCT02601209|58913075|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
30880984|NCT02601209|58913076|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
30880985|NCT02601209|58913077|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
30880986|NCT02601209|58913078|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
30880987|NCT02601209|58913079|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
30880988|NCT02601209|58913080|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
30880989|NCT02601209|58913081|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
30880990|NCT02601209|58913082|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
30880991|NCT02601209|58913074|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
30880992|NCT02601209|58913075|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
30880993|NCT02601209|58913076|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
30880994|NCT02601209|58913077|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
30880995|NCT02601209|58913078|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
30880996|NCT02601209|58913079|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
30880997|NCT02601209|58913080|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
30880998|NCT02601209|58913081|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
30880999|NCT02601209|58913082|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
30881000|NCT01659021|58913098|FG000|Main Study|Adverse Event|2|||
30881001|NCT01659021|58913099|FG001|Main Study|Adverse Event|3|||
30881002|NCT01659021|58913098|FG000|Main Study|Lost to Follow-up|1|||
30881003|NCT01659021|58913099|FG001|Main Study|Lost to Follow-up|0|||
30881004|NCT01659021|58913098|FG000|Main Study|Unknown Reasons|2|||
30881005|NCT01659021|58913099|FG001|Main Study|Unknown Reasons|1|||
30881006|NCT01659021|58913098|FG000|Main Study|Physician Decision|34|||
30881007|NCT01659021|58913099|FG001|Main Study|Physician Decision|16|||
30881008|NCT01659021|58913098|FG000|Main Study|Withdrawal by Subject|19|||
30881009|NCT01659021|58913099|FG001|Main Study|Withdrawal by Subject|16|||
30881010|NCT01659021|58913098|FG000|Main Study|Study Terminated by Sponsor|16|||
30881011|NCT01659021|58913099|FG001|Main Study|Study Terminated by Sponsor|1|||
30881012|NCT01659021|58913098|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
30881013|NCT01659021|58913099|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
30881014|NCT01659021|58913098|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
30881015|NCT01659021|58913099|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
30881016|NCT02524665|58913109|FG000|Overall Study|Lost to Follow-up|1|||
30881017|NCT02638129|58913116|FG000|Overall Study|Study terminated|28|||
30881018|NCT02638129|58913117|FG001|Overall Study|Study terminated|30|||
30881019|NCT02524275|58913123|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
30881020|NCT01658943|58913129|FG000|Overall Study|Adverse Event|6|||
30881021|NCT01658943|58913130|FG001|Overall Study|Adverse Event|13|||
30881022|NCT01658943|58913129|FG000|Overall Study|Withdrawal by Subject|9|||
30881023|NCT01658943|58913130|FG001|Overall Study|Withdrawal by Subject|2|||
30881024|NCT01658943|58913129|FG000|Overall Study|Progression/Relapse|39|||
30881025|NCT01658943|58913130|FG001|Overall Study|Progression/Relapse|40|||
30881026|NCT01658943|58913129|FG000|Overall Study|Death|4|||
30881027|NCT01658943|58913130|FG001|Overall Study|Death|2|||
30881028|NCT01658943|58913129|FG000|Overall Study|not protocol specified|4|||
30881029|NCT01658943|58913130|FG001|Overall Study|not protocol specified|1|||
30881030|NCT01658943|58913129|FG000|Overall Study|Not eligible|7|||
30881031|NCT01658943|58913130|FG001|Overall Study|Not eligible|9|||
30881032|NCT01658943|58913129|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
30881033|NCT01658943|58913130|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
30881034|NCT02600819|58913136|FG000|GEN Phase|Adverse Event|2|||
30881035|NCT02600819|58913137|FG001|GEN Phase|Adverse Event|0|||
30881036|NCT02600819|58913136|FG000|GEN Phase|Death|2|||
30881037|NCT02600819|58913137|FG001|GEN Phase|Death|0|||
30881038|NCT02600819|58913136|FG000|GEN Phase|Investigator's Discretion|4|||
30881039|NCT02600819|58913137|FG001|GEN Phase|Investigator's Discretion|0|||
30881040|NCT02600819|58913136|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
30881041|NCT02600819|58913137|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
30881042|NCT02600819|58913136|FG000|GEN Phase|Withdrew Consent|5|||
30881043|NCT02600819|58913137|FG001|GEN Phase|Withdrew Consent|0|||
30881044|NCT02600819|58913136|FG000|GEN Phase|Lost to Follow-up|2|||
30881045|NCT02600819|58913137|FG001|GEN Phase|Lost to Follow-up|0|||
30881046|NCT02597933|58913145|FG000|Overall Study|Withdrawal by Subject|7|||
30881047|NCT02597933|58913146|FG001|Overall Study|Withdrawal by Subject|5|||
30881048|NCT02597933|58913145|FG000|Overall Study|Protocol Violation|2|||
30975481|NCT02607228|59056937|FG003|Overall Study|Progressive Disease|5|||
30881049|NCT02597933|58913146|FG001|Overall Study|Protocol Violation|2|||
30881050|NCT02597933|58913145|FG000|Overall Study|Adverse Event|20|||
30881051|NCT02597933|58913146|FG001|Overall Study|Adverse Event|28|||
30881052|NCT02597933|58913145|FG000|Overall Study|Not treated|2|||
30881053|NCT02597933|58913146|FG001|Overall Study|Not treated|2|||
30881054|NCT02597933|58913145|FG000|Overall Study|Other than stated above|7|||
30881055|NCT02597933|58913146|FG001|Overall Study|Other than stated above|14|||
30881056|NCT02597855|58913154|FG000|Overall Study|Lost to Follow-up|2|||
30881057|NCT02597855|58913155|FG001|Overall Study|Lost to Follow-up|1|||
30881058|NCT02604407|58913164|FG000|Overall Study|Adverse Event|0|||
30881059|NCT02604407|58913165|FG001|Overall Study|Adverse Event|7|||
30881060|NCT02604407|58913166|FG002|Overall Study|Adverse Event|5|||
30881061|NCT02604407|58913164|FG000|Overall Study|Protocol Violation|2|||
30881062|NCT02604407|58913165|FG001|Overall Study|Protocol Violation|0|||
30881063|NCT02604407|58913166|FG002|Overall Study|Protocol Violation|0|||
30881064|NCT02604407|58913164|FG000|Overall Study|Withdrawal by Subject|3|||
30881065|NCT02604407|58913165|FG001|Overall Study|Withdrawal by Subject|3|||
30881066|NCT02604407|58913166|FG002|Overall Study|Withdrawal by Subject|5|||
30881067|NCT02604407|58913164|FG000|Overall Study|Lost to Follow-up|2|||
30881068|NCT02604407|58913165|FG001|Overall Study|Lost to Follow-up|1|||
30881069|NCT02604407|58913166|FG002|Overall Study|Lost to Follow-up|2|||
30881070|NCT02604407|58913164|FG000|Overall Study|Lack of Efficacy|1|||
30881071|NCT02604407|58913165|FG001|Overall Study|Lack of Efficacy|0|||
30881072|NCT02604407|58913166|FG002|Overall Study|Lack of Efficacy|0|||
30881073|NCT02604407|58913164|FG000|Overall Study|Other|3|||
30881074|NCT02604407|58913165|FG001|Overall Study|Other|1|||
30881075|NCT02604407|58913166|FG002|Overall Study|Other|4|||
30881076|NCT02593097|58913176|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
30881077|NCT02593097|58913177|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
30881078|NCT02593097|58913176|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
30881079|NCT02593097|58913177|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
30881080|NCT02593097|58913176|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
30881081|NCT02593097|58913177|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
30881082|NCT02593097|58913176|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
30881083|NCT02593097|58913177|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
30881084|NCT02593097|58913176|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
30881085|NCT02593097|58913177|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
30881086|NCT01657461|58913185|FG000|Overall Study|Death|9|||
30881087|NCT01657461|58913186|FG001|Overall Study|Death|12|||
30881088|NCT01657461|58913185|FG000|Overall Study|Lost to Follow-up|0|||
30881089|NCT01657461|58913186|FG001|Overall Study|Lost to Follow-up|3|||
30881090|NCT01657461|58913185|FG000|Overall Study|Physician Decision|0|||
30881091|NCT01657461|58913186|FG001|Overall Study|Physician Decision|2|||
30881092|NCT01657461|58913185|FG000|Overall Study|Withdrawal by Subject|1|||
30881093|NCT01657461|58913186|FG001|Overall Study|Withdrawal by Subject|3|||
30881094|NCT02592551|58913195|FG000|Overall Study|Not evaluable|1|||
30881095|NCT02592551|58913196|FG001|Overall Study|Not evaluable|3|||
30881096|NCT02592551|58913197|FG002|Overall Study|Not evaluable|0|||
30881097|NCT02595749|58913208|FG000|Overall Study|Withdrawal by Subject|12|||
30881098|NCT02595749|58913209|FG001|Overall Study|Withdrawal by Subject|7|||
30881099|NCT01657305|58913215|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
30881100|NCT01657305|58913215|FG000|Overall Study|Withdrawal by Subject|4|||
30881101|NCT01657305|58913215|FG000|Overall Study|Adverse Event|1|||
30881102|NCT01657305|58913215|FG000|Overall Study|Lost to Follow-up|1|||
30881103|NCT01657305|58913215|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
30881104|NCT02634307|58913258|FG000|Overall Study|Adverse Event|50|||
30881105|NCT02634307|58913259|FG001|Overall Study|Adverse Event|24|||
30881106|NCT02634307|58913260|FG002|Overall Study|Adverse Event|14|||
30881107|NCT02634307|58913258|FG000|Overall Study|Lost to Follow-up|21|||
30881108|NCT02634307|58913259|FG001|Overall Study|Lost to Follow-up|5|||
30881109|NCT02634307|58913260|FG002|Overall Study|Lost to Follow-up|6|||
30881110|NCT02634307|58913258|FG000|Overall Study|Pregnancy|5|||
30881111|NCT02634307|58913259|FG001|Overall Study|Pregnancy|1|||
30881112|NCT02634307|58913260|FG002|Overall Study|Pregnancy|3|||
30881113|NCT02634307|58913258|FG000|Overall Study|Withdrawal by Subject|38|||
30881114|NCT02634307|58913259|FG001|Overall Study|Withdrawal by Subject|24|||
30881115|NCT02634307|58913260|FG002|Overall Study|Withdrawal by Subject|18|||
30881116|NCT02634307|58913258|FG000|Overall Study|Non-Compliance with Study Drug|0|||
30881117|NCT02634307|58913259|FG001|Overall Study|Non-Compliance with Study Drug|2|||
30881118|NCT02634307|58913260|FG002|Overall Study|Non-Compliance with Study Drug|2|||
30881119|NCT02634307|58913258|FG000|Overall Study|Lack of Efficacy|1|||
30881120|NCT02634307|58913259|FG001|Overall Study|Lack of Efficacy|5|||
30881121|NCT02634307|58913260|FG002|Overall Study|Lack of Efficacy|3|||
30881122|NCT02634307|58913258|FG000|Overall Study|Physician Decision|7|||
30881123|NCT02634307|58913259|FG001|Overall Study|Physician Decision|5|||
30881124|NCT02634307|58913260|FG002|Overall Study|Physician Decision|5|||
30881125|NCT02634307|58913258|FG000|Overall Study|Reason not Specified|3|||
30881126|NCT02634307|58913259|FG001|Overall Study|Reason not Specified|5|||
30881127|NCT02634307|58913260|FG002|Overall Study|Reason not Specified|10|||
30881128|NCT01365273|58913270|FG000|Overall Study|Lost to Follow-up|1|||
30881129|NCT01365273|58913271|FG001|Overall Study|Lost to Follow-up|0|||
30881130|NCT01365273|58913270|FG000|Overall Study|Protocol Violation|0|||
30881131|NCT01365273|58913271|FG001|Overall Study|Protocol Violation|1|||
30881132|NCT01365273|58913270|FG000|Overall Study|Physician Decision|1|||
30881133|NCT01365273|58913271|FG001|Overall Study|Physician Decision|0|||
30881134|NCT02595437|58913277|FG000|Triferic Via IV|Withdrawal by Subject|1|||
30881135|NCT02594735|58913298|FG000|Overall Study|Adverse Event|1|||
30881136|NCT02634151|58913306|FG000|Overall Study|Withdrawal by Subject|1|||
30881137|NCT02634151|58913307|FG001|Overall Study|Withdrawal by Subject|0|||
30881138|NCT02634151|58913306|FG000|Overall Study|Non-Compliance|0|||
30881139|NCT02634151|58913307|FG001|Overall Study|Non-Compliance|1|||
30881140|NCT02634151|58913306|FG000|Overall Study|Other|0|||
30881141|NCT02634151|58913307|FG001|Overall Study|Other|1|||
30881142|NCT01655823|58913318|FG000|Overall Study|Lost to Follow-up|0|||
30881143|NCT01655823|58913319|FG001|Overall Study|Lost to Follow-up|1|||
30881144|NCT01655823|58913320|FG002|Overall Study|Lost to Follow-up|0|||
30881145|NCT01655823|58913321|FG003|Overall Study|Lost to Follow-up|0|||
30881146|NCT01655823|58913322|FG004|Overall Study|Lost to Follow-up|1|||
30881147|NCT01655823|58913318|FG000|Overall Study|Withdrawal by Subject|0|||
30881148|NCT01655823|58913319|FG001|Overall Study|Withdrawal by Subject|1|||
30881149|NCT01655823|58913320|FG002|Overall Study|Withdrawal by Subject|0|||
30881150|NCT01655823|58913321|FG003|Overall Study|Withdrawal by Subject|1|||
30881151|NCT01655823|58913322|FG004|Overall Study|Withdrawal by Subject|0|||
30881152|NCT01360645|58913336|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
30881153|NCT01360645|58913337|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
30881154|NCT01360645|58913338|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
30881155|NCT01360645|58913339|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
30881156|NCT01360645|58913336|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
30881157|NCT01360645|58913337|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
30881158|NCT01360645|58913338|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
30881159|NCT01360645|58913339|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
30881160|NCT01360645|58913336|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
30881161|NCT01360645|58913337|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
30881162|NCT01360645|58913338|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
30881163|NCT01360645|58913339|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
30881164|NCT01360645|58913336|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
30881165|NCT01360645|58913337|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
30881166|NCT01360645|58913338|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
30881167|NCT01360645|58913339|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
30881168|NCT01360645|58913336|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
30881169|NCT01360645|58913337|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
30881170|NCT01360645|58913338|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
30881171|NCT01360645|58913339|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
30881172|NCT01360645|58913336|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
30881173|NCT01360645|58913337|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
30881174|NCT01360645|58913338|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
30881175|NCT01360645|58913339|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
30881176|NCT01360645|58913336|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
30881177|NCT01360645|58913337|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
30881178|NCT01360645|58913338|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
30881179|NCT01360645|58913339|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
30881180|NCT01360645|58913336|FG000|Phase B (6 Weeks)|Adverse Event|0|||
30881181|NCT01360645|58913337|FG001|Phase B (6 Weeks)|Adverse Event|6|||
30881182|NCT01360645|58913338|FG002|Phase B (6 Weeks)|Adverse Event|0|||
30881183|NCT01360645|58913339|FG003|Phase B (6 Weeks)|Adverse Event|0|||
30881184|NCT01360645|58913336|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
30881185|NCT01360645|58913337|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
30881186|NCT01360645|58913338|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
30881187|NCT01360645|58913339|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
30881188|NCT01360645|58913336|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
30881189|NCT01360645|58913337|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
30881190|NCT01360645|58913338|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
30881191|NCT01360645|58913339|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
30881192|NCT01360645|58913336|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
30881193|NCT01360645|58913337|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
30881194|NCT01360645|58913338|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
30881195|NCT01360645|58913339|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
30881196|NCT01360645|58913336|FG000|Phase A+|Lost to Follow-up|0|||
30881197|NCT01360645|58913337|FG001|Phase A+|Lost to Follow-up|0|||
30881198|NCT01360645|58913338|FG002|Phase A+|Lost to Follow-up|0|||
30881199|NCT01360645|58913339|FG003|Phase A+|Lost to Follow-up|7|||
30881200|NCT01360645|58913336|FG000|Phase A+|Adverse Event|0|||
30881201|NCT01360645|58913337|FG001|Phase A+|Adverse Event|0|||
30881202|NCT01360645|58913338|FG002|Phase A+|Adverse Event|0|||
30881203|NCT01360645|58913339|FG003|Phase A+|Adverse Event|2|||
30881204|NCT01360645|58913336|FG000|Phase A+|Met Withdrawal Criteria|0|||
30881205|NCT01360645|58913337|FG001|Phase A+|Met Withdrawal Criteria|0|||
30881206|NCT01360645|58913338|FG002|Phase A+|Met Withdrawal Criteria|0|||
30881207|NCT01360645|58913339|FG003|Phase A+|Met Withdrawal Criteria|4|||
30881208|NCT01360645|58913336|FG000|Phase A+|Physician Decision|0|||
30881209|NCT01360645|58913337|FG001|Phase A+|Physician Decision|0|||
30975482|NCT02607228|59056938|FG004|Overall Study|Progressive Disease|4|||
30975483|NCT02607228|59056939|FG005|Overall Study|Progressive Disease|3|||
30881210|NCT01360645|58913338|FG002|Phase A+|Physician Decision|0|||
30881211|NCT01360645|58913339|FG003|Phase A+|Physician Decision|2|||
30881212|NCT01360645|58913336|FG000|Phase A+|Withdrawal by Subject|0|||
30881213|NCT01360645|58913337|FG001|Phase A+|Withdrawal by Subject|0|||
30881214|NCT01360645|58913338|FG002|Phase A+|Withdrawal by Subject|0|||
30881215|NCT01360645|58913339|FG003|Phase A+|Withdrawal by Subject|5|||
30881216|NCT01360645|58913336|FG000|Phase A+|Protocol Deviation|0|||
30881217|NCT01360645|58913337|FG001|Phase A+|Protocol Deviation|0|||
30881218|NCT01360645|58913338|FG002|Phase A+|Protocol Deviation|0|||
30881219|NCT01360645|58913339|FG003|Phase A+|Protocol Deviation|4|||
30881220|NCT02633527|58913354|FG000|Overall Study|Failed to meet eligibility|0|||
30881221|NCT02633527|58913355|FG001|Overall Study|Failed to meet eligibility|1|||
30881222|NCT02633527|58913356|FG002|Overall Study|Failed to meet eligibility|1|||
30881223|NCT02633527|58913357|FG003|Overall Study|Failed to meet eligibility|0|||
30881224|NCT02633527|58913358|FG004|Overall Study|Failed to meet eligibility|1|||
30881225|NCT02633527|58913354|FG000|Overall Study|Adverse Event|0|||
30881226|NCT02633527|58913355|FG001|Overall Study|Adverse Event|4|||
30881227|NCT02633527|58913356|FG002|Overall Study|Adverse Event|3|||
30881228|NCT02633527|58913357|FG003|Overall Study|Adverse Event|1|||
30881229|NCT02633527|58913358|FG004|Overall Study|Adverse Event|5|||
30881230|NCT02633527|58913354|FG000|Overall Study|Lost to Follow-up|1|||
30881231|NCT02633527|58913355|FG001|Overall Study|Lost to Follow-up|2|||
30881232|NCT02633527|58913356|FG002|Overall Study|Lost to Follow-up|5|||
30881233|NCT02633527|58913357|FG003|Overall Study|Lost to Follow-up|5|||
30881234|NCT02633527|58913358|FG004|Overall Study|Lost to Follow-up|4|||
30881235|NCT02633527|58913354|FG000|Overall Study|Withdrawal by Subject|0|||
30881236|NCT02633527|58913355|FG001|Overall Study|Withdrawal by Subject|3|||
30881237|NCT02633527|58913356|FG002|Overall Study|Withdrawal by Subject|5|||
30881238|NCT02633527|58913357|FG003|Overall Study|Withdrawal by Subject|4|||
30881239|NCT02633527|58913358|FG004|Overall Study|Withdrawal by Subject|4|||
30881240|NCT02633527|58913354|FG000|Overall Study|Protocol Violation|0|||
30881241|NCT02633527|58913355|FG001|Overall Study|Protocol Violation|1|||
30881242|NCT02633527|58913356|FG002|Overall Study|Protocol Violation|1|||
30881243|NCT02633527|58913357|FG003|Overall Study|Protocol Violation|1|||
30881244|NCT02633527|58913358|FG004|Overall Study|Protocol Violation|1|||
30881245|NCT02633527|58913354|FG000|Overall Study|Physician Decision|0|||
30881246|NCT02633527|58913355|FG001|Overall Study|Physician Decision|0|||
30881247|NCT02633527|58913356|FG002|Overall Study|Physician Decision|0|||
30881248|NCT02633527|58913357|FG003|Overall Study|Physician Decision|0|||
30881249|NCT02633527|58913358|FG004|Overall Study|Physician Decision|1|||
30881250|NCT02633527|58913354|FG000|Overall Study|Administrative reason|1|||
30881251|NCT02633527|58913355|FG001|Overall Study|Administrative reason|0|||
30881252|NCT02633527|58913356|FG002|Overall Study|Administrative reason|0|||
30881253|NCT02633527|58913357|FG003|Overall Study|Administrative reason|1|||
30881254|NCT02633527|58913358|FG004|Overall Study|Administrative reason|0|||
30881255|NCT02633527|58913354|FG000|Overall Study|Multiple reasons|1|||
30881256|NCT02633527|58913355|FG001|Overall Study|Multiple reasons|0|||
30881257|NCT02633527|58913356|FG002|Overall Study|Multiple reasons|2|||
30881258|NCT02633527|58913357|FG003|Overall Study|Multiple reasons|2|||
30881259|NCT02633527|58913358|FG004|Overall Study|Multiple reasons|1|||
30881260|NCT01667549|58913375|FG000|Overall Study|Withdrawal by Subject|3|||
30881261|NCT01667549|58913376|FG001|Overall Study|Withdrawal by Subject|5|||
30881262|NCT01667549|58913377|FG002|Overall Study|Withdrawal by Subject|7|||
30881263|NCT01667549|58913378|FG003|Overall Study|Withdrawal by Subject|6|||
30881264|NCT01667549|58913379|FG004|Overall Study|Withdrawal by Subject|1|||
30881265|NCT01672801|58913418|FG000|Overall Study|Screen Failure|0|||
30881266|NCT01672801|58913419|FG001|Overall Study|Screen Failure|1|||
30881267|NCT01655901|58913425|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
30881268|NCT01655901|58913426|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
30881269|NCT01655901|58913427|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
30881270|NCT01655901|58913428|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
30881271|NCT01655901|58913429|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
30881272|NCT01655901|58913430|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
30881273|NCT01656759|58913441|FG000|Overall Study|Protocol Violation|2|||
30881274|NCT01656759|58913442|FG001|Overall Study|Protocol Violation|3|||
30881275|NCT02631577|58913450|FG000|Overall Study|Death|1|||
30881276|NCT02631577|58913451|FG001|Overall Study|Death|7|||
30881277|NCT02631577|58913450|FG000|Overall Study|Withdrawal by Subject|0|||
30881278|NCT02631577|58913451|FG001|Overall Study|Withdrawal by Subject|3|||
30881279|NCT01667081|58913459|FG000|Overall Study|Death|43|||
30881280|NCT01667081|58913460|FG001|Overall Study|Death|3|||
30881281|NCT01667081|58913459|FG000|Overall Study|Lost to Follow-up|99|||
30881282|NCT01667081|58913460|FG001|Overall Study|Lost to Follow-up|48|||
30881283|NCT01667081|58913459|FG000|Overall Study|Physician Decision|16|||
30881284|NCT01667081|58913460|FG001|Overall Study|Physician Decision|2|||
30881285|NCT01667081|58913459|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
30948405|NCT01729819|58994256|FG000|Overall Study|Withdrawal by Subject|0|||
30948406|NCT01729819|58994257|FG001|Overall Study|Withdrawal by Subject|2|||
30948407|NCT01776541|58994268|FG000|Overall Study|Administrative Reason|6|||
30881286|NCT01667081|58913460|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
30881287|NCT01667081|58913459|FG000|Overall Study|Withdrawal by Subject|90|||
30881288|NCT01667081|58913460|FG001|Overall Study|Withdrawal by Subject|35|||
30881289|NCT04545619|58913477|FG000|Overall Study|due to equipment challenges|1|||
30881290|NCT02518971|58913483|FG000|Overall Study|Lost to Follow-up|0|||
30881291|NCT02518971|58913484|FG001|Overall Study|Lost to Follow-up|1|||
30881292|NCT02518971|58913483|FG000|Overall Study|Physician Decision|6|||
30881293|NCT02518971|58913484|FG001|Overall Study|Physician Decision|6|||
30881294|NCT02518971|58913483|FG000|Overall Study|Protocol Violation|6|||
30881295|NCT02518971|58913484|FG001|Overall Study|Protocol Violation|4|||
30881296|NCT02518971|58913483|FG000|Overall Study|Withdrawal by Subject|4|||
30881297|NCT02518971|58913484|FG001|Overall Study|Withdrawal by Subject|5|||
30881298|NCT02518971|58913483|FG000|Overall Study|Side effects|1|||
30881299|NCT02518971|58913484|FG001|Overall Study|Side effects|0|||
30881300|NCT02518971|58913483|FG000|Overall Study|medication lost in mail|0|||
30881301|NCT02518971|58913484|FG001|Overall Study|medication lost in mail|1|||
30881302|NCT02518971|58913483|FG000|Overall Study|eligibility criteria no longer met|6|||
30881303|NCT02518971|58913484|FG001|Overall Study|eligibility criteria no longer met|3|||
30881304|NCT01365039|58913493|FG000|Overall Study|Study related symptoms and complaints|1|||
30881305|NCT01365039|58913494|FG001|Overall Study|Study related symptoms and complaints|0|||
30881306|NCT01364727|58913501|FG000|Overall Study|Not Eligible|2|||
30881307|NCT02633215|58913509|FG000|Overall Study|Lost to Follow-up|2|||
30881308|NCT02633215|58913510|FG001|Overall Study|Lost to Follow-up|3|||
30881309|NCT01364649|58913518|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
30881310|NCT01364649|58913519|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
30881311|NCT01364649|58913518|FG000|Overall Study|Lack of Efficacy|6|||
30881312|NCT01364649|58913519|FG001|Overall Study|Lack of Efficacy|0|||
30881313|NCT01364649|58913518|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
30881314|NCT01364649|58913519|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
30881315|NCT01364649|58913518|FG000|Overall Study|Protocol Deviations|4|||
30881316|NCT01364649|58913519|FG001|Overall Study|Protocol Deviations|8|||
30881317|NCT01364649|58913518|FG000|Overall Study|Withdrawal of Consent|9|||
30881318|NCT01364649|58913519|FG001|Overall Study|Withdrawal of Consent|7|||
30881319|NCT01364649|58913518|FG000|Overall Study|Lost to Follow-up|12|||
30881320|NCT01364649|58913519|FG001|Overall Study|Lost to Follow-up|13|||
30881321|NCT01364649|58913518|FG000|Overall Study|Other|4|||
30881322|NCT01364649|58913519|FG001|Overall Study|Other|1|||
30881323|NCT02588261|58913527|FG000|Overall Study|Study Terminated by Sponsor|157|||
30881324|NCT02588261|58913528|FG001|Overall Study|Study Terminated by Sponsor|142|||
30881325|NCT02588261|58913527|FG000|Overall Study|Protocol Deviation|1|||
30881326|NCT02588261|58913528|FG001|Overall Study|Protocol Deviation|0|||
30881327|NCT02588261|58913527|FG000|Overall Study|Death|1|||
30881328|NCT02588261|58913528|FG001|Overall Study|Death|2|||
30881329|NCT02588261|58913527|FG000|Overall Study|Withdrawal by Subject|12|||
30881330|NCT02588261|58913528|FG001|Overall Study|Withdrawal by Subject|8|||
30881331|NCT02588261|58913527|FG000|Overall Study|Noncompliance with Study Drug|0|||
30881332|NCT02588261|58913528|FG001|Overall Study|Noncompliance with Study Drug|1|||
30881333|NCT02588261|58913527|FG000|Overall Study|Miscellaneous|5|||
30881334|NCT02588261|58913528|FG001|Overall Study|Miscellaneous|4|||
30881335|NCT02588261|58913527|FG000|Overall Study|Progressive Disease|61|||
30881336|NCT02588261|58913528|FG001|Overall Study|Progressive Disease|82|||
30881337|NCT02588261|58913527|FG000|Overall Study|Adverse Event|29|||
30881338|NCT02588261|58913528|FG001|Overall Study|Adverse Event|24|||
30881339|NCT02588261|58913527|FG000|Overall Study|Lost to Follow-up|1|||
30881340|NCT02588261|58913528|FG001|Overall Study|Lost to Follow-up|0|||
30881341|NCT01359449|58913536|FG000|Overall Study|Lost to Follow-up|1|||
30881342|NCT01359449|58913537|FG001|Overall Study|Lost to Follow-up|0|||
30881343|NCT01359449|58913536|FG000|Overall Study|Protocol Violation|0|||
30881344|NCT01359449|58913537|FG001|Overall Study|Protocol Violation|2|||
30881345|NCT01359449|58913536|FG000|Overall Study|Withdrawal by Subject|3|||
30881346|NCT01359449|58913537|FG001|Overall Study|Withdrawal by Subject|2|||
30881347|NCT01672723|58913543|FG000|First Intervention|Adverse Event|3|||
30881348|NCT01672723|58913544|FG001|First Intervention|Adverse Event|0|||
30975484|NCT02607228|59056940|FG006|Overall Study|Progressive Disease|1|||
30881349|NCT02632747|58913552|FG000|Wash-out Period|Adverse Event|1|||
30881350|NCT02632747|58913553|FG001|Wash-out Period|Adverse Event|0|||
30881351|NCT02520531|58913572|FG000|Overall Study|Revision of study device components|2|||
30881352|NCT02520531|58913573|FG001|Overall Study|Revision of study device components|2|||
30881353|NCT02520531|58913572|FG000|Overall Study|Death|1|||
30881354|NCT02520531|58913573|FG001|Overall Study|Death|2|||
30881355|NCT02520531|58913572|FG000|Overall Study|Lost to Follow-up|1|||
30881356|NCT02520531|58913573|FG001|Overall Study|Lost to Follow-up|1|||
30881357|NCT02520531|58913572|FG000|Overall Study|Meet exclusion criterion|0|||
30881358|NCT02520531|58913573|FG001|Overall Study|Meet exclusion criterion|1|||
30881359|NCT02520531|58913572|FG000|Overall Study|Withdrawal by Subject|1|||
30881360|NCT02520531|58913573|FG001|Overall Study|Withdrawal by Subject|0|||
30881361|NCT02520531|58913572|FG000|Overall Study|Not study device|1|||
30881362|NCT02520531|58913573|FG001|Overall Study|Not study device|0|||
30881363|NCT01671319|58913579|FG000|Overall Study|Withdrawal by Subject|1|||
30881364|NCT01670539|58913583|FG000|Overall Study|Death|3|||
30881365|NCT01670539|58913584|FG001|Overall Study|Death|5|||
30881366|NCT01670539|58913583|FG000|Overall Study|Withdrawal by Subject|3|||
30881367|NCT01670539|58913584|FG001|Overall Study|Withdrawal by Subject|0|||
30881368|NCT02516163|58913591|FG000|Overall Study|Withdrawal by Subject|1|||
30881369|NCT02516163|58913591|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
30881370|NCT02516163|58913591|FG000|Overall Study|Unfit/delay in surgery|3|||
30881371|NCT02516163|58913591|FG000|Overall Study|Use of incorrect measurement technique|5|||
30881372|NCT02516163|58913591|FG000|Overall Study|Data not recorded|2|||
30881373|NCT02516163|58913591|FG000|Overall Study|MRI contraindication exclusion|6|||
30881374|NCT02589665|58913599|FG000|Induction Period|Did not receive drug|0|||
30881375|NCT02589665|58913600|FG001|Induction Period|Did not receive drug|0|||
30881376|NCT02589665|58913601|FG002|Induction Period|Did not receive drug|0|||
30881377|NCT02589665|58913602|FG003|Induction Period|Did not receive drug|1|||
30881378|NCT02589665|58913603|FG004|Induction Period|Did not receive drug|0|||
30881379|NCT02589665|58913604|FG005|Induction Period|Did not receive drug|0|||
30881380|NCT02589665|58913605|FG006|Induction Period|Did not receive drug|0|||
30881381|NCT02589665|58913606|FG007|Induction Period|Did not receive drug|0|||
30881382|NCT02589665|58913607|FG008|Induction Period|Did not receive drug|0|||
30881383|NCT02589665|58913608|FG009|Induction Period|Did not receive drug|0|||
30881384|NCT02589665|58913599|FG000|Induction Period|Adverse Event|3|||
30881385|NCT02589665|58913600|FG001|Induction Period|Adverse Event|0|||
30881386|NCT02589665|58913601|FG002|Induction Period|Adverse Event|2|||
30881387|NCT02589665|58913602|FG003|Induction Period|Adverse Event|2|||
30881388|NCT02589665|58913603|FG004|Induction Period|Adverse Event|0|||
30881389|NCT02589665|58913604|FG005|Induction Period|Adverse Event|0|||
30881390|NCT02589665|58913605|FG006|Induction Period|Adverse Event|0|||
30881391|NCT02589665|58913606|FG007|Induction Period|Adverse Event|0|||
30881392|NCT02589665|58913607|FG008|Induction Period|Adverse Event|0|||
30881393|NCT02589665|58913608|FG009|Induction Period|Adverse Event|0|||
30881394|NCT02589665|58913599|FG000|Induction Period|Withdrawal by Subject|0|||
30881395|NCT02589665|58913600|FG001|Induction Period|Withdrawal by Subject|1|||
30881396|NCT02589665|58913601|FG002|Induction Period|Withdrawal by Subject|0|||
30881397|NCT02589665|58913602|FG003|Induction Period|Withdrawal by Subject|1|||
30881398|NCT02589665|58913603|FG004|Induction Period|Withdrawal by Subject|0|||
30881399|NCT02589665|58913604|FG005|Induction Period|Withdrawal by Subject|0|||
30881400|NCT02589665|58913605|FG006|Induction Period|Withdrawal by Subject|0|||
30881401|NCT02589665|58913606|FG007|Induction Period|Withdrawal by Subject|0|||
30881402|NCT02589665|58913607|FG008|Induction Period|Withdrawal by Subject|0|||
30881403|NCT02589665|58913608|FG009|Induction Period|Withdrawal by Subject|0|||
30881404|NCT02589665|58913599|FG000|Induction Period|Protocol Violation|0|||
30881405|NCT02589665|58913600|FG001|Induction Period|Protocol Violation|1|||
30881406|NCT02589665|58913601|FG002|Induction Period|Protocol Violation|0|||
30881407|NCT02589665|58913602|FG003|Induction Period|Protocol Violation|0|||
30881408|NCT02589665|58913603|FG004|Induction Period|Protocol Violation|0|||
30881409|NCT02589665|58913604|FG005|Induction Period|Protocol Violation|0|||
30881410|NCT02589665|58913605|FG006|Induction Period|Protocol Violation|0|||
30881411|NCT02589665|58913606|FG007|Induction Period|Protocol Violation|0|||
30881412|NCT02589665|58913607|FG008|Induction Period|Protocol Violation|0|||
30881413|NCT02589665|58913608|FG009|Induction Period|Protocol Violation|0|||
30881414|NCT02589665|58913599|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881415|NCT02589665|58913600|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881416|NCT02589665|58913601|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881417|NCT02589665|58913602|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881418|NCT02589665|58913603|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
30881419|NCT02589665|58913604|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
30881420|NCT02589665|58913605|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
30881421|NCT02589665|58913606|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881422|NCT02589665|58913607|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881423|NCT02589665|58913608|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881424|NCT02589665|58913599|FG000|Maintenance Period|Withdrawal by Subject|0|||
30881425|NCT02589665|58913600|FG001|Maintenance Period|Withdrawal by Subject|0|||
30881426|NCT02589665|58913601|FG002|Maintenance Period|Withdrawal by Subject|0|||
30881427|NCT02589665|58913602|FG003|Maintenance Period|Withdrawal by Subject|0|||
30881428|NCT02589665|58913603|FG004|Maintenance Period|Withdrawal by Subject|4|||
30881429|NCT02589665|58913604|FG005|Maintenance Period|Withdrawal by Subject|2|||
30881430|NCT02589665|58913605|FG006|Maintenance Period|Withdrawal by Subject|4|||
30881431|NCT02589665|58913606|FG007|Maintenance Period|Withdrawal by Subject|0|||
30881432|NCT02589665|58913607|FG008|Maintenance Period|Withdrawal by Subject|0|||
30881433|NCT02589665|58913608|FG009|Maintenance Period|Withdrawal by Subject|0|||
30881434|NCT02589665|58913599|FG000|Maintenance Period|Lack of Efficacy|0|||
30881435|NCT02589665|58913600|FG001|Maintenance Period|Lack of Efficacy|0|||
30881436|NCT02589665|58913601|FG002|Maintenance Period|Lack of Efficacy|0|||
30881437|NCT02589665|58913602|FG003|Maintenance Period|Lack of Efficacy|0|||
30881438|NCT02589665|58913603|FG004|Maintenance Period|Lack of Efficacy|2|||
30881439|NCT02589665|58913604|FG005|Maintenance Period|Lack of Efficacy|1|||
30881440|NCT02589665|58913605|FG006|Maintenance Period|Lack of Efficacy|0|||
30881441|NCT02589665|58913606|FG007|Maintenance Period|Lack of Efficacy|0|||
30881442|NCT02589665|58913607|FG008|Maintenance Period|Lack of Efficacy|0|||
30881443|NCT02589665|58913608|FG009|Maintenance Period|Lack of Efficacy|0|||
30881444|NCT02589665|58913599|FG000|Maintenance Period|Adverse Event|0|||
30881445|NCT02589665|58913600|FG001|Maintenance Period|Adverse Event|0|||
30881446|NCT02589665|58913601|FG002|Maintenance Period|Adverse Event|0|||
30881447|NCT02589665|58913602|FG003|Maintenance Period|Adverse Event|0|||
30881448|NCT02589665|58913603|FG004|Maintenance Period|Adverse Event|0|||
30881449|NCT02589665|58913604|FG005|Maintenance Period|Adverse Event|0|||
30881450|NCT02589665|58913605|FG006|Maintenance Period|Adverse Event|2|||
30881451|NCT02589665|58913606|FG007|Maintenance Period|Adverse Event|0|||
30881452|NCT02589665|58913607|FG008|Maintenance Period|Adverse Event|0|||
30881453|NCT02589665|58913608|FG009|Maintenance Period|Adverse Event|0|||
30881454|NCT02589665|58913599|FG000|Maintenance Period|Lost to Follow-up|0|||
30881455|NCT02589665|58913600|FG001|Maintenance Period|Lost to Follow-up|0|||
30881456|NCT02589665|58913601|FG002|Maintenance Period|Lost to Follow-up|0|||
30881457|NCT02589665|58913602|FG003|Maintenance Period|Lost to Follow-up|0|||
30881458|NCT02589665|58913603|FG004|Maintenance Period|Lost to Follow-up|0|||
30881459|NCT02589665|58913604|FG005|Maintenance Period|Lost to Follow-up|1|||
30881460|NCT02589665|58913605|FG006|Maintenance Period|Lost to Follow-up|0|||
30881461|NCT02589665|58913606|FG007|Maintenance Period|Lost to Follow-up|0|||
30881462|NCT02589665|58913607|FG008|Maintenance Period|Lost to Follow-up|0|||
30881463|NCT02589665|58913608|FG009|Maintenance Period|Lost to Follow-up|0|||
30881464|NCT02589665|58913599|FG000|Maintenance Period|Physician Decision|0|||
30881465|NCT02589665|58913600|FG001|Maintenance Period|Physician Decision|0|||
30881466|NCT02589665|58913601|FG002|Maintenance Period|Physician Decision|0|||
30881467|NCT02589665|58913602|FG003|Maintenance Period|Physician Decision|0|||
30881468|NCT02589665|58913603|FG004|Maintenance Period|Physician Decision|0|||
30881469|NCT02589665|58913604|FG005|Maintenance Period|Physician Decision|1|||
30881470|NCT02589665|58913605|FG006|Maintenance Period|Physician Decision|0|||
30975485|NCT02607228|59056934|FG000|Overall Study|Adverse Event|1|||
30975486|NCT02607228|59056935|FG001|Overall Study|Adverse Event|0|||
30975487|NCT02607228|59056936|FG002|Overall Study|Adverse Event|1|||
30975488|NCT02607228|59056937|FG003|Overall Study|Adverse Event|0|||
30975489|NCT02607228|59056938|FG004|Overall Study|Adverse Event|1|||
30975490|NCT02607228|59056939|FG005|Overall Study|Adverse Event|1|||
30975491|NCT02607228|59056940|FG006|Overall Study|Adverse Event|1|||
30975492|NCT02607228|59056934|FG000|Overall Study|Investigator's Discretion|0|||
30975493|NCT02607228|59056935|FG001|Overall Study|Investigator's Discretion|0|||
30975494|NCT02607228|59056936|FG002|Overall Study|Investigator's Discretion|1|||
30975495|NCT02607228|59056937|FG003|Overall Study|Investigator's Discretion|0|||
30975496|NCT02607228|59056938|FG004|Overall Study|Investigator's Discretion|0|||
30975497|NCT02607228|59056939|FG005|Overall Study|Investigator's Discretion|1|||
30975498|NCT02607228|59056940|FG006|Overall Study|Investigator's Discretion|0|||
30975499|NCT02607228|59056934|FG000|Overall Study|Withdrew Consent|0|||
30975500|NCT02607228|59056935|FG001|Overall Study|Withdrew Consent|1|||
30975501|NCT02607228|59056936|FG002|Overall Study|Withdrew Consent|0|||
30975502|NCT02607228|59056937|FG003|Overall Study|Withdrew Consent|0|||
30975503|NCT02607228|59056938|FG004|Overall Study|Withdrew Consent|0|||
30975504|NCT02607228|59056939|FG005|Overall Study|Withdrew Consent|1|||
30975505|NCT02607228|59056940|FG006|Overall Study|Withdrew Consent|0|||
30975506|NCT02607228|59056934|FG000|Overall Study|Study Terminated by Sponsor|0|||
30975507|NCT02607228|59056935|FG001|Overall Study|Study Terminated by Sponsor|0|||
30975508|NCT02607228|59056936|FG002|Overall Study|Study Terminated by Sponsor|0|||
30975509|NCT02607228|59056937|FG003|Overall Study|Study Terminated by Sponsor|1|||
30975510|NCT02607228|59056938|FG004|Overall Study|Study Terminated by Sponsor|0|||
30975511|NCT02607228|59056939|FG005|Overall Study|Study Terminated by Sponsor|0|||
30975512|NCT02607228|59056940|FG006|Overall Study|Study Terminated by Sponsor|0|||
30975513|NCT01668654|59056982|FG000|Overall Study|Study Closed/Terminated|3|||
30975514|NCT01668654|59056982|FG000|Overall Study|Withdrawal by Subject|1|||
30975515|NCT02608476|59057076|FG000|Overall Study|Withdrawal by Subject|30|||
30975516|NCT02608476|59057077|FG001|Overall Study|Withdrawal by Subject|37|||
30975517|NCT02608476|59057076|FG000|Overall Study|Lost to Follow-up|24|||
30975518|NCT02608476|59057077|FG001|Overall Study|Lost to Follow-up|24|||
30975519|NCT02608476|59057076|FG000|Overall Study|Adverse Event|2|||
30975520|NCT02608476|59057077|FG001|Overall Study|Adverse Event|8|||
30975521|NCT02608476|59057076|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
30881471|NCT02589665|58913606|FG007|Maintenance Period|Physician Decision|0|||
30881472|NCT02589665|58913607|FG008|Maintenance Period|Physician Decision|0|||
30881473|NCT02589665|58913608|FG009|Maintenance Period|Physician Decision|0|||
30881474|NCT02589665|58913599|FG000|Maintenance Period|Reason Not Collected|0|||
30975522|NCT02608476|59057077|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
30881475|NCT02589665|58913600|FG001|Maintenance Period|Reason Not Collected|0|||
30881476|NCT02589665|58913601|FG002|Maintenance Period|Reason Not Collected|0|||
30881477|NCT02589665|58913602|FG003|Maintenance Period|Reason Not Collected|0|||
30881478|NCT02589665|58913603|FG004|Maintenance Period|Reason Not Collected|0|||
30881479|NCT02589665|58913604|FG005|Maintenance Period|Reason Not Collected|1|||
30881480|NCT02589665|58913605|FG006|Maintenance Period|Reason Not Collected|1|||
30881481|NCT02589665|58913606|FG007|Maintenance Period|Reason Not Collected|0|||
30881482|NCT02589665|58913607|FG008|Maintenance Period|Reason Not Collected|0|||
30881483|NCT02589665|58913608|FG009|Maintenance Period|Reason Not Collected|0|||
30881484|NCT02589665|58913599|FG000|Induction Extension Period|Adverse Event|0|||
30881485|NCT02589665|58913600|FG001|Induction Extension Period|Adverse Event|0|||
30881486|NCT02589665|58913601|FG002|Induction Extension Period|Adverse Event|0|||
30881487|NCT02589665|58913602|FG003|Induction Extension Period|Adverse Event|0|||
30881488|NCT02589665|58913603|FG004|Induction Extension Period|Adverse Event|0|||
30881489|NCT02589665|58913604|FG005|Induction Extension Period|Adverse Event|0|||
30881490|NCT02589665|58913605|FG006|Induction Extension Period|Adverse Event|0|||
30881491|NCT02589665|58913606|FG007|Induction Extension Period|Adverse Event|0|||
30881492|NCT02589665|58913607|FG008|Induction Extension Period|Adverse Event|4|||
30881493|NCT02589665|58913608|FG009|Induction Extension Period|Adverse Event|0|||
30881494|NCT02589665|58913599|FG000|Induction Extension Period|Lack of Efficacy|0|||
30881495|NCT02589665|58913600|FG001|Induction Extension Period|Lack of Efficacy|0|||
30881496|NCT02589665|58913601|FG002|Induction Extension Period|Lack of Efficacy|0|||
30881497|NCT02589665|58913602|FG003|Induction Extension Period|Lack of Efficacy|0|||
30881498|NCT02589665|58913603|FG004|Induction Extension Period|Lack of Efficacy|0|||
30881499|NCT02589665|58913604|FG005|Induction Extension Period|Lack of Efficacy|0|||
30881500|NCT02589665|58913605|FG006|Induction Extension Period|Lack of Efficacy|0|||
30881501|NCT02589665|58913606|FG007|Induction Extension Period|Lack of Efficacy|0|||
30881502|NCT02589665|58913607|FG008|Induction Extension Period|Lack of Efficacy|3|||
30881503|NCT02589665|58913608|FG009|Induction Extension Period|Lack of Efficacy|0|||
30881504|NCT02589665|58913599|FG000|Induction Extension Period|Withdrawal by Subject|0|||
30881505|NCT02589665|58913600|FG001|Induction Extension Period|Withdrawal by Subject|0|||
30881506|NCT02589665|58913601|FG002|Induction Extension Period|Withdrawal by Subject|0|||
30881507|NCT02589665|58913602|FG003|Induction Extension Period|Withdrawal by Subject|0|||
30881508|NCT02589665|58913603|FG004|Induction Extension Period|Withdrawal by Subject|0|||
30881509|NCT02589665|58913604|FG005|Induction Extension Period|Withdrawal by Subject|0|||
30881510|NCT02589665|58913605|FG006|Induction Extension Period|Withdrawal by Subject|0|||
30881511|NCT02589665|58913606|FG007|Induction Extension Period|Withdrawal by Subject|2|||
30881512|NCT02589665|58913607|FG008|Induction Extension Period|Withdrawal by Subject|3|||
30881513|NCT02589665|58913608|FG009|Induction Extension Period|Withdrawal by Subject|0|||
30881514|NCT02589665|58913599|FG000|Induction Extension Period|Physician Decision|0|||
30881515|NCT02589665|58913600|FG001|Induction Extension Period|Physician Decision|0|||
30881516|NCT02589665|58913601|FG002|Induction Extension Period|Physician Decision|0|||
30881517|NCT02589665|58913602|FG003|Induction Extension Period|Physician Decision|0|||
30881518|NCT02589665|58913603|FG004|Induction Extension Period|Physician Decision|0|||
30881519|NCT02589665|58913604|FG005|Induction Extension Period|Physician Decision|0|||
30881520|NCT02589665|58913605|FG006|Induction Extension Period|Physician Decision|0|||
30881521|NCT02589665|58913606|FG007|Induction Extension Period|Physician Decision|0|||
30881522|NCT02589665|58913607|FG008|Induction Extension Period|Physician Decision|1|||
30881523|NCT02589665|58913608|FG009|Induction Extension Period|Physician Decision|0|||
30881524|NCT02589665|58913599|FG000|Induction Extension Period|Reason Not Collected|0|||
30881525|NCT02589665|58913600|FG001|Induction Extension Period|Reason Not Collected|0|||
30881526|NCT02589665|58913601|FG002|Induction Extension Period|Reason Not Collected|0|||
30881527|NCT02589665|58913602|FG003|Induction Extension Period|Reason Not Collected|0|||
30881528|NCT02589665|58913603|FG004|Induction Extension Period|Reason Not Collected|0|||
30881529|NCT02589665|58913604|FG005|Induction Extension Period|Reason Not Collected|0|||
30881530|NCT02589665|58913605|FG006|Induction Extension Period|Reason Not Collected|0|||
30881531|NCT02589665|58913606|FG007|Induction Extension Period|Reason Not Collected|0|||
30881532|NCT02589665|58913607|FG008|Induction Extension Period|Reason Not Collected|1|||
30881533|NCT02589665|58913608|FG009|Induction Extension Period|Reason Not Collected|0|||
30881534|NCT02589665|58913599|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881535|NCT02589665|58913600|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881536|NCT02589665|58913601|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881537|NCT02589665|58913602|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881538|NCT02589665|58913603|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881539|NCT02589665|58913604|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881540|NCT02589665|58913605|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881541|NCT02589665|58913606|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881542|NCT02589665|58913607|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
30881543|NCT02589665|58913608|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
30881544|NCT02589665|58913599|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
30881545|NCT02589665|58913600|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
30881546|NCT02589665|58913601|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
30881547|NCT02589665|58913602|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
30881548|NCT02589665|58913603|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
30881549|NCT02589665|58913604|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
30881550|NCT02589665|58913605|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
30881551|NCT02589665|58913606|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
30881552|NCT02589665|58913607|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
30881553|NCT02589665|58913608|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
30881554|NCT02589665|58913599|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
30881555|NCT02589665|58913600|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
30881556|NCT02589665|58913601|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
30881557|NCT02589665|58913602|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
30881558|NCT02589665|58913603|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
30881559|NCT02589665|58913604|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
30881560|NCT02589665|58913605|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
30881561|NCT02589665|58913606|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
30881562|NCT02589665|58913607|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
30881563|NCT02589665|58913608|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
30881564|NCT02589665|58913599|FG000|Maintenance Extension Period|Adverse Event|0|||
30881565|NCT02589665|58913600|FG001|Maintenance Extension Period|Adverse Event|0|||
30881566|NCT02589665|58913601|FG002|Maintenance Extension Period|Adverse Event|0|||
30881567|NCT02589665|58913602|FG003|Maintenance Extension Period|Adverse Event|0|||
30881568|NCT02589665|58913603|FG004|Maintenance Extension Period|Adverse Event|0|||
30881569|NCT02589665|58913604|FG005|Maintenance Extension Period|Adverse Event|0|||
30881570|NCT02589665|58913605|FG006|Maintenance Extension Period|Adverse Event|0|||
30881571|NCT02589665|58913606|FG007|Maintenance Extension Period|Adverse Event|0|||
30881572|NCT02589665|58913607|FG008|Maintenance Extension Period|Adverse Event|0|||
30881573|NCT02589665|58913608|FG009|Maintenance Extension Period|Adverse Event|2|||
30881574|NCT02589665|58913599|FG000|Maintenance Extension Period|Non-responder|0|||
30881575|NCT02589665|58913600|FG001|Maintenance Extension Period|Non-responder|0|||
30881576|NCT02589665|58913601|FG002|Maintenance Extension Period|Non-responder|0|||
30881577|NCT02589665|58913602|FG003|Maintenance Extension Period|Non-responder|0|||
30881578|NCT02589665|58913603|FG004|Maintenance Extension Period|Non-responder|0|||
30881579|NCT02589665|58913604|FG005|Maintenance Extension Period|Non-responder|0|||
30881580|NCT02589665|58913605|FG006|Maintenance Extension Period|Non-responder|0|||
30881581|NCT02589665|58913606|FG007|Maintenance Extension Period|Non-responder|0|||
30881582|NCT02589665|58913607|FG008|Maintenance Extension Period|Non-responder|0|||
30881583|NCT02589665|58913608|FG009|Maintenance Extension Period|Non-responder|1|||
30881584|NCT01905397|58913634|FG000|Overall Study|Death|0|||
30881585|NCT01905397|58913635|FG001|Overall Study|Death|1|||
30881586|NCT01905397|58913634|FG000|Overall Study|Withdrawal by Subject|2|||
30881587|NCT01905397|58913635|FG001|Overall Study|Withdrawal by Subject|0|||
30881588|NCT01905397|58913634|FG000|Overall Study|Surgery canceled/aborted|9|||
30881589|NCT01905397|58913635|FG001|Overall Study|Surgery canceled/aborted|5|||
30881590|NCT01905397|58913634|FG000|Overall Study|Incision < 7 cm|2|||
30881591|NCT01905397|58913635|FG001|Overall Study|Incision < 7 cm|0|||
30881592|NCT01905397|58913634|FG000|Overall Study|Wrong treatment|1|||
30881593|NCT01905397|58913635|FG001|Overall Study|Wrong treatment|1|||
30881594|NCT01905397|58913634|FG000|Overall Study|Device not applied|3|||
30881595|NCT01905397|58913635|FG001|Overall Study|Device not applied|0|||
30881596|NCT01905397|58913634|FG000|Overall Study|Dressing not applied in operating room|1|||
30881597|NCT01905397|58913635|FG001|Overall Study|Dressing not applied in operating room|0|||
30881598|NCT01905397|58913634|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
30881599|NCT01905397|58913635|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
30881600|NCT01362595|58913641|FG000|Overall Study|Screen failure|10|||
30881601|NCT01362595|58913641|FG000|Overall Study|Withdrawal by Subject|2|||
30881602|NCT02519595|58913648|FG000|Overall Study|Protocol Violation|8|||
30881603|NCT02519595|58913649|FG001|Overall Study|Protocol Violation|22|||
30881604|NCT02519595|58913650|FG002|Overall Study|Protocol Violation|16|||
30881605|NCT00660673|58913662|FG000|Overall Study|Adverse Event|84|||
30881606|NCT00660673|58913662|FG000|Overall Study|Lack of Efficacy|7|||
30881607|NCT00660673|58913662|FG000|Overall Study|Withdrawal by Subject|22|||
30881608|NCT00660673|58913662|FG000|Overall Study|Administrative|2|||
30881609|NCT00660673|58913662|FG000|Overall Study|Protocol Violation|2|||
30881610|NCT02630563|58913677|FG000|Overall Study|Administrative|1|||
30881611|NCT02588339|58913691|FG000|Overall Study|Withdrawal by Subject|1|||
30881612|NCT02588339|58913691|FG000|Overall Study|GVHD Progression prior to treatment|2|||
30881613|NCT02629159|58913698|FG000|Overall Study|Adverse Event|17|||
30881614|NCT02629159|58913699|FG001|Overall Study|Adverse Event|20|||
30881615|NCT02629159|58913700|FG002|Overall Study|Adverse Event|22|||
30881616|NCT02629159|58913698|FG000|Overall Study|Withdrawal by Subject|22|||
30881617|NCT02629159|58913699|FG001|Overall Study|Withdrawal by Subject|11|||
30881618|NCT02629159|58913700|FG002|Overall Study|Withdrawal by Subject|15|||
30881619|NCT02629159|58913698|FG000|Overall Study|Lost to Follow-up|7|||
30881620|NCT02629159|58913699|FG001|Overall Study|Lost to Follow-up|4|||
30881621|NCT02629159|58913700|FG002|Overall Study|Lost to Follow-up|5|||
30881622|NCT02629159|58913698|FG000|Overall Study|Lack of Efficacy|4|||
30881623|NCT02629159|58913699|FG001|Overall Study|Lack of Efficacy|0|||
30881624|NCT02629159|58913700|FG002|Overall Study|Lack of Efficacy|1|||
30881625|NCT02629159|58913698|FG000|Overall Study|Other|6|||
30881626|NCT02629159|58913699|FG001|Overall Study|Other|4|||
30881627|NCT02629159|58913700|FG002|Overall Study|Other|8|||
30881628|NCT02628769|58913711|FG000|First Intervention|Adverse Event|1|||
30881629|NCT02628769|58913712|FG001|First Intervention|Adverse Event|0|||
30881630|NCT02628769|58913711|FG000|First Intervention|Withdrawal by Subject|0|||
30881631|NCT02628769|58913712|FG001|First Intervention|Withdrawal by Subject|1|||
30881632|NCT02628769|58913711|FG000|Second Intervention|Adverse Event|2|||
30881633|NCT02628769|58913712|FG001|Second Intervention|Adverse Event|0|||
30881634|NCT02628769|58913711|FG000|Second Intervention|Physician Decision|0|||
30881635|NCT02628769|58913712|FG001|Second Intervention|Physician Decision|1|||
30881636|NCT02626819|58913720|FG000|Overall Study|Lost to Follow-up|3|||
30881637|NCT02626819|58913721|FG001|Overall Study|Lost to Follow-up|2|||
30881638|NCT02626819|58913720|FG000|Overall Study|Withdrawal by Subject|1|||
30881639|NCT02626819|58913721|FG001|Overall Study|Withdrawal by Subject|0|||
30881640|NCT02626819|58913720|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
30881641|NCT02626819|58913721|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
30881642|NCT02630251|58913731|FG000|Overall Study|Physician Decision|0|||
30881643|NCT02630251|58913732|FG001|Overall Study|Physician Decision|0|||
30881644|NCT02630251|58913733|FG002|Overall Study|Physician Decision|1|||
30881645|NCT02630251|58913734|FG003|Overall Study|Physician Decision|0|||
30881646|NCT02518113|58913748|FG000|Overall Study|Adverse Event|1|||
30881647|NCT02518113|58913749|FG001|Overall Study|Adverse Event|0|||
30881648|NCT02518113|58913750|FG002|Overall Study|Adverse Event|1|||
30881649|NCT02518113|58913751|FG003|Overall Study|Adverse Event|0|||
30881650|NCT02518113|58913748|FG000|Overall Study|Death|1|||
30881651|NCT02518113|58913749|FG001|Overall Study|Death|2|||
30881652|NCT02518113|58913750|FG002|Overall Study|Death|0|||
30881653|NCT02518113|58913751|FG003|Overall Study|Death|0|||
30881654|NCT02518113|58913748|FG000|Overall Study|Physician Decision|0|||
30881655|NCT02518113|58913749|FG001|Overall Study|Physician Decision|1|||
30881656|NCT02518113|58913750|FG002|Overall Study|Physician Decision|0|||
30881657|NCT02518113|58913751|FG003|Overall Study|Physician Decision|0|||
30881658|NCT02518113|58913748|FG000|Overall Study|Progressive Disease|1|||
30881659|NCT02518113|58913749|FG001|Overall Study|Progressive Disease|2|||
30881660|NCT02518113|58913750|FG002|Overall Study|Progressive Disease|3|||
30881661|NCT02518113|58913751|FG003|Overall Study|Progressive Disease|0|||
30881662|NCT02629861|58913767|FG000|Overall Study|Adverse Event|7|||
30881663|NCT02629861|58913768|FG001|Overall Study|Adverse Event|5|||
30881664|NCT02629861|58913769|FG002|Overall Study|Adverse Event|4|||
30881665|NCT02629861|58913767|FG000|Overall Study|Withdrawal by Subject|5|||
30881666|NCT02629861|58913768|FG001|Overall Study|Withdrawal by Subject|8|||
30881667|NCT02629861|58913769|FG002|Overall Study|Withdrawal by Subject|13|||
30881668|NCT02629861|58913767|FG000|Overall Study|Protocol Violation|2|||
30881669|NCT02629861|58913768|FG001|Overall Study|Protocol Violation|3|||
30881670|NCT02629861|58913769|FG002|Overall Study|Protocol Violation|7|||
30881671|NCT02629861|58913767|FG000|Overall Study|Lost to Follow-up|12|||
30881672|NCT02629861|58913768|FG001|Overall Study|Lost to Follow-up|9|||
30881673|NCT02629861|58913769|FG002|Overall Study|Lost to Follow-up|4|||
30881674|NCT02629861|58913767|FG000|Overall Study|Other|1|||
30881675|NCT02629861|58913768|FG001|Overall Study|Other|1|||
30881676|NCT02629861|58913769|FG002|Overall Study|Other|0|||
30881677|NCT02629861|58913767|FG000|Overall Study|Pregnancy|2|||
30881678|NCT02629861|58913768|FG001|Overall Study|Pregnancy|1|||
30881679|NCT02629861|58913769|FG002|Overall Study|Pregnancy|0|||
30881680|NCT02482935|58913777|FG000|Period 1|Withdrawal by Subject|1|||
30881681|NCT02482935|58913778|FG001|Period 1|Withdrawal by Subject|0|||
30881682|NCT02513823|58913784|FG000|Overall Study|Lost to Follow-up|4|||
30881683|NCT02513823|58913784|FG000|Overall Study|Physician Decision|1|||
30881684|NCT02513745|58913790|FG000|Overall Study|Criteria at time of surgery not met.|3|||
30881685|NCT02513745|58913791|FG001|Overall Study|Criteria at time of surgery not met.|3|||
30881686|NCT02477553|58913799|FG000|Overall Study|Screening up-to-date|12|||
30881687|NCT02477553|58913800|FG001|Overall Study|Screening up-to-date|13|||
30881688|NCT02477553|58913799|FG000|Overall Study|No MD visit|1|||
30881689|NCT02477553|58913800|FG001|Overall Study|No MD visit|1|||
30881690|NCT02477553|58913799|FG000|Overall Study|Workup consistent w/CRC|1|||
30881691|NCT02477553|58913800|FG001|Overall Study|Workup consistent w/CRC|1|||
30881692|NCT02477553|58913799|FG000|Overall Study|Technical issues with intervention|2|||
30881693|NCT02477553|58913800|FG001|Overall Study|Technical issues with intervention|0|||
30881694|NCT02477553|58913799|FG000|Overall Study|Elevated risk for CRC|2|||
30881695|NCT02477553|58913800|FG001|Overall Study|Elevated risk for CRC|2|||
30881696|NCT02477553|58913799|FG000|Overall Study|MD advised against screening|1|||
30881697|NCT02477553|58913800|FG001|Overall Study|MD advised against screening|3|||
30881698|NCT02477553|58913799|FG000|Overall Study|patient deceased|1|||
30881699|NCT02477553|58913800|FG001|Overall Study|patient deceased|0|||
30881700|NCT01665911|58913806|FG000|Overall Study|Protocol Violation|4|||
30881701|NCT01665911|58913806|FG000|Overall Study|Withdrawal by Subject|1|||
30881702|NCT01665911|58913806|FG000|Overall Study|Adverse Event|1|||
30881703|NCT02452359|58913811|FG000|Overall Study|Adverse Event|1|||
30881704|NCT02452359|58913811|FG000|Overall Study|Lost to Follow-up|15|||
30881705|NCT02452359|58913811|FG000|Overall Study|Pregnancy|1|||
30881706|NCT02452359|58913811|FG000|Overall Study|Withdrawal by Subject|4|||
30881707|NCT02476617|58913815|FG000|Overall Study|Adverse Event|1|||
30881708|NCT02476617|58913815|FG000|Overall Study|Lost to Follow-up|1|||
30881709|NCT01665599|58913832|FG000|Overall Study|Adverse Event|1|||
30881710|NCT01665599|58913832|FG000|Overall Study|Consent Withdrawn|1|||
30881711|NCT01665599|58913832|FG000|Overall Study|Investigator/Sponsor decision|1|||
30881712|NCT01665599|58913832|FG000|Overall Study|Death|1|||
30881713|NCT01665599|58913832|FG000|Overall Study|Lost to Follow-up|2|||
30881714|NCT01665599|58913832|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
30881715|NCT01665599|58913832|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
30881716|NCT01671085|58913838|FG000|Overall Study|Withdrawal by Subject|1|||
30881717|NCT01671085|58913839|FG001|Overall Study|Withdrawal by Subject|0|||
30881718|NCT02510001|58913854|FG000|Overall Study|Early disease progression|0|||
30881719|NCT02510001|58913855|FG001|Overall Study|Early disease progression|0|||
30881720|NCT02510001|58913856|FG002|Overall Study|Early disease progression|0|||
30881721|NCT02510001|58913857|FG003|Overall Study|Early disease progression|1|||
30881722|NCT02510001|58913858|FG004|Overall Study|Early disease progression|1|||
30881723|NCT02510001|58913859|FG005|Overall Study|Early disease progression|1|||
30881724|NCT02510001|58913860|FG006|Overall Study|Early disease progression|0|||
30881725|NCT02510001|58913861|FG007|Overall Study|Early disease progression|0|||
30881726|NCT02510001|58913854|FG000|Overall Study|Adverse Event|0|||
30881727|NCT02510001|58913855|FG001|Overall Study|Adverse Event|0|||
30881728|NCT02510001|58913856|FG002|Overall Study|Adverse Event|0|||
30881729|NCT02510001|58913857|FG003|Overall Study|Adverse Event|1|||
30881730|NCT02510001|58913858|FG004|Overall Study|Adverse Event|2|||
30881731|NCT02510001|58913859|FG005|Overall Study|Adverse Event|1|||
30881732|NCT02510001|58913860|FG006|Overall Study|Adverse Event|2|||
30881733|NCT02510001|58913861|FG007|Overall Study|Adverse Event|5|||
30881734|NCT02510001|58913854|FG000|Overall Study|Physician Decision|0|||
30881735|NCT02510001|58913855|FG001|Overall Study|Physician Decision|0|||
30881736|NCT02510001|58913856|FG002|Overall Study|Physician Decision|0|||
30881737|NCT02510001|58913857|FG003|Overall Study|Physician Decision|0|||
30881738|NCT02510001|58913858|FG004|Overall Study|Physician Decision|1|||
30881739|NCT02510001|58913859|FG005|Overall Study|Physician Decision|0|||
30881740|NCT02510001|58913860|FG006|Overall Study|Physician Decision|0|||
30881741|NCT02510001|58913861|FG007|Overall Study|Physician Decision|0|||
30881742|NCT02510001|58913854|FG000|Overall Study|Withdrawal by Subject|0|||
30881743|NCT02510001|58913855|FG001|Overall Study|Withdrawal by Subject|0|||
30881744|NCT02510001|58913856|FG002|Overall Study|Withdrawal by Subject|0|||
30881745|NCT02510001|58913857|FG003|Overall Study|Withdrawal by Subject|0|||
30881746|NCT02510001|58913858|FG004|Overall Study|Withdrawal by Subject|0|||
30881747|NCT02510001|58913859|FG005|Overall Study|Withdrawal by Subject|0|||
30881748|NCT02510001|58913860|FG006|Overall Study|Withdrawal by Subject|0|||
30881749|NCT02510001|58913861|FG007|Overall Study|Withdrawal by Subject|2|||
30881750|NCT02452047|58913900|FG000|Overall Study|Adverse Event|0|||
30881751|NCT02452047|58913901|FG001|Overall Study|Adverse Event|1|||
30881752|NCT02452047|58913902|FG002|Overall Study|Adverse Event|1|||
30881753|NCT02452047|58913900|FG000|Overall Study|Death|1|||
30881754|NCT02452047|58913901|FG001|Overall Study|Death|3|||
30881755|NCT02452047|58913902|FG002|Overall Study|Death|1|||
30881756|NCT02452047|58913900|FG000|Overall Study|Physician Decision|1|||
30881757|NCT02452047|58913901|FG001|Overall Study|Physician Decision|0|||
30881758|NCT02452047|58913902|FG002|Overall Study|Physician Decision|0|||
30881759|NCT02452047|58913900|FG000|Overall Study|Lost to Follow-up|1|||
30881760|NCT02452047|58913901|FG001|Overall Study|Lost to Follow-up|1|||
30881761|NCT02452047|58913902|FG002|Overall Study|Lost to Follow-up|0|||
30881762|NCT02452047|58913900|FG000|Overall Study|Withdrawal by Subject|1|||
30881763|NCT02452047|58913901|FG001|Overall Study|Withdrawal by Subject|0|||
30881764|NCT02452047|58913902|FG002|Overall Study|Withdrawal by Subject|0|||
30881765|NCT02475369|58913910|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
30881766|NCT02475369|58913911|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
30881767|NCT02474589|58913924|FG000|Overall Study|Adverse Event|6|||
30881768|NCT02474589|58913925|FG001|Overall Study|Adverse Event|2|||
30881769|NCT02474589|58913924|FG000|Overall Study|Lost to Follow-up|6|||
30881770|NCT02474589|58913925|FG001|Overall Study|Lost to Follow-up|1|||
30881771|NCT02474589|58913924|FG000|Overall Study|Protocol Violation|4|||
30881772|NCT02474589|58913925|FG001|Overall Study|Protocol Violation|1|||
30881773|NCT02474589|58913924|FG000|Overall Study|Withdrawal by Subject|4|||
30881774|NCT02474589|58913925|FG001|Overall Study|Withdrawal by Subject|0|||
30881775|NCT02474589|58913924|FG000|Overall Study|Inability to complete study procedures|5|||
30881776|NCT02474589|58913925|FG001|Overall Study|Inability to complete study procedures|1|||
30881777|NCT02586233|58913938|FG000|Overall Study|Randomized but did not receive treatment|0|||
30881778|NCT02586233|58913939|FG001|Overall Study|Randomized but did not receive treatment|1|||
30881779|NCT02586233|58913940|FG002|Overall Study|Randomized but did not receive treatment|0|||
30881780|NCT02586233|58913941|FG003|Overall Study|Randomized but did not receive treatment|0|||
30881781|NCT02586233|58913942|FG004|Overall Study|Randomized but did not receive treatment|0|||
30881782|NCT02586233|58913943|FG005|Overall Study|Randomized but did not receive treatment|2|||
30881783|NCT02586233|58913944|FG006|Overall Study|Randomized but did not receive treatment|2|||
30881784|NCT02586233|58913938|FG000|Overall Study|Death|0|||
30881785|NCT02586233|58913939|FG001|Overall Study|Death|1|||
30881786|NCT02586233|58913940|FG002|Overall Study|Death|0|||
30881787|NCT02586233|58913941|FG003|Overall Study|Death|0|||
30881788|NCT02586233|58913942|FG004|Overall Study|Death|2|||
30881789|NCT02586233|58913943|FG005|Overall Study|Death|0|||
30881790|NCT02586233|58913944|FG006|Overall Study|Death|0|||
30881791|NCT02474355|58913964|FG000|Overall Study|Other|43|||
30881792|NCT02474355|58913964|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
30881793|NCT02474355|58913964|FG000|Overall Study|Lost to Follow-up|98|||
30881794|NCT02474355|58913964|FG000|Overall Study|Withdrawal by Subject|124|||
30881795|NCT02474355|58913964|FG000|Overall Study|Death|1361|||
30881796|NCT02474199|58913970|FG000|Overall Study|Lost to Follow-up|1|||
30881797|NCT02474199|58913971|FG001|Overall Study|Lost to Follow-up|0|||
30881798|NCT02474199|58913972|FG002|Overall Study|Lost to Follow-up|0|||
30881799|NCT02474199|58913973|FG003|Overall Study|Lost to Follow-up|0|||
30881800|NCT02474199|58913970|FG000|Overall Study|Withdrawal by Subject|1|||
30881801|NCT02474199|58913971|FG001|Overall Study|Withdrawal by Subject|2|||
30881802|NCT02474199|58913972|FG002|Overall Study|Withdrawal by Subject|0|||
30881803|NCT02474199|58913973|FG003|Overall Study|Withdrawal by Subject|1|||
30881804|NCT02474199|58913970|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
30881805|NCT02474199|58913971|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
30881806|NCT02474199|58913972|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
30881807|NCT02474199|58913973|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
30881808|NCT02474199|58913970|FG000|Overall Study|Did not meet eligibility criteria|0|||
30881809|NCT02474199|58913971|FG001|Overall Study|Did not meet eligibility criteria|0|||
30881810|NCT02474199|58913972|FG002|Overall Study|Did not meet eligibility criteria|2|||
30881811|NCT02474199|58913973|FG003|Overall Study|Did not meet eligibility criteria|2|||
30881812|NCT02450487|58913980|FG000|Overall Study|Lost to Follow-up|3|||
30881813|NCT02473965|58913987|FG000|Overall Study|Adverse Event|6|||
30881814|NCT02473965|58913988|FG001|Overall Study|Adverse Event|4|||
30881815|NCT02473965|58913987|FG000|Overall Study|MG worsening|4|||
30881816|NCT02473965|58913988|FG001|Overall Study|MG worsening|1|||
30881817|NCT02473965|58913987|FG000|Overall Study|Withdrawal by Subject|2|||
30881818|NCT02473965|58913988|FG001|Overall Study|Withdrawal by Subject|3|||
30881819|NCT02473965|58913987|FG000|Overall Study|Physician Decision|0|||
30881820|NCT02473965|58913988|FG001|Overall Study|Physician Decision|2|||
30881821|NCT02472795|58913999|FG000|Overall Study|Adverse Event|0|||
30881822|NCT02472795|58914000|FG001|Overall Study|Adverse Event|1|||
30881823|NCT02472795|58914001|FG002|Overall Study|Adverse Event|0|||
30881824|NCT02472795|58914002|FG003|Overall Study|Adverse Event|0|||
30881825|NCT02472795|58914003|FG004|Overall Study|Adverse Event|2|||
30881826|NCT02472795|58913999|FG000|Overall Study|Withdrawal by Subject|0|||
30881827|NCT02472795|58914000|FG001|Overall Study|Withdrawal by Subject|0|||
30881828|NCT02472795|58914001|FG002|Overall Study|Withdrawal by Subject|0|||
30881829|NCT02472795|58914002|FG003|Overall Study|Withdrawal by Subject|0|||
30881830|NCT02472795|58914003|FG004|Overall Study|Withdrawal by Subject|1|||
30881831|NCT02507349|58914017|FG000|Overall Study|Death|12|||
30881832|NCT02507349|58914018|FG001|Overall Study|Death|16|||
30881833|NCT02507349|58914017|FG000|Overall Study|Withdrawal by Subject|1|||
30881834|NCT02507349|58914018|FG001|Overall Study|Withdrawal by Subject|1|||
30881835|NCT02507349|58914017|FG000|Overall Study|Lost to Follow-up|174|||
30881836|NCT02507349|58914018|FG001|Overall Study|Lost to Follow-up|144|||
30608432|NCT01288430|58619221|FG000|Part 2|Progressive disease|0|||
30608433|NCT01288430|58619222|FG001|Part 2|Progressive disease|0|||
30608434|NCT01288430|58619223|FG002|Part 2|Progressive disease|0|||
30881837|NCT02506881|58914028|FG000|First Intervention (Day 1)|Protocol Violation|0|||
30881838|NCT02506881|58914029|FG001|First Intervention (Day 1)|Protocol Violation|0|||
30881839|NCT02506881|58914030|FG002|First Intervention (Day 1)|Protocol Violation|1|||
30881840|NCT02506881|58914031|FG003|First Intervention (Day 1)|Protocol Violation|0|||
30881841|NCT02506881|58914028|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
30881842|NCT02506881|58914029|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
30881843|NCT02506881|58914030|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
30881844|NCT02506881|58914031|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
30881845|NCT02506881|58914028|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
30881846|NCT02506881|58914029|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
30881847|NCT02506881|58914030|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
30881848|NCT02506881|58914031|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
30881849|NCT02506257|58914055|FG000|Overall Study|Adverse Event|0|||
30881850|NCT02506257|58914056|FG001|Overall Study|Adverse Event|2|||
30881851|NCT02506257|58914057|FG002|Overall Study|Adverse Event|3|||
30881852|NCT02506257|58914058|FG003|Overall Study|Adverse Event|0|||
30881853|NCT02506257|58914055|FG000|Overall Study|Protocol Violation|0|||
30881854|NCT02506257|58914056|FG001|Overall Study|Protocol Violation|0|||
30881855|NCT02506257|58914057|FG002|Overall Study|Protocol Violation|1|||
30881856|NCT02506257|58914058|FG003|Overall Study|Protocol Violation|0|||
30881857|NCT02506101|58914070|FG000|Overall Study|Transportation issues|1|||
30881858|NCT02506101|58914071|FG001|Overall Study|Transportation issues|0|||
30881859|NCT02506101|58914070|FG000|Overall Study|No enrollment and staff unavailability|1|||
30881860|NCT02506101|58914071|FG001|Overall Study|No enrollment and staff unavailability|0|||
30881861|NCT01671007|58914086|FG000|Overall Study|Other reasons than listed|166|||
30881862|NCT01671007|58914087|FG001|Overall Study|Other reasons than listed|373|||
30881863|NCT01671007|58914088|FG002|Overall Study|Other reasons than listed|197|||
30881864|NCT01671007|58914089|FG003|Overall Study|Other reasons than listed|228|||
30881865|NCT01671007|58914090|FG004|Overall Study|Other reasons than listed|14|||
30881866|NCT01671007|58914091|FG005|Overall Study|Other reasons than listed|71|||
30881867|NCT01671007|58914092|FG006|Overall Study|Other reasons than listed|17|||
30881868|NCT01671007|58914093|FG007|Overall Study|Other reasons than listed|66|||
30881869|NCT01671007|58914094|FG008|Overall Study|Other reasons than listed|0|||
30881870|NCT01671007|58914086|FG000|Overall Study|Withdrawal by Subject|36|||
30881871|NCT01671007|58914087|FG001|Overall Study|Withdrawal by Subject|59|||
30881872|NCT01671007|58914088|FG002|Overall Study|Withdrawal by Subject|53|||
30881873|NCT01671007|58914089|FG003|Overall Study|Withdrawal by Subject|58|||
30881874|NCT01671007|58914090|FG004|Overall Study|Withdrawal by Subject|4|||
30881875|NCT01671007|58914091|FG005|Overall Study|Withdrawal by Subject|15|||
30881876|NCT01671007|58914092|FG006|Overall Study|Withdrawal by Subject|1|||
30881877|NCT01671007|58914093|FG007|Overall Study|Withdrawal by Subject|19|||
30881878|NCT01671007|58914094|FG008|Overall Study|Withdrawal by Subject|0|||
30881879|NCT01671007|58914086|FG000|Overall Study|Lost to Follow-up|93|||
30881880|NCT01671007|58914087|FG001|Overall Study|Lost to Follow-up|142|||
30881881|NCT01671007|58914088|FG002|Overall Study|Lost to Follow-up|91|||
30881882|NCT01671007|58914089|FG003|Overall Study|Lost to Follow-up|63|||
30881883|NCT01671007|58914090|FG004|Overall Study|Lost to Follow-up|7|||
30881884|NCT01671007|58914091|FG005|Overall Study|Lost to Follow-up|20|||
30881885|NCT01671007|58914092|FG006|Overall Study|Lost to Follow-up|2|||
30881886|NCT01671007|58914093|FG007|Overall Study|Lost to Follow-up|28|||
30881887|NCT01671007|58914094|FG008|Overall Study|Lost to Follow-up|0|||
30881888|NCT01671007|58914086|FG000|Overall Study|No end of study case report form|3|||
30881889|NCT01671007|58914087|FG001|Overall Study|No end of study case report form|1|||
30881890|NCT01671007|58914088|FG002|Overall Study|No end of study case report form|0|||
30881891|NCT01671007|58914089|FG003|Overall Study|No end of study case report form|2|||
30881892|NCT01671007|58914090|FG004|Overall Study|No end of study case report form|0|||
30881893|NCT01671007|58914091|FG005|Overall Study|No end of study case report form|0|||
30881894|NCT01671007|58914092|FG006|Overall Study|No end of study case report form|0|||
30881895|NCT01671007|58914093|FG007|Overall Study|No end of study case report form|0|||
30881896|NCT01671007|58914094|FG008|Overall Study|No end of study case report form|0|||
30881897|NCT01671007|58914086|FG000|Overall Study|Not eligible|23|||
30881898|NCT01671007|58914087|FG001|Overall Study|Not eligible|76|||
30881899|NCT01671007|58914088|FG002|Overall Study|Not eligible|25|||
30881900|NCT01671007|58914089|FG003|Overall Study|Not eligible|17|||
30881901|NCT01671007|58914090|FG004|Overall Study|Not eligible|0|||
30881902|NCT01671007|58914091|FG005|Overall Study|Not eligible|6|||
30881903|NCT01671007|58914092|FG006|Overall Study|Not eligible|1|||
30881904|NCT01671007|58914093|FG007|Overall Study|Not eligible|19|||
30881905|NCT01671007|58914094|FG008|Overall Study|Not eligible|0|||
30881906|NCT02505945|58914107|FG000|Overall Study|Withdrawal by Subject|13|||
30881907|NCT02505945|58914108|FG001|Overall Study|Withdrawal by Subject|2|||
30881908|NCT02505945|58914107|FG000|Overall Study|Adverse Event|1|||
30881909|NCT02505945|58914108|FG001|Overall Study|Adverse Event|0|||
30881910|NCT02505945|58914107|FG000|Overall Study|Physician Decision|2|||
30881911|NCT02505945|58914108|FG001|Overall Study|Physician Decision|1|||
30881912|NCT02505945|58914107|FG000|Overall Study|Lost to Follow-up|6|||
30881913|NCT02505945|58914108|FG001|Overall Study|Lost to Follow-up|1|||
30881914|NCT02505867|58914116|FG000|Overall Study|Lack of Efficacy|6|||
30881915|NCT02505867|58914117|FG001|Overall Study|Lack of Efficacy|6|||
30881916|NCT02472639|58914125|FG000|Overall Study|Physician Decision|4|||
30881917|NCT02472639|58914126|FG001|Overall Study|Physician Decision|3|||
30881918|NCT02472405|58914132|FG000|Overall Study|Lost to Follow-up|9|||
30881919|NCT02472405|58914132|FG000|Overall Study|Adverse Event|1|||
30881920|NCT02448771|58914138|FG000|Overall Study|Disease Progression|30|||
30881921|NCT02448771|58914138|FG000|Overall Study|Unacceptable Toxicity|1|||
30881922|NCT02448771|58914138|FG000|Overall Study|Physician Decision|3|||
30881923|NCT02448771|58914138|FG000|Overall Study|Started new therapy|2|||
30881924|NCT02504541|58914143|FG000|Overall Study|Adverse Event|4|||
30881925|NCT02504541|58914143|FG000|Overall Study|Withdrawal by Subject|4|||
30881926|NCT02504541|58914143|FG000|Overall Study|Lost to Follow-up|1|||
30881927|NCT02504541|58914143|FG000|Overall Study|Met Stopping Criteria|1|||
30881928|NCT02504541|58914143|FG000|Overall Study|Protocol Violation|2|||
30881929|NCT02504541|58914143|FG000|Overall Study|Termination by Sponsor|1|||
30881930|NCT02504541|58914143|FG000|Overall Study|Other|2|||
30881931|NCT02504541|58914143|FG000|Overall Study|Multiple|5|||
30881932|NCT02725177|58914147|FG000|Overall Study|Physician Decision|4|||
30881933|NCT02725177|58914147|FG000|Overall Study|Adverse Event|1|||
30881934|NCT02448537|58914154|FG000|Overall Study|Withdrawal by Subject|1|||
30881935|NCT02448537|58914155|FG001|Overall Study|Withdrawal by Subject|1|||
30881936|NCT02448537|58914156|FG002|Overall Study|Withdrawal by Subject|1|||
30881937|NCT02504151|58914166|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
30881938|NCT02504151|58914167|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
30881939|NCT02504151|58914166|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
30881940|NCT02504151|58914167|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
30881941|NCT02504151|58914166|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
30881942|NCT02504151|58914167|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
30881943|NCT02504151|58914166|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
30881944|NCT02504151|58914167|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
30881945|NCT02448381|58914175|FG000|Overall Study|Adverse Event|2|||
30881946|NCT02448381|58914176|FG001|Overall Study|Adverse Event|0|||
30881947|NCT02448381|58914175|FG000|Overall Study|Lost to Follow-up|16|||
30881948|NCT02448381|58914176|FG001|Overall Study|Lost to Follow-up|9|||
30881949|NCT02448381|58914175|FG000|Overall Study|Physician Decision|1|||
30881950|NCT02448381|58914176|FG001|Overall Study|Physician Decision|1|||
30881951|NCT02448381|58914175|FG000|Overall Study|Pregnancy|1|||
30881952|NCT02448381|58914176|FG001|Overall Study|Pregnancy|0|||
30881953|NCT02448381|58914175|FG000|Overall Study|Withdrawal by Subject|13|||
30881954|NCT02448381|58914176|FG001|Overall Study|Withdrawal by Subject|9|||
30881955|NCT02448381|58914175|FG000|Overall Study|Noncompliance with Study Procedures|2|||
30881956|NCT02448381|58914176|FG001|Overall Study|Noncompliance with Study Procedures|0|||
30881957|NCT02448225|58914188|FG000|Overall Study|Withdrawal by Subject|1|||
30881958|NCT02448225|58914188|FG000|Overall Study|Did not get FSPG scan|18|||
30881959|NCT02448225|58914188|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
30881960|NCT02503215|58914195|FG000|Overall Study|Unable to wear compression stockings|1|||
30881961|NCT02503215|58914195|FG000|Overall Study|Unable to use positive airway pressure|2|||
30881962|NCT02447991|58914201|FG000|Overall Study|Withdrawn by subject - no data|0|||
30881963|NCT02447991|58914202|FG001|Overall Study|Withdrawn by subject - no data|2|||
30881964|NCT02447991|58914201|FG000|Overall Study|Withdrawn by Subject - with data|4|||
30881965|NCT02447991|58914202|FG001|Overall Study|Withdrawn by Subject - with data|4|||
30881966|NCT02447991|58914201|FG000|Overall Study|Lost to Follow-up - no data|3|||
30881967|NCT02447991|58914202|FG001|Overall Study|Lost to Follow-up - no data|6|||
30881968|NCT02447991|58914201|FG000|Overall Study|Lost to follow-up - with data|0|||
30881969|NCT02447991|58914202|FG001|Overall Study|Lost to follow-up - with data|3|||
30881970|NCT02447991|58914201|FG000|Overall Study|End of study - no treatment results|3|||
30881971|NCT02447991|58914202|FG001|Overall Study|End of study - no treatment results|6|||
30881972|NCT02447991|58914201|FG000|Overall Study|End of study - partial treatment results|0|||
30881973|NCT02447991|58914202|FG001|Overall Study|End of study - partial treatment results|9|||
30881974|NCT02586155|58914214|FG000|Overall Study|Adverse Event|2|||
30881975|NCT02586155|58914215|FG001|Overall Study|Adverse Event|3|||
30881976|NCT02586155|58914214|FG000|Overall Study|Withdrawal by Subject|31|||
30881977|NCT02586155|58914215|FG001|Overall Study|Withdrawal by Subject|24|||
30881978|NCT02586155|58914214|FG000|Overall Study|Lost to Follow-up|7|||
30881979|NCT02586155|58914215|FG001|Overall Study|Lost to Follow-up|13|||
30881980|NCT02586155|58914214|FG000|Overall Study|Death|61|||
30881981|NCT02586155|58914215|FG001|Overall Study|Death|72|||
30881982|NCT02586155|58914214|FG000|Overall Study|Other reasons|26|||
30881983|NCT02586155|58914215|FG001|Overall Study|Other reasons|15|||
30881984|NCT02446743|58914223|FG000|Overall Study|Withdrawal by Subject|1|||
30975523|NCT02608476|59057076|FG000|Overall Study|Noncompliance with treatment|1|||
30975524|NCT02608476|59057077|FG001|Overall Study|Noncompliance with treatment|5|||
30881985|NCT02446743|58914224|FG001|Overall Study|Withdrawal by Subject|1|||
30881986|NCT02446743|58914223|FG000|Overall Study|Lost to Follow-up|1|||
30881987|NCT02446743|58914224|FG001|Overall Study|Lost to Follow-up|0|||
30881988|NCT02446743|58914223|FG000|Overall Study|Adverse Event|1|||
30881989|NCT02446743|58914224|FG001|Overall Study|Adverse Event|1|||
30881990|NCT02446743|58914223|FG000|Overall Study|Other|2|||
30881991|NCT02446743|58914224|FG001|Overall Study|Other|3|||
30881992|NCT02586077|58914239|FG000|Overall Study|Withdrawal by Subject|1|||
30975525|NCT02608476|59057076|FG000|Overall Study|Lack of Efficacy|3|||
30881993|NCT02586077|58914239|FG000|Overall Study|Physician Decision|4|||
30881994|NCT02586077|58914239|FG000|Overall Study|Lost to Follow-up|3|||
30881995|NCT02583425|58914244|FG000|Screening|Did not meet entry criteria|12|||
30881996|NCT02583425|58914244|FG000|Baseline|Did not meet continued criteria|5|||
30881997|NCT02583425|58914244|FG000|Treatment Period|Adverse Event|1|||
30881998|NCT02581163|58914249|FG000|Overall Study|Failure to return|15|||
30881999|NCT02581163|58914249|FG000|Overall Study|Insufficient virological response|3|||
30882000|NCT02581163|58914249|FG000|Overall Study|Withdrew consent|1|||
30882001|NCT02581163|58914249|FG000|Overall Study|Death|1|||
30882002|NCT02581163|58914249|FG000|Overall Study|Other, not specified|9|||
30882003|NCT02627677|58914259|FG000|Overall Study|Adverse event (not progressive disease)|1|||
30882004|NCT02627677|58914260|FG001|Overall Study|Adverse event (not progressive disease)|4|||
30882005|NCT02627677|58914261|FG002|Overall Study|Adverse event (not progressive disease)|1|||
30882006|NCT02627677|58914259|FG000|Overall Study|Progressive disease|1|||
30882007|NCT02627677|58914260|FG001|Overall Study|Progressive disease|3|||
30882008|NCT02627677|58914261|FG002|Overall Study|Progressive disease|0|||
30882009|NCT02627677|58914259|FG000|Overall Study|Lack of Efficacy|1|||
30882010|NCT02627677|58914260|FG001|Overall Study|Lack of Efficacy|2|||
30882011|NCT02627677|58914261|FG002|Overall Study|Lack of Efficacy|0|||
30882012|NCT02627677|58914259|FG000|Overall Study|Lost to Follow-up|0|||
30882013|NCT02627677|58914260|FG001|Overall Study|Lost to Follow-up|0|||
30882014|NCT02627677|58914261|FG002|Overall Study|Lost to Follow-up|1|||
30882015|NCT02627677|58914259|FG000|Overall Study|Pregnancy|0|||
30882016|NCT02627677|58914260|FG001|Overall Study|Pregnancy|1|||
30882017|NCT02627677|58914261|FG002|Overall Study|Pregnancy|0|||
30882018|NCT02627677|58914259|FG000|Overall Study|Study Terminated by Sponsor|5|||
30882019|NCT02627677|58914260|FG001|Overall Study|Study Terminated by Sponsor|10|||
30882020|NCT02627677|58914261|FG002|Overall Study|Study Terminated by Sponsor|6|||
30882021|NCT02627677|58914259|FG000|Overall Study|Physician Decision|0|||
30882022|NCT02627677|58914260|FG001|Overall Study|Physician Decision|0|||
30882023|NCT02627677|58914261|FG002|Overall Study|Physician Decision|2|||
30882024|NCT02627677|58914259|FG000|Overall Study|Withdrawal by Subject|2|||
30882025|NCT02627677|58914260|FG001|Overall Study|Withdrawal by Subject|1|||
30882026|NCT02627677|58914261|FG002|Overall Study|Withdrawal by Subject|1|||
30882027|NCT02627677|58914259|FG000|Overall Study|Reason not Specified|0|||
30882028|NCT02627677|58914260|FG001|Overall Study|Reason not Specified|0|||
30882029|NCT02627677|58914261|FG002|Overall Study|Reason not Specified|1|||
30882030|NCT02627677|58914259|FG000|Overall Study|Randomized but not Treated|1|||
30882031|NCT02627677|58914260|FG001|Overall Study|Randomized but not Treated|0|||
30882032|NCT02627677|58914261|FG002|Overall Study|Randomized but not Treated|0|||
30882033|NCT02501811|58914274|FG000|Overall Study|Death|1|||
30882034|NCT02501811|58914275|FG001|Overall Study|Death|3|||
30882035|NCT02501811|58914276|FG002|Overall Study|Death|2|||
30882036|NCT02501811|58914277|FG003|Overall Study|Death|3|||
30882037|NCT02501811|58914274|FG000|Overall Study|Withdrawal by Subject|3|||
30882038|NCT02501811|58914275|FG001|Overall Study|Withdrawal by Subject|3|||
30882039|NCT02501811|58914276|FG002|Overall Study|Withdrawal by Subject|2|||
30882040|NCT02501811|58914277|FG003|Overall Study|Withdrawal by Subject|3|||
30882041|NCT02501811|58914274|FG000|Overall Study|Lost to Follow-up|0|||
30882042|NCT02501811|58914275|FG001|Overall Study|Lost to Follow-up|0|||
30882043|NCT02501811|58914276|FG002|Overall Study|Lost to Follow-up|2|||
30882044|NCT02501811|58914277|FG003|Overall Study|Lost to Follow-up|1|||
30882045|NCT02585999|58914287|FG000|Overall Study|Lost to Follow-up|1|||
30882046|NCT02585999|58914287|FG000|Overall Study|Protocol Violation|1|||
30882047|NCT02582255|58914294|FG000|Overall Study|Protocol Violation|0|||
30882048|NCT02582255|58914295|FG001|Overall Study|Protocol Violation|3|||
30882049|NCT02500719|58914304|FG000|Overall Study|Lost to Follow-up|2|||
30882050|NCT02500719|58914305|FG001|Overall Study|Lost to Follow-up|3|||
30882051|NCT02500719|58914304|FG000|Overall Study|Trauma history|1|||
30882052|NCT02500719|58914305|FG001|Overall Study|Trauma history|0|||
30882053|NCT02500719|58914304|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
30882054|NCT02500719|58914305|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
30882055|NCT02500719|58914304|FG000|Overall Study|Did not meet criteria for PTSD|0|||
30882056|NCT02500719|58914305|FG001|Overall Study|Did not meet criteria for PTSD|1|||
30882057|NCT02500719|58914304|FG000|Overall Study|Claustrophobia|0|||
30882058|NCT02500719|58914305|FG001|Overall Study|Claustrophobia|1|||
30882059|NCT02500719|58914304|FG000|Overall Study|History of head trauma|0|||
30882060|NCT02500719|58914305|FG001|Overall Study|History of head trauma|1|||
30882061|NCT02500641|58914313|FG000|Overall Study|Adverse Event|0|||
30882062|NCT02500641|58914314|FG001|Overall Study|Adverse Event|2|||
30882063|NCT02500641|58914313|FG000|Overall Study|Withdrawal by Subject|4|||
30882064|NCT02500641|58914314|FG001|Overall Study|Withdrawal by Subject|5|||
30882065|NCT02500641|58914313|FG000|Overall Study|Unable to follow study procedures|3|||
30882066|NCT02500641|58914314|FG001|Overall Study|Unable to follow study procedures|2|||
30882067|NCT02500641|58914313|FG000|Overall Study|Protocol Violation|1|||
30882068|NCT02500641|58914314|FG001|Overall Study|Protocol Violation|2|||
30882069|NCT02500641|58914313|FG000|Overall Study|Lost to Follow-up|1|||
30882070|NCT02500641|58914314|FG001|Overall Study|Lost to Follow-up|0|||
30882071|NCT02500641|58914313|FG000|Overall Study|Sponsor decision|1|||
30882072|NCT02500641|58914314|FG001|Overall Study|Sponsor decision|0|||
30882073|NCT02500641|58914313|FG000|Overall Study|Non compliance to study drug|0|||
30882074|NCT02500641|58914314|FG001|Overall Study|Non compliance to study drug|1|||
30882075|NCT02499783|58914322|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
30882076|NCT02499783|58914323|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
30882077|NCT02499783|58914324|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
30882078|NCT02499783|58914322|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
30882079|NCT02499783|58914323|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
30882080|NCT02499783|58914324|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
30882081|NCT02499783|58914322|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
30882082|NCT02499783|58914323|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
30882083|NCT02499783|58914324|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
30882084|NCT02499783|58914322|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
30882085|NCT02499783|58914323|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
30882086|NCT02499783|58914324|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
30882087|NCT02499783|58914322|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
30882088|NCT02499783|58914323|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
30882089|NCT02499783|58914324|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
30882090|NCT02499783|58914322|FG000|DB Period: Weeks 0-8|Other|1|||
30882091|NCT02499783|58914323|FG001|DB Period: Weeks 0-8|Other|1|||
30882092|NCT02499783|58914324|FG002|DB Period: Weeks 0-8|Other|0|||
30882093|NCT02499783|58914322|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
30882094|NCT02499783|58914323|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
30882095|NCT02499783|58914324|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
30882096|NCT02499783|58914322|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
30882097|NCT02499783|58914323|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
30882098|NCT02499783|58914324|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
30882099|NCT02499783|58914322|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
30882100|NCT02499783|58914323|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
30882101|NCT02499783|58914324|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
30882102|NCT02499783|58914322|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
30882103|NCT02499783|58914323|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
30882104|NCT02499783|58914324|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
30882105|NCT02468193|58914334|FG000|Overall Study|Adverse Event|4|||
30882106|NCT02468193|58914334|FG000|Overall Study|Subject/ Guardian decision|2|||
30882107|NCT02466555|58914354|FG000|Overall Study|Lost to Follow-up|2|||
30882108|NCT02466399|58914361|FG000|Overall Study|Adverse Event|1|||
30882109|NCT02466399|58914362|FG001|Overall Study|Adverse Event|0|||
30882110|NCT02466399|58914361|FG000|Overall Study|Early exit due to family emergency|1|||
30882111|NCT02466399|58914362|FG001|Overall Study|Early exit due to family emergency|0|||
30882112|NCT02465931|58914370|FG000|Overall Study|Lost to Follow-up|9|||
30882113|NCT02465931|58914371|FG001|Overall Study|Lost to Follow-up|11|||
30882114|NCT02465931|58914370|FG000|Overall Study|Protocol Violation|1|||
30882115|NCT02465931|58914371|FG001|Overall Study|Protocol Violation|0|||
30882116|NCT02465931|58914370|FG000|Overall Study|Withdrawal by Subject|1|||
30882117|NCT02465931|58914371|FG001|Overall Study|Withdrawal by Subject|0|||
30882118|NCT02465463|58914379|FG000|Overall Study|Lost to Follow-up|2|||
30882119|NCT02465463|58914380|FG001|Overall Study|Lost to Follow-up|1|||
30882120|NCT02465463|58914379|FG000|Overall Study|Death|1|||
30882121|NCT02465463|58914380|FG001|Overall Study|Death|0|||
30882122|NCT02465463|58914379|FG000|Overall Study|Protocol Violation|1|||
30882123|NCT02465463|58914380|FG001|Overall Study|Protocol Violation|0|||
30882124|NCT02464059|58914387|FG000|Overall Study|Lost to Follow-up|6|||
30882125|NCT02463357|58914396|FG000|Overall Study|Withdrawal by Subject|1|||
30882126|NCT02463357|58914397|FG001|Overall Study|Withdrawal by Subject|0|||
30882127|NCT02463357|58914398|FG002|Overall Study|Withdrawal by Subject|0|||
30882128|NCT02463357|58914399|FG003|Overall Study|Withdrawal by Subject|0|||
30882129|NCT02463357|58914400|FG004|Overall Study|Withdrawal by Subject|0|||
30882130|NCT02463357|58914396|FG000|Overall Study|Withdrawal by Subject|0|||
30882131|NCT02463357|58914397|FG001|Overall Study|Withdrawal by Subject|0|||
30882132|NCT02463357|58914398|FG002|Overall Study|Withdrawal by Subject|0|||
30882133|NCT02463357|58914399|FG003|Overall Study|Withdrawal by Subject|0|||
30882134|NCT02463357|58914400|FG004|Overall Study|Withdrawal by Subject|1|||
30882135|NCT02579759|58914415|FG000|Overall Study|Protocol Violation|2|||
30882136|NCT02579759|58914416|FG001|Overall Study|Protocol Violation|0|||
30882137|NCT02579759|58914417|FG002|Overall Study|Protocol Violation|0|||
30882138|NCT02579759|58914415|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
30882139|NCT02579759|58914416|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
30882140|NCT02579759|58914417|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
30882141|NCT02579759|58914415|FG000|Overall Study|BfArM hold|13|||
30882142|NCT02579759|58914416|FG001|Overall Study|BfArM hold|12|||
30882143|NCT02579759|58914417|FG002|Overall Study|BfArM hold|12|||
30882144|NCT02579759|58914415|FG000|Overall Study|Sponsor stopped Dose 2|0|||
30882145|NCT02579759|58914416|FG001|Overall Study|Sponsor stopped Dose 2|41|||
30882146|NCT02579759|58914417|FG002|Overall Study|Sponsor stopped Dose 2|0|||
30882147|NCT02579759|58914415|FG000|Overall Study|Non compliance|0|||
30882148|NCT02579759|58914416|FG001|Overall Study|Non compliance|1|||
30882149|NCT02579759|58914417|FG002|Overall Study|Non compliance|0|||
30882150|NCT02579759|58914415|FG000|Overall Study|Pregnancy|0|||
30882151|NCT02579759|58914416|FG001|Overall Study|Pregnancy|1|||
30882152|NCT02579759|58914417|FG002|Overall Study|Pregnancy|0|||
30882153|NCT02579759|58914415|FG000|Overall Study|Inclusion/exclusion criteria|0|||
30882154|NCT02579759|58914416|FG001|Overall Study|Inclusion/exclusion criteria|0|||
30882155|NCT02579759|58914417|FG002|Overall Study|Inclusion/exclusion criteria|1|||
30882156|NCT02579759|58914415|FG000|Overall Study|Adverse Event|4|||
30882157|NCT02579759|58914416|FG001|Overall Study|Adverse Event|3|||
30882158|NCT02579759|58914417|FG002|Overall Study|Adverse Event|1|||
30882159|NCT02579759|58914415|FG000|Overall Study|Withdrawal by Subject|3|||
30882160|NCT02579759|58914416|FG001|Overall Study|Withdrawal by Subject|3|||
30882161|NCT02579759|58914417|FG002|Overall Study|Withdrawal by Subject|5|||
30882162|NCT02579759|58914415|FG000|Overall Study|Lost to Follow-up|2|||
30882163|NCT02579759|58914416|FG001|Overall Study|Lost to Follow-up|2|||
30882164|NCT02579759|58914417|FG002|Overall Study|Lost to Follow-up|2|||
30882165|NCT02445963|58914431|FG000|Overall Study|Lost to Follow-up|1|||
30882166|NCT02445963|58914432|FG001|Overall Study|Lost to Follow-up|0|||
30882167|NCT02445963|58914433|FG002|Overall Study|Lost to Follow-up|0|||
30882168|NCT02445963|58914434|FG003|Overall Study|Lost to Follow-up|0|||
30882169|NCT02445963|58914431|FG000|Overall Study|Change in employment|1|||
30882170|NCT02445963|58914432|FG001|Overall Study|Change in employment|0|||
30882171|NCT02445963|58914433|FG002|Overall Study|Change in employment|0|||
30882172|NCT02445963|58914434|FG003|Overall Study|Change in employment|0|||
30882173|NCT02445963|58914431|FG000|Overall Study|Symptoms post-vaccination|0|||
30882174|NCT02445963|58914432|FG001|Overall Study|Symptoms post-vaccination|0|||
30882175|NCT02445963|58914433|FG002|Overall Study|Symptoms post-vaccination|1|||
30975526|NCT02608476|59057077|FG001|Overall Study|Lack of Efficacy|1|||
30975527|NCT02608476|59057076|FG000|Overall Study|Other|0|||
30975528|NCT02608476|59057077|FG001|Overall Study|Other|1|||
30975529|NCT02608476|59057076|FG000|Overall Study|Physician Decision|1|||
30975530|NCT02608476|59057077|FG001|Overall Study|Physician Decision|0|||
30975531|NCT02608476|59057076|FG000|Overall Study|Pregnancy|0|||
30975532|NCT02608476|59057077|FG001|Overall Study|Pregnancy|1|||
30882176|NCT02445963|58914434|FG003|Overall Study|Symptoms post-vaccination|0|||
30975533|NCT02608476|59057076|FG000|Overall Study|Progressive disease|1|||
30882177|NCT02499159|58914448|FG000|Randomization|Protocol Violation|1|||
30975534|NCT02608476|59057077|FG001|Overall Study|Progressive disease|0|||
30975535|NCT02607306|59057215|FG000|Overall Study|Adverse Event|8|||
30975536|NCT02607306|59057216|FG001|Overall Study|Adverse Event|6|||
30975537|NCT02607306|59057217|FG002|Overall Study|Adverse Event|6|||
30975538|NCT02607306|59057215|FG000|Overall Study|Unclassified|1|||
30975539|NCT02607306|59057216|FG001|Overall Study|Unclassified|4|||
30975540|NCT02607306|59057217|FG002|Overall Study|Unclassified|0|||
30975541|NCT02607306|59057215|FG000|Overall Study|Withdrawal by Subject|8|||
30975542|NCT02607306|59057216|FG001|Overall Study|Withdrawal by Subject|10|||
30975543|NCT02607306|59057217|FG002|Overall Study|Withdrawal by Subject|2|||
30975544|NCT02607306|59057215|FG000|Overall Study|Lack of Efficacy|0|||
30975545|NCT02607306|59057216|FG001|Overall Study|Lack of Efficacy|1|||
30975546|NCT02607306|59057217|FG002|Overall Study|Lack of Efficacy|1|||
30975547|NCT02607306|59057215|FG000|Overall Study|Protocol Violation|4|||
30975548|NCT02607306|59057216|FG001|Overall Study|Protocol Violation|2|||
30975549|NCT02607306|59057217|FG002|Overall Study|Protocol Violation|1|||
30975550|NCT02603952|59057540|FG000|Overall Study|Withdrawal by Subject|1|||
30975551|NCT02603952|59057541|FG001|Overall Study|Withdrawal by Subject|0|||
30975552|NCT02603952|59057542|FG002|Overall Study|Withdrawal by Subject|0|||
30975553|NCT02603952|59057543|FG003|Overall Study|Withdrawal by Subject|0|||
30882178|NCT02499159|58914449|FG001|Randomization|Protocol Violation|1|||
30882179|NCT02499159|58914448|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
30975554|NCT02603952|59057540|FG000|Overall Study|Received oseltamivir by error|0|||
30975555|NCT02603952|59057541|FG001|Overall Study|Received oseltamivir by error|0|||
30975556|NCT02603952|59057542|FG002|Overall Study|Received oseltamivir by error|0|||
30975557|NCT02603952|59057543|FG003|Overall Study|Received oseltamivir by error|1|||
30975558|NCT02603172|59058057|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
30790014|NCT00048581|58803258|FG000|Double-Blind Period|Lack of Efficacy|14|||
30790015|NCT00048581|58803259|FG001|Double-Blind Period|Lack of Efficacy|27|||
30882180|NCT02499159|58914449|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
30882181|NCT02499159|58914448|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
30882182|NCT02499159|58914449|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
30882183|NCT02499159|58914448|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
30882184|NCT02499159|58914449|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
30882185|NCT02499159|58914448|FG000|30-Day Follow-Up Phone Call|Other|1|||
30882186|NCT02499159|58914449|FG001|30-Day Follow-Up Phone Call|Other|0|||
30975559|NCT02603172|59058058|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
30975560|NCT02603172|59058059|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
30975561|NCT02603172|59058060|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
30882187|NCT01664039|58914457|FG000|Overall Study|Adverse Event|3|||
30882188|NCT01664039|58914458|FG001|Overall Study|Adverse Event|4|||
30882189|NCT01664039|58914457|FG000|Overall Study|Lost to Follow-up|1|||
30882190|NCT01664039|58914458|FG001|Overall Study|Lost to Follow-up|1|||
30882191|NCT01664039|58914457|FG000|Overall Study|Withdrawal by Subject|1|||
30882192|NCT01664039|58914458|FG001|Overall Study|Withdrawal by Subject|3|||
30882193|NCT01664039|58914457|FG000|Overall Study|Noncompliance|1|||
30882194|NCT01664039|58914458|FG001|Overall Study|Noncompliance|1|||
30882195|NCT02445573|58914466|FG000|Overall Study|Withdrawal by Subject|1|||
30882196|NCT02445573|58914467|FG001|Overall Study|Withdrawal by Subject|1|||
30882197|NCT02445573|58914466|FG000|Overall Study|Lost to Follow-up|0|||
30882198|NCT02445573|58914467|FG001|Overall Study|Lost to Follow-up|1|||
30882199|NCT02445339|58914475|FG000|Overall Study|Physician Decision|1|||
30882200|NCT02445339|58914476|FG001|Overall Study|Physician Decision|0|||
30882201|NCT02445339|58914475|FG000|Overall Study|Lost to Follow-up|11|||
30882202|NCT02445339|58914476|FG001|Overall Study|Lost to Follow-up|15|||
30882203|NCT02579603|58914484|FG000|Overall Study|Not treated|1|||
30882204|NCT02579603|58914485|FG001|Overall Study|Not treated|0|||
30882205|NCT02579603|58914484|FG000|Overall Study|Adverse Event|2|||
30882206|NCT02579603|58914485|FG001|Overall Study|Adverse Event|2|||
30882207|NCT02579603|58914484|FG000|Overall Study|Other than stated|1|||
30882208|NCT02579603|58914485|FG001|Overall Study|Other than stated|0|||
30882209|NCT02625259|58914497|FG000|First Intervention (Day 1)|Other|0|||
30882210|NCT02625259|58914498|FG001|First Intervention (Day 1)|Other|0|||
30882211|NCT02625259|58914499|FG002|First Intervention (Day 1)|Other|1|||
30882212|NCT02625259|58914500|FG003|First Intervention (Day 1)|Other|0|||
30882213|NCT02625259|58914501|FG004|First Intervention (Day 1)|Other|0|||
30882214|NCT02625259|58914497|FG000|First Intervention (Day 1)|Adverse Event|2|||
30882215|NCT02625259|58914498|FG001|First Intervention (Day 1)|Adverse Event|1|||
30882216|NCT02625259|58914499|FG002|First Intervention (Day 1)|Adverse Event|0|||
30882217|NCT02625259|58914500|FG003|First Intervention (Day 1)|Adverse Event|0|||
30882218|NCT02625259|58914501|FG004|First Intervention (Day 1)|Adverse Event|0|||
30882219|NCT02625259|58914497|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
30882220|NCT02625259|58914498|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
30882221|NCT02625259|58914499|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
30882222|NCT02625259|58914500|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
30882223|NCT02625259|58914501|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
30882224|NCT02577107|58914518|FG000|Overall Study|Protocol deviation|0|||
30882225|NCT02577107|58914519|FG001|Overall Study|Protocol deviation|1|||
30882226|NCT02444793|58914529|FG000|Overall Study|Lost to Follow-up|2|||
30882227|NCT02444793|58914530|FG001|Overall Study|Lost to Follow-up|2|||
30882228|NCT02444793|58914531|FG002|Overall Study|Lost to Follow-up|0|||
30882229|NCT02444793|58914532|FG003|Overall Study|Lost to Follow-up|0|||
30882230|NCT02444793|58914529|FG000|Overall Study|Death|0|||
30882231|NCT02444793|58914530|FG001|Overall Study|Death|3|||
30882232|NCT02444793|58914531|FG002|Overall Study|Death|0|||
30882233|NCT02444793|58914532|FG003|Overall Study|Death|0|||
30882234|NCT02444793|58914529|FG000|Overall Study|Other|0|||
30882235|NCT02444793|58914530|FG001|Overall Study|Other|0|||
30882236|NCT02444793|58914531|FG002|Overall Study|Other|2|||
30882237|NCT02444793|58914532|FG003|Overall Study|Other|0|||
30882238|NCT02444793|58914529|FG000|Overall Study|Objective progression or relapse|9|||
30882239|NCT02444793|58914530|FG001|Overall Study|Objective progression or relapse|1|||
30975562|NCT02603172|59058061|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
30975563|NCT02603172|59058062|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
30975564|NCT02603172|59058063|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
30975565|NCT02603172|59058064|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
30975566|NCT02605824|59058185|FG000|Overall Study|Physician Decision|1|||
30975567|NCT02605824|59058186|FG001|Overall Study|Physician Decision|0|||
30975568|NCT02605122|59058316|FG000|Overall Study|Withdrawal by Subject|4|||
30882240|NCT02444793|58914531|FG002|Overall Study|Objective progression or relapse|2|||
30882241|NCT02444793|58914532|FG003|Overall Study|Objective progression or relapse|3|||
30882242|NCT02624713|58914545|FG000|Overall Study|Lost to Follow-up|14|||
30882243|NCT02624713|58914546|FG001|Overall Study|Lost to Follow-up|0|||
30882244|NCT02624791|58914553|FG000|Overall Study|Withdrawal by Subject|2|||
30882245|NCT02624791|58914554|FG001|Overall Study|Withdrawal by Subject|0|||
30882246|NCT02624791|58914555|FG002|Overall Study|Withdrawal by Subject|0|||
30882247|NCT02624791|58914556|FG003|Overall Study|Withdrawal by Subject|0|||
30882248|NCT02624791|58914557|FG004|Overall Study|Withdrawal by Subject|0|||
30882249|NCT02624791|58914558|FG005|Overall Study|Withdrawal by Subject|0|||
30882250|NCT02577029|58914570|FG000|Overall Study|Adverse Event|1|||
30882251|NCT02577029|58914571|FG001|Overall Study|Adverse Event|0|||
30882252|NCT02577029|58914572|FG002|Overall Study|Adverse Event|2|||
30882253|NCT02577029|58914573|FG003|Overall Study|Adverse Event|0|||
30882254|NCT02577029|58914574|FG004|Overall Study|Adverse Event|1|||
30882255|NCT02577029|58914575|FG005|Overall Study|Adverse Event|0|||
30882256|NCT02577029|58914576|FG006|Overall Study|Adverse Event|0|||
30882257|NCT02577029|58914577|FG007|Overall Study|Adverse Event|0|||
30882258|NCT02577029|58914570|FG000|Overall Study|Withdrawal by Subject|0|||
30882259|NCT02577029|58914571|FG001|Overall Study|Withdrawal by Subject|0|||
30882260|NCT02577029|58914572|FG002|Overall Study|Withdrawal by Subject|0|||
30882261|NCT02577029|58914573|FG003|Overall Study|Withdrawal by Subject|0|||
30882262|NCT02577029|58914574|FG004|Overall Study|Withdrawal by Subject|0|||
30882263|NCT02577029|58914575|FG005|Overall Study|Withdrawal by Subject|1|||
30882264|NCT02577029|58914576|FG006|Overall Study|Withdrawal by Subject|0|||
30882265|NCT02577029|58914577|FG007|Overall Study|Withdrawal by Subject|0|||
30882266|NCT02577029|58914570|FG000|Overall Study|Sponsor Termination of the Study|9|||
30882267|NCT02577029|58914571|FG001|Overall Study|Sponsor Termination of the Study|2|||
30882268|NCT02577029|58914572|FG002|Overall Study|Sponsor Termination of the Study|5|||
30882269|NCT02577029|58914573|FG003|Overall Study|Sponsor Termination of the Study|12|||
30882270|NCT02577029|58914574|FG004|Overall Study|Sponsor Termination of the Study|10|||
30882271|NCT02577029|58914575|FG005|Overall Study|Sponsor Termination of the Study|12|||
30882272|NCT02577029|58914576|FG006|Overall Study|Sponsor Termination of the Study|12|||
30882273|NCT02577029|58914577|FG007|Overall Study|Sponsor Termination of the Study|12|||
30882274|NCT02577887|58914595|FG000|Overall Study|Death|93|||
30882275|NCT02577887|58914595|FG000|Overall Study|Protocol Violation|125|||
30882276|NCT02577887|58914595|FG000|Overall Study|Withdrawal by Subject|80|||
30882277|NCT03597347|58914602|FG000|Overall Study|Withdrawal by Subject|1|||
30882278|NCT03597347|58914603|FG001|Overall Study|Withdrawal by Subject|1|||
30882279|NCT03597347|58914604|FG002|Overall Study|Withdrawal by Subject|0|||
30882280|NCT03597347|58914602|FG000|Overall Study|Withdrawal due to Covid-19|3|||
30882281|NCT03597347|58914603|FG001|Overall Study|Withdrawal due to Covid-19|0|||
30882282|NCT03597347|58914604|FG002|Overall Study|Withdrawal due to Covid-19|0|||
30882283|NCT03597347|58914602|FG000|Overall Study|Sponsor decision to terminate study|3|||
30882284|NCT03597347|58914603|FG001|Overall Study|Sponsor decision to terminate study|2|||
30882285|NCT03597347|58914604|FG002|Overall Study|Sponsor decision to terminate study|4|||
30882286|NCT02576951|58914616|FG000|Overall Study|Lost to Follow-up|0|||
30882287|NCT02576951|58914617|FG001|Overall Study|Lost to Follow-up|0|||
30882288|NCT02576951|58914618|FG002|Overall Study|Lost to Follow-up|2|||
30882289|NCT02576951|58914619|FG003|Overall Study|Lost to Follow-up|2|||
30882290|NCT02576951|58914616|FG000|Overall Study|Withdrawal by Subject|1|||
30882291|NCT02576951|58914617|FG001|Overall Study|Withdrawal by Subject|0|||
30882292|NCT02576951|58914618|FG002|Overall Study|Withdrawal by Subject|0|||
30882293|NCT02576951|58914619|FG003|Overall Study|Withdrawal by Subject|2|||
30882294|NCT02576951|58914616|FG000|Overall Study|Protocol Violation|0|||
30882295|NCT02576951|58914617|FG001|Overall Study|Protocol Violation|0|||
30882296|NCT02576951|58914618|FG002|Overall Study|Protocol Violation|0|||
30882297|NCT02576951|58914619|FG003|Overall Study|Protocol Violation|1|||
30882298|NCT02621047|58914634|FG000|Overall Study|Adverse Event|0|||
30882299|NCT02621047|58914635|FG001|Overall Study|Adverse Event|0|||
30882300|NCT02621047|58914636|FG002|Overall Study|Adverse Event|1|||
30882301|NCT02443155|58914649|FG000|Overall Study|Adverse Event|3|||
30882302|NCT02443155|58914650|FG001|Overall Study|Adverse Event|4|||
30882303|NCT02443155|58914651|FG002|Overall Study|Adverse Event|1|||
30882304|NCT02443155|58914652|FG003|Overall Study|Adverse Event|2|||
30882305|NCT02443155|58914649|FG000|Overall Study|Unclassified|0|||
30882306|NCT02443155|58914650|FG001|Overall Study|Unclassified|0|||
30882307|NCT02443155|58914651|FG002|Overall Study|Unclassified|2|||
30882308|NCT02443155|58914652|FG003|Overall Study|Unclassified|1|||
30882309|NCT02443155|58914649|FG000|Overall Study|Withdrawal by Subject|4|||
30882310|NCT02443155|58914650|FG001|Overall Study|Withdrawal by Subject|7|||
30882311|NCT02443155|58914651|FG002|Overall Study|Withdrawal by Subject|3|||
30882312|NCT02443155|58914652|FG003|Overall Study|Withdrawal by Subject|9|||
30790016|NCT00048581|58803260|FG002|Double-Blind Period|Lack of Efficacy|0|||
30790017|NCT00048581|58803258|FG000|Double-Blind Period|Lost to Follow-up|5|||
30790018|NCT00048581|58803259|FG001|Double-Blind Period|Lost to Follow-up|0|||
30790019|NCT00048581|58803260|FG002|Double-Blind Period|Lost to Follow-up|0|||
30790020|NCT00048581|58803258|FG000|Double-Blind Period|Withdrawal by Subject|5|||
30790021|NCT00048581|58803259|FG001|Double-Blind Period|Withdrawal by Subject|2|||
30790022|NCT00048581|58803260|FG002|Double-Blind Period|Withdrawal by Subject|0|||
30790023|NCT00048581|58803258|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
30790024|NCT00048581|58803259|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
30790025|NCT00048581|58803260|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
30790026|NCT00048581|58803258|FG000|Double-Blind Period|Investigator Decision|1|||
30882313|NCT02443155|58914649|FG000|Overall Study|Pregnancy|3|||
30882314|NCT02443155|58914650|FG001|Overall Study|Pregnancy|1|||
30882315|NCT02443155|58914651|FG002|Overall Study|Pregnancy|1|||
30882316|NCT02443155|58914652|FG003|Overall Study|Pregnancy|2|||
30882317|NCT02443155|58914649|FG000|Overall Study|Lost to Follow-up|1|||
30882318|NCT02443155|58914650|FG001|Overall Study|Lost to Follow-up|2|||
30882319|NCT02443155|58914651|FG002|Overall Study|Lost to Follow-up|0|||
30882320|NCT02443155|58914652|FG003|Overall Study|Lost to Follow-up|1|||
30882321|NCT02443155|58914649|FG000|Overall Study|Protocol Violation|1|||
30882322|NCT02443155|58914650|FG001|Overall Study|Protocol Violation|0|||
30608435|NCT01288430|58619224|FG003|Part 2|Progressive disease|0|||
30882323|NCT02443155|58914651|FG002|Overall Study|Protocol Violation|1|||
30882324|NCT02443155|58914652|FG003|Overall Study|Protocol Violation|1|||
30882325|NCT02443155|58914649|FG000|Overall Study|Death|0|||
30882326|NCT02443155|58914650|FG001|Overall Study|Death|0|||
30882327|NCT02443155|58914651|FG002|Overall Study|Death|1|||
30882328|NCT02443155|58914652|FG003|Overall Study|Death|0|||
30882329|NCT02460159|58914665|FG000|Overall Study|Adverse Event|4|||
30882330|NCT02460159|58914666|FG001|Overall Study|Adverse Event|1|||
30882331|NCT02460159|58914665|FG000|Overall Study|Withdrawal by Subject|2|||
30882332|NCT02460159|58914666|FG001|Overall Study|Withdrawal by Subject|0|||
30882333|NCT02498067|58914672|FG000|Overall Study|Lost to Follow-up|22|||
30882334|NCT02498067|58914672|FG000|Overall Study|Did not meet inclusion criteria|11|||
30882335|NCT02497755|58914680|FG000|Overall Study|Protocol Violation|1|||
30882336|NCT02497755|58914681|FG001|Overall Study|Protocol Violation|0|||
30882337|NCT02619175|58914690|FG000|Overall Study|Withdrawal by Subject|1|||
30882338|NCT02619175|58914691|FG001|Overall Study|Withdrawal by Subject|0|||
30882339|NCT02619175|58914690|FG000|Overall Study|foot pain|1|||
30882340|NCT02619175|58914691|FG001|Overall Study|foot pain|0|||
30882341|NCT01360021|58914708|FG000|Overall Study|Eligibility criteria + other|2|||
30882342|NCT01360021|58914709|FG001|Overall Study|Eligibility criteria + other|1|||
30882343|NCT01360021|58914710|FG002|Overall Study|Eligibility criteria + other|1|||
30882344|NCT01360021|58914708|FG000|Overall Study|Protocol Violation|0|||
30882345|NCT01360021|58914709|FG001|Overall Study|Protocol Violation|0|||
30882346|NCT01360021|58914710|FG002|Overall Study|Protocol Violation|1|||
30882347|NCT01360021|58914708|FG000|Overall Study|Withdrawal by Subject|4|||
30882348|NCT01360021|58914709|FG001|Overall Study|Withdrawal by Subject|0|||
30882349|NCT01360021|58914710|FG002|Overall Study|Withdrawal by Subject|2|||
30882350|NCT01360021|58914708|FG000|Overall Study|Adverse Event|2|||
30882351|NCT01360021|58914709|FG001|Overall Study|Adverse Event|3|||
30882352|NCT01360021|58914710|FG002|Overall Study|Adverse Event|3|||
30882353|NCT02497287|58914727|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
30608436|NCT01288430|58619225|FG004|Part 2|Progressive disease|0|||
30790027|NCT00048581|58803259|FG001|Double-Blind Period|Investigator Decision|0|||
30790028|NCT00048581|58803260|FG002|Double-Blind Period|Investigator Decision|0|||
30790029|NCT00048581|58803258|FG000|Open-Label Period|Death|0|||
30790030|NCT00048581|58803259|FG001|Open-Label Period|Death|0|||
30790031|NCT00048581|58803260|FG002|Open-Label Period|Death|4|||
30790032|NCT00048581|58803258|FG000|Open-Label Period|Adverse Event|0|||
30790033|NCT00048581|58803259|FG001|Open-Label Period|Adverse Event|0|||
30790034|NCT00048581|58803260|FG002|Open-Label Period|Adverse Event|37|||
30790035|NCT00048581|58803258|FG000|Open-Label Period|Lack of Efficacy|0|||
30790036|NCT00048581|58803259|FG001|Open-Label Period|Lack of Efficacy|0|||
30790037|NCT00048581|58803260|FG002|Open-Label Period|Lack of Efficacy|69|||
30790038|NCT00048581|58803258|FG000|Open-Label Period|Lost to Follow-up|0|||
30790039|NCT00048581|58803259|FG001|Open-Label Period|Lost to Follow-up|0|||
30790040|NCT00048581|58803260|FG002|Open-Label Period|Lost to Follow-up|14|||
30790041|NCT00048581|58803258|FG000|Open-Label Period|Withdrawal by Subject|0|||
30790042|NCT00048581|58803259|FG001|Open-Label Period|Withdrawal by Subject|0|||
30790043|NCT00048581|58803260|FG002|Open-Label Period|Withdrawal by Subject|20|||
30790044|NCT00048581|58803258|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
30790045|NCT00048581|58803259|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
30790046|NCT00048581|58803260|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
30790047|NCT00048581|58803258|FG000|Open-Label Period|Poor/Non-compliance|0|||
30790048|NCT00048581|58803259|FG001|Open-Label Period|Poor/Non-compliance|0|||
30790049|NCT00048581|58803260|FG002|Open-Label Period|Poor/Non-compliance|5|||
30790050|NCT00048581|58803258|FG000|Open-Label Period|Pregnancy|0|||
30790051|NCT00048581|58803259|FG001|Open-Label Period|Pregnancy|0|||
30790052|NCT00048581|58803260|FG002|Open-Label Period|Pregnancy|7|||
30790053|NCT00048581|58803258|FG000|Open-Label Period|Study Site Closure|0|||
30790054|NCT00048581|58803259|FG001|Open-Label Period|Study Site Closure|0|||
30790055|NCT00048581|58803260|FG002|Open-Label Period|Study Site Closure|2|||
30790056|NCT00048581|58803258|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
30790057|NCT00048581|58803259|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
30790058|NCT00048581|58803260|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
30790059|NCT00048581|58803258|FG000|Open-Label Period|Problem With Transportation To Site|0|||
30790060|NCT00048581|58803259|FG001|Open-Label Period|Problem With Transportation To Site|0|||
30790061|NCT00048581|58803260|FG002|Open-Label Period|Problem With Transportation To Site|1|||
30790062|NCT00048581|58803258|FG000|Open-Label Period|Primary Investigator Retired|0|||
30790063|NCT00048581|58803259|FG001|Open-Label Period|Primary Investigator Retired|0|||
30790064|NCT00048581|58803260|FG002|Open-Label Period|Primary Investigator Retired|2|||
30882354|NCT02497287|58914727|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
30882355|NCT02497287|58914727|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
30882356|NCT02497287|58914727|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
30882357|NCT02497287|58914727|FG000|Induction Phase (4 Weeks)|Other|13|||
30882358|NCT02497287|58914727|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
30882359|NCT02497287|58914727|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
30790065|NCT00048581|58803258|FG000|Open-Label Period|Study Ended By Sponsor|0|||
30790066|NCT00048581|58803259|FG001|Open-Label Period|Study Ended By Sponsor|0|||
30790067|NCT00048581|58803260|FG002|Open-Label Period|Study Ended By Sponsor|1|||
30790068|NCT00048347|58803273|FG000|Overall Study|Screen failure|2|||
30790069|NCT00065507|58803279|FG000|Overall Study|Death|16|||
30790070|NCT00065507|58803280|FG001|Overall Study|Death|17|||
30790071|NCT00065507|58803279|FG000|Overall Study|Adverse Event|4|||
30790072|NCT00065507|58803280|FG001|Overall Study|Adverse Event|3|||
30790073|NCT00065507|58803279|FG000|Overall Study|Lack of Efficacy|0|||
30790074|NCT00065507|58803280|FG001|Overall Study|Lack of Efficacy|6|||
30790075|NCT00065507|58803279|FG000|Overall Study|Poor/Non-compliance|3|||
30790076|NCT00065507|58803280|FG001|Overall Study|Poor/Non-compliance|2|||
30790077|NCT00065507|58803279|FG000|Overall Study|Lost to Follow-up|3|||
30790078|NCT00065507|58803280|FG001|Overall Study|Lost to Follow-up|0|||
30790079|NCT00065507|58803279|FG000|Overall Study|Subject Withdrew Consent|2|||
30790080|NCT00065507|58803280|FG001|Overall Study|Subject Withdrew Consent|1|||
30790081|NCT00065507|58803279|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
30790082|NCT00065507|58803280|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
30790083|NCT00065429|58803297|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
30790084|NCT00065429|58803298|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
30790085|NCT00065429|58803299|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
30790086|NCT00065429|58803300|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
30975569|NCT02605122|59058317|FG001|Overall Study|Withdrawal by Subject|1|||
30975570|NCT02605122|59058316|FG000|Overall Study|Lost to Follow-up|1|||
30975571|NCT02605122|59058317|FG001|Overall Study|Lost to Follow-up|1|||
30975572|NCT01454102|59058368|FG000|Overall Study|Continuing in the treatment period|0|||
30975573|NCT01454102|59058369|FG001|Overall Study|Continuing in the treatment period|0|||
30975574|NCT01454102|59058370|FG002|Overall Study|Continuing in the treatment period|0|||
30975575|NCT01454102|59058371|FG003|Overall Study|Continuing in the treatment period|0|||
30975576|NCT01454102|59058372|FG004|Overall Study|Continuing in the treatment period|3|||
30975577|NCT01454102|59058373|FG005|Overall Study|Continuing in the treatment period|3|||
30975578|NCT01454102|59058374|FG006|Overall Study|Continuing in the treatment period|2|||
30975579|NCT01454102|59058375|FG007|Overall Study|Continuing in the treatment period|0|||
30975580|NCT01454102|59058376|FG008|Overall Study|Continuing in the treatment period|1|||
30975581|NCT01454102|59058377|FG009|Overall Study|Continuing in the treatment period|0|||
30975582|NCT01454102|59058378|FG010|Overall Study|Continuing in the treatment period|0|||
30975583|NCT01454102|59058379|FG011|Overall Study|Continuing in the treatment period|4|||
30975584|NCT01454102|59058380|FG012|Overall Study|Continuing in the treatment period|7|||
30975585|NCT01454102|59058381|FG013|Overall Study|Continuing in the treatment period|4|||
30975586|NCT01454102|59058382|FG014|Overall Study|Continuing in the treatment period|3|||
30975587|NCT01454102|59058383|FG015|Overall Study|Continuing in the treatment period|1|||
30975588|NCT02602080|59058477|FG000|Overall Study|Protocol Violation|6|||
30975589|NCT02602080|59058478|FG001|Overall Study|Protocol Violation|1|||
30975590|NCT02602080|59058479|FG002|Overall Study|Protocol Violation|3|||
30975591|NCT02604342|59058563|FG000|Overall Study|Death|32|||
30975592|NCT02604342|59058564|FG001|Overall Study|Death|16|||
30975593|NCT02604342|59058563|FG000|Overall Study|Progression of disease|1|||
30975594|NCT02604342|59058564|FG001|Overall Study|Progression of disease|0|||
30975595|NCT02604342|59058563|FG000|Overall Study|Withdrawal by Subject|5|||
30975596|NCT02604342|59058564|FG001|Overall Study|Withdrawal by Subject|6|||
30975597|NCT02604342|59058563|FG000|Overall Study|Other|1|||
30975598|NCT02604342|59058564|FG001|Overall Study|Other|0|||
30975599|NCT02604342|59058563|FG000|Overall Study|Study Termination by Sponsor|1|||
30975600|NCT02604342|59058564|FG001|Overall Study|Study Termination by Sponsor|0|||
30975601|NCT02604342|59058563|FG000|Overall Study|Lost to Follow-up|1|||
30975602|NCT02604342|59058564|FG001|Overall Study|Lost to Follow-up|1|||
30790087|NCT00065429|58803301|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
30790088|NCT00065429|58803302|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
30790089|NCT00065429|58803303|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
30790090|NCT00065429|58803297|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
30790091|NCT00065429|58803298|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
30790092|NCT00065429|58803299|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
30790093|NCT00065429|58803300|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
30975603|NCT02604342|59058563|FG000|Overall Study|Physician Decision|2|||
30790094|NCT00065429|58803301|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
30790095|NCT00065429|58803302|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
30790096|NCT00065429|58803303|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
30790097|NCT00065429|58803297|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
30790098|NCT00065429|58803298|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
30790099|NCT00065429|58803299|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
30790100|NCT00065429|58803300|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
30975604|NCT02604342|59058564|FG001|Overall Study|Physician Decision|0|||
30975605|NCT02604264|59058593|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
30975606|NCT02604264|59058594|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
30790101|NCT00065429|58803301|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
30790102|NCT00065429|58803302|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
30790103|NCT00065429|58803303|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
30790104|NCT00065429|58803297|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
30790105|NCT00065429|58803298|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
30790106|NCT00065429|58803299|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
30790107|NCT00065429|58803300|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
30790108|NCT00065429|58803301|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
30790109|NCT00065429|58803302|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
30790110|NCT00065429|58803303|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
30790111|NCT00065429|58803297|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
30790112|NCT00065429|58803298|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
30790113|NCT00065429|58803299|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
30790114|NCT00065429|58803300|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
30790115|NCT00065429|58803301|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
30790116|NCT00065429|58803302|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
30790117|NCT00065429|58803303|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
30790118|NCT00065429|58803297|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
30790119|NCT00065429|58803298|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
30790120|NCT00065429|58803299|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
30790121|NCT00065429|58803300|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
30790122|NCT00065429|58803301|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
30790123|NCT00065429|58803302|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
30790124|NCT00065429|58803303|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
30790125|NCT00065429|58803297|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
30790126|NCT00065429|58803298|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
30790127|NCT00065429|58803299|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
30790128|NCT00065429|58803300|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
30790129|NCT00065429|58803301|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
30790130|NCT00065429|58803302|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
30790131|NCT00065429|58803303|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
30790132|NCT00048035|58803320|FG000|Core Period|Early Withdrawals|4|||
30790133|NCT00048035|58803321|FG001|Core Period|Early Withdrawals|2|||
30882360|NCT02497287|58914727|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
30882361|NCT02497287|58914727|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
30882362|NCT02497287|58914727|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
30882363|NCT02497287|58914727|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
30882364|NCT02497287|58914727|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
30882365|NCT02497287|58914727|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
30882366|NCT02497287|58914727|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
30882367|NCT02497287|58914727|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
30882368|NCT02497287|58914727|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
30882369|NCT02497287|58914727|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
30882370|NCT02497287|58914727|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
30882371|NCT02497287|58914727|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
30882372|NCT02497287|58914727|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
30882373|NCT02497287|58914727|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
30882374|NCT02497287|58914727|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
30882375|NCT02497287|58914727|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
30882376|NCT02497287|58914727|FG000|Follow-up Phase (4 Week)|Other|1|||
30882377|NCT02458287|58914737|FG000|Overall Study|Adverse Event|0|||
30882378|NCT02458287|58914738|FG001|Overall Study|Adverse Event|0|||
30882379|NCT02458287|58914739|FG002|Overall Study|Adverse Event|0|||
30882380|NCT02458287|58914740|FG003|Overall Study|Adverse Event|1|||
30882381|NCT02458287|58914737|FG000|Overall Study|Lost to Follow-up|0|||
30882382|NCT02458287|58914738|FG001|Overall Study|Lost to Follow-up|1|||
30882383|NCT02458287|58914739|FG002|Overall Study|Lost to Follow-up|1|||
30882384|NCT02458287|58914740|FG003|Overall Study|Lost to Follow-up|0|||
30882385|NCT02458287|58914737|FG000|Overall Study|Protocol Violation|0|||
30882386|NCT02458287|58914738|FG001|Overall Study|Protocol Violation|1|||
30882387|NCT02458287|58914739|FG002|Overall Study|Protocol Violation|0|||
30882388|NCT02458287|58914740|FG003|Overall Study|Protocol Violation|0|||
30882389|NCT02458287|58914737|FG000|Overall Study|Withdrawal by Subject|0|||
30882390|NCT02458287|58914738|FG001|Overall Study|Withdrawal by Subject|2|||
30882391|NCT02458287|58914739|FG002|Overall Study|Withdrawal by Subject|2|||
30882392|NCT02458287|58914740|FG003|Overall Study|Withdrawal by Subject|1|||
30882393|NCT02458287|58914737|FG000|Overall Study|Relocated Out of State|0|||
30975607|NCT02601300|59058631|FG000|Induction Phase|Lack of Efficacy|2|||
30975608|NCT02601300|59058631|FG000|Induction Phase|Protocol Violation|1|||
30882394|NCT02458287|58914738|FG001|Overall Study|Relocated Out of State|0|||
30882395|NCT02458287|58914739|FG002|Overall Study|Relocated Out of State|0|||
30975609|NCT02601300|59058631|FG000|Extension Phase|Withdrawal by Subject|3|||
30975610|NCT02601300|59058631|FG000|Extension Phase|Adverse Event|4|||
30882396|NCT02458287|58914740|FG003|Overall Study|Relocated Out of State|1|||
30882397|NCT02441517|58914756|FG000|Overall Study|Lost to Follow-up|1|||
30882398|NCT02441517|58914756|FG000|Overall Study|Withdrawal by Subject|2|||
30882399|NCT02441517|58914756|FG000|Overall Study|Study Terminated by Sponsor|1|||
30882400|NCT02457819|58914760|FG000|Overall Study|reason not given|8|||
30882401|NCT02457819|58914760|FG000|Overall Study|Withdrawal by Subject|24|||
30882402|NCT02457819|58914760|FG000|Overall Study|Protocol Violation|1|||
30882403|NCT02457819|58914760|FG000|Overall Study|non compliance with study drug|4|||
30882404|NCT02457819|58914760|FG000|Overall Study|Lost to Follow-up|10|||
30882405|NCT02457819|58914760|FG000|Overall Study|Lack of Efficacy|19|||
30882406|NCT02457819|58914760|FG000|Overall Study|Adverse Event|33|||
30882407|NCT02496039|58914764|FG000|Overall Study|Adverse Event|3|||
30882408|NCT02496039|58914764|FG000|Overall Study|Protocol Violation|1|||
30882409|NCT02441283|58914768|FG000|Overall Study|Withdrew consent|15|||
30882410|NCT02441283|58914768|FG000|Overall Study|Lost to Follow-up|42|||
30882411|NCT02441283|58914768|FG000|Overall Study|Death|1|||
30882412|NCT02441283|58914768|FG000|Overall Study|Other, not specified|32|||
30882413|NCT02495883|58914774|FG000|Overall Study|Excessive head motion|1|||
30882414|NCT02495883|58914775|FG001|Overall Study|Excessive head motion|0|||
30882415|NCT02495025|58914782|FG000|Overall Study|Lost to Follow-up|21|||
30882416|NCT02495025|58914783|FG001|Overall Study|Lost to Follow-up|14|||
30882417|NCT02495025|58914782|FG000|Overall Study|Withdrawal by Subject|5|||
30882418|NCT02495025|58914783|FG001|Overall Study|Withdrawal by Subject|0|||
30882419|NCT02439957|58914791|FG000|Overall Study|Study Terminated|3|||
30882420|NCT02439957|58914792|FG001|Overall Study|Study Terminated|3|||
30882421|NCT02494401|58914800|FG000|Overall Study|Lost to Follow-up|22|||
30882422|NCT02494401|58914801|FG001|Overall Study|Lost to Follow-up|25|||
30882423|NCT02494401|58914800|FG000|Overall Study|Withdrawal by Subject|3|||
30882424|NCT02494401|58914801|FG001|Overall Study|Withdrawal by Subject|2|||
30882425|NCT02457195|58914807|FG000|Overall Study|Adverse Event|3|||
30882426|NCT02457195|58914807|FG000|Overall Study|Protocol Violation|2|||
30882427|NCT02457195|58914807|FG000|Overall Study|Withdrawal by Subject|4|||
30882428|NCT02456727|58914813|FG000|Overall Study|Lost to Follow-up|63|||
30882429|NCT02456727|58914814|FG001|Overall Study|Lost to Follow-up|65|||
30882430|NCT02456727|58914813|FG000|Overall Study|Death|2|||
30882431|NCT02456727|58914814|FG001|Overall Study|Death|1|||
30882432|NCT02456727|58914813|FG000|Overall Study|Withdrawal by Subject|1|||
30882433|NCT02456727|58914814|FG001|Overall Study|Withdrawal by Subject|10|||
30882434|NCT02456727|58914813|FG000|Overall Study|Never Initiated Treatment|43|||
30882435|NCT02456727|58914814|FG001|Overall Study|Never Initiated Treatment|30|||
30882436|NCT02456103|58914836|FG000|Overall Study|Study Closure|207|||
30882437|NCT02456103|58914836|FG000|Overall Study|Physician Decision|1|||
30882438|NCT02456103|58914836|FG000|Overall Study|Required prohibited medications|5|||
30882439|NCT02456103|58914836|FG000|Overall Study|Protocol Violation|1|||
30882440|NCT02456103|58914836|FG000|Overall Study|Adverse Event|5|||
30882441|NCT02456103|58914836|FG000|Overall Study|Abnormal Laboratory Value|2|||
30882442|NCT02456103|58914836|FG000|Overall Study|Lost to Follow-up|1|||
30882443|NCT02456103|58914836|FG000|Overall Study|Withdrawal by Subject|24|||
30882444|NCT01653327|58914840|FG000|Overall Study|Withdrawal by Subject|1|||
30882445|NCT02493855|58914849|FG000|Overall Study|Non-compliance|1|||
30882446|NCT02493855|58914850|FG001|Overall Study|Non-compliance|0|||
30882447|NCT02493855|58914851|FG002|Overall Study|Non-compliance|0|||
30882448|NCT02493855|58914849|FG000|Overall Study|Adverse Event|0|||
30882449|NCT02493855|58914850|FG001|Overall Study|Adverse Event|1|||
30882450|NCT02493855|58914851|FG002|Overall Study|Adverse Event|0|||
30882451|NCT02493855|58914849|FG000|Overall Study|Withdrawal by Subject|1|||
30882452|NCT02493855|58914850|FG001|Overall Study|Withdrawal by Subject|0|||
30882453|NCT02493855|58914851|FG002|Overall Study|Withdrawal by Subject|0|||
30882454|NCT02438787|58914862|FG000|Overall Study|Adverse Event|1|||
30882455|NCT02438787|58914863|FG001|Overall Study|Adverse Event|0|||
30882456|NCT02438787|58914864|FG002|Overall Study|Adverse Event|2|||
30882457|NCT02438787|58914862|FG000|Overall Study|Lack of Efficacy|1|||
30790134|NCT00048035|58803322|FG002|Core Period|Early Withdrawals|1|||
30882458|NCT02438787|58914863|FG001|Overall Study|Lack of Efficacy|2|||
30882459|NCT02438787|58914864|FG002|Overall Study|Lack of Efficacy|0|||
30882460|NCT02438787|58914862|FG000|Overall Study|Lost to Follow-up|0|||
30882461|NCT02438787|58914863|FG001|Overall Study|Lost to Follow-up|1|||
30882462|NCT02438787|58914864|FG002|Overall Study|Lost to Follow-up|0|||
30882463|NCT02438787|58914862|FG000|Overall Study|Protocol Violation|0|||
30882464|NCT02438787|58914863|FG001|Overall Study|Protocol Violation|0|||
30882465|NCT02438787|58914864|FG002|Overall Study|Protocol Violation|1|||
30882466|NCT02438787|58914862|FG000|Overall Study|Withdrawal by Subject|15|||
30882467|NCT02438787|58914863|FG001|Overall Study|Withdrawal by Subject|7|||
30882468|NCT02438787|58914864|FG002|Overall Study|Withdrawal by Subject|10|||
30882469|NCT02438787|58914862|FG000|Overall Study|Study discontinued by sponsor|64|||
30882470|NCT02438787|58914863|FG001|Overall Study|Study discontinued by sponsor|72|||
30882471|NCT02438787|58914864|FG002|Overall Study|Study discontinued by sponsor|69|||
30882472|NCT02438787|58914862|FG000|Overall Study|Other|0|||
30882473|NCT02438787|58914863|FG001|Overall Study|Other|1|||
30882474|NCT02438787|58914864|FG002|Overall Study|Other|0|||
30882475|NCT02438787|58914862|FG000|Overall Study|Site terminated by sponsor|0|||
30882476|NCT02438787|58914863|FG001|Overall Study|Site terminated by sponsor|0|||
30882477|NCT02438787|58914864|FG002|Overall Study|Site terminated by sponsor|1|||
30882478|NCT02493777|58914879|FG000|Overall Study|Lost to Follow-up|0|||
30882479|NCT02493777|58914880|FG001|Overall Study|Lost to Follow-up|1|||
30882480|NCT02616601|58914889|FG000|Overall Study|Withdrawal by Subject|4|||
30882481|NCT02616601|58914890|FG001|Overall Study|Withdrawal by Subject|4|||
30882482|NCT02616601|58914891|FG002|Overall Study|Withdrawal by Subject|3|||
30882483|NCT02616601|58914889|FG000|Overall Study|Adverse Event|2|||
30882484|NCT02616601|58914890|FG001|Overall Study|Adverse Event|0|||
30882485|NCT02616601|58914891|FG002|Overall Study|Adverse Event|2|||
30882486|NCT02616601|58914889|FG000|Overall Study|Death|1|||
30882487|NCT02616601|58914890|FG001|Overall Study|Death|0|||
30882488|NCT02616601|58914891|FG002|Overall Study|Death|0|||
30882489|NCT02616601|58914889|FG000|Overall Study|Lost to Follow-up|1|||
30882490|NCT02616601|58914890|FG001|Overall Study|Lost to Follow-up|0|||
30882491|NCT02616601|58914891|FG002|Overall Study|Lost to Follow-up|1|||
30882492|NCT02616601|58914889|FG000|Overall Study|Non-Compliance with Test Article|1|||
30882493|NCT02616601|58914890|FG001|Overall Study|Non-Compliance with Test Article|0|||
30882494|NCT02616601|58914891|FG002|Overall Study|Non-Compliance with Test Article|1|||
30882495|NCT02492997|58914901|FG000|Overall Study|Withdrawal by Subject|1|||
30882496|NCT02492997|58914902|FG001|Overall Study|Withdrawal by Subject|0|||
30882497|NCT02492997|58914901|FG000|Overall Study|Gained Weight|1|||
30882498|NCT02492997|58914902|FG001|Overall Study|Gained Weight|0|||
30882499|NCT02492997|58914901|FG000|Overall Study|Lost to Follow-up|0|||
30882500|NCT02492997|58914902|FG001|Overall Study|Lost to Follow-up|1|||
30882501|NCT02437305|58914910|FG000|Overall Study|Lost to Follow-up|18|||
30882502|NCT02437305|58914911|FG001|Overall Study|Lost to Follow-up|12|||
30882503|NCT02492841|58914920|FG000|Overall Study|Lost to Follow-up|34|||
30882504|NCT02492841|58914921|FG001|Overall Study|Lost to Follow-up|31|||
30882505|NCT02492841|58914922|FG002|Overall Study|Lost to Follow-up|35|||
30882506|NCT02436915|58914935|FG000|Overall Study|Withdrawal by Subject|0|||
30882507|NCT02436915|58914936|FG001|Overall Study|Withdrawal by Subject|1|||
30882508|NCT02492763|58914948|FG000|Overall Study|Withdrawal by Subject|0|||
30882509|NCT02492763|58914949|FG001|Overall Study|Withdrawal by Subject|2|||
30882510|NCT02492763|58914950|FG002|Overall Study|Withdrawal by Subject|1|||
30882511|NCT02492763|58914951|FG003|Overall Study|Withdrawal by Subject|0|||
30882512|NCT02492763|58914948|FG000|Overall Study|Adverse Event|3|||
30882513|NCT02492763|58914949|FG001|Overall Study|Adverse Event|1|||
30882514|NCT02492763|58914950|FG002|Overall Study|Adverse Event|1|||
30882515|NCT02492763|58914951|FG003|Overall Study|Adverse Event|2|||
30882516|NCT02492763|58914948|FG000|Overall Study|Death|0|||
30882517|NCT02492763|58914949|FG001|Overall Study|Death|0|||
30882518|NCT02492763|58914950|FG002|Overall Study|Death|1|||
30882519|NCT02492763|58914951|FG003|Overall Study|Death|0|||
30882520|NCT02492763|58914948|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
30882521|NCT02492763|58914949|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
30882522|NCT02492763|58914950|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
30882523|NCT02492763|58914951|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
30882524|NCT02492763|58914948|FG000|Overall Study|Lost to Follow-up|0|||
30882525|NCT02492763|58914949|FG001|Overall Study|Lost to Follow-up|0|||
30882526|NCT02492763|58914950|FG002|Overall Study|Lost to Follow-up|1|||
30882527|NCT02492763|58914951|FG003|Overall Study|Lost to Follow-up|0|||
30882528|NCT02492763|58914948|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30882529|NCT02492763|58914949|FG001|Overall Study|Non-Compliance With Study Drug|1|||
30882530|NCT02492763|58914950|FG002|Overall Study|Non-Compliance With Study Drug|0|||
30882531|NCT02492763|58914951|FG003|Overall Study|Non-Compliance With Study Drug|0|||
30882532|NCT02492763|58914948|FG000|Overall Study|Screen Failure|0|||
30882533|NCT02492763|58914949|FG001|Overall Study|Screen Failure|0|||
30882534|NCT02492763|58914950|FG002|Overall Study|Screen Failure|0|||
30975611|NCT02601300|59058631|FG000|Extension Phase|Lack of Efficacy|10|||
30882535|NCT02492763|58914951|FG003|Overall Study|Screen Failure|1|||
30975612|NCT01471340|59058670|FG000|Overall Study|Death|5|||
30975613|NCT01471340|59058671|FG001|Overall Study|Death|4|||
30882536|NCT02492763|58914948|FG000|Overall Study|Study Terminated by Sponsor|13|||
30882537|NCT02492763|58914949|FG001|Overall Study|Study Terminated by Sponsor|10|||
30882538|NCT02492763|58914950|FG002|Overall Study|Study Terminated by Sponsor|6|||
30882539|NCT02492763|58914951|FG003|Overall Study|Study Terminated by Sponsor|10|||
30882540|NCT02491671|58914963|FG000|Overall Study|Adverse Event|6|||
30882541|NCT02491671|58914964|FG001|Overall Study|Adverse Event|8|||
30882542|NCT02491671|58914963|FG000|Overall Study|Death|0|||
30882543|NCT02491671|58914964|FG001|Overall Study|Death|2|||
30882544|NCT02491671|58914963|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
30882545|NCT02491671|58914964|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
30882546|NCT02453841|58914970|FG000|Overall Study|Protocol Violation|1|||
30882547|NCT02453841|58914970|FG000|Overall Study|Unable to obtain blood samples|2|||
30975614|NCT01471340|59058670|FG000|Overall Study|Lost to Follow-up|0|||
30882548|NCT02453685|58914976|FG000|Overall Study|Adverse Event|0|||
30882549|NCT02453685|58914977|FG001|Overall Study|Adverse Event|1|||
30882550|NCT02453685|58914976|FG000|Overall Study|Protocol Violation|7|||
30882551|NCT02453685|58914977|FG001|Overall Study|Protocol Violation|4|||
30882552|NCT02453685|58914976|FG000|Overall Study|Lost to Follow-up|0|||
30882553|NCT02453685|58914977|FG001|Overall Study|Lost to Follow-up|1|||
30882554|NCT02453685|58914976|FG000|Overall Study|Withdrawal by Subject|8|||
30882555|NCT02453685|58914977|FG001|Overall Study|Withdrawal by Subject|4|||
30882556|NCT02453685|58914976|FG000|Overall Study|Unclassified|4|||
30882557|NCT02453685|58914977|FG001|Overall Study|Unclassified|2|||
30882558|NCT02436759|58914985|FG000|Overall Study|Adverse Event|3|||
30882559|NCT02436759|58914986|FG001|Overall Study|Adverse Event|0|||
30882560|NCT02436759|58914985|FG000|Overall Study|Protocol Violation|1|||
30882561|NCT02436759|58914986|FG001|Overall Study|Protocol Violation|0|||
30882562|NCT02436759|58914985|FG000|Overall Study|Withdrawal by Subject|0|||
30882563|NCT02436759|58914986|FG001|Overall Study|Withdrawal by Subject|1|||
30882564|NCT02436681|58914992|FG000|Overall Study|Lost to Follow-up|10|||
30882565|NCT02436681|58914992|FG000|Overall Study|Withdrawal by Subject|2|||
30882566|NCT02436681|58914992|FG000|Overall Study|Death|2|||
30882567|NCT02436135|58914998|FG000|Overall Study|Progressive Disease|3|||
30882568|NCT02436135|58914999|FG001|Overall Study|Progressive Disease|1|||
30882569|NCT02436135|58914998|FG000|Overall Study|Investigator Discretion|1|||
30882570|NCT02436135|58914999|FG001|Overall Study|Investigator Discretion|2|||
30882571|NCT02436135|58914998|FG000|Overall Study|Adverse Event|1|||
30882572|NCT02436135|58914999|FG001|Overall Study|Adverse Event|0|||
30882573|NCT02436135|58914998|FG000|Overall Study|Withdrawal by Participant|1|||
30882574|NCT02436135|58914999|FG001|Overall Study|Withdrawal by Participant|0|||
30882575|NCT02436135|58914998|FG000|Overall Study|Study Terminated By Sponsor|0|||
30882576|NCT02436135|58914999|FG001|Overall Study|Study Terminated By Sponsor|1|||
30882577|NCT02489799|58915007|FG000|Overall Study|Lost to Follow-up|4|||
30882578|NCT02489799|58915008|FG001|Overall Study|Lost to Follow-up|1|||
30882579|NCT02489799|58915007|FG000|Overall Study|Failure to Maintain Eligibility|4|||
30882580|NCT02489799|58915008|FG001|Overall Study|Failure to Maintain Eligibility|6|||
30882581|NCT02489799|58915007|FG000|Overall Study|Withdrawal by Subject|1|||
30882582|NCT02489799|58915008|FG001|Overall Study|Withdrawal by Subject|1|||
30882583|NCT02489799|58915007|FG000|Overall Study|Death|0|||
30882584|NCT02489799|58915008|FG001|Overall Study|Death|1|||
30882585|NCT02435277|58915018|FG000|Overall Study|Adverse Event|1|||
30882586|NCT02435277|58915019|FG001|Overall Study|Adverse Event|1|||
30882587|NCT02435277|58915020|FG002|Overall Study|Adverse Event|0|||
30882588|NCT02435277|58915021|FG003|Overall Study|Adverse Event|0|||
30882589|NCT02435277|58915018|FG000|Overall Study|Withdrawal by Subject|1|||
30882590|NCT02435277|58915019|FG001|Overall Study|Withdrawal by Subject|0|||
30882591|NCT02435277|58915020|FG002|Overall Study|Withdrawal by Subject|0|||
30882592|NCT02435277|58915021|FG003|Overall Study|Withdrawal by Subject|0|||
30882593|NCT02420223|58915033|FG000|Overall Study|Adverse Event|1|||
30882594|NCT02420223|58915034|FG001|Overall Study|Adverse Event|0|||
30882595|NCT02420223|58915033|FG000|Overall Study|Physician Decision|0|||
30882596|NCT02420223|58915034|FG001|Overall Study|Physician Decision|2|||
30882597|NCT02433483|58915040|FG000|Overall Study|Unacceptable toxicity|1|||
30882598|NCT02433483|58915040|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
30882599|NCT02419755|58915046|FG000|Overall Study|Death|1|||
30882600|NCT02419755|58915047|FG001|Overall Study|Death|3|||
30882601|NCT02419755|58915046|FG000|Overall Study|Relapse|0|||
30882602|NCT02419755|58915047|FG001|Overall Study|Relapse|1|||
30882603|NCT02419755|58915046|FG000|Overall Study|Ineligible|1|||
30882604|NCT02419755|58915047|FG001|Overall Study|Ineligible|0|||
30882605|NCT02419755|58915046|FG000|Overall Study|Withdrawal by Subject|1|||
30882606|NCT02419755|58915047|FG001|Overall Study|Withdrawal by Subject|0|||
30882607|NCT02488551|58915057|FG000|Overall Study|Lost to Follow-up|4|||
30882608|NCT02488551|58915058|FG001|Overall Study|Lost to Follow-up|7|||
30882609|NCT02488551|58915059|FG002|Overall Study|Lost to Follow-up|0|||
30882610|NCT02488551|58915060|FG003|Overall Study|Lost to Follow-up|0|||
30882611|NCT02488551|58915057|FG000|Overall Study|Military Deployment|1|||
30882612|NCT02488551|58915058|FG001|Overall Study|Military Deployment|1|||
30882613|NCT02488551|58915059|FG002|Overall Study|Military Deployment|0|||
30975615|NCT01471340|59058671|FG001|Overall Study|Lost to Follow-up|1|||
30975616|NCT01471340|59058670|FG000|Overall Study|Investigational site closure|0|||
30882614|NCT02488551|58915060|FG003|Overall Study|Military Deployment|0|||
30882615|NCT02488239|58915070|FG000|Overall Study|Death|3|||
30882616|NCT02488239|58915070|FG000|Overall Study|Withdrawal by Subject|3|||
30882617|NCT02488239|58915070|FG000|Overall Study|Physician Decision|2|||
30882618|NCT02488239|58915070|FG000|Overall Study|Consent ineligible|1|||
30882619|NCT02488239|58915070|FG000|Overall Study|Did not undergo implant procedure|1|||
30882620|NCT02488005|58915075|FG000|Overall Study|Lost to Follow-up|2|||
30882621|NCT02487771|58915081|FG000|Overall Study|Lost to Follow-up|2|||
30882622|NCT02487771|58915082|FG001|Overall Study|Lost to Follow-up|3|||
30882623|NCT02487771|58915081|FG000|Overall Study|Moved out of area|5|||
30882624|NCT02487771|58915082|FG001|Overall Study|Moved out of area|6|||
30882625|NCT02487771|58915081|FG000|Overall Study|Withdrawal by Subject|3|||
30882626|NCT02487771|58915082|FG001|Overall Study|Withdrawal by Subject|5|||
30882627|NCT01359943|58915091|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
30882628|NCT01359943|58915092|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
30882629|NCT01359943|58915093|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
30882630|NCT01359943|58915091|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
30882631|NCT01359943|58915092|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
30882632|NCT01359943|58915093|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
30882633|NCT01359943|58915091|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
30882634|NCT01359943|58915092|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
30882635|NCT01359943|58915093|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
30882636|NCT01359943|58915091|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
30882637|NCT01359943|58915092|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
30882638|NCT01359943|58915093|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
30882639|NCT01359943|58915091|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
30882640|NCT01359943|58915092|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
30882641|NCT01359943|58915093|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
30882642|NCT01359943|58915091|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
30882643|NCT01359943|58915092|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
30882644|NCT01359943|58915093|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
30882645|NCT01359943|58915091|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
30882646|NCT01359943|58915092|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
30882647|NCT01359943|58915093|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
30882648|NCT01359943|58915091|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
30882649|NCT01359943|58915092|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
30882650|NCT01359943|58915093|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
30882651|NCT01359943|58915091|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
30882652|NCT01359943|58915092|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
30882653|NCT01359943|58915093|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
30882654|NCT01359943|58915091|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
30882655|NCT01359943|58915092|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
30882656|NCT01359943|58915093|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
30882657|NCT01359943|58915091|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
30882658|NCT01359943|58915092|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
30882659|NCT01359943|58915093|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
30882660|NCT01359943|58915091|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
30882661|NCT01359943|58915092|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
30882662|NCT01359943|58915093|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
30882663|NCT01359943|58915091|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
30882664|NCT01359943|58915092|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
30882665|NCT01359943|58915093|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
30882666|NCT01359943|58915091|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
30882667|NCT01359943|58915092|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
30882668|NCT01359943|58915093|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
30882669|NCT01359943|58915091|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
30882670|NCT01359943|58915092|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
30882671|NCT01359943|58915093|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
30882672|NCT02432703|58915105|FG000|Overall Study|Adverse Event|1|||
30882673|NCT02432703|58915106|FG001|Overall Study|Adverse Event|4|||
30882674|NCT02432703|58915105|FG000|Overall Study|Lack of Efficacy|1|||
30882675|NCT02432703|58915106|FG001|Overall Study|Lack of Efficacy|0|||
30882676|NCT02432703|58915105|FG000|Overall Study|Lost to Follow-up|5|||
30882677|NCT02432703|58915106|FG001|Overall Study|Lost to Follow-up|3|||
30882678|NCT02432703|58915105|FG000|Overall Study|Withdrawal by Subject|9|||
30882679|NCT02432703|58915106|FG001|Overall Study|Withdrawal by Subject|6|||
30882680|NCT02432703|58915105|FG000|Overall Study|Other|6|||
30882681|NCT02432703|58915106|FG001|Overall Study|Other|5|||
30882682|NCT02486757|58915112|FG000|Overall Study|Lost to Follow-up|1|||
30882683|NCT02418819|58915120|FG000|Overall Study|Adverse Event|0|||
30882684|NCT02418819|58915121|FG001|Overall Study|Adverse Event|0|||
30882685|NCT02418819|58915122|FG002|Overall Study|Adverse Event|1|||
30882686|NCT02418819|58915123|FG003|Overall Study|Adverse Event|0|||
30882687|NCT02418819|58915120|FG000|Overall Study|Lost to Follow-up|1|||
30882688|NCT02418819|58915121|FG001|Overall Study|Lost to Follow-up|0|||
30882689|NCT02418819|58915122|FG002|Overall Study|Lost to Follow-up|0|||
30882690|NCT02418819|58915123|FG003|Overall Study|Lost to Follow-up|0|||
30882691|NCT02418819|58915120|FG000|Overall Study|No longer meets eligibility criteria|0|||
30882692|NCT02418819|58915121|FG001|Overall Study|No longer meets eligibility criteria|0|||
30975617|NCT01471340|59058671|FG001|Overall Study|Investigational site closure|1|||
30975618|NCT01471340|59058670|FG000|Overall Study|Invalid informed consent|1|||
30790135|NCT00048035|58803323|FG003|Core Period|Early Withdrawals|1|||
30882693|NCT02418819|58915122|FG002|Overall Study|No longer meets eligibility criteria|1|||
30882694|NCT02418819|58915123|FG003|Overall Study|No longer meets eligibility criteria|0|||
30882695|NCT02418819|58915120|FG000|Overall Study|No longer willing to participate|0|||
30882696|NCT02418819|58915121|FG001|Overall Study|No longer willing to participate|0|||
30882697|NCT02418819|58915122|FG002|Overall Study|No longer willing to participate|2|||
30882698|NCT02418819|58915123|FG003|Overall Study|No longer willing to participate|1|||
30882699|NCT02576639|58915138|FG000|Overall Study|Withdrawal by Subject|1|||
30882700|NCT02576639|58915139|FG001|Overall Study|Withdrawal by Subject|2|||
30882701|NCT02576639|58915140|FG002|Overall Study|Withdrawal by Subject|1|||
30882702|NCT02576639|58915141|FG003|Overall Study|Withdrawal by Subject|0|||
30882703|NCT02576639|58915142|FG004|Overall Study|Withdrawal by Subject|1|||
30882704|NCT02576639|58915138|FG000|Overall Study|Adverse Event|1|||
30882705|NCT02576639|58915139|FG001|Overall Study|Adverse Event|0|||
30882706|NCT02576639|58915140|FG002|Overall Study|Adverse Event|1|||
30882707|NCT02576639|58915141|FG003|Overall Study|Adverse Event|1|||
30882708|NCT02576639|58915142|FG004|Overall Study|Adverse Event|2|||
30882709|NCT02576639|58915138|FG000|Overall Study|Physician Decision|0|||
30882710|NCT02576639|58915139|FG001|Overall Study|Physician Decision|0|||
30882711|NCT02576639|58915140|FG002|Overall Study|Physician Decision|0|||
30882712|NCT02576639|58915141|FG003|Overall Study|Physician Decision|0|||
30882713|NCT02576639|58915142|FG004|Overall Study|Physician Decision|1|||
30882714|NCT02418585|58915160|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
30882715|NCT02418585|58915161|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
30882716|NCT02418585|58915160|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
30882717|NCT02418585|58915161|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
30882718|NCT02418585|58915160|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
30882719|NCT02418585|58915161|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
30882720|NCT02418585|58915160|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
30882721|NCT02418585|58915161|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
30882722|NCT02418585|58915160|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
30882723|NCT02418585|58915161|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
30882724|NCT02418585|58915160|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
30882725|NCT02418585|58915161|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
30882726|NCT02418585|58915160|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
30882727|NCT02418585|58915161|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
30882728|NCT02418585|58915160|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
30882729|NCT02418585|58915161|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
30882730|NCT02418585|58915160|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
30882731|NCT02418585|58915161|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
30882732|NCT02418585|58915160|FG000|Follow-up Phase (24 Weeks)|Other|3|||
30882733|NCT02418585|58915161|FG001|Follow-up Phase (24 Weeks)|Other|2|||
30882734|NCT02417961|58915169|FG000|Overall Study|Adverse Event|1|||
30882735|NCT02417961|58915169|FG000|Overall Study|Lost to Follow-up|1|||
30882736|NCT02417961|58915169|FG000|Overall Study|Withdrawal by Subject|2|||
30882737|NCT01596127|58915173|FG000|Overall Study|Patient Ineligible|1|||
30882738|NCT01595581|58915179|FG000|Overall Study|Withdrawal by Subject|1|||
30882739|NCT01595581|58915180|FG001|Overall Study|Withdrawal by Subject|0|||
30882740|NCT01610687|58915188|FG000|Overall Study|Lack of Efficacy|26|||
30882741|NCT01610687|58915188|FG000|Overall Study|Adverse Event|18|||
30882742|NCT01610687|58915188|FG000|Overall Study|Moved out of area|6|||
30882743|NCT01610687|58915188|FG000|Overall Study|Withdrawal by Subject|7|||
30882744|NCT01610687|58915188|FG000|Overall Study|Lost to Follow-up|4|||
30882745|NCT01610687|58915188|FG000|Overall Study|Symptom control without study medication|2|||
30882746|NCT01610687|58915188|FG000|Overall Study|Unable to make journey|1|||
30882747|NCT01610687|58915188|FG000|Overall Study|Death|1|||
30882748|NCT01610687|58915188|FG000|Overall Study|Cannabis affecting job|1|||
30882749|NCT01610687|58915188|FG000|Overall Study|Felt more alter without study medication|1|||
30882750|NCT02615509|58915192|FG000|Overall Study|Lost to Follow-up|134|||
30882751|NCT02615509|58915192|FG000|Overall Study|Death|4|||
30975619|NCT01471340|59058671|FG001|Overall Study|Invalid informed consent|0|||
30975620|NCT01492400|59058693|FG000|Overall Study|Miscellaneous Reasons|2|||
30975621|NCT01492400|59058694|FG001|Overall Study|Miscellaneous Reasons|3|||
30975622|NCT01492400|59058693|FG000|Overall Study|Personal Reasons|0|||
30975623|NCT01492400|59058694|FG001|Overall Study|Personal Reasons|5|||
30975624|NCT01492400|59058693|FG000|Overall Study|Lost to Follow-up|3|||
30975625|NCT01492400|59058694|FG001|Overall Study|Lost to Follow-up|1|||
30975626|NCT01492400|59058693|FG000|Overall Study|Pregnancy|0|||
30975627|NCT01492400|59058694|FG001|Overall Study|Pregnancy|1|||
30975628|NCT01492400|59058693|FG000|Overall Study|Lack of Efficacy|1|||
30882752|NCT02615509|58915192|FG000|Overall Study|Withdrawal by Subject|8|||
30975629|NCT01492400|59058694|FG001|Overall Study|Lack of Efficacy|1|||
30882753|NCT02575079|58915198|FG000|Overall Study|Death|3|||
30975630|NCT01492400|59058693|FG000|Overall Study|Adverse Event|10|||
30975631|NCT01492400|59058694|FG001|Overall Study|Adverse Event|5|||
30975632|NCT02596854|59058819|FG000|Overall Study|Withdrawn|8|||
30882754|NCT02575079|58915199|FG001|Overall Study|Death|0|||
30882755|NCT02575079|58915198|FG000|Overall Study|Withdrawal by Subject|3|||
30882756|NCT02575079|58915199|FG001|Overall Study|Withdrawal by Subject|0|||
30882757|NCT02574845|58915210|FG000|Overall Study|Consent withdrawn further participation|0|||
30882758|NCT02574845|58915211|FG001|Overall Study|Consent withdrawn further participation|0|||
30882759|NCT02574845|58915212|FG002|Overall Study|Consent withdrawn further participation|0|||
30882760|NCT02574845|58915213|FG003|Overall Study|Consent withdrawn further participation|0|||
30882761|NCT02574845|58915214|FG004|Overall Study|Consent withdrawn further participation|1|||
30882762|NCT02574845|58915215|FG005|Overall Study|Consent withdrawn further participation|0|||
30882763|NCT02574845|58915210|FG000|Overall Study|Adverse Event|0|||
30882764|NCT02574845|58915211|FG001|Overall Study|Adverse Event|1|||
30882765|NCT02574845|58915212|FG002|Overall Study|Adverse Event|0|||
30882766|NCT02574845|58915213|FG003|Overall Study|Adverse Event|0|||
30882767|NCT02574845|58915214|FG004|Overall Study|Adverse Event|0|||
30882768|NCT02574845|58915215|FG005|Overall Study|Adverse Event|1|||
30882769|NCT02614183|58915232|FG000|Double Blind Treatment Phase|Adverse Event|10|||
30882770|NCT02614183|58915233|FG001|Double Blind Treatment Phase|Adverse Event|9|||
30882771|NCT02614183|58915234|FG002|Double Blind Treatment Phase|Adverse Event|7|||
30882772|NCT02614183|58915232|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
30882773|NCT02614183|58915233|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
30882774|NCT02614183|58915234|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
30882775|NCT02614183|58915232|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
30882776|NCT02614183|58915233|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
30882777|NCT02614183|58915234|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
30882778|NCT02614183|58915232|FG000|Double Blind Treatment Phase|Physician Decision|7|||
30882779|NCT02614183|58915233|FG001|Double Blind Treatment Phase|Physician Decision|3|||
30882780|NCT02614183|58915234|FG002|Double Blind Treatment Phase|Physician Decision|2|||
30882781|NCT02614183|58915232|FG000|Double Blind Treatment Phase|Pregnancy|2|||
30882782|NCT02614183|58915233|FG001|Double Blind Treatment Phase|Pregnancy|1|||
30882783|NCT02614183|58915234|FG002|Double Blind Treatment Phase|Pregnancy|3|||
30882784|NCT02614183|58915232|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
30882785|NCT02614183|58915233|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
30975633|NCT02592876|59058956|FG000|Overall Study|Withdrawal by Subject|3|||
30975634|NCT02592876|59058957|FG001|Overall Study|Withdrawal by Subject|3|||
30975635|NCT02592876|59058956|FG000|Overall Study|Study Termination by Sponsor|32|||
30975636|NCT02592876|59058957|FG001|Overall Study|Study Termination by Sponsor|27|||
30975637|NCT02592876|59058956|FG000|Overall Study|Lost to Follow-up|0|||
30975638|NCT02592876|59058957|FG001|Overall Study|Lost to Follow-up|1|||
30975639|NCT02592876|59058956|FG000|Overall Study|Death|6|||
30975640|NCT02592876|59058957|FG001|Overall Study|Death|9|||
30975641|NCT01492088|59058974|FG000|Overall Study|Withdrawal by Patient|0|||
30975642|NCT01492088|59058975|FG001|Overall Study|Withdrawal by Patient|2|||
30975643|NCT01492088|59058976|FG002|Overall Study|Withdrawal by Patient|0|||
30975644|NCT01492088|59058974|FG000|Overall Study|Death|1|||
30975645|NCT01492088|59058975|FG001|Overall Study|Death|6|||
30975646|NCT01492088|59058976|FG002|Overall Study|Death|2|||
30975647|NCT01492088|59058974|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
30975648|NCT01492088|59058975|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
30882786|NCT02614183|58915234|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
30882787|NCT02614183|58915232|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
30882788|NCT02614183|58915233|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
30882789|NCT02614183|58915234|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
30882790|NCT02614183|58915232|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
30882791|NCT02614183|58915233|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
30882792|NCT02614183|58915234|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
30882793|NCT02614183|58915232|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
30882794|NCT02614183|58915233|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
30882795|NCT02614183|58915234|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
30882796|NCT02614183|58915232|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
30882797|NCT02614183|58915233|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
30882798|NCT02614183|58915234|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
30882799|NCT02614183|58915232|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
30882800|NCT02614183|58915233|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
30882801|NCT02614183|58915234|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
30975649|NCT01492088|59058976|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
30790136|NCT00048035|58803324|FG004|Core Period|Early Withdrawals|1|||
30882802|NCT02614183|58915232|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
30882803|NCT02614183|58915233|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
30882804|NCT02614183|58915234|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
30975650|NCT01492088|59058974|FG000|Overall Study|Alive at Last Follow-up|0|||
30975651|NCT01492088|59058975|FG001|Overall Study|Alive at Last Follow-up|6|||
30975652|NCT01492088|59058976|FG002|Overall Study|Alive at Last Follow-up|11|||
30882805|NCT02612155|58915259|FG000|Overall Study|Death|1|||
30882806|NCT02612155|58915260|FG001|Overall Study|Death|1|||
30882807|NCT02612155|58915259|FG000|Overall Study|Lost to Follow-up|2|||
30882808|NCT02612155|58915260|FG001|Overall Study|Lost to Follow-up|2|||
30882809|NCT02614729|58915268|FG000|Overall Study|Withdrawal by Subject|1|||
30882810|NCT02614729|58915269|FG001|Overall Study|Withdrawal by Subject|0|||
30882811|NCT02613871|58915277|FG000|Overall Study|Death|2|||
30882812|NCT02613871|58915277|FG000|Overall Study|Withdrew Consent|1|||
30882813|NCT05021081|58915283|FG000|Phase 2|Subject enrolled in error|1|||
30882814|NCT05021081|58915284|FG001|Phase 2|Subject enrolled in error|1|||
30882815|NCT05021081|58915285|FG002|Phase 2|Subject enrolled in error|0|||
30882816|NCT02612077|58915301|FG000|Overall Study|Adverse Event|3|||
30882817|NCT02612077|58915301|FG000|Overall Study|Withdrawal by Subject|9|||
30882818|NCT02612077|58915301|FG000|Overall Study|Protocol Violation|28|||
30882819|NCT02612077|58915301|FG000|Overall Study|Lost to Follow-up|20|||
30882820|NCT02612077|58915301|FG000|Overall Study|Death|377|||
30882821|NCT02612077|58915301|FG000|Overall Study|Moved or Changed Medical Team|23|||
30882822|NCT02612077|58915301|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
30882823|NCT02612077|58915301|FG000|Overall Study|Disease Progression|3|||
30882824|NCT02612077|58915301|FG000|Overall Study|Unknown reason|2|||
30882825|NCT02613481|58915308|FG000|Overall Study|Lost to Follow-up|7|||
30882826|NCT02613481|58915308|FG000|Overall Study|Withdrawal by Subject|2|||
30882827|NCT02613403|58915316|FG000|Overall Study|Lost to Follow-up|0|||
30882828|NCT02613403|58915317|FG001|Overall Study|Lost to Follow-up|1|||
30882829|NCT02613403|58915318|FG002|Overall Study|Lost to Follow-up|0|||
30882830|NCT02613403|58915319|FG003|Overall Study|Lost to Follow-up|0|||
30882831|NCT02613403|58915320|FG004|Overall Study|Lost to Follow-up|0|||
30882832|NCT02613403|58915316|FG000|Overall Study|Withdrawal by Subject|2|||
30882833|NCT02613403|58915317|FG001|Overall Study|Withdrawal by Subject|0|||
30882834|NCT02613403|58915318|FG002|Overall Study|Withdrawal by Subject|0|||
30882835|NCT02613403|58915319|FG003|Overall Study|Withdrawal by Subject|0|||
30882836|NCT02613403|58915320|FG004|Overall Study|Withdrawal by Subject|0|||
30882837|NCT02572817|58915332|FG000|Overall Study|Death|6|||
30882838|NCT02572817|58915333|FG001|Overall Study|Death|3|||
30882839|NCT02572817|58915332|FG000|Overall Study|Lost to Follow-up|3|||
30882840|NCT02572817|58915333|FG001|Overall Study|Lost to Follow-up|3|||
30882841|NCT02566109|58915339|FG000|Overall Study|Withdrawal by Subject|1|||
30882842|NCT02566031|58915345|FG000|Overall Study|Patient/guardian decision|14|||
30882843|NCT02566031|58915346|FG001|Overall Study|Patient/guardian decision|7|||
30882844|NCT02566031|58915345|FG000|Overall Study|Protocol deviation|2|||
30882845|NCT02566031|58915346|FG001|Overall Study|Protocol deviation|3|||
30882846|NCT02566031|58915345|FG000|Overall Study|Adverse Event|3|||
30882847|NCT02566031|58915346|FG001|Overall Study|Adverse Event|1|||
30882848|NCT02566031|58915345|FG000|Overall Study|Lost to Follow-up|1|||
30882849|NCT02566031|58915346|FG001|Overall Study|Lost to Follow-up|1|||
30882850|NCT02569853|58915355|FG000|Overall Study|Adverse Event|2|||
30882851|NCT02569853|58915356|FG001|Overall Study|Adverse Event|0|||
30882852|NCT02569853|58915355|FG000|Overall Study|Withdrawal by Subject|3|||
30882853|NCT02569853|58915356|FG001|Overall Study|Withdrawal by Subject|2|||
30882854|NCT02569853|58915355|FG000|Overall Study|Lost to Follow-up|3|||
30882855|NCT02569853|58915356|FG001|Overall Study|Lost to Follow-up|3|||
30882856|NCT02569853|58915355|FG000|Overall Study|Protocol Violation|1|||
30882857|NCT02569853|58915356|FG001|Overall Study|Protocol Violation|1|||
30882858|NCT02569853|58915355|FG000|Overall Study|Did not experience migraine attack|10|||
30882859|NCT02569853|58915356|FG001|Overall Study|Did not experience migraine attack|7|||
30882860|NCT02569853|58915355|FG000|Overall Study|Physician Decision|1|||
30882861|NCT02569853|58915356|FG001|Overall Study|Physician Decision|1|||
30882862|NCT02570711|58915366|FG000|Overall Study|Death|1|||
30882863|NCT02570711|58915367|FG001|Overall Study|Death|0|||
30882864|NCT02570711|58915366|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
30882865|NCT02570711|58915367|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
30882866|NCT02570165|58915380|FG000|Overall Study|Adverse Event|1|||
30882867|NCT02570165|58915381|FG001|Overall Study|Adverse Event|0|||
30882868|NCT02570165|58915382|FG002|Overall Study|Adverse Event|2|||
30882869|NCT02570165|58915383|FG003|Overall Study|Adverse Event|0|||
30975653|NCT02592798|59059218|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
30975654|NCT02592798|59059219|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
30882870|NCT02570165|58915384|FG004|Overall Study|Adverse Event|0|||
30882871|NCT02570165|58915385|FG005|Overall Study|Adverse Event|0|||
30882872|NCT02570165|58915386|FG006|Overall Study|Adverse Event|0|||
30882873|NCT02570165|58915380|FG000|Overall Study|Lack of Efficacy|0|||
30882874|NCT02570165|58915381|FG001|Overall Study|Lack of Efficacy|1|||
30882875|NCT02570165|58915382|FG002|Overall Study|Lack of Efficacy|0|||
30882876|NCT02570165|58915383|FG003|Overall Study|Lack of Efficacy|0|||
30975655|NCT02592798|59059218|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
30882877|NCT02570165|58915384|FG004|Overall Study|Lack of Efficacy|4|||
30882878|NCT02570165|58915385|FG005|Overall Study|Lack of Efficacy|0|||
30882879|NCT02570165|58915386|FG006|Overall Study|Lack of Efficacy|0|||
30882880|NCT02570165|58915380|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
30882881|NCT02570165|58915381|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
30882882|NCT02570165|58915382|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
30882883|NCT02570165|58915383|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
30882884|NCT02570165|58915384|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
30882885|NCT02570165|58915385|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
30882886|NCT02570165|58915386|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
30882887|NCT02570165|58915380|FG000|Overall Study|Lost to Follow-up|0|||
30882888|NCT02570165|58915381|FG001|Overall Study|Lost to Follow-up|0|||
30882889|NCT02570165|58915382|FG002|Overall Study|Lost to Follow-up|1|||
30882890|NCT02570165|58915383|FG003|Overall Study|Lost to Follow-up|1|||
30882891|NCT02570165|58915384|FG004|Overall Study|Lost to Follow-up|0|||
30882892|NCT02570165|58915385|FG005|Overall Study|Lost to Follow-up|0|||
30882893|NCT02570165|58915386|FG006|Overall Study|Lost to Follow-up|0|||
30882894|NCT02570165|58915380|FG000|Overall Study|Physician Decision|0|||
30882895|NCT02570165|58915381|FG001|Overall Study|Physician Decision|1|||
30882896|NCT02570165|58915382|FG002|Overall Study|Physician Decision|0|||
30882897|NCT02570165|58915383|FG003|Overall Study|Physician Decision|0|||
30882898|NCT02570165|58915384|FG004|Overall Study|Physician Decision|0|||
30882899|NCT02570165|58915385|FG005|Overall Study|Physician Decision|0|||
30882900|NCT02570165|58915386|FG006|Overall Study|Physician Decision|0|||
30882901|NCT02570165|58915380|FG000|Overall Study|Withdrawal by Subject|0|||
30882902|NCT02570165|58915381|FG001|Overall Study|Withdrawal by Subject|0|||
30882903|NCT02570165|58915382|FG002|Overall Study|Withdrawal by Subject|0|||
30882904|NCT02570165|58915383|FG003|Overall Study|Withdrawal by Subject|2|||
30882905|NCT02570165|58915384|FG004|Overall Study|Withdrawal by Subject|1|||
30882906|NCT02570165|58915385|FG005|Overall Study|Withdrawal by Subject|0|||
30882907|NCT02570165|58915386|FG006|Overall Study|Withdrawal by Subject|0|||
30882908|NCT02570165|58915380|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
30882909|NCT02570165|58915381|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
30882910|NCT02570165|58915382|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
30882911|NCT02570165|58915383|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
30882912|NCT02570165|58915384|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
30882913|NCT02570165|58915385|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
30882914|NCT02570165|58915386|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
30882915|NCT02570165|58915380|FG000|Overall Study|Withdrawal Request by GSK|0|||
30882916|NCT02570165|58915381|FG001|Overall Study|Withdrawal Request by GSK|0|||
30882917|NCT02570165|58915382|FG002|Overall Study|Withdrawal Request by GSK|2|||
30882918|NCT02570165|58915383|FG003|Overall Study|Withdrawal Request by GSK|0|||
30882919|NCT02570165|58915384|FG004|Overall Study|Withdrawal Request by GSK|0|||
30882920|NCT02570165|58915385|FG005|Overall Study|Withdrawal Request by GSK|0|||
30882921|NCT02570165|58915386|FG006|Overall Study|Withdrawal Request by GSK|0|||
30882922|NCT02564471|58915406|FG000|Overall Study|Adverse Event|1|||
30882923|NCT02564471|58915407|FG001|Overall Study|Adverse Event|0|||
30882924|NCT02564471|58915408|FG002|Overall Study|Adverse Event|0|||
30882925|NCT02564471|58915409|FG003|Overall Study|Adverse Event|0|||
30882926|NCT02564471|58915406|FG000|Overall Study|Withdrawal by Subject|2|||
30882927|NCT02564471|58915407|FG001|Overall Study|Withdrawal by Subject|1|||
30882928|NCT02564471|58915408|FG002|Overall Study|Withdrawal by Subject|3|||
30882929|NCT02564471|58915409|FG003|Overall Study|Withdrawal by Subject|0|||
30882930|NCT02564471|58915406|FG000|Overall Study|Lost to Follow-up|0|||
30882931|NCT02564471|58915407|FG001|Overall Study|Lost to Follow-up|2|||
30882932|NCT02564471|58915408|FG002|Overall Study|Lost to Follow-up|0|||
30882933|NCT02564471|58915409|FG003|Overall Study|Lost to Follow-up|0|||
30882934|NCT02563067|58915422|FG000|Overall Study|Subject/guardian decision|14|||
30882935|NCT02563067|58915423|FG001|Overall Study|Subject/guardian decision|20|||
30882936|NCT02563067|58915424|FG002|Overall Study|Subject/guardian decision|16|||
30882937|NCT02563067|58915422|FG000|Overall Study|Physician Decision|0|||
30882938|NCT02563067|58915423|FG001|Overall Study|Physician Decision|1|||
30882939|NCT02563067|58915424|FG002|Overall Study|Physician Decision|3|||
30882940|NCT02563067|58915422|FG000|Overall Study|Lost to Follow-up|1|||
30882941|NCT02563067|58915423|FG001|Overall Study|Lost to Follow-up|2|||
30882942|NCT02563067|58915424|FG002|Overall Study|Lost to Follow-up|0|||
30882943|NCT02563067|58915422|FG000|Overall Study|Technical problems|0|||
30882944|NCT02563067|58915423|FG001|Overall Study|Technical problems|1|||
30882945|NCT02563067|58915424|FG002|Overall Study|Technical problems|0|||
30882946|NCT02563067|58915422|FG000|Overall Study|Lack of Efficacy|1|||
30882947|NCT02563067|58915423|FG001|Overall Study|Lack of Efficacy|0|||
30882948|NCT02563067|58915424|FG002|Overall Study|Lack of Efficacy|0|||
30882949|NCT02563067|58915422|FG000|Overall Study|Death|0|||
30882950|NCT02563067|58915423|FG001|Overall Study|Death|1|||
30882951|NCT02563067|58915424|FG002|Overall Study|Death|1|||
30882952|NCT02563067|58915422|FG000|Overall Study|Adverse Event|2|||
30882953|NCT02563067|58915423|FG001|Overall Study|Adverse Event|1|||
30882954|NCT02563067|58915424|FG002|Overall Study|Adverse Event|0|||
30882955|NCT02563067|58915422|FG000|Overall Study|Death post Treatment/safety period|1|||
30882956|NCT02563067|58915423|FG001|Overall Study|Death post Treatment/safety period|0|||
30882957|NCT02563067|58915424|FG002|Overall Study|Death post Treatment/safety period|0|||
30882958|NCT02568683|58915434|FG000|Overall Study|Death|0|||
30882959|NCT02568683|58915435|FG001|Overall Study|Death|2|||
30882960|NCT02568683|58915434|FG000|Overall Study|Withdrew Consent|1|||
30882961|NCT02568683|58915435|FG001|Overall Study|Withdrew Consent|0|||
30882962|NCT02568683|58915434|FG000|Overall Study|Study Terminated By Sponsor|5|||
30882963|NCT02568683|58915435|FG001|Overall Study|Study Terminated By Sponsor|2|||
30882964|NCT02563925|58915441|FG000|Overall Study|Withdrawal by Subject|2|||
30882965|NCT01663727|58915448|FG000|Overall Study|Death|161|||
30882966|NCT01663727|58915449|FG001|Overall Study|Death|155|||
30882967|NCT01663727|58915448|FG000|Overall Study|Lost to Follow-up|10|||
30882968|NCT01663727|58915449|FG001|Overall Study|Lost to Follow-up|8|||
30882969|NCT01663727|58915448|FG000|Overall Study|Withdrawal by Subject|18|||
30882970|NCT01663727|58915449|FG001|Overall Study|Withdrawal by Subject|25|||
30882971|NCT01663727|58915448|FG000|Overall Study|Study Terminated|51|||
30882972|NCT01663727|58915449|FG001|Overall Study|Study Terminated|50|||
30882973|NCT01663727|58915448|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
30882974|NCT01663727|58915449|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
30882975|NCT01663727|58915448|FG000|Overall Study|Withdrawal prior to dosing.|1|||
30882976|NCT01663727|58915449|FG001|Overall Study|Withdrawal prior to dosing.|0|||
30882977|NCT02614261|58915458|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
30882978|NCT02614261|58915459|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
30882979|NCT02614261|58915460|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
30882980|NCT02614261|58915461|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
30882981|NCT02614261|58915458|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
30882982|NCT02614261|58915459|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
30882983|NCT02614261|58915460|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
30882984|NCT02614261|58915461|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
30882985|NCT02614261|58915458|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
30882986|NCT02614261|58915459|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
30882987|NCT02614261|58915460|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
30882988|NCT02614261|58915461|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
30882989|NCT02614261|58915458|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
30882990|NCT02614261|58915459|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
30882991|NCT02614261|58915460|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
30882992|NCT02614261|58915461|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
30882993|NCT02614261|58915458|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
30882994|NCT02614261|58915459|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
30882995|NCT02614261|58915460|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
30882996|NCT02614261|58915461|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
30882997|NCT02614261|58915458|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
30882998|NCT02614261|58915459|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
30882999|NCT02614261|58915460|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
30883000|NCT02614261|58915461|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
30883001|NCT02614261|58915458|FG000|Double-Blind Treatment Phase|Screen failure|0|||
30883002|NCT02614261|58915459|FG001|Double-Blind Treatment Phase|Screen failure|1|||
30883003|NCT02614261|58915460|FG002|Double-Blind Treatment Phase|Screen failure|2|||
30883004|NCT02614261|58915461|FG003|Double-Blind Treatment Phase|Screen failure|0|||
30883005|NCT02614261|58915458|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
30883006|NCT02614261|58915459|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
30883007|NCT02614261|58915460|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
30883008|NCT02614261|58915461|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
30883009|NCT02614261|58915458|FG000|Open-Label Extension Phase|Adverse Event|23|||
30883010|NCT02614261|58915459|FG001|Open-Label Extension Phase|Adverse Event|12|||
30883011|NCT02614261|58915460|FG002|Open-Label Extension Phase|Adverse Event|11|||
30883012|NCT02614261|58915461|FG003|Open-Label Extension Phase|Adverse Event|0|||
30883013|NCT02614261|58915458|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
30883014|NCT02614261|58915459|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
30883015|NCT02614261|58915460|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
30883016|NCT02614261|58915461|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
30883017|NCT02614261|58915458|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
30883018|NCT02614261|58915459|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
30883019|NCT02614261|58915460|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
30883020|NCT02614261|58915461|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
30883021|NCT02614261|58915458|FG000|Open-Label Extension Phase|Physician Decision|2|||
30883022|NCT02614261|58915459|FG001|Open-Label Extension Phase|Physician Decision|0|||
30883023|NCT02614261|58915460|FG002|Open-Label Extension Phase|Physician Decision|0|||
30883024|NCT02614261|58915461|FG003|Open-Label Extension Phase|Physician Decision|0|||
30883025|NCT02614261|58915458|FG000|Open-Label Extension Phase|Pregnancy|1|||
30608437|NCT01288430|58619226|FG005|Part 2|Progressive disease|0|||
30608438|NCT01288430|58619227|FG006|Part 2|Progressive disease|0|||
30883026|NCT02614261|58915459|FG001|Open-Label Extension Phase|Pregnancy|2|||
30883027|NCT02614261|58915460|FG002|Open-Label Extension Phase|Pregnancy|1|||
30883028|NCT02614261|58915461|FG003|Open-Label Extension Phase|Pregnancy|0|||
30883029|NCT02614261|58915458|FG000|Open-Label Extension Phase|Protocol Violation|3|||
30883030|NCT02614261|58915459|FG001|Open-Label Extension Phase|Protocol Violation|4|||
30883031|NCT02614261|58915460|FG002|Open-Label Extension Phase|Protocol Violation|1|||
30883032|NCT02614261|58915461|FG003|Open-Label Extension Phase|Protocol Violation|0|||
30883033|NCT02614261|58915458|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
30883034|NCT02614261|58915459|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
30883035|NCT02614261|58915460|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
30883036|NCT02614261|58915461|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
30883037|NCT02614261|58915458|FG000|Follow-up Phase|Adverse Event|2|||
30883038|NCT02614261|58915459|FG001|Follow-up Phase|Adverse Event|0|||
30883039|NCT02614261|58915460|FG002|Follow-up Phase|Adverse Event|1|||
30883040|NCT02614261|58915461|FG003|Follow-up Phase|Adverse Event|0|||
30883041|NCT02614261|58915458|FG000|Follow-up Phase|Lost to Follow-up|12|||
30883042|NCT02614261|58915459|FG001|Follow-up Phase|Lost to Follow-up|5|||
30883043|NCT02614261|58915460|FG002|Follow-up Phase|Lost to Follow-up|2|||
30883044|NCT02614261|58915461|FG003|Follow-up Phase|Lost to Follow-up|0|||
30883045|NCT02614261|58915458|FG000|Follow-up Phase|Physician Decision|5|||
30883046|NCT02614261|58915459|FG001|Follow-up Phase|Physician Decision|1|||
30883047|NCT02614261|58915460|FG002|Follow-up Phase|Physician Decision|0|||
30883048|NCT02614261|58915461|FG003|Follow-up Phase|Physician Decision|0|||
30883049|NCT02614261|58915458|FG000|Follow-up Phase|Pregnancy|0|||
30883050|NCT02614261|58915459|FG001|Follow-up Phase|Pregnancy|1|||
30883051|NCT02614261|58915460|FG002|Follow-up Phase|Pregnancy|0|||
30883052|NCT02614261|58915461|FG003|Follow-up Phase|Pregnancy|0|||
30883053|NCT02614261|58915458|FG000|Follow-up Phase|Protocol Violation|1|||
30883054|NCT02614261|58915459|FG001|Follow-up Phase|Protocol Violation|0|||
30883055|NCT02614261|58915460|FG002|Follow-up Phase|Protocol Violation|0|||
30883056|NCT02614261|58915461|FG003|Follow-up Phase|Protocol Violation|0|||
30883057|NCT02614261|58915458|FG000|Follow-up Phase|Withdrawal by Subject|12|||
30883058|NCT02614261|58915459|FG001|Follow-up Phase|Withdrawal by Subject|4|||
30883059|NCT02614261|58915460|FG002|Follow-up Phase|Withdrawal by Subject|11|||
30883060|NCT02614261|58915461|FG003|Follow-up Phase|Withdrawal by Subject|0|||
30883061|NCT02614261|58915458|FG000|Israel Addendum|Withdrawal by Subject|0|||
30883062|NCT02614261|58915459|FG001|Israel Addendum|Withdrawal by Subject|0|||
30883063|NCT02614261|58915460|FG002|Israel Addendum|Withdrawal by Subject|0|||
30883064|NCT02614261|58915461|FG003|Israel Addendum|Withdrawal by Subject|4|||
30883065|NCT01594411|58915487|FG000|Overall Study|Lost to Follow-up|2|||
30883066|NCT01594333|58915496|FG000|Overall Study|Death|96|||
30883067|NCT01594333|58915497|FG001|Overall Study|Death|83|||
30883068|NCT01594333|58915496|FG000|Overall Study|Lost to Follow-up|5|||
30883069|NCT01594333|58915497|FG001|Overall Study|Lost to Follow-up|5|||
30883070|NCT01594333|58915496|FG000|Overall Study|Withdrawal by Subject|60|||
30883071|NCT01594333|58915497|FG001|Overall Study|Withdrawal by Subject|63|||
30883072|NCT02609659|58915503|FG000|Overall Study|Adverse Event|1|||
30883073|NCT02609659|58915503|FG000|Overall Study|Lost to Follow-up|6|||
30883074|NCT02609659|58915503|FG000|Overall Study|Other|1|||
30883075|NCT02612779|58915509|FG000|Overall Study|Administrative reason by sponsor|4|||
30883076|NCT02612779|58915510|FG001|Overall Study|Administrative reason by sponsor|1|||
30883077|NCT02612779|58915509|FG000|Overall Study|No longer meet study criteria|0|||
30883078|NCT02612779|58915510|FG001|Overall Study|No longer meet study criteria|1|||
30883079|NCT02612779|58915509|FG000|Overall Study|Disease progression|29|||
30883080|NCT02612779|58915510|FG001|Overall Study|Disease progression|2|||
30883081|NCT02612779|58915509|FG000|Overall Study|Study drug toxicity|10|||
30883082|NCT02612779|58915510|FG001|Overall Study|Study drug toxicity|1|||
30883083|NCT02612779|58915509|FG000|Overall Study|Death|1|||
30883084|NCT02612779|58915510|FG001|Overall Study|Death|0|||
30883085|NCT02612779|58915509|FG000|Overall Study|Adverse event unrelated to study drug|5|||
30883086|NCT02612779|58915510|FG001|Overall Study|Adverse event unrelated to study drug|0|||
30883087|NCT02612779|58915509|FG000|Overall Study|Participant withdrew consent|4|||
30883088|NCT02612779|58915510|FG001|Overall Study|Participant withdrew consent|0|||
30975656|NCT02592798|59059219|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
30608439|NCT01288430|58619228|FG007|Part 2|Progressive disease|8|||
30883089|NCT02612779|58915509|FG000|Overall Study|Lost to Follow-up|1|||
30883090|NCT02612779|58915510|FG001|Overall Study|Lost to Follow-up|0|||
30883091|NCT02612779|58915509|FG000|Overall Study|Maximum clinical benefit|10|||
30883092|NCT02612779|58915510|FG001|Overall Study|Maximum clinical benefit|1|||
30883093|NCT02612779|58915509|FG000|Overall Study|Other reasons|4|||
30883094|NCT02612779|58915510|FG001|Overall Study|Other reasons|0|||
30883095|NCT02612623|58915521|FG000|Overall Study|Withdrawal by Subject|0|||
30883096|NCT02612623|58915522|FG001|Overall Study|Withdrawal by Subject|1|||
30883097|NCT02612623|58915523|FG002|Overall Study|Withdrawal by Subject|0|||
30608440|NCT01288430|58619229|FG008|Part 2|Progressive disease|7|||
30883098|NCT02612623|58915524|FG003|Overall Study|Withdrawal by Subject|0|||
30608441|NCT01288430|58619230|FG009|Part 2|Progressive disease|2|||
30883099|NCT02612623|58915521|FG000|Overall Study|Adverse Event|1|||
30883100|NCT02612623|58915522|FG001|Overall Study|Adverse Event|0|||
30883101|NCT02612623|58915523|FG002|Overall Study|Adverse Event|1|||
30883102|NCT02612623|58915524|FG003|Overall Study|Adverse Event|0|||
30883103|NCT02607865|58915538|FG000|Overall Study|Lost to Follow-up|9|||
30883104|NCT02607865|58915539|FG001|Overall Study|Lost to Follow-up|7|||
30883105|NCT02607865|58915540|FG002|Overall Study|Lost to Follow-up|7|||
30883106|NCT02607865|58915541|FG003|Overall Study|Lost to Follow-up|5|||
30883107|NCT02607865|58915538|FG000|Overall Study|Withdrawal by Subject|18|||
30883108|NCT02607865|58915539|FG001|Overall Study|Withdrawal by Subject|18|||
30883109|NCT02607865|58915540|FG002|Overall Study|Withdrawal by Subject|17|||
30883110|NCT02607865|58915541|FG003|Overall Study|Withdrawal by Subject|8|||
30883111|NCT02607865|58915538|FG000|Overall Study|Death|5|||
30883112|NCT02607865|58915539|FG001|Overall Study|Death|4|||
30883113|NCT02607865|58915540|FG002|Overall Study|Death|1|||
30883114|NCT02607865|58915541|FG003|Overall Study|Death|3|||
30883115|NCT02607865|58915538|FG000|Overall Study|Unclassified|1|||
30883116|NCT02607865|58915539|FG001|Overall Study|Unclassified|1|||
30883117|NCT02607865|58915540|FG002|Overall Study|Unclassified|2|||
30883118|NCT02607865|58915541|FG003|Overall Study|Unclassified|0|||
30883119|NCT01668667|58915555|FG000|Overall Study|Adverse Event|3|||
30883120|NCT01668667|58915556|FG001|Overall Study|Adverse Event|6|||
30883121|NCT01668667|58915557|FG002|Overall Study|Adverse Event|4|||
30883122|NCT01668667|58915558|FG003|Overall Study|Adverse Event|4|||
30883123|NCT01668667|58915555|FG000|Overall Study|Lack of Efficacy|3|||
30883124|NCT01668667|58915556|FG001|Overall Study|Lack of Efficacy|2|||
30883125|NCT01668667|58915557|FG002|Overall Study|Lack of Efficacy|2|||
30883126|NCT01668667|58915558|FG003|Overall Study|Lack of Efficacy|3|||
30883127|NCT01668667|58915555|FG000|Overall Study|Protocol Violation|6|||
30883128|NCT01668667|58915556|FG001|Overall Study|Protocol Violation|10|||
30883129|NCT01668667|58915557|FG002|Overall Study|Protocol Violation|12|||
30883130|NCT01668667|58915558|FG003|Overall Study|Protocol Violation|5|||
30883131|NCT01668667|58915555|FG000|Overall Study|Lost to Follow-up|9|||
30883132|NCT01668667|58915556|FG001|Overall Study|Lost to Follow-up|4|||
30883133|NCT01668667|58915557|FG002|Overall Study|Lost to Follow-up|7|||
30883134|NCT01668667|58915558|FG003|Overall Study|Lost to Follow-up|6|||
30883135|NCT01668667|58915555|FG000|Overall Study|Physician Decision|3|||
30883136|NCT01668667|58915556|FG001|Overall Study|Physician Decision|0|||
30883137|NCT01668667|58915557|FG002|Overall Study|Physician Decision|1|||
30883138|NCT01668667|58915558|FG003|Overall Study|Physician Decision|0|||
30883139|NCT01668667|58915555|FG000|Overall Study|Withdrawal by Subject|7|||
30883140|NCT01668667|58915556|FG001|Overall Study|Withdrawal by Subject|4|||
30883141|NCT01668667|58915557|FG002|Overall Study|Withdrawal by Subject|5|||
30883142|NCT01668667|58915558|FG003|Overall Study|Withdrawal by Subject|5|||
30883143|NCT02608879|58915571|FG000|Overall Study|Lost to Follow-up|1|||
30883144|NCT02608879|58915572|FG001|Overall Study|Lost to Follow-up|0|||
30883145|NCT02608879|58915573|FG002|Overall Study|Lost to Follow-up|0|||
30883146|NCT02608879|58915571|FG000|Overall Study|Did not meet continuation criteria|0|||
30883147|NCT02608879|58915572|FG001|Overall Study|Did not meet continuation criteria|0|||
30883148|NCT02608879|58915573|FG002|Overall Study|Did not meet continuation criteria|3|||
30883149|NCT02608099|58915583|FG000|Overall Study|Ablation procedure not initiated|3|||
30883150|NCT02608099|58915584|FG001|Overall Study|Ablation procedure not initiated|2|||
30883151|NCT01668589|58915594|FG000|Overall Study|Lost to Follow-up|29|||
30883152|NCT01668589|58915595|FG001|Overall Study|Lost to Follow-up|37|||
30883153|NCT01668589|58915596|FG002|Overall Study|Lost to Follow-up|15|||
30883154|NCT01668589|58915597|FG003|Overall Study|Lost to Follow-up|5|||
30883155|NCT01668589|58915594|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
30883156|NCT01668589|58915595|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
30883157|NCT01668589|58915596|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
30883158|NCT01668589|58915597|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
30883159|NCT01668589|58915594|FG000|Overall Study|Death|12|||
30883160|NCT01668589|58915595|FG001|Overall Study|Death|3|||
30883161|NCT01668589|58915596|FG002|Overall Study|Death|2|||
30883162|NCT01668589|58915597|FG003|Overall Study|Death|11|||
30883163|NCT01668589|58915594|FG000|Overall Study|Other|44|||
30883164|NCT01668589|58915595|FG001|Overall Study|Other|10|||
30883165|NCT01668589|58915596|FG002|Overall Study|Other|7|||
30883166|NCT01668589|58915597|FG003|Overall Study|Other|15|||
30883167|NCT02432235|58915619|FG000|Overall Study|Death|1|||
30883168|NCT02432235|58915620|FG001|Overall Study|Death|1|||
30883169|NCT02432235|58915621|FG002|Overall Study|Death|2|||
30883170|NCT02432235|58915622|FG003|Overall Study|Death|2|||
30883171|NCT02432235|58915623|FG004|Overall Study|Death|1|||
30883172|NCT02432235|58915624|FG005|Overall Study|Death|3|||
30883173|NCT02432235|58915625|FG006|Overall Study|Death|11|||
30883174|NCT02432235|58915626|FG007|Overall Study|Death|15|||
30883175|NCT02432235|58915627|FG008|Overall Study|Death|15|||
30883176|NCT02432235|58915628|FG009|Overall Study|Death|3|||
30883177|NCT02432235|58915629|FG010|Overall Study|Death|1|||
30883178|NCT02432235|58915630|FG011|Overall Study|Death|0|||
30883179|NCT02432235|58915619|FG000|Overall Study|Withdrawal by Subject|0|||
30883180|NCT02432235|58915620|FG001|Overall Study|Withdrawal by Subject|1|||
30883181|NCT02432235|58915621|FG002|Overall Study|Withdrawal by Subject|0|||
30883182|NCT02432235|58915622|FG003|Overall Study|Withdrawal by Subject|0|||
30883183|NCT02432235|58915623|FG004|Overall Study|Withdrawal by Subject|0|||
30883184|NCT02432235|58915624|FG005|Overall Study|Withdrawal by Subject|2|||
30883185|NCT02432235|58915625|FG006|Overall Study|Withdrawal by Subject|5|||
30883186|NCT02432235|58915626|FG007|Overall Study|Withdrawal by Subject|3|||
30883187|NCT02432235|58915627|FG008|Overall Study|Withdrawal by Subject|1|||
30883188|NCT02432235|58915628|FG009|Overall Study|Withdrawal by Subject|0|||
30883189|NCT02432235|58915629|FG010|Overall Study|Withdrawal by Subject|0|||
30883190|NCT02432235|58915630|FG011|Overall Study|Withdrawal by Subject|0|||
30883191|NCT02432235|58915619|FG000|Overall Study|Lost to Follow-up|0|||
30883192|NCT02432235|58915620|FG001|Overall Study|Lost to Follow-up|0|||
30883193|NCT02432235|58915621|FG002|Overall Study|Lost to Follow-up|0|||
30883194|NCT02432235|58915622|FG003|Overall Study|Lost to Follow-up|0|||
30883195|NCT02432235|58915623|FG004|Overall Study|Lost to Follow-up|0|||
30883196|NCT02432235|58915624|FG005|Overall Study|Lost to Follow-up|1|||
30883197|NCT02432235|58915625|FG006|Overall Study|Lost to Follow-up|0|||
30883198|NCT02432235|58915626|FG007|Overall Study|Lost to Follow-up|0|||
30883199|NCT02432235|58915627|FG008|Overall Study|Lost to Follow-up|1|||
30883200|NCT02432235|58915628|FG009|Overall Study|Lost to Follow-up|0|||
30883201|NCT02432235|58915629|FG010|Overall Study|Lost to Follow-up|0|||
30883202|NCT02432235|58915630|FG011|Overall Study|Lost to Follow-up|0|||
30883203|NCT02432235|58915619|FG000|Overall Study|Miscellaneous|0|||
30883204|NCT02432235|58915620|FG001|Overall Study|Miscellaneous|0|||
30883205|NCT02432235|58915621|FG002|Overall Study|Miscellaneous|0|||
30883206|NCT02432235|58915622|FG003|Overall Study|Miscellaneous|0|||
30883207|NCT02432235|58915623|FG004|Overall Study|Miscellaneous|1|||
30883208|NCT02432235|58915624|FG005|Overall Study|Miscellaneous|6|||
30883209|NCT02432235|58915625|FG006|Overall Study|Miscellaneous|2|||
30883210|NCT02432235|58915626|FG007|Overall Study|Miscellaneous|2|||
30883211|NCT02432235|58915627|FG008|Overall Study|Miscellaneous|4|||
30883212|NCT02432235|58915628|FG009|Overall Study|Miscellaneous|0|||
30883213|NCT02432235|58915629|FG010|Overall Study|Miscellaneous|0|||
30883214|NCT02432235|58915630|FG011|Overall Study|Miscellaneous|1|||
30883215|NCT02431533|58915660|FG000|Overall Study|Withdrawal by Subject|1|||
30883216|NCT02431533|58915661|FG001|Overall Study|Withdrawal by Subject|3|||
30883217|NCT02431533|58915660|FG000|Overall Study|Developed Exclusionary criteria|1|||
30883218|NCT02431533|58915661|FG001|Overall Study|Developed Exclusionary criteria|0|||
30883219|NCT02416791|58915670|FG000|6 Months|Lost to Follow-up|0|||
30883220|NCT02416791|58915671|FG001|6 Months|Lost to Follow-up|0|||
30883221|NCT02416791|58915672|FG002|6 Months|Lost to Follow-up|1|||
30883222|NCT02414841|58915682|FG000|Overall Study|Withdrawal by Subject|7|||
30883223|NCT02414841|58915683|FG001|Overall Study|Withdrawal by Subject|5|||
30883224|NCT02414841|58915682|FG000|Overall Study|Lost to Follow-up|13|||
30883225|NCT02414841|58915683|FG001|Overall Study|Lost to Follow-up|6|||
30883226|NCT02414841|58915682|FG000|Overall Study|Death|17|||
30883227|NCT02414841|58915683|FG001|Overall Study|Death|14|||
30883228|NCT02414841|58915682|FG000|Overall Study|Received a Kidney Transplant|13|||
30883229|NCT02414841|58915683|FG001|Overall Study|Received a Kidney Transplant|4|||
30883230|NCT02414841|58915682|FG000|Overall Study|Randomized But Not Treated|6|||
30883231|NCT02414841|58915683|FG001|Overall Study|Randomized But Not Treated|4|||
30883232|NCT02413593|58915691|FG000|Overall Study|Lost to Follow-up|3|||
30883233|NCT02413593|58915691|FG000|Overall Study|Adverse Event|1|||
30883234|NCT01652703|58915701|FG000|Overall Study|Withdrawal by Subject|0|||
30883235|NCT01652703|58915702|FG001|Overall Study|Withdrawal by Subject|1|||
30883236|NCT01652703|58915703|FG002|Overall Study|Withdrawal by Subject|3|||
30883237|NCT01652703|58915704|FG003|Overall Study|Withdrawal by Subject|1|||
30883238|NCT01652703|58915705|FG004|Overall Study|Withdrawal by Subject|0|||
30883239|NCT01652703|58915706|FG005|Overall Study|Withdrawal by Subject|1|||
30883240|NCT01652703|58915701|FG000|Overall Study|Other|0|||
30883241|NCT01652703|58915702|FG001|Overall Study|Other|0|||
30883242|NCT01652703|58915703|FG002|Overall Study|Other|0|||
30883243|NCT01652703|58915704|FG003|Overall Study|Other|1|||
30883244|NCT01652703|58915705|FG004|Overall Study|Other|1|||
30608442|NCT01288430|58619221|FG000|Part 2|Clinical disease progression|0|||
30608443|NCT01288430|58619222|FG001|Part 2|Clinical disease progression|0|||
30883245|NCT01652703|58915706|FG005|Overall Study|Other|1|||
30883246|NCT01652469|58915722|FG000|Overall Study|Withdrawal by Subject|1|||
30883247|NCT01652469|58915723|FG001|Overall Study|Withdrawal by Subject|4|||
30883248|NCT01652469|58915722|FG000|Overall Study|Lost to Follow-up|0|||
30883249|NCT01652469|58915723|FG001|Overall Study|Lost to Follow-up|2|||
30883250|NCT02429427|58915731|FG000|Overall Study|Adverse Event|220|||
30883251|NCT02429427|58915732|FG001|Overall Study|Adverse Event|92|||
30883252|NCT02429427|58915731|FG000|Overall Study|Protocol Violation|10|||
30883253|NCT02429427|58915732|FG001|Overall Study|Protocol Violation|6|||
30883254|NCT02429427|58915731|FG000|Overall Study|Lost to Follow-up|15|||
30883255|NCT02429427|58915732|FG001|Overall Study|Lost to Follow-up|6|||
30790137|NCT00048035|58803325|FG005|Core Period|Early Withdrawals|1|||
30883256|NCT02429427|58915731|FG000|Overall Study|Withdrawal by Subject|64|||
30883257|NCT02429427|58915732|FG001|Overall Study|Withdrawal by Subject|34|||
30883258|NCT02429427|58915731|FG000|Overall Study|Other|62|||
30883259|NCT02429427|58915732|FG001|Overall Study|Other|41|||
30883260|NCT02412735|58915741|FG000|Overall Study|Adverse Event|0|||
30883261|NCT02412735|58915742|FG001|Overall Study|Adverse Event|1|||
30883262|NCT02412735|58915743|FG002|Overall Study|Adverse Event|2|||
30883263|NCT02412735|58915741|FG000|Overall Study|Withdrawal by Subject|23|||
30883264|NCT02412735|58915742|FG001|Overall Study|Withdrawal by Subject|27|||
30883265|NCT02412735|58915743|FG002|Overall Study|Withdrawal by Subject|22|||
30883266|NCT02412735|58915741|FG000|Overall Study|Investigator Decision|3|||
30883267|NCT02412735|58915742|FG001|Overall Study|Investigator Decision|3|||
30883268|NCT02412735|58915743|FG002|Overall Study|Investigator Decision|2|||
30883269|NCT02412735|58915741|FG000|Overall Study|Lost to Follow-up|17|||
30883270|NCT02412735|58915742|FG001|Overall Study|Lost to Follow-up|11|||
30883271|NCT02412735|58915743|FG002|Overall Study|Lost to Follow-up|18|||
30883272|NCT02412735|58915741|FG000|Overall Study|Reason not Specified|3|||
30883273|NCT02412735|58915742|FG001|Overall Study|Reason not Specified|2|||
30883274|NCT02412735|58915743|FG002|Overall Study|Reason not Specified|2|||
30883275|NCT02412657|58915754|FG000|Overall Study|Lost to Follow-up|1|||
30883276|NCT02412657|58915755|FG001|Overall Study|Lost to Follow-up|0|||
30883277|NCT02412657|58915756|FG002|Overall Study|Lost to Follow-up|0|||
30883278|NCT02412657|58915754|FG000|Overall Study|Protocol Violation|0|||
30883279|NCT02412657|58915755|FG001|Overall Study|Protocol Violation|2|||
30883280|NCT02412657|58915756|FG002|Overall Study|Protocol Violation|3|||
30883281|NCT02428413|58915766|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
30883282|NCT02428413|58915767|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
30883283|NCT02428413|58915766|FG000|Overall Study|Protocol Violation|1|||
30883284|NCT02428413|58915767|FG001|Overall Study|Protocol Violation|2|||
30883285|NCT02428413|58915766|FG000|Overall Study|Case Cancelled|2|||
30883286|NCT02428413|58915767|FG001|Overall Study|Case Cancelled|0|||
30883287|NCT02428413|58915766|FG000|Overall Study|Missed Cases|1|||
30883288|NCT02428413|58915767|FG001|Overall Study|Missed Cases|2|||
30883289|NCT02428413|58915766|FG000|Overall Study|Nurse Refusal|1|||
30883290|NCT02428413|58915767|FG001|Overall Study|Nurse Refusal|0|||
30883291|NCT02412111|58915775|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
30883292|NCT02412111|58915776|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
30883293|NCT02412111|58915777|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
30883294|NCT02412111|58915775|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
30883295|NCT02412111|58915776|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
30883296|NCT02412111|58915777|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
30883297|NCT02412111|58915775|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
30883298|NCT02412111|58915776|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
30883299|NCT02412111|58915777|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
30883300|NCT02412111|58915775|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
30883301|NCT02412111|58915776|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
30883302|NCT02412111|58915777|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
30883303|NCT02412111|58915775|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
30883304|NCT02412111|58915776|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
30883305|NCT02412111|58915777|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
30883306|NCT02412111|58915775|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
30883307|NCT02412111|58915776|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
30883308|NCT02412111|58915777|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
30883309|NCT02412111|58915775|FG000|Active Comparator Period (8 Weeks)|Other|0|||
30883310|NCT02412111|58915776|FG001|Active Comparator Period (8 Weeks)|Other|0|||
30883311|NCT02412111|58915777|FG002|Active Comparator Period (8 Weeks)|Other|2|||
30883312|NCT02427477|58915789|FG000|Period 1|Adverse Event|1|||
30883313|NCT02427477|58915790|FG001|Period 1|Adverse Event|0|||
30883314|NCT02427399|58915801|FG000|Overall Study|Protocol Violation|14|||
30883315|NCT02427399|58915802|FG001|Overall Study|Protocol Violation|16|||
30883316|NCT02427399|58915803|FG002|Overall Study|Protocol Violation|12|||
30883317|NCT02427399|58915804|FG003|Overall Study|Protocol Violation|18|||
30883318|NCT02427399|58915805|FG004|Overall Study|Protocol Violation|15|||
30883319|NCT02426541|58915819|FG000|Overall Study|Protocol Violation|1|||
30883320|NCT02426541|58915820|FG001|Overall Study|Protocol Violation|0|||
30883321|NCT02484651|58915828|FG000|Overall Study|Patients' data files were corrupted.|1|||
30883322|NCT02484651|58915829|FG001|Overall Study|Patients' data files were corrupted.|1|||
30883323|NCT02484651|58915828|FG000|Overall Study|BIS monitoring failed.|1|||
30883324|NCT02484651|58915829|FG001|Overall Study|BIS monitoring failed.|1|||
30883325|NCT02484651|58915828|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
30883326|NCT02484651|58915829|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
30883327|NCT02410551|58915836|FG000|Overall Study|Adverse Event|1|||
30883328|NCT02410551|58915836|FG000|Overall Study|Withdrawal by Subject|1|||
30883329|NCT02410551|58915836|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
30883330|NCT02424591|58915843|FG000|Overall Study|Protocol Violation|2|||
30883331|NCT02424591|58915844|FG001|Overall Study|Protocol Violation|3|||
30883332|NCT02408523|58915852|FG000|Overall Study|Adverse Event|4|||
30883333|NCT02408523|58915853|FG001|Overall Study|Adverse Event|10|||
30883334|NCT02408523|58915852|FG000|Overall Study|Lack of Efficacy|0|||
30883335|NCT02408523|58915853|FG001|Overall Study|Lack of Efficacy|1|||
30883336|NCT02408523|58915852|FG000|Overall Study|Protocol Violation|1|||
30883337|NCT02408523|58915853|FG001|Overall Study|Protocol Violation|2|||
30883338|NCT02408523|58915852|FG000|Overall Study|Lost to Follow-up|2|||
30883339|NCT02408523|58915853|FG001|Overall Study|Lost to Follow-up|3|||
30883340|NCT02408523|58915852|FG000|Overall Study|Withdrawal by Subject|3|||
30883341|NCT02408523|58915853|FG001|Overall Study|Withdrawal by Subject|1|||
30883342|NCT02408523|58915852|FG000|Overall Study|Sponsor request|1|||
30883343|NCT02408523|58915853|FG001|Overall Study|Sponsor request|0|||
30883344|NCT02408523|58915852|FG000|Overall Study|Did not satisfy extension conditions|0|||
30883345|NCT02408523|58915853|FG001|Overall Study|Did not satisfy extension conditions|1|||
30883346|NCT02603419|58915873|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
30883347|NCT02603419|58915874|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
30883348|NCT02603419|58915875|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
30883349|NCT02603419|58915876|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
30883350|NCT02603419|58915877|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
30883351|NCT02603419|58915878|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
30883352|NCT02603419|58915873|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
30883353|NCT02603419|58915874|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
30883354|NCT02603419|58915875|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
30883355|NCT02603419|58915876|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
30883356|NCT02603419|58915877|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
30883357|NCT02603419|58915878|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
30883358|NCT02603419|58915873|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
30883359|NCT02603419|58915874|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
30883360|NCT02603419|58915875|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
30883361|NCT02603419|58915876|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
30883362|NCT02603419|58915877|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
30883363|NCT02603419|58915878|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
30883364|NCT02603419|58915873|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
30883365|NCT02603419|58915874|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
30883366|NCT02603419|58915875|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
30883367|NCT02603419|58915876|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
30883368|NCT02603419|58915877|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
30883369|NCT02603419|58915878|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
30883370|NCT02603419|58915873|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
30883371|NCT02603419|58915874|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
30883372|NCT02603419|58915875|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
30883373|NCT02603419|58915876|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
30883374|NCT02603419|58915877|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
30883375|NCT02603419|58915878|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
30883376|NCT02603419|58915873|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
30883377|NCT02603419|58915874|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
30883378|NCT02603419|58915875|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
30883379|NCT02603419|58915876|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
30883380|NCT02603419|58915877|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
30883381|NCT02603419|58915878|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
30883382|NCT02603419|58915873|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
30883383|NCT02603419|58915874|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
30883384|NCT02603419|58915875|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
30883385|NCT02603419|58915876|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
30883386|NCT02603419|58915877|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
30883387|NCT02603419|58915878|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
30883388|NCT02603419|58915873|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
30883389|NCT02603419|58915874|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
30883390|NCT02603419|58915875|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
30883391|NCT02603419|58915876|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
30883392|NCT02603419|58915877|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
30883393|NCT02603419|58915878|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
30883394|NCT02603419|58915873|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
30883395|NCT02603419|58915874|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
30883396|NCT02603419|58915875|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
30883397|NCT02603419|58915876|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
30883398|NCT02603419|58915877|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
30883399|NCT02603419|58915878|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
30883400|NCT02603419|58915873|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
30883401|NCT02603419|58915874|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
30883402|NCT02603419|58915875|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
30883403|NCT02603419|58915876|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
30883404|NCT02603419|58915877|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
30883405|NCT02603419|58915878|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
30883406|NCT01668355|58915895|FG000|Overall Study|Death|3|||
30883407|NCT01668355|58915896|FG001|Overall Study|Death|1|||
30883408|NCT01668355|58915895|FG000|Overall Study|Withdrawal by Subject|6|||
30883409|NCT01668355|58915896|FG001|Overall Study|Withdrawal by Subject|1|||
30883410|NCT01667731|58915908|FG000|Overall Study|Enrolled but not treated|0|||
30883411|NCT01667731|58915909|FG001|Overall Study|Enrolled but not treated|0|||
30883412|NCT01667731|58915910|FG002|Overall Study|Enrolled but not treated|0|||
30883413|NCT01667731|58915911|FG003|Overall Study|Enrolled but not treated|0|||
30883414|NCT01667731|58915912|FG004|Overall Study|Enrolled but not treated|1|||
30883415|NCT01667731|58915908|FG000|Overall Study|Efficacy Failure|1|||
30883416|NCT01667731|58915909|FG001|Overall Study|Efficacy Failure|12|||
30883417|NCT01667731|58915910|FG002|Overall Study|Efficacy Failure|0|||
30883418|NCT01667731|58915911|FG003|Overall Study|Efficacy Failure|1|||
30883419|NCT01667731|58915912|FG004|Overall Study|Efficacy Failure|24|||
30883420|NCT01667731|58915908|FG000|Overall Study|Lost to Follow-up|2|||
30883421|NCT01667731|58915909|FG001|Overall Study|Lost to Follow-up|3|||
30883422|NCT01667731|58915910|FG002|Overall Study|Lost to Follow-up|1|||
30883423|NCT01667731|58915911|FG003|Overall Study|Lost to Follow-up|1|||
30883424|NCT01667731|58915912|FG004|Overall Study|Lost to Follow-up|2|||
30883425|NCT01667731|58915908|FG000|Overall Study|Subject Withdrew Consent|2|||
30883426|NCT01667731|58915909|FG001|Overall Study|Subject Withdrew Consent|0|||
30883427|NCT01667731|58915910|FG002|Overall Study|Subject Withdrew Consent|1|||
30883428|NCT01667731|58915911|FG003|Overall Study|Subject Withdrew Consent|0|||
30883429|NCT01667731|58915912|FG004|Overall Study|Subject Withdrew Consent|1|||
30883430|NCT01667731|58915908|FG000|Overall Study|Death|0|||
30883431|NCT01667731|58915909|FG001|Overall Study|Death|1|||
30883432|NCT01667731|58915910|FG002|Overall Study|Death|0|||
30883433|NCT01667731|58915911|FG003|Overall Study|Death|0|||
30883434|NCT01667731|58915912|FG004|Overall Study|Death|0|||
30883435|NCT02605837|58915927|FG000|Overall Study|Adverse Event|3|||
30883436|NCT02605837|58915928|FG001|Overall Study|Adverse Event|1|||
30883437|NCT02605837|58915927|FG000|Overall Study|Non-Compliance with Study Drug|0|||
30883438|NCT02605837|58915928|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30883439|NCT02605837|58915927|FG000|Overall Study|Withdrawal by Subject|8|||
30883440|NCT02605837|58915928|FG001|Overall Study|Withdrawal by Subject|8|||
30883441|NCT02605837|58915927|FG000|Overall Study|Physician Decision|0|||
30883442|NCT02605837|58915928|FG001|Overall Study|Physician Decision|1|||
30883443|NCT02423343|58915941|FG000|Overall Study|Withdrawal by Subject|0|||
30883444|NCT02423343|58915942|FG001|Overall Study|Withdrawal by Subject|1|||
30883445|NCT02423343|58915943|FG002|Overall Study|Withdrawal by Subject|0|||
30883446|NCT02423343|58915944|FG003|Overall Study|Withdrawal by Subject|0|||
30883447|NCT02423343|58915945|FG004|Overall Study|Withdrawal by Subject|0|||
30883448|NCT02423343|58915946|FG005|Overall Study|Withdrawal by Subject|0|||
30883449|NCT02423343|58915941|FG000|Overall Study|Progressive Disease|0|||
30883450|NCT02423343|58915942|FG001|Overall Study|Progressive Disease|0|||
30883451|NCT02423343|58915943|FG002|Overall Study|Progressive Disease|0|||
30883452|NCT02423343|58915944|FG003|Overall Study|Progressive Disease|0|||
30883453|NCT02423343|58915945|FG004|Overall Study|Progressive Disease|2|||
30883454|NCT02423343|58915946|FG005|Overall Study|Progressive Disease|0|||
30883455|NCT02423343|58915941|FG000|Overall Study|Adverse Event|0|||
30883456|NCT02423343|58915942|FG001|Overall Study|Adverse Event|0|||
30883457|NCT02423343|58915943|FG002|Overall Study|Adverse Event|0|||
30883458|NCT02423343|58915944|FG003|Overall Study|Adverse Event|0|||
30883459|NCT02423343|58915945|FG004|Overall Study|Adverse Event|2|||
30883460|NCT02423343|58915946|FG005|Overall Study|Adverse Event|0|||
30883461|NCT02423343|58915941|FG000|Overall Study|Death|0|||
30883462|NCT02423343|58915942|FG001|Overall Study|Death|0|||
30790138|NCT00048035|58803326|FG006|Core Period|Early Withdrawals|0|||
30883463|NCT02423343|58915943|FG002|Overall Study|Death|0|||
30883464|NCT02423343|58915944|FG003|Overall Study|Death|0|||
30883465|NCT02423343|58915945|FG004|Overall Study|Death|1|||
30883466|NCT02423343|58915946|FG005|Overall Study|Death|0|||
30883467|NCT02605447|58915974|FG000|Overall Study|Death|66|||
30883468|NCT02605447|58915974|FG000|Overall Study|Physician Decision|1|||
30883469|NCT02605447|58915974|FG000|Overall Study|Lost to Follow-up|24|||
30883470|NCT02605447|58915974|FG000|Overall Study|Withdrawal by Subject|10|||
30883471|NCT02605447|58915974|FG000|Overall Study|Not disclosed|1|||
30883472|NCT02485899|58915981|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
30883473|NCT02485899|58915982|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
30883474|NCT02485899|58915981|FG000|Overall Study|Withdrawal by Subject|1|||
30883475|NCT02485899|58915982|FG001|Overall Study|Withdrawal by Subject|0|||
30883476|NCT02485899|58915981|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
30883477|NCT02485899|58915982|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
30883478|NCT02423109|58915988|FG000|Lens 1|Adverse Event|1|||
30883479|NCT02423109|58915989|FG001|Lens 1|Adverse Event|0|||
30883480|NCT02420691|58915997|FG000|Overall Study|Adverse Event|3|||
30883481|NCT02420691|58915997|FG000|Overall Study|Withdrawal by Subject|3|||
30883482|NCT02406651|58916001|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
30883483|NCT02406261|58916008|FG000|Period 1|Lost to Follow-up|2|||
30883484|NCT02406261|58916009|FG001|Period 1|Lost to Follow-up|0|||
30883485|NCT02406261|58916008|FG000|Period 1|Adverse Event|1|||
30883486|NCT02406261|58916009|FG001|Period 1|Adverse Event|0|||
30883487|NCT02406261|58916008|FG000|Period 2|Physician Decision|0|||
30883488|NCT02406261|58916009|FG001|Period 2|Physician Decision|1|||
30883489|NCT02406261|58916008|FG000|Period 2|Protocol Violation|0|||
30883490|NCT02406261|58916009|FG001|Period 2|Protocol Violation|1|||
30883491|NCT02406261|58916008|FG000|Period 2|Withdrawal by Subject|0|||
30883492|NCT02406261|58916009|FG001|Period 2|Withdrawal by Subject|1|||
30883493|NCT02405091|58916019|FG000|Overall Study|Adverse Event|16|||
30883494|NCT02405091|58916020|FG001|Overall Study|Adverse Event|10|||
30883495|NCT02405091|58916021|FG002|Overall Study|Adverse Event|0|||
30883496|NCT02405091|58916019|FG000|Overall Study|Protocol Violation|1|||
30883497|NCT02405091|58916020|FG001|Overall Study|Protocol Violation|0|||
30883498|NCT02405091|58916021|FG002|Overall Study|Protocol Violation|0|||
30883499|NCT02405091|58916019|FG000|Overall Study|Noncompliance|1|||
30883500|NCT02405091|58916020|FG001|Overall Study|Noncompliance|6|||
30883501|NCT02405091|58916021|FG002|Overall Study|Noncompliance|2|||
30883502|NCT02405091|58916019|FG000|Overall Study|Withdrawal by Subject|4|||
30883503|NCT02405091|58916020|FG001|Overall Study|Withdrawal by Subject|8|||
30883504|NCT02405091|58916021|FG002|Overall Study|Withdrawal by Subject|0|||
30883505|NCT02405091|58916019|FG000|Overall Study|Death|0|||
30883506|NCT02405091|58916020|FG001|Overall Study|Death|1|||
30883507|NCT02405091|58916021|FG002|Overall Study|Death|0|||
30883508|NCT02405091|58916019|FG000|Overall Study|Lost to Follow-up|5|||
30883509|NCT02405091|58916020|FG001|Overall Study|Lost to Follow-up|6|||
30883510|NCT02405091|58916021|FG002|Overall Study|Lost to Follow-up|0|||
30883511|NCT02405091|58916019|FG000|Overall Study|Physician Decision|2|||
30883512|NCT02405091|58916020|FG001|Overall Study|Physician Decision|2|||
30883513|NCT02405091|58916021|FG002|Overall Study|Physician Decision|0|||
30883514|NCT02485353|58916032|FG000|Overall Study|Death|1|||
30883515|NCT02485353|58916032|FG000|Overall Study|Disease Progression|1|||
30883516|NCT02603107|58916038|FG000|Randomized Phase|Withdrew consent|8|||
30883517|NCT02603107|58916039|FG001|Randomized Phase|Withdrew consent|15|||
30883518|NCT02603107|58916038|FG000|Randomized Phase|Lost to Follow-up|1|||
30883519|NCT02603107|58916039|FG001|Randomized Phase|Lost to Follow-up|3|||
30883520|NCT02603107|58916038|FG000|Randomized Phase|Adverse Event|2|||
30883521|NCT02603107|58916039|FG001|Randomized Phase|Adverse Event|0|||
30883522|NCT02603107|58916038|FG000|Randomized Phase|Death|1|||
30883523|NCT02603107|58916039|FG001|Randomized Phase|Death|1|||
30883524|NCT02603107|58916038|FG000|Randomized Phase|Non-compliance with study drug|1|||
30883525|NCT02603107|58916039|FG001|Randomized Phase|Non-compliance with study drug|1|||
30883526|NCT02603107|58916038|FG000|Randomized Phase|Investigator's discretion|0|||
30883527|NCT02603107|58916039|FG001|Randomized Phase|Investigator's discretion|1|||
30883528|NCT02603107|58916038|FG000|Randomized Phase|Lack of Efficacy|1|||
30883529|NCT02603107|58916039|FG001|Randomized Phase|Lack of Efficacy|0|||
30883530|NCT02603107|58916038|FG000|Randomized Phase|Protocol Violation|1|||
30883531|NCT02603107|58916039|FG001|Randomized Phase|Protocol Violation|0|||
30883532|NCT02603107|58916038|FG000|Optional Extension Phase|Lost to Follow-up|3|||
30883533|NCT02603107|58916039|FG001|Optional Extension Phase|Lost to Follow-up|3|||
30883534|NCT02603107|58916038|FG000|Optional Extension Phase|Withdrew consent|3|||
30883535|NCT02603107|58916039|FG001|Optional Extension Phase|Withdrew consent|2|||
30883536|NCT02603107|58916038|FG000|Optional Extension Phase|Investigator's discretion|2|||
30883537|NCT02603107|58916039|FG001|Optional Extension Phase|Investigator's discretion|2|||
30883538|NCT02603107|58916038|FG000|Optional Extension Phase|Pregnancy|0|||
30883539|NCT02603107|58916039|FG001|Optional Extension Phase|Pregnancy|3|||
30883540|NCT02603107|58916038|FG000|Optional Extension Phase|Adverse Event|0|||
30883541|NCT02603107|58916039|FG001|Optional Extension Phase|Adverse Event|2|||
30883542|NCT02603107|58916038|FG000|Optional Extension Phase|Not treated in extension phase|0|||
30883543|NCT02603107|58916039|FG001|Optional Extension Phase|Not treated in extension phase|1|||
30883544|NCT02603107|58916038|FG000|Optional Extension Phase|Protocol Violation|1|||
30883545|NCT02603107|58916039|FG001|Optional Extension Phase|Protocol Violation|0|||
30883546|NCT02484729|58916057|FG000|Overall Study|Failure of IntelliCap Error|0|||
30883547|NCT02484729|58916058|FG001|Overall Study|Failure of IntelliCap Error|0|||
30883548|NCT02484729|58916059|FG002|Overall Study|Failure of IntelliCap Error|0|||
30883549|NCT02484729|58916060|FG003|Overall Study|Failure of IntelliCap Error|0|||
30883550|NCT02484729|58916061|FG004|Overall Study|Failure of IntelliCap Error|0|||
30883551|NCT02484729|58916062|FG005|Overall Study|Failure of IntelliCap Error|0|||
30883552|NCT02484729|58916063|FG006|Overall Study|Failure of IntelliCap Error|0|||
30883553|NCT02484729|58916064|FG007|Overall Study|Failure of IntelliCap Error|0|||
30883554|NCT02484729|58916065|FG008|Overall Study|Failure of IntelliCap Error|0|||
30883555|NCT02484729|58916066|FG009|Overall Study|Failure of IntelliCap Error|1|||
30883556|NCT02601625|58916104|FG000|Overall Study|Lost to Follow-up|0|||
30883557|NCT02601625|58916105|FG001|Overall Study|Lost to Follow-up|0|||
30883558|NCT02601625|58916106|FG002|Overall Study|Lost to Follow-up|1|||
30883559|NCT02601625|58916107|FG003|Overall Study|Lost to Follow-up|1|||
30883560|NCT02601469|58916133|FG000|Overall Study|Enrolled in Error|1|||
30883561|NCT02601469|58916134|FG001|Overall Study|Enrolled in Error|0|||
30883562|NCT02604589|58916143|FG000|Overall Study|catheter dislodgement|0|||
30883563|NCT02604589|58916144|FG001|Overall Study|catheter dislodgement|0|||
30883564|NCT02604589|58916145|FG002|Overall Study|catheter dislodgement|1|||
30883565|NCT02601001|58916156|FG000|Dosing Period 2|Adverse Event|0|||
30883566|NCT02601001|58916157|FG001|Dosing Period 2|Adverse Event|0|||
30883567|NCT02601001|58916158|FG002|Dosing Period 2|Adverse Event|0|||
30883568|NCT02601001|58916159|FG003|Dosing Period 2|Adverse Event|0|||
30883569|NCT02601001|58916160|FG004|Dosing Period 2|Adverse Event|0|||
30883570|NCT02601001|58916161|FG005|Dosing Period 2|Adverse Event|0|||
30883571|NCT02601001|58916162|FG006|Dosing Period 2|Adverse Event|1|||
30883572|NCT02604199|58916187|FG000|Overall Study|Pregnancy|0|||
30883573|NCT02604199|58916188|FG001|Overall Study|Pregnancy|0|||
30883574|NCT02604199|58916189|FG002|Overall Study|Pregnancy|0|||
30883575|NCT02604199|58916190|FG003|Overall Study|Pregnancy|1|||
30883576|NCT02604199|58916187|FG000|Overall Study|Study terminated by sponsor|0|||
30883577|NCT02604199|58916188|FG001|Overall Study|Study terminated by sponsor|2|||
30883578|NCT02604199|58916189|FG002|Overall Study|Study terminated by sponsor|0|||
30883579|NCT02604199|58916190|FG003|Overall Study|Study terminated by sponsor|2|||
30883580|NCT02604199|58916187|FG000|Overall Study|Withdrawal by Subject|0|||
30883581|NCT02604199|58916188|FG001|Overall Study|Withdrawal by Subject|1|||
30883582|NCT02604199|58916189|FG002|Overall Study|Withdrawal by Subject|0|||
30883583|NCT02604199|58916190|FG003|Overall Study|Withdrawal by Subject|0|||
30883584|NCT02600845|58916203|FG000|Overall Study|Reason Not Specified|3|||
30883585|NCT02600845|58916203|FG000|Overall Study|Non-compliance with Study Procedures|10|||
30883586|NCT02600845|58916203|FG000|Overall Study|Consent Withdrawal|5|||
30883587|NCT02599129|58916209|FG000|Overall Study|Lack of Efficacy|2|||
30883588|NCT02599129|58916210|FG001|Overall Study|Lack of Efficacy|2|||
30883589|NCT02599129|58916209|FG000|Overall Study|Lost to Follow-up|1|||
30883590|NCT02599129|58916210|FG001|Overall Study|Lost to Follow-up|0|||
30883591|NCT02599129|58916209|FG000|Overall Study|Withdrawal by Subject|2|||
30883592|NCT02599129|58916210|FG001|Overall Study|Withdrawal by Subject|1|||
30883593|NCT02596711|58916219|FG000|Overall Study|Lost to Follow-up|1|||
30883594|NCT02596711|58916220|FG001|Overall Study|Lost to Follow-up|2|||
30883595|NCT02596711|58916221|FG002|Overall Study|Lost to Follow-up|3|||
30883596|NCT02596009|58916229|FG000|Overall Study|Administrative problems|0|||
30883597|NCT02596009|58916230|FG001|Overall Study|Administrative problems|1|||
30883598|NCT02596009|58916231|FG002|Overall Study|Administrative problems|0|||
30883599|NCT02596009|58916232|FG003|Overall Study|Administrative problems|0|||
30883600|NCT02596009|58916233|FG004|Overall Study|Administrative problems|0|||
30883601|NCT02596009|58916234|FG005|Overall Study|Administrative problems|0|||
30883602|NCT02590939|58916242|FG000|Overall Study|Withdrawal by Subject|3|||
30883603|NCT02590939|58916243|FG001|Overall Study|Withdrawal by Subject|1|||
30883604|NCT02590939|58916242|FG000|Overall Study|Failed the nociceptive test|2|||
30883605|NCT02590939|58916243|FG001|Overall Study|Failed the nociceptive test|1|||
30883606|NCT04351087|58916251|FG000|Overall Study|Lost to Follow-up|7|||
30883607|NCT04351087|58916252|FG001|Overall Study|Lost to Follow-up|3|||
30883608|NCT04351087|58916251|FG000|Overall Study|Withdrawal by Subject|3|||
30883609|NCT04351087|58916252|FG001|Overall Study|Withdrawal by Subject|4|||
30883610|NCT04351087|58916251|FG000|Overall Study|Lack of Efficacy|3|||
30883611|NCT04351087|58916252|FG001|Overall Study|Lack of Efficacy|2|||
30883612|NCT02598193|58916258|FG000|Overall Study|Adverse Event|13|||
30883613|NCT02598193|58916258|FG000|Overall Study|Withdrawal by Subject|1|||
30883614|NCT02598193|58916258|FG000|Overall Study|Listed in active lung transplant list|1|||
30883615|NCT02598193|58916258|FG000|Overall Study|Does not want to take Nintedanib|1|||
30883616|NCT02595073|58916264|FG000|Overall Study|Progressive Disease|0|||
30883617|NCT02595073|58916265|FG001|Overall Study|Progressive Disease|1|||
30883618|NCT02595073|58916264|FG000|Overall Study|Protocol Violation|2|||
30883619|NCT02595073|58916265|FG001|Overall Study|Protocol Violation|0|||
30883620|NCT02593825|58916273|FG000|Intervention|Lost to Follow-up|10|||
30883621|NCT02593825|58916274|FG001|Intervention|Lost to Follow-up|12|||
30883622|NCT02388165|58916284|FG000|Overall Study|Study terminated by sponsor|5|||
30883623|NCT02388165|58916285|FG001|Overall Study|Study terminated by sponsor|5|||
30883624|NCT02388165|58916284|FG000|Overall Study|Other|11|||
30883625|NCT02388165|58916285|FG001|Overall Study|Other|13|||
30883626|NCT02388165|58916284|FG000|Overall Study|No longer meet eligibility criteria|40|||
30883627|NCT02388165|58916285|FG001|Overall Study|No longer meet eligibility criteria|43|||
30883628|NCT02388165|58916284|FG000|Overall Study|Withdrawal of consent|31|||
30883629|NCT02388165|58916285|FG001|Overall Study|Withdrawal of consent|32|||
30883630|NCT02388165|58916284|FG000|Overall Study|Lost to Follow-up|19|||
30883631|NCT02388165|58916285|FG001|Overall Study|Lost to Follow-up|20|||
30883632|NCT02388165|58916284|FG000|Overall Study|Death|13|||
30883633|NCT02388165|58916285|FG001|Overall Study|Death|10|||
30883634|NCT02388165|58916284|FG000|Overall Study|Adverse Event|3|||
30883635|NCT02388165|58916285|FG001|Overall Study|Adverse Event|5|||
30883636|NCT02388165|58916284|FG000|Overall Study|Did not meet entrance criteria|5|||
30975657|NCT02592798|59059218|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
30975658|NCT02592798|59059219|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
30975659|NCT02592798|59059218|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
30975660|NCT02592798|59059219|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
30883637|NCT02388165|58916285|FG001|Overall Study|Did not meet entrance criteria|2|||
30883638|NCT02404545|58916293|FG000|Overall Study|Sponsor Termination|6|||
30883639|NCT02404545|58916294|FG001|Overall Study|Sponsor Termination|6|||
30883640|NCT02420379|58916303|FG000|Overall Study|Withdrawal by Subject|0|||
30883641|NCT02420379|58916304|FG001|Overall Study|Withdrawal by Subject|3|||
30883642|NCT02420379|58916303|FG000|Overall Study|Unable to complete due to schooling|0|||
30883643|NCT02420379|58916304|FG001|Overall Study|Unable to complete due to schooling|1|||
30883644|NCT02420379|58916303|FG000|Overall Study|Transitioned to commercial drug|1|||
30883645|NCT02420379|58916304|FG001|Overall Study|Transitioned to commercial drug|0|||
30883646|NCT02347761|58916313|FG000|All Collected|Death|1|||
30883647|NCT02347761|58916314|FG001|All Collected|Death|0|||
30883648|NCT02347761|58916315|FG002|All Collected|Death|0|||
30883649|NCT02347761|58916313|FG000|All Collected|Lost to Follow-up|3|||
30883650|NCT02347761|58916314|FG001|All Collected|Lost to Follow-up|2|||
30883651|NCT02347761|58916315|FG002|All Collected|Lost to Follow-up|3|||
30883652|NCT02347761|58916313|FG000|All Collected|Withdrawal by Subject|11|||
30883653|NCT02347761|58916314|FG001|All Collected|Withdrawal by Subject|11|||
30883654|NCT02347761|58916315|FG002|All Collected|Withdrawal by Subject|22|||
30883655|NCT02347761|58916313|FG000|All Collected|invetigator disretion|2|||
30883656|NCT02347761|58916314|FG001|All Collected|invetigator disretion|0|||
30883657|NCT02347761|58916315|FG002|All Collected|invetigator disretion|0|||
30883658|NCT02347761|58916313|FG000|All Collected|instillation site pain|0|||
30883659|NCT02347761|58916314|FG001|All Collected|instillation site pain|0|||
30883660|NCT02347761|58916315|FG002|All Collected|instillation site pain|1|||
30883661|NCT02347761|58916313|FG000|All Collected|exacerbation of COPD|0|||
30883662|NCT02347761|58916314|FG001|All Collected|exacerbation of COPD|0|||
30883663|NCT02347761|58916315|FG002|All Collected|exacerbation of COPD|1|||
30883664|NCT02347761|58916313|FG000|All Collected|moved/travel|0|||
30883665|NCT02347761|58916314|FG001|All Collected|moved/travel|1|||
30883666|NCT02347761|58916315|FG002|All Collected|moved/travel|0|||
30975661|NCT02592798|59059218|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
30975662|NCT02592798|59059219|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
30975663|NCT02592798|59059218|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
30975664|NCT02592798|59059219|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
30975665|NCT02592798|59059218|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
30975666|NCT02592798|59059219|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
30975667|NCT02592798|59059218|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
30975668|NCT02592798|59059219|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
30883667|NCT02347761|58916313|FG000|On Study Treatment|Lack of Efficacy|2|||
30975669|NCT02592798|59059218|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
30975670|NCT02592798|59059219|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
30975671|NCT02592798|59059218|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
30975672|NCT02592798|59059219|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
30975673|NCT02592798|59059218|FG000|Transition From DB2 to OLE|Other reasons|1|||
30975674|NCT02592798|59059219|FG001|Transition From DB2 to OLE|Other reasons|0|||
30975675|NCT02592798|59059218|FG000|Open Label Period (OLE)|Other reasons|0|||
30975676|NCT02592798|59059219|FG001|Open Label Period (OLE)|Other reasons|2|||
30975677|NCT02592798|59059218|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
30975678|NCT02592798|59059219|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
30975679|NCT02592798|59059218|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
30975680|NCT02592798|59059219|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
30975681|NCT02592798|59059218|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
30975682|NCT02592798|59059219|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
30975683|NCT02592798|59059218|FG000|Open Label Period (OLE)|Adverse Event|0|||
30975684|NCT02592798|59059219|FG001|Open Label Period (OLE)|Adverse Event|1|||
30975685|NCT00081653|59059259|FG000|Overall Study|Adverse Event|23|||
30883668|NCT02347761|58916314|FG001|On Study Treatment|Lack of Efficacy|3|||
30883669|NCT02347761|58916315|FG002|On Study Treatment|Lack of Efficacy|4|||
30883670|NCT02347761|58916313|FG000|On Study Treatment|non-compliance with study medication|0|||
30883671|NCT02347761|58916314|FG001|On Study Treatment|non-compliance with study medication|0|||
30883672|NCT02347761|58916315|FG002|On Study Treatment|non-compliance with study medication|2|||
30975686|NCT00081653|59059260|FG001|Overall Study|Adverse Event|17|||
30975687|NCT00081653|59059259|FG000|Overall Study|Lost to Follow-up|2|||
30975688|NCT00081653|59059260|FG001|Overall Study|Lost to Follow-up|4|||
30975689|NCT00081653|59059259|FG000|Overall Study|Refused Treatment|18|||
30975690|NCT00081653|59059260|FG001|Overall Study|Refused Treatment|14|||
30975691|NCT00081653|59059259|FG000|Overall Study|Low bone mineral density|1|||
30975692|NCT00081653|59059260|FG001|Overall Study|Low bone mineral density|0|||
30975693|NCT00081653|59059259|FG000|Overall Study|Bone loss|2|||
30975694|NCT00081653|59059260|FG001|Overall Study|Bone loss|0|||
30975695|NCT00081653|59059259|FG000|Overall Study|Participant leaving country|1|||
30975696|NCT00081653|59059260|FG001|Overall Study|Participant leaving country|0|||
30975697|NCT00081653|59059259|FG000|Overall Study|Loss of bone mass|0|||
30975698|NCT00081653|59059260|FG001|Overall Study|Loss of bone mass|2|||
30975699|NCT02596620|59059330|FG000|Overall Study|Lost to Follow-up|1|||
30975700|NCT02596620|59059331|FG001|Overall Study|Lost to Follow-up|1|||
30975701|NCT02596230|59059487|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
30975702|NCT02596230|59059488|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
30975703|NCT02596230|59059489|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
30975704|NCT02596230|59059490|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
30975705|NCT02596230|59059491|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
30975706|NCT02596230|59059487|FG000|Objective 2, One Year|Lost to Follow-up|0|||
30975707|NCT02596230|59059488|FG001|Objective 2, One Year|Lost to Follow-up|41|||
30975708|NCT02596230|59059489|FG002|Objective 2, One Year|Lost to Follow-up|41|||
30975709|NCT02596230|59059490|FG003|Objective 2, One Year|Lost to Follow-up|32|||
30975710|NCT02596230|59059491|FG004|Objective 2, One Year|Lost to Follow-up|46|||
30975711|NCT02596230|59059487|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
30975712|NCT02596230|59059488|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
30975713|NCT02596230|59059489|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
30975714|NCT02596230|59059490|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
30975715|NCT02596230|59059491|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
30975716|NCT02596230|59059487|FG000|Objective 2, One Year|Adverse drug reaction|0|||
30975717|NCT02596230|59059488|FG001|Objective 2, One Year|Adverse drug reaction|1|||
30975718|NCT02596230|59059489|FG002|Objective 2, One Year|Adverse drug reaction|0|||
30975719|NCT02596230|59059490|FG003|Objective 2, One Year|Adverse drug reaction|0|||
30975720|NCT02596230|59059491|FG004|Objective 2, One Year|Adverse drug reaction|0|||
30975721|NCT02596230|59059487|FG000|Objective 2, One Year|Death|0|||
30975722|NCT02596230|59059488|FG001|Objective 2, One Year|Death|12|||
30975723|NCT02596230|59059489|FG002|Objective 2, One Year|Death|41|||
30975724|NCT02596230|59059490|FG003|Objective 2, One Year|Death|21|||
30975725|NCT02596230|59059491|FG004|Objective 2, One Year|Death|30|||
30975726|NCT02596230|59059487|FG000|Objective 2, One Year|Other|0|||
30975727|NCT02596230|59059488|FG001|Objective 2, One Year|Other|3|||
30975728|NCT02596230|59059489|FG002|Objective 2, One Year|Other|2|||
30975729|NCT02596230|59059490|FG003|Objective 2, One Year|Other|0|||
30975730|NCT02596230|59059491|FG004|Objective 2, One Year|Other|0|||
30975731|NCT01667562|59059540|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
30975732|NCT01667562|59059541|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
30975733|NCT01667562|59059540|FG000|Erlotinib Phase|Lost to Follow-up|0|||
30975734|NCT01667562|59059541|FG001|Erlotinib Phase|Lost to Follow-up|1|||
30975735|NCT01667562|59059540|FG000|Erlotinib Phase|Adverse Event|0|||
30975736|NCT01667562|59059541|FG001|Erlotinib Phase|Adverse Event|1|||
30975737|NCT01667562|59059540|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
30975738|NCT01667562|59059541|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
30975739|NCT02595528|59059578|FG000|Overall Study|Withdrawal by Subject|1|||
30975740|NCT02595528|59059579|FG001|Overall Study|Withdrawal by Subject|2|||
30975741|NCT02595528|59059580|FG002|Overall Study|Withdrawal by Subject|1|||
30975742|NCT02595528|59059581|FG003|Overall Study|Withdrawal by Subject|3|||
30975743|NCT02595528|59059578|FG000|Overall Study|Lost to Follow-up|1|||
30975744|NCT02595528|59059579|FG001|Overall Study|Lost to Follow-up|1|||
30975745|NCT02595528|59059580|FG002|Overall Study|Lost to Follow-up|0|||
30975746|NCT02595528|59059581|FG003|Overall Study|Lost to Follow-up|1|||
30975747|NCT02595450|59059609|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
30975748|NCT02595450|59059609|FG000|Overall Study|Enrolled, but not treated|8|||
30975749|NCT02592018|59059613|FG000|Overall Study|Adverse Event|1|||
30883673|NCT02347761|58916313|FG000|On Study Treatment|Withdrawal by Subject|7|||
30883674|NCT02347761|58916314|FG001|On Study Treatment|Withdrawal by Subject|3|||
30883675|NCT02347761|58916315|FG002|On Study Treatment|Withdrawal by Subject|5|||
30883676|NCT02347761|58916313|FG000|On Study Treatment|move/travel|2|||
30975750|NCT02592018|59059613|FG000|Overall Study|Lost to Follow-up|1|||
30975751|NCT02591238|59059621|FG000|Overall Study|Pregnancy|1|||
30883677|NCT02347761|58916314|FG001|On Study Treatment|move/travel|6|||
30883678|NCT02347761|58916315|FG002|On Study Treatment|move/travel|5|||
30975752|NCT02591238|59059622|FG001|Overall Study|Pregnancy|0|||
30975753|NCT02591238|59059623|FG002|Overall Study|Pregnancy|0|||
30883679|NCT02347761|58916313|FG000|On Study Treatment|dissastisfaction with device|2|||
30975754|NCT02591238|59059624|FG003|Overall Study|Pregnancy|0|||
30883680|NCT02347761|58916314|FG001|On Study Treatment|dissastisfaction with device|1|||
30883681|NCT02347761|58916315|FG002|On Study Treatment|dissastisfaction with device|4|||
30883682|NCT02347761|58916313|FG000|On Study Treatment|Lost to Follow-up|2|||
30883683|NCT02347761|58916314|FG001|On Study Treatment|Lost to Follow-up|1|||
30883684|NCT02347761|58916315|FG002|On Study Treatment|Lost to Follow-up|1|||
30883685|NCT02347761|58916313|FG000|On Study Treatment|investigator discretion|2|||
30883686|NCT02347761|58916314|FG001|On Study Treatment|investigator discretion|0|||
30883687|NCT02347761|58916315|FG002|On Study Treatment|investigator discretion|0|||
30883688|NCT02347761|58916313|FG000|On Study Treatment|durg not working|0|||
30883689|NCT02347761|58916314|FG001|On Study Treatment|durg not working|1|||
30883690|NCT02347761|58916315|FG002|On Study Treatment|durg not working|1|||
30883691|NCT02347761|58916313|FG000|On Study Treatment|Adverse Event|10|||
30883692|NCT02347761|58916314|FG001|On Study Treatment|Adverse Event|8|||
30883693|NCT02347761|58916315|FG002|On Study Treatment|Adverse Event|20|||
30883694|NCT02596945|58916323|FG000|Overall Study|No documentation of study drug dosing|3|||
30883695|NCT02596945|58916323|FG000|Overall Study|Other|32|||
30883696|NCT02596945|58916323|FG000|Overall Study|Change to hemodialysis|15|||
30883697|NCT02596945|58916323|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
30883698|NCT02596945|58916323|FG000|Overall Study|Withdrawal by Subject|1|||
30883699|NCT02596945|58916323|FG000|Overall Study|Missing|1|||
30883700|NCT02404389|58916341|FG000|Overall Study|Adverse Event|1|||
30883701|NCT02404389|58916342|FG001|Overall Study|Adverse Event|0|||
30883702|NCT02404389|58916343|FG002|Overall Study|Adverse Event|1|||
30883703|NCT02404389|58916344|FG003|Overall Study|Adverse Event|0|||
30883704|NCT02404389|58916345|FG004|Overall Study|Adverse Event|2|||
30883705|NCT02404389|58916341|FG000|Overall Study|Subject/guardian decision|1|||
30883706|NCT02404389|58916342|FG001|Overall Study|Subject/guardian decision|0|||
30883707|NCT02404389|58916343|FG002|Overall Study|Subject/guardian decision|0|||
30883708|NCT02404389|58916344|FG003|Overall Study|Subject/guardian decision|1|||
30883709|NCT02404389|58916345|FG004|Overall Study|Subject/guardian decision|1|||
30883710|NCT01667419|58916363|FG000|Overall Study|Reason Not Specified|1|||
30883711|NCT01667419|58916364|FG001|Overall Study|Reason Not Specified|0|||
30883712|NCT01667419|58916365|FG002|Overall Study|Reason Not Specified|0|||
30883713|NCT01667419|58916366|FG003|Overall Study|Reason Not Specified|0|||
30883714|NCT01667419|58916363|FG000|Overall Study|Withdrawal by Subject|16|||
30883715|NCT01667419|58916364|FG001|Overall Study|Withdrawal by Subject|8|||
30883716|NCT01667419|58916365|FG002|Overall Study|Withdrawal by Subject|9|||
30883717|NCT01667419|58916366|FG003|Overall Study|Withdrawal by Subject|8|||
30883718|NCT01667419|58916363|FG000|Overall Study|Non-compliance|0|||
30883719|NCT01667419|58916364|FG001|Overall Study|Non-compliance|0|||
30883720|NCT01667419|58916365|FG002|Overall Study|Non-compliance|0|||
30883721|NCT01667419|58916366|FG003|Overall Study|Non-compliance|1|||
30883722|NCT01667419|58916363|FG000|Overall Study|Protocol Violation|1|||
30883723|NCT01667419|58916364|FG001|Overall Study|Protocol Violation|0|||
30883724|NCT01667419|58916365|FG002|Overall Study|Protocol Violation|0|||
30883725|NCT01667419|58916366|FG003|Overall Study|Protocol Violation|0|||
30975755|NCT02591238|59059621|FG000|Overall Study|Withdrawal by Subject|0|||
30975756|NCT02591238|59059622|FG001|Overall Study|Withdrawal by Subject|0|||
30975757|NCT02591238|59059623|FG002|Overall Study|Withdrawal by Subject|0|||
30975758|NCT02591238|59059624|FG003|Overall Study|Withdrawal by Subject|1|||
30975759|NCT02591238|59059621|FG000|Overall Study|influenza|0|||
30975760|NCT02591238|59059622|FG001|Overall Study|influenza|0|||
30975761|NCT02591238|59059623|FG002|Overall Study|influenza|0|||
30975762|NCT02591238|59059624|FG003|Overall Study|influenza|1|||
30975763|NCT02591238|59059621|FG000|Overall Study|personal circumstances|0|||
30975764|NCT02591238|59059622|FG001|Overall Study|personal circumstances|0|||
30975765|NCT02591238|59059623|FG002|Overall Study|personal circumstances|0|||
30975766|NCT02591238|59059624|FG003|Overall Study|personal circumstances|1|||
30975767|NCT02591238|59059621|FG000|Overall Study|personal circumstances|0|||
30975768|NCT02591238|59059622|FG001|Overall Study|personal circumstances|1|||
30975769|NCT02591238|59059623|FG002|Overall Study|personal circumstances|0|||
30975770|NCT02591238|59059624|FG003|Overall Study|personal circumstances|0|||
30883726|NCT01667419|58916363|FG000|Overall Study|Lost to Follow-up|7|||
30975771|NCT02597946|59059706|FG000|Overall Study|Withdrawal by Subject|1|||
30975772|NCT02597946|59059706|FG000|Overall Study|Progressive disease|16|||
30975773|NCT02597946|59059706|FG000|Overall Study|Other than above|1|||
30975774|NCT02597712|59059712|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
30975775|NCT02597712|59059713|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
30975776|NCT02597712|59059712|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
30975777|NCT02597712|59059713|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
30975778|NCT02597712|59059712|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
30883727|NCT01667419|58916364|FG001|Overall Study|Lost to Follow-up|6|||
30883728|NCT01667419|58916365|FG002|Overall Study|Lost to Follow-up|2|||
30883729|NCT01667419|58916366|FG003|Overall Study|Lost to Follow-up|4|||
30883730|NCT01667419|58916363|FG000|Overall Study|Death|18|||
30883731|NCT01667419|58916364|FG001|Overall Study|Death|33|||
30883732|NCT01667419|58916365|FG002|Overall Study|Death|25|||
30883733|NCT01667419|58916366|FG003|Overall Study|Death|26|||
30883734|NCT02588833|58916383|FG000|Part 1|Withdrawal by Subject|1|||
30883735|NCT02588833|58916384|FG001|Part 1|Withdrawal by Subject|0|||
30883736|NCT02588833|58916383|FG000|Part 2A|Physician Decision|0|||
30883737|NCT02588833|58916384|FG001|Part 2A|Physician Decision|1|||
30883738|NCT02588833|58916383|FG000|Part 2A|Withdrawal by Subject|0|||
30883739|NCT02588833|58916384|FG001|Part 2A|Withdrawal by Subject|1|||
30883740|NCT02588833|58916383|FG000|Part 2B|Adverse Event|0|||
30883741|NCT02588833|58916384|FG001|Part 2B|Adverse Event|1|||
30883742|NCT02588833|58916383|FG000|Part 2C|Adverse Event|0|||
30883743|NCT02588833|58916384|FG001|Part 2C|Adverse Event|1|||
30883744|NCT02588833|58916383|FG000|Part 2C|Withdrawal by Subject|0|||
30883745|NCT02588833|58916384|FG001|Part 2C|Withdrawal by Subject|1|||
30883746|NCT02588833|58916383|FG000|Part 3 (Safety Follow-up)|Other|0|||
30883747|NCT02588833|58916384|FG001|Part 3 (Safety Follow-up)|Other|2|||
30883748|NCT01667107|58916393|FG000|Overall Study|Adverse Event|4|||
30883749|NCT01667107|58916394|FG001|Overall Study|Adverse Event|3|||
30883750|NCT01667107|58916393|FG000|Overall Study|Tolerability issues|0|||
30883751|NCT01667107|58916394|FG001|Overall Study|Tolerability issues|2|||
30883752|NCT01667107|58916393|FG000|Overall Study|Protocol Violation|0|||
30883753|NCT01667107|58916394|FG001|Overall Study|Protocol Violation|1|||
30883754|NCT01667107|58916393|FG000|Overall Study|Lack of Efficacy|0|||
30883755|NCT01667107|58916394|FG001|Overall Study|Lack of Efficacy|1|||
30883756|NCT02590003|58916418|FG000|Overall Study|Death|1|||
30883757|NCT02590003|58916419|FG001|Overall Study|Death|2|||
30883758|NCT02404311|58916448|FG000|Part A: Month 0-18|Death|2|||
30883759|NCT02404311|58916449|FG001|Part A: Month 0-18|Death|0|||
30883760|NCT02404311|58916450|FG002|Part A: Month 0-18|Death|0|||
30883761|NCT02404311|58916451|FG003|Part A: Month 0-18|Death|0|||
30883762|NCT02404311|58916452|FG004|Part A: Month 0-18|Death|0|||
30883763|NCT02404311|58916448|FG000|Part A: Month 0-18|Physician Decision|1|||
30883764|NCT02404311|58916449|FG001|Part A: Month 0-18|Physician Decision|0|||
30883765|NCT02404311|58916450|FG002|Part A: Month 0-18|Physician Decision|0|||
30883766|NCT02404311|58916451|FG003|Part A: Month 0-18|Physician Decision|0|||
30883767|NCT02404311|58916452|FG004|Part A: Month 0-18|Physician Decision|0|||
30883768|NCT02404311|58916448|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
30883769|NCT02404311|58916449|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
30883770|NCT02404311|58916450|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
30883771|NCT02404311|58916451|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
30883772|NCT02404311|58916452|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
30883773|NCT02404311|58916448|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
30883774|NCT02404311|58916449|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
30883775|NCT02404311|58916450|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
30883776|NCT02404311|58916451|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
30883777|NCT02404311|58916452|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
30883778|NCT02404311|58916448|FG000|Part A: Month 0-18|HIV Infection|6|||
30883779|NCT02404311|58916449|FG001|Part A: Month 0-18|HIV Infection|2|||
30883780|NCT02404311|58916450|FG002|Part A: Month 0-18|HIV Infection|0|||
30883781|NCT02404311|58916451|FG003|Part A: Month 0-18|HIV Infection|0|||
30883782|NCT02404311|58916452|FG004|Part A: Month 0-18|HIV Infection|0|||
30883783|NCT02404311|58916448|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
30883784|NCT02404311|58916449|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
30883785|NCT02404311|58916450|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
30883786|NCT02404311|58916451|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
30883787|NCT02404311|58916452|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
30883788|NCT01650519|58916466|FG000|Overall Study|Withdrawal by Subject|1|||
30883789|NCT01650519|58916467|FG001|Overall Study|Withdrawal by Subject|0|||
30883790|NCT01650285|58916473|FG000|Overall Study|Adverse Event|1|||
30883791|NCT02347527|58916481|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
30883792|NCT02347527|58916482|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
30883793|NCT02347527|58916483|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
30883794|NCT02347527|58916484|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
30883795|NCT02347527|58916481|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
30975779|NCT02597712|59059713|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
30975780|NCT02597478|59059721|FG000|Overall Study|Withdrawal by Subject|2|||
30883796|NCT02347527|58916482|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
30883797|NCT02347527|58916483|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
30883798|NCT02347527|58916484|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
30883799|NCT02347527|58916481|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
30975781|NCT02597478|59059722|FG001|Overall Study|Withdrawal by Subject|0|||
30975782|NCT02597478|59059721|FG000|Overall Study|Change of opioid dose|1|||
30883800|NCT02347527|58916482|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
30883801|NCT02347527|58916483|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
30883802|NCT02347527|58916484|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
30883803|NCT02347527|58916481|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
30883804|NCT02347527|58916482|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
30883805|NCT02347527|58916483|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
30883806|NCT02347527|58916484|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
30883807|NCT02347527|58916481|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
30883808|NCT02347527|58916482|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
30883809|NCT02347527|58916483|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
30883810|NCT02347527|58916484|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
30883811|NCT02386839|58916498|FG000|Overall Study|Death|1|||
30883812|NCT02386839|58916499|FG001|Overall Study|Death|0|||
30883813|NCT02386839|58916498|FG000|Overall Study|Withdrawal by Subject|9|||
30883814|NCT02386839|58916499|FG001|Overall Study|Withdrawal by Subject|10|||
30883815|NCT02386839|58916498|FG000|Overall Study|Lost to Follow-up|4|||
30883816|NCT02386839|58916499|FG001|Overall Study|Lost to Follow-up|4|||
30883817|NCT02386839|58916498|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
30883818|NCT02386839|58916499|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
30883819|NCT02386839|58916498|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
30883820|NCT02386839|58916499|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
30883821|NCT02386839|58916498|FG000|Overall Study|Other (unspecified)|1|||
30883822|NCT02386839|58916499|FG001|Overall Study|Other (unspecified)|0|||
30883823|NCT01649271|58916511|FG000|Overall Study|Progressive disease|4|||
30883824|NCT01649271|58916512|FG001|Overall Study|Progressive disease|5|||
30883825|NCT01649271|58916511|FG000|Overall Study|Other Adverse Event|0|||
30883826|NCT01649271|58916512|FG001|Overall Study|Other Adverse Event|2|||
30883827|NCT01649271|58916511|FG000|Overall Study|Withdrawal by Subject|1|||
30883828|NCT01649271|58916512|FG001|Overall Study|Withdrawal by Subject|0|||
30883829|NCT01649271|58916511|FG000|Overall Study|Other than stated above|1|||
30883830|NCT01649271|58916512|FG001|Overall Study|Other than stated above|0|||
30883831|NCT02385669|58916519|FG000|Overall Study|Adverse Event|2|||
30883832|NCT02402907|58916525|FG000|Overall Study|Delivered vaginally|9|||
30883833|NCT02402907|58916526|FG001|Overall Study|Delivered vaginally|3|||
30883834|NCT02402907|58916525|FG000|Overall Study|Delivered outside of Sinai|1|||
30883835|NCT02402907|58916526|FG001|Overall Study|Delivered outside of Sinai|1|||
30883836|NCT02402907|58916525|FG000|Overall Study|Lost to follow up after C-Section|10|||
30883837|NCT02402907|58916526|FG001|Overall Study|Lost to follow up after C-Section|23|||
30883838|NCT02345889|58916536|FG000|Overall Study|Inadequate Bowel Prep|17|||
30883839|NCT02345889|58916537|FG001|Overall Study|Inadequate Bowel Prep|16|||
30883840|NCT02345889|58916538|FG002|Overall Study|Inadequate Bowel Prep|18|||
30883841|NCT02345889|58916539|FG003|Overall Study|Inadequate Bowel Prep|14|||
30883842|NCT02345889|58916536|FG000|Overall Study|Polyposis identified during procedure|1|||
30883843|NCT02345889|58916537|FG001|Overall Study|Polyposis identified during procedure|1|||
30883844|NCT02345889|58916538|FG002|Overall Study|Polyposis identified during procedure|0|||
30883845|NCT02345889|58916539|FG003|Overall Study|Polyposis identified during procedure|1|||
30883846|NCT02345889|58916536|FG000|Overall Study|Recognized ineligible post-randomization|1|||
30883847|NCT02345889|58916537|FG001|Overall Study|Recognized ineligible post-randomization|0|||
30883848|NCT02345889|58916538|FG002|Overall Study|Recognized ineligible post-randomization|2|||
30883849|NCT02345889|58916539|FG003|Overall Study|Recognized ineligible post-randomization|1|||
30883850|NCT02345889|58916536|FG000|Overall Study|Ulcerative Colitis identified|1|||
30883851|NCT02345889|58916537|FG001|Overall Study|Ulcerative Colitis identified|0|||
30883852|NCT02345889|58916538|FG002|Overall Study|Ulcerative Colitis identified|0|||
30883853|NCT02345889|58916539|FG003|Overall Study|Ulcerative Colitis identified|0|||
30883854|NCT02345889|58916536|FG000|Overall Study|Cecum not intubated|1|||
30883855|NCT02345889|58916537|FG001|Overall Study|Cecum not intubated|0|||
30883856|NCT02345889|58916538|FG002|Overall Study|Cecum not intubated|0|||
30883857|NCT02345889|58916539|FG003|Overall Study|Cecum not intubated|0|||
30883858|NCT02345811|58916549|FG000|First Intervention|Withdrawal by Subject|1|||
30883859|NCT02345811|58916550|FG001|First Intervention|Withdrawal by Subject|1|||
30883860|NCT02344173|58916558|FG000|Procedure|Ablation Procedure Not Performed|7|||
30883861|NCT02344173|58916558|FG000|12-month Visit|Death|8|||
30883862|NCT02344173|58916558|FG000|12-month Visit|Withdrawal by Subject|30|||
30883863|NCT02344173|58916558|FG000|12-month Visit|Lost to Follow-up|58|||
30883864|NCT02586493|58916564|FG000|Overall Study|Adverse Event|4|||
30883865|NCT02586493|58916564|FG000|Overall Study|Protocol Violation|6|||
30883866|NCT02586493|58916564|FG000|Overall Study|Lost to Follow-up|1|||
30883867|NCT02586493|58916564|FG000|Overall Study|Withdrawal by Subject|1|||
30883868|NCT02400333|58916572|FG000|Overall Study|Withdrawal by Subject|0|||
30883869|NCT02400333|58916573|FG001|Overall Study|Withdrawal by Subject|1|||
30883870|NCT02400333|58916574|FG002|Overall Study|Withdrawal by Subject|0|||
30883871|NCT02400333|58916575|FG003|Overall Study|Withdrawal by Subject|1|||
30883872|NCT02400333|58916572|FG000|Overall Study|Protocol Violation|1|||
30883873|NCT02400333|58916573|FG001|Overall Study|Protocol Violation|0|||
30975783|NCT02597478|59059722|FG001|Overall Study|Change of opioid dose|0|||
30883874|NCT02400333|58916574|FG002|Overall Study|Protocol Violation|2|||
30883875|NCT02400333|58916575|FG003|Overall Study|Protocol Violation|1|||
30883876|NCT02399475|58916588|FG000|Overall Study|Physician Decision|1|||
30883877|NCT02399475|58916589|FG001|Overall Study|Physician Decision|0|||
30883878|NCT02399163|58916595|FG000|Overall Study|Adverse Event|2|||
30883879|NCT02399163|58916595|FG000|Overall Study|Protocol Deviation|2|||
30883880|NCT02399163|58916595|FG000|Overall Study|Withdrawal by Participant|5|||
30883881|NCT02398227|58916609|FG000|Overall Study|Lost to Follow-up|21|||
30883882|NCT02398227|58916610|FG001|Overall Study|Lost to Follow-up|12|||
30883883|NCT02398227|58916609|FG000|Overall Study|Withdrawal by Subject|5|||
30883884|NCT02398227|58916610|FG001|Overall Study|Withdrawal by Subject|6|||
30883885|NCT02398227|58916609|FG000|Overall Study|Removed from treatment and dropped out|1|||
30883886|NCT02398227|58916610|FG001|Overall Study|Removed from treatment and dropped out|0|||
30883887|NCT02397915|58916616|FG000|Period 1|Protocol Violation|0|||
30883888|NCT02397915|58916617|FG001|Period 1|Protocol Violation|1|||
30883889|NCT02397915|58916618|FG002|Period 1|Protocol Violation|0|||
30883890|NCT02397915|58916619|FG003|Period 1|Protocol Violation|0|||
30883891|NCT02397915|58916616|FG000|Period 1|Physician Decision|1|||
30883892|NCT02397915|58916617|FG001|Period 1|Physician Decision|0|||
30883893|NCT02397915|58916618|FG002|Period 1|Physician Decision|0|||
30883894|NCT02397915|58916619|FG003|Period 1|Physician Decision|0|||
30883895|NCT02397837|58916629|FG000|Overall Study|Withdrawal by Subject|6|||
30883896|NCT02397837|58916630|FG001|Overall Study|Withdrawal by Subject|5|||
30883897|NCT02397837|58916629|FG000|Overall Study|Physician Decision|1|||
30883898|NCT02397837|58916630|FG001|Overall Study|Physician Decision|1|||
30883899|NCT02586415|58916638|FG000|Overall Study|Death|13|||
30883900|NCT02586415|58916639|FG001|Overall Study|Death|23|||
30975784|NCT02597478|59059721|FG000|Overall Study|Insufficient exertional dyspnea|0|||
30975785|NCT02597478|59059722|FG001|Overall Study|Insufficient exertional dyspnea|1|||
30883901|NCT02586415|58916638|FG000|Overall Study|Lost to Follow-up|1|||
30883902|NCT02586415|58916639|FG001|Overall Study|Lost to Follow-up|2|||
30883903|NCT02383017|58916648|FG000|Overall Study|Injury Sustained Outside Study|1|||
30883904|NCT02383017|58916649|FG001|Overall Study|Injury Sustained Outside Study|0|||
30883905|NCT02383017|58916648|FG000|Overall Study|Compliance|3|||
30883906|NCT02383017|58916649|FG001|Overall Study|Compliance|2|||
30883907|NCT02383017|58916648|FG000|Overall Study|Found to be Hypogonadal|1|||
30883908|NCT02383017|58916649|FG001|Overall Study|Found to be Hypogonadal|0|||
30883909|NCT02382939|58916657|FG000|Overall Study|Adverse Event|1|||
30883910|NCT02382939|58916658|FG001|Overall Study|Adverse Event|1|||
30883911|NCT02382939|58916657|FG000|Overall Study|Withdrawal by Subject|2|||
30883912|NCT02382939|58916658|FG001|Overall Study|Withdrawal by Subject|2|||
30883913|NCT02587819|58916665|FG000|Overall Study|Adverse Event|1|||
30883914|NCT02587819|58916665|FG000|Overall Study|Lost to Follow-up|1|||
30883915|NCT01666951|58916672|FG000|Overall Study|Not dosed|1|||
30883916|NCT01666951|58916673|FG001|Overall Study|Not dosed|1|||
30883917|NCT02586805|58916683|FG000|Overall Study|Withdrawal by Subject|3|||
30883918|NCT02586805|58916684|FG001|Overall Study|Withdrawal by Subject|1|||
30883919|NCT02586805|58916685|FG002|Overall Study|Withdrawal by Subject|1|||
30883920|NCT02586805|58916686|FG003|Overall Study|Withdrawal by Subject|2|||
30883921|NCT02586805|58916683|FG000|Overall Study|Adverse Event|2|||
30883922|NCT02586805|58916684|FG001|Overall Study|Adverse Event|0|||
30883923|NCT02586805|58916685|FG002|Overall Study|Adverse Event|1|||
30883924|NCT02586805|58916686|FG003|Overall Study|Adverse Event|0|||
30883925|NCT02586805|58916683|FG000|Overall Study|Lost to Follow-up|0|||
30883926|NCT02586805|58916684|FG001|Overall Study|Lost to Follow-up|0|||
30883927|NCT02586805|58916685|FG002|Overall Study|Lost to Follow-up|1|||
30975786|NCT01471028|59059817|FG000|VTI-208|Adverse Event|39|||
30975787|NCT01471028|59059818|FG001|VTI-208|Adverse Event|41|||
30975788|NCT01471028|59059817|FG000|VTI-208|Withdrawal by Subject|0|||
30975789|NCT01471028|59059818|FG001|VTI-208|Withdrawal by Subject|2|||
30975790|NCT01471028|59059817|FG000|VTI-208|Lost to Follow-up|1|||
30975791|NCT01471028|59059818|FG001|VTI-208|Lost to Follow-up|1|||
30975792|NCT01471028|59059817|FG000|VTI-208E|Death|7|||
30883928|NCT02586805|58916686|FG003|Overall Study|Lost to Follow-up|0|||
30883929|NCT02586805|58916683|FG000|Overall Study|Physician Decision|1|||
30883930|NCT02586805|58916684|FG001|Overall Study|Physician Decision|0|||
30883931|NCT02586805|58916685|FG002|Overall Study|Physician Decision|0|||
30883932|NCT02586805|58916686|FG003|Overall Study|Physician Decision|0|||
30883933|NCT02586727|58916698|FG000|Overall Study|Lost to Follow-up|1|||
30883934|NCT02586727|58916699|FG001|Overall Study|Lost to Follow-up|0|||
30883935|NCT02580877|58916707|FG000|Overall Study|Withdrawal by Subject|1|||
30883936|NCT02580877|58916708|FG001|Overall Study|Withdrawal by Subject|3|||
30883937|NCT02580877|58916707|FG000|Overall Study|Adverse Event|0|||
30883938|NCT02580877|58916708|FG001|Overall Study|Adverse Event|1|||
30975793|NCT01471028|59059818|FG001|VTI-208E|Death|10|||
30883939|NCT02582983|58916724|FG000|Overall Study|Death|3|||
30883940|NCT02582983|58916724|FG000|Overall Study|Withdrawal by Subject|2|||
30883941|NCT02582983|58916724|FG000|Overall Study|Adverse Event|1|||
30883942|NCT02582749|58916730|FG000|Overall Study|Study terminated by funder|5|||
30883943|NCT02582749|58916731|FG001|Overall Study|Study terminated by funder|10|||
30883944|NCT02582749|58916730|FG000|Overall Study|Withdrawal by Subject|0|||
30883945|NCT02582749|58916731|FG001|Overall Study|Withdrawal by Subject|1|||
30883946|NCT02582671|58916737|FG000|Overall Study|Failure to return|1|||
30883947|NCT02582671|58916737|FG000|Overall Study|Other, not specified|1|||
30883948|NCT02585713|58916744|FG000|Overall Study|Withdrew prior to treatment|2|||
30883949|NCT02585713|58916745|FG001|Overall Study|Withdrew prior to treatment|7|||
30883950|NCT02585713|58916744|FG000|Overall Study|Other|3|||
30883951|NCT02585713|58916745|FG001|Overall Study|Other|1|||
30883952|NCT02579863|58916753|FG000|Overall Study|Final Disposition Unknown|2|||
30883953|NCT02579863|58916754|FG001|Overall Study|Final Disposition Unknown|1|||
30883954|NCT02579863|58916753|FG000|Overall Study|Adverse Event|18|||
30883955|NCT02579863|58916754|FG001|Overall Study|Adverse Event|11|||
30883956|NCT02579863|58916753|FG000|Overall Study|Death|31|||
30883957|NCT02579863|58916754|FG001|Overall Study|Death|29|||
30883958|NCT02579863|58916753|FG000|Overall Study|Lost to Follow-up|2|||
30883959|NCT02579863|58916754|FG001|Overall Study|Lost to Follow-up|1|||
30883960|NCT02579863|58916753|FG000|Overall Study|Physician Decision|1|||
30883961|NCT02579863|58916754|FG001|Overall Study|Physician Decision|2|||
30883962|NCT02579863|58916753|FG000|Overall Study|Screen Failure|0|||
30883963|NCT02579863|58916754|FG001|Overall Study|Screen Failure|2|||
30883964|NCT02579863|58916753|FG000|Overall Study|Study Terminated at Selected Sites|82|||
30883965|NCT02579863|58916754|FG001|Overall Study|Study Terminated at Selected Sites|88|||
30883966|NCT02579863|58916753|FG000|Overall Study|Withdrawal by Subject|20|||
30883967|NCT02579863|58916754|FG001|Overall Study|Withdrawal by Subject|20|||
30883968|NCT02582515|58916762|FG000|Overall Study|Withdrawal by Subject|0|||
30883969|NCT02582515|58916763|FG001|Overall Study|Withdrawal by Subject|1|||
30883970|NCT02579629|58916772|FG000|Overall Study|Withdrawal by Subject|0|||
30883971|NCT02579629|58916773|FG001|Overall Study|Withdrawal by Subject|1|||
30883972|NCT02579629|58916774|FG002|Overall Study|Withdrawal by Subject|0|||
30883973|NCT02579629|58916772|FG000|Overall Study|Screen Failure|2|||
30883974|NCT02579629|58916773|FG001|Overall Study|Screen Failure|0|||
30883975|NCT02579629|58916774|FG002|Overall Study|Screen Failure|2|||
30883976|NCT02343939|58916791|FG000|Overall Study|Death|0|||
30883977|NCT02343939|58916792|FG001|Overall Study|Death|15|||
30883978|NCT02343939|58916793|FG002|Overall Study|Death|4|||
30883979|NCT02343939|58916794|FG003|Overall Study|Death|2|||
30883980|NCT02343939|58916795|FG004|Overall Study|Death|5|||
30883981|NCT02343939|58916796|FG005|Overall Study|Death|11|||
30883982|NCT02343939|58916797|FG006|Overall Study|Death|8|||
30883983|NCT02343939|58916798|FG007|Overall Study|Death|22|||
30883984|NCT02343939|58916799|FG008|Overall Study|Death|1|||
30883985|NCT02343939|58916791|FG000|Overall Study|Study terminated by sponsor|0|||
30883986|NCT02343939|58916792|FG001|Overall Study|Study terminated by sponsor|27|||
30883987|NCT02343939|58916793|FG002|Overall Study|Study terminated by sponsor|0|||
30883988|NCT02343939|58916794|FG003|Overall Study|Study terminated by sponsor|1|||
30883989|NCT02343939|58916795|FG004|Overall Study|Study terminated by sponsor|1|||
30883990|NCT02343939|58916796|FG005|Overall Study|Study terminated by sponsor|5|||
30883991|NCT02343939|58916797|FG006|Overall Study|Study terminated by sponsor|3|||
30883992|NCT02343939|58916798|FG007|Overall Study|Study terminated by sponsor|4|||
30883993|NCT02343939|58916799|FG008|Overall Study|Study terminated by sponsor|0|||
30883994|NCT02343939|58916791|FG000|Overall Study|Withdrew consent|3|||
30883995|NCT02343939|58916792|FG001|Overall Study|Withdrew consent|6|||
30883996|NCT02343939|58916793|FG002|Overall Study|Withdrew consent|1|||
30883997|NCT02343939|58916794|FG003|Overall Study|Withdrew consent|2|||
30883998|NCT02343939|58916795|FG004|Overall Study|Withdrew consent|2|||
30883999|NCT02343939|58916796|FG005|Overall Study|Withdrew consent|0|||
30884000|NCT02343939|58916797|FG006|Overall Study|Withdrew consent|0|||
30884001|NCT02343939|58916798|FG007|Overall Study|Withdrew consent|8|||
30884002|NCT02343939|58916799|FG008|Overall Study|Withdrew consent|6|||
30884003|NCT02343939|58916791|FG000|Overall Study|Treatment failure|0|||
30884004|NCT02343939|58916792|FG001|Overall Study|Treatment failure|0|||
30884005|NCT02343939|58916793|FG002|Overall Study|Treatment failure|0|||
30884006|NCT02343939|58916794|FG003|Overall Study|Treatment failure|0|||
30975794|NCT01471028|59059817|FG000|VTI-208E|Withdrawal by Subject|1|||
30884007|NCT02343939|58916795|FG004|Overall Study|Treatment failure|0|||
30884008|NCT02343939|58916796|FG005|Overall Study|Treatment failure|0|||
30884009|NCT02343939|58916797|FG006|Overall Study|Treatment failure|2|||
30884010|NCT02343939|58916798|FG007|Overall Study|Treatment failure|1|||
30790139|NCT00048035|58803327|FG007|Core Period|Early Withdrawals|0|||
30884011|NCT02343939|58916799|FG008|Overall Study|Treatment failure|0|||
30884012|NCT02343939|58916791|FG000|Overall Study|Investigator's discretion|0|||
30884013|NCT02343939|58916792|FG001|Overall Study|Investigator's discretion|0|||
30884014|NCT02343939|58916793|FG002|Overall Study|Investigator's discretion|0|||
30884015|NCT02343939|58916794|FG003|Overall Study|Investigator's discretion|1|||
30884016|NCT02343939|58916795|FG004|Overall Study|Investigator's discretion|0|||
30975795|NCT01471028|59059818|FG001|VTI-208E|Withdrawal by Subject|0|||
30884017|NCT02343939|58916796|FG005|Overall Study|Investigator's discretion|0|||
30884018|NCT02343939|58916797|FG006|Overall Study|Investigator's discretion|1|||
30884019|NCT02343939|58916798|FG007|Overall Study|Investigator's discretion|0|||
30884020|NCT02343939|58916799|FG008|Overall Study|Investigator's discretion|0|||
30884021|NCT02343939|58916791|FG000|Overall Study|Adverse Event|0|||
30884022|NCT02343939|58916792|FG001|Overall Study|Adverse Event|0|||
30884023|NCT02343939|58916793|FG002|Overall Study|Adverse Event|0|||
30884024|NCT02343939|58916794|FG003|Overall Study|Adverse Event|0|||
30884025|NCT02343939|58916795|FG004|Overall Study|Adverse Event|0|||
30884026|NCT02343939|58916796|FG005|Overall Study|Adverse Event|1|||
30884027|NCT02343939|58916797|FG006|Overall Study|Adverse Event|0|||
30884028|NCT02343939|58916798|FG007|Overall Study|Adverse Event|0|||
30884029|NCT02343939|58916799|FG008|Overall Study|Adverse Event|0|||
30884030|NCT02343939|58916791|FG000|Overall Study|Never Treated With ENTO|0|||
30884031|NCT02343939|58916792|FG001|Overall Study|Never Treated With ENTO|0|||
30884032|NCT02343939|58916793|FG002|Overall Study|Never Treated With ENTO|0|||
30884033|NCT02343939|58916794|FG003|Overall Study|Never Treated With ENTO|0|||
30884034|NCT02343939|58916795|FG004|Overall Study|Never Treated With ENTO|0|||
30884035|NCT02343939|58916796|FG005|Overall Study|Never Treated With ENTO|0|||
30884036|NCT02343939|58916797|FG006|Overall Study|Never Treated With ENTO|1|||
30884037|NCT02343939|58916798|FG007|Overall Study|Never Treated With ENTO|2|||
30884038|NCT02343939|58916799|FG008|Overall Study|Never Treated With ENTO|0|||
30884039|NCT02397447|58916835|FG000|Overall Study|Lost to Follow-up|2|||
30884040|NCT02397447|58916836|FG001|Overall Study|Lost to Follow-up|2|||
30884041|NCT02397057|58916844|FG000|Overall Study|Withdrawal by Subject|6|||
30884042|NCT02397057|58916845|FG001|Overall Study|Withdrawal by Subject|7|||
30884043|NCT02397057|58916844|FG000|Overall Study|Lost to Follow-up|4|||
30884044|NCT02397057|58916845|FG001|Overall Study|Lost to Follow-up|3|||
30884045|NCT02397057|58916844|FG000|Overall Study|Death|1|||
30884046|NCT02397057|58916845|FG001|Overall Study|Death|0|||
30884047|NCT02397057|58916844|FG000|Overall Study|Adverse Event|0|||
30884048|NCT02397057|58916845|FG001|Overall Study|Adverse Event|1|||
30884049|NCT02397057|58916844|FG000|Overall Study|Physician Decision|0|||
30884050|NCT02397057|58916845|FG001|Overall Study|Physician Decision|1|||
30884051|NCT02397057|58916844|FG000|Overall Study|Subject did not receive study drug|0|||
30884052|NCT02397057|58916845|FG001|Overall Study|Subject did not receive study drug|1|||
30884053|NCT02343549|58916851|FG000|Overall Study|Death|11|||
30884054|NCT02343549|58916851|FG000|Overall Study|Withdrawal by Subject|2|||
30884055|NCT02343159|58916858|FG000|Overall Study|Early Study Termination|16|||
30884056|NCT02343159|58916859|FG001|Overall Study|Early Study Termination|19|||
30884057|NCT02343159|58916860|FG002|Overall Study|Early Study Termination|23|||
30884058|NCT02343159|58916858|FG000|Overall Study|Physician Decision|2|||
30884059|NCT02343159|58916859|FG001|Overall Study|Physician Decision|0|||
30884060|NCT02343159|58916860|FG002|Overall Study|Physician Decision|1|||
30884061|NCT02343159|58916858|FG000|Overall Study|Withdrawal by Subject|3|||
30884062|NCT02343159|58916859|FG001|Overall Study|Withdrawal by Subject|0|||
30884063|NCT02343159|58916860|FG002|Overall Study|Withdrawal by Subject|2|||
30884064|NCT02343159|58916858|FG000|Overall Study|Lost to Follow-up|0|||
30884065|NCT02343159|58916859|FG001|Overall Study|Lost to Follow-up|2|||
30884066|NCT02343159|58916860|FG002|Overall Study|Lost to Follow-up|2|||
30884067|NCT02343159|58916858|FG000|Overall Study|Adverse Event|4|||
30884068|NCT02343159|58916859|FG001|Overall Study|Adverse Event|4|||
30884069|NCT02343159|58916860|FG002|Overall Study|Adverse Event|2|||
30884070|NCT02343159|58916858|FG000|Overall Study|Sponsor Decision|0|||
30975796|NCT01471028|59059817|FG000|VTI-208E|Lost to Follow-up|0|||
30790140|NCT00048035|58803320|FG000|Extension Year 1|Early Withdrawals|0|||
30790141|NCT00048035|58803321|FG001|Extension Year 1|Early Withdrawals|0|||
30790142|NCT00048035|58803322|FG002|Extension Year 1|Early Withdrawals|0|||
30790143|NCT00048035|58803323|FG003|Extension Year 1|Early Withdrawals|0|||
30790144|NCT00048035|58803324|FG004|Extension Year 1|Early Withdrawals|0|||
30790145|NCT00048035|58803325|FG005|Extension Year 1|Early Withdrawals|0|||
30790146|NCT00048035|58803326|FG006|Extension Year 1|Early Withdrawals|11|||
30790147|NCT00048035|58803327|FG007|Extension Year 1|Early Withdrawals|11|||
30790148|NCT00048035|58803320|FG000|Extension Year 2|Early Withdrawals|0|||
30790149|NCT00048035|58803321|FG001|Extension Year 2|Early Withdrawals|0|||
30790150|NCT00048035|58803322|FG002|Extension Year 2|Early Withdrawals|0|||
30884071|NCT02343159|58916859|FG001|Overall Study|Sponsor Decision|1|||
30884072|NCT02343159|58916860|FG002|Overall Study|Sponsor Decision|0|||
30884073|NCT02343159|58916858|FG000|Overall Study|Enrollment Error|1|||
30884074|NCT02343159|58916859|FG001|Overall Study|Enrollment Error|0|||
30884075|NCT02343159|58916860|FG002|Overall Study|Enrollment Error|0|||
30884076|NCT02395653|58916869|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
30884077|NCT02395653|58916869|FG000|Overall Study|Consent Withdrawn at Screening|1|||
30884078|NCT02395653|58916869|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
30884079|NCT02395653|58916869|FG000|Overall Study|Investigator Decision at Screening|1|||
30884080|NCT02395653|58916869|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
30884081|NCT02395653|58916869|FG000|Overall Study|Withdrawal by Subject|1|||
30884082|NCT02395653|58916869|FG000|Overall Study|Lost to Follow-up|1|||
30975797|NCT01471028|59059818|FG001|VTI-208E|Lost to Follow-up|2|||
30884083|NCT01664923|58916875|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
30884084|NCT01664923|58916876|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
30884085|NCT01664923|58916875|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
30884086|NCT01664923|58916876|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
30884087|NCT01664923|58916875|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
30884088|NCT01664923|58916876|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
30884089|NCT01664923|58916875|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
30884090|NCT01664923|58916876|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
30884091|NCT01664923|58916875|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
30884092|NCT01664923|58916876|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
30884093|NCT01664923|58916875|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
30884094|NCT01664923|58916876|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
30884095|NCT01664923|58916875|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
30884096|NCT01664923|58916876|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
30884097|NCT01664923|58916875|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
30884098|NCT01664923|58916876|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
30884099|NCT01664923|58916875|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
30884100|NCT01664923|58916876|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
30884101|NCT01664923|58916875|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
30884102|NCT01664923|58916876|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
30884103|NCT01664923|58916875|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
30884104|NCT01664923|58916876|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
30884105|NCT01664923|58916875|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
30884106|NCT01664923|58916876|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
30884107|NCT01664923|58916875|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
30884108|NCT01664923|58916876|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
30884109|NCT01664923|58916875|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
30884110|NCT01664923|58916876|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
30884111|NCT01664533|58916886|FG000|Overall Study|Death|42|||
30884112|NCT01664533|58916886|FG000|Overall Study|Lost to Follow-up|3|||
30884113|NCT01664533|58916886|FG000|Overall Study|Study termination|9|||
30884114|NCT01664533|58916886|FG000|Overall Study|Protocol Violation|3|||
30884115|NCT02584855|58916891|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
30884116|NCT02584855|58916892|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
30884117|NCT02584855|58916893|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
30884118|NCT02584855|58916894|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
30884119|NCT02584855|58916895|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
30884120|NCT02584855|58916896|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
30884121|NCT02584855|58916891|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
30884122|NCT02584855|58916892|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
30884123|NCT02584855|58916893|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
30884124|NCT02584855|58916894|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
30884125|NCT02584855|58916895|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
30884126|NCT02584855|58916896|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
30884127|NCT02584855|58916891|FG000|Open-Label Treatment Period|Adverse Event|14|||
30884128|NCT02584855|58916892|FG001|Open-Label Treatment Period|Adverse Event|0|||
30884129|NCT02584855|58916893|FG002|Open-Label Treatment Period|Adverse Event|0|||
30884130|NCT02584855|58916894|FG003|Open-Label Treatment Period|Adverse Event|0|||
30884131|NCT02584855|58916895|FG004|Open-Label Treatment Period|Adverse Event|0|||
30884132|NCT02584855|58916896|FG005|Open-Label Treatment Period|Adverse Event|0|||
30884133|NCT02584855|58916891|FG000|Open-Label Treatment Period|Death|2|||
30884134|NCT02584855|58916892|FG001|Open-Label Treatment Period|Death|0|||
30884135|NCT02584855|58916893|FG002|Open-Label Treatment Period|Death|0|||
30884136|NCT02584855|58916894|FG003|Open-Label Treatment Period|Death|0|||
30884137|NCT02584855|58916895|FG004|Open-Label Treatment Period|Death|0|||
30884138|NCT02584855|58916896|FG005|Open-Label Treatment Period|Death|0|||
30884139|NCT02584855|58916891|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
30884140|NCT02584855|58916892|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
30884141|NCT02584855|58916893|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
30884142|NCT02584855|58916894|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
30884143|NCT02584855|58916895|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
30884144|NCT02584855|58916896|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
30884145|NCT02584855|58916891|FG000|Open-Label Treatment Period|Protocol Violation|1|||
30884146|NCT02584855|58916892|FG001|Open-Label Treatment Period|Protocol Violation|0|||
30884147|NCT02584855|58916893|FG002|Open-Label Treatment Period|Protocol Violation|0|||
30884148|NCT02584855|58916894|FG003|Open-Label Treatment Period|Protocol Violation|0|||
30884149|NCT02584855|58916895|FG004|Open-Label Treatment Period|Protocol Violation|0|||
30884150|NCT02584855|58916896|FG005|Open-Label Treatment Period|Protocol Violation|0|||
30884151|NCT02584855|58916891|FG000|Open-Label Treatment Period|No PI Available|2|||
30884152|NCT02584855|58916892|FG001|Open-Label Treatment Period|No PI Available|0|||
30884153|NCT02584855|58916893|FG002|Open-Label Treatment Period|No PI Available|0|||
30884154|NCT02584855|58916894|FG003|Open-Label Treatment Period|No PI Available|0|||
30884155|NCT02584855|58916895|FG004|Open-Label Treatment Period|No PI Available|0|||
30884156|NCT02584855|58916896|FG005|Open-Label Treatment Period|No PI Available|0|||
30884157|NCT02584855|58916891|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
30884158|NCT02584855|58916892|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
30884159|NCT02584855|58916893|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
30884160|NCT02584855|58916894|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
30884161|NCT02584855|58916895|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
30975798|NCT01491854|59059832|FG000|Overall Study|mainly due to premature termination|93|||
30975799|NCT01491854|59059832|FG000|Overall Study|Death|1|||
30975800|NCT01491854|59059832|FG000|Overall Study|Withdrawal by Subject|3|||
30975801|NCT01491854|59059832|FG000|Overall Study|Lost to Follow-up|33|||
30975802|NCT01470248|59059840|FG000|Overall Study|Withdrawal by Subject|1|||
30975803|NCT01490918|59059860|FG000|Overall Study|Lost to Follow-up|2|||
30975804|NCT01490918|59059861|FG001|Overall Study|Lost to Follow-up|1|||
30975805|NCT01490918|59059862|FG002|Overall Study|Lost to Follow-up|0|||
30975806|NCT01490918|59059860|FG000|Overall Study|Withdrawal by Subject|7|||
30975807|NCT01490918|59059861|FG001|Overall Study|Withdrawal by Subject|8|||
30975808|NCT01490918|59059862|FG002|Overall Study|Withdrawal by Subject|3|||
30975809|NCT01490918|59059860|FG000|Overall Study|Adverse Event|0|||
30975810|NCT01490918|59059861|FG001|Overall Study|Adverse Event|0|||
30975811|NCT01490918|59059862|FG002|Overall Study|Adverse Event|1|||
30975812|NCT01490918|59059860|FG000|Overall Study|other cause|4|||
30975813|NCT01490918|59059861|FG001|Overall Study|other cause|5|||
30975814|NCT01490918|59059862|FG002|Overall Study|other cause|8|||
30975815|NCT01490840|59059894|FG000|Phase 1|Lost to Follow-up|1|||
30975816|NCT01490840|59059895|FG001|Phase 1|Lost to Follow-up|0|||
30975817|NCT01490840|59059894|FG000|Phase 1|Adverse Event|2|||
30975818|NCT01490840|59059895|FG001|Phase 1|Adverse Event|1|||
30975819|NCT01490840|59059894|FG000|Phase 1|Withdrawal by Subject|6|||
30975820|NCT01490840|59059895|FG001|Phase 1|Withdrawal by Subject|5|||
30975821|NCT01490840|59059894|FG000|Phase 1|Visit 6a omitted|1|||
30975822|NCT01490840|59059895|FG001|Phase 1|Visit 6a omitted|0|||
30975823|NCT01490840|59059894|FG000|Phase 2|Withdrawal by Subject|4|||
30884162|NCT02584855|58916896|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
30975824|NCT01490840|59059895|FG001|Phase 2|Withdrawal by Subject|3|||
30975825|NCT01490840|59059894|FG000|Phase 2|Permanent interruption of fingolimod|0|||
30975826|NCT01490840|59059895|FG001|Phase 2|Permanent interruption of fingolimod|1|||
30975827|NCT01490840|59059894|FG000|Phase 2|Lost to Follow-up|1|||
30975828|NCT01490840|59059895|FG001|Phase 2|Lost to Follow-up|1|||
30975829|NCT01490840|59059894|FG000|Phase 2|Adverse Event|1|||
30975830|NCT01490840|59059895|FG001|Phase 2|Adverse Event|1|||
30975831|NCT01490450|59059927|FG000|Period 1|Lack of Efficacy|2|||
30975832|NCT01490450|59059928|FG001|Period 1|Lack of Efficacy|0|||
30975833|NCT01490450|59059929|FG002|Period 1|Lack of Efficacy|3|||
30975834|NCT01490450|59059930|FG003|Period 1|Lack of Efficacy|0|||
30975835|NCT01490450|59059927|FG000|Period 1|Adverse Event|0|||
30975836|NCT01490450|59059928|FG001|Period 1|Adverse Event|0|||
30975837|NCT01490450|59059929|FG002|Period 1|Adverse Event|0|||
30975838|NCT01490450|59059930|FG003|Period 1|Adverse Event|5|||
30975839|NCT01490450|59059927|FG000|Period 1|Request to discontinue treatment|1|||
30975840|NCT01490450|59059928|FG001|Period 1|Request to discontinue treatment|0|||
30975841|NCT01490450|59059929|FG002|Period 1|Request to discontinue treatment|0|||
30975842|NCT01490450|59059930|FG003|Period 1|Request to discontinue treatment|0|||
30975843|NCT01490450|59059927|FG000|Period 1|Withdrawal by Subject|0|||
30975844|NCT01490450|59059928|FG001|Period 1|Withdrawal by Subject|0|||
30975845|NCT01490450|59059929|FG002|Period 1|Withdrawal by Subject|0|||
30975846|NCT01490450|59059930|FG003|Period 1|Withdrawal by Subject|3|||
30975847|NCT01490450|59059927|FG000|Period 1|No longer met study criteria|0|||
30975848|NCT01490450|59059928|FG001|Period 1|No longer met study criteria|1|||
30975849|NCT01490450|59059929|FG002|Period 1|No longer met study criteria|1|||
30975850|NCT01490450|59059930|FG003|Period 1|No longer met study criteria|0|||
30975851|NCT01490450|59059927|FG000|Period 2|Lack of Efficacy|0|||
30975852|NCT01490450|59059928|FG001|Period 2|Lack of Efficacy|0|||
30975853|NCT01490450|59059929|FG002|Period 2|Lack of Efficacy|0|||
30975854|NCT01490450|59059930|FG003|Period 2|Lack of Efficacy|1|||
30975855|NCT01490450|59059927|FG000|Period 2|Adverse Event|1|||
30975856|NCT01490450|59059928|FG001|Period 2|Adverse Event|1|||
30975857|NCT01490450|59059929|FG002|Period 2|Adverse Event|0|||
30884163|NCT02584855|58916891|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
30975858|NCT01490450|59059930|FG003|Period 2|Adverse Event|1|||
30975859|NCT01490450|59059927|FG000|Period 2|Withdrawal by Subject|1|||
30975860|NCT01490450|59059928|FG001|Period 2|Withdrawal by Subject|0|||
30975861|NCT01490450|59059929|FG002|Period 2|Withdrawal by Subject|0|||
30975862|NCT01490450|59059930|FG003|Period 2|Withdrawal by Subject|0|||
30975863|NCT01490450|59059927|FG000|Period 2|Lost to Follow-up|0|||
30975864|NCT01490450|59059928|FG001|Period 2|Lost to Follow-up|0|||
30975865|NCT01490450|59059929|FG002|Period 2|Lost to Follow-up|0|||
30975866|NCT01490450|59059930|FG003|Period 2|Lost to Follow-up|2|||
30884164|NCT02584855|58916892|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
30884165|NCT02584855|58916893|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
30884166|NCT02584855|58916894|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
30884167|NCT02584855|58916895|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
30884168|NCT02584855|58916896|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
30884169|NCT02584855|58916891|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
30884170|NCT02584855|58916892|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
30884171|NCT02584855|58916893|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
30884172|NCT02584855|58916894|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
30884173|NCT02584855|58916895|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
30884174|NCT02584855|58916896|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
30884175|NCT02584855|58916891|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
30884176|NCT02584855|58916892|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
30884177|NCT02584855|58916893|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
30884178|NCT02584855|58916894|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
30884179|NCT02584855|58916895|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
30884180|NCT02584855|58916896|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
30884181|NCT02584855|58916891|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
30884182|NCT02584855|58916892|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
30884183|NCT02584855|58916893|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
30884184|NCT02584855|58916894|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
30884185|NCT02584855|58916895|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
30884186|NCT02584855|58916896|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
30884187|NCT02584855|58916891|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
30884188|NCT02584855|58916892|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
30884189|NCT02584855|58916893|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
30884190|NCT02584855|58916894|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
30884191|NCT02584855|58916895|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
30884192|NCT02584855|58916896|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
30884193|NCT02584855|58916891|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
30884194|NCT02584855|58916892|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
30884195|NCT02584855|58916893|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
30884196|NCT02584855|58916894|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
30884197|NCT02584855|58916895|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
30884198|NCT02584855|58916896|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
30884199|NCT02581891|58916911|FG000|Overall Study|Adverse Event|4|||
30884200|NCT02581891|58916912|FG001|Overall Study|Adverse Event|6|||
30884201|NCT02581891|58916911|FG000|Overall Study|Death|3|||
30975867|NCT01469546|59059974|FG000|Received 5 mg Dose|Adverse Event|13|||
30975868|NCT01469546|59059974|FG000|Received 5 mg Dose|Death|2|||
30975869|NCT01469546|59059974|FG000|Received 5 mg Dose|Protocol Violation|2|||
30975870|NCT01469546|59059974|FG000|Received 5 mg Dose|Progressive Disease|3|||
30975871|NCT01469546|59059974|FG000|Received 5 mg Dose|Physician Decision|3|||
30975872|NCT00081497|59059980|FG000|Overall Study|Adverse Event|2|||
30975873|NCT00081497|59059981|FG001|Overall Study|Adverse Event|0|||
30975874|NCT00081497|59059980|FG000|Overall Study|Death|0|||
30884202|NCT02581891|58916912|FG001|Overall Study|Death|4|||
30884203|NCT02581891|58916911|FG000|Overall Study|Lost to Follow-up|1|||
30884204|NCT02581891|58916912|FG001|Overall Study|Lost to Follow-up|2|||
30884205|NCT02581891|58916911|FG000|Overall Study|Physician Decision|0|||
30884206|NCT02581891|58916912|FG001|Overall Study|Physician Decision|1|||
30884207|NCT02581891|58916911|FG000|Overall Study|Withdrawal by Subject|4|||
30884208|NCT02581891|58916912|FG001|Overall Study|Withdrawal by Subject|5|||
30884209|NCT02581891|58916911|FG000|Overall Study|Other Reasons|3|||
30884210|NCT02581891|58916912|FG001|Overall Study|Other Reasons|1|||
30884211|NCT02581891|58916911|FG000|Overall Study|Discontinued during followup|1|||
30884212|NCT02581891|58916912|FG001|Overall Study|Discontinued during followup|0|||
30884213|NCT02581345|58916921|FG000|Part 1: up to Week 16|Adverse Event|3|||
30884214|NCT02581345|58916922|FG001|Part 1: up to Week 16|Adverse Event|8|||
30884215|NCT02581345|58916923|FG002|Part 1: up to Week 16|Adverse Event|0|||
30884216|NCT02581345|58916924|FG003|Part 1: up to Week 16|Adverse Event|0|||
30884217|NCT02581345|58916921|FG000|Part 1: up to Week 16|Physician Decision|2|||
30884218|NCT02581345|58916922|FG001|Part 1: up to Week 16|Physician Decision|4|||
30884219|NCT02581345|58916923|FG002|Part 1: up to Week 16|Physician Decision|0|||
30975875|NCT00081497|59059981|FG001|Overall Study|Death|1|||
30884220|NCT02581345|58916924|FG003|Part 1: up to Week 16|Physician Decision|0|||
30884221|NCT02581345|58916921|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
30884222|NCT02581345|58916922|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
30884223|NCT02581345|58916923|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
30975876|NCT00081497|59059980|FG000|Overall Study|Withdrawal by Subject|1|||
30975877|NCT00081497|59059981|FG001|Overall Study|Withdrawal by Subject|0|||
30884224|NCT02581345|58916924|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
30884225|NCT02581345|58916921|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
30884226|NCT02581345|58916922|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
30884227|NCT02581345|58916923|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
30884228|NCT02581345|58916924|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
30884229|NCT02581345|58916921|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
30884230|NCT02581345|58916922|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
30884231|NCT02581345|58916923|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
30884232|NCT02581345|58916924|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
30884233|NCT02581345|58916921|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
30884234|NCT02581345|58916922|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
30884235|NCT02581345|58916923|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
30884236|NCT02581345|58916924|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
30884237|NCT02581345|58916921|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
30884238|NCT02581345|58916922|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
30884239|NCT02581345|58916923|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
30884240|NCT02581345|58916924|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
30884241|NCT02581345|58916921|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
30884242|NCT02581345|58916922|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
30884243|NCT02581345|58916923|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
30884244|NCT02581345|58916924|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
30884245|NCT02581345|58916921|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
30884246|NCT02581345|58916922|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
30884247|NCT02581345|58916923|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
30884248|NCT02581345|58916924|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
30884249|NCT02581345|58916921|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
30884250|NCT02581345|58916922|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
30884251|NCT02581345|58916923|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
30884252|NCT02581345|58916924|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
30884253|NCT02581345|58916921|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
30884254|NCT02581345|58916922|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
30884255|NCT02581345|58916923|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
30884256|NCT02581345|58916924|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
30884257|NCT02581345|58916921|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
30884258|NCT02581345|58916922|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
30884259|NCT02581345|58916923|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
30884260|NCT02581345|58916924|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
30884261|NCT02581189|58916942|FG000|Overall Study|Failure to return|36|||
30884262|NCT02581189|58916942|FG000|Overall Study|Withdrew consent|5|||
30884263|NCT02581189|58916942|FG000|Overall Study|Death|3|||
30884264|NCT02581189|58916942|FG000|Overall Study|Insufficient virological response|2|||
30884265|NCT02581189|58916942|FG000|Overall Study|Other, not specified|7|||
30884266|NCT00352027|58916949|FG000|Overall Study|Progressive disease|3|||
30884267|NCT02576977|58916977|FG000|Overall Study|Adverse Event|13|||
30884268|NCT02576977|58916978|FG001|Overall Study|Adverse Event|2|||
30884269|NCT02576977|58916977|FG000|Overall Study|Death|73|||
30884270|NCT02576977|58916978|FG001|Overall Study|Death|60|||
30884271|NCT02576977|58916977|FG000|Overall Study|Screen failure|1|||
30884272|NCT02576977|58916978|FG001|Overall Study|Screen failure|0|||
30884273|NCT02576977|58916977|FG000|Overall Study|Study Terminated at Selected Sites|27|||
30884274|NCT02576977|58916978|FG001|Overall Study|Study Terminated at Selected Sites|50|||
30884275|NCT02576977|58916977|FG000|Overall Study|Withdrawal by Subject|11|||
30884276|NCT02576977|58916978|FG001|Overall Study|Withdrawal by Subject|11|||
30884277|NCT02576977|58916977|FG000|Overall Study|Final Disposition Unknown|0|||
30884278|NCT02576977|58916978|FG001|Overall Study|Final Disposition Unknown|1|||
30884279|NCT02576977|58916977|FG000|Overall Study|Lost to Follow-up|1|||
30884280|NCT02576977|58916978|FG001|Overall Study|Lost to Follow-up|0|||
30884281|NCT02576977|58916977|FG000|Overall Study|Progressive Disease|0|||
30884282|NCT02576977|58916978|FG001|Overall Study|Progressive Disease|1|||
30884283|NCT05150964|58916984|FG000|Overall Study|Lost to Follow-up|2|||
30884284|NCT04952402|58916992|FG000|Overall Study|Lost to Follow-up|1|||
30884285|NCT04952402|58916993|FG001|Overall Study|Lost to Follow-up|3|||
30884286|NCT04952402|58916992|FG000|Overall Study|Lack Of Venous Access|0|||
30884287|NCT04952402|58916993|FG001|Overall Study|Lack Of Venous Access|1|||
30884288|NCT04378010|58917032|FG000|Overall Study|Adverse Event|8|||
30884289|NCT04378010|58917033|FG001|Overall Study|Adverse Event|14|||
30884290|NCT04378010|58917034|FG002|Overall Study|Adverse Event|4|||
30884291|NCT04378010|58917032|FG000|Overall Study|Withdrawal by Subject|0|||
30975878|NCT00081497|59059980|FG000|Overall Study|Non-compliance|0|||
30975879|NCT00081497|59059981|FG001|Overall Study|Non-compliance|1|||
30975880|NCT00081263|59059995|FG000|Overall Study|clerical error|1|||
30975881|NCT00081263|59059996|FG001|Overall Study|clerical error|0|||
30975882|NCT00081263|59059995|FG000|Overall Study|wrong cell type|7|||
30975883|NCT00081263|59059996|FG001|Overall Study|wrong cell type|5|||
30975884|NCT00081263|59059995|FG000|Overall Study|improper pre-protocol therapy|0|||
30884292|NCT04378010|58917033|FG001|Overall Study|Withdrawal by Subject|2|||
30884293|NCT04378010|58917034|FG002|Overall Study|Withdrawal by Subject|1|||
30884294|NCT04378010|58917032|FG000|Overall Study|Protocol Violation|2|||
30884295|NCT04378010|58917033|FG001|Overall Study|Protocol Violation|1|||
30884296|NCT04378010|58917034|FG002|Overall Study|Protocol Violation|4|||
30884297|NCT04378010|58917032|FG000|Overall Study|Study terminated by Sponsor|22|||
30884298|NCT04378010|58917033|FG001|Overall Study|Study terminated by Sponsor|16|||
30884299|NCT04378010|58917034|FG002|Overall Study|Study terminated by Sponsor|22|||
30884300|NCT04378010|58917032|FG000|Overall Study|Subject inability to complete study visit|0|||
30884301|NCT04378010|58917033|FG001|Overall Study|Subject inability to complete study visit|0|||
30884302|NCT04378010|58917034|FG002|Overall Study|Subject inability to complete study visit|1|||
30884303|NCT04378010|58917032|FG000|Overall Study|Subject never dosed|0|||
30884304|NCT04378010|58917033|FG001|Overall Study|Subject never dosed|1|||
30884305|NCT04378010|58917034|FG002|Overall Study|Subject never dosed|0|||
30884306|NCT04349072|58917045|FG000|Randomization Period|Found ineligible post enrollment|0|||
30884307|NCT04349072|58917046|FG001|Randomization Period|Found ineligible post enrollment|1|||
30884308|NCT04349072|58917045|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
30884309|NCT04349072|58917046|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
30884310|NCT04349072|58917045|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
30884311|NCT04349072|58917046|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
30884312|NCT04349072|58917045|FG000|Treatment Period|Physician Decision|0|||
30884313|NCT04349072|58917046|FG001|Treatment Period|Physician Decision|1|||
30884314|NCT04349072|58917045|FG000|Treatment Period|Protocol Violation|0|||
30884315|NCT04349072|58917046|FG001|Treatment Period|Protocol Violation|1|||
30884316|NCT04349072|58917045|FG000|Treatment Period|Withdrawal by Subject|1|||
30884317|NCT04349072|58917046|FG001|Treatment Period|Withdrawal by Subject|1|||
30884318|NCT04240886|58917052|FG000|Treatment Phase|Death|4|||
30884319|NCT04240886|58917052|FG000|Treatment Phase|Discontinuation by Subject|1|||
30884320|NCT04240886|58917052|FG000|Treatment Phase|Adverse Event|5|||
30884321|NCT04240886|58917052|FG000|Follow-up Phase|Withdrawal by Subject|1|||
30884322|NCT04240886|58917052|FG000|Follow-up Phase|Discontinuation by Subject|1|||
30884323|NCT04240886|58917052|FG000|Follow-up Phase|Death|2|||
30884324|NCT04074161|58917068|FG000|Overall Study|Withdrawal by Subject|2|||
30884325|NCT04074161|58917069|FG001|Overall Study|Withdrawal by Subject|4|||
30884326|NCT04074161|58917070|FG002|Overall Study|Withdrawal by Subject|1|||
30884327|NCT04074161|58917068|FG000|Overall Study|Lost to Follow-up|4|||
30884328|NCT04074161|58917069|FG001|Overall Study|Lost to Follow-up|5|||
30884329|NCT04074161|58917070|FG002|Overall Study|Lost to Follow-up|3|||
30884330|NCT03966157|58917080|FG000|Overall Study|Physician Decision|1|||
30884331|NCT03966157|58917081|FG001|Overall Study|Physician Decision|0|||
30884332|NCT03733210|58917089|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
30975885|NCT00081263|59059996|FG001|Overall Study|improper pre-protocol therapy|1|||
30975886|NCT00081263|59059995|FG000|Overall Study|Inadequate pathology|0|||
30975887|NCT00081263|59059996|FG001|Overall Study|Inadequate pathology|1|||
30975888|NCT00081263|59059995|FG000|Overall Study|Never treated|4|||
30975889|NCT00081263|59059996|FG001|Overall Study|Never treated|5|||
30975890|NCT00081263|59059995|FG000|Overall Study|Inadequate data|5|||
30975891|NCT00081263|59059996|FG001|Overall Study|Inadequate data|10|||
30975892|NCT01490294|59060006|FG000|Overall Study|Prematurely discontinuation|4|||
30975893|NCT01490294|59060007|FG001|Overall Study|Prematurely discontinuation|0|||
30975894|NCT01490294|59060008|FG002|Overall Study|Prematurely discontinuation|1|||
30975895|NCT01490294|59060009|FG003|Overall Study|Prematurely discontinuation|1|||
30975896|NCT01490294|59060006|FG000|Overall Study|Adverse Event|1|||
30975897|NCT01490294|59060007|FG001|Overall Study|Adverse Event|0|||
30975898|NCT01490294|59060008|FG002|Overall Study|Adverse Event|0|||
30975899|NCT01490294|59060009|FG003|Overall Study|Adverse Event|0|||
30975900|NCT00080483|59060036|FG000|Overall Study|Lost to Follow-up|1|||
30975901|NCT00080483|59060037|FG001|Overall Study|Lost to Follow-up|1|||
30975902|NCT00080483|59060036|FG000|Overall Study|Physician Decision|1|||
30975903|NCT00080483|59060037|FG001|Overall Study|Physician Decision|1|||
30975904|NCT00089141|59060058|FG000|Overall Study|Termination of trial|18|||
30884333|NCT03733210|58917090|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
30884334|NCT03698994|58917096|FG000|Overall Study|Adverse Event|2|||
30884335|NCT03698994|58917096|FG000|Overall Study|Death|1|||
30884336|NCT03698994|58917096|FG000|Overall Study|Physician Decision|1|||
30884337|NCT03698994|58917096|FG000|Overall Study|Withdrawal by Subject|3|||
30884338|NCT03698994|58917096|FG000|Overall Study|Progressive Disease|12|||
30884339|NCT03627468|58917102|FG000|Overall Study|Adverse Event|5|||
30884340|NCT03627468|58917103|FG001|Overall Study|Adverse Event|33|||
30884341|NCT03627468|58917102|FG000|Overall Study|Withdrawal by Subject|13|||
30884342|NCT03627468|58917103|FG001|Overall Study|Withdrawal by Subject|23|||
30884343|NCT03627468|58917102|FG000|Overall Study|Physician Decision|1|||
30884344|NCT03627468|58917103|FG001|Overall Study|Physician Decision|0|||
30884345|NCT03627468|58917102|FG000|Overall Study|Protocol Violation|0|||
30884346|NCT03627468|58917103|FG001|Overall Study|Protocol Violation|2|||
30975905|NCT00089141|59060059|FG001|Overall Study|Termination of trial|24|||
30975906|NCT02588664|59060105|FG000|Overall Study|Death|56|||
30975907|NCT02588664|59060106|FG001|Overall Study|Death|55|||
30975908|NCT02588664|59060105|FG000|Overall Study|Lost to Follow-up|1305|||
30975909|NCT02588664|59060106|FG001|Overall Study|Lost to Follow-up|990|||
30975910|NCT00083759|59060169|FG000|Overall Study|Adverse Event|5|||
30884347|NCT03627468|58917102|FG000|Overall Study|Lost to Follow-up|10|||
30884348|NCT03627468|58917103|FG001|Overall Study|Lost to Follow-up|16|||
30884349|NCT03627468|58917102|FG000|Overall Study|Death|1|||
30884350|NCT03627468|58917103|FG001|Overall Study|Death|0|||
30884351|NCT03627468|58917102|FG000|Overall Study|Pregnancy|1|||
30884352|NCT03627468|58917103|FG001|Overall Study|Pregnancy|1|||
30884353|NCT03627468|58917102|FG000|Overall Study|Lack of Efficacy|0|||
30884354|NCT03627468|58917103|FG001|Overall Study|Lack of Efficacy|2|||
30884355|NCT03627468|58917102|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
30884356|NCT03627468|58917103|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
30884357|NCT03595176|58917111|FG000|Overall Study|Death|0|||
30884358|NCT03595176|58917112|FG001|Overall Study|Death|2|||
30884359|NCT03595176|58917111|FG000|Overall Study|Lost to Follow-up|0|||
30884360|NCT03595176|58917112|FG001|Overall Study|Lost to Follow-up|1|||
30884361|NCT03052816|58917121|FG000|Overall Study|Withdrawal by Subject|1|||
30884362|NCT03052816|58917122|FG001|Overall Study|Withdrawal by Subject|0|||
30884363|NCT03052816|58917121|FG000|Overall Study|Desired opioids|2|||
30884364|NCT03052816|58917122|FG001|Overall Study|Desired opioids|0|||
30884365|NCT02684058|58917142|FG000|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|61|||
30884366|NCT02684058|58917143|FG001|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|8|||
30884367|NCT02684058|58917144|FG002|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|21|||
30884368|NCT02684058|58917142|FG000|Treatment Period|Progressive disease|5|||
30884369|NCT02684058|58917143|FG001|Treatment Period|Progressive disease|9|||
30884370|NCT02684058|58917144|FG002|Treatment Period|Progressive disease|16|||
30884371|NCT02684058|58917142|FG000|Treatment Period|Adverse Event|3|||
30884372|NCT02684058|58917143|FG001|Treatment Period|Adverse Event|6|||
30884373|NCT02684058|58917144|FG002|Treatment Period|Adverse Event|1|||
30884374|NCT02684058|58917142|FG000|Treatment Period|Physician Decision|2|||
30884375|NCT02684058|58917143|FG001|Treatment Period|Physician Decision|1|||
30884376|NCT02684058|58917144|FG002|Treatment Period|Physician Decision|1|||
30884377|NCT02684058|58917142|FG000|Treatment Period|New therapy for study indication|1|||
30884378|NCT02684058|58917143|FG001|Treatment Period|New therapy for study indication|0|||
30884379|NCT02684058|58917144|FG002|Treatment Period|New therapy for study indication|0|||
30884380|NCT02684058|58917142|FG000|Treatment Period|Protocol deviation|0|||
30884381|NCT02684058|58917143|FG001|Treatment Period|Protocol deviation|1|||
30884382|NCT02684058|58917144|FG002|Treatment Period|Protocol deviation|0|||
30884383|NCT02684058|58917142|FG000|Treatment Period|Patient/guardian decision|1|||
30884384|NCT02684058|58917143|FG001|Treatment Period|Patient/guardian decision|3|||
30884385|NCT02684058|58917144|FG002|Treatment Period|Patient/guardian decision|0|||
30884386|NCT02684058|58917142|FG000|Treatment Period|Death|0|||
30884387|NCT02684058|58917143|FG001|Treatment Period|Death|0|||
30884388|NCT02684058|58917144|FG002|Treatment Period|Death|2|||
30884389|NCT02684058|58917142|FG000|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|5|||
30884390|NCT02684058|58917143|FG001|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|13|||
30884391|NCT02684058|58917144|FG002|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|2|||
30884392|NCT02684058|58917142|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
30884393|NCT02684058|58917143|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
30884394|NCT02684058|58917144|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
30884395|NCT02684058|58917142|FG000|Post-treatment Efficacy Follow-up|Progressive disease|0|||
30884396|NCT02684058|58917143|FG001|Post-treatment Efficacy Follow-up|Progressive disease|1|||
30884397|NCT02684058|58917144|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
30884398|NCT02684058|58917142|FG000|Post-treatment Efficacy Follow-up|Patient/guardian decision|1|||
30884399|NCT02684058|58917143|FG001|Post-treatment Efficacy Follow-up|Patient/guardian decision|0|||
30884400|NCT02684058|58917144|FG002|Post-treatment Efficacy Follow-up|Patient/guardian decision|0|||
30884401|NCT02684058|58917142|FG000|Post-treatment Efficacy Follow-up|Death|0|||
30884402|NCT02684058|58917143|FG001|Post-treatment Efficacy Follow-up|Death|0|||
30884403|NCT02684058|58917144|FG002|Post-treatment Efficacy Follow-up|Death|3|||
30884404|NCT02684058|58917142|FG000|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|4|||
30884405|NCT02684058|58917143|FG001|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|0|||
30884406|NCT02684058|58917144|FG002|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|2|||
30884407|NCT02684058|58917142|FG000|Survival Follow-up|Other|2|||
30884408|NCT02684058|58917143|FG001|Survival Follow-up|Other|1|||
30884409|NCT02684058|58917144|FG002|Survival Follow-up|Other|0|||
30884410|NCT02684058|58917142|FG000|Survival Follow-up|Death|0|||
30884411|NCT02684058|58917143|FG001|Survival Follow-up|Death|0|||
30884412|NCT02684058|58917144|FG002|Survival Follow-up|Death|6|||
30975911|NCT00083759|59060170|FG001|Overall Study|Adverse Event|3|||
30884413|NCT02684058|58917142|FG000|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|0|||
30884414|NCT02684058|58917143|FG001|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|8|||
30884415|NCT02684058|58917144|FG002|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|0|||
30884416|NCT02684058|58917142|FG000|Crossover Treatment Period|Progressive disease|0|||
30884417|NCT02684058|58917143|FG001|Crossover Treatment Period|Progressive disease|1|||
30884418|NCT02684058|58917144|FG002|Crossover Treatment Period|Progressive disease|0|||
30884419|NCT02684058|58917142|FG000|Crossover Survival Follow-up|Death|0|||
30884420|NCT02684058|58917143|FG001|Crossover Survival Follow-up|Death|1|||
30884421|NCT02684058|58917144|FG002|Crossover Survival Follow-up|Death|0|||
30884422|NCT02682238|58917160|FG000|Overall Study|Lost to Follow-up|0|||
30884423|NCT02682238|58917161|FG001|Overall Study|Lost to Follow-up|2|||
30884424|NCT02682238|58917160|FG000|Overall Study|Withdrawal by Subject|1|||
30884425|NCT02682238|58917161|FG001|Overall Study|Withdrawal by Subject|0|||
30884426|NCT02682238|58917160|FG000|Overall Study|Adverse Event|1|||
30884427|NCT02682238|58917161|FG001|Overall Study|Adverse Event|0|||
30884428|NCT02682238|58917160|FG000|Overall Study|Non-compliance with Study Drug|1|||
30884429|NCT02682238|58917161|FG001|Overall Study|Non-compliance with Study Drug|0|||
30884430|NCT02682238|58917160|FG000|Overall Study|Non-compliance with Protocol|0|||
30884431|NCT02682238|58917161|FG001|Overall Study|Non-compliance with Protocol|2|||
30884432|NCT02657356|58917185|FG000|Overall Study|Death|1|||
30884433|NCT02657356|58917186|FG001|Overall Study|Death|0|||
30884434|NCT02657356|58917185|FG000|Overall Study|Withdrawal by Subject|5|||
30884435|NCT02657356|58917186|FG001|Overall Study|Withdrawal by Subject|6|||
30884436|NCT02657356|58917185|FG000|Overall Study|Terminated by Sponsor|8|||
30884437|NCT02657356|58917186|FG001|Overall Study|Terminated by Sponsor|5|||
30884438|NCT02657356|58917185|FG000|Overall Study|Rolled over to EAP study|6|||
30884439|NCT02657356|58917186|FG001|Overall Study|Rolled over to EAP study|4|||
30884440|NCT01719562|58917212|FG000|Overall Study|Lost to Follow-up|1|||
30884441|NCT01719562|58917213|FG001|Overall Study|Lost to Follow-up|0|||
30884442|NCT01719562|58917212|FG000|Overall Study|Death|1|||
30884443|NCT01719562|58917213|FG001|Overall Study|Death|0|||
30884444|NCT01719562|58917212|FG000|Overall Study|New cancer diagnosis|1|||
30884445|NCT01719562|58917213|FG001|Overall Study|New cancer diagnosis|0|||
30884446|NCT01700439|58917219|FG000|Overall Study|Lost to Follow-up|47|||
30884447|NCT01700439|58917219|FG000|Overall Study|Withdrawal by Subject|183|||
30884448|NCT01700439|58917219|FG000|Overall Study|Death|186|||
30884449|NCT01433289|58917241|FG000|Overall Study|Pregnancy|0|||
30884450|NCT01433289|58917242|FG001|Overall Study|Pregnancy|1|||
30884451|NCT01433289|58917243|FG002|Overall Study|Pregnancy|0|||
30884452|NCT01433289|58917244|FG003|Overall Study|Pregnancy|0|||
30884453|NCT02576587|58917288|FG000|Baseline|Equipment failure|0|||
30884454|NCT02576587|58917289|FG001|Baseline|Equipment failure|1|||
30884455|NCT02576587|58917288|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
30884456|NCT02576587|58917289|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
30884457|NCT02576587|58917288|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
30884458|NCT02576587|58917289|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
30884459|NCT02576587|58917288|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
30884460|NCT02576587|58917289|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
30884461|NCT03016975|58917313|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
30884462|NCT03016975|58917314|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
30884463|NCT03016975|58917315|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
30884464|NCT03016975|58917313|FG000|At 6 Months Follow-up|Death|2|||
30884465|NCT03016975|58917314|FG001|At 6 Months Follow-up|Death|0|||
30884466|NCT03016975|58917315|FG002|At 6 Months Follow-up|Death|0|||
30884467|NCT03016975|58917313|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
30884468|NCT03016975|58917314|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
30884469|NCT03016975|58917315|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
30884470|NCT03016975|58917313|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
30884471|NCT03016975|58917314|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
30884472|NCT03016975|58917315|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
30884473|NCT03016975|58917313|FG000|At 6 Months Follow-up|Aborted implant|1|||
30884474|NCT03016975|58917314|FG001|At 6 Months Follow-up|Aborted implant|0|||
30884475|NCT03016975|58917315|FG002|At 6 Months Follow-up|Aborted implant|0|||
30884476|NCT03016975|58917313|FG000|At 2 Year Follow-up|Death|1|||
30884477|NCT03016975|58917314|FG001|At 2 Year Follow-up|Death|0|||
30884478|NCT03016975|58917315|FG002|At 2 Year Follow-up|Death|0|||
30884479|NCT03016975|58917313|FG000|At 3 Year Follow-up|Death|1|||
30884480|NCT03016975|58917314|FG001|At 3 Year Follow-up|Death|0|||
30884481|NCT03016975|58917315|FG002|At 3 Year Follow-up|Death|0|||
30884482|NCT03016975|58917313|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
30884483|NCT03016975|58917314|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
30884484|NCT03016975|58917315|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
30884485|NCT05340751|58917369|FG000|Overall Study|Physician Decision|3|||
30884486|NCT02575807|58917378|FG000|Overall Study|Death|8|||
30884487|NCT02575807|58917379|FG001|Overall Study|Death|3|||
30884488|NCT02575807|58917380|FG002|Overall Study|Death|7|||
30884489|NCT02575807|58917381|FG003|Overall Study|Death|0|||
30884490|NCT02575807|58917382|FG004|Overall Study|Death|1|||
30884491|NCT02575807|58917378|FG000|Overall Study|Study terminated by Sponsor|0|||
30884492|NCT02575807|58917379|FG001|Overall Study|Study terminated by Sponsor|1|||
30884493|NCT02575807|58917380|FG002|Overall Study|Study terminated by Sponsor|7|||
30884494|NCT02575807|58917381|FG003|Overall Study|Study terminated by Sponsor|0|||
30884495|NCT02575807|58917382|FG004|Overall Study|Study terminated by Sponsor|1|||
30884496|NCT02575807|58917378|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
30884497|NCT02575807|58917379|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
30884498|NCT02575807|58917380|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
30884499|NCT02575807|58917381|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
30884500|NCT02575807|58917382|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
30884501|NCT02575807|58917378|FG000|Overall Study|Terminated due to physician decision|0|||
30884502|NCT02575807|58917379|FG001|Overall Study|Terminated due to physician decision|0|||
30884503|NCT02575807|58917380|FG002|Overall Study|Terminated due to physician decision|1|||
30884504|NCT02575807|58917381|FG003|Overall Study|Terminated due to physician decision|0|||
30884505|NCT02575807|58917382|FG004|Overall Study|Terminated due to physician decision|0|||
30884506|NCT02575807|58917378|FG000|Overall Study|Subject ineligible - medical implant|0|||
30884507|NCT02575807|58917379|FG001|Overall Study|Subject ineligible - medical implant|0|||
30884508|NCT02575807|58917380|FG002|Overall Study|Subject ineligible - medical implant|0|||
30884509|NCT02575807|58917381|FG003|Overall Study|Subject ineligible - medical implant|1|||
30884510|NCT02575807|58917382|FG004|Overall Study|Subject ineligible - medical implant|0|||
30884511|NCT02575807|58917378|FG000|Overall Study|Withdrawal by Subject|0|||
30884512|NCT02575807|58917379|FG001|Overall Study|Withdrawal by Subject|0|||
30884513|NCT02575807|58917380|FG002|Overall Study|Withdrawal by Subject|1|||
30884514|NCT02575807|58917381|FG003|Overall Study|Withdrawal by Subject|1|||
30884515|NCT02575807|58917382|FG004|Overall Study|Withdrawal by Subject|2|||
30884516|NCT02575339|58917417|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
30884517|NCT02575339|58917418|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
30884518|NCT02575339|58917419|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
30884519|NCT02575339|58917417|FG000|Study Treatment|Disease Progression|5|||
30884520|NCT02575339|58917418|FG001|Study Treatment|Disease Progression|2|||
30884521|NCT02575339|58917419|FG002|Study Treatment|Disease Progression|0|||
30884522|NCT02575339|58917417|FG000|Study Treatment|Adverse Event|1|||
30884523|NCT02575339|58917418|FG001|Study Treatment|Adverse Event|2|||
30884524|NCT02575339|58917419|FG002|Study Treatment|Adverse Event|0|||
30884525|NCT02575339|58917417|FG000|Follow up|Death|6|||
30884526|NCT02575339|58917418|FG001|Follow up|Death|2|||
30884527|NCT02575339|58917419|FG002|Follow up|Death|0|||
30884528|NCT02575339|58917417|FG000|Follow up|Study Terminated|0|||
30884529|NCT02575339|58917418|FG001|Follow up|Study Terminated|2|||
30884530|NCT02575339|58917419|FG002|Follow up|Study Terminated|0|||
30884531|NCT02575339|58917417|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
30884532|NCT02575339|58917418|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
30884533|NCT02575339|58917419|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
30884534|NCT01712659|58917432|FG000|Dose Escalation|Physician Decision|0|||
30884535|NCT01712659|58917433|FG001|Dose Escalation|Physician Decision|1|||
30884536|NCT01712659|58917434|FG002|Dose Escalation|Physician Decision|0|||
30884537|NCT01712659|58917435|FG003|Dose Escalation|Physician Decision|0|||
30884538|NCT01712659|58917436|FG004|Dose Escalation|Physician Decision|0|||
30884539|NCT01712659|58917432|FG000|Dose Escalation|Unable to take study drug|0|||
30884540|NCT01712659|58917433|FG001|Dose Escalation|Unable to take study drug|1|||
30884541|NCT01712659|58917434|FG002|Dose Escalation|Unable to take study drug|0|||
30884542|NCT01712659|58917435|FG003|Dose Escalation|Unable to take study drug|0|||
30884543|NCT01712659|58917436|FG004|Dose Escalation|Unable to take study drug|0|||
30884544|NCT01712659|58917432|FG000|Dose Expansion|Early disease progression|1|||
30884545|NCT01712659|58917433|FG001|Dose Expansion|Early disease progression|0|||
30884546|NCT01712659|58917434|FG002|Dose Expansion|Early disease progression|0|||
30884547|NCT01712659|58917435|FG003|Dose Expansion|Early disease progression|0|||
30884548|NCT01712659|58917436|FG004|Dose Expansion|Early disease progression|0|||
30884549|NCT01712659|58917432|FG000|Dose Expansion|Physician Decision|1|||
30884550|NCT01712659|58917433|FG001|Dose Expansion|Physician Decision|0|||
30884551|NCT01712659|58917434|FG002|Dose Expansion|Physician Decision|0|||
30884552|NCT01712659|58917435|FG003|Dose Expansion|Physician Decision|0|||
30884553|NCT01712659|58917436|FG004|Dose Expansion|Physician Decision|0|||
30884554|NCT01610713|58917462|FG000|Overall Study|Adverse Event|3|||
30884555|NCT01610713|58917463|FG001|Overall Study|Adverse Event|0|||
30884556|NCT01610713|58917462|FG000|Overall Study|Lack of Efficacy|1|||
30884557|NCT01610713|58917463|FG001|Overall Study|Lack of Efficacy|0|||
30884558|NCT01610713|58917462|FG000|Overall Study|low mood and poor motivation|1|||
30884559|NCT01610713|58917463|FG001|Overall Study|low mood and poor motivation|0|||
30884560|NCT01610713|58917462|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
30884561|NCT01610713|58917463|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
30884562|NCT01610713|58917462|FG000|Overall Study|Lost to Follow-up|0|||
30884563|NCT01610713|58917463|FG001|Overall Study|Lost to Follow-up|1|||
30884564|NCT01606189|58917469|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
30884565|NCT01606189|58917470|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
30884566|NCT01606189|58917471|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
30884567|NCT01606189|58917472|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
30884568|NCT01606189|58917473|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
30884569|NCT01606189|58917474|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
30884570|NCT01606189|58917469|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
30884571|NCT01606189|58917470|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
30884572|NCT01606189|58917471|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
30884573|NCT01606189|58917472|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
30884574|NCT01606189|58917473|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
30884575|NCT01606189|58917474|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
30884576|NCT01663987|58917484|FG000|Overall Study|Adverse Event|7|||
30884577|NCT01663987|58917485|FG001|Overall Study|Adverse Event|2|||
30884578|NCT01663987|58917484|FG000|Overall Study|Lost to Follow-up|1|||
30884579|NCT01663987|58917485|FG001|Overall Study|Lost to Follow-up|1|||
30884580|NCT01663987|58917484|FG000|Overall Study|Withdrawal by Subject|2|||
30884581|NCT01663987|58917485|FG001|Overall Study|Withdrawal by Subject|3|||
30884582|NCT01663987|58917484|FG000|Overall Study|Other reason not defined above|3|||
30884583|NCT01663987|58917485|FG001|Overall Study|Other reason not defined above|0|||
30884584|NCT02380677|58917503|FG000|Overall Study|Adverse Event|0|||
30884585|NCT02380677|58917504|FG001|Overall Study|Adverse Event|0|||
30884586|NCT02380677|58917505|FG002|Overall Study|Adverse Event|0|||
30884587|NCT02380677|58917506|FG003|Overall Study|Adverse Event|1|||
30884588|NCT02380677|58917507|FG004|Overall Study|Adverse Event|1|||
30884589|NCT02380677|58917508|FG005|Overall Study|Adverse Event|4|||
30884590|NCT02380677|58917509|FG006|Overall Study|Adverse Event|2|||
30884591|NCT02380677|58917510|FG007|Overall Study|Adverse Event|2|||
30884592|NCT02380677|58917511|FG008|Overall Study|Adverse Event|2|||
30884593|NCT02380677|58917512|FG009|Overall Study|Adverse Event|1|||
30884594|NCT02380677|58917513|FG010|Overall Study|Adverse Event|2|||
30884595|NCT02380677|58917514|FG011|Overall Study|Adverse Event|1|||
30884596|NCT02380677|58917503|FG000|Overall Study|Physician Decision|1|||
30884597|NCT02380677|58917504|FG001|Overall Study|Physician Decision|0|||
30884598|NCT02380677|58917505|FG002|Overall Study|Physician Decision|1|||
30884599|NCT02380677|58917506|FG003|Overall Study|Physician Decision|1|||
30884600|NCT02380677|58917507|FG004|Overall Study|Physician Decision|0|||
30884601|NCT02380677|58917508|FG005|Overall Study|Physician Decision|0|||
30884602|NCT02380677|58917509|FG006|Overall Study|Physician Decision|0|||
30884603|NCT02380677|58917510|FG007|Overall Study|Physician Decision|0|||
30884604|NCT02380677|58917511|FG008|Overall Study|Physician Decision|0|||
30884605|NCT02380677|58917512|FG009|Overall Study|Physician Decision|0|||
30884606|NCT02380677|58917513|FG010|Overall Study|Physician Decision|0|||
30884607|NCT02380677|58917514|FG011|Overall Study|Physician Decision|0|||
30884608|NCT02380677|58917503|FG000|Overall Study|Lack of Efficacy|0|||
30884609|NCT02380677|58917504|FG001|Overall Study|Lack of Efficacy|1|||
30884610|NCT02380677|58917505|FG002|Overall Study|Lack of Efficacy|2|||
30884611|NCT02380677|58917506|FG003|Overall Study|Lack of Efficacy|0|||
30884612|NCT02380677|58917507|FG004|Overall Study|Lack of Efficacy|4|||
30884613|NCT02380677|58917508|FG005|Overall Study|Lack of Efficacy|1|||
30884614|NCT02380677|58917509|FG006|Overall Study|Lack of Efficacy|1|||
30884615|NCT02380677|58917510|FG007|Overall Study|Lack of Efficacy|2|||
30884616|NCT02380677|58917511|FG008|Overall Study|Lack of Efficacy|2|||
30884617|NCT02380677|58917512|FG009|Overall Study|Lack of Efficacy|0|||
30884618|NCT02380677|58917513|FG010|Overall Study|Lack of Efficacy|2|||
30884619|NCT02380677|58917514|FG011|Overall Study|Lack of Efficacy|1|||
30884620|NCT02380677|58917503|FG000|Overall Study|Withdrawal by Subject|0|||
30884621|NCT02380677|58917504|FG001|Overall Study|Withdrawal by Subject|0|||
30884622|NCT02380677|58917505|FG002|Overall Study|Withdrawal by Subject|0|||
30884623|NCT02380677|58917506|FG003|Overall Study|Withdrawal by Subject|0|||
30884624|NCT02380677|58917507|FG004|Overall Study|Withdrawal by Subject|0|||
30884625|NCT02380677|58917508|FG005|Overall Study|Withdrawal by Subject|0|||
30884626|NCT02380677|58917509|FG006|Overall Study|Withdrawal by Subject|0|||
30884627|NCT02380677|58917510|FG007|Overall Study|Withdrawal by Subject|0|||
30884628|NCT02380677|58917511|FG008|Overall Study|Withdrawal by Subject|0|||
30884629|NCT02380677|58917512|FG009|Overall Study|Withdrawal by Subject|1|||
30884630|NCT02380677|58917513|FG010|Overall Study|Withdrawal by Subject|0|||
30884631|NCT02380677|58917514|FG011|Overall Study|Withdrawal by Subject|3|||
30884632|NCT02380677|58917503|FG000|Overall Study|Other|0|||
30884633|NCT02380677|58917504|FG001|Overall Study|Other|0|||
30884634|NCT02380677|58917505|FG002|Overall Study|Other|0|||
30884635|NCT02380677|58917506|FG003|Overall Study|Other|1|||
30884636|NCT02380677|58917507|FG004|Overall Study|Other|1|||
30884637|NCT02380677|58917508|FG005|Overall Study|Other|1|||
30884638|NCT02380677|58917509|FG006|Overall Study|Other|0|||
30884639|NCT02380677|58917510|FG007|Overall Study|Other|0|||
30884640|NCT02380677|58917511|FG008|Overall Study|Other|0|||
30884641|NCT02380677|58917512|FG009|Overall Study|Other|0|||
30884642|NCT02380677|58917513|FG010|Overall Study|Other|0|||
30884643|NCT02380677|58917514|FG011|Overall Study|Other|0|||
30884644|NCT02380287|58917550|FG000|Overall Study|Adverse Event|0|||
30884645|NCT02380287|58917551|FG001|Overall Study|Adverse Event|0|||
30884646|NCT02380287|58917552|FG002|Overall Study|Adverse Event|1|||
30884647|NCT02380287|58917553|FG003|Overall Study|Adverse Event|0|||
30884648|NCT02380287|58917554|FG004|Overall Study|Adverse Event|0|||
30884649|NCT02380287|58917555|FG005|Overall Study|Adverse Event|0|||
30884650|NCT02380287|58917556|FG006|Overall Study|Adverse Event|0|||
30884651|NCT02380287|58917557|FG007|Overall Study|Adverse Event|0|||
30884652|NCT02343003|58917584|FG000|Overall Study|Withdrawal by Subject|9|||
30884653|NCT02343003|58917585|FG001|Overall Study|Withdrawal by Subject|4|||
30884654|NCT02343003|58917584|FG000|Overall Study|Lost to Follow-up|5|||
30884655|NCT02343003|58917585|FG001|Overall Study|Lost to Follow-up|1|||
30884656|NCT02343003|58917584|FG000|Overall Study|Protocol Violation|1|||
30884657|NCT02343003|58917585|FG001|Overall Study|Protocol Violation|0|||
30884658|NCT02343003|58917584|FG000|Overall Study|Death|0|||
30884659|NCT02343003|58917585|FG001|Overall Study|Death|1|||
30884660|NCT02343003|58917584|FG000|Overall Study|exclusion criteria met|1|||
30884661|NCT02343003|58917585|FG001|Overall Study|exclusion criteria met|1|||
30884662|NCT02343003|58917584|FG000|Overall Study|terminated by sponsor|2|||
30884663|NCT02343003|58917585|FG001|Overall Study|terminated by sponsor|0|||
30884664|NCT02394561|58917593|FG000|CORE Phase|Adverse Event|7|||
30884665|NCT02394561|58917594|FG001|CORE Phase|Adverse Event|9|||
30884666|NCT02394561|58917593|FG000|CORE Phase|Death|0|||
30884667|NCT02394561|58917594|FG001|CORE Phase|Death|1|||
30884668|NCT02394561|58917593|FG000|CORE Phase|Pregnancy|1|||
30884669|NCT02394561|58917594|FG001|CORE Phase|Pregnancy|0|||
30884670|NCT02394561|58917593|FG000|CORE Phase|Lost to Follow-up|1|||
30884671|NCT02394561|58917594|FG001|CORE Phase|Lost to Follow-up|0|||
30884672|NCT02394561|58917593|FG000|CORE Phase|Physician Decision|1|||
30884673|NCT02394561|58917594|FG001|CORE Phase|Physician Decision|1|||
30884674|NCT02394561|58917593|FG000|CORE Phase|Withdrawal by Subject|2|||
30884675|NCT02394561|58917594|FG001|CORE Phase|Withdrawal by Subject|2|||
30884676|NCT02394561|58917593|FG000|CORE Phase|Lack of Efficacy|1|||
30884677|NCT02394561|58917594|FG001|CORE Phase|Lack of Efficacy|6|||
30884678|NCT02394561|58917593|FG000|Extension Phase|Adverse Event|6|||
30884679|NCT02394561|58917594|FG001|Extension Phase|Adverse Event|1|||
30884680|NCT02394561|58917593|FG000|Extension Phase|Death|0|||
30884681|NCT02394561|58917594|FG001|Extension Phase|Death|1|||
30884682|NCT02394561|58917593|FG000|Extension Phase|Protocol Violation|1|||
30884683|NCT02394561|58917594|FG001|Extension Phase|Protocol Violation|0|||
30884684|NCT02394561|58917593|FG000|Extension Phase|Lost to Follow-up|1|||
30884685|NCT02394561|58917594|FG001|Extension Phase|Lost to Follow-up|0|||
30884686|NCT02394561|58917593|FG000|Extension Phase|Physician Decision|0|||
30884687|NCT02394561|58917594|FG001|Extension Phase|Physician Decision|2|||
30884688|NCT02394561|58917593|FG000|Extension Phase|Withdrawal by Subject|0|||
30884689|NCT02394561|58917594|FG001|Extension Phase|Withdrawal by Subject|5|||
30884690|NCT02394561|58917593|FG000|Extension Phase|Lack of Efficacy|3|||
30884691|NCT02394561|58917594|FG001|Extension Phase|Lack of Efficacy|3|||
30884692|NCT02342223|58917603|FG000|Overall Study|Lost to Follow-up|1|||
30884693|NCT02393547|58917607|FG000|Overall Study|Adverse Event|2|||
30884694|NCT02393547|58917607|FG000|Overall Study|Withdrawal by Subject|3|||
30884695|NCT02393547|58917607|FG000|Overall Study|Lost to Follow-up|1|||
30884696|NCT02574637|58917616|FG000|Double-blind Period|Adverse Event|1|||
30884697|NCT02574637|58917617|FG001|Double-blind Period|Adverse Event|0|||
30884698|NCT02574637|58917618|FG002|Double-blind Period|Adverse Event|0|||
30884699|NCT02574637|58917619|FG003|Double-blind Period|Adverse Event|0|||
30884700|NCT02574637|58917620|FG004|Double-blind Period|Adverse Event|0|||
30884701|NCT02574637|58917621|FG005|Double-blind Period|Adverse Event|0|||
30884702|NCT02574637|58917622|FG006|Double-blind Period|Adverse Event|0|||
30884703|NCT02574637|58917623|FG007|Double-blind Period|Adverse Event|0|||
30884704|NCT02574637|58917624|FG008|Double-blind Period|Adverse Event|0|||
30884705|NCT02574637|58917625|FG009|Double-blind Period|Adverse Event|0|||
30884706|NCT02574637|58917616|FG000|Double-blind Period|Lack of Efficacy|0|||
30884707|NCT02574637|58917617|FG001|Double-blind Period|Lack of Efficacy|0|||
30884708|NCT02574637|58917618|FG002|Double-blind Period|Lack of Efficacy|2|||
30884709|NCT02574637|58917619|FG003|Double-blind Period|Lack of Efficacy|0|||
30884710|NCT02574637|58917620|FG004|Double-blind Period|Lack of Efficacy|0|||
30884711|NCT02574637|58917621|FG005|Double-blind Period|Lack of Efficacy|0|||
30884712|NCT02574637|58917622|FG006|Double-blind Period|Lack of Efficacy|0|||
30884713|NCT02574637|58917623|FG007|Double-blind Period|Lack of Efficacy|0|||
30884714|NCT02574637|58917624|FG008|Double-blind Period|Lack of Efficacy|0|||
30884715|NCT02574637|58917625|FG009|Double-blind Period|Lack of Efficacy|0|||
30884716|NCT02574637|58917616|FG000|Double-blind Period|Protocol Deviation|1|||
30884717|NCT02574637|58917617|FG001|Double-blind Period|Protocol Deviation|0|||
30884718|NCT02574637|58917618|FG002|Double-blind Period|Protocol Deviation|0|||
30884719|NCT02574637|58917619|FG003|Double-blind Period|Protocol Deviation|0|||
30884720|NCT02574637|58917620|FG004|Double-blind Period|Protocol Deviation|0|||
30884721|NCT02574637|58917621|FG005|Double-blind Period|Protocol Deviation|0|||
30884722|NCT02574637|58917622|FG006|Double-blind Period|Protocol Deviation|0|||
30884723|NCT02574637|58917623|FG007|Double-blind Period|Protocol Deviation|0|||
30884724|NCT02574637|58917624|FG008|Double-blind Period|Protocol Deviation|0|||
30884725|NCT02574637|58917625|FG009|Double-blind Period|Protocol Deviation|0|||
30884726|NCT02574637|58917616|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
30884727|NCT02574637|58917617|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
30884728|NCT02574637|58917618|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
30884729|NCT02574637|58917619|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
30884730|NCT02574637|58917620|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
30884731|NCT02574637|58917621|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
30884732|NCT02574637|58917622|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
30884733|NCT02574637|58917623|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
30884734|NCT02574637|58917624|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
30884735|NCT02574637|58917625|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
30884736|NCT02574637|58917616|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
30884737|NCT02574637|58917617|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
30884738|NCT02574637|58917618|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
30884739|NCT02574637|58917619|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
30884740|NCT02574637|58917620|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
30884741|NCT02574637|58917621|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
30884742|NCT02574637|58917622|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
30884743|NCT02574637|58917623|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
30884744|NCT02574637|58917624|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
30884745|NCT02574637|58917625|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
30884746|NCT02574637|58917616|FG000|Double-blind Period|Reason Not Specified|0|||
30884747|NCT02574637|58917617|FG001|Double-blind Period|Reason Not Specified|0|||
30884748|NCT02574637|58917618|FG002|Double-blind Period|Reason Not Specified|0|||
30884749|NCT02574637|58917619|FG003|Double-blind Period|Reason Not Specified|1|||
30884750|NCT02574637|58917620|FG004|Double-blind Period|Reason Not Specified|0|||
30884751|NCT02574637|58917621|FG005|Double-blind Period|Reason Not Specified|0|||
30884752|NCT02574637|58917622|FG006|Double-blind Period|Reason Not Specified|0|||
30884753|NCT02574637|58917623|FG007|Double-blind Period|Reason Not Specified|0|||
30884754|NCT02574637|58917624|FG008|Double-blind Period|Reason Not Specified|0|||
30884755|NCT02574637|58917625|FG009|Double-blind Period|Reason Not Specified|0|||
30884756|NCT02574637|58917616|FG000|Open-label (OL) Period|Adverse Event|0|||
30884757|NCT02574637|58917617|FG001|Open-label (OL) Period|Adverse Event|0|||
30884758|NCT02574637|58917618|FG002|Open-label (OL) Period|Adverse Event|0|||
30884759|NCT02574637|58917619|FG003|Open-label (OL) Period|Adverse Event|0|||
30884760|NCT02574637|58917620|FG004|Open-label (OL) Period|Adverse Event|0|||
30884761|NCT02574637|58917621|FG005|Open-label (OL) Period|Adverse Event|0|||
30884762|NCT02574637|58917622|FG006|Open-label (OL) Period|Adverse Event|0|||
30884763|NCT02574637|58917623|FG007|Open-label (OL) Period|Adverse Event|0|||
30884764|NCT02574637|58917624|FG008|Open-label (OL) Period|Adverse Event|1|||
30884765|NCT02574637|58917625|FG009|Open-label (OL) Period|Adverse Event|0|||
30884766|NCT02574637|58917616|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
30884767|NCT02574637|58917617|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
30975912|NCT00083759|59060169|FG000|Overall Study|Lost to Follow-up|1|||
30975913|NCT00083759|59060170|FG001|Overall Study|Lost to Follow-up|0|||
30975914|NCT00083759|59060169|FG000|Overall Study|Death|1|||
30975915|NCT00083759|59060170|FG001|Overall Study|Death|1|||
30884768|NCT02574637|58917618|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
30884769|NCT02574637|58917619|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
30884770|NCT02574637|58917620|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
30975916|NCT00083759|59060169|FG000|Overall Study|Inadequate Therapeutic Response|32|||
30975917|NCT00083759|59060170|FG001|Overall Study|Inadequate Therapeutic Response|35|||
30975918|NCT00083759|59060169|FG000|Overall Study|Subject Withdrew Consent|2|||
30975919|NCT00083759|59060170|FG001|Overall Study|Subject Withdrew Consent|2|||
30975920|NCT00083759|59060169|FG000|Overall Study|Non-Compliance|1|||
30975921|NCT00083759|59060170|FG001|Overall Study|Non-Compliance|0|||
30975922|NCT00083759|59060169|FG000|Overall Study|Sponsor's Discretion|28|||
30884771|NCT02574637|58917621|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
30884772|NCT02574637|58917622|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
30884773|NCT02574637|58917623|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
30975923|NCT00083759|59060170|FG001|Overall Study|Sponsor's Discretion|29|||
30975924|NCT00083759|59060169|FG000|Overall Study|Other|14|||
30975925|NCT00083759|59060170|FG001|Overall Study|Other|13|||
30884774|NCT02574637|58917624|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
30884775|NCT02574637|58917625|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
30884776|NCT02574637|58917616|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
30884777|NCT02574637|58917617|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
30884778|NCT02574637|58917618|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
30884779|NCT02574637|58917619|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
30884780|NCT02574637|58917620|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
30884781|NCT02574637|58917621|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
30884782|NCT02574637|58917622|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
30884783|NCT02574637|58917623|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
30884784|NCT02574637|58917624|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
30884785|NCT02574637|58917625|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
30884786|NCT02392611|58917655|FG000|Overall Study|Adverse Event|0|||
30884787|NCT02392611|58917656|FG001|Overall Study|Adverse Event|0|||
30884788|NCT02392611|58917657|FG002|Overall Study|Adverse Event|0|||
30884789|NCT02392611|58917658|FG003|Overall Study|Adverse Event|1|||
30884790|NCT02392611|58917659|FG004|Overall Study|Adverse Event|0|||
30884791|NCT02392611|58917660|FG005|Overall Study|Adverse Event|0|||
30884792|NCT02392611|58917661|FG006|Overall Study|Adverse Event|0|||
30884793|NCT02392611|58917662|FG007|Overall Study|Adverse Event|0|||
30884794|NCT02392611|58917663|FG008|Overall Study|Adverse Event|0|||
30884795|NCT02392611|58917655|FG000|Overall Study|Progressive disease|0|||
30884796|NCT02392611|58917656|FG001|Overall Study|Progressive disease|0|||
30975926|NCT00089609|59060296|FG000|Overall Study|Withdrawal by Subject|3|||
30975927|NCT00089609|59060297|FG001|Overall Study|Withdrawal by Subject|1|||
30975928|NCT02440581|59060438|FG000|Overall Study|Death|0|||
30975929|NCT02440581|59060439|FG001|Overall Study|Death|0|||
30975930|NCT02440581|59060440|FG002|Overall Study|Death|7|||
30975931|NCT02440581|59060441|FG003|Overall Study|Death|5|||
30975932|NCT02440581|59060438|FG000|Overall Study|Transplanted|1|||
30975933|NCT02440581|59060439|FG001|Overall Study|Transplanted|0|||
30975934|NCT02440581|59060440|FG002|Overall Study|Transplanted|3|||
30975935|NCT02440581|59060441|FG003|Overall Study|Transplanted|2|||
30975936|NCT02440581|59060438|FG000|Overall Study|Withdrawal by Subject|4|||
30975937|NCT02440581|59060439|FG001|Overall Study|Withdrawal by Subject|11|||
30975938|NCT02440581|59060440|FG002|Overall Study|Withdrawal by Subject|3|||
30975939|NCT02440581|59060441|FG003|Overall Study|Withdrawal by Subject|7|||
30975940|NCT01359150|59060453|FG000|Overall Study|Lack of Efficacy|1|||
30975941|NCT01359150|59060454|FG001|Overall Study|Lack of Efficacy|1|||
30975942|NCT01359150|59060453|FG000|Overall Study|Withdrawal by Subject|1|||
30975943|NCT01359150|59060454|FG001|Overall Study|Withdrawal by Subject|1|||
30975944|NCT01359150|59060453|FG000|Overall Study|Adverse Event|4|||
30975945|NCT01359150|59060454|FG001|Overall Study|Adverse Event|3|||
30975946|NCT01359150|59060453|FG000|Overall Study|Other|1|||
30975947|NCT01359150|59060454|FG001|Overall Study|Other|0|||
30975948|NCT01469000|59060515|FG000|Overall Study|Withdrawal by Subject|16|||
30975949|NCT01469000|59060516|FG001|Overall Study|Withdrawal by Subject|3|||
30975950|NCT01469000|59060515|FG000|Overall Study|Sponsor Decision|4|||
30975951|NCT01469000|59060516|FG001|Overall Study|Sponsor Decision|1|||
30975952|NCT01490060|59060529|FG000|Cycle 1|Change of Treatment|0|||
30975953|NCT01490060|59060530|FG001|Cycle 1|Change of Treatment|1|||
30975954|NCT01490060|59060531|FG002|Cycle 1|Change of Treatment|1|||
30975955|NCT01490060|59060532|FG003|Cycle 1|Change of Treatment|1|||
30975956|NCT01490060|59060529|FG000|Cycle 1|Insurance Denied|0|||
30975957|NCT01490060|59060530|FG001|Cycle 1|Insurance Denied|0|||
30975958|NCT01490060|59060531|FG002|Cycle 1|Insurance Denied|2|||
30975959|NCT01490060|59060532|FG003|Cycle 1|Insurance Denied|0|||
30975960|NCT01490060|59060529|FG000|Cycle 1|Withdrawal by Subject|0|||
30975961|NCT01490060|59060530|FG001|Cycle 1|Withdrawal by Subject|0|||
30975962|NCT01490060|59060531|FG002|Cycle 1|Withdrawal by Subject|0|||
30884797|NCT02392611|58917657|FG002|Overall Study|Progressive disease|0|||
30884798|NCT02392611|58917658|FG003|Overall Study|Progressive disease|2|||
30884799|NCT02392611|58917659|FG004|Overall Study|Progressive disease|1|||
30975963|NCT01490060|59060532|FG003|Cycle 1|Withdrawal by Subject|1|||
30975964|NCT01490060|59060529|FG000|Cycle 1|Treatment at Another Facility|0|||
30884800|NCT02392611|58917660|FG005|Overall Study|Progressive disease|0|||
30884801|NCT02392611|58917661|FG006|Overall Study|Progressive disease|0|||
30884802|NCT02392611|58917662|FG007|Overall Study|Progressive disease|0|||
30884803|NCT02392611|58917663|FG008|Overall Study|Progressive disease|0|||
30884804|NCT02392611|58917655|FG000|Overall Study|Death|1|||
30884805|NCT02392611|58917656|FG001|Overall Study|Death|0|||
30884806|NCT02392611|58917657|FG002|Overall Study|Death|0|||
30975965|NCT01490060|59060530|FG001|Cycle 1|Treatment at Another Facility|0|||
30884807|NCT02392611|58917658|FG003|Overall Study|Death|0|||
30975966|NCT01490060|59060531|FG002|Cycle 1|Treatment at Another Facility|0|||
30975967|NCT01490060|59060532|FG003|Cycle 1|Treatment at Another Facility|1|||
30975968|NCT01490060|59060529|FG000|Cycle 2|Change of Treatment|1|||
30975969|NCT01490060|59060530|FG001|Cycle 2|Change of Treatment|1|||
30884808|NCT02392611|58917659|FG004|Overall Study|Death|0|||
30884809|NCT02392611|58917660|FG005|Overall Study|Death|1|||
30884810|NCT02392611|58917661|FG006|Overall Study|Death|0|||
30884811|NCT02392611|58917662|FG007|Overall Study|Death|0|||
30884812|NCT02392611|58917663|FG008|Overall Study|Death|0|||
30884813|NCT02392611|58917655|FG000|Overall Study|Withdrawal by Subject|0|||
30884814|NCT02392611|58917656|FG001|Overall Study|Withdrawal by Subject|0|||
30884815|NCT02392611|58917657|FG002|Overall Study|Withdrawal by Subject|0|||
30884816|NCT02392611|58917658|FG003|Overall Study|Withdrawal by Subject|1|||
30884817|NCT02392611|58917659|FG004|Overall Study|Withdrawal by Subject|0|||
30884818|NCT02392611|58917660|FG005|Overall Study|Withdrawal by Subject|0|||
30884819|NCT02392611|58917661|FG006|Overall Study|Withdrawal by Subject|0|||
30884820|NCT02392611|58917662|FG007|Overall Study|Withdrawal by Subject|0|||
30884821|NCT02392611|58917663|FG008|Overall Study|Withdrawal by Subject|0|||
30884822|NCT02392611|58917655|FG000|Overall Study|Lost to Follow-up|0|||
30884823|NCT02392611|58917656|FG001|Overall Study|Lost to Follow-up|0|||
30884824|NCT02392611|58917657|FG002|Overall Study|Lost to Follow-up|0|||
30884825|NCT02392611|58917658|FG003|Overall Study|Lost to Follow-up|0|||
30884826|NCT02392611|58917659|FG004|Overall Study|Lost to Follow-up|0|||
30884827|NCT02392611|58917660|FG005|Overall Study|Lost to Follow-up|0|||
30884828|NCT02392611|58917661|FG006|Overall Study|Lost to Follow-up|1|||
30884829|NCT02392611|58917662|FG007|Overall Study|Lost to Follow-up|0|||
30884830|NCT02392611|58917663|FG008|Overall Study|Lost to Follow-up|0|||
30884831|NCT02392611|58917655|FG000|Overall Study|Enrolled, not treated|0|||
30884832|NCT02392611|58917656|FG001|Overall Study|Enrolled, not treated|0|||
30884833|NCT02392611|58917657|FG002|Overall Study|Enrolled, not treated|0|||
30884834|NCT02392611|58917658|FG003|Overall Study|Enrolled, not treated|2|||
30884835|NCT02392611|58917659|FG004|Overall Study|Enrolled, not treated|0|||
30884836|NCT02392611|58917660|FG005|Overall Study|Enrolled, not treated|0|||
30884837|NCT02392611|58917661|FG006|Overall Study|Enrolled, not treated|0|||
30884838|NCT02392611|58917662|FG007|Overall Study|Enrolled, not treated|0|||
30884839|NCT02392611|58917663|FG008|Overall Study|Enrolled, not treated|0|||
30884840|NCT02378961|58917687|FG000|Overall Study|Lack of Efficacy|4|||
30884841|NCT02378961|58917688|FG001|Overall Study|Lack of Efficacy|2|||
30884842|NCT02378961|58917689|FG002|Overall Study|Lack of Efficacy|0|||
30884843|NCT02378961|58917690|FG003|Overall Study|Lack of Efficacy|1|||
30884844|NCT02378961|58917687|FG000|Overall Study|Death|0|||
30884845|NCT02378961|58917688|FG001|Overall Study|Death|0|||
30884846|NCT02378961|58917689|FG002|Overall Study|Death|1|||
30884847|NCT02378961|58917690|FG003|Overall Study|Death|0|||
30884848|NCT02378883|58917700|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
30884849|NCT02378883|58917700|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
30884850|NCT02378883|58917700|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
30884851|NCT02378883|58917700|FG000|30 Day Follow-Up|Physician Decision|2|||
30884852|NCT02378883|58917700|FG000|30 Day Follow-Up|Missed Visit|2|||
30884853|NCT02378883|58917700|FG000|30 Day Follow-Up|Death|1|||
30884854|NCT02378883|58917700|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
30884855|NCT02378883|58917700|FG000|12 Months Follow-Up|Death|2|||
30884856|NCT02340975|58917711|FG000|Overall Study|Death|6|||
30884857|NCT02340975|58917712|FG001|Overall Study|Death|23|||
30884858|NCT02340975|58917713|FG002|Overall Study|Death|21|||
30884859|NCT02340975|58917714|FG003|Overall Study|Death|7|||
30884860|NCT02340975|58917715|FG004|Overall Study|Death|21|||
30884861|NCT02340975|58917716|FG005|Overall Study|Death|13|||
30884862|NCT02340975|58917711|FG000|Overall Study|Lost to Follow-up|0|||
30884863|NCT02340975|58917712|FG001|Overall Study|Lost to Follow-up|0|||
30884864|NCT02340975|58917713|FG002|Overall Study|Lost to Follow-up|0|||
30884865|NCT02340975|58917714|FG003|Overall Study|Lost to Follow-up|0|||
30884866|NCT02340975|58917715|FG004|Overall Study|Lost to Follow-up|2|||
30884867|NCT02340975|58917716|FG005|Overall Study|Lost to Follow-up|0|||
30884868|NCT02340975|58917711|FG000|Overall Study|Withdrawal by Subject|0|||
30884869|NCT02340975|58917712|FG001|Overall Study|Withdrawal by Subject|0|||
30884870|NCT02340975|58917713|FG002|Overall Study|Withdrawal by Subject|3|||
30884871|NCT02340975|58917714|FG003|Overall Study|Withdrawal by Subject|3|||
30884872|NCT02340975|58917715|FG004|Overall Study|Withdrawal by Subject|2|||
30884873|NCT02340975|58917716|FG005|Overall Study|Withdrawal by Subject|0|||
30608444|NCT01288430|58619223|FG002|Part 2|Clinical disease progression|0|||
30884874|NCT02340975|58917711|FG000|Overall Study|Other|0|||
30884875|NCT02340975|58917712|FG001|Overall Study|Other|4|||
30884876|NCT02340975|58917713|FG002|Overall Study|Other|0|||
30884877|NCT02340975|58917714|FG003|Overall Study|Other|2|||
30884878|NCT02340975|58917715|FG004|Overall Study|Other|0|||
30608445|NCT01288430|58619224|FG003|Part 2|Clinical disease progression|0|||
30884879|NCT02340975|58917716|FG005|Overall Study|Other|6|||
30884880|NCT02392377|58917733|FG000|Overall Study|Withdrawal by Subject|0|||
30884881|NCT02392377|58917734|FG001|Overall Study|Withdrawal by Subject|1|||
30884882|NCT02340819|58917742|FG000|Overall Study|Adverse Event|1|||
30884883|NCT02340819|58917742|FG000|Overall Study|Withdrawal by Subject|2|||
30884884|NCT02340819|58917742|FG000|Overall Study|Discontinued with other reason|1|||
30884885|NCT02340663|58917748|FG000|Overall Study|Lost to Follow-up|1|||
30884886|NCT02340663|58917749|FG001|Overall Study|Lost to Follow-up|0|||
30884887|NCT02340663|58917748|FG000|Overall Study|Protocol Violation|1|||
30884888|NCT02340663|58917749|FG001|Overall Study|Protocol Violation|0|||
30884889|NCT02340663|58917748|FG000|Overall Study|Withdrawal by Subject|3|||
30884890|NCT02340663|58917749|FG001|Overall Study|Withdrawal by Subject|1|||
30884891|NCT02573467|58917759|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
30884892|NCT02573467|58917760|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
30884893|NCT02573467|58917761|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
30884894|NCT02573467|58917762|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
30884895|NCT02573467|58917759|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
30884896|NCT02573467|58917760|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
30884897|NCT02573467|58917761|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
30884898|NCT02573467|58917762|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
30884899|NCT02573467|58917759|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
30884900|NCT02573467|58917760|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
30884901|NCT02573467|58917761|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
30884902|NCT02573467|58917762|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
30884903|NCT02573467|58917759|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
30884904|NCT02573467|58917760|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
30884905|NCT02573467|58917761|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
30884906|NCT02573467|58917762|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
30884907|NCT02573467|58917759|FG000|Post-treatment Follow up Epoch|Death|1|||
30884908|NCT02573467|58917760|FG001|Post-treatment Follow up Epoch|Death|1|||
30884909|NCT02573467|58917761|FG002|Post-treatment Follow up Epoch|Death|0|||
30884910|NCT02573467|58917762|FG003|Post-treatment Follow up Epoch|Death|1|||
30884911|NCT02573467|58917759|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
30884912|NCT02573467|58917760|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
30884913|NCT02573467|58917761|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
30884914|NCT02573467|58917762|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
30884915|NCT02573467|58917759|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
30884916|NCT02573467|58917760|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
30884917|NCT02573467|58917761|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
30884918|NCT02573467|58917762|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
30884919|NCT02337387|58917777|FG000|Overall Study|Adverse Event|0|||
30884920|NCT02337387|58917778|FG001|Overall Study|Adverse Event|1|||
30884921|NCT02337387|58917779|FG002|Overall Study|Adverse Event|0|||
30884922|NCT02337387|58917780|FG003|Overall Study|Adverse Event|0|||
30884923|NCT02337387|58917777|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
30884924|NCT02337387|58917778|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
30884925|NCT02337387|58917779|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
30884926|NCT02337387|58917780|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
30884927|NCT02574247|58917793|FG000|Overall Study|Withdrawal by Subject|1|||
30884928|NCT02574247|58917794|FG001|Overall Study|Withdrawal by Subject|0|||
30884929|NCT02574247|58917795|FG002|Overall Study|Withdrawal by Subject|0|||
30884930|NCT02574247|58917793|FG000|Overall Study|Did not meet inclusion criteria|4|||
30884931|NCT02574247|58917794|FG001|Overall Study|Did not meet inclusion criteria|3|||
30884932|NCT02574247|58917795|FG002|Overall Study|Did not meet inclusion criteria|5|||
30884933|NCT02391363|58917807|FG000|Overall Study|Lost to Follow-up|5|||
30884934|NCT02391363|58917808|FG001|Overall Study|Lost to Follow-up|5|||
30884935|NCT02391363|58917807|FG000|Overall Study|Withdrawal by Subject|6|||
30884936|NCT02391363|58917808|FG001|Overall Study|Withdrawal by Subject|3|||
30884937|NCT02569957|58917816|FG000|Overall Study|Withdrawal by Subject|0|||
30884938|NCT02569957|58917817|FG001|Overall Study|Withdrawal by Subject|1|||
30884939|NCT01649427|58917825|FG000|Overall Study|Adverse Event|1|||
30884940|NCT01649427|58917826|FG001|Overall Study|Adverse Event|1|||
30884941|NCT01649427|58917825|FG000|Overall Study|Withdrawal by Subject|8|||
30884942|NCT01649427|58917826|FG001|Overall Study|Withdrawal by Subject|7|||
30884943|NCT01649427|58917825|FG000|Overall Study|Lost to Follow-up|0|||
30884944|NCT01649427|58917826|FG001|Overall Study|Lost to Follow-up|1|||
30884945|NCT01649427|58917825|FG000|Overall Study|Graft loss|0|||
30884946|NCT01649427|58917826|FG001|Overall Study|Graft loss|1|||
30884947|NCT01649427|58917825|FG000|Overall Study|Surgical problems during nephrectomy|2|||
30884948|NCT01649427|58917826|FG001|Overall Study|Surgical problems during nephrectomy|2|||
30884949|NCT02375373|58917832|FG000|Overall Study|Withdrawal by Subject|11|||
30884950|NCT02336607|58917840|FG000|Overall Study|Physician Decision|1|||
30884951|NCT02336607|58917841|FG001|Overall Study|Physician Decision|4|||
30884952|NCT02336607|58917842|FG002|Overall Study|Physician Decision|3|||
30884953|NCT02336607|58917843|FG003|Overall Study|Physician Decision|15|||
30884954|NCT02336607|58917840|FG000|Overall Study|Lack of Efficacy|1|||
30884955|NCT02336607|58917841|FG001|Overall Study|Lack of Efficacy|0|||
30884956|NCT02336607|58917842|FG002|Overall Study|Lack of Efficacy|0|||
30884957|NCT02336607|58917843|FG003|Overall Study|Lack of Efficacy|2|||
30884958|NCT02336607|58917840|FG000|Overall Study|Lost to Follow-up|2|||
30884959|NCT02336607|58917841|FG001|Overall Study|Lost to Follow-up|1|||
30884960|NCT02336607|58917842|FG002|Overall Study|Lost to Follow-up|0|||
30884961|NCT02336607|58917843|FG003|Overall Study|Lost to Follow-up|21|||
30884962|NCT02336607|58917840|FG000|Overall Study|Protocol Violation|0|||
30884963|NCT02336607|58917841|FG001|Overall Study|Protocol Violation|1|||
30884964|NCT02336607|58917842|FG002|Overall Study|Protocol Violation|1|||
30884965|NCT02336607|58917843|FG003|Overall Study|Protocol Violation|3|||
30884966|NCT02336607|58917840|FG000|Overall Study|Adverse Event|0|||
30884967|NCT02336607|58917841|FG001|Overall Study|Adverse Event|2|||
30884968|NCT02336607|58917842|FG002|Overall Study|Adverse Event|2|||
30884969|NCT02336607|58917843|FG003|Overall Study|Adverse Event|26|||
30884970|NCT02336607|58917840|FG000|Overall Study|Withdrawal by Subject|0|||
30884971|NCT02336607|58917841|FG001|Overall Study|Withdrawal by Subject|2|||
30884972|NCT02336607|58917842|FG002|Overall Study|Withdrawal by Subject|0|||
30884973|NCT02336607|58917843|FG003|Overall Study|Withdrawal by Subject|20|||
30884974|NCT02374671|58917856|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
30884975|NCT02374671|58917857|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
30884976|NCT02374671|58917858|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
30884977|NCT02374671|58917856|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
30884978|NCT02374671|58917857|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
30884979|NCT02374671|58917858|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
30884980|NCT02374671|58917856|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
30884981|NCT02374671|58917857|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
30884982|NCT02374671|58917858|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
30884983|NCT02374671|58917856|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
30884984|NCT02374671|58917857|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
30884985|NCT02374671|58917858|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
30884986|NCT02374671|58917856|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
30884987|NCT02374671|58917857|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
30884988|NCT02374671|58917858|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
30884989|NCT02569801|58917866|FG000|Overall Study|Withdrawal by Subject|9|||
30884990|NCT02569801|58917867|FG001|Overall Study|Withdrawal by Subject|9|||
30884991|NCT02569801|58917866|FG000|Overall Study|Sponsor Decision|13|||
30884992|NCT02569801|58917867|FG001|Overall Study|Sponsor Decision|14|||
30884993|NCT02569801|58917866|FG000|Overall Study|Progressive Disease|2|||
30884994|NCT02569801|58917867|FG001|Overall Study|Progressive Disease|7|||
30884995|NCT02569801|58917866|FG000|Overall Study|Lost to Follow-up|0|||
30884996|NCT02569801|58917867|FG001|Overall Study|Lost to Follow-up|1|||
30884997|NCT02569801|58917866|FG000|Overall Study|Death|12|||
30884998|NCT02569801|58917867|FG001|Overall Study|Death|4|||
30884999|NCT02573311|58917875|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
30885000|NCT02573311|58917876|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
30885001|NCT02573311|58917875|FG000|Disposition for Part 2|Physician Decision|25|||
30885002|NCT02573311|58917876|FG001|Disposition for Part 2|Physician Decision|7|||
30885003|NCT02573311|58917875|FG000|Disposition for Part 2|Adverse Event|36|||
30885004|NCT02573311|58917876|FG001|Disposition for Part 2|Adverse Event|5|||
30885005|NCT02573311|58917875|FG000|Disposition for Part 2|Lost to Follow-up|76|||
30885006|NCT02573311|58917876|FG001|Disposition for Part 2|Lost to Follow-up|7|||
30885007|NCT02573311|58917875|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
30885008|NCT02573311|58917876|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
30885009|NCT02573311|58917875|FG000|Disposition for Part 2|Investigator decision|0|||
30885010|NCT02573311|58917876|FG001|Disposition for Part 2|Investigator decision|1|||
30885011|NCT02573311|58917875|FG000|Disposition for Part 2|Other than specified above|13|||
30885012|NCT02573311|58917876|FG001|Disposition for Part 2|Other than specified above|3|||
30885013|NCT02571049|58917882|FG000|Screening|Did not meet entry criteria|2|||
30885014|NCT02571049|58917883|FG001|Screening|Did not meet entry criteria|2|||
30885015|NCT02571049|58917882|FG000|Randomization|No migraine attack|0|||
30885016|NCT02571049|58917883|FG001|Randomization|No migraine attack|1|||
30885017|NCT02571049|58917882|FG000|Randomization|Adverse Event|0|||
30885018|NCT02571049|58917883|FG001|Randomization|Adverse Event|1|||
30885019|NCT02573155|58917891|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
30885020|NCT02573155|58917892|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
30885021|NCT02573155|58917891|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
30885022|NCT02573155|58917892|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
30608446|NCT01288430|58619225|FG004|Part 2|Clinical disease progression|0|||
30885023|NCT02573155|58917891|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
30885024|NCT02573155|58917892|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
30885025|NCT02573155|58917891|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
30885026|NCT02573155|58917892|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
30885027|NCT02573155|58917891|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
30885028|NCT02573155|58917892|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
30885029|NCT02573155|58917891|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
30975970|NCT01490060|59060531|FG002|Cycle 2|Change of Treatment|0|||
30885030|NCT02573155|58917892|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
30885031|NCT02573155|58917891|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
30885032|NCT02573155|58917892|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
30885033|NCT02573155|58917891|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
30885034|NCT02573155|58917892|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
30885035|NCT02568475|58917920|FG000|Overall Study|Lost to Follow-up|40|||
30885036|NCT02568475|58917921|FG001|Overall Study|Lost to Follow-up|39|||
30885037|NCT02568475|58917920|FG000|Overall Study|Withdrawal by Subject|2|||
30885038|NCT02568475|58917921|FG001|Overall Study|Withdrawal by Subject|0|||
30885039|NCT02568475|58917920|FG000|Overall Study|Discharged home|4|||
30885040|NCT02568475|58917921|FG001|Overall Study|Discharged home|4|||
30885041|NCT02568475|58917920|FG000|Overall Study|Short-term: Discharge location unknown|4|||
30885042|NCT02568475|58917921|FG001|Overall Study|Short-term: Discharge location unknown|0|||
30885043|NCT02568475|58917920|FG000|Overall Study|Transferred to another facility|1|||
30885044|NCT02568475|58917921|FG001|Overall Study|Transferred to another facility|0|||
30885045|NCT02568397|58917927|FG000|Period 2|Withdrawal by Subject|0|||
30885046|NCT02568397|58917928|FG001|Period 2|Withdrawal by Subject|1|||
30885047|NCT02568397|58917927|FG000|Period 2|Physician Decision|0|||
30885048|NCT02568397|58917928|FG001|Period 2|Physician Decision|1|||
30885049|NCT02566525|58917945|FG000|Overall Study|Protocol Violation|3|||
30885050|NCT02566525|58917946|FG001|Overall Study|Protocol Violation|5|||
30885051|NCT02567227|58917956|FG000|9 Weeks|Adverse Event|5|||
30885052|NCT02567227|58917957|FG001|9 Weeks|Adverse Event|5|||
30885053|NCT02567227|58917956|FG000|9 Weeks|Withdrawal by Subject|18|||
30885054|NCT02567227|58917957|FG001|9 Weeks|Withdrawal by Subject|8|||
30885055|NCT02567227|58917956|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
30885056|NCT02567227|58917957|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
30885057|NCT02567227|58917956|FG000|6 Month|Death|2|||
30885058|NCT02567227|58917957|FG001|6 Month|Death|0|||
30885059|NCT02567227|58917956|FG000|6 Month|Lost to Follow-up|43|||
30885060|NCT02567227|58917957|FG001|6 Month|Lost to Follow-up|40|||
30885061|NCT02567227|58917956|FG000|12 Months|Lost to Follow-up|31|||
30885062|NCT02567227|58917957|FG001|12 Months|Lost to Follow-up|32|||
30885063|NCT02567227|58917956|FG000|12 Months|Death|0|||
30885064|NCT02567227|58917957|FG001|12 Months|Death|2|||
30885065|NCT02336451|58917968|FG000|Overall Study|Adverse Event|1|||
30885066|NCT02336451|58917969|FG001|Overall Study|Adverse Event|2|||
30885067|NCT02336451|58917970|FG002|Overall Study|Adverse Event|0|||
30885068|NCT02336451|58917971|FG003|Overall Study|Adverse Event|6|||
30885069|NCT02336451|58917972|FG004|Overall Study|Adverse Event|4|||
30885070|NCT02336451|58917968|FG000|Overall Study|Death|6|||
30885071|NCT02336451|58917969|FG001|Overall Study|Death|2|||
30885072|NCT02336451|58917970|FG002|Overall Study|Death|3|||
30885073|NCT02336451|58917971|FG003|Overall Study|Death|6|||
30885074|NCT02336451|58917972|FG004|Overall Study|Death|6|||
30885075|NCT02336451|58917968|FG000|Overall Study|Physician Decision|9|||
30885076|NCT02336451|58917969|FG001|Overall Study|Physician Decision|6|||
30885077|NCT02336451|58917970|FG002|Overall Study|Physician Decision|7|||
30885078|NCT02336451|58917971|FG003|Overall Study|Physician Decision|16|||
30885079|NCT02336451|58917972|FG004|Overall Study|Physician Decision|3|||
30885080|NCT02336451|58917968|FG000|Overall Study|Progressive disease|23|||
30885081|NCT02336451|58917969|FG001|Overall Study|Progressive disease|26|||
30885082|NCT02336451|58917970|FG002|Overall Study|Progressive disease|2|||
30885083|NCT02336451|58917971|FG003|Overall Study|Progressive disease|14|||
30885084|NCT02336451|58917972|FG004|Overall Study|Progressive disease|4|||
30885085|NCT02336451|58917968|FG000|Overall Study|Protocol Violation|1|||
30885086|NCT02336451|58917969|FG001|Overall Study|Protocol Violation|0|||
30885087|NCT02336451|58917970|FG002|Overall Study|Protocol Violation|0|||
30885088|NCT02336451|58917971|FG003|Overall Study|Protocol Violation|0|||
30885089|NCT02336451|58917972|FG004|Overall Study|Protocol Violation|0|||
30975971|NCT01490060|59060532|FG003|Cycle 2|Change of Treatment|0|||
30975972|NCT01490060|59060529|FG000|Cycle 2|Non-Compliance|0|||
30885090|NCT02336451|58917968|FG000|Overall Study|Patient/guardian decision|2|||
30885091|NCT02336451|58917969|FG001|Overall Study|Patient/guardian decision|4|||
30885092|NCT02336451|58917970|FG002|Overall Study|Patient/guardian decision|0|||
30885093|NCT02336451|58917971|FG003|Overall Study|Patient/guardian decision|2|||
30885094|NCT02336451|58917972|FG004|Overall Study|Patient/guardian decision|1|||
30885095|NCT02374593|58917988|FG000|Overall Study|non-compliant|2|||
30975973|NCT01490060|59060530|FG001|Cycle 2|Non-Compliance|0|||
30885096|NCT02374593|58917989|FG001|Overall Study|non-compliant|0|||
30885097|NCT01648101|58918002|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
30885098|NCT01648101|58918003|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
30885099|NCT01648101|58918004|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
30885100|NCT01648101|58918002|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
30885101|NCT01648101|58918003|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
30885102|NCT01648101|58918004|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
30885103|NCT01648101|58918002|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
30975974|NCT01490060|59060531|FG002|Cycle 2|Non-Compliance|1|||
30885104|NCT01648101|58918003|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
30885105|NCT01648101|58918004|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
30885106|NCT01648101|58918002|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
30885107|NCT01648101|58918003|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
30885108|NCT01648101|58918004|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
30885109|NCT01648101|58918002|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
30885110|NCT01648101|58918003|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
30885111|NCT01648101|58918004|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
30885112|NCT01648101|58918002|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
30885113|NCT01648101|58918003|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
30885114|NCT01648101|58918004|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
30885115|NCT01648101|58918002|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
30885116|NCT01648101|58918003|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
30885117|NCT01648101|58918004|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
30885118|NCT01648101|58918002|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
30885119|NCT01648101|58918003|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
30885120|NCT01648101|58918004|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
30885121|NCT01648101|58918002|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
30885122|NCT01648101|58918003|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
30885123|NCT01648101|58918004|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
30885124|NCT01648101|58918002|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
30885125|NCT01648101|58918003|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
30885126|NCT01648101|58918004|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
30885127|NCT01648101|58918002|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
30885128|NCT01648101|58918003|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
30885129|NCT01648101|58918004|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
30885130|NCT02336373|58918016|FG000|Overall Study|Protocol closed early|4|||
30885131|NCT02336373|58918016|FG000|Overall Study|Physician Decision|14|||
30885132|NCT02372799|58918025|FG000|Treatment Period|Adverse Event|3|||
30885133|NCT02372799|58918026|FG001|Treatment Period|Adverse Event|10|||
30885134|NCT02372799|58918027|FG002|Treatment Period|Adverse Event|6|||
30885135|NCT02372799|58918025|FG000|Treatment Period|Insufficient therapeutic response|2|||
30885136|NCT02372799|58918026|FG001|Treatment Period|Insufficient therapeutic response|2|||
30885137|NCT02372799|58918027|FG002|Treatment Period|Insufficient therapeutic response|0|||
30885138|NCT02372799|58918025|FG000|Treatment Period|Withdrawal by Subject|10|||
30885139|NCT02372799|58918026|FG001|Treatment Period|Withdrawal by Subject|10|||
30885140|NCT02372799|58918027|FG002|Treatment Period|Withdrawal by Subject|2|||
30885141|NCT02372799|58918025|FG000|Treatment Period|Lost to Follow-up|11|||
30885142|NCT02372799|58918026|FG001|Treatment Period|Lost to Follow-up|5|||
30885143|NCT02372799|58918027|FG002|Treatment Period|Lost to Follow-up|3|||
30885144|NCT02372799|58918025|FG000|Treatment Period|Protocol Violation|3|||
30885145|NCT02372799|58918026|FG001|Treatment Period|Protocol Violation|0|||
30885146|NCT02372799|58918027|FG002|Treatment Period|Protocol Violation|0|||
30885147|NCT02372799|58918025|FG000|Treatment Period|Non-compliance with study drug|4|||
30885148|NCT02372799|58918026|FG001|Treatment Period|Non-compliance with study drug|4|||
30885149|NCT02372799|58918027|FG002|Treatment Period|Non-compliance with study drug|4|||
30885150|NCT02372799|58918025|FG000|Treatment Period|Miscellaneous Reasons|1|||
30885151|NCT02372799|58918026|FG001|Treatment Period|Miscellaneous Reasons|1|||
30885152|NCT02372799|58918027|FG002|Treatment Period|Miscellaneous Reasons|0|||
30885153|NCT02372799|58918025|FG000|Down-taper Period|Lost to Follow-up|1|||
30885154|NCT02372799|58918026|FG001|Down-taper Period|Lost to Follow-up|2|||
30885155|NCT02372799|58918027|FG002|Down-taper Period|Lost to Follow-up|2|||
30885156|NCT02566993|58918037|FG000|Overall Study|Randomized but not treated|5|||
30885157|NCT02566993|58918038|FG001|Overall Study|Randomized but not treated|16|||
30885158|NCT02566993|58918037|FG000|Overall Study|Progressive disease|213|||
30885159|NCT02566993|58918038|FG001|Overall Study|Progressive disease|152|||
30885160|NCT02566993|58918037|FG000|Overall Study|Withdrawal by Subject|12|||
30885161|NCT02566993|58918038|FG001|Overall Study|Withdrawal by Subject|28|||
30885162|NCT02566993|58918037|FG000|Overall Study|Death|17|||
30885163|NCT02566993|58918038|FG001|Overall Study|Death|23|||
30885164|NCT02566993|58918037|FG000|Overall Study|Physician Decision|10|||
30885165|NCT02566993|58918038|FG001|Overall Study|Physician Decision|17|||
30885166|NCT02566993|58918037|FG000|Overall Study|Study drug-related adverse event|20|||
30885167|NCT02566993|58918038|FG001|Overall Study|Study drug-related adverse event|41|||
30885168|NCT02566993|58918037|FG000|Overall Study|Non study drug-related adverse event|9|||
30885169|NCT02566993|58918038|FG001|Overall Study|Non study drug-related adverse event|9|||
30885170|NCT02566993|58918037|FG000|Overall Study|Symptomatic deterioration|9|||
30885171|NCT02566993|58918038|FG001|Overall Study|Symptomatic deterioration|16|||
30885172|NCT02566993|58918037|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
30885173|NCT02566993|58918038|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
30885174|NCT02566993|58918037|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
30885175|NCT02566993|58918038|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
30885176|NCT02566993|58918037|FG000|Overall Study|Screening failure|2|||
30885177|NCT02566993|58918038|FG001|Overall Study|Screening failure|0|||
30975975|NCT01490060|59060532|FG003|Cycle 2|Non-Compliance|0|||
30885178|NCT02566993|58918037|FG000|Overall Study|Lost to Follow-up|0|||
30885179|NCT02566993|58918038|FG001|Overall Study|Lost to Follow-up|1|||
30885180|NCT02566993|58918037|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
30885181|NCT02566993|58918038|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
30885182|NCT02311881|58918049|FG000|Overall Study|Did not meet the study criteria|2|||
30885183|NCT02311881|58918050|FG001|Overall Study|Did not meet the study criteria|2|||
30885184|NCT02311881|58918051|FG002|Overall Study|Did not meet the study criteria|0|||
30885185|NCT02311881|58918049|FG000|Overall Study|Adverse Event|7|||
30885186|NCT02311881|58918050|FG001|Overall Study|Adverse Event|15|||
30885187|NCT02311881|58918051|FG002|Overall Study|Adverse Event|8|||
30885188|NCT02311881|58918049|FG000|Overall Study|Lost to Follow-up|3|||
30885189|NCT02311881|58918050|FG001|Overall Study|Lost to Follow-up|3|||
30885190|NCT02311881|58918051|FG002|Overall Study|Lost to Follow-up|2|||
30885191|NCT02311881|58918049|FG000|Overall Study|Protocol Violation|1|||
30885192|NCT02311881|58918050|FG001|Overall Study|Protocol Violation|2|||
30885193|NCT02311881|58918051|FG002|Overall Study|Protocol Violation|3|||
30885194|NCT02311881|58918049|FG000|Overall Study|Withdrawal of consent|14|||
30885195|NCT02311881|58918050|FG001|Overall Study|Withdrawal of consent|16|||
30885196|NCT02311881|58918051|FG002|Overall Study|Withdrawal of consent|17|||
30885197|NCT02311881|58918049|FG000|Overall Study|Other|0|||
30885198|NCT02311881|58918050|FG001|Overall Study|Other|0|||
30885199|NCT02311881|58918051|FG002|Overall Study|Other|1|||
30885200|NCT02311881|58918049|FG000|Overall Study|Lack of Efficacy|1|||
30885201|NCT02311881|58918050|FG001|Overall Study|Lack of Efficacy|2|||
30885202|NCT02311881|58918051|FG002|Overall Study|Lack of Efficacy|0|||
30885203|NCT02311881|58918049|FG000|Overall Study|Subject has border line pregnancy test|1|||
30885204|NCT02311881|58918050|FG001|Overall Study|Subject has border line pregnancy test|0|||
30885205|NCT02311881|58918051|FG002|Overall Study|Subject has border line pregnancy test|0|||
30885206|NCT02311881|58918049|FG000|Overall Study|Withdrawal by Subject|3|||
30885207|NCT02311881|58918050|FG001|Overall Study|Withdrawal by Subject|1|||
30885208|NCT02311881|58918051|FG002|Overall Study|Withdrawal by Subject|4|||
30885209|NCT02311881|58918049|FG000|Overall Study|Sponsor Decision|1|||
30885210|NCT02311881|58918050|FG001|Overall Study|Sponsor Decision|1|||
30885211|NCT02311881|58918051|FG002|Overall Study|Sponsor Decision|1|||
30885212|NCT02311881|58918049|FG000|Overall Study|Protocol Deviation|1|||
30885213|NCT02311881|58918050|FG001|Overall Study|Protocol Deviation|0|||
30885214|NCT02311881|58918051|FG002|Overall Study|Protocol Deviation|0|||
30885215|NCT02311881|58918049|FG000|Overall Study|Non-Compliance|1|||
30885216|NCT02311881|58918050|FG001|Overall Study|Non-Compliance|0|||
30885217|NCT02311881|58918051|FG002|Overall Study|Non-Compliance|2|||
30885218|NCT02311881|58918049|FG000|Overall Study|Physician Decision|0|||
30885219|NCT02311881|58918050|FG001|Overall Study|Physician Decision|0|||
30885220|NCT02311881|58918051|FG002|Overall Study|Physician Decision|1|||
30885221|NCT02311881|58918049|FG000|Overall Study|Medical Monitor Discretion|0|||
30885222|NCT02311881|58918050|FG001|Overall Study|Medical Monitor Discretion|0|||
30885223|NCT02311881|58918051|FG002|Overall Study|Medical Monitor Discretion|1|||
30885224|NCT02311881|58918049|FG000|Overall Study|Participant taking another medication|0|||
30885225|NCT02311881|58918050|FG001|Overall Study|Participant taking another medication|0|||
30885226|NCT02311881|58918051|FG002|Overall Study|Participant taking another medication|1|||
30885227|NCT02311881|58918049|FG000|Overall Study|Serious Adverse Event|0|||
30885228|NCT02311881|58918050|FG001|Overall Study|Serious Adverse Event|1|||
30885229|NCT02311881|58918051|FG002|Overall Study|Serious Adverse Event|0|||
30885230|NCT02565511|58918066|FG000|Overall Study|Study terminated by Sponsor|35|||
30885231|NCT02565511|58918067|FG001|Overall Study|Study terminated by Sponsor|22|||
30885232|NCT02565511|58918068|FG002|Overall Study|Study terminated by Sponsor|235|||
30885233|NCT02565511|58918069|FG003|Overall Study|Study terminated by Sponsor|156|||
30885234|NCT02565511|58918066|FG000|Overall Study|Withdrawal by Subject|3|||
30885235|NCT02565511|58918067|FG001|Overall Study|Withdrawal by Subject|0|||
30885236|NCT02565511|58918068|FG002|Overall Study|Withdrawal by Subject|12|||
30885237|NCT02565511|58918069|FG003|Overall Study|Withdrawal by Subject|5|||
30975976|NCT01490060|59060529|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
30975977|NCT01490060|59060530|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
30975978|NCT01490060|59060531|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
30975979|NCT01490060|59060532|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
30975980|NCT01452152|59060584|FG000|Overall Study|Study termination by sponsor|5|||
30975981|NCT01452152|59060585|FG001|Overall Study|Study termination by sponsor|0|||
30885238|NCT02565511|58918066|FG000|Overall Study|Adverse Event|0|||
30885239|NCT02565511|58918067|FG001|Overall Study|Adverse Event|0|||
30885240|NCT02565511|58918068|FG002|Overall Study|Adverse Event|1|||
30885241|NCT02565511|58918069|FG003|Overall Study|Adverse Event|1|||
30885242|NCT02565511|58918066|FG000|Overall Study|Lost to Follow-up|4|||
30885243|NCT02565511|58918067|FG001|Overall Study|Lost to Follow-up|1|||
30885244|NCT02565511|58918068|FG002|Overall Study|Lost to Follow-up|0|||
30885245|NCT02565511|58918069|FG003|Overall Study|Lost to Follow-up|1|||
30885246|NCT02565511|58918066|FG000|Overall Study|Physician Decision|0|||
30885247|NCT02565511|58918067|FG001|Overall Study|Physician Decision|0|||
30885248|NCT02565511|58918068|FG002|Overall Study|Physician Decision|0|||
30885249|NCT02565511|58918069|FG003|Overall Study|Physician Decision|1|||
30885250|NCT02565511|58918066|FG000|Overall Study|Protocol deviation|0|||
30885251|NCT02565511|58918067|FG001|Overall Study|Protocol deviation|0|||
30885252|NCT02565511|58918068|FG002|Overall Study|Protocol deviation|3|||
30885253|NCT02565511|58918069|FG003|Overall Study|Protocol deviation|0|||
30885254|NCT02561455|58918083|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
30885255|NCT02561455|58918084|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
30885256|NCT02561455|58918085|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
30885257|NCT02561455|58918086|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
30885258|NCT02561455|58918083|FG000|Overall Study|Withdrawal by Subject|1|||
30885259|NCT02561455|58918084|FG001|Overall Study|Withdrawal by Subject|0|||
30885260|NCT02561455|58918085|FG002|Overall Study|Withdrawal by Subject|1|||
30885261|NCT02561455|58918086|FG003|Overall Study|Withdrawal by Subject|0|||
30885262|NCT02561455|58918083|FG000|Overall Study|Disease Progression|0|||
30885263|NCT02561455|58918084|FG001|Overall Study|Disease Progression|1|||
30885264|NCT02561455|58918085|FG002|Overall Study|Disease Progression|0|||
30885265|NCT02561455|58918086|FG003|Overall Study|Disease Progression|0|||
30885266|NCT02561299|58918098|FG000|Overall Study|Death|2|||
30885267|NCT02561299|58918099|FG001|Overall Study|Death|4|||
30885268|NCT02561299|58918098|FG000|Overall Study|Lost to Follow-up|1|||
30885269|NCT02561299|58918099|FG001|Overall Study|Lost to Follow-up|0|||
30885270|NCT02561299|58918098|FG000|Overall Study|Withdrawal by Subject|2|||
30885271|NCT02561299|58918099|FG001|Overall Study|Withdrawal by Subject|2|||
30885272|NCT02566759|58918122|FG000|All Parts|Withdrawal by Subject|0|||
30885273|NCT02566759|58918123|FG001|All Parts|Withdrawal by Subject|1|||
30885274|NCT02566759|58918124|FG002|All Parts|Withdrawal by Subject|0|||
30885275|NCT02566759|58918125|FG003|All Parts|Withdrawal by Subject|0|||
30885276|NCT02566759|58918126|FG004|All Parts|Withdrawal by Subject|0|||
30885277|NCT02566759|58918127|FG005|All Parts|Withdrawal by Subject|0|||
30885278|NCT02566759|58918128|FG006|All Parts|Withdrawal by Subject|0|||
30885279|NCT02566759|58918129|FG007|All Parts|Withdrawal by Subject|0|||
30885280|NCT02566759|58918130|FG008|All Parts|Withdrawal by Subject|0|||
30885281|NCT02566759|58918131|FG009|All Parts|Withdrawal by Subject|0|||
30885282|NCT02566759|58918132|FG010|All Parts|Withdrawal by Subject|0|||
30885283|NCT02566759|58918133|FG011|All Parts|Withdrawal by Subject|0|||
30885284|NCT02566759|58918134|FG012|All Parts|Withdrawal by Subject|0|||
30885285|NCT02566759|58918135|FG013|All Parts|Withdrawal by Subject|0|||
30885286|NCT02566759|58918136|FG014|All Parts|Withdrawal by Subject|0|||
30885287|NCT02566759|58918137|FG015|All Parts|Withdrawal by Subject|0|||
30885288|NCT02566759|58918138|FG016|All Parts|Withdrawal by Subject|0|||
30885289|NCT02566759|58918122|FG000|All Parts|Adverse Event|0|||
30885290|NCT02566759|58918123|FG001|All Parts|Adverse Event|0|||
30885291|NCT02566759|58918124|FG002|All Parts|Adverse Event|0|||
30885292|NCT02566759|58918125|FG003|All Parts|Adverse Event|0|||
30885293|NCT02566759|58918126|FG004|All Parts|Adverse Event|0|||
30885294|NCT02566759|58918127|FG005|All Parts|Adverse Event|0|||
30975982|NCT01452152|59060586|FG002|Overall Study|Study termination by sponsor|4|||
30975983|NCT01451762|59060597|FG000|Overall Study|Lost to Follow-up|3|||
30975984|NCT01451762|59060598|FG001|Overall Study|Lost to Follow-up|6|||
30975985|NCT01451762|59060599|FG002|Overall Study|Lost to Follow-up|6|||
30975986|NCT01468844|59060634|FG000|Overall Study|Adverse Event|1|||
30975987|NCT01468844|59060635|FG001|Overall Study|Adverse Event|0|||
30885295|NCT02566759|58918128|FG006|All Parts|Adverse Event|0|||
30885296|NCT02566759|58918129|FG007|All Parts|Adverse Event|0|||
30975988|NCT01468844|59060634|FG000|Overall Study|Withdrawal by Subject|1|||
30975989|NCT01468844|59060635|FG001|Overall Study|Withdrawal by Subject|0|||
30975990|NCT01451606|59060659|FG000|Overall Study|Withdrawal by Subject|4|||
30975991|NCT01451606|59060660|FG001|Overall Study|Withdrawal by Subject|3|||
30885297|NCT02566759|58918130|FG008|All Parts|Adverse Event|0|||
30885298|NCT02566759|58918131|FG009|All Parts|Adverse Event|0|||
30975992|NCT00473343|59060715|FG000|Overall Study|Adverse Event|9|||
30975993|NCT00473343|59060715|FG000|Overall Study|Lost to Follow-up|8|||
30975994|NCT00473343|59060715|FG000|Overall Study|Treatment failure|27|||
30975995|NCT00473343|59060715|FG000|Overall Study|Withdrew consent|3|||
30885299|NCT02566759|58918132|FG010|All Parts|Adverse Event|0|||
30885300|NCT02566759|58918133|FG011|All Parts|Adverse Event|0|||
30885301|NCT02566759|58918134|FG012|All Parts|Adverse Event|1|||
30885302|NCT02566759|58918135|FG013|All Parts|Adverse Event|3|||
30975996|NCT00473343|59060715|FG000|Overall Study|Other un-specified reason|3|||
30885303|NCT02566759|58918136|FG014|All Parts|Adverse Event|0|||
30885304|NCT02566759|58918137|FG015|All Parts|Adverse Event|0|||
30885305|NCT02566759|58918138|FG016|All Parts|Adverse Event|0|||
30885306|NCT02566759|58918122|FG000|All Parts|Other|0|||
30885307|NCT02566759|58918123|FG001|All Parts|Other|0|||
30975997|NCT02587962|59061172|FG000|Overall Study|Adverse Event|0|||
30885308|NCT02566759|58918124|FG002|All Parts|Other|0|||
30885309|NCT02566759|58918125|FG003|All Parts|Other|0|||
30885310|NCT02566759|58918126|FG004|All Parts|Other|0|||
30885311|NCT02566759|58918127|FG005|All Parts|Other|0|||
30885312|NCT02566759|58918128|FG006|All Parts|Other|0|||
30885313|NCT02566759|58918129|FG007|All Parts|Other|0|||
30885314|NCT02566759|58918130|FG008|All Parts|Other|0|||
30885315|NCT02566759|58918131|FG009|All Parts|Other|0|||
30885316|NCT02566759|58918132|FG010|All Parts|Other|0|||
30885317|NCT02566759|58918133|FG011|All Parts|Other|0|||
30885318|NCT02566759|58918134|FG012|All Parts|Other|0|||
30885319|NCT02566759|58918135|FG013|All Parts|Other|2|||
30885320|NCT02566759|58918136|FG014|All Parts|Other|0|||
30885321|NCT02566759|58918137|FG015|All Parts|Other|0|||
30885322|NCT02566759|58918138|FG016|All Parts|Other|0|||
30885323|NCT02566759|58918122|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885324|NCT02566759|58918123|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885325|NCT02566759|58918124|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885326|NCT02566759|58918125|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885327|NCT02566759|58918126|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885328|NCT02566759|58918127|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885329|NCT02566759|58918128|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885330|NCT02566759|58918129|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885331|NCT02566759|58918130|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885332|NCT02566759|58918131|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885333|NCT02566759|58918132|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885334|NCT02566759|58918133|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885335|NCT02566759|58918134|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885336|NCT02566759|58918135|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885337|NCT02566759|58918136|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885338|NCT02566759|58918137|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
30885339|NCT02566759|58918138|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
30885340|NCT02335983|58918203|FG000|Overall Study|Sponsor Decision|0|||
30885341|NCT02335983|58918204|FG001|Overall Study|Sponsor Decision|0|||
30885342|NCT02335983|58918205|FG002|Overall Study|Sponsor Decision|1|||
30885343|NCT02335983|58918206|FG003|Overall Study|Sponsor Decision|1|||
30885344|NCT02335983|58918207|FG004|Overall Study|Sponsor Decision|0|||
30885345|NCT02335983|58918208|FG005|Overall Study|Sponsor Decision|1|||
30885346|NCT02335983|58918203|FG000|Overall Study|Withdrawal by Subject|3|||
30885347|NCT02335983|58918204|FG001|Overall Study|Withdrawal by Subject|2|||
30975998|NCT02587962|59061173|FG001|Overall Study|Adverse Event|0|||
30975999|NCT02587962|59061174|FG002|Overall Study|Adverse Event|1|||
30976000|NCT02587962|59061175|FG003|Overall Study|Adverse Event|0|||
30976001|NCT02587962|59061176|FG004|Overall Study|Adverse Event|0|||
30976002|NCT02587962|59061172|FG000|Overall Study|Withdrawal by Subject|0|||
30976003|NCT02587962|59061173|FG001|Overall Study|Withdrawal by Subject|0|||
30885348|NCT02335983|58918205|FG002|Overall Study|Withdrawal by Subject|2|||
30885349|NCT02335983|58918206|FG003|Overall Study|Withdrawal by Subject|1|||
30885350|NCT02335983|58918207|FG004|Overall Study|Withdrawal by Subject|3|||
30885351|NCT02335983|58918208|FG005|Overall Study|Withdrawal by Subject|9|||
30885352|NCT02335983|58918203|FG000|Overall Study|Death|0|||
30885353|NCT02335983|58918204|FG001|Overall Study|Death|0|||
30885354|NCT02335983|58918205|FG002|Overall Study|Death|2|||
30885355|NCT02335983|58918206|FG003|Overall Study|Death|0|||
30885356|NCT02335983|58918207|FG004|Overall Study|Death|0|||
30885357|NCT02335983|58918208|FG005|Overall Study|Death|0|||
30885358|NCT02335983|58918203|FG000|Overall Study|Lost to Follow-up|0|||
30885359|NCT02335983|58918204|FG001|Overall Study|Lost to Follow-up|0|||
30885360|NCT02335983|58918205|FG002|Overall Study|Lost to Follow-up|0|||
30976004|NCT02587962|59061174|FG002|Overall Study|Withdrawal by Subject|1|||
30976005|NCT02587962|59061175|FG003|Overall Study|Withdrawal by Subject|1|||
30976006|NCT02587962|59061176|FG004|Overall Study|Withdrawal by Subject|4|||
30976007|NCT02587962|59061172|FG000|Overall Study|Radiological progression|2|||
30976008|NCT02587962|59061173|FG001|Overall Study|Radiological progression|2|||
30976009|NCT02587962|59061174|FG002|Overall Study|Radiological progression|2|||
30976010|NCT02587962|59061175|FG003|Overall Study|Radiological progression|5|||
30976011|NCT02587962|59061176|FG004|Overall Study|Radiological progression|10|||
30976012|NCT02587962|59061172|FG000|Overall Study|Clinical progression|0|||
30976013|NCT02587962|59061173|FG001|Overall Study|Clinical progression|1|||
30885361|NCT02335983|58918206|FG003|Overall Study|Lost to Follow-up|0|||
30885362|NCT02335983|58918207|FG004|Overall Study|Lost to Follow-up|0|||
30885363|NCT02335983|58918208|FG005|Overall Study|Lost to Follow-up|1|||
30885364|NCT02335983|58918203|FG000|Overall Study|Protocol Specified Criteria|5|||
30885365|NCT02335983|58918204|FG001|Overall Study|Protocol Specified Criteria|7|||
30885366|NCT02335983|58918205|FG002|Overall Study|Protocol Specified Criteria|27|||
30885367|NCT02335983|58918206|FG003|Overall Study|Protocol Specified Criteria|7|||
30885368|NCT02335983|58918207|FG004|Overall Study|Protocol Specified Criteria|5|||
30885369|NCT02335983|58918208|FG005|Overall Study|Protocol Specified Criteria|21|||
30885370|NCT04640311|58918244|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
30885371|NCT04640311|58918245|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885372|NCT04640311|58918246|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885373|NCT04640311|58918247|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885374|NCT04640311|58918248|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885375|NCT04640311|58918249|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885376|NCT04640311|58918250|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885377|NCT04640311|58918251|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885378|NCT04640311|58918252|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885379|NCT04640311|58918253|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885380|NCT04640311|58918254|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885381|NCT04640311|58918255|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885382|NCT04640311|58918256|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885383|NCT04640311|58918244|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885384|NCT04640311|58918245|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
30885385|NCT04640311|58918246|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885386|NCT04640311|58918247|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885387|NCT04640311|58918248|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885388|NCT04640311|58918249|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885389|NCT04640311|58918250|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885390|NCT04640311|58918251|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885391|NCT04640311|58918252|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885392|NCT04640311|58918253|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885393|NCT04640311|58918254|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885394|NCT04640311|58918255|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885395|NCT04640311|58918256|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
30885396|NCT04640311|58918244|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885397|NCT04640311|58918245|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
30885398|NCT04640311|58918246|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885399|NCT04640311|58918247|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885400|NCT04640311|58918248|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885401|NCT04640311|58918249|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885402|NCT04640311|58918250|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885403|NCT04640311|58918251|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885404|NCT04640311|58918252|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885405|NCT04640311|58918253|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885406|NCT04640311|58918254|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885407|NCT04640311|58918255|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885408|NCT04640311|58918256|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885409|NCT04640311|58918244|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
30885410|NCT04640311|58918245|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
30885411|NCT04640311|58918246|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
30885412|NCT04640311|58918247|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885413|NCT04640311|58918248|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885414|NCT04640311|58918249|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885415|NCT04640311|58918250|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885416|NCT04640311|58918251|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885417|NCT04640311|58918252|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885418|NCT04640311|58918253|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885419|NCT04640311|58918254|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885420|NCT04640311|58918255|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30885421|NCT04640311|58918256|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
30976014|NCT02587962|59061174|FG002|Overall Study|Clinical progression|2|||
30976015|NCT02587962|59061175|FG003|Overall Study|Clinical progression|0|||
30885422|NCT04640311|58918244|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885423|NCT04640311|58918245|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885424|NCT04640311|58918246|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
30885425|NCT04640311|58918247|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885426|NCT04640311|58918248|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885427|NCT04640311|58918249|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885428|NCT04640311|58918250|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885429|NCT04640311|58918251|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885430|NCT04640311|58918252|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885431|NCT04640311|58918253|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885432|NCT04640311|58918254|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885433|NCT04640311|58918255|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885434|NCT04640311|58918256|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
30885435|NCT04640311|58918244|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
30885436|NCT04640311|58918245|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
30885437|NCT04640311|58918246|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
30885438|NCT04640311|58918247|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
30885439|NCT04640311|58918248|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
30885440|NCT04640311|58918249|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
30885441|NCT04640311|58918250|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
30885442|NCT04640311|58918251|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
30885443|NCT04640311|58918252|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
30885444|NCT04640311|58918253|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
30885445|NCT04640311|58918254|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
30885446|NCT04640311|58918255|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
30885447|NCT04640311|58918256|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
30885448|NCT04640311|58918244|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885449|NCT04640311|58918245|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885450|NCT04640311|58918246|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885451|NCT04640311|58918247|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885452|NCT04640311|58918248|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885453|NCT04640311|58918249|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
30885454|NCT04640311|58918250|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885455|NCT04640311|58918251|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885456|NCT04640311|58918252|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
30885457|NCT04640311|58918253|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885458|NCT04640311|58918254|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885459|NCT04640311|58918255|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885460|NCT04640311|58918256|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
30885461|NCT04640311|58918244|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
30885462|NCT04640311|58918245|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
30885463|NCT04640311|58918246|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
30885464|NCT04640311|58918247|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
30885465|NCT04640311|58918248|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
30885466|NCT04640311|58918249|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
30885467|NCT04640311|58918250|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
30885468|NCT04640311|58918251|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
30885469|NCT04640311|58918252|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
30885470|NCT04640311|58918253|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
30885471|NCT04640311|58918254|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
30885472|NCT04640311|58918255|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
30885473|NCT04640311|58918256|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
30885474|NCT04640311|58918244|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885475|NCT04640311|58918245|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885476|NCT04640311|58918246|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885477|NCT04640311|58918247|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885478|NCT04640311|58918248|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885479|NCT04640311|58918249|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885480|NCT04640311|58918250|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885481|NCT04640311|58918251|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885482|NCT04640311|58918252|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885483|NCT04640311|58918253|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885484|NCT04640311|58918254|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885485|NCT04640311|58918255|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
30885486|NCT04640311|58918256|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
30885487|NCT02334423|58918287|FG000|Overall Study|Protocol Violation|10|||
30885488|NCT02334423|58918288|FG001|Overall Study|Protocol Violation|3|||
30885489|NCT02310789|58918294|FG000|Overall Study|Adverse Event|1|||
30885490|NCT02372253|58918300|FG000|Overall Study|Non Compliance|2|||
30885491|NCT02372253|58918301|FG001|Overall Study|Non Compliance|0|||
30885492|NCT02559895|58918313|FG000|Overall Study|Adverse Event|3|||
30885493|NCT02559895|58918314|FG001|Overall Study|Adverse Event|3|||
30885494|NCT02559895|58918315|FG002|Overall Study|Adverse Event|2|||
30885495|NCT02559895|58918316|FG003|Overall Study|Adverse Event|1|||
30885496|NCT02559895|58918313|FG000|Overall Study|Lack of Efficacy|2|||
30885497|NCT02559895|58918314|FG001|Overall Study|Lack of Efficacy|3|||
30885498|NCT02559895|58918315|FG002|Overall Study|Lack of Efficacy|2|||
30885499|NCT02559895|58918316|FG003|Overall Study|Lack of Efficacy|8|||
30885500|NCT02559895|58918313|FG000|Overall Study|Lost to Follow-up|22|||
30885501|NCT02559895|58918314|FG001|Overall Study|Lost to Follow-up|16|||
30885502|NCT02559895|58918315|FG002|Overall Study|Lost to Follow-up|12|||
30885503|NCT02559895|58918316|FG003|Overall Study|Lost to Follow-up|17|||
30885504|NCT02559895|58918313|FG000|Overall Study|Physician Decision|1|||
30885505|NCT02559895|58918314|FG001|Overall Study|Physician Decision|1|||
30885506|NCT02559895|58918315|FG002|Overall Study|Physician Decision|3|||
30885507|NCT02559895|58918316|FG003|Overall Study|Physician Decision|0|||
30885508|NCT02559895|58918313|FG000|Overall Study|Withdrawal by Subject|16|||
30885509|NCT02559895|58918314|FG001|Overall Study|Withdrawal by Subject|9|||
30885510|NCT02559895|58918315|FG002|Overall Study|Withdrawal by Subject|20|||
30885511|NCT02559895|58918316|FG003|Overall Study|Withdrawal by Subject|9|||
30885512|NCT02559895|58918313|FG000|Overall Study|Study Burden|10|||
30885513|NCT02559895|58918314|FG001|Overall Study|Study Burden|16|||
30885514|NCT02559895|58918315|FG002|Overall Study|Study Burden|12|||
30885515|NCT02559895|58918316|FG003|Overall Study|Study Burden|22|||
30885516|NCT02559895|58918313|FG000|Overall Study|Other|1|||
30885517|NCT02559895|58918314|FG001|Overall Study|Other|5|||
30885518|NCT02559895|58918315|FG002|Overall Study|Other|3|||
30885519|NCT02559895|58918316|FG003|Overall Study|Other|3|||
30885520|NCT02371629|58918328|FG000|Overall Study|Patient decision|14|||
30885521|NCT02371629|58918329|FG001|Overall Study|Patient decision|10|||
30885522|NCT02371629|58918328|FG000|Overall Study|Adverse Event|8|||
30885523|NCT02371629|58918329|FG001|Overall Study|Adverse Event|8|||
30885524|NCT02371629|58918328|FG000|Overall Study|Physician Decision|2|||
30885525|NCT02371629|58918329|FG001|Overall Study|Physician Decision|3|||
30885526|NCT02371629|58918328|FG000|Overall Study|Death|1|||
30885527|NCT02371629|58918329|FG001|Overall Study|Death|1|||
30885528|NCT02371629|58918328|FG000|Overall Study|Noncompliance with study treatment|1|||
30885529|NCT02371629|58918329|FG001|Overall Study|Noncompliance with study treatment|0|||
30885530|NCT02371629|58918328|FG000|Overall Study|Lack of Efficacy|0|||
30885531|NCT02371629|58918329|FG001|Overall Study|Lack of Efficacy|2|||
30885532|NCT02371629|58918328|FG000|Overall Study|Protocol deviation|0|||
30885533|NCT02371629|58918329|FG001|Overall Study|Protocol deviation|1|||
30885534|NCT02559817|58918340|FG000|Treatment Period|Adverse Event|1|||
30885535|NCT02559817|58918341|FG001|Treatment Period|Adverse Event|0|||
30885536|NCT02559817|58918342|FG002|Treatment Period|Adverse Event|1|||
30885537|NCT02559817|58918343|FG003|Treatment Period|Adverse Event|0|||
30885538|NCT02559817|58918344|FG004|Treatment Period|Adverse Event|0|||
30885539|NCT02559817|58918340|FG000|Treatment Period|Lack of Efficacy|0|||
30885540|NCT02559817|58918341|FG001|Treatment Period|Lack of Efficacy|1|||
30885541|NCT02559817|58918342|FG002|Treatment Period|Lack of Efficacy|0|||
30885542|NCT02559817|58918343|FG003|Treatment Period|Lack of Efficacy|0|||
30885543|NCT02559817|58918344|FG004|Treatment Period|Lack of Efficacy|0|||
30885544|NCT02559817|58918340|FG000|Treatment Period|Lost to Follow-up|0|||
30885545|NCT02559817|58918341|FG001|Treatment Period|Lost to Follow-up|1|||
30885546|NCT02559817|58918342|FG002|Treatment Period|Lost to Follow-up|0|||
30885547|NCT02559817|58918343|FG003|Treatment Period|Lost to Follow-up|1|||
30885548|NCT02559817|58918344|FG004|Treatment Period|Lost to Follow-up|0|||
30885549|NCT02559817|58918340|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
30885550|NCT02559817|58918341|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
30885551|NCT02559817|58918342|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
30885552|NCT02559817|58918343|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
30885553|NCT02559817|58918344|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
30885554|NCT02559817|58918340|FG000|Treatment Period|Protocol Violation|0|||
30885555|NCT02559817|58918341|FG001|Treatment Period|Protocol Violation|0|||
30885556|NCT02559817|58918342|FG002|Treatment Period|Protocol Violation|0|||
30885557|NCT02559817|58918343|FG003|Treatment Period|Protocol Violation|1|||
30885558|NCT02559817|58918344|FG004|Treatment Period|Protocol Violation|0|||
30885559|NCT02564887|58918358|FG000|Overall Study|Lost to Follow-up|6|||
30885560|NCT02564887|58918359|FG001|Overall Study|Lost to Follow-up|0|||
30885561|NCT02333487|58918370|FG000|Overall Study|Adverse Event|0|||
30885562|NCT02333487|58918371|FG001|Overall Study|Adverse Event|2|||
30885563|NCT02333487|58918372|FG002|Overall Study|Adverse Event|0|||
30885564|NCT02333331|58918385|FG000|Overall Study|Adverse Event|1|||
30885565|NCT02333331|58918386|FG001|Overall Study|Adverse Event|0|||
30885566|NCT02333331|58918387|FG002|Overall Study|Adverse Event|4|||
30885567|NCT02333331|58918388|FG003|Overall Study|Adverse Event|1|||
30885568|NCT02333331|58918385|FG000|Overall Study|Death|0|||
30885569|NCT02333331|58918386|FG001|Overall Study|Death|0|||
30885570|NCT02333331|58918387|FG002|Overall Study|Death|2|||
30885571|NCT02333331|58918388|FG003|Overall Study|Death|0|||
30885572|NCT02333331|58918385|FG000|Overall Study|Lost to Follow-up|0|||
30885573|NCT02333331|58918386|FG001|Overall Study|Lost to Follow-up|0|||
30885574|NCT02333331|58918387|FG002|Overall Study|Lost to Follow-up|1|||
30885575|NCT02333331|58918388|FG003|Overall Study|Lost to Follow-up|0|||
30885576|NCT02333331|58918385|FG000|Overall Study|Physician Decision|0|||
30885577|NCT02333331|58918386|FG001|Overall Study|Physician Decision|1|||
30885578|NCT02333331|58918387|FG002|Overall Study|Physician Decision|0|||
30885579|NCT02333331|58918388|FG003|Overall Study|Physician Decision|0|||
30885580|NCT02333331|58918385|FG000|Overall Study|Protocol Deviation|0|||
30885581|NCT02333331|58918386|FG001|Overall Study|Protocol Deviation|3|||
30885582|NCT02333331|58918387|FG002|Overall Study|Protocol Deviation|2|||
30885583|NCT02333331|58918388|FG003|Overall Study|Protocol Deviation|1|||
30885584|NCT02333331|58918385|FG000|Overall Study|Patient/Guardian Decision|1|||
30885585|NCT02333331|58918386|FG001|Overall Study|Patient/Guardian Decision|2|||
30885586|NCT02333331|58918387|FG002|Overall Study|Patient/Guardian Decision|9|||
30885587|NCT02333331|58918388|FG003|Overall Study|Patient/Guardian Decision|1|||
30885588|NCT02563561|58918401|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
30885589|NCT02563561|58918402|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
30885590|NCT02563561|58918403|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
30885591|NCT02563561|58918401|FG000|Overall Study|Withdrew of Consent|1|||
30885592|NCT02563561|58918402|FG001|Overall Study|Withdrew of Consent|1|||
30885593|NCT02563561|58918403|FG002|Overall Study|Withdrew of Consent|2|||
30885594|NCT02563561|58918401|FG000|Overall Study|Lost to Follow-up|1|||
30885595|NCT02563561|58918402|FG001|Overall Study|Lost to Follow-up|1|||
30885596|NCT02563561|58918403|FG002|Overall Study|Lost to Follow-up|0|||
30885597|NCT02563561|58918401|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
30885598|NCT02563561|58918402|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
30885599|NCT02563561|58918403|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
30885600|NCT02563561|58918401|FG000|Overall Study|Investigator Decision|3|||
30885601|NCT02563561|58918402|FG001|Overall Study|Investigator Decision|4|||
30885602|NCT02563561|58918403|FG002|Overall Study|Investigator Decision|2|||
30885603|NCT02563561|58918401|FG000|Overall Study|Sponsor Decision|5|||
30885604|NCT02563561|58918402|FG001|Overall Study|Sponsor Decision|2|||
30885605|NCT02563561|58918403|FG002|Overall Study|Sponsor Decision|4|||
30885606|NCT02563561|58918401|FG000|Overall Study|Other|1|||
30885607|NCT02563561|58918402|FG001|Overall Study|Other|5|||
30885608|NCT02563561|58918403|FG002|Overall Study|Other|2|||
30885609|NCT02559505|58918419|FG000|Overall Study|Lost to Follow-up|23|||
30885610|NCT02559505|58918420|FG001|Overall Study|Lost to Follow-up|20|||
30885611|NCT02559505|58918419|FG000|Overall Study|Withdrawal by Subject|4|||
30885612|NCT02559505|58918420|FG001|Overall Study|Withdrawal by Subject|2|||
30885613|NCT04191967|58918442|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
30885614|NCT04191967|58918442|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
30885615|NCT02556307|58918448|FG000|Overall Study|Premature treatment interruption|11|||
30885616|NCT02556307|58918448|FG000|Overall Study|Lost to Follow-up|36|||
30885617|NCT02556307|58918448|FG000|Overall Study|Change to triple therapy|4|||
30885618|NCT02556307|58918448|FG000|Overall Study|Enrolled but not treated|2|||
30885619|NCT04364737|58918454|FG000|Overall Study|Withdrawal by Subject|4|||
30885620|NCT04364737|58918455|FG001|Overall Study|Withdrawal by Subject|9|||
30885621|NCT04364737|58918454|FG000|Overall Study|Lost to Follow-up|1|||
30885622|NCT04364737|58918455|FG001|Overall Study|Lost to Follow-up|1|||
30885623|NCT02559115|58918461|FG000|Overall Study|Withdrawal by Subject|3|||
30885624|NCT01662895|58918479|FG000|Overall Study|Lost to Follow-up|0|||
30885625|NCT01662895|58918480|FG001|Overall Study|Lost to Follow-up|1|||
30885626|NCT02557399|58918488|FG000|Overall Study|Adverse Event|6|||
30885627|NCT02557399|58918489|FG001|Overall Study|Adverse Event|5|||
30885628|NCT02557399|58918488|FG000|Overall Study|Protocol Violation|0|||
30885629|NCT02557399|58918489|FG001|Overall Study|Protocol Violation|1|||
30885630|NCT02557399|58918488|FG000|Overall Study|Protocol-defined stopping criteria|0|||
30885631|NCT02557399|58918489|FG001|Overall Study|Protocol-defined stopping criteria|1|||
30885632|NCT02557399|58918488|FG000|Overall Study|Withdrawal by Subject|1|||
30885633|NCT02557399|58918489|FG001|Overall Study|Withdrawal by Subject|1|||
30885634|NCT02555371|58918498|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
30885635|NCT02555371|58918499|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
30885636|NCT02555371|58918500|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
30885637|NCT02555371|58918501|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
30885638|NCT02555371|58918502|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
30885639|NCT02555371|58918498|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
30885640|NCT02555371|58918499|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
30885641|NCT02555371|58918500|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
30885642|NCT02555371|58918501|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
30885643|NCT02555371|58918502|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
30885644|NCT02555371|58918498|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
30885645|NCT02555371|58918499|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
30885646|NCT02555371|58918500|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
30885647|NCT02555371|58918501|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
30885648|NCT02555371|58918502|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
30885649|NCT02555371|58918498|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
30885650|NCT02555371|58918499|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
30885651|NCT02555371|58918500|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
30885652|NCT02555371|58918501|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
30885653|NCT02555371|58918502|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
30885654|NCT02555371|58918498|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
30885655|NCT02555371|58918499|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
30885656|NCT02555371|58918500|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
30885657|NCT02555371|58918501|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
30885658|NCT02555371|58918502|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
30885659|NCT02555371|58918498|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
30885660|NCT02555371|58918499|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
30885661|NCT02555371|58918500|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
30885662|NCT02555371|58918501|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
30885663|NCT02555371|58918502|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
30885664|NCT02555371|58918498|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
30885665|NCT02555371|58918499|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
30885666|NCT02555371|58918500|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
30885667|NCT02555371|58918501|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
30885668|NCT02555371|58918502|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
30885669|NCT02555371|58918498|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
30885670|NCT02555371|58918499|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
30885671|NCT02555371|58918500|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
30885672|NCT02555371|58918501|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
30885673|NCT02555371|58918502|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
30885674|NCT02555371|58918498|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
30885675|NCT02555371|58918499|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
30885676|NCT02555371|58918500|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
30885677|NCT02555371|58918501|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
30885678|NCT02555371|58918502|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
30885679|NCT02555371|58918498|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
30885680|NCT02555371|58918499|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
30885681|NCT02555371|58918500|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
30885682|NCT02555371|58918501|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
30885683|NCT02555371|58918502|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
30885684|NCT02555371|58918498|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
30885685|NCT02555371|58918499|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
30885686|NCT02555371|58918500|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
30885687|NCT02555371|58918501|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
30885688|NCT02555371|58918502|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
30885689|NCT02555371|58918498|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
30885690|NCT02555371|58918499|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
30885691|NCT02555371|58918500|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
30885692|NCT02555371|58918501|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
30885693|NCT02555371|58918502|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
30885694|NCT02555371|58918498|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
30885695|NCT02555371|58918499|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
30885696|NCT02555371|58918500|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
30885697|NCT02555371|58918501|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
30885698|NCT02555371|58918502|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
30885699|NCT02555371|58918498|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
30885700|NCT02555371|58918499|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
30885701|NCT02555371|58918500|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
30885702|NCT02555371|58918501|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
30885703|NCT02555371|58918502|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
30885704|NCT02555215|58918511|FG000|Overall Study|Other|1|||
30885705|NCT02555215|58918511|FG000|Overall Study|Investigator Decision|2|||
30885706|NCT02555683|58918518|FG000|Overall Study|Physician Decision|1|||
30885707|NCT02555683|58918519|FG001|Overall Study|Physician Decision|0|||
30885708|NCT02555683|58918520|FG002|Overall Study|Physician Decision|2|||
30885709|NCT02555683|58918518|FG000|Overall Study|Lost to Follow-up|2|||
30885710|NCT02555683|58918519|FG001|Overall Study|Lost to Follow-up|1|||
30885711|NCT02555683|58918520|FG002|Overall Study|Lost to Follow-up|2|||
30885712|NCT02555683|58918518|FG000|Overall Study|Technical Problems|1|||
30885713|NCT02555683|58918519|FG001|Overall Study|Technical Problems|1|||
30885714|NCT02555683|58918520|FG002|Overall Study|Technical Problems|0|||
30885715|NCT02555683|58918518|FG000|Overall Study|Protocol deviation|0|||
30885716|NCT02555683|58918519|FG001|Overall Study|Protocol deviation|1|||
30885717|NCT02555683|58918520|FG002|Overall Study|Protocol deviation|0|||
30885718|NCT02555683|58918518|FG000|Overall Study|Lack of Efficacy|2|||
30885719|NCT02555683|58918519|FG001|Overall Study|Lack of Efficacy|0|||
30885720|NCT02555683|58918520|FG002|Overall Study|Lack of Efficacy|0|||
30885721|NCT02555683|58918518|FG000|Overall Study|Death|0|||
30885722|NCT02555683|58918519|FG001|Overall Study|Death|1|||
30885723|NCT02555683|58918520|FG002|Overall Study|Death|2|||
30885724|NCT02555683|58918518|FG000|Overall Study|Adverse Event|1|||
30885725|NCT02555683|58918519|FG001|Overall Study|Adverse Event|0|||
30885726|NCT02555683|58918520|FG002|Overall Study|Adverse Event|1|||
30885727|NCT02555683|58918518|FG000|Overall Study|Subject/guardian decision|12|||
30885728|NCT02555683|58918519|FG001|Overall Study|Subject/guardian decision|12|||
30885729|NCT02555683|58918520|FG002|Overall Study|Subject/guardian decision|22|||
30885730|NCT02555683|58918518|FG000|Overall Study|Death post Treatment/safety period|0|||
30885731|NCT02555683|58918519|FG001|Overall Study|Death post Treatment/safety period|1|||
30885732|NCT02555683|58918520|FG002|Overall Study|Death post Treatment/safety period|0|||
30885733|NCT02554981|58918528|FG000|Overall Study|Adverse Event|1|||
30885734|NCT02554981|58918528|FG000|Overall Study|Administrative Reasons|1|||
30885735|NCT02554981|58918528|FG000|Overall Study|Other Miscellaneous Reasons|3|||
30885736|NCT02556775|58918536|FG000|Overall Study|Withdrawal by Subject|1|||
30885737|NCT02556775|58918537|FG001|Overall Study|Withdrawal by Subject|0|||
30885738|NCT02556775|58918538|FG002|Overall Study|Withdrawal by Subject|1|||
30885739|NCT02556775|58918539|FG003|Overall Study|Withdrawal by Subject|0|||
30885740|NCT02556775|58918536|FG000|Overall Study|Lost to Follow-up|1|||
30885741|NCT02556775|58918537|FG001|Overall Study|Lost to Follow-up|0|||
30885742|NCT02556775|58918538|FG002|Overall Study|Lost to Follow-up|0|||
30885743|NCT02556775|58918539|FG003|Overall Study|Lost to Follow-up|0|||
30885744|NCT01662505|58918554|FG000|Overall Study|Progressive disease|6|||
30885745|NCT01662505|58918555|FG001|Overall Study|Progressive disease|1|||
30885746|NCT01662505|58918556|FG002|Overall Study|Progressive disease|5|||
30885747|NCT01662505|58918554|FG000|Overall Study|Refused cont. medication|0|||
30885748|NCT01662505|58918555|FG001|Overall Study|Refused cont. medication|0|||
30885749|NCT01662505|58918556|FG002|Overall Study|Refused cont. medication|1|||
30885750|NCT01662505|58918554|FG000|Overall Study|Not specified above|1|||
30885751|NCT01662505|58918555|FG001|Overall Study|Not specified above|3|||
30885752|NCT01662505|58918556|FG002|Overall Study|Not specified above|2|||
30885753|NCT03796195|58918565|FG000|Overall Study|Study closed early|1|||
30885754|NCT02554513|58918569|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
30885755|NCT02554513|58918570|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
30885756|NCT02554279|58918584|FG000|Overall Study|Adverse Event|2|||
30885757|NCT02554279|58918585|FG001|Overall Study|Adverse Event|5|||
30885758|NCT02554279|58918584|FG000|Overall Study|Lost to Follow-up|3|||
30885759|NCT02554279|58918585|FG001|Overall Study|Lost to Follow-up|2|||
30976016|NCT02587962|59061176|FG004|Overall Study|Clinical progression|1|||
30976017|NCT01440374|59061330|FG000|Part 1: Open-label Phase|Adverse Event|5|||
30976018|NCT01440374|59061331|FG001|Part 1: Open-label Phase|Adverse Event|0|||
30976019|NCT01440374|59061332|FG002|Part 1: Open-label Phase|Adverse Event|0|||
30976020|NCT01440374|59061333|FG003|Part 1: Open-label Phase|Adverse Event|0|||
30976021|NCT01440374|59061330|FG000|Part 1: Open-label Phase|Physician Decision|1|||
30976022|NCT01440374|59061331|FG001|Part 1: Open-label Phase|Physician Decision|0|||
30976023|NCT01440374|59061332|FG002|Part 1: Open-label Phase|Physician Decision|0|||
30885760|NCT02554279|58918584|FG000|Overall Study|Withdrawal by Subject|6|||
30885761|NCT02554279|58918585|FG001|Overall Study|Withdrawal by Subject|4|||
30885762|NCT02554279|58918584|FG000|Overall Study|Protocol Violation|2|||
30885763|NCT02554279|58918585|FG001|Overall Study|Protocol Violation|1|||
30885764|NCT02554279|58918584|FG000|Overall Study|Other reason|19|||
30885765|NCT02554279|58918585|FG001|Overall Study|Other reason|6|||
30885766|NCT02554903|58918600|FG000|Overall Study|Death|1|||
30885767|NCT02554903|58918601|FG001|Overall Study|Death|1|||
30885768|NCT02554903|58918600|FG000|Overall Study|Physician Decision|2|||
30885769|NCT02554903|58918601|FG001|Overall Study|Physician Decision|2|||
30885770|NCT02554903|58918600|FG000|Overall Study|Heart Transplant|1|||
30885771|NCT02554903|58918601|FG001|Overall Study|Heart Transplant|2|||
30885772|NCT02332707|58918626|FG000|Overall Study|Adverse Event|0|||
30885773|NCT02332707|58918627|FG001|Overall Study|Adverse Event|0|||
30976024|NCT01440374|59061333|FG003|Part 1: Open-label Phase|Physician Decision|0|||
30976025|NCT01440374|59061330|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
30976026|NCT01440374|59061331|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
30976027|NCT01440374|59061332|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
30885774|NCT02332707|58918628|FG002|Overall Study|Adverse Event|0|||
30885775|NCT02332707|58918629|FG003|Overall Study|Adverse Event|0|||
30885776|NCT02332707|58918630|FG004|Overall Study|Adverse Event|0|||
30885777|NCT02332707|58918631|FG005|Overall Study|Adverse Event|0|||
30885778|NCT02332707|58918632|FG006|Overall Study|Adverse Event|0|||
30885779|NCT02332707|58918633|FG007|Overall Study|Adverse Event|0|||
30885780|NCT02332707|58918634|FG008|Overall Study|Adverse Event|0|||
30885781|NCT02332707|58918635|FG009|Overall Study|Adverse Event|0|||
30885782|NCT02332707|58918636|FG010|Overall Study|Adverse Event|0|||
30885783|NCT02332707|58918637|FG011|Overall Study|Adverse Event|0|||
30885784|NCT02332707|58918638|FG012|Overall Study|Adverse Event|1|||
30885785|NCT02332707|58918639|FG013|Overall Study|Adverse Event|0|||
30885786|NCT02332707|58918640|FG014|Overall Study|Adverse Event|0|||
30885787|NCT02332707|58918641|FG015|Overall Study|Adverse Event|0|||
30885788|NCT02332707|58918642|FG016|Overall Study|Adverse Event|0|||
30885789|NCT02332707|58918643|FG017|Overall Study|Adverse Event|0|||
30885790|NCT02332707|58918626|FG000|Overall Study|Lost to Follow-up|0|||
30885791|NCT02332707|58918627|FG001|Overall Study|Lost to Follow-up|0|||
30885792|NCT02332707|58918628|FG002|Overall Study|Lost to Follow-up|0|||
30885793|NCT02332707|58918629|FG003|Overall Study|Lost to Follow-up|0|||
30885794|NCT02332707|58918630|FG004|Overall Study|Lost to Follow-up|0|||
30885795|NCT02332707|58918631|FG005|Overall Study|Lost to Follow-up|1|||
30885796|NCT02332707|58918632|FG006|Overall Study|Lost to Follow-up|0|||
30885797|NCT02332707|58918633|FG007|Overall Study|Lost to Follow-up|0|||
30885798|NCT02332707|58918634|FG008|Overall Study|Lost to Follow-up|0|||
30885799|NCT02332707|58918635|FG009|Overall Study|Lost to Follow-up|0|||
30885800|NCT02332707|58918636|FG010|Overall Study|Lost to Follow-up|2|||
30885801|NCT02332707|58918637|FG011|Overall Study|Lost to Follow-up|0|||
30885802|NCT02332707|58918638|FG012|Overall Study|Lost to Follow-up|3|||
30885803|NCT02332707|58918639|FG013|Overall Study|Lost to Follow-up|0|||
30885804|NCT02332707|58918640|FG014|Overall Study|Lost to Follow-up|0|||
30885805|NCT02332707|58918641|FG015|Overall Study|Lost to Follow-up|0|||
30885806|NCT02332707|58918642|FG016|Overall Study|Lost to Follow-up|0|||
30885807|NCT02332707|58918643|FG017|Overall Study|Lost to Follow-up|0|||
30885808|NCT02332707|58918626|FG000|Overall Study|Physician Decision|0|||
30885809|NCT02332707|58918627|FG001|Overall Study|Physician Decision|0|||
30885810|NCT02332707|58918628|FG002|Overall Study|Physician Decision|0|||
30885811|NCT02332707|58918629|FG003|Overall Study|Physician Decision|1|||
30885812|NCT02332707|58918630|FG004|Overall Study|Physician Decision|0|||
30885813|NCT02332707|58918631|FG005|Overall Study|Physician Decision|0|||
30885814|NCT02332707|58918632|FG006|Overall Study|Physician Decision|0|||
30885815|NCT02332707|58918633|FG007|Overall Study|Physician Decision|0|||
30885816|NCT02332707|58918634|FG008|Overall Study|Physician Decision|0|||
30885817|NCT02332707|58918635|FG009|Overall Study|Physician Decision|0|||
30885818|NCT02332707|58918636|FG010|Overall Study|Physician Decision|0|||
30885819|NCT02332707|58918637|FG011|Overall Study|Physician Decision|0|||
30885820|NCT02332707|58918638|FG012|Overall Study|Physician Decision|1|||
30885821|NCT02332707|58918639|FG013|Overall Study|Physician Decision|0|||
30885822|NCT02332707|58918640|FG014|Overall Study|Physician Decision|0|||
30885823|NCT02332707|58918641|FG015|Overall Study|Physician Decision|0|||
30885824|NCT02332707|58918642|FG016|Overall Study|Physician Decision|0|||
30885825|NCT02332707|58918643|FG017|Overall Study|Physician Decision|0|||
30885826|NCT02332707|58918626|FG000|Overall Study|Withdrawal by Subject|0|||
30885827|NCT02332707|58918627|FG001|Overall Study|Withdrawal by Subject|0|||
30885828|NCT02332707|58918628|FG002|Overall Study|Withdrawal by Subject|1|||
30885829|NCT02332707|58918629|FG003|Overall Study|Withdrawal by Subject|0|||
30885830|NCT02332707|58918630|FG004|Overall Study|Withdrawal by Subject|0|||
30885831|NCT02332707|58918631|FG005|Overall Study|Withdrawal by Subject|0|||
30885832|NCT02332707|58918632|FG006|Overall Study|Withdrawal by Subject|0|||
30885833|NCT02332707|58918633|FG007|Overall Study|Withdrawal by Subject|0|||
30885834|NCT02332707|58918634|FG008|Overall Study|Withdrawal by Subject|0|||
30885835|NCT02332707|58918635|FG009|Overall Study|Withdrawal by Subject|3|||
30885836|NCT02332707|58918636|FG010|Overall Study|Withdrawal by Subject|0|||
30885837|NCT02332707|58918637|FG011|Overall Study|Withdrawal by Subject|0|||
30885838|NCT02332707|58918638|FG012|Overall Study|Withdrawal by Subject|0|||
30885839|NCT02332707|58918639|FG013|Overall Study|Withdrawal by Subject|0|||
30885840|NCT02332707|58918640|FG014|Overall Study|Withdrawal by Subject|0|||
30976028|NCT01440374|59061333|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
30976029|NCT01440374|59061330|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
30976030|NCT01440374|59061331|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
30976031|NCT01440374|59061332|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
30885841|NCT02332707|58918641|FG015|Overall Study|Withdrawal by Subject|0|||
30885842|NCT02332707|58918642|FG016|Overall Study|Withdrawal by Subject|0|||
30885843|NCT02332707|58918643|FG017|Overall Study|Withdrawal by Subject|0|||
30885844|NCT02370615|58918683|FG000|Overall Study|Adverse Event|1|||
30885845|NCT02370615|58918684|FG001|Overall Study|Adverse Event|0|||
30885846|NCT02307513|58918699|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
30885847|NCT02307513|58918700|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
30885848|NCT02307513|58918699|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
30885849|NCT02307513|58918700|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
30885850|NCT02307513|58918699|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
30885851|NCT02307513|58918700|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
30885852|NCT02307513|58918699|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
30885853|NCT02307513|58918700|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
30885854|NCT02307513|58918699|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
30885855|NCT02307513|58918700|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
30885856|NCT02307513|58918699|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
30885857|NCT02307513|58918700|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
30885858|NCT02307513|58918699|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
30885859|NCT02307513|58918700|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
30885860|NCT02307513|58918699|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
30885861|NCT02307513|58918700|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
30885862|NCT02307513|58918699|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
30885863|NCT02307513|58918700|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
30885864|NCT02307513|58918699|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
30885865|NCT02307513|58918700|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
30885866|NCT02307513|58918699|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
30885867|NCT02307513|58918700|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
30885868|NCT02307513|58918699|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
30885869|NCT02307513|58918700|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
30885870|NCT02307513|58918699|FG000|Long-term Extension|Physician Decision|1|||
30885871|NCT02307513|58918700|FG001|Long-term Extension|Physician Decision|0|||
30885872|NCT02332239|58918712|FG000|Overall Study|Lost to Follow-up|4|||
30885873|NCT02332239|58918713|FG001|Overall Study|Lost to Follow-up|6|||
30885874|NCT02370537|58918724|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
30885875|NCT02370537|58918725|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
30885876|NCT02370537|58918726|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
30885877|NCT02370537|58918724|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
30885878|NCT02370537|58918725|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
30885879|NCT02370537|58918726|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
30885880|NCT02370537|58918724|FG000|Part B|Not randomised to receive treatment|1|||
30885881|NCT02370537|58918725|FG001|Part B|Not randomised to receive treatment|2|||
30885882|NCT02370537|58918726|FG002|Part B|Not randomised to receive treatment|259|||
30885883|NCT02370537|58918724|FG000|Part B|Withdrawal by Subject|0|||
30885884|NCT02370537|58918725|FG001|Part B|Withdrawal by Subject|1|||
30885885|NCT02370537|58918726|FG002|Part B|Withdrawal by Subject|0|||
30885886|NCT02330055|58918745|FG000|Overall Study|technical issues|2|||
30885887|NCT02330055|58918746|FG001|Overall Study|technical issues|0|||
30885888|NCT02330055|58918745|FG000|Overall Study|participant forgot to wear device|5|||
30885889|NCT02330055|58918746|FG001|Overall Study|participant forgot to wear device|5|||
30885890|NCT02330055|58918745|FG000|Overall Study|data for less than 60 minutes|3|||
30885891|NCT02330055|58918746|FG001|Overall Study|data for less than 60 minutes|3|||
30885892|NCT02330055|58918745|FG000|Overall Study|participant did not sleep|0|||
30885893|NCT02330055|58918746|FG001|Overall Study|participant did not sleep|1|||
30885894|NCT02306265|58918752|FG000|Overall Study|Withdrawal by Subject|1|||
30885895|NCT02329743|58918760|FG000|Overall Study|Adverse Event|1|||
30885896|NCT02329743|58918761|FG001|Overall Study|Adverse Event|1|||
30885897|NCT02329743|58918762|FG002|Overall Study|Adverse Event|3|||
30885898|NCT02329743|58918760|FG000|Overall Study|Lost to Follow-up|1|||
30885899|NCT02329743|58918761|FG001|Overall Study|Lost to Follow-up|0|||
30885900|NCT02329743|58918762|FG002|Overall Study|Lost to Follow-up|1|||
30885901|NCT02329743|58918760|FG000|Overall Study|Withdrawal by Subject|4|||
30885902|NCT02329743|58918761|FG001|Overall Study|Withdrawal by Subject|4|||
30885903|NCT02329743|58918762|FG002|Overall Study|Withdrawal by Subject|1|||
30885904|NCT02329743|58918760|FG000|Overall Study|Other|0|||
30885905|NCT02329743|58918761|FG001|Overall Study|Other|2|||
30885906|NCT02329743|58918762|FG002|Overall Study|Other|3|||
30885907|NCT02329431|58918772|FG000|Overall Study|Lost to Follow-up|20|||
30885908|NCT02329431|58918773|FG001|Overall Study|Lost to Follow-up|13|||
30885909|NCT02328105|58918779|FG000|Overall Study|Death|6|||
30885910|NCT02328105|58918779|FG000|Overall Study|Withdrawal by Subject|1|||
30885911|NCT02328105|58918779|FG000|Overall Study|Still On Study in Follow-Up|4|||
30885912|NCT02305797|58918785|FG000|Overall Study|Adverse Event|11|||
30885913|NCT02305797|58918786|FG001|Overall Study|Adverse Event|2|||
30885914|NCT02305797|58918785|FG000|Overall Study|Withdrawal by Subject|9|||
30885915|NCT02305797|58918786|FG001|Overall Study|Withdrawal by Subject|10|||
30885916|NCT02305797|58918785|FG000|Overall Study|Lack of Efficacy|6|||
30885917|NCT02305797|58918786|FG001|Overall Study|Lack of Efficacy|0|||
30885918|NCT02305797|58918785|FG000|Overall Study|Lost to Follow-up|5|||
30885919|NCT02305797|58918786|FG001|Overall Study|Lost to Follow-up|11|||
30885920|NCT02305797|58918785|FG000|Overall Study|Pregnancy|0|||
30885921|NCT02305797|58918786|FG001|Overall Study|Pregnancy|2|||
30885922|NCT02305797|58918785|FG000|Overall Study|Noncompliance|14|||
30885923|NCT02305797|58918786|FG001|Overall Study|Noncompliance|12|||
30885924|NCT02305797|58918785|FG000|Overall Study|Reason not collected|0|||
30885925|NCT02305797|58918786|FG001|Overall Study|Reason not collected|1|||
30885926|NCT01646073|58918794|FG000|Period A (12 Weeks)|Adverse Event|0|||
30885927|NCT01646073|58918795|FG001|Period A (12 Weeks)|Adverse Event|2|||
30885928|NCT01646073|58918794|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
30885929|NCT01646073|58918795|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
30885930|NCT01646073|58918794|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
30885931|NCT01646073|58918795|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
30885932|NCT01646073|58918794|FG000|Period A (12 Weeks)|Protocol Violation|0|||
30885933|NCT01646073|58918795|FG001|Period A (12 Weeks)|Protocol Violation|1|||
30885934|NCT01646073|58918794|FG000|Period A (12 Weeks)|Other|0|||
30885935|NCT01646073|58918795|FG001|Period A (12 Weeks)|Other|1|||
30885936|NCT01646073|58918794|FG000|Period B (12 Weeks)|Adverse Event|0|||
30885937|NCT01646073|58918795|FG001|Period B (12 Weeks)|Adverse Event|7|||
30885938|NCT01646073|58918794|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
30885939|NCT01646073|58918795|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
30885940|NCT01646073|58918794|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
30885941|NCT01646073|58918795|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
30885942|NCT02328027|58918806|FG000|Overall Study|Withdrawal by Subject|0|||
30885943|NCT02328027|58918807|FG001|Overall Study|Withdrawal by Subject|1|||
30885944|NCT02551159|58918817|FG000|Overall Study|Death|352|||
30885945|NCT02551159|58918818|FG001|Overall Study|Death|174|||
30885946|NCT02551159|58918819|FG002|Overall Study|Death|161|||
30885947|NCT02551159|58918817|FG000|Overall Study|Withdrawal by Subject|8|||
30885948|NCT02551159|58918818|FG001|Overall Study|Withdrawal by Subject|5|||
30885949|NCT02551159|58918819|FG002|Overall Study|Withdrawal by Subject|16|||
30885950|NCT02551159|58918817|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
30885951|NCT02551159|58918818|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
30885952|NCT02551159|58918819|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
30885953|NCT02305563|58918832|FG000|Treatment Period|Disease progression|0|||
30885954|NCT02305563|58918833|FG001|Treatment Period|Disease progression|0|||
30885955|NCT02305563|58918834|FG002|Treatment Period|Disease progression|15|||
30885956|NCT02305563|58918835|FG003|Treatment Period|Disease progression|6|||
30885957|NCT02305563|58918836|FG004|Treatment Period|Disease progression|6|||
30885958|NCT02305563|58918832|FG000|Treatment Period|Study drug toxicity|0|||
30885959|NCT02305563|58918833|FG001|Treatment Period|Study drug toxicity|0|||
30885960|NCT02305563|58918834|FG002|Treatment Period|Study drug toxicity|0|||
30885961|NCT02305563|58918835|FG003|Treatment Period|Study drug toxicity|1|||
30885962|NCT02305563|58918836|FG004|Treatment Period|Study drug toxicity|2|||
30885963|NCT02305563|58918832|FG000|Treatment Period|Death|0|||
30885964|NCT02305563|58918833|FG001|Treatment Period|Death|0|||
30885965|NCT02305563|58918834|FG002|Treatment Period|Death|1|||
30885966|NCT02305563|58918835|FG003|Treatment Period|Death|2|||
30885967|NCT02305563|58918836|FG004|Treatment Period|Death|1|||
30885968|NCT02305563|58918832|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
30885969|NCT02305563|58918833|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
30885970|NCT02305563|58918834|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
30885971|NCT02305563|58918835|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
30885972|NCT02305563|58918836|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
30885973|NCT02305563|58918832|FG000|Treatment Period|Participant request to stop therapy|0|||
30885974|NCT02305563|58918833|FG001|Treatment Period|Participant request to stop therapy|2|||
30885975|NCT02305563|58918834|FG002|Treatment Period|Participant request to stop therapy|0|||
30885976|NCT02305563|58918835|FG003|Treatment Period|Participant request to stop therapy|1|||
30885977|NCT02305563|58918836|FG004|Treatment Period|Participant request to stop therapy|0|||
30885978|NCT02305563|58918832|FG000|Treatment Period|Participant withdrew consent|0|||
30885979|NCT02305563|58918833|FG001|Treatment Period|Participant withdrew consent|0|||
30885980|NCT02305563|58918834|FG002|Treatment Period|Participant withdrew consent|1|||
30885981|NCT02305563|58918835|FG003|Treatment Period|Participant withdrew consent|1|||
30976032|NCT01440374|59061333|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
30976033|NCT01440374|59061330|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
30976034|NCT01440374|59061331|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
30885982|NCT02305563|58918836|FG004|Treatment Period|Participant withdrew consent|1|||
30885983|NCT02305563|58918832|FG000|Treatment Period|Maximum clinical benefit|0|||
30885984|NCT02305563|58918833|FG001|Treatment Period|Maximum clinical benefit|0|||
30885985|NCT02305563|58918834|FG002|Treatment Period|Maximum clinical benefit|0|||
30885986|NCT02305563|58918835|FG003|Treatment Period|Maximum clinical benefit|0|||
30885987|NCT02305563|58918836|FG004|Treatment Period|Maximum clinical benefit|1|||
30885988|NCT02305563|58918832|FG000|Treatment Period|Poor/non-compliance|0|||
30885989|NCT02305563|58918833|FG001|Treatment Period|Poor/non-compliance|0|||
30885990|NCT02305563|58918834|FG002|Treatment Period|Poor/non-compliance|0|||
30885991|NCT02305563|58918835|FG003|Treatment Period|Poor/non-compliance|0|||
30885992|NCT02305563|58918836|FG004|Treatment Period|Poor/non-compliance|1|||
30885993|NCT02305563|58918832|FG000|Treatment Period|Administrative reason by Sponsor|0|||
30885994|NCT02305563|58918833|FG001|Treatment Period|Administrative reason by Sponsor|0|||
30885995|NCT02305563|58918834|FG002|Treatment Period|Administrative reason by Sponsor|0|||
30885996|NCT02305563|58918835|FG003|Treatment Period|Administrative reason by Sponsor|0|||
30885997|NCT02305563|58918836|FG004|Treatment Period|Administrative reason by Sponsor|1|||
30885998|NCT02305563|58918832|FG000|Treatment Period|other reason|2|||
30885999|NCT02305563|58918833|FG001|Treatment Period|other reason|0|||
30886000|NCT02305563|58918834|FG002|Treatment Period|other reason|2|||
30886001|NCT02305563|58918835|FG003|Treatment Period|other reason|2|||
30886002|NCT02305563|58918836|FG004|Treatment Period|other reason|1|||
30886003|NCT02305563|58918832|FG000|Treatment Period|Randomized but not treated|0|||
30886004|NCT02305563|58918833|FG001|Treatment Period|Randomized but not treated|0|||
30886005|NCT02305563|58918834|FG002|Treatment Period|Randomized but not treated|0|||
30886006|NCT02305563|58918835|FG003|Treatment Period|Randomized but not treated|0|||
30886007|NCT02305563|58918836|FG004|Treatment Period|Randomized but not treated|2|||
30886008|NCT02305563|58918832|FG000|Treatment Period|added ULO, then disease progression|0|||
30886009|NCT02305563|58918833|FG001|Treatment Period|added ULO, then disease progression|0|||
30886010|NCT02305563|58918834|FG002|Treatment Period|added ULO, then disease progression|0|||
30886011|NCT02305563|58918835|FG003|Treatment Period|added ULO, then disease progression|0|||
30886012|NCT02305563|58918836|FG004|Treatment Period|added ULO, then disease progression|4|||
30886013|NCT02305563|58918832|FG000|Treatment Period|added ULO; then other reason|0|||
30886014|NCT02305563|58918833|FG001|Treatment Period|added ULO; then other reason|0|||
30886015|NCT02305563|58918834|FG002|Treatment Period|added ULO; then other reason|0|||
30886016|NCT02305563|58918835|FG003|Treatment Period|added ULO; then other reason|0|||
30886017|NCT02305563|58918836|FG004|Treatment Period|added ULO; then other reason|1|||
30886018|NCT02305563|58918832|FG000|Treatment Period|added ULO, then request to stop|0|||
30886019|NCT02305563|58918833|FG001|Treatment Period|added ULO, then request to stop|0|||
30886020|NCT02305563|58918834|FG002|Treatment Period|added ULO, then request to stop|0|||
30886021|NCT02305563|58918835|FG003|Treatment Period|added ULO, then request to stop|0|||
30886022|NCT02305563|58918836|FG004|Treatment Period|added ULO, then request to stop|1|||
30886023|NCT02305563|58918832|FG000|Follow-up Period|Death|0|||
30886024|NCT02305563|58918833|FG001|Follow-up Period|Death|0|||
30886025|NCT02305563|58918834|FG002|Follow-up Period|Death|5|||
30886026|NCT02305563|58918835|FG003|Follow-up Period|Death|4|||
30886027|NCT02305563|58918836|FG004|Follow-up Period|Death|7|||
30886028|NCT02305563|58918832|FG000|Follow-up Period|Participant withdrew consent|0|||
30886029|NCT02305563|58918833|FG001|Follow-up Period|Participant withdrew consent|0|||
30886030|NCT02305563|58918834|FG002|Follow-up Period|Participant withdrew consent|2|||
30886031|NCT02305563|58918835|FG003|Follow-up Period|Participant withdrew consent|1|||
30886032|NCT02305563|58918836|FG004|Follow-up Period|Participant withdrew consent|0|||
30886033|NCT02305563|58918832|FG000|Follow-up Period|other reason|0|||
30886034|NCT02305563|58918833|FG001|Follow-up Period|other reason|0|||
30886035|NCT02305563|58918834|FG002|Follow-up Period|other reason|0|||
30886036|NCT02305563|58918835|FG003|Follow-up Period|other reason|0|||
30886037|NCT02305563|58918836|FG004|Follow-up Period|other reason|1|||
30886038|NCT02305563|58918832|FG000|Follow-up Period|Followup no longer required per protocol|3|||
30886039|NCT02305563|58918833|FG001|Follow-up Period|Followup no longer required per protocol|3|||
30886040|NCT02305563|58918834|FG002|Follow-up Period|Followup no longer required per protocol|4|||
30886041|NCT02305563|58918835|FG003|Follow-up Period|Followup no longer required per protocol|1|||
30886042|NCT02305563|58918836|FG004|Follow-up Period|Followup no longer required per protocol|4|||
30886043|NCT02327325|58918855|FG000|Overall Study|Withdrawal by Subject|1|||
30886044|NCT02327325|58918856|FG001|Overall Study|Withdrawal by Subject|4|||
30886045|NCT02327325|58918857|FG002|Overall Study|Withdrawal by Subject|4|||
30886046|NCT02327325|58918855|FG000|Overall Study|Excluded by Study Team|0|||
30886047|NCT02327325|58918856|FG001|Overall Study|Excluded by Study Team|0|||
30886048|NCT02327325|58918857|FG002|Overall Study|Excluded by Study Team|1|||
30886049|NCT02304705|58918867|FG000|Overall Study|Withdrawal by Subject|2|||
30886050|NCT02304705|58918868|FG001|Overall Study|Withdrawal by Subject|0|||
30886051|NCT02304705|58918867|FG000|Overall Study|Physician Decision|2|||
30886052|NCT02304705|58918868|FG001|Overall Study|Physician Decision|4|||
30886053|NCT02304705|58918867|FG000|Overall Study|Death|0|||
30886054|NCT02304705|58918868|FG001|Overall Study|Death|1|||
30886055|NCT02304705|58918867|FG000|Overall Study|Lost to Follow-up|0|||
30886056|NCT02304705|58918868|FG001|Overall Study|Lost to Follow-up|2|||
30976035|NCT01440374|59061332|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
30886057|NCT02553499|58918888|FG000|Overall Study|Adverse Event|0|||
30886058|NCT02553499|58918889|FG001|Overall Study|Adverse Event|0|||
30886059|NCT02553499|58918890|FG002|Overall Study|Adverse Event|0|||
30886060|NCT02553499|58918891|FG003|Overall Study|Adverse Event|0|||
30886061|NCT02553499|58918892|FG004|Overall Study|Adverse Event|0|||
30886062|NCT02553499|58918893|FG005|Overall Study|Adverse Event|0|||
30886063|NCT02553499|58918894|FG006|Overall Study|Adverse Event|1|||
30886064|NCT02553499|58918895|FG007|Overall Study|Adverse Event|1|||
30886065|NCT02553499|58918896|FG008|Overall Study|Adverse Event|0|||
30886066|NCT02553499|58918897|FG009|Overall Study|Adverse Event|0|||
30886067|NCT02553499|58918898|FG010|Overall Study|Adverse Event|0|||
30886068|NCT02553499|58918899|FG011|Overall Study|Adverse Event|0|||
30886069|NCT02553499|58918900|FG012|Overall Study|Adverse Event|0|||
30886070|NCT02553499|58918901|FG013|Overall Study|Adverse Event|1|||
30886071|NCT02553499|58918888|FG000|Overall Study|Death|0|||
30886072|NCT02553499|58918889|FG001|Overall Study|Death|1|||
30886073|NCT02553499|58918890|FG002|Overall Study|Death|1|||
30886074|NCT02553499|58918891|FG003|Overall Study|Death|0|||
30886075|NCT02553499|58918892|FG004|Overall Study|Death|1|||
30886076|NCT02553499|58918893|FG005|Overall Study|Death|2|||
30886077|NCT02553499|58918894|FG006|Overall Study|Death|0|||
30886078|NCT02553499|58918895|FG007|Overall Study|Death|0|||
30886079|NCT02553499|58918896|FG008|Overall Study|Death|0|||
30886080|NCT02553499|58918897|FG009|Overall Study|Death|0|||
30886081|NCT02553499|58918898|FG010|Overall Study|Death|1|||
30886082|NCT02553499|58918899|FG011|Overall Study|Death|0|||
30886083|NCT02553499|58918900|FG012|Overall Study|Death|0|||
30886084|NCT02553499|58918901|FG013|Overall Study|Death|0|||
30886085|NCT02553499|58918888|FG000|Overall Study|Lost to Follow-up|0|||
30886086|NCT02553499|58918889|FG001|Overall Study|Lost to Follow-up|0|||
30886087|NCT02553499|58918890|FG002|Overall Study|Lost to Follow-up|0|||
30886088|NCT02553499|58918891|FG003|Overall Study|Lost to Follow-up|0|||
30886089|NCT02553499|58918892|FG004|Overall Study|Lost to Follow-up|0|||
30886090|NCT02553499|58918893|FG005|Overall Study|Lost to Follow-up|0|||
30886091|NCT02553499|58918894|FG006|Overall Study|Lost to Follow-up|1|||
30886092|NCT02553499|58918895|FG007|Overall Study|Lost to Follow-up|0|||
30886093|NCT02553499|58918896|FG008|Overall Study|Lost to Follow-up|0|||
30886094|NCT02553499|58918897|FG009|Overall Study|Lost to Follow-up|0|||
30886095|NCT02553499|58918898|FG010|Overall Study|Lost to Follow-up|0|||
30886096|NCT02553499|58918899|FG011|Overall Study|Lost to Follow-up|0|||
30886097|NCT02553499|58918900|FG012|Overall Study|Lost to Follow-up|0|||
30886098|NCT02553499|58918901|FG013|Overall Study|Lost to Follow-up|0|||
30886099|NCT02553499|58918888|FG000|Overall Study|Physician Decision|0|||
30886100|NCT02553499|58918889|FG001|Overall Study|Physician Decision|1|||
30886101|NCT02553499|58918890|FG002|Overall Study|Physician Decision|1|||
30886102|NCT02553499|58918891|FG003|Overall Study|Physician Decision|0|||
30886103|NCT02553499|58918892|FG004|Overall Study|Physician Decision|1|||
30886104|NCT02553499|58918893|FG005|Overall Study|Physician Decision|0|||
30886105|NCT02553499|58918894|FG006|Overall Study|Physician Decision|0|||
30886106|NCT02553499|58918895|FG007|Overall Study|Physician Decision|1|||
30886107|NCT02553499|58918896|FG008|Overall Study|Physician Decision|1|||
30886108|NCT02553499|58918897|FG009|Overall Study|Physician Decision|2|||
30886109|NCT02553499|58918898|FG010|Overall Study|Physician Decision|1|||
30886110|NCT02553499|58918899|FG011|Overall Study|Physician Decision|3|||
30886111|NCT02553499|58918900|FG012|Overall Study|Physician Decision|1|||
30886112|NCT02553499|58918901|FG013|Overall Study|Physician Decision|0|||
30886113|NCT02553499|58918888|FG000|Overall Study|Progressive Disease|0|||
30886114|NCT02553499|58918889|FG001|Overall Study|Progressive Disease|0|||
30886115|NCT02553499|58918890|FG002|Overall Study|Progressive Disease|0|||
30886116|NCT02553499|58918891|FG003|Overall Study|Progressive Disease|2|||
30886117|NCT02553499|58918892|FG004|Overall Study|Progressive Disease|1|||
30886118|NCT02553499|58918893|FG005|Overall Study|Progressive Disease|1|||
30886119|NCT02553499|58918894|FG006|Overall Study|Progressive Disease|1|||
30886120|NCT02553499|58918895|FG007|Overall Study|Progressive Disease|0|||
30886121|NCT02553499|58918896|FG008|Overall Study|Progressive Disease|0|||
30976036|NCT01440374|59061333|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
30976037|NCT01440374|59061330|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
30976038|NCT01440374|59061331|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
30976039|NCT01440374|59061332|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
30976040|NCT01440374|59061333|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
30886122|NCT02553499|58918897|FG009|Overall Study|Progressive Disease|1|||
30886123|NCT02553499|58918898|FG010|Overall Study|Progressive Disease|0|||
30886124|NCT02553499|58918899|FG011|Overall Study|Progressive Disease|0|||
30886125|NCT02553499|58918900|FG012|Overall Study|Progressive Disease|2|||
30886126|NCT02553499|58918901|FG013|Overall Study|Progressive Disease|1|||
30886127|NCT02553499|58918888|FG000|Overall Study|Study Terminated by Sponsor|0|||
30886128|NCT02553499|58918889|FG001|Overall Study|Study Terminated by Sponsor|0|||
30886129|NCT02553499|58918890|FG002|Overall Study|Study Terminated by Sponsor|0|||
30886130|NCT02553499|58918891|FG003|Overall Study|Study Terminated by Sponsor|0|||
30886131|NCT02553499|58918892|FG004|Overall Study|Study Terminated by Sponsor|0|||
30886132|NCT02553499|58918893|FG005|Overall Study|Study Terminated by Sponsor|0|||
30886133|NCT02553499|58918894|FG006|Overall Study|Study Terminated by Sponsor|0|||
30886134|NCT02553499|58918895|FG007|Overall Study|Study Terminated by Sponsor|0|||
30886135|NCT02553499|58918896|FG008|Overall Study|Study Terminated by Sponsor|1|||
30886136|NCT02553499|58918897|FG009|Overall Study|Study Terminated by Sponsor|0|||
30886137|NCT02553499|58918898|FG010|Overall Study|Study Terminated by Sponsor|0|||
30886138|NCT02553499|58918899|FG011|Overall Study|Study Terminated by Sponsor|0|||
30886139|NCT02553499|58918900|FG012|Overall Study|Study Terminated by Sponsor|0|||
30886140|NCT02553499|58918901|FG013|Overall Study|Study Terminated by Sponsor|0|||
30886141|NCT02553499|58918888|FG000|Overall Study|Withdrawal by Subject|2|||
30886142|NCT02553499|58918889|FG001|Overall Study|Withdrawal by Subject|0|||
30886143|NCT02553499|58918890|FG002|Overall Study|Withdrawal by Subject|0|||
30886144|NCT02553499|58918891|FG003|Overall Study|Withdrawal by Subject|0|||
30886145|NCT02553499|58918892|FG004|Overall Study|Withdrawal by Subject|0|||
30886146|NCT02553499|58918893|FG005|Overall Study|Withdrawal by Subject|0|||
30886147|NCT02553499|58918894|FG006|Overall Study|Withdrawal by Subject|0|||
30886148|NCT02553499|58918895|FG007|Overall Study|Withdrawal by Subject|1|||
30886149|NCT02553499|58918896|FG008|Overall Study|Withdrawal by Subject|1|||
30886150|NCT02553499|58918897|FG009|Overall Study|Withdrawal by Subject|0|||
30886151|NCT02553499|58918898|FG010|Overall Study|Withdrawal by Subject|1|||
30886152|NCT02553499|58918899|FG011|Overall Study|Withdrawal by Subject|0|||
30886153|NCT02553499|58918900|FG012|Overall Study|Withdrawal by Subject|0|||
30886154|NCT02553499|58918901|FG013|Overall Study|Withdrawal by Subject|0|||
30886155|NCT02553421|58918934|FG000|Overall Study|Lost to Follow-up|21|||
30886156|NCT02553421|58918935|FG001|Overall Study|Lost to Follow-up|1|||
30886157|NCT02553421|58918934|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
30886158|NCT02553421|58918935|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
30886159|NCT02553421|58918934|FG000|Overall Study|Improper Device Placement|3|||
30886160|NCT02553421|58918935|FG001|Overall Study|Improper Device Placement|0|||
30886161|NCT02549287|58918944|FG000|Overall Study|Lost to Follow-up|65|||
30886162|NCT02549287|58918945|FG001|Overall Study|Lost to Follow-up|26|||
30886163|NCT02549287|58918944|FG000|Overall Study|Withdrawal by Subject|15|||
30886164|NCT02549287|58918945|FG001|Overall Study|Withdrawal by Subject|6|||
30886165|NCT02553265|58918951|FG000|Enrollment|Death|0|||
30886166|NCT02553265|58918952|FG001|Enrollment|Death|0|||
30886167|NCT02553265|58918953|FG002|Enrollment|Death|1|||
30886168|NCT02553265|58918951|FG000|First Intervention (28 Days)|Adverse Event|1|||
30886169|NCT02553265|58918952|FG001|First Intervention (28 Days)|Adverse Event|0|||
30886170|NCT02553265|58918953|FG002|First Intervention (28 Days)|Adverse Event|0|||
30886171|NCT02553265|58918951|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
30886172|NCT02553265|58918952|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
30886173|NCT02553265|58918953|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
30886174|NCT02553265|58918951|FG000|Second Intervention (28 Days)|Adverse Event|1|||
30886175|NCT02553265|58918952|FG001|Second Intervention (28 Days)|Adverse Event|0|||
30886176|NCT02553265|58918953|FG002|Second Intervention (28 Days)|Adverse Event|0|||
30886177|NCT02553265|58918951|FG000|Third Intervention (28 Days)|Adverse Event|1|||
30886178|NCT02553265|58918952|FG001|Third Intervention (28 Days)|Adverse Event|0|||
30886179|NCT02553265|58918953|FG002|Third Intervention (28 Days)|Adverse Event|0|||
30886180|NCT02553265|58918951|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
30886181|NCT02553265|58918952|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
30886182|NCT02553265|58918953|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
30886183|NCT02561195|58918970|FG000|Vaccination 1 to 3|Adverse Event|4|||
30886184|NCT02561195|58918971|FG001|Vaccination 1 to 3|Adverse Event|5|||
30886185|NCT02561195|58918972|FG002|Vaccination 1 to 3|Adverse Event|0|||
30886186|NCT02561195|58918973|FG003|Vaccination 1 to 3|Adverse Event|3|||
30886187|NCT02561195|58918974|FG004|Vaccination 1 to 3|Adverse Event|4|||
30886188|NCT02561195|58918975|FG005|Vaccination 1 to 3|Adverse Event|0|||
30886189|NCT02561195|58918976|FG006|Vaccination 1 to 3|Adverse Event|0|||
30886190|NCT02561195|58918977|FG007|Vaccination 1 to 3|Adverse Event|0|||
30886191|NCT02561195|58918978|FG008|Vaccination 1 to 3|Adverse Event|0|||
30886192|NCT02561195|58918979|FG009|Vaccination 1 to 3|Adverse Event|0|||
30886193|NCT02561195|58918980|FG010|Vaccination 1 to 3|Adverse Event|0|||
30886194|NCT02561195|58918981|FG011|Vaccination 1 to 3|Adverse Event|0|||
30886195|NCT02561195|58918982|FG012|Vaccination 1 to 3|Adverse Event|0|||
30886196|NCT02561195|58918983|FG013|Vaccination 1 to 3|Adverse Event|0|||
30886197|NCT02561195|58918970|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
30886198|NCT02561195|58918971|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
30886199|NCT02561195|58918972|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
30886200|NCT02561195|58918973|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
30886201|NCT02561195|58918974|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
30886202|NCT02561195|58918975|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
30886203|NCT02561195|58918976|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
30886204|NCT02561195|58918977|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
30886205|NCT02561195|58918978|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
30886206|NCT02561195|58918979|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
30886207|NCT02561195|58918980|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
30886208|NCT02561195|58918981|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
30886209|NCT02561195|58918982|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
30886210|NCT02561195|58918983|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
30886211|NCT02561195|58918970|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
30976041|NCT01440374|59061330|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
30886212|NCT02561195|58918971|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
30886213|NCT02561195|58918972|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
30886214|NCT02561195|58918973|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
30886215|NCT02561195|58918974|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
30886216|NCT02561195|58918975|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
30886217|NCT02561195|58918976|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
30886218|NCT02561195|58918977|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
30886219|NCT02561195|58918978|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
30886220|NCT02561195|58918979|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
30886221|NCT02561195|58918980|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
30886222|NCT02561195|58918981|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
30886223|NCT02561195|58918982|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
30886224|NCT02561195|58918983|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
30886225|NCT02561195|58918970|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
30886226|NCT02561195|58918971|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
30886227|NCT02561195|58918972|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
30886228|NCT02561195|58918973|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
30886229|NCT02561195|58918974|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
30886230|NCT02561195|58918975|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
30886231|NCT02561195|58918976|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
30886232|NCT02561195|58918977|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
30886233|NCT02561195|58918978|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
30886234|NCT02561195|58918979|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
30886235|NCT02561195|58918980|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
30886236|NCT02561195|58918981|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
30886237|NCT02561195|58918982|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
30976042|NCT01440374|59061331|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
30976043|NCT01440374|59061332|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
30976044|NCT01440374|59061333|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
30976045|NCT01440374|59061330|FG000|Part 2; Double-blind Phase|Not treated|0|||
30976046|NCT01440374|59061331|FG001|Part 2; Double-blind Phase|Not treated|0|||
30976047|NCT01440374|59061332|FG002|Part 2; Double-blind Phase|Not treated|1|||
30976048|NCT01440374|59061333|FG003|Part 2; Double-blind Phase|Not treated|0|||
30976049|NCT01440374|59061330|FG000|Part 3: Extension|Withdrawal by Subject|0|||
30976050|NCT01440374|59061331|FG001|Part 3: Extension|Withdrawal by Subject|0|||
30976051|NCT01440374|59061332|FG002|Part 3: Extension|Withdrawal by Subject|0|||
30976052|NCT01440374|59061333|FG003|Part 3: Extension|Withdrawal by Subject|5|||
30976053|NCT01440374|59061330|FG000|Part 3: Extension|Adverse Event|0|||
30976054|NCT01440374|59061331|FG001|Part 3: Extension|Adverse Event|0|||
30976055|NCT01440374|59061332|FG002|Part 3: Extension|Adverse Event|0|||
30976056|NCT01440374|59061333|FG003|Part 3: Extension|Adverse Event|13|||
30976057|NCT01440374|59061330|FG000|Part 3: Extension|Physician Decision|0|||
30976058|NCT01440374|59061331|FG001|Part 3: Extension|Physician Decision|0|||
30976059|NCT01440374|59061332|FG002|Part 3: Extension|Physician Decision|0|||
30976060|NCT01440374|59061333|FG003|Part 3: Extension|Physician Decision|14|||
30976061|NCT01666782|59061481|FG000|Overall Study|Received 2 doses of vaccine|0|||
30976062|NCT01666782|59061482|FG001|Overall Study|Received 2 doses of vaccine|1|||
30976063|NCT01666782|59061481|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
30976064|NCT01666782|59061482|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
30976065|NCT01439360|59061498|FG000|Overall Study|Adverse Event|4|||
30976066|NCT01439360|59061499|FG001|Overall Study|Adverse Event|16|||
30976067|NCT01439360|59061498|FG000|Overall Study|Lost to Follow-up|43|||
30976068|NCT01439360|59061499|FG001|Overall Study|Lost to Follow-up|58|||
30976069|NCT01439360|59061498|FG000|Overall Study|Others|10|||
30886238|NCT02561195|58918983|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
30886239|NCT02561195|58918970|FG000|Vaccination 1 to 3|Other|7|||
30886240|NCT02561195|58918971|FG001|Vaccination 1 to 3|Other|3|||
30886241|NCT02561195|58918972|FG002|Vaccination 1 to 3|Other|1|||
30886242|NCT02561195|58918973|FG003|Vaccination 1 to 3|Other|7|||
30886243|NCT02561195|58918974|FG004|Vaccination 1 to 3|Other|5|||
30886244|NCT02561195|58918975|FG005|Vaccination 1 to 3|Other|1|||
30886245|NCT02561195|58918976|FG006|Vaccination 1 to 3|Other|0|||
30976070|NCT01439360|59061499|FG001|Overall Study|Others|5|||
30976071|NCT01439360|59061498|FG000|Overall Study|Protocol Violation|1|||
30976072|NCT01439360|59061499|FG001|Overall Study|Protocol Violation|0|||
30976073|NCT01439360|59061498|FG000|Overall Study|Withdrawal by Subject|140|||
30976074|NCT01439360|59061499|FG001|Overall Study|Withdrawal by Subject|129|||
30976075|NCT01439204|59061676|FG000|Overall Study|Withdrawal by Subject|0|||
30976076|NCT01439204|59061677|FG001|Overall Study|Withdrawal by Subject|1|||
30976077|NCT01439204|59061676|FG000|Overall Study|Lost to Follow-up|0|||
30976078|NCT01439204|59061677|FG001|Overall Study|Lost to Follow-up|2|||
30886246|NCT02561195|58918977|FG007|Vaccination 1 to 3|Other|0|||
30886247|NCT02561195|58918978|FG008|Vaccination 1 to 3|Other|0|||
30886248|NCT02561195|58918979|FG009|Vaccination 1 to 3|Other|0|||
30886249|NCT02561195|58918980|FG010|Vaccination 1 to 3|Other|0|||
30886250|NCT02561195|58918981|FG011|Vaccination 1 to 3|Other|0|||
30886251|NCT02561195|58918982|FG012|Vaccination 1 to 3|Other|0|||
30886252|NCT02561195|58918983|FG013|Vaccination 1 to 3|Other|0|||
30886253|NCT02561195|58918970|FG000|Vaccination 1 to 3|Protocol Violation|1|||
30886254|NCT02561195|58918971|FG001|Vaccination 1 to 3|Protocol Violation|0|||
30886255|NCT02561195|58918972|FG002|Vaccination 1 to 3|Protocol Violation|1|||
30886256|NCT02561195|58918973|FG003|Vaccination 1 to 3|Protocol Violation|2|||
30886257|NCT02561195|58918974|FG004|Vaccination 1 to 3|Protocol Violation|5|||
30886258|NCT02561195|58918975|FG005|Vaccination 1 to 3|Protocol Violation|2|||
30886259|NCT02561195|58918976|FG006|Vaccination 1 to 3|Protocol Violation|0|||
30886260|NCT02561195|58918977|FG007|Vaccination 1 to 3|Protocol Violation|0|||
30886261|NCT02561195|58918978|FG008|Vaccination 1 to 3|Protocol Violation|0|||
30886262|NCT02561195|58918979|FG009|Vaccination 1 to 3|Protocol Violation|0|||
30886263|NCT02561195|58918980|FG010|Vaccination 1 to 3|Protocol Violation|0|||
30886264|NCT02561195|58918981|FG011|Vaccination 1 to 3|Protocol Violation|0|||
30886265|NCT02561195|58918982|FG012|Vaccination 1 to 3|Protocol Violation|0|||
30886266|NCT02561195|58918983|FG013|Vaccination 1 to 3|Protocol Violation|0|||
30886267|NCT02561195|58918970|FG000|Vaccination 1 to 3|Death|2|||
30886268|NCT02561195|58918971|FG001|Vaccination 1 to 3|Death|1|||
30886269|NCT02561195|58918972|FG002|Vaccination 1 to 3|Death|0|||
30886270|NCT02561195|58918973|FG003|Vaccination 1 to 3|Death|2|||
30886271|NCT02561195|58918974|FG004|Vaccination 1 to 3|Death|0|||
30886272|NCT02561195|58918975|FG005|Vaccination 1 to 3|Death|0|||
30886273|NCT02561195|58918976|FG006|Vaccination 1 to 3|Death|0|||
30886274|NCT02561195|58918977|FG007|Vaccination 1 to 3|Death|0|||
30886275|NCT02561195|58918978|FG008|Vaccination 1 to 3|Death|0|||
30886276|NCT02561195|58918979|FG009|Vaccination 1 to 3|Death|0|||
30886277|NCT02561195|58918980|FG010|Vaccination 1 to 3|Death|0|||
30886278|NCT02561195|58918981|FG011|Vaccination 1 to 3|Death|0|||
30886279|NCT02561195|58918982|FG012|Vaccination 1 to 3|Death|0|||
30886280|NCT02561195|58918983|FG013|Vaccination 1 to 3|Death|0|||
30886281|NCT02561195|58918970|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
30886282|NCT02561195|58918971|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
30886283|NCT02561195|58918972|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
30886284|NCT02561195|58918973|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
30886285|NCT02561195|58918974|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
30886286|NCT02561195|58918975|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
30886287|NCT02561195|58918976|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
30886288|NCT02561195|58918977|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
30886289|NCT02561195|58918978|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
30886290|NCT02561195|58918979|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
30886291|NCT02561195|58918980|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
30886292|NCT02561195|58918981|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
30886293|NCT02561195|58918982|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
30886294|NCT02561195|58918983|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
30886295|NCT02561195|58918970|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
30886296|NCT02561195|58918971|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
30886297|NCT02561195|58918972|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
30886298|NCT02561195|58918973|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
30886299|NCT02561195|58918974|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
30886300|NCT02561195|58918975|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
30886301|NCT02561195|58918976|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
30886302|NCT02561195|58918977|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
30886303|NCT02561195|58918978|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
30886304|NCT02561195|58918979|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
30886305|NCT02561195|58918980|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
30886306|NCT02561195|58918981|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
30886307|NCT02561195|58918982|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
30886308|NCT02561195|58918983|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
30886309|NCT02561195|58918970|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
30886310|NCT02561195|58918971|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
30886311|NCT02561195|58918972|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
30886312|NCT02561195|58918973|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
30886313|NCT02561195|58918974|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
30886314|NCT02561195|58918975|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
30886315|NCT02561195|58918976|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
30886316|NCT02561195|58918977|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
30886317|NCT02561195|58918978|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
30886318|NCT02561195|58918979|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
30886319|NCT02561195|58918980|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
30886320|NCT02561195|58918981|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
30886321|NCT02561195|58918982|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
30886322|NCT02561195|58918983|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
30886323|NCT02561195|58918970|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886324|NCT02561195|58918971|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886325|NCT02561195|58918972|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886326|NCT02561195|58918973|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886327|NCT02561195|58918974|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886328|NCT02561195|58918975|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886329|NCT02561195|58918976|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886330|NCT02561195|58918977|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886331|NCT02561195|58918978|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886332|NCT02561195|58918979|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886333|NCT02561195|58918980|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886334|NCT02561195|58918981|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886335|NCT02561195|58918982|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
30886336|NCT02561195|58918983|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
30886337|NCT02561195|58918970|FG000|Extension Stage (Vaccination 4)|Death|0|||
30886338|NCT02561195|58918971|FG001|Extension Stage (Vaccination 4)|Death|0|||
30886339|NCT02561195|58918972|FG002|Extension Stage (Vaccination 4)|Death|0|||
30886340|NCT02561195|58918973|FG003|Extension Stage (Vaccination 4)|Death|0|||
30886341|NCT02561195|58918974|FG004|Extension Stage (Vaccination 4)|Death|0|||
30886342|NCT02561195|58918975|FG005|Extension Stage (Vaccination 4)|Death|0|||
30886343|NCT02561195|58918976|FG006|Extension Stage (Vaccination 4)|Death|0|||
30886344|NCT02561195|58918977|FG007|Extension Stage (Vaccination 4)|Death|0|||
30886345|NCT02561195|58918978|FG008|Extension Stage (Vaccination 4)|Death|0|||
30886346|NCT02561195|58918979|FG009|Extension Stage (Vaccination 4)|Death|1|||
30886347|NCT02561195|58918980|FG010|Extension Stage (Vaccination 4)|Death|0|||
30886348|NCT02561195|58918981|FG011|Extension Stage (Vaccination 4)|Death|0|||
30886349|NCT02561195|58918982|FG012|Extension Stage (Vaccination 4)|Death|0|||
30886350|NCT02561195|58918983|FG013|Extension Stage (Vaccination 4)|Death|0|||
30886351|NCT02561195|58918970|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
30886352|NCT02561195|58918971|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
30886353|NCT02561195|58918972|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
30886354|NCT02561195|58918973|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
30886355|NCT02561195|58918974|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
30886356|NCT02561195|58918975|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
30886357|NCT02561195|58918976|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
30886358|NCT02561195|58918977|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
30886359|NCT02561195|58918978|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
30886360|NCT02561195|58918979|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
30886361|NCT02561195|58918980|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
30886362|NCT02561195|58918981|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
30886363|NCT02561195|58918982|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
30886364|NCT02561195|58918983|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
30886365|NCT02561195|58918970|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
30886366|NCT02561195|58918971|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
30886367|NCT02561195|58918972|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
30886368|NCT02561195|58918973|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
30886369|NCT02561195|58918974|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
30886370|NCT02561195|58918975|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
30886371|NCT02561195|58918976|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
30886372|NCT02561195|58918977|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
30886373|NCT02561195|58918978|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
30886374|NCT02561195|58918979|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
30886375|NCT02561195|58918980|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
30886376|NCT02561195|58918981|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
30886377|NCT02561195|58918982|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
30886378|NCT02561195|58918983|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
30886379|NCT02561195|58918970|FG000|Extension Stage (Vaccination 4)|Other|0|||
30886380|NCT02561195|58918971|FG001|Extension Stage (Vaccination 4)|Other|0|||
30886381|NCT02561195|58918972|FG002|Extension Stage (Vaccination 4)|Other|0|||
30886382|NCT02561195|58918973|FG003|Extension Stage (Vaccination 4)|Other|0|||
30886383|NCT02561195|58918974|FG004|Extension Stage (Vaccination 4)|Other|0|||
30886384|NCT02561195|58918975|FG005|Extension Stage (Vaccination 4)|Other|0|||
30886385|NCT02561195|58918976|FG006|Extension Stage (Vaccination 4)|Other|0|||
30886386|NCT02561195|58918977|FG007|Extension Stage (Vaccination 4)|Other|0|||
30886387|NCT02561195|58918978|FG008|Extension Stage (Vaccination 4)|Other|0|||
30886388|NCT02561195|58918979|FG009|Extension Stage (Vaccination 4)|Other|0|||
30886389|NCT02561195|58918980|FG010|Extension Stage (Vaccination 4)|Other|2|||
30886390|NCT02561195|58918981|FG011|Extension Stage (Vaccination 4)|Other|2|||
30886391|NCT02561195|58918982|FG012|Extension Stage (Vaccination 4)|Other|1|||
30886392|NCT02561195|58918983|FG013|Extension Stage (Vaccination 4)|Other|0|||
30886393|NCT02561195|58918970|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
30886394|NCT02561195|58918971|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
30886395|NCT02561195|58918972|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
30886396|NCT02561195|58918973|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
30886397|NCT02561195|58918974|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
30886398|NCT02561195|58918975|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
30886399|NCT02561195|58918976|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
30886400|NCT02561195|58918977|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
30886401|NCT02561195|58918978|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
30886402|NCT02561195|58918979|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
30886403|NCT02561195|58918980|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
30886404|NCT02561195|58918981|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
30886405|NCT02561195|58918982|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
30886406|NCT02561195|58918983|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
30886407|NCT01663103|58919017|FG000|Overall Study|Withdrawal by Subject|1|||
30886408|NCT01663103|58919018|FG001|Overall Study|Withdrawal by Subject|2|||
30886409|NCT01663103|58919017|FG000|Overall Study|Adverse Event|1|||
30886410|NCT01663103|58919018|FG001|Overall Study|Adverse Event|0|||
30886411|NCT01663103|58919017|FG000|Overall Study|dog bite|1|||
30886412|NCT01663103|58919018|FG001|Overall Study|dog bite|0|||
30886413|NCT02560025|58919037|FG000|Overall Study|Ineligible after consent/ registration|3|||
30886414|NCT02566889|58919052|FG000|Overall Study|Withdrawal by Subject|3|||
30886415|NCT02566889|58919053|FG001|Overall Study|Withdrawal by Subject|1|||
30886416|NCT02566889|58919052|FG000|Overall Study|Adverse Event|4|||
30886417|NCT02566889|58919053|FG001|Overall Study|Adverse Event|2|||
30886418|NCT02566889|58919052|FG000|Overall Study|Other|6|||
30886419|NCT02566889|58919053|FG001|Overall Study|Other|2|||
30886420|NCT02566577|58919060|FG000|Overall Study|Withdrawal by Subject|1|||
30886421|NCT02566577|58919061|FG001|Overall Study|Withdrawal by Subject|1|||
30886422|NCT02566577|58919060|FG000|Overall Study|Equipment failure|1|||
30886423|NCT02566577|58919061|FG001|Overall Study|Equipment failure|1|||
30886424|NCT02566577|58919060|FG000|Overall Study|Physical limitation|1|||
30886425|NCT02566577|58919061|FG001|Overall Study|Physical limitation|0|||
30886426|NCT02559713|58919069|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
30886427|NCT01358981|58919080|FG000|Period 1|Withdrawal by Subject|0|||
30886428|NCT01358981|58919081|FG001|Period 1|Withdrawal by Subject|0|||
30886429|NCT01358981|58919082|FG002|Period 1|Withdrawal by Subject|0|||
30886430|NCT01358981|58919083|FG003|Period 1|Withdrawal by Subject|1|||
30886431|NCT01358981|58919084|FG004|Period 1|Withdrawal by Subject|0|||
30886432|NCT01358981|58919085|FG005|Period 1|Withdrawal by Subject|0|||
30886433|NCT01358981|58919086|FG006|Period 1|Withdrawal by Subject|0|||
30886434|NCT02548585|58919118|FG000|Overall Study|Withdrawal by Subject|0|||
30886435|NCT02548585|58919119|FG001|Overall Study|Withdrawal by Subject|0|||
30886436|NCT02548585|58919120|FG002|Overall Study|Withdrawal by Subject|0|||
30886437|NCT02548585|58919121|FG003|Overall Study|Withdrawal by Subject|0|||
30886438|NCT02548585|58919122|FG004|Overall Study|Withdrawal by Subject|0|||
30886439|NCT02548585|58919123|FG005|Overall Study|Withdrawal by Subject|1|||
30886440|NCT02548585|58919124|FG006|Overall Study|Withdrawal by Subject|0|||
30886441|NCT02548585|58919118|FG000|Overall Study|Lost to Follow-up|1|||
30886442|NCT02548585|58919119|FG001|Overall Study|Lost to Follow-up|0|||
30886443|NCT02548585|58919120|FG002|Overall Study|Lost to Follow-up|0|||
30886444|NCT02548585|58919121|FG003|Overall Study|Lost to Follow-up|0|||
30886445|NCT02548585|58919122|FG004|Overall Study|Lost to Follow-up|0|||
30886446|NCT02548585|58919123|FG005|Overall Study|Lost to Follow-up|0|||
30886447|NCT02548585|58919124|FG006|Overall Study|Lost to Follow-up|0|||
30886448|NCT02548585|58919118|FG000|Overall Study|Other|1|||
30886449|NCT02548585|58919119|FG001|Overall Study|Other|0|||
30886450|NCT02548585|58919120|FG002|Overall Study|Other|0|||
30886451|NCT02548585|58919121|FG003|Overall Study|Other|2|||
30886452|NCT02548585|58919122|FG004|Overall Study|Other|3|||
30886453|NCT02548585|58919123|FG005|Overall Study|Other|0|||
30886454|NCT02548585|58919124|FG006|Overall Study|Other|1|||
30976079|NCT01439204|59061676|FG000|Overall Study|No longer meets study criteria|1|||
30886455|NCT02548585|58919118|FG000|Overall Study|Randomized but not treated|0|||
30886456|NCT02548585|58919119|FG001|Overall Study|Randomized but not treated|0|||
30886457|NCT02548585|58919120|FG002|Overall Study|Randomized but not treated|0|||
30886458|NCT02548585|58919121|FG003|Overall Study|Randomized but not treated|0|||
30886459|NCT02548585|58919122|FG004|Overall Study|Randomized but not treated|0|||
30886460|NCT02548585|58919123|FG005|Overall Study|Randomized but not treated|1|||
30886461|NCT02548585|58919124|FG006|Overall Study|Randomized but not treated|0|||
30886462|NCT02547649|58919168|FG000|Overall Study|Lost to Follow-up|3|||
30886463|NCT02547649|58919169|FG001|Overall Study|Lost to Follow-up|1|||
30886464|NCT02547649|58919170|FG002|Overall Study|Lost to Follow-up|1|||
30886465|NCT02547649|58919168|FG000|Overall Study|Not vaccinated|0|||
30886466|NCT02547649|58919169|FG001|Overall Study|Not vaccinated|0|||
30886467|NCT02547649|58919170|FG002|Overall Study|Not vaccinated|1|||
30886468|NCT02547649|58919168|FG000|Overall Study|Withdrawal by Subject|0|||
30886469|NCT02547649|58919169|FG001|Overall Study|Withdrawal by Subject|4|||
30886470|NCT02547649|58919170|FG002|Overall Study|Withdrawal by Subject|2|||
30886471|NCT02535715|58919190|FG000|Overall Study|Withdrawal by Subject|0|||
30886472|NCT02535715|58919191|FG001|Overall Study|Withdrawal by Subject|0|||
30886473|NCT02535715|58919192|FG002|Overall Study|Withdrawal by Subject|1|||
30886474|NCT02336815|58919205|FG000|Overall Study|Disease Progression|45|||
30886475|NCT02336815|58919206|FG001|Overall Study|Disease Progression|70|||
30886476|NCT02336815|58919205|FG000|Overall Study|Adverse Event|18|||
30886477|NCT02336815|58919206|FG001|Overall Study|Adverse Event|39|||
30886478|NCT02336815|58919205|FG000|Overall Study|Physician Decision|11|||
30886479|NCT02336815|58919206|FG001|Overall Study|Physician Decision|4|||
30886480|NCT02336815|58919205|FG000|Overall Study|Withdrawal by Subject|3|||
30886481|NCT02336815|58919206|FG001|Overall Study|Withdrawal by Subject|2|||
30886482|NCT02336815|58919205|FG000|Overall Study|Lost to Follow-up|1|||
30886483|NCT02336815|58919206|FG001|Overall Study|Lost to Follow-up|3|||
30886484|NCT02336815|58919205|FG000|Overall Study|Other|1|||
30886485|NCT02336815|58919206|FG001|Overall Study|Other|5|||
30886486|NCT02543203|58919216|FG000|Overall Study|Unpalatable Fragrance|2|||
30886487|NCT02543203|58919217|FG001|Overall Study|Unpalatable Fragrance|2|||
30886488|NCT02543203|58919216|FG000|Overall Study|Lost to Follow-up|1|||
30886489|NCT02543203|58919217|FG001|Overall Study|Lost to Follow-up|0|||
30886490|NCT02543203|58919216|FG000|Overall Study|Increased Irritability|1|||
30886491|NCT02543203|58919217|FG001|Overall Study|Increased Irritability|0|||
30886492|NCT02543203|58919216|FG000|Overall Study|Family|1|||
30886493|NCT02543203|58919217|FG001|Overall Study|Family|2|||
30886494|NCT02543203|58919216|FG000|Overall Study|Negative Behavior|1|||
30886495|NCT02543203|58919217|FG001|Overall Study|Negative Behavior|0|||
30886496|NCT02543203|58919216|FG000|Overall Study|Withdrawal by Subject|0|||
30886497|NCT02543203|58919217|FG001|Overall Study|Withdrawal by Subject|1|||
30886498|NCT02546323|58919233|FG000|Overall Study|Withdrawal by Subject|36|||
30886499|NCT02546323|58919234|FG001|Overall Study|Withdrawal by Subject|33|||
30886500|NCT02546323|58919233|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
30886501|NCT02546323|58919234|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
30886502|NCT02546323|58919233|FG000|Overall Study|Adverse Event|17|||
30886503|NCT02546323|58919234|FG001|Overall Study|Adverse Event|11|||
30886504|NCT02546323|58919233|FG000|Overall Study|Patient Specific Reasons|1|||
30886505|NCT02546323|58919234|FG001|Overall Study|Patient Specific Reasons|2|||
30886506|NCT02546323|58919233|FG000|Overall Study|Lost to Follow-up|2|||
30886507|NCT02546323|58919234|FG001|Overall Study|Lost to Follow-up|3|||
30886508|NCT02546323|58919233|FG000|Overall Study|Non-compliance with Study Drug|2|||
30886509|NCT02546323|58919234|FG001|Overall Study|Non-compliance with Study Drug|2|||
30886510|NCT02546323|58919233|FG000|Overall Study|Met Withdrawal Criteria|2|||
30886511|NCT02546323|58919234|FG001|Overall Study|Met Withdrawal Criteria|14|||
30886512|NCT02545933|58919243|FG000|Overall Study|Adverse Event|3|||
30886513|NCT02545933|58919244|FG001|Overall Study|Adverse Event|0|||
30886514|NCT02545933|58919245|FG002|Overall Study|Adverse Event|0|||
30886515|NCT02545933|58919243|FG000|Overall Study|Withdrawal by Subject|2|||
30886516|NCT02545933|58919244|FG001|Overall Study|Withdrawal by Subject|3|||
30886517|NCT02545933|58919245|FG002|Overall Study|Withdrawal by Subject|3|||
30886518|NCT02545933|58919243|FG000|Overall Study|Protocol Violation|1|||
30886519|NCT02545933|58919244|FG001|Overall Study|Protocol Violation|0|||
30886520|NCT02545933|58919245|FG002|Overall Study|Protocol Violation|1|||
30886521|NCT01661179|58919253|FG000|Overall Study|Death|1|||
30886522|NCT01661179|58919253|FG000|Overall Study|Withdrawal by Subject|1|||
30886523|NCT01661179|58919253|FG000|Overall Study|Other Eligibility criteria|4|||
30886524|NCT02545543|58919259|FG000|Overall Study|Lost to Follow-up|67|||
30886525|NCT02545543|58919260|FG001|Overall Study|Lost to Follow-up|25|||
30886526|NCT02545543|58919259|FG000|Overall Study|Physician Decision|3|||
30886527|NCT02545543|58919260|FG001|Overall Study|Physician Decision|0|||
30886528|NCT02545543|58919259|FG000|Overall Study|Withdrawal by Subject|9|||
30886529|NCT02545543|58919260|FG001|Overall Study|Withdrawal by Subject|8|||
30886530|NCT02545543|58919259|FG000|Overall Study|Noncomplaince|1|||
30886531|NCT02545543|58919260|FG001|Overall Study|Noncomplaince|0|||
30886532|NCT02545543|58919259|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
30886533|NCT02545543|58919260|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
30886534|NCT02542267|58919268|FG000|Overall Study|Withdrawal by Subject|10|||
30886535|NCT02542267|58919268|FG000|Overall Study|Physician Decision|6|||
30886536|NCT02542267|58919268|FG000|Overall Study|Lost to Follow-up|4|||
30886537|NCT02542267|58919268|FG000|Overall Study|Death|13|||
30976080|NCT01439204|59061677|FG001|Overall Study|No longer meets study criteria|0|||
30886538|NCT02542267|58919268|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
30886539|NCT02542267|58919268|FG000|Overall Study|Other|9|||
30886540|NCT02545075|58919274|FG000|Randomization|Lost to Follow-up|0|||
30886541|NCT02545075|58919275|FG001|Randomization|Lost to Follow-up|1|||
30976081|NCT01439204|59061676|FG000|Overall Study|poor/non-compliance|3|||
30886542|NCT02545075|58919274|FG000|Randomization|Withdrawal by Subject|0|||
30886543|NCT02545075|58919275|FG001|Randomization|Withdrawal by Subject|6|||
30886544|NCT02545075|58919274|FG000|Treatment|Disease progression|71|||
30886545|NCT02545075|58919275|FG001|Treatment|Disease progression|32|||
30886546|NCT02545075|58919274|FG000|Treatment|Participant dicontinued study treatment|7|||
30886547|NCT02545075|58919275|FG001|Treatment|Participant dicontinued study treatment|9|||
30886548|NCT02545075|58919274|FG000|Treatment|Withdrawal by Subject|1|||
30886549|NCT02545075|58919275|FG001|Treatment|Withdrawal by Subject|0|||
30886550|NCT02545075|58919274|FG000|Treatment|Adverse event not related to study drug|1|||
30886551|NCT02545075|58919275|FG001|Treatment|Adverse event not related to study drug|0|||
30886552|NCT02545075|58919274|FG000|Treatment|Death|1|||
30886553|NCT02545075|58919275|FG001|Treatment|Death|0|||
30886554|NCT02545075|58919274|FG000|Treatment|Participant drug toxicity|1|||
30886555|NCT02545075|58919275|FG001|Treatment|Participant drug toxicity|0|||
30886556|NCT02545075|58919274|FG000|Treatment|Completed treatment|40|||
30886557|NCT02545075|58919275|FG001|Treatment|Completed treatment|12|||
30886558|NCT03004183|58919290|FG000|Overall Study|Adverse Event|7|||
30886559|NCT03004183|58919290|FG000|Overall Study|Lost to Follow-up|1|||
30886560|NCT03004183|58919290|FG000|Overall Study|Physician Decision|40|||
30886561|NCT03004183|58919290|FG000|Overall Study|Withdrawal by Subject|1|||
30886562|NCT03004183|58919290|FG000|Overall Study|COVID-19|1|||
30886563|NCT02544763|58919297|FG000|Overall Study|Adverse Event|8|||
30886564|NCT02544763|58919298|FG001|Overall Study|Adverse Event|8|||
30886565|NCT02544763|58919299|FG002|Overall Study|Adverse Event|0|||
30886566|NCT02544763|58919297|FG000|Overall Study|Withdrawn by parent/guardian|1|||
30886567|NCT02544763|58919298|FG001|Overall Study|Withdrawn by parent/guardian|1|||
30886568|NCT02544763|58919299|FG002|Overall Study|Withdrawn by parent/guardian|1|||
30886569|NCT02544763|58919297|FG000|Overall Study|Met withdrawal criteria|0|||
30886570|NCT02544763|58919298|FG001|Overall Study|Met withdrawal criteria|2|||
30886571|NCT02544763|58919299|FG002|Overall Study|Met withdrawal criteria|0|||
30886572|NCT02544763|58919297|FG000|Overall Study|Physician Decision|0|||
30886573|NCT02544763|58919298|FG001|Overall Study|Physician Decision|1|||
30886574|NCT02544763|58919299|FG002|Overall Study|Physician Decision|0|||
30886575|NCT02544763|58919297|FG000|Overall Study|Difficulties taking IMP|1|||
30886576|NCT02544763|58919298|FG001|Overall Study|Difficulties taking IMP|0|||
30886577|NCT02544763|58919299|FG002|Overall Study|Difficulties taking IMP|0|||
30886578|NCT02556203|58919309|FG000|Overall Study|Withdrawal by Subject|21|||
30886579|NCT02556203|58919310|FG001|Overall Study|Withdrawal by Subject|21|||
30886580|NCT02556203|58919309|FG000|Overall Study|Lost to Follow-up|5|||
30886581|NCT02556203|58919310|FG001|Overall Study|Lost to Follow-up|5|||
30886582|NCT02556203|58919309|FG000|Overall Study|Adverse Event|1|||
30886583|NCT02556203|58919310|FG001|Overall Study|Adverse Event|0|||
30886584|NCT02558231|58919327|FG000|Overall Study|Death|4|||
30886585|NCT02558231|58919328|FG001|Overall Study|Death|12|||
30886586|NCT02558231|58919327|FG000|Overall Study|Lost to Follow-up|7|||
30886587|NCT02558231|58919328|FG001|Overall Study|Lost to Follow-up|4|||
30886588|NCT02558231|58919327|FG000|Overall Study|Withdrawal by Subject|7|||
30886589|NCT02558231|58919328|FG001|Overall Study|Withdrawal by Subject|4|||
30886590|NCT02558231|58919327|FG000|Overall Study|Physician Decision|7|||
30886591|NCT02558231|58919328|FG001|Overall Study|Physician Decision|5|||
30886592|NCT02558231|58919327|FG000|Overall Study|Sponsor Decision|0|||
30886593|NCT02558231|58919328|FG001|Overall Study|Sponsor Decision|1|||
30886594|NCT02554877|58919338|FG000|Overall Study|Adverse Event|2|||
30886595|NCT02554877|58919339|FG001|Overall Study|Adverse Event|0|||
30886596|NCT02554877|58919340|FG002|Overall Study|Adverse Event|0|||
30886597|NCT02554877|58919341|FG003|Overall Study|Adverse Event|1|||
30886598|NCT02554877|58919338|FG000|Overall Study|Lost to Follow-up|1|||
30886599|NCT02554877|58919339|FG001|Overall Study|Lost to Follow-up|1|||
30886600|NCT02554877|58919340|FG002|Overall Study|Lost to Follow-up|1|||
30886601|NCT02554877|58919341|FG003|Overall Study|Lost to Follow-up|2|||
30886602|NCT02554877|58919338|FG000|Overall Study|Did not meet entrance criteria|0|||
30886603|NCT02554877|58919339|FG001|Overall Study|Did not meet entrance criteria|0|||
30886604|NCT02554877|58919340|FG002|Overall Study|Did not meet entrance criteria|1|||
30886605|NCT02554877|58919341|FG003|Overall Study|Did not meet entrance criteria|0|||
30886606|NCT02554877|58919338|FG000|Overall Study|No longer met eligibility criteria|1|||
30886607|NCT02554877|58919339|FG001|Overall Study|No longer met eligibility criteria|0|||
30886608|NCT02554877|58919340|FG002|Overall Study|No longer met eligibility criteria|1|||
30886609|NCT02554877|58919341|FG003|Overall Study|No longer met eligibility criteria|1|||
30886610|NCT02554877|58919338|FG000|Overall Study|Protocol Violation|3|||
30886611|NCT02554877|58919339|FG001|Overall Study|Protocol Violation|1|||
30608447|NCT01288430|58619226|FG005|Part 2|Clinical disease progression|0|||
30886612|NCT02554877|58919340|FG002|Overall Study|Protocol Violation|1|||
30886613|NCT02554877|58919341|FG003|Overall Study|Protocol Violation|0|||
30886614|NCT02554877|58919338|FG000|Overall Study|Other|1|||
30886615|NCT02554877|58919339|FG001|Overall Study|Other|3|||
30886616|NCT02554877|58919340|FG002|Overall Study|Other|0|||
30886617|NCT02554877|58919341|FG003|Overall Study|Other|3|||
30886618|NCT02554877|58919338|FG000|Overall Study|Insufficient clinical response|4|||
30886619|NCT02554877|58919339|FG001|Overall Study|Insufficient clinical response|0|||
30886620|NCT02554877|58919340|FG002|Overall Study|Insufficient clinical response|0|||
30886621|NCT02554877|58919341|FG003|Overall Study|Insufficient clinical response|0|||
30886622|NCT02554877|58919338|FG000|Overall Study|No longer willing to participate|0|||
30886623|NCT02554877|58919339|FG001|Overall Study|No longer willing to participate|2|||
30886624|NCT02554877|58919340|FG002|Overall Study|No longer willing to participate|2|||
30886625|NCT02554877|58919341|FG003|Overall Study|No longer willing to participate|0|||
30886626|NCT02554721|58919356|FG000|Overall Study|Adverse Event|1|||
30886627|NCT02554721|58919357|FG001|Overall Study|Adverse Event|0|||
30886628|NCT02554721|58919358|FG002|Overall Study|Adverse Event|0|||
30886629|NCT02554721|58919359|FG003|Overall Study|Adverse Event|0|||
30886630|NCT02554721|58919360|FG004|Overall Study|Adverse Event|1|||
30886631|NCT02554721|58919356|FG000|Overall Study|Noncompliance|0|||
30886632|NCT02554721|58919357|FG001|Overall Study|Noncompliance|0|||
30886633|NCT02554721|58919358|FG002|Overall Study|Noncompliance|0|||
30886634|NCT02554721|58919359|FG003|Overall Study|Noncompliance|0|||
30886635|NCT02554721|58919360|FG004|Overall Study|Noncompliance|1|||
30886636|NCT02552225|58919371|FG000|Overall Study|Withdrawal by Subject|1|||
30886637|NCT02552225|58919372|FG001|Overall Study|Withdrawal by Subject|0|||
30886638|NCT02552147|58919378|FG000|First Intervention (7 Days)|Protocol Violation|1|||
30886639|NCT02552147|58919379|FG001|First Intervention (7 Days)|Protocol Violation|0|||
30886640|NCT02552147|58919378|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
30886641|NCT02552147|58919379|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
30886642|NCT01662635|58919385|FG000|Overall Study|scarce samples for evaluation|30|||
30886643|NCT02534935|58919394|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
30886644|NCT02534935|58919395|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
30886645|NCT02534935|58919396|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
30886646|NCT02534935|58919394|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
30886647|NCT02534935|58919395|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
30886648|NCT02534935|58919396|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
30886649|NCT02534935|58919394|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
30886650|NCT02534935|58919395|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
30886651|NCT02534935|58919396|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
30886652|NCT02534935|58919394|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
30886653|NCT02534935|58919395|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
30886654|NCT02534935|58919396|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
30886655|NCT02534935|58919394|FG000|Stage 1: 24 Months|Adverse Event|0|||
30886656|NCT02534935|58919395|FG001|Stage 1: 24 Months|Adverse Event|2|||
30886657|NCT02534935|58919396|FG002|Stage 1: 24 Months|Adverse Event|0|||
30886658|NCT02534935|58919394|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
30886659|NCT02534935|58919395|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
30886660|NCT02534935|58919396|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
30886661|NCT02534935|58919394|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
30886662|NCT02534935|58919395|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
30886663|NCT02534935|58919396|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
30886664|NCT02544451|58919425|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
30886665|NCT02544451|58919426|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
30886666|NCT02544451|58919427|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
30886667|NCT02544451|58919428|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
30886668|NCT02544451|58919425|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
30886669|NCT02544451|58919426|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
30886670|NCT02544451|58919427|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
30886671|NCT02544451|58919428|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
30886672|NCT02544451|58919425|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
30886673|NCT02544451|58919426|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
30886674|NCT02544451|58919427|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
30886675|NCT02544451|58919428|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
30886676|NCT02544451|58919425|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
30886677|NCT02544451|58919426|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
30886678|NCT02544451|58919427|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
30886679|NCT02544451|58919428|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
30886680|NCT02544451|58919425|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
30886681|NCT02544451|58919426|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
30886682|NCT02544451|58919427|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
30886683|NCT02544451|58919428|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
30886684|NCT02544451|58919425|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
30976082|NCT01439204|59061677|FG001|Overall Study|poor/non-compliance|0|||
30976083|NCT01439126|59061723|FG000|Overall Study|Adverse Event|2|||
30886685|NCT02544451|58919426|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
30886686|NCT02544451|58919427|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
30886687|NCT02544451|58919428|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
30886688|NCT02544373|58919448|FG000|Overall Study|Lost to Follow-up|5|||
30886689|NCT02544373|58919449|FG001|Overall Study|Lost to Follow-up|3|||
30886690|NCT02544373|58919448|FG000|Overall Study|Withdrawal by Subject|8|||
30886691|NCT02544373|58919449|FG001|Overall Study|Withdrawal by Subject|2|||
30886692|NCT02551991|58919461|FG000|Overall Study|Death|5|||
30886693|NCT02551991|58919462|FG001|Overall Study|Death|7|||
30886694|NCT02551991|58919463|FG002|Overall Study|Death|8|||
30886695|NCT02551991|58919464|FG003|Overall Study|Death|7|||
30886696|NCT02551991|58919465|FG004|Overall Study|Death|17|||
30886697|NCT02551991|58919461|FG000|Overall Study|Withdrawal by Subject|1|||
30886698|NCT02551991|58919462|FG001|Overall Study|Withdrawal by Subject|0|||
30886699|NCT02551991|58919463|FG002|Overall Study|Withdrawal by Subject|0|||
30886700|NCT02551991|58919464|FG003|Overall Study|Withdrawal by Subject|0|||
30886701|NCT02551991|58919465|FG004|Overall Study|Withdrawal by Subject|2|||
30886702|NCT02551991|58919461|FG000|Overall Study|Lost to Follow-up|0|||
30886703|NCT02551991|58919462|FG001|Overall Study|Lost to Follow-up|0|||
30886704|NCT02551991|58919463|FG002|Overall Study|Lost to Follow-up|1|||
30886705|NCT02551991|58919464|FG003|Overall Study|Lost to Follow-up|0|||
30886706|NCT02551991|58919465|FG004|Overall Study|Lost to Follow-up|0|||
30886707|NCT02551991|58919461|FG000|Overall Study|Sponsor Decision|1|||
30886708|NCT02551991|58919462|FG001|Overall Study|Sponsor Decision|0|||
30886709|NCT02551991|58919463|FG002|Overall Study|Sponsor Decision|1|||
30886710|NCT02551991|58919464|FG003|Overall Study|Sponsor Decision|0|||
30886711|NCT02551991|58919465|FG004|Overall Study|Sponsor Decision|5|||
30886712|NCT02551991|58919461|FG000|Overall Study|Other|0|||
30886713|NCT02551991|58919462|FG001|Overall Study|Other|0|||
30886714|NCT02551991|58919463|FG002|Overall Study|Other|0|||
30886715|NCT02551991|58919464|FG003|Overall Study|Other|0|||
30886716|NCT02551991|58919465|FG004|Overall Study|Other|1|||
30886717|NCT01661933|58919478|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
30886718|NCT01661933|58919478|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
30886719|NCT02544217|58919490|FG000|Overall Study|Withdrawal by Subject|1|||
30886720|NCT02544217|58919491|FG001|Overall Study|Withdrawal by Subject|1|||
30886721|NCT02544217|58919492|FG002|Overall Study|Withdrawal by Subject|0|||
30886722|NCT02544217|58919493|FG003|Overall Study|Withdrawal by Subject|0|||
30886723|NCT02544217|58919494|FG004|Overall Study|Withdrawal by Subject|0|||
30886724|NCT02544217|58919495|FG005|Overall Study|Withdrawal by Subject|0|||
30886725|NCT02533999|58919564|FG000|Overall Study|Lost to Follow-up|3|||
30886726|NCT02533999|58919565|FG001|Overall Study|Lost to Follow-up|5|||
30976084|NCT01439126|59061724|FG001|Overall Study|Adverse Event|0|||
30976085|NCT01439126|59061723|FG000|Overall Study|Withdrawal by Subject|5|||
30976086|NCT01439126|59061724|FG001|Overall Study|Withdrawal by Subject|21|||
30976087|NCT01439126|59061723|FG000|Overall Study|Protocol Violation|6|||
30976088|NCT01439126|59061724|FG001|Overall Study|Protocol Violation|4|||
30976089|NCT01439126|59061723|FG000|Overall Study|Lost to Follow-up|6|||
30886727|NCT02533999|58919564|FG000|Overall Study|Protocol Violation|3|||
30886728|NCT02533999|58919565|FG001|Overall Study|Protocol Violation|0|||
30886729|NCT02533999|58919564|FG000|Overall Study|Adverse Event|0|||
30886730|NCT02533999|58919565|FG001|Overall Study|Adverse Event|1|||
30886731|NCT02533999|58919564|FG000|Overall Study|Randomized but intervention not received|0|||
30886732|NCT02533999|58919565|FG001|Overall Study|Randomized but intervention not received|1|||
30886733|NCT02533531|58919571|FG000|Overall Study|Device did not turn on|1|||
30948408|NCT01776541|58994269|FG001|Overall Study|Administrative Reason|2|||
30948409|NCT01776541|58994268|FG000|Overall Study|Death|4|||
30948410|NCT01776541|58994269|FG001|Overall Study|Death|0|||
30948411|NCT01776541|58994268|FG000|Overall Study|Lost to Follow-up|27|||
30948412|NCT01776541|58994269|FG001|Overall Study|Lost to Follow-up|48|||
30948413|NCT01776541|58994268|FG000|Overall Study|Unclassified|5|||
30948414|NCT01776541|58994269|FG001|Overall Study|Unclassified|4|||
30948415|NCT01776541|58994268|FG000|Overall Study|Protocol Violation|2|||
30948416|NCT01776541|58994269|FG001|Overall Study|Protocol Violation|1|||
30976090|NCT01439126|59061724|FG001|Overall Study|Lost to Follow-up|3|||
30948417|NCT01776541|58994268|FG000|Overall Study|Withdrawal by Subject|12|||
30948418|NCT01776541|58994269|FG001|Overall Study|Withdrawal by Subject|20|||
30948419|NCT01742078|58994298|FG000|Overall Study|Withdrawal by Subject|0|||
30948420|NCT01742078|58994299|FG001|Overall Study|Withdrawal by Subject|0|||
30948421|NCT01742078|58994300|FG002|Overall Study|Withdrawal by Subject|0|||
30948422|NCT01742078|58994301|FG003|Overall Study|Withdrawal by Subject|1|||
30948423|NCT01742078|58994302|FG004|Overall Study|Withdrawal by Subject|0|||
30948424|NCT01742078|58994303|FG005|Overall Study|Withdrawal by Subject|0|||
30976091|NCT01439126|59061723|FG000|Overall Study|Other-Use of prohibited treatment|0|||
30976092|NCT01439126|59061724|FG001|Overall Study|Other-Use of prohibited treatment|2|||
30948425|NCT01742078|58994304|FG006|Overall Study|Withdrawal by Subject|0|||
30948426|NCT01742078|58994305|FG007|Overall Study|Withdrawal by Subject|0|||
30948427|NCT01742078|58994306|FG008|Overall Study|Withdrawal by Subject|0|||
30948428|NCT01741688|58994328|FG000|Overall Study|Lack of insurance coverage|2|||
30948429|NCT01741688|58994328|FG000|Overall Study|Withdrawal by Subject|1|||
30948430|NCT01709084|58994335|FG000|Overall Study|Lost to Follow-up|4|||
30948431|NCT01709084|58994336|FG001|Overall Study|Lost to Follow-up|7|||
30948432|NCT01709084|58994335|FG000|Overall Study|Withdrawal by Subject|2|||
30886734|NCT02533453|58919575|FG000|Overall Study|Adverse Event|6|||
30886735|NCT02533453|58919575|FG000|Overall Study|Protocol Violation|1|||
30886736|NCT02533453|58919575|FG000|Overall Study|Withdrawal by Subject|2|||
30886737|NCT02533375|58919579|FG000|Overall Study|Lack of Efficacy|3|||
30886738|NCT02533375|58919579|FG000|Overall Study|Adverse Event|2|||
30886739|NCT01553149|58919585|FG000|Overall Study|Adverse Event|0|||
30886740|NCT01553149|58919586|FG001|Overall Study|Adverse Event|9|||
30886741|NCT01553149|58919585|FG000|Overall Study|Physician Decision|5|||
30886742|NCT01553149|58919586|FG001|Overall Study|Physician Decision|10|||
30886743|NCT01553149|58919585|FG000|Overall Study|Ineligible|0|||
30886744|NCT01553149|58919586|FG001|Overall Study|Ineligible|1|||
30886745|NCT02551055|58919599|FG000|Overall Study|Death|2|||
30886746|NCT02551055|58919600|FG001|Overall Study|Death|4|||
30886747|NCT02551055|58919601|FG002|Overall Study|Death|2|||
30886748|NCT02551055|58919602|FG003|Overall Study|Death|2|||
30886749|NCT02551055|58919603|FG004|Overall Study|Death|2|||
30886750|NCT02551055|58919604|FG005|Overall Study|Death|1|||
30886751|NCT02551055|58919605|FG006|Overall Study|Death|2|||
30886752|NCT02551055|58919606|FG007|Overall Study|Death|0|||
30886753|NCT02551055|58919599|FG000|Overall Study|Study Terminated by Sponsor|1|||
30886754|NCT02551055|58919600|FG001|Overall Study|Study Terminated by Sponsor|1|||
30886755|NCT02551055|58919601|FG002|Overall Study|Study Terminated by Sponsor|0|||
30886756|NCT02551055|58919602|FG003|Overall Study|Study Terminated by Sponsor|2|||
30976093|NCT01439126|59061723|FG000|Overall Study|Other-Miscellaneous|12|||
30976094|NCT01439126|59061724|FG001|Overall Study|Other-Miscellaneous|12|||
30976095|NCT01449812|59061750|FG000|Overall Study|Migrated/moved from study area|1|||
30976096|NCT01449812|59061751|FG001|Overall Study|Migrated/moved from study area|0|||
30976097|NCT01449812|59061752|FG002|Overall Study|Migrated/moved from study area|0|||
30976098|NCT01449812|59061750|FG000|Overall Study|Withdrawal by Subject|0|||
30976099|NCT01449812|59061751|FG001|Overall Study|Withdrawal by Subject|0|||
30976100|NCT01449812|59061752|FG002|Overall Study|Withdrawal by Subject|1|||
30976101|NCT01449812|59061750|FG000|Overall Study|Lost to Follow-up|1|||
30976102|NCT01449812|59061751|FG001|Overall Study|Lost to Follow-up|0|||
30976103|NCT01449812|59061752|FG002|Overall Study|Lost to Follow-up|0|||
30976104|NCT01665144|59061805|FG000|Overall Study|New therapy for study indication|2|||
30976105|NCT01665144|59061806|FG001|Overall Study|New therapy for study indication|1|||
30976106|NCT01665144|59061805|FG000|Overall Study|Technical problems|2|||
30976107|NCT01665144|59061806|FG001|Overall Study|Technical problems|0|||
30976108|NCT01665144|59061805|FG000|Overall Study|Death|3|||
30976109|NCT01665144|59061806|FG001|Overall Study|Death|1|||
30976110|NCT01665144|59061805|FG000|Overall Study|Protocol deviation|3|||
30976111|NCT01665144|59061806|FG001|Overall Study|Protocol deviation|1|||
30976112|NCT01665144|59061805|FG000|Overall Study|Non-compliance w/study treatment|5|||
30976113|NCT01665144|59061806|FG001|Overall Study|Non-compliance w/study treatment|0|||
30976114|NCT01665144|59061805|FG000|Overall Study|Progressive disease|8|||
30976115|NCT01665144|59061806|FG001|Overall Study|Progressive disease|4|||
30976116|NCT01665144|59061805|FG000|Overall Study|Lost to Follow-up|9|||
30976117|NCT01665144|59061806|FG001|Overall Study|Lost to Follow-up|8|||
30976118|NCT01665144|59061805|FG000|Overall Study|Physician Decision|13|||
30976119|NCT01665144|59061806|FG001|Overall Study|Physician Decision|1|||
30976120|NCT01665144|59061805|FG000|Overall Study|Lack of Efficacy|16|||
30976121|NCT01665144|59061806|FG001|Overall Study|Lack of Efficacy|11|||
30976122|NCT01665144|59061805|FG000|Overall Study|Adverse Event|45|||
30976123|NCT01665144|59061806|FG001|Overall Study|Adverse Event|18|||
30976124|NCT01665144|59061805|FG000|Overall Study|Withdrawal by Subject|96|||
30976125|NCT01665144|59061806|FG001|Overall Study|Withdrawal by Subject|77|||
30976126|NCT01466660|59061941|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
30976127|NCT01466660|59061942|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
30976128|NCT01466660|59061941|FG000|Overall Study|Worsening of underlying cancer disease|5|||
30976129|NCT01466660|59061942|FG001|Overall Study|Worsening of underlying cancer disease|2|||
30976130|NCT01466660|59061941|FG000|Overall Study|Other adverse event|19|||
30976131|NCT01466660|59061942|FG001|Overall Study|Other adverse event|18|||
30976132|NCT01466660|59061941|FG000|Overall Study|Protocol Violation|2|||
30976133|NCT01466660|59061942|FG001|Overall Study|Protocol Violation|1|||
30976134|NCT01466660|59061941|FG000|Overall Study|Refused continuation of trial medication|4|||
30976135|NCT01466660|59061942|FG001|Overall Study|Refused continuation of trial medication|3|||
30886757|NCT02551055|58919603|FG004|Overall Study|Study Terminated by Sponsor|2|||
30886758|NCT02551055|58919604|FG005|Overall Study|Study Terminated by Sponsor|0|||
30886759|NCT02551055|58919605|FG006|Overall Study|Study Terminated by Sponsor|0|||
30886760|NCT02551055|58919606|FG007|Overall Study|Study Terminated by Sponsor|0|||
30886761|NCT02551055|58919599|FG000|Overall Study|Withdrawal by Subject|1|||
30886762|NCT02551055|58919600|FG001|Overall Study|Withdrawal by Subject|1|||
30976136|NCT01466660|59061941|FG000|Overall Study|Other reason not defined above|10|||
30976137|NCT01466660|59061942|FG001|Overall Study|Other reason not defined above|8|||
30976138|NCT01466348|59061967|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
30976139|NCT01466348|59061968|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
30886763|NCT02551055|58919601|FG002|Overall Study|Withdrawal by Subject|0|||
30976140|NCT01466270|59061991|FG000|Overall Study|Withdrawal by Subject|4|||
30976141|NCT01466270|59061992|FG001|Overall Study|Withdrawal by Subject|1|||
30976142|NCT01466270|59061991|FG000|Overall Study|Physician Decision|1|||
30976143|NCT01466270|59061992|FG001|Overall Study|Physician Decision|0|||
30976144|NCT01466270|59061991|FG000|Overall Study|Lost to Follow-up|1|||
30976145|NCT01466270|59061992|FG001|Overall Study|Lost to Follow-up|3|||
30976146|NCT01466270|59061991|FG000|Overall Study|Progression|1|||
30976147|NCT01466270|59061992|FG001|Overall Study|Progression|0|||
30976148|NCT01466270|59061991|FG000|Overall Study|Toxicity|4|||
30976149|NCT01466270|59061992|FG001|Overall Study|Toxicity|1|||
30976150|NCT01466270|59061991|FG000|Overall Study|Multiple|1|||
30976151|NCT01466270|59061992|FG001|Overall Study|Multiple|1|||
30976152|NCT01466192|59062025|FG000|Overall Study|Physician Decision|1|||
30976153|NCT01466192|59062025|FG000|Overall Study|Withdrawal by Subject|3|||
30976154|NCT01438814|59062045|FG000|Overall Study|Adverse Event|3|||
30976155|NCT01438814|59062046|FG001|Overall Study|Adverse Event|3|||
30976156|NCT01438814|59062045|FG000|Overall Study|Protocol Violation|1|||
30976157|NCT01438814|59062046|FG001|Overall Study|Protocol Violation|2|||
30976158|NCT01438814|59062045|FG000|Overall Study|Lost to Follow-up|4|||
30976159|NCT01438814|59062046|FG001|Overall Study|Lost to Follow-up|3|||
30976160|NCT01438814|59062045|FG000|Overall Study|Withdrawal by Subject|4|||
30976161|NCT01438814|59062046|FG001|Overall Study|Withdrawal by Subject|2|||
30976162|NCT01438814|59062045|FG000|Overall Study|Other|2|||
30886764|NCT02551055|58919602|FG003|Overall Study|Withdrawal by Subject|1|||
30886765|NCT02551055|58919603|FG004|Overall Study|Withdrawal by Subject|2|||
30886766|NCT02551055|58919604|FG005|Overall Study|Withdrawal by Subject|0|||
30886767|NCT02551055|58919605|FG006|Overall Study|Withdrawal by Subject|0|||
30886768|NCT02551055|58919606|FG007|Overall Study|Withdrawal by Subject|0|||
30886769|NCT02551055|58919599|FG000|Overall Study|Reason not specified|0|||
30886770|NCT02551055|58919600|FG001|Overall Study|Reason not specified|0|||
30886771|NCT02551055|58919601|FG002|Overall Study|Reason not specified|0|||
30886772|NCT02551055|58919602|FG003|Overall Study|Reason not specified|0|||
30886773|NCT02551055|58919603|FG004|Overall Study|Reason not specified|1|||
30886774|NCT02551055|58919604|FG005|Overall Study|Reason not specified|0|||
30886775|NCT02551055|58919605|FG006|Overall Study|Reason not specified|1|||
30886776|NCT02551055|58919606|FG007|Overall Study|Reason not specified|0|||
30886777|NCT02542943|58919627|FG000|Overall Study|Lost to Follow-up|1|||
30886778|NCT02542943|58919628|FG001|Overall Study|Lost to Follow-up|0|||
30886779|NCT02542943|58919629|FG002|Overall Study|Lost to Follow-up|0|||
30886780|NCT02542943|58919627|FG000|Overall Study|Withdrawal by Subject|0|||
30886781|NCT02542943|58919628|FG001|Overall Study|Withdrawal by Subject|1|||
30886782|NCT02542943|58919629|FG002|Overall Study|Withdrawal by Subject|0|||
30886783|NCT02542865|58919640|FG000|Overall Study|Identified as screen failure|1|||
30886784|NCT02542865|58919641|FG001|Overall Study|Identified as screen failure|0|||
30886785|NCT02542865|58919640|FG000|Overall Study|Withdrawal by Subject|16|||
30886786|NCT02542865|58919641|FG001|Overall Study|Withdrawal by Subject|0|||
30886787|NCT03644927|58919647|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
30886788|NCT03644927|58919648|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
30886789|NCT02542631|58919655|FG000|Overall Study|Adverse Event|1|||
30886790|NCT02542631|58919656|FG001|Overall Study|Adverse Event|1|||
30886791|NCT02542631|58919655|FG000|Overall Study|Sponsor Termination|1|||
30886792|NCT02542631|58919656|FG001|Overall Study|Sponsor Termination|0|||
30886793|NCT02542631|58919655|FG000|Overall Study|Withdrawal by Subject|11|||
30886794|NCT02542631|58919656|FG001|Overall Study|Withdrawal by Subject|16|||
30886795|NCT02542631|58919655|FG000|Overall Study|Protocol Violation|1|||
30886796|NCT02542631|58919656|FG001|Overall Study|Protocol Violation|1|||
30886797|NCT02542631|58919655|FG000|Overall Study|Physician Decision|6|||
30886798|NCT02542631|58919656|FG001|Overall Study|Physician Decision|4|||
30886799|NCT02542631|58919655|FG000|Overall Study|Lost to Follow-up|6|||
30886800|NCT02542631|58919656|FG001|Overall Study|Lost to Follow-up|5|||
30886801|NCT02542631|58919655|FG000|Overall Study|Death|1|||
30976163|NCT01438814|59062046|FG001|Overall Study|Other|4|||
30976164|NCT02926833|59062627|FG000|Overall Study|Full Consent Withdrawal|0|||
30976165|NCT02926833|59062628|FG001|Overall Study|Full Consent Withdrawal|0|||
30976166|NCT02926833|59062629|FG002|Overall Study|Full Consent Withdrawal|0|||
30886802|NCT02542631|58919656|FG001|Overall Study|Death|2|||
30886803|NCT02542631|58919655|FG000|Overall Study|Other|2|||
30886804|NCT02542631|58919656|FG001|Overall Study|Other|1|||
30886805|NCT02542631|58919655|FG000|Overall Study|Used Prohibited Medication|2|||
30886806|NCT02542631|58919656|FG001|Overall Study|Used Prohibited Medication|1|||
30886807|NCT02549573|58919664|FG000|Overall Study|Withdrawal by Subject|0|||
30886808|NCT02549573|58919665|FG001|Overall Study|Withdrawal by Subject|2|||
30886809|NCT02549573|58919664|FG000|Overall Study|Protocol Violation|0|||
30886810|NCT02549573|58919665|FG001|Overall Study|Protocol Violation|1|||
30976167|NCT02926833|59062630|FG003|Overall Study|Full Consent Withdrawal|2|||
30976168|NCT02926833|59062627|FG000|Overall Study|Death|1|||
30976169|NCT02926833|59062628|FG001|Overall Study|Death|1|||
30976170|NCT02926833|59062629|FG002|Overall Study|Death|1|||
30886811|NCT02542397|58919671|FG000|Overall Study|Death|2|||
30886812|NCT02542397|58919671|FG000|Overall Study|Physician Decision|6|||
30886813|NCT02542397|58919671|FG000|Overall Study|Withdrawal by Subject|6|||
30886814|NCT02542397|58919671|FG000|Overall Study|Lost to Follow-up|2|||
30886815|NCT02549339|58919678|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
30886816|NCT02549339|58919679|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
30886817|NCT02549339|58919678|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
30886818|NCT02549339|58919679|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
30886819|NCT02549339|58919678|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
30886820|NCT02549339|58919679|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
30886821|NCT02549339|58919678|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
30886822|NCT02549339|58919679|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
30886823|NCT02549339|58919678|FG000|12-month Follow-up|Lack of Efficacy|0|||
30886824|NCT02549339|58919679|FG001|12-month Follow-up|Lack of Efficacy|2|||
30886825|NCT02549339|58919678|FG000|12-month Follow-up|Withdrawal by Subject|8|||
30886826|NCT02549339|58919679|FG001|12-month Follow-up|Withdrawal by Subject|3|||
30886827|NCT02549339|58919678|FG000|12-month Follow-up|Lost to Follow-up|1|||
30886828|NCT02549339|58919679|FG001|12-month Follow-up|Lost to Follow-up|3|||
30886829|NCT02549339|58919678|FG000|12-month Follow-up|Other|0|||
30886830|NCT02549339|58919679|FG001|12-month Follow-up|Other|3|||
30886831|NCT02549027|58919687|FG000|Washout After Period 4|Withdrawal by Subject|0|||
30886832|NCT02549027|58919688|FG001|Washout After Period 4|Withdrawal by Subject|1|||
30886833|NCT02549027|58919689|FG002|Washout After Period 4|Withdrawal by Subject|1|||
30886834|NCT02549027|58919690|FG003|Washout After Period 4|Withdrawal by Subject|1|||
30886835|NCT02549027|58919691|FG004|Washout After Period 4|Withdrawal by Subject|0|||
30886836|NCT02549027|58919692|FG005|Washout After Period 4|Withdrawal by Subject|0|||
30886837|NCT02549027|58919687|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
30886838|NCT02549027|58919688|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
30886839|NCT02549027|58919689|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
30886840|NCT02549027|58919690|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
30886841|NCT02549027|58919691|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
30886842|NCT02549027|58919692|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
30886843|NCT02529553|58919720|FG000|Overall Study|Progressive Disease|1|||
30886844|NCT02529553|58919721|FG001|Overall Study|Progressive Disease|0|||
30886845|NCT02529553|58919722|FG002|Overall Study|Progressive Disease|1|||
30886846|NCT02529553|58919723|FG003|Overall Study|Progressive Disease|3|||
30886847|NCT02529553|58919724|FG004|Overall Study|Progressive Disease|2|||
30886848|NCT02529553|58919725|FG005|Overall Study|Progressive Disease|3|||
30886849|NCT02529553|58919726|FG006|Overall Study|Progressive Disease|3|||
30886850|NCT02529553|58919727|FG007|Overall Study|Progressive Disease|5|||
30886851|NCT02529553|58919728|FG008|Overall Study|Progressive Disease|3|||
30886852|NCT02529553|58919720|FG000|Overall Study|Physician Decision|0|||
30886853|NCT02529553|58919721|FG001|Overall Study|Physician Decision|1|||
30886854|NCT02529553|58919722|FG002|Overall Study|Physician Decision|0|||
30886855|NCT02529553|58919723|FG003|Overall Study|Physician Decision|0|||
30886856|NCT02529553|58919724|FG004|Overall Study|Physician Decision|1|||
30886857|NCT02529553|58919725|FG005|Overall Study|Physician Decision|0|||
30886858|NCT02529553|58919726|FG006|Overall Study|Physician Decision|0|||
30886859|NCT02529553|58919727|FG007|Overall Study|Physician Decision|0|||
30886860|NCT02529553|58919728|FG008|Overall Study|Physician Decision|0|||
30886861|NCT02529553|58919720|FG000|Overall Study|Withdrawal by Subject|0|||
30886862|NCT02529553|58919721|FG001|Overall Study|Withdrawal by Subject|0|||
30886863|NCT02529553|58919722|FG002|Overall Study|Withdrawal by Subject|0|||
30886864|NCT02529553|58919723|FG003|Overall Study|Withdrawal by Subject|0|||
30886865|NCT02529553|58919724|FG004|Overall Study|Withdrawal by Subject|0|||
30886866|NCT02529553|58919725|FG005|Overall Study|Withdrawal by Subject|1|||
30886867|NCT02529553|58919726|FG006|Overall Study|Withdrawal by Subject|0|||
30886868|NCT02529553|58919727|FG007|Overall Study|Withdrawal by Subject|1|||
30886869|NCT02529553|58919728|FG008|Overall Study|Withdrawal by Subject|0|||
30886870|NCT02547935|58919752|FG000|Overall Study|Other|0|||
30886871|NCT02547935|58919753|FG001|Overall Study|Other|1|||
30886872|NCT02547935|58919754|FG002|Overall Study|Other|0|||
30886873|NCT02547935|58919752|FG000|Overall Study|Withdrawal by Subject|2|||
30886874|NCT02547935|58919753|FG001|Overall Study|Withdrawal by Subject|3|||
30886875|NCT02547935|58919754|FG002|Overall Study|Withdrawal by Subject|4|||
30886876|NCT02547935|58919752|FG000|Overall Study|Screen Failure|2|||
30886877|NCT02547935|58919753|FG001|Overall Study|Screen Failure|0|||
30886878|NCT02547935|58919754|FG002|Overall Study|Screen Failure|0|||
30886879|NCT02547935|58919752|FG000|Overall Study|Physician Decision|0|||
30886880|NCT02547935|58919753|FG001|Overall Study|Physician Decision|1|||
30976171|NCT02926833|59062630|FG003|Overall Study|Death|7|||
30886881|NCT02547935|58919754|FG002|Overall Study|Physician Decision|0|||
30886882|NCT02547935|58919752|FG000|Overall Study|Lost to Follow-up|0|||
30886883|NCT02547935|58919753|FG001|Overall Study|Lost to Follow-up|2|||
30886884|NCT02547935|58919754|FG002|Overall Study|Lost to Follow-up|1|||
30886885|NCT02547935|58919752|FG000|Overall Study|Death|1|||
30886886|NCT02547935|58919753|FG001|Overall Study|Death|1|||
30886887|NCT02547935|58919754|FG002|Overall Study|Death|0|||
30886888|NCT02554019|58919767|FG000|Overall Study|Withdrawal by Subject|1|||
30886889|NCT02554019|58919768|FG001|Overall Study|Withdrawal by Subject|0|||
30886890|NCT02554019|58919769|FG002|Overall Study|Withdrawal by Subject|2|||
30886891|NCT02554019|58919767|FG000|Overall Study|Adverse Event|1|||
30886892|NCT02554019|58919768|FG001|Overall Study|Adverse Event|0|||
30886893|NCT02554019|58919769|FG002|Overall Study|Adverse Event|0|||
30886894|NCT02327169|58919792|FG000|Overall Study|Progressive Disease|1|||
30886895|NCT02327169|58919793|FG001|Overall Study|Progressive Disease|3|||
30886896|NCT02327169|58919794|FG002|Overall Study|Progressive Disease|4|||
30886897|NCT02327169|58919795|FG003|Overall Study|Progressive Disease|3|||
30886898|NCT02327169|58919796|FG004|Overall Study|Progressive Disease|4|||
30886899|NCT02327169|58919797|FG005|Overall Study|Progressive Disease|3|||
30886900|NCT02327169|58919798|FG006|Overall Study|Progressive Disease|3|||
30886901|NCT02327169|58919799|FG007|Overall Study|Progressive Disease|3|||
30886902|NCT02327169|58919800|FG008|Overall Study|Progressive Disease|4|||
30886903|NCT02327169|58919801|FG009|Overall Study|Progressive Disease|4|||
30886904|NCT02327169|58919802|FG010|Overall Study|Progressive Disease|4|||
30886905|NCT02327169|58919803|FG011|Overall Study|Progressive Disease|3|||
30886906|NCT02327169|58919804|FG012|Overall Study|Progressive Disease|1|||
30886907|NCT02327169|58919805|FG013|Overall Study|Progressive Disease|3|||
30886908|NCT02327169|58919806|FG014|Overall Study|Progressive Disease|3|||
30886909|NCT02327169|58919792|FG000|Overall Study|Adverse Event|2|||
30886910|NCT02327169|58919793|FG001|Overall Study|Adverse Event|0|||
30886911|NCT02327169|58919794|FG002|Overall Study|Adverse Event|1|||
30886912|NCT02327169|58919795|FG003|Overall Study|Adverse Event|0|||
30886913|NCT02327169|58919796|FG004|Overall Study|Adverse Event|1|||
30886914|NCT02327169|58919797|FG005|Overall Study|Adverse Event|0|||
30886915|NCT02327169|58919798|FG006|Overall Study|Adverse Event|0|||
30886916|NCT02327169|58919799|FG007|Overall Study|Adverse Event|0|||
30886917|NCT02327169|58919800|FG008|Overall Study|Adverse Event|0|||
30886918|NCT02327169|58919801|FG009|Overall Study|Adverse Event|2|||
30886919|NCT02327169|58919802|FG010|Overall Study|Adverse Event|0|||
30886920|NCT02327169|58919803|FG011|Overall Study|Adverse Event|3|||
30886921|NCT02327169|58919804|FG012|Overall Study|Adverse Event|0|||
30886922|NCT02327169|58919805|FG013|Overall Study|Adverse Event|2|||
30886923|NCT02327169|58919806|FG014|Overall Study|Adverse Event|1|||
30886924|NCT02327169|58919792|FG000|Overall Study|Symptomatic Deterioration|0|||
30886925|NCT02327169|58919793|FG001|Overall Study|Symptomatic Deterioration|0|||
30886926|NCT02327169|58919794|FG002|Overall Study|Symptomatic Deterioration|1|||
30886927|NCT02327169|58919795|FG003|Overall Study|Symptomatic Deterioration|0|||
30886928|NCT02327169|58919796|FG004|Overall Study|Symptomatic Deterioration|1|||
30886929|NCT02327169|58919797|FG005|Overall Study|Symptomatic Deterioration|1|||
30886930|NCT02327169|58919798|FG006|Overall Study|Symptomatic Deterioration|0|||
30886931|NCT02327169|58919799|FG007|Overall Study|Symptomatic Deterioration|0|||
30886932|NCT02327169|58919800|FG008|Overall Study|Symptomatic Deterioration|2|||
30886933|NCT02327169|58919801|FG009|Overall Study|Symptomatic Deterioration|1|||
30886934|NCT02327169|58919802|FG010|Overall Study|Symptomatic Deterioration|0|||
30886935|NCT02327169|58919803|FG011|Overall Study|Symptomatic Deterioration|0|||
30886936|NCT02327169|58919804|FG012|Overall Study|Symptomatic Deterioration|0|||
30886937|NCT02327169|58919805|FG013|Overall Study|Symptomatic Deterioration|2|||
30886938|NCT02327169|58919806|FG014|Overall Study|Symptomatic Deterioration|1|||
30886939|NCT02327169|58919792|FG000|Overall Study|Reason Not Specified|0|||
30886940|NCT02327169|58919793|FG001|Overall Study|Reason Not Specified|0|||
30886941|NCT02327169|58919794|FG002|Overall Study|Reason Not Specified|1|||
30886942|NCT02327169|58919795|FG003|Overall Study|Reason Not Specified|0|||
30886943|NCT02327169|58919796|FG004|Overall Study|Reason Not Specified|0|||
30886944|NCT02327169|58919797|FG005|Overall Study|Reason Not Specified|0|||
30886945|NCT02327169|58919798|FG006|Overall Study|Reason Not Specified|0|||
30886946|NCT02327169|58919799|FG007|Overall Study|Reason Not Specified|0|||
30886947|NCT02327169|58919800|FG008|Overall Study|Reason Not Specified|0|||
30976172|NCT02926833|59062627|FG000|Overall Study|Still on study|2|||
30886948|NCT02327169|58919801|FG009|Overall Study|Reason Not Specified|1|||
30886949|NCT02327169|58919802|FG010|Overall Study|Reason Not Specified|2|||
30886950|NCT02327169|58919803|FG011|Overall Study|Reason Not Specified|1|||
30886951|NCT02327169|58919804|FG012|Overall Study|Reason Not Specified|0|||
30886952|NCT02327169|58919805|FG013|Overall Study|Reason Not Specified|0|||
30976173|NCT02926833|59062628|FG001|Overall Study|Still on study|3|||
30886953|NCT02327169|58919806|FG014|Overall Study|Reason Not Specified|2|||
30886954|NCT02327169|58919792|FG000|Overall Study|Withdrawal by Subject|1|||
30886955|NCT02327169|58919793|FG001|Overall Study|Withdrawal by Subject|0|||
30886956|NCT02327169|58919794|FG002|Overall Study|Withdrawal by Subject|0|||
30886957|NCT02327169|58919795|FG003|Overall Study|Withdrawal by Subject|0|||
30886958|NCT02327169|58919796|FG004|Overall Study|Withdrawal by Subject|1|||
30886959|NCT02327169|58919797|FG005|Overall Study|Withdrawal by Subject|0|||
30886960|NCT02327169|58919798|FG006|Overall Study|Withdrawal by Subject|0|||
30886961|NCT02327169|58919799|FG007|Overall Study|Withdrawal by Subject|1|||
30886962|NCT02327169|58919800|FG008|Overall Study|Withdrawal by Subject|0|||
30886963|NCT02327169|58919801|FG009|Overall Study|Withdrawal by Subject|0|||
30886964|NCT02327169|58919802|FG010|Overall Study|Withdrawal by Subject|0|||
30886965|NCT02327169|58919803|FG011|Overall Study|Withdrawal by Subject|0|||
30886966|NCT02327169|58919804|FG012|Overall Study|Withdrawal by Subject|0|||
30886967|NCT02327169|58919805|FG013|Overall Study|Withdrawal by Subject|0|||
30886968|NCT02327169|58919806|FG014|Overall Study|Withdrawal by Subject|3|||
30886969|NCT02327169|58919792|FG000|Overall Study|Lost to Follow-up|0|||
30886970|NCT02327169|58919793|FG001|Overall Study|Lost to Follow-up|0|||
30886971|NCT02327169|58919794|FG002|Overall Study|Lost to Follow-up|0|||
30886972|NCT02327169|58919795|FG003|Overall Study|Lost to Follow-up|0|||
30886973|NCT02327169|58919796|FG004|Overall Study|Lost to Follow-up|1|||
30886974|NCT02327169|58919797|FG005|Overall Study|Lost to Follow-up|0|||
30886975|NCT02327169|58919798|FG006|Overall Study|Lost to Follow-up|0|||
30886976|NCT02327169|58919799|FG007|Overall Study|Lost to Follow-up|0|||
30886977|NCT02327169|58919800|FG008|Overall Study|Lost to Follow-up|0|||
30886978|NCT02327169|58919801|FG009|Overall Study|Lost to Follow-up|0|||
30886979|NCT02327169|58919802|FG010|Overall Study|Lost to Follow-up|0|||
30886980|NCT02327169|58919803|FG011|Overall Study|Lost to Follow-up|0|||
30886981|NCT02327169|58919804|FG012|Overall Study|Lost to Follow-up|0|||
30886982|NCT02327169|58919805|FG013|Overall Study|Lost to Follow-up|0|||
30886983|NCT02327169|58919806|FG014|Overall Study|Lost to Follow-up|0|||
30886984|NCT02327013|58919851|FG000|Overall Study|Adverse Event|4|||
30886985|NCT02327013|58919852|FG001|Overall Study|Adverse Event|4|||
30886986|NCT02327013|58919853|FG002|Overall Study|Adverse Event|3|||
30886987|NCT02327013|58919854|FG003|Overall Study|Adverse Event|0|||
30886988|NCT02327013|58919855|FG004|Overall Study|Adverse Event|1|||
30886989|NCT02327013|58919851|FG000|Overall Study|Lack of Efficacy|2|||
30886990|NCT02327013|58919852|FG001|Overall Study|Lack of Efficacy|0|||
30886991|NCT02327013|58919853|FG002|Overall Study|Lack of Efficacy|5|||
30886992|NCT02327013|58919854|FG003|Overall Study|Lack of Efficacy|0|||
30886993|NCT02327013|58919855|FG004|Overall Study|Lack of Efficacy|1|||
30886994|NCT02327013|58919851|FG000|Overall Study|Non-compliance with IMP|1|||
30886995|NCT02327013|58919852|FG001|Overall Study|Non-compliance with IMP|2|||
30886996|NCT02327013|58919853|FG002|Overall Study|Non-compliance with IMP|7|||
30886997|NCT02327013|58919854|FG003|Overall Study|Non-compliance with IMP|0|||
30886998|NCT02327013|58919855|FG004|Overall Study|Non-compliance with IMP|0|||
30886999|NCT02327013|58919851|FG000|Overall Study|Withdrawal of Consent|1|||
30887000|NCT02327013|58919852|FG001|Overall Study|Withdrawal of Consent|0|||
30887001|NCT02327013|58919853|FG002|Overall Study|Withdrawal of Consent|3|||
30887002|NCT02327013|58919854|FG003|Overall Study|Withdrawal of Consent|0|||
30887003|NCT02327013|58919855|FG004|Overall Study|Withdrawal of Consent|0|||
30887004|NCT02327013|58919851|FG000|Overall Study|Lost to Follow-up|2|||
30887005|NCT02327013|58919852|FG001|Overall Study|Lost to Follow-up|4|||
30887006|NCT02327013|58919853|FG002|Overall Study|Lost to Follow-up|5|||
30887007|NCT02327013|58919854|FG003|Overall Study|Lost to Follow-up|0|||
30887008|NCT02327013|58919855|FG004|Overall Study|Lost to Follow-up|0|||
30887009|NCT02327013|58919851|FG000|Overall Study|Administrative or other reason(s)|1|||
30887010|NCT02327013|58919852|FG001|Overall Study|Administrative or other reason(s)|5|||
30887011|NCT02327013|58919853|FG002|Overall Study|Administrative or other reason(s)|11|||
30887012|NCT02327013|58919854|FG003|Overall Study|Administrative or other reason(s)|1|||
30887013|NCT02327013|58919855|FG004|Overall Study|Administrative or other reason(s)|1|||
30887014|NCT02327013|58919851|FG000|Overall Study|Protocol Violation|0|||
30887015|NCT02327013|58919852|FG001|Overall Study|Protocol Violation|0|||
30887016|NCT02327013|58919853|FG002|Overall Study|Protocol Violation|3|||
30887017|NCT02327013|58919854|FG003|Overall Study|Protocol Violation|0|||
30887018|NCT02327013|58919855|FG004|Overall Study|Protocol Violation|1|||
30887019|NCT02327013|58919851|FG000|Overall Study|Withdrawal before treatment|2|||
30887020|NCT02327013|58919852|FG001|Overall Study|Withdrawal before treatment|1|||
30887021|NCT02327013|58919853|FG002|Overall Study|Withdrawal before treatment|5|||
30887022|NCT02327013|58919854|FG003|Overall Study|Withdrawal before treatment|0|||
30887023|NCT02327013|58919855|FG004|Overall Study|Withdrawal before treatment|0|||
30887024|NCT02301975|58919878|FG000|Overall Study|Adverse Event|8|||
30887025|NCT02301975|58919879|FG001|Overall Study|Adverse Event|3|||
30887026|NCT02301975|58919880|FG002|Overall Study|Adverse Event|2|||
30887027|NCT02301975|58919878|FG000|Overall Study|Lack of Efficacy|1|||
30887028|NCT02301975|58919879|FG001|Overall Study|Lack of Efficacy|1|||
30887029|NCT02301975|58919880|FG002|Overall Study|Lack of Efficacy|1|||
30887030|NCT02301975|58919878|FG000|Overall Study|Protocol Violation|3|||
30887031|NCT02301975|58919879|FG001|Overall Study|Protocol Violation|5|||
30887032|NCT02301975|58919880|FG002|Overall Study|Protocol Violation|3|||
30887033|NCT02301975|58919878|FG000|Overall Study|Lost to Follow-up|0|||
30887034|NCT02301975|58919879|FG001|Overall Study|Lost to Follow-up|2|||
30887035|NCT02301975|58919880|FG002|Overall Study|Lost to Follow-up|2|||
30887036|NCT02301975|58919878|FG000|Overall Study|Physician Decision|4|||
30887037|NCT02301975|58919879|FG001|Overall Study|Physician Decision|2|||
30887038|NCT02301975|58919880|FG002|Overall Study|Physician Decision|3|||
30887039|NCT02301975|58919878|FG000|Overall Study|Withdrawal by Subject|15|||
30976174|NCT02926833|59062629|FG002|Overall Study|Still on study|5|||
30887040|NCT02301975|58919879|FG001|Overall Study|Withdrawal by Subject|12|||
30887041|NCT02301975|58919880|FG002|Overall Study|Withdrawal by Subject|11|||
30887042|NCT02301897|58919891|FG000|Treatment Course 1|Non-Compliance|0|||
30887043|NCT02301897|58919892|FG001|Treatment Course 1|Non-Compliance|0|||
30887044|NCT02301897|58919893|FG002|Treatment Course 1|Non-Compliance|1|||
30887045|NCT02301897|58919891|FG000|Treatment Course 1|Adverse Event|1|||
30887046|NCT02301897|58919892|FG001|Treatment Course 1|Adverse Event|1|||
30887047|NCT02301897|58919893|FG002|Treatment Course 1|Adverse Event|0|||
30887048|NCT02301897|58919891|FG000|Treatment Course 1|Lost to Follow-up|1|||
30887049|NCT02301897|58919892|FG001|Treatment Course 1|Lost to Follow-up|2|||
30887050|NCT02301897|58919893|FG002|Treatment Course 1|Lost to Follow-up|1|||
30887051|NCT02301897|58919891|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
30887052|NCT02301897|58919892|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
30887053|NCT02301897|58919893|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
30887054|NCT02301897|58919891|FG000|Treatment Course 1|Withdrawal by Subject|0|||
30887055|NCT02301897|58919892|FG001|Treatment Course 1|Withdrawal by Subject|0|||
30887056|NCT02301897|58919893|FG002|Treatment Course 1|Withdrawal by Subject|2|||
30887057|NCT02301897|58919891|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
30887058|NCT02301897|58919892|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
30887059|NCT02301897|58919893|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
30887060|NCT02301897|58919891|FG000|Treatment Course 2|Lost to Follow-up|0|||
30887061|NCT02301897|58919892|FG001|Treatment Course 2|Lost to Follow-up|2|||
30887062|NCT02301897|58919893|FG002|Treatment Course 2|Lost to Follow-up|0|||
30887063|NCT02301897|58919891|FG000|Treatment Course 2|Pregnancy|0|||
30887064|NCT02301897|58919892|FG001|Treatment Course 2|Pregnancy|1|||
30887065|NCT02301897|58919893|FG002|Treatment Course 2|Pregnancy|1|||
30887066|NCT02301897|58919891|FG000|Treatment Course 2|Withdrawal by Subject|0|||
30887067|NCT02301897|58919892|FG001|Treatment Course 2|Withdrawal by Subject|2|||
30887068|NCT02301897|58919893|FG002|Treatment Course 2|Withdrawal by Subject|0|||
30887069|NCT02301897|58919891|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
30887070|NCT02301897|58919892|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
30887071|NCT02301897|58919893|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
30887072|NCT02301429|58919901|FG000|Overall Study|not acceptable vascular anatomy|3|||
30887073|NCT02300259|58919908|FG000|Period 1|Adverse Event|0|||
30887074|NCT02300259|58919909|FG001|Period 1|Adverse Event|0|||
30887075|NCT02300259|58919910|FG002|Period 1|Adverse Event|1|||
30887076|NCT02300259|58919908|FG000|Period 1|Withdrawal by Subject|0|||
30887077|NCT02300259|58919909|FG001|Period 1|Withdrawal by Subject|0|||
30887078|NCT02300259|58919910|FG002|Period 1|Withdrawal by Subject|1|||
30887079|NCT02300259|58919908|FG000|Period 2|Adverse Event|1|||
30887080|NCT02300259|58919909|FG001|Period 2|Adverse Event|0|||
30887081|NCT02300259|58919910|FG002|Period 2|Adverse Event|0|||
30887082|NCT02300259|58919908|FG000|Period 2|Withdrawal by Subject|0|||
30887083|NCT02300259|58919909|FG001|Period 2|Withdrawal by Subject|0|||
30887084|NCT02300259|58919910|FG002|Period 2|Withdrawal by Subject|1|||
30887085|NCT02367885|58919932|FG000|Overall Study|Lost to Follow-up|1|||
30887086|NCT02367885|58919933|FG001|Overall Study|Lost to Follow-up|0|||
30887087|NCT02367885|58919934|FG002|Overall Study|Lost to Follow-up|0|||
30887088|NCT02367885|58919932|FG000|Overall Study|Withdrawal by Subject|1|||
30887089|NCT02367885|58919933|FG001|Overall Study|Withdrawal by Subject|0|||
30887090|NCT02367885|58919934|FG002|Overall Study|Withdrawal by Subject|0|||
30887091|NCT02367729|58919947|FG000|Overall Study|Organic disorder diagnosed|2|||
30887092|NCT02367729|58919948|FG001|Overall Study|Organic disorder diagnosed|1|||
30887093|NCT02367729|58919947|FG000|Overall Study|Adverse Event|1|||
30887094|NCT02367729|58919948|FG001|Overall Study|Adverse Event|2|||
30887095|NCT02367729|58919947|FG000|Overall Study|Withdrawal by Subject|0|||
30887096|NCT02367729|58919948|FG001|Overall Study|Withdrawal by Subject|5|||
30887097|NCT02366637|58919955|FG000|First Intervention Period|Adverse Event|0|||
30887098|NCT02366637|58919956|FG001|First Intervention Period|Adverse Event|1|||
30887099|NCT02366637|58919955|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
30887100|NCT02366637|58919956|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
30887101|NCT02366637|58919955|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
30887102|NCT02366637|58919956|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
30976175|NCT02926833|59062630|FG003|Overall Study|Still on study|14|||
30976176|NCT02926833|59062627|FG000|Overall Study|Adverse Event|0|||
30887103|NCT02300103|58919962|FG000|Overall Study|Lack of Efficacy|3|||
30887104|NCT02300103|58919962|FG000|Overall Study|Protocol Violation|1|||
30887105|NCT02300103|58919962|FG000|Overall Study|Withdrew Consent|2|||
30887106|NCT02326467|58919966|FG000|Overall Study|Withdrawal by Subject|1|||
30887107|NCT02299635|58919971|FG000|Overall Study|Adverse Event|2|||
30887108|NCT02299635|58919971|FG000|Overall Study|Death|1|||
30887109|NCT02299635|58919971|FG000|Overall Study|Global deterioration of health status|1|||
30887110|NCT02299635|58919971|FG000|Overall Study|Objective progression or relapse|10|||
30887111|NCT02299635|58919971|FG000|Overall Study|Withdrawal by Subject|2|||
30887112|NCT02299635|58919971|FG000|Overall Study|Other|3|||
30887113|NCT02366091|58919979|FG000|Overall Study|Withdrawal by Subject|3|||
30976177|NCT02926833|59062628|FG001|Overall Study|Adverse Event|0|||
30887114|NCT02366091|58919980|FG001|Overall Study|Withdrawal by Subject|7|||
30887115|NCT02366091|58919981|FG002|Overall Study|Withdrawal by Subject|3|||
30887116|NCT02366091|58919982|FG003|Overall Study|Withdrawal by Subject|1|||
30887117|NCT02326155|58919994|FG000|Overall Study|Adverse Event|21|||
30887118|NCT02326155|58919995|FG001|Overall Study|Adverse Event|5|||
30887119|NCT02326155|58919994|FG000|Overall Study|Death|3|||
30887120|NCT02326155|58919995|FG001|Overall Study|Death|0|||
30887121|NCT02326155|58919994|FG000|Overall Study|Lack of Efficacy|49|||
30887122|NCT02326155|58919995|FG001|Overall Study|Lack of Efficacy|5|||
30887123|NCT02326155|58919994|FG000|Overall Study|Lost to Follow-up|14|||
30887124|NCT02326155|58919995|FG001|Overall Study|Lost to Follow-up|3|||
30887125|NCT02326155|58919994|FG000|Overall Study|Protocol Violation|2|||
30887126|NCT02326155|58919995|FG001|Overall Study|Protocol Violation|0|||
30887127|NCT02326155|58919994|FG000|Overall Study|Withdrawal by Subject|34|||
30887128|NCT02326155|58919995|FG001|Overall Study|Withdrawal by Subject|11|||
30887129|NCT02326155|58919994|FG000|Overall Study|Disease progression|37|||
30887130|NCT02326155|58919995|FG001|Overall Study|Disease progression|4|||
30887131|NCT02326155|58919994|FG000|Overall Study|Study close|188|||
30887132|NCT02326155|58919995|FG001|Overall Study|Study close|21|||
30887133|NCT02326155|58919994|FG000|Overall Study|except for study close|46|||
30887134|NCT02326155|58919995|FG001|Overall Study|except for study close|13|||
30887135|NCT02299167|58920001|FG000|Overall Study|patients were excluded from the study|11|||
30887136|NCT01647711|58920010|FG000|Overall Study|Progressive disease|6|||
30887137|NCT01647711|58920011|FG001|Overall Study|Progressive disease|2|||
30887138|NCT01647711|58920012|FG002|Overall Study|Progressive disease|6|||
30887139|NCT01647711|58920013|FG003|Overall Study|Progressive disease|8|||
30887140|NCT01647711|58920014|FG004|Overall Study|Progressive disease|2|||
30887141|NCT01647711|58920010|FG000|Overall Study|Other adverse event|0|||
30887142|NCT01647711|58920011|FG001|Overall Study|Other adverse event|0|||
30887143|NCT01647711|58920012|FG002|Overall Study|Other adverse event|2|||
30887144|NCT01647711|58920013|FG003|Overall Study|Other adverse event|0|||
30887145|NCT01647711|58920014|FG004|Overall Study|Other adverse event|2|||
30887146|NCT01647711|58920010|FG000|Overall Study|Protocol Violation|0|||
30887147|NCT01647711|58920011|FG001|Overall Study|Protocol Violation|0|||
30887148|NCT01647711|58920012|FG002|Overall Study|Protocol Violation|0|||
30887149|NCT01647711|58920013|FG003|Overall Study|Protocol Violation|0|||
30887150|NCT01647711|58920014|FG004|Overall Study|Protocol Violation|1|||
30887151|NCT01647711|58920010|FG000|Overall Study|Refused to continue taking medication|0|||
30887152|NCT01647711|58920011|FG001|Overall Study|Refused to continue taking medication|0|||
30887153|NCT01647711|58920012|FG002|Overall Study|Refused to continue taking medication|0|||
30887154|NCT01647711|58920013|FG003|Overall Study|Refused to continue taking medication|2|||
30887155|NCT01647711|58920014|FG004|Overall Study|Refused to continue taking medication|1|||
30887156|NCT01647711|58920010|FG000|Overall Study|Other reason not defined|0|||
30887157|NCT01647711|58920011|FG001|Overall Study|Other reason not defined|1|||
30887158|NCT01647711|58920012|FG002|Overall Study|Other reason not defined|1|||
30887159|NCT01647711|58920013|FG003|Overall Study|Other reason not defined|1|||
30887160|NCT01647711|58920014|FG004|Overall Study|Other reason not defined|0|||
30887161|NCT02547233|58920030|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
30887162|NCT02547233|58920031|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
30887163|NCT02547233|58920030|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
30887164|NCT02547233|58920031|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
30887165|NCT02547233|58920030|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
30976178|NCT02926833|59062629|FG002|Overall Study|Adverse Event|1|||
30976179|NCT02926833|59062630|FG003|Overall Study|Adverse Event|0|||
30976180|NCT02851797|59062677|FG000|Overall Study|Withdrawal by Subject|4|||
30976181|NCT02851797|59062678|FG001|Overall Study|Withdrawal by Subject|2|||
30976182|NCT02851797|59062677|FG000|Overall Study|Adverse Event|3|||
30976183|NCT02851797|59062678|FG001|Overall Study|Adverse Event|0|||
30976184|NCT01666314|59062902|FG000|Overall Study|Adverse Event|3|||
30976185|NCT01666314|59062903|FG001|Overall Study|Adverse Event|13|||
30976186|NCT01666314|59062904|FG002|Overall Study|Adverse Event|7|||
30976187|NCT01666314|59062905|FG003|Overall Study|Adverse Event|7|||
30976188|NCT01666314|59062902|FG000|Overall Study|Progressive Disease|11|||
30976189|NCT01666314|59062903|FG001|Overall Study|Progressive Disease|9|||
30976190|NCT01666314|59062904|FG002|Overall Study|Progressive Disease|19|||
30887166|NCT02547233|58920031|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
30887167|NCT02547233|58920030|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
30887168|NCT02547233|58920031|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
30887169|NCT02547233|58920030|FG000|12-month Follow-up|Withdrawal by Subject|10|||
30887170|NCT02547233|58920031|FG001|12-month Follow-up|Withdrawal by Subject|10|||
30887171|NCT02547233|58920030|FG000|12-month Follow-up|Lost to Follow-up|3|||
30887172|NCT02547233|58920031|FG001|12-month Follow-up|Lost to Follow-up|3|||
30887173|NCT02547233|58920030|FG000|12-month Follow-up|Lack of Efficacy|1|||
30887174|NCT02547233|58920031|FG001|12-month Follow-up|Lack of Efficacy|2|||
30976191|NCT01666314|59062905|FG003|Overall Study|Progressive Disease|20|||
30976192|NCT01666314|59062902|FG000|Overall Study|Symptomatic Deterioration|1|||
30887175|NCT02547233|58920030|FG000|12-month Follow-up|Protocol Violation|0|||
30887176|NCT02547233|58920031|FG001|12-month Follow-up|Protocol Violation|1|||
30887177|NCT02547233|58920030|FG000|12-month Follow-up|Other|0|||
30887178|NCT02547233|58920031|FG001|12-month Follow-up|Other|1|||
30887179|NCT02546765|58920043|FG000|Overall Study|Withdrawal by Subject|0|||
30887180|NCT02546765|58920044|FG001|Overall Study|Withdrawal by Subject|1|||
30887181|NCT02546765|58920045|FG002|Overall Study|Withdrawal by Subject|0|||
30887182|NCT02546765|58920046|FG003|Overall Study|Withdrawal by Subject|0|||
30887183|NCT02553629|58920069|FG000|Overall Study|Logistic reasons|3|||
30887184|NCT02553629|58920070|FG001|Overall Study|Logistic reasons|6|||
30887185|NCT02546609|58920079|FG000|Overall Study|Withdrawal by Subject|0|||
30887186|NCT02546609|58920080|FG001|Overall Study|Withdrawal by Subject|1|||
30887187|NCT02546609|58920081|FG002|Overall Study|Withdrawal by Subject|2|||
30887188|NCT02546609|58920079|FG000|Overall Study|Adverse Event|0|||
30887189|NCT02546609|58920080|FG001|Overall Study|Adverse Event|6|||
30887190|NCT02546609|58920081|FG002|Overall Study|Adverse Event|1|||
30887191|NCT02546609|58920079|FG000|Overall Study|Protocol Violation|0|||
30887192|NCT02546609|58920080|FG001|Overall Study|Protocol Violation|1|||
30887193|NCT02546609|58920081|FG002|Overall Study|Protocol Violation|1|||
30887194|NCT02546609|58920079|FG000|Overall Study|Lost to Follow-up|2|||
30887195|NCT02546609|58920080|FG001|Overall Study|Lost to Follow-up|3|||
30887196|NCT02546609|58920081|FG002|Overall Study|Lost to Follow-up|1|||
30887197|NCT02546609|58920079|FG000|Overall Study|travel or work schedule restriction|0|||
30887198|NCT02546609|58920080|FG001|Overall Study|travel or work schedule restriction|0|||
30887199|NCT02546609|58920081|FG002|Overall Study|travel or work schedule restriction|2|||
30887200|NCT02553317|58920091|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
30887201|NCT02553317|58920092|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
30887202|NCT02553317|58920091|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
30887203|NCT02553317|58920092|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
30887204|NCT02553317|58920091|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
30887205|NCT02553317|58920092|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
30887206|NCT02553317|58920091|FG000|Overall Treatment Period + Follow-up|Death|1|||
30887207|NCT02553317|58920092|FG001|Overall Treatment Period + Follow-up|Death|3|||
30887208|NCT02553317|58920091|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
30887209|NCT02553317|58920092|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
30887210|NCT02553317|58920091|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
30887211|NCT02553317|58920092|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
30887212|NCT02553317|58920091|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
30887213|NCT02553317|58920092|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
30887214|NCT02553317|58920091|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
30887215|NCT02553317|58920092|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
30887216|NCT02553317|58920091|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
30887217|NCT02553317|58920092|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
30887218|NCT02553317|58920091|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
30887219|NCT02553317|58920092|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
30887220|NCT02325219|58920102|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
30887221|NCT02325219|58920103|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
30887222|NCT02325219|58920104|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
30887223|NCT02325219|58920105|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
30887224|NCT02325219|58920106|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
30887225|NCT02325219|58920102|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
30887226|NCT02325219|58920103|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
30887227|NCT02325219|58920104|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
30976193|NCT01666314|59062903|FG001|Overall Study|Symptomatic Deterioration|0|||
30976194|NCT01666314|59062904|FG002|Overall Study|Symptomatic Deterioration|2|||
30976195|NCT01666314|59062905|FG003|Overall Study|Symptomatic Deterioration|0|||
30976196|NCT01666314|59062902|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
30976197|NCT01666314|59062903|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
30976198|NCT01666314|59062904|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
30976199|NCT01666314|59062905|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
30976200|NCT01666314|59062902|FG000|Overall Study|Withdrawal by Subject|1|||
30976201|NCT01666314|59062903|FG001|Overall Study|Withdrawal by Subject|1|||
30976202|NCT01666314|59062904|FG002|Overall Study|Withdrawal by Subject|2|||
30976203|NCT01666314|59062905|FG003|Overall Study|Withdrawal by Subject|3|||
30790151|NCT00048035|58803323|FG003|Extension Year 2|Early Withdrawals|0|||
30887228|NCT02325219|58920105|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
30887229|NCT02325219|58920106|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
30887230|NCT02325219|58920102|FG000|Controlled Period (Week 0 - 16)|Other|0|||
30887231|NCT02325219|58920103|FG001|Controlled Period (Week 0 - 16)|Other|0|||
30887232|NCT02325219|58920104|FG002|Controlled Period (Week 0 - 16)|Other|1|||
30887233|NCT02325219|58920105|FG003|Controlled Period (Week 0 - 16)|Other|0|||
30887234|NCT02325219|58920106|FG004|Controlled Period (Week 0 - 16)|Other|0|||
30887235|NCT02325219|58920102|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
30887236|NCT02325219|58920103|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
30887237|NCT02325219|58920104|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
30887238|NCT02325219|58920105|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
30887239|NCT02325219|58920106|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
30887240|NCT02325219|58920102|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
30887241|NCT02325219|58920103|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
30887242|NCT02325219|58920104|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
30887243|NCT02325219|58920105|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
30887244|NCT02325219|58920106|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
30887245|NCT02325219|58920102|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
30887246|NCT02325219|58920103|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
30887247|NCT02325219|58920104|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
30887248|NCT02325219|58920105|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
30887249|NCT02325219|58920106|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
30887250|NCT02297841|58920122|FG000|Overall Study|Withdrawal by Subject|1|||
30887251|NCT02297841|58920122|FG000|Overall Study|Protocol Violation|7|||
30887252|NCT02365467|58920126|FG000|Overall Study|Death|3|||
30887253|NCT02324361|58920132|FG000|Overall Study|Lost to Follow-up|5|||
30887254|NCT02324361|58920133|FG001|Overall Study|Lost to Follow-up|2|||
30887255|NCT02365233|58920142|FG000|Overall Study|IRB withheld the data|1|||
30887256|NCT02365233|58920143|FG001|Overall Study|IRB withheld the data|2|||
30887257|NCT02365233|58920144|FG002|Overall Study|IRB withheld the data|2|||
30887258|NCT02324205|58920152|FG000|Overall Study|Withdrawal by Subject|37|||
30887259|NCT02324049|58920156|FG000|Part C|Study terminated|11|||
30887260|NCT02364999|58920162|FG000|Overall Study|Death|136|||
30887261|NCT02364999|58920163|FG001|Overall Study|Death|138|||
30887262|NCT02364999|58920162|FG000|Overall Study|Lost to Follow-up|10|||
30887263|NCT02364999|58920163|FG001|Overall Study|Lost to Follow-up|15|||
30887264|NCT02364999|58920162|FG000|Overall Study|Protocol Violation|3|||
30887265|NCT02364999|58920163|FG001|Overall Study|Protocol Violation|2|||
30887266|NCT02364999|58920162|FG000|Overall Study|Withdrawal by Subject|14|||
30887267|NCT02364999|58920163|FG001|Overall Study|Withdrawal by Subject|14|||
30887268|NCT02364999|58920162|FG000|Overall Study|Other|0|||
30887269|NCT02364999|58920163|FG001|Overall Study|Other|1|||
30887270|NCT02364999|58920162|FG000|Overall Study|Randomized but did not receive treatment|2|||
30887271|NCT02364999|58920163|FG001|Overall Study|Randomized but did not receive treatment|3|||
30887272|NCT02322879|58920172|FG000|First Intervention|Physician Decision|1|||
30887273|NCT02322879|58920173|FG001|First Intervention|Physician Decision|0|||
30887274|NCT02322411|58920181|FG000|Overall Study|Lost to Follow-up|4|||
30887275|NCT02322411|58920182|FG001|Overall Study|Lost to Follow-up|7|||
30887276|NCT02322411|58920181|FG000|Overall Study|Withdrawal by Subject|1|||
30887277|NCT02322411|58920182|FG001|Overall Study|Withdrawal by Subject|0|||
30887278|NCT02322021|58920192|FG000|Core Phase|Adverse Event|1|||
30887279|NCT02322021|58920193|FG001|Core Phase|Adverse Event|3|||
30887280|NCT02322021|58920194|FG002|Core Phase|Adverse Event|4|||
30887281|NCT02322021|58920195|FG003|Core Phase|Adverse Event|2|||
30887282|NCT02322021|58920196|FG004|Core Phase|Adverse Event|0|||
30887283|NCT02322021|58920192|FG000|Core Phase|Participant Choice|4|||
30887284|NCT02322021|58920193|FG001|Core Phase|Participant Choice|5|||
30887285|NCT02322021|58920194|FG002|Core Phase|Participant Choice|4|||
30887286|NCT02322021|58920195|FG003|Core Phase|Participant Choice|2|||
30887287|NCT02322021|58920196|FG004|Core Phase|Participant Choice|0|||
30887288|NCT02322021|58920192|FG000|Core Phase|Lost to Follow-up|0|||
30887289|NCT02322021|58920193|FG001|Core Phase|Lost to Follow-up|0|||
30887290|NCT02322021|58920194|FG002|Core Phase|Lost to Follow-up|0|||
30887291|NCT02322021|58920195|FG003|Core Phase|Lost to Follow-up|1|||
30887292|NCT02322021|58920196|FG004|Core Phase|Lost to Follow-up|0|||
30976204|NCT01666314|59062902|FG000|Overall Study|Reason not Specified|10|||
30976205|NCT01666314|59062903|FG001|Overall Study|Reason not Specified|7|||
30976206|NCT01666314|59062904|FG002|Overall Study|Reason not Specified|5|||
30976207|NCT01666314|59062905|FG003|Overall Study|Reason not Specified|5|||
30976208|NCT01666002|59062936|FG000|Overall Study|Lost to Follow-up|5|||
30790152|NCT00048035|58803324|FG004|Extension Year 2|Early Withdrawals|0|||
30887293|NCT02322021|58920192|FG000|Core Phase|Other|0|||
30887294|NCT02322021|58920193|FG001|Core Phase|Other|0|||
30887295|NCT02322021|58920194|FG002|Core Phase|Other|1|||
30887296|NCT02322021|58920195|FG003|Core Phase|Other|0|||
30887297|NCT02322021|58920196|FG004|Core Phase|Other|0|||
30887298|NCT02322021|58920192|FG000|Extension Phase|Adverse Event|0|||
30887299|NCT02322021|58920193|FG001|Extension Phase|Adverse Event|0|||
30887300|NCT02322021|58920194|FG002|Extension Phase|Adverse Event|0|||
30887301|NCT02322021|58920195|FG003|Extension Phase|Adverse Event|0|||
30887302|NCT02322021|58920196|FG004|Extension Phase|Adverse Event|3|||
30887303|NCT02322021|58920192|FG000|Extension Phase|Participant Choice|0|||
30887304|NCT02322021|58920193|FG001|Extension Phase|Participant Choice|0|||
30887305|NCT02322021|58920194|FG002|Extension Phase|Participant Choice|0|||
30887306|NCT02322021|58920195|FG003|Extension Phase|Participant Choice|0|||
30887307|NCT02322021|58920196|FG004|Extension Phase|Participant Choice|6|||
30887308|NCT02322021|58920192|FG000|Extension Phase|Other|0|||
30887309|NCT02322021|58920193|FG001|Extension Phase|Other|0|||
30887310|NCT02322021|58920194|FG002|Extension Phase|Other|0|||
30887311|NCT02322021|58920195|FG003|Extension Phase|Other|0|||
30887312|NCT02322021|58920196|FG004|Extension Phase|Other|3|||
30887313|NCT02322021|58920192|FG000|Extension Phase|Lost to Follow-up|0|||
30887314|NCT02322021|58920193|FG001|Extension Phase|Lost to Follow-up|0|||
30887315|NCT02322021|58920194|FG002|Extension Phase|Lost to Follow-up|0|||
30887316|NCT02322021|58920195|FG003|Extension Phase|Lost to Follow-up|0|||
30887317|NCT02322021|58920196|FG004|Extension Phase|Lost to Follow-up|1|||
30887318|NCT02322021|58920192|FG000|Extension Phase|Study terminated by sponsor|0|||
30887319|NCT02322021|58920193|FG001|Extension Phase|Study terminated by sponsor|0|||
30887320|NCT02322021|58920194|FG002|Extension Phase|Study terminated by sponsor|0|||
30887321|NCT02322021|58920195|FG003|Extension Phase|Study terminated by sponsor|0|||
30887322|NCT02322021|58920196|FG004|Extension Phase|Study terminated by sponsor|28|||
30887323|NCT02363439|58920211|FG000|Overall Study|Lack of Efficacy|4|||
30887324|NCT02363283|58920215|FG000|Overall Study|Withdrawal by Subject|1|||
30887325|NCT02363283|58920215|FG000|Overall Study|Not eligible due to transaminitis|1|||
30887326|NCT02321319|58920219|FG000|Overall Study|Product discontinued|5|||
30887327|NCT02294175|58920225|FG000|Overall Study|Withdrawal by Subject|1|||
30887328|NCT02294175|58920226|FG001|Overall Study|Withdrawal by Subject|2|||
30887329|NCT02294175|58920225|FG000|Overall Study|pt taking excluded medication|3|||
30887330|NCT02294175|58920226|FG001|Overall Study|pt taking excluded medication|1|||
30887331|NCT02294175|58920225|FG000|Overall Study|Protocol Violation|1|||
30887332|NCT02294175|58920226|FG001|Overall Study|Protocol Violation|0|||
30887333|NCT02294175|58920225|FG000|Overall Study|Lost to Follow-up|0|||
30887334|NCT02294175|58920226|FG001|Overall Study|Lost to Follow-up|1|||
30887335|NCT02294175|58920225|FG000|Overall Study|wound healed|0|||
30887336|NCT02294175|58920226|FG001|Overall Study|wound healed|2|||
30887337|NCT02088541|58920237|FG000|Overall Study|Adverse Event|3|||
30887338|NCT02088541|58920238|FG001|Overall Study|Adverse Event|0|||
30887339|NCT02088541|58920239|FG002|Overall Study|Adverse Event|3|||
30887340|NCT02088541|58920240|FG003|Overall Study|Adverse Event|3|||
30887341|NCT02088541|58920241|FG004|Overall Study|Adverse Event|0|||
30887342|NCT02088541|58920237|FG000|Overall Study|Death|51|||
30887343|NCT02088541|58920238|FG001|Overall Study|Death|21|||
30887344|NCT02088541|58920239|FG002|Overall Study|Death|85|||
30887345|NCT02088541|58920240|FG003|Overall Study|Death|28|||
30887346|NCT02088541|58920241|FG004|Overall Study|Death|38|||
30887347|NCT02088541|58920237|FG000|Overall Study|Lost to Follow-up|2|||
30887348|NCT02088541|58920238|FG001|Overall Study|Lost to Follow-up|0|||
30887349|NCT02088541|58920239|FG002|Overall Study|Lost to Follow-up|1|||
30887350|NCT02088541|58920240|FG003|Overall Study|Lost to Follow-up|0|||
30887351|NCT02088541|58920241|FG004|Overall Study|Lost to Follow-up|0|||
30887352|NCT02088541|58920237|FG000|Overall Study|Physician Decision|2|||
30887353|NCT02088541|58920238|FG001|Overall Study|Physician Decision|1|||
30887354|NCT02088541|58920239|FG002|Overall Study|Physician Decision|2|||
30887355|NCT02088541|58920240|FG003|Overall Study|Physician Decision|0|||
30887356|NCT02088541|58920241|FG004|Overall Study|Physician Decision|2|||
30887357|NCT02088541|58920237|FG000|Overall Study|Disease progression|7|||
30887358|NCT02088541|58920238|FG001|Overall Study|Disease progression|1|||
30887359|NCT02088541|58920239|FG002|Overall Study|Disease progression|2|||
30887360|NCT02088541|58920240|FG003|Overall Study|Disease progression|3|||
30887361|NCT02088541|58920241|FG004|Overall Study|Disease progression|1|||
30887362|NCT02088541|58920237|FG000|Overall Study|Study terminated by sponsor|1|||
30887363|NCT02088541|58920238|FG001|Overall Study|Study terminated by sponsor|1|||
30887364|NCT02088541|58920239|FG002|Overall Study|Study terminated by sponsor|12|||
30887365|NCT02088541|58920240|FG003|Overall Study|Study terminated by sponsor|2|||
30887366|NCT02088541|58920241|FG004|Overall Study|Study terminated by sponsor|6|||
30887367|NCT02088541|58920237|FG000|Overall Study|Withdrawal by Subject|3|||
30887368|NCT02088541|58920238|FG001|Overall Study|Withdrawal by Subject|2|||
30887369|NCT02088541|58920239|FG002|Overall Study|Withdrawal by Subject|9|||
30887370|NCT02088541|58920240|FG003|Overall Study|Withdrawal by Subject|7|||
30887371|NCT02088541|58920241|FG004|Overall Study|Withdrawal by Subject|10|||
30887372|NCT02088541|58920237|FG000|Overall Study|Other|2|||
30887373|NCT02088541|58920238|FG001|Overall Study|Other|1|||
30887374|NCT02088541|58920239|FG002|Overall Study|Other|3|||
30887375|NCT02088541|58920240|FG003|Overall Study|Other|1|||
30887376|NCT02088541|58920241|FG004|Overall Study|Other|1|||
30887377|NCT02294019|58920251|FG000|Overall Study|Adverse Event|2|||
30887378|NCT02294019|58920251|FG000|Overall Study|Protocol Violation|68|||
30887379|NCT02294019|58920251|FG000|Overall Study|Lost to Follow-up|31|||
30887380|NCT02294019|58920251|FG000|Overall Study|Other|1|||
30887381|NCT02294019|58920251|FG000|Overall Study|Withdrawal by Subject|1|||
30887382|NCT02320149|58920257|FG000|Overall Study|Adverse Event|3|||
30887383|NCT02320149|58920258|FG001|Overall Study|Adverse Event|7|||
30887384|NCT02320149|58920257|FG000|Overall Study|Withdrawal of Consent|28|||
30887385|NCT02320149|58920258|FG001|Overall Study|Withdrawal of Consent|32|||
30887386|NCT02320149|58920257|FG000|Overall Study|Lost to Follow-up|21|||
30887387|NCT02320149|58920258|FG001|Overall Study|Lost to Follow-up|34|||
30887388|NCT02320149|58920257|FG000|Overall Study|Protocol Violation|2|||
30887389|NCT02320149|58920258|FG001|Overall Study|Protocol Violation|1|||
30887390|NCT02320149|58920257|FG000|Overall Study|Noncompliance with Study Treatment|7|||
30887391|NCT02320149|58920258|FG001|Overall Study|Noncompliance with Study Treatment|2|||
30887392|NCT02320149|58920257|FG000|Overall Study|Lack of Efficacy|0|||
30887393|NCT02320149|58920258|FG001|Overall Study|Lack of Efficacy|1|||
30887394|NCT02320149|58920257|FG000|Overall Study|Other Miscellaneous Reasons|2|||
30887395|NCT02320149|58920258|FG001|Overall Study|Other Miscellaneous Reasons|3|||
30887396|NCT02540083|58920264|FG000|Overall Study|Withdrawal by Subject|16|||
30887397|NCT02293863|58920271|FG000|Overall Study|Death|4|||
30887398|NCT02293863|58920272|FG001|Overall Study|Death|6|||
30887399|NCT02293863|58920273|FG002|Overall Study|Death|4|||
30887400|NCT02293863|58920271|FG000|Overall Study|Lost to Follow-up|2|||
30887401|NCT02293863|58920272|FG001|Overall Study|Lost to Follow-up|2|||
30887402|NCT02293863|58920273|FG002|Overall Study|Lost to Follow-up|2|||
30887403|NCT02293863|58920271|FG000|Overall Study|Withdrawal by Subject|3|||
30887404|NCT02293863|58920272|FG001|Overall Study|Withdrawal by Subject|3|||
30887405|NCT02293863|58920273|FG002|Overall Study|Withdrawal by Subject|1|||
30887406|NCT02293863|58920271|FG000|Overall Study|Reason Not Specified|0|||
30887407|NCT02293863|58920272|FG001|Overall Study|Reason Not Specified|2|||
30887408|NCT02293863|58920273|FG002|Overall Study|Reason Not Specified|2|||
30887409|NCT02293395|58920285|FG000|Overall Study|Lost to Follow-up|1|||
30887410|NCT02293395|58920286|FG001|Overall Study|Lost to Follow-up|0|||
30887411|NCT02293395|58920285|FG000|Overall Study|Withdrawal by Subject|8|||
30887412|NCT02293395|58920286|FG001|Overall Study|Withdrawal by Subject|7|||
30887413|NCT02025985|58920297|FG000|Overall Study|Consent withdrawn|0|||
30887414|NCT02025985|58920298|FG001|Overall Study|Consent withdrawn|0|||
30887415|NCT02025985|58920299|FG002|Overall Study|Consent withdrawn|1|||
30887416|NCT02025985|58920300|FG003|Overall Study|Consent withdrawn|0|||
30887417|NCT02025985|58920301|FG004|Overall Study|Consent withdrawn|0|||
30887418|NCT02025985|58920297|FG000|Overall Study|Termination of study by Sponsor|4|||
30887419|NCT02025985|58920298|FG001|Overall Study|Termination of study by Sponsor|3|||
30887420|NCT02025985|58920299|FG002|Overall Study|Termination of study by Sponsor|1|||
30887421|NCT02025985|58920300|FG003|Overall Study|Termination of study by Sponsor|1|||
30887422|NCT02025985|58920301|FG004|Overall Study|Termination of study by Sponsor|3|||
30887423|NCT02025985|58920297|FG000|Overall Study|Death|21|||
30887424|NCT02025985|58920298|FG001|Overall Study|Death|20|||
30887425|NCT02025985|58920299|FG002|Overall Study|Death|23|||
30887426|NCT02025985|58920300|FG003|Overall Study|Death|20|||
30887427|NCT02025985|58920301|FG004|Overall Study|Death|17|||
30887428|NCT02528305|58920315|FG000|Overall Study|Withdrawal by Subject|1|||
30887429|NCT02528305|58920315|FG000|Overall Study|Adverse Event|1|||
30887430|NCT02528305|58920315|FG000|Overall Study|Physician Decision|1|||
30887431|NCT02532517|58920321|FG000|Overall Study|Did not complete 24-Month visit|4|||
30887432|NCT02532517|58920321|FG000|Overall Study|Failed Angiographic eligibility|1|||
30887433|NCT02532517|58920321|FG000|Overall Study|Lost to Follow-up|4|||
30887434|NCT02532517|58920321|FG000|Overall Study|Withdrawal by Subject|4|||
30887435|NCT02532517|58920321|FG000|Overall Study|Death|4|||
30887436|NCT02545049|58920327|FG000|Overall Study|Withdrawal by Subject|1|||
30887437|NCT02545049|58920328|FG001|Overall Study|Withdrawal by Subject|7|||
30887438|NCT02545049|58920327|FG000|Overall Study|Lost to Follow-up|4|||
30887439|NCT02545049|58920328|FG001|Overall Study|Lost to Follow-up|6|||
30887440|NCT02545049|58920327|FG000|Overall Study|GCP violations|37|||
30887441|NCT02545049|58920328|FG001|Overall Study|GCP violations|48|||
30887442|NCT02532283|58920336|FG000|Overall Study|Adverse Event|0|||
30887443|NCT02532283|58920337|FG001|Overall Study|Adverse Event|1|||
30887444|NCT02532283|58920336|FG000|Overall Study|Death|1|||
30887445|NCT02532283|58920337|FG001|Overall Study|Death|0|||
30887446|NCT02532283|58920336|FG000|Overall Study|Lost to Follow-up|0|||
30887447|NCT02532283|58920337|FG001|Overall Study|Lost to Follow-up|1|||
30887448|NCT02532283|58920336|FG000|Overall Study|Withdrawal by Subject|8|||
30887449|NCT02532283|58920337|FG001|Overall Study|Withdrawal by Subject|3|||
30887450|NCT01349959|58920358|FG000|Overall Study|Adverse Event|7|||
30887451|NCT01295125|58920362|FG000|Overall Study|Study stopped prematurely|9|||
30887452|NCT02540291|58920370|FG000|Overall Study|Death|7|||
30887453|NCT02540291|58920371|FG001|Overall Study|Death|7|||
30887454|NCT02540291|58920372|FG002|Overall Study|Death|5|||
30887455|NCT02540291|58920373|FG003|Overall Study|Death|7|||
30887456|NCT02540291|58920370|FG000|Overall Study|Lost to Follow-up|0|||
30887457|NCT02540291|58920371|FG001|Overall Study|Lost to Follow-up|0|||
30887458|NCT02540291|58920372|FG002|Overall Study|Lost to Follow-up|1|||
30887459|NCT02540291|58920373|FG003|Overall Study|Lost to Follow-up|0|||
30887460|NCT02540291|58920370|FG000|Overall Study|Withdrawal Of Consent|0|||
30887461|NCT02540291|58920371|FG001|Overall Study|Withdrawal Of Consent|1|||
30887462|NCT02540291|58920372|FG002|Overall Study|Withdrawal Of Consent|0|||
30887463|NCT02540291|58920373|FG003|Overall Study|Withdrawal Of Consent|0|||
30887464|NCT02540291|58920370|FG000|Overall Study|Study Terminated By Sponsor|1|||
30887465|NCT02540291|58920371|FG001|Overall Study|Study Terminated By Sponsor|0|||
30887466|NCT02540291|58920372|FG002|Overall Study|Study Terminated By Sponsor|0|||
30887467|NCT02540291|58920373|FG003|Overall Study|Study Terminated By Sponsor|0|||
30887468|NCT02540291|58920370|FG000|Overall Study|Other|0|||
30887469|NCT02540291|58920371|FG001|Overall Study|Other|0|||
30887470|NCT02540291|58920372|FG002|Overall Study|Other|1|||
30887471|NCT02540291|58920373|FG003|Overall Study|Other|0|||
30887472|NCT02540213|58920385|FG000|Overall Study|Death/adverse event|18|||
30887473|NCT02540213|58920385|FG000|Overall Study|Administrative reasons|3|||
30887474|NCT02540213|58920385|FG000|Overall Study|Kidney transplant|3|||
30887475|NCT02540213|58920385|FG000|Overall Study|Lack of Efficacy|6|||
30887476|NCT02540213|58920385|FG000|Overall Study|Consent withdrawn|7|||
30887477|NCT02540213|58920385|FG000|Overall Study|Enrolled but not treated|2|||
30887484|NCT02552303|58920402|FG000|Allocation|Withdrawal by Subject|2|||
30887485|NCT02552303|58920403|FG001|Allocation|Withdrawal by Subject|1|||
30887486|NCT02552303|58920404|FG002|Allocation|Withdrawal by Subject|1|||
30887487|NCT02552303|58920405|FG003|Allocation|Withdrawal by Subject|1|||
30887488|NCT02552303|58920402|FG000|Allocation|ineligible|1|||
30887489|NCT02552303|58920403|FG001|Allocation|ineligible|1|||
30887490|NCT02552303|58920404|FG002|Allocation|ineligible|0|||
30887491|NCT02552303|58920405|FG003|Allocation|ineligible|0|||
30887492|NCT02552303|58920402|FG000|Follow-Up|Lost to Follow-up|0|||
30887493|NCT02552303|58920403|FG001|Follow-Up|Lost to Follow-up|0|||
30887494|NCT02552303|58920404|FG002|Follow-Up|Lost to Follow-up|1|||
30887495|NCT02552303|58920405|FG003|Follow-Up|Lost to Follow-up|0|||
30887496|NCT02552303|58920402|FG000|Follow-Up|ineligible|0|||
30887497|NCT02552303|58920403|FG001|Follow-Up|ineligible|2|||
30887498|NCT02552303|58920404|FG002|Follow-Up|ineligible|0|||
30887499|NCT02552303|58920405|FG003|Follow-Up|ineligible|0|||
30887500|NCT01660711|58920415|FG000|Overall Study|Adverse Event|7|||
30887501|NCT01660711|58920415|FG000|Overall Study|Withdrawal by Subject|1|||
30887502|NCT02544113|58920421|FG000|Overall Study|Death|3|||
30887503|NCT02544113|58920422|FG001|Overall Study|Death|4|||
30887504|NCT02538965|58920428|FG000|Treatment Period|Other = Death due to disease progression|1|||
30887505|NCT02538965|58920428|FG000|Treatment Period|Adverse Event|2|||
30887506|NCT02538965|58920428|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
30887507|NCT02538965|58920428|FG000|Treatment Period|Treatment Failure|9|||
30887508|NCT02538965|58920428|FG000|Treatment Period|Disease Progression|1|||
30887509|NCT02538965|58920428|FG000|Treatment Period|Physician Decision|2|||
30887510|NCT02538965|58920428|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
30887511|NCT02538965|58920428|FG000|Follow-Up Period|Withdrawal by Parent|4|||
30887512|NCT02543801|58920436|FG000|Overall Study|Protocol Violation|1|||
30887513|NCT02543801|58920437|FG001|Overall Study|Protocol Violation|2|||
30887514|NCT02543801|58920438|FG002|Overall Study|Protocol Violation|0|||
30887515|NCT02543801|58920439|FG003|Overall Study|Protocol Violation|0|||
30887516|NCT02470091|58920451|FG000|Overall Study|Withdrawal by Subject|1|||
30887517|NCT02470091|58920452|FG001|Overall Study|Withdrawal by Subject|0|||
30887518|NCT02470091|58920451|FG000|Overall Study|Ineligible|0|||
30887519|NCT02470091|58920452|FG001|Overall Study|Ineligible|2|||
30887520|NCT02362503|58920463|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
30887521|NCT02362503|58920464|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
30887522|NCT02362503|58920465|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
30887523|NCT02362503|58920463|FG000|Double-blind Period-Up to 8 Days|Death|1|||
30887524|NCT02362503|58920464|FG001|Double-blind Period-Up to 8 Days|Death|0|||
30976209|NCT01666002|59062937|FG001|Overall Study|Lost to Follow-up|0|||
30976210|NCT01665768|59063009|FG000|Overall Study|Adverse Event|3|||
30976211|NCT01665768|59063009|FG000|Overall Study|Lack of Efficacy|19|||
30887525|NCT02362503|58920465|FG002|Double-blind Period-Up to 8 Days|Death|0|||
30887526|NCT02362503|58920463|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
30887527|NCT02362503|58920464|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
30887528|NCT02362503|58920465|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
30887529|NCT02362503|58920463|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
30887530|NCT02362503|58920464|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
30887531|NCT02362503|58920465|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
30887532|NCT02362503|58920463|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
30887533|NCT02362503|58920464|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
30887534|NCT02362503|58920465|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
30887535|NCT02362503|58920463|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
30887536|NCT02362503|58920464|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
30887537|NCT02362503|58920465|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
30887538|NCT02362503|58920463|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
30887539|NCT02362503|58920464|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
30887540|NCT02362503|58920465|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
30887541|NCT02362503|58920463|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
30887542|NCT02362503|58920464|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
30887543|NCT02362503|58920465|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
30887544|NCT02362503|58920463|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
30887545|NCT02362503|58920464|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
30887546|NCT02362503|58920465|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
30887547|NCT02362503|58920463|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
30887548|NCT02362503|58920464|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
30887549|NCT02362503|58920465|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
30887550|NCT02362503|58920463|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
30887551|NCT02362503|58920464|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
30887552|NCT02362503|58920465|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
30887553|NCT02362503|58920463|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
30887554|NCT02362503|58920464|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
30887555|NCT02362503|58920465|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
30887556|NCT02362503|58920463|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
30887557|NCT02362503|58920464|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
30887558|NCT02362503|58920465|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
30887559|NCT02362503|58920463|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
30887560|NCT02362503|58920464|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
30887561|NCT02362503|58920465|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
30887562|NCT02535065|58920476|FG000|Overall Study|Death|13|||
30887563|NCT02535065|58920476|FG000|Overall Study|Lost to Follow-up|1|||
30887564|NCT02535065|58920476|FG000|Overall Study|Withdrawal by Subject|6|||
30887565|NCT02530619|58920480|FG000|Registered for Study|Withdrawal by Subject|2|||
30887566|NCT02530619|58920480|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
30887567|NCT02530619|58920480|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
30887568|NCT02530619|58920480|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
30887569|NCT02530619|58920480|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
30887570|NCT02530619|58920480|FG000|Follow-up Period (6 Months)|Death|4|||
30887571|NCT02530619|58920480|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
30887572|NCT02530619|58920480|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
30887573|NCT02530385|58920486|FG000|Overall Study|Withdrawal by Subject|0|||
30887574|NCT02530385|58920487|FG001|Overall Study|Withdrawal by Subject|1|||
30887575|NCT02362425|58920497|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
30887576|NCT02362425|58920498|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
30887577|NCT02362425|58920499|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
30887578|NCT02362425|58920500|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
30887579|NCT02362425|58920497|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
30887580|NCT02362425|58920498|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
30887581|NCT02362425|58920499|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
30887582|NCT02362425|58920500|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
30887583|NCT02362425|58920497|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
30887584|NCT02362425|58920498|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
30887585|NCT02362425|58920499|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
30887586|NCT02362425|58920500|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
30887587|NCT02362425|58920497|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
30887588|NCT02362425|58920498|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
30887589|NCT02362425|58920499|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
30887590|NCT02362425|58920500|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
30887591|NCT02362425|58920497|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
30887592|NCT02362425|58920498|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
30887593|NCT02362425|58920499|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
30887594|NCT02362425|58920500|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
30887595|NCT02362425|58920497|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
30887596|NCT02362425|58920498|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
30887597|NCT02362425|58920499|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
30887598|NCT02362425|58920500|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
30887599|NCT02362425|58920497|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
30887600|NCT02362425|58920498|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
30887601|NCT02362425|58920499|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
30887602|NCT02362425|58920500|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
30948433|NCT01709084|58994336|FG001|Overall Study|Withdrawal by Subject|2|||
30887603|NCT02362425|58920497|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
30887604|NCT02362425|58920498|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
30887605|NCT02362425|58920499|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
30887606|NCT02362425|58920500|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
30887607|NCT02362269|58920513|FG000|Overall Study|Moved|1|||
30887608|NCT02362269|58920514|FG001|Overall Study|Moved|0|||
30887609|NCT02362269|58920513|FG000|Overall Study|Lost to Follow-up|0|||
30887610|NCT02362269|58920514|FG001|Overall Study|Lost to Follow-up|6|||
30887611|NCT02529995|58920522|FG000|Part A|Ongoing Study at Data Cut-off|14|||
30887612|NCT02529995|58920523|FG001|Part A|Ongoing Study at Data Cut-off|16|||
30887613|NCT02529995|58920522|FG000|Part A|Discontinued Study|1|||
30887614|NCT02529995|58920523|FG001|Part A|Discontinued Study|0|||
30887615|NCT02529995|58920522|FG000|Part B|Ongoing Study at Data Cut-off|0|||
30887616|NCT02529995|58920523|FG001|Part B|Ongoing Study at Data Cut-off|7|||
30887617|NCT02529995|58920522|FG000|Part B|Discontinued Study|6|||
30887618|NCT02529995|58920523|FG001|Part B|Discontinued Study|5|||
30887619|NCT02529137|58920529|FG000|Overall Study|Discontinuation for different reasons|8|||
30887620|NCT02319759|58920536|FG000|Week 0 - 16|Lack of Efficacy|1|||
30887621|NCT02319759|58920537|FG001|Week 0 - 16|Lack of Efficacy|0|||
30887622|NCT02319759|58920538|FG002|Week 0 - 16|Lack of Efficacy|0|||
30887623|NCT02319759|58920539|FG003|Week 0 - 16|Lack of Efficacy|0|||
30887624|NCT02319759|58920540|FG004|Week 0 - 16|Lack of Efficacy|0|||
30887625|NCT02319759|58920536|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
30887626|NCT02319759|58920537|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
30887627|NCT02319759|58920538|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
30887628|NCT02319759|58920539|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
30887629|NCT02319759|58920540|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
30887630|NCT02319759|58920536|FG000|Week 16 - 24|Lack of Efficacy|1|||
30887631|NCT02319759|58920537|FG001|Week 16 - 24|Lack of Efficacy|0|||
30887632|NCT02319759|58920538|FG002|Week 16 - 24|Lack of Efficacy|1|||
30887633|NCT02319759|58920539|FG003|Week 16 - 24|Lack of Efficacy|0|||
30887634|NCT02319759|58920540|FG004|Week 16 - 24|Lack of Efficacy|0|||
30887635|NCT02319759|58920536|FG000|Week 16 - 24|Lost to Follow-up|1|||
30887636|NCT02319759|58920537|FG001|Week 16 - 24|Lost to Follow-up|0|||
30887637|NCT02319759|58920538|FG002|Week 16 - 24|Lost to Follow-up|0|||
30887638|NCT02319759|58920539|FG003|Week 16 - 24|Lost to Follow-up|0|||
30887639|NCT02319759|58920540|FG004|Week 16 - 24|Lost to Follow-up|0|||
30887640|NCT02319759|58920536|FG000|Week 16 - 24|Withdrawal by Subject|0|||
30887641|NCT02319759|58920537|FG001|Week 16 - 24|Withdrawal by Subject|0|||
30887642|NCT02319759|58920538|FG002|Week 16 - 24|Withdrawal by Subject|2|||
30887643|NCT02319759|58920539|FG003|Week 16 - 24|Withdrawal by Subject|0|||
30887644|NCT02319759|58920540|FG004|Week 16 - 24|Withdrawal by Subject|0|||
30887645|NCT02319759|58920536|FG000|Week 24 - 56|Adverse Event|0|||
30887646|NCT02319759|58920537|FG001|Week 24 - 56|Adverse Event|0|||
30887647|NCT02319759|58920538|FG002|Week 24 - 56|Adverse Event|2|||
30887648|NCT02319759|58920539|FG003|Week 24 - 56|Adverse Event|0|||
30887649|NCT02319759|58920540|FG004|Week 24 - 56|Adverse Event|0|||
30887650|NCT02319759|58920536|FG000|Week 24 - 56|Lack of Efficacy|0|||
30887651|NCT02319759|58920537|FG001|Week 24 - 56|Lack of Efficacy|0|||
30887652|NCT02319759|58920538|FG002|Week 24 - 56|Lack of Efficacy|0|||
30887653|NCT02319759|58920539|FG003|Week 24 - 56|Lack of Efficacy|2|||
30887654|NCT02319759|58920540|FG004|Week 24 - 56|Lack of Efficacy|1|||
30887655|NCT02319759|58920536|FG000|Week 24 - 56|Withdrawal by Subject|0|||
30887656|NCT02319759|58920537|FG001|Week 24 - 56|Withdrawal by Subject|1|||
30887657|NCT02319759|58920538|FG002|Week 24 - 56|Withdrawal by Subject|0|||
30887658|NCT02319759|58920539|FG003|Week 24 - 56|Withdrawal by Subject|0|||
30887659|NCT02319759|58920540|FG004|Week 24 - 56|Withdrawal by Subject|0|||
30887660|NCT02319759|58920536|FG000|Week 24 - 56|Lost to Follow-up|0|||
30887661|NCT02319759|58920537|FG001|Week 24 - 56|Lost to Follow-up|0|||
30887662|NCT02319759|58920538|FG002|Week 24 - 56|Lost to Follow-up|0|||
30887663|NCT02319759|58920539|FG003|Week 24 - 56|Lost to Follow-up|0|||
30887664|NCT02319759|58920540|FG004|Week 24 - 56|Lost to Follow-up|1|||
30887665|NCT02293005|58920553|FG000|Overall Study|Adverse Event|2|||
30887666|NCT02293005|58920553|FG000|Overall Study|Death|4|||
30887667|NCT02293005|58920553|FG000|Overall Study|Lost to Follow-up|1|||
30887668|NCT02293005|58920553|FG000|Overall Study|Withdrawal by Subject|2|||
30887669|NCT02293005|58920553|FG000|Overall Study|Progression|17|||
30887670|NCT02319525|58920559|FG000|Overall Study|Withdrawal by Subject|2|||
30887671|NCT02319525|58920560|FG001|Overall Study|Withdrawal by Subject|1|||
30887672|NCT02292927|58920568|FG000|Overall Study|Protocol Violation|13|||
30887673|NCT02292927|58920569|FG001|Overall Study|Protocol Violation|7|||
30887674|NCT02292849|58920581|FG000|Overall Study|Lost to Follow-up|0|||
30887675|NCT02292849|58920582|FG001|Overall Study|Lost to Follow-up|2|||
30887676|NCT02292849|58920583|FG002|Overall Study|Lost to Follow-up|2|||
30887677|NCT02292849|58920581|FG000|Overall Study|Physician Decision|4|||
30887678|NCT02292849|58920582|FG001|Overall Study|Physician Decision|0|||
30887679|NCT02292849|58920583|FG002|Overall Study|Physician Decision|0|||
30887680|NCT02318667|58920591|FG000|Overall Study|Adverse Event|1|||
30887681|NCT02318667|58920591|FG000|Overall Study|Lack of Efficacy|6|||
30887682|NCT02318667|58920591|FG000|Overall Study|Protocol Violation|2|||
30887683|NCT02292771|58920601|FG000|Overall Study|Withdrawal by Subject|2|||
30887684|NCT02292771|58920602|FG001|Overall Study|Withdrawal by Subject|1|||
30887685|NCT02292771|58920601|FG000|Overall Study|Lost to Follow-up|2|||
30887686|NCT02292771|58920602|FG001|Overall Study|Lost to Follow-up|1|||
30887687|NCT02291913|58920612|FG000|Overall Study|Progressive Disease|32|||
30887688|NCT02291913|58920612|FG000|Overall Study|Adverse Event|11|||
30887689|NCT02291913|58920612|FG000|Overall Study|Death|2|||
30887690|NCT02291913|58920612|FG000|Overall Study|Physician Decision|1|||
30887691|NCT02291913|58920612|FG000|Overall Study|Withdrawal by Subject|1|||
30887692|NCT02291913|58920612|FG000|Overall Study|Protocol Violation|1|||
30887693|NCT02291679|58920619|FG000|Overall Study|Adverse Event|2|||
30887694|NCT02291679|58920620|FG001|Overall Study|Adverse Event|12|||
30887695|NCT02291679|58920621|FG002|Overall Study|Adverse Event|19|||
30887696|NCT02291679|58920619|FG000|Overall Study|Protocol Violation|5|||
30887697|NCT02291679|58920620|FG001|Overall Study|Protocol Violation|1|||
30887698|NCT02291679|58920621|FG002|Overall Study|Protocol Violation|7|||
30887699|NCT02291679|58920619|FG000|Overall Study|Withdrew Consent|18|||
30887700|NCT02291679|58920620|FG001|Overall Study|Withdrew Consent|10|||
30887701|NCT02291679|58920621|FG002|Overall Study|Withdrew Consent|15|||
30887702|NCT02291679|58920619|FG000|Overall Study|Lost to Follow-up|12|||
30887703|NCT02291679|58920620|FG001|Overall Study|Lost to Follow-up|10|||
30887704|NCT02291679|58920621|FG002|Overall Study|Lost to Follow-up|9|||
30887705|NCT02291679|58920619|FG000|Overall Study|Insufficient Therapeutic Response|5|||
30887706|NCT02291679|58920620|FG001|Overall Study|Insufficient Therapeutic Response|5|||
30887707|NCT02291679|58920621|FG002|Overall Study|Insufficient Therapeutic Response|7|||
30887708|NCT02291679|58920619|FG000|Overall Study|Other|2|||
30887709|NCT02291679|58920620|FG001|Overall Study|Other|4|||
30887710|NCT02291679|58920621|FG002|Overall Study|Other|2|||
30887711|NCT02291601|58920628|FG000|Abdomen|Did not qualify|333|||
30887712|NCT02291601|58920629|FG001|Abdomen|Did not qualify|54|||
30887713|NCT02291601|58920630|FG002|Abdomen|Did not qualify|339|||
30887714|NCT02291601|58920628|FG000|Groin|Did not qualify|183|||
30887715|NCT02291601|58920629|FG001|Groin|Did not qualify|30|||
30887716|NCT02291601|58920630|FG002|Groin|Did not qualify|177|||
30887717|NCT02360475|58920645|FG000|Overall Study|Lost to Follow-up|4|||
30887718|NCT02360475|58920646|FG001|Overall Study|Lost to Follow-up|12|||
30887719|NCT02360475|58920647|FG002|Overall Study|Lost to Follow-up|6|||
30887720|NCT02360475|58920648|FG003|Overall Study|Lost to Follow-up|4|||
30887721|NCT02360475|58920645|FG000|Overall Study|Withdrawal by Subject|0|||
30887722|NCT02360475|58920646|FG001|Overall Study|Withdrawal by Subject|1|||
30887723|NCT02360475|58920647|FG002|Overall Study|Withdrawal by Subject|2|||
30887724|NCT02360475|58920648|FG003|Overall Study|Withdrawal by Subject|0|||
30887725|NCT02360475|58920645|FG000|Overall Study|Migrated/moved from study area|0|||
30887726|NCT02360475|58920646|FG001|Overall Study|Migrated/moved from study area|0|||
30887727|NCT02360475|58920647|FG002|Overall Study|Migrated/moved from study area|0|||
30887728|NCT02360475|58920648|FG003|Overall Study|Migrated/moved from study area|1|||
30887729|NCT02360397|58920658|FG000|Overall Study|Incomplete screening|3|||
30887730|NCT02360397|58920658|FG000|Overall Study|Adverse Event|1|||
30887731|NCT02317809|58920663|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
30887732|NCT02317809|58920664|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
30887733|NCT02317809|58920663|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
30887734|NCT02317809|58920664|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
30887735|NCT02359851|58920673|FG000|Overall Study|Death|1|||
30887736|NCT02359851|58920673|FG000|Overall Study|Disease progression|1|||
30887737|NCT01607905|58920684|FG000|Overall Study|Withdrawal by participant|7|||
30887738|NCT01607905|58920685|FG001|Overall Study|Withdrawal by participant|2|||
30887739|NCT01607905|58920686|FG002|Overall Study|Withdrawal by participant|4|||
30887740|NCT01607905|58920687|FG003|Overall Study|Withdrawal by participant|6|||
30887741|NCT01607905|58920688|FG004|Overall Study|Withdrawal by participant|0|||
30887742|NCT01607905|58920689|FG005|Overall Study|Withdrawal by participant|4|||
30887743|NCT01607905|58920690|FG006|Overall Study|Withdrawal by participant|12|||
30887744|NCT01607905|58920684|FG000|Overall Study|Incidence or severity of AEs|5|||
30887745|NCT01607905|58920685|FG001|Overall Study|Incidence or severity of AEs|1|||
30887746|NCT01607905|58920686|FG002|Overall Study|Incidence or severity of AEs|1|||
30887747|NCT01607905|58920687|FG003|Overall Study|Incidence or severity of AEs|3|||
30887748|NCT01607905|58920688|FG004|Overall Study|Incidence or severity of AEs|0|||
30887749|NCT01607905|58920689|FG005|Overall Study|Incidence or severity of AEs|2|||
30887750|NCT01607905|58920690|FG006|Overall Study|Incidence or severity of AEs|8|||
30887751|NCT01607905|58920684|FG000|Overall Study|Disease progression|44|||
30887752|NCT01607905|58920685|FG001|Overall Study|Disease progression|16|||
30887753|NCT01607905|58920686|FG002|Overall Study|Disease progression|15|||
30887754|NCT01607905|58920687|FG003|Overall Study|Disease progression|11|||
30887755|NCT01607905|58920688|FG004|Overall Study|Disease progression|6|||
30887756|NCT01607905|58920689|FG005|Overall Study|Disease progression|7|||
30887757|NCT01607905|58920690|FG006|Overall Study|Disease progression|21|||
30887758|NCT01607905|58920684|FG000|Overall Study|Non-compliance with study procedures|0|||
30887759|NCT01607905|58920685|FG001|Overall Study|Non-compliance with study procedures|0|||
30887760|NCT01607905|58920686|FG002|Overall Study|Non-compliance with study procedures|0|||
30887761|NCT01607905|58920687|FG003|Overall Study|Non-compliance with study procedures|0|||
30887762|NCT01607905|58920688|FG004|Overall Study|Non-compliance with study procedures|0|||
30887763|NCT01607905|58920689|FG005|Overall Study|Non-compliance with study procedures|0|||
30887764|NCT01607905|58920690|FG006|Overall Study|Non-compliance with study procedures|1|||
30887765|NCT01607905|58920684|FG000|Overall Study|Death|1|||
30887766|NCT01607905|58920685|FG001|Overall Study|Death|1|||
30887767|NCT01607905|58920686|FG002|Overall Study|Death|1|||
30887768|NCT01607905|58920687|FG003|Overall Study|Death|1|||
30887769|NCT01607905|58920688|FG004|Overall Study|Death|0|||
30887770|NCT01607905|58920689|FG005|Overall Study|Death|0|||
30887771|NCT01607905|58920690|FG006|Overall Study|Death|3|||
30887772|NCT01607905|58920684|FG000|Overall Study|Other treatments become available|1|||
30887773|NCT01607905|58920685|FG001|Overall Study|Other treatments become available|0|||
30887774|NCT01607905|58920686|FG002|Overall Study|Other treatments become available|0|||
30887775|NCT01607905|58920687|FG003|Overall Study|Other treatments become available|0|||
30887776|NCT01607905|58920688|FG004|Overall Study|Other treatments become available|0|||
30887777|NCT01607905|58920689|FG005|Overall Study|Other treatments become available|0|||
30887778|NCT01607905|58920690|FG006|Overall Study|Other treatments become available|1|||
30887779|NCT01607905|58920684|FG000|Overall Study|Investigator discretion|0|||
30887780|NCT01607905|58920685|FG001|Overall Study|Investigator discretion|0|||
30887781|NCT01607905|58920686|FG002|Overall Study|Investigator discretion|0|||
30887782|NCT01607905|58920687|FG003|Overall Study|Investigator discretion|0|||
30887783|NCT01607905|58920688|FG004|Overall Study|Investigator discretion|0|||
30887784|NCT01607905|58920689|FG005|Overall Study|Investigator discretion|1|||
30887785|NCT01607905|58920690|FG006|Overall Study|Investigator discretion|0|||
30887786|NCT01607905|58920684|FG000|Overall Study|Other|1|||
30887787|NCT01607905|58920685|FG001|Overall Study|Other|0|||
30887788|NCT01607905|58920686|FG002|Overall Study|Other|0|||
30887789|NCT01607905|58920687|FG003|Overall Study|Other|0|||
30887790|NCT01607905|58920688|FG004|Overall Study|Other|0|||
30887791|NCT01607905|58920689|FG005|Overall Study|Other|0|||
30887792|NCT01607905|58920690|FG006|Overall Study|Other|1|||
30887793|NCT01607905|58920684|FG000|Overall Study|Randomized but not treated|1|||
30887794|NCT01607905|58920685|FG001|Overall Study|Randomized but not treated|0|||
30887795|NCT01607905|58920686|FG002|Overall Study|Randomized but not treated|0|||
30887796|NCT01607905|58920687|FG003|Overall Study|Randomized but not treated|0|||
30887797|NCT01607905|58920688|FG004|Overall Study|Randomized but not treated|1|||
30887798|NCT01607905|58920689|FG005|Overall Study|Randomized but not treated|1|||
30887799|NCT01607905|58920690|FG006|Overall Study|Randomized but not treated|0|||
30887800|NCT02536963|58920748|FG000|Overall Study|Withdrawal by Subject|18|||
30887801|NCT02531035|58920754|FG000|Overall Study|Death|0|||
30887802|NCT02531035|58920755|FG001|Overall Study|Death|1|||
30887803|NCT02531035|58920754|FG000|Overall Study|Protocol Violation|1|||
30887804|NCT02531035|58920755|FG001|Overall Study|Protocol Violation|1|||
30887805|NCT02531035|58920754|FG000|Overall Study|Noncompliance with study drug|8|||
30887806|NCT02531035|58920755|FG001|Overall Study|Noncompliance with study drug|3|||
30887807|NCT02531035|58920754|FG000|Overall Study|Physician Decision|1|||
30887808|NCT02531035|58920755|FG001|Overall Study|Physician Decision|0|||
30887809|NCT02531035|58920754|FG000|Overall Study|Adverse Event|16|||
30887810|NCT02531035|58920755|FG001|Overall Study|Adverse Event|45|||
30887811|NCT02531035|58920754|FG000|Overall Study|Other|3|||
30887812|NCT02531035|58920755|FG001|Overall Study|Other|2|||
30887813|NCT02531035|58920754|FG000|Overall Study|Withdrawal by Subject|42|||
30887814|NCT02531035|58920755|FG001|Overall Study|Withdrawal by Subject|32|||
30887815|NCT02531035|58920754|FG000|Overall Study|Lost to Follow-up|8|||
30887816|NCT02531035|58920755|FG001|Overall Study|Lost to Follow-up|10|||
30887817|NCT02531035|58920754|FG000|Overall Study|Randomized, not treated|2|||
30887818|NCT02531035|58920755|FG001|Overall Study|Randomized, not treated|1|||
30887819|NCT01659853|58920771|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
30887820|NCT01659853|58920772|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
30887821|NCT01659853|58920771|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
30887822|NCT01659853|58920772|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
30887823|NCT01660243|58920784|FG000|Overall Study|Adverse Event|1|||
30887824|NCT01660243|58920785|FG001|Overall Study|Adverse Event|0|||
30887825|NCT01660243|58920786|FG002|Overall Study|Adverse Event|1|||
30887826|NCT01660243|58920787|FG003|Overall Study|Adverse Event|0|||
30887827|NCT01660243|58920784|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
30887828|NCT01660243|58920785|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
30887829|NCT01660243|58920786|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
30887830|NCT01660243|58920787|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
30887831|NCT01660243|58920784|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
30948434|NCT01709084|58994335|FG000|Overall Study|Adverse Event|5|||
30887832|NCT01660243|58920785|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
30887833|NCT01660243|58920786|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
30887834|NCT01660243|58920787|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
30887835|NCT01660243|58920784|FG000|Overall Study|Randomization error|0|||
30887836|NCT01660243|58920785|FG001|Overall Study|Randomization error|0|||
30887837|NCT01660243|58920786|FG002|Overall Study|Randomization error|0|||
30887838|NCT01660243|58920787|FG003|Overall Study|Randomization error|1|||
30887839|NCT02531113|58920797|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
30887840|NCT02531113|58920797|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
30887841|NCT02531113|58920797|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
30887842|NCT02531113|58920797|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
30887843|NCT02531113|58920797|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
30887844|NCT02531113|58920797|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
30887845|NCT02531113|58920797|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
30887846|NCT02531113|58920797|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
30887847|NCT02522767|58920807|FG000|Double-blind|Withdrawal by Subject|8|||
30887848|NCT02522767|58920808|FG001|Double-blind|Withdrawal by Subject|11|||
30887849|NCT02522767|58920807|FG000|Double-blind|Lost to Follow-up|1|||
30887850|NCT02522767|58920808|FG001|Double-blind|Lost to Follow-up|0|||
30887851|NCT02522767|58920807|FG000|Double-blind|Adverse Event|1|||
30887852|NCT02522767|58920808|FG001|Double-blind|Adverse Event|10|||
30887853|NCT02522767|58920807|FG000|Double-blind|Protocol Violation|0|||
30887854|NCT02522767|58920808|FG001|Double-blind|Protocol Violation|1|||
30887855|NCT02522767|58920807|FG000|Double-blind|Lack of Efficacy|0|||
30887856|NCT02522767|58920808|FG001|Double-blind|Lack of Efficacy|2|||
30887857|NCT02522767|58920807|FG000|Double-blind|Protocol Deviation|1|||
30887858|NCT02522767|58920808|FG001|Double-blind|Protocol Deviation|0|||
30887859|NCT02522767|58920807|FG000|Open-label|Withdrawal by Subject|2|||
30887860|NCT02522767|58920808|FG001|Open-label|Withdrawal by Subject|3|||
30887861|NCT02522767|58920807|FG000|Open-label|Lost to Follow-up|0|||
30887862|NCT02522767|58920808|FG001|Open-label|Lost to Follow-up|1|||
30887863|NCT02522767|58920807|FG000|Open-label|Adverse Event|2|||
30887864|NCT02522767|58920808|FG001|Open-label|Adverse Event|1|||
30887865|NCT02522767|58920807|FG000|Open-label|Lack of Efficacy|1|||
30887866|NCT02522767|58920808|FG001|Open-label|Lack of Efficacy|1|||
30887867|NCT02522767|58920807|FG000|Open-label|Protocol Violation|0|||
30887868|NCT02522767|58920808|FG001|Open-label|Protocol Violation|1|||
30887869|NCT02522377|58920818|FG000|Overall Study|Withdrawal by Subject|1|||
30887870|NCT02522377|58920819|FG001|Overall Study|Withdrawal by Subject|0|||
30887871|NCT02522377|58920818|FG000|Overall Study|Remission Achieved|3|||
30887872|NCT02522377|58920819|FG001|Overall Study|Remission Achieved|0|||
30887873|NCT01657903|58920825|FG000|Overall Study|Lost to Follow-up|1|||
30887874|NCT01657903|58920825|FG000|Overall Study|Withdrawal by Subject|1|||
30887875|NCT01656733|58920838|FG000|Overall Study|No permission to collect birth outcomes|0|||
30887876|NCT01656733|58920839|FG001|Overall Study|No permission to collect birth outcomes|1|||
30887877|NCT01656733|58920838|FG000|Overall Study|Delivery at another hospital|0|||
30887878|NCT01656733|58920839|FG001|Overall Study|Delivery at another hospital|2|||
30887879|NCT01656733|58920838|FG000|Overall Study|Spontaneous abortion|0|||
30887880|NCT01656733|58920839|FG001|Overall Study|Spontaneous abortion|1|||
30887881|NCT01656967|58920847|FG000|Overall Study|faulty monitor|1|||
30887882|NCT01656967|58920848|FG001|Overall Study|faulty monitor|0|||
30887883|NCT01656967|58920847|FG000|Overall Study|unsuccessful ETT insertion|3|||
30887884|NCT01656967|58920848|FG001|Overall Study|unsuccessful ETT insertion|2|||
30887885|NCT01656889|58920860|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
30887886|NCT01656889|58920861|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
30887887|NCT01656889|58920860|FG000|Treatment Period, 12 Weeks|Death|0|||
30887888|NCT01656889|58920861|FG001|Treatment Period, 12 Weeks|Death|1|||
30887889|NCT01656889|58920860|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
30887890|NCT01656889|58920861|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
30887891|NCT01656889|58920860|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
30887892|NCT01656889|58920861|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
30887893|NCT01656889|58920860|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
30887894|NCT01656889|58920861|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
30887895|NCT01656889|58920860|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
30887896|NCT01656889|58920861|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
30887897|NCT01656889|58920860|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
30887898|NCT01656889|58920861|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
30887899|NCT01656889|58920860|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
30887900|NCT01656889|58920861|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
30887901|NCT01656889|58920860|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
30887902|NCT01656889|58920861|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
30887903|NCT01656889|58920860|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
30948435|NCT01709084|58994336|FG001|Overall Study|Adverse Event|0|||
30887904|NCT01656889|58920861|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
30887905|NCT02522299|58920869|FG000|Overall Study|Adverse Event|2|||
30887906|NCT02522299|58920870|FG001|Overall Study|Adverse Event|0|||
30887907|NCT02522299|58920869|FG000|Overall Study|Physician Decision|0|||
30887908|NCT02522299|58920870|FG001|Overall Study|Physician Decision|1|||
30887909|NCT02522299|58920869|FG000|Overall Study|Withdrawal by Subject|2|||
30887910|NCT02522299|58920870|FG001|Overall Study|Withdrawal by Subject|0|||
30887911|NCT01365091|58920894|FG000|Period 1|Adverse Event|1|||
30887912|NCT01365091|58920895|FG001|Period 1|Adverse Event|0|||
30887913|NCT01365091|58920896|FG002|Period 1|Adverse Event|2|||
30887914|NCT01365091|58920897|FG003|Period 1|Adverse Event|3|||
30887915|NCT01365091|58920894|FG000|Period 1|Positive test result for drugs of abuse|1|||
30887916|NCT01365091|58920895|FG001|Period 1|Positive test result for drugs of abuse|0|||
30887917|NCT01365091|58920896|FG002|Period 1|Positive test result for drugs of abuse|0|||
30887918|NCT01365091|58920897|FG003|Period 1|Positive test result for drugs of abuse|0|||
30887919|NCT01365091|58920894|FG000|Period 1|No longer met study criteria|0|||
30887920|NCT01365091|58920895|FG001|Period 1|No longer met study criteria|1|||
30887921|NCT01365091|58920896|FG002|Period 1|No longer met study criteria|0|||
30887922|NCT01365091|58920897|FG003|Period 1|No longer met study criteria|0|||
30887923|NCT01365091|58920894|FG000|Period 1|Withdrawal by Subject|0|||
30887924|NCT01365091|58920895|FG001|Period 1|Withdrawal by Subject|1|||
30887925|NCT01365091|58920896|FG002|Period 1|Withdrawal by Subject|0|||
30887926|NCT01365091|58920897|FG003|Period 1|Withdrawal by Subject|0|||
30887927|NCT01365091|58920894|FG000|Period 1|Personal reasons|0|||
30887928|NCT01365091|58920895|FG001|Period 1|Personal reasons|0|||
30887929|NCT01365091|58920896|FG002|Period 1|Personal reasons|1|||
30887930|NCT01365091|58920897|FG003|Period 1|Personal reasons|0|||
30887931|NCT01365091|58920894|FG000|Period 2|Withdrawal by Subject|1|||
30887932|NCT01365091|58920895|FG001|Period 2|Withdrawal by Subject|0|||
30887933|NCT01365091|58920896|FG002|Period 2|Withdrawal by Subject|0|||
30887934|NCT01365091|58920897|FG003|Period 2|Withdrawal by Subject|0|||
30887935|NCT01365091|58920894|FG000|Period 2|Adverse Event|0|||
30887936|NCT01365091|58920895|FG001|Period 2|Adverse Event|0|||
30887937|NCT01365091|58920896|FG002|Period 2|Adverse Event|1|||
30887938|NCT01365091|58920897|FG003|Period 2|Adverse Event|0|||
30887939|NCT01364467|58920923|FG000|Overall Study|Lost to Follow-up|1|||
30887940|NCT01364467|58920924|FG001|Overall Study|Lost to Follow-up|2|||
30887941|NCT02520661|58920932|FG000|Overall Study|Lost to Follow-up|7|||
30887942|NCT02520661|58920933|FG001|Overall Study|Lost to Follow-up|3|||
30887943|NCT02520661|58920932|FG000|Overall Study|Admitted from ED|49|||
30887944|NCT02520661|58920933|FG001|Overall Study|Admitted from ED|48|||
30887945|NCT02520661|58920932|FG000|Overall Study|ED greater than 24 hours|29|||
30887946|NCT02520661|58920933|FG001|Overall Study|ED greater than 24 hours|38|||
30887947|NCT02520661|58920932|FG000|Overall Study|other ineligibility|14|||
30887948|NCT02520661|58920933|FG001|Overall Study|other ineligibility|22|||
30887949|NCT02520661|58920932|FG000|Overall Study|Withdrawal by Subject|7|||
30887950|NCT02520661|58920933|FG001|Overall Study|Withdrawal by Subject|16|||
30887951|NCT01364389|58920946|FG000|Overall Study|Withdrawal by Subject|0|||
30887952|NCT01364389|58920947|FG001|Overall Study|Withdrawal by Subject|1|||
30887953|NCT01364389|58920948|FG002|Overall Study|Withdrawal by Subject|0|||
30887954|NCT01364389|58920946|FG000|Overall Study|Protocol deviation|0|||
30887955|NCT01364389|58920947|FG001|Overall Study|Protocol deviation|0|||
30887956|NCT01364389|58920948|FG002|Overall Study|Protocol deviation|1|||
30887957|NCT01364389|58920946|FG000|Overall Study|Administrative problems|1|||
30887958|NCT01364389|58920947|FG001|Overall Study|Administrative problems|0|||
30887959|NCT01364389|58920948|FG002|Overall Study|Administrative problems|0|||
30887960|NCT01364389|58920946|FG000|Overall Study|Adverse Event|1|||
30887961|NCT01364389|58920947|FG001|Overall Study|Adverse Event|0|||
30887962|NCT01364389|58920948|FG002|Overall Study|Adverse Event|0|||
30887963|NCT01364233|58920956|FG000|Overall Study|Lost to Follow-up|1|||
30887964|NCT02291289|58920964|FG000|Induction Treatment|Not Dosed|2|||
30887965|NCT02291289|58920965|FG001|Induction Treatment|Not Dosed|0|||
30887966|NCT02291289|58920966|FG002|Induction Treatment|Not Dosed|0|||
30887967|NCT02291289|58920967|FG003|Induction Treatment|Not Dosed|9|||
30887968|NCT02291289|58920968|FG004|Induction Treatment|Not Dosed|0|||
30887969|NCT02291289|58920969|FG005|Induction Treatment|Not Dosed|0|||
30976212|NCT01665768|59063009|FG000|Overall Study|Withdrawal by Subject|1|||
30976213|NCT02584452|59063217|FG000|Overall Study|Physician Decision|1|||
30887970|NCT02291289|58920970|FG006|Induction Treatment|Not Dosed|0|||
30976214|NCT02584452|59063218|FG001|Overall Study|Physician Decision|1|||
30976215|NCT02584452|59063217|FG000|Overall Study|Lost to Follow-up|1|||
30887971|NCT02291289|58920971|FG007|Induction Treatment|Not Dosed|0|||
30887972|NCT02291289|58920972|FG008|Induction Treatment|Not Dosed|0|||
30887973|NCT02291289|58920973|FG009|Induction Treatment|Not Dosed|1|||
30887974|NCT02291289|58920974|FG010|Induction Treatment|Not Dosed|0|||
30887975|NCT02291289|58920975|FG011|Induction Treatment|Not Dosed|0|||
30887976|NCT02291289|58920964|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
30976216|NCT02584452|59063218|FG001|Overall Study|Lost to Follow-up|1|||
30887977|NCT02291289|58920965|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
30976217|NCT02586012|59063265|FG000|Overall Study|Withdrawal by Subject|1|||
30887978|NCT02291289|58920966|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
30887979|NCT02291289|58920967|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
30887980|NCT02291289|58920968|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13|||
30887981|NCT02291289|58920969|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11|||
30887982|NCT02291289|58920970|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
30887983|NCT02291289|58920971|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
30887984|NCT02291289|58920972|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
30887985|NCT02291289|58920973|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
30887986|NCT02291289|58920974|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
30887987|NCT02291289|58920975|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
30887988|NCT02291289|58920964|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
30887989|NCT02291289|58920965|FG001|Maintenance Treatment Phase|Protocol Violation|1|||
30887990|NCT02291289|58920966|FG002|Maintenance Treatment Phase|Protocol Violation|0|||
30887991|NCT02291289|58920967|FG003|Maintenance Treatment Phase|Protocol Violation|0|||
30887992|NCT02291289|58920968|FG004|Maintenance Treatment Phase|Protocol Violation|2|||
30887993|NCT02291289|58920969|FG005|Maintenance Treatment Phase|Protocol Violation|1|||
30887994|NCT02291289|58920970|FG006|Maintenance Treatment Phase|Protocol Violation|0|||
30887995|NCT02291289|58920971|FG007|Maintenance Treatment Phase|Protocol Violation|0|||
30887996|NCT02291289|58920972|FG008|Maintenance Treatment Phase|Protocol Violation|0|||
30887997|NCT02291289|58920973|FG009|Maintenance Treatment Phase|Protocol Violation|0|||
30887998|NCT02291289|58920974|FG010|Maintenance Treatment Phase|Protocol Violation|0|||
30887999|NCT02291289|58920975|FG011|Maintenance Treatment Phase|Protocol Violation|0|||
30888000|NCT02291289|58920964|FG000|Maintenance Treatment Phase|Death|0|||
30888001|NCT02291289|58920965|FG001|Maintenance Treatment Phase|Death|23|||
30888002|NCT02291289|58920966|FG002|Maintenance Treatment Phase|Death|13|||
30888003|NCT02291289|58920967|FG003|Maintenance Treatment Phase|Death|0|||
30888004|NCT02291289|58920968|FG004|Maintenance Treatment Phase|Death|185|||
30888005|NCT02291289|58920969|FG005|Maintenance Treatment Phase|Death|100|||
30888006|NCT02291289|58920970|FG006|Maintenance Treatment Phase|Death|0|||
30888007|NCT02291289|58920971|FG007|Maintenance Treatment Phase|Death|1|||
30888008|NCT02291289|58920972|FG008|Maintenance Treatment Phase|Death|1|||
30888009|NCT02291289|58920973|FG009|Maintenance Treatment Phase|Death|0|||
30888010|NCT02291289|58920974|FG010|Maintenance Treatment Phase|Death|26|||
30888011|NCT02291289|58920975|FG011|Maintenance Treatment Phase|Death|11|||
30888012|NCT02291289|58920964|FG000|Maintenance Treatment Phase|Adverse Event|0|||
30888013|NCT02291289|58920965|FG001|Maintenance Treatment Phase|Adverse Event|0|||
30888014|NCT02291289|58920966|FG002|Maintenance Treatment Phase|Adverse Event|0|||
30888015|NCT02291289|58920967|FG003|Maintenance Treatment Phase|Adverse Event|0|||
30888016|NCT02291289|58920968|FG004|Maintenance Treatment Phase|Adverse Event|1|||
30888017|NCT02291289|58920969|FG005|Maintenance Treatment Phase|Adverse Event|0|||
30888018|NCT02291289|58920970|FG006|Maintenance Treatment Phase|Adverse Event|0|||
30888019|NCT02291289|58920971|FG007|Maintenance Treatment Phase|Adverse Event|0|||
30888020|NCT02291289|58920972|FG008|Maintenance Treatment Phase|Adverse Event|0|||
30888021|NCT02291289|58920973|FG009|Maintenance Treatment Phase|Adverse Event|0|||
30888022|NCT02291289|58920974|FG010|Maintenance Treatment Phase|Adverse Event|0|||
30888023|NCT02291289|58920975|FG011|Maintenance Treatment Phase|Adverse Event|0|||
30888024|NCT02291289|58920964|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
30888025|NCT02291289|58920965|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
30888026|NCT02291289|58920966|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
30888027|NCT02291289|58920967|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
30888028|NCT02291289|58920968|FG004|Maintenance Treatment Phase|Lost to Follow-up|12|||
30888029|NCT02291289|58920969|FG005|Maintenance Treatment Phase|Lost to Follow-up|3|||
30888030|NCT02291289|58920970|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
30888031|NCT02291289|58920971|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
30888032|NCT02291289|58920972|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
30888033|NCT02291289|58920973|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
30888034|NCT02291289|58920974|FG010|Maintenance Treatment Phase|Lost to Follow-up|2|||
30888035|NCT02291289|58920975|FG011|Maintenance Treatment Phase|Lost to Follow-up|1|||
30888036|NCT02291289|58920964|FG000|Maintenance Treatment Phase|Other|0|||
30976218|NCT02586012|59063266|FG001|Overall Study|Withdrawal by Subject|1|||
30976219|NCT02586012|59063267|FG002|Overall Study|Withdrawal by Subject|0|||
30888037|NCT02291289|58920965|FG001|Maintenance Treatment Phase|Other|0|||
30888038|NCT02291289|58920966|FG002|Maintenance Treatment Phase|Other|1|||
30976220|NCT02586012|59063268|FG003|Overall Study|Withdrawal by Subject|1|||
30976221|NCT02586012|59063269|FG004|Overall Study|Withdrawal by Subject|0|||
30976222|NCT02586012|59063270|FG005|Overall Study|Withdrawal by Subject|2|||
30976223|NCT02586012|59063265|FG000|Overall Study|Protocol Violation|0|||
30976224|NCT02586012|59063266|FG001|Overall Study|Protocol Violation|0|||
30976225|NCT02586012|59063267|FG002|Overall Study|Protocol Violation|0|||
30888039|NCT02291289|58920967|FG003|Maintenance Treatment Phase|Other|0|||
30888040|NCT02291289|58920968|FG004|Maintenance Treatment Phase|Other|29|||
30888041|NCT02291289|58920969|FG005|Maintenance Treatment Phase|Other|8|||
30976226|NCT02586012|59063268|FG003|Overall Study|Protocol Violation|0|||
30976227|NCT02586012|59063269|FG004|Overall Study|Protocol Violation|0|||
30976228|NCT02586012|59063270|FG005|Overall Study|Protocol Violation|1|||
30976229|NCT02586012|59063265|FG000|Overall Study|study terminated|0|||
30976230|NCT02586012|59063266|FG001|Overall Study|study terminated|2|||
30976231|NCT02586012|59063267|FG002|Overall Study|study terminated|1|||
30976232|NCT02586012|59063268|FG003|Overall Study|study terminated|1|||
30976233|NCT02586012|59063269|FG004|Overall Study|study terminated|1|||
30976234|NCT02586012|59063270|FG005|Overall Study|study terminated|0|||
30976235|NCT02582814|59063281|FG000|Overall Study|Study-specific withdrawal criteria|1|||
30976236|NCT02582814|59063282|FG001|Overall Study|Study-specific withdrawal criteria|0|||
30976237|NCT02582814|59063281|FG000|Overall Study|Withdrawal by Subject|4|||
30976238|NCT02582814|59063282|FG001|Overall Study|Withdrawal by Subject|3|||
30976239|NCT02582814|59063281|FG000|Overall Study|Adverse Event|4|||
30976240|NCT02582814|59063282|FG001|Overall Study|Adverse Event|4|||
30976241|NCT02585934|59063430|FG000|Overall Study|Lost to Follow-up|2|||
30976242|NCT02585934|59063431|FG001|Overall Study|Lost to Follow-up|2|||
30976243|NCT02585934|59063430|FG000|Overall Study|Protocol Violation|14|||
30976244|NCT02585934|59063431|FG001|Overall Study|Protocol Violation|11|||
30976245|NCT02585934|59063430|FG000|Overall Study|Adverse Event|21|||
30976246|NCT02585934|59063431|FG001|Overall Study|Adverse Event|22|||
30976247|NCT02585934|59063430|FG000|Overall Study|Physician Decision|3|||
30976248|NCT02585934|59063431|FG001|Overall Study|Physician Decision|2|||
30888042|NCT02291289|58920970|FG006|Maintenance Treatment Phase|Other|0|||
30888043|NCT02291289|58920971|FG007|Maintenance Treatment Phase|Other|0|||
30888044|NCT02291289|58920972|FG008|Maintenance Treatment Phase|Other|1|||
30888045|NCT02291289|58920973|FG009|Maintenance Treatment Phase|Other|0|||
30888046|NCT02291289|58920974|FG010|Maintenance Treatment Phase|Other|0|||
30888047|NCT02291289|58920975|FG011|Maintenance Treatment Phase|Other|0|||
30888048|NCT02291289|58920964|FG000|Maintenance Treatment Phase|Physician Decision|0|||
30888049|NCT02291289|58920965|FG001|Maintenance Treatment Phase|Physician Decision|0|||
30888050|NCT02291289|58920966|FG002|Maintenance Treatment Phase|Physician Decision|0|||
30888051|NCT02291289|58920967|FG003|Maintenance Treatment Phase|Physician Decision|0|||
30888052|NCT02291289|58920968|FG004|Maintenance Treatment Phase|Physician Decision|2|||
30888053|NCT02291289|58920969|FG005|Maintenance Treatment Phase|Physician Decision|0|||
30888054|NCT02291289|58920970|FG006|Maintenance Treatment Phase|Physician Decision|0|||
30888055|NCT02291289|58920971|FG007|Maintenance Treatment Phase|Physician Decision|0|||
30888056|NCT02291289|58920972|FG008|Maintenance Treatment Phase|Physician Decision|0|||
30888057|NCT02291289|58920973|FG009|Maintenance Treatment Phase|Physician Decision|0|||
30888058|NCT02291289|58920974|FG010|Maintenance Treatment Phase|Physician Decision|0|||
30888059|NCT02291289|58920975|FG011|Maintenance Treatment Phase|Physician Decision|1|||
30888060|NCT02291289|58920964|FG000|Maintenance Treatment Phase|Multiple Reasons|0|||
30888061|NCT02291289|58920965|FG001|Maintenance Treatment Phase|Multiple Reasons|0|||
30888062|NCT02291289|58920966|FG002|Maintenance Treatment Phase|Multiple Reasons|0|||
30888063|NCT02291289|58920967|FG003|Maintenance Treatment Phase|Multiple Reasons|0|||
30888064|NCT02291289|58920968|FG004|Maintenance Treatment Phase|Multiple Reasons|4|||
30888065|NCT02291289|58920969|FG005|Maintenance Treatment Phase|Multiple Reasons|1|||
30888066|NCT02291289|58920970|FG006|Maintenance Treatment Phase|Multiple Reasons|0|||
30888067|NCT02291289|58920971|FG007|Maintenance Treatment Phase|Multiple Reasons|0|||
30888068|NCT02291289|58920972|FG008|Maintenance Treatment Phase|Multiple Reasons|0|||
30888069|NCT02291289|58920973|FG009|Maintenance Treatment Phase|Multiple Reasons|0|||
30888070|NCT02291289|58920974|FG010|Maintenance Treatment Phase|Multiple Reasons|0|||
30888071|NCT02291289|58920975|FG011|Maintenance Treatment Phase|Multiple Reasons|0|||
30888072|NCT02291289|58920964|FG000|Maintenance Treatment Phase|No Treatment Received|0|||
30888073|NCT02291289|58920965|FG001|Maintenance Treatment Phase|No Treatment Received|0|||
30888074|NCT02291289|58920966|FG002|Maintenance Treatment Phase|No Treatment Received|2|||
30888075|NCT02291289|58920967|FG003|Maintenance Treatment Phase|No Treatment Received|0|||
30888076|NCT02291289|58920968|FG004|Maintenance Treatment Phase|No Treatment Received|4|||
30888077|NCT02291289|58920969|FG005|Maintenance Treatment Phase|No Treatment Received|5|||
30888078|NCT02291289|58920970|FG006|Maintenance Treatment Phase|No Treatment Received|0|||
30888079|NCT02291289|58920971|FG007|Maintenance Treatment Phase|No Treatment Received|0|||
30888080|NCT02291289|58920972|FG008|Maintenance Treatment Phase|No Treatment Received|0|||
30888081|NCT02291289|58920973|FG009|Maintenance Treatment Phase|No Treatment Received|0|||
30888082|NCT02291289|58920974|FG010|Maintenance Treatment Phase|No Treatment Received|1|||
30888083|NCT02291289|58920975|FG011|Maintenance Treatment Phase|No Treatment Received|0|||
30888084|NCT02317575|58921000|FG000|Period 1|Difficulty with venous cannulation|0|||
30888085|NCT02317575|58921001|FG001|Period 1|Difficulty with venous cannulation|1|||
30888086|NCT02317575|58921002|FG002|Period 1|Difficulty with venous cannulation|0|||
30888087|NCT02317575|58921003|FG003|Period 1|Difficulty with venous cannulation|0|||
30976249|NCT02585934|59063430|FG000|Overall Study|Withdrawal by Subject|7|||
30976250|NCT02585934|59063431|FG001|Overall Study|Withdrawal by Subject|21|||
30976251|NCT02585934|59063430|FG000|Overall Study|Lack of Efficacy|2|||
30976252|NCT02585934|59063431|FG001|Overall Study|Lack of Efficacy|1|||
30976253|NCT02585934|59063430|FG000|Overall Study|Death|2|||
30976254|NCT02585934|59063431|FG001|Overall Study|Death|0|||
30976255|NCT02585934|59063430|FG000|Overall Study|Caregiver Withdrew Consent|7|||
30888088|NCT02317575|58921004|FG004|Period 1|Difficulty with venous cannulation|0|||
30888089|NCT02317575|58921000|FG000|Period 1|Withdrawal by Subject|1|||
30888090|NCT02317575|58921001|FG001|Period 1|Withdrawal by Subject|0|||
30888091|NCT02317575|58921002|FG002|Period 1|Withdrawal by Subject|0|||
30888092|NCT02317575|58921003|FG003|Period 1|Withdrawal by Subject|0|||
30888093|NCT02317575|58921004|FG004|Period 1|Withdrawal by Subject|0|||
30888094|NCT02316717|58921025|FG000|Overall Study|Adverse Event|2|||
30888095|NCT02316717|58921026|FG001|Overall Study|Adverse Event|2|||
30888096|NCT02316717|58921027|FG002|Overall Study|Adverse Event|0|||
30888097|NCT02316717|58921025|FG000|Overall Study|Lost to Follow-up|1|||
30888098|NCT02316717|58921026|FG001|Overall Study|Lost to Follow-up|2|||
30888099|NCT02316717|58921027|FG002|Overall Study|Lost to Follow-up|1|||
30888100|NCT02316717|58921025|FG000|Overall Study|Non compliance|3|||
30888101|NCT02316717|58921026|FG001|Overall Study|Non compliance|1|||
30888102|NCT02316717|58921027|FG002|Overall Study|Non compliance|0|||
30888103|NCT02316717|58921025|FG000|Overall Study|Protocol Violation|2|||
30888104|NCT02316717|58921026|FG001|Overall Study|Protocol Violation|0|||
30888105|NCT02316717|58921027|FG002|Overall Study|Protocol Violation|0|||
30888106|NCT02316717|58921025|FG000|Overall Study|Withdrawal by Subject|2|||
30888107|NCT02316717|58921026|FG001|Overall Study|Withdrawal by Subject|1|||
30888108|NCT02316717|58921027|FG002|Overall Study|Withdrawal by Subject|1|||
30888109|NCT02316717|58921025|FG000|Overall Study|Death|0|||
30888110|NCT02316717|58921026|FG001|Overall Study|Death|0|||
30888111|NCT02316717|58921027|FG002|Overall Study|Death|1|||
30888112|NCT02316717|58921025|FG000|Overall Study|Physician Decision|0|||
30888113|NCT02316717|58921026|FG001|Overall Study|Physician Decision|1|||
30888114|NCT02316717|58921027|FG002|Overall Study|Physician Decision|0|||
30888115|NCT02316717|58921025|FG000|Overall Study|TBC|1|||
30888116|NCT02316717|58921026|FG001|Overall Study|TBC|0|||
30888117|NCT02316717|58921027|FG002|Overall Study|TBC|0|||
30888118|NCT02290821|58921040|FG000|Overall Study|Withdrawal by Subject|1|||
30888119|NCT02290821|58921041|FG001|Overall Study|Withdrawal by Subject|1|||
30888120|NCT02290821|58921040|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
30888121|NCT02290821|58921041|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
30888122|NCT02290821|58921040|FG000|Overall Study|Lost to Follow-up|3|||
30888123|NCT02290821|58921041|FG001|Overall Study|Lost to Follow-up|2|||
30888124|NCT02289963|58921049|FG000|Overall Study|Adverse Event|1|||
30888125|NCT02289963|58921050|FG001|Overall Study|Adverse Event|2|||
30888126|NCT02289963|58921049|FG000|Overall Study|Poor compliance to protocol|1|||
30888127|NCT02289963|58921050|FG001|Overall Study|Poor compliance to protocol|0|||
30888128|NCT02289963|58921049|FG000|Overall Study|Withdrawal by Subject|1|||
30888129|NCT02289963|58921050|FG001|Overall Study|Withdrawal by Subject|0|||
30888130|NCT02289963|58921049|FG000|Overall Study|Last injection missed|2|||
30888131|NCT02289963|58921050|FG001|Overall Study|Last injection missed|2|||
30888132|NCT02289963|58921049|FG000|Overall Study|End treatment visit outside visit window|0|||
30888133|NCT02289963|58921050|FG001|Overall Study|End treatment visit outside visit window|4|||
30888134|NCT02289963|58921049|FG000|Overall Study|Other than specified above|0|||
30888135|NCT02289963|58921050|FG001|Overall Study|Other than specified above|2|||
30888136|NCT02358369|58921059|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
30888137|NCT02358369|58921060|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
30888138|NCT02358369|58921061|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
30888139|NCT02358369|58921062|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
30888140|NCT02358369|58921063|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
30888141|NCT02358369|58921059|FG000|Treatment Period A/B|Adverse Event|0|||
30888142|NCT02358369|58921060|FG001|Treatment Period A/B|Adverse Event|0|||
30888143|NCT02358369|58921061|FG002|Treatment Period A/B|Adverse Event|1|||
30888144|NCT02358369|58921062|FG003|Treatment Period A/B|Adverse Event|2|||
30888145|NCT02358369|58921063|FG004|Treatment Period A/B|Adverse Event|0|||
30888146|NCT02358369|58921059|FG000|Treatment Period A/B|Death|0|||
30888147|NCT02358369|58921060|FG001|Treatment Period A/B|Death|0|||
30888148|NCT02358369|58921061|FG002|Treatment Period A/B|Death|1|||
30888149|NCT02358369|58921062|FG003|Treatment Period A/B|Death|0|||
30888150|NCT02358369|58921063|FG004|Treatment Period A/B|Death|0|||
30888151|NCT02358369|58921059|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
30888152|NCT02358369|58921060|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
30888153|NCT02358369|58921061|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
30888154|NCT02358369|58921062|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
30888155|NCT02358369|58921063|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
30888156|NCT02358369|58921059|FG000|Treatment Period C|Adverse Event|0|||
30888157|NCT02358369|58921060|FG001|Treatment Period C|Adverse Event|0|||
30888158|NCT02358369|58921061|FG002|Treatment Period C|Adverse Event|0|||
30888159|NCT02358369|58921062|FG003|Treatment Period C|Adverse Event|0|||
30888160|NCT02358369|58921063|FG004|Treatment Period C|Adverse Event|7|||
30888161|NCT02316171|58921075|FG000|Overall Study|difficulties with urinary catheter|1|||
30888162|NCT02316171|58921076|FG001|Overall Study|difficulties with urinary catheter|0|||
30888163|NCT02316171|58921077|FG002|Overall Study|difficulties with urinary catheter|0|||
30888164|NCT02316171|58921078|FG003|Overall Study|difficulties with urinary catheter|0|||
30888165|NCT02289729|58921084|FG000|Overall Study|Lack of Efficacy|3|||
30888166|NCT02289729|58921084|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
30888167|NCT02289729|58921084|FG000|Overall Study|Withdrawal by Subject|1|||
30888168|NCT02289729|58921084|FG000|Overall Study|Death|1|||
30888169|NCT02315625|58921090|FG000|First Intervention|Disease Progression|1|||
30888170|NCT02315625|58921091|FG001|First Intervention|Disease Progression|0|||
30888171|NCT02315625|58921090|FG000|Second Intervention|Physician Decision|2|||
30888172|NCT02315625|58921091|FG001|Second Intervention|Physician Decision|1|||
30888173|NCT02315625|58921090|FG000|Second Intervention|Study closure|1|||
30888174|NCT02315625|58921091|FG001|Second Intervention|Study closure|0|||
30888175|NCT02315625|58921090|FG000|Second Intervention|Disease Progression|1|||
30888176|NCT02315625|58921091|FG001|Second Intervention|Disease Progression|0|||
30888177|NCT02357979|58921101|FG000|Overall Study|Lost to Follow-up|5|||
30888178|NCT02357979|58921102|FG001|Overall Study|Lost to Follow-up|5|||
30888179|NCT02357901|58921111|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
30888180|NCT02357901|58921112|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
30888181|NCT02357901|58921113|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
30888182|NCT02357901|58921114|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
30888183|NCT02357901|58921111|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
30888184|NCT02357901|58921112|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
30888185|NCT02357901|58921113|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
30888186|NCT02357901|58921114|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
30888187|NCT02357901|58921111|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
30888188|NCT02357901|58921112|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
30888189|NCT02357901|58921113|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
30888190|NCT02357901|58921114|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
30888191|NCT02357901|58921111|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
30888192|NCT02357901|58921112|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
30888193|NCT02357901|58921113|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
30888194|NCT02357901|58921114|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
30888195|NCT02357901|58921111|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
30888196|NCT02357901|58921112|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
30888197|NCT02357901|58921113|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
30888198|NCT02357901|58921114|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
30888199|NCT02357901|58921111|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
30888200|NCT02357901|58921112|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
30888201|NCT02357901|58921113|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
30888202|NCT02357901|58921114|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
30888203|NCT02357901|58921111|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
30888204|NCT02357901|58921112|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
30888205|NCT02357901|58921113|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
30888206|NCT02357901|58921114|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
30888207|NCT02357901|58921111|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
30888208|NCT02357901|58921112|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
30888209|NCT02357901|58921113|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
30888210|NCT02357901|58921114|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
30888211|NCT02357901|58921111|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
30888212|NCT02357901|58921112|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
30888213|NCT02357901|58921113|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
30888214|NCT02357901|58921114|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
30888215|NCT02357901|58921111|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
30888216|NCT02357901|58921112|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
30888217|NCT02357901|58921113|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
30888218|NCT02357901|58921114|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
30888219|NCT02357901|58921111|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
30888220|NCT02357901|58921112|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
30888221|NCT02357901|58921113|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
30888222|NCT02357901|58921114|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
30888223|NCT01601847|58921124|FG000|Overall Study|Death|1|||
30888224|NCT01601847|58921125|FG001|Overall Study|Death|0|||
30888225|NCT01601847|58921124|FG000|Overall Study|Withdrawal by Subject|11|||
30888226|NCT01601847|58921125|FG001|Overall Study|Withdrawal by Subject|7|||
30888227|NCT01601847|58921124|FG000|Overall Study|Lost to Follow-up|1|||
30888228|NCT01601847|58921125|FG001|Overall Study|Lost to Follow-up|3|||
30888229|NCT02515669|58921135|FG000|228 Week Open-Label Phase|Other|0|||
30888230|NCT02515669|58921136|FG001|228 Week Open-Label Phase|Other|0|||
30888231|NCT02515669|58921137|FG002|228 Week Open-Label Phase|Other|1|||
30888232|NCT02515669|58921138|FG003|228 Week Open-Label Phase|Other|4|||
30888233|NCT02515669|58921135|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
30888234|NCT02515669|58921136|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
30888235|NCT02515669|58921137|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
30888236|NCT02515669|58921138|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
30888237|NCT02515669|58921135|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
30888238|NCT02515669|58921136|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
30888239|NCT02515669|58921137|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
30888240|NCT02515669|58921138|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
30888241|NCT02515669|58921135|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
30888242|NCT02515669|58921136|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
30888243|NCT02515669|58921137|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
30888244|NCT02515669|58921138|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
30888245|NCT02515669|58921135|FG000|228 Week Open-Label Phase|Missing|0|||
30888246|NCT02515669|58921136|FG001|228 Week Open-Label Phase|Missing|2|||
30888247|NCT02515669|58921137|FG002|228 Week Open-Label Phase|Missing|2|||
30888248|NCT02515669|58921138|FG003|228 Week Open-Label Phase|Missing|2|||
30888249|NCT02515279|58921168|FG000|Overall Study|Adverse Event|7|||
30888250|NCT02515279|58921168|FG000|Overall Study|Lack of Efficacy|31|||
30888251|NCT02515279|58921168|FG000|Overall Study|Lost to Follow-up|9|||
30888252|NCT02515279|58921168|FG000|Overall Study|Withdrawal by Subject|18|||
30888253|NCT02515279|58921168|FG000|Overall Study|End-of-treatment visit not attended|17|||
30888254|NCT02515279|58921168|FG000|Overall Study|Other|22|||
30888255|NCT02515045|58921174|FG000|Overall Study|Adverse Event|0|||
30888256|NCT02515045|58921175|FG001|Overall Study|Adverse Event|3|||
30888257|NCT02515045|58921176|FG002|Overall Study|Adverse Event|3|||
30888258|NCT02515045|58921174|FG000|Overall Study|Lost to Follow-up|0|||
30888259|NCT02515045|58921175|FG001|Overall Study|Lost to Follow-up|1|||
30888260|NCT02515045|58921176|FG002|Overall Study|Lost to Follow-up|1|||
30888261|NCT02514577|58921186|FG000|Overall Study|Lost to Follow-up|6|||
30888262|NCT02514577|58921187|FG001|Overall Study|Lost to Follow-up|6|||
30888263|NCT02514577|58921186|FG000|Overall Study|Protocol Violation|1|||
30888264|NCT02514577|58921187|FG001|Overall Study|Protocol Violation|0|||
30888265|NCT02514577|58921186|FG000|Overall Study|Withdrawal by Subject|6|||
30888266|NCT02514577|58921187|FG001|Overall Study|Withdrawal by Subject|6|||
30888267|NCT02514577|58921186|FG000|Overall Study|Adverse Event|1|||
30888268|NCT02514577|58921187|FG001|Overall Study|Adverse Event|1|||
30888269|NCT02513485|58921195|FG000|Overall Study|Adverse Event|1|||
30888270|NCT02513485|58921196|FG001|Overall Study|Adverse Event|0|||
30888271|NCT02289417|58921205|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
30888272|NCT02289417|58921206|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
30888273|NCT02289417|58921207|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
30888274|NCT02289417|58921208|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
30888275|NCT02289417|58921209|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
30888276|NCT02289417|58921210|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
30888277|NCT02289417|58921211|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
30888278|NCT02289417|58921212|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
30888279|NCT02289417|58921213|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
30888280|NCT02289417|58921205|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
30888281|NCT02289417|58921206|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
30888282|NCT02289417|58921207|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
30888283|NCT02289417|58921208|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
30888284|NCT02289417|58921209|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
30888285|NCT02289417|58921210|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
30888286|NCT02289417|58921211|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
30888287|NCT02289417|58921212|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
30888288|NCT02289417|58921213|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
30888289|NCT02289417|58921205|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
30888290|NCT02289417|58921206|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
30888291|NCT02289417|58921207|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
30888292|NCT02289417|58921208|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
30888293|NCT02289417|58921209|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
30888294|NCT02289417|58921210|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
30888295|NCT02289417|58921211|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
30888296|NCT02289417|58921212|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
30888297|NCT02289417|58921213|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
30888298|NCT02289417|58921205|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
30888299|NCT02289417|58921206|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
30888300|NCT02289417|58921207|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
30888301|NCT02289417|58921208|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
30888302|NCT02289417|58921209|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
30888303|NCT02289417|58921210|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
30888304|NCT02289417|58921211|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
30888305|NCT02289417|58921212|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
30888306|NCT02289417|58921213|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
30888307|NCT02289417|58921205|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
30888308|NCT02289417|58921206|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
30888309|NCT02289417|58921207|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
30888310|NCT02289417|58921208|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
30888311|NCT02289417|58921209|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
30888312|NCT02289417|58921210|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
30888313|NCT02289417|58921211|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
30888314|NCT02289417|58921212|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
30888315|NCT02289417|58921213|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
30888316|NCT02289417|58921205|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
30888317|NCT02289417|58921206|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
30888318|NCT02289417|58921207|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
30888319|NCT02289417|58921208|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
30888320|NCT02289417|58921209|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
30888321|NCT02289417|58921210|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
30888322|NCT02289417|58921211|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
30888323|NCT02289417|58921212|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
30888324|NCT02289417|58921213|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
30888325|NCT02289417|58921205|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
30888326|NCT02289417|58921206|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
30888327|NCT02289417|58921207|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
30888328|NCT02289417|58921208|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
30888329|NCT02289417|58921209|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
30888330|NCT02289417|58921210|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
30888331|NCT02289417|58921211|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
30888332|NCT02289417|58921212|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
30888333|NCT02289417|58921213|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
30888334|NCT02289417|58921205|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
30888335|NCT02289417|58921206|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
30888336|NCT02289417|58921207|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
30888337|NCT02289417|58921208|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
30888338|NCT02289417|58921209|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
30888339|NCT02289417|58921210|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
30888340|NCT02289417|58921211|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
30888341|NCT02289417|58921212|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
30888342|NCT02289417|58921213|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
30888343|NCT02289417|58921205|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
30888344|NCT02289417|58921206|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
30888345|NCT02289417|58921207|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
30888346|NCT02289417|58921208|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
30888347|NCT02289417|58921209|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
30888348|NCT02289417|58921210|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
30888349|NCT02289417|58921211|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
30888350|NCT02289417|58921212|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
30888351|NCT02289417|58921213|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
30888352|NCT02289417|58921205|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
30888353|NCT02289417|58921206|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
30888354|NCT02289417|58921207|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
30888355|NCT02289417|58921208|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
30888356|NCT02289417|58921209|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
30888357|NCT02289417|58921210|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
30888358|NCT02289417|58921211|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
30888359|NCT02289417|58921212|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
30888360|NCT02289417|58921213|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
30888361|NCT02289417|58921205|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
30888362|NCT02289417|58921206|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
30888363|NCT02289417|58921207|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
30888364|NCT02289417|58921208|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
30976256|NCT02585934|59063431|FG001|Overall Study|Caregiver Withdrew Consent|7|||
30976257|NCT02585934|59063430|FG000|Overall Study|Sponsor Termination|1|||
30976258|NCT02585934|59063431|FG001|Overall Study|Sponsor Termination|2|||
30976259|NCT02585934|59063430|FG000|Overall Study|Another Reason|10|||
30888365|NCT02289417|58921209|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
30888366|NCT02289417|58921210|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
30888367|NCT02289417|58921211|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
30888368|NCT02289417|58921212|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
30888369|NCT02289417|58921213|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
30888370|NCT02289417|58921205|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
30888371|NCT02289417|58921206|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
30888372|NCT02289417|58921207|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
30888373|NCT02289417|58921208|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
30888374|NCT02289417|58921209|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
30888375|NCT02289417|58921210|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
30888376|NCT02289417|58921211|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
30888377|NCT02289417|58921212|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
30888378|NCT02289417|58921213|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
30888379|NCT02289417|58921205|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
30888380|NCT02289417|58921206|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
30888381|NCT02289417|58921207|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
30888382|NCT02289417|58921208|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
30888383|NCT02289417|58921209|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
30888384|NCT02289417|58921210|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
30888385|NCT02289417|58921211|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
30888386|NCT02289417|58921212|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
30888387|NCT02289417|58921213|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
30888388|NCT02289417|58921205|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
30888389|NCT02289417|58921206|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
30888390|NCT02289417|58921207|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
30888391|NCT02289417|58921208|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
30888392|NCT02289417|58921209|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
30888393|NCT02289417|58921210|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
30888394|NCT02289417|58921211|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
30888395|NCT02289417|58921212|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
30888396|NCT02289417|58921213|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
30888397|NCT02512861|58921231|FG000|Overall Study|Protocol Violation|3|||
30888398|NCT02512861|58921232|FG001|Overall Study|Protocol Violation|7|||
30888399|NCT02512861|58921231|FG000|Overall Study|Physician Decision|3|||
30888400|NCT02512861|58921232|FG001|Overall Study|Physician Decision|1|||
30888401|NCT02512861|58921231|FG000|Overall Study|Withdrawal by Subject|0|||
30888402|NCT02512861|58921232|FG001|Overall Study|Withdrawal by Subject|1|||
30888403|NCT02288559|58921242|FG000|Overall Study|Adverse Event|1|||
30888404|NCT02288559|58921243|FG001|Overall Study|Adverse Event|1|||
30888405|NCT02288559|58921244|FG002|Overall Study|Adverse Event|5|||
30888406|NCT02288559|58921245|FG003|Overall Study|Adverse Event|0|||
30888407|NCT02288559|58921242|FG000|Overall Study|Death|0|||
30888408|NCT02288559|58921243|FG001|Overall Study|Death|0|||
30888409|NCT02288559|58921244|FG002|Overall Study|Death|1|||
30888410|NCT02288559|58921245|FG003|Overall Study|Death|0|||
30888411|NCT02288559|58921242|FG000|Overall Study|Lost to Follow-up|0|||
30888412|NCT02288559|58921243|FG001|Overall Study|Lost to Follow-up|0|||
30888413|NCT02288559|58921244|FG002|Overall Study|Lost to Follow-up|0|||
30888414|NCT02288559|58921245|FG003|Overall Study|Lost to Follow-up|1|||
30888415|NCT02288559|58921242|FG000|Overall Study|Withdrawal by Subject|0|||
30888416|NCT02288559|58921243|FG001|Overall Study|Withdrawal by Subject|0|||
30888417|NCT02288559|58921244|FG002|Overall Study|Withdrawal by Subject|2|||
30888418|NCT02288559|58921245|FG003|Overall Study|Withdrawal by Subject|1|||
30888419|NCT02288559|58921242|FG000|Overall Study|Reason Not Specified|0|||
30888420|NCT02288559|58921243|FG001|Overall Study|Reason Not Specified|0|||
30888421|NCT02288559|58921244|FG002|Overall Study|Reason Not Specified|3|||
30888422|NCT02288559|58921245|FG003|Overall Study|Reason Not Specified|0|||
30888423|NCT02288325|58921257|FG000|Run-in Period|Adverse Event|48|||
30888424|NCT02288325|58921258|FG001|Run-in Period|Adverse Event|0|||
30888425|NCT02288325|58921259|FG002|Run-in Period|Adverse Event|0|||
30888426|NCT02288325|58921257|FG000|Run-in Period|Lack of Efficacy|16|||
30888427|NCT02288325|58921258|FG001|Run-in Period|Lack of Efficacy|0|||
30888428|NCT02288325|58921259|FG002|Run-in Period|Lack of Efficacy|0|||
30888429|NCT02288325|58921257|FG000|Run-in Period|Withdrawal of Consent|28|||
30888430|NCT02288325|58921258|FG001|Run-in Period|Withdrawal of Consent|0|||
30888431|NCT02288325|58921259|FG002|Run-in Period|Withdrawal of Consent|0|||
30888432|NCT02288325|58921257|FG000|Run-in Period|Lost to Follow-up|25|||
30888433|NCT02288325|58921258|FG001|Run-in Period|Lost to Follow-up|0|||
30888434|NCT02288325|58921259|FG002|Run-in Period|Lost to Follow-up|0|||
30888435|NCT02288325|58921257|FG000|Run-in Period|Protocol Violation|17|||
30888436|NCT02288325|58921258|FG001|Run-in Period|Protocol Violation|0|||
30888437|NCT02288325|58921259|FG002|Run-in Period|Protocol Violation|0|||
30948436|NCT01709084|58994335|FG000|Overall Study|Other|5|||
30888438|NCT02288325|58921257|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
30888439|NCT02288325|58921258|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
30888440|NCT02288325|58921259|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
30888441|NCT02288325|58921257|FG000|Run-in Period|Reason not Specified|8|||
30888442|NCT02288325|58921258|FG001|Run-in Period|Reason not Specified|0|||
30888443|NCT02288325|58921259|FG002|Run-in Period|Reason not Specified|0|||
30888444|NCT02288325|58921257|FG000|Stabilization Period|Adverse Event|13|||
30888445|NCT02288325|58921258|FG001|Stabilization Period|Adverse Event|0|||
30888446|NCT02288325|58921259|FG002|Stabilization Period|Adverse Event|0|||
30888447|NCT02288325|58921257|FG000|Stabilization Period|Lack of Efficacy|22|||
30888448|NCT02288325|58921258|FG001|Stabilization Period|Lack of Efficacy|0|||
30888449|NCT02288325|58921259|FG002|Stabilization Period|Lack of Efficacy|0|||
30888450|NCT02288325|58921257|FG000|Stabilization Period|Withdrawal of Consent|23|||
30888451|NCT02288325|58921258|FG001|Stabilization Period|Withdrawal of Consent|0|||
30888452|NCT02288325|58921259|FG002|Stabilization Period|Withdrawal of Consent|0|||
30888453|NCT02288325|58921257|FG000|Stabilization Period|Lost to Follow-up|12|||
30888454|NCT02288325|58921258|FG001|Stabilization Period|Lost to Follow-up|0|||
30888455|NCT02288325|58921259|FG002|Stabilization Period|Lost to Follow-up|0|||
30888456|NCT02288325|58921257|FG000|Stabilization Period|Protocol Violation|8|||
30888457|NCT02288325|58921258|FG001|Stabilization Period|Protocol Violation|0|||
30888458|NCT02288325|58921259|FG002|Stabilization Period|Protocol Violation|0|||
30888459|NCT02288325|58921257|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
30888460|NCT02288325|58921258|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
30888461|NCT02288325|58921259|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
30888462|NCT02288325|58921257|FG000|Stabilization Period|Reason not Specified|15|||
30888463|NCT02288325|58921258|FG001|Stabilization Period|Reason not Specified|0|||
30888464|NCT02288325|58921259|FG002|Stabilization Period|Reason not Specified|0|||
30888465|NCT02288325|58921257|FG000|Double-blind Treatment Period|Adverse Event|0|||
30888466|NCT02288325|58921258|FG001|Double-blind Treatment Period|Adverse Event|2|||
30888467|NCT02288325|58921259|FG002|Double-blind Treatment Period|Adverse Event|5|||
30888468|NCT02288325|58921257|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
30888469|NCT02288325|58921258|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
30888470|NCT02288325|58921259|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
30888471|NCT02288325|58921257|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
30888472|NCT02288325|58921258|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
30888473|NCT02288325|58921259|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
30888474|NCT02288325|58921257|FG000|Double-blind Treatment Period|Protocol Violation|0|||
30888475|NCT02288325|58921258|FG001|Double-blind Treatment Period|Protocol Violation|1|||
30888476|NCT02288325|58921259|FG002|Double-blind Treatment Period|Protocol Violation|2|||
30888477|NCT02288325|58921257|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
30888478|NCT02288325|58921258|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
30888479|NCT02288325|58921259|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
30888480|NCT02288325|58921257|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
30888481|NCT02288325|58921258|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
30888482|NCT02288325|58921259|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
30888483|NCT02509117|58921276|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
30888484|NCT02509117|58921277|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
30888485|NCT02509117|58921278|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
30888486|NCT02509117|58921279|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
30888487|NCT02509117|58921280|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
30888488|NCT02509117|58921281|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
30888489|NCT02509117|58921282|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
30888490|NCT02509117|58921283|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
30888491|NCT02509117|58921284|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
30888492|NCT02509117|58921285|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
30888493|NCT02509117|58921276|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
30888494|NCT02509117|58921277|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
30888495|NCT02509117|58921278|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
30888496|NCT02509117|58921279|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
30888497|NCT02509117|58921280|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
30888498|NCT02509117|58921281|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
30888499|NCT02509117|58921282|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
30888500|NCT02509117|58921283|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
30888501|NCT02509117|58921284|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
30888502|NCT02509117|58921285|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
30888503|NCT02509117|58921276|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
30888504|NCT02509117|58921277|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
30888505|NCT02509117|58921278|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
30888506|NCT02509117|58921279|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
30888507|NCT02509117|58921280|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
30888508|NCT02509117|58921281|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
30888509|NCT02509117|58921282|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
30888510|NCT02509117|58921283|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
30888511|NCT02509117|58921284|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
30888512|NCT02509117|58921285|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
30888513|NCT01654549|58921325|FG000|Overall Study|H.pylori eradication not successful|0|||
30888514|NCT01654549|58921326|FG001|Overall Study|H.pylori eradication not successful|1|||
30888515|NCT02508649|58921340|FG000|Overall Study|Withdrawal by Subject|4|||
30888516|NCT02508649|58921341|FG001|Overall Study|Withdrawal by Subject|6|||
30888517|NCT02508649|58921342|FG002|Overall Study|Withdrawal by Subject|5|||
30888518|NCT02508649|58921343|FG003|Overall Study|Withdrawal by Subject|6|||
30888519|NCT02508649|58921340|FG000|Overall Study|Investigator withdrew the subject|1|||
30888520|NCT02508649|58921341|FG001|Overall Study|Investigator withdrew the subject|2|||
30888521|NCT02508649|58921342|FG002|Overall Study|Investigator withdrew the subject|1|||
30888522|NCT02508649|58921343|FG003|Overall Study|Investigator withdrew the subject|0|||
30888523|NCT02508649|58921340|FG000|Overall Study|Post randomization screening failure|12|||
30888524|NCT02508649|58921341|FG001|Overall Study|Post randomization screening failure|4|||
30888525|NCT02508649|58921342|FG002|Overall Study|Post randomization screening failure|9|||
30888526|NCT02508649|58921343|FG003|Overall Study|Post randomization screening failure|3|||
30888527|NCT02508649|58921340|FG000|Overall Study|Lost to Follow-up|1|||
30888528|NCT02508649|58921341|FG001|Overall Study|Lost to Follow-up|1|||
30888529|NCT02508649|58921342|FG002|Overall Study|Lost to Follow-up|0|||
30888530|NCT02508649|58921343|FG003|Overall Study|Lost to Follow-up|1|||
30888531|NCT02505217|58921358|FG000|Overall Study|Withdrawal by Subject|1|||
30888532|NCT02505217|58921359|FG001|Overall Study|Withdrawal by Subject|2|||
30888533|NCT02504827|58921365|FG000|Overall Study|Could not produce sputum|1|||
30888534|NCT02504671|58921375|FG000|Overall Study|Withdrawal by Subject|1|||
30888535|NCT02504671|58921376|FG001|Overall Study|Withdrawal by Subject|5|||
30888536|NCT02504671|58921377|FG002|Overall Study|Withdrawal by Subject|4|||
30888537|NCT02504671|58921378|FG003|Overall Study|Withdrawal by Subject|4|||
30888538|NCT02504671|58921379|FG004|Overall Study|Withdrawal by Subject|5|||
30888539|NCT02504671|58921380|FG005|Overall Study|Withdrawal by Subject|3|||
30888540|NCT02504671|58921375|FG000|Overall Study|Lack of Efficacy|1|||
30888541|NCT02504671|58921376|FG001|Overall Study|Lack of Efficacy|3|||
30888542|NCT02504671|58921377|FG002|Overall Study|Lack of Efficacy|1|||
30888543|NCT02504671|58921378|FG003|Overall Study|Lack of Efficacy|0|||
30888544|NCT02504671|58921379|FG004|Overall Study|Lack of Efficacy|4|||
30888545|NCT02504671|58921380|FG005|Overall Study|Lack of Efficacy|4|||
30888546|NCT02504671|58921375|FG000|Overall Study|Adverse Event|1|||
30888547|NCT02504671|58921376|FG001|Overall Study|Adverse Event|1|||
30888548|NCT02504671|58921377|FG002|Overall Study|Adverse Event|0|||
30888549|NCT02504671|58921378|FG003|Overall Study|Adverse Event|1|||
30888550|NCT02504671|58921379|FG004|Overall Study|Adverse Event|0|||
30888551|NCT02504671|58921380|FG005|Overall Study|Adverse Event|2|||
30888552|NCT02504671|58921375|FG000|Overall Study|Protocol Violation|2|||
30888553|NCT02504671|58921376|FG001|Overall Study|Protocol Violation|1|||
30888554|NCT02504671|58921377|FG002|Overall Study|Protocol Violation|0|||
30888555|NCT02504671|58921378|FG003|Overall Study|Protocol Violation|0|||
30888556|NCT02504671|58921379|FG004|Overall Study|Protocol Violation|0|||
30888557|NCT02504671|58921380|FG005|Overall Study|Protocol Violation|1|||
30888558|NCT02504671|58921375|FG000|Overall Study|Lost to Follow-up|0|||
30888559|NCT02504671|58921376|FG001|Overall Study|Lost to Follow-up|0|||
30888560|NCT02504671|58921377|FG002|Overall Study|Lost to Follow-up|2|||
30888561|NCT02504671|58921378|FG003|Overall Study|Lost to Follow-up|0|||
30888562|NCT02504671|58921379|FG004|Overall Study|Lost to Follow-up|0|||
30888563|NCT02504671|58921380|FG005|Overall Study|Lost to Follow-up|1|||
30888564|NCT02504671|58921375|FG000|Overall Study|Protocol defined stopping criteria|7|||
30888565|NCT02504671|58921376|FG001|Overall Study|Protocol defined stopping criteria|4|||
30888566|NCT02504671|58921377|FG002|Overall Study|Protocol defined stopping criteria|3|||
30888567|NCT02504671|58921378|FG003|Overall Study|Protocol defined stopping criteria|5|||
30888568|NCT02504671|58921379|FG004|Overall Study|Protocol defined stopping criteria|3|||
30888569|NCT02504671|58921380|FG005|Overall Study|Protocol defined stopping criteria|3|||
30888570|NCT02314143|58921397|FG000|Overall Study|Adverse Event|0|||
30888571|NCT02314143|58921398|FG001|Overall Study|Adverse Event|6|||
30888572|NCT02314143|58921399|FG002|Overall Study|Adverse Event|4|||
30888573|NCT02314143|58921397|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
30888574|NCT02314143|58921398|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
30888575|NCT02314143|58921399|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
30888576|NCT02314143|58921397|FG000|Overall Study|Physician Decision|2|||
30888577|NCT02314143|58921398|FG001|Overall Study|Physician Decision|1|||
30888578|NCT02314143|58921399|FG002|Overall Study|Physician Decision|0|||
30888579|NCT02314143|58921397|FG000|Overall Study|Withdrawal by Subject|1|||
30888580|NCT02314143|58921398|FG001|Overall Study|Withdrawal by Subject|0|||
30888581|NCT02314143|58921399|FG002|Overall Study|Withdrawal by Subject|1|||
30888582|NCT02288091|58921408|FG000|Overall Study|Lost to Follow-up|1|||
30888583|NCT02288091|58921408|FG000|Overall Study|Screen fail|7|||
30888584|NCT02503501|58921414|FG000|Overall Study|Physician Decision|1|||
30888585|NCT02503501|58921415|FG001|Overall Study|Physician Decision|0|||
30888586|NCT02503501|58921414|FG000|Overall Study|Protocol Violation|0|||
30888587|NCT02503501|58921415|FG001|Overall Study|Protocol Violation|1|||
30888588|NCT02503501|58921414|FG000|Overall Study|Withdrawal by Subject|0|||
30888589|NCT02503501|58921415|FG001|Overall Study|Withdrawal by Subject|2|||
30888590|NCT02502097|58921425|FG000|Period 1|Adverse Event|0|||
30888591|NCT02502097|58921426|FG001|Period 1|Adverse Event|0|||
30888592|NCT02502097|58921427|FG002|Period 1|Adverse Event|1|||
30888593|NCT02502097|58921428|FG003|Period 1|Adverse Event|0|||
30888594|NCT02502097|58921425|FG000|Wash Out Period|Adverse Event|0|||
30888595|NCT02502097|58921426|FG001|Wash Out Period|Adverse Event|1|||
30888596|NCT02502097|58921427|FG002|Wash Out Period|Adverse Event|1|||
30888597|NCT02502097|58921428|FG003|Wash Out Period|Adverse Event|1|||
30888598|NCT02502097|58921425|FG000|Period 2|Adverse Event|0|||
30888599|NCT02502097|58921426|FG001|Period 2|Adverse Event|0|||
30888600|NCT02502097|58921427|FG002|Period 2|Adverse Event|1|||
30888601|NCT02502097|58921428|FG003|Period 2|Adverse Event|0|||
30888602|NCT02501629|58921437|FG000|Overall Study|Death|0|||
30888603|NCT02501629|58921438|FG001|Overall Study|Death|1|||
30888604|NCT02501629|58921437|FG000|Overall Study|Withdrawn from study by sponsor|1|||
30888605|NCT02501629|58921438|FG001|Overall Study|Withdrawn from study by sponsor|0|||
30888606|NCT02501629|58921437|FG000|Overall Study|Early termination by sponsor|1|||
30888607|NCT02501629|58921438|FG001|Overall Study|Early termination by sponsor|0|||
30888608|NCT02501629|58921437|FG000|Overall Study|Withdrawal by Subject|3|||
30888609|NCT02501629|58921438|FG001|Overall Study|Withdrawal by Subject|5|||
30888610|NCT02501629|58921437|FG000|Overall Study|Subject did not return to site|0|||
30888611|NCT02501629|58921438|FG001|Overall Study|Subject did not return to site|1|||
30888612|NCT02501473|58921451|FG000|Overall Study|Study Terminated|2|||
30888613|NCT02501473|58921452|FG001|Overall Study|Study Terminated|3|||
30888614|NCT02501473|58921453|FG002|Overall Study|Study Terminated|7|||
30888615|NCT02501473|58921454|FG003|Overall Study|Study Terminated|9|||
30888616|NCT02501473|58921455|FG004|Overall Study|Study Terminated|2|||
30888617|NCT02501473|58921456|FG005|Overall Study|Study Terminated|10|||
30888618|NCT02501473|58921457|FG006|Overall Study|Study Terminated|1|||
30888619|NCT02501473|58921458|FG007|Overall Study|Study Terminated|0|||
30888620|NCT02501473|58921451|FG000|Overall Study|Withdrawal by Subject|0|||
30888621|NCT02501473|58921452|FG001|Overall Study|Withdrawal by Subject|0|||
30888622|NCT02501473|58921453|FG002|Overall Study|Withdrawal by Subject|3|||
30888623|NCT02501473|58921454|FG003|Overall Study|Withdrawal by Subject|3|||
30888624|NCT02501473|58921455|FG004|Overall Study|Withdrawal by Subject|2|||
30888625|NCT02501473|58921456|FG005|Overall Study|Withdrawal by Subject|2|||
30888626|NCT02501473|58921457|FG006|Overall Study|Withdrawal by Subject|0|||
30888627|NCT02501473|58921458|FG007|Overall Study|Withdrawal by Subject|0|||
30888628|NCT02501473|58921451|FG000|Overall Study|Death|0|||
30888629|NCT02501473|58921452|FG001|Overall Study|Death|0|||
30888630|NCT02501473|58921453|FG002|Overall Study|Death|1|||
30888631|NCT02501473|58921454|FG003|Overall Study|Death|1|||
30888632|NCT02501473|58921455|FG004|Overall Study|Death|0|||
30888633|NCT02501473|58921456|FG005|Overall Study|Death|1|||
30888634|NCT02501473|58921457|FG006|Overall Study|Death|0|||
30888635|NCT02501473|58921458|FG007|Overall Study|Death|0|||
30888636|NCT02501473|58921451|FG000|Overall Study|Lost to Follow-up|1|||
30888637|NCT02501473|58921452|FG001|Overall Study|Lost to Follow-up|0|||
30888638|NCT02501473|58921453|FG002|Overall Study|Lost to Follow-up|1|||
30888639|NCT02501473|58921454|FG003|Overall Study|Lost to Follow-up|0|||
30888640|NCT02501473|58921455|FG004|Overall Study|Lost to Follow-up|0|||
30888641|NCT02501473|58921456|FG005|Overall Study|Lost to Follow-up|1|||
30888642|NCT02501473|58921457|FG006|Overall Study|Lost to Follow-up|0|||
30888643|NCT02501473|58921458|FG007|Overall Study|Lost to Follow-up|0|||
30888644|NCT02501473|58921451|FG000|Overall Study|Reason not specified|0|||
30888645|NCT02501473|58921452|FG001|Overall Study|Reason not specified|0|||
30888646|NCT02501473|58921453|FG002|Overall Study|Reason not specified|1|||
30888647|NCT02501473|58921454|FG003|Overall Study|Reason not specified|1|||
30888648|NCT02501473|58921455|FG004|Overall Study|Reason not specified|0|||
30888649|NCT02501473|58921456|FG005|Overall Study|Reason not specified|0|||
30888650|NCT02501473|58921457|FG006|Overall Study|Reason not specified|0|||
30888651|NCT02501473|58921458|FG007|Overall Study|Reason not specified|0|||
30888652|NCT02501161|58921476|FG000|Overall Study|Adverse Event|2|||
30888653|NCT02501161|58921477|FG001|Overall Study|Adverse Event|6|||
30888654|NCT02501161|58921476|FG000|Overall Study|Lost to Follow-up|7|||
30888655|NCT02501161|58921477|FG001|Overall Study|Lost to Follow-up|4|||
30888656|NCT02501161|58921476|FG000|Overall Study|Withdrawal by Subject|10|||
30888657|NCT02501161|58921477|FG001|Overall Study|Withdrawal by Subject|15|||
30888658|NCT02501161|58921476|FG000|Overall Study|Other|3|||
30888659|NCT02501161|58921477|FG001|Overall Study|Other|0|||
30888660|NCT02500537|58921485|FG000|Overall Study|Death|2|||
30888661|NCT02500537|58921486|FG001|Overall Study|Death|0|||
30888662|NCT02500537|58921485|FG000|Overall Study|Lost to Follow-up|0|||
30888663|NCT02500537|58921486|FG001|Overall Study|Lost to Follow-up|1|||
30888664|NCT02500537|58921485|FG000|Overall Study|Withdrawal by Subject|1|||
30888665|NCT02500537|58921486|FG001|Overall Study|Withdrawal by Subject|0|||
30888666|NCT02498821|58921495|FG000|Overall Study|Screen failure|3|||
30888667|NCT02498821|58921496|FG001|Overall Study|Screen failure|5|||
30888668|NCT02313909|58921504|FG000|Overall Study|Consent withdrawn by participant|33|||
30888669|NCT02313909|58921505|FG001|Overall Study|Consent withdrawn by participant|33|||
30888670|NCT02313909|58921504|FG000|Overall Study|Lost to Follow-up|24|||
30888671|NCT02313909|58921505|FG001|Overall Study|Lost to Follow-up|17|||
30888672|NCT02287467|58921513|FG000|Overall Study|Protocol Violation|12|||
30888673|NCT02287467|58921514|FG001|Overall Study|Protocol Violation|9|||
30888674|NCT02287233|58921526|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
30888675|NCT02287233|58921527|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
30888676|NCT02287233|58921528|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
30888677|NCT02287233|58921526|FG000|Overall Study|Adverse Event Related to Progression|0|||
30888678|NCT02287233|58921527|FG001|Overall Study|Adverse Event Related to Progression|2|||
30888679|NCT02287233|58921528|FG002|Overall Study|Adverse Event Related to Progression|8|||
30888680|NCT02287233|58921526|FG000|Overall Study|Physician Decision|1|||
30888681|NCT02287233|58921527|FG001|Overall Study|Physician Decision|2|||
30888682|NCT02287233|58921528|FG002|Overall Study|Physician Decision|4|||
30888683|NCT02287233|58921526|FG000|Overall Study|Progressive Disease with Death|0|||
30888684|NCT02287233|58921527|FG001|Overall Study|Progressive Disease with Death|0|||
30888685|NCT02287233|58921528|FG002|Overall Study|Progressive Disease with Death|10|||
30888686|NCT02287233|58921526|FG000|Overall Study|Progressive Disease Without Death|2|||
30888687|NCT02287233|58921527|FG001|Overall Study|Progressive Disease Without Death|3|||
30888688|NCT02287233|58921528|FG002|Overall Study|Progressive Disease Without Death|20|||
30888689|NCT02287233|58921526|FG000|Overall Study|Withdrawal by Subject|1|||
30888690|NCT02287233|58921527|FG001|Overall Study|Withdrawal by Subject|1|||
30888691|NCT02287233|58921528|FG002|Overall Study|Withdrawal by Subject|7|||
30888692|NCT02287233|58921526|FG000|Overall Study|Other|3|||
30888693|NCT02287233|58921527|FG001|Overall Study|Other|0|||
30888694|NCT02287233|58921528|FG002|Overall Study|Other|15|||
30888695|NCT02287233|58921526|FG000|Overall Study|Did Not Receive Treatment|0|||
30888696|NCT02287233|58921527|FG001|Overall Study|Did Not Receive Treatment|0|||
30888697|NCT02287233|58921528|FG002|Overall Study|Did Not Receive Treatment|2|||
30888698|NCT01646385|58921541|FG000|Overall Study|Death|202|||
30888699|NCT01646385|58921542|FG001|Overall Study|Death|222|||
30888700|NCT01646385|58921541|FG000|Overall Study|Switched to alternate biologic|636|||
30888701|NCT01646385|58921542|FG001|Overall Study|Switched to alternate biologic|649|||
30888702|NCT02286843|58921548|FG000|Overall Study|Not Treated|4|||
30888703|NCT02286843|58921548|FG000|Overall Study|Protocol Violation|1|||
30888704|NCT02286843|58921548|FG000|Overall Study|Withdrawal by Subject|1|||
30888705|NCT02282163|58921552|FG000|Overall Study|Protocol Violation|1|||
30888706|NCT02281773|58921570|FG000|Overall Study|Adverse Event|6|||
30888707|NCT02281773|58921571|FG001|Overall Study|Adverse Event|1|||
30888708|NCT02281773|58921572|FG002|Overall Study|Adverse Event|4|||
30888709|NCT02281773|58921573|FG003|Overall Study|Adverse Event|8|||
30888710|NCT02281773|58921574|FG004|Overall Study|Adverse Event|9|||
30888711|NCT02281773|58921570|FG000|Overall Study|Protocol Violation|1|||
30888712|NCT02281773|58921571|FG001|Overall Study|Protocol Violation|0|||
30888713|NCT02281773|58921572|FG002|Overall Study|Protocol Violation|0|||
30888714|NCT02281773|58921573|FG003|Overall Study|Protocol Violation|2|||
30888715|NCT02281773|58921574|FG004|Overall Study|Protocol Violation|2|||
30888716|NCT02281773|58921570|FG000|Overall Study|Lost to Follow-up|2|||
30888717|NCT02281773|58921571|FG001|Overall Study|Lost to Follow-up|2|||
30888718|NCT02281773|58921572|FG002|Overall Study|Lost to Follow-up|6|||
30888719|NCT02281773|58921573|FG003|Overall Study|Lost to Follow-up|2|||
30888720|NCT02281773|58921574|FG004|Overall Study|Lost to Follow-up|10|||
30888721|NCT02281773|58921570|FG000|Overall Study|Withdrawal by Subject|2|||
30888722|NCT02281773|58921571|FG001|Overall Study|Withdrawal by Subject|8|||
30888723|NCT02281773|58921572|FG002|Overall Study|Withdrawal by Subject|6|||
30888724|NCT02281773|58921573|FG003|Overall Study|Withdrawal by Subject|6|||
30888725|NCT02281773|58921574|FG004|Overall Study|Withdrawal by Subject|8|||
30888726|NCT02281773|58921570|FG000|Overall Study|Other Reason|0|||
30888727|NCT02281773|58921571|FG001|Overall Study|Other Reason|4|||
30888728|NCT02281773|58921572|FG002|Overall Study|Other Reason|2|||
30888729|NCT02281773|58921573|FG003|Overall Study|Other Reason|3|||
30888730|NCT02281773|58921574|FG004|Overall Study|Other Reason|1|||
30888731|NCT02285361|58921586|FG000|Overall Study|Protocol Violation|43|||
30888732|NCT02285361|58921586|FG000|Overall Study|Lost to Follow-up|5|||
30888733|NCT02285361|58921586|FG000|Overall Study|Not taken GIOTRIF|2|||
30888734|NCT02285361|58921586|FG000|Overall Study|Consented prior to the contract date|1|||
30888735|NCT02354235|58921592|FG000|Overall Study|Adverse Event|2|||
30888736|NCT02354235|58921593|FG001|Overall Study|Adverse Event|2|||
30888737|NCT02354235|58921592|FG000|Overall Study|Physician Decision|0|||
30888738|NCT02354235|58921593|FG001|Overall Study|Physician Decision|1|||
30888739|NCT02354235|58921592|FG000|Overall Study|Withdrawal by Subject|1|||
30888740|NCT02354235|58921593|FG001|Overall Study|Withdrawal by Subject|3|||
30888741|NCT02354235|58921592|FG000|Overall Study|Conflict with the stopping criteria|0|||
30888742|NCT02354235|58921593|FG001|Overall Study|Conflict with the stopping criteria|1|||
30888743|NCT02280291|58921603|FG000|Overall Study|Lost to Follow-up|2|||
30888744|NCT02280291|58921604|FG001|Overall Study|Lost to Follow-up|1|||
30888745|NCT02280291|58921605|FG002|Overall Study|Lost to Follow-up|3|||
30888746|NCT02280291|58921606|FG003|Overall Study|Lost to Follow-up|8|||
30888747|NCT02280291|58921603|FG000|Overall Study|Protocol Violation|1|||
30888748|NCT02280291|58921604|FG001|Overall Study|Protocol Violation|0|||
30888749|NCT02280291|58921605|FG002|Overall Study|Protocol Violation|0|||
30888750|NCT02280291|58921606|FG003|Overall Study|Protocol Violation|0|||
30888751|NCT02280291|58921603|FG000|Overall Study|Other|1|||
30888752|NCT02280291|58921604|FG001|Overall Study|Other|1|||
30888753|NCT02280291|58921605|FG002|Overall Study|Other|0|||
30888754|NCT02280291|58921606|FG003|Overall Study|Other|0|||
30888755|NCT02284893|58921620|FG000|26 Week (Short Term)|Adverse Event|1|||
30888756|NCT02284893|58921621|FG001|26 Week (Short Term)|Adverse Event|9|||
30888757|NCT02284893|58921620|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
30976260|NCT02585934|59063431|FG001|Overall Study|Another Reason|5|||
30976261|NCT02582658|59063460|FG000|Overall Study|Failure to Return|10|||
30976262|NCT02582658|59063460|FG000|Overall Study|Insufficient Virological Response|2|||
30976263|NCT02582658|59063460|FG000|Overall Study|Withdrawn Consent|1|||
30976264|NCT02582658|59063460|FG000|Overall Study|Death|1|||
30888758|NCT02284893|58921621|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
30888759|NCT02284893|58921620|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
30888760|NCT02284893|58921621|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
30888761|NCT02284893|58921620|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
30888762|NCT02284893|58921621|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
30888763|NCT02284893|58921620|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
30888764|NCT02284893|58921621|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
30888765|NCT02284893|58921620|FG000|26 Week (Short Term)|Other|1|||
30888766|NCT02284893|58921621|FG001|26 Week (Short Term)|Other|1|||
30888767|NCT02284893|58921620|FG000|52 Week (Long Term)|Adverse Event|3|||
30888768|NCT02284893|58921621|FG001|52 Week (Long Term)|Adverse Event|1|||
30888769|NCT02284893|58921620|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
30888770|NCT02284893|58921621|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
30888771|NCT02284893|58921620|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
30976265|NCT02582658|59063460|FG000|Overall Study|Not further specified|11|||
30976266|NCT02585778|59063562|FG000|Overall Study|Adverse Event|17|||
30976267|NCT02585778|59063563|FG001|Overall Study|Adverse Event|4|||
30888772|NCT02284893|58921621|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
30888773|NCT02284893|58921620|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
30888774|NCT02284893|58921621|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
30888775|NCT02284893|58921620|FG000|52 Week (Long Term)|Non-Compliance|2|||
30888776|NCT02284893|58921621|FG001|52 Week (Long Term)|Non-Compliance|3|||
30888777|NCT02284347|58921627|FG000|Overall Study|Lost to Follow-up|2|||
30888778|NCT02284347|58921627|FG000|Overall Study|Withdrawn prior to treatment|1|||
30888779|NCT02279043|58921634|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
30888780|NCT02279043|58921635|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
30888781|NCT02279043|58921636|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
30790153|NCT00048035|58803325|FG005|Extension Year 2|Early Withdrawals|0|||
30790154|NCT00048035|58803326|FG006|Extension Year 2|Early Withdrawals|3|||
30790155|NCT00048035|58803327|FG007|Extension Year 2|Early Withdrawals|3|||
30888782|NCT02279043|58921634|FG000|Overall Study|Lost to Follow-up|46|||
30888783|NCT02279043|58921635|FG001|Overall Study|Lost to Follow-up|88|||
30888784|NCT02279043|58921636|FG002|Overall Study|Lost to Follow-up|0|||
30888785|NCT02283411|58921642|FG000|Overall Study|Withdrawal by Subject|3|||
30888786|NCT02283411|58921642|FG000|Overall Study|Screen Failed|28|||
30888787|NCT02351817|58921646|FG000|Period 1|Adverse Event|1|||
30888788|NCT02351817|58921647|FG001|Period 1|Adverse Event|2|||
30888789|NCT02351817|58921646|FG000|Period 1|Lack of Efficacy|0|||
30888790|NCT02351817|58921647|FG001|Period 1|Lack of Efficacy|1|||
30888791|NCT02351817|58921646|FG000|Period 2|Adverse Event|0|||
30888792|NCT02351817|58921647|FG001|Period 2|Adverse Event|2|||
30888793|NCT02351817|58921646|FG000|Period 2|Protocol Violation|1|||
30888794|NCT02351817|58921647|FG001|Period 2|Protocol Violation|0|||
30888795|NCT02351349|58921656|FG000|Overall Study|Withdrawal by Subject|2|||
30888796|NCT02351349|58921657|FG001|Overall Study|Withdrawal by Subject|3|||
30888797|NCT02484547|58921671|FG000|Placebo-Controlled Period|Adverse Event|10|||
30888798|NCT02484547|58921672|FG001|Placebo-Controlled Period|Adverse Event|13|||
30888799|NCT02484547|58921673|FG002|Placebo-Controlled Period|Adverse Event|20|||
30888800|NCT02484547|58921674|FG003|Placebo-Controlled Period|Adverse Event|0|||
30888801|NCT02484547|58921675|FG004|Placebo-Controlled Period|Adverse Event|0|||
30888802|NCT02484547|58921676|FG005|Placebo-Controlled Period|Adverse Event|0|||
30888803|NCT02484547|58921677|FG006|Placebo-Controlled Period|Adverse Event|0|||
30888804|NCT02484547|58921671|FG000|Placebo-Controlled Period|Change of Treatment|0|||
30888805|NCT02484547|58921672|FG001|Placebo-Controlled Period|Change of Treatment|0|||
30888806|NCT02484547|58921673|FG002|Placebo-Controlled Period|Change of Treatment|1|||
30888807|NCT02484547|58921674|FG003|Placebo-Controlled Period|Change of Treatment|0|||
30888808|NCT02484547|58921675|FG004|Placebo-Controlled Period|Change of Treatment|0|||
30888809|NCT02484547|58921676|FG005|Placebo-Controlled Period|Change of Treatment|0|||
30888810|NCT02484547|58921677|FG006|Placebo-Controlled Period|Change of Treatment|0|||
30888811|NCT02484547|58921671|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
30888812|NCT02484547|58921672|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
30888813|NCT02484547|58921673|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
30888814|NCT02484547|58921674|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
30888815|NCT02484547|58921675|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
30888816|NCT02484547|58921676|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
30888817|NCT02484547|58921677|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
30888818|NCT02484547|58921671|FG000|Placebo-Controlled Period|Death|5|||
30888819|NCT02484547|58921672|FG001|Placebo-Controlled Period|Death|0|||
30888820|NCT02484547|58921673|FG002|Placebo-Controlled Period|Death|6|||
30888821|NCT02484547|58921674|FG003|Placebo-Controlled Period|Death|0|||
30888822|NCT02484547|58921675|FG004|Placebo-Controlled Period|Death|0|||
30888823|NCT02484547|58921676|FG005|Placebo-Controlled Period|Death|0|||
30888824|NCT02484547|58921677|FG006|Placebo-Controlled Period|Death|0|||
30888825|NCT02484547|58921671|FG000|Placebo-Controlled Period|Disease Progression|2|||
30976268|NCT02585778|59063562|FG000|Overall Study|Participant did not wish to continue|9|||
30976269|NCT02585778|59063563|FG001|Overall Study|Participant did not wish to continue|4|||
30790156|NCT00047879|58803344|FG000|Overall Study|Progressive disease|4|||
30790157|NCT00047879|58803345|FG001|Overall Study|Progressive disease|3|||
30790158|NCT00064337|58803351|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
30790159|NCT00064337|58803351|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
30790160|NCT00064337|58803351|FG000|PBSCC or Induction/PBSCC|Progression|3|||
30790161|NCT00064337|58803351|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
30790162|NCT00064337|58803351|FG000|PBSCC or Induction/PBSCC|Death|2|||
30888826|NCT02484547|58921672|FG001|Placebo-Controlled Period|Disease Progression|0|||
30888827|NCT02484547|58921673|FG002|Placebo-Controlled Period|Disease Progression|1|||
30888828|NCT02484547|58921674|FG003|Placebo-Controlled Period|Disease Progression|0|||
30888829|NCT02484547|58921675|FG004|Placebo-Controlled Period|Disease Progression|0|||
30888830|NCT02484547|58921676|FG005|Placebo-Controlled Period|Disease Progression|0|||
30888831|NCT02484547|58921677|FG006|Placebo-Controlled Period|Disease Progression|0|||
30888832|NCT02484547|58921671|FG000|Placebo-Controlled Period|Investigator Decision|2|||
30888833|NCT02484547|58921672|FG001|Placebo-Controlled Period|Investigator Decision|2|||
30976270|NCT02585778|59063562|FG000|Overall Study|Poor compliance to study protocol|0|||
30888834|NCT02484547|58921673|FG002|Placebo-Controlled Period|Investigator Decision|5|||
30888835|NCT02484547|58921674|FG003|Placebo-Controlled Period|Investigator Decision|0|||
30888836|NCT02484547|58921675|FG004|Placebo-Controlled Period|Investigator Decision|0|||
30888837|NCT02484547|58921676|FG005|Placebo-Controlled Period|Investigator Decision|0|||
30888838|NCT02484547|58921677|FG006|Placebo-Controlled Period|Investigator Decision|0|||
30888839|NCT02484547|58921671|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
30888840|NCT02484547|58921672|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
30888841|NCT02484547|58921673|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
30888842|NCT02484547|58921674|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
30888843|NCT02484547|58921675|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
30888844|NCT02484547|58921676|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
30888845|NCT02484547|58921677|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
30888846|NCT02484547|58921671|FG000|Placebo-Controlled Period|Relocation|1|||
30888847|NCT02484547|58921672|FG001|Placebo-Controlled Period|Relocation|1|||
30888848|NCT02484547|58921673|FG002|Placebo-Controlled Period|Relocation|1|||
30888849|NCT02484547|58921674|FG003|Placebo-Controlled Period|Relocation|0|||
30888850|NCT02484547|58921675|FG004|Placebo-Controlled Period|Relocation|0|||
30888851|NCT02484547|58921676|FG005|Placebo-Controlled Period|Relocation|0|||
30888852|NCT02484547|58921677|FG006|Placebo-Controlled Period|Relocation|0|||
30888853|NCT02484547|58921671|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
30888854|NCT02484547|58921672|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
30888855|NCT02484547|58921673|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
30888856|NCT02484547|58921674|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
30888857|NCT02484547|58921675|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
30888858|NCT02484547|58921676|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
30888859|NCT02484547|58921677|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
30888860|NCT02484547|58921671|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
30888861|NCT02484547|58921672|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
30888862|NCT02484547|58921673|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
30888863|NCT02484547|58921674|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
30888864|NCT02484547|58921675|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
30888865|NCT02484547|58921676|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
30888866|NCT02484547|58921677|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
30888867|NCT02484547|58921671|FG000|Placebo-Controlled Period|Reason not Specified|216|||
30888868|NCT02484547|58921672|FG001|Placebo-Controlled Period|Reason not Specified|194|||
30888869|NCT02484547|58921673|FG002|Placebo-Controlled Period|Reason not Specified|183|||
30888870|NCT02484547|58921674|FG003|Placebo-Controlled Period|Reason not Specified|0|||
30888871|NCT02484547|58921675|FG004|Placebo-Controlled Period|Reason not Specified|0|||
30888872|NCT02484547|58921676|FG005|Placebo-Controlled Period|Reason not Specified|0|||
30888873|NCT02484547|58921677|FG006|Placebo-Controlled Period|Reason not Specified|0|||
30888874|NCT02484547|58921671|FG000|Long-Term Extension Period|Adverse Event|0|||
30888875|NCT02484547|58921672|FG001|Long-Term Extension Period|Adverse Event|0|||
30888876|NCT02484547|58921673|FG002|Long-Term Extension Period|Adverse Event|0|||
30888877|NCT02484547|58921674|FG003|Long-Term Extension Period|Adverse Event|0|||
30888878|NCT02484547|58921675|FG004|Long-Term Extension Period|Adverse Event|1|||
30888879|NCT02484547|58921676|FG005|Long-Term Extension Period|Adverse Event|3|||
30888880|NCT02484547|58921677|FG006|Long-Term Extension Period|Adverse Event|2|||
30888881|NCT02484547|58921671|FG000|Long-Term Extension Period|Death|0|||
30888882|NCT02484547|58921672|FG001|Long-Term Extension Period|Death|0|||
30888883|NCT02484547|58921673|FG002|Long-Term Extension Period|Death|0|||
30888884|NCT02484547|58921674|FG003|Long-Term Extension Period|Death|0|||
30888885|NCT02484547|58921675|FG004|Long-Term Extension Period|Death|0|||
30888886|NCT02484547|58921676|FG005|Long-Term Extension Period|Death|3|||
30888887|NCT02484547|58921677|FG006|Long-Term Extension Period|Death|0|||
30888888|NCT02484547|58921671|FG000|Long-Term Extension Period|Disease Progression|0|||
30888889|NCT02484547|58921672|FG001|Long-Term Extension Period|Disease Progression|0|||
30888890|NCT02484547|58921673|FG002|Long-Term Extension Period|Disease Progression|0|||
30888891|NCT02484547|58921674|FG003|Long-Term Extension Period|Disease Progression|0|||
30888892|NCT02484547|58921675|FG004|Long-Term Extension Period|Disease Progression|2|||
30888893|NCT02484547|58921676|FG005|Long-Term Extension Period|Disease Progression|4|||
30888894|NCT02484547|58921677|FG006|Long-Term Extension Period|Disease Progression|0|||
30888895|NCT02484547|58921671|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
30888896|NCT02484547|58921672|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
30976271|NCT02585778|59063563|FG001|Overall Study|Poor compliance to study protocol|2|||
30888897|NCT02484547|58921673|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
30888898|NCT02484547|58921674|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
30888899|NCT02484547|58921675|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
30888900|NCT02484547|58921676|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
30888901|NCT02484547|58921677|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
30888902|NCT02484547|58921671|FG000|Long-Term Extension Period|Loss of Capacity|0|||
30888903|NCT02484547|58921672|FG001|Long-Term Extension Period|Loss of Capacity|0|||
30976272|NCT02585778|59063562|FG000|Overall Study|Death|0|||
30888904|NCT02484547|58921673|FG002|Long-Term Extension Period|Loss of Capacity|0|||
30888905|NCT02484547|58921674|FG003|Long-Term Extension Period|Loss of Capacity|0|||
30888906|NCT02484547|58921675|FG004|Long-Term Extension Period|Loss of Capacity|1|||
30888907|NCT02484547|58921676|FG005|Long-Term Extension Period|Loss of Capacity|0|||
30888908|NCT02484547|58921677|FG006|Long-Term Extension Period|Loss of Capacity|0|||
30888909|NCT02484547|58921671|FG000|Long-Term Extension Period|Change of Treatment|0|||
30888910|NCT02484547|58921672|FG001|Long-Term Extension Period|Change of Treatment|0|||
30888911|NCT02484547|58921673|FG002|Long-Term Extension Period|Change of Treatment|0|||
30888912|NCT02484547|58921674|FG003|Long-Term Extension Period|Change of Treatment|0|||
30888913|NCT02484547|58921675|FG004|Long-Term Extension Period|Change of Treatment|0|||
30888914|NCT02484547|58921676|FG005|Long-Term Extension Period|Change of Treatment|0|||
30888915|NCT02484547|58921677|FG006|Long-Term Extension Period|Change of Treatment|1|||
30888916|NCT02484547|58921671|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
30888917|NCT02484547|58921672|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
30888918|NCT02484547|58921673|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
30888919|NCT02484547|58921674|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
30888920|NCT02484547|58921675|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
30888921|NCT02484547|58921676|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
30888922|NCT02484547|58921677|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
30888923|NCT02484547|58921671|FG000|Long-Term Extension Period|Investigator Decision|0|||
30888924|NCT02484547|58921672|FG001|Long-Term Extension Period|Investigator Decision|0|||
30888925|NCT02484547|58921673|FG002|Long-Term Extension Period|Investigator Decision|0|||
30888926|NCT02484547|58921674|FG003|Long-Term Extension Period|Investigator Decision|2|||
30888927|NCT02484547|58921675|FG004|Long-Term Extension Period|Investigator Decision|1|||
30888928|NCT02484547|58921676|FG005|Long-Term Extension Period|Investigator Decision|0|||
30888929|NCT02484547|58921677|FG006|Long-Term Extension Period|Investigator Decision|1|||
30888930|NCT02484547|58921671|FG000|Long-Term Extension Period|Relocation|0|||
30888931|NCT02484547|58921672|FG001|Long-Term Extension Period|Relocation|0|||
30888932|NCT02484547|58921673|FG002|Long-Term Extension Period|Relocation|0|||
30888933|NCT02484547|58921674|FG003|Long-Term Extension Period|Relocation|1|||
30888934|NCT02484547|58921675|FG004|Long-Term Extension Period|Relocation|1|||
30888935|NCT02484547|58921676|FG005|Long-Term Extension Period|Relocation|0|||
30888936|NCT02484547|58921677|FG006|Long-Term Extension Period|Relocation|0|||
30888937|NCT02484547|58921671|FG000|Long-Term Extension Period|Study Visit Burden|0|||
30888938|NCT02484547|58921672|FG001|Long-Term Extension Period|Study Visit Burden|0|||
30888939|NCT02484547|58921673|FG002|Long-Term Extension Period|Study Visit Burden|0|||
30888940|NCT02484547|58921674|FG003|Long-Term Extension Period|Study Visit Burden|2|||
30888941|NCT02484547|58921675|FG004|Long-Term Extension Period|Study Visit Burden|0|||
30888942|NCT02484547|58921676|FG005|Long-Term Extension Period|Study Visit Burden|0|||
30888943|NCT02484547|58921677|FG006|Long-Term Extension Period|Study Visit Burden|3|||
30888944|NCT02484547|58921671|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
30888945|NCT02484547|58921672|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
30888946|NCT02484547|58921673|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
30888947|NCT02484547|58921674|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
30888948|NCT02484547|58921675|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
30888949|NCT02484547|58921676|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
30888950|NCT02484547|58921677|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
30888951|NCT02484547|58921671|FG000|Long-Term Extension Period|Reason not Specified|0|||
30888952|NCT02484547|58921672|FG001|Long-Term Extension Period|Reason not Specified|0|||
30888953|NCT02484547|58921673|FG002|Long-Term Extension Period|Reason not Specified|0|||
30888954|NCT02484547|58921674|FG003|Long-Term Extension Period|Reason not Specified|119|||
30888955|NCT02484547|58921675|FG004|Long-Term Extension Period|Reason not Specified|117|||
30888956|NCT02484547|58921676|FG005|Long-Term Extension Period|Reason not Specified|223|||
30888957|NCT02484547|58921677|FG006|Long-Term Extension Period|Reason not Specified|231|||
30888958|NCT02517541|58921689|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
30888959|NCT02517541|58921689|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
30888960|NCT02517541|58921689|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
30888961|NCT02517541|58921689|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
30888962|NCT02517541|58921689|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
30888963|NCT02517541|58921689|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
30888964|NCT02496091|58921695|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
30888965|NCT02483611|58921703|FG000|Overall Study|Protocol Violation|0|||
30888966|NCT02483611|58921704|FG001|Overall Study|Protocol Violation|0|||
30888967|NCT02483611|58921705|FG002|Overall Study|Protocol Violation|1|||
30888968|NCT02483533|58921715|FG000|Overall Study|Lack of Efficacy|50|||
30888969|NCT02483533|58921716|FG001|Overall Study|Lack of Efficacy|50|||
30888970|NCT02482129|58921724|FG000|Overall Study|Adverse Event-prior to treatment|0|||
30888971|NCT02482129|58921725|FG001|Overall Study|Adverse Event-prior to treatment|1|||
30888972|NCT02482129|58921724|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
30888973|NCT02482129|58921725|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
30888974|NCT02482129|58921724|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
30888975|NCT02482129|58921725|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
30888976|NCT02482129|58921724|FG000|Overall Study|Criteria not met-prior to treatment|1|||
30888977|NCT02482129|58921725|FG001|Overall Study|Criteria not met-prior to treatment|0|||
30888978|NCT02482129|58921724|FG000|Overall Study|Adverse Event|1|||
30888979|NCT02482129|58921725|FG001|Overall Study|Adverse Event|0|||
30888980|NCT02482129|58921724|FG000|Overall Study|Withdrawal by Subject|2|||
30888981|NCT02482129|58921725|FG001|Overall Study|Withdrawal by Subject|0|||
30888982|NCT02482129|58921724|FG000|Overall Study|Criteria not met|1|||
30888983|NCT02482129|58921725|FG001|Overall Study|Criteria not met|0|||
30888984|NCT02495857|58921736|FG000|Overall Study|Adverse Event|5|||
30888985|NCT02495857|58921737|FG001|Overall Study|Adverse Event|0|||
30888986|NCT02495857|58921738|FG002|Overall Study|Adverse Event|1|||
30888987|NCT02495857|58921736|FG000|Overall Study|Withdrawal by Subject|9|||
30888988|NCT02495857|58921737|FG001|Overall Study|Withdrawal by Subject|6|||
30888989|NCT02495857|58921738|FG002|Overall Study|Withdrawal by Subject|10|||
30888990|NCT02495857|58921736|FG000|Overall Study|Physician Decision|0|||
30888991|NCT02495857|58921737|FG001|Overall Study|Physician Decision|1|||
30888992|NCT02495857|58921738|FG002|Overall Study|Physician Decision|0|||
30888993|NCT02495857|58921736|FG000|Overall Study|Protocol Violation|1|||
30888994|NCT02495857|58921737|FG001|Overall Study|Protocol Violation|1|||
30888995|NCT02495857|58921738|FG002|Overall Study|Protocol Violation|2|||
30888996|NCT02495857|58921736|FG000|Overall Study|Lost to Follow-up|4|||
30888997|NCT02495857|58921737|FG001|Overall Study|Lost to Follow-up|5|||
30888998|NCT02495857|58921738|FG002|Overall Study|Lost to Follow-up|3|||
30888999|NCT02495857|58921736|FG000|Overall Study|Other|3|||
30889000|NCT02495857|58921737|FG001|Overall Study|Other|3|||
30889001|NCT02495857|58921738|FG002|Overall Study|Other|2|||
30889002|NCT02495389|58921746|FG000|Overall Study|Withdrawal by Subject|40|||
30889003|NCT02495233|58921752|FG000|Overall Study|Miscellaneous|0|||
30889004|NCT02495233|58921753|FG001|Overall Study|Miscellaneous|1|||
30889005|NCT02495077|58921761|FG000|Overall Study|Adverse Event|0|||
30889006|NCT02495077|58921762|FG001|Overall Study|Adverse Event|1|||
30889007|NCT02495077|58921763|FG002|Overall Study|Adverse Event|1|||
30889008|NCT02495077|58921764|FG003|Overall Study|Adverse Event|0|||
30889009|NCT02495077|58921761|FG000|Overall Study|Death|3|||
30889010|NCT02495077|58921762|FG001|Overall Study|Death|5|||
30889011|NCT02495077|58921763|FG002|Overall Study|Death|0|||
30889012|NCT02495077|58921764|FG003|Overall Study|Death|0|||
30889013|NCT02495077|58921761|FG000|Overall Study|Lost to Follow-up|6|||
30889014|NCT02495077|58921762|FG001|Overall Study|Lost to Follow-up|4|||
30889015|NCT02495077|58921763|FG002|Overall Study|Lost to Follow-up|0|||
30889016|NCT02495077|58921764|FG003|Overall Study|Lost to Follow-up|0|||
30889017|NCT02495077|58921761|FG000|Overall Study|Physician Decision|2|||
30889018|NCT02495077|58921762|FG001|Overall Study|Physician Decision|1|||
30889019|NCT02495077|58921763|FG002|Overall Study|Physician Decision|4|||
30889020|NCT02495077|58921764|FG003|Overall Study|Physician Decision|0|||
30889021|NCT02495077|58921761|FG000|Overall Study|Protocol Violation|0|||
30889022|NCT02495077|58921762|FG001|Overall Study|Protocol Violation|1|||
30889023|NCT02495077|58921763|FG002|Overall Study|Protocol Violation|0|||
30889024|NCT02495077|58921764|FG003|Overall Study|Protocol Violation|0|||
30889025|NCT02495077|58921761|FG000|Overall Study|Screen Failure|0|||
30889026|NCT02495077|58921762|FG001|Overall Study|Screen Failure|0|||
30889027|NCT02495077|58921763|FG002|Overall Study|Screen Failure|0|||
30889028|NCT02495077|58921764|FG003|Overall Study|Screen Failure|48|||
30889029|NCT02495077|58921761|FG000|Overall Study|Withdrawal by Subject|7|||
30889030|NCT02495077|58921762|FG001|Overall Study|Withdrawal by Subject|7|||
30889031|NCT02495077|58921763|FG002|Overall Study|Withdrawal by Subject|7|||
30889032|NCT02495077|58921764|FG003|Overall Study|Withdrawal by Subject|0|||
30889033|NCT02495077|58921761|FG000|Overall Study|Covid-19 research restrictions|1|||
30889034|NCT02495077|58921762|FG001|Overall Study|Covid-19 research restrictions|0|||
30889035|NCT02495077|58921763|FG002|Overall Study|Covid-19 research restrictions|0|||
30889036|NCT02495077|58921764|FG003|Overall Study|Covid-19 research restrictions|0|||
30889037|NCT02495077|58921761|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
30889038|NCT02495077|58921762|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
30889039|NCT02495077|58921763|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
30889040|NCT02495077|58921764|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
30889041|NCT02495077|58921761|FG000|Overall Study|Incarcerated|0|||
30889042|NCT02495077|58921762|FG001|Overall Study|Incarcerated|1|||
30889043|NCT02495077|58921763|FG002|Overall Study|Incarcerated|0|||
30889044|NCT02495077|58921764|FG003|Overall Study|Incarcerated|0|||
30889045|NCT02495077|58921761|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
30889046|NCT02495077|58921762|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
30889047|NCT02495077|58921763|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
30889048|NCT02495077|58921764|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
30889049|NCT02495077|58921761|FG000|Overall Study|Timing of transplant and randomization|0|||
30889050|NCT02495077|58921762|FG001|Overall Study|Timing of transplant and randomization|0|||
30889051|NCT02495077|58921763|FG002|Overall Study|Timing of transplant and randomization|5|||
30889052|NCT02495077|58921764|FG003|Overall Study|Timing of transplant and randomization|0|||
30889053|NCT02278341|58921772|FG000|Overall Study|Randomized but never received study drug|1|||
30889054|NCT02278341|58921773|FG001|Overall Study|Randomized but never received study drug|1|||
30889055|NCT02278341|58921772|FG000|Overall Study|Adverse Event|3|||
30889056|NCT02278341|58921773|FG001|Overall Study|Adverse Event|0|||
30889057|NCT02278341|58921772|FG000|Overall Study|Death|68|||
30889058|NCT02278341|58921773|FG001|Overall Study|Death|56|||
30889059|NCT02278341|58921772|FG000|Overall Study|Withdrawal by Subject|30|||
30889060|NCT02278341|58921773|FG001|Overall Study|Withdrawal by Subject|19|||
30889061|NCT02278341|58921772|FG000|Overall Study|Lost to Follow-up|0|||
30889062|NCT02278341|58921773|FG001|Overall Study|Lost to Follow-up|1|||
30889063|NCT02278341|58921772|FG000|Overall Study|Physician Decision|1|||
30889064|NCT02278341|58921773|FG001|Overall Study|Physician Decision|1|||
30889065|NCT02278341|58921772|FG000|Overall Study|Miscellaneous|15|||
30889066|NCT02278341|58921773|FG001|Overall Study|Miscellaneous|14|||
30889067|NCT02282631|58921782|FG000|Overall Study|Lost to Follow-up|2|||
30889068|NCT02282631|58921783|FG001|Overall Study|Lost to Follow-up|0|||
30889069|NCT02278263|58921798|FG000|Overall Study|Protocol Violation|7|||
30889070|NCT02278263|58921799|FG001|Overall Study|Protocol Violation|0|||
30889071|NCT02278263|58921800|FG002|Overall Study|Protocol Violation|9|||
30889072|NCT02349789|58921811|FG000|Overall Study|Withdrawal by Subject|2|||
30889073|NCT02349711|58921817|FG000|Overall Study|Withdrawal by Subject|2|||
30889074|NCT02349711|58921818|FG001|Overall Study|Withdrawal by Subject|1|||
30889075|NCT02349711|58921817|FG000|Overall Study|Lost to Follow-up|1|||
30889076|NCT02349711|58921818|FG001|Overall Study|Lost to Follow-up|1|||
30889077|NCT02494921|58921829|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
30889078|NCT02494921|58921830|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
30889079|NCT02494921|58921831|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
30889080|NCT02494921|58921832|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
30889081|NCT02494921|58921833|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
30889082|NCT02494921|58921829|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
30889083|NCT02494921|58921830|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
30889084|NCT02494921|58921831|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
30889085|NCT02494921|58921832|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
30889086|NCT02494921|58921833|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
30889087|NCT02494921|58921829|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
30889088|NCT02494921|58921830|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
30889089|NCT02494921|58921831|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
30889090|NCT02494921|58921832|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
30889091|NCT02494921|58921833|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
30889092|NCT01653847|58921853|FG000|Overall Study|Withdrawal by Subject|1|||
30889093|NCT01653847|58921854|FG001|Overall Study|Withdrawal by Subject|0|||
30889094|NCT02493751|58921862|FG000|Overall Study|Withdrawal by Subject|2|||
30889095|NCT02493751|58921863|FG001|Overall Study|Withdrawal by Subject|8|||
30889096|NCT02493751|58921862|FG000|Overall Study|Death|6|||
30889097|NCT02493751|58921863|FG001|Overall Study|Death|13|||
30889098|NCT02493751|58921862|FG000|Overall Study|Lost to Follow-up|2|||
30889099|NCT02493751|58921863|FG001|Overall Study|Lost to Follow-up|3|||
30889100|NCT02493751|58921862|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
30889101|NCT02493751|58921863|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
30889102|NCT02493517|58921872|FG000|Overall Study|Protocol Violation|1|||
30889103|NCT02493517|58921873|FG001|Overall Study|Protocol Violation|2|||
30889104|NCT02493517|58921872|FG000|Overall Study|Withdrawal by Subject|1|||
30889105|NCT02493517|58921873|FG001|Overall Study|Withdrawal by Subject|2|||
30889106|NCT02493517|58921872|FG000|Overall Study|Adverse Event|0|||
30889107|NCT02493517|58921873|FG001|Overall Study|Adverse Event|2|||
30889108|NCT02493517|58921872|FG000|Overall Study|Missed study visit|0|||
30889109|NCT02493517|58921873|FG001|Overall Study|Missed study visit|1|||
30889110|NCT02493361|58921881|FG000|Overall Study|Withdrawal by Subject|3|||
30889111|NCT02493127|58921887|FG000|Overall Study|Lost to Follow-up|1|||
30889112|NCT02493127|58921888|FG001|Overall Study|Lost to Follow-up|1|||
30889113|NCT02478463|58921896|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
30889114|NCT02478463|58921896|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
30889115|NCT02478463|58921896|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
30889116|NCT02491411|58921902|FG000|Overall Study|Physician Decision|4|||
30889117|NCT02517463|58921908|FG000|Overall Study|Lost to Follow-up|5|||
30889118|NCT02517463|58921909|FG001|Overall Study|Lost to Follow-up|2|||
30889119|NCT02516605|58921920|FG000|Overall Study|Protocol Violation|0|||
30889120|NCT02516605|58921921|FG001|Overall Study|Protocol Violation|0|||
30889121|NCT02516605|58921922|FG002|Overall Study|Protocol Violation|0|||
30889122|NCT02516605|58921923|FG003|Overall Study|Protocol Violation|0|||
30889123|NCT02516605|58921924|FG004|Overall Study|Protocol Violation|1|||
30889124|NCT02516605|58921920|FG000|Overall Study|Withdrawal by Subject|0|||
30889125|NCT02516605|58921921|FG001|Overall Study|Withdrawal by Subject|0|||
30889126|NCT02516605|58921922|FG002|Overall Study|Withdrawal by Subject|0|||
30889127|NCT02516605|58921923|FG003|Overall Study|Withdrawal by Subject|1|||
30889128|NCT02516605|58921924|FG004|Overall Study|Withdrawal by Subject|0|||
30889129|NCT02490475|58921944|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
30889130|NCT02490475|58921945|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
30889131|NCT02490475|58921946|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
30889132|NCT02490475|58921947|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
30889133|NCT02490475|58921944|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
30889134|NCT02490475|58921945|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
30889135|NCT02490475|58921946|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
30889136|NCT02490475|58921947|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
30889137|NCT02490475|58921944|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
30889138|NCT02490475|58921945|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
30889139|NCT02490475|58921946|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
30889140|NCT02490475|58921947|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
30889141|NCT02490475|58921944|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
30889142|NCT02490475|58921945|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
30889143|NCT02490475|58921946|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
30889144|NCT02490475|58921947|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
30889145|NCT02490475|58921944|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
30889146|NCT02490475|58921945|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
30889147|NCT02490475|58921946|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
30889148|NCT02490475|58921947|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
30889149|NCT02490475|58921944|FG000|Period 2: Extension Phase|Refused Treatment|0|||
30889150|NCT02490475|58921945|FG001|Period 2: Extension Phase|Refused Treatment|0|||
30889151|NCT02490475|58921946|FG002|Period 2: Extension Phase|Refused Treatment|0|||
30889152|NCT02490475|58921947|FG003|Period 2: Extension Phase|Refused Treatment|1|||
30889153|NCT02490475|58921944|FG000|Period 2: Extension Phase|Adverse Event|0|||
30889154|NCT02490475|58921945|FG001|Period 2: Extension Phase|Adverse Event|0|||
30889155|NCT02490475|58921946|FG002|Period 2: Extension Phase|Adverse Event|1|||
30889156|NCT02490475|58921947|FG003|Period 2: Extension Phase|Adverse Event|0|||
30889157|NCT02477839|58921970|FG000|Overall Study|Adverse Event|0|||
30889158|NCT02477839|58921971|FG001|Overall Study|Adverse Event|1|||
30889159|NCT02477839|58921970|FG000|Overall Study|Protocol Violation|0|||
30889160|NCT02477839|58921971|FG001|Overall Study|Protocol Violation|2|||
30889161|NCT02477839|58921970|FG000|Overall Study|Withdrawal by Subject|3|||
30889162|NCT02477839|58921971|FG001|Overall Study|Withdrawal by Subject|3|||
30889163|NCT02477839|58921970|FG000|Overall Study|Participant had PGS during V6|0|||
30889164|NCT02477839|58921971|FG001|Overall Study|Participant had PGS during V6|1|||
30889165|NCT02477839|58921970|FG000|Overall Study|Parents decided to stop medication|0|||
30889166|NCT02477839|58921971|FG001|Overall Study|Parents decided to stop medication|1|||
30889167|NCT02477839|58921970|FG000|Overall Study|Lack of tolerability|0|||
30889168|NCT02477839|58921971|FG001|Overall Study|Lack of tolerability|1|||
30889169|NCT02477839|58921970|FG000|Overall Study|Exclusion criterion|0|||
30889170|NCT02477839|58921971|FG001|Overall Study|Exclusion criterion|1|||
30889171|NCT02489773|58921981|FG000|Overall Study|Lost to Follow-up|4|||
30889172|NCT02489773|58921982|FG001|Overall Study|Lost to Follow-up|1|||
30889173|NCT02489773|58921981|FG000|Overall Study|Physician Decision|1|||
30889174|NCT02489773|58921982|FG001|Overall Study|Physician Decision|0|||
30889175|NCT02489773|58921981|FG000|Overall Study|Withdrawal by Subject|1|||
30889176|NCT02489773|58921982|FG001|Overall Study|Withdrawal by Subject|0|||
30889177|NCT02489773|58921981|FG000|Overall Study|Leave the country or the state|1|||
30889178|NCT02489773|58921982|FG001|Overall Study|Leave the country or the state|1|||
30889179|NCT02488915|58921988|FG000|Overall Study|Death|21|||
30889180|NCT02488915|58921988|FG000|Overall Study|Lost to Follow-up|4|||
30889181|NCT02488915|58921988|FG000|Overall Study|Withdrawal by Subject|1|||
30889182|NCT02488681|58921992|FG000|Overall Study|Implant unsuccessful|7|||
30790163|NCT00064337|58803351|FG000|Transplant|Adverse Event|9|||
30889183|NCT02477605|58921998|FG000|Overall Study|Discontinued prior to treatment|1|||
30889184|NCT02477605|58921999|FG001|Overall Study|Discontinued prior to treatment|0|||
30889185|NCT02477605|58921998|FG000|Overall Study|Lost to Follow-up|0|||
30889186|NCT02477605|58921999|FG001|Overall Study|Lost to Follow-up|2|||
30889187|NCT02477605|58921998|FG000|Overall Study|Withdrawal by Subject|0|||
30889188|NCT02477605|58921999|FG001|Overall Study|Withdrawal by Subject|1|||
30889189|NCT02477605|58921998|FG000|Overall Study|Administered gas during surgery|0|||
30889190|NCT02477605|58921999|FG001|Overall Study|Administered gas during surgery|1|||
30889191|NCT02477527|58922009|FG000|Overall Study|Lost to Follow-up|2|||
30889192|NCT02477527|58922009|FG000|Overall Study|Withdrawal by Subject|1|||
30889193|NCT02477527|58922009|FG000|Overall Study|Screen Failure|3|||
30889194|NCT02477215|58922017|FG000|Dose Escalation Phase|Physician Decision|1|||
30889195|NCT02477215|58922018|FG001|Dose Escalation Phase|Physician Decision|2|||
30889196|NCT02477215|58922019|FG002|Dose Escalation Phase|Physician Decision|0|||
30889197|NCT02477215|58922017|FG000|Fixed Dose Phase|Physician Decision|0|||
30889198|NCT02477215|58922018|FG001|Fixed Dose Phase|Physician Decision|7|||
30889199|NCT02477215|58922019|FG002|Fixed Dose Phase|Physician Decision|0|||
30889200|NCT02487199|58922032|FG000|Overall Study|Withdrew Consent|0|||
30889201|NCT02487199|58922033|FG001|Overall Study|Withdrew Consent|1|||
30889202|NCT02475733|58922041|FG000|Overall Study|Withdrawal by Subject|1|||
30889203|NCT02475733|58922042|FG001|Overall Study|Withdrawal by Subject|0|||
30889204|NCT02475733|58922041|FG000|Overall Study|Physician Decision|1|||
30889205|NCT02475733|58922042|FG001|Overall Study|Physician Decision|0|||
30889206|NCT02486653|58922050|FG000|Overall Study|Withdrawal by Subject|1|||
30889207|NCT02486653|58922051|FG001|Overall Study|Withdrawal by Subject|3|||
30889208|NCT02486653|58922050|FG000|Overall Study|Protocol Violation|1|||
30889209|NCT02486653|58922051|FG001|Overall Study|Protocol Violation|0|||
30889210|NCT02486653|58922050|FG000|Overall Study|surgery cancelled|4|||
30889211|NCT02486653|58922051|FG001|Overall Study|surgery cancelled|1|||
30889212|NCT02475655|58922059|FG000|Overall Study|Lost to Follow-up|0|||
30889213|NCT02475655|58922060|FG001|Overall Study|Lost to Follow-up|1|||
30889214|NCT02475265|58922066|FG000|Overall Study|Physician Decision|1|||
30889215|NCT02475265|58922066|FG000|Overall Study|Withdrawal by Subject|2|||
30889216|NCT02485717|58922073|FG000|Overall Study|Lost to Follow-up|6|||
30889217|NCT02485717|58922074|FG001|Overall Study|Lost to Follow-up|0|||
30889218|NCT02485717|58922075|FG002|Overall Study|Lost to Follow-up|0|||
30889219|NCT02485717|58922073|FG000|Overall Study|Withdrawal by Subject|0|||
30889220|NCT02485717|58922074|FG001|Overall Study|Withdrawal by Subject|0|||
30889221|NCT02485717|58922075|FG002|Overall Study|Withdrawal by Subject|1|||
30889222|NCT02485717|58922073|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
30889223|NCT02485717|58922074|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
30889224|NCT02485717|58922075|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
30889225|NCT02485717|58922073|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
30889226|NCT02485717|58922074|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
30889227|NCT02485717|58922075|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
30889228|NCT02451007|58922083|FG000|Overall Study|Withdrawal by Subject|4|||
30889229|NCT02451007|58922083|FG000|Overall Study|Adverse Event|1|||
30889230|NCT02451007|58922083|FG000|Overall Study|Disease Progression|2|||
30889231|NCT02485483|58922089|FG000|Overall Study|Depression at baseline|15|||
30889232|NCT02485483|58922090|FG001|Overall Study|Depression at baseline|0|||
30889233|NCT02485483|58922089|FG000|Overall Study|Discontinued after baseline|39|||
30889234|NCT02485483|58922090|FG001|Overall Study|Discontinued after baseline|0|||
30889235|NCT02473471|58922096|FG000|Overall Study|poor oral hygiene|2|||
30889236|NCT02473471|58922096|FG000|Overall Study|Lost to Follow-up|1|||
30889237|NCT02450539|58922108|FG000|Overall Study|Withdrawal by Subject|12|||
30889238|NCT02450539|58922109|FG001|Overall Study|Withdrawal by Subject|6|||
30889239|NCT02450539|58922108|FG000|Overall Study|Lost to Follow-up|4|||
30889240|NCT02450539|58922109|FG001|Overall Study|Lost to Follow-up|1|||
30889241|NCT02449915|58922120|FG000|Overall Study|Exclusion criteria - drug use|1|||
30889242|NCT02449915|58922121|FG001|Overall Study|Exclusion criteria - drug use|0|||
30889243|NCT02449915|58922120|FG000|Overall Study|Withdrawal by Subject|0|||
30889244|NCT02449915|58922121|FG001|Overall Study|Withdrawal by Subject|2|||
30889245|NCT02449915|58922120|FG000|Overall Study|Intraoperative surgical findings|1|||
30889246|NCT02449915|58922121|FG001|Overall Study|Intraoperative surgical findings|1|||
30889247|NCT02449915|58922120|FG000|Overall Study|Abnormal preop lab|0|||
30889248|NCT02449915|58922121|FG001|Overall Study|Abnormal preop lab|1|||
30889249|NCT02420119|58922127|FG000|Overall Study|insufficient laboratory data|5|||
30889250|NCT02473393|58922135|FG000|Overall Study|Adverse Event|0|||
30889251|NCT02473393|58922136|FG001|Overall Study|Adverse Event|0|||
30889252|NCT02473393|58922137|FG002|Overall Study|Adverse Event|1|||
30889253|NCT02473393|58922138|FG003|Overall Study|Adverse Event|0|||
30889254|NCT02473393|58922135|FG000|Overall Study|Withdrawal by Subject|0|||
30889255|NCT02473393|58922136|FG001|Overall Study|Withdrawal by Subject|0|||
30889256|NCT02473393|58922137|FG002|Overall Study|Withdrawal by Subject|1|||
30889257|NCT02473393|58922138|FG003|Overall Study|Withdrawal by Subject|1|||
30889258|NCT02419573|58922150|FG000|Overall Study|Lost to Follow-up|3|||
30889259|NCT02419573|58922151|FG001|Overall Study|Lost to Follow-up|0|||
30889260|NCT02419573|58922150|FG000|Overall Study|Withdrawal by Subject|1|||
30889261|NCT02419573|58922151|FG001|Overall Study|Withdrawal by Subject|0|||
30889262|NCT02472847|58922159|FG000|Overall Study|Withdrawal by Subject|1|||
30889263|NCT02472847|58922160|FG001|Overall Study|Withdrawal by Subject|5|||
30889264|NCT02472145|58922169|FG000|Overall Study|Death|10|||
30889265|NCT02472145|58922170|FG001|Overall Study|Death|101|||
30889266|NCT02472145|58922171|FG002|Overall Study|Death|99|||
30889267|NCT02472145|58922169|FG000|Overall Study|Lost to Follow-up|0|||
30889268|NCT02472145|58922170|FG001|Overall Study|Lost to Follow-up|1|||
30889269|NCT02472145|58922171|FG002|Overall Study|Lost to Follow-up|0|||
30889270|NCT02472145|58922169|FG000|Overall Study|Withdrawal by Subject|0|||
30889271|NCT02472145|58922170|FG001|Overall Study|Withdrawal by Subject|9|||
30889272|NCT02472145|58922171|FG002|Overall Study|Withdrawal by Subject|13|||
30889273|NCT02472145|58922169|FG000|Overall Study|Sponsor decision|0|||
30889274|NCT02472145|58922170|FG001|Overall Study|Sponsor decision|3|||
30889275|NCT02472145|58922171|FG002|Overall Study|Sponsor decision|2|||
30889276|NCT02472145|58922169|FG000|Overall Study|Other|0|||
30889277|NCT02472145|58922170|FG001|Overall Study|Other|45|||
30889278|NCT02472145|58922171|FG002|Overall Study|Other|43|||
30889279|NCT02418949|58922182|FG000|Overall Study|Withdrawal by Subject|1|||
30889280|NCT02418949|58922183|FG001|Overall Study|Withdrawal by Subject|0|||
30889281|NCT02418949|58922184|FG002|Overall Study|Withdrawal by Subject|1|||
30889282|NCT02418949|58922185|FG003|Overall Study|Withdrawal by Subject|1|||
30889283|NCT02418949|58922182|FG000|Overall Study|Lost to Follow-up|1|||
30889284|NCT02418949|58922183|FG001|Overall Study|Lost to Follow-up|0|||
30889285|NCT02418949|58922184|FG002|Overall Study|Lost to Follow-up|1|||
30889286|NCT02418949|58922185|FG003|Overall Study|Lost to Follow-up|0|||
30889287|NCT02418949|58922182|FG000|Overall Study|Physician Decision|1|||
30889288|NCT02418949|58922183|FG001|Overall Study|Physician Decision|1|||
30889289|NCT02418949|58922184|FG002|Overall Study|Physician Decision|1|||
30889290|NCT02418949|58922185|FG003|Overall Study|Physician Decision|0|||
30889291|NCT02448043|58922197|FG000|Overall Study|Withdrawal by Subject|2|||
30889292|NCT02448043|58922198|FG001|Overall Study|Withdrawal by Subject|2|||
30889293|NCT02448043|58922197|FG000|Overall Study|Protocol Violation|1|||
30889294|NCT02448043|58922198|FG001|Overall Study|Protocol Violation|2|||
30889295|NCT02447887|58922207|FG000|Overall Study|Study was terminated|3|||
30889296|NCT02471755|58922213|FG000|Overall Study|Withdrawal by Subject|1|||
30889297|NCT02471755|58922214|FG001|Overall Study|Withdrawal by Subject|0|||
30889298|NCT02471755|58922213|FG000|Overall Study|Lost to Follow-up|0|||
30889299|NCT02471755|58922214|FG001|Overall Study|Lost to Follow-up|1|||
30889300|NCT02470429|58922222|FG000|Overall Study|Adverse Event|1|||
30889301|NCT02470429|58922223|FG001|Overall Study|Adverse Event|0|||
30889302|NCT02470429|58922222|FG000|Overall Study|Withdrawal by Subject|1|||
30889303|NCT02470429|58922223|FG001|Overall Study|Withdrawal by Subject|0|||
30889304|NCT02447497|58922234|FG000|Overall Study|Did not meet treatment day baseline.|6|||
30889305|NCT02447497|58922235|FG001|Overall Study|Did not meet treatment day baseline.|5|||
30889306|NCT02447497|58922236|FG002|Overall Study|Did not meet treatment day baseline.|2|||
30889307|NCT02447497|58922237|FG003|Overall Study|Did not meet treatment day baseline.|2|||
30889308|NCT02447497|58922234|FG000|Overall Study|Dressing was compromised|0|||
30889309|NCT02447497|58922235|FG001|Overall Study|Dressing was compromised|1|||
30889310|NCT02447497|58922236|FG002|Overall Study|Dressing was compromised|0|||
30889311|NCT02447497|58922237|FG003|Overall Study|Dressing was compromised|0|||
30889312|NCT02417935|58922257|FG000|Treatment Period|Adverse Event|12|||
30889313|NCT02417935|58922258|FG001|Treatment Period|Adverse Event|10|||
30889314|NCT02417935|58922257|FG000|Treatment Period|Lost to Follow-up|1|||
30889315|NCT02417935|58922258|FG001|Treatment Period|Lost to Follow-up|0|||
30889316|NCT02417935|58922257|FG000|Treatment Period|Entry Criteria not met|0|||
30889317|NCT02417935|58922258|FG001|Treatment Period|Entry Criteria not met|1|||
30889318|NCT02417935|58922257|FG000|Treatment Period|Protocol Violation|2|||
30889319|NCT02417935|58922258|FG001|Treatment Period|Protocol Violation|1|||
30889320|NCT02417935|58922257|FG000|Treatment Period|Withdrawal by Subject|3|||
30889321|NCT02417935|58922258|FG001|Treatment Period|Withdrawal by Subject|3|||
30976273|NCT02585778|59063563|FG001|Overall Study|Death|1|||
30889322|NCT02417935|58922257|FG000|Treatment Period|Physician Decision|3|||
30889323|NCT02417935|58922258|FG001|Treatment Period|Physician Decision|1|||
30889324|NCT02417233|58922267|FG000|Overall Study|Death|4|||
30889325|NCT02417233|58922268|FG001|Overall Study|Death|10|||
30889326|NCT02417233|58922269|FG002|Overall Study|Death|14|||
30889327|NCT02417233|58922267|FG000|Overall Study|Lost to Follow-up|27|||
30889328|NCT02417233|58922268|FG001|Overall Study|Lost to Follow-up|39|||
30889329|NCT02417233|58922269|FG002|Overall Study|Lost to Follow-up|34|||
30889330|NCT02417233|58922267|FG000|Overall Study|Protocol Violation|2|||
30889331|NCT02417233|58922268|FG001|Overall Study|Protocol Violation|0|||
30889332|NCT02417233|58922269|FG002|Overall Study|Protocol Violation|2|||
30889333|NCT02417233|58922267|FG000|Overall Study|Withdrawal by Subject|2|||
30889334|NCT02417233|58922268|FG001|Overall Study|Withdrawal by Subject|1|||
30790164|NCT00064337|58803351|FG000|Transplant|Not protocol-specified|5|||
30889335|NCT02417233|58922269|FG002|Overall Study|Withdrawal by Subject|8|||
30889336|NCT02417233|58922267|FG000|Overall Study|Relocation out of study area|1|||
30976274|NCT02585778|59063562|FG000|Overall Study|Randomized but not treated|1|||
30889337|NCT02417233|58922268|FG001|Overall Study|Relocation out of study area|0|||
30889338|NCT02417233|58922269|FG002|Overall Study|Relocation out of study area|1|||
30889339|NCT02417233|58922267|FG000|Overall Study|Mentally unstable|0|||
30889340|NCT02417233|58922268|FG001|Overall Study|Mentally unstable|1|||
30889341|NCT02417233|58922269|FG002|Overall Study|Mentally unstable|0|||
30889342|NCT02447029|58922280|FG000|Overall Study|Withdrawal by Subject|3|||
30889343|NCT02447029|58922281|FG001|Overall Study|Withdrawal by Subject|2|||
30889344|NCT02416453|58922298|FG000|Overall Study|Adverse Event|0|||
30889345|NCT02416453|58922299|FG001|Overall Study|Adverse Event|0|||
30889346|NCT02416453|58922300|FG002|Overall Study|Adverse Event|0|||
30889347|NCT02416453|58922301|FG003|Overall Study|Adverse Event|2|||
30889348|NCT02416453|58922302|FG004|Overall Study|Adverse Event|0|||
30889349|NCT02416453|58922303|FG005|Overall Study|Adverse Event|1|||
30889350|NCT02416453|58922304|FG006|Overall Study|Adverse Event|0|||
30889351|NCT02416453|58922305|FG007|Overall Study|Adverse Event|0|||
30889352|NCT02416453|58922306|FG008|Overall Study|Adverse Event|0|||
30889353|NCT02416453|58922307|FG009|Overall Study|Adverse Event|0|||
30889354|NCT02416453|58922308|FG010|Overall Study|Adverse Event|0|||
30889355|NCT02416453|58922298|FG000|Overall Study|Lost to Follow-up|1|||
30889356|NCT02416453|58922299|FG001|Overall Study|Lost to Follow-up|3|||
30889357|NCT02416453|58922300|FG002|Overall Study|Lost to Follow-up|0|||
30889358|NCT02416453|58922301|FG003|Overall Study|Lost to Follow-up|8|||
30889359|NCT02416453|58922302|FG004|Overall Study|Lost to Follow-up|0|||
30889360|NCT02416453|58922303|FG005|Overall Study|Lost to Follow-up|5|||
30889361|NCT02416453|58922304|FG006|Overall Study|Lost to Follow-up|1|||
30889362|NCT02416453|58922305|FG007|Overall Study|Lost to Follow-up|3|||
30889363|NCT02416453|58922306|FG008|Overall Study|Lost to Follow-up|1|||
30889364|NCT02416453|58922307|FG009|Overall Study|Lost to Follow-up|0|||
30889365|NCT02416453|58922308|FG010|Overall Study|Lost to Follow-up|0|||
30889366|NCT02416453|58922298|FG000|Overall Study|Physician Decision|0|||
30889367|NCT02416453|58922299|FG001|Overall Study|Physician Decision|0|||
30889368|NCT02416453|58922300|FG002|Overall Study|Physician Decision|0|||
30889369|NCT02416453|58922301|FG003|Overall Study|Physician Decision|0|||
30889370|NCT02416453|58922302|FG004|Overall Study|Physician Decision|0|||
30889371|NCT02416453|58922303|FG005|Overall Study|Physician Decision|1|||
30889372|NCT02416453|58922304|FG006|Overall Study|Physician Decision|1|||
30889373|NCT02416453|58922305|FG007|Overall Study|Physician Decision|1|||
30889374|NCT02416453|58922306|FG008|Overall Study|Physician Decision|0|||
30889375|NCT02416453|58922307|FG009|Overall Study|Physician Decision|0|||
30889376|NCT02416453|58922308|FG010|Overall Study|Physician Decision|0|||
30889377|NCT02416453|58922298|FG000|Overall Study|Withdrawal by Subject|2|||
30889378|NCT02416453|58922299|FG001|Overall Study|Withdrawal by Subject|0|||
30889379|NCT02416453|58922300|FG002|Overall Study|Withdrawal by Subject|0|||
30889380|NCT02416453|58922301|FG003|Overall Study|Withdrawal by Subject|5|||
30889381|NCT02416453|58922302|FG004|Overall Study|Withdrawal by Subject|1|||
30889382|NCT02416453|58922303|FG005|Overall Study|Withdrawal by Subject|8|||
30889383|NCT02416453|58922304|FG006|Overall Study|Withdrawal by Subject|0|||
30889384|NCT02416453|58922305|FG007|Overall Study|Withdrawal by Subject|8|||
30889385|NCT02416453|58922306|FG008|Overall Study|Withdrawal by Subject|4|||
30889386|NCT02416453|58922307|FG009|Overall Study|Withdrawal by Subject|0|||
30889387|NCT02416453|58922308|FG010|Overall Study|Withdrawal by Subject|0|||
30889388|NCT02416453|58922298|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
30889389|NCT02416453|58922299|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
30889390|NCT02416453|58922300|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
30889391|NCT02416453|58922301|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
30889392|NCT02416453|58922302|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
30889393|NCT02416453|58922303|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
30889394|NCT02416453|58922304|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
30889395|NCT02416453|58922305|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
30889396|NCT02416453|58922306|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
30889397|NCT02416453|58922307|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
30889398|NCT02416453|58922308|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
30889399|NCT02416453|58922298|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
30889400|NCT02416453|58922299|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
30889401|NCT02416453|58922300|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
30889402|NCT02416453|58922301|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
30889403|NCT02416453|58922302|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
30889404|NCT02416453|58922303|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
30889405|NCT02416453|58922304|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
30889406|NCT02416453|58922305|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
30889407|NCT02416453|58922306|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
30889408|NCT02416453|58922307|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
30889409|NCT02416453|58922308|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
30889410|NCT02469961|58922340|FG000|Overall Study|Physician Decision|4|||
30889411|NCT02469961|58922341|FG001|Overall Study|Physician Decision|1|||
30889412|NCT02415595|58922356|FG000|Overall Study|Administrative reason by sponsor|39|||
30889413|NCT02415595|58922357|FG001|Overall Study|Administrative reason by sponsor|40|||
30889414|NCT02415595|58922358|FG002|Overall Study|Administrative reason by sponsor|41|||
30889415|NCT02415595|58922359|FG003|Overall Study|Administrative reason by sponsor|39|||
30889416|NCT02415595|58922356|FG000|Overall Study|Adverse Event|1|||
30889417|NCT02415595|58922357|FG001|Overall Study|Adverse Event|3|||
30889418|NCT02415595|58922358|FG002|Overall Study|Adverse Event|5|||
30889419|NCT02415595|58922359|FG003|Overall Study|Adverse Event|10|||
30889420|NCT02415595|58922356|FG000|Overall Study|Lack of Efficacy|4|||
30889421|NCT02415595|58922357|FG001|Overall Study|Lack of Efficacy|4|||
30889422|NCT02415595|58922358|FG002|Overall Study|Lack of Efficacy|0|||
30889423|NCT02415595|58922359|FG003|Overall Study|Lack of Efficacy|0|||
30889424|NCT02415595|58922356|FG000|Overall Study|Lost to Follow-up|1|||
30889425|NCT02415595|58922357|FG001|Overall Study|Lost to Follow-up|3|||
30889426|NCT02415595|58922358|FG002|Overall Study|Lost to Follow-up|1|||
30889427|NCT02415595|58922359|FG003|Overall Study|Lost to Follow-up|1|||
30889428|NCT02415595|58922356|FG000|Overall Study|Poor/Non-compliance|1|||
30889429|NCT02415595|58922357|FG001|Overall Study|Poor/Non-compliance|0|||
30889430|NCT02415595|58922358|FG002|Overall Study|Poor/Non-compliance|1|||
30889431|NCT02415595|58922359|FG003|Overall Study|Poor/Non-compliance|0|||
30889432|NCT02415595|58922356|FG000|Overall Study|Reached stopping criteria|0|||
30889433|NCT02415595|58922357|FG001|Overall Study|Reached stopping criteria|1|||
30889434|NCT02415595|58922358|FG002|Overall Study|Reached stopping criteria|1|||
30889435|NCT02415595|58922359|FG003|Overall Study|Reached stopping criteria|0|||
30889436|NCT02415595|58922356|FG000|Overall Study|Withdrawal by Subject|4|||
30889437|NCT02415595|58922357|FG001|Overall Study|Withdrawal by Subject|0|||
30889438|NCT02415595|58922358|FG002|Overall Study|Withdrawal by Subject|1|||
30889439|NCT02415595|58922359|FG003|Overall Study|Withdrawal by Subject|3|||
30889440|NCT02415595|58922356|FG000|Overall Study|Other|0|||
30889441|NCT02415595|58922357|FG001|Overall Study|Other|1|||
30889442|NCT02415595|58922358|FG002|Overall Study|Other|1|||
30889443|NCT02415595|58922359|FG003|Overall Study|Other|0|||
30889444|NCT02446717|58922375|FG000|Overall Study|Adverse Event|0|||
30889445|NCT02446717|58922376|FG001|Overall Study|Adverse Event|0|||
30889446|NCT02446717|58922377|FG002|Overall Study|Adverse Event|1|||
30889447|NCT02446717|58922378|FG003|Overall Study|Adverse Event|0|||
30889448|NCT02446717|58922379|FG004|Overall Study|Adverse Event|0|||
30889449|NCT02446717|58922375|FG000|Overall Study|Lost to Follow-up|0|||
30889450|NCT02446717|58922376|FG001|Overall Study|Lost to Follow-up|1|||
30889451|NCT02446717|58922377|FG002|Overall Study|Lost to Follow-up|1|||
30889452|NCT02446717|58922378|FG003|Overall Study|Lost to Follow-up|0|||
30889453|NCT02446717|58922379|FG004|Overall Study|Lost to Follow-up|1|||
30889454|NCT02446717|58922375|FG000|Overall Study|Withdrew consent|0|||
30889455|NCT02446717|58922376|FG001|Overall Study|Withdrew consent|0|||
30889456|NCT02446717|58922377|FG002|Overall Study|Withdrew consent|0|||
30889457|NCT02446717|58922378|FG003|Overall Study|Withdrew consent|1|||
30889458|NCT02446717|58922379|FG004|Overall Study|Withdrew consent|0|||
30889459|NCT02469415|58922391|FG000|Overall Study|Withdrawal by Subject|1|||
30889460|NCT02469415|58922391|FG000|Overall Study|Investigational agent placed on hold|2|||
30889461|NCT02446171|58922399|FG000|Overall Study|Withdrawal by Subject|0|||
30889462|NCT02446171|58922400|FG001|Overall Study|Withdrawal by Subject|0|||
30889463|NCT02446171|58922401|FG002|Overall Study|Withdrawal by Subject|2|||
30889464|NCT02446171|58922402|FG003|Overall Study|Withdrawal by Subject|0|||
30889465|NCT02446015|58922416|FG000|Overall Study|Adverse Event|0|||
30889466|NCT02446015|58922417|FG001|Overall Study|Adverse Event|1|||
30889467|NCT02446015|58922416|FG000|Overall Study|Withdrawal by Subject|1|||
30889468|NCT02446015|58922417|FG001|Overall Study|Withdrawal by Subject|0|||
30889469|NCT02415127|58922426|FG000|Overall Study|Adverse Event|1|||
30889470|NCT02415127|58922427|FG001|Overall Study|Adverse Event|0|||
30889471|NCT02468557|58922433|FG000|Overall Study|Adverse Event|1|||
30889472|NCT02468557|58922433|FG000|Overall Study|Death|1|||
30889473|NCT02468557|58922433|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
30889474|NCT02468557|58922433|FG000|Overall Study|All Enrolled but Never Dosed|4|||
30889475|NCT02413489|58922444|FG000|Overall Study|Death|11|||
30889476|NCT02413489|58922445|FG001|Overall Study|Death|3|||
30889477|NCT02413489|58922446|FG002|Overall Study|Death|4|||
30889478|NCT02413489|58922444|FG000|Overall Study|Withdrawal by Subject|2|||
30889479|NCT02413489|58922445|FG001|Overall Study|Withdrawal by Subject|0|||
30889480|NCT02413489|58922446|FG002|Overall Study|Withdrawal by Subject|0|||
30889481|NCT02413489|58922444|FG000|Overall Study|Study Terminated By Sponsor|2|||
30889482|NCT02413489|58922445|FG001|Overall Study|Study Terminated By Sponsor|13|||
30889483|NCT02413489|58922446|FG002|Overall Study|Study Terminated By Sponsor|1|||
30889484|NCT02413333|58922458|FG000|Period 1|Adverse Event|1|||
30889485|NCT02413333|58922459|FG001|Period 1|Adverse Event|0|||
30889486|NCT02413333|58922458|FG000|Period 1|Reason Not Specified|0|||
30889487|NCT02413333|58922459|FG001|Period 1|Reason Not Specified|1|||
30889488|NCT02413333|58922458|FG000|Period 2|Protocol Deviation|1|||
30889489|NCT02413333|58922459|FG001|Period 2|Protocol Deviation|0|||
30889490|NCT02413255|58922482|FG000|Overall Study|Voluntary Withdrawal|0|||
30889491|NCT02413255|58922483|FG001|Overall Study|Voluntary Withdrawal|0|||
30889492|NCT02413255|58922484|FG002|Overall Study|Voluntary Withdrawal|0|||
30889493|NCT02413255|58922485|FG003|Overall Study|Voluntary Withdrawal|0|||
30889494|NCT02413255|58922486|FG004|Overall Study|Voluntary Withdrawal|0|||
30889495|NCT02413255|58922487|FG005|Overall Study|Voluntary Withdrawal|0|||
30889496|NCT02413255|58922488|FG006|Overall Study|Voluntary Withdrawal|0|||
30889497|NCT02413255|58922489|FG007|Overall Study|Voluntary Withdrawal|0|||
30889498|NCT02413255|58922490|FG008|Overall Study|Voluntary Withdrawal|0|||
30889499|NCT02413255|58922491|FG009|Overall Study|Voluntary Withdrawal|0|||
30889500|NCT02413255|58922492|FG010|Overall Study|Voluntary Withdrawal|0|||
30889501|NCT02413255|58922493|FG011|Overall Study|Voluntary Withdrawal|0|||
30889502|NCT02413255|58922494|FG012|Overall Study|Voluntary Withdrawal|0|||
30889503|NCT02413255|58922495|FG013|Overall Study|Voluntary Withdrawal|0|||
30889504|NCT02413255|58922496|FG014|Overall Study|Voluntary Withdrawal|1|||
30889505|NCT02413255|58922497|FG015|Overall Study|Voluntary Withdrawal|0|||
30889506|NCT02413255|58922498|FG016|Overall Study|Voluntary Withdrawal|0|||
30889507|NCT02444533|58922551|FG000|Overall Study|Not able to complete forms|0|||
30889508|NCT02444533|58922552|FG001|Overall Study|Not able to complete forms|2|||
30889509|NCT02444533|58922551|FG000|Overall Study|Only gave post-procedure complications|2|||
30889510|NCT02444533|58922552|FG001|Overall Study|Only gave post-procedure complications|2|||
30889511|NCT01651039|58922558|FG000|Overall Study|Non-evaluables|5|||
30889512|NCT01651039|58922558|FG000|Overall Study|Physician Decision|2|||
30889513|NCT01651039|58922558|FG000|Overall Study|Withdrawal by Subject|1|||
30889514|NCT01651039|58922558|FG000|Overall Study|Progressive Disease|22|||
30889515|NCT02349633|58922576|FG000|Overall Study|Death|0|||
30889516|NCT02349633|58922577|FG001|Overall Study|Death|1|||
30889517|NCT02349633|58922578|FG002|Overall Study|Death|0|||
30889518|NCT02349633|58922579|FG003|Overall Study|Death|0|||
30889519|NCT02349633|58922580|FG004|Overall Study|Death|0|||
30889520|NCT02349633|58922581|FG005|Overall Study|Death|1|||
30889521|NCT02349633|58922582|FG006|Overall Study|Death|1|||
30889522|NCT02349633|58922583|FG007|Overall Study|Death|1|||
30889523|NCT02349633|58922584|FG008|Overall Study|Death|0|||
30889524|NCT02349633|58922585|FG009|Overall Study|Death|1|||
30889525|NCT02349633|58922586|FG010|Overall Study|Death|0|||
30889526|NCT02349633|58922587|FG011|Overall Study|Death|0|||
30889527|NCT02349633|58922588|FG012|Overall Study|Death|0|||
30889528|NCT02349633|58922589|FG013|Overall Study|Death|0|||
30889529|NCT02349633|58922576|FG000|Overall Study|Withdrawal by Subject|0|||
30889530|NCT02349633|58922577|FG001|Overall Study|Withdrawal by Subject|0|||
30889531|NCT02349633|58922578|FG002|Overall Study|Withdrawal by Subject|0|||
30889532|NCT02349633|58922579|FG003|Overall Study|Withdrawal by Subject|1|||
30889533|NCT02349633|58922580|FG004|Overall Study|Withdrawal by Subject|0|||
30889534|NCT02349633|58922581|FG005|Overall Study|Withdrawal by Subject|0|||
30889535|NCT02349633|58922582|FG006|Overall Study|Withdrawal by Subject|0|||
30889536|NCT02349633|58922583|FG007|Overall Study|Withdrawal by Subject|2|||
30889537|NCT02349633|58922584|FG008|Overall Study|Withdrawal by Subject|2|||
30889538|NCT02349633|58922585|FG009|Overall Study|Withdrawal by Subject|1|||
30889539|NCT02349633|58922586|FG010|Overall Study|Withdrawal by Subject|0|||
30889540|NCT02349633|58922587|FG011|Overall Study|Withdrawal by Subject|0|||
30889541|NCT02349633|58922588|FG012|Overall Study|Withdrawal by Subject|0|||
30889542|NCT02349633|58922589|FG013|Overall Study|Withdrawal by Subject|0|||
30889543|NCT02349633|58922576|FG000|Overall Study|Withdrawal of informed consent|0|||
30889544|NCT02349633|58922577|FG001|Overall Study|Withdrawal of informed consent|0|||
30889545|NCT02349633|58922578|FG002|Overall Study|Withdrawal of informed consent|0|||
30889546|NCT02349633|58922579|FG003|Overall Study|Withdrawal of informed consent|1|||
30889547|NCT02349633|58922580|FG004|Overall Study|Withdrawal of informed consent|1|||
30976275|NCT02585778|59063563|FG001|Overall Study|Randomized but not treated|2|||
30976276|NCT02585778|59063562|FG000|Overall Study|Other than specified above|6|||
30889548|NCT02349633|58922581|FG005|Overall Study|Withdrawal of informed consent|0|||
30889549|NCT02349633|58922582|FG006|Overall Study|Withdrawal of informed consent|0|||
30889550|NCT02349633|58922583|FG007|Overall Study|Withdrawal of informed consent|3|||
30889551|NCT02349633|58922584|FG008|Overall Study|Withdrawal of informed consent|0|||
30889552|NCT02349633|58922585|FG009|Overall Study|Withdrawal of informed consent|0|||
30889553|NCT02349633|58922586|FG010|Overall Study|Withdrawal of informed consent|0|||
30889554|NCT02349633|58922587|FG011|Overall Study|Withdrawal of informed consent|0|||
30889555|NCT02349633|58922588|FG012|Overall Study|Withdrawal of informed consent|0|||
30889556|NCT02349633|58922589|FG013|Overall Study|Withdrawal of informed consent|0|||
30889557|NCT02349633|58922576|FG000|Overall Study|Transition to compassionate use|0|||
30889558|NCT02349633|58922577|FG001|Overall Study|Transition to compassionate use|0|||
30889559|NCT02349633|58922578|FG002|Overall Study|Transition to compassionate use|0|||
30889560|NCT02349633|58922579|FG003|Overall Study|Transition to compassionate use|0|||
30889561|NCT02349633|58922580|FG004|Overall Study|Transition to compassionate use|1|||
30889562|NCT02349633|58922581|FG005|Overall Study|Transition to compassionate use|0|||
30889563|NCT02349633|58922582|FG006|Overall Study|Transition to compassionate use|0|||
30889564|NCT02349633|58922583|FG007|Overall Study|Transition to compassionate use|3|||
30889565|NCT02349633|58922584|FG008|Overall Study|Transition to compassionate use|0|||
30889566|NCT02349633|58922585|FG009|Overall Study|Transition to compassionate use|1|||
30889567|NCT02349633|58922586|FG010|Overall Study|Transition to compassionate use|0|||
30889568|NCT02349633|58922587|FG011|Overall Study|Transition to compassionate use|0|||
30889569|NCT02349633|58922588|FG012|Overall Study|Transition to compassionate use|0|||
30889570|NCT02349633|58922589|FG013|Overall Study|Transition to compassionate use|0|||
30889571|NCT02349633|58922576|FG000|Overall Study|Early termination of survival follow-up|0|||
30889572|NCT02349633|58922577|FG001|Overall Study|Early termination of survival follow-up|0|||
30889573|NCT02349633|58922578|FG002|Overall Study|Early termination of survival follow-up|0|||
30889574|NCT02349633|58922579|FG003|Overall Study|Early termination of survival follow-up|0|||
30889575|NCT02349633|58922580|FG004|Overall Study|Early termination of survival follow-up|0|||
30889576|NCT02349633|58922581|FG005|Overall Study|Early termination of survival follow-up|0|||
30889577|NCT02349633|58922582|FG006|Overall Study|Early termination of survival follow-up|0|||
30889578|NCT02349633|58922583|FG007|Overall Study|Early termination of survival follow-up|4|||
30889579|NCT02349633|58922584|FG008|Overall Study|Early termination of survival follow-up|0|||
30889580|NCT02349633|58922585|FG009|Overall Study|Early termination of survival follow-up|0|||
30889581|NCT02349633|58922586|FG010|Overall Study|Early termination of survival follow-up|0|||
30889582|NCT02349633|58922587|FG011|Overall Study|Early termination of survival follow-up|0|||
30889583|NCT02349633|58922588|FG012|Overall Study|Early termination of survival follow-up|0|||
30889584|NCT02349633|58922589|FG013|Overall Study|Early termination of survival follow-up|0|||
30889585|NCT02349633|58922576|FG000|Overall Study|Termination by sponsor|0|||
30889586|NCT02349633|58922577|FG001|Overall Study|Termination by sponsor|0|||
30889587|NCT02349633|58922578|FG002|Overall Study|Termination by sponsor|0|||
30889588|NCT02349633|58922579|FG003|Overall Study|Termination by sponsor|0|||
30889589|NCT02349633|58922580|FG004|Overall Study|Termination by sponsor|0|||
30889590|NCT02349633|58922581|FG005|Overall Study|Termination by sponsor|0|||
30889591|NCT02349633|58922582|FG006|Overall Study|Termination by sponsor|0|||
30889592|NCT02349633|58922583|FG007|Overall Study|Termination by sponsor|1|||
30889593|NCT02349633|58922584|FG008|Overall Study|Termination by sponsor|0|||
30889594|NCT02349633|58922585|FG009|Overall Study|Termination by sponsor|2|||
30889595|NCT02349633|58922586|FG010|Overall Study|Termination by sponsor|0|||
30889596|NCT02349633|58922587|FG011|Overall Study|Termination by sponsor|0|||
30889597|NCT02349633|58922588|FG012|Overall Study|Termination by sponsor|0|||
30889598|NCT02349633|58922589|FG013|Overall Study|Termination by sponsor|0|||
30889599|NCT02349633|58922576|FG000|Overall Study|Other|0|||
30889600|NCT02349633|58922577|FG001|Overall Study|Other|0|||
30889601|NCT02349633|58922578|FG002|Overall Study|Other|0|||
30889602|NCT02349633|58922579|FG003|Overall Study|Other|0|||
30889603|NCT02349633|58922580|FG004|Overall Study|Other|0|||
30889604|NCT02349633|58922581|FG005|Overall Study|Other|0|||
30889605|NCT02349633|58922582|FG006|Overall Study|Other|0|||
30889606|NCT02349633|58922583|FG007|Overall Study|Other|2|||
30889607|NCT02349633|58922584|FG008|Overall Study|Other|0|||
30889608|NCT02349633|58922585|FG009|Overall Study|Other|0|||
30889609|NCT02349633|58922586|FG010|Overall Study|Other|0|||
30889610|NCT02349633|58922587|FG011|Overall Study|Other|0|||
30889611|NCT02349633|58922588|FG012|Overall Study|Other|0|||
30889612|NCT02349633|58922589|FG013|Overall Study|Other|0|||
30889613|NCT02275611|58922654|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
30889614|NCT02275611|58922655|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
30889615|NCT02275611|58922656|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
30889616|NCT02275611|58922657|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
30889617|NCT02275065|58922674|FG000|Overall Study|Randomized but not treated|1|||
30889618|NCT02275065|58922675|FG001|Overall Study|Randomized but not treated|0|||
30889619|NCT02275065|58922676|FG002|Overall Study|Randomized but not treated|1|||
30889620|NCT02275065|58922677|FG003|Overall Study|Randomized but not treated|1|||
30889621|NCT02275065|58922678|FG004|Overall Study|Randomized but not treated|0|||
30889622|NCT02273973|58922692|FG000|Overall Study|Adverse Event|4|||
30889623|NCT02273973|58922693|FG001|Overall Study|Adverse Event|0|||
30889624|NCT02273973|58922692|FG000|Overall Study|Withdrawal by Subject|2|||
30889625|NCT02273973|58922693|FG001|Overall Study|Withdrawal by Subject|3|||
30889626|NCT02273973|58922692|FG000|Overall Study|Death|1|||
30889627|NCT02273973|58922693|FG001|Overall Study|Death|0|||
30889628|NCT02273973|58922692|FG000|Overall Study|Non-compliance|1|||
30889629|NCT02273973|58922693|FG001|Overall Study|Non-compliance|0|||
30889630|NCT02273973|58922692|FG000|Overall Study|Protocol Violation|1|||
30889631|NCT02273973|58922693|FG001|Overall Study|Protocol Violation|0|||
30889632|NCT02273973|58922692|FG000|Overall Study|Progression of disease|0|||
30889633|NCT02273973|58922693|FG001|Overall Study|Progression of disease|2|||
30889634|NCT02273973|58922692|FG000|Overall Study|Lost to Follow-up|0|||
30889635|NCT02273973|58922693|FG001|Overall Study|Lost to Follow-up|1|||
30889636|NCT02273973|58922692|FG000|Overall Study|Physician Decision|0|||
30889637|NCT02273973|58922693|FG001|Overall Study|Physician Decision|1|||
30889638|NCT02273973|58922692|FG000|Overall Study|Reason not specified|0|||
30889639|NCT02273973|58922693|FG001|Overall Study|Reason not specified|1|||
30889640|NCT02273739|58922703|FG000|Overall Study|Progression of Disease|3|||
30889641|NCT02273739|58922704|FG001|Overall Study|Progression of Disease|4|||
30889642|NCT02273739|58922705|FG002|Overall Study|Progression of Disease|5|||
30889643|NCT02273739|58922706|FG003|Overall Study|Progression of Disease|2|||
30889644|NCT02273739|58922703|FG000|Overall Study|Death|0|||
30889645|NCT02273739|58922704|FG001|Overall Study|Death|0|||
30889646|NCT02273739|58922705|FG002|Overall Study|Death|0|||
30889647|NCT02273739|58922706|FG003|Overall Study|Death|2|||
30889648|NCT02273739|58922703|FG000|Overall Study|Adverse Event|0|||
30889649|NCT02273739|58922704|FG001|Overall Study|Adverse Event|0|||
30889650|NCT02273739|58922705|FG002|Overall Study|Adverse Event|0|||
30889651|NCT02273739|58922706|FG003|Overall Study|Adverse Event|1|||
30889652|NCT02273739|58922703|FG000|Overall Study|Withdrawal by Subject|0|||
30889653|NCT02273739|58922704|FG001|Overall Study|Withdrawal by Subject|0|||
30889654|NCT02273739|58922705|FG002|Overall Study|Withdrawal by Subject|2|||
30889655|NCT02273739|58922706|FG003|Overall Study|Withdrawal by Subject|1|||
30889656|NCT02273739|58922703|FG000|Overall Study|Physician Decision|0|||
30889657|NCT02273739|58922704|FG001|Overall Study|Physician Decision|0|||
30889658|NCT02273739|58922705|FG002|Overall Study|Physician Decision|0|||
30889659|NCT02273739|58922706|FG003|Overall Study|Physician Decision|1|||
30889660|NCT02273037|58922723|FG000|Overall Study|Lost to Follow-up|1|||
30889661|NCT02273037|58922724|FG001|Overall Study|Lost to Follow-up|0|||
30889662|NCT02273037|58922723|FG000|Overall Study|Delivered before monitoring initiated|1|||
30889663|NCT02273037|58922724|FG001|Overall Study|Delivered before monitoring initiated|3|||
30889664|NCT02273037|58922723|FG000|Overall Study|Breech delivery|2|||
30889665|NCT02273037|58922724|FG001|Overall Study|Breech delivery|3|||
30889666|NCT02273037|58922723|FG000|Overall Study|Multiple delivery|2|||
30889667|NCT02273037|58922724|FG001|Overall Study|Multiple delivery|2|||
30889668|NCT02273037|58922723|FG000|Overall Study|Other complication|2|||
30889669|NCT02273037|58922724|FG001|Overall Study|Other complication|0|||
30889670|NCT02465515|58922734|FG000|Overall Study|Investigator site closed|4|||
30889671|NCT02465515|58922735|FG001|Overall Study|Investigator site closed|5|||
30889672|NCT02465515|58922734|FG000|Overall Study|Withdrawal by Subject|74|||
30889673|NCT02465515|58922735|FG001|Overall Study|Withdrawal by Subject|43|||
30889674|NCT02465515|58922734|FG000|Overall Study|Physician Decision|8|||
30889675|NCT02465515|58922735|FG001|Overall Study|Physician Decision|12|||
30889676|NCT02465515|58922734|FG000|Overall Study|Lost to Follow-up|68|||
30889677|NCT02465515|58922735|FG001|Overall Study|Lost to Follow-up|51|||
30889678|NCT02412631|58922743|FG000|Overall Study|Adverse Event|1|||
30889679|NCT02412631|58922744|FG001|Overall Study|Adverse Event|2|||
30889680|NCT02412631|58922743|FG000|Overall Study|Lost to Follow-up|5|||
30889681|NCT02412631|58922744|FG001|Overall Study|Lost to Follow-up|9|||
30889682|NCT02412631|58922743|FG000|Overall Study|Withdrawal by Subject|9|||
30889683|NCT02412631|58922744|FG001|Overall Study|Withdrawal by Subject|3|||
30889684|NCT02412631|58922743|FG000|Overall Study|Early stop by FDA|5|||
30889685|NCT02412631|58922744|FG001|Overall Study|Early stop by FDA|2|||
30889686|NCT02412631|58922743|FG000|Overall Study|Unspecified reason|6|||
30889687|NCT02412631|58922744|FG001|Overall Study|Unspecified reason|8|||
30889688|NCT02272803|58922752|FG000|Overall Study|Disease progression|16|||
30889689|NCT02272803|58922753|FG001|Overall Study|Disease progression|8|||
30889690|NCT02272803|58922752|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
30889691|NCT02272803|58922753|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
30889692|NCT02272803|58922752|FG000|Overall Study|Study drug toxicity|4|||
30889693|NCT02272803|58922753|FG001|Overall Study|Study drug toxicity|9|||
30889694|NCT02272803|58922752|FG000|Overall Study|Participant request to discontinue study treatment|3|||
30889695|NCT02272803|58922753|FG001|Overall Study|Participant request to discontinue study treatment|7|||
30889696|NCT02272803|58922752|FG000|Overall Study|Maximum clinical benefit|4|||
30889697|NCT02272803|58922753|FG001|Overall Study|Maximum clinical benefit|2|||
30889698|NCT02272803|58922752|FG000|Overall Study|Poor/non-compliance|2|||
30889699|NCT02272803|58922753|FG001|Overall Study|Poor/non-compliance|2|||
30889700|NCT02272803|58922752|FG000|Overall Study|Withdrawal by Subject|2|||
30889701|NCT02272803|58922753|FG001|Overall Study|Withdrawal by Subject|1|||
30889702|NCT02272803|58922752|FG000|Overall Study|Death|0|||
30889703|NCT02272803|58922753|FG001|Overall Study|Death|1|||
30889704|NCT02272803|58922752|FG000|Overall Study|Other reasons|1|||
30889705|NCT02272803|58922753|FG001|Overall Study|Other reasons|3|||
30889706|NCT02272803|58922752|FG000|Overall Study|Administrative reason by sponsor|5|||
30889707|NCT02272803|58922753|FG001|Overall Study|Administrative reason by sponsor|4|||
30889708|NCT02272725|58922761|FG000|Overall Study|equipment malfunction|2|||
30889709|NCT02272725|58922762|FG001|Overall Study|equipment malfunction|0|||
30889710|NCT01650805|58922770|FG000|Overall Study|Withdrawal by Subject|1|||
30889711|NCT01650805|58922771|FG001|Overall Study|Withdrawal by Subject|0|||
30889712|NCT02442349|58922777|FG000|Overall Study|Death|14|||
30889713|NCT02442349|58922777|FG000|Overall Study|Withdrawal by Subject|8|||
30889714|NCT02442349|58922777|FG000|Overall Study|On-going Study at Data Cut-off|149|||
30889715|NCT02411539|58922783|FG000|Overall Study|Lost to Follow-up|2|||
30889716|NCT02411539|58922784|FG001|Overall Study|Lost to Follow-up|0|||
30889717|NCT02411539|58922783|FG000|Overall Study|Confounding medical condition|0|||
30889718|NCT02411539|58922784|FG001|Overall Study|Confounding medical condition|1|||
30889719|NCT02465437|58922797|FG000|Overall Study|Physician Decision|0|||
30889720|NCT02465437|58922798|FG001|Overall Study|Physician Decision|0|||
30889721|NCT02465437|58922799|FG002|Overall Study|Physician Decision|1|||
30889722|NCT02465437|58922800|FG003|Overall Study|Physician Decision|0|||
30889723|NCT02465437|58922797|FG000|Overall Study|Withdrawal by Subject|1|||
30889724|NCT02465437|58922798|FG001|Overall Study|Withdrawal by Subject|0|||
30889725|NCT02465437|58922799|FG002|Overall Study|Withdrawal by Subject|0|||
30889726|NCT02465437|58922800|FG003|Overall Study|Withdrawal by Subject|1|||
30889727|NCT02465437|58922797|FG000|Overall Study|Adverse Event|0|||
30889728|NCT02465437|58922798|FG001|Overall Study|Adverse Event|1|||
30889729|NCT02465437|58922799|FG002|Overall Study|Adverse Event|0|||
30889730|NCT02465437|58922800|FG003|Overall Study|Adverse Event|0|||
30889731|NCT02442271|58922808|FG000|Overall Study|Adverse Event|1|||
30889732|NCT02442271|58922808|FG000|Overall Study|Withdrew Consent|1|||
30889733|NCT02442271|58922808|FG000|Overall Study|Lost to Follow-up|1|||
30889734|NCT02442271|58922808|FG000|Overall Study|Other|1|||
30889735|NCT02465203|58922829|FG000|Overall Study|Protocol Violation|1|||
30889736|NCT02465203|58922830|FG001|Overall Study|Protocol Violation|1|||
30889737|NCT02465203|58922831|FG002|Overall Study|Protocol Violation|1|||
30889738|NCT02465203|58922829|FG000|Overall Study|Study terminated by sponsor|50|||
30889739|NCT02465203|58922830|FG001|Overall Study|Study terminated by sponsor|34|||
30889740|NCT02465203|58922831|FG002|Overall Study|Study terminated by sponsor|11|||
30889741|NCT02465203|58922829|FG000|Overall Study|New therapy for study indication|4|||
30889742|NCT02465203|58922830|FG001|Overall Study|New therapy for study indication|0|||
30889743|NCT02465203|58922831|FG002|Overall Study|New therapy for study indication|0|||
30889744|NCT02465203|58922829|FG000|Overall Study|Patient/guardian decision|1|||
30889745|NCT02465203|58922830|FG001|Overall Study|Patient/guardian decision|1|||
30889746|NCT02465203|58922831|FG002|Overall Study|Patient/guardian decision|1|||
30889747|NCT02463409|58922838|FG000|Overall Study|Withdrawal by Subject|1|||
30889748|NCT02463409|58922838|FG000|Overall Study|Screen failure|1|||
30889749|NCT02528357|58922861|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889750|NCT02528357|58922862|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
30889751|NCT02528357|58922863|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889752|NCT02528357|58922864|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889753|NCT02528357|58922865|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889754|NCT02528357|58922866|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889755|NCT02528357|58922867|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889756|NCT02528357|58922868|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889757|NCT02528357|58922869|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889758|NCT02528357|58922870|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889759|NCT02528357|58922871|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889760|NCT02528357|58922872|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889761|NCT02528357|58922873|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889762|NCT02528357|58922874|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889763|NCT02528357|58922875|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889764|NCT02528357|58922876|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889765|NCT02528357|58922877|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889766|NCT02528357|58922878|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889767|NCT02528357|58922879|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
30889768|NCT02528357|58922861|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889769|NCT02528357|58922862|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889770|NCT02528357|58922863|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889771|NCT02528357|58922864|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
30948437|NCT01709084|58994336|FG001|Overall Study|Other|3|||
30948438|NCT01709084|58994335|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
30790165|NCT00064337|58803351|FG000|Transplant|Death|3|||
30889772|NCT02528357|58922865|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889773|NCT02528357|58922866|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
30889774|NCT02528357|58922867|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889775|NCT02528357|58922868|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
30889776|NCT02528357|58922869|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889777|NCT02528357|58922870|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889778|NCT02528357|58922871|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889779|NCT02528357|58922872|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889780|NCT02528357|58922873|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889781|NCT02528357|58922874|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889782|NCT02528357|58922875|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889783|NCT02528357|58922876|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889784|NCT02528357|58922877|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889785|NCT02528357|58922878|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889786|NCT02528357|58922879|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
30889787|NCT02528357|58922861|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889788|NCT02528357|58922862|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889789|NCT02528357|58922863|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
30889790|NCT02528357|58922864|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889791|NCT02528357|58922865|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
30889792|NCT02528357|58922866|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889793|NCT02528357|58922867|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
30889794|NCT02528357|58922868|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
30889795|NCT02528357|58922869|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889796|NCT02528357|58922870|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889797|NCT02528357|58922871|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889798|NCT02528357|58922872|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889799|NCT02528357|58922873|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889800|NCT02528357|58922874|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889801|NCT02528357|58922875|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889802|NCT02528357|58922876|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889803|NCT02528357|58922877|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889804|NCT02528357|58922878|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889805|NCT02528357|58922879|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
30889806|NCT02528357|58922861|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889807|NCT02528357|58922862|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889808|NCT02528357|58922863|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889809|NCT02528357|58922864|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889810|NCT02528357|58922865|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
30889811|NCT02528357|58922866|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889812|NCT02528357|58922867|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889813|NCT02528357|58922868|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889814|NCT02528357|58922869|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889815|NCT02528357|58922870|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889816|NCT02528357|58922871|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889817|NCT02528357|58922872|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889818|NCT02528357|58922873|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889819|NCT02528357|58922874|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889820|NCT02528357|58922875|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889821|NCT02528357|58922876|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889822|NCT02528357|58922877|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889823|NCT02528357|58922878|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889824|NCT02528357|58922879|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889825|NCT02528357|58922861|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889826|NCT02528357|58922862|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889827|NCT02528357|58922863|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30790166|NCT00064337|58803351|FG000|Transplant|Patient Refusal|2|||
30889828|NCT02528357|58922864|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889829|NCT02528357|58922865|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889830|NCT02528357|58922866|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889831|NCT02528357|58922867|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889832|NCT02528357|58922868|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889833|NCT02528357|58922869|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889834|NCT02528357|58922870|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889835|NCT02528357|58922871|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889836|NCT02528357|58922872|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889837|NCT02528357|58922873|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889838|NCT02528357|58922874|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
30889839|NCT02528357|58922875|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
30889840|NCT02528357|58922876|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889841|NCT02528357|58922877|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889842|NCT02528357|58922878|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889843|NCT02528357|58922879|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
30889844|NCT02528357|58922861|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889845|NCT02528357|58922862|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889846|NCT02528357|58922863|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889847|NCT02528357|58922864|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889848|NCT02528357|58922865|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889849|NCT02528357|58922866|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889850|NCT02528357|58922867|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889851|NCT02528357|58922868|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889852|NCT02528357|58922869|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889853|NCT02528357|58922870|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889854|NCT02528357|58922871|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889855|NCT02528357|58922872|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889856|NCT02528357|58922873|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889857|NCT02528357|58922874|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
30889858|NCT02528357|58922875|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889859|NCT02528357|58922876|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889860|NCT02528357|58922877|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889861|NCT02528357|58922878|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889862|NCT02528357|58922879|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
30889863|NCT02528357|58922861|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889864|NCT02528357|58922862|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889865|NCT02528357|58922863|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889866|NCT02528357|58922864|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889867|NCT02528357|58922865|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889868|NCT02528357|58922866|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889869|NCT02528357|58922867|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889870|NCT02528357|58922868|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889871|NCT02528357|58922869|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889872|NCT02528357|58922870|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889873|NCT02528357|58922871|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
30889874|NCT02528357|58922872|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889875|NCT02528357|58922873|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
30889876|NCT02528357|58922874|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
30889877|NCT02528357|58922875|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
30889878|NCT02528357|58922876|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889879|NCT02528357|58922877|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889880|NCT02528357|58922878|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889881|NCT02528357|58922879|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
30889882|NCT02528357|58922861|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889883|NCT02528357|58922862|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889884|NCT02528357|58922863|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889885|NCT02528357|58922864|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889886|NCT02528357|58922865|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889887|NCT02528357|58922866|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889888|NCT02528357|58922867|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889889|NCT02528357|58922868|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889890|NCT02528357|58922869|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
30889891|NCT02528357|58922870|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
30889892|NCT02528357|58922871|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889893|NCT02528357|58922872|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
30889894|NCT02528357|58922873|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
30889895|NCT02528357|58922874|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
30889896|NCT02528357|58922875|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
30889897|NCT02528357|58922876|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889898|NCT02528357|58922877|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889899|NCT02528357|58922878|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889900|NCT02528357|58922879|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889901|NCT02528357|58922861|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889902|NCT02528357|58922862|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889903|NCT02528357|58922863|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889904|NCT02528357|58922864|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889905|NCT02528357|58922865|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889906|NCT02528357|58922866|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889907|NCT02528357|58922867|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889908|NCT02528357|58922868|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889909|NCT02528357|58922869|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889910|NCT02528357|58922870|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889911|NCT02528357|58922871|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889912|NCT02528357|58922872|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889913|NCT02528357|58922873|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889914|NCT02528357|58922874|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889915|NCT02528357|58922875|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889916|NCT02528357|58922876|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889917|NCT02528357|58922877|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
30889918|NCT02528357|58922878|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889919|NCT02528357|58922879|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
30889920|NCT02528357|58922861|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889921|NCT02528357|58922862|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889922|NCT02528357|58922863|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889923|NCT02528357|58922864|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889924|NCT02528357|58922865|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889925|NCT02528357|58922866|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889926|NCT02528357|58922867|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889927|NCT02528357|58922868|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889928|NCT02528357|58922869|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889929|NCT02528357|58922870|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889930|NCT02528357|58922871|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889931|NCT02528357|58922872|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889932|NCT02528357|58922873|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889933|NCT02528357|58922874|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889934|NCT02528357|58922875|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889935|NCT02528357|58922876|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
30889936|NCT02528357|58922877|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
30889937|NCT02528357|58922878|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
30889938|NCT02528357|58922879|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
30889939|NCT02463331|58922921|FG000|Overall Study|Adverse Event|4|||
30608448|NCT01288430|58619227|FG006|Part 2|Clinical disease progression|0|||
30889940|NCT02463331|58922922|FG001|Overall Study|Adverse Event|2|||
30889941|NCT02463331|58922921|FG000|Overall Study|Lost to Follow-up|1|||
30889942|NCT02463331|58922922|FG001|Overall Study|Lost to Follow-up|1|||
30889943|NCT02463331|58922921|FG000|Overall Study|Pregnancy|2|||
30889944|NCT02463331|58922922|FG001|Overall Study|Pregnancy|3|||
30889945|NCT02463331|58922921|FG000|Overall Study|Lack of Efficacy|6|||
30889946|NCT02463331|58922922|FG001|Overall Study|Lack of Efficacy|0|||
30889947|NCT02463331|58922921|FG000|Overall Study|Physician Decision|3|||
30889948|NCT02463331|58922922|FG001|Overall Study|Physician Decision|0|||
30889949|NCT02410837|58922928|FG000|Overall Study|Death|387|||
30889950|NCT02410837|58922928|FG000|Overall Study|Lost to Follow-up|50|||
30889951|NCT02410837|58922928|FG000|Overall Study|Withdrawal by Subject|44|||
30889952|NCT02410837|58922928|FG000|Overall Study|Physician Decision|6|||
30889953|NCT02410837|58922928|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
30889954|NCT02314247|58922934|FG000|Overall Study|Adverse Event|2|||
30889955|NCT02314247|58922935|FG001|Overall Study|Adverse Event|1|||
30889956|NCT02314247|58922936|FG002|Overall Study|Adverse Event|0|||
30889957|NCT02314247|58922934|FG000|Overall Study|Withdrawal by Subject|1|||
30889958|NCT02314247|58922935|FG001|Overall Study|Withdrawal by Subject|3|||
30889959|NCT02314247|58922936|FG002|Overall Study|Withdrawal by Subject|1|||
30889960|NCT02314247|58922934|FG000|Overall Study|Progression of Disease|6|||
30889961|NCT02314247|58922935|FG001|Overall Study|Progression of Disease|2|||
30889962|NCT02314247|58922936|FG002|Overall Study|Progression of Disease|0|||
30889963|NCT02463097|58922946|FG000|Overall Study|Withdrawal by Subject|1|||
30889964|NCT02441179|58922952|FG000|Overall Study|Withdrawal by Subject|1|||
30889965|NCT02441179|58922953|FG001|Overall Study|Withdrawal by Subject|1|||
30889966|NCT02462473|58922960|FG000|Overall Study|Death|1|||
30889967|NCT02462473|58922960|FG000|Overall Study|Other|3|||
30889968|NCT02440789|58922973|FG000|Overall Study|Withdrawal by Subject|3|||
30889969|NCT02440789|58922973|FG000|Overall Study|Not willing to adhere to reqs|1|||
30889970|NCT02462083|58922977|FG000|Overall Study|Sponsor request|39|||
30889971|NCT02462083|58922977|FG000|Overall Study|Withdrawal by Subject|87|||
30889972|NCT02462083|58922977|FG000|Overall Study|Lost to Follow-up|41|||
30889973|NCT02462083|58922977|FG000|Overall Study|Lack of Efficacy|151|||
30889974|NCT02462083|58922977|FG000|Overall Study|Pregnancy|1|||
30889975|NCT02462083|58922977|FG000|Overall Study|Protocol Violation|6|||
30889976|NCT02462083|58922977|FG000|Overall Study|Adverse Event|33|||
30889977|NCT02462083|58922977|FG000|Overall Study|Worsening condition|16|||
30889978|NCT02462083|58922977|FG000|Overall Study|Other than specified|45|||
30889979|NCT02538341|58922983|FG000|Overall Study|Lost to Follow-up|51|||
30889980|NCT02538341|58922984|FG001|Overall Study|Lost to Follow-up|46|||
30889981|NCT02538341|58922983|FG000|Overall Study|Withdrawal by Subject|3|||
30889982|NCT02538341|58922984|FG001|Overall Study|Withdrawal by Subject|1|||
30889983|NCT02538341|58922983|FG000|Overall Study|Death|2|||
30889984|NCT02538341|58922984|FG001|Overall Study|Death|0|||
30889985|NCT02538107|58922990|FG000|Overall Study|Did not receive any Mircera dose|11|||
30889986|NCT02538107|58922990|FG000|Overall Study|Missing|5|||
30889987|NCT02538107|58922990|FG000|Overall Study|Necessity of dialysis|20|||
30889988|NCT02538107|58922990|FG000|Overall Study|Administration of other ESA|11|||
30889989|NCT02538107|58922990|FG000|Overall Study|No further treatment necessary|18|||
30889990|NCT02538107|58922990|FG000|Overall Study|Withdrawal by Subject|17|||
30889991|NCT02538107|58922990|FG000|Overall Study|Death|4|||
30889992|NCT02538107|58922990|FG000|Overall Study|Administrative reason|5|||
30889993|NCT02538107|58922990|FG000|Overall Study|Adverse Event|4|||
30889994|NCT02538107|58922990|FG000|Overall Study|Surgery|1|||
30889995|NCT02538107|58922990|FG000|Overall Study|Other|7|||
30889996|NCT02538107|58922990|FG000|Overall Study|Not recorded|7|||
30889997|NCT02538029|58923007|FG000|Overall Study|unable to complete cognitive assessments|1|||
30889998|NCT02538029|58923008|FG001|Overall Study|unable to complete cognitive assessments|0|||
30889999|NCT02538029|58923009|FG002|Overall Study|unable to complete cognitive assessments|1|||
30890000|NCT02272413|58923021|FG000|Randomized Through Treatment Start|Not treated|3|||
30890001|NCT02272413|58923022|FG001|Randomized Through Treatment Start|Not treated|5|||
30890002|NCT02272413|58923021|FG000|Pre-switch Period|Adverse Event|38|||
30890003|NCT02272413|58923022|FG001|Pre-switch Period|Adverse Event|37|||
30890004|NCT02272413|58923021|FG000|Pre-switch Period|Death|26|||
30890005|NCT02272413|58923022|FG001|Pre-switch Period|Death|26|||
30890006|NCT02272413|58923021|FG000|Pre-switch Period|Withdrawal by Subject|27|||
30890007|NCT02272413|58923022|FG001|Pre-switch Period|Withdrawal by Subject|15|||
30890008|NCT02272413|58923021|FG000|Pre-switch Period|Physician Decision|6|||
30890009|NCT02272413|58923022|FG001|Pre-switch Period|Physician Decision|18|||
30890010|NCT02272413|58923021|FG000|Pre-switch Period|Progressive disease|185|||
30890011|NCT02272413|58923022|FG001|Pre-switch Period|Progressive disease|173|||
30890012|NCT02272413|58923021|FG000|Pre-switch Period|Lost to Follow-up|0|||
30890013|NCT02272413|58923022|FG001|Pre-switch Period|Lost to Follow-up|2|||
30890014|NCT02272413|58923021|FG000|Pre-switch Period|Protocol Violation|1|||
30890015|NCT02272413|58923022|FG001|Pre-switch Period|Protocol Violation|0|||
30890016|NCT02272413|58923021|FG000|Pre-switch Period|Other than listed|10|||
30890017|NCT02272413|58923022|FG001|Pre-switch Period|Other than listed|11|||
30890018|NCT02272413|58923021|FG000|Post-switch Period|Adverse Event|4|||
30890019|NCT02272413|58923022|FG001|Post-switch Period|Adverse Event|4|||
30890020|NCT02272413|58923021|FG000|Post-switch Period|Death|3|||
30890021|NCT02272413|58923022|FG001|Post-switch Period|Death|2|||
30890022|NCT02272413|58923021|FG000|Post-switch Period|Withdrawal by Subject|1|||
30890023|NCT02272413|58923022|FG001|Post-switch Period|Withdrawal by Subject|2|||
30890024|NCT02272413|58923021|FG000|Post-switch Period|Physician Decision|1|||
30890025|NCT02272413|58923022|FG001|Post-switch Period|Physician Decision|1|||
30890026|NCT02272413|58923021|FG000|Post-switch Period|Progressive disease|21|||
30890027|NCT02272413|58923022|FG001|Post-switch Period|Progressive disease|21|||
30890028|NCT02272413|58923021|FG000|Post-switch Period|Study terminated by sponsor|8|||
30890029|NCT02272413|58923022|FG001|Post-switch Period|Study terminated by sponsor|11|||
30890030|NCT02272413|58923021|FG000|Post-switch Period|Other than listed|4|||
30890031|NCT02272413|58923022|FG001|Post-switch Period|Other than listed|5|||
30890032|NCT02396381|58923034|FG000|Overall Study|Adverse Event|3|||
30890033|NCT02396381|58923035|FG001|Overall Study|Adverse Event|2|||
30890034|NCT02396381|58923034|FG000|Overall Study|Withdrawal by Subject|33|||
30890035|NCT02396381|58923035|FG001|Overall Study|Withdrawal by Subject|24|||
30890036|NCT02396381|58923034|FG000|Overall Study|Lost to Follow-up|49|||
30890037|NCT02396381|58923035|FG001|Overall Study|Lost to Follow-up|31|||
30890038|NCT02396381|58923034|FG000|Overall Study|Protocol Violation|1|||
30890039|NCT02396381|58923035|FG001|Overall Study|Protocol Violation|0|||
30890040|NCT02396381|58923034|FG000|Overall Study|Site terminated by sponsor|7|||
30890041|NCT02396381|58923035|FG001|Overall Study|Site terminated by sponsor|8|||
30890042|NCT02396381|58923034|FG000|Overall Study|Physician Decision|5|||
30890043|NCT02396381|58923035|FG001|Overall Study|Physician Decision|5|||
30890044|NCT02396381|58923034|FG000|Overall Study|Pregnancy|2|||
30976277|NCT02585778|59063563|FG001|Overall Study|Other than specified above|2|||
30976278|NCT01438424|59063586|FG000|Overall Study|Continuing treatment|29|||
30976279|NCT01438424|59063586|FG000|Overall Study|Minimal virologic response|95|||
30976280|NCT01438424|59063586|FG000|Overall Study|Not identified|55|||
30976281|NCT01438424|59063586|FG000|Overall Study|Withdrawal by Subject|104|||
30976282|NCT01438424|59063586|FG000|Overall Study|Progression of chronic hepatitis B|22|||
30976283|NCT01438424|59063586|FG000|Overall Study|Death|22|||
30976284|NCT01438424|59063586|FG000|Overall Study|Adverse Event|17|||
30976285|NCT01438424|59063586|FG000|Overall Study|Lost to Follow-up|17|||
30976286|NCT01438424|59063586|FG000|Overall Study|Abnormal laboratory test result|14|||
30976287|NCT01438424|59063586|FG000|Overall Study|Need for drug prohibited by protocol|14|||
30976288|NCT01438424|59063586|FG000|Overall Study|Pregnancy|7|||
30976289|NCT01438424|59063586|FG000|Overall Study|No longer met inclusion criteria|1|||
30976290|NCT01438424|59063586|FG000|Overall Study|Participant noncompliance|20|||
30976291|NCT02580240|59063602|FG000|Overall Study|Physician Decision|2|||
30976292|NCT02580240|59063603|FG001|Overall Study|Physician Decision|0|||
30976293|NCT01465958|59063609|FG000|Run-in Phase|Protocol Violation|1|||
30976294|NCT01465958|59063610|FG001|Run-in Phase|Protocol Violation|0|||
30976295|NCT01465958|59063609|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
30976296|NCT01465958|59063610|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
30976297|NCT02581488|59063823|FG000|Overall Study|Adverse Event|6|||
30976298|NCT02581488|59063824|FG001|Overall Study|Adverse Event|7|||
30976299|NCT02581488|59063823|FG000|Overall Study|Lost to Follow-up|1|||
30976300|NCT02581488|59063824|FG001|Overall Study|Lost to Follow-up|0|||
30976301|NCT02581488|59063823|FG000|Overall Study|Withdrawal by Subject|1|||
30976302|NCT02581488|59063824|FG001|Overall Study|Withdrawal by Subject|0|||
30976303|NCT02581488|59063823|FG000|Overall Study|Non-Compliance|1|||
30976304|NCT02581488|59063824|FG001|Overall Study|Non-Compliance|0|||
30976305|NCT02581488|59063823|FG000|Overall Study|Protocol Violation|0|||
30890045|NCT02396381|58923035|FG001|Overall Study|Pregnancy|0|||
30890046|NCT02396381|58923034|FG000|Overall Study|Non-compliance with study procedures|1|||
30890047|NCT02396381|58923035|FG001|Overall Study|Non-compliance with study procedures|0|||
30890048|NCT02396381|58923034|FG000|Overall Study|Moved out of town/state|1|||
30890049|NCT02396381|58923035|FG001|Overall Study|Moved out of town/state|3|||
30890050|NCT02396381|58923034|FG000|Overall Study|Could not complete visit|1|||
30890051|NCT02396381|58923035|FG001|Overall Study|Could not complete visit|0|||
30890052|NCT02396381|58923034|FG000|Overall Study|Possible conflict of interest|1|||
30976306|NCT02581488|59063824|FG001|Overall Study|Protocol Violation|4|||
30976307|NCT02581410|59063867|FG000|Vaccination Phase|Adverse Event|2|||
30976308|NCT02581410|59063868|FG001|Vaccination Phase|Adverse Event|1|||
30976309|NCT02581410|59063867|FG000|Vaccination Phase|Withdrawal by Subject|0|||
30976310|NCT02581410|59063868|FG001|Vaccination Phase|Withdrawal by Subject|1|||
30976311|NCT02581410|59063867|FG000|Vaccination Phase|Migrated/moved from study area|0|||
30976312|NCT02581410|59063868|FG001|Vaccination Phase|Migrated/moved from study area|1|||
30976313|NCT02581410|59063867|FG000|End of Study Phase|Adverse Event|4|||
30976314|NCT02581410|59063868|FG001|End of Study Phase|Adverse Event|3|||
30976315|NCT02581410|59063867|FG000|End of Study Phase|Withdrawal by Subject|1|||
30890053|NCT02396381|58923035|FG001|Overall Study|Possible conflict of interest|0|||
30890054|NCT02396381|58923034|FG000|Overall Study|Randomization/Screening Error|3|||
30890055|NCT02396381|58923035|FG001|Overall Study|Randomization/Screening Error|1|||
30890056|NCT02532647|58923047|FG000|Overall Study|Did not receive trial medication|1|||
30890057|NCT02532647|58923048|FG001|Overall Study|Did not receive trial medication|0|||
30890058|NCT02532647|58923049|FG002|Overall Study|Did not receive trial medication|1|||
30890059|NCT02537015|58923057|FG000|Overall Study|Adverse Event|3|||
30890060|NCT02537015|58923057|FG000|Overall Study|Withdrawal by Subject|2|||
30890061|NCT02537015|58923057|FG000|Overall Study|Other Miscellaneous Reasons|1|||
30890062|NCT02271945|58923063|FG000|Overall Study|Death|3|||
30890063|NCT02271945|58923064|FG001|Overall Study|Death|3|||
30890064|NCT02271945|58923063|FG000|Overall Study|Withdrawal by Subject|1|||
30890065|NCT02271945|58923064|FG001|Overall Study|Withdrawal by Subject|1|||
30890066|NCT02271945|58923063|FG000|Overall Study|Other|1|||
30890067|NCT02271945|58923064|FG001|Overall Study|Other|1|||
30890068|NCT01660763|58923072|FG000|Overall Study|Lack of Efficacy|45|||
30890069|NCT01660763|58923073|FG001|Overall Study|Lack of Efficacy|50|||
30890070|NCT01660763|58923072|FG000|Overall Study|Adverse Event|22|||
30890071|NCT01660763|58923073|FG001|Overall Study|Adverse Event|7|||
30890072|NCT01660763|58923072|FG000|Overall Study|Protocol Violation|1|||
30890073|NCT01660763|58923073|FG001|Overall Study|Protocol Violation|0|||
30890074|NCT01660763|58923072|FG000|Overall Study|Withdrawal by Subject|4|||
30890075|NCT01660763|58923073|FG001|Overall Study|Withdrawal by Subject|0|||
30890076|NCT01660763|58923072|FG000|Overall Study|Patient ready for early discharge|28|||
30890077|NCT01660763|58923073|FG001|Overall Study|Patient ready for early discharge|4|||
30890078|NCT01937117|58923079|FG000|Overall Study|Disease Progression|7|||
30890079|NCT01937117|58923079|FG000|Overall Study|Physician Decision|4|||
30890080|NCT01937117|58923079|FG000|Overall Study|Adverse Event|2|||
30890081|NCT02268045|58923085|FG000|Overall Study|Death|4|||
30890082|NCT02268045|58923086|FG001|Overall Study|Death|4|||
30890083|NCT02268045|58923085|FG000|Overall Study|Disease Progression|2|||
30890084|NCT02268045|58923086|FG001|Overall Study|Disease Progression|1|||
30890085|NCT02268045|58923085|FG000|Overall Study|Adverse Event|7|||
30890086|NCT02268045|58923086|FG001|Overall Study|Adverse Event|7|||
30890087|NCT02268045|58923085|FG000|Overall Study|Withdrawal by Subject|2|||
30890088|NCT02268045|58923086|FG001|Overall Study|Withdrawal by Subject|6|||
30890089|NCT02268045|58923085|FG000|Overall Study|Physician Decision|0|||
30890090|NCT02268045|58923086|FG001|Overall Study|Physician Decision|1|||
30890091|NCT02268045|58923085|FG000|Overall Study|Protocol Violation|1|||
30890092|NCT02268045|58923086|FG001|Overall Study|Protocol Violation|1|||
30890093|NCT02536781|58923096|FG000|Overall Study|Lost to Follow-up|2|||
30890094|NCT02536781|58923097|FG001|Overall Study|Lost to Follow-up|0|||
30890095|NCT02267187|58923103|FG000|Overall Study|Physician Decision|2|||
30890096|NCT02267187|58923103|FG000|Overall Study|Screen fail|3|||
30890097|NCT02532179|58923107|FG000|Overall Study|Lost to Follow-up|1|||
30890098|NCT02532179|58923107|FG000|Overall Study|Pregnancy|1|||
30890099|NCT02532179|58923107|FG000|Overall Study|Subject received depot steroid injection|1|||
30890100|NCT02409667|58923111|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
30890101|NCT02409667|58923112|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
30890102|NCT02409667|58923113|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
30890103|NCT02409667|58923114|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
30890104|NCT02409667|58923115|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
30890105|NCT02409667|58923111|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
30890106|NCT02409667|58923112|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
30890107|NCT02409667|58923113|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
30890108|NCT02409667|58923114|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
30890109|NCT02409667|58923115|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
30976316|NCT02581410|59063868|FG001|End of Study Phase|Withdrawal by Subject|2|||
30976317|NCT02581410|59063867|FG000|End of Study Phase|Migrated/moved from study area|0|||
30976318|NCT02581410|59063868|FG001|End of Study Phase|Migrated/moved from study area|3|||
30976319|NCT02581410|59063867|FG000|End of Study Phase|Lost to Follow-up|0|||
30976320|NCT02581410|59063868|FG001|End of Study Phase|Lost to Follow-up|2|||
30976321|NCT02581410|59063867|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
30890110|NCT02409667|58923111|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
30890111|NCT02409667|58923112|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
30890112|NCT02409667|58923113|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
30890113|NCT02409667|58923114|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
30890114|NCT02409667|58923115|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
30976322|NCT02581410|59063868|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
30976323|NCT01664130|59063927|FG000|Overall Study|competing secondary disease|2|||
30890115|NCT02409667|58923111|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
30890116|NCT02409667|58923112|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
30890117|NCT02409667|58923113|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
30890118|NCT02409667|58923114|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
30890119|NCT02409667|58923115|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
30890120|NCT02409667|58923111|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
30890121|NCT02409667|58923112|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
30890122|NCT02409667|58923113|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
30890123|NCT02409667|58923114|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
30890124|NCT02409667|58923115|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
30890125|NCT02409667|58923111|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
30890126|NCT02409667|58923112|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
30890127|NCT02409667|58923113|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
30890128|NCT02409667|58923114|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
30890129|NCT02409667|58923115|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
30890130|NCT02409667|58923111|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
30890131|NCT02409667|58923112|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
30890132|NCT02409667|58923113|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
30890133|NCT02409667|58923114|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
30890134|NCT02409667|58923115|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
30890135|NCT02409667|58923111|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
30890136|NCT02409667|58923112|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
30890137|NCT02409667|58923113|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
30890138|NCT02409667|58923114|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
30890139|NCT02409667|58923115|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
30890140|NCT02409667|58923111|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
30890141|NCT02409667|58923112|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
30890142|NCT02409667|58923113|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
30890143|NCT02409667|58923114|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
30890144|NCT02409667|58923115|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
30890145|NCT02409667|58923111|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
30890146|NCT02409667|58923112|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
30890147|NCT02409667|58923113|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
30890148|NCT02409667|58923114|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
30890149|NCT02409667|58923115|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
30890150|NCT02409667|58923111|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
30890151|NCT02409667|58923112|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
30890152|NCT02409667|58923113|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
30890153|NCT02409667|58923114|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
30890154|NCT02409667|58923115|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
30890155|NCT02409667|58923111|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
30890156|NCT02409667|58923112|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
30890157|NCT02409667|58923113|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
30890158|NCT02409667|58923114|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
30890159|NCT02409667|58923115|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
30890160|NCT02409667|58923111|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
30890161|NCT02409667|58923112|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
30948439|NCT01709084|58994336|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
30948440|NCT01709084|58994335|FG000|Overall Study|Not Treated|0|||
30948441|NCT01709084|58994336|FG001|Overall Study|Not Treated|2|||
30948442|NCT01776307|58994345|FG000|Overall Study|Not dosed|0|||
30948443|NCT01776307|58994346|FG001|Overall Study|Not dosed|0|||
30608449|NCT01288430|58619228|FG007|Part 2|Clinical disease progression|2|||
30790167|NCT00064337|58803351|FG000|Transplant|Progression|2|||
30790168|NCT00064337|58803351|FG000|Maintenance|Adverse Event|3|||
30790169|NCT00064337|58803351|FG000|Maintenance|Progression|2|||
30790170|NCT00064337|58803351|FG000|Maintenance|On treatment at time of analysis|2|||
30790171|NCT00064337|58803351|FG000|Maintenance|Not protocol-specified|2|||
30790172|NCT00064337|58803351|FG000|Maintenance|Death|1|||
30790173|NCT00064259|58803358|FG000|Overall Study|Adverse Event|1|||
30790174|NCT00064259|58803359|FG001|Overall Study|Adverse Event|0|||
30790175|NCT00064259|58803360|FG002|Overall Study|Adverse Event|0|||
30790176|NCT00064259|58803361|FG003|Overall Study|Adverse Event|1|||
30790177|NCT00044213|58803370|FG000|Overall Study|Withdrawal by Subject|50|||
30790178|NCT00044213|58803371|FG001|Overall Study|Withdrawal by Subject|65|||
30790179|NCT00044213|58803372|FG002|Overall Study|Withdrawal by Subject|91|||
30790180|NCT00044213|58803373|FG003|Overall Study|Withdrawal by Subject|83|||
30790181|NCT00044213|58803370|FG000|Overall Study|Death|42|||
30890162|NCT02409667|58923113|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
30890163|NCT02409667|58923114|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
30890164|NCT02409667|58923115|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
30890165|NCT02409667|58923111|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
30890166|NCT02409667|58923112|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
30890167|NCT02409667|58923113|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
30890168|NCT02409667|58923114|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
30890169|NCT02409667|58923115|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
30890170|NCT02409667|58923111|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
30890171|NCT02409667|58923112|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
30890172|NCT02409667|58923113|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
30890173|NCT02409667|58923114|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
30890174|NCT02409667|58923115|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
30890175|NCT02409667|58923111|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
30890176|NCT02409667|58923112|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
30890177|NCT02409667|58923113|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
30890178|NCT02409667|58923114|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
30890179|NCT02409667|58923115|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
30890180|NCT01641939|58923129|FG000|Overall Study|Death|90|||
30890181|NCT01641939|58923130|FG001|Overall Study|Death|187|||
30890182|NCT01641939|58923131|FG002|Overall Study|Death|61|||
30890183|NCT01641939|58923129|FG000|Overall Study|Lost to Follow-up|3|||
30890184|NCT01641939|58923130|FG001|Overall Study|Lost to Follow-up|2|||
30890185|NCT01641939|58923131|FG002|Overall Study|Lost to Follow-up|1|||
30890186|NCT01641939|58923129|FG000|Overall Study|Withdrawal by Subject|14|||
30890187|NCT01641939|58923130|FG001|Overall Study|Withdrawal by Subject|11|||
30890188|NCT01641939|58923131|FG002|Overall Study|Withdrawal by Subject|5|||
30890189|NCT01641939|58923129|FG000|Overall Study|Study Terminated by Sponsor|10|||
30890190|NCT01641939|58923130|FG001|Overall Study|Study Terminated by Sponsor|28|||
30890191|NCT01641939|58923131|FG002|Overall Study|Study Terminated by Sponsor|3|||
30890192|NCT01641861|58923143|FG000|Overall Study|Lost to Follow-up|21|||
30890193|NCT01641861|58923144|FG001|Overall Study|Lost to Follow-up|16|||
30890194|NCT01641861|58923143|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
30890195|NCT01641861|58923144|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
30890196|NCT01641861|58923143|FG000|Overall Study|Died due to drowning|0|||
30890197|NCT01641861|58923144|FG001|Overall Study|Died due to drowning|1|||
30890198|NCT02409355|58923152|FG000|Overall Study|Withdrawal by Subject|1|||
30890199|NCT02409355|58923153|FG001|Overall Study|Withdrawal by Subject|0|||
30890200|NCT02409355|58923152|FG000|Overall Study|Death|1|||
30890201|NCT02409355|58923153|FG001|Overall Study|Death|1|||
30890202|NCT02409355|58923152|FG000|Overall Study|Study terminated by Sponsor|2|||
30890203|NCT02409355|58923153|FG001|Overall Study|Study terminated by Sponsor|3|||
30890204|NCT02408887|58923161|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
30890205|NCT02408887|58923162|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
30890206|NCT02408887|58923161|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
30890207|NCT02408887|58923162|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
30890208|NCT02266875|58923170|FG000|Overall Study|Withdrawal by Subject|9|||
30890209|NCT02266875|58923171|FG001|Overall Study|Withdrawal by Subject|0|||
30890210|NCT02266875|58923170|FG000|Overall Study|Lost to Follow-up|2|||
30890211|NCT02266875|58923171|FG001|Overall Study|Lost to Follow-up|0|||
30890212|NCT02438371|58923179|FG000|Overall Study|Lost to Follow-up|3|||
30890213|NCT02438371|58923180|FG001|Overall Study|Lost to Follow-up|2|||
30890214|NCT02438371|58923179|FG000|Overall Study|Withdrawal by Subject|1|||
30890215|NCT02438371|58923180|FG001|Overall Study|Withdrawal by Subject|1|||
30890216|NCT02438137|58923188|FG000|Overall Study|Lost to Follow-up|3|||
30890217|NCT02438137|58923189|FG001|Overall Study|Lost to Follow-up|2|||
30890218|NCT02438137|58923188|FG000|Overall Study|Adverse Event|1|||
30890219|NCT02438137|58923189|FG001|Overall Study|Adverse Event|0|||
30890220|NCT02438137|58923188|FG000|Overall Study|Withdrawal by Subject|4|||
30890221|NCT02438137|58923189|FG001|Overall Study|Withdrawal by Subject|3|||
30890222|NCT02438137|58923188|FG000|Overall Study|Physician Decision|0|||
30890223|NCT02438137|58923189|FG001|Overall Study|Physician Decision|1|||
30890224|NCT02437903|58923197|FG000|Overall Study|Adverse Event|1|||
30890225|NCT02437903|58923197|FG000|Overall Study|Withdrawal by Subject|1|||
30890226|NCT02437903|58923197|FG000|Overall Study|Lost to Follow-up|3|||
30890227|NCT02437513|58923202|FG000|Overall Study|Withdrawal by Subject|2|||
30890228|NCT02460991|58923208|FG000|Overall Study|Withdrawal by Subject|0|||
30890229|NCT02460991|58923209|FG001|Overall Study|Withdrawal by Subject|2|||
30890230|NCT02407249|58923220|FG000|Overall Study|Did not complete 12-month follow-up|13|||
30890231|NCT02407249|58923220|FG000|Overall Study|Not treated|13|||
30890232|NCT02460679|58923224|FG000|Overall Study|Investigator Decision|1|||
30890233|NCT02460679|58923224|FG000|Overall Study|Withdrawal by Subject|4|||
30890234|NCT02459899|58923232|FG000|Overall Study|Adverse Event|1|||
30890235|NCT02459899|58923233|FG001|Overall Study|Adverse Event|1|||
30890236|NCT02459899|58923234|FG002|Overall Study|Adverse Event|0|||
30890237|NCT02459899|58923235|FG003|Overall Study|Adverse Event|0|||
30890238|NCT02459899|58923232|FG000|Overall Study|Lost to Follow-up|1|||
30890239|NCT02459899|58923233|FG001|Overall Study|Lost to Follow-up|2|||
30890240|NCT02459899|58923234|FG002|Overall Study|Lost to Follow-up|0|||
30890241|NCT02459899|58923235|FG003|Overall Study|Lost to Follow-up|1|||
30890242|NCT02459899|58923232|FG000|Overall Study|Non-compliance with the treatment|0|||
30890243|NCT02459899|58923233|FG001|Overall Study|Non-compliance with the treatment|0|||
30890244|NCT02459899|58923234|FG002|Overall Study|Non-compliance with the treatment|0|||
30890245|NCT02459899|58923235|FG003|Overall Study|Non-compliance with the treatment|1|||
30890246|NCT02459899|58923232|FG000|Overall Study|Withdrawal by Subject|1|||
30890247|NCT02459899|58923233|FG001|Overall Study|Withdrawal by Subject|3|||
30890248|NCT02459899|58923234|FG002|Overall Study|Withdrawal by Subject|0|||
30890249|NCT02459899|58923235|FG003|Overall Study|Withdrawal by Subject|0|||
30890250|NCT02436889|58923247|FG000|Overall Study|No improvement in symptoms|1|||
30890251|NCT02436889|58923248|FG001|Overall Study|No improvement in symptoms|0|||
30890252|NCT02436889|58923247|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
30890253|NCT02436889|58923248|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
30890254|NCT02436811|58923257|FG000|Overall Study|Lost to Follow-up|2|||
30890255|NCT02436811|58923258|FG001|Overall Study|Lost to Follow-up|9|||
30890256|NCT02436811|58923259|FG002|Overall Study|Lost to Follow-up|7|||
30890257|NCT02436577|58923273|FG000|Overall Study|Protocol Deviation|0|||
30890258|NCT02436577|58923274|FG001|Overall Study|Protocol Deviation|1|||
30890259|NCT02436577|58923275|FG002|Overall Study|Protocol Deviation|0|||
30890260|NCT02436577|58923276|FG003|Overall Study|Protocol Deviation|0|||
30890261|NCT02436577|58923277|FG004|Overall Study|Protocol Deviation|0|||
30890262|NCT02436577|58923278|FG005|Overall Study|Protocol Deviation|0|||
30890263|NCT02265705|58923288|FG000|Treatment Period Week 0-24|Adverse Event|3|||
30890264|NCT02265705|58923289|FG001|Treatment Period Week 0-24|Adverse Event|2|||
30890265|NCT02265705|58923290|FG002|Treatment Period Week 0-24|Adverse Event|0|||
30890266|NCT02265705|58923291|FG003|Treatment Period Week 0-24|Adverse Event|0|||
30890267|NCT02265705|58923292|FG004|Treatment Period Week 0-24|Adverse Event|0|||
30890268|NCT02265705|58923293|FG005|Treatment Period Week 0-24|Adverse Event|0|||
30890269|NCT02265705|58923294|FG006|Treatment Period Week 0-24|Adverse Event|0|||
30890270|NCT02265705|58923288|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
30890271|NCT02265705|58923289|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
30890272|NCT02265705|58923290|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
30890273|NCT02265705|58923291|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
30890274|NCT02265705|58923292|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
30890275|NCT02265705|58923293|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
30890276|NCT02265705|58923294|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
30890277|NCT02265705|58923288|FG000|Treatment Period Week 0-24|Physician Decision|1|||
30890278|NCT02265705|58923289|FG001|Treatment Period Week 0-24|Physician Decision|0|||
30890279|NCT02265705|58923290|FG002|Treatment Period Week 0-24|Physician Decision|0|||
30890280|NCT02265705|58923291|FG003|Treatment Period Week 0-24|Physician Decision|0|||
30890281|NCT02265705|58923292|FG004|Treatment Period Week 0-24|Physician Decision|0|||
30890282|NCT02265705|58923293|FG005|Treatment Period Week 0-24|Physician Decision|0|||
30890283|NCT02265705|58923294|FG006|Treatment Period Week 0-24|Physician Decision|0|||
30890284|NCT02265705|58923288|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
30890285|NCT02265705|58923289|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
30890286|NCT02265705|58923290|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
30890287|NCT02265705|58923291|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
30890288|NCT02265705|58923292|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
30890289|NCT02265705|58923293|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
30890290|NCT02265705|58923294|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
30890291|NCT02265705|58923288|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
30976324|NCT02579928|59063958|FG000|Overall Study|Withdrawal by Subject|1|||
30890292|NCT02265705|58923289|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
30890293|NCT02265705|58923290|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
30890294|NCT02265705|58923291|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
30890295|NCT02265705|58923292|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
30890296|NCT02265705|58923293|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
30890297|NCT02265705|58923294|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
30890298|NCT02265705|58923288|FG000|Rescue Period|Withdrawal by Subject|0|||
30890299|NCT02265705|58923289|FG001|Rescue Period|Withdrawal by Subject|0|||
30890300|NCT02265705|58923290|FG002|Rescue Period|Withdrawal by Subject|1|||
30890301|NCT02265705|58923291|FG003|Rescue Period|Withdrawal by Subject|0|||
30890302|NCT02265705|58923292|FG004|Rescue Period|Withdrawal by Subject|0|||
30890303|NCT02265705|58923293|FG005|Rescue Period|Withdrawal by Subject|0|||
30890304|NCT02265705|58923294|FG006|Rescue Period|Withdrawal by Subject|0|||
30890305|NCT02265705|58923288|FG000|Rescue Period|Death|0|||
30890306|NCT02265705|58923289|FG001|Rescue Period|Death|0|||
30890307|NCT02265705|58923290|FG002|Rescue Period|Death|1|||
30890308|NCT02265705|58923291|FG003|Rescue Period|Death|0|||
30890309|NCT02265705|58923292|FG004|Rescue Period|Death|0|||
30890310|NCT02265705|58923293|FG005|Rescue Period|Death|0|||
30890311|NCT02265705|58923294|FG006|Rescue Period|Death|0|||
30890312|NCT02265705|58923288|FG000|Rescue Period|Lack of Efficacy|0|||
30890313|NCT02265705|58923289|FG001|Rescue Period|Lack of Efficacy|0|||
30890314|NCT02265705|58923290|FG002|Rescue Period|Lack of Efficacy|1|||
30890315|NCT02265705|58923291|FG003|Rescue Period|Lack of Efficacy|0|||
30890316|NCT02265705|58923292|FG004|Rescue Period|Lack of Efficacy|0|||
30890317|NCT02265705|58923293|FG005|Rescue Period|Lack of Efficacy|0|||
30890318|NCT02265705|58923294|FG006|Rescue Period|Lack of Efficacy|0|||
30890319|NCT02265705|58923288|FG000|Open Label Period|Adverse Event|0|||
30890320|NCT02265705|58923289|FG001|Open Label Period|Adverse Event|0|||
30890321|NCT02265705|58923290|FG002|Open Label Period|Adverse Event|0|||
30890322|NCT02265705|58923291|FG003|Open Label Period|Adverse Event|2|||
30890323|NCT02265705|58923292|FG004|Open Label Period|Adverse Event|2|||
30890324|NCT02265705|58923293|FG005|Open Label Period|Adverse Event|0|||
30890325|NCT02265705|58923294|FG006|Open Label Period|Adverse Event|0|||
30890326|NCT02265705|58923288|FG000|Open Label Period|Physician Decision|0|||
30890327|NCT02265705|58923289|FG001|Open Label Period|Physician Decision|0|||
30890328|NCT02265705|58923290|FG002|Open Label Period|Physician Decision|0|||
30890329|NCT02265705|58923291|FG003|Open Label Period|Physician Decision|0|||
30890330|NCT02265705|58923292|FG004|Open Label Period|Physician Decision|1|||
30890331|NCT02265705|58923293|FG005|Open Label Period|Physician Decision|0|||
30890332|NCT02265705|58923294|FG006|Open Label Period|Physician Decision|0|||
30890333|NCT02265705|58923288|FG000|Open Label Period|Withdrawal by Subject|0|||
30890334|NCT02265705|58923289|FG001|Open Label Period|Withdrawal by Subject|0|||
30890335|NCT02265705|58923290|FG002|Open Label Period|Withdrawal by Subject|0|||
30890336|NCT02265705|58923291|FG003|Open Label Period|Withdrawal by Subject|0|||
30890337|NCT02265705|58923292|FG004|Open Label Period|Withdrawal by Subject|2|||
30890338|NCT02265705|58923293|FG005|Open Label Period|Withdrawal by Subject|0|||
30890339|NCT02265705|58923294|FG006|Open Label Period|Withdrawal by Subject|0|||
30890340|NCT02265705|58923288|FG000|Follow-up Period|Sponsor Decision|0|||
30890341|NCT02265705|58923289|FG001|Follow-up Period|Sponsor Decision|0|||
30890342|NCT02265705|58923290|FG002|Follow-up Period|Sponsor Decision|0|||
30890343|NCT02265705|58923291|FG003|Follow-up Period|Sponsor Decision|0|||
30890344|NCT02265705|58923292|FG004|Follow-up Period|Sponsor Decision|0|||
30890345|NCT02265705|58923293|FG005|Follow-up Period|Sponsor Decision|1|||
30890346|NCT02265705|58923294|FG006|Follow-up Period|Sponsor Decision|6|||
30890347|NCT02265705|58923288|FG000|Follow-up Period|Adverse Event|0|||
30890348|NCT02265705|58923289|FG001|Follow-up Period|Adverse Event|0|||
30890349|NCT02265705|58923290|FG002|Follow-up Period|Adverse Event|0|||
30890350|NCT02265705|58923291|FG003|Follow-up Period|Adverse Event|0|||
30890351|NCT02265705|58923292|FG004|Follow-up Period|Adverse Event|0|||
30890352|NCT02265705|58923293|FG005|Follow-up Period|Adverse Event|0|||
30890353|NCT02265705|58923294|FG006|Follow-up Period|Adverse Event|3|||
30890354|NCT02265705|58923288|FG000|Follow-up Period|Physician Decision|0|||
30890355|NCT02265705|58923289|FG001|Follow-up Period|Physician Decision|0|||
30890356|NCT02265705|58923290|FG002|Follow-up Period|Physician Decision|0|||
30890357|NCT02265705|58923291|FG003|Follow-up Period|Physician Decision|0|||
30890358|NCT02265705|58923292|FG004|Follow-up Period|Physician Decision|0|||
30890359|NCT02265705|58923293|FG005|Follow-up Period|Physician Decision|0|||
30890360|NCT02265705|58923294|FG006|Follow-up Period|Physician Decision|1|||
30890361|NCT02265705|58923288|FG000|Follow-up Period|Withdrawal by Subject|0|||
30890362|NCT02265705|58923289|FG001|Follow-up Period|Withdrawal by Subject|0|||
30890363|NCT02265705|58923290|FG002|Follow-up Period|Withdrawal by Subject|0|||
30890364|NCT02265705|58923291|FG003|Follow-up Period|Withdrawal by Subject|0|||
30890365|NCT02265705|58923292|FG004|Follow-up Period|Withdrawal by Subject|0|||
30890366|NCT02265705|58923293|FG005|Follow-up Period|Withdrawal by Subject|0|||
30890367|NCT02265705|58923294|FG006|Follow-up Period|Withdrawal by Subject|1|||
30890368|NCT02459665|58923309|FG000|Overall Study|Withdrawal by Subject|0|||
30890369|NCT02459665|58923310|FG001|Overall Study|Withdrawal by Subject|1|||
30890370|NCT02459665|58923311|FG002|Overall Study|Withdrawal by Subject|1|||
30890371|NCT02459665|58923312|FG003|Overall Study|Withdrawal by Subject|2|||
30890372|NCT02265237|58923333|FG000|As Treated (Overall Study)|Adverse Event|1|||
30890373|NCT02265237|58923334|FG001|As Treated (Overall Study)|Adverse Event|1|||
30890374|NCT02265237|58923335|FG002|As Treated (Overall Study)|Adverse Event|0|||
30890375|NCT02265237|58923336|FG003|As Treated (Overall Study)|Adverse Event|0|||
30890376|NCT02265237|58923333|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
30890377|NCT02265237|58923334|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
30890378|NCT02265237|58923335|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
30890379|NCT02265237|58923336|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
30890380|NCT02265237|58923333|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
30890381|NCT02265237|58923334|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
30890382|NCT02265237|58923335|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
30890383|NCT02265237|58923336|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
30890384|NCT02265237|58923333|FG000|As Treated (Overall Study)|Other|2|||
30890385|NCT02265237|58923334|FG001|As Treated (Overall Study)|Other|0|||
30890386|NCT02265237|58923335|FG002|As Treated (Overall Study)|Other|3|||
30890387|NCT02265237|58923336|FG003|As Treated (Overall Study)|Other|1|||
30890388|NCT02263365|58923349|FG000|Overall Study|Physician Decision|22|||
30890389|NCT02263365|58923350|FG001|Overall Study|Physician Decision|18|||
30890390|NCT02261493|58923360|FG000|Overall Study|Noncompliance|0|||
30890391|NCT02261493|58923361|FG001|Overall Study|Noncompliance|0|||
30890392|NCT02261493|58923362|FG002|Overall Study|Noncompliance|2|||
30890393|NCT02261493|58923360|FG000|Overall Study|Physician Decision|0|||
30890394|NCT02261493|58923361|FG001|Overall Study|Physician Decision|1|||
30890395|NCT02261493|58923362|FG002|Overall Study|Physician Decision|0|||
30890396|NCT02261493|58923360|FG000|Overall Study|Undisclosed alcohol abuse|0|||
30890397|NCT02261493|58923361|FG001|Overall Study|Undisclosed alcohol abuse|1|||
30890398|NCT02261493|58923362|FG002|Overall Study|Undisclosed alcohol abuse|0|||
30890399|NCT02261493|58923360|FG000|Overall Study|Protocol Violation|1|||
30890400|NCT02261493|58923361|FG001|Overall Study|Protocol Violation|0|||
30890401|NCT02261493|58923362|FG002|Overall Study|Protocol Violation|0|||
30890402|NCT02261493|58923360|FG000|Overall Study|Personal Reasons|14|||
30890403|NCT02261493|58923361|FG001|Overall Study|Personal Reasons|14|||
30890404|NCT02261493|58923362|FG002|Overall Study|Personal Reasons|16|||
30890405|NCT02261493|58923360|FG000|Overall Study|Lost to Follow-up|14|||
30890406|NCT02261493|58923361|FG001|Overall Study|Lost to Follow-up|27|||
30890407|NCT02261493|58923362|FG002|Overall Study|Lost to Follow-up|8|||
30890408|NCT02261493|58923360|FG000|Overall Study|Pregnancy|1|||
30890409|NCT02261493|58923361|FG001|Overall Study|Pregnancy|2|||
30890410|NCT02261493|58923362|FG002|Overall Study|Pregnancy|0|||
30890411|NCT02261493|58923360|FG000|Overall Study|Lack of Efficacy|0|||
30890412|NCT02261493|58923361|FG001|Overall Study|Lack of Efficacy|1|||
30890413|NCT02261493|58923362|FG002|Overall Study|Lack of Efficacy|0|||
30890414|NCT02261493|58923360|FG000|Overall Study|Adverse Event|0|||
30890415|NCT02261493|58923361|FG001|Overall Study|Adverse Event|1|||
30890416|NCT02261493|58923362|FG002|Overall Study|Adverse Event|0|||
30890417|NCT02260791|58923372|FG000|Overall Study|Lost to Follow-up|4|||
30890418|NCT02260791|58923373|FG001|Overall Study|Lost to Follow-up|4|||
30890419|NCT02260791|58923372|FG000|Overall Study|Lack of Efficacy|2|||
30890420|NCT02260791|58923373|FG001|Overall Study|Lack of Efficacy|1|||
30890421|NCT02260791|58923372|FG000|Overall Study|Adverse Event|13|||
30890422|NCT02260791|58923373|FG001|Overall Study|Adverse Event|9|||
30890423|NCT02260791|58923372|FG000|Overall Study|Death|1|||
30890424|NCT02260791|58923373|FG001|Overall Study|Death|0|||
30890425|NCT02260791|58923372|FG000|Overall Study|Withdrawal by Subject|11|||
30890426|NCT02260791|58923373|FG001|Overall Study|Withdrawal by Subject|16|||
30890427|NCT02260791|58923372|FG000|Overall Study|Screen failure|0|||
30890428|NCT02260791|58923373|FG001|Overall Study|Screen failure|1|||
30890429|NCT02260791|58923372|FG000|Overall Study|Protocol deviation|2|||
30890430|NCT02260791|58923373|FG001|Overall Study|Protocol deviation|3|||
30890431|NCT02260635|58923381|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
30890432|NCT02260635|58923382|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
30890433|NCT02260635|58923381|FG000|Open-Label Extension|Study Termination|25|||
30890434|NCT02260635|58923382|FG001|Open-Label Extension|Study Termination|25|||
30890435|NCT02260635|58923381|FG000|Open-Label Extension|Withdrawal by Subject|1|||
30890436|NCT02260635|58923382|FG001|Open-Label Extension|Withdrawal by Subject|0|||
30890437|NCT02259231|58923397|FG000|Overall Study|Adverse Event|1|||
30890438|NCT02259231|58923398|FG001|Overall Study|Adverse Event|1|||
30890439|NCT02259231|58923399|FG002|Overall Study|Adverse Event|2|||
30890440|NCT02259231|58923400|FG003|Overall Study|Adverse Event|0|||
30890441|NCT02259231|58923401|FG004|Overall Study|Adverse Event|0|||
30890442|NCT02259231|58923402|FG005|Overall Study|Adverse Event|0|||
30890443|NCT02259231|58923403|FG006|Overall Study|Adverse Event|0|||
30890444|NCT02259231|58923397|FG000|Overall Study|Progressive Disease|4|||
30890445|NCT02259231|58923398|FG001|Overall Study|Progressive Disease|5|||
30976325|NCT02579928|59063959|FG001|Overall Study|Withdrawal by Subject|0|||
30890446|NCT02259231|58923399|FG002|Overall Study|Progressive Disease|4|||
30890447|NCT02259231|58923400|FG003|Overall Study|Progressive Disease|5|||
30890448|NCT02259231|58923401|FG004|Overall Study|Progressive Disease|4|||
30890449|NCT02259231|58923402|FG005|Overall Study|Progressive Disease|5|||
30890450|NCT02259231|58923403|FG006|Overall Study|Progressive Disease|4|||
30890451|NCT02259231|58923397|FG000|Overall Study|Sponsor termination of study|1|||
30890452|NCT02259231|58923398|FG001|Overall Study|Sponsor termination of study|0|||
30890453|NCT02259231|58923399|FG002|Overall Study|Sponsor termination of study|0|||
30890454|NCT02259231|58923400|FG003|Overall Study|Sponsor termination of study|1|||
30890455|NCT02259231|58923401|FG004|Overall Study|Sponsor termination of study|2|||
30890456|NCT02259231|58923402|FG005|Overall Study|Sponsor termination of study|1|||
30890457|NCT02259231|58923403|FG006|Overall Study|Sponsor termination of study|1|||
30890458|NCT02258529|58923419|FG000|Overall Study|Study Terminated by Sponsor|9|||
30890459|NCT02258529|58923419|FG000|Overall Study|Adverse Event|1|||
30890460|NCT02256969|58923426|FG000|Overall Study|Screenfailed or withdrew|2|||
30890461|NCT02256969|58923427|FG001|Overall Study|Screenfailed or withdrew|1|||
30890462|NCT02256969|58923428|FG002|Overall Study|Screenfailed or withdrew|1|||
30890463|NCT02256891|58923438|FG000|Overall Study|Death|0|||
30890464|NCT02256891|58923439|FG001|Overall Study|Death|2|||
30890465|NCT02256891|58923438|FG000|Overall Study|Lost to Follow-up|0|||
30890466|NCT02256891|58923439|FG001|Overall Study|Lost to Follow-up|3|||
30890467|NCT02256891|58923438|FG000|Overall Study|Physician Decision|7|||
30890468|NCT02256891|58923439|FG001|Overall Study|Physician Decision|3|||
30890469|NCT02256891|58923438|FG000|Overall Study|Screen Fail|5|||
30890470|NCT02256891|58923439|FG001|Overall Study|Screen Fail|4|||
30890471|NCT02256891|58923438|FG000|Overall Study|Equipment Malfunction|0|||
30890472|NCT02256891|58923439|FG001|Overall Study|Equipment Malfunction|1|||
30890473|NCT02256267|58923447|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
30890474|NCT02256267|58923447|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
30890475|NCT01641471|58923456|FG000|Overall Study|Withdrawal by Subject|19|||
30890476|NCT01641471|58923457|FG001|Overall Study|Withdrawal by Subject|19|||
30890477|NCT01641471|58923456|FG000|Overall Study|Lost to Follow-up|2|||
30890478|NCT01641471|58923457|FG001|Overall Study|Lost to Follow-up|4|||
30890479|NCT01641471|58923456|FG000|Overall Study|Protocol Violation|2|||
30890480|NCT01641471|58923457|FG001|Overall Study|Protocol Violation|4|||
30890481|NCT02255565|58923466|FG000|Overall Study|Withdrawal by Subject|0|||
30890482|NCT02255565|58923467|FG001|Overall Study|Withdrawal by Subject|1|||
30890483|NCT02255565|58923468|FG002|Overall Study|Withdrawal by Subject|0|||
30890484|NCT01640301|58923511|FG000|Overall Study|Death|0|||
30890485|NCT01640301|58923512|FG001|Overall Study|Death|8|||
30890486|NCT01642407|58923520|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
30890487|NCT01642407|58923520|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
30890488|NCT01642407|58923520|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
30890489|NCT02255097|58923524|FG000|Overall Study|Death|151|||
30890490|NCT02255097|58923524|FG000|Overall Study|Lost to Follow-up|5|||
30890491|NCT02255097|58923524|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
30890492|NCT02255097|58923524|FG000|Overall Study|Withdrawal by Subject|7|||
30890493|NCT02255097|58923524|FG000|Overall Study|Allocated but not treated|1|||
30890494|NCT02254551|58923529|FG000|Dose Escalation|Physician Decision|1|||
30890495|NCT02254551|58923529|FG000|Dose Escalation|Dose-limiting toxicity|2|||
30890496|NCT01641237|58923536|FG000|Period II|Withdrawal by Subject|1|||
30890497|NCT01641237|58923537|FG001|Period II|Withdrawal by Subject|0|||
30890498|NCT01641237|58923538|FG002|Period II|Withdrawal by Subject|0|||
30890499|NCT01641237|58923539|FG003|Period II|Withdrawal by Subject|0|||
30890500|NCT01641237|58923536|FG000|Period III|Lost to Follow-up|1|||
30890501|NCT01641237|58923537|FG001|Period III|Lost to Follow-up|0|||
30890502|NCT01641237|58923538|FG002|Period III|Lost to Follow-up|0|||
30890503|NCT01641237|58923539|FG003|Period III|Lost to Follow-up|0|||
30890504|NCT01639833|58923551|FG000|Overall Study|Death|4|||
30890505|NCT01639833|58923552|FG001|Overall Study|Death|2|||
30890506|NCT01639833|58923551|FG000|Overall Study|Withdrawal by Subject|2|||
30890507|NCT01639833|58923552|FG001|Overall Study|Withdrawal by Subject|2|||
30890508|NCT01639131|58923558|FG000|Overall Study|Disease Progression|6|||
30890509|NCT01641159|58923564|FG000|Overall Study|Lost to Follow-up|2|||
30890510|NCT01641159|58923565|FG001|Overall Study|Lost to Follow-up|1|||
30890511|NCT01641159|58923564|FG000|Overall Study|Withdrawal by Subject|0|||
30890512|NCT01641159|58923565|FG001|Overall Study|Withdrawal by Subject|1|||
30890513|NCT01641081|58923571|FG000|Period 1|Sponsor request (potential unblinding)|0|||
30890514|NCT01641081|58923572|FG001|Period 1|Sponsor request (potential unblinding)|0|||
30890515|NCT01641081|58923573|FG002|Period 1|Sponsor request (potential unblinding)|0|||
30890516|NCT01641081|58923574|FG003|Period 1|Sponsor request (potential unblinding)|0|||
30890517|NCT01641081|58923575|FG004|Period 1|Sponsor request (potential unblinding)|0|||
30890518|NCT01641081|58923576|FG005|Period 1|Sponsor request (potential unblinding)|0|||
30890519|NCT01641081|58923577|FG006|Period 1|Sponsor request (potential unblinding)|1|||
30890520|NCT01641081|58923578|FG007|Period 1|Sponsor request (potential unblinding)|0|||
30890521|NCT01641081|58923579|FG008|Period 1|Sponsor request (potential unblinding)|0|||
30890522|NCT01641081|58923580|FG009|Period 1|Sponsor request (potential unblinding)|0|||
30890523|NCT01641081|58923571|FG000|Period 1|Protocol Violation|0|||
30890524|NCT01641081|58923572|FG001|Period 1|Protocol Violation|0|||
30890525|NCT01641081|58923573|FG002|Period 1|Protocol Violation|0|||
30976326|NCT00551460|59064053|FG000|Overall Study|Adverse Event|1|||
30890526|NCT01641081|58923574|FG003|Period 1|Protocol Violation|0|||
30890527|NCT01641081|58923575|FG004|Period 1|Protocol Violation|1|||
30890528|NCT01641081|58923576|FG005|Period 1|Protocol Violation|0|||
30890529|NCT01641081|58923577|FG006|Period 1|Protocol Violation|0|||
30890530|NCT01641081|58923578|FG007|Period 1|Protocol Violation|1|||
30890531|NCT01641081|58923579|FG008|Period 1|Protocol Violation|0|||
30890532|NCT01641081|58923580|FG009|Period 1|Protocol Violation|0|||
30890533|NCT01641081|58923571|FG000|Period 1|Adverse Event|1|||
30890534|NCT01641081|58923572|FG001|Period 1|Adverse Event|0|||
30890535|NCT01641081|58923573|FG002|Period 1|Adverse Event|0|||
30890536|NCT01641081|58923574|FG003|Period 1|Adverse Event|0|||
30890537|NCT01641081|58923575|FG004|Period 1|Adverse Event|0|||
30890538|NCT01641081|58923576|FG005|Period 1|Adverse Event|0|||
30890539|NCT01641081|58923577|FG006|Period 1|Adverse Event|0|||
30890540|NCT01641081|58923578|FG007|Period 1|Adverse Event|2|||
30890541|NCT01641081|58923579|FG008|Period 1|Adverse Event|0|||
30890542|NCT01641081|58923580|FG009|Period 1|Adverse Event|0|||
30890543|NCT01641081|58923571|FG000|Period 2|Adverse Event|0|||
30890544|NCT01641081|58923572|FG001|Period 2|Adverse Event|0|||
30890545|NCT01641081|58923573|FG002|Period 2|Adverse Event|0|||
30890546|NCT01641081|58923574|FG003|Period 2|Adverse Event|0|||
30890547|NCT01641081|58923575|FG004|Period 2|Adverse Event|0|||
30890548|NCT01641081|58923576|FG005|Period 2|Adverse Event|1|||
30890549|NCT01641081|58923577|FG006|Period 2|Adverse Event|0|||
30890550|NCT01641081|58923578|FG007|Period 2|Adverse Event|0|||
30890551|NCT01641081|58923579|FG008|Period 2|Adverse Event|0|||
30976327|NCT00551460|59064053|FG000|Overall Study|Withdrawal by Subject|1|||
30976328|NCT00551460|59064053|FG000|Overall Study|Physician Decision|1|||
30976329|NCT00551460|59064053|FG000|Overall Study|Death|7|||
30976330|NCT00551460|59064053|FG000|Overall Study|Ineligible|4|||
30976331|NCT00551460|59064053|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
30976332|NCT02579772|59064114|FG000|Overall Study|Withdrawal by Subject|0|||
30976333|NCT02579772|59064115|FG001|Overall Study|Withdrawal by Subject|1|||
30976334|NCT02579772|59064114|FG000|Overall Study|Usage of additional antioxidants|1|||
30976335|NCT02579772|59064115|FG001|Overall Study|Usage of additional antioxidants|0|||
30976336|NCT02579772|59064114|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
30976337|NCT02579772|59064115|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
30976338|NCT02579616|59064188|FG000|Overall Study|Participants did not receive treatment|3|||
30976339|NCT04027608|59064265|FG000|Overall Study|Withdrawal by Subject|13|||
30976340|NCT04027608|59064266|FG001|Overall Study|Withdrawal by Subject|2|||
30976341|NCT04027608|59064265|FG000|Overall Study|Protocol Violation|2|||
30976342|NCT04027608|59064266|FG001|Overall Study|Protocol Violation|1|||
30976343|NCT04027608|59064265|FG000|Overall Study|Physician Decision|1|||
30976344|NCT04027608|59064266|FG001|Overall Study|Physician Decision|0|||
30976345|NCT04027608|59064265|FG000|Overall Study|Lost to Follow-up|20|||
30976346|NCT04027608|59064266|FG001|Overall Study|Lost to Follow-up|4|||
30976347|NCT01664052|59064357|FG000|Phase 1|No device placement|6|||
30976348|NCT01664052|59064358|FG001|Phase 1|No device placement|0|||
30976349|NCT01664052|59064357|FG000|Phase 1|No HSG 1 hr post placement|1|||
30976350|NCT01664052|59064358|FG001|Phase 1|No HSG 1 hr post placement|0|||
30976351|NCT01664052|59064357|FG000|Phase 2|No device placement|0|||
30976352|NCT01664052|59064358|FG001|Phase 2|No device placement|4|||
30976353|NCT01465802|59064405|FG000|Overall Study|Study terminated by sponsor|1|||
30976354|NCT01465802|59064406|FG001|Overall Study|Study terminated by sponsor|0|||
30976355|NCT01465802|59064407|FG002|Overall Study|Study terminated by sponsor|0|||
30976356|NCT01465802|59064408|FG003|Overall Study|Study terminated by sponsor|1|||
30976357|NCT01465802|59064409|FG004|Overall Study|Study terminated by sponsor|7|||
30976358|NCT01465802|59064405|FG000|Overall Study|Withdrawal by Subject|7|||
30976359|NCT01465802|59064406|FG001|Overall Study|Withdrawal by Subject|7|||
30976360|NCT01465802|59064407|FG002|Overall Study|Withdrawal by Subject|0|||
30976361|NCT01465802|59064408|FG003|Overall Study|Withdrawal by Subject|8|||
30976362|NCT01465802|59064409|FG004|Overall Study|Withdrawal by Subject|1|||
30976363|NCT01465802|59064405|FG000|Overall Study|Lost to Follow-up|1|||
30976364|NCT01465802|59064406|FG001|Overall Study|Lost to Follow-up|1|||
30976365|NCT01465802|59064407|FG002|Overall Study|Lost to Follow-up|0|||
30976366|NCT01465802|59064408|FG003|Overall Study|Lost to Follow-up|0|||
30976367|NCT01465802|59064409|FG004|Overall Study|Lost to Follow-up|0|||
30976368|NCT01465802|59064405|FG000|Overall Study|Reason not specified|9|||
30976369|NCT01465802|59064406|FG001|Overall Study|Reason not specified|4|||
30976370|NCT01465802|59064407|FG002|Overall Study|Reason not specified|0|||
30976371|NCT01465802|59064408|FG003|Overall Study|Reason not specified|10|||
30890552|NCT01641081|58923580|FG009|Period 2|Adverse Event|0|||
30890553|NCT01641081|58923571|FG000|Period 2|Withdrawal by Subject|0|||
30890554|NCT01641081|58923572|FG001|Period 2|Withdrawal by Subject|0|||
30890555|NCT01641081|58923573|FG002|Period 2|Withdrawal by Subject|0|||
30890556|NCT01641081|58923574|FG003|Period 2|Withdrawal by Subject|1|||
30890557|NCT01641081|58923575|FG004|Period 2|Withdrawal by Subject|0|||
30890558|NCT01641081|58923576|FG005|Period 2|Withdrawal by Subject|0|||
30890559|NCT01641081|58923577|FG006|Period 2|Withdrawal by Subject|2|||
30976372|NCT01465802|59064409|FG004|Overall Study|Reason not specified|2|||
30976373|NCT01465802|59064405|FG000|Overall Study|Death|15|||
30976374|NCT01465802|59064406|FG001|Overall Study|Death|12|||
30976375|NCT01465802|59064407|FG002|Overall Study|Death|0|||
30976376|NCT01465802|59064408|FG003|Overall Study|Death|10|||
30976377|NCT01465802|59064409|FG004|Overall Study|Death|2|||
30976378|NCT01437878|59064454|FG000|Overall Study|Withdrawal by Subject|1|||
30976379|NCT01437878|59064455|FG001|Overall Study|Withdrawal by Subject|0|||
30976380|NCT01465178|59064481|FG000|Overall Study|Withdrawal by Subject|1|||
30976381|NCT01465178|59064482|FG001|Overall Study|Withdrawal by Subject|0|||
30976382|NCT01445678|59064588|FG000|Overall Study|Adverse Event|12|||
30976383|NCT01445678|59064589|FG001|Overall Study|Adverse Event|8|||
30976384|NCT01445678|59064588|FG000|Overall Study|Lack of Efficacy|0|||
30976385|NCT01445678|59064589|FG001|Overall Study|Lack of Efficacy|2|||
30976386|NCT01445678|59064588|FG000|Overall Study|Lost to Follow-up|8|||
30976387|NCT01445678|59064589|FG001|Overall Study|Lost to Follow-up|5|||
30976388|NCT01445678|59064588|FG000|Overall Study|Protocol Violation|1|||
30976389|NCT01445678|59064589|FG001|Overall Study|Protocol Violation|1|||
30976390|NCT01445678|59064588|FG000|Overall Study|Withdrawal by Subject|9|||
30976391|NCT01445678|59064589|FG001|Overall Study|Withdrawal by Subject|5|||
30976392|NCT03769194|59064608|FG000|Overall Study|Withdrawal by Subject|0|||
30976393|NCT03769194|59064609|FG001|Overall Study|Withdrawal by Subject|7|||
30976394|NCT03769194|59064610|FG002|Overall Study|Withdrawal by Subject|4|||
30976395|NCT03769194|59064611|FG003|Overall Study|Withdrawal by Subject|1|||
30976396|NCT03769194|59064608|FG000|Overall Study|moved from study area|0|||
30976397|NCT03769194|59064609|FG001|Overall Study|moved from study area|2|||
30976398|NCT03769194|59064610|FG002|Overall Study|moved from study area|1|||
30976399|NCT03769194|59064611|FG003|Overall Study|moved from study area|1|||
30976400|NCT03769194|59064608|FG000|Overall Study|Lost to Follow-up|3|||
30976401|NCT03769194|59064609|FG001|Overall Study|Lost to Follow-up|6|||
30976402|NCT03769194|59064610|FG002|Overall Study|Lost to Follow-up|3|||
30976403|NCT03769194|59064611|FG003|Overall Study|Lost to Follow-up|6|||
30976404|NCT03769194|59064608|FG000|Overall Study|other|1|||
30976405|NCT03769194|59064609|FG001|Overall Study|other|3|||
30976406|NCT03769194|59064610|FG002|Overall Study|other|0|||
30976407|NCT03769194|59064611|FG003|Overall Study|other|1|||
30976408|NCT01465022|59064637|FG000|Overall Study|Lost to Follow-up|15|||
30976409|NCT01465022|59064638|FG001|Overall Study|Lost to Follow-up|14|||
30976410|NCT01465022|59064639|FG002|Overall Study|Lost to Follow-up|0|||
30976411|NCT01465022|59064637|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
30976412|NCT01465022|59064638|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
30976413|NCT01465022|59064639|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
30976414|NCT01465022|59064637|FG000|Overall Study|Not Randomized|0|||
30976415|NCT01465022|59064638|FG001|Overall Study|Not Randomized|0|||
30976416|NCT01465022|59064639|FG002|Overall Study|Not Randomized|70|||
30976417|NCT01464788|59064683|FG000|Overall Study|Lost to Follow-up|0|||
30976418|NCT01464788|59064684|FG001|Overall Study|Lost to Follow-up|1|||
30976419|NCT01464788|59064685|FG002|Overall Study|Lost to Follow-up|0|||
30976420|NCT01464788|59064683|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
30976421|NCT01464788|59064684|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
30976422|NCT01464788|59064685|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
30976423|NCT01444898|59064695|FG000|Overall Study|Withdrawal by Subject|1|||
30976424|NCT01419626|59064717|FG000|Overall Study|Protocol Violation|3|||
30976425|NCT01419626|59064718|FG001|Overall Study|Protocol Violation|2|||
30976426|NCT01419626|59064719|FG002|Overall Study|Protocol Violation|2|||
30976427|NCT01419626|59064717|FG000|Overall Study|Withdrawal by Subject|1|||
30976428|NCT01419626|59064718|FG001|Overall Study|Withdrawal by Subject|0|||
30976429|NCT01419626|59064719|FG002|Overall Study|Withdrawal by Subject|0|||
30976430|NCT01419626|59064717|FG000|Overall Study|Lost to Follow-up|0|||
30890560|NCT01641081|58923578|FG007|Period 2|Withdrawal by Subject|0|||
30890561|NCT01641081|58923579|FG008|Period 2|Withdrawal by Subject|0|||
30890562|NCT01641081|58923580|FG009|Period 2|Withdrawal by Subject|0|||
30890563|NCT01641081|58923571|FG000|Period 2|Protocol Violation|1|||
30890564|NCT01641081|58923572|FG001|Period 2|Protocol Violation|0|||
30890565|NCT01641081|58923573|FG002|Period 2|Protocol Violation|0|||
30890566|NCT01641081|58923574|FG003|Period 2|Protocol Violation|0|||
30890567|NCT01641081|58923575|FG004|Period 2|Protocol Violation|0|||
30890568|NCT01641081|58923576|FG005|Period 2|Protocol Violation|0|||
30890569|NCT01641081|58923577|FG006|Period 2|Protocol Violation|0|||
30890570|NCT01641081|58923578|FG007|Period 2|Protocol Violation|0|||
30890571|NCT01641081|58923579|FG008|Period 2|Protocol Violation|0|||
30890572|NCT01641081|58923580|FG009|Period 2|Protocol Violation|0|||
30976431|NCT01419626|59064718|FG001|Overall Study|Lost to Follow-up|1|||
30976432|NCT01419626|59064719|FG002|Overall Study|Lost to Follow-up|1|||
30976433|NCT01444742|59064758|FG000|Overall Study|Death|1|||
30976434|NCT01444430|59064958|FG000|Overall Study|Withdrawal by Subject|53|||
30976435|NCT01444430|59064959|FG001|Overall Study|Withdrawal by Subject|72|||
30976436|NCT01444430|59064958|FG000|Overall Study|Death|6|||
30976437|NCT01444430|59064959|FG001|Overall Study|Death|8|||
30976438|NCT01444430|59064958|FG000|Overall Study|Lost to Follow-up|2|||
30976439|NCT01444430|59064959|FG001|Overall Study|Lost to Follow-up|0|||
30976440|NCT01444430|59064958|FG000|Overall Study|CRF termination module not completed.|0|||
30976441|NCT01444430|59064959|FG001|Overall Study|CRF termination module not completed.|1|||
30890573|NCT01641081|58923571|FG000|Period 3|Adverse Event|0|||
30890574|NCT01641081|58923572|FG001|Period 3|Adverse Event|0|||
30976442|NCT01436162|59065035|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
30976443|NCT01436162|59065036|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
30976444|NCT01436162|59065037|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
30976445|NCT01436162|59065035|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
30976446|NCT01436162|59065036|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
30976447|NCT01436162|59065037|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
30976448|NCT01436162|59065035|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
30976449|NCT01436162|59065036|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
30976450|NCT01436162|59065037|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
30976451|NCT01436162|59065035|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
30976452|NCT01436162|59065036|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
30976453|NCT01436162|59065037|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
30976454|NCT01436162|59065035|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
30976455|NCT01436162|59065036|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
30976456|NCT01436162|59065037|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
30976457|NCT01436162|59065035|FG000|Single-blind Lead-in Phase|Other|107|||
30976458|NCT01436162|59065036|FG001|Single-blind Lead-in Phase|Other|0|||
30976459|NCT01436162|59065037|FG002|Single-blind Lead-in Phase|Other|0|||
30976460|NCT01436162|59065035|FG000|Randomized Phase|Adverse Event|1|||
30976461|NCT01436162|59065036|FG001|Randomized Phase|Adverse Event|5|||
30976462|NCT01436162|59065037|FG002|Randomized Phase|Adverse Event|6|||
30976463|NCT01436162|59065035|FG000|Randomized Phase|Protocol Violation|4|||
30976464|NCT01436162|59065036|FG001|Randomized Phase|Protocol Violation|4|||
30976465|NCT01436162|59065037|FG002|Randomized Phase|Protocol Violation|2|||
30976466|NCT01436162|59065035|FG000|Randomized Phase|Withdrawal by Subject|16|||
30976467|NCT01436162|59065036|FG001|Randomized Phase|Withdrawal by Subject|9|||
30976468|NCT01436162|59065037|FG002|Randomized Phase|Withdrawal by Subject|8|||
30976469|NCT01436162|59065035|FG000|Randomized Phase|Lost to Follow-up|17|||
30976470|NCT01436162|59065036|FG001|Randomized Phase|Lost to Follow-up|5|||
30976471|NCT01436162|59065037|FG002|Randomized Phase|Lost to Follow-up|4|||
30976472|NCT01436162|59065035|FG000|Randomized Phase|Lack of Efficacy|0|||
30976473|NCT01436162|59065036|FG001|Randomized Phase|Lack of Efficacy|1|||
30976474|NCT01436162|59065037|FG002|Randomized Phase|Lack of Efficacy|1|||
30976475|NCT01436162|59065035|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
30976476|NCT01436162|59065036|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
30976477|NCT01436162|59065037|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
30976478|NCT01436162|59065035|FG000|Randomized Phase|Other|2|||
30976479|NCT01436162|59065036|FG001|Randomized Phase|Other|5|||
30976480|NCT01436162|59065037|FG002|Randomized Phase|Other|4|||
30976481|NCT02579382|59065049|FG000|Main Study Phase|Lost to Follow-up|0|||
30976482|NCT02579382|59065050|FG001|Main Study Phase|Lost to Follow-up|0|||
30976483|NCT02579382|59065051|FG002|Main Study Phase|Lost to Follow-up|2|||
30976484|NCT02579382|59065052|FG003|Main Study Phase|Lost to Follow-up|0|||
30976485|NCT02579382|59065049|FG000|Main Study Phase|Withdrew Consent|0|||
30976486|NCT02579382|59065050|FG001|Main Study Phase|Withdrew Consent|0|||
30976487|NCT02579382|59065051|FG002|Main Study Phase|Withdrew Consent|0|||
30976488|NCT02579382|59065052|FG003|Main Study Phase|Withdrew Consent|2|||
30976489|NCT02579382|59065049|FG000|Main Study Phase|Lack of Efficacy|0|||
30976490|NCT02579382|59065050|FG001|Main Study Phase|Lack of Efficacy|0|||
30976491|NCT02579382|59065051|FG002|Main Study Phase|Lack of Efficacy|0|||
30976492|NCT02579382|59065052|FG003|Main Study Phase|Lack of Efficacy|1|||
30976493|NCT02579382|59065049|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
30976494|NCT02579382|59065050|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
30976495|NCT02579382|59065051|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
30976496|NCT02579382|59065052|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
30976497|NCT02579382|59065049|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
30976498|NCT02579382|59065050|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
30976499|NCT02579382|59065051|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
30976500|NCT02579382|59065052|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
30976501|NCT02579382|59065049|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
30976502|NCT02579382|59065050|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
30976503|NCT02579382|59065051|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
30976504|NCT02579382|59065052|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
30976505|NCT02579382|59065049|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
30976506|NCT02579382|59065050|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
30976507|NCT02579382|59065051|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
30976508|NCT02579382|59065052|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
30976509|NCT02579382|59065049|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
30976510|NCT02579382|59065050|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
30790182|NCT00044213|58803371|FG001|Overall Study|Death|42|||
30976511|NCT02579382|59065051|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
30976512|NCT02579382|59065052|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
30976513|NCT02579382|59065049|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
30976514|NCT02579382|59065050|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
30976515|NCT02579382|59065051|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
30976516|NCT02579382|59065052|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
30976517|NCT01436084|59065088|FG000|Overall Study|Disease Progression|2|||
30976518|NCT01436084|59065088|FG000|Overall Study|Withdrawal by Subject|1|||
30976519|NCT01436084|59065088|FG000|Overall Study|Early Closure of Study|1|||
30976520|NCT01419314|59065103|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
30976521|NCT01419314|59065104|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
30976522|NCT01419314|59065103|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
30976523|NCT01419314|59065104|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
30976524|NCT01419314|59065103|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
30976525|NCT01419314|59065104|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
30976526|NCT01419236|59065161|FG000|Overall Study|Adverse Event|1|||
30976527|NCT01419236|59065162|FG001|Overall Study|Adverse Event|0|||
30976528|NCT01419236|59065161|FG000|Overall Study|Lack of Efficacy|0|||
30976529|NCT01419236|59065162|FG001|Overall Study|Lack of Efficacy|1|||
30976530|NCT01419236|59065161|FG000|Overall Study|Lost to Follow-up|1|||
30976531|NCT01419236|59065162|FG001|Overall Study|Lost to Follow-up|0|||
30976532|NCT01419236|59065161|FG000|Overall Study|Physician Decision|1|||
30976533|NCT01419236|59065162|FG001|Overall Study|Physician Decision|0|||
30976534|NCT01419236|59065161|FG000|Overall Study|Withdrawal by Subject|1|||
30976535|NCT01419236|59065162|FG001|Overall Study|Withdrawal by Subject|4|||
30976536|NCT01419236|59065161|FG000|Overall Study|Entry Criteria Not Met|1|||
30976537|NCT01419236|59065162|FG001|Overall Study|Entry Criteria Not Met|0|||
30976538|NCT03323658|59065175|FG000|Overall Study|Adverse Event|0|||
30976539|NCT03323658|59065176|FG001|Overall Study|Adverse Event|1|||
30976540|NCT03323658|59065177|FG002|Overall Study|Adverse Event|0|||
30976541|NCT01443026|59065202|FG000|Overall Study|Physician Decision|1|||
30976542|NCT01443026|59065203|FG001|Overall Study|Physician Decision|0|||
30976543|NCT01443026|59065202|FG000|Overall Study|Death|0|||
30976544|NCT01443026|59065203|FG001|Overall Study|Death|1|||
30976545|NCT01443026|59065202|FG000|Overall Study|Withdrawal by Subject|0|||
30976546|NCT01443026|59065203|FG001|Overall Study|Withdrawal by Subject|3|||
30976547|NCT01443026|59065202|FG000|Overall Study|Lost to Follow-up|2|||
30976548|NCT01443026|59065203|FG001|Overall Study|Lost to Follow-up|1|||
30976549|NCT01442714|59065237|FG000|Overall Study|Death|11|||
30976550|NCT01442714|59065237|FG000|Overall Study|Withdrawal by Subject|1|||
30976551|NCT01418378|59065250|FG000|Overall Study|Death|1|||
30976552|NCT01418378|59065251|FG001|Overall Study|Death|2|||
30976553|NCT01418378|59065250|FG000|Overall Study|Physician Decision|0|||
30976554|NCT01418378|59065251|FG001|Overall Study|Physician Decision|1|||
30976555|NCT01418378|59065250|FG000|Overall Study|ligament imbalance|0|||
30976556|NCT01418378|59065251|FG001|Overall Study|ligament imbalance|1|||
30976557|NCT01418378|59065250|FG000|Overall Study|developed chronic myopathy|0|||
30976558|NCT01418378|59065251|FG001|Overall Study|developed chronic myopathy|1|||
30976559|NCT01435928|59065272|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
30976560|NCT01435928|59065273|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
30976561|NCT01435928|59065274|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
30976562|NCT01435928|59065272|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
30976563|NCT01435928|59065273|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
30976564|NCT01435928|59065274|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
30976565|NCT01435928|59065272|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
30976566|NCT01435928|59065273|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
30976567|NCT01435928|59065274|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
30976568|NCT01435928|59065272|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
30976569|NCT01435928|59065273|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
30976570|NCT01435928|59065274|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
30976571|NCT01435928|59065272|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
30976572|NCT01435928|59065273|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
30976573|NCT01435928|59065274|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
30976574|NCT01435928|59065272|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
30608450|NCT01288430|58619229|FG008|Part 2|Clinical disease progression|0|||
30976575|NCT01435928|59065273|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
30976576|NCT01435928|59065274|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
30976577|NCT01435928|59065272|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
30976578|NCT01435928|59065273|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
30976579|NCT01435928|59065274|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
30976580|NCT01435928|59065272|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
30976581|NCT01435928|59065273|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
30976582|NCT01435928|59065274|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
30976583|NCT01435928|59065272|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
30976584|NCT01435928|59065273|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
30976585|NCT01435928|59065274|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
30976586|NCT01435928|59065272|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
30976587|NCT01435928|59065273|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
30976588|NCT01435928|59065274|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
30976589|NCT01435928|59065272|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
30976590|NCT01435928|59065273|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
30976591|NCT01435928|59065274|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
30976592|NCT01435928|59065272|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
30976593|NCT01435928|59065273|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
30976594|NCT01435928|59065274|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
30976595|NCT01435928|59065272|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
30976596|NCT01435928|59065273|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
30976597|NCT01435928|59065274|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
30976598|NCT01435928|59065272|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
30976599|NCT01435928|59065273|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
30976600|NCT01435928|59065274|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
30976601|NCT01435928|59065272|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
30976602|NCT01435928|59065273|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
30976603|NCT01435928|59065274|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
30976604|NCT01435928|59065272|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
30976605|NCT01435928|59065273|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
30976606|NCT01435928|59065274|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
30976607|NCT01416272|59065286|FG000|Overall Study|Unacceptable distance visual acuity|2|||
30976608|NCT01416272|59065286|FG000|Overall Study|Lost to Follow-up|1|||
30976609|NCT01416272|59065286|FG000|Overall Study|Study related complaints|1|||
30976610|NCT01435772|59065776|FG000|Overall Study|Adverse Event|1|||
30976611|NCT01435772|59065777|FG001|Overall Study|Adverse Event|0|||
30976612|NCT01435772|59065778|FG002|Overall Study|Adverse Event|2|||
30976613|NCT01435772|59065776|FG000|Overall Study|Withdrawal by Subject|0|||
30976614|NCT01435772|59065777|FG001|Overall Study|Withdrawal by Subject|1|||
30976615|NCT01435772|59065778|FG002|Overall Study|Withdrawal by Subject|3|||
30976616|NCT01435772|59065776|FG000|Overall Study|Other - study termination|2|||
30976617|NCT01435772|59065777|FG001|Overall Study|Other - study termination|2|||
30976618|NCT01435772|59065778|FG002|Overall Study|Other - study termination|10|||
30976619|NCT01435616|59065997|FG000|Overall Study|Adverse Event|39|||
30976620|NCT01435616|59065998|FG001|Overall Study|Adverse Event|21|||
30976621|NCT01435616|59065997|FG000|Overall Study|Death|7|||
30976622|NCT01435616|59065998|FG001|Overall Study|Death|2|||
30976623|NCT01435616|59065997|FG000|Overall Study|Lost to Follow-up|22|||
30976624|NCT01435616|59065998|FG001|Overall Study|Lost to Follow-up|13|||
30976625|NCT01435616|59065997|FG000|Overall Study|Protocol Violation|16|||
30976626|NCT01435616|59065998|FG001|Overall Study|Protocol Violation|13|||
30976627|NCT01435616|59065997|FG000|Overall Study|Withdrawal by Subject|66|||
30976628|NCT01435616|59065998|FG001|Overall Study|Withdrawal by Subject|24|||
30976629|NCT01435616|59065997|FG000|Overall Study|Physician Decision|20|||
30976630|NCT01435616|59065998|FG001|Overall Study|Physician Decision|7|||
30976631|NCT01435616|59065997|FG000|Overall Study|Sponsor Decision|1|||
30976632|NCT01435616|59065998|FG001|Overall Study|Sponsor Decision|0|||
30976633|NCT01435460|59066048|FG000|Overall Study|Adverse Event|2|||
30976634|NCT01435460|59066049|FG001|Overall Study|Adverse Event|1|||
30976635|NCT01435460|59066048|FG000|Overall Study|Lost to Follow-up|6|||
30890575|NCT01641081|58923573|FG002|Period 3|Adverse Event|1|||
30890576|NCT01641081|58923574|FG003|Period 3|Adverse Event|0|||
30890577|NCT01641081|58923575|FG004|Period 3|Adverse Event|0|||
30890578|NCT01641081|58923576|FG005|Period 3|Adverse Event|0|||
30890579|NCT01641081|58923577|FG006|Period 3|Adverse Event|0|||
30890580|NCT01641081|58923578|FG007|Period 3|Adverse Event|0|||
30890581|NCT01641081|58923579|FG008|Period 3|Adverse Event|0|||
30890582|NCT01641081|58923580|FG009|Period 3|Adverse Event|0|||
30890583|NCT01641081|58923571|FG000|Period 3|Withdrawal by Subject|0|||
30890584|NCT01641081|58923572|FG001|Period 3|Withdrawal by Subject|0|||
30890585|NCT01641081|58923573|FG002|Period 3|Withdrawal by Subject|0|||
30976636|NCT01435460|59066049|FG001|Overall Study|Lost to Follow-up|1|||
30976637|NCT01435460|59066048|FG000|Overall Study|Withdrawal by Subject|1|||
30976638|NCT01435460|59066049|FG001|Overall Study|Withdrawal by Subject|3|||
30976639|NCT01435460|59066048|FG000|Overall Study|Protocol Violation|0|||
30976640|NCT01435460|59066049|FG001|Overall Study|Protocol Violation|1|||
30976641|NCT01435460|59066048|FG000|Overall Study|Did not meet eligibility criteria|2|||
30890586|NCT01641081|58923574|FG003|Period 3|Withdrawal by Subject|0|||
30976642|NCT01435460|59066049|FG001|Overall Study|Did not meet eligibility criteria|0|||
30976643|NCT01435382|59066135|FG000|Overall Study|Lost to Follow-up|1|||
30976644|NCT01435382|59066136|FG001|Overall Study|Lost to Follow-up|0|||
30976645|NCT01435382|59066137|FG002|Overall Study|Lost to Follow-up|1|||
30976646|NCT01435382|59066138|FG003|Overall Study|Lost to Follow-up|0|||
30976647|NCT01435382|59066135|FG000|Overall Study|Withdrawal by Subject|0|||
30976648|NCT01435382|59066136|FG001|Overall Study|Withdrawal by Subject|2|||
30976649|NCT01435382|59066137|FG002|Overall Study|Withdrawal by Subject|0|||
30976650|NCT01435382|59066138|FG003|Overall Study|Withdrawal by Subject|1|||
30976651|NCT01414166|59066203|FG000|Overall Study|Adverse Event|10|||
30976652|NCT01414166|59066204|FG001|Overall Study|Adverse Event|2|||
30976653|NCT01414166|59066203|FG000|Overall Study|Lost to Follow-up|4|||
30976654|NCT01414166|59066204|FG001|Overall Study|Lost to Follow-up|1|||
30976655|NCT01414166|59066203|FG000|Overall Study|Non-compliance with study drug|2|||
30976656|NCT01414166|59066204|FG001|Overall Study|Non-compliance with study drug|0|||
30976657|NCT01414166|59066203|FG000|Overall Study|Physician Decision|2|||
30976658|NCT01414166|59066204|FG001|Overall Study|Physician Decision|0|||
30976659|NCT01414166|59066203|FG000|Overall Study|Protocol Violation|2|||
30976660|NCT01414166|59066204|FG001|Overall Study|Protocol Violation|0|||
30976661|NCT01414166|59066203|FG000|Overall Study|Study terminated by Sponsor|68|||
30976662|NCT01414166|59066204|FG001|Overall Study|Study terminated by Sponsor|75|||
30976663|NCT01414166|59066203|FG000|Overall Study|Withdrawal by Subject|3|||
30976664|NCT01414166|59066204|FG001|Overall Study|Withdrawal by Subject|5|||
30976665|NCT01434680|59066214|FG000|Overall Study|Withdrawal by Subject|1|||
30976666|NCT01434680|59066215|FG001|Overall Study|Withdrawal by Subject|0|||
30976667|NCT01434680|59066216|FG002|Overall Study|Withdrawal by Subject|2|||
30976668|NCT01434680|59066217|FG003|Overall Study|Withdrawal by Subject|0|||
30976669|NCT01434680|59066214|FG000|Overall Study|Lost to Follow-up|1|||
30976670|NCT01434680|59066215|FG001|Overall Study|Lost to Follow-up|1|||
30976671|NCT01434680|59066216|FG002|Overall Study|Lost to Follow-up|0|||
30976672|NCT01434680|59066217|FG003|Overall Study|Lost to Follow-up|0|||
30976673|NCT01434680|59066214|FG000|Overall Study|Protocol Violation|1|||
30976674|NCT01434680|59066215|FG001|Overall Study|Protocol Violation|1|||
30976675|NCT01434680|59066216|FG002|Overall Study|Protocol Violation|0|||
30976676|NCT01434680|59066217|FG003|Overall Study|Protocol Violation|0|||
30976677|NCT01433978|59066350|FG000|Core Study|Adverse Event, Non-Fatal|0|||
30976678|NCT01433978|59066351|FG001|Core Study|Adverse Event, Non-Fatal|1|||
30976679|NCT01433978|59066352|FG002|Core Study|Adverse Event, Non-Fatal|0|||
30976680|NCT01433978|59066350|FG000|Core Study|Lack of Efficacy|5|||
30976681|NCT01433978|59066351|FG001|Core Study|Lack of Efficacy|1|||
30976682|NCT01433978|59066352|FG002|Core Study|Lack of Efficacy|0|||
30976683|NCT01433978|59066350|FG000|Core Study|Study Terminated by Sponsor|6|||
30976684|NCT01433978|59066351|FG001|Core Study|Study Terminated by Sponsor|9|||
30976685|NCT01433978|59066352|FG002|Core Study|Study Terminated by Sponsor|0|||
30976686|NCT01433978|59066350|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
30976687|NCT01433978|59066351|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
30976688|NCT01433978|59066352|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
30976689|NCT01433978|59066350|FG000|Extension Phase|Lack of Efficacy|0|||
30976690|NCT01433978|59066351|FG001|Extension Phase|Lack of Efficacy|0|||
30976691|NCT01433978|59066352|FG002|Extension Phase|Lack of Efficacy|1|||
30976692|NCT01433978|59066350|FG000|Extension Phase|Study Terminated by Sponsor|0|||
30976693|NCT01433978|59066351|FG001|Extension Phase|Study Terminated by Sponsor|0|||
30976694|NCT01433978|59066352|FG002|Extension Phase|Study Terminated by Sponsor|4|||
30976695|NCT01433354|59066401|FG000|Overall Study|Adverse Event|6|||
30976696|NCT01433354|59066401|FG000|Overall Study|Lost to Follow-up|1|||
30976697|NCT01433354|59066401|FG000|Overall Study|Administrative problems|90|||
30976698|NCT01433354|59066401|FG000|Overall Study|Protocol Violation|2|||
30976699|NCT01433354|59066401|FG000|Overall Study|Lack of Efficacy|17|||
30976700|NCT01433354|59066401|FG000|Overall Study|Subject Withdrew Consent|3|||
30976701|NCT04508023|59066912|FG000|Overall Study|Withdrawal by Subject|1|||
30976702|NCT04508023|59066913|FG001|Overall Study|Withdrawal by Subject|2|||
30976703|NCT04187144|59066921|FG000|Overall Study|Lost to Follow-up|12|||
30976704|NCT04187144|59066922|FG001|Overall Study|Lost to Follow-up|11|||
30976705|NCT04187144|59066921|FG000|Overall Study|Withdrawal by Subject|20|||
30976706|NCT04187144|59066922|FG001|Overall Study|Withdrawal by Subject|18|||
30976707|NCT04187144|59066921|FG000|Overall Study|Adverse Event|19|||
30976708|NCT04187144|59066922|FG001|Overall Study|Adverse Event|4|||
30976709|NCT04187144|59066921|FG000|Overall Study|Physician Decision|5|||
30976710|NCT04187144|59066922|FG001|Overall Study|Physician Decision|3|||
30976711|NCT04187144|59066921|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
30976712|NCT04187144|59066922|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
30976713|NCT04187144|59066921|FG000|Overall Study|Protocol Deviation|1|||
30976714|NCT04187144|59066922|FG001|Overall Study|Protocol Deviation|4|||
30976715|NCT04027946|59066928|FG000|Overall Study|Screen failures|3|||
30976716|NCT03856047|59066949|FG000|Overall Study|Withdrawal by Subject|0|||
30976717|NCT03856047|59066950|FG001|Overall Study|Withdrawal by Subject|1|||
30976718|NCT03856047|59066951|FG002|Overall Study|Withdrawal by Subject|1|||
30976719|NCT03856047|59066952|FG003|Overall Study|Withdrawal by Subject|0|||
30976720|NCT03856047|59066953|FG004|Overall Study|Withdrawal by Subject|3|||
30976721|NCT03856047|59066954|FG005|Overall Study|Withdrawal by Subject|0|||
30976722|NCT03856047|59066955|FG006|Overall Study|Withdrawal by Subject|2|||
30976723|NCT03856047|59066949|FG000|Overall Study|Lost to Follow-up|4|||
30976724|NCT03856047|59066950|FG001|Overall Study|Lost to Follow-up|2|||
30976725|NCT03856047|59066951|FG002|Overall Study|Lost to Follow-up|3|||
30976726|NCT03856047|59066952|FG003|Overall Study|Lost to Follow-up|1|||
30976727|NCT03856047|59066953|FG004|Overall Study|Lost to Follow-up|4|||
30976728|NCT03856047|59066954|FG005|Overall Study|Lost to Follow-up|4|||
30976729|NCT03856047|59066955|FG006|Overall Study|Lost to Follow-up|4|||
30976730|NCT03797014|59066972|FG000|Overall Study|Withdrawal by Subject|1|||
30976731|NCT03797014|59066972|FG000|Overall Study|Lost to Follow-up|1|||
30976732|NCT03797014|59066972|FG000|Overall Study|Protocol Violation|1|||
30976733|NCT03112603|59067010|FG000|End of Randomization Period|Lost to Follow-up|3|||
30976734|NCT03112603|59067011|FG001|End of Randomization Period|Lost to Follow-up|0|||
30976735|NCT03112603|59067012|FG002|End of Randomization Period|Lost to Follow-up|0|||
30976736|NCT03112603|59067010|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
30976737|NCT03112603|59067011|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
30976738|NCT03112603|59067012|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
30976739|NCT03112603|59067010|FG000|End of Randomization Period|Physician Decision|43|||
30976740|NCT03112603|59067011|FG001|End of Randomization Period|Physician Decision|18|||
30976741|NCT03112603|59067012|FG002|End of Randomization Period|Physician Decision|0|||
30976742|NCT03112603|59067010|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
30976743|NCT03112603|59067011|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
30976744|NCT03112603|59067012|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
30976745|NCT03112603|59067010|FG000|End of Randomization Period|Death|10|||
30976746|NCT03112603|59067011|FG001|End of Randomization Period|Death|7|||
30976747|NCT03112603|59067012|FG002|End of Randomization Period|Death|0|||
30976748|NCT03112603|59067010|FG000|End of Randomization Period|Disease Relapse|12|||
30976749|NCT03112603|59067011|FG001|End of Randomization Period|Disease Relapse|7|||
30976750|NCT03112603|59067012|FG002|End of Randomization Period|Disease Relapse|0|||
30976751|NCT03112603|59067010|FG000|End of Randomization Period|Lack of Efficacy|25|||
30976752|NCT03112603|59067011|FG001|End of Randomization Period|Lack of Efficacy|77|||
30976753|NCT03112603|59067012|FG002|End of Randomization Period|Lack of Efficacy|0|||
30976754|NCT03112603|59067010|FG000|End of Randomization Period|Adverse Event|32|||
30976755|NCT03112603|59067011|FG001|End of Randomization Period|Adverse Event|12|||
30976756|NCT03112603|59067012|FG002|End of Randomization Period|Adverse Event|0|||
30976757|NCT03112603|59067010|FG000|End of Cross Over Period|Death|0|||
30976758|NCT03112603|59067011|FG001|End of Cross Over Period|Death|0|||
30976759|NCT03112603|59067012|FG002|End of Cross Over Period|Death|2|||
30976760|NCT03112603|59067010|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
30976761|NCT03112603|59067011|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
30976762|NCT03112603|59067012|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
30976763|NCT03112603|59067010|FG000|End of Cross Over Period|Physician Decision|0|||
30976764|NCT03112603|59067011|FG001|End of Cross Over Period|Physician Decision|0|||
30976765|NCT03112603|59067012|FG002|End of Cross Over Period|Physician Decision|29|||
30976766|NCT03112603|59067010|FG000|End of Cross Over Period|Lack of Efficacy|0|||
30976767|NCT03112603|59067011|FG001|End of Cross Over Period|Lack of Efficacy|0|||
30976768|NCT03112603|59067012|FG002|End of Cross Over Period|Lack of Efficacy|8|||
30976769|NCT03112603|59067010|FG000|End of Cross Over Period|Adverse Event|0|||
30976770|NCT03112603|59067011|FG001|End of Cross Over Period|Adverse Event|0|||
30976771|NCT03112603|59067012|FG002|End of Cross Over Period|Adverse Event|6|||
30976772|NCT03112603|59067010|FG000|End of Cross Over Period|Disease Relapse|0|||
30976773|NCT03112603|59067011|FG001|End of Cross Over Period|Disease Relapse|0|||
30976774|NCT03112603|59067012|FG002|End of Cross Over Period|Disease Relapse|2|||
30976775|NCT03056001|59067021|FG000|Overall Study|Death|24|||
30976776|NCT03056001|59067021|FG000|Overall Study|Still On Study (in follow up)|1|||
30976777|NCT02725528|59067031|FG000|Overall Study|Lost to Follow-up|1|||
30976778|NCT02725528|59067032|FG001|Overall Study|Lost to Follow-up|4|||
30976779|NCT02725528|59067031|FG000|Overall Study|Withdrawal by Subject|0|||
30976780|NCT02725528|59067032|FG001|Overall Study|Withdrawal by Subject|1|||
30976781|NCT02627963|59067049|FG000|Overall Study|Randomized but not treated|2|||
30976782|NCT02627963|59067050|FG001|Overall Study|Randomized but not treated|6|||
30976783|NCT02585258|59067058|FG000|Overall Study|Adverse Event|28|||
30976784|NCT02585258|59067059|FG001|Overall Study|Adverse Event|29|||
30976785|NCT02585258|59067058|FG000|Overall Study|Death|3|||
30976786|NCT02585258|59067059|FG001|Overall Study|Death|2|||
30976787|NCT02585258|59067058|FG000|Overall Study|Lack of Efficacy|7|||
30976788|NCT02585258|59067059|FG001|Overall Study|Lack of Efficacy|9|||
30976789|NCT02585258|59067058|FG000|Overall Study|includes covid-related access problems|42|||
30976790|NCT02585258|59067059|FG001|Overall Study|includes covid-related access problems|46|||
30976791|NCT02585258|59067058|FG000|Overall Study|Lost to Follow-up|5|||
30976792|NCT02585258|59067059|FG001|Overall Study|Lost to Follow-up|2|||
30976793|NCT02132611|59067085|FG000|Overall Study|Death|2|||
30976794|NCT01941030|59067091|FG000|Overall Study|Death|3|||
30976795|NCT01941030|59067092|FG001|Overall Study|Death|2|||
30976796|NCT01941030|59067091|FG000|Overall Study|Lost to Follow-up|6|||
30976797|NCT01941030|59067092|FG001|Overall Study|Lost to Follow-up|5|||
30976798|NCT01941030|59067091|FG000|Overall Study|Withdrawal by Subject|4|||
30976799|NCT01941030|59067092|FG001|Overall Study|Withdrawal by Subject|6|||
30976800|NCT01874353|59067100|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
30976801|NCT01874353|59067101|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
30976802|NCT01874353|59067102|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
30976803|NCT01874353|59067103|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
30976804|NCT01874353|59067100|FG000|Overall Study|Lost to Follow-up|2|||
30976805|NCT01874353|59067101|FG001|Overall Study|Lost to Follow-up|2|||
30976806|NCT01874353|59067102|FG002|Overall Study|Lost to Follow-up|2|||
30976807|NCT01874353|59067103|FG003|Overall Study|Lost to Follow-up|0|||
30976808|NCT01874353|59067100|FG000|Overall Study|Death|110|||
30976809|NCT01874353|59067101|FG001|Overall Study|Death|60|||
30976810|NCT01874353|59067102|FG002|Overall Study|Death|13|||
30976811|NCT01874353|59067103|FG003|Overall Study|Death|7|||
30976812|NCT01874353|59067100|FG000|Overall Study|Withdrawal by Subject|13|||
30976813|NCT01874353|59067101|FG001|Overall Study|Withdrawal by Subject|11|||
30976814|NCT01874353|59067102|FG002|Overall Study|Withdrawal by Subject|0|||
30976815|NCT01874353|59067103|FG003|Overall Study|Withdrawal by Subject|0|||
30976816|NCT01092416|59067120|FG000|Enrollment|Atherectomy device not inserted|3|||
30976817|NCT01092416|59067120|FG000|30-Day Follow-up|Death|2|||
30976818|NCT01092416|59067120|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
30976819|NCT01092416|59067120|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
30976820|NCT01092416|59067120|FG000|12-Month Follow-up|Death|16|||
30976821|NCT01092416|59067120|FG000|12-Month Follow-up|Lost to Follow-up|4|||
30976822|NCT01092416|59067120|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
30976823|NCT01092416|59067120|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
30976824|NCT01092416|59067120|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
30976825|NCT00701220|59067129|FG000|Overall Study|Withdrawal by Subject|0|||
30976826|NCT00701220|59067130|FG001|Overall Study|Withdrawal by Subject|2|||
30976827|NCT00701220|59067129|FG000|Overall Study|Protocol Violation|2|||
30976828|NCT00701220|59067130|FG001|Overall Study|Protocol Violation|0|||
30976829|NCT00559845|59067204|FG000|Overall Study|Withdrew Consent|1|||
30976830|NCT00559845|59067204|FG000|Overall Study|Disease Progression|1|||
30976831|NCT00559845|59067204|FG000|Overall Study|Adverse Event|3|||
30976832|NCT00559845|59067204|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
30976833|NCT00559845|59067204|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
30976834|NCT01393964|59067307|FG000|Overall Study|Disease Progression|4|||
30976835|NCT01393964|59067308|FG001|Overall Study|Disease Progression|3|||
30976836|NCT01393964|59067309|FG002|Overall Study|Disease Progression|5|||
30976837|NCT01393964|59067307|FG000|Overall Study|Study drug toxicity|1|||
30976838|NCT01393964|59067308|FG001|Overall Study|Study drug toxicity|0|||
30976839|NCT01393964|59067309|FG002|Overall Study|Study drug toxicity|0|||
30976840|NCT01393964|59067307|FG000|Overall Study|Withdrawal by Subject|0|||
30976841|NCT01393964|59067308|FG001|Overall Study|Withdrawal by Subject|0|||
30976842|NCT01393964|59067309|FG002|Overall Study|Withdrawal by Subject|1|||
30976843|NCT01393964|59067307|FG000|Overall Study|Adverse event unrelated to study drug|0|||
30976844|NCT01393964|59067308|FG001|Overall Study|Adverse event unrelated to study drug|3|||
30976845|NCT01393964|59067309|FG002|Overall Study|Adverse event unrelated to study drug|0|||
30976846|NCT01393964|59067307|FG000|Overall Study|Subject request stop study treatment|0|||
30976847|NCT01393964|59067308|FG001|Overall Study|Subject request stop study treatment|1|||
30976848|NCT01393964|59067309|FG002|Overall Study|Subject request stop study treatment|0|||
30976849|NCT01393964|59067307|FG000|Overall Study|Subject decided to move to transplant|1|||
30976850|NCT01393964|59067308|FG001|Overall Study|Subject decided to move to transplant|0|||
30976851|NCT01393964|59067309|FG002|Overall Study|Subject decided to move to transplant|0|||
30976852|NCT01393964|59067307|FG000|Overall Study|Subject switched to commercial supply|1|||
30976853|NCT01393964|59067308|FG001|Overall Study|Subject switched to commercial supply|0|||
30976854|NCT01393964|59067309|FG002|Overall Study|Subject switched to commercial supply|2|||
30976855|NCT01393964|59067307|FG000|Overall Study|Subject plateaued in terms of effect|1|||
30976856|NCT01393964|59067308|FG001|Overall Study|Subject plateaued in terms of effect|0|||
30976857|NCT01393964|59067309|FG002|Overall Study|Subject plateaued in terms of effect|0|||
30976858|NCT01393964|59067307|FG000|Overall Study|Investigator removed subject from study|0|||
30976859|NCT01393964|59067308|FG001|Overall Study|Investigator removed subject from study|1|||
30976860|NCT01393964|59067309|FG002|Overall Study|Investigator removed subject from study|0|||
30976861|NCT01393964|59067307|FG000|Overall Study|Subject converted to roll-over study|0|||
30976862|NCT01393964|59067308|FG001|Overall Study|Subject converted to roll-over study|1|||
30976863|NCT01393964|59067309|FG002|Overall Study|Subject converted to roll-over study|0|||
30976864|NCT01393964|59067307|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
30976865|NCT01393964|59067308|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
30976866|NCT01393964|59067309|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
30976867|NCT01393730|59067397|FG000|Overall Study|Withdrawal by Subject|3|||
30976868|NCT01393730|59067397|FG000|Overall Study|Other|2|||
30976869|NCT01393730|59067397|FG000|Overall Study|Adverse Event|1|||
30976870|NCT01393106|59067416|FG000|Overall Study|Adverse Event|3|||
30976871|NCT01393106|59067416|FG000|Overall Study|Withdrawal by Subject|1|||
30976872|NCT01393106|59067416|FG000|Overall Study|Lack of Efficacy|1|||
30976873|NCT00553059|59067422|FG000|Overall Study|Deemed ineligible|1|||
30976874|NCT00553059|59067423|FG001|Overall Study|Deemed ineligible|1|||
30976875|NCT00553059|59067422|FG000|Overall Study|Drug supply not available|0|||
30976876|NCT00553059|59067423|FG001|Overall Study|Drug supply not available|1|||
30976877|NCT01413542|59067456|FG000|Overall Study|Physician Decision|1|||
30976878|NCT01413542|59067457|FG001|Overall Study|Physician Decision|0|||
30976879|NCT01413542|59067458|FG002|Overall Study|Physician Decision|3|||
30976880|NCT01413542|59067459|FG003|Overall Study|Physician Decision|0|||
30976881|NCT01413542|59067456|FG000|Overall Study|Adverse Event|0|||
30976882|NCT01413542|59067457|FG001|Overall Study|Adverse Event|0|||
30976883|NCT01413542|59067458|FG002|Overall Study|Adverse Event|0|||
30976884|NCT01413542|59067459|FG003|Overall Study|Adverse Event|1|||
30976885|NCT01432730|59067491|FG000|Period 1|Adverse Event|2|||
30976886|NCT01432730|59067492|FG001|Period 1|Adverse Event|0|||
30976887|NCT01432730|59067491|FG000|Period 2|Adverse Event|0|||
30976888|NCT01432730|59067492|FG001|Period 2|Adverse Event|4|||
30976889|NCT01432574|59067507|FG000|Overall Study|Moved|2|||
30976890|NCT01432574|59067507|FG000|Overall Study|Not interested|1|||
30976891|NCT01392560|59067540|FG000|Overall Study|Adverse Event|2|||
30976892|NCT01392560|59067540|FG000|Overall Study|not entered|8|||
30976893|NCT01392560|59067540|FG000|Overall Study|discontinued during placebo run-in|2|||
30976894|NCT00552279|59067601|FG000|Overall Study|Adverse Event|0|||
30976895|NCT00552279|59067602|FG001|Overall Study|Adverse Event|1|||
30976896|NCT00552279|59067601|FG000|Overall Study|Withdrawal by Subject|12|||
30976897|NCT00552279|59067602|FG001|Overall Study|Withdrawal by Subject|1|||
30976898|NCT00552279|59067601|FG000|Overall Study|Lost to Follow-up|1|||
30976899|NCT00552279|59067602|FG001|Overall Study|Lost to Follow-up|0|||
30976900|NCT00552279|59067601|FG000|Overall Study|Other|1|||
30976901|NCT00552279|59067602|FG001|Overall Study|Other|1|||
30976902|NCT00559377|59067643|FG000|Overall Study|Withdrawal by Subject|9|||
30976903|NCT01412060|59067650|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
30976904|NCT01412060|59067651|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
30976905|NCT01412060|59067652|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
30976906|NCT01412060|59067650|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
30976907|NCT01412060|59067651|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
30976908|NCT01412060|59067652|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
30976909|NCT01412060|59067650|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
30976910|NCT01412060|59067651|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
30976911|NCT01412060|59067652|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
30976912|NCT01412060|59067650|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
30976913|NCT01412060|59067651|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
30608451|NCT01288430|58619230|FG009|Part 2|Clinical disease progression|0|||
30890587|NCT01641081|58923575|FG004|Period 3|Withdrawal by Subject|0|||
30890588|NCT01641081|58923576|FG005|Period 3|Withdrawal by Subject|0|||
30890589|NCT01641081|58923577|FG006|Period 3|Withdrawal by Subject|0|||
30890590|NCT01641081|58923578|FG007|Period 3|Withdrawal by Subject|0|||
30890591|NCT01641081|58923579|FG008|Period 3|Withdrawal by Subject|1|||
30890592|NCT01641081|58923580|FG009|Period 3|Withdrawal by Subject|0|||
30890593|NCT01641081|58923571|FG000|Period 4|Adverse Event|0|||
30890594|NCT01641081|58923572|FG001|Period 4|Adverse Event|1|||
30890595|NCT01641081|58923573|FG002|Period 4|Adverse Event|0|||
30890596|NCT01641081|58923574|FG003|Period 4|Adverse Event|1|||
30890597|NCT01641081|58923575|FG004|Period 4|Adverse Event|0|||
30976914|NCT01412060|59067652|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
30890598|NCT01641081|58923576|FG005|Period 4|Adverse Event|0|||
30890599|NCT01641081|58923577|FG006|Period 4|Adverse Event|0|||
30976915|NCT01412060|59067650|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
30976916|NCT01412060|59067651|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
30976917|NCT01412060|59067652|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
30976918|NCT01412060|59067650|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
30976919|NCT01412060|59067651|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
30976920|NCT01412060|59067652|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
30976921|NCT01412060|59067650|FG000|Period Between RIP and SP|Adverse Event|4|||
30976922|NCT01412060|59067651|FG001|Period Between RIP and SP|Adverse Event|0|||
30976923|NCT01412060|59067652|FG002|Period Between RIP and SP|Adverse Event|0|||
30976924|NCT01412060|59067650|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
30608452|NCT01288430|58619221|FG000|Part 2|Withdrawal by Subject|0|||
30608453|NCT01288430|58619222|FG001|Part 2|Withdrawal by Subject|0|||
30608454|NCT01288430|58619223|FG002|Part 2|Withdrawal by Subject|0|||
30608455|NCT01288430|58619224|FG003|Part 2|Withdrawal by Subject|0|||
30608456|NCT01288430|58619225|FG004|Part 2|Withdrawal by Subject|0|||
30608457|NCT01288430|58619226|FG005|Part 2|Withdrawal by Subject|0|||
30608458|NCT01288430|58619227|FG006|Part 2|Withdrawal by Subject|0|||
30976925|NCT01412060|59067651|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
30976926|NCT01412060|59067652|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
30976927|NCT01412060|59067650|FG000|Period Between RIP and SP|Protocol Violation|2|||
30976928|NCT01412060|59067651|FG001|Period Between RIP and SP|Protocol Violation|0|||
30976929|NCT01412060|59067652|FG002|Period Between RIP and SP|Protocol Violation|0|||
30976930|NCT01412060|59067650|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
30976931|NCT01412060|59067651|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
30976932|NCT01412060|59067652|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
30976933|NCT01412060|59067650|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
30976934|NCT01412060|59067651|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
30976935|NCT01412060|59067652|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
30976936|NCT01412060|59067650|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
30976937|NCT01412060|59067651|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
30976938|NCT01412060|59067652|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
30976939|NCT01412060|59067650|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
30976940|NCT01412060|59067651|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
30976941|NCT01412060|59067652|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
30976942|NCT01412060|59067650|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
30976943|NCT01412060|59067651|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
30976944|NCT01412060|59067652|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
30976945|NCT01412060|59067650|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
30976946|NCT01412060|59067651|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
30608459|NCT01288430|58619228|FG007|Part 2|Withdrawal by Subject|1|||
30608460|NCT01288430|58619229|FG008|Part 2|Withdrawal by Subject|4|||
30976947|NCT01412060|59067652|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
30976948|NCT01412060|59067650|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
30976949|NCT01412060|59067651|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
30976950|NCT01412060|59067652|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
30976951|NCT01412060|59067650|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
30976952|NCT01412060|59067651|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
30976953|NCT01412060|59067652|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
30976954|NCT01412060|59067650|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
30976955|NCT01412060|59067651|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
30976956|NCT01412060|59067652|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
30976957|NCT01412060|59067650|FG000|Period Between SP and DBP|Protocol Violation|2|||
30976958|NCT01412060|59067651|FG001|Period Between SP and DBP|Protocol Violation|0|||
30976959|NCT01412060|59067652|FG002|Period Between SP and DBP|Protocol Violation|0|||
30976960|NCT01412060|59067650|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
30976961|NCT01412060|59067651|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
30976962|NCT01412060|59067652|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
30976963|NCT01412060|59067650|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
30976964|NCT01412060|59067651|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
30976965|NCT01412060|59067652|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
30976966|NCT01412060|59067650|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
30976967|NCT01412060|59067651|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
30976968|NCT01412060|59067652|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
30976969|NCT01412060|59067650|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
30976970|NCT01412060|59067651|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
30976971|NCT01412060|59067652|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
30976972|NCT01412060|59067650|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
30976973|NCT01412060|59067651|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
30976974|NCT01412060|59067652|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
30976975|NCT01412060|59067650|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
30976976|NCT01412060|59067651|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
30976977|NCT01412060|59067652|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
30976978|NCT01412060|59067650|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
30976979|NCT01412060|59067651|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
30976980|NCT01412060|59067652|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
30976981|NCT01412060|59067650|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
30976982|NCT01412060|59067651|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
30976983|NCT01412060|59067652|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
30976984|NCT01412060|59067650|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
30976985|NCT01412060|59067651|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
30976986|NCT01412060|59067652|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
30976987|NCT01412060|59067650|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
30976988|NCT01412060|59067651|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
30976989|NCT01412060|59067652|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
30976990|NCT00551421|59067683|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
30976991|NCT01891643|59067703|FG000|Overall Study|Adverse event unrelated to study drug|2|||
30976992|NCT01891643|59067704|FG001|Overall Study|Adverse event unrelated to study drug|5|||
30976993|NCT01891643|59067703|FG000|Overall Study|Disease Progression|4|||
30976994|NCT01891643|59067704|FG001|Overall Study|Disease Progression|3|||
30976995|NCT01891643|59067703|FG000|Overall Study|Study Drug Toxicity|3|||
30976996|NCT01891643|59067704|FG001|Overall Study|Study Drug Toxicity|0|||
30976997|NCT01891643|59067703|FG000|Overall Study|Maximum Clinical Benefit|0|||
30976998|NCT01891643|59067704|FG001|Overall Study|Maximum Clinical Benefit|1|||
30976999|NCT01891643|59067703|FG000|Overall Study|Poor/Non-compliance|0|||
30977000|NCT01891643|59067704|FG001|Overall Study|Poor/Non-compliance|1|||
30977001|NCT01891643|59067703|FG000|Overall Study|Participant request to discontinue|1|||
30977002|NCT01891643|59067704|FG001|Overall Study|Participant request to discontinue|0|||
30977003|NCT01392326|59067838|FG000|Overall Study|Death|2|||
30977004|NCT01392326|59067839|FG001|Overall Study|Death|0|||
30977005|NCT01392326|59067840|FG002|Overall Study|Death|0|||
30977006|NCT01392326|59067838|FG000|Overall Study|Withdrawal by Subject|12|||
30977007|NCT01392326|59067839|FG001|Overall Study|Withdrawal by Subject|11|||
30977008|NCT01392326|59067840|FG002|Overall Study|Withdrawal by Subject|15|||
30977009|NCT01392326|59067838|FG000|Overall Study|Protocol Violation|2|||
30977010|NCT01392326|59067839|FG001|Overall Study|Protocol Violation|0|||
30977011|NCT01392326|59067840|FG002|Overall Study|Protocol Violation|0|||
30977012|NCT01392326|59067838|FG000|Overall Study|Pregnancy|0|||
30977013|NCT01392326|59067839|FG001|Overall Study|Pregnancy|0|||
30977014|NCT01392326|59067840|FG002|Overall Study|Pregnancy|1|||
30977015|NCT01392326|59067838|FG000|Overall Study|Physician Decision|7|||
30977016|NCT01392326|59067839|FG001|Overall Study|Physician Decision|5|||
30977017|NCT01392326|59067840|FG002|Overall Study|Physician Decision|2|||
30977018|NCT01392326|59067838|FG000|Overall Study|Lost to Follow-up|1|||
30977019|NCT01392326|59067839|FG001|Overall Study|Lost to Follow-up|3|||
30977020|NCT01392326|59067840|FG002|Overall Study|Lost to Follow-up|4|||
30977021|NCT01392326|59067838|FG000|Overall Study|Lack of Efficacy|14|||
30977022|NCT01392326|59067839|FG001|Overall Study|Lack of Efficacy|10|||
30977023|NCT01392326|59067840|FG002|Overall Study|Lack of Efficacy|15|||
30977024|NCT01392326|59067838|FG000|Overall Study|Adverse Event|9|||
30977025|NCT01392326|59067839|FG001|Overall Study|Adverse Event|6|||
30977026|NCT01392326|59067840|FG002|Overall Study|Adverse Event|11|||
30977027|NCT01432262|59067883|FG000|Overall Study|Withdrawal by Subject|2|||
30977028|NCT01432262|59067884|FG001|Overall Study|Withdrawal by Subject|1|||
30977029|NCT01410890|59067904|FG000|Overall Study|Withdrawal by Subject|0|||
30977030|NCT01410890|59067905|FG001|Overall Study|Withdrawal by Subject|1|||
30977031|NCT01431950|59067915|FG000|Overall Study|Study Site Closed/Terminated|7|||
30977032|NCT01431950|59067916|FG001|Overall Study|Study Site Closed/Terminated|3|||
30977033|NCT01431950|59067915|FG000|Overall Study|Withdrawal by Subject|4|||
30977034|NCT01431950|59067916|FG001|Overall Study|Withdrawal by Subject|3|||
30977035|NCT01431950|59067915|FG000|Overall Study|Protocol Violation|2|||
30977036|NCT01431950|59067916|FG001|Overall Study|Protocol Violation|3|||
30977037|NCT01431950|59067915|FG000|Overall Study|Adverse Event|2|||
30977038|NCT01431950|59067916|FG001|Overall Study|Adverse Event|2|||
30977039|NCT01431950|59067915|FG000|Overall Study|Physician Decision|2|||
30977040|NCT01431950|59067916|FG001|Overall Study|Physician Decision|1|||
30977041|NCT01431950|59067915|FG000|Overall Study|Lack of Efficacy|2|||
30977042|NCT01431950|59067916|FG001|Overall Study|Lack of Efficacy|1|||
30977043|NCT01431950|59067915|FG000|Overall Study|Lost to Follow-up|0|||
30977044|NCT01431950|59067916|FG001|Overall Study|Lost to Follow-up|1|||
30977045|NCT01431950|59067915|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
30977046|NCT01431950|59067916|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
30977047|NCT00551031|59067927|FG000|Overall Study|Adverse Event|0|||
30977048|NCT00551031|59067928|FG001|Overall Study|Adverse Event|1|||
30977049|NCT00551031|59067929|FG002|Overall Study|Adverse Event|0|||
30977050|NCT00551031|59067930|FG003|Overall Study|Adverse Event|0|||
30977051|NCT00551031|59067931|FG004|Overall Study|Adverse Event|0|||
30977052|NCT00551031|59067927|FG000|Overall Study|Protocol Violation|1|||
30977053|NCT00551031|59067928|FG001|Overall Study|Protocol Violation|1|||
30977054|NCT00551031|59067929|FG002|Overall Study|Protocol Violation|0|||
30977055|NCT00551031|59067930|FG003|Overall Study|Protocol Violation|0|||
30977056|NCT00551031|59067931|FG004|Overall Study|Protocol Violation|0|||
30977057|NCT00551031|59067927|FG000|Overall Study|Lost to Follow-up|0|||
30977058|NCT00551031|59067928|FG001|Overall Study|Lost to Follow-up|1|||
30977059|NCT00551031|59067929|FG002|Overall Study|Lost to Follow-up|0|||
30977060|NCT00551031|59067930|FG003|Overall Study|Lost to Follow-up|1|||
30890600|NCT01641081|58923578|FG007|Period 4|Adverse Event|0|||
30890601|NCT01641081|58923579|FG008|Period 4|Adverse Event|0|||
30890602|NCT01641081|58923580|FG009|Period 4|Adverse Event|0|||
30890603|NCT01641081|58923571|FG000|Period 5|Adverse Event|0|||
30890604|NCT01641081|58923572|FG001|Period 5|Adverse Event|0|||
30890605|NCT01641081|58923573|FG002|Period 5|Adverse Event|2|||
30890606|NCT01641081|58923574|FG003|Period 5|Adverse Event|0|||
30890607|NCT01641081|58923575|FG004|Period 5|Adverse Event|0|||
30890608|NCT01641081|58923576|FG005|Period 5|Adverse Event|0|||
30890609|NCT01641081|58923577|FG006|Period 5|Adverse Event|0|||
30890610|NCT01641081|58923578|FG007|Period 5|Adverse Event|0|||
30890611|NCT01641081|58923579|FG008|Period 5|Adverse Event|0|||
30890612|NCT01641081|58923580|FG009|Period 5|Adverse Event|0|||
30890613|NCT01640925|58923594|FG000|Overall Study|Withdrawal by Subject|1|||
30890614|NCT01640925|58923595|FG001|Overall Study|Withdrawal by Subject|0|||
30890615|NCT01640925|58923594|FG000|Overall Study|Previously enrolled in this trial|13|||
30890616|NCT01640925|58923595|FG001|Overall Study|Previously enrolled in this trial|11|||
30890617|NCT01638429|58923601|FG000|Overall Study|Withdrawal by Subject|1|||
30977061|NCT00551031|59067931|FG004|Overall Study|Lost to Follow-up|1|||
30977062|NCT00551031|59067927|FG000|Overall Study|Withdrawal by Subject|0|||
30977063|NCT00551031|59067928|FG001|Overall Study|Withdrawal by Subject|4|||
30977064|NCT00551031|59067929|FG002|Overall Study|Withdrawal by Subject|1|||
30977065|NCT00551031|59067930|FG003|Overall Study|Withdrawal by Subject|2|||
30890618|NCT01639755|58923609|FG000|Overall Study|Study Ongoing|15|||
30890619|NCT01639755|58923609|FG000|Overall Study|Patient had device explantation|4|||
30890620|NCT01601535|58923619|FG000|Phase 1|Adverse Event|1|||
30890621|NCT01601535|58923620|FG001|Phase 1|Adverse Event|0|||
30977066|NCT00551031|59067931|FG004|Overall Study|Withdrawal by Subject|0|||
30977067|NCT00551031|59067927|FG000|Overall Study|Serious Adverse Event|0|||
30890622|NCT01601535|58923621|FG002|Phase 1|Adverse Event|2|||
30890623|NCT01601535|58923622|FG003|Phase 1|Adverse Event|1|||
30977068|NCT00551031|59067928|FG001|Overall Study|Serious Adverse Event|2|||
30977069|NCT00551031|59067929|FG002|Overall Study|Serious Adverse Event|1|||
30977070|NCT00551031|59067930|FG003|Overall Study|Serious Adverse Event|0|||
30977071|NCT00551031|59067931|FG004|Overall Study|Serious Adverse Event|0|||
30977072|NCT00551031|59067927|FG000|Overall Study|Did not receive vaccine|1|||
30977073|NCT00551031|59067928|FG001|Overall Study|Did not receive vaccine|2|||
30977074|NCT00551031|59067929|FG002|Overall Study|Did not receive vaccine|0|||
30977075|NCT00551031|59067930|FG003|Overall Study|Did not receive vaccine|0|||
30977076|NCT00551031|59067931|FG004|Overall Study|Did not receive vaccine|0|||
30977077|NCT01431716|59067943|FG000|Overall Study|Withdrawal of consent|1|||
30977078|NCT00550953|59067949|FG000|Overall Study|Adverse Event|4|||
30977079|NCT00550953|59067950|FG001|Overall Study|Adverse Event|3|||
30977080|NCT00550953|59067949|FG000|Overall Study|Not able to visit the site|2|||
30977081|NCT00550953|59067950|FG001|Overall Study|Not able to visit the site|3|||
30977082|NCT00558831|59067985|FG000|Overall Study|Lost to Follow-up|1|||
30977083|NCT01431638|59067994|FG000|Overall Study|Adverse Event|1|||
30977084|NCT01431638|59067995|FG001|Overall Study|Adverse Event|3|||
30977085|NCT01431638|59067996|FG002|Overall Study|Adverse Event|1|||
30977086|NCT01431638|59067994|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30977087|NCT01431638|59067995|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30977088|NCT01431638|59067996|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
30977089|NCT01431638|59067994|FG000|Overall Study|Participants condition no longer requires study drug|0|||
30977090|NCT01431638|59067995|FG001|Overall Study|Participants condition no longer requires study drug|1|||
30977091|NCT01431638|59067996|FG002|Overall Study|Participants condition no longer requires study drug|0|||
30977092|NCT01431638|59067994|FG000|Overall Study|Participant withdrew consent|14|||
30977093|NCT01431638|59067995|FG001|Overall Study|Participant withdrew consent|5|||
30977094|NCT01431638|59067996|FG002|Overall Study|Participant withdrew consent|8|||
30977095|NCT01431638|59067994|FG000|Overall Study|Lost to Follow-up|7|||
30977096|NCT01431638|59067995|FG001|Overall Study|Lost to Follow-up|9|||
30977097|NCT01431638|59067996|FG002|Overall Study|Lost to Follow-up|7|||
30977098|NCT01431638|59067994|FG000|Overall Study|Administrative problems|1|||
30977099|NCT01431638|59067995|FG001|Overall Study|Administrative problems|4|||
30977100|NCT01431638|59067996|FG002|Overall Study|Administrative problems|6|||
30977101|NCT01431638|59067994|FG000|Overall Study|Death|1|||
30977102|NCT01431638|59067995|FG001|Overall Study|Death|0|||
30977103|NCT01431638|59067996|FG002|Overall Study|Death|0|||
30977104|NCT01431638|59067994|FG000|Overall Study|Protocol deviation|1|||
30977105|NCT01431638|59067995|FG001|Overall Study|Protocol deviation|1|||
30977106|NCT01431638|59067996|FG002|Overall Study|Protocol deviation|4|||
30977107|NCT01431638|59067994|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
30977108|NCT01431638|59067995|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
30977109|NCT01431638|59067996|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
30977110|NCT01392170|59068004|FG000|Overall Study|Withdrawal by Subject|1|||
30977111|NCT01392170|59068004|FG000|Overall Study|Ineligible|1|||
30977112|NCT00558753|59068010|FG000|Overall Study|Lost to Follow-up|5|||
30977113|NCT00558753|59068011|FG001|Overall Study|Lost to Follow-up|7|||
30977114|NCT01391546|59068019|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
30977115|NCT01391546|59068020|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
30977116|NCT01410110|59068029|FG000|Overall Study|Withdrawal by Subject|4|||
30977117|NCT01410110|59068030|FG001|Overall Study|Withdrawal by Subject|2|||
30977118|NCT01391000|59068038|FG000|Overall Study|Lost to Follow-up|2|||
30977119|NCT01391000|59068039|FG001|Overall Study|Lost to Follow-up|0|||
30977120|NCT01390844|59068114|FG000|Treatment Phase|Adverse Event|12|||
30977121|NCT01390844|59068115|FG001|Treatment Phase|Adverse Event|2|||
30977122|NCT01390844|59068116|FG002|Treatment Phase|Adverse Event|3|||
30977123|NCT01390844|59068117|FG003|Treatment Phase|Adverse Event|2|||
30977124|NCT01390844|59068114|FG000|Treatment Phase|Treatment Failure|23|||
30977125|NCT01390844|59068115|FG001|Treatment Phase|Treatment Failure|25|||
30977126|NCT01390844|59068116|FG002|Treatment Phase|Treatment Failure|10|||
30977127|NCT01390844|59068117|FG003|Treatment Phase|Treatment Failure|13|||
30977128|NCT01390844|59068114|FG000|Treatment Phase|Non-Medical Reasons|5|||
30977129|NCT01390844|59068115|FG001|Treatment Phase|Non-Medical Reasons|1|||
30977130|NCT01390844|59068116|FG002|Treatment Phase|Non-Medical Reasons|8|||
30977131|NCT01390844|59068117|FG003|Treatment Phase|Non-Medical Reasons|1|||
30977132|NCT01390844|59068114|FG000|Treatment Phase|Non-GCP Compliant|0|||
30977133|NCT01390844|59068115|FG001|Treatment Phase|Non-GCP Compliant|0|||
30977134|NCT01390844|59068116|FG002|Treatment Phase|Non-GCP Compliant|10|||
30977135|NCT01390844|59068117|FG003|Treatment Phase|Non-GCP Compliant|3|||
30977136|NCT01390844|59068114|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
30977137|NCT01390844|59068115|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
30977138|NCT01390844|59068116|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
30977139|NCT01390844|59068117|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
30977140|NCT01430624|59068130|FG000|Overall Study|Lost to Follow-up|23|||
30977141|NCT01430624|59068131|FG001|Overall Study|Lost to Follow-up|29|||
30977142|NCT01430624|59068132|FG002|Overall Study|Lost to Follow-up|27|||
30977143|NCT01430624|59068130|FG000|Overall Study|technical or eligibility|5|||
30977144|NCT01430624|59068131|FG001|Overall Study|technical or eligibility|5|||
30977145|NCT01430624|59068132|FG002|Overall Study|technical or eligibility|2|||
30977146|NCT01430468|59068157|FG000|Overall Study|Physician Decision|2|||
30977147|NCT01430468|59068158|FG001|Overall Study|Physician Decision|1|||
30977148|NCT01430468|59068157|FG000|Overall Study|Withdrawal by Subject|5|||
30977149|NCT01430468|59068158|FG001|Overall Study|Withdrawal by Subject|5|||
30977150|NCT01409564|59068179|FG000|Overall Study|low medication compliance|4|||
30977151|NCT01409564|59068180|FG001|Overall Study|low medication compliance|3|||
30977152|NCT01409564|59068179|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
30977153|NCT01409564|59068180|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
30977154|NCT01390298|59068190|FG000|Overall Study|Death|1|||
30977155|NCT01390298|59068190|FG000|Overall Study|long term ICU admission|1|||
30977156|NCT01390298|59068190|FG000|Overall Study|Withdrawal by Subject|14|||
30977157|NCT01390298|59068190|FG000|Overall Study|Lost to Follow-up|7|||
30977158|NCT01390298|59068190|FG000|Overall Study|Surgery cancelled|1|||
30977159|NCT01390220|59068208|FG000|Test Dose Phase|Adverse Event|17|||
30977160|NCT01390220|59068209|FG001|Test Dose Phase|Adverse Event|0|||
30977161|NCT01390220|59068210|FG002|Test Dose Phase|Adverse Event|0|||
30977162|NCT01390220|59068208|FG000|Test Dose Phase|Withdrawal by Subject|8|||
30977163|NCT01390220|59068209|FG001|Test Dose Phase|Withdrawal by Subject|0|||
30977164|NCT01390220|59068210|FG002|Test Dose Phase|Withdrawal by Subject|0|||
30977165|NCT01390220|59068208|FG000|Test Dose Phase|Lost to Follow-up|2|||
30977166|NCT01390220|59068209|FG001|Test Dose Phase|Lost to Follow-up|0|||
30977167|NCT01390220|59068210|FG002|Test Dose Phase|Lost to Follow-up|0|||
30977168|NCT01390220|59068208|FG000|Test Dose Phase|Protocol Violation|8|||
30977169|NCT01390220|59068209|FG001|Test Dose Phase|Protocol Violation|0|||
30977170|NCT01390220|59068210|FG002|Test Dose Phase|Protocol Violation|0|||
30977171|NCT01390220|59068208|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
30977172|NCT01390220|59068209|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
30977173|NCT01390220|59068210|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
30977174|NCT01390220|59068208|FG000|Test Dose Phase|Study/Site closure|6|||
30977175|NCT01390220|59068209|FG001|Test Dose Phase|Study/Site closure|0|||
30977176|NCT01390220|59068210|FG002|Test Dose Phase|Study/Site closure|0|||
30977177|NCT01390220|59068208|FG000|Test Dose Phase|Caregiver no longer available|5|||
30977178|NCT01390220|59068209|FG001|Test Dose Phase|Caregiver no longer available|0|||
30977179|NCT01390220|59068210|FG002|Test Dose Phase|Caregiver no longer available|0|||
30977180|NCT01390220|59068208|FG000|Test Dose Phase|Noncompliance|2|||
30977181|NCT01390220|59068209|FG001|Test Dose Phase|Noncompliance|0|||
30977182|NCT01390220|59068210|FG002|Test Dose Phase|Noncompliance|0|||
30977183|NCT01390220|59068208|FG000|Test Dose Phase|Logistical|6|||
30977184|NCT01390220|59068209|FG001|Test Dose Phase|Logistical|0|||
30977185|NCT01390220|59068210|FG002|Test Dose Phase|Logistical|0|||
30977186|NCT01390220|59068208|FG000|Comparative Phase|Withdrawal by Subject|0|||
30977187|NCT01390220|59068209|FG001|Comparative Phase|Withdrawal by Subject|1|||
30977188|NCT01390220|59068210|FG002|Comparative Phase|Withdrawal by Subject|0|||
30977189|NCT00550173|59068240|FG000|Overall Study|Death|45|||
30977190|NCT00550173|59068241|FG001|Overall Study|Death|38|||
30977191|NCT00550173|59068242|FG002|Overall Study|Death|50|||
30977192|NCT00550173|59068240|FG000|Overall Study|Physician Decision|1|||
30977193|NCT00550173|59068241|FG001|Overall Study|Physician Decision|2|||
30977194|NCT00550173|59068242|FG002|Overall Study|Physician Decision|2|||
30977195|NCT00550173|59068240|FG000|Overall Study|Withdrawal by Subject|9|||
30977196|NCT00550173|59068241|FG001|Overall Study|Withdrawal by Subject|12|||
30977197|NCT00550173|59068242|FG002|Overall Study|Withdrawal by Subject|17|||
30977198|NCT00550173|59068240|FG000|Overall Study|Sponsor Decision|13|||
30977199|NCT00550173|59068241|FG001|Overall Study|Sponsor Decision|7|||
30977200|NCT00550173|59068242|FG002|Overall Study|Sponsor Decision|1|||
30977201|NCT00550173|59068240|FG000|Overall Study|Lost to Follow-up|4|||
30977202|NCT00550173|59068241|FG001|Overall Study|Lost to Follow-up|4|||
30977203|NCT00550173|59068242|FG002|Overall Study|Lost to Follow-up|3|||
30977204|NCT01429298|59068253|FG000|Overall Study|Protocol Violation|4|||
30977205|NCT01429298|59068254|FG001|Overall Study|Protocol Violation|6|||
30977206|NCT01408706|59068266|FG000|Overall Study|Physician Decision|1|||
30977207|NCT01408706|59068267|FG001|Overall Study|Physician Decision|0|||
30977208|NCT01408628|59068275|FG000|Consented|Withdrawal by Subject|12|||
30977209|NCT01408628|59068275|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
30977210|NCT01408628|59068275|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
30977211|NCT01408628|59068275|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
30977212|NCT01389752|59068280|FG000|Study Period 1|Sponsor decision|0|||
30977213|NCT01389752|59068281|FG001|Study Period 1|Sponsor decision|2|||
30977214|NCT01389752|59068280|FG000|Study Period 2|Sponsor decision|1|||
30977215|NCT01389752|59068281|FG001|Study Period 2|Sponsor decision|0|||
30977216|NCT01428128|59068288|FG000|Overall Study|Withdrawal by Subject|4|||
30977217|NCT01428128|59068288|FG000|Overall Study|Screen failure by p53|10|||
30977218|NCT01428128|59068288|FG000|Overall Study|Received Neulasta in one cycle|2|||
30977219|NCT01428128|59068288|FG000|Overall Study|Adverse Event|1|||
30977220|NCT01407926|59068293|FG000|Overall Study|Lost to Follow-up|55|||
30977221|NCT01427972|59068320|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
30977222|NCT01427972|59068321|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
30977223|NCT01427972|59068322|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
30977224|NCT01427972|59068323|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
30977225|NCT01427972|59068324|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
30977226|NCT01427972|59068325|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
30977227|NCT01427972|59068326|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
30977228|NCT01427972|59068327|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
30977229|NCT01427972|59068328|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
30977230|NCT01427972|59068329|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
30977231|NCT01427972|59068330|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
30977232|NCT01427972|59068331|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
30977233|NCT01427972|59068320|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
30977234|NCT01427972|59068321|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
30977235|NCT01427972|59068322|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
30977236|NCT01427972|59068323|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
30977237|NCT01427972|59068324|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
30977238|NCT01427972|59068325|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
30977239|NCT01427972|59068326|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
30977240|NCT01427972|59068327|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
30977241|NCT01427972|59068328|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
30977242|NCT01427972|59068329|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
30977243|NCT01427972|59068330|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
30977244|NCT01427972|59068331|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
30977245|NCT01427972|59068320|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
30977246|NCT01427972|59068321|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
30977247|NCT01427972|59068322|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
30977248|NCT01427972|59068323|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
30977249|NCT01427972|59068324|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
30977250|NCT01427972|59068325|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
30977251|NCT01427972|59068326|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
30977252|NCT01427972|59068327|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
30977253|NCT01427972|59068328|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
30977254|NCT01427972|59068329|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
30977255|NCT01427972|59068330|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
30977256|NCT01427972|59068331|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
30977257|NCT01427738|59068368|FG000|Overall Study|Death|12|||
30977258|NCT01427738|59068369|FG001|Overall Study|Death|9|||
30977259|NCT01427738|59068368|FG000|Overall Study|Severe debilitation, unable to continue|0|||
30977260|NCT01427738|59068369|FG001|Overall Study|Severe debilitation, unable to continue|1|||
30977261|NCT01427738|59068368|FG000|Overall Study|Subject unable to get to clinic|5|||
30977262|NCT01427738|59068369|FG001|Overall Study|Subject unable to get to clinic|2|||
30977263|NCT01427738|59068368|FG000|Overall Study|Withdrawal by Subject|0|||
30977264|NCT01427738|59068369|FG001|Overall Study|Withdrawal by Subject|2|||
30977265|NCT01427738|59068368|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
30977266|NCT01427738|59068369|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
30977267|NCT01427738|59068368|FG000|Overall Study|Lost to Follow-up|1|||
30977268|NCT01427738|59068369|FG001|Overall Study|Lost to Follow-up|5|||
30977269|NCT01426958|59068375|FG000|Overall Study|Adverse Event|2|||
30977270|NCT02578992|59068553|FG000|Overall Study|equipment not available or malfunction|3|||
30977271|NCT02578992|59068554|FG001|Overall Study|equipment not available or malfunction|3|||
30977272|NCT00558519|59068618|FG000|Overall Study|Ph+|20|||
30977273|NCT00558519|59068618|FG000|Overall Study|Ineligible|1|||
30977274|NCT00558519|59068618|FG000|Overall Study|Insufficient data|1|||
30977275|NCT00558519|59068618|FG000|Overall Study|Never received treatment|1|||
30977276|NCT00558285|59068662|FG000|Overall Study|Adverse Event|1|||
30977277|NCT00558285|59068663|FG001|Overall Study|Adverse Event|1|||
30977278|NCT00558285|59068664|FG002|Overall Study|Adverse Event|4|||
30977279|NCT00558285|59068665|FG003|Overall Study|Adverse Event|1|||
30977280|NCT00558285|59068666|FG004|Overall Study|Adverse Event|2|||
30977281|NCT00558285|59068662|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30977282|NCT00558285|59068663|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30977283|NCT00558285|59068664|FG002|Overall Study|Abnormal test procedure result(s)|0|||
30977284|NCT00558285|59068665|FG003|Overall Study|Abnormal test procedure result(s)|0|||
30977285|NCT00558285|59068666|FG004|Overall Study|Abnormal test procedure result(s)|0|||
30977286|NCT00558285|59068662|FG000|Overall Study|Subject withdrew consent|2|||
30977287|NCT00558285|59068663|FG001|Overall Study|Subject withdrew consent|0|||
30977288|NCT00558285|59068664|FG002|Overall Study|Subject withdrew consent|1|||
30977289|NCT00558285|59068665|FG003|Overall Study|Subject withdrew consent|1|||
30977290|NCT00558285|59068666|FG004|Overall Study|Subject withdrew consent|1|||
30977291|NCT00558285|59068662|FG000|Overall Study|Lost to Follow-up|1|||
30977292|NCT00558285|59068663|FG001|Overall Study|Lost to Follow-up|1|||
30977293|NCT00558285|59068664|FG002|Overall Study|Lost to Follow-up|0|||
30977294|NCT00558285|59068665|FG003|Overall Study|Lost to Follow-up|0|||
30977295|NCT00558285|59068666|FG004|Overall Study|Lost to Follow-up|0|||
30977296|NCT00558285|59068662|FG000|Overall Study|Administrative problems|0|||
30977297|NCT00558285|59068663|FG001|Overall Study|Administrative problems|0|||
30977298|NCT00558285|59068664|FG002|Overall Study|Administrative problems|0|||
30977299|NCT00558285|59068665|FG003|Overall Study|Administrative problems|1|||
30977300|NCT00558285|59068666|FG004|Overall Study|Administrative problems|1|||
30977301|NCT00558285|59068662|FG000|Overall Study|Protocol deviation|1|||
30977302|NCT00558285|59068663|FG001|Overall Study|Protocol deviation|1|||
30977303|NCT00558285|59068664|FG002|Overall Study|Protocol deviation|0|||
30977304|NCT00558285|59068665|FG003|Overall Study|Protocol deviation|1|||
30977305|NCT00558285|59068666|FG004|Overall Study|Protocol deviation|0|||
30977306|NCT01389596|59068681|FG000|Overall Study|Protocol Violation|3|||
30977307|NCT01389596|59068682|FG001|Overall Study|Protocol Violation|4|||
30977308|NCT01389596|59068683|FG002|Overall Study|Protocol Violation|3|||
30977309|NCT01389596|59068681|FG000|Overall Study|Withdrawal by Subject|1|||
30977310|NCT01389596|59068682|FG001|Overall Study|Withdrawal by Subject|2|||
30977311|NCT01389596|59068683|FG002|Overall Study|Withdrawal by Subject|2|||
30977312|NCT01389596|59068681|FG000|Overall Study|Insufficient Clinical Response|3|||
30977313|NCT01389596|59068682|FG001|Overall Study|Insufficient Clinical Response|4|||
30977314|NCT01389596|59068683|FG002|Overall Study|Insufficient Clinical Response|5|||
30977315|NCT01389596|59068681|FG000|Overall Study|Adverse Event|1|||
30977316|NCT01389596|59068682|FG001|Overall Study|Adverse Event|4|||
30977317|NCT01389596|59068683|FG002|Overall Study|Adverse Event|0|||
30977318|NCT01389596|59068681|FG000|Overall Study|Death|0|||
30977319|NCT01389596|59068682|FG001|Overall Study|Death|1|||
30977320|NCT01389596|59068683|FG002|Overall Study|Death|0|||
30977321|NCT01389596|59068681|FG000|Overall Study|Other Unspecified|2|||
30977322|NCT01389596|59068682|FG001|Overall Study|Other Unspecified|1|||
30977323|NCT01389596|59068683|FG002|Overall Study|Other Unspecified|0|||
30977324|NCT01405898|59068719|FG000|Overall Study|Withdrawal by Subject|2|||
30977325|NCT01405898|59068720|FG001|Overall Study|Withdrawal by Subject|2|||
30977326|NCT01389128|59068746|FG000|Overall Study|Fetal distress|1|||
30977327|NCT01389128|59068747|FG001|Overall Study|Fetal distress|0|||
30977328|NCT01389128|59068746|FG000|Overall Study|Cervix dilation stop|1|||
30977329|NCT01389128|59068747|FG001|Overall Study|Cervix dilation stop|2|||
30977330|NCT01389128|59068746|FG000|Overall Study|Rapid labor evolution|3|||
30977331|NCT01389128|59068747|FG001|Overall Study|Rapid labor evolution|2|||
30977332|NCT01389128|59068746|FG000|Overall Study|Intolerance to procedure|0|||
30977333|NCT01389128|59068747|FG001|Overall Study|Intolerance to procedure|2|||
30977334|NCT01388816|59068778|FG000|Overall Study|Adverse Event|0|||
30977335|NCT01388816|59068779|FG001|Overall Study|Adverse Event|2|||
30977336|NCT01388816|59068780|FG002|Overall Study|Adverse Event|0|||
30977337|NCT01388816|59068781|FG003|Overall Study|Adverse Event|0|||
30977338|NCT01388816|59068778|FG000|Overall Study|Lost to Follow-up|0|||
30977339|NCT01388816|59068779|FG001|Overall Study|Lost to Follow-up|1|||
30977340|NCT01388816|59068780|FG002|Overall Study|Lost to Follow-up|0|||
30977341|NCT01388816|59068781|FG003|Overall Study|Lost to Follow-up|0|||
30977342|NCT01388816|59068778|FG000|Overall Study|Withdrawal by Subject|2|||
30977343|NCT01388816|59068779|FG001|Overall Study|Withdrawal by Subject|1|||
30977344|NCT01388816|59068780|FG002|Overall Study|Withdrawal by Subject|1|||
30977345|NCT01388816|59068781|FG003|Overall Study|Withdrawal by Subject|0|||
30977346|NCT01388816|59068778|FG000|Overall Study|Protocol Violation|0|||
30977347|NCT01388816|59068779|FG001|Overall Study|Protocol Violation|0|||
30977348|NCT01388816|59068780|FG002|Overall Study|Protocol Violation|2|||
30977349|NCT01388816|59068781|FG003|Overall Study|Protocol Violation|0|||
30977350|NCT00555477|59068935|FG000|Overall Study|Adverse Event|0|||
30977351|NCT00555477|59068936|FG001|Overall Study|Adverse Event|9|||
30977352|NCT00555477|59068935|FG000|Overall Study|Withdrawal by Subject|1|||
30977353|NCT00555477|59068936|FG001|Overall Study|Withdrawal by Subject|2|||
30977354|NCT00555477|59068935|FG000|Overall Study|Physician Decision|1|||
30977355|NCT00555477|59068936|FG001|Overall Study|Physician Decision|2|||
30977356|NCT00554619|59068953|FG000|Overall Study|Adverse Event|1|||
30977357|NCT00554619|59068953|FG000|Overall Study|Physician Decision|1|||
30977358|NCT00554619|59068953|FG000|Overall Study|Liver Function Test Abnormality|1|||
30977359|NCT01426412|59069013|FG000|Overall Study|Withdrawal by Subject|1|||
30977360|NCT01426412|59069014|FG001|Overall Study|Withdrawal by Subject|0|||
30977361|NCT01426412|59069015|FG002|Overall Study|Withdrawal by Subject|0|||
30977362|NCT01426412|59069016|FG003|Overall Study|Withdrawal by Subject|0|||
30977363|NCT01426412|59069017|FG004|Overall Study|Withdrawal by Subject|1|||
30977364|NCT01426412|59069018|FG005|Overall Study|Withdrawal by Subject|0|||
30977365|NCT01426412|59069019|FG006|Overall Study|Withdrawal by Subject|0|||
30977366|NCT01426412|59069020|FG007|Overall Study|Withdrawal by Subject|3|||
30977367|NCT01426412|59069021|FG008|Overall Study|Withdrawal by Subject|1|||
30977368|NCT00554229|59069225|FG000|Overall Study|Lost to Follow-up|3|||
30977369|NCT00554229|59069226|FG001|Overall Study|Lost to Follow-up|6|||
30977370|NCT00554229|59069225|FG000|Overall Study|Withdrawal by Subject|29|||
30977371|NCT00554229|59069226|FG001|Overall Study|Withdrawal by Subject|37|||
30977372|NCT00554229|59069225|FG000|Overall Study|Adverse Event|71|||
30977373|NCT00554229|59069226|FG001|Overall Study|Adverse Event|39|||
30977374|NCT00554229|59069225|FG000|Overall Study|Protocol Violation|3|||
30977375|NCT00554229|59069226|FG001|Overall Study|Protocol Violation|3|||
30977376|NCT00554229|59069225|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
30977377|NCT00554229|59069226|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
30977378|NCT00554229|59069225|FG000|Overall Study|Randomised but no treatment received|1|||
30977379|NCT00554229|59069226|FG001|Overall Study|Randomised but no treatment received|0|||
30977380|NCT01405820|59069336|FG000|Randomized Treatment Period|Adverse Event|3|||
30977381|NCT01405820|59069337|FG001|Randomized Treatment Period|Adverse Event|3|||
30977382|NCT01405820|59069338|FG002|Randomized Treatment Period|Adverse Event|3|||
30890624|NCT01601535|58923623|FG004|Phase 1|Adverse Event|0|||
30890625|NCT01601535|58923624|FG005|Phase 1|Adverse Event|0|||
30890626|NCT01601535|58923619|FG000|Phase 1|Withdrawal by Subject|2|||
30890627|NCT01601535|58923620|FG001|Phase 1|Withdrawal by Subject|1|||
30890628|NCT01601535|58923621|FG002|Phase 1|Withdrawal by Subject|1|||
30890629|NCT01601535|58923622|FG003|Phase 1|Withdrawal by Subject|2|||
30890630|NCT01601535|58923623|FG004|Phase 1|Withdrawal by Subject|0|||
30890631|NCT01601535|58923624|FG005|Phase 1|Withdrawal by Subject|0|||
30890632|NCT01601535|58923619|FG000|Phase 1|Progressive Disease|2|||
30890633|NCT01601535|58923620|FG001|Phase 1|Progressive Disease|3|||
30890634|NCT01601535|58923621|FG002|Phase 1|Progressive Disease|2|||
30890635|NCT01601535|58923622|FG003|Phase 1|Progressive Disease|1|||
30977383|NCT01405820|59069339|FG003|Randomized Treatment Period|Adverse Event|0|||
30977384|NCT01405820|59069340|FG004|Randomized Treatment Period|Adverse Event|2|||
30977385|NCT01405820|59069341|FG005|Randomized Treatment Period|Adverse Event|1|||
30977386|NCT01405820|59069336|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
30977387|NCT01405820|59069337|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
30890636|NCT01601535|58923623|FG004|Phase 1|Progressive Disease|0|||
30977388|NCT01405820|59069338|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
30890637|NCT01601535|58923624|FG005|Phase 1|Progressive Disease|0|||
30890638|NCT01601535|58923619|FG000|Phase 1|Started Another Treatment|1|||
30977389|NCT01405820|59069339|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
30977390|NCT01405820|59069340|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
30977391|NCT01405820|59069341|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
30977392|NCT01405820|59069336|FG000|Randomized Treatment Period|Other|2|||
30977393|NCT01405820|59069337|FG001|Randomized Treatment Period|Other|2|||
30977394|NCT01405820|59069338|FG002|Randomized Treatment Period|Other|1|||
30977395|NCT01405820|59069339|FG003|Randomized Treatment Period|Other|1|||
30977396|NCT01405820|59069340|FG004|Randomized Treatment Period|Other|0|||
30977397|NCT01405820|59069341|FG005|Randomized Treatment Period|Other|0|||
30977398|NCT01405820|59069336|FG000|Randomized Treatment Period|Physician Decision|0|||
30977399|NCT01405820|59069337|FG001|Randomized Treatment Period|Physician Decision|2|||
30977400|NCT01405820|59069338|FG002|Randomized Treatment Period|Physician Decision|1|||
30977401|NCT01405820|59069339|FG003|Randomized Treatment Period|Physician Decision|0|||
30977402|NCT01405820|59069340|FG004|Randomized Treatment Period|Physician Decision|0|||
30977403|NCT01405820|59069341|FG005|Randomized Treatment Period|Physician Decision|0|||
30977404|NCT01405820|59069336|FG000|Randomized Treatment Period|Rescue|0|||
30977405|NCT01405820|59069337|FG001|Randomized Treatment Period|Rescue|1|||
30977406|NCT01405820|59069338|FG002|Randomized Treatment Period|Rescue|13|||
30977407|NCT01405820|59069339|FG003|Randomized Treatment Period|Rescue|10|||
30977408|NCT01405820|59069340|FG004|Randomized Treatment Period|Rescue|8|||
30977409|NCT01405820|59069341|FG005|Randomized Treatment Period|Rescue|8|||
30977410|NCT01405820|59069336|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
30977411|NCT01405820|59069337|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
30977412|NCT01405820|59069338|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
30977413|NCT01405820|59069339|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
30977414|NCT01405820|59069340|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
30977415|NCT01405820|59069341|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
30608461|NCT01288430|58619230|FG009|Part 2|Withdrawal by Subject|0|||
30608462|NCT01288430|58619221|FG000|Part 2|Adverse Event|0|||
30608463|NCT01288430|58619222|FG001|Part 2|Adverse Event|0|||
30790183|NCT00044213|58803372|FG002|Overall Study|Death|42|||
30977416|NCT01405820|59069336|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
30977417|NCT01405820|59069337|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
30977418|NCT01405820|59069338|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
30977419|NCT01405820|59069339|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
30977420|NCT01405820|59069340|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
30977421|NCT01405820|59069341|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
30977422|NCT01405820|59069336|FG000|Randomized Treatment Period|Death|0|||
30977423|NCT01405820|59069337|FG001|Randomized Treatment Period|Death|0|||
30977424|NCT01405820|59069338|FG002|Randomized Treatment Period|Death|0|||
30977425|NCT01405820|59069339|FG003|Randomized Treatment Period|Death|1|||
30977426|NCT01405820|59069340|FG004|Randomized Treatment Period|Death|0|||
30977427|NCT01405820|59069341|FG005|Randomized Treatment Period|Death|0|||
30977428|NCT01405820|59069336|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
30977429|NCT01405820|59069337|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
30977430|NCT01405820|59069338|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
30977431|NCT01405820|59069339|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
30977432|NCT01405820|59069340|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
30977433|NCT01405820|59069341|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
30977434|NCT01405820|59069336|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
30977435|NCT01405820|59069337|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
30977436|NCT01405820|59069338|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
30977437|NCT01405820|59069339|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
30977438|NCT01405820|59069340|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
30977439|NCT01405820|59069341|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
30977440|NCT01405820|59069336|FG000|Open-Label Treatment Period|Other|1|||
30977441|NCT01405820|59069337|FG001|Open-Label Treatment Period|Other|1|||
30977442|NCT01405820|59069338|FG002|Open-Label Treatment Period|Other|1|||
30977443|NCT01405820|59069339|FG003|Open-Label Treatment Period|Other|1|||
30977444|NCT01405820|59069340|FG004|Open-Label Treatment Period|Other|1|||
30977445|NCT01405820|59069341|FG005|Open-Label Treatment Period|Other|1|||
30977446|NCT01405820|59069336|FG000|Open-Label Treatment Period|Physician Decision|0|||
30977447|NCT01405820|59069337|FG001|Open-Label Treatment Period|Physician Decision|0|||
30977448|NCT01405820|59069338|FG002|Open-Label Treatment Period|Physician Decision|1|||
30977449|NCT01405820|59069339|FG003|Open-Label Treatment Period|Physician Decision|2|||
30977450|NCT01405820|59069340|FG004|Open-Label Treatment Period|Physician Decision|1|||
30977451|NCT01405820|59069341|FG005|Open-Label Treatment Period|Physician Decision|0|||
30977452|NCT01405820|59069336|FG000|Open-Label Treatment Period|Adverse Event|0|||
30977453|NCT01405820|59069337|FG001|Open-Label Treatment Period|Adverse Event|0|||
30977454|NCT01405820|59069338|FG002|Open-Label Treatment Period|Adverse Event|0|||
30977455|NCT01405820|59069339|FG003|Open-Label Treatment Period|Adverse Event|1|||
30977456|NCT01405820|59069340|FG004|Open-Label Treatment Period|Adverse Event|0|||
30790184|NCT00044213|58803373|FG003|Overall Study|Death|49|||
30977457|NCT01405820|59069341|FG005|Open-Label Treatment Period|Adverse Event|0|||
30977458|NCT01405742|59069370|FG000|Overall Study|Lost to Follow-up|1|||
30977459|NCT01405742|59069371|FG001|Overall Study|Lost to Follow-up|0|||
30977460|NCT01425632|59069400|FG000|Overall Study|Adverse Event|0|||
30977461|NCT01425632|59069401|FG001|Overall Study|Adverse Event|1|||
30977462|NCT01425632|59069402|FG002|Overall Study|Adverse Event|1|||
30977463|NCT01425632|59069400|FG000|Overall Study|Physician Decision|1|||
30977464|NCT01425632|59069401|FG001|Overall Study|Physician Decision|0|||
30977465|NCT01425632|59069402|FG002|Overall Study|Physician Decision|0|||
30977466|NCT01425632|59069400|FG000|Overall Study|Protocol Violation|0|||
30977467|NCT01425632|59069401|FG001|Overall Study|Protocol Violation|0|||
30977468|NCT01425632|59069402|FG002|Overall Study|Protocol Violation|2|||
30977469|NCT01425632|59069400|FG000|Overall Study|Withdrawal by Subject|0|||
30977470|NCT01425632|59069401|FG001|Overall Study|Withdrawal by Subject|0|||
30977471|NCT01425632|59069402|FG002|Overall Study|Withdrawal by Subject|1|||
30977472|NCT01405508|59069439|FG000|Overall Study|AE, non-serious non-fatal|1|||
30977473|NCT01405508|59069440|FG001|Overall Study|AE, non-serious non-fatal|1|||
30977474|NCT01405508|59069441|FG002|Overall Study|AE, non-serious non-fatal|0|||
30977475|NCT01405508|59069442|FG003|Overall Study|AE, non-serious non-fatal|0|||
30977476|NCT01405196|59069578|FG000|Overall Study|Study Terminated by Sponsor|0|||
30977477|NCT01405196|59069579|FG001|Overall Study|Study Terminated by Sponsor|0|||
30977478|NCT01405196|59069580|FG002|Overall Study|Study Terminated by Sponsor|9|||
30977479|NCT01405196|59069581|FG003|Overall Study|Study Terminated by Sponsor|0|||
30977480|NCT01405196|59069578|FG000|Overall Study|Other|2|||
30977481|NCT01405196|59069579|FG001|Overall Study|Other|2|||
30977482|NCT01405196|59069580|FG002|Overall Study|Other|5|||
30977483|NCT01405196|59069581|FG003|Overall Study|Other|0|||
30977484|NCT01405196|59069578|FG000|Overall Study|Withdrawal by Subject|4|||
30977485|NCT01405196|59069579|FG001|Overall Study|Withdrawal by Subject|6|||
30977486|NCT01405196|59069580|FG002|Overall Study|Withdrawal by Subject|3|||
30977487|NCT01405196|59069581|FG003|Overall Study|Withdrawal by Subject|6|||
30977488|NCT01405196|59069578|FG000|Overall Study|Adverse Event|2|||
30977489|NCT01405196|59069579|FG001|Overall Study|Adverse Event|2|||
30977490|NCT01405196|59069580|FG002|Overall Study|Adverse Event|0|||
30977491|NCT01405196|59069581|FG003|Overall Study|Adverse Event|2|||
30977492|NCT01405196|59069578|FG000|Overall Study|Death|1|||
30977493|NCT01405196|59069579|FG001|Overall Study|Death|0|||
30977494|NCT01405196|59069580|FG002|Overall Study|Death|3|||
30977495|NCT01405196|59069581|FG003|Overall Study|Death|0|||
30977496|NCT01405196|59069578|FG000|Overall Study|Lost to Follow-up|2|||
30977497|NCT01405196|59069579|FG001|Overall Study|Lost to Follow-up|2|||
30977498|NCT01405196|59069580|FG002|Overall Study|Lost to Follow-up|3|||
30977499|NCT01405196|59069581|FG003|Overall Study|Lost to Follow-up|1|||
30977500|NCT01402700|59069631|FG000|Overall Study|Death|3|||
30977501|NCT01402700|59069631|FG000|Overall Study|Withdrawal by Subject|3|||
30977502|NCT01402700|59069631|FG000|Overall Study|Missed Visit|1|||
30977503|NCT01424930|59069753|FG000|Overall Study|Adverse Event|0|||
30977504|NCT01424930|59069754|FG001|Overall Study|Adverse Event|1|||
30977505|NCT01424930|59069753|FG000|Overall Study|Death|1|||
30977506|NCT01424930|59069754|FG001|Overall Study|Death|0|||
30977507|NCT01424930|59069753|FG000|Overall Study|Progressive Disease|3|||
30977508|NCT01424930|59069754|FG001|Overall Study|Progressive Disease|6|||
30977509|NCT01424930|59069753|FG000|Overall Study|Screen Failure|0|||
30977510|NCT01424930|59069754|FG001|Overall Study|Screen Failure|1|||
30977511|NCT01424930|59069753|FG000|Overall Study|Reason not specified|0|||
30977512|NCT01424930|59069754|FG001|Overall Study|Reason not specified|6|||
30977513|NCT01424306|59069769|FG000|Overall Study|Protocol Violation|0|||
30977514|NCT01424306|59069770|FG001|Overall Study|Protocol Violation|0|||
30977515|NCT01424306|59069771|FG002|Overall Study|Protocol Violation|0|||
30977516|NCT01424306|59069772|FG003|Overall Study|Protocol Violation|0|||
30977517|NCT01424306|59069773|FG004|Overall Study|Protocol Violation|1|||
30977518|NCT01424306|59069774|FG005|Overall Study|Protocol Violation|0|||
30977519|NCT01424228|59069818|FG000|Overall Study|Withdrawal by Subject|27|||
30977520|NCT01424228|59069819|FG001|Overall Study|Withdrawal by Subject|11|||
30977521|NCT01424228|59069818|FG000|Overall Study|Adverse Event|10|||
30977522|NCT01424228|59069819|FG001|Overall Study|Adverse Event|14|||
30977523|NCT01424228|59069818|FG000|Overall Study|Sponsor's decision|9|||
30977524|NCT01424228|59069819|FG001|Overall Study|Sponsor's decision|12|||
30977525|NCT01424228|59069818|FG000|Overall Study|Lack of Efficacy|5|||
30977526|NCT01424228|59069819|FG001|Overall Study|Lack of Efficacy|7|||
30977527|NCT01424228|59069818|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
30977528|NCT01424228|59069819|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
30977529|NCT01424228|59069818|FG000|Overall Study|Non-compliance|2|||
30977530|NCT01424228|59069819|FG001|Overall Study|Non-compliance|0|||
30977531|NCT01424228|59069818|FG000|Overall Study|Worsening of symptoms|1|||
30977532|NCT01424228|59069819|FG001|Overall Study|Worsening of symptoms|0|||
30977533|NCT01424228|59069818|FG000|Overall Study|Unplanned journey|0|||
30977534|NCT01424228|59069819|FG001|Overall Study|Unplanned journey|1|||
30977535|NCT01423916|59069828|FG000|Overall Study|Adverse Event|5|||
30977536|NCT01423916|59069829|FG001|Overall Study|Adverse Event|9|||
30977537|NCT01423916|59069830|FG002|Overall Study|Adverse Event|2|||
30977538|NCT01423916|59069828|FG000|Overall Study|Met Withdrawal Criteria|1|||
30977539|NCT01423916|59069829|FG001|Overall Study|Met Withdrawal Criteria|1|||
30977540|NCT01423916|59069830|FG002|Overall Study|Met Withdrawal Criteria|1|||
30977541|NCT01423916|59069828|FG000|Overall Study|Physician Decision|1|||
30977542|NCT01423916|59069829|FG001|Overall Study|Physician Decision|0|||
30977543|NCT01423916|59069830|FG002|Overall Study|Physician Decision|1|||
30977544|NCT01423916|59069828|FG000|Overall Study|Withdrawal by Subject|3|||
30977545|NCT01423916|59069829|FG001|Overall Study|Withdrawal by Subject|10|||
30977546|NCT01423916|59069830|FG002|Overall Study|Withdrawal by Subject|3|||
30977547|NCT01423916|59069828|FG000|Overall Study|Protocol Deviation|1|||
30977548|NCT01423916|59069829|FG001|Overall Study|Protocol Deviation|0|||
30977549|NCT01423916|59069830|FG002|Overall Study|Protocol Deviation|0|||
30977550|NCT01423604|59069949|FG000|Safety Run-In|Adverse Event|3|||
30977551|NCT01423604|59069950|FG001|Safety Run-In|Adverse Event|0|||
30977552|NCT01423604|59069949|FG000|Safety Run-In|Death|1|||
30977553|NCT01423604|59069950|FG001|Safety Run-In|Death|0|||
30977554|NCT01423604|59069949|FG000|Safety Run-In|Physician Decision|1|||
30977555|NCT01423604|59069950|FG001|Safety Run-In|Physician Decision|0|||
30977556|NCT01423604|59069949|FG000|Safety Run-In|Disease progression|3|||
30977557|NCT01423604|59069950|FG001|Safety Run-In|Disease progression|0|||
30977558|NCT01423604|59069949|FG000|Safety Run-In|Patient decision|1|||
30977559|NCT01423604|59069950|FG001|Safety Run-In|Patient decision|0|||
30977560|NCT01423604|59069949|FG000|Randomized|Adverse Event|4|||
30977561|NCT01423604|59069950|FG001|Randomized|Adverse Event|10|||
30977562|NCT01423604|59069949|FG000|Randomized|Death|1|||
30977563|NCT01423604|59069950|FG001|Randomized|Death|0|||
30977564|NCT01423604|59069949|FG000|Randomized|Physician Decision|16|||
30977565|NCT01423604|59069950|FG001|Randomized|Physician Decision|13|||
30977566|NCT01423604|59069949|FG000|Randomized|Other - unspecified|37|||
30977567|NCT01423604|59069950|FG001|Randomized|Other - unspecified|31|||
30977568|NCT01423604|59069949|FG000|Randomized|Patient decision|5|||
30977569|NCT01423604|59069950|FG001|Randomized|Patient decision|9|||
30977570|NCT01402544|59069966|FG000|Overall Study|Withdrawal by Subject|6|||
30977571|NCT01401842|59069972|FG000|Overall Study|Withdrawal by Subject|3|||
30977572|NCT01401842|59069973|FG001|Overall Study|Withdrawal by Subject|2|||
30977573|NCT01401842|59069972|FG000|Overall Study|academic reason|4|||
30977574|NCT01401842|59069973|FG001|Overall Study|academic reason|1|||
30977575|NCT01401842|59069972|FG000|Overall Study|changed companies|20|||
30977576|NCT01401842|59069973|FG001|Overall Study|changed companies|34|||
30977577|NCT01401842|59069972|FG000|Overall Study|discharged from US Army|3|||
30977578|NCT01401842|59069973|FG001|Overall Study|discharged from US Army|4|||
30977579|NCT01401842|59069972|FG000|Overall Study|invalid follow-up strength data|1|||
30977580|NCT01401842|59069973|FG001|Overall Study|invalid follow-up strength data|4|||
30977581|NCT01401842|59069972|FG000|Overall Study|on profile|9|||
30977582|NCT01401842|59069973|FG001|Overall Study|on profile|5|||
30977583|NCT01401842|59069972|FG000|Overall Study|other/unknown|28|||
30977584|NCT01401842|59069973|FG001|Overall Study|other/unknown|17|||
30977585|NCT01422824|59069979|FG000|Overall Study|Case record form not evaluated|1|||
30890639|NCT01601535|58923620|FG001|Phase 1|Started Another Treatment|2|||
30890640|NCT01601535|58923621|FG002|Phase 1|Started Another Treatment|0|||
30890641|NCT01601535|58923622|FG003|Phase 1|Started Another Treatment|0|||
30890642|NCT01601535|58923623|FG004|Phase 1|Started Another Treatment|0|||
30890643|NCT01601535|58923624|FG005|Phase 1|Started Another Treatment|0|||
30890644|NCT01601535|58923619|FG000|Phase 2|Adverse Event|0|||
30890645|NCT01601535|58923620|FG001|Phase 2|Adverse Event|0|||
30890646|NCT01601535|58923621|FG002|Phase 2|Adverse Event|0|||
30890647|NCT01601535|58923622|FG003|Phase 2|Adverse Event|0|||
30890648|NCT01601535|58923623|FG004|Phase 2|Adverse Event|5|||
30890649|NCT01601535|58923624|FG005|Phase 2|Adverse Event|1|||
30890650|NCT01601535|58923619|FG000|Phase 2|Withdrawal by Subject|0|||
30890651|NCT01601535|58923620|FG001|Phase 2|Withdrawal by Subject|0|||
30890652|NCT01601535|58923621|FG002|Phase 2|Withdrawal by Subject|0|||
30890653|NCT01601535|58923622|FG003|Phase 2|Withdrawal by Subject|0|||
30977586|NCT01422824|59069979|FG000|Overall Study|Lost to Follow-up|37|||
30977587|NCT01401530|59070042|FG000|Overall Study|Disease Progression|1|||
30890654|NCT01601535|58923623|FG004|Phase 2|Withdrawal by Subject|8|||
30977588|NCT01401530|59070043|FG001|Overall Study|Disease Progression|2|||
30977589|NCT01401530|59070044|FG002|Overall Study|Disease Progression|1|||
30977590|NCT01401530|59070042|FG000|Overall Study|Adverse Event|1|||
30977591|NCT01401530|59070043|FG001|Overall Study|Adverse Event|1|||
30890655|NCT01601535|58923624|FG005|Phase 2|Withdrawal by Subject|2|||
30890656|NCT01601535|58923619|FG000|Phase 2|Progressive Disease|0|||
30977592|NCT01401530|59070044|FG002|Overall Study|Adverse Event|1|||
30977593|NCT01401530|59070042|FG000|Overall Study|Participant Choice|1|||
30977594|NCT01401530|59070043|FG001|Overall Study|Participant Choice|2|||
30977595|NCT01401530|59070044|FG002|Overall Study|Participant Choice|1|||
30977596|NCT01401530|59070042|FG000|Overall Study|Physician Decision|0|||
30977597|NCT01401530|59070043|FG001|Overall Study|Physician Decision|1|||
30977598|NCT01401530|59070044|FG002|Overall Study|Physician Decision|0|||
30977599|NCT01387022|59070056|FG000|Overall Study|Death|1|||
30977600|NCT01387022|59070057|FG001|Overall Study|Death|1|||
30977601|NCT01387022|59070056|FG000|Overall Study|Lost to Follow-up|0|||
30977602|NCT01387022|59070057|FG001|Overall Study|Lost to Follow-up|3|||
30977603|NCT01386944|59070083|FG000|Overall Study|Adverse Event|26|||
30977604|NCT01386944|59070083|FG000|Overall Study|Lack of Efficacy|14|||
30977605|NCT01386944|59070083|FG000|Overall Study|Lost to Follow-up|8|||
30977606|NCT01386944|59070083|FG000|Overall Study|Unspecified reason|8|||
30977607|NCT01386788|59070094|FG000|Overall Study|Lost to Follow-up|2|||
30977608|NCT01386554|59070159|FG000|Overall Study|Lost to Follow-up|0|||
30977609|NCT01386554|59070160|FG001|Overall Study|Lost to Follow-up|0|||
30890657|NCT01601535|58923620|FG001|Phase 2|Progressive Disease|0|||
30890658|NCT01601535|58923621|FG002|Phase 2|Progressive Disease|0|||
30890659|NCT01601535|58923622|FG003|Phase 2|Progressive Disease|0|||
30890660|NCT01601535|58923623|FG004|Phase 2|Progressive Disease|5|||
30890661|NCT01601535|58923624|FG005|Phase 2|Progressive Disease|7|||
30890662|NCT01601535|58923619|FG000|Phase 2|Started Another Treatment|0|||
30890663|NCT01601535|58923620|FG001|Phase 2|Started Another Treatment|0|||
30890664|NCT01601535|58923621|FG002|Phase 2|Started Another Treatment|0|||
30890665|NCT01601535|58923622|FG003|Phase 2|Started Another Treatment|0|||
30890666|NCT01601535|58923623|FG004|Phase 2|Started Another Treatment|1|||
30890667|NCT01601535|58923624|FG005|Phase 2|Started Another Treatment|2|||
30890668|NCT01638819|58923649|FG000|Overall Study|Lost to Follow-up|1|||
30890669|NCT01638819|58923650|FG001|Overall Study|Lost to Follow-up|0|||
30890670|NCT01363713|58923655|FG000|Overall Study|Adverse Event|1|||
30890671|NCT01363713|58923655|FG000|Overall Study|Protocol Violation|3|||
30890672|NCT01363713|58923655|FG000|Overall Study|Withdrawal by Subject|2|||
30890673|NCT01637961|58923659|FG000|Overall Study|Ineligible: wrong primary|1|||
30890674|NCT01637961|58923659|FG000|Overall Study|Ineligible: inadequate pathology|1|||
30890675|NCT04183335|58923671|FG000|Overall Study|Adverse Event|1|||
30890676|NCT04183335|58923672|FG001|Overall Study|Adverse Event|0|||
30890677|NCT04183335|58923671|FG000|Overall Study|Withdrawal by Subject|12|||
30890678|NCT04183335|58923672|FG001|Overall Study|Withdrawal by Subject|3|||
30890679|NCT04199793|58923680|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
30890680|NCT04199793|58923681|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
30890681|NCT04199793|58923680|FG000|Overall Study|Withdrawal by Subject|1|||
30890682|NCT04199793|58923681|FG001|Overall Study|Withdrawal by Subject|1|||
30890683|NCT01636947|58923689|FG000|Overall Study|Not Treated|2|||
30890684|NCT01636947|58923690|FG001|Overall Study|Not Treated|2|||
30890685|NCT01636947|58923689|FG000|Overall Study|Lost to Follow-up|4|||
30890686|NCT01636947|58923690|FG001|Overall Study|Lost to Follow-up|0|||
30890687|NCT01636947|58923689|FG000|Overall Study|Protocol Violation|1|||
30890688|NCT01636947|58923690|FG001|Overall Study|Protocol Violation|1|||
30890689|NCT01636947|58923689|FG000|Overall Study|Withdrawal by Subject|3|||
30890690|NCT01636947|58923690|FG001|Overall Study|Withdrawal by Subject|3|||
30890691|NCT01636947|58923689|FG000|Overall Study|Adverse Event|1|||
30890692|NCT01636947|58923690|FG001|Overall Study|Adverse Event|1|||
30890693|NCT01636947|58923689|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
30890694|NCT01636947|58923690|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
30890695|NCT01635933|58923698|FG000|Overall Study|Adverse Event|1|||
30890696|NCT01635933|58923699|FG001|Overall Study|Adverse Event|0|||
30890697|NCT01635933|58923698|FG000|Overall Study|Lost to Follow-up|0|||
30890698|NCT01635933|58923699|FG001|Overall Study|Lost to Follow-up|5|||
30890699|NCT01635933|58923698|FG000|Overall Study|Subject decision|1|||
30890700|NCT01635933|58923699|FG001|Overall Study|Subject decision|1|||
30890701|NCT01635933|58923698|FG000|Overall Study|Noncompliance|0|||
30890702|NCT01635933|58923699|FG001|Overall Study|Noncompliance|1|||
30890703|NCT01635933|58923698|FG000|Overall Study|No longer had transportation|0|||
30890704|NCT01635933|58923699|FG001|Overall Study|No longer had transportation|1|||
30890705|NCT01635855|58923705|FG000|Overall Study|Withdrawal by Subject|4|||
30890706|NCT03052725|58923711|FG000|Overall Study|Adverse Event|2|||
30890707|NCT03052725|58923712|FG001|Overall Study|Adverse Event|0|||
30890708|NCT03052725|58923711|FG000|Overall Study|Withdrawal by Subject|3|||
30977610|NCT01386554|59070161|FG002|Overall Study|Lost to Follow-up|1|||
30890709|NCT03052725|58923712|FG001|Overall Study|Withdrawal by Subject|4|||
30977611|NCT01386554|59070159|FG000|Overall Study|Adverse Event|2|||
30977612|NCT01386554|59070160|FG001|Overall Study|Adverse Event|5|||
30977613|NCT01386554|59070161|FG002|Overall Study|Adverse Event|2|||
30977614|NCT01386554|59070159|FG000|Overall Study|Progressive disease|1|||
30890710|NCT03052725|58923711|FG000|Overall Study|Pregnancy|0|||
30890711|NCT03052725|58923712|FG001|Overall Study|Pregnancy|1|||
30890712|NCT03052725|58923711|FG000|Overall Study|Site closure|0|||
30890713|NCT03052725|58923712|FG001|Overall Study|Site closure|1|||
30977615|NCT01386554|59070160|FG001|Overall Study|Progressive disease|2|||
30977616|NCT01386554|59070161|FG002|Overall Study|Progressive disease|2|||
30977617|NCT01386554|59070159|FG000|Overall Study|Administration of live vaccines|0|||
30977618|NCT01386554|59070160|FG001|Overall Study|Administration of live vaccines|1|||
30977619|NCT01386554|59070161|FG002|Overall Study|Administration of live vaccines|0|||
30977620|NCT01386554|59070159|FG000|Overall Study|Investigator discretion|0|||
30977621|NCT01386554|59070160|FG001|Overall Study|Investigator discretion|0|||
30977622|NCT01386554|59070161|FG002|Overall Study|Investigator discretion|1|||
30977623|NCT01386554|59070159|FG000|Overall Study|Reason not collected|0|||
30977624|NCT01386554|59070160|FG001|Overall Study|Reason not collected|1|||
30977625|NCT01386554|59070161|FG002|Overall Study|Reason not collected|0|||
30977626|NCT01386008|59070186|FG000|Overall Study|exited w/o incident /study discontinued|17|||
30977627|NCT01386008|59070186|FG000|Overall Study|Adverse Event|3|||
30977628|NCT01421342|59070334|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
30977629|NCT01421342|59070335|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
30977630|NCT01421342|59070336|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
30977631|NCT01421342|59070334|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
30977632|NCT01421342|59070335|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
30977633|NCT01421342|59070336|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
30977634|NCT01421342|59070334|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
30977635|NCT01421342|59070335|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
30977636|NCT01421342|59070336|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
30977637|NCT01421342|59070334|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
30977638|NCT01421342|59070335|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
30977639|NCT01421342|59070336|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
30977640|NCT01421342|59070334|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
30977641|NCT01421342|59070335|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
30977642|NCT01421342|59070336|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
30977643|NCT01421342|59070334|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
30977644|NCT01421342|59070335|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
30977645|NCT01421342|59070336|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
30977646|NCT01421342|59070334|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
30977647|NCT01421342|59070335|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
30977648|NCT01421342|59070336|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
30977649|NCT01421342|59070334|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
30977650|NCT01421342|59070335|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
30977651|NCT01421342|59070336|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
30977652|NCT01421342|59070334|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
30977653|NCT01421342|59070335|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
30977654|NCT01421342|59070336|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
30977655|NCT01421342|59070334|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
30977656|NCT01421342|59070335|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
30977657|NCT01421342|59070336|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
30977658|NCT01421342|59070334|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
30977659|NCT01421342|59070335|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
30977660|NCT01421342|59070336|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
30977661|NCT01421342|59070334|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
30977662|NCT01421342|59070335|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
30977663|NCT01421342|59070336|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
30977664|NCT01421342|59070334|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
30977665|NCT01421342|59070335|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
30977666|NCT01421342|59070336|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
30977667|NCT01421342|59070334|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
30977668|NCT01421342|59070335|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
30977669|NCT01421342|59070336|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
30977670|NCT01421342|59070334|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
30977671|NCT01421342|59070335|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
30977672|NCT01421342|59070336|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
30977673|NCT01421342|59070334|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
30977674|NCT01421342|59070335|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
30977675|NCT01421342|59070336|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
30977676|NCT01421342|59070334|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
30977677|NCT01421342|59070335|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
30977678|NCT01421342|59070336|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
30977679|NCT01421342|59070334|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
30977680|NCT01421342|59070335|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
30977681|NCT01421342|59070336|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
30977682|NCT01421342|59070334|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
30977683|NCT01421342|59070335|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
30977684|NCT01421342|59070336|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
30977685|NCT01421342|59070334|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
30977686|NCT01421342|59070335|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
30977687|NCT01421342|59070336|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
30977688|NCT01421342|59070334|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
30977689|NCT01421342|59070335|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
30977690|NCT01421342|59070336|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
30977691|NCT01421342|59070334|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
30977692|NCT01421342|59070335|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
30977693|NCT01421342|59070336|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
30977694|NCT01421342|59070334|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
30977695|NCT01421342|59070335|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
30977696|NCT01421342|59070336|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
30977697|NCT01421342|59070334|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
30977698|NCT01421342|59070335|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
30977699|NCT01421342|59070336|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
30977700|NCT01421342|59070334|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
30977701|NCT01421342|59070335|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
30977702|NCT01421342|59070336|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
30977703|NCT01421342|59070334|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
30977704|NCT01421342|59070335|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
30977705|NCT01421342|59070336|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
30977706|NCT01421342|59070334|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
30977707|NCT01421342|59070335|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
30977708|NCT01421342|59070336|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
30977709|NCT01421342|59070334|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
30977710|NCT01421342|59070335|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
30977711|NCT01421342|59070336|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
30977712|NCT01384760|59070359|FG000|Overall Study|Lost to Follow-up|0|||
30977713|NCT01384760|59070360|FG001|Overall Study|Lost to Follow-up|6|||
30977714|NCT01384760|59070359|FG000|Overall Study|Protocol Violation|16|||
30977715|NCT01384760|59070360|FG001|Overall Study|Protocol Violation|0|||
30977716|NCT01384292|59070400|FG000|Part B|Severe non-compliance to protocol|1|||
30977717|NCT01384292|59070401|FG001|Part B|Severe non-compliance to protocol|0|||
30977718|NCT01384292|59070402|FG002|Part B|Severe non-compliance to protocol|0|||
30977719|NCT01401452|59070412|FG000|Overall Study|Adverse reaction|9|||
30977720|NCT01401452|59070412|FG000|Overall Study|Lost to Follow-up|12|||
30977721|NCT01401452|59070412|FG000|Overall Study|Lack of Efficacy|30|||
30977722|NCT01401452|59070412|FG000|Overall Study|Participant developed breast cancer|1|||
30977723|NCT01401452|59070412|FG000|Overall Study|Tx stopped due to financial reasons|1|||
30977724|NCT01401452|59070412|FG000|Overall Study|Tx stopped by psychiatrist|1|||
30977725|NCT01401452|59070412|FG000|Overall Study|No more visits within the 36 wk followup|4|||
30977726|NCT01401452|59070412|FG000|Overall Study|Subject did not come to follow up visits|2|||
30977727|NCT01401452|59070412|FG000|Overall Study|Subject didn't return for routine visits|1|||
30977728|NCT01401452|59070412|FG000|Overall Study|Subject moved to another city|1|||
30977729|NCT01401452|59070412|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
30977730|NCT01401452|59070412|FG000|Overall Study|Psoriatic arthritis|1|||
30977731|NCT01401452|59070412|FG000|Overall Study|Participant stopped Tx|2|||
30977732|NCT01401452|59070412|FG000|Overall Study|Discontinuation for personal reasons|1|||
30977733|NCT01401452|59070412|FG000|Overall Study|Treatment failure|1|||
30977734|NCT01401452|59070412|FG000|Overall Study|Unsatisfactory output|1|||
30977735|NCT01401452|59070412|FG000|Overall Study|Subject withdrew because of Tx success|1|||
30977736|NCT01401452|59070412|FG000|Overall Study|Subject chose to discontinue treatment|1|||
30977737|NCT01401452|59070412|FG000|Overall Study|Participant withdrew consent|1|||
30977738|NCT01401062|59070447|FG000|Overall Study|Death|9|||
30977739|NCT01401062|59070448|FG001|Overall Study|Death|7|||
30977740|NCT01401062|59070447|FG000|Overall Study|Physician Decision|1|||
30977741|NCT01401062|59070448|FG001|Overall Study|Physician Decision|0|||
30977742|NCT01401062|59070447|FG000|Overall Study|Withdrawal by Subject|1|||
30977743|NCT01401062|59070448|FG001|Overall Study|Withdrawal by Subject|1|||
30977744|NCT01400516|59070481|FG000|Primary Trial|Withdrawal by Subject|0|||
30977745|NCT01400516|59070482|FG001|Primary Trial|Withdrawal by Subject|2|||
30977746|NCT01383356|59070488|FG000|Period 1|Adverse Event|5|||
30977747|NCT01383356|59070489|FG001|Period 1|Adverse Event|3|||
30977748|NCT01383356|59070488|FG000|Period 1|Non-compliance|3|||
30977749|NCT01383356|59070489|FG001|Period 1|Non-compliance|0|||
30977750|NCT01383356|59070488|FG000|Period 1|Out of Range Mid-study-Test|0|||
30977751|NCT01383356|59070489|FG001|Period 1|Out of Range Mid-study-Test|1|||
30977752|NCT01383356|59070488|FG000|Period 1|Personal|0|||
30977753|NCT01383356|59070489|FG001|Period 1|Personal|2|||
30977754|NCT05740098|59070515|FG000|Overall Study|Lost to Follow-up|26|||
30977755|NCT05740098|59070516|FG001|Overall Study|Lost to Follow-up|17|||
30977756|NCT05740098|59070517|FG002|Overall Study|Lost to Follow-up|21|||
30977757|NCT05299359|59070528|FG000|Overall Study|Ongoing in Study|149|||
30977758|NCT05299359|59070528|FG000|Overall Study|Other|1|||
30890714|NCT03052725|58923711|FG000|Overall Study|Study terminated by sponsor|143|||
30890715|NCT03052725|58923712|FG001|Overall Study|Study terminated by sponsor|144|||
30890716|NCT02775435|58923719|FG000|Overall Study|Adverse Event|48|||
30890717|NCT02775435|58923720|FG001|Overall Study|Adverse Event|25|||
30890718|NCT02775435|58923719|FG000|Overall Study|Lost to Follow-up|0|||
30890719|NCT02775435|58923720|FG001|Overall Study|Lost to Follow-up|2|||
30890720|NCT02775435|58923719|FG000|Overall Study|Physician Decision|5|||
30890721|NCT02775435|58923720|FG001|Overall Study|Physician Decision|6|||
30890722|NCT02775435|58923719|FG000|Overall Study|Withdrawal by Subject|5|||
30890723|NCT02775435|58923720|FG001|Overall Study|Withdrawal by Subject|9|||
30890724|NCT02775435|58923719|FG000|Overall Study|Progressive Disease|86|||
30890725|NCT02775435|58923720|FG001|Overall Study|Progressive Disease|140|||
30890726|NCT02775435|58923719|FG000|Overall Study|Clinical Progression|13|||
30890727|NCT02775435|58923720|FG001|Overall Study|Clinical Progression|26|||
30890728|NCT02775435|58923719|FG000|Overall Study|Ongoing in Study|121|||
30890729|NCT02775435|58923720|FG001|Overall Study|Ongoing in Study|72|||
30890730|NCT02775435|58923719|FG000|Overall Study|Not Treated|0|||
30890731|NCT02775435|58923720|FG001|Overall Study|Not Treated|1|||
30890732|NCT01635153|58923745|FG000|Overall Study|Lost to Follow-up|40|||
30890733|NCT01635153|58923746|FG001|Overall Study|Lost to Follow-up|43|||
30890734|NCT01636713|58923755|FG000|Overall Study|Adverse Event|16|||
30890735|NCT01636713|58923756|FG001|Overall Study|Adverse Event|16|||
30890736|NCT01636713|58923757|FG002|Overall Study|Adverse Event|7|||
30890737|NCT01636713|58923755|FG000|Overall Study|Lack of Efficacy|6|||
30890738|NCT01636713|58923756|FG001|Overall Study|Lack of Efficacy|6|||
30890739|NCT01636713|58923757|FG002|Overall Study|Lack of Efficacy|2|||
30890740|NCT01636713|58923755|FG000|Overall Study|Protocol Violation|3|||
30890741|NCT01636713|58923756|FG001|Overall Study|Protocol Violation|0|||
30890742|NCT01636713|58923757|FG002|Overall Study|Protocol Violation|1|||
30890743|NCT01636713|58923755|FG000|Overall Study|Lost to Follow-up|0|||
30890744|NCT01636713|58923756|FG001|Overall Study|Lost to Follow-up|0|||
30890745|NCT01636713|58923757|FG002|Overall Study|Lost to Follow-up|1|||
30890746|NCT01636713|58923755|FG000|Overall Study|Withdrawal by Subject|5|||
30890747|NCT01636713|58923756|FG001|Overall Study|Withdrawal by Subject|4|||
30890748|NCT01636713|58923757|FG002|Overall Study|Withdrawal by Subject|8|||
30890749|NCT01636713|58923755|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
30890750|NCT01636713|58923756|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
30890751|NCT01636713|58923757|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
30890752|NCT01600053|58923765|FG000|Overall Study|Adverse Event|2|||
30890753|NCT01600053|58923765|FG000|Overall Study|trial will not meet the interim endpoint|9|||
30890754|NCT01068249|58923769|FG000|Overall Study|Death|1|||
30890755|NCT01068249|58923769|FG000|Overall Study|Withdrawal by Subject|3|||
30890756|NCT02246673|58923788|FG000|Overall Study|Sponsor Decision|1|||
30890757|NCT02246673|58923789|FG001|Overall Study|Sponsor Decision|0|||
30890758|NCT02246673|58923790|FG002|Overall Study|Sponsor Decision|0|||
30890759|NCT02246673|58923791|FG003|Overall Study|Sponsor Decision|0|||
30890760|NCT02246673|58923792|FG004|Overall Study|Sponsor Decision|0|||
30890761|NCT02246673|58923788|FG000|Overall Study|Withdrawal by Subject|0|||
30890762|NCT02246673|58923789|FG001|Overall Study|Withdrawal by Subject|0|||
30890763|NCT02246673|58923790|FG002|Overall Study|Withdrawal by Subject|0|||
30890764|NCT02246673|58923791|FG003|Overall Study|Withdrawal by Subject|0|||
30890765|NCT02246673|58923792|FG004|Overall Study|Withdrawal by Subject|1|||
30890766|NCT02246673|58923788|FG000|Overall Study|Lost to Follow-up|0|||
30890767|NCT02246673|58923789|FG001|Overall Study|Lost to Follow-up|0|||
30890768|NCT02246673|58923790|FG002|Overall Study|Lost to Follow-up|0|||
30890769|NCT02246673|58923791|FG003|Overall Study|Lost to Follow-up|1|||
30977759|NCT05059080|59070534|FG000|Overall Study|Withdrawal by Subject|3|||
30977760|NCT05059080|59070534|FG000|Overall Study|Study Terminated by Sponsor|64|||
30977761|NCT05012163|59070542|FG000|Overall Study|Protocol Violation|0|||
30890770|NCT02246673|58923792|FG004|Overall Study|Lost to Follow-up|0|||
30890771|NCT02246673|58923788|FG000|Overall Study|Protocol Violation|0|||
30890772|NCT02246673|58923789|FG001|Overall Study|Protocol Violation|0|||
30977762|NCT05012163|59070543|FG001|Overall Study|Protocol Violation|0|||
30890773|NCT02246673|58923790|FG002|Overall Study|Protocol Violation|0|||
30890774|NCT02246673|58923791|FG003|Overall Study|Protocol Violation|1|||
30890775|NCT02246673|58923792|FG004|Overall Study|Protocol Violation|0|||
30890776|NCT02246439|58923854|FG000|Overall Study|Adverse Event|3|||
30890777|NCT02246439|58923855|FG001|Overall Study|Adverse Event|0|||
30977763|NCT05012163|59070544|FG002|Overall Study|Protocol Violation|1|||
30977764|NCT05012163|59070545|FG003|Overall Study|Protocol Violation|1|||
30977765|NCT05009251|59070560|FG000|Overall Study|Protocol Violation|100|||
30977766|NCT05009251|59070561|FG001|Overall Study|Protocol Violation|105|||
30977767|NCT05009251|59070562|FG002|Overall Study|Protocol Violation|119|||
30977768|NCT05009251|59070563|FG003|Overall Study|Protocol Violation|120|||
30977769|NCT05009251|59070564|FG004|Overall Study|Protocol Violation|119|||
30977770|NCT05009251|59070560|FG000|Overall Study|Death|25|||
30977771|NCT05009251|59070561|FG001|Overall Study|Death|22|||
30977772|NCT05009251|59070562|FG002|Overall Study|Death|24|||
30977773|NCT05009251|59070563|FG003|Overall Study|Death|19|||
30977774|NCT05009251|59070564|FG004|Overall Study|Death|15|||
30977775|NCT04839692|59070578|FG000|Overall Study|Withdrawal by Subject|0|||
30977776|NCT04839692|59070579|FG001|Overall Study|Withdrawal by Subject|3|||
30977777|NCT04839692|59070578|FG000|Overall Study|Physician Decision|1|||
30977778|NCT04839692|59070579|FG001|Overall Study|Physician Decision|0|||
30977779|NCT04476017|59070607|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
30977780|NCT04476017|59070608|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
30977781|NCT04422639|59070617|FG000|Overall Study|Death|1|||
30977782|NCT04422639|59070618|FG001|Overall Study|Death|0|||
30977783|NCT04422639|59070617|FG000|Overall Study|study closed prior to completion of FU visits|0|||
30977784|NCT04422639|59070618|FG001|Overall Study|study closed prior to completion of FU visits|2|||
30977785|NCT04384107|59070626|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
30977786|NCT04384107|59070627|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
30977787|NCT04384107|59070626|FG000|Overall Study|Lost to Follow-up|1|||
30977788|NCT04384107|59070627|FG001|Overall Study|Lost to Follow-up|0|||
30977789|NCT04275089|59070633|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
30977790|NCT04096326|59070668|FG000|Overall Study|Withdrawal by Subject|0|||
30977791|NCT04096326|59070669|FG001|Overall Study|Withdrawal by Subject|0|||
30977792|NCT04096326|59070670|FG002|Overall Study|Withdrawal by Subject|0|||
30977793|NCT04096326|59070671|FG003|Overall Study|Withdrawal by Subject|0|||
30977794|NCT04096326|59070672|FG004|Overall Study|Withdrawal by Subject|0|||
30977795|NCT04096326|59070673|FG005|Overall Study|Withdrawal by Subject|0|||
30977796|NCT04096326|59070674|FG006|Overall Study|Withdrawal by Subject|1|||
30977797|NCT04096326|59070675|FG007|Overall Study|Withdrawal by Subject|0|||
30977798|NCT04096326|59070676|FG008|Overall Study|Withdrawal by Subject|0|||
30977799|NCT04096326|59070677|FG009|Overall Study|Withdrawal by Subject|0|||
30977800|NCT04096326|59070668|FG000|Overall Study|Lost to Follow-up|0|||
30977801|NCT04096326|59070669|FG001|Overall Study|Lost to Follow-up|1|||
30977802|NCT04096326|59070670|FG002|Overall Study|Lost to Follow-up|0|||
30977803|NCT04096326|59070671|FG003|Overall Study|Lost to Follow-up|0|||
30977804|NCT04096326|59070672|FG004|Overall Study|Lost to Follow-up|0|||
30977805|NCT04096326|59070673|FG005|Overall Study|Lost to Follow-up|0|||
30977806|NCT04096326|59070674|FG006|Overall Study|Lost to Follow-up|0|||
30977807|NCT04096326|59070675|FG007|Overall Study|Lost to Follow-up|0|||
30977808|NCT04096326|59070676|FG008|Overall Study|Lost to Follow-up|0|||
30977809|NCT04096326|59070677|FG009|Overall Study|Lost to Follow-up|0|||
30977810|NCT04096326|59070668|FG000|Overall Study|COVID-19-related reasons|0|||
30977811|NCT04096326|59070669|FG001|Overall Study|COVID-19-related reasons|0|||
30977812|NCT04096326|59070670|FG002|Overall Study|COVID-19-related reasons|0|||
30977813|NCT04096326|59070671|FG003|Overall Study|COVID-19-related reasons|0|||
30977814|NCT04096326|59070672|FG004|Overall Study|COVID-19-related reasons|1|||
30977815|NCT04096326|59070673|FG005|Overall Study|COVID-19-related reasons|5|||
30977816|NCT04096326|59070674|FG006|Overall Study|COVID-19-related reasons|0|||
30977817|NCT04096326|59070675|FG007|Overall Study|COVID-19-related reasons|0|||
30977818|NCT04096326|59070676|FG008|Overall Study|COVID-19-related reasons|0|||
30977819|NCT04096326|59070677|FG009|Overall Study|COVID-19-related reasons|0|||
30977820|NCT04072822|59070701|FG000|Treatment|Adverse Event|9|||
30977821|NCT04072822|59070702|FG001|Treatment|Adverse Event|5|||
30977822|NCT04072822|59070701|FG000|Treatment|Met Stopping Criteria|13|||
30977823|NCT04072822|59070702|FG001|Treatment|Met Stopping Criteria|24|||
30977824|NCT04072822|59070701|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
30977825|NCT04072822|59070702|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
30977826|NCT04072822|59070701|FG000|Treatment|Withdrawal by Subject|0|||
30977827|NCT04072822|59070702|FG001|Treatment|Withdrawal by Subject|2|||
30977828|NCT04072822|59070701|FG000|Treatment|Death|0|||
30977829|NCT04072822|59070702|FG001|Treatment|Death|2|||
30977830|NCT04072822|59070701|FG000|Treatment|Lost to Follow-up|11|||
30977831|NCT04072822|59070702|FG001|Treatment|Lost to Follow-up|3|||
30977832|NCT04072822|59070701|FG000|Treatment|Physician Decision|1|||
30977833|NCT04072822|59070702|FG001|Treatment|Physician Decision|0|||
30977834|NCT04072822|59070701|FG000|Treatment|Other|7|||
30977835|NCT04072822|59070702|FG001|Treatment|Other|9|||
30977836|NCT04072822|59070701|FG000|Follow-up|Withdrawal by Subject|1|||
30977837|NCT04072822|59070702|FG001|Follow-up|Withdrawal by Subject|0|||
30977838|NCT04072822|59070701|FG000|Follow-up|Lost to Follow-up|5|||
30977839|NCT04072822|59070702|FG001|Follow-up|Lost to Follow-up|4|||
30977840|NCT04031846|59070710|FG000|Overall Study|Lost to Follow-up|4|||
30977841|NCT04031846|59070711|FG001|Overall Study|Lost to Follow-up|4|||
30977842|NCT04031846|59070710|FG000|Overall Study|Physician Decision|0|||
30977843|NCT04031846|59070711|FG001|Overall Study|Physician Decision|1|||
30977844|NCT04031846|59070710|FG000|Overall Study|Protocol Violation|1|||
30977845|NCT04031846|59070711|FG001|Overall Study|Protocol Violation|1|||
30977846|NCT04031846|59070710|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
30977847|NCT04031846|59070711|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
30977848|NCT03893448|59070720|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
30977849|NCT03893448|59070721|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
30977850|NCT03893448|59070720|FG000|Overall Study|Physician Decision|8|||
30977851|NCT03893448|59070721|FG001|Overall Study|Physician Decision|14|||
30977852|NCT03893448|59070720|FG000|Overall Study|Lost to Follow-up|34|||
30977853|NCT03893448|59070721|FG001|Overall Study|Lost to Follow-up|27|||
30977854|NCT03893448|59070720|FG000|Overall Study|Death|1|||
30977855|NCT03893448|59070721|FG001|Overall Study|Death|0|||
30977856|NCT03692871|59070744|FG000|Overall Study|Death|1|||
30977857|NCT03692871|59070745|FG001|Overall Study|Death|1|||
30977858|NCT03692871|59070744|FG000|Overall Study|Lost to Follow-up|24|||
30977859|NCT03692871|59070745|FG001|Overall Study|Lost to Follow-up|9|||
30977860|NCT03692871|59070744|FG000|Overall Study|Physician Decision|22|||
30977861|NCT03692871|59070745|FG001|Overall Study|Physician Decision|7|||
30977862|NCT03692871|59070744|FG000|Overall Study|Protocol Deviation|1|||
30977863|NCT03692871|59070745|FG001|Overall Study|Protocol Deviation|0|||
30977864|NCT03692871|59070744|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
30977865|NCT03692871|59070745|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
30977866|NCT03565900|59070770|FG000|Overall Study|Disposition Unknown|4|||
30977867|NCT03565900|59070771|FG001|Overall Study|Disposition Unknown|1|||
30977868|NCT03565900|59070770|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
30977869|NCT03565900|59070771|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
30977870|NCT03565900|59070770|FG000|Overall Study|Withdrawal by Subject|4|||
30977871|NCT03565900|59070771|FG001|Overall Study|Withdrawal by Subject|5|||
30977872|NCT03565900|59070770|FG000|Overall Study|Randomized By Mistake|0|||
30977873|NCT03565900|59070771|FG001|Overall Study|Randomized By Mistake|2|||
30977874|NCT03565900|59070770|FG000|Overall Study|Physician Decision|7|||
30977875|NCT03565900|59070771|FG001|Overall Study|Physician Decision|11|||
30977876|NCT03565900|59070770|FG000|Overall Study|Death|9|||
30977877|NCT03565900|59070771|FG001|Overall Study|Death|7|||
30977878|NCT03443869|59070810|FG000|Overall Study|Death|3|||
30977879|NCT03443869|59070811|FG001|Overall Study|Death|3|||
30977880|NCT03443869|59070810|FG000|Overall Study|Withdrawal by Subject|34|||
30977881|NCT03443869|59070811|FG001|Overall Study|Withdrawal by Subject|22|||
30977882|NCT03443869|59070810|FG000|Overall Study|Lost to Follow-up|1|||
30977883|NCT03443869|59070811|FG001|Overall Study|Lost to Follow-up|2|||
30977884|NCT03443869|59070810|FG000|Overall Study|Physician Decision|3|||
30977885|NCT03443869|59070811|FG001|Overall Study|Physician Decision|3|||
30977886|NCT03443869|59070810|FG000|Overall Study|Other|4|||
30890778|NCT02246439|58923854|FG000|Overall Study|Lost to Follow-up|7|||
30977887|NCT03443869|59070811|FG001|Overall Study|Other|4|||
30977888|NCT03260140|59070819|FG000|Overall Study|Death|4|||
30977889|NCT03260140|59070820|FG001|Overall Study|Death|1|||
30977890|NCT03260140|59070819|FG000|Overall Study|Withdrawal by Subject|1|||
30977891|NCT03260140|59070820|FG001|Overall Study|Withdrawal by Subject|4|||
30977892|NCT03253796|59070831|FG000|Period 1: Run-In|Adverse Event|4|||
30977893|NCT03253796|59070832|FG001|Period 1: Run-In|Adverse Event|0|||
30977894|NCT03253796|59070833|FG002|Period 1: Run-In|Adverse Event|0|||
30977895|NCT03253796|59070834|FG003|Period 1: Run-In|Adverse Event|0|||
30890779|NCT02246439|58923855|FG001|Overall Study|Lost to Follow-up|5|||
30890780|NCT02246439|58923854|FG000|Overall Study|Protocol Violation|0|||
30890781|NCT02246439|58923855|FG001|Overall Study|Protocol Violation|2|||
30890782|NCT02246439|58923854|FG000|Overall Study|Physician Decision|0|||
30890783|NCT02246439|58923855|FG001|Overall Study|Physician Decision|1|||
30890784|NCT02246439|58923854|FG000|Overall Study|Unkonwn|1|||
30890785|NCT02246439|58923855|FG001|Overall Study|Unkonwn|3|||
30890786|NCT02246439|58923854|FG000|Overall Study|Withdrawal by Subject|1|||
30977896|NCT03253796|59070835|FG004|Period 1: Run-In|Adverse Event|0|||
30977897|NCT03253796|59070831|FG000|Period 1: Run-In|Lack of Efficacy|1|||
30977898|NCT03253796|59070832|FG001|Period 1: Run-In|Lack of Efficacy|0|||
30977899|NCT03253796|59070833|FG002|Period 1: Run-In|Lack of Efficacy|0|||
30977900|NCT03253796|59070834|FG003|Period 1: Run-In|Lack of Efficacy|0|||
30977901|NCT03253796|59070835|FG004|Period 1: Run-In|Lack of Efficacy|0|||
30977902|NCT03253796|59070831|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
30977903|NCT03253796|59070832|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
30977904|NCT03253796|59070833|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
30977905|NCT03253796|59070834|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
30977906|NCT03253796|59070835|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
30977907|NCT03253796|59070831|FG000|Period 1: Run-In|Protocol Violation|5|||
30977908|NCT03253796|59070832|FG001|Period 1: Run-In|Protocol Violation|0|||
30890787|NCT02246439|58923855|FG001|Overall Study|Withdrawal by Subject|0|||
30890788|NCT02245737|58923864|FG000|Overall Study|Adverse Event|23|||
30890789|NCT02245737|58923865|FG001|Overall Study|Adverse Event|26|||
30977909|NCT03253796|59070833|FG002|Period 1: Run-In|Protocol Violation|0|||
30977910|NCT03253796|59070834|FG003|Period 1: Run-In|Protocol Violation|0|||
30977911|NCT03253796|59070835|FG004|Period 1: Run-In|Protocol Violation|0|||
30977912|NCT03253796|59070831|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
30977913|NCT03253796|59070832|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
30977914|NCT03253796|59070833|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
30977915|NCT03253796|59070834|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
30977916|NCT03253796|59070835|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
30977917|NCT03253796|59070831|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
30977918|NCT03253796|59070832|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
30977919|NCT03253796|59070833|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
30977920|NCT03253796|59070834|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
30977921|NCT03253796|59070835|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
30977922|NCT03253796|59070831|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
30977923|NCT03253796|59070832|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
30977924|NCT03253796|59070833|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
30977925|NCT03253796|59070834|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
30977926|NCT03253796|59070835|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
30977927|NCT03253796|59070831|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
30977928|NCT03253796|59070832|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
30977929|NCT03253796|59070833|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
30977930|NCT03253796|59070834|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
30977931|NCT03253796|59070835|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
30977932|NCT03253796|59070831|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
30977933|NCT03253796|59070832|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
30977934|NCT03253796|59070833|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
30977935|NCT03253796|59070834|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
30977936|NCT03253796|59070835|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
30977937|NCT03253796|59070831|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
30977938|NCT03253796|59070832|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
30977939|NCT03253796|59070833|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
30977940|NCT03253796|59070834|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
30977941|NCT03253796|59070835|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
30977942|NCT03253796|59070831|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
30977943|NCT03253796|59070832|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
30977944|NCT03253796|59070833|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
30977945|NCT03253796|59070834|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
30977946|NCT03253796|59070835|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
30977947|NCT03073733|59070853|FG000|Overall Study|Lost to Follow-up|1|||
30977948|NCT03073733|59070854|FG001|Overall Study|Lost to Follow-up|0|||
30977949|NCT03073733|59070855|FG002|Overall Study|Lost to Follow-up|0|||
30977950|NCT03073733|59070853|FG000|Overall Study|Physician Decision|0|||
30977951|NCT03073733|59070854|FG001|Overall Study|Physician Decision|1|||
30977952|NCT03073733|59070855|FG002|Overall Study|Physician Decision|0|||
30977953|NCT03073733|59070853|FG000|Overall Study|Withdrawal by Subject|0|||
30977954|NCT03073733|59070854|FG001|Overall Study|Withdrawal by Subject|0|||
30977955|NCT03073733|59070855|FG002|Overall Study|Withdrawal by Subject|1|||
30977956|NCT03029143|59070865|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
30977957|NCT03029143|59070866|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
30977958|NCT03029143|59070867|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
30977959|NCT03029143|59070865|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
30977960|NCT03029143|59070866|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
30977961|NCT03029143|59070867|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
30977962|NCT03029143|59070865|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
30977963|NCT03029143|59070866|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
30977964|NCT03029143|59070867|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
30977965|NCT03029143|59070865|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
30977966|NCT03029143|59070866|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
30977967|NCT03029143|59070867|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
30977968|NCT03029143|59070865|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
30790185|NCT00044213|58803370|FG000|Overall Study|Lost to Follow-up|8|||
30977969|NCT03029143|59070866|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
30977970|NCT03029143|59070867|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
30977971|NCT03029143|59070865|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
30977972|NCT03029143|59070866|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
30977973|NCT03029143|59070867|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
30977974|NCT03029143|59070865|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
30977975|NCT03029143|59070866|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
30977976|NCT03029143|59070867|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
30977977|NCT03029143|59070865|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30977978|NCT03029143|59070866|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
30977979|NCT03029143|59070867|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
30977980|NCT03029143|59070865|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
30977981|NCT03029143|59070866|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
30977982|NCT03029143|59070867|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
30977983|NCT03029143|59070865|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
30977984|NCT03029143|59070866|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
30977985|NCT03029143|59070867|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
30977986|NCT03029143|59070865|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
30977987|NCT03029143|59070866|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
30977988|NCT03029143|59070867|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
30977989|NCT02971137|59070878|FG000|Overall Study|Lost to Follow-up|44|||
30977990|NCT02971137|59070879|FG001|Overall Study|Lost to Follow-up|56|||
30977991|NCT02953262|59070889|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
30977992|NCT02953262|59070890|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
30977993|NCT02953262|59070891|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
30977994|NCT02953262|59070892|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
30977995|NCT02763579|59070908|FG000|Global Period|Death|167|||
30977996|NCT02763579|59070909|FG001|Global Period|Death|151|||
30977997|NCT02763579|59070910|FG002|Global Period|Death|0|||
30977998|NCT02763579|59070911|FG003|Global Period|Death|0|||
30977999|NCT02763579|59070908|FG000|Global Period|Lost to Follow-up|2|||
30978000|NCT02763579|59070909|FG001|Global Period|Lost to Follow-up|4|||
30978001|NCT02763579|59070910|FG002|Global Period|Lost to Follow-up|0|||
30978002|NCT02763579|59070911|FG003|Global Period|Lost to Follow-up|0|||
30978003|NCT02763579|59070908|FG000|Global Period|Physician Decision|0|||
30978004|NCT02763579|59070909|FG001|Global Period|Physician Decision|2|||
30978005|NCT02763579|59070910|FG002|Global Period|Physician Decision|0|||
30978006|NCT02763579|59070911|FG003|Global Period|Physician Decision|0|||
30978007|NCT02763579|59070908|FG000|Global Period|Study Terminated By Sponsor|21|||
30978008|NCT02763579|59070909|FG001|Global Period|Study Terminated By Sponsor|26|||
30978009|NCT02763579|59070910|FG002|Global Period|Study Terminated By Sponsor|0|||
30978010|NCT02763579|59070911|FG003|Global Period|Study Terminated By Sponsor|0|||
30978011|NCT02763579|59070908|FG000|Global Period|Withdrawal by Subject|12|||
30978012|NCT02763579|59070909|FG001|Global Period|Withdrawal by Subject|18|||
30978013|NCT02763579|59070910|FG002|Global Period|Withdrawal by Subject|0|||
30978014|NCT02763579|59070911|FG003|Global Period|Withdrawal by Subject|0|||
30978015|NCT02763579|59070908|FG000|China Period|Death|0|||
30978016|NCT02763579|59070909|FG001|China Period|Death|0|||
30978017|NCT02763579|59070910|FG002|China Period|Death|46|||
30978018|NCT02763579|59070911|FG003|China Period|Death|48|||
30978019|NCT02763579|59070908|FG000|China Period|Lost to Follow-up|0|||
30978020|NCT02763579|59070909|FG001|China Period|Lost to Follow-up|0|||
30978021|NCT02763579|59070910|FG002|China Period|Lost to Follow-up|1|||
30978022|NCT02763579|59070911|FG003|China Period|Lost to Follow-up|1|||
30978023|NCT02763579|59070908|FG000|China Period|Physician Decision|0|||
30978024|NCT02763579|59070909|FG001|China Period|Physician Decision|0|||
30978025|NCT02763579|59070910|FG002|China Period|Physician Decision|0|||
30978026|NCT02763579|59070911|FG003|China Period|Physician Decision|1|||
30978027|NCT02763579|59070908|FG000|China Period|Study Terminated By Sponsor|0|||
30978028|NCT02763579|59070909|FG001|China Period|Study Terminated By Sponsor|0|||
30978029|NCT02763579|59070910|FG002|China Period|Study Terminated By Sponsor|3|||
30978030|NCT02763579|59070911|FG003|China Period|Study Terminated By Sponsor|4|||
30978031|NCT02763579|59070908|FG000|China Period|Withdrawal by Subject|0|||
30978032|NCT02763579|59070909|FG001|China Period|Withdrawal by Subject|0|||
30978033|NCT02763579|59070910|FG002|China Period|Withdrawal by Subject|3|||
30978034|NCT02763579|59070911|FG003|China Period|Withdrawal by Subject|3|||
30978035|NCT02623699|59070955|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
30978036|NCT02623699|59070956|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
30978037|NCT02623699|59070957|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
30978038|NCT02623699|59070958|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
30978039|NCT02623699|59070959|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
30978040|NCT02623699|59070960|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
30978041|NCT02623699|59070961|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
30978042|NCT02623699|59070962|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
30790186|NCT00044213|58803371|FG001|Overall Study|Lost to Follow-up|5|||
30978043|NCT02623699|59070963|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
30978044|NCT02623699|59070964|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
30978045|NCT02623699|59070965|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
30978046|NCT02623699|59070966|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
30978047|NCT02623699|59070955|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
30978048|NCT02623699|59070956|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
30978049|NCT02623699|59070957|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
30978050|NCT02623699|59070958|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
30978051|NCT02623699|59070959|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
30978052|NCT02623699|59070960|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
30978053|NCT02623699|59070961|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
30978054|NCT02623699|59070962|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
30978055|NCT02623699|59070963|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
30978056|NCT02623699|59070964|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
30978057|NCT02623699|59070965|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
30978058|NCT02623699|59070966|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
30978059|NCT02623699|59070955|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
30978060|NCT02623699|59070956|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
30978061|NCT02623699|59070957|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
30978062|NCT02623699|59070958|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
30978063|NCT02623699|59070959|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
30978064|NCT02623699|59070960|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
30978065|NCT02623699|59070961|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
30978066|NCT02623699|59070962|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
30978067|NCT02623699|59070963|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
30978068|NCT02623699|59070964|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
30978069|NCT02623699|59070965|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
30978070|NCT02623699|59070966|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
30978071|NCT02623699|59070955|FG000|Part B (Up to 289 Days)|Death|0|||
30978072|NCT02623699|59070956|FG001|Part B (Up to 289 Days)|Death|0|||
30978073|NCT02623699|59070957|FG002|Part B (Up to 289 Days)|Death|0|||
30978074|NCT02623699|59070958|FG003|Part B (Up to 289 Days)|Death|0|||
30978075|NCT02623699|59070959|FG004|Part B (Up to 289 Days)|Death|0|||
30978076|NCT02623699|59070960|FG005|Part B (Up to 289 Days)|Death|1|||
30978077|NCT02623699|59070961|FG006|Part B (Up to 289 Days)|Death|1|||
30978078|NCT02623699|59070962|FG007|Part B (Up to 289 Days)|Death|0|||
30978079|NCT02623699|59070963|FG008|Part B (Up to 289 Days)|Death|1|||
30978080|NCT02623699|59070964|FG009|Part B (Up to 289 Days)|Death|0|||
30978081|NCT02623699|59070965|FG010|Part B (Up to 289 Days)|Death|0|||
30978082|NCT02623699|59070966|FG011|Part B (Up to 289 Days)|Death|0|||
30978083|NCT02623699|59070955|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
30978084|NCT02623699|59070956|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
30978085|NCT02623699|59070957|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
30978086|NCT02623699|59070958|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
30978087|NCT02623699|59070959|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
30978088|NCT02623699|59070960|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
30978089|NCT02623699|59070961|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
30978090|NCT02623699|59070962|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
30978091|NCT02623699|59070963|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
30978092|NCT02623699|59070964|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
30978093|NCT02623699|59070965|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
30978094|NCT02623699|59070966|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
30978095|NCT02623699|59070955|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
30978096|NCT02623699|59070956|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
30978097|NCT02623699|59070957|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
30978098|NCT02623699|59070958|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
30978099|NCT02623699|59070959|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
30978100|NCT02623699|59070960|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
30978101|NCT02623699|59070961|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
30978102|NCT02623699|59070962|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
30978103|NCT02623699|59070963|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
30978104|NCT02623699|59070964|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
30978105|NCT02623699|59070965|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
30978106|NCT02623699|59070966|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
30978107|NCT02623699|59070955|FG000|Part C (Up to 236 Days)|Death|0|||
30978108|NCT02623699|59070956|FG001|Part C (Up to 236 Days)|Death|0|||
30978109|NCT02623699|59070957|FG002|Part C (Up to 236 Days)|Death|0|||
30978110|NCT02623699|59070958|FG003|Part C (Up to 236 Days)|Death|0|||
30978111|NCT02623699|59070959|FG004|Part C (Up to 236 Days)|Death|0|||
30978112|NCT02623699|59070960|FG005|Part C (Up to 236 Days)|Death|0|||
30978113|NCT02623699|59070961|FG006|Part C (Up to 236 Days)|Death|0|||
30978114|NCT02623699|59070962|FG007|Part C (Up to 236 Days)|Death|0|||
30978115|NCT02623699|59070963|FG008|Part C (Up to 236 Days)|Death|0|||
30978116|NCT02623699|59070964|FG009|Part C (Up to 236 Days)|Death|0|||
30978117|NCT02623699|59070965|FG010|Part C (Up to 236 Days)|Death|0|||
30978118|NCT02623699|59070966|FG011|Part C (Up to 236 Days)|Death|1|||
30978119|NCT02623699|59070955|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
30978120|NCT02623699|59070956|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
30978121|NCT02623699|59070957|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
30978122|NCT02623699|59070958|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
30978123|NCT02623699|59070959|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
30978124|NCT02623699|59070960|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
30978125|NCT02623699|59070961|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
30978126|NCT02623699|59070962|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
30978127|NCT02623699|59070963|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
30978128|NCT02623699|59070964|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
30978129|NCT02623699|59070965|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
30978130|NCT02623699|59070966|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
30978131|NCT02550652|59071007|FG000|Overall Study|Death|1|||
30978132|NCT02550652|59071008|FG001|Overall Study|Death|4|||
30978133|NCT02550652|59071007|FG000|Overall Study|Lack of Efficacy|1|||
30978134|NCT02550652|59071008|FG001|Overall Study|Lack of Efficacy|0|||
30978135|NCT02550652|59071007|FG000|Overall Study|Withdrawal by Subject|3|||
30978136|NCT02550652|59071008|FG001|Overall Study|Withdrawal by Subject|7|||
30978137|NCT02550652|59071007|FG000|Overall Study|Post Trial Access|1|||
30978138|NCT02550652|59071008|FG001|Overall Study|Post Trial Access|0|||
30978139|NCT02550652|59071007|FG000|Overall Study|Lost to Follow-up|1|||
30978140|NCT02550652|59071008|FG001|Overall Study|Lost to Follow-up|3|||
30978141|NCT02550652|59071007|FG000|Overall Study|Physician Decision|0|||
30978142|NCT02550652|59071008|FG001|Overall Study|Physician Decision|2|||
30978143|NCT02550652|59071007|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14|||
30978144|NCT02550652|59071008|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5|||
30978145|NCT02501642|59071016|FG000|Overall Study|Lost to Follow-up|7|||
30978146|NCT02501642|59071017|FG001|Overall Study|Lost to Follow-up|11|||
30978147|NCT02475954|59071025|FG000|Overall Study|Withdrawal by Subject|2|||
30978148|NCT02475954|59071026|FG001|Overall Study|Withdrawal by Subject|2|||
30978149|NCT02475954|59071025|FG000|Overall Study|Lost to Follow-up|11|||
30978150|NCT02475954|59071026|FG001|Overall Study|Lost to Follow-up|9|||
30978151|NCT02475954|59071025|FG000|Overall Study|Death|1|||
30978152|NCT02475954|59071026|FG001|Overall Study|Death|1|||
30978153|NCT02459587|59071035|FG000|3-Month Follow-up Assessment|Death|0|||
30978154|NCT02459587|59071036|FG001|3-Month Follow-up Assessment|Death|2|||
30978155|NCT02459587|59071035|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
30978156|NCT02459587|59071036|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
30978157|NCT02459587|59071035|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
30978158|NCT02459587|59071036|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
30978159|NCT02459587|59071035|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
30978160|NCT02459587|59071036|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
30978161|NCT02459587|59071035|FG000|6-month Follow-up Assessment|Death|2|||
30978162|NCT02459587|59071036|FG001|6-month Follow-up Assessment|Death|1|||
30978163|NCT02459587|59071035|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
30978164|NCT02459587|59071036|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
30978165|NCT02459587|59071035|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
30978166|NCT02459587|59071036|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
30978167|NCT02459587|59071035|FG000|12-month Follow-up Assessment|Death|2|||
30978168|NCT02459587|59071036|FG001|12-month Follow-up Assessment|Death|0|||
30978169|NCT02459587|59071035|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
30978170|NCT02459587|59071036|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
30978171|NCT02459587|59071035|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
30978172|NCT02459587|59071036|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
30978173|NCT02459587|59071035|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
30978174|NCT02459587|59071036|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
30978175|NCT02281084|59071047|FG000|Overall Study|Adverse Event|1|||
30978176|NCT02281084|59071048|FG001|Overall Study|Adverse Event|0|||
30978177|NCT02281084|59071049|FG002|Overall Study|Adverse Event|0|||
30978178|NCT02281084|59071050|FG003|Overall Study|Adverse Event|0|||
30978179|NCT02281084|59071047|FG000|Overall Study|Withdrawal by Subject|1|||
30978180|NCT02281084|59071048|FG001|Overall Study|Withdrawal by Subject|2|||
30890790|NCT02245737|58923866|FG002|Overall Study|Adverse Event|33|||
30890791|NCT02245737|58923864|FG000|Overall Study|Condition Worsened|9|||
30890792|NCT02245737|58923865|FG001|Overall Study|Condition Worsened|10|||
30890793|NCT02245737|58923866|FG002|Overall Study|Condition Worsened|9|||
30890794|NCT02245737|58923864|FG000|Overall Study|Death|2|||
30890795|NCT02245737|58923865|FG001|Overall Study|Death|4|||
30890796|NCT02245737|58923866|FG002|Overall Study|Death|4|||
30890797|NCT02245737|58923864|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
30890798|NCT02245737|58923865|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
30978181|NCT02281084|59071049|FG002|Overall Study|Withdrawal by Subject|0|||
30978182|NCT02281084|59071050|FG003|Overall Study|Withdrawal by Subject|0|||
30978183|NCT02281084|59071047|FG000|Overall Study|Death|20|||
30978184|NCT02281084|59071048|FG001|Overall Study|Death|16|||
30890799|NCT02245737|58923866|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
30890800|NCT02245737|58923864|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
30978185|NCT02281084|59071049|FG002|Overall Study|Death|3|||
30978186|NCT02281084|59071050|FG003|Overall Study|Death|5|||
30978187|NCT02281084|59071047|FG000|Overall Study|Physician Decision|0|||
30978188|NCT02281084|59071048|FG001|Overall Study|Physician Decision|0|||
30978189|NCT02281084|59071049|FG002|Overall Study|Physician Decision|1|||
30978190|NCT02281084|59071050|FG003|Overall Study|Physician Decision|0|||
30978191|NCT01966120|59071071|FG000|Overall Study|Withdrawal by Subject|0|||
30978192|NCT01966120|59071072|FG001|Overall Study|Withdrawal by Subject|5|||
30978193|NCT01966120|59071071|FG000|Overall Study|Lost to Follow-up|1|||
30978194|NCT01966120|59071072|FG001|Overall Study|Lost to Follow-up|1|||
30978195|NCT01101438|59071089|FG000|Overall Study|Withdrawal by Subject|8|||
30978196|NCT01101438|59071090|FG001|Overall Study|Withdrawal by Subject|9|||
30978197|NCT01399736|59071128|FG000|Overall Study|Withdrawal by Subject|4|||
30978198|NCT01399736|59071129|FG001|Overall Study|Withdrawal by Subject|2|||
30978199|NCT01399736|59071128|FG000|Overall Study|Lost to Follow-up|0|||
30978200|NCT01399736|59071129|FG001|Overall Study|Lost to Follow-up|2|||
30978201|NCT04372927|59071259|FG000|Overall Study|Death|1|||
30978202|NCT01381874|59071266|FG000|Overall Study|Lost to Follow-up|1|||
30978203|NCT01381874|59071267|FG001|Overall Study|Lost to Follow-up|1|||
30978204|NCT01381874|59071268|FG002|Overall Study|Lost to Follow-up|0|||
30978205|NCT01381874|59071266|FG000|Overall Study|Withdrawal by Subject|9|||
30978206|NCT01381874|59071267|FG001|Overall Study|Withdrawal by Subject|10|||
30978207|NCT01381874|59071268|FG002|Overall Study|Withdrawal by Subject|9|||
30978208|NCT01381874|59071266|FG000|Overall Study|Other|67|||
30978209|NCT01381874|59071267|FG001|Overall Study|Other|52|||
30978210|NCT01381874|59071268|FG002|Overall Study|Other|67|||
30978211|NCT01399190|59071276|FG000|Overall Study|Not Eligible for Final Analysis|5|||
30978212|NCT01399190|59071276|FG000|Overall Study|Adverse Event|8|||
30978213|NCT01399190|59071276|FG000|Overall Study|Participant's Request|5|||
30978214|NCT01399190|59071276|FG000|Overall Study|Physician Decision|2|||
30978215|NCT01381718|59071294|FG000|Overall Study|Withdrawal by Subject|2|||
30978216|NCT01381718|59071295|FG001|Overall Study|Withdrawal by Subject|5|||
30978217|NCT01381718|59071294|FG000|Overall Study|Lost to Follow-up|3|||
30978218|NCT01381718|59071295|FG001|Overall Study|Lost to Follow-up|5|||
30978219|NCT01381718|59071294|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
30978220|NCT01381718|59071295|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
30978221|NCT01398956|59071314|FG000|Overall Study|Withdrawal by Subject|4|||
30978222|NCT01398956|59071314|FG000|Overall Study|AE, non-serious non-fatal|4|||
30978223|NCT01398956|59071314|FG000|Overall Study|Withdrawal Criteria No.3|1|||
30978224|NCT01398956|59071314|FG000|Overall Study|Subject moved a long distance|1|||
30978225|NCT01381562|59071340|FG000|Overall Study|Adverse Event|0|||
30978226|NCT01381562|59071341|FG001|Overall Study|Adverse Event|1|||
30978227|NCT01381562|59071342|FG002|Overall Study|Adverse Event|0|||
30978228|NCT01381016|59071365|FG000|Overall Study|Lost to Follow-up|1|||
30978229|NCT01381016|59071366|FG001|Overall Study|Lost to Follow-up|1|||
30978230|NCT01381016|59071365|FG000|Overall Study|Screen Failure|2|||
30978231|NCT01381016|59071366|FG001|Overall Study|Screen Failure|2|||
30978232|NCT01381016|59071365|FG000|Overall Study|Withdrawal by Subject|0|||
30978233|NCT01381016|59071366|FG001|Overall Study|Withdrawal by Subject|1|||
30978234|NCT01381016|59071365|FG000|Overall Study|Physician Decision|0|||
30978235|NCT01381016|59071366|FG001|Overall Study|Physician Decision|2|||
30978236|NCT01398410|59071393|FG000|Overall Study|Adverse Event|12|||
30978237|NCT01398410|59071394|FG001|Overall Study|Adverse Event|16|||
30978238|NCT01398410|59071393|FG000|Overall Study|Participants Choice|8|||
30978239|NCT01398410|59071394|FG001|Overall Study|Participants Choice|11|||
30978240|NCT01398410|59071393|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
30978241|NCT01398410|59071394|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
30978242|NCT01398410|59071393|FG000|Overall Study|Other|36|||
30978243|NCT01398410|59071394|FG001|Overall Study|Other|29|||
30978244|NCT01380782|59071460|FG000|Overall Study|Adverse Event|0|||
30978245|NCT01380782|59071461|FG001|Overall Study|Adverse Event|1|||
30978246|NCT01380782|59071462|FG002|Overall Study|Adverse Event|0|||
30978247|NCT01380782|59071463|FG003|Overall Study|Adverse Event|0|||
30978248|NCT01380782|59071460|FG000|Overall Study|Death|1|||
30978249|NCT01380782|59071461|FG001|Overall Study|Death|0|||
30978250|NCT01380782|59071462|FG002|Overall Study|Death|0|||
30978251|NCT01380782|59071463|FG003|Overall Study|Death|0|||
30978252|NCT01380782|59071460|FG000|Overall Study|Lack of Efficacy|10|||
30978253|NCT01380782|59071461|FG001|Overall Study|Lack of Efficacy|9|||
30790187|NCT00044213|58803372|FG002|Overall Study|Lost to Follow-up|5|||
30978254|NCT01380782|59071462|FG002|Overall Study|Lack of Efficacy|10|||
30978255|NCT01380782|59071463|FG003|Overall Study|Lack of Efficacy|3|||
30978256|NCT01380782|59071460|FG000|Overall Study|Physician Decision|1|||
30978257|NCT01380782|59071461|FG001|Overall Study|Physician Decision|0|||
30978258|NCT01380782|59071462|FG002|Overall Study|Physician Decision|0|||
30978259|NCT01380782|59071463|FG003|Overall Study|Physician Decision|0|||
30978260|NCT01380782|59071460|FG000|Overall Study|Withdrawal by Subject|0|||
30978261|NCT01380782|59071461|FG001|Overall Study|Withdrawal by Subject|0|||
30978262|NCT01380782|59071462|FG002|Overall Study|Withdrawal by Subject|1|||
30978263|NCT01380782|59071463|FG003|Overall Study|Withdrawal by Subject|1|||
30978264|NCT01398176|59071477|FG000|Overall Study|Lost to Follow-up|1|||
30978265|NCT01398176|59071478|FG001|Overall Study|Lost to Follow-up|3|||
30978266|NCT01398176|59071477|FG000|Overall Study|Physician Decision|2|||
30978267|NCT01398176|59071478|FG001|Overall Study|Physician Decision|3|||
30978268|NCT01397786|59071531|FG000|Phase A|Lost to Follow-up|0|||
30978269|NCT01397786|59071532|FG001|Phase A|Lost to Follow-up|0|||
30978270|NCT01397786|59071533|FG002|Phase A|Lost to Follow-up|6|||
30978271|NCT01397786|59071531|FG000|Phase A|Adverse Event|0|||
30978272|NCT01397786|59071532|FG001|Phase A|Adverse Event|0|||
30978273|NCT01397786|59071533|FG002|Phase A|Adverse Event|8|||
30978274|NCT01397786|59071531|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
30978275|NCT01397786|59071532|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
30978276|NCT01397786|59071533|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
30978277|NCT01397786|59071531|FG000|Phase A|Physician Decision|0|||
30978278|NCT01397786|59071532|FG001|Phase A|Physician Decision|0|||
30978279|NCT01397786|59071533|FG002|Phase A|Physician Decision|1|||
30978280|NCT01397786|59071531|FG000|Phase A|Withdrawal by Subject|0|||
30978281|NCT01397786|59071532|FG001|Phase A|Withdrawal by Subject|0|||
30978282|NCT01397786|59071533|FG002|Phase A|Withdrawal by Subject|5|||
30978283|NCT01397786|59071531|FG000|Phase A|Lack of Efficacy|0|||
30978284|NCT01397786|59071532|FG001|Phase A|Lack of Efficacy|0|||
30978285|NCT01397786|59071533|FG002|Phase A|Lack of Efficacy|1|||
30978286|NCT01397786|59071531|FG000|Phase B|Lost to Follow-up|22|||
30978287|NCT01397786|59071532|FG001|Phase B|Lost to Follow-up|12|||
30978288|NCT01397786|59071533|FG002|Phase B|Lost to Follow-up|22|||
30978289|NCT01397786|59071531|FG000|Phase B|Adverse Event|109|||
30978290|NCT01397786|59071532|FG001|Phase B|Adverse Event|23|||
30978291|NCT01397786|59071533|FG002|Phase B|Adverse Event|27|||
30978292|NCT01397786|59071531|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
30978293|NCT01397786|59071532|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
30978294|NCT01397786|59071533|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
30978295|NCT01397786|59071531|FG000|Phase B|Physician Decision|9|||
30978296|NCT01397786|59071532|FG001|Phase B|Physician Decision|1|||
30978297|NCT01397786|59071533|FG002|Phase B|Physician Decision|3|||
30978298|NCT01397786|59071531|FG000|Phase B|Withdrawal by Subject|102|||
30978299|NCT01397786|59071532|FG001|Phase B|Withdrawal by Subject|45|||
30978300|NCT01397786|59071533|FG002|Phase B|Withdrawal by Subject|30|||
30978301|NCT01397786|59071531|FG000|Phase B|Protocol Deviation|1|||
30978302|NCT01397786|59071532|FG001|Phase B|Protocol Deviation|2|||
30978303|NCT01397786|59071533|FG002|Phase B|Protocol Deviation|4|||
30978304|NCT01397786|59071531|FG000|Phase B|Lack of Efficacy|22|||
30978305|NCT01397786|59071532|FG001|Phase B|Lack of Efficacy|7|||
30978306|NCT01397786|59071533|FG002|Phase B|Lack of Efficacy|14|||
30978307|NCT01397552|59071583|FG000|Overall Study|Adverse Event|1|||
30978308|NCT01397552|59071584|FG001|Overall Study|Adverse Event|0|||
30978309|NCT01397552|59071583|FG000|Overall Study|Withdrawal by Subject|2|||
30978310|NCT01397552|59071584|FG001|Overall Study|Withdrawal by Subject|1|||
30978311|NCT01397162|59071604|FG000|Overall Study|Adverse Event|4|||
30978312|NCT01397162|59071605|FG001|Overall Study|Adverse Event|0|||
30978313|NCT01397162|59071606|FG002|Overall Study|Adverse Event|0|||
30978314|NCT01397162|59071607|FG003|Overall Study|Adverse Event|0|||
30978315|NCT01397162|59071608|FG004|Overall Study|Adverse Event|0|||
30978316|NCT01397162|59071604|FG000|Overall Study|Not yet defined|3|||
30978317|NCT01397162|59071605|FG001|Overall Study|Not yet defined|4|||
30978318|NCT01397162|59071606|FG002|Overall Study|Not yet defined|3|||
30978319|NCT01397162|59071607|FG003|Overall Study|Not yet defined|5|||
30978320|NCT01397162|59071608|FG004|Overall Study|Not yet defined|3|||
30978321|NCT01397084|59071641|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
30978322|NCT01397084|59071641|FG000|Overall Study|Protocol Violation|2|||
30978323|NCT01397084|59071641|FG000|Overall Study|Adverse Event|2|||
30978324|NCT01397084|59071641|FG000|Overall Study|Withdrawal by Subject|1|||
30978325|NCT01397084|59071641|FG000|Overall Study|Lost to Follow-up|1|||
30978326|NCT01397084|59071641|FG000|Overall Study|Used other proton pump inhibitor|1|||
30978327|NCT01396148|59071681|FG000|Overall Study|Patient Decision|1|||
30978328|NCT01396070|59071714|FG000|Overall Study|Withdrawal by Subject|2|||
30978329|NCT01396070|59071714|FG000|Overall Study|Death|2|||
30978330|NCT01396070|59071714|FG000|Overall Study|Adverse Event|8|||
30978331|NCT01396070|59071714|FG000|Overall Study|Physician Decision|3|||
30978332|NCT01396070|59071714|FG000|Overall Study|Lack of Efficacy|4|||
30978333|NCT01395914|59071731|FG000|Overall Study|Unrelated to study drug AE|6|||
30978334|NCT01395914|59071732|FG001|Overall Study|Unrelated to study drug AE|1|||
30978335|NCT01395914|59071731|FG000|Overall Study|Death|23|||
30978336|NCT01395914|59071732|FG001|Overall Study|Death|17|||
30978337|NCT01395914|59071731|FG000|Overall Study|Other|9|||
30978338|NCT01395914|59071732|FG001|Overall Study|Other|3|||
30978339|NCT01395914|59071731|FG000|Overall Study|Withdrawal by patient|27|||
30978340|NCT01395914|59071732|FG001|Overall Study|Withdrawal by patient|14|||
30978341|NCT01395914|59071731|FG000|Overall Study|Study drug-related AE|1|||
30978342|NCT01395914|59071732|FG001|Overall Study|Study drug-related AE|0|||
30978343|NCT01395914|59071731|FG000|Overall Study|Lost to Follow-up|6|||
30978344|NCT01395914|59071732|FG001|Overall Study|Lost to Follow-up|2|||
30978345|NCT01395758|59071994|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
30978346|NCT01395758|59071995|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
30978347|NCT01395758|59071996|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
30978348|NCT01395524|59072050|FG000|Overall Study|Non-compliance with study schedule|1|||
30978349|NCT01395524|59072051|FG001|Overall Study|Non-compliance with study schedule|0|||
30978350|NCT01395524|59072052|FG002|Overall Study|Non-compliance with study schedule|1|||
30978351|NCT01395524|59072050|FG000|Overall Study|Lost to Follow-up|3|||
30978352|NCT01395524|59072051|FG001|Overall Study|Lost to Follow-up|1|||
30978353|NCT01395524|59072052|FG002|Overall Study|Lost to Follow-up|1|||
30978354|NCT01395524|59072050|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
30978355|NCT01395524|59072051|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
30978356|NCT01395524|59072052|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
30978357|NCT01395524|59072050|FG000|Overall Study|Severe noncompliance with protocol|1|||
30978358|NCT01395524|59072051|FG001|Overall Study|Severe noncompliance with protocol|0|||
30978359|NCT01395524|59072052|FG002|Overall Study|Severe noncompliance with protocol|0|||
30978360|NCT01395524|59072050|FG000|Overall Study|Adverse Event|4|||
30978361|NCT01395524|59072051|FG001|Overall Study|Adverse Event|4|||
30978362|NCT01395524|59072052|FG002|Overall Study|Adverse Event|3|||
30978363|NCT01395524|59072050|FG000|Overall Study|Death|1|||
30978364|NCT01395524|59072051|FG001|Overall Study|Death|0|||
30978365|NCT01395524|59072052|FG002|Overall Study|Death|0|||
30978366|NCT01395524|59072050|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
30978367|NCT01395524|59072051|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
30978368|NCT01395524|59072052|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
30978369|NCT01395524|59072050|FG000|Overall Study|Withdrawal by Subject|4|||
30978370|NCT01395524|59072051|FG001|Overall Study|Withdrawal by Subject|8|||
30978371|NCT01395524|59072052|FG002|Overall Study|Withdrawal by Subject|8|||
30978372|NCT01395524|59072050|FG000|Overall Study|Did not receive treatment|1|||
30978373|NCT01395524|59072051|FG001|Overall Study|Did not receive treatment|1|||
30978374|NCT01395524|59072052|FG002|Overall Study|Did not receive treatment|3|||
30978375|NCT01395524|59072050|FG000|Overall Study|Subject had spinal surgery|0|||
30978376|NCT01395524|59072051|FG001|Overall Study|Subject had spinal surgery|0|||
30978377|NCT01395524|59072052|FG002|Overall Study|Subject had spinal surgery|1|||
30978378|NCT01395368|59072060|FG000|Overall Study|Physician Decision|14|||
30978379|NCT01395368|59072060|FG000|Overall Study|Withdrawal by Subject|2|||
30978380|NCT01394978|59072067|FG000|Overall Study|Withdrawal by Subject|2|||
30978381|NCT01394978|59072068|FG001|Overall Study|Withdrawal by Subject|4|||
30978382|NCT01394978|59072067|FG000|Overall Study|Lost to Follow-up|13|||
30978383|NCT01394978|59072068|FG001|Overall Study|Lost to Follow-up|20|||
30978384|NCT01394978|59072067|FG000|Overall Study|Death|6|||
30978385|NCT01394978|59072068|FG001|Overall Study|Death|7|||
30978386|NCT01394276|59072075|FG000|Overall Study|Related Adverse event (AEs)|15|||
30978387|NCT01394276|59072075|FG000|Overall Study|Not related AEs|9|||
30978388|NCT01394276|59072075|FG000|Overall Study|Remission of disease|2|||
30978389|NCT01394276|59072075|FG000|Overall Study|Insufficient therapeutic effect|17|||
30978390|NCT01394276|59072075|FG000|Overall Study|Insufficient compliance|9|||
30978391|NCT01394276|59072075|FG000|Overall Study|Lost to Follow-up|5|||
30978392|NCT01394276|59072075|FG000|Overall Study|Participant moved to another site|1|||
30978393|NCT01394276|59072075|FG000|Overall Study|Pregnancy|1|||
30978394|NCT01394276|59072075|FG000|Overall Study|unavailability of drug at the Hospital|2|||
30978395|NCT01394276|59072075|FG000|Overall Study|Symptoms of concurrent diseases|1|||
30978396|NCT00211172|59072175|FG000|Overall Study|Died or lost health plan eligibility|39|||
30978397|NCT00211172|59072176|FG001|Overall Study|Died or lost health plan eligibility|32|||
30978398|NCT00210626|59072227|FG000|Overall Study|Adverse Event|1|||
30978399|NCT00210626|59072228|FG001|Overall Study|Adverse Event|2|||
30978400|NCT00210626|59072227|FG000|Overall Study|Protocol Violation|1|||
30978401|NCT00210626|59072228|FG001|Overall Study|Protocol Violation|5|||
30978402|NCT00210626|59072227|FG000|Overall Study|Lost to Follow-up|11|||
30978403|NCT00210626|59072228|FG001|Overall Study|Lost to Follow-up|11|||
30978404|NCT00210626|59072227|FG000|Overall Study|Death|1|||
30978405|NCT00210626|59072228|FG001|Overall Study|Death|0|||
30978406|NCT00210626|59072227|FG000|Overall Study|Withdrawal by Subject|29|||
30978407|NCT00210626|59072228|FG001|Overall Study|Withdrawal by Subject|20|||
30978408|NCT00210626|59072227|FG000|Overall Study|Physician Decision|0|||
30978409|NCT00210626|59072228|FG001|Overall Study|Physician Decision|2|||
30608464|NCT01288430|58619223|FG002|Part 2|Adverse Event|0|||
30978410|NCT00210626|59072227|FG000|Overall Study|Sponser Request|1|||
30978411|NCT00210626|59072228|FG001|Overall Study|Sponser Request|0|||
30978412|NCT00210626|59072227|FG000|Overall Study|Other|4|||
30978413|NCT00210626|59072228|FG001|Overall Study|Other|5|||
30978414|NCT00217022|59072250|FG000|Overall Study|Withdrawal by Subject|1|||
30978415|NCT00217022|59072251|FG001|Overall Study|Withdrawal by Subject|1|||
30978416|NCT00219284|59072598|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
30978417|NCT00219284|59072599|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
30978418|NCT00219284|59072598|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
30978419|NCT00219284|59072599|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
30978420|NCT00219284|59072598|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
30978421|NCT00219284|59072599|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
30978422|NCT00219284|59072598|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
30978423|NCT00219284|59072599|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
30978424|NCT00219284|59072598|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
30978425|NCT00219284|59072599|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
30978426|NCT00219284|59072598|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
30978427|NCT00219284|59072599|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
30978428|NCT00219284|59072598|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
30978429|NCT00219284|59072599|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
30978430|NCT00219284|59072598|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
30978431|NCT00219284|59072599|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
30978432|NCT00219284|59072598|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
30978433|NCT00219284|59072599|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
30978434|NCT00216476|59072738|FG000|Overall Study|Withdrawal by Subject|59|||
30978435|NCT00216476|59072739|FG001|Overall Study|Withdrawal by Subject|72|||
30978436|NCT00216476|59072740|FG002|Overall Study|Withdrawal by Subject|9|||
30978437|NCT00216476|59072738|FG000|Overall Study|Lost to Follow-up|10|||
30978438|NCT00216476|59072739|FG001|Overall Study|Lost to Follow-up|9|||
30978439|NCT00216476|59072740|FG002|Overall Study|Lost to Follow-up|1|||
30978440|NCT00216476|59072738|FG000|Overall Study|Adverse Event|6|||
30978441|NCT00216476|59072739|FG001|Overall Study|Adverse Event|10|||
30978442|NCT00216476|59072740|FG002|Overall Study|Adverse Event|1|||
30978443|NCT00216476|59072738|FG000|Overall Study|Lack of Efficacy|4|||
30978444|NCT00216476|59072739|FG001|Overall Study|Lack of Efficacy|3|||
30978445|NCT00216476|59072740|FG002|Overall Study|Lack of Efficacy|0|||
30890801|NCT02245737|58923865|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
30890802|NCT02245737|58923866|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
30890803|NCT02245737|58923864|FG000|Overall Study|Lost to Follow-up|2|||
30890804|NCT02245737|58923865|FG001|Overall Study|Lost to Follow-up|5|||
30890805|NCT02245737|58923866|FG002|Overall Study|Lost to Follow-up|4|||
30890806|NCT02245737|58923864|FG000|Overall Study|Other-determined by Investigator|9|||
30890807|NCT02245737|58923865|FG001|Overall Study|Other-determined by Investigator|10|||
30890808|NCT02245737|58923866|FG002|Overall Study|Other-determined by Investigator|10|||
30890809|NCT02245737|58923864|FG000|Overall Study|Physician Decision|6|||
30890810|NCT02245737|58923865|FG001|Overall Study|Physician Decision|3|||
30890811|NCT02245737|58923866|FG002|Overall Study|Physician Decision|6|||
30890812|NCT02245737|58923864|FG000|Overall Study|Protocol Violation|3|||
30890813|NCT02245737|58923865|FG001|Overall Study|Protocol Violation|2|||
30890814|NCT02245737|58923866|FG002|Overall Study|Protocol Violation|3|||
30890815|NCT02245737|58923864|FG000|Overall Study|Withdrawal by Subject|40|||
30890816|NCT02245737|58923865|FG001|Overall Study|Withdrawal by Subject|41|||
30890817|NCT02245737|58923866|FG002|Overall Study|Withdrawal by Subject|44|||
30890818|NCT02245737|58923864|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
30890819|NCT02245737|58923865|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
30890820|NCT02245737|58923866|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
30890821|NCT02245737|58923864|FG000|Overall Study|Sponsor Decision|445|||
30890822|NCT02245737|58923865|FG001|Overall Study|Sponsor Decision|430|||
30890823|NCT02245737|58923866|FG002|Overall Study|Sponsor Decision|432|||
30890824|NCT02244957|58923878|FG000|Overall Study|Lack of Efficacy|1|||
30890825|NCT02244957|58923879|FG001|Overall Study|Lack of Efficacy|0|||
30890826|NCT02243865|58923889|FG000|Overall Study|Protocol Violation|1|||
30890827|NCT02243865|58923890|FG001|Overall Study|Protocol Violation|3|||
30890828|NCT02243865|58923889|FG000|Overall Study|Lost to Follow-up|1|||
30890829|NCT02243865|58923890|FG001|Overall Study|Lost to Follow-up|1|||
30890830|NCT02243865|58923889|FG000|Overall Study|Withdrawal by Subject|1|||
30890831|NCT02243865|58923890|FG001|Overall Study|Withdrawal by Subject|0|||
30890832|NCT02243865|58923889|FG000|Overall Study|Adverse Event|1|||
30890833|NCT02243865|58923890|FG001|Overall Study|Adverse Event|1|||
30890834|NCT02243631|58923900|FG000|Overall Study|no synovial fluid on second aspirate|0|||
30978446|NCT00216476|59072738|FG000|Overall Study|Death|2|||
30890835|NCT02243631|58923901|FG001|Overall Study|no synovial fluid on second aspirate|1|||
30890836|NCT02242305|58923909|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
30890837|NCT02242305|58923910|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
30890838|NCT02242305|58923909|FG000|Overall Study|Adverse Event|1|||
30978447|NCT00216476|59072739|FG001|Overall Study|Death|0|||
30978448|NCT00216476|59072740|FG002|Overall Study|Death|0|||
30978449|NCT00216476|59072738|FG000|Overall Study|Pregnancy|0|||
30978450|NCT00216476|59072739|FG001|Overall Study|Pregnancy|1|||
30978451|NCT00216476|59072740|FG002|Overall Study|Pregnancy|1|||
30978452|NCT00216476|59072738|FG000|Overall Study|Other|0|||
30978453|NCT00216476|59072739|FG001|Overall Study|Other|0|||
30978454|NCT00216476|59072740|FG002|Overall Study|Other|1|||
30978455|NCT00216476|59072738|FG000|Overall Study|Refuses Injection|11|||
30978456|NCT00216476|59072739|FG001|Overall Study|Refuses Injection|0|||
30978457|NCT00216476|59072740|FG002|Overall Study|Refuses Injection|0|||
30978458|NCT00216476|59072738|FG000|Overall Study|No Further Need for Treatment|3|||
30978459|NCT00216476|59072739|FG001|Overall Study|No Further Need for Treatment|4|||
30978460|NCT00216476|59072740|FG002|Overall Study|No Further Need for Treatment|1|||
30978461|NCT00216476|59072738|FG000|Overall Study|Non-compliance|0|||
30978462|NCT00216476|59072739|FG001|Overall Study|Non-compliance|4|||
30978463|NCT00216476|59072740|FG002|Overall Study|Non-compliance|1|||
30978464|NCT00216476|59072738|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
30978465|NCT00216476|59072739|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
30978466|NCT00216476|59072740|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
30978467|NCT00216476|59072738|FG000|Overall Study|Administrative Reasons|1|||
30978468|NCT00216476|59072739|FG001|Overall Study|Administrative Reasons|1|||
30978469|NCT00216476|59072740|FG002|Overall Study|Administrative Reasons|0|||
30978470|NCT00216476|59072738|FG000|Overall Study|Protocol Deviation|5|||
30978471|NCT00216476|59072739|FG001|Overall Study|Protocol Deviation|1|||
30978472|NCT00216476|59072740|FG002|Overall Study|Protocol Deviation|0|||
30978473|NCT00216476|59072738|FG000|Overall Study|Patient Moved|2|||
30978474|NCT00216476|59072739|FG001|Overall Study|Patient Moved|2|||
30978475|NCT00216476|59072740|FG002|Overall Study|Patient Moved|0|||
30978476|NCT00216086|59072791|FG000|Overall Study|Protocol Violation|1|||
30978477|NCT00216086|59072791|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
30978478|NCT00216086|59072791|FG000|Overall Study|Social Reasons|2|||
30978479|NCT00215150|59072822|FG000|Open Label Phase|Lost to Follow-up|7|||
30978480|NCT00215150|59072822|FG000|Open Label Phase|Withdrawal by Subject|1|||
30978481|NCT00215150|59072822|FG000|Open Label Phase|Did not complete a post base visit|13|||
30978482|NCT00215150|59072822|FG000|Open Label Phase|Did not meet randomization criteria|9|||
30978483|NCT00215150|59072822|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
30978484|NCT00215150|59072822|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
30978485|NCT00215150|59072822|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
30978486|NCT00214136|59072830|FG000|Overall Study|Death|5|||
30978487|NCT00213980|59072836|FG000|Overall Study|Withdrawal by Subject|3|||
30978488|NCT00213980|59072837|FG001|Overall Study|Withdrawal by Subject|1|||
30978489|NCT00213980|59072836|FG000|Overall Study|Adverse Event|1|||
30978490|NCT00213980|59072837|FG001|Overall Study|Adverse Event|1|||
30978491|NCT00213980|59072836|FG000|Overall Study|Disease progression|0|||
30978492|NCT00213980|59072837|FG001|Overall Study|Disease progression|2|||
30978493|NCT00213980|59072836|FG000|Overall Study|Developed ovarian cancer|1|||
30978494|NCT00213980|59072837|FG001|Overall Study|Developed ovarian cancer|0|||
30978495|NCT00213980|59072836|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
30978496|NCT00213980|59072837|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
30978497|NCT04388527|59073277|FG000|Overall Study|Death|14|||
30978498|NCT04388527|59073277|FG000|Overall Study|Withdrawal by Subject|2|||
30978499|NCT04388527|59073277|FG000|Overall Study|Lost to Follow-up|1|||
30978500|NCT04149002|59073529|FG000|Overall Study|Lost to Follow-up|1|||
30978501|NCT04149002|59073530|FG001|Overall Study|Lost to Follow-up|0|||
30978502|NCT04149002|59073529|FG000|Overall Study|Withdrawal by Subject|1|||
30978503|NCT04149002|59073530|FG001|Overall Study|Withdrawal by Subject|0|||
30978504|NCT00555321|59073604|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
30978505|NCT00555321|59073605|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
30978506|NCT00555321|59073606|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
30978507|NCT00555321|59073607|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
30978508|NCT00555321|59073608|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
30978509|NCT00555321|59073604|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
30978510|NCT00555321|59073605|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
30978511|NCT00555321|59073606|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
30978512|NCT00555321|59073607|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
30978513|NCT00555321|59073608|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
30978514|NCT00555321|59073604|FG000|Treatment Phase up to 12-months|Death|2|||
30978515|NCT00555321|59073605|FG001|Treatment Phase up to 12-months|Death|1|||
30978516|NCT00555321|59073606|FG002|Treatment Phase up to 12-months|Death|4|||
30790188|NCT00044213|58803373|FG003|Overall Study|Lost to Follow-up|4|||
30978517|NCT00555321|59073607|FG003|Treatment Phase up to 12-months|Death|0|||
30978518|NCT00555321|59073608|FG004|Treatment Phase up to 12-months|Death|0|||
30978519|NCT00555321|59073604|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
30978520|NCT00555321|59073605|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
30978521|NCT00555321|59073606|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
30978522|NCT00555321|59073607|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
30978523|NCT00555321|59073608|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
30978524|NCT00555321|59073604|FG000|Treatment Phase up to 12-months|Other Reason|1|||
30978525|NCT00555321|59073605|FG001|Treatment Phase up to 12-months|Other Reason|3|||
30978526|NCT00555321|59073606|FG002|Treatment Phase up to 12-months|Other Reason|2|||
30978527|NCT00555321|59073607|FG003|Treatment Phase up to 12-months|Other Reason|0|||
30978528|NCT00555321|59073608|FG004|Treatment Phase up to 12-months|Other Reason|0|||
30978529|NCT00555321|59073604|FG000|Treatment Phase up to 12-months|Never treated|2|||
30978530|NCT00555321|59073605|FG001|Treatment Phase up to 12-months|Never treated|3|||
30978531|NCT00555321|59073606|FG002|Treatment Phase up to 12-months|Never treated|1|||
30978532|NCT00555321|59073607|FG003|Treatment Phase up to 12-months|Never treated|0|||
30978533|NCT00555321|59073608|FG004|Treatment Phase up to 12-months|Never treated|4|||
30978534|NCT00555321|59073604|FG000|Long-term Extension Phase|Adverse Event|2|||
30978535|NCT00555321|59073605|FG001|Long-term Extension Phase|Adverse Event|5|||
30978536|NCT00555321|59073606|FG002|Long-term Extension Phase|Adverse Event|2|||
30978537|NCT00555321|59073607|FG003|Long-term Extension Phase|Adverse Event|1|||
30978538|NCT00555321|59073608|FG004|Long-term Extension Phase|Adverse Event|0|||
30978539|NCT00555321|59073604|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
30978540|NCT00555321|59073605|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
30978541|NCT00555321|59073606|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
30978542|NCT00555321|59073607|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
30978543|NCT00555321|59073608|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
30978544|NCT00555321|59073604|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
30978545|NCT00555321|59073605|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
30978546|NCT00555321|59073606|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
30978547|NCT00555321|59073607|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
30978548|NCT00555321|59073608|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
30978549|NCT00555321|59073604|FG000|Long-term Extension Phase|Death|2|||
30978550|NCT00555321|59073605|FG001|Long-term Extension Phase|Death|0|||
30978551|NCT00555321|59073606|FG002|Long-term Extension Phase|Death|0|||
30978552|NCT00555321|59073607|FG003|Long-term Extension Phase|Death|3|||
30978553|NCT00555321|59073608|FG004|Long-term Extension Phase|Death|0|||
30978554|NCT00555321|59073604|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
30978555|NCT00555321|59073605|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
30978556|NCT00555321|59073606|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
30978557|NCT00555321|59073607|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
30978558|NCT00555321|59073608|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
30978559|NCT00555321|59073604|FG000|Long-term Extension Phase|Other Reason|1|||
30978560|NCT00555321|59073605|FG001|Long-term Extension Phase|Other Reason|0|||
30978561|NCT00555321|59073606|FG002|Long-term Extension Phase|Other Reason|2|||
30978562|NCT00555321|59073607|FG003|Long-term Extension Phase|Other Reason|0|||
30978563|NCT00555321|59073608|FG004|Long-term Extension Phase|Other Reason|0|||
30978564|NCT03589976|59074120|FG000|Overall Study|Death|5|||
30978565|NCT03589976|59074121|FG001|Overall Study|Death|1|||
30978566|NCT03589976|59074120|FG000|Overall Study|Adverse Event|5|||
30978567|NCT03589976|59074121|FG001|Overall Study|Adverse Event|1|||
30978568|NCT03589976|59074120|FG000|Overall Study|Withdrawal by Subject|4|||
30978569|NCT03589976|59074121|FG001|Overall Study|Withdrawal by Subject|1|||
30978570|NCT03589976|59074120|FG000|Overall Study|Lost to Follow-up|1|||
30978571|NCT03589976|59074121|FG001|Overall Study|Lost to Follow-up|0|||
30978572|NCT03589976|59074120|FG000|Overall Study|Other|4|||
30978573|NCT03589976|59074121|FG001|Overall Study|Other|3|||
30978574|NCT03029780|59074277|FG000|Overall Study|Disease Progression|20|||
30978575|NCT03029780|59074278|FG001|Overall Study|Disease Progression|22|||
30978576|NCT03029780|59074277|FG000|Overall Study|Study Drug Toxicity|15|||
30978577|NCT03029780|59074278|FG001|Overall Study|Study Drug Toxicity|11|||
30978578|NCT03029780|59074277|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
30978579|NCT03029780|59074278|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
30978580|NCT03029780|59074277|FG000|Overall Study|Participant request to discontinue study treatment|4|||
30978581|NCT03029780|59074278|FG001|Overall Study|Participant request to discontinue study treatment|1|||
30978582|NCT03029780|59074277|FG000|Overall Study|Maximum clinical benefit|1|||
30978583|NCT03029780|59074278|FG001|Overall Study|Maximum clinical benefit|0|||
30978584|NCT03029780|59074277|FG000|Overall Study|Participant no longer meets study criteria|0|||
30978585|NCT03029780|59074278|FG001|Overall Study|Participant no longer meets study criteria|1|||
30978586|NCT03029780|59074277|FG000|Overall Study|Other reasons|6|||
30978587|NCT03029780|59074278|FG001|Overall Study|Other reasons|6|||
30978588|NCT03029780|59074277|FG000|Overall Study|Not reported|1|||
30978589|NCT03029780|59074278|FG001|Overall Study|Not reported|1|||
30978590|NCT03029780|59074277|FG000|Overall Study|Death|2|||
30978591|NCT03029780|59074278|FG001|Overall Study|Death|6|||
30978592|NCT03029234|59074338|FG000|Overall Study|Sponsor Decision|1|||
30978593|NCT03029234|59074338|FG000|Overall Study|Withdrawal by Subject|5|||
30978594|NCT03029234|59074338|FG000|Overall Study|Death|91|||
30890839|NCT02242305|58923910|FG001|Overall Study|Adverse Event|0|||
30890840|NCT02242305|58923909|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
30890841|NCT02242305|58923910|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
30890842|NCT02242305|58923909|FG000|Overall Study|Subject withdraws inform consent|0|||
30890843|NCT02242305|58923910|FG001|Overall Study|Subject withdraws inform consent|4|||
30890844|NCT02242305|58923909|FG000|Overall Study|Lost to Follow-up|2|||
30890845|NCT02242305|58923910|FG001|Overall Study|Lost to Follow-up|0|||
30890846|NCT02240121|58923918|FG000|Overall Study|Protocol Violation|1|||
30890847|NCT02240121|58923919|FG001|Overall Study|Protocol Violation|2|||
30890848|NCT02240121|58923918|FG000|Overall Study|Physician Decision|0|||
30890849|NCT02240121|58923919|FG001|Overall Study|Physician Decision|1|||
30890850|NCT02240121|58923918|FG000|Overall Study|Change in protocol interpretation|1|||
30890851|NCT02240121|58923919|FG001|Overall Study|Change in protocol interpretation|0|||
30890852|NCT02240121|58923918|FG000|Overall Study|Lack of Efficacy|2|||
30890853|NCT02240121|58923919|FG001|Overall Study|Lack of Efficacy|3|||
30890854|NCT02240121|58923918|FG000|Overall Study|Site closed|1|||
30890855|NCT02240121|58923919|FG001|Overall Study|Site closed|1|||
30890856|NCT02240121|58923918|FG000|Overall Study|Pregnancy|1|||
30890857|NCT02240121|58923919|FG001|Overall Study|Pregnancy|0|||
30890858|NCT02240121|58923918|FG000|Overall Study|Adverse Event|2|||
30890859|NCT02240121|58923919|FG001|Overall Study|Adverse Event|4|||
30890860|NCT02240121|58923918|FG000|Overall Study|Withdrawal by Subject|6|||
30890861|NCT02240121|58923919|FG001|Overall Study|Withdrawal by Subject|2|||
30890862|NCT02240121|58923918|FG000|Overall Study|Lost to Follow-up|3|||
30890863|NCT02240121|58923919|FG001|Overall Study|Lost to Follow-up|4|||
30890864|NCT02240121|58923918|FG000|Overall Study|Other than specified|1|||
30890865|NCT02240121|58923919|FG001|Overall Study|Other than specified|3|||
30890866|NCT02239263|58923925|FG000|Overall Study|Protocol Violation|6|||
30890867|NCT02238483|58923933|FG000|Overall Study|Withdrawal by Subject|2|||
30890868|NCT02238483|58923934|FG001|Overall Study|Withdrawal by Subject|7|||
30890869|NCT02238483|58923933|FG000|Overall Study|Lost to Follow-up|1|||
30890870|NCT02238483|58923934|FG001|Overall Study|Lost to Follow-up|1|||
30890871|NCT02238483|58923933|FG000|Overall Study|Protocol Violation|1|||
30890872|NCT02238483|58923934|FG001|Overall Study|Protocol Violation|2|||
30890873|NCT02238483|58923933|FG000|Overall Study|Death|1|||
30890874|NCT02238483|58923934|FG001|Overall Study|Death|0|||
30890875|NCT02238483|58923933|FG000|Overall Study|Adverse Event|7|||
30890876|NCT02238483|58923934|FG001|Overall Study|Adverse Event|3|||
30890877|NCT02238483|58923933|FG000|Overall Study|Withdrawn due to physician decision|1|||
30890878|NCT02238483|58923934|FG001|Overall Study|Withdrawn due to physician decision|0|||
30890879|NCT02238483|58923933|FG000|Overall Study|Completion status not recorded|1|||
30890880|NCT02238483|58923934|FG001|Overall Study|Completion status not recorded|1|||
30890881|NCT02238483|58923933|FG000|Overall Study|Illness in family member|1|||
30890882|NCT02238483|58923934|FG001|Overall Study|Illness in family member|0|||
30890883|NCT01632891|58923942|FG000|Overall Study|Lost to Follow-up|0|||
30890884|NCT01632891|58923943|FG001|Overall Study|Lost to Follow-up|1|||
30890885|NCT01632891|58923942|FG000|Overall Study|Withdrawal by Subject|1|||
30890886|NCT01632891|58923943|FG001|Overall Study|Withdrawal by Subject|0|||
30890887|NCT02208999|58923955|FG000|Overall Study|Lost to Follow-up|1|||
30890888|NCT02208843|58923974|FG000|Overall Study|Clinical symptoms of progression|2|||
30890889|NCT02208843|58923974|FG000|Overall Study|Progression disease according to RECIST|24|||
30890890|NCT02208843|58923974|FG000|Overall Study|Adverse Event|12|||
30890891|NCT02208843|58923974|FG000|Overall Study|Protocol Violation|1|||
30890892|NCT02208843|58923974|FG000|Overall Study|Withdrawal by Subject|1|||
30890893|NCT02208843|58923974|FG000|Overall Study|Switched to commercial afatinib|20|||
30890894|NCT02208063|58923980|FG000|Overall Study|Death|3|||
30890895|NCT02208063|58923981|FG001|Overall Study|Death|5|||
30890896|NCT02208063|58923980|FG000|Overall Study|Not Specified in report|3|||
30890897|NCT02208063|58923981|FG001|Overall Study|Not Specified in report|4|||
30890898|NCT02208063|58923980|FG000|Overall Study|Withdrawal by Subject|5|||
30890899|NCT02208063|58923981|FG001|Overall Study|Withdrawal by Subject|2|||
30890900|NCT02208063|58923980|FG000|Overall Study|Lost to Follow-up|1|||
30890901|NCT02208063|58923981|FG001|Overall Study|Lost to Follow-up|0|||
30890902|NCT02207907|58923989|FG000|Overall Study|Lost to Follow-up|3|||
30890903|NCT02207907|58923990|FG001|Overall Study|Lost to Follow-up|1|||
30890904|NCT02207907|58923989|FG000|Overall Study|Withdrawal by Subject|5|||
30890905|NCT02207907|58923990|FG001|Overall Study|Withdrawal by Subject|6|||
30890906|NCT02207907|58923989|FG000|Overall Study|Did not meet study criteria|3|||
30890907|NCT02207907|58923990|FG001|Overall Study|Did not meet study criteria|0|||
30890908|NCT02207907|58923989|FG000|Overall Study|Pregnancy|0|||
30890909|NCT02207907|58923990|FG001|Overall Study|Pregnancy|1|||
30890910|NCT02207829|58923999|FG000|Overall Study|Adverse Event|10|||
30890911|NCT02207829|58924000|FG001|Overall Study|Adverse Event|9|||
30890912|NCT02207829|58923999|FG000|Overall Study|Lack of Efficacy|7|||
30890913|NCT02207829|58924000|FG001|Overall Study|Lack of Efficacy|5|||
30890914|NCT02207829|58923999|FG000|Overall Study|Lost to Follow-up|2|||
30890915|NCT02207829|58924000|FG001|Overall Study|Lost to Follow-up|2|||
30890916|NCT02207829|58923999|FG000|Overall Study|Protocol deviation|5|||
30978595|NCT03029234|59074338|FG000|Overall Study|Lost to Follow-up|2|||
30978596|NCT00557193|59074982|FG000|Induction|Adverse Event|2|||
30890917|NCT02207829|58924000|FG001|Overall Study|Protocol deviation|4|||
30890918|NCT02207829|58923999|FG000|Overall Study|Withdrew consent|18|||
30890919|NCT02207829|58924000|FG001|Overall Study|Withdrew consent|14|||
30890920|NCT02237157|58924006|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
30890921|NCT02237157|58924007|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
30890922|NCT02237157|58924008|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
30890923|NCT02237157|58924009|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
30890924|NCT02237157|58924006|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
30890925|NCT02237157|58924007|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
30890926|NCT02237157|58924008|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
30890927|NCT02237157|58924009|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
30890928|NCT02237001|58924016|FG000|Overall Study|Lost to Follow-up|2|||
30890929|NCT02237001|58924016|FG000|Overall Study|Withdrawal by Subject|1|||
30890930|NCT02237001|58924016|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
30890931|NCT02237001|58924016|FG000|Overall Study|Re-operation|4|||
30890932|NCT02237001|58924016|FG000|Overall Study|Incarceration|1|||
30890933|NCT02236611|58924022|FG000|Overall Study|Adverse Event|10|||
30890934|NCT02236611|58924023|FG001|Overall Study|Adverse Event|16|||
30890935|NCT02236611|58924022|FG000|Overall Study|Lack of Efficacy|4|||
30890936|NCT02236611|58924023|FG001|Overall Study|Lack of Efficacy|7|||
30890937|NCT02236611|58924022|FG000|Overall Study|Lost to Follow-up|0|||
30890938|NCT02236611|58924023|FG001|Overall Study|Lost to Follow-up|2|||
30890939|NCT02236611|58924022|FG000|Overall Study|Protocol deviation|3|||
30890940|NCT02236611|58924023|FG001|Overall Study|Protocol deviation|5|||
30890941|NCT02236611|58924022|FG000|Overall Study|Withdrew consent|9|||
30890942|NCT02236611|58924023|FG001|Overall Study|Withdrew consent|4|||
30890943|NCT02234583|58924031|FG000|Overall Study|Adverse Event|172|||
30890944|NCT02234583|58924032|FG001|Overall Study|Adverse Event|156|||
30890945|NCT02234583|58924031|FG000|Overall Study|Withdrawal by Subject|109|||
30890946|NCT02234583|58924032|FG001|Overall Study|Withdrawal by Subject|157|||
30890947|NCT02234583|58924031|FG000|Overall Study|Lost to Follow-up|0|||
30890948|NCT02234583|58924032|FG001|Overall Study|Lost to Follow-up|1|||
30890949|NCT02234583|58924031|FG000|Overall Study|Lack of Efficacy|58|||
30890950|NCT02234583|58924032|FG001|Overall Study|Lack of Efficacy|103|||
30890951|NCT02234583|58924031|FG000|Overall Study|Protocol Violation|35|||
30890952|NCT02234583|58924032|FG001|Overall Study|Protocol Violation|42|||
30890953|NCT02234583|58924031|FG000|Overall Study|Other|39|||
30890954|NCT02234583|58924032|FG001|Overall Study|Other|97|||
30890955|NCT03686397|58924046|FG000|Overall Study|Lack of Efficacy|3|||
30890956|NCT03686397|58924047|FG001|Overall Study|Lack of Efficacy|5|||
30890957|NCT03686397|58924046|FG000|Overall Study|Adverse Event|0|||
30890958|NCT03686397|58924047|FG001|Overall Study|Adverse Event|1|||
30890959|NCT03686397|58924046|FG000|Overall Study|Protocol Violation|0|||
30890960|NCT03686397|58924047|FG001|Overall Study|Protocol Violation|1|||
30890961|NCT03686397|58924046|FG000|Overall Study|Withdrawal by Subject|0|||
30890962|NCT03686397|58924047|FG001|Overall Study|Withdrawal by Subject|1|||
30890963|NCT03686397|58924046|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
30890964|NCT03686397|58924047|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
30890965|NCT02233803|58924053|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
30890966|NCT02233803|58924054|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
30890967|NCT02233803|58924053|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
30890968|NCT02233803|58924054|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
30890969|NCT02233803|58924053|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
30890970|NCT02233803|58924054|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
30890971|NCT02233803|58924053|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
30890972|NCT02233803|58924054|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
30890973|NCT02233803|58924053|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
30890974|NCT02233803|58924054|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
30890975|NCT02233803|58924053|FG000|Washout Period (4-Wks)|Physician Decision|1|||
30890976|NCT02233803|58924054|FG001|Washout Period (4-Wks)|Physician Decision|0|||
30890977|NCT02233803|58924053|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
30890978|NCT02233803|58924054|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
30890979|NCT02233803|58924053|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
30890980|NCT02233803|58924054|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
30890981|NCT02233803|58924053|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
30890982|NCT02233803|58924054|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
30978597|NCT00557193|59074983|FG001|Induction|Adverse Event|0|||
30890983|NCT02233647|58924062|FG000|Overall Study|Adverse Event|1|||
30890984|NCT02233413|58924068|FG000|Overall Study|Lost to Follow-up|7|||
30890985|NCT02233413|58924069|FG001|Overall Study|Lost to Follow-up|9|||
30890986|NCT02233413|58924068|FG000|Overall Study|Withdrawal by Subject|4|||
30978598|NCT00557193|59074984|FG002|Induction|Adverse Event|0|||
30890987|NCT02233413|58924069|FG001|Overall Study|Withdrawal by Subject|5|||
30978599|NCT00557193|59074985|FG003|Induction|Adverse Event|0|||
30978600|NCT00557193|59074986|FG004|Induction|Adverse Event|0|||
30978601|NCT00557193|59074987|FG005|Induction|Adverse Event|0|||
30978602|NCT00557193|59074982|FG000|Induction|Death|6|||
30978603|NCT00557193|59074983|FG001|Induction|Death|0|||
30978604|NCT00557193|59074984|FG002|Induction|Death|0|||
30978605|NCT00557193|59074985|FG003|Induction|Death|0|||
30978606|NCT00557193|59074986|FG004|Induction|Death|0|||
30978607|NCT00557193|59074987|FG005|Induction|Death|0|||
30978608|NCT00557193|59074982|FG000|Induction|Physician Decision|3|||
30978609|NCT00557193|59074983|FG001|Induction|Physician Decision|0|||
30978610|NCT00557193|59074984|FG002|Induction|Physician Decision|0|||
30978611|NCT00557193|59074985|FG003|Induction|Physician Decision|0|||
30978612|NCT00557193|59074986|FG004|Induction|Physician Decision|0|||
30978613|NCT00557193|59074987|FG005|Induction|Physician Decision|0|||
30978614|NCT00557193|59074982|FG000|Induction|Withdrawal by Subject|1|||
30978615|NCT00557193|59074983|FG001|Induction|Withdrawal by Subject|0|||
30978616|NCT00557193|59074984|FG002|Induction|Withdrawal by Subject|0|||
30978617|NCT00557193|59074985|FG003|Induction|Withdrawal by Subject|0|||
30978618|NCT00557193|59074986|FG004|Induction|Withdrawal by Subject|0|||
30978619|NCT00557193|59074987|FG005|Induction|Withdrawal by Subject|0|||
30978620|NCT00557193|59074982|FG000|Induction|Refusal of Further Protocol Therapy|2|||
30978621|NCT00557193|59074983|FG001|Induction|Refusal of Further Protocol Therapy|0|||
30978622|NCT00557193|59074984|FG002|Induction|Refusal of Further Protocol Therapy|0|||
30978623|NCT00557193|59074985|FG003|Induction|Refusal of Further Protocol Therapy|0|||
30978624|NCT00557193|59074986|FG004|Induction|Refusal of Further Protocol Therapy|0|||
30978625|NCT00557193|59074987|FG005|Induction|Refusal of Further Protocol Therapy|0|||
30978626|NCT00557193|59074982|FG000|Induction|Ineligible|8|||
30978627|NCT00557193|59074983|FG001|Induction|Ineligible|0|||
30978628|NCT00557193|59074984|FG002|Induction|Ineligible|0|||
30978629|NCT00557193|59074985|FG003|Induction|Ineligible|0|||
30978630|NCT00557193|59074986|FG004|Induction|Ineligible|0|||
30978631|NCT00557193|59074987|FG005|Induction|Ineligible|0|||
30978632|NCT00557193|59074982|FG000|Induction|Inevaluable for post Induction|2|||
30978633|NCT00557193|59074983|FG001|Induction|Inevaluable for post Induction|0|||
30978634|NCT00557193|59074984|FG002|Induction|Inevaluable for post Induction|0|||
30978635|NCT00557193|59074985|FG003|Induction|Inevaluable for post Induction|0|||
30978636|NCT00557193|59074986|FG004|Induction|Inevaluable for post Induction|0|||
30978637|NCT00557193|59074987|FG005|Induction|Inevaluable for post Induction|0|||
30978638|NCT00557193|59074982|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
30978639|NCT00557193|59074983|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
30978640|NCT00557193|59074984|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
30978641|NCT00557193|59074985|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
30978642|NCT00557193|59074986|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
30978643|NCT00557193|59074987|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
30978644|NCT00557193|59074982|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
30978645|NCT00557193|59074983|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
30978646|NCT00557193|59074984|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
30608465|NCT01288430|58619224|FG003|Part 2|Adverse Event|0|||
30890988|NCT01632579|58924075|FG000|Washout Period|Adverse Event|1|||
30890989|NCT01632579|58924076|FG001|Washout Period|Adverse Event|0|||
30890990|NCT01632579|58924077|FG002|Washout Period|Adverse Event|0|||
30890991|NCT01632579|58924078|FG003|Washout Period|Adverse Event|0|||
30890992|NCT01632579|58924079|FG004|Washout Period|Adverse Event|0|||
30890993|NCT01632579|58924080|FG005|Washout Period|Adverse Event|0|||
30890994|NCT01632579|58924081|FG006|Washout Period|Adverse Event|0|||
30890995|NCT01632579|58924082|FG007|Washout Period|Adverse Event|0|||
30890996|NCT01632579|58924083|FG008|Washout Period|Adverse Event|0|||
30890997|NCT01632579|58924075|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
30890998|NCT01632579|58924076|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
30890999|NCT01632579|58924077|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
30891000|NCT01632579|58924078|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
30891001|NCT01632579|58924079|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
30891002|NCT01632579|58924080|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
30891003|NCT01632579|58924081|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
30891004|NCT01632579|58924082|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
30891005|NCT01632579|58924083|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
30891006|NCT01632345|58924112|FG000|Treatment: Part I|Adverse Event|1|||
30891007|NCT01632345|58924113|FG001|Treatment: Part I|Adverse Event|4|||
30891008|NCT01632345|58924114|FG002|Treatment: Part I|Adverse Event|2|||
30978647|NCT00557193|59074985|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
30978648|NCT00557193|59074986|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
30978649|NCT00557193|59074987|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
30978650|NCT00557193|59074982|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
30978651|NCT00557193|59074983|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
30978652|NCT00557193|59074984|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
30978653|NCT00557193|59074985|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
30978654|NCT00557193|59074986|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
30978655|NCT00557193|59074987|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
30978656|NCT00557193|59074982|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
30978657|NCT00557193|59074983|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
30978658|NCT00557193|59074984|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
30978659|NCT00557193|59074985|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
30978660|NCT00557193|59074986|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
30978661|NCT00557193|59074987|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
30978662|NCT00557193|59074982|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
30978663|NCT00557193|59074983|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
30978664|NCT00557193|59074984|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
30978665|NCT00557193|59074985|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
30978666|NCT00557193|59074986|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
30978667|NCT00557193|59074987|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
30978668|NCT00557193|59074982|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
30978669|NCT00557193|59074983|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
30978670|NCT00557193|59074984|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
30978671|NCT00557193|59074985|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
30978672|NCT00557193|59074986|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
30978673|NCT00557193|59074987|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
30978674|NCT00557193|59074982|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
30978675|NCT00557193|59074983|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
30978676|NCT00557193|59074984|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
30978677|NCT00557193|59074985|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
30978678|NCT00557193|59074986|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
30978679|NCT00557193|59074987|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
30978680|NCT00557193|59074982|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
30978681|NCT00557193|59074983|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
30978682|NCT00557193|59074984|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
30978683|NCT00557193|59074985|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
30978684|NCT00557193|59074986|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
30978685|NCT00557193|59074987|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
30978686|NCT00557193|59074982|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
30978687|NCT00557193|59074983|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
30978688|NCT00557193|59074984|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
30978689|NCT00557193|59074985|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
30978690|NCT00557193|59074986|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
30978691|NCT00557193|59074987|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
30978692|NCT03991299|59075043|FG000|Overall Study|Study closed, sponsor decision|3|||
30978693|NCT03991299|59075043|FG000|Overall Study|Withdrawal by Subject|1|||
30978694|NCT03155373|59075061|FG000|Overall Study|No longer required surgery|1|||
30978695|NCT03155373|59075061|FG000|Overall Study|Protocol Violation|1|||
30978696|NCT03155373|59075061|FG000|Overall Study|Death|2|||
30978697|NCT03155373|59075061|FG000|Overall Study|Withdrawal by Subject|3|||
30978698|NCT02775903|59075765|FG000|Overall Study|Death|7|||
30978699|NCT02775903|59075766|FG001|Overall Study|Death|11|||
30978700|NCT02775903|59075767|FG002|Overall Study|Death|12|||
30978701|NCT02775903|59075768|FG003|Overall Study|Death|11|||
30978702|NCT02775903|59075765|FG000|Overall Study|Adverse Event|0|||
30978703|NCT02775903|59075766|FG001|Overall Study|Adverse Event|1|||
30978704|NCT02775903|59075767|FG002|Overall Study|Adverse Event|12|||
30978705|NCT02775903|59075768|FG003|Overall Study|Adverse Event|3|||
30978706|NCT02775903|59075765|FG000|Overall Study|Progressive disease|15|||
30978707|NCT02775903|59075766|FG001|Overall Study|Progressive disease|14|||
30978708|NCT02775903|59075767|FG002|Overall Study|Progressive disease|30|||
30978709|NCT02775903|59075768|FG003|Overall Study|Progressive disease|20|||
30978710|NCT02775903|59075765|FG000|Overall Study|Lack of Efficacy|2|||
30978711|NCT02775903|59075766|FG001|Overall Study|Lack of Efficacy|2|||
30978712|NCT02775903|59075767|FG002|Overall Study|Lack of Efficacy|2|||
30978713|NCT02775903|59075768|FG003|Overall Study|Lack of Efficacy|6|||
30978714|NCT02775903|59075765|FG000|Overall Study|Withdrawal by Subject|7|||
30978715|NCT02775903|59075766|FG001|Overall Study|Withdrawal by Subject|5|||
30978716|NCT02775903|59075767|FG002|Overall Study|Withdrawal by Subject|5|||
30978717|NCT02775903|59075768|FG003|Overall Study|Withdrawal by Subject|8|||
30978718|NCT02775903|59075765|FG000|Overall Study|Other reasons|7|||
30978719|NCT02775903|59075766|FG001|Overall Study|Other reasons|8|||
30978720|NCT02775903|59075767|FG002|Overall Study|Other reasons|2|||
30978721|NCT02775903|59075768|FG003|Overall Study|Other reasons|12|||
30978722|NCT02723019|59075837|FG000|Overall Study|Death|17|||
30978723|NCT02723019|59075838|FG001|Overall Study|Death|13|||
30978724|NCT02723019|59075837|FG000|Overall Study|Withdrawal by Subject|11|||
30978725|NCT02723019|59075838|FG001|Overall Study|Withdrawal by Subject|7|||
30978726|NCT02723019|59075837|FG000|Overall Study|Lost to Follow-up|57|||
30978727|NCT02723019|59075838|FG001|Overall Study|Lost to Follow-up|70|||
30978728|NCT00088166|59076088|FG000|Overall Study|Adverse Event|11|||
30978729|NCT00088166|59076089|FG001|Overall Study|Adverse Event|9|||
30978730|NCT00088166|59076088|FG000|Overall Study|Death|3|||
30978731|NCT00088166|59076089|FG001|Overall Study|Death|1|||
30978732|NCT00088166|59076088|FG000|Overall Study|Lost to Follow-up|0|||
30978733|NCT00088166|59076089|FG001|Overall Study|Lost to Follow-up|1|||
30978734|NCT00088166|59076088|FG000|Overall Study|Physician Decision|4|||
30978735|NCT00088166|59076089|FG001|Overall Study|Physician Decision|1|||
30978736|NCT00088166|59076088|FG000|Overall Study|Protocol Violation|1|||
30978737|NCT00088166|59076089|FG001|Overall Study|Protocol Violation|5|||
30978738|NCT00088166|59076088|FG000|Overall Study|Patient deterioration|29|||
30978739|NCT00088166|59076089|FG001|Overall Study|Patient deterioration|39|||
30978740|NCT00088166|59076088|FG000|Overall Study|Withdrawal by Subject|5|||
30978741|NCT00088166|59076089|FG001|Overall Study|Withdrawal by Subject|5|||
30978742|NCT00087698|59076133|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
30978743|NCT00087698|59076133|FG000|Overall Study|Death from Other Causes|3|||
30978744|NCT00087698|59076133|FG000|Overall Study|Adverse Event|4|||
30978745|NCT00087698|59076133|FG000|Overall Study|Withdrawal by Subject|4|||
30978746|NCT00087698|59076133|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
30978747|NCT00087698|59076133|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
30978748|NCT00087698|59076133|FG000|Overall Study|Clinical Relapse|1|||
30978749|NCT00087698|59076133|FG000|Overall Study|Death from Study Disease|2|||
30978750|NCT00087698|59076133|FG000|Overall Study|Death from Study Drug Toxicity|2|||
30978751|NCT00087698|59076133|FG000|Overall Study|Protocol Violation|1|||
30978752|NCT00087152|59076151|FG000|Overall Study|Ineligible|6|||
30978753|NCT00086996|59076203|FG000|Overall Study|Adverse Event|29|||
30978754|NCT00086996|59076203|FG000|Overall Study|Death|4|||
30978755|NCT00086996|59076203|FG000|Overall Study|progression/relapse|7|||
30978756|NCT00086996|59076203|FG000|Overall Study|Withdrawal by Subject|13|||
30978757|NCT00086996|59076203|FG000|Overall Study|Other|6|||
30978758|NCT00086996|59076203|FG000|Overall Study|not eligible|5|||
30978759|NCT00086684|59076505|FG000|Overall Study|Adverse Event|12|||
30978760|NCT00086684|59076506|FG001|Overall Study|Adverse Event|17|||
30978761|NCT00086684|59076507|FG002|Overall Study|Adverse Event|14|||
30978762|NCT00086684|59076505|FG000|Overall Study|Lack of Efficacy|6|||
30978763|NCT00086684|59076506|FG001|Overall Study|Lack of Efficacy|6|||
30978764|NCT00086684|59076507|FG002|Overall Study|Lack of Efficacy|5|||
30978765|NCT00086684|59076505|FG000|Overall Study|Lost to Follow-up|15|||
30978766|NCT00086684|59076506|FG001|Overall Study|Lost to Follow-up|8|||
30978767|NCT00086684|59076507|FG002|Overall Study|Lost to Follow-up|10|||
30978768|NCT00086684|59076505|FG000|Overall Study|Protocol Violation|8|||
30978769|NCT00086684|59076506|FG001|Overall Study|Protocol Violation|3|||
30978770|NCT00086684|59076507|FG002|Overall Study|Protocol Violation|0|||
30978771|NCT00086684|59076505|FG000|Overall Study|Withdrawal by Subject|0|||
30978772|NCT00086684|59076506|FG001|Overall Study|Withdrawal by Subject|4|||
30978773|NCT00086684|59076507|FG002|Overall Study|Withdrawal by Subject|10|||
30978774|NCT00086684|59076505|FG000|Overall Study|NONCOMPLIANCE|5|||
30978775|NCT00086684|59076506|FG001|Overall Study|NONCOMPLIANCE|7|||
30978776|NCT00086684|59076507|FG002|Overall Study|NONCOMPLIANCE|6|||
30978777|NCT00086684|59076505|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
30978778|NCT00086684|59076506|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
30978779|NCT00086684|59076507|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
30978780|NCT00086684|59076505|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
30978781|NCT00086684|59076506|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
30978782|NCT00086684|59076507|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
30978783|NCT00086684|59076505|FG000|Overall Study|Other|4|||
30978784|NCT00086684|59076506|FG001|Overall Study|Other|2|||
30978785|NCT00086684|59076507|FG002|Overall Study|Other|3|||
30978786|NCT00082628|59076571|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
30978787|NCT00082628|59076572|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
30978788|NCT00082628|59076573|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
30978789|NCT00082628|59076574|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
30978790|NCT00082628|59076575|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
30978791|NCT00082628|59076571|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
30978792|NCT00082628|59076572|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
30978793|NCT00082628|59076573|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
30978794|NCT00082628|59076574|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
30978795|NCT00082628|59076575|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
30978796|NCT00082628|59076571|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
30978797|NCT00082628|59076572|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
30978798|NCT00082628|59076573|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
30978799|NCT00082628|59076574|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
30978800|NCT00082628|59076575|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
30978801|NCT00082628|59076571|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
30978802|NCT00082628|59076572|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
30978803|NCT00082628|59076573|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
30978804|NCT00082628|59076574|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
30978805|NCT00082628|59076575|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
30978806|NCT00082628|59076571|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
30978807|NCT00082628|59076572|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
30978808|NCT00082628|59076573|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
30978809|NCT00082628|59076574|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
30978810|NCT00082628|59076575|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
30978811|NCT00082628|59076571|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
30978812|NCT00082628|59076572|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
30978813|NCT00082628|59076573|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
30978814|NCT00082628|59076574|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
30978815|NCT00082628|59076575|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
30978816|NCT00082628|59076571|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
30978817|NCT00082628|59076572|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
30978818|NCT00082628|59076573|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
30978819|NCT00082628|59076574|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
30978820|NCT00082628|59076575|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
30978821|NCT02993263|59076931|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
30978822|NCT01274533|59076959|FG000|Overall Study|Withdrawal by Subject|1|||
30978823|NCT01274533|59076959|FG000|Overall Study|Non-compliance|1|||
30978824|NCT01274533|59076959|FG000|Overall Study|Disease progression|2|||
30978825|NCT01273597|59076963|FG000|Overall Study|Adverse Event|5|||
30978826|NCT01273597|59076963|FG000|Overall Study|Underwent Kidney Transplantation|2|||
30978827|NCT01273597|59076963|FG000|Overall Study|Reason Not Reported|1|||
30978828|NCT01273519|59076970|FG000|Overall Study|Adverse Event|3|||
30978829|NCT01273519|59076971|FG001|Overall Study|Adverse Event|0|||
30978830|NCT01273519|59076972|FG002|Overall Study|Adverse Event|0|||
30978831|NCT01273519|59076970|FG000|Overall Study|Lost to Follow-up|2|||
30978832|NCT01273519|59076971|FG001|Overall Study|Lost to Follow-up|1|||
30978833|NCT01273519|59076972|FG002|Overall Study|Lost to Follow-up|3|||
30978834|NCT01273519|59076970|FG000|Overall Study|Lack of Efficacy|8|||
30978835|NCT01273519|59076971|FG001|Overall Study|Lack of Efficacy|3|||
30978836|NCT01273519|59076972|FG002|Overall Study|Lack of Efficacy|4|||
30978837|NCT01273519|59076970|FG000|Overall Study|Other|6|||
30978838|NCT01273519|59076971|FG001|Overall Study|Other|1|||
30978839|NCT01273519|59076972|FG002|Overall Study|Other|1|||
30978840|NCT01272661|59077029|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
30978841|NCT01272661|59077030|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
30978842|NCT01272661|59077031|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
30978843|NCT04276051|59077197|FG000|Overall Study|Lost to Follow-up|0|||
30978844|NCT04276051|59077198|FG001|Overall Study|Lost to Follow-up|1|||
30978845|NCT04276051|59077197|FG000|Overall Study|Physician Decision|0|||
30978846|NCT04276051|59077198|FG001|Overall Study|Physician Decision|1|||
30978847|NCT04276051|59077197|FG000|Overall Study|Withdrawal by Subject|1|||
30978848|NCT04276051|59077198|FG001|Overall Study|Withdrawal by Subject|1|||
30978849|NCT00081770|59077458|FG000|Overall Study|Adverse Event|130|||
30978850|NCT00081770|59077459|FG001|Overall Study|Adverse Event|98|||
30978851|NCT00081770|59077460|FG002|Overall Study|Adverse Event|136|||
30978852|NCT00081770|59077458|FG000|Overall Study|Lack of Efficacy|262|||
30978853|NCT00081770|59077459|FG001|Overall Study|Lack of Efficacy|357|||
30978854|NCT00081770|59077460|FG002|Overall Study|Lack of Efficacy|211|||
30978855|NCT00081770|59077458|FG000|Overall Study|Lost to Follow-up|45|||
30978856|NCT00081770|59077459|FG001|Overall Study|Lost to Follow-up|34|||
30978857|NCT00081770|59077460|FG002|Overall Study|Lost to Follow-up|45|||
30978858|NCT00081770|59077458|FG000|Overall Study|Protocol Violation|15|||
30978859|NCT00081770|59077459|FG001|Overall Study|Protocol Violation|10|||
30978860|NCT00081770|59077460|FG002|Overall Study|Protocol Violation|10|||
30978861|NCT00081770|59077458|FG000|Overall Study|Withdrawal by Subject|45|||
30978862|NCT00081770|59077459|FG001|Overall Study|Withdrawal by Subject|40|||
30978863|NCT00081770|59077460|FG002|Overall Study|Withdrawal by Subject|42|||
30978864|NCT00081770|59077458|FG000|Overall Study|Did not meet protocol eligibility|2|||
30978865|NCT00081770|59077459|FG001|Overall Study|Did not meet protocol eligibility|0|||
30978866|NCT00081770|59077460|FG002|Overall Study|Did not meet protocol eligibility|3|||
30978867|NCT00081770|59077458|FG000|Overall Study|Administrative|1|||
30978868|NCT00081770|59077459|FG001|Overall Study|Administrative|0|||
30978869|NCT00081770|59077460|FG002|Overall Study|Administrative|1|||
30978870|NCT00081770|59077458|FG000|Overall Study|Other|2|||
30978871|NCT00081770|59077459|FG001|Overall Study|Other|7|||
30978872|NCT00081770|59077460|FG002|Overall Study|Other|8|||
30978873|NCT00081458|59077560|FG000|Overall Study|Adverse Event|1|||
30978874|NCT00081458|59077561|FG001|Overall Study|Adverse Event|5|||
30978875|NCT00081458|59077562|FG002|Overall Study|Adverse Event|2|||
30978876|NCT00081458|59077560|FG000|Overall Study|Withdrawal by Subject|0|||
30978877|NCT00081458|59077561|FG001|Overall Study|Withdrawal by Subject|3|||
30978878|NCT00081458|59077562|FG002|Overall Study|Withdrawal by Subject|1|||
30978879|NCT00081458|59077560|FG000|Overall Study|Randomized but not dosed|0|||
30978880|NCT00081458|59077561|FG001|Overall Study|Randomized but not dosed|0|||
30978881|NCT00081458|59077562|FG002|Overall Study|Randomized but not dosed|1|||
30978882|NCT01271803|59077639|FG000|Overall Study|Progressive disease|0|||
30978883|NCT01271803|59077640|FG001|Overall Study|Progressive disease|0|||
30978884|NCT01271803|59077641|FG002|Overall Study|Progressive disease|2|||
30978885|NCT01271803|59077639|FG000|Overall Study|Death|53|||
30978886|NCT01271803|59077640|FG001|Overall Study|Death|34|||
30978887|NCT01271803|59077641|FG002|Overall Study|Death|0|||
30978888|NCT01271803|59077639|FG000|Overall Study|Withdrawal by Subject|1|||
30978889|NCT01271803|59077640|FG001|Overall Study|Withdrawal by Subject|5|||
30978890|NCT01271803|59077641|FG002|Overall Study|Withdrawal by Subject|0|||
30978891|NCT01271803|59077639|FG000|Overall Study|Lost to Follow-up|1|||
30978892|NCT01271803|59077640|FG001|Overall Study|Lost to Follow-up|0|||
30978893|NCT01271803|59077641|FG002|Overall Study|Lost to Follow-up|0|||
30978894|NCT00080288|59077692|FG000|Overall Study|Adverse Event|7|||
30978895|NCT00080288|59077693|FG001|Overall Study|Adverse Event|4|||
30978896|NCT00080288|59077692|FG000|Overall Study|Lost to Follow-up|3|||
30978897|NCT00080288|59077693|FG001|Overall Study|Lost to Follow-up|5|||
30978898|NCT00080288|59077692|FG000|Overall Study|Physician Decision|6|||
30978899|NCT00080288|59077693|FG001|Overall Study|Physician Decision|2|||
30978900|NCT00080288|59077692|FG000|Overall Study|Withdrawal by Subject|3|||
30978901|NCT00080288|59077693|FG001|Overall Study|Withdrawal by Subject|16|||
30978902|NCT00080288|59077692|FG000|Overall Study|Miscellaneous|11|||
30978903|NCT00080288|59077693|FG001|Overall Study|Miscellaneous|11|||
30978904|NCT01271725|59077767|FG000|Part A|Progressive disease according to RECIST|8|||
30978905|NCT01271725|59077768|FG001|Part A|Progressive disease according to RECIST|0|||
30978906|NCT01271725|59077767|FG000|Part A|Clinical signs/symptoms of progression|2|||
30978907|NCT01271725|59077768|FG001|Part A|Clinical signs/symptoms of progression|0|||
30978908|NCT01271725|59077767|FG000|Part A|Other Adverse Event|8|||
30978909|NCT01271725|59077768|FG001|Part A|Other Adverse Event|0|||
30978910|NCT01271725|59077767|FG000|Part A|Lost to Follow-up|1|||
30978911|NCT01271725|59077768|FG001|Part A|Lost to Follow-up|0|||
30978912|NCT01271725|59077767|FG000|Part A|Withdrawal by Subject|12|||
30978913|NCT01271725|59077768|FG001|Part A|Withdrawal by Subject|0|||
30978914|NCT01271725|59077767|FG000|Part A|Other than specified|3|||
30978915|NCT01271725|59077768|FG001|Part A|Other than specified|0|||
30978916|NCT01271725|59077767|FG000|Part A|Protocol Violation|1|||
30978917|NCT01271725|59077768|FG001|Part A|Protocol Violation|0|||
30978918|NCT01271725|59077767|FG000|Part B|Other than specified|0|||
30978919|NCT01271725|59077768|FG001|Part B|Other than specified|2|||
30978920|NCT01271725|59077767|FG000|Part B|Clinical signs/symptoms of progression|0|||
30978921|NCT01271725|59077768|FG001|Part B|Clinical signs/symptoms of progression|2|||
30978922|NCT01271725|59077767|FG000|Part B|Other Adverse Event|0|||
30978923|NCT01271725|59077768|FG001|Part B|Other Adverse Event|1|||
30978924|NCT01271725|59077767|FG000|Part B|Protocol Violation|0|||
30978925|NCT01271725|59077768|FG001|Part B|Protocol Violation|1|||
30978926|NCT01271725|59077767|FG000|Part B|Withdrawal by Subject|0|||
30978927|NCT01271725|59077768|FG001|Part B|Withdrawal by Subject|6|||
30978928|NCT01270321|59077793|FG000|Overall Study|Death|3|||
30978929|NCT01270321|59077794|FG001|Overall Study|Death|1|||
30978930|NCT01270321|59077795|FG002|Overall Study|Death|4|||
30978931|NCT01270321|59077793|FG000|Overall Study|Adverse Event|7|||
30978932|NCT01270321|59077794|FG001|Overall Study|Adverse Event|9|||
30978933|NCT01270321|59077795|FG002|Overall Study|Adverse Event|5|||
30978934|NCT00249769|59077889|FG000|Overall Study|Withdrawal by Subject|1|||
30978935|NCT00249769|59077890|FG001|Overall Study|Withdrawal by Subject|10|||
30978936|NCT00249769|59077891|FG002|Overall Study|Withdrawal by Subject|6|||
30978937|NCT00249769|59077889|FG000|Overall Study|Migration from Study Area|1|||
30978938|NCT00249769|59077890|FG001|Overall Study|Migration from Study Area|3|||
30978939|NCT00249769|59077891|FG002|Overall Study|Migration from Study Area|14|||
30978940|NCT00249769|59077889|FG000|Overall Study|Miscellaneous|0|||
30978941|NCT00249769|59077890|FG001|Overall Study|Miscellaneous|2|||
30978942|NCT00249769|59077891|FG002|Overall Study|Miscellaneous|2|||
30978943|NCT00249769|59077889|FG000|Overall Study|Adverse Event|0|||
30978944|NCT00249769|59077890|FG001|Overall Study|Adverse Event|0|||
30978945|NCT00249769|59077891|FG002|Overall Study|Adverse Event|1|||
30978946|NCT00249769|59077889|FG000|Overall Study|Physician Decision|0|||
30978947|NCT00249769|59077890|FG001|Overall Study|Physician Decision|0|||
30978948|NCT00249769|59077891|FG002|Overall Study|Physician Decision|2|||
30978949|NCT00249769|59077889|FG000|Overall Study|Lost to Follow-up|0|||
30978950|NCT00249769|59077890|FG001|Overall Study|Lost to Follow-up|0|||
30978951|NCT00249769|59077891|FG002|Overall Study|Lost to Follow-up|3|||
30978952|NCT00249613|59077901|FG000|12 Month Follow-up|Death|1|||
30978953|NCT00249613|59077902|FG001|12 Month Follow-up|Death|1|||
30978954|NCT00249613|59077901|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
30978955|NCT00249613|59077902|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
30978956|NCT00249613|59077901|FG000|12 Month Follow-up|Lost to Follow-up|10|||
30978957|NCT00249613|59077902|FG001|12 Month Follow-up|Lost to Follow-up|8|||
30978958|NCT00248833|59077938|FG000|Overall Study|Adverse Event|2|||
30978959|NCT00248833|59077939|FG001|Overall Study|Adverse Event|0|||
30978960|NCT00248833|59077940|FG002|Overall Study|Adverse Event|0|||
30978961|NCT00248833|59077938|FG000|Overall Study|Withdrawal by Subject|0|||
30978962|NCT00248833|59077939|FG001|Overall Study|Withdrawal by Subject|1|||
30978963|NCT00248833|59077940|FG002|Overall Study|Withdrawal by Subject|1|||
30978964|NCT00248833|59077938|FG000|Overall Study|Lost to Follow-up|1|||
30978965|NCT00248833|59077939|FG001|Overall Study|Lost to Follow-up|1|||
30978966|NCT00248833|59077940|FG002|Overall Study|Lost to Follow-up|1|||
30978967|NCT00248833|59077938|FG000|Overall Study|Other|0|||
30978968|NCT00248833|59077939|FG001|Overall Study|Other|1|||
30978969|NCT00248833|59077940|FG002|Overall Study|Other|0|||
30978970|NCT00247273|59078120|FG000|Overall Study|Adverse Event|85|||
30978971|NCT00247273|59078121|FG001|Overall Study|Adverse Event|80|||
30978972|NCT00247273|59078120|FG000|Overall Study|Physician Decision|6|||
30978973|NCT00247273|59078121|FG001|Overall Study|Physician Decision|3|||
30978974|NCT00247273|59078120|FG000|Overall Study|Lost to Follow-up|7|||
30978975|NCT00247273|59078121|FG001|Overall Study|Lost to Follow-up|7|||
30978976|NCT00247273|59078120|FG000|Overall Study|Withdrawal by Subject|46|||
30978977|NCT00247273|59078121|FG001|Overall Study|Withdrawal by Subject|47|||
30978978|NCT00247273|59078120|FG000|Overall Study|Did not take any study drug|2|||
30978979|NCT00247273|59078121|FG001|Overall Study|Did not take any study drug|0|||
30978980|NCT00246259|59078209|FG000|Overall Study|Other|3|||
30978981|NCT00246259|59078210|FG001|Overall Study|Other|3|||
30978982|NCT00246259|59078209|FG000|Overall Study|Not stable by Week 18|2|||
30978983|NCT00246259|59078210|FG001|Overall Study|Not stable by Week 18|1|||
30978984|NCT00246259|59078209|FG000|Overall Study|Participant non-compliant|4|||
30978985|NCT00246259|59078210|FG001|Overall Study|Participant non-compliant|9|||
30978986|NCT00246259|59078209|FG000|Overall Study|Lack of Efficacy|2|||
30978987|NCT00246259|59078210|FG001|Overall Study|Lack of Efficacy|2|||
30978988|NCT00246259|59078209|FG000|Overall Study|Investigator withdrew participant|2|||
30978989|NCT00246259|59078210|FG001|Overall Study|Investigator withdrew participant|0|||
30978990|NCT00246259|59078209|FG000|Overall Study|Adverse Event|5|||
30978991|NCT00246259|59078210|FG001|Overall Study|Adverse Event|0|||
30978992|NCT00246259|59078209|FG000|Overall Study|Lost to Follow-up|3|||
30978993|NCT00246259|59078210|FG001|Overall Study|Lost to Follow-up|4|||
30978994|NCT00246259|59078209|FG000|Overall Study|Withdrawal by Subject|5|||
30978995|NCT00246259|59078210|FG001|Overall Study|Withdrawal by Subject|1|||
30978996|NCT00246259|59078209|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
30978997|NCT00246259|59078210|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
30978998|NCT00246025|59078262|FG000|Overall Study|Adverse Event|7|||
30978999|NCT00246025|59078263|FG001|Overall Study|Adverse Event|9|||
30979000|NCT00246025|59078264|FG002|Overall Study|Adverse Event|9|||
30979001|NCT00246025|59078265|FG003|Overall Study|Adverse Event|10|||
30979002|NCT00246025|59078262|FG000|Overall Study|Withdrawal by Subject|3|||
30979003|NCT00246025|59078263|FG001|Overall Study|Withdrawal by Subject|0|||
30979004|NCT00246025|59078264|FG002|Overall Study|Withdrawal by Subject|1|||
30979005|NCT00246025|59078265|FG003|Overall Study|Withdrawal by Subject|2|||
30979006|NCT00246025|59078262|FG000|Overall Study|unsuitable medical history was found|0|||
30979007|NCT00246025|59078263|FG001|Overall Study|unsuitable medical history was found|0|||
30979008|NCT00246025|59078264|FG002|Overall Study|unsuitable medical history was found|0|||
30979009|NCT00246025|59078265|FG003|Overall Study|unsuitable medical history was found|1|||
30979010|NCT00245011|59078395|FG000|Overall Study|Lack of Efficacy|1|||
30979011|NCT00244855|59078414|FG000|Overall Study|Withdrawal by Subject|0|||
30979012|NCT00244855|59078415|FG001|Overall Study|Withdrawal by Subject|1|||
30979013|NCT00244621|59078445|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
30979014|NCT00244621|59078446|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
30979015|NCT00244621|59078447|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
30979016|NCT00244621|59078445|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
30979017|NCT00244621|59078446|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
30979018|NCT00244621|59078447|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
30979019|NCT00244621|59078445|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
30979020|NCT00244621|59078446|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
30979021|NCT00244621|59078447|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
30979022|NCT00244621|59078445|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
30979023|NCT00244621|59078446|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
30979024|NCT00244621|59078447|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
30979025|NCT00244621|59078445|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
30979026|NCT00244621|59078446|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
30979027|NCT00244621|59078447|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
30979028|NCT00244621|59078445|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
30979029|NCT00244621|59078446|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
30979030|NCT00244621|59078447|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
30979031|NCT00244621|59078445|FG000|Open-label Treatment Period|Adverse Event|0|||
30979032|NCT00244621|59078446|FG001|Open-label Treatment Period|Adverse Event|0|||
30979033|NCT00244621|59078447|FG002|Open-label Treatment Period|Adverse Event|1|||
30979034|NCT00244621|59078445|FG000|Open-label Treatment Period|Moved abroad|0|||
30979035|NCT00244621|59078446|FG001|Open-label Treatment Period|Moved abroad|0|||
30979036|NCT00244621|59078447|FG002|Open-label Treatment Period|Moved abroad|1|||
30979037|NCT00243841|59078530|FG000|Overall Study|Physician Decision|0|||
30979038|NCT00243841|59078531|FG001|Overall Study|Physician Decision|0|||
30979039|NCT00243841|59078532|FG002|Overall Study|Physician Decision|1|||
30979040|NCT00243841|59078533|FG003|Overall Study|Physician Decision|0|||
30979041|NCT00243841|59078534|FG004|Overall Study|Physician Decision|0|||
30979042|NCT00243841|59078535|FG005|Overall Study|Physician Decision|2|||
30979043|NCT02980731|59078728|FG000|Overall Study|Death|63|||
30979044|NCT02980731|59078728|FG000|Overall Study|Withdrawal by Subject|6|||
30979045|NCT02980731|59078728|FG000|Overall Study|Lost to Follow-up|5|||
30979046|NCT02980731|59078728|FG000|Overall Study|Study terminated by Sponsor|4|||
30979047|NCT02980731|59078728|FG000|Overall Study|Completed survival follow-up period|65|||
30979048|NCT02980731|59078728|FG000|Overall Study|COVID-19 infection|1|||
30979049|NCT02980731|59078728|FG000|Overall Study|Other, not specified|66|||
30979050|NCT02641587|59078768|FG000|Confinement Period|Adverse Event|1|||
30979051|NCT02641587|59078769|FG001|Confinement Period|Adverse Event|0|||
30979052|NCT02641587|59078768|FG000|Confinement Period|Withdrawal by Subject|2|||
30979053|NCT02641587|59078769|FG001|Confinement Period|Withdrawal by Subject|1|||
30979054|NCT02641587|59078768|FG000|Ambulatory Period|Withdrawal by Subject|1|||
30979055|NCT02641587|59078769|FG001|Ambulatory Period|Withdrawal by Subject|0|||
30979056|NCT04672083|59078887|FG000|Overall Study|Lost to Follow-up|1|||
30979057|NCT04672083|59078888|FG001|Overall Study|Lost to Follow-up|0|||
30979058|NCT04672083|59078889|FG002|Overall Study|Lost to Follow-up|0|||
30979059|NCT04672083|59078890|FG003|Overall Study|Lost to Follow-up|0|||
30979060|NCT04672083|59078891|FG004|Overall Study|Lost to Follow-up|0|||
30979061|NCT01781637|59078994|FG000|Overall Study|Adverse Event|1|||
30979062|NCT01781637|59078995|FG001|Overall Study|Adverse Event|0|||
30979063|NCT01781637|59078994|FG000|Overall Study|Lack of Efficacy|2|||
30979064|NCT01781637|59078995|FG001|Overall Study|Lack of Efficacy|6|||
30979065|NCT01781637|59078994|FG000|Overall Study|Withdrawal by Subject|1|||
30979066|NCT01781637|59078995|FG001|Overall Study|Withdrawal by Subject|0|||
30979067|NCT01459497|59079043|FG000|Overall Study|Inability to meet trial constraints.|1|||
30979068|NCT01459497|59079044|FG001|Overall Study|Inability to meet trial constraints.|0|||
30979069|NCT01459497|59079043|FG000|Overall Study|Physician Decision|1|||
30979070|NCT01459497|59079044|FG001|Overall Study|Physician Decision|1|||
30979071|NCT01459497|59079043|FG000|Overall Study|Hospitalization.|0|||
30979072|NCT01459497|59079044|FG001|Overall Study|Hospitalization.|3|||
30979073|NCT01459497|59079043|FG000|Overall Study|Disease progression.|0|||
30979074|NCT01459497|59079044|FG001|Overall Study|Disease progression.|1|||
30979075|NCT04575584|59079393|FG000|Overall Study|Death|6|||
30979076|NCT04575584|59079394|FG001|Overall Study|Death|4|||
30979077|NCT04575584|59079395|FG002|Overall Study|Death|6|||
30979078|NCT04575584|59079396|FG003|Overall Study|Death|2|||
30979079|NCT04575584|59079397|FG004|Overall Study|Death|0|||
30979080|NCT04575584|59079398|FG005|Overall Study|Death|0|||
30979081|NCT04575584|59079393|FG000|Overall Study|Lost to Follow-up|1|||
30979082|NCT04575584|59079394|FG001|Overall Study|Lost to Follow-up|1|||
30979083|NCT04575584|59079395|FG002|Overall Study|Lost to Follow-up|1|||
30979084|NCT04575584|59079396|FG003|Overall Study|Lost to Follow-up|1|||
30979085|NCT04575584|59079397|FG004|Overall Study|Lost to Follow-up|0|||
30979086|NCT04575584|59079398|FG005|Overall Study|Lost to Follow-up|0|||
30979087|NCT04575584|59079393|FG000|Overall Study|Physician Decision|0|||
30979088|NCT04575584|59079394|FG001|Overall Study|Physician Decision|1|||
30979089|NCT04575584|59079395|FG002|Overall Study|Physician Decision|1|||
30979090|NCT04575584|59079396|FG003|Overall Study|Physician Decision|1|||
30979091|NCT04575584|59079397|FG004|Overall Study|Physician Decision|0|||
30979092|NCT04575584|59079398|FG005|Overall Study|Physician Decision|0|||
30979093|NCT04575584|59079393|FG000|Overall Study|Withdrawal by Subject|7|||
30979094|NCT04575584|59079394|FG001|Overall Study|Withdrawal by Subject|9|||
30979095|NCT04575584|59079395|FG002|Overall Study|Withdrawal by Subject|5|||
30979096|NCT04575584|59079396|FG003|Overall Study|Withdrawal by Subject|3|||
30979097|NCT04575584|59079397|FG004|Overall Study|Withdrawal by Subject|0|||
30979098|NCT04575584|59079398|FG005|Overall Study|Withdrawal by Subject|0|||
30979099|NCT04575584|59079393|FG000|Overall Study|Not recorded|0|||
30979100|NCT04575584|59079394|FG001|Overall Study|Not recorded|0|||
30979101|NCT04575584|59079395|FG002|Overall Study|Not recorded|0|||
30979102|NCT04575584|59079396|FG003|Overall Study|Not recorded|1|||
30979103|NCT04575584|59079397|FG004|Overall Study|Not recorded|0|||
30979104|NCT04575584|59079398|FG005|Overall Study|Not recorded|0|||
30979105|NCT03721965|59079437|FG000|Overall Study|Death|1|||
30979106|NCT03721965|59079437|FG000|Overall Study|Study Terminated by Sponsor|1|||
30979107|NCT03873116|59079493|FG000|Overall Study|Study drug discontinuation due to rash|0|||
30979108|NCT03873116|59079494|FG001|Overall Study|Study drug discontinuation due to rash|0|||
30979109|NCT03873116|59079495|FG002|Overall Study|Study drug discontinuation due to rash|1|||
30979110|NCT02312258|59079781|FG000|Overall Study|Adverse Event|15|||
30979111|NCT02312258|59079782|FG001|Overall Study|Adverse Event|47|||
30979112|NCT02312258|59079781|FG000|Overall Study|Lost to Follow-up|0|||
30979113|NCT02312258|59079782|FG001|Overall Study|Lost to Follow-up|1|||
30979114|NCT02312258|59079781|FG000|Overall Study|Progressive Disease|174|||
30979115|NCT02312258|59079782|FG001|Overall Study|Progressive Disease|188|||
30979116|NCT02312258|59079781|FG000|Overall Study|Withdrawal by Subject|8|||
30979117|NCT02312258|59079782|FG001|Overall Study|Withdrawal by Subject|9|||
30979118|NCT02312258|59079781|FG000|Overall Study|Reason not Specified|11|||
30979119|NCT02312258|59079782|FG001|Overall Study|Reason not Specified|31|||
30979120|NCT02312258|59079781|FG000|Overall Study|Participants Ongoing Treatment|43|||
30979121|NCT02312258|59079782|FG001|Overall Study|Participants Ongoing Treatment|83|||
30979122|NCT03686384|59079952|FG000|Overall Study|Lack of Efficacy|4|||
30979123|NCT03686384|59079953|FG001|Overall Study|Lack of Efficacy|13|||
30979124|NCT03686384|59079952|FG000|Overall Study|Lost to Follow-up|3|||
30979125|NCT03686384|59079953|FG001|Overall Study|Lost to Follow-up|0|||
30979126|NCT03686384|59079952|FG000|Overall Study|Physician Decision|0|||
30979127|NCT03686384|59079953|FG001|Overall Study|Physician Decision|1|||
30979128|NCT03686384|59079952|FG000|Overall Study|Took prohibited medication|0|||
30979129|NCT03686384|59079953|FG001|Overall Study|Took prohibited medication|1|||
30979130|NCT00240331|59080025|FG000|Overall Study|Withdrawal by Subject|125|||
30979131|NCT00240331|59080026|FG001|Overall Study|Withdrawal by Subject|132|||
30979132|NCT00240331|59080025|FG000|Overall Study|Option selected by investigator|1|||
30979133|NCT00240331|59080026|FG001|Overall Study|Option selected by investigator|2|||
30979134|NCT00240097|59080032|FG000|Part I|Adverse Event|1|||
30979135|NCT00240097|59080032|FG000|Part I|Death|1|||
30979136|NCT00240097|59080032|FG000|Part I|histology|1|||
30979137|NCT00240097|59080032|FG000|Part I|unevaluable|1|||
30979138|NCT00240097|59080032|FG000|Part II|did not continue from Part I|23|||
30979139|NCT03620162|59080123|FG000|Overall Study|Physician Decision|4|||
30979140|NCT03620162|59080124|FG001|Overall Study|Physician Decision|0|||
30979141|NCT03620162|59080125|FG002|Overall Study|Physician Decision|1|||
30979142|NCT03620162|59080126|FG003|Overall Study|Physician Decision|0|||
30891009|NCT01632345|58924115|FG003|Treatment: Part I|Adverse Event|1|||
30891010|NCT01632345|58924116|FG004|Treatment: Part I|Adverse Event|3|||
30891011|NCT01632345|58924117|FG005|Treatment: Part I|Adverse Event|0|||
30891012|NCT01632345|58924118|FG006|Treatment: Part I|Adverse Event|0|||
30891013|NCT01632345|58924112|FG000|Treatment: Part I|Lack of Efficacy|0|||
30891014|NCT01632345|58924113|FG001|Treatment: Part I|Lack of Efficacy|1|||
30891015|NCT01632345|58924114|FG002|Treatment: Part I|Lack of Efficacy|0|||
30891016|NCT01632345|58924115|FG003|Treatment: Part I|Lack of Efficacy|1|||
30891017|NCT01632345|58924116|FG004|Treatment: Part I|Lack of Efficacy|1|||
30891018|NCT01632345|58924117|FG005|Treatment: Part I|Lack of Efficacy|0|||
30891019|NCT01632345|58924118|FG006|Treatment: Part I|Lack of Efficacy|0|||
30891020|NCT01632345|58924112|FG000|Treatment: Part I|Lost to Follow-up|3|||
30891021|NCT01632345|58924113|FG001|Treatment: Part I|Lost to Follow-up|2|||
30891022|NCT01632345|58924114|FG002|Treatment: Part I|Lost to Follow-up|1|||
30891023|NCT01632345|58924115|FG003|Treatment: Part I|Lost to Follow-up|3|||
30891024|NCT01632345|58924116|FG004|Treatment: Part I|Lost to Follow-up|4|||
30891025|NCT01632345|58924117|FG005|Treatment: Part I|Lost to Follow-up|0|||
30891026|NCT01632345|58924118|FG006|Treatment: Part I|Lost to Follow-up|0|||
30891027|NCT01632345|58924112|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
30891028|NCT01632345|58924113|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
30891029|NCT01632345|58924114|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
30891030|NCT01632345|58924115|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
30891031|NCT01632345|58924116|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
30608466|NCT01288430|58619225|FG004|Part 2|Adverse Event|0|||
30608467|NCT01288430|58619226|FG005|Part 2|Adverse Event|0|||
30608468|NCT01288430|58619227|FG006|Part 2|Adverse Event|0|||
30608469|NCT01288430|58619228|FG007|Part 2|Adverse Event|1|||
30608470|NCT01288430|58619229|FG008|Part 2|Adverse Event|1|||
30608471|NCT01288430|58619230|FG009|Part 2|Adverse Event|0|||
30608472|NCT01288430|58619221|FG000|Part 2|Other|0|||
30608473|NCT01288430|58619222|FG001|Part 2|Other|0|||
30608474|NCT01288430|58619223|FG002|Part 2|Other|0|||
30608475|NCT01288430|58619224|FG003|Part 2|Other|0|||
30608476|NCT01288430|58619225|FG004|Part 2|Other|0|||
30608477|NCT01288430|58619226|FG005|Part 2|Other|0|||
30608478|NCT01288430|58619227|FG006|Part 2|Other|0|||
30608479|NCT01288430|58619228|FG007|Part 2|Other|0|||
30608480|NCT01288430|58619229|FG008|Part 2|Other|0|||
30608481|NCT01288430|58619230|FG009|Part 2|Other|1|||
30608482|NCT01287416|58619259|FG000|Pre-post Training|Withdrawal by Subject|17|||
30608483|NCT01287416|58619260|FG001|Pre-post Training|Withdrawal by Subject|24|||
30979143|NCT03620162|59080127|FG004|Overall Study|Physician Decision|2|||
30979144|NCT03620162|59080123|FG000|Overall Study|Lost to Follow-up|2|||
30979145|NCT03620162|59080124|FG001|Overall Study|Lost to Follow-up|6|||
30979146|NCT03620162|59080125|FG002|Overall Study|Lost to Follow-up|7|||
30979147|NCT03620162|59080126|FG003|Overall Study|Lost to Follow-up|3|||
30979148|NCT03620162|59080127|FG004|Overall Study|Lost to Follow-up|2|||
30979149|NCT03620162|59080123|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
30979150|NCT03620162|59080124|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
30979151|NCT03620162|59080125|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
30979152|NCT03620162|59080126|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
30979153|NCT03620162|59080127|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
30979154|NCT03084302|59080268|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
30979155|NCT03084302|59080268|FG000|Overall Study|No valid objective monitor data|6|||
30979156|NCT01279681|59080410|FG000|Overall Study|Disease Progression|9|||
30979157|NCT01279681|59080411|FG001|Overall Study|Disease Progression|6|||
30979158|NCT01279681|59080410|FG000|Overall Study|Withdrawal by Subject|3|||
30979159|NCT01279681|59080411|FG001|Overall Study|Withdrawal by Subject|4|||
30979160|NCT01279681|59080410|FG000|Overall Study|Adverse Event|2|||
30979161|NCT01279681|59080411|FG001|Overall Study|Adverse Event|3|||
30979162|NCT01279681|59080410|FG000|Overall Study|Death|0|||
30979163|NCT01279681|59080411|FG001|Overall Study|Death|1|||
30979164|NCT01279681|59080410|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
30979165|NCT01279681|59080411|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
30979166|NCT01279681|59080410|FG000|Overall Study|Physician Decision|1|||
30979167|NCT01279681|59080411|FG001|Overall Study|Physician Decision|0|||
30979168|NCT01279681|59080410|FG000|Overall Study|Other Reason|0|||
30979169|NCT01279681|59080411|FG001|Overall Study|Other Reason|2|||
30979170|NCT01279057|59080429|FG000|Overall Study|Adverse Event|1|||
30979171|NCT01279057|59080430|FG001|Overall Study|Adverse Event|0|||
30979172|NCT01279057|59080431|FG002|Overall Study|Adverse Event|1|||
30979173|NCT01279057|59080429|FG000|Overall Study|Insufficient therapeutic response|0|||
30979174|NCT01279057|59080430|FG001|Overall Study|Insufficient therapeutic response|0|||
30979175|NCT01279057|59080431|FG002|Overall Study|Insufficient therapeutic response|1|||
30979176|NCT01279057|59080429|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
30979177|NCT01279057|59080430|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
30979178|NCT01279057|59080431|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
30979179|NCT01279057|59080429|FG000|Overall Study|Withdrew consent|2|||
30979180|NCT01279057|59080430|FG001|Overall Study|Withdrew consent|0|||
30979181|NCT01279057|59080431|FG002|Overall Study|Withdrew consent|1|||
30979182|NCT01279057|59080429|FG000|Overall Study|Pregnancy|0|||
30979183|NCT01279057|59080430|FG001|Overall Study|Pregnancy|1|||
30979184|NCT01279057|59080431|FG002|Overall Study|Pregnancy|0|||
30979185|NCT01279057|59080429|FG000|Overall Study|Other|3|||
30979186|NCT01279057|59080430|FG001|Overall Study|Other|3|||
30979187|NCT01279057|59080431|FG002|Overall Study|Other|0|||
30979188|NCT02999633|59080439|FG000|Overall Study|Adverse Event|2|||
30979189|NCT02999633|59080439|FG000|Overall Study|Progressive disease|12|||
30979190|NCT01278745|59080541|FG000|Overall Study|Death|2|||
30979191|NCT01278745|59080542|FG001|Overall Study|Death|5|||
30979192|NCT01278745|59080543|FG002|Overall Study|Death|7|||
30979193|NCT01278745|59080544|FG003|Overall Study|Death|0|||
30979194|NCT01278745|59080541|FG000|Overall Study|Physician Decision|1|||
30979195|NCT01278745|59080542|FG001|Overall Study|Physician Decision|0|||
30979196|NCT01278745|59080543|FG002|Overall Study|Physician Decision|0|||
30979197|NCT01278745|59080544|FG003|Overall Study|Physician Decision|9|||
30979198|NCT01278745|59080541|FG000|Overall Study|Withdrawal by Subject|1|||
30979199|NCT01278745|59080542|FG001|Overall Study|Withdrawal by Subject|1|||
30979200|NCT01278745|59080543|FG002|Overall Study|Withdrawal by Subject|5|||
30979201|NCT01278745|59080544|FG003|Overall Study|Withdrawal by Subject|1|||
30979202|NCT01278745|59080541|FG000|Overall Study|Sponsor Decision|1|||
30979203|NCT01278745|59080542|FG001|Overall Study|Sponsor Decision|0|||
30979204|NCT01278745|59080543|FG002|Overall Study|Sponsor Decision|62|||
30979205|NCT01278745|59080544|FG003|Overall Study|Sponsor Decision|6|||
30979206|NCT01278745|59080541|FG000|Overall Study|Ineligible|0|||
30979207|NCT01278745|59080542|FG001|Overall Study|Ineligible|0|||
30979208|NCT01278745|59080543|FG002|Overall Study|Ineligible|42|||
30979209|NCT01278745|59080544|FG003|Overall Study|Ineligible|61|||
30979210|NCT01278745|59080541|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
30979211|NCT01278745|59080542|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
30979212|NCT01278745|59080543|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
30979213|NCT01278745|59080544|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
30979214|NCT03006926|59080554|FG000|Overall Study|Death|0|||
30979215|NCT03006926|59080555|FG001|Overall Study|Death|33|||
30979216|NCT03006926|59080554|FG000|Overall Study|Ongoing Survival Follow-up|0|||
30979217|NCT03006926|59080555|FG001|Overall Study|Ongoing Survival Follow-up|26|||
30979218|NCT03006926|59080554|FG000|Overall Study|Ongoing-on Treatment|0|||
30979219|NCT03006926|59080555|FG001|Overall Study|Ongoing-on Treatment|36|||
30979220|NCT03006926|59080554|FG000|Overall Study|Lost to Follow-up|0|||
30979221|NCT03006926|59080555|FG001|Overall Study|Lost to Follow-up|1|||
30979222|NCT03006926|59080554|FG000|Overall Study|Withdrawal by Subject|0|||
30979223|NCT03006926|59080555|FG001|Overall Study|Withdrawal by Subject|2|||
30979224|NCT01277887|59080617|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
30979225|NCT01277887|59080618|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
30979226|NCT01277887|59080617|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
30979227|NCT01277887|59080618|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
30979228|NCT01277887|59080617|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
30979229|NCT01277887|59080618|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
30979230|NCT01276327|59080632|FG000|Overall Study|Adverse Event|1|||
30979231|NCT01276327|59080633|FG001|Overall Study|Adverse Event|3|||
30979232|NCT01276327|59080632|FG000|Overall Study|Withdrawal by Subject|1|||
30979233|NCT01276327|59080633|FG001|Overall Study|Withdrawal by Subject|0|||
30979234|NCT00639002|59080755|FG000|Overall Study|Death|1|||
30979235|NCT00639002|59080755|FG000|Overall Study|Adverse Event|1|||
30979236|NCT00639002|59080755|FG000|Overall Study|Protocol Violation|1|||
30979237|NCT00639002|59080755|FG000|Overall Study|Disease progression|3|||
30979238|NCT00639002|59080755|FG000|Overall Study|Physician Decision|6|||
30979239|NCT00639002|59080755|FG000|Overall Study|Lack of Efficacy|1|||
30979240|NCT00638846|59080791|FG000|Overall Study|Adverse Event|0|||
30979241|NCT00638846|59080792|FG001|Overall Study|Adverse Event|1|||
30979242|NCT00638846|59080791|FG000|Overall Study|Lost to Follow-up|3|||
30979243|NCT00638846|59080792|FG001|Overall Study|Lost to Follow-up|2|||
30979244|NCT00638846|59080791|FG000|Overall Study|lens issue|1|||
30979245|NCT00638846|59080792|FG001|Overall Study|lens issue|3|||
30979246|NCT00638456|59080800|FG000|Overall Study|Withdrawal by Subject|6|||
30979247|NCT00638456|59080801|FG001|Overall Study|Withdrawal by Subject|2|||
30979248|NCT00638378|59080830|FG000|Overall Study|Death|2|||
30979249|NCT00638378|59080830|FG000|Overall Study|Adverse Event|1|||
30979250|NCT00638378|59080830|FG000|Overall Study|Disease progression|15|||
30979251|NCT00638378|59080830|FG000|Overall Study|Physician Decision|4|||
30979252|NCT03807349|59081007|FG000|Overall Study|Early Study Termination|9|||
30979253|NCT03802825|59081017|FG000|Overall Study|Lost to follow-up for intervention|12|||
30979254|NCT03802825|59081018|FG001|Overall Study|Lost to follow-up for intervention|3|||
30979255|NCT03802825|59081017|FG000|Overall Study|Received only 1 component of intervention|0|||
30979256|NCT03802825|59081018|FG001|Overall Study|Received only 1 component of intervention|13|||
30979257|NCT03808909|59081037|FG000|Overall Study|Lost to Follow-up|3|||
30979258|NCT03808909|59081038|FG001|Overall Study|Lost to Follow-up|0|||
30979259|NCT03802513|59081059|FG000|Overall Study|Lost to Follow-up|1|||
30979260|NCT01276223|59081250|FG000|Overall Study|Adverse Event|7|||
30979261|NCT01276223|59081251|FG001|Overall Study|Adverse Event|4|||
30979262|NCT01276223|59081252|FG002|Overall Study|Adverse Event|1|||
30979263|NCT01276223|59081250|FG000|Overall Study|Lost to Follow-up|0|||
30979264|NCT01276223|59081251|FG001|Overall Study|Lost to Follow-up|0|||
30979265|NCT01276223|59081252|FG002|Overall Study|Lost to Follow-up|1|||
30979266|NCT01276223|59081250|FG000|Overall Study|Other|0|||
30979267|NCT01276223|59081251|FG001|Overall Study|Other|0|||
30979268|NCT01276223|59081252|FG002|Overall Study|Other|1|||
30979269|NCT01276223|59081250|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
30979270|NCT01276223|59081251|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
30979271|NCT01276223|59081252|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
30979272|NCT01276223|59081250|FG000|Overall Study|Protocol Violation|1|||
30979273|NCT01276223|59081251|FG001|Overall Study|Protocol Violation|0|||
30979274|NCT01276223|59081252|FG002|Overall Study|Protocol Violation|0|||
30979275|NCT01275833|59081261|FG000|Overall Study|Study terminated|1|||
30979276|NCT01275833|59081262|FG001|Overall Study|Study terminated|1|||
30979277|NCT01275755|59081270|FG000|Double-blind Treatment Period|Adverse Event|0|||
30979278|NCT01275755|59081271|FG001|Double-blind Treatment Period|Adverse Event|2|||
30979279|NCT01275755|59081270|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
30979280|NCT01275755|59081271|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
30979281|NCT01275755|59081270|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
30979282|NCT01275755|59081271|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
30979283|NCT01275755|59081270|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
30979284|NCT01275755|59081271|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
30979285|NCT01275131|59081302|FG000|Period 1|Withdrawal by Subject|1|||
30979286|NCT01275131|59081303|FG001|Period 1|Withdrawal by Subject|0|||
30979287|NCT01275131|59081304|FG002|Period 1|Withdrawal by Subject|3|||
30979288|NCT01275131|59081305|FG003|Period 1|Withdrawal by Subject|2|||
30979289|NCT01275131|59081302|FG000|Period 1|Physician Decision|1|||
30979290|NCT01275131|59081303|FG001|Period 1|Physician Decision|0|||
30979291|NCT01275131|59081304|FG002|Period 1|Physician Decision|0|||
30979292|NCT01275131|59081305|FG003|Period 1|Physician Decision|0|||
30979293|NCT01275131|59081302|FG000|Period 2 (Crossover)|Adverse Event|0|||
30979294|NCT01275131|59081303|FG001|Period 2 (Crossover)|Adverse Event|1|||
30979295|NCT01275131|59081304|FG002|Period 2 (Crossover)|Adverse Event|0|||
30979296|NCT01275131|59081305|FG003|Period 2 (Crossover)|Adverse Event|0|||
30979297|NCT01275131|59081302|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
30979298|NCT01275131|59081303|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
30979299|NCT01275131|59081304|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
30979300|NCT01275131|59081305|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
30979301|NCT01274429|59081334|FG000|Overall Study|Study closed do to lack of funding|5|||
30979302|NCT01273883|59081338|FG000|First Intervention|Adverse Event|2|||
30979303|NCT01273883|59081339|FG001|First Intervention|Adverse Event|1|||
30979304|NCT01273883|59081338|FG000|Second Intervention|Lost to Follow-up|1|||
30979305|NCT01273883|59081339|FG001|Second Intervention|Lost to Follow-up|1|||
30979306|NCT01273883|59081338|FG000|Second Intervention|Lack of Efficacy|1|||
30979307|NCT01273883|59081339|FG001|Second Intervention|Lack of Efficacy|0|||
30979308|NCT01273805|59081347|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
30979309|NCT01273805|59081348|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
30979310|NCT01273181|59081358|FG000|Phase I, Dose 1|Study termination|1|||
30979311|NCT01273181|59081359|FG001|Phase I, Dose 1|Study termination|0|||
30979312|NCT01273181|59081360|FG002|Phase I, Dose 1|Study termination|0|||
30979313|NCT01273181|59081361|FG003|Phase I, Dose 1|Study termination|0|||
30979314|NCT01273181|59081358|FG000|Phase I, Dose 2|Death during treatment|0|||
30979315|NCT01273181|59081359|FG001|Phase I, Dose 2|Death during treatment|1|||
30979316|NCT01273181|59081360|FG002|Phase I, Dose 2|Death during treatment|0|||
30979317|NCT01273181|59081361|FG003|Phase I, Dose 2|Death during treatment|0|||
30979318|NCT01273181|59081358|FG000|Phase 2, Dose 1|Study termination|0|||
30979319|NCT01273181|59081359|FG001|Phase 2, Dose 1|Study termination|0|||
30979320|NCT01273181|59081360|FG002|Phase 2, Dose 1|Study termination|1|||
30979321|NCT01273181|59081361|FG003|Phase 2, Dose 1|Study termination|0|||
30979322|NCT01273181|59081358|FG000|Phase 2, Dose 2|Death during treatment|0|||
30979323|NCT01273181|59081359|FG001|Phase 2, Dose 2|Death during treatment|0|||
30979324|NCT01273181|59081360|FG002|Phase 2, Dose 2|Death during treatment|0|||
30979325|NCT01273181|59081361|FG003|Phase 2, Dose 2|Death during treatment|1|||
30979326|NCT01272947|59081377|FG000|Overall Study|Abnormal Laboratory Value|2|||
30979327|NCT01272947|59081378|FG001|Overall Study|Abnormal Laboratory Value|2|||
30979328|NCT01279343|59081386|FG000|Overall Study|Did not receive treatment|2|||
30979329|NCT01279343|59081387|FG001|Overall Study|Did not receive treatment|6|||
30979330|NCT01278797|59081393|FG000|Period 1|Adverse Event|0|||
30979331|NCT01278797|59081394|FG001|Period 1|Adverse Event|1|||
30979332|NCT01278797|59081393|FG000|Period 1|Protocol Violation|1|||
30979333|NCT01278797|59081394|FG001|Period 1|Protocol Violation|0|||
30979334|NCT01272869|59081402|FG000|Period 2 (14 Days)|Adverse Event|1|||
30979335|NCT01272869|59081403|FG001|Period 2 (14 Days)|Adverse Event|0|||
30979336|NCT01272635|59081411|FG000|Overall Study|Lost to Follow-up|31|||
30979337|NCT01272635|59081412|FG001|Overall Study|Lost to Follow-up|20|||
30979338|NCT01272635|59081413|FG002|Overall Study|Lost to Follow-up|31|||
30979339|NCT01272635|59081414|FG003|Overall Study|Lost to Follow-up|23|||
30979340|NCT01272011|59081425|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
30979341|NCT01272011|59081426|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
30979342|NCT01272011|59081427|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
30979343|NCT01270841|59081448|FG000|Overall Study|Adverse Event|0|||
30979344|NCT01270841|59081449|FG001|Overall Study|Adverse Event|1|||
30979345|NCT01270841|59081450|FG002|Overall Study|Adverse Event|0|||
30979346|NCT01270841|59081451|FG003|Overall Study|Adverse Event|3|||
30979347|NCT01270841|59081448|FG000|Overall Study|Withdrawal by Subject|3|||
30979348|NCT01270841|59081449|FG001|Overall Study|Withdrawal by Subject|2|||
30979349|NCT01270841|59081450|FG002|Overall Study|Withdrawal by Subject|3|||
30979350|NCT01270841|59081451|FG003|Overall Study|Withdrawal by Subject|3|||
30979351|NCT01270841|59081448|FG000|Overall Study|Lost to Follow-up|3|||
30979352|NCT01270841|59081449|FG001|Overall Study|Lost to Follow-up|1|||
30979353|NCT01270841|59081450|FG002|Overall Study|Lost to Follow-up|4|||
30979354|NCT01270841|59081451|FG003|Overall Study|Lost to Follow-up|2|||
30979355|NCT01270841|59081448|FG000|Overall Study|Physician Decision|0|||
30979356|NCT01270841|59081449|FG001|Overall Study|Physician Decision|1|||
30979357|NCT01270841|59081450|FG002|Overall Study|Physician Decision|0|||
30979358|NCT01270841|59081451|FG003|Overall Study|Physician Decision|0|||
30979359|NCT01270841|59081448|FG000|Overall Study|Did not qualify|6|||
30979360|NCT01270841|59081449|FG001|Overall Study|Did not qualify|3|||
30979361|NCT01270841|59081450|FG002|Overall Study|Did not qualify|4|||
30979362|NCT01270841|59081451|FG003|Overall Study|Did not qualify|5|||
30979363|NCT01270841|59081448|FG000|Overall Study|Protocol Violation|1|||
30979364|NCT01270841|59081449|FG001|Overall Study|Protocol Violation|5|||
30979365|NCT01270841|59081450|FG002|Overall Study|Protocol Violation|0|||
30979366|NCT01270841|59081451|FG003|Overall Study|Protocol Violation|0|||
30979367|NCT01270841|59081448|FG000|Overall Study|Enrolled in error|0|||
30979368|NCT01270841|59081449|FG001|Overall Study|Enrolled in error|1|||
30979369|NCT01270841|59081450|FG002|Overall Study|Enrolled in error|0|||
30979370|NCT01270841|59081451|FG003|Overall Study|Enrolled in error|0|||
30979371|NCT01270139|59081464|FG000|Overall Study|Adverse Event|8|||
30979372|NCT01270139|59081465|FG001|Overall Study|Adverse Event|17|||
30979373|NCT01270139|59081466|FG002|Overall Study|Adverse Event|18|||
30979374|NCT01270139|59081464|FG000|Overall Study|Lost to Follow-up|10|||
30979375|NCT01270139|59081465|FG001|Overall Study|Lost to Follow-up|9|||
30979376|NCT01270139|59081466|FG002|Overall Study|Lost to Follow-up|2|||
30979377|NCT01278407|59081484|FG000|Confirmatory Phase|Adverse Event|5|||
30979378|NCT01278407|59081485|FG001|Confirmatory Phase|Adverse Event|10|||
30979379|NCT01278407|59081486|FG002|Confirmatory Phase|Adverse Event|1|||
30979380|NCT01278407|59081487|FG003|Confirmatory Phase|Adverse Event|0|||
30979381|NCT01278407|59081488|FG004|Confirmatory Phase|Adverse Event|0|||
30979382|NCT01278407|59081484|FG000|Confirmatory Phase|Participant's Choice|3|||
30979383|NCT01278407|59081485|FG001|Confirmatory Phase|Participant's Choice|5|||
30979384|NCT01278407|59081486|FG002|Confirmatory Phase|Participant's Choice|3|||
30979385|NCT01278407|59081487|FG003|Confirmatory Phase|Participant's Choice|0|||
30979386|NCT01278407|59081488|FG004|Confirmatory Phase|Participant's Choice|0|||
30979387|NCT01278407|59081484|FG000|Confirmatory Phase|Other|1|||
30979388|NCT01278407|59081485|FG001|Confirmatory Phase|Other|1|||
30979389|NCT01278407|59081486|FG002|Confirmatory Phase|Other|2|||
30979390|NCT01278407|59081487|FG003|Confirmatory Phase|Other|0|||
30979391|NCT01278407|59081488|FG004|Confirmatory Phase|Other|0|||
30979392|NCT01278407|59081484|FG000|Extension Phase|Adverse Event|0|||
30979393|NCT01278407|59081485|FG001|Extension Phase|Adverse Event|0|||
30979394|NCT01278407|59081486|FG002|Extension Phase|Adverse Event|0|||
30979395|NCT01278407|59081487|FG003|Extension Phase|Adverse Event|7|||
30979396|NCT01278407|59081488|FG004|Extension Phase|Adverse Event|16|||
30979397|NCT01278407|59081484|FG000|Extension Phase|Participant's Choice|0|||
30979398|NCT01278407|59081485|FG001|Extension Phase|Participant's Choice|0|||
30979399|NCT01278407|59081486|FG002|Extension Phase|Participant's Choice|0|||
30979400|NCT01278407|59081487|FG003|Extension Phase|Participant's Choice|4|||
30979401|NCT01278407|59081488|FG004|Extension Phase|Participant's Choice|11|||
30979402|NCT01278407|59081484|FG000|Extension Phase|Other|0|||
30979403|NCT01278407|59081485|FG001|Extension Phase|Other|0|||
30979404|NCT01278407|59081486|FG002|Extension Phase|Other|0|||
30979405|NCT01278407|59081487|FG003|Extension Phase|Other|1|||
30979406|NCT01278407|59081488|FG004|Extension Phase|Other|3|||
30979407|NCT01278173|59081498|FG000|Overall Study|Lack of Efficacy|13|||
30979408|NCT01278173|59081498|FG000|Overall Study|Adverse Event|8|||
30979409|NCT01278173|59081498|FG000|Overall Study|Administrative or other reason|4|||
30979410|NCT01278173|59081498|FG000|Overall Study|Protocol Violation|1|||
30979411|NCT01278173|59081498|FG000|Overall Study|Withdrawal by Subject|1|||
30979412|NCT01277861|59081531|FG000|Overall Study|Physician Decision|2|||
30979413|NCT01277861|59081532|FG001|Overall Study|Physician Decision|2|||
30979414|NCT01277549|59081559|FG000|Overall Study|Failed to meet eligibility criteria|13|||
30979415|NCT01277549|59081560|FG001|Overall Study|Failed to meet eligibility criteria|9|||
30979416|NCT01277549|59081559|FG000|Overall Study|Withdrawal by Subject|1|||
30979417|NCT01277549|59081560|FG001|Overall Study|Withdrawal by Subject|3|||
30979418|NCT01277549|59081559|FG000|Overall Study|Protocol Violation|10|||
30979419|NCT01277549|59081560|FG001|Overall Study|Protocol Violation|1|||
30979420|NCT01277549|59081559|FG000|Overall Study|Physician Decision|2|||
30979421|NCT01277549|59081560|FG001|Overall Study|Physician Decision|1|||
30979422|NCT01276847|59081572|FG000|Overall Study|Withdrawal by Subject|1|||
30979423|NCT01276847|59081573|FG001|Overall Study|Withdrawal by Subject|0|||
30979424|NCT01276847|59081574|FG002|Overall Study|Withdrawal by Subject|0|||
30979425|NCT01276457|59081606|FG000|Core Study|Adverse Event|6|||
30979426|NCT01276457|59081607|FG001|Core Study|Adverse Event|3|||
30979427|NCT01276457|59081606|FG000|Core Study|Lost to Follow-up|1|||
30979428|NCT01276457|59081607|FG001|Core Study|Lost to Follow-up|2|||
30979429|NCT01276457|59081606|FG000|Core Study|Administrative problems|1|||
30979430|NCT01276457|59081607|FG001|Core Study|Administrative problems|1|||
30979431|NCT01276457|59081606|FG000|Core Study|Death|2|||
30979432|NCT01276457|59081607|FG001|Core Study|Death|2|||
30979433|NCT01276457|59081606|FG000|Core Study|Lack of Efficacy|3|||
30979434|NCT01276457|59081607|FG001|Core Study|Lack of Efficacy|12|||
30979435|NCT01276457|59081606|FG000|Extension Study|Lost to Follow-up|3|||
30979436|NCT01276457|59081607|FG001|Extension Study|Lost to Follow-up|0|||
30979437|NCT01276457|59081606|FG000|Extension Study|Death|0|||
30979438|NCT01276457|59081607|FG001|Extension Study|Death|1|||
30979439|NCT01276457|59081606|FG000|Extension Study|Lack of Efficacy|3|||
30979440|NCT01276457|59081607|FG001|Extension Study|Lack of Efficacy|1|||
30979441|NCT01276379|59081697|FG000|Overall Study|Screening failure|40|||
30979442|NCT03809663|59081993|FG000|Overall Study|Decision by sponsor|24|||
30979443|NCT03809663|59081994|FG001|Overall Study|Decision by sponsor|18|||
30979444|NCT03809663|59081995|FG002|Overall Study|Decision by sponsor|20|||
30979445|NCT03809663|59081996|FG003|Overall Study|Decision by sponsor|20|||
30979446|NCT03809663|59081997|FG004|Overall Study|Decision by sponsor|0|||
30979447|NCT03809663|59081998|FG005|Overall Study|Decision by sponsor|0|||
30979448|NCT03809663|59081993|FG000|Overall Study|Withdrawal by Subject|26|||
30979449|NCT03809663|59081994|FG001|Overall Study|Withdrawal by Subject|22|||
30979450|NCT03809663|59081995|FG002|Overall Study|Withdrawal by Subject|27|||
30979451|NCT03809663|59081996|FG003|Overall Study|Withdrawal by Subject|26|||
30979452|NCT03809663|59081997|FG004|Overall Study|Withdrawal by Subject|0|||
30979453|NCT03809663|59081998|FG005|Overall Study|Withdrawal by Subject|0|||
30979454|NCT03809663|59081993|FG000|Overall Study|Lost to Follow-up|1|||
30979455|NCT03809663|59081994|FG001|Overall Study|Lost to Follow-up|4|||
30979456|NCT03809663|59081995|FG002|Overall Study|Lost to Follow-up|1|||
30979457|NCT03809663|59081996|FG003|Overall Study|Lost to Follow-up|1|||
30979458|NCT03809663|59081997|FG004|Overall Study|Lost to Follow-up|0|||
30979459|NCT03809663|59081998|FG005|Overall Study|Lost to Follow-up|0|||
30979460|NCT00249821|59082060|FG000|Overall Study|Technical problem|0|||
30979461|NCT00249821|59082061|FG001|Overall Study|Technical problem|1|||
30979462|NCT00248651|59082136|FG000|Overall Study|Withdrawal by Subject|28|||
30979463|NCT00248651|59082137|FG001|Overall Study|Withdrawal by Subject|40|||
30979464|NCT00248651|59082138|FG002|Overall Study|Withdrawal by Subject|32|||
30979465|NCT00248495|59082175|FG000|Overall Study|Withdrawal by Subject|1|||
30979466|NCT03802565|59082272|FG000|Overall Study|Adverse Event|0|||
30979467|NCT03802565|59082273|FG001|Overall Study|Adverse Event|1|||
30979468|NCT03802565|59082274|FG002|Overall Study|Adverse Event|2|||
30979469|NCT03802565|59082275|FG003|Overall Study|Adverse Event|1|||
30979470|NCT03802565|59082276|FG004|Overall Study|Adverse Event|1|||
30979471|NCT03802565|59082272|FG000|Overall Study|Withdrawal by Subject|2|||
30979472|NCT03802565|59082273|FG001|Overall Study|Withdrawal by Subject|2|||
30979473|NCT03802565|59082274|FG002|Overall Study|Withdrawal by Subject|2|||
30979474|NCT03802565|59082275|FG003|Overall Study|Withdrawal by Subject|0|||
30979475|NCT03802565|59082276|FG004|Overall Study|Withdrawal by Subject|1|||
30979476|NCT03802565|59082272|FG000|Overall Study|Protocol Violation|2|||
30979477|NCT03802565|59082273|FG001|Overall Study|Protocol Violation|1|||
30979478|NCT03802565|59082274|FG002|Overall Study|Protocol Violation|4|||
30979479|NCT03802565|59082275|FG003|Overall Study|Protocol Violation|5|||
30979480|NCT03802565|59082276|FG004|Overall Study|Protocol Violation|1|||
30979481|NCT03802565|59082272|FG000|Overall Study|Lost to Follow-up|0|||
30979482|NCT03802565|59082273|FG001|Overall Study|Lost to Follow-up|0|||
30979483|NCT03802565|59082274|FG002|Overall Study|Lost to Follow-up|1|||
30979484|NCT03802565|59082275|FG003|Overall Study|Lost to Follow-up|0|||
30979485|NCT03802565|59082276|FG004|Overall Study|Lost to Follow-up|0|||
30979486|NCT03802565|59082272|FG000|Overall Study|Subjects Related to Each Other|1|||
30979487|NCT03802565|59082273|FG001|Overall Study|Subjects Related to Each Other|0|||
30979488|NCT03802565|59082274|FG002|Overall Study|Subjects Related to Each Other|0|||
30979489|NCT03802565|59082275|FG003|Overall Study|Subjects Related to Each Other|2|||
30979490|NCT03802565|59082276|FG004|Overall Study|Subjects Related to Each Other|1|||
30979491|NCT03802565|59082272|FG000|Overall Study|Elevated Enzymes|0|||
30979492|NCT03802565|59082273|FG001|Overall Study|Elevated Enzymes|0|||
30979493|NCT03802565|59082274|FG002|Overall Study|Elevated Enzymes|0|||
30979494|NCT03802565|59082275|FG003|Overall Study|Elevated Enzymes|0|||
30979495|NCT03802565|59082276|FG004|Overall Study|Elevated Enzymes|2|||
30979496|NCT00245765|59082320|FG000|Overall Study|Adverse Event|1|||
30979497|NCT00245765|59082321|FG001|Overall Study|Adverse Event|1|||
30979498|NCT00245765|59082322|FG002|Overall Study|Adverse Event|0|||
30979499|NCT00245765|59082320|FG000|Overall Study|Lack of Efficacy|14|||
30979500|NCT00245765|59082321|FG001|Overall Study|Lack of Efficacy|7|||
30979501|NCT00245765|59082322|FG002|Overall Study|Lack of Efficacy|0|||
30979502|NCT00245765|59082320|FG000|Overall Study|Lost to Follow-up|1|||
30979503|NCT00245765|59082321|FG001|Overall Study|Lost to Follow-up|2|||
30979504|NCT00245765|59082322|FG002|Overall Study|Lost to Follow-up|0|||
30979505|NCT00245765|59082320|FG000|Overall Study|Withdrawal by Subject|1|||
30979506|NCT00245765|59082321|FG001|Overall Study|Withdrawal by Subject|0|||
30979507|NCT00245765|59082322|FG002|Overall Study|Withdrawal by Subject|3|||
30979508|NCT00245765|59082320|FG000|Overall Study|Other reason|2|||
30979509|NCT00245765|59082321|FG001|Overall Study|Other reason|0|||
30979510|NCT00245765|59082322|FG002|Overall Study|Other reason|1|||
30979511|NCT00245765|59082320|FG000|Overall Study|Other|13|||
30979512|NCT00245765|59082321|FG001|Overall Study|Other|4|||
30979513|NCT00245765|59082322|FG002|Overall Study|Other|4|||
30979514|NCT00245063|59082394|FG000|Overall Study|Adverse Event|6|||
30979515|NCT00245063|59082395|FG001|Overall Study|Adverse Event|5|||
30979516|NCT00245063|59082394|FG000|Overall Study|Death|1|||
30979517|NCT00245063|59082395|FG001|Overall Study|Death|0|||
30979518|NCT04329091|59082460|FG000|Overall Study|Physician Decision|5|||
30979519|NCT00244751|59082467|FG000|Overall Study|Adverse Event|7|||
30891032|NCT01632345|58924117|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
30891033|NCT01632345|58924118|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
30891034|NCT01632345|58924112|FG000|Treatment: Part I|Physician Decision|2|||
30891035|NCT01632345|58924113|FG001|Treatment: Part I|Physician Decision|1|||
30891036|NCT01632345|58924114|FG002|Treatment: Part I|Physician Decision|0|||
30891037|NCT01632345|58924115|FG003|Treatment: Part I|Physician Decision|0|||
30891038|NCT01632345|58924116|FG004|Treatment: Part I|Physician Decision|1|||
30891039|NCT01632345|58924117|FG005|Treatment: Part I|Physician Decision|0|||
30891040|NCT01632345|58924118|FG006|Treatment: Part I|Physician Decision|0|||
30891041|NCT01632345|58924112|FG000|Treatment: Part I|Pregnancy|0|||
30891042|NCT01632345|58924113|FG001|Treatment: Part I|Pregnancy|1|||
30891043|NCT01632345|58924114|FG002|Treatment: Part I|Pregnancy|0|||
30891044|NCT01632345|58924115|FG003|Treatment: Part I|Pregnancy|0|||
30891045|NCT01632345|58924116|FG004|Treatment: Part I|Pregnancy|0|||
30891046|NCT01632345|58924117|FG005|Treatment: Part I|Pregnancy|0|||
30891047|NCT01632345|58924118|FG006|Treatment: Part I|Pregnancy|0|||
30891048|NCT01632345|58924112|FG000|Treatment: Part I|Protocol Deviation|0|||
30979520|NCT00244751|59082468|FG001|Overall Study|Adverse Event|7|||
30979521|NCT00244751|59082469|FG002|Overall Study|Adverse Event|5|||
30979522|NCT00244751|59082467|FG000|Overall Study|Lost to Follow-up|0|||
30979523|NCT00244751|59082468|FG001|Overall Study|Lost to Follow-up|1|||
30979524|NCT00244751|59082469|FG002|Overall Study|Lost to Follow-up|0|||
30979525|NCT00244751|59082467|FG000|Overall Study|Protocol Violation|1|||
30979526|NCT00244751|59082468|FG001|Overall Study|Protocol Violation|0|||
30979527|NCT00244751|59082469|FG002|Overall Study|Protocol Violation|1|||
30979528|NCT00244751|59082467|FG000|Overall Study|Withdrawal by Subject|7|||
30979529|NCT00244751|59082468|FG001|Overall Study|Withdrawal by Subject|5|||
30979530|NCT00244751|59082469|FG002|Overall Study|Withdrawal by Subject|3|||
30891049|NCT01632345|58924113|FG001|Treatment: Part I|Protocol Deviation|0|||
30891050|NCT01632345|58924114|FG002|Treatment: Part I|Protocol Deviation|1|||
30891051|NCT01632345|58924115|FG003|Treatment: Part I|Protocol Deviation|1|||
30891052|NCT01632345|58924116|FG004|Treatment: Part I|Protocol Deviation|0|||
30979531|NCT00244751|59082467|FG000|Overall Study|Elevated liver enzymes|1|||
30979532|NCT00244751|59082468|FG001|Overall Study|Elevated liver enzymes|0|||
30979533|NCT00244751|59082469|FG002|Overall Study|Elevated liver enzymes|0|||
30979534|NCT00244751|59082467|FG000|Overall Study|Lack of compliance with protocol|0|||
30979535|NCT00244751|59082468|FG001|Overall Study|Lack of compliance with protocol|1|||
30979536|NCT00244751|59082469|FG002|Overall Study|Lack of compliance with protocol|0|||
30979537|NCT00244751|59082467|FG000|Overall Study|Safety reasons|0|||
30979538|NCT00244751|59082468|FG001|Overall Study|Safety reasons|1|||
30979539|NCT00244751|59082469|FG002|Overall Study|Safety reasons|0|||
30979540|NCT00244751|59082467|FG000|Overall Study|Participant randomized by mistake|0|||
30979541|NCT00244751|59082468|FG001|Overall Study|Participant randomized by mistake|0|||
30979542|NCT00244751|59082469|FG002|Overall Study|Participant randomized by mistake|1|||
30979543|NCT00243659|59082511|FG000|Overall Study|Withdrawal by Subject|1|||
30979544|NCT00243659|59082512|FG001|Overall Study|Withdrawal by Subject|1|||
30979545|NCT00243659|59082511|FG000|Overall Study|Protocol Violation|1|||
30979546|NCT00243659|59082512|FG001|Overall Study|Protocol Violation|2|||
30979547|NCT00243347|59082527|FG000|Overall Study|Lack of Efficacy|4|||
30979548|NCT00243347|59082527|FG000|Overall Study|Adverse Event|2|||
30979549|NCT00243347|59082527|FG000|Overall Study|Death|1|||
30979550|NCT00243347|59082527|FG000|Overall Study|Withdrawal by Subject|5|||
30979551|NCT00243347|59082527|FG000|Overall Study|Condition worsened|7|||
30979552|NCT00243269|59082535|FG000|Overall Study|Protocol Violation|2|||
30979553|NCT00243269|59082536|FG001|Overall Study|Protocol Violation|1|||
30979554|NCT00243269|59082537|FG002|Overall Study|Protocol Violation|0|||
30979555|NCT00243269|59082538|FG003|Overall Study|Protocol Violation|1|||
30979556|NCT00243269|59082535|FG000|Overall Study|Lost to Follow-up|1|||
30979557|NCT00243269|59082536|FG001|Overall Study|Lost to Follow-up|0|||
30979558|NCT00243269|59082537|FG002|Overall Study|Lost to Follow-up|1|||
30979559|NCT00243269|59082538|FG003|Overall Study|Lost to Follow-up|3|||
30979560|NCT00242567|59083762|FG000|Overall Study|Adverse Event|70|||
30979561|NCT00242567|59083763|FG001|Overall Study|Adverse Event|43|||
30979562|NCT00242567|59083762|FG000|Overall Study|Disease Progression|17|||
30979563|NCT00242567|59083763|FG001|Overall Study|Disease Progression|22|||
30979564|NCT00242567|59083762|FG000|Overall Study|Symptomatic deterioration|9|||
30979565|NCT00242567|59083763|FG001|Overall Study|Symptomatic deterioration|3|||
30979566|NCT00242567|59083762|FG000|Overall Study|Lack of Efficacy|2|||
30979567|NCT00242567|59083763|FG001|Overall Study|Lack of Efficacy|2|||
30979568|NCT00242567|59083762|FG000|Overall Study|Lost to Follow-up|9|||
30979569|NCT00242567|59083763|FG001|Overall Study|Lost to Follow-up|19|||
30979570|NCT00242567|59083762|FG000|Overall Study|Withdrawal by Subject|33|||
30979571|NCT00242567|59083763|FG001|Overall Study|Withdrawal by Subject|28|||
30979572|NCT00242567|59083762|FG000|Overall Study|Protocol Violation|12|||
30979573|NCT00242567|59083763|FG001|Overall Study|Protocol Violation|12|||
30979574|NCT00242567|59083762|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
30979575|NCT00242567|59083763|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
30979576|NCT00242567|59083762|FG000|Overall Study|Other|14|||
30979577|NCT00242567|59083763|FG001|Overall Study|Other|9|||
30979578|NCT00241631|59083773|FG000|Run in (2 Weeks)|Physician Decision|3|||
30979579|NCT00241631|59083774|FG001|Run in (2 Weeks)|Physician Decision|3|||
30979580|NCT00241631|59083773|FG000|Phase 1 (4 Weeks)|sore throat|1|||
30979581|NCT00241631|59083774|FG001|Phase 1 (4 Weeks)|sore throat|0|||
30979582|NCT00241631|59083773|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
30979583|NCT00241631|59083774|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
30979584|NCT00241631|59083773|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
30979585|NCT00241631|59083774|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
30979586|NCT00241631|59083773|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
30979587|NCT00241631|59083774|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
30979588|NCT00240071|59083789|FG000|Overall Study|Withdrawal by Subject|3|||
30979589|NCT03761277|59084786|FG000|Enrollment to Implant|Screen Failure|17|||
30979590|NCT03761277|59084786|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
30979591|NCT03761277|59084786|FG000|Enrollment to Implant|Physician Decision|2|||
30979592|NCT03761277|59084786|FG000|Enrollment to Implant|Site Closure|3|||
30979593|NCT03761277|59084786|FG000|Enrollment to Implant|Sponsor Request|2|||
30979594|NCT03761277|59084786|FG000|Post-Implant to 6 Months|Adverse Event|2|||
30979595|NCT03761277|59084786|FG000|Post-Implant to 6 Months|Death|1|||
30979596|NCT03761277|59084786|FG000|Post-Implant to 6 Months|Site Closure|2|||
30979597|NCT03761277|59084786|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
30979598|NCT03761277|59084786|FG000|6 Months to 12 Months|Physician Decision|2|||
30979599|NCT03761277|59084786|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
30979600|NCT04099641|59084837|FG000|Overall Study|Death|46|||
30979601|NCT04099641|59084838|FG001|Overall Study|Death|12|||
30979602|NCT04099641|59084837|FG000|Overall Study|Lost to Follow-up|1|||
30979603|NCT04099641|59084838|FG001|Overall Study|Lost to Follow-up|0|||
30979604|NCT04099641|59084837|FG000|Overall Study|Withdrawal by Subject|2|||
30979605|NCT04099641|59084838|FG001|Overall Study|Withdrawal by Subject|0|||
30979606|NCT03123393|59084964|FG000|Overall Study|Study Terminated by Sponsor|6|||
30979607|NCT03123393|59084965|FG001|Overall Study|Study Terminated by Sponsor|9|||
30979608|NCT03123393|59084964|FG000|Overall Study|Withdrawal by Subject|2|||
30979609|NCT03123393|59084965|FG001|Overall Study|Withdrawal by Subject|1|||
30979610|NCT03123393|59084964|FG000|Overall Study|Reason not Specified|13|||
30979611|NCT03123393|59084965|FG001|Overall Study|Reason not Specified|13|||
30979612|NCT02834247|59085596|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
30979613|NCT02834247|59085597|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
30979614|NCT02834247|59085598|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
30979615|NCT02834247|59085599|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
30979616|NCT02834247|59085596|FG000|Dose Escalation Phase|Death|5|||
30979617|NCT02834247|59085597|FG001|Dose Escalation Phase|Death|6|||
30979618|NCT02834247|59085598|FG002|Dose Escalation Phase|Death|5|||
30979619|NCT02834247|59085599|FG003|Dose Escalation Phase|Death|0|||
30979620|NCT02834247|59085596|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
30979621|NCT02834247|59085597|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
30979622|NCT02834247|59085598|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
30979623|NCT02834247|59085599|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
30979624|NCT02834247|59085596|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
30979625|NCT02834247|59085597|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
30979626|NCT02834247|59085598|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
30979627|NCT02834247|59085599|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
30979628|NCT02834247|59085596|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
30979629|NCT02834247|59085597|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
30979630|NCT02834247|59085598|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
30979631|NCT02834247|59085599|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
30979632|NCT02834247|59085596|FG000|Dose Expansion Phase|Death|0|||
30979633|NCT02834247|59085597|FG001|Dose Expansion Phase|Death|0|||
30979634|NCT02834247|59085598|FG002|Dose Expansion Phase|Death|0|||
30979635|NCT02834247|59085599|FG003|Dose Expansion Phase|Death|8|||
30979636|NCT02834247|59085596|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
30979637|NCT02834247|59085597|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
30979638|NCT02834247|59085598|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
30979639|NCT02834247|59085599|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
30979640|NCT02834247|59085596|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
30979641|NCT02834247|59085597|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
30979642|NCT02834247|59085598|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
30979643|NCT02834247|59085599|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
30979644|NCT01839331|59086887|FG000|Overall Study|Early Termination|3|||
30979645|NCT01839331|59086888|FG001|Overall Study|Early Termination|0|||
30979646|NCT01839331|59086889|FG002|Overall Study|Early Termination|1|||
30979647|NCT01839331|59086890|FG003|Overall Study|Early Termination|2|||
30979648|NCT01839331|59086887|FG000|Overall Study|Protocol Violation|1|||
30979649|NCT01839331|59086888|FG001|Overall Study|Protocol Violation|6|||
30979650|NCT01839331|59086889|FG002|Overall Study|Protocol Violation|4|||
30979651|NCT01839331|59086890|FG003|Overall Study|Protocol Violation|3|||
30979652|NCT02733042|59087036|FG000|Treatment Period|Adverse Event|1|||
30979653|NCT02733042|59087037|FG001|Treatment Period|Adverse Event|0|||
30979654|NCT02733042|59087038|FG002|Treatment Period|Adverse Event|1|||
30979655|NCT02733042|59087039|FG003|Treatment Period|Adverse Event|1|||
30979656|NCT02733042|59087040|FG004|Treatment Period|Adverse Event|0|||
30979657|NCT02733042|59087041|FG005|Treatment Period|Adverse Event|0|||
30979658|NCT02733042|59087042|FG006|Treatment Period|Adverse Event|0|||
30979659|NCT02733042|59087043|FG007|Treatment Period|Adverse Event|0|||
30979660|NCT02733042|59087044|FG008|Treatment Period|Adverse Event|0|||
30979661|NCT02733042|59087045|FG009|Treatment Period|Adverse Event|0|||
30979662|NCT02733042|59087046|FG010|Treatment Period|Adverse Event|2|||
30979663|NCT02733042|59087047|FG011|Treatment Period|Adverse Event|2|||
30979664|NCT02733042|59087048|FG012|Treatment Period|Adverse Event|0|||
30979665|NCT02733042|59087049|FG013|Treatment Period|Adverse Event|2|||
30979666|NCT02733042|59087050|FG014|Treatment Period|Adverse Event|0|||
30979667|NCT02733042|59087051|FG015|Treatment Period|Adverse Event|0|||
30979668|NCT02733042|59087052|FG016|Treatment Period|Adverse Event|0|||
30979669|NCT02733042|59087053|FG017|Treatment Period|Adverse Event|1|||
30979670|NCT02733042|59087054|FG018|Treatment Period|Adverse Event|0|||
30979671|NCT02733042|59087036|FG000|Treatment Period|Progressive Disease|2|||
30979672|NCT02733042|59087037|FG001|Treatment Period|Progressive Disease|1|||
30979673|NCT02733042|59087038|FG002|Treatment Period|Progressive Disease|3|||
30979674|NCT02733042|59087039|FG003|Treatment Period|Progressive Disease|1|||
30979675|NCT02733042|59087040|FG004|Treatment Period|Progressive Disease|1|||
30979676|NCT02733042|59087041|FG005|Treatment Period|Progressive Disease|3|||
30979677|NCT02733042|59087042|FG006|Treatment Period|Progressive Disease|0|||
30979678|NCT02733042|59087043|FG007|Treatment Period|Progressive Disease|3|||
30979679|NCT02733042|59087044|FG008|Treatment Period|Progressive Disease|3|||
30979680|NCT02733042|59087045|FG009|Treatment Period|Progressive Disease|0|||
30979681|NCT02733042|59087046|FG010|Treatment Period|Progressive Disease|2|||
30979682|NCT02733042|59087047|FG011|Treatment Period|Progressive Disease|2|||
30979683|NCT02733042|59087048|FG012|Treatment Period|Progressive Disease|8|||
30979684|NCT02733042|59087049|FG013|Treatment Period|Progressive Disease|1|||
30979685|NCT02733042|59087050|FG014|Treatment Period|Progressive Disease|4|||
30979686|NCT02733042|59087051|FG015|Treatment Period|Progressive Disease|7|||
30979687|NCT02733042|59087052|FG016|Treatment Period|Progressive Disease|2|||
30979688|NCT02733042|59087053|FG017|Treatment Period|Progressive Disease|3|||
30979689|NCT02733042|59087054|FG018|Treatment Period|Progressive Disease|4|||
30979690|NCT02733042|59087036|FG000|Treatment Period|Withdrawal by Subject|0|||
30979691|NCT02733042|59087037|FG001|Treatment Period|Withdrawal by Subject|1|||
30979692|NCT02733042|59087038|FG002|Treatment Period|Withdrawal by Subject|2|||
30979693|NCT02733042|59087039|FG003|Treatment Period|Withdrawal by Subject|1|||
30979694|NCT02733042|59087040|FG004|Treatment Period|Withdrawal by Subject|0|||
30979695|NCT02733042|59087041|FG005|Treatment Period|Withdrawal by Subject|0|||
30979696|NCT02733042|59087042|FG006|Treatment Period|Withdrawal by Subject|0|||
30979697|NCT02733042|59087043|FG007|Treatment Period|Withdrawal by Subject|0|||
30979698|NCT02733042|59087044|FG008|Treatment Period|Withdrawal by Subject|1|||
30979699|NCT02733042|59087045|FG009|Treatment Period|Withdrawal by Subject|1|||
30979700|NCT02733042|59087046|FG010|Treatment Period|Withdrawal by Subject|0|||
30979701|NCT02733042|59087047|FG011|Treatment Period|Withdrawal by Subject|2|||
30979702|NCT02733042|59087048|FG012|Treatment Period|Withdrawal by Subject|1|||
30979703|NCT02733042|59087049|FG013|Treatment Period|Withdrawal by Subject|1|||
30979704|NCT02733042|59087050|FG014|Treatment Period|Withdrawal by Subject|0|||
30979705|NCT02733042|59087051|FG015|Treatment Period|Withdrawal by Subject|0|||
30979706|NCT02733042|59087052|FG016|Treatment Period|Withdrawal by Subject|0|||
30979707|NCT02733042|59087053|FG017|Treatment Period|Withdrawal by Subject|0|||
30979708|NCT02733042|59087054|FG018|Treatment Period|Withdrawal by Subject|0|||
30979709|NCT02733042|59087036|FG000|Treatment Period|Other|0|||
30979710|NCT02733042|59087037|FG001|Treatment Period|Other|0|||
30979711|NCT02733042|59087038|FG002|Treatment Period|Other|1|||
30979712|NCT02733042|59087039|FG003|Treatment Period|Other|0|||
30979713|NCT02733042|59087040|FG004|Treatment Period|Other|0|||
30979714|NCT02733042|59087041|FG005|Treatment Period|Other|0|||
30979715|NCT02733042|59087042|FG006|Treatment Period|Other|0|||
30979716|NCT02733042|59087043|FG007|Treatment Period|Other|0|||
30979717|NCT02733042|59087044|FG008|Treatment Period|Other|0|||
30979718|NCT02733042|59087045|FG009|Treatment Period|Other|1|||
30979719|NCT02733042|59087046|FG010|Treatment Period|Other|1|||
30979720|NCT02733042|59087047|FG011|Treatment Period|Other|0|||
30979721|NCT02733042|59087048|FG012|Treatment Period|Other|0|||
30979722|NCT02733042|59087049|FG013|Treatment Period|Other|0|||
30979723|NCT02733042|59087050|FG014|Treatment Period|Other|0|||
30979724|NCT02733042|59087051|FG015|Treatment Period|Other|1|||
30979725|NCT02733042|59087052|FG016|Treatment Period|Other|0|||
30979726|NCT02733042|59087053|FG017|Treatment Period|Other|1|||
30979727|NCT02733042|59087054|FG018|Treatment Period|Other|0|||
30979728|NCT02733042|59087036|FG000|Treatment Period|Ongoing on Assigned Treatment|0|||
30979729|NCT02733042|59087037|FG001|Treatment Period|Ongoing on Assigned Treatment|0|||
30979730|NCT02733042|59087038|FG002|Treatment Period|Ongoing on Assigned Treatment|0|||
30979731|NCT02733042|59087039|FG003|Treatment Period|Ongoing on Assigned Treatment|0|||
30979732|NCT02733042|59087040|FG004|Treatment Period|Ongoing on Assigned Treatment|3|||
30979733|NCT02733042|59087041|FG005|Treatment Period|Ongoing on Assigned Treatment|0|||
30979734|NCT02733042|59087042|FG006|Treatment Period|Ongoing on Assigned Treatment|0|||
30979735|NCT02733042|59087043|FG007|Treatment Period|Ongoing on Assigned Treatment|0|||
30979736|NCT02733042|59087044|FG008|Treatment Period|Ongoing on Assigned Treatment|0|||
30979737|NCT02733042|59087045|FG009|Treatment Period|Ongoing on Assigned Treatment|8|||
30979738|NCT02733042|59087046|FG010|Treatment Period|Ongoing on Assigned Treatment|4|||
30979739|NCT02733042|59087047|FG011|Treatment Period|Ongoing on Assigned Treatment|0|||
30979740|NCT02733042|59087048|FG012|Treatment Period|Ongoing on Assigned Treatment|0|||
30979741|NCT02733042|59087049|FG013|Treatment Period|Ongoing on Assigned Treatment|0|||
30979742|NCT02733042|59087050|FG014|Treatment Period|Ongoing on Assigned Treatment|0|||
30979743|NCT02733042|59087051|FG015|Treatment Period|Ongoing on Assigned Treatment|0|||
30979744|NCT02733042|59087052|FG016|Treatment Period|Ongoing on Assigned Treatment|0|||
30979745|NCT02733042|59087053|FG017|Treatment Period|Ongoing on Assigned Treatment|0|||
30979746|NCT02733042|59087054|FG018|Treatment Period|Ongoing on Assigned Treatment|1|||
30979747|NCT02733042|59087036|FG000|Treatment Period|Death|0|||
30979748|NCT02733042|59087037|FG001|Treatment Period|Death|0|||
30979749|NCT02733042|59087038|FG002|Treatment Period|Death|0|||
30891053|NCT01632345|58924117|FG005|Treatment: Part I|Protocol Deviation|0|||
30891054|NCT01632345|58924118|FG006|Treatment: Part I|Protocol Deviation|0|||
30891055|NCT01632345|58924112|FG000|Treatment: Part I|Withdrawal by Subject|3|||
30891056|NCT01632345|58924113|FG001|Treatment: Part I|Withdrawal by Subject|4|||
30891057|NCT01632345|58924114|FG002|Treatment: Part I|Withdrawal by Subject|4|||
30891058|NCT01632345|58924115|FG003|Treatment: Part I|Withdrawal by Subject|1|||
30891059|NCT01632345|58924116|FG004|Treatment: Part I|Withdrawal by Subject|4|||
30891060|NCT01632345|58924117|FG005|Treatment: Part I|Withdrawal by Subject|0|||
30891061|NCT01632345|58924118|FG006|Treatment: Part I|Withdrawal by Subject|0|||
30891062|NCT01632345|58924112|FG000|Treatment: Part II|Adverse Event|0|||
30891063|NCT01632345|58924113|FG001|Treatment: Part II|Adverse Event|0|||
30891064|NCT01632345|58924114|FG002|Treatment: Part II|Adverse Event|0|||
30891065|NCT01632345|58924115|FG003|Treatment: Part II|Adverse Event|0|||
30891066|NCT01632345|58924116|FG004|Treatment: Part II|Adverse Event|0|||
30891067|NCT01632345|58924117|FG005|Treatment: Part II|Adverse Event|3|||
30891068|NCT01632345|58924118|FG006|Treatment: Part II|Adverse Event|8|||
30891069|NCT01632345|58924112|FG000|Treatment: Part II|Lost to Follow-up|0|||
30891070|NCT01632345|58924113|FG001|Treatment: Part II|Lost to Follow-up|0|||
30891071|NCT01632345|58924114|FG002|Treatment: Part II|Lost to Follow-up|0|||
30891072|NCT01632345|58924115|FG003|Treatment: Part II|Lost to Follow-up|0|||
30891073|NCT01632345|58924116|FG004|Treatment: Part II|Lost to Follow-up|0|||
30891074|NCT01632345|58924117|FG005|Treatment: Part II|Lost to Follow-up|3|||
30891075|NCT01632345|58924118|FG006|Treatment: Part II|Lost to Follow-up|1|||
30891076|NCT01632345|58924112|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
30891077|NCT01632345|58924113|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
30891078|NCT01632345|58924114|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
30891079|NCT01632345|58924115|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
30891080|NCT01632345|58924116|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
30891081|NCT01632345|58924117|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
30891082|NCT01632345|58924118|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
30891083|NCT01632345|58924112|FG000|Treatment: Part II|Withdrawal by Subject|0|||
30891084|NCT01632345|58924113|FG001|Treatment: Part II|Withdrawal by Subject|0|||
30891085|NCT01632345|58924114|FG002|Treatment: Part II|Withdrawal by Subject|0|||
30891086|NCT01632345|58924115|FG003|Treatment: Part II|Withdrawal by Subject|0|||
30891087|NCT01632345|58924116|FG004|Treatment: Part II|Withdrawal by Subject|0|||
30891088|NCT01632345|58924117|FG005|Treatment: Part II|Withdrawal by Subject|2|||
30891089|NCT01632345|58924118|FG006|Treatment: Part II|Withdrawal by Subject|2|||
30891090|NCT02232243|58924136|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
30891091|NCT02232243|58924137|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
30891092|NCT02232243|58924138|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
30891093|NCT02205333|58924156|FG000|Overall Study|Death|5|||
30891094|NCT02205333|58924157|FG001|Overall Study|Death|6|||
30891095|NCT02205333|58924158|FG002|Overall Study|Death|2|||
30891096|NCT02205333|58924159|FG003|Overall Study|Death|6|||
30891097|NCT02205333|58924160|FG004|Overall Study|Death|5|||
30891098|NCT02205333|58924161|FG005|Overall Study|Death|3|||
30891099|NCT02205333|58924162|FG006|Overall Study|Death|3|||
30891100|NCT02205333|58924163|FG007|Overall Study|Death|2|||
30891101|NCT02205333|58924164|FG008|Overall Study|Death|0|||
30891102|NCT02205333|58924156|FG000|Overall Study|Withdrawal by Subject|1|||
30891103|NCT02205333|58924157|FG001|Overall Study|Withdrawal by Subject|0|||
30891104|NCT02205333|58924158|FG002|Overall Study|Withdrawal by Subject|0|||
30891105|NCT02205333|58924159|FG003|Overall Study|Withdrawal by Subject|1|||
30891106|NCT02205333|58924160|FG004|Overall Study|Withdrawal by Subject|0|||
30891107|NCT02205333|58924161|FG005|Overall Study|Withdrawal by Subject|0|||
30891108|NCT02205333|58924162|FG006|Overall Study|Withdrawal by Subject|2|||
30891109|NCT02205333|58924163|FG007|Overall Study|Withdrawal by Subject|0|||
30891110|NCT02205333|58924164|FG008|Overall Study|Withdrawal by Subject|0|||
30891111|NCT02230683|58924184|FG000|Overall Study|Adverse Event|1|||
30891112|NCT02230527|58924196|FG000|Overall Study|Withdrawal by Subject|1|||
30891113|NCT02230527|58924197|FG001|Overall Study|Withdrawal by Subject|1|||
30891114|NCT02230527|58924196|FG000|Overall Study|Death|1|||
30891115|NCT02230527|58924197|FG001|Overall Study|Death|0|||
30891116|NCT02230527|58924196|FG000|Overall Study|Lost to Follow-up|2|||
30891117|NCT02230527|58924197|FG001|Overall Study|Lost to Follow-up|1|||
30891118|NCT02230527|58924196|FG000|Overall Study|Other|1|||
30891119|NCT02230527|58924197|FG001|Overall Study|Other|0|||
30891120|NCT02204319|58924203|FG000|Overall Study|Pregnancy|1|||
30891121|NCT02204319|58924203|FG000|Overall Study|Withdrawal by Subject|2|||
30891122|NCT02204007|58924210|FG000|Overall Study|Surgery Canceled|1|||
30979750|NCT02733042|59087039|FG003|Treatment Period|Death|0|||
30979751|NCT02733042|59087040|FG004|Treatment Period|Death|0|||
30979752|NCT02733042|59087041|FG005|Treatment Period|Death|0|||
30979753|NCT02733042|59087042|FG006|Treatment Period|Death|1|||
30979754|NCT02733042|59087043|FG007|Treatment Period|Death|0|||
30979755|NCT02733042|59087044|FG008|Treatment Period|Death|1|||
30979756|NCT02733042|59087045|FG009|Treatment Period|Death|0|||
30979757|NCT02733042|59087046|FG010|Treatment Period|Death|1|||
30979758|NCT02733042|59087047|FG011|Treatment Period|Death|0|||
30979759|NCT02733042|59087048|FG012|Treatment Period|Death|0|||
30979760|NCT02733042|59087049|FG013|Treatment Period|Death|0|||
30979761|NCT02733042|59087050|FG014|Treatment Period|Death|1|||
30979762|NCT02733042|59087051|FG015|Treatment Period|Death|2|||
30979763|NCT02733042|59087052|FG016|Treatment Period|Death|0|||
30979764|NCT02733042|59087053|FG017|Treatment Period|Death|0|||
30979765|NCT02733042|59087054|FG018|Treatment Period|Death|0|||
30979766|NCT02733042|59087036|FG000|Follow-up Period|Ongoing on Follow-up|2|||
30979767|NCT02733042|59087037|FG001|Follow-up Period|Ongoing on Follow-up|2|||
30979768|NCT02733042|59087038|FG002|Follow-up Period|Ongoing on Follow-up|4|||
30979769|NCT02733042|59087039|FG003|Follow-up Period|Ongoing on Follow-up|2|||
30979770|NCT02733042|59087040|FG004|Follow-up Period|Ongoing on Follow-up|0|||
30979771|NCT02733042|59087041|FG005|Follow-up Period|Ongoing on Follow-up|0|||
30979772|NCT02733042|59087042|FG006|Follow-up Period|Ongoing on Follow-up|0|||
30979773|NCT02733042|59087043|FG007|Follow-up Period|Ongoing on Follow-up|1|||
30979774|NCT02733042|59087044|FG008|Follow-up Period|Ongoing on Follow-up|0|||
30979775|NCT02733042|59087045|FG009|Follow-up Period|Ongoing on Follow-up|2|||
30979776|NCT02733042|59087046|FG010|Follow-up Period|Ongoing on Follow-up|4|||
30979777|NCT02733042|59087047|FG011|Follow-up Period|Ongoing on Follow-up|9|||
30979778|NCT02733042|59087048|FG012|Follow-up Period|Ongoing on Follow-up|1|||
30979779|NCT02733042|59087049|FG013|Follow-up Period|Ongoing on Follow-up|3|||
30979780|NCT02733042|59087050|FG014|Follow-up Period|Ongoing on Follow-up|0|||
30979781|NCT02733042|59087051|FG015|Follow-up Period|Ongoing on Follow-up|0|||
30979782|NCT02733042|59087052|FG016|Follow-up Period|Ongoing on Follow-up|0|||
30979783|NCT02733042|59087053|FG017|Follow-up Period|Ongoing on Follow-up|1|||
30979784|NCT02733042|59087054|FG018|Follow-up Period|Ongoing on Follow-up|0|||
30979785|NCT02733042|59087036|FG000|Follow-up Period|Death|1|||
30979786|NCT02733042|59087037|FG001|Follow-up Period|Death|1|||
30979787|NCT02733042|59087038|FG002|Follow-up Period|Death|2|||
30979788|NCT02733042|59087039|FG003|Follow-up Period|Death|0|||
30979789|NCT02733042|59087040|FG004|Follow-up Period|Death|1|||
30979790|NCT02733042|59087041|FG005|Follow-up Period|Death|2|||
30979791|NCT02733042|59087042|FG006|Follow-up Period|Death|0|||
30979792|NCT02733042|59087043|FG007|Follow-up Period|Death|3|||
30979793|NCT02733042|59087044|FG008|Follow-up Period|Death|3|||
30979794|NCT02733042|59087045|FG009|Follow-up Period|Death|0|||
30979795|NCT02733042|59087046|FG010|Follow-up Period|Death|0|||
30979796|NCT02733042|59087047|FG011|Follow-up Period|Death|0|||
30979797|NCT02733042|59087048|FG012|Follow-up Period|Death|8|||
30979798|NCT02733042|59087049|FG013|Follow-up Period|Death|1|||
30979799|NCT02733042|59087050|FG014|Follow-up Period|Death|1|||
30979800|NCT02733042|59087051|FG015|Follow-up Period|Death|4|||
30979801|NCT02733042|59087052|FG016|Follow-up Period|Death|0|||
30979802|NCT02733042|59087053|FG017|Follow-up Period|Death|1|||
30979803|NCT02733042|59087054|FG018|Follow-up Period|Death|2|||
30979804|NCT02733042|59087036|FG000|Follow-up Period|Other|0|||
30979805|NCT02733042|59087037|FG001|Follow-up Period|Other|0|||
30979806|NCT02733042|59087038|FG002|Follow-up Period|Other|0|||
30979807|NCT02733042|59087039|FG003|Follow-up Period|Other|1|||
30979808|NCT02733042|59087040|FG004|Follow-up Period|Other|0|||
30979809|NCT02733042|59087041|FG005|Follow-up Period|Other|0|||
30979810|NCT02733042|59087042|FG006|Follow-up Period|Other|0|||
30979811|NCT02733042|59087043|FG007|Follow-up Period|Other|0|||
30979812|NCT02733042|59087044|FG008|Follow-up Period|Other|0|||
30979813|NCT02733042|59087045|FG009|Follow-up Period|Other|0|||
30979814|NCT02733042|59087046|FG010|Follow-up Period|Other|0|||
30979815|NCT02733042|59087047|FG011|Follow-up Period|Other|0|||
30979816|NCT02733042|59087048|FG012|Follow-up Period|Other|0|||
30979817|NCT02733042|59087049|FG013|Follow-up Period|Other|0|||
30979818|NCT02733042|59087050|FG014|Follow-up Period|Other|0|||
30979819|NCT02733042|59087051|FG015|Follow-up Period|Other|0|||
30979820|NCT02733042|59087052|FG016|Follow-up Period|Other|0|||
30979821|NCT02733042|59087053|FG017|Follow-up Period|Other|0|||
30979822|NCT02733042|59087054|FG018|Follow-up Period|Other|0|||
30979823|NCT02733042|59087036|FG000|Follow-up Period|Withdrawal by Subject|0|||
30979824|NCT02733042|59087037|FG001|Follow-up Period|Withdrawal by Subject|0|||
30979825|NCT02733042|59087038|FG002|Follow-up Period|Withdrawal by Subject|0|||
30979826|NCT02733042|59087039|FG003|Follow-up Period|Withdrawal by Subject|0|||
30979827|NCT02733042|59087040|FG004|Follow-up Period|Withdrawal by Subject|0|||
30979828|NCT02733042|59087041|FG005|Follow-up Period|Withdrawal by Subject|0|||
30979829|NCT02733042|59087042|FG006|Follow-up Period|Withdrawal by Subject|0|||
30979830|NCT02733042|59087043|FG007|Follow-up Period|Withdrawal by Subject|0|||
30979831|NCT02733042|59087044|FG008|Follow-up Period|Withdrawal by Subject|1|||
30979832|NCT02733042|59087045|FG009|Follow-up Period|Withdrawal by Subject|0|||
30979833|NCT02733042|59087046|FG010|Follow-up Period|Withdrawal by Subject|1|||
30979834|NCT02733042|59087047|FG011|Follow-up Period|Withdrawal by Subject|0|||
30979835|NCT02733042|59087048|FG012|Follow-up Period|Withdrawal by Subject|0|||
30979836|NCT02733042|59087049|FG013|Follow-up Period|Withdrawal by Subject|0|||
30979837|NCT02733042|59087050|FG014|Follow-up Period|Withdrawal by Subject|0|||
30979838|NCT02733042|59087051|FG015|Follow-up Period|Withdrawal by Subject|1|||
30979839|NCT02733042|59087052|FG016|Follow-up Period|Withdrawal by Subject|0|||
30979840|NCT02733042|59087053|FG017|Follow-up Period|Withdrawal by Subject|0|||
30979841|NCT02733042|59087054|FG018|Follow-up Period|Withdrawal by Subject|0|||
30979842|NCT02859064|59087287|FG000|Overall Study|Progressive Disease|3|||
30979843|NCT02859064|59087287|FG000|Overall Study|Physician Decision|1|||
30979844|NCT02859064|59087287|FG000|Overall Study|Withdrawal by Subject|1|||
30979845|NCT02859064|59087287|FG000|Overall Study|Death|1|||
30979846|NCT01606176|59087326|FG000|Overall Study|Adverse Event|2|||
30979847|NCT01606176|59087327|FG001|Overall Study|Adverse Event|3|||
30979848|NCT01606176|59087326|FG000|Overall Study|Disease progression|1|||
30979849|NCT01606176|59087327|FG001|Overall Study|Disease progression|0|||
30979850|NCT01606176|59087326|FG000|Overall Study|Withdrawal by Subject|1|||
30979851|NCT01606176|59087327|FG001|Overall Study|Withdrawal by Subject|0|||
30979852|NCT01663896|59087393|FG000|Overall Study|Various reasons|43|||
30979853|NCT02576652|59087446|FG000|Overall Study|Withdrawal by Subject|2|||
30979854|NCT02575950|59087530|FG000|Overall Study|Withdrawal by Subject|0|||
30979855|NCT02575950|59087531|FG001|Overall Study|Withdrawal by Subject|0|||
30979856|NCT02575950|59087532|FG002|Overall Study|Withdrawal by Subject|0|||
30979857|NCT02575950|59087533|FG003|Overall Study|Withdrawal by Subject|2|||
30979858|NCT02575950|59087530|FG000|Overall Study|Lost to Follow-up|0|||
30979859|NCT02575950|59087531|FG001|Overall Study|Lost to Follow-up|1|||
30979860|NCT02575950|59087532|FG002|Overall Study|Lost to Follow-up|0|||
30979861|NCT02575950|59087533|FG003|Overall Study|Lost to Follow-up|3|||
30979862|NCT01049581|59087632|FG000|Overall Study|Lost to Follow-up|2|||
30979863|NCT01049581|59087633|FG001|Overall Study|Lost to Follow-up|1|||
30979864|NCT02571972|59087651|FG000|Overall Study|Protocol Violation|2|||
30979865|NCT02571972|59087651|FG000|Overall Study|Withdrawal by Subject|2|||
30979866|NCT02166905|59087749|FG000|Overall Study|Withdrawal by Subject|1|||
30979867|NCT02166905|59087750|FG001|Overall Study|Withdrawal by Subject|0|||
30979868|NCT02166905|59087751|FG002|Overall Study|Withdrawal by Subject|0|||
30979869|NCT02166905|59087752|FG003|Overall Study|Withdrawal by Subject|0|||
30979870|NCT01501955|59087799|FG000|Overall Study|Withdrawal by Subject|1|||
30979871|NCT01501955|59087800|FG001|Overall Study|Withdrawal by Subject|0|||
30979872|NCT01501955|59087799|FG000|Overall Study|Adverse Event|1|||
30979873|NCT01501955|59087800|FG001|Overall Study|Adverse Event|3|||
30979874|NCT02574312|59087928|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
30979875|NCT02574312|59087929|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
30979876|NCT01049035|59087951|FG000|Overall Study|Serious adverse event|0|||
30979877|NCT01049035|59087952|FG001|Overall Study|Serious adverse event|1|||
30979878|NCT01049035|59087953|FG002|Overall Study|Serious adverse event|1|||
30979879|NCT01049035|59087954|FG003|Overall Study|Serious adverse event|2|||
30979880|NCT01049035|59087955|FG004|Overall Study|Serious adverse event|0|||
30979881|NCT01049035|59087956|FG005|Overall Study|Serious adverse event|0|||
30891123|NCT02204007|58924211|FG001|Overall Study|Surgery Canceled|1|||
30891124|NCT02203851|58924217|FG000|Overall Study|Lost to Follow-up|4|||
30891125|NCT02203851|58924217|FG000|Overall Study|Withdrawal by Subject|6|||
30891126|NCT02203851|58924217|FG000|Overall Study|Other|1|||
30891127|NCT02228967|58924230|FG000|Overall Study|Lost to Follow-up|146|||
30891128|NCT02228967|58924231|FG001|Overall Study|Lost to Follow-up|142|||
30891129|NCT02228967|58924230|FG000|Overall Study|Withdrawal by Subject|13|||
30891130|NCT02228967|58924231|FG001|Overall Study|Withdrawal by Subject|18|||
30891131|NCT02227875|58924239|FG000|Overall Study|Protocol Violation|10|||
30891132|NCT02227875|58924240|FG001|Overall Study|Protocol Violation|7|||
30891133|NCT02227875|58924239|FG000|Overall Study|Other|1|||
30891134|NCT02227875|58924240|FG001|Overall Study|Other|3|||
30891135|NCT02227875|58924239|FG000|Overall Study|Physician Decision|1|||
30891136|NCT02227875|58924240|FG001|Overall Study|Physician Decision|0|||
30891137|NCT02227875|58924239|FG000|Overall Study|Adverse Event|3|||
30979882|NCT01049035|59087957|FG006|Overall Study|Serious adverse event|0|||
30979883|NCT01049035|59087951|FG000|Overall Study|Other adverse event (AE)|0|||
30979884|NCT01049035|59087952|FG001|Overall Study|Other adverse event (AE)|0|||
30979885|NCT01049035|59087953|FG002|Overall Study|Other adverse event (AE)|0|||
30979886|NCT01049035|59087954|FG003|Overall Study|Other adverse event (AE)|1|||
30891138|NCT02227875|58924240|FG001|Overall Study|Adverse Event|0|||
30891139|NCT02227875|58924239|FG000|Overall Study|Withdrawal by Subject|12|||
30891140|NCT02227875|58924240|FG001|Overall Study|Withdrawal by Subject|13|||
30891141|NCT02227875|58924239|FG000|Overall Study|Lost to Follow-up|10|||
30891142|NCT02227875|58924240|FG001|Overall Study|Lost to Follow-up|10|||
30979887|NCT01049035|59087955|FG004|Overall Study|Other adverse event (AE)|0|||
30979888|NCT01049035|59087956|FG005|Overall Study|Other adverse event (AE)|0|||
30979889|NCT01049035|59087957|FG006|Overall Study|Other adverse event (AE)|0|||
30979890|NCT01049035|59087951|FG000|Overall Study|Non-compliance with the protocol|12|||
30979891|NCT01049035|59087952|FG001|Overall Study|Non-compliance with the protocol|6|||
30979892|NCT01049035|59087953|FG002|Overall Study|Non-compliance with the protocol|14|||
30979893|NCT01049035|59087954|FG003|Overall Study|Non-compliance with the protocol|5|||
30979894|NCT01049035|59087955|FG004|Overall Study|Non-compliance with the protocol|3|||
30979895|NCT01049035|59087956|FG005|Overall Study|Non-compliance with the protocol|4|||
30979896|NCT01049035|59087957|FG006|Overall Study|Non-compliance with the protocol|10|||
30979897|NCT01049035|59087951|FG000|Overall Study|Lost to Follow-up|5|||
30979898|NCT01049035|59087952|FG001|Overall Study|Lost to Follow-up|4|||
30979899|NCT01049035|59087953|FG002|Overall Study|Lost to Follow-up|4|||
30979900|NCT01049035|59087954|FG003|Overall Study|Lost to Follow-up|1|||
30979901|NCT01049035|59087955|FG004|Overall Study|Lost to Follow-up|0|||
30979902|NCT01049035|59087956|FG005|Overall Study|Lost to Follow-up|3|||
30979903|NCT01049035|59087957|FG006|Overall Study|Lost to Follow-up|3|||
30979904|NCT01049035|59087951|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
30979905|NCT01049035|59087952|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
30979906|NCT01049035|59087953|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
30979907|NCT01049035|59087954|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
30979908|NCT01049035|59087955|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
30979909|NCT01049035|59087956|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
30979910|NCT01049035|59087957|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
30979911|NCT01048333|59087983|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
30979912|NCT01048333|59087984|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
30979913|NCT01048333|59087985|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
30979914|NCT01048333|59087986|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
30979915|NCT01048333|59087987|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
30979916|NCT01048333|59087988|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
30979917|NCT02323113|59088003|FG000|Overall Study|Adverse Event|3|||
30979918|NCT02323113|59088004|FG001|Overall Study|Adverse Event|3|||
30979919|NCT02323113|59088005|FG002|Overall Study|Adverse Event|2|||
30979920|NCT02323113|59088006|FG003|Overall Study|Adverse Event|5|||
30979921|NCT02323113|59088007|FG004|Overall Study|Adverse Event|8|||
30979922|NCT02323113|59088008|FG005|Overall Study|Adverse Event|3|||
30979923|NCT02323113|59088009|FG006|Overall Study|Adverse Event|6|||
30979924|NCT02323113|59088010|FG007|Overall Study|Adverse Event|0|||
30979925|NCT02323113|59088003|FG000|Overall Study|Progressive Disease|0|||
30979926|NCT02323113|59088004|FG001|Overall Study|Progressive Disease|1|||
30979927|NCT02323113|59088005|FG002|Overall Study|Progressive Disease|1|||
30979928|NCT02323113|59088006|FG003|Overall Study|Progressive Disease|0|||
30979929|NCT02323113|59088007|FG004|Overall Study|Progressive Disease|0|||
30979930|NCT02323113|59088008|FG005|Overall Study|Progressive Disease|3|||
30979931|NCT02323113|59088009|FG006|Overall Study|Progressive Disease|0|||
30979932|NCT02323113|59088010|FG007|Overall Study|Progressive Disease|0|||
30979933|NCT02323113|59088003|FG000|Overall Study|Symptomatic Deterioration|0|||
30979934|NCT02323113|59088004|FG001|Overall Study|Symptomatic Deterioration|0|||
30979935|NCT02323113|59088005|FG002|Overall Study|Symptomatic Deterioration|1|||
30979936|NCT02323113|59088006|FG003|Overall Study|Symptomatic Deterioration|0|||
30979937|NCT02323113|59088007|FG004|Overall Study|Symptomatic Deterioration|1|||
30979938|NCT02323113|59088008|FG005|Overall Study|Symptomatic Deterioration|0|||
30979939|NCT02323113|59088009|FG006|Overall Study|Symptomatic Deterioration|0|||
30979940|NCT02323113|59088010|FG007|Overall Study|Symptomatic Deterioration|0|||
30979941|NCT02323113|59088003|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
30979942|NCT02323113|59088004|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
30979943|NCT02323113|59088005|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
30979944|NCT02323113|59088006|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
30891143|NCT02203149|58924251|FG000|Part 1|Adverse Event|0|||
30891144|NCT02203149|58924252|FG001|Part 1|Adverse Event|1|||
30891145|NCT02203149|58924253|FG002|Part 1|Adverse Event|0|||
30891146|NCT02203149|58924254|FG003|Part 1|Adverse Event|0|||
30891147|NCT02203149|58924255|FG004|Part 1|Adverse Event|0|||
30891148|NCT02203149|58924251|FG000|Part 2|Death|0|||
30891149|NCT02203149|58924252|FG001|Part 2|Death|0|||
30891150|NCT02203149|58924253|FG002|Part 2|Death|1|||
30891151|NCT02203149|58924254|FG003|Part 2|Death|1|||
30891152|NCT02203149|58924255|FG004|Part 2|Death|0|||
30891153|NCT02203149|58924251|FG000|Part 2|Withdrawal by Subject|0|||
30891154|NCT02203149|58924252|FG001|Part 2|Withdrawal by Subject|0|||
30891155|NCT02203149|58924253|FG002|Part 2|Withdrawal by Subject|0|||
30891156|NCT02203149|58924254|FG003|Part 2|Withdrawal by Subject|1|||
30979945|NCT02323113|59088007|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
30979946|NCT02323113|59088008|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
30979947|NCT02323113|59088009|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
30891157|NCT02203149|58924255|FG004|Part 2|Withdrawal by Subject|0|||
30891158|NCT02203149|58924251|FG000|Part 2|Adverse Event|0|||
30979948|NCT02323113|59088010|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
30891159|NCT02203149|58924252|FG001|Part 2|Adverse Event|0|||
30891160|NCT02203149|58924253|FG002|Part 2|Adverse Event|0|||
30891161|NCT02203149|58924254|FG003|Part 2|Adverse Event|1|||
30979949|NCT02323113|59088003|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
30979950|NCT02323113|59088004|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
30979951|NCT02323113|59088005|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
30979952|NCT02323113|59088006|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
30979953|NCT02323113|59088007|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
30979954|NCT02323113|59088008|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
30979955|NCT02323113|59088009|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
30979956|NCT02323113|59088010|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
30979957|NCT02281383|59088057|FG000|Overall Study|Progressive Disease|1|||
30979958|NCT02281383|59088057|FG000|Overall Study|Withdrawal by Subject|6|||
30979959|NCT02281383|59088057|FG000|Overall Study|Protocol Violation|2|||
30979960|NCT02281383|59088057|FG000|Overall Study|Death|1|||
30979961|NCT02281383|59088057|FG000|Overall Study|Adverse Event|2|||
30979962|NCT01047553|59088063|FG000|Overall Study|Adverse Event|10|||
30979963|NCT01047553|59088064|FG001|Overall Study|Adverse Event|5|||
30979964|NCT01047553|59088063|FG000|Overall Study|Withdrawal by Subject|4|||
30979965|NCT01047553|59088064|FG001|Overall Study|Withdrawal by Subject|2|||
30979966|NCT01047553|59088063|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
30979967|NCT01047553|59088064|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
30979968|NCT01047553|59088063|FG000|Overall Study|Lost to Follow-up|1|||
30979969|NCT01047553|59088064|FG001|Overall Study|Lost to Follow-up|0|||
30979970|NCT01047553|59088063|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
30979971|NCT01047553|59088064|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
30979972|NCT01047553|59088063|FG000|Overall Study|PI's decision|0|||
30979973|NCT01047553|59088064|FG001|Overall Study|PI's decision|1|||
30979974|NCT01047007|59088098|FG000|Overall Study|Adverse Event|0|||
30979975|NCT01047007|59088099|FG001|Overall Study|Adverse Event|2|||
30979976|NCT01047007|59088100|FG002|Overall Study|Adverse Event|1|||
30979977|NCT01047007|59088101|FG003|Overall Study|Adverse Event|0|||
30979978|NCT01047007|59088098|FG000|Overall Study|Progressive Disease|2|||
30979979|NCT01047007|59088099|FG001|Overall Study|Progressive Disease|4|||
30979980|NCT01047007|59088100|FG002|Overall Study|Progressive Disease|1|||
30979981|NCT01047007|59088101|FG003|Overall Study|Progressive Disease|0|||
30979982|NCT01046695|59088113|FG000|Overall Study|Subject had a pacemaker|0|||
30979983|NCT01046695|59088114|FG001|Overall Study|Subject had a pacemaker|1|||
30979984|NCT01046695|59088113|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
30979985|NCT01046695|59088114|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
30979986|NCT03304379|59088129|FG000|Overall Study|Protocol Violation|8|||
30979987|NCT03304379|59088130|FG001|Overall Study|Protocol Violation|10|||
30979988|NCT03304379|59088131|FG002|Overall Study|Protocol Violation|5|||
30979989|NCT03304379|59088132|FG003|Overall Study|Protocol Violation|0|||
30979990|NCT03304379|59088133|FG004|Overall Study|Protocol Violation|2|||
30979991|NCT03304379|59088129|FG000|Overall Study|Adverse Event|4|||
30979992|NCT03304379|59088130|FG001|Overall Study|Adverse Event|20|||
30979993|NCT03304379|59088131|FG002|Overall Study|Adverse Event|17|||
30979994|NCT03304379|59088132|FG003|Overall Study|Adverse Event|1|||
30979995|NCT03304379|59088133|FG004|Overall Study|Adverse Event|0|||
30979996|NCT03304379|59088129|FG000|Overall Study|Lack of Efficacy|17|||
30979997|NCT03304379|59088130|FG001|Overall Study|Lack of Efficacy|16|||
30979998|NCT03304379|59088131|FG002|Overall Study|Lack of Efficacy|20|||
30979999|NCT03304379|59088132|FG003|Overall Study|Lack of Efficacy|0|||
30980000|NCT03304379|59088133|FG004|Overall Study|Lack of Efficacy|0|||
30980001|NCT03304379|59088129|FG000|Overall Study|Physician Decision|6|||
30980002|NCT03304379|59088130|FG001|Overall Study|Physician Decision|10|||
30980003|NCT03304379|59088131|FG002|Overall Study|Physician Decision|6|||
30980004|NCT03304379|59088132|FG003|Overall Study|Physician Decision|9|||
30980005|NCT03304379|59088133|FG004|Overall Study|Physician Decision|10|||
30980006|NCT03304379|59088129|FG000|Overall Study|Withdrawal by Subject|26|||
30980007|NCT03304379|59088130|FG001|Overall Study|Withdrawal by Subject|58|||
30980008|NCT03304379|59088131|FG002|Overall Study|Withdrawal by Subject|66|||
30980009|NCT03304379|59088132|FG003|Overall Study|Withdrawal by Subject|3|||
30980010|NCT03304379|59088133|FG004|Overall Study|Withdrawal by Subject|5|||
30980011|NCT03304379|59088129|FG000|Overall Study|Lost to Follow-up|8|||
30980012|NCT03304379|59088130|FG001|Overall Study|Lost to Follow-up|24|||
30790189|NCT00064025|58803383|FG000|Overall Study|Ineligible|4|||
30980013|NCT03304379|59088131|FG002|Overall Study|Lost to Follow-up|35|||
30980014|NCT03304379|59088132|FG003|Overall Study|Lost to Follow-up|4|||
30980015|NCT03304379|59088133|FG004|Overall Study|Lost to Follow-up|0|||
30980016|NCT03304379|59088129|FG000|Overall Study|Death|1|||
30980017|NCT03304379|59088130|FG001|Overall Study|Death|2|||
30980018|NCT03304379|59088131|FG002|Overall Study|Death|0|||
30980019|NCT03304379|59088132|FG003|Overall Study|Death|0|||
30980020|NCT03304379|59088133|FG004|Overall Study|Death|0|||
30980021|NCT03304379|59088129|FG000|Overall Study|Other|0|||
30980022|NCT03304379|59088130|FG001|Overall Study|Other|1|||
30980023|NCT03304379|59088131|FG002|Overall Study|Other|0|||
30980024|NCT03304379|59088132|FG003|Overall Study|Other|0|||
30980025|NCT03304379|59088133|FG004|Overall Study|Other|0|||
30980026|NCT01044745|59088188|FG000|Overall Study|Ineiligible|2|||
30980027|NCT01044433|59088211|FG000|Overall Study|Lost to Follow-up|3|||
30980028|NCT01044433|59088211|FG000|Overall Study|Withdrawal by Subject|3|||
30980029|NCT01043185|59088220|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
30980030|NCT01043185|59088221|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
30980031|NCT01043185|59088222|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
30980032|NCT01043185|59088223|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
30980033|NCT01043185|59088224|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
30980034|NCT01043185|59088225|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
30980035|NCT01043185|59088226|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
30980036|NCT01043185|59088227|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
30980037|NCT01043185|59088228|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
30980038|NCT01043185|59088229|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
30980039|NCT01042093|59088254|FG000|Overall Study|Protocol Violation|2|||
30980040|NCT01042093|59088255|FG001|Overall Study|Protocol Violation|2|||
30980041|NCT01042093|59088256|FG002|Overall Study|Protocol Violation|2|||
30980042|NCT01042093|59088257|FG003|Overall Study|Protocol Violation|3|||
30980043|NCT01042093|59088254|FG000|Overall Study|Withdrawal by Subject|0|||
30980044|NCT01042093|59088255|FG001|Overall Study|Withdrawal by Subject|0|||
30980045|NCT01042093|59088256|FG002|Overall Study|Withdrawal by Subject|0|||
30980046|NCT01042093|59088257|FG003|Overall Study|Withdrawal by Subject|1|||
30980047|NCT01041859|59088287|FG000|Open-Label Titration|Adverse Event|69|||
30980048|NCT01041859|59088288|FG001|Open-Label Titration|Adverse Event|0|||
30980049|NCT01041859|59088289|FG002|Open-Label Titration|Adverse Event|0|||
30980050|NCT01041859|59088287|FG000|Open-Label Titration|Lack of Efficacy|3|||
30980051|NCT01041859|59088288|FG001|Open-Label Titration|Lack of Efficacy|0|||
30980052|NCT01041859|59088289|FG002|Open-Label Titration|Lack of Efficacy|0|||
30980053|NCT01041859|59088287|FG000|Open-Label Titration|Lost to Follow-up|1|||
30980054|NCT01041859|59088288|FG001|Open-Label Titration|Lost to Follow-up|0|||
30980055|NCT01041859|59088289|FG002|Open-Label Titration|Lost to Follow-up|0|||
30980056|NCT01041859|59088287|FG000|Open-Label Titration|Physician Decision|1|||
30980057|NCT01041859|59088288|FG001|Open-Label Titration|Physician Decision|0|||
30980058|NCT01041859|59088289|FG002|Open-Label Titration|Physician Decision|0|||
30980059|NCT01041859|59088287|FG000|Open-Label Titration|Protocol Violation|1|||
30980060|NCT01041859|59088288|FG001|Open-Label Titration|Protocol Violation|0|||
30980061|NCT01041859|59088289|FG002|Open-Label Titration|Protocol Violation|0|||
30980062|NCT01041859|59088287|FG000|Open-Label Titration|Other|7|||
30980063|NCT01041859|59088288|FG001|Open-Label Titration|Other|0|||
30980064|NCT01041859|59088289|FG002|Open-Label Titration|Other|0|||
30980065|NCT01041859|59088287|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
30980066|NCT01041859|59088288|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
30980067|NCT01041859|59088289|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
30980068|NCT01041859|59088287|FG000|Open-Label Titration|Withdrawal by Subject|11|||
30980069|NCT01041859|59088288|FG001|Open-Label Titration|Withdrawal by Subject|0|||
30980070|NCT01041859|59088289|FG002|Open-Label Titration|Withdrawal by Subject|0|||
30980071|NCT01041859|59088287|FG000|Double-Blind Maintenance|Adverse Event|0|||
30980072|NCT01041859|59088288|FG001|Double-Blind Maintenance|Adverse Event|23|||
30980073|NCT01041859|59088289|FG002|Double-Blind Maintenance|Adverse Event|13|||
30980074|NCT01041859|59088287|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
30980075|NCT01041859|59088288|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
30980076|NCT01041859|59088289|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
30980077|NCT01041859|59088287|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
30980078|NCT01041859|59088288|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
30980079|NCT01041859|59088289|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
30980080|NCT01041859|59088287|FG000|Double-Blind Maintenance|Physician Decision|0|||
30980081|NCT01041859|59088288|FG001|Double-Blind Maintenance|Physician Decision|2|||
30980082|NCT01041859|59088289|FG002|Double-Blind Maintenance|Physician Decision|1|||
30980083|NCT01041859|59088287|FG000|Double-Blind Maintenance|Protocol Violation|0|||
30980084|NCT01041859|59088288|FG001|Double-Blind Maintenance|Protocol Violation|1|||
30980085|NCT01041859|59088289|FG002|Double-Blind Maintenance|Protocol Violation|3|||
30980086|NCT01041859|59088287|FG000|Double-Blind Maintenance|Other|0|||
30980087|NCT01041859|59088288|FG001|Double-Blind Maintenance|Other|6|||
30980088|NCT01041859|59088289|FG002|Double-Blind Maintenance|Other|2|||
30980089|NCT01041859|59088287|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
30980090|NCT01041859|59088288|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
30980091|NCT01041859|59088289|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
30980092|NCT01041859|59088287|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
30980093|NCT01041859|59088288|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
30980094|NCT01041859|59088289|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
30980095|NCT01040845|59088298|FG000|Overall Study|Withdrawal by Subject|1|||
30980096|NCT01040845|59088299|FG001|Overall Study|Withdrawal by Subject|1|||
30980097|NCT01040845|59088298|FG000|Overall Study|Physician Decision|1|||
30980098|NCT01040845|59088299|FG001|Overall Study|Physician Decision|0|||
30980099|NCT01040689|59088307|FG000|Overall Study|Adverse Event|0|||
30980100|NCT01040689|59088308|FG001|Overall Study|Adverse Event|0|||
30980101|NCT01040689|59088309|FG002|Overall Study|Adverse Event|2|||
30980102|NCT01040689|59088310|FG003|Overall Study|Adverse Event|4|||
30980103|NCT01040689|59088307|FG000|Overall Study|Lack of Efficacy|0|||
30980104|NCT01040689|59088308|FG001|Overall Study|Lack of Efficacy|0|||
30980105|NCT01040689|59088309|FG002|Overall Study|Lack of Efficacy|1|||
30980106|NCT01040689|59088310|FG003|Overall Study|Lack of Efficacy|0|||
30980107|NCT01040689|59088307|FG000|Overall Study|Lost to Follow-up|1|||
30980108|NCT01040689|59088308|FG001|Overall Study|Lost to Follow-up|0|||
30980109|NCT01040689|59088309|FG002|Overall Study|Lost to Follow-up|0|||
30980110|NCT01040689|59088310|FG003|Overall Study|Lost to Follow-up|0|||
30980111|NCT01040689|59088307|FG000|Overall Study|Withdrawal by Subject|2|||
30980112|NCT01040689|59088308|FG001|Overall Study|Withdrawal by Subject|1|||
30980113|NCT01040689|59088309|FG002|Overall Study|Withdrawal by Subject|1|||
30980114|NCT01040689|59088310|FG003|Overall Study|Withdrawal by Subject|0|||
30980115|NCT01040689|59088307|FG000|Overall Study|Other reasons not listed above|0|||
30980116|NCT01040689|59088308|FG001|Overall Study|Other reasons not listed above|1|||
30980117|NCT01040689|59088309|FG002|Overall Study|Other reasons not listed above|0|||
30980118|NCT01040689|59088310|FG003|Overall Study|Other reasons not listed above|0|||
30980119|NCT01047319|59088359|FG000|Overall Study|Teva requested participant withdrawal|3|||
30980120|NCT01047319|59088360|FG001|Overall Study|Teva requested participant withdrawal|0|||
30980121|NCT01047319|59088361|FG002|Overall Study|Teva requested participant withdrawal|1|||
30980122|NCT01047319|59088359|FG000|Overall Study|Protocol Violation|3|||
30980123|NCT01047319|59088360|FG001|Overall Study|Protocol Violation|2|||
30980124|NCT01047319|59088361|FG002|Overall Study|Protocol Violation|4|||
30980125|NCT01047319|59088359|FG000|Overall Study|Lack of Efficacy|4|||
30980126|NCT01047319|59088360|FG001|Overall Study|Lack of Efficacy|3|||
30980127|NCT01047319|59088361|FG002|Overall Study|Lack of Efficacy|3|||
30980128|NCT01047319|59088359|FG000|Overall Study|Death|5|||
30980129|NCT01047319|59088360|FG001|Overall Study|Death|1|||
30980130|NCT01047319|59088361|FG002|Overall Study|Death|5|||
30980131|NCT01047319|59088359|FG000|Overall Study|Pregnancy|13|||
30980132|NCT01047319|59088360|FG001|Overall Study|Pregnancy|8|||
30980133|NCT01047319|59088361|FG002|Overall Study|Pregnancy|8|||
30980134|NCT01047319|59088359|FG000|Overall Study|Physician Decision|12|||
30980135|NCT01047319|59088360|FG001|Overall Study|Physician Decision|9|||
30980136|NCT01047319|59088361|FG002|Overall Study|Physician Decision|10|||
30980137|NCT01047319|59088359|FG000|Overall Study|Lost to Follow-up|14|||
30980138|NCT01047319|59088360|FG001|Overall Study|Lost to Follow-up|10|||
30980139|NCT01047319|59088361|FG002|Overall Study|Lost to Follow-up|10|||
30980140|NCT01047319|59088359|FG000|Overall Study|Adverse Event|16|||
30980141|NCT01047319|59088360|FG001|Overall Study|Adverse Event|27|||
30980142|NCT01047319|59088361|FG002|Overall Study|Adverse Event|21|||
30980143|NCT01047319|59088359|FG000|Overall Study|Withdrawal by Subject|77|||
30980144|NCT01047319|59088360|FG001|Overall Study|Withdrawal by Subject|75|||
30980145|NCT01047319|59088361|FG002|Overall Study|Withdrawal by Subject|87|||
30980146|NCT01047319|59088359|FG000|Overall Study|Study terminated by Sponsor|198|||
30980147|NCT01047319|59088360|FG001|Overall Study|Study terminated by Sponsor|215|||
30980148|NCT01047319|59088361|FG002|Overall Study|Study terminated by Sponsor|203|||
30980149|NCT00014911|59088678|FG000|Overall Study|Adverse Event|1|||
30980150|NCT00014911|59088678|FG000|Overall Study|Lost to Follow-up|1|||
30980151|NCT00014911|59088678|FG000|Overall Study|Withdrawal by Subject|6|||
30980152|NCT00014911|59088678|FG000|Overall Study|Unknown Reasons|2|||
30980153|NCT00014911|59088678|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
30980154|NCT01049009|59089211|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
30980155|NCT01049009|59089212|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
30980156|NCT01049009|59089211|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30980157|NCT01049009|59089212|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
30980158|NCT01049009|59089211|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
30980159|NCT01049009|59089212|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
30980160|NCT01049009|59089211|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
30980161|NCT01049009|59089212|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
30980162|NCT01047683|59089234|FG000|Overall Study|Adverse Event|3|||
30980163|NCT01047683|59089235|FG001|Overall Study|Adverse Event|1|||
30980164|NCT01047683|59089236|FG002|Overall Study|Adverse Event|0|||
30980165|NCT01047683|59089234|FG000|Overall Study|Withdrew Consent|1|||
30980166|NCT01047683|59089235|FG001|Overall Study|Withdrew Consent|4|||
30980167|NCT01047683|59089236|FG002|Overall Study|Withdrew Consent|2|||
30980168|NCT01047683|59089234|FG000|Overall Study|Lost to Follow-up|0|||
30980169|NCT01047683|59089235|FG001|Overall Study|Lost to Follow-up|1|||
30980170|NCT01047683|59089236|FG002|Overall Study|Lost to Follow-up|0|||
30980171|NCT01047683|59089234|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
30980172|NCT01047683|59089235|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
30980173|NCT01047683|59089236|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
30980174|NCT01047293|59089324|FG000|Overall Study|DLT criteria not fulfilled|1|||
30980175|NCT01047293|59089325|FG001|Overall Study|DLT criteria not fulfilled|1|||
30980176|NCT01047293|59089326|FG002|Overall Study|DLT criteria not fulfilled|0|||
30980177|NCT01047293|59089327|FG003|Overall Study|DLT criteria not fulfilled|0|||
30980178|NCT01045967|59089336|FG000|Second Intervention|Protocol Violation|0|||
30980179|NCT01045967|59089337|FG001|Second Intervention|Protocol Violation|1|||
30980180|NCT01045421|59089923|FG000|Phase 1|Progressive Disease|0|||
30980181|NCT01045421|59089924|FG001|Phase 1|Progressive Disease|0|||
30980182|NCT01045421|59089925|FG002|Phase 1|Progressive Disease|0|||
30980183|NCT01045421|59089926|FG003|Phase 1|Progressive Disease|0|||
30980184|NCT01045421|59089927|FG004|Phase 1|Progressive Disease|1|||
30980185|NCT01045421|59089928|FG005|Phase 1|Progressive Disease|0|||
30980186|NCT01045421|59089929|FG006|Phase 1|Progressive Disease|0|||
30980187|NCT01045421|59089930|FG007|Phase 1|Progressive Disease|0|||
30980188|NCT01045421|59089931|FG008|Phase 1|Progressive Disease|0|||
30980189|NCT01045421|59089932|FG009|Phase 1|Progressive Disease|0|||
30980190|NCT01045421|59089933|FG010|Phase 1|Progressive Disease|0|||
30980191|NCT01045421|59089923|FG000|Phase 1|Withdrawal by Subject|0|||
30980192|NCT01045421|59089924|FG001|Phase 1|Withdrawal by Subject|0|||
30980193|NCT01045421|59089925|FG002|Phase 1|Withdrawal by Subject|0|||
30980194|NCT01045421|59089926|FG003|Phase 1|Withdrawal by Subject|1|||
30980195|NCT01045421|59089927|FG004|Phase 1|Withdrawal by Subject|0|||
30980196|NCT01045421|59089928|FG005|Phase 1|Withdrawal by Subject|0|||
30980197|NCT01045421|59089929|FG006|Phase 1|Withdrawal by Subject|0|||
30980198|NCT01045421|59089930|FG007|Phase 1|Withdrawal by Subject|0|||
30980199|NCT01045421|59089931|FG008|Phase 1|Withdrawal by Subject|0|||
30980200|NCT01045421|59089932|FG009|Phase 1|Withdrawal by Subject|0|||
30980201|NCT01045421|59089933|FG010|Phase 1|Withdrawal by Subject|0|||
30980202|NCT01045421|59089923|FG000|Phase 2|Progressive Disease|0|||
30980203|NCT01045421|59089924|FG001|Phase 2|Progressive Disease|0|||
30980204|NCT01045421|59089925|FG002|Phase 2|Progressive Disease|0|||
30980205|NCT01045421|59089926|FG003|Phase 2|Progressive Disease|0|||
30980206|NCT01045421|59089927|FG004|Phase 2|Progressive Disease|0|||
30980207|NCT01045421|59089928|FG005|Phase 2|Progressive Disease|0|||
30980208|NCT01045421|59089929|FG006|Phase 2|Progressive Disease|0|||
30980209|NCT01045421|59089930|FG007|Phase 2|Progressive Disease|1|||
30980210|NCT01045421|59089931|FG008|Phase 2|Progressive Disease|1|||
30980211|NCT01045421|59089932|FG009|Phase 2|Progressive Disease|1|||
30980212|NCT01045421|59089933|FG010|Phase 2|Progressive Disease|1|||
30980213|NCT01045421|59089923|FG000|Phase 2|Death|0|||
30980214|NCT01045421|59089924|FG001|Phase 2|Death|0|||
30980215|NCT01045421|59089925|FG002|Phase 2|Death|0|||
30980216|NCT01045421|59089926|FG003|Phase 2|Death|0|||
30980217|NCT01045421|59089927|FG004|Phase 2|Death|0|||
30980218|NCT01045421|59089928|FG005|Phase 2|Death|0|||
30980219|NCT01045421|59089929|FG006|Phase 2|Death|0|||
30980220|NCT01045421|59089930|FG007|Phase 2|Death|1|||
30980221|NCT01045421|59089931|FG008|Phase 2|Death|1|||
30980222|NCT01045421|59089932|FG009|Phase 2|Death|2|||
30980223|NCT01045421|59089933|FG010|Phase 2|Death|0|||
30980224|NCT01045421|59089923|FG000|Phase 2|Other|0|||
30980225|NCT01045421|59089924|FG001|Phase 2|Other|0|||
30980226|NCT01045421|59089925|FG002|Phase 2|Other|0|||
30980227|NCT01045421|59089926|FG003|Phase 2|Other|0|||
30980228|NCT01045421|59089927|FG004|Phase 2|Other|0|||
30980229|NCT01045421|59089928|FG005|Phase 2|Other|0|||
30980230|NCT01045421|59089929|FG006|Phase 2|Other|0|||
30980231|NCT01045421|59089930|FG007|Phase 2|Other|3|||
30980232|NCT01045421|59089931|FG008|Phase 2|Other|0|||
30980233|NCT01045421|59089932|FG009|Phase 2|Other|0|||
30980234|NCT01045421|59089933|FG010|Phase 2|Other|1|||
30980235|NCT01042535|59089981|FG000|Overall Study|disease progression prior to treatment|3|||
30891162|NCT02203149|58924255|FG004|Part 2|Adverse Event|1|||
30980236|NCT01042535|59089981|FG000|Overall Study|disease progression during treatment|3|||
30980237|NCT01042535|59089981|FG000|Overall Study|complications from other disease|2|||
30980238|NCT01041287|59089987|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
30980239|NCT01041287|59089988|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
30980240|NCT01041287|59089987|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
30980241|NCT01041287|59089988|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
30980242|NCT01040351|59090009|FG000|Overall Study|poor ovarian response|1|||
30980243|NCT01040351|59090010|FG001|Overall Study|poor ovarian response|2|||
30891163|NCT02203071|58924279|FG000|Overall Study|Lost to Follow-up|3|||
30891164|NCT02203071|58924280|FG001|Overall Study|Lost to Follow-up|1|||
30891165|NCT02202837|58924288|FG000|Overall Study|Enbrel treatment discontinued|36|||
30891166|NCT02202837|58924289|FG001|Overall Study|Enbrel treatment discontinued|4|||
30891167|NCT02202837|58924288|FG000|Overall Study|Other|10|||
30891168|NCT02202837|58924289|FG001|Overall Study|Other|0|||
30891169|NCT02202837|58924288|FG000|Overall Study|Lost to Follow-up|7|||
30891170|NCT02202837|58924289|FG001|Overall Study|Lost to Follow-up|1|||
30980244|NCT02049957|59090030|FG000|Overall Study|Progressive Disease|5|||
30980245|NCT02049957|59090031|FG001|Overall Study|Progressive Disease|4|||
30980246|NCT02049957|59090032|FG002|Overall Study|Progressive Disease|2|||
30980247|NCT02049957|59090033|FG003|Overall Study|Progressive Disease|2|||
30980248|NCT02049957|59090034|FG004|Overall Study|Progressive Disease|6|||
30980249|NCT02049957|59090035|FG005|Overall Study|Progressive Disease|35|||
30980250|NCT02049957|59090036|FG006|Overall Study|Progressive Disease|7|||
30980251|NCT02049957|59090037|FG007|Overall Study|Progressive Disease|26|||
30980252|NCT02049957|59090038|FG008|Overall Study|Progressive Disease|6|||
30980253|NCT02049957|59090030|FG000|Overall Study|Adverse Event|1|||
30980254|NCT02049957|59090031|FG001|Overall Study|Adverse Event|1|||
30980255|NCT02049957|59090032|FG002|Overall Study|Adverse Event|1|||
30980256|NCT02049957|59090033|FG003|Overall Study|Adverse Event|0|||
30980257|NCT02049957|59090034|FG004|Overall Study|Adverse Event|0|||
30980258|NCT02049957|59090035|FG005|Overall Study|Adverse Event|5|||
30980259|NCT02049957|59090036|FG006|Overall Study|Adverse Event|0|||
30980260|NCT02049957|59090037|FG007|Overall Study|Adverse Event|6|||
30980261|NCT02049957|59090038|FG008|Overall Study|Adverse Event|1|||
30980262|NCT02049957|59090030|FG000|Overall Study|Study Terminated by Sponsor|0|||
30980263|NCT02049957|59090031|FG001|Overall Study|Study Terminated by Sponsor|1|||
30980264|NCT02049957|59090032|FG002|Overall Study|Study Terminated by Sponsor|0|||
30980265|NCT02049957|59090033|FG003|Overall Study|Study Terminated by Sponsor|0|||
30980266|NCT02049957|59090034|FG004|Overall Study|Study Terminated by Sponsor|0|||
30980267|NCT02049957|59090035|FG005|Overall Study|Study Terminated by Sponsor|0|||
30980268|NCT02049957|59090036|FG006|Overall Study|Study Terminated by Sponsor|1|||
30980269|NCT02049957|59090037|FG007|Overall Study|Study Terminated by Sponsor|0|||
30980270|NCT02049957|59090038|FG008|Overall Study|Study Terminated by Sponsor|0|||
30980271|NCT02049957|59090030|FG000|Overall Study|Withdrawal by Subject|0|||
30980272|NCT02049957|59090031|FG001|Overall Study|Withdrawal by Subject|0|||
30980273|NCT02049957|59090032|FG002|Overall Study|Withdrawal by Subject|0|||
30980274|NCT02049957|59090033|FG003|Overall Study|Withdrawal by Subject|1|||
30980275|NCT02049957|59090034|FG004|Overall Study|Withdrawal by Subject|0|||
30980276|NCT02049957|59090035|FG005|Overall Study|Withdrawal by Subject|2|||
30980277|NCT02049957|59090036|FG006|Overall Study|Withdrawal by Subject|0|||
30980278|NCT02049957|59090037|FG007|Overall Study|Withdrawal by Subject|3|||
30980279|NCT02049957|59090038|FG008|Overall Study|Withdrawal by Subject|1|||
30980280|NCT02049957|59090030|FG000|Overall Study|Physician Decision|0|||
30980281|NCT02049957|59090031|FG001|Overall Study|Physician Decision|0|||
30980282|NCT02049957|59090032|FG002|Overall Study|Physician Decision|0|||
30980283|NCT02049957|59090033|FG003|Overall Study|Physician Decision|0|||
30980284|NCT02049957|59090034|FG004|Overall Study|Physician Decision|0|||
30980285|NCT02049957|59090035|FG005|Overall Study|Physician Decision|1|||
30980286|NCT02049957|59090036|FG006|Overall Study|Physician Decision|0|||
30980287|NCT02049957|59090037|FG007|Overall Study|Physician Decision|0|||
30980288|NCT02049957|59090038|FG008|Overall Study|Physician Decision|0|||
30980289|NCT00014495|59090301|FG000|Overall Study|Death|0|||
30980290|NCT00014495|59090302|FG001|Overall Study|Death|0|||
30980291|NCT00014495|59090303|FG002|Overall Study|Death|1|||
30980292|NCT00014495|59090304|FG003|Overall Study|Death|0|||
30980293|NCT00014495|59090301|FG000|Overall Study|Clinical deterioration|0|||
30980294|NCT00014495|59090302|FG001|Overall Study|Clinical deterioration|0|||
30980295|NCT00014495|59090303|FG002|Overall Study|Clinical deterioration|0|||
30980296|NCT00014495|59090304|FG003|Overall Study|Clinical deterioration|1|||
30980297|NCT01351623|59092339|FG000|Overall Study|Protocol Violation|2|||
30980298|NCT01351623|59092339|FG000|Overall Study|Adverse Event|4|||
30980299|NCT01351623|59092339|FG000|Overall Study|Withdrawal by Subject|1|||
30980300|NCT01351623|59092339|FG000|Overall Study|Death|2|||
30980301|NCT03670953|59092476|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
30980302|NCT03670953|59092477|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
30980303|NCT03670953|59092478|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
30980304|NCT03670953|59092479|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
30980305|NCT03670953|59092476|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
30980306|NCT03670953|59092477|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
30980307|NCT03670953|59092478|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
30980308|NCT03670953|59092479|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
30980309|NCT03670953|59092476|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
30980310|NCT03670953|59092477|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
30980311|NCT03670953|59092478|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
30980312|NCT03670953|59092479|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
30980313|NCT03670953|59092476|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
30980314|NCT03670953|59092477|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
30980315|NCT03670953|59092478|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
30980316|NCT03670953|59092479|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
30980317|NCT03670953|59092476|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
30980318|NCT03670953|59092477|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
30980319|NCT03670953|59092478|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
30980320|NCT03670953|59092479|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
30980321|NCT03670953|59092476|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
30980322|NCT03670953|59092477|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
30980323|NCT03670953|59092478|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
30980324|NCT03670953|59092479|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
30980325|NCT03670953|59092476|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
30980326|NCT03670953|59092477|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
30980327|NCT03670953|59092478|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
30980328|NCT03670953|59092479|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
30980329|NCT03670953|59092476|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
30980330|NCT03670953|59092477|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
30980331|NCT03670953|59092478|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
30980332|NCT03670953|59092479|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
30980333|NCT03670953|59092476|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
30980334|NCT03670953|59092477|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
30980335|NCT03670953|59092478|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
30980336|NCT03670953|59092479|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
30980337|NCT03670953|59092476|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
30980338|NCT03670953|59092477|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
30980339|NCT03670953|59092478|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
30980340|NCT03670953|59092479|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
30980341|NCT03670953|59092476|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
30980342|NCT03670953|59092477|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
30980343|NCT03670953|59092478|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
30980344|NCT03670953|59092479|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
30980345|NCT03670953|59092476|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
30980346|NCT03670953|59092477|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
30980347|NCT03670953|59092478|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
30980348|NCT03670953|59092479|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
30980349|NCT03670953|59092476|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
30980350|NCT03670953|59092477|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
30980351|NCT03670953|59092478|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
30980352|NCT03670953|59092479|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
30980353|NCT03670953|59092476|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
30980354|NCT03670953|59092477|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
30980355|NCT03670953|59092478|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
30980356|NCT03670953|59092479|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
30980357|NCT03670953|59092476|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
30980358|NCT03670953|59092477|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
30980359|NCT03670953|59092478|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
30980360|NCT03670953|59092479|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
30980361|NCT03670953|59092476|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
30980362|NCT03670953|59092477|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
30891171|NCT02202759|58924298|FG000|Overall Study|Study Terminated by Sponsor|3|||
30891172|NCT02202759|58924299|FG001|Overall Study|Study Terminated by Sponsor|3|||
30891173|NCT02202759|58924300|FG002|Overall Study|Study Terminated by Sponsor|3|||
30980363|NCT03670953|59092478|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
30980364|NCT03670953|59092479|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
30980365|NCT03670953|59092476|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
30980366|NCT03670953|59092477|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
30980367|NCT03670953|59092478|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
30980368|NCT03670953|59092479|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
30980369|NCT03670953|59092476|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
30980370|NCT03670953|59092477|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
30980371|NCT03670953|59092478|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
30980372|NCT03670953|59092479|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
30980373|NCT02519348|59092514|FG000|Overall Study|Death|31|||
30980374|NCT02519348|59092515|FG001|Overall Study|Death|74|||
30891174|NCT02202759|58924298|FG000|Overall Study|Withdrawal by Subject|2|||
30891175|NCT02202759|58924299|FG001|Overall Study|Withdrawal by Subject|1|||
30891176|NCT02202759|58924300|FG002|Overall Study|Withdrawal by Subject|1|||
30891177|NCT02202759|58924298|FG000|Overall Study|Reason not Specified|4|||
30891178|NCT02202759|58924299|FG001|Overall Study|Reason not Specified|11|||
30891179|NCT02202759|58924300|FG002|Overall Study|Reason not Specified|10|||
30891180|NCT02226549|58924309|FG000|Overall Study|Randomized but Never Treated|1|||
30891181|NCT02226549|58924310|FG001|Overall Study|Randomized but Never Treated|0|||
30790190|NCT00064025|58803383|FG000|Overall Study|Inevaluable|3|||
30891182|NCT02226549|58924309|FG000|Overall Study|Lost to Follow-up|0|||
30891183|NCT02226549|58924310|FG001|Overall Study|Lost to Follow-up|1|||
30980375|NCT02519348|59092516|FG002|Overall Study|Death|47|||
30980376|NCT02519348|59092517|FG003|Overall Study|Death|54|||
30980377|NCT02519348|59092518|FG004|Overall Study|Death|63|||
30980378|NCT02519348|59092519|FG005|Overall Study|Death|18|||
30980379|NCT02519348|59092520|FG006|Overall Study|Death|2|||
30980380|NCT02519348|59092521|FG007|Overall Study|Death|5|||
30980381|NCT02519348|59092522|FG008|Overall Study|Death|5|||
30980382|NCT02519348|59092514|FG000|Overall Study|Withdrawal by Subject|4|||
30980383|NCT02519348|59092515|FG001|Overall Study|Withdrawal by Subject|7|||
30980384|NCT02519348|59092516|FG002|Overall Study|Withdrawal by Subject|4|||
30980385|NCT02519348|59092517|FG003|Overall Study|Withdrawal by Subject|3|||
30980386|NCT02519348|59092518|FG004|Overall Study|Withdrawal by Subject|3|||
30980387|NCT02519348|59092519|FG005|Overall Study|Withdrawal by Subject|2|||
30980388|NCT02519348|59092520|FG006|Overall Study|Withdrawal by Subject|0|||
30980389|NCT02519348|59092521|FG007|Overall Study|Withdrawal by Subject|0|||
30980390|NCT02519348|59092522|FG008|Overall Study|Withdrawal by Subject|1|||
30980391|NCT02519348|59092514|FG000|Overall Study|Lost to Follow-up|0|||
30980392|NCT02519348|59092515|FG001|Overall Study|Lost to Follow-up|0|||
30980393|NCT02519348|59092516|FG002|Overall Study|Lost to Follow-up|1|||
30980394|NCT02519348|59092517|FG003|Overall Study|Lost to Follow-up|0|||
30980395|NCT02519348|59092518|FG004|Overall Study|Lost to Follow-up|2|||
30980396|NCT02519348|59092519|FG005|Overall Study|Lost to Follow-up|1|||
30980397|NCT02519348|59092520|FG006|Overall Study|Lost to Follow-up|1|||
30980398|NCT02519348|59092521|FG007|Overall Study|Lost to Follow-up|0|||
30980399|NCT02519348|59092522|FG008|Overall Study|Lost to Follow-up|0|||
30980400|NCT02519348|59092514|FG000|Overall Study|Other|0|||
30980401|NCT02519348|59092515|FG001|Overall Study|Other|3|||
30980402|NCT02519348|59092516|FG002|Overall Study|Other|0|||
30980403|NCT02519348|59092517|FG003|Overall Study|Other|0|||
30980404|NCT02519348|59092518|FG004|Overall Study|Other|1|||
30980405|NCT02519348|59092519|FG005|Overall Study|Other|0|||
30980406|NCT02519348|59092520|FG006|Overall Study|Other|0|||
30980407|NCT02519348|59092521|FG007|Overall Study|Other|0|||
30980408|NCT02519348|59092522|FG008|Overall Study|Other|0|||
30980409|NCT02519348|59092514|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
30980410|NCT02519348|59092515|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
30980411|NCT02519348|59092516|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
30980412|NCT02519348|59092517|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
30980413|NCT02519348|59092518|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
30980414|NCT02519348|59092519|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
30980415|NCT02519348|59092520|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
30980416|NCT02519348|59092521|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
30980417|NCT02519348|59092522|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
30980418|NCT00636818|59092543|FG000|Overall Study|Adverse Event|1|||
30980419|NCT00636818|59092543|FG000|Overall Study|Lost to Follow-up|2|||
30980420|NCT00636818|59092543|FG000|Overall Study|Entry Criteria Exclusion|3|||
30980421|NCT00636818|59092543|FG000|Overall Study|Protocol Violation|1|||
30980422|NCT00636818|59092543|FG000|Overall Study|Withdrawal by Subject|4|||
30980423|NCT03127137|59092549|FG000|Overall Study|Requested sedation after consent|1|||
30980424|NCT03127137|59092550|FG001|Overall Study|Requested sedation after consent|0|||
30980425|NCT03127137|59092549|FG000|Overall Study|Malfunction in electronic data collection|1|||
30980426|NCT03127137|59092550|FG001|Overall Study|Malfunction in electronic data collection|0|||
30980427|NCT03127137|59092549|FG000|Overall Study|Post procedure testing could not be obtained|0|||
30980428|NCT03127137|59092550|FG001|Overall Study|Post procedure testing could not be obtained|1|||
30980429|NCT00636506|59092558|FG000|Overall Study|Lost to Follow-up|8|||
30980430|NCT00636506|59092558|FG000|Overall Study|Explanted|1|||
30980431|NCT00636506|59092558|FG000|Overall Study|Withdrawal by Subject|6|||
30980432|NCT00636506|59092558|FG000|Overall Study|Procedure aborted|1|||
30980433|NCT00636194|59092582|FG000|Overall Study|Study related symptoms and complaints|1|||
30980434|NCT00636194|59092583|FG001|Overall Study|Study related symptoms and complaints|0|||
30980435|NCT00636194|59092582|FG000|Overall Study|Protocol Violation|2|||
30980436|NCT00636194|59092583|FG001|Overall Study|Protocol Violation|0|||
30980437|NCT00635804|59092649|FG000|Overall Study|Adverse Event|0|||
30891184|NCT02226003|58924319|FG000|Overall Study|Lost to Follow-up|2|||
30891185|NCT02226003|58924320|FG001|Overall Study|Lost to Follow-up|1|||
30891186|NCT02226003|58924321|FG002|Overall Study|Lost to Follow-up|3|||
30891187|NCT02226003|58924319|FG000|Overall Study|Withdrawal by Subject|0|||
30891188|NCT02226003|58924320|FG001|Overall Study|Withdrawal by Subject|0|||
30891189|NCT02226003|58924321|FG002|Overall Study|Withdrawal by Subject|3|||
30980438|NCT00635804|59092650|FG001|Overall Study|Adverse Event|0|||
30980439|NCT00635804|59092651|FG002|Overall Study|Adverse Event|0|||
30980440|NCT00635804|59092652|FG003|Overall Study|Adverse Event|0|||
30980441|NCT00635804|59092653|FG004|Overall Study|Adverse Event|0|||
30980442|NCT00635804|59092654|FG005|Overall Study|Adverse Event|1|||
30980443|NCT00635804|59092655|FG006|Overall Study|Adverse Event|0|||
30980444|NCT00635804|59092656|FG007|Overall Study|Adverse Event|0|||
30980445|NCT00635804|59092649|FG000|Overall Study|Withdrawal by Subject|1|||
30980446|NCT00635804|59092650|FG001|Overall Study|Withdrawal by Subject|0|||
30980447|NCT00635804|59092651|FG002|Overall Study|Withdrawal by Subject|0|||
30980448|NCT00635804|59092652|FG003|Overall Study|Withdrawal by Subject|0|||
30980449|NCT00635804|59092653|FG004|Overall Study|Withdrawal by Subject|0|||
30980450|NCT00635804|59092654|FG005|Overall Study|Withdrawal by Subject|0|||
30980451|NCT00635804|59092655|FG006|Overall Study|Withdrawal by Subject|0|||
30980452|NCT00635804|59092656|FG007|Overall Study|Withdrawal by Subject|0|||
30980453|NCT00635648|59092686|FG000|Overall Study|Adverse Event|12|||
30980454|NCT00635648|59092686|FG000|Overall Study|Withdrawal by Subject|9|||
30980455|NCT00635648|59092686|FG000|Overall Study|Physician Decision|4|||
30980456|NCT00635648|59092686|FG000|Overall Study|Rapid progression of baseline disease|4|||
30980457|NCT00635648|59092686|FG000|Overall Study|Use of other antifungal agent needed|1|||
30980458|NCT00635648|59092686|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
30980459|NCT00635648|59092686|FG000|Overall Study|Noncompliance with protocol|1|||
30980460|NCT00635648|59092686|FG000|Overall Study|Other reason|2|||
30980461|NCT00635102|59092711|FG000|Overall Study|Withdrawal by Subject|7|||
30980462|NCT00635102|59092712|FG001|Overall Study|Withdrawal by Subject|8|||
30980463|NCT00635024|59092727|FG000|Overall Study|Adverse Event|1|||
30980464|NCT00634244|59092776|FG000|Overall Study|Never started treatment|0|||
30980465|NCT00634244|59092777|FG001|Overall Study|Never started treatment|1|||
30980466|NCT00634244|59092778|FG002|Overall Study|Never started treatment|0|||
30980467|NCT00634244|59092776|FG000|Overall Study|Death|1|||
30980468|NCT00634244|59092777|FG001|Overall Study|Death|6|||
30980469|NCT00634244|59092778|FG002|Overall Study|Death|0|||
30980470|NCT00634244|59092776|FG000|Overall Study|Adverse Event|0|||
30891190|NCT02225223|58924331|FG000|Overall Study|Death|10|||
30891191|NCT02225223|58924332|FG001|Overall Study|Death|1|||
30980471|NCT00634244|59092777|FG001|Overall Study|Adverse Event|2|||
30980472|NCT00634244|59092778|FG002|Overall Study|Adverse Event|0|||
30980473|NCT00634244|59092776|FG000|Overall Study|Withdrawal by Subject|0|||
30980474|NCT00634244|59092777|FG001|Overall Study|Withdrawal by Subject|1|||
30891192|NCT02225223|58924331|FG000|Overall Study|Lost to Follow-up|5|||
30891193|NCT02225223|58924332|FG001|Overall Study|Lost to Follow-up|0|||
30891194|NCT02225223|58924331|FG000|Overall Study|Other|1|||
30891195|NCT02225223|58924332|FG001|Overall Study|Other|2|||
30891196|NCT02225223|58924331|FG000|Overall Study|Physician Decision|1|||
30891197|NCT02225223|58924332|FG001|Overall Study|Physician Decision|0|||
30980475|NCT00634244|59092778|FG002|Overall Study|Withdrawal by Subject|0|||
30980476|NCT00634244|59092776|FG000|Overall Study|Physician Decision|0|||
30891198|NCT02225223|58924331|FG000|Overall Study|Withdrawal by Subject|2|||
30891199|NCT02225223|58924332|FG001|Overall Study|Withdrawal by Subject|2|||
30980477|NCT00634244|59092777|FG001|Overall Study|Physician Decision|1|||
30980478|NCT00634244|59092778|FG002|Overall Study|Physician Decision|0|||
30980479|NCT00634244|59092776|FG000|Overall Study|Disease progression/relapse|0|||
30980480|NCT00634244|59092777|FG001|Overall Study|Disease progression/relapse|1|||
30980481|NCT00634244|59092778|FG002|Overall Study|Disease progression/relapse|0|||
30980482|NCT00634244|59092776|FG000|Overall Study|Other complicating disease|0|||
30980483|NCT00634244|59092777|FG001|Overall Study|Other complicating disease|1|||
30980484|NCT00634244|59092778|FG002|Overall Study|Other complicating disease|0|||
30980485|NCT00634088|59092962|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
30980486|NCT00634088|59092963|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
30980487|NCT00634088|59092964|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
30980488|NCT00634088|59092965|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
30980489|NCT00634088|59092962|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
30980490|NCT00634088|59092963|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
30980491|NCT00634088|59092964|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
30980492|NCT00634088|59092965|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
30980493|NCT00634088|59092962|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
30980494|NCT00634088|59092963|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
30980495|NCT00634088|59092964|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
30980496|NCT00634088|59092965|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
30980497|NCT00634088|59092962|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
30980498|NCT00634088|59092963|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
30980499|NCT00634088|59092964|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
30980500|NCT00634088|59092965|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
30980501|NCT00634088|59092962|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
30980502|NCT00634088|59092963|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
30980503|NCT00634088|59092964|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
30980504|NCT00634088|59092965|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
30980505|NCT00634088|59092962|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
30980506|NCT00634088|59092963|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
30980507|NCT00634088|59092964|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
30980508|NCT00634088|59092965|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
30980509|NCT00634010|59093065|FG000|Overall Study|Adverse Event|2|||
30980510|NCT00634010|59093066|FG001|Overall Study|Adverse Event|5|||
30980511|NCT00634010|59093065|FG000|Overall Study|Withdrawal by Subject|5|||
30980512|NCT00634010|59093066|FG001|Overall Study|Withdrawal by Subject|6|||
30980513|NCT00634010|59093065|FG000|Overall Study|Physician Decision|1|||
30980514|NCT00634010|59093066|FG001|Overall Study|Physician Decision|1|||
30980515|NCT00634010|59093065|FG000|Overall Study|Disease Progression|1|||
30980516|NCT00634010|59093066|FG001|Overall Study|Disease Progression|1|||
30980517|NCT00634010|59093065|FG000|Overall Study|Non-Compliant|1|||
30980518|NCT00634010|59093066|FG001|Overall Study|Non-Compliant|1|||
30980519|NCT00633932|59093079|FG000|Overall Study|Adverse Event|1|||
30980520|NCT00633932|59093080|FG001|Overall Study|Adverse Event|3|||
30980521|NCT00633932|59093081|FG002|Overall Study|Adverse Event|4|||
30980522|NCT00633932|59093079|FG000|Overall Study|Withdrawal by Subject|3|||
30980523|NCT00633932|59093080|FG001|Overall Study|Withdrawal by Subject|9|||
30980524|NCT00633932|59093081|FG002|Overall Study|Withdrawal by Subject|1|||
30980525|NCT00633932|59093079|FG000|Overall Study|Lost to Follow-up|1|||
30980526|NCT00633932|59093080|FG001|Overall Study|Lost to Follow-up|0|||
30980527|NCT00633932|59093081|FG002|Overall Study|Lost to Follow-up|2|||
30980528|NCT00633932|59093079|FG000|Overall Study|Protocol Violation|5|||
30980529|NCT00633932|59093080|FG001|Overall Study|Protocol Violation|2|||
30980530|NCT00633932|59093081|FG002|Overall Study|Protocol Violation|3|||
30980531|NCT00633932|59093079|FG000|Overall Study|Physician Decision|0|||
30980532|NCT00633932|59093080|FG001|Overall Study|Physician Decision|0|||
30980533|NCT00633932|59093081|FG002|Overall Study|Physician Decision|1|||
30980534|NCT00633932|59093079|FG000|Overall Study|Doctor's judgement|1|||
30980535|NCT00633932|59093080|FG001|Overall Study|Doctor's judgement|0|||
30980536|NCT00633932|59093081|FG002|Overall Study|Doctor's judgement|0|||
30980537|NCT00633932|59093079|FG000|Overall Study|Moved Away|1|||
30980538|NCT00633932|59093080|FG001|Overall Study|Moved Away|0|||
30980539|NCT00633932|59093081|FG002|Overall Study|Moved Away|0|||
30980540|NCT00633464|59093211|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
30980541|NCT00633464|59093212|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
30980542|NCT00633464|59093211|FG000|Overall Study|Never Treated (Randomized in error)|0|||
30980543|NCT00633464|59093212|FG001|Overall Study|Never Treated (Randomized in error)|1|||
30980544|NCT00633152|59093253|FG000|Overall Study|Adverse Event|1|||
30980545|NCT00633152|59093254|FG001|Overall Study|Adverse Event|0|||
30980546|NCT00633152|59093253|FG000|Overall Study|Randomized, did not receive study drug|5|||
30980547|NCT00633152|59093254|FG001|Overall Study|Randomized, did not receive study drug|2|||
30980548|NCT00633152|59093253|FG000|Overall Study|Withdrawal by Subject|1|||
30980549|NCT00633152|59093254|FG001|Overall Study|Withdrawal by Subject|1|||
30980550|NCT00633152|59093253|FG000|Overall Study|Lost to Follow-up|4|||
30980551|NCT00633152|59093254|FG001|Overall Study|Lost to Follow-up|1|||
30980552|NCT00633152|59093253|FG000|Overall Study|Miscellaneous Other|3|||
30980553|NCT00633152|59093254|FG001|Overall Study|Miscellaneous Other|2|||
30980554|NCT00633074|59093273|FG000|Overall Study|Adverse Event|1|||
30980555|NCT00633074|59093274|FG001|Overall Study|Adverse Event|0|||
30980556|NCT00630344|59093461|FG000|Overall Study|Adverse Event|5|||
30891200|NCT01634139|58924341|FG000|Overall Study|Non compliant with protocol|1|||
30891201|NCT01634139|58924342|FG001|Overall Study|Non compliant with protocol|0|||
30891202|NCT01634139|58924343|FG002|Overall Study|Non compliant with protocol|0|||
30891203|NCT01634139|58924341|FG000|Overall Study|Consent withdrawn not due to AE|4|||
30891204|NCT01634139|58924342|FG001|Overall Study|Consent withdrawn not due to AE|3|||
30891205|NCT01634139|58924343|FG002|Overall Study|Consent withdrawn not due to AE|2|||
30891206|NCT01634139|58924341|FG000|Overall Study|Other|4|||
30891207|NCT01634139|58924342|FG001|Overall Study|Other|0|||
30891208|NCT01634139|58924343|FG002|Overall Study|Other|3|||
30891209|NCT01634139|58924341|FG000|Overall Study|Lost to Follow-up|0|||
30891210|NCT01634139|58924342|FG001|Overall Study|Lost to Follow-up|2|||
30891211|NCT01634139|58924343|FG002|Overall Study|Lost to Follow-up|0|||
30891212|NCT01634139|58924341|FG000|Overall Study|Not treated|1|||
30891213|NCT01634139|58924342|FG001|Overall Study|Not treated|1|||
30891214|NCT01634139|58924343|FG002|Overall Study|Not treated|0|||
30891215|NCT02224755|58924353|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
30891216|NCT02224755|58924354|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
30891217|NCT02224755|58924353|FG000|Two Year Follow up Post-implant|Death|103|||
30891218|NCT02224755|58924354|FG001|Two Year Follow up Post-implant|Death|98|||
30891219|NCT02224755|58924353|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
30891220|NCT02224755|58924354|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
30891221|NCT02224755|58924353|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
30891222|NCT02224755|58924354|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
30891223|NCT02224755|58924353|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
30891224|NCT02224755|58924354|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
30891225|NCT02404441|58924374|FG000|Phase 1 Part|Adverse Event|1|||
30891226|NCT02404441|58924375|FG001|Phase 1 Part|Adverse Event|0|||
30891227|NCT02404441|58924376|FG002|Phase 1 Part|Adverse Event|0|||
30891228|NCT02404441|58924377|FG003|Phase 1 Part|Adverse Event|0|||
30891229|NCT02404441|58924378|FG004|Phase 1 Part|Adverse Event|0|||
30891230|NCT02404441|58924379|FG005|Phase 1 Part|Adverse Event|0|||
30891231|NCT02404441|58924380|FG006|Phase 1 Part|Adverse Event|0|||
30891232|NCT02404441|58924381|FG007|Phase 1 Part|Adverse Event|0|||
30891233|NCT02404441|58924382|FG008|Phase 1 Part|Adverse Event|0|||
30891234|NCT02404441|58924383|FG009|Phase 1 Part|Adverse Event|0|||
30891235|NCT02404441|58924374|FG000|Phase 1 Part|Physician Decision|0|||
30891236|NCT02404441|58924375|FG001|Phase 1 Part|Physician Decision|1|||
30891237|NCT02404441|58924376|FG002|Phase 1 Part|Physician Decision|0|||
30891238|NCT02404441|58924377|FG003|Phase 1 Part|Physician Decision|0|||
30891239|NCT02404441|58924378|FG004|Phase 1 Part|Physician Decision|0|||
30891240|NCT02404441|58924379|FG005|Phase 1 Part|Physician Decision|0|||
30891241|NCT02404441|58924380|FG006|Phase 1 Part|Physician Decision|0|||
30891242|NCT02404441|58924381|FG007|Phase 1 Part|Physician Decision|0|||
30891243|NCT02404441|58924382|FG008|Phase 1 Part|Physician Decision|0|||
30891244|NCT02404441|58924383|FG009|Phase 1 Part|Physician Decision|0|||
30891245|NCT02404441|58924374|FG000|Phase 1 Part|Progressive Disease|14|||
30891246|NCT02404441|58924375|FG001|Phase 1 Part|Progressive Disease|11|||
30891247|NCT02404441|58924376|FG002|Phase 1 Part|Progressive Disease|7|||
30891248|NCT02404441|58924377|FG003|Phase 1 Part|Progressive Disease|6|||
30891249|NCT02404441|58924378|FG004|Phase 1 Part|Progressive Disease|9|||
30891250|NCT02404441|58924379|FG005|Phase 1 Part|Progressive Disease|0|||
30891251|NCT02404441|58924380|FG006|Phase 1 Part|Progressive Disease|0|||
30891252|NCT02404441|58924381|FG007|Phase 1 Part|Progressive Disease|0|||
30891253|NCT02404441|58924382|FG008|Phase 1 Part|Progressive Disease|0|||
30891254|NCT02404441|58924383|FG009|Phase 1 Part|Progressive Disease|0|||
30891255|NCT02404441|58924374|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
30891256|NCT02404441|58924375|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
30891257|NCT02404441|58924376|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
30891258|NCT02404441|58924377|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
30891259|NCT02404441|58924378|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
30891260|NCT02404441|58924379|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
30891261|NCT02404441|58924380|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
30891262|NCT02404441|58924381|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
30891263|NCT02404441|58924382|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
30891264|NCT02404441|58924383|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
30891265|NCT02404441|58924374|FG000|Phase 1 Part|Death|1|||
30891266|NCT02404441|58924375|FG001|Phase 1 Part|Death|1|||
30891267|NCT02404441|58924376|FG002|Phase 1 Part|Death|1|||
30891268|NCT02404441|58924377|FG003|Phase 1 Part|Death|0|||
30891269|NCT02404441|58924378|FG004|Phase 1 Part|Death|1|||
30891270|NCT02404441|58924379|FG005|Phase 1 Part|Death|0|||
30891271|NCT02404441|58924380|FG006|Phase 1 Part|Death|0|||
30980557|NCT00630344|59093461|FG000|Overall Study|Progressive Disease|19|||
30891272|NCT02404441|58924381|FG007|Phase 1 Part|Death|0|||
30891273|NCT02404441|58924382|FG008|Phase 1 Part|Death|0|||
30891274|NCT02404441|58924383|FG009|Phase 1 Part|Death|0|||
30891275|NCT02404441|58924374|FG000|Phase 2 Part|Adverse Event|0|||
30891276|NCT02404441|58924375|FG001|Phase 2 Part|Adverse Event|0|||
30891277|NCT02404441|58924376|FG002|Phase 2 Part|Adverse Event|0|||
30980558|NCT00630344|59093461|FG000|Overall Study|Physician Decision|9|||
30980559|NCT00630344|59093461|FG000|Overall Study|Withdrawal by Subject|1|||
30980560|NCT00630344|59093461|FG000|Overall Study|Intercurrent Illness|1|||
30980561|NCT00630344|59093461|FG000|Overall Study|Other|1|||
30980562|NCT02913261|59093487|FG000|Overall Study|Technical problems|0|||
30980563|NCT02913261|59093488|FG001|Overall Study|Technical problems|1|||
30980564|NCT02913261|59093487|FG000|Overall Study|Lack of Efficacy|32|||
30980565|NCT02913261|59093488|FG001|Overall Study|Lack of Efficacy|69|||
30980566|NCT02913261|59093487|FG000|Overall Study|Adverse Event|27|||
30980567|NCT02913261|59093488|FG001|Overall Study|Adverse Event|5|||
30980568|NCT02913261|59093487|FG000|Overall Study|Death|25|||
30980569|NCT02913261|59093488|FG001|Overall Study|Death|22|||
30980570|NCT02913261|59093487|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
30980571|NCT02913261|59093488|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
30980572|NCT02913261|59093487|FG000|Overall Study|Disease relapse|8|||
30980573|NCT02913261|59093488|FG001|Overall Study|Disease relapse|13|||
30980574|NCT02913261|59093487|FG000|Overall Study|Physician Decision|8|||
30980575|NCT02913261|59093488|FG001|Overall Study|Physician Decision|9|||
30980576|NCT02913261|59093487|FG000|Overall Study|Subject/guardian decision|4|||
30980577|NCT02913261|59093488|FG001|Overall Study|Subject/guardian decision|6|||
30980578|NCT02913261|59093487|FG000|Overall Study|Graft loss|2|||
30980579|NCT02913261|59093488|FG001|Overall Study|Graft loss|0|||
30980580|NCT00635882|59093552|FG000|Overall Study|Protocol Violation|1|||
30980581|NCT00635882|59093553|FG001|Overall Study|Protocol Violation|0|||
30980582|NCT00635882|59093554|FG002|Overall Study|Protocol Violation|0|||
30980583|NCT00635882|59093555|FG003|Overall Study|Protocol Violation|0|||
30980584|NCT00635882|59093556|FG004|Overall Study|Protocol Violation|0|||
30980585|NCT00635882|59093557|FG005|Overall Study|Protocol Violation|0|||
30980586|NCT00986570|59093808|FG000|Overall Study|Lost to Follow-up|6|||
30980587|NCT00986570|59093808|FG000|Overall Study|Potential bias for objective assessment|1|||
30980588|NCT00986258|59093812|FG000|Observation Period|Not eligible to be dosed|11|||
30980589|NCT00986258|59093812|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
30980590|NCT00986258|59093812|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
30980591|NCT00986258|59093812|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
30980592|NCT00986258|59093812|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
30980593|NCT00986258|59093812|FG000|Titration and Optimal Dose Period|Other|1|||
30980594|NCT00986258|59093812|FG000|Maintenance Period|Adverse Event|5|||
30980595|NCT00986258|59093812|FG000|Maintenance Period|Lack of Efficacy|2|||
30980596|NCT00986258|59093812|FG000|Maintenance Period|Withdrawal by Subject|2|||
30980597|NCT00986180|59093828|FG000|Overall Study|Adverse Event|21|||
30980598|NCT00986180|59093829|FG001|Overall Study|Adverse Event|23|||
30980599|NCT00986180|59093828|FG000|Overall Study|Lack of Efficacy|4|||
30980600|NCT00986180|59093829|FG001|Overall Study|Lack of Efficacy|3|||
30980601|NCT00986180|59093828|FG000|Overall Study|Lost to Follow-up|5|||
30980602|NCT00986180|59093829|FG001|Overall Study|Lost to Follow-up|7|||
30980603|NCT00986180|59093828|FG000|Overall Study|Physician Decision|1|||
30980604|NCT00986180|59093829|FG001|Overall Study|Physician Decision|3|||
30980605|NCT00986180|59093828|FG000|Overall Study|Protocol Violation|2|||
30980606|NCT00986180|59093829|FG001|Overall Study|Protocol Violation|0|||
30980607|NCT00986180|59093828|FG000|Overall Study|Withdrawal by Subject|1|||
30980608|NCT00986180|59093829|FG001|Overall Study|Withdrawal by Subject|9|||
30980609|NCT00986180|59093828|FG000|Overall Study|Miscellanies|10|||
30980610|NCT00986180|59093829|FG001|Overall Study|Miscellanies|11|||
30980611|NCT00986102|59094011|FG000|Overall Study|Lost to Follow-up|0|||
30980612|NCT00986102|59094012|FG001|Overall Study|Lost to Follow-up|1|||
30980613|NCT00986102|59094013|FG002|Overall Study|Lost to Follow-up|0|||
30980614|NCT00986102|59094014|FG003|Overall Study|Lost to Follow-up|1|||
30980615|NCT00986102|59094011|FG000|Overall Study|Withdrawal by Subject|1|||
30980616|NCT00986102|59094012|FG001|Overall Study|Withdrawal by Subject|1|||
30980617|NCT00986102|59094013|FG002|Overall Study|Withdrawal by Subject|0|||
30980618|NCT00986102|59094014|FG003|Overall Study|Withdrawal by Subject|0|||
30980619|NCT00985946|59094037|FG000|Overall Study|Lost to Follow-up|6|||
30980620|NCT00985946|59094037|FG000|Overall Study|Withdrawal by Subject|1|||
30891278|NCT02404441|58924377|FG003|Phase 2 Part|Adverse Event|0|||
30891279|NCT02404441|58924378|FG004|Phase 2 Part|Adverse Event|0|||
30891280|NCT02404441|58924379|FG005|Phase 2 Part|Adverse Event|2|||
30891281|NCT02404441|58924380|FG006|Phase 2 Part|Adverse Event|3|||
30891282|NCT02404441|58924381|FG007|Phase 2 Part|Adverse Event|3|||
30891283|NCT02404441|58924382|FG008|Phase 2 Part|Adverse Event|6|||
30891284|NCT02404441|58924383|FG009|Phase 2 Part|Adverse Event|1|||
30891285|NCT02404441|58924374|FG000|Phase 2 Part|Physician Decision|0|||
30891286|NCT02404441|58924375|FG001|Phase 2 Part|Physician Decision|0|||
30891287|NCT02404441|58924376|FG002|Phase 2 Part|Physician Decision|0|||
30891288|NCT02404441|58924377|FG003|Phase 2 Part|Physician Decision|0|||
30980621|NCT00985790|59094052|FG000|Overall Study|Withdrawal by Subject|1|||
30980622|NCT00985790|59094053|FG001|Overall Study|Withdrawal by Subject|1|||
30980623|NCT00985790|59094052|FG000|Overall Study|Lost to Follow-up|6|||
30980624|NCT00985790|59094053|FG001|Overall Study|Lost to Follow-up|7|||
30980625|NCT00985712|59094080|FG000|Overall Study|Adverse Event|0|||
30980626|NCT00985712|59094081|FG001|Overall Study|Adverse Event|1|||
30980627|NCT00985712|59094080|FG000|Overall Study|Lost to Follow-up|2|||
30980628|NCT00985712|59094081|FG001|Overall Study|Lost to Follow-up|2|||
30980629|NCT00985712|59094080|FG000|Overall Study|Protocol Violation|0|||
30980630|NCT00985712|59094081|FG001|Overall Study|Protocol Violation|1|||
30980631|NCT00985712|59094080|FG000|Overall Study|Withdrawal by Subject|4|||
30980632|NCT00985712|59094081|FG001|Overall Study|Withdrawal by Subject|1|||
30980633|NCT00985712|59094080|FG000|Overall Study|Sponsor decision|0|||
30980634|NCT00985712|59094081|FG001|Overall Study|Sponsor decision|2|||
30980635|NCT00985166|59094188|FG000|Overall Study|Lost to Follow-up|3|||
30980636|NCT00985166|59094189|FG001|Overall Study|Lost to Follow-up|2|||
30980637|NCT00985166|59094190|FG002|Overall Study|Lost to Follow-up|2|||
30980638|NCT00985166|59094188|FG000|Overall Study|Withdrawal by Subject|3|||
30980639|NCT00985166|59094189|FG001|Overall Study|Withdrawal by Subject|2|||
30980640|NCT00985166|59094190|FG002|Overall Study|Withdrawal by Subject|0|||
30980641|NCT00985166|59094188|FG000|Overall Study|Test not done|2|||
30980642|NCT00985166|59094189|FG001|Overall Study|Test not done|0|||
30980643|NCT00985166|59094190|FG002|Overall Study|Test not done|4|||
30980644|NCT00985166|59094188|FG000|Overall Study|Other|1|||
30980645|NCT00985166|59094189|FG001|Overall Study|Other|0|||
30980646|NCT00985166|59094190|FG002|Overall Study|Other|1|||
30980647|NCT02184195|59094352|FG000|Overall Study|Patients ongoing Study Treatment|19|||
30980648|NCT02184195|59094353|FG001|Overall Study|Patients ongoing Study Treatment|7|||
30980649|NCT01341405|59094445|FG000|Overall Study|Adverse Event|0|||
30980650|NCT01341405|59094446|FG001|Overall Study|Adverse Event|1|||
30980651|NCT01341405|59094447|FG002|Overall Study|Adverse Event|1|||
30980652|NCT01341405|59094445|FG000|Overall Study|Withdrawal by Subject|3|||
30980653|NCT01341405|59094446|FG001|Overall Study|Withdrawal by Subject|2|||
30980654|NCT01341405|59094447|FG002|Overall Study|Withdrawal by Subject|1|||
30980655|NCT00633945|59095699|FG000|Overall Study|Physician Decision|2|||
30980656|NCT02574078|59095963|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30980657|NCT02574078|59095964|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30980658|NCT02574078|59095965|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30980659|NCT02574078|59095966|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30980660|NCT02574078|59095967|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30980661|NCT02574078|59095968|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
30980662|NCT02574078|59095969|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
30980663|NCT02574078|59095970|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30980664|NCT02574078|59095971|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
30980665|NCT02574078|59095972|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30980666|NCT02574078|59095973|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30980667|NCT02574078|59095974|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30980668|NCT02574078|59095975|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30980669|NCT02574078|59095963|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
30980670|NCT02574078|59095964|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
30980671|NCT02574078|59095965|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
30980672|NCT02574078|59095966|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
30980673|NCT02574078|59095967|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
30980674|NCT02574078|59095968|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
30980675|NCT02574078|59095969|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
30980676|NCT02574078|59095970|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
30980677|NCT02574078|59095971|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
30980678|NCT02574078|59095972|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
30980679|NCT02574078|59095973|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
30980680|NCT02574078|59095974|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
30980681|NCT02574078|59095975|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
30980682|NCT02574078|59095963|FG000|Pre-Treatment Period|Other reasons|0|||
30980683|NCT02574078|59095964|FG001|Pre-Treatment Period|Other reasons|0|||
30980684|NCT02574078|59095965|FG002|Pre-Treatment Period|Other reasons|0|||
30980685|NCT02574078|59095966|FG003|Pre-Treatment Period|Other reasons|0|||
30980686|NCT02574078|59095967|FG004|Pre-Treatment Period|Other reasons|0|||
30980687|NCT02574078|59095968|FG005|Pre-Treatment Period|Other reasons|0|||
30980688|NCT02574078|59095969|FG006|Pre-Treatment Period|Other reasons|2|||
30980689|NCT02574078|59095970|FG007|Pre-Treatment Period|Other reasons|0|||
30980690|NCT02574078|59095971|FG008|Pre-Treatment Period|Other reasons|0|||
30980691|NCT02574078|59095972|FG009|Pre-Treatment Period|Other reasons|0|||
30980692|NCT02574078|59095973|FG010|Pre-Treatment Period|Other reasons|2|||
30980693|NCT02574078|59095974|FG011|Pre-Treatment Period|Other reasons|0|||
30980694|NCT02574078|59095975|FG012|Pre-Treatment Period|Other reasons|0|||
30980695|NCT02574078|59095963|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
30980696|NCT02574078|59095964|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
30980697|NCT02574078|59095965|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
30980698|NCT02574078|59095966|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
30980699|NCT02574078|59095967|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
30980700|NCT02574078|59095968|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
30980701|NCT02574078|59095969|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
30980702|NCT02574078|59095970|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
30980703|NCT02574078|59095971|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
30980704|NCT02574078|59095972|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
30980705|NCT02574078|59095973|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
30980706|NCT02574078|59095974|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
30980707|NCT02574078|59095975|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
30980708|NCT02574078|59095963|FG000|Treatment Period|Disease progression|6|||
30980709|NCT02574078|59095964|FG001|Treatment Period|Disease progression|4|||
30980710|NCT02574078|59095965|FG002|Treatment Period|Disease progression|7|||
30980711|NCT02574078|59095966|FG003|Treatment Period|Disease progression|18|||
30980712|NCT02574078|59095967|FG004|Treatment Period|Disease progression|16|||
30980713|NCT02574078|59095968|FG005|Treatment Period|Disease progression|26|||
30980714|NCT02574078|59095969|FG006|Treatment Period|Disease progression|5|||
30980715|NCT02574078|59095970|FG007|Treatment Period|Disease progression|9|||
30980716|NCT02574078|59095971|FG008|Treatment Period|Disease progression|8|||
30980717|NCT02574078|59095972|FG009|Treatment Period|Disease progression|5|||
30980718|NCT02574078|59095973|FG010|Treatment Period|Disease progression|20|||
30980719|NCT02574078|59095974|FG011|Treatment Period|Disease progression|29|||
30980720|NCT02574078|59095975|FG012|Treatment Period|Disease progression|2|||
30980721|NCT02574078|59095963|FG000|Treatment Period|Study drug toxicity|1|||
30980722|NCT02574078|59095964|FG001|Treatment Period|Study drug toxicity|1|||
30980723|NCT02574078|59095965|FG002|Treatment Period|Study drug toxicity|0|||
30980724|NCT02574078|59095966|FG003|Treatment Period|Study drug toxicity|5|||
30980725|NCT02574078|59095967|FG004|Treatment Period|Study drug toxicity|3|||
30980726|NCT02574078|59095968|FG005|Treatment Period|Study drug toxicity|1|||
30980727|NCT02574078|59095969|FG006|Treatment Period|Study drug toxicity|2|||
30980728|NCT02574078|59095970|FG007|Treatment Period|Study drug toxicity|0|||
30980729|NCT02574078|59095971|FG008|Treatment Period|Study drug toxicity|2|||
30980730|NCT02574078|59095972|FG009|Treatment Period|Study drug toxicity|1|||
30980731|NCT02574078|59095973|FG010|Treatment Period|Study drug toxicity|16|||
30980732|NCT02574078|59095974|FG011|Treatment Period|Study drug toxicity|2|||
30980733|NCT02574078|59095975|FG012|Treatment Period|Study drug toxicity|4|||
30980734|NCT02574078|59095963|FG000|Treatment Period|Death|2|||
30980735|NCT02574078|59095964|FG001|Treatment Period|Death|0|||
30980736|NCT02574078|59095965|FG002|Treatment Period|Death|0|||
30980737|NCT02574078|59095966|FG003|Treatment Period|Death|0|||
30980738|NCT02574078|59095967|FG004|Treatment Period|Death|1|||
30980739|NCT02574078|59095968|FG005|Treatment Period|Death|1|||
30980740|NCT02574078|59095969|FG006|Treatment Period|Death|1|||
30980741|NCT02574078|59095970|FG007|Treatment Period|Death|1|||
30980742|NCT02574078|59095971|FG008|Treatment Period|Death|7|||
30980743|NCT02574078|59095972|FG009|Treatment Period|Death|1|||
30980744|NCT02574078|59095973|FG010|Treatment Period|Death|0|||
30980745|NCT02574078|59095974|FG011|Treatment Period|Death|2|||
30980746|NCT02574078|59095975|FG012|Treatment Period|Death|1|||
30980747|NCT02574078|59095963|FG000|Treatment Period|Adverse event unrelated to drug|0|||
30980748|NCT02574078|59095964|FG001|Treatment Period|Adverse event unrelated to drug|0|||
30980749|NCT02574078|59095965|FG002|Treatment Period|Adverse event unrelated to drug|1|||
30980750|NCT02574078|59095966|FG003|Treatment Period|Adverse event unrelated to drug|0|||
30980751|NCT02574078|59095967|FG004|Treatment Period|Adverse event unrelated to drug|2|||
30980752|NCT02574078|59095968|FG005|Treatment Period|Adverse event unrelated to drug|3|||
30980753|NCT02574078|59095969|FG006|Treatment Period|Adverse event unrelated to drug|0|||
30980754|NCT02574078|59095970|FG007|Treatment Period|Adverse event unrelated to drug|0|||
30980755|NCT02574078|59095971|FG008|Treatment Period|Adverse event unrelated to drug|1|||
30980756|NCT02574078|59095972|FG009|Treatment Period|Adverse event unrelated to drug|2|||
30980757|NCT02574078|59095973|FG010|Treatment Period|Adverse event unrelated to drug|4|||
30980758|NCT02574078|59095974|FG011|Treatment Period|Adverse event unrelated to drug|1|||
30980759|NCT02574078|59095975|FG012|Treatment Period|Adverse event unrelated to drug|0|||
30980760|NCT02574078|59095963|FG000|Treatment Period|Administrative reason by Sponsor|0|||
30980761|NCT02574078|59095964|FG001|Treatment Period|Administrative reason by Sponsor|1|||
30980762|NCT02574078|59095965|FG002|Treatment Period|Administrative reason by Sponsor|0|||
30980763|NCT02574078|59095966|FG003|Treatment Period|Administrative reason by Sponsor|0|||
30980764|NCT02574078|59095967|FG004|Treatment Period|Administrative reason by Sponsor|0|||
30980765|NCT02574078|59095968|FG005|Treatment Period|Administrative reason by Sponsor|0|||
30891289|NCT02404441|58924378|FG004|Phase 2 Part|Physician Decision|0|||
30891290|NCT02404441|58924379|FG005|Phase 2 Part|Physician Decision|7|||
30891291|NCT02404441|58924380|FG006|Phase 2 Part|Physician Decision|9|||
30891292|NCT02404441|58924381|FG007|Phase 2 Part|Physician Decision|2|||
30891293|NCT02404441|58924382|FG008|Phase 2 Part|Physician Decision|1|||
30891294|NCT02404441|58924383|FG009|Phase 2 Part|Physician Decision|3|||
30891295|NCT02404441|58924374|FG000|Phase 2 Part|Progressive disease|0|||
30891296|NCT02404441|58924375|FG001|Phase 2 Part|Progressive disease|0|||
30891297|NCT02404441|58924376|FG002|Phase 2 Part|Progressive disease|0|||
30891298|NCT02404441|58924377|FG003|Phase 2 Part|Progressive disease|0|||
30891299|NCT02404441|58924378|FG004|Phase 2 Part|Progressive disease|0|||
30891300|NCT02404441|58924379|FG005|Phase 2 Part|Progressive disease|43|||
30891301|NCT02404441|58924380|FG006|Phase 2 Part|Progressive disease|32|||
30891302|NCT02404441|58924381|FG007|Phase 2 Part|Progressive disease|31|||
30891303|NCT02404441|58924382|FG008|Phase 2 Part|Progressive disease|39|||
30891304|NCT02404441|58924383|FG009|Phase 2 Part|Progressive disease|27|||
30891305|NCT02404441|58924374|FG000|Phase 2 Part|Subject/guardian decision|0|||
30891306|NCT02404441|58924375|FG001|Phase 2 Part|Subject/guardian decision|0|||
30891307|NCT02404441|58924376|FG002|Phase 2 Part|Subject/guardian decision|0|||
30891308|NCT02404441|58924377|FG003|Phase 2 Part|Subject/guardian decision|0|||
30891309|NCT02404441|58924378|FG004|Phase 2 Part|Subject/guardian decision|0|||
30891310|NCT02404441|58924379|FG005|Phase 2 Part|Subject/guardian decision|3|||
30891311|NCT02404441|58924380|FG006|Phase 2 Part|Subject/guardian decision|9|||
30891312|NCT02404441|58924381|FG007|Phase 2 Part|Subject/guardian decision|0|||
30891313|NCT02404441|58924382|FG008|Phase 2 Part|Subject/guardian decision|3|||
30891314|NCT02404441|58924383|FG009|Phase 2 Part|Subject/guardian decision|2|||
30891315|NCT02404441|58924374|FG000|Phase 2 Part|Death|0|||
30891316|NCT02404441|58924375|FG001|Phase 2 Part|Death|0|||
30891317|NCT02404441|58924376|FG002|Phase 2 Part|Death|0|||
30891318|NCT02404441|58924377|FG003|Phase 2 Part|Death|0|||
30891319|NCT02404441|58924378|FG004|Phase 2 Part|Death|0|||
30891320|NCT02404441|58924379|FG005|Phase 2 Part|Death|4|||
30891321|NCT02404441|58924380|FG006|Phase 2 Part|Death|8|||
30891322|NCT02404441|58924381|FG007|Phase 2 Part|Death|4|||
30891323|NCT02404441|58924382|FG008|Phase 2 Part|Death|10|||
30891324|NCT02404441|58924383|FG009|Phase 2 Part|Death|9|||
30891325|NCT02101281|58924429|FG000|Overall Study|Adverse Event|0|||
30891326|NCT02101281|58924430|FG001|Overall Study|Adverse Event|1|||
30891327|NCT02224599|58924442|FG000|Overall Study|Physician Decision|1|||
30891328|NCT02224599|58924442|FG000|Overall Study|Progression of Disease|1|||
30891329|NCT02201901|58924449|FG000|Overall Study|Randomized but never treated|0|||
30891330|NCT02201901|58924450|FG001|Overall Study|Randomized but never treated|1|||
30891331|NCT02201901|58924451|FG002|Overall Study|Randomized but never treated|0|||
30891332|NCT02201901|58924449|FG000|Overall Study|Lack of Efficacy|7|||
30891333|NCT02201901|58924450|FG001|Overall Study|Lack of Efficacy|1|||
30891334|NCT02201901|58924451|FG002|Overall Study|Lack of Efficacy|6|||
30891335|NCT02201901|58924449|FG000|Overall Study|Death|3|||
30891336|NCT02201901|58924450|FG001|Overall Study|Death|3|||
30891337|NCT02201901|58924451|FG002|Overall Study|Death|3|||
30891338|NCT02201901|58924449|FG000|Overall Study|Lost to Follow-up|2|||
30891339|NCT02201901|58924450|FG001|Overall Study|Lost to Follow-up|3|||
30891340|NCT02201901|58924451|FG002|Overall Study|Lost to Follow-up|2|||
30891341|NCT02201901|58924449|FG000|Overall Study|Withdrew Consent|2|||
30891342|NCT02201901|58924450|FG001|Overall Study|Withdrew Consent|0|||
30891343|NCT02201901|58924451|FG002|Overall Study|Withdrew Consent|2|||
30891344|NCT02201901|58924449|FG000|Overall Study|Adverse Event|1|||
30891345|NCT02201901|58924450|FG001|Overall Study|Adverse Event|1|||
30891346|NCT02201901|58924451|FG002|Overall Study|Adverse Event|0|||
30891347|NCT02201277|58924462|FG000|Overall Study|Death|3|||
30891348|NCT02201277|58924463|FG001|Overall Study|Death|4|||
30891349|NCT02201277|58924462|FG000|Overall Study|Lost to Follow-up|2|||
30891350|NCT02201277|58924463|FG001|Overall Study|Lost to Follow-up|1|||
30891351|NCT02201277|58924462|FG000|Overall Study|Failed retrieval|1|||
30891352|NCT02201277|58924463|FG001|Overall Study|Failed retrieval|0|||
30980766|NCT02574078|59095969|FG006|Treatment Period|Administrative reason by Sponsor|1|||
30980767|NCT02574078|59095970|FG007|Treatment Period|Administrative reason by Sponsor|0|||
30891353|NCT02201277|58924462|FG000|Overall Study|Physician Decision|1|||
30891354|NCT02201277|58924463|FG001|Overall Study|Physician Decision|0|||
30891355|NCT02224053|58924473|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
30891356|NCT02224053|58924473|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
30891357|NCT02224053|58924473|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
30891358|NCT02224053|58924473|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
30891359|NCT02224053|58924473|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
30891360|NCT02457793|58924485|FG000|Overall Study|Reason not specified|0|||
30891361|NCT02457793|58924486|FG001|Overall Study|Reason not specified|0|||
30891362|NCT02457793|58924487|FG002|Overall Study|Reason not specified|0|||
30891363|NCT02457793|58924488|FG003|Overall Study|Reason not specified|1|||
30891364|NCT02457793|58924489|FG004|Overall Study|Reason not specified|1|||
30980768|NCT02574078|59095971|FG008|Treatment Period|Administrative reason by Sponsor|0|||
30980769|NCT02574078|59095972|FG009|Treatment Period|Administrative reason by Sponsor|0|||
30980770|NCT02574078|59095973|FG010|Treatment Period|Administrative reason by Sponsor|0|||
30980771|NCT02574078|59095974|FG011|Treatment Period|Administrative reason by Sponsor|0|||
30980772|NCT02574078|59095975|FG012|Treatment Period|Administrative reason by Sponsor|3|||
30980773|NCT02574078|59095963|FG000|Treatment Period|Other reasons|1|||
30980774|NCT02574078|59095964|FG001|Treatment Period|Other reasons|0|||
30980775|NCT02574078|59095965|FG002|Treatment Period|Other reasons|1|||
30980776|NCT02574078|59095966|FG003|Treatment Period|Other reasons|3|||
30980777|NCT02574078|59095967|FG004|Treatment Period|Other reasons|3|||
30980778|NCT02574078|59095968|FG005|Treatment Period|Other reasons|1|||
30980779|NCT02574078|59095969|FG006|Treatment Period|Other reasons|2|||
30980780|NCT02574078|59095970|FG007|Treatment Period|Other reasons|1|||
30980781|NCT02574078|59095971|FG008|Treatment Period|Other reasons|3|||
30980782|NCT02574078|59095972|FG009|Treatment Period|Other reasons|1|||
30980783|NCT02574078|59095973|FG010|Treatment Period|Other reasons|1|||
30980784|NCT02574078|59095974|FG011|Treatment Period|Other reasons|3|||
30980785|NCT02574078|59095975|FG012|Treatment Period|Other reasons|1|||
30980786|NCT02574078|59095963|FG000|Treatment Period|Participant request to stop drug|0|||
30980787|NCT02574078|59095964|FG001|Treatment Period|Participant request to stop drug|0|||
30980788|NCT02574078|59095965|FG002|Treatment Period|Participant request to stop drug|0|||
30980789|NCT02574078|59095966|FG003|Treatment Period|Participant request to stop drug|2|||
30980790|NCT02574078|59095967|FG004|Treatment Period|Participant request to stop drug|4|||
30980791|NCT02574078|59095968|FG005|Treatment Period|Participant request to stop drug|0|||
30980792|NCT02574078|59095969|FG006|Treatment Period|Participant request to stop drug|1|||
30980793|NCT02574078|59095970|FG007|Treatment Period|Participant request to stop drug|0|||
30980794|NCT02574078|59095971|FG008|Treatment Period|Participant request to stop drug|3|||
30980795|NCT02574078|59095972|FG009|Treatment Period|Participant request to stop drug|2|||
30980796|NCT02574078|59095973|FG010|Treatment Period|Participant request to stop drug|2|||
30980797|NCT02574078|59095974|FG011|Treatment Period|Participant request to stop drug|4|||
30980798|NCT02574078|59095975|FG012|Treatment Period|Participant request to stop drug|1|||
30980799|NCT02574078|59095963|FG000|Treatment Period|Participant withdrew consent|0|||
30980800|NCT02574078|59095964|FG001|Treatment Period|Participant withdrew consent|0|||
30980801|NCT02574078|59095965|FG002|Treatment Period|Participant withdrew consent|0|||
30980802|NCT02574078|59095966|FG003|Treatment Period|Participant withdrew consent|0|||
30980803|NCT02574078|59095967|FG004|Treatment Period|Participant withdrew consent|1|||
30980804|NCT02574078|59095968|FG005|Treatment Period|Participant withdrew consent|1|||
30980805|NCT02574078|59095969|FG006|Treatment Period|Participant withdrew consent|0|||
30980806|NCT02574078|59095970|FG007|Treatment Period|Participant withdrew consent|1|||
30980807|NCT02574078|59095971|FG008|Treatment Period|Participant withdrew consent|0|||
30980808|NCT02574078|59095972|FG009|Treatment Period|Participant withdrew consent|2|||
30980809|NCT02574078|59095973|FG010|Treatment Period|Participant withdrew consent|1|||
30980810|NCT02574078|59095974|FG011|Treatment Period|Participant withdrew consent|4|||
30980811|NCT02574078|59095975|FG012|Treatment Period|Participant withdrew consent|1|||
30980812|NCT02574078|59095963|FG000|Treatment Period|Participant no longer meets criteria|0|||
30980813|NCT02574078|59095964|FG001|Treatment Period|Participant no longer meets criteria|0|||
30980814|NCT02574078|59095965|FG002|Treatment Period|Participant no longer meets criteria|0|||
30980815|NCT02574078|59095966|FG003|Treatment Period|Participant no longer meets criteria|0|||
30980816|NCT02574078|59095967|FG004|Treatment Period|Participant no longer meets criteria|1|||
30980817|NCT02574078|59095968|FG005|Treatment Period|Participant no longer meets criteria|0|||
30980818|NCT02574078|59095969|FG006|Treatment Period|Participant no longer meets criteria|0|||
30980819|NCT02574078|59095970|FG007|Treatment Period|Participant no longer meets criteria|0|||
30980820|NCT02574078|59095971|FG008|Treatment Period|Participant no longer meets criteria|0|||
30980821|NCT02574078|59095972|FG009|Treatment Period|Participant no longer meets criteria|1|||
30980822|NCT02574078|59095973|FG010|Treatment Period|Participant no longer meets criteria|1|||
30980823|NCT02574078|59095974|FG011|Treatment Period|Participant no longer meets criteria|1|||
30980824|NCT02574078|59095975|FG012|Treatment Period|Participant no longer meets criteria|0|||
30980825|NCT02574078|59095963|FG000|Treatment Period|Lost to Follow-up|0|||
30980826|NCT02574078|59095964|FG001|Treatment Period|Lost to Follow-up|0|||
30980827|NCT02574078|59095965|FG002|Treatment Period|Lost to Follow-up|0|||
30980828|NCT02574078|59095966|FG003|Treatment Period|Lost to Follow-up|0|||
30980829|NCT02574078|59095967|FG004|Treatment Period|Lost to Follow-up|0|||
30980830|NCT02574078|59095968|FG005|Treatment Period|Lost to Follow-up|0|||
30980831|NCT02574078|59095969|FG006|Treatment Period|Lost to Follow-up|0|||
30980832|NCT02574078|59095970|FG007|Treatment Period|Lost to Follow-up|0|||
30980833|NCT02574078|59095971|FG008|Treatment Period|Lost to Follow-up|0|||
30891365|NCT02457793|58924490|FG005|Overall Study|Reason not specified|1|||
30891366|NCT02457793|58924485|FG000|Overall Study|Withdrawal by Subject|0|||
30891367|NCT02457793|58924486|FG001|Overall Study|Withdrawal by Subject|4|||
30891368|NCT02457793|58924487|FG002|Overall Study|Withdrawal by Subject|2|||
30891369|NCT02457793|58924488|FG003|Overall Study|Withdrawal by Subject|2|||
30891370|NCT02457793|58924489|FG004|Overall Study|Withdrawal by Subject|2|||
30891371|NCT02457793|58924490|FG005|Overall Study|Withdrawal by Subject|2|||
30891372|NCT02457793|58924485|FG000|Overall Study|Adverse Event|0|||
30891373|NCT02457793|58924486|FG001|Overall Study|Adverse Event|0|||
30891374|NCT02457793|58924487|FG002|Overall Study|Adverse Event|0|||
30891375|NCT02457793|58924488|FG003|Overall Study|Adverse Event|1|||
30891376|NCT02457793|58924489|FG004|Overall Study|Adverse Event|0|||
30891377|NCT02457793|58924490|FG005|Overall Study|Adverse Event|0|||
30891378|NCT02457793|58924485|FG000|Overall Study|Physician Decision|1|||
30891379|NCT02457793|58924486|FG001|Overall Study|Physician Decision|0|||
30891380|NCT02457793|58924487|FG002|Overall Study|Physician Decision|1|||
30891381|NCT02457793|58924488|FG003|Overall Study|Physician Decision|1|||
30891382|NCT02457793|58924489|FG004|Overall Study|Physician Decision|1|||
30891383|NCT02457793|58924490|FG005|Overall Study|Physician Decision|3|||
30891384|NCT01650259|58924507|FG000|Overall Study|Improvement|105|||
30891385|NCT01650259|58924508|FG001|Overall Study|Improvement|0|||
30891386|NCT01650259|58924507|FG000|Overall Study|Adverse Event|127|||
30891387|NCT01650259|58924508|FG001|Overall Study|Adverse Event|0|||
30891388|NCT01650259|58924507|FG000|Overall Study|Lack of Efficacy|143|||
30891389|NCT01650259|58924508|FG001|Overall Study|Lack of Efficacy|0|||
30891390|NCT01650259|58924507|FG000|Overall Study|Lost to Follow-up|435|||
30891391|NCT01650259|58924508|FG001|Overall Study|Lost to Follow-up|0|||
30891392|NCT01650259|58924507|FG000|Overall Study|Patients had no visit after entry|70|||
30891393|NCT01650259|58924508|FG001|Overall Study|Patients had no visit after entry|0|||
30891394|NCT01650259|58924507|FG000|Overall Study|CRF not collected|98|||
30891395|NCT01650259|58924508|FG001|Overall Study|CRF not collected|82|||
30891396|NCT01650259|58924507|FG000|Overall Study|Not treated|1|||
30891397|NCT01650259|58924508|FG001|Overall Study|Not treated|7|||
30891398|NCT01650259|58924507|FG000|Overall Study|Other than listed|64|||
30891399|NCT01650259|58924508|FG001|Overall Study|Other than listed|146|||
30891400|NCT02434939|58924514|FG000|Overall Study|Lack of Efficacy|34|||
30891401|NCT02434939|58924515|FG001|Overall Study|Lack of Efficacy|48|||
30891402|NCT02434939|58924514|FG000|Overall Study|Withdrawal by Subject|3|||
30891403|NCT02434939|58924515|FG001|Overall Study|Withdrawal by Subject|0|||
30891404|NCT02434939|58924514|FG000|Overall Study|Adverse Event|0|||
30891405|NCT02434939|58924515|FG001|Overall Study|Adverse Event|1|||
30891406|NCT02434471|58924522|FG000|Overall Study|Physician Decision|9|||
30891407|NCT02457637|58924527|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
30891408|NCT02457325|58924534|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
30891409|NCT02457325|58924535|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
30891410|NCT02434081|58924541|FG000|Overall Study|Death (never started treatment)|2|||
30891411|NCT02434081|58924541|FG000|Overall Study|Death|2|||
30891412|NCT02434081|58924541|FG000|Overall Study|Progression|20|||
30891413|NCT02434081|58924541|FG000|Overall Study|Adverse Event|20|||
30891414|NCT02434081|58924541|FG000|Overall Study|Physician Decision|2|||
30891415|NCT02434081|58924541|FG000|Overall Study|Withdrawal by Subject|1|||
30891416|NCT02434081|58924541|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
30891417|NCT02222493|58924547|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
30891418|NCT02222493|58924548|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
30891419|NCT02222493|58924547|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
30891420|NCT02222493|58924548|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
30891421|NCT02222493|58924547|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
30891422|NCT02222493|58924548|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
30891423|NCT02222493|58924547|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
30891424|NCT02222493|58924548|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
30891425|NCT02222493|58924547|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
30891426|NCT02222493|58924548|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
30891427|NCT02222493|58924547|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
30891428|NCT02222493|58924548|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
30891429|NCT02222493|58924547|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
30891430|NCT02222493|58924548|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
30891431|NCT02222493|58924547|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
30790191|NCT00043979|58803391|FG000|Period 1|recipient with progressive disease|7|||
30790192|NCT00043979|58803392|FG001|Period 1|recipient with progressive disease|4|||
30948444|NCT01776307|58994347|FG002|Overall Study|Not dosed|1|||
30948445|NCT01729039|58994378|FG000|Overall Study|disqualified|2|||
30948446|NCT01729039|58994379|FG001|Overall Study|disqualified|5|||
30948447|NCT01729039|58994378|FG000|Overall Study|Withdrawal by Subject|8|||
30948448|NCT01729039|58994379|FG001|Overall Study|Withdrawal by Subject|7|||
30948449|NCT01775995|58994390|FG000|Overall Study|Lost to Follow-up|1|||
30980834|NCT02574078|59095972|FG009|Treatment Period|Lost to Follow-up|1|||
30980835|NCT02574078|59095973|FG010|Treatment Period|Lost to Follow-up|0|||
30980836|NCT02574078|59095974|FG011|Treatment Period|Lost to Follow-up|1|||
30980837|NCT02574078|59095975|FG012|Treatment Period|Lost to Follow-up|0|||
30980838|NCT02574078|59095963|FG000|Treatment Period|Maximum clinical benefit|0|||
30980839|NCT02574078|59095964|FG001|Treatment Period|Maximum clinical benefit|0|||
30980840|NCT02574078|59095965|FG002|Treatment Period|Maximum clinical benefit|0|||
30980841|NCT02574078|59095966|FG003|Treatment Period|Maximum clinical benefit|0|||
30980842|NCT02574078|59095967|FG004|Treatment Period|Maximum clinical benefit|0|||
30980843|NCT02574078|59095968|FG005|Treatment Period|Maximum clinical benefit|0|||
30980844|NCT02574078|59095969|FG006|Treatment Period|Maximum clinical benefit|0|||
30980845|NCT02574078|59095970|FG007|Treatment Period|Maximum clinical benefit|0|||
30980846|NCT02574078|59095971|FG008|Treatment Period|Maximum clinical benefit|0|||
30980847|NCT02574078|59095972|FG009|Treatment Period|Maximum clinical benefit|1|||
30980848|NCT02574078|59095973|FG010|Treatment Period|Maximum clinical benefit|0|||
30980849|NCT02574078|59095974|FG011|Treatment Period|Maximum clinical benefit|0|||
30980850|NCT02574078|59095975|FG012|Treatment Period|Maximum clinical benefit|0|||
30980851|NCT02565810|59096093|FG000|Overall Study|Withdrawal by Subject|1|||
30980852|NCT02561832|59096258|FG000|Overall Study|Withdrawal by Subject|1|||
30980853|NCT02561832|59096259|FG001|Overall Study|Withdrawal by Subject|1|||
30980854|NCT02561832|59096258|FG000|Overall Study|Adverse Event|3|||
30980855|NCT02561832|59096259|FG001|Overall Study|Adverse Event|0|||
30980856|NCT02561832|59096258|FG000|Overall Study|Disease progression|3|||
30980857|NCT02561832|59096259|FG001|Overall Study|Disease progression|3|||
30980858|NCT00985088|59097907|FG000|Overall Study|Serious Adverse Event|1|||
30980859|NCT00985088|59097908|FG001|Overall Study|Serious Adverse Event|1|||
30980860|NCT00985088|59097909|FG002|Overall Study|Serious Adverse Event|0|||
30980861|NCT00985088|59097910|FG003|Overall Study|Serious Adverse Event|0|||
30980862|NCT00985088|59097911|FG004|Overall Study|Serious Adverse Event|0|||
30980863|NCT00985088|59097912|FG005|Overall Study|Serious Adverse Event|0|||
30980864|NCT00985088|59097913|FG006|Overall Study|Serious Adverse Event|0|||
30980865|NCT00985088|59097914|FG007|Overall Study|Serious Adverse Event|1|||
30980866|NCT00985088|59097907|FG000|Overall Study|Adverse Event|0|||
30980867|NCT00985088|59097908|FG001|Overall Study|Adverse Event|0|||
30980868|NCT00985088|59097909|FG002|Overall Study|Adverse Event|1|||
30980869|NCT00985088|59097910|FG003|Overall Study|Adverse Event|0|||
30980870|NCT00985088|59097911|FG004|Overall Study|Adverse Event|0|||
30980871|NCT00985088|59097912|FG005|Overall Study|Adverse Event|0|||
30980872|NCT00985088|59097913|FG006|Overall Study|Adverse Event|0|||
30980873|NCT00985088|59097914|FG007|Overall Study|Adverse Event|0|||
30980874|NCT00985088|59097907|FG000|Overall Study|Withdrawal by Subject|4|||
30980875|NCT00985088|59097908|FG001|Overall Study|Withdrawal by Subject|0|||
30980876|NCT00985088|59097909|FG002|Overall Study|Withdrawal by Subject|0|||
30980877|NCT00985088|59097910|FG003|Overall Study|Withdrawal by Subject|1|||
30980878|NCT00985088|59097911|FG004|Overall Study|Withdrawal by Subject|3|||
30980879|NCT00985088|59097912|FG005|Overall Study|Withdrawal by Subject|2|||
30980880|NCT00985088|59097913|FG006|Overall Study|Withdrawal by Subject|1|||
30980881|NCT00985088|59097914|FG007|Overall Study|Withdrawal by Subject|2|||
30980882|NCT00985088|59097907|FG000|Overall Study|Migrated/moved from study area|0|||
30980883|NCT00985088|59097908|FG001|Overall Study|Migrated/moved from study area|0|||
30980884|NCT00985088|59097909|FG002|Overall Study|Migrated/moved from study area|1|||
30980885|NCT00985088|59097910|FG003|Overall Study|Migrated/moved from study area|0|||
30980886|NCT00985088|59097911|FG004|Overall Study|Migrated/moved from study area|0|||
30980887|NCT00985088|59097912|FG005|Overall Study|Migrated/moved from study area|0|||
30980888|NCT00985088|59097913|FG006|Overall Study|Migrated/moved from study area|0|||
30980889|NCT00985088|59097914|FG007|Overall Study|Migrated/moved from study area|1|||
30980890|NCT00985088|59097907|FG000|Overall Study|Lost to Follow-up|6|||
30980891|NCT00985088|59097908|FG001|Overall Study|Lost to Follow-up|1|||
30980892|NCT00985088|59097909|FG002|Overall Study|Lost to Follow-up|2|||
30980893|NCT00985088|59097910|FG003|Overall Study|Lost to Follow-up|6|||
30980894|NCT00985088|59097911|FG004|Overall Study|Lost to Follow-up|6|||
30980895|NCT00985088|59097912|FG005|Overall Study|Lost to Follow-up|5|||
30980896|NCT00985088|59097913|FG006|Overall Study|Lost to Follow-up|3|||
30980897|NCT00985088|59097914|FG007|Overall Study|Lost to Follow-up|2|||
30980898|NCT00984542|59097960|FG000|Overall Study|disease progression|19|||
30980899|NCT00984542|59097960|FG000|Overall Study|toxicity|7|||
30980900|NCT00984542|59097960|FG000|Overall Study|Death|7|||
30980901|NCT00984542|59097960|FG000|Overall Study|complicating disease|3|||
30980902|NCT00984542|59097960|FG000|Overall Study|Withdrawal by Subject|3|||
30980903|NCT00984542|59097960|FG000|Overall Study|clinical deterioration|2|||
30980904|NCT00983918|59097969|FG000|Overall Study|conversion to open cholecystectomy|0|||
30980905|NCT00983918|59097970|FG001|Overall Study|conversion to open cholecystectomy|2|||
30980906|NCT00983918|59097971|FG002|Overall Study|conversion to open cholecystectomy|2|||
30980907|NCT00983918|59097972|FG003|Overall Study|conversion to open cholecystectomy|2|||
30980908|NCT00983528|59097982|FG000|Overall Study|Death|4|||
30980909|NCT00983528|59097982|FG000|Overall Study|Lost to Follow-up|1|||
30980910|NCT00983528|59097982|FG000|Overall Study|Study Terminated|1|||
30980911|NCT00983372|59097986|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
30980912|NCT00983372|59097986|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
30980913|NCT00983372|59097986|FG000|Diltiazem ER Alone|Adverse Event|1|||
30980914|NCT00983294|59098018|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
30980915|NCT00983294|59098018|FG000|Colchicine With Azithromycin|Adverse Event|1|||
30980916|NCT00982280|59098034|FG000|Observation Period|Not eligible to be dosed|19|||
30980917|NCT00982280|59098034|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
30980918|NCT00982280|59098034|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
30980919|NCT00982280|59098034|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
30980920|NCT00982280|59098034|FG000|Maintenance Period|Adverse Event|1|||
30980921|NCT00981578|59098052|FG000|Overall Study|Death|1|||
30980922|NCT00981578|59098052|FG000|Overall Study|Withdrawal by Subject|2|||
30980923|NCT00980798|59098075|FG000|Overall Study|Adverse Event|7|||
30980924|NCT00980798|59098076|FG001|Overall Study|Adverse Event|36|||
30980925|NCT00980798|59098075|FG000|Overall Study|Lack of Efficacy|16|||
30980926|NCT00980798|59098076|FG001|Overall Study|Lack of Efficacy|5|||
30980927|NCT00980798|59098075|FG000|Overall Study|Lost to Follow-up|0|||
30980928|NCT00980798|59098076|FG001|Overall Study|Lost to Follow-up|1|||
30980929|NCT00980798|59098075|FG000|Overall Study|Physician Decision|2|||
30980930|NCT00980798|59098076|FG001|Overall Study|Physician Decision|1|||
30980931|NCT00980798|59098075|FG000|Overall Study|Withdrawal by Subject|8|||
30980932|NCT00980798|59098076|FG001|Overall Study|Withdrawal by Subject|11|||
30980933|NCT00980798|59098075|FG000|Overall Study|Other|0|||
30980934|NCT00980798|59098076|FG001|Overall Study|Other|1|||
30980935|NCT00980330|59098221|FG000|Overall Study|Adverse Event|0|||
30980936|NCT00980330|59098222|FG001|Overall Study|Adverse Event|0|||
30980937|NCT00980330|59098223|FG002|Overall Study|Adverse Event|0|||
30980938|NCT00980330|59098224|FG003|Overall Study|Adverse Event|1|||
30980939|NCT00980330|59098225|FG004|Overall Study|Adverse Event|0|||
30980940|NCT00980330|59098226|FG005|Overall Study|Adverse Event|0|||
30980941|NCT00980330|59098227|FG006|Overall Study|Adverse Event|0|||
30980942|NCT00980330|59098221|FG000|Overall Study|Lost to Follow-up|1|||
30980943|NCT00980330|59098222|FG001|Overall Study|Lost to Follow-up|1|||
30980944|NCT00980330|59098223|FG002|Overall Study|Lost to Follow-up|4|||
30980945|NCT00980330|59098224|FG003|Overall Study|Lost to Follow-up|2|||
30980946|NCT00980330|59098225|FG004|Overall Study|Lost to Follow-up|1|||
30980947|NCT00980330|59098226|FG005|Overall Study|Lost to Follow-up|1|||
30980948|NCT00980330|59098227|FG006|Overall Study|Lost to Follow-up|2|||
30980949|NCT00980330|59098221|FG000|Overall Study|Withdrawal by Subject|2|||
30980950|NCT00980330|59098222|FG001|Overall Study|Withdrawal by Subject|4|||
30980951|NCT00980330|59098223|FG002|Overall Study|Withdrawal by Subject|4|||
30980952|NCT00980330|59098224|FG003|Overall Study|Withdrawal by Subject|1|||
30980953|NCT00980330|59098225|FG004|Overall Study|Withdrawal by Subject|3|||
30980954|NCT00980330|59098226|FG005|Overall Study|Withdrawal by Subject|2|||
30980955|NCT00980330|59098227|FG006|Overall Study|Withdrawal by Subject|5|||
30980956|NCT00980330|59098221|FG000|Overall Study|(not specified)|2|||
30980957|NCT00980330|59098222|FG001|Overall Study|(not specified)|0|||
30980958|NCT00980330|59098223|FG002|Overall Study|(not specified)|0|||
30980959|NCT00980330|59098224|FG003|Overall Study|(not specified)|1|||
30980960|NCT00980330|59098225|FG004|Overall Study|(not specified)|1|||
30980961|NCT00980330|59098226|FG005|Overall Study|(not specified)|1|||
30980962|NCT00980330|59098227|FG006|Overall Study|(not specified)|0|||
30980963|NCT00980174|59098271|FG000|Overall Study|Withdrawal by Subject|1|||
30980964|NCT00980174|59098272|FG001|Overall Study|Withdrawal by Subject|4|||
30980965|NCT00980174|59098271|FG000|Overall Study|Adverse Event|0|||
30980966|NCT00980174|59098272|FG001|Overall Study|Adverse Event|3|||
30980967|NCT00980174|59098271|FG000|Overall Study|Ineligibility determined|2|||
30980968|NCT00980174|59098272|FG001|Overall Study|Ineligibility determined|1|||
30980969|NCT00980174|59098271|FG000|Overall Study|Death|1|||
30980970|NCT00980174|59098272|FG001|Overall Study|Death|1|||
30980971|NCT00980174|59098271|FG000|Overall Study|Other|0|||
30980972|NCT00980174|59098272|FG001|Overall Study|Other|1|||
30980973|NCT00980018|59098300|FG000|Overall Study|Adverse Event|8|||
30980974|NCT00980018|59098300|FG000|Overall Study|Patient withdrew consent|3|||
30980975|NCT00980018|59098300|FG000|Overall Study|Lost to Follow-up|1|||
30980976|NCT00981656|59098321|FG000|Overall Study|Protocol Violation|1|||
30980977|NCT00981656|59098321|FG000|Overall Study|Did not start protocol treatment|2|||
30980978|NCT00988052|59098327|FG000|Overall Study|Missing|1|||
30980979|NCT00988052|59098328|FG001|Overall Study|Missing|0|||
30980980|NCT00988052|59098327|FG000|Overall Study|Teva requested subject withdrawal|3|||
30980981|NCT00988052|59098328|FG001|Overall Study|Teva requested subject withdrawal|1|||
30980982|NCT00988052|59098327|FG000|Overall Study|Death|1|||
30980983|NCT00988052|59098328|FG001|Overall Study|Death|3|||
30980984|NCT00988052|59098327|FG000|Overall Study|Protocol Violation|6|||
30980985|NCT00988052|59098328|FG001|Overall Study|Protocol Violation|5|||
30980986|NCT00988052|59098327|FG000|Overall Study|Pregnancy|6|||
30980987|NCT00988052|59098328|FG001|Overall Study|Pregnancy|6|||
30980988|NCT00988052|59098327|FG000|Overall Study|Lack of Efficacy|8|||
30980989|NCT00988052|59098328|FG001|Overall Study|Lack of Efficacy|7|||
30980990|NCT00988052|59098327|FG000|Overall Study|Lost to Follow-up|6|||
30980991|NCT00988052|59098328|FG001|Overall Study|Lost to Follow-up|11|||
30980992|NCT00988052|59098327|FG000|Overall Study|Physician Decision|27|||
30980993|NCT00988052|59098328|FG001|Overall Study|Physician Decision|28|||
30980994|NCT00988052|59098327|FG000|Overall Study|Adverse Event|35|||
30980995|NCT00988052|59098328|FG001|Overall Study|Adverse Event|28|||
30980996|NCT00988052|59098327|FG000|Overall Study|Withdrawal by Subject|90|||
30980997|NCT00988052|59098328|FG001|Overall Study|Withdrawal by Subject|91|||
30980998|NCT00988052|59098327|FG000|Overall Study|Study terminated by sponsor|240|||
30980999|NCT00988052|59098328|FG001|Overall Study|Study terminated by sponsor|236|||
30981000|NCT02569710|59098429|FG000|Overall Study|Adverse Event|1|||
30981001|NCT02569710|59098430|FG001|Overall Study|Adverse Event|0|||
30981002|NCT02569710|59098431|FG002|Overall Study|Adverse Event|0|||
30981003|NCT02569710|59098432|FG003|Overall Study|Adverse Event|0|||
30981004|NCT02569710|59098433|FG004|Overall Study|Adverse Event|0|||
30981005|NCT02569710|59098434|FG005|Overall Study|Adverse Event|0|||
30981006|NCT02569710|59098435|FG006|Overall Study|Adverse Event|0|||
30981007|NCT02569710|59098436|FG007|Overall Study|Adverse Event|0|||
30981008|NCT02569710|59098437|FG008|Overall Study|Adverse Event|0|||
30981009|NCT02569710|59098438|FG009|Overall Study|Adverse Event|0|||
30981010|NCT02569710|59098429|FG000|Overall Study|Lost to Follow-up|0|||
30981011|NCT02569710|59098430|FG001|Overall Study|Lost to Follow-up|0|||
30981012|NCT02569710|59098431|FG002|Overall Study|Lost to Follow-up|0|||
30981013|NCT02569710|59098432|FG003|Overall Study|Lost to Follow-up|0|||
30981014|NCT02569710|59098433|FG004|Overall Study|Lost to Follow-up|0|||
30981015|NCT02569710|59098434|FG005|Overall Study|Lost to Follow-up|0|||
30981016|NCT02569710|59098435|FG006|Overall Study|Lost to Follow-up|1|||
30981017|NCT02569710|59098436|FG007|Overall Study|Lost to Follow-up|0|||
30981018|NCT02569710|59098437|FG008|Overall Study|Lost to Follow-up|1|||
30981019|NCT02569710|59098438|FG009|Overall Study|Lost to Follow-up|0|||
30981020|NCT02569710|59098429|FG000|Overall Study|Virologic failure|0|||
30981021|NCT02569710|59098430|FG001|Overall Study|Virologic failure|0|||
30981022|NCT02569710|59098431|FG002|Overall Study|Virologic failure|0|||
30981023|NCT02569710|59098432|FG003|Overall Study|Virologic failure|0|||
30981024|NCT02569710|59098433|FG004|Overall Study|Virologic failure|1|||
30981025|NCT02569710|59098434|FG005|Overall Study|Virologic failure|0|||
30981026|NCT02569710|59098435|FG006|Overall Study|Virologic failure|1|||
30981027|NCT02569710|59098436|FG007|Overall Study|Virologic failure|0|||
30981028|NCT02569710|59098437|FG008|Overall Study|Virologic failure|0|||
30981029|NCT02569710|59098438|FG009|Overall Study|Virologic failure|0|||
30981030|NCT02569710|59098429|FG000|Overall Study|Withdrawal by Subject|0|||
30981031|NCT02569710|59098430|FG001|Overall Study|Withdrawal by Subject|0|||
30981032|NCT02569710|59098431|FG002|Overall Study|Withdrawal by Subject|0|||
30981033|NCT02569710|59098432|FG003|Overall Study|Withdrawal by Subject|0|||
30981034|NCT02569710|59098433|FG004|Overall Study|Withdrawal by Subject|0|||
30981035|NCT02569710|59098434|FG005|Overall Study|Withdrawal by Subject|1|||
30981036|NCT02569710|59098435|FG006|Overall Study|Withdrawal by Subject|0|||
30981037|NCT02569710|59098436|FG007|Overall Study|Withdrawal by Subject|0|||
30981038|NCT02569710|59098437|FG008|Overall Study|Withdrawal by Subject|0|||
30981039|NCT02569710|59098438|FG009|Overall Study|Withdrawal by Subject|0|||
30981040|NCT02569476|59098540|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
30981041|NCT02569476|59098540|FG000|Overall Study|Death|33|||
30981042|NCT02569476|59098540|FG000|Overall Study|Withdrawal by Subject|9|||
30981043|NCT02569476|59098540|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
30981044|NCT02569476|59098540|FG000|Overall Study|Palliative care|1|||
30981045|NCT02569476|59098540|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
30981046|NCT02569476|59098540|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
30981047|NCT02565576|59098612|FG000|Overall Study|abnormal lab value|2|||
30981048|NCT02565576|59098613|FG001|Overall Study|abnormal lab value|0|||
30981049|NCT02565576|59098612|FG000|Overall Study|subject / guardian decision|1|||
30981050|NCT02565576|59098613|FG001|Overall Study|subject / guardian decision|3|||
30981051|NCT02565576|59098612|FG000|Overall Study|Lost to Follow-up|1|||
30981052|NCT02565576|59098613|FG001|Overall Study|Lost to Follow-up|0|||
30981053|NCT02565576|59098612|FG000|Overall Study|Death|0|||
30981054|NCT02565576|59098613|FG001|Overall Study|Death|2|||
30981055|NCT02565576|59098612|FG000|Overall Study|Adverse Event|1|||
30981056|NCT02565576|59098613|FG001|Overall Study|Adverse Event|0|||
30981057|NCT02569398|59098644|FG000|Overall Study|Adverse Event|0|||
30981058|NCT02569398|59098645|FG001|Overall Study|Adverse Event|1|||
30981059|NCT02569398|59098646|FG002|Overall Study|Adverse Event|6|||
30981060|NCT02569398|59098644|FG000|Overall Study|Withdrawal by Subject|43|||
30981061|NCT02569398|59098645|FG001|Overall Study|Withdrawal by Subject|43|||
30981062|NCT02569398|59098646|FG002|Overall Study|Withdrawal by Subject|30|||
30981063|NCT02569398|59098644|FG000|Overall Study|Study terminated by sponsor|130|||
30981064|NCT02569398|59098645|FG001|Overall Study|Study terminated by sponsor|131|||
30981065|NCT02569398|59098646|FG002|Overall Study|Study terminated by sponsor|134|||
30981066|NCT02569398|59098644|FG000|Overall Study|Other|12|||
30981067|NCT02569398|59098645|FG001|Overall Study|Other|14|||
30981068|NCT02569398|59098646|FG002|Overall Study|Other|13|||
30981069|NCT02569242|59098690|FG000|Overall Study|Death|1|||
30981070|NCT02569242|59098691|FG001|Overall Study|Death|0|||
30981071|NCT02569242|59098690|FG000|Overall Study|Withdrawal by Subject|0|||
30981072|NCT02569242|59098691|FG001|Overall Study|Withdrawal by Subject|1|||
30981073|NCT01663740|59098759|FG000|Overall Study|Lost to Follow-up|1|||
30981074|NCT01663740|59098760|FG001|Overall Study|Lost to Follow-up|4|||
30981075|NCT01663740|59098759|FG000|Overall Study|Other|9|||
30981076|NCT01663740|59098760|FG001|Overall Study|Other|2|||
30981077|NCT01663740|59098759|FG000|Overall Study|Inclusion/Exclusion not met|1|||
30981078|NCT01663740|59098760|FG001|Overall Study|Inclusion/Exclusion not met|0|||
30981079|NCT01663740|59098759|FG000|Overall Study|Death|0|||
30981080|NCT01663740|59098760|FG001|Overall Study|Death|1|||
30981081|NCT01663740|59098759|FG000|Overall Study|Withdrawal by Subject|2|||
30981082|NCT01663740|59098760|FG001|Overall Study|Withdrawal by Subject|1|||
30981083|NCT01663740|59098759|FG000|Overall Study|No end of study status|3|||
30981084|NCT01663740|59098760|FG001|Overall Study|No end of study status|0|||
30981085|NCT01663506|59098876|FG000|Overall Study|Lack of Efficacy|3|||
30981086|NCT01663506|59098876|FG000|Overall Study|Consent Withdrawal by Subject|1|||
30981087|NCT01663506|59098876|FG000|Overall Study|Lost to Follow-up|1|||
30981088|NCT01663506|59098876|FG000|Overall Study|Adverse Event|1|||
30981089|NCT01663506|59098876|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
30981090|NCT02568384|59098880|FG000|Overall Study|Mobile devices incompatible with App|2|||
30981091|NCT02965976|59098976|FG000|Overall Study|Withdrawal by Subject|2|||
30981092|NCT02965976|59098977|FG001|Overall Study|Withdrawal by Subject|0|||
30981093|NCT04125680|59098995|FG000|Overall Study|Lost to Follow-up|15|||
30981094|NCT02565186|59099019|FG000|Overall Study|Adverse Event|113|||
30981095|NCT02565186|59099020|FG001|Overall Study|Adverse Event|148|||
30981096|NCT02565186|59099019|FG000|Overall Study|Lost to Follow-up|102|||
30981097|NCT02565186|59099020|FG001|Overall Study|Lost to Follow-up|93|||
30981098|NCT02565186|59099019|FG000|Overall Study|Non-Compliance|57|||
30981099|NCT02565186|59099020|FG001|Overall Study|Non-Compliance|55|||
30981100|NCT02565186|59099019|FG000|Overall Study|Withdrawal by Subject|229|||
30981101|NCT02565186|59099020|FG001|Overall Study|Withdrawal by Subject|214|||
30981102|NCT02565186|59099019|FG000|Overall Study|Physician Decision|18|||
30981103|NCT02565186|59099020|FG001|Overall Study|Physician Decision|16|||
30981104|NCT02565186|59099019|FG000|Overall Study|Sponsor Request|5|||
30981105|NCT02565186|59099020|FG001|Overall Study|Sponsor Request|9|||
30981106|NCT02565186|59099019|FG000|Overall Study|Missing|1|||
30981107|NCT02565186|59099020|FG001|Overall Study|Missing|0|||
30981108|NCT02565186|59099019|FG000|Overall Study|Did Not Receive Study Drug|55|||
30981109|NCT02565186|59099020|FG001|Overall Study|Did Not Receive Study Drug|86|||
30981110|NCT02568072|59099026|FG000|Overall Study|Unavailable for appointment|23|||
30981111|NCT02568072|59099026|FG000|Overall Study|Unable to contact|3|||
30981112|NCT02568072|59099026|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
30981113|NCT02568072|59099026|FG000|Overall Study|Withdrawal by Subject|1|||
30981114|NCT02568072|59099026|FG000|Overall Study|Sustained injury, marathon not run|24|||
30981115|NCT02565108|59099033|FG000|Overall Study|Adverse Event|1|||
30981116|NCT02565108|59099034|FG001|Overall Study|Adverse Event|0|||
30981117|NCT02565108|59099033|FG000|Overall Study|Withdrew Consent|1|||
30981118|NCT02565108|59099034|FG001|Overall Study|Withdrew Consent|0|||
30981119|NCT02564952|59099040|FG000|Overall Study|Adverse Event|6|||
30981120|NCT02564952|59099040|FG000|Overall Study|Lost to Follow-up|1|||
30981121|NCT02564952|59099040|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
30981122|NCT02564952|59099040|FG000|Overall Study|Withdrawal by Subject|1|||
30981123|NCT02564952|59099040|FG000|Overall Study|Low Efficacy|1|||
30981124|NCT02564952|59099040|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
30981125|NCT02566902|59099046|FG000|Overall Study|Protocol Violation|2|||
30981126|NCT02566902|59099047|FG001|Overall Study|Protocol Violation|1|||
30981127|NCT02564796|59099055|FG000|Overall Study|Physician Decision|2|||
30981128|NCT02564796|59099056|FG001|Overall Study|Physician Decision|2|||
30981129|NCT02564718|59099064|FG000|Overall Study|Withdrew from treatment|0|||
30981130|NCT02564718|59099065|FG001|Overall Study|Withdrew from treatment|1|||
30981131|NCT01453946|59099071|FG000|Overall Study|Did not receive drug for the taper phase|1|||
30981132|NCT01453946|59099071|FG000|Overall Study|Protocol Violation|2|||
30981133|NCT01453946|59099071|FG000|Overall Study|Lack of Efficacy|3|||
30981134|NCT01453946|59099071|FG000|Overall Study|Adverse Event|3|||
30981135|NCT02563548|59099193|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
30981136|NCT02563548|59099194|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
30981137|NCT02563548|59099195|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
30981138|NCT02563548|59099196|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
30981139|NCT02563548|59099197|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
30981140|NCT02563548|59099198|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
30981141|NCT02563548|59099193|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
30981142|NCT02563548|59099194|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
30981143|NCT02563548|59099195|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
30981144|NCT02563548|59099196|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
30981145|NCT02563548|59099197|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
30981146|NCT02563548|59099198|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
30981147|NCT02563548|59099193|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
30981148|NCT02563548|59099194|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
30981149|NCT02563548|59099195|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
30981150|NCT02563548|59099196|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
30981151|NCT02563548|59099197|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
30981152|NCT02563548|59099198|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
30981153|NCT02563548|59099193|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
30981154|NCT02563548|59099194|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
30981155|NCT02563548|59099195|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
30981156|NCT02563548|59099196|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
30981157|NCT02563548|59099197|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
30981158|NCT02563548|59099198|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
30981159|NCT02563548|59099193|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
30981160|NCT02563548|59099194|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
30981161|NCT02563548|59099195|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
30981162|NCT02563548|59099196|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
30981163|NCT02563548|59099197|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
30981164|NCT02563548|59099198|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
30981165|NCT02563548|59099193|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
30981166|NCT02563548|59099194|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
30981167|NCT02563548|59099195|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
30981168|NCT02563548|59099196|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
30981169|NCT02563548|59099197|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
30981170|NCT02563548|59099198|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
30981171|NCT02563548|59099193|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
30981172|NCT02563548|59099194|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
30981173|NCT02563548|59099195|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
30981174|NCT02563548|59099196|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
30981175|NCT02563548|59099197|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
30981176|NCT02563548|59099198|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
30981177|NCT02563548|59099193|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
30981178|NCT02563548|59099194|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
30981179|NCT02563548|59099195|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
30981180|NCT02563548|59099196|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
30981181|NCT02563548|59099197|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
30981182|NCT02563548|59099198|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
30981183|NCT02563548|59099193|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
30981184|NCT02563548|59099194|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
30981185|NCT02563548|59099195|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
30981186|NCT02563548|59099196|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
30981187|NCT02563548|59099197|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
30981188|NCT02563548|59099198|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
30981189|NCT02563548|59099193|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
30981190|NCT02563548|59099194|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
30981191|NCT02563548|59099195|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
30948450|NCT01775995|58994391|FG001|Overall Study|Lost to Follow-up|1|||
30948451|NCT01741532|58994399|FG000|Overall Study|Adverse Event|4|||
30948452|NCT01741532|58994400|FG001|Overall Study|Adverse Event|0|||
30948453|NCT01741532|58994399|FG000|Overall Study|Withdrawal by Subject|1|||
30948454|NCT01741532|58994400|FG001|Overall Study|Withdrawal by Subject|1|||
30948455|NCT01741532|58994399|FG000|Overall Study|Protocol Violation|0|||
30948456|NCT01741532|58994400|FG001|Overall Study|Protocol Violation|1|||
30948457|NCT01741532|58994399|FG000|Overall Study|Worsening of the disease|3|||
30948458|NCT01741532|58994400|FG001|Overall Study|Worsening of the disease|1|||
30948459|NCT01741532|58994399|FG000|Overall Study|Sponsor decision|1|||
30948460|NCT01741532|58994400|FG001|Overall Study|Sponsor decision|0|||
30948461|NCT01741532|58994399|FG000|Overall Study|Medical event|1|||
30948462|NCT01741532|58994400|FG001|Overall Study|Medical event|0|||
30981192|NCT02563548|59099196|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
30981193|NCT02563548|59099197|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
30981194|NCT02563548|59099198|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
30981195|NCT02563548|59099193|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
30981196|NCT02563548|59099194|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
30981197|NCT02563548|59099195|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
30981198|NCT02563548|59099196|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
30981199|NCT02563548|59099197|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
30981200|NCT02563548|59099198|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
30981201|NCT02563548|59099193|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
30981202|NCT02563548|59099194|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
30981203|NCT02563548|59099195|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
30981204|NCT02563548|59099196|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
30981205|NCT02563548|59099197|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
30981206|NCT02563548|59099198|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
30981207|NCT02559570|59099279|FG000|Overall Study|Adverse Event|0|||
30981208|NCT02559570|59099280|FG001|Overall Study|Adverse Event|2|||
30981209|NCT02559570|59099281|FG002|Overall Study|Adverse Event|0|||
30981210|NCT02559570|59099282|FG003|Overall Study|Adverse Event|1|||
30981211|NCT02559570|59099283|FG004|Overall Study|Adverse Event|0|||
30981212|NCT02559570|59099279|FG000|Overall Study|Withdrawal of Consent|0|||
30981213|NCT02559570|59099280|FG001|Overall Study|Withdrawal of Consent|0|||
30981214|NCT02559570|59099281|FG002|Overall Study|Withdrawal of Consent|1|||
30981215|NCT02559570|59099282|FG003|Overall Study|Withdrawal of Consent|2|||
30981216|NCT02559570|59099283|FG004|Overall Study|Withdrawal of Consent|1|||
30981217|NCT02559570|59099279|FG000|Overall Study|Lost to Follow-up|1|||
30981218|NCT02559570|59099280|FG001|Overall Study|Lost to Follow-up|0|||
30981219|NCT02559570|59099281|FG002|Overall Study|Lost to Follow-up|0|||
30981220|NCT02559570|59099282|FG003|Overall Study|Lost to Follow-up|0|||
30981221|NCT02559570|59099283|FG004|Overall Study|Lost to Follow-up|0|||
30981222|NCT02559570|59099279|FG000|Overall Study|Protocol Violation|1|||
30981223|NCT02559570|59099280|FG001|Overall Study|Protocol Violation|0|||
30981224|NCT02559570|59099281|FG002|Overall Study|Protocol Violation|0|||
30981225|NCT02559570|59099282|FG003|Overall Study|Protocol Violation|0|||
30981226|NCT02559570|59099283|FG004|Overall Study|Protocol Violation|1|||
30981227|NCT02559570|59099279|FG000|Overall Study|Other Miscellaneous Reasons|0|||
30981228|NCT02559570|59099280|FG001|Overall Study|Other Miscellaneous Reasons|0|||
30981229|NCT02559570|59099281|FG002|Overall Study|Other Miscellaneous Reasons|1|||
30981230|NCT02559570|59099282|FG003|Overall Study|Other Miscellaneous Reasons|0|||
30981231|NCT02559570|59099283|FG004|Overall Study|Other Miscellaneous Reasons|0|||
30981232|NCT02559414|59099638|FG000|Overall Study|Lost to Follow-up|0|||
30981233|NCT02559414|59099639|FG001|Overall Study|Lost to Follow-up|1|||
30981234|NCT02559414|59099640|FG002|Overall Study|Lost to Follow-up|0|||
30981235|NCT02559414|59099638|FG000|Overall Study|Withdrawal by Subject|1|||
30981236|NCT02559414|59099639|FG001|Overall Study|Withdrawal by Subject|0|||
30981237|NCT02559414|59099640|FG002|Overall Study|Withdrawal by Subject|1|||
30981238|NCT02559414|59099638|FG000|Overall Study|Other|0|||
30981239|NCT02559414|59099639|FG001|Overall Study|Other|1|||
30981240|NCT02559414|59099640|FG002|Overall Study|Other|1|||
30981241|NCT02558790|59099715|FG000|Overall Study|Lost to Follow-up|2|||
30981242|NCT02558790|59099715|FG000|Overall Study|Physician Decision|1|||
30981243|NCT02558790|59099715|FG000|Overall Study|Withdrawal by Subject|1|||
30981244|NCT02558790|59099715|FG000|Overall Study|Screen Fail|3|||
30981245|NCT02556138|59099741|FG000|Overall Study|Withdrawal by Subject|1|||
30981246|NCT02558400|59099824|FG000|Overall Study|Adverse Event|47|||
30981247|NCT02558400|59099825|FG001|Overall Study|Adverse Event|53|||
30981248|NCT02558400|59099826|FG002|Overall Study|Adverse Event|4|||
30981249|NCT02558400|59099824|FG000|Overall Study|Withdrawal by Subject|13|||
30981250|NCT02558400|59099825|FG001|Overall Study|Withdrawal by Subject|9|||
30981251|NCT02558400|59099826|FG002|Overall Study|Withdrawal by Subject|8|||
30981252|NCT02558400|59099824|FG000|Overall Study|Non-Compliant|0|||
30981253|NCT02558400|59099825|FG001|Overall Study|Non-Compliant|1|||
30981254|NCT02558400|59099826|FG002|Overall Study|Non-Compliant|3|||
30981255|NCT02558400|59099824|FG000|Overall Study|Lost to Follow-up|5|||
30981256|NCT02558400|59099825|FG001|Overall Study|Lost to Follow-up|5|||
30981257|NCT02558400|59099826|FG002|Overall Study|Lost to Follow-up|4|||
30981258|NCT02558400|59099824|FG000|Overall Study|Lack of Efficacy|0|||
30981259|NCT02558400|59099825|FG001|Overall Study|Lack of Efficacy|13|||
30981260|NCT02558400|59099826|FG002|Overall Study|Lack of Efficacy|1|||
30981261|NCT02558400|59099824|FG000|Overall Study|Disallowed Concurrent Medication|6|||
30981262|NCT02558400|59099825|FG001|Overall Study|Disallowed Concurrent Medication|7|||
30981263|NCT02558400|59099826|FG002|Overall Study|Disallowed Concurrent Medication|5|||
30981264|NCT02558400|59099824|FG000|Overall Study|Physician Decision|2|||
30981265|NCT02558400|59099825|FG001|Overall Study|Physician Decision|2|||
30981266|NCT02558400|59099826|FG002|Overall Study|Physician Decision|0|||
30981267|NCT02558400|59099824|FG000|Overall Study|Protocol Violation|6|||
30981268|NCT02558400|59099825|FG001|Overall Study|Protocol Violation|3|||
30981269|NCT02558400|59099826|FG002|Overall Study|Protocol Violation|8|||
30981270|NCT02558400|59099824|FG000|Overall Study|Death|0|||
30981271|NCT02558400|59099825|FG001|Overall Study|Death|1|||
30981272|NCT02558400|59099826|FG002|Overall Study|Death|0|||
30981273|NCT02558400|59099824|FG000|Overall Study|Ineligible for the study|0|||
30981274|NCT02558400|59099825|FG001|Overall Study|Ineligible for the study|2|||
30981275|NCT02558400|59099826|FG002|Overall Study|Ineligible for the study|0|||
30981276|NCT01662648|59099958|FG000|Overall Study|Death|1|||
30981277|NCT01662648|59099959|FG001|Overall Study|Death|3|||
30981278|NCT01662648|59099958|FG000|Overall Study|Adverse Event|40|||
30981279|NCT01662648|59099959|FG001|Overall Study|Adverse Event|37|||
30981280|NCT01662648|59099958|FG000|Overall Study|Lack of Efficacy|17|||
30981281|NCT01662648|59099959|FG001|Overall Study|Lack of Efficacy|16|||
30981282|NCT01662648|59099958|FG000|Overall Study|Participant ineligible to continue trial|1|||
30981283|NCT01662648|59099959|FG001|Overall Study|Participant ineligible to continue trial|1|||
30981284|NCT01662648|59099958|FG000|Overall Study|Lost to Follow-up|24|||
30981285|NCT01662648|59099959|FG001|Overall Study|Lost to Follow-up|36|||
30981286|NCT01662648|59099958|FG000|Overall Study|Withdrawal by Subject|36|||
30981287|NCT01662648|59099959|FG001|Overall Study|Withdrawal by Subject|53|||
30981288|NCT01662648|59099958|FG000|Overall Study|Participant non-compliant|16|||
30981289|NCT01662648|59099959|FG001|Overall Study|Participant non-compliant|20|||
30981290|NCT01662648|59099958|FG000|Overall Study|Other|8|||
30981291|NCT01662648|59099959|FG001|Overall Study|Other|11|||
30981292|NCT01662648|59099958|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
30981293|NCT01662648|59099959|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
30981294|NCT01662648|59099958|FG000|Overall Study|LOE and other reason unspecified|1|||
30981295|NCT01662648|59099959|FG001|Overall Study|LOE and other reason unspecified|0|||
30981296|NCT01662648|59099958|FG000|Overall Study|LOE and Participant non-compliant|0|||
30981297|NCT01662648|59099959|FG001|Overall Study|LOE and Participant non-compliant|1|||
30981298|NCT02556918|59100024|FG000|Overall Study|Protocol Violation|5|||
30981299|NCT02556918|59100025|FG001|Overall Study|Protocol Violation|6|||
30981300|NCT02556918|59100024|FG000|Overall Study|Withdrawal by Subject|4|||
30981301|NCT02556918|59100025|FG001|Overall Study|Withdrawal by Subject|4|||
30981302|NCT01662492|59100141|FG000|Overall Study|Other miscellaneous reasons.|1|||
30981303|NCT01662492|59100142|FG001|Overall Study|Other miscellaneous reasons.|0|||
30981304|NCT01662492|59100143|FG002|Overall Study|Other miscellaneous reasons.|1|||
30981305|NCT01662492|59100141|FG000|Overall Study|Withdrawal by Subject|0|||
30981306|NCT01662492|59100142|FG001|Overall Study|Withdrawal by Subject|0|||
30981307|NCT01662492|59100143|FG002|Overall Study|Withdrawal by Subject|1|||
30981308|NCT01662492|59100141|FG000|Overall Study|Protocol Violation|1|||
30981309|NCT01662492|59100142|FG001|Overall Study|Protocol Violation|0|||
30981310|NCT01662492|59100143|FG002|Overall Study|Protocol Violation|0|||
30981311|NCT01662492|59100141|FG000|Overall Study|Lost to Follow-up|0|||
30981312|NCT01662492|59100142|FG001|Overall Study|Lost to Follow-up|0|||
30981313|NCT01662492|59100143|FG002|Overall Study|Lost to Follow-up|2|||
30981314|NCT01662492|59100141|FG000|Overall Study|Lack of Efficacy|1|||
30981315|NCT01662492|59100142|FG001|Overall Study|Lack of Efficacy|1|||
30981316|NCT01662492|59100143|FG002|Overall Study|Lack of Efficacy|2|||
30981317|NCT02552238|59100313|FG000|Overall Study|Withdrawal by Subject|2|||
30981318|NCT02552238|59100313|FG000|Overall Study|Adverse Event|2|||
30981319|NCT01662102|59100531|FG000|Overall Study|Sponsor's decision|1|||
30981320|NCT01662102|59100532|FG001|Overall Study|Sponsor's decision|0|||
30981321|NCT02554656|59100572|FG000|Overall Study|Protocol Violation|3|||
30981322|NCT04053868|59100620|FG000|Overall Study|Withdrawal by Subject|1|||
30981323|NCT04053868|59100621|FG001|Overall Study|Withdrawal by Subject|0|||
30981324|NCT03414684|59100736|FG000|First-course Treatment|Complete response|0|||
30981325|NCT03414684|59100737|FG001|First-course Treatment|Complete response|1|||
30981326|NCT03414684|59100736|FG000|First-course Treatment|Intercurrent illness|1|||
30981327|NCT03414684|59100737|FG001|First-course Treatment|Intercurrent illness|0|||
30981328|NCT03414684|59100736|FG000|First-course Treatment|Progressive Disease|31|||
30981329|NCT03414684|59100737|FG001|First-course Treatment|Progressive Disease|32|||
30981330|NCT03414684|59100736|FG000|First-course Treatment|Adverse Event|1|||
30981331|NCT03414684|59100737|FG001|First-course Treatment|Adverse Event|2|||
30981332|NCT03414684|59100736|FG000|First-course Treatment|Physician Decision|0|||
30981333|NCT03414684|59100737|FG001|First-course Treatment|Physician Decision|1|||
30981334|NCT03414684|59100736|FG000|First-course Treatment|Withdrawal by Subject|0|||
30981335|NCT03414684|59100737|FG001|First-course Treatment|Withdrawal by Subject|1|||
30981336|NCT03414684|59100736|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
30981337|NCT03414684|59100737|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
30981338|NCT03414684|59100736|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
30981339|NCT03414684|59100737|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
30981340|NCT03414684|59100736|FG000|First-course Treatment|Still on treatment|3|||
30981341|NCT03414684|59100737|FG001|First-course Treatment|Still on treatment|0|||
30981342|NCT03414684|59100736|FG000|First-course Treatment|Never started protocol therapy|2|||
30981343|NCT03414684|59100737|FG001|First-course Treatment|Never started protocol therapy|1|||
30981344|NCT03414684|59100736|FG000|Crossover Treatment|Progressive disease|0|||
30981345|NCT03414684|59100737|FG001|Crossover Treatment|Progressive disease|12|||
30981346|NCT03414684|59100736|FG000|Crossover Treatment|Adverse Event|0|||
30981347|NCT03414684|59100737|FG001|Crossover Treatment|Adverse Event|3|||
30981348|NCT03414684|59100736|FG000|Crossover Treatment|Physician Decision|0|||
30981349|NCT03414684|59100737|FG001|Crossover Treatment|Physician Decision|1|||
30981350|NCT03414684|59100736|FG000|Crossover Treatment|Still on treatment|0|||
30981351|NCT03414684|59100737|FG001|Crossover Treatment|Still on treatment|2|||
30981352|NCT02551692|59100816|FG000|Overall Study|Lost to Follow-up|0|||
30981353|NCT02551692|59100817|FG001|Overall Study|Lost to Follow-up|1|||
30981354|NCT02551692|59100818|FG002|Overall Study|Lost to Follow-up|4|||
30981355|NCT02551692|59100816|FG000|Overall Study|Withdrawal by Subject|1|||
30981356|NCT02551692|59100817|FG001|Overall Study|Withdrawal by Subject|0|||
30981357|NCT02551692|59100818|FG002|Overall Study|Withdrawal by Subject|1|||
30981358|NCT02553330|59100905|FG000|Overall Study|Study Terminated by Sponsor|2|||
30981359|NCT02553330|59100906|FG001|Overall Study|Study Terminated by Sponsor|13|||
30981360|NCT02553330|59100907|FG002|Overall Study|Study Terminated by Sponsor|12|||
30981361|NCT02553330|59100905|FG000|Overall Study|Withdrawal by Subject|3|||
30981362|NCT02553330|59100906|FG001|Overall Study|Withdrawal by Subject|19|||
30981363|NCT02553330|59100907|FG002|Overall Study|Withdrawal by Subject|21|||
30981364|NCT02553330|59100905|FG000|Overall Study|Other|0|||
30981365|NCT02553330|59100906|FG001|Overall Study|Other|1|||
30981366|NCT02553330|59100907|FG002|Overall Study|Other|0|||
30981367|NCT02553330|59100905|FG000|Overall Study|Non compliance to study treatment|0|||
30981368|NCT02553330|59100906|FG001|Overall Study|Non compliance to study treatment|1|||
30981369|NCT02553330|59100907|FG002|Overall Study|Non compliance to study treatment|0|||
30981370|NCT02553330|59100905|FG000|Overall Study|Adverse Event|0|||
30981371|NCT02553330|59100906|FG001|Overall Study|Adverse Event|1|||
30981372|NCT02553330|59100907|FG002|Overall Study|Adverse Event|0|||
30981373|NCT02553330|59100905|FG000|Overall Study|Lost to Follow-up|0|||
30981374|NCT02553330|59100906|FG001|Overall Study|Lost to Follow-up|4|||
30981375|NCT02553330|59100907|FG002|Overall Study|Lost to Follow-up|4|||
30981376|NCT02550288|59100949|FG000|Overall Study|Adverse Event|0|||
30981377|NCT02550288|59100950|FG001|Overall Study|Adverse Event|1|||
30981378|NCT02550288|59100951|FG002|Overall Study|Adverse Event|0|||
30981379|NCT02550288|59100952|FG003|Overall Study|Adverse Event|0|||
30981380|NCT02550288|59100953|FG004|Overall Study|Adverse Event|0|||
30981381|NCT02550288|59100949|FG000|Overall Study|Physician Decision|0|||
30981382|NCT02550288|59100950|FG001|Overall Study|Physician Decision|0|||
30981383|NCT02550288|59100951|FG002|Overall Study|Physician Decision|0|||
30981384|NCT02550288|59100952|FG003|Overall Study|Physician Decision|1|||
30981385|NCT02550288|59100953|FG004|Overall Study|Physician Decision|0|||
30981386|NCT02550288|59100949|FG000|Overall Study|Protocol Violation|2|||
30981387|NCT02550288|59100950|FG001|Overall Study|Protocol Violation|2|||
30981388|NCT02550288|59100951|FG002|Overall Study|Protocol Violation|1|||
30981389|NCT02550288|59100952|FG003|Overall Study|Protocol Violation|0|||
30981390|NCT02550288|59100953|FG004|Overall Study|Protocol Violation|3|||
30981391|NCT02550288|59100949|FG000|Overall Study|Participant moved|0|||
30981392|NCT02550288|59100950|FG001|Overall Study|Participant moved|0|||
30981393|NCT02550288|59100951|FG002|Overall Study|Participant moved|0|||
30981394|NCT02550288|59100952|FG003|Overall Study|Participant moved|1|||
30981395|NCT02550288|59100953|FG004|Overall Study|Participant moved|0|||
30981396|NCT02550288|59100949|FG000|Overall Study|Withdrawal by Subject|0|||
30981397|NCT02550288|59100950|FG001|Overall Study|Withdrawal by Subject|0|||
30981398|NCT02550288|59100951|FG002|Overall Study|Withdrawal by Subject|0|||
30981399|NCT02550288|59100952|FG003|Overall Study|Withdrawal by Subject|1|||
30981400|NCT02550288|59100953|FG004|Overall Study|Withdrawal by Subject|0|||
30981401|NCT01662336|59101018|FG000|Overall Study|Adverse Event|1|||
30981402|NCT01662336|59101018|FG000|Overall Study|No longer on LPV/r|30|||
30981403|NCT01662336|59101018|FG000|Overall Study|Other|29|||
30981404|NCT01662336|59101018|FG000|Overall Study|Withdrawal by Subject|6|||
30981405|NCT02549352|59101037|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
30981406|NCT02549352|59101038|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
30981407|NCT02549352|59101037|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
30981408|NCT02549352|59101038|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
30981409|NCT02549352|59101037|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
30981410|NCT02549352|59101038|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
30981411|NCT02549352|59101037|FG000|12-month Follow-up|Withdrawal by Subject|4|||
30981412|NCT02549352|59101038|FG001|12-month Follow-up|Withdrawal by Subject|5|||
30981413|NCT02549352|59101037|FG000|12-month Follow-up|Lost to Follow-up|3|||
30981414|NCT02549352|59101038|FG001|12-month Follow-up|Lost to Follow-up|2|||
30981415|NCT02549352|59101037|FG000|12-month Follow-up|Death|0|||
30981416|NCT02549352|59101038|FG001|12-month Follow-up|Death|1|||
30981417|NCT02549352|59101037|FG000|12-month Follow-up|Protocol Violation|0|||
30981418|NCT02549352|59101038|FG001|12-month Follow-up|Protocol Violation|1|||
30981419|NCT02549352|59101037|FG000|12-month Follow-up|Other|1|||
30981420|NCT02549352|59101038|FG001|12-month Follow-up|Other|3|||
30981421|NCT02554890|59101215|FG000|Double-blind|Adverse Event|45|||
30981422|NCT02554890|59101216|FG001|Double-blind|Adverse Event|51|||
30981423|NCT02554890|59101215|FG000|Double-blind|Death|6|||
30981424|NCT02554890|59101216|FG001|Double-blind|Death|4|||
30981425|NCT02554890|59101215|FG000|Double-blind|Protocol Violation|1|||
30981426|NCT02554890|59101216|FG001|Double-blind|Protocol Violation|1|||
30981427|NCT02554890|59101215|FG000|Double-blind|Physician Decision|4|||
30981428|NCT02554890|59101216|FG001|Double-blind|Physician Decision|3|||
30981429|NCT02554890|59101215|FG000|Double-blind|Subject/Guardian decision|21|||
30981430|NCT02554890|59101216|FG001|Double-blind|Subject/Guardian decision|16|||
30981431|NCT02554890|59101215|FG000|Double-blind|Lost to Follow-up|7|||
30981432|NCT02554890|59101216|FG001|Double-blind|Lost to Follow-up|5|||
30981433|NCT02554890|59101215|FG000|Double-blind|Technical problems|1|||
30981434|NCT02554890|59101216|FG001|Double-blind|Technical problems|0|||
30981435|NCT02554890|59101215|FG000|Double-blind|Withdrawal by Subject|5|||
30981436|NCT02554890|59101216|FG001|Double-blind|Withdrawal by Subject|6|||
30981437|NCT02554890|59101215|FG000|Double-blind|Noncompliance with study treatment|6|||
30981438|NCT02554890|59101216|FG001|Double-blind|Noncompliance with study treatment|5|||
30981439|NCT02554890|59101215|FG000|Open-label|Adverse Event|0|||
30981440|NCT02554890|59101216|FG001|Open-label|Adverse Event|30|||
30981441|NCT02554890|59101215|FG000|Open-label|Death|0|||
30981442|NCT02554890|59101216|FG001|Open-label|Death|1|||
30981443|NCT02554890|59101215|FG000|Open-label|Physician Decision|0|||
30981444|NCT02554890|59101216|FG001|Open-label|Physician Decision|1|||
30981445|NCT02554890|59101215|FG000|Open-label|Subject/Guardian decision|0|||
30981446|NCT02554890|59101216|FG001|Open-label|Subject/Guardian decision|11|||
30981447|NCT02554890|59101215|FG000|Open-label|Lost to Follow-up|0|||
30981448|NCT02554890|59101216|FG001|Open-label|Lost to Follow-up|7|||
30981449|NCT02554890|59101215|FG000|Open-label|Technical problems|0|||
30981450|NCT02554890|59101216|FG001|Open-label|Technical problems|1|||
30981451|NCT02554890|59101215|FG000|Open-label|Withdrawal by Subject|0|||
30981452|NCT02554890|59101216|FG001|Open-label|Withdrawal by Subject|1|||
30981453|NCT02552316|59101233|FG000|Overall Study|Withdrawal by Subject|1|||
30981454|NCT02552316|59101233|FG000|Overall Study|Withdrawal due to non-compliance|1|||
30981455|NCT02543346|59101281|FG000|Second Priming Visit|Withdrawal by Subject|0|||
30981456|NCT02543346|59101282|FG001|Second Priming Visit|Withdrawal by Subject|2|||
30981457|NCT02543346|59101283|FG002|Second Priming Visit|Withdrawal by Subject|2|||
30981458|NCT02543346|59101284|FG003|Second Priming Visit|Withdrawal by Subject|2|||
30981459|NCT02543346|59101281|FG000|Second Priming Visit|Adverse Event|1|||
30981460|NCT02543346|59101282|FG001|Second Priming Visit|Adverse Event|0|||
30981461|NCT02543346|59101283|FG002|Second Priming Visit|Adverse Event|0|||
30981462|NCT02543346|59101284|FG003|Second Priming Visit|Adverse Event|0|||
30981463|NCT02549196|59101298|FG000|Overall Study|Protocol Violation|0|||
30981464|NCT02549196|59101299|FG001|Overall Study|Protocol Violation|0|||
30981465|NCT02549196|59101300|FG002|Overall Study|Protocol Violation|0|||
30981466|NCT02549196|59101301|FG003|Overall Study|Protocol Violation|1|||
30981467|NCT02549196|59101298|FG000|Overall Study|Withdrawal by Subject|1|||
30981468|NCT02549196|59101299|FG001|Overall Study|Withdrawal by Subject|0|||
30981469|NCT02549196|59101300|FG002|Overall Study|Withdrawal by Subject|1|||
30981470|NCT02549196|59101301|FG003|Overall Study|Withdrawal by Subject|0|||
30981471|NCT02904954|59101313|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
30981472|NCT02904954|59101314|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
30981473|NCT02904954|59101313|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
30981474|NCT02904954|59101314|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
30981475|NCT02904954|59101313|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
30981476|NCT02904954|59101314|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
30981477|NCT02904954|59101313|FG000|Adjuvant Durvalumab|Recurrence|2|||
30981478|NCT02904954|59101314|FG001|Adjuvant Durvalumab|Recurrence|0|||
30981479|NCT02904954|59101313|FG000|Adjuvant Durvalumab|Adverse Event|2|||
30981480|NCT02904954|59101314|FG001|Adjuvant Durvalumab|Adverse Event|6|||
30981481|NCT02904954|59101313|FG000|Adjuvant Durvalumab|Participant wishes|12|||
30981482|NCT02904954|59101314|FG001|Adjuvant Durvalumab|Participant wishes|7|||
30981483|NCT02904954|59101313|FG000|Adjuvant Durvalumab|Physician Decision|2|||
30981484|NCT02904954|59101314|FG001|Adjuvant Durvalumab|Physician Decision|1|||
30981485|NCT02904954|59101313|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
30981486|NCT02904954|59101314|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
30981487|NCT02904954|59101313|FG000|Adjuvant Durvalumab|Death|0|||
30981488|NCT02904954|59101314|FG001|Adjuvant Durvalumab|Death|1|||
30981489|NCT02904954|59101313|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
30981490|NCT02904954|59101314|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
30981491|NCT02548962|59101430|FG000|Overall Study|Withdrawal by Subject|1|||
30981492|NCT02548962|59101431|FG001|Overall Study|Withdrawal by Subject|0|||
30981493|NCT02548650|59101458|FG000|Triple Therapy|Adverse Event|1|||
30981494|NCT02548650|59101459|FG001|Triple Therapy|Adverse Event|0|||
30981495|NCT02548650|59101458|FG000|Triple Therapy|Withdrawal by Subject|0|||
30981496|NCT02548650|59101459|FG001|Triple Therapy|Withdrawal by Subject|4|||
30981497|NCT02548650|59101458|FG000|Double Therapy|Adverse Event|1|||
30981498|NCT02548650|59101459|FG001|Double Therapy|Adverse Event|1|||
30981499|NCT02548650|59101458|FG000|Double Therapy|Withdrawal by Subject|0|||
30981500|NCT02548650|59101459|FG001|Double Therapy|Withdrawal by Subject|1|||
30981501|NCT02535000|59101554|FG000|Overall Study|Cancellation of surgery.|1|||
30981502|NCT02535000|59101555|FG001|Overall Study|Cancellation of surgery.|2|||
30981503|NCT03110562|59101684|FG000|Overall Study|Withdrawal by Subject|37|||
30981504|NCT03110562|59101685|FG001|Overall Study|Withdrawal by Subject|35|||
30981505|NCT03110562|59101684|FG000|Overall Study|Death|47|||
30981506|NCT03110562|59101685|FG001|Overall Study|Death|61|||
30981507|NCT03110562|59101684|FG000|Overall Study|Lost to Follow-up|7|||
30981508|NCT03110562|59101685|FG001|Overall Study|Lost to Follow-up|6|||
30981509|NCT03110562|59101684|FG000|Overall Study|Other|2|||
30981510|NCT03110562|59101685|FG001|Overall Study|Other|1|||
30981511|NCT03110562|59101684|FG000|Overall Study|Randomized but never treated|0|||
30981512|NCT03110562|59101685|FG001|Overall Study|Randomized but never treated|3|||
30981513|NCT03110562|59101684|FG000|Overall Study|Ongoing|102|||
30981514|NCT03110562|59101685|FG001|Overall Study|Ongoing|101|||
30981515|NCT02546856|59101728|FG000|4 Months Evaluation|Death|2|||
30981516|NCT02546856|59101729|FG001|4 Months Evaluation|Death|3|||
30981517|NCT02546856|59101728|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
30981518|NCT02546856|59101729|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
30981519|NCT02546856|59101728|FG000|4 Months Evaluation|Lost to Follow-up|3|||
30981520|NCT02546856|59101729|FG001|4 Months Evaluation|Lost to Follow-up|3|||
30981521|NCT02546856|59101728|FG000|4 Months Evaluation|Physician Decision|3|||
30981522|NCT02546856|59101729|FG001|4 Months Evaluation|Physician Decision|0|||
30981523|NCT02546856|59101728|FG000|4 Months Evaluation|Working or living abroad|5|||
30981524|NCT02546856|59101729|FG001|4 Months Evaluation|Working or living abroad|1|||
30981525|NCT02546856|59101728|FG000|4 Months Evaluation|reasons not due to titration|4|||
30981526|NCT02546856|59101729|FG001|4 Months Evaluation|reasons not due to titration|1|||
30981527|NCT02546856|59101728|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
30981528|NCT02546856|59101729|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
30981529|NCT02546856|59101728|FG000|6 Months Evaluation|Death|1|||
30981530|NCT02546856|59101729|FG001|6 Months Evaluation|Death|1|||
30981531|NCT02546856|59101728|FG000|6 Months Evaluation|Lost to Follow-up|1|||
30981532|NCT02546856|59101729|FG001|6 Months Evaluation|Lost to Follow-up|1|||
30981533|NCT02546856|59101728|FG000|6 Months Evaluation|Working or living abroad|6|||
30981534|NCT02546856|59101729|FG001|6 Months Evaluation|Working or living abroad|4|||
30981535|NCT02546856|59101728|FG000|6 Months Evaluation|reasons not due to titration|0|||
30981536|NCT02546856|59101729|FG001|6 Months Evaluation|reasons not due to titration|1|||
30981537|NCT02696616|59101854|FG000|Overall Study|Adverse Event|0|||
30981538|NCT02696616|59101855|FG001|Overall Study|Adverse Event|1|||
30981539|NCT02696616|59101856|FG002|Overall Study|Adverse Event|0|||
30981540|NCT02696616|59101857|FG003|Overall Study|Adverse Event|0|||
30981541|NCT02696616|59101858|FG004|Overall Study|Adverse Event|0|||
30981542|NCT02696616|59101859|FG005|Overall Study|Adverse Event|0|||
30981543|NCT02696616|59101860|FG006|Overall Study|Adverse Event|0|||
30981544|NCT01661790|59101903|FG000|Overall Study|Lost to Follow-up|0|||
30981545|NCT01661790|59101904|FG001|Overall Study|Lost to Follow-up|2|||
30981546|NCT02546544|59101924|FG000|Overall Study|Disease Progression|14|||
30981547|NCT02546544|59101924|FG000|Overall Study|Adverse Event|1|||
30981548|NCT02546544|59101924|FG000|Overall Study|Withdrawal by Subject|1|||
30981549|NCT05593211|59102219|FG000|Overall Study|Withdrawal by Subject|1|||
30981550|NCT02533674|59102558|FG000|Dose Level I|Progressive disease|1|||
30981551|NCT02533674|59102559|FG001|Dose Level I|Progressive disease|0|||
30981552|NCT02533674|59102560|FG002|Dose Level I|Progressive disease|0|||
30981553|NCT02533674|59102561|FG003|Dose Level I|Progressive disease|0|||
30981554|NCT02533674|59102562|FG004|Dose Level I|Progressive disease|0|||
30981555|NCT02533674|59102563|FG005|Dose Level I|Progressive disease|0|||
30981556|NCT02533674|59102564|FG006|Dose Level I|Progressive disease|0|||
30981557|NCT02533674|59102565|FG007|Dose Level I|Progressive disease|0|||
30981558|NCT02533674|59102558|FG000|Dose Level I|Withdrawal by Subject|1|||
30981559|NCT02533674|59102559|FG001|Dose Level I|Withdrawal by Subject|0|||
30981560|NCT02533674|59102560|FG002|Dose Level I|Withdrawal by Subject|0|||
30981561|NCT02533674|59102561|FG003|Dose Level I|Withdrawal by Subject|0|||
30981562|NCT02533674|59102562|FG004|Dose Level I|Withdrawal by Subject|0|||
30981563|NCT02533674|59102563|FG005|Dose Level I|Withdrawal by Subject|0|||
30981564|NCT02533674|59102564|FG006|Dose Level I|Withdrawal by Subject|0|||
30981565|NCT02533674|59102565|FG007|Dose Level I|Withdrawal by Subject|0|||
30981566|NCT02533674|59102558|FG000|Dose Level I|Physician Decision|1|||
30981567|NCT02533674|59102559|FG001|Dose Level I|Physician Decision|0|||
30981568|NCT02533674|59102560|FG002|Dose Level I|Physician Decision|0|||
30981569|NCT02533674|59102561|FG003|Dose Level I|Physician Decision|0|||
30981570|NCT02533674|59102562|FG004|Dose Level I|Physician Decision|0|||
30981571|NCT02533674|59102563|FG005|Dose Level I|Physician Decision|0|||
30981572|NCT02533674|59102564|FG006|Dose Level I|Physician Decision|0|||
30981573|NCT02533674|59102565|FG007|Dose Level I|Physician Decision|0|||
30981574|NCT02533674|59102558|FG000|Dose Level I|Death|1|||
30981575|NCT02533674|59102559|FG001|Dose Level I|Death|0|||
30981576|NCT02533674|59102560|FG002|Dose Level I|Death|0|||
30981577|NCT02533674|59102561|FG003|Dose Level I|Death|0|||
30981578|NCT02533674|59102562|FG004|Dose Level I|Death|0|||
30981579|NCT02533674|59102563|FG005|Dose Level I|Death|0|||
30981580|NCT02533674|59102564|FG006|Dose Level I|Death|0|||
30981581|NCT02533674|59102565|FG007|Dose Level I|Death|0|||
30981582|NCT02533674|59102558|FG000|Dose Level I|Never Treated|1|||
30981583|NCT02533674|59102559|FG001|Dose Level I|Never Treated|0|||
30981584|NCT02533674|59102560|FG002|Dose Level I|Never Treated|0|||
30981585|NCT02533674|59102561|FG003|Dose Level I|Never Treated|0|||
30981586|NCT02533674|59102562|FG004|Dose Level I|Never Treated|0|||
30981587|NCT02533674|59102563|FG005|Dose Level I|Never Treated|0|||
30981588|NCT02533674|59102564|FG006|Dose Level I|Never Treated|0|||
30981589|NCT02533674|59102565|FG007|Dose Level I|Never Treated|0|||
30981590|NCT02533674|59102558|FG000|Dose Level II|Progressive disease|0|||
30981591|NCT02533674|59102559|FG001|Dose Level II|Progressive disease|3|||
30981592|NCT02533674|59102560|FG002|Dose Level II|Progressive disease|0|||
30981593|NCT02533674|59102561|FG003|Dose Level II|Progressive disease|0|||
30981594|NCT02533674|59102562|FG004|Dose Level II|Progressive disease|0|||
30981595|NCT02533674|59102563|FG005|Dose Level II|Progressive disease|0|||
30981596|NCT02533674|59102564|FG006|Dose Level II|Progressive disease|0|||
30981597|NCT02533674|59102565|FG007|Dose Level II|Progressive disease|0|||
30981598|NCT02533674|59102558|FG000|Dose Level II|Withdrawal by Subject|0|||
30981599|NCT02533674|59102559|FG001|Dose Level II|Withdrawal by Subject|1|||
30981600|NCT02533674|59102560|FG002|Dose Level II|Withdrawal by Subject|0|||
30981601|NCT02533674|59102561|FG003|Dose Level II|Withdrawal by Subject|0|||
30981602|NCT02533674|59102562|FG004|Dose Level II|Withdrawal by Subject|0|||
30981603|NCT02533674|59102563|FG005|Dose Level II|Withdrawal by Subject|0|||
30981604|NCT02533674|59102564|FG006|Dose Level II|Withdrawal by Subject|0|||
30981605|NCT02533674|59102565|FG007|Dose Level II|Withdrawal by Subject|0|||
30981606|NCT02533674|59102558|FG000|Dose Level II|Treatment-related AE|0|||
30981607|NCT02533674|59102559|FG001|Dose Level II|Treatment-related AE|1|||
30981608|NCT02533674|59102560|FG002|Dose Level II|Treatment-related AE|0|||
30981609|NCT02533674|59102561|FG003|Dose Level II|Treatment-related AE|0|||
30981610|NCT02533674|59102562|FG004|Dose Level II|Treatment-related AE|0|||
30981611|NCT02533674|59102563|FG005|Dose Level II|Treatment-related AE|0|||
30981612|NCT02533674|59102564|FG006|Dose Level II|Treatment-related AE|0|||
30981613|NCT02533674|59102565|FG007|Dose Level II|Treatment-related AE|0|||
30981614|NCT02533674|59102558|FG000|Dose Level II|Physician Decision|0|||
30981615|NCT02533674|59102559|FG001|Dose Level II|Physician Decision|1|||
30981616|NCT02533674|59102560|FG002|Dose Level II|Physician Decision|0|||
30981617|NCT02533674|59102561|FG003|Dose Level II|Physician Decision|0|||
30981618|NCT02533674|59102562|FG004|Dose Level II|Physician Decision|0|||
30981619|NCT02533674|59102563|FG005|Dose Level II|Physician Decision|0|||
30981620|NCT02533674|59102564|FG006|Dose Level II|Physician Decision|0|||
30981621|NCT02533674|59102565|FG007|Dose Level II|Physician Decision|0|||
30981622|NCT02533674|59102558|FG000|Dose Level II|Non-treatment-related AE|0|||
30981623|NCT02533674|59102559|FG001|Dose Level II|Non-treatment-related AE|1|||
30981624|NCT02533674|59102560|FG002|Dose Level II|Non-treatment-related AE|0|||
30981625|NCT02533674|59102561|FG003|Dose Level II|Non-treatment-related AE|0|||
30981626|NCT02533674|59102562|FG004|Dose Level II|Non-treatment-related AE|0|||
30981627|NCT02533674|59102563|FG005|Dose Level II|Non-treatment-related AE|0|||
30981628|NCT02533674|59102564|FG006|Dose Level II|Non-treatment-related AE|0|||
30981629|NCT02533674|59102565|FG007|Dose Level II|Non-treatment-related AE|0|||
30981630|NCT02533674|59102558|FG000|Dose Level III|Progressive disease|0|||
30981631|NCT02533674|59102559|FG001|Dose Level III|Progressive disease|0|||
30981632|NCT02533674|59102560|FG002|Dose Level III|Progressive disease|2|||
30981633|NCT02533674|59102561|FG003|Dose Level III|Progressive disease|0|||
30981634|NCT02533674|59102562|FG004|Dose Level III|Progressive disease|0|||
30981635|NCT02533674|59102563|FG005|Dose Level III|Progressive disease|0|||
30981636|NCT02533674|59102564|FG006|Dose Level III|Progressive disease|0|||
30981637|NCT02533674|59102565|FG007|Dose Level III|Progressive disease|0|||
30891432|NCT02222493|58924548|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
30891433|NCT02222493|58924547|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
30891434|NCT02222493|58924548|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
30891435|NCT02222493|58924547|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
30891436|NCT02222493|58924548|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
30891437|NCT02222493|58924547|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
30891438|NCT02222493|58924548|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
30891439|NCT02222493|58924547|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
30891440|NCT02222493|58924548|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
30891441|NCT02222493|58924547|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
30891442|NCT02222493|58924548|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
30891443|NCT02222493|58924547|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
30891444|NCT02222493|58924548|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
30891445|NCT02222493|58924547|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
30891446|NCT02222493|58924548|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
30891447|NCT02222493|58924547|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
30891448|NCT02222493|58924548|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
30891449|NCT02222493|58924547|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
30891450|NCT02222493|58924548|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
30981638|NCT02533674|59102558|FG000|Dose Level III|Withdrawal by Subject|0|||
30981639|NCT02533674|59102559|FG001|Dose Level III|Withdrawal by Subject|0|||
30981640|NCT02533674|59102560|FG002|Dose Level III|Withdrawal by Subject|1|||
30981641|NCT02533674|59102561|FG003|Dose Level III|Withdrawal by Subject|0|||
30981642|NCT02533674|59102562|FG004|Dose Level III|Withdrawal by Subject|0|||
30981643|NCT02533674|59102563|FG005|Dose Level III|Withdrawal by Subject|0|||
30981644|NCT02533674|59102564|FG006|Dose Level III|Withdrawal by Subject|0|||
30981645|NCT02533674|59102565|FG007|Dose Level III|Withdrawal by Subject|0|||
30981646|NCT02533674|59102558|FG000|Dose Level III|Treatment-related AE|0|||
30981647|NCT02533674|59102559|FG001|Dose Level III|Treatment-related AE|0|||
30981648|NCT02533674|59102560|FG002|Dose Level III|Treatment-related AE|1|||
30981649|NCT02533674|59102561|FG003|Dose Level III|Treatment-related AE|0|||
30981650|NCT02533674|59102562|FG004|Dose Level III|Treatment-related AE|0|||
30981651|NCT02533674|59102563|FG005|Dose Level III|Treatment-related AE|0|||
30981652|NCT02533674|59102564|FG006|Dose Level III|Treatment-related AE|0|||
30981653|NCT02533674|59102565|FG007|Dose Level III|Treatment-related AE|0|||
30981654|NCT02533674|59102558|FG000|Dose Level IV|Progressive disease|0|||
30981655|NCT02533674|59102559|FG001|Dose Level IV|Progressive disease|0|||
30981656|NCT02533674|59102560|FG002|Dose Level IV|Progressive disease|0|||
30981657|NCT02533674|59102561|FG003|Dose Level IV|Progressive disease|3|||
30981658|NCT02533674|59102562|FG004|Dose Level IV|Progressive disease|0|||
30981659|NCT02533674|59102563|FG005|Dose Level IV|Progressive disease|0|||
30981660|NCT02533674|59102564|FG006|Dose Level IV|Progressive disease|0|||
30981661|NCT02533674|59102565|FG007|Dose Level IV|Progressive disease|0|||
30981662|NCT02533674|59102558|FG000|Dose Level IV|Withdrawal by Subject|0|||
30981663|NCT02533674|59102559|FG001|Dose Level IV|Withdrawal by Subject|0|||
30981664|NCT02533674|59102560|FG002|Dose Level IV|Withdrawal by Subject|0|||
30981665|NCT02533674|59102561|FG003|Dose Level IV|Withdrawal by Subject|1|||
30981666|NCT02533674|59102562|FG004|Dose Level IV|Withdrawal by Subject|0|||
30981667|NCT02533674|59102563|FG005|Dose Level IV|Withdrawal by Subject|0|||
30981668|NCT02533674|59102564|FG006|Dose Level IV|Withdrawal by Subject|0|||
30981669|NCT02533674|59102565|FG007|Dose Level IV|Withdrawal by Subject|0|||
30981670|NCT02533674|59102558|FG000|Dose Level IV|Physician Decision|0|||
30981671|NCT02533674|59102559|FG001|Dose Level IV|Physician Decision|0|||
30981672|NCT02533674|59102560|FG002|Dose Level IV|Physician Decision|0|||
30981673|NCT02533674|59102561|FG003|Dose Level IV|Physician Decision|1|||
30981674|NCT02533674|59102562|FG004|Dose Level IV|Physician Decision|0|||
30981675|NCT02533674|59102563|FG005|Dose Level IV|Physician Decision|0|||
30981676|NCT02533674|59102564|FG006|Dose Level IV|Physician Decision|0|||
30981677|NCT02533674|59102565|FG007|Dose Level IV|Physician Decision|0|||
30981678|NCT02533674|59102558|FG000|Dose Level V|Progressive disease|0|||
30981679|NCT02533674|59102559|FG001|Dose Level V|Progressive disease|0|||
30981680|NCT02533674|59102560|FG002|Dose Level V|Progressive disease|0|||
30981681|NCT02533674|59102561|FG003|Dose Level V|Progressive disease|0|||
30981682|NCT02533674|59102562|FG004|Dose Level V|Progressive disease|3|||
30981683|NCT02533674|59102563|FG005|Dose Level V|Progressive disease|0|||
30981684|NCT02533674|59102564|FG006|Dose Level V|Progressive disease|0|||
30981685|NCT02533674|59102565|FG007|Dose Level V|Progressive disease|0|||
30981686|NCT02533674|59102558|FG000|Dose Level V|Withdrawal by Subject|0|||
30981687|NCT02533674|59102559|FG001|Dose Level V|Withdrawal by Subject|0|||
30981688|NCT02533674|59102560|FG002|Dose Level V|Withdrawal by Subject|0|||
30981689|NCT02533674|59102561|FG003|Dose Level V|Withdrawal by Subject|0|||
30981690|NCT02533674|59102562|FG004|Dose Level V|Withdrawal by Subject|1|||
30981691|NCT02533674|59102563|FG005|Dose Level V|Withdrawal by Subject|0|||
30981692|NCT02533674|59102564|FG006|Dose Level V|Withdrawal by Subject|0|||
30981693|NCT02533674|59102565|FG007|Dose Level V|Withdrawal by Subject|0|||
30981694|NCT02533674|59102558|FG000|Dose Level V|Physician Decision|0|||
30981695|NCT02533674|59102559|FG001|Dose Level V|Physician Decision|0|||
30981696|NCT02533674|59102560|FG002|Dose Level V|Physician Decision|0|||
30981697|NCT02533674|59102561|FG003|Dose Level V|Physician Decision|0|||
30981698|NCT02533674|59102562|FG004|Dose Level V|Physician Decision|1|||
30981699|NCT02533674|59102563|FG005|Dose Level V|Physician Decision|0|||
30981700|NCT02533674|59102564|FG006|Dose Level V|Physician Decision|0|||
30981701|NCT02533674|59102565|FG007|Dose Level V|Physician Decision|0|||
30981702|NCT02533674|59102558|FG000|Dose Level VI|Progressive disease|0|||
30981703|NCT02533674|59102559|FG001|Dose Level VI|Progressive disease|0|||
30981704|NCT02533674|59102560|FG002|Dose Level VI|Progressive disease|0|||
30981705|NCT02533674|59102561|FG003|Dose Level VI|Progressive disease|0|||
30981706|NCT02533674|59102562|FG004|Dose Level VI|Progressive disease|0|||
30981707|NCT02533674|59102563|FG005|Dose Level VI|Progressive disease|7|||
30981708|NCT02533674|59102564|FG006|Dose Level VI|Progressive disease|0|||
30981709|NCT02533674|59102565|FG007|Dose Level VI|Progressive disease|0|||
30981710|NCT02533674|59102558|FG000|Dose Level VI|Withdrawal by Subject|0|||
30981711|NCT02533674|59102559|FG001|Dose Level VI|Withdrawal by Subject|0|||
30981712|NCT02533674|59102560|FG002|Dose Level VI|Withdrawal by Subject|0|||
30981713|NCT02533674|59102561|FG003|Dose Level VI|Withdrawal by Subject|0|||
30981714|NCT02533674|59102562|FG004|Dose Level VI|Withdrawal by Subject|0|||
30981715|NCT02533674|59102563|FG005|Dose Level VI|Withdrawal by Subject|1|||
30981716|NCT02533674|59102564|FG006|Dose Level VI|Withdrawal by Subject|0|||
30981717|NCT02533674|59102565|FG007|Dose Level VI|Withdrawal by Subject|0|||
30981718|NCT02533674|59102558|FG000|Dose Level VI|Treatment-related AE|0|||
30981719|NCT02533674|59102559|FG001|Dose Level VI|Treatment-related AE|0|||
30981720|NCT02533674|59102560|FG002|Dose Level VI|Treatment-related AE|0|||
30981721|NCT02533674|59102561|FG003|Dose Level VI|Treatment-related AE|0|||
30981722|NCT02533674|59102562|FG004|Dose Level VI|Treatment-related AE|0|||
30981723|NCT02533674|59102563|FG005|Dose Level VI|Treatment-related AE|1|||
30981724|NCT02533674|59102564|FG006|Dose Level VI|Treatment-related AE|0|||
30981725|NCT02533674|59102565|FG007|Dose Level VI|Treatment-related AE|0|||
30981726|NCT02533674|59102558|FG000|Dose Level VII|Progressive disease|0|||
30981727|NCT02533674|59102559|FG001|Dose Level VII|Progressive disease|0|||
30981728|NCT02533674|59102560|FG002|Dose Level VII|Progressive disease|0|||
30981729|NCT02533674|59102561|FG003|Dose Level VII|Progressive disease|0|||
30981730|NCT02533674|59102562|FG004|Dose Level VII|Progressive disease|0|||
30981731|NCT02533674|59102563|FG005|Dose Level VII|Progressive disease|0|||
30981732|NCT02533674|59102564|FG006|Dose Level VII|Progressive disease|10|||
30981733|NCT02533674|59102565|FG007|Dose Level VII|Progressive disease|0|||
30981734|NCT02533674|59102558|FG000|Dose Level VII|Withdrawal by Subject|0|||
30981735|NCT02533674|59102559|FG001|Dose Level VII|Withdrawal by Subject|0|||
30981736|NCT02533674|59102560|FG002|Dose Level VII|Withdrawal by Subject|0|||
30981737|NCT02533674|59102561|FG003|Dose Level VII|Withdrawal by Subject|0|||
30981738|NCT02533674|59102562|FG004|Dose Level VII|Withdrawal by Subject|0|||
30981739|NCT02533674|59102563|FG005|Dose Level VII|Withdrawal by Subject|0|||
30981740|NCT02533674|59102564|FG006|Dose Level VII|Withdrawal by Subject|3|||
30981741|NCT02533674|59102565|FG007|Dose Level VII|Withdrawal by Subject|0|||
30981742|NCT02533674|59102558|FG000|Dose Level VII|Treatment-related AE|0|||
30981743|NCT02533674|59102559|FG001|Dose Level VII|Treatment-related AE|0|||
30981744|NCT02533674|59102560|FG002|Dose Level VII|Treatment-related AE|0|||
30981745|NCT02533674|59102561|FG003|Dose Level VII|Treatment-related AE|0|||
30981746|NCT02533674|59102562|FG004|Dose Level VII|Treatment-related AE|0|||
30981747|NCT02533674|59102563|FG005|Dose Level VII|Treatment-related AE|0|||
30981748|NCT02533674|59102564|FG006|Dose Level VII|Treatment-related AE|1|||
30981749|NCT02533674|59102565|FG007|Dose Level VII|Treatment-related AE|0|||
30981750|NCT02533674|59102558|FG000|Dose Level VII|Death|0|||
30981751|NCT02533674|59102559|FG001|Dose Level VII|Death|0|||
30981752|NCT02533674|59102560|FG002|Dose Level VII|Death|0|||
30981753|NCT02533674|59102561|FG003|Dose Level VII|Death|0|||
30981754|NCT02533674|59102562|FG004|Dose Level VII|Death|0|||
30981755|NCT02533674|59102563|FG005|Dose Level VII|Death|0|||
30981756|NCT02533674|59102564|FG006|Dose Level VII|Death|2|||
30981757|NCT02533674|59102565|FG007|Dose Level VII|Death|0|||
30981758|NCT02533674|59102558|FG000|Dose Level VIII|Progressive disease|0|||
30981759|NCT02533674|59102559|FG001|Dose Level VIII|Progressive disease|0|||
30981760|NCT02533674|59102560|FG002|Dose Level VIII|Progressive disease|0|||
30981761|NCT02533674|59102561|FG003|Dose Level VIII|Progressive disease|0|||
30981762|NCT02533674|59102562|FG004|Dose Level VIII|Progressive disease|0|||
30981763|NCT02533674|59102563|FG005|Dose Level VIII|Progressive disease|0|||
30981764|NCT02533674|59102564|FG006|Dose Level VIII|Progressive disease|0|||
30981765|NCT02533674|59102565|FG007|Dose Level VIII|Progressive disease|3|||
30981766|NCT02533674|59102558|FG000|Dose Level VIII|Withdrawal by Subject|0|||
30981767|NCT02533674|59102559|FG001|Dose Level VIII|Withdrawal by Subject|0|||
30981768|NCT02533674|59102560|FG002|Dose Level VIII|Withdrawal by Subject|0|||
30981769|NCT02533674|59102561|FG003|Dose Level VIII|Withdrawal by Subject|0|||
30981770|NCT02533674|59102562|FG004|Dose Level VIII|Withdrawal by Subject|0|||
30981771|NCT02533674|59102563|FG005|Dose Level VIII|Withdrawal by Subject|0|||
30981772|NCT02533674|59102564|FG006|Dose Level VIII|Withdrawal by Subject|0|||
30981773|NCT02533674|59102565|FG007|Dose Level VIII|Withdrawal by Subject|1|||
30981774|NCT02533674|59102558|FG000|Dose Level VIII|Treatment-related AE|0|||
30981775|NCT02533674|59102559|FG001|Dose Level VIII|Treatment-related AE|0|||
30981776|NCT02533674|59102560|FG002|Dose Level VIII|Treatment-related AE|0|||
30981777|NCT02533674|59102561|FG003|Dose Level VIII|Treatment-related AE|0|||
30981778|NCT02533674|59102562|FG004|Dose Level VIII|Treatment-related AE|0|||
30981779|NCT02533674|59102563|FG005|Dose Level VIII|Treatment-related AE|0|||
30981780|NCT02533674|59102564|FG006|Dose Level VIII|Treatment-related AE|0|||
30981781|NCT02533674|59102565|FG007|Dose Level VIII|Treatment-related AE|1|||
30981782|NCT02533674|59102558|FG000|Dose Level VIII|Never treated|0|||
30981783|NCT02533674|59102559|FG001|Dose Level VIII|Never treated|0|||
30981784|NCT02533674|59102560|FG002|Dose Level VIII|Never treated|0|||
30981785|NCT02533674|59102561|FG003|Dose Level VIII|Never treated|0|||
30981786|NCT02533674|59102562|FG004|Dose Level VIII|Never treated|0|||
30981787|NCT02533674|59102563|FG005|Dose Level VIII|Never treated|0|||
30981788|NCT02533674|59102564|FG006|Dose Level VIII|Never treated|0|||
30981789|NCT02533674|59102565|FG007|Dose Level VIII|Never treated|1|||
30981790|NCT02540850|59102586|FG000|Overall Study|Lost to Follow-up|69|||
30981791|NCT02540850|59102587|FG001|Overall Study|Lost to Follow-up|66|||
30981792|NCT02540850|59102588|FG002|Overall Study|Lost to Follow-up|34|||
30981793|NCT01662024|59102596|FG000|Overall Study|Pregnancy|2|||
30981794|NCT01662024|59102596|FG000|Overall Study|Withdrawal by Subject|3|||
30981795|NCT02544750|59102665|FG000|Overall Study|Physician Decision|3|||
30981796|NCT02544750|59102666|FG001|Overall Study|Physician Decision|1|||
30981797|NCT02544750|59102665|FG000|Overall Study|Other reasons|69|||
30981798|NCT02544750|59102666|FG001|Overall Study|Other reasons|39|||
30981799|NCT02544750|59102665|FG000|Overall Study|Met withdrawal criteria|2|||
30981800|NCT02544750|59102666|FG001|Overall Study|Met withdrawal criteria|2|||
30981801|NCT02544750|59102665|FG000|Overall Study|Transition To Commercial Product|1|||
30981802|NCT02544750|59102666|FG001|Overall Study|Transition To Commercial Product|0|||
30981803|NCT02544750|59102665|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
30981804|NCT02544750|59102666|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
30981805|NCT02544750|59102665|FG000|Overall Study|Adverse Event|8|||
30981806|NCT02544750|59102666|FG001|Overall Study|Adverse Event|10|||
30981807|NCT02544750|59102665|FG000|Overall Study|Withdrawal by Subject|10|||
30981808|NCT02544750|59102666|FG001|Overall Study|Withdrawal by Subject|4|||
30981809|NCT02544750|59102665|FG000|Overall Study|Lost to Follow-up|1|||
30981810|NCT02544750|59102666|FG001|Overall Study|Lost to Follow-up|0|||
30981811|NCT02540538|59102712|FG000|Overall Study|Pregnancy|0|||
30981812|NCT02540538|59102713|FG001|Overall Study|Pregnancy|1|||
30981813|NCT02540538|59102714|FG002|Overall Study|Pregnancy|0|||
30981814|NCT04697056|59102747|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
30981815|NCT04697056|59102748|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
30981816|NCT02181738|59102872|FG000|Overall Study|Death|1|||
30981817|NCT02181738|59102873|FG001|Overall Study|Death|1|||
30981818|NCT02181738|59102874|FG002|Overall Study|Death|6|||
30981819|NCT02181738|59102875|FG003|Overall Study|Death|1|||
30981820|NCT02181738|59102872|FG000|Overall Study|Subject Withdrew Consent|1|||
30981821|NCT02181738|59102873|FG001|Overall Study|Subject Withdrew Consent|3|||
30981822|NCT02181738|59102874|FG002|Overall Study|Subject Withdrew Consent|2|||
30981823|NCT02181738|59102875|FG003|Overall Study|Subject Withdrew Consent|1|||
30981824|NCT02181738|59102872|FG000|Overall Study|Lost to Follow-up|0|||
30981825|NCT02181738|59102873|FG001|Overall Study|Lost to Follow-up|4|||
30981826|NCT02181738|59102874|FG002|Overall Study|Lost to Follow-up|2|||
30981827|NCT02181738|59102875|FG003|Overall Study|Lost to Follow-up|0|||
30981828|NCT02181738|59102872|FG000|Overall Study|Patient Return to Home Country|0|||
30981829|NCT02181738|59102873|FG001|Overall Study|Patient Return to Home Country|1|||
30981830|NCT02181738|59102874|FG002|Overall Study|Patient Return to Home Country|0|||
30981831|NCT02181738|59102875|FG003|Overall Study|Patient Return to Home Country|0|||
30981832|NCT03493282|59102906|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
30981833|NCT03493282|59102907|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
30981834|NCT03493282|59102908|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
30981835|NCT03493282|59102906|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
30981836|NCT03493282|59102907|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
30981837|NCT03493282|59102908|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
30981838|NCT02532972|59102922|FG000|Overall Study|Withdrawal by Subject|1|||
30981839|NCT03187834|59102975|FG000|Overall Study|Lost to Follow-up|0|||
30981840|NCT03187834|59102976|FG001|Overall Study|Lost to Follow-up|1|||
30981841|NCT03187834|59102977|FG002|Overall Study|Lost to Follow-up|2|||
30981842|NCT03187834|59102978|FG003|Overall Study|Lost to Follow-up|2|||
30981843|NCT03187834|59102975|FG000|Overall Study|Had invalid anthropometric measurements|5|||
30981844|NCT03187834|59102976|FG001|Overall Study|Had invalid anthropometric measurements|3|||
30981845|NCT03187834|59102977|FG002|Overall Study|Had invalid anthropometric measurements|4|||
30981846|NCT03187834|59102978|FG003|Overall Study|Had invalid anthropometric measurements|2|||
30981847|NCT03713944|59103131|FG000|Study Treatment|Patient non-compliance|1|||
30981848|NCT03713944|59103131|FG000|Study Treatment|Alternative Cancer Therapy|3|||
30981849|NCT03713944|59103131|FG000|Study Treatment|Disease Progression|18|||
30981850|NCT03713944|59103131|FG000|Study Treatment|AE/Side Effects/Complications|2|||
30981851|NCT03713944|59103131|FG000|Study Treatment|Death|2|||
30981852|NCT03713944|59103131|FG000|Study Treatment|Withdrawal by Subject|1|||
30981853|NCT03713944|59103131|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
30981854|NCT03713944|59103131|FG000|Study Treatment|Symptomatic Deterioration|2|||
30981855|NCT03713944|59103131|FG000|Follow up|Withdrawal by Subject|2|||
30981856|NCT03713944|59103131|FG000|Follow up|Death|11|||
30981857|NCT03713944|59103131|FG000|Follow up|Study Terminated|3|||
30981858|NCT01572662|59103209|FG000|Overall Study|Withdrawal by Subject|1|||
30981859|NCT01572662|59103210|FG001|Overall Study|Withdrawal by Subject|0|||
30981860|NCT01572662|59103209|FG000|Overall Study|Physician Decision|0|||
30981861|NCT01572662|59103210|FG001|Overall Study|Physician Decision|1|||
30981862|NCT02325154|59103240|FG000|Overall Study|Physician Decision|1|||
30981863|NCT00493870|59103367|FG000|Overall Study|Lost to Follow-up|12|||
30981864|NCT00493870|59103368|FG001|Overall Study|Lost to Follow-up|15|||
30981865|NCT04439344|59103625|FG000|Overall Study|Never started threapy|3|||
30981866|NCT04439344|59103625|FG000|Overall Study|Ineligible|3|||
30981867|NCT04439344|59103625|FG000|Overall Study|Adverse Event|13|||
30981868|NCT04439344|59103625|FG000|Overall Study|Death|2|||
30981869|NCT04439344|59103625|FG000|Overall Study|Disease progression|29|||
30981870|NCT04439344|59103625|FG000|Overall Study|Withdrawal by Subject|2|||
30981871|NCT04439344|59103625|FG000|Overall Study|Alternative therapy|1|||
30981872|NCT04439279|59103629|FG000|Overall Study|Adverse Event|7|||
30981873|NCT04439279|59103629|FG000|Overall Study|Death|4|||
30981874|NCT04439279|59103629|FG000|Overall Study|Disease progression|17|||
30981875|NCT04439279|59103629|FG000|Overall Study|Complicating disease|3|||
30981876|NCT04439279|59103629|FG000|Overall Study|Withdrawal by Subject|2|||
30981877|NCT04439279|59103629|FG000|Overall Study|Ineligible|1|||
30981878|NCT04439279|59103629|FG000|Overall Study|Treatment still ongoing|1|||
30981879|NCT04439175|59103633|FG000|Overall Study|Never started treatment|4|||
30981880|NCT04439175|59103633|FG000|Overall Study|Ineligible|5|||
30981881|NCT04439175|59103633|FG000|Overall Study|Adverse Event|6|||
30981882|NCT04439175|59103633|FG000|Overall Study|Death|4|||
30981883|NCT04439175|59103633|FG000|Overall Study|Disease progression|44|||
30981884|NCT04439175|59103633|FG000|Overall Study|Withdrawal by Subject|4|||
30981885|NCT04439175|59103633|FG000|Overall Study|Alternative Therapy|1|||
30981886|NCT04439175|59103633|FG000|Overall Study|Other|2|||
30981887|NCT03951753|59103653|FG000|Overall Study|Adverse Event|1|||
30981888|NCT03951753|59103654|FG001|Overall Study|Adverse Event|0|||
30981889|NCT03951753|59103655|FG002|Overall Study|Adverse Event|3|||
30981890|NCT03951753|59103653|FG000|Overall Study|Withdrawal by Subject|3|||
30981891|NCT03951753|59103654|FG001|Overall Study|Withdrawal by Subject|1|||
30981892|NCT03951753|59103655|FG002|Overall Study|Withdrawal by Subject|0|||
30981893|NCT03951753|59103653|FG000|Overall Study|Lost to Follow-up|0|||
30981894|NCT03951753|59103654|FG001|Overall Study|Lost to Follow-up|0|||
30981895|NCT03951753|59103655|FG002|Overall Study|Lost to Follow-up|1|||
30981896|NCT03941964|59103665|FG000|Overall Study|Adverse Event|1|||
30981897|NCT03941964|59103666|FG001|Overall Study|Adverse Event|8|||
30981898|NCT03941964|59103665|FG000|Overall Study|Progressive disease|7|||
30981899|NCT03941964|59103666|FG001|Overall Study|Progressive disease|3|||
30981900|NCT03941964|59103665|FG000|Overall Study|Lack of Efficacy|0|||
30981901|NCT03941964|59103666|FG001|Overall Study|Lack of Efficacy|1|||
30981902|NCT03941964|59103665|FG000|Overall Study|Death|3|||
30981903|NCT03941964|59103666|FG001|Overall Study|Death|1|||
30981904|NCT03941964|59103665|FG000|Overall Study|Withdrew consent|1|||
30981905|NCT03941964|59103666|FG001|Overall Study|Withdrew consent|3|||
30981906|NCT03941964|59103665|FG000|Overall Study|Physician Decision|9|||
30981907|NCT03941964|59103666|FG001|Overall Study|Physician Decision|2|||
30981908|NCT03941964|59103665|FG000|Overall Study|Other, not specified|2|||
30981909|NCT03941964|59103666|FG001|Overall Study|Other, not specified|1|||
30981910|NCT03837509|59103696|FG000|Phase 1|Death|5|||
30981911|NCT03837509|59103697|FG001|Phase 1|Death|2|||
30981912|NCT03837509|59103698|FG002|Phase 1|Death|0|||
30981913|NCT03837509|59103699|FG003|Phase 1|Death|0|||
30981914|NCT03837509|59103700|FG004|Phase 1|Death|0|||
30981915|NCT03837509|59103696|FG000|Phase 2|Death|0|||
30981916|NCT03837509|59103697|FG001|Phase 2|Death|0|||
30981917|NCT03837509|59103698|FG002|Phase 2|Death|0|||
30981918|NCT03837509|59103699|FG003|Phase 2|Death|1|||
30981919|NCT03837509|59103700|FG004|Phase 2|Death|1|||
30981920|NCT03822117|59103720|FG000|Overall Study|Death|18|||
30981921|NCT03822117|59103721|FG001|Overall Study|Death|17|||
30981922|NCT03822117|59103722|FG002|Overall Study|Death|12|||
30981923|NCT03822117|59103723|FG003|Overall Study|Death|4|||
30981924|NCT03822117|59103720|FG000|Overall Study|Lost to Follow-up|1|||
30981925|NCT03822117|59103721|FG001|Overall Study|Lost to Follow-up|2|||
30981926|NCT03822117|59103722|FG002|Overall Study|Lost to Follow-up|3|||
30981927|NCT03822117|59103723|FG003|Overall Study|Lost to Follow-up|0|||
30981928|NCT03822117|59103720|FG000|Overall Study|Study Terminated by Sponsor|25|||
30981929|NCT03822117|59103721|FG001|Overall Study|Study Terminated by Sponsor|11|||
30981930|NCT03822117|59103722|FG002|Overall Study|Study Terminated by Sponsor|6|||
30981931|NCT03822117|59103723|FG003|Overall Study|Study Terminated by Sponsor|0|||
30981932|NCT03822117|59103720|FG000|Overall Study|Withdrawal by Subject|4|||
30981933|NCT03822117|59103721|FG001|Overall Study|Withdrawal by Subject|0|||
30981934|NCT03822117|59103722|FG002|Overall Study|Withdrawal by Subject|3|||
30981935|NCT03822117|59103723|FG003|Overall Study|Withdrawal by Subject|0|||
30981936|NCT03822117|59103720|FG000|Overall Study|Disease Progression|1|||
30981937|NCT03822117|59103721|FG001|Overall Study|Disease Progression|2|||
30981938|NCT03822117|59103722|FG002|Overall Study|Disease Progression|1|||
30981939|NCT03822117|59103723|FG003|Overall Study|Disease Progression|0|||
30981940|NCT03822117|59103720|FG000|Overall Study|Never Returned to Hospital|0|||
30981941|NCT03822117|59103721|FG001|Overall Study|Never Returned to Hospital|0|||
30981942|NCT03822117|59103722|FG002|Overall Study|Never Returned to Hospital|1|||
30981943|NCT03822117|59103723|FG003|Overall Study|Never Returned to Hospital|0|||
30981944|NCT03497897|59103737|FG000|Overall Study|Adverse Event|1|||
30981945|NCT03497897|59103738|FG001|Overall Study|Adverse Event|1|||
30981946|NCT03497897|59103739|FG002|Overall Study|Adverse Event|1|||
30981947|NCT03497897|59103737|FG000|Overall Study|Lost to Follow-up|2|||
30981948|NCT03497897|59103738|FG001|Overall Study|Lost to Follow-up|0|||
30981949|NCT03497897|59103739|FG002|Overall Study|Lost to Follow-up|2|||
30981950|NCT03497897|59103737|FG000|Overall Study|Physician Decision|1|||
30981951|NCT03497897|59103738|FG001|Overall Study|Physician Decision|0|||
30981952|NCT03497897|59103739|FG002|Overall Study|Physician Decision|0|||
30981953|NCT03497897|59103737|FG000|Overall Study|Subject/Guardian Decision|2|||
30981954|NCT03497897|59103738|FG001|Overall Study|Subject/Guardian Decision|1|||
30981955|NCT03497897|59103739|FG002|Overall Study|Subject/Guardian Decision|3|||
30981956|NCT03428217|59103750|FG000|Overall Study|Death|89|||
30981957|NCT03428217|59103751|FG001|Overall Study|Death|93|||
30981958|NCT03428217|59103750|FG000|Overall Study|Withdrawal by Subject|8|||
30981959|NCT03428217|59103751|FG001|Overall Study|Withdrawal by Subject|7|||
30981960|NCT03428217|59103750|FG000|Overall Study|Lost to Follow-up|1|||
30981961|NCT03428217|59103751|FG001|Overall Study|Lost to Follow-up|3|||
30981962|NCT03428217|59103750|FG000|Overall Study|Study terminated by sponsor|124|||
30981963|NCT03428217|59103751|FG001|Overall Study|Study terminated by sponsor|118|||
30981964|NCT03428217|59103750|FG000|Overall Study|Other, Not Specified|1|||
30981965|NCT03428217|59103751|FG001|Overall Study|Other, Not Specified|0|||
30981966|NCT03189719|59103761|FG000|Overall Study|Death|260|||
30981967|NCT03189719|59103762|FG001|Overall Study|Death|308|||
30981968|NCT03189719|59103761|FG000|Overall Study|Withdrawal by Subject|5|||
30981969|NCT03189719|59103762|FG001|Overall Study|Withdrawal by Subject|3|||
30981970|NCT03189719|59103761|FG000|Overall Study|Ongoing in Study|108|||
30981971|NCT03189719|59103762|FG001|Overall Study|Ongoing in Study|65|||
30981972|NCT02969525|59103773|FG000|Double-Blind Period|Adverse Event|0|||
30981973|NCT02969525|59103774|FG001|Double-Blind Period|Adverse Event|0|||
30981974|NCT02969525|59103775|FG002|Double-Blind Period|Adverse Event|1|||
30981975|NCT02969525|59103776|FG003|Double-Blind Period|Adverse Event|1|||
30981976|NCT02969525|59103777|FG004|Double-Blind Period|Adverse Event|0|||
30981977|NCT02969525|59103778|FG005|Double-Blind Period|Adverse Event|0|||
30981978|NCT02969525|59103779|FG006|Double-Blind Period|Adverse Event|0|||
30981979|NCT02969525|59103780|FG007|Double-Blind Period|Adverse Event|0|||
30981980|NCT02969525|59103781|FG008|Double-Blind Period|Adverse Event|0|||
30981981|NCT02969525|59103782|FG009|Double-Blind Period|Adverse Event|0|||
30981982|NCT02969525|59103783|FG010|Double-Blind Period|Adverse Event|0|||
30981983|NCT02969525|59103784|FG011|Double-Blind Period|Adverse Event|0|||
30981984|NCT02969525|59103773|FG000|Double-Blind Period|LOW EGFR|0|||
30981985|NCT02969525|59103774|FG001|Double-Blind Period|LOW EGFR|0|||
30981986|NCT02969525|59103775|FG002|Double-Blind Period|LOW EGFR|0|||
30981987|NCT02969525|59103776|FG003|Double-Blind Period|LOW EGFR|1|||
30981988|NCT02969525|59103777|FG004|Double-Blind Period|LOW EGFR|0|||
30981989|NCT02969525|59103778|FG005|Double-Blind Period|LOW EGFR|0|||
30981990|NCT02969525|59103779|FG006|Double-Blind Period|LOW EGFR|0|||
30981991|NCT02969525|59103780|FG007|Double-Blind Period|LOW EGFR|0|||
30981992|NCT02969525|59103781|FG008|Double-Blind Period|LOW EGFR|0|||
30981993|NCT02969525|59103782|FG009|Double-Blind Period|LOW EGFR|0|||
30981994|NCT02969525|59103783|FG010|Double-Blind Period|LOW EGFR|0|||
30981995|NCT02969525|59103784|FG011|Double-Blind Period|LOW EGFR|0|||
30981996|NCT02969525|59103773|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
30981997|NCT02969525|59103774|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
30981998|NCT02969525|59103775|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
30981999|NCT02969525|59103776|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
30982000|NCT02969525|59103777|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
30982001|NCT02969525|59103778|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
30982002|NCT02969525|59103779|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
30982003|NCT02969525|59103780|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
30982004|NCT02969525|59103781|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
30982005|NCT02969525|59103782|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
30982006|NCT02969525|59103783|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
30891451|NCT02222493|58924547|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
30891452|NCT02222493|58924548|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
30891453|NCT02222493|58924547|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
30891454|NCT02222493|58924548|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
30891455|NCT02222493|58924547|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
30891456|NCT02222493|58924548|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
30891457|NCT02222493|58924547|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
30891458|NCT02222493|58924548|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
30891459|NCT02222493|58924547|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
30891460|NCT02222493|58924548|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
30891461|NCT02433379|58924567|FG000|Overall Study|Screen Failures|55|||
30891462|NCT02433379|58924567|FG000|Overall Study|Death|57|||
30891463|NCT02433379|58924567|FG000|Overall Study|Total Withdrawals|209|||
30982007|NCT02969525|59103784|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
30982008|NCT02969525|59103773|FG000|Dose-Blind Period|Adverse Event|0|||
30982009|NCT02969525|59103774|FG001|Dose-Blind Period|Adverse Event|0|||
30982010|NCT02969525|59103775|FG002|Dose-Blind Period|Adverse Event|0|||
30982011|NCT02969525|59103776|FG003|Dose-Blind Period|Adverse Event|0|||
30982012|NCT02969525|59103777|FG004|Dose-Blind Period|Adverse Event|0|||
30982013|NCT02969525|59103778|FG005|Dose-Blind Period|Adverse Event|0|||
30982014|NCT02969525|59103779|FG006|Dose-Blind Period|Adverse Event|0|||
30982015|NCT02969525|59103780|FG007|Dose-Blind Period|Adverse Event|0|||
30982016|NCT02969525|59103781|FG008|Dose-Blind Period|Adverse Event|0|||
30982017|NCT02969525|59103782|FG009|Dose-Blind Period|Adverse Event|1|||
30982018|NCT02969525|59103783|FG010|Dose-Blind Period|Adverse Event|1|||
30982019|NCT02969525|59103784|FG011|Dose-Blind Period|Adverse Event|1|||
30982020|NCT02969525|59103773|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
30982021|NCT02969525|59103774|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
30982022|NCT02969525|59103775|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
30982023|NCT02969525|59103776|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
30982024|NCT02969525|59103777|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
30982025|NCT02969525|59103778|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
30982026|NCT02969525|59103779|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
30982027|NCT02969525|59103780|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
30982028|NCT02969525|59103781|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
30982029|NCT02969525|59103782|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
30982030|NCT02969525|59103783|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
30982031|NCT02969525|59103784|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
30982032|NCT02969525|59103773|FG000|Dose-Blind Period|Non-cooperating patient|0|||
30982033|NCT02969525|59103774|FG001|Dose-Blind Period|Non-cooperating patient|0|||
30982034|NCT02969525|59103775|FG002|Dose-Blind Period|Non-cooperating patient|0|||
30982035|NCT02969525|59103776|FG003|Dose-Blind Period|Non-cooperating patient|0|||
30982036|NCT02969525|59103777|FG004|Dose-Blind Period|Non-cooperating patient|0|||
30982037|NCT02969525|59103778|FG005|Dose-Blind Period|Non-cooperating patient|0|||
30982038|NCT02969525|59103779|FG006|Dose-Blind Period|Non-cooperating patient|0|||
30982039|NCT02969525|59103780|FG007|Dose-Blind Period|Non-cooperating patient|0|||
30982040|NCT02969525|59103781|FG008|Dose-Blind Period|Non-cooperating patient|0|||
30982041|NCT02969525|59103782|FG009|Dose-Blind Period|Non-cooperating patient|0|||
30982042|NCT02969525|59103783|FG010|Dose-Blind Period|Non-cooperating patient|0|||
30982043|NCT02969525|59103784|FG011|Dose-Blind Period|Non-cooperating patient|1|||
30982044|NCT02969525|59103773|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
30982045|NCT02969525|59103774|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
30982046|NCT02969525|59103775|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
30982047|NCT02969525|59103776|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
30982048|NCT02969525|59103777|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
30982049|NCT02969525|59103778|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
30982050|NCT02969525|59103779|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
30982051|NCT02969525|59103780|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
30982052|NCT02969525|59103781|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
30982053|NCT02969525|59103782|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
30982054|NCT02969525|59103783|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
30982055|NCT02969525|59103784|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
30982056|NCT04232215|59103815|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
30982057|NCT04232215|59103816|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
30982058|NCT02399813|59103831|FG000|Overall Study|Progressive Disease-Radiographic|2|||
30982059|NCT02399813|59103831|FG000|Overall Study|Death|20|||
30982060|NCT02399813|59103831|FG000|Overall Study|Withdrawal by Subject|3|||
30982061|NCT02399813|59103831|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
30982062|NCT02399813|59103831|FG000|Overall Study|Lost to Follow-up|2|||
30982063|NCT02399813|59103831|FG000|Overall Study|Other than specified|5|||
30982064|NCT02291055|59103840|FG000|Overall Study|Death|2|||
30982065|NCT02291055|59103841|FG001|Overall Study|Death|2|||
30982066|NCT02291055|59103842|FG002|Overall Study|Death|5|||
30982067|NCT02291055|59103843|FG003|Overall Study|Death|8|||
30982068|NCT02291055|59103844|FG004|Overall Study|Death|12|||
30982069|NCT02291055|59103840|FG000|Overall Study|Lost to Follow-up|0|||
30982070|NCT02291055|59103841|FG001|Overall Study|Lost to Follow-up|0|||
30982071|NCT02291055|59103842|FG002|Overall Study|Lost to Follow-up|0|||
30982072|NCT02291055|59103843|FG003|Overall Study|Lost to Follow-up|1|||
30982073|NCT02291055|59103844|FG004|Overall Study|Lost to Follow-up|2|||
30982074|NCT02291055|59103840|FG000|Overall Study|Withdrawal by Subject|3|||
30982075|NCT02291055|59103841|FG001|Overall Study|Withdrawal by Subject|1|||
30982076|NCT02291055|59103842|FG002|Overall Study|Withdrawal by Subject|1|||
30982077|NCT02291055|59103843|FG003|Overall Study|Withdrawal by Subject|5|||
30982078|NCT02291055|59103844|FG004|Overall Study|Withdrawal by Subject|10|||
30982079|NCT02291055|59103840|FG000|Overall Study|Progressive Disease|0|||
30982080|NCT02291055|59103841|FG001|Overall Study|Progressive Disease|0|||
30982081|NCT02291055|59103842|FG002|Overall Study|Progressive Disease|1|||
30982082|NCT02291055|59103843|FG003|Overall Study|Progressive Disease|4|||
30982083|NCT02291055|59103844|FG004|Overall Study|Progressive Disease|2|||
30982084|NCT02291055|59103840|FG000|Overall Study|Study Terminated by Sponsor|0|||
30982085|NCT02291055|59103841|FG001|Overall Study|Study Terminated by Sponsor|0|||
30982086|NCT02291055|59103842|FG002|Overall Study|Study Terminated by Sponsor|0|||
30982087|NCT02291055|59103843|FG003|Overall Study|Study Terminated by Sponsor|5|||
30982088|NCT02291055|59103844|FG004|Overall Study|Study Terminated by Sponsor|1|||
30982089|NCT02291055|59103840|FG000|Overall Study|Other|0|||
30982090|NCT02291055|59103841|FG001|Overall Study|Other|2|||
30982091|NCT02291055|59103842|FG002|Overall Study|Other|1|||
30982092|NCT02291055|59103843|FG003|Overall Study|Other|4|||
30982093|NCT02291055|59103844|FG004|Overall Study|Other|0|||
30982094|NCT00723697|59103860|FG000|Overall Study|Physician questionnaires not received|2|||
30982095|NCT00723697|59103860|FG000|Overall Study|Missing Informed Consent Form|10|||
30982096|NCT00723697|59103860|FG000|Overall Study|Other exclusion criteria applied|6|||
30982097|NCT00684073|59103867|FG000|Selection|Selection/non-selection criteria|3|||
30982098|NCT00684073|59103867|FG000|Selection|Death|1|||
30982099|NCT00684073|59103867|FG000|Selection|noncompliance|1|||
30982100|NCT00684073|59103867|FG000|Selection|Lost to Follow-up|1|||
30982101|NCT00684073|59103867|FG000|Selection|request of the sponsor|1|||
30982102|NCT00684073|59103867|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
30982103|NCT02539368|59105812|FG000|Overall Study|Death|4|||
30982104|NCT02539368|59105813|FG001|Overall Study|Death|2|||
30982105|NCT02539368|59105814|FG002|Overall Study|Death|1|||
30982106|NCT02539368|59105815|FG003|Overall Study|Death|0|||
30982107|NCT02539368|59105816|FG004|Overall Study|Death|0|||
30982108|NCT02539368|59105812|FG000|Overall Study|Withdrawal by Subject|44|||
30982109|NCT02539368|59105813|FG001|Overall Study|Withdrawal by Subject|35|||
30982110|NCT02539368|59105814|FG002|Overall Study|Withdrawal by Subject|9|||
30982111|NCT02539368|59105815|FG003|Overall Study|Withdrawal by Subject|1|||
30982112|NCT02539368|59105816|FG004|Overall Study|Withdrawal by Subject|3|||
30982113|NCT02539368|59105812|FG000|Overall Study|Physician Decision|49|||
30982114|NCT02539368|59105813|FG001|Overall Study|Physician Decision|15|||
30982115|NCT02539368|59105814|FG002|Overall Study|Physician Decision|7|||
30982116|NCT02539368|59105815|FG003|Overall Study|Physician Decision|0|||
30982117|NCT02539368|59105816|FG004|Overall Study|Physician Decision|2|||
30982118|NCT02539368|59105812|FG000|Overall Study|Lost to Follow-up|96|||
30982119|NCT02539368|59105813|FG001|Overall Study|Lost to Follow-up|21|||
30982120|NCT02539368|59105814|FG002|Overall Study|Lost to Follow-up|16|||
30982121|NCT02539368|59105815|FG003|Overall Study|Lost to Follow-up|4|||
30982122|NCT02539368|59105816|FG004|Overall Study|Lost to Follow-up|3|||
30982123|NCT02539368|59105812|FG000|Overall Study|Adverse Event|44|||
30982124|NCT02539368|59105813|FG001|Overall Study|Adverse Event|5|||
30982125|NCT02539368|59105814|FG002|Overall Study|Adverse Event|9|||
30982126|NCT02539368|59105815|FG003|Overall Study|Adverse Event|0|||
30982127|NCT02539368|59105816|FG004|Overall Study|Adverse Event|3|||
30982128|NCT02539368|59105812|FG000|Overall Study|Participant Non-compliant|13|||
30982129|NCT02539368|59105813|FG001|Overall Study|Participant Non-compliant|2|||
30982130|NCT02539368|59105814|FG002|Overall Study|Participant Non-compliant|1|||
30982131|NCT02539368|59105815|FG003|Overall Study|Participant Non-compliant|1|||
30982132|NCT02539368|59105816|FG004|Overall Study|Participant Non-compliant|0|||
30982133|NCT02539368|59105812|FG000|Overall Study|Other|145|||
30982134|NCT02539368|59105813|FG001|Overall Study|Other|18|||
30982135|NCT02539368|59105814|FG002|Overall Study|Other|24|||
30982136|NCT02539368|59105815|FG003|Overall Study|Other|1|||
30982137|NCT02539368|59105816|FG004|Overall Study|Other|3|||
30982138|NCT02539368|59105812|FG000|Overall Study|Missing|10|||
30982139|NCT02539368|59105813|FG001|Overall Study|Missing|3|||
30982140|NCT02539368|59105814|FG002|Overall Study|Missing|0|||
30982141|NCT02539368|59105815|FG003|Overall Study|Missing|0|||
30982142|NCT02539368|59105816|FG004|Overall Study|Missing|0|||
30982143|NCT02539134|59105969|FG000|Overall Study|Lost to Follow-up|1|||
30982144|NCT02539134|59105970|FG001|Overall Study|Lost to Follow-up|0|||
30982145|NCT02539134|59105971|FG002|Overall Study|Lost to Follow-up|0|||
30982146|NCT02539134|59105972|FG003|Overall Study|Lost to Follow-up|0|||
30982147|NCT02539134|59105973|FG004|Overall Study|Lost to Follow-up|0|||
30982148|NCT02539134|59105974|FG005|Overall Study|Lost to Follow-up|0|||
30982149|NCT02538900|59106078|FG000|Overall Study|Death|2|||
30982150|NCT02538900|59106079|FG001|Overall Study|Death|2|||
30982151|NCT02538900|59106080|FG002|Overall Study|Death|2|||
30982152|NCT02538900|59106078|FG000|Overall Study|Withdrawal by Subject|18|||
30982153|NCT02538900|59106079|FG001|Overall Study|Withdrawal by Subject|16|||
30982154|NCT02538900|59106080|FG002|Overall Study|Withdrawal by Subject|15|||
30982155|NCT01986348|59106560|FG000|Overall Study|Death|8|||
30982156|NCT01986348|59106561|FG001|Overall Study|Death|22|||
30982157|NCT01986348|59106562|FG002|Overall Study|Death|10|||
30982158|NCT01986348|59106563|FG003|Overall Study|Death|21|||
30982159|NCT01986348|59106560|FG000|Overall Study|Lost to Follow-up|0|||
30982160|NCT01986348|59106561|FG001|Overall Study|Lost to Follow-up|0|||
30982161|NCT01986348|59106562|FG002|Overall Study|Lost to Follow-up|0|||
30982162|NCT01986348|59106563|FG003|Overall Study|Lost to Follow-up|2|||
30982163|NCT01986348|59106560|FG000|Overall Study|Physician Decision|0|||
30982164|NCT01986348|59106561|FG001|Overall Study|Physician Decision|0|||
30982165|NCT01986348|59106562|FG002|Overall Study|Physician Decision|0|||
30982166|NCT01986348|59106563|FG003|Overall Study|Physician Decision|1|||
30982167|NCT01986348|59106560|FG000|Overall Study|Progressive Disease|0|||
30982168|NCT01986348|59106561|FG001|Overall Study|Progressive Disease|0|||
30982169|NCT01986348|59106562|FG002|Overall Study|Progressive Disease|2|||
30982170|NCT01986348|59106563|FG003|Overall Study|Progressive Disease|0|||
30982171|NCT01986348|59106560|FG000|Overall Study|Withdrawal by Participant|0|||
30982172|NCT01986348|59106561|FG001|Overall Study|Withdrawal by Participant|1|||
30982173|NCT01986348|59106562|FG002|Overall Study|Withdrawal by Participant|2|||
30982174|NCT01986348|59106563|FG003|Overall Study|Withdrawal by Participant|1|||
30982175|NCT01986348|59106560|FG000|Overall Study|Study Terminated by Sponsor|0|||
30982176|NCT01986348|59106561|FG001|Overall Study|Study Terminated by Sponsor|0|||
30982177|NCT01986348|59106562|FG002|Overall Study|Study Terminated by Sponsor|0|||
30982178|NCT01986348|59106563|FG003|Overall Study|Study Terminated by Sponsor|3|||
30982179|NCT01986348|59106560|FG000|Overall Study|Other-unspecified|0|||
30982180|NCT01986348|59106561|FG001|Overall Study|Other-unspecified|1|||
30982181|NCT01986348|59106562|FG002|Overall Study|Other-unspecified|0|||
30982182|NCT01986348|59106563|FG003|Overall Study|Other-unspecified|2|||
30982183|NCT02543892|59107141|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
30982184|NCT02543892|59107142|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
30982185|NCT02543892|59107143|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
30982186|NCT02543892|59107144|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
30982187|NCT02543892|59107145|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
30982188|NCT02543892|59107146|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
30982189|NCT02543892|59107147|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
30982190|NCT02543892|59107148|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
30982191|NCT02543892|59107141|FG000|Received Vaccination 2|Physician Decision|0|||
30982192|NCT02543892|59107142|FG001|Received Vaccination 2|Physician Decision|0|||
30982193|NCT02543892|59107143|FG002|Received Vaccination 2|Physician Decision|0|||
30982194|NCT02543892|59107144|FG003|Received Vaccination 2|Physician Decision|0|||
30982195|NCT02543892|59107145|FG004|Received Vaccination 2|Physician Decision|0|||
30982196|NCT02543892|59107146|FG005|Received Vaccination 2|Physician Decision|1|||
30982197|NCT02543892|59107147|FG006|Received Vaccination 2|Physician Decision|0|||
30982198|NCT02543892|59107148|FG007|Received Vaccination 2|Physician Decision|0|||
30982199|NCT02543892|59107141|FG000|Received Vaccination 2|Adverse Event|0|||
30982200|NCT02543892|59107142|FG001|Received Vaccination 2|Adverse Event|1|||
30982201|NCT02543892|59107143|FG002|Received Vaccination 2|Adverse Event|0|||
30982202|NCT02543892|59107144|FG003|Received Vaccination 2|Adverse Event|0|||
30982203|NCT02543892|59107145|FG004|Received Vaccination 2|Adverse Event|0|||
30982204|NCT02543892|59107146|FG005|Received Vaccination 2|Adverse Event|0|||
30982205|NCT02543892|59107147|FG006|Received Vaccination 2|Adverse Event|0|||
30982206|NCT02543892|59107148|FG007|Received Vaccination 2|Adverse Event|0|||
30982207|NCT02543892|59107141|FG000|Had Immunology Data|Withdrawal by Subject|0|||
30982208|NCT02543892|59107142|FG001|Had Immunology Data|Withdrawal by Subject|0|||
30982209|NCT02543892|59107143|FG002|Had Immunology Data|Withdrawal by Subject|0|||
30982210|NCT02543892|59107144|FG003|Had Immunology Data|Withdrawal by Subject|0|||
30982211|NCT02543892|59107145|FG004|Had Immunology Data|Withdrawal by Subject|0|||
30982212|NCT02543892|59107146|FG005|Had Immunology Data|Withdrawal by Subject|0|||
30982213|NCT02543892|59107147|FG006|Had Immunology Data|Withdrawal by Subject|1|||
30982214|NCT02543892|59107148|FG007|Had Immunology Data|Withdrawal by Subject|0|||
30982215|NCT02543658|59107229|FG000|Overall Study|Lack of Efficacy|0|||
30982216|NCT02543658|59107230|FG001|Overall Study|Lack of Efficacy|4|||
30982217|NCT01607892|59107985|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
30982218|NCT01607892|59107986|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
30982219|NCT01607892|59107987|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
30982220|NCT01607892|59107988|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
30982221|NCT01607892|59107989|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
30982222|NCT01607892|59107985|FG000|Overall Study|Death|4|||
30982223|NCT01607892|59107986|FG001|Overall Study|Death|2|||
30982224|NCT01607892|59107987|FG002|Overall Study|Death|8|||
30982225|NCT01607892|59107988|FG003|Overall Study|Death|10|||
30982226|NCT01607892|59107989|FG004|Overall Study|Death|3|||
30982227|NCT01607892|59107985|FG000|Overall Study|Investigator discretion|2|||
30982228|NCT01607892|59107986|FG001|Overall Study|Investigator discretion|4|||
30982229|NCT01607892|59107987|FG002|Overall Study|Investigator discretion|4|||
30982230|NCT01607892|59107988|FG003|Overall Study|Investigator discretion|8|||
30982231|NCT01607892|59107989|FG004|Overall Study|Investigator discretion|0|||
30982232|NCT01607892|59107985|FG000|Overall Study|Other treatments became available|1|||
30982233|NCT01607892|59107986|FG001|Overall Study|Other treatments became available|1|||
30982234|NCT01607892|59107987|FG002|Overall Study|Other treatments became available|0|||
30982235|NCT01607892|59107988|FG003|Overall Study|Other treatments became available|0|||
30982236|NCT01607892|59107989|FG004|Overall Study|Other treatments became available|2|||
30982237|NCT01607892|59107985|FG000|Overall Study|Intercurrent illness|1|||
30982238|NCT01607892|59107986|FG001|Overall Study|Intercurrent illness|0|||
30982239|NCT01607892|59107987|FG002|Overall Study|Intercurrent illness|0|||
30982240|NCT01607892|59107988|FG003|Overall Study|Intercurrent illness|3|||
30982241|NCT01607892|59107989|FG004|Overall Study|Intercurrent illness|0|||
30982242|NCT01607892|59107985|FG000|Overall Study|Non-Compliance with study procedures|0|||
30982243|NCT01607892|59107986|FG001|Overall Study|Non-Compliance with study procedures|0|||
30982244|NCT01607892|59107987|FG002|Overall Study|Non-Compliance with study procedures|1|||
30982245|NCT01607892|59107988|FG003|Overall Study|Non-Compliance with study procedures|0|||
30982246|NCT01607892|59107989|FG004|Overall Study|Non-Compliance with study procedures|0|||
30982247|NCT01607892|59107985|FG000|Overall Study|Consent withdrawn by participant|9|||
30982248|NCT01607892|59107986|FG001|Overall Study|Consent withdrawn by participant|4|||
30982249|NCT01607892|59107987|FG002|Overall Study|Consent withdrawn by participant|24|||
30982250|NCT01607892|59107988|FG003|Overall Study|Consent withdrawn by participant|14|||
30982251|NCT01607892|59107989|FG004|Overall Study|Consent withdrawn by participant|4|||
30982252|NCT01607892|59107985|FG000|Overall Study|Disease progression|38|||
30982253|NCT01607892|59107986|FG001|Overall Study|Disease progression|13|||
30982254|NCT01607892|59107987|FG002|Overall Study|Disease progression|37|||
30982255|NCT01607892|59107988|FG003|Overall Study|Disease progression|57|||
30982256|NCT01607892|59107989|FG004|Overall Study|Disease progression|9|||
30982257|NCT01607892|59107985|FG000|Overall Study|Incidence or severity of Adverse events|3|||
30982258|NCT01607892|59107986|FG001|Overall Study|Incidence or severity of Adverse events|3|||
30982259|NCT01607892|59107987|FG002|Overall Study|Incidence or severity of Adverse events|7|||
30982260|NCT01607892|59107988|FG003|Overall Study|Incidence or severity of Adverse events|2|||
30982261|NCT01607892|59107989|FG004|Overall Study|Incidence or severity of Adverse events|6|||
30982262|NCT02530242|59108035|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
30982263|NCT02530242|59108036|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
30982264|NCT02537574|59108060|FG000|Overall Study|Adverse Event|1|||
30982265|NCT02537574|59108061|FG001|Overall Study|Adverse Event|3|||
30982266|NCT02537574|59108062|FG002|Overall Study|Adverse Event|2|||
30982267|NCT02537574|59108060|FG000|Overall Study|Lost to Follow-up|40|||
30982268|NCT02537574|59108061|FG001|Overall Study|Lost to Follow-up|51|||
30982269|NCT02537574|59108062|FG002|Overall Study|Lost to Follow-up|55|||
30982270|NCT02537574|59108060|FG000|Overall Study|Noncompliance with study drug|0|||
30982271|NCT02537574|59108061|FG001|Overall Study|Noncompliance with study drug|1|||
30982272|NCT02537574|59108062|FG002|Overall Study|Noncompliance with study drug|1|||
30982273|NCT02537574|59108060|FG000|Overall Study|Physician Decision|2|||
30982274|NCT02537574|59108061|FG001|Overall Study|Physician Decision|0|||
30982275|NCT02537574|59108062|FG002|Overall Study|Physician Decision|0|||
30982276|NCT02537574|59108060|FG000|Overall Study|Protocol Violation|4|||
30982277|NCT02537574|59108061|FG001|Overall Study|Protocol Violation|2|||
30982278|NCT02537574|59108062|FG002|Overall Study|Protocol Violation|3|||
30982279|NCT02537574|59108060|FG000|Overall Study|Withdrawal by Subject|37|||
30982280|NCT02537574|59108061|FG001|Overall Study|Withdrawal by Subject|27|||
30982281|NCT02537574|59108062|FG002|Overall Study|Withdrawal by Subject|29|||
30982282|NCT02537574|59108060|FG000|Overall Study|Lack of Efficacy|14|||
30982283|NCT02537574|59108061|FG001|Overall Study|Lack of Efficacy|16|||
30982284|NCT02537574|59108062|FG002|Overall Study|Lack of Efficacy|15|||
30982285|NCT02537574|59108060|FG000|Overall Study|Duplicate Patient|1|||
30982286|NCT02537574|59108061|FG001|Overall Study|Duplicate Patient|0|||
30982287|NCT02537574|59108062|FG002|Overall Study|Duplicate Patient|0|||
30982288|NCT02537574|59108060|FG000|Overall Study|Patient not Stable|0|||
30982289|NCT02537574|59108061|FG001|Overall Study|Patient not Stable|1|||
30982290|NCT02537574|59108062|FG002|Overall Study|Patient not Stable|0|||
30982291|NCT02537574|59108060|FG000|Overall Study|Incarceration|0|||
30982292|NCT02537574|59108061|FG001|Overall Study|Incarceration|1|||
30982293|NCT02537574|59108062|FG002|Overall Study|Incarceration|0|||
30982294|NCT02537574|59108060|FG000|Overall Study|Failed Naloxone Challenge|0|||
30982295|NCT02537574|59108061|FG001|Overall Study|Failed Naloxone Challenge|1|||
30982296|NCT02537574|59108062|FG002|Overall Study|Failed Naloxone Challenge|0|||
30982297|NCT02537574|59108060|FG000|Overall Study|Transportation Issues|0|||
30982298|NCT02537574|59108061|FG001|Overall Study|Transportation Issues|0|||
30982299|NCT02537574|59108062|FG002|Overall Study|Transportation Issues|1|||
30982300|NCT02537574|59108060|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
30982301|NCT02537574|59108061|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
30982302|NCT02537574|59108062|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
30982303|NCT02537574|59108060|FG000|Overall Study|Noncompliance with Protocol|0|||
30982304|NCT02537574|59108061|FG001|Overall Study|Noncompliance with Protocol|0|||
30982305|NCT02537574|59108062|FG002|Overall Study|Noncompliance with Protocol|1|||
30982306|NCT02531802|59108727|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
30982307|NCT02531802|59108728|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
30982308|NCT02531802|59108729|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
30982309|NCT02531802|59108730|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
30982310|NCT02531802|59108731|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
30982311|NCT02531802|59108732|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
30982312|NCT02531802|59108733|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
30982313|NCT02531802|59108734|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
30982314|NCT02531802|59108735|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
30982315|NCT02531802|59108736|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
30982316|NCT02531802|59108737|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
30982317|NCT02531802|59108738|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
30982318|NCT02531802|59108739|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
30982319|NCT02531802|59108740|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
30982320|NCT02531802|59108741|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
30982321|NCT02531802|59108742|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
30982322|NCT02531802|59108743|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
30982323|NCT02531802|59108744|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
30982324|NCT02531802|59108745|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
30982325|NCT02531802|59108746|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
30982326|NCT02531802|59108747|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
30982327|NCT02531802|59108727|FG000|Received Vaccination 2|Physician Decision|0|||
30982328|NCT02531802|59108728|FG001|Received Vaccination 2|Physician Decision|0|||
30982329|NCT02531802|59108729|FG002|Received Vaccination 2|Physician Decision|0|||
30982330|NCT02531802|59108730|FG003|Received Vaccination 2|Physician Decision|0|||
30982331|NCT02531802|59108731|FG004|Received Vaccination 2|Physician Decision|0|||
30982332|NCT02531802|59108732|FG005|Received Vaccination 2|Physician Decision|1|||
30982333|NCT02531802|59108733|FG006|Received Vaccination 2|Physician Decision|0|||
30982334|NCT02531802|59108734|FG007|Received Vaccination 2|Physician Decision|0|||
30982335|NCT02531802|59108735|FG008|Received Vaccination 2|Physician Decision|0|||
30982336|NCT02531802|59108736|FG009|Received Vaccination 2|Physician Decision|2|||
30982337|NCT02531802|59108737|FG010|Received Vaccination 2|Physician Decision|0|||
30982338|NCT02531802|59108738|FG011|Received Vaccination 2|Physician Decision|0|||
30982339|NCT02531802|59108739|FG012|Received Vaccination 2|Physician Decision|0|||
30982340|NCT02531802|59108740|FG013|Received Vaccination 2|Physician Decision|1|||
30982341|NCT02531802|59108741|FG014|Received Vaccination 2|Physician Decision|0|||
30982342|NCT02531802|59108742|FG015|Received Vaccination 2|Physician Decision|0|||
30982343|NCT02531802|59108743|FG016|Received Vaccination 2|Physician Decision|0|||
30982344|NCT02531802|59108744|FG017|Received Vaccination 2|Physician Decision|1|||
30982345|NCT02531802|59108745|FG018|Received Vaccination 2|Physician Decision|0|||
30982346|NCT02531802|59108746|FG019|Received Vaccination 2|Physician Decision|0|||
30982347|NCT02531802|59108747|FG020|Received Vaccination 2|Physician Decision|0|||
30982348|NCT02531802|59108727|FG000|Received Vaccination 2|Adverse Event|0|||
30982349|NCT02531802|59108728|FG001|Received Vaccination 2|Adverse Event|0|||
30982350|NCT02531802|59108729|FG002|Received Vaccination 2|Adverse Event|0|||
30982351|NCT02531802|59108730|FG003|Received Vaccination 2|Adverse Event|0|||
30982352|NCT02531802|59108731|FG004|Received Vaccination 2|Adverse Event|0|||
30982353|NCT02531802|59108732|FG005|Received Vaccination 2|Adverse Event|2|||
30982354|NCT02531802|59108733|FG006|Received Vaccination 2|Adverse Event|0|||
30982355|NCT02531802|59108734|FG007|Received Vaccination 2|Adverse Event|0|||
30891464|NCT02199795|58924575|FG000|Overall Study|no longer met inclusion criteria|1|||
30891465|NCT02199795|58924576|FG001|Overall Study|no longer met inclusion criteria|0|||
30891466|NCT02199795|58924575|FG000|Overall Study|withdrew due to shoulder pain|1|||
30891467|NCT02199795|58924576|FG001|Overall Study|withdrew due to shoulder pain|0|||
30891468|NCT02403817|58924584|FG000|Overall Study|Withdrawal by Subject|5|||
30891469|NCT02403817|58924585|FG001|Overall Study|Withdrawal by Subject|0|||
30891470|NCT02403271|58924591|FG000|Period 1|Other varied reasons|1|||
30891471|NCT02403271|58924592|FG001|Period 1|Other varied reasons|0|||
30891472|NCT02403271|58924591|FG000|Period 2|Withdrawal by Subject|0|||
30891473|NCT02403271|58924592|FG001|Period 2|Withdrawal by Subject|14|||
30891474|NCT02403271|58924591|FG000|Period 2|Death|0|||
30891475|NCT02403271|58924592|FG001|Period 2|Death|84|||
30891476|NCT02403271|58924591|FG000|Period 2|Lost to Follow-up|0|||
30891477|NCT02403271|58924592|FG001|Period 2|Lost to Follow-up|2|||
30891478|NCT02403271|58924591|FG000|Period 2|Study Terminated by Sponsor|0|||
30891479|NCT02403271|58924592|FG001|Period 2|Study Terminated by Sponsor|14|||
30891480|NCT02403271|58924591|FG000|Period 2|Other varied reasons|0|||
30891481|NCT02403271|58924592|FG001|Period 2|Other varied reasons|10|||
30891482|NCT02219685|58924600|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
30891483|NCT02219685|58924601|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
30891484|NCT02219685|58924600|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
30891485|NCT02219685|58924601|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
30891486|NCT02457247|58924613|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
30891487|NCT02457247|58924614|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
30891488|NCT02457247|58924615|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
30891489|NCT02457247|58924616|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
30891490|NCT02457247|58924613|FG000|Period 1|Significant Protocol Deviation|1|||
30891491|NCT02457247|58924614|FG001|Period 1|Significant Protocol Deviation|1|||
30891492|NCT02457247|58924615|FG002|Period 1|Significant Protocol Deviation|0|||
30891493|NCT02457247|58924616|FG003|Period 1|Significant Protocol Deviation|0|||
30982356|NCT02531802|59108735|FG008|Received Vaccination 2|Adverse Event|0|||
30982357|NCT02531802|59108736|FG009|Received Vaccination 2|Adverse Event|0|||
30982358|NCT02531802|59108737|FG010|Received Vaccination 2|Adverse Event|0|||
30982359|NCT02531802|59108738|FG011|Received Vaccination 2|Adverse Event|0|||
30982360|NCT02531802|59108739|FG012|Received Vaccination 2|Adverse Event|0|||
30982361|NCT02531802|59108740|FG013|Received Vaccination 2|Adverse Event|0|||
30982362|NCT02531802|59108741|FG014|Received Vaccination 2|Adverse Event|0|||
30982363|NCT02531802|59108742|FG015|Received Vaccination 2|Adverse Event|0|||
30982364|NCT02531802|59108743|FG016|Received Vaccination 2|Adverse Event|0|||
30982365|NCT02531802|59108744|FG017|Received Vaccination 2|Adverse Event|2|||
30982366|NCT02531802|59108745|FG018|Received Vaccination 2|Adverse Event|1|||
30982367|NCT02531802|59108746|FG019|Received Vaccination 2|Adverse Event|0|||
30982368|NCT02531802|59108747|FG020|Received Vaccination 2|Adverse Event|1|||
30982369|NCT02531802|59108727|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
30982370|NCT02531802|59108728|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
30982371|NCT02531802|59108729|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
30982372|NCT02531802|59108730|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
30982373|NCT02531802|59108731|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
30982374|NCT02531802|59108732|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
30982375|NCT02531802|59108733|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
30982376|NCT02531802|59108734|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
30982377|NCT02531802|59108735|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
30982378|NCT02531802|59108736|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
30982379|NCT02531802|59108737|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
30982380|NCT02531802|59108738|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
30982381|NCT02531802|59108739|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
30982382|NCT02531802|59108740|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
30982383|NCT02531802|59108741|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
30982384|NCT02531802|59108742|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
30982385|NCT02531802|59108743|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
30982386|NCT02531802|59108744|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
30982387|NCT02531802|59108745|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
30982388|NCT02531802|59108746|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
30982389|NCT02531802|59108747|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
30982390|NCT01602666|59108850|FG000|Induction Chemotherapy|Death|2|||
30982391|NCT01602666|59108851|FG001|Induction Chemotherapy|Death|1|||
30982392|NCT01602666|59108850|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
30982393|NCT01602666|59108851|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
30982394|NCT01602666|59108850|FG000|Induction Chemotherapy|Physician Decision|12|||
30982395|NCT01602666|59108851|FG001|Induction Chemotherapy|Physician Decision|5|||
30982396|NCT01602666|59108850|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
30982397|NCT01602666|59108851|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
30982398|NCT01602666|59108850|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
30982399|NCT01602666|59108851|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
30982400|NCT01602666|59108850|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
30982401|NCT01602666|59108851|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
30982402|NCT01602666|59108850|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
30982403|NCT01602666|59108851|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
30982404|NCT01602666|59108850|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
30982405|NCT01602666|59108851|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
30982406|NCT01602666|59108850|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
30982407|NCT01602666|59108851|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
30982408|NCT01602666|59108850|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
30982409|NCT01602666|59108851|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
30982410|NCT01602666|59108850|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
30982411|NCT01602666|59108851|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
30982412|NCT02531646|59108862|FG000|Overall Study|equip. image processing issue|5|||
30982413|NCT02531646|59108863|FG001|Overall Study|equip. image processing issue|1|||
30982414|NCT02531646|59108864|FG002|Overall Study|equip. image processing issue|0|||
30982415|NCT02536404|59108929|FG000|Overall Study|Adverse Event|5|||
30982416|NCT02536404|59108930|FG001|Overall Study|Adverse Event|0|||
30982417|NCT02536404|59108929|FG000|Overall Study|Withdrawal by Subject|4|||
30982418|NCT02536404|59108930|FG001|Overall Study|Withdrawal by Subject|1|||
30982419|NCT02536404|59108929|FG000|Overall Study|Physician Decision|10|||
30982420|NCT02536404|59108930|FG001|Overall Study|Physician Decision|0|||
30982421|NCT02536404|59108929|FG000|Overall Study|Sponsor decision|1|||
30982422|NCT02536404|59108930|FG001|Overall Study|Sponsor decision|0|||
30982423|NCT01659996|59109890|FG000|Overall Study|Protocol Violation|3|||
30982424|NCT01659996|59109891|FG001|Overall Study|Protocol Violation|3|||
30982425|NCT01659996|59109892|FG002|Overall Study|Protocol Violation|3|||
30982426|NCT01659996|59109890|FG000|Overall Study|Lost to Follow-up|1|||
30982427|NCT01659996|59109891|FG001|Overall Study|Lost to Follow-up|3|||
30982428|NCT01659996|59109892|FG002|Overall Study|Lost to Follow-up|2|||
30982429|NCT01659996|59109890|FG000|Overall Study|Adverse Event|0|||
30982430|NCT01659996|59109891|FG001|Overall Study|Adverse Event|0|||
30982431|NCT01659996|59109892|FG002|Overall Study|Adverse Event|1|||
30982432|NCT01659996|59109890|FG000|Overall Study|Withdrawal by Subject|4|||
30982433|NCT01659996|59109891|FG001|Overall Study|Withdrawal by Subject|1|||
30982434|NCT01659996|59109892|FG002|Overall Study|Withdrawal by Subject|5|||
30982435|NCT02525874|59110256|FG000|Overall Study|Other|1|||
30982436|NCT02525874|59110256|FG000|Overall Study|Investigator Decision|1|||
30982437|NCT02525874|59110256|FG000|Overall Study|Consent withdrawn|22|||
30982438|NCT02525874|59110256|FG000|Overall Study|Non-compliance with study drug|3|||
30982439|NCT02525874|59110256|FG000|Overall Study|Adverse Event|17|||
30982440|NCT02525874|59110256|FG000|Overall Study|Lost to Follow-up|7|||
30982441|NCT02525874|59110256|FG000|Overall Study|Disease progression, defined by protocol|2|||
30982442|NCT02525874|59110256|FG000|Overall Study|Disease relapse|4|||
30982443|NCT02525874|59110256|FG000|Overall Study|Alternative Treatment for MS|2|||
30982444|NCT02525874|59110256|FG000|Overall Study|New lesions in Brain|1|||
30982445|NCT02528214|59110266|FG000|Overall Study|Protocol Violation|0|||
30982446|NCT02528214|59110267|FG001|Overall Study|Protocol Violation|1|||
30982447|NCT02528214|59110266|FG000|Overall Study|Adverse Event|0|||
30982448|NCT02528214|59110267|FG001|Overall Study|Adverse Event|1|||
30982449|NCT02528214|59110266|FG000|Overall Study|Other than specified above|0|||
30982450|NCT02528214|59110267|FG001|Overall Study|Other than specified above|1|||
30982451|NCT05348681|59110311|FG000|Overall Study|Study terminated by Sponsor|8|||
30982452|NCT05348681|59110312|FG001|Overall Study|Study terminated by Sponsor|3|||
30982453|NCT05348681|59110311|FG000|Overall Study|Withdrawal by Subject|1|||
30982454|NCT05348681|59110312|FG001|Overall Study|Withdrawal by Subject|1|||
30982455|NCT05348681|59110311|FG000|Overall Study|Lost to Follow-up|1|||
30982456|NCT05348681|59110312|FG001|Overall Study|Lost to Follow-up|1|||
30982457|NCT05348681|59110311|FG000|Overall Study|Adverse Event|1|||
30982458|NCT05348681|59110312|FG001|Overall Study|Adverse Event|0|||
30982459|NCT05348681|59110311|FG000|Overall Study|Other|2|||
30982460|NCT05348681|59110312|FG001|Overall Study|Other|1|||
30982461|NCT04423757|59110338|FG000|Overall Study|Adverse Event|2|||
30982462|NCT04423757|59110339|FG001|Overall Study|Adverse Event|0|||
30982463|NCT04423757|59110338|FG000|Overall Study|Not treated|1|||
30982464|NCT04423757|59110339|FG001|Overall Study|Not treated|1|||
30982465|NCT04379713|59110347|FG000|Overall Study|Adverse Event|2|||
30982466|NCT04379713|59110348|FG001|Overall Study|Adverse Event|0|||
30982467|NCT04379713|59110347|FG000|Overall Study|Physician Decision|2|||
30982468|NCT04379713|59110348|FG001|Overall Study|Physician Decision|1|||
30982469|NCT04379713|59110347|FG000|Overall Study|Protocol Violation|11|||
30891494|NCT02457247|58924613|FG000|Period 1|Voluntary Withdrawal|1|||
30891495|NCT02457247|58924614|FG001|Period 1|Voluntary Withdrawal|0|||
30891496|NCT02457247|58924615|FG002|Period 1|Voluntary Withdrawal|0|||
30891497|NCT02457247|58924616|FG003|Period 1|Voluntary Withdrawal|0|||
30891498|NCT02457247|58924613|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
30891499|NCT02457247|58924614|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
30891500|NCT02457247|58924615|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
30891501|NCT02457247|58924616|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
30891502|NCT02457247|58924613|FG000|Period 2|Significant Protocol Deviation|1|||
30891503|NCT02457247|58924614|FG001|Period 2|Significant Protocol Deviation|0|||
30891504|NCT02457247|58924615|FG002|Period 2|Significant Protocol Deviation|0|||
30891505|NCT02457247|58924616|FG003|Period 2|Significant Protocol Deviation|0|||
30891506|NCT02457247|58924613|FG000|Period 2|Lost to Follow-up|0|||
30891507|NCT02457247|58924614|FG001|Period 2|Lost to Follow-up|1|||
30891508|NCT02457247|58924615|FG002|Period 2|Lost to Follow-up|0|||
30891509|NCT02457247|58924616|FG003|Period 2|Lost to Follow-up|0|||
30891510|NCT02457247|58924613|FG000|Period 2|Voluntary Withdrawal|1|||
30891511|NCT02457247|58924614|FG001|Period 2|Voluntary Withdrawal|1|||
30891512|NCT02457247|58924615|FG002|Period 2|Voluntary Withdrawal|0|||
30891513|NCT02457247|58924616|FG003|Period 2|Voluntary Withdrawal|0|||
30891514|NCT02401867|58924632|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
30891515|NCT02401867|58924632|FG000|Analysis|Cervical assay could not be conducted|9|||
30891516|NCT02198235|58924640|FG000|Overall Study|Lost to Follow-up|3|||
30891517|NCT02198235|58924641|FG001|Overall Study|Lost to Follow-up|2|||
30891518|NCT02198235|58924642|FG002|Overall Study|Lost to Follow-up|2|||
30891519|NCT02253147|58924650|FG000|Overall Study|Protocol Violation|30|||
30891520|NCT02253147|58924650|FG000|Overall Study|Did not consent to study extension|9|||
30891521|NCT02253147|58924650|FG000|Overall Study|Conditional re-treatment at W52|5|||
30891522|NCT02253147|58924650|FG000|Overall Study|Lost to Follow-up|2|||
30891523|NCT02253147|58924650|FG000|Overall Study|Withdrawal by Subject|1|||
30891524|NCT02217501|58924658|FG000|Overall Study|Death|3|||
30891525|NCT02217501|58924659|FG001|Overall Study|Death|4|||
30891526|NCT01649869|58924667|FG000|Overall Study|Family member illness|1|||
30891527|NCT01649869|58924668|FG001|Overall Study|Family member illness|0|||
30891528|NCT01649869|58924667|FG000|Overall Study|Required treatment outside protocol|1|||
30891529|NCT01649869|58924668|FG001|Overall Study|Required treatment outside protocol|0|||
30891530|NCT01649869|58924667|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
30982470|NCT04379713|59110348|FG001|Overall Study|Protocol Violation|6|||
30982471|NCT04379713|59110347|FG000|Overall Study|No longer met eligibility criteria|14|||
30982472|NCT04379713|59110348|FG001|Overall Study|No longer met eligibility criteria|11|||
30982473|NCT04379713|59110347|FG000|Overall Study|Withdrawal by parent/guardian|36|||
30982474|NCT04379713|59110348|FG001|Overall Study|Withdrawal by parent/guardian|15|||
30982475|NCT04379713|59110347|FG000|Overall Study|Lost to Follow-up|31|||
30982476|NCT04379713|59110348|FG001|Overall Study|Lost to Follow-up|21|||
30982477|NCT04085328|59110356|FG000|Overall Study|Witihdrew Consent|16|||
30982478|NCT04085328|59110357|FG001|Overall Study|Witihdrew Consent|16|||
30982479|NCT04085328|59110356|FG000|Overall Study|Adverse Event|8|||
30982480|NCT04085328|59110357|FG001|Overall Study|Adverse Event|7|||
30982481|NCT04085328|59110356|FG000|Overall Study|Lost to Follow-up|7|||
30982482|NCT04085328|59110357|FG001|Overall Study|Lost to Follow-up|2|||
30982483|NCT04085328|59110356|FG000|Overall Study|Physician Decision|0|||
30982484|NCT04085328|59110357|FG001|Overall Study|Physician Decision|1|||
30982485|NCT04085328|59110356|FG000|Overall Study|Pregnancy|0|||
30982486|NCT04085328|59110357|FG001|Overall Study|Pregnancy|1|||
30982487|NCT04085328|59110356|FG000|Overall Study|Reasons Related to COVID-19|5|||
30982488|NCT04085328|59110357|FG001|Overall Study|Reasons Related to COVID-19|8|||
30982489|NCT04085328|59110356|FG000|Overall Study|Did not meet inclusion criteria|1|||
30982490|NCT04085328|59110357|FG001|Overall Study|Did not meet inclusion criteria|1|||
30982491|NCT04085328|59110356|FG000|Overall Study|Early termination|1|||
30982492|NCT04085328|59110357|FG001|Overall Study|Early termination|0|||
30982493|NCT03789110|59110370|FG000|Overall Study|Adverse Event|2|||
30982494|NCT03789110|59110370|FG000|Overall Study|Physician Decision|1|||
30982495|NCT03789110|59110370|FG000|Overall Study|Withdrawal by Subject|2|||
30982496|NCT03789110|59110370|FG000|Overall Study|Lack of Efficacy|22|||
30982497|NCT03789110|59110370|FG000|Overall Study|still on treatment|3|||
30982498|NCT03074474|59110392|FG000|Overall Study|Lost to Follow-up|10|||
30982499|NCT03074474|59110392|FG000|Overall Study|Withdrawal by Subject|10|||
30982500|NCT03074474|59110392|FG000|Overall Study|Death|4|||
30982501|NCT03074474|59110392|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
30982502|NCT03043313|59110400|FG000|Overall Study|Withdrawal by Subject|4|||
30982503|NCT03043313|59110401|FG001|Overall Study|Withdrawal by Subject|1|||
30982504|NCT03043313|59110402|FG002|Overall Study|Withdrawal by Subject|1|||
30982505|NCT03043313|59110400|FG000|Overall Study|Lost to Follow-up|1|||
30982506|NCT03043313|59110401|FG001|Overall Study|Lost to Follow-up|0|||
30982507|NCT03043313|59110402|FG002|Overall Study|Lost to Follow-up|0|||
30982508|NCT03043313|59110400|FG000|Overall Study|Death|26|||
30982509|NCT03043313|59110401|FG001|Overall Study|Death|13|||
30982510|NCT03043313|59110402|FG002|Overall Study|Death|8|||
30982511|NCT03043313|59110400|FG000|Overall Study|On Treatment|7|||
30982512|NCT03043313|59110401|FG001|Overall Study|On Treatment|12|||
30982513|NCT03043313|59110402|FG002|Overall Study|On Treatment|11|||
30982514|NCT03043313|59110400|FG000|Overall Study|In follow up|7|||
30982515|NCT03043313|59110401|FG001|Overall Study|In follow up|15|||
30982516|NCT03043313|59110402|FG002|Overall Study|In follow up|11|||
30982517|NCT02744391|59110413|FG000|Overall Study|Lost to Follow-up|9|||
30982518|NCT02744391|59110413|FG000|Overall Study|Physician Decision|2|||
30982519|NCT02744391|59110413|FG000|Overall Study|Withdrawal by Subject|3|||
30982520|NCT02462837|59110419|FG000|Overall Study|pt developed hives|1|||
30982521|NCT02462837|59110420|FG001|Overall Study|pt developed hives|0|||
30982522|NCT02462837|59110419|FG000|Overall Study|Withdrawal by Subject|1|||
30982523|NCT02462837|59110420|FG001|Overall Study|Withdrawal by Subject|0|||
30982524|NCT02346201|59110428|FG000|Overall Study|Adverse Event|3|||
30982525|NCT02346201|59110429|FG001|Overall Study|Adverse Event|2|||
30982526|NCT02346201|59110428|FG000|Overall Study|Lost to Follow-up|1|||
30982527|NCT02346201|59110429|FG001|Overall Study|Lost to Follow-up|0|||
30982528|NCT02346201|59110428|FG000|Overall Study|Withdrawal by Subject|6|||
30982529|NCT02346201|59110429|FG001|Overall Study|Withdrawal by Subject|3|||
30982530|NCT02346201|59110428|FG000|Overall Study|Unavailable for future follow-up|0|||
30982531|NCT02346201|59110429|FG001|Overall Study|Unavailable for future follow-up|1|||
30790193|NCT00043979|58803393|FG002|Period 1|recipient with progressive disease|3|||
30891531|NCT01649869|58924668|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
30982532|NCT02346201|59110428|FG000|Overall Study|Physician Decision|0|||
30891532|NCT02197377|58924678|FG000|Overall Study|Insertion Failure|0|||
30891533|NCT02197377|58924679|FG001|Overall Study|Insertion Failure|3|||
30891534|NCT02400307|58924687|FG000|Overall Study|Enrolled and Never Dosed|1|||
30891535|NCT02400307|58924688|FG001|Overall Study|Enrolled and Never Dosed|0|||
30891536|NCT02196675|58924697|FG000|Overall Study|Withdrawal by Subject|1|||
30891537|NCT02196675|58924698|FG001|Overall Study|Withdrawal by Subject|0|||
30891538|NCT02196675|58924699|FG002|Overall Study|Withdrawal by Subject|0|||
30891539|NCT02196675|58924697|FG000|Overall Study|Intra-operative surgical exclusion|1|||
30982533|NCT02346201|59110429|FG001|Overall Study|Physician Decision|1|||
30982534|NCT02346201|59110428|FG000|Overall Study|Missed final visit|0|||
30982535|NCT02346201|59110429|FG001|Overall Study|Missed final visit|2|||
30982536|NCT01866930|59110449|FG000|Treatment Period|Other|1|||
30982537|NCT01866930|59110450|FG001|Treatment Period|Other|0|||
30982538|NCT01866930|59110449|FG000|Treatment Period|Death|0|||
30982539|NCT01866930|59110450|FG001|Treatment Period|Death|2|||
30982540|NCT01866930|59110449|FG000|Treatment Period|Poor/non compliance|0|||
30982541|NCT01866930|59110450|FG001|Treatment Period|Poor/non compliance|2|||
30982542|NCT01866930|59110449|FG000|Treatment Period|No longer meets study criteria|0|||
30982543|NCT01866930|59110450|FG001|Treatment Period|No longer meets study criteria|1|||
30982544|NCT01866930|59110449|FG000|Treatment Period|Withdrawal by Subject|2|||
30982545|NCT01866930|59110450|FG001|Treatment Period|Withdrawal by Subject|8|||
30982546|NCT01866930|59110449|FG000|Treatment Period|Lack of Efficacy|1|||
30982547|NCT01866930|59110450|FG001|Treatment Period|Lack of Efficacy|9|||
30982548|NCT01866930|59110449|FG000|Treatment Period|Adverse Event|4|||
30982549|NCT01866930|59110450|FG001|Treatment Period|Adverse Event|12|||
30982550|NCT01866930|59110449|FG000|Treatment Period|Lost to Follow-up|1|||
30982551|NCT01866930|59110450|FG001|Treatment Period|Lost to Follow-up|1|||
30982552|NCT01866930|59110449|FG000|Follow-up Period|Lost to Follow-up|1|||
30982553|NCT01866930|59110450|FG001|Follow-up Period|Lost to Follow-up|1|||
30982554|NCT01866930|59110449|FG000|Follow-up Period|Other|1|||
30982555|NCT01866930|59110450|FG001|Follow-up Period|Other|5|||
30982556|NCT01866930|59110449|FG000|Follow-up Period|No longer required per protocol|1|||
30982557|NCT01866930|59110450|FG001|Follow-up Period|No longer required per protocol|0|||
30982558|NCT01866930|59110449|FG000|Follow-up Period|Withdrawal by Subject|3|||
30982559|NCT01866930|59110450|FG001|Follow-up Period|Withdrawal by Subject|3|||
30982560|NCT01621568|59110458|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
30982561|NCT01621568|59110459|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
30982562|NCT01621568|59110458|FG000|Week 5-6 No Treatment|Death|1|||
30982563|NCT01621568|59110459|FG001|Week 5-6 No Treatment|Death|0|||
30982564|NCT00813293|59110488|FG000|Overall Study|Intercurrent illness|1|||
30982565|NCT00813293|59110489|FG001|Overall Study|Intercurrent illness|0|||
30982566|NCT00813293|59110488|FG000|Overall Study|Adverse Event|0|||
30982567|NCT00813293|59110489|FG001|Overall Study|Adverse Event|1|||
30982568|NCT00777036|59110498|FG000|On Treatment|Reason Not Specified|4|||
30982569|NCT00777036|59110499|FG001|On Treatment|Reason Not Specified|7|||
30982570|NCT00777036|59110500|FG002|On Treatment|Reason Not Specified|12|||
30982571|NCT00777036|59110498|FG000|On Treatment|Failure to Meet Study Criteria|0|||
30982572|NCT00777036|59110499|FG001|On Treatment|Failure to Meet Study Criteria|1|||
30982573|NCT00777036|59110500|FG002|On Treatment|Failure to Meet Study Criteria|0|||
30982574|NCT00777036|59110498|FG000|On Treatment|Non-compliance with Study Drug|1|||
30982575|NCT00777036|59110499|FG001|On Treatment|Non-compliance with Study Drug|0|||
30982576|NCT00777036|59110500|FG002|On Treatment|Non-compliance with Study Drug|0|||
30982577|NCT00777036|59110498|FG000|On Treatment|Maximum Clinical Benefit|2|||
30982578|NCT00777036|59110499|FG001|On Treatment|Maximum Clinical Benefit|0|||
30982579|NCT00777036|59110500|FG002|On Treatment|Maximum Clinical Benefit|1|||
30982580|NCT00777036|59110498|FG000|On Treatment|Withdrawal by Subject|3|||
30982581|NCT00777036|59110499|FG001|On Treatment|Withdrawal by Subject|2|||
30982582|NCT00777036|59110500|FG002|On Treatment|Withdrawal by Subject|3|||
30982583|NCT00777036|59110498|FG000|On Treatment|Death|0|||
30982584|NCT00777036|59110499|FG001|On Treatment|Death|2|||
30982585|NCT00777036|59110500|FG002|On Treatment|Death|0|||
30982586|NCT00777036|59110498|FG000|On Treatment|Study Drug Toxicity|0|||
30982587|NCT00777036|59110499|FG001|On Treatment|Study Drug Toxicity|0|||
30982588|NCT00777036|59110500|FG002|On Treatment|Study Drug Toxicity|1|||
30982589|NCT00777036|59110498|FG000|On Treatment|Progressive Disease|5|||
30982590|NCT00777036|59110499|FG001|On Treatment|Progressive Disease|4|||
30982591|NCT00777036|59110500|FG002|On Treatment|Progressive Disease|6|||
30982592|NCT00777036|59110498|FG000|Follow-Up|Lost to Follow-up|1|||
30982593|NCT00777036|59110499|FG001|Follow-Up|Lost to Follow-up|0|||
30982594|NCT00777036|59110500|FG002|Follow-Up|Lost to Follow-up|0|||
30982595|NCT00777036|59110498|FG000|Follow-Up|Reason Not Specified|2|||
30982596|NCT00777036|59110499|FG001|Follow-Up|Reason Not Specified|0|||
30982597|NCT00777036|59110500|FG002|Follow-Up|Reason Not Specified|0|||
30982598|NCT00777036|59110498|FG000|Follow-Up|Withdrawal by Subject|1|||
30982599|NCT00777036|59110499|FG001|Follow-Up|Withdrawal by Subject|0|||
30982600|NCT00777036|59110500|FG002|Follow-Up|Withdrawal by Subject|4|||
30982601|NCT00777036|59110498|FG000|Follow-Up|Death|1|||
30982602|NCT00777036|59110499|FG001|Follow-Up|Death|8|||
30982603|NCT00777036|59110500|FG002|Follow-Up|Death|0|||
30982604|NCT00481091|59110525|FG000|Overall Study|Withdrawal by Subject|0|||
30982605|NCT00481091|59110526|FG001|Overall Study|Withdrawal by Subject|1|||
30982606|NCT00481091|59110527|FG002|Overall Study|Withdrawal by Subject|1|||
30982607|NCT00481091|59110528|FG003|Overall Study|Withdrawal by Subject|0|||
30982608|NCT00481091|59110529|FG004|Overall Study|Withdrawal by Subject|0|||
30982609|NCT00481091|59110530|FG005|Overall Study|Withdrawal by Subject|0|||
30982610|NCT00481091|59110531|FG006|Overall Study|Withdrawal by Subject|0|||
30982611|NCT00481091|59110532|FG007|Overall Study|Withdrawal by Subject|0|||
30982612|NCT00481091|59110533|FG008|Overall Study|Withdrawal by Subject|1|||
30982613|NCT00481091|59110534|FG009|Overall Study|Withdrawal by Subject|6|||
30982614|NCT00481091|59110525|FG000|Overall Study|Other, Not Specified|0|||
30982615|NCT00481091|59110526|FG001|Overall Study|Other, Not Specified|1|||
30982616|NCT00481091|59110527|FG002|Overall Study|Other, Not Specified|1|||
30982617|NCT00481091|59110528|FG003|Overall Study|Other, Not Specified|0|||
30982618|NCT00481091|59110529|FG004|Overall Study|Other, Not Specified|0|||
30982619|NCT00481091|59110530|FG005|Overall Study|Other, Not Specified|1|||
30982620|NCT00481091|59110531|FG006|Overall Study|Other, Not Specified|0|||
30982621|NCT00481091|59110532|FG007|Overall Study|Other, Not Specified|0|||
30982622|NCT00481091|59110533|FG008|Overall Study|Other, Not Specified|0|||
30982623|NCT00481091|59110534|FG009|Overall Study|Other, Not Specified|4|||
30982624|NCT00481091|59110525|FG000|Overall Study|Adverse Event|1|||
30982625|NCT00481091|59110526|FG001|Overall Study|Adverse Event|2|||
30982626|NCT00481091|59110527|FG002|Overall Study|Adverse Event|0|||
30982627|NCT00481091|59110528|FG003|Overall Study|Adverse Event|1|||
30982628|NCT00481091|59110529|FG004|Overall Study|Adverse Event|1|||
30982629|NCT00481091|59110530|FG005|Overall Study|Adverse Event|1|||
30982630|NCT00481091|59110531|FG006|Overall Study|Adverse Event|2|||
30982631|NCT00481091|59110532|FG007|Overall Study|Adverse Event|1|||
30982632|NCT00481091|59110533|FG008|Overall Study|Adverse Event|1|||
30982633|NCT00481091|59110534|FG009|Overall Study|Adverse Event|6|||
30982634|NCT00481091|59110525|FG000|Overall Study|Progressive disease clinical|0|||
30982635|NCT00481091|59110526|FG001|Overall Study|Progressive disease clinical|0|||
30982636|NCT00481091|59110527|FG002|Overall Study|Progressive disease clinical|0|||
30982637|NCT00481091|59110528|FG003|Overall Study|Progressive disease clinical|0|||
30982638|NCT00481091|59110529|FG004|Overall Study|Progressive disease clinical|0|||
30982639|NCT00481091|59110530|FG005|Overall Study|Progressive disease clinical|0|||
30982640|NCT00481091|59110531|FG006|Overall Study|Progressive disease clinical|0|||
30982641|NCT00481091|59110532|FG007|Overall Study|Progressive disease clinical|0|||
30982642|NCT00481091|59110533|FG008|Overall Study|Progressive disease clinical|1|||
30982643|NCT00481091|59110534|FG009|Overall Study|Progressive disease clinical|7|||
30982644|NCT00481091|59110525|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
30982645|NCT00481091|59110526|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
30982646|NCT00481091|59110527|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
30982647|NCT00481091|59110528|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
30982648|NCT00481091|59110529|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
30982649|NCT00481091|59110530|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
30982650|NCT00481091|59110531|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
30982651|NCT00481091|59110532|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
30982652|NCT00481091|59110533|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
30982653|NCT00481091|59110534|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
30982654|NCT00481091|59110525|FG000|Overall Study|Progressive disease other|1|||
30982655|NCT00481091|59110526|FG001|Overall Study|Progressive disease other|1|||
30982656|NCT00481091|59110527|FG002|Overall Study|Progressive disease other|0|||
30982657|NCT00481091|59110528|FG003|Overall Study|Progressive disease other|1|||
30982658|NCT00481091|59110529|FG004|Overall Study|Progressive disease other|1|||
30982659|NCT00481091|59110530|FG005|Overall Study|Progressive disease other|1|||
30982660|NCT00481091|59110531|FG006|Overall Study|Progressive disease other|0|||
30982661|NCT00481091|59110532|FG007|Overall Study|Progressive disease other|2|||
30982662|NCT00481091|59110533|FG008|Overall Study|Progressive disease other|0|||
30982663|NCT00481091|59110534|FG009|Overall Study|Progressive disease other|0|||
30982664|NCT00481091|59110525|FG000|Overall Study|No reason given|0|||
30982665|NCT00481091|59110526|FG001|Overall Study|No reason given|0|||
30982666|NCT00481091|59110527|FG002|Overall Study|No reason given|1|||
30982667|NCT00481091|59110528|FG003|Overall Study|No reason given|1|||
30982668|NCT00481091|59110529|FG004|Overall Study|No reason given|1|||
30982669|NCT00481091|59110530|FG005|Overall Study|No reason given|0|||
30982670|NCT00481091|59110531|FG006|Overall Study|No reason given|1|||
30982671|NCT00481091|59110532|FG007|Overall Study|No reason given|1|||
30982672|NCT00481091|59110533|FG008|Overall Study|No reason given|1|||
30982673|NCT00481091|59110534|FG009|Overall Study|No reason given|4|||
30982674|NCT00003641|59110565|FG000|Overall Study|Withdrawal by Subject|0|||
30982675|NCT00003641|59110566|FG001|Overall Study|Withdrawal by Subject|100|||
30982676|NCT00003641|59110565|FG000|Overall Study|Adverse Event|0|||
30982677|NCT00003641|59110566|FG001|Overall Study|Adverse Event|38|||
30982678|NCT00003641|59110565|FG000|Overall Study|Disease progression|0|||
30982679|NCT00003641|59110566|FG001|Overall Study|Disease progression|2|||
30982680|NCT00003641|59110565|FG000|Overall Study|Unknown/missing|0|||
30982681|NCT00003641|59110566|FG001|Overall Study|Unknown/missing|22|||
30982682|NCT00003641|59110565|FG000|Overall Study|Should not receive interferon therapy|2|||
30982683|NCT00003641|59110566|FG001|Overall Study|Should not receive interferon therapy|0|||
30982684|NCT00003641|59110565|FG000|Overall Study|Never started interferon|567|||
30982685|NCT00003641|59110566|FG001|Overall Study|Never started interferon|12|||
30982686|NCT02524158|59110596|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
30982687|NCT02524158|59110597|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
30982688|NCT02524158|59110596|FG000|12-weeks Assessment|Lost to Follow-up|18|||
30982689|NCT02524158|59110597|FG001|12-weeks Assessment|Lost to Follow-up|12|||
30982690|NCT02524158|59110596|FG000|6-month Assessment|Withdrawal by Subject|1|||
30982691|NCT02524158|59110597|FG001|6-month Assessment|Withdrawal by Subject|1|||
30982692|NCT02524158|59110596|FG000|6-month Assessment|Lost to Follow-up|21|||
30982693|NCT02524158|59110597|FG001|6-month Assessment|Lost to Follow-up|20|||
30982694|NCT02525094|59110617|FG000|Overall Study|Lost to Follow-up|2|||
30982695|NCT02525094|59110618|FG001|Overall Study|Lost to Follow-up|1|||
30982696|NCT02525094|59110617|FG000|Overall Study|Withdrawal by Subject|5|||
30982697|NCT02525094|59110618|FG001|Overall Study|Withdrawal by Subject|6|||
30982698|NCT02525094|59110617|FG000|Overall Study|Not Treated|1|||
30982699|NCT02525094|59110618|FG001|Overall Study|Not Treated|1|||
30982700|NCT01657266|59110775|FG000|Overall Study|Lost to Follow-up|2|||
30982701|NCT01657266|59110776|FG001|Overall Study|Lost to Follow-up|2|||
30982702|NCT01657266|59110775|FG000|Overall Study|Adverse Event|2|||
30982703|NCT01657266|59110776|FG001|Overall Study|Adverse Event|3|||
30982704|NCT01657032|59110861|FG000|Overall Study|Lost to Follow-up|0|||
30982705|NCT01657032|59110862|FG001|Overall Study|Lost to Follow-up|7|||
30982706|NCT01657500|59110990|FG000|Overall Study|set impropperly matched|3|||
30982707|NCT01657500|59110991|FG001|Overall Study|set impropperly matched|3|||
30982708|NCT01657500|59110990|FG000|Overall Study|Lost to Follow-up|2|||
30982709|NCT01657500|59110991|FG001|Overall Study|Lost to Follow-up|2|||
30982710|NCT01658904|59111004|FG000|Overall Study|Principal Investigator discretion|2|||
30982711|NCT01658904|59111005|FG001|Overall Study|Principal Investigator discretion|0|||
30982712|NCT01658904|59111006|FG002|Overall Study|Principal Investigator discretion|0|||
30982713|NCT01658514|59111190|FG000|Overall Study|Protocol Violation|1|||
30982714|NCT01658514|59111191|FG001|Overall Study|Protocol Violation|0|||
30982715|NCT01658514|59111192|FG002|Overall Study|Protocol Violation|2|||
30982716|NCT01658436|59111213|FG000|Overall Study|Adverse Event|6|||
30982717|NCT01658436|59111214|FG001|Overall Study|Adverse Event|5|||
30982718|NCT01658436|59111213|FG000|Overall Study|Physician Decision|1|||
30982719|NCT01658436|59111214|FG001|Overall Study|Physician Decision|0|||
30982720|NCT01658436|59111213|FG000|Overall Study|Progressive disease|12|||
30982721|NCT01658436|59111214|FG001|Overall Study|Progressive disease|4|||
30982722|NCT01658436|59111213|FG000|Overall Study|Study terminated by sponsor|0|||
30982723|NCT01658436|59111214|FG001|Overall Study|Study terminated by sponsor|1|||
30982724|NCT01658436|59111213|FG000|Overall Study|Subject/guardian decision|0|||
30982725|NCT01658436|59111214|FG001|Overall Study|Subject/guardian decision|1|||
30982726|NCT01658436|59111213|FG000|Overall Study|Death|1|||
30982727|NCT01658436|59111214|FG001|Overall Study|Death|0|||
30982728|NCT01656408|59111769|FG000|Overall Study|Adverse Event|0|||
30982729|NCT01656408|59111770|FG001|Overall Study|Adverse Event|0|||
30982730|NCT01656408|59111771|FG002|Overall Study|Adverse Event|1|||
30982731|NCT01656408|59111772|FG003|Overall Study|Adverse Event|0|||
30982732|NCT01656408|59111773|FG004|Overall Study|Adverse Event|0|||
30982733|NCT01656408|59111774|FG005|Overall Study|Adverse Event|1|||
30982734|NCT01656408|59111775|FG006|Overall Study|Adverse Event|1|||
30982735|NCT01656408|59111776|FG007|Overall Study|Adverse Event|0|||
30982736|NCT01656408|59111777|FG008|Overall Study|Adverse Event|1|||
30982737|NCT01656408|59111778|FG009|Overall Study|Adverse Event|0|||
30982738|NCT01656408|59111769|FG000|Overall Study|Physician Decision|1|||
30982739|NCT01656408|59111770|FG001|Overall Study|Physician Decision|0|||
30982740|NCT01656408|59111771|FG002|Overall Study|Physician Decision|1|||
30982741|NCT01656408|59111772|FG003|Overall Study|Physician Decision|0|||
30982742|NCT01656408|59111773|FG004|Overall Study|Physician Decision|1|||
30982743|NCT01656408|59111774|FG005|Overall Study|Physician Decision|1|||
30982744|NCT01656408|59111775|FG006|Overall Study|Physician Decision|0|||
30982745|NCT01656408|59111776|FG007|Overall Study|Physician Decision|1|||
30982746|NCT01656408|59111777|FG008|Overall Study|Physician Decision|1|||
30982747|NCT01656408|59111778|FG009|Overall Study|Physician Decision|3|||
30982748|NCT01364298|59112221|FG000|Overall Study|Adverse Event|3|||
30982749|NCT01364298|59112222|FG001|Overall Study|Adverse Event|4|||
30982750|NCT01364298|59112221|FG000|Overall Study|Lack of adherence to treatment|1|||
30982751|NCT01364298|59112222|FG001|Overall Study|Lack of adherence to treatment|3|||
30982752|NCT01364298|59112221|FG000|Overall Study|Lack of Efficacy|1|||
30982753|NCT01364298|59112222|FG001|Overall Study|Lack of Efficacy|0|||
30982754|NCT01364298|59112221|FG000|Overall Study|Lost to Follow-up|5|||
30982755|NCT01364298|59112222|FG001|Overall Study|Lost to Follow-up|10|||
30982756|NCT01364298|59112221|FG000|Overall Study|Withdrawal by Subject|3|||
30982757|NCT01364298|59112222|FG001|Overall Study|Withdrawal by Subject|3|||
30982758|NCT01364298|59112221|FG000|Overall Study|Other|1|||
30982759|NCT01364298|59112222|FG001|Overall Study|Other|3|||
30982760|NCT01364922|59112281|FG000|Open-label (OL) Period|Adverse Event|7|||
30982761|NCT01364922|59112282|FG001|Open-label (OL) Period|Adverse Event|0|||
30982762|NCT01364922|59112283|FG002|Open-label (OL) Period|Adverse Event|0|||
30982763|NCT01364922|59112281|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
30982764|NCT01364922|59112282|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
30982765|NCT01364922|59112283|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
30982766|NCT01364922|59112281|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
30982767|NCT01364922|59112282|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
30982768|NCT01364922|59112283|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
30982769|NCT01364922|59112281|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
30982770|NCT01364922|59112282|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
30982771|NCT01364922|59112283|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
30982772|NCT01364922|59112281|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
30982773|NCT01364922|59112282|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
30982774|NCT01364922|59112283|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
30982775|NCT01364922|59112281|FG000|Open-label (OL) Period|Other, Unspecified|1|||
30982776|NCT01364922|59112282|FG001|Open-label (OL) Period|Other, Unspecified|0|||
30982777|NCT01364922|59112283|FG002|Open-label (OL) Period|Other, Unspecified|0|||
30982778|NCT01364922|59112281|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
30982779|NCT01364922|59112282|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
30982780|NCT01364922|59112283|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
30982781|NCT01364922|59112281|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
30982782|NCT01364922|59112282|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
30982783|NCT01364922|59112283|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
30982784|NCT01364922|59112281|FG000|Double-Blind (DB) Period|Adverse Event|0|||
30982785|NCT01364922|59112282|FG001|Double-Blind (DB) Period|Adverse Event|0|||
30982786|NCT01364922|59112283|FG002|Double-Blind (DB) Period|Adverse Event|1|||
30982787|NCT01364922|59112281|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
30982788|NCT01364922|59112282|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
30982789|NCT01364922|59112283|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
30982790|NCT02522286|59112457|FG000|Overall Study|Withdrawal by Subject|3|||
30982791|NCT02522286|59112458|FG001|Overall Study|Withdrawal by Subject|0|||
30982792|NCT02522286|59112459|FG002|Overall Study|Withdrawal by Subject|0|||
30982793|NCT02522286|59112460|FG003|Overall Study|Withdrawal by Subject|3|||
30982794|NCT02520726|59112481|FG000|Overall Study|Lost to Follow-up|3|||
30982795|NCT02520726|59112482|FG001|Overall Study|Lost to Follow-up|2|||
30982796|NCT02519712|59112505|FG000|Overall Study|Disease Relapse|1|||
30982797|NCT02519712|59112505|FG000|Overall Study|Disease Progression|1|||
30982798|NCT02519712|59112505|FG000|Overall Study|Accruals are donors|2|||
30982799|NCT02516202|59112748|FG000|Overall Study|Withdrawal by Subject|1|||
30982800|NCT02516202|59112749|FG001|Overall Study|Withdrawal by Subject|0|||
30982801|NCT02516202|59112750|FG002|Overall Study|Withdrawal by Subject|1|||
30982802|NCT02516202|59112748|FG000|Overall Study|Lost to Follow-up|1|||
30982803|NCT02516202|59112749|FG001|Overall Study|Lost to Follow-up|1|||
30982804|NCT02516202|59112750|FG002|Overall Study|Lost to Follow-up|1|||
30982805|NCT02516202|59112748|FG000|Overall Study|Stopped Follow-up|0|||
30982806|NCT02516202|59112749|FG001|Overall Study|Stopped Follow-up|0|||
30982807|NCT02516202|59112750|FG002|Overall Study|Stopped Follow-up|1|||
30982808|NCT02518620|59112956|FG000|Overall Study|Adverse Event|23|||
30982809|NCT02518620|59112957|FG001|Overall Study|Adverse Event|11|||
30982810|NCT02518620|59112956|FG000|Overall Study|Lack of Efficacy|2|||
30982811|NCT02518620|59112957|FG001|Overall Study|Lack of Efficacy|0|||
30982812|NCT02518620|59112956|FG000|Overall Study|Non-Compliance with Study Drug|1|||
30982813|NCT02518620|59112957|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30982814|NCT02518620|59112956|FG000|Overall Study|Physician Decision|1|||
30982815|NCT02518620|59112957|FG001|Overall Study|Physician Decision|1|||
30982816|NCT02518620|59112956|FG000|Overall Study|Sponsor's Decision|0|||
30982817|NCT02518620|59112957|FG001|Overall Study|Sponsor's Decision|3|||
30982818|NCT02518620|59112956|FG000|Overall Study|Lost to Follow-up|1|||
30982819|NCT02518620|59112957|FG001|Overall Study|Lost to Follow-up|1|||
30982820|NCT02518620|59112956|FG000|Overall Study|Withdrawal by Subject|17|||
30982821|NCT02518620|59112957|FG001|Overall Study|Withdrawal by Subject|9|||
30982822|NCT02518620|59112956|FG000|Overall Study|Death|1|||
30982823|NCT02518620|59112957|FG001|Overall Study|Death|0|||
30982824|NCT02518620|59112956|FG000|Overall Study|Pregnancy Wish|3|||
30982825|NCT02518620|59112957|FG001|Overall Study|Pregnancy Wish|0|||
30982826|NCT02518620|59112956|FG000|Overall Study|Pregnancy|1|||
30982827|NCT02518620|59112957|FG001|Overall Study|Pregnancy|0|||
30982828|NCT02518620|59112956|FG000|Overall Study|Relocation|2|||
30982829|NCT02518620|59112957|FG001|Overall Study|Relocation|1|||
30982830|NCT01653912|59113136|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
30982831|NCT01653912|59113137|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
30982832|NCT01653912|59113138|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
30982833|NCT01653912|59113139|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
30982834|NCT01653912|59113140|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
30982835|NCT01653912|59113141|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
30982836|NCT01653912|59113136|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
30982837|NCT01653912|59113137|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
30982838|NCT01653912|59113138|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
30982839|NCT01653912|59113139|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
30982840|NCT01653912|59113140|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
30982841|NCT01653912|59113141|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
30982842|NCT01653912|59113136|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
30982843|NCT01653912|59113137|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
30982844|NCT01653912|59113138|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
30982845|NCT01653912|59113139|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
30982846|NCT01653912|59113140|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
30982847|NCT01653912|59113141|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
30982848|NCT01653912|59113136|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
30982849|NCT01653912|59113137|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
30982850|NCT01653912|59113138|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
30982851|NCT01653912|59113139|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
30982852|NCT01653912|59113140|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
30982853|NCT01653912|59113141|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
30982854|NCT01653912|59113136|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
30982855|NCT01653912|59113137|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
30982856|NCT01653912|59113138|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
30982857|NCT01653912|59113139|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
30982858|NCT01653912|59113140|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
30982859|NCT01653912|59113141|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
30982860|NCT01653912|59113136|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
30982861|NCT01653912|59113137|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
30982862|NCT01653912|59113138|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
30982863|NCT01653912|59113139|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
30982864|NCT01653912|59113140|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
30982865|NCT01653912|59113141|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
30982866|NCT01653912|59113136|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
30982867|NCT01653912|59113137|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
30982868|NCT01653912|59113138|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
30982869|NCT01653912|59113139|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
30982870|NCT01653912|59113140|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
30982871|NCT01653912|59113141|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
30982872|NCT02483520|59113167|FG000|Overall Study|Lost to Follow-up|3|||
30982873|NCT02483520|59113168|FG001|Overall Study|Lost to Follow-up|4|||
30982874|NCT02483520|59113167|FG000|Overall Study|Withdrawal by Subject|4|||
30982875|NCT02483520|59113168|FG001|Overall Study|Withdrawal by Subject|14|||
30982876|NCT02483520|59113167|FG000|Overall Study|Hospitalized|2|||
30982877|NCT02483520|59113168|FG001|Overall Study|Hospitalized|3|||
30982878|NCT02483520|59113167|FG000|Overall Study|Moved to LTC|2|||
30982879|NCT02483520|59113168|FG001|Overall Study|Moved to LTC|3|||
30982880|NCT02514174|59113174|FG000|Overall Study|Patient refused to continue medication|1|||
30982881|NCT02514174|59113174|FG000|Overall Study|Adverse Event|2|||
30982882|NCT02514174|59113174|FG000|Overall Study|Study closed by sponsor|9|||
30982883|NCT02514174|59113174|FG000|Overall Study|Progressive disease|11|||
30982884|NCT02514174|59113174|FG000|Overall Study|Treatment change|1|||
30891540|NCT02196675|58924698|FG001|Overall Study|Intra-operative surgical exclusion|1|||
30891541|NCT02196675|58924699|FG002|Overall Study|Intra-operative surgical exclusion|0|||
30891542|NCT02196675|58924697|FG000|Overall Study|Protocol Violation|0|||
30891543|NCT02196675|58924698|FG001|Overall Study|Protocol Violation|1|||
30891544|NCT02196675|58924699|FG002|Overall Study|Protocol Violation|0|||
30891545|NCT02196675|58924697|FG000|Overall Study|Death|0|||
30891546|NCT02196675|58924698|FG001|Overall Study|Death|0|||
30891547|NCT02196675|58924699|FG002|Overall Study|Death|1|||
30891548|NCT02399449|58924709|FG000|Overall Study|Withdrawal by Subject|3|||
30891549|NCT02399449|58924710|FG001|Overall Study|Withdrawal by Subject|9|||
30891550|NCT02399449|58924709|FG000|Overall Study|Physician Decision|0|||
30891551|NCT02399449|58924710|FG001|Overall Study|Physician Decision|1|||
30891552|NCT02217345|58924718|FG000|Overall Study|Lost to Follow-up|2|||
30982885|NCT02514174|59113174|FG000|Overall Study|Treated off study with Afatinib.|1|||
30982886|NCT02482428|59113234|FG000|Overall Study|Lost to Follow-up|4|||
30982887|NCT02482428|59113235|FG001|Overall Study|Lost to Follow-up|9|||
30982888|NCT02482428|59113236|FG002|Overall Study|Lost to Follow-up|1|||
30891553|NCT02217345|58924719|FG001|Overall Study|Lost to Follow-up|1|||
30891554|NCT02217345|58924718|FG000|Overall Study|Withdrawal by Subject|3|||
30891555|NCT02217345|58924719|FG001|Overall Study|Withdrawal by Subject|2|||
30982889|NCT02482428|59113237|FG003|Overall Study|Lost to Follow-up|2|||
30982890|NCT02482428|59113238|FG004|Overall Study|Lost to Follow-up|4|||
30982891|NCT02482428|59113234|FG000|Overall Study|Physician Decision|0|||
30982892|NCT02482428|59113235|FG001|Overall Study|Physician Decision|0|||
30982893|NCT02482428|59113236|FG002|Overall Study|Physician Decision|0|||
30982894|NCT02482428|59113237|FG003|Overall Study|Physician Decision|0|||
30982895|NCT02482428|59113238|FG004|Overall Study|Physician Decision|1|||
30982896|NCT02482428|59113234|FG000|Overall Study|protocol deviation|1|||
30982897|NCT02482428|59113235|FG001|Overall Study|protocol deviation|1|||
30982898|NCT02482428|59113236|FG002|Overall Study|protocol deviation|0|||
30982899|NCT02482428|59113237|FG003|Overall Study|protocol deviation|0|||
30982900|NCT02482428|59113238|FG004|Overall Study|protocol deviation|0|||
30982901|NCT02482428|59113234|FG000|Overall Study|subject/guardian decision|4|||
30982902|NCT02482428|59113235|FG001|Overall Study|subject/guardian decision|2|||
30982903|NCT02482428|59113236|FG002|Overall Study|subject/guardian decision|0|||
30982904|NCT02482428|59113237|FG003|Overall Study|subject/guardian decision|0|||
30982905|NCT02482428|59113238|FG004|Overall Study|subject/guardian decision|2|||
30982906|NCT02480712|59113297|FG000|Overall Study|Enrolled but Never Treated|1|||
30982907|NCT02480712|59113297|FG000|Overall Study|Lost to Follow-up|5|||
30982908|NCT02480712|59113297|FG000|Overall Study|Withdrew Consent|3|||
30982909|NCT02480712|59113297|FG000|Overall Study|Death|1|||
30982910|NCT02480712|59113297|FG000|Overall Study|Lack of Efficacy|1|||
30982911|NCT02513550|59114606|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
30982912|NCT02513550|59114607|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
30982913|NCT02513550|59114608|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
30982914|NCT02513550|59114609|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
30982915|NCT02513550|59114610|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
30982916|NCT02513550|59114611|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
30982917|NCT02513550|59114606|FG000|Double Blind Treatment Period|Adverse Event|5|||
30982918|NCT02513550|59114607|FG001|Double Blind Treatment Period|Adverse Event|13|||
30982919|NCT02513550|59114608|FG002|Double Blind Treatment Period|Adverse Event|17|||
30982920|NCT02513550|59114609|FG003|Double Blind Treatment Period|Adverse Event|0|||
30982921|NCT02513550|59114610|FG004|Double Blind Treatment Period|Adverse Event|1|||
30982922|NCT02513550|59114611|FG005|Double Blind Treatment Period|Adverse Event|0|||
30982923|NCT02513550|59114606|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
30982924|NCT02513550|59114607|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
30982925|NCT02513550|59114608|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
30982926|NCT02513550|59114609|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
30982927|NCT02513550|59114610|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
30982928|NCT02513550|59114611|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
30982929|NCT02513550|59114606|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
30982930|NCT02513550|59114607|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
30982931|NCT02513550|59114608|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
30982932|NCT02513550|59114609|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
30982933|NCT02513550|59114610|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
30982934|NCT02513550|59114611|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
30982935|NCT02513550|59114606|FG000|Double Blind Treatment Period|Protocol Violation|1|||
30982936|NCT02513550|59114607|FG001|Double Blind Treatment Period|Protocol Violation|1|||
30982937|NCT02513550|59114608|FG002|Double Blind Treatment Period|Protocol Violation|4|||
30982938|NCT02513550|59114609|FG003|Double Blind Treatment Period|Protocol Violation|0|||
30982939|NCT02513550|59114610|FG004|Double Blind Treatment Period|Protocol Violation|0|||
30982940|NCT02513550|59114611|FG005|Double Blind Treatment Period|Protocol Violation|0|||
30982941|NCT02513550|59114606|FG000|Double Blind Treatment Period|Physician Decision|2|||
30982942|NCT02513550|59114607|FG001|Double Blind Treatment Period|Physician Decision|0|||
30982943|NCT02513550|59114608|FG002|Double Blind Treatment Period|Physician Decision|4|||
30982944|NCT02513550|59114609|FG003|Double Blind Treatment Period|Physician Decision|0|||
30982945|NCT02513550|59114610|FG004|Double Blind Treatment Period|Physician Decision|0|||
30982946|NCT02513550|59114611|FG005|Double Blind Treatment Period|Physician Decision|0|||
30982947|NCT02513550|59114606|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
30982948|NCT02513550|59114607|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
30982949|NCT02513550|59114608|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
30982950|NCT02513550|59114609|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
30982951|NCT02513550|59114610|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
30982952|NCT02513550|59114611|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
30982953|NCT02513550|59114606|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
30982954|NCT02513550|59114607|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
30982955|NCT02513550|59114608|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
30982956|NCT02513550|59114609|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
30982957|NCT02513550|59114610|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
30982958|NCT02513550|59114611|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
30982959|NCT02513550|59114606|FG000|Double Blind Treatment Period|Due to personal business|2|||
30982960|NCT02513550|59114607|FG001|Double Blind Treatment Period|Due to personal business|0|||
30982961|NCT02513550|59114608|FG002|Double Blind Treatment Period|Due to personal business|1|||
30982962|NCT02513550|59114609|FG003|Double Blind Treatment Period|Due to personal business|0|||
30982963|NCT02513550|59114610|FG004|Double Blind Treatment Period|Due to personal business|0|||
30982964|NCT02513550|59114611|FG005|Double Blind Treatment Period|Due to personal business|0|||
30982965|NCT02513550|59114606|FG000|Double Blind Treatment Period|Death|1|||
30982966|NCT02513550|59114607|FG001|Double Blind Treatment Period|Death|0|||
30982967|NCT02513550|59114608|FG002|Double Blind Treatment Period|Death|2|||
30982968|NCT02513550|59114609|FG003|Double Blind Treatment Period|Death|0|||
30982969|NCT02513550|59114610|FG004|Double Blind Treatment Period|Death|0|||
30982970|NCT02513550|59114611|FG005|Double Blind Treatment Period|Death|0|||
30982971|NCT02513550|59114606|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
30982972|NCT02513550|59114607|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
30982973|NCT02513550|59114608|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
30982974|NCT02513550|59114609|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
30982975|NCT02513550|59114610|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
30982976|NCT02513550|59114611|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
30982977|NCT02513550|59114606|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
30982978|NCT02513550|59114607|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
30982979|NCT02513550|59114608|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
30982980|NCT02513550|59114609|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
30982981|NCT02513550|59114610|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
30982982|NCT02513550|59114611|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
30982983|NCT02513550|59114606|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
30982984|NCT02513550|59114607|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
30982985|NCT02513550|59114608|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
30982986|NCT02513550|59114609|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
30982987|NCT02513550|59114610|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
30982988|NCT02513550|59114611|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
30982989|NCT02513550|59114606|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
30982990|NCT02513550|59114607|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
30982991|NCT02513550|59114608|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
30982992|NCT02513550|59114609|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
30982993|NCT02513550|59114610|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
30982994|NCT02513550|59114611|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
30982995|NCT02513550|59114606|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
30982996|NCT02513550|59114607|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
30982997|NCT02513550|59114608|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
30982998|NCT02513550|59114609|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
30982999|NCT02513550|59114610|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
30983000|NCT02513550|59114611|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
30983001|NCT02513550|59114606|FG000|Post-Treatment Follow-up Period|Death|0|||
30983002|NCT02513550|59114607|FG001|Post-Treatment Follow-up Period|Death|0|||
30983003|NCT02513550|59114608|FG002|Post-Treatment Follow-up Period|Death|1|||
30983004|NCT02513550|59114609|FG003|Post-Treatment Follow-up Period|Death|0|||
30983005|NCT02513550|59114610|FG004|Post-Treatment Follow-up Period|Death|0|||
30983006|NCT02513550|59114611|FG005|Post-Treatment Follow-up Period|Death|0|||
30983007|NCT02513550|59114606|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
30983008|NCT02513550|59114607|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
30983009|NCT02513550|59114608|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
30983010|NCT02513550|59114609|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
30983011|NCT02513550|59114610|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
30983012|NCT02513550|59114611|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
30983013|NCT02513550|59114606|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
30983014|NCT02513550|59114607|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
30983015|NCT02513550|59114608|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
30983016|NCT02513550|59114609|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
30983017|NCT02513550|59114610|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
30983018|NCT02513550|59114611|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
30983019|NCT02513550|59114606|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
30983020|NCT02513550|59114607|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
30983021|NCT02513550|59114608|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
30983022|NCT02513550|59114609|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
30983023|NCT02513550|59114610|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
30983024|NCT02513550|59114611|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
30983025|NCT02513472|59114928|FG000|Overall Study|Radiological Disease Progression|45|||
30983026|NCT02513472|59114929|FG001|Overall Study|Radiological Disease Progression|57|||
30983027|NCT02513472|59114928|FG000|Overall Study|Clinical Disease Progression|5|||
30983028|NCT02513472|59114929|FG001|Overall Study|Clinical Disease Progression|13|||
30983029|NCT02513472|59114928|FG000|Overall Study|Adverse Event|8|||
30983030|NCT02513472|59114929|FG001|Overall Study|Adverse Event|11|||
30983031|NCT02513472|59114928|FG000|Overall Study|Withdrawal by Subject|0|||
30983032|NCT02513472|59114929|FG001|Overall Study|Withdrawal by Subject|4|||
30983033|NCT02513472|59114928|FG000|Overall Study|Subject Choice|2|||
30983034|NCT02513472|59114929|FG001|Overall Study|Subject Choice|7|||
30983035|NCT02513472|59114928|FG000|Overall Study|Treatment Completed as per Protocol|3|||
30983036|NCT02513472|59114929|FG001|Overall Study|Treatment Completed as per Protocol|3|||
30983037|NCT02513472|59114928|FG000|Overall Study|Other|3|||
30983038|NCT02513472|59114929|FG001|Overall Study|Other|6|||
30983039|NCT04490395|59115158|FG000|Overall Study|Lost to Follow-up|0|||
30983040|NCT04490395|59115159|FG001|Overall Study|Lost to Follow-up|1|||
30983041|NCT03843541|59115602|FG000|Overall Study|Adverse Event|4|||
30983042|NCT03843541|59115603|FG001|Overall Study|Adverse Event|2|||
30983043|NCT03843541|59115604|FG002|Overall Study|Adverse Event|3|||
30983044|NCT03843541|59115602|FG000|Overall Study|Death|1|||
30983045|NCT03843541|59115603|FG001|Overall Study|Death|0|||
30983046|NCT03843541|59115604|FG002|Overall Study|Death|0|||
30983047|NCT03843541|59115602|FG000|Overall Study|Lack of adherence to study medication|0|||
30983048|NCT03843541|59115603|FG001|Overall Study|Lack of adherence to study medication|0|||
30983049|NCT03843541|59115604|FG002|Overall Study|Lack of adherence to study medication|1|||
30983050|NCT03843541|59115602|FG000|Overall Study|Physician Decision|1|||
30983051|NCT03843541|59115603|FG001|Overall Study|Physician Decision|2|||
30983052|NCT03843541|59115604|FG002|Overall Study|Physician Decision|2|||
30983053|NCT03843541|59115602|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
30983054|NCT03843541|59115603|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
30983055|NCT03843541|59115604|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
30983056|NCT03843541|59115602|FG000|Overall Study|Withdrawal by Subject|6|||
30983057|NCT03843541|59115603|FG001|Overall Study|Withdrawal by Subject|9|||
30983058|NCT03843541|59115604|FG002|Overall Study|Withdrawal by Subject|7|||
30983059|NCT03843541|59115602|FG000|Overall Study|Administration of rescue mucolytic|0|||
30983060|NCT03843541|59115603|FG001|Overall Study|Administration of rescue mucolytic|0|||
30983061|NCT03843541|59115604|FG002|Overall Study|Administration of rescue mucolytic|1|||
30983062|NCT03843541|59115602|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
30983063|NCT03843541|59115603|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
30983064|NCT03843541|59115604|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
30983065|NCT02992418|59116867|FG000|Overall Study|Withdrawal by Subject|11|||
30983066|NCT02992418|59116868|FG001|Overall Study|Withdrawal by Subject|12|||
30983067|NCT02992418|59116867|FG000|Overall Study|Non-compliance with the protocol|308|||
30983068|NCT02992418|59116868|FG001|Overall Study|Non-compliance with the protocol|308|||
30983069|NCT02992418|59116867|FG000|Overall Study|Lost to Follow-up|27|||
30983070|NCT02992418|59116868|FG001|Overall Study|Lost to Follow-up|22|||
30983071|NCT01276106|59117110|FG000|Overall Study|Adverse Event|3|||
30983072|NCT01276106|59117111|FG001|Overall Study|Adverse Event|3|||
30983073|NCT01276106|59117112|FG002|Overall Study|Adverse Event|11|||
30983074|NCT01276106|59117113|FG003|Overall Study|Adverse Event|3|||
30983075|NCT01276106|59117110|FG000|Overall Study|Withdrawal by Subject|6|||
30983076|NCT01276106|59117111|FG001|Overall Study|Withdrawal by Subject|3|||
30983077|NCT01276106|59117112|FG002|Overall Study|Withdrawal by Subject|1|||
30983078|NCT01276106|59117113|FG003|Overall Study|Withdrawal by Subject|6|||
30983079|NCT01276106|59117110|FG000|Overall Study|Lack of Efficacy|0|||
30983080|NCT01276106|59117111|FG001|Overall Study|Lack of Efficacy|1|||
30983081|NCT01276106|59117112|FG002|Overall Study|Lack of Efficacy|0|||
30983082|NCT01276106|59117113|FG003|Overall Study|Lack of Efficacy|1|||
30983083|NCT01276106|59117110|FG000|Overall Study|Lost to Follow-up|2|||
30983084|NCT01276106|59117111|FG001|Overall Study|Lost to Follow-up|1|||
30983085|NCT01276106|59117112|FG002|Overall Study|Lost to Follow-up|1|||
30983086|NCT01276106|59117113|FG003|Overall Study|Lost to Follow-up|0|||
30983087|NCT01276106|59117110|FG000|Overall Study|Physician Decision|0|||
30983088|NCT01276106|59117111|FG001|Overall Study|Physician Decision|0|||
30983089|NCT01276106|59117112|FG002|Overall Study|Physician Decision|1|||
30983090|NCT01276106|59117113|FG003|Overall Study|Physician Decision|1|||
30983091|NCT01276106|59117110|FG000|Overall Study|Protocol Violation|1|||
30983092|NCT01276106|59117111|FG001|Overall Study|Protocol Violation|1|||
30983093|NCT01276106|59117112|FG002|Overall Study|Protocol Violation|0|||
30983094|NCT01276106|59117113|FG003|Overall Study|Protocol Violation|2|||
30983095|NCT01276106|59117110|FG000|Overall Study|Insufficient therapeutic effects|0|||
30983096|NCT01276106|59117111|FG001|Overall Study|Insufficient therapeutic effects|0|||
30983097|NCT01276106|59117112|FG002|Overall Study|Insufficient therapeutic effects|2|||
30983098|NCT01276106|59117113|FG003|Overall Study|Insufficient therapeutic effects|0|||
30983099|NCT01275170|59117131|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
30983100|NCT01275170|59117132|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
30983101|NCT01275170|59117133|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
30983102|NCT01275170|59117134|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
30983103|NCT01275170|59117135|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
30983104|NCT01275170|59117136|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
30983105|NCT01275170|59117137|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
30983106|NCT01275170|59117138|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
30983107|NCT01273064|59117185|FG000|Overall Study|Adverse Event|5|||
30983108|NCT01273064|59117186|FG001|Overall Study|Adverse Event|1|||
30983109|NCT01273064|59117187|FG002|Overall Study|Adverse Event|3|||
30983110|NCT01273064|59117188|FG003|Overall Study|Adverse Event|2|||
30983111|NCT01273064|59117189|FG004|Overall Study|Adverse Event|1|||
30983112|NCT01273064|59117185|FG000|Overall Study|Withdrawal by Subject|4|||
30983113|NCT01273064|59117186|FG001|Overall Study|Withdrawal by Subject|2|||
30983114|NCT01273064|59117187|FG002|Overall Study|Withdrawal by Subject|2|||
30983115|NCT01273064|59117188|FG003|Overall Study|Withdrawal by Subject|2|||
30983116|NCT01273064|59117189|FG004|Overall Study|Withdrawal by Subject|0|||
30983117|NCT01273064|59117185|FG000|Overall Study|Study Termination|13|||
30983118|NCT01273064|59117186|FG001|Overall Study|Study Termination|27|||
30983119|NCT01273064|59117187|FG002|Overall Study|Study Termination|26|||
30983120|NCT01273064|59117188|FG003|Overall Study|Study Termination|16|||
30983121|NCT01273064|59117189|FG004|Overall Study|Study Termination|8|||
30983122|NCT01273064|59117185|FG000|Overall Study|Lost to Follow-up|1|||
30983123|NCT01273064|59117186|FG001|Overall Study|Lost to Follow-up|0|||
30983124|NCT01273064|59117187|FG002|Overall Study|Lost to Follow-up|0|||
30983125|NCT01273064|59117188|FG003|Overall Study|Lost to Follow-up|0|||
30983126|NCT01273064|59117189|FG004|Overall Study|Lost to Follow-up|0|||
30983127|NCT01273064|59117185|FG000|Overall Study|Physician Decision|0|||
30983128|NCT01273064|59117186|FG001|Overall Study|Physician Decision|0|||
30983129|NCT01273064|59117187|FG002|Overall Study|Physician Decision|0|||
30983130|NCT01273064|59117188|FG003|Overall Study|Physician Decision|0|||
30983131|NCT01273064|59117189|FG004|Overall Study|Physician Decision|1|||
30983132|NCT01272908|59117201|FG000|Initial Treatment Period|Adverse Event|1|||
30983133|NCT01272908|59117201|FG000|Initial Treatment Period|Lack of Efficacy|5|||
30983134|NCT01272908|59117201|FG000|Initial Treatment Period|Protocol Violation|1|||
30983135|NCT01272908|59117201|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
30983136|NCT01272908|59117201|FG000|Re-Treatment Period|Adverse Event|2|||
30983137|NCT01272908|59117201|FG000|Re-Treatment Period|Lack of Efficacy|3|||
30983138|NCT01272908|59117201|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
30983139|NCT01271504|59117211|FG000|Overall Study|Death|7|||
30983140|NCT01271504|59117212|FG001|Overall Study|Death|6|||
30983141|NCT01271504|59117213|FG002|Overall Study|Death|32|||
30983142|NCT01271504|59117214|FG003|Overall Study|Death|32|||
30983143|NCT01271504|59117211|FG000|Overall Study|Lost to Follow-up|0|||
30983144|NCT01271504|59117212|FG001|Overall Study|Lost to Follow-up|1|||
30983145|NCT01271504|59117213|FG002|Overall Study|Lost to Follow-up|3|||
30983146|NCT01271504|59117214|FG003|Overall Study|Lost to Follow-up|1|||
30983147|NCT01271504|59117211|FG000|Overall Study|Protocol Violation|0|||
30983148|NCT01271504|59117212|FG001|Overall Study|Protocol Violation|0|||
30983149|NCT01271504|59117213|FG002|Overall Study|Protocol Violation|0|||
30983150|NCT01271504|59117214|FG003|Overall Study|Protocol Violation|2|||
30983151|NCT01271504|59117211|FG000|Overall Study|Administrative Reasons|0|||
30983152|NCT01271504|59117212|FG001|Overall Study|Administrative Reasons|0|||
30983153|NCT01271504|59117213|FG002|Overall Study|Administrative Reasons|6|||
30983154|NCT01271504|59117214|FG003|Overall Study|Administrative Reasons|5|||
30983155|NCT01271504|59117211|FG000|Overall Study|Withdrawal by Subject|0|||
30983156|NCT01271504|59117212|FG001|Overall Study|Withdrawal by Subject|0|||
30983157|NCT01271504|59117213|FG002|Overall Study|Withdrawal by Subject|1|||
30983158|NCT01271504|59117214|FG003|Overall Study|Withdrawal by Subject|3|||
30891556|NCT02217345|58924718|FG000|Overall Study|Adverse Event|2|||
30891557|NCT02217345|58924719|FG001|Overall Study|Adverse Event|1|||
30891558|NCT02217345|58924718|FG000|Overall Study|Physician Decision|0|||
30891559|NCT02217345|58924719|FG001|Overall Study|Physician Decision|1|||
30891560|NCT01652287|58924727|FG000|Overall Study|Withdrawal by Subject|2|||
30891561|NCT01652287|58924728|FG001|Overall Study|Withdrawal by Subject|0|||
30891562|NCT02251743|58924736|FG000|Overall Study|Withdrawal by Subject|1|||
30983159|NCT01271504|59117211|FG000|Overall Study|Other|0|||
30983160|NCT01271504|59117212|FG001|Overall Study|Other|1|||
30983161|NCT01271504|59117213|FG002|Overall Study|Other|2|||
30983162|NCT01271504|59117214|FG003|Overall Study|Other|0|||
30983163|NCT01270958|59117257|FG000|Overall Study|Lost to Follow-up|2|||
30891563|NCT02251743|58924737|FG001|Overall Study|Withdrawal by Subject|1|||
30983164|NCT01270958|59117257|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
30983165|NCT01270880|59117261|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
30983166|NCT01270802|59117267|FG000|Overall Study|Withdrawal by Subject|1|||
30983167|NCT01270802|59117268|FG001|Overall Study|Withdrawal by Subject|0|||
30983168|NCT01270802|59117267|FG000|Overall Study|Adverse Event|1|||
30983169|NCT01270802|59117268|FG001|Overall Study|Adverse Event|0|||
30983170|NCT01270802|59117267|FG000|Overall Study|Lost to Follow-up|0|||
30983171|NCT01270802|59117268|FG001|Overall Study|Lost to Follow-up|1|||
30983172|NCT01270256|59117277|FG000|Overall Study|Withdrawal by Subject|1|||
30983173|NCT01270256|59117278|FG001|Overall Study|Withdrawal by Subject|0|||
30983174|NCT01279616|59117348|FG000|Overall Study|donor could not be located|5|||
30983175|NCT01279616|59117348|FG000|Overall Study|no signs of sickle cell disease|2|||
30983176|NCT01279070|59117359|FG000|Overall Study|Withdrawal by Subject|2|||
30983177|NCT01279070|59117360|FG001|Overall Study|Withdrawal by Subject|3|||
30983178|NCT01279070|59117359|FG000|Overall Study|Acute exacerbation|3|||
30983179|NCT01279070|59117360|FG001|Overall Study|Acute exacerbation|1|||
30983180|NCT01277744|59117370|FG000|Overall Study|Physician Decision|2|||
30983181|NCT01277822|59117376|FG000|Overall Study|Adverse Event|2|||
30983182|NCT01277822|59117377|FG001|Overall Study|Adverse Event|1|||
30983183|NCT01277822|59117376|FG000|Overall Study|Withdrawal by Subject|6|||
30983184|NCT01277822|59117377|FG001|Overall Study|Withdrawal by Subject|7|||
30983185|NCT01277822|59117376|FG000|Overall Study|Physician Decision|1|||
30983186|NCT01277822|59117377|FG001|Overall Study|Physician Decision|1|||
30983187|NCT01277822|59117376|FG000|Overall Study|Protocol Violation|1|||
30983188|NCT01277822|59117377|FG001|Overall Study|Protocol Violation|0|||
30983189|NCT01277822|59117376|FG000|Overall Study|Lost to Follow-up|2|||
30983190|NCT01277822|59117377|FG001|Overall Study|Lost to Follow-up|1|||
30983191|NCT01277822|59117376|FG000|Overall Study|Contraindicated medication used|2|||
30983192|NCT01277822|59117377|FG001|Overall Study|Contraindicated medication used|1|||
30983193|NCT01277822|59117376|FG000|Overall Study|Participant moved|1|||
30983194|NCT01277822|59117377|FG001|Overall Study|Participant moved|0|||
30983195|NCT01277666|59117386|FG000|Overall Study|Adverse Event|26|||
30983196|NCT01277666|59117387|FG001|Overall Study|Adverse Event|25|||
30983197|NCT01277666|59117388|FG002|Overall Study|Adverse Event|20|||
30983198|NCT01277666|59117386|FG000|Overall Study|Lack of Efficacy|8|||
30983199|NCT01277666|59117387|FG001|Overall Study|Lack of Efficacy|20|||
30983200|NCT01277666|59117388|FG002|Overall Study|Lack of Efficacy|12|||
30983201|NCT01277666|59117386|FG000|Overall Study|Protocol Violation|2|||
30983202|NCT01277666|59117387|FG001|Overall Study|Protocol Violation|3|||
30983203|NCT01277666|59117388|FG002|Overall Study|Protocol Violation|2|||
30983204|NCT01277666|59117386|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
30983205|NCT01277666|59117387|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
30983206|NCT01277666|59117388|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
30983207|NCT01277666|59117386|FG000|Overall Study|Lost to Follow-up|1|||
30983208|NCT01277666|59117387|FG001|Overall Study|Lost to Follow-up|1|||
30983209|NCT01277666|59117388|FG002|Overall Study|Lost to Follow-up|2|||
30983210|NCT01277666|59117386|FG000|Overall Study|Withdrawal by Subject|7|||
30983211|NCT01277666|59117387|FG001|Overall Study|Withdrawal by Subject|8|||
30983212|NCT01277666|59117388|FG002|Overall Study|Withdrawal by Subject|6|||
30983213|NCT01277666|59117386|FG000|Overall Study|Death|0|||
30983214|NCT01277666|59117387|FG001|Overall Study|Death|0|||
30983215|NCT01277666|59117388|FG002|Overall Study|Death|1|||
30983216|NCT00249002|59117396|FG000|Overall Study|Adverse Event|2|||
30983217|NCT00249002|59117396|FG000|Overall Study|Study cancellation|3|||
30983218|NCT00249002|59117396|FG000|Overall Study|Other|2|||
30983219|NCT01277042|59117402|FG000|Overall Study|Adverse Event|4|||
30983220|NCT01277042|59117403|FG001|Overall Study|Adverse Event|3|||
30983221|NCT01277042|59117402|FG000|Overall Study|Lost to Follow-up|2|||
30983222|NCT01277042|59117403|FG001|Overall Study|Lost to Follow-up|2|||
30983223|NCT01277042|59117402|FG000|Overall Study|Withdrawal by Subject|2|||
30983224|NCT01277042|59117403|FG001|Overall Study|Withdrawal by Subject|0|||
30983225|NCT00246740|59117443|FG000|Initial Enrollment|Death|1|||
30983226|NCT00246740|59117444|FG001|Initial Enrollment|Death|0|||
30983227|NCT00246740|59117443|FG000|Initial Enrollment|Additional surgery scheduled|0|||
30983228|NCT00246740|59117444|FG001|Initial Enrollment|Additional surgery scheduled|2|||
30983229|NCT00246740|59117443|FG000|Initial Enrollment|Surgery schedule change|4|||
30983230|NCT00246740|59117444|FG001|Initial Enrollment|Surgery schedule change|4|||
30983231|NCT00246740|59117443|FG000|Initial Enrollment|Other|1|||
30983232|NCT00246740|59117444|FG001|Initial Enrollment|Other|2|||
30983233|NCT00245102|59117489|FG000|Overall Study|Not Treated|1|||
30983234|NCT00245102|59117490|FG001|Overall Study|Not Treated|0|||
30983235|NCT00245102|59117491|FG002|Overall Study|Not Treated|1|||
30983236|NCT00245102|59117492|FG003|Overall Study|Not Treated|0|||
30983237|NCT00245102|59117493|FG004|Overall Study|Not Treated|0|||
30983238|NCT00245102|59117494|FG005|Overall Study|Not Treated|0|||
30983239|NCT00245102|59117489|FG000|Overall Study|Protocol Violation|1|||
30983240|NCT00245102|59117490|FG001|Overall Study|Protocol Violation|0|||
30983241|NCT00245102|59117491|FG002|Overall Study|Protocol Violation|0|||
30983242|NCT00245102|59117492|FG003|Overall Study|Protocol Violation|0|||
30983243|NCT00245102|59117493|FG004|Overall Study|Protocol Violation|0|||
30983244|NCT00245102|59117494|FG005|Overall Study|Protocol Violation|0|||
30983245|NCT00245102|59117489|FG000|Overall Study|Death|0|||
30983246|NCT00245102|59117490|FG001|Overall Study|Death|0|||
30983247|NCT00245102|59117491|FG002|Overall Study|Death|0|||
30983248|NCT00245102|59117492|FG003|Overall Study|Death|1|||
30983249|NCT00245102|59117493|FG004|Overall Study|Death|0|||
30983250|NCT00245102|59117494|FG005|Overall Study|Death|0|||
30983251|NCT00245102|59117489|FG000|Overall Study|Adverse Event|4|||
30983252|NCT00245102|59117490|FG001|Overall Study|Adverse Event|2|||
30983253|NCT00245102|59117491|FG002|Overall Study|Adverse Event|5|||
30983254|NCT00245102|59117492|FG003|Overall Study|Adverse Event|1|||
30983255|NCT00245102|59117493|FG004|Overall Study|Adverse Event|0|||
30983256|NCT00245102|59117494|FG005|Overall Study|Adverse Event|2|||
30983257|NCT00245102|59117489|FG000|Overall Study|Decline in performance|0|||
30983258|NCT00245102|59117490|FG001|Overall Study|Decline in performance|2|||
30983259|NCT00245102|59117491|FG002|Overall Study|Decline in performance|0|||
30983260|NCT00245102|59117492|FG003|Overall Study|Decline in performance|1|||
30983261|NCT00245102|59117493|FG004|Overall Study|Decline in performance|0|||
30983262|NCT00245102|59117494|FG005|Overall Study|Decline in performance|2|||
30983263|NCT00245102|59117489|FG000|Overall Study|Participant needed surgery|0|||
30983264|NCT00245102|59117490|FG001|Overall Study|Participant needed surgery|0|||
30983265|NCT00245102|59117491|FG002|Overall Study|Participant needed surgery|1|||
30983266|NCT00245102|59117492|FG003|Overall Study|Participant needed surgery|0|||
30983267|NCT00245102|59117493|FG004|Overall Study|Participant needed surgery|0|||
30983268|NCT00245102|59117494|FG005|Overall Study|Participant needed surgery|0|||
30983269|NCT00245102|59117489|FG000|Overall Study|Clinical progression|1|||
30983270|NCT00245102|59117490|FG001|Overall Study|Clinical progression|0|||
30983271|NCT00245102|59117491|FG002|Overall Study|Clinical progression|0|||
30983272|NCT00245102|59117492|FG003|Overall Study|Clinical progression|0|||
30983273|NCT00245102|59117493|FG004|Overall Study|Clinical progression|0|||
30983274|NCT00245102|59117494|FG005|Overall Study|Clinical progression|0|||
30983275|NCT00244712|59117539|FG000|Overall Study|Adverse Event|20|||
30983276|NCT00244712|59117540|FG001|Overall Study|Adverse Event|21|||
30983277|NCT00244712|59117539|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
30983278|NCT00244712|59117540|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
30983279|NCT00244712|59117539|FG000|Overall Study|Lack of Compliance|10|||
30983280|NCT00244712|59117540|FG001|Overall Study|Lack of Compliance|11|||
30983281|NCT00244712|59117539|FG000|Overall Study|Lost to Follow-up|45|||
30983282|NCT00244712|59117540|FG001|Overall Study|Lost to Follow-up|52|||
30983283|NCT00244712|59117539|FG000|Overall Study|Withdrawal by Subject|13|||
30983284|NCT00244712|59117540|FG001|Overall Study|Withdrawal by Subject|23|||
30983285|NCT00244712|59117539|FG000|Overall Study|Protocol Violation, disease progression|13|||
30983286|NCT00244712|59117540|FG001|Overall Study|Protocol Violation, disease progression|11|||
30983287|NCT00243932|59117558|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
30983288|NCT00243932|59117559|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
30983289|NCT00243932|59117560|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
30983290|NCT00243386|59117568|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
30983291|NCT00243386|59117569|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
30983292|NCT00243386|59117570|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
30983293|NCT00243386|59117568|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
30891564|NCT02428855|58924743|FG000|Overall Study|Withdrawal by Subject|2|||
30891565|NCT02428699|58924747|FG000|Washout Period 1|Screen Failure|1|||
30891566|NCT02428699|58924748|FG001|Washout Period 1|Screen Failure|2|||
30891567|NCT02428231|58924761|FG000|Overall Study|Other|10|||
30891568|NCT02428231|58924762|FG001|Overall Study|Other|16|||
30891569|NCT02428231|58924761|FG000|Overall Study|Required Symptomatic Therapy|0|||
30891570|NCT02428231|58924762|FG001|Overall Study|Required Symptomatic Therapy|1|||
30891571|NCT02428231|58924761|FG000|Overall Study|Adverse Event|3|||
30983294|NCT00243386|59117569|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
30983295|NCT00243386|59117570|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
30983296|NCT00243386|59117568|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
30983297|NCT00243386|59117569|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
30983298|NCT00243386|59117570|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
30983299|NCT00243386|59117568|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
30983300|NCT00243386|59117569|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
30983301|NCT00243386|59117570|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
30983302|NCT00243386|59117568|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
30983303|NCT00243386|59117569|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
30983304|NCT00243386|59117570|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
30983305|NCT00243386|59117568|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
30983306|NCT00243386|59117569|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
30983307|NCT00243386|59117570|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
30983308|NCT00243386|59117568|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
30983309|NCT00243386|59117569|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
30983310|NCT00243386|59117570|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
30983311|NCT00243386|59117568|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
30983312|NCT00243386|59117569|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
30983313|NCT00243386|59117570|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
30983314|NCT00243230|59117629|FG000|Double-Blind Period|Adverse Event|0|||
30983315|NCT00243230|59117630|FG001|Double-Blind Period|Adverse Event|2|||
30983316|NCT00243230|59117631|FG002|Double-Blind Period|Adverse Event|2|||
30983317|NCT00243230|59117632|FG003|Double-Blind Period|Adverse Event|0|||
30983318|NCT00243230|59117629|FG000|Double-Blind Period|Withdrawal by Subject|1|||
30983319|NCT00243230|59117630|FG001|Double-Blind Period|Withdrawal by Subject|0|||
30983320|NCT00243230|59117631|FG002|Double-Blind Period|Withdrawal by Subject|0|||
30983321|NCT00243230|59117632|FG003|Double-Blind Period|Withdrawal by Subject|0|||
30983322|NCT00243230|59117629|FG000|Double-Blind Period|Protocol Violation|0|||
30983323|NCT00243230|59117630|FG001|Double-Blind Period|Protocol Violation|0|||
30983324|NCT00243230|59117631|FG002|Double-Blind Period|Protocol Violation|1|||
30983325|NCT00243230|59117632|FG003|Double-Blind Period|Protocol Violation|0|||
30983326|NCT00243230|59117629|FG000|Double-Blind Period|Randomized but Not Treated|0|||
30983327|NCT00243230|59117630|FG001|Double-Blind Period|Randomized but Not Treated|0|||
30983328|NCT00243230|59117631|FG002|Double-Blind Period|Randomized but Not Treated|2|||
30983329|NCT00243230|59117632|FG003|Double-Blind Period|Randomized but Not Treated|0|||
30983330|NCT00243230|59117629|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
30983331|NCT00243230|59117630|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
30983332|NCT00243230|59117631|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
30983333|NCT00243230|59117632|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
30983334|NCT00243230|59117629|FG000|Open Label Period|Adverse Event|0|||
30983335|NCT00243230|59117630|FG001|Open Label Period|Adverse Event|0|||
30983336|NCT00243230|59117631|FG002|Open Label Period|Adverse Event|0|||
30983337|NCT00243230|59117632|FG003|Open Label Period|Adverse Event|2|||
30983338|NCT00243230|59117629|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
30983339|NCT00243230|59117630|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
30983340|NCT00243230|59117631|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
30983341|NCT00243230|59117632|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
30983342|NCT00243230|59117629|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
30983343|NCT00243230|59117630|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
30983344|NCT00243230|59117631|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
30983345|NCT00243230|59117632|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
30983346|NCT00243230|59117629|FG000|Open Label Period|Lost to Follow-up|0|||
30983347|NCT00243230|59117630|FG001|Open Label Period|Lost to Follow-up|0|||
30983348|NCT00243230|59117631|FG002|Open Label Period|Lost to Follow-up|0|||
30983349|NCT00243230|59117632|FG003|Open Label Period|Lost to Follow-up|2|||
30983350|NCT00243230|59117629|FG000|Open Label Period|Withdrawal by Subject|0|||
30983351|NCT00243230|59117630|FG001|Open Label Period|Withdrawal by Subject|0|||
30983352|NCT00243230|59117631|FG002|Open Label Period|Withdrawal by Subject|0|||
30983353|NCT00243230|59117632|FG003|Open Label Period|Withdrawal by Subject|2|||
30983354|NCT00243230|59117629|FG000|Open Label Period|Protocol Violation|0|||
30983355|NCT00243230|59117630|FG001|Open Label Period|Protocol Violation|0|||
30983356|NCT00243230|59117631|FG002|Open Label Period|Protocol Violation|0|||
30983357|NCT00243230|59117632|FG003|Open Label Period|Protocol Violation|2|||
30983358|NCT00243230|59117629|FG000|Open Label Period|Administrative Reason|0|||
30983359|NCT00243230|59117630|FG001|Open Label Period|Administrative Reason|0|||
30983360|NCT00243230|59117631|FG002|Open Label Period|Administrative Reason|0|||
30983361|NCT00243230|59117632|FG003|Open Label Period|Administrative Reason|63|||
30983362|NCT00243074|59117642|FG000|Overall Study|Ineligible|6|||
30983363|NCT00243074|59117642|FG000|Overall Study|Adverse Event|6|||
30983364|NCT00243074|59117642|FG000|Overall Study|Withdrawal by Subject|2|||
30983365|NCT00243074|59117642|FG000|Overall Study|Lack of Efficacy|36|||
30983366|NCT00243074|59117642|FG000|Overall Study|Death|2|||
30983367|NCT00243074|59117642|FG000|Overall Study|not protocol specified|1|||
30983368|NCT00243074|59117642|FG000|Overall Study|Did not receive any treatment|1|||
30983369|NCT00241358|59117650|FG000|Overall Study|Determined to be not ineligible|0|||
30983370|NCT00241358|59117651|FG001|Overall Study|Determined to be not ineligible|1|||
30983371|NCT00241358|59117652|FG002|Overall Study|Determined to be not ineligible|1|||
30983372|NCT00241280|59117661|FG000|Overall Study|Adverse Event|2|||
30983373|NCT00241280|59117662|FG001|Overall Study|Adverse Event|6|||
30983374|NCT00241280|59117661|FG000|Overall Study|Discomfort|11|||
30983375|NCT00241280|59117662|FG001|Overall Study|Discomfort|16|||
30983376|NCT00241280|59117661|FG000|Overall Study|Pregnancy|1|||
30983377|NCT00241280|59117662|FG001|Overall Study|Pregnancy|5|||
30983378|NCT00241280|59117661|FG000|Overall Study|Lost to Follow-up|5|||
30983379|NCT00241280|59117662|FG001|Overall Study|Lost to Follow-up|8|||
30983380|NCT00241280|59117661|FG000|Overall Study|Withdrawal by Subject|7|||
30983381|NCT00241280|59117662|FG001|Overall Study|Withdrawal by Subject|4|||
30983382|NCT00241280|59117661|FG000|Overall Study|Protocol Violation|4|||
30983383|NCT00241280|59117662|FG001|Overall Study|Protocol Violation|10|||
30983384|NCT00241280|59117661|FG000|Overall Study|Relocation|4|||
30983385|NCT00241280|59117662|FG001|Overall Study|Relocation|4|||
30983386|NCT00241280|59117661|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
30983387|NCT00241280|59117662|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
30983388|NCT00241280|59117661|FG000|Overall Study|Unsatisfactory Visual Response|1|||
30983389|NCT00241280|59117662|FG001|Overall Study|Unsatisfactory Visual Response|1|||
30983390|NCT00241280|59117661|FG000|Overall Study|Diabetic|1|||
30983391|NCT00241280|59117662|FG001|Overall Study|Diabetic|0|||
30983392|NCT00241280|59117661|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
30983393|NCT00241280|59117662|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
30983394|NCT00241280|59117661|FG000|Overall Study|Dispensed incorrect test article|1|||
30983395|NCT00241280|59117662|FG001|Overall Study|Dispensed incorrect test article|2|||
30983396|NCT00241280|59117661|FG000|Overall Study|Unacceptable Fit|0|||
30983397|NCT00241280|59117662|FG001|Overall Study|Unacceptable Fit|1|||
30983398|NCT00241280|59117661|FG000|Overall Study|Scheduling Conflict|0|||
30983399|NCT00241280|59117662|FG001|Overall Study|Scheduling Conflict|2|||
30983400|NCT00241280|59117661|FG000|Overall Study|History of Ocular Surgery|0|||
30983401|NCT00241280|59117662|FG001|Overall Study|History of Ocular Surgery|1|||
30983402|NCT00241280|59117661|FG000|Overall Study|Coating on Lens|1|||
30983403|NCT00241280|59117662|FG001|Overall Study|Coating on Lens|0|||
30983404|NCT00241280|59117661|FG000|Overall Study|Excessive Dryness|0|||
30983405|NCT00241280|59117662|FG001|Overall Study|Excessive Dryness|1|||
30983406|NCT04278872|59118239|FG000|Overall Study|Adverse Event|1|||
30983407|NCT04278872|59118240|FG001|Overall Study|Adverse Event|0|||
30983408|NCT04278872|59118239|FG000|Overall Study|Protocol Violation|0|||
30983409|NCT04278872|59118240|FG001|Overall Study|Protocol Violation|1|||
30983410|NCT04278872|59118239|FG000|Overall Study|Study Termination|2|||
30983411|NCT04278872|59118240|FG001|Overall Study|Study Termination|0|||
30983412|NCT02513160|59120720|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
30983413|NCT02513160|59120721|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
30983414|NCT02513160|59120722|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
30983415|NCT02513160|59120723|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
30983416|NCT02513160|59120720|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
30983417|NCT02513160|59120721|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
30983418|NCT02513160|59120722|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
30983419|NCT02513160|59120723|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
30983420|NCT02513160|59120720|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
30983421|NCT02513160|59120721|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
30983422|NCT02513160|59120722|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
30983423|NCT02513160|59120723|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
30983424|NCT02513160|59120720|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
30983425|NCT02513160|59120721|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
30983426|NCT02513160|59120722|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
30983427|NCT02513160|59120723|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
30983428|NCT02513160|59120720|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
30983429|NCT02513160|59120721|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
30983430|NCT02513160|59120722|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
30983431|NCT02513160|59120723|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
30983432|NCT02513160|59120720|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
30983433|NCT02513160|59120721|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
30983434|NCT02513160|59120722|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
30983435|NCT02513160|59120723|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
30983436|NCT02513160|59120720|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
30983437|NCT02513160|59120721|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
30983438|NCT02513160|59120722|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
30983439|NCT02513160|59120723|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
30983440|NCT02513160|59120720|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
30983441|NCT02513160|59120721|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
30983442|NCT02513160|59120722|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
30983443|NCT02513160|59120723|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
30983444|NCT02513160|59120720|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
30983445|NCT02513160|59120721|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
30983446|NCT02513160|59120722|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
30983447|NCT02513160|59120723|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
30983448|NCT02513160|59120720|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
30983449|NCT02513160|59120721|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
30983450|NCT02513160|59120722|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
30983451|NCT02513160|59120723|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
30983452|NCT02513160|59120720|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
30983453|NCT02513160|59120721|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
30983454|NCT02513160|59120722|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
30983455|NCT02513160|59120723|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
30983456|NCT02513160|59120720|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
30983457|NCT02513160|59120721|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
30983458|NCT02513160|59120722|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
30983459|NCT02513160|59120723|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
30983460|NCT02480010|59120758|FG000|Overall Study|Adverse Event|3|||
30983461|NCT02480010|59120759|FG001|Overall Study|Adverse Event|1|||
30983462|NCT02480010|59120758|FG000|Overall Study|Death|1|||
30983463|NCT02480010|59120759|FG001|Overall Study|Death|0|||
30983464|NCT02480010|59120758|FG000|Overall Study|Insufficient therapeutic response|31|||
30983465|NCT02480010|59120759|FG001|Overall Study|Insufficient therapeutic response|29|||
30983466|NCT02480010|59120758|FG000|Overall Study|Refused Treatment|0|||
30983467|NCT02480010|59120759|FG001|Overall Study|Refused Treatment|3|||
30983468|NCT02512302|59120787|FG000|Period 1|Adverse Event|0|||
30983469|NCT02512302|59120788|FG001|Period 1|Adverse Event|1|||
30983470|NCT02512302|59120789|FG002|Period 1|Adverse Event|0|||
30983471|NCT02512302|59120790|FG003|Period 1|Adverse Event|0|||
30983472|NCT02512302|59120791|FG004|Period 1|Adverse Event|0|||
30983473|NCT02512302|59120792|FG005|Period 1|Adverse Event|0|||
30983474|NCT02512302|59120793|FG006|Period 1|Adverse Event|0|||
30983475|NCT02512302|59120794|FG007|Period 1|Adverse Event|0|||
30983476|NCT02512302|59120795|FG008|Period 1|Adverse Event|0|||
30983477|NCT02512302|59120796|FG009|Period 1|Adverse Event|0|||
30983478|NCT02512302|59120787|FG000|Period 2|Adverse Event|0|||
30983479|NCT02512302|59120788|FG001|Period 2|Adverse Event|0|||
30983480|NCT02512302|59120789|FG002|Period 2|Adverse Event|0|||
30983481|NCT02512302|59120790|FG003|Period 2|Adverse Event|0|||
30983482|NCT02512302|59120791|FG004|Period 2|Adverse Event|0|||
30983483|NCT02512302|59120792|FG005|Period 2|Adverse Event|0|||
30983484|NCT02512302|59120793|FG006|Period 2|Adverse Event|0|||
30983485|NCT02512302|59120794|FG007|Period 2|Adverse Event|0|||
30983486|NCT02512302|59120795|FG008|Period 2|Adverse Event|0|||
30983487|NCT02512302|59120796|FG009|Period 2|Adverse Event|1|||
30983488|NCT02512302|59120787|FG000|Period 3|Lost to Follow-up|0|||
30983489|NCT02512302|59120788|FG001|Period 3|Lost to Follow-up|0|||
30983490|NCT02512302|59120789|FG002|Period 3|Lost to Follow-up|1|||
30983491|NCT02512302|59120790|FG003|Period 3|Lost to Follow-up|0|||
30983492|NCT02512302|59120791|FG004|Period 3|Lost to Follow-up|0|||
30983493|NCT02512302|59120792|FG005|Period 3|Lost to Follow-up|0|||
30983494|NCT02512302|59120793|FG006|Period 3|Lost to Follow-up|0|||
30983495|NCT02512302|59120794|FG007|Period 3|Lost to Follow-up|0|||
30983496|NCT02512302|59120795|FG008|Period 3|Lost to Follow-up|0|||
30983497|NCT02512302|59120796|FG009|Period 3|Lost to Follow-up|0|||
30983498|NCT02512302|59120787|FG000|Period 4|Adverse Event|0|||
30983499|NCT02512302|59120788|FG001|Period 4|Adverse Event|0|||
30983500|NCT02512302|59120789|FG002|Period 4|Adverse Event|0|||
30983501|NCT02512302|59120790|FG003|Period 4|Adverse Event|0|||
30983502|NCT02512302|59120791|FG004|Period 4|Adverse Event|0|||
30983503|NCT02512302|59120792|FG005|Period 4|Adverse Event|0|||
30983504|NCT02512302|59120793|FG006|Period 4|Adverse Event|1|||
30983505|NCT02512302|59120794|FG007|Period 4|Adverse Event|0|||
30983506|NCT02512302|59120795|FG008|Period 4|Adverse Event|0|||
30983507|NCT02512302|59120796|FG009|Period 4|Adverse Event|0|||
30983508|NCT02512068|59120904|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
30983509|NCT02512068|59120905|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
30983510|NCT02512068|59120904|FG000|Overall Study|Major Protocol Deviation|1|||
30983511|NCT02512068|59120905|FG001|Overall Study|Major Protocol Deviation|0|||
30983512|NCT02512068|59120904|FG000|Overall Study|Voluntary Withdrawal|0|||
30983513|NCT02512068|59120905|FG001|Overall Study|Voluntary Withdrawal|1|||
30983514|NCT02512068|59120904|FG000|Overall Study|Lack of Efficacy|0|||
30983515|NCT02512068|59120905|FG001|Overall Study|Lack of Efficacy|1|||
30983516|NCT02512068|59120904|FG000|Overall Study|Reason Not Specified|3|||
30983517|NCT02512068|59120905|FG001|Overall Study|Reason Not Specified|5|||
30983518|NCT02511678|59120920|FG000|Overall Study|Withdrawal by Subject|2|||
30983519|NCT02511678|59120920|FG000|Overall Study|Lost to Follow-up|4|||
30983520|NCT02511678|59120920|FG000|Overall Study|Death|19|||
30983521|NCT02511678|59120920|FG000|Overall Study|Adverse Event|1|||
30983522|NCT02511678|59120920|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
30983523|NCT02511678|59120920|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
30983524|NCT02511678|59120920|FG000|Overall Study|Required Radiofrequency Ablation|1|||
30983525|NCT02511678|59120920|FG000|Overall Study|Biopsy was Negative|1|||
30983526|NCT02511678|59120920|FG000|Overall Study|Protocol Violation|1|||
30983527|NCT02511678|59120920|FG000|Overall Study|Received Radiation Treatment|1|||
30983528|NCT02518464|59120947|FG000|Overall Study|Adverse Event|2|||
30983529|NCT02510820|59120951|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
30983530|NCT02510820|59120952|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
30983531|NCT02510820|59120951|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
30983532|NCT02510820|59120952|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
30983533|NCT02510664|59120962|FG000|Overall Study|Transferred Care|9|||
30983534|NCT02510664|59120963|FG001|Overall Study|Transferred Care|9|||
30983535|NCT02510664|59120964|FG002|Overall Study|Transferred Care|0|||
30983536|NCT02510664|59120962|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
30983537|NCT02510664|59120963|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
30983538|NCT02510664|59120964|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
30983539|NCT02510664|59120962|FG000|Overall Study|Time Constraints|1|||
30983540|NCT02510664|59120963|FG001|Overall Study|Time Constraints|1|||
30983541|NCT02510664|59120964|FG002|Overall Study|Time Constraints|0|||
30983542|NCT01363986|59120995|FG000|Overall Study|Disease progression|1|||
30983543|NCT02478372|59121029|FG000|Overall Study|Protocol Violation|12|||
30983544|NCT02478372|59121030|FG001|Overall Study|Protocol Violation|8|||
30983545|NCT02478372|59121029|FG000|Overall Study|Lost to Follow-up|1|||
30983546|NCT02478372|59121030|FG001|Overall Study|Lost to Follow-up|4|||
30983547|NCT02478372|59121029|FG000|Overall Study|Death|0|||
30983548|NCT02478372|59121030|FG001|Overall Study|Death|2|||
30983549|NCT01654536|59121042|FG000|Overall Study|Lost to Follow-up|5|||
30983550|NCT01654536|59121043|FG001|Overall Study|Lost to Follow-up|5|||
30983551|NCT01654536|59121042|FG000|Overall Study|Physician Decision|12|||
30983552|NCT01654536|59121043|FG001|Overall Study|Physician Decision|8|||
30983553|NCT01654536|59121042|FG000|Overall Study|Withdrawal by Subject|27|||
30983554|NCT01654536|59121043|FG001|Overall Study|Withdrawal by Subject|25|||
30983555|NCT01654380|59121052|FG000|Part B, Period 1|Physician Decision|0|||
30983556|NCT01654380|59121053|FG001|Part B, Period 1|Physician Decision|0|||
30983557|NCT01654380|59121054|FG002|Part B, Period 1|Physician Decision|1|||
30983558|NCT01654380|59121055|FG003|Part B, Period 1|Physician Decision|0|||
30983559|NCT02477670|59121074|FG000|Stage 1|Adverse Event|2|||
30983560|NCT02477670|59121075|FG001|Stage 1|Adverse Event|7|||
30983561|NCT02477670|59121076|FG002|Stage 1|Adverse Event|0|||
30983562|NCT02477670|59121077|FG003|Stage 1|Adverse Event|0|||
30983563|NCT02477670|59121078|FG004|Stage 1|Adverse Event|0|||
30983564|NCT02477670|59121079|FG005|Stage 1|Adverse Event|0|||
30983565|NCT02477670|59121080|FG006|Stage 1|Adverse Event|0|||
30983566|NCT02477670|59121074|FG000|Stage 1|Lost to Follow-up|0|||
30983567|NCT02477670|59121075|FG001|Stage 1|Lost to Follow-up|2|||
30983568|NCT02477670|59121076|FG002|Stage 1|Lost to Follow-up|0|||
30983569|NCT02477670|59121077|FG003|Stage 1|Lost to Follow-up|0|||
30983570|NCT02477670|59121078|FG004|Stage 1|Lost to Follow-up|0|||
30983571|NCT02477670|59121079|FG005|Stage 1|Lost to Follow-up|0|||
30983572|NCT02477670|59121080|FG006|Stage 1|Lost to Follow-up|0|||
30983573|NCT02477670|59121074|FG000|Stage 1|Withdrawal by Subject|1|||
30983574|NCT02477670|59121075|FG001|Stage 1|Withdrawal by Subject|2|||
30983575|NCT02477670|59121076|FG002|Stage 1|Withdrawal by Subject|0|||
30983576|NCT02477670|59121077|FG003|Stage 1|Withdrawal by Subject|0|||
30983577|NCT02477670|59121078|FG004|Stage 1|Withdrawal by Subject|0|||
30983578|NCT02477670|59121079|FG005|Stage 1|Withdrawal by Subject|0|||
30983579|NCT02477670|59121080|FG006|Stage 1|Withdrawal by Subject|0|||
30983580|NCT02477670|59121074|FG000|Stage 1|Non-compliance with Study Drug|1|||
30983581|NCT02477670|59121075|FG001|Stage 1|Non-compliance with Study Drug|2|||
30983582|NCT02477670|59121076|FG002|Stage 1|Non-compliance with Study Drug|0|||
30983583|NCT02477670|59121077|FG003|Stage 1|Non-compliance with Study Drug|0|||
30983584|NCT02477670|59121078|FG004|Stage 1|Non-compliance with Study Drug|0|||
30983585|NCT02477670|59121079|FG005|Stage 1|Non-compliance with Study Drug|0|||
30983586|NCT02477670|59121080|FG006|Stage 1|Non-compliance with Study Drug|0|||
30983587|NCT02477670|59121074|FG000|Stage 2|Adverse Event|0|||
30983588|NCT02477670|59121075|FG001|Stage 2|Adverse Event|0|||
30983589|NCT02477670|59121076|FG002|Stage 2|Adverse Event|1|||
30983590|NCT02477670|59121077|FG003|Stage 2|Adverse Event|0|||
30983591|NCT02477670|59121078|FG004|Stage 2|Adverse Event|0|||
30983592|NCT02477670|59121079|FG005|Stage 2|Adverse Event|0|||
30983593|NCT02477670|59121080|FG006|Stage 2|Adverse Event|0|||
30983594|NCT02477670|59121074|FG000|Stage 2|Antipsychotic Medication Changed|0|||
30983595|NCT02477670|59121075|FG001|Stage 2|Antipsychotic Medication Changed|0|||
30983596|NCT02477670|59121076|FG002|Stage 2|Antipsychotic Medication Changed|1|||
30983597|NCT02477670|59121077|FG003|Stage 2|Antipsychotic Medication Changed|0|||
30983598|NCT02477670|59121078|FG004|Stage 2|Antipsychotic Medication Changed|0|||
30983599|NCT02477670|59121079|FG005|Stage 2|Antipsychotic Medication Changed|0|||
30983600|NCT02477670|59121080|FG006|Stage 2|Antipsychotic Medication Changed|0|||
30983601|NCT02477670|59121074|FG000|Stage 2|Withdrawal by Subject|0|||
30983602|NCT02477670|59121075|FG001|Stage 2|Withdrawal by Subject|0|||
30983603|NCT02477670|59121076|FG002|Stage 2|Withdrawal by Subject|0|||
30983604|NCT02477670|59121077|FG003|Stage 2|Withdrawal by Subject|1|||
30983605|NCT02477670|59121078|FG004|Stage 2|Withdrawal by Subject|0|||
30983606|NCT02477670|59121079|FG005|Stage 2|Withdrawal by Subject|0|||
30983607|NCT02477670|59121080|FG006|Stage 2|Withdrawal by Subject|0|||
30983608|NCT02509026|59121091|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
30983609|NCT02509026|59121091|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
30983610|NCT02509026|59121091|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
30983611|NCT02509026|59121091|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
30983612|NCT02509026|59121091|FG000|Induction Period (24 Weeks)|Other|2|||
30983613|NCT02509026|59121091|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
30983614|NCT02509026|59121091|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
30983615|NCT02509026|59121091|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
30983616|NCT02509026|59121091|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
30983617|NCT02509026|59121091|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
30983618|NCT02509026|59121091|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
30983619|NCT02509026|59121091|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
30983620|NCT02509026|59121091|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
30983621|NCT02476968|59121474|FG000|Overall Study|Other|0|||
30983622|NCT02476968|59121475|FG001|Overall Study|Other|2|||
30983623|NCT02476968|59121476|FG002|Overall Study|Other|0|||
30983624|NCT02476968|59121474|FG000|Overall Study|Lost to Follow-up|10|||
30983625|NCT02476968|59121475|FG001|Overall Study|Lost to Follow-up|0|||
30983626|NCT02476968|59121476|FG002|Overall Study|Lost to Follow-up|1|||
30983627|NCT02476968|59121474|FG000|Overall Study|Death|48|||
30983628|NCT02476968|59121475|FG001|Overall Study|Death|8|||
30983629|NCT02476968|59121476|FG002|Overall Study|Death|1|||
30983630|NCT02476968|59121474|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30983631|NCT02476968|59121475|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30983632|NCT02476968|59121476|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
30983633|NCT02476968|59121474|FG000|Overall Study|Patient decision|37|||
30983634|NCT02476968|59121475|FG001|Overall Study|Patient decision|8|||
30983635|NCT02476968|59121476|FG002|Overall Study|Patient decision|0|||
30983636|NCT02476578|59121497|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
30983637|NCT02476578|59121498|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
30983638|NCT02476578|59121497|FG000|Overall Study|Lost to Follow-up|6|||
30983639|NCT02476578|59121498|FG001|Overall Study|Lost to Follow-up|13|||
30983640|NCT02504892|59121516|FG000|Overall Study|Adverse event-pneumonitis|2|||
30983641|NCT02504502|59121522|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
30983642|NCT02504502|59121523|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
30983643|NCT02504502|59121522|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
30983644|NCT02504502|59121523|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
30983645|NCT04184622|59121546|FG000|Overall Study|Adverse Event|7|||
30983646|NCT04184622|59121547|FG001|Overall Study|Adverse Event|7|||
30983647|NCT04184622|59121548|FG002|Overall Study|Adverse Event|11|||
30983648|NCT04184622|59121549|FG003|Overall Study|Adverse Event|8|||
30983649|NCT04184622|59121546|FG000|Overall Study|Death|4|||
30983650|NCT04184622|59121547|FG001|Overall Study|Death|4|||
30983651|NCT04184622|59121548|FG002|Overall Study|Death|2|||
30983652|NCT04184622|59121549|FG003|Overall Study|Death|1|||
30983653|NCT04184622|59121546|FG000|Overall Study|Lost to Follow-up|41|||
30983654|NCT04184622|59121547|FG001|Overall Study|Lost to Follow-up|19|||
30983655|NCT04184622|59121548|FG002|Overall Study|Lost to Follow-up|20|||
30983656|NCT04184622|59121549|FG003|Overall Study|Lost to Follow-up|15|||
30983657|NCT04184622|59121546|FG000|Overall Study|Missing Weight at Week 72|1|||
30983658|NCT04184622|59121547|FG001|Overall Study|Missing Weight at Week 72|0|||
30983659|NCT04184622|59121548|FG002|Overall Study|Missing Weight at Week 72|1|||
30983660|NCT04184622|59121549|FG003|Overall Study|Missing Weight at Week 72|0|||
30983661|NCT04184622|59121546|FG000|Overall Study|Other - as reported by the investigator|22|||
30983662|NCT04184622|59121547|FG001|Overall Study|Other - as reported by the investigator|7|||
30983663|NCT04184622|59121548|FG002|Overall Study|Other - as reported by the investigator|5|||
30983664|NCT04184622|59121549|FG003|Overall Study|Other - as reported by the investigator|12|||
30983665|NCT04184622|59121546|FG000|Overall Study|Physician Decision|0|||
30983666|NCT04184622|59121547|FG001|Overall Study|Physician Decision|0|||
30983667|NCT04184622|59121548|FG002|Overall Study|Physician Decision|3|||
30983668|NCT04184622|59121549|FG003|Overall Study|Physician Decision|1|||
30983669|NCT04184622|59121546|FG000|Overall Study|Pregnancy|4|||
30983670|NCT04184622|59121547|FG001|Overall Study|Pregnancy|4|||
30983671|NCT04184622|59121548|FG002|Overall Study|Pregnancy|3|||
30983672|NCT04184622|59121549|FG003|Overall Study|Pregnancy|5|||
30983673|NCT04184622|59121546|FG000|Overall Study|Protocol Deviation|1|||
30891572|NCT02428231|58924762|FG001|Overall Study|Adverse Event|0|||
30891573|NCT02427841|58924768|FG000|Overall Study|Physician Decision|8|||
30983674|NCT04184622|59121547|FG001|Overall Study|Protocol Deviation|0|||
30983675|NCT04184622|59121548|FG002|Overall Study|Protocol Deviation|0|||
30983676|NCT04184622|59121549|FG003|Overall Study|Protocol Deviation|0|||
30983677|NCT04184622|59121546|FG000|Overall Study|Withdrawal by Subject|68|||
30983678|NCT04184622|59121547|FG001|Overall Study|Withdrawal by Subject|28|||
30983679|NCT04184622|59121548|FG002|Overall Study|Withdrawal by Subject|29|||
30983680|NCT04184622|59121549|FG003|Overall Study|Withdrawal by Subject|22|||
30983681|NCT03772717|59121582|FG000|Overall Study|Withdrawal by Subject|2|||
30983682|NCT03770403|59121586|FG000|Overall Study|Adverse Event|8|||
30983683|NCT03770403|59121586|FG000|Overall Study|Death|5|||
30983684|NCT03770403|59121586|FG000|Overall Study|Physician Decision|1|||
30983685|NCT03770403|59121586|FG000|Overall Study|Sponsor decision|1|||
30983686|NCT03770403|59121586|FG000|Overall Study|Study terminated by Sponsor|1|||
30983687|NCT03770403|59121586|FG000|Overall Study|Withdrawal by Subject|13|||
30983688|NCT03770403|59121586|FG000|Overall Study|Other|88|||
30983689|NCT03740100|59121590|FG000|Overall Study|Adverse Event|1|||
30983690|NCT03740100|59121590|FG000|Overall Study|Death|1|||
30983691|NCT03536884|59121596|FG000|Initial Treatment Period Week 0-16|Adverse Event|8|||
30983692|NCT03536884|59121597|FG001|Initial Treatment Period Week 0-16|Adverse Event|6|||
30983693|NCT03536884|59121598|FG002|Initial Treatment Period Week 0-16|Adverse Event|0|||
30983694|NCT03536884|59121599|FG003|Initial Treatment Period Week 0-16|Adverse Event|0|||
30983695|NCT03536884|59121600|FG004|Initial Treatment Period Week 0-16|Adverse Event|0|||
30983696|NCT03536884|59121596|FG000|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
30983697|NCT03536884|59121597|FG001|Initial Treatment Period Week 0-16|Lost to Follow-up|3|||
30983698|NCT03536884|59121598|FG002|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
30983699|NCT03536884|59121599|FG003|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
30983700|NCT03536884|59121600|FG004|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
30983701|NCT03536884|59121596|FG000|Initial Treatment Period Week 0-16|Withdrawal by Subject|3|||
30983702|NCT03536884|59121597|FG001|Initial Treatment Period Week 0-16|Withdrawal by Subject|4|||
30983703|NCT03536884|59121598|FG002|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
30983704|NCT03536884|59121599|FG003|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
30983705|NCT03536884|59121600|FG004|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
30983706|NCT03536884|59121596|FG000|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
30983707|NCT03536884|59121597|FG001|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|1|||
30983708|NCT03536884|59121598|FG002|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
30983709|NCT03536884|59121599|FG003|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
30983710|NCT03536884|59121600|FG004|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
30983711|NCT03536884|59121596|FG000|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
30983712|NCT03536884|59121597|FG001|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|1|||
30983713|NCT03536884|59121598|FG002|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
30983714|NCT03536884|59121599|FG003|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
30983715|NCT03536884|59121600|FG004|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
30983716|NCT03536884|59121596|FG000|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
30983717|NCT03536884|59121597|FG001|Initial Treatment Period Week 0-16|Unable to attend visits|1|||
30983718|NCT03536884|59121598|FG002|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
30983719|NCT03536884|59121599|FG003|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
30983720|NCT03536884|59121600|FG004|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
30983721|NCT03536884|59121596|FG000|Maintenance Treatment Period Week 16-48|Death|0|||
30983722|NCT03536884|59121597|FG001|Maintenance Treatment Period Week 16-48|Death|0|||
30983723|NCT03536884|59121598|FG002|Maintenance Treatment Period Week 16-48|Death|1|||
30983724|NCT03536884|59121599|FG003|Maintenance Treatment Period Week 16-48|Death|0|||
30983725|NCT03536884|59121600|FG004|Maintenance Treatment Period Week 16-48|Death|1|||
30983726|NCT03536884|59121596|FG000|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
30983727|NCT03536884|59121597|FG001|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
30983728|NCT03536884|59121598|FG002|Maintenance Treatment Period Week 16-48|Adverse Event|1|||
30983729|NCT03536884|59121599|FG003|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
30983730|NCT03536884|59121600|FG004|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
30983731|NCT03536884|59121596|FG000|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
30983732|NCT03536884|59121597|FG001|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
30983733|NCT03536884|59121598|FG002|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
30983734|NCT03536884|59121599|FG003|Maintenance Treatment Period Week 16-48|Lack of Efficacy|1|||
30891574|NCT02397889|58924774|FG000|Overall Study|Physician Decision|1|||
30891575|NCT02397889|58924775|FG001|Overall Study|Physician Decision|0|||
30891576|NCT02397655|58924781|FG000|Overall Study|data not completed|1301|||
30891577|NCT02396953|58924788|FG000|Overall Study|Withdrawal by Subject|0|||
30891578|NCT02396953|58924789|FG001|Overall Study|Withdrawal by Subject|0|||
30891579|NCT02396953|58924790|FG002|Overall Study|Withdrawal by Subject|1|||
30891580|NCT02396953|58924788|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
30891581|NCT02396953|58924789|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
30891582|NCT02396953|58924790|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
30891583|NCT02396953|58924788|FG000|Overall Study|Personal Reasons|1|||
30891584|NCT02396953|58924789|FG001|Overall Study|Personal Reasons|1|||
30891585|NCT02396953|58924790|FG002|Overall Study|Personal Reasons|0|||
30983735|NCT03536884|59121600|FG004|Maintenance Treatment Period Week 16-48|Lack of Efficacy|4|||
30983736|NCT03536884|59121596|FG000|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
30983737|NCT03536884|59121597|FG001|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
30983738|NCT03536884|59121598|FG002|Maintenance Treatment Period Week 16-48|Lost to Follow-up|1|||
30983739|NCT03536884|59121599|FG003|Maintenance Treatment Period Week 16-48|Lost to Follow-up|2|||
30983740|NCT03536884|59121600|FG004|Maintenance Treatment Period Week 16-48|Lost to Follow-up|8|||
30983741|NCT03536884|59121596|FG000|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
30983742|NCT03536884|59121597|FG001|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
30983743|NCT03536884|59121598|FG002|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|7|||
30983744|NCT03536884|59121599|FG003|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|3|||
30983745|NCT03536884|59121600|FG004|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|12|||
30983746|NCT03536884|59121596|FG000|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
30983747|NCT03536884|59121597|FG001|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
30983748|NCT03536884|59121598|FG002|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
30983749|NCT03536884|59121599|FG003|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
30983750|NCT03536884|59121600|FG004|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|1|||
30983751|NCT03499795|59121615|FG000|Overall Study|Adverse Event|1|||
30983752|NCT03499795|59121615|FG000|Overall Study|Lost to Follow-up|1|||
30983753|NCT03456700|59121632|FG000|Overall Study|Withdrawal by Subject|1|||
30983754|NCT03401450|59121638|FG000|Overall Study|Lost to Follow-up|4|||
30983755|NCT03401450|59121639|FG001|Overall Study|Lost to Follow-up|6|||
30983756|NCT03401450|59121638|FG000|Overall Study|Anesthesia plan changed|2|||
30983757|NCT03401450|59121639|FG001|Overall Study|Anesthesia plan changed|2|||
30983758|NCT03401450|59121638|FG000|Overall Study|Did not complete medication diary|4|||
30983759|NCT03401450|59121639|FG001|Overall Study|Did not complete medication diary|2|||
30983760|NCT03401450|59121638|FG000|Overall Study|post surgery medication change|2|||
30983761|NCT03401450|59121639|FG001|Overall Study|post surgery medication change|1|||
30983762|NCT03401450|59121638|FG000|Overall Study|Cancelled surgery|0|||
30983763|NCT03401450|59121639|FG001|Overall Study|Cancelled surgery|2|||
30983764|NCT03326063|59121647|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
30983765|NCT03326063|59121648|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
30983766|NCT03155997|59121669|FG000|Overall Study|Withdrawal by Subject|119|||
30983767|NCT03155997|59121670|FG001|Overall Study|Withdrawal by Subject|134|||
30983768|NCT03155997|59121669|FG000|Overall Study|Lost to Follow-up|12|||
30983769|NCT03155997|59121670|FG001|Overall Study|Lost to Follow-up|13|||
30983770|NCT03155997|59121669|FG000|Overall Study|Missing disposition data|0|||
30983771|NCT03155997|59121670|FG001|Overall Study|Missing disposition data|1|||
30983772|NCT03155997|59121669|FG000|Overall Study|On study treatment|2027|||
30983773|NCT03155997|59121670|FG001|Overall Study|On study treatment|2074|||
30983774|NCT02764762|59121687|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
30983775|NCT02764762|59121687|FG000|Overall Study|Lost to Follow-up|4|||
30983776|NCT02764762|59121687|FG000|Overall Study|Voluntary Withdrawal|8|||
30983777|NCT02764762|59121687|FG000|Overall Study|Site Termination|1|||
30983778|NCT02764762|59121687|FG000|Overall Study|Lack of Efficacy|16|||
30983779|NCT02764762|59121687|FG000|Overall Study|Reason not Specified|1|||
30983780|NCT02340962|59121697|FG000|Overall Study|Lost to Follow-up|1|||
30983781|NCT02340962|59121698|FG001|Overall Study|Lost to Follow-up|0|||
30983782|NCT02272634|59121718|FG000|Overall Study|Adverse Event|1|||
30983783|NCT02272634|59121719|FG001|Overall Study|Adverse Event|0|||
30983784|NCT02272634|59121720|FG002|Overall Study|Adverse Event|0|||
30983785|NCT02272634|59121718|FG000|Overall Study|Protocol Violation|0|||
30983786|NCT02272634|59121719|FG001|Overall Study|Protocol Violation|0|||
30983787|NCT02272634|59121720|FG002|Overall Study|Protocol Violation|1|||
30983788|NCT02272634|59121718|FG000|Overall Study|Withdrawal by Subject|0|||
30983789|NCT02272634|59121719|FG001|Overall Study|Withdrawal by Subject|1|||
30983790|NCT02272634|59121720|FG002|Overall Study|Withdrawal by Subject|0|||
30983791|NCT00788125|59121731|FG000|Overall Study|Death|6|||
30983792|NCT00676715|59121739|FG000|Overall Study|Withdrawal by Subject|7|||
30983793|NCT00676715|59121740|FG001|Overall Study|Withdrawal by Subject|9|||
30983794|NCT00676715|59121741|FG002|Overall Study|Withdrawal by Subject|10|||
30983795|NCT00676715|59121742|FG003|Overall Study|Withdrawal by Subject|10|||
30983796|NCT00676715|59121739|FG000|Overall Study|Other|2|||
30983797|NCT00676715|59121740|FG001|Overall Study|Other|6|||
30983798|NCT00676715|59121741|FG002|Overall Study|Other|4|||
30983799|NCT00676715|59121742|FG003|Overall Study|Other|3|||
30983800|NCT00676715|59121739|FG000|Overall Study|Lost to Follow-up|1|||
30983801|NCT00676715|59121740|FG001|Overall Study|Lost to Follow-up|1|||
30983802|NCT00676715|59121741|FG002|Overall Study|Lost to Follow-up|7|||
30983803|NCT00676715|59121742|FG003|Overall Study|Lost to Follow-up|3|||
30983804|NCT00676715|59121739|FG000|Overall Study|Death|1|||
30983805|NCT00676715|59121740|FG001|Overall Study|Death|1|||
30983806|NCT00676715|59121741|FG002|Overall Study|Death|1|||
30983807|NCT00676715|59121742|FG003|Overall Study|Death|0|||
30891586|NCT02387983|58924805|FG000|Overall Study|Adverse Event|4|||
30983808|NCT00676715|59121739|FG000|Overall Study|Adverse Event|0|||
30983809|NCT00676715|59121740|FG001|Overall Study|Adverse Event|1|||
30983810|NCT00676715|59121741|FG002|Overall Study|Adverse Event|2|||
30983811|NCT00676715|59121742|FG003|Overall Study|Adverse Event|0|||
30983812|NCT00676715|59121739|FG000|Overall Study|Participants Ongoing|29|||
30983813|NCT00676715|59121740|FG001|Overall Study|Participants Ongoing|29|||
30983814|NCT00676715|59121741|FG002|Overall Study|Participants Ongoing|17|||
30983815|NCT00676715|59121742|FG003|Overall Study|Participants Ongoing|24|||
30983816|NCT02504424|59121761|FG000|Overall Study|Withdrawal by Subject|2|||
30983817|NCT02548832|59122091|FG000|Overall Study|Lost to Follow-up|2|||
30983818|NCT02548832|59122092|FG001|Overall Study|Lost to Follow-up|2|||
30983819|NCT02548832|59122093|FG002|Overall Study|Lost to Follow-up|2|||
30983820|NCT02504268|59122344|FG000|Overall Study|Adverse Event|18|||
30983821|NCT02504268|59122345|FG001|Overall Study|Adverse Event|8|||
30983822|NCT02504268|59122346|FG002|Overall Study|Adverse Event|14|||
30983823|NCT02504268|59122347|FG003|Overall Study|Adverse Event|0|||
30983824|NCT02504268|59122348|FG004|Overall Study|Adverse Event|0|||
30983825|NCT02504268|59122349|FG005|Overall Study|Adverse Event|0|||
30983826|NCT02504268|59122350|FG006|Overall Study|Adverse Event|0|||
30983827|NCT02504268|59122351|FG007|Overall Study|Adverse Event|0|||
30983828|NCT02504268|59122352|FG008|Overall Study|Adverse Event|0|||
30983829|NCT02504268|59122344|FG000|Overall Study|Withdrawal of Consent|11|||
30983830|NCT02504268|59122345|FG001|Overall Study|Withdrawal of Consent|10|||
30983831|NCT02504268|59122346|FG002|Overall Study|Withdrawal of Consent|3|||
30983832|NCT02504268|59122347|FG003|Overall Study|Withdrawal of Consent|0|||
30983833|NCT02504268|59122348|FG004|Overall Study|Withdrawal of Consent|0|||
30983834|NCT02504268|59122349|FG005|Overall Study|Withdrawal of Consent|0|||
30983835|NCT02504268|59122350|FG006|Overall Study|Withdrawal of Consent|0|||
30983836|NCT02504268|59122351|FG007|Overall Study|Withdrawal of Consent|0|||
30983837|NCT02504268|59122352|FG008|Overall Study|Withdrawal of Consent|0|||
30983838|NCT02504268|59122344|FG000|Overall Study|Pregnancy|2|||
30983839|NCT02504268|59122345|FG001|Overall Study|Pregnancy|0|||
30983840|NCT02504268|59122346|FG002|Overall Study|Pregnancy|0|||
30983841|NCT02504268|59122347|FG003|Overall Study|Pregnancy|0|||
30983842|NCT02504268|59122348|FG004|Overall Study|Pregnancy|0|||
30983843|NCT02504268|59122349|FG005|Overall Study|Pregnancy|0|||
30983844|NCT02504268|59122350|FG006|Overall Study|Pregnancy|0|||
30983845|NCT02504268|59122351|FG007|Overall Study|Pregnancy|0|||
30983846|NCT02504268|59122352|FG008|Overall Study|Pregnancy|0|||
30983847|NCT02504268|59122344|FG000|Overall Study|Lost to Follow-up|3|||
30983848|NCT02504268|59122345|FG001|Overall Study|Lost to Follow-up|6|||
30983849|NCT02504268|59122346|FG002|Overall Study|Lost to Follow-up|4|||
30983850|NCT02504268|59122347|FG003|Overall Study|Lost to Follow-up|0|||
30983851|NCT02504268|59122348|FG004|Overall Study|Lost to Follow-up|0|||
30983852|NCT02504268|59122349|FG005|Overall Study|Lost to Follow-up|0|||
30983853|NCT02504268|59122350|FG006|Overall Study|Lost to Follow-up|0|||
30983854|NCT02504268|59122351|FG007|Overall Study|Lost to Follow-up|0|||
30983855|NCT02504268|59122352|FG008|Overall Study|Lost to Follow-up|0|||
30983856|NCT02504268|59122344|FG000|Overall Study|Death|1|||
30983857|NCT02504268|59122345|FG001|Overall Study|Death|1|||
30983858|NCT02504268|59122346|FG002|Overall Study|Death|0|||
30983859|NCT02504268|59122347|FG003|Overall Study|Death|0|||
30983860|NCT02504268|59122348|FG004|Overall Study|Death|0|||
30983861|NCT02504268|59122349|FG005|Overall Study|Death|0|||
30983862|NCT02504268|59122350|FG006|Overall Study|Death|0|||
30983863|NCT02504268|59122351|FG007|Overall Study|Death|0|||
30983864|NCT02504268|59122352|FG008|Overall Study|Death|0|||
30983865|NCT02504268|59122344|FG000|Overall Study|Subject Request to Discontinue|11|||
30983866|NCT02504268|59122345|FG001|Overall Study|Subject Request to Discontinue|3|||
30983867|NCT02504268|59122346|FG002|Overall Study|Subject Request to Discontinue|6|||
30983868|NCT02504268|59122347|FG003|Overall Study|Subject Request to Discontinue|0|||
30983869|NCT02504268|59122348|FG004|Overall Study|Subject Request to Discontinue|0|||
30983870|NCT02504268|59122349|FG005|Overall Study|Subject Request to Discontinue|0|||
30891587|NCT02387983|58924805|FG000|Overall Study|Protocol Violation|1|||
30983871|NCT02504268|59122350|FG006|Overall Study|Subject Request to Discontinue|0|||
30983872|NCT02504268|59122351|FG007|Overall Study|Subject Request to Discontinue|0|||
30983873|NCT02504268|59122352|FG008|Overall Study|Subject Request to Discontinue|0|||
30983874|NCT02504268|59122344|FG000|Overall Study|No Longer Meets Study Criteria|2|||
30983875|NCT02504268|59122345|FG001|Overall Study|No Longer Meets Study Criteria|3|||
30983876|NCT02504268|59122346|FG002|Overall Study|No Longer Meets Study Criteria|0|||
30891588|NCT02387983|58924805|FG000|Overall Study|Withdrawal by Subject|2|||
30983877|NCT02504268|59122347|FG003|Overall Study|No Longer Meets Study Criteria|0|||
30983878|NCT02504268|59122348|FG004|Overall Study|No Longer Meets Study Criteria|0|||
30983879|NCT02504268|59122349|FG005|Overall Study|No Longer Meets Study Criteria|0|||
30983880|NCT02504268|59122350|FG006|Overall Study|No Longer Meets Study Criteria|0|||
30983881|NCT02504268|59122351|FG007|Overall Study|No Longer Meets Study Criteria|0|||
30983882|NCT02504268|59122352|FG008|Overall Study|No Longer Meets Study Criteria|0|||
30983883|NCT02504268|59122344|FG000|Overall Study|Lack of Efficacy|11|||
30983884|NCT02504268|59122345|FG001|Overall Study|Lack of Efficacy|35|||
30983885|NCT02504268|59122346|FG002|Overall Study|Lack of Efficacy|9|||
30983886|NCT02504268|59122347|FG003|Overall Study|Lack of Efficacy|0|||
30983887|NCT02504268|59122348|FG004|Overall Study|Lack of Efficacy|0|||
30983888|NCT02504268|59122349|FG005|Overall Study|Lack of Efficacy|0|||
30983889|NCT02504268|59122350|FG006|Overall Study|Lack of Efficacy|0|||
30983890|NCT02504268|59122351|FG007|Overall Study|Lack of Efficacy|0|||
30983891|NCT02504268|59122352|FG008|Overall Study|Lack of Efficacy|0|||
30983892|NCT02504268|59122344|FG000|Overall Study|Poor/Non-Compliance|3|||
30983893|NCT02504268|59122345|FG001|Overall Study|Poor/Non-Compliance|2|||
30983894|NCT02504268|59122346|FG002|Overall Study|Poor/Non-Compliance|3|||
30983895|NCT02504268|59122347|FG003|Overall Study|Poor/Non-Compliance|0|||
30983896|NCT02504268|59122348|FG004|Overall Study|Poor/Non-Compliance|0|||
30983897|NCT02504268|59122349|FG005|Overall Study|Poor/Non-Compliance|0|||
30983898|NCT02504268|59122350|FG006|Overall Study|Poor/Non-Compliance|0|||
30983899|NCT02504268|59122351|FG007|Overall Study|Poor/Non-Compliance|0|||
30983900|NCT02504268|59122352|FG008|Overall Study|Poor/Non-Compliance|0|||
30983901|NCT02504268|59122344|FG000|Overall Study|Not Disclosed|1|||
30983902|NCT02504268|59122345|FG001|Overall Study|Not Disclosed|0|||
30983903|NCT02504268|59122346|FG002|Overall Study|Not Disclosed|2|||
30983904|NCT02504268|59122347|FG003|Overall Study|Not Disclosed|0|||
30983905|NCT02504268|59122348|FG004|Overall Study|Not Disclosed|0|||
30983906|NCT02504268|59122349|FG005|Overall Study|Not Disclosed|0|||
30983907|NCT02504268|59122350|FG006|Overall Study|Not Disclosed|0|||
30983908|NCT02504268|59122351|FG007|Overall Study|Not Disclosed|0|||
30983909|NCT02504268|59122352|FG008|Overall Study|Not Disclosed|0|||
30983910|NCT01654302|59122396|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
30983911|NCT01654302|59122397|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
30983912|NCT02476422|59122413|FG000|Overall Study|Subject/guardian decision|0|||
30983913|NCT02476422|59122414|FG001|Overall Study|Subject/guardian decision|1|||
30983914|NCT02475564|59122444|FG000|Overall Study|Withdrawal by Subject|1|||
30983915|NCT02475564|59122445|FG001|Overall Study|Withdrawal by Subject|0|||
30983916|NCT02475564|59122444|FG000|Overall Study|Lost to Follow-up|2|||
30983917|NCT02475564|59122445|FG001|Overall Study|Lost to Follow-up|1|||
30983918|NCT02475564|59122444|FG000|Overall Study|Intense Menstrual bleeding|1|||
30983919|NCT02475564|59122445|FG001|Overall Study|Intense Menstrual bleeding|0|||
30983920|NCT02503332|59122733|FG000|Overall Study|Adverse Event|17|||
30983921|NCT02503332|59122734|FG001|Overall Study|Adverse Event|5|||
30983922|NCT02503332|59122735|FG002|Overall Study|Adverse Event|3|||
30983923|NCT02503332|59122736|FG003|Overall Study|Adverse Event|1|||
30983924|NCT02503332|59122733|FG000|Overall Study|Investigator's Decision|5|||
30983925|NCT02503332|59122734|FG001|Overall Study|Investigator's Decision|1|||
30983926|NCT02503332|59122735|FG002|Overall Study|Investigator's Decision|0|||
30983927|NCT02503332|59122736|FG003|Overall Study|Investigator's Decision|0|||
30983928|NCT02503332|59122733|FG000|Overall Study|Sponsor's Decision|1|||
30983929|NCT02503332|59122734|FG001|Overall Study|Sponsor's Decision|0|||
30983930|NCT02503332|59122735|FG002|Overall Study|Sponsor's Decision|0|||
30983931|NCT02503332|59122736|FG003|Overall Study|Sponsor's Decision|1|||
30891589|NCT02395627|58924812|FG000|Overall Study|Withdrawal by Subject|0|||
30891590|NCT02395627|58924813|FG001|Overall Study|Withdrawal by Subject|2|||
30891591|NCT02395627|58924814|FG002|Overall Study|Withdrawal by Subject|0|||
30891592|NCT02395627|58924812|FG000|Overall Study|Did not receive pembrolizumab|3|||
30891593|NCT02395627|58924813|FG001|Overall Study|Did not receive pembrolizumab|1|||
30891594|NCT02395627|58924814|FG002|Overall Study|Did not receive pembrolizumab|0|||
30891595|NCT02395471|58924826|FG000|Overall Study|Lost to Follow-up|2|||
30891596|NCT02395471|58924827|FG001|Overall Study|Lost to Follow-up|0|||
30891597|NCT02395471|58924826|FG000|Overall Study|Withdrawal by Subject|2|||
30891598|NCT02395471|58924827|FG001|Overall Study|Withdrawal by Subject|1|||
30891599|NCT02395471|58924826|FG000|Overall Study|Physician Decision|1|||
30891600|NCT02395471|58924827|FG001|Overall Study|Physician Decision|0|||
30891601|NCT02395471|58924826|FG000|Overall Study|Protocol Violation|0|||
30891602|NCT02395471|58924827|FG001|Overall Study|Protocol Violation|1|||
30891603|NCT02395471|58924826|FG000|Overall Study|Failure to swollow sponge twice|1|||
30891604|NCT02395471|58924827|FG001|Overall Study|Failure to swollow sponge twice|0|||
30891605|NCT02395471|58924826|FG000|Overall Study|Patient did not return for procedure|0|||
30891606|NCT02395471|58924827|FG001|Overall Study|Patient did not return for procedure|1|||
30891607|NCT02395471|58924826|FG000|Overall Study|Subject not eligible|1|||
30891608|NCT02395471|58924827|FG001|Overall Study|Subject not eligible|0|||
30983932|NCT02503332|59122733|FG000|Overall Study|Subject Request|6|||
30983933|NCT02503332|59122734|FG001|Overall Study|Subject Request|5|||
30983934|NCT02503332|59122735|FG002|Overall Study|Subject Request|2|||
30983935|NCT02503332|59122736|FG003|Overall Study|Subject Request|1|||
30983936|NCT02503332|59122733|FG000|Overall Study|Death|0|||
30983937|NCT02503332|59122734|FG001|Overall Study|Death|2|||
30891609|NCT02395081|58924845|FG000|Overall Study|Withdrawal by Subject|1|||
30891610|NCT02395081|58924846|FG001|Overall Study|Withdrawal by Subject|1|||
30891611|NCT02395081|58924847|FG002|Overall Study|Withdrawal by Subject|0|||
30983938|NCT02503332|59122735|FG002|Overall Study|Death|2|||
30983939|NCT02503332|59122736|FG003|Overall Study|Death|0|||
30983940|NCT02503332|59122733|FG000|Overall Study|Other|5|||
30983941|NCT02503332|59122734|FG001|Overall Study|Other|6|||
30983942|NCT02503332|59122735|FG002|Overall Study|Other|1|||
30983943|NCT02503332|59122736|FG003|Overall Study|Other|1|||
30983944|NCT02502864|59122754|FG000|Overall Study|Withdrawal by Subject|1|||
30983945|NCT02474082|59122788|FG000|Overall Study|Adverse Event|2|||
30983946|NCT02474082|59122789|FG001|Overall Study|Adverse Event|32|||
30983947|NCT02474082|59122788|FG000|Overall Study|Withdrawal of informed consent|1|||
30983948|NCT02474082|59122789|FG001|Overall Study|Withdrawal of informed consent|11|||
30983949|NCT02474082|59122788|FG000|Overall Study|Lost to Follow-up|2|||
30983950|NCT02474082|59122789|FG001|Overall Study|Lost to Follow-up|2|||
30983951|NCT02474082|59122788|FG000|Overall Study|Dose tapering not achieved|0|||
30983952|NCT02474082|59122789|FG001|Overall Study|Dose tapering not achieved|4|||
30983953|NCT02474082|59122788|FG000|Overall Study|Participant/guardian decision|1|||
30983954|NCT02474082|59122789|FG001|Overall Study|Participant/guardian decision|2|||
30983955|NCT02474082|59122788|FG000|Overall Study|Non-compliance with study treatment|0|||
30983956|NCT02474082|59122789|FG001|Overall Study|Non-compliance with study treatment|2|||
30983957|NCT02474082|59122788|FG000|Overall Study|Protocol deviation|0|||
30983958|NCT02474082|59122789|FG001|Overall Study|Protocol deviation|1|||
30983959|NCT02501928|59122899|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
30983960|NCT02501928|59122900|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
30983961|NCT02501928|59122901|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
30983962|NCT02501928|59122902|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
30983963|NCT02501928|59122903|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
30983964|NCT02501928|59122904|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
30983965|NCT02473614|59122968|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
30983966|NCT02473614|59122969|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
30983967|NCT02500758|59122991|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
30983968|NCT02500758|59122992|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
30983969|NCT02500758|59122991|FG000|Washout (1 Week)|Lost to Follow-up|2|||
30983970|NCT02500758|59122992|FG001|Washout (1 Week)|Lost to Follow-up|2|||
30983971|NCT02500758|59122991|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
30983972|NCT02500758|59122992|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
30983973|NCT02500758|59122991|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
30983974|NCT02500758|59122992|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
30983975|NCT02500758|59122991|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
30983976|NCT02500758|59122992|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
30983977|NCT02500056|59123006|FG000|Overall Study|Lost to Follow-up|3|||
30983978|NCT02500056|59123007|FG001|Overall Study|Lost to Follow-up|7|||
30983979|NCT02500056|59123006|FG000|Overall Study|Recurrence|1|||
30983980|NCT02500056|59123007|FG001|Overall Study|Recurrence|0|||
30983981|NCT02500056|59123006|FG000|Overall Study|Death|3|||
30983982|NCT02500056|59123007|FG001|Overall Study|Death|1|||
30983983|NCT02472756|59123056|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
30983984|NCT02472756|59123056|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
30983985|NCT02472756|59123056|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
30983986|NCT02472756|59123056|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
30983987|NCT02472756|59123056|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
30983988|NCT02498652|59123066|FG000|Overall Study|Protocol Violation|0|||
30983989|NCT02498652|59123067|FG001|Overall Study|Protocol Violation|1|||
30983990|NCT03213158|59123091|FG000|Overall Study|Withdrawal by Subject|1|||
30983991|NCT03213158|59123091|FG000|Overall Study|Physician Decision|2|||
30983992|NCT02498418|59123098|FG000|Overall Study|Lack of Efficacy|0|||
30983993|NCT02498418|59123099|FG001|Overall Study|Lack of Efficacy|0|||
30983994|NCT02498418|59123100|FG002|Overall Study|Lack of Efficacy|1|||
30983995|NCT02498418|59123098|FG000|Overall Study|Withdrawal by Subject|2|||
30983996|NCT02498418|59123099|FG001|Overall Study|Withdrawal by Subject|0|||
30983997|NCT02498418|59123100|FG002|Overall Study|Withdrawal by Subject|3|||
30983998|NCT02498418|59123098|FG000|Overall Study|Lost to Follow-up|0|||
30983999|NCT02498418|59123099|FG001|Overall Study|Lost to Follow-up|1|||
30984000|NCT02498418|59123100|FG002|Overall Study|Lost to Follow-up|1|||
30984001|NCT02498418|59123098|FG000|Overall Study|Participant taken prohibited medication|0|||
30984002|NCT02498418|59123099|FG001|Overall Study|Participant taken prohibited medication|1|||
30984003|NCT02498418|59123100|FG002|Overall Study|Participant taken prohibited medication|1|||
30984004|NCT02472366|59123118|FG000|Overall Study|Lost to Follow-up|1|||
30984005|NCT02472366|59123119|FG001|Overall Study|Lost to Follow-up|0|||
30984006|NCT03219164|59123127|FG000|Overall Study|Study Terminated by Sponsor|16|||
30984007|NCT03219164|59123128|FG001|Overall Study|Study Terminated by Sponsor|12|||
30984008|NCT03219164|59123127|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
30984009|NCT03219164|59123128|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
30984010|NCT03219164|59123127|FG000|Overall Study|Lost to Follow-up|1|||
30984011|NCT03219164|59123128|FG001|Overall Study|Lost to Follow-up|1|||
30984012|NCT03219164|59123127|FG000|Overall Study|Adverse Event|1|||
30984013|NCT03219164|59123128|FG001|Overall Study|Adverse Event|0|||
30984014|NCT03219164|59123127|FG000|Overall Study|Non-Compliance with Study Drug|1|||
30984015|NCT03219164|59123128|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30984016|NCT03219164|59123127|FG000|Overall Study|Protocol Violation|0|||
30984017|NCT03219164|59123128|FG001|Overall Study|Protocol Violation|1|||
30984018|NCT03219164|59123127|FG000|Overall Study|Withdrew Assent|1|||
30984019|NCT03219164|59123128|FG001|Overall Study|Withdrew Assent|0|||
30984020|NCT02471586|59123146|FG000|Overall Study|Lost to Follow-up|3|||
30984021|NCT02471586|59123147|FG001|Overall Study|Lost to Follow-up|8|||
30984022|NCT02471586|59123148|FG002|Overall Study|Lost to Follow-up|4|||
30984023|NCT02471586|59123146|FG000|Overall Study|Death|2|||
30984024|NCT02471586|59123147|FG001|Overall Study|Death|2|||
30984025|NCT02471586|59123148|FG002|Overall Study|Death|0|||
30984026|NCT02470806|59123299|FG000|Overall Study|Lost to Follow-up|1|||
30984027|NCT02470806|59123300|FG001|Overall Study|Lost to Follow-up|1|||
30984028|NCT02470806|59123299|FG000|Overall Study|Adverse Event|5|||
30984029|NCT02470806|59123300|FG001|Overall Study|Adverse Event|2|||
30984030|NCT02470806|59123299|FG000|Overall Study|Protocol Violation|4|||
30984031|NCT02470806|59123300|FG001|Overall Study|Protocol Violation|11|||
30984032|NCT02470806|59123299|FG000|Overall Study|Physician Decision|0|||
30984033|NCT02470806|59123300|FG001|Overall Study|Physician Decision|3|||
30984034|NCT02470806|59123299|FG000|Overall Study|Withdrawal by Subject|3|||
30984035|NCT02470806|59123300|FG001|Overall Study|Withdrawal by Subject|10|||
30984036|NCT02470806|59123299|FG000|Overall Study|Lack of Efficacy|5|||
30984037|NCT02470806|59123300|FG001|Overall Study|Lack of Efficacy|15|||
30984038|NCT01363908|59123342|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
30984039|NCT01363908|59123343|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
30984040|NCT01363908|59123342|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
30984041|NCT01363908|59123343|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
30984042|NCT01363908|59123342|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
30984043|NCT01363908|59123343|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
30984044|NCT01363908|59123342|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
30984045|NCT01363908|59123343|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
30984046|NCT02497404|59123381|FG000|Overall Study|Adverse Event|1|||
30984047|NCT02496702|59123414|FG000|Overall Study|Lost to Follow-up|8|||
30984048|NCT02496702|59123415|FG001|Overall Study|Lost to Follow-up|6|||
30984049|NCT02496702|59123414|FG000|Overall Study|Only partially tested|0|||
30984050|NCT02496702|59123415|FG001|Overall Study|Only partially tested|2|||
30984051|NCT02469246|59123491|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
30984052|NCT02469246|59123492|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
30984053|NCT02469246|59123491|FG000|Double-Blind Phase|Adverse Event|12|||
30984054|NCT02469246|59123492|FG001|Double-Blind Phase|Adverse Event|9|||
30984055|NCT02469246|59123491|FG000|Double-Blind Phase|Death|2|||
30984056|NCT02469246|59123492|FG001|Double-Blind Phase|Death|0|||
30984057|NCT02469246|59123491|FG000|Double-Blind Phase|Lack of Efficacy|2|||
30984058|NCT02469246|59123492|FG001|Double-Blind Phase|Lack of Efficacy|1|||
30984059|NCT02469246|59123491|FG000|Double-Blind Phase|Investigator's Discretion|8|||
30984060|NCT02469246|59123492|FG001|Double-Blind Phase|Investigator's Discretion|8|||
30984061|NCT02469246|59123491|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
30984062|NCT02469246|59123492|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
30984063|NCT02469246|59123491|FG000|Double-Blind Phase|Protocol Violation|1|||
30984064|NCT02469246|59123492|FG001|Double-Blind Phase|Protocol Violation|1|||
30984065|NCT02469246|59123491|FG000|Double-Blind Phase|Withdrew Consent|25|||
30984066|NCT02469246|59123492|FG001|Double-Blind Phase|Withdrew Consent|25|||
30984067|NCT02469246|59123491|FG000|Double-Blind Phase|Lost to Follow-up|9|||
30984068|NCT02469246|59123492|FG001|Double-Blind Phase|Lost to Follow-up|5|||
30984069|NCT02469168|59123511|FG000|Overall Study|Trial closed|1|||
30984070|NCT02469168|59123512|FG001|Overall Study|Trial closed|0|||
30984071|NCT02469090|59123520|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
30984072|NCT02469090|59123521|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
30984073|NCT02469090|59123522|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
30790194|NCT00039377|58803410|FG000|Initial Registration|Adverse Event|2|||
30790195|NCT00039377|58803411|FG001|Initial Registration|Adverse Event|0|||
30984074|NCT02469090|59123520|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
30984075|NCT02469090|59123521|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
30984076|NCT02469090|59123522|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
30984077|NCT02469090|59123520|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
30984078|NCT02469090|59123521|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
30984079|NCT02469090|59123522|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
30984080|NCT02469090|59123520|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
30984081|NCT02469090|59123521|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
30984082|NCT02469090|59123522|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
30984083|NCT02469090|59123520|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
30984084|NCT02469090|59123521|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
30984085|NCT02469090|59123522|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
30984086|NCT02469090|59123520|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
30984087|NCT02469090|59123521|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
30984088|NCT02469090|59123522|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
30984089|NCT02469090|59123520|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
30984090|NCT02469090|59123521|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
30984091|NCT02469090|59123522|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
30984092|NCT02469090|59123520|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
30984093|NCT02469090|59123521|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
30984094|NCT02469090|59123522|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
30984095|NCT02496000|59123532|FG000|Overall Study|Withdrawal by Subject|1|||
30984096|NCT02496000|59123533|FG001|Overall Study|Withdrawal by Subject|2|||
30984097|NCT02496000|59123534|FG002|Overall Study|Withdrawal by Subject|0|||
30984098|NCT02496000|59123532|FG000|Overall Study|Lost to Follow-up|1|||
30984099|NCT02496000|59123533|FG001|Overall Study|Lost to Follow-up|0|||
30984100|NCT02496000|59123534|FG002|Overall Study|Lost to Follow-up|1|||
30984101|NCT02496000|59123532|FG000|Overall Study|Protocol Violation|0|||
30984102|NCT02496000|59123533|FG001|Overall Study|Protocol Violation|0|||
30984103|NCT02496000|59123534|FG002|Overall Study|Protocol Violation|1|||
30984104|NCT02496000|59123532|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
30984105|NCT02496000|59123533|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
30984106|NCT02496000|59123534|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
30984107|NCT02496000|59123532|FG000|Overall Study|undetermined|0|||
30984108|NCT02496000|59123533|FG001|Overall Study|undetermined|1|||
30984109|NCT02496000|59123534|FG002|Overall Study|undetermined|0|||
30984110|NCT02468934|59123543|FG000|Overall Study|Withdrawal by Subject|4|||
30984111|NCT02468934|59123543|FG000|Overall Study|Screen Failure|3|||
30984112|NCT02517528|59123549|FG000|Overall Study|Withdrawal by Subject|1|||
30984113|NCT02495844|59123555|FG000|Overall Study|Lack of Efficacy|1|||
30984114|NCT02495844|59123556|FG001|Overall Study|Lack of Efficacy|2|||
30984115|NCT02495844|59123555|FG000|Overall Study|AE, non-fatal|0|||
30984116|NCT02495844|59123556|FG001|Overall Study|AE, non-fatal|1|||
30984117|NCT02495844|59123555|FG000|Overall Study|Hepatitis Positivity|0|||
30984118|NCT02495844|59123556|FG001|Overall Study|Hepatitis Positivity|1|||
30984119|NCT02468778|59123567|FG000|Overall Study|Death|2|||
30984120|NCT02468778|59123568|FG001|Overall Study|Death|1|||
30984121|NCT02468778|59123569|FG002|Overall Study|Death|0|||
30984122|NCT02468778|59123567|FG000|Overall Study|Lost to Follow-up|1|||
30984123|NCT02468778|59123568|FG001|Overall Study|Lost to Follow-up|2|||
30984124|NCT02468778|59123569|FG002|Overall Study|Lost to Follow-up|2|||
30984125|NCT02468778|59123567|FG000|Overall Study|Withdrawal by Subject|0|||
30984126|NCT02468778|59123568|FG001|Overall Study|Withdrawal by Subject|1|||
30984127|NCT02468778|59123569|FG002|Overall Study|Withdrawal by Subject|1|||
30984128|NCT01727336|59123583|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
30984129|NCT01727336|59123584|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
30984130|NCT01727336|59123585|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
30984131|NCT01727336|59123586|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
30984132|NCT01727336|59123587|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
30984133|NCT01727336|59123588|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
30984134|NCT01727336|59123583|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
30984135|NCT01727336|59123584|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
30984136|NCT01727336|59123585|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
30984137|NCT01727336|59123586|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
30984138|NCT01727336|59123587|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
30984139|NCT01727336|59123588|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
30984140|NCT01727336|59123583|FG000|Part 2 Blinded|Death|0|||
30984141|NCT01727336|59123584|FG001|Part 2 Blinded|Death|0|||
30984142|NCT01727336|59123585|FG002|Part 2 Blinded|Death|0|||
30984143|NCT01727336|59123586|FG003|Part 2 Blinded|Death|0|||
30984144|NCT01727336|59123587|FG004|Part 2 Blinded|Death|20|||
30984145|NCT01727336|59123588|FG005|Part 2 Blinded|Death|16|||
30984146|NCT01727336|59123583|FG000|Part 2 Blinded|Lack of Efficacy|0|||
30984147|NCT01727336|59123584|FG001|Part 2 Blinded|Lack of Efficacy|0|||
30984148|NCT01727336|59123585|FG002|Part 2 Blinded|Lack of Efficacy|0|||
30984149|NCT01727336|59123586|FG003|Part 2 Blinded|Lack of Efficacy|0|||
30984150|NCT01727336|59123587|FG004|Part 2 Blinded|Lack of Efficacy|42|||
30984151|NCT01727336|59123588|FG005|Part 2 Blinded|Lack of Efficacy|44|||
30984152|NCT01727336|59123583|FG000|Part 2 Blinded|Lost to Follow-up|0|||
30984153|NCT01727336|59123584|FG001|Part 2 Blinded|Lost to Follow-up|0|||
30984154|NCT01727336|59123585|FG002|Part 2 Blinded|Lost to Follow-up|0|||
30984155|NCT01727336|59123586|FG003|Part 2 Blinded|Lost to Follow-up|0|||
30984156|NCT01727336|59123587|FG004|Part 2 Blinded|Lost to Follow-up|0|||
30984157|NCT01727336|59123588|FG005|Part 2 Blinded|Lost to Follow-up|1|||
30984158|NCT01727336|59123583|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
30984159|NCT01727336|59123584|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
30984160|NCT01727336|59123585|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
30984161|NCT01727336|59123586|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
30984162|NCT01727336|59123587|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
30984163|NCT01727336|59123588|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
30984164|NCT01727336|59123583|FG000|Part 2 Blinded|use of prohibited medications|0|||
30984165|NCT01727336|59123584|FG001|Part 2 Blinded|use of prohibited medications|0|||
30984166|NCT01727336|59123585|FG002|Part 2 Blinded|use of prohibited medications|0|||
30984167|NCT01727336|59123586|FG003|Part 2 Blinded|use of prohibited medications|0|||
30984168|NCT01727336|59123587|FG004|Part 2 Blinded|use of prohibited medications|1|||
30984169|NCT01727336|59123588|FG005|Part 2 Blinded|use of prohibited medications|3|||
30984170|NCT02466516|59123622|FG000|Overall Study|Adverse Event|1|||
30984171|NCT02466516|59123623|FG001|Overall Study|Adverse Event|1|||
30984172|NCT02466516|59123624|FG002|Overall Study|Adverse Event|0|||
30984173|NCT02466516|59123625|FG003|Overall Study|Adverse Event|0|||
30984174|NCT02466516|59123626|FG004|Overall Study|Adverse Event|0|||
30984175|NCT02466516|59123622|FG000|Overall Study|Withdrew Consent|1|||
30984176|NCT02466516|59123623|FG001|Overall Study|Withdrew Consent|0|||
30984177|NCT02466516|59123624|FG002|Overall Study|Withdrew Consent|0|||
30984178|NCT02466516|59123625|FG003|Overall Study|Withdrew Consent|0|||
30984179|NCT02466516|59123626|FG004|Overall Study|Withdrew Consent|0|||
30984180|NCT02466516|59123622|FG000|Overall Study|Lost to Follow-up|2|||
30984181|NCT02466516|59123623|FG001|Overall Study|Lost to Follow-up|0|||
30984182|NCT02466516|59123624|FG002|Overall Study|Lost to Follow-up|1|||
30984183|NCT02466516|59123625|FG003|Overall Study|Lost to Follow-up|0|||
30984184|NCT02466516|59123626|FG004|Overall Study|Lost to Follow-up|0|||
30984185|NCT01725152|59123640|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
30984186|NCT01725152|59123641|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
30984187|NCT01725152|59123640|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
30984188|NCT01725152|59123641|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
30984189|NCT01725152|59123640|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
30984190|NCT01725152|59123641|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
30984191|NCT01725152|59123640|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
30984192|NCT01725152|59123641|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
30984193|NCT01049984|59123657|FG000|Overall Study|Withdrawal by Subject|1|||
30984194|NCT01049984|59123658|FG001|Overall Study|Withdrawal by Subject|5|||
30984195|NCT01049984|59123657|FG000|Overall Study|Protocol Violation|3|||
30984196|NCT01049984|59123658|FG001|Overall Study|Protocol Violation|4|||
30984197|NCT01049984|59123657|FG000|Overall Study|Lost to Follow-up|2|||
30984198|NCT01049984|59123658|FG001|Overall Study|Lost to Follow-up|1|||
30984199|NCT01049984|59123657|FG000|Overall Study|Adverse Event|13|||
30984200|NCT01049984|59123658|FG001|Overall Study|Adverse Event|7|||
30984201|NCT01049984|59123657|FG000|Overall Study|Treatment failure|0|||
30984202|NCT01049984|59123658|FG001|Overall Study|Treatment failure|2|||
30984203|NCT01049360|59123664|FG000|Period 1|Adverse Event|0|||
30984204|NCT01049360|59123665|FG001|Period 1|Adverse Event|1|||
30984205|NCT01049360|59123666|FG002|Period 1|Adverse Event|0|||
30984206|NCT01049360|59123667|FG003|Period 1|Adverse Event|1|||
30984207|NCT01049360|59123668|FG004|Period 1|Adverse Event|0|||
30984208|NCT01049360|59123669|FG005|Period 1|Adverse Event|0|||
30984209|NCT01049360|59123670|FG006|Period 1|Adverse Event|0|||
30984210|NCT01049360|59123671|FG007|Period 1|Adverse Event|1|||
30984211|NCT01049360|59123672|FG008|Period 1|Adverse Event|0|||
30984212|NCT01049360|59123673|FG009|Period 1|Adverse Event|0|||
30984213|NCT01049360|59123674|FG010|Period 1|Adverse Event|0|||
30984214|NCT01049360|59123675|FG011|Period 1|Adverse Event|0|||
30984215|NCT01049360|59123676|FG012|Period 1|Adverse Event|1|||
30984216|NCT01049360|59123677|FG013|Period 1|Adverse Event|1|||
30984217|NCT01049360|59123678|FG014|Period 1|Adverse Event|0|||
30984218|NCT01049360|59123679|FG015|Period 1|Adverse Event|0|||
30984219|NCT01049360|59123680|FG016|Period 1|Adverse Event|1|||
30984220|NCT01049360|59123681|FG017|Period 1|Adverse Event|0|||
30984221|NCT01049360|59123682|FG018|Period 1|Adverse Event|1|||
30984222|NCT01049360|59123683|FG019|Period 1|Adverse Event|0|||
30984223|NCT01049360|59123664|FG000|Period 1|Did not meet inc/exc criteria|0|||
30984224|NCT01049360|59123665|FG001|Period 1|Did not meet inc/exc criteria|0|||
30984225|NCT01049360|59123666|FG002|Period 1|Did not meet inc/exc criteria|0|||
30790196|NCT00039377|58803412|FG002|Initial Registration|Adverse Event|0|||
30984226|NCT01049360|59123667|FG003|Period 1|Did not meet inc/exc criteria|0|||
30984227|NCT01049360|59123668|FG004|Period 1|Did not meet inc/exc criteria|0|||
30984228|NCT01049360|59123669|FG005|Period 1|Did not meet inc/exc criteria|0|||
30984229|NCT01049360|59123670|FG006|Period 1|Did not meet inc/exc criteria|0|||
30984230|NCT01049360|59123671|FG007|Period 1|Did not meet inc/exc criteria|1|||
30984231|NCT01049360|59123672|FG008|Period 1|Did not meet inc/exc criteria|1|||
30984232|NCT01049360|59123673|FG009|Period 1|Did not meet inc/exc criteria|0|||
30984233|NCT01049360|59123674|FG010|Period 1|Did not meet inc/exc criteria|0|||
30984234|NCT01049360|59123675|FG011|Period 1|Did not meet inc/exc criteria|0|||
30984235|NCT01049360|59123676|FG012|Period 1|Did not meet inc/exc criteria|0|||
30984236|NCT01049360|59123677|FG013|Period 1|Did not meet inc/exc criteria|0|||
30984237|NCT01049360|59123678|FG014|Period 1|Did not meet inc/exc criteria|0|||
30984238|NCT01049360|59123679|FG015|Period 1|Did not meet inc/exc criteria|0|||
30984239|NCT01049360|59123680|FG016|Period 1|Did not meet inc/exc criteria|0|||
30984240|NCT01049360|59123681|FG017|Period 1|Did not meet inc/exc criteria|0|||
30984241|NCT01049360|59123682|FG018|Period 1|Did not meet inc/exc criteria|0|||
30984242|NCT01049360|59123683|FG019|Period 1|Did not meet inc/exc criteria|0|||
30984243|NCT01049360|59123664|FG000|Period 1|Withdrawal by Subject|0|||
30984244|NCT01049360|59123665|FG001|Period 1|Withdrawal by Subject|0|||
30984245|NCT01049360|59123666|FG002|Period 1|Withdrawal by Subject|0|||
30984246|NCT01049360|59123667|FG003|Period 1|Withdrawal by Subject|0|||
30984247|NCT01049360|59123668|FG004|Period 1|Withdrawal by Subject|0|||
30984248|NCT01049360|59123669|FG005|Period 1|Withdrawal by Subject|0|||
30984249|NCT01049360|59123670|FG006|Period 1|Withdrawal by Subject|0|||
30984250|NCT01049360|59123671|FG007|Period 1|Withdrawal by Subject|0|||
30984251|NCT01049360|59123672|FG008|Period 1|Withdrawal by Subject|1|||
30984252|NCT01049360|59123673|FG009|Period 1|Withdrawal by Subject|0|||
30984253|NCT01049360|59123674|FG010|Period 1|Withdrawal by Subject|1|||
30984254|NCT01049360|59123675|FG011|Period 1|Withdrawal by Subject|0|||
30984255|NCT01049360|59123676|FG012|Period 1|Withdrawal by Subject|1|||
30984256|NCT01049360|59123677|FG013|Period 1|Withdrawal by Subject|0|||
30984257|NCT01049360|59123678|FG014|Period 1|Withdrawal by Subject|0|||
30984258|NCT01049360|59123679|FG015|Period 1|Withdrawal by Subject|0|||
30984259|NCT01049360|59123680|FG016|Period 1|Withdrawal by Subject|0|||
30984260|NCT01049360|59123681|FG017|Period 1|Withdrawal by Subject|0|||
30984261|NCT01049360|59123682|FG018|Period 1|Withdrawal by Subject|0|||
30984262|NCT01049360|59123683|FG019|Period 1|Withdrawal by Subject|0|||
30984263|NCT01049360|59123664|FG000|Period 2|Protocol Violation|0|||
30984264|NCT01049360|59123665|FG001|Period 2|Protocol Violation|0|||
30984265|NCT01049360|59123666|FG002|Period 2|Protocol Violation|0|||
30984266|NCT01049360|59123667|FG003|Period 2|Protocol Violation|1|||
30984267|NCT01049360|59123668|FG004|Period 2|Protocol Violation|0|||
30984268|NCT01049360|59123669|FG005|Period 2|Protocol Violation|0|||
30984269|NCT01049360|59123670|FG006|Period 2|Protocol Violation|0|||
30984270|NCT01049360|59123671|FG007|Period 2|Protocol Violation|0|||
30984271|NCT01049360|59123672|FG008|Period 2|Protocol Violation|0|||
30984272|NCT01049360|59123673|FG009|Period 2|Protocol Violation|0|||
30984273|NCT01049360|59123674|FG010|Period 2|Protocol Violation|0|||
30984274|NCT01049360|59123675|FG011|Period 2|Protocol Violation|0|||
30984275|NCT01049360|59123676|FG012|Period 2|Protocol Violation|0|||
30984276|NCT01049360|59123677|FG013|Period 2|Protocol Violation|0|||
30984277|NCT01049360|59123678|FG014|Period 2|Protocol Violation|1|||
30984278|NCT01049360|59123679|FG015|Period 2|Protocol Violation|1|||
30984279|NCT01049360|59123680|FG016|Period 2|Protocol Violation|0|||
30984280|NCT01049360|59123681|FG017|Period 2|Protocol Violation|0|||
30984281|NCT01049360|59123682|FG018|Period 2|Protocol Violation|0|||
30984282|NCT01049360|59123683|FG019|Period 2|Protocol Violation|0|||
30984283|NCT01049360|59123664|FG000|Period 2|Adverse Event|0|||
30984284|NCT01049360|59123665|FG001|Period 2|Adverse Event|1|||
30984285|NCT01049360|59123666|FG002|Period 2|Adverse Event|0|||
30984286|NCT01049360|59123667|FG003|Period 2|Adverse Event|0|||
30984287|NCT01049360|59123668|FG004|Period 2|Adverse Event|0|||
30984288|NCT01049360|59123669|FG005|Period 2|Adverse Event|0|||
30984289|NCT01049360|59123670|FG006|Period 2|Adverse Event|0|||
30984290|NCT01049360|59123671|FG007|Period 2|Adverse Event|0|||
30984291|NCT01049360|59123672|FG008|Period 2|Adverse Event|1|||
30984292|NCT01049360|59123673|FG009|Period 2|Adverse Event|0|||
30984293|NCT01049360|59123674|FG010|Period 2|Adverse Event|0|||
30984294|NCT01049360|59123675|FG011|Period 2|Adverse Event|0|||
30984295|NCT01049360|59123676|FG012|Period 2|Adverse Event|0|||
30891612|NCT02395081|58924845|FG000|Overall Study|Moved where blood couldn't be collected|4|||
30984296|NCT01049360|59123677|FG013|Period 2|Adverse Event|0|||
30984297|NCT01049360|59123678|FG014|Period 2|Adverse Event|0|||
30984298|NCT01049360|59123679|FG015|Period 2|Adverse Event|0|||
30984299|NCT01049360|59123680|FG016|Period 2|Adverse Event|0|||
30984300|NCT01049360|59123681|FG017|Period 2|Adverse Event|0|||
30984301|NCT01049360|59123682|FG018|Period 2|Adverse Event|0|||
30984302|NCT01049360|59123683|FG019|Period 2|Adverse Event|1|||
30984303|NCT01049360|59123664|FG000|Period 2|Withdrawal by Subject|0|||
30984304|NCT01049360|59123665|FG001|Period 2|Withdrawal by Subject|0|||
30984305|NCT01049360|59123666|FG002|Period 2|Withdrawal by Subject|0|||
30984306|NCT01049360|59123667|FG003|Period 2|Withdrawal by Subject|1|||
30984307|NCT01049360|59123668|FG004|Period 2|Withdrawal by Subject|0|||
30984308|NCT01049360|59123669|FG005|Period 2|Withdrawal by Subject|0|||
30984309|NCT01049360|59123670|FG006|Period 2|Withdrawal by Subject|0|||
30984310|NCT01049360|59123671|FG007|Period 2|Withdrawal by Subject|0|||
30984311|NCT01049360|59123672|FG008|Period 2|Withdrawal by Subject|0|||
30984312|NCT01049360|59123673|FG009|Period 2|Withdrawal by Subject|0|||
30984313|NCT01049360|59123674|FG010|Period 2|Withdrawal by Subject|0|||
30984314|NCT01049360|59123675|FG011|Period 2|Withdrawal by Subject|0|||
30984315|NCT01049360|59123676|FG012|Period 2|Withdrawal by Subject|0|||
30984316|NCT01049360|59123677|FG013|Period 2|Withdrawal by Subject|0|||
30984317|NCT01049360|59123678|FG014|Period 2|Withdrawal by Subject|1|||
30984318|NCT01049360|59123679|FG015|Period 2|Withdrawal by Subject|0|||
30984319|NCT01049360|59123680|FG016|Period 2|Withdrawal by Subject|0|||
30984320|NCT01049360|59123681|FG017|Period 2|Withdrawal by Subject|0|||
30984321|NCT01049360|59123682|FG018|Period 2|Withdrawal by Subject|0|||
30984322|NCT01049360|59123683|FG019|Period 2|Withdrawal by Subject|1|||
30984323|NCT01049360|59123664|FG000|Period 2|Lack of Efficacy|0|||
30984324|NCT01049360|59123665|FG001|Period 2|Lack of Efficacy|0|||
30984325|NCT01049360|59123666|FG002|Period 2|Lack of Efficacy|0|||
30984326|NCT01049360|59123667|FG003|Period 2|Lack of Efficacy|0|||
30984327|NCT01049360|59123668|FG004|Period 2|Lack of Efficacy|0|||
30984328|NCT01049360|59123669|FG005|Period 2|Lack of Efficacy|1|||
30984329|NCT01049360|59123670|FG006|Period 2|Lack of Efficacy|0|||
30984330|NCT01049360|59123671|FG007|Period 2|Lack of Efficacy|0|||
30984331|NCT01049360|59123672|FG008|Period 2|Lack of Efficacy|0|||
30984332|NCT01049360|59123673|FG009|Period 2|Lack of Efficacy|0|||
30984333|NCT01049360|59123674|FG010|Period 2|Lack of Efficacy|0|||
30984334|NCT01049360|59123675|FG011|Period 2|Lack of Efficacy|0|||
30984335|NCT01049360|59123676|FG012|Period 2|Lack of Efficacy|0|||
30984336|NCT01049360|59123677|FG013|Period 2|Lack of Efficacy|0|||
30984337|NCT01049360|59123678|FG014|Period 2|Lack of Efficacy|0|||
30984338|NCT01049360|59123679|FG015|Period 2|Lack of Efficacy|0|||
30984339|NCT01049360|59123680|FG016|Period 2|Lack of Efficacy|0|||
30984340|NCT01049360|59123681|FG017|Period 2|Lack of Efficacy|0|||
30984341|NCT01049360|59123682|FG018|Period 2|Lack of Efficacy|0|||
30984342|NCT01049360|59123683|FG019|Period 2|Lack of Efficacy|0|||
30984343|NCT01049360|59123664|FG000|Period 4|Protocol Violation|0|||
30984344|NCT01049360|59123665|FG001|Period 4|Protocol Violation|0|||
30984345|NCT01049360|59123666|FG002|Period 4|Protocol Violation|0|||
30984346|NCT01049360|59123667|FG003|Period 4|Protocol Violation|0|||
30984347|NCT01049360|59123668|FG004|Period 4|Protocol Violation|0|||
30984348|NCT01049360|59123669|FG005|Period 4|Protocol Violation|0|||
30984349|NCT01049360|59123670|FG006|Period 4|Protocol Violation|0|||
30984350|NCT01049360|59123671|FG007|Period 4|Protocol Violation|0|||
30984351|NCT01049360|59123672|FG008|Period 4|Protocol Violation|0|||
30984352|NCT01049360|59123673|FG009|Period 4|Protocol Violation|0|||
30984353|NCT01049360|59123674|FG010|Period 4|Protocol Violation|0|||
30984354|NCT01049360|59123675|FG011|Period 4|Protocol Violation|0|||
30984355|NCT01049360|59123676|FG012|Period 4|Protocol Violation|0|||
30984356|NCT01049360|59123677|FG013|Period 4|Protocol Violation|0|||
30984357|NCT01049360|59123678|FG014|Period 4|Protocol Violation|0|||
30984358|NCT01049360|59123679|FG015|Period 4|Protocol Violation|0|||
30984359|NCT01049360|59123680|FG016|Period 4|Protocol Violation|0|||
30984360|NCT01049360|59123681|FG017|Period 4|Protocol Violation|1|||
30984361|NCT01049360|59123682|FG018|Period 4|Protocol Violation|0|||
30984362|NCT01049360|59123683|FG019|Period 4|Protocol Violation|0|||
30984363|NCT01049360|59123664|FG000|Period 4|Withdrawal by Subject|0|||
30984364|NCT01049360|59123665|FG001|Period 4|Withdrawal by Subject|0|||
30984365|NCT01049360|59123666|FG002|Period 4|Withdrawal by Subject|0|||
30984366|NCT01049360|59123667|FG003|Period 4|Withdrawal by Subject|1|||
30984367|NCT01049360|59123668|FG004|Period 4|Withdrawal by Subject|0|||
30984368|NCT01049360|59123669|FG005|Period 4|Withdrawal by Subject|0|||
30984369|NCT01049360|59123670|FG006|Period 4|Withdrawal by Subject|0|||
30984370|NCT01049360|59123671|FG007|Period 4|Withdrawal by Subject|0|||
30984371|NCT01049360|59123672|FG008|Period 4|Withdrawal by Subject|0|||
30984372|NCT01049360|59123673|FG009|Period 4|Withdrawal by Subject|0|||
30984373|NCT01049360|59123674|FG010|Period 4|Withdrawal by Subject|0|||
30984374|NCT01049360|59123675|FG011|Period 4|Withdrawal by Subject|0|||
30984375|NCT01049360|59123676|FG012|Period 4|Withdrawal by Subject|0|||
30984376|NCT01049360|59123677|FG013|Period 4|Withdrawal by Subject|0|||
30984377|NCT01049360|59123678|FG014|Period 4|Withdrawal by Subject|0|||
30984378|NCT01049360|59123679|FG015|Period 4|Withdrawal by Subject|0|||
30984379|NCT01049360|59123680|FG016|Period 4|Withdrawal by Subject|0|||
30984380|NCT01049360|59123681|FG017|Period 4|Withdrawal by Subject|0|||
30608484|NCT01287416|58619259|FG000|Pre-post Training|Lost to Follow-up|5|||
30984381|NCT01049360|59123682|FG018|Period 4|Withdrawal by Subject|0|||
30984382|NCT01049360|59123683|FG019|Period 4|Withdrawal by Subject|0|||
30984383|NCT02494596|59123695|FG000|Overall Study|Insufficient Therapeutic Response|3|||
30984384|NCT02494596|59123696|FG001|Overall Study|Insufficient Therapeutic Response|3|||
30984385|NCT02494596|59123697|FG002|Overall Study|Insufficient Therapeutic Response|1|||
30984386|NCT02494596|59123695|FG000|Overall Study|Adverse Event|0|||
30984387|NCT02494596|59123696|FG001|Overall Study|Adverse Event|1|||
30984388|NCT02494596|59123697|FG002|Overall Study|Adverse Event|0|||
30984389|NCT02494596|59123695|FG000|Overall Study|Refused Treatment|0|||
30984390|NCT02494596|59123696|FG001|Overall Study|Refused Treatment|1|||
30984391|NCT02494596|59123697|FG002|Overall Study|Refused Treatment|0|||
30984392|NCT02494206|59123716|FG000|Overall Study|Adverse Event|1|||
30984393|NCT02494206|59123716|FG000|Overall Study|Disease Progression|1|||
30984394|NCT01048502|59123733|FG000|Overall Study|Lost to Follow-up|2|||
30984395|NCT01048502|59123734|FG001|Overall Study|Lost to Follow-up|0|||
30984396|NCT01048502|59123735|FG002|Overall Study|Lost to Follow-up|0|||
30984397|NCT01048502|59123736|FG003|Overall Study|Lost to Follow-up|0|||
30984398|NCT01048502|59123733|FG000|Overall Study|Adverse Event|1|||
30984399|NCT01048502|59123734|FG001|Overall Study|Adverse Event|0|||
30984400|NCT01048502|59123735|FG002|Overall Study|Adverse Event|0|||
30984401|NCT01048502|59123736|FG003|Overall Study|Adverse Event|0|||
30984402|NCT01048502|59123733|FG000|Overall Study|Withdrawal by Subject|1|||
30984403|NCT01048502|59123734|FG001|Overall Study|Withdrawal by Subject|4|||
30984404|NCT01048502|59123735|FG002|Overall Study|Withdrawal by Subject|5|||
30984405|NCT01048502|59123736|FG003|Overall Study|Withdrawal by Subject|3|||
30984406|NCT01048502|59123733|FG000|Overall Study|Physician Decision|0|||
30984407|NCT01048502|59123734|FG001|Overall Study|Physician Decision|3|||
30984408|NCT01048502|59123735|FG002|Overall Study|Physician Decision|0|||
30984409|NCT01048502|59123736|FG003|Overall Study|Physician Decision|1|||
30984410|NCT02465034|59123749|FG000|Overall Study|Withdrawal by Subject|1|||
30984411|NCT02465034|59123750|FG001|Overall Study|Withdrawal by Subject|1|||
30984412|NCT02465034|59123749|FG000|Overall Study|Screen fail|2|||
30984413|NCT02465034|59123750|FG001|Overall Study|Screen fail|0|||
30984414|NCT02465034|59123749|FG000|Overall Study|Could not be scheduled for study visit|0|||
30984415|NCT02465034|59123750|FG001|Overall Study|Could not be scheduled for study visit|5|||
30984416|NCT02516982|59123777|FG000|Overall Study|Called in to antenatal appointment|32|||
30984417|NCT02516982|59123778|FG001|Overall Study|Called in to antenatal appointment|35|||
30984418|NCT02516982|59123779|FG002|Overall Study|Called in to antenatal appointment|0|||
30984419|NCT02516982|59123780|FG003|Overall Study|Called in to antenatal appointment|0|||
30984420|NCT02516982|59123777|FG000|Overall Study|Withdrawal by Subject|0|||
30984421|NCT02516982|59123778|FG001|Overall Study|Withdrawal by Subject|0|||
30984422|NCT02516982|59123779|FG002|Overall Study|Withdrawal by Subject|1|||
30984423|NCT02516982|59123780|FG003|Overall Study|Withdrawal by Subject|2|||
30984424|NCT02516982|59123777|FG000|Overall Study|Protocol Violation|0|||
30984425|NCT02516982|59123778|FG001|Overall Study|Protocol Violation|0|||
30984426|NCT02516982|59123779|FG002|Overall Study|Protocol Violation|1|||
30984427|NCT02516982|59123780|FG003|Overall Study|Protocol Violation|1|||
30984428|NCT02516982|59123777|FG000|Overall Study|Did not install the app|0|||
30984429|NCT02516982|59123778|FG001|Overall Study|Did not install the app|0|||
30984430|NCT02516982|59123779|FG002|Overall Study|Did not install the app|46|||
30984431|NCT02516982|59123780|FG003|Overall Study|Did not install the app|47|||
30984432|NCT02464410|59123825|FG000|Overall Study|Death|3|||
30984433|NCT02464410|59123826|FG001|Overall Study|Death|4|||
30984434|NCT02464410|59123825|FG000|Overall Study|Lost to Follow-up|7|||
30984435|NCT02464410|59123826|FG001|Overall Study|Lost to Follow-up|9|||
30984436|NCT02464410|59123825|FG000|Overall Study|Withdrawal by Subject|12|||
30984437|NCT02464410|59123826|FG001|Overall Study|Withdrawal by Subject|3|||
30984438|NCT01047332|59123834|FG000|Overall Study|SEMS Obstruction|11|||
30984439|NCT01047332|59123835|FG001|Overall Study|SEMS Obstruction|20|||
30984440|NCT01047332|59123834|FG000|Overall Study|Died Unobstructed|38|||
30984441|NCT01047332|59123835|FG001|Overall Study|Died Unobstructed|41|||
30984442|NCT01047332|59123834|FG000|Overall Study|Lost to Follow-up|8|||
30984443|NCT01047332|59123835|FG001|Overall Study|Lost to Follow-up|3|||
30984444|NCT01046396|59123841|FG000|Overall Study|Withdrawal by Subject|5|||
30984445|NCT01046084|59123867|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
30984446|NCT01046084|59123868|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
30984447|NCT01045694|59123887|FG000|Overall Study|Withdrawal by Subject|2|||
30984448|NCT01044290|59123947|FG000|Follow-up 1|Death|3|||
30984449|NCT01044290|59123948|FG001|Follow-up 1|Death|3|||
30984450|NCT01044290|59123949|FG002|Follow-up 1|Death|1|||
30984451|NCT01044290|59123947|FG000|Follow-up 1|Withdrawal by Subject|2|||
30984452|NCT01044290|59123948|FG001|Follow-up 1|Withdrawal by Subject|2|||
30984453|NCT01044290|59123949|FG002|Follow-up 1|Withdrawal by Subject|0|||
30984454|NCT01044290|59123947|FG000|Follow-Up 2|Death|0|||
30984455|NCT01044290|59123948|FG001|Follow-Up 2|Death|1|||
30984456|NCT01044290|59123949|FG002|Follow-Up 2|Death|1|||
30984457|NCT01044290|59123947|FG000|Follow-Up 2|Withdrawal by Subject|0|||
30984458|NCT01044290|59123948|FG001|Follow-Up 2|Withdrawal by Subject|1|||
30984459|NCT01044290|59123949|FG002|Follow-Up 2|Withdrawal by Subject|1|||
30984460|NCT01041638|59124030|FG000|Overall Study|Adverse Event|4|||
30984461|NCT01041638|59124030|FG000|Overall Study|Death|1|||
30984462|NCT01041638|59124030|FG000|Overall Study|Lack of Efficacy|7|||
30984463|NCT01041638|59124030|FG000|Overall Study|Physician Decision|4|||
30984464|NCT01041638|59124030|FG000|Overall Study|Withdrawal by Subject|11|||
30984465|NCT01045460|59124054|FG000|Overall Study|Physician Decision|3|||
30984466|NCT01045460|59124055|FG001|Overall Study|Physician Decision|2|||
30984467|NCT01045460|59124054|FG000|Overall Study|Lost to Follow-up|0|||
30984468|NCT01045460|59124055|FG001|Overall Study|Lost to Follow-up|1|||
30984469|NCT01045460|59124054|FG000|Overall Study|Lack of Efficacy|3|||
30984470|NCT01045460|59124055|FG001|Overall Study|Lack of Efficacy|0|||
30984471|NCT05014919|59124066|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
30984472|NCT05014919|59124067|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
30984473|NCT05014919|59124068|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
30984474|NCT05014919|59124066|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
30984475|NCT05014919|59124067|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
30984476|NCT05014919|59124068|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
30984477|NCT05014919|59124066|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
30984478|NCT05014919|59124067|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
30984479|NCT05014919|59124068|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
30984480|NCT05014919|59124066|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
30984481|NCT05014919|59124067|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
30984482|NCT05014919|59124068|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
30984483|NCT05014919|59124066|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
30984484|NCT05014919|59124067|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
30984485|NCT05014919|59124068|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
30984486|NCT05014919|59124066|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
30984487|NCT05014919|59124067|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
30984488|NCT05014919|59124068|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
30984489|NCT05014919|59124066|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
30984490|NCT05014919|59124067|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
30984491|NCT05014919|59124068|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
30984492|NCT05014919|59124066|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
30984493|NCT05014919|59124067|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
30984494|NCT05014919|59124068|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
30984495|NCT03409796|59124111|FG000|Overall Study|Adverse Event|2|||
30984496|NCT03409796|59124112|FG001|Overall Study|Adverse Event|0|||
30984497|NCT03409796|59124111|FG000|Overall Study|Other|0|||
30984498|NCT03409796|59124112|FG001|Overall Study|Other|1|||
30984499|NCT02462928|59124121|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
30984500|NCT02462928|59124122|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
30984501|NCT02462928|59124123|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
30984502|NCT02462928|59124121|FG000|Overall Study|Adverse Event|47|||
30984503|NCT02462928|59124122|FG001|Overall Study|Adverse Event|51|||
30984504|NCT02462928|59124123|FG002|Overall Study|Adverse Event|25|||
30984505|NCT02462928|59124121|FG000|Overall Study|Lack of Efficacy|3|||
30984506|NCT02462928|59124122|FG001|Overall Study|Lack of Efficacy|8|||
30984507|NCT02462928|59124123|FG002|Overall Study|Lack of Efficacy|3|||
30984508|NCT02462928|59124121|FG000|Overall Study|Lost to Follow-up|4|||
30984509|NCT02462928|59124122|FG001|Overall Study|Lost to Follow-up|4|||
30984510|NCT02462928|59124123|FG002|Overall Study|Lost to Follow-up|1|||
30984511|NCT02462928|59124121|FG000|Overall Study|Withdrawal by Patient|31|||
30984512|NCT02462928|59124122|FG001|Overall Study|Withdrawal by Patient|21|||
30984513|NCT02462928|59124123|FG002|Overall Study|Withdrawal by Patient|21|||
30984514|NCT02462928|59124121|FG000|Overall Study|Protocol Violation|0|||
30984515|NCT02462928|59124122|FG001|Overall Study|Protocol Violation|1|||
30984516|NCT02462928|59124123|FG002|Overall Study|Protocol Violation|0|||
30984517|NCT02462928|59124121|FG000|Overall Study|Reason not Specified|4|||
30984518|NCT02462928|59124122|FG001|Overall Study|Reason not Specified|6|||
30984519|NCT02462928|59124123|FG002|Overall Study|Reason not Specified|5|||
30984520|NCT00019604|59124140|FG000|Overall Study|Death|1|||
30984521|NCT00019604|59124140|FG000|Overall Study|Progressive disease|23|||
30984522|NCT00019604|59124140|FG000|Overall Study|Refused treatment|1|||
30984523|NCT00019604|59124140|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
30984524|NCT00019604|59124140|FG000|Overall Study|Going to have liver transplant|1|||
30984525|NCT00019604|59124140|FG000|Overall Study|Move to a different study|1|||
30984526|NCT00019604|59124140|FG000|Overall Study|Non compliant on systemic CH|1|||
30984527|NCT00019604|59124140|FG000|Overall Study|Non compliant|1|||
30984528|NCT00019604|59124140|FG000|Overall Study|Resectable disease|1|||
30984529|NCT00019604|59124140|FG000|Overall Study|Started new chemo regimen|1|||
30984530|NCT00019604|59124140|FG000|Overall Study|Pt going to immunotherapy study|1|||
30984531|NCT00019604|59124140|FG000|Overall Study|Too much disease|1|||
30984532|NCT00019604|59124140|FG000|Overall Study|Unable to evaluate|1|||
30984533|NCT00019604|59124140|FG000|Overall Study|Details for other not available|4|||
30984534|NCT02492958|59124156|FG000|Overall Study|Withdrawal by Subject|0|||
30984535|NCT02492958|59124157|FG001|Overall Study|Withdrawal by Subject|0|||
30984536|NCT02492958|59124158|FG002|Overall Study|Withdrawal by Subject|1|||
30984537|NCT02492958|59124159|FG003|Overall Study|Withdrawal by Subject|0|||
30984538|NCT02492958|59124156|FG000|Overall Study|Adverse Event|1|||
30984539|NCT02492958|59124157|FG001|Overall Study|Adverse Event|0|||
30984540|NCT02492958|59124158|FG002|Overall Study|Adverse Event|1|||
30984541|NCT02492958|59124159|FG003|Overall Study|Adverse Event|0|||
30984542|NCT02492880|59124169|FG000|Overall Study|Lost to Follow-up|1|||
30984543|NCT02492880|59124169|FG000|Overall Study|Protocol Violation|1|||
30984544|NCT02516592|59124175|FG000|Overall Study|Patient withdrew consent|5|||
30984545|NCT02516592|59124176|FG001|Overall Study|Patient withdrew consent|2|||
30984546|NCT02516592|59124175|FG000|Overall Study|Protocol deviation|4|||
30984547|NCT02516592|59124176|FG001|Overall Study|Protocol deviation|4|||
30984548|NCT02516592|59124175|FG000|Overall Study|Lost to Follow-up|2|||
30984549|NCT02516592|59124176|FG001|Overall Study|Lost to Follow-up|3|||
30984550|NCT02516592|59124175|FG000|Overall Study|Patient/guardian decision|2|||
30984551|NCT02516592|59124176|FG001|Overall Study|Patient/guardian decision|1|||
30984552|NCT02516592|59124175|FG000|Overall Study|Adverse Event|1|||
30984553|NCT02516592|59124176|FG001|Overall Study|Adverse Event|2|||
30984554|NCT02516592|59124175|FG000|Overall Study|Abnormal test procedure result|1|||
30984555|NCT02516592|59124176|FG001|Overall Study|Abnormal test procedure result|0|||
30984556|NCT02516592|59124175|FG000|Overall Study|Death|1|||
30984557|NCT02516592|59124176|FG001|Overall Study|Death|1|||
30984558|NCT02492100|59124204|FG000|Overall Study|Death|1|||
30984559|NCT02461758|59124227|FG000|Overall Study|Lost to Follow-up|0|||
30984560|NCT02461758|59124228|FG001|Overall Study|Lost to Follow-up|1|||
30984561|NCT02461758|59124229|FG002|Overall Study|Lost to Follow-up|1|||
30984562|NCT02461758|59124230|FG003|Overall Study|Lost to Follow-up|0|||
30984563|NCT02461290|59124252|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
30984564|NCT02461290|59124252|FG000|Overall Study|Lost to Follow-up|3|||
30984565|NCT02461134|59124256|FG000|Overall Study|Adverse Event|1|||
30984566|NCT02460978|59124285|FG000|Overall Study|Adverse Event|17|||
30984567|NCT02460978|59124286|FG001|Overall Study|Adverse Event|11|||
30984568|NCT02460978|59124287|FG002|Overall Study|Adverse Event|11|||
30984569|NCT02460978|59124285|FG000|Overall Study|Withdrawal by Subject|5|||
30984570|NCT02460978|59124286|FG001|Overall Study|Withdrawal by Subject|5|||
30984571|NCT02460978|59124287|FG002|Overall Study|Withdrawal by Subject|14|||
30984572|NCT02460978|59124285|FG000|Overall Study|Lost to Follow-up|2|||
30984573|NCT02460978|59124286|FG001|Overall Study|Lost to Follow-up|3|||
30984574|NCT02460978|59124287|FG002|Overall Study|Lost to Follow-up|1|||
30984575|NCT02460978|59124285|FG000|Overall Study|Protocol Violation|1|||
30984576|NCT02460978|59124286|FG001|Overall Study|Protocol Violation|1|||
30984577|NCT02460978|59124287|FG002|Overall Study|Protocol Violation|1|||
30984578|NCT02460978|59124285|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
30984579|NCT02460978|59124286|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
30984580|NCT02460978|59124287|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
30984581|NCT02460978|59124285|FG000|Overall Study|Pregnancy|0|||
30984582|NCT02460978|59124286|FG001|Overall Study|Pregnancy|0|||
30984583|NCT02460978|59124287|FG002|Overall Study|Pregnancy|2|||
30984584|NCT02489448|59124302|FG000|Overall Study|Death|3|||
30984585|NCT02489448|59124302|FG000|Overall Study|Withdrawal by Subject|2|||
30984586|NCT02488980|59124323|FG000|Overall Study|Protocol Violation|2|||
30984587|NCT02488980|59124324|FG001|Overall Study|Protocol Violation|2|||
30984588|NCT02488980|59124325|FG002|Overall Study|Protocol Violation|2|||
30984589|NCT02460822|59124337|FG000|Overall Study|Withdrawal by Subject|1|||
30984590|NCT02488824|59124343|FG000|Overall Study|Adverse Event|1|||
30984591|NCT02488824|59124344|FG001|Overall Study|Adverse Event|1|||
30984592|NCT02308241|59124447|FG000|Overall Study|Withdrawal by Subject|3|||
30984593|NCT02460198|59124486|FG000|Overall Study|Adverse Event|1|||
30984594|NCT02460198|59124487|FG001|Overall Study|Adverse Event|3|||
30984595|NCT02460198|59124486|FG000|Overall Study|Death|36|||
30984596|NCT02460198|59124487|FG001|Overall Study|Death|28|||
30984597|NCT02460198|59124486|FG000|Overall Study|Lost to Follow-up|1|||
30984598|NCT02460198|59124487|FG001|Overall Study|Lost to Follow-up|1|||
30984599|NCT02460198|59124486|FG000|Overall Study|Transferred to Extension Study|15|||
30984600|NCT02460198|59124487|FG001|Overall Study|Transferred to Extension Study|15|||
30984601|NCT02460198|59124486|FG000|Overall Study|Withdrawal by Subject|2|||
30984602|NCT02460198|59124487|FG001|Overall Study|Withdrawal by Subject|4|||
30984603|NCT02460198|59124486|FG000|Overall Study|Site Terminated By Sponsor|0|||
30984604|NCT02460198|59124487|FG001|Overall Study|Site Terminated By Sponsor|1|||
30984605|NCT02460198|59124486|FG000|Overall Study|Did Not Continue on Extension Study|6|||
30984606|NCT02460198|59124487|FG001|Overall Study|Did Not Continue on Extension Study|11|||
30984607|NCT02487810|59124507|FG000|Overall Study|Withdrawal by Subject|1|||
30984608|NCT02487810|59124508|FG001|Overall Study|Withdrawal by Subject|0|||
30984609|NCT02452320|59124516|FG000|Overall Study|Adverse Event|0|||
30984610|NCT02452320|59124517|FG001|Overall Study|Adverse Event|1|||
30984611|NCT02459964|59124526|FG000|Overall Study|Withdrawal by Subject|0|||
30984612|NCT02459964|59124527|FG001|Overall Study|Withdrawal by Subject|0|||
30984613|NCT02459964|59124528|FG002|Overall Study|Withdrawal by Subject|1|||
30984614|NCT02459964|59124526|FG000|Overall Study|Abnormal EKG changes|0|||
30984615|NCT02459964|59124527|FG001|Overall Study|Abnormal EKG changes|0|||
30984616|NCT02459964|59124528|FG002|Overall Study|Abnormal EKG changes|1|||
30984617|NCT02451930|59124605|FG000|Overall Study|Death|0|||
30984618|NCT02451930|59124606|FG001|Overall Study|Death|15|||
30984619|NCT02451930|59124605|FG000|Overall Study|Lost to Follow-up|0|||
30984620|NCT02451930|59124606|FG001|Overall Study|Lost to Follow-up|3|||
30984621|NCT02451930|59124605|FG000|Overall Study|Sponsor Decision|2|||
30984622|NCT02451930|59124606|FG001|Overall Study|Sponsor Decision|10|||
30984623|NCT02451930|59124605|FG000|Overall Study|Withdrawal by Subject|0|||
30984624|NCT02451930|59124606|FG001|Overall Study|Withdrawal by Subject|1|||
30984625|NCT02451930|59124605|FG000|Overall Study|Other|0|||
30984626|NCT02451930|59124606|FG001|Overall Study|Other|1|||
30984627|NCT02451696|59124642|FG000|Overall Study|Surgery postponed|1|||
30984628|NCT02451696|59124643|FG001|Overall Study|Surgery postponed|0|||
30984629|NCT02459418|59124666|FG000|Overall Study|Exclusion Criteria|4|||
30984630|NCT02459418|59124667|FG001|Overall Study|Exclusion Criteria|0|||
30984631|NCT02459418|59124666|FG000|Overall Study|Protocol Violation|0|||
30984632|NCT02459418|59124667|FG001|Overall Study|Protocol Violation|2|||
30984633|NCT02459418|59124666|FG000|Overall Study|Physician Decision|0|||
30984634|NCT02459418|59124667|FG001|Overall Study|Physician Decision|2|||
30984635|NCT02459418|59124666|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
30984636|NCT02459418|59124667|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
30984637|NCT02459418|59124666|FG000|Overall Study|Adverse Event|0|||
30984638|NCT02459418|59124667|FG001|Overall Study|Adverse Event|1|||
30984639|NCT02459418|59124666|FG000|Overall Study|Withdrawal by Subject|1|||
30984640|NCT02459418|59124667|FG001|Overall Study|Withdrawal by Subject|1|||
30984641|NCT02459418|59124666|FG000|Overall Study|Elevated Creatine Kinase|1|||
30984642|NCT02459418|59124667|FG001|Overall Study|Elevated Creatine Kinase|0|||
30984643|NCT02459418|59124666|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
30984644|NCT02459418|59124667|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
30984645|NCT02487498|59124697|FG000|Period: Period 1|Adverse Event|2|||
30984646|NCT02487498|59124698|FG001|Period: Period 1|Adverse Event|4|||
30984647|NCT02487498|59124697|FG000|Period: Period 1|Subject/guardian decision|2|||
30984648|NCT02487498|59124698|FG001|Period: Period 1|Subject/guardian decision|4|||
30984649|NCT02487498|59124697|FG000|Period: Period 1|Lost to Follow-up|0|||
30984650|NCT02487498|59124698|FG001|Period: Period 1|Lost to Follow-up|2|||
30984651|NCT02487498|59124697|FG000|Period: Period 1|Lack of Efficacy|1|||
30984652|NCT02487498|59124698|FG001|Period: Period 1|Lack of Efficacy|0|||
30984653|NCT02487498|59124697|FG000|Period: Period 1|Physician Decision|0|||
30984654|NCT02487498|59124698|FG001|Period: Period 1|Physician Decision|1|||
30984655|NCT02487498|59124697|FG000|Period: Period 1|Protocol deviation|1|||
30984656|NCT02487498|59124698|FG001|Period: Period 1|Protocol deviation|0|||
30984657|NCT02487498|59124697|FG000|Period: Washout|Subject/guardian decision|0|||
30984658|NCT02487498|59124698|FG001|Period: Washout|Subject/guardian decision|5|||
30984659|NCT02487498|59124697|FG000|Period: Washout|Lack of Efficacy|1|||
30984660|NCT02487498|59124698|FG001|Period: Washout|Lack of Efficacy|1|||
30984661|NCT02487498|59124697|FG000|Period: Washout|Physician Decision|1|||
30984662|NCT02487498|59124698|FG001|Period: Washout|Physician Decision|0|||
30984663|NCT02487498|59124697|FG000|Period: Washout|Non-compliance with study treatment|0|||
30984664|NCT02487498|59124698|FG001|Period: Washout|Non-compliance with study treatment|1|||
30984665|NCT02487498|59124697|FG000|Period: Period 2|Adverse Event|2|||
30984666|NCT02487498|59124698|FG001|Period: Period 2|Adverse Event|2|||
30984667|NCT02487498|59124697|FG000|Period: Period 2|Subject/guardian decision|2|||
30984668|NCT02487498|59124698|FG001|Period: Period 2|Subject/guardian decision|1|||
30984669|NCT02487498|59124697|FG000|Period: Period 2|Lost to Follow-up|1|||
30984670|NCT02487498|59124698|FG001|Period: Period 2|Lost to Follow-up|1|||
30984671|NCT02487498|59124697|FG000|Period: Period 2|Death|0|||
30984672|NCT02487498|59124698|FG001|Period: Period 2|Death|1|||
30984673|NCT02487498|59124697|FG000|Period: Period 2|Physician Decision|1|||
30984674|NCT02487498|59124698|FG001|Period: Period 2|Physician Decision|0|||
30984675|NCT02487108|59124709|FG000|Overall Study|Adverse Event|1|||
30984676|NCT02487108|59124710|FG001|Overall Study|Adverse Event|6|||
30984677|NCT02487108|59124711|FG002|Overall Study|Adverse Event|12|||
30984678|NCT02487108|59124712|FG003|Overall Study|Adverse Event|6|||
30984679|NCT02487108|59124709|FG000|Overall Study|Withdrawal by Subject|8|||
30984680|NCT02487108|59124710|FG001|Overall Study|Withdrawal by Subject|5|||
30984681|NCT02487108|59124711|FG002|Overall Study|Withdrawal by Subject|5|||
30984682|NCT02487108|59124712|FG003|Overall Study|Withdrawal by Subject|0|||
30984683|NCT02487108|59124709|FG000|Overall Study|Non-compliance to study medication|3|||
30984684|NCT02487108|59124710|FG001|Overall Study|Non-compliance to study medication|2|||
30984685|NCT02487108|59124711|FG002|Overall Study|Non-compliance to study medication|5|||
30984686|NCT02487108|59124712|FG003|Overall Study|Non-compliance to study medication|4|||
30984687|NCT02487108|59124709|FG000|Overall Study|Protocol Violation|1|||
30984688|NCT02487108|59124710|FG001|Overall Study|Protocol Violation|1|||
30984689|NCT02487108|59124711|FG002|Overall Study|Protocol Violation|2|||
30984690|NCT02487108|59124712|FG003|Overall Study|Protocol Violation|0|||
30984691|NCT02487108|59124709|FG000|Overall Study|Non-compliance to study procedures|0|||
30984692|NCT02487108|59124710|FG001|Overall Study|Non-compliance to study procedures|0|||
30984693|NCT02487108|59124711|FG002|Overall Study|Non-compliance to study procedures|0|||
30984694|NCT02487108|59124712|FG003|Overall Study|Non-compliance to study procedures|1|||
30984695|NCT02487108|59124709|FG000|Overall Study|Other than specified|3|||
30984696|NCT02487108|59124710|FG001|Overall Study|Other than specified|2|||
30984697|NCT02487108|59124711|FG002|Overall Study|Other than specified|2|||
30984698|NCT02487108|59124712|FG003|Overall Study|Other than specified|0|||
30984699|NCT02487030|59124729|FG000|Overall Study|Lack of Efficacy|2|||
30984700|NCT02487030|59124730|FG001|Overall Study|Lack of Efficacy|4|||
30984701|NCT02487030|59124731|FG002|Overall Study|Lack of Efficacy|1|||
30984702|NCT02487030|59124732|FG003|Overall Study|Lack of Efficacy|0|||
30984703|NCT02487030|59124733|FG004|Overall Study|Lack of Efficacy|1|||
30984704|NCT02487030|59124734|FG005|Overall Study|Lack of Efficacy|0|||
30984705|NCT02487030|59124735|FG006|Overall Study|Lack of Efficacy|0|||
30984706|NCT02487030|59124729|FG000|Overall Study|Lost to Follow-up|0|||
30984707|NCT02487030|59124730|FG001|Overall Study|Lost to Follow-up|0|||
30984708|NCT02487030|59124731|FG002|Overall Study|Lost to Follow-up|1|||
30984709|NCT02487030|59124732|FG003|Overall Study|Lost to Follow-up|1|||
30984710|NCT02487030|59124733|FG004|Overall Study|Lost to Follow-up|0|||
30984711|NCT02487030|59124734|FG005|Overall Study|Lost to Follow-up|1|||
30984712|NCT02487030|59124735|FG006|Overall Study|Lost to Follow-up|0|||
30984713|NCT02487030|59124729|FG000|Overall Study|Adverse Event|0|||
30984714|NCT02487030|59124730|FG001|Overall Study|Adverse Event|0|||
30984715|NCT02487030|59124731|FG002|Overall Study|Adverse Event|0|||
30984716|NCT02487030|59124732|FG003|Overall Study|Adverse Event|1|||
30984717|NCT02487030|59124733|FG004|Overall Study|Adverse Event|0|||
30984718|NCT02487030|59124734|FG005|Overall Study|Adverse Event|0|||
30984719|NCT02487030|59124735|FG006|Overall Study|Adverse Event|0|||
30984720|NCT02487030|59124729|FG000|Overall Study|Death|0|||
30984721|NCT02487030|59124730|FG001|Overall Study|Death|0|||
30984722|NCT02487030|59124731|FG002|Overall Study|Death|0|||
30984723|NCT02487030|59124732|FG003|Overall Study|Death|0|||
30984724|NCT02487030|59124733|FG004|Overall Study|Death|1|||
30984725|NCT02487030|59124734|FG005|Overall Study|Death|0|||
30984726|NCT02487030|59124735|FG006|Overall Study|Death|0|||
30984727|NCT02486952|59124752|FG000|Overall Study|Not Started Induction Therapy|3|||
30984728|NCT02486952|59124752|FG000|Overall Study|Adverse Event|1|||
30984729|NCT02486952|59124752|FG000|Overall Study|Death|15|||
30984730|NCT02486952|59124752|FG000|Overall Study|Lack of Efficacy|3|||
30984731|NCT02486952|59124752|FG000|Overall Study|Lost to Follow-up|26|||
30984732|NCT02486952|59124752|FG000|Overall Study|Other|2|||
30984733|NCT02486796|59124758|FG000|Overall Study|Withdrawal by Subject|1|||
30984734|NCT02486796|59124759|FG001|Overall Study|Withdrawal by Subject|1|||
30984735|NCT02486796|59124758|FG000|Overall Study|Physician Decision|1|||
30984736|NCT02486796|59124759|FG001|Overall Study|Physician Decision|0|||
30984737|NCT02459262|59124776|FG000|Overall Study|Withdrawal by Subject|0|||
30984738|NCT02459262|59124777|FG001|Overall Study|Withdrawal by Subject|0|||
30984739|NCT02459262|59124778|FG002|Overall Study|Withdrawal by Subject|0|||
30984740|NCT02459262|59124779|FG003|Overall Study|Withdrawal by Subject|0|||
30984741|NCT02459262|59124780|FG004|Overall Study|Withdrawal by Subject|0|||
30984742|NCT02459262|59124781|FG005|Overall Study|Withdrawal by Subject|0|||
30984743|NCT02459262|59124782|FG006|Overall Study|Withdrawal by Subject|0|||
30984744|NCT02459262|59124783|FG007|Overall Study|Withdrawal by Subject|0|||
30984745|NCT02459262|59124784|FG008|Overall Study|Withdrawal by Subject|0|||
30984746|NCT02459262|59124785|FG009|Overall Study|Withdrawal by Subject|1|||
30984747|NCT02459262|59124786|FG010|Overall Study|Withdrawal by Subject|0|||
30984748|NCT02450526|59124870|FG000|DB Period (Cycle 1)|Adverse Event|0|||
30984749|NCT02450526|59124871|FG001|DB Period (Cycle 1)|Adverse Event|0|||
30984750|NCT02450526|59124872|FG002|DB Period (Cycle 1)|Adverse Event|2|||
30984751|NCT02450526|59124873|FG003|DB Period (Cycle 1)|Adverse Event|0|||
30984752|NCT02450526|59124874|FG004|DB Period (Cycle 1)|Adverse Event|0|||
30984753|NCT02450526|59124870|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
30984754|NCT02450526|59124871|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
30984755|NCT02450526|59124872|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
30984756|NCT02450526|59124873|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
30984757|NCT02450526|59124874|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
30984758|NCT02450526|59124870|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
30984759|NCT02450526|59124871|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
30984760|NCT02450526|59124872|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
30984761|NCT02450526|59124873|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
30984762|NCT02450526|59124874|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
30984763|NCT02450526|59124870|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
30984764|NCT02450526|59124871|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
30984765|NCT02450526|59124872|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
30984766|NCT02450526|59124873|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
30984767|NCT02450526|59124874|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
30984768|NCT02450526|59124870|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
30984769|NCT02450526|59124871|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
30984770|NCT02450526|59124872|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
30984771|NCT02450526|59124873|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
30984772|NCT02450526|59124874|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
30984773|NCT02450526|59124870|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
30984774|NCT02450526|59124871|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
30984775|NCT02450526|59124872|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
30984776|NCT02450526|59124873|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
30984777|NCT02450526|59124874|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
30984778|NCT02450526|59124870|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
30984779|NCT02450526|59124871|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
30984780|NCT02450526|59124872|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
30984781|NCT02450526|59124873|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
30984782|NCT02450526|59124874|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
30984783|NCT02450526|59124870|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
30984784|NCT02450526|59124871|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
30984785|NCT02450526|59124872|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
30984786|NCT02450526|59124873|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
30984787|NCT02450526|59124874|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
30984788|NCT02458638|59124941|FG000|Overall Study|Death|309|||
30984789|NCT02458638|59124941|FG000|Overall Study|End of Cohort/End of Study|67|||
30984790|NCT02458638|59124941|FG000|Overall Study|Lost to Follow-up|31|||
30984791|NCT02458638|59124941|FG000|Overall Study|Other Reasons|4|||
30984792|NCT02458638|59124941|FG000|Overall Study|Physician Decision|1|||
30984793|NCT02458638|59124941|FG000|Overall Study|Withdrawal by Subject|47|||
30984794|NCT02458092|59125079|FG000|Overall Study|Withdrawal by Subject|1|||
30984795|NCT02458092|59125080|FG001|Overall Study|Withdrawal by Subject|0|||
30984796|NCT02449902|59125103|FG000|Overall Study|Adverse Event|0|||
30984797|NCT02449902|59125104|FG001|Overall Study|Adverse Event|1|||
30984798|NCT02449902|59125103|FG000|Overall Study|Withdrawal by Subject|0|||
30984799|NCT02449902|59125104|FG001|Overall Study|Withdrawal by Subject|1|||
30984800|NCT02449044|59125112|FG000|Overall Study|Lost to Follow-up|2|||
30984801|NCT02449044|59125112|FG000|Overall Study|Withdrawal by Subject|13|||
30984802|NCT02449044|59125112|FG000|Overall Study|Adverse Event|30|||
30984803|NCT02449044|59125112|FG000|Overall Study|Met Withdrawal Criteria|7|||
30984804|NCT02449044|59125112|FG000|Overall Study|Physician Decision|9|||
30984805|NCT02449044|59125112|FG000|Overall Study|Sponsor Discontinued Trial|3|||
30984806|NCT02448810|59125983|FG000|Overall Study|Adverse Event|0|||
30984807|NCT02448810|59125984|FG001|Overall Study|Adverse Event|0|||
30984808|NCT02448810|59125985|FG002|Overall Study|Adverse Event|1|||
30984809|NCT02448810|59125986|FG003|Overall Study|Adverse Event|0|||
30984810|NCT02448810|59125987|FG004|Overall Study|Adverse Event|0|||
30984811|NCT02448810|59125988|FG005|Overall Study|Adverse Event|0|||
30984812|NCT02448810|59125989|FG006|Overall Study|Adverse Event|0|||
30984813|NCT02448810|59125990|FG007|Overall Study|Adverse Event|0|||
30984814|NCT02448810|59125983|FG000|Overall Study|Withdrawal by Subject|0|||
30984815|NCT02448810|59125984|FG001|Overall Study|Withdrawal by Subject|0|||
30984816|NCT02448810|59125985|FG002|Overall Study|Withdrawal by Subject|1|||
30984817|NCT02448810|59125986|FG003|Overall Study|Withdrawal by Subject|0|||
30984818|NCT02448810|59125987|FG004|Overall Study|Withdrawal by Subject|3|||
30984819|NCT02448810|59125988|FG005|Overall Study|Withdrawal by Subject|5|||
30984820|NCT02448810|59125989|FG006|Overall Study|Withdrawal by Subject|0|||
30984821|NCT02448810|59125990|FG007|Overall Study|Withdrawal by Subject|2|||
30984822|NCT02448810|59125983|FG000|Overall Study|Other (study terminated by sponsor)|0|||
30984823|NCT02448810|59125984|FG001|Overall Study|Other (study terminated by sponsor)|0|||
30984824|NCT02448810|59125985|FG002|Overall Study|Other (study terminated by sponsor)|0|||
30984825|NCT02448810|59125986|FG003|Overall Study|Other (study terminated by sponsor)|0|||
30984826|NCT02448810|59125987|FG004|Overall Study|Other (study terminated by sponsor)|4|||
30984827|NCT02448810|59125988|FG005|Overall Study|Other (study terminated by sponsor)|2|||
30984828|NCT02448810|59125989|FG006|Overall Study|Other (study terminated by sponsor)|2|||
30984829|NCT02448810|59125990|FG007|Overall Study|Other (study terminated by sponsor)|1|||
30984830|NCT02448810|59125983|FG000|Overall Study|Death|1|||
30984831|NCT02448810|59125984|FG001|Overall Study|Death|0|||
30984832|NCT02448810|59125985|FG002|Overall Study|Death|1|||
30984833|NCT02448810|59125986|FG003|Overall Study|Death|0|||
30984834|NCT02448810|59125987|FG004|Overall Study|Death|1|||
30984835|NCT02448810|59125988|FG005|Overall Study|Death|0|||
30984836|NCT02448810|59125989|FG006|Overall Study|Death|0|||
30984837|NCT02448810|59125990|FG007|Overall Study|Death|0|||
30984838|NCT02448810|59125983|FG000|Overall Study|Other (Progressive disease)|2|||
30984839|NCT02448810|59125984|FG001|Overall Study|Other (Progressive disease)|2|||
30984840|NCT02448810|59125985|FG002|Overall Study|Other (Progressive disease)|0|||
30984841|NCT02448810|59125986|FG003|Overall Study|Other (Progressive disease)|3|||
30984842|NCT02448810|59125987|FG004|Overall Study|Other (Progressive disease)|23|||
30984843|NCT02448810|59125988|FG005|Overall Study|Other (Progressive disease)|9|||
30984844|NCT02448810|59125989|FG006|Overall Study|Other (Progressive disease)|14|||
30984845|NCT02448810|59125990|FG007|Overall Study|Other (Progressive disease)|5|||
30984846|NCT02448810|59125983|FG000|Overall Study|Lost to Follow-up|0|||
30984847|NCT02448810|59125984|FG001|Overall Study|Lost to Follow-up|1|||
30984848|NCT02448810|59125985|FG002|Overall Study|Lost to Follow-up|0|||
30984849|NCT02448810|59125986|FG003|Overall Study|Lost to Follow-up|0|||
30984850|NCT02448810|59125987|FG004|Overall Study|Lost to Follow-up|0|||
30984851|NCT02448810|59125988|FG005|Overall Study|Lost to Follow-up|0|||
30984852|NCT02448810|59125989|FG006|Overall Study|Lost to Follow-up|0|||
30984853|NCT02448810|59125990|FG007|Overall Study|Lost to Follow-up|0|||
30984854|NCT02448810|59125983|FG000|Overall Study|Other (unspecified)|0|||
30984855|NCT02448810|59125984|FG001|Overall Study|Other (unspecified)|0|||
30984856|NCT02448810|59125985|FG002|Overall Study|Other (unspecified)|0|||
30984857|NCT02448810|59125986|FG003|Overall Study|Other (unspecified)|0|||
30984858|NCT02448810|59125987|FG004|Overall Study|Other (unspecified)|0|||
30984859|NCT02448810|59125988|FG005|Overall Study|Other (unspecified)|0|||
30984860|NCT02448810|59125989|FG006|Overall Study|Other (unspecified)|2|||
30984861|NCT02448810|59125990|FG007|Overall Study|Other (unspecified)|0|||
30984862|NCT02457546|59126063|FG000|Overall Study|Other reasons|4|||
30984863|NCT02457546|59126064|FG001|Overall Study|Other reasons|1|||
30984864|NCT02457546|59126063|FG000|Overall Study|Refused to complete study/procedures|1|||
30984865|NCT02457546|59126064|FG001|Overall Study|Refused to complete study/procedures|1|||
30984866|NCT02457546|59126063|FG000|Overall Study|Lost to Follow-up|4|||
30984867|NCT02457546|59126064|FG001|Overall Study|Lost to Follow-up|1|||
30984868|NCT02457546|59126063|FG000|Overall Study|Adverse Event|0|||
30984869|NCT02457546|59126064|FG001|Overall Study|Adverse Event|1|||
30984870|NCT02447952|59126085|FG000|Overall Study|Adverse Event|2|||
30984871|NCT02447952|59126085|FG000|Overall Study|Physician Decision|1|||
30984872|NCT02447952|59126085|FG000|Overall Study|Withdrawal by Subject|4|||
30984873|NCT02447718|59126119|FG000|Overall Study|Lost to Follow-up|8|||
30984874|NCT02447718|59126120|FG001|Overall Study|Lost to Follow-up|0|||
30984875|NCT02447718|59126119|FG000|Overall Study|Withdrawal by Subject|3|||
30984876|NCT02447718|59126120|FG001|Overall Study|Withdrawal by Subject|0|||
30984877|NCT02447718|59126119|FG000|Overall Study|Screen Failure|1|||
30984878|NCT02447718|59126120|FG001|Overall Study|Screen Failure|0|||
30984879|NCT02486406|59126297|FG000|Overall Study|Withdrew consent|1|||
30984880|NCT02486406|59126298|FG001|Overall Study|Withdrew consent|0|||
30984881|NCT02486406|59126299|FG002|Overall Study|Withdrew consent|0|||
30984882|NCT02486406|59126300|FG003|Overall Study|Withdrew consent|1|||
30984883|NCT02486406|59126297|FG000|Overall Study|Lost to Follow-up|1|||
30984884|NCT02486406|59126298|FG001|Overall Study|Lost to Follow-up|3|||
30984885|NCT02486406|59126299|FG002|Overall Study|Lost to Follow-up|1|||
30984886|NCT02486406|59126300|FG003|Overall Study|Lost to Follow-up|3|||
30608485|NCT01287416|58619260|FG001|Pre-post Training|Lost to Follow-up|1|||
30984887|NCT02486406|59126297|FG000|Overall Study|Other, not specified|0|||
30984888|NCT02486406|59126298|FG001|Overall Study|Other, not specified|0|||
30984889|NCT02486406|59126299|FG002|Overall Study|Other, not specified|1|||
30984890|NCT02486406|59126300|FG003|Overall Study|Other, not specified|0|||
30984891|NCT02485704|59126372|FG000|Overall Study|Lost to Follow-up|4|||
30984892|NCT02485704|59126373|FG001|Overall Study|Lost to Follow-up|5|||
30984893|NCT02485704|59126372|FG000|Overall Study|Withdrawal by Subject|0|||
30984894|NCT02485704|59126373|FG001|Overall Study|Withdrawal by Subject|3|||
30984895|NCT02485704|59126372|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
30984896|NCT02485704|59126373|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
30984897|NCT02485158|59126383|FG000|Overall Study|Withdrawal by Subject|3|||
30984898|NCT02485158|59126383|FG000|Overall Study|expected drug side effect|1|||
30984899|NCT02455518|59126402|FG000|Overall Study|Protocol Violation|0|||
30984900|NCT02455518|59126403|FG001|Overall Study|Protocol Violation|1|||
30984901|NCT02455518|59126404|FG002|Overall Study|Protocol Violation|1|||
30984902|NCT02455518|59126405|FG003|Overall Study|Protocol Violation|3|||
30984903|NCT02435849|59126580|FG000|Overall Study|Enrolled but not infused|18|||
30984904|NCT02435849|59126580|FG000|Overall Study|Death|16|||
30984905|NCT02435849|59126580|FG000|Overall Study|Lack of Efficacy|9|||
30984906|NCT02435849|59126580|FG000|Overall Study|New therapy for study indication|7|||
30984907|NCT02435849|59126580|FG000|Overall Study|Subject/guardian decision|2|||
30984908|NCT02435849|59126580|FG000|Overall Study|Study follow-up ongoing|45|||
30984909|NCT02240069|59126627|FG000|Overall Study|Withdrawal by Subject|5|||
30984910|NCT02240069|59126628|FG001|Overall Study|Withdrawal by Subject|5|||
30984911|NCT02240069|59126629|FG002|Overall Study|Withdrawal by Subject|2|||
30984912|NCT02484690|59126715|FG000|Overall Study|Adverse Event|1|||
30984913|NCT02484690|59126716|FG001|Overall Study|Adverse Event|3|||
30984914|NCT02484690|59126717|FG002|Overall Study|Adverse Event|0|||
30984915|NCT02484690|59126718|FG003|Overall Study|Adverse Event|0|||
30984916|NCT02484690|59126719|FG004|Overall Study|Adverse Event|5|||
30984917|NCT02484690|59126715|FG000|Overall Study|Death|0|||
30984918|NCT02484690|59126716|FG001|Overall Study|Death|0|||
30984919|NCT02484690|59126717|FG002|Overall Study|Death|0|||
30984920|NCT02484690|59126718|FG003|Overall Study|Death|0|||
30984921|NCT02484690|59126719|FG004|Overall Study|Death|1|||
30984922|NCT02484690|59126715|FG000|Overall Study|Withdrawal by Subject|1|||
30984923|NCT02484690|59126716|FG001|Overall Study|Withdrawal by Subject|3|||
30984924|NCT02484690|59126717|FG002|Overall Study|Withdrawal by Subject|1|||
30984925|NCT02484690|59126718|FG003|Overall Study|Withdrawal by Subject|2|||
30984926|NCT02484690|59126719|FG004|Overall Study|Withdrawal by Subject|0|||
30984927|NCT02484690|59126715|FG000|Overall Study|Physician Decision|2|||
30984928|NCT02484690|59126716|FG001|Overall Study|Physician Decision|0|||
30984929|NCT02484690|59126717|FG002|Overall Study|Physician Decision|1|||
30984930|NCT02484690|59126718|FG003|Overall Study|Physician Decision|0|||
30984931|NCT02484690|59126719|FG004|Overall Study|Physician Decision|0|||
30984932|NCT02484690|59126715|FG000|Overall Study|Lost to Follow-up|0|||
30984933|NCT02484690|59126716|FG001|Overall Study|Lost to Follow-up|0|||
30984934|NCT02484690|59126717|FG002|Overall Study|Lost to Follow-up|1|||
30984935|NCT02484690|59126718|FG003|Overall Study|Lost to Follow-up|0|||
30984936|NCT02484690|59126719|FG004|Overall Study|Lost to Follow-up|0|||
30984937|NCT01654224|59126743|FG000|Overall Study|Lost to Follow-up|2|||
30984938|NCT01654224|59126744|FG001|Overall Study|Lost to Follow-up|2|||
30984939|NCT01654224|59126743|FG000|Overall Study|Did not receive allocation|1|||
30984940|NCT01654224|59126744|FG001|Overall Study|Did not receive allocation|8|||
30984941|NCT01654224|59126743|FG000|Overall Study|Insufficient blood sample|3|||
30984942|NCT01654224|59126744|FG001|Overall Study|Insufficient blood sample|2|||
30984943|NCT02447328|59126750|FG000|Overall Study|Withdrawal by Subject|1|||
30984944|NCT02447250|59126754|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
30984945|NCT02447250|59126754|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
30984946|NCT02447250|59126754|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
30984947|NCT02447172|59126858|FG000|Overall Study|Adverse Event|11|||
30984948|NCT02447172|59126859|FG001|Overall Study|Adverse Event|8|||
30984949|NCT02447172|59126860|FG002|Overall Study|Adverse Event|7|||
30984950|NCT02447172|59126858|FG000|Overall Study|Death|3|||
30984951|NCT02447172|59126859|FG001|Overall Study|Death|1|||
30984952|NCT02447172|59126860|FG002|Overall Study|Death|0|||
30984953|NCT02447172|59126858|FG000|Overall Study|Protocol Violation|2|||
30984954|NCT02447172|59126859|FG001|Overall Study|Protocol Violation|1|||
30984955|NCT02447172|59126860|FG002|Overall Study|Protocol Violation|2|||
30984956|NCT02447172|59126858|FG000|Overall Study|Lost to Follow-up|7|||
30984957|NCT02447172|59126859|FG001|Overall Study|Lost to Follow-up|4|||
30984958|NCT02447172|59126860|FG002|Overall Study|Lost to Follow-up|4|||
30984959|NCT02447172|59126858|FG000|Overall Study|Withdrawal by Subject|5|||
30984960|NCT02447172|59126859|FG001|Overall Study|Withdrawal by Subject|1|||
30984961|NCT02447172|59126860|FG002|Overall Study|Withdrawal by Subject|3|||
30984962|NCT02447172|59126858|FG000|Overall Study|protocol specific treatment unrelated|3|||
30984963|NCT02447172|59126859|FG001|Overall Study|protocol specific treatment unrelated|0|||
30984964|NCT02447172|59126860|FG002|Overall Study|protocol specific treatment unrelated|2|||
30984965|NCT02455050|59126893|FG000|Treatment Period 1|Lost to Follow-up|1|||
30984966|NCT02455050|59126894|FG001|Treatment Period 1|Lost to Follow-up|1|||
30984967|NCT02455050|59126895|FG002|Treatment Period 1|Lost to Follow-up|1|||
30984968|NCT02455050|59126896|FG003|Treatment Period 1|Lost to Follow-up|2|||
30984969|NCT02455050|59126893|FG000|Treatment Period 2|Lost to Follow-up|1|||
30984970|NCT02455050|59126894|FG001|Treatment Period 2|Lost to Follow-up|0|||
30984971|NCT02455050|59126895|FG002|Treatment Period 2|Lost to Follow-up|2|||
30984972|NCT02455050|59126896|FG003|Treatment Period 2|Lost to Follow-up|1|||
30984973|NCT02418468|59126936|FG000|Overall Study|Adverse Event|1|||
30984974|NCT02418468|59126937|FG001|Overall Study|Adverse Event|0|||
30984975|NCT02418468|59126936|FG000|Overall Study|Withdrawal of informed consent|1|||
30984976|NCT02418468|59126937|FG001|Overall Study|Withdrawal of informed consent|1|||
30984977|NCT02418000|59127068|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
30984978|NCT02418000|59127069|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
30984979|NCT02418000|59127070|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
30984980|NCT02418000|59127071|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
30984981|NCT02418000|59127072|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
30984982|NCT02418000|59127068|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
30984983|NCT02418000|59127069|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
30984984|NCT02418000|59127070|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
30984985|NCT02418000|59127071|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
30984986|NCT02418000|59127072|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
30984987|NCT02418000|59127068|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
30984988|NCT02418000|59127069|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
30984989|NCT02418000|59127070|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
30984990|NCT02418000|59127071|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
30984991|NCT02418000|59127072|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
30984992|NCT02418000|59127068|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
30984993|NCT02418000|59127069|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
30984994|NCT02418000|59127070|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
30984995|NCT02418000|59127071|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
30984996|NCT02418000|59127072|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
30984997|NCT02418000|59127068|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
30984998|NCT02418000|59127069|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
30984999|NCT02418000|59127070|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
30985000|NCT02418000|59127071|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
30985001|NCT02418000|59127072|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
30985002|NCT02418000|59127068|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985003|NCT02418000|59127069|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985004|NCT02418000|59127070|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
30985005|NCT02418000|59127071|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985006|NCT02418000|59127072|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985007|NCT02418000|59127068|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985008|NCT02418000|59127069|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985009|NCT02418000|59127070|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985010|NCT02418000|59127071|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
30985011|NCT02418000|59127072|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985012|NCT02418000|59127068|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
30985013|NCT02418000|59127069|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
30985014|NCT02418000|59127070|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
30985015|NCT02418000|59127071|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
30985016|NCT02418000|59127072|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
30985017|NCT02418000|59127068|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985018|NCT02418000|59127069|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985019|NCT02418000|59127070|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985020|NCT02418000|59127071|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
30985021|NCT02418000|59127072|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
30985022|NCT02417064|59127176|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
30985023|NCT02417064|59127177|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
30985024|NCT02417064|59127178|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
30985025|NCT02417064|59127176|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
30985026|NCT02417064|59127177|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
30985027|NCT02417064|59127178|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
30985028|NCT02417064|59127176|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
30985029|NCT02417064|59127177|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
30985030|NCT02417064|59127178|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
30985031|NCT02417064|59127176|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
30985032|NCT02417064|59127177|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
30985033|NCT02417064|59127178|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
30985034|NCT02417064|59127176|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
30985035|NCT02417064|59127177|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
30985036|NCT02417064|59127178|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
30985037|NCT02417064|59127176|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
30985038|NCT02417064|59127177|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
30985039|NCT02417064|59127178|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
30985040|NCT02417064|59127176|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
30985041|NCT02417064|59127177|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
30985042|NCT02417064|59127178|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
30985043|NCT02417064|59127176|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
30985044|NCT02417064|59127177|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
30985045|NCT02417064|59127178|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
30985046|NCT02417064|59127176|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
30985047|NCT02417064|59127177|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
30985048|NCT02417064|59127178|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
30985049|NCT02417064|59127176|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
30985050|NCT02417064|59127177|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
30985051|NCT02417064|59127178|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
30985052|NCT02417064|59127176|FG000|Follow-up Phase (24 Weeks)|Other|2|||
30985053|NCT02417064|59127177|FG001|Follow-up Phase (24 Weeks)|Other|2|||
30985054|NCT02417064|59127178|FG002|Follow-up Phase (24 Weeks)|Other|3|||
30985055|NCT01653132|59127193|FG000|First Intervention|Protocol Violation|1|||
30985056|NCT01653132|59127194|FG001|First Intervention|Protocol Violation|0|||
30985057|NCT02453334|59127219|FG000|Overall Study|Death|15|||
30985058|NCT02453334|59127220|FG001|Overall Study|Death|13|||
30985059|NCT02453334|59127219|FG000|Overall Study|Adverse Event|2|||
30985060|NCT02453334|59127220|FG001|Overall Study|Adverse Event|1|||
30985061|NCT02453334|59127219|FG000|Overall Study|Lost to Follow-up|5|||
30985062|NCT02453334|59127220|FG001|Overall Study|Lost to Follow-up|9|||
30985063|NCT02453334|59127219|FG000|Overall Study|Physician Decision|1|||
30985064|NCT02453334|59127220|FG001|Overall Study|Physician Decision|0|||
30985065|NCT02453334|59127219|FG000|Overall Study|Withdrawal by Subject|17|||
30985066|NCT02453334|59127220|FG001|Overall Study|Withdrawal by Subject|13|||
30985067|NCT02453334|59127219|FG000|Overall Study|Other reason|1|||
30985068|NCT02453334|59127220|FG001|Overall Study|Other reason|4|||
30985069|NCT02443740|59127306|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
30985070|NCT02443740|59127307|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
30985071|NCT02443740|59127308|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
30985072|NCT02443740|59127309|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
30985073|NCT02443740|59127310|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
30985074|NCT02443740|59127311|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
30985075|NCT02443740|59127312|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
30985076|NCT02443740|59127313|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
30985077|NCT02443740|59127314|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
30985078|NCT02443740|59127315|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
30985079|NCT02443740|59127316|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
30985080|NCT02443740|59127306|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
30985081|NCT02443740|59127307|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
30985082|NCT02443740|59127308|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
30985083|NCT02443740|59127309|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
30985084|NCT02443740|59127310|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
30985085|NCT02443740|59127311|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
30985086|NCT02443740|59127312|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
30985087|NCT02443740|59127313|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
30985088|NCT02443740|59127314|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
30985089|NCT02443740|59127315|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
30790197|NCT00039377|58803413|FG003|Initial Registration|Adverse Event|0|||
30790198|NCT00039377|58803410|FG000|Initial Registration|Relapsed|6|||
30790199|NCT00039377|58803411|FG001|Initial Registration|Relapsed|0|||
30985090|NCT02443740|59127316|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
30985091|NCT02443740|59127306|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
30985092|NCT02443740|59127307|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
30985093|NCT02443740|59127308|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
30985094|NCT02443740|59127309|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
30985095|NCT02443740|59127310|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
30985096|NCT02443740|59127311|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
30985097|NCT02443740|59127312|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
30985098|NCT02443740|59127313|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
30985099|NCT02443740|59127314|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
30985100|NCT02443740|59127315|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
30985101|NCT02443740|59127316|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
30985102|NCT02416908|59127547|FG000|Dose Escalation Phase|Adverse Event|0|||
30985103|NCT02416908|59127548|FG001|Dose Escalation Phase|Adverse Event|0|||
30985104|NCT02416908|59127549|FG002|Dose Escalation Phase|Adverse Event|3|||
30985105|NCT02416908|59127550|FG003|Dose Escalation Phase|Adverse Event|0|||
30985106|NCT02416908|59127547|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
30985107|NCT02416908|59127548|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
30985108|NCT02416908|59127549|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
30985109|NCT02416908|59127550|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
30985110|NCT02453256|59127640|FG000|Double Blind Period|Death|1|||
30985111|NCT02453256|59127641|FG001|Double Blind Period|Death|1|||
30985112|NCT02453256|59127640|FG000|Double Blind Period|Adverse Event|3|||
30985113|NCT02453256|59127641|FG001|Double Blind Period|Adverse Event|2|||
30985114|NCT02453256|59127640|FG000|Double Blind Period|Withdrawal by Subject|9|||
30985115|NCT02453256|59127641|FG001|Double Blind Period|Withdrawal by Subject|5|||
30985116|NCT02453256|59127640|FG000|Double Blind Period|Other|0|||
30985117|NCT02453256|59127641|FG001|Double Blind Period|Other|1|||
30985118|NCT02453256|59127640|FG000|Open Label Period|Adverse Event|1|||
30985119|NCT02453256|59127641|FG001|Open Label Period|Adverse Event|3|||
30985120|NCT02453256|59127640|FG000|Open Label Period|Death|0|||
30985121|NCT02453256|59127641|FG001|Open Label Period|Death|1|||
30985122|NCT02453256|59127640|FG000|Open Label Period|Lost to Follow-up|1|||
30985123|NCT02453256|59127641|FG001|Open Label Period|Lost to Follow-up|0|||
30985124|NCT02453256|59127640|FG000|Open Label Period|Other|0|||
30985125|NCT02453256|59127641|FG001|Open Label Period|Other|2|||
30985126|NCT02453256|59127640|FG000|Open Label Period|Withdrawal by Subject|5|||
30985127|NCT02453256|59127641|FG001|Open Label Period|Withdrawal by Subject|1|||
30985128|NCT02442804|59127656|FG000|Overall Study|Withdrawal by Subject|0|||
30985129|NCT02442804|59127657|FG001|Overall Study|Withdrawal by Subject|1|||
30985130|NCT02442804|59127656|FG000|Overall Study|Adverse Event|1|||
30985131|NCT02442804|59127657|FG001|Overall Study|Adverse Event|0|||
30985132|NCT02414958|59127746|FG000|Overall Study|Adverse Event|6|||
30985133|NCT02414958|59127747|FG001|Overall Study|Adverse Event|6|||
30985134|NCT02414958|59127748|FG002|Overall Study|Adverse Event|3|||
30985135|NCT02414958|59127746|FG000|Overall Study|Protocol Violation|10|||
30985136|NCT02414958|59127747|FG001|Overall Study|Protocol Violation|3|||
30985137|NCT02414958|59127748|FG002|Overall Study|Protocol Violation|1|||
30985138|NCT02414958|59127746|FG000|Overall Study|Lost to Follow-up|7|||
30985139|NCT02414958|59127747|FG001|Overall Study|Lost to Follow-up|4|||
30985140|NCT02414958|59127748|FG002|Overall Study|Lost to Follow-up|0|||
30985141|NCT02414958|59127746|FG000|Overall Study|Withdrawal by Subject|5|||
30985142|NCT02414958|59127747|FG001|Overall Study|Withdrawal by Subject|3|||
30985143|NCT02414958|59127748|FG002|Overall Study|Withdrawal by Subject|5|||
30985144|NCT02414958|59127746|FG000|Overall Study|Other than specified|4|||
30985145|NCT02414958|59127747|FG001|Overall Study|Other than specified|4|||
30985146|NCT02414958|59127748|FG002|Overall Study|Other than specified|5|||
30985147|NCT02452476|59127821|FG000|Overall Study|Death|4|||
30985148|NCT02452476|59127822|FG001|Overall Study|Death|7|||
30985149|NCT02452476|59127821|FG000|Overall Study|Lost to Follow-up|1|||
30985150|NCT02452476|59127822|FG001|Overall Study|Lost to Follow-up|1|||
30985151|NCT02452476|59127821|FG000|Overall Study|Physician Decision|1|||
30985152|NCT02452476|59127822|FG001|Overall Study|Physician Decision|1|||
30985153|NCT02452476|59127821|FG000|Overall Study|Not treated|5|||
30985154|NCT02452476|59127822|FG001|Overall Study|Not treated|1|||
30985155|NCT02442336|59127837|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
30985156|NCT02442336|59127837|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
30985157|NCT02442336|59127837|FG000|Overall Study|Lost to Follow-up|11|||
30985158|NCT02452398|59127841|FG000|Overall Study|Adverse Event|1|||
30985159|NCT02452398|59127841|FG000|Overall Study|Lost to Follow-up|28|||
30985160|NCT02452398|59127841|FG000|Overall Study|Physician Decision|2|||
30985161|NCT02452398|59127841|FG000|Overall Study|Withdrawal by Subject|6|||
30985162|NCT02452398|59127841|FG000|Overall Study|Moved away|4|||
30985163|NCT02413398|59127847|FG000|Overall Study|Lost to Follow-up|2|||
30985164|NCT02413398|59127848|FG001|Overall Study|Lost to Follow-up|4|||
30985165|NCT02413398|59127847|FG000|Overall Study|Withdrawal by Subject|1|||
30985166|NCT02413398|59127848|FG001|Overall Study|Withdrawal by Subject|1|||
30985167|NCT02413398|59127847|FG000|Overall Study|Other Eligibility criteria|1|||
30985168|NCT02413398|59127848|FG001|Overall Study|Other Eligibility criteria|2|||
30985169|NCT02441946|59127857|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
30985170|NCT02441946|59127858|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
30985171|NCT02441946|59127859|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
30985172|NCT02441946|59127857|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
30985173|NCT02441946|59127858|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
30985174|NCT02441946|59127859|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
30985175|NCT02441946|59127857|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
30985176|NCT02441946|59127858|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
30985177|NCT02441946|59127859|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
30985178|NCT02441946|59127857|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
30985179|NCT02441946|59127858|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
30985180|NCT02441946|59127859|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
30985181|NCT02441946|59127857|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
30985182|NCT02441946|59127858|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
30985183|NCT02441946|59127859|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
30985184|NCT02441946|59127857|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
30985185|NCT02441946|59127858|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
30985186|NCT02441946|59127859|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
30985187|NCT02441946|59127857|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
30985188|NCT02441946|59127858|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
30985189|NCT02441946|59127859|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
30985190|NCT02441946|59127857|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
30985191|NCT02441946|59127858|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
30985192|NCT02441946|59127859|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
30985193|NCT02441946|59127857|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
30985194|NCT02441946|59127858|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
30985195|NCT02441946|59127859|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
30985196|NCT02441946|59127857|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
30985197|NCT02441946|59127858|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
30985198|NCT02441946|59127859|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
30985199|NCT02441946|59127857|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
30985200|NCT02441946|59127858|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
30985201|NCT02441946|59127859|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
30985202|NCT02387580|59127893|FG000|Overall Study|Withdrawal by Subject|0|||
30985203|NCT02387580|59127894|FG001|Overall Study|Withdrawal by Subject|0|||
30985204|NCT02387580|59127895|FG002|Overall Study|Withdrawal by Subject|0|||
30985205|NCT02387580|59127896|FG003|Overall Study|Withdrawal by Subject|1|||
30985206|NCT02387580|59127897|FG004|Overall Study|Withdrawal by Subject|0|||
30985207|NCT02387580|59127898|FG005|Overall Study|Withdrawal by Subject|0|||
30985208|NCT02440854|59127914|FG000|Overall Study|Relocation of patient|1|||
30790200|NCT00039377|58803412|FG002|Initial Registration|Relapsed|0|||
30790201|NCT00039377|58803413|FG003|Initial Registration|Relapsed|0|||
30985209|NCT02440854|59127914|FG000|Overall Study|Death|6|||
30985210|NCT02440854|59127914|FG000|Overall Study|Lost to Follow-up|10|||
30985211|NCT02440854|59127914|FG000|Overall Study|Afatinib discontinuation|46|||
30985212|NCT02440854|59127914|FG000|Overall Study|stopped study at earlier timepoint|14|||
30985213|NCT02440854|59127914|FG000|Overall Study|Study medication not received|1|||
30985214|NCT02440854|59127914|FG000|Overall Study|Violation of inclusion criteria|2|||
30985215|NCT02412852|59127969|FG000|Overall Study|Withdrawal by Subject|0|||
30985216|NCT02412852|59127970|FG001|Overall Study|Withdrawal by Subject|1|||
30985217|NCT02412852|59127971|FG002|Overall Study|Withdrawal by Subject|0|||
30985218|NCT02412852|59127972|FG003|Overall Study|Withdrawal by Subject|0|||
30985219|NCT02412852|59127969|FG000|Overall Study|Physician Decision|0|||
30985220|NCT02412852|59127970|FG001|Overall Study|Physician Decision|0|||
30985221|NCT02412852|59127971|FG002|Overall Study|Physician Decision|0|||
30985222|NCT02412852|59127972|FG003|Overall Study|Physician Decision|1|||
30985223|NCT02386098|59128028|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
30985224|NCT02386098|59128029|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
30985225|NCT02386098|59128030|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
30985226|NCT02386098|59128031|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
30985227|NCT02386098|59128032|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
30985228|NCT02386098|59128028|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
30985229|NCT02386098|59128029|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
30985230|NCT02386098|59128030|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
30985231|NCT02386098|59128031|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
30985232|NCT02386098|59128032|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
30985233|NCT02386098|59128028|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
30985234|NCT02386098|59128029|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
30985235|NCT02386098|59128030|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
30985236|NCT02386098|59128031|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
30985237|NCT02386098|59128032|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
30985238|NCT02386098|59128028|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
30985239|NCT02386098|59128029|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
30985240|NCT02386098|59128030|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
30985241|NCT02386098|59128031|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
30985242|NCT02386098|59128032|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
30985243|NCT02386098|59128028|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
30985244|NCT02386098|59128029|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
30985245|NCT02386098|59128030|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
30985246|NCT02386098|59128031|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
30985247|NCT02386098|59128032|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
30985248|NCT02386098|59128028|FG000|Stage 1 (96 Weeks)|Other|1|||
30985249|NCT02386098|59128029|FG001|Stage 1 (96 Weeks)|Other|0|||
30985250|NCT02386098|59128030|FG002|Stage 1 (96 Weeks)|Other|0|||
30985251|NCT02386098|59128031|FG003|Stage 1 (96 Weeks)|Other|0|||
30985252|NCT02386098|59128032|FG004|Stage 1 (96 Weeks)|Other|0|||
30985253|NCT02386098|59128028|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
30985254|NCT02386098|59128029|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
30985255|NCT02386098|59128030|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
30985256|NCT02386098|59128031|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
30790202|NCT00039377|58803410|FG000|Initial Registration|Received non-protocol therapy|11|||
30790203|NCT00039377|58803411|FG001|Initial Registration|Received non-protocol therapy|0|||
30985257|NCT02386098|59128032|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
30985258|NCT02412618|59128075|FG000|Overall Study|Withdrawal by Subject|1|||
30985259|NCT02412618|59128076|FG001|Overall Study|Withdrawal by Subject|1|||
30985260|NCT02412618|59128075|FG000|Overall Study|Expulsion|1|||
30985261|NCT02412618|59128076|FG001|Overall Study|Expulsion|1|||
30985262|NCT00585195|59128273|FG000|Overall Study|Adverse Event|0|||
30985263|NCT00585195|59128274|FG001|Overall Study|Adverse Event|0|||
30985264|NCT00585195|59128275|FG002|Overall Study|Adverse Event|0|||
30985265|NCT00585195|59128276|FG003|Overall Study|Adverse Event|0|||
30985266|NCT00585195|59128277|FG004|Overall Study|Adverse Event|2|||
30985267|NCT00585195|59128278|FG005|Overall Study|Adverse Event|1|||
30985268|NCT00585195|59128279|FG006|Overall Study|Adverse Event|0|||
30985269|NCT00585195|59128280|FG007|Overall Study|Adverse Event|1|||
30985270|NCT00585195|59128281|FG008|Overall Study|Adverse Event|0|||
30985271|NCT00585195|59128282|FG009|Overall Study|Adverse Event|0|||
30985272|NCT00585195|59128283|FG010|Overall Study|Adverse Event|3|||
30985273|NCT00585195|59128284|FG011|Overall Study|Adverse Event|0|||
30985274|NCT00585195|59128285|FG012|Overall Study|Adverse Event|8|||
30985275|NCT00585195|59128286|FG013|Overall Study|Adverse Event|6|||
30985276|NCT00585195|59128287|FG014|Overall Study|Adverse Event|4|||
30985277|NCT00585195|59128288|FG015|Overall Study|Adverse Event|1|||
30985278|NCT00585195|59128289|FG016|Overall Study|Adverse Event|14|||
30891613|NCT02395081|58924846|FG001|Overall Study|Moved where blood couldn't be collected|1|||
30985279|NCT00585195|59128290|FG017|Overall Study|Adverse Event|9|||
30985280|NCT00585195|59128291|FG018|Overall Study|Adverse Event|2|||
30985281|NCT00585195|59128292|FG019|Overall Study|Adverse Event|3|||
30985282|NCT00585195|59128293|FG020|Overall Study|Adverse Event|1|||
30985283|NCT00585195|59128273|FG000|Overall Study|Progressive Disease|2|||
30985284|NCT00585195|59128274|FG001|Overall Study|Progressive Disease|2|||
30985285|NCT00585195|59128275|FG002|Overall Study|Progressive Disease|5|||
30985286|NCT00585195|59128276|FG003|Overall Study|Progressive Disease|4|||
30985287|NCT00585195|59128277|FG004|Overall Study|Progressive Disease|6|||
30985288|NCT00585195|59128278|FG005|Overall Study|Progressive Disease|4|||
30985289|NCT00585195|59128279|FG006|Overall Study|Progressive Disease|6|||
30985290|NCT00585195|59128280|FG007|Overall Study|Progressive Disease|3|||
30985291|NCT00585195|59128281|FG008|Overall Study|Progressive Disease|0|||
30985292|NCT00585195|59128282|FG009|Overall Study|Progressive Disease|5|||
30985293|NCT00585195|59128283|FG010|Overall Study|Progressive Disease|2|||
30985294|NCT00585195|59128284|FG011|Overall Study|Progressive Disease|25|||
30985295|NCT00585195|59128285|FG012|Overall Study|Progressive Disease|29|||
30985296|NCT00585195|59128286|FG013|Overall Study|Progressive Disease|26|||
30985297|NCT00585195|59128287|FG014|Overall Study|Progressive Disease|21|||
30985298|NCT00585195|59128288|FG015|Overall Study|Progressive Disease|12|||
30985299|NCT00585195|59128289|FG016|Overall Study|Progressive Disease|94|||
30985300|NCT00585195|59128290|FG017|Overall Study|Progressive Disease|42|||
30985301|NCT00585195|59128291|FG018|Overall Study|Progressive Disease|4|||
30985302|NCT00585195|59128292|FG019|Overall Study|Progressive Disease|9|||
30985303|NCT00585195|59128293|FG020|Overall Study|Progressive Disease|8|||
30985304|NCT00585195|59128273|FG000|Overall Study|Withdrawal by Subject|1|||
30985305|NCT00585195|59128274|FG001|Overall Study|Withdrawal by Subject|1|||
30985306|NCT00585195|59128275|FG002|Overall Study|Withdrawal by Subject|2|||
30985307|NCT00585195|59128276|FG003|Overall Study|Withdrawal by Subject|2|||
30985308|NCT00585195|59128277|FG004|Overall Study|Withdrawal by Subject|0|||
30985309|NCT00585195|59128278|FG005|Overall Study|Withdrawal by Subject|0|||
30985310|NCT00585195|59128279|FG006|Overall Study|Withdrawal by Subject|0|||
30985311|NCT00585195|59128280|FG007|Overall Study|Withdrawal by Subject|1|||
30985312|NCT00585195|59128281|FG008|Overall Study|Withdrawal by Subject|0|||
30985313|NCT00585195|59128282|FG009|Overall Study|Withdrawal by Subject|0|||
30985314|NCT00585195|59128283|FG010|Overall Study|Withdrawal by Subject|3|||
30985315|NCT00585195|59128284|FG011|Overall Study|Withdrawal by Subject|8|||
30985316|NCT00585195|59128285|FG012|Overall Study|Withdrawal by Subject|15|||
30985317|NCT00585195|59128286|FG013|Overall Study|Withdrawal by Subject|0|||
30985318|NCT00585195|59128287|FG014|Overall Study|Withdrawal by Subject|3|||
30985319|NCT00585195|59128288|FG015|Overall Study|Withdrawal by Subject|0|||
30985320|NCT00585195|59128289|FG016|Overall Study|Withdrawal by Subject|7|||
30985321|NCT00585195|59128290|FG017|Overall Study|Withdrawal by Subject|1|||
30985322|NCT00585195|59128291|FG018|Overall Study|Withdrawal by Subject|2|||
30985323|NCT00585195|59128292|FG019|Overall Study|Withdrawal by Subject|2|||
30985324|NCT00585195|59128293|FG020|Overall Study|Withdrawal by Subject|0|||
30985325|NCT00585195|59128273|FG000|Overall Study|Other|0|||
30985326|NCT00585195|59128274|FG001|Overall Study|Other|1|||
30985327|NCT00585195|59128275|FG002|Overall Study|Other|1|||
30985328|NCT00585195|59128276|FG003|Overall Study|Other|1|||
30985329|NCT00585195|59128277|FG004|Overall Study|Other|0|||
30985330|NCT00585195|59128278|FG005|Overall Study|Other|1|||
30985331|NCT00585195|59128279|FG006|Overall Study|Other|0|||
30985332|NCT00585195|59128280|FG007|Overall Study|Other|0|||
30985333|NCT00585195|59128281|FG008|Overall Study|Other|2|||
30985334|NCT00585195|59128282|FG009|Overall Study|Other|1|||
30985335|NCT00585195|59128283|FG010|Overall Study|Other|0|||
30891614|NCT02395081|58924847|FG002|Overall Study|Moved where blood couldn't be collected|3|||
30985336|NCT00585195|59128284|FG011|Overall Study|Other|19|||
30985337|NCT00585195|59128285|FG012|Overall Study|Other|24|||
30985338|NCT00585195|59128286|FG013|Overall Study|Other|7|||
30985339|NCT00585195|59128287|FG014|Overall Study|Other|11|||
30985340|NCT00585195|59128288|FG015|Overall Study|Other|3|||
30985341|NCT00585195|59128289|FG016|Overall Study|Other|28|||
30985342|NCT00585195|59128290|FG017|Overall Study|Other|12|||
30985343|NCT00585195|59128291|FG018|Overall Study|Other|10|||
30985344|NCT00585195|59128292|FG019|Overall Study|Other|4|||
30985345|NCT00585195|59128293|FG020|Overall Study|Other|2|||
30985346|NCT00585195|59128273|FG000|Overall Study|Randomized not treated|0|||
30985347|NCT00585195|59128274|FG001|Overall Study|Randomized not treated|0|||
30985348|NCT00585195|59128275|FG002|Overall Study|Randomized not treated|1|||
30985349|NCT00585195|59128276|FG003|Overall Study|Randomized not treated|0|||
30985350|NCT00585195|59128277|FG004|Overall Study|Randomized not treated|1|||
30985351|NCT00585195|59128278|FG005|Overall Study|Randomized not treated|0|||
30985352|NCT00585195|59128279|FG006|Overall Study|Randomized not treated|1|||
30985353|NCT00585195|59128280|FG007|Overall Study|Randomized not treated|0|||
30985354|NCT00585195|59128281|FG008|Overall Study|Randomized not treated|0|||
30985355|NCT00585195|59128282|FG009|Overall Study|Randomized not treated|0|||
30985356|NCT00585195|59128283|FG010|Overall Study|Randomized not treated|2|||
30985357|NCT00585195|59128284|FG011|Overall Study|Randomized not treated|0|||
30985358|NCT00585195|59128285|FG012|Overall Study|Randomized not treated|0|||
30985359|NCT00585195|59128286|FG013|Overall Study|Randomized not treated|0|||
30985360|NCT00585195|59128287|FG014|Overall Study|Randomized not treated|0|||
30985361|NCT00585195|59128288|FG015|Overall Study|Randomized not treated|1|||
30985362|NCT00585195|59128289|FG016|Overall Study|Randomized not treated|0|||
30985363|NCT00585195|59128290|FG017|Overall Study|Randomized not treated|1|||
30985364|NCT00585195|59128291|FG018|Overall Study|Randomized not treated|3|||
30985365|NCT00585195|59128292|FG019|Overall Study|Randomized not treated|0|||
30985366|NCT00585195|59128293|FG020|Overall Study|Randomized not treated|2|||
30985367|NCT00585195|59128273|FG000|Overall Study|Death|0|||
30985368|NCT00585195|59128274|FG001|Overall Study|Death|0|||
30985369|NCT00585195|59128275|FG002|Overall Study|Death|0|||
30985370|NCT00585195|59128276|FG003|Overall Study|Death|0|||
30985371|NCT00585195|59128277|FG004|Overall Study|Death|0|||
30985372|NCT00585195|59128278|FG005|Overall Study|Death|0|||
30985373|NCT00585195|59128279|FG006|Overall Study|Death|0|||
30985374|NCT00585195|59128280|FG007|Overall Study|Death|0|||
30985375|NCT00585195|59128281|FG008|Overall Study|Death|1|||
30985376|NCT00585195|59128282|FG009|Overall Study|Death|0|||
30985377|NCT00585195|59128283|FG010|Overall Study|Death|1|||
30985378|NCT00585195|59128284|FG011|Overall Study|Death|1|||
30985379|NCT00585195|59128285|FG012|Overall Study|Death|7|||
30985380|NCT00585195|59128286|FG013|Overall Study|Death|2|||
30985381|NCT00585195|59128287|FG014|Overall Study|Death|8|||
30985382|NCT00585195|59128288|FG015|Overall Study|Death|2|||
30985383|NCT00585195|59128289|FG016|Overall Study|Death|11|||
30985384|NCT00585195|59128290|FG017|Overall Study|Death|0|||
30985385|NCT00585195|59128291|FG018|Overall Study|Death|0|||
30985386|NCT00585195|59128292|FG019|Overall Study|Death|0|||
30985387|NCT00585195|59128293|FG020|Overall Study|Death|1|||
30985388|NCT00585195|59128273|FG000|Overall Study|Lost to Follow-up|0|||
30985389|NCT00585195|59128274|FG001|Overall Study|Lost to Follow-up|0|||
30985390|NCT00585195|59128275|FG002|Overall Study|Lost to Follow-up|0|||
30985391|NCT00585195|59128276|FG003|Overall Study|Lost to Follow-up|0|||
30985392|NCT00585195|59128277|FG004|Overall Study|Lost to Follow-up|0|||
30985393|NCT00585195|59128278|FG005|Overall Study|Lost to Follow-up|0|||
30985394|NCT00585195|59128279|FG006|Overall Study|Lost to Follow-up|0|||
30985395|NCT00585195|59128280|FG007|Overall Study|Lost to Follow-up|0|||
30985396|NCT00585195|59128281|FG008|Overall Study|Lost to Follow-up|0|||
30985397|NCT00585195|59128282|FG009|Overall Study|Lost to Follow-up|0|||
30985398|NCT00585195|59128283|FG010|Overall Study|Lost to Follow-up|0|||
30985399|NCT00585195|59128284|FG011|Overall Study|Lost to Follow-up|0|||
30985400|NCT00585195|59128285|FG012|Overall Study|Lost to Follow-up|1|||
30985401|NCT00585195|59128286|FG013|Overall Study|Lost to Follow-up|0|||
30985402|NCT00585195|59128287|FG014|Overall Study|Lost to Follow-up|0|||
30985403|NCT00585195|59128288|FG015|Overall Study|Lost to Follow-up|0|||
30985404|NCT00585195|59128289|FG016|Overall Study|Lost to Follow-up|0|||
30985405|NCT00585195|59128290|FG017|Overall Study|Lost to Follow-up|2|||
30985406|NCT00585195|59128291|FG018|Overall Study|Lost to Follow-up|0|||
30985407|NCT00585195|59128292|FG019|Overall Study|Lost to Follow-up|0|||
30985408|NCT00585195|59128293|FG020|Overall Study|Lost to Follow-up|0|||
30985409|NCT00585195|59128273|FG000|Overall Study|Site Terminated by Sponsor|0|||
30985410|NCT00585195|59128274|FG001|Overall Study|Site Terminated by Sponsor|0|||
30985411|NCT00585195|59128275|FG002|Overall Study|Site Terminated by Sponsor|0|||
30985412|NCT00585195|59128276|FG003|Overall Study|Site Terminated by Sponsor|0|||
30985413|NCT00585195|59128277|FG004|Overall Study|Site Terminated by Sponsor|0|||
30985414|NCT00585195|59128278|FG005|Overall Study|Site Terminated by Sponsor|0|||
30985415|NCT00585195|59128279|FG006|Overall Study|Site Terminated by Sponsor|0|||
30985416|NCT00585195|59128280|FG007|Overall Study|Site Terminated by Sponsor|0|||
30985417|NCT00585195|59128281|FG008|Overall Study|Site Terminated by Sponsor|0|||
30985418|NCT00585195|59128282|FG009|Overall Study|Site Terminated by Sponsor|0|||
30985419|NCT00585195|59128283|FG010|Overall Study|Site Terminated by Sponsor|0|||
30985420|NCT00585195|59128284|FG011|Overall Study|Site Terminated by Sponsor|0|||
30985421|NCT00585195|59128285|FG012|Overall Study|Site Terminated by Sponsor|1|||
30985422|NCT00585195|59128286|FG013|Overall Study|Site Terminated by Sponsor|0|||
30985423|NCT00585195|59128287|FG014|Overall Study|Site Terminated by Sponsor|0|||
30985424|NCT00585195|59128288|FG015|Overall Study|Site Terminated by Sponsor|0|||
30985425|NCT00585195|59128289|FG016|Overall Study|Site Terminated by Sponsor|0|||
30985426|NCT00585195|59128290|FG017|Overall Study|Site Terminated by Sponsor|0|||
30985427|NCT00585195|59128291|FG018|Overall Study|Site Terminated by Sponsor|0|||
30985428|NCT00585195|59128292|FG019|Overall Study|Site Terminated by Sponsor|0|||
30985429|NCT00585195|59128293|FG020|Overall Study|Site Terminated by Sponsor|0|||
30985430|NCT00585195|59128273|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
30985431|NCT00585195|59128274|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
30985432|NCT00585195|59128275|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
30985433|NCT00585195|59128276|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
30985434|NCT00585195|59128277|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
30985435|NCT00585195|59128278|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
30985436|NCT00585195|59128279|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
30985437|NCT00585195|59128280|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
30985438|NCT00585195|59128281|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
30985439|NCT00585195|59128282|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
30985440|NCT00585195|59128283|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
30985441|NCT00585195|59128284|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
30985442|NCT00585195|59128285|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
30985443|NCT00585195|59128286|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
30985444|NCT00585195|59128287|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
30985445|NCT00585195|59128288|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
30985446|NCT00585195|59128289|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
30985447|NCT00585195|59128290|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
30985448|NCT00585195|59128291|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
30985449|NCT00585195|59128292|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
30985450|NCT00585195|59128293|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
30985451|NCT02439216|59128465|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
30985452|NCT02439216|59128466|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
30985453|NCT02439216|59128467|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
30985454|NCT02439216|59128468|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
30985455|NCT02439216|59128469|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
30985456|NCT02439216|59128470|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
30985457|NCT02439216|59128471|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
30985458|NCT02439216|59128472|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
30985459|NCT02439216|59128473|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
30985460|NCT02439216|59128465|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
30985461|NCT02439216|59128466|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
30985462|NCT02439216|59128467|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
30985463|NCT02439216|59128468|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
30985464|NCT02439216|59128469|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
30985465|NCT02439216|59128470|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
30985466|NCT02439216|59128471|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
30985467|NCT02439216|59128472|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
30985468|NCT02439216|59128473|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
30985469|NCT02439216|59128465|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
30985470|NCT02439216|59128466|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
30985471|NCT02439216|59128467|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
30985472|NCT02439216|59128468|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
30985473|NCT02439216|59128469|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
30985474|NCT02439216|59128470|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
30985475|NCT02439216|59128471|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
30985476|NCT02439216|59128472|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
30985477|NCT02439216|59128473|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
30985478|NCT02439216|59128465|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
30985479|NCT02439216|59128466|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
30985480|NCT02439216|59128467|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
30985481|NCT02439216|59128468|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
30985482|NCT02439216|59128469|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
30985483|NCT02439216|59128470|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
30985484|NCT02439216|59128471|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
30985485|NCT02439216|59128472|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
30985486|NCT02439216|59128473|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
30985487|NCT02439216|59128465|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
30985488|NCT02439216|59128466|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
30985489|NCT02439216|59128467|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
30985490|NCT02439216|59128468|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
30985491|NCT02439216|59128469|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
30985492|NCT02439216|59128470|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
30985493|NCT02439216|59128471|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
30985494|NCT02439216|59128472|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
30985495|NCT02439216|59128473|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
30985496|NCT02439138|59128501|FG000|Overall Study|Adverse Event|1|||
30985497|NCT02439138|59128501|FG000|Overall Study|PI decision to terminate the study|2|||
30985498|NCT02438826|59128877|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
30985499|NCT02438826|59128878|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
30985500|NCT02438826|59128879|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
30985501|NCT02438826|59128880|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
30985502|NCT02438826|59128877|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
30985503|NCT02438826|59128878|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
30985504|NCT02438826|59128879|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
30985505|NCT02438826|59128880|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
30985506|NCT02438826|59128877|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
30985507|NCT02438826|59128878|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
30985508|NCT02438826|59128879|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
30985509|NCT02438826|59128880|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
30985510|NCT02438826|59128877|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
30985511|NCT02438826|59128878|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
30985512|NCT02438826|59128879|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
30985513|NCT02438826|59128880|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
30985514|NCT02438826|59128877|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
30985515|NCT02438826|59128878|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
30985516|NCT02438826|59128879|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
30985517|NCT02438826|59128880|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
30985518|NCT02438826|59128877|FG000|Open-Label Treatment Phase|Adverse Event|11|||
30985519|NCT02438826|59128878|FG001|Open-Label Treatment Phase|Adverse Event|6|||
30985520|NCT02438826|59128879|FG002|Open-Label Treatment Phase|Adverse Event|0|||
30985521|NCT02438826|59128880|FG003|Open-Label Treatment Phase|Adverse Event|0|||
30985522|NCT02438826|59128877|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
30985523|NCT02438826|59128878|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
30985524|NCT02438826|59128879|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
30985525|NCT02438826|59128880|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
30985526|NCT02438826|59128877|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
30985527|NCT02438826|59128878|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
30985528|NCT02438826|59128879|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
30985529|NCT02438826|59128880|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
30985530|NCT02438826|59128877|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
30985531|NCT02438826|59128878|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
30985532|NCT02438826|59128879|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
30985533|NCT02438826|59128880|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
30985534|NCT02438826|59128877|FG000|Post-Treatment Phase|Adverse Event|3|||
30985535|NCT02438826|59128878|FG001|Post-Treatment Phase|Adverse Event|0|||
30985536|NCT02438826|59128879|FG002|Post-Treatment Phase|Adverse Event|0|||
30985537|NCT02438826|59128880|FG003|Post-Treatment Phase|Adverse Event|0|||
30985538|NCT02438826|59128877|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
30985539|NCT02438826|59128878|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
30985540|NCT02438826|59128879|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
30985541|NCT02438826|59128880|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
30985542|NCT02438826|59128877|FG000|Post-Treatment Phase|Physician Decision|1|||
30985543|NCT02438826|59128878|FG001|Post-Treatment Phase|Physician Decision|0|||
30985544|NCT02438826|59128879|FG002|Post-Treatment Phase|Physician Decision|0|||
30985545|NCT02438826|59128880|FG003|Post-Treatment Phase|Physician Decision|0|||
30985546|NCT02438826|59128877|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
30985547|NCT02438826|59128878|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
30985548|NCT02438826|59128879|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
30985549|NCT02438826|59128880|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
30985550|NCT02438280|59128897|FG000|Overall Study|Physician Decision|1|||
30985551|NCT02438280|59128898|FG001|Overall Study|Physician Decision|0|||
30985552|NCT02385708|59128916|FG000|Overall Study|Withdrawal by Subject|0|||
30985553|NCT02385708|59128917|FG001|Overall Study|Withdrawal by Subject|2|||
30985554|NCT02385708|59128916|FG000|Overall Study|Withdrawn - surgery canceled|2|||
30985555|NCT02385708|59128917|FG001|Overall Study|Withdrawn - surgery canceled|5|||
30985556|NCT02385708|59128916|FG000|Overall Study|Investigator decision|5|||
30985557|NCT02385708|59128917|FG001|Overall Study|Investigator decision|7|||
30985558|NCT02385708|59128916|FG000|Overall Study|Protocol Violation|1|||
30985559|NCT02385708|59128917|FG001|Overall Study|Protocol Violation|1|||
30985560|NCT02385084|59129656|FG000|Period 2|Protocol Violation|0|||
30985561|NCT02385084|59129657|FG001|Period 2|Protocol Violation|0|||
30985562|NCT02385084|59129658|FG002|Period 2|Protocol Violation|1|||
30985563|NCT02385084|59129659|FG003|Period 2|Protocol Violation|0|||
30985564|NCT02385084|59129660|FG004|Period 2|Protocol Violation|0|||
30985565|NCT02385084|59129661|FG005|Period 2|Protocol Violation|0|||
30985566|NCT02411292|59129670|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
30985567|NCT02411292|59129670|FG000|Overall Study|Death|2|||
30985568|NCT02411292|59129670|FG000|Overall Study|Lost to Follow-up|3|||
30985569|NCT02384850|59129733|FG000|Overall Study|Withdrawal by Subject|2|||
30985570|NCT02384850|59129734|FG001|Overall Study|Withdrawal by Subject|2|||
30985571|NCT02437890|59129956|FG000|Overall Study|Non-compliance to study drug|0|||
30985572|NCT02437890|59129957|FG001|Overall Study|Non-compliance to study drug|1|||
30985573|NCT02437890|59129958|FG002|Overall Study|Non-compliance to study drug|0|||
30985574|NCT02437890|59129959|FG003|Overall Study|Non-compliance to study drug|0|||
30985575|NCT02437890|59129960|FG004|Overall Study|Non-compliance to study drug|1|||
30985576|NCT02437890|59129956|FG000|Overall Study|Sponsor's decision|1|||
30985577|NCT02437890|59129957|FG001|Overall Study|Sponsor's decision|1|||
30985578|NCT02437890|59129958|FG002|Overall Study|Sponsor's decision|4|||
30985579|NCT02437890|59129959|FG003|Overall Study|Sponsor's decision|0|||
30985580|NCT02437890|59129960|FG004|Overall Study|Sponsor's decision|2|||
30985581|NCT02437890|59129956|FG000|Overall Study|Physician Decision|0|||
30985582|NCT02437890|59129957|FG001|Overall Study|Physician Decision|0|||
30985583|NCT02437890|59129958|FG002|Overall Study|Physician Decision|0|||
30985584|NCT02437890|59129959|FG003|Overall Study|Physician Decision|1|||
30985585|NCT02437890|59129960|FG004|Overall Study|Physician Decision|0|||
30985586|NCT02437890|59129956|FG000|Overall Study|Unable to attend visit(s)|1|||
30985587|NCT02437890|59129957|FG001|Overall Study|Unable to attend visit(s)|0|||
30985588|NCT02437890|59129958|FG002|Overall Study|Unable to attend visit(s)|0|||
30985589|NCT02437890|59129959|FG003|Overall Study|Unable to attend visit(s)|0|||
30985590|NCT02437890|59129960|FG004|Overall Study|Unable to attend visit(s)|0|||
30985591|NCT02437890|59129956|FG000|Overall Study|Lack of Efficacy|1|||
30985592|NCT02437890|59129957|FG001|Overall Study|Lack of Efficacy|3|||
30985593|NCT02437890|59129958|FG002|Overall Study|Lack of Efficacy|0|||
30985594|NCT02437890|59129959|FG003|Overall Study|Lack of Efficacy|3|||
30985595|NCT02437890|59129960|FG004|Overall Study|Lack of Efficacy|1|||
30985596|NCT02437890|59129956|FG000|Overall Study|Adverse Event|4|||
30985597|NCT02437890|59129957|FG001|Overall Study|Adverse Event|9|||
30985598|NCT02437890|59129958|FG002|Overall Study|Adverse Event|5|||
30985599|NCT02437890|59129959|FG003|Overall Study|Adverse Event|11|||
30985600|NCT02437890|59129960|FG004|Overall Study|Adverse Event|7|||
30985601|NCT02437890|59129956|FG000|Overall Study|Withdrawal by Subject|1|||
30985602|NCT02437890|59129957|FG001|Overall Study|Withdrawal by Subject|2|||
30985603|NCT02437890|59129958|FG002|Overall Study|Withdrawal by Subject|6|||
30985604|NCT02437890|59129959|FG003|Overall Study|Withdrawal by Subject|5|||
30985605|NCT02437890|59129960|FG004|Overall Study|Withdrawal by Subject|5|||
30985606|NCT02437890|59129956|FG000|Overall Study|Death|0|||
30985607|NCT02437890|59129957|FG001|Overall Study|Death|0|||
30985608|NCT02437890|59129958|FG002|Overall Study|Death|0|||
30985609|NCT02437890|59129959|FG003|Overall Study|Death|2|||
30985610|NCT02437890|59129960|FG004|Overall Study|Death|0|||
30985611|NCT02384538|59130021|FG000|Overall Study|Adverse Event|1|||
30985612|NCT02384538|59130022|FG001|Overall Study|Adverse Event|4|||
30985613|NCT02384538|59130021|FG000|Overall Study|Lack of Efficacy|4|||
30985614|NCT02384538|59130022|FG001|Overall Study|Lack of Efficacy|4|||
30985615|NCT02384538|59130021|FG000|Overall Study|Withdrew Consent|0|||
30985616|NCT02384538|59130022|FG001|Overall Study|Withdrew Consent|4|||
30985617|NCT02384538|59130021|FG000|Overall Study|Other|1|||
30985618|NCT02384538|59130022|FG001|Overall Study|Other|3|||
30985619|NCT02410824|59130046|FG000|First Intervention (One Week)|Headache|0|||
30985620|NCT02410824|59130047|FG001|First Intervention (One Week)|Headache|1|||
30985621|NCT02384460|59130077|FG000|Overall Study|Protocol Violation|0|||
30985622|NCT02384460|59130078|FG001|Overall Study|Protocol Violation|1|||
30985623|NCT02384460|59130077|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
30985624|NCT02384460|59130078|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
30985625|NCT02384460|59130077|FG000|Overall Study|Adverse Event|5|||
30985626|NCT02384460|59130078|FG001|Overall Study|Adverse Event|2|||
30985627|NCT02384460|59130077|FG000|Overall Study|Withdrawal by Subject|0|||
30985628|NCT02384460|59130078|FG001|Overall Study|Withdrawal by Subject|3|||
30985629|NCT02384460|59130077|FG000|Overall Study|Elective medical treatment|1|||
30985630|NCT02384460|59130078|FG001|Overall Study|Elective medical treatment|0|||
30985631|NCT02384460|59130077|FG000|Overall Study|Non-compliance|1|||
30985632|NCT02384460|59130078|FG001|Overall Study|Non-compliance|0|||
30985633|NCT02384382|59130101|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
30985634|NCT02384382|59130101|FG000|Overall Study|Death|1|||
30985635|NCT02384382|59130101|FG000|Overall Study|Adverse Event|1|||
30985636|NCT02384382|59130101|FG000|Overall Study|Disease progression|16|||
30985637|NCT02437188|59130121|FG000|Overall Study|Randomized but did not receive surgery|4|||
30985638|NCT02437188|59130122|FG001|Overall Study|Randomized but did not receive surgery|8|||
30985639|NCT02437188|59130121|FG000|Overall Study|Adverse Event|0|||
30985640|NCT02437188|59130122|FG001|Overall Study|Adverse Event|1|||
30985641|NCT02383758|59130144|FG000|Overall Study|Withdrawal by Subject|0|||
30985642|NCT02383758|59130145|FG001|Overall Study|Withdrawal by Subject|2|||
30985643|NCT02410278|59130195|FG000|Run-in Period|Adverse Event|5|||
30985644|NCT02410278|59130196|FG001|Run-in Period|Adverse Event|0|||
30985645|NCT02410278|59130197|FG002|Run-in Period|Adverse Event|0|||
30985646|NCT02410278|59130195|FG000|Run-in Period|GSRS Threshold Not Met|30|||
30985647|NCT02410278|59130196|FG001|Run-in Period|GSRS Threshold Not Met|0|||
30985648|NCT02410278|59130197|FG002|Run-in Period|GSRS Threshold Not Met|0|||
30985649|NCT02410278|59130195|FG000|Run-in Period|Lost to Follow-up|1|||
30985650|NCT02410278|59130196|FG001|Run-in Period|Lost to Follow-up|0|||
30985651|NCT02410278|59130197|FG002|Run-in Period|Lost to Follow-up|0|||
30985652|NCT02410278|59130195|FG000|Run-in Period|Withdrawal by Subject|1|||
30985653|NCT02410278|59130196|FG001|Run-in Period|Withdrawal by Subject|0|||
30985654|NCT02410278|59130197|FG002|Run-in Period|Withdrawal by Subject|0|||
30985655|NCT02410278|59130195|FG000|Run-in Period|Pregnancy|1|||
30985656|NCT02410278|59130196|FG001|Run-in Period|Pregnancy|0|||
30985657|NCT02410278|59130197|FG002|Run-in Period|Pregnancy|0|||
30985658|NCT02410278|59130195|FG000|Study Treatment Period|Adverse Event|0|||
30985659|NCT02410278|59130196|FG001|Study Treatment Period|Adverse Event|6|||
30985660|NCT02410278|59130197|FG002|Study Treatment Period|Adverse Event|3|||
30985661|NCT02410278|59130195|FG000|Study Treatment Period|Physician Decision|0|||
30985662|NCT02410278|59130196|FG001|Study Treatment Period|Physician Decision|0|||
30985663|NCT02410278|59130197|FG002|Study Treatment Period|Physician Decision|1|||
30985664|NCT02410278|59130195|FG000|Study Treatment Period|Withdrawal by Subject|0|||
30985665|NCT02410278|59130196|FG001|Study Treatment Period|Withdrawal by Subject|1|||
30985666|NCT02410278|59130197|FG002|Study Treatment Period|Withdrawal by Subject|0|||
30985667|NCT02410278|59130195|FG000|Study Treatment Period|Other|0|||
30985668|NCT02410278|59130196|FG001|Study Treatment Period|Other|3|||
30985669|NCT02410278|59130197|FG002|Study Treatment Period|Other|0|||
30985670|NCT02410278|59130195|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
30985671|NCT02410278|59130196|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
30985672|NCT02410278|59130197|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
30985673|NCT02410200|59130230|FG000|Overall Study|Adverse Event|2|||
30985674|NCT02383056|59130249|FG000|Overall Study|Adverse Event|1|||
30985675|NCT02383056|59130250|FG001|Overall Study|Adverse Event|0|||
30985676|NCT02383056|59130249|FG000|Overall Study|Lost to Follow-up|0|||
30985677|NCT02383056|59130250|FG001|Overall Study|Lost to Follow-up|2|||
30985678|NCT02409732|59130256|FG000|Overall Study|Withdrawal by Subject|4|||
30985679|NCT02409732|59130256|FG000|Overall Study|Lost to Follow-up|2|||
30985680|NCT01650636|59130267|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
30985681|NCT01650636|59130268|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
30985682|NCT01650636|59130267|FG000|Washout up to 5 Months|Physician Decision|2|||
30985683|NCT01650636|59130268|FG001|Washout up to 5 Months|Physician Decision|2|||
30985684|NCT01650636|59130267|FG000|Washout up to 5 Months|Death|1|||
30985685|NCT01650636|59130268|FG001|Washout up to 5 Months|Death|0|||
30985686|NCT01650636|59130267|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
30985687|NCT01650636|59130268|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
30985688|NCT01650636|59130267|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
30985689|NCT01650636|59130268|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
30985690|NCT01650636|59130267|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
30985691|NCT01650636|59130268|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
30985692|NCT02436876|59130278|FG000|Overall Study|Lost to Follow-up|0|||
30985693|NCT02436876|59130279|FG001|Overall Study|Lost to Follow-up|1|||
30985694|NCT02436876|59130280|FG002|Overall Study|Lost to Follow-up|1|||
30985695|NCT02436876|59130281|FG003|Overall Study|Lost to Follow-up|1|||
30985696|NCT02436876|59130278|FG000|Overall Study|Withdrawal by Subject|1|||
30985697|NCT02436876|59130279|FG001|Overall Study|Withdrawal by Subject|0|||
30985698|NCT02436876|59130280|FG002|Overall Study|Withdrawal by Subject|0|||
30985699|NCT02436876|59130281|FG003|Overall Study|Withdrawal by Subject|1|||
30985700|NCT02436876|59130278|FG000|Overall Study|Physician Decision|0|||
30985701|NCT02436876|59130279|FG001|Overall Study|Physician Decision|2|||
30985702|NCT02436876|59130280|FG002|Overall Study|Physician Decision|1|||
30985703|NCT02436876|59130281|FG003|Overall Study|Physician Decision|0|||
30985704|NCT02436876|59130278|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
30985705|NCT02436876|59130279|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
30985706|NCT02436876|59130280|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
30985707|NCT02436876|59130281|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
30985708|NCT02382276|59130310|FG000|Overall Study|Withdrawal by Subject|4|||
30985709|NCT02382276|59130311|FG001|Overall Study|Withdrawal by Subject|8|||
30985710|NCT02382276|59130312|FG002|Overall Study|Withdrawal by Subject|5|||
30985711|NCT02382276|59130310|FG000|Overall Study|Adverse Event|7|||
30985712|NCT02382276|59130311|FG001|Overall Study|Adverse Event|2|||
30985713|NCT02382276|59130312|FG002|Overall Study|Adverse Event|32|||
30985714|NCT02382276|59130310|FG000|Overall Study|Physician Decision|0|||
30985715|NCT02382276|59130311|FG001|Overall Study|Physician Decision|0|||
30985716|NCT02382276|59130312|FG002|Overall Study|Physician Decision|2|||
30985717|NCT02436408|59130353|FG000|Overall Study|Death|1|||
30985718|NCT02436330|59130376|FG000|Cohort 1|Lost to Follow-up|5|||
30985719|NCT02436330|59130377|FG001|Cohort 1|Lost to Follow-up|2|||
30790204|NCT00039377|58803412|FG002|Initial Registration|Received non-protocol therapy|0|||
30985720|NCT02436330|59130376|FG000|Cohort 1|Withdrawal by Subject|0|||
30985721|NCT02436330|59130377|FG001|Cohort 1|Withdrawal by Subject|1|||
30985722|NCT02436330|59130376|FG000|Cohort 2|Lost to Follow-up|2|||
30985723|NCT02436330|59130377|FG001|Cohort 2|Lost to Follow-up|0|||
30985724|NCT02436330|59130376|FG000|Cohort 2|Withdrawal by Subject|2|||
30985725|NCT02436330|59130377|FG001|Cohort 2|Withdrawal by Subject|3|||
30985726|NCT02436330|59130376|FG000|Cohort 3|Lost to Follow-up|1|||
30985727|NCT02436330|59130377|FG001|Cohort 3|Lost to Follow-up|0|||
30790205|NCT00039377|58803413|FG003|Initial Registration|Received non-protocol therapy|0|||
30790206|NCT00039377|58803410|FG000|Initial Registration|Withdrawal by Subject|3|||
30985728|NCT02436330|59130376|FG000|Cohort 3|Withdrawal by Subject|4|||
30985729|NCT02436330|59130377|FG001|Cohort 3|Withdrawal by Subject|0|||
30985730|NCT02436330|59130376|FG000|Cohort 4|Lost to Follow-up|1|||
30985731|NCT02436330|59130377|FG001|Cohort 4|Lost to Follow-up|0|||
30985732|NCT02436330|59130376|FG000|Cohort 4|Withdrawal by Subject|1|||
30985733|NCT02436330|59130377|FG001|Cohort 4|Withdrawal by Subject|0|||
30985734|NCT02436330|59130376|FG000|Cohort 5|Lost to Follow-up|3|||
30985735|NCT02436330|59130377|FG001|Cohort 5|Lost to Follow-up|2|||
30985736|NCT02436330|59130376|FG000|Cohort 5|Withdrawal by Subject|3|||
30985737|NCT02436330|59130377|FG001|Cohort 5|Withdrawal by Subject|2|||
30985738|NCT02436330|59130376|FG000|Cohort 6|Lost to Follow-up|2|||
30985739|NCT02436330|59130377|FG001|Cohort 6|Lost to Follow-up|0|||
30985740|NCT02436330|59130376|FG000|Cohort 6|Withdrawal by Subject|1|||
30985741|NCT02436330|59130377|FG001|Cohort 6|Withdrawal by Subject|1|||
30985742|NCT01650558|59130414|FG000|Overall Study|Migration out of study area|61|||
30985743|NCT01650558|59130415|FG001|Overall Study|Migration out of study area|71|||
30985744|NCT01650558|59130416|FG002|Overall Study|Migration out of study area|56|||
30985745|NCT01650558|59130414|FG000|Overall Study|Lost to Follow-up|10|||
30985746|NCT01650558|59130415|FG001|Overall Study|Lost to Follow-up|13|||
30985747|NCT01650558|59130416|FG002|Overall Study|Lost to Follow-up|6|||
30985748|NCT01650558|59130414|FG000|Overall Study|Death|10|||
30985749|NCT01650558|59130415|FG001|Overall Study|Death|6|||
30985750|NCT01650558|59130416|FG002|Overall Study|Death|8|||
30985751|NCT01650558|59130414|FG000|Overall Study|Withdrawal by Subject|1|||
30985752|NCT01650558|59130415|FG001|Overall Study|Withdrawal by Subject|1|||
30985753|NCT01650558|59130416|FG002|Overall Study|Withdrawal by Subject|3|||
30985754|NCT01650558|59130414|FG000|Overall Study|Non-compliant participant|1|||
30985755|NCT01650558|59130415|FG001|Overall Study|Non-compliant participant|0|||
30985756|NCT01650558|59130416|FG002|Overall Study|Non-compliant participant|2|||
30985757|NCT01650558|59130414|FG000|Overall Study|Physician Decision|0|||
30985758|NCT01650558|59130415|FG001|Overall Study|Physician Decision|1|||
30790207|NCT00039377|58803411|FG001|Initial Registration|Withdrawal by Subject|0|||
30985759|NCT01650558|59130416|FG002|Overall Study|Physician Decision|0|||
30985760|NCT02408484|59130455|FG000|Overall Study|Withdrawal by Subject|3|||
30985761|NCT02408484|59130455|FG000|Overall Study|Not treated during study period|1|||
30985762|NCT02380248|59130483|FG000|Overall Study|Lost to Follow-up|11|||
30985763|NCT02380248|59130483|FG000|Overall Study|Withdrawal by Subject|3|||
30985764|NCT02408016|59130530|FG000|Overall Study|Death|6|||
30985765|NCT02408016|59130531|FG001|Overall Study|Death|1|||
30985766|NCT02408016|59130532|FG002|Overall Study|Death|0|||
30985767|NCT02408016|59130530|FG000|Overall Study|Physician Decision|0|||
30985768|NCT02408016|59130531|FG001|Overall Study|Physician Decision|2|||
30985769|NCT02408016|59130532|FG002|Overall Study|Physician Decision|0|||
30985770|NCT02407704|59130596|FG000|Overall Study|Lost to Follow-up|0|||
30985771|NCT02407704|59130597|FG001|Overall Study|Lost to Follow-up|0|||
30985772|NCT02407704|59130598|FG002|Overall Study|Lost to Follow-up|0|||
30985773|NCT02407704|59130599|FG003|Overall Study|Lost to Follow-up|2|||
30985774|NCT02407704|59130596|FG000|Overall Study|Protocol Violation|0|||
30985775|NCT02407704|59130597|FG001|Overall Study|Protocol Violation|0|||
30985776|NCT02407704|59130598|FG002|Overall Study|Protocol Violation|0|||
30985777|NCT02407704|59130599|FG003|Overall Study|Protocol Violation|1|||
30985778|NCT02407704|59130596|FG000|Overall Study|Withdrawal by Subject|0|||
30985779|NCT02407704|59130597|FG001|Overall Study|Withdrawal by Subject|0|||
30985780|NCT02407704|59130598|FG002|Overall Study|Withdrawal by Subject|1|||
30985781|NCT02407704|59130599|FG003|Overall Study|Withdrawal by Subject|0|||
30985782|NCT02406612|59130620|FG000|Overall Study|Screening Failure|3|||
30985783|NCT02406612|59130621|FG001|Overall Study|Screening Failure|0|||
30985784|NCT02406612|59130620|FG000|Overall Study|Intra-procedural Exclusion|1|||
30985785|NCT02406612|59130621|FG001|Overall Study|Intra-procedural Exclusion|3|||
30985786|NCT02406612|59130620|FG000|Overall Study|Guidewire Failure|0|||
30985787|NCT02406612|59130621|FG001|Overall Study|Guidewire Failure|1|||
30985788|NCT02405442|59130765|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
30985789|NCT02405442|59130766|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
30985790|NCT02405442|59130767|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
30985791|NCT02405442|59130768|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
30985792|NCT02405442|59130765|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
30985793|NCT02405442|59130766|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
30985794|NCT02405442|59130767|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
30985795|NCT02405442|59130768|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
30985796|NCT02405442|59130765|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
30985797|NCT02405442|59130766|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
30985798|NCT02405442|59130767|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
30985799|NCT02405442|59130768|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
30985800|NCT02405442|59130765|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
30985801|NCT02405442|59130766|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
30985802|NCT02405442|59130767|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
30985803|NCT02405442|59130768|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
30985804|NCT02405442|59130765|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
30985805|NCT02405442|59130766|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
30985806|NCT02405442|59130767|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
30985807|NCT02405442|59130768|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
30985808|NCT02405442|59130765|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
30985809|NCT02405442|59130766|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
30985810|NCT02405442|59130767|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
30985811|NCT02405442|59130768|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
30985812|NCT02405442|59130765|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
30985813|NCT02405442|59130766|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
30985814|NCT02405442|59130767|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
30985815|NCT02405442|59130768|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
30985816|NCT02405442|59130765|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
30985817|NCT02405442|59130766|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
30985818|NCT02405442|59130767|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
30985819|NCT02405442|59130768|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
30985820|NCT02405442|59130765|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
30985821|NCT02405442|59130766|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
30985822|NCT02405442|59130767|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
30985823|NCT02405442|59130768|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
30985824|NCT02405442|59130765|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
30985825|NCT02405442|59130766|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
30985826|NCT02405442|59130767|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
30985827|NCT02405442|59130768|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
30985828|NCT02405442|59130765|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
30985829|NCT02405442|59130766|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
30985830|NCT02405442|59130767|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
30985831|NCT02405442|59130768|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
30985832|NCT02405442|59130765|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
30985833|NCT02405442|59130766|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
30985834|NCT02405442|59130767|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
30985835|NCT02405442|59130768|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
30985836|NCT02405442|59130765|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
30985837|NCT02405442|59130766|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
30985838|NCT02405442|59130767|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
30985839|NCT02405442|59130768|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
30985840|NCT02405442|59130765|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
30985841|NCT02405442|59130766|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
30985842|NCT02405442|59130767|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
30985843|NCT02405442|59130768|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
30985844|NCT02404350|59130884|FG000|Overall Study|Adverse Event|2|||
30985845|NCT02404350|59130885|FG001|Overall Study|Adverse Event|2|||
30985846|NCT02404350|59130886|FG002|Overall Study|Adverse Event|3|||
30985847|NCT02404350|59130887|FG003|Overall Study|Adverse Event|9|||
30985848|NCT02404350|59130884|FG000|Overall Study|Lack of Efficacy|3|||
30985849|NCT02404350|59130885|FG001|Overall Study|Lack of Efficacy|1|||
30985850|NCT02404350|59130886|FG002|Overall Study|Lack of Efficacy|0|||
30985851|NCT02404350|59130887|FG003|Overall Study|Lack of Efficacy|3|||
30985852|NCT02404350|59130884|FG000|Overall Study|Lost to Follow-up|2|||
30985853|NCT02404350|59130885|FG001|Overall Study|Lost to Follow-up|0|||
30985854|NCT02404350|59130886|FG002|Overall Study|Lost to Follow-up|0|||
30985855|NCT02404350|59130887|FG003|Overall Study|Lost to Follow-up|1|||
30985856|NCT02404350|59130884|FG000|Overall Study|Physician Decision|1|||
30985857|NCT02404350|59130885|FG001|Overall Study|Physician Decision|0|||
30985858|NCT02404350|59130886|FG002|Overall Study|Physician Decision|0|||
30985859|NCT02404350|59130887|FG003|Overall Study|Physician Decision|2|||
30985860|NCT02404350|59130884|FG000|Overall Study|Pregnancy|0|||
30985861|NCT02404350|59130885|FG001|Overall Study|Pregnancy|0|||
30985862|NCT02404350|59130886|FG002|Overall Study|Pregnancy|0|||
30985863|NCT02404350|59130887|FG003|Overall Study|Pregnancy|1|||
30985864|NCT02404350|59130884|FG000|Overall Study|Withdrawal by Subject|7|||
30985865|NCT02404350|59130885|FG001|Overall Study|Withdrawal by Subject|3|||
30985866|NCT02404350|59130886|FG002|Overall Study|Withdrawal by Subject|3|||
30985867|NCT02404350|59130887|FG003|Overall Study|Withdrawal by Subject|19|||
30985868|NCT02404350|59130884|FG000|Overall Study|Due to Non-compliance with treatment|0|||
30985869|NCT02404350|59130885|FG001|Overall Study|Due to Non-compliance with treatment|0|||
30985870|NCT02404350|59130886|FG002|Overall Study|Due to Non-compliance with treatment|0|||
30985871|NCT02404350|59130887|FG003|Overall Study|Due to Non-compliance with treatment|1|||
30985872|NCT02404350|59130884|FG000|Overall Study|Due to Technical problems|0|||
30985873|NCT02404350|59130885|FG001|Overall Study|Due to Technical problems|0|||
30985874|NCT02404350|59130886|FG002|Overall Study|Due to Technical problems|0|||
30985875|NCT02404350|59130887|FG003|Overall Study|Due to Technical problems|1|||
30985876|NCT02434770|59131186|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
30985877|NCT02434770|59131187|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
30985878|NCT02434770|59131188|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
30985879|NCT02434770|59131186|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
30985880|NCT02434770|59131187|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
30985881|NCT02434770|59131188|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
30985882|NCT02434770|59131186|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
30985883|NCT02434770|59131187|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
30985884|NCT02434770|59131188|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
30985885|NCT02434770|59131186|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
30985886|NCT02434770|59131187|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
30985887|NCT02434770|59131188|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
30985888|NCT02434770|59131186|FG000|Week 1 to Week 18|Death|1|||
30985889|NCT02434770|59131187|FG001|Week 1 to Week 18|Death|0|||
30985890|NCT02434770|59131188|FG002|Week 1 to Week 18|Death|0|||
30608486|NCT01287416|58619259|FG000|6 Month Follow-up|Lost to Follow-up|3|||
30608487|NCT01287416|58619260|FG001|6 Month Follow-up|Lost to Follow-up|2|||
30608488|NCT00998296|58619277|FG000|Overall Study|Progressive disease|0|||
30608489|NCT00998296|58619278|FG001|Overall Study|Progressive disease|1|||
30608490|NCT00998296|58619279|FG002|Overall Study|Progressive disease|0|||
30608491|NCT00998296|58619280|FG003|Overall Study|Progressive disease|0|||
30608492|NCT00998296|58619281|FG004|Overall Study|Progressive disease|0|||
30608493|NCT00998296|58619282|FG005|Overall Study|Progressive disease|0|||
30608494|NCT00998296|58619283|FG006|Overall Study|Progressive disease|1|||
30985891|NCT02434770|59131186|FG000|Week 18 to Week|Lost to Follow-up|2|||
30985892|NCT02434770|59131187|FG001|Week 18 to Week|Lost to Follow-up|2|||
30985893|NCT02434770|59131188|FG002|Week 18 to Week|Lost to Follow-up|1|||
30985894|NCT02434770|59131186|FG000|Week 18 to Week|Withdrawal by Subject|0|||
30985895|NCT02434770|59131187|FG001|Week 18 to Week|Withdrawal by Subject|0|||
30985896|NCT02434770|59131188|FG002|Week 18 to Week|Withdrawal by Subject|2|||
30985897|NCT02434770|59131186|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
30985898|NCT02434770|59131187|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
30985899|NCT02434770|59131188|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
30985900|NCT02433834|59131219|FG000|Overall Study|Protocol-specified criteria|7|||
30985901|NCT02433834|59131219|FG000|Overall Study|Protocol Violation|3|||
30985902|NCT02433834|59131219|FG000|Overall Study|Lost to Follow-up|6|||
30608495|NCT00998296|58619284|FG007|Overall Study|Progressive disease|0|||
30608496|NCT00998296|58619285|FG008|Overall Study|Progressive disease|0|||
30608497|NCT00998296|58619286|FG009|Overall Study|Progressive disease|14|||
30608498|NCT00998296|58619287|FG010|Overall Study|Progressive disease|5|||
30985903|NCT02433834|59131219|FG000|Overall Study|Withdrawal by Subject|14|||
30985904|NCT02433834|59131219|FG000|Overall Study|Adverse Event|6|||
30985905|NCT02433834|59131219|FG000|Overall Study|Physician Decision|1|||
30985906|NCT02433678|59131263|FG000|Overall Study|Lost to Follow-up|1|||
30985907|NCT02433678|59131264|FG001|Overall Study|Lost to Follow-up|2|||
30985908|NCT02433288|59131277|FG000|Overall Study|Severe non-compliance to protocol|13|||
30985909|NCT02433288|59131278|FG001|Overall Study|Severe non-compliance to protocol|7|||
30985910|NCT02433288|59131277|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
30985911|NCT02433288|59131278|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
30985912|NCT02433288|59131277|FG000|Overall Study|Withdrawal by Subject|101|||
30985913|NCT02433288|59131278|FG001|Overall Study|Withdrawal by Subject|99|||
30790208|NCT00039377|58803412|FG002|Initial Registration|Withdrawal by Subject|0|||
30985914|NCT02433288|59131277|FG000|Overall Study|Lost to Follow-up|2|||
30985915|NCT02433288|59131278|FG001|Overall Study|Lost to Follow-up|14|||
30985916|NCT02433288|59131277|FG000|Overall Study|Death|0|||
30985917|NCT02433288|59131278|FG001|Overall Study|Death|3|||
30985918|NCT02433210|59131298|FG000|Overall Study|Physician Decision|1|||
30985919|NCT02433210|59131299|FG001|Overall Study|Physician Decision|0|||
30985920|NCT02433210|59131300|FG002|Overall Study|Physician Decision|0|||
30985921|NCT02432040|59131435|FG000|Overall Study|Lack of Efficacy|3|||
30985922|NCT02432040|59131436|FG001|Overall Study|Lack of Efficacy|0|||
30985923|NCT02432040|59131435|FG000|Overall Study|Lost to Follow-up|4|||
30985924|NCT02432040|59131436|FG001|Overall Study|Lost to Follow-up|5|||
30985925|NCT02432040|59131435|FG000|Overall Study|Physician Decision|1|||
30985926|NCT02432040|59131436|FG001|Overall Study|Physician Decision|1|||
30985927|NCT04418076|59131482|FG000|Overall Study|Death|1|||
30985928|NCT04418076|59131483|FG001|Overall Study|Death|0|||
30985929|NCT04418076|59131484|FG002|Overall Study|Death|0|||
30985930|NCT04418076|59131485|FG003|Overall Study|Death|0|||
30985931|NCT04418076|59131482|FG000|Overall Study|Lost to Follow-up|2|||
30985932|NCT04418076|59131483|FG001|Overall Study|Lost to Follow-up|5|||
30985933|NCT04418076|59131484|FG002|Overall Study|Lost to Follow-up|1|||
30985934|NCT04418076|59131485|FG003|Overall Study|Lost to Follow-up|2|||
30985935|NCT04418076|59131482|FG000|Overall Study|Withdrawal by Subject|1|||
30985936|NCT04418076|59131483|FG001|Overall Study|Withdrawal by Subject|0|||
30985937|NCT04418076|59131484|FG002|Overall Study|Withdrawal by Subject|1|||
30985938|NCT04418076|59131485|FG003|Overall Study|Withdrawal by Subject|1|||
30985939|NCT04418076|59131482|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
30985940|NCT04418076|59131483|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
30985941|NCT04418076|59131484|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
30985942|NCT04418076|59131485|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
30985943|NCT04165824|59131495|FG000|Overall Study|Adverse Event|23|||
30985944|NCT04165824|59131495|FG000|Overall Study|Physician Decision|1|||
30985945|NCT04165824|59131495|FG000|Overall Study|Withdrawal by Subject|17|||
30985946|NCT04165824|59131495|FG000|Overall Study|Other|5|||
30985947|NCT03809039|59131508|FG000|Part 1|Withdrawal by Subject|1|||
30985948|NCT03809039|59131509|FG001|Part 1|Withdrawal by Subject|0|||
30985949|NCT03809039|59131510|FG002|Part 1|Withdrawal by Subject|0|||
30985950|NCT03809039|59131511|FG003|Part 1|Withdrawal by Subject|1|||
30985951|NCT03809039|59131512|FG004|Part 1|Withdrawal by Subject|0|||
30985952|NCT03809039|59131513|FG005|Part 1|Withdrawal by Subject|0|||
30985953|NCT03809039|59131514|FG006|Part 1|Withdrawal by Subject|0|||
30985954|NCT03809039|59131515|FG007|Part 1|Withdrawal by Subject|0|||
30985955|NCT03809039|59131516|FG008|Part 1|Withdrawal by Subject|0|||
30985956|NCT03809039|59131508|FG000|Part 3|Withdrawn by study termination|0|||
30985957|NCT03809039|59131509|FG001|Part 3|Withdrawn by study termination|0|||
30985958|NCT03809039|59131510|FG002|Part 3|Withdrawn by study termination|0|||
30985959|NCT03809039|59131511|FG003|Part 3|Withdrawn by study termination|0|||
30985960|NCT03809039|59131512|FG004|Part 3|Withdrawn by study termination|0|||
30985961|NCT03809039|59131513|FG005|Part 3|Withdrawn by study termination|0|||
30985962|NCT03809039|59131514|FG006|Part 3|Withdrawn by study termination|0|||
30985963|NCT03809039|59131515|FG007|Part 3|Withdrawn by study termination|2|||
30790209|NCT00039377|58803413|FG003|Initial Registration|Withdrawal by Subject|0|||
30790210|NCT00154102|58803423|FG000|Overall Study|investigational study phase ongoing|7|||
30985964|NCT03809039|59131516|FG008|Part 3|Withdrawn by study termination|6|||
30985965|NCT03541200|59131584|FG000|Overall Study|Adverse Event|19|||
30985966|NCT03541200|59131584|FG000|Overall Study|Death|1|||
30985967|NCT03541200|59131584|FG000|Overall Study|Lost to Follow-up|10|||
30985968|NCT03541200|59131584|FG000|Overall Study|Physician Decision|1|||
30985969|NCT03541200|59131584|FG000|Overall Study|Protocol Violation|51|||
30985970|NCT03541200|59131584|FG000|Overall Study|Withdrawal by Subject|23|||
30985971|NCT03541200|59131584|FG000|Overall Study|other|8|||
30985972|NCT03520036|59131591|FG000|Overall Study|Adverse Event|1|||
30985973|NCT03520036|59131592|FG001|Overall Study|Adverse Event|2|||
30985974|NCT03520036|59131593|FG002|Overall Study|Adverse Event|0|||
30891615|NCT02395081|58924845|FG000|Overall Study|Fetal Loss|2|||
30985975|NCT03520036|59131591|FG000|Overall Study|Protocol Violation|1|||
30985976|NCT03520036|59131592|FG001|Overall Study|Protocol Violation|0|||
30985977|NCT03520036|59131593|FG002|Overall Study|Protocol Violation|0|||
30985978|NCT03520036|59131591|FG000|Overall Study|Withdrawal by Subject|0|||
30985979|NCT03520036|59131592|FG001|Overall Study|Withdrawal by Subject|1|||
30985980|NCT03520036|59131593|FG002|Overall Study|Withdrawal by Subject|4|||
30985981|NCT03520036|59131591|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
30985982|NCT03520036|59131592|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
30985983|NCT03520036|59131593|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
30985984|NCT03505710|59131604|FG000|Overall Study|Progressive Disease|22|||
30985985|NCT03505710|59131605|FG001|Overall Study|Progressive Disease|9|||
30985986|NCT03505710|59131606|FG002|Overall Study|Progressive Disease|34|||
30985987|NCT03505710|59131604|FG000|Overall Study|Clinical Progression|6|||
30985988|NCT03505710|59131605|FG001|Overall Study|Clinical Progression|6|||
30985989|NCT03505710|59131606|FG002|Overall Study|Clinical Progression|3|||
30985990|NCT03505710|59131604|FG000|Overall Study|Adverse Event|12|||
30985991|NCT03505710|59131605|FG001|Overall Study|Adverse Event|5|||
30985992|NCT03505710|59131606|FG002|Overall Study|Adverse Event|27|||
30985993|NCT03505710|59131604|FG000|Overall Study|Withdrawal by Subject|1|||
30985994|NCT03505710|59131605|FG001|Overall Study|Withdrawal by Subject|3|||
30985995|NCT03505710|59131606|FG002|Overall Study|Withdrawal by Subject|3|||
30985996|NCT03505710|59131604|FG000|Overall Study|Physician Decision|1|||
30985997|NCT03505710|59131605|FG001|Overall Study|Physician Decision|0|||
30985998|NCT03505710|59131606|FG002|Overall Study|Physician Decision|2|||
30985999|NCT03505710|59131604|FG000|Overall Study|Death|4|||
30986000|NCT03505710|59131605|FG001|Overall Study|Death|3|||
30986001|NCT03505710|59131606|FG002|Overall Study|Death|6|||
30986002|NCT03505710|59131604|FG000|Overall Study|Other Reasons|1|||
30986003|NCT03505710|59131605|FG001|Overall Study|Other Reasons|1|||
30986004|NCT03505710|59131606|FG002|Overall Study|Other Reasons|1|||
30986005|NCT03459729|59131614|FG000|Overall Study|Physician Decision|2|||
30986006|NCT03291067|59131622|FG000|Overall Study|Adverse Event|0|||
30986007|NCT03291067|59131623|FG001|Overall Study|Adverse Event|2|||
30986008|NCT03291067|59131624|FG002|Overall Study|Adverse Event|17|||
30986009|NCT03291067|59131625|FG003|Overall Study|Adverse Event|3|||
30986010|NCT03291067|59131622|FG000|Overall Study|Lost to Follow-up|2|||
30986011|NCT03291067|59131623|FG001|Overall Study|Lost to Follow-up|1|||
30986012|NCT03291067|59131624|FG002|Overall Study|Lost to Follow-up|0|||
30986013|NCT03291067|59131625|FG003|Overall Study|Lost to Follow-up|1|||
30986014|NCT03291067|59131622|FG000|Overall Study|Physician Decision|0|||
30986015|NCT03291067|59131623|FG001|Overall Study|Physician Decision|0|||
30986016|NCT03291067|59131624|FG002|Overall Study|Physician Decision|1|||
30986017|NCT03291067|59131625|FG003|Overall Study|Physician Decision|0|||
30986018|NCT03291067|59131622|FG000|Overall Study|Protocol Violation|5|||
30986019|NCT03291067|59131623|FG001|Overall Study|Protocol Violation|3|||
30986020|NCT03291067|59131624|FG002|Overall Study|Protocol Violation|4|||
30986021|NCT03291067|59131625|FG003|Overall Study|Protocol Violation|2|||
30986022|NCT03291067|59131622|FG000|Overall Study|Withdrawal by Subject|3|||
30986023|NCT03291067|59131623|FG001|Overall Study|Withdrawal by Subject|4|||
30986024|NCT03291067|59131624|FG002|Overall Study|Withdrawal by Subject|7|||
30986025|NCT03291067|59131625|FG003|Overall Study|Withdrawal by Subject|5|||
30986026|NCT03291067|59131622|FG000|Overall Study|Other|0|||
30986027|NCT03291067|59131623|FG001|Overall Study|Other|4|||
30986028|NCT03291067|59131624|FG002|Overall Study|Other|4|||
30986029|NCT03291067|59131625|FG003|Overall Study|Other|6|||
30986030|NCT03035409|59131635|FG000|Overall Study|Adverse Event|5|||
30986031|NCT03035409|59131635|FG000|Overall Study|Death|2|||
30986032|NCT03035409|59131635|FG000|Overall Study|Withdrawal by Subject|2|||
30986033|NCT03035409|59131635|FG000|Overall Study|Non compliance|4|||
30986034|NCT03035409|59131635|FG000|Overall Study|Patient was jittery|1|||
30986035|NCT03035409|59131635|FG000|Overall Study|Did not like Questionnaire|1|||
30986036|NCT03035409|59131635|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
30986037|NCT03035409|59131635|FG000|Overall Study|Did not like taking drugs|1|||
30986038|NCT02847598|59131647|FG000|Overall Study|Adverse Event|0|||
30986039|NCT02847598|59131648|FG001|Overall Study|Adverse Event|0|||
30986040|NCT02847598|59131649|FG002|Overall Study|Adverse Event|0|||
30986041|NCT02847598|59131650|FG003|Overall Study|Adverse Event|0|||
30986042|NCT02847598|59131651|FG004|Overall Study|Adverse Event|0|||
30986043|NCT02847598|59131652|FG005|Overall Study|Adverse Event|0|||
30986044|NCT02847598|59131653|FG006|Overall Study|Adverse Event|0|||
30986045|NCT02847598|59131654|FG007|Overall Study|Adverse Event|1|||
30986046|NCT02847598|59131647|FG000|Overall Study|Consent withdrawn|2|||
30986047|NCT02847598|59131648|FG001|Overall Study|Consent withdrawn|0|||
30986048|NCT02847598|59131649|FG002|Overall Study|Consent withdrawn|0|||
30986049|NCT02847598|59131650|FG003|Overall Study|Consent withdrawn|4|||
30986050|NCT02847598|59131651|FG004|Overall Study|Consent withdrawn|3|||
30986051|NCT02847598|59131652|FG005|Overall Study|Consent withdrawn|2|||
30986052|NCT02847598|59131653|FG006|Overall Study|Consent withdrawn|1|||
30986053|NCT02847598|59131654|FG007|Overall Study|Consent withdrawn|3|||
30986054|NCT02847598|59131647|FG000|Overall Study|Death|3|||
30986055|NCT02847598|59131648|FG001|Overall Study|Death|0|||
30986056|NCT02847598|59131649|FG002|Overall Study|Death|0|||
30986057|NCT02847598|59131650|FG003|Overall Study|Death|0|||
30986058|NCT02847598|59131651|FG004|Overall Study|Death|0|||
30986059|NCT02847598|59131652|FG005|Overall Study|Death|0|||
30986060|NCT02847598|59131653|FG006|Overall Study|Death|0|||
30986061|NCT02847598|59131654|FG007|Overall Study|Death|0|||
30986062|NCT02847598|59131647|FG000|Overall Study|Lost to Follow-up|0|||
30986063|NCT02847598|59131648|FG001|Overall Study|Lost to Follow-up|0|||
30986064|NCT02847598|59131649|FG002|Overall Study|Lost to Follow-up|0|||
30986065|NCT02847598|59131650|FG003|Overall Study|Lost to Follow-up|0|||
30986066|NCT02847598|59131651|FG004|Overall Study|Lost to Follow-up|0|||
30986067|NCT02847598|59131652|FG005|Overall Study|Lost to Follow-up|1|||
30986068|NCT02847598|59131653|FG006|Overall Study|Lost to Follow-up|1|||
30986069|NCT02847598|59131654|FG007|Overall Study|Lost to Follow-up|0|||
30986070|NCT02841280|59131680|FG000|Overall Study|Adverse Event|2|||
30986071|NCT02841280|59131681|FG001|Overall Study|Adverse Event|1|||
30986072|NCT02841280|59131680|FG000|Overall Study|Death|1|||
30986073|NCT02841280|59131681|FG001|Overall Study|Death|0|||
30986074|NCT02841280|59131680|FG000|Overall Study|Lost to Follow-up|2|||
30986075|NCT02841280|59131681|FG001|Overall Study|Lost to Follow-up|2|||
30986076|NCT02841280|59131680|FG000|Overall Study|Withdrawal by Subject|7|||
30986077|NCT02841280|59131681|FG001|Overall Study|Withdrawal by Subject|3|||
30986078|NCT02841280|59131680|FG000|Overall Study|Stop Point: BP above threshold|2|||
30986079|NCT02841280|59131681|FG001|Overall Study|Stop Point: BP above threshold|0|||
30986080|NCT02345330|59131695|FG000|Overall Study|Death|1|||
30986081|NCT02345330|59131695|FG000|Overall Study|Progressive Disease|2|||
30986082|NCT01513343|59131710|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
30986083|NCT01513343|59131711|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
30986084|NCT01513343|59131710|FG000|Post Data Collection|Dropped/withdrew from study|7|||
30986085|NCT01513343|59131711|FG001|Post Data Collection|Dropped/withdrew from study|1|||
30986086|NCT01513343|59131710|FG000|Post Data Collection|Lost to Follow-up|10|||
30986087|NCT01513343|59131711|FG001|Post Data Collection|Lost to Follow-up|23|||
30986088|NCT01513343|59131710|FG000|6-month Follow-up|Lost to Follow-up|28|||
30986089|NCT01513343|59131711|FG001|6-month Follow-up|Lost to Follow-up|17|||
30986090|NCT01513343|59131710|FG000|12-month Follow-up|Lost to Follow-up|10|||
30986091|NCT01513343|59131711|FG001|12-month Follow-up|Lost to Follow-up|3|||
30986092|NCT01440816|59131738|FG000|Overall Study|Disease Progression|0|||
30986093|NCT01440816|59131739|FG001|Overall Study|Disease Progression|9|||
30986094|NCT01440816|59131738|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
30986095|NCT01440816|59131739|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
30986096|NCT01348919|59131750|FG000|Overall Study|Adverse Event|3|||
30986097|NCT01348919|59131751|FG001|Overall Study|Adverse Event|1|||
30986098|NCT01348919|59131752|FG002|Overall Study|Adverse Event|0|||
30986099|NCT01348919|59131750|FG000|Overall Study|Withdrawal by Subject|0|||
30986100|NCT01348919|59131751|FG001|Overall Study|Withdrawal by Subject|1|||
30986101|NCT01348919|59131752|FG002|Overall Study|Withdrawal by Subject|0|||
30986102|NCT01348919|59131750|FG000|Overall Study|Disease progression|0|||
30986103|NCT01348919|59131751|FG001|Overall Study|Disease progression|1|||
30986104|NCT01348919|59131752|FG002|Overall Study|Disease progression|1|||
30986105|NCT00966381|59131764|FG000|Overall Study|Withdrawal by Subject|2|||
30986106|NCT00966381|59131765|FG001|Overall Study|Withdrawal by Subject|2|||
30986107|NCT02431806|59131777|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
30986108|NCT02431806|59131778|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
30986109|NCT02431806|59131779|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
30986110|NCT02431806|59131780|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
30986111|NCT02431806|59131777|FG000|Double-blind Treatment Period|Adverse Event|4|||
30986112|NCT02431806|59131778|FG001|Double-blind Treatment Period|Adverse Event|7|||
30986113|NCT02431806|59131779|FG002|Double-blind Treatment Period|Adverse Event|11|||
30986114|NCT02431806|59131780|FG003|Double-blind Treatment Period|Adverse Event|7|||
30986115|NCT02431806|59131777|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
30986116|NCT02431806|59131778|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
30986117|NCT02431806|59131779|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
30986118|NCT02431806|59131780|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
30986119|NCT02431806|59131777|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
30986120|NCT02431806|59131778|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
30986121|NCT02431806|59131779|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
30986122|NCT02431806|59131780|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
30986123|NCT02431806|59131777|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
30986124|NCT02431806|59131778|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
30986125|NCT02431806|59131779|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
30986126|NCT02431806|59131780|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
30986127|NCT02431806|59131777|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
30986128|NCT02431806|59131778|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
30986129|NCT02431806|59131779|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
30986130|NCT02431806|59131780|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
30986131|NCT02431806|59131777|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
30986132|NCT02431806|59131778|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
30986133|NCT02431806|59131779|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
30986134|NCT02431806|59131780|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
30986135|NCT01650246|59131821|FG000|Overall Study|Adverse Event|23|||
30986136|NCT01650246|59131821|FG000|Overall Study|Protocol Violation|5|||
30986137|NCT01650246|59131821|FG000|Overall Study|Sponsor terminated study|53|||
30986138|NCT01650246|59131821|FG000|Overall Study|Lost to Follow-up|5|||
30986139|NCT01650246|59131821|FG000|Overall Study|Withdrawal by Subject|26|||
30986140|NCT01650246|59131821|FG000|Overall Study|Death|1|||
30986141|NCT01650246|59131821|FG000|Overall Study|Lack of Efficacy|30|||
30986142|NCT01652664|59131840|FG000|Overall Study|Treatment Failure|5|||
30986143|NCT01652664|59131841|FG001|Overall Study|Treatment Failure|1|||
30986144|NCT01652664|59131840|FG000|Overall Study|Inadequate IOP control|1|||
30986145|NCT01652664|59131841|FG001|Overall Study|Inadequate IOP control|0|||
30986146|NCT02379390|59131881|FG000|Overall Study|Adverse Event|1|||
30986147|NCT02379390|59131882|FG001|Overall Study|Adverse Event|1|||
30986148|NCT02379390|59131881|FG000|Overall Study|Investigator's decision|1|||
30986149|NCT02379390|59131882|FG001|Overall Study|Investigator's decision|0|||
30986150|NCT02379390|59131881|FG000|Overall Study|Study Termination|0|||
30986151|NCT02379390|59131882|FG001|Overall Study|Study Termination|1|||
30986152|NCT02379078|59131893|FG000|Overall Study|Lost to Follow-up|33|||
30986153|NCT02379078|59131894|FG001|Overall Study|Lost to Follow-up|30|||
30986154|NCT02379078|59131893|FG000|Overall Study|Withdrawal by Subject|6|||
30986155|NCT02379078|59131894|FG001|Overall Study|Withdrawal by Subject|5|||
30986156|NCT01714739|59131987|FG000|Overall Study|Disease progression|3|||
30986157|NCT01714739|59131988|FG001|Overall Study|Disease progression|5|||
30986158|NCT01714739|59131989|FG002|Overall Study|Disease progression|5|||
30986159|NCT01714739|59131990|FG003|Overall Study|Disease progression|204|||
30986160|NCT01714739|59131991|FG004|Overall Study|Disease progression|1|||
30986161|NCT01714739|59131992|FG005|Overall Study|Disease progression|3|||
30986162|NCT01714739|59131993|FG006|Overall Study|Disease progression|5|||
30986163|NCT01714739|59131987|FG000|Overall Study|Study drug toxicity|1|||
30986164|NCT01714739|59131988|FG001|Overall Study|Study drug toxicity|1|||
30986165|NCT01714739|59131989|FG002|Overall Study|Study drug toxicity|1|||
30986166|NCT01714739|59131990|FG003|Overall Study|Study drug toxicity|15|||
30986167|NCT01714739|59131991|FG004|Overall Study|Study drug toxicity|0|||
30986168|NCT01714739|59131992|FG005|Overall Study|Study drug toxicity|0|||
30986169|NCT01714739|59131993|FG006|Overall Study|Study drug toxicity|5|||
30986170|NCT01714739|59131987|FG000|Overall Study|Death|0|||
30986171|NCT01714739|59131988|FG001|Overall Study|Death|0|||
30986172|NCT01714739|59131989|FG002|Overall Study|Death|0|||
30986173|NCT01714739|59131990|FG003|Overall Study|Death|1|||
30986174|NCT01714739|59131991|FG004|Overall Study|Death|0|||
30986175|NCT01714739|59131992|FG005|Overall Study|Death|0|||
30986176|NCT01714739|59131993|FG006|Overall Study|Death|0|||
30986177|NCT01714739|59131987|FG000|Overall Study|Adverse Event unrelated to drug|0|||
30986178|NCT01714739|59131988|FG001|Overall Study|Adverse Event unrelated to drug|0|||
30986179|NCT01714739|59131989|FG002|Overall Study|Adverse Event unrelated to drug|3|||
30986180|NCT01714739|59131990|FG003|Overall Study|Adverse Event unrelated to drug|21|||
30986181|NCT01714739|59131991|FG004|Overall Study|Adverse Event unrelated to drug|0|||
30986182|NCT01714739|59131992|FG005|Overall Study|Adverse Event unrelated to drug|0|||
30986183|NCT01714739|59131993|FG006|Overall Study|Adverse Event unrelated to drug|0|||
30986184|NCT01714739|59131987|FG000|Overall Study|Participant request to stop therapy|0|||
30986185|NCT01714739|59131988|FG001|Overall Study|Participant request to stop therapy|1|||
30986186|NCT01714739|59131989|FG002|Overall Study|Participant request to stop therapy|0|||
30986187|NCT01714739|59131990|FG003|Overall Study|Participant request to stop therapy|6|||
30986188|NCT01714739|59131991|FG004|Overall Study|Participant request to stop therapy|0|||
30986189|NCT01714739|59131992|FG005|Overall Study|Participant request to stop therapy|0|||
30986190|NCT01714739|59131993|FG006|Overall Study|Participant request to stop therapy|0|||
30986191|NCT01714739|59131987|FG000|Overall Study|Participant withdrew consent|0|||
30986192|NCT01714739|59131988|FG001|Overall Study|Participant withdrew consent|1|||
30986193|NCT01714739|59131989|FG002|Overall Study|Participant withdrew consent|0|||
30986194|NCT01714739|59131990|FG003|Overall Study|Participant withdrew consent|8|||
30986195|NCT01714739|59131991|FG004|Overall Study|Participant withdrew consent|0|||
30986196|NCT01714739|59131992|FG005|Overall Study|Participant withdrew consent|0|||
30986197|NCT01714739|59131993|FG006|Overall Study|Participant withdrew consent|0|||
30790211|NCT00154102|58803424|FG001|Overall Study|investigational study phase ongoing|2|||
30986198|NCT01714739|59131987|FG000|Overall Study|Lost to Follow-up|0|||
30986199|NCT01714739|59131988|FG001|Overall Study|Lost to Follow-up|0|||
30986200|NCT01714739|59131989|FG002|Overall Study|Lost to Follow-up|0|||
30986201|NCT01714739|59131990|FG003|Overall Study|Lost to Follow-up|1|||
30986202|NCT01714739|59131991|FG004|Overall Study|Lost to Follow-up|0|||
30986203|NCT01714739|59131992|FG005|Overall Study|Lost to Follow-up|0|||
30986204|NCT01714739|59131993|FG006|Overall Study|Lost to Follow-up|0|||
30986205|NCT01714739|59131987|FG000|Overall Study|Maximum clinical benefit|0|||
30986206|NCT01714739|59131988|FG001|Overall Study|Maximum clinical benefit|1|||
30986207|NCT01714739|59131989|FG002|Overall Study|Maximum clinical benefit|1|||
30986208|NCT01714739|59131990|FG003|Overall Study|Maximum clinical benefit|3|||
30986209|NCT01714739|59131991|FG004|Overall Study|Maximum clinical benefit|0|||
30986210|NCT01714739|59131992|FG005|Overall Study|Maximum clinical benefit|0|||
30986211|NCT01714739|59131993|FG006|Overall Study|Maximum clinical benefit|0|||
30986212|NCT01714739|59131987|FG000|Overall Study|Poor/non-comliance|0|||
30986213|NCT01714739|59131988|FG001|Overall Study|Poor/non-comliance|1|||
30986214|NCT01714739|59131989|FG002|Overall Study|Poor/non-comliance|0|||
30986215|NCT01714739|59131990|FG003|Overall Study|Poor/non-comliance|1|||
30986216|NCT01714739|59131991|FG004|Overall Study|Poor/non-comliance|0|||
30986217|NCT01714739|59131992|FG005|Overall Study|Poor/non-comliance|0|||
30986218|NCT01714739|59131993|FG006|Overall Study|Poor/non-comliance|0|||
30986219|NCT01714739|59131987|FG000|Overall Study|No longer meets study criteria|0|||
30986220|NCT01714739|59131988|FG001|Overall Study|No longer meets study criteria|0|||
30986221|NCT01714739|59131989|FG002|Overall Study|No longer meets study criteria|0|||
30986222|NCT01714739|59131990|FG003|Overall Study|No longer meets study criteria|1|||
30986223|NCT01714739|59131991|FG004|Overall Study|No longer meets study criteria|0|||
30986224|NCT01714739|59131992|FG005|Overall Study|No longer meets study criteria|0|||
30986225|NCT01714739|59131993|FG006|Overall Study|No longer meets study criteria|0|||
30986226|NCT01714739|59131987|FG000|Overall Study|Other reason|0|||
30986227|NCT01714739|59131988|FG001|Overall Study|Other reason|0|||
30986228|NCT01714739|59131989|FG002|Overall Study|Other reason|0|||
30986229|NCT01714739|59131990|FG003|Overall Study|Other reason|3|||
30986230|NCT01714739|59131991|FG004|Overall Study|Other reason|1|||
30986231|NCT01714739|59131992|FG005|Overall Study|Other reason|0|||
30986232|NCT01714739|59131993|FG006|Overall Study|Other reason|0|||
30986233|NCT03823287|59133993|FG000|Overall Study|Withdrawal by Subject|25|||
30986234|NCT03823287|59133994|FG001|Overall Study|Withdrawal by Subject|17|||
30986235|NCT03823287|59133993|FG000|Overall Study|Death|13|||
30986236|NCT03823287|59133994|FG001|Overall Study|Death|7|||
30986237|NCT03823287|59133993|FG000|Overall Study|Lost to Follow-up|7|||
30986238|NCT03823287|59133994|FG001|Overall Study|Lost to Follow-up|8|||
30986239|NCT03823287|59133993|FG000|Overall Study|Adverse Event|6|||
30986240|NCT03823287|59133994|FG001|Overall Study|Adverse Event|8|||
30986241|NCT03823287|59133993|FG000|Overall Study|Physician Decision|5|||
30986242|NCT03823287|59133994|FG001|Overall Study|Physician Decision|2|||
30986243|NCT03823287|59133993|FG000|Overall Study|Lack of Efficacy|2|||
30986244|NCT03823287|59133994|FG001|Overall Study|Lack of Efficacy|0|||
30986245|NCT03823287|59133993|FG000|Overall Study|Other|2|||
30986246|NCT03823287|59133994|FG001|Overall Study|Other|4|||
30986247|NCT03707925|59134155|FG000|Overall Study|Inevaluable|1|||
30986248|NCT03461757|59134215|FG000|Overall Study|Adverse Event|1|||
30986249|NCT03461757|59134216|FG001|Overall Study|Adverse Event|0|||
30986250|NCT03461757|59134215|FG000|Overall Study|Lost to Follow-up|13|||
30986251|NCT03461757|59134216|FG001|Overall Study|Lost to Follow-up|7|||
30986252|NCT03461757|59134215|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
30986253|NCT03461757|59134216|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
30986254|NCT03461757|59134215|FG000|Overall Study|Non-compliance with study treatment|0|||
30986255|NCT03461757|59134216|FG001|Overall Study|Non-compliance with study treatment|1|||
30986256|NCT03461757|59134215|FG000|Overall Study|Pregnancy|2|||
30986257|NCT03461757|59134216|FG001|Overall Study|Pregnancy|0|||
30986258|NCT03461757|59134215|FG000|Overall Study|Protocol Violation|1|||
30986259|NCT03461757|59134216|FG001|Overall Study|Protocol Violation|1|||
30986260|NCT03461757|59134215|FG000|Overall Study|Withdrawal by Subject|7|||
30986261|NCT03461757|59134216|FG001|Overall Study|Withdrawal by Subject|7|||
30986262|NCT03461757|59134215|FG000|Overall Study|Other Reasons|1|||
30986263|NCT03461757|59134216|FG001|Overall Study|Other Reasons|4|||
30986264|NCT03235479|59134704|FG000|Overall Study|Lost to Follow-up|8|||
30986265|NCT03235479|59134705|FG001|Overall Study|Lost to Follow-up|11|||
30986266|NCT03235479|59134704|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
30986267|NCT03235479|59134705|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
30986268|NCT03235479|59134704|FG000|Overall Study|Pregnancy|1|||
30986269|NCT03235479|59134705|FG001|Overall Study|Pregnancy|0|||
30986270|NCT03235479|59134704|FG000|Overall Study|Protocol Deviation|1|||
30986271|NCT03235479|59134705|FG001|Overall Study|Protocol Deviation|3|||
30986272|NCT03235479|59134704|FG000|Overall Study|Technical Problems|3|||
30986273|NCT03235479|59134705|FG001|Overall Study|Technical Problems|2|||
30986274|NCT03235479|59134704|FG000|Overall Study|Withdrawal by Subject|2|||
30986275|NCT03235479|59134705|FG001|Overall Study|Withdrawal by Subject|2|||
30986276|NCT03235479|59134704|FG000|Overall Study|Other Reasons|3|||
30986277|NCT03235479|59134705|FG001|Overall Study|Other Reasons|5|||
30986278|NCT03193437|59134761|FG000|Overall Study|Adverse Event|4|||
30986279|NCT03193437|59134761|FG000|Overall Study|Withdrawal by Subject|2|||
30986280|NCT03193437|59134761|FG000|Overall Study|Disease Progression|2|||
30986281|NCT02906787|59134814|FG000|Overall Study|Withdrawal by Subject|12|||
30986282|NCT02906787|59134815|FG001|Overall Study|Withdrawal by Subject|10|||
30986283|NCT02906787|59134814|FG000|Overall Study|Missed|24|||
30986284|NCT02906787|59134815|FG001|Overall Study|Missed|22|||
30986285|NCT02107443|59135401|FG000|Overall Study|Death|42|||
30986286|NCT02107443|59135402|FG001|Overall Study|Death|30|||
30986287|NCT02107443|59135401|FG000|Overall Study|Study Protocol Violation|3|||
30986288|NCT02107443|59135402|FG001|Overall Study|Study Protocol Violation|1|||
30986289|NCT02107443|59135401|FG000|Overall Study|Registered but Not Eligible|0|||
30986290|NCT02107443|59135402|FG001|Overall Study|Registered but Not Eligible|1|||
30986291|NCT02107443|59135401|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
30986292|NCT02107443|59135402|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
30986293|NCT02107443|59135401|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
30986294|NCT02107443|59135402|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
30986295|NCT02107443|59135401|FG000|Overall Study|Withdrawal: Changed Mind|2|||
30986296|NCT02107443|59135402|FG001|Overall Study|Withdrawal: Changed Mind|0|||
30986297|NCT02107443|59135401|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
30986298|NCT02107443|59135402|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
30986299|NCT02107443|59135401|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
30986300|NCT02107443|59135402|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
30986301|NCT02107443|59135401|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
30986302|NCT02107443|59135402|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
30986303|NCT02107443|59135401|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
30986304|NCT02107443|59135402|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
30986305|NCT02107443|59135401|FG000|Overall Study|Withdrawal: Other Medical|9|||
30986306|NCT02107443|59135402|FG001|Overall Study|Withdrawal: Other Medical|5|||
30986307|NCT02107443|59135401|FG000|Overall Study|Withdrawal: Disease Progression|4|||
30986308|NCT02107443|59135402|FG001|Overall Study|Withdrawal: Disease Progression|2|||
30986309|NCT02107443|59135401|FG000|Overall Study|Withdrawal: Personal Issues|0|||
30986310|NCT02107443|59135402|FG001|Overall Study|Withdrawal: Personal Issues|3|||
30986311|NCT00559949|59136319|FG000|Overall Study|Progressive Disease during cycle 1|1|||
30986312|NCT00559949|59136319|FG000|Overall Study|Adverse Event|1|||
30986313|NCT00559949|59136319|FG000|Overall Study|Withdrawal by Subject|4|||
30986314|NCT00559949|59136319|FG000|Overall Study|No disease evaluation per protocol|1|||
30986315|NCT00559637|59136371|FG000|Overall Study|Adverse Event|22|||
30986316|NCT00559637|59136371|FG000|Overall Study|Withdrawal by Subject|4|||
30986317|NCT00559637|59136371|FG000|Overall Study|Protocol Violation|6|||
30986318|NCT00559637|59136371|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
30986319|NCT00559637|59136371|FG000|Overall Study|Failure to return|6|||
30986320|NCT00559637|59136371|FG000|Overall Study|Insufficient response|3|||
30986321|NCT00559637|59136371|FG000|Overall Study|Started requiring dialysis after month 7|2|||
30986322|NCT00559637|59136371|FG000|Overall Study|Suspected lung cancer|1|||
30986323|NCT00559637|59136371|FG000|Overall Study|Participation in another study|1|||
30986324|NCT00559637|59136371|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
30986325|NCT00559637|59136371|FG000|Overall Study|Change of center|1|||
30986326|NCT00559637|59136371|FG000|Overall Study|Change of home|1|||
30986327|NCT00559637|59136371|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
30986328|NCT02578641|59136444|FG000|Overall Study|Adverse Event|5|||
30986329|NCT02578641|59136445|FG001|Overall Study|Adverse Event|15|||
30986330|NCT02578641|59136444|FG000|Overall Study|Death|16|||
30986331|NCT02578641|59136445|FG001|Overall Study|Death|8|||
30986332|NCT02578641|59136444|FG000|Overall Study|Lost to Follow-up|0|||
30986333|NCT02578641|59136445|FG001|Overall Study|Lost to Follow-up|1|||
30986334|NCT02578641|59136444|FG000|Overall Study|Withdrawal by Subject|14|||
30986335|NCT02578641|59136445|FG001|Overall Study|Withdrawal by Subject|7|||
30986336|NCT02578641|59136444|FG000|Overall Study|Progressive Disease|69|||
30986337|NCT02578641|59136445|FG001|Overall Study|Progressive Disease|21|||
30986338|NCT02578641|59136444|FG000|Overall Study|No Study Drug|2|||
30986339|NCT02578641|59136445|FG001|Overall Study|No Study Drug|0|||
30986340|NCT02578641|59136444|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
30986341|NCT02578641|59136445|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
30986342|NCT02578641|59136444|FG000|Overall Study|Non-compliance with Study Schedule|1|||
30986343|NCT02578641|59136445|FG001|Overall Study|Non-compliance with Study Schedule|0|||
30986344|NCT02578641|59136444|FG000|Overall Study|Other|1|||
30986345|NCT02578641|59136445|FG001|Overall Study|Other|10|||
30986346|NCT02578641|59136444|FG000|Overall Study|Not treated|1|||
30986347|NCT02578641|59136445|FG001|Overall Study|Not treated|4|||
30986348|NCT02431260|59136473|FG000|Overall Study|Subject Decision|0|||
30986349|NCT02431260|59136474|FG001|Overall Study|Subject Decision|1|||
30986350|NCT02431260|59136475|FG002|Overall Study|Subject Decision|1|||
30986351|NCT02431260|59136476|FG003|Overall Study|Subject Decision|0|||
30986352|NCT02431260|59136477|FG004|Overall Study|Subject Decision|0|||
30986353|NCT02431260|59136478|FG005|Overall Study|Subject Decision|0|||
30986354|NCT02431260|59136479|FG006|Overall Study|Subject Decision|0|||
30986355|NCT02431260|59136480|FG007|Overall Study|Subject Decision|0|||
30891616|NCT02395081|58924846|FG001|Overall Study|Fetal Loss|3|||
30986356|NCT02431260|59136481|FG008|Overall Study|Subject Decision|1|||
30986357|NCT02431260|59136482|FG009|Overall Study|Subject Decision|1|||
30986358|NCT02431260|59136483|FG010|Overall Study|Subject Decision|0|||
30986359|NCT02431260|59136484|FG011|Overall Study|Subject Decision|1|||
30986360|NCT02431260|59136485|FG012|Overall Study|Subject Decision|0|||
30986361|NCT02431260|59136486|FG013|Overall Study|Subject Decision|0|||
30986362|NCT02431260|59136473|FG000|Overall Study|Death|4|||
30986363|NCT02431260|59136474|FG001|Overall Study|Death|4|||
30986364|NCT02431260|59136475|FG002|Overall Study|Death|3|||
30986365|NCT02431260|59136476|FG003|Overall Study|Death|4|||
30986366|NCT02431260|59136477|FG004|Overall Study|Death|2|||
30986367|NCT02431260|59136478|FG005|Overall Study|Death|2|||
30986368|NCT02431260|59136479|FG006|Overall Study|Death|3|||
30986369|NCT02431260|59136480|FG007|Overall Study|Death|1|||
30986370|NCT02431260|59136481|FG008|Overall Study|Death|6|||
30986371|NCT02431260|59136482|FG009|Overall Study|Death|6|||
30986372|NCT02431260|59136483|FG010|Overall Study|Death|3|||
30986373|NCT02431260|59136484|FG011|Overall Study|Death|2|||
30986374|NCT02431260|59136485|FG012|Overall Study|Death|5|||
30986375|NCT02431260|59136486|FG013|Overall Study|Death|1|||
30986376|NCT02431260|59136473|FG000|Overall Study|Lost to Follow-up|0|||
30986377|NCT02431260|59136474|FG001|Overall Study|Lost to Follow-up|0|||
30986378|NCT02431260|59136475|FG002|Overall Study|Lost to Follow-up|0|||
30986379|NCT02431260|59136476|FG003|Overall Study|Lost to Follow-up|0|||
30986380|NCT02431260|59136477|FG004|Overall Study|Lost to Follow-up|0|||
30986381|NCT02431260|59136478|FG005|Overall Study|Lost to Follow-up|1|||
30986382|NCT02431260|59136479|FG006|Overall Study|Lost to Follow-up|0|||
30986383|NCT02431260|59136480|FG007|Overall Study|Lost to Follow-up|0|||
30986384|NCT02431260|59136481|FG008|Overall Study|Lost to Follow-up|0|||
30986385|NCT02431260|59136482|FG009|Overall Study|Lost to Follow-up|0|||
30986386|NCT02431260|59136483|FG010|Overall Study|Lost to Follow-up|0|||
30986387|NCT02431260|59136484|FG011|Overall Study|Lost to Follow-up|0|||
30986388|NCT02431260|59136485|FG012|Overall Study|Lost to Follow-up|0|||
30986389|NCT02431260|59136486|FG013|Overall Study|Lost to Follow-up|0|||
30891617|NCT02395081|58924847|FG002|Overall Study|Fetal Loss|1|||
30891618|NCT02394925|58924858|FG000|Overall Study|Adverse Event|1|||
30891619|NCT02394925|58924858|FG000|Overall Study|Lens Discomfort|3|||
30891620|NCT02394925|58924858|FG000|Overall Study|Lens handling difficulities|5|||
30891621|NCT02394925|58924858|FG000|Overall Study|Lost to Follow-up|9|||
30891622|NCT02394925|58924858|FG000|Overall Study|Protocol Violation|5|||
30891623|NCT02394925|58924858|FG000|Overall Study|No longer meet eligibility criteria|1|||
30891624|NCT02394925|58924858|FG000|Overall Study|Unsatisfactory Visual Response|5|||
30891625|NCT02427607|58924862|FG000|Overall Study|Withdrawal by Subject|1|||
30891626|NCT02425111|58924866|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
30891627|NCT02425111|58924866|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
30891628|NCT02425111|58924866|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
30891629|NCT02425111|58924866|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
30891630|NCT02425111|58924866|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
30891631|NCT02425111|58924866|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
30891632|NCT02424565|58924871|FG000|Period 1 (D0)|Protocol Violation|0|||
30891633|NCT02424565|58924872|FG001|Period 1 (D0)|Protocol Violation|1|||
30891634|NCT02424253|58924880|FG000|Overall Study|Other, unspecified|1|||
30891635|NCT02424253|58924881|FG001|Overall Study|Other, unspecified|0|||
30891636|NCT02424253|58924880|FG000|Overall Study|Compliance problems|1|||
30891637|NCT02424253|58924881|FG001|Overall Study|Compliance problems|0|||
30891638|NCT02424253|58924880|FG000|Overall Study|Physician Decision|2|||
30891639|NCT02424253|58924881|FG001|Overall Study|Physician Decision|0|||
30891640|NCT02424253|58924880|FG000|Overall Study|Lack of Efficacy|0|||
30891641|NCT02424253|58924881|FG001|Overall Study|Lack of Efficacy|7|||
30891642|NCT02424253|58924880|FG000|Overall Study|Adverse Event|2|||
30891643|NCT02424253|58924881|FG001|Overall Study|Adverse Event|0|||
30891644|NCT02424253|58924880|FG000|Overall Study|Consent withdrawn by subject|4|||
30986390|NCT02431260|59136473|FG000|Overall Study|Study Terminated by the Sponsor|0|||
30986391|NCT02431260|59136474|FG001|Overall Study|Study Terminated by the Sponsor|0|||
30891645|NCT02424253|58924881|FG001|Overall Study|Consent withdrawn by subject|1|||
30891646|NCT02424253|58924880|FG000|Overall Study|Lost to Follow-up|1|||
30891647|NCT02424253|58924881|FG001|Overall Study|Lost to Follow-up|1|||
30891648|NCT02393755|58924889|FG000|Overall Study|Withdrawal by Subject|0|||
30891649|NCT02393755|58924890|FG001|Overall Study|Withdrawal by Subject|3|||
30891650|NCT02393755|58924889|FG000|Overall Study|Adverse Event|0|||
30986392|NCT02431260|59136475|FG002|Overall Study|Study Terminated by the Sponsor|2|||
30986393|NCT02431260|59136476|FG003|Overall Study|Study Terminated by the Sponsor|1|||
30986394|NCT02431260|59136477|FG004|Overall Study|Study Terminated by the Sponsor|1|||
30986395|NCT02431260|59136478|FG005|Overall Study|Study Terminated by the Sponsor|0|||
30986396|NCT02431260|59136479|FG006|Overall Study|Study Terminated by the Sponsor|1|||
30986397|NCT02431260|59136480|FG007|Overall Study|Study Terminated by the Sponsor|2|||
30891651|NCT02393755|58924890|FG001|Overall Study|Adverse Event|2|||
30891652|NCT02393755|58924889|FG000|Overall Study|Physician Decision|0|||
30891653|NCT02393755|58924890|FG001|Overall Study|Physician Decision|2|||
30891654|NCT02393209|58924897|FG000|Overall Study|Study Terminated by Sponsor|1|||
30891655|NCT02393209|58924898|FG001|Overall Study|Study Terminated by Sponsor|1|||
30891656|NCT02393209|58924899|FG002|Overall Study|Study Terminated by Sponsor|0|||
30891657|NCT02393209|58924900|FG003|Overall Study|Study Terminated by Sponsor|0|||
30891658|NCT02393209|58924897|FG000|Overall Study|Withdrawal by Patient|1|||
30891659|NCT02393209|58924898|FG001|Overall Study|Withdrawal by Patient|0|||
30891660|NCT02393209|58924899|FG002|Overall Study|Withdrawal by Patient|0|||
30891661|NCT02393209|58924900|FG003|Overall Study|Withdrawal by Patient|0|||
30891662|NCT02393209|58924897|FG000|Overall Study|Death|2|||
30891663|NCT02393209|58924898|FG001|Overall Study|Death|2|||
30891664|NCT02393209|58924899|FG002|Overall Study|Death|0|||
30891665|NCT02393209|58924900|FG003|Overall Study|Death|0|||
30891666|NCT02393209|58924897|FG000|Overall Study|Death due to Disease Progression|2|||
30891667|NCT02393209|58924898|FG001|Overall Study|Death due to Disease Progression|2|||
30891668|NCT02393209|58924899|FG002|Overall Study|Death due to Disease Progression|0|||
30891669|NCT02393209|58924900|FG003|Overall Study|Death due to Disease Progression|0|||
30891670|NCT02393209|58924897|FG000|Overall Study|Death from Legionella Infection|0|||
30891671|NCT02393209|58924898|FG001|Overall Study|Death from Legionella Infection|1|||
30891672|NCT02393209|58924899|FG002|Overall Study|Death from Legionella Infection|0|||
30891673|NCT02393209|58924900|FG003|Overall Study|Death from Legionella Infection|0|||
30891674|NCT02393209|58924897|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
30891675|NCT02393209|58924898|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
30891676|NCT02393209|58924899|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
30891677|NCT02393209|58924900|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
30891678|NCT02393209|58924897|FG000|Overall Study|Lost to Follow-up|0|||
30891679|NCT02393209|58924898|FG001|Overall Study|Lost to Follow-up|1|||
30891680|NCT02393209|58924899|FG002|Overall Study|Lost to Follow-up|0|||
30891681|NCT02393209|58924900|FG003|Overall Study|Lost to Follow-up|0|||
30891682|NCT02424097|58924911|FG000|Overall Study|Lost to Follow-up|1|||
30891683|NCT02424097|58924912|FG001|Overall Study|Lost to Follow-up|2|||
30891684|NCT02392507|58924918|FG000|Induction Regimen|Death|3|||
30891685|NCT02392507|58924918|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
30891686|NCT02392507|58924918|FG000|Induction Regimen|Physician Decision|1|||
30891687|NCT02392507|58924918|FG000|Induction Regimen|Withdrawal by Subject|2|||
30891688|NCT02392507|58924918|FG000|Maintenance Regimen|Death|1|||
30891689|NCT02392507|58924918|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
30891690|NCT02386345|58924927|FG000|Overall Study|Not treated|14|||
30891691|NCT02386345|58924927|FG000|Overall Study|Lost to Follow-up|1|||
30891692|NCT02386345|58924927|FG000|Overall Study|Adverse Event|5|||
30891693|NCT02386345|58924927|FG000|Overall Study|Repeat Procedure|10|||
30891694|NCT02386345|58924927|FG000|Overall Study|Did not complete 12-month follow-up|72|||
30891695|NCT01651117|58924935|FG000|Overall Study|Death|2|||
30891696|NCT01651117|58924936|FG001|Overall Study|Death|3|||
30891697|NCT01651117|58924937|FG002|Overall Study|Death|2|||
30891698|NCT01651117|58924938|FG003|Overall Study|Death|2|||
30891699|NCT02386189|58924953|FG000|Overall Study|Lost to Follow-up|2|||
30891700|NCT02386189|58924954|FG001|Overall Study|Lost to Follow-up|3|||
30986398|NCT02431260|59136481|FG008|Overall Study|Study Terminated by the Sponsor|1|||
30986399|NCT02431260|59136482|FG009|Overall Study|Study Terminated by the Sponsor|1|||
30986400|NCT02431260|59136483|FG010|Overall Study|Study Terminated by the Sponsor|1|||
30986401|NCT02431260|59136484|FG011|Overall Study|Study Terminated by the Sponsor|0|||
30986402|NCT02431260|59136485|FG012|Overall Study|Study Terminated by the Sponsor|4|||
30986403|NCT02431260|59136486|FG013|Overall Study|Study Terminated by the Sponsor|0|||
30986404|NCT02431260|59136473|FG000|Overall Study|Physician Decision|0|||
30986405|NCT02431260|59136474|FG001|Overall Study|Physician Decision|0|||
30986406|NCT02431260|59136475|FG002|Overall Study|Physician Decision|0|||
30986407|NCT02431260|59136476|FG003|Overall Study|Physician Decision|0|||
30986408|NCT02431260|59136477|FG004|Overall Study|Physician Decision|0|||
30986409|NCT02431260|59136478|FG005|Overall Study|Physician Decision|1|||
30891701|NCT02386189|58924953|FG000|Overall Study|Withdrawal by Subject|1|||
30891702|NCT02386189|58924954|FG001|Overall Study|Withdrawal by Subject|0|||
30891703|NCT02386189|58924953|FG000|Overall Study|Death|1|||
30891704|NCT02386189|58924954|FG001|Overall Study|Death|0|||
30891705|NCT02385799|58924962|FG000|Overall Study|Lost to Follow-up|1|||
30891706|NCT02385799|58924963|FG001|Overall Study|Lost to Follow-up|2|||
30891707|NCT02385799|58924962|FG000|Overall Study|Adverse Event|4|||
30891708|NCT02385799|58924963|FG001|Overall Study|Adverse Event|2|||
30891709|NCT02385799|58924962|FG000|Overall Study|Withdrawal by Subject|0|||
30891710|NCT02385799|58924963|FG001|Overall Study|Withdrawal by Subject|4|||
30891711|NCT02422303|58924971|FG000|Overall Study|Lost to Follow-up|1|||
30891712|NCT02422303|58924972|FG001|Overall Study|Lost to Follow-up|1|||
30891713|NCT02392195|58924978|FG000|Overall Study|Lost to Follow-up|4|||
30891714|NCT02392195|58924978|FG000|Overall Study|Withdrawal by Subject|4|||
30891715|NCT02391961|58924984|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
30891716|NCT02391961|58924985|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
30891717|NCT02391961|58924984|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
30891718|NCT02391961|58924985|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
30891719|NCT02391961|58924984|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
30891720|NCT02391961|58924985|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
30891721|NCT02384941|58924994|FG000|Overall Study|Adverse Event|11|||
30891722|NCT02384941|58924995|FG001|Overall Study|Adverse Event|13|||
30891723|NCT02384941|58924996|FG002|Overall Study|Adverse Event|17|||
30891724|NCT02384941|58924994|FG000|Overall Study|Lost to Follow-up|3|||
30891725|NCT02384941|58924995|FG001|Overall Study|Lost to Follow-up|2|||
30891726|NCT02384941|58924996|FG002|Overall Study|Lost to Follow-up|1|||
30891727|NCT02384941|58924994|FG000|Overall Study|Non-Compliance With Study Drug|2|||
30891728|NCT02384941|58924995|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30891729|NCT02384941|58924996|FG002|Overall Study|Non-Compliance With Study Drug|1|||
30891730|NCT02384941|58924994|FG000|Overall Study|Physician Decision|1|||
30986410|NCT02431260|59136479|FG006|Overall Study|Physician Decision|0|||
30986411|NCT02431260|59136480|FG007|Overall Study|Physician Decision|0|||
30986412|NCT02431260|59136481|FG008|Overall Study|Physician Decision|0|||
30986413|NCT02431260|59136482|FG009|Overall Study|Physician Decision|0|||
30986414|NCT02431260|59136483|FG010|Overall Study|Physician Decision|0|||
30986415|NCT02431260|59136484|FG011|Overall Study|Physician Decision|0|||
30986416|NCT02431260|59136485|FG012|Overall Study|Physician Decision|0|||
30986417|NCT02431260|59136486|FG013|Overall Study|Physician Decision|0|||
30986418|NCT02431260|59136473|FG000|Overall Study|Other Unspecified|0|||
30986419|NCT02431260|59136474|FG001|Overall Study|Other Unspecified|0|||
30986420|NCT02431260|59136475|FG002|Overall Study|Other Unspecified|0|||
30986421|NCT02431260|59136476|FG003|Overall Study|Other Unspecified|0|||
30986422|NCT02431260|59136477|FG004|Overall Study|Other Unspecified|0|||
30986423|NCT02431260|59136478|FG005|Overall Study|Other Unspecified|0|||
30986424|NCT02431260|59136479|FG006|Overall Study|Other Unspecified|0|||
30986425|NCT02431260|59136480|FG007|Overall Study|Other Unspecified|0|||
30986426|NCT02431260|59136481|FG008|Overall Study|Other Unspecified|0|||
30986427|NCT02431260|59136482|FG009|Overall Study|Other Unspecified|0|||
30986428|NCT02431260|59136483|FG010|Overall Study|Other Unspecified|0|||
30986429|NCT02431260|59136484|FG011|Overall Study|Other Unspecified|1|||
30986430|NCT02431260|59136485|FG012|Overall Study|Other Unspecified|1|||
30986431|NCT02431260|59136486|FG013|Overall Study|Other Unspecified|0|||
30986432|NCT02430870|59136681|FG000|Part 2|Voluntary Withdrawal|0|||
30986433|NCT02430870|59136682|FG001|Part 2|Voluntary Withdrawal|0|||
30986434|NCT02430870|59136683|FG002|Part 2|Voluntary Withdrawal|0|||
30986435|NCT02430870|59136684|FG003|Part 2|Voluntary Withdrawal|0|||
30986436|NCT02430870|59136685|FG004|Part 2|Voluntary Withdrawal|0|||
30986437|NCT02430870|59136686|FG005|Part 2|Voluntary Withdrawal|0|||
30986438|NCT02430870|59136687|FG006|Part 2|Voluntary Withdrawal|1|||
30986439|NCT02430870|59136688|FG007|Part 2|Voluntary Withdrawal|0|||
30986440|NCT02430870|59136681|FG000|Part 2|Other Reason Not Specified|0|||
30986441|NCT02430870|59136682|FG001|Part 2|Other Reason Not Specified|0|||
30986442|NCT02430870|59136683|FG002|Part 2|Other Reason Not Specified|0|||
30986443|NCT02430870|59136684|FG003|Part 2|Other Reason Not Specified|0|||
30986444|NCT02430870|59136685|FG004|Part 2|Other Reason Not Specified|0|||
30986445|NCT02430870|59136686|FG005|Part 2|Other Reason Not Specified|0|||
30986446|NCT02430870|59136687|FG006|Part 2|Other Reason Not Specified|0|||
30986447|NCT02430870|59136688|FG007|Part 2|Other Reason Not Specified|1|||
30986448|NCT02429934|59136754|FG000|Overall Study|Withdrawal by Subject|0|||
30986449|NCT02429934|59136755|FG001|Overall Study|Withdrawal by Subject|2|||
30986450|NCT02429934|59136754|FG000|Overall Study|Adverse Event|2|||
30986451|NCT02429934|59136755|FG001|Overall Study|Adverse Event|0|||
30986452|NCT02429934|59136754|FG000|Overall Study|Lost to Follow-up|1|||
30986453|NCT02429934|59136755|FG001|Overall Study|Lost to Follow-up|1|||
30986454|NCT02429934|59136754|FG000|Overall Study|Physician Decision|1|||
30986455|NCT02429934|59136755|FG001|Overall Study|Physician Decision|0|||
30986456|NCT02429856|59136769|FG000|Overall Study|Death|12|||
30986457|NCT02429856|59136770|FG001|Overall Study|Death|13|||
30986458|NCT02429856|59136769|FG000|Overall Study|Lost to Follow-up|6|||
30986459|NCT02429856|59136770|FG001|Overall Study|Lost to Follow-up|5|||
30986460|NCT02429856|59136769|FG000|Overall Study|Withdrawal by Subject|1|||
30986461|NCT02429856|59136770|FG001|Overall Study|Withdrawal by Subject|1|||
30986462|NCT02429778|59136780|FG000|Overall Study|Lost to Follow-up|2|||
30986463|NCT02429778|59136781|FG001|Overall Study|Lost to Follow-up|0|||
30986464|NCT02429778|59136780|FG000|Overall Study|Withdrawal by Subject|5|||
30986465|NCT02429778|59136781|FG001|Overall Study|Withdrawal by Subject|0|||
30891731|NCT02384941|58924995|FG001|Overall Study|Physician Decision|1|||
30986466|NCT02403180|59136789|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
30986467|NCT02403180|59136790|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
30986468|NCT02403180|59136789|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
30891732|NCT02384941|58924996|FG002|Overall Study|Physician Decision|0|||
30891733|NCT02384941|58924994|FG000|Overall Study|Protocol Violation|3|||
30891734|NCT02384941|58924995|FG001|Overall Study|Protocol Violation|0|||
30986469|NCT02403180|59136790|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
30986470|NCT00558467|59136824|FG000|Overall Study|Adverse Event|1|||
30986471|NCT00558467|59136825|FG001|Overall Study|Adverse Event|2|||
30986472|NCT00558467|59136824|FG000|Overall Study|Lack of Efficacy|0|||
30986473|NCT00558467|59136825|FG001|Overall Study|Lack of Efficacy|1|||
30986474|NCT00558467|59136824|FG000|Overall Study|Patient moving out of state|0|||
30986475|NCT00558467|59136825|FG001|Overall Study|Patient moving out of state|1|||
30986476|NCT02402166|59136831|FG000|Overall Study|Adverse Event|2|||
30986477|NCT02402166|59136831|FG000|Overall Study|Withdrawal by Subject|2|||
30986478|NCT02402166|59136831|FG000|Overall Study|Lost to Follow-up|1|||
30986479|NCT02378220|59136851|FG000|Overall Study|Death|6|||
30986480|NCT02378220|59136852|FG001|Overall Study|Death|1|||
30986481|NCT04226495|59136861|FG000|Overall Study|Withdrawal by Subject|3|||
30986482|NCT04226495|59136862|FG001|Overall Study|Withdrawal by Subject|3|||
30986483|NCT04226495|59136861|FG000|Overall Study|PI discretion|2|||
30986484|NCT04226495|59136862|FG001|Overall Study|PI discretion|4|||
30986485|NCT02401308|59136870|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
30986486|NCT02401308|59136871|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
30986487|NCT02401230|59136880|FG000|Overall Study|Adverse Event|3|||
30986488|NCT02401230|59136881|FG001|Overall Study|Adverse Event|2|||
30986489|NCT02401230|59136882|FG002|Overall Study|Adverse Event|0|||
30986490|NCT02401230|59136880|FG000|Overall Study|Withdrawal by Subject|2|||
30986491|NCT02401230|59136881|FG001|Overall Study|Withdrawal by Subject|1|||
30986492|NCT02401230|59136882|FG002|Overall Study|Withdrawal by Subject|1|||
30986493|NCT02401230|59136880|FG000|Overall Study|Lost to Follow-up|1|||
30986494|NCT02401230|59136881|FG001|Overall Study|Lost to Follow-up|3|||
30986495|NCT02401230|59136882|FG002|Overall Study|Lost to Follow-up|3|||
30986496|NCT02429310|59136923|FG000|Overall Study|Lost to Follow-up|1|||
30986497|NCT02429310|59136924|FG001|Overall Study|Lost to Follow-up|2|||
30986498|NCT02429310|59136923|FG000|Overall Study|Protocol Violation|1|||
30986499|NCT02429310|59136924|FG001|Overall Study|Protocol Violation|1|||
30986500|NCT02428608|59136950|FG000|Overall Study|Pregnancy|2|||
30986501|NCT02428608|59136950|FG000|Overall Study|Lost to Follow-up|37|||
30986502|NCT02428608|59136950|FG000|Overall Study|Withdrawal by Subject|2|||
30986503|NCT02428608|59136950|FG000|Overall Study|scheduling conflicts|15|||
30986504|NCT02428608|59136950|FG000|Overall Study|moved away|10|||
30986505|NCT02428608|59136950|FG000|Overall Study|Death|1|||
30986506|NCT02428608|59136950|FG000|Overall Study|various|16|||
30986507|NCT02428296|59136970|FG000|Overall Study|Adverse Event|7|||
30986508|NCT02428296|59136970|FG000|Overall Study|Withdrawal by Subject|2|||
30986509|NCT02427984|59136984|FG000|Overall Study|Lost to Follow-up|13|||
30986510|NCT02427984|59136985|FG001|Overall Study|Lost to Follow-up|5|||
30986511|NCT02427984|59136986|FG002|Overall Study|Lost to Follow-up|18|||
30986512|NCT00556673|59137204|FG000|Overall Study|Protocol deviation|3|||
30986513|NCT00556673|59137205|FG001|Overall Study|Protocol deviation|2|||
30986514|NCT02402322|59137229|FG000|Pretreatment|Withdrawal by Subject|3|||
30986515|NCT02402322|59137230|FG001|Pretreatment|Withdrawal by Subject|1|||
30986516|NCT02402322|59137231|FG002|Pretreatment|Withdrawal by Subject|1|||
30986517|NCT02402322|59137229|FG000|Follow-up|Withdrawal by Subject|6|||
30986518|NCT02402322|59137230|FG001|Follow-up|Withdrawal by Subject|3|||
30986519|NCT02402322|59137231|FG002|Follow-up|Withdrawal by Subject|24|||
30986520|NCT00555425|59137347|FG000|Overall Study|Missed Medication > 1 wk|34|||
30986521|NCT00555425|59137348|FG001|Overall Study|Missed Medication > 1 wk|15|||
30986522|NCT00555425|59137347|FG000|Overall Study|Missed 3 physician management visits|1|||
30986523|NCT00555425|59137348|FG001|Overall Study|Missed 3 physician management visits|0|||
30986524|NCT00555425|59137347|FG000|Overall Study|Met criteria for protective transfer|16|||
30986525|NCT00555425|59137348|FG001|Overall Study|Met criteria for protective transfer|3|||
30986526|NCT00555425|59137347|FG000|Overall Study|Became pregnant and transferred care|0|||
30986527|NCT00555425|59137348|FG001|Overall Study|Became pregnant and transferred care|1|||
30986528|NCT00554099|59137529|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
30986529|NCT00554099|59137530|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
30986530|NCT00554099|59137531|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
30986531|NCT00554099|59137529|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
30986532|NCT00554099|59137530|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
30986533|NCT00554099|59137531|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
30986534|NCT00554099|59137529|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
30986535|NCT00554099|59137530|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
30986536|NCT00554099|59137531|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
30986537|NCT00554099|59137529|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
30986538|NCT00554099|59137530|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
30843489|NCT02306161|58869582|FG000|Overall Study|Withdrawal by Subject|4|||
30986539|NCT00554099|59137531|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
30986540|NCT00554099|59137529|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
30986541|NCT00554099|59137530|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
30986542|NCT00554099|59137531|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
30986543|NCT00554099|59137529|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
30986544|NCT00554099|59137530|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
30986545|NCT00554099|59137531|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
30986546|NCT00554099|59137529|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
30986547|NCT00554099|59137530|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
30986548|NCT00554099|59137531|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
30986549|NCT00554099|59137529|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
30986550|NCT00554099|59137530|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
30986551|NCT00554099|59137531|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
30986552|NCT00554099|59137529|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
30986553|NCT00554099|59137530|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
30986554|NCT00554099|59137531|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
30986555|NCT02377362|59137565|FG000|Part A Second Treatment|Protocol Violation|0|||
30986556|NCT02377362|59137566|FG001|Part A Second Treatment|Protocol Violation|0|||
30986557|NCT02377362|59137567|FG002|Part A Second Treatment|Protocol Violation|0|||
30986558|NCT02377362|59137568|FG003|Part A Second Treatment|Protocol Violation|0|||
30986559|NCT02377362|59137569|FG004|Part A Second Treatment|Protocol Violation|1|||
30986560|NCT02377362|59137570|FG005|Part A Second Treatment|Protocol Violation|0|||
30986561|NCT02377362|59137571|FG006|Part A Second Treatment|Protocol Violation|0|||
30986562|NCT02377362|59137572|FG007|Part A Second Treatment|Protocol Violation|0|||
30986563|NCT02377362|59137573|FG008|Part A Second Treatment|Protocol Violation|0|||
30986564|NCT02377362|59137574|FG009|Part A Second Treatment|Protocol Violation|0|||
30986565|NCT02377362|59137575|FG010|Part A Second Treatment|Protocol Violation|0|||
30986566|NCT02377362|59137576|FG011|Part A Second Treatment|Protocol Violation|0|||
30986567|NCT02377362|59137577|FG012|Part A Second Treatment|Protocol Violation|0|||
30986568|NCT02377362|59137565|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
30986569|NCT02377362|59137566|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
30986570|NCT02377362|59137567|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
30986571|NCT02377362|59137568|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
30986572|NCT02377362|59137569|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
30986573|NCT02377362|59137570|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
30986574|NCT02377362|59137571|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
30986575|NCT02377362|59137572|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
30986576|NCT02377362|59137573|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
30986577|NCT02377362|59137574|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
30986578|NCT02377362|59137575|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
30986579|NCT02377362|59137576|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
30986580|NCT02377362|59137577|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
30986581|NCT02377362|59137565|FG000|Part B Overall|Protocol Violation|0|||
30986582|NCT02377362|59137566|FG001|Part B Overall|Protocol Violation|0|||
30986583|NCT02377362|59137567|FG002|Part B Overall|Protocol Violation|0|||
30986584|NCT02377362|59137568|FG003|Part B Overall|Protocol Violation|0|||
30986585|NCT02377362|59137569|FG004|Part B Overall|Protocol Violation|0|||
30986586|NCT02377362|59137570|FG005|Part B Overall|Protocol Violation|0|||
30986587|NCT02377362|59137571|FG006|Part B Overall|Protocol Violation|0|||
30986588|NCT02377362|59137572|FG007|Part B Overall|Protocol Violation|0|||
30986589|NCT02377362|59137573|FG008|Part B Overall|Protocol Violation|0|||
30986590|NCT02377362|59137574|FG009|Part B Overall|Protocol Violation|1|||
30986591|NCT02377362|59137575|FG010|Part B Overall|Protocol Violation|0|||
30986592|NCT02377362|59137576|FG011|Part B Overall|Protocol Violation|0|||
30986593|NCT02377362|59137577|FG012|Part B Overall|Protocol Violation|0|||
30986594|NCT02377362|59137565|FG000|Part B Overall|Adverse Event|0|||
30986595|NCT02377362|59137566|FG001|Part B Overall|Adverse Event|0|||
30986596|NCT02377362|59137567|FG002|Part B Overall|Adverse Event|0|||
30986597|NCT02377362|59137568|FG003|Part B Overall|Adverse Event|0|||
30986598|NCT02377362|59137569|FG004|Part B Overall|Adverse Event|0|||
30986599|NCT02377362|59137570|FG005|Part B Overall|Adverse Event|0|||
30986600|NCT02377362|59137571|FG006|Part B Overall|Adverse Event|1|||
30986601|NCT02377362|59137572|FG007|Part B Overall|Adverse Event|1|||
30986602|NCT02377362|59137573|FG008|Part B Overall|Adverse Event|0|||
30986603|NCT02377362|59137574|FG009|Part B Overall|Adverse Event|0|||
30986604|NCT02377362|59137575|FG010|Part B Overall|Adverse Event|0|||
30986605|NCT02377362|59137576|FG011|Part B Overall|Adverse Event|0|||
30986606|NCT02377362|59137577|FG012|Part B Overall|Adverse Event|0|||
30986607|NCT02377362|59137565|FG000|Part B Overall|Withdrawal by Subject|0|||
30986608|NCT02377362|59137566|FG001|Part B Overall|Withdrawal by Subject|0|||
30986609|NCT02377362|59137567|FG002|Part B Overall|Withdrawal by Subject|0|||
30986610|NCT02377362|59137568|FG003|Part B Overall|Withdrawal by Subject|0|||
30986611|NCT02377362|59137569|FG004|Part B Overall|Withdrawal by Subject|0|||
30986612|NCT02377362|59137570|FG005|Part B Overall|Withdrawal by Subject|0|||
30986613|NCT02377362|59137571|FG006|Part B Overall|Withdrawal by Subject|1|||
30986614|NCT02377362|59137572|FG007|Part B Overall|Withdrawal by Subject|0|||
30986615|NCT02377362|59137573|FG008|Part B Overall|Withdrawal by Subject|0|||
30986616|NCT02377362|59137574|FG009|Part B Overall|Withdrawal by Subject|0|||
30986617|NCT02377362|59137575|FG010|Part B Overall|Withdrawal by Subject|0|||
30986618|NCT02377362|59137576|FG011|Part B Overall|Withdrawal by Subject|1|||
30986619|NCT02377362|59137577|FG012|Part B Overall|Withdrawal by Subject|0|||
30986620|NCT00553631|59137617|FG000|Overall Study|Withdrawal by Subject|0|||
30986621|NCT00553631|59137618|FG001|Overall Study|Withdrawal by Subject|1|||
30986622|NCT00553631|59137617|FG000|Overall Study|Lost to Follow-up|1|||
30986623|NCT00553631|59137618|FG001|Overall Study|Lost to Follow-up|0|||
30986624|NCT00553319|59137627|FG000|Overall Study|Lost to Follow-up|10|||
30986625|NCT00553319|59137628|FG001|Overall Study|Lost to Follow-up|9|||
30986626|NCT00553319|59137629|FG002|Overall Study|Lost to Follow-up|5|||
30986627|NCT00553319|59137627|FG000|Overall Study|wanted treatment elsewhere|2|||
30986628|NCT00553319|59137628|FG001|Overall Study|wanted treatment elsewhere|1|||
30986629|NCT00553319|59137629|FG002|Overall Study|wanted treatment elsewhere|1|||
30986630|NCT00553319|59137627|FG000|Overall Study|non-compliance|0|||
30986631|NCT00553319|59137628|FG001|Overall Study|non-compliance|0|||
30986632|NCT00553319|59137629|FG002|Overall Study|non-compliance|2|||
30986633|NCT00553319|59137627|FG000|Overall Study|incarceration|1|||
30986634|NCT00553319|59137628|FG001|Overall Study|incarceration|0|||
30986635|NCT00553319|59137629|FG002|Overall Study|incarceration|0|||
30986636|NCT00553319|59137627|FG000|Overall Study|moved|1|||
30986637|NCT00553319|59137628|FG001|Overall Study|moved|0|||
30986638|NCT00553319|59137629|FG002|Overall Study|moved|1|||
30986639|NCT01649856|59137815|FG000|Overall Study|Withdrawal by Subject|14|||
30986640|NCT01649856|59137816|FG001|Overall Study|Withdrawal by Subject|14|||
30986641|NCT01649856|59137815|FG000|Overall Study|Protocol Violation|4|||
30986642|NCT01649856|59137816|FG001|Overall Study|Protocol Violation|4|||
30986643|NCT01649856|59137815|FG000|Overall Study|Treatment Failure|1|||
30986644|NCT01649856|59137816|FG001|Overall Study|Treatment Failure|1|||
30986645|NCT01649856|59137815|FG000|Overall Study|Death|69|||
30986646|NCT01649856|59137816|FG001|Overall Study|Death|34|||
30986647|NCT01649856|59137815|FG000|Overall Study|Stable or Progressed Disease|5|||
30986648|NCT01649856|59137816|FG001|Overall Study|Stable or Progressed Disease|3|||
30986649|NCT01649856|59137815|FG000|Overall Study|Lost to Follow-up|20|||
30986650|NCT01649856|59137816|FG001|Overall Study|Lost to Follow-up|16|||
30986651|NCT01649856|59137815|FG000|Overall Study|Lack of Compliance|6|||
30986652|NCT01649856|59137816|FG001|Overall Study|Lack of Compliance|1|||
30986653|NCT01649856|59137815|FG000|Overall Study|Other|20|||
30986654|NCT01649856|59137816|FG001|Overall Study|Other|5|||
30986655|NCT02375724|59137837|FG000|Overall Study|Lack of Efficacy|1|||
30986656|NCT02375724|59137838|FG001|Overall Study|Lack of Efficacy|1|||
30986657|NCT02375724|59137837|FG000|Overall Study|Withdrawal by Subject|1|||
30986658|NCT02375724|59137838|FG001|Overall Study|Withdrawal by Subject|1|||
30986659|NCT02375724|59137837|FG000|Overall Study|Lost to Follow-up|1|||
30986660|NCT02375724|59137838|FG001|Overall Study|Lost to Follow-up|0|||
30986661|NCT02375724|59137837|FG000|Overall Study|Protocol Violation|1|||
30986662|NCT02375724|59137838|FG001|Overall Study|Protocol Violation|0|||
30986663|NCT02375724|59137837|FG000|Overall Study|Adverse Event|2|||
30986664|NCT02375724|59137838|FG001|Overall Study|Adverse Event|4|||
30986665|NCT02398188|59137846|FG000|Overall Study|Adverse Event|2|||
30986666|NCT02398188|59137847|FG001|Overall Study|Adverse Event|3|||
30986667|NCT02398188|59137846|FG000|Overall Study|Lost to Follow-up|5|||
30986668|NCT02398188|59137847|FG001|Overall Study|Lost to Follow-up|0|||
30986669|NCT02398188|59137846|FG000|Overall Study|Non-compliance|4|||
30986670|NCT02398188|59137847|FG001|Overall Study|Non-compliance|4|||
30986671|NCT02398188|59137846|FG000|Overall Study|Protocol Violation|6|||
30986672|NCT02398188|59137847|FG001|Overall Study|Protocol Violation|10|||
30986673|NCT02398188|59137846|FG000|Overall Study|Sponsor Decision|2|||
30986674|NCT02398188|59137847|FG001|Overall Study|Sponsor Decision|1|||
30986675|NCT02398188|59137846|FG000|Overall Study|Pregnancy|1|||
30986676|NCT02398188|59137847|FG001|Overall Study|Pregnancy|0|||
30986677|NCT02398188|59137846|FG000|Overall Study|Withdrawal by Subject|7|||
30986678|NCT02398188|59137847|FG001|Overall Study|Withdrawal by Subject|16|||
30986679|NCT02426580|59137855|FG000|Overall Study|Death|2|||
30891735|NCT02384941|58924996|FG002|Overall Study|Protocol Violation|0|||
30891736|NCT02384941|58924994|FG000|Overall Study|Withdrawal by Subject|26|||
30986680|NCT02426580|59137856|FG001|Overall Study|Death|2|||
30986681|NCT02426580|59137855|FG000|Overall Study|Lost to Follow-up|0|||
30986682|NCT02426580|59137856|FG001|Overall Study|Lost to Follow-up|9|||
30986683|NCT02426580|59137855|FG000|Overall Study|transfer to hemodialysis|5|||
30891737|NCT02384941|58924995|FG001|Overall Study|Withdrawal by Subject|19|||
30891738|NCT02384941|58924996|FG002|Overall Study|Withdrawal by Subject|20|||
30986684|NCT02426580|59137856|FG001|Overall Study|transfer to hemodialysis|5|||
30986685|NCT02426580|59137855|FG000|Overall Study|Kidney transplant|3|||
30986686|NCT02426580|59137856|FG001|Overall Study|Kidney transplant|0|||
30986687|NCT02426580|59137855|FG000|Overall Study|Allergic to egg white|1|||
30986688|NCT02426580|59137856|FG001|Overall Study|Allergic to egg white|0|||
30986689|NCT01651260|59137862|FG000|Overall Study|unable to apply product|3|||
30986690|NCT02425098|59137882|FG000|Overall Study|Lost to Follow-up|7|||
30986691|NCT02425098|59137883|FG001|Overall Study|Lost to Follow-up|7|||
30986692|NCT02425098|59137882|FG000|Overall Study|Withdrawal by Subject|4|||
30986693|NCT02425098|59137883|FG001|Overall Study|Withdrawal by Subject|8|||
30986694|NCT02425098|59137882|FG000|Overall Study|Pregnancy|2|||
30986695|NCT02425098|59137883|FG001|Overall Study|Pregnancy|0|||
30986696|NCT02425098|59137882|FG000|Overall Study|Reason not Specified|0|||
30986697|NCT02425098|59137883|FG001|Overall Study|Reason not Specified|1|||
30986698|NCT02424630|59137891|FG000|Overall Study|No rotator cuff tear|1|||
30986699|NCT02424630|59137892|FG001|Overall Study|No rotator cuff tear|2|||
30986700|NCT02424630|59137891|FG000|Overall Study|Open procedure|0|||
30986701|NCT02424630|59137892|FG001|Overall Study|Open procedure|1|||
30986702|NCT02397408|59137898|FG000|Overall Study|Physician Decision|4|||
30986703|NCT02397408|59137898|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
30986704|NCT02397096|59137904|FG000|Day 1 to Week 24|Adverse Event|7|||
30986705|NCT02397096|59137905|FG001|Day 1 to Week 24|Adverse Event|1|||
30986706|NCT02397096|59137904|FG000|Day 1 to Week 24|Death|1|||
30986707|NCT02397096|59137905|FG001|Day 1 to Week 24|Death|0|||
30986708|NCT02397096|59137904|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
30986709|NCT02397096|59137905|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
30986710|NCT02397096|59137904|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
30986711|NCT02397096|59137905|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
30986712|NCT02397096|59137904|FG000|Day 1 to Week 24|Physician Decision|2|||
30986713|NCT02397096|59137905|FG001|Day 1 to Week 24|Physician Decision|3|||
30986714|NCT02397096|59137904|FG000|Day 1 to Week 24|Protocol Violation|1|||
30986715|NCT02397096|59137905|FG001|Day 1 to Week 24|Protocol Violation|4|||
30986716|NCT02397096|59137904|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
30986717|NCT02397096|59137905|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
30986718|NCT02397096|59137904|FG000|Week 24 to Week 48|Adverse Event|6|||
30986719|NCT02397096|59137905|FG001|Week 24 to Week 48|Adverse Event|2|||
30986720|NCT02397096|59137904|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
30986721|NCT02397096|59137905|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
30986722|NCT02397096|59137904|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
30986723|NCT02397096|59137905|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
30986724|NCT02397096|59137904|FG000|Week 24 to Week 48|Physician Decision|2|||
30986725|NCT02397096|59137905|FG001|Week 24 to Week 48|Physician Decision|1|||
30986726|NCT02397096|59137904|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
30986727|NCT02397096|59137905|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
30986728|NCT02397096|59137904|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
30986729|NCT02397096|59137905|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
30986730|NCT02397096|59137904|FG000|Study Extensions|Ongoing|399|||
30986731|NCT02397096|59137905|FG001|Study Extensions|Ongoing|202|||
30986732|NCT02372058|59137915|FG000|Overall Study|Withdrawal by Subject|3|||
30986733|NCT02396316|59137923|FG000|Overall Study|Physician Decision|1|||
30986734|NCT02396316|59137924|FG001|Overall Study|Physician Decision|0|||
30986735|NCT02396316|59137923|FG000|Overall Study|Progressive disease|6|||
30986736|NCT02396316|59137924|FG001|Overall Study|Progressive disease|3|||
30986737|NCT02396316|59137923|FG000|Overall Study|Protocol Violation|0|||
30986738|NCT02396316|59137924|FG001|Overall Study|Protocol Violation|1|||
30986739|NCT02396316|59137923|FG000|Overall Study|Treatment unblinded|0|||
30986740|NCT02396316|59137924|FG001|Overall Study|Treatment unblinded|1|||
30986741|NCT02395536|59137934|FG000|Overall Study|Lost to Follow-up|4|||
30986742|NCT02395536|59137935|FG001|Overall Study|Lost to Follow-up|4|||
30986743|NCT02395536|59137934|FG000|Overall Study|Death|2|||
30986744|NCT02395536|59137935|FG001|Overall Study|Death|0|||
30986745|NCT02395536|59137934|FG000|Overall Study|Physician Decision|4|||
30986746|NCT02395536|59137935|FG001|Overall Study|Physician Decision|6|||
30986747|NCT02395536|59137934|FG000|Overall Study|Withdrawal by Subject|9|||
30986748|NCT02395536|59137935|FG001|Overall Study|Withdrawal by Subject|17|||
30986749|NCT02395536|59137934|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
30986750|NCT02395536|59137935|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
30986751|NCT02395536|59137934|FG000|Overall Study|Insurance issue|0|||
30986752|NCT02395536|59137935|FG001|Overall Study|Insurance issue|1|||
30986753|NCT00552929|59137951|FG000|Overall Study|Lost to Follow-up|0|||
30986754|NCT00552929|59137952|FG001|Overall Study|Lost to Follow-up|0|||
30986755|NCT00552929|59137953|FG002|Overall Study|Lost to Follow-up|0|||
30986756|NCT00552929|59137954|FG003|Overall Study|Lost to Follow-up|0|||
30986757|NCT00552929|59137955|FG004|Overall Study|Lost to Follow-up|0|||
30986758|NCT00552929|59137956|FG005|Overall Study|Lost to Follow-up|0|||
30986759|NCT00552929|59137957|FG006|Overall Study|Lost to Follow-up|0|||
30986760|NCT00552929|59137958|FG007|Overall Study|Lost to Follow-up|0|||
30986761|NCT00552929|59137959|FG008|Overall Study|Lost to Follow-up|1|||
30986762|NCT00552929|59137960|FG009|Overall Study|Lost to Follow-up|0|||
30986763|NCT00552929|59137951|FG000|Overall Study|Not Eligible|0|||
30986764|NCT00552929|59137952|FG001|Overall Study|Not Eligible|0|||
30986765|NCT00552929|59137953|FG002|Overall Study|Not Eligible|0|||
30986766|NCT00552929|59137954|FG003|Overall Study|Not Eligible|0|||
30986767|NCT00552929|59137955|FG004|Overall Study|Not Eligible|0|||
30986768|NCT00552929|59137956|FG005|Overall Study|Not Eligible|1|||
30986769|NCT00552929|59137957|FG006|Overall Study|Not Eligible|0|||
30986770|NCT00552929|59137958|FG007|Overall Study|Not Eligible|0|||
30986771|NCT00552929|59137959|FG008|Overall Study|Not Eligible|0|||
30986772|NCT00552929|59137960|FG009|Overall Study|Not Eligible|0|||
30986773|NCT02395302|59137982|FG000|Overall Study|Screen Failure|3|||
30986774|NCT02395302|59137982|FG000|Overall Study|Run In Failure|7|||
30986775|NCT02395302|59137982|FG000|Overall Study|Withdrawal by Subject|2|||
30986776|NCT02395302|59137982|FG000|Overall Study|Physician Decision|2|||
30986777|NCT02371980|59138016|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
30986778|NCT02371980|59138017|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
30986779|NCT02371980|59138018|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
30986780|NCT02371980|59138019|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
30986781|NCT02371980|59138020|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
30986782|NCT02371980|59138016|FG000|Open-label Period|Significant Protocol Deviation|19|||
30986783|NCT02371980|59138017|FG001|Open-label Period|Significant Protocol Deviation|0|||
30986784|NCT02371980|59138018|FG002|Open-label Period|Significant Protocol Deviation|0|||
30986785|NCT02371980|59138019|FG003|Open-label Period|Significant Protocol Deviation|0|||
30986786|NCT02371980|59138020|FG004|Open-label Period|Significant Protocol Deviation|0|||
30986787|NCT02371980|59138016|FG000|Open-label Period|Noncompliance with Study Drug|10|||
30986788|NCT02371980|59138017|FG001|Open-label Period|Noncompliance with Study Drug|0|||
30986789|NCT02371980|59138018|FG002|Open-label Period|Noncompliance with Study Drug|0|||
30986790|NCT02371980|59138019|FG003|Open-label Period|Noncompliance with Study Drug|0|||
30986791|NCT02371980|59138020|FG004|Open-label Period|Noncompliance with Study Drug|0|||
30986792|NCT02371980|59138016|FG000|Open-label Period|Lost to Follow-up|55|||
30986793|NCT02371980|59138017|FG001|Open-label Period|Lost to Follow-up|0|||
30986794|NCT02371980|59138018|FG002|Open-label Period|Lost to Follow-up|0|||
30986795|NCT02371980|59138019|FG003|Open-label Period|Lost to Follow-up|0|||
30986796|NCT02371980|59138020|FG004|Open-label Period|Lost to Follow-up|0|||
30986797|NCT02371980|59138016|FG000|Open-label Period|Voluntary Withdrawal|91|||
30986798|NCT02371980|59138017|FG001|Open-label Period|Voluntary Withdrawal|0|||
30986799|NCT02371980|59138018|FG002|Open-label Period|Voluntary Withdrawal|0|||
30986800|NCT02371980|59138019|FG003|Open-label Period|Voluntary Withdrawal|0|||
30986801|NCT02371980|59138020|FG004|Open-label Period|Voluntary Withdrawal|0|||
30986802|NCT02371980|59138016|FG000|Open-label Period|Pregnancy|1|||
30986803|NCT02371980|59138017|FG001|Open-label Period|Pregnancy|0|||
30986804|NCT02371980|59138018|FG002|Open-label Period|Pregnancy|0|||
30986805|NCT02371980|59138019|FG003|Open-label Period|Pregnancy|0|||
30986806|NCT02371980|59138020|FG004|Open-label Period|Pregnancy|0|||
30986807|NCT02371980|59138016|FG000|Open-label Period|Lack of Efficacy|116|||
30986808|NCT02371980|59138017|FG001|Open-label Period|Lack of Efficacy|0|||
30986809|NCT02371980|59138018|FG002|Open-label Period|Lack of Efficacy|0|||
30986810|NCT02371980|59138019|FG003|Open-label Period|Lack of Efficacy|0|||
30986811|NCT02371980|59138020|FG004|Open-label Period|Lack of Efficacy|0|||
30986812|NCT02371980|59138016|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
30986813|NCT02371980|59138017|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
30986814|NCT02371980|59138018|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
30986815|NCT02371980|59138019|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
30986816|NCT02371980|59138020|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
30986817|NCT02371980|59138016|FG000|Open-label Period|Reason not Specified|9|||
30986818|NCT02371980|59138017|FG001|Open-label Period|Reason not Specified|0|||
30986819|NCT02371980|59138018|FG002|Open-label Period|Reason not Specified|0|||
30986820|NCT02371980|59138019|FG003|Open-label Period|Reason not Specified|0|||
30986821|NCT02371980|59138020|FG004|Open-label Period|Reason not Specified|0|||
30986822|NCT02371980|59138016|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
30986823|NCT02371980|59138017|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
30986824|NCT02371980|59138018|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
30986825|NCT02371980|59138019|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
30986826|NCT02371980|59138020|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
30986827|NCT02371980|59138016|FG000|Double-blind Period|Significant Protocol Deviation|0|||
30986828|NCT02371980|59138017|FG001|Double-blind Period|Significant Protocol Deviation|2|||
30986829|NCT02371980|59138018|FG002|Double-blind Period|Significant Protocol Deviation|7|||
30986830|NCT02371980|59138019|FG003|Double-blind Period|Significant Protocol Deviation|3|||
30986831|NCT02371980|59138020|FG004|Double-blind Period|Significant Protocol Deviation|3|||
30986832|NCT02371980|59138016|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
30986833|NCT02371980|59138017|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
30986834|NCT02371980|59138018|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
30986835|NCT02371980|59138019|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
30986836|NCT02371980|59138020|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
30986837|NCT02371980|59138016|FG000|Double-blind Period|Lost to Follow-up|0|||
30986838|NCT02371980|59138017|FG001|Double-blind Period|Lost to Follow-up|8|||
30986839|NCT02371980|59138018|FG002|Double-blind Period|Lost to Follow-up|8|||
30986840|NCT02371980|59138019|FG003|Double-blind Period|Lost to Follow-up|6|||
30986841|NCT02371980|59138020|FG004|Double-blind Period|Lost to Follow-up|5|||
30986842|NCT02371980|59138016|FG000|Double-blind Period|Voluntary Withdrawal|0|||
30986843|NCT02371980|59138017|FG001|Double-blind Period|Voluntary Withdrawal|12|||
30986844|NCT02371980|59138018|FG002|Double-blind Period|Voluntary Withdrawal|8|||
30986845|NCT02371980|59138019|FG003|Double-blind Period|Voluntary Withdrawal|9|||
30986846|NCT02371980|59138020|FG004|Double-blind Period|Voluntary Withdrawal|11|||
30986847|NCT02371980|59138016|FG000|Double-blind Period|Relapse|0|||
30986848|NCT02371980|59138017|FG001|Double-blind Period|Relapse|50|||
30986849|NCT02371980|59138018|FG002|Double-blind Period|Relapse|25|||
30986850|NCT02371980|59138019|FG003|Double-blind Period|Relapse|25|||
30986851|NCT02371980|59138020|FG004|Double-blind Period|Relapse|26|||
30986852|NCT02371980|59138016|FG000|Double-blind Period|Reason not Specified|0|||
30986853|NCT02371980|59138017|FG001|Double-blind Period|Reason not Specified|3|||
30986854|NCT02371980|59138018|FG002|Double-blind Period|Reason not Specified|3|||
30986855|NCT02371980|59138019|FG003|Double-blind Period|Reason not Specified|2|||
30986856|NCT02371980|59138020|FG004|Double-blind Period|Reason not Specified|1|||
30986857|NCT02371980|59138016|FG000|Double-blind Period|Missing|0|||
30986858|NCT02371980|59138017|FG001|Double-blind Period|Missing|1|||
30986859|NCT02371980|59138018|FG002|Double-blind Period|Missing|0|||
30986860|NCT02371980|59138019|FG003|Double-blind Period|Missing|0|||
30986861|NCT02371980|59138020|FG004|Double-blind Period|Missing|0|||
30986862|NCT02371746|59138160|FG000|Overall Study|Consent withdrawn|0|||
30986863|NCT02371746|59138161|FG001|Overall Study|Consent withdrawn|0|||
30986864|NCT02371746|59138162|FG002|Overall Study|Consent withdrawn|0|||
30986865|NCT02371746|59138163|FG003|Overall Study|Consent withdrawn|0|||
30986866|NCT02371746|59138164|FG004|Overall Study|Consent withdrawn|0|||
30986867|NCT02371746|59138165|FG005|Overall Study|Consent withdrawn|0|||
30986868|NCT02371746|59138166|FG006|Overall Study|Consent withdrawn|1|||
30986869|NCT02421666|59138214|FG000|6-month Follow-up|Lost to Follow-up|8|||
30986870|NCT02421666|59138215|FG001|6-month Follow-up|Lost to Follow-up|7|||
30986871|NCT02421666|59138214|FG000|6-month Follow-up|Withdrawal by Subject|5|||
30986872|NCT02421666|59138215|FG001|6-month Follow-up|Withdrawal by Subject|6|||
30986873|NCT02421666|59138214|FG000|12-month Follow-up|Lost to Follow-up|5|||
30986874|NCT02421666|59138215|FG001|12-month Follow-up|Lost to Follow-up|5|||
30986875|NCT02421666|59138214|FG000|12-month Follow-up|Withdrawal by Subject|6|||
30986876|NCT02421666|59138215|FG001|12-month Follow-up|Withdrawal by Subject|11|||
30986877|NCT02394756|59138225|FG000|Period 1|Lens Discomfort|0|||
30986878|NCT02394756|59138226|FG001|Period 1|Lens Discomfort|0|||
30986879|NCT02394756|59138227|FG002|Period 1|Lens Discomfort|0|||
30986880|NCT02394756|59138228|FG003|Period 1|Lens Discomfort|0|||
30986881|NCT02394756|59138229|FG004|Period 1|Lens Discomfort|0|||
30986882|NCT02394756|59138230|FG005|Period 1|Lens Discomfort|1|||
30986883|NCT02394756|59138225|FG000|Period 1|Withdrawal by Subject|0|||
30986884|NCT02394756|59138226|FG001|Period 1|Withdrawal by Subject|1|||
30986885|NCT02394756|59138227|FG002|Period 1|Withdrawal by Subject|1|||
30986886|NCT02394756|59138228|FG003|Period 1|Withdrawal by Subject|1|||
30986887|NCT02394756|59138229|FG004|Period 1|Withdrawal by Subject|0|||
30986888|NCT02394756|59138230|FG005|Period 1|Withdrawal by Subject|0|||
30986889|NCT02394756|59138225|FG000|Period 2|Unsatisfactory Visual Response|0|||
30986890|NCT02394756|59138226|FG001|Period 2|Unsatisfactory Visual Response|0|||
30986891|NCT02394756|59138227|FG002|Period 2|Unsatisfactory Visual Response|0|||
30986892|NCT02394756|59138228|FG003|Period 2|Unsatisfactory Visual Response|0|||
30986893|NCT02394756|59138229|FG004|Period 2|Unsatisfactory Visual Response|1|||
30986894|NCT02394756|59138230|FG005|Period 2|Unsatisfactory Visual Response|0|||
30986895|NCT02370888|59138251|FG000|Overall Study|disease progression|2|||
30986896|NCT02370888|59138251|FG000|Overall Study|did not meet chimerism criteria|6|||
30986897|NCT02394600|59138275|FG000|Overall Study|Adverse Event|3|||
30986898|NCT02394600|59138276|FG001|Overall Study|Adverse Event|0|||
30986899|NCT02394600|59138275|FG000|Overall Study|Lost to Follow-up|0|||
30986900|NCT02394600|59138276|FG001|Overall Study|Lost to Follow-up|1|||
30986901|NCT02394600|59138275|FG000|Overall Study|Withdrawal by Subject|0|||
30986902|NCT02394600|59138276|FG001|Overall Study|Withdrawal by Subject|1|||
30986903|NCT02394600|59138275|FG000|Overall Study|Protocol Violation|1|||
30986904|NCT02394600|59138276|FG001|Overall Study|Protocol Violation|0|||
30986905|NCT04685499|59138292|FG000|Overall Study|Study Terminated Early|1|||
30986906|NCT02421588|59138368|FG000|Overall Study|Non-treatment-related AE|8|||
30986907|NCT02421588|59138369|FG001|Overall Study|Non-treatment-related AE|8|||
30986908|NCT02421588|59138368|FG000|Overall Study|Progressive disease|152|||
30986909|NCT02421588|59138369|FG001|Overall Study|Progressive disease|135|||
30986910|NCT02421588|59138368|FG000|Overall Study|Death|11|||
30986911|NCT02421588|59138369|FG001|Overall Study|Death|3|||
30986912|NCT02421588|59138368|FG000|Overall Study|Physician Decision|8|||
30986913|NCT02421588|59138369|FG001|Overall Study|Physician Decision|17|||
30843490|NCT02306161|58869583|FG001|Overall Study|Withdrawal by Subject|0|||
30986914|NCT02421588|59138368|FG000|Overall Study|Other reason not specified|3|||
30986915|NCT02421588|59138369|FG001|Overall Study|Other reason not specified|1|||
30986916|NCT02421588|59138368|FG000|Overall Study|Symptomatic deterioration|13|||
30986917|NCT02421588|59138369|FG001|Overall Study|Symptomatic deterioration|19|||
30986918|NCT02421588|59138368|FG000|Overall Study|Treatment-related AE|10|||
30986919|NCT02421588|59138369|FG001|Overall Study|Treatment-related AE|14|||
30986920|NCT02421588|59138368|FG000|Overall Study|Withdrawal by Subject|14|||
30986921|NCT02421588|59138369|FG001|Overall Study|Withdrawal by Subject|16|||
30986922|NCT02421588|59138368|FG000|Overall Study|Not treated|2|||
30986923|NCT02421588|59138369|FG001|Overall Study|Not treated|8|||
30986924|NCT02421510|59138378|FG000|Overall Study|Other|4|||
30986925|NCT02421510|59138379|FG001|Overall Study|Other|2|||
30986926|NCT02421510|59138380|FG002|Overall Study|Other|3|||
30986927|NCT02421510|59138378|FG000|Overall Study|Protocol Violation|1|||
30986928|NCT02421510|59138379|FG001|Overall Study|Protocol Violation|2|||
30986929|NCT02421510|59138380|FG002|Overall Study|Protocol Violation|0|||
30986930|NCT02421510|59138378|FG000|Overall Study|Death|1|||
30986931|NCT02421510|59138379|FG001|Overall Study|Death|0|||
30986932|NCT02421510|59138380|FG002|Overall Study|Death|0|||
30986933|NCT02421510|59138378|FG000|Overall Study|Noncompliance with study drug|1|||
30986934|NCT02421510|59138379|FG001|Overall Study|Noncompliance with study drug|0|||
30986935|NCT02421510|59138380|FG002|Overall Study|Noncompliance with study drug|0|||
30986936|NCT02421510|59138378|FG000|Overall Study|Physician Decision|1|||
30986937|NCT02421510|59138379|FG001|Overall Study|Physician Decision|1|||
30986938|NCT02421510|59138380|FG002|Overall Study|Physician Decision|3|||
30986939|NCT02421510|59138378|FG000|Overall Study|Adverse Event|9|||
30986940|NCT02421510|59138379|FG001|Overall Study|Adverse Event|10|||
30986941|NCT02421510|59138380|FG002|Overall Study|Adverse Event|18|||
30986942|NCT02421510|59138378|FG000|Overall Study|Pregnancy|1|||
30986943|NCT02421510|59138379|FG001|Overall Study|Pregnancy|1|||
30986944|NCT02421510|59138380|FG002|Overall Study|Pregnancy|0|||
30986945|NCT02421510|59138378|FG000|Overall Study|Withdrawal by Subject|14|||
30986946|NCT02421510|59138379|FG001|Overall Study|Withdrawal by Subject|18|||
30986947|NCT02421510|59138380|FG002|Overall Study|Withdrawal by Subject|12|||
30986948|NCT02421510|59138378|FG000|Overall Study|Lost to Follow-up|1|||
30986949|NCT02421510|59138379|FG001|Overall Study|Lost to Follow-up|1|||
30986950|NCT02421510|59138380|FG002|Overall Study|Lost to Follow-up|0|||
30986951|NCT00552617|59138398|FG000|Overall Study|Not Treated|0|||
30986952|NCT00552617|59138399|FG001|Overall Study|Not Treated|0|||
30986953|NCT00552617|59138400|FG002|Overall Study|Not Treated|1|||
30986954|NCT00552617|59138401|FG003|Overall Study|Not Treated|0|||
30986955|NCT00552617|59138402|FG004|Overall Study|Not Treated|0|||
30986956|NCT00552617|59138403|FG005|Overall Study|Not Treated|0|||
30986957|NCT00552617|59138404|FG006|Overall Study|Not Treated|0|||
30986958|NCT00552617|59138405|FG007|Overall Study|Not Treated|0|||
30986959|NCT00552617|59138406|FG008|Overall Study|Not Treated|0|||
30986960|NCT00552617|59138407|FG009|Overall Study|Not Treated|1|||
30986961|NCT00552617|59138398|FG000|Overall Study|Lost to Follow-up|0|||
30986962|NCT00552617|59138399|FG001|Overall Study|Lost to Follow-up|0|||
30986963|NCT00552617|59138400|FG002|Overall Study|Lost to Follow-up|0|||
30986964|NCT00552617|59138401|FG003|Overall Study|Lost to Follow-up|1|||
30986965|NCT00552617|59138402|FG004|Overall Study|Lost to Follow-up|0|||
30986966|NCT00552617|59138403|FG005|Overall Study|Lost to Follow-up|2|||
30986967|NCT00552617|59138404|FG006|Overall Study|Lost to Follow-up|0|||
30986968|NCT00552617|59138405|FG007|Overall Study|Lost to Follow-up|0|||
30986969|NCT00552617|59138406|FG008|Overall Study|Lost to Follow-up|2|||
30986970|NCT00552617|59138407|FG009|Overall Study|Lost to Follow-up|0|||
30986971|NCT02421120|59138429|FG000|Overall Study|Adverse Event|1|||
30986972|NCT02420262|59138435|FG000|Overall Study|Adverse Event|1|||
30986973|NCT02420262|59138436|FG001|Overall Study|Adverse Event|0|||
30986974|NCT02420262|59138435|FG000|Overall Study|Withdrawal by Subject|1|||
30986975|NCT02420262|59138436|FG001|Overall Study|Withdrawal by Subject|4|||
30986976|NCT02420262|59138435|FG000|Overall Study|Unclassified|0|||
30986977|NCT02420262|59138436|FG001|Overall Study|Unclassified|1|||
30986978|NCT00552305|59138442|FG000|Overall Study|Adverse Event|43|||
30986979|NCT00552305|59138442|FG000|Overall Study|Lack of Efficacy|120|||
30986980|NCT00552305|59138442|FG000|Overall Study|Lost to Follow-up|4|||
30986981|NCT00552305|59138442|FG000|Overall Study|Protocol Violation|3|||
30986982|NCT00552305|59138442|FG000|Overall Study|Withdrawal by Subject|44|||
30986983|NCT00552305|59138442|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
30986984|NCT00552305|59138442|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
30986985|NCT00552305|59138442|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
30986986|NCT00552305|59138442|FG000|Overall Study|Unsatisfactory compliance|11|||
30986987|NCT00552305|59138442|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
30986988|NCT00552305|59138442|FG000|Overall Study|AE/Other: prohibited drug required|1|||
30986989|NCT00552305|59138442|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
30986990|NCT00552305|59138442|FG000|Overall Study|Other: Site closed|4|||
30986991|NCT00552305|59138442|FG000|Overall Study|Other: Personal problems|1|||
30986992|NCT00552305|59138442|FG000|Overall Study|Other: Unable to attend visits|1|||
30986993|NCT00552305|59138442|FG000|Overall Study|Other: Subject underwent surgery|4|||
30986994|NCT00552305|59138442|FG000|Overall Study|Other: Subject became pregnant|1|||
30986995|NCT00552305|59138442|FG000|Overall Study|Other: Health problems, not drug related|1|||
30986996|NCT00552305|59138442|FG000|Overall Study|Other: Subject moved from area|2|||
30986997|NCT00552305|59138442|FG000|Overall Study|Other: Subject incarcerated|1|||
30986998|NCT00552305|59138442|FG000|Overall Study|Other: Subject went to rehab|1|||
30986999|NCT00552071|59138468|FG000|Overall Study|Adverse Event|1|||
30987000|NCT00552071|59138469|FG001|Overall Study|Adverse Event|0|||
30987001|NCT00552071|59138468|FG000|Overall Study|Lack of Efficacy|1|||
30987002|NCT00552071|59138469|FG001|Overall Study|Lack of Efficacy|0|||
30987003|NCT00552071|59138468|FG000|Overall Study|Physician Decision|1|||
30987004|NCT00552071|59138469|FG001|Overall Study|Physician Decision|0|||
30987005|NCT00552071|59138468|FG000|Overall Study|Pregnancy|1|||
30987006|NCT00552071|59138469|FG001|Overall Study|Pregnancy|0|||
30987007|NCT00552071|59138468|FG000|Overall Study|Death|0|||
30987008|NCT00552071|59138469|FG001|Overall Study|Death|1|||
30987009|NCT00552071|59138468|FG000|Overall Study|Withdrawal by Subject|0|||
30987010|NCT00552071|59138469|FG001|Overall Study|Withdrawal by Subject|1|||
30987011|NCT00551525|59138477|FG000|Overall Study|Protocol Violation|5|||
30987012|NCT02370498|59138504|FG000|Overall Study|Adverse Event|10|||
30987013|NCT02370498|59138505|FG001|Overall Study|Adverse Event|8|||
30987014|NCT02370498|59138504|FG000|Overall Study|Death|263|||
30987015|NCT02370498|59138505|FG001|Overall Study|Death|265|||
30987016|NCT02370498|59138504|FG000|Overall Study|Protocol Violation|1|||
30987017|NCT02370498|59138505|FG001|Overall Study|Protocol Violation|2|||
30987018|NCT02370498|59138504|FG000|Overall Study|Withdrawal by Subject|7|||
30987019|NCT02370498|59138505|FG001|Overall Study|Withdrawal by Subject|12|||
30987020|NCT02370498|59138504|FG000|Overall Study|Sponsor's decision|15|||
30987021|NCT02370498|59138505|FG001|Overall Study|Sponsor's decision|9|||
30987022|NCT02347332|59138530|FG000|Overall Study|Not treated|5|||
30987023|NCT02347332|59138531|FG001|Overall Study|Not treated|2|||
30987024|NCT02347332|59138530|FG000|Overall Study|Progressive disease|141|||
30987025|NCT02347332|59138531|FG001|Overall Study|Progressive disease|159|||
30987026|NCT02347332|59138530|FG000|Overall Study|Adverse Event|50|||
30987027|NCT02347332|59138531|FG001|Overall Study|Adverse Event|41|||
30987028|NCT02347332|59138530|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
30987029|NCT02347332|59138531|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
30987030|NCT02347332|59138530|FG000|Overall Study|Protocol Violation|1|||
30987031|NCT02347332|59138531|FG001|Overall Study|Protocol Violation|1|||
30987032|NCT02347332|59138530|FG000|Overall Study|Lost to Follow-up|2|||
30987033|NCT02347332|59138531|FG001|Overall Study|Lost to Follow-up|1|||
30987034|NCT02347332|59138530|FG000|Overall Study|Physician Decision|4|||
30987035|NCT02347332|59138531|FG001|Overall Study|Physician Decision|3|||
30987036|NCT02347332|59138530|FG000|Overall Study|Withdrawal by Subject|20|||
30987037|NCT02347332|59138531|FG001|Overall Study|Withdrawal by Subject|14|||
30987038|NCT02347332|59138530|FG000|Overall Study|Protocol requirement|1|||
30987039|NCT02347332|59138531|FG001|Overall Study|Protocol requirement|1|||
30987040|NCT02347332|59138530|FG000|Overall Study|Switch Post-Trial program|0|||
30987041|NCT02347332|59138531|FG001|Overall Study|Switch Post-Trial program|1|||
30987042|NCT02347176|59138554|FG000|Overall Study|Lost to Follow-up|2|||
30987043|NCT02347176|59138555|FG001|Overall Study|Lost to Follow-up|3|||
30987044|NCT02347176|59138556|FG002|Overall Study|Lost to Follow-up|1|||
30987045|NCT02347176|59138557|FG003|Overall Study|Lost to Follow-up|1|||
30987046|NCT02347176|59138554|FG000|Overall Study|Withdrawal by Subject|9|||
30987047|NCT02347176|59138555|FG001|Overall Study|Withdrawal by Subject|5|||
30987048|NCT02347176|59138556|FG002|Overall Study|Withdrawal by Subject|5|||
30987049|NCT02347176|59138557|FG003|Overall Study|Withdrawal by Subject|3|||
30987050|NCT02347176|59138554|FG000|Overall Study|Other|1|||
30987051|NCT02347176|59138555|FG001|Overall Study|Other|2|||
30987052|NCT02347176|59138556|FG002|Overall Study|Other|2|||
30987053|NCT02347176|59138557|FG003|Overall Study|Other|0|||
30987054|NCT02370420|59138569|FG000|Overall Study|Physician Decision|3|||
30987055|NCT02370420|59138570|FG001|Overall Study|Physician Decision|3|||
30987056|NCT02370420|59138569|FG000|Overall Study|Lost to Follow-up|11|||
30987057|NCT02370420|59138570|FG001|Overall Study|Lost to Follow-up|9|||
30987058|NCT02347098|59138592|FG000|Overall Study|Death|1|||
30987059|NCT02347098|59138593|FG001|Overall Study|Death|0|||
30987060|NCT02347098|59138592|FG000|Overall Study|Withdrawal by Subject|1|||
30987061|NCT02347098|59138593|FG001|Overall Study|Withdrawal by Subject|0|||
30987062|NCT02347098|59138592|FG000|Overall Study|Lost to Follow-up|2|||
30987063|NCT02347098|59138593|FG001|Overall Study|Lost to Follow-up|2|||
30987064|NCT02347098|59138592|FG000|Overall Study|Refuse Follow-up Visit|1|||
30987065|NCT02347098|59138593|FG001|Overall Study|Refuse Follow-up Visit|5|||
30987066|NCT02347098|59138592|FG000|Overall Study|no visit due to illness|2|||
30987067|NCT02347098|59138593|FG001|Overall Study|no visit due to illness|1|||
30987068|NCT02346708|59138610|FG000|Overall Study|Adverse Event|2|||
30987069|NCT02346708|59138611|FG001|Overall Study|Adverse Event|0|||
30987070|NCT02346708|59138610|FG000|Overall Study|Protocol Violation|0|||
30987071|NCT02346708|59138611|FG001|Overall Study|Protocol Violation|1|||
30987072|NCT02346240|59139101|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987073|NCT02346240|59139102|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
30987074|NCT02346240|59139103|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
30987075|NCT02346240|59139104|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
30987076|NCT02346240|59139105|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987077|NCT02346240|59139106|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987078|NCT02346240|59139107|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987079|NCT02346240|59139108|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987080|NCT02346240|59139109|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987081|NCT02346240|59139110|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987082|NCT02346240|59139111|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987083|NCT02346240|59139112|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987084|NCT02346240|59139113|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987085|NCT02346240|59139114|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987086|NCT02346240|59139115|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987087|NCT02346240|59139116|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987088|NCT02346240|59139117|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987089|NCT02346240|59139118|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987090|NCT02346240|59139119|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987091|NCT02346240|59139120|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987092|NCT02346240|59139121|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987093|NCT02346240|59139122|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987094|NCT02346240|59139123|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987095|NCT02346240|59139124|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
30987096|NCT02346240|59139101|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987097|NCT02346240|59139102|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
30987098|NCT02346240|59139103|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987099|NCT02346240|59139104|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987100|NCT02346240|59139105|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987101|NCT02346240|59139106|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987102|NCT02346240|59139107|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987103|NCT02346240|59139108|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987104|NCT02346240|59139109|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987105|NCT02346240|59139110|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987106|NCT02346240|59139111|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987107|NCT02346240|59139112|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987108|NCT02346240|59139113|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987109|NCT02346240|59139114|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987110|NCT02346240|59139115|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987111|NCT02346240|59139116|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987112|NCT02346240|59139117|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987113|NCT02346240|59139118|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987114|NCT02346240|59139119|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987115|NCT02346240|59139120|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987116|NCT02346240|59139121|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987117|NCT02346240|59139122|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987118|NCT02346240|59139123|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987119|NCT02346240|59139124|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
30987120|NCT02346240|59139101|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987121|NCT02346240|59139102|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
30987122|NCT02346240|59139103|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987123|NCT02346240|59139104|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987124|NCT02346240|59139105|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987125|NCT02346240|59139106|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987126|NCT02346240|59139107|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987127|NCT02346240|59139108|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987128|NCT02346240|59139109|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987129|NCT02346240|59139110|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30891739|NCT02384941|58924994|FG000|Overall Study|Pregnancy|0|||
30987130|NCT02346240|59139111|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987131|NCT02346240|59139112|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987132|NCT02346240|59139113|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30891740|NCT02384941|58924995|FG001|Overall Study|Pregnancy|0|||
30987133|NCT02346240|59139114|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987134|NCT02346240|59139115|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987135|NCT02346240|59139116|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987136|NCT02346240|59139117|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987137|NCT02346240|59139118|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987138|NCT02346240|59139119|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987139|NCT02346240|59139120|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987140|NCT02346240|59139121|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987141|NCT02346240|59139122|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987142|NCT02346240|59139123|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987143|NCT02346240|59139124|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
30987144|NCT02346240|59139101|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
30987145|NCT02346240|59139102|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
30987146|NCT02346240|59139103|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
30987147|NCT02346240|59139104|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
30987148|NCT02346240|59139105|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987149|NCT02346240|59139106|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987150|NCT02346240|59139107|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987151|NCT02346240|59139108|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987152|NCT02346240|59139109|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987153|NCT02346240|59139110|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987154|NCT02346240|59139111|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987155|NCT02346240|59139112|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987156|NCT02346240|59139113|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987157|NCT02346240|59139114|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987158|NCT02346240|59139115|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987159|NCT02346240|59139116|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987160|NCT02346240|59139117|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987161|NCT02346240|59139118|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987162|NCT02346240|59139119|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987163|NCT02346240|59139120|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987164|NCT02346240|59139121|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987165|NCT02346240|59139122|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987166|NCT02346240|59139123|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987167|NCT02346240|59139124|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
30987168|NCT02346240|59139101|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
30987169|NCT02346240|59139102|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
30987170|NCT02346240|59139103|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
30987171|NCT02346240|59139104|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
30987172|NCT02346240|59139105|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987173|NCT02346240|59139106|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987174|NCT02346240|59139107|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987175|NCT02346240|59139108|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987176|NCT02346240|59139109|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987177|NCT02346240|59139110|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987178|NCT02346240|59139111|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987179|NCT02346240|59139112|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987180|NCT02346240|59139113|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987181|NCT02346240|59139114|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987182|NCT02346240|59139115|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987183|NCT02346240|59139116|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987184|NCT02346240|59139117|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987185|NCT02346240|59139118|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987186|NCT02346240|59139119|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987187|NCT02346240|59139120|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987188|NCT02346240|59139121|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987189|NCT02346240|59139122|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987190|NCT02346240|59139123|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987191|NCT02346240|59139124|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
30987192|NCT02346240|59139101|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987193|NCT02346240|59139102|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
30987194|NCT02346240|59139103|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30891741|NCT02384941|58924996|FG002|Overall Study|Pregnancy|1|||
30891742|NCT02384941|58924994|FG000|Overall Study|Other than specified above|4|||
30987195|NCT02346240|59139104|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
30987196|NCT02346240|59139105|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987197|NCT02346240|59139106|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987198|NCT02346240|59139107|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987199|NCT02346240|59139108|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987200|NCT02346240|59139109|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987201|NCT02346240|59139110|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987202|NCT02346240|59139111|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987203|NCT02346240|59139112|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987204|NCT02346240|59139113|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987205|NCT02346240|59139114|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987206|NCT02346240|59139115|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987207|NCT02346240|59139116|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987208|NCT02346240|59139117|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987209|NCT02346240|59139118|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987210|NCT02346240|59139119|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987211|NCT02346240|59139120|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987212|NCT02346240|59139121|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987213|NCT02346240|59139122|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987214|NCT02346240|59139123|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987215|NCT02346240|59139124|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
30987216|NCT02346240|59139101|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987217|NCT02346240|59139102|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987218|NCT02346240|59139103|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
30987219|NCT02346240|59139104|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987220|NCT02346240|59139105|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987221|NCT02346240|59139106|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987222|NCT02346240|59139107|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987223|NCT02346240|59139108|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987224|NCT02346240|59139109|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987225|NCT02346240|59139110|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987226|NCT02346240|59139111|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987227|NCT02346240|59139112|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987228|NCT02346240|59139113|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987229|NCT02346240|59139114|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987230|NCT02346240|59139115|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987231|NCT02346240|59139116|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987232|NCT02346240|59139117|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987233|NCT02346240|59139118|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987234|NCT02346240|59139119|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987235|NCT02346240|59139120|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987236|NCT02346240|59139121|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987237|NCT02346240|59139122|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987238|NCT02346240|59139123|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987239|NCT02346240|59139124|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
30987240|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987241|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987242|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987243|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987244|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987245|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987246|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987247|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
30987248|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
30987249|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987250|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987251|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987252|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987253|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
30987254|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
30987255|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
30987256|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
30987257|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987258|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987259|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987260|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987261|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987262|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987263|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30987264|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987265|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987266|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987267|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987268|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987269|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987270|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987271|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987272|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987273|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987274|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987275|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987276|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987277|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
30987278|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987279|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
30987280|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987281|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987282|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987283|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987284|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987285|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987286|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987287|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30987288|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987289|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987290|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987291|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987292|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987293|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987294|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987295|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987296|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987297|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987298|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987299|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987300|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987301|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987302|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
30987303|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987304|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987305|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987306|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987307|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987308|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987309|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987310|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987311|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30987312|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987313|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987314|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987315|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987316|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987317|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30987318|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30987319|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30987320|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30987321|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987322|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30987323|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
30987324|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987325|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
30987326|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
30987327|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
30987328|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30987329|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987330|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987331|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987332|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987333|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987334|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987335|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30987336|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987337|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987338|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987339|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987340|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987341|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987342|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987343|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987344|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987345|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987346|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987347|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987348|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987349|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
30987350|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
30987351|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
30987352|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
30987353|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987354|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987355|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987356|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987357|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987358|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987359|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30987360|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987361|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987362|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987363|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987364|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987365|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987366|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
30987367|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987368|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987369|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987370|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30608499|NCT00998296|58619277|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
30608500|NCT00998296|58619278|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
30891743|NCT02384941|58924995|FG001|Overall Study|Other than specified above|0|||
30891744|NCT02384941|58924996|FG002|Overall Study|Other than specified above|1|||
30891745|NCT02384395|58925005|FG000|Overall Study|Physician Decision|4|||
30608501|NCT00998296|58619279|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
30608502|NCT00998296|58619280|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
30608503|NCT00998296|58619281|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
30608504|NCT00998296|58619282|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
30608505|NCT00998296|58619283|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
30608506|NCT00998296|58619284|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
30608507|NCT00998296|58619285|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
30891746|NCT02384395|58925005|FG000|Overall Study|Withdrawal by Subject|3|||
30891747|NCT02384395|58925005|FG000|Overall Study|Lost to Follow-up|3|||
30608508|NCT00998296|58619286|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
30608509|NCT00998296|58619287|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
30608510|NCT00998296|58619277|FG000|Overall Study|Other adverse event|0|||
30608511|NCT00998296|58619278|FG001|Overall Study|Other adverse event|0|||
30608512|NCT00998296|58619279|FG002|Overall Study|Other adverse event|0|||
30608513|NCT00998296|58619280|FG003|Overall Study|Other adverse event|0|||
30608514|NCT00998296|58619281|FG004|Overall Study|Other adverse event|1|||
30608515|NCT00998296|58619282|FG005|Overall Study|Other adverse event|0|||
30608516|NCT00998296|58619283|FG006|Overall Study|Other adverse event|0|||
30608517|NCT00998296|58619284|FG007|Overall Study|Other adverse event|0|||
30608518|NCT00998296|58619285|FG008|Overall Study|Other adverse event|0|||
30608519|NCT00998296|58619286|FG009|Overall Study|Other adverse event|1|||
30608520|NCT00998296|58619287|FG010|Overall Study|Other adverse event|2|||
30608521|NCT00998296|58619277|FG000|Overall Study|Refused to continue taking trial med.|0|||
30608522|NCT00998296|58619278|FG001|Overall Study|Refused to continue taking trial med.|0|||
30608523|NCT00998296|58619279|FG002|Overall Study|Refused to continue taking trial med.|0|||
30608524|NCT00998296|58619280|FG003|Overall Study|Refused to continue taking trial med.|0|||
30608525|NCT00998296|58619281|FG004|Overall Study|Refused to continue taking trial med.|0|||
30608526|NCT00998296|58619282|FG005|Overall Study|Refused to continue taking trial med.|0|||
30608527|NCT00998296|58619283|FG006|Overall Study|Refused to continue taking trial med.|0|||
30608528|NCT00998296|58619284|FG007|Overall Study|Refused to continue taking trial med.|0|||
30608529|NCT00998296|58619285|FG008|Overall Study|Refused to continue taking trial med.|0|||
30608530|NCT00998296|58619286|FG009|Overall Study|Refused to continue taking trial med.|2|||
30608531|NCT00998296|58619287|FG010|Overall Study|Refused to continue taking trial med.|0|||
30608532|NCT00998296|58619277|FG000|Overall Study|Reason other than those specified above|0|||
30608533|NCT00998296|58619278|FG001|Overall Study|Reason other than those specified above|0|||
30608534|NCT00998296|58619279|FG002|Overall Study|Reason other than those specified above|0|||
30608535|NCT00998296|58619280|FG003|Overall Study|Reason other than those specified above|0|||
30608536|NCT00998296|58619281|FG004|Overall Study|Reason other than those specified above|0|||
30608537|NCT00998296|58619282|FG005|Overall Study|Reason other than those specified above|0|||
30608538|NCT00998296|58619283|FG006|Overall Study|Reason other than those specified above|0|||
30608539|NCT00998296|58619284|FG007|Overall Study|Reason other than those specified above|0|||
30608540|NCT00998296|58619285|FG008|Overall Study|Reason other than those specified above|0|||
30608541|NCT00998296|58619286|FG009|Overall Study|Reason other than those specified above|1|||
30608542|NCT00998296|58619287|FG010|Overall Study|Reason other than those specified above|0|||
30608543|NCT01178073|58619319|FG000|Overall Study|Adverse Event|34|||
30608544|NCT01178073|58619320|FG001|Overall Study|Adverse Event|27|||
30608545|NCT01178073|58619321|FG002|Overall Study|Adverse Event|24|||
30608546|NCT01178073|58619319|FG000|Overall Study|Protocol Violation|1|||
30608547|NCT01178073|58619320|FG001|Overall Study|Protocol Violation|1|||
30608548|NCT01178073|58619321|FG002|Overall Study|Protocol Violation|1|||
30608549|NCT01178073|58619319|FG000|Overall Study|Lost to Follow-up|2|||
30608550|NCT01178073|58619320|FG001|Overall Study|Lost to Follow-up|0|||
30608551|NCT01178073|58619321|FG002|Overall Study|Lost to Follow-up|3|||
30608552|NCT01178073|58619319|FG000|Overall Study|Physician Decision|14|||
30608553|NCT01178073|58619320|FG001|Overall Study|Physician Decision|10|||
30608554|NCT01178073|58619321|FG002|Overall Study|Physician Decision|10|||
30608555|NCT01178073|58619319|FG000|Overall Study|Withdrawal by Subject|10|||
30608556|NCT01178073|58619320|FG001|Overall Study|Withdrawal by Subject|6|||
30608557|NCT01178073|58619321|FG002|Overall Study|Withdrawal by Subject|8|||
30608558|NCT01178073|58619319|FG000|Overall Study|Missing Completion Status|1|||
30608559|NCT01178073|58619320|FG001|Overall Study|Missing Completion Status|0|||
30608560|NCT01178073|58619321|FG002|Overall Study|Missing Completion Status|0|||
30608561|NCT00997984|58619333|FG000|Overall Study|Adverse Event|1|||
30608562|NCT00997984|58619334|FG001|Overall Study|Adverse Event|8|||
30608563|NCT00997984|58619335|FG002|Overall Study|Adverse Event|8|||
30608564|NCT00997984|58619333|FG000|Overall Study|Protocol Violation|1|||
30608565|NCT00997984|58619334|FG001|Overall Study|Protocol Violation|3|||
30608566|NCT00997984|58619335|FG002|Overall Study|Protocol Violation|0|||
30608567|NCT00997984|58619333|FG000|Overall Study|Withdrawal by Subject|6|||
30608568|NCT00997984|58619334|FG001|Overall Study|Withdrawal by Subject|9|||
30608569|NCT00997984|58619335|FG002|Overall Study|Withdrawal by Subject|5|||
30608570|NCT00997984|58619333|FG000|Overall Study|Lost to Follow-up|8|||
30608571|NCT00997984|58619334|FG001|Overall Study|Lost to Follow-up|5|||
30608572|NCT00997984|58619335|FG002|Overall Study|Lost to Follow-up|4|||
30608573|NCT00997984|58619333|FG000|Overall Study|Lack of Efficacy|20|||
30608574|NCT00997984|58619334|FG001|Overall Study|Lack of Efficacy|6|||
30608575|NCT00997984|58619335|FG002|Overall Study|Lack of Efficacy|3|||
30608576|NCT00997984|58619333|FG000|Overall Study|Met exclusion criteria|1|||
30608577|NCT00997984|58619334|FG001|Overall Study|Met exclusion criteria|0|||
30608578|NCT00997984|58619335|FG002|Overall Study|Met exclusion criteria|0|||
30608579|NCT00997984|58619333|FG000|Overall Study|non-compliance|0|||
30608580|NCT00997984|58619334|FG001|Overall Study|non-compliance|2|||
30608581|NCT00997984|58619335|FG002|Overall Study|non-compliance|3|||
30608582|NCT00997984|58619333|FG000|Overall Study|Wrong medication dispensed|0|||
30608583|NCT00997984|58619334|FG001|Overall Study|Wrong medication dispensed|1|||
30608584|NCT00997984|58619335|FG002|Overall Study|Wrong medication dispensed|0|||
30608585|NCT00997984|58619333|FG000|Overall Study|Suicidal ideation|0|||
30608586|NCT00997984|58619334|FG001|Overall Study|Suicidal ideation|0|||
30608587|NCT00997984|58619335|FG002|Overall Study|Suicidal ideation|1|||
30608588|NCT00997984|58619333|FG000|Overall Study|Work schedule|0|||
30608589|NCT00997984|58619334|FG001|Overall Study|Work schedule|0|||
30608590|NCT00997984|58619335|FG002|Overall Study|Work schedule|2|||
30608591|NCT01177293|58619345|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
30608592|NCT01177293|58619346|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
30608593|NCT01177137|58619355|FG000|Overall Study|Withdrawal by Subject|10|||
30608594|NCT01177137|58619356|FG001|Overall Study|Withdrawal by Subject|10|||
30608595|NCT01177137|58619357|FG002|Overall Study|Withdrawal by Subject|2|||
30608596|NCT01177059|58619368|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
30608597|NCT01177059|58619368|FG000|Overall Study|Withdrew consent|2|||
30608598|NCT01177059|58619368|FG000|Overall Study|Lost to Follow-up|18|||
30608599|NCT01176513|58619372|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
30608600|NCT01299389|58619378|FG000|Double-blind|Adverse Event|45|||
30608601|NCT01299389|58619379|FG001|Double-blind|Adverse Event|27|||
30608602|NCT01299389|58619380|FG002|Double-blind|Adverse Event|0|||
30608603|NCT01299389|58619381|FG003|Double-blind|Adverse Event|0|||
30608604|NCT01299389|58619378|FG000|Double-blind|Lack of Efficacy|45|||
30608605|NCT01299389|58619379|FG001|Double-blind|Lack of Efficacy|21|||
30608606|NCT01299389|58619380|FG002|Double-blind|Lack of Efficacy|0|||
30608607|NCT01299389|58619381|FG003|Double-blind|Lack of Efficacy|0|||
30608608|NCT01299389|58619378|FG000|Double-blind|Lost to Follow-up|2|||
30608609|NCT01299389|58619379|FG001|Double-blind|Lost to Follow-up|1|||
30608610|NCT01299389|58619380|FG002|Double-blind|Lost to Follow-up|0|||
30608611|NCT01299389|58619381|FG003|Double-blind|Lost to Follow-up|0|||
30608612|NCT01299389|58619378|FG000|Double-blind|Withdrawal by Subject|16|||
30608613|NCT01299389|58619379|FG001|Double-blind|Withdrawal by Subject|13|||
30608614|NCT01299389|58619380|FG002|Double-blind|Withdrawal by Subject|0|||
30608615|NCT01299389|58619381|FG003|Double-blind|Withdrawal by Subject|0|||
30608616|NCT01299389|58619378|FG000|Double-blind|Other|1|||
30608617|NCT01299389|58619379|FG001|Double-blind|Other|1|||
30608618|NCT01299389|58619380|FG002|Double-blind|Other|0|||
30608619|NCT01299389|58619381|FG003|Double-blind|Other|0|||
30608620|NCT01299389|58619378|FG000|Double-blind|"fail to meet study population criteria"|0|||
30608621|NCT01299389|58619379|FG001|Double-blind|"fail to meet study population criteria"|1|||
30608622|NCT01299389|58619380|FG002|Double-blind|"fail to meet study population criteria"|0|||
30608623|NCT01299389|58619381|FG003|Double-blind|"fail to meet study population criteria"|0|||
30608624|NCT01299389|58619378|FG000|Post-observational|Other|0|||
30608625|NCT01299389|58619379|FG001|Post-observational|Other|0|||
30608626|NCT01299389|58619380|FG002|Post-observational|Other|12|||
30608627|NCT01299389|58619381|FG003|Post-observational|Other|6|||
30608628|NCT01298999|58619392|FG000|Overall Study|Physician Decision|0|||
30608629|NCT01298999|58619393|FG001|Overall Study|Physician Decision|1|||
30608630|NCT01298999|58619392|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
30608631|NCT01298999|58619393|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
30608632|NCT01007032|58619403|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
30608633|NCT01007032|58619404|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
30608634|NCT01007032|58619405|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
30608635|NCT01007032|58619406|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
30608636|NCT01007032|58619403|FG000|Overall Study|Withdrawal by Subject|0|||
30608637|NCT01007032|58619404|FG001|Overall Study|Withdrawal by Subject|0|||
30608638|NCT01007032|58619405|FG002|Overall Study|Withdrawal by Subject|0|||
30608639|NCT01007032|58619406|FG003|Overall Study|Withdrawal by Subject|1|||
30608640|NCT00976027|58619423|FG000|Overall Study|Serious Adverse Event|36|||
30608641|NCT00976027|58619424|FG001|Overall Study|Serious Adverse Event|17|||
30608642|NCT00976027|58619423|FG000|Overall Study|Adverse Event|0|||
30608643|NCT00976027|58619424|FG001|Overall Study|Adverse Event|2|||
30608644|NCT00976027|58619423|FG000|Overall Study|Protocol Violation|60|||
30608645|NCT00976027|58619424|FG001|Overall Study|Protocol Violation|27|||
30608646|NCT00976027|58619423|FG000|Overall Study|Lost to Follow-up|208|||
30608647|NCT00976027|58619424|FG001|Overall Study|Lost to Follow-up|103|||
30608648|NCT00976027|58619423|FG000|Overall Study|Withdrawal by Subject|107|||
30608649|NCT00976027|58619424|FG001|Overall Study|Withdrawal by Subject|66|||
30608650|NCT01298765|58619430|FG000|Titration Period|Adverse Event|26|||
30608651|NCT01298765|58619430|FG000|Titration Period|Death|1|||
30608652|NCT01298765|58619430|FG000|Titration Period|Lack of Efficacy|21|||
30608653|NCT01298765|58619430|FG000|Titration Period|Lost to Follow-up|9|||
30608654|NCT01298765|58619430|FG000|Titration Period|Physician Decision|1|||
30608655|NCT01298765|58619430|FG000|Titration Period|Withdrawal by Subject|10|||
30608656|NCT01298765|58619430|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
30608657|NCT01298765|58619430|FG000|Long-Term Treatment Period|Adverse Event|19|||
30608658|NCT01298765|58619430|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
30608659|NCT01298765|58619430|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
30608660|NCT01298765|58619430|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
30608661|NCT01298765|58619430|FG000|Long-Term Treatment Period|Physician Decision|1|||
30608662|NCT01298765|58619430|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
30608663|NCT00997438|58619437|FG000|Overall Study|Blood draw difficulty|2|||
30608664|NCT00997438|58619438|FG001|Overall Study|Blood draw difficulty|0|||
30608665|NCT00997438|58619439|FG002|Overall Study|Blood draw difficulty|1|||
30608666|NCT00997438|58619437|FG000|Overall Study|Withdrawal by Subject|1|||
30608667|NCT00997438|58619438|FG001|Overall Study|Withdrawal by Subject|1|||
30608668|NCT00997438|58619439|FG002|Overall Study|Withdrawal by Subject|0|||
30608669|NCT00997438|58619437|FG000|Overall Study|Exclusion criteria at visit 1|2|||
30608670|NCT00997438|58619438|FG001|Overall Study|Exclusion criteria at visit 1|2|||
30608671|NCT00997438|58619439|FG002|Overall Study|Exclusion criteria at visit 1|3|||
30608672|NCT00997126|58619450|FG000|Overall Study|Physician Decision|7|||
30608673|NCT00997126|58619451|FG001|Overall Study|Physician Decision|11|||
30608674|NCT01000636|58619457|FG000|Overall Study|Withdrawal by Subject|1|||
30608675|NCT01000636|58619457|FG000|Overall Study|Adverse Event|1|||
30608676|NCT00965419|58619461|FG000|Open Label Treatment for Responders|Adverse Event|33|||
30608677|NCT00965419|58619461|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
30608678|NCT00965419|58619461|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
30608679|NCT00965419|58619461|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
30608680|NCT00965419|58619461|FG000|Open Label Treatment for Responders|Physician Decision|6|||
30608681|NCT00965419|58619461|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
30608682|NCT00965419|58619461|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
30608683|NCT00965419|58619461|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
30608684|NCT00965419|58619461|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
30608685|NCT00965419|58619461|FG000|Follow-up Phase|Adverse Event|9|||
30608686|NCT00965419|58619461|FG000|Follow-up Phase|Protocol Violation|4|||
30608687|NCT00965419|58619461|FG000|Follow-up Phase|Withdrawal by Subject|8|||
30608688|NCT00965419|58619461|FG000|Follow-up Phase|Physician Decision|4|||
30608689|NCT00965419|58619461|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
30608690|NCT00965419|58619461|FG000|Follow-up Phase|Lack of Efficacy|28|||
30608691|NCT01000480|58619466|FG000|Induction Phase|Adverse Event|2|||
30608692|NCT01000480|58619466|FG000|Induction Phase|Lost to Follow-up|1|||
30608693|NCT01000480|58619466|FG000|Induction Phase|Physician Decision|1|||
30608694|NCT01000480|58619466|FG000|Induction Phase|Entry Criteria Not Met|3|||
30608695|NCT01000480|58619466|FG000|Concurrent Therapy Phase|Adverse Event|4|||
30608696|NCT01000480|58619466|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
30608697|NCT01000480|58619466|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
30608698|NCT01000480|58619466|FG000|Concurrent Therapy Phase|Physician Decision|1|||
30608699|NCT00965341|58619472|FG000|Overall Study|Withdrew consent|1|||
30608700|NCT00965341|58619473|FG001|Overall Study|Withdrew consent|5|||
30608701|NCT00965341|58619472|FG000|Overall Study|Lost to Follow-up|1|||
30608702|NCT00965341|58619473|FG001|Overall Study|Lost to Follow-up|0|||
30608703|NCT00965341|58619472|FG000|Overall Study|Transportation issues|4|||
30608704|NCT00965341|58619473|FG001|Overall Study|Transportation issues|3|||
30608705|NCT01175811|58619481|FG000|Overall Study|Adverse Event|1|||
30608706|NCT01175811|58619482|FG001|Overall Study|Adverse Event|1|||
30608707|NCT01175811|58619481|FG000|Overall Study|Entry criteria not met|3|||
30608708|NCT01175811|58619482|FG001|Overall Study|Entry criteria not met|1|||
30608709|NCT01175811|58619481|FG000|Overall Study|Lack of Efficacy|1|||
30608710|NCT01175811|58619482|FG001|Overall Study|Lack of Efficacy|0|||
30608711|NCT01175811|58619481|FG000|Overall Study|Lost to Follow-up|3|||
30608712|NCT01175811|58619482|FG001|Overall Study|Lost to Follow-up|2|||
30608713|NCT01175811|58619481|FG000|Overall Study|Physician Decision|1|||
30608714|NCT01175811|58619482|FG001|Overall Study|Physician Decision|1|||
30891748|NCT02420353|58925011|FG000|Overall Study|Withdrawal by Subject|0|||
30891749|NCT02420353|58925012|FG001|Overall Study|Withdrawal by Subject|1|||
30891750|NCT02391337|58925020|FG000|6 Months Follow-up|Death|5|||
30608715|NCT01175811|58619481|FG000|Overall Study|Protocol Violation|1|||
30891751|NCT02391337|58925021|FG001|6 Months Follow-up|Death|4|||
30891752|NCT02391337|58925020|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
30891753|NCT02391337|58925021|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
30608716|NCT01175811|58619482|FG001|Overall Study|Protocol Violation|2|||
30608717|NCT01175811|58619481|FG000|Overall Study|Withdrawal by Subject|6|||
30608718|NCT01175811|58619482|FG001|Overall Study|Withdrawal by Subject|7|||
30608719|NCT00965263|58619490|FG000|Overall Study|Physician Decision|2|||
30608720|NCT00965263|58619491|FG001|Overall Study|Physician Decision|0|||
30608721|NCT00965263|58619490|FG000|Overall Study|Family emergency|0|||
30608722|NCT00965263|58619491|FG001|Overall Study|Family emergency|1|||
30608723|NCT00965263|58619490|FG000|Overall Study|Protocol Violation|0|||
30608724|NCT00965263|58619491|FG001|Overall Study|Protocol Violation|2|||
30608725|NCT00965185|58619517|FG000|Overall Study|Lost to Follow-up|2|||
30608726|NCT00965185|58619518|FG001|Overall Study|Lost to Follow-up|0|||
30608727|NCT00965185|58619517|FG000|Overall Study|Withdrawal by Subject|0|||
30608728|NCT00965185|58619518|FG001|Overall Study|Withdrawal by Subject|1|||
30608729|NCT01174563|58619526|FG000|Overall Study|Progressive Disease|45|||
30608730|NCT01174563|58619526|FG000|Overall Study|Death|5|||
30608731|NCT01174563|58619526|FG000|Overall Study|Investigator's Discretion|5|||
30608732|NCT01174563|58619526|FG000|Overall Study|Participant Withdrew Consent|3|||
30608733|NCT01174563|58619526|FG000|Overall Study|Rash Adverse Event|1|||
30608734|NCT01174563|58619526|FG000|Overall Study|Sponsor's decision|1|||
30608735|NCT01298531|58619532|FG000|Overall Study|Lack of Efficacy|0|||
30608736|NCT01298531|58619533|FG001|Overall Study|Lack of Efficacy|1|||
30608737|NCT01298531|58619532|FG000|Overall Study|Lost to Follow-up|2|||
30608738|NCT01298531|58619533|FG001|Overall Study|Lost to Follow-up|0|||
30608739|NCT01298531|58619532|FG000|Overall Study|Protocol Violation|1|||
30608740|NCT01298531|58619533|FG001|Overall Study|Protocol Violation|1|||
30608741|NCT01298531|58619532|FG000|Overall Study|Adverse Event|4|||
30608742|NCT01298531|58619533|FG001|Overall Study|Adverse Event|3|||
30608743|NCT01298531|58619532|FG000|Overall Study|Does not meet entrance criteria|0|||
30608744|NCT01298531|58619533|FG001|Overall Study|Does not meet entrance criteria|1|||
30608745|NCT01298531|58619532|FG000|Overall Study|Other|2|||
30608746|NCT01298531|58619533|FG001|Overall Study|Other|1|||
30608747|NCT01174173|58619540|FG000|Overall Study|drug-drug interaction|1|||
30608748|NCT00964795|58619545|FG000|Overall Study|Withdrawal by Subject|79|||
30608749|NCT00964795|58619545|FG000|Overall Study|Adverse Event|12|||
30608750|NCT00964795|58619545|FG000|Overall Study|Death|14|||
30608751|NCT00964795|58619545|FG000|Overall Study|Lost to Follow-up|7|||
30608752|NCT00964795|58619545|FG000|Overall Study|Termination of Study by Sponsor|169|||
30608753|NCT00964795|58619545|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
30608754|NCT00964795|58619545|FG000|Overall Study|Other|23|||
30608755|NCT01173471|58619554|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30608756|NCT01173471|58619555|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30608757|NCT01173471|58619556|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
30608758|NCT01173471|58619557|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
30608759|NCT01173471|58619554|FG000|Overall Study|Condition under investigation worsened|2|||
30608760|NCT01173471|58619555|FG001|Overall Study|Condition under investigation worsened|0|||
30608761|NCT01173471|58619556|FG002|Overall Study|Condition under investigation worsened|0|||
30608762|NCT01173471|58619557|FG003|Overall Study|Condition under investigation worsened|0|||
30608763|NCT01173471|58619554|FG000|Overall Study|Lost to Follow-up|0|||
30608764|NCT01173471|58619555|FG001|Overall Study|Lost to Follow-up|0|||
30608765|NCT01173471|58619556|FG002|Overall Study|Lost to Follow-up|1|||
30608766|NCT01173471|58619557|FG003|Overall Study|Lost to Follow-up|0|||
30608767|NCT01173471|58619554|FG000|Overall Study|Reason given as Other|0|||
30608768|NCT01173471|58619555|FG001|Overall Study|Reason given as Other|0|||
30608769|NCT01173471|58619556|FG002|Overall Study|Reason given as Other|1|||
30608770|NCT01173471|58619557|FG003|Overall Study|Reason given as Other|0|||
30608771|NCT01172847|58619567|FG000|Overall Study|Withdrawal by Subject|3|||
30608772|NCT00966355|58619580|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
30608773|NCT00966355|58619581|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
30608774|NCT00966355|58619582|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
30608775|NCT00966355|58619580|FG000|Overall Study|newly diagnosed advanced HCC|11|||
30608776|NCT00966355|58619581|FG001|Overall Study|newly diagnosed advanced HCC|12|||
30608777|NCT00966355|58619582|FG002|Overall Study|newly diagnosed advanced HCC|10|||
30608778|NCT00966355|58619580|FG000|Overall Study|Lost to Follow-up|5|||
30608779|NCT00966355|58619581|FG001|Overall Study|Lost to Follow-up|4|||
30608780|NCT00966355|58619582|FG002|Overall Study|Lost to Follow-up|3|||
30608781|NCT01172535|58619590|FG000|Overall Study|Death|3|||
30608782|NCT01172535|58619590|FG000|Overall Study|Withdrawal by Subject|2|||
30608783|NCT01172535|58619590|FG000|Overall Study|Lost to Follow-up|1|||
30608784|NCT01172535|58619590|FG000|Overall Study|Ineligible at study entry|1|||
30608785|NCT01172535|58619590|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
30891754|NCT02391337|58925020|FG000|12 Months Follow-up|Death|2|||
30608786|NCT00966277|58619599|FG000|Overall Study|Withdrawal by Subject|3|||
30608787|NCT00966277|58619600|FG001|Overall Study|Withdrawal by Subject|0|||
30608788|NCT00966277|58619599|FG000|Overall Study|Ineligible|1|||
30608789|NCT00966277|58619600|FG001|Overall Study|Ineligible|3|||
30608790|NCT00966277|58619599|FG000|Overall Study|Treatment Plan Changed|0|||
30843491|NCT02306161|58869582|FG000|Overall Study|Ineligible|9|||
30608791|NCT00966277|58619600|FG001|Overall Study|Treatment Plan Changed|1|||
30608792|NCT01298141|58619606|FG000|Overall Study|Adverse Event|3|||
30608793|NCT01298141|58619606|FG000|Overall Study|Refusal of Required Study Procedures|1|||
30608794|NCT01298141|58619606|FG000|Overall Study|Withdrawal by Subject|6|||
30608795|NCT01298141|58619606|FG000|Overall Study|Termination of Study by the Investigator|5|||
30608796|NCT01298141|58619606|FG000|Overall Study|Other|5|||
30608797|NCT01298141|58619606|FG000|Overall Study|Lost to Follow-up|1|||
30608798|NCT01298141|58619606|FG000|Overall Study|Death|6|||
30843492|NCT02306161|58869583|FG001|Overall Study|Ineligible|5|||
30843493|NCT02254278|58869591|FG000|Overall Study|Protocol Violation|1|||
30843494|NCT02254278|58869592|FG001|Overall Study|Protocol Violation|1|||
30608799|NCT01298141|58619606|FG000|Overall Study|Not treated|4|||
30608800|NCT01171989|58619613|FG000|Overall Study|Lost to Follow-up|0|||
30608801|NCT01171989|58619614|FG001|Overall Study|Lost to Follow-up|0|||
30608802|NCT01171989|58619615|FG002|Overall Study|Lost to Follow-up|1|||
30608803|NCT01297517|58619626|FG000|Overall Study|Adverse Event|21|||
30608804|NCT01297517|58619627|FG001|Overall Study|Adverse Event|7|||
30608805|NCT01297517|58619628|FG002|Overall Study|Adverse Event|16|||
30608806|NCT01297517|58619626|FG000|Overall Study|Lost to Follow-up|1|||
30608807|NCT01297517|58619627|FG001|Overall Study|Lost to Follow-up|0|||
30608808|NCT01297517|58619628|FG002|Overall Study|Lost to Follow-up|1|||
30608809|NCT01297517|58619626|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
30608810|NCT01297517|58619627|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
30608811|NCT01297517|58619628|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
30608812|NCT01297517|58619626|FG000|Overall Study|Noncompliance|1|||
30608813|NCT01297517|58619627|FG001|Overall Study|Noncompliance|0|||
30608814|NCT01297517|58619628|FG002|Overall Study|Noncompliance|0|||
30608815|NCT01297517|58619626|FG000|Overall Study|Protocol Violation|1|||
30608816|NCT01297517|58619627|FG001|Overall Study|Protocol Violation|1|||
30608817|NCT01297517|58619628|FG002|Overall Study|Protocol Violation|1|||
30608818|NCT01297517|58619626|FG000|Overall Study|Inadequate Control of IOP|1|||
30608819|NCT01297517|58619627|FG001|Overall Study|Inadequate Control of IOP|1|||
30608820|NCT01297517|58619628|FG002|Overall Study|Inadequate Control of IOP|2|||
30608821|NCT01171677|58619638|FG000|Overall Study|Withdrawal by Subject|0|||
30608822|NCT01171677|58619639|FG001|Overall Study|Withdrawal by Subject|3|||
30608823|NCT01171677|58619638|FG000|Overall Study|Adverse Event|1|||
30608824|NCT01171677|58619639|FG001|Overall Study|Adverse Event|0|||
30608825|NCT01171677|58619638|FG000|Overall Study|completed <70% IntenSati classes|5|||
30608826|NCT01171677|58619639|FG001|Overall Study|completed <70% IntenSati classes|0|||
30608827|NCT01171521|58619645|FG000|Overall Study|Lost to Follow-up|5|||
30608828|NCT01171521|58619645|FG000|Overall Study|screen failure|1|||
30608829|NCT01296347|58619651|FG000|Allocation|Withdrawal by Subject|1|||
30608830|NCT01296347|58619652|FG001|Allocation|Withdrawal by Subject|2|||
30608831|NCT01296347|58619651|FG000|Allocation|Lack of Efficacy|1|||
30608832|NCT01296347|58619652|FG001|Allocation|Lack of Efficacy|2|||
30608833|NCT01296347|58619651|FG000|Allocation|not received infusion|1|||
30608834|NCT01296347|58619652|FG001|Allocation|not received infusion|0|||
30608835|NCT01296347|58619651|FG000|6 Week Follow up|Death|0|||
30608836|NCT01296347|58619652|FG001|6 Week Follow up|Death|1|||
30608837|NCT01296347|58619651|FG000|3 Month Follow up|Death|1|||
30608838|NCT01296347|58619652|FG001|3 Month Follow up|Death|0|||
30608839|NCT01296347|58619651|FG000|3 Month Follow up|Lost to Follow-up|0|||
30608840|NCT01296347|58619652|FG001|3 Month Follow up|Lost to Follow-up|1|||
30608841|NCT01296347|58619651|FG000|6 Month Follow up|Death|2|||
30608842|NCT01296347|58619652|FG001|6 Month Follow up|Death|1|||
30608843|NCT01296347|58619651|FG000|6 Month Follow up|Lost to Follow-up|0|||
30608844|NCT01296347|58619652|FG001|6 Month Follow up|Lost to Follow-up|1|||
30608845|NCT01296347|58619651|FG000|12 Month Follow up|Lost to Follow-up|3|||
30608846|NCT01296347|58619652|FG001|12 Month Follow up|Lost to Follow-up|1|||
30608847|NCT01296347|58619651|FG000|12 Month Follow up|Death|1|||
30608848|NCT01296347|58619652|FG001|12 Month Follow up|Death|1|||
30608849|NCT01296347|58619651|FG000|12 Month Follow up|Withdrawal by Subject|0|||
30608850|NCT01296347|58619652|FG001|12 Month Follow up|Withdrawal by Subject|1|||
30608851|NCT01296035|58619661|FG000|Overall Study|Withdrawal by Subject|1|||
30608852|NCT01294787|58619665|FG000|Period 1|Adverse Event|0|||
30608853|NCT01294787|58619666|FG001|Period 1|Adverse Event|0|||
30608854|NCT01294787|58619667|FG002|Period 1|Adverse Event|0|||
30608855|NCT01294787|58619668|FG003|Period 1|Adverse Event|0|||
30608856|NCT01294787|58619669|FG004|Period 1|Adverse Event|1|||
30608857|NCT01294787|58619670|FG005|Period 1|Adverse Event|0|||
30608858|NCT01294787|58619665|FG000|Period 1|Withdrawal by Subject|0|||
30608859|NCT01294787|58619666|FG001|Period 1|Withdrawal by Subject|0|||
30608860|NCT01294787|58619667|FG002|Period 1|Withdrawal by Subject|0|||
30608861|NCT01294787|58619668|FG003|Period 1|Withdrawal by Subject|1|||
30608862|NCT01294787|58619669|FG004|Period 1|Withdrawal by Subject|1|||
30608863|NCT01294787|58619670|FG005|Period 1|Withdrawal by Subject|1|||
30608864|NCT01294787|58619665|FG000|Period 1|Administrative problem|0|||
30608865|NCT01294787|58619666|FG001|Period 1|Administrative problem|0|||
30608866|NCT01294787|58619667|FG002|Period 1|Administrative problem|1|||
30608867|NCT01294787|58619668|FG003|Period 1|Administrative problem|0|||
30608868|NCT01294787|58619669|FG004|Period 1|Administrative problem|0|||
30608869|NCT01294787|58619670|FG005|Period 1|Administrative problem|1|||
30608870|NCT01294787|58619665|FG000|Period 2|Adverse Event|0|||
30608871|NCT01294787|58619666|FG001|Period 2|Adverse Event|3|||
30608872|NCT01294787|58619667|FG002|Period 2|Adverse Event|0|||
30608873|NCT01294787|58619668|FG003|Period 2|Adverse Event|1|||
30608874|NCT01294787|58619669|FG004|Period 2|Adverse Event|0|||
30608875|NCT01294787|58619670|FG005|Period 2|Adverse Event|0|||
30608876|NCT01294787|58619665|FG000|Period 2|No longer needs study drug|0|||
30608877|NCT01294787|58619666|FG001|Period 2|No longer needs study drug|0|||
30608878|NCT01294787|58619667|FG002|Period 2|No longer needs study drug|0|||
30608879|NCT01294787|58619668|FG003|Period 2|No longer needs study drug|1|||
30608880|NCT01294787|58619669|FG004|Period 2|No longer needs study drug|0|||
30608881|NCT01294787|58619670|FG005|Period 2|No longer needs study drug|0|||
30608882|NCT01294787|58619665|FG000|Period 3|Adverse Event|0|||
30608883|NCT01294787|58619666|FG001|Period 3|Adverse Event|0|||
30608884|NCT01294787|58619667|FG002|Period 3|Adverse Event|0|||
30608885|NCT01294787|58619668|FG003|Period 3|Adverse Event|0|||
30608886|NCT01294787|58619669|FG004|Period 3|Adverse Event|1|||
30608887|NCT01294787|58619670|FG005|Period 3|Adverse Event|0|||
30608888|NCT01294553|58619681|FG000|Overall Study|Duplicated Participants|1|||
30608889|NCT01294553|58619681|FG000|Overall Study|Protocol Violation|268|||
30608890|NCT01294397|58619686|FG000|Overall Study|Withdrawal by Subject|1|||
30608891|NCT01294397|58619686|FG000|Overall Study|Administrative Decision|1|||
30608892|NCT01293695|58619694|FG000|Overall Study|Withdrawal by Subject|7|||
30608893|NCT01293695|58619695|FG001|Overall Study|Withdrawal by Subject|1|||
30608894|NCT01293695|58619694|FG000|Overall Study|Lost to Follow-up|8|||
30608895|NCT01293695|58619695|FG001|Overall Study|Lost to Follow-up|6|||
30608896|NCT01293539|58619704|FG000|Overall Study|Physician Decision|1|||
30608897|NCT01292837|58619708|FG000|Overall Study|Adverse Event|1|||
30608898|NCT01292837|58619708|FG000|Overall Study|Further treatment determined|1|||
30608899|NCT00965731|58619714|FG000|Overall Study|Death|0|||
30608900|NCT00965731|58619715|FG001|Overall Study|Death|4|||
30608901|NCT00965731|58619714|FG000|Overall Study|Withdrawal by Subject|0|||
30608902|NCT00965731|58619715|FG001|Overall Study|Withdrawal by Subject|1|||
30608903|NCT00965731|58619714|FG000|Overall Study|Other|7|||
30608904|NCT00965731|58619715|FG001|Overall Study|Other|15|||
30608905|NCT00965575|58619728|FG000|Overall Study|subject unwillingness to swallow study c|1|||
30608906|NCT00965575|58619729|FG001|Overall Study|subject unwillingness to swallow study c|0|||
30608907|NCT00965497|58619737|FG000|Overall Study|Physician Decision|1|||
30608908|NCT00963937|58619744|FG000|Overall Study|Protocol Violation|1|||
30608909|NCT00963937|58619745|FG001|Overall Study|Protocol Violation|1|||
30608910|NCT00963937|58619746|FG002|Overall Study|Protocol Violation|0|||
30608911|NCT00963937|58619744|FG000|Overall Study|Physician Decision|18|||
30608912|NCT00963937|58619745|FG001|Overall Study|Physician Decision|10|||
30608913|NCT00963937|58619746|FG002|Overall Study|Physician Decision|4|||
30608914|NCT01170663|58619759|FG000|Overall Study|Lost to Follow-up|3|||
30608915|NCT01170663|58619760|FG001|Overall Study|Lost to Follow-up|9|||
30608916|NCT01170663|58619759|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
30608917|NCT01170663|58619760|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
30608918|NCT01170273|58619768|FG000|Overall Study|Lost to Follow-up|6|||
30608919|NCT01170273|58619769|FG001|Overall Study|Lost to Follow-up|8|||
30608920|NCT01170273|58619768|FG000|Overall Study|Protocol Violation|1|||
30608921|NCT01170273|58619769|FG001|Overall Study|Protocol Violation|0|||
30608922|NCT01170273|58619768|FG000|Overall Study|Death|1|||
30608923|NCT01170273|58619769|FG001|Overall Study|Death|0|||
30608924|NCT01170273|58619768|FG000|Overall Study|Adverse Event|0|||
30608925|NCT01170273|58619769|FG001|Overall Study|Adverse Event|1|||
30608926|NCT01170039|58619777|FG000|Overall Study|Withdrawal by Subject|5|||
30608927|NCT01170039|58619778|FG001|Overall Study|Withdrawal by Subject|3|||
30608928|NCT01170039|58619777|FG000|Overall Study|Lack of funding, drug not available|3|||
30608929|NCT01170039|58619778|FG001|Overall Study|Lack of funding, drug not available|3|||
30608930|NCT01169649|58619784|FG000|Overall Study|Patient Not Treated|3|||
30608931|NCT01169493|58619794|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
30608932|NCT01169493|58619795|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
30608933|NCT01169493|58619796|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
30608934|NCT01169493|58619797|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
30608935|NCT01169493|58619798|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
30608936|NCT01169493|58619799|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
30608937|NCT01169493|58619794|FG000|Period 3 (6 Months)|Adverse Event|0|||
30608938|NCT01169493|58619795|FG001|Period 3 (6 Months)|Adverse Event|1|||
30608939|NCT01169493|58619796|FG002|Period 3 (6 Months)|Adverse Event|0|||
30608940|NCT01169493|58619797|FG003|Period 3 (6 Months)|Adverse Event|0|||
30608941|NCT01169493|58619798|FG004|Period 3 (6 Months)|Adverse Event|0|||
30608942|NCT01169493|58619799|FG005|Period 3 (6 Months)|Adverse Event|0|||
30608943|NCT01169493|58619794|FG000|Period 3 (6 Months)|Physician Decision|0|||
30608944|NCT01169493|58619795|FG001|Period 3 (6 Months)|Physician Decision|1|||
30891755|NCT02391337|58925021|FG001|12 Months Follow-up|Death|0|||
30608945|NCT01169493|58619796|FG002|Period 3 (6 Months)|Physician Decision|1|||
30608946|NCT01169493|58619797|FG003|Period 3 (6 Months)|Physician Decision|0|||
30608947|NCT01169493|58619798|FG004|Period 3 (6 Months)|Physician Decision|0|||
30608948|NCT01169493|58619799|FG005|Period 3 (6 Months)|Physician Decision|0|||
30608949|NCT01287104|58619811|FG000|Overall Study|Patient developed progressive disease|1|||
30608950|NCT01287104|58619812|FG001|Overall Study|Patient developed progressive disease|1|||
30608951|NCT01287104|58619813|FG002|Overall Study|Patient developed progressive disease|3|||
30608952|NCT01287104|58619814|FG003|Overall Study|Patient developed progressive disease|2|||
30608953|NCT01287104|58619811|FG000|Overall Study|Donor anaphylaxis|0|||
30608954|NCT01287104|58619812|FG001|Overall Study|Donor anaphylaxis|1|||
30608955|NCT01287104|58619813|FG002|Overall Study|Donor anaphylaxis|0|||
30608956|NCT01287104|58619814|FG003|Overall Study|Donor anaphylaxis|1|||
30608957|NCT01287104|58619811|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
30608958|NCT01287104|58619812|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
30987371|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987372|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987373|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987374|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987375|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987376|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987377|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987378|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987379|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987380|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987381|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987382|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987383|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
30987384|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987385|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987386|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987387|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987388|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987389|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987390|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987391|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987392|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
30987393|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987394|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987395|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
30987396|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987397|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
30987398|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
30987399|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987400|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987401|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987402|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987403|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987404|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987405|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987406|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987407|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
30987408|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987409|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987410|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987411|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987412|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987413|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987414|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987415|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987416|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987417|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
30987418|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987419|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987420|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987421|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987422|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987423|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987424|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987425|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987426|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987427|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987428|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987429|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987430|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987431|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
30987432|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987433|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987434|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987435|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987436|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987437|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987438|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987439|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987440|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987441|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987442|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
30987443|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987444|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987445|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987446|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987447|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987448|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987449|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987450|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987451|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987452|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987453|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987454|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987455|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
30987456|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987457|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987458|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987459|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987460|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987461|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987462|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987463|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987464|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987465|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987466|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987467|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987468|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987469|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987470|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
30987471|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987472|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987473|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987474|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987475|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987476|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987477|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987478|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987479|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
30987480|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987481|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987482|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987483|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987484|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987485|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987486|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987487|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987488|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987489|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987490|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987491|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987492|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987493|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987494|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
30987495|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987496|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987497|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987498|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987499|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987500|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987501|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987502|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987503|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
30987504|NCT02346240|59139101|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987505|NCT02346240|59139102|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987506|NCT02346240|59139103|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987507|NCT02346240|59139104|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987508|NCT02346240|59139105|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987509|NCT02346240|59139106|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987510|NCT02346240|59139107|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987511|NCT02346240|59139108|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987512|NCT02346240|59139109|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987513|NCT02346240|59139110|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987514|NCT02346240|59139111|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987515|NCT02346240|59139112|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987516|NCT02346240|59139113|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987517|NCT02346240|59139114|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987518|NCT02346240|59139115|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
30987519|NCT02346240|59139116|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987520|NCT02346240|59139117|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987521|NCT02346240|59139118|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987522|NCT02346240|59139119|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987523|NCT02346240|59139120|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987524|NCT02346240|59139121|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987525|NCT02346240|59139122|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987526|NCT02346240|59139123|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987527|NCT02346240|59139124|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
30987528|NCT02346240|59139101|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987529|NCT02346240|59139102|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987530|NCT02346240|59139103|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987531|NCT02346240|59139104|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987532|NCT02346240|59139105|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987533|NCT02346240|59139106|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987534|NCT02346240|59139107|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987535|NCT02346240|59139108|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987536|NCT02346240|59139109|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987537|NCT02346240|59139110|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987538|NCT02346240|59139111|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987539|NCT02346240|59139112|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987540|NCT02346240|59139113|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987541|NCT02346240|59139114|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987542|NCT02346240|59139115|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987543|NCT02346240|59139116|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987544|NCT02346240|59139117|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
30987545|NCT02346240|59139118|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
30987546|NCT02346240|59139119|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
30987547|NCT02346240|59139120|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
30987548|NCT02346240|59139121|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
30987549|NCT02346240|59139122|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
30987550|NCT02346240|59139123|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
30987551|NCT02346240|59139124|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
30987552|NCT02346240|59139101|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987553|NCT02346240|59139102|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987554|NCT02346240|59139103|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987555|NCT02346240|59139104|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987556|NCT02346240|59139105|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987557|NCT02346240|59139106|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987558|NCT02346240|59139107|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987559|NCT02346240|59139108|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987560|NCT02346240|59139109|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987561|NCT02346240|59139110|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987562|NCT02346240|59139111|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987563|NCT02346240|59139112|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987564|NCT02346240|59139113|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987565|NCT02346240|59139114|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987566|NCT02346240|59139115|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987567|NCT02346240|59139116|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987568|NCT02346240|59139117|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987569|NCT02346240|59139118|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987570|NCT02346240|59139119|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
30987571|NCT02346240|59139120|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
30987572|NCT02346240|59139121|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987573|NCT02346240|59139122|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
30987574|NCT02346240|59139123|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987575|NCT02346240|59139124|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
30987576|NCT02346240|59139101|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987577|NCT02346240|59139102|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987578|NCT02346240|59139103|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987579|NCT02346240|59139104|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987580|NCT02346240|59139105|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987581|NCT02346240|59139106|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987582|NCT02346240|59139107|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987583|NCT02346240|59139108|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987584|NCT02346240|59139109|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987585|NCT02346240|59139110|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987586|NCT02346240|59139111|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987587|NCT02346240|59139112|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987588|NCT02346240|59139113|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987589|NCT02346240|59139114|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987590|NCT02346240|59139115|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987591|NCT02346240|59139116|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987592|NCT02346240|59139117|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987593|NCT02346240|59139118|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987594|NCT02346240|59139119|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
30987595|NCT02346240|59139120|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987596|NCT02346240|59139121|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987597|NCT02346240|59139122|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
30987598|NCT02346240|59139123|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987599|NCT02346240|59139124|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30987600|NCT02346240|59139101|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987601|NCT02346240|59139102|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987602|NCT02346240|59139103|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987603|NCT02346240|59139104|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987604|NCT02346240|59139105|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987605|NCT02346240|59139106|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987606|NCT02346240|59139107|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987607|NCT02346240|59139108|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987608|NCT02346240|59139109|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987609|NCT02346240|59139110|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987610|NCT02346240|59139111|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987611|NCT02346240|59139112|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987612|NCT02346240|59139113|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987613|NCT02346240|59139114|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987614|NCT02346240|59139115|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987615|NCT02346240|59139116|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987616|NCT02346240|59139117|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987617|NCT02346240|59139118|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987618|NCT02346240|59139119|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987619|NCT02346240|59139120|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987620|NCT02346240|59139121|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987621|NCT02346240|59139122|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
30987622|NCT02346240|59139123|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987623|NCT02346240|59139124|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
30987624|NCT02346240|59139101|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987625|NCT02346240|59139102|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987626|NCT02346240|59139103|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987627|NCT02346240|59139104|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987628|NCT02346240|59139105|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987629|NCT02346240|59139106|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987630|NCT02346240|59139107|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987631|NCT02346240|59139108|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987632|NCT02346240|59139109|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987633|NCT02346240|59139110|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987634|NCT02346240|59139111|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987635|NCT02346240|59139112|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987636|NCT02346240|59139113|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987637|NCT02346240|59139114|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987638|NCT02346240|59139115|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987639|NCT02346240|59139116|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987640|NCT02346240|59139117|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987641|NCT02346240|59139118|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
30987642|NCT02346240|59139119|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
30987643|NCT02346240|59139120|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
30987644|NCT02346240|59139121|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30987645|NCT02346240|59139122|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
30987646|NCT02346240|59139123|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
30987647|NCT02346240|59139124|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
30987648|NCT02346240|59139101|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987649|NCT02346240|59139102|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987650|NCT02346240|59139103|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987651|NCT02346240|59139104|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987652|NCT02346240|59139105|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987653|NCT02346240|59139106|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987654|NCT02346240|59139107|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987655|NCT02346240|59139108|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987656|NCT02346240|59139109|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987657|NCT02346240|59139110|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987658|NCT02346240|59139111|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987659|NCT02346240|59139112|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987660|NCT02346240|59139113|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987661|NCT02346240|59139114|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987662|NCT02346240|59139115|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987663|NCT02346240|59139116|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987664|NCT02346240|59139117|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987665|NCT02346240|59139118|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987666|NCT02346240|59139119|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
30891756|NCT02391337|58925020|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
30891757|NCT02391337|58925021|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
30891758|NCT02391337|58925020|FG000|12 Months Follow-up|Lost to Follow-up|0|||
30891759|NCT02391337|58925021|FG001|12 Months Follow-up|Lost to Follow-up|2|||
30891760|NCT02382991|58925029|FG000|Overall Study|Adverse Event|1|||
30987667|NCT02346240|59139120|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
30987668|NCT02346240|59139121|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30987669|NCT02346240|59139122|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
30987670|NCT02346240|59139123|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
30987671|NCT02346240|59139124|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
30987672|NCT02346240|59139101|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987673|NCT02346240|59139102|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987674|NCT02346240|59139103|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987675|NCT02346240|59139104|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987676|NCT02346240|59139105|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987677|NCT02346240|59139106|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987678|NCT02346240|59139107|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987679|NCT02346240|59139108|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987680|NCT02346240|59139109|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987681|NCT02346240|59139110|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987682|NCT02346240|59139111|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987683|NCT02346240|59139112|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987684|NCT02346240|59139113|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987685|NCT02346240|59139114|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987686|NCT02346240|59139115|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987687|NCT02346240|59139116|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987688|NCT02346240|59139117|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987689|NCT02346240|59139118|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987690|NCT02346240|59139119|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
30987691|NCT02346240|59139120|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987692|NCT02346240|59139121|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
30987693|NCT02346240|59139122|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
30987694|NCT02346240|59139123|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
30987695|NCT02346240|59139124|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
30987696|NCT02346240|59139101|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987697|NCT02346240|59139102|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987698|NCT02346240|59139103|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987699|NCT02346240|59139104|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987700|NCT02346240|59139105|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987701|NCT02346240|59139106|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987702|NCT02346240|59139107|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987703|NCT02346240|59139108|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987704|NCT02346240|59139109|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987705|NCT02346240|59139110|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987706|NCT02346240|59139111|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987707|NCT02346240|59139112|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987708|NCT02346240|59139113|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987709|NCT02346240|59139114|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987710|NCT02346240|59139115|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987711|NCT02346240|59139116|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987712|NCT02346240|59139117|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987713|NCT02346240|59139118|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987714|NCT02346240|59139119|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
30987715|NCT02346240|59139120|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987716|NCT02346240|59139121|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987717|NCT02346240|59139122|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987718|NCT02346240|59139123|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987719|NCT02346240|59139124|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
30987720|NCT02392104|59139175|FG000|Overall Study|discontinuation of warfarin|3|||
30987721|NCT02392104|59139175|FG000|Overall Study|bleeding event|1|||
30987722|NCT02392104|59139175|FG000|Overall Study|transferred care to another doctor|2|||
30987723|NCT02392104|59139175|FG000|Overall Study|INR goal range changed|1|||
30987724|NCT02392104|59139175|FG000|Overall Study|admitted to skilled nursing facility|3|||
30987725|NCT02392104|59139175|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
30987726|NCT02391948|59139193|FG000|6-month Assessment|Death|0|||
30987727|NCT02391948|59139194|FG001|6-month Assessment|Death|0|||
30987728|NCT02391948|59139195|FG002|6-month Assessment|Death|0|||
30987729|NCT02391948|59139196|FG003|6-month Assessment|Death|0|||
30987730|NCT02391948|59139197|FG004|6-month Assessment|Death|1|||
30987731|NCT02391948|59139193|FG000|6-month Assessment|Withdrawal by Subject|0|||
30987732|NCT02391948|59139194|FG001|6-month Assessment|Withdrawal by Subject|0|||
30987733|NCT02391948|59139195|FG002|6-month Assessment|Withdrawal by Subject|1|||
30987734|NCT02391948|59139196|FG003|6-month Assessment|Withdrawal by Subject|2|||
30987735|NCT02391948|59139197|FG004|6-month Assessment|Withdrawal by Subject|0|||
30987736|NCT02391948|59139193|FG000|6-month Assessment|Lost to Follow-up|4|||
30987737|NCT02391948|59139194|FG001|6-month Assessment|Lost to Follow-up|5|||
30987738|NCT02391948|59139195|FG002|6-month Assessment|Lost to Follow-up|2|||
30987739|NCT02391948|59139196|FG003|6-month Assessment|Lost to Follow-up|3|||
30987740|NCT02391948|59139197|FG004|6-month Assessment|Lost to Follow-up|1|||
30987741|NCT02391948|59139193|FG000|6-month Assessment|Medical issue/illness|1|||
30987742|NCT02391948|59139194|FG001|6-month Assessment|Medical issue/illness|1|||
30987743|NCT02391948|59139195|FG002|6-month Assessment|Medical issue/illness|0|||
30987744|NCT02391948|59139196|FG003|6-month Assessment|Medical issue/illness|0|||
30987745|NCT02391948|59139197|FG004|6-month Assessment|Medical issue/illness|0|||
30987746|NCT02391948|59139193|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
30987747|NCT02391948|59139194|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
30987748|NCT02391948|59139195|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
30987749|NCT02391948|59139196|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
30987750|NCT02391948|59139197|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
30987751|NCT02391948|59139193|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
30987752|NCT02391948|59139194|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
30987753|NCT02391948|59139195|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
30987754|NCT02391948|59139196|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
30987755|NCT02391948|59139197|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
30987756|NCT02391948|59139193|FG000|12-month Assessment|Death|0|||
30987757|NCT02391948|59139194|FG001|12-month Assessment|Death|0|||
30987758|NCT02391948|59139195|FG002|12-month Assessment|Death|0|||
30987759|NCT02391948|59139196|FG003|12-month Assessment|Death|1|||
30987760|NCT02391948|59139197|FG004|12-month Assessment|Death|0|||
30987761|NCT02391948|59139193|FG000|12-month Assessment|Withdrawal by Subject|1|||
30987762|NCT02391948|59139194|FG001|12-month Assessment|Withdrawal by Subject|0|||
30987763|NCT02391948|59139195|FG002|12-month Assessment|Withdrawal by Subject|0|||
30987764|NCT02391948|59139196|FG003|12-month Assessment|Withdrawal by Subject|1|||
30987765|NCT02391948|59139197|FG004|12-month Assessment|Withdrawal by Subject|0|||
30987766|NCT02391948|59139193|FG000|12-month Assessment|Lost to Follow-up|5|||
30987767|NCT02391948|59139194|FG001|12-month Assessment|Lost to Follow-up|4|||
30987768|NCT02391948|59139195|FG002|12-month Assessment|Lost to Follow-up|4|||
30987769|NCT02391948|59139196|FG003|12-month Assessment|Lost to Follow-up|4|||
30987770|NCT02391948|59139197|FG004|12-month Assessment|Lost to Follow-up|5|||
30987771|NCT02391948|59139193|FG000|12-month Assessment|Medical issue/illness|0|||
30987772|NCT02391948|59139194|FG001|12-month Assessment|Medical issue/illness|1|||
30987773|NCT02391948|59139195|FG002|12-month Assessment|Medical issue/illness|0|||
30987774|NCT02391948|59139196|FG003|12-month Assessment|Medical issue/illness|1|||
30987775|NCT02391948|59139197|FG004|12-month Assessment|Medical issue/illness|0|||
30987776|NCT02391948|59139193|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
30987777|NCT02391948|59139194|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
30987778|NCT02391948|59139195|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
30987779|NCT02391948|59139196|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
30987780|NCT02391948|59139197|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
30987781|NCT02391948|59139193|FG000|18-month Assessment|Death|0|||
30987782|NCT02391948|59139194|FG001|18-month Assessment|Death|0|||
30987783|NCT02391948|59139195|FG002|18-month Assessment|Death|0|||
30987784|NCT02391948|59139196|FG003|18-month Assessment|Death|1|||
30987785|NCT02391948|59139197|FG004|18-month Assessment|Death|1|||
30987786|NCT02391948|59139193|FG000|18-month Assessment|Withdrawal by Subject|1|||
30987787|NCT02391948|59139194|FG001|18-month Assessment|Withdrawal by Subject|0|||
30987788|NCT02391948|59139195|FG002|18-month Assessment|Withdrawal by Subject|0|||
30987789|NCT02391948|59139196|FG003|18-month Assessment|Withdrawal by Subject|1|||
30987790|NCT02391948|59139197|FG004|18-month Assessment|Withdrawal by Subject|0|||
30987791|NCT02391948|59139193|FG000|18-month Assessment|Lost to Follow-up|2|||
30987792|NCT02391948|59139194|FG001|18-month Assessment|Lost to Follow-up|6|||
30987793|NCT02391948|59139195|FG002|18-month Assessment|Lost to Follow-up|2|||
30987794|NCT02391948|59139196|FG003|18-month Assessment|Lost to Follow-up|2|||
30987795|NCT02391948|59139197|FG004|18-month Assessment|Lost to Follow-up|3|||
30987796|NCT02391948|59139193|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
30987797|NCT02391948|59139194|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
30987798|NCT02391948|59139195|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
30987799|NCT02391948|59139196|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
30987800|NCT02391948|59139197|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
30987801|NCT02391948|59139193|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
30987802|NCT02391948|59139194|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
30987803|NCT02391948|59139195|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
30987804|NCT02391948|59139196|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
30987805|NCT02391948|59139197|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
30987806|NCT02391948|59139193|FG000|24-month Assessment|Death|0|||
30987807|NCT02391948|59139194|FG001|24-month Assessment|Death|0|||
30987808|NCT02391948|59139195|FG002|24-month Assessment|Death|0|||
30987809|NCT02391948|59139196|FG003|24-month Assessment|Death|0|||
30987810|NCT02391948|59139197|FG004|24-month Assessment|Death|1|||
30987811|NCT02391948|59139193|FG000|24-month Assessment|Withdrawal by Subject|1|||
30987812|NCT02391948|59139194|FG001|24-month Assessment|Withdrawal by Subject|1|||
30987813|NCT02391948|59139195|FG002|24-month Assessment|Withdrawal by Subject|0|||
30987814|NCT02391948|59139196|FG003|24-month Assessment|Withdrawal by Subject|0|||
30987815|NCT02391948|59139197|FG004|24-month Assessment|Withdrawal by Subject|1|||
30987816|NCT02391948|59139193|FG000|24-month Assessment|Lost to Follow-up|5|||
30987817|NCT02391948|59139194|FG001|24-month Assessment|Lost to Follow-up|4|||
30987818|NCT02391948|59139195|FG002|24-month Assessment|Lost to Follow-up|0|||
30987819|NCT02391948|59139196|FG003|24-month Assessment|Lost to Follow-up|0|||
30987820|NCT02391948|59139197|FG004|24-month Assessment|Lost to Follow-up|0|||
30987821|NCT02391948|59139193|FG000|24-month Assessment|Medical issue/illness|0|||
30987822|NCT02391948|59139194|FG001|24-month Assessment|Medical issue/illness|0|||
30987823|NCT02391948|59139195|FG002|24-month Assessment|Medical issue/illness|1|||
30987824|NCT02391948|59139196|FG003|24-month Assessment|Medical issue/illness|0|||
30987825|NCT02391948|59139197|FG004|24-month Assessment|Medical issue/illness|0|||
30987826|NCT02391948|59139193|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
30987827|NCT02391948|59139194|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
30987828|NCT02391948|59139195|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
30987829|NCT02391948|59139196|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
30987830|NCT02391948|59139197|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
30987831|NCT02369874|59139440|FG000|Overall Study|Lost to Follow-up|2|||
30987832|NCT02369874|59139441|FG001|Overall Study|Lost to Follow-up|2|||
30987833|NCT02369874|59139442|FG002|Overall Study|Lost to Follow-up|2|||
30987834|NCT02369874|59139440|FG000|Overall Study|Withdrawal by Subject|7|||
30987835|NCT02369874|59139441|FG001|Overall Study|Withdrawal by Subject|9|||
30987836|NCT02369874|59139442|FG002|Overall Study|Withdrawal by Subject|27|||
30987837|NCT02369874|59139440|FG000|Overall Study|Miscellaneous|1|||
30987838|NCT02369874|59139441|FG001|Overall Study|Miscellaneous|1|||
30987839|NCT02369874|59139442|FG002|Overall Study|Miscellaneous|0|||
30987840|NCT02369874|59139440|FG000|Overall Study|On Treatment/Off Study|34|||
30987841|NCT02369874|59139441|FG001|Overall Study|On Treatment/Off Study|45|||
30987842|NCT02369874|59139442|FG002|Overall Study|On Treatment/Off Study|32|||
30987843|NCT02368314|59139585|FG000|Overall Study|Withdrawal by Subject|2|||
30987844|NCT02368314|59139586|FG001|Overall Study|Withdrawal by Subject|1|||
30987845|NCT02368314|59139585|FG000|Overall Study|Adverse Event|1|||
30987846|NCT02368314|59139586|FG001|Overall Study|Adverse Event|2|||
30987847|NCT02366910|59139596|FG000|Overall Study|Withdrawal by Subject|2|||
30987848|NCT02366910|59139596|FG000|Overall Study|Screen Failure|3|||
30987849|NCT02345226|59139900|FG000|Double-Blind Phase|Adverse Event|5|||
30987850|NCT02345226|59139901|FG001|Double-Blind Phase|Adverse Event|6|||
30987851|NCT02345226|59139900|FG000|Double-Blind Phase|Death|3|||
30987852|NCT02345226|59139901|FG001|Double-Blind Phase|Death|0|||
30987853|NCT02345226|59139900|FG000|Double-Blind Phase|Pregnancy|0|||
30987854|NCT02345226|59139901|FG001|Double-Blind Phase|Pregnancy|1|||
30987855|NCT02345226|59139900|FG000|Double-Blind Phase|Lack of Efficacy|1|||
30987856|NCT02345226|59139901|FG001|Double-Blind Phase|Lack of Efficacy|0|||
30987857|NCT02345226|59139900|FG000|Double-Blind Phase|Investigator's Discretion|4|||
30987858|NCT02345226|59139901|FG001|Double-Blind Phase|Investigator's Discretion|3|||
30987859|NCT02345226|59139900|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
30987860|NCT02345226|59139901|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
30987861|NCT02345226|59139900|FG000|Double-Blind Phase|Withdrew Consent|41|||
30987862|NCT02345226|59139901|FG001|Double-Blind Phase|Withdrew Consent|39|||
30987863|NCT02345226|59139900|FG000|Double-Blind Phase|Lost to Follow-up|12|||
30987864|NCT02345226|59139901|FG001|Double-Blind Phase|Lost to Follow-up|16|||
30987865|NCT02345226|59139900|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
30987866|NCT02345226|59139901|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
30987867|NCT02345226|59139900|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
30987868|NCT02345226|59139901|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
30987869|NCT00551369|59140472|FG000|Overall Study|Protocol Violation|5|||
30987870|NCT00551369|59140472|FG000|Overall Study|Withdrawal by Subject|1|||
30987871|NCT00551369|59140472|FG000|Overall Study|Not treated per protocol and re|1|||
30987872|NCT00551291|59140485|FG000|Overall Study|Physician Decision|1|||
30987873|NCT00551213|59140591|FG000|Overall Study|Adverse Event|6|||
30987874|NCT00551213|59140592|FG001|Overall Study|Adverse Event|3|||
30987875|NCT00551213|59140591|FG000|Overall Study|Progressive Disease|41|||
30987876|NCT00551213|59140592|FG001|Overall Study|Progressive Disease|12|||
30987877|NCT00551213|59140591|FG000|Overall Study|Withdrawal by Subject|2|||
30987878|NCT00551213|59140592|FG001|Overall Study|Withdrawal by Subject|0|||
30987879|NCT00551213|59140591|FG000|Overall Study|Not Treated|1|||
30987880|NCT00551213|59140592|FG001|Overall Study|Not Treated|2|||
30987881|NCT00550043|59140729|FG000|Overall Study|Adverse Event|0|||
30987882|NCT00550043|59140730|FG001|Overall Study|Adverse Event|0|||
30987883|NCT00550043|59140731|FG002|Overall Study|Adverse Event|0|||
30987884|NCT00550043|59140732|FG003|Overall Study|Adverse Event|1|||
30987885|NCT00550043|59140733|FG004|Overall Study|Adverse Event|1|||
30987886|NCT00550043|59140729|FG000|Overall Study|Subject Withdrew Consent|0|||
30987887|NCT00550043|59140730|FG001|Overall Study|Subject Withdrew Consent|2|||
30987888|NCT00550043|59140731|FG002|Overall Study|Subject Withdrew Consent|1|||
30987889|NCT00550043|59140732|FG003|Overall Study|Subject Withdrew Consent|0|||
30987890|NCT00550043|59140733|FG004|Overall Study|Subject Withdrew Consent|0|||
30987891|NCT00550043|59140729|FG000|Overall Study|Other Reasons- Unspecified|0|||
30987892|NCT00550043|59140730|FG001|Overall Study|Other Reasons- Unspecified|1|||
30987893|NCT00550043|59140731|FG002|Overall Study|Other Reasons- Unspecified|0|||
30987894|NCT00550043|59140732|FG003|Overall Study|Other Reasons- Unspecified|1|||
30987895|NCT00550043|59140733|FG004|Overall Study|Other Reasons- Unspecified|0|||
30987896|NCT03188822|59141461|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
30987897|NCT03188822|59141461|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
30987898|NCT04976777|59141604|FG000|Overall Study|COVID-19 Infection|1|||
30987899|NCT04976777|59141605|FG001|Overall Study|COVID-19 Infection|0|||
30987900|NCT00555971|59141779|FG000|Overall Study|Adverse Event|1|||
30987901|NCT00555971|59141780|FG001|Overall Study|Adverse Event|1|||
30987902|NCT02343120|59142656|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
30987903|NCT02343120|59142657|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
30987904|NCT02343120|59142658|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
30987905|NCT02343120|59142659|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
30987906|NCT02343120|59142660|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
30987907|NCT02343120|59142656|FG000|Part 1: Dose Escalation|Death|1|||
30987908|NCT02343120|59142657|FG001|Part 1: Dose Escalation|Death|2|||
30987909|NCT02343120|59142658|FG002|Part 1: Dose Escalation|Death|2|||
30987910|NCT02343120|59142659|FG003|Part 1: Dose Escalation|Death|2|||
30987911|NCT02343120|59142660|FG004|Part 1: Dose Escalation|Death|1|||
30987912|NCT02343120|59142656|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
30987913|NCT02343120|59142657|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
30987914|NCT02343120|59142658|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
30987915|NCT02343120|59142659|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
30987916|NCT02343120|59142660|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
30987917|NCT02343120|59142656|FG000|Part 2: Expansion|Sponsor decision|0|||
30987918|NCT02343120|59142657|FG001|Part 2: Expansion|Sponsor decision|0|||
30987919|NCT02343120|59142658|FG002|Part 2: Expansion|Sponsor decision|0|||
30987920|NCT02343120|59142659|FG003|Part 2: Expansion|Sponsor decision|165|||
30987921|NCT02343120|59142660|FG004|Part 2: Expansion|Sponsor decision|67|||
30987922|NCT02343120|59142656|FG000|Part 2: Expansion|Death|0|||
30987923|NCT02343120|59142657|FG001|Part 2: Expansion|Death|0|||
30987924|NCT02343120|59142658|FG002|Part 2: Expansion|Death|0|||
30987925|NCT02343120|59142659|FG003|Part 2: Expansion|Death|74|||
30987926|NCT02343120|59142660|FG004|Part 2: Expansion|Death|17|||
30987927|NCT02343120|59142656|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
30987928|NCT02343120|59142657|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
30987929|NCT02343120|59142658|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
30987930|NCT02343120|59142659|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
30987931|NCT02343120|59142660|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
30987932|NCT02343120|59142656|FG000|Part 2: Expansion|Lost to Follow-up|0|||
30987933|NCT02343120|59142657|FG001|Part 2: Expansion|Lost to Follow-up|0|||
30987934|NCT02343120|59142658|FG002|Part 2: Expansion|Lost to Follow-up|0|||
30987935|NCT02343120|59142659|FG003|Part 2: Expansion|Lost to Follow-up|5|||
30987936|NCT02343120|59142660|FG004|Part 2: Expansion|Lost to Follow-up|2|||
30987937|NCT02343120|59142656|FG000|Part 2: Expansion|Other|0|||
30987938|NCT02343120|59142657|FG001|Part 2: Expansion|Other|0|||
30987939|NCT02343120|59142658|FG002|Part 2: Expansion|Other|0|||
30987940|NCT02343120|59142659|FG003|Part 2: Expansion|Other|1|||
30987941|NCT02343120|59142660|FG004|Part 2: Expansion|Other|5|||
30987942|NCT02343120|59142656|FG000|Part 2: Expansion|Adverse Event|0|||
30987943|NCT02343120|59142657|FG001|Part 2: Expansion|Adverse Event|0|||
30891761|NCT02382991|58925030|FG001|Overall Study|Adverse Event|2|||
30891762|NCT02382991|58925029|FG000|Overall Study|Lost to Follow-up|1|||
30987944|NCT02343120|59142658|FG002|Part 2: Expansion|Adverse Event|0|||
30987945|NCT02343120|59142659|FG003|Part 2: Expansion|Adverse Event|1|||
30987946|NCT02343120|59142660|FG004|Part 2: Expansion|Adverse Event|1|||
30891763|NCT02382991|58925030|FG001|Overall Study|Lost to Follow-up|0|||
30987947|NCT02342886|59142917|FG000|Overall Study|Treatment non-compliance|1|||
30987948|NCT02342886|59142918|FG001|Overall Study|Treatment non-compliance|0|||
30987949|NCT02342886|59142919|FG002|Overall Study|Treatment non-compliance|0|||
30987950|NCT02342886|59142920|FG003|Overall Study|Treatment non-compliance|1|||
30987951|NCT02342886|59142921|FG004|Overall Study|Treatment non-compliance|0|||
30987952|NCT02342886|59142917|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
30987953|NCT02342886|59142918|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
30987954|NCT02342886|59142919|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
30987955|NCT02342886|59142920|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
30987956|NCT02342886|59142921|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
30987957|NCT02342886|59142917|FG000|Overall Study|Adverse event/specific toxicity|4|||
30987958|NCT02342886|59142918|FG001|Overall Study|Adverse event/specific toxicity|3|||
30987959|NCT02342886|59142919|FG002|Overall Study|Adverse event/specific toxicity|11|||
30987960|NCT02342886|59142920|FG003|Overall Study|Adverse event/specific toxicity|2|||
30987961|NCT02342886|59142921|FG004|Overall Study|Adverse event/specific toxicity|1|||
30987962|NCT02342886|59142917|FG000|Overall Study|Lost to Follow-up|1|||
30987963|NCT02342886|59142918|FG001|Overall Study|Lost to Follow-up|0|||
30987964|NCT02342886|59142919|FG002|Overall Study|Lost to Follow-up|0|||
30987965|NCT02342886|59142920|FG003|Overall Study|Lost to Follow-up|0|||
30987966|NCT02342886|59142921|FG004|Overall Study|Lost to Follow-up|0|||
30987967|NCT02342886|59142917|FG000|Overall Study|Death|1|||
30987968|NCT02342886|59142918|FG001|Overall Study|Death|2|||
30987969|NCT02342886|59142919|FG002|Overall Study|Death|1|||
30987970|NCT02342886|59142920|FG003|Overall Study|Death|0|||
30987971|NCT02342886|59142921|FG004|Overall Study|Death|1|||
30987972|NCT02342886|59142917|FG000|Overall Study|Withdrawal by Subject|0|||
30987973|NCT02342886|59142918|FG001|Overall Study|Withdrawal by Subject|1|||
30987974|NCT02342886|59142919|FG002|Overall Study|Withdrawal by Subject|0|||
30987975|NCT02342886|59142920|FG003|Overall Study|Withdrawal by Subject|1|||
30987976|NCT02342886|59142921|FG004|Overall Study|Withdrawal by Subject|0|||
30987977|NCT02342886|59142917|FG000|Overall Study|Investigator/sponsor decision|0|||
30987978|NCT02342886|59142918|FG001|Overall Study|Investigator/sponsor decision|2|||
30987979|NCT02342886|59142919|FG002|Overall Study|Investigator/sponsor decision|0|||
30987980|NCT02342886|59142920|FG003|Overall Study|Investigator/sponsor decision|3|||
30987981|NCT02342886|59142921|FG004|Overall Study|Investigator/sponsor decision|1|||
30987982|NCT02342886|59142917|FG000|Overall Study|Pregnancy|0|||
30987983|NCT02342886|59142918|FG001|Overall Study|Pregnancy|0|||
30987984|NCT02342886|59142919|FG002|Overall Study|Pregnancy|2|||
30987985|NCT02342886|59142920|FG003|Overall Study|Pregnancy|0|||
30987986|NCT02342886|59142921|FG004|Overall Study|Pregnancy|0|||
30987987|NCT02342886|59142917|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
30987988|NCT02342886|59142918|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
30987989|NCT02342886|59142919|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
30987990|NCT02342886|59142920|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
30987991|NCT02342886|59142921|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
30987992|NCT02342886|59142917|FG000|Overall Study|Protocol Violation|0|||
30987993|NCT02342886|59142918|FG001|Overall Study|Protocol Violation|0|||
30987994|NCT02342886|59142919|FG002|Overall Study|Protocol Violation|0|||
30987995|NCT02342886|59142920|FG003|Overall Study|Protocol Violation|2|||
30987996|NCT02342886|59142921|FG004|Overall Study|Protocol Violation|0|||
30987997|NCT02390076|59142957|FG000|Overall Study|Lost to Follow-up|2|||
30987998|NCT02390076|59142958|FG001|Overall Study|Lost to Follow-up|1|||
30987999|NCT02390076|59142959|FG002|Overall Study|Lost to Follow-up|4|||
30988000|NCT02389998|59142978|FG000|Overall Study|car accident|1|||
30988001|NCT02389998|59142979|FG001|Overall Study|car accident|0|||
30988002|NCT02389764|59143005|FG000|Overall Study|Lack of Efficacy|9|||
30988003|NCT02366130|59143076|FG000|Overall Study|Withdrawal by Subject|3|||
30988004|NCT02366130|59143076|FG000|Overall Study|Ineligible|6|||
30988005|NCT02389452|59143138|FG000|Overall Study|Lost to Follow-up|13|||
30988006|NCT02389452|59143138|FG000|Overall Study|Adverse Event|1|||
30988007|NCT02389452|59143138|FG000|Overall Study|Withdrawal by Subject|5|||
30988008|NCT02389452|59143138|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
30988009|NCT02365584|59143176|FG000|Overall Study|Adverse Event|2|||
30988010|NCT02365584|59143177|FG001|Overall Study|Adverse Event|2|||
30988011|NCT02365584|59143176|FG000|Overall Study|Withdrawal by Subject|1|||
30988012|NCT02365584|59143177|FG001|Overall Study|Withdrawal by Subject|0|||
30988013|NCT02365584|59143176|FG000|Overall Study|Disease Progression|9|||
30988014|NCT02365584|59143177|FG001|Overall Study|Disease Progression|12|||
30988015|NCT02342418|59143189|FG000|Overall Study|Adverse Event|0|||
30988016|NCT02342418|59143190|FG001|Overall Study|Adverse Event|1|||
30988017|NCT02365506|59143231|FG000|Overall Study|Investigator's Discretion|0|||
30988018|NCT02365506|59143232|FG001|Overall Study|Investigator's Discretion|0|||
30988019|NCT02365506|59143233|FG002|Overall Study|Investigator's Discretion|1|||
30988020|NCT02312934|59143270|FG000|Overall Study|Lost to Follow-up|1|||
30988021|NCT02312934|59143271|FG001|Overall Study|Lost to Follow-up|0|||
30988022|NCT02312934|59143270|FG000|Overall Study|Physician Decision|1|||
30988023|NCT02312934|59143271|FG001|Overall Study|Physician Decision|0|||
30988024|NCT02341482|59143305|FG000|Overall Study|Adverse Event|1|||
30988025|NCT02312856|59143345|FG000|Overall Study|Death|1|||
30988026|NCT02312856|59143345|FG000|Overall Study|Lost to Follow-up|3|||
30988027|NCT01602120|59143810|FG000|Overall Study|Adverse Event|3|||
30988028|NCT01602120|59143811|FG001|Overall Study|Adverse Event|6|||
30988029|NCT01602120|59143812|FG002|Overall Study|Adverse Event|0|||
30988030|NCT01602120|59143813|FG003|Overall Study|Adverse Event|2|||
30988031|NCT01602120|59143810|FG000|Overall Study|Death|0|||
30988032|NCT01602120|59143811|FG001|Overall Study|Death|4|||
30988033|NCT01602120|59143812|FG002|Overall Study|Death|0|||
30988034|NCT01602120|59143813|FG003|Overall Study|Death|0|||
30988035|NCT01602120|59143810|FG000|Overall Study|Lost to Follow-up|0|||
30988036|NCT01602120|59143811|FG001|Overall Study|Lost to Follow-up|1|||
30988037|NCT01602120|59143812|FG002|Overall Study|Lost to Follow-up|0|||
30988038|NCT01602120|59143813|FG003|Overall Study|Lost to Follow-up|1|||
30988039|NCT01602120|59143810|FG000|Overall Study|Protocol Violation|1|||
30988040|NCT01602120|59143811|FG001|Overall Study|Protocol Violation|1|||
30988041|NCT01602120|59143812|FG002|Overall Study|Protocol Violation|0|||
30988042|NCT01602120|59143813|FG003|Overall Study|Protocol Violation|0|||
30988043|NCT01602120|59143810|FG000|Overall Study|Non-compliance|0|||
30988044|NCT01602120|59143811|FG001|Overall Study|Non-compliance|3|||
30988045|NCT01602120|59143812|FG002|Overall Study|Non-compliance|0|||
30988046|NCT01602120|59143813|FG003|Overall Study|Non-compliance|1|||
30988047|NCT01602120|59143810|FG000|Overall Study|Withdrawal by Subject|8|||
30988048|NCT01602120|59143811|FG001|Overall Study|Withdrawal by Subject|17|||
30988049|NCT01602120|59143812|FG002|Overall Study|Withdrawal by Subject|0|||
30988050|NCT01602120|59143813|FG003|Overall Study|Withdrawal by Subject|3|||
30988051|NCT01602120|59143810|FG000|Overall Study|Study Terminated by Sponsor|12|||
30988052|NCT01602120|59143811|FG001|Overall Study|Study Terminated by Sponsor|24|||
30988053|NCT01602120|59143812|FG002|Overall Study|Study Terminated by Sponsor|17|||
30988054|NCT01602120|59143813|FG003|Overall Study|Study Terminated by Sponsor|44|||
30988055|NCT01602120|59143810|FG000|Overall Study|Physician Decision|2|||
30988056|NCT01602120|59143811|FG001|Overall Study|Physician Decision|3|||
30988057|NCT01602120|59143812|FG002|Overall Study|Physician Decision|0|||
30988058|NCT01602120|59143813|FG003|Overall Study|Physician Decision|0|||
30988059|NCT01602120|59143810|FG000|Overall Study|Unspecified Reason|3|||
30988060|NCT01602120|59143811|FG001|Overall Study|Unspecified Reason|1|||
30988061|NCT01602120|59143812|FG002|Overall Study|Unspecified Reason|0|||
30988062|NCT01602120|59143813|FG003|Overall Study|Unspecified Reason|2|||
30988063|NCT04543955|59144620|FG000|Overall Study|Company cancelled study|1|||
30988064|NCT04543955|59144621|FG001|Overall Study|Company cancelled study|0|||
30988065|NCT02049515|59144689|FG000|Overall Study|Adverse Event|46|||
30988066|NCT02049515|59144690|FG001|Overall Study|Adverse Event|2|||
30988067|NCT02049515|59144689|FG000|Overall Study|Protocol-specified Disease Progression|23|||
30988068|NCT02049515|59144690|FG001|Overall Study|Protocol-specified Disease Progression|2|||
30988069|NCT02049515|59144689|FG000|Overall Study|Death|6|||
30988070|NCT02049515|59144690|FG001|Overall Study|Death|0|||
30988071|NCT02049515|59144689|FG000|Overall Study|Physician Decision|5|||
30988072|NCT02049515|59144690|FG001|Overall Study|Physician Decision|1|||
30988073|NCT02049515|59144689|FG000|Overall Study|Withdrawal by Subject|3|||
30988074|NCT02049515|59144690|FG001|Overall Study|Withdrawal by Subject|0|||
30988075|NCT02049515|59144689|FG000|Overall Study|Termination of the Study by Sponsor|2|||
30988076|NCT02049515|59144690|FG001|Overall Study|Termination of the Study by Sponsor|0|||
30988077|NCT02049515|59144689|FG000|Overall Study|Protocol Violation|1|||
30988078|NCT02049515|59144690|FG001|Overall Study|Protocol Violation|1|||
30988079|NCT02049515|59144689|FG000|Overall Study|Clinical Deterioration|1|||
30988080|NCT02049515|59144690|FG001|Overall Study|Clinical Deterioration|0|||
30988081|NCT02049515|59144689|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
30988082|NCT02049515|59144690|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
30988083|NCT02049515|59144689|FG000|Overall Study|Treatment Interruption >42 Days|1|||
30988084|NCT02049515|59144690|FG001|Overall Study|Treatment Interruption >42 Days|0|||
30988085|NCT02049515|59144689|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
30988086|NCT02049515|59144690|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
30988087|NCT04436744|59145180|FG000|Overall Study|Adverse Event|1|||
30988088|NCT04436744|59145181|FG001|Overall Study|Adverse Event|1|||
30988089|NCT04436744|59145180|FG000|Overall Study|Death|1|||
30988090|NCT04436744|59145181|FG001|Overall Study|Death|0|||
30988091|NCT04436744|59145180|FG000|Overall Study|Lost to Follow-up|0|||
30988092|NCT04436744|59145181|FG001|Overall Study|Lost to Follow-up|2|||
30988093|NCT04436744|59145180|FG000|Overall Study|Physician Decision|0|||
30988094|NCT04436744|59145181|FG001|Overall Study|Physician Decision|1|||
30988095|NCT04436744|59145180|FG000|Overall Study|Progressive Disease|0|||
30988096|NCT04436744|59145181|FG001|Overall Study|Progressive Disease|4|||
30988097|NCT04436744|59145180|FG000|Overall Study|Protocol Deviation|1|||
30988098|NCT04436744|59145181|FG001|Overall Study|Protocol Deviation|1|||
30988099|NCT04436744|59145180|FG000|Overall Study|Withdrawal by Subject|1|||
30988100|NCT04436744|59145181|FG001|Overall Study|Withdrawal by Subject|2|||
30988101|NCT04359758|59145221|FG000|Overall Study|Lost to Follow-up|0|||
30988102|NCT04359758|59145222|FG001|Overall Study|Lost to Follow-up|2|||
30988103|NCT04359758|59145221|FG000|Overall Study|Protocol Violation|3|||
30988104|NCT04359758|59145222|FG001|Overall Study|Protocol Violation|0|||
30988105|NCT02243306|59145337|FG000|Overall Study|Adverse Event|0|||
30988106|NCT02243306|59145338|FG001|Overall Study|Adverse Event|1|||
30988107|NCT02243306|59145337|FG000|Overall Study|Other: Reached stopping criteria|0|||
30988108|NCT02243306|59145338|FG001|Overall Study|Other: Reached stopping criteria|1|||
30988109|NCT02243306|59145337|FG000|Overall Study|Physician Decision|0|||
30988110|NCT02243306|59145338|FG001|Overall Study|Physician Decision|1|||
30988111|NCT03214679|59145494|FG000|Overall Study|Lost to Follow-up|12|||
30988112|NCT03214679|59145495|FG001|Overall Study|Lost to Follow-up|14|||
30988113|NCT03214679|59145494|FG000|Overall Study|not eligible|2|||
30988114|NCT03214679|59145495|FG001|Overall Study|not eligible|0|||
30988115|NCT01602380|59145842|FG000|Overall Study|Death|63|||
30988116|NCT01602380|59145843|FG001|Overall Study|Death|68|||
30988117|NCT01602380|59145842|FG000|Overall Study|Withdrawal by Subject|22|||
30988118|NCT01602380|59145843|FG001|Overall Study|Withdrawal by Subject|29|||
30988119|NCT01602380|59145842|FG000|Overall Study|Lost to Follow-up|6|||
30988120|NCT01602380|59145843|FG001|Overall Study|Lost to Follow-up|1|||
30988121|NCT01602380|59145842|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
30988122|NCT01602380|59145843|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
30988123|NCT01349465|59146790|FG000|Overall Study|Adverse Event|1|||
30988124|NCT01349465|59146791|FG001|Overall Study|Adverse Event|0|||
30988125|NCT01349465|59146790|FG000|Overall Study|Death|3|||
30988126|NCT01349465|59146791|FG001|Overall Study|Death|0|||
30988127|NCT01349465|59146790|FG000|Overall Study|Lost to Follow-up|10|||
30988128|NCT01349465|59146791|FG001|Overall Study|Lost to Follow-up|1|||
30988129|NCT01349465|59146790|FG000|Overall Study|Withdrawal by Subject|4|||
30988130|NCT01349465|59146791|FG001|Overall Study|Withdrawal by Subject|2|||
30988131|NCT01349465|59146790|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
30988132|NCT01349465|59146791|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
30988133|NCT01648764|59147910|FG000|Overall Study|Progressive Disease|0|||
30988134|NCT01648764|59147911|FG001|Overall Study|Progressive Disease|1|||
30988135|NCT01648764|59147912|FG002|Overall Study|Progressive Disease|0|||
30988136|NCT01648764|59147913|FG003|Overall Study|Progressive Disease|0|||
30988137|NCT01648764|59147914|FG004|Overall Study|Progressive Disease|0|||
30988138|NCT01648764|59147915|FG005|Overall Study|Progressive Disease|1|||
30988139|NCT01648764|59147916|FG006|Overall Study|Progressive Disease|1|||
30988140|NCT01648764|59147917|FG007|Overall Study|Progressive Disease|0|||
30988141|NCT01648764|59147918|FG008|Overall Study|Progressive Disease|0|||
30988142|NCT01648764|59147919|FG009|Overall Study|Progressive Disease|2|||
30988143|NCT01648764|59147920|FG010|Overall Study|Progressive Disease|0|||
30988144|NCT01648764|59147921|FG011|Overall Study|Progressive Disease|1|||
30988145|NCT01648764|59147922|FG012|Overall Study|Progressive Disease|2|||
30988146|NCT01648764|59147923|FG013|Overall Study|Progressive Disease|1|||
30988147|NCT01648764|59147910|FG000|Overall Study|Adverse Event|0|||
30988148|NCT01648764|59147911|FG001|Overall Study|Adverse Event|0|||
30988149|NCT01648764|59147912|FG002|Overall Study|Adverse Event|0|||
30988150|NCT01648764|59147913|FG003|Overall Study|Adverse Event|0|||
30988151|NCT01648764|59147914|FG004|Overall Study|Adverse Event|0|||
30988152|NCT01648764|59147915|FG005|Overall Study|Adverse Event|1|||
30988153|NCT01648764|59147916|FG006|Overall Study|Adverse Event|0|||
30988154|NCT01648764|59147917|FG007|Overall Study|Adverse Event|0|||
30988155|NCT01648764|59147918|FG008|Overall Study|Adverse Event|0|||
30988156|NCT01648764|59147919|FG009|Overall Study|Adverse Event|1|||
30988157|NCT01648764|59147920|FG010|Overall Study|Adverse Event|0|||
30988158|NCT01648764|59147921|FG011|Overall Study|Adverse Event|3|||
30988159|NCT01648764|59147922|FG012|Overall Study|Adverse Event|1|||
30988160|NCT01648764|59147923|FG013|Overall Study|Adverse Event|1|||
30988161|NCT01648764|59147910|FG000|Overall Study|Death|0|||
30988162|NCT01648764|59147911|FG001|Overall Study|Death|0|||
30988163|NCT01648764|59147912|FG002|Overall Study|Death|0|||
30988164|NCT01648764|59147913|FG003|Overall Study|Death|0|||
30988165|NCT01648764|59147914|FG004|Overall Study|Death|0|||
30988166|NCT01648764|59147915|FG005|Overall Study|Death|0|||
30988167|NCT01648764|59147916|FG006|Overall Study|Death|1|||
30988168|NCT01648764|59147917|FG007|Overall Study|Death|0|||
30988169|NCT01648764|59147918|FG008|Overall Study|Death|0|||
30988170|NCT01648764|59147919|FG009|Overall Study|Death|0|||
30988171|NCT01648764|59147920|FG010|Overall Study|Death|0|||
30988172|NCT01648764|59147921|FG011|Overall Study|Death|0|||
30988173|NCT01648764|59147922|FG012|Overall Study|Death|0|||
30988174|NCT01648764|59147923|FG013|Overall Study|Death|1|||
30988175|NCT01648764|59147910|FG000|Overall Study|Withdrawal by Subject|0|||
30988176|NCT01648764|59147911|FG001|Overall Study|Withdrawal by Subject|0|||
30988177|NCT01648764|59147912|FG002|Overall Study|Withdrawal by Subject|0|||
30988178|NCT01648764|59147913|FG003|Overall Study|Withdrawal by Subject|0|||
30988179|NCT01648764|59147914|FG004|Overall Study|Withdrawal by Subject|0|||
30988180|NCT01648764|59147915|FG005|Overall Study|Withdrawal by Subject|0|||
30988181|NCT01648764|59147916|FG006|Overall Study|Withdrawal by Subject|2|||
30988182|NCT01648764|59147917|FG007|Overall Study|Withdrawal by Subject|0|||
30988183|NCT01648764|59147918|FG008|Overall Study|Withdrawal by Subject|0|||
30988184|NCT01648764|59147919|FG009|Overall Study|Withdrawal by Subject|0|||
30988185|NCT01648764|59147920|FG010|Overall Study|Withdrawal by Subject|0|||
30988186|NCT01648764|59147921|FG011|Overall Study|Withdrawal by Subject|0|||
30988187|NCT01648764|59147922|FG012|Overall Study|Withdrawal by Subject|1|||
30988188|NCT01648764|59147923|FG013|Overall Study|Withdrawal by Subject|0|||
30988189|NCT01648764|59147910|FG000|Overall Study|Investigator Decision|0|||
30988190|NCT01648764|59147911|FG001|Overall Study|Investigator Decision|0|||
30988191|NCT01648764|59147912|FG002|Overall Study|Investigator Decision|0|||
30988192|NCT01648764|59147913|FG003|Overall Study|Investigator Decision|0|||
30988193|NCT01648764|59147914|FG004|Overall Study|Investigator Decision|0|||
30988194|NCT01648764|59147915|FG005|Overall Study|Investigator Decision|0|||
30988195|NCT01648764|59147916|FG006|Overall Study|Investigator Decision|1|||
30988196|NCT01648764|59147917|FG007|Overall Study|Investigator Decision|0|||
30988197|NCT01648764|59147918|FG008|Overall Study|Investigator Decision|0|||
30988198|NCT01648764|59147919|FG009|Overall Study|Investigator Decision|0|||
30988199|NCT01648764|59147920|FG010|Overall Study|Investigator Decision|0|||
30988200|NCT01648764|59147921|FG011|Overall Study|Investigator Decision|1|||
30988201|NCT01648764|59147922|FG012|Overall Study|Investigator Decision|0|||
30988202|NCT01648764|59147923|FG013|Overall Study|Investigator Decision|0|||
30988203|NCT02364336|59147959|FG000|Overall Study|Adverse Event|0|||
30988204|NCT02364336|59147960|FG001|Overall Study|Adverse Event|1|||
30988205|NCT02810951|59148191|FG000|Overall Study|Adverse Event|1|||
30988206|NCT02310906|59148287|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
30988207|NCT02310906|59148288|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
30988208|NCT02310906|59148289|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
30988209|NCT02310906|59148290|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
30988210|NCT02310906|59148287|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
30988211|NCT02310906|59148288|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
30988212|NCT02310906|59148289|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
30988213|NCT02310906|59148290|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
30988214|NCT02310906|59148287|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
30988215|NCT02310906|59148288|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
30988216|NCT02310906|59148289|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
30988217|NCT02310906|59148290|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
30988218|NCT02310906|59148287|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
30988219|NCT02310906|59148288|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
30988220|NCT02310906|59148289|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
30988221|NCT02310906|59148290|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
30988222|NCT02340078|59148340|FG000|Overall Study|Protocol Violation|1|||
30988223|NCT02340000|59148356|FG000|Time Period 1|Withdrawal by Subject|6|||
30988224|NCT02340000|59148357|FG001|Time Period 1|Withdrawal by Subject|8|||
30988225|NCT02340000|59148356|FG000|Time Period 1|Lost to Follow-up|6|||
30988226|NCT02340000|59148357|FG001|Time Period 1|Lost to Follow-up|7|||
30988227|NCT02340000|59148356|FG000|Time Period 2|Withdrawal by Subject|9|||
30988228|NCT02340000|59148357|FG001|Time Period 2|Withdrawal by Subject|7|||
30988229|NCT02340000|59148356|FG000|Time Period 2|Lost to Follow-up|10|||
30988230|NCT02340000|59148357|FG001|Time Period 2|Lost to Follow-up|8|||
30988231|NCT02364180|59148388|FG000|Overall Study|Screen Fail|1|||
30988232|NCT02310750|59149033|FG000|HP Period 1|Lost to Follow-up|0|||
30988233|NCT02310750|59149034|FG001|HP Period 1|Lost to Follow-up|0|||
30988234|NCT02310750|59149035|FG002|HP Period 1|Lost to Follow-up|0|||
30988235|NCT02310750|59149036|FG003|HP Period 1|Lost to Follow-up|0|||
30988236|NCT02310750|59149037|FG004|HP Period 1|Lost to Follow-up|0|||
30988237|NCT02310750|59149038|FG005|HP Period 1|Lost to Follow-up|0|||
30988238|NCT02310750|59149039|FG006|HP Period 1|Lost to Follow-up|1|||
30988239|NCT02310750|59149040|FG007|HP Period 1|Lost to Follow-up|0|||
30988240|NCT02310750|59149041|FG008|HP Period 1|Lost to Follow-up|0|||
30988241|NCT02310750|59149042|FG009|HP Period 1|Lost to Follow-up|0|||
30988242|NCT02310750|59149043|FG010|HP Period 1|Lost to Follow-up|0|||
30988243|NCT02310750|59149044|FG011|HP Period 1|Lost to Follow-up|0|||
30988244|NCT02310750|59149045|FG012|HP Period 1|Lost to Follow-up|0|||
30988245|NCT02310750|59149046|FG013|HP Period 1|Lost to Follow-up|0|||
30988246|NCT02310750|59149047|FG014|HP Period 1|Lost to Follow-up|0|||
30988247|NCT02310750|59149048|FG015|HP Period 1|Lost to Follow-up|0|||
30988248|NCT02310750|59149033|FG000|HP Period 1|Withdrawal by Subject|1|||
30988249|NCT02310750|59149034|FG001|HP Period 1|Withdrawal by Subject|0|||
30988250|NCT02310750|59149035|FG002|HP Period 1|Withdrawal by Subject|0|||
30988251|NCT02310750|59149036|FG003|HP Period 1|Withdrawal by Subject|1|||
30988252|NCT02310750|59149037|FG004|HP Period 1|Withdrawal by Subject|0|||
30988253|NCT02310750|59149038|FG005|HP Period 1|Withdrawal by Subject|0|||
30988254|NCT02310750|59149039|FG006|HP Period 1|Withdrawal by Subject|0|||
30988255|NCT02310750|59149040|FG007|HP Period 1|Withdrawal by Subject|0|||
30988256|NCT02310750|59149041|FG008|HP Period 1|Withdrawal by Subject|0|||
30988257|NCT02310750|59149042|FG009|HP Period 1|Withdrawal by Subject|0|||
30988258|NCT02310750|59149043|FG010|HP Period 1|Withdrawal by Subject|0|||
30988259|NCT02310750|59149044|FG011|HP Period 1|Withdrawal by Subject|0|||
30988260|NCT02310750|59149045|FG012|HP Period 1|Withdrawal by Subject|0|||
30988261|NCT02310750|59149046|FG013|HP Period 1|Withdrawal by Subject|0|||
30988262|NCT02310750|59149047|FG014|HP Period 1|Withdrawal by Subject|0|||
30988263|NCT02310750|59149048|FG015|HP Period 1|Withdrawal by Subject|0|||
30988264|NCT02310750|59149033|FG000|HP Washout 1|Lost to Follow-up|0|||
30988265|NCT02310750|59149034|FG001|HP Washout 1|Lost to Follow-up|0|||
30988266|NCT02310750|59149035|FG002|HP Washout 1|Lost to Follow-up|1|||
30988267|NCT02310750|59149036|FG003|HP Washout 1|Lost to Follow-up|1|||
30988268|NCT02310750|59149037|FG004|HP Washout 1|Lost to Follow-up|2|||
30988269|NCT02310750|59149038|FG005|HP Washout 1|Lost to Follow-up|2|||
30988270|NCT02310750|59149039|FG006|HP Washout 1|Lost to Follow-up|3|||
30988271|NCT02310750|59149040|FG007|HP Washout 1|Lost to Follow-up|0|||
30988272|NCT02310750|59149041|FG008|HP Washout 1|Lost to Follow-up|0|||
30988273|NCT02310750|59149042|FG009|HP Washout 1|Lost to Follow-up|0|||
30988274|NCT02310750|59149043|FG010|HP Washout 1|Lost to Follow-up|0|||
30988275|NCT02310750|59149044|FG011|HP Washout 1|Lost to Follow-up|0|||
30988276|NCT02310750|59149045|FG012|HP Washout 1|Lost to Follow-up|0|||
30988277|NCT02310750|59149046|FG013|HP Washout 1|Lost to Follow-up|0|||
30988278|NCT02310750|59149047|FG014|HP Washout 1|Lost to Follow-up|0|||
30988279|NCT02310750|59149048|FG015|HP Washout 1|Lost to Follow-up|0|||
30988280|NCT02310750|59149033|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30988281|NCT02310750|59149034|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30988282|NCT02310750|59149035|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30988283|NCT02310750|59149036|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
30988284|NCT02310750|59149037|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30988285|NCT02310750|59149038|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
30988286|NCT02310750|59149039|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30988287|NCT02310750|59149040|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30988288|NCT02310750|59149041|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
30988289|NCT02310750|59149042|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
30988290|NCT02310750|59149043|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30891764|NCT02382991|58925029|FG000|Overall Study|Withdrawal by Subject|0|||
30891765|NCT02382991|58925030|FG001|Overall Study|Withdrawal by Subject|1|||
30891766|NCT02390557|58925038|FG000|Wave 2|Survey non-respondent|72|||
30891767|NCT02390557|58925039|FG001|Wave 2|Survey non-respondent|41|||
30891768|NCT02390557|58925040|FG002|Wave 2|Survey non-respondent|23|||
30988291|NCT02310750|59149044|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30988292|NCT02310750|59149045|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30988293|NCT02310750|59149046|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30988294|NCT02310750|59149047|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30988295|NCT02310750|59149048|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
30988296|NCT02310750|59149033|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988297|NCT02310750|59149034|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988298|NCT02310750|59149035|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988299|NCT02310750|59149036|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988300|NCT02310750|59149037|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988301|NCT02310750|59149038|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988302|NCT02310750|59149039|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988303|NCT02310750|59149040|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988304|NCT02310750|59149041|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988305|NCT02310750|59149042|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
30988306|NCT02310750|59149043|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988307|NCT02310750|59149044|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988308|NCT02310750|59149045|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988309|NCT02310750|59149046|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988310|NCT02310750|59149047|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988311|NCT02310750|59149048|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
30988312|NCT02310750|59149033|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30891769|NCT01649791|58925048|FG000|Overall Study|Disease Progression|2|||
30891770|NCT01649791|58925048|FG000|Overall Study|Adverse Event|1|||
30988313|NCT02310750|59149034|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988314|NCT02310750|59149035|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988315|NCT02310750|59149036|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988316|NCT02310750|59149037|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988317|NCT02310750|59149038|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988318|NCT02310750|59149039|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988319|NCT02310750|59149040|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
30988320|NCT02310750|59149041|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
30988321|NCT02310750|59149042|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
30988322|NCT02310750|59149043|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988323|NCT02310750|59149044|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988324|NCT02310750|59149045|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988325|NCT02310750|59149046|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988326|NCT02310750|59149047|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988327|NCT02310750|59149048|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
30988328|NCT02310750|59149033|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988329|NCT02310750|59149034|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988330|NCT02310750|59149035|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988331|NCT02310750|59149036|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988332|NCT02310750|59149037|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988333|NCT02310750|59149038|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988334|NCT02310750|59149039|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988335|NCT02310750|59149040|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
30988336|NCT02310750|59149041|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
30988337|NCT02310750|59149042|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988338|NCT02310750|59149043|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988339|NCT02310750|59149044|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988340|NCT02310750|59149045|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988341|NCT02310750|59149046|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988342|NCT02310750|59149047|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988343|NCT02310750|59149048|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
30988344|NCT02310750|59149033|FG000|HP Washout 2|Lost to Follow-up|0|||
30988345|NCT02310750|59149034|FG001|HP Washout 2|Lost to Follow-up|0|||
30988346|NCT02310750|59149035|FG002|HP Washout 2|Lost to Follow-up|0|||
30988347|NCT02310750|59149036|FG003|HP Washout 2|Lost to Follow-up|0|||
30988348|NCT02310750|59149037|FG004|HP Washout 2|Lost to Follow-up|1|||
30988349|NCT02310750|59149038|FG005|HP Washout 2|Lost to Follow-up|0|||
30988350|NCT02310750|59149039|FG006|HP Washout 2|Lost to Follow-up|7|||
30988351|NCT02310750|59149040|FG007|HP Washout 2|Lost to Follow-up|0|||
30988352|NCT02310750|59149041|FG008|HP Washout 2|Lost to Follow-up|0|||
30988353|NCT02310750|59149042|FG009|HP Washout 2|Lost to Follow-up|0|||
30988354|NCT02310750|59149043|FG010|HP Washout 2|Lost to Follow-up|0|||
30988355|NCT02310750|59149044|FG011|HP Washout 2|Lost to Follow-up|0|||
30988356|NCT02310750|59149045|FG012|HP Washout 2|Lost to Follow-up|0|||
30988357|NCT02310750|59149046|FG013|HP Washout 2|Lost to Follow-up|0|||
30988358|NCT02310750|59149047|FG014|HP Washout 2|Lost to Follow-up|0|||
30988359|NCT02310750|59149048|FG015|HP Washout 2|Lost to Follow-up|0|||
30988360|NCT02310672|59149153|FG000|Overall Study|Death|1|||
30988361|NCT02310672|59149153|FG000|Overall Study|Lost to Follow-up|1|||
30988362|NCT02310672|59149153|FG000|Overall Study|Withdrawal by Subject|1|||
30988363|NCT02310672|59149153|FG000|Overall Study|Sponsor's decision|12|||
30988364|NCT02363946|59149299|FG000|Overall Study|Lost to Follow-up|0|||
30988365|NCT02363946|59149300|FG001|Overall Study|Lost to Follow-up|0|||
30988366|NCT02363946|59149301|FG002|Overall Study|Lost to Follow-up|0|||
30988367|NCT02363946|59149302|FG003|Overall Study|Lost to Follow-up|0|||
30988368|NCT02363946|59149303|FG004|Overall Study|Lost to Follow-up|0|||
30988369|NCT02363946|59149304|FG005|Overall Study|Lost to Follow-up|0|||
30988370|NCT02363946|59149305|FG006|Overall Study|Lost to Follow-up|0|||
30988371|NCT02363946|59149306|FG007|Overall Study|Lost to Follow-up|1|||
30988372|NCT02363946|59149307|FG008|Overall Study|Lost to Follow-up|0|||
30988373|NCT02363946|59149308|FG009|Overall Study|Lost to Follow-up|0|||
30988374|NCT02363946|59149309|FG010|Overall Study|Lost to Follow-up|0|||
30988375|NCT02363946|59149310|FG011|Overall Study|Lost to Follow-up|0|||
30988376|NCT02363946|59149311|FG012|Overall Study|Lost to Follow-up|0|||
30988377|NCT02363478|59149339|FG000|Overall Study|Lost to Follow-up|4|||
30988378|NCT02363478|59149339|FG000|Overall Study|Adverse Event|4|||
30988379|NCT02310126|59149346|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
30988380|NCT02310126|59149347|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
30988381|NCT02310126|59149346|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
30988382|NCT02310126|59149347|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
30988383|NCT02338362|59149355|FG000|Overall Study|Withdrawal by Subject|1|||
30988384|NCT02338362|59149356|FG001|Overall Study|Withdrawal by Subject|1|||
30988385|NCT02363322|59149364|FG000|Overall Study|Lost to Follow-up|1|||
30988386|NCT02363322|59149365|FG001|Overall Study|Lost to Follow-up|0|||
30988387|NCT02361762|59149373|FG000|Overall Study|Withdrawal by Subject|0|||
30988388|NCT02361762|59149374|FG001|Overall Study|Withdrawal by Subject|1|||
30988389|NCT02361762|59149373|FG000|Overall Study|Lost to Follow-up|0|||
30988390|NCT02361762|59149374|FG001|Overall Study|Lost to Follow-up|1|||
30988391|NCT02337738|59149383|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
30988392|NCT02337738|59149384|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
30988393|NCT02337738|59149385|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
30988394|NCT02337738|59149383|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
30988395|NCT02337738|59149384|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
30988396|NCT02337738|59149385|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
30988397|NCT02337738|59149383|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
30988398|NCT02337738|59149384|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
30988399|NCT02337738|59149385|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
30988400|NCT02337738|59149383|FG000|Overall Study|Voluntary Withdrawal|10|||
30988401|NCT02337738|59149384|FG001|Overall Study|Voluntary Withdrawal|5|||
30988402|NCT02337738|59149385|FG002|Overall Study|Voluntary Withdrawal|2|||
30988403|NCT02337738|59149383|FG000|Overall Study|Lack of Efficacy|2|||
30988404|NCT02337738|59149384|FG001|Overall Study|Lack of Efficacy|4|||
30988405|NCT02337738|59149385|FG002|Overall Study|Lack of Efficacy|0|||
30988406|NCT02337738|59149383|FG000|Overall Study|Investigator's Judgment|1|||
30988407|NCT02337738|59149384|FG001|Overall Study|Investigator's Judgment|1|||
30988408|NCT02337738|59149385|FG002|Overall Study|Investigator's Judgment|3|||
30988409|NCT02309112|59149396|FG000|Overall Study|Withdrawal by Subject|1|||
30988410|NCT02309112|59149397|FG001|Overall Study|Withdrawal by Subject|0|||
30988411|NCT02309112|59149398|FG002|Overall Study|Withdrawal by Subject|1|||
30988412|NCT02309112|59149396|FG000|Overall Study|Lost to Follow-up|0|||
30988413|NCT02309112|59149397|FG001|Overall Study|Lost to Follow-up|1|||
30988414|NCT02309112|59149398|FG002|Overall Study|Lost to Follow-up|0|||
30988415|NCT02361216|59149410|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
30988416|NCT02361216|59149411|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
30988417|NCT02361216|59149410|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
30988418|NCT02361216|59149411|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
30988419|NCT02361216|59149410|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
30988420|NCT02361216|59149411|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
30988421|NCT02361216|59149410|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
30988422|NCT02361216|59149411|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
30988423|NCT02361216|59149410|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
30988424|NCT02361216|59149411|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
30988425|NCT02361216|59149410|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
30988426|NCT02361216|59149411|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
30988427|NCT00559988|59149844|FG000|Overall Study|Death|147|||
30988428|NCT00559988|59149845|FG001|Overall Study|Death|140|||
30988429|NCT00559988|59149844|FG000|Overall Study|Withdrawal by Subject|152|||
30988430|NCT00559988|59149845|FG001|Overall Study|Withdrawal by Subject|139|||
30988431|NCT00559988|59149844|FG000|Overall Study|Lost to Follow-up|42|||
30988432|NCT00559988|59149845|FG001|Overall Study|Lost to Follow-up|56|||
30988433|NCT00559988|59149844|FG000|Overall Study|ICD device explanted|10|||
30988434|NCT00559988|59149845|FG001|Overall Study|ICD device explanted|17|||
30988435|NCT00559754|59149907|FG000|Overall Study|Disease progression|1|||
30988436|NCT00559754|59149907|FG000|Overall Study|Adverse Event|5|||
30988437|NCT00559754|59149907|FG000|Overall Study|Protocol Violation|1|||
30988438|NCT00559754|59149907|FG000|Overall Study|Investigator criteria|2|||
30988439|NCT00559754|59149907|FG000|Overall Study|Withdrawal by Subject|2|||
30988440|NCT00559364|59150021|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
30988441|NCT00559364|59150022|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
30988442|NCT02308020|59150085|FG000|Overall Study|Lost to Follow-up|1|||
30988443|NCT02308020|59150086|FG001|Overall Study|Lost to Follow-up|7|||
30988444|NCT02308020|59150087|FG002|Overall Study|Lost to Follow-up|0|||
30988445|NCT02308020|59150088|FG003|Overall Study|Lost to Follow-up|0|||
30988446|NCT02308020|59150089|FG004|Overall Study|Lost to Follow-up|1|||
30988447|NCT02308020|59150090|FG005|Overall Study|Lost to Follow-up|2|||
30988448|NCT02308020|59150085|FG000|Overall Study|Sponsor Decision|0|||
30988449|NCT02308020|59150086|FG001|Overall Study|Sponsor Decision|8|||
30608959|NCT01287104|58619813|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
30988450|NCT02308020|59150087|FG002|Overall Study|Sponsor Decision|0|||
30988451|NCT02308020|59150088|FG003|Overall Study|Sponsor Decision|2|||
30988452|NCT02308020|59150089|FG004|Overall Study|Sponsor Decision|2|||
30988453|NCT02308020|59150090|FG005|Overall Study|Sponsor Decision|1|||
30988454|NCT02308020|59150085|FG000|Overall Study|Withdrawal by Subject|3|||
30988455|NCT02308020|59150086|FG001|Overall Study|Withdrawal by Subject|5|||
30988456|NCT02308020|59150087|FG002|Overall Study|Withdrawal by Subject|3|||
30988457|NCT02308020|59150088|FG003|Overall Study|Withdrawal by Subject|2|||
30988458|NCT02308020|59150089|FG004|Overall Study|Withdrawal by Subject|1|||
30988459|NCT02308020|59150090|FG005|Overall Study|Withdrawal by Subject|2|||
30988460|NCT02359890|59150110|FG000|Overall Study|Not meeting eligibility|4|||
30988461|NCT02359890|59150110|FG000|Overall Study|Never treated with study catheter|6|||
30988462|NCT02306850|59150114|FG000|Overall Study|Lack of Efficacy|2|||
30988463|NCT02306694|59150119|FG000|Overall Study|Withdrawal by Subject|3|||
30988464|NCT02306694|59150119|FG000|Overall Study|Lost to Follow-up|1|||
30988465|NCT01648140|59150131|FG000|Overall Study|Physician Decision|1|||
30988466|NCT01648140|59150132|FG001|Overall Study|Physician Decision|0|||
30988467|NCT01648140|59150133|FG002|Overall Study|Physician Decision|0|||
30988468|NCT01648140|59150134|FG003|Overall Study|Physician Decision|0|||
30988469|NCT01648140|59150131|FG000|Overall Study|Lack of Efficacy|4|||
30988470|NCT01648140|59150132|FG001|Overall Study|Lack of Efficacy|7|||
30988471|NCT01648140|59150133|FG002|Overall Study|Lack of Efficacy|1|||
30988472|NCT01648140|59150134|FG003|Overall Study|Lack of Efficacy|0|||
30988473|NCT01648140|59150131|FG000|Overall Study|Adverse Event|3|||
30988474|NCT01648140|59150132|FG001|Overall Study|Adverse Event|1|||
30988475|NCT01648140|59150133|FG002|Overall Study|Adverse Event|2|||
30988476|NCT01648140|59150134|FG003|Overall Study|Adverse Event|0|||
30988477|NCT01648140|59150131|FG000|Overall Study|Withdrawal by Subject|2|||
30988478|NCT01648140|59150132|FG001|Overall Study|Withdrawal by Subject|3|||
30988479|NCT01648140|59150133|FG002|Overall Study|Withdrawal by Subject|3|||
30988480|NCT01648140|59150134|FG003|Overall Study|Withdrawal by Subject|2|||
30988481|NCT01648140|59150131|FG000|Overall Study|Lost to Follow-up|2|||
30988482|NCT01648140|59150132|FG001|Overall Study|Lost to Follow-up|1|||
30988483|NCT01648140|59150133|FG002|Overall Study|Lost to Follow-up|2|||
30988484|NCT01648140|59150134|FG003|Overall Study|Lost to Follow-up|0|||
30988485|NCT02336178|59150153|FG000|Overall Study|Lost to Follow-up|1|||
30988486|NCT02336178|59150153|FG000|Overall Study|Protocol Violation|1|||
30988487|NCT02336178|59150153|FG000|Overall Study|Withdrawal by Subject|1|||
30988488|NCT02336178|59150153|FG000|Overall Study|Other|1|||
30988489|NCT02357940|59150167|FG000|Overall Study|Adverse Event|0|||
30988490|NCT02357940|59150168|FG001|Overall Study|Adverse Event|1|||
30988491|NCT02357940|59150167|FG000|Overall Study|Investigator's judgement|0|||
30988492|NCT02357940|59150168|FG001|Overall Study|Investigator's judgement|1|||
30988493|NCT02335242|59150176|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
30988494|NCT02335242|59150177|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
30988495|NCT02335242|59150176|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
30988496|NCT02335242|59150177|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
30988497|NCT02335242|59150176|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
30988498|NCT02335242|59150177|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
30988499|NCT02334384|59150189|FG000|Overall Study|Lost to Follow-up|1|||
30988500|NCT02334384|59150190|FG001|Overall Study|Lost to Follow-up|1|||
30988501|NCT02334306|59150198|FG000|Double-blind Period|Adverse Event|0|||
30988502|NCT02334306|59150199|FG001|Double-blind Period|Adverse Event|1|||
30988503|NCT02334306|59150198|FG000|Double-blind Period|Withdrawal by Subject|1|||
30988504|NCT02334306|59150199|FG001|Double-blind Period|Withdrawal by Subject|1|||
30988505|NCT02305758|59150208|FG000|Overall Study|Death|27|||
30988506|NCT02305758|59150209|FG001|Overall Study|Death|27|||
30988507|NCT02305758|59150208|FG000|Overall Study|Withdrew consent|9|||
30988508|NCT02305758|59150209|FG001|Overall Study|Withdrew consent|2|||
30988509|NCT02305758|59150208|FG000|Overall Study|Lost to Follow-up|6|||
30988510|NCT02305758|59150209|FG001|Overall Study|Lost to Follow-up|1|||
30988511|NCT02305758|59150208|FG000|Overall Study|Study Terminated by Sponsor|21|||
30988512|NCT02305758|59150209|FG001|Overall Study|Study Terminated by Sponsor|34|||
30988513|NCT02305758|59150208|FG000|Overall Study|Other, not specified|2|||
30988514|NCT02305758|59150209|FG001|Overall Study|Other, not specified|1|||
30988515|NCT02305446|59150215|FG000|Overall Study|Adverse Event|1|||
30988516|NCT02303574|59150352|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
30988517|NCT02303574|59150353|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
30988518|NCT02303574|59150354|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
30988519|NCT02303574|59150355|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
30988520|NCT02303574|59150356|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
30988521|NCT02303574|59150357|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
30988522|NCT02303574|59150358|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
30988523|NCT02303574|59150359|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
30988524|NCT02303574|59150360|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
30988525|NCT02303574|59150361|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
30988526|NCT02303574|59150352|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
30988527|NCT02303574|59150353|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
30988528|NCT02303574|59150354|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
30988529|NCT02303574|59150355|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
30988530|NCT02303574|59150356|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
30988531|NCT02303574|59150357|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
30988532|NCT02303574|59150358|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
30988533|NCT02303574|59150359|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
30988534|NCT02303574|59150360|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
30988535|NCT02303574|59150361|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
30988536|NCT02354976|59150397|FG000|Overall Study|Other - reason not specified|1|||
30988537|NCT02354976|59150398|FG001|Overall Study|Other - reason not specified|0|||
30988538|NCT02354976|59150399|FG002|Overall Study|Other - reason not specified|1|||
30608960|NCT01287104|58619814|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
30988539|NCT02354976|59150397|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
30988540|NCT02354976|59150398|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
30988541|NCT02354976|59150399|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
30988542|NCT02354976|59150397|FG000|Overall Study|Adverse Event|1|||
30988543|NCT02354976|59150398|FG001|Overall Study|Adverse Event|0|||
30988544|NCT02354976|59150399|FG002|Overall Study|Adverse Event|2|||
30988545|NCT02303262|59150407|FG000|Overall Study|Withdrawal by Subject|2|||
30988546|NCT00558896|59150418|FG000|Overall Study|Adverse Event|1|||
30988547|NCT00558896|59150419|FG001|Overall Study|Adverse Event|1|||
30988548|NCT00558896|59150420|FG002|Overall Study|Adverse Event|1|||
30988549|NCT00558896|59150421|FG003|Overall Study|Adverse Event|3|||
30988550|NCT00558896|59150422|FG004|Overall Study|Adverse Event|4|||
30988551|NCT00558896|59150423|FG005|Overall Study|Adverse Event|10|||
30988552|NCT00558896|59150424|FG006|Overall Study|Adverse Event|3|||
30988553|NCT00558896|59150418|FG000|Overall Study|Death|3|||
30988554|NCT00558896|59150419|FG001|Overall Study|Death|0|||
30988555|NCT00558896|59150420|FG002|Overall Study|Death|2|||
30988556|NCT00558896|59150421|FG003|Overall Study|Death|3|||
30988557|NCT00558896|59150422|FG004|Overall Study|Death|2|||
30988558|NCT00558896|59150423|FG005|Overall Study|Death|2|||
30988559|NCT00558896|59150424|FG006|Overall Study|Death|6|||
30988560|NCT00558896|59150418|FG000|Overall Study|Withdrawal by Subject|2|||
30988561|NCT00558896|59150419|FG001|Overall Study|Withdrawal by Subject|1|||
30988562|NCT00558896|59150420|FG002|Overall Study|Withdrawal by Subject|1|||
30988563|NCT00558896|59150421|FG003|Overall Study|Withdrawal by Subject|1|||
30988564|NCT00558896|59150422|FG004|Overall Study|Withdrawal by Subject|1|||
30988565|NCT00558896|59150423|FG005|Overall Study|Withdrawal by Subject|5|||
30988566|NCT00558896|59150424|FG006|Overall Study|Withdrawal by Subject|5|||
30988567|NCT00558896|59150418|FG000|Overall Study|Alternative Treatment|2|||
30988568|NCT00558896|59150419|FG001|Overall Study|Alternative Treatment|2|||
30988569|NCT00558896|59150420|FG002|Overall Study|Alternative Treatment|0|||
30988570|NCT00558896|59150421|FG003|Overall Study|Alternative Treatment|2|||
30988571|NCT00558896|59150422|FG004|Overall Study|Alternative Treatment|6|||
30988572|NCT00558896|59150423|FG005|Overall Study|Alternative Treatment|7|||
30988573|NCT00558896|59150424|FG006|Overall Study|Alternative Treatment|1|||
30988574|NCT00558896|59150418|FG000|Overall Study|Physician discretion|3|||
30988575|NCT00558896|59150419|FG001|Overall Study|Physician discretion|2|||
30988576|NCT00558896|59150420|FG002|Overall Study|Physician discretion|1|||
30988577|NCT00558896|59150421|FG003|Overall Study|Physician discretion|2|||
30988578|NCT00558896|59150422|FG004|Overall Study|Physician discretion|1|||
30988579|NCT00558896|59150423|FG005|Overall Study|Physician discretion|3|||
30988580|NCT00558896|59150424|FG006|Overall Study|Physician discretion|3|||
30988581|NCT00558896|59150418|FG000|Overall Study|Continues on treatment|10|||
30988582|NCT00558896|59150419|FG001|Overall Study|Continues on treatment|1|||
30988583|NCT00558896|59150420|FG002|Overall Study|Continues on treatment|0|||
30988584|NCT00558896|59150421|FG003|Overall Study|Continues on treatment|1|||
30988585|NCT00558896|59150422|FG004|Overall Study|Continues on treatment|9|||
30988586|NCT00558896|59150423|FG005|Overall Study|Continues on treatment|25|||
30988587|NCT00558896|59150424|FG006|Overall Study|Continues on treatment|6|||
30988588|NCT00558428|59150558|FG000|Overall Study|Adverse Event|6|||
30988589|NCT00558428|59150559|FG001|Overall Study|Adverse Event|22|||
30988590|NCT00558428|59150560|FG002|Overall Study|Adverse Event|3|||
30988591|NCT00558428|59150561|FG003|Overall Study|Adverse Event|4|||
30988592|NCT00558428|59150558|FG000|Overall Study|Lost to Follow-up|0|||
30988593|NCT00558428|59150559|FG001|Overall Study|Lost to Follow-up|1|||
30988594|NCT00558428|59150560|FG002|Overall Study|Lost to Follow-up|0|||
30988595|NCT00558428|59150561|FG003|Overall Study|Lost to Follow-up|0|||
30988596|NCT00558428|59150558|FG000|Overall Study|Lack of Efficacy|0|||
30988597|NCT00558428|59150559|FG001|Overall Study|Lack of Efficacy|0|||
30988598|NCT00558428|59150560|FG002|Overall Study|Lack of Efficacy|1|||
30988599|NCT00558428|59150561|FG003|Overall Study|Lack of Efficacy|2|||
30988600|NCT00558428|59150558|FG000|Overall Study|Non compliant with protocol|1|||
30988601|NCT00558428|59150559|FG001|Overall Study|Non compliant with protocol|0|||
30988602|NCT00558428|59150560|FG002|Overall Study|Non compliant with protocol|0|||
30988603|NCT00558428|59150561|FG003|Overall Study|Non compliant with protocol|3|||
30988604|NCT00558428|59150558|FG000|Overall Study|Consent withdrawn|2|||
30988605|NCT00558428|59150559|FG001|Overall Study|Consent withdrawn|1|||
30988606|NCT00558428|59150560|FG002|Overall Study|Consent withdrawn|0|||
30988607|NCT00558428|59150561|FG003|Overall Study|Consent withdrawn|1|||
30988608|NCT00558428|59150558|FG000|Overall Study|Other|3|||
30988609|NCT00558428|59150559|FG001|Overall Study|Other|0|||
30988610|NCT00558428|59150560|FG002|Overall Study|Other|0|||
30988611|NCT00558428|59150561|FG003|Overall Study|Other|1|||
30988612|NCT00558272|59150600|FG000|Overall Study|Adverse Event|10|||
30988613|NCT00558272|59150601|FG001|Overall Study|Adverse Event|0|||
30988614|NCT00558272|59150600|FG000|Overall Study|Death|1|||
30988615|NCT00558272|59150601|FG001|Overall Study|Death|0|||
30988616|NCT00558272|59150600|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
30988617|NCT00558272|59150601|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
30988618|NCT00558272|59150600|FG000|Overall Study|AZ study team decision|0|||
30988619|NCT00558272|59150601|FG001|Overall Study|AZ study team decision|1|||
30988620|NCT00558272|59150600|FG000|Overall Study|Incorrectly enrolled|1|||
30988621|NCT00558272|59150601|FG001|Overall Study|Incorrectly enrolled|0|||
30988622|NCT00558272|59150600|FG000|Overall Study|Withdrawal by Subject|0|||
30988623|NCT00558272|59150601|FG001|Overall Study|Withdrawal by Subject|1|||
30988624|NCT00557492|59150751|FG000|Overall Study|Change in health insurance|1|||
30988625|NCT02354586|59150854|FG000|Overall Study|Death|230|||
30988626|NCT02354586|59150854|FG000|Overall Study|Withdrawal by Subject|59|||
30988627|NCT02354586|59150854|FG000|Overall Study|Lost to Follow-up|11|||
30988628|NCT02354586|59150854|FG000|Overall Study|Sponsor decision|51|||
30988629|NCT02354586|59150854|FG000|Overall Study|Site closure|2|||
30988630|NCT02354586|59150854|FG000|Overall Study|Intercurrent illness|1|||
30988631|NCT02354586|59150854|FG000|Overall Study|Protocol Violation|3|||
30988632|NCT02354586|59150854|FG000|Overall Study|Physician Decision|13|||
30988633|NCT02354586|59150854|FG000|Overall Study|Lack of Efficacy|86|||
30988634|NCT02354586|59150854|FG000|Overall Study|Adverse Event|7|||
30988635|NCT02332824|59150879|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
30988636|NCT02332824|59150880|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
30988637|NCT02332824|59150881|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
30988638|NCT02332824|59150882|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
30988639|NCT02332824|59150883|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
30988640|NCT02332824|59150884|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
30988641|NCT02332824|59150879|FG000|Overall Study|Voluntary Withdrawal|1|||
30988642|NCT02332824|59150880|FG001|Overall Study|Voluntary Withdrawal|0|||
30988643|NCT02332824|59150881|FG002|Overall Study|Voluntary Withdrawal|0|||
30988644|NCT02332824|59150882|FG003|Overall Study|Voluntary Withdrawal|0|||
30988645|NCT02332824|59150883|FG004|Overall Study|Voluntary Withdrawal|0|||
30988646|NCT02332824|59150884|FG005|Overall Study|Voluntary Withdrawal|0|||
30988647|NCT02332824|59150879|FG000|Overall Study|Inconvenient schedule|1|||
30988648|NCT02332824|59150880|FG001|Overall Study|Inconvenient schedule|1|||
30988649|NCT02332824|59150881|FG002|Overall Study|Inconvenient schedule|0|||
30988650|NCT02332824|59150882|FG003|Overall Study|Inconvenient schedule|0|||
30988651|NCT02332824|59150883|FG004|Overall Study|Inconvenient schedule|0|||
30988652|NCT02332824|59150884|FG005|Overall Study|Inconvenient schedule|0|||
30988653|NCT02332824|59150879|FG000|Overall Study|Transfer|0|||
30988654|NCT02332824|59150880|FG001|Overall Study|Transfer|0|||
30988655|NCT02332824|59150881|FG002|Overall Study|Transfer|1|||
30988656|NCT02332824|59150882|FG003|Overall Study|Transfer|1|||
30988657|NCT02332824|59150883|FG004|Overall Study|Transfer|0|||
30988658|NCT02332824|59150884|FG005|Overall Study|Transfer|0|||
30988659|NCT00556712|59151031|FG000|Overall Study|Adverse Event|7|||
30988660|NCT00556712|59151032|FG001|Overall Study|Adverse Event|19|||
30988661|NCT00556712|59151031|FG000|Overall Study|Death|5|||
30988662|NCT00556712|59151032|FG001|Overall Study|Death|10|||
30988663|NCT00556712|59151031|FG000|Overall Study|Progressive Disease|383|||
30988664|NCT00556712|59151032|FG001|Overall Study|Progressive Disease|320|||
30988665|NCT00556712|59151031|FG000|Overall Study|Protocol Violation|3|||
30988666|NCT00556712|59151032|FG001|Overall Study|Protocol Violation|2|||
30988667|NCT00556712|59151031|FG000|Overall Study|Refused Treatment|17|||
30988668|NCT00556712|59151032|FG001|Overall Study|Refused Treatment|16|||
30988669|NCT00556712|59151031|FG000|Overall Study|Failure to Return|2|||
30988670|NCT00556712|59151032|FG001|Overall Study|Failure to Return|3|||
30988671|NCT00556712|59151031|FG000|Overall Study|Other|2|||
30988672|NCT00556712|59151032|FG001|Overall Study|Other|2|||
30988673|NCT00556712|59151031|FG000|Overall Study|Ongoing at Data Cutoff|32|||
30988674|NCT00556712|59151032|FG001|Overall Study|Ongoing at Data Cutoff|66|||
30988675|NCT00556322|59151106|FG000|Overall Study|Insufficient therapeutic response|158|||
30988676|NCT00556322|59151107|FG001|Overall Study|Insufficient therapeutic response|168|||
30988677|NCT00556322|59151106|FG000|Overall Study|Adverse Event|7|||
30988678|NCT00556322|59151107|FG001|Overall Study|Adverse Event|4|||
30988679|NCT00556322|59151106|FG000|Overall Study|Other|4|||
30988680|NCT00556322|59151107|FG001|Overall Study|Other|1|||
30988681|NCT00556322|59151106|FG000|Overall Study|Lost to Follow-up|5|||
30988682|NCT00556322|59151107|FG001|Overall Study|Lost to Follow-up|3|||
30988683|NCT00556322|59151106|FG000|Overall Study|Withdrawal by Subject|19|||
30988684|NCT00556322|59151107|FG001|Overall Study|Withdrawal by Subject|7|||
30988685|NCT00556322|59151106|FG000|Overall Study|Protocol Violation|5|||
30988686|NCT00556322|59151107|FG001|Overall Study|Protocol Violation|1|||
30988687|NCT00556322|59151106|FG000|Overall Study|Ongoing at data cutoff|3|||
30988688|NCT00556322|59151107|FG001|Overall Study|Ongoing at data cutoff|5|||
30988689|NCT00556322|59151106|FG000|Overall Study|Death|20|||
30988690|NCT00556322|59151107|FG001|Overall Study|Death|14|||
30988691|NCT00556166|59151125|FG000|Overall Study|Withdrawal by Subject|1|||
30988692|NCT02332590|59151285|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
30988693|NCT02332590|59151286|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
30988694|NCT02332590|59151285|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
30988695|NCT02332590|59151286|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
30988696|NCT02332590|59151285|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
30988697|NCT02332590|59151286|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
30988698|NCT02332590|59151285|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
30988699|NCT02332590|59151286|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
30988700|NCT02332590|59151285|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
30988701|NCT02332590|59151286|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
30988702|NCT02332590|59151285|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
30988703|NCT02332590|59151286|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
30988704|NCT02332590|59151285|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
30988705|NCT02332590|59151286|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
30988706|NCT02332590|59151285|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
30988707|NCT02332590|59151286|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
30988708|NCT02332590|59151285|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
30988709|NCT02332590|59151286|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
30988710|NCT00554840|59151357|FG000|Overall Study|Physician Decision|0|||
30988711|NCT00554840|59151358|FG001|Overall Study|Physician Decision|1|||
30988712|NCT02302716|59151383|FG000|Overall Study|Adverse Event|1|||
30988713|NCT02302716|59151384|FG001|Overall Study|Adverse Event|1|||
30988714|NCT02302716|59151383|FG000|Overall Study|Death|0|||
30988715|NCT02302716|59151384|FG001|Overall Study|Death|1|||
30988716|NCT02302716|59151383|FG000|Overall Study|Lack of Efficacy|0|||
30988717|NCT02302716|59151384|FG001|Overall Study|Lack of Efficacy|1|||
30988718|NCT02302716|59151383|FG000|Overall Study|Lost to Follow-up|2|||
30988719|NCT02302716|59151384|FG001|Overall Study|Lost to Follow-up|4|||
30988720|NCT02302716|59151383|FG000|Overall Study|Physician Decision|3|||
30988721|NCT02302716|59151384|FG001|Overall Study|Physician Decision|4|||
30988722|NCT02302716|59151383|FG000|Overall Study|Withdrawal by Subject|13|||
30988723|NCT02302716|59151384|FG001|Overall Study|Withdrawal by Subject|7|||
30988724|NCT02302716|59151383|FG000|Overall Study|Protocol Violation|0|||
30988725|NCT02302716|59151384|FG001|Overall Study|Protocol Violation|1|||
30988726|NCT00554606|59151413|FG000|Overall Study|Adverse Event|3|||
30988727|NCT00554606|59151413|FG000|Overall Study|Abnormal laboratory values|1|||
30988728|NCT00554606|59151413|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
30988729|NCT00554606|59151413|FG000|Overall Study|Subject withdrew consent|2|||
30988730|NCT00554606|59151413|FG000|Overall Study|Lost to Follow-up|2|||
30988731|NCT00554606|59151413|FG000|Overall Study|Administrative problems|60|||
30988732|NCT00554606|59151413|FG000|Overall Study|Death|1|||
30988733|NCT00554606|59151413|FG000|Overall Study|Protocol deviation|2|||
30988734|NCT02354508|59151449|FG000|Period 1: Core Phase|Adverse Event|1|||
30988735|NCT02354508|59151450|FG001|Period 1: Core Phase|Adverse Event|1|||
30988736|NCT02354508|59151451|FG002|Period 1: Core Phase|Adverse Event|2|||
30988737|NCT02354508|59151449|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
30988738|NCT02354508|59151450|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
30988739|NCT02354508|59151451|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
30988740|NCT02354508|59151449|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
30988741|NCT02354508|59151450|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
30988742|NCT02354508|59151451|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
30988743|NCT02354508|59151449|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
30988744|NCT02354508|59151450|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
30988745|NCT02354508|59151451|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
30988746|NCT02354508|59151449|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
30988747|NCT02354508|59151450|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
30988748|NCT02354508|59151451|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
30988749|NCT02354508|59151449|FG000|Period 2: Extension Phase|Physician Decision|5|||
30988750|NCT02354508|59151450|FG001|Period 2: Extension Phase|Physician Decision|0|||
30988751|NCT02354508|59151451|FG002|Period 2: Extension Phase|Physician Decision|1|||
30988752|NCT02354508|59151449|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
30988753|NCT02354508|59151450|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
30988754|NCT02354508|59151451|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
30988755|NCT02354508|59151449|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
30988756|NCT02354508|59151450|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
30988757|NCT02354508|59151451|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
30988758|NCT02354508|59151449|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
30988759|NCT02354508|59151450|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
30988760|NCT02354508|59151451|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
30988761|NCT00554216|59151503|FG000|Overall Study|Lost to Follow-up|92|||
30988762|NCT00554216|59151504|FG001|Overall Study|Lost to Follow-up|31|||
30988763|NCT00554216|59151505|FG002|Overall Study|Lost to Follow-up|63|||
30988764|NCT00554216|59151503|FG000|Overall Study|Adverse Event|16|||
30988765|NCT00554216|59151504|FG001|Overall Study|Adverse Event|16|||
30988766|NCT00554216|59151505|FG002|Overall Study|Adverse Event|36|||
30988767|NCT00554216|59151503|FG000|Overall Study|Withdrawal by Subject|92|||
30988768|NCT00554216|59151504|FG001|Overall Study|Withdrawal by Subject|31|||
30988769|NCT00554216|59151505|FG002|Overall Study|Withdrawal by Subject|43|||
30988770|NCT00554216|59151503|FG000|Overall Study|Non compliance|10|||
30988771|NCT00554216|59151504|FG001|Overall Study|Non compliance|4|||
30988772|NCT00554216|59151505|FG002|Overall Study|Non compliance|5|||
30988773|NCT00554216|59151503|FG000|Overall Study|Pregnancy|2|||
30988774|NCT00554216|59151504|FG001|Overall Study|Pregnancy|1|||
30988775|NCT00554216|59151505|FG002|Overall Study|Pregnancy|14|||
30988776|NCT00554216|59151503|FG000|Overall Study|Restricted med|3|||
30988777|NCT00554216|59151504|FG001|Overall Study|Restricted med|1|||
30988778|NCT00554216|59151505|FG002|Overall Study|Restricted med|1|||
30988779|NCT00554216|59151503|FG000|Overall Study|Other|12|||
30988780|NCT00554216|59151504|FG001|Overall Study|Other|7|||
30988781|NCT00554216|59151505|FG002|Overall Study|Other|10|||
30988782|NCT00554216|59151503|FG000|Overall Study|Lack of Efficacy|15|||
30988783|NCT00554216|59151504|FG001|Overall Study|Lack of Efficacy|3|||
30988784|NCT00554216|59151505|FG002|Overall Study|Lack of Efficacy|0|||
30988785|NCT02353572|59151530|FG000|Overall Study|Withdrawal by Subject|1|||
30988786|NCT02353572|59151530|FG000|Overall Study|Study terminated|2|||
30988787|NCT00552578|59151542|FG000|Overall Study|Lost to Follow-up|1|||
30988788|NCT00552578|59151543|FG001|Overall Study|Lost to Follow-up|1|||
30988789|NCT02301936|59151551|FG000|Overall Study|Lost to Follow-up|1|||
30988790|NCT02301936|59151552|FG001|Overall Study|Lost to Follow-up|0|||
30988791|NCT00552344|59151591|FG000|Overall Study|Lack of Efficacy|55|||
30988792|NCT00552344|59151591|FG000|Overall Study|Loss of efficacy|75|||
30988793|NCT00552344|59151591|FG000|Overall Study|Lost to Follow-up|8|||
30988794|NCT00552344|59151591|FG000|Overall Study|Withdrawal by Subject|48|||
30988795|NCT00552344|59151591|FG000|Overall Study|SAE, non-fatal|6|||
30988796|NCT00552344|59151591|FG000|Overall Study|AE, non-serious non-fatal|38|||
30988797|NCT00552344|59151591|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
30988798|NCT00552344|59151591|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
30988799|NCT00552344|59151591|FG000|Overall Study|Other Reason|22|||
30988800|NCT00553514|59151628|FG000|Overall Study|Protocol deviation|0|||
30988801|NCT00553514|59151629|FG001|Overall Study|Protocol deviation|0|||
30988802|NCT00553514|59151630|FG002|Overall Study|Protocol deviation|0|||
30988803|NCT00553514|59151631|FG003|Overall Study|Protocol deviation|1|||
30988804|NCT00553514|59151632|FG004|Overall Study|Protocol deviation|0|||
30988805|NCT00553514|59151628|FG000|Overall Study|Lack of ovarian response|4|||
30988806|NCT00553514|59151629|FG001|Overall Study|Lack of ovarian response|5|||
30988807|NCT00553514|59151630|FG002|Overall Study|Lack of ovarian response|5|||
30988808|NCT00553514|59151631|FG003|Overall Study|Lack of ovarian response|5|||
30988809|NCT00553514|59151632|FG004|Overall Study|Lack of ovarian response|6|||
30988810|NCT00553514|59151628|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
30988811|NCT00553514|59151629|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
30988812|NCT00553514|59151630|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
30988813|NCT00553514|59151631|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
30988814|NCT00553514|59151632|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
30988815|NCT00553514|59151628|FG000|Overall Study|Risk of multiple pregnancy|0|||
30988816|NCT00553514|59151629|FG001|Overall Study|Risk of multiple pregnancy|2|||
30988817|NCT00553514|59151630|FG002|Overall Study|Risk of multiple pregnancy|0|||
30988818|NCT00553514|59151631|FG003|Overall Study|Risk of multiple pregnancy|1|||
30988819|NCT00553514|59151632|FG004|Overall Study|Risk of multiple pregnancy|0|||
30988820|NCT00553514|59151628|FG000|Overall Study|Other|1|||
30988821|NCT00553514|59151629|FG001|Overall Study|Other|1|||
30988822|NCT00553514|59151630|FG002|Overall Study|Other|0|||
30988823|NCT00553514|59151631|FG003|Overall Study|Other|0|||
30988824|NCT00553514|59151632|FG004|Overall Study|Other|1|||
30988825|NCT00553436|59151656|FG000|Overall Study|Conversion to another procedure|1|||
30988826|NCT00553202|59151687|FG000|Overall Study|Death|16|||
30988827|NCT00553202|59151687|FG000|Overall Study|Lost to Follow-up|1|||
30988828|NCT00553202|59151687|FG000|Overall Study|Physician Decision|28|||
30988829|NCT00553202|59151687|FG000|Overall Study|Withdrawal by Subject|1|||
30988830|NCT00553202|59151687|FG000|Overall Study|No donor identified|16|||
30988831|NCT00553202|59151687|FG000|Overall Study|Fails to meet organ function|6|||
30988832|NCT00552188|59151711|FG000|Overall Study|Adverse Event|0|||
30988833|NCT00552188|59151712|FG001|Overall Study|Adverse Event|2|||
30988834|NCT00552188|59151711|FG000|Overall Study|Lost to Follow-up|2|||
30988835|NCT00552188|59151712|FG001|Overall Study|Lost to Follow-up|1|||
30988836|NCT00552188|59151711|FG000|Overall Study|Withdrawal of consent|0|||
30988837|NCT00552188|59151712|FG001|Overall Study|Withdrawal of consent|1|||
30988838|NCT00552188|59151711|FG000|Overall Study|Subject returned to home country|0|||
30988839|NCT00552188|59151712|FG001|Overall Study|Subject returned to home country|1|||
30988840|NCT00552110|59151732|FG000|Overall Study|Serious or Life-Threatening AE|0|||
30988841|NCT00552110|59151733|FG001|Overall Study|Serious or Life-Threatening AE|0|||
30988842|NCT00552110|59151734|FG002|Overall Study|Serious or Life-Threatening AE|1|||
30988843|NCT00552110|59151735|FG003|Overall Study|Serious or Life-Threatening AE|0|||
30988844|NCT00552110|59151736|FG004|Overall Study|Serious or Life-Threatening AE|0|||
30988845|NCT00552110|59151732|FG000|Overall Study|Lack of Efficacy|1|||
30988846|NCT00552110|59151733|FG001|Overall Study|Lack of Efficacy|0|||
30988847|NCT00552110|59151734|FG002|Overall Study|Lack of Efficacy|0|||
30988848|NCT00552110|59151735|FG003|Overall Study|Lack of Efficacy|1|||
30988849|NCT00552110|59151736|FG004|Overall Study|Lack of Efficacy|4|||
30988850|NCT00552110|59151732|FG000|Overall Study|Withdrawal by Subject|0|||
30988851|NCT00552110|59151733|FG001|Overall Study|Withdrawal by Subject|2|||
30988852|NCT00552110|59151734|FG002|Overall Study|Withdrawal by Subject|0|||
30608961|NCT01287104|58619811|FG000|Overall Study|Low donor chimerism|0|||
30988853|NCT00552110|59151735|FG003|Overall Study|Withdrawal by Subject|3|||
30988854|NCT00552110|59151736|FG004|Overall Study|Withdrawal by Subject|2|||
30988855|NCT00552110|59151732|FG000|Overall Study|Lost to Follow-up|0|||
30988856|NCT00552110|59151733|FG001|Overall Study|Lost to Follow-up|0|||
30988857|NCT00552110|59151734|FG002|Overall Study|Lost to Follow-up|0|||
30988858|NCT00552110|59151735|FG003|Overall Study|Lost to Follow-up|1|||
30988859|NCT00552110|59151736|FG004|Overall Study|Lost to Follow-up|1|||
30988860|NCT00552110|59151732|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
30988861|NCT00552110|59151733|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
30988862|NCT00552110|59151734|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
30988863|NCT00552110|59151735|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
30988864|NCT00552110|59151736|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
30988865|NCT00552110|59151732|FG000|Overall Study|Withdrawn per Sponsor|0|||
30988866|NCT00552110|59151733|FG001|Overall Study|Withdrawn per Sponsor|1|||
30988867|NCT00552110|59151734|FG002|Overall Study|Withdrawn per Sponsor|0|||
30988868|NCT00552110|59151735|FG003|Overall Study|Withdrawn per Sponsor|0|||
30988869|NCT00552110|59151736|FG004|Overall Study|Withdrawn per Sponsor|1|||
30988870|NCT00552110|59151732|FG000|Overall Study|Use of Prohibited Medication|1|||
30988871|NCT00552110|59151733|FG001|Overall Study|Use of Prohibited Medication|1|||
30988872|NCT00552110|59151734|FG002|Overall Study|Use of Prohibited Medication|0|||
30988873|NCT00552110|59151735|FG003|Overall Study|Use of Prohibited Medication|0|||
30988874|NCT00552110|59151736|FG004|Overall Study|Use of Prohibited Medication|0|||
30988875|NCT00552110|59151732|FG000|Overall Study|Delay of Study due to Relabeling|0|||
30988876|NCT00552110|59151733|FG001|Overall Study|Delay of Study due to Relabeling|0|||
30988877|NCT00552110|59151734|FG002|Overall Study|Delay of Study due to Relabeling|0|||
30988878|NCT00552110|59151735|FG003|Overall Study|Delay of Study due to Relabeling|1|||
30988879|NCT00552110|59151736|FG004|Overall Study|Delay of Study due to Relabeling|0|||
30988880|NCT00552110|59151732|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
30988881|NCT00552110|59151733|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
30988882|NCT00552110|59151734|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
30988883|NCT00552110|59151735|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
30988884|NCT00552110|59151736|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
30988885|NCT00552110|59151732|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
30988886|NCT00552110|59151733|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
30988887|NCT00552110|59151734|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
30988888|NCT00552110|59151735|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
30988889|NCT00552110|59151736|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
30988890|NCT02301624|59151759|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
30988891|NCT02301624|59151760|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
30988892|NCT02301624|59151759|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
30988893|NCT02301624|59151760|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
30988894|NCT02301624|59151759|FG000|Open-label Maintenance Phase|Adverse Event|2|||
30988895|NCT02301624|59151760|FG001|Open-label Maintenance Phase|Adverse Event|5|||
30988896|NCT02301624|59151759|FG000|Open-label Maintenance Phase|Physician Decision|3|||
30988897|NCT02301624|59151760|FG001|Open-label Maintenance Phase|Physician Decision|3|||
30988898|NCT02301624|59151759|FG000|Open-label Maintenance Phase|Death|2|||
30988899|NCT02301624|59151760|FG001|Open-label Maintenance Phase|Death|1|||
30988900|NCT02301624|59151759|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
30988901|NCT02301624|59151760|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
30988902|NCT02301546|59151801|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
30988903|NCT02301546|59151802|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
30988904|NCT02301546|59151801|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
30988905|NCT02301546|59151802|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
30988906|NCT02301546|59151801|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
30988907|NCT02301546|59151802|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
30988908|NCT02301546|59151801|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
30988909|NCT02301546|59151802|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
30988910|NCT02301546|59151801|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
30988911|NCT02301546|59151802|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
30988912|NCT02301546|59151801|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
30988913|NCT02301546|59151802|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
30988914|NCT02301546|59151801|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
30988915|NCT02301546|59151802|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
30988916|NCT02351934|59151826|FG000|Allocation|POD weight<pre-op weight|3|||
30988917|NCT02351934|59151827|FG001|Allocation|POD weight<pre-op weight|0|||
30988918|NCT02351934|59151826|FG000|Allocation|Hypotension preventing administration|2|||
30988919|NCT02351934|59151827|FG001|Allocation|Hypotension preventing administration|0|||
30988920|NCT02351934|59151826|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
30988921|NCT02351934|59151827|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
30988922|NCT02351934|59151826|FG000|Follow-Up|POD weight<pre-op weight|3|||
30988923|NCT02351934|59151827|FG001|Follow-Up|POD weight<pre-op weight|0|||
30988924|NCT02351934|59151826|FG000|Follow-Up|Acute Kidney Injury|1|||
30988925|NCT02351934|59151827|FG001|Follow-Up|Acute Kidney Injury|0|||
30988926|NCT02351934|59151826|FG000|Follow-Up|Early dismissal|3|||
30988927|NCT02351934|59151827|FG001|Follow-Up|Early dismissal|0|||
30988928|NCT02351934|59151826|FG000|Follow-Up|Hypotension|3|||
30988929|NCT02351934|59151827|FG001|Follow-Up|Hypotension|0|||
30988930|NCT02351934|59151826|FG000|Follow-Up|No documentation|2|||
30988931|NCT02351934|59151827|FG001|Follow-Up|No documentation|0|||
30988932|NCT02351934|59151826|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
30988933|NCT02351934|59151827|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
30988934|NCT02351934|59151826|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
30988935|NCT02351934|59151827|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
30988936|NCT02351856|59151867|FG000|Overall Study|Adverse Event|2|||
30988937|NCT02351856|59151867|FG000|Overall Study|Physician Decision|5|||
30988938|NCT02351856|59151867|FG000|Overall Study|Study terminated by sponsor|1|||
30988939|NCT02349360|59151907|FG000|Overall Study|Withdrawal by Subject|0|||
30988940|NCT02349360|59151908|FG001|Overall Study|Withdrawal by Subject|1|||
30988941|NCT00551642|59151933|FG000|Treatment Period|Protocol Deviation|6|||
30988942|NCT00551642|59151934|FG001|Treatment Period|Protocol Deviation|11|||
30988943|NCT00551642|59151933|FG000|Treatment Period|Delivery device failure|1|||
30988944|NCT00551642|59151934|FG001|Treatment Period|Delivery device failure|3|||
30988945|NCT00551642|59151933|FG000|Treatment Period|Physician Decision|0|||
30988946|NCT00551642|59151934|FG001|Treatment Period|Physician Decision|1|||
30988947|NCT00551642|59151933|FG000|Treatment Period|Death|33|||
30988948|NCT00551642|59151934|FG001|Treatment Period|Death|31|||
30988949|NCT00551642|59151933|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
30988950|NCT00551642|59151934|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
30988951|NCT00551642|59151933|FG000|Treatment Period|Adverse Event|15|||
30988952|NCT00551642|59151934|FG001|Treatment Period|Adverse Event|12|||
30988953|NCT00551642|59151933|FG000|Treatment Period|Withdrawal by Subject|2|||
30988954|NCT00551642|59151934|FG001|Treatment Period|Withdrawal by Subject|1|||
30988955|NCT00550550|59152028|FG000|Overall Study|Adverse Event|13|||
30988956|NCT00550550|59152029|FG001|Overall Study|Adverse Event|5|||
30988957|NCT00550550|59152028|FG000|Overall Study|Treatment Failure|0|||
30988958|NCT00550550|59152029|FG001|Overall Study|Treatment Failure|1|||
30988959|NCT00550550|59152028|FG000|Overall Study|Lost to Follow-up|4|||
30988960|NCT00550550|59152029|FG001|Overall Study|Lost to Follow-up|0|||
30988961|NCT00550550|59152028|FG000|Overall Study|Withdrawal by Subject|10|||
30988962|NCT00550550|59152029|FG001|Overall Study|Withdrawal by Subject|8|||
30988963|NCT00550550|59152028|FG000|Overall Study|Protocol Violation|5|||
30988964|NCT00550550|59152029|FG001|Overall Study|Protocol Violation|14|||
30988965|NCT00550550|59152028|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
30988966|NCT00550550|59152029|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
30988967|NCT00550550|59152028|FG000|Overall Study|Randomized But Not Treated|1|||
30988968|NCT00550550|59152029|FG001|Overall Study|Randomized But Not Treated|0|||
30988969|NCT02301156|59152080|FG000|Overall Study|Adverse Event|13|||
30988970|NCT02301156|59152081|FG001|Overall Study|Adverse Event|14|||
30988971|NCT02301156|59152080|FG000|Overall Study|Death|1|||
30988972|NCT02301156|59152081|FG001|Overall Study|Death|5|||
30988973|NCT02301156|59152080|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
30988974|NCT02301156|59152081|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
30988975|NCT02301156|59152080|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
30988976|NCT02301156|59152081|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
30988977|NCT02301156|59152080|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
30988978|NCT02301156|59152081|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
30988979|NCT02301156|59152080|FG000|Overall Study|Reason not Specified|6|||
30988980|NCT02301156|59152081|FG001|Overall Study|Reason not Specified|3|||
30988981|NCT02301390|59152162|FG000|Overall Study|Withdrawal by Subject|3|||
30988982|NCT02301390|59152163|FG001|Overall Study|Withdrawal by Subject|5|||
30988983|NCT02301390|59152162|FG000|Overall Study|Protocol Violation|1|||
30988984|NCT02301390|59152163|FG001|Overall Study|Protocol Violation|0|||
30988985|NCT02301390|59152162|FG000|Overall Study|Physician Decision|1|||
30988986|NCT02301390|59152163|FG001|Overall Study|Physician Decision|0|||
30988987|NCT02301390|59152162|FG000|Overall Study|Lost to Follow-up|0|||
30988988|NCT02301390|59152163|FG001|Overall Study|Lost to Follow-up|1|||
30988989|NCT02301390|59152162|FG000|Overall Study|Death|2|||
30988990|NCT02301390|59152163|FG001|Overall Study|Death|2|||
30988991|NCT02301390|59152162|FG000|Overall Study|Procedure not completed|0|||
30988992|NCT02301390|59152163|FG001|Overall Study|Procedure not completed|4|||
30988993|NCT02301390|59152162|FG000|Overall Study|Missed multiple visits|1|||
30988994|NCT02301390|59152163|FG001|Overall Study|Missed multiple visits|1|||
30988995|NCT02301390|59152162|FG000|Overall Study|study terminated|2|||
30988996|NCT02301390|59152163|FG001|Overall Study|study terminated|0|||
30988997|NCT02300610|59152280|FG000|Overall Study|Withdrawal by Subject|1|||
30988998|NCT02300610|59152281|FG001|Overall Study|Withdrawal by Subject|0|||
30988999|NCT02300610|59152282|FG002|Overall Study|Withdrawal by Subject|1|||
30989000|NCT02300298|59152327|FG000|Disposition for Nintedanib|Progressive disease|10|||
30989001|NCT02300298|59152328|FG001|Disposition for Nintedanib|Progressive disease|0|||
30989002|NCT02300298|59152327|FG000|Disposition for Docetaxel|Progressive disease|0|||
30989003|NCT02300298|59152328|FG001|Disposition for Docetaxel|Progressive disease|6|||
30989004|NCT02300298|59152327|FG000|Disposition for Docetaxel|other adverse event|0|||
30989005|NCT02300298|59152328|FG001|Disposition for Docetaxel|other adverse event|4|||
30989006|NCT02300220|59152334|FG000|Overall Study|Lost to Follow-up|1|||
30989007|NCT02300220|59152335|FG001|Overall Study|Lost to Follow-up|2|||
30989008|NCT02300220|59152334|FG000|Overall Study|Death|1|||
30989009|NCT02300220|59152335|FG001|Overall Study|Death|1|||
30989010|NCT02300220|59152334|FG000|Overall Study|Adverse Event|1|||
30989011|NCT02300220|59152335|FG001|Overall Study|Adverse Event|1|||
30989012|NCT02300220|59152334|FG000|Overall Study|Protocol Violation|1|||
30989013|NCT02300220|59152335|FG001|Overall Study|Protocol Violation|0|||
30989014|NCT02300220|59152334|FG000|Overall Study|Withdrawal by Subject|0|||
30989015|NCT02300220|59152335|FG001|Overall Study|Withdrawal by Subject|2|||
30989016|NCT02300220|59152334|FG000|Overall Study|Did not tolerate IMP|0|||
30989017|NCT02300220|59152335|FG001|Overall Study|Did not tolerate IMP|1|||
30989018|NCT02327130|59152359|FG000|Overall Study|Discharged in less than 5 days|5|||
30989019|NCT02327130|59152359|FG000|Overall Study|Physician Decision|2|||
30989020|NCT02327130|59152359|FG000|Overall Study|Unable to provide breath sample|1|||
30989021|NCT02327130|59152359|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
30989022|NCT02327130|59152359|FG000|Overall Study|Met exclusion criteria|3|||
30989023|NCT02326272|59152414|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989024|NCT02326272|59152415|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
30989025|NCT02326272|59152416|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
30989026|NCT02326272|59152417|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989027|NCT02326272|59152418|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989028|NCT02326272|59152419|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989029|NCT02326272|59152420|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989030|NCT02326272|59152421|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989031|NCT02326272|59152422|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989032|NCT02326272|59152423|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989033|NCT02326272|59152424|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989034|NCT02326272|59152425|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989035|NCT02326272|59152426|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989036|NCT02326272|59152427|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989037|NCT02326272|59152428|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30989038|NCT02326272|59152414|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
30989039|NCT02326272|59152415|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
30989040|NCT02326272|59152416|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989041|NCT02326272|59152417|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989042|NCT02326272|59152418|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989043|NCT02326272|59152419|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989044|NCT02326272|59152420|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989045|NCT02326272|59152421|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989046|NCT02326272|59152422|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989047|NCT02326272|59152423|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989048|NCT02326272|59152424|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989049|NCT02326272|59152425|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989050|NCT02326272|59152426|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989051|NCT02326272|59152427|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989052|NCT02326272|59152428|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30989053|NCT02326272|59152414|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
30989054|NCT02326272|59152415|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
30989055|NCT02326272|59152416|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
30989056|NCT02326272|59152417|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989057|NCT02326272|59152418|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989058|NCT02326272|59152419|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989059|NCT02326272|59152420|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989060|NCT02326272|59152421|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989061|NCT02326272|59152422|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989062|NCT02326272|59152423|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989063|NCT02326272|59152424|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989064|NCT02326272|59152425|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989065|NCT02326272|59152426|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989066|NCT02326272|59152427|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989067|NCT02326272|59152428|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30989068|NCT02326272|59152414|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989069|NCT02326272|59152415|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989070|NCT02326272|59152416|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
30989071|NCT02326272|59152417|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989072|NCT02326272|59152418|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989073|NCT02326272|59152419|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989074|NCT02326272|59152420|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989075|NCT02326272|59152421|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989076|NCT02326272|59152422|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989077|NCT02326272|59152423|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989078|NCT02326272|59152424|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989079|NCT02326272|59152425|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989080|NCT02326272|59152426|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989081|NCT02326272|59152427|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989082|NCT02326272|59152428|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
30989083|NCT02326272|59152414|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989084|NCT02326272|59152415|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989085|NCT02326272|59152416|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
30989086|NCT02326272|59152417|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989087|NCT02326272|59152418|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989088|NCT02326272|59152419|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989089|NCT02326272|59152420|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989090|NCT02326272|59152421|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989091|NCT02326272|59152422|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989092|NCT02326272|59152423|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989093|NCT02326272|59152424|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989094|NCT02326272|59152425|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989095|NCT02326272|59152426|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989096|NCT02326272|59152427|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989097|NCT02326272|59152428|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
30989098|NCT02326272|59152414|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989099|NCT02326272|59152415|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989100|NCT02326272|59152416|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
30989101|NCT02326272|59152417|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989102|NCT02326272|59152418|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989103|NCT02326272|59152419|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989104|NCT02326272|59152420|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989105|NCT02326272|59152421|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989106|NCT02326272|59152422|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989107|NCT02326272|59152423|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989108|NCT02326272|59152424|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989109|NCT02326272|59152425|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989110|NCT02326272|59152426|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989111|NCT02326272|59152427|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989112|NCT02326272|59152428|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
30989113|NCT02326272|59152414|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989114|NCT02326272|59152415|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989115|NCT02326272|59152416|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
30989116|NCT02326272|59152417|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989117|NCT02326272|59152418|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989118|NCT02326272|59152419|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989119|NCT02326272|59152420|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989120|NCT02326272|59152421|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989121|NCT02326272|59152422|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989122|NCT02326272|59152423|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989123|NCT02326272|59152424|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989124|NCT02326272|59152425|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989125|NCT02326272|59152426|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989126|NCT02326272|59152427|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989127|NCT02326272|59152428|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
30989128|NCT02326272|59152414|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30989129|NCT02326272|59152415|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30989130|NCT02326272|59152416|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30989131|NCT02326272|59152417|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30989132|NCT02326272|59152418|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
30989133|NCT02326272|59152419|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
30989134|NCT02326272|59152420|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
30989135|NCT02326272|59152421|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
30989136|NCT02326272|59152422|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
30989137|NCT02326272|59152423|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30989138|NCT02326272|59152424|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30989139|NCT02326272|59152425|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30989140|NCT02326272|59152426|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30989141|NCT02326272|59152427|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30989142|NCT02326272|59152428|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30989143|NCT02326272|59152414|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30989144|NCT02326272|59152415|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30989145|NCT02326272|59152416|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30989146|NCT02326272|59152417|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30989147|NCT02326272|59152418|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30989148|NCT02326272|59152419|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
30989149|NCT02326272|59152420|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
30989150|NCT02326272|59152421|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30989151|NCT02326272|59152422|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
30989152|NCT02326272|59152423|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
30989153|NCT02326272|59152424|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30989154|NCT02326272|59152425|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30989155|NCT02326272|59152426|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30989156|NCT02326272|59152427|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30989157|NCT02326272|59152428|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
30989158|NCT02326272|59152414|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989159|NCT02326272|59152415|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989160|NCT02326272|59152416|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989161|NCT02326272|59152417|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989162|NCT02326272|59152418|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989163|NCT02326272|59152419|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
30989164|NCT02326272|59152420|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989165|NCT02326272|59152421|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
30989166|NCT02326272|59152422|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989167|NCT02326272|59152423|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989168|NCT02326272|59152424|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989169|NCT02326272|59152425|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989170|NCT02326272|59152426|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989171|NCT02326272|59152427|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989172|NCT02326272|59152428|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30989173|NCT02326272|59152414|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30989174|NCT02326272|59152415|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30989175|NCT02326272|59152416|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30989176|NCT02326272|59152417|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30989177|NCT02326272|59152418|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30989178|NCT02326272|59152419|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
30989179|NCT02326272|59152420|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30989180|NCT02326272|59152421|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30989181|NCT02326272|59152422|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30989182|NCT02326272|59152423|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30989183|NCT02326272|59152424|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30989184|NCT02326272|59152425|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30891771|NCT01649557|58925055|FG000|Overall Study|Lost to Follow-up|5|||
30891772|NCT01649557|58925056|FG001|Overall Study|Lost to Follow-up|0|||
30891773|NCT01649557|58925057|FG002|Overall Study|Lost to Follow-up|3|||
30989185|NCT02326272|59152426|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30989186|NCT02326272|59152427|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30989187|NCT02326272|59152428|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30989188|NCT02326272|59152414|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989189|NCT02326272|59152415|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989190|NCT02326272|59152416|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989191|NCT02326272|59152417|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989192|NCT02326272|59152418|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989193|NCT02326272|59152419|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989194|NCT02326272|59152420|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989195|NCT02326272|59152421|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
30989196|NCT02326272|59152422|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989197|NCT02326272|59152423|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989198|NCT02326272|59152424|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989199|NCT02326272|59152425|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989200|NCT02326272|59152426|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989201|NCT02326272|59152427|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989202|NCT02326272|59152428|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
30989203|NCT02326272|59152414|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989204|NCT02326272|59152415|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989205|NCT02326272|59152416|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989206|NCT02326272|59152417|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989207|NCT02326272|59152418|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989208|NCT02326272|59152419|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989209|NCT02326272|59152420|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
30989210|NCT02326272|59152421|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989211|NCT02326272|59152422|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989212|NCT02326272|59152423|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989213|NCT02326272|59152424|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989214|NCT02326272|59152425|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989215|NCT02326272|59152426|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989216|NCT02326272|59152427|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989217|NCT02326272|59152428|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30989218|NCT02326272|59152414|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989219|NCT02326272|59152415|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989220|NCT02326272|59152416|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989221|NCT02326272|59152417|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989222|NCT02326272|59152418|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989223|NCT02326272|59152419|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989224|NCT02326272|59152420|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989225|NCT02326272|59152421|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989226|NCT02326272|59152422|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
30989227|NCT02326272|59152423|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989228|NCT02326272|59152424|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989229|NCT02326272|59152425|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989230|NCT02326272|59152426|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989231|NCT02326272|59152427|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989232|NCT02326272|59152428|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
30989233|NCT02326272|59152414|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30989234|NCT02326272|59152415|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30989235|NCT02326272|59152416|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30989236|NCT02326272|59152417|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30989237|NCT02326272|59152418|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30989238|NCT02326272|59152419|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
30989239|NCT02326272|59152420|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
30989240|NCT02326272|59152421|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
30989241|NCT02326272|59152422|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
30843495|NCT02178098|58869603|FG000|Overall Study|Withdrawal by Subject|0|||
30843496|NCT02178098|58869604|FG001|Overall Study|Withdrawal by Subject|6|||
30989242|NCT02326272|59152423|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30989243|NCT02326272|59152424|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30989244|NCT02326272|59152425|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30989245|NCT02326272|59152426|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30989246|NCT02326272|59152427|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30989247|NCT02326272|59152428|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
30989248|NCT02326272|59152414|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989249|NCT02326272|59152415|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989250|NCT02326272|59152416|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989251|NCT02326272|59152417|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989252|NCT02326272|59152418|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989253|NCT02326272|59152419|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
30989254|NCT02326272|59152420|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989255|NCT02326272|59152421|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989256|NCT02326272|59152422|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989257|NCT02326272|59152423|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989258|NCT02326272|59152424|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989259|NCT02326272|59152425|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989260|NCT02326272|59152426|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989261|NCT02326272|59152427|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989262|NCT02326272|59152428|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
30989263|NCT02326272|59152414|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989264|NCT02326272|59152415|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989265|NCT02326272|59152416|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989266|NCT02326272|59152417|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989267|NCT02326272|59152418|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989268|NCT02326272|59152419|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989269|NCT02326272|59152420|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
30989270|NCT02326272|59152421|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989271|NCT02326272|59152422|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989272|NCT02326272|59152423|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989273|NCT02326272|59152424|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989274|NCT02326272|59152425|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989275|NCT02326272|59152426|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989276|NCT02326272|59152427|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989277|NCT02326272|59152428|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
30989278|NCT02326272|59152414|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
30989279|NCT02326272|59152415|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
30989280|NCT02326272|59152416|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
30989281|NCT02326272|59152417|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
30989282|NCT02326272|59152418|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
30989283|NCT02326272|59152419|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
30989284|NCT02326272|59152420|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
30989285|NCT02326272|59152421|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
30989286|NCT02326272|59152422|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
30989287|NCT02326272|59152423|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
30989288|NCT02326272|59152424|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
30989289|NCT02326272|59152425|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
30989290|NCT02326272|59152426|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
30989291|NCT02326272|59152427|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
30989292|NCT02326272|59152428|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
30989293|NCT02326272|59152414|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30989294|NCT02326272|59152415|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30989295|NCT02326272|59152416|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30989296|NCT02326272|59152417|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30989297|NCT02326272|59152418|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30989298|NCT02326272|59152419|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30989299|NCT02326272|59152420|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30989300|NCT02326272|59152421|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30989301|NCT02326272|59152422|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30989302|NCT02326272|59152423|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30989303|NCT02326272|59152424|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
30989304|NCT02326272|59152425|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
30989305|NCT02326272|59152426|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
30989306|NCT02326272|59152427|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30989307|NCT02326272|59152428|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
30989308|NCT02326272|59152414|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989309|NCT02326272|59152415|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989310|NCT02326272|59152416|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989311|NCT02326272|59152417|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989312|NCT02326272|59152418|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989313|NCT02326272|59152419|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989314|NCT02326272|59152420|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989315|NCT02326272|59152421|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989316|NCT02326272|59152422|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989317|NCT02326272|59152423|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989318|NCT02326272|59152424|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
30989319|NCT02326272|59152425|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989320|NCT02326272|59152426|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
30989321|NCT02326272|59152427|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989322|NCT02326272|59152428|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30989323|NCT02326272|59152414|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989324|NCT02326272|59152415|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989325|NCT02326272|59152416|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989326|NCT02326272|59152417|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989327|NCT02326272|59152418|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989328|NCT02326272|59152419|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989329|NCT02326272|59152420|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989330|NCT02326272|59152421|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989331|NCT02326272|59152422|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989332|NCT02326272|59152423|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989333|NCT02326272|59152424|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989334|NCT02326272|59152425|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
30989335|NCT02326272|59152426|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989336|NCT02326272|59152427|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989337|NCT02326272|59152428|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30989338|NCT02326272|59152414|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989339|NCT02326272|59152415|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989340|NCT02326272|59152416|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989341|NCT02326272|59152417|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989342|NCT02326272|59152418|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989343|NCT02326272|59152419|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989344|NCT02326272|59152420|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989345|NCT02326272|59152421|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989346|NCT02326272|59152422|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989347|NCT02326272|59152423|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989348|NCT02326272|59152424|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
30989349|NCT02326272|59152425|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989350|NCT02326272|59152426|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
30989351|NCT02326272|59152427|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30989352|NCT02326272|59152428|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
30989353|NCT02326272|59152414|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989354|NCT02326272|59152415|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989355|NCT02326272|59152416|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989356|NCT02326272|59152417|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989357|NCT02326272|59152418|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989358|NCT02326272|59152419|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989359|NCT02326272|59152420|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989360|NCT02326272|59152421|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989361|NCT02326272|59152422|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989362|NCT02326272|59152423|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989363|NCT02326272|59152424|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989364|NCT02326272|59152425|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
30989365|NCT02326272|59152426|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989366|NCT02326272|59152427|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30989367|NCT02326272|59152428|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
30989368|NCT02326272|59152414|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989369|NCT02326272|59152415|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989370|NCT02326272|59152416|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989371|NCT02326272|59152417|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989372|NCT02326272|59152418|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989373|NCT02326272|59152419|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989374|NCT02326272|59152420|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989375|NCT02326272|59152421|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989376|NCT02326272|59152422|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989377|NCT02326272|59152423|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989378|NCT02326272|59152424|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989379|NCT02326272|59152425|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
30989380|NCT02326272|59152426|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
30989381|NCT02326272|59152427|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30989382|NCT02326272|59152428|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
30989383|NCT02326272|59152414|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989384|NCT02326272|59152415|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989385|NCT02326272|59152416|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989386|NCT02326272|59152417|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989387|NCT02326272|59152418|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989388|NCT02326272|59152419|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989389|NCT02326272|59152420|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989390|NCT02326272|59152421|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989391|NCT02326272|59152422|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989392|NCT02326272|59152423|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989393|NCT02326272|59152424|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989394|NCT02326272|59152425|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
30989395|NCT02326272|59152426|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989396|NCT02326272|59152427|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989397|NCT02326272|59152428|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
30989398|NCT02326272|59152414|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989399|NCT02326272|59152415|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989400|NCT02326272|59152416|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989401|NCT02326272|59152417|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989402|NCT02326272|59152418|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989403|NCT02326272|59152419|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989404|NCT02326272|59152420|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989405|NCT02326272|59152421|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989406|NCT02326272|59152422|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989407|NCT02326272|59152423|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989408|NCT02326272|59152424|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989409|NCT02326272|59152425|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989410|NCT02326272|59152426|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
30989411|NCT02326272|59152427|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989412|NCT02326272|59152428|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
30989413|NCT02325414|59152465|FG000|Overall Study|Withdrawal by Subject|3|||
30989414|NCT02325414|59152466|FG001|Overall Study|Withdrawal by Subject|1|||
30989415|NCT02325414|59152465|FG000|Overall Study|Lost to Follow-up|5|||
30989416|NCT02325414|59152466|FG001|Overall Study|Lost to Follow-up|5|||
30989417|NCT02349048|59152484|FG000|Overall Study|Withdrawal by Subject|4|||
30989418|NCT02349048|59152485|FG001|Overall Study|Withdrawal by Subject|0|||
30989419|NCT02349048|59152484|FG000|Overall Study|Lost to Follow-up|1|||
30989420|NCT02349048|59152485|FG001|Overall Study|Lost to Follow-up|0|||
30989421|NCT02299206|59152532|FG000|Overall Study|Lost to Follow-up|1|||
30989422|NCT02299206|59152532|FG000|Overall Study|Withdrawal by Subject|1|||
30989423|NCT02298192|59152551|FG000|Overall Study|Unclassified|3|||
30989424|NCT02298192|59152552|FG001|Overall Study|Unclassified|2|||
30989425|NCT02298192|59152551|FG000|Overall Study|Withdrawal criteria|2|||
30989426|NCT02298192|59152552|FG001|Overall Study|Withdrawal criteria|0|||
30989427|NCT02298192|59152551|FG000|Overall Study|Withdrawal by Subject|6|||
30989428|NCT02298192|59152552|FG001|Overall Study|Withdrawal by Subject|1|||
30989429|NCT02298192|59152551|FG000|Overall Study|Lost to Follow-up|2|||
30989430|NCT02298192|59152552|FG001|Overall Study|Lost to Follow-up|1|||
30989431|NCT02298192|59152551|FG000|Overall Study|Adverse Event|6|||
30989432|NCT02298192|59152552|FG001|Overall Study|Adverse Event|2|||
30989433|NCT02280408|59152678|FG000|Overall Study|Lost to Follow-up|0|||
30989434|NCT02280408|59152679|FG001|Overall Study|Lost to Follow-up|2|||
30989435|NCT02280408|59152680|FG002|Overall Study|Lost to Follow-up|0|||
30989436|NCT02280408|59152681|FG003|Overall Study|Lost to Follow-up|0|||
30989437|NCT02296476|59152757|FG000|Overall Study|Disease Progression|6|||
30989438|NCT02296476|59152758|FG001|Overall Study|Disease Progression|4|||
30989439|NCT02296476|59152759|FG002|Overall Study|Disease Progression|2|||
30989440|NCT00552032|59152800|FG000|Overall Study|Withdrawal by Subject|2|||
30989441|NCT00552032|59152801|FG001|Overall Study|Withdrawal by Subject|2|||
30989442|NCT00552032|59152800|FG000|Overall Study|Protocol Violation|7|||
30989443|NCT00552032|59152801|FG001|Overall Study|Protocol Violation|12|||
30989444|NCT00552032|59152800|FG000|Overall Study|Lost to Follow-up|8|||
30989445|NCT00552032|59152801|FG001|Overall Study|Lost to Follow-up|5|||
30989446|NCT03312530|59153608|FG000|Overall Study|Death|5|||
30989447|NCT03312530|59153609|FG001|Overall Study|Death|5|||
30989448|NCT03312530|59153610|FG002|Overall Study|Death|4|||
30989449|NCT03312530|59153611|FG003|Overall Study|Death|10|||
30989450|NCT03312530|59153612|FG004|Overall Study|Death|8|||
30989451|NCT03312530|59153608|FG000|Overall Study|Lost to Follow-up|0|||
30989452|NCT03312530|59153609|FG001|Overall Study|Lost to Follow-up|0|||
30989453|NCT03312530|59153610|FG002|Overall Study|Lost to Follow-up|0|||
30989454|NCT03312530|59153611|FG003|Overall Study|Lost to Follow-up|1|||
30989455|NCT03312530|59153612|FG004|Overall Study|Lost to Follow-up|0|||
30989456|NCT03312530|59153608|FG000|Overall Study|Participant in another sponsor study.|0|||
30989457|NCT03312530|59153609|FG001|Overall Study|Participant in another sponsor study.|0|||
30989458|NCT03312530|59153610|FG002|Overall Study|Participant in another sponsor study.|0|||
30989459|NCT03312530|59153611|FG003|Overall Study|Participant in another sponsor study.|1|||
30989460|NCT03312530|59153612|FG004|Overall Study|Participant in another sponsor study.|0|||
30989461|NCT03312530|59153608|FG000|Overall Study|Study terminated by sponsor|1|||
30989462|NCT03312530|59153609|FG001|Overall Study|Study terminated by sponsor|0|||
30989463|NCT03312530|59153610|FG002|Overall Study|Study terminated by sponsor|2|||
30989464|NCT03312530|59153611|FG003|Overall Study|Study terminated by sponsor|3|||
30989465|NCT03312530|59153612|FG004|Overall Study|Study terminated by sponsor|7|||
30989466|NCT03312530|59153608|FG000|Overall Study|Withdrawal by Subject|0|||
30989467|NCT03312530|59153609|FG001|Overall Study|Withdrawal by Subject|1|||
30989468|NCT03312530|59153610|FG002|Overall Study|Withdrawal by Subject|0|||
30989469|NCT03312530|59153611|FG003|Overall Study|Withdrawal by Subject|0|||
30989470|NCT03312530|59153612|FG004|Overall Study|Withdrawal by Subject|0|||
30989471|NCT03312530|59153608|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
30989472|NCT03312530|59153609|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
30989473|NCT03312530|59153610|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
30989474|NCT03312530|59153611|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
30989475|NCT03312530|59153612|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
30989476|NCT02296320|59153743|FG000|Overall Study|Withdrawal by Subject|4|||
30989477|NCT02296320|59153744|FG001|Overall Study|Withdrawal by Subject|0|||
30608962|NCT01287104|58619812|FG001|Overall Study|Low donor chimerism|1|||
30989478|NCT02296320|59153745|FG002|Overall Study|Withdrawal by Subject|2|||
30989479|NCT02296320|59153743|FG000|Overall Study|Death|24|||
30989480|NCT02296320|59153744|FG001|Overall Study|Death|3|||
30891774|NCT01649557|58925055|FG000|Overall Study|Adverse Event|7|||
30989481|NCT02296320|59153745|FG002|Overall Study|Death|27|||
30989482|NCT02296320|59153743|FG000|Overall Study|Lost to Follow-up|5|||
30989483|NCT02296320|59153744|FG001|Overall Study|Lost to Follow-up|2|||
30989484|NCT02296320|59153745|FG002|Overall Study|Lost to Follow-up|7|||
30989485|NCT02296320|59153743|FG000|Overall Study|Not treated|2|||
30989486|NCT02296320|59153744|FG001|Overall Study|Not treated|0|||
30989487|NCT02296320|59153745|FG002|Overall Study|Not treated|0|||
30989488|NCT02296320|59153743|FG000|Overall Study|Not - specified|0|||
30989489|NCT02296320|59153744|FG001|Overall Study|Not - specified|0|||
30989490|NCT02296320|59153745|FG002|Overall Study|Not - specified|1|||
30989491|NCT02296242|59153784|FG000|Overall Study|Death|1|||
30989492|NCT02296242|59153785|FG001|Overall Study|Death|1|||
30989493|NCT02296242|59153786|FG002|Overall Study|Death|1|||
30989494|NCT02296242|59153787|FG003|Overall Study|Death|1|||
30989495|NCT02296242|59153788|FG004|Overall Study|Death|1|||
30989496|NCT02296242|59153784|FG000|Overall Study|Withdrawal by Subject|0|||
30989497|NCT02296242|59153785|FG001|Overall Study|Withdrawal by Subject|0|||
30989498|NCT02296242|59153786|FG002|Overall Study|Withdrawal by Subject|1|||
30989499|NCT02296242|59153787|FG003|Overall Study|Withdrawal by Subject|1|||
30989500|NCT02296242|59153788|FG004|Overall Study|Withdrawal by Subject|3|||
30989501|NCT02296242|59153784|FG000|Overall Study|Disease Progression|1|||
30989502|NCT02296242|59153785|FG001|Overall Study|Disease Progression|3|||
30989503|NCT02296242|59153786|FG002|Overall Study|Disease Progression|2|||
30989504|NCT02296242|59153787|FG003|Overall Study|Disease Progression|8|||
30989505|NCT02296242|59153788|FG004|Overall Study|Disease Progression|11|||
30989506|NCT02296242|59153784|FG000|Overall Study|Unacceptable Toxicity|0|||
30989507|NCT02296242|59153785|FG001|Overall Study|Unacceptable Toxicity|0|||
30989508|NCT02296242|59153786|FG002|Overall Study|Unacceptable Toxicity|0|||
30989509|NCT02296242|59153787|FG003|Overall Study|Unacceptable Toxicity|0|||
30989510|NCT02296242|59153788|FG004|Overall Study|Unacceptable Toxicity|1|||
30989511|NCT02296242|59153784|FG000|Overall Study|Patient Condition Changed|0|||
30989512|NCT02296242|59153785|FG001|Overall Study|Patient Condition Changed|0|||
30989513|NCT02296242|59153786|FG002|Overall Study|Patient Condition Changed|2|||
30989514|NCT02296242|59153787|FG003|Overall Study|Patient Condition Changed|0|||
30989515|NCT02296242|59153788|FG004|Overall Study|Patient Condition Changed|1|||
30891775|NCT01649557|58925056|FG001|Overall Study|Adverse Event|5|||
30891776|NCT01649557|58925057|FG002|Overall Study|Adverse Event|1|||
30891777|NCT01649557|58925055|FG000|Overall Study|Met withdrawal criteria|4|||
30891778|NCT01649557|58925056|FG001|Overall Study|Met withdrawal criteria|0|||
30891779|NCT01649557|58925057|FG002|Overall Study|Met withdrawal criteria|0|||
30891780|NCT01649557|58925055|FG000|Overall Study|Physician Decision|8|||
30891781|NCT01649557|58925056|FG001|Overall Study|Physician Decision|2|||
30891782|NCT01649557|58925057|FG002|Overall Study|Physician Decision|1|||
30891783|NCT01649557|58925055|FG000|Overall Study|Withdrawal by Subject|15|||
30891784|NCT01649557|58925056|FG001|Overall Study|Withdrawal by Subject|5|||
30891785|NCT01649557|58925057|FG002|Overall Study|Withdrawal by Subject|4|||
30891786|NCT01649557|58925055|FG000|Overall Study|Protocol deviation|0|||
30891787|NCT01649557|58925056|FG001|Overall Study|Protocol deviation|2|||
30891788|NCT01649557|58925057|FG002|Overall Study|Protocol deviation|0|||
30891789|NCT01649557|58925055|FG000|Overall Study|Lack of Efficacy|5|||
30891790|NCT01649557|58925056|FG001|Overall Study|Lack of Efficacy|0|||
30891791|NCT01649557|58925057|FG002|Overall Study|Lack of Efficacy|0|||
30891792|NCT02390245|58925065|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
30891793|NCT02390245|58925066|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
30891794|NCT02390245|58925067|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
30891795|NCT02390245|58925065|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
30891796|NCT02390245|58925066|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
30891797|NCT02390245|58925067|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
30891798|NCT02390167|58925076|FG000|Overall Study|Lost to Follow-up|1|||
30989516|NCT02296242|59153784|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
30989517|NCT02296242|59153785|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
30989518|NCT02296242|59153786|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
30989519|NCT02296242|59153787|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
30989520|NCT02296242|59153788|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
30989521|NCT02296242|59153784|FG000|Overall Study|Lost to Follow-up|1|||
30989522|NCT02296242|59153785|FG001|Overall Study|Lost to Follow-up|0|||
30989523|NCT02296242|59153786|FG002|Overall Study|Lost to Follow-up|0|||
30891799|NCT02347657|58925086|FG000|Overall Study|Physician Decision|0|||
30891800|NCT02347657|58925087|FG001|Overall Study|Physician Decision|1|||
30891801|NCT02347657|58925086|FG000|Overall Study|Adverse Event|8|||
30891802|NCT02347657|58925087|FG001|Overall Study|Adverse Event|4|||
30891803|NCT02347657|58925086|FG000|Overall Study|Withdrawal by Subject|6|||
30989524|NCT02296242|59153787|FG003|Overall Study|Lost to Follow-up|0|||
30989525|NCT02296242|59153788|FG004|Overall Study|Lost to Follow-up|0|||
30989526|NCT02296242|59153784|FG000|Overall Study|Need for Hydroxyurea|2|||
30989527|NCT02296242|59153785|FG001|Overall Study|Need for Hydroxyurea|0|||
30989528|NCT02296242|59153786|FG002|Overall Study|Need for Hydroxyurea|0|||
30989529|NCT02296242|59153787|FG003|Overall Study|Need for Hydroxyurea|0|||
30989530|NCT02296242|59153788|FG004|Overall Study|Need for Hydroxyurea|0|||
30989531|NCT02296242|59153784|FG000|Overall Study|Screened for Other Protocol|0|||
30989532|NCT02296242|59153785|FG001|Overall Study|Screened for Other Protocol|1|||
30989533|NCT02296242|59153786|FG002|Overall Study|Screened for Other Protocol|0|||
30989534|NCT02296242|59153787|FG003|Overall Study|Screened for Other Protocol|0|||
30989535|NCT02296242|59153788|FG004|Overall Study|Screened for Other Protocol|0|||
30989536|NCT02296242|59153784|FG000|Overall Study|Physician Decision|0|||
30989537|NCT02296242|59153785|FG001|Overall Study|Physician Decision|1|||
30989538|NCT02296242|59153786|FG002|Overall Study|Physician Decision|0|||
30989539|NCT02296242|59153787|FG003|Overall Study|Physician Decision|1|||
30989540|NCT02296242|59153788|FG004|Overall Study|Physician Decision|0|||
30989541|NCT02296242|59153784|FG000|Overall Study|Alternative Treatment|0|||
30989542|NCT02296242|59153785|FG001|Overall Study|Alternative Treatment|0|||
30989543|NCT02296242|59153786|FG002|Overall Study|Alternative Treatment|0|||
30989544|NCT02296242|59153787|FG003|Overall Study|Alternative Treatment|1|||
30989545|NCT02296242|59153788|FG004|Overall Study|Alternative Treatment|0|||
30989546|NCT02296242|59153784|FG000|Overall Study|Adverse Event|0|||
30989547|NCT02296242|59153785|FG001|Overall Study|Adverse Event|0|||
30989548|NCT02296242|59153786|FG002|Overall Study|Adverse Event|0|||
30989549|NCT02296242|59153787|FG003|Overall Study|Adverse Event|1|||
30989550|NCT02296242|59153788|FG004|Overall Study|Adverse Event|0|||
30989551|NCT02296242|59153784|FG000|Overall Study|Lack of Efficacy|0|||
30989552|NCT02296242|59153785|FG001|Overall Study|Lack of Efficacy|0|||
30989553|NCT02296242|59153786|FG002|Overall Study|Lack of Efficacy|0|||
30989554|NCT02296242|59153787|FG003|Overall Study|Lack of Efficacy|0|||
30989555|NCT02296242|59153788|FG004|Overall Study|Lack of Efficacy|3|||
30989556|NCT02295774|59153808|FG000|Overall Study|Physician Decision|1|||
30989557|NCT02295774|59153808|FG000|Overall Study|Withdrawal by Subject|2|||
30989558|NCT02294682|59153823|FG000|Overall Study|Could not swallow pills|1|||
30989559|NCT02294682|59153824|FG001|Overall Study|Could not swallow pills|0|||
30989560|NCT02294604|59153833|FG000|Overall Study|Did not provide samples for culture|0|||
30989561|NCT02294604|59153834|FG001|Overall Study|Did not provide samples for culture|1|||
30989562|NCT02294604|59153835|FG002|Overall Study|Did not provide samples for culture|0|||
30989563|NCT02294604|59153833|FG000|Overall Study|Culture contamination|1|||
30989564|NCT02294604|59153834|FG001|Overall Study|Culture contamination|2|||
30989565|NCT02294604|59153835|FG002|Overall Study|Culture contamination|0|||
30989566|NCT01645176|59153854|FG000|Overall Study|Lack of Efficacy|4|||
30989567|NCT01645176|59153854|FG000|Overall Study|did not complete final MRI|1|||
30989568|NCT02322216|59153869|FG000|Overall Study|Adverse Event|1|||
30989569|NCT02322216|59153870|FG001|Overall Study|Adverse Event|0|||
30989570|NCT02322216|59153869|FG000|Overall Study|Withdrawal by Subject|1|||
30989571|NCT02322216|59153870|FG001|Overall Study|Withdrawal by Subject|4|||
30989572|NCT01647516|59153911|FG000|Induction Period (IP)|Physician Decision|2|||
30989573|NCT01647516|59153912|FG001|Induction Period (IP)|Physician Decision|0|||
30989574|NCT01647516|59153913|FG002|Induction Period (IP)|Physician Decision|0|||
30989575|NCT01647516|59153914|FG003|Induction Period (IP)|Physician Decision|0|||
30989576|NCT01647516|59153915|FG004|Induction Period (IP)|Physician Decision|0|||
30989577|NCT01647516|59153916|FG005|Induction Period (IP)|Physician Decision|0|||
30989578|NCT01647516|59153911|FG000|Induction Period (IP)|Adverse Event|1|||
30989579|NCT01647516|59153912|FG001|Induction Period (IP)|Adverse Event|2|||
30989580|NCT01647516|59153913|FG002|Induction Period (IP)|Adverse Event|0|||
30989581|NCT01647516|59153914|FG003|Induction Period (IP)|Adverse Event|0|||
30989582|NCT01647516|59153915|FG004|Induction Period (IP)|Adverse Event|0|||
30989583|NCT01647516|59153916|FG005|Induction Period (IP)|Adverse Event|0|||
30989584|NCT01647516|59153911|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
30989585|NCT01647516|59153912|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
30989586|NCT01647516|59153913|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
30989587|NCT01647516|59153914|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
30989588|NCT01647516|59153915|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
30989589|NCT01647516|59153916|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
30989590|NCT01647516|59153911|FG000|Induction Period (IP)|Participant Choice|0|||
30989591|NCT01647516|59153912|FG001|Induction Period (IP)|Participant Choice|0|||
30989592|NCT01647516|59153913|FG002|Induction Period (IP)|Participant Choice|1|||
30989593|NCT01647516|59153914|FG003|Induction Period (IP)|Participant Choice|0|||
30989594|NCT01647516|59153915|FG004|Induction Period (IP)|Participant Choice|0|||
30989595|NCT01647516|59153916|FG005|Induction Period (IP)|Participant Choice|0|||
30989596|NCT01647516|59153911|FG000|Induction Period (IP)|Lack of Efficacy|1|||
30989597|NCT01647516|59153912|FG001|Induction Period (IP)|Lack of Efficacy|0|||
30989598|NCT01647516|59153913|FG002|Induction Period (IP)|Lack of Efficacy|0|||
30843497|NCT02178098|58869603|FG000|Overall Study|Adverse Event|1|||
30989599|NCT01647516|59153914|FG003|Induction Period (IP)|Lack of Efficacy|0|||
30989600|NCT01647516|59153915|FG004|Induction Period (IP)|Lack of Efficacy|0|||
30989601|NCT01647516|59153916|FG005|Induction Period (IP)|Lack of Efficacy|0|||
30989602|NCT01647516|59153911|FG000|Induction Period (IP)|No study drug received|1|||
30989603|NCT01647516|59153912|FG001|Induction Period (IP)|No study drug received|1|||
30989604|NCT01647516|59153913|FG002|Induction Period (IP)|No study drug received|0|||
30989605|NCT01647516|59153914|FG003|Induction Period (IP)|No study drug received|0|||
30989606|NCT01647516|59153915|FG004|Induction Period (IP)|No study drug received|0|||
30989607|NCT01647516|59153916|FG005|Induction Period (IP)|No study drug received|0|||
30989608|NCT01647516|59153911|FG000|Maintenance Period (MP)|Adverse Event|2|||
30989609|NCT01647516|59153912|FG001|Maintenance Period (MP)|Adverse Event|1|||
30989610|NCT01647516|59153913|FG002|Maintenance Period (MP)|Adverse Event|0|||
30989611|NCT01647516|59153914|FG003|Maintenance Period (MP)|Adverse Event|0|||
30989612|NCT01647516|59153915|FG004|Maintenance Period (MP)|Adverse Event|0|||
30989613|NCT01647516|59153916|FG005|Maintenance Period (MP)|Adverse Event|0|||
30989614|NCT01647516|59153911|FG000|Maintenance Period (MP)|Non-compliance|1|||
30989615|NCT01647516|59153912|FG001|Maintenance Period (MP)|Non-compliance|0|||
30989616|NCT01647516|59153913|FG002|Maintenance Period (MP)|Non-compliance|0|||
30989617|NCT01647516|59153914|FG003|Maintenance Period (MP)|Non-compliance|0|||
30989618|NCT01647516|59153915|FG004|Maintenance Period (MP)|Non-compliance|0|||
30989619|NCT01647516|59153916|FG005|Maintenance Period (MP)|Non-compliance|0|||
30989620|NCT01647516|59153911|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
30989621|NCT01647516|59153912|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
30989622|NCT01647516|59153913|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
30989623|NCT01647516|59153914|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
30989624|NCT01647516|59153915|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
30989625|NCT01647516|59153916|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
30989626|NCT01647516|59153911|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
30989627|NCT01647516|59153912|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
30989628|NCT01647516|59153913|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
30989629|NCT01647516|59153914|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
30989630|NCT01647516|59153915|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
30989631|NCT01647516|59153916|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
30989632|NCT01647516|59153911|FG000|Open-Label Period|Adverse Event|0|||
30989633|NCT01647516|59153912|FG001|Open-Label Period|Adverse Event|0|||
30989634|NCT01647516|59153913|FG002|Open-Label Period|Adverse Event|0|||
30989635|NCT01647516|59153914|FG003|Open-Label Period|Adverse Event|5|||
30989636|NCT01647516|59153915|FG004|Open-Label Period|Adverse Event|6|||
30989637|NCT01647516|59153916|FG005|Open-Label Period|Adverse Event|3|||
30989638|NCT01647516|59153911|FG000|Open-Label Period|Pregnancy|0|||
30989639|NCT01647516|59153912|FG001|Open-Label Period|Pregnancy|0|||
30989640|NCT01647516|59153913|FG002|Open-Label Period|Pregnancy|0|||
30989641|NCT01647516|59153914|FG003|Open-Label Period|Pregnancy|0|||
30989642|NCT01647516|59153915|FG004|Open-Label Period|Pregnancy|0|||
30989643|NCT01647516|59153916|FG005|Open-Label Period|Pregnancy|1|||
30989644|NCT01647516|59153911|FG000|Open-Label Period|Non-compliance|0|||
30989645|NCT01647516|59153912|FG001|Open-Label Period|Non-compliance|0|||
30989646|NCT01647516|59153913|FG002|Open-Label Period|Non-compliance|0|||
30989647|NCT01647516|59153914|FG003|Open-Label Period|Non-compliance|1|||
30989648|NCT01647516|59153915|FG004|Open-Label Period|Non-compliance|0|||
30989649|NCT01647516|59153916|FG005|Open-Label Period|Non-compliance|1|||
30989650|NCT01647516|59153911|FG000|Open-Label Period|Physician Decision|0|||
30989651|NCT01647516|59153912|FG001|Open-Label Period|Physician Decision|0|||
30989652|NCT01647516|59153913|FG002|Open-Label Period|Physician Decision|0|||
30989653|NCT01647516|59153914|FG003|Open-Label Period|Physician Decision|1|||
30989654|NCT01647516|59153915|FG004|Open-Label Period|Physician Decision|1|||
30989655|NCT01647516|59153916|FG005|Open-Label Period|Physician Decision|0|||
30989656|NCT01647516|59153911|FG000|Open-Label Period|Withdrawal by Subject|0|||
30989657|NCT01647516|59153912|FG001|Open-Label Period|Withdrawal by Subject|0|||
30989658|NCT01647516|59153913|FG002|Open-Label Period|Withdrawal by Subject|0|||
30989659|NCT01647516|59153914|FG003|Open-Label Period|Withdrawal by Subject|9|||
30989660|NCT01647516|59153915|FG004|Open-Label Period|Withdrawal by Subject|11|||
30989661|NCT01647516|59153916|FG005|Open-Label Period|Withdrawal by Subject|6|||
30989662|NCT01647516|59153911|FG000|Open-Label Period|Lost to Follow-up|0|||
30989663|NCT01647516|59153912|FG001|Open-Label Period|Lost to Follow-up|0|||
30989664|NCT01647516|59153913|FG002|Open-Label Period|Lost to Follow-up|0|||
30989665|NCT01647516|59153914|FG003|Open-Label Period|Lost to Follow-up|1|||
30989666|NCT01647516|59153915|FG004|Open-Label Period|Lost to Follow-up|0|||
30989667|NCT01647516|59153916|FG005|Open-Label Period|Lost to Follow-up|1|||
30989668|NCT01647516|59153911|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
30989669|NCT01647516|59153912|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
30989670|NCT01647516|59153913|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
30989671|NCT01647516|59153914|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
30989672|NCT01647516|59153915|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
30989673|NCT01647516|59153916|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
30989674|NCT01647516|59153911|FG000|Open-Label Period|Lack of Efficacy|0|||
30989675|NCT01647516|59153912|FG001|Open-Label Period|Lack of Efficacy|0|||
30989676|NCT01647516|59153913|FG002|Open-Label Period|Lack of Efficacy|0|||
30989677|NCT01647516|59153914|FG003|Open-Label Period|Lack of Efficacy|7|||
30989678|NCT01647516|59153915|FG004|Open-Label Period|Lack of Efficacy|9|||
30989679|NCT01647516|59153916|FG005|Open-Label Period|Lack of Efficacy|10|||
30989680|NCT01647516|59153911|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
30989681|NCT01647516|59153912|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
30989682|NCT01647516|59153913|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
30989683|NCT01647516|59153914|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
30989684|NCT01647516|59153915|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
30989685|NCT01647516|59153916|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
30989686|NCT01647516|59153911|FG000|Open-Label Period|No completion / discontinuation visit|0|||
30989687|NCT01647516|59153912|FG001|Open-Label Period|No completion / discontinuation visit|0|||
30989688|NCT01647516|59153913|FG002|Open-Label Period|No completion / discontinuation visit|0|||
30989689|NCT01647516|59153914|FG003|Open-Label Period|No completion / discontinuation visit|0|||
30989690|NCT01647516|59153915|FG004|Open-Label Period|No completion / discontinuation visit|2|||
30989691|NCT01647516|59153916|FG005|Open-Label Period|No completion / discontinuation visit|1|||
30989692|NCT01647282|59153933|FG000|Overall Study|Physician Decision|7|||
30989693|NCT01647282|59153934|FG001|Overall Study|Physician Decision|5|||
30989694|NCT02321436|59153942|FG000|Overall Study|Withdrawal by Subject|1|||
30989695|NCT02321436|59153943|FG001|Overall Study|Withdrawal by Subject|0|||
30989696|NCT02321436|59153942|FG000|Overall Study|Lost to Follow-up|0|||
30989697|NCT02321436|59153943|FG001|Overall Study|Lost to Follow-up|1|||
30989698|NCT02319642|59153952|FG000|Overall Study|Adverse Event|2|||
30989699|NCT02319642|59153953|FG001|Overall Study|Adverse Event|4|||
30989700|NCT02319642|59153952|FG000|Overall Study|Lack of Efficacy|1|||
30989701|NCT02319642|59153953|FG001|Overall Study|Lack of Efficacy|1|||
30989702|NCT02319642|59153952|FG000|Overall Study|Withdrawal by Subject|1|||
30989703|NCT02319642|59153953|FG001|Overall Study|Withdrawal by Subject|1|||
30989704|NCT02280096|59153963|FG000|Overall Study|Pregnancy|1|||
30989705|NCT02280096|59153964|FG001|Overall Study|Pregnancy|0|||
30989706|NCT02280096|59153963|FG000|Overall Study|Functional neurological disorder|1|||
30989707|NCT02280096|59153964|FG001|Overall Study|Functional neurological disorder|0|||
30989708|NCT02280096|59153963|FG000|Overall Study|Lack of attachment|0|||
30989709|NCT02280096|59153964|FG001|Overall Study|Lack of attachment|1|||
30989710|NCT02279862|59153981|FG000|Overall Study|Study drug toxicity|3|||
30989711|NCT02279862|59153982|FG001|Overall Study|Study drug toxicity|6|||
30989712|NCT02279862|59153981|FG000|Overall Study|No longer meets criteria|0|||
30989713|NCT02279862|59153982|FG001|Overall Study|No longer meets criteria|1|||
30989714|NCT02279862|59153981|FG000|Overall Study|Administrative reason by sponsor|0|||
30989715|NCT02279862|59153982|FG001|Overall Study|Administrative reason by sponsor|1|||
30989716|NCT02279862|59153981|FG000|Overall Study|Disease progression|5|||
30989717|NCT02279862|59153982|FG001|Overall Study|Disease progression|2|||
30989718|NCT02279862|59153981|FG000|Overall Study|Study closed by sponsor|16|||
30989719|NCT02279862|59153982|FG001|Overall Study|Study closed by sponsor|13|||
30989720|NCT02279862|59153981|FG000|Overall Study|Other|1|||
30989721|NCT02279862|59153982|FG001|Overall Study|Other|2|||
30989722|NCT02279862|59153981|FG000|Overall Study|Withdrawal by Subject|1|||
30989723|NCT02279862|59153982|FG001|Overall Study|Withdrawal by Subject|0|||
30989724|NCT02318940|59153990|FG000|Overall Study|lost the record|1|||
30989725|NCT02318940|59153991|FG001|Overall Study|lost the record|0|||
30989726|NCT02294058|59154000|FG000|Overall Study|Adverse Event|16|||
30989727|NCT02294058|59154001|FG001|Overall Study|Adverse Event|7|||
30989728|NCT02294058|59154002|FG002|Overall Study|Adverse Event|13|||
30989729|NCT02294058|59154000|FG000|Overall Study|Lack of Efficacy|3|||
30989730|NCT02294058|59154001|FG001|Overall Study|Lack of Efficacy|3|||
30989731|NCT02294058|59154002|FG002|Overall Study|Lack of Efficacy|0|||
30790212|NCT03687502|58803447|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
30989732|NCT02294058|59154000|FG000|Overall Study|Lost to Follow-up|1|||
30989733|NCT02294058|59154001|FG001|Overall Study|Lost to Follow-up|0|||
30989734|NCT02294058|59154002|FG002|Overall Study|Lost to Follow-up|2|||
30989735|NCT02294058|59154000|FG000|Overall Study|Withdrawal by Subject|10|||
30989736|NCT02294058|59154001|FG001|Overall Study|Withdrawal by Subject|14|||
30989737|NCT02294058|59154002|FG002|Overall Study|Withdrawal by Subject|13|||
30989738|NCT02294058|59154000|FG000|Overall Study|Physician Decision|2|||
30989739|NCT02294058|59154001|FG001|Overall Study|Physician Decision|1|||
30989740|NCT02294058|59154002|FG002|Overall Study|Physician Decision|0|||
30989741|NCT02294058|59154000|FG000|Overall Study|Miscellaneous|4|||
30989742|NCT02294058|59154001|FG001|Overall Study|Miscellaneous|1|||
30989743|NCT02294058|59154002|FG002|Overall Study|Miscellaneous|1|||
30989744|NCT05065619|59154013|FG000|Overall Study|Lost to Follow-up|1|||
30989745|NCT05065619|59154014|FG001|Overall Study|Lost to Follow-up|0|||
30989746|NCT05065619|59154013|FG000|Overall Study|Withdrawal by Subject|1|||
30989747|NCT05065619|59154014|FG001|Overall Study|Withdrawal by Subject|0|||
30989748|NCT02293902|59154023|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
30989749|NCT02293902|59154024|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
30989750|NCT02293902|59154025|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
30989751|NCT02293902|59154026|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
30989752|NCT02293902|59154027|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
30989753|NCT02293902|59154023|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
30989754|NCT02293902|59154024|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
30989755|NCT02293902|59154025|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
30989756|NCT02293902|59154026|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
30989757|NCT02293902|59154027|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
30989758|NCT02293902|59154023|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
30989759|NCT02293902|59154024|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
30989760|NCT02293902|59154025|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
30989761|NCT02293902|59154026|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
30989762|NCT02293902|59154027|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
30989763|NCT02293902|59154023|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
30989764|NCT02293902|59154024|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
30989765|NCT02293902|59154025|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
30989766|NCT02293902|59154026|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
30989767|NCT02293902|59154027|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
30989768|NCT02293902|59154023|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
30989769|NCT02293902|59154024|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
30989770|NCT02293902|59154025|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
30989771|NCT02293902|59154026|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
30989772|NCT02293902|59154027|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
30989773|NCT02278614|59154047|FG000|Overall Study|Withdrawal by Subject|3|||
30989774|NCT02278614|59154048|FG001|Overall Study|Withdrawal by Subject|5|||
30989775|NCT02278614|59154047|FG000|Overall Study|Adverse Event|1|||
30989776|NCT02278614|59154048|FG001|Overall Study|Adverse Event|0|||
30989777|NCT02278614|59154047|FG000|Overall Study|left eye was not eligible|1|||
30989778|NCT02278614|59154048|FG001|Overall Study|left eye was not eligible|0|||
30989779|NCT02318706|59154058|FG000|Double-blind Phase|Adverse Event|7|||
30989780|NCT02318706|59154059|FG001|Double-blind Phase|Adverse Event|4|||
30989781|NCT02318706|59154060|FG002|Double-blind Phase|Adverse Event|3|||
30989782|NCT02318706|59154061|FG003|Double-blind Phase|Adverse Event|10|||
30989783|NCT02318706|59154062|FG004|Double-blind Phase|Adverse Event|0|||
30989784|NCT02318706|59154058|FG000|Double-blind Phase|Lost to Follow-up|1|||
30989785|NCT02318706|59154059|FG001|Double-blind Phase|Lost to Follow-up|0|||
30989786|NCT02318706|59154060|FG002|Double-blind Phase|Lost to Follow-up|0|||
30989787|NCT02318706|59154061|FG003|Double-blind Phase|Lost to Follow-up|0|||
30989788|NCT02318706|59154062|FG004|Double-blind Phase|Lost to Follow-up|0|||
30989789|NCT02318706|59154058|FG000|Double-blind Phase|Protocol Violation|4|||
30989790|NCT02318706|59154059|FG001|Double-blind Phase|Protocol Violation|2|||
30989791|NCT02318706|59154060|FG002|Double-blind Phase|Protocol Violation|4|||
30989792|NCT02318706|59154061|FG003|Double-blind Phase|Protocol Violation|3|||
30989793|NCT02318706|59154062|FG004|Double-blind Phase|Protocol Violation|0|||
30989794|NCT02318706|59154058|FG000|Double-blind Phase|Withdrawal by Subject|9|||
30989795|NCT02318706|59154059|FG001|Double-blind Phase|Withdrawal by Subject|5|||
30989796|NCT02318706|59154060|FG002|Double-blind Phase|Withdrawal by Subject|7|||
30989797|NCT02318706|59154061|FG003|Double-blind Phase|Withdrawal by Subject|10|||
30989798|NCT02318706|59154062|FG004|Double-blind Phase|Withdrawal by Subject|0|||
30989799|NCT02318706|59154058|FG000|Double-blind Phase|Other|4|||
30989800|NCT02318706|59154059|FG001|Double-blind Phase|Other|1|||
30989801|NCT02318706|59154060|FG002|Double-blind Phase|Other|2|||
30989802|NCT02318706|59154061|FG003|Double-blind Phase|Other|1|||
30989803|NCT02318706|59154062|FG004|Double-blind Phase|Other|0|||
30989804|NCT02318706|59154058|FG000|Double-blind Phase|Death|0|||
30989805|NCT02318706|59154059|FG001|Double-blind Phase|Death|0|||
30989806|NCT02318706|59154060|FG002|Double-blind Phase|Death|2|||
30989807|NCT02318706|59154061|FG003|Double-blind Phase|Death|0|||
30989808|NCT02318706|59154062|FG004|Double-blind Phase|Death|0|||
30989809|NCT02318706|59154058|FG000|Open-label Extension Phase|Adverse Event|0|||
30989810|NCT02318706|59154059|FG001|Open-label Extension Phase|Adverse Event|0|||
30989811|NCT02318706|59154060|FG002|Open-label Extension Phase|Adverse Event|0|||
30989812|NCT02318706|59154061|FG003|Open-label Extension Phase|Adverse Event|0|||
30989813|NCT02318706|59154062|FG004|Open-label Extension Phase|Adverse Event|21|||
30989814|NCT02318706|59154058|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
30989815|NCT02318706|59154059|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
30989816|NCT02318706|59154060|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
30989817|NCT02318706|59154061|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
30989818|NCT02318706|59154062|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
30989819|NCT02318706|59154058|FG000|Open-label Extension Phase|Death|0|||
30989820|NCT02318706|59154059|FG001|Open-label Extension Phase|Death|0|||
30989821|NCT02318706|59154060|FG002|Open-label Extension Phase|Death|0|||
30989822|NCT02318706|59154061|FG003|Open-label Extension Phase|Death|0|||
30989823|NCT02318706|59154062|FG004|Open-label Extension Phase|Death|1|||
30989824|NCT02318706|59154058|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
30989825|NCT02318706|59154059|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
30989826|NCT02318706|59154060|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
30989827|NCT02318706|59154061|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
30989828|NCT02318706|59154062|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
30989829|NCT04747275|59154104|FG000|Overall Study|Study terminated|0|||
30989830|NCT04747275|59154105|FG001|Overall Study|Study terminated|1|||
30989831|NCT04583280|59154113|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
30989832|NCT04583280|59154114|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
30989833|NCT04489940|59154133|FG000|Overall Study|Other|2|||
30989834|NCT04489940|59154133|FG000|Overall Study|Withdrawal by Subject|2|||
30989835|NCT04489940|59154133|FG000|Overall Study|Death|5|||
30989836|NCT04489940|59154133|FG000|Overall Study|Lost to Follow-up|1|||
30989837|NCT04365257|59154139|FG000|Overall Study|Physician Decision|1|||
30989838|NCT04365257|59154140|FG001|Overall Study|Physician Decision|0|||
30989839|NCT04365257|59154139|FG000|Overall Study|Patient Noncompliance|1|||
30989840|NCT04365257|59154140|FG001|Overall Study|Patient Noncompliance|0|||
30989841|NCT04365257|59154139|FG000|Overall Study|Withdrawal by Subject|0|||
30989842|NCT04365257|59154140|FG001|Overall Study|Withdrawal by Subject|1|||
30989843|NCT03395223|59154172|FG000|Overall Study|Lost to Follow-up|3|||
30989844|NCT03395223|59154172|FG000|Overall Study|Other|1|||
30989845|NCT02864940|59154202|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
30989846|NCT02864940|59154203|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
30989847|NCT02756611|59154222|FG000|Overall Study|Death|70|||
30989848|NCT02756611|59154222|FG000|Overall Study|Withdrawal by Subject|2|||
30989849|NCT02756611|59154222|FG000|Overall Study|Lost to Follow-up|3|||
30989850|NCT02756611|59154222|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
30989851|NCT02756611|59154222|FG000|Overall Study|Other|10|||
30989852|NCT02624518|59154226|FG000|Overall Study|Physician Decision|1|||
30989853|NCT02287623|59154232|FG000|Overall Study|Protocol Violation|0|||
30989854|NCT02287623|59154233|FG001|Overall Study|Protocol Violation|1|||
30989855|NCT01794520|59154255|FG000|Overall Study|Adverse events- related to progression|0|||
30989856|NCT01794520|59154256|FG001|Overall Study|Adverse events- related to progression|0|||
30989857|NCT01794520|59154257|FG002|Overall Study|Adverse events- related to progression|1|||
30989858|NCT01794520|59154258|FG003|Overall Study|Adverse events- related to progression|2|||
30989859|NCT01794520|59154259|FG004|Overall Study|Adverse events- related to progression|0|||
30989860|NCT01794520|59154260|FG005|Overall Study|Adverse events- related to progression|1|||
30989861|NCT01794520|59154261|FG006|Overall Study|Adverse events- related to progression|0|||
30989862|NCT01794520|59154255|FG000|Overall Study|Adverse event- not related to progression|1|||
30989863|NCT01794520|59154256|FG001|Overall Study|Adverse event- not related to progression|1|||
30989864|NCT01794520|59154257|FG002|Overall Study|Adverse event- not related to progression|0|||
30989865|NCT01794520|59154258|FG003|Overall Study|Adverse event- not related to progression|0|||
30989866|NCT01794520|59154259|FG004|Overall Study|Adverse event- not related to progression|2|||
30989867|NCT01794520|59154260|FG005|Overall Study|Adverse event- not related to progression|0|||
30989868|NCT01794520|59154261|FG006|Overall Study|Adverse event- not related to progression|0|||
30989869|NCT01794520|59154255|FG000|Overall Study|Progressive disease|5|||
30989870|NCT01794520|59154256|FG001|Overall Study|Progressive disease|6|||
30989871|NCT01794520|59154257|FG002|Overall Study|Progressive disease|2|||
30989872|NCT01794520|59154258|FG003|Overall Study|Progressive disease|5|||
30989873|NCT01794520|59154259|FG004|Overall Study|Progressive disease|27|||
30989874|NCT01794520|59154260|FG005|Overall Study|Progressive disease|18|||
30989875|NCT01794520|59154261|FG006|Overall Study|Progressive disease|0|||
30989876|NCT01794520|59154255|FG000|Overall Study|Withdrew consent|0|||
30989877|NCT01794520|59154256|FG001|Overall Study|Withdrew consent|0|||
30989878|NCT01794520|59154257|FG002|Overall Study|Withdrew consent|1|||
30989879|NCT01794520|59154258|FG003|Overall Study|Withdrew consent|1|||
30989880|NCT01794520|59154259|FG004|Overall Study|Withdrew consent|0|||
30989881|NCT01794520|59154260|FG005|Overall Study|Withdrew consent|0|||
30989882|NCT01794520|59154261|FG006|Overall Study|Withdrew consent|0|||
30989883|NCT01794520|59154255|FG000|Overall Study|Lost to Follow-up|0|||
30989884|NCT01794520|59154256|FG001|Overall Study|Lost to Follow-up|0|||
30989885|NCT01794520|59154257|FG002|Overall Study|Lost to Follow-up|0|||
30989886|NCT01794520|59154258|FG003|Overall Study|Lost to Follow-up|0|||
30989887|NCT01794520|59154259|FG004|Overall Study|Lost to Follow-up|1|||
30989888|NCT01794520|59154260|FG005|Overall Study|Lost to Follow-up|0|||
30989889|NCT01794520|59154261|FG006|Overall Study|Lost to Follow-up|0|||
30989890|NCT01794520|59154255|FG000|Overall Study|Toxicity|0|||
30989891|NCT01794520|59154256|FG001|Overall Study|Toxicity|2|||
30989892|NCT01794520|59154257|FG002|Overall Study|Toxicity|0|||
30989893|NCT01794520|59154258|FG003|Overall Study|Toxicity|0|||
30989894|NCT01794520|59154259|FG004|Overall Study|Toxicity|0|||
30989895|NCT01794520|59154260|FG005|Overall Study|Toxicity|0|||
30989896|NCT01794520|59154261|FG006|Overall Study|Toxicity|0|||
30989897|NCT01794520|59154255|FG000|Overall Study|Study terminated by sponsor|0|||
30989898|NCT01794520|59154256|FG001|Overall Study|Study terminated by sponsor|0|||
30989899|NCT01794520|59154257|FG002|Overall Study|Study terminated by sponsor|1|||
30989900|NCT01794520|59154258|FG003|Overall Study|Study terminated by sponsor|0|||
30989901|NCT01794520|59154259|FG004|Overall Study|Study terminated by sponsor|1|||
30989902|NCT01794520|59154260|FG005|Overall Study|Study terminated by sponsor|0|||
30989903|NCT01794520|59154261|FG006|Overall Study|Study terminated by sponsor|7|||
30989904|NCT01794520|59154255|FG000|Overall Study|Death|0|||
30989905|NCT01794520|59154256|FG001|Overall Study|Death|0|||
30989906|NCT01794520|59154257|FG002|Overall Study|Death|0|||
30989907|NCT01794520|59154258|FG003|Overall Study|Death|0|||
30989908|NCT01794520|59154259|FG004|Overall Study|Death|1|||
30989909|NCT01794520|59154260|FG005|Overall Study|Death|0|||
30989910|NCT01794520|59154261|FG006|Overall Study|Death|22|||
30989911|NCT01794520|59154255|FG000|Overall Study|Other, not specified|0|||
30989912|NCT01794520|59154256|FG001|Overall Study|Other, not specified|0|||
30989913|NCT01794520|59154257|FG002|Overall Study|Other, not specified|1|||
30989914|NCT01794520|59154258|FG003|Overall Study|Other, not specified|1|||
30989915|NCT01794520|59154259|FG004|Overall Study|Other, not specified|4|||
30989916|NCT01794520|59154260|FG005|Overall Study|Other, not specified|1|||
30989917|NCT01794520|59154261|FG006|Overall Study|Other, not specified|2|||
30989918|NCT01774019|59154284|FG000|Overall Study|No longer meets protocol criteria|2|||
30989919|NCT01774019|59154285|FG001|Overall Study|No longer meets protocol criteria|0|||
30989920|NCT01774019|59154284|FG000|Overall Study|Withdrawal by Subject|1|||
30989921|NCT01774019|59154285|FG001|Overall Study|Withdrawal by Subject|0|||
30989922|NCT01774019|59154284|FG000|Overall Study|Surgery delayed > 120 days|1|||
30989923|NCT01774019|59154285|FG001|Overall Study|Surgery delayed > 120 days|0|||
30989924|NCT01774019|59154284|FG000|Overall Study|Patient refused surgery|1|||
30989925|NCT01774019|59154285|FG001|Overall Study|Patient refused surgery|1|||
30989926|NCT01774019|59154284|FG000|Overall Study|Unable to implant study device|1|||
30989927|NCT01774019|59154285|FG001|Overall Study|Unable to implant study device|0|||
30989928|NCT01774019|59154284|FG000|Overall Study|Lost to Follow-up|0|||
30989929|NCT01774019|59154285|FG001|Overall Study|Lost to Follow-up|3|||
30989930|NCT03251924|59154661|FG000|Overall Study|Disease Progression|6|||
30989931|NCT03251924|59154662|FG001|Overall Study|Disease Progression|6|||
30989932|NCT03251924|59154663|FG002|Overall Study|Disease Progression|7|||
30989933|NCT03251924|59154664|FG003|Overall Study|Disease Progression|8|||
30989934|NCT03251924|59154665|FG004|Overall Study|Disease Progression|8|||
30989935|NCT03251924|59154666|FG005|Overall Study|Disease Progression|7|||
30989936|NCT03251924|59154667|FG006|Overall Study|Disease Progression|6|||
30989937|NCT03251924|59154668|FG007|Overall Study|Disease Progression|10|||
30989938|NCT03251924|59154669|FG008|Overall Study|Disease Progression|6|||
30989939|NCT03251924|59154661|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
30989940|NCT03251924|59154662|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
30989941|NCT03251924|59154663|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
30989942|NCT03251924|59154664|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
30989943|NCT03251924|59154665|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
30989944|NCT03251924|59154666|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
30989945|NCT03251924|59154667|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
30989946|NCT03251924|59154668|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
30989947|NCT03251924|59154669|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
30989948|NCT03251924|59154661|FG000|Overall Study|Death|0|||
30989949|NCT03251924|59154662|FG001|Overall Study|Death|1|||
30989950|NCT03251924|59154663|FG002|Overall Study|Death|0|||
30989951|NCT03251924|59154664|FG003|Overall Study|Death|1|||
30989952|NCT03251924|59154665|FG004|Overall Study|Death|1|||
30989953|NCT03251924|59154666|FG005|Overall Study|Death|1|||
30989954|NCT03251924|59154667|FG006|Overall Study|Death|0|||
30989955|NCT03251924|59154668|FG007|Overall Study|Death|0|||
30989956|NCT03251924|59154669|FG008|Overall Study|Death|0|||
30989957|NCT03251924|59154661|FG000|Overall Study|Study Drug Toxicity|0|||
30989958|NCT03251924|59154662|FG001|Overall Study|Study Drug Toxicity|0|||
30790213|NCT03687502|58803447|FG000|Overall Study|Lumason not available|1|||
30989959|NCT03251924|59154663|FG002|Overall Study|Study Drug Toxicity|0|||
30989960|NCT03251924|59154664|FG003|Overall Study|Study Drug Toxicity|1|||
30989961|NCT03251924|59154665|FG004|Overall Study|Study Drug Toxicity|0|||
30989962|NCT03251924|59154666|FG005|Overall Study|Study Drug Toxicity|0|||
30989963|NCT03251924|59154667|FG006|Overall Study|Study Drug Toxicity|0|||
30989964|NCT03251924|59154668|FG007|Overall Study|Study Drug Toxicity|0|||
30989965|NCT03251924|59154669|FG008|Overall Study|Study Drug Toxicity|1|||
30989966|NCT03251924|59154661|FG000|Overall Study|Other Reasons|0|||
30989967|NCT03251924|59154662|FG001|Overall Study|Other Reasons|0|||
30989968|NCT03251924|59154663|FG002|Overall Study|Other Reasons|0|||
30989969|NCT03251924|59154664|FG003|Overall Study|Other Reasons|0|||
30989970|NCT03251924|59154665|FG004|Overall Study|Other Reasons|0|||
30989971|NCT03251924|59154666|FG005|Overall Study|Other Reasons|0|||
30989972|NCT03251924|59154667|FG006|Overall Study|Other Reasons|0|||
30989973|NCT03251924|59154668|FG007|Overall Study|Other Reasons|0|||
30989974|NCT03251924|59154669|FG008|Overall Study|Other Reasons|1|||
30989975|NCT03251924|59154661|FG000|Overall Study|Participant request to discontinue study treatment|0|||
30989976|NCT03251924|59154662|FG001|Overall Study|Participant request to discontinue study treatment|0|||
30989977|NCT03251924|59154663|FG002|Overall Study|Participant request to discontinue study treatment|0|||
30989978|NCT03251924|59154664|FG003|Overall Study|Participant request to discontinue study treatment|0|||
30989979|NCT03251924|59154665|FG004|Overall Study|Participant request to discontinue study treatment|0|||
30989980|NCT03251924|59154666|FG005|Overall Study|Participant request to discontinue study treatment|0|||
30989981|NCT03251924|59154667|FG006|Overall Study|Participant request to discontinue study treatment|0|||
30989982|NCT03251924|59154668|FG007|Overall Study|Participant request to discontinue study treatment|1|||
30989983|NCT03251924|59154669|FG008|Overall Study|Participant request to discontinue study treatment|0|||
30989984|NCT01350141|59154865|FG000|Overall Study|Lost to Follow-up|1|||
30989985|NCT01350141|59154866|FG001|Overall Study|Lost to Follow-up|0|||
30989986|NCT01350141|59154867|FG002|Overall Study|Lost to Follow-up|1|||
30989987|NCT01350141|59154865|FG000|Overall Study|Withdrawal by Subject|1|||
30989988|NCT01350141|59154866|FG001|Overall Study|Withdrawal by Subject|0|||
30989989|NCT01350141|59154867|FG002|Overall Study|Withdrawal by Subject|0|||
30989990|NCT01350141|59154865|FG000|Overall Study|Randomized but not treated|1|||
30989991|NCT01350141|59154866|FG001|Overall Study|Randomized but not treated|0|||
30989992|NCT01350141|59154867|FG002|Overall Study|Randomized but not treated|0|||
30989993|NCT05045625|59155406|FG000|Overall Study|Lost to Follow-up|3|||
30989994|NCT04830969|59155788|FG000|Overall Study|Withdrawal by Subject|6|||
30989995|NCT04830969|59155789|FG001|Overall Study|Withdrawal by Subject|2|||
30989996|NCT04830969|59155788|FG000|Overall Study|Protocol Violation|3|||
30989997|NCT04830969|59155789|FG001|Overall Study|Protocol Violation|9|||
30989998|NCT04830969|59155788|FG000|Overall Study|Lost to Follow-up|4|||
30989999|NCT04830969|59155789|FG001|Overall Study|Lost to Follow-up|4|||
30990000|NCT02384993|59156100|FG000|Overall Study|Adverse Event|0|||
30990001|NCT02384993|59156101|FG001|Overall Study|Adverse Event|1|||
30990002|NCT01352117|59156149|FG000|Overall Study|Death|15|||
30990003|NCT01352117|59156150|FG001|Overall Study|Death|16|||
30990004|NCT01352117|59156149|FG000|Overall Study|Withdrawal by Subject|1|||
30990005|NCT01352117|59156150|FG001|Overall Study|Withdrawal by Subject|0|||
30990006|NCT01352117|59156149|FG000|Overall Study|Lost to Follow-up|2|||
30990007|NCT01352117|59156150|FG001|Overall Study|Lost to Follow-up|7|||
30990008|NCT01352117|59156149|FG000|Overall Study|Non-adherent to study requirements|1|||
30990009|NCT01352117|59156150|FG001|Overall Study|Non-adherent to study requirements|1|||
30990010|NCT01352117|59156149|FG000|Overall Study|Did not initiate study treatment|1|||
30990011|NCT01352117|59156150|FG001|Overall Study|Did not initiate study treatment|0|||
30990012|NCT01352117|59156149|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
30990013|NCT01352117|59156150|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
30990014|NCT03578237|59156221|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
30990015|NCT03578237|59156222|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
30990016|NCT04173507|59156301|FG000|Overall Study|On Treatment|3|||
30990017|NCT04173507|59156301|FG000|Overall Study|Adverse Event|3|||
30990018|NCT04173507|59156301|FG000|Overall Study|Progression/Relapse|34|||
30990019|NCT04173507|59156301|FG000|Overall Study|Death|2|||
30990020|NCT02220725|59156309|FG000|Overall Study|Lost to Follow-up|0|||
30990021|NCT02220725|59156310|FG001|Overall Study|Lost to Follow-up|0|||
30990022|NCT02220725|59156311|FG002|Overall Study|Lost to Follow-up|0|||
30990023|NCT02220725|59156312|FG003|Overall Study|Lost to Follow-up|1|||
30990024|NCT02220725|59156309|FG000|Overall Study|Withdrawal by Subject|0|||
30990025|NCT02220725|59156310|FG001|Overall Study|Withdrawal by Subject|0|||
30990026|NCT02220725|59156311|FG002|Overall Study|Withdrawal by Subject|0|||
30990027|NCT02220725|59156312|FG003|Overall Study|Withdrawal by Subject|1|||
30990028|NCT02259517|59156358|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
30990029|NCT02259517|59156359|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
30990030|NCT02259517|59156360|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
30990031|NCT02259517|59156358|FG000|Overall Study|Withdrawal by Subject|0|||
30990032|NCT02259517|59156359|FG001|Overall Study|Withdrawal by Subject|0|||
30990033|NCT02259517|59156360|FG002|Overall Study|Withdrawal by Subject|3|||
30990034|NCT02277990|59156403|FG000|Overall Study|Death|170|||
30990035|NCT02277990|59156404|FG001|Overall Study|Death|188|||
30990036|NCT02277990|59156403|FG000|Overall Study|Withdrawal by Subject|64|||
30990037|NCT02277990|59156404|FG001|Overall Study|Withdrawal by Subject|53|||
30990038|NCT02277990|59156403|FG000|Overall Study|Physician Decision|40|||
30990039|NCT02277990|59156404|FG001|Overall Study|Physician Decision|34|||
30990040|NCT02277990|59156403|FG000|Overall Study|Lost to Follow-up|66|||
30990041|NCT02277990|59156404|FG001|Overall Study|Lost to Follow-up|69|||
30990042|NCT02277990|59156403|FG000|Overall Study|Had other reason|26|||
30990043|NCT02277990|59156404|FG001|Overall Study|Had other reason|32|||
30990044|NCT02317614|59156426|FG000|Overall Study|Lost to Follow-up|1|||
30990045|NCT02317614|59156427|FG001|Overall Study|Lost to Follow-up|1|||
30990046|NCT02317614|59156426|FG000|Overall Study|Withdrawal by Subject|1|||
30990047|NCT02317614|59156427|FG001|Overall Study|Withdrawal by Subject|0|||
30990048|NCT02317614|59156426|FG000|Overall Study|Death|1|||
30990049|NCT02317614|59156427|FG001|Overall Study|Death|1|||
30990050|NCT02276040|59156440|FG000|Overall Study|Physician Decision|15|||
30990051|NCT02315664|59156446|FG000|Overall Study|Lost to Follow-up|1|||
30990052|NCT02315664|59156447|FG001|Overall Study|Lost to Follow-up|1|||
30990053|NCT02315664|59156446|FG000|Overall Study|Withdrawal by Subject|0|||
30990054|NCT02315664|59156447|FG001|Overall Study|Withdrawal by Subject|3|||
30990055|NCT02314728|59156475|FG000|Overall Study|Protocol Violation|1|||
30990056|NCT02314728|59156476|FG001|Overall Study|Protocol Violation|0|||
30990057|NCT02314728|59156475|FG000|Overall Study|Lost to Follow-up|0|||
30990058|NCT02314728|59156476|FG001|Overall Study|Lost to Follow-up|1|||
30990059|NCT02275338|59156495|FG000|Overall Study|Adverse Event|15|||
30990060|NCT02275338|59156495|FG000|Overall Study|Lack of Efficacy|3|||
30990061|NCT02275338|59156495|FG000|Overall Study|Withdrawal by Subject|4|||
30990062|NCT02275338|59156495|FG000|Overall Study|Disease progression (death)|1|||
30990063|NCT02275338|59156495|FG000|Overall Study|Ineligible to start Phase 2|4|||
30990064|NCT02275338|59156495|FG000|Overall Study|Reason not specified|5|||
30990065|NCT02275338|59156495|FG000|Overall Study|Does not meet entry criteria|1|||
30990066|NCT02313558|59156502|FG000|Overall Study|Withdrawal by Subject|2|||
30990067|NCT02313558|59156503|FG001|Overall Study|Withdrawal by Subject|0|||
30990068|NCT02313558|59156502|FG000|Overall Study|Lost to Follow-up|4|||
30990069|NCT02313558|59156503|FG001|Overall Study|Lost to Follow-up|4|||
30990070|NCT01646268|59156531|FG000|Overall Study|Adverse Event|6|||
30990071|NCT01646268|59156532|FG001|Overall Study|Adverse Event|7|||
30990072|NCT01646268|59156531|FG000|Overall Study|Lack of Efficacy|1|||
30990073|NCT01646268|59156532|FG001|Overall Study|Lack of Efficacy|3|||
30990074|NCT01646268|59156531|FG000|Overall Study|Protocol Violation|0|||
30990075|NCT01646268|59156532|FG001|Overall Study|Protocol Violation|1|||
30990076|NCT01646268|59156531|FG000|Overall Study|Withdrawal by Subject|2|||
30990077|NCT01646268|59156532|FG001|Overall Study|Withdrawal by Subject|5|||
30990078|NCT01646268|59156531|FG000|Overall Study|Other|2|||
30990079|NCT01646268|59156532|FG001|Overall Study|Other|0|||
30990080|NCT02275026|59156538|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
30990081|NCT02275026|59156538|FG000|Overall Study|Withdrawal by Subject|4|||
30990082|NCT02275026|59156538|FG000|Overall Study|Ineligible due to medical history|13|||
30990083|NCT02275026|59156538|FG000|Overall Study|MRI malfunction precluded testing|1|||
30990084|NCT02275026|59156538|FG000|Overall Study|Ineligible after MRI findings|1|||
30990085|NCT02275026|59156538|FG000|Overall Study|Lost to Follow-up|2|||
30990086|NCT02275026|59156538|FG000|Overall Study|Scanner failure|1|||
30990087|NCT02711852|59156605|FG000|Overall Study|Death|5|||
30990088|NCT02711852|59156605|FG000|Overall Study|Lost to Follow-up|1|||
30990089|NCT02711852|59156605|FG000|Overall Study|Completed follow-up|3|||
30990090|NCT02711852|59156605|FG000|Overall Study|Withdrawal by Subject|1|||
30990091|NCT04579250|59156645|FG000|Overall Study|Withdrawal by Subject|1|||
30990092|NCT04579250|59156646|FG001|Overall Study|Withdrawal by Subject|1|||
30990093|NCT04579250|59156647|FG002|Overall Study|Withdrawal by Subject|0|||
30990094|NCT04579250|59156645|FG000|Overall Study|Lost to Follow-up|1|||
30990095|NCT04579250|59156646|FG001|Overall Study|Lost to Follow-up|1|||
30990096|NCT04579250|59156647|FG002|Overall Study|Lost to Follow-up|0|||
30990097|NCT04579250|59156645|FG000|Overall Study|Moved from area|0|||
30990098|NCT04579250|59156646|FG001|Overall Study|Moved from area|1|||
30990099|NCT04579250|59156647|FG002|Overall Study|Moved from area|2|||
30990100|NCT03175367|59156674|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
30990101|NCT03175367|59156675|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
30990102|NCT03175367|59156676|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
30990103|NCT03175367|59156677|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
30990104|NCT03175367|59156678|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
30990105|NCT03175367|59156679|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
30990106|NCT03175367|59156680|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
30990107|NCT03175367|59156674|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
30990108|NCT03175367|59156675|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
30990109|NCT03175367|59156676|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
30990110|NCT03175367|59156677|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
30990111|NCT03175367|59156678|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
30990112|NCT03175367|59156679|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
30990113|NCT03175367|59156680|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
30990114|NCT03175367|59156674|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
30990115|NCT03175367|59156675|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
30990116|NCT03175367|59156676|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
30990117|NCT03175367|59156677|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
30990118|NCT03175367|59156678|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
30990119|NCT03175367|59156679|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
30990120|NCT03175367|59156680|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
30990121|NCT03175367|59156674|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
30990122|NCT03175367|59156675|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
30990123|NCT03175367|59156676|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
30990124|NCT03175367|59156677|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
30990125|NCT03175367|59156678|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
30990126|NCT03175367|59156679|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
30990127|NCT03175367|59156680|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
30990128|NCT03175367|59156674|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
30990129|NCT03175367|59156675|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
30990130|NCT03175367|59156676|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
30990131|NCT03175367|59156677|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
30990132|NCT03175367|59156678|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
30990133|NCT03175367|59156679|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
30990134|NCT03175367|59156680|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
30990135|NCT03175367|59156674|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
30990136|NCT03175367|59156675|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
30990137|NCT03175367|59156676|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
30990138|NCT03175367|59156677|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
30990139|NCT03175367|59156678|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
30990140|NCT03175367|59156679|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
30990141|NCT03175367|59156680|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
30990142|NCT03175367|59156674|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
30990143|NCT03175367|59156675|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
30990144|NCT03175367|59156676|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
30990145|NCT03175367|59156677|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
30990146|NCT03175367|59156678|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
30990147|NCT03175367|59156679|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
30990148|NCT03175367|59156680|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
30990149|NCT03174275|59156737|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
30990150|NCT03174275|59156737|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
30990151|NCT03174275|59156737|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
30990152|NCT03174275|59156737|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
30990153|NCT03174275|59156737|FG000|Adjuvant Chemotherapy|Progression|1|||
30990154|NCT03174275|59156737|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
30990155|NCT03174275|59156737|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
30990156|NCT03174275|59156737|FG000|Adjuvant Durvalumab|Progression|1|||
30990157|NCT03174275|59156737|FG000|Adjuvant Durvalumab|Adverse Event|3|||
30990158|NCT03174275|59156737|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
30990159|NCT03174275|59156737|FG000|Adjuvant Radiotherapy|Progression|1|||
30990160|NCT03174275|59156737|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
30990161|NCT03990363|59156838|FG000|Overall Study|Withdrawal by Subject|10|||
30990162|NCT03990363|59156839|FG001|Overall Study|Withdrawal by Subject|9|||
30990163|NCT03990363|59156840|FG002|Overall Study|Withdrawal by Subject|18|||
30990164|NCT03990363|59156841|FG003|Overall Study|Withdrawal by Subject|11|||
30608963|NCT01287104|58619813|FG002|Overall Study|Low donor chimerism|0|||
30608964|NCT01287104|58619814|FG003|Overall Study|Low donor chimerism|0|||
30608965|NCT01287104|58619811|FG000|Overall Study|NK cells did not meet release criteria|0|||
30608966|NCT01287104|58619812|FG001|Overall Study|NK cells did not meet release criteria|1|||
30608967|NCT01287104|58619813|FG002|Overall Study|NK cells did not meet release criteria|0|||
30608968|NCT01287104|58619814|FG003|Overall Study|NK cells did not meet release criteria|0|||
30608969|NCT01286558|58619833|FG000|Overall Study|Adverse Event|1|||
30608970|NCT01286558|58619834|FG001|Overall Study|Adverse Event|1|||
30608971|NCT01286558|58619833|FG000|Overall Study|Withdrawal by Subject|0|||
30608972|NCT01286558|58619834|FG001|Overall Study|Withdrawal by Subject|1|||
30608973|NCT01169103|58619842|FG000|Overall Study|Lost to Follow-up|3|||
30608974|NCT01169103|58619843|FG001|Overall Study|Lost to Follow-up|3|||
30608975|NCT01169103|58619842|FG000|Overall Study|Withdrawal by Subject|3|||
30608976|NCT01169103|58619843|FG001|Overall Study|Withdrawal by Subject|1|||
30608977|NCT01286480|58619851|FG000|Overall Study|Withdrawal by Subject|5|||
30608978|NCT01286480|58619852|FG001|Overall Study|Withdrawal by Subject|3|||
30608979|NCT01286168|58619858|FG000|Overall Study|Withdrawal by Subject|1|||
30608980|NCT01286168|58619858|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
30608981|NCT01286012|58619865|FG000|Overall Study|Adverse Event|3|||
30608982|NCT01286012|58619866|FG001|Overall Study|Adverse Event|3|||
30608983|NCT01286012|58619865|FG000|Overall Study|Death|2|||
30608984|NCT01286012|58619866|FG001|Overall Study|Death|3|||
30608985|NCT01286012|58619865|FG000|Overall Study|Protocol Violation|1|||
30990165|NCT03990363|59156842|FG004|Overall Study|Withdrawal by Subject|9|||
30990166|NCT03990363|59156838|FG000|Overall Study|Physician Decision|1|||
30990167|NCT03990363|59156839|FG001|Overall Study|Physician Decision|0|||
30990168|NCT03990363|59156840|FG002|Overall Study|Physician Decision|0|||
30990169|NCT03990363|59156841|FG003|Overall Study|Physician Decision|0|||
30990170|NCT03990363|59156842|FG004|Overall Study|Physician Decision|0|||
30990171|NCT03990363|59156838|FG000|Overall Study|Adverse Event|1|||
30990172|NCT03990363|59156839|FG001|Overall Study|Adverse Event|3|||
30990173|NCT03990363|59156840|FG002|Overall Study|Adverse Event|2|||
30990174|NCT03990363|59156841|FG003|Overall Study|Adverse Event|2|||
30990175|NCT03990363|59156842|FG004|Overall Study|Adverse Event|0|||
30990176|NCT03990363|59156838|FG000|Overall Study|Death|14|||
30990177|NCT03990363|59156839|FG001|Overall Study|Death|8|||
30990178|NCT03990363|59156840|FG002|Overall Study|Death|14|||
30990179|NCT03990363|59156841|FG003|Overall Study|Death|10|||
30990180|NCT03990363|59156842|FG004|Overall Study|Death|11|||
30990181|NCT03990363|59156838|FG000|Overall Study|Failure to meet randomization criteria|0|||
30990182|NCT03990363|59156839|FG001|Overall Study|Failure to meet randomization criteria|1|||
30990183|NCT03990363|59156840|FG002|Overall Study|Failure to meet randomization criteria|1|||
30990184|NCT03990363|59156841|FG003|Overall Study|Failure to meet randomization criteria|0|||
30990185|NCT03990363|59156842|FG004|Overall Study|Failure to meet randomization criteria|0|||
30990186|NCT03990363|59156838|FG000|Overall Study|Lost to Follow-up|0|||
30990187|NCT03990363|59156839|FG001|Overall Study|Lost to Follow-up|0|||
30990188|NCT03990363|59156840|FG002|Overall Study|Lost to Follow-up|0|||
30990189|NCT03990363|59156841|FG003|Overall Study|Lost to Follow-up|1|||
30990190|NCT03990363|59156842|FG004|Overall Study|Lost to Follow-up|2|||
30990191|NCT03990363|59156838|FG000|Overall Study|Non-compliance with study drug|2|||
30990192|NCT03990363|59156839|FG001|Overall Study|Non-compliance with study drug|1|||
30990193|NCT03990363|59156840|FG002|Overall Study|Non-compliance with study drug|2|||
30990194|NCT03990363|59156841|FG003|Overall Study|Non-compliance with study drug|0|||
30990195|NCT03990363|59156842|FG004|Overall Study|Non-compliance with study drug|0|||
30990196|NCT03990363|59156838|FG000|Overall Study|Study terminated by sponsor|0|||
30990197|NCT03990363|59156839|FG001|Overall Study|Study terminated by sponsor|1|||
30990198|NCT03990363|59156840|FG002|Overall Study|Study terminated by sponsor|0|||
30990199|NCT03990363|59156841|FG003|Overall Study|Study terminated by sponsor|0|||
30990200|NCT03990363|59156842|FG004|Overall Study|Study terminated by sponsor|0|||
30990201|NCT03990363|59156838|FG000|Overall Study|Site terminated by sponsor|2|||
30990202|NCT03990363|59156839|FG001|Overall Study|Site terminated by sponsor|1|||
30990203|NCT03990363|59156840|FG002|Overall Study|Site terminated by sponsor|2|||
30990204|NCT03990363|59156841|FG003|Overall Study|Site terminated by sponsor|0|||
30990205|NCT03990363|59156842|FG004|Overall Study|Site terminated by sponsor|2|||
30990206|NCT03990363|59156838|FG000|Overall Study|Not categorized|5|||
30990207|NCT03990363|59156839|FG001|Overall Study|Not categorized|5|||
30990208|NCT03990363|59156840|FG002|Overall Study|Not categorized|3|||
30990209|NCT03990363|59156841|FG003|Overall Study|Not categorized|2|||
30990210|NCT03990363|59156842|FG004|Overall Study|Not categorized|2|||
30990211|NCT04661839|59156912|FG000|Overall Study|Not Treated|0|||
30990212|NCT04661839|59156913|FG001|Overall Study|Not Treated|0|||
30990213|NCT04661839|59156914|FG002|Overall Study|Not Treated|1|||
30990214|NCT04661839|59156915|FG003|Overall Study|Not Treated|0|||
30990215|NCT04661839|59156912|FG000|Overall Study|Lost to Follow-up|1|||
30990216|NCT04661839|59156913|FG001|Overall Study|Lost to Follow-up|0|||
30990217|NCT04661839|59156914|FG002|Overall Study|Lost to Follow-up|0|||
30990218|NCT04661839|59156915|FG003|Overall Study|Lost to Follow-up|1|||
30990219|NCT02240485|59157016|FG000|3 Months Post-admission|Lost to Follow-up|1|||
30608986|NCT01286012|58619866|FG001|Overall Study|Protocol Violation|1|||
30990220|NCT02240485|59157017|FG001|3 Months Post-admission|Lost to Follow-up|5|||
30990221|NCT02240485|59157016|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
30990222|NCT02240485|59157017|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
30990223|NCT02240485|59157016|FG000|9 Months Post-admission|Lost to Follow-up|3|||
30990224|NCT02240485|59157017|FG001|9 Months Post-admission|Lost to Follow-up|1|||
30990225|NCT02240485|59157016|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
30990226|NCT02240485|59157017|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
30990227|NCT02240485|59157016|FG000|18 Months Post-admission|Lost to Follow-up|1|||
30990228|NCT02240485|59157017|FG001|18 Months Post-admission|Lost to Follow-up|1|||
30990229|NCT02240485|59157016|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
30990230|NCT02240485|59157017|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
30990231|NCT04149535|59157040|FG000|Overall Study|Death|11|||
30990232|NCT04149535|59157041|FG001|Overall Study|Death|7|||
30990233|NCT04149535|59157040|FG000|Overall Study|Physician Decision|10|||
30990234|NCT04149535|59157041|FG001|Overall Study|Physician Decision|4|||
30990235|NCT04149535|59157040|FG000|Overall Study|Withdrawal by Subject|6|||
30990236|NCT04149535|59157041|FG001|Overall Study|Withdrawal by Subject|7|||
30990237|NCT04149535|59157040|FG000|Overall Study|Not described|2|||
30990238|NCT04149535|59157041|FG001|Overall Study|Not described|0|||
30990239|NCT02210559|59157059|FG000|Overall Study|Progressive Disease|3|||
30990240|NCT02210559|59157060|FG001|Overall Study|Progressive Disease|2|||
30990241|NCT02210559|59157059|FG000|Overall Study|Adverse Event|2|||
30990242|NCT02210559|59157060|FG001|Overall Study|Adverse Event|2|||
30990243|NCT02210559|59157059|FG000|Overall Study|Physician Decision|1|||
30990244|NCT02210559|59157060|FG001|Overall Study|Physician Decision|0|||
30990245|NCT02210559|59157059|FG000|Overall Study|Withdrawal by Subject|0|||
30990246|NCT02210559|59157060|FG001|Overall Study|Withdrawal by Subject|1|||
30990247|NCT02210559|59157059|FG000|Overall Study|Other than specified|0|||
30990248|NCT02210559|59157060|FG001|Overall Study|Other than specified|1|||
30990249|NCT02073279|59157217|FG000|Double-blind Period|Adverse Event|1|||
30990250|NCT02073279|59157218|FG001|Double-blind Period|Adverse Event|1|||
30990251|NCT02073279|59157217|FG000|Double-blind Period|Switched to another treatment|1|||
30990252|NCT02073279|59157218|FG001|Double-blind Period|Switched to another treatment|2|||
30990253|NCT02073279|59157217|FG000|Double-blind Period|Protocol Violation|0|||
30990254|NCT02073279|59157218|FG001|Double-blind Period|Protocol Violation|1|||
30990255|NCT02073279|59157217|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
30990256|NCT02073279|59157218|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
30990257|NCT02073279|59157217|FG000|Double-blind Period|Withdrawal by Subject|2|||
30990258|NCT02073279|59157218|FG001|Double-blind Period|Withdrawal by Subject|2|||
30990259|NCT02073279|59157217|FG000|Open-label Extension Period|Adverse Event|1|||
30990260|NCT02073279|59157218|FG001|Open-label Extension Period|Adverse Event|0|||
30990261|NCT02073279|59157217|FG000|Open-label Extension Period|Lack of Efficacy|1|||
30990262|NCT02073279|59157218|FG001|Open-label Extension Period|Lack of Efficacy|0|||
30990263|NCT02073279|59157217|FG000|Open-label Extension Period|Lost to Follow-up|0|||
30990264|NCT02073279|59157218|FG001|Open-label Extension Period|Lost to Follow-up|4|||
30990265|NCT02073279|59157217|FG000|Open-label Extension Period|Switched to another treatment|1|||
30990266|NCT02073279|59157218|FG001|Open-label Extension Period|Switched to another treatment|4|||
30990267|NCT02073279|59157217|FG000|Open-label Extension Period|Protocol Violation|0|||
30990268|NCT02073279|59157218|FG001|Open-label Extension Period|Protocol Violation|1|||
30990269|NCT02073279|59157217|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
30990270|NCT02073279|59157218|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
30990271|NCT02073279|59157217|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
30990272|NCT02073279|59157218|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
30990273|NCT01673867|59157474|FG000|Randomization|Adverse event unrelated to study drug|1|||
30990274|NCT01673867|59157475|FG001|Randomization|Adverse event unrelated to study drug|0|||
30990275|NCT01673867|59157474|FG000|Randomization|Participant request to discontinue study treatment|0|||
30990276|NCT01673867|59157475|FG001|Randomization|Participant request to discontinue study treatment|4|||
30990277|NCT01673867|59157474|FG000|Randomization|Withdrawal by participant|0|||
30990278|NCT01673867|59157475|FG001|Randomization|Withdrawal by participant|12|||
30990279|NCT01673867|59157474|FG000|Randomization|Lost to Follow-up|0|||
30990280|NCT01673867|59157475|FG001|Randomization|Lost to Follow-up|1|||
30990281|NCT01673867|59157474|FG000|Randomization|Participant no longer meets study criteria|4|||
30990282|NCT01673867|59157475|FG001|Randomization|Participant no longer meets study criteria|5|||
30990283|NCT01673867|59157474|FG000|Treatment|Disease Progression|208|||
30990284|NCT01673867|59157475|FG001|Treatment|Disease Progression|178|||
30990285|NCT01673867|59157474|FG000|Treatment|Study Drug Toxicity|23|||
30990286|NCT01673867|59157475|FG001|Treatment|Study Drug Toxicity|43|||
30990287|NCT01673867|59157474|FG000|Treatment|Death|2|||
30990288|NCT01673867|59157475|FG001|Treatment|Death|3|||
30990289|NCT01673867|59157474|FG000|Treatment|Adverse event unrelated to study drug|23|||
30990290|NCT01673867|59157475|FG001|Treatment|Adverse event unrelated to study drug|10|||
30790214|NCT00035555|58803456|FG000|Overall Study|Adverse Event|5|||
30990291|NCT01673867|59157474|FG000|Treatment|Participant request to discontinue study treatment|7|||
30990292|NCT01673867|59157475|FG001|Treatment|Participant request to discontinue study treatment|17|||
30990293|NCT01673867|59157474|FG000|Treatment|Withdrawal by participant|5|||
30990294|NCT01673867|59157475|FG001|Treatment|Withdrawal by participant|5|||
30990295|NCT01673867|59157474|FG000|Treatment|Maximum clinical benefit|1|||
30990296|NCT01673867|59157475|FG001|Treatment|Maximum clinical benefit|10|||
30990297|NCT01673867|59157474|FG000|Treatment|Participant no longer meets study criteria|2|||
30990298|NCT01673867|59157475|FG001|Treatment|Participant no longer meets study criteria|0|||
30990299|NCT01673867|59157474|FG000|Treatment|Administrative reason by sponsor|3|||
30990300|NCT01673867|59157475|FG001|Treatment|Administrative reason by sponsor|0|||
30990301|NCT01673867|59157474|FG000|Treatment|Other reason|11|||
30990302|NCT01673867|59157475|FG001|Treatment|Other reason|2|||
30990303|NCT02041533|59157571|FG000|Pre-Treatment Period|Disease Progression|1|||
30990304|NCT02041533|59157572|FG001|Pre-Treatment Period|Disease Progression|1|||
30990305|NCT02041533|59157571|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
30990306|NCT02041533|59157572|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
30990307|NCT02041533|59157571|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
30990308|NCT02041533|59157572|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
30990309|NCT02041533|59157571|FG000|Treatment Period|Disease progression|189|||
30990310|NCT02041533|59157572|FG001|Treatment Period|Disease progression|146|||
30990311|NCT02041533|59157571|FG000|Treatment Period|Study drug toxicity|30|||
30990312|NCT02041533|59157572|FG001|Treatment Period|Study drug toxicity|34|||
30990313|NCT02041533|59157571|FG000|Treatment Period|Death|1|||
30990314|NCT02041533|59157572|FG001|Treatment Period|Death|0|||
30990315|NCT02041533|59157571|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
30990316|NCT02041533|59157572|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
30990317|NCT02041533|59157571|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
30990318|NCT02041533|59157572|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
30990319|NCT02041533|59157571|FG000|Treatment Period|Participant withdrew consent|2|||
30990320|NCT02041533|59157572|FG001|Treatment Period|Participant withdrew consent|2|||
30990321|NCT02041533|59157571|FG000|Treatment Period|Maximum clinical benefit|0|||
30990322|NCT02041533|59157572|FG001|Treatment Period|Maximum clinical benefit|18|||
30990323|NCT02041533|59157571|FG000|Treatment Period|Poor/Non-compliance|1|||
30990324|NCT02041533|59157572|FG001|Treatment Period|Poor/Non-compliance|0|||
30990325|NCT02041533|59157571|FG000|Treatment Period|Administrative reason by sponsor|1|||
30990326|NCT02041533|59157572|FG001|Treatment Period|Administrative reason by sponsor|0|||
30990327|NCT02041533|59157571|FG000|Treatment Period|Other reasons|9|||
30990328|NCT02041533|59157572|FG001|Treatment Period|Other reasons|2|||
30990329|NCT02041533|59157571|FG000|Treatment Period|Not Reported|0|||
30990330|NCT02041533|59157572|FG001|Treatment Period|Not Reported|1|||
30990331|NCT02907203|59157579|FG000|Overall Study|Death|1|||
30990332|NCT02907203|59157579|FG000|Overall Study|Lost to Follow-up|3|||
30990333|NCT02907203|59157579|FG000|Overall Study|Withdrawal by Subject|3|||
30990334|NCT02907203|59157579|FG000|Overall Study|Surgical bypass|1|||
30990335|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
30990336|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
30990337|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
30990338|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
30990339|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
30990340|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
30990341|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
30990342|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
30990343|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Death|1|||
30990344|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Death|1|||
30990345|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
30990346|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
30990347|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
30990348|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
30990349|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
30990350|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
30990351|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
30990352|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
30990353|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
30990354|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
30990355|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
30990356|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
30990357|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
30990358|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
30990359|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
30990360|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
30990361|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
30990362|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
30990363|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
30990364|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
30990365|NCT00559585|59158741|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
30990366|NCT00559585|59158742|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
30990367|NCT00559585|59158741|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
30990368|NCT00559585|59158742|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
30990369|NCT00559585|59158741|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
30990370|NCT00559585|59158742|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
30990371|NCT00559585|59158741|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
30990372|NCT00559585|59158742|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
30990373|NCT00559585|59158741|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
30990374|NCT00559585|59158742|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
30990375|NCT00559585|59158741|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
30990376|NCT00559585|59158742|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
30990377|NCT00559585|59158741|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
30990378|NCT00559585|59158742|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
30990379|NCT00559585|59158741|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
30990380|NCT00559585|59158742|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
30891804|NCT02347657|58925087|FG001|Overall Study|Withdrawal by Subject|7|||
30891805|NCT02347657|58925086|FG000|Overall Study|Randomized but not treated|1|||
30891806|NCT02347657|58925087|FG001|Overall Study|Randomized but not treated|0|||
30891807|NCT02347657|58925086|FG000|Overall Study|Other|3|||
30891808|NCT02347657|58925087|FG001|Overall Study|Other|3|||
30891809|NCT02347189|58925094|FG000|Overall Study|No implant attempted of study device|9|||
30891810|NCT02347189|58925094|FG000|Overall Study|No primary outcome data available|2|||
30891811|NCT02382133|58925109|FG000|Overall Study|Death|22|||
30891812|NCT02382133|58925109|FG000|Overall Study|transfer out of ICU|4|||
30891813|NCT02382133|58925109|FG000|Overall Study|Physician Decision|2|||
30891814|NCT02382133|58925109|FG000|Overall Study|arterial catheter loss|4|||
30891815|NCT02382133|58925109|FG000|Overall Study|pressure injury both sites|1|||
30891816|NCT02346877|58925115|FG000|Overall Study|Adverse Event|1|||
30891817|NCT02346877|58925116|FG001|Overall Study|Adverse Event|0|||
30891818|NCT02346877|58925115|FG000|Overall Study|Administrative Decision|1|||
30891819|NCT02346877|58925116|FG001|Overall Study|Administrative Decision|0|||
30891820|NCT02346877|58925115|FG000|Overall Study|Sponsor Decision|12|||
30891821|NCT02346877|58925116|FG001|Overall Study|Sponsor Decision|0|||
30891822|NCT02346877|58925115|FG000|Overall Study|Missing|5|||
30891823|NCT02346877|58925116|FG001|Overall Study|Missing|0|||
30891824|NCT02346721|58925122|FG000|Overall Study|Withdrew Consent|3|||
30891825|NCT02346721|58925122|FG000|Overall Study|Lack of Efficacy|1|||
30891826|NCT02389621|58925130|FG000|Treatment Period|Withdrawal by Subject|1|||
30990381|NCT00559585|59158741|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
30891827|NCT02389621|58925131|FG001|Treatment Period|Withdrawal by Subject|1|||
30891828|NCT02389621|58925130|FG000|Posttreatment Period|Adverse Event|3|||
30891829|NCT02389621|58925131|FG001|Posttreatment Period|Adverse Event|1|||
30990382|NCT00559585|59158742|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
30990383|NCT00559585|59158741|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
30990384|NCT00559585|59158742|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
30990385|NCT00559585|59158741|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
30990386|NCT00559585|59158742|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
30990387|NCT00559585|59158741|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
30990388|NCT00559585|59158742|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
30990389|NCT00559585|59158741|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
30990390|NCT00559585|59158742|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
30990391|NCT00559507|59158782|FG000|Overall Study|Not treated, patient ineligible|3|||
30990392|NCT00559273|59159050|FG000|Correction Period (20 Weeks)|Death|3|||
30990393|NCT00559273|59159051|FG001|Correction Period (20 Weeks)|Death|4|||
30990394|NCT00559273|59159050|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
30990395|NCT00559273|59159051|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
30990396|NCT00559273|59159050|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
30990397|NCT00559273|59159051|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
30990398|NCT00559273|59159050|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
30990399|NCT00559273|59159051|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
30990400|NCT00559273|59159050|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
30990401|NCT00559273|59159051|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
30990402|NCT00559273|59159050|FG000|Evaluation Period (8 Weeks)|Death|1|||
30990403|NCT00559273|59159051|FG001|Evaluation Period (8 Weeks)|Death|3|||
30990404|NCT00559273|59159050|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
30990405|NCT00559273|59159051|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
30990406|NCT00559273|59159050|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
30990407|NCT00559273|59159051|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
30990408|NCT00559273|59159050|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
30990409|NCT00559273|59159051|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
30990410|NCT00558259|59159106|FG000|Overall Study|Adverse Event|50|||
30990411|NCT00558259|59159107|FG001|Overall Study|Adverse Event|81|||
30990412|NCT00558259|59159106|FG000|Overall Study|Protocol Violation|9|||
30990413|NCT00558259|59159107|FG001|Overall Study|Protocol Violation|5|||
30990414|NCT00558259|59159106|FG000|Overall Study|Withdrawal by Subject|12|||
30990415|NCT00558259|59159107|FG001|Overall Study|Withdrawal by Subject|13|||
30990416|NCT00558103|59159254|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
30990417|NCT00558103|59159255|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
30990418|NCT00558103|59159256|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
30990419|NCT00558103|59159257|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
30990420|NCT00558103|59159258|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
30990421|NCT00558103|59159259|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
30990422|NCT00558103|59159254|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
30990423|NCT00558103|59159255|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
30990424|NCT00558103|59159256|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
30990425|NCT00558103|59159257|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
30990426|NCT00558103|59159258|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
30990427|NCT00558103|59159259|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
30990428|NCT00558103|59159254|FG000|Randomized Treatment Phase|Disease Progression|1|||
30990429|NCT00558103|59159255|FG001|Randomized Treatment Phase|Disease Progression|0|||
30990430|NCT00558103|59159256|FG002|Randomized Treatment Phase|Disease Progression|1|||
30990431|NCT00558103|59159257|FG003|Randomized Treatment Phase|Disease Progression|0|||
30990432|NCT00558103|59159258|FG004|Randomized Treatment Phase|Disease Progression|0|||
30790215|NCT00035555|58803457|FG001|Overall Study|Adverse Event|8|||
30990433|NCT00558103|59159259|FG005|Randomized Treatment Phase|Disease Progression|0|||
30990434|NCT00558103|59159254|FG000|Randomized Treatment Phase|Adverse Event|0|||
30990435|NCT00558103|59159255|FG001|Randomized Treatment Phase|Adverse Event|0|||
30990436|NCT00558103|59159256|FG002|Randomized Treatment Phase|Adverse Event|0|||
30990437|NCT00558103|59159257|FG003|Randomized Treatment Phase|Adverse Event|1|||
30990438|NCT00558103|59159258|FG004|Randomized Treatment Phase|Adverse Event|1|||
30990439|NCT00558103|59159259|FG005|Randomized Treatment Phase|Adverse Event|0|||
30990440|NCT00558103|59159254|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
30990441|NCT00558103|59159255|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
30990442|NCT00558103|59159256|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
30990443|NCT00558103|59159257|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
30990444|NCT00558103|59159258|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
30990445|NCT00558103|59159259|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
30990446|NCT00558103|59159254|FG000|Monotherapy Extension Phase|Disease Progression|0|||
30990447|NCT00558103|59159255|FG001|Monotherapy Extension Phase|Disease Progression|0|||
30990448|NCT00558103|59159256|FG002|Monotherapy Extension Phase|Disease Progression|0|||
30990449|NCT00558103|59159257|FG003|Monotherapy Extension Phase|Disease Progression|0|||
30990450|NCT00558103|59159258|FG004|Monotherapy Extension Phase|Disease Progression|0|||
30990451|NCT00558103|59159259|FG005|Monotherapy Extension Phase|Disease Progression|8|||
30990452|NCT00558025|59159296|FG000|Overall Study|Adverse Event|1|||
30990453|NCT00558025|59159297|FG001|Overall Study|Adverse Event|1|||
30990454|NCT00558025|59159296|FG000|Overall Study|Withdrawal by Subject|2|||
30990455|NCT00558025|59159297|FG001|Overall Study|Withdrawal by Subject|2|||
30990456|NCT00558025|59159296|FG000|Overall Study|Protocol Violation|1|||
30990457|NCT00558025|59159297|FG001|Overall Study|Protocol Violation|0|||
30990458|NCT00557323|59159350|FG000|Overall Study|Death|3|||
30990459|NCT00557323|59159350|FG000|Overall Study|Withdrawal by Subject|2|||
30990460|NCT00557323|59159350|FG000|Overall Study|Administrative change|2|||
30990461|NCT00557245|59159384|FG000|Overall Study|Lost to Follow-up|7|||
30990462|NCT00557245|59159385|FG001|Overall Study|Lost to Follow-up|8|||
30990463|NCT00557245|59159386|FG002|Overall Study|Lost to Follow-up|10|||
30990464|NCT00557245|59159384|FG000|Overall Study|Ineligible|5|||
30990465|NCT00557245|59159385|FG001|Overall Study|Ineligible|4|||
30990466|NCT00557245|59159386|FG002|Overall Study|Ineligible|2|||
30990467|NCT00556075|59159447|FG000|Overall Study|Lost to Follow-up|3|||
30990468|NCT00556075|59159448|FG001|Overall Study|Lost to Follow-up|0|||
30990469|NCT00556075|59159449|FG002|Overall Study|Lost to Follow-up|3|||
30990470|NCT00556075|59159447|FG000|Overall Study|Withdrawal by Subject|3|||
30990471|NCT00556075|59159448|FG001|Overall Study|Withdrawal by Subject|3|||
30990472|NCT00556075|59159449|FG002|Overall Study|Withdrawal by Subject|0|||
30990473|NCT00556075|59159447|FG000|Overall Study|Protocol Violation|1|||
30990474|NCT00556075|59159448|FG001|Overall Study|Protocol Violation|1|||
30990475|NCT00556075|59159449|FG002|Overall Study|Protocol Violation|3|||
30990476|NCT00556075|59159447|FG000|Overall Study|Not eligible|1|||
30990477|NCT00556075|59159448|FG001|Overall Study|Not eligible|1|||
30990478|NCT00556075|59159449|FG002|Overall Study|Not eligible|2|||
30990479|NCT00556075|59159447|FG000|Overall Study|Adverse Event|1|||
30990480|NCT00556075|59159448|FG001|Overall Study|Adverse Event|2|||
30990481|NCT00556075|59159449|FG002|Overall Study|Adverse Event|0|||
30990482|NCT00556075|59159447|FG000|Overall Study|Personal issues|4|||
30990483|NCT00556075|59159448|FG001|Overall Study|Personal issues|1|||
30990484|NCT00556075|59159449|FG002|Overall Study|Personal issues|0|||
30990485|NCT00556075|59159447|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
30990486|NCT00556075|59159448|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
30990487|NCT00556075|59159449|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
30990488|NCT02289690|59159480|FG000|Overall Study|Adverse Event Related to Progression|0|||
30990489|NCT02289690|59159481|FG001|Overall Study|Adverse Event Related to Progression|1|||
30990490|NCT02289690|59159482|FG002|Overall Study|Adverse Event Related to Progression|1|||
30990491|NCT02289690|59159483|FG003|Overall Study|Adverse Event Related to Progression|0|||
30990492|NCT02289690|59159484|FG004|Overall Study|Adverse Event Related to Progression|1|||
30990493|NCT02289690|59159485|FG005|Overall Study|Adverse Event Related to Progression|0|||
30990494|NCT02289690|59159486|FG006|Overall Study|Adverse Event Related to Progression|1|||
30990495|NCT02289690|59159487|FG007|Overall Study|Adverse Event Related to Progression|0|||
30990496|NCT02289690|59159488|FG008|Overall Study|Adverse Event Related to Progression|0|||
30990497|NCT02289690|59159489|FG009|Overall Study|Adverse Event Related to Progression|0|||
30990498|NCT02289690|59159480|FG000|Overall Study|Withdrawal by Subject|1|||
30990499|NCT02289690|59159481|FG001|Overall Study|Withdrawal by Subject|0|||
30990500|NCT02289690|59159482|FG002|Overall Study|Withdrawal by Subject|0|||
30990501|NCT02289690|59159483|FG003|Overall Study|Withdrawal by Subject|0|||
30990502|NCT02289690|59159484|FG004|Overall Study|Withdrawal by Subject|1|||
30990503|NCT02289690|59159485|FG005|Overall Study|Withdrawal by Subject|1|||
30990504|NCT02289690|59159486|FG006|Overall Study|Withdrawal by Subject|0|||
30990505|NCT02289690|59159487|FG007|Overall Study|Withdrawal by Subject|0|||
30990506|NCT02289690|59159488|FG008|Overall Study|Withdrawal by Subject|4|||
30990507|NCT02289690|59159489|FG009|Overall Study|Withdrawal by Subject|2|||
30990508|NCT02289690|59159480|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
30990509|NCT02289690|59159481|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
30990510|NCT02289690|59159482|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
30990511|NCT02289690|59159483|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
30990512|NCT02289690|59159484|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
30990513|NCT02289690|59159485|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
30990514|NCT02289690|59159486|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
30990515|NCT02289690|59159487|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
30990516|NCT02289690|59159488|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
30990517|NCT02289690|59159489|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
30990518|NCT02289690|59159480|FG000|Overall Study|Lost to Follow-up|0|||
30990519|NCT02289690|59159481|FG001|Overall Study|Lost to Follow-up|0|||
30990520|NCT02289690|59159482|FG002|Overall Study|Lost to Follow-up|0|||
30990521|NCT02289690|59159483|FG003|Overall Study|Lost to Follow-up|0|||
30990522|NCT02289690|59159484|FG004|Overall Study|Lost to Follow-up|0|||
30990523|NCT02289690|59159485|FG005|Overall Study|Lost to Follow-up|0|||
30990524|NCT02289690|59159486|FG006|Overall Study|Lost to Follow-up|0|||
30990525|NCT02289690|59159487|FG007|Overall Study|Lost to Follow-up|1|||
30990526|NCT02289690|59159488|FG008|Overall Study|Lost to Follow-up|0|||
30990527|NCT02289690|59159489|FG009|Overall Study|Lost to Follow-up|2|||
30990528|NCT02289690|59159480|FG000|Overall Study|Death|0|||
30990529|NCT02289690|59159481|FG001|Overall Study|Death|0|||
30990530|NCT02289690|59159482|FG002|Overall Study|Death|0|||
30990531|NCT02289690|59159483|FG003|Overall Study|Death|0|||
30990532|NCT02289690|59159484|FG004|Overall Study|Death|0|||
30990533|NCT02289690|59159485|FG005|Overall Study|Death|0|||
30990534|NCT02289690|59159486|FG006|Overall Study|Death|0|||
30990535|NCT02289690|59159487|FG007|Overall Study|Death|49|||
30990536|NCT02289690|59159488|FG008|Overall Study|Death|45|||
30990537|NCT02289690|59159489|FG009|Overall Study|Death|41|||
30990538|NCT02289690|59159480|FG000|Overall Study|Sponsor Discontinued Study|0|||
30990539|NCT02289690|59159481|FG001|Overall Study|Sponsor Discontinued Study|0|||
30990540|NCT02289690|59159482|FG002|Overall Study|Sponsor Discontinued Study|0|||
30990541|NCT02289690|59159483|FG003|Overall Study|Sponsor Discontinued Study|0|||
30990542|NCT02289690|59159484|FG004|Overall Study|Sponsor Discontinued Study|0|||
30990543|NCT02289690|59159485|FG005|Overall Study|Sponsor Discontinued Study|0|||
30990544|NCT02289690|59159486|FG006|Overall Study|Sponsor Discontinued Study|0|||
30990545|NCT02289690|59159487|FG007|Overall Study|Sponsor Discontinued Study|9|||
30990546|NCT02289690|59159488|FG008|Overall Study|Sponsor Discontinued Study|7|||
30990547|NCT02289690|59159489|FG009|Overall Study|Sponsor Discontinued Study|15|||
30990548|NCT02289690|59159480|FG000|Overall Study|Other|0|||
30990549|NCT02289690|59159481|FG001|Overall Study|Other|0|||
30990550|NCT02289690|59159482|FG002|Overall Study|Other|0|||
30990551|NCT02289690|59159483|FG003|Overall Study|Other|1|||
30990552|NCT02289690|59159484|FG004|Overall Study|Other|1|||
30990553|NCT02289690|59159485|FG005|Overall Study|Other|0|||
30990554|NCT02289690|59159486|FG006|Overall Study|Other|1|||
30990555|NCT02289690|59159487|FG007|Overall Study|Other|2|||
30990556|NCT02289690|59159488|FG008|Overall Study|Other|3|||
30990557|NCT02289690|59159489|FG009|Overall Study|Other|1|||
30990558|NCT02289456|59159592|FG000|Induction Period|Death|2|||
30990559|NCT02289456|59159592|FG000|Induction Period|Adverse Event|11|||
30990560|NCT02289456|59159592|FG000|Induction Period|Progressive Disease (PD)|4|||
30990561|NCT02289456|59159592|FG000|Induction Period|Symptomatic Deterioration|4|||
30990562|NCT02289456|59159592|FG000|Induction Period|Withdrawal by Subject|2|||
30990563|NCT02289456|59159592|FG000|Induction Period|Miscellaneous|1|||
30990564|NCT02289456|59159592|FG000|Monotherapy Period|Death|1|||
30990565|NCT02289456|59159592|FG000|Monotherapy Period|Adverse Event|1|||
30990566|NCT02289456|59159592|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
30990567|NCT02289456|59159592|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
30990568|NCT02289456|59159592|FG000|Monotherapy Period|Withdrawal by Subject|2|||
30990569|NCT02289456|59159592|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
30990570|NCT02289456|59159592|FG000|Monotherapy Period|Miscellaneous|1|||
30990571|NCT02274948|59159641|FG000|Overall Study|Lost to Follow-up|28|||
30990572|NCT02274948|59159642|FG001|Overall Study|Lost to Follow-up|25|||
30990573|NCT02274948|59159641|FG000|Overall Study|Withdrawal by Subject|64|||
30990574|NCT02274948|59159642|FG001|Overall Study|Withdrawal by Subject|58|||
30990575|NCT02274948|59159641|FG000|Overall Study|Stopped on family Practitioner advice|2|||
30990576|NCT02274948|59159642|FG001|Overall Study|Stopped on family Practitioner advice|5|||
30990577|NCT02274948|59159641|FG000|Overall Study|Left the area|4|||
30990578|NCT02274948|59159642|FG001|Overall Study|Left the area|3|||
30990579|NCT02274792|59159658|FG000|Overall Study|Withdrawal by Subject|13|||
30990580|NCT02274792|59159658|FG000|Overall Study|Lost to Follow-up|8|||
30990581|NCT02274792|59159658|FG000|Overall Study|Protocol Specified Criteria|2|||
30990582|NCT02274792|59159658|FG000|Overall Study|Sponsor Decision|2|||
30990583|NCT02274558|59159688|FG000|Overall Study|Adverse Event|2|||
30990584|NCT02274558|59159689|FG001|Overall Study|Adverse Event|4|||
30990585|NCT02274558|59159690|FG002|Overall Study|Adverse Event|2|||
30990586|NCT02274558|59159688|FG000|Overall Study|Non-compliance|2|||
30990587|NCT02274558|59159689|FG001|Overall Study|Non-compliance|1|||
30990588|NCT02274558|59159690|FG002|Overall Study|Non-compliance|0|||
30990589|NCT02274558|59159688|FG000|Overall Study|Withdrawal by Subject|1|||
30990590|NCT02274558|59159689|FG001|Overall Study|Withdrawal by Subject|5|||
30990591|NCT02274558|59159690|FG002|Overall Study|Withdrawal by Subject|4|||
30990592|NCT02274558|59159688|FG000|Overall Study|Death|0|||
30990593|NCT02274558|59159689|FG001|Overall Study|Death|0|||
30990594|NCT02274558|59159690|FG002|Overall Study|Death|1|||
30990595|NCT02274558|59159688|FG000|Overall Study|Lost to Follow-up|2|||
30990596|NCT02274558|59159689|FG001|Overall Study|Lost to Follow-up|1|||
30990597|NCT02274558|59159690|FG002|Overall Study|Lost to Follow-up|1|||
30990598|NCT02274558|59159688|FG000|Overall Study|Physician Decision|0|||
30990599|NCT02274558|59159689|FG001|Overall Study|Physician Decision|2|||
30990600|NCT02274558|59159690|FG002|Overall Study|Physician Decision|1|||
30990601|NCT02287896|59159707|FG000|Second Injection Visit|Withdrawal by Subject|0|||
30990602|NCT02287896|59159708|FG001|Second Injection Visit|Withdrawal by Subject|1|||
30990603|NCT00553501|59159766|FG000|Overall Study|Adverse Event|2|||
30990604|NCT00553501|59159766|FG000|Overall Study|Death|1|||
30990605|NCT00553501|59159766|FG000|Overall Study|Progression|1|||
30990606|NCT02287584|59159794|FG000|the Double-blind Phase|Adverse Event|17|||
30990607|NCT02287584|59159795|FG001|the Double-blind Phase|Adverse Event|17|||
30990608|NCT02287584|59159796|FG002|the Double-blind Phase|Adverse Event|12|||
30990609|NCT02287584|59159797|FG003|the Double-blind Phase|Adverse Event|0|||
30990610|NCT02287584|59159798|FG004|the Double-blind Phase|Adverse Event|0|||
30990611|NCT02287584|59159799|FG005|the Double-blind Phase|Adverse Event|0|||
30990612|NCT02287584|59159794|FG000|the Double-blind Phase|Lack of Efficacy|18|||
30990613|NCT02287584|59159795|FG001|the Double-blind Phase|Lack of Efficacy|8|||
30990614|NCT02287584|59159796|FG002|the Double-blind Phase|Lack of Efficacy|8|||
30990615|NCT02287584|59159797|FG003|the Double-blind Phase|Lack of Efficacy|0|||
30990616|NCT02287584|59159798|FG004|the Double-blind Phase|Lack of Efficacy|0|||
30891830|NCT02389621|58925130|FG000|Posttreatment Period|Withdrawal by Subject|3|||
30891831|NCT02389621|58925131|FG001|Posttreatment Period|Withdrawal by Subject|2|||
30891832|NCT02389621|58925130|FG000|Posttreatment Period|Lost to Follow-up|1|||
30891833|NCT02389621|58925131|FG001|Posttreatment Period|Lost to Follow-up|1|||
30891834|NCT02389621|58925130|FG000|Posttreatment Period|Other - Miscellaneous|2|||
30891835|NCT02389621|58925131|FG001|Posttreatment Period|Other - Miscellaneous|0|||
30891836|NCT02388997|58925143|FG000|Overall Study|Adverse Event|1|||
30891837|NCT02388997|58925144|FG001|Overall Study|Adverse Event|2|||
30891838|NCT02388997|58925143|FG000|Overall Study|Withdrawal by Subject|2|||
30891839|NCT02388997|58925144|FG001|Overall Study|Withdrawal by Subject|1|||
30891840|NCT02388997|58925143|FG000|Overall Study|Lung function exclusion criteria|0|||
30891841|NCT02388997|58925144|FG001|Overall Study|Lung function exclusion criteria|2|||
30891842|NCT02388997|58925143|FG000|Overall Study|Tested positive for virus during run-in|0|||
30891843|NCT02388997|58925144|FG001|Overall Study|Tested positive for virus during run-in|1|||
30891844|NCT02388763|58925150|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
30891845|NCT02388763|58925151|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
30891846|NCT02388763|58925150|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
30891847|NCT02388763|58925151|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
30891848|NCT02388295|58925163|FG000|Dose Escalation Week 1|Adverse Event|1|||
30891849|NCT02388295|58925164|FG001|Dose Escalation Week 1|Adverse Event|2|||
30891850|NCT02388295|58925165|FG002|Dose Escalation Week 1|Adverse Event|1|||
30891851|NCT02388295|58925163|FG000|Dose Escalation Week 1|Determined not eligible|1|||
30891852|NCT02388295|58925164|FG001|Dose Escalation Week 1|Determined not eligible|1|||
30891853|NCT02388295|58925165|FG002|Dose Escalation Week 1|Determined not eligible|1|||
30891854|NCT02388295|58925163|FG000|Dose Escalation Week 2|Protocol Violation|0|||
30891855|NCT02388295|58925164|FG001|Dose Escalation Week 2|Protocol Violation|1|||
30891856|NCT02388295|58925165|FG002|Dose Escalation Week 2|Protocol Violation|0|||
30891857|NCT02388295|58925163|FG000|Dose Escalation Week 2|Determined not eligible|1|||
30891858|NCT02388295|58925164|FG001|Dose Escalation Week 2|Determined not eligible|1|||
30891859|NCT02388295|58925165|FG002|Dose Escalation Week 2|Determined not eligible|1|||
30891860|NCT02388295|58925163|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
30891861|NCT02388295|58925164|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
30891862|NCT02388295|58925165|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
30891863|NCT02345161|58925175|FG000|Overall Study|Withdrawal by Subject|25|||
30891864|NCT02345161|58925176|FG001|Overall Study|Withdrawal by Subject|33|||
30891865|NCT02345161|58925175|FG000|Overall Study|Adverse Event|16|||
30891866|NCT02345161|58925176|FG001|Overall Study|Adverse Event|19|||
30990617|NCT02287584|59159799|FG005|the Double-blind Phase|Lack of Efficacy|0|||
30990618|NCT02287584|59159794|FG000|the Double-blind Phase|Lost to Follow-up|0|||
30990619|NCT02287584|59159795|FG001|the Double-blind Phase|Lost to Follow-up|1|||
30990620|NCT02287584|59159796|FG002|the Double-blind Phase|Lost to Follow-up|1|||
30990621|NCT02287584|59159797|FG003|the Double-blind Phase|Lost to Follow-up|0|||
30990622|NCT02287584|59159798|FG004|the Double-blind Phase|Lost to Follow-up|0|||
30990623|NCT02287584|59159799|FG005|the Double-blind Phase|Lost to Follow-up|0|||
30891867|NCT02345161|58925175|FG000|Overall Study|Physician Decision|4|||
30891868|NCT02345161|58925176|FG001|Overall Study|Physician Decision|4|||
30990624|NCT02287584|59159794|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
30990625|NCT02287584|59159795|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
30990626|NCT02287584|59159796|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
30990627|NCT02287584|59159797|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
30990628|NCT02287584|59159798|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
30990629|NCT02287584|59159799|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
30990630|NCT02287584|59159794|FG000|the Double-blind Phase|Pregnancy|0|||
30990631|NCT02287584|59159795|FG001|the Double-blind Phase|Pregnancy|1|||
30990632|NCT02287584|59159796|FG002|the Double-blind Phase|Pregnancy|0|||
30990633|NCT02287584|59159797|FG003|the Double-blind Phase|Pregnancy|0|||
30990634|NCT02287584|59159798|FG004|the Double-blind Phase|Pregnancy|0|||
30990635|NCT02287584|59159799|FG005|the Double-blind Phase|Pregnancy|0|||
30990636|NCT02287584|59159794|FG000|the Double-blind Phase|Protocol Violation|0|||
30990637|NCT02287584|59159795|FG001|the Double-blind Phase|Protocol Violation|3|||
30990638|NCT02287584|59159796|FG002|the Double-blind Phase|Protocol Violation|0|||
30990639|NCT02287584|59159797|FG003|the Double-blind Phase|Protocol Violation|0|||
30990640|NCT02287584|59159798|FG004|the Double-blind Phase|Protocol Violation|0|||
30990641|NCT02287584|59159799|FG005|the Double-blind Phase|Protocol Violation|0|||
30990642|NCT02287584|59159794|FG000|the Double-blind Phase|other reasons|0|||
30990643|NCT02287584|59159795|FG001|the Double-blind Phase|other reasons|0|||
30990644|NCT02287584|59159796|FG002|the Double-blind Phase|other reasons|1|||
30990645|NCT02287584|59159797|FG003|the Double-blind Phase|other reasons|0|||
30990646|NCT02287584|59159798|FG004|the Double-blind Phase|other reasons|0|||
30990647|NCT02287584|59159799|FG005|the Double-blind Phase|other reasons|0|||
30990648|NCT02287584|59159794|FG000|the Open-label Phase|Did not receive drug|0|||
30990649|NCT02287584|59159795|FG001|the Open-label Phase|Did not receive drug|0|||
30990650|NCT02287584|59159796|FG002|the Open-label Phase|Did not receive drug|0|||
30990651|NCT02287584|59159797|FG003|the Open-label Phase|Did not receive drug|7|||
30990652|NCT02287584|59159798|FG004|the Open-label Phase|Did not receive drug|6|||
30990653|NCT02287584|59159799|FG005|the Open-label Phase|Did not receive drug|4|||
30990654|NCT02287584|59159794|FG000|the Open-label Phase|Adverse Event|0|||
30990655|NCT02287584|59159795|FG001|the Open-label Phase|Adverse Event|0|||
30990656|NCT02287584|59159796|FG002|the Open-label Phase|Adverse Event|0|||
30990657|NCT02287584|59159797|FG003|the Open-label Phase|Adverse Event|15|||
30990658|NCT02287584|59159798|FG004|the Open-label Phase|Adverse Event|12|||
30990659|NCT02287584|59159799|FG005|the Open-label Phase|Adverse Event|16|||
30990660|NCT02287584|59159794|FG000|the Open-label Phase|Lack of Efficacy|0|||
30990661|NCT02287584|59159795|FG001|the Open-label Phase|Lack of Efficacy|0|||
30990662|NCT02287584|59159796|FG002|the Open-label Phase|Lack of Efficacy|0|||
30990663|NCT02287584|59159797|FG003|the Open-label Phase|Lack of Efficacy|8|||
30990664|NCT02287584|59159798|FG004|the Open-label Phase|Lack of Efficacy|3|||
30990665|NCT02287584|59159799|FG005|the Open-label Phase|Lack of Efficacy|7|||
30990666|NCT02287584|59159794|FG000|the Open-label Phase|Lost to Follow-up|0|||
30990667|NCT02287584|59159795|FG001|the Open-label Phase|Lost to Follow-up|0|||
30990668|NCT02287584|59159796|FG002|the Open-label Phase|Lost to Follow-up|0|||
30990669|NCT02287584|59159797|FG003|the Open-label Phase|Lost to Follow-up|4|||
30990670|NCT02287584|59159798|FG004|the Open-label Phase|Lost to Follow-up|1|||
30990671|NCT02287584|59159799|FG005|the Open-label Phase|Lost to Follow-up|2|||
30990672|NCT02287584|59159794|FG000|the Open-label Phase|Withdrawal by Subject|0|||
30990673|NCT02287584|59159795|FG001|the Open-label Phase|Withdrawal by Subject|0|||
30990674|NCT02287584|59159796|FG002|the Open-label Phase|Withdrawal by Subject|0|||
30990675|NCT02287584|59159797|FG003|the Open-label Phase|Withdrawal by Subject|18|||
30990676|NCT02287584|59159798|FG004|the Open-label Phase|Withdrawal by Subject|29|||
30990677|NCT02287584|59159799|FG005|the Open-label Phase|Withdrawal by Subject|21|||
30990678|NCT02287584|59159794|FG000|the Open-label Phase|non-compliance|0|||
30990679|NCT02287584|59159795|FG001|the Open-label Phase|non-compliance|0|||
30990680|NCT02287584|59159796|FG002|the Open-label Phase|non-compliance|0|||
30990681|NCT02287584|59159797|FG003|the Open-label Phase|non-compliance|2|||
30990682|NCT02287584|59159798|FG004|the Open-label Phase|non-compliance|5|||
30990683|NCT02287584|59159799|FG005|the Open-label Phase|non-compliance|1|||
30990684|NCT02287584|59159794|FG000|the Open-label Phase|other reasons|0|||
30990685|NCT02287584|59159795|FG001|the Open-label Phase|other reasons|0|||
30990686|NCT02287584|59159796|FG002|the Open-label Phase|other reasons|0|||
30990687|NCT02287584|59159797|FG003|the Open-label Phase|other reasons|3|||
30990688|NCT02287584|59159798|FG004|the Open-label Phase|other reasons|6|||
30990689|NCT02287584|59159799|FG005|the Open-label Phase|other reasons|6|||
30990690|NCT00553267|59159832|FG000|Overall Study|Adverse Event|8|||
30990691|NCT00553267|59159833|FG001|Overall Study|Adverse Event|10|||
30990692|NCT00553267|59159834|FG002|Overall Study|Adverse Event|5|||
30990693|NCT00553267|59159832|FG000|Overall Study|Non compliant with protocol|3|||
30990694|NCT00553267|59159833|FG001|Overall Study|Non compliant with protocol|3|||
30990695|NCT00553267|59159834|FG002|Overall Study|Non compliant with protocol|2|||
30990696|NCT00553267|59159832|FG000|Overall Study|Lost to Follow-up|0|||
30990697|NCT00553267|59159833|FG001|Overall Study|Lost to Follow-up|0|||
30990698|NCT00553267|59159834|FG002|Overall Study|Lost to Follow-up|1|||
30990699|NCT00553267|59159832|FG000|Overall Study|Consent withdrawn|2|||
30990700|NCT00553267|59159833|FG001|Overall Study|Consent withdrawn|3|||
30990701|NCT00553267|59159834|FG002|Overall Study|Consent withdrawn|1|||
30990702|NCT00553267|59159832|FG000|Overall Study|Specified category|1|||
30990703|NCT00553267|59159833|FG001|Overall Study|Specified category|2|||
30990704|NCT00553267|59159834|FG002|Overall Study|Specified category|1|||
30990705|NCT02271984|59159848|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
30990706|NCT02271984|59159849|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
30990707|NCT02271984|59159850|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
30990708|NCT02271984|59159851|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
30990709|NCT02271984|59159852|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
30990710|NCT02271984|59159853|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
30990711|NCT02271984|59159854|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
30990712|NCT02271984|59159855|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
30990713|NCT02271984|59159856|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
30990714|NCT02271984|59159857|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
30990715|NCT02271984|59159858|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
30990716|NCT02271984|59159859|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
30990717|NCT02287038|59159910|FG000|Overall Study|Stopped attending appointments|3|||
30990718|NCT02287038|59159911|FG001|Overall Study|Stopped attending appointments|2|||
30990719|NCT02287038|59159910|FG000|Overall Study|Anxiety after starting medication|0|||
30990720|NCT02287038|59159911|FG001|Overall Study|Anxiety after starting medication|1|||
30990721|NCT02287038|59159910|FG000|Overall Study|Nausea after starting medication|1|||
30990722|NCT02287038|59159911|FG001|Overall Study|Nausea after starting medication|0|||
30990723|NCT02287038|59159910|FG000|Overall Study|Abnormal ECG after starting medication|1|||
30990724|NCT02287038|59159911|FG001|Overall Study|Abnormal ECG after starting medication|0|||
30990725|NCT02286960|59159921|FG000|Overall Study|Lost to Follow-up|3|||
30990726|NCT02286960|59159922|FG001|Overall Study|Lost to Follow-up|3|||
30990727|NCT02286102|59159939|FG000|Overall Study|Screen Failure|1|||
30990728|NCT02286102|59159940|FG001|Overall Study|Screen Failure|1|||
30990729|NCT02285166|59159946|FG000|Overall Study|Case Report Forms Uncollected|564|||
30990730|NCT02285166|59159946|FG000|Overall Study|Protocol Deviation|402|||
30990731|NCT00555061|59160009|FG000|Overall Study|Adverse Event|3|||
30990732|NCT00555061|59160009|FG000|Overall Study|Protocol Violation|1|||
30990733|NCT00555061|59160009|FG000|Overall Study|Lost to Follow-up|2|||
30990734|NCT00555061|59160009|FG000|Overall Study|Withdrawal by Subject|2|||
30990735|NCT00555061|59160009|FG000|Overall Study|Participant enrolled, but never treated|1|||
30990736|NCT01642212|59160027|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
30990737|NCT01642212|59160028|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
30990738|NCT01642212|59160029|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
30990739|NCT01642212|59160030|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
30990740|NCT01642212|59160031|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
30990741|NCT01642212|59160027|FG000|Double-blind Treatment|Other|0|||
30990742|NCT01642212|59160028|FG001|Double-blind Treatment|Other|2|||
30990743|NCT01642212|59160029|FG002|Double-blind Treatment|Other|1|||
30990744|NCT01642212|59160030|FG003|Double-blind Treatment|Other|0|||
30990745|NCT01642212|59160031|FG004|Double-blind Treatment|Other|0|||
30990746|NCT01642212|59160027|FG000|Double-blind Treatment|Non-compliance|0|||
30990747|NCT01642212|59160028|FG001|Double-blind Treatment|Non-compliance|1|||
30990748|NCT01642212|59160029|FG002|Double-blind Treatment|Non-compliance|0|||
30990749|NCT01642212|59160030|FG003|Double-blind Treatment|Non-compliance|0|||
30990750|NCT01642212|59160031|FG004|Double-blind Treatment|Non-compliance|0|||
30990751|NCT01642212|59160027|FG000|Double-blind Treatment|Adverse Event|0|||
30990752|NCT01642212|59160028|FG001|Double-blind Treatment|Adverse Event|0|||
30990753|NCT01642212|59160029|FG002|Double-blind Treatment|Adverse Event|1|||
30990754|NCT01642212|59160030|FG003|Double-blind Treatment|Adverse Event|0|||
30990755|NCT01642212|59160031|FG004|Double-blind Treatment|Adverse Event|0|||
30990756|NCT01642212|59160027|FG000|Open-label Extension|Adverse Event|0|||
30990757|NCT01642212|59160028|FG001|Open-label Extension|Adverse Event|0|||
30990758|NCT01642212|59160029|FG002|Open-label Extension|Adverse Event|0|||
30990759|NCT01642212|59160030|FG003|Open-label Extension|Adverse Event|3|||
30990760|NCT01642212|59160031|FG004|Open-label Extension|Adverse Event|0|||
30990761|NCT01642212|59160027|FG000|Open-label Extension|Sponsor Decision|0|||
30990762|NCT01642212|59160028|FG001|Open-label Extension|Sponsor Decision|0|||
30990763|NCT01642212|59160029|FG002|Open-label Extension|Sponsor Decision|0|||
30990764|NCT01642212|59160030|FG003|Open-label Extension|Sponsor Decision|7|||
30990765|NCT01642212|59160031|FG004|Open-label Extension|Sponsor Decision|4|||
30990766|NCT01642212|59160027|FG000|Open-label Extension|Consent Withdrawn|0|||
30990767|NCT01642212|59160028|FG001|Open-label Extension|Consent Withdrawn|0|||
30990768|NCT01642212|59160029|FG002|Open-label Extension|Consent Withdrawn|0|||
30990769|NCT01642212|59160030|FG003|Open-label Extension|Consent Withdrawn|0|||
30990770|NCT01642212|59160031|FG004|Open-label Extension|Consent Withdrawn|2|||
30990771|NCT01642212|59160027|FG000|Open-label Extension|Lost to Follow-up|0|||
30990772|NCT01642212|59160028|FG001|Open-label Extension|Lost to Follow-up|0|||
30990773|NCT01642212|59160029|FG002|Open-label Extension|Lost to Follow-up|0|||
30990774|NCT01642212|59160030|FG003|Open-label Extension|Lost to Follow-up|0|||
30990775|NCT01642212|59160031|FG004|Open-label Extension|Lost to Follow-up|1|||
30990776|NCT01642212|59160027|FG000|Open-label Extension|Other|0|||
30990777|NCT01642212|59160028|FG001|Open-label Extension|Other|0|||
30990778|NCT01642212|59160029|FG002|Open-label Extension|Other|0|||
30990779|NCT01642212|59160030|FG003|Open-label Extension|Other|0|||
30990780|NCT01642212|59160031|FG004|Open-label Extension|Other|1|||
30990781|NCT00552175|59160056|FG000|Overall Study|Lack of Efficacy|2|||
30990782|NCT00552175|59160057|FG001|Overall Study|Lack of Efficacy|0|||
30990783|NCT00552175|59160058|FG002|Overall Study|Lack of Efficacy|1|||
30990784|NCT00552175|59160056|FG000|Overall Study|Adverse Event|9|||
30990785|NCT00552175|59160057|FG001|Overall Study|Adverse Event|9|||
30990786|NCT00552175|59160058|FG002|Overall Study|Adverse Event|10|||
30990787|NCT00552175|59160056|FG000|Overall Study|Withdrawal by Subject|2|||
30990788|NCT00552175|59160057|FG001|Overall Study|Withdrawal by Subject|2|||
30990789|NCT00552175|59160058|FG002|Overall Study|Withdrawal by Subject|1|||
30990790|NCT00552175|59160056|FG000|Overall Study|Lost to Follow-up|0|||
30990791|NCT00552175|59160057|FG001|Overall Study|Lost to Follow-up|0|||
30990792|NCT00552175|59160058|FG002|Overall Study|Lost to Follow-up|1|||
30990793|NCT00552175|59160056|FG000|Overall Study|Entry Criteria Not Met|1|||
30990794|NCT00552175|59160057|FG001|Overall Study|Entry Criteria Not Met|1|||
30990795|NCT00552175|59160058|FG002|Overall Study|Entry Criteria Not Met|0|||
30990796|NCT00552175|59160056|FG000|Overall Study|Reason Not Specified|3|||
30990797|NCT00552175|59160057|FG001|Overall Study|Reason Not Specified|1|||
30990798|NCT00552175|59160058|FG002|Overall Study|Reason Not Specified|1|||
30990799|NCT01644474|59160069|FG000|Overall Study|Poor compliance to protocol|1|||
30990800|NCT01644474|59160070|FG001|Overall Study|Poor compliance to protocol|0|||
30990801|NCT01644474|59160069|FG000|Overall Study|Consent withdrawn by participant|0|||
30990802|NCT01644474|59160070|FG001|Overall Study|Consent withdrawn by participant|1|||
30990803|NCT01644474|59160069|FG000|Overall Study|Participant moved|0|||
30990804|NCT01644474|59160070|FG001|Overall Study|Participant moved|1|||
30990805|NCT01644474|59160069|FG000|Overall Study|Adverse Event|4|||
30990806|NCT01644474|59160070|FG001|Overall Study|Adverse Event|5|||
30990807|NCT01644474|59160069|FG000|Overall Study|Site scheduling error|1|||
30990808|NCT01644474|59160070|FG001|Overall Study|Site scheduling error|1|||
30990809|NCT01644474|59160069|FG000|Overall Study|Protocol Violation|1|||
30990810|NCT01644474|59160070|FG001|Overall Study|Protocol Violation|0|||
30990811|NCT02285010|59160105|FG000|Overall Study|not abdominal hysterectomy|2|||
30990812|NCT02285010|59160106|FG001|Overall Study|not abdominal hysterectomy|0|||
30990813|NCT02285010|59160105|FG000|Overall Study|Not spinal anesthesia|3|||
30990814|NCT02285010|59160106|FG001|Overall Study|Not spinal anesthesia|1|||
30990815|NCT00551161|59160150|FG000|Overall Study|Withdrawal by Subject|1|||
30990816|NCT00550771|59160186|FG000|Overall Study|Adverse Event|11|||
30990817|NCT00550771|59160187|FG001|Overall Study|Adverse Event|3|||
30990818|NCT00550771|59160186|FG000|Overall Study|Discontinued for study-related reasons|0|||
30990819|NCT00550771|59160187|FG001|Overall Study|Discontinued for study-related reasons|1|||
30990820|NCT00550771|59160186|FG000|Overall Study|Physician Decision|2|||
30990821|NCT00550771|59160187|FG001|Overall Study|Physician Decision|0|||
30990822|NCT00550771|59160186|FG000|Overall Study|Withdrawal by Subject|0|||
30990823|NCT00550771|59160187|FG001|Overall Study|Withdrawal by Subject|1|||
30990824|NCT00550771|59160186|FG000|Overall Study|Protocol Violation|4|||
30990825|NCT00550771|59160187|FG001|Overall Study|Protocol Violation|5|||
30990826|NCT00550537|59160220|FG000|Overall Study|Death|18|||
30990827|NCT00550537|59160220|FG000|Overall Study|Adverse Event|20|||
30990828|NCT00550537|59160220|FG000|Overall Study|Disease progression before|46|||
30990829|NCT00550537|59160220|FG000|Overall Study|Withdrawal by Subject|7|||
30990830|NCT00550537|59160220|FG000|Overall Study|Change in treatment plan|4|||
30990831|NCT00550537|59160220|FG000|Overall Study|Other complicating ilness|3|||
30990832|NCT00550537|59160220|FG000|Overall Study|Declining performance status|2|||
30990833|NCT00550537|59160220|FG000|Overall Study|Treated closer to home|4|||
30990834|NCT00550147|59160238|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
30990835|NCT00550147|59160238|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
30990836|NCT00550147|59160238|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
30990837|NCT00550147|59160238|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
30990838|NCT00550147|59160238|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
30990839|NCT00550459|59160449|FG000|Overall Study|Adverse Event|0|||
30990840|NCT00550459|59160450|FG001|Overall Study|Adverse Event|2|||
30990841|NCT00550459|59160449|FG000|Overall Study|Withdrawal by Subject|1|||
30990842|NCT00550459|59160450|FG001|Overall Study|Withdrawal by Subject|1|||
30990843|NCT01643928|59160749|FG000|Overall Study|Lost to Follow-up|1|||
30990844|NCT01643928|59160750|FG001|Overall Study|Lost to Follow-up|0|||
30990845|NCT01643928|59160751|FG002|Overall Study|Lost to Follow-up|2|||
30990846|NCT01643928|59160752|FG003|Overall Study|Lost to Follow-up|0|||
30990847|NCT01643928|59160753|FG004|Overall Study|Lost to Follow-up|0|||
30990848|NCT01643928|59160749|FG000|Overall Study|Withdrawal by Subject|2|||
30990849|NCT01643928|59160750|FG001|Overall Study|Withdrawal by Subject|0|||
30990850|NCT01643928|59160751|FG002|Overall Study|Withdrawal by Subject|0|||
30990851|NCT01643928|59160752|FG003|Overall Study|Withdrawal by Subject|1|||
30990852|NCT01643928|59160753|FG004|Overall Study|Withdrawal by Subject|0|||
30990853|NCT01643928|59160749|FG000|Overall Study|Pregnancy|0|||
30990854|NCT01643928|59160750|FG001|Overall Study|Pregnancy|0|||
30990855|NCT01643928|59160751|FG002|Overall Study|Pregnancy|0|||
30990856|NCT01643928|59160752|FG003|Overall Study|Pregnancy|1|||
30990857|NCT01643928|59160753|FG004|Overall Study|Pregnancy|0|||
30990858|NCT01643928|59160749|FG000|Overall Study|Other|5|||
30990859|NCT01643928|59160750|FG001|Overall Study|Other|1|||
30990860|NCT01643928|59160751|FG002|Overall Study|Other|1|||
30990861|NCT01643928|59160752|FG003|Overall Study|Other|0|||
30990862|NCT01643928|59160753|FG004|Overall Study|Other|0|||
30990863|NCT01643928|59160749|FG000|Overall Study|Adverse Event|2|||
30990864|NCT01643928|59160750|FG001|Overall Study|Adverse Event|1|||
30990865|NCT01643928|59160751|FG002|Overall Study|Adverse Event|0|||
30990866|NCT01643928|59160752|FG003|Overall Study|Adverse Event|1|||
30990867|NCT01643928|59160753|FG004|Overall Study|Adverse Event|2|||
30990868|NCT03237845|59160964|FG000|Overall Study|Adverse Event|0|||
30990869|NCT03237845|59160965|FG001|Overall Study|Adverse Event|1|||
30990870|NCT03237845|59160964|FG000|Overall Study|Lost to Follow-up|13|||
30990871|NCT03237845|59160965|FG001|Overall Study|Lost to Follow-up|10|||
30990872|NCT03237845|59160964|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
30990873|NCT03237845|59160965|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
30990874|NCT03237845|59160964|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
30990875|NCT03237845|59160965|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
30990876|NCT03237845|59160964|FG000|Overall Study|Physician Decision|1|||
30990877|NCT03237845|59160965|FG001|Overall Study|Physician Decision|2|||
30990878|NCT03237845|59160964|FG000|Overall Study|Pregnancy|1|||
30990879|NCT03237845|59160965|FG001|Overall Study|Pregnancy|0|||
30990880|NCT03237845|59160964|FG000|Overall Study|Protocol Deviation|0|||
30990881|NCT03237845|59160965|FG001|Overall Study|Protocol Deviation|1|||
30990882|NCT03237845|59160964|FG000|Overall Study|Technical Problems|8|||
30990883|NCT03237845|59160965|FG001|Overall Study|Technical Problems|1|||
30990884|NCT03237845|59160964|FG000|Overall Study|Withdrawal by Subject|3|||
30990885|NCT03237845|59160965|FG001|Overall Study|Withdrawal by Subject|3|||
30990886|NCT03237845|59160964|FG000|Overall Study|Other Reasons|4|||
30990887|NCT03237845|59160965|FG001|Overall Study|Other Reasons|0|||
30990888|NCT01643850|59161052|FG000|Overall Study|Withdrawal by Subject|0|||
30990889|NCT01643850|59161053|FG001|Overall Study|Withdrawal by Subject|0|||
30990890|NCT01643850|59161054|FG002|Overall Study|Withdrawal by Subject|0|||
30990891|NCT01643850|59161055|FG003|Overall Study|Withdrawal by Subject|0|||
30990892|NCT01643850|59161056|FG004|Overall Study|Withdrawal by Subject|1|||
30990893|NCT01643850|59161057|FG005|Overall Study|Withdrawal by Subject|0|||
30990894|NCT01643850|59161058|FG006|Overall Study|Withdrawal by Subject|0|||
30990895|NCT01643850|59161059|FG007|Overall Study|Withdrawal by Subject|0|||
30990896|NCT01643850|59161060|FG008|Overall Study|Withdrawal by Subject|0|||
30990897|NCT01643850|59161052|FG000|Overall Study|Lost to Follow-up|0|||
30990898|NCT01643850|59161053|FG001|Overall Study|Lost to Follow-up|0|||
30990899|NCT01643850|59161054|FG002|Overall Study|Lost to Follow-up|0|||
30990900|NCT01643850|59161055|FG003|Overall Study|Lost to Follow-up|0|||
30990901|NCT01643850|59161056|FG004|Overall Study|Lost to Follow-up|0|||
30990902|NCT01643850|59161057|FG005|Overall Study|Lost to Follow-up|0|||
30990903|NCT01643850|59161058|FG006|Overall Study|Lost to Follow-up|1|||
30990904|NCT01643850|59161059|FG007|Overall Study|Lost to Follow-up|0|||
30990905|NCT01643850|59161060|FG008|Overall Study|Lost to Follow-up|1|||
30990906|NCT01643850|59161052|FG000|Overall Study|Adverse Event|0|||
30990907|NCT01643850|59161053|FG001|Overall Study|Adverse Event|0|||
30990908|NCT01643850|59161054|FG002|Overall Study|Adverse Event|0|||
30990909|NCT01643850|59161055|FG003|Overall Study|Adverse Event|0|||
30990910|NCT01643850|59161056|FG004|Overall Study|Adverse Event|1|||
30990911|NCT01643850|59161057|FG005|Overall Study|Adverse Event|0|||
30990912|NCT01643850|59161058|FG006|Overall Study|Adverse Event|0|||
30990913|NCT01643850|59161059|FG007|Overall Study|Adverse Event|0|||
30990914|NCT01643850|59161060|FG008|Overall Study|Adverse Event|0|||
30990915|NCT01643850|59161052|FG000|Overall Study|Administrative Problems|0|||
30990916|NCT01643850|59161053|FG001|Overall Study|Administrative Problems|0|||
30990917|NCT01643850|59161054|FG002|Overall Study|Administrative Problems|1|||
30990918|NCT01643850|59161055|FG003|Overall Study|Administrative Problems|0|||
30990919|NCT01643850|59161056|FG004|Overall Study|Administrative Problems|1|||
30990920|NCT01643850|59161057|FG005|Overall Study|Administrative Problems|0|||
30990921|NCT01643850|59161058|FG006|Overall Study|Administrative Problems|0|||
30990922|NCT01643850|59161059|FG007|Overall Study|Administrative Problems|0|||
30990923|NCT01643850|59161060|FG008|Overall Study|Administrative Problems|0|||
30990924|NCT02271594|59161128|FG000|Overall Study|Study closed; recruiting failure|19|||
30990925|NCT02271594|59161129|FG001|Overall Study|Study closed; recruiting failure|12|||
30990926|NCT02535923|59161148|FG000|Overall Study|Lost to Follow-up|5|||
30990927|NCT02535923|59161149|FG001|Overall Study|Lost to Follow-up|5|||
30990928|NCT02535923|59161148|FG000|Overall Study|Withdrawal by Subject|4|||
30990929|NCT02535923|59161149|FG001|Overall Study|Withdrawal by Subject|3|||
30990930|NCT02270736|59161158|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
30990931|NCT02270736|59161159|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
30990932|NCT02270736|59161160|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
30990933|NCT02270736|59161161|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
30990934|NCT02270736|59161162|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
30990935|NCT02270736|59161158|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
30990936|NCT02270736|59161159|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
30990937|NCT02270736|59161160|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
30990938|NCT02270736|59161161|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
30990939|NCT02270736|59161162|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
30990940|NCT02270736|59161158|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
30990941|NCT02270736|59161159|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
30990942|NCT02270736|59161160|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
30990943|NCT02270736|59161161|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
30990944|NCT02270736|59161162|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
30990945|NCT02270736|59161158|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
30990946|NCT02270736|59161159|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
30990947|NCT02270736|59161160|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
30990948|NCT02270736|59161161|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
30990949|NCT02270736|59161162|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
30990950|NCT02270736|59161158|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
30990951|NCT02270736|59161159|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
30990952|NCT02270736|59161160|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
30990953|NCT02270736|59161161|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
30990954|NCT02270736|59161162|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
30990955|NCT02270736|59161158|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
30990956|NCT02270736|59161159|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
30990957|NCT02270736|59161160|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
30990958|NCT02270736|59161161|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
30990959|NCT02270736|59161162|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
30990960|NCT02270736|59161158|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
30990961|NCT02270736|59161159|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
30990962|NCT02270736|59161160|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
30990963|NCT02270736|59161161|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
30990964|NCT02270736|59161162|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
30990965|NCT02270736|59161158|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
30990966|NCT02270736|59161159|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
30990967|NCT02270736|59161160|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
30990968|NCT02270736|59161161|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
30990969|NCT02270736|59161162|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
30990970|NCT02270736|59161158|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
30990971|NCT02270736|59161159|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
30990972|NCT02270736|59161160|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
30990973|NCT02270736|59161161|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
30990974|NCT02270736|59161162|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
30990975|NCT02269098|59161177|FG000|Overall Study|Lost to Follow-up|14|||
30990976|NCT02269098|59161178|FG001|Overall Study|Lost to Follow-up|9|||
30990977|NCT02283762|59161322|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
30990978|NCT02283762|59161323|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
30990979|NCT02283762|59161322|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
30990980|NCT02283762|59161323|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
30990981|NCT02283762|59161322|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
30990982|NCT02283762|59161323|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
30990983|NCT02283762|59161322|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
30990984|NCT02283762|59161323|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
30990985|NCT02283762|59161322|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
30990986|NCT02283762|59161323|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
30990987|NCT02283762|59161322|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
30990988|NCT02283762|59161323|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
30990989|NCT02283762|59161322|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
30990990|NCT02283762|59161323|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
30990991|NCT02283762|59161322|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
30990992|NCT02283762|59161323|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
30990993|NCT02283762|59161322|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
30990994|NCT02283762|59161323|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
30990995|NCT02283762|59161322|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
30990996|NCT02283762|59161323|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
30990997|NCT02283762|59161322|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
30990998|NCT02283762|59161323|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
30990999|NCT02283762|59161322|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
30991000|NCT02283762|59161323|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
30991001|NCT02283294|59161423|FG000|Overall Study|Lost to Follow-up|1|||
30991002|NCT02283294|59161424|FG001|Overall Study|Lost to Follow-up|1|||
30991003|NCT02283294|59161423|FG000|Overall Study|Withdrawal by Subject|1|||
30991004|NCT02283294|59161424|FG001|Overall Study|Withdrawal by Subject|6|||
30991005|NCT02283294|59161423|FG000|Overall Study|Protocol Violation|1|||
30991006|NCT02283294|59161424|FG001|Overall Study|Protocol Violation|0|||
30991007|NCT02283294|59161423|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
30991008|NCT02283294|59161424|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
30991009|NCT02282982|59161440|FG000|Overall Study|Lost to Follow-up|15|||
30991010|NCT02282982|59161440|FG000|Overall Study|Withdrew consent|2|||
30991011|NCT02282982|59161440|FG000|Overall Study|Death|4|||
30991012|NCT02282982|59161440|FG000|Overall Study|Lack of product|156|||
30991013|NCT02282982|59161440|FG000|Overall Study|Palivizumab is ended|11|||
30991014|NCT02282982|59161440|FG000|Overall Study|Other, not specified|18|||
30991015|NCT02268864|59161482|FG000|Overall Study|Withdrawal by Subject|2|||
30991016|NCT02268864|59161483|FG001|Overall Study|Withdrawal by Subject|0|||
30991017|NCT02268864|59161484|FG002|Overall Study|Withdrawal by Subject|0|||
30991018|NCT02268864|59161482|FG000|Overall Study|Death|0|||
30991019|NCT02268864|59161483|FG001|Overall Study|Death|1|||
30991020|NCT02268864|59161484|FG002|Overall Study|Death|0|||
30991021|NCT02268786|59161513|FG000|Overall Study|No Euploid Embryos available|42|||
30991022|NCT02268786|59161514|FG001|Overall Study|No Euploid Embryos available|0|||
30991023|NCT02268786|59161513|FG000|Overall Study|Withdrawal by Subject|7|||
30991024|NCT02268786|59161514|FG001|Overall Study|Withdrawal by Subject|14|||
30991025|NCT02268786|59161513|FG000|Overall Study|Thaw Failure|6|||
30991026|NCT02268786|59161514|FG001|Overall Study|Thaw Failure|4|||
30991027|NCT02268786|59161513|FG000|Overall Study|Protocol Violation|1|||
30991028|NCT02268786|59161514|FG001|Overall Study|Protocol Violation|0|||
30991029|NCT02268396|59161529|FG000|Overall Study|Adverse Event|3|||
30991030|NCT02268396|59161529|FG000|Overall Study|Administrative|2|||
30991031|NCT02268396|59161529|FG000|Overall Study|Withdrawal by Subject|1|||
30991032|NCT02268396|59161529|FG000|Overall Study|Lost to Follow-up|2|||
30991033|NCT02268396|59161529|FG000|Overall Study|Protocol-Specified Criteria|2|||
30991034|NCT02268396|59161529|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
30991035|NCT02268084|59161535|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
30991036|NCT02268084|59161536|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
30991037|NCT02268084|59161535|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
30991038|NCT02268084|59161536|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
30991039|NCT01643772|59161565|FG000|Overall Study|Protocol Violation|0|||
30991040|NCT01643772|59161566|FG001|Overall Study|Protocol Violation|0|||
30991041|NCT01643772|59161567|FG002|Overall Study|Protocol Violation|0|||
30991042|NCT01643772|59161568|FG003|Overall Study|Protocol Violation|1|||
30991043|NCT01643772|59161565|FG000|Overall Study|Adverse Event|0|||
30790216|NCT00035555|58803458|FG002|Overall Study|Adverse Event|9|||
30991044|NCT01643772|59161566|FG001|Overall Study|Adverse Event|0|||
30991045|NCT01643772|59161567|FG002|Overall Study|Adverse Event|0|||
30991046|NCT01643772|59161568|FG003|Overall Study|Adverse Event|1|||
30991047|NCT02265744|59161671|FG000|Overall Study|Poor/Non-compliance|1|||
30991048|NCT02265744|59161672|FG001|Overall Study|Poor/Non-compliance|1|||
30991049|NCT02265744|59161673|FG002|Overall Study|Poor/Non-compliance|0|||
30991050|NCT02265744|59161674|FG003|Overall Study|Poor/Non-compliance|0|||
30991051|NCT02265744|59161675|FG004|Overall Study|Poor/Non-compliance|2|||
30991052|NCT02265744|59161671|FG000|Overall Study|Lost to Follow-up|0|||
30991053|NCT02265744|59161672|FG001|Overall Study|Lost to Follow-up|0|||
30991054|NCT02265744|59161673|FG002|Overall Study|Lost to Follow-up|0|||
30991055|NCT02265744|59161674|FG003|Overall Study|Lost to Follow-up|1|||
30991056|NCT02265744|59161675|FG004|Overall Study|Lost to Follow-up|0|||
30991057|NCT02265744|59161671|FG000|Overall Study|Death|0|||
30991058|NCT02265744|59161672|FG001|Overall Study|Death|0|||
30991059|NCT02265744|59161673|FG002|Overall Study|Death|0|||
30991060|NCT02265744|59161674|FG003|Overall Study|Death|2|||
30991061|NCT02265744|59161675|FG004|Overall Study|Death|0|||
30991062|NCT02265744|59161671|FG000|Overall Study|Withdrawal by Subject|2|||
30991063|NCT02265744|59161672|FG001|Overall Study|Withdrawal by Subject|0|||
30991064|NCT02265744|59161673|FG002|Overall Study|Withdrawal by Subject|0|||
30991065|NCT02265744|59161674|FG003|Overall Study|Withdrawal by Subject|2|||
30991066|NCT02265744|59161675|FG004|Overall Study|Withdrawal by Subject|0|||
30991067|NCT02265744|59161671|FG000|Overall Study|Participant request to discontinue|2|||
30991068|NCT02265744|59161672|FG001|Overall Study|Participant request to discontinue|2|||
30991069|NCT02265744|59161673|FG002|Overall Study|Participant request to discontinue|2|||
30991070|NCT02265744|59161674|FG003|Overall Study|Participant request to discontinue|0|||
30991071|NCT02265744|59161675|FG004|Overall Study|Participant request to discontinue|0|||
30991072|NCT02265744|59161671|FG000|Overall Study|Adverse Event|8|||
30991073|NCT02265744|59161672|FG001|Overall Study|Adverse Event|4|||
30991074|NCT02265744|59161673|FG002|Overall Study|Adverse Event|9|||
30991075|NCT02265744|59161674|FG003|Overall Study|Adverse Event|8|||
30991076|NCT02265744|59161675|FG004|Overall Study|Adverse Event|2|||
30991077|NCT02265744|59161671|FG000|Overall Study|Lack of Efficacy|2|||
30991078|NCT02265744|59161672|FG001|Overall Study|Lack of Efficacy|4|||
30991079|NCT02265744|59161673|FG002|Overall Study|Lack of Efficacy|3|||
30991080|NCT02265744|59161674|FG003|Overall Study|Lack of Efficacy|4|||
30991081|NCT02265744|59161675|FG004|Overall Study|Lack of Efficacy|5|||
30991082|NCT02265744|59161671|FG000|Overall Study|Reason not provided by Investigator|1|||
30991083|NCT02265744|59161672|FG001|Overall Study|Reason not provided by Investigator|0|||
30991084|NCT02265744|59161673|FG002|Overall Study|Reason not provided by Investigator|0|||
30991085|NCT02265744|59161674|FG003|Overall Study|Reason not provided by Investigator|2|||
30991086|NCT02265744|59161675|FG004|Overall Study|Reason not provided by Investigator|0|||
30991087|NCT02265744|59161671|FG000|Overall Study|Administrative reason by sponsor|3|||
30991088|NCT02265744|59161672|FG001|Overall Study|Administrative reason by sponsor|2|||
30991089|NCT02265744|59161673|FG002|Overall Study|Administrative reason by sponsor|2|||
30991090|NCT02265744|59161674|FG003|Overall Study|Administrative reason by sponsor|3|||
30991091|NCT02265744|59161675|FG004|Overall Study|Administrative reason by sponsor|3|||
30991092|NCT02265744|59161671|FG000|Overall Study|Subject no longer meets study criteria|0|||
30991093|NCT02265744|59161672|FG001|Overall Study|Subject no longer meets study criteria|0|||
30991094|NCT02265744|59161673|FG002|Overall Study|Subject no longer meets study criteria|0|||
30991095|NCT02265744|59161674|FG003|Overall Study|Subject no longer meets study criteria|0|||
30991096|NCT02265744|59161675|FG004|Overall Study|Subject no longer meets study criteria|1|||
30991097|NCT02265744|59161671|FG000|Overall Study|Pregnancy|1|||
30991098|NCT02265744|59161672|FG001|Overall Study|Pregnancy|2|||
30991099|NCT02265744|59161673|FG002|Overall Study|Pregnancy|1|||
30991100|NCT02265744|59161674|FG003|Overall Study|Pregnancy|1|||
30991101|NCT02265744|59161675|FG004|Overall Study|Pregnancy|0|||
30991102|NCT00085735|59161704|FG000|Overall Study|Adverse Event|1|||
30991103|NCT00085735|59161705|FG001|Overall Study|Adverse Event|0|||
30991104|NCT00085735|59161706|FG002|Overall Study|Adverse Event|0|||
30991105|NCT00085735|59161707|FG003|Overall Study|Adverse Event|0|||
30991106|NCT00085735|59161708|FG004|Overall Study|Adverse Event|0|||
30991107|NCT00085735|59161709|FG005|Overall Study|Adverse Event|0|||
30991108|NCT00085735|59161704|FG000|Overall Study|Lack of Efficacy|2|||
30991109|NCT00085735|59161705|FG001|Overall Study|Lack of Efficacy|4|||
30991110|NCT00085735|59161706|FG002|Overall Study|Lack of Efficacy|6|||
30991111|NCT00085735|59161707|FG003|Overall Study|Lack of Efficacy|3|||
30991112|NCT00085735|59161708|FG004|Overall Study|Lack of Efficacy|4|||
30991113|NCT00085735|59161709|FG005|Overall Study|Lack of Efficacy|3|||
30991114|NCT00085735|59161704|FG000|Overall Study|Lost to Follow-up|0|||
30991115|NCT00085735|59161705|FG001|Overall Study|Lost to Follow-up|1|||
30991116|NCT00085735|59161706|FG002|Overall Study|Lost to Follow-up|0|||
30991117|NCT00085735|59161707|FG003|Overall Study|Lost to Follow-up|0|||
30991118|NCT00085735|59161708|FG004|Overall Study|Lost to Follow-up|1|||
30991119|NCT00085735|59161709|FG005|Overall Study|Lost to Follow-up|0|||
30991120|NCT00085735|59161704|FG000|Overall Study|Physician Decision|2|||
30991121|NCT00085735|59161705|FG001|Overall Study|Physician Decision|3|||
30991122|NCT00085735|59161706|FG002|Overall Study|Physician Decision|2|||
30991123|NCT00085735|59161707|FG003|Overall Study|Physician Decision|3|||
30991124|NCT00085735|59161708|FG004|Overall Study|Physician Decision|11|||
30991125|NCT00085735|59161709|FG005|Overall Study|Physician Decision|8|||
30991126|NCT00085735|59161704|FG000|Overall Study|Protocol Violation|1|||
30991127|NCT00085735|59161705|FG001|Overall Study|Protocol Violation|0|||
30991128|NCT00085735|59161706|FG002|Overall Study|Protocol Violation|0|||
30991129|NCT00085735|59161707|FG003|Overall Study|Protocol Violation|0|||
30991130|NCT00085735|59161708|FG004|Overall Study|Protocol Violation|0|||
30991131|NCT00085735|59161709|FG005|Overall Study|Protocol Violation|0|||
30991132|NCT00085735|59161704|FG000|Overall Study|Withdrawal by Subject|1|||
30991133|NCT00085735|59161705|FG001|Overall Study|Withdrawal by Subject|0|||
30991134|NCT00085735|59161706|FG002|Overall Study|Withdrawal by Subject|4|||
30991135|NCT00085735|59161707|FG003|Overall Study|Withdrawal by Subject|5|||
30991136|NCT00085735|59161708|FG004|Overall Study|Withdrawal by Subject|7|||
30991137|NCT00085735|59161709|FG005|Overall Study|Withdrawal by Subject|8|||
30991138|NCT00085735|59161704|FG000|Overall Study|Patient ineligible|1|||
30991139|NCT00085735|59161705|FG001|Overall Study|Patient ineligible|0|||
30991140|NCT00085735|59161706|FG002|Overall Study|Patient ineligible|3|||
30991141|NCT00085735|59161707|FG003|Overall Study|Patient ineligible|7|||
30991142|NCT00085735|59161708|FG004|Overall Study|Patient ineligible|17|||
30991143|NCT00085735|59161709|FG005|Overall Study|Patient ineligible|8|||
30991144|NCT00085735|59161704|FG000|Overall Study|Excess residual disease|2|||
30991145|NCT00085735|59161705|FG001|Overall Study|Excess residual disease|2|||
30991146|NCT00085735|59161706|FG002|Overall Study|Excess residual disease|1|||
30991147|NCT00085735|59161707|FG003|Overall Study|Excess residual disease|1|||
30991148|NCT00085735|59161708|FG004|Overall Study|Excess residual disease|1|||
30991149|NCT00085735|59161709|FG005|Overall Study|Excess residual disease|4|||
30991150|NCT00085735|59161704|FG000|Overall Study|Reason not documented|1|||
30991151|NCT00085735|59161705|FG001|Overall Study|Reason not documented|0|||
30991152|NCT00085735|59161706|FG002|Overall Study|Reason not documented|1|||
30991153|NCT00085735|59161707|FG003|Overall Study|Reason not documented|0|||
30991154|NCT00085735|59161708|FG004|Overall Study|Reason not documented|1|||
30991155|NCT00085735|59161709|FG005|Overall Study|Reason not documented|0|||
30991156|NCT00085735|59161704|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
30991157|NCT00085735|59161705|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
30991158|NCT00085735|59161706|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
30991159|NCT00085735|59161707|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
30991160|NCT00085735|59161708|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
30991161|NCT00085735|59161709|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
30991162|NCT04537793|59162011|FG000|Part B (24 Weeks)|Adverse Event|0|||
30991163|NCT04537793|59162012|FG001|Part B (24 Weeks)|Adverse Event|1|||
30991164|NCT01938001|59163270|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
30991165|NCT01938001|59163271|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
30991166|NCT01938001|59163270|FG000|Pre-Treatment|Death|1|||
30991167|NCT01938001|59163271|FG001|Pre-Treatment|Death|0|||
30991168|NCT01938001|59163270|FG000|Treatment|Death|2|||
30991169|NCT01938001|59163271|FG001|Treatment|Death|0|||
30991170|NCT01938001|59163270|FG000|Treatment|Adverse Event|14|||
30991171|NCT01938001|59163271|FG001|Treatment|Adverse Event|8|||
30991172|NCT01938001|59163270|FG000|Treatment|Progressive Disease|21|||
30991173|NCT01938001|59163271|FG001|Treatment|Progressive Disease|54|||
30991174|NCT01938001|59163270|FG000|Treatment|Withdrawal by Subject|13|||
30991175|NCT01938001|59163271|FG001|Treatment|Withdrawal by Subject|7|||
30991176|NCT01938001|59163270|FG000|Treatment|Other reasons|2|||
30991177|NCT01938001|59163271|FG001|Treatment|Other reasons|1|||
30991178|NCT01066663|59163444|FG000|Overall Study|Adverse Event|0|||
30991179|NCT01066663|59163445|FG001|Overall Study|Adverse Event|0|||
30991180|NCT01066663|59163446|FG002|Overall Study|Adverse Event|1|||
30991181|NCT03930745|59165661|FG000|Overall Study|Lost to Follow-up|10|||
30991182|NCT03930745|59165662|FG001|Overall Study|Lost to Follow-up|5|||
30991183|NCT03930745|59165661|FG000|Overall Study|Withdrawal by Subject|1|||
30991184|NCT03930745|59165662|FG001|Overall Study|Withdrawal by Subject|2|||
30991185|NCT03930745|59165661|FG000|Overall Study|Protocol Violation|2|||
30991186|NCT03930745|59165662|FG001|Overall Study|Protocol Violation|2|||
30991187|NCT03930745|59165661|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
30991188|NCT03930745|59165662|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
30991189|NCT03930745|59165661|FG000|Overall Study|Adverse Event|0|||
30991190|NCT03930745|59165662|FG001|Overall Study|Adverse Event|1|||
30991191|NCT03930745|59165661|FG000|Overall Study|Pregnancy|0|||
30991192|NCT03930745|59165662|FG001|Overall Study|Pregnancy|1|||
30991193|NCT04473326|59168407|FG000|Overall Study|Death|0|||
30991194|NCT04473326|59168408|FG001|Overall Study|Death|1|||
30991195|NCT04473326|59168407|FG000|Overall Study|Withdrawal by Subject|1|||
30991196|NCT04473326|59168408|FG001|Overall Study|Withdrawal by Subject|2|||
30991197|NCT05239598|59168812|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
30991198|NCT05239598|59168813|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
30991199|NCT05239598|59168812|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
30991200|NCT05239598|59168813|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
30991201|NCT05010070|59168856|FG000|Overall Study|Lost to Follow-up|1|||
30991202|NCT05010070|59168856|FG000|Overall Study|Withdrawal by Subject|1|||
30991203|NCT04523480|59168894|FG000|Overall Study|Lost to Follow-up|30|||
30991204|NCT04523480|59168895|FG001|Overall Study|Lost to Follow-up|35|||
30991205|NCT04523480|59168896|FG002|Overall Study|Lost to Follow-up|0|||
30991206|NCT04454125|59168906|FG000|Overall Study|Lost to Follow-up|0|||
30991207|NCT04454125|59168907|FG001|Overall Study|Lost to Follow-up|1|||
30991208|NCT04307446|59168919|FG000|Overall Study|Lost to Follow-up|2|||
30991209|NCT04307446|59168920|FG001|Overall Study|Lost to Follow-up|0|||
30991210|NCT04143009|59168942|FG000|Pilot Trial|Lost to Follow-up|0|||
30991211|NCT04143009|59168943|FG001|Pilot Trial|Lost to Follow-up|1|||
30991212|NCT04143009|59168944|FG002|Pilot Trial|Lost to Follow-up|1|||
30991213|NCT04126317|59168954|FG000|Overall Study|Adverse Event|0|||
30991214|NCT04126317|59168955|FG001|Overall Study|Adverse Event|1|||
30991215|NCT04126317|59168954|FG000|Overall Study|Withdrawal by Subject|4|||
30991216|NCT04126317|59168955|FG001|Overall Study|Withdrawal by Subject|1|||
30991217|NCT04089865|59168965|FG000|Overall Study|Withdrawal by Subject|2|||
30991218|NCT04089865|59168966|FG001|Overall Study|Withdrawal by Subject|2|||
30991219|NCT04089865|59168967|FG002|Overall Study|Withdrawal by Subject|7|||
30991220|NCT04089865|59168968|FG003|Overall Study|Withdrawal by Subject|2|||
30991221|NCT04066894|59168978|FG000|Overall Study|Lack of Efficacy|1|||
30991222|NCT04066894|59168978|FG000|Overall Study|Screen Failure|1|||
30991223|NCT03929913|59169004|FG000|Overall Study|Death|4|||
30991224|NCT03929913|59169004|FG000|Overall Study|Lost to Follow-up|1|||
30991225|NCT03929913|59169004|FG000|Overall Study|Failed Procedure|2|||
30991226|NCT03832192|59169019|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
30991227|NCT03832192|59169020|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
30991228|NCT03748823|59169035|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
30991229|NCT03748823|59169036|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
30991230|NCT03748823|59169035|FG000|Extension Period|Withdrawal by Subject|1|||
30991231|NCT03748823|59169036|FG001|Extension Period|Withdrawal by Subject|2|||
30991232|NCT03748823|59169035|FG000|Extension Period|Death|0|||
30991233|NCT03748823|59169036|FG001|Extension Period|Death|1|||
30991234|NCT03748823|59169035|FG000|Extension Period|Protocol Violation|1|||
30991235|NCT03748823|59169036|FG001|Extension Period|Protocol Violation|0|||
30991236|NCT03748823|59169035|FG000|Extension Period|Ongoing in the Extension Period|41|||
30991237|NCT03748823|59169036|FG001|Extension Period|Ongoing in the Extension Period|84|||
30991238|NCT03738800|59169046|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
30991239|NCT03738800|59169047|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
30991240|NCT03738800|59169048|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
30991241|NCT03738800|59169046|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
30991242|NCT03738800|59169047|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
30991243|NCT03738800|59169048|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
30991244|NCT03738800|59169046|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
30991245|NCT03738800|59169047|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
30991246|NCT03738800|59169048|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
30991247|NCT03682055|59169097|FG000|Overall Study|Lack of Efficacy|1|||
30991248|NCT03682055|59169098|FG001|Overall Study|Lack of Efficacy|2|||
30991249|NCT03682055|59169099|FG002|Overall Study|Lack of Efficacy|1|||
30991250|NCT03682055|59169100|FG003|Overall Study|Lack of Efficacy|2|||
30991251|NCT03682055|59169101|FG004|Overall Study|Lack of Efficacy|1|||
30991252|NCT03682055|59169102|FG005|Overall Study|Lack of Efficacy|3|||
30991253|NCT03682055|59169097|FG000|Overall Study|Withdrawal by Subject|0|||
30991254|NCT03682055|59169098|FG001|Overall Study|Withdrawal by Subject|0|||
30991255|NCT03682055|59169099|FG002|Overall Study|Withdrawal by Subject|0|||
30991256|NCT03682055|59169100|FG003|Overall Study|Withdrawal by Subject|0|||
30991257|NCT03682055|59169101|FG004|Overall Study|Withdrawal by Subject|0|||
30991258|NCT03682055|59169102|FG005|Overall Study|Withdrawal by Subject|1|||
30991259|NCT03682055|59169097|FG000|Overall Study|Termination of Study by Sponsor|0|||
30991260|NCT03682055|59169098|FG001|Overall Study|Termination of Study by Sponsor|0|||
30991261|NCT03682055|59169099|FG002|Overall Study|Termination of Study by Sponsor|0|||
30991262|NCT03682055|59169100|FG003|Overall Study|Termination of Study by Sponsor|0|||
30991263|NCT03682055|59169101|FG004|Overall Study|Termination of Study by Sponsor|0|||
30991264|NCT03682055|59169102|FG005|Overall Study|Termination of Study by Sponsor|3|||
30991265|NCT03596450|59169122|FG000|Overall Study|Death|4|||
30991266|NCT03596450|59169123|FG001|Overall Study|Death|4|||
30991267|NCT03596450|59169122|FG000|Overall Study|Protocol Violation|7|||
30991268|NCT03596450|59169123|FG001|Overall Study|Protocol Violation|12|||
30991269|NCT03596450|59169122|FG000|Overall Study|Lost to Follow-up|7|||
30991270|NCT03596450|59169123|FG001|Overall Study|Lost to Follow-up|6|||
30991271|NCT03596450|59169122|FG000|Overall Study|Adverse Event|9|||
30991272|NCT03596450|59169123|FG001|Overall Study|Adverse Event|6|||
30991273|NCT03596450|59169122|FG000|Overall Study|Withdrawal by Subject|16|||
30991274|NCT03596450|59169123|FG001|Overall Study|Withdrawal by Subject|9|||
30991275|NCT03596450|59169122|FG000|Overall Study|Accidentally Randomized|2|||
30991276|NCT03596450|59169123|FG001|Overall Study|Accidentally Randomized|0|||
30991277|NCT03596450|59169122|FG000|Overall Study|Other reasons|21|||
30991278|NCT03596450|59169123|FG001|Overall Study|Other reasons|22|||
30991279|NCT03596450|59169122|FG000|Overall Study|Missed the Year 1 study visit|56|||
30991280|NCT03596450|59169123|FG001|Overall Study|Missed the Year 1 study visit|50|||
30991281|NCT03551496|59169131|FG000|Overall Study|Death|11|||
30991282|NCT03551496|59169132|FG001|Overall Study|Death|7|||
30991283|NCT03551496|59169131|FG000|Overall Study|Withdrawal by Subject|4|||
30991284|NCT03551496|59169132|FG001|Overall Study|Withdrawal by Subject|3|||
30991285|NCT03551496|59169131|FG000|Overall Study|Other Reasons|1|||
30991286|NCT03551496|59169132|FG001|Overall Study|Other Reasons|0|||
30991287|NCT03547518|59169140|FG000|Overall Study|Lost to Follow-up|2|||
30991288|NCT03547518|59169141|FG001|Overall Study|Lost to Follow-up|0|||
30991289|NCT03519347|59169152|FG000|Interventional Crossover Period 1|Death|0|||
30991290|NCT03519347|59169153|FG001|Interventional Crossover Period 1|Death|0|||
30991291|NCT03519347|59169154|FG002|Interventional Crossover Period 1|Death|0|||
30991292|NCT03519347|59169155|FG003|Interventional Crossover Period 1|Death|1|||
30991293|NCT03199638|59169193|FG000|Overall Study|inability to drink glutamine during regularly|0|||
30991294|NCT03199638|59169194|FG001|Overall Study|inability to drink glutamine during regularly|2|||
30991295|NCT03176771|59169216|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
30991296|NCT03176771|59169217|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
30991297|NCT03176771|59169218|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
30991298|NCT03176771|59169219|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
30991299|NCT03176771|59169220|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
30991300|NCT03176771|59169216|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
30991301|NCT03176771|59169217|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
30991302|NCT03176771|59169218|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
30991303|NCT03176771|59169219|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
30991304|NCT03176771|59169220|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
30991305|NCT03176771|59169216|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
30991306|NCT03176771|59169217|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
30991307|NCT03176771|59169218|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
30991308|NCT03176771|59169219|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
30991309|NCT03176771|59169220|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
30991310|NCT03176771|59169216|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
30991311|NCT03176771|59169217|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
30991312|NCT03176771|59169218|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
30991313|NCT03176771|59169219|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
30991314|NCT03176771|59169220|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
30991315|NCT03176771|59169216|FG000|Double-Blind Extension Period|Adverse Event|0|||
30991316|NCT03176771|59169217|FG001|Double-Blind Extension Period|Adverse Event|0|||
30991317|NCT03176771|59169218|FG002|Double-Blind Extension Period|Adverse Event|0|||
30991318|NCT03176771|59169219|FG003|Double-Blind Extension Period|Adverse Event|15|||
30991319|NCT03176771|59169220|FG004|Double-Blind Extension Period|Adverse Event|18|||
30991320|NCT03176771|59169216|FG000|Double-Blind Extension Period|Death|0|||
30991321|NCT03176771|59169217|FG001|Double-Blind Extension Period|Death|0|||
30991322|NCT03176771|59169218|FG002|Double-Blind Extension Period|Death|0|||
30991323|NCT03176771|59169219|FG003|Double-Blind Extension Period|Death|3|||
30991324|NCT03176771|59169220|FG004|Double-Blind Extension Period|Death|4|||
30991325|NCT03176771|59169216|FG000|Double-Blind Extension Period|Physician Decision|0|||
30991326|NCT03176771|59169217|FG001|Double-Blind Extension Period|Physician Decision|0|||
30991327|NCT03176771|59169218|FG002|Double-Blind Extension Period|Physician Decision|0|||
30991328|NCT03176771|59169219|FG003|Double-Blind Extension Period|Physician Decision|3|||
30991329|NCT03176771|59169220|FG004|Double-Blind Extension Period|Physician Decision|1|||
30991330|NCT03176771|59169216|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
30991331|NCT03176771|59169217|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
30991332|NCT03176771|59169218|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
30991333|NCT03176771|59169219|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
30991334|NCT03176771|59169220|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
30991335|NCT03015194|59169230|FG000|Overall Study|Death|10|||
30991336|NCT03015194|59169230|FG000|Overall Study|Withdrawal by Subject|2|||
30891869|NCT02345161|58925175|FG000|Overall Study|Lost to Follow-up|0|||
30991337|NCT02927262|59169237|FG000|Overall Study|Adverse Event|7|||
30991338|NCT02927262|59169238|FG001|Overall Study|Adverse Event|1|||
30991339|NCT02927262|59169237|FG000|Overall Study|Death|1|||
30991340|NCT02927262|59169238|FG001|Overall Study|Death|0|||
30991341|NCT02927262|59169237|FG000|Overall Study|Withdrawal by Subject|3|||
30991342|NCT02927262|59169238|FG001|Overall Study|Withdrawal by Subject|0|||
30991343|NCT02927262|59169237|FG000|Overall Study|Disease Relapse|23|||
30991344|NCT02927262|59169238|FG001|Overall Study|Disease Relapse|18|||
30991345|NCT02927262|59169237|FG000|Overall Study|Miscellaneous|5|||
30991346|NCT02927262|59169238|FG001|Overall Study|Miscellaneous|4|||
30991347|NCT02927262|59169237|FG000|Overall Study|Ongoing|4|||
30991348|NCT02927262|59169238|FG001|Overall Study|Ongoing|0|||
30991349|NCT02873715|59169250|FG000|Overall Study|Lost to Follow-up|84|||
30991350|NCT02873715|59169251|FG001|Overall Study|Lost to Follow-up|94|||
30991351|NCT02873715|59169250|FG000|Overall Study|Withdrawal by Subject|7|||
30991352|NCT02873715|59169251|FG001|Overall Study|Withdrawal by Subject|26|||
30991353|NCT02840877|59169257|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
30991354|NCT02840877|59169257|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
30991355|NCT02840877|59169257|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
30991356|NCT02840877|59169257|FG000|Baseline to 12 Weeks|Death|1|||
30991357|NCT02840877|59169257|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
30991358|NCT02840877|59169257|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
30991359|NCT02840877|59169257|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
30991360|NCT02840877|59169257|FG000|12 Weeks to 6 Months|Treatment failure|1|||
30991361|NCT02840877|59169257|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
30991362|NCT02840877|59169257|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
30991363|NCT02840877|59169257|FG000|12 Weeks to 6 Months|Death|1|||
30991364|NCT02840877|59169257|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
30991365|NCT02840877|59169257|FG000|6 Months to 18 Months|Treatment failure|7|||
30991366|NCT02840877|59169257|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
30991367|NCT02840877|59169257|FG000|6 Months to 18 Months|Moved/transferred out|6|||
30991368|NCT02840877|59169257|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
30991369|NCT02840877|59169257|FG000|6 Months to 18 Months|Death|4|||
30991370|NCT02840877|59169257|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
30991371|NCT02840877|59169257|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
30991372|NCT02840877|59169257|FG000|6 Months to 18 Months|Still in study.|14|||
30991373|NCT02536300|59169273|FG000|Overall Study|Investigator's Discretion|17|||
30991374|NCT02536300|59169274|FG001|Overall Study|Investigator's Discretion|11|||
30991375|NCT02536300|59169275|FG002|Overall Study|Investigator's Discretion|2|||
30991376|NCT02536300|59169273|FG000|Overall Study|Progressive Disease|11|||
30991377|NCT02536300|59169274|FG001|Overall Study|Progressive Disease|7|||
30991378|NCT02536300|59169275|FG002|Overall Study|Progressive Disease|6|||
30991379|NCT02536300|59169273|FG000|Overall Study|Study Terminated by Sponsor|6|||
30991380|NCT02536300|59169274|FG001|Overall Study|Study Terminated by Sponsor|4|||
30991381|NCT02536300|59169275|FG002|Overall Study|Study Terminated by Sponsor|7|||
30991382|NCT02536300|59169273|FG000|Overall Study|Death|7|||
30991383|NCT02536300|59169274|FG001|Overall Study|Death|0|||
30991384|NCT02536300|59169275|FG002|Overall Study|Death|5|||
30991385|NCT02536300|59169273|FG000|Overall Study|Withdrew Consent|4|||
30991386|NCT02536300|59169274|FG001|Overall Study|Withdrew Consent|2|||
30991387|NCT02536300|59169275|FG002|Overall Study|Withdrew Consent|0|||
30991388|NCT02536300|59169273|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
30991389|NCT02536300|59169274|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
30991390|NCT02536300|59169275|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
30991391|NCT02536300|59169273|FG000|Overall Study|Enrolled but Never Treated|0|||
30991392|NCT02536300|59169274|FG001|Overall Study|Enrolled but Never Treated|0|||
30991393|NCT02536300|59169275|FG002|Overall Study|Enrolled but Never Treated|1|||
30991394|NCT02536300|59169273|FG000|Overall Study|Non-compliance With Study Drug|1|||
30991395|NCT02536300|59169274|FG001|Overall Study|Non-compliance With Study Drug|0|||
30991396|NCT02536300|59169275|FG002|Overall Study|Non-compliance With Study Drug|0|||
30991397|NCT02536300|59169273|FG000|Overall Study|Protocol Violation|0|||
30991398|NCT02536300|59169274|FG001|Overall Study|Protocol Violation|1|||
30991399|NCT02536300|59169275|FG002|Overall Study|Protocol Violation|0|||
30991400|NCT02499354|59169294|FG000|Overall Study|Withdrawal by Subject|1|||
30991401|NCT02499354|59169295|FG001|Overall Study|Withdrawal by Subject|0|||
30991402|NCT02365649|59169307|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
30991403|NCT02365649|59169308|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
30991404|NCT02365649|59169309|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
30991405|NCT02365649|59169310|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
30991406|NCT02365649|59169311|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
30991407|NCT02365649|59169312|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
30991408|NCT02365649|59169313|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
30991409|NCT02365649|59169314|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
30991410|NCT02365649|59169315|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
30991411|NCT02365649|59169316|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
30991412|NCT02365649|59169307|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
30991413|NCT02365649|59169308|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
30991414|NCT02365649|59169309|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
30991415|NCT02365649|59169310|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
30991416|NCT02365649|59169311|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
30991417|NCT02365649|59169312|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
30991418|NCT02365649|59169313|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
30991419|NCT02365649|59169314|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
30991420|NCT02365649|59169315|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
30991421|NCT02365649|59169316|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
30991422|NCT02365649|59169307|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
30991423|NCT02365649|59169308|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
30991424|NCT02365649|59169309|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
30991425|NCT02365649|59169310|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
30991426|NCT02365649|59169311|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
30991427|NCT02365649|59169312|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
30991428|NCT02365649|59169313|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
30991429|NCT02365649|59169314|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
30991430|NCT02365649|59169315|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
30991431|NCT02365649|59169316|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
30991432|NCT02365649|59169307|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
30991433|NCT02365649|59169308|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
30991434|NCT02365649|59169309|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
30991435|NCT02365649|59169310|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
30991436|NCT02365649|59169311|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
30991437|NCT02365649|59169312|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
30991438|NCT02365649|59169313|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
30991439|NCT02365649|59169314|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
30991440|NCT02365649|59169315|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
30991441|NCT02365649|59169316|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
30991442|NCT02365649|59169307|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
30991443|NCT02365649|59169308|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
30991444|NCT02365649|59169309|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
30991445|NCT02365649|59169310|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
30991446|NCT02365649|59169311|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
30991447|NCT02365649|59169312|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
30991448|NCT02365649|59169313|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
30991449|NCT02365649|59169314|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
30991450|NCT02365649|59169315|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
30991451|NCT02365649|59169316|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
30991452|NCT02365649|59169307|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
30991453|NCT02365649|59169308|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
30991454|NCT02365649|59169309|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
30991455|NCT02365649|59169310|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
30991456|NCT02365649|59169311|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
30991457|NCT02365649|59169312|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
30991458|NCT02365649|59169313|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
30991459|NCT02365649|59169314|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
30991460|NCT02365649|59169315|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
30991461|NCT02365649|59169316|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
30991462|NCT02365649|59169307|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
30991463|NCT02365649|59169308|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
30991464|NCT02365649|59169309|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
30991465|NCT02365649|59169310|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
30991466|NCT02365649|59169311|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
30991467|NCT02365649|59169312|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
30991468|NCT02365649|59169313|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
30991469|NCT02365649|59169314|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
30991470|NCT02365649|59169315|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
30991471|NCT02365649|59169316|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
30991472|NCT02365649|59169307|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
30991473|NCT02365649|59169308|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
30991474|NCT02365649|59169309|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
30991475|NCT02365649|59169310|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
30991476|NCT02365649|59169311|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
30991477|NCT02365649|59169312|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
30991478|NCT02365649|59169313|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
30991479|NCT02365649|59169314|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
30991480|NCT02365649|59169315|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
30991481|NCT02365649|59169316|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
30991482|NCT02365649|59169307|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
30991483|NCT02365649|59169308|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
30991484|NCT02365649|59169309|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
30991485|NCT02365649|59169310|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
30991486|NCT02365649|59169311|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
30991487|NCT02365649|59169312|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
30991488|NCT02365649|59169313|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
30991489|NCT02365649|59169314|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
30991490|NCT02365649|59169315|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
30991491|NCT02365649|59169316|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
30991492|NCT02365649|59169307|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
30991493|NCT02365649|59169308|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
30991494|NCT02365649|59169309|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
30991495|NCT02365649|59169310|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
30991496|NCT02365649|59169311|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
30991497|NCT02365649|59169312|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
30991498|NCT02365649|59169313|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
30991499|NCT02365649|59169314|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
30991500|NCT02365649|59169315|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
30991501|NCT02365649|59169316|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
30991502|NCT02365649|59169307|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
30991503|NCT02365649|59169308|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
30991504|NCT02365649|59169309|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
30991505|NCT02365649|59169310|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
30991506|NCT02365649|59169311|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
30991507|NCT02365649|59169312|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
30991508|NCT02365649|59169313|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
30991509|NCT02365649|59169314|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
30991510|NCT02365649|59169315|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
30991511|NCT02365649|59169316|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
30991512|NCT02365649|59169307|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
30991513|NCT02365649|59169308|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
30991514|NCT02365649|59169309|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
30991515|NCT02365649|59169310|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
30991516|NCT02365649|59169311|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
30991517|NCT02365649|59169312|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
30991518|NCT02365649|59169313|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
30991519|NCT02365649|59169314|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
30991520|NCT02365649|59169315|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
30991521|NCT02365649|59169316|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
30991522|NCT02048813|59169346|FG000|Overall Study|Still on treatment|279|||
30991523|NCT02048813|59169347|FG001|Overall Study|Still on treatment|0|||
30991524|NCT02048813|59169346|FG000|Overall Study|Adverse Event|40|||
30991525|NCT02048813|59169347|FG001|Overall Study|Adverse Event|38|||
30991526|NCT02048813|59169346|FG000|Overall Study|Disease progression|13|||
30991527|NCT02048813|59169347|FG001|Overall Study|Disease progression|3|||
30991528|NCT02048813|59169346|FG000|Overall Study|Withdrawal by Subject|7|||
30991529|NCT02048813|59169347|FG001|Overall Study|Withdrawal by Subject|8|||
30991530|NCT02048813|59169346|FG000|Overall Study|Death|2|||
30991531|NCT02048813|59169347|FG001|Overall Study|Death|1|||
30991532|NCT02048813|59169346|FG000|Overall Study|Complication|2|||
30991533|NCT02048813|59169347|FG001|Overall Study|Complication|2|||
30991534|NCT02048813|59169346|FG000|Overall Study|Non-protocol therapy|0|||
30991535|NCT02048813|59169347|FG001|Overall Study|Non-protocol therapy|1|||
30991536|NCT02048813|59169346|FG000|Overall Study|Second primary cancer|2|||
30991537|NCT02048813|59169347|FG001|Overall Study|Second primary cancer|0|||
30991538|NCT02048813|59169346|FG000|Overall Study|Insurance|2|||
30991539|NCT02048813|59169347|FG001|Overall Study|Insurance|0|||
30991540|NCT02048813|59169346|FG000|Overall Study|Wound infection/healing|2|||
30991541|NCT02048813|59169347|FG001|Overall Study|Wound infection/healing|0|||
30991542|NCT02048813|59169346|FG000|Overall Study|Missed appointment|3|||
30991543|NCT02048813|59169347|FG001|Overall Study|Missed appointment|0|||
30991544|NCT02048813|59169346|FG000|Overall Study|Never started treatment|2|||
30991545|NCT02048813|59169347|FG001|Overall Study|Never started treatment|17|||
30991546|NCT01984346|59169355|FG000|Overall Study|Physician Decision|4|||
30991547|NCT01984346|59169356|FG001|Overall Study|Physician Decision|2|||
30991548|NCT01984346|59169355|FG000|Overall Study|Withdrawal by Subject|2|||
30991549|NCT01984346|59169356|FG001|Overall Study|Withdrawal by Subject|2|||
30991550|NCT01984346|59169355|FG000|Overall Study|Enrollment Closed|8|||
30991551|NCT01984346|59169356|FG001|Overall Study|Enrollment Closed|1|||
30991552|NCT01984346|59169355|FG000|Overall Study|Insurance Coverage|1|||
30991553|NCT01984346|59169356|FG001|Overall Study|Insurance Coverage|0|||
30991554|NCT01984346|59169355|FG000|Overall Study|Intra-operative Exclusion|2|||
30991555|NCT01984346|59169356|FG001|Overall Study|Intra-operative Exclusion|0|||
30991556|NCT01949662|59169364|FG000|Overall Study|Death|9|||
30991557|NCT01949662|59169365|FG001|Overall Study|Death|7|||
30991558|NCT01949662|59169364|FG000|Overall Study|Discharged before an agitation event|8|||
30991559|NCT01949662|59169365|FG001|Overall Study|Discharged before an agitation event|3|||
30991560|NCT01949662|59169364|FG000|Overall Study|Dropped out|1|||
30991561|NCT01949662|59169365|FG001|Overall Study|Dropped out|3|||
30991562|NCT01949662|59169364|FG000|Overall Study|Ineligible|0|||
30991563|NCT01949662|59169365|FG001|Overall Study|Ineligible|1|||
30991564|NCT01892722|59169373|FG000|Overall Study|Protocol deviation|0|||
30991565|NCT01892722|59169374|FG001|Overall Study|Protocol deviation|1|||
30991566|NCT01892722|59169373|FG000|Overall Study|Administrative problems|0|||
30991567|NCT01892722|59169374|FG001|Overall Study|Administrative problems|1|||
30991568|NCT01892722|59169373|FG000|Overall Study|Patient/guardian decision|0|||
30991569|NCT01892722|59169374|FG001|Overall Study|Patient/guardian decision|2|||
30991570|NCT01892722|59169373|FG000|Overall Study|Physician Decision|1|||
30991571|NCT01892722|59169374|FG001|Overall Study|Physician Decision|2|||
30991572|NCT01892722|59169373|FG000|Overall Study|Adverse Event|3|||
30991573|NCT01892722|59169374|FG001|Overall Study|Adverse Event|2|||
30991574|NCT01892722|59169373|FG000|Overall Study|Lack of Efficacy|0|||
30991575|NCT01892722|59169374|FG001|Overall Study|Lack of Efficacy|7|||
30991576|NCT01892722|59169373|FG000|Overall Study|Withdrawal by Subject|3|||
30991577|NCT01892722|59169374|FG001|Overall Study|Withdrawal by Subject|5|||
30991578|NCT01856686|59169382|FG000|Overall Study|Lost to Follow-up|5|||
30991579|NCT01856686|59169383|FG001|Overall Study|Lost to Follow-up|11|||
30991580|NCT01770145|59169389|FG000|Baseline|Adverse Event|20|||
30991581|NCT01770145|59169389|FG000|Baseline|Withdrawal by Subject|1|||
30991582|NCT01770145|59169389|FG000|Baseline|Lost to Follow-up|1|||
30991583|NCT01770145|59169389|FG000|Baseline|Unable to define optimal dose|4|||
30991584|NCT01770145|59169389|FG000|Treatment|Adverse Event|3|||
30991585|NCT01770145|59169389|FG000|Treatment|Withdrawal by Subject|1|||
30991586|NCT01749137|59169395|FG000|Overall Study|Adverse Event|4|||
30991587|NCT01749137|59169396|FG001|Overall Study|Adverse Event|4|||
30991588|NCT01749137|59169395|FG000|Overall Study|Lost to Follow-up|2|||
30991589|NCT01749137|59169396|FG001|Overall Study|Lost to Follow-up|3|||
30991590|NCT01749137|59169395|FG000|Overall Study|Physician Decision|1|||
30991591|NCT01749137|59169396|FG001|Overall Study|Physician Decision|0|||
30991592|NCT01749137|59169395|FG000|Overall Study|Withdrawal by Subject|8|||
30991593|NCT01749137|59169396|FG001|Overall Study|Withdrawal by Subject|4|||
30991594|NCT01726582|59169402|FG000|Overall Study|Physician Decision|99|||
30991595|NCT01726582|59169402|FG000|Overall Study|Death|85|||
30991596|NCT01385176|59169410|FG000|Randomization Phase|Death|1|||
30991597|NCT01385176|59169411|FG001|Randomization Phase|Death|2|||
30991598|NCT01385176|59169410|FG000|6-18 Month All VNS Active|Death|1|||
30991599|NCT01385176|59169411|FG001|6-18 Month All VNS Active|Death|2|||
30991600|NCT01385176|59169410|FG000|6-18 Month All VNS Active|Physician Decision|0|||
30991601|NCT01385176|59169411|FG001|6-18 Month All VNS Active|Physician Decision|1|||
30991602|NCT01385176|59169410|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
30991603|NCT01385176|59169411|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
30991604|NCT01385176|59169410|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
30991605|NCT01385176|59169411|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
30991606|NCT00794339|59169431|FG000|Overall Study|Withdrawal by Subject|3|||
30991607|NCT00794339|59169431|FG000|Overall Study|Ineligible|4|||
30991608|NCT00794339|59169431|FG000|Overall Study|Tx prior to ATSM|3|||
30991609|NCT00794339|59169431|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
30991610|NCT00794339|59169431|FG000|Overall Study|Tx not per protocol|1|||
30991611|NCT00506662|59169458|FG000|Overall Study|Adverse Event|0|||
30991612|NCT00506662|59169459|FG001|Overall Study|Adverse Event|2|||
30991613|NCT00506662|59169458|FG000|Overall Study|Lack of Efficacy|1|||
30991614|NCT00506662|59169459|FG001|Overall Study|Lack of Efficacy|0|||
30991615|NCT00506662|59169458|FG000|Overall Study|Protocol Violation|2|||
30991616|NCT00506662|59169459|FG001|Overall Study|Protocol Violation|4|||
30991617|NCT00506662|59169458|FG000|Overall Study|Trial terminated|10|||
30991618|NCT00506662|59169459|FG001|Overall Study|Trial terminated|16|||
30991619|NCT00506662|59169458|FG000|Overall Study|Not recorded|4|||
30991620|NCT00506662|59169459|FG001|Overall Study|Not recorded|6|||
30991621|NCT00161213|59169465|FG000|Overall Study|Withdrawal by Subject|1|||
30991622|NCT00161213|59169465|FG000|Overall Study|Evaluable for toxicity but not response|1|||
30991623|NCT00006436|59169473|FG000|Overall Study|Refused further treatment|2|||
30991624|NCT00006436|59169473|FG000|Overall Study|Declined to participate (before treatment started)|1|||
30991625|NCT03838484|59169711|FG000|Overall Study|Lost to Follow-up|0|||
30991626|NCT03838484|59169712|FG001|Overall Study|Lost to Follow-up|1|||
30991627|NCT03838484|59169713|FG002|Overall Study|Lost to Follow-up|0|||
30991628|NCT03838484|59169714|FG003|Overall Study|Lost to Follow-up|0|||
30991629|NCT01349192|59169946|FG000|Overall Study|Protocol Violation|0|||
30991630|NCT01349192|59169947|FG001|Overall Study|Protocol Violation|1|||
30991631|NCT01349192|59169946|FG000|Overall Study|Withdrawal by Subject|0|||
30991632|NCT01349192|59169947|FG001|Overall Study|Withdrawal by Subject|2|||
30991633|NCT01349192|59169946|FG000|Overall Study|Lost to Follow-up|1|||
30991634|NCT01349192|59169947|FG001|Overall Study|Lost to Follow-up|3|||
30991635|NCT01349192|59169946|FG000|Overall Study|Failure to adhere to Protocol|2|||
30991636|NCT01349192|59169947|FG001|Overall Study|Failure to adhere to Protocol|0|||
30991637|NCT01721876|59170302|FG000|Overall Study|Not treated|1|||
30991638|NCT01721876|59170303|FG001|Overall Study|Not treated|4|||
30991639|NCT01721876|59170302|FG000|Overall Study|Disease progression / relapse|123|||
30991640|NCT01721876|59170303|FG001|Overall Study|Disease progression / relapse|156|||
30991641|NCT01721876|59170302|FG000|Overall Study|Death|6|||
30991642|NCT01721876|59170303|FG001|Overall Study|Death|13|||
30991643|NCT01721876|59170302|FG000|Overall Study|Adverse Event|41|||
30991644|NCT01721876|59170303|FG001|Overall Study|Adverse Event|165|||
30991645|NCT01721876|59170302|FG000|Overall Study|Protocol Violation|2|||
30991646|NCT01721876|59170303|FG001|Overall Study|Protocol Violation|1|||
30991647|NCT01721876|59170302|FG000|Overall Study|Withdrawal by Subject|15|||
30991648|NCT01721876|59170303|FG001|Overall Study|Withdrawal by Subject|38|||
30991649|NCT01721876|59170302|FG000|Overall Study|Reason not listed|34|||
30991650|NCT01721876|59170303|FG001|Overall Study|Reason not listed|63|||
30991651|NCT01721876|59170302|FG000|Overall Study|Sponsor terminated trial|0|||
30991652|NCT01721876|59170303|FG001|Overall Study|Sponsor terminated trial|4|||
30991653|NCT02265510|59170538|FG000|Overall Study|Withdrawal by Subject|1|||
30991654|NCT02265510|59170539|FG001|Overall Study|Withdrawal by Subject|1|||
30991655|NCT02265510|59170540|FG002|Overall Study|Withdrawal by Subject|2|||
30991656|NCT02265510|59170541|FG003|Overall Study|Withdrawal by Subject|1|||
30991657|NCT02265510|59170542|FG004|Overall Study|Withdrawal by Subject|0|||
30991658|NCT02265510|59170543|FG005|Overall Study|Withdrawal by Subject|2|||
30991659|NCT02265510|59170544|FG006|Overall Study|Withdrawal by Subject|0|||
30991660|NCT02265510|59170545|FG007|Overall Study|Withdrawal by Subject|2|||
30991661|NCT02265510|59170546|FG008|Overall Study|Withdrawal by Subject|0|||
30991662|NCT02265510|59170547|FG009|Overall Study|Withdrawal by Subject|0|||
30991663|NCT02265510|59170548|FG010|Overall Study|Withdrawal by Subject|0|||
30991664|NCT02265510|59170549|FG011|Overall Study|Withdrawal by Subject|0|||
30991665|NCT02265510|59170550|FG012|Overall Study|Withdrawal by Subject|1|||
30991666|NCT02265510|59170551|FG013|Overall Study|Withdrawal by Subject|0|||
30991667|NCT02265510|59170538|FG000|Overall Study|Disease Progression|0|||
30991668|NCT02265510|59170539|FG001|Overall Study|Disease Progression|1|||
30991669|NCT02265510|59170540|FG002|Overall Study|Disease Progression|2|||
30991670|NCT02265510|59170541|FG003|Overall Study|Disease Progression|1|||
30991671|NCT02265510|59170542|FG004|Overall Study|Disease Progression|1|||
30991672|NCT02265510|59170543|FG005|Overall Study|Disease Progression|0|||
30991673|NCT02265510|59170544|FG006|Overall Study|Disease Progression|0|||
30991674|NCT02265510|59170545|FG007|Overall Study|Disease Progression|0|||
30991675|NCT02265510|59170546|FG008|Overall Study|Disease Progression|0|||
30991676|NCT02265510|59170547|FG009|Overall Study|Disease Progression|0|||
30991677|NCT02265510|59170548|FG010|Overall Study|Disease Progression|0|||
30991678|NCT02265510|59170549|FG011|Overall Study|Disease Progression|0|||
30991679|NCT02265510|59170550|FG012|Overall Study|Disease Progression|0|||
30991680|NCT02265510|59170551|FG013|Overall Study|Disease Progression|0|||
30991681|NCT02265510|59170538|FG000|Overall Study|Death|2|||
30991682|NCT02265510|59170539|FG001|Overall Study|Death|0|||
30991683|NCT02265510|59170540|FG002|Overall Study|Death|2|||
30991684|NCT02265510|59170541|FG003|Overall Study|Death|2|||
30991685|NCT02265510|59170542|FG004|Overall Study|Death|1|||
30991686|NCT02265510|59170543|FG005|Overall Study|Death|3|||
30991687|NCT02265510|59170544|FG006|Overall Study|Death|2|||
30991688|NCT02265510|59170545|FG007|Overall Study|Death|1|||
30991689|NCT02265510|59170546|FG008|Overall Study|Death|3|||
30991690|NCT02265510|59170547|FG009|Overall Study|Death|3|||
30991691|NCT02265510|59170548|FG010|Overall Study|Death|4|||
30991692|NCT02265510|59170549|FG011|Overall Study|Death|12|||
30991693|NCT02265510|59170550|FG012|Overall Study|Death|7|||
30991694|NCT02265510|59170551|FG013|Overall Study|Death|6|||
30991695|NCT02265510|59170538|FG000|Overall Study|Lost to Follow-up|0|||
30991696|NCT02265510|59170539|FG001|Overall Study|Lost to Follow-up|0|||
30991697|NCT02265510|59170540|FG002|Overall Study|Lost to Follow-up|0|||
30991698|NCT02265510|59170541|FG003|Overall Study|Lost to Follow-up|0|||
30991699|NCT02265510|59170542|FG004|Overall Study|Lost to Follow-up|1|||
30991700|NCT02265510|59170543|FG005|Overall Study|Lost to Follow-up|0|||
30991701|NCT02265510|59170544|FG006|Overall Study|Lost to Follow-up|0|||
30991702|NCT02265510|59170545|FG007|Overall Study|Lost to Follow-up|0|||
30991703|NCT02265510|59170546|FG008|Overall Study|Lost to Follow-up|0|||
30991704|NCT02265510|59170547|FG009|Overall Study|Lost to Follow-up|2|||
30991705|NCT02265510|59170548|FG010|Overall Study|Lost to Follow-up|0|||
30991706|NCT02265510|59170549|FG011|Overall Study|Lost to Follow-up|0|||
30991707|NCT02265510|59170550|FG012|Overall Study|Lost to Follow-up|0|||
30991708|NCT02265510|59170551|FG013|Overall Study|Lost to Follow-up|2|||
30991709|NCT02265510|59170538|FG000|Overall Study|Other|0|||
30991710|NCT02265510|59170539|FG001|Overall Study|Other|1|||
30991711|NCT02265510|59170540|FG002|Overall Study|Other|0|||
30991712|NCT02265510|59170541|FG003|Overall Study|Other|0|||
30991713|NCT02265510|59170542|FG004|Overall Study|Other|0|||
30991714|NCT02265510|59170543|FG005|Overall Study|Other|0|||
30991715|NCT02265510|59170544|FG006|Overall Study|Other|0|||
30991716|NCT02265510|59170545|FG007|Overall Study|Other|0|||
30991717|NCT02265510|59170546|FG008|Overall Study|Other|0|||
30991718|NCT02265510|59170547|FG009|Overall Study|Other|0|||
30991719|NCT02265510|59170548|FG010|Overall Study|Other|0|||
30991720|NCT02265510|59170549|FG011|Overall Study|Other|0|||
30991721|NCT02265510|59170550|FG012|Overall Study|Other|0|||
30991722|NCT02265510|59170551|FG013|Overall Study|Other|0|||
30991723|NCT02265510|59170538|FG000|Overall Study|Study Terminated by Sponsor|0|||
30991724|NCT02265510|59170539|FG001|Overall Study|Study Terminated by Sponsor|0|||
30991725|NCT02265510|59170540|FG002|Overall Study|Study Terminated by Sponsor|0|||
30991726|NCT02265510|59170541|FG003|Overall Study|Study Terminated by Sponsor|0|||
30991727|NCT02265510|59170542|FG004|Overall Study|Study Terminated by Sponsor|0|||
30991728|NCT02265510|59170543|FG005|Overall Study|Study Terminated by Sponsor|1|||
30991729|NCT02265510|59170544|FG006|Overall Study|Study Terminated by Sponsor|1|||
30991730|NCT02265510|59170545|FG007|Overall Study|Study Terminated by Sponsor|1|||
30991731|NCT02265510|59170546|FG008|Overall Study|Study Terminated by Sponsor|1|||
30991732|NCT02265510|59170547|FG009|Overall Study|Study Terminated by Sponsor|2|||
30991733|NCT02265510|59170548|FG010|Overall Study|Study Terminated by Sponsor|1|||
30991734|NCT02265510|59170549|FG011|Overall Study|Study Terminated by Sponsor|4|||
30991735|NCT02265510|59170550|FG012|Overall Study|Study Terminated by Sponsor|1|||
30991736|NCT02265510|59170551|FG013|Overall Study|Study Terminated by Sponsor|2|||
30991737|NCT01238211|59170652|FG000|Overall Study|Continues active treatment|31|||
30991738|NCT01238211|59170652|FG000|Overall Study|Adverse Event|7|||
30991739|NCT01238211|59170652|FG000|Overall Study|Death|4|||
30991740|NCT01238211|59170652|FG000|Overall Study|Relapse/Progression|2|||
30991741|NCT01238211|59170652|FG000|Overall Study|Withdrawal by Subject|7|||
30991742|NCT01238211|59170652|FG000|Overall Study|Non-protocol treatment|4|||
30991743|NCT01238211|59170652|FG000|Overall Study|Investigator/Patient Decision|3|||
30991744|NCT02264574|59170828|FG000|Overall Study|Death|21|||
30991745|NCT02264574|59170829|FG001|Overall Study|Death|21|||
30991746|NCT02264574|59170828|FG000|Overall Study|Withdrawal by Subject|8|||
30991747|NCT02264574|59170829|FG001|Overall Study|Withdrawal by Subject|6|||
30991748|NCT02264574|59170828|FG000|Overall Study|Other, Not Specified|0|||
30991749|NCT02264574|59170829|FG001|Overall Study|Other, Not Specified|3|||
30991750|NCT01641900|59170869|FG000|Overall Study|Withdrawal by Subject|2|||
30991751|NCT01641900|59170870|FG001|Overall Study|Withdrawal by Subject|2|||
30991752|NCT01640808|59170943|FG000|Overall Study|Unable to continue dynamic CT|14|||
30991753|NCT01640808|59170944|FG001|Overall Study|Unable to continue dynamic CT|4|||
30991754|NCT01640808|59170943|FG000|Overall Study|Withdrawal by Subject|12|||
30991755|NCT01640808|59170944|FG001|Overall Study|Withdrawal by Subject|4|||
30991756|NCT01640808|59170943|FG000|Overall Study|Lost to Follow-up|4|||
30991757|NCT01640808|59170944|FG001|Overall Study|Lost to Follow-up|0|||
30991758|NCT01640808|59170943|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
30991759|NCT01640808|59170944|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
30891870|NCT02345161|58925176|FG001|Overall Study|Lost to Follow-up|1|||
30991760|NCT01640808|59170943|FG000|Overall Study|Administration of anticancer drugs|2|||
30991761|NCT01640808|59170944|FG001|Overall Study|Administration of anticancer drugs|1|||
30991762|NCT01640808|59170943|FG000|Overall Study|Physician Decision|19|||
30991763|NCT01640808|59170944|FG001|Overall Study|Physician Decision|5|||
30991764|NCT01640808|59170943|FG000|Overall Study|Randomized but not treated|4|||
30991765|NCT01640808|59170944|FG001|Overall Study|Randomized but not treated|2|||
30991766|NCT02263326|59170965|FG000|Overall Study|Lost to Follow-up|1|||
30991767|NCT02263326|59170966|FG001|Overall Study|Lost to Follow-up|1|||
30991768|NCT02260986|59171077|FG000|Overall Study|Adverse Event|24|||
30991769|NCT02260986|59171078|FG001|Overall Study|Adverse Event|0|||
30991770|NCT02260986|59171079|FG002|Overall Study|Adverse Event|11|||
30991771|NCT02260986|59171077|FG000|Overall Study|Lack of Efficacy|27|||
30991772|NCT02260986|59171078|FG001|Overall Study|Lack of Efficacy|3|||
30991773|NCT02260986|59171079|FG002|Overall Study|Lack of Efficacy|0|||
30991774|NCT02260986|59171077|FG000|Overall Study|Protocol Violation|14|||
30991775|NCT02260986|59171078|FG001|Overall Study|Protocol Violation|5|||
30991776|NCT02260986|59171079|FG002|Overall Study|Protocol Violation|16|||
30991777|NCT02260986|59171077|FG000|Overall Study|Car accident|0|||
30991778|NCT02260986|59171078|FG001|Overall Study|Car accident|0|||
30991779|NCT02260986|59171079|FG002|Overall Study|Car accident|1|||
30991780|NCT02260986|59171077|FG000|Overall Study|Withdrawal by Subject|17|||
30991781|NCT02260986|59171078|FG001|Overall Study|Withdrawal by Subject|4|||
30991782|NCT02260986|59171079|FG002|Overall Study|Withdrawal by Subject|9|||
30991783|NCT02260986|59171077|FG000|Overall Study|Incorrect randomization|0|||
30608987|NCT01286012|58619865|FG000|Overall Study|Withdrawal by Subject|4|||
30608988|NCT01286012|58619866|FG001|Overall Study|Withdrawal by Subject|4|||
30608989|NCT01286012|58619865|FG000|Overall Study|Physician Decision|2|||
30608990|NCT01286012|58619866|FG001|Overall Study|Physician Decision|0|||
30608991|NCT01286012|58619865|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
30991784|NCT02260986|59171078|FG001|Overall Study|Incorrect randomization|1|||
30991785|NCT02260986|59171079|FG002|Overall Study|Incorrect randomization|0|||
30991786|NCT02260986|59171077|FG000|Overall Study|Lack of investigation product supply|2|||
30991787|NCT02260986|59171078|FG001|Overall Study|Lack of investigation product supply|0|||
30991788|NCT02260986|59171079|FG002|Overall Study|Lack of investigation product supply|1|||
30991789|NCT02260986|59171077|FG000|Overall Study|Lost to Follow-up|4|||
30991790|NCT02260986|59171078|FG001|Overall Study|Lost to Follow-up|0|||
30991791|NCT02260986|59171079|FG002|Overall Study|Lost to Follow-up|3|||
30991792|NCT02260986|59171077|FG000|Overall Study|Pregnancy|2|||
30991793|NCT02260986|59171078|FG001|Overall Study|Pregnancy|0|||
30991794|NCT02260986|59171079|FG002|Overall Study|Pregnancy|0|||
30991795|NCT02259582|59171095|FG000|Overall Study|Physician Decision|0|||
30991796|NCT02259582|59171096|FG001|Overall Study|Physician Decision|1|||
30991797|NCT02259582|59171097|FG002|Overall Study|Physician Decision|0|||
30991798|NCT02259582|59171095|FG000|Overall Study|Death|0|||
30991799|NCT02259582|59171096|FG001|Overall Study|Death|0|||
30991800|NCT02259582|59171097|FG002|Overall Study|Death|1|||
30991801|NCT02259582|59171095|FG000|Overall Study|Adverse Event|1|||
30991802|NCT02259582|59171096|FG001|Overall Study|Adverse Event|0|||
30991803|NCT02259582|59171097|FG002|Overall Study|Adverse Event|1|||
30991804|NCT02259582|59171095|FG000|Overall Study|Withdrawal by Subject|0|||
30991805|NCT02259582|59171096|FG001|Overall Study|Withdrawal by Subject|0|||
30991806|NCT02259582|59171097|FG002|Overall Study|Withdrawal by Subject|1|||
30991807|NCT02259582|59171095|FG000|Overall Study|Disease progression|14|||
30991808|NCT02259582|59171096|FG001|Overall Study|Disease progression|15|||
30991809|NCT02259582|59171097|FG002|Overall Study|Disease progression|17|||
30991810|NCT02259582|59171095|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
30991811|NCT02259582|59171096|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
30991812|NCT02259582|59171097|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
30991813|NCT03238651|59171110|FG000|Overall Study|Other|0|||
30991814|NCT03238651|59171111|FG001|Overall Study|Other|0|||
30991815|NCT03238651|59171112|FG002|Overall Study|Other|0|||
30991816|NCT03238651|59171113|FG003|Overall Study|Other|0|||
30991817|NCT03238651|59171114|FG004|Overall Study|Other|1|||
30991818|NCT03238651|59171110|FG000|Overall Study|Progressive Disease|2|||
30991819|NCT03238651|59171111|FG001|Overall Study|Progressive Disease|2|||
30991820|NCT03238651|59171112|FG002|Overall Study|Progressive Disease|2|||
30991821|NCT03238651|59171113|FG003|Overall Study|Progressive Disease|2|||
30991822|NCT03238651|59171114|FG004|Overall Study|Progressive Disease|0|||
30991823|NCT03238651|59171110|FG000|Overall Study|Withdrawal by Subject|0|||
30991824|NCT03238651|59171111|FG001|Overall Study|Withdrawal by Subject|1|||
30991825|NCT03238651|59171112|FG002|Overall Study|Withdrawal by Subject|0|||
30991826|NCT03238651|59171113|FG003|Overall Study|Withdrawal by Subject|1|||
30991827|NCT03238651|59171114|FG004|Overall Study|Withdrawal by Subject|0|||
30991828|NCT03238651|59171110|FG000|Overall Study|Adverse Event|1|||
30991829|NCT03238651|59171111|FG001|Overall Study|Adverse Event|3|||
30991830|NCT03238651|59171112|FG002|Overall Study|Adverse Event|2|||
30991831|NCT03238651|59171113|FG003|Overall Study|Adverse Event|0|||
30991832|NCT03238651|59171114|FG004|Overall Study|Adverse Event|0|||
30991833|NCT05490771|59171138|FG000|Overall Study|Disease progression|18|||
30991834|NCT05490771|59171138|FG000|Overall Study|Adverse Event|3|||
30991835|NCT05490771|59171138|FG000|Overall Study|Other complicating disease|1|||
30991836|NCT05490771|59171138|FG000|Overall Study|Withdrawal by Subject|3|||
30991837|NCT05490771|59171138|FG000|Overall Study|Physician Decision|1|||
30608992|NCT01286012|58619866|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
30608993|NCT00963547|58619877|FG000|Overall Study|Adverse Event|0|||
30991838|NCT05490771|59171138|FG000|Overall Study|Still on treatment|2|||
30991839|NCT05490771|59171138|FG000|Overall Study|Never start protocol therapy|5|||
30991840|NCT05490771|59171138|FG000|Overall Study|Ineligible|2|||
30991841|NCT05346055|59171142|FG000|Overall Study|Withdrawal by Subject|1|||
30991842|NCT05346055|59171142|FG000|Overall Study|Protocol Violation|1|||
30991843|NCT05346055|59171142|FG000|Overall Study|Therapist decision|1|||
30991844|NCT05211739|59171152|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
30991845|NCT05211739|59171153|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
30991846|NCT05211739|59171152|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
30991847|NCT05211739|59171153|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
30991848|NCT05211739|59171152|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
30991849|NCT05211739|59171153|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
30991850|NCT05211739|59171152|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
30991851|NCT05211739|59171153|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
30991852|NCT05085405|59171181|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
30991853|NCT05085405|59171182|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
30991854|NCT05085405|59171183|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
30991855|NCT05085405|59171184|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
30991856|NCT05085405|59171185|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
30991857|NCT05085405|59171186|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
30991858|NCT05085405|59171181|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
30991859|NCT05085405|59171182|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
30991860|NCT05085405|59171183|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
30991861|NCT05085405|59171184|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
30991862|NCT05085405|59171185|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
30991863|NCT05085405|59171186|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
30991864|NCT04932941|59171198|FG000|Overall Study|Lost to Follow-up|3|||
30991865|NCT04932941|59171199|FG001|Overall Study|Lost to Follow-up|1|||
30991866|NCT04932941|59171198|FG000|Overall Study|Withdrawal by Subject|7|||
30991867|NCT04932941|59171199|FG001|Overall Study|Withdrawal by Subject|4|||
30991868|NCT04932941|59171198|FG000|Overall Study|Other|4|||
30991869|NCT04932941|59171199|FG001|Overall Study|Other|2|||
30991870|NCT04662073|59171259|FG000|Overall Study|Withdrawal by Subject|1|||
30991871|NCT04662073|59171260|FG001|Overall Study|Withdrawal by Subject|0|||
30991872|NCT04656418|59171268|FG000|Overall Study|Withdrawal by Subject|1|||
30991873|NCT04656418|59171269|FG001|Overall Study|Withdrawal by Subject|3|||
30991874|NCT04622306|59171276|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
30991875|NCT04622306|59171277|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
30991876|NCT04622306|59171278|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
30991877|NCT04622306|59171279|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
30991878|NCT04622306|59171280|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
30991879|NCT04622306|59171281|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
30991880|NCT04622306|59171276|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
30991881|NCT04622306|59171277|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
30991882|NCT04622306|59171278|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
30991883|NCT04622306|59171279|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
30991884|NCT04622306|59171280|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
30991885|NCT04622306|59171281|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
30991886|NCT04601103|59171293|FG000|Overall Study|Needed crown & cleaning|0|||
30991887|NCT04601103|59171294|FG001|Overall Study|Needed crown & cleaning|0|||
30991888|NCT04601103|59171295|FG002|Overall Study|Needed crown & cleaning|1|||
30991889|NCT04601103|59171293|FG000|Overall Study|study was terminated|18|||
30991890|NCT04601103|59171294|FG001|Overall Study|study was terminated|18|||
30991891|NCT04601103|59171295|FG002|Overall Study|study was terminated|16|||
30991892|NCT04575597|59171309|FG000|Overall Study|Death|0|||
30991893|NCT04575597|59171310|FG001|Overall Study|Death|0|||
30991894|NCT04575597|59171311|FG002|Overall Study|Death|0|||
30991895|NCT04575597|59171312|FG003|Overall Study|Death|1|||
30991896|NCT04575597|59171313|FG004|Overall Study|Death|3|||
30991897|NCT04575597|59171314|FG005|Overall Study|Death|14|||
30991898|NCT04575597|59171309|FG000|Overall Study|Lost to Follow-up|2|||
30991899|NCT04575597|59171310|FG001|Overall Study|Lost to Follow-up|1|||
30991900|NCT04575597|59171311|FG002|Overall Study|Lost to Follow-up|1|||
30991901|NCT04575597|59171312|FG003|Overall Study|Lost to Follow-up|2|||
30991902|NCT04575597|59171313|FG004|Overall Study|Lost to Follow-up|10|||
30991903|NCT04575597|59171314|FG005|Overall Study|Lost to Follow-up|8|||
30991904|NCT04575597|59171309|FG000|Overall Study|Withdrawal by Subject|2|||
30991905|NCT04575597|59171310|FG001|Overall Study|Withdrawal by Subject|2|||
30991906|NCT04575597|59171311|FG002|Overall Study|Withdrawal by Subject|4|||
30991907|NCT04575597|59171312|FG003|Overall Study|Withdrawal by Subject|2|||
30991908|NCT04575597|59171313|FG004|Overall Study|Withdrawal by Subject|25|||
30991909|NCT04575597|59171314|FG005|Overall Study|Withdrawal by Subject|28|||
30991910|NCT04575597|59171309|FG000|Overall Study|Not Recorded|0|||
30991911|NCT04575597|59171310|FG001|Overall Study|Not Recorded|0|||
30991912|NCT04575597|59171311|FG002|Overall Study|Not Recorded|0|||
30991913|NCT04575597|59171312|FG003|Overall Study|Not Recorded|0|||
30991914|NCT04575597|59171313|FG004|Overall Study|Not Recorded|0|||
30991915|NCT04575597|59171314|FG005|Overall Study|Not Recorded|2|||
30991916|NCT04575597|59171309|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
30991917|NCT04575597|59171310|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
30991918|NCT04575597|59171311|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
30991919|NCT04575597|59171312|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
30991920|NCT04575597|59171313|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
30991921|NCT04575597|59171314|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
30991922|NCT04546724|59171336|FG000|Overall Study|Withdrawal by Subject|145|||
30991923|NCT04546724|59171337|FG001|Overall Study|Withdrawal by Subject|41|||
30991924|NCT04546724|59171336|FG000|Overall Study|Adverse Event|1|||
30991925|NCT04546724|59171337|FG001|Overall Study|Adverse Event|1|||
30991926|NCT04546724|59171336|FG000|Overall Study|Lost to Follow-up|186|||
30991927|NCT04546724|59171337|FG001|Overall Study|Lost to Follow-up|63|||
30991928|NCT04546724|59171336|FG000|Overall Study|Physician Decision|8|||
30991929|NCT04546724|59171337|FG001|Overall Study|Physician Decision|2|||
30991930|NCT04546724|59171336|FG000|Overall Study|Death|2|||
30991931|NCT04546724|59171337|FG001|Overall Study|Death|1|||
30991932|NCT04546724|59171336|FG000|Overall Study|subject has been out of town|1|||
30991933|NCT04546724|59171337|FG001|Overall Study|subject has been out of town|0|||
30991934|NCT04546724|59171336|FG000|Overall Study|subject is incarcerated|2|||
30991935|NCT04546724|59171337|FG001|Overall Study|subject is incarcerated|0|||
30991936|NCT04546724|59171336|FG000|Overall Study|subject is relocating|12|||
30991937|NCT04546724|59171337|FG001|Overall Study|subject is relocating|4|||
30991938|NCT04546724|59171336|FG000|Overall Study|Subject in another study|1|||
30991939|NCT04546724|59171337|FG001|Overall Study|Subject in another study|1|||
30991940|NCT04514510|59171349|FG000|Overall Study|Lost to Follow-up|0|||
30991941|NCT04514510|59171350|FG001|Overall Study|Lost to Follow-up|1|||
30991942|NCT04514510|59171349|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
30991943|NCT04514510|59171350|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
30991944|NCT04439136|59171362|FG000|Overall Study|Ineligible|1|||
30991945|NCT04439136|59171362|FG000|Overall Study|Never Started Treatment|2|||
30991946|NCT04439136|59171362|FG000|Overall Study|Adverse Event|4|||
30991947|NCT04439136|59171362|FG000|Overall Study|Death|3|||
30991948|NCT04439136|59171362|FG000|Overall Study|Disease Progression|27|||
30991949|NCT04439136|59171362|FG000|Overall Study|Alternative Therapy|1|||
30991950|NCT04439136|59171362|FG000|Overall Study|Increased Tumor Burden|1|||
30991951|NCT04439136|59171362|FG000|Overall Study|Symptomatic Detrioration|1|||
30991952|NCT04439123|59171366|FG000|Overall Study|Adverse Event|11|||
30991953|NCT04439123|59171366|FG000|Overall Study|Death|1|||
30991954|NCT04439123|59171366|FG000|Overall Study|Disease progression|19|||
30991955|NCT04439123|59171366|FG000|Overall Study|Withdrawal by Subject|2|||
30991956|NCT04439123|59171366|FG000|Overall Study|Still on treatment|2|||
30991957|NCT04439110|59171370|FG000|Overall Study|Ineligible|2|||
30991958|NCT04439110|59171370|FG000|Overall Study|Adverse Event|4|||
30991959|NCT04439110|59171370|FG000|Overall Study|Death|2|||
30991960|NCT04439110|59171370|FG000|Overall Study|Disease proression|25|||
30991961|NCT04439110|59171370|FG000|Overall Study|Withdrawal by Subject|1|||
30991962|NCT04439110|59171370|FG000|Overall Study|Alternative therapy|1|||
30991963|NCT04439110|59171370|FG000|Overall Study|Other complicating disease|1|||
30991964|NCT04439110|59171370|FG000|Overall Study|Personal reasons|1|||
30991965|NCT04439110|59171370|FG000|Overall Study|Still on treatment|1|||
30991966|NCT04391842|59171374|FG000|Overall Study|Withdrawal by Subject|2|||
30991967|NCT04327024|59171397|FG000|Overall Study|Death|1|||
30991968|NCT04327024|59171398|FG001|Overall Study|Death|2|||
30991969|NCT04327024|59171399|FG002|Overall Study|Death|1|||
30991970|NCT04327024|59171397|FG000|Overall Study|Non-compliance with study drug|0|||
30991971|NCT04327024|59171398|FG001|Overall Study|Non-compliance with study drug|1|||
30991972|NCT04327024|59171399|FG002|Overall Study|Non-compliance with study drug|0|||
30991973|NCT04327024|59171397|FG000|Overall Study|Withdrawal by Subject|1|||
30991974|NCT04327024|59171398|FG001|Overall Study|Withdrawal by Subject|1|||
30991975|NCT04327024|59171399|FG002|Overall Study|Withdrawal by Subject|2|||
30991976|NCT04322149|59171412|FG000|Overall Study|Adverse Event|1|||
30991977|NCT04322149|59171413|FG001|Overall Study|Adverse Event|1|||
30991978|NCT04322149|59171414|FG002|Overall Study|Adverse Event|0|||
30991979|NCT04322149|59171415|FG003|Overall Study|Adverse Event|0|||
30991980|NCT04322149|59171412|FG000|Overall Study|Withdrawal by Subject|0|||
30991981|NCT04322149|59171413|FG001|Overall Study|Withdrawal by Subject|0|||
30991982|NCT04322149|59171414|FG002|Overall Study|Withdrawal by Subject|0|||
30991983|NCT04322149|59171415|FG003|Overall Study|Withdrawal by Subject|2|||
30991984|NCT04322149|59171412|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
30991985|NCT04322149|59171413|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
30991986|NCT04322149|59171414|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
30991987|NCT04322149|59171415|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
30991988|NCT04294459|59171436|FG000|Overall Study|Adverse Event|0|||
30991989|NCT04294459|59171437|FG001|Overall Study|Adverse Event|1|||
30991990|NCT04226742|59171446|FG000|Overall Study|Lost to Follow-up|16|||
30991991|NCT04226742|59171447|FG001|Overall Study|Lost to Follow-up|13|||
30991992|NCT04226742|59171446|FG000|Overall Study|Withdrawal by Subject|5|||
30991993|NCT04226742|59171447|FG001|Overall Study|Withdrawal by Subject|3|||
30991994|NCT04194528|59171453|FG000|Overall Study|Adverse Event|1|||
30991995|NCT04146012|59171485|FG000|Overall Study|Study Terminated|30|||
30991996|NCT04146012|59171486|FG001|Overall Study|Study Terminated|15|||
30991997|NCT04085458|59171492|FG000|Overall Study|Other|1|||
30991998|NCT04085458|59171492|FG000|Overall Study|Withdrawal by Subject|2|||
30991999|NCT04085458|59171492|FG000|Overall Study|Adverse Event|2|||
30992000|NCT04033159|59171498|FG000|Washout Period|Physician Decision|0|||
30992001|NCT04033159|59171499|FG001|Washout Period|Physician Decision|1|||
30992002|NCT04033159|59171500|FG002|Washout Period|Physician Decision|0|||
30992003|NCT04033159|59171498|FG000|Washout Period|Study terminated by Sponsor|0|||
30992004|NCT04033159|59171499|FG001|Washout Period|Study terminated by Sponsor|7|||
30992005|NCT04033159|59171500|FG002|Washout Period|Study terminated by Sponsor|0|||
30992006|NCT04033159|59171498|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
30992007|NCT04033159|59171499|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
30992008|NCT04033159|59171500|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
30992009|NCT03969888|59171516|FG000|Overall Study|Never Received Study Drug|0|||
30992010|NCT03969888|59171517|FG001|Overall Study|Never Received Study Drug|0|||
30992011|NCT03969888|59171518|FG002|Overall Study|Never Received Study Drug|1|||
30992012|NCT03969888|59171519|FG003|Overall Study|Never Received Study Drug|0|||
30992013|NCT03969888|59171520|FG004|Overall Study|Never Received Study Drug|0|||
30992014|NCT03969888|59171521|FG005|Overall Study|Never Received Study Drug|0|||
30992015|NCT03969888|59171522|FG006|Overall Study|Never Received Study Drug|1|||
30992016|NCT03969888|59171523|FG007|Overall Study|Never Received Study Drug|0|||
30992017|NCT03969888|59171516|FG000|Overall Study|Reason Not Specified|0|||
30992018|NCT03969888|59171517|FG001|Overall Study|Reason Not Specified|0|||
30992019|NCT03969888|59171518|FG002|Overall Study|Reason Not Specified|0|||
30992020|NCT03969888|59171519|FG003|Overall Study|Reason Not Specified|0|||
30992021|NCT03969888|59171520|FG004|Overall Study|Reason Not Specified|0|||
30992022|NCT03969888|59171521|FG005|Overall Study|Reason Not Specified|0|||
30992023|NCT03969888|59171522|FG006|Overall Study|Reason Not Specified|0|||
30992024|NCT03969888|59171523|FG007|Overall Study|Reason Not Specified|1|||
30992025|NCT03952559|59171547|FG000|Double Blind Treatment Period|Adverse Event|0|||
30992026|NCT03952559|59171548|FG001|Double Blind Treatment Period|Adverse Event|2|||
30992027|NCT03952559|59171549|FG002|Double Blind Treatment Period|Adverse Event|1|||
30992028|NCT03952559|59171550|FG003|Double Blind Treatment Period|Adverse Event|0|||
30992029|NCT03952559|59171551|FG004|Double Blind Treatment Period|Adverse Event|1|||
30992030|NCT03952559|59171547|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
30992031|NCT03952559|59171548|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
30992032|NCT03952559|59171549|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
30992033|NCT03952559|59171550|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
30992034|NCT03952559|59171551|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
30992035|NCT03952559|59171547|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
30992036|NCT03952559|59171548|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
30992037|NCT03952559|59171549|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
30992038|NCT03952559|59171550|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
30992039|NCT03952559|59171551|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
30992040|NCT03952559|59171547|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
30992041|NCT03952559|59171548|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
30992042|NCT03952559|59171549|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
30992043|NCT03952559|59171550|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
30992044|NCT03952559|59171551|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
30992045|NCT03945175|59171587|FG000|Overall Study|Did not meet inclusion criteria|31|||
30992046|NCT03945175|59171587|FG000|Overall Study|Withdrew consent|2|||
30992047|NCT03945175|59171587|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
30992048|NCT03945175|59171587|FG000|Overall Study|Early termination during Mydayis treatment|1|||
30992049|NCT03942406|59171598|FG000|Overall Study|Lost to Follow-up|4|||
30992050|NCT03942406|59171599|FG001|Overall Study|Lost to Follow-up|5|||
30992051|NCT03942406|59171600|FG002|Overall Study|Lost to Follow-up|3|||
30992052|NCT03942406|59171601|FG003|Overall Study|Lost to Follow-up|7|||
30992053|NCT03942406|59171602|FG004|Overall Study|Lost to Follow-up|1|||
30992054|NCT03942406|59171603|FG005|Overall Study|Lost to Follow-up|0|||
30992055|NCT03942406|59171604|FG006|Overall Study|Lost to Follow-up|0|||
30992056|NCT03942406|59171598|FG000|Overall Study|Withdrawal by Subject|3|||
30992057|NCT03942406|59171599|FG001|Overall Study|Withdrawal by Subject|1|||
30992058|NCT03942406|59171600|FG002|Overall Study|Withdrawal by Subject|1|||
30992059|NCT03942406|59171601|FG003|Overall Study|Withdrawal by Subject|3|||
30992060|NCT03942406|59171602|FG004|Overall Study|Withdrawal by Subject|0|||
30992061|NCT03942406|59171603|FG005|Overall Study|Withdrawal by Subject|0|||
30992062|NCT03942406|59171604|FG006|Overall Study|Withdrawal by Subject|0|||
30992063|NCT03942406|59171598|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
30992064|NCT03942406|59171599|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
30992065|NCT03942406|59171600|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
30992066|NCT03942406|59171601|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
30992067|NCT03942406|59171602|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
30992068|NCT03942406|59171603|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
30992069|NCT03942406|59171604|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
30992070|NCT03909100|59171638|FG000|Overall Study|Protocol Deviation|2|||
30992071|NCT03909100|59171638|FG000|Overall Study|Technical Problems|4|||
30992072|NCT03909100|59171638|FG000|Overall Study|Withdrawal by Subject|4|||
30992073|NCT03909100|59171638|FG000|Overall Study|Lost to Follow-up|1|||
30992074|NCT03909100|59171638|FG000|Overall Study|Reason not Specified|4|||
30992075|NCT03896295|59171660|FG000|Overall Study|Adverse Event|0|||
30992076|NCT03896295|59171661|FG001|Overall Study|Adverse Event|1|||
30992077|NCT03896295|59171660|FG000|Overall Study|COVID-19|7|||
30992078|NCT03896295|59171661|FG001|Overall Study|COVID-19|29|||
30992079|NCT03734666|59171711|FG000|Overall Study|Other|7|||
30992080|NCT03734666|59171712|FG001|Overall Study|Other|4|||
30992081|NCT03734666|59171711|FG000|Overall Study|Lost to Follow-up|12|||
30992082|NCT03734666|59171712|FG001|Overall Study|Lost to Follow-up|12|||
30992083|NCT03635489|59171725|FG000|Overall Study|Death|6|||
30992084|NCT03635489|59171726|FG001|Overall Study|Death|3|||
30992085|NCT03635489|59171725|FG000|Overall Study|Lost to Follow-up|0|||
30992086|NCT03635489|59171726|FG001|Overall Study|Lost to Follow-up|1|||
30992087|NCT03635489|59171725|FG000|Overall Study|Withdrawal by Subject|1|||
30992088|NCT03635489|59171726|FG001|Overall Study|Withdrawal by Subject|2|||
30992089|NCT03633617|59171737|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
30992090|NCT03633617|59171738|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
30992091|NCT03633617|59171739|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
30992092|NCT03633617|59171740|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
30992093|NCT03633617|59171741|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
30992094|NCT03633617|59171742|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
30992095|NCT03633617|59171743|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
30992096|NCT03633617|59171744|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
30992097|NCT03633617|59171745|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
30992098|NCT03633617|59171746|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
30992099|NCT03633617|59171747|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
30992100|NCT03633617|59171737|FG000|Part A|Unconfirmed early termination visit|1|||
30992101|NCT03633617|59171738|FG001|Part A|Unconfirmed early termination visit|0|||
30992102|NCT03633617|59171739|FG002|Part A|Unconfirmed early termination visit|0|||
30992103|NCT03633617|59171740|FG003|Part A|Unconfirmed early termination visit|0|||
30992104|NCT03633617|59171741|FG004|Part A|Unconfirmed early termination visit|0|||
30992105|NCT03633617|59171742|FG005|Part A|Unconfirmed early termination visit|0|||
30992106|NCT03633617|59171743|FG006|Part A|Unconfirmed early termination visit|0|||
30992107|NCT03633617|59171744|FG007|Part A|Unconfirmed early termination visit|0|||
30992108|NCT03633617|59171745|FG008|Part A|Unconfirmed early termination visit|0|||
30992109|NCT03633617|59171746|FG009|Part A|Unconfirmed early termination visit|0|||
30992110|NCT03633617|59171747|FG010|Part A|Unconfirmed early termination visit|0|||
30992111|NCT03633617|59171737|FG000|Part A|Adverse Event|0|||
30992112|NCT03633617|59171738|FG001|Part A|Adverse Event|1|||
30992113|NCT03633617|59171739|FG002|Part A|Adverse Event|0|||
30992114|NCT03633617|59171740|FG003|Part A|Adverse Event|0|||
30992115|NCT03633617|59171741|FG004|Part A|Adverse Event|0|||
30992116|NCT03633617|59171742|FG005|Part A|Adverse Event|0|||
30992117|NCT03633617|59171743|FG006|Part A|Adverse Event|0|||
30992118|NCT03633617|59171744|FG007|Part A|Adverse Event|0|||
30992119|NCT03633617|59171745|FG008|Part A|Adverse Event|0|||
30992120|NCT03633617|59171746|FG009|Part A|Adverse Event|0|||
30992121|NCT03633617|59171747|FG010|Part A|Adverse Event|0|||
30992122|NCT03633617|59171737|FG000|Part A|Pregnancy|1|||
30992123|NCT03633617|59171738|FG001|Part A|Pregnancy|0|||
30992124|NCT03633617|59171739|FG002|Part A|Pregnancy|0|||
30992125|NCT03633617|59171740|FG003|Part A|Pregnancy|0|||
30992126|NCT03633617|59171741|FG004|Part A|Pregnancy|0|||
30992127|NCT03633617|59171742|FG005|Part A|Pregnancy|0|||
30992128|NCT03633617|59171743|FG006|Part A|Pregnancy|0|||
30992129|NCT03633617|59171744|FG007|Part A|Pregnancy|0|||
30992130|NCT03633617|59171745|FG008|Part A|Pregnancy|0|||
30992131|NCT03633617|59171746|FG009|Part A|Pregnancy|0|||
30992132|NCT03633617|59171747|FG010|Part A|Pregnancy|0|||
30992133|NCT03633617|59171737|FG000|Part A|Withdrawal by Subject|0|||
30992134|NCT03633617|59171738|FG001|Part A|Withdrawal by Subject|1|||
30992135|NCT03633617|59171739|FG002|Part A|Withdrawal by Subject|0|||
30992136|NCT03633617|59171740|FG003|Part A|Withdrawal by Subject|0|||
30992137|NCT03633617|59171741|FG004|Part A|Withdrawal by Subject|0|||
30992138|NCT03633617|59171742|FG005|Part A|Withdrawal by Subject|0|||
30992139|NCT03633617|59171743|FG006|Part A|Withdrawal by Subject|0|||
30992140|NCT03633617|59171744|FG007|Part A|Withdrawal by Subject|0|||
30992141|NCT03633617|59171745|FG008|Part A|Withdrawal by Subject|0|||
30992142|NCT03633617|59171746|FG009|Part A|Withdrawal by Subject|0|||
30992143|NCT03633617|59171747|FG010|Part A|Withdrawal by Subject|0|||
30992144|NCT03633617|59171737|FG000|Part B|Adverse Event|0|||
30992145|NCT03633617|59171738|FG001|Part B|Adverse Event|0|||
30992146|NCT03633617|59171739|FG002|Part B|Adverse Event|2|||
30992147|NCT03633617|59171740|FG003|Part B|Adverse Event|2|||
30992148|NCT03633617|59171741|FG004|Part B|Adverse Event|1|||
30992149|NCT03633617|59171742|FG005|Part B|Adverse Event|0|||
30992150|NCT03633617|59171743|FG006|Part B|Adverse Event|0|||
30992151|NCT03633617|59171744|FG007|Part B|Adverse Event|0|||
30992152|NCT03633617|59171745|FG008|Part B|Adverse Event|0|||
30992153|NCT03633617|59171746|FG009|Part B|Adverse Event|0|||
30992154|NCT03633617|59171747|FG010|Part B|Adverse Event|0|||
30992155|NCT03633617|59171737|FG000|Part B|Withdrawal by Subject|0|||
30992156|NCT03633617|59171738|FG001|Part B|Withdrawal by Subject|0|||
30992157|NCT03633617|59171739|FG002|Part B|Withdrawal by Subject|1|||
30992158|NCT03633617|59171740|FG003|Part B|Withdrawal by Subject|0|||
30992159|NCT03633617|59171741|FG004|Part B|Withdrawal by Subject|2|||
30992160|NCT03633617|59171742|FG005|Part B|Withdrawal by Subject|0|||
30992161|NCT03633617|59171743|FG006|Part B|Withdrawal by Subject|0|||
30992162|NCT03633617|59171744|FG007|Part B|Withdrawal by Subject|0|||
30992163|NCT03633617|59171745|FG008|Part B|Withdrawal by Subject|0|||
30992164|NCT03633617|59171746|FG009|Part B|Withdrawal by Subject|0|||
30992165|NCT03633617|59171747|FG010|Part B|Withdrawal by Subject|0|||
30992166|NCT03633617|59171737|FG000|Part B|Lost to Follow-up|0|||
30992167|NCT03633617|59171738|FG001|Part B|Lost to Follow-up|0|||
30992168|NCT03633617|59171739|FG002|Part B|Lost to Follow-up|0|||
30992169|NCT03633617|59171740|FG003|Part B|Lost to Follow-up|0|||
30992170|NCT03633617|59171741|FG004|Part B|Lost to Follow-up|1|||
30992171|NCT03633617|59171742|FG005|Part B|Lost to Follow-up|0|||
30992172|NCT03633617|59171743|FG006|Part B|Lost to Follow-up|0|||
30992173|NCT03633617|59171744|FG007|Part B|Lost to Follow-up|0|||
30992174|NCT03633617|59171745|FG008|Part B|Lost to Follow-up|0|||
30992175|NCT03633617|59171746|FG009|Part B|Lost to Follow-up|0|||
30992176|NCT03633617|59171747|FG010|Part B|Lost to Follow-up|0|||
30992177|NCT03633617|59171737|FG000|Part B|Physician Decision|0|||
30992178|NCT03633617|59171738|FG001|Part B|Physician Decision|0|||
30992179|NCT03633617|59171739|FG002|Part B|Physician Decision|0|||
30992180|NCT03633617|59171740|FG003|Part B|Physician Decision|0|||
30992181|NCT03633617|59171741|FG004|Part B|Physician Decision|1|||
30992182|NCT03633617|59171742|FG005|Part B|Physician Decision|0|||
30992183|NCT03633617|59171743|FG006|Part B|Physician Decision|0|||
30992184|NCT03633617|59171744|FG007|Part B|Physician Decision|0|||
30992185|NCT03633617|59171745|FG008|Part B|Physician Decision|0|||
30992186|NCT03633617|59171746|FG009|Part B|Physician Decision|0|||
30992187|NCT03633617|59171747|FG010|Part B|Physician Decision|0|||
30992188|NCT03633617|59171737|FG000|Part B|COVID-19 Restrictions|0|||
30992189|NCT03633617|59171738|FG001|Part B|COVID-19 Restrictions|0|||
30992190|NCT03633617|59171739|FG002|Part B|COVID-19 Restrictions|1|||
30992191|NCT03633617|59171740|FG003|Part B|COVID-19 Restrictions|0|||
30992192|NCT03633617|59171741|FG004|Part B|COVID-19 Restrictions|0|||
30992193|NCT03633617|59171742|FG005|Part B|COVID-19 Restrictions|0|||
30992194|NCT03633617|59171743|FG006|Part B|COVID-19 Restrictions|0|||
30992195|NCT03633617|59171744|FG007|Part B|COVID-19 Restrictions|0|||
30992196|NCT03633617|59171745|FG008|Part B|COVID-19 Restrictions|0|||
30992197|NCT03633617|59171746|FG009|Part B|COVID-19 Restrictions|0|||
30992198|NCT03633617|59171747|FG010|Part B|COVID-19 Restrictions|0|||
30992199|NCT03633617|59171737|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
30992200|NCT03633617|59171738|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
30992201|NCT03633617|59171739|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
30992202|NCT03633617|59171740|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
30992203|NCT03633617|59171741|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
30992204|NCT03633617|59171742|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
30992205|NCT03633617|59171743|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
30992206|NCT03633617|59171744|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
30992207|NCT03633617|59171745|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
30992208|NCT03633617|59171746|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
30992209|NCT03633617|59171747|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
30992210|NCT03633617|59171737|FG000|Part C (& Follow-up)|Adverse Event|0|||
30992211|NCT03633617|59171738|FG001|Part C (& Follow-up)|Adverse Event|0|||
30992212|NCT03633617|59171739|FG002|Part C (& Follow-up)|Adverse Event|0|||
30992213|NCT03633617|59171740|FG003|Part C (& Follow-up)|Adverse Event|0|||
30992214|NCT03633617|59171741|FG004|Part C (& Follow-up)|Adverse Event|0|||
30992215|NCT03633617|59171742|FG005|Part C (& Follow-up)|Adverse Event|1|||
30992216|NCT03633617|59171743|FG006|Part C (& Follow-up)|Adverse Event|0|||
30992217|NCT03633617|59171744|FG007|Part C (& Follow-up)|Adverse Event|1|||
30992218|NCT03633617|59171745|FG008|Part C (& Follow-up)|Adverse Event|0|||
30992219|NCT03633617|59171746|FG009|Part C (& Follow-up)|Adverse Event|0|||
30992220|NCT03633617|59171747|FG010|Part C (& Follow-up)|Adverse Event|0|||
30992221|NCT03633617|59171737|FG000|Part C (& Follow-up)|Pregnancy|0|||
30992222|NCT03633617|59171738|FG001|Part C (& Follow-up)|Pregnancy|0|||
30992223|NCT03633617|59171739|FG002|Part C (& Follow-up)|Pregnancy|0|||
30992224|NCT03633617|59171740|FG003|Part C (& Follow-up)|Pregnancy|0|||
30992225|NCT03633617|59171741|FG004|Part C (& Follow-up)|Pregnancy|0|||
30992226|NCT03633617|59171742|FG005|Part C (& Follow-up)|Pregnancy|0|||
30992227|NCT03633617|59171743|FG006|Part C (& Follow-up)|Pregnancy|0|||
30992228|NCT03633617|59171744|FG007|Part C (& Follow-up)|Pregnancy|0|||
30992229|NCT03633617|59171745|FG008|Part C (& Follow-up)|Pregnancy|0|||
30992230|NCT03633617|59171746|FG009|Part C (& Follow-up)|Pregnancy|1|||
30992231|NCT03633617|59171747|FG010|Part C (& Follow-up)|Pregnancy|0|||
30992232|NCT03633617|59171737|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
30992233|NCT03633617|59171738|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
30992234|NCT03633617|59171739|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
30992235|NCT03633617|59171740|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
30992236|NCT03633617|59171741|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
30992237|NCT03633617|59171742|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
30992238|NCT03633617|59171743|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
30992239|NCT03633617|59171744|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
30992240|NCT03633617|59171745|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
30992241|NCT03633617|59171746|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
30992242|NCT03633617|59171747|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
30992243|NCT03633617|59171737|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
30992244|NCT03633617|59171738|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
30992245|NCT03633617|59171739|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
30992246|NCT03633617|59171740|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
30992247|NCT03633617|59171741|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
30992248|NCT03633617|59171742|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
30992249|NCT03633617|59171743|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
30992250|NCT03633617|59171744|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
30992251|NCT03633617|59171745|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
30992252|NCT03633617|59171746|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
30992253|NCT03633617|59171747|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
30992254|NCT03633617|59171737|FG000|Part C (& Follow-up)|Physician Decision|0|||
30992255|NCT03633617|59171738|FG001|Part C (& Follow-up)|Physician Decision|0|||
30992256|NCT03633617|59171739|FG002|Part C (& Follow-up)|Physician Decision|0|||
30992257|NCT03633617|59171740|FG003|Part C (& Follow-up)|Physician Decision|0|||
30992258|NCT03633617|59171741|FG004|Part C (& Follow-up)|Physician Decision|0|||
30992259|NCT03633617|59171742|FG005|Part C (& Follow-up)|Physician Decision|0|||
30992260|NCT03633617|59171743|FG006|Part C (& Follow-up)|Physician Decision|0|||
30992261|NCT03633617|59171744|FG007|Part C (& Follow-up)|Physician Decision|1|||
30992262|NCT03633617|59171745|FG008|Part C (& Follow-up)|Physician Decision|0|||
30992263|NCT03633617|59171746|FG009|Part C (& Follow-up)|Physician Decision|0|||
30992264|NCT03633617|59171747|FG010|Part C (& Follow-up)|Physician Decision|1|||
30992265|NCT03633617|59171737|FG000|Part C (& Follow-up)|COVID-19 related|0|||
30992266|NCT03633617|59171738|FG001|Part C (& Follow-up)|COVID-19 related|0|||
30992267|NCT03633617|59171739|FG002|Part C (& Follow-up)|COVID-19 related|0|||
30992268|NCT03633617|59171740|FG003|Part C (& Follow-up)|COVID-19 related|0|||
30992269|NCT03633617|59171741|FG004|Part C (& Follow-up)|COVID-19 related|0|||
30992270|NCT03633617|59171742|FG005|Part C (& Follow-up)|COVID-19 related|1|||
30992271|NCT03633617|59171743|FG006|Part C (& Follow-up)|COVID-19 related|0|||
30992272|NCT03633617|59171744|FG007|Part C (& Follow-up)|COVID-19 related|0|||
30992273|NCT03633617|59171745|FG008|Part C (& Follow-up)|COVID-19 related|0|||
30992274|NCT03633617|59171746|FG009|Part C (& Follow-up)|COVID-19 related|0|||
30992275|NCT03633617|59171747|FG010|Part C (& Follow-up)|COVID-19 related|0|||
30992276|NCT03633617|59171737|FG000|Part C (& Follow-up)|Protocol Violation|0|||
30992277|NCT03633617|59171738|FG001|Part C (& Follow-up)|Protocol Violation|0|||
30992278|NCT03633617|59171739|FG002|Part C (& Follow-up)|Protocol Violation|0|||
30992279|NCT03633617|59171740|FG003|Part C (& Follow-up)|Protocol Violation|0|||
30992280|NCT03633617|59171741|FG004|Part C (& Follow-up)|Protocol Violation|0|||
30992281|NCT03633617|59171742|FG005|Part C (& Follow-up)|Protocol Violation|0|||
30992282|NCT03633617|59171743|FG006|Part C (& Follow-up)|Protocol Violation|0|||
30992283|NCT03633617|59171744|FG007|Part C (& Follow-up)|Protocol Violation|0|||
30992284|NCT03633617|59171745|FG008|Part C (& Follow-up)|Protocol Violation|0|||
30992285|NCT03633617|59171746|FG009|Part C (& Follow-up)|Protocol Violation|3|||
30992286|NCT03633617|59171747|FG010|Part C (& Follow-up)|Protocol Violation|1|||
30992287|NCT03633617|59171737|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
30992288|NCT03633617|59171738|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
30992289|NCT03633617|59171739|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
30992290|NCT03633617|59171740|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
30992291|NCT03633617|59171741|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
30992292|NCT03633617|59171742|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
30992293|NCT03633617|59171743|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
30992294|NCT03633617|59171744|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
30992295|NCT03633617|59171745|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
30992296|NCT03633617|59171746|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
30992297|NCT03633617|59171747|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
30992298|NCT03631784|59171777|FG000|Overall Study|Death|48|||
30992299|NCT03631784|59171778|FG001|Overall Study|Death|28|||
30992300|NCT03631784|59171777|FG000|Overall Study|Lost to Follow-up|1|||
30992301|NCT03631784|59171778|FG001|Overall Study|Lost to Follow-up|0|||
30992302|NCT03631784|59171777|FG000|Overall Study|Withdrawal by Subject|0|||
30992303|NCT03631784|59171778|FG001|Overall Study|Withdrawal by Subject|3|||
30992304|NCT03631784|59171777|FG000|Overall Study|Participants Ongoing|63|||
30992305|NCT03631784|59171778|FG001|Overall Study|Participants Ongoing|71|||
30992306|NCT03617705|59171784|FG000|Overall Study|Withdrawal by Subject|2|||
30992307|NCT03617705|59171784|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
30992308|NCT03617705|59171784|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
30992309|NCT03607422|59171794|FG000|Overall Study|Adverse Event|7|||
30992310|NCT03607422|59171795|FG001|Overall Study|Adverse Event|3|||
30992311|NCT03607422|59171796|FG002|Overall Study|Adverse Event|2|||
30992312|NCT03607422|59171797|FG003|Overall Study|Adverse Event|0|||
30992313|NCT03607422|59171798|FG004|Overall Study|Adverse Event|2|||
30992314|NCT03607422|59171799|FG005|Overall Study|Adverse Event|0|||
30992315|NCT03607422|59171794|FG000|Overall Study|Withdrawal by Subject|11|||
30992316|NCT03607422|59171795|FG001|Overall Study|Withdrawal by Subject|3|||
30992317|NCT03607422|59171796|FG002|Overall Study|Withdrawal by Subject|6|||
30992318|NCT03607422|59171797|FG003|Overall Study|Withdrawal by Subject|2|||
30992319|NCT03607422|59171798|FG004|Overall Study|Withdrawal by Subject|0|||
30992320|NCT03607422|59171799|FG005|Overall Study|Withdrawal by Subject|0|||
30992321|NCT03607422|59171794|FG000|Overall Study|Lost to Follow-up|0|||
30992322|NCT03607422|59171795|FG001|Overall Study|Lost to Follow-up|0|||
30992323|NCT03607422|59171796|FG002|Overall Study|Lost to Follow-up|1|||
30992324|NCT03607422|59171797|FG003|Overall Study|Lost to Follow-up|0|||
30992325|NCT03607422|59171798|FG004|Overall Study|Lost to Follow-up|0|||
30992326|NCT03607422|59171799|FG005|Overall Study|Lost to Follow-up|0|||
30992327|NCT03607422|59171794|FG000|Overall Study|Other|12|||
30992328|NCT03607422|59171795|FG001|Overall Study|Other|4|||
30992329|NCT03607422|59171796|FG002|Overall Study|Other|1|||
30992330|NCT03607422|59171797|FG003|Overall Study|Other|2|||
30992331|NCT03607422|59171798|FG004|Overall Study|Other|0|||
30992332|NCT03607422|59171799|FG005|Overall Study|Other|2|||
30992333|NCT03607422|59171794|FG000|Overall Study|Ongoing at Time of Analysis|8|||
30992334|NCT03607422|59171795|FG001|Overall Study|Ongoing at Time of Analysis|0|||
30992335|NCT03607422|59171796|FG002|Overall Study|Ongoing at Time of Analysis|2|||
30992336|NCT03607422|59171797|FG003|Overall Study|Ongoing at Time of Analysis|1|||
30992337|NCT03607422|59171798|FG004|Overall Study|Ongoing at Time of Analysis|1|||
30992338|NCT03607422|59171799|FG005|Overall Study|Ongoing at Time of Analysis|1|||
30992339|NCT03568318|59171837|FG000|Overall Study|Adverse Event|3|||
30992340|NCT03568318|59171838|FG001|Overall Study|Adverse Event|1|||
30992341|NCT03568318|59171839|FG002|Overall Study|Adverse Event|1|||
30992342|NCT03568318|59171840|FG003|Overall Study|Adverse Event|0|||
30992343|NCT03568318|59171841|FG004|Overall Study|Adverse Event|1|||
30992344|NCT03568318|59171842|FG005|Overall Study|Adverse Event|0|||
30992345|NCT03568318|59171837|FG000|Overall Study|Withdrawal by Subject|6|||
30992346|NCT03568318|59171838|FG001|Overall Study|Withdrawal by Subject|5|||
30992347|NCT03568318|59171839|FG002|Overall Study|Withdrawal by Subject|2|||
30992348|NCT03568318|59171840|FG003|Overall Study|Withdrawal by Subject|1|||
30992349|NCT03568318|59171841|FG004|Overall Study|Withdrawal by Subject|0|||
30992350|NCT03568318|59171842|FG005|Overall Study|Withdrawal by Subject|0|||
30992351|NCT03568318|59171837|FG000|Overall Study|Lost to Follow-up|3|||
30992352|NCT03568318|59171838|FG001|Overall Study|Lost to Follow-up|2|||
30992353|NCT03568318|59171839|FG002|Overall Study|Lost to Follow-up|2|||
30992354|NCT03568318|59171840|FG003|Overall Study|Lost to Follow-up|2|||
30992355|NCT03568318|59171841|FG004|Overall Study|Lost to Follow-up|1|||
30992356|NCT03568318|59171842|FG005|Overall Study|Lost to Follow-up|0|||
30992357|NCT03568318|59171837|FG000|Overall Study|Other|3|||
30992358|NCT03568318|59171838|FG001|Overall Study|Other|1|||
30992359|NCT03568318|59171839|FG002|Overall Study|Other|3|||
30992360|NCT03568318|59171840|FG003|Overall Study|Other|0|||
30992361|NCT03568318|59171841|FG004|Overall Study|Other|0|||
30992362|NCT03568318|59171842|FG005|Overall Study|Other|0|||
30992363|NCT03568318|59171837|FG000|Overall Study|Ongoing at Time of Analysis|5|||
30992364|NCT03568318|59171838|FG001|Overall Study|Ongoing at Time of Analysis|3|||
30992365|NCT03568318|59171839|FG002|Overall Study|Ongoing at Time of Analysis|2|||
30992366|NCT03568318|59171840|FG003|Overall Study|Ongoing at Time of Analysis|1|||
30992367|NCT03568318|59171841|FG004|Overall Study|Ongoing at Time of Analysis|0|||
30992368|NCT03568318|59171842|FG005|Overall Study|Ongoing at Time of Analysis|0|||
30992369|NCT03550794|59171858|FG000|Overall Study|No longer met inclusion criteria|1|||
30992370|NCT03550794|59171859|FG001|Overall Study|No longer met inclusion criteria|2|||
30992371|NCT03550794|59171858|FG000|Overall Study|Goals of care changed|1|||
30992372|NCT03550794|59171859|FG001|Overall Study|Goals of care changed|0|||
30992373|NCT03550794|59171858|FG000|Overall Study|Withdrawal by Subject|2|||
30992374|NCT03550794|59171859|FG001|Overall Study|Withdrawal by Subject|0|||
30992375|NCT03550794|59171858|FG000|Overall Study|Death|0|||
30992376|NCT03550794|59171859|FG001|Overall Study|Death|1|||
30992377|NCT03459846|59171884|FG000|Overall Study|Death|52|||
30992378|NCT03459846|59171885|FG001|Overall Study|Death|46|||
30992379|NCT03459846|59171884|FG000|Overall Study|Study terminated by sponsor|24|||
30992380|NCT03459846|59171885|FG001|Overall Study|Study terminated by sponsor|28|||
30992381|NCT03459846|59171884|FG000|Overall Study|Withdrawal by Subject|2|||
30992382|NCT03459846|59171885|FG001|Overall Study|Withdrawal by Subject|2|||
30992383|NCT03427125|59171911|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
30992384|NCT03427125|59171912|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
30992385|NCT03427125|59171913|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
30992386|NCT03341273|59171928|FG000|Overall Study|Lost to Follow-up|7|||
30992387|NCT03341273|59171929|FG001|Overall Study|Lost to Follow-up|7|||
30992388|NCT03341273|59171928|FG000|Overall Study|Withdrawal by Subject|4|||
30992389|NCT03341273|59171929|FG001|Overall Study|Withdrawal by Subject|2|||
30992390|NCT03341273|59171928|FG000|Overall Study|Physician Decision|1|||
30992391|NCT03341273|59171929|FG001|Overall Study|Physician Decision|0|||
30992392|NCT03341273|59171928|FG000|Overall Study|Protocol Violation|0|||
30992393|NCT03341273|59171929|FG001|Overall Study|Protocol Violation|1|||
30992394|NCT03341273|59171928|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
30992395|NCT03341273|59171929|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
30992396|NCT03341273|59171928|FG000|Overall Study|Became ineligible after enrollment|1|||
30992397|NCT03341273|59171929|FG001|Overall Study|Became ineligible after enrollment|0|||
30992398|NCT03341273|59171928|FG000|Overall Study|Not Eligible at Enrollment|0|||
30992399|NCT03341273|59171929|FG001|Overall Study|Not Eligible at Enrollment|1|||
30992400|NCT03341273|59171928|FG000|Overall Study|Participant incarcerated|1|||
30992401|NCT03341273|59171929|FG001|Overall Study|Participant incarcerated|0|||
30992402|NCT03307785|59171946|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
30992403|NCT03307785|59171947|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
30992404|NCT03307785|59171948|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
30992405|NCT03307785|59171949|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
30992406|NCT03307785|59171950|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
30992407|NCT03307785|59171951|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
30992408|NCT03307785|59171952|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
30992409|NCT03307785|59171953|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
30992410|NCT03307785|59171954|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
30992411|NCT03307785|59171955|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
30992412|NCT03307785|59171956|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
30992413|NCT03307785|59171946|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
30992414|NCT03307785|59171947|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
30992415|NCT03307785|59171948|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
30992416|NCT03307785|59171949|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
30992417|NCT03307785|59171950|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
30992418|NCT03307785|59171951|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
30992419|NCT03307785|59171952|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
30608994|NCT00963547|58619878|FG001|Overall Study|Adverse Event|1|||
30992420|NCT03307785|59171953|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
30992421|NCT03307785|59171954|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
30992422|NCT03307785|59171955|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
30992423|NCT03307785|59171956|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
30992424|NCT03307785|59171946|FG000|Part A: Up to 28.5 Months|Death|4|||
30992425|NCT03307785|59171947|FG001|Part A: Up to 28.5 Months|Death|4|||
30992426|NCT03307785|59171948|FG002|Part A: Up to 28.5 Months|Death|0|||
30992427|NCT03307785|59171949|FG003|Part A: Up to 28.5 Months|Death|0|||
30992428|NCT03307785|59171950|FG004|Part A: Up to 28.5 Months|Death|0|||
30992429|NCT03307785|59171951|FG005|Part A: Up to 28.5 Months|Death|0|||
30992430|NCT03307785|59171952|FG006|Part A: Up to 28.5 Months|Death|0|||
30992431|NCT03307785|59171953|FG007|Part A: Up to 28.5 Months|Death|0|||
30992432|NCT03307785|59171954|FG008|Part A: Up to 28.5 Months|Death|0|||
30992433|NCT03307785|59171955|FG009|Part A: Up to 28.5 Months|Death|0|||
30992434|NCT03307785|59171956|FG010|Part A: Up to 28.5 Months|Death|0|||
30992435|NCT03307785|59171946|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
30992436|NCT03307785|59171947|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
30992437|NCT03307785|59171948|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
30992438|NCT03307785|59171949|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
30992439|NCT03307785|59171950|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
30992440|NCT03307785|59171951|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
30992441|NCT03307785|59171952|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
30992442|NCT03307785|59171953|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
30992443|NCT03307785|59171954|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
30992444|NCT03307785|59171955|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
30992445|NCT03307785|59171956|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
30992446|NCT03307785|59171946|FG000|Part B: Up to 28.5 Months|Disease progression|0|||
30992447|NCT03307785|59171947|FG001|Part B: Up to 28.5 Months|Disease progression|0|||
30992448|NCT03307785|59171948|FG002|Part B: Up to 28.5 Months|Disease progression|1|||
30992449|NCT03307785|59171949|FG003|Part B: Up to 28.5 Months|Disease progression|0|||
30992450|NCT03307785|59171950|FG004|Part B: Up to 28.5 Months|Disease progression|0|||
30992451|NCT03307785|59171951|FG005|Part B: Up to 28.5 Months|Disease progression|0|||
30992452|NCT03307785|59171952|FG006|Part B: Up to 28.5 Months|Disease progression|0|||
30992453|NCT03307785|59171953|FG007|Part B: Up to 28.5 Months|Disease progression|0|||
30992454|NCT03307785|59171954|FG008|Part B: Up to 28.5 Months|Disease progression|0|||
30992455|NCT03307785|59171955|FG009|Part B: Up to 28.5 Months|Disease progression|0|||
30992456|NCT03307785|59171956|FG010|Part B: Up to 28.5 Months|Disease progression|0|||
30992457|NCT03307785|59171946|FG000|Part B: Up to 28.5 Months|Physician Decision|0|||
30992458|NCT03307785|59171947|FG001|Part B: Up to 28.5 Months|Physician Decision|0|||
30992459|NCT03307785|59171948|FG002|Part B: Up to 28.5 Months|Physician Decision|1|||
30992460|NCT03307785|59171949|FG003|Part B: Up to 28.5 Months|Physician Decision|0|||
30992461|NCT03307785|59171950|FG004|Part B: Up to 28.5 Months|Physician Decision|0|||
30992462|NCT03307785|59171951|FG005|Part B: Up to 28.5 Months|Physician Decision|0|||
30992463|NCT03307785|59171952|FG006|Part B: Up to 28.5 Months|Physician Decision|0|||
30992464|NCT03307785|59171953|FG007|Part B: Up to 28.5 Months|Physician Decision|0|||
30992465|NCT03307785|59171954|FG008|Part B: Up to 28.5 Months|Physician Decision|0|||
30992466|NCT03307785|59171955|FG009|Part B: Up to 28.5 Months|Physician Decision|0|||
30992467|NCT03307785|59171956|FG010|Part B: Up to 28.5 Months|Physician Decision|0|||
30992468|NCT03307785|59171946|FG000|Part B: Up to 28.5 Months|Death|0|||
30992469|NCT03307785|59171947|FG001|Part B: Up to 28.5 Months|Death|0|||
30992470|NCT03307785|59171948|FG002|Part B: Up to 28.5 Months|Death|7|||
30992471|NCT03307785|59171949|FG003|Part B: Up to 28.5 Months|Death|0|||
30992472|NCT03307785|59171950|FG004|Part B: Up to 28.5 Months|Death|0|||
30992473|NCT03307785|59171951|FG005|Part B: Up to 28.5 Months|Death|0|||
30992474|NCT03307785|59171952|FG006|Part B: Up to 28.5 Months|Death|0|||
30992475|NCT03307785|59171953|FG007|Part B: Up to 28.5 Months|Death|0|||
30992476|NCT03307785|59171954|FG008|Part B: Up to 28.5 Months|Death|0|||
30992477|NCT03307785|59171955|FG009|Part B: Up to 28.5 Months|Death|0|||
30992478|NCT03307785|59171956|FG010|Part B: Up to 28.5 Months|Death|0|||
30992479|NCT03307785|59171946|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
30992480|NCT03307785|59171947|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
30992481|NCT03307785|59171948|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1|||
30992482|NCT03307785|59171949|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
30992483|NCT03307785|59171950|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
30992484|NCT03307785|59171951|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
30992485|NCT03307785|59171952|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
30992486|NCT03307785|59171953|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
30992487|NCT03307785|59171954|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
30992488|NCT03307785|59171955|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
30992489|NCT03307785|59171956|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
30992490|NCT03307785|59171946|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
30992491|NCT03307785|59171947|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
30992492|NCT03307785|59171948|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4|||
30992493|NCT03307785|59171949|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
30992494|NCT03307785|59171950|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
30992495|NCT03307785|59171951|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
30992496|NCT03307785|59171952|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
30992497|NCT03307785|59171953|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
30992498|NCT03307785|59171954|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
30992499|NCT03307785|59171955|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
30992500|NCT03307785|59171956|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
30992501|NCT03307785|59171946|FG000|Part C: Up to 22.5 Months|Disease progression|0|||
30992502|NCT03307785|59171947|FG001|Part C: Up to 22.5 Months|Disease progression|0|||
30992503|NCT03307785|59171948|FG002|Part C: Up to 22.5 Months|Disease progression|0|||
30992504|NCT03307785|59171949|FG003|Part C: Up to 22.5 Months|Disease progression|0|||
30992505|NCT03307785|59171950|FG004|Part C: Up to 22.5 Months|Disease progression|1|||
30992506|NCT03307785|59171951|FG005|Part C: Up to 22.5 Months|Disease progression|0|||
30992507|NCT03307785|59171952|FG006|Part C: Up to 22.5 Months|Disease progression|0|||
30992508|NCT03307785|59171953|FG007|Part C: Up to 22.5 Months|Disease progression|0|||
30992509|NCT03307785|59171954|FG008|Part C: Up to 22.5 Months|Disease progression|0|||
30992510|NCT03307785|59171955|FG009|Part C: Up to 22.5 Months|Disease progression|0|||
30992511|NCT03307785|59171956|FG010|Part C: Up to 22.5 Months|Disease progression|0|||
30992512|NCT03307785|59171946|FG000|Part C: Up to 22.5 Months|Physician Decision|0|||
30992513|NCT03307785|59171947|FG001|Part C: Up to 22.5 Months|Physician Decision|0|||
30992514|NCT03307785|59171948|FG002|Part C: Up to 22.5 Months|Physician Decision|0|||
30992515|NCT03307785|59171949|FG003|Part C: Up to 22.5 Months|Physician Decision|3|||
30992516|NCT03307785|59171950|FG004|Part C: Up to 22.5 Months|Physician Decision|1|||
30992517|NCT03307785|59171951|FG005|Part C: Up to 22.5 Months|Physician Decision|0|||
30992518|NCT03307785|59171952|FG006|Part C: Up to 22.5 Months|Physician Decision|0|||
30992519|NCT03307785|59171953|FG007|Part C: Up to 22.5 Months|Physician Decision|0|||
30992520|NCT03307785|59171954|FG008|Part C: Up to 22.5 Months|Physician Decision|0|||
30992521|NCT03307785|59171955|FG009|Part C: Up to 22.5 Months|Physician Decision|0|||
30992522|NCT03307785|59171956|FG010|Part C: Up to 22.5 Months|Physician Decision|0|||
30992523|NCT03307785|59171946|FG000|Part C: Up to 22.5 Months|Death|0|||
30992524|NCT03307785|59171947|FG001|Part C: Up to 22.5 Months|Death|0|||
30992525|NCT03307785|59171948|FG002|Part C: Up to 22.5 Months|Death|0|||
30992526|NCT03307785|59171949|FG003|Part C: Up to 22.5 Months|Death|1|||
30992527|NCT03307785|59171950|FG004|Part C: Up to 22.5 Months|Death|4|||
30992528|NCT03307785|59171951|FG005|Part C: Up to 22.5 Months|Death|0|||
30992529|NCT03307785|59171952|FG006|Part C: Up to 22.5 Months|Death|0|||
30992530|NCT03307785|59171953|FG007|Part C: Up to 22.5 Months|Death|0|||
30992531|NCT03307785|59171954|FG008|Part C: Up to 22.5 Months|Death|0|||
30992532|NCT03307785|59171955|FG009|Part C: Up to 22.5 Months|Death|0|||
30992533|NCT03307785|59171956|FG010|Part C: Up to 22.5 Months|Death|0|||
30992534|NCT03307785|59171946|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
30992535|NCT03307785|59171947|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
30992536|NCT03307785|59171948|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
30992537|NCT03307785|59171949|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1|||
30992538|NCT03307785|59171950|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
30992539|NCT03307785|59171951|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
30992540|NCT03307785|59171952|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
30992541|NCT03307785|59171953|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
30992542|NCT03307785|59171954|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
30992543|NCT03307785|59171955|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
30992544|NCT03307785|59171956|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
30992545|NCT03307785|59171946|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
30992546|NCT03307785|59171947|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
30992547|NCT03307785|59171948|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
30992548|NCT03307785|59171949|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
30992549|NCT03307785|59171950|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
30992550|NCT03307785|59171951|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
30992551|NCT03307785|59171952|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
30992552|NCT03307785|59171953|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
30992553|NCT03307785|59171954|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
30992554|NCT03307785|59171955|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
30992555|NCT03307785|59171956|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
30992556|NCT03307785|59171946|FG000|Part D: Up to 9.5 Months|Physician Decision|0|||
30992557|NCT03307785|59171947|FG001|Part D: Up to 9.5 Months|Physician Decision|0|||
30992558|NCT03307785|59171948|FG002|Part D: Up to 9.5 Months|Physician Decision|0|||
30992559|NCT03307785|59171949|FG003|Part D: Up to 9.5 Months|Physician Decision|0|||
30992560|NCT03307785|59171950|FG004|Part D: Up to 9.5 Months|Physician Decision|0|||
30992561|NCT03307785|59171951|FG005|Part D: Up to 9.5 Months|Physician Decision|1|||
30992562|NCT03307785|59171952|FG006|Part D: Up to 9.5 Months|Physician Decision|0|||
30992563|NCT03307785|59171953|FG007|Part D: Up to 9.5 Months|Physician Decision|0|||
30992564|NCT03307785|59171954|FG008|Part D: Up to 9.5 Months|Physician Decision|0|||
30992565|NCT03307785|59171955|FG009|Part D: Up to 9.5 Months|Physician Decision|0|||
30992566|NCT03307785|59171956|FG010|Part D: Up to 9.5 Months|Physician Decision|0|||
30992567|NCT03307785|59171946|FG000|Part D: Up to 9.5 Months|Death|0|||
30992568|NCT03307785|59171947|FG001|Part D: Up to 9.5 Months|Death|0|||
30992569|NCT03307785|59171948|FG002|Part D: Up to 9.5 Months|Death|0|||
30992570|NCT03307785|59171949|FG003|Part D: Up to 9.5 Months|Death|0|||
30992571|NCT03307785|59171950|FG004|Part D: Up to 9.5 Months|Death|0|||
30992572|NCT03307785|59171951|FG005|Part D: Up to 9.5 Months|Death|1|||
30992573|NCT03307785|59171952|FG006|Part D: Up to 9.5 Months|Death|0|||
30992574|NCT03307785|59171953|FG007|Part D: Up to 9.5 Months|Death|0|||
30992575|NCT03307785|59171954|FG008|Part D: Up to 9.5 Months|Death|0|||
30992576|NCT03307785|59171955|FG009|Part D: Up to 9.5 Months|Death|0|||
30992577|NCT03307785|59171956|FG010|Part D: Up to 9.5 Months|Death|0|||
30992578|NCT03307785|59171946|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
30992579|NCT03307785|59171947|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
30992580|NCT03307785|59171948|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
30992581|NCT03307785|59171949|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
30992582|NCT03307785|59171950|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
30992583|NCT03307785|59171951|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1|||
30992584|NCT03307785|59171952|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
30992585|NCT03307785|59171953|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
30992586|NCT03307785|59171954|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
30992587|NCT03307785|59171955|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
30992588|NCT03307785|59171956|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
30992589|NCT03307785|59171946|FG000|Part E: Up to 4.4 Months|Death|0|||
30992590|NCT03307785|59171947|FG001|Part E: Up to 4.4 Months|Death|0|||
30992591|NCT03307785|59171948|FG002|Part E: Up to 4.4 Months|Death|0|||
30992592|NCT03307785|59171949|FG003|Part E: Up to 4.4 Months|Death|0|||
30992593|NCT03307785|59171950|FG004|Part E: Up to 4.4 Months|Death|0|||
30992594|NCT03307785|59171951|FG005|Part E: Up to 4.4 Months|Death|0|||
30992595|NCT03307785|59171952|FG006|Part E: Up to 4.4 Months|Death|1|||
30992596|NCT03307785|59171953|FG007|Part E: Up to 4.4 Months|Death|0|||
30992597|NCT03307785|59171954|FG008|Part E: Up to 4.4 Months|Death|0|||
30992598|NCT03307785|59171955|FG009|Part E: Up to 4.4 Months|Death|0|||
30992599|NCT03307785|59171956|FG010|Part E: Up to 4.4 Months|Death|0|||
30992600|NCT03307785|59171946|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
30992601|NCT03307785|59171947|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
30992602|NCT03307785|59171948|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
30992603|NCT03307785|59171949|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
30992604|NCT03307785|59171950|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
30992605|NCT03307785|59171951|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
30992606|NCT03307785|59171952|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
30992607|NCT03307785|59171953|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
30992608|NCT03307785|59171954|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
30992609|NCT03307785|59171955|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
30992610|NCT03307785|59171956|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
30992611|NCT03307785|59171946|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
30992612|NCT03307785|59171947|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
30992613|NCT03307785|59171948|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
30992614|NCT03307785|59171949|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
30992615|NCT03307785|59171950|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
30992616|NCT03307785|59171951|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
30992617|NCT03307785|59171952|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
30992618|NCT03307785|59171953|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
30992619|NCT03307785|59171954|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
30992620|NCT03307785|59171955|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
30992621|NCT03307785|59171956|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
30992622|NCT03284710|59171981|FG000|Overall Study|Withdrawal by Subject|1|||
30992623|NCT03284710|59171982|FG001|Overall Study|Withdrawal by Subject|0|||
30992624|NCT03284710|59171983|FG002|Overall Study|Withdrawal by Subject|1|||
30992625|NCT03284710|59171984|FG003|Overall Study|Withdrawal by Subject|6|||
30992626|NCT03284710|59171981|FG000|Overall Study|Lost to Follow-up|3|||
30992627|NCT03284710|59171982|FG001|Overall Study|Lost to Follow-up|3|||
30992628|NCT03284710|59171983|FG002|Overall Study|Lost to Follow-up|1|||
30992629|NCT03284710|59171984|FG003|Overall Study|Lost to Follow-up|0|||
30992630|NCT03284710|59171981|FG000|Overall Study|Physician Decision|1|||
30992631|NCT03284710|59171982|FG001|Overall Study|Physician Decision|0|||
30992632|NCT03284710|59171983|FG002|Overall Study|Physician Decision|0|||
30992633|NCT03284710|59171984|FG003|Overall Study|Physician Decision|0|||
30992634|NCT03284710|59171981|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
30992635|NCT03284710|59171982|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
30992636|NCT03284710|59171983|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
30992637|NCT03284710|59171984|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
30992638|NCT03284710|59171981|FG000|Overall Study|HIV Infection|0|||
30992639|NCT03284710|59171982|FG001|Overall Study|HIV Infection|2|||
30992640|NCT03284710|59171983|FG002|Overall Study|HIV Infection|2|||
30992641|NCT03284710|59171984|FG003|Overall Study|HIV Infection|1|||
30992642|NCT03248167|59172003|FG000|Overall Study|Withdrawal by Subject|2|||
30992643|NCT03248167|59172004|FG001|Overall Study|Withdrawal by Subject|2|||
30992644|NCT03248167|59172003|FG000|Overall Study|Physician Decision|0|||
30992645|NCT03248167|59172004|FG001|Overall Study|Physician Decision|1|||
30992646|NCT03248167|59172003|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
30992647|NCT03248167|59172004|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
30992648|NCT03248167|59172003|FG000|Overall Study|Lost to Follow-up|1|||
30992649|NCT03248167|59172004|FG001|Overall Study|Lost to Follow-up|0|||
30992650|NCT03220737|59172018|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
30992651|NCT03220737|59172019|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
30992652|NCT03220737|59172020|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
30992653|NCT03220737|59172021|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
30992654|NCT03220737|59172022|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
30992655|NCT03220737|59172023|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
30992656|NCT03220737|59172024|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
30992657|NCT03220737|59172018|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
30992658|NCT03220737|59172019|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
30992659|NCT03220737|59172020|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
30992660|NCT03220737|59172021|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
30992661|NCT03220737|59172022|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
30992662|NCT03220737|59172023|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
30992663|NCT03220737|59172024|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
30992664|NCT03220737|59172018|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
30992665|NCT03220737|59172019|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
30992666|NCT03220737|59172020|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
30992667|NCT03220737|59172021|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
30992668|NCT03220737|59172022|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
30992669|NCT03220737|59172023|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
30992670|NCT03220737|59172024|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
30992671|NCT03220737|59172018|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
30992672|NCT03220737|59172019|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
30992673|NCT03220737|59172020|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
30992674|NCT03220737|59172021|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
30992675|NCT03220737|59172022|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
30992676|NCT03220737|59172023|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
30992677|NCT03220737|59172024|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
30992678|NCT03220737|59172018|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
30992679|NCT03220737|59172019|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
30992680|NCT03220737|59172020|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
30992681|NCT03220737|59172021|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
30992682|NCT03220737|59172022|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
30992683|NCT03220737|59172023|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
30992684|NCT03220737|59172024|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
30992685|NCT03220737|59172018|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
30992686|NCT03220737|59172019|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
30992687|NCT03220737|59172020|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
30992688|NCT03220737|59172021|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
30992689|NCT03220737|59172022|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
30992690|NCT03220737|59172023|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
30992691|NCT03220737|59172024|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
30992692|NCT03220737|59172018|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
30992693|NCT03220737|59172019|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
30992694|NCT03220737|59172020|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
30992695|NCT03220737|59172021|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
30992696|NCT03220737|59172022|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
30992697|NCT03220737|59172023|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
30992698|NCT03220737|59172024|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
30992699|NCT03220737|59172018|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
30992700|NCT03220737|59172019|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
30992701|NCT03220737|59172020|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
30992702|NCT03220737|59172021|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
30992703|NCT03220737|59172022|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
30992704|NCT03220737|59172023|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
30992705|NCT03220737|59172024|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
30992706|NCT03198728|59172048|FG000|Overall Study|Adverse Event|10|||
30992707|NCT03198728|59172049|FG001|Overall Study|Adverse Event|5|||
30992708|NCT03198728|59172048|FG000|Overall Study|Lost to Follow-up|21|||
30992709|NCT03198728|59172049|FG001|Overall Study|Lost to Follow-up|7|||
30992710|NCT03198728|59172048|FG000|Overall Study|Physician Decision|7|||
30992711|NCT03198728|59172049|FG001|Overall Study|Physician Decision|2|||
30992712|NCT03198728|59172048|FG000|Overall Study|Withdrawal by Subject|14|||
30992713|NCT03198728|59172049|FG001|Overall Study|Withdrawal by Subject|10|||
30992714|NCT03144804|59172081|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
30992715|NCT03142334|59172087|FG000|Overall Study|Death|18|||
30992716|NCT03142334|59172088|FG001|Overall Study|Death|33|||
30992717|NCT03142334|59172087|FG000|Overall Study|Withdrawal by Subject|15|||
30992718|NCT03142334|59172088|FG001|Overall Study|Withdrawal by Subject|11|||
30992719|NCT03142334|59172087|FG000|Overall Study|Ongoing on trial follow up|463|||
30992720|NCT03142334|59172088|FG001|Overall Study|Ongoing on trial follow up|454|||
30992721|NCT03126539|59172096|FG000|Overall Study|Lost to Follow-up|1|||
30992722|NCT03126539|59172097|FG001|Overall Study|Lost to Follow-up|1|||
30992723|NCT03126539|59172098|FG002|Overall Study|Lost to Follow-up|1|||
30992724|NCT03126539|59172099|FG003|Overall Study|Lost to Follow-up|0|||
30992725|NCT03126539|59172100|FG004|Overall Study|Lost to Follow-up|0|||
30992726|NCT03123250|59172113|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
30992727|NCT03099096|59172117|FG000|Overall Study|Adverse Event|1|||
30992728|NCT03099096|59172117|FG000|Overall Study|Physician Decision|1|||
30992729|NCT03064126|59172125|FG000|Overall Study|Death|6|||
30992730|NCT03064126|59172126|FG001|Overall Study|Death|2|||
30992731|NCT03064126|59172127|FG002|Overall Study|Death|2|||
30992732|NCT03064126|59172128|FG003|Overall Study|Death|1|||
30992733|NCT03064126|59172125|FG000|Overall Study|Investigator Discretion|1|||
30992734|NCT03064126|59172126|FG001|Overall Study|Investigator Discretion|0|||
30992735|NCT03064126|59172127|FG002|Overall Study|Investigator Discretion|0|||
30992736|NCT03064126|59172128|FG003|Overall Study|Investigator Discretion|0|||
30992737|NCT03064126|59172125|FG000|Overall Study|Withdrawal by Subject|7|||
30992738|NCT03064126|59172126|FG001|Overall Study|Withdrawal by Subject|4|||
30992739|NCT03064126|59172127|FG002|Overall Study|Withdrawal by Subject|0|||
30992740|NCT03064126|59172128|FG003|Overall Study|Withdrawal by Subject|0|||
30992741|NCT03064126|59172125|FG000|Overall Study|Subject moved|1|||
30992742|NCT03064126|59172126|FG001|Overall Study|Subject moved|0|||
30992743|NCT03064126|59172127|FG002|Overall Study|Subject moved|0|||
30992744|NCT03064126|59172128|FG003|Overall Study|Subject moved|0|||
30992745|NCT03064126|59172125|FG000|Overall Study|Protocol Violation|11|||
30992746|NCT03064126|59172126|FG001|Overall Study|Protocol Violation|1|||
30992747|NCT03064126|59172127|FG002|Overall Study|Protocol Violation|1|||
30992748|NCT03064126|59172128|FG003|Overall Study|Protocol Violation|0|||
30992749|NCT03043664|59172139|FG000|Overall Study|Lost to Follow-up|1|||
30992750|NCT03041467|59172145|FG000|Overall Study|Death|40|||
30992751|NCT03041467|59172146|FG001|Overall Study|Death|36|||
30992752|NCT03041467|59172145|FG000|Overall Study|Withdrawal by Subject|36|||
30992753|NCT03041467|59172146|FG001|Overall Study|Withdrawal by Subject|37|||
30992754|NCT03041467|59172145|FG000|Overall Study|Lost to Follow-up|6|||
30992755|NCT03041467|59172146|FG001|Overall Study|Lost to Follow-up|7|||
30992756|NCT03041467|59172145|FG000|Overall Study|Declined consent for study extension|21|||
30992757|NCT03041467|59172146|FG001|Overall Study|Declined consent for study extension|33|||
30992758|NCT03041467|59172145|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
30992759|NCT03041467|59172146|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
30992760|NCT03041467|59172145|FG000|Overall Study|48 Month visit not completed|9|||
30992761|NCT03041467|59172146|FG001|Overall Study|48 Month visit not completed|4|||
30992762|NCT03019406|59172158|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
30992763|NCT03019406|59172159|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
30992764|NCT03019406|59172160|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
30992765|NCT03019406|59172161|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
30992766|NCT02972593|59172176|FG000|Overall Study|Lost to Follow-up|19|||
30992767|NCT02972593|59172177|FG001|Overall Study|Lost to Follow-up|15|||
30992768|NCT02972593|59172176|FG000|Overall Study|Protocol Violation|1|||
30992769|NCT02972593|59172177|FG001|Overall Study|Protocol Violation|0|||
30992770|NCT02949700|59172189|FG000|Phase I|Withdrawal by Subject|1|||
30992771|NCT02949700|59172190|FG001|Phase I|Withdrawal by Subject|1|||
30992772|NCT02949700|59172191|FG002|Phase I|Withdrawal by Subject|0|||
30992773|NCT02949700|59172192|FG003|Phase I|Withdrawal by Subject|0|||
30992774|NCT02949700|59172189|FG000|Phase I|Protocol Violation|1|||
30992775|NCT02949700|59172190|FG001|Phase I|Protocol Violation|0|||
30992776|NCT02949700|59172191|FG002|Phase I|Protocol Violation|0|||
30992777|NCT02949700|59172192|FG003|Phase I|Protocol Violation|0|||
30992778|NCT02949700|59172189|FG000|Phase II|Withdrawal by Subject|0|||
30992779|NCT02949700|59172190|FG001|Phase II|Withdrawal by Subject|0|||
30992780|NCT02949700|59172191|FG002|Phase II|Withdrawal by Subject|0|||
30992781|NCT02949700|59172192|FG003|Phase II|Withdrawal by Subject|2|||
30992782|NCT02949700|59172189|FG000|Phase II|Protocol Violation|0|||
30992783|NCT02949700|59172190|FG001|Phase II|Protocol Violation|0|||
30992784|NCT02949700|59172191|FG002|Phase II|Protocol Violation|1|||
30992785|NCT02949700|59172192|FG003|Phase II|Protocol Violation|3|||
30992786|NCT02947087|59172203|FG000|Overall Study|Withdrawal by Subject|3|||
30992787|NCT02947087|59172204|FG001|Overall Study|Withdrawal by Subject|2|||
30992788|NCT02879448|59172212|FG000|Overall Study|No implant attempt|17|||
30992789|NCT02879448|59172213|FG001|Overall Study|No implant attempt|28|||
30992790|NCT02879448|59172212|FG000|Overall Study|Withdrawal by Subject|20|||
30992791|NCT02879448|59172213|FG001|Overall Study|Withdrawal by Subject|46|||
30992792|NCT02879448|59172212|FG000|Overall Study|Death|63|||
30992793|NCT02879448|59172213|FG001|Overall Study|Death|85|||
30992794|NCT02879448|59172212|FG000|Overall Study|Lost to Follow-up|3|||
30992795|NCT02879448|59172213|FG001|Overall Study|Lost to Follow-up|4|||
30992796|NCT02879448|59172212|FG000|Overall Study|Missing visit|34|||
30992797|NCT02879448|59172213|FG001|Overall Study|Missing visit|39|||
30992798|NCT02879448|59172212|FG000|Overall Study|Pending evaluation|1|||
30992799|NCT02879448|59172213|FG001|Overall Study|Pending evaluation|0|||
30992800|NCT02868216|59172221|FG000|Overall Study|Death|0|||
30992801|NCT02868216|59172222|FG001|Overall Study|Death|1|||
30992802|NCT02868216|59172221|FG000|Overall Study|coronary artery bypass|1|||
30992803|NCT02868216|59172222|FG001|Overall Study|coronary artery bypass|0|||
30992804|NCT02868216|59172221|FG000|Overall Study|Withdrawal by Subject|7|||
30992805|NCT02868216|59172222|FG001|Overall Study|Withdrawal by Subject|5|||
30992806|NCT02841995|59172231|FG000|Overall Study|Disease progression|5|||
30992807|NCT02841995|59172232|FG001|Overall Study|Disease progression|11|||
30992808|NCT02841995|59172233|FG002|Overall Study|Disease progression|8|||
30992809|NCT02841995|59172231|FG000|Overall Study|Withdrawal by Subject|2|||
30992810|NCT02841995|59172232|FG001|Overall Study|Withdrawal by Subject|4|||
30992811|NCT02841995|59172233|FG002|Overall Study|Withdrawal by Subject|4|||
30992812|NCT02841995|59172231|FG000|Overall Study|Adverse Event|2|||
30992813|NCT02841995|59172232|FG001|Overall Study|Adverse Event|0|||
30992814|NCT02841995|59172233|FG002|Overall Study|Adverse Event|1|||
30992815|NCT02841995|59172231|FG000|Overall Study|Investigator decision|2|||
30992816|NCT02841995|59172232|FG001|Overall Study|Investigator decision|0|||
30992817|NCT02841995|59172233|FG002|Overall Study|Investigator decision|1|||
30992818|NCT02841995|59172231|FG000|Overall Study|Death|0|||
30992819|NCT02841995|59172232|FG001|Overall Study|Death|0|||
30992820|NCT02841995|59172233|FG002|Overall Study|Death|2|||
30992821|NCT02841995|59172231|FG000|Overall Study|Noncompliance to protocol|1|||
30992822|NCT02841995|59172232|FG001|Overall Study|Noncompliance to protocol|0|||
30992823|NCT02841995|59172233|FG002|Overall Study|Noncompliance to protocol|0|||
30992824|NCT02841995|59172231|FG000|Overall Study|Sponsor decision|1|||
30992825|NCT02841995|59172232|FG001|Overall Study|Sponsor decision|0|||
30992826|NCT02841995|59172233|FG002|Overall Study|Sponsor decision|0|||
30992827|NCT02841995|59172231|FG000|Overall Study|Other|4|||
30992828|NCT02841995|59172232|FG001|Overall Study|Other|1|||
30992829|NCT02841995|59172233|FG002|Overall Study|Other|5|||
30992830|NCT02702414|59172252|FG000|Overall Study|Death|77|||
30992831|NCT02702414|59172253|FG001|Overall Study|Death|34|||
30992832|NCT02702414|59172252|FG000|Overall Study|Lost to Follow-up|0|||
30992833|NCT02702414|59172253|FG001|Overall Study|Lost to Follow-up|1|||
30992834|NCT02702414|59172252|FG000|Overall Study|Withdrawal by Subject|0|||
30992835|NCT02702414|59172253|FG001|Overall Study|Withdrawal by Subject|1|||
30992836|NCT02702414|59172252|FG000|Overall Study|Participants Ongoing in Study|27|||
30992837|NCT02702414|59172253|FG001|Overall Study|Participants Ongoing in Study|15|||
30992838|NCT02702414|59172252|FG000|Overall Study|Not Treated|1|||
30992839|NCT02702414|59172253|FG001|Overall Study|Not Treated|0|||
30992840|NCT02643966|59172261|FG000|First Screening Round|ineligible|1|||
30992841|NCT02643966|59172261|FG000|First Screening Round|excluded from analysis|2|||
30992842|NCT02643966|59172261|FG000|First Screening Round|Lost to Follow-up|56|||
30992843|NCT02643966|59172261|FG000|First Screening Round|Withdrawal by Subject|28|||
30992844|NCT02643966|59172261|FG000|First Screening Round|Death|1|||
30992845|NCT02643966|59172261|FG000|Between First and Second Screening|Lost to Follow-up|65|||
30992846|NCT02643966|59172261|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
30992847|NCT02643966|59172261|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
30992848|NCT02643966|59172261|FG000|Second Screening Round|Withdrawal by Subject|20|||
30992849|NCT02643966|59172261|FG000|Second Screening Round|Lost to Follow-up|57|||
30992850|NCT02643966|59172261|FG000|Second Screening Round|Physician Decision|2|||
30992851|NCT02643966|59172261|FG000|Second Screening Round|Death|4|||
30992852|NCT02643966|59172261|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
30992853|NCT02643966|59172261|FG000|Between Second and Third Screening|Death|1|||
30992854|NCT02643966|59172261|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
30992855|NCT02643966|59172261|FG000|Third Screening Round|PI excluded|2|||
30992856|NCT02643966|59172261|FG000|Third Screening Round|Lost to Follow-up|241|||
30992857|NCT02632409|59172275|FG000|Randomized|AE unrelated to study Drug|0|||
30992858|NCT02632409|59172276|FG001|Randomized|AE unrelated to study Drug|1|||
30992859|NCT02632409|59172275|FG000|Randomized|Participant withdrew consent|2|||
30992860|NCT02632409|59172276|FG001|Randomized|Participant withdrew consent|1|||
30992861|NCT02632409|59172275|FG000|Randomized|No Longer meets study criteria|5|||
30992862|NCT02632409|59172276|FG001|Randomized|No Longer meets study criteria|0|||
30992863|NCT02632409|59172275|FG000|Randomized|other reasons|1|||
30992864|NCT02632409|59172276|FG001|Randomized|other reasons|0|||
30992865|NCT02632409|59172275|FG000|Treatment Period|Ongoing Treatment|20|||
30992866|NCT02632409|59172276|FG001|Treatment Period|Ongoing Treatment|21|||
30992867|NCT02632409|59172275|FG000|Treatment Period|Disease Recurrence|147|||
30992868|NCT02632409|59172276|FG001|Treatment Period|Disease Recurrence|90|||
30992869|NCT02632409|59172275|FG000|Treatment Period|Study Drug Toxicity|8|||
30992870|NCT02632409|59172276|FG001|Treatment Period|Study Drug Toxicity|49|||
30992871|NCT02632409|59172275|FG000|Treatment Period|Death|1|||
30992872|NCT02632409|59172276|FG001|Treatment Period|Death|0|||
30992873|NCT02632409|59172275|FG000|Treatment Period|AE unrelated to study drug|15|||
30992874|NCT02632409|59172276|FG001|Treatment Period|AE unrelated to study drug|16|||
30992875|NCT02632409|59172275|FG000|Treatment Period|Request to discontinue treatment|4|||
30992876|NCT02632409|59172276|FG001|Treatment Period|Request to discontinue treatment|19|||
30992877|NCT02632409|59172275|FG000|Treatment Period|Participant withdrew consent|7|||
30992878|NCT02632409|59172276|FG001|Treatment Period|Participant withdrew consent|5|||
30992879|NCT02632409|59172275|FG000|Treatment Period|Lost to Follow-up|0|||
30891871|NCT02251275|58925192|FG000|Overall Study|Adverse Event|23|||
30891872|NCT02251275|58925193|FG001|Overall Study|Adverse Event|60|||
30891873|NCT02251275|58925194|FG002|Overall Study|Adverse Event|28|||
30891874|NCT02251275|58925195|FG003|Overall Study|Adverse Event|0|||
30891875|NCT02251275|58925196|FG004|Overall Study|Adverse Event|0|||
30891876|NCT02251275|58925192|FG000|Overall Study|Lost to Follow-up|5|||
30891877|NCT02251275|58925193|FG001|Overall Study|Lost to Follow-up|6|||
30891878|NCT02251275|58925194|FG002|Overall Study|Lost to Follow-up|4|||
30891879|NCT02251275|58925195|FG003|Overall Study|Lost to Follow-up|0|||
30891880|NCT02251275|58925196|FG004|Overall Study|Lost to Follow-up|0|||
30891881|NCT02251275|58925192|FG000|Overall Study|Physician Decision|19|||
30891882|NCT02251275|58925193|FG001|Overall Study|Physician Decision|30|||
30891883|NCT02251275|58925194|FG002|Overall Study|Physician Decision|26|||
30992880|NCT02632409|59172276|FG001|Treatment Period|Lost to Follow-up|1|||
30992881|NCT02632409|59172275|FG000|Treatment Period|Maximum clinical benefit|1|||
30992882|NCT02632409|59172276|FG001|Treatment Period|Maximum clinical benefit|0|||
30992883|NCT02632409|59172275|FG000|Treatment Period|No longer meets study criteria|3|||
30992884|NCT02632409|59172276|FG001|Treatment Period|No longer meets study criteria|0|||
30992885|NCT02632409|59172275|FG000|Treatment Period|Administrative Reason by sponsor|0|||
30992886|NCT02632409|59172276|FG001|Treatment Period|Administrative Reason by sponsor|1|||
30992887|NCT02632409|59172275|FG000|Treatment Period|Other Reasons|10|||
30992888|NCT02632409|59172276|FG001|Treatment Period|Other Reasons|6|||
30992889|NCT02554383|59172299|FG000|Overall Study|Ineligible|3|||
30992890|NCT02554383|59172300|FG001|Overall Study|Ineligible|2|||
30992891|NCT02554383|59172299|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
30992892|NCT02554383|59172300|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
30992893|NCT02554383|59172299|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
30992894|NCT02554383|59172300|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
30992895|NCT02554383|59172299|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
30992896|NCT02554383|59172300|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
30992897|NCT02522871|59172308|FG000|Overall Study|Protocol Violation|1|||
30992898|NCT02522871|59172309|FG001|Overall Study|Protocol Violation|4|||
30992899|NCT02522871|59172308|FG000|Overall Study|Treated without randomization|1|||
30992900|NCT02522871|59172309|FG001|Overall Study|Treated without randomization|0|||
30992901|NCT02522871|59172308|FG000|Overall Study|Death|9|||
30992902|NCT02522871|59172309|FG001|Overall Study|Death|9|||
30992903|NCT02522871|59172308|FG000|Overall Study|Died in operating room prior to transplant|0|||
30992904|NCT02522871|59172309|FG001|Overall Study|Died in operating room prior to transplant|1|||
30992905|NCT02519439|59172324|FG000|Overall Study|Study Termination|19|||
30992906|NCT02519439|59172324|FG000|Overall Study|Withdrawal by Subject|1|||
30992907|NCT02519439|59172324|FG000|Overall Study|Adverse Event|1|||
30992908|NCT02500797|59172336|FG000|Overall Study|Cancel (rapid disease progression)|0|||
30992909|NCT02500797|59172337|FG001|Overall Study|Cancel (rapid disease progression)|0|||
30992910|NCT02500797|59172338|FG002|Overall Study|Cancel (rapid disease progression)|0|||
30992911|NCT02500797|59172339|FG003|Overall Study|Cancel (rapid disease progression)|0|||
30992912|NCT02500797|59172340|FG004|Overall Study|Cancel (rapid disease progression)|1|||
30992913|NCT02500797|59172341|FG005|Overall Study|Cancel (rapid disease progression)|1|||
30992914|NCT02500797|59172342|FG006|Overall Study|Cancel (rapid disease progression)|0|||
30992915|NCT02500797|59172343|FG007|Overall Study|Cancel (rapid disease progression)|0|||
30992916|NCT02500797|59172336|FG000|Overall Study|Withdrawal by Subject|1|||
30992917|NCT02500797|59172337|FG001|Overall Study|Withdrawal by Subject|0|||
30992918|NCT02500797|59172338|FG002|Overall Study|Withdrawal by Subject|0|||
30992919|NCT02500797|59172339|FG003|Overall Study|Withdrawal by Subject|0|||
30992920|NCT02500797|59172340|FG004|Overall Study|Withdrawal by Subject|0|||
30992921|NCT02500797|59172341|FG005|Overall Study|Withdrawal by Subject|0|||
30992922|NCT02500797|59172342|FG006|Overall Study|Withdrawal by Subject|0|||
30992923|NCT02500797|59172343|FG007|Overall Study|Withdrawal by Subject|0|||
30992924|NCT02147184|59172374|FG000|Overall Study|Lost to Follow-up|28|||
30992925|NCT02147184|59172375|FG001|Overall Study|Lost to Follow-up|15|||
30992926|NCT02147184|59172374|FG000|Overall Study|Study Burden|11|||
30992927|NCT02147184|59172375|FG001|Overall Study|Study Burden|7|||
30992928|NCT02147184|59172374|FG000|Overall Study|Pregnancy|6|||
30992929|NCT02147184|59172375|FG001|Overall Study|Pregnancy|0|||
30992930|NCT02147184|59172374|FG000|Overall Study|Moved out of state|3|||
30992931|NCT02147184|59172375|FG001|Overall Study|Moved out of state|3|||
30992932|NCT02147184|59172374|FG000|Overall Study|Physician Decision|0|||
30992933|NCT02147184|59172375|FG001|Overall Study|Physician Decision|2|||
30992934|NCT02147184|59172374|FG000|Overall Study|Other|1|||
30992935|NCT02147184|59172375|FG001|Overall Study|Other|0|||
30992936|NCT02101021|59172386|FG000|Overall Study|Death|4|||
30992937|NCT02101021|59172387|FG001|Overall Study|Death|3|||
30992938|NCT02101021|59172388|FG002|Overall Study|Death|6|||
30992939|NCT02101021|59172389|FG003|Overall Study|Death|0|||
30992940|NCT02101021|59172390|FG004|Overall Study|Death|3|||
30992941|NCT02101021|59172386|FG000|Overall Study|Withdrew Consent from study|1|||
30992942|NCT02101021|59172387|FG001|Overall Study|Withdrew Consent from study|1|||
30992943|NCT02101021|59172388|FG002|Overall Study|Withdrew Consent from study|0|||
30992944|NCT02101021|59172389|FG003|Overall Study|Withdrew Consent from study|2|||
30992945|NCT02101021|59172390|FG004|Overall Study|Withdrew Consent from study|0|||
30992946|NCT02101021|59172386|FG000|Overall Study|Lost to Follow-up|1|||
30992947|NCT02101021|59172387|FG001|Overall Study|Lost to Follow-up|0|||
30992948|NCT02101021|59172388|FG002|Overall Study|Lost to Follow-up|0|||
30992949|NCT02101021|59172389|FG003|Overall Study|Lost to Follow-up|0|||
30992950|NCT02101021|59172390|FG004|Overall Study|Lost to Follow-up|0|||
30992951|NCT02101021|59172386|FG000|Overall Study|Study Terminated by Sponsor|1|||
30992952|NCT02101021|59172387|FG001|Overall Study|Study Terminated by Sponsor|0|||
30992953|NCT02101021|59172388|FG002|Overall Study|Study Terminated by Sponsor|1|||
30992954|NCT02101021|59172389|FG003|Overall Study|Study Terminated by Sponsor|1|||
30992955|NCT02101021|59172390|FG004|Overall Study|Study Terminated by Sponsor|1|||
30992956|NCT02031536|59172415|FG000|Overall Study|ineligible|1|||
30992957|NCT02031536|59172416|FG001|Overall Study|ineligible|0|||
30992958|NCT02028455|59172430|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
30992959|NCT02028455|59172431|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
30992960|NCT02028455|59172432|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
30992961|NCT02028455|59172433|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
30992962|NCT02028455|59172434|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
30992963|NCT02028455|59172435|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
30992964|NCT02028455|59172436|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
30992965|NCT02028455|59172437|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
30992966|NCT02028455|59172430|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
30992967|NCT02028455|59172431|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
30992968|NCT02028455|59172432|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
30992969|NCT02028455|59172433|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
30992970|NCT02028455|59172434|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
30992971|NCT02028455|59172435|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
30992972|NCT02028455|59172436|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
30992973|NCT02028455|59172437|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
30992974|NCT02028455|59172430|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
30992975|NCT02028455|59172431|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
30992976|NCT02028455|59172432|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
30992977|NCT02028455|59172433|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
30992978|NCT02028455|59172434|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
30992979|NCT02028455|59172435|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
30992980|NCT02028455|59172436|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
30992981|NCT02028455|59172437|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
30992982|NCT02028455|59172430|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
30992983|NCT02028455|59172431|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
30992984|NCT02028455|59172432|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
30992985|NCT02028455|59172433|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
30992986|NCT02028455|59172434|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
30992987|NCT02028455|59172435|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
30992988|NCT02028455|59172436|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
30992989|NCT02028455|59172437|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
30992990|NCT02019641|59172461|FG000|10-Week Follow up|Withdrawal by investigator|2|||
30992991|NCT02019641|59172462|FG001|10-Week Follow up|Withdrawal by investigator|0|||
30992992|NCT02019641|59172463|FG002|10-Week Follow up|Withdrawal by investigator|0|||
30992993|NCT02019641|59172461|FG000|10-Week Follow up|Withdrawal by Subject|1|||
30992994|NCT02019641|59172462|FG001|10-Week Follow up|Withdrawal by Subject|1|||
30992995|NCT02019641|59172463|FG002|10-Week Follow up|Withdrawal by Subject|0|||
30992996|NCT02019641|59172461|FG000|20-Week Follow up|Withdrawal by investigator|0|||
30992997|NCT02019641|59172462|FG001|20-Week Follow up|Withdrawal by investigator|0|||
30992998|NCT02019641|59172463|FG002|20-Week Follow up|Withdrawal by investigator|1|||
30992999|NCT01964430|59172472|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
30993000|NCT01964430|59172473|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
30993001|NCT01964430|59172472|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
30993002|NCT01964430|59172473|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
30993003|NCT01964430|59172472|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
30993004|NCT01964430|59172473|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
30993005|NCT01964430|59172472|FG000|Treatment Period|Adverse Event|71|||
30993006|NCT01964430|59172473|FG001|Treatment Period|Adverse Event|37|||
30993007|NCT01964430|59172472|FG000|Treatment Period|Withdrawal by Subject|36|||
30993008|NCT01964430|59172473|FG001|Treatment Period|Withdrawal by Subject|27|||
30993009|NCT01964430|59172472|FG000|Treatment Period|Death|1|||
30993010|NCT01964430|59172473|FG001|Treatment Period|Death|3|||
30993011|NCT01964430|59172472|FG000|Treatment Period|Protocol Deviation|0|||
30993012|NCT01964430|59172473|FG001|Treatment Period|Protocol Deviation|1|||
30993013|NCT01964430|59172472|FG000|Treatment Period|Physician Decision|5|||
30993014|NCT01964430|59172473|FG001|Treatment Period|Physician Decision|4|||
30993015|NCT01964430|59172472|FG000|Treatment Period|Disease Relapse|28|||
30993016|NCT01964430|59172473|FG001|Treatment Period|Disease Relapse|38|||
30993017|NCT01964430|59172472|FG000|Treatment Period|Other reasons|1|||
30993018|NCT01964430|59172473|FG001|Treatment Period|Other reasons|3|||
30993019|NCT01928394|59172502|FG000|Treatment Period|Disease progression|17|||
30993020|NCT01928394|59172503|FG001|Treatment Period|Disease progression|2|||
30993021|NCT01928394|59172504|FG002|Treatment Period|Disease progression|12|||
30993022|NCT01928394|59172505|FG003|Treatment Period|Disease progression|48|||
30993023|NCT01928394|59172506|FG004|Treatment Period|Disease progression|3|||
30993024|NCT01928394|59172507|FG005|Treatment Period|Disease progression|25|||
30993025|NCT01928394|59172508|FG006|Treatment Period|Disease progression|38|||
30993026|NCT01928394|59172509|FG007|Treatment Period|Disease progression|16|||
30993027|NCT01928394|59172510|FG008|Treatment Period|Disease progression|3|||
30993028|NCT01928394|59172511|FG009|Treatment Period|Disease progression|11|||
30993029|NCT01928394|59172512|FG010|Treatment Period|Disease progression|22|||
30993030|NCT01928394|59172513|FG011|Treatment Period|Disease progression|73|||
30993031|NCT01928394|59172514|FG012|Treatment Period|Disease progression|38|||
30993032|NCT01928394|59172515|FG013|Treatment Period|Disease progression|118|||
30993033|NCT01928394|59172516|FG014|Treatment Period|Disease progression|59|||
30993034|NCT01928394|59172517|FG015|Treatment Period|Disease progression|1|||
30993035|NCT01928394|59172518|FG016|Treatment Period|Disease progression|43|||
30993036|NCT01928394|59172519|FG017|Treatment Period|Disease progression|56|||
30993037|NCT01928394|59172520|FG018|Treatment Period|Disease progression|50|||
30993038|NCT01928394|59172521|FG019|Treatment Period|Disease progression|71|||
30993039|NCT01928394|59172522|FG020|Treatment Period|Disease progression|30|||
30993040|NCT01928394|59172523|FG021|Treatment Period|Disease progression|31|||
30993041|NCT01928394|59172524|FG022|Treatment Period|Disease progression|31|||
30993042|NCT01928394|59172502|FG000|Treatment Period|Study drug toxicity|1|||
30993043|NCT01928394|59172503|FG001|Treatment Period|Study drug toxicity|1|||
30993044|NCT01928394|59172504|FG002|Treatment Period|Study drug toxicity|3|||
30993045|NCT01928394|59172505|FG003|Treatment Period|Study drug toxicity|3|||
30993046|NCT01928394|59172506|FG004|Treatment Period|Study drug toxicity|0|||
30993047|NCT01928394|59172507|FG005|Treatment Period|Study drug toxicity|9|||
30993048|NCT01928394|59172508|FG006|Treatment Period|Study drug toxicity|7|||
30993049|NCT01928394|59172509|FG007|Treatment Period|Study drug toxicity|1|||
30993050|NCT01928394|59172510|FG008|Treatment Period|Study drug toxicity|0|||
30993051|NCT01928394|59172511|FG009|Treatment Period|Study drug toxicity|5|||
30993052|NCT01928394|59172512|FG010|Treatment Period|Study drug toxicity|2|||
30993053|NCT01928394|59172513|FG011|Treatment Period|Study drug toxicity|3|||
30993054|NCT01928394|59172514|FG012|Treatment Period|Study drug toxicity|7|||
30993055|NCT01928394|59172515|FG013|Treatment Period|Study drug toxicity|5|||
30993056|NCT01928394|59172516|FG014|Treatment Period|Study drug toxicity|12|||
30993057|NCT01928394|59172517|FG015|Treatment Period|Study drug toxicity|0|||
30993058|NCT01928394|59172518|FG016|Treatment Period|Study drug toxicity|3|||
30993059|NCT01928394|59172519|FG017|Treatment Period|Study drug toxicity|3|||
30993060|NCT01928394|59172520|FG018|Treatment Period|Study drug toxicity|12|||
30993061|NCT01928394|59172521|FG019|Treatment Period|Study drug toxicity|15|||
30993062|NCT01928394|59172522|FG020|Treatment Period|Study drug toxicity|4|||
30993063|NCT01928394|59172523|FG021|Treatment Period|Study drug toxicity|7|||
30993064|NCT01928394|59172524|FG022|Treatment Period|Study drug toxicity|4|||
30993065|NCT01928394|59172502|FG000|Treatment Period|AE unrelated to study drug|0|||
30993066|NCT01928394|59172503|FG001|Treatment Period|AE unrelated to study drug|0|||
30993067|NCT01928394|59172504|FG002|Treatment Period|AE unrelated to study drug|2|||
30993068|NCT01928394|59172505|FG003|Treatment Period|AE unrelated to study drug|3|||
30993069|NCT01928394|59172506|FG004|Treatment Period|AE unrelated to study drug|0|||
30993070|NCT01928394|59172507|FG005|Treatment Period|AE unrelated to study drug|5|||
30993071|NCT01928394|59172508|FG006|Treatment Period|AE unrelated to study drug|1|||
30993072|NCT01928394|59172509|FG007|Treatment Period|AE unrelated to study drug|0|||
30993073|NCT01928394|59172510|FG008|Treatment Period|AE unrelated to study drug|0|||
30993074|NCT01928394|59172511|FG009|Treatment Period|AE unrelated to study drug|2|||
30993075|NCT01928394|59172512|FG010|Treatment Period|AE unrelated to study drug|0|||
30993076|NCT01928394|59172513|FG011|Treatment Period|AE unrelated to study drug|12|||
30993077|NCT01928394|59172514|FG012|Treatment Period|AE unrelated to study drug|6|||
30993078|NCT01928394|59172515|FG013|Treatment Period|AE unrelated to study drug|13|||
30993079|NCT01928394|59172516|FG014|Treatment Period|AE unrelated to study drug|6|||
30993080|NCT01928394|59172517|FG015|Treatment Period|AE unrelated to study drug|1|||
30993081|NCT01928394|59172518|FG016|Treatment Period|AE unrelated to study drug|1|||
30993082|NCT01928394|59172519|FG017|Treatment Period|AE unrelated to study drug|6|||
30993083|NCT01928394|59172520|FG018|Treatment Period|AE unrelated to study drug|3|||
30993084|NCT01928394|59172521|FG019|Treatment Period|AE unrelated to study drug|5|||
30993085|NCT01928394|59172522|FG020|Treatment Period|AE unrelated to study drug|1|||
30993086|NCT01928394|59172523|FG021|Treatment Period|AE unrelated to study drug|1|||
30993087|NCT01928394|59172524|FG022|Treatment Period|AE unrelated to study drug|0|||
30993088|NCT01928394|59172502|FG000|Treatment Period|Participant request to stop therapy|0|||
30993089|NCT01928394|59172503|FG001|Treatment Period|Participant request to stop therapy|0|||
30993090|NCT01928394|59172504|FG002|Treatment Period|Participant request to stop therapy|0|||
30993091|NCT01928394|59172505|FG003|Treatment Period|Participant request to stop therapy|0|||
30993092|NCT01928394|59172506|FG004|Treatment Period|Participant request to stop therapy|0|||
30993093|NCT01928394|59172507|FG005|Treatment Period|Participant request to stop therapy|3|||
30993094|NCT01928394|59172508|FG006|Treatment Period|Participant request to stop therapy|3|||
30993095|NCT01928394|59172509|FG007|Treatment Period|Participant request to stop therapy|0|||
30993096|NCT01928394|59172510|FG008|Treatment Period|Participant request to stop therapy|0|||
30993097|NCT01928394|59172511|FG009|Treatment Period|Participant request to stop therapy|0|||
30993098|NCT01928394|59172512|FG010|Treatment Period|Participant request to stop therapy|3|||
30993099|NCT01928394|59172513|FG011|Treatment Period|Participant request to stop therapy|2|||
30993100|NCT01928394|59172514|FG012|Treatment Period|Participant request to stop therapy|1|||
30993101|NCT01928394|59172515|FG013|Treatment Period|Participant request to stop therapy|2|||
30993102|NCT01928394|59172516|FG014|Treatment Period|Participant request to stop therapy|4|||
30993103|NCT01928394|59172517|FG015|Treatment Period|Participant request to stop therapy|0|||
30993104|NCT01928394|59172518|FG016|Treatment Period|Participant request to stop therapy|1|||
30993105|NCT01928394|59172519|FG017|Treatment Period|Participant request to stop therapy|3|||
30993106|NCT01928394|59172520|FG018|Treatment Period|Participant request to stop therapy|1|||
30993107|NCT01928394|59172521|FG019|Treatment Period|Participant request to stop therapy|1|||
30993108|NCT01928394|59172522|FG020|Treatment Period|Participant request to stop therapy|3|||
30993109|NCT01928394|59172523|FG021|Treatment Period|Participant request to stop therapy|1|||
30993110|NCT01928394|59172524|FG022|Treatment Period|Participant request to stop therapy|3|||
30993111|NCT01928394|59172502|FG000|Treatment Period|Participant withdrew consent|0|||
30993112|NCT01928394|59172503|FG001|Treatment Period|Participant withdrew consent|0|||
30993113|NCT01928394|59172504|FG002|Treatment Period|Participant withdrew consent|1|||
30993114|NCT01928394|59172505|FG003|Treatment Period|Participant withdrew consent|1|||
30993115|NCT01928394|59172506|FG004|Treatment Period|Participant withdrew consent|0|||
30993116|NCT01928394|59172507|FG005|Treatment Period|Participant withdrew consent|1|||
30993117|NCT01928394|59172508|FG006|Treatment Period|Participant withdrew consent|0|||
30993118|NCT01928394|59172509|FG007|Treatment Period|Participant withdrew consent|1|||
30993119|NCT01928394|59172510|FG008|Treatment Period|Participant withdrew consent|0|||
30993120|NCT01928394|59172511|FG009|Treatment Period|Participant withdrew consent|0|||
30993121|NCT01928394|59172512|FG010|Treatment Period|Participant withdrew consent|1|||
30993122|NCT01928394|59172513|FG011|Treatment Period|Participant withdrew consent|1|||
30993123|NCT01928394|59172514|FG012|Treatment Period|Participant withdrew consent|1|||
30993124|NCT01928394|59172515|FG013|Treatment Period|Participant withdrew consent|0|||
30993125|NCT01928394|59172516|FG014|Treatment Period|Participant withdrew consent|2|||
30993126|NCT01928394|59172517|FG015|Treatment Period|Participant withdrew consent|0|||
30993127|NCT01928394|59172518|FG016|Treatment Period|Participant withdrew consent|2|||
30993128|NCT01928394|59172519|FG017|Treatment Period|Participant withdrew consent|1|||
30993129|NCT01928394|59172520|FG018|Treatment Period|Participant withdrew consent|1|||
30993130|NCT01928394|59172521|FG019|Treatment Period|Participant withdrew consent|1|||
30993131|NCT01928394|59172522|FG020|Treatment Period|Participant withdrew consent|0|||
30993132|NCT01928394|59172523|FG021|Treatment Period|Participant withdrew consent|2|||
30993133|NCT01928394|59172524|FG022|Treatment Period|Participant withdrew consent|0|||
30993134|NCT01928394|59172502|FG000|Treatment Period|Poor/non-compliance|0|||
30993135|NCT01928394|59172503|FG001|Treatment Period|Poor/non-compliance|0|||
30993136|NCT01928394|59172504|FG002|Treatment Period|Poor/non-compliance|0|||
30993137|NCT01928394|59172505|FG003|Treatment Period|Poor/non-compliance|1|||
30993138|NCT01928394|59172506|FG004|Treatment Period|Poor/non-compliance|0|||
30993139|NCT01928394|59172507|FG005|Treatment Period|Poor/non-compliance|0|||
30993140|NCT01928394|59172508|FG006|Treatment Period|Poor/non-compliance|0|||
30993141|NCT01928394|59172509|FG007|Treatment Period|Poor/non-compliance|0|||
30993142|NCT01928394|59172510|FG008|Treatment Period|Poor/non-compliance|0|||
30993143|NCT01928394|59172511|FG009|Treatment Period|Poor/non-compliance|0|||
30993144|NCT01928394|59172512|FG010|Treatment Period|Poor/non-compliance|0|||
30993145|NCT01928394|59172513|FG011|Treatment Period|Poor/non-compliance|0|||
30993146|NCT01928394|59172514|FG012|Treatment Period|Poor/non-compliance|1|||
30993147|NCT01928394|59172515|FG013|Treatment Period|Poor/non-compliance|0|||
30993148|NCT01928394|59172516|FG014|Treatment Period|Poor/non-compliance|1|||
30993149|NCT01928394|59172517|FG015|Treatment Period|Poor/non-compliance|0|||
30993150|NCT01928394|59172518|FG016|Treatment Period|Poor/non-compliance|0|||
30993151|NCT01928394|59172519|FG017|Treatment Period|Poor/non-compliance|1|||
30993152|NCT01928394|59172520|FG018|Treatment Period|Poor/non-compliance|0|||
30993153|NCT01928394|59172521|FG019|Treatment Period|Poor/non-compliance|1|||
30993154|NCT01928394|59172522|FG020|Treatment Period|Poor/non-compliance|0|||
30993155|NCT01928394|59172523|FG021|Treatment Period|Poor/non-compliance|0|||
30993156|NCT01928394|59172524|FG022|Treatment Period|Poor/non-compliance|0|||
30993157|NCT01928394|59172502|FG000|Treatment Period|other reason|0|||
30993158|NCT01928394|59172503|FG001|Treatment Period|other reason|0|||
30993159|NCT01928394|59172504|FG002|Treatment Period|other reason|0|||
30993160|NCT01928394|59172505|FG003|Treatment Period|other reason|0|||
30993161|NCT01928394|59172506|FG004|Treatment Period|other reason|0|||
30993162|NCT01928394|59172507|FG005|Treatment Period|other reason|0|||
30993163|NCT01928394|59172508|FG006|Treatment Period|other reason|0|||
30993164|NCT01928394|59172509|FG007|Treatment Period|other reason|0|||
30993165|NCT01928394|59172510|FG008|Treatment Period|other reason|0|||
30993166|NCT01928394|59172511|FG009|Treatment Period|other reason|0|||
30993167|NCT01928394|59172512|FG010|Treatment Period|other reason|1|||
30993168|NCT01928394|59172513|FG011|Treatment Period|other reason|1|||
30993169|NCT01928394|59172514|FG012|Treatment Period|other reason|1|||
30993170|NCT01928394|59172515|FG013|Treatment Period|other reason|0|||
30993171|NCT01928394|59172516|FG014|Treatment Period|other reason|1|||
30993172|NCT01928394|59172517|FG015|Treatment Period|other reason|0|||
30993173|NCT01928394|59172518|FG016|Treatment Period|other reason|0|||
30993174|NCT01928394|59172519|FG017|Treatment Period|other reason|0|||
30993175|NCT01928394|59172520|FG018|Treatment Period|other reason|2|||
30993176|NCT01928394|59172521|FG019|Treatment Period|other reason|2|||
30993177|NCT01928394|59172522|FG020|Treatment Period|other reason|0|||
30993178|NCT01928394|59172523|FG021|Treatment Period|other reason|0|||
30993179|NCT01928394|59172524|FG022|Treatment Period|other reason|0|||
30993180|NCT01928394|59172502|FG000|Treatment Period|Maximum clinical benefit|0|||
30993181|NCT01928394|59172503|FG001|Treatment Period|Maximum clinical benefit|0|||
30993182|NCT01928394|59172504|FG002|Treatment Period|Maximum clinical benefit|0|||
30993183|NCT01928394|59172505|FG003|Treatment Period|Maximum clinical benefit|0|||
30993184|NCT01928394|59172506|FG004|Treatment Period|Maximum clinical benefit|0|||
30993185|NCT01928394|59172507|FG005|Treatment Period|Maximum clinical benefit|0|||
30993186|NCT01928394|59172508|FG006|Treatment Period|Maximum clinical benefit|0|||
30993187|NCT01928394|59172509|FG007|Treatment Period|Maximum clinical benefit|0|||
30993188|NCT01928394|59172510|FG008|Treatment Period|Maximum clinical benefit|0|||
30993189|NCT01928394|59172511|FG009|Treatment Period|Maximum clinical benefit|0|||
30993190|NCT01928394|59172512|FG010|Treatment Period|Maximum clinical benefit|1|||
30993191|NCT01928394|59172513|FG011|Treatment Period|Maximum clinical benefit|1|||
30993192|NCT01928394|59172514|FG012|Treatment Period|Maximum clinical benefit|0|||
30993193|NCT01928394|59172515|FG013|Treatment Period|Maximum clinical benefit|0|||
30993194|NCT01928394|59172516|FG014|Treatment Period|Maximum clinical benefit|1|||
30993195|NCT01928394|59172517|FG015|Treatment Period|Maximum clinical benefit|0|||
30993196|NCT01928394|59172518|FG016|Treatment Period|Maximum clinical benefit|0|||
30993197|NCT01928394|59172519|FG017|Treatment Period|Maximum clinical benefit|1|||
30993198|NCT01928394|59172520|FG018|Treatment Period|Maximum clinical benefit|1|||
30993199|NCT01928394|59172521|FG019|Treatment Period|Maximum clinical benefit|0|||
30993200|NCT01928394|59172522|FG020|Treatment Period|Maximum clinical benefit|2|||
30993201|NCT01928394|59172523|FG021|Treatment Period|Maximum clinical benefit|0|||
30993202|NCT01928394|59172524|FG022|Treatment Period|Maximum clinical benefit|0|||
30993203|NCT01928394|59172502|FG000|Treatment Period|Lost to Follow-up|0|||
30993204|NCT01928394|59172503|FG001|Treatment Period|Lost to Follow-up|0|||
30993205|NCT01928394|59172504|FG002|Treatment Period|Lost to Follow-up|0|||
30790217|NCT00035555|58803456|FG000|Overall Study|Allograft loss|1|||
30993206|NCT01928394|59172505|FG003|Treatment Period|Lost to Follow-up|0|||
30993207|NCT01928394|59172506|FG004|Treatment Period|Lost to Follow-up|0|||
30993208|NCT01928394|59172507|FG005|Treatment Period|Lost to Follow-up|0|||
30993209|NCT01928394|59172508|FG006|Treatment Period|Lost to Follow-up|0|||
30993210|NCT01928394|59172509|FG007|Treatment Period|Lost to Follow-up|0|||
30993211|NCT01928394|59172510|FG008|Treatment Period|Lost to Follow-up|0|||
30993212|NCT01928394|59172511|FG009|Treatment Period|Lost to Follow-up|0|||
30993213|NCT01928394|59172512|FG010|Treatment Period|Lost to Follow-up|0|||
30993214|NCT01928394|59172513|FG011|Treatment Period|Lost to Follow-up|0|||
30993215|NCT01928394|59172514|FG012|Treatment Period|Lost to Follow-up|0|||
30993216|NCT01928394|59172515|FG013|Treatment Period|Lost to Follow-up|0|||
30993217|NCT01928394|59172516|FG014|Treatment Period|Lost to Follow-up|0|||
30993218|NCT01928394|59172517|FG015|Treatment Period|Lost to Follow-up|0|||
30993219|NCT01928394|59172518|FG016|Treatment Period|Lost to Follow-up|0|||
30993220|NCT01928394|59172519|FG017|Treatment Period|Lost to Follow-up|0|||
30993221|NCT01928394|59172520|FG018|Treatment Period|Lost to Follow-up|0|||
30993222|NCT01928394|59172521|FG019|Treatment Period|Lost to Follow-up|0|||
30993223|NCT01928394|59172522|FG020|Treatment Period|Lost to Follow-up|0|||
30993224|NCT01928394|59172523|FG021|Treatment Period|Lost to Follow-up|0|||
30993225|NCT01928394|59172524|FG022|Treatment Period|Lost to Follow-up|1|||
30993226|NCT01928394|59172502|FG000|Treatment Period|Death|0|||
30993227|NCT01928394|59172503|FG001|Treatment Period|Death|0|||
30993228|NCT01928394|59172504|FG002|Treatment Period|Death|0|||
30993229|NCT01928394|59172505|FG003|Treatment Period|Death|0|||
30993230|NCT01928394|59172506|FG004|Treatment Period|Death|0|||
30993231|NCT01928394|59172507|FG005|Treatment Period|Death|0|||
30993232|NCT01928394|59172508|FG006|Treatment Period|Death|0|||
30993233|NCT01928394|59172509|FG007|Treatment Period|Death|0|||
30993234|NCT01928394|59172510|FG008|Treatment Period|Death|0|||
30993235|NCT01928394|59172511|FG009|Treatment Period|Death|0|||
30993236|NCT01928394|59172512|FG010|Treatment Period|Death|0|||
30993237|NCT01928394|59172513|FG011|Treatment Period|Death|0|||
30993238|NCT01928394|59172514|FG012|Treatment Period|Death|0|||
30993239|NCT01928394|59172515|FG013|Treatment Period|Death|1|||
30993240|NCT01928394|59172516|FG014|Treatment Period|Death|2|||
30993241|NCT01928394|59172517|FG015|Treatment Period|Death|0|||
30993242|NCT01928394|59172518|FG016|Treatment Period|Death|0|||
30993243|NCT01928394|59172519|FG017|Treatment Period|Death|0|||
30993244|NCT01928394|59172520|FG018|Treatment Period|Death|0|||
30993245|NCT01928394|59172521|FG019|Treatment Period|Death|0|||
30993246|NCT01928394|59172522|FG020|Treatment Period|Death|0|||
30993247|NCT01928394|59172523|FG021|Treatment Period|Death|0|||
30993248|NCT01928394|59172524|FG022|Treatment Period|Death|0|||
30993249|NCT01928394|59172502|FG000|Follow-up Period|Participant withdrew consent|3|||
30993250|NCT01928394|59172503|FG001|Follow-up Period|Participant withdrew consent|0|||
30993251|NCT01928394|59172504|FG002|Follow-up Period|Participant withdrew consent|1|||
30993252|NCT01928394|59172505|FG003|Follow-up Period|Participant withdrew consent|4|||
30993253|NCT01928394|59172506|FG004|Follow-up Period|Participant withdrew consent|0|||
30993254|NCT01928394|59172507|FG005|Follow-up Period|Participant withdrew consent|2|||
30993255|NCT01928394|59172508|FG006|Follow-up Period|Participant withdrew consent|5|||
30993256|NCT01928394|59172509|FG007|Follow-up Period|Participant withdrew consent|1|||
30993257|NCT01928394|59172510|FG008|Follow-up Period|Participant withdrew consent|0|||
30993258|NCT01928394|59172511|FG009|Follow-up Period|Participant withdrew consent|0|||
30993259|NCT01928394|59172512|FG010|Follow-up Period|Participant withdrew consent|5|||
30993260|NCT01928394|59172513|FG011|Follow-up Period|Participant withdrew consent|8|||
30993261|NCT01928394|59172514|FG012|Follow-up Period|Participant withdrew consent|2|||
30993262|NCT01928394|59172515|FG013|Follow-up Period|Participant withdrew consent|12|||
30993263|NCT01928394|59172516|FG014|Follow-up Period|Participant withdrew consent|7|||
30993264|NCT01928394|59172517|FG015|Follow-up Period|Participant withdrew consent|0|||
30993265|NCT01928394|59172518|FG016|Follow-up Period|Participant withdrew consent|5|||
30993266|NCT01928394|59172519|FG017|Follow-up Period|Participant withdrew consent|3|||
30993267|NCT01928394|59172520|FG018|Follow-up Period|Participant withdrew consent|2|||
30993268|NCT01928394|59172521|FG019|Follow-up Period|Participant withdrew consent|7|||
30993269|NCT01928394|59172522|FG020|Follow-up Period|Participant withdrew consent|4|||
30993270|NCT01928394|59172523|FG021|Follow-up Period|Participant withdrew consent|6|||
30993271|NCT01928394|59172524|FG022|Follow-up Period|Participant withdrew consent|2|||
30993272|NCT01928394|59172502|FG000|Follow-up Period|Death|0|||
30993273|NCT01928394|59172503|FG001|Follow-up Period|Death|0|||
30993274|NCT01928394|59172504|FG002|Follow-up Period|Death|2|||
30993275|NCT01928394|59172505|FG003|Follow-up Period|Death|6|||
30993276|NCT01928394|59172506|FG004|Follow-up Period|Death|0|||
30993277|NCT01928394|59172507|FG005|Follow-up Period|Death|6|||
30993278|NCT01928394|59172508|FG006|Follow-up Period|Death|6|||
30993279|NCT01928394|59172509|FG007|Follow-up Period|Death|2|||
30993280|NCT01928394|59172510|FG008|Follow-up Period|Death|1|||
30993281|NCT01928394|59172511|FG009|Follow-up Period|Death|2|||
30993282|NCT01928394|59172512|FG010|Follow-up Period|Death|4|||
30993283|NCT01928394|59172513|FG011|Follow-up Period|Death|12|||
30993284|NCT01928394|59172514|FG012|Follow-up Period|Death|11|||
30993285|NCT01928394|59172515|FG013|Follow-up Period|Death|25|||
30993286|NCT01928394|59172516|FG014|Follow-up Period|Death|18|||
30993287|NCT01928394|59172517|FG015|Follow-up Period|Death|0|||
30993288|NCT01928394|59172518|FG016|Follow-up Period|Death|6|||
30993289|NCT01928394|59172519|FG017|Follow-up Period|Death|5|||
30993290|NCT01928394|59172520|FG018|Follow-up Period|Death|13|||
30993291|NCT01928394|59172521|FG019|Follow-up Period|Death|13|||
30993292|NCT01928394|59172522|FG020|Follow-up Period|Death|5|||
30993293|NCT01928394|59172523|FG021|Follow-up Period|Death|3|||
30993294|NCT01928394|59172524|FG022|Follow-up Period|Death|2|||
30993295|NCT01928394|59172502|FG000|Follow-up Period|other reason|0|||
30993296|NCT01928394|59172503|FG001|Follow-up Period|other reason|0|||
30993297|NCT01928394|59172504|FG002|Follow-up Period|other reason|0|||
30993298|NCT01928394|59172505|FG003|Follow-up Period|other reason|0|||
30993299|NCT01928394|59172506|FG004|Follow-up Period|other reason|0|||
30993300|NCT01928394|59172507|FG005|Follow-up Period|other reason|0|||
30993301|NCT01928394|59172508|FG006|Follow-up Period|other reason|1|||
30993302|NCT01928394|59172509|FG007|Follow-up Period|other reason|3|||
30993303|NCT01928394|59172510|FG008|Follow-up Period|other reason|0|||
30993304|NCT01928394|59172511|FG009|Follow-up Period|other reason|0|||
30993305|NCT01928394|59172512|FG010|Follow-up Period|other reason|2|||
30993306|NCT01928394|59172513|FG011|Follow-up Period|other reason|1|||
30993307|NCT01928394|59172514|FG012|Follow-up Period|other reason|0|||
30993308|NCT01928394|59172515|FG013|Follow-up Period|other reason|1|||
30993309|NCT01928394|59172516|FG014|Follow-up Period|other reason|4|||
30993310|NCT01928394|59172517|FG015|Follow-up Period|other reason|0|||
30993311|NCT01928394|59172518|FG016|Follow-up Period|other reason|2|||
30993312|NCT01928394|59172519|FG017|Follow-up Period|other reason|0|||
30993313|NCT01928394|59172520|FG018|Follow-up Period|other reason|1|||
30993314|NCT01928394|59172521|FG019|Follow-up Period|other reason|1|||
30993315|NCT01928394|59172522|FG020|Follow-up Period|other reason|0|||
30993316|NCT01928394|59172523|FG021|Follow-up Period|other reason|0|||
30993317|NCT01928394|59172524|FG022|Follow-up Period|other reason|1|||
30993318|NCT01928394|59172502|FG000|Follow-up Period|Lost to Follow-up|0|||
30993319|NCT01928394|59172503|FG001|Follow-up Period|Lost to Follow-up|0|||
30993320|NCT01928394|59172504|FG002|Follow-up Period|Lost to Follow-up|0|||
30993321|NCT01928394|59172505|FG003|Follow-up Period|Lost to Follow-up|0|||
30993322|NCT01928394|59172506|FG004|Follow-up Period|Lost to Follow-up|0|||
30993323|NCT01928394|59172507|FG005|Follow-up Period|Lost to Follow-up|0|||
30993324|NCT01928394|59172508|FG006|Follow-up Period|Lost to Follow-up|0|||
30993325|NCT01928394|59172509|FG007|Follow-up Period|Lost to Follow-up|0|||
30993326|NCT01928394|59172510|FG008|Follow-up Period|Lost to Follow-up|0|||
30993327|NCT01928394|59172511|FG009|Follow-up Period|Lost to Follow-up|0|||
30993328|NCT01928394|59172512|FG010|Follow-up Period|Lost to Follow-up|0|||
30993329|NCT01928394|59172513|FG011|Follow-up Period|Lost to Follow-up|1|||
30993330|NCT01928394|59172514|FG012|Follow-up Period|Lost to Follow-up|1|||
30993331|NCT01928394|59172515|FG013|Follow-up Period|Lost to Follow-up|0|||
30993332|NCT01928394|59172516|FG014|Follow-up Period|Lost to Follow-up|1|||
30993333|NCT01928394|59172517|FG015|Follow-up Period|Lost to Follow-up|0|||
30993334|NCT01928394|59172518|FG016|Follow-up Period|Lost to Follow-up|1|||
30993335|NCT01928394|59172519|FG017|Follow-up Period|Lost to Follow-up|0|||
30993336|NCT01928394|59172520|FG018|Follow-up Period|Lost to Follow-up|0|||
30993337|NCT01928394|59172521|FG019|Follow-up Period|Lost to Follow-up|0|||
30993338|NCT01928394|59172522|FG020|Follow-up Period|Lost to Follow-up|0|||
30993339|NCT01928394|59172523|FG021|Follow-up Period|Lost to Follow-up|0|||
30993340|NCT01928394|59172524|FG022|Follow-up Period|Lost to Follow-up|1|||
30993341|NCT01898494|59172576|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
30891884|NCT02251275|58925195|FG003|Overall Study|Physician Decision|0|||
30891885|NCT02251275|58925196|FG004|Overall Study|Physician Decision|1|||
30891886|NCT02251275|58925192|FG000|Overall Study|Protocol Deviation|0|||
30891887|NCT02251275|58925193|FG001|Overall Study|Protocol Deviation|0|||
30993342|NCT01898494|59172577|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
30993343|NCT01898494|59172578|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
30993344|NCT01898494|59172579|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
30993345|NCT01898494|59172580|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
30891888|NCT02251275|58925194|FG002|Overall Study|Protocol Deviation|1|||
30993346|NCT01898494|59172576|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
30993347|NCT01898494|59172577|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
30993348|NCT01898494|59172578|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
30993349|NCT01898494|59172579|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
30993350|NCT01898494|59172580|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
30993351|NCT01898494|59172576|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
30993352|NCT01898494|59172577|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
30993353|NCT01898494|59172578|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
30993354|NCT01898494|59172579|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
30993355|NCT01898494|59172580|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
30993356|NCT01898494|59172576|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
30993357|NCT01898494|59172577|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
30993358|NCT01898494|59172578|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
30993359|NCT01898494|59172579|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
30993360|NCT01898494|59172580|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
30993361|NCT01898494|59172576|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
30993362|NCT01898494|59172577|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
30993363|NCT01898494|59172578|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
30993364|NCT01898494|59172579|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
30993365|NCT01898494|59172580|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
30993366|NCT01898494|59172576|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
30993367|NCT01898494|59172577|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
30993368|NCT01898494|59172578|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
30993369|NCT01898494|59172579|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
30993370|NCT01898494|59172580|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
30993371|NCT01898494|59172576|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
30993372|NCT01898494|59172577|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
30993373|NCT01898494|59172578|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
30993374|NCT01898494|59172579|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
30993375|NCT01898494|59172580|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
30993376|NCT01898494|59172576|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
30993377|NCT01898494|59172577|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
30993378|NCT01898494|59172578|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
30993379|NCT01898494|59172579|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
30993380|NCT01898494|59172580|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
30993381|NCT01898494|59172576|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
30993382|NCT01898494|59172577|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
30993383|NCT01898494|59172578|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
30993384|NCT01898494|59172579|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
30993385|NCT01898494|59172580|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
30993386|NCT01898494|59172576|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
30993387|NCT01898494|59172577|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
30993388|NCT01898494|59172578|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
30993389|NCT01898494|59172579|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
30993390|NCT01898494|59172580|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
30993391|NCT01898494|59172576|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
30993392|NCT01898494|59172577|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
30993393|NCT01898494|59172578|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
30993394|NCT01898494|59172579|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
30993395|NCT01898494|59172580|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
30993396|NCT01898494|59172576|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
30993397|NCT01898494|59172577|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
30993398|NCT01898494|59172578|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
30993399|NCT01898494|59172579|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
30993400|NCT01898494|59172580|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
30993401|NCT01898494|59172576|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
30993402|NCT01898494|59172577|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
30993403|NCT01898494|59172578|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
30993404|NCT01898494|59172579|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
30993405|NCT01898494|59172580|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
30993406|NCT01898494|59172576|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
30993407|NCT01898494|59172577|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
30993408|NCT01898494|59172578|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
30993409|NCT01898494|59172579|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
30993410|NCT01898494|59172580|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
30993411|NCT01863043|59172598|FG000|Overall Study|Death|6|||
30993412|NCT01863043|59172599|FG001|Overall Study|Death|1|||
30993413|NCT01863043|59172598|FG000|Overall Study|Withdrawal by Subject|0|||
30993414|NCT01863043|59172599|FG001|Overall Study|Withdrawal by Subject|2|||
30993415|NCT01863043|59172598|FG000|Overall Study|Adverse Event|7|||
30993416|NCT01863043|59172599|FG001|Overall Study|Adverse Event|8|||
30993417|NCT01863043|59172598|FG000|Overall Study|exclusion criteria found after enrollment|0|||
30993418|NCT01863043|59172599|FG001|Overall Study|exclusion criteria found after enrollment|1|||
30993419|NCT01841359|59172605|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
30993420|NCT01841359|59172605|FG000|Overall Study|Concommitant medical issues|2|||
30993421|NCT01841359|59172605|FG000|Overall Study|Adverse Event|3|||
30993422|NCT01841359|59172605|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
30993423|NCT01824875|59172614|FG000|Overall Study|Disease progression|22|||
30993424|NCT01824875|59172615|FG001|Overall Study|Disease progression|15|||
30993425|NCT01824875|59172614|FG000|Overall Study|Withdrawal by Subject|5|||
30993426|NCT01824875|59172615|FG001|Overall Study|Withdrawal by Subject|4|||
30993427|NCT01824875|59172614|FG000|Overall Study|Adverse Event|4|||
30993428|NCT01824875|59172615|FG001|Overall Study|Adverse Event|10|||
30993429|NCT01824875|59172614|FG000|Overall Study|Alternative therapy|3|||
30993430|NCT01824875|59172615|FG001|Overall Study|Alternative therapy|0|||
30993431|NCT01824875|59172614|FG000|Overall Study|Complicating disease|1|||
30993432|NCT01824875|59172615|FG001|Overall Study|Complicating disease|0|||
30993433|NCT01824875|59172614|FG000|Overall Study|Physician Decision|0|||
30993434|NCT01824875|59172615|FG001|Overall Study|Physician Decision|1|||
30993435|NCT01824875|59172614|FG000|Overall Study|Non-compliance|1|||
30993436|NCT01824875|59172615|FG001|Overall Study|Non-compliance|1|||
30993437|NCT01824875|59172614|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
30993438|NCT01824875|59172615|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
30993439|NCT01824875|59172614|FG000|Overall Study|Administrative issues|0|||
30993440|NCT01824875|59172615|FG001|Overall Study|Administrative issues|2|||
30993441|NCT01824875|59172614|FG000|Overall Study|Ineligible or never started treatment|9|||
30993442|NCT01824875|59172615|FG001|Overall Study|Ineligible or never started treatment|5|||
30993443|NCT01824875|59172614|FG000|Overall Study|Other|0|||
30993444|NCT01824875|59172615|FG001|Overall Study|Other|2|||
30993445|NCT01660451|59172637|FG000|Overall Study|Protocol Violation|0|||
30993446|NCT01660451|59172638|FG001|Overall Study|Protocol Violation|1|||
30993447|NCT01660451|59172639|FG002|Overall Study|Protocol Violation|1|||
30993448|NCT01660451|59172637|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11|||
30993449|NCT01660451|59172638|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8|||
30993450|NCT01660451|59172639|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26|||
30993451|NCT01660451|59172637|FG000|Overall Study|AE with Clinical PD|1|||
30993452|NCT01660451|59172638|FG001|Overall Study|AE with Clinical PD|3|||
30993453|NCT01660451|59172639|FG002|Overall Study|AE with Clinical PD|9|||
30993454|NCT01660451|59172637|FG000|Overall Study|Sponsor Decision|0|||
30993455|NCT01660451|59172638|FG001|Overall Study|Sponsor Decision|0|||
30993456|NCT01660451|59172639|FG002|Overall Study|Sponsor Decision|1|||
30993457|NCT01660451|59172637|FG000|Overall Study|Protocol Deviation|0|||
30993458|NCT01660451|59172638|FG001|Overall Study|Protocol Deviation|0|||
30993459|NCT01660451|59172639|FG002|Overall Study|Protocol Deviation|1|||
30993460|NCT01660451|59172637|FG000|Overall Study|Physician Decision|1|||
30993461|NCT01660451|59172638|FG001|Overall Study|Physician Decision|2|||
30993462|NCT01660451|59172639|FG002|Overall Study|Physician Decision|5|||
30993463|NCT01660451|59172637|FG000|Overall Study|Withdrawal by Subject|1|||
30993464|NCT01660451|59172638|FG001|Overall Study|Withdrawal by Subject|0|||
30993465|NCT01660451|59172639|FG002|Overall Study|Withdrawal by Subject|16|||
30993466|NCT01660451|59172637|FG000|Overall Study|Ongoing with treatment|3|||
30993467|NCT01660451|59172638|FG001|Overall Study|Ongoing with treatment|3|||
30993468|NCT01660451|59172639|FG002|Overall Study|Ongoing with treatment|46|||
30993469|NCT01390584|59172658|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
30993470|NCT01390584|59172659|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
30993471|NCT01390584|59172660|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
30993472|NCT01251965|59172672|FG000|Overall Study|Participant/physician decision|1|||
30993473|NCT01251965|59172673|FG001|Overall Study|Participant/physician decision|2|||
30993474|NCT01251965|59172674|FG002|Overall Study|Participant/physician decision|0|||
30993475|NCT01251965|59172672|FG000|Overall Study|Death|0|||
30993476|NCT01251965|59172673|FG001|Overall Study|Death|0|||
30993477|NCT01251965|59172674|FG002|Overall Study|Death|11|||
30993478|NCT01242800|59172685|FG000|Overall Study|Patient refusal|0|||
30993479|NCT01242800|59172686|FG001|Overall Study|Patient refusal|10|||
30993480|NCT01242800|59172685|FG000|Overall Study|Physician Decision|0|||
30993481|NCT01242800|59172686|FG001|Overall Study|Physician Decision|1|||
30993482|NCT01242800|59172685|FG000|Overall Study|Disease progression|0|||
30993483|NCT01242800|59172686|FG001|Overall Study|Disease progression|3|||
30993484|NCT01242800|59172685|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
30993485|NCT01242800|59172686|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
30993486|NCT01242800|59172685|FG000|Overall Study|Reasons not reported|0|||
30993487|NCT01242800|59172686|FG001|Overall Study|Reasons not reported|4|||
30993488|NCT01216683|59172695|FG000|Induction|Never started treatment|0|||
30993489|NCT01216683|59172696|FG001|Induction|Never started treatment|6|||
30993490|NCT01216683|59172697|FG002|Induction|Never started treatment|3|||
30993491|NCT01216683|59172695|FG000|Induction|Lack of Efficacy|4|||
30993492|NCT01216683|59172696|FG001|Induction|Lack of Efficacy|3|||
30993493|NCT01216683|59172697|FG002|Induction|Lack of Efficacy|7|||
30993494|NCT01216683|59172695|FG000|Induction|Adverse Event|0|||
30993495|NCT01216683|59172696|FG001|Induction|Adverse Event|5|||
30993496|NCT01216683|59172697|FG002|Induction|Adverse Event|5|||
30993497|NCT01216683|59172695|FG000|Induction|Death|0|||
30993498|NCT01216683|59172696|FG001|Induction|Death|0|||
30993499|NCT01216683|59172697|FG002|Induction|Death|2|||
30993500|NCT01216683|59172695|FG000|Induction|Withdrawal by Subject|0|||
30993501|NCT01216683|59172696|FG001|Induction|Withdrawal by Subject|4|||
30993502|NCT01216683|59172697|FG002|Induction|Withdrawal by Subject|2|||
30993503|NCT01216683|59172695|FG000|Induction|Other disease|0|||
30993504|NCT01216683|59172696|FG001|Induction|Other disease|1|||
30993505|NCT01216683|59172697|FG002|Induction|Other disease|2|||
30993506|NCT01216683|59172695|FG000|Continuation|Lack of Efficacy|3|||
30993507|NCT01216683|59172696|FG001|Continuation|Lack of Efficacy|2|||
30993508|NCT01216683|59172697|FG002|Continuation|Lack of Efficacy|7|||
30790218|NCT00035555|58803457|FG001|Overall Study|Allograft loss|1|||
30993509|NCT01216683|59172695|FG000|Continuation|Adverse Event|5|||
30993510|NCT01216683|59172696|FG001|Continuation|Adverse Event|3|||
30993511|NCT01216683|59172697|FG002|Continuation|Adverse Event|16|||
30993512|NCT01216683|59172695|FG000|Continuation|Death|1|||
30993513|NCT01216683|59172696|FG001|Continuation|Death|0|||
30993514|NCT01216683|59172697|FG002|Continuation|Death|2|||
30993515|NCT01216683|59172695|FG000|Continuation|Withdrawal by Subject|4|||
30993516|NCT01216683|59172696|FG001|Continuation|Withdrawal by Subject|5|||
30993517|NCT01216683|59172697|FG002|Continuation|Withdrawal by Subject|9|||
30993518|NCT01216683|59172695|FG000|Continuation|Other diseases|0|||
30993519|NCT01216683|59172696|FG001|Continuation|Other diseases|2|||
30993520|NCT01216683|59172697|FG002|Continuation|Other diseases|1|||
30993521|NCT01216683|59172695|FG000|Continuation|Physician Decision|1|||
30993522|NCT01216683|59172696|FG001|Continuation|Physician Decision|0|||
30993523|NCT01216683|59172697|FG002|Continuation|Physician Decision|1|||
30993524|NCT01216683|59172695|FG000|Continuation|Non-compliance|1|||
30993525|NCT01216683|59172696|FG001|Continuation|Non-compliance|0|||
30993526|NCT01216683|59172697|FG002|Continuation|Non-compliance|1|||
30993527|NCT01216683|59172695|FG000|Continuation|Insurance change|0|||
30993528|NCT01216683|59172696|FG001|Continuation|Insurance change|1|||
30993529|NCT01216683|59172697|FG002|Continuation|Insurance change|0|||
30993530|NCT01216683|59172695|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
30993531|NCT01216683|59172696|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
30993532|NCT01216683|59172697|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
30993533|NCT01216683|59172695|FG000|Continuation|Not reported|0|||
30993534|NCT01216683|59172696|FG001|Continuation|Not reported|0|||
30993535|NCT01216683|59172697|FG002|Continuation|Not reported|1|||
30993536|NCT01216683|59172695|FG000|Continuation|Never started treatment|0|||
30993537|NCT01216683|59172696|FG001|Continuation|Never started treatment|1|||
30993538|NCT01216683|59172697|FG002|Continuation|Never started treatment|5|||
30993539|NCT01145495|59172718|FG000|Overall Study|Adverse Event|6|||
30993540|NCT01145495|59172718|FG000|Overall Study|Withdrawal by Subject|6|||
30993541|NCT01145495|59172718|FG000|Overall Study|Disease progression after respone|2|||
30993542|NCT01124695|59172724|FG000|Overall Study|Disease progression|77|||
30993543|NCT01124695|59172724|FG000|Overall Study|Adverse Event|11|||
30993544|NCT01124695|59172724|FG000|Overall Study|Death|1|||
30993545|NCT01124695|59172724|FG000|Overall Study|Withdrawal by Subject|7|||
30993546|NCT01124695|59172724|FG000|Overall Study|Physician Decision|3|||
30993547|NCT01124695|59172724|FG000|Overall Study|Alternative therapy|9|||
30993548|NCT01124695|59172724|FG000|Overall Study|No documentation that patient went off treatment|4|||
30993549|NCT01124695|59172724|FG000|Overall Study|Ineligible|9|||
30993550|NCT01124695|59172724|FG000|Overall Study|Ineligible and never start treatment|2|||
30993551|NCT01084083|59172735|FG000|Overall Study|Adverse Event|5|||
30993552|NCT01084083|59172735|FG000|Overall Study|Death|1|||
30993553|NCT01084083|59172735|FG000|Overall Study|Withdrawal by Subject|2|||
30993554|NCT01084083|59172735|FG000|Overall Study|Complicating disease|1|||
30993555|NCT01084083|59172735|FG000|Overall Study|Other|2|||
30993556|NCT01084083|59172735|FG000|Overall Study|Never started assigned therapy|1|||
30993557|NCT01079780|59172743|FG000|Overall Study|Disease progression|43|||
30993558|NCT01079780|59172744|FG001|Overall Study|Disease progression|7|||
30993559|NCT01079780|59172745|FG002|Overall Study|Disease progression|31|||
30993560|NCT01079780|59172743|FG000|Overall Study|Adverse Event|13|||
30993561|NCT01079780|59172744|FG001|Overall Study|Adverse Event|5|||
30993562|NCT01079780|59172745|FG002|Overall Study|Adverse Event|7|||
30993563|NCT01079780|59172743|FG000|Overall Study|Death|2|||
30993564|NCT01079780|59172744|FG001|Overall Study|Death|0|||
30993565|NCT01079780|59172745|FG002|Overall Study|Death|2|||
30993566|NCT01079780|59172743|FG000|Overall Study|Withdrawal by Subject|6|||
30993567|NCT01079780|59172744|FG001|Overall Study|Withdrawal by Subject|4|||
30993568|NCT01079780|59172745|FG002|Overall Study|Withdrawal by Subject|4|||
30993569|NCT01079780|59172743|FG000|Overall Study|Alternative therapy|2|||
30993570|NCT01079780|59172744|FG001|Overall Study|Alternative therapy|0|||
30993571|NCT01079780|59172745|FG002|Overall Study|Alternative therapy|2|||
30993572|NCT01079780|59172743|FG000|Overall Study|Physician Decision|1|||
30993573|NCT01079780|59172744|FG001|Overall Study|Physician Decision|0|||
30993574|NCT01079780|59172745|FG002|Overall Study|Physician Decision|1|||
30993575|NCT01079780|59172743|FG000|Overall Study|Error made in lesion measurement|1|||
30993576|NCT01079780|59172744|FG001|Overall Study|Error made in lesion measurement|0|||
30993577|NCT01079780|59172745|FG002|Overall Study|Error made in lesion measurement|0|||
30993578|NCT01079780|59172743|FG000|Overall Study|Patient had surgery|1|||
30993579|NCT01079780|59172744|FG001|Overall Study|Patient had surgery|0|||
30993580|NCT01079780|59172745|FG002|Overall Study|Patient had surgery|0|||
30993581|NCT01079780|59172743|FG000|Overall Study|Treatment cycle delay|0|||
30993582|NCT01079780|59172744|FG001|Overall Study|Treatment cycle delay|0|||
30993583|NCT01079780|59172745|FG002|Overall Study|Treatment cycle delay|1|||
30993584|NCT01079780|59172743|FG000|Overall Study|Never started treatment|1|||
30993585|NCT01079780|59172744|FG001|Overall Study|Never started treatment|0|||
30993586|NCT01079780|59172745|FG002|Overall Study|Never started treatment|2|||
30993587|NCT01013961|59172755|FG000|Overall Study|Adverse Event|2|||
30993588|NCT01013961|59172756|FG001|Overall Study|Adverse Event|2|||
30993589|NCT01013961|59172755|FG000|Overall Study|Withdrawal by Subject|1|||
30993590|NCT01013961|59172756|FG001|Overall Study|Withdrawal by Subject|0|||
30993591|NCT01013961|59172755|FG000|Overall Study|Physician Decision|0|||
30993592|NCT01013961|59172756|FG001|Overall Study|Physician Decision|1|||
30993593|NCT00834093|59172771|FG000|Overall Study|Progressive Disease|3|||
30993594|NCT00834093|59172771|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
30993595|NCT00606294|59172777|FG000|Overall Study|Withdrawal by Subject|36|||
30993596|NCT00606294|59172778|FG001|Overall Study|Withdrawal by Subject|0|||
30993597|NCT00583596|59172784|FG000|Overall Study|Lost to Follow-up|110|||
30993598|NCT00583596|59172784|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
30993599|NCT00583596|59172784|FG000|Overall Study|Death|2|||
30993600|NCT00583596|59172784|FG000|Overall Study|Withdrawal by Subject|6|||
30993601|NCT00583596|59172784|FG000|Overall Study|Lost to Follow-up|94|||
30993602|NCT00583596|59172784|FG000|Overall Study|Data not complete|1|||
30993603|NCT00583596|59172784|FG000|Overall Study|Not consented|15|||
30993604|NCT00583596|59172784|FG000|Overall Study|Outside f-up window|26|||
30993605|NCT00316888|59172795|FG000|Overall Study|Adverse Event|4|||
30993606|NCT00316888|59172796|FG001|Overall Study|Adverse Event|5|||
30993607|NCT00316888|59172795|FG000|Overall Study|Withdrawal by Subject|2|||
30993608|NCT00316888|59172796|FG001|Overall Study|Withdrawal by Subject|2|||
30993609|NCT00316888|59172795|FG000|Overall Study|Not start protocol therapy|0|||
30993610|NCT00316888|59172796|FG001|Overall Study|Not start protocol therapy|1|||
30993611|NCT00274924|59172805|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
30993612|NCT00274924|59172806|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
30993613|NCT00274924|59172807|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
30993614|NCT00274924|59172805|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
30993615|NCT00274924|59172806|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
30993616|NCT00274924|59172807|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
30993617|NCT00274924|59172805|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
30993618|NCT00274924|59172806|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
30993619|NCT00274924|59172807|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
30993620|NCT00274924|59172805|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
30993621|NCT00274924|59172806|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
30993622|NCT00274924|59172807|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
30993623|NCT00274924|59172805|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
30993624|NCT00274924|59172806|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
30993625|NCT00274924|59172807|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
30993626|NCT00274924|59172805|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
30993627|NCT00274924|59172806|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
30993628|NCT00274924|59172807|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
30993629|NCT00274924|59172805|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
30993630|NCT00274924|59172806|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
30993631|NCT00274924|59172807|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
30993632|NCT00274924|59172805|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
30993633|NCT00274924|59172806|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
30993634|NCT00274924|59172807|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
30993635|NCT00274924|59172805|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
30993636|NCT00274924|59172806|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
30993637|NCT00274924|59172807|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
30993638|NCT00274924|59172805|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
30993639|NCT00274924|59172806|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
30993640|NCT00274924|59172807|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
30993641|NCT00274924|59172805|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
30993642|NCT00274924|59172806|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
30993643|NCT00274924|59172807|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
30993644|NCT00274924|59172805|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
30993645|NCT00274924|59172806|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
30993646|NCT00274924|59172807|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
30993647|NCT00274924|59172805|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
30993648|NCT00274924|59172806|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
30993649|NCT00274924|59172807|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
30993650|NCT00104884|59172814|FG000|Overall Study|Disease progression|4|||
30993651|NCT00096174|59172818|FG000|Overall Study|Lack of Efficacy|9|||
30993652|NCT00096174|59172818|FG000|Overall Study|Adverse Event|15|||
30993653|NCT00096174|59172818|FG000|Overall Study|Death|6|||
30993654|NCT00096174|59172818|FG000|Overall Study|Withdrawal by Subject|15|||
30993655|NCT00096174|59172818|FG000|Overall Study|Not started protocol therapy|3|||
30993656|NCT00096174|59172818|FG000|Overall Study|Ineligible|6|||
30993657|NCT00096174|59172818|FG000|Overall Study|other reason|8|||
30993658|NCT00080938|59172822|FG000|Overall Study|Adverse Event|3|||
30993659|NCT00080938|59172822|FG000|Overall Study|Withdrawal by Subject|6|||
30993660|NCT00080938|59172822|FG000|Overall Study|Death|2|||
30993661|NCT00080938|59172822|FG000|Overall Study|Lack of Efficacy|7|||
30993662|NCT00080938|59172822|FG000|Overall Study|other disease|1|||
30993663|NCT00080938|59172822|FG000|Overall Study|Not started protocol therapy|1|||
30993664|NCT00080938|59172822|FG000|Overall Study|Ineligible|4|||
30993665|NCT00074282|59172826|FG000|Step 1|Adverse Event|32|||
30993666|NCT00074282|59172827|FG001|Step 1|Adverse Event|0|||
30993667|NCT00074282|59172828|FG002|Step 1|Adverse Event|0|||
30993668|NCT00074282|59172826|FG000|Step 1|Death|6|||
30993669|NCT00074282|59172827|FG001|Step 1|Death|0|||
30993670|NCT00074282|59172828|FG002|Step 1|Death|0|||
30993671|NCT00074282|59172826|FG000|Step 1|Withdrawal by Subject|7|||
30993672|NCT00074282|59172827|FG001|Step 1|Withdrawal by Subject|0|||
30993673|NCT00074282|59172828|FG002|Step 1|Withdrawal by Subject|0|||
30993674|NCT00074282|59172826|FG000|Step 1|Disease progression|2|||
30993675|NCT00074282|59172827|FG001|Step 1|Disease progression|0|||
30993676|NCT00074282|59172828|FG002|Step 1|Disease progression|0|||
30993677|NCT00074282|59172826|FG000|Step 1|Alternative therapy|2|||
30993678|NCT00074282|59172827|FG001|Step 1|Alternative therapy|0|||
30993679|NCT00074282|59172828|FG002|Step 1|Alternative therapy|0|||
30993680|NCT00074282|59172826|FG000|Step 1|Other complicating disease|2|||
30993681|NCT00074282|59172827|FG001|Step 1|Other complicating disease|0|||
30993682|NCT00074282|59172828|FG002|Step 1|Other complicating disease|0|||
30993683|NCT00074282|59172826|FG000|Step 1|Physician Decision|1|||
30993684|NCT00074282|59172827|FG001|Step 1|Physician Decision|0|||
30993685|NCT00074282|59172828|FG002|Step 1|Physician Decision|0|||
30993686|NCT00074282|59172826|FG000|Step 1|Ineligible|4|||
30993687|NCT00074282|59172827|FG001|Step 1|Ineligible|0|||
30993688|NCT00074282|59172828|FG002|Step 1|Ineligible|0|||
30993689|NCT00074282|59172826|FG000|Step 1|Never started treatment|2|||
30993690|NCT00074282|59172827|FG001|Step 1|Never started treatment|0|||
30993691|NCT00074282|59172828|FG002|Step 1|Never started treatment|0|||
30993692|NCT00074282|59172826|FG000|Step 2|Adverse Event|0|||
30993693|NCT00074282|59172827|FG001|Step 2|Adverse Event|2|||
30993694|NCT00074282|59172828|FG002|Step 2|Adverse Event|12|||
30993695|NCT00074282|59172826|FG000|Step 2|Disease progression|0|||
30993696|NCT00074282|59172827|FG001|Step 2|Disease progression|0|||
30993697|NCT00074282|59172828|FG002|Step 2|Disease progression|5|||
30993698|NCT00074282|59172826|FG000|Step 2|Death|0|||
30993699|NCT00074282|59172827|FG001|Step 2|Death|0|||
30993700|NCT00074282|59172828|FG002|Step 2|Death|3|||
30993701|NCT00074282|59172826|FG000|Step 2|Withdrawal by Subject|0|||
30993702|NCT00074282|59172827|FG001|Step 2|Withdrawal by Subject|0|||
30993703|NCT00074282|59172828|FG002|Step 2|Withdrawal by Subject|2|||
30993704|NCT00074282|59172826|FG000|Step 2|Physician Decision|0|||
30993705|NCT00074282|59172827|FG001|Step 2|Physician Decision|0|||
30993706|NCT00074282|59172828|FG002|Step 2|Physician Decision|1|||
30993707|NCT00074282|59172826|FG000|Step 2|Ineligible|0|||
30993708|NCT00074282|59172827|FG001|Step 2|Ineligible|0|||
30993709|NCT00074282|59172828|FG002|Step 2|Ineligible|1|||
30993710|NCT00071981|59172840|FG000|Overall Study|Lack of Efficacy|37|||
30993711|NCT00071981|59172841|FG001|Overall Study|Lack of Efficacy|29|||
30993712|NCT00071981|59172842|FG002|Overall Study|Lack of Efficacy|30|||
30993713|NCT00071981|59172843|FG003|Overall Study|Lack of Efficacy|43|||
30993714|NCT00071981|59172840|FG000|Overall Study|Adverse Event|4|||
30993715|NCT00071981|59172841|FG001|Overall Study|Adverse Event|4|||
30993716|NCT00071981|59172842|FG002|Overall Study|Adverse Event|3|||
30993717|NCT00071981|59172843|FG003|Overall Study|Adverse Event|1|||
30993718|NCT00071981|59172840|FG000|Overall Study|Death|0|||
30993719|NCT00071981|59172841|FG001|Overall Study|Death|0|||
30993720|NCT00071981|59172842|FG002|Overall Study|Death|1|||
30993721|NCT00071981|59172843|FG003|Overall Study|Death|1|||
30993722|NCT00071981|59172840|FG000|Overall Study|Withdrawal by Subject|3|||
30993723|NCT00071981|59172841|FG001|Overall Study|Withdrawal by Subject|1|||
30993724|NCT00071981|59172842|FG002|Overall Study|Withdrawal by Subject|0|||
30993725|NCT00071981|59172843|FG003|Overall Study|Withdrawal by Subject|0|||
30993726|NCT00071981|59172840|FG000|Overall Study|No protocol therapy|2|||
30993727|NCT00071981|59172841|FG001|Overall Study|No protocol therapy|5|||
30993728|NCT00071981|59172842|FG002|Overall Study|No protocol therapy|1|||
30993729|NCT00071981|59172843|FG003|Overall Study|No protocol therapy|0|||
30993730|NCT00071981|59172840|FG000|Overall Study|others (not specified in the study)|0|||
30993731|NCT00071981|59172841|FG001|Overall Study|others (not specified in the study)|2|||
30993732|NCT00071981|59172842|FG002|Overall Study|others (not specified in the study)|2|||
30993733|NCT00071981|59172843|FG003|Overall Study|others (not specified in the study)|0|||
30993734|NCT00070291|59172853|FG000|Step 1|Withdrawal by Subject|1|||
30993735|NCT00070291|59172853|FG000|Step 1|Adverse Event|1|||
30993736|NCT00070291|59172853|FG000|Step 2|Adverse Event|1|||
30993737|NCT00064350|59172860|FG000|Induction Treatment|Disease Progression|5|||
30993738|NCT00064350|59172861|FG001|Induction Treatment|Disease Progression|1|||
30993739|NCT00064350|59172862|FG002|Induction Treatment|Disease Progression|110|||
30993740|NCT00064350|59172860|FG000|Induction Treatment|Adverse Event|0|||
30993741|NCT00064350|59172861|FG001|Induction Treatment|Adverse Event|2|||
30993742|NCT00064350|59172862|FG002|Induction Treatment|Adverse Event|49|||
30993743|NCT00064350|59172860|FG000|Induction Treatment|Death|0|||
30993744|NCT00064350|59172861|FG001|Induction Treatment|Death|0|||
30993745|NCT00064350|59172862|FG002|Induction Treatment|Death|9|||
30993746|NCT00064350|59172860|FG000|Induction Treatment|Withdrawal by Subject|0|||
30993747|NCT00064350|59172861|FG001|Induction Treatment|Withdrawal by Subject|0|||
30993748|NCT00064350|59172862|FG002|Induction Treatment|Withdrawal by Subject|21|||
30993749|NCT00064350|59172860|FG000|Induction Treatment|Ineligible or never started treatment|3|||
30993750|NCT00064350|59172861|FG001|Induction Treatment|Ineligible or never started treatment|6|||
30993751|NCT00064350|59172862|FG002|Induction Treatment|Ineligible or never started treatment|34|||
30993752|NCT00064350|59172860|FG000|Induction Treatment|Other|0|||
30993753|NCT00064350|59172861|FG001|Induction Treatment|Other|0|||
30993754|NCT00064350|59172862|FG002|Induction Treatment|Other|13|||
30993755|NCT00064350|59172860|FG000|Randomization|Adverse Event|8|||
30993756|NCT00064350|59172861|FG001|Randomization|Adverse Event|3|||
30993757|NCT00064350|59172862|FG002|Randomization|Adverse Event|0|||
30993758|NCT00064350|59172860|FG000|Randomization|Death|3|||
30993759|NCT00064350|59172861|FG001|Randomization|Death|0|||
30993760|NCT00064350|59172862|FG002|Randomization|Death|0|||
30993761|NCT00064350|59172860|FG000|Randomization|Withdrawal by Subject|1|||
30993762|NCT00064350|59172861|FG001|Randomization|Withdrawal by Subject|0|||
30993763|NCT00064350|59172862|FG002|Randomization|Withdrawal by Subject|0|||
30993764|NCT00064350|59172860|FG000|Randomization|Ineligible or never started treatment|9|||
30993765|NCT00064350|59172861|FG001|Randomization|Ineligible or never started treatment|15|||
30993766|NCT00064350|59172862|FG002|Randomization|Ineligible or never started treatment|0|||
30993767|NCT00064350|59172860|FG000|Randomization|Other|5|||
30993768|NCT00064350|59172861|FG001|Randomization|Other|0|||
30993769|NCT00064350|59172862|FG002|Randomization|Other|0|||
30993770|NCT00064350|59172860|FG000|Cross-Over|Adverse Event|0|||
30993771|NCT00064350|59172861|FG001|Cross-Over|Adverse Event|1|||
30993772|NCT00064350|59172862|FG002|Cross-Over|Adverse Event|0|||
30993773|NCT00064350|59172860|FG000|Cross-Over|Death|1|||
30993774|NCT00064350|59172861|FG001|Cross-Over|Death|3|||
30993775|NCT00064350|59172862|FG002|Cross-Over|Death|0|||
30993776|NCT00064350|59172860|FG000|Cross-Over|Withdrawal by Subject|2|||
30993777|NCT00064350|59172861|FG001|Cross-Over|Withdrawal by Subject|2|||
30993778|NCT00064350|59172862|FG002|Cross-Over|Withdrawal by Subject|0|||
30993779|NCT00064350|59172860|FG000|Cross-Over|Ineligible or never started treatment|3|||
30993780|NCT00064350|59172861|FG001|Cross-Over|Ineligible or never started treatment|6|||
30993781|NCT00064350|59172862|FG002|Cross-Over|Ineligible or never started treatment|0|||
30993782|NCT00064350|59172860|FG000|Cross-Over|Other|0|||
30993783|NCT00064350|59172861|FG001|Cross-Over|Other|2|||
30993784|NCT00064350|59172862|FG002|Cross-Over|Other|0|||
30993785|NCT00063986|59172871|FG000|Overall Study|Withdrawal by Subject|1|||
30993786|NCT00063986|59172871|FG000|Overall Study|Ineligible|1|||
30993787|NCT00063986|59172871|FG000|Overall Study|Intra-operatively ineligible|4|||
30993788|NCT00057954|59172879|FG000|Overall Study|Death|1|||
30993789|NCT00057954|59172879|FG000|Overall Study|Disease progression|1|||
30993790|NCT00049530|59172883|FG000|Overall Study|Lack of Efficacy|25|||
30993791|NCT00049530|59172883|FG000|Overall Study|Adverse Event|2|||
30993792|NCT00049530|59172883|FG000|Overall Study|Death|1|||
30993793|NCT00049530|59172883|FG000|Overall Study|symptomatic deterioration|1|||
30993794|NCT00049530|59172883|FG000|Overall Study|ineligible|3|||
30993795|NCT00045305|59172887|FG000|Overall Study|Lack of Efficacy|6|||
30993796|NCT00045305|59172887|FG000|Overall Study|Adverse Event|3|||
30993797|NCT00045305|59172887|FG000|Overall Study|Death|3|||
30993798|NCT00045305|59172887|FG000|Overall Study|site error|2|||
30993799|NCT00033657|59172893|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
30993800|NCT00033657|59172894|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
30993801|NCT00033657|59172893|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
30993802|NCT00033657|59172894|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
30993803|NCT00033657|59172893|FG000|Neoadjuvant Chemotherapy|Death|1|||
30993804|NCT00033657|59172894|FG001|Neoadjuvant Chemotherapy|Death|1|||
30993805|NCT00033657|59172893|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
30993806|NCT00033657|59172894|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
30993807|NCT00033657|59172893|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
30993808|NCT00033657|59172894|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
30993809|NCT00033657|59172893|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
30993810|NCT00033657|59172894|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
30993811|NCT00033657|59172893|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
30993812|NCT00033657|59172894|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
30993813|NCT00033657|59172893|FG000|Surgical Resection|not complete resection|0|||
30993814|NCT00033657|59172894|FG001|Surgical Resection|not complete resection|3|||
30993815|NCT00033657|59172893|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
30993816|NCT00033657|59172894|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
30993817|NCT00033657|59172893|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
30993818|NCT00033657|59172894|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
30993819|NCT00033657|59172893|FG000|Adjuvant Chemotherapy|Death|2|||
30993820|NCT00033657|59172894|FG001|Adjuvant Chemotherapy|Death|1|||
30993821|NCT00033657|59172893|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
30993822|NCT00033657|59172894|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
30993823|NCT00033657|59172893|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
30993824|NCT00033657|59172894|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
30993825|NCT00033657|59172893|FG000|Adjuvant Chemotherapy|Other|0|||
30993826|NCT00033657|59172894|FG001|Adjuvant Chemotherapy|Other|2|||
30993827|NCT00003389|59172904|FG000|Overall Study|Disease progression|6|||
30993828|NCT00003389|59172905|FG001|Overall Study|Disease progression|1|||
30993829|NCT00003389|59172904|FG000|Overall Study|Adverse Event|13|||
30993830|NCT00003389|59172905|FG001|Overall Study|Adverse Event|2|||
30993831|NCT00003389|59172904|FG000|Overall Study|Death|0|||
30993832|NCT00003389|59172905|FG001|Overall Study|Death|3|||
30993833|NCT00003389|59172904|FG000|Overall Study|Withdrawal by Subject|12|||
30993834|NCT00003389|59172905|FG001|Overall Study|Withdrawal by Subject|5|||
30993835|NCT00003389|59172904|FG000|Overall Study|Alternative therapy|2|||
30993836|NCT00003389|59172905|FG001|Overall Study|Alternative therapy|1|||
30993837|NCT00003389|59172904|FG000|Overall Study|Complicating disease|1|||
30993838|NCT00003389|59172905|FG001|Overall Study|Complicating disease|0|||
30993839|NCT00003389|59172904|FG000|Overall Study|Off-treatment reason missing|31|||
30993840|NCT00003389|59172905|FG001|Overall Study|Off-treatment reason missing|21|||
30993841|NCT00003389|59172904|FG000|Overall Study|Ineligible|33|||
30993842|NCT00003389|59172905|FG001|Overall Study|Ineligible|27|||
30993843|NCT00003138|59172913|FG000|Step 1|Reasons off treatment not documented|60|||
30993844|NCT00003138|59172914|FG001|Step 1|Reasons off treatment not documented|57|||
30993845|NCT00003138|59172913|FG000|Step 1|Never started treatment|1|||
30993846|NCT00003138|59172914|FG001|Step 1|Never started treatment|0|||
30993847|NCT00003138|59172913|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
30993848|NCT00003138|59172914|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
30993849|NCT00003138|59172913|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
30993850|NCT00003138|59172914|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
30993851|NCT00003138|59172913|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
30993852|NCT00003138|59172914|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
30993853|NCT00003138|59172913|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
30993854|NCT00003138|59172914|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
30993855|NCT00002525|59172925|FG000|Overall Study|Adverse Event|36|||
30993856|NCT00002525|59172926|FG001|Overall Study|Adverse Event|0|||
30993857|NCT00002525|59172925|FG000|Overall Study|Death|5|||
30993858|NCT00002525|59172926|FG001|Overall Study|Death|0|||
30993859|NCT00002525|59172925|FG000|Overall Study|Withdrawal by Subject|11|||
30993860|NCT00002525|59172926|FG001|Overall Study|Withdrawal by Subject|0|||
30993861|NCT00002525|59172925|FG000|Overall Study|Start non-protocol therapy|1|||
30993862|NCT00002525|59172926|FG001|Overall Study|Start non-protocol therapy|0|||
30993863|NCT00002525|59172925|FG000|Overall Study|Other complicating disease|1|||
30993864|NCT00002525|59172926|FG001|Overall Study|Other complicating disease|0|||
30993865|NCT00002525|59172925|FG000|Overall Study|Duke's A, B1, D disease|92|||
30993866|NCT00002525|59172926|FG001|Overall Study|Duke's A, B1, D disease|0|||
30993867|NCT00002525|59172925|FG000|Overall Study|Error|6|||
30993868|NCT00002525|59172926|FG001|Overall Study|Error|0|||
30993869|NCT00002525|59172925|FG000|Overall Study|Other|26|||
30993870|NCT00002525|59172926|FG001|Overall Study|Other|0|||
30993871|NCT00002525|59172925|FG000|Overall Study|Never start protocol therapy|8|||
30993872|NCT00002525|59172926|FG001|Overall Study|Never start protocol therapy|0|||
30993873|NCT02259348|59172934|FG000|Overall Study|Donors|6|||
30993874|NCT02259348|59172934|FG000|Overall Study|Death|4|||
30993875|NCT02259114|59173195|FG000|Overall Study|Progressive Disease|14|||
30993876|NCT02259114|59173196|FG001|Overall Study|Progressive Disease|2|||
30891889|NCT02251275|58925195|FG003|Overall Study|Protocol Deviation|0|||
30891890|NCT02251275|58925196|FG004|Overall Study|Protocol Deviation|0|||
30891891|NCT02251275|58925192|FG000|Overall Study|Withdrawal by Subject|25|||
30891892|NCT02251275|58925193|FG001|Overall Study|Withdrawal by Subject|51|||
30891893|NCT02251275|58925194|FG002|Overall Study|Withdrawal by Subject|35|||
30891894|NCT02251275|58925195|FG003|Overall Study|Withdrawal by Subject|1|||
30891895|NCT02251275|58925196|FG004|Overall Study|Withdrawal by Subject|0|||
30891896|NCT02379637|58925210|FG000|Overall Study|Protocol Violation|0|||
30891897|NCT02379637|58925211|FG001|Overall Study|Protocol Violation|1|||
30891898|NCT02379637|58925210|FG000|Overall Study|Adverse Event|1|||
30891899|NCT02379637|58925211|FG001|Overall Study|Adverse Event|0|||
30891900|NCT02379637|58925210|FG000|Overall Study|Withdrawal by Subject|1|||
30993877|NCT02259114|59173197|FG002|Overall Study|Progressive Disease|10|||
30993878|NCT02259114|59173198|FG003|Overall Study|Progressive Disease|2|||
30993879|NCT02259114|59173199|FG004|Overall Study|Progressive Disease|5|||
30993880|NCT02259114|59173195|FG000|Overall Study|Adverse Event|2|||
30993881|NCT02259114|59173196|FG001|Overall Study|Adverse Event|1|||
30891901|NCT02379637|58925211|FG001|Overall Study|Withdrawal by Subject|0|||
30891902|NCT02195583|58925217|FG000|Overall Study|Lost to Follow-up|1|||
30993882|NCT02259114|59173197|FG002|Overall Study|Adverse Event|0|||
30993883|NCT02259114|59173198|FG003|Overall Study|Adverse Event|0|||
30993884|NCT02259114|59173199|FG004|Overall Study|Adverse Event|1|||
30993885|NCT02259114|59173195|FG000|Overall Study|Death|3|||
30993886|NCT02259114|59173196|FG001|Overall Study|Death|0|||
30993887|NCT02259114|59173197|FG002|Overall Study|Death|1|||
30993888|NCT02259114|59173198|FG003|Overall Study|Death|0|||
30993889|NCT02259114|59173199|FG004|Overall Study|Death|0|||
30993890|NCT02259114|59173195|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
30993891|NCT02259114|59173196|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
30993892|NCT02259114|59173197|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
30993893|NCT02259114|59173198|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
30993894|NCT02259114|59173199|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
30993895|NCT02259114|59173195|FG000|Overall Study|Withdrawal by Subject|0|||
30993896|NCT02259114|59173196|FG001|Overall Study|Withdrawal by Subject|0|||
30993897|NCT02259114|59173197|FG002|Overall Study|Withdrawal by Subject|1|||
30993898|NCT02259114|59173198|FG003|Overall Study|Withdrawal by Subject|1|||
30993899|NCT02259114|59173199|FG004|Overall Study|Withdrawal by Subject|0|||
30993900|NCT02259114|59173195|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
30993901|NCT02259114|59173196|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
30993902|NCT02259114|59173197|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
30993903|NCT02259114|59173198|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
30993904|NCT02259114|59173199|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
30993905|NCT02259114|59173195|FG000|Overall Study|Not Treated|1|||
30993906|NCT02259114|59173196|FG001|Overall Study|Not Treated|0|||
30993907|NCT02259114|59173197|FG002|Overall Study|Not Treated|0|||
30993908|NCT02259114|59173198|FG003|Overall Study|Not Treated|0|||
30993909|NCT02259114|59173199|FG004|Overall Study|Not Treated|0|||
30993910|NCT02258334|59173254|FG000|Overall Study|Adverse Event|1|||
30993911|NCT02258334|59173255|FG001|Overall Study|Adverse Event|0|||
30993912|NCT02258334|59173256|FG002|Overall Study|Adverse Event|0|||
30993913|NCT02258334|59173257|FG003|Overall Study|Adverse Event|0|||
30993914|NCT04960202|59173294|FG000|Overall Study|Other|12|||
30993915|NCT04960202|59173295|FG001|Overall Study|Other|10|||
30993916|NCT04960202|59173294|FG000|Overall Study|Withdrawal by Subject|43|||
30993917|NCT04960202|59173295|FG001|Overall Study|Withdrawal by Subject|45|||
30993918|NCT04960202|59173294|FG000|Overall Study|Lost to Follow-up|20|||
30993919|NCT04960202|59173295|FG001|Overall Study|Lost to Follow-up|17|||
30993920|NCT04960202|59173294|FG000|Overall Study|Death|0|||
30993921|NCT04960202|59173295|FG001|Overall Study|Death|15|||
30993922|NCT02257632|59173365|FG000|Overall Study|Withdrawal by Subject|0|||
30993923|NCT02257632|59173366|FG001|Overall Study|Withdrawal by Subject|1|||
30993924|NCT02257632|59173365|FG000|Overall Study|Adverse Event|1|||
30993925|NCT02257632|59173366|FG001|Overall Study|Adverse Event|2|||
30993926|NCT01642914|59173400|FG000|Overall Study|Adverse Event|11|||
30993927|NCT01642914|59173401|FG001|Overall Study|Adverse Event|7|||
30993928|NCT01642914|59173402|FG002|Overall Study|Adverse Event|15|||
30993929|NCT01642914|59173400|FG000|Overall Study|Lack of Efficacy|9|||
30993930|NCT01642914|59173401|FG001|Overall Study|Lack of Efficacy|4|||
30993931|NCT01642914|59173402|FG002|Overall Study|Lack of Efficacy|2|||
30993932|NCT01642914|59173400|FG000|Overall Study|Protocol Violation|15|||
30993933|NCT01642914|59173401|FG001|Overall Study|Protocol Violation|13|||
30993934|NCT01642914|59173402|FG002|Overall Study|Protocol Violation|6|||
30993935|NCT01642914|59173400|FG000|Overall Study|Withdrawal by Subject|5|||
30993936|NCT01642914|59173401|FG001|Overall Study|Withdrawal by Subject|5|||
30993937|NCT01642914|59173402|FG002|Overall Study|Withdrawal by Subject|10|||
30993938|NCT01642914|59173400|FG000|Overall Study|Lost to Follow-up|5|||
30993939|NCT01642914|59173401|FG001|Overall Study|Lost to Follow-up|3|||
30993940|NCT01642914|59173402|FG002|Overall Study|Lost to Follow-up|7|||
30993941|NCT01642914|59173400|FG000|Overall Study|Other Reason|1|||
30993942|NCT01642914|59173401|FG001|Overall Study|Other Reason|0|||
30993943|NCT01642914|59173402|FG002|Overall Study|Other Reason|0|||
30993944|NCT01642602|59173461|FG000|Overall Study|Adverse Event|2|||
30993945|NCT02256540|59173527|FG000|Overall Study|Withdrawal by Subject|0|||
30993946|NCT02256540|59173528|FG001|Overall Study|Withdrawal by Subject|1|||
30993947|NCT02256540|59173529|FG002|Overall Study|Withdrawal by Subject|1|||
30993948|NCT02256540|59173527|FG000|Overall Study|Back pain preventing exercise|0|||
30993949|NCT02256540|59173528|FG001|Overall Study|Back pain preventing exercise|0|||
30993950|NCT02256540|59173529|FG002|Overall Study|Back pain preventing exercise|1|||
30993951|NCT01640184|59173553|FG000|Overall Study|Death|1|||
30993952|NCT01640184|59173554|FG001|Overall Study|Death|0|||
30993953|NCT01640184|59173555|FG002|Overall Study|Death|0|||
30993954|NCT01640184|59173553|FG000|Overall Study|Lost to Follow-up|4|||
30993955|NCT01640184|59173554|FG001|Overall Study|Lost to Follow-up|1|||
30993956|NCT01640184|59173555|FG002|Overall Study|Lost to Follow-up|0|||
30993957|NCT01640184|59173553|FG000|Overall Study|Physician Decision|3|||
30993958|NCT01640184|59173554|FG001|Overall Study|Physician Decision|0|||
30993959|NCT01640184|59173555|FG002|Overall Study|Physician Decision|0|||
30993960|NCT01640184|59173553|FG000|Overall Study|Withdrawal by Subject|0|||
30993961|NCT01640184|59173554|FG001|Overall Study|Withdrawal by Subject|1|||
30993962|NCT01640184|59173555|FG002|Overall Study|Withdrawal by Subject|1|||
30993963|NCT01640184|59173553|FG000|Overall Study|Protocol Violation|0|||
30993964|NCT01640184|59173554|FG001|Overall Study|Protocol Violation|0|||
30993965|NCT01640184|59173555|FG002|Overall Study|Protocol Violation|1|||
30993966|NCT02256384|59173575|FG000|Overall Study|Withdrawal by Subject|12|||
30993967|NCT02256384|59173575|FG000|Overall Study|Equipment not capturing data|2|||
30993968|NCT02255760|59173618|FG000|Overall Study|Lost to Follow-up|0|||
30993969|NCT02255760|59173619|FG001|Overall Study|Lost to Follow-up|1|||
30993970|NCT02255760|59173620|FG002|Overall Study|Lost to Follow-up|0|||
30993971|NCT02255760|59173621|FG003|Overall Study|Lost to Follow-up|0|||
30993972|NCT02255760|59173622|FG004|Overall Study|Lost to Follow-up|0|||
30993973|NCT01641822|59173718|FG000|Run-in Phase|Noncompliance with study drug|1|||
30993974|NCT01641822|59173719|FG001|Run-in Phase|Noncompliance with study drug|0|||
30993975|NCT01641822|59173720|FG002|Run-in Phase|Noncompliance with study drug|0|||
30993976|NCT01641822|59173718|FG000|Run-in Phase|Adverse Event|3|||
30993977|NCT01641822|59173719|FG001|Run-in Phase|Adverse Event|0|||
30993978|NCT01641822|59173720|FG002|Run-in Phase|Adverse Event|0|||
30993979|NCT01641822|59173718|FG000|Run-in Phase|Withdrew consent|1|||
30993980|NCT01641822|59173719|FG001|Run-in Phase|Withdrew consent|0|||
30993981|NCT01641822|59173720|FG002|Run-in Phase|Withdrew consent|0|||
30993982|NCT01641822|59173718|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
30993983|NCT01641822|59173719|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
30993984|NCT01641822|59173720|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
30993985|NCT01641822|59173718|FG000|Comparative Phase|Noncompliance with study drug|0|||
30993986|NCT01641822|59173719|FG001|Comparative Phase|Noncompliance with study drug|1|||
30993987|NCT01641822|59173720|FG002|Comparative Phase|Noncompliance with study drug|0|||
30993988|NCT01641822|59173718|FG000|Comparative Phase|Investigator's discretion|0|||
30993989|NCT01641822|59173719|FG001|Comparative Phase|Investigator's discretion|0|||
30993990|NCT01641822|59173720|FG002|Comparative Phase|Investigator's discretion|1|||
30993991|NCT01641822|59173718|FG000|Comparative Phase|Pregnancy|0|||
30993992|NCT01641822|59173719|FG001|Comparative Phase|Pregnancy|0|||
30993993|NCT01641822|59173720|FG002|Comparative Phase|Pregnancy|1|||
30993994|NCT01641822|59173718|FG000|Comparative Phase|Adverse event, serious fatal|0|||
30993995|NCT01641822|59173719|FG001|Comparative Phase|Adverse event, serious fatal|1|||
30993996|NCT01641822|59173720|FG002|Comparative Phase|Adverse event, serious fatal|0|||
30993997|NCT01641822|59173718|FG000|Comparative Phase|Withdrew consent|0|||
30993998|NCT01641822|59173719|FG001|Comparative Phase|Withdrew consent|3|||
30993999|NCT01641822|59173720|FG002|Comparative Phase|Withdrew consent|7|||
30994000|NCT01641822|59173718|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
30994001|NCT01641822|59173719|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
30994002|NCT01641822|59173720|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
30994003|NCT01641198|59173800|FG000|After 12 Months of Function|Lost to Follow-up|3|||
30994004|NCT01641198|59173801|FG001|After 12 Months of Function|Lost to Follow-up|2|||
30994005|NCT01641198|59173802|FG002|After 12 Months of Function|Lost to Follow-up|2|||
30994006|NCT01641198|59173800|FG000|After 12 Months of Function|Protocol Violation|1|||
30994007|NCT01641198|59173801|FG001|After 12 Months of Function|Protocol Violation|0|||
30994008|NCT01641198|59173802|FG002|After 12 Months of Function|Protocol Violation|0|||
30994009|NCT01641198|59173800|FG000|After 12 Months of Function|Adverse Event|0|||
30994010|NCT01641198|59173801|FG001|After 12 Months of Function|Adverse Event|1|||
30994011|NCT01641198|59173802|FG002|After 12 Months of Function|Adverse Event|0|||
30994012|NCT01641198|59173800|FG000|After 24 Months of Function|Lost to Follow-up|4|||
30994013|NCT01641198|59173801|FG001|After 24 Months of Function|Lost to Follow-up|9|||
30994014|NCT01641198|59173802|FG002|After 24 Months of Function|Lost to Follow-up|6|||
30994015|NCT01641198|59173800|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
30994016|NCT01641198|59173801|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
30994017|NCT01641198|59173802|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
30994018|NCT01641198|59173800|FG000|At 15-20 Years of Function|Death|1|||
30994019|NCT01641198|59173801|FG001|At 15-20 Years of Function|Death|0|||
30994020|NCT01641198|59173802|FG002|At 15-20 Years of Function|Death|1|||
30994021|NCT01639560|59173887|FG000|Overall Study|Withdrawal by Subject|9|||
30994022|NCT01639560|59173888|FG001|Overall Study|Withdrawal by Subject|14|||
30994023|NCT01639560|59173887|FG000|Overall Study|Lack of Efficacy|1|||
30994024|NCT01639560|59173888|FG001|Overall Study|Lack of Efficacy|2|||
30994025|NCT01639560|59173887|FG000|Overall Study|Lost to Follow-up|9|||
30994026|NCT01639560|59173888|FG001|Overall Study|Lost to Follow-up|11|||
30994027|NCT01639560|59173887|FG000|Overall Study|Adverse Event|0|||
30994028|NCT01639560|59173888|FG001|Overall Study|Adverse Event|2|||
30994029|NCT01601652|59173910|FG000|Overall Study|Death|1|||
30790219|NCT00035555|58803458|FG002|Overall Study|Allograft loss|2|||
30790220|NCT00035555|58803456|FG000|Overall Study|Death|0|||
30891903|NCT02195583|58925217|FG000|Overall Study|Withdrawal by Subject|4|||
30891904|NCT02195583|58925217|FG000|Overall Study|Adverse Event|2|||
30994030|NCT03952130|59173948|FG000|Overall Study|Adverse Event|0|||
30994031|NCT03952130|59173949|FG001|Overall Study|Adverse Event|1|||
30994032|NCT03952130|59173948|FG000|Overall Study|Lost to Follow-up|1|||
30994033|NCT03952130|59173949|FG001|Overall Study|Lost to Follow-up|0|||
30994034|NCT03952130|59173948|FG000|Overall Study|Withdrawal by Subject|1|||
30994035|NCT03952130|59173949|FG001|Overall Study|Withdrawal by Subject|5|||
30994036|NCT01640964|59173993|FG000|Overall Study|Lost to Follow-up|0|||
30994037|NCT01640964|59173994|FG001|Overall Study|Lost to Follow-up|0|||
30994038|NCT01640964|59173995|FG002|Overall Study|Lost to Follow-up|1|||
30994039|NCT01640964|59173993|FG000|Overall Study|Protocol Deviation|1|||
30994040|NCT01640964|59173994|FG001|Overall Study|Protocol Deviation|1|||
30994041|NCT01640964|59173995|FG002|Overall Study|Protocol Deviation|2|||
30994042|NCT01638390|59174115|FG000|Overall Study|screening failures|21|||
30994043|NCT01600716|59174146|FG000|Overall Study|Other Reasons|3|||
30994044|NCT01600716|59174147|FG001|Overall Study|Other Reasons|1|||
30994045|NCT01600716|59174146|FG000|Overall Study|Personal Reasons|0|||
30994046|NCT01600716|59174147|FG001|Overall Study|Personal Reasons|2|||
30994047|NCT01600716|59174146|FG000|Overall Study|Lost to Follow-up|0|||
30994048|NCT01600716|59174147|FG001|Overall Study|Lost to Follow-up|2|||
30994049|NCT01600716|59174146|FG000|Overall Study|Pregnancy|1|||
30994050|NCT01600716|59174147|FG001|Overall Study|Pregnancy|0|||
30994051|NCT01600716|59174146|FG000|Overall Study|Lack of Efficacy|2|||
30994052|NCT01600716|59174147|FG001|Overall Study|Lack of Efficacy|1|||
30994053|NCT01600716|59174146|FG000|Overall Study|Adverse Event|1|||
30994054|NCT01600716|59174147|FG001|Overall Study|Adverse Event|1|||
30994055|NCT01600326|59174263|FG000|Overall Study|Lost to Follow-up|1|||
30994056|NCT01600326|59174264|FG001|Overall Study|Lost to Follow-up|1|||
30994057|NCT01637142|59174400|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
30994058|NCT01636986|59174418|FG000|Overall Study|Withdrawal by Subject|0|||
30994059|NCT01636986|59174419|FG001|Overall Study|Withdrawal by Subject|1|||
30994060|NCT01636986|59174418|FG000|Overall Study|Corneal Staining|0|||
30994061|NCT01636986|59174419|FG001|Overall Study|Corneal Staining|1|||
30994062|NCT01601496|59174505|FG000|Overall Study|Physician Decision|1|||
30994063|NCT01601496|59174505|FG000|Overall Study|Withdrawal by Subject|1|||
30994064|NCT01601496|59174505|FG000|Overall Study|Lost to Follow-up|6|||
30994065|NCT01601496|59174505|FG000|Overall Study|Death|4|||
30994066|NCT01601496|59174505|FG000|Overall Study|Other: patient refusal to continue|3|||
30994067|NCT03211832|59174511|FG000|Overall Study|No longer with agency|32|||
30994068|NCT03211832|59174512|FG001|Overall Study|No longer with agency|49|||
30994069|NCT03211832|59174513|FG002|Overall Study|No longer with agency|30|||
30994070|NCT03211832|59174511|FG000|Overall Study|Declined survey|3|||
30994071|NCT03211832|59174512|FG001|Overall Study|Declined survey|3|||
30994072|NCT03211832|59174513|FG002|Overall Study|Declined survey|2|||
30994073|NCT03211832|59174511|FG000|Overall Study|Not available during data collection|1|||
30994074|NCT03211832|59174512|FG001|Overall Study|Not available during data collection|0|||
30994075|NCT03211832|59174513|FG002|Overall Study|Not available during data collection|2|||
30994076|NCT04887948|59174522|FG000|Overall Study|Death|1|||
30994077|NCT04887948|59174523|FG001|Overall Study|Death|0|||
30994078|NCT04887948|59174524|FG002|Overall Study|Death|0|||
30994079|NCT04887948|59174522|FG000|Overall Study|Lost to Follow-up|1|||
30994080|NCT04887948|59174523|FG001|Overall Study|Lost to Follow-up|0|||
30994081|NCT04887948|59174524|FG002|Overall Study|Lost to Follow-up|3|||
30994082|NCT04887948|59174522|FG000|Overall Study|Physician Decision|0|||
30994083|NCT04887948|59174523|FG001|Overall Study|Physician Decision|4|||
30994084|NCT04887948|59174524|FG002|Overall Study|Physician Decision|1|||
30994085|NCT04887948|59174522|FG000|Overall Study|Protocol Violation|1|||
30994086|NCT04887948|59174523|FG001|Overall Study|Protocol Violation|1|||
30994087|NCT04887948|59174524|FG002|Overall Study|Protocol Violation|0|||
30994088|NCT04887948|59174522|FG000|Overall Study|Withdrawal by Subject|0|||
30994089|NCT04887948|59174523|FG001|Overall Study|Withdrawal by Subject|6|||
30994090|NCT04887948|59174524|FG002|Overall Study|Withdrawal by Subject|1|||
30994091|NCT04887948|59174522|FG000|Overall Study|No longer met eligibility criteria|1|||
30994092|NCT04887948|59174523|FG001|Overall Study|No longer met eligibility criteria|2|||
30994093|NCT04887948|59174524|FG002|Overall Study|No longer met eligibility criteria|1|||
30994094|NCT04887948|59174522|FG000|Overall Study|Other|2|||
30994095|NCT04887948|59174523|FG001|Overall Study|Other|1|||
30994096|NCT04887948|59174524|FG002|Overall Study|Other|1|||
30994097|NCT01638000|59174662|FG000|Overall Study|Randomized but Never Received Drug|7|||
30994098|NCT01638000|59174663|FG001|Overall Study|Randomized but Never Received Drug|10|||
30994099|NCT01638000|59174662|FG000|Overall Study|Adverse Event|14|||
30994100|NCT01638000|59174663|FG001|Overall Study|Adverse Event|16|||
30994101|NCT01638000|59174662|FG000|Overall Study|Lack of Efficacy|5|||
30994102|NCT01638000|59174663|FG001|Overall Study|Lack of Efficacy|6|||
30994103|NCT01638000|59174662|FG000|Overall Study|Protocol Violation|11|||
30994104|NCT01638000|59174663|FG001|Overall Study|Protocol Violation|13|||
30994105|NCT01638000|59174662|FG000|Overall Study|Withdrawal by Subject|21|||
30994106|NCT01638000|59174663|FG001|Overall Study|Withdrawal by Subject|24|||
30994107|NCT01638000|59174662|FG000|Overall Study|Miscellaneous|2|||
30994108|NCT01638000|59174663|FG001|Overall Study|Miscellaneous|2|||
30994109|NCT01637922|59174722|FG000|Overall Study|Adverse Event|0|||
30994110|NCT01637922|59174723|FG001|Overall Study|Adverse Event|1|||
30994111|NCT01637922|59174722|FG000|Overall Study|Protocol Violation|0|||
30994112|NCT01637922|59174723|FG001|Overall Study|Protocol Violation|1|||
30994113|NCT01637922|59174722|FG000|Overall Study|Withdrawal by Subject|0|||
30994114|NCT01637922|59174723|FG001|Overall Study|Withdrawal by Subject|3|||
30994115|NCT01637922|59174722|FG000|Overall Study|Lost to Follow-up|2|||
30994116|NCT01637922|59174723|FG001|Overall Study|Lost to Follow-up|0|||
30994117|NCT03496662|59174928|FG000|Overall Study|Adverse Event|1|||
30994118|NCT03496662|59174929|FG001|Overall Study|Adverse Event|0|||
30994119|NCT03496662|59174930|FG002|Overall Study|Adverse Event|1|||
30994120|NCT03496662|59174928|FG000|Overall Study|Physician Decision|1|||
30994121|NCT03496662|59174929|FG001|Overall Study|Physician Decision|0|||
30994122|NCT03496662|59174930|FG002|Overall Study|Physician Decision|3|||
30994123|NCT03496662|59174928|FG000|Overall Study|Withdrawal by Subject|0|||
30994124|NCT03496662|59174929|FG001|Overall Study|Withdrawal by Subject|0|||
30994125|NCT03496662|59174930|FG002|Overall Study|Withdrawal by Subject|2|||
30994126|NCT03496662|59174928|FG000|Overall Study|Death|0|||
30994127|NCT03496662|59174929|FG001|Overall Study|Death|0|||
30994128|NCT03496662|59174930|FG002|Overall Study|Death|2|||
30994129|NCT03496662|59174928|FG000|Overall Study|Noncompliance|0|||
30994130|NCT03496662|59174929|FG001|Overall Study|Noncompliance|0|||
30994131|NCT03496662|59174930|FG002|Overall Study|Noncompliance|1|||
30994132|NCT01638546|59174940|FG000|Overall Study|Adverse Event|1|||
30994133|NCT01638546|59174941|FG001|Overall Study|Adverse Event|3|||
30994134|NCT01000051|59174951|FG000|Overall Study|Withdrawal by Subject|1|||
30994135|NCT01000051|59174952|FG001|Overall Study|Withdrawal by Subject|1|||
30994136|NCT01000051|59174951|FG000|Overall Study|Disease Progression|1|||
30994137|NCT01000051|59174952|FG001|Overall Study|Disease Progression|0|||
30994138|NCT01000051|59174951|FG000|Overall Study|Serious noncompliance|1|||
30994139|NCT01000051|59174952|FG001|Overall Study|Serious noncompliance|0|||
30994140|NCT03172494|59174970|FG000|Overall Study|Adverse Event|5|||
30994141|NCT03172494|59174971|FG001|Overall Study|Adverse Event|1|||
30994142|NCT03172494|59174972|FG002|Overall Study|Adverse Event|15|||
30994143|NCT03172494|59174970|FG000|Overall Study|Protocol Violation|3|||
30994144|NCT03172494|59174971|FG001|Overall Study|Protocol Violation|2|||
30994145|NCT03172494|59174972|FG002|Overall Study|Protocol Violation|1|||
30994146|NCT03172494|59174970|FG000|Overall Study|Lack of Efficacy|0|||
30994147|NCT03172494|59174971|FG001|Overall Study|Lack of Efficacy|0|||
30994148|NCT03172494|59174972|FG002|Overall Study|Lack of Efficacy|4|||
30994149|NCT03172494|59174970|FG000|Overall Study|Pregnancy|0|||
30994150|NCT03172494|59174971|FG001|Overall Study|Pregnancy|1|||
30994151|NCT03172494|59174972|FG002|Overall Study|Pregnancy|0|||
30994152|NCT03172494|59174970|FG000|Overall Study|Withdrawal by Subject|10|||
30994153|NCT03172494|59174971|FG001|Overall Study|Withdrawal by Subject|8|||
30994154|NCT03172494|59174972|FG002|Overall Study|Withdrawal by Subject|8|||
30994155|NCT03172494|59174970|FG000|Overall Study|Severe hypoglycaemic episode|0|||
30994156|NCT03172494|59174971|FG001|Overall Study|Severe hypoglycaemic episode|0|||
30994157|NCT03172494|59174972|FG002|Overall Study|Severe hypoglycaemic episode|1|||
30994158|NCT03172494|59174970|FG000|Overall Study|Non-compliance towards treatment|2|||
30994159|NCT03172494|59174971|FG001|Overall Study|Non-compliance towards treatment|0|||
30994160|NCT03172494|59174972|FG002|Overall Study|Non-compliance towards treatment|0|||
30994161|NCT01636362|59175073|FG000|Overall Study|Physician Decision|6|||
30994162|NCT01636362|59175073|FG000|Overall Study|Subject healed, not returning|1|||
30994163|NCT01636362|59175073|FG000|Overall Study|Withdrawal by Subject|1|||
30994164|NCT02797184|59175102|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
30994165|NCT02797184|59175103|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
30994166|NCT03042468|59175145|FG000|Overall Study|Death|0|||
30994167|NCT03042468|59175146|FG001|Overall Study|Death|1|||
30994168|NCT03042468|59175147|FG002|Overall Study|Death|1|||
30994169|NCT03042468|59175148|FG003|Overall Study|Death|0|||
30994170|NCT03042468|59175149|FG004|Overall Study|Death|0|||
30994171|NCT03042468|59175150|FG005|Overall Study|Death|0|||
30994172|NCT03042468|59175145|FG000|Overall Study|Withdrawal by Subject|0|||
30994173|NCT03042468|59175146|FG001|Overall Study|Withdrawal by Subject|0|||
30994174|NCT03042468|59175147|FG002|Overall Study|Withdrawal by Subject|0|||
30994175|NCT03042468|59175148|FG003|Overall Study|Withdrawal by Subject|0|||
30994176|NCT03042468|59175149|FG004|Overall Study|Withdrawal by Subject|0|||
30994177|NCT03042468|59175150|FG005|Overall Study|Withdrawal by Subject|1|||
30994178|NCT03042468|59175145|FG000|Overall Study|Lost to Follow-up|0|||
30994179|NCT03042468|59175146|FG001|Overall Study|Lost to Follow-up|0|||
30994180|NCT03042468|59175147|FG002|Overall Study|Lost to Follow-up|0|||
30994181|NCT03042468|59175148|FG003|Overall Study|Lost to Follow-up|0|||
30994182|NCT03042468|59175149|FG004|Overall Study|Lost to Follow-up|1|||
30994183|NCT03042468|59175150|FG005|Overall Study|Lost to Follow-up|1|||
30994184|NCT01634178|59175168|FG000|Treatment Period 1|Adverse Event|0|||
30994185|NCT01634178|59175169|FG001|Treatment Period 1|Adverse Event|1|||
30994186|NCT01634178|59175168|FG000|Treatment Period 2|Adverse Event|1|||
30994187|NCT01634178|59175169|FG001|Treatment Period 2|Adverse Event|0|||
30994188|NCT02412306|59175211|FG000|Overall Study|Lost to Follow-up|0|||
30994189|NCT02412306|59175212|FG001|Overall Study|Lost to Follow-up|1|||
30994190|NCT02412306|59175213|FG002|Overall Study|Lost to Follow-up|0|||
30994191|NCT02412306|59175214|FG003|Overall Study|Lost to Follow-up|0|||
30994192|NCT02412306|59175215|FG004|Overall Study|Lost to Follow-up|0|||
30994193|NCT02412306|59175211|FG000|Overall Study|Withdrawal by Subject|0|||
30994194|NCT02412306|59175212|FG001|Overall Study|Withdrawal by Subject|0|||
30994195|NCT02412306|59175213|FG002|Overall Study|Withdrawal by Subject|1|||
30994196|NCT02412306|59175214|FG003|Overall Study|Withdrawal by Subject|0|||
30994197|NCT02412306|59175215|FG004|Overall Study|Withdrawal by Subject|0|||
30994198|NCT02412306|59175211|FG000|Overall Study|Death|5|||
30994199|NCT02412306|59175212|FG001|Overall Study|Death|7|||
30994200|NCT02412306|59175213|FG002|Overall Study|Death|15|||
30994201|NCT02412306|59175214|FG003|Overall Study|Death|0|||
30994202|NCT02412306|59175215|FG004|Overall Study|Death|2|||
30994203|NCT04285723|59175238|FG000|Overall Study|Subject decision|1|||
30994204|NCT04285723|59175239|FG001|Overall Study|Subject decision|2|||
30994205|NCT04285723|59175238|FG000|Overall Study|Physician Decision|1|||
30994206|NCT04285723|59175239|FG001|Overall Study|Physician Decision|0|||
30994207|NCT04285723|59175238|FG000|Overall Study|No efficiency|1|||
30994208|NCT04285723|59175239|FG001|Overall Study|No efficiency|0|||
30994209|NCT01352221|59175253|FG000|Double-blind Phase|Adverse Event|6|||
30994210|NCT01352221|59175254|FG001|Double-blind Phase|Adverse Event|4|||
30994211|NCT01352221|59175255|FG002|Double-blind Phase|Adverse Event|0|||
30994212|NCT01352221|59175256|FG003|Double-blind Phase|Adverse Event|0|||
30994213|NCT01352221|59175253|FG000|Double-blind Phase|Withdrawal by Subject|3|||
30994214|NCT01352221|59175254|FG001|Double-blind Phase|Withdrawal by Subject|5|||
30994215|NCT01352221|59175255|FG002|Double-blind Phase|Withdrawal by Subject|0|||
30994216|NCT01352221|59175256|FG003|Double-blind Phase|Withdrawal by Subject|0|||
30994217|NCT01352221|59175253|FG000|Double-blind Phase|Lost to Follow-up|0|||
30994218|NCT01352221|59175254|FG001|Double-blind Phase|Lost to Follow-up|1|||
30994219|NCT01352221|59175255|FG002|Double-blind Phase|Lost to Follow-up|0|||
30994220|NCT01352221|59175256|FG003|Double-blind Phase|Lost to Follow-up|0|||
30994221|NCT01352221|59175253|FG000|Double-blind Phase|Protocol Violation|0|||
30994222|NCT01352221|59175254|FG001|Double-blind Phase|Protocol Violation|1|||
30994223|NCT01352221|59175255|FG002|Double-blind Phase|Protocol Violation|0|||
30994224|NCT01352221|59175256|FG003|Double-blind Phase|Protocol Violation|0|||
30994225|NCT01352221|59175253|FG000|Open-label Phase|Physician Decision|0|||
30994226|NCT01352221|59175254|FG001|Open-label Phase|Physician Decision|0|||
30994227|NCT01352221|59175255|FG002|Open-label Phase|Physician Decision|2|||
30994228|NCT01352221|59175256|FG003|Open-label Phase|Physician Decision|1|||
30994229|NCT01352221|59175253|FG000|Open-label Phase|Pregnancy|0|||
30994230|NCT01352221|59175254|FG001|Open-label Phase|Pregnancy|0|||
30994231|NCT01352221|59175255|FG002|Open-label Phase|Pregnancy|1|||
30994232|NCT01352221|59175256|FG003|Open-label Phase|Pregnancy|0|||
30994233|NCT01352221|59175253|FG000|Open-label Phase|Adverse Event|0|||
30994234|NCT01352221|59175254|FG001|Open-label Phase|Adverse Event|0|||
30994235|NCT01352221|59175255|FG002|Open-label Phase|Adverse Event|8|||
30994236|NCT01352221|59175256|FG003|Open-label Phase|Adverse Event|4|||
30994237|NCT01352221|59175253|FG000|Open-label Phase|Withdrawal by Subject|0|||
30994238|NCT01352221|59175254|FG001|Open-label Phase|Withdrawal by Subject|0|||
30994239|NCT01352221|59175255|FG002|Open-label Phase|Withdrawal by Subject|1|||
30994240|NCT01352221|59175256|FG003|Open-label Phase|Withdrawal by Subject|6|||
30994241|NCT01352221|59175253|FG000|Open-label Phase|Worsening of IBD|0|||
30994242|NCT01352221|59175254|FG001|Open-label Phase|Worsening of IBD|0|||
30994243|NCT01352221|59175255|FG002|Open-label Phase|Worsening of IBD|1|||
30994244|NCT01352221|59175256|FG003|Open-label Phase|Worsening of IBD|0|||
30994245|NCT01634100|59175282|FG000|Overall Study|Withdrawal by Subject|1|||
30994246|NCT01634100|59175283|FG001|Overall Study|Withdrawal by Subject|0|||
30994247|NCT01634100|59175284|FG002|Overall Study|Withdrawal by Subject|1|||
30994248|NCT01634100|59175285|FG003|Overall Study|Withdrawal by Subject|0|||
30994249|NCT01634100|59175286|FG004|Overall Study|Withdrawal by Subject|0|||
30994250|NCT01634100|59175287|FG005|Overall Study|Withdrawal by Subject|0|||
30994251|NCT03662659|59175297|FG000|Pre-treatment|Participant no longer met study criteria|1|||
30994252|NCT03662659|59175298|FG001|Pre-treatment|Participant no longer met study criteria|1|||
30994253|NCT03662659|59175297|FG000|Pre-treatment|Other reasons|1|||
30994254|NCT03662659|59175298|FG001|Pre-treatment|Other reasons|0|||
30994255|NCT03662659|59175297|FG000|Treatment|Completed Treatment|0|||
30994256|NCT03662659|59175298|FG001|Treatment|Completed Treatment|3|||
30994257|NCT03662659|59175297|FG000|Treatment|Disease Progression|69|||
30994258|NCT03662659|59175298|FG001|Treatment|Disease Progression|78|||
30994259|NCT03662659|59175297|FG000|Treatment|Study Drug Toxicity|18|||
30994260|NCT03662659|59175298|FG001|Treatment|Study Drug Toxicity|8|||
30994261|NCT03662659|59175297|FG000|Treatment|Death|12|||
30994262|NCT03662659|59175298|FG001|Treatment|Death|7|||
30994263|NCT03662659|59175297|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
30994264|NCT03662659|59175298|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
30994265|NCT03662659|59175297|FG000|Treatment|Withdrawal by Subject|1|||
30994266|NCT03662659|59175298|FG001|Treatment|Withdrawal by Subject|1|||
30994267|NCT03662659|59175297|FG000|Treatment|Poor/Non-compliance|1|||
30994268|NCT03662659|59175298|FG001|Treatment|Poor/Non-compliance|0|||
30994269|NCT03662659|59175297|FG000|Treatment|Participant no longer meets study criteria|1|||
30994270|NCT03662659|59175298|FG001|Treatment|Participant no longer meets study criteria|0|||
30994271|NCT03662659|59175297|FG000|Treatment|Other reasons|6|||
30994272|NCT03662659|59175298|FG001|Treatment|Other reasons|5|||
30994273|NCT01633944|59175306|FG000|Open-label Titration Phase|Adverse Event|109|||
30994274|NCT01633944|59175307|FG001|Open-label Titration Phase|Adverse Event|0|||
30994275|NCT01633944|59175308|FG002|Open-label Titration Phase|Adverse Event|0|||
30994276|NCT01633944|59175306|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
30994277|NCT01633944|59175307|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
30994278|NCT01633944|59175308|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
30994279|NCT01633944|59175306|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
30994280|NCT01633944|59175307|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
30994281|NCT01633944|59175308|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
30994282|NCT01633944|59175306|FG000|Open-label Titration Phase|Protocol Violation|24|||
30994283|NCT01633944|59175307|FG001|Open-label Titration Phase|Protocol Violation|0|||
30994284|NCT01633944|59175308|FG002|Open-label Titration Phase|Protocol Violation|0|||
30994285|NCT01633944|59175306|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
30994286|NCT01633944|59175307|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
30994287|NCT01633944|59175308|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
30994288|NCT01633944|59175306|FG000|Open-label Titration Phase|Other|68|||
30994289|NCT01633944|59175307|FG001|Open-label Titration Phase|Other|0|||
30994290|NCT01633944|59175308|FG002|Open-label Titration Phase|Other|0|||
30994291|NCT01633944|59175306|FG000|Double-blind Treatment Phase|Adverse Event|0|||
30994292|NCT01633944|59175307|FG001|Double-blind Treatment Phase|Adverse Event|13|||
30994293|NCT01633944|59175308|FG002|Double-blind Treatment Phase|Adverse Event|7|||
30994294|NCT01633944|59175306|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
30994295|NCT01633944|59175307|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
30994296|NCT01633944|59175308|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
30994297|NCT01633944|59175306|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
30994298|NCT01633944|59175307|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
30994299|NCT01633944|59175308|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
30994300|NCT01633944|59175306|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
30994301|NCT01633944|59175307|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
30994302|NCT01633944|59175308|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
30994303|NCT01633944|59175306|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
30994304|NCT01633944|59175307|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
30994305|NCT01633944|59175308|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
30994306|NCT01633944|59175306|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
30994307|NCT01633944|59175307|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
30994308|NCT01633944|59175308|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
30994309|NCT01633944|59175306|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
30994310|NCT01633944|59175307|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
30994311|NCT01633944|59175308|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
30994312|NCT01633944|59175306|FG000|Double-blind Treatment Phase|Other|0|||
30994313|NCT01633944|59175307|FG001|Double-blind Treatment Phase|Other|7|||
30994314|NCT01633944|59175308|FG002|Double-blind Treatment Phase|Other|0|||
30994315|NCT01633788|59175353|FG000|Overall Study|Adverse Event|1|||
30994316|NCT01633788|59175354|FG001|Overall Study|Adverse Event|3|||
30994317|NCT01633788|59175355|FG002|Overall Study|Adverse Event|3|||
30994318|NCT01633788|59175356|FG003|Overall Study|Adverse Event|3|||
30994319|NCT01633788|59175353|FG000|Overall Study|Lost to Follow-up|2|||
30994320|NCT01633788|59175354|FG001|Overall Study|Lost to Follow-up|2|||
30994321|NCT01633788|59175355|FG002|Overall Study|Lost to Follow-up|2|||
30994322|NCT01633788|59175356|FG003|Overall Study|Lost to Follow-up|0|||
30994323|NCT01633788|59175353|FG000|Overall Study|Personal Reasons|3|||
30994324|NCT01633788|59175354|FG001|Overall Study|Personal Reasons|1|||
30994325|NCT01633788|59175355|FG002|Overall Study|Personal Reasons|1|||
30994326|NCT01633788|59175356|FG003|Overall Study|Personal Reasons|3|||
30994327|NCT01633788|59175353|FG000|Overall Study|Protocol Violation|1|||
30994328|NCT01633788|59175354|FG001|Overall Study|Protocol Violation|0|||
30994329|NCT01633788|59175355|FG002|Overall Study|Protocol Violation|1|||
30994330|NCT01633788|59175356|FG003|Overall Study|Protocol Violation|0|||
30994331|NCT01633788|59175353|FG000|Overall Study|Other Reasons|0|||
30994332|NCT01633788|59175354|FG001|Overall Study|Other Reasons|2|||
30994333|NCT01633788|59175355|FG002|Overall Study|Other Reasons|3|||
30994334|NCT01633788|59175356|FG003|Overall Study|Other Reasons|7|||
30994335|NCT04154943|59175366|FG000|Overall Study|Study Ongoing|68|||
30994336|NCT04154943|59175366|FG000|Overall Study|Lost to Follow-up|1|||
30994337|NCT04154943|59175366|FG000|Overall Study|Decision by the Investigator|1|||
30994338|NCT04154943|59175366|FG000|Overall Study|Death|5|||
30994339|NCT04154943|59175366|FG000|Overall Study|Withdrawal by Subject|4|||
30994340|NCT03476239|59175387|FG000|Overall Study|Withdrawal by Subject|10|||
30994341|NCT03476239|59175387|FG000|Overall Study|Death|80|||
30994342|NCT03476239|59175387|FG000|Overall Study|Lost to Follow-up|8|||
30994343|NCT03468985|59175395|FG000|Overall Study|Adverse Event|0|||
30994344|NCT03468985|59175396|FG001|Overall Study|Adverse Event|2|||
30994345|NCT03468985|59175397|FG002|Overall Study|Adverse Event|0|||
30994346|NCT03468985|59175398|FG003|Overall Study|Adverse Event|0|||
30994347|NCT03468985|59175395|FG000|Overall Study|Withdrawal by Subject|0|||
30994348|NCT03468985|59175396|FG001|Overall Study|Withdrawal by Subject|0|||
30994349|NCT03468985|59175397|FG002|Overall Study|Withdrawal by Subject|0|||
30994350|NCT03468985|59175398|FG003|Overall Study|Withdrawal by Subject|1|||
30994351|NCT02678312|59175413|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
30994352|NCT02678312|59175414|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
30994353|NCT02678312|59175415|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
30994354|NCT02678312|59175416|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
30994355|NCT02678312|59175417|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
30994356|NCT02678312|59175413|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
30994357|NCT02678312|59175414|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
30994358|NCT02678312|59175415|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
30994359|NCT02678312|59175416|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
30994360|NCT02678312|59175417|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
30994361|NCT02678312|59175413|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
30994362|NCT02678312|59175414|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
30994363|NCT02678312|59175415|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
30994364|NCT02678312|59175416|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
30994365|NCT02678312|59175417|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
30994366|NCT02678312|59175413|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
30994367|NCT02678312|59175414|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
30994368|NCT02678312|59175415|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
30994369|NCT02678312|59175416|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
30994370|NCT02678312|59175417|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
30994371|NCT02678312|59175413|FG000|Part 2 Double Blind Epoch|Death|0|||
30994372|NCT02678312|59175414|FG001|Part 2 Double Blind Epoch|Death|0|||
30994373|NCT02678312|59175415|FG002|Part 2 Double Blind Epoch|Death|0|||
30994374|NCT02678312|59175416|FG003|Part 2 Double Blind Epoch|Death|8|||
30994375|NCT02678312|59175417|FG004|Part 2 Double Blind Epoch|Death|12|||
30994376|NCT02678312|59175413|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
30994377|NCT02678312|59175414|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
30994378|NCT02678312|59175415|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
30994379|NCT02678312|59175416|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
30994380|NCT02678312|59175417|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
30994381|NCT02678312|59175413|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
30994382|NCT02678312|59175414|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
30994383|NCT02678312|59175415|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
30994384|NCT02678312|59175416|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
30994385|NCT02678312|59175417|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
30994386|NCT02678312|59175413|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
30994387|NCT02678312|59175414|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
30994388|NCT02678312|59175415|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
30994389|NCT02678312|59175416|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
30994390|NCT02678312|59175417|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
30994391|NCT02256631|59175664|FG000|Overall Study|Lost to Follow-up|1|||
30994392|NCT02256631|59175665|FG001|Overall Study|Lost to Follow-up|1|||
30994393|NCT02256631|59175666|FG002|Overall Study|Lost to Follow-up|0|||
30994394|NCT02256631|59175667|FG003|Overall Study|Lost to Follow-up|2|||
30994395|NCT02256631|59175668|FG004|Overall Study|Lost to Follow-up|0|||
30994396|NCT02256631|59175669|FG005|Overall Study|Lost to Follow-up|4|||
30994397|NCT02256631|59175670|FG006|Overall Study|Lost to Follow-up|1|||
30994398|NCT02256631|59175664|FG000|Overall Study|Withdrawal by Subject|0|||
30994399|NCT02256631|59175665|FG001|Overall Study|Withdrawal by Subject|0|||
30994400|NCT02256631|59175666|FG002|Overall Study|Withdrawal by Subject|0|||
30994401|NCT02256631|59175667|FG003|Overall Study|Withdrawal by Subject|1|||
30994402|NCT02256631|59175668|FG004|Overall Study|Withdrawal by Subject|1|||
30994403|NCT02256631|59175669|FG005|Overall Study|Withdrawal by Subject|0|||
30994404|NCT02256631|59175670|FG006|Overall Study|Withdrawal by Subject|1|||
30994405|NCT02256631|59175664|FG000|Overall Study|Unable to get to clinic|0|||
30994406|NCT02256631|59175665|FG001|Overall Study|Unable to get to clinic|2|||
30994407|NCT02256631|59175666|FG002|Overall Study|Unable to get to clinic|0|||
30994408|NCT02256631|59175667|FG003|Overall Study|Unable to get to clinic|1|||
30994409|NCT02256631|59175668|FG004|Overall Study|Unable to get to clinic|0|||
30994410|NCT02256631|59175669|FG005|Overall Study|Unable to get to clinic|1|||
30994411|NCT02256631|59175670|FG006|Overall Study|Unable to get to clinic|2|||
30994412|NCT02163733|59175768|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
30994413|NCT02163733|59175769|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
30994414|NCT02163733|59175770|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
30994415|NCT02163733|59175768|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
30994416|NCT02163733|59175769|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
30994417|NCT02163733|59175770|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
30994418|NCT02279745|59175800|FG000|Overall Study|Adverse Event|7|||
30994419|NCT02279745|59175800|FG000|Overall Study|Death|6|||
30994420|NCT02279745|59175800|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
30994421|NCT02279745|59175800|FG000|Overall Study|Withdrawal by Subject|2|||
30994422|NCT02279745|59175800|FG000|Overall Study|Pregnancy|1|||
30994423|NCT02279745|59175800|FG000|Overall Study|Study Non-compliance|1|||
30994424|NCT02279745|59175800|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
30994425|NCT01761877|59175839|FG000|Overall Study|Adverse Event|7|||
30994426|NCT01761877|59175840|FG001|Overall Study|Adverse Event|0|||
30994427|NCT01761877|59175839|FG000|Overall Study|Withdrawal by Subject|6|||
30994428|NCT01761877|59175840|FG001|Overall Study|Withdrawal by Subject|4|||
30994429|NCT01761877|59175839|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
30994430|NCT01761877|59175840|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
30994431|NCT01761877|59175839|FG000|Overall Study|Death|0|||
30994432|NCT01761877|59175840|FG001|Overall Study|Death|1|||
30994433|NCT01761877|59175839|FG000|Overall Study|MRI intolerant|1|||
30994434|NCT01761877|59175840|FG001|Overall Study|MRI intolerant|6|||
30994435|NCT03093259|59176094|FG000|Overall Study|Adverse Event|1|||
30994436|NCT03093259|59176095|FG001|Overall Study|Adverse Event|0|||
30994437|NCT03093259|59176094|FG000|Overall Study|Withdrawal by Subject|1|||
30994438|NCT03093259|59176095|FG001|Overall Study|Withdrawal by Subject|0|||
30994439|NCT02997865|59176387|FG000|Overall Study|Death|2|||
30994440|NCT02997865|59176388|FG001|Overall Study|Death|1|||
30994441|NCT02997865|59176387|FG000|Overall Study|Lost to Follow-up|6|||
30994442|NCT02997865|59176388|FG001|Overall Study|Lost to Follow-up|3|||
30994443|NCT02997865|59176387|FG000|Overall Study|Withdrawal by Subject|5|||
30994444|NCT02997865|59176388|FG001|Overall Study|Withdrawal by Subject|0|||
30994445|NCT01575834|59177617|FG000|Overall Study|Withdrawal by Subject|352|||
30994446|NCT01575834|59177618|FG001|Overall Study|Withdrawal by Subject|390|||
30994447|NCT01575834|59177617|FG000|Overall Study|Death|81|||
30994448|NCT01575834|59177618|FG001|Overall Study|Death|74|||
30994449|NCT01575834|59177617|FG000|Overall Study|Other|70|||
30994450|NCT01575834|59177618|FG001|Overall Study|Other|70|||
30994451|NCT01575834|59177617|FG000|Overall Study|Adverse Event|63|||
30994452|NCT01575834|59177618|FG001|Overall Study|Adverse Event|61|||
30994453|NCT01575834|59177617|FG000|Overall Study|Lost to Follow-up|55|||
30994454|NCT01575834|59177618|FG001|Overall Study|Lost to Follow-up|68|||
30994455|NCT01575834|59177617|FG000|Overall Study|Noncompliance|52|||
30994456|NCT01575834|59177618|FG001|Overall Study|Noncompliance|27|||
30994457|NCT01575834|59177617|FG000|Overall Study|Administrative decision|15|||
30994458|NCT01575834|59177618|FG001|Overall Study|Administrative decision|33|||
30994459|NCT01575834|59177617|FG000|Overall Study|Ineligibility Determined|5|||
30994460|NCT01575834|59177618|FG001|Overall Study|Ineligibility Determined|8|||
30994461|NCT01575834|59177617|FG000|Overall Study|Protocol Deviation|4|||
30994462|NCT01575834|59177618|FG001|Overall Study|Protocol Deviation|3|||
30994463|NCT01575834|59177617|FG000|Overall Study|Requirement for Alternative Therapy|2|||
30994464|NCT01575834|59177618|FG001|Overall Study|Requirement for Alternative Therapy|4|||
30994465|NCT02253654|59177730|FG000|Overall Study|Withdrawal by Subject|12|||
30994466|NCT02253654|59177731|FG001|Overall Study|Withdrawal by Subject|4|||
30994467|NCT02253654|59177730|FG000|Overall Study|Decision by Sponsor|1|||
30994468|NCT02253654|59177731|FG001|Overall Study|Decision by Sponsor|1|||
30994469|NCT02253654|59177730|FG000|Overall Study|Lost to Follow-up|2|||
30994470|NCT02253654|59177731|FG001|Overall Study|Lost to Follow-up|5|||
30994471|NCT02253654|59177730|FG000|Overall Study|Death|4|||
30994472|NCT02253654|59177731|FG001|Overall Study|Death|7|||
30994473|NCT02253654|59177730|FG000|Overall Study|Did Not Receive Study Treatment|4|||
30994474|NCT02253654|59177731|FG001|Overall Study|Did Not Receive Study Treatment|1|||
30994475|NCT02252406|59177739|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
30994476|NCT02252406|59177740|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
30994477|NCT02252406|59177739|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
30994478|NCT02252406|59177740|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
30994479|NCT02252406|59177739|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
30994480|NCT02252406|59177740|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
30994481|NCT02252406|59177739|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
30994482|NCT02252406|59177740|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
30994483|NCT02252406|59177739|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
30994484|NCT02252406|59177740|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
30994485|NCT02246478|59177750|FG000|Multiple-dose Phase|Protocol Violation|1|||
30994486|NCT02246478|59177751|FG001|Multiple-dose Phase|Protocol Violation|0|||
30994487|NCT02246478|59177752|FG002|Multiple-dose Phase|Protocol Violation|0|||
30994488|NCT02246478|59177753|FG003|Multiple-dose Phase|Protocol Violation|1|||
30994489|NCT02252016|59177772|FG000|Overall Study|Lost to Follow-up|2|||
30994490|NCT02252016|59177773|FG001|Overall Study|Lost to Follow-up|1|||
30994491|NCT02252016|59177772|FG000|Overall Study|Physician Decision|1|||
30994492|NCT02252016|59177773|FG001|Overall Study|Physician Decision|0|||
30994493|NCT02252016|59177772|FG000|Overall Study|Withdrawal by Subject|0|||
30994494|NCT02252016|59177773|FG001|Overall Study|Withdrawal by Subject|2|||
30994495|NCT02249832|59177779|FG000|Overall Study|Withdrawal by Subject|3|||
30994496|NCT02249832|59177779|FG000|Overall Study|Lost to Follow-up|10|||
30994497|NCT02248974|59177790|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
30994498|NCT02248974|59177791|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
30994499|NCT02248974|59177790|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
30994500|NCT02248974|59177791|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
30994501|NCT02248974|59177790|FG000|1-Day Follow-Up|Enrolled in another study|1|||
30994502|NCT02248974|59177791|FG001|1-Day Follow-Up|Enrolled in another study|0|||
30994503|NCT02248974|59177790|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
30994504|NCT02248974|59177791|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
30994505|NCT02248974|59177790|FG000|1-Week Follow-Up|Enrolled in another study|1|||
30994506|NCT02248974|59177791|FG001|1-Week Follow-Up|Enrolled in another study|1|||
30994507|NCT02248974|59177790|FG000|1-Week Follow-Up|Transferred to another facility|1|||
30994508|NCT02248974|59177791|FG001|1-Week Follow-Up|Transferred to another facility|0|||
30994509|NCT02248974|59177790|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
30994510|NCT02248974|59177791|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
30994511|NCT02248974|59177790|FG000|1-Week Follow-Up|Death|1|||
30994512|NCT02248974|59177791|FG001|1-Week Follow-Up|Death|1|||
30994513|NCT02248974|59177790|FG000|1-Week Follow-Up|Excluded because of age|0|||
30994514|NCT02248974|59177791|FG001|1-Week Follow-Up|Excluded because of age|1|||
30994515|NCT02248974|59177790|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
30994516|NCT02248974|59177791|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
30994517|NCT02248974|59177790|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
30994518|NCT02248974|59177791|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
30994519|NCT02248974|59177790|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
30994520|NCT02248974|59177791|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
30994521|NCT02248974|59177790|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
30994522|NCT02248974|59177791|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
30994523|NCT02248974|59177790|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
30994524|NCT02248974|59177791|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
30994525|NCT02246166|59177799|FG000|Overall Study|Protocol Violation|1|||
30994526|NCT02246166|59177800|FG001|Overall Study|Protocol Violation|0|||
30994527|NCT02706847|59177809|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
30994528|NCT02706847|59177810|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
30994529|NCT02706847|59177811|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
30994530|NCT02706847|59177812|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
30994531|NCT02706847|59177809|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
30994532|NCT02706847|59177810|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
30994533|NCT02706847|59177811|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
30994534|NCT02706847|59177812|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
30994535|NCT02706847|59177809|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
30994536|NCT02706847|59177810|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
30994537|NCT02706847|59177811|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
30994538|NCT02706847|59177812|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
30994539|NCT02706847|59177809|FG000|Period 1: Day 1 to Week 12|Other|4|||
30994540|NCT02706847|59177810|FG001|Period 1: Day 1 to Week 12|Other|4|||
30994541|NCT02706847|59177811|FG002|Period 1: Day 1 to Week 12|Other|2|||
30994542|NCT02706847|59177812|FG003|Period 1: Day 1 to Week 12|Other|2|||
30994543|NCT02706847|59177809|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
30994544|NCT02706847|59177810|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
30994545|NCT02706847|59177811|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
30994546|NCT02706847|59177812|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
30994547|NCT02706847|59177809|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
30994548|NCT02706847|59177810|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
30994549|NCT02706847|59177811|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
30994550|NCT02706847|59177812|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
30994551|NCT02706847|59177809|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
30994552|NCT02706847|59177810|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
30994553|NCT02706847|59177811|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
30994554|NCT02706847|59177812|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
30994555|NCT02706847|59177809|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
30994556|NCT02706847|59177810|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
30994557|NCT02706847|59177811|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
30994558|NCT02706847|59177812|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
30994559|NCT02706847|59177809|FG000|Period 1: Week 12 to Week 24|Other|1|||
30994560|NCT02706847|59177810|FG001|Period 1: Week 12 to Week 24|Other|0|||
30994561|NCT02706847|59177811|FG002|Period 1: Week 12 to Week 24|Other|1|||
30994562|NCT02706847|59177812|FG003|Period 1: Week 12 to Week 24|Other|4|||
30994563|NCT02706847|59177809|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
30994564|NCT02706847|59177810|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
30994565|NCT02706847|59177811|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
30994566|NCT02706847|59177812|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
30994567|NCT02706847|59177809|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
30994568|NCT02706847|59177810|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
30994569|NCT02706847|59177811|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
30994570|NCT02706847|59177812|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
30994571|NCT02706847|59177809|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
30994572|NCT02706847|59177810|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
30994573|NCT02706847|59177811|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
30994574|NCT02706847|59177812|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
30994575|NCT02706847|59177809|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
30994576|NCT02706847|59177810|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
30994577|NCT02706847|59177811|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
30994578|NCT02706847|59177812|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
30994579|NCT02706847|59177809|FG000|Period 2: Week 24 to Week 260|Other|8|||
30994580|NCT02706847|59177810|FG001|Period 2: Week 24 to Week 260|Other|5|||
30994581|NCT02706847|59177811|FG002|Period 2: Week 24 to Week 260|Other|15|||
30994582|NCT02706847|59177812|FG003|Period 2: Week 24 to Week 260|Other|15|||
30994583|NCT02245620|59177825|FG000|Overall Study|Physician Decision|1|||
30994584|NCT02245620|59177826|FG001|Overall Study|Physician Decision|1|||
30994585|NCT02244996|59177834|FG000|Overall Study|Lack of Efficacy|2|||
30994586|NCT02244996|59177835|FG001|Overall Study|Lack of Efficacy|6|||
30994587|NCT02243280|59177870|FG000|Treated|Adverse Event|1|||
30994588|NCT02243280|59177871|FG001|Treated|Adverse Event|0|||
30994589|NCT02243280|59177872|FG002|Treated|Adverse Event|0|||
30994590|NCT02243280|59177873|FG003|Treated|Adverse Event|0|||
30994591|NCT02243280|59177874|FG004|Treated|Adverse Event|0|||
30994592|NCT02243280|59177875|FG005|Treated|Adverse Event|0|||
30994593|NCT02243280|59177876|FG006|Treated|Adverse Event|0|||
30994594|NCT02243280|59177877|FG007|Treated|Adverse Event|0|||
30994595|NCT02243280|59177878|FG008|Treated|Adverse Event|0|||
30994596|NCT02243280|59177879|FG009|Treated|Adverse Event|0|||
30994597|NCT02243280|59177880|FG010|Treated|Adverse Event|1|||
30994598|NCT02243280|59177870|FG000|Treated|Lost to Follow-up|0|||
30994599|NCT02243280|59177871|FG001|Treated|Lost to Follow-up|0|||
30994600|NCT02243280|59177872|FG002|Treated|Lost to Follow-up|0|||
30994601|NCT02243280|59177873|FG003|Treated|Lost to Follow-up|0|||
30994602|NCT02243280|59177874|FG004|Treated|Lost to Follow-up|0|||
30994603|NCT02243280|59177875|FG005|Treated|Lost to Follow-up|0|||
30994604|NCT02243280|59177876|FG006|Treated|Lost to Follow-up|0|||
30994605|NCT02243280|59177877|FG007|Treated|Lost to Follow-up|0|||
30994606|NCT02243280|59177878|FG008|Treated|Lost to Follow-up|1|||
30994607|NCT02243280|59177879|FG009|Treated|Lost to Follow-up|0|||
30994608|NCT02243280|59177880|FG010|Treated|Lost to Follow-up|2|||
30994609|NCT02248818|59177938|FG000|Screening|Protocol Violation|0|||
30994610|NCT02248818|59177939|FG001|Screening|Protocol Violation|0|||
30994611|NCT02248818|59177940|FG002|Screening|Protocol Violation|0|||
30994612|NCT02248818|59177941|FG003|Screening|Protocol Violation|0|||
30994613|NCT02248818|59177942|FG004|Screening|Protocol Violation|0|||
30994614|NCT02248818|59177943|FG005|Screening|Protocol Violation|0|||
30994615|NCT02248818|59177944|FG006|Screening|Protocol Violation|0|||
30994616|NCT02248818|59177945|FG007|Screening|Protocol Violation|0|||
30994617|NCT02248818|59177946|FG008|Screening|Protocol Violation|7|||
30994618|NCT02248818|59177938|FG000|Screening|Study fully enrolled|0|||
30994619|NCT02248818|59177939|FG001|Screening|Study fully enrolled|0|||
30994620|NCT02248818|59177940|FG002|Screening|Study fully enrolled|0|||
30994621|NCT02248818|59177941|FG003|Screening|Study fully enrolled|0|||
30994622|NCT02248818|59177942|FG004|Screening|Study fully enrolled|0|||
30994623|NCT02248818|59177943|FG005|Screening|Study fully enrolled|0|||
30994624|NCT02248818|59177944|FG006|Screening|Study fully enrolled|0|||
30994625|NCT02248818|59177945|FG007|Screening|Study fully enrolled|0|||
30994626|NCT02248818|59177946|FG008|Screening|Study fully enrolled|14|||
30994627|NCT02248818|59177938|FG000|Screening|Physician Decision|0|||
30994628|NCT02248818|59177939|FG001|Screening|Physician Decision|0|||
30994629|NCT02248818|59177940|FG002|Screening|Physician Decision|0|||
30994630|NCT02248818|59177941|FG003|Screening|Physician Decision|0|||
30994631|NCT02248818|59177942|FG004|Screening|Physician Decision|0|||
30994632|NCT02248818|59177943|FG005|Screening|Physician Decision|0|||
30994633|NCT02248818|59177944|FG006|Screening|Physician Decision|0|||
30994634|NCT02248818|59177945|FG007|Screening|Physician Decision|0|||
30994635|NCT02248818|59177946|FG008|Screening|Physician Decision|73|||
30994636|NCT02248818|59177938|FG000|Screening|Withdrawal by Subject|0|||
30994637|NCT02248818|59177939|FG001|Screening|Withdrawal by Subject|0|||
30994638|NCT02248818|59177940|FG002|Screening|Withdrawal by Subject|0|||
30994639|NCT02248818|59177941|FG003|Screening|Withdrawal by Subject|0|||
30994640|NCT02248818|59177942|FG004|Screening|Withdrawal by Subject|0|||
30994641|NCT02248818|59177943|FG005|Screening|Withdrawal by Subject|0|||
30994642|NCT02248818|59177944|FG006|Screening|Withdrawal by Subject|0|||
30994643|NCT02248818|59177945|FG007|Screening|Withdrawal by Subject|0|||
30994644|NCT02248818|59177946|FG008|Screening|Withdrawal by Subject|6|||
30994645|NCT02248818|59177938|FG000|Screening|Lost to Follow-up|0|||
30994646|NCT02248818|59177939|FG001|Screening|Lost to Follow-up|0|||
30994647|NCT02248818|59177940|FG002|Screening|Lost to Follow-up|0|||
30994648|NCT02248818|59177941|FG003|Screening|Lost to Follow-up|0|||
30994649|NCT02248818|59177942|FG004|Screening|Lost to Follow-up|0|||
30994650|NCT02248818|59177943|FG005|Screening|Lost to Follow-up|0|||
30994651|NCT02248818|59177944|FG006|Screening|Lost to Follow-up|0|||
30994652|NCT02248818|59177945|FG007|Screening|Lost to Follow-up|0|||
30994653|NCT02248818|59177946|FG008|Screening|Lost to Follow-up|7|||
30994654|NCT02248818|59177938|FG000|Randomised Study|Administrative - randomization error|0|||
30994655|NCT02248818|59177939|FG001|Randomised Study|Administrative - randomization error|0|||
30994656|NCT02248818|59177940|FG002|Randomised Study|Administrative - randomization error|0|||
30994657|NCT02248818|59177941|FG003|Randomised Study|Administrative - randomization error|0|||
30994658|NCT02248818|59177942|FG004|Randomised Study|Administrative - randomization error|0|||
30994659|NCT02248818|59177943|FG005|Randomised Study|Administrative - randomization error|8|||
30994660|NCT02248818|59177944|FG006|Randomised Study|Administrative - randomization error|0|||
30994661|NCT02248818|59177945|FG007|Randomised Study|Administrative - randomization error|0|||
30994662|NCT02248818|59177946|FG008|Randomised Study|Administrative - randomization error|0|||
30994663|NCT02247960|59177975|FG000|Patient Consent and Randomization|Physician Decision|2|||
30994664|NCT02247960|59177976|FG001|Patient Consent and Randomization|Physician Decision|2|||
30994665|NCT02247960|59177975|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
30994666|NCT02247960|59177976|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
30994667|NCT02247960|59177975|FG000|Catheter Removed|Lost to Follow-up|7|||
30994668|NCT02247960|59177976|FG001|Catheter Removed|Lost to Follow-up|10|||
30994669|NCT02247804|59178065|FG000|Treatment Period 1|Adverse Event|9|||
30994670|NCT02247804|59178066|FG001|Treatment Period 1|Adverse Event|2|||
30994671|NCT02247804|59178067|FG002|Treatment Period 1|Adverse Event|0|||
30994672|NCT02247804|59178065|FG000|Treatment Period 1|Lack of Efficacy|0|||
30994673|NCT02247804|59178066|FG001|Treatment Period 1|Lack of Efficacy|0|||
30994674|NCT02247804|59178067|FG002|Treatment Period 1|Lack of Efficacy|2|||
30994675|NCT02247804|59178065|FG000|Treatment Period 1|Lost to Follow-up|1|||
30994676|NCT02247804|59178066|FG001|Treatment Period 1|Lost to Follow-up|0|||
30994677|NCT02247804|59178067|FG002|Treatment Period 1|Lost to Follow-up|2|||
30994678|NCT02247804|59178065|FG000|Treatment Period 1|Personal Reasons|7|||
30994679|NCT02247804|59178066|FG001|Treatment Period 1|Personal Reasons|1|||
30994680|NCT02247804|59178067|FG002|Treatment Period 1|Personal Reasons|2|||
30994681|NCT02247804|59178065|FG000|Treatment Period 1|Protocol Deviation|0|||
30994682|NCT02247804|59178066|FG001|Treatment Period 1|Protocol Deviation|0|||
30994683|NCT02247804|59178067|FG002|Treatment Period 1|Protocol Deviation|1|||
30994684|NCT02247804|59178065|FG000|Treatment Period 1|Randomized but not Treated|5|||
30994685|NCT02247804|59178066|FG001|Treatment Period 1|Randomized but not Treated|1|||
30994686|NCT02247804|59178067|FG002|Treatment Period 1|Randomized but not Treated|1|||
30994687|NCT02247804|59178065|FG000|Treatment Period 2|Adverse Event|6|||
30994688|NCT02247804|59178066|FG001|Treatment Period 2|Adverse Event|3|||
30994689|NCT02247804|59178067|FG002|Treatment Period 2|Adverse Event|3|||
30994690|NCT02247804|59178065|FG000|Treatment Period 2|Lack of Efficacy|0|||
30994691|NCT02247804|59178066|FG001|Treatment Period 2|Lack of Efficacy|0|||
30994692|NCT02247804|59178067|FG002|Treatment Period 2|Lack of Efficacy|1|||
30994693|NCT02247804|59178065|FG000|Treatment Period 2|Lost to Follow-up|0|||
30994694|NCT02247804|59178066|FG001|Treatment Period 2|Lost to Follow-up|1|||
30994695|NCT02247804|59178067|FG002|Treatment Period 2|Lost to Follow-up|1|||
30994696|NCT02247804|59178065|FG000|Treatment Period 2|Personal Reasons|2|||
30994697|NCT02247804|59178066|FG001|Treatment Period 2|Personal Reasons|1|||
30994698|NCT02247804|59178067|FG002|Treatment Period 2|Personal Reasons|1|||
30994699|NCT02247804|59178065|FG000|Treatment Period 2|Reason not Specified|0|||
30994700|NCT02247804|59178066|FG001|Treatment Period 2|Reason not Specified|0|||
30994701|NCT02247804|59178067|FG002|Treatment Period 2|Reason not Specified|2|||
30994702|NCT02247804|59178065|FG000|Treatment Period 3|Adverse Event|4|||
30994703|NCT02247804|59178066|FG001|Treatment Period 3|Adverse Event|3|||
30994704|NCT02247804|59178067|FG002|Treatment Period 3|Adverse Event|3|||
30994705|NCT02247804|59178065|FG000|Treatment Period 3|Lack of Efficacy|0|||
30994706|NCT02247804|59178066|FG001|Treatment Period 3|Lack of Efficacy|1|||
30994707|NCT02247804|59178067|FG002|Treatment Period 3|Lack of Efficacy|0|||
30994708|NCT02247804|59178065|FG000|Treatment Period 3|Lost to Follow-up|1|||
30994709|NCT02247804|59178066|FG001|Treatment Period 3|Lost to Follow-up|2|||
30994710|NCT02247804|59178067|FG002|Treatment Period 3|Lost to Follow-up|2|||
30994711|NCT02247804|59178065|FG000|Treatment Period 3|Personal Reasons|4|||
30994712|NCT02247804|59178066|FG001|Treatment Period 3|Personal Reasons|3|||
30994713|NCT02247804|59178067|FG002|Treatment Period 3|Personal Reasons|2|||
30994714|NCT02247804|59178065|FG000|Treatment Period 3|Reason not Specified|2|||
30994715|NCT02247804|59178066|FG001|Treatment Period 3|Reason not Specified|1|||
30994716|NCT02247804|59178067|FG002|Treatment Period 3|Reason not Specified|3|||
30994717|NCT02243202|59178092|FG000|Overall Study|Adverse Event|5|||
30994718|NCT02243202|59178093|FG001|Overall Study|Adverse Event|6|||
30994719|NCT02243202|59178094|FG002|Overall Study|Adverse Event|10|||
30994720|NCT02243202|59178095|FG003|Overall Study|Adverse Event|4|||
30994721|NCT02243202|59178092|FG000|Overall Study|Lost to Follow-up|9|||
30994722|NCT02243202|59178093|FG001|Overall Study|Lost to Follow-up|9|||
30994723|NCT02243202|59178094|FG002|Overall Study|Lost to Follow-up|14|||
30994724|NCT02243202|59178095|FG003|Overall Study|Lost to Follow-up|11|||
30994725|NCT02243202|59178092|FG000|Overall Study|Protocol Violation|3|||
30891905|NCT02195583|58925217|FG000|Overall Study|Other Reason|2|||
30891906|NCT02379091|58925236|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
30891907|NCT02379091|58925237|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
30891908|NCT02379091|58925238|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
30891909|NCT02379091|58925239|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
30891910|NCT02379091|58925236|FG000|Overall Study|Principal Investigator Discretion|0|||
30891911|NCT02379091|58925237|FG001|Overall Study|Principal Investigator Discretion|1|||
30891912|NCT02379091|58925238|FG002|Overall Study|Principal Investigator Discretion|0|||
30891913|NCT02379091|58925239|FG003|Overall Study|Principal Investigator Discretion|0|||
30891914|NCT02379091|58925236|FG000|Overall Study|Lost to Follow-up|0|||
30891915|NCT02379091|58925237|FG001|Overall Study|Lost to Follow-up|0|||
30891916|NCT02379091|58925238|FG002|Overall Study|Lost to Follow-up|0|||
30891917|NCT02379091|58925239|FG003|Overall Study|Lost to Follow-up|1|||
30891918|NCT02379091|58925236|FG000|Overall Study|Voluntary Withdrawal|2|||
30891919|NCT02379091|58925237|FG001|Overall Study|Voluntary Withdrawal|5|||
30891920|NCT02379091|58925238|FG002|Overall Study|Voluntary Withdrawal|2|||
30891921|NCT02379091|58925239|FG003|Overall Study|Voluntary Withdrawal|4|||
30891922|NCT02379091|58925236|FG000|Overall Study|Study Termination|7|||
30891923|NCT02379091|58925237|FG001|Overall Study|Study Termination|2|||
30891924|NCT02379091|58925238|FG002|Overall Study|Study Termination|5|||
30891925|NCT02379091|58925239|FG003|Overall Study|Study Termination|8|||
30891926|NCT02379091|58925236|FG000|Overall Study|Lack of Efficacy|3|||
30891927|NCT02379091|58925237|FG001|Overall Study|Lack of Efficacy|0|||
30891928|NCT02379091|58925238|FG002|Overall Study|Lack of Efficacy|0|||
30891929|NCT02379091|58925239|FG003|Overall Study|Lack of Efficacy|0|||
30891930|NCT02378935|58925258|FG000|Overall Study|Lack of Efficacy|10|||
30891931|NCT02378935|58925259|FG001|Overall Study|Lack of Efficacy|0|||
30891932|NCT02378935|58925260|FG002|Overall Study|Lack of Efficacy|2|||
30891933|NCT02378935|58925261|FG003|Overall Study|Lack of Efficacy|6|||
30891934|NCT02378935|58925262|FG004|Overall Study|Lack of Efficacy|0|||
30891935|NCT02378935|58925263|FG005|Overall Study|Lack of Efficacy|0|||
30891936|NCT02378935|58925264|FG006|Overall Study|Lack of Efficacy|0|||
30891937|NCT02378935|58925258|FG000|Overall Study|Death|0|||
30891938|NCT02378935|58925259|FG001|Overall Study|Death|0|||
30891939|NCT02378935|58925260|FG002|Overall Study|Death|1|||
30891940|NCT02378935|58925261|FG003|Overall Study|Death|0|||
30891941|NCT02378935|58925262|FG004|Overall Study|Death|0|||
30891942|NCT02378935|58925263|FG005|Overall Study|Death|0|||
30891943|NCT02378935|58925264|FG006|Overall Study|Death|0|||
30891944|NCT02250651|58925283|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
30891945|NCT02250651|58925284|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
30891946|NCT02250651|58925285|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
30891947|NCT02250651|58925283|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
30891948|NCT02250651|58925284|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
30891949|NCT02250651|58925285|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
30891950|NCT02250651|58925283|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
30891951|NCT02250651|58925284|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
30891952|NCT02250651|58925285|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
30891953|NCT02250651|58925283|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
30891954|NCT02250651|58925284|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
30891955|NCT02250651|58925285|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
30891956|NCT02250651|58925283|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
30891957|NCT02250651|58925284|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
30891958|NCT02250651|58925285|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
30891959|NCT02250651|58925283|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
30891960|NCT02250651|58925284|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
30891961|NCT02250651|58925285|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
30891962|NCT02250651|58925283|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
30891963|NCT02250651|58925284|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
30994726|NCT02243202|59178093|FG001|Overall Study|Protocol Violation|1|||
30994727|NCT02243202|59178094|FG002|Overall Study|Protocol Violation|2|||
30891964|NCT02250651|58925285|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
30891965|NCT02250651|58925283|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
30994728|NCT02243202|59178095|FG003|Overall Study|Protocol Violation|1|||
30994729|NCT02243202|59178092|FG000|Overall Study|Withdrawal by Subject|7|||
30891966|NCT02250651|58925284|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
30891967|NCT02250651|58925285|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
30891968|NCT02250651|58925283|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
30891969|NCT02250651|58925284|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
30891970|NCT02250651|58925285|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
30891971|NCT02250651|58925283|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
30891972|NCT02250651|58925284|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
30891973|NCT02250651|58925285|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
30891974|NCT02250651|58925283|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
30891975|NCT02250651|58925284|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
30891976|NCT02250651|58925285|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
30891977|NCT02250651|58925283|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
30891978|NCT02250651|58925284|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
30994730|NCT02243202|59178093|FG001|Overall Study|Withdrawal by Subject|6|||
30994731|NCT02243202|59178094|FG002|Overall Study|Withdrawal by Subject|4|||
30994732|NCT02243202|59178095|FG003|Overall Study|Withdrawal by Subject|4|||
30994733|NCT02243202|59178092|FG000|Overall Study|Other|1|||
30994734|NCT02243202|59178093|FG001|Overall Study|Other|3|||
30994735|NCT02243202|59178094|FG002|Overall Study|Other|1|||
30994736|NCT02243202|59178095|FG003|Overall Study|Other|2|||
30994737|NCT02243202|59178092|FG000|Overall Study|Randomized but not received treatment|0|||
30994738|NCT02243202|59178093|FG001|Overall Study|Randomized but not received treatment|0|||
30994739|NCT02243202|59178094|FG002|Overall Study|Randomized but not received treatment|0|||
30994740|NCT02243202|59178095|FG003|Overall Study|Randomized but not received treatment|1|||
30994741|NCT02243046|59178108|FG000|Overall Study|Lost to Follow-up|1|||
30994742|NCT02243046|59178109|FG001|Overall Study|Lost to Follow-up|1|||
30994743|NCT02243046|59178110|FG002|Overall Study|Lost to Follow-up|4|||
30994744|NCT02207946|59178120|FG000|Overall Study|Lost to Follow-up|1|||
30994745|NCT02207946|59178121|FG001|Overall Study|Lost to Follow-up|0|||
30994746|NCT02207946|59178120|FG000|Overall Study|Adverse Event|0|||
30994747|NCT02207946|59178121|FG001|Overall Study|Adverse Event|1|||
30994748|NCT03976076|59178128|FG000|Overall Study|Withdrawal by Subject|2|||
30994749|NCT03551210|59178327|FG000|Overall Study|Adverse Event|5|||
30994750|NCT03551210|59178328|FG001|Overall Study|Adverse Event|6|||
30994751|NCT03551210|59178327|FG000|Overall Study|Withdrawal by Subject|1|||
30994752|NCT03551210|59178328|FG001|Overall Study|Withdrawal by Subject|7|||
30994753|NCT03551210|59178327|FG000|Overall Study|Needed in other antibiotic treatment|2|||
30994754|NCT03551210|59178328|FG001|Overall Study|Needed in other antibiotic treatment|5|||
30994755|NCT03551210|59178327|FG000|Overall Study|Lost to Follow-up|1|||
30994756|NCT03551210|59178328|FG001|Overall Study|Lost to Follow-up|1|||
30994757|NCT03551210|59178327|FG000|Overall Study|Absence of visit 4 and 5|1|||
30994758|NCT03551210|59178328|FG001|Overall Study|Absence of visit 4 and 5|0|||
30994759|NCT03551210|59178327|FG000|Overall Study|No drug for dispensing|0|||
30994760|NCT03551210|59178328|FG001|Overall Study|No drug for dispensing|1|||
30994761|NCT02207634|59178465|FG000|Overall Study|Withdrawal by Subject|21|||
30994762|NCT02207634|59178466|FG001|Overall Study|Withdrawal by Subject|31|||
30994763|NCT02207634|59178465|FG000|Overall Study|Lost to Follow-up|1|||
30994764|NCT02207634|59178466|FG001|Overall Study|Lost to Follow-up|0|||
30994765|NCT03452228|59178509|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
30994766|NCT03452228|59178510|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
30994767|NCT03452228|59178511|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
30994768|NCT03452228|59178509|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
30994769|NCT03452228|59178510|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
30994770|NCT03452228|59178511|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
30994771|NCT03452228|59178509|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
30994772|NCT03452228|59178510|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
30994773|NCT03452228|59178511|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
30994774|NCT03452228|59178509|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
30994775|NCT03452228|59178510|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
30994776|NCT03452228|59178511|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
30994777|NCT02207556|59178574|FG000|Overall Study|Physician Decision|1|||
30994778|NCT02207556|59178575|FG001|Overall Study|Physician Decision|0|||
30994779|NCT02207556|59178574|FG000|Overall Study|Withdrawal by Subject|1|||
30994780|NCT02207556|59178575|FG001|Overall Study|Withdrawal by Subject|0|||
30994781|NCT02207556|59178574|FG000|Overall Study|Death|0|||
30994782|NCT02207556|59178575|FG001|Overall Study|Death|5|||
30994783|NCT03732638|59178590|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
30994784|NCT03732638|59178591|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
30994785|NCT03732638|59178590|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
30994786|NCT03732638|59178591|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
30994787|NCT03732638|59178590|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
30994788|NCT03732638|59178591|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
30994789|NCT03732638|59178590|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
30994790|NCT03732638|59178591|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
30994791|NCT03732638|59178590|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
30994792|NCT03732638|59178591|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
30994793|NCT03732638|59178590|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
30994794|NCT03732638|59178591|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
30994795|NCT03732638|59178590|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
30994796|NCT03732638|59178591|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
30994797|NCT03732638|59178590|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
30994798|NCT03732638|59178591|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
30994799|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
30994800|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
30994801|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
30994802|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
30994803|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
30994804|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
30994805|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
30994806|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
30994807|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
30994808|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
30994809|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
30994810|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
30994811|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
30994812|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
30994813|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
30994814|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
30994815|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
30994816|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
30994817|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
30994818|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
30994819|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
30994820|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
30994821|NCT03732638|59178590|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
30994822|NCT03732638|59178591|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
30994823|NCT03732638|59178590|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
30994824|NCT03732638|59178591|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
30994825|NCT03732638|59178590|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
30994826|NCT03732638|59178591|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
30994827|NCT03732638|59178590|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
30994828|NCT03732638|59178591|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
30994829|NCT03732638|59178590|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
30994830|NCT03732638|59178591|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
30994831|NCT03266588|59178630|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
30994832|NCT03266588|59178631|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
30994833|NCT03266588|59178632|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
30994834|NCT03266588|59178630|FG000|Observational Period|Withdrawal by Subject|44|||
30994835|NCT03266588|59178631|FG001|Observational Period|Withdrawal by Subject|22|||
30994836|NCT03266588|59178632|FG002|Observational Period|Withdrawal by Subject|13|||
30994837|NCT03266588|59178630|FG000|Observational Period|Non-compliance|18|||
30994838|NCT03266588|59178631|FG001|Observational Period|Non-compliance|12|||
30994839|NCT03266588|59178632|FG002|Observational Period|Non-compliance|10|||
30994840|NCT03266588|59178630|FG000|Observational Period|Lost to Follow-up|8|||
30994841|NCT03266588|59178631|FG001|Observational Period|Lost to Follow-up|12|||
30994842|NCT03266588|59178632|FG002|Observational Period|Lost to Follow-up|4|||
30994843|NCT03266588|59178630|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
30994844|NCT03266588|59178631|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
30994845|NCT03266588|59178632|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
30994846|NCT03266588|59178630|FG000|Observational Period|Protocol Deviation|1|||
30994847|NCT03266588|59178631|FG001|Observational Period|Protocol Deviation|0|||
30994848|NCT03266588|59178632|FG002|Observational Period|Protocol Deviation|0|||
30994849|NCT03266588|59178630|FG000|Observational Period|Other Reasons|3|||
30994850|NCT03266588|59178631|FG001|Observational Period|Other Reasons|0|||
30994851|NCT03266588|59178632|FG002|Observational Period|Other Reasons|1|||
30994852|NCT03266588|59178630|FG000|Long-term Treatment Period|Adverse Event|33|||
30994853|NCT03266588|59178631|FG001|Long-term Treatment Period|Adverse Event|17|||
30994854|NCT03266588|59178632|FG002|Long-term Treatment Period|Adverse Event|8|||
30994855|NCT03266588|59178630|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
30994856|NCT03266588|59178631|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
30994857|NCT03266588|59178632|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
30994858|NCT03266588|59178630|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
30994859|NCT03266588|59178631|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
30994860|NCT03266588|59178632|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
30994861|NCT03266588|59178630|FG000|Long-term Treatment Period|Non-Compliance|126|||
30994862|NCT03266588|59178631|FG001|Long-term Treatment Period|Non-Compliance|57|||
30994863|NCT03266588|59178632|FG002|Long-term Treatment Period|Non-Compliance|7|||
30994864|NCT03266588|59178630|FG000|Long-term Treatment Period|Pregnancy|11|||
30994865|NCT03266588|59178631|FG001|Long-term Treatment Period|Pregnancy|5|||
30994866|NCT03266588|59178632|FG002|Long-term Treatment Period|Pregnancy|0|||
30994867|NCT03266588|59178630|FG000|Long-term Treatment Period|Protocol Deviation|17|||
30994868|NCT03266588|59178631|FG001|Long-term Treatment Period|Protocol Deviation|10|||
30994869|NCT03266588|59178632|FG002|Long-term Treatment Period|Protocol Deviation|4|||
30994870|NCT03266588|59178630|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
30994871|NCT03266588|59178631|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
30994872|NCT03266588|59178632|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
30994873|NCT03266588|59178630|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
30994874|NCT03266588|59178631|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
30994875|NCT03266588|59178632|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
30994876|NCT03266588|59178630|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
30994877|NCT03266588|59178631|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
30994878|NCT03266588|59178632|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
30994879|NCT03266588|59178630|FG000|Long-term Treatment Period|Other Reasons|5|||
30994880|NCT03266588|59178631|FG001|Long-term Treatment Period|Other Reasons|0|||
30994881|NCT03266588|59178632|FG002|Long-term Treatment Period|Other Reasons|0|||
30994882|NCT03266588|59178630|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
30994883|NCT03266588|59178631|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
30994884|NCT03266588|59178632|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
30994885|NCT03238196|59178696|FG000|Overall Study|Adverse Event|3|||
30994886|NCT03238196|59178697|FG001|Overall Study|Adverse Event|0|||
30994887|NCT03238196|59178698|FG002|Overall Study|Adverse Event|2|||
30994888|NCT03238196|59178699|FG003|Overall Study|Adverse Event|2|||
30994889|NCT03238196|59178696|FG000|Overall Study|Withdrawal by Subject|4|||
30994890|NCT03238196|59178697|FG001|Overall Study|Withdrawal by Subject|1|||
30994891|NCT03238196|59178698|FG002|Overall Study|Withdrawal by Subject|1|||
30994892|NCT03238196|59178699|FG003|Overall Study|Withdrawal by Subject|0|||
30994893|NCT03238196|59178696|FG000|Overall Study|Disease progression|14|||
30994894|NCT03238196|59178697|FG001|Overall Study|Disease progression|2|||
30994895|NCT03238196|59178698|FG002|Overall Study|Disease progression|3|||
30994896|NCT03238196|59178699|FG003|Overall Study|Disease progression|2|||
30994897|NCT03238196|59178696|FG000|Overall Study|Still on treatment|1|||
30994898|NCT03238196|59178697|FG001|Overall Study|Still on treatment|0|||
30994899|NCT03238196|59178698|FG002|Overall Study|Still on treatment|0|||
30994900|NCT03238196|59178699|FG003|Overall Study|Still on treatment|0|||
30994901|NCT03019640|59178718|FG000|Overall Study|Screen Failures|4|||
30994902|NCT03019640|59178718|FG000|Overall Study|Adverse Event|3|||
30994903|NCT03019640|59178718|FG000|Overall Study|Participant Relapsed|1|||
30994904|NCT02240706|59178786|FG000|Overall Study|Lack of Efficacy|2|||
30994905|NCT02240706|59178787|FG001|Overall Study|Lack of Efficacy|2|||
30994906|NCT02240706|59178788|FG002|Overall Study|Lack of Efficacy|2|||
30994907|NCT02240706|59178789|FG003|Overall Study|Lack of Efficacy|2|||
30994908|NCT02240706|59178790|FG004|Overall Study|Lack of Efficacy|5|||
30994909|NCT02240706|59178791|FG005|Overall Study|Lack of Efficacy|0|||
30994910|NCT02240706|59178792|FG006|Overall Study|Lack of Efficacy|0|||
30994911|NCT02240706|59178786|FG000|Overall Study|Adverse Event|1|||
30994912|NCT02240706|59178787|FG001|Overall Study|Adverse Event|0|||
30994913|NCT02240706|59178788|FG002|Overall Study|Adverse Event|1|||
30994914|NCT02240706|59178789|FG003|Overall Study|Adverse Event|0|||
30994915|NCT02240706|59178790|FG004|Overall Study|Adverse Event|2|||
30994916|NCT02240706|59178791|FG005|Overall Study|Adverse Event|0|||
30994917|NCT02240706|59178792|FG006|Overall Study|Adverse Event|0|||
30994918|NCT02240706|59178786|FG000|Overall Study|Progressive disease|0|||
30994919|NCT02240706|59178787|FG001|Overall Study|Progressive disease|0|||
30994920|NCT02240706|59178788|FG002|Overall Study|Progressive disease|0|||
30994921|NCT02240706|59178789|FG003|Overall Study|Progressive disease|0|||
30994922|NCT02240706|59178790|FG004|Overall Study|Progressive disease|1|||
30994923|NCT02240706|59178791|FG005|Overall Study|Progressive disease|0|||
30994924|NCT02240706|59178792|FG006|Overall Study|Progressive disease|0|||
30994925|NCT02240706|59178786|FG000|Overall Study|Dose limiting toxicity|0|||
30994926|NCT02240706|59178787|FG001|Overall Study|Dose limiting toxicity|0|||
30994927|NCT02240706|59178788|FG002|Overall Study|Dose limiting toxicity|0|||
30994928|NCT02240706|59178789|FG003|Overall Study|Dose limiting toxicity|0|||
30994929|NCT02240706|59178790|FG004|Overall Study|Dose limiting toxicity|1|||
30994930|NCT02240706|59178791|FG005|Overall Study|Dose limiting toxicity|0|||
30994931|NCT02240706|59178792|FG006|Overall Study|Dose limiting toxicity|0|||
30994932|NCT02240706|59178786|FG000|Overall Study|Refused to continue taking medication|0|||
30994933|NCT02240706|59178787|FG001|Overall Study|Refused to continue taking medication|1|||
30994934|NCT02240706|59178788|FG002|Overall Study|Refused to continue taking medication|3|||
30994935|NCT02240706|59178789|FG003|Overall Study|Refused to continue taking medication|1|||
30994936|NCT02240706|59178790|FG004|Overall Study|Refused to continue taking medication|2|||
30994937|NCT02240706|59178791|FG005|Overall Study|Refused to continue taking medication|0|||
30994938|NCT02240706|59178792|FG006|Overall Study|Refused to continue taking medication|0|||
30994939|NCT02240706|59178786|FG000|Overall Study|Insurance billing concerns|0|||
30994940|NCT02240706|59178787|FG001|Overall Study|Insurance billing concerns|0|||
30994941|NCT02240706|59178788|FG002|Overall Study|Insurance billing concerns|0|||
30994942|NCT02240706|59178789|FG003|Overall Study|Insurance billing concerns|1|||
30994943|NCT02240706|59178790|FG004|Overall Study|Insurance billing concerns|0|||
30994944|NCT02240706|59178791|FG005|Overall Study|Insurance billing concerns|0|||
30994945|NCT02240706|59178792|FG006|Overall Study|Insurance billing concerns|0|||
30994946|NCT01600092|59178817|FG000|Overall Study|Adverse Event|2|||
30994947|NCT01600092|59178818|FG001|Overall Study|Adverse Event|0|||
30994948|NCT01600092|59178817|FG000|Overall Study|Lost to Follow-up|4|||
30994949|NCT01600092|59178818|FG001|Overall Study|Lost to Follow-up|6|||
30994950|NCT01600092|59178817|FG000|Overall Study|Withdrawal by parent/guardian|8|||
30994951|NCT01600092|59178818|FG001|Overall Study|Withdrawal by parent/guardian|6|||
30994952|NCT01600092|59178817|FG000|Overall Study|Physician Decision|1|||
30994953|NCT01600092|59178818|FG001|Overall Study|Physician Decision|1|||
30994954|NCT01600092|59178817|FG000|Overall Study|Randomized but not vaccinated|3|||
30994955|NCT01600092|59178818|FG001|Overall Study|Randomized but not vaccinated|3|||
30994956|NCT02240628|59178830|FG000|Overall Study|Physician Decision|6|||
30994957|NCT02240628|59178831|FG001|Overall Study|Physician Decision|5|||
30994958|NCT02207400|59178853|FG000|Overall Study|Adverse Event|1|||
30994959|NCT02207400|59178854|FG001|Overall Study|Adverse Event|1|||
30994960|NCT02207400|59178853|FG000|Overall Study|Lost to Follow-up|6|||
30994961|NCT02207400|59178854|FG001|Overall Study|Lost to Follow-up|7|||
30994962|NCT02207400|59178853|FG000|Overall Study|Protocol Violation|1|||
30994963|NCT02207400|59178854|FG001|Overall Study|Protocol Violation|1|||
30994964|NCT02207400|59178853|FG000|Overall Study|Withdrawal by Subject|8|||
30994965|NCT02207400|59178854|FG001|Overall Study|Withdrawal by Subject|4|||
30994966|NCT02207400|59178853|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
30994967|NCT02207400|59178854|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
30994968|NCT02207244|59179226|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
30994969|NCT02207244|59179227|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
30994970|NCT02207244|59179228|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
30994971|NCT02207244|59179229|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
30994972|NCT02207244|59179230|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
30994973|NCT02207244|59179231|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
30994974|NCT02207244|59179232|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
30994975|NCT02207244|59179233|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
30994976|NCT02207244|59179234|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
30994977|NCT02207244|59179235|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
30994978|NCT02207244|59179236|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
30994979|NCT02207244|59179226|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
30994980|NCT02207244|59179227|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
30994981|NCT02207244|59179228|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
30994982|NCT02207244|59179229|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
30994983|NCT02207244|59179230|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
30994984|NCT02207244|59179231|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
30994985|NCT02207244|59179232|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
30994986|NCT02207244|59179233|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
30994987|NCT02207244|59179234|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
30994988|NCT02207244|59179235|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
30994989|NCT02207244|59179236|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
30994990|NCT02207244|59179226|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
30994991|NCT02207244|59179227|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
30994992|NCT02207244|59179228|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
30994993|NCT02207244|59179229|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
30994994|NCT02207244|59179230|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
30994995|NCT02207244|59179231|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
30994996|NCT02207244|59179232|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
30994997|NCT02207244|59179233|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
30994998|NCT02207244|59179234|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
30994999|NCT02207244|59179235|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
30995000|NCT02207244|59179236|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
30995001|NCT02207244|59179226|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
30995002|NCT02207244|59179227|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
30995003|NCT02207244|59179228|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
30995004|NCT02207244|59179229|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
30995005|NCT02207244|59179230|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
30995006|NCT02207244|59179231|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
30995007|NCT02207244|59179232|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
30995008|NCT02207244|59179233|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
30995009|NCT02207244|59179234|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
30995010|NCT02207244|59179235|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
30995011|NCT02207244|59179236|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
30995012|NCT02207244|59179226|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
30995013|NCT02207244|59179227|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
30995014|NCT02207244|59179228|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
30995015|NCT02207244|59179229|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
30995016|NCT02207244|59179230|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
30995017|NCT02207244|59179231|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
30995018|NCT02207244|59179232|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
30995019|NCT02207244|59179233|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
30995020|NCT02207244|59179234|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
30995021|NCT02207244|59179235|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
30995022|NCT02207244|59179236|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
30995023|NCT02207244|59179226|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
30995024|NCT02207244|59179227|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
30995025|NCT02207244|59179228|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
30995026|NCT02207244|59179229|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
30995027|NCT02207244|59179230|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
30995028|NCT02207244|59179231|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
30995029|NCT02207244|59179232|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
30995030|NCT02207244|59179233|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
30995031|NCT02207244|59179234|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
30995032|NCT02207244|59179235|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
30995033|NCT02207244|59179236|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
30995034|NCT02207244|59179226|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
30995035|NCT02207244|59179227|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
30891979|NCT02250651|58925285|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
30995036|NCT02207244|59179228|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
30995037|NCT02207244|59179229|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
30995038|NCT02207244|59179230|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
30995039|NCT02207244|59179231|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
30995040|NCT02207244|59179232|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
30995041|NCT02207244|59179233|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
30995042|NCT02207244|59179234|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
30995043|NCT02207244|59179235|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
30995044|NCT02207244|59179236|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
30995045|NCT02207244|59179226|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
30995046|NCT02207244|59179227|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
30995047|NCT02207244|59179228|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
30995048|NCT02207244|59179229|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
30995049|NCT02207244|59179230|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
30995050|NCT02207244|59179231|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
30995051|NCT02207244|59179232|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
30995052|NCT02207244|59179233|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
30995053|NCT02207244|59179234|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
30995054|NCT02207244|59179235|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
30995055|NCT02207244|59179236|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
30995056|NCT02207244|59179226|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
30995057|NCT02207244|59179227|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
30995058|NCT02207244|59179228|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
30995059|NCT02207244|59179229|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
30995060|NCT02207244|59179230|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
30995061|NCT02207244|59179231|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
30995062|NCT02207244|59179232|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
30995063|NCT02207244|59179233|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
30995064|NCT02207244|59179234|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
30995065|NCT02207244|59179235|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
30995066|NCT02207244|59179236|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
30995067|NCT02207244|59179226|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
30995068|NCT02207244|59179227|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
30995069|NCT02207244|59179228|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
30995070|NCT02207244|59179229|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
30995071|NCT02207244|59179230|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
30995072|NCT02207244|59179231|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
30995073|NCT02207244|59179232|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
30995074|NCT02207244|59179233|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
30995075|NCT02207244|59179234|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
30995076|NCT02207244|59179235|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
30995077|NCT02207244|59179236|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
30995078|NCT02207244|59179226|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
30995079|NCT02207244|59179227|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
30995080|NCT02207244|59179228|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
30995081|NCT02207244|59179229|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
30995082|NCT02207244|59179230|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
30995083|NCT02207244|59179231|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
30995084|NCT02207244|59179232|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
30995085|NCT02207244|59179233|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
30995086|NCT02207244|59179234|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
30995087|NCT02207244|59179235|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
30995088|NCT02207244|59179236|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
30995089|NCT02207244|59179226|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
30995090|NCT02207244|59179227|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
30995091|NCT02207244|59179228|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
30995092|NCT02207244|59179229|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
30995093|NCT02207244|59179230|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
30995094|NCT02207244|59179231|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
30995095|NCT02207244|59179232|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
30995096|NCT02207244|59179233|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
30995097|NCT02207244|59179234|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
30995098|NCT02207244|59179235|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
30995099|NCT02207244|59179236|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
30995100|NCT02207244|59179226|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
30995101|NCT02207244|59179227|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
30995102|NCT02207244|59179228|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
30995103|NCT02207244|59179229|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
30995104|NCT02207244|59179230|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
30995105|NCT02207244|59179231|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
30995106|NCT02207244|59179232|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
30995107|NCT02207244|59179233|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
30995108|NCT02207244|59179234|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
30995109|NCT02207244|59179235|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
30995110|NCT02207244|59179236|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
30995111|NCT02207244|59179226|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
30995112|NCT02207244|59179227|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
30995113|NCT02207244|59179228|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
30995114|NCT02207244|59179229|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
30995115|NCT02207244|59179230|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
30995116|NCT02207244|59179231|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
30995117|NCT02207244|59179232|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
30995118|NCT02207244|59179233|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
30995119|NCT02207244|59179234|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
30995120|NCT02207244|59179235|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
30995121|NCT02207244|59179236|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
30995122|NCT02207244|59179226|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
30995123|NCT02207244|59179227|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
30995124|NCT02207244|59179228|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
30995125|NCT02207244|59179229|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
30995126|NCT02207244|59179230|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
30995127|NCT02207244|59179231|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
30995128|NCT02207244|59179232|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
30995129|NCT02207244|59179233|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
30995130|NCT02207244|59179234|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
30995131|NCT02207244|59179235|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
30995132|NCT02207244|59179236|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
30995133|NCT02207244|59179226|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
30995134|NCT02207244|59179227|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
30995135|NCT02207244|59179228|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
30995136|NCT02207244|59179229|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
30995137|NCT02207244|59179230|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
30995138|NCT02207244|59179231|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
30995139|NCT02207244|59179232|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
30995140|NCT02207244|59179233|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
30995141|NCT02207244|59179234|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
30995142|NCT02207244|59179235|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
30995143|NCT02207244|59179236|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
30995144|NCT02207244|59179226|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
30995145|NCT02207244|59179227|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
30995146|NCT02207244|59179228|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
30995147|NCT02207244|59179229|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
30995148|NCT02207244|59179230|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
30995149|NCT02207244|59179231|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
30995150|NCT02207244|59179232|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
30995151|NCT02207244|59179233|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
30995152|NCT02207244|59179234|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
30995153|NCT02207244|59179235|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
30995154|NCT02207244|59179236|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
30995155|NCT02207244|59179226|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
30995156|NCT02207244|59179227|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
30995157|NCT02207244|59179228|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
30995158|NCT02207244|59179229|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
30995159|NCT02207244|59179230|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
30995160|NCT02207244|59179231|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
30995161|NCT02207244|59179232|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
30995162|NCT02207244|59179233|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
30995163|NCT02207244|59179234|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
30995164|NCT02207244|59179235|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
30995165|NCT02207244|59179236|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
30995166|NCT02207244|59179226|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
30995167|NCT02207244|59179227|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
30995168|NCT02207244|59179228|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
30995169|NCT02207244|59179229|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
30995170|NCT02207244|59179230|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
30995171|NCT02207244|59179231|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
30995172|NCT02207244|59179232|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
30995173|NCT02207244|59179233|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
30995174|NCT02207244|59179234|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
30995175|NCT02207244|59179235|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
30995176|NCT02207244|59179236|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
30995177|NCT02207244|59179226|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
30995178|NCT02207244|59179227|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
30995179|NCT02207244|59179228|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
30995180|NCT02207244|59179229|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
30995181|NCT02207244|59179230|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
30995182|NCT02207244|59179231|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
30995183|NCT02207244|59179232|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
30995184|NCT02207244|59179233|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
30995185|NCT02207244|59179234|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
30995186|NCT02207244|59179235|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
30995187|NCT02207244|59179236|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
30995188|NCT02207244|59179226|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
30995189|NCT02207244|59179227|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
30995190|NCT02207244|59179228|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
30995191|NCT02207244|59179229|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
30995192|NCT02207244|59179230|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
30995193|NCT02207244|59179231|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
30995194|NCT02207244|59179232|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
30995195|NCT02207244|59179233|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
30995196|NCT02207244|59179234|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
30995197|NCT02207244|59179235|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
30995198|NCT02207244|59179236|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
30995199|NCT02207244|59179226|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
30995200|NCT02207244|59179227|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
30995201|NCT02207244|59179228|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
30995202|NCT02207244|59179229|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
30995203|NCT02207244|59179230|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
30995204|NCT02207244|59179231|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
30995205|NCT02207244|59179232|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
30995206|NCT02207244|59179233|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
30995207|NCT02207244|59179234|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
30995208|NCT02207244|59179235|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
30995209|NCT02207244|59179236|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
30995210|NCT02207244|59179226|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
30995211|NCT02207244|59179227|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
30995212|NCT02207244|59179228|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
30995213|NCT02207244|59179229|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
30995214|NCT02207244|59179230|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
30995215|NCT02207244|59179231|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
30995216|NCT02207244|59179232|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
30995217|NCT02207244|59179233|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
30995218|NCT02207244|59179234|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
30995219|NCT02207244|59179235|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
30995220|NCT02207244|59179236|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
30995221|NCT02207244|59179226|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
30995222|NCT02207244|59179227|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
30995223|NCT02207244|59179228|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
30995224|NCT02207244|59179229|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
30995225|NCT02207244|59179230|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
30995226|NCT02207244|59179231|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
30995227|NCT02207244|59179232|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
30995228|NCT02207244|59179233|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
30995229|NCT02207244|59179234|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
30995230|NCT02207244|59179235|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
30995231|NCT02207244|59179236|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
30995232|NCT02207244|59179226|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
30995233|NCT02207244|59179227|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
30995234|NCT02207244|59179228|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
30995235|NCT02207244|59179229|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
30995236|NCT02207244|59179230|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
30995237|NCT02207244|59179231|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
30995238|NCT02207244|59179232|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
30995239|NCT02207244|59179233|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
30995240|NCT02207244|59179234|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
30995241|NCT02207244|59179235|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
30995242|NCT02207244|59179236|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
30995243|NCT02207244|59179226|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
30995244|NCT02207244|59179227|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
30995245|NCT02207244|59179228|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
30995246|NCT02207244|59179229|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
30995247|NCT02207244|59179230|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
30995248|NCT02207244|59179231|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
30995249|NCT02207244|59179232|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
30995250|NCT02207244|59179233|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
30995251|NCT02207244|59179234|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
30995252|NCT02207244|59179235|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
30995253|NCT02207244|59179236|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
30995254|NCT02207244|59179226|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
30995255|NCT02207244|59179227|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
30995256|NCT02207244|59179228|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
30995257|NCT02207244|59179229|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
30995258|NCT02207244|59179230|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
30995259|NCT02207244|59179231|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
30995260|NCT02207244|59179232|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
30995261|NCT02207244|59179233|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
30995262|NCT02207244|59179234|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
30995263|NCT02207244|59179235|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
30995264|NCT02207244|59179236|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
30995265|NCT02207244|59179226|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
30995266|NCT02207244|59179227|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
30995267|NCT02207244|59179228|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
30995268|NCT02207244|59179229|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
30995269|NCT02207244|59179230|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
30995270|NCT02207244|59179231|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
30995271|NCT02207244|59179232|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
30995272|NCT02207244|59179233|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
30995273|NCT02207244|59179234|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
30995274|NCT02207244|59179235|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
30995275|NCT02207244|59179236|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
30995276|NCT02207244|59179226|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
30995277|NCT02207244|59179227|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
30995278|NCT02207244|59179228|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
30995279|NCT02207244|59179229|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
30995280|NCT02207244|59179230|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
30995281|NCT02207244|59179231|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
30995282|NCT02207244|59179232|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
30790221|NCT00035555|58803457|FG001|Overall Study|Death|0|||
30790222|NCT00035555|58803458|FG002|Overall Study|Death|2|||
30995283|NCT02207244|59179233|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
30995284|NCT02207244|59179234|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
30995285|NCT02207244|59179235|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
30790223|NCT00035555|58803456|FG000|Overall Study|Lost to Follow-up|0|||
30995286|NCT02207244|59179236|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
30995287|NCT02207088|59179289|FG000|Overall Study|Adverse Event|2|||
30995288|NCT02206620|59179304|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
30995289|NCT02206620|59179305|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
30995290|NCT02206620|59179304|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
30995291|NCT02206620|59179305|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
30995292|NCT02239926|59179319|FG000|Overall Study|Withdrawal by Subject|0|||
30995293|NCT02239926|59179320|FG001|Overall Study|Withdrawal by Subject|1|||
30995294|NCT02239692|59179328|FG000|Overall Study|Incomplete colonoscopy|1|||
30995295|NCT02239692|59179329|FG001|Overall Study|Incomplete colonoscopy|2|||
30995296|NCT02239692|59179328|FG000|Overall Study|Adverse Event|0|||
30995297|NCT02239692|59179329|FG001|Overall Study|Adverse Event|1|||
30995298|NCT02239692|59179328|FG000|Overall Study|Physician Decision|0|||
30995299|NCT02239692|59179329|FG001|Overall Study|Physician Decision|1|||
30995300|NCT02239692|59179328|FG000|Overall Study|Lost to Follow-up|1|||
30995301|NCT02239692|59179329|FG001|Overall Study|Lost to Follow-up|4|||
30790224|NCT00035555|58803457|FG001|Overall Study|Lost to Follow-up|0|||
30995302|NCT02239692|59179328|FG000|Overall Study|Withdrawal by Subject|3|||
30995303|NCT02239692|59179329|FG001|Overall Study|Withdrawal by Subject|5|||
30995304|NCT02239692|59179328|FG000|Overall Study|Other reason|1|||
30995305|NCT02239692|59179329|FG001|Overall Study|Other reason|0|||
30995306|NCT02206152|59179357|FG000|Pre-Randomization|Withdrawal by Subject|2|||
30995307|NCT02204982|59179365|FG000|Overall Study|Patient ineligible-medical monitor|1|||
30995308|NCT02204982|59179366|FG001|Overall Study|Patient ineligible-medical monitor|0|||
30995309|NCT02204982|59179365|FG000|Overall Study|Withdrawal by Subject|1|||
30995310|NCT02204982|59179366|FG001|Overall Study|Withdrawal by Subject|0|||
30995311|NCT02204982|59179365|FG000|Overall Study|Adverse Event|1|||
30995312|NCT02204982|59179366|FG001|Overall Study|Adverse Event|0|||
30995313|NCT02204982|59179365|FG000|Overall Study|Adverse Event and Investigator decision|1|||
30995314|NCT02204982|59179366|FG001|Overall Study|Adverse Event and Investigator decision|0|||
30995315|NCT02204982|59179365|FG000|Overall Study|Physician Decision|0|||
30995316|NCT02204982|59179366|FG001|Overall Study|Physician Decision|2|||
30995317|NCT02204982|59179365|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
30995318|NCT02204982|59179366|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
30995319|NCT02204982|59179365|FG000|Overall Study|Termination of Study bySponsor|0|||
30995320|NCT02204982|59179366|FG001|Overall Study|Termination of Study bySponsor|1|||
30995321|NCT02239536|59179374|FG000|Overall Study|Non-neoplastic polyp|23|||
30995322|NCT02239536|59179375|FG001|Overall Study|Non-neoplastic polyp|17|||
30995323|NCT02239224|59179385|FG000|Overall Study|Administrative|0|||
30995324|NCT02239224|59179386|FG001|Overall Study|Administrative|0|||
30995325|NCT02239224|59179387|FG002|Overall Study|Administrative|3|||
30995326|NCT02239224|59179388|FG003|Overall Study|Administrative|1|||
30995327|NCT01600014|59179398|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
30995328|NCT01600014|59179399|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
30995329|NCT01600014|59179398|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
30995330|NCT01600014|59179399|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
30995331|NCT01600014|59179398|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
30995332|NCT01600014|59179399|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
30995333|NCT01600014|59179398|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
30995334|NCT01600014|59179399|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
30995335|NCT01600014|59179398|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
30995336|NCT01600014|59179399|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
30995337|NCT01600014|59179398|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
30995338|NCT01600014|59179399|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
30995339|NCT01600014|59179398|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
30995340|NCT01600014|59179399|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
30995341|NCT01600014|59179398|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
30995342|NCT01600014|59179399|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
30995343|NCT01600014|59179398|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
30995344|NCT01600014|59179399|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
30995345|NCT01600014|59179398|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
30995346|NCT01600014|59179399|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
30995347|NCT01600014|59179398|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
30995348|NCT01600014|59179399|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
30995349|NCT01600014|59179398|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
30995350|NCT01600014|59179399|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
30995351|NCT01600014|59179398|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
30995352|NCT01600014|59179399|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
30995353|NCT01600014|59179398|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
30995354|NCT01600014|59179399|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
30995355|NCT01600014|59179398|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
30995356|NCT01600014|59179399|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
30995357|NCT01600014|59179398|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
30995358|NCT01600014|59179399|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
30995359|NCT01600014|59179398|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
30995360|NCT01600014|59179399|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
30995361|NCT02237196|59179421|FG000|Overall Study|Adverse Event|0|||
30995362|NCT02237196|59179422|FG001|Overall Study|Adverse Event|1|||
30995363|NCT02237196|59179423|FG002|Overall Study|Adverse Event|1|||
30995364|NCT02237196|59179424|FG003|Overall Study|Adverse Event|0|||
30995365|NCT02237196|59179421|FG000|Overall Study|Lost to Follow-up|4|||
30995366|NCT02237196|59179422|FG001|Overall Study|Lost to Follow-up|2|||
30995367|NCT02237196|59179423|FG002|Overall Study|Lost to Follow-up|4|||
30995368|NCT02237196|59179424|FG003|Overall Study|Lost to Follow-up|6|||
30995369|NCT02237196|59179421|FG000|Overall Study|Physician Decision|2|||
30995370|NCT02237196|59179422|FG001|Overall Study|Physician Decision|0|||
30995371|NCT02237196|59179423|FG002|Overall Study|Physician Decision|0|||
30995372|NCT02237196|59179424|FG003|Overall Study|Physician Decision|1|||
30995373|NCT02237196|59179421|FG000|Overall Study|Pregnancy|0|||
30608995|NCT00963547|58619879|FG002|Overall Study|Adverse Event|0|||
30608996|NCT00963547|58619880|FG003|Overall Study|Adverse Event|1|||
30608997|NCT00963547|58619881|FG004|Overall Study|Adverse Event|0|||
30995374|NCT02237196|59179422|FG001|Overall Study|Pregnancy|0|||
30995375|NCT02237196|59179423|FG002|Overall Study|Pregnancy|1|||
30995376|NCT02237196|59179424|FG003|Overall Study|Pregnancy|1|||
30995377|NCT02237196|59179421|FG000|Overall Study|Withdrawal by Subject|1|||
30995378|NCT02237196|59179422|FG001|Overall Study|Withdrawal by Subject|1|||
30995379|NCT02237196|59179423|FG002|Overall Study|Withdrawal by Subject|4|||
30995380|NCT02237196|59179424|FG003|Overall Study|Withdrawal by Subject|1|||
30995381|NCT02237196|59179421|FG000|Overall Study|Site Error|1|||
30995382|NCT02237196|59179422|FG001|Overall Study|Site Error|2|||
30995383|NCT02237196|59179423|FG002|Overall Study|Site Error|0|||
30995384|NCT02237196|59179424|FG003|Overall Study|Site Error|2|||
30995385|NCT02237118|59179440|FG000|Overall Study|Protocol Violation|0|||
30995386|NCT02237118|59179441|FG001|Overall Study|Protocol Violation|1|||
30995387|NCT02237118|59179440|FG000|Overall Study|consent withdrawn|1|||
30995388|NCT02237118|59179441|FG001|Overall Study|consent withdrawn|0|||
30995389|NCT02234622|59179457|FG000|Overall Study|Withdrawal by Subject|16|||
30995390|NCT02234622|59179458|FG001|Overall Study|Withdrawal by Subject|22|||
30995391|NCT02234622|59179457|FG000|Overall Study|Lost to Follow-up|27|||
30995392|NCT02234622|59179458|FG001|Overall Study|Lost to Follow-up|14|||
30995393|NCT03250273|59179468|FG000|Overall Study|Disease Progression|2|||
30995394|NCT03250273|59179469|FG001|Overall Study|Disease Progression|11|||
30995395|NCT03250273|59179468|FG000|Overall Study|Death|0|||
30995396|NCT03250273|59179469|FG001|Overall Study|Death|1|||
30995397|NCT02203032|59179475|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
30995398|NCT02203032|59179476|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
30995399|NCT02203032|59179477|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
30995400|NCT02203032|59179478|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
30995401|NCT02203032|59179475|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
30995402|NCT02203032|59179476|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
30995403|NCT02203032|59179477|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
30995404|NCT02203032|59179478|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
30995405|NCT02203032|59179475|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
30995406|NCT02203032|59179476|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
30995407|NCT02203032|59179477|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
30995408|NCT02203032|59179478|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
30995409|NCT02203032|59179475|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
30995410|NCT02203032|59179476|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
30995411|NCT02203032|59179477|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
30995412|NCT02203032|59179478|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
30995413|NCT02203032|59179475|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
30995414|NCT02203032|59179476|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
30995415|NCT02203032|59179477|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
30995416|NCT02203032|59179478|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
30995417|NCT02203032|59179475|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
30995418|NCT02203032|59179476|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
30995419|NCT02203032|59179477|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
30995420|NCT02203032|59179478|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
30995421|NCT02203032|59179475|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
30995422|NCT02203032|59179476|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
30995423|NCT02203032|59179477|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
30995424|NCT02203032|59179478|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
30995425|NCT02203032|59179475|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
30995426|NCT02203032|59179476|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
30995427|NCT02203032|59179477|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
30995428|NCT02203032|59179478|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
30995429|NCT02203032|59179475|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
30995430|NCT02203032|59179476|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
30995431|NCT02203032|59179477|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
30995432|NCT02203032|59179478|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
30995433|NCT02203032|59179475|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
30995434|NCT02203032|59179476|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
30995435|NCT02203032|59179477|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
30995436|NCT02203032|59179478|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
30995437|NCT02203032|59179475|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
30995438|NCT02203032|59179476|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
30995439|NCT02203032|59179477|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
30995440|NCT02203032|59179478|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
30995441|NCT02203032|59179475|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
30995442|NCT02203032|59179476|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
30995443|NCT02203032|59179477|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
30995444|NCT02203032|59179478|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
30995445|NCT02169414|59179490|FG000|Overall Study|Withdrawal by Subject|1|||
30995446|NCT02169414|59179491|FG001|Overall Study|Withdrawal by Subject|0|||
30995447|NCT02169414|59179492|FG002|Overall Study|Withdrawal by Subject|0|||
30995448|NCT02169414|59179493|FG003|Overall Study|Withdrawal by Subject|0|||
30995449|NCT02169414|59179490|FG000|Overall Study|Adverse Event|0|||
30995450|NCT02169414|59179491|FG001|Overall Study|Adverse Event|1|||
30995451|NCT02169414|59179492|FG002|Overall Study|Adverse Event|0|||
30995452|NCT02169414|59179493|FG003|Overall Study|Adverse Event|0|||
30995453|NCT03213457|59179510|FG000|Overall Study|Not Treated|1|||
30995454|NCT03213457|59179511|FG001|Overall Study|Not Treated|1|||
30995455|NCT03213457|59179512|FG002|Overall Study|Not Treated|0|||
30995456|NCT03213457|59179510|FG000|Overall Study|Adverse Event|16|||
30995457|NCT03213457|59179511|FG001|Overall Study|Adverse Event|9|||
30995458|NCT03213457|59179512|FG002|Overall Study|Adverse Event|41|||
30995459|NCT03213457|59179510|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30995460|NCT03213457|59179511|FG001|Overall Study|Non-Compliance With Study Drug|2|||
30995461|NCT03213457|59179512|FG002|Overall Study|Non-Compliance With Study Drug|7|||
30995462|NCT03213457|59179510|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
30995463|NCT03213457|59179511|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
30995464|NCT03213457|59179512|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
30995465|NCT03213457|59179510|FG000|Overall Study|Withdrawal by Subject|18|||
30995466|NCT03213457|59179511|FG001|Overall Study|Withdrawal by Subject|7|||
30995467|NCT03213457|59179512|FG002|Overall Study|Withdrawal by Subject|35|||
30995468|NCT03213457|59179510|FG000|Overall Study|Lost to Follow-up|12|||
30995469|NCT03213457|59179511|FG001|Overall Study|Lost to Follow-up|12|||
30995470|NCT03213457|59179512|FG002|Overall Study|Lost to Follow-up|33|||
30995471|NCT03213457|59179510|FG000|Overall Study|Pregnancy|11|||
30995472|NCT03213457|59179511|FG001|Overall Study|Pregnancy|0|||
30995473|NCT03213457|59179512|FG002|Overall Study|Pregnancy|7|||
30995474|NCT03213457|59179510|FG000|Overall Study|Protocol Violation|1|||
30995475|NCT03213457|59179511|FG001|Overall Study|Protocol Violation|1|||
30995476|NCT03213457|59179512|FG002|Overall Study|Protocol Violation|6|||
30995477|NCT03213457|59179510|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
30995478|NCT03213457|59179511|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
30995479|NCT03213457|59179512|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
30995480|NCT03213457|59179510|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
30995481|NCT03213457|59179511|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
30995482|NCT03213457|59179512|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
30995483|NCT03213457|59179510|FG000|Overall Study|Lack of Efficacy|12|||
30995484|NCT03213457|59179511|FG001|Overall Study|Lack of Efficacy|2|||
30995485|NCT03213457|59179512|FG002|Overall Study|Lack of Efficacy|9|||
30995486|NCT03213457|59179510|FG000|Overall Study|Other, Not Specified|11|||
30995487|NCT03213457|59179511|FG001|Overall Study|Other, Not Specified|3|||
30995488|NCT03213457|59179512|FG002|Overall Study|Other, Not Specified|26|||
30995489|NCT02201940|59179522|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
30995490|NCT02201940|59179523|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
30995491|NCT02201940|59179522|FG000|Overall Study|Lack of Efficacy|2|||
30995492|NCT02201940|59179523|FG001|Overall Study|Lack of Efficacy|113|||
30995493|NCT02201940|59179522|FG000|Overall Study|Lost to Follow-up|5|||
30995494|NCT02201940|59179523|FG001|Overall Study|Lost to Follow-up|0|||
30995495|NCT02201940|59179522|FG000|Overall Study|Withdrew Consent|2|||
30995496|NCT02201940|59179523|FG001|Overall Study|Withdrew Consent|1|||
30995497|NCT02201940|59179522|FG000|Overall Study|Investigator's Discretion|1|||
30995498|NCT02201940|59179523|FG001|Overall Study|Investigator's Discretion|1|||
30995499|NCT02201940|59179522|FG000|Overall Study|Death|1|||
30995500|NCT02201940|59179523|FG001|Overall Study|Death|0|||
30995501|NCT02201940|59179522|FG000|Overall Study|Adverse Event|0|||
30995502|NCT02201940|59179523|FG001|Overall Study|Adverse Event|1|||
30995503|NCT02232984|59179529|FG000|Overall Study|Withdrawal by Subject|5|||
30995504|NCT02232984|59179529|FG000|Overall Study|Death|1|||
30995505|NCT02232984|59179529|FG000|Overall Study|Investigator withdrawal|10|||
30995506|NCT02232984|59179529|FG000|Overall Study|Device implant unsuccessful|53|||
30995507|NCT02232984|59179529|FG000|Overall Study|not disclosed by site|7|||
30995508|NCT02232984|59179529|FG000|Overall Study|Protocol Violation|1|||
30995509|NCT02169336|59179539|FG000|Overall Study|Lack of Efficacy|1|||
30995510|NCT02169336|59179540|FG001|Overall Study|Lack of Efficacy|1|||
30995511|NCT02169336|59179541|FG002|Overall Study|Lack of Efficacy|0|||
30995512|NCT02169336|59179539|FG000|Overall Study|Adverse Event|2|||
30995513|NCT02169336|59179540|FG001|Overall Study|Adverse Event|3|||
30995514|NCT02169336|59179541|FG002|Overall Study|Adverse Event|1|||
30995515|NCT02169336|59179539|FG000|Overall Study|Withdrawal by Subject|1|||
30995516|NCT02169336|59179540|FG001|Overall Study|Withdrawal by Subject|0|||
30995517|NCT02169336|59179541|FG002|Overall Study|Withdrawal by Subject|0|||
30995518|NCT02169336|59179539|FG000|Overall Study|Physician Decision|0|||
30995519|NCT02169336|59179540|FG001|Overall Study|Physician Decision|0|||
30995520|NCT02169336|59179541|FG002|Overall Study|Physician Decision|1|||
30995521|NCT02169336|59179539|FG000|Overall Study|Subject declined to continue dosing|0|||
30995522|NCT02169336|59179540|FG001|Overall Study|Subject declined to continue dosing|0|||
30995523|NCT02169336|59179541|FG002|Overall Study|Subject declined to continue dosing|1|||
30995524|NCT02609828|59179557|FG000|Overall Study|Adverse Event|8|||
30995525|NCT02609828|59179558|FG001|Overall Study|Adverse Event|1|||
30995526|NCT02609828|59179559|FG002|Overall Study|Adverse Event|0|||
30995527|NCT02609828|59179560|FG003|Overall Study|Adverse Event|6|||
30995528|NCT02609828|59179557|FG000|Overall Study|Death|15|||
30995529|NCT02609828|59179558|FG001|Overall Study|Death|1|||
30995530|NCT02609828|59179559|FG002|Overall Study|Death|1|||
30995531|NCT02609828|59179560|FG003|Overall Study|Death|19|||
30995532|NCT02609828|59179557|FG000|Overall Study|Insufficient clinical response|2|||
30995533|NCT02609828|59179558|FG001|Overall Study|Insufficient clinical response|1|||
30995534|NCT02609828|59179559|FG002|Overall Study|Insufficient clinical response|0|||
30995535|NCT02609828|59179560|FG003|Overall Study|Insufficient clinical response|0|||
30995536|NCT02609828|59179557|FG000|Overall Study|Lost to Follow-up|0|||
30995537|NCT02609828|59179558|FG001|Overall Study|Lost to Follow-up|0|||
30995538|NCT02609828|59179559|FG002|Overall Study|Lost to Follow-up|0|||
30995539|NCT02609828|59179560|FG003|Overall Study|Lost to Follow-up|1|||
30995540|NCT02609828|59179557|FG000|Overall Study|Protocol Violation|2|||
30995541|NCT02609828|59179558|FG001|Overall Study|Protocol Violation|0|||
30995542|NCT02609828|59179559|FG002|Overall Study|Protocol Violation|0|||
30995543|NCT02609828|59179560|FG003|Overall Study|Protocol Violation|1|||
30995544|NCT02609828|59179557|FG000|Overall Study|Withdrawal by Subject|12|||
30995545|NCT02609828|59179558|FG001|Overall Study|Withdrawal by Subject|1|||
30995546|NCT02609828|59179559|FG002|Overall Study|Withdrawal by Subject|0|||
30995547|NCT02609828|59179560|FG003|Overall Study|Withdrawal by Subject|10|||
30995548|NCT02609828|59179557|FG000|Overall Study|Other|3|||
30995549|NCT02609828|59179558|FG001|Overall Study|Other|0|||
30995550|NCT02609828|59179559|FG002|Overall Study|Other|0|||
30995551|NCT02609828|59179560|FG003|Overall Study|Other|6|||
30995552|NCT02609828|59179557|FG000|Overall Study|Randomized but not treated|1|||
30995553|NCT02609828|59179558|FG001|Overall Study|Randomized but not treated|0|||
30995554|NCT02609828|59179559|FG002|Overall Study|Randomized but not treated|0|||
30995555|NCT02609828|59179560|FG003|Overall Study|Randomized but not treated|0|||
30995556|NCT01632306|59179576|FG000|Overall Study|Protocol Violation|1|||
30995557|NCT01632306|59179577|FG001|Overall Study|Protocol Violation|0|||
30995558|NCT01632306|59179578|FG002|Overall Study|Protocol Violation|0|||
30995559|NCT02201784|59179586|FG000|Overall Study|Failure to achieve adequate block|2|||
30995560|NCT02201784|59179587|FG001|Overall Study|Failure to achieve adequate block|0|||
30995561|NCT02201472|59179593|FG000|Overall Study|Lack of Efficacy|2|||
30995562|NCT02168946|59179638|FG000|Overall Study|Adverse Event|8|||
30995563|NCT02168946|59179639|FG001|Overall Study|Adverse Event|5|||
30995564|NCT02168946|59179638|FG000|Overall Study|Lost to Follow-up|3|||
30995565|NCT02168946|59179639|FG001|Overall Study|Lost to Follow-up|0|||
30995566|NCT02168946|59179638|FG000|Overall Study|Subject unable to come back for visits|1|||
30995567|NCT02168946|59179639|FG001|Overall Study|Subject unable to come back for visits|0|||
30995568|NCT02168478|59179660|FG000|Overall Study|Withdrawal by Subject|1|||
30995569|NCT02168478|59179660|FG000|Overall Study|Did Not Consent to Participation|2|||
30995570|NCT02168478|59179660|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
30995571|NCT02200614|59180837|FG000|Double Blind Treatment|Adverse Event|86|||
30995572|NCT02200614|59180838|FG001|Double Blind Treatment|Adverse Event|48|||
30995573|NCT02200614|59180837|FG000|Double Blind Treatment|Confirmed metastasis|120|||
30995574|NCT02200614|59180838|FG001|Double Blind Treatment|Confirmed metastasis|140|||
30995575|NCT02200614|59180837|FG000|Double Blind Treatment|Judgment of the investigator|59|||
30995576|NCT02200614|59180838|FG001|Double Blind Treatment|Judgment of the investigator|99|||
30995577|NCT02200614|59180837|FG000|Double Blind Treatment|Metastasis by local reading|1|||
30995578|NCT02200614|59180838|FG001|Double Blind Treatment|Metastasis by local reading|3|||
30995579|NCT02200614|59180837|FG000|Double Blind Treatment|Other reason|6|||
30995580|NCT02200614|59180838|FG001|Double Blind Treatment|Other reason|2|||
30995581|NCT02200614|59180837|FG000|Double Blind Treatment|Personal reason|77|||
30995582|NCT02200614|59180838|FG001|Double Blind Treatment|Personal reason|85|||
30995583|NCT02200614|59180837|FG000|Double Blind Treatment|Protocol deviation|14|||
30995584|NCT02200614|59180838|FG001|Double Blind Treatment|Protocol deviation|7|||
30995585|NCT02200614|59180837|FG000|Double Blind Treatment|Not treated|1|||
30995586|NCT02200614|59180838|FG001|Double Blind Treatment|Not treated|0|||
30995587|NCT02200614|59180837|FG000|Open Label|Adverse Event|41|||
30995588|NCT02200614|59180838|FG001|Open Label|Adverse Event|11|||
30995589|NCT02200614|59180837|FG000|Open Label|Confirmed metastasis|1|||
30995590|NCT02200614|59180838|FG001|Open Label|Confirmed metastasis|0|||
30995591|NCT02200614|59180837|FG000|Open Label|Judgment of the investigator|29|||
30995592|NCT02200614|59180838|FG001|Open Label|Judgment of the investigator|2|||
30995593|NCT02200614|59180837|FG000|Open Label|Metastasis by local reading|138|||
30995594|NCT02200614|59180838|FG001|Open Label|Metastasis by local reading|27|||
30995595|NCT02200614|59180837|FG000|Open Label|Other reason|22|||
30995596|NCT02200614|59180838|FG001|Open Label|Other reason|4|||
30995597|NCT02200614|59180837|FG000|Open Label|Personal reason|60|||
30995598|NCT02200614|59180838|FG001|Open Label|Personal reason|8|||
30995599|NCT02200614|59180837|FG000|Open Label|Protocol deviation|3|||
30995600|NCT02200614|59180838|FG001|Open Label|Protocol deviation|2|||
30995601|NCT02200614|59180837|FG000|Open Label|Missing|2|||
30995602|NCT02200614|59180838|FG001|Open Label|Missing|2|||
30995603|NCT02231892|59180849|FG000|Overall Study|Lost to Follow-up|1|||
30995604|NCT02231892|59180850|FG001|Overall Study|Lost to Follow-up|0|||
30995605|NCT02231892|59180851|FG002|Overall Study|Lost to Follow-up|3|||
30995606|NCT02231892|59180849|FG000|Overall Study|Withdrawal by Subject|4|||
30995607|NCT02231892|59180850|FG001|Overall Study|Withdrawal by Subject|3|||
30995608|NCT02231892|59180851|FG002|Overall Study|Withdrawal by Subject|15|||
30995609|NCT02231892|59180849|FG000|Overall Study|Physician Decision|0|||
30995610|NCT02231892|59180850|FG001|Overall Study|Physician Decision|2|||
30995611|NCT02231892|59180851|FG002|Overall Study|Physician Decision|4|||
30995612|NCT02231892|59180849|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
30995613|NCT02231892|59180850|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
30995614|NCT02231892|59180851|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
30995615|NCT02231892|59180849|FG000|Overall Study|Participant motor threshold was >83%|0|||
30995616|NCT02231892|59180850|FG001|Overall Study|Participant motor threshold was >83%|0|||
30995617|NCT02231892|59180851|FG002|Overall Study|Participant motor threshold was >83%|9|||
30995618|NCT02231892|59180849|FG000|Overall Study|Could not find motor threshold|2|||
30995619|NCT02231892|59180850|FG001|Overall Study|Could not find motor threshold|0|||
30995620|NCT02231892|59180851|FG002|Overall Study|Could not find motor threshold|1|||
30995621|NCT02231892|59180849|FG000|Overall Study|Could not find reliable motor hotspot|0|||
30995622|NCT02231892|59180850|FG001|Overall Study|Could not find reliable motor hotspot|0|||
30995623|NCT02231892|59180851|FG002|Overall Study|Could not find reliable motor hotspot|1|||
30995624|NCT02231580|59180867|FG000|Overall Study|Adverse Event|5|||
30995625|NCT02231580|59180868|FG001|Overall Study|Adverse Event|0|||
30995626|NCT02166606|59180876|FG000|Overall Study|Adverse Event|3|||
30995627|NCT02166606|59180876|FG000|Overall Study|Death|31|||
30995628|NCT02166606|59180876|FG000|Overall Study|Protocol Violation|7|||
30995629|NCT02166606|59180876|FG000|Overall Study|Lost to Follow-up|30|||
30995630|NCT02166606|59180876|FG000|Overall Study|Withdrawal by Subject|1|||
30995631|NCT02166606|59180876|FG000|Overall Study|Physician Decision|1|||
30995632|NCT02166606|59180876|FG000|Overall Study|Device upgrade|1|||
30995633|NCT02166606|59180876|FG000|Overall Study|Enrolled after End of Enrollment|4|||
30995634|NCT02230956|59180883|FG000|Overall Study|Adverse Event|1|||
30995635|NCT02230956|59180884|FG001|Overall Study|Adverse Event|1|||
30995636|NCT02230956|59180885|FG002|Overall Study|Adverse Event|0|||
30995637|NCT02230956|59180883|FG000|Overall Study|Lack of Efficacy|1|||
30995638|NCT02230956|59180884|FG001|Overall Study|Lack of Efficacy|1|||
30995639|NCT02230956|59180885|FG002|Overall Study|Lack of Efficacy|1|||
30995640|NCT02230956|59180883|FG000|Overall Study|Lost to Follow-up|1|||
30995641|NCT02230956|59180884|FG001|Overall Study|Lost to Follow-up|1|||
30995642|NCT02230956|59180885|FG002|Overall Study|Lost to Follow-up|2|||
30995643|NCT02230956|59180883|FG000|Overall Study|Personal Reasons|2|||
30995644|NCT02230956|59180884|FG001|Overall Study|Personal Reasons|1|||
30995645|NCT02230956|59180885|FG002|Overall Study|Personal Reasons|1|||
30995646|NCT02230956|59180883|FG000|Overall Study|Protocol Violation|0|||
30995647|NCT02230956|59180884|FG001|Overall Study|Protocol Violation|1|||
30995648|NCT02230956|59180885|FG002|Overall Study|Protocol Violation|1|||
30995649|NCT02230956|59180883|FG000|Overall Study|Other Miscellaneous Reason|0|||
30995650|NCT02230956|59180884|FG001|Overall Study|Other Miscellaneous Reason|1|||
30995651|NCT02230956|59180885|FG002|Overall Study|Other Miscellaneous Reason|2|||
30995652|NCT02230410|59180893|FG000|Overall Study|Screen Failure|3|||
30995653|NCT02230332|59180899|FG000|Overall Study|Adverse Event|2|||
30995654|NCT02230332|59180900|FG001|Overall Study|Adverse Event|1|||
30995655|NCT02230332|59180899|FG000|Overall Study|Lost to Follow-up|1|||
30995656|NCT02230332|59180900|FG001|Overall Study|Lost to Follow-up|0|||
30995657|NCT02230332|59180899|FG000|Overall Study|Protocol Violation|1|||
30995658|NCT02230332|59180900|FG001|Overall Study|Protocol Violation|0|||
30995659|NCT02230254|59180906|FG000|Overall Study|Lost to Follow-up|3|||
30995660|NCT02198664|59180912|FG000|Overall Study|Adverse Event|2|||
30995661|NCT02198664|59180913|FG001|Overall Study|Adverse Event|0|||
30995662|NCT02198664|59180912|FG000|Overall Study|Withdrawal by Subject|11|||
30995663|NCT02198664|59180913|FG001|Overall Study|Withdrawal by Subject|8|||
30995664|NCT02198664|59180912|FG000|Overall Study|Failure to tolerate|2|||
30995665|NCT02198664|59180913|FG001|Overall Study|Failure to tolerate|0|||
30995666|NCT02198664|59180912|FG000|Overall Study|Not stated|1|||
30995667|NCT02198664|59180913|FG001|Overall Study|Not stated|0|||
30995668|NCT02165826|59180924|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
30995669|NCT02165826|59180925|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
30995670|NCT02165826|59180926|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
30995671|NCT02165826|59180924|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
30995672|NCT02165826|59180925|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
30995673|NCT02165826|59180926|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
30995674|NCT02165826|59180924|FG000|Main Treatment Period|Lost to Follow-up|4|||
30995675|NCT02165826|59180925|FG001|Main Treatment Period|Lost to Follow-up|2|||
30995676|NCT02165826|59180926|FG002|Main Treatment Period|Lost to Follow-up|1|||
30995677|NCT02165826|59180924|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
30995678|NCT02165826|59180925|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
30995679|NCT02165826|59180926|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
30995680|NCT02165826|59180924|FG000|Main Treatment Period|Lack of Efficacy|2|||
30995681|NCT02165826|59180925|FG001|Main Treatment Period|Lack of Efficacy|0|||
30995682|NCT02165826|59180926|FG002|Main Treatment Period|Lack of Efficacy|0|||
30995683|NCT02165826|59180924|FG000|Main Treatment Period|Reason Not Specified|8|||
30995684|NCT02165826|59180925|FG001|Main Treatment Period|Reason Not Specified|5|||
30995685|NCT02165826|59180926|FG002|Main Treatment Period|Reason Not Specified|16|||
30995686|NCT02165826|59180924|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
30995687|NCT02165826|59180925|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
30995688|NCT02165826|59180926|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
30995689|NCT02165826|59180924|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
30995690|NCT02165826|59180925|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
30995691|NCT02165826|59180926|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
30995692|NCT02165826|59180924|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
30995693|NCT02165826|59180925|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
30995694|NCT02165826|59180926|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
30995695|NCT02165826|59180924|FG000|Down-Titration Period|Reason Not Specified|1|||
30995696|NCT02165826|59180925|FG001|Down-Titration Period|Reason Not Specified|0|||
30995697|NCT02165826|59180926|FG002|Down-Titration Period|Reason Not Specified|2|||
30995698|NCT02198040|59180963|FG000|Overall Study|Work reasons|0|||
30995699|NCT02198040|59180964|FG001|Overall Study|Work reasons|1|||
30995700|NCT02198040|59180965|FG002|Overall Study|Work reasons|0|||
30995701|NCT02198040|59180963|FG000|Overall Study|Withdrawal by Subject|0|||
30995702|NCT02198040|59180964|FG001|Overall Study|Withdrawal by Subject|0|||
30995703|NCT02198040|59180965|FG002|Overall Study|Withdrawal by Subject|1|||
30995704|NCT02197806|59180979|FG000|Overall Study|Adverse Event|0|||
30995705|NCT02197806|59180980|FG001|Overall Study|Adverse Event|1|||
30995706|NCT02197806|59180981|FG002|Overall Study|Adverse Event|0|||
30995707|NCT02197806|59180982|FG003|Overall Study|Adverse Event|1|||
30995708|NCT02229864|59181029|FG000|Overall Study|Death|2|||
30995709|NCT02229864|59181029|FG000|Overall Study|Lost to Follow-up|1|||
30995710|NCT02229552|59181033|FG000|Baseline|Withdrawal by Subject|6|||
30995711|NCT02229552|59181033|FG000|1-year Follow up|Withdrawal by Subject|7|||
30995712|NCT02229552|59181033|FG000|1-year Follow up|Lost to Follow-up|18|||
30995713|NCT02229552|59181033|FG000|2-Year Follow up|Withdrawal by Subject|9|||
30995714|NCT02229552|59181033|FG000|2-Year Follow up|Lost to Follow-up|17|||
30995715|NCT02229396|59181040|FG000|Overall Study|Adverse Event|6|||
30995716|NCT02229396|59181041|FG001|Overall Study|Adverse Event|12|||
30995717|NCT02229396|59181042|FG002|Overall Study|Adverse Event|12|||
30995718|NCT02229396|59181040|FG000|Overall Study|Death|2|||
30995719|NCT02229396|59181041|FG001|Overall Study|Death|3|||
30995720|NCT02229396|59181042|FG002|Overall Study|Death|1|||
30995721|NCT02229396|59181040|FG000|Overall Study|Lost to Follow-up|14|||
30995722|NCT02229396|59181041|FG001|Overall Study|Lost to Follow-up|14|||
30995723|NCT02229396|59181042|FG002|Overall Study|Lost to Follow-up|21|||
30995724|NCT02229396|59181040|FG000|Overall Study|Protocol Violation|2|||
30995725|NCT02229396|59181041|FG001|Overall Study|Protocol Violation|1|||
30995726|NCT02229396|59181042|FG002|Overall Study|Protocol Violation|0|||
30995727|NCT02229396|59181040|FG000|Overall Study|Patient Incorrectly Randomized|0|||
30995728|NCT02229396|59181041|FG001|Overall Study|Patient Incorrectly Randomized|0|||
30995729|NCT02229396|59181042|FG002|Overall Study|Patient Incorrectly Randomized|1|||
30995730|NCT02229396|59181040|FG000|Overall Study|Other|10|||
30995731|NCT02229396|59181041|FG001|Overall Study|Other|18|||
30995732|NCT02229396|59181042|FG002|Overall Study|Other|15|||
30995733|NCT02229396|59181040|FG000|Overall Study|Withdrawal by Subject|42|||
30995734|NCT02229396|59181041|FG001|Overall Study|Withdrawal by Subject|28|||
30995735|NCT02229396|59181042|FG002|Overall Study|Withdrawal by Subject|41|||
30995736|NCT02229396|59181040|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
30995737|NCT02229396|59181041|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
30995738|NCT02229396|59181042|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
30995739|NCT02229396|59181040|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
30995740|NCT02229396|59181041|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
30995741|NCT02229396|59181042|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
30995742|NCT02197416|59181057|FG000|Overall Study|Other reasons|0|||
30995743|NCT02197416|59181058|FG001|Overall Study|Other reasons|2|||
30995744|NCT02197416|59181059|FG002|Overall Study|Other reasons|5|||
30995745|NCT02197416|59181057|FG000|Overall Study|Withdrawal by Subject|0|||
30995746|NCT02197416|59181058|FG001|Overall Study|Withdrawal by Subject|2|||
30995747|NCT02197416|59181059|FG002|Overall Study|Withdrawal by Subject|1|||
30995748|NCT02197416|59181057|FG000|Overall Study|Protocol Violation|1|||
30995749|NCT02197416|59181058|FG001|Overall Study|Protocol Violation|0|||
30995750|NCT02197416|59181059|FG002|Overall Study|Protocol Violation|1|||
30995751|NCT02197416|59181057|FG000|Overall Study|Adverse Event|0|||
30995752|NCT02197416|59181058|FG001|Overall Study|Adverse Event|0|||
30995753|NCT02197416|59181059|FG002|Overall Study|Adverse Event|1|||
30995754|NCT02165202|59181067|FG000|Oral Phase|Refused further participation|5|||
30995755|NCT02165202|59181068|FG001|Oral Phase|Refused further participation|1|||
30995756|NCT02165202|59181067|FG000|Oral Phase|Study product Related Toxicity|1|||
30995757|NCT02165202|59181068|FG001|Oral Phase|Study product Related Toxicity|0|||
30995758|NCT02165202|59181067|FG000|Oral Phase|Unable to contact Participant|1|||
30995759|NCT02165202|59181068|FG001|Oral Phase|Unable to contact Participant|1|||
30995760|NCT02165202|59181067|FG000|Oral Phase|Clinical reasons|1|||
30995761|NCT02165202|59181068|FG001|Oral Phase|Clinical reasons|0|||
30995762|NCT02165202|59181067|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
30995763|NCT02165202|59181068|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
30995764|NCT02165202|59181067|FG000|Oral Phase|CMC advised termination|1|||
30995765|NCT02165202|59181068|FG001|Oral Phase|CMC advised termination|0|||
30995766|NCT02165202|59181067|FG000|Oral Phase|Relocated, no follow-up planned|1|||
30995767|NCT02165202|59181068|FG001|Oral Phase|Relocated, no follow-up planned|0|||
30995768|NCT02165202|59181067|FG000|Oral Phase|Abnormal EKG|0|||
30995769|NCT02165202|59181068|FG001|Oral Phase|Abnormal EKG|1|||
30995770|NCT02165202|59181067|FG000|Injection Phase|Abnormal Lab Value|5|||
30995771|NCT02165202|59181068|FG001|Injection Phase|Abnormal Lab Value|1|||
30995772|NCT02165202|59181067|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
30995773|NCT02165202|59181068|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
30995774|NCT02165202|59181067|FG000|Injection Phase|Unable to attend within Visit Window|1|||
30995775|NCT02165202|59181068|FG001|Injection Phase|Unable to attend within Visit Window|0|||
30995776|NCT02165202|59181067|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
30995777|NCT02165202|59181068|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
30995778|NCT02165202|59181067|FG000|Injection Phase|End of Study|2|||
30995779|NCT02165202|59181068|FG001|Injection Phase|End of Study|1|||
30790225|NCT00035555|58803458|FG002|Overall Study|Lost to Follow-up|1|||
30995780|NCT02165202|59181067|FG000|Injection Phase|Study Product related Toxicity|1|||
30995781|NCT02165202|59181068|FG001|Injection Phase|Study Product related Toxicity|0|||
30995782|NCT02165202|59181067|FG000|Injection Phase|No longer interested|0|||
30995783|NCT02165202|59181068|FG001|Injection Phase|No longer interested|1|||
30995784|NCT02165202|59181067|FG000|Injection Phase|Participant unwilling to comply|1|||
30995785|NCT02165202|59181068|FG001|Injection Phase|Participant unwilling to comply|0|||
30995786|NCT01628874|59181076|FG000|Overall Study|Physician Decision|1|||
30995787|NCT01628874|59181077|FG001|Overall Study|Physician Decision|1|||
30995788|NCT01628874|59181076|FG000|Overall Study|Age >4 months|4|||
30995789|NCT01628874|59181077|FG001|Overall Study|Age >4 months|2|||
30995790|NCT02196714|59181102|FG000|Overall Study|Protocol Violation|0|||
30995791|NCT02196714|59181103|FG001|Overall Study|Protocol Violation|0|||
30995792|NCT02196714|59181104|FG002|Overall Study|Protocol Violation|1|||
30995793|NCT02196714|59181105|FG003|Overall Study|Protocol Violation|0|||
30995794|NCT02196558|59181129|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
30995795|NCT02196558|59181130|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
30995796|NCT02196558|59181131|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
30995797|NCT02196558|59181129|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
30995798|NCT02196558|59181130|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
30995799|NCT02196558|59181131|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
30995800|NCT02196558|59181129|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
30995801|NCT02196558|59181130|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
30995802|NCT02196558|59181131|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
30995803|NCT02196558|59181129|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
30995804|NCT02196558|59181130|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
30995805|NCT02196558|59181131|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
30995806|NCT02196558|59181129|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
30995807|NCT02196558|59181130|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
30995808|NCT02196558|59181131|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
30995809|NCT02196324|59181152|FG000|Overall Study|Withdrawal by Subject|8|||
30995810|NCT02196324|59181153|FG001|Overall Study|Withdrawal by Subject|4|||
30995811|NCT02196324|59181152|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
30995812|NCT02196324|59181153|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
30995813|NCT02196324|59181152|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
30995814|NCT02196324|59181153|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
30995815|NCT02196324|59181152|FG000|Overall Study|Other|1|||
30995816|NCT02196324|59181153|FG001|Overall Study|Other|0|||
30995817|NCT02195700|59181161|FG000|Overall Study|Protocol Violation|0|||
30995818|NCT02195700|59181162|FG001|Overall Study|Protocol Violation|2|||
30995819|NCT02195700|59181161|FG000|Overall Study|Noncompliance|1|||
30995820|NCT02195700|59181162|FG001|Overall Study|Noncompliance|0|||
30995821|NCT02195700|59181161|FG000|Overall Study|Adverse Event|1|||
30995822|NCT02195700|59181162|FG001|Overall Study|Adverse Event|2|||
30995823|NCT02195700|59181161|FG000|Overall Study|Withdrawal by Subject|3|||
30995824|NCT02195700|59181162|FG001|Overall Study|Withdrawal by Subject|2|||
30995825|NCT02195700|59181161|FG000|Overall Study|Lost to Follow-up|1|||
30995826|NCT02195700|59181162|FG001|Overall Study|Lost to Follow-up|1|||
30995827|NCT02228460|59181177|FG000|Overall Study|Adverse Event|1|||
30995828|NCT02228460|59181177|FG000|Overall Study|Lost to Follow-up|1|||
30995829|NCT02227446|59181193|FG000|Overall Study|not eligible post randomization|18|||
30995830|NCT02227446|59181194|FG001|Overall Study|not eligible post randomization|29|||
30995831|NCT02227446|59181193|FG000|Overall Study|Withdrawal by Subject|4|||
30995832|NCT02227446|59181194|FG001|Overall Study|Withdrawal by Subject|5|||
30995833|NCT02227368|59181202|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
30995834|NCT02227368|59181203|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
30995835|NCT02227368|59181202|FG000|Overall Study|Lost to Follow-up|1|||
30995836|NCT02227368|59181203|FG001|Overall Study|Lost to Follow-up|0|||
30995837|NCT02227368|59181202|FG000|Overall Study|Adverse Event|1|||
30995838|NCT02227368|59181203|FG001|Overall Study|Adverse Event|0|||
30995839|NCT02162862|59181212|FG000|Overall Study|Lost to Follow-up|0|||
30995840|NCT02162862|59181213|FG001|Overall Study|Lost to Follow-up|11|||
30995841|NCT02162862|59181214|FG002|Overall Study|Lost to Follow-up|0|||
30995842|NCT02162862|59181212|FG000|Overall Study|Subject did not feel the med was needed|0|||
30995843|NCT02162862|59181213|FG001|Overall Study|Subject did not feel the med was needed|0|||
30995844|NCT02162862|59181214|FG002|Overall Study|Subject did not feel the med was needed|4|||
30995845|NCT02226198|59181252|FG000|Lead-in Phase|Protocol Violation|1|||
30995846|NCT02226198|59181253|FG001|Lead-in Phase|Protocol Violation|0|||
30995847|NCT02226198|59181254|FG002|Lead-in Phase|Protocol Violation|0|||
30995848|NCT02226198|59181252|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
30995849|NCT02226198|59181253|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
30995850|NCT02226198|59181254|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
30995851|NCT02226120|59181425|FG000|Overall Study|Adverse Event|60|||
30995852|NCT02226120|59181425|FG000|Overall Study|Death|172|||
30995853|NCT02226120|59181425|FG000|Overall Study|Study terminated by sponsor|1|||
30995854|NCT02226120|59181425|FG000|Overall Study|Technical problems|4|||
30995855|NCT02226120|59181425|FG000|Overall Study|Lost to Follow-up|13|||
30995856|NCT02226120|59181425|FG000|Overall Study|Physician Decision|21|||
30995857|NCT02226120|59181425|FG000|Overall Study|Withdrawal by parent/guardian|36|||
30995858|NCT02226120|59181425|FG000|Overall Study|Non-compliance with study drug|10|||
30995859|NCT02226120|59181425|FG000|Overall Study|Protocol deviation|1|||
30995860|NCT02226120|59181425|FG000|Overall Study|missing treatment disposition pages|2|||
30995861|NCT02194998|59181603|FG000|On-HCV Treatment|Did not pick up study medication|0|||
30995862|NCT02194998|59181604|FG001|On-HCV Treatment|Did not pick up study medication|1|||
30995863|NCT02194998|59181605|FG002|On-HCV Treatment|Did not pick up study medication|0|||
30995864|NCT02194998|59181606|FG003|On-HCV Treatment|Did not pick up study medication|0|||
30995865|NCT02194998|59181603|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
30995866|NCT02194998|59181604|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
30995867|NCT02194998|59181605|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
30995868|NCT02194998|59181606|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
30995869|NCT02194062|59181619|FG000|Overall Study|Lost to Follow-up|2|||
30995870|NCT02194062|59181620|FG001|Overall Study|Lost to Follow-up|2|||
30995871|NCT02194062|59181621|FG002|Overall Study|Lost to Follow-up|5|||
30995872|NCT02193828|59181642|FG000|Overall Study|Withdrawal by Subject|0|||
30995873|NCT02193828|59181643|FG001|Overall Study|Withdrawal by Subject|0|||
30995874|NCT02193828|59181644|FG002|Overall Study|Withdrawal by Subject|1|||
30995875|NCT02193828|59181645|FG003|Overall Study|Withdrawal by Subject|1|||
30995876|NCT02192970|59181666|FG000|Overall Study|Lost to Follow-up|6|||
30995877|NCT02192970|59181667|FG001|Overall Study|Lost to Follow-up|0|||
30995878|NCT02192190|59181851|FG000|Overall Study|Adverse Event|1|||
30995879|NCT02192190|59181852|FG001|Overall Study|Adverse Event|1|||
30995880|NCT02192190|59181853|FG002|Overall Study|Adverse Event|0|||
30995881|NCT02192190|59181854|FG003|Overall Study|Adverse Event|0|||
30995882|NCT02192190|59181855|FG004|Overall Study|Adverse Event|0|||
30995883|NCT02192190|59181856|FG005|Overall Study|Adverse Event|0|||
30995884|NCT02192190|59181851|FG000|Overall Study|Lost to Follow-up|3|||
30995885|NCT02192190|59181852|FG001|Overall Study|Lost to Follow-up|3|||
30995886|NCT02192190|59181853|FG002|Overall Study|Lost to Follow-up|2|||
30995887|NCT02192190|59181854|FG003|Overall Study|Lost to Follow-up|1|||
30995888|NCT02192190|59181855|FG004|Overall Study|Lost to Follow-up|4|||
30995889|NCT02192190|59181856|FG005|Overall Study|Lost to Follow-up|3|||
30995890|NCT02192190|59181851|FG000|Overall Study|Physician Decision|2|||
30995891|NCT02192190|59181852|FG001|Overall Study|Physician Decision|0|||
30995892|NCT02192190|59181853|FG002|Overall Study|Physician Decision|0|||
30995893|NCT02192190|59181854|FG003|Overall Study|Physician Decision|0|||
30995894|NCT02192190|59181855|FG004|Overall Study|Physician Decision|0|||
30995895|NCT02192190|59181856|FG005|Overall Study|Physician Decision|0|||
30995896|NCT02192190|59181851|FG000|Overall Study|Terminated by Sponsor|43|||
30995897|NCT02192190|59181852|FG001|Overall Study|Terminated by Sponsor|23|||
30995898|NCT02192190|59181853|FG002|Overall Study|Terminated by Sponsor|20|||
30995899|NCT02192190|59181854|FG003|Overall Study|Terminated by Sponsor|23|||
30995900|NCT02192190|59181855|FG004|Overall Study|Terminated by Sponsor|21|||
30995901|NCT02192190|59181856|FG005|Overall Study|Terminated by Sponsor|23|||
30995902|NCT02192190|59181851|FG000|Overall Study|Withdrawal by Subject|4|||
30995903|NCT02192190|59181852|FG001|Overall Study|Withdrawal by Subject|1|||
30995904|NCT02192190|59181853|FG002|Overall Study|Withdrawal by Subject|2|||
30995905|NCT02192190|59181854|FG003|Overall Study|Withdrawal by Subject|1|||
30995906|NCT02192190|59181855|FG004|Overall Study|Withdrawal by Subject|5|||
30995907|NCT02192190|59181856|FG005|Overall Study|Withdrawal by Subject|3|||
30995908|NCT02192190|59181851|FG000|Overall Study|Could not Keep Visit Schedule|1|||
30995909|NCT02192190|59181852|FG001|Overall Study|Could not Keep Visit Schedule|0|||
30995910|NCT02192190|59181853|FG002|Overall Study|Could not Keep Visit Schedule|0|||
30995911|NCT02192190|59181854|FG003|Overall Study|Could not Keep Visit Schedule|0|||
30995912|NCT02192190|59181855|FG004|Overall Study|Could not Keep Visit Schedule|0|||
30995913|NCT02192190|59181856|FG005|Overall Study|Could not Keep Visit Schedule|0|||
30995914|NCT02192190|59181851|FG000|Overall Study|Positive Drug Screen|0|||
30995915|NCT02192190|59181852|FG001|Overall Study|Positive Drug Screen|0|||
30995916|NCT02192190|59181853|FG002|Overall Study|Positive Drug Screen|0|||
30995917|NCT02192190|59181854|FG003|Overall Study|Positive Drug Screen|1|||
30995918|NCT02192190|59181855|FG004|Overall Study|Positive Drug Screen|0|||
30995919|NCT02192190|59181856|FG005|Overall Study|Positive Drug Screen|0|||
30995920|NCT02192190|59181851|FG000|Overall Study|Inadequate Pain Relief|0|||
30995921|NCT02192190|59181852|FG001|Overall Study|Inadequate Pain Relief|1|||
30995922|NCT02192190|59181853|FG002|Overall Study|Inadequate Pain Relief|1|||
30995923|NCT02192190|59181854|FG003|Overall Study|Inadequate Pain Relief|0|||
30995924|NCT02192190|59181855|FG004|Overall Study|Inadequate Pain Relief|0|||
30995925|NCT02192190|59181856|FG005|Overall Study|Inadequate Pain Relief|0|||
30995926|NCT02224638|59181884|FG000|Overall Study|Adverse Event|1|||
30995927|NCT02224638|59181885|FG001|Overall Study|Adverse Event|1|||
30995928|NCT02224560|59181900|FG000|Overall Study|Protocol Deviation|1|||
30995929|NCT02224560|59181901|FG001|Overall Study|Protocol Deviation|0|||
30995930|NCT02224560|59181902|FG002|Overall Study|Protocol Deviation|0|||
30995931|NCT02224560|59181900|FG000|Overall Study|Withdrawal by Subject|2|||
30995932|NCT02224560|59181901|FG001|Overall Study|Withdrawal by Subject|0|||
30995933|NCT02224560|59181902|FG002|Overall Study|Withdrawal by Subject|1|||
30995934|NCT02224560|59181900|FG000|Overall Study|Met Withdrawal Criteria|1|||
30995935|NCT02224560|59181901|FG001|Overall Study|Met Withdrawal Criteria|0|||
30995936|NCT02224560|59181902|FG002|Overall Study|Met Withdrawal Criteria|0|||
30995937|NCT02224560|59181900|FG000|Overall Study|Adverse Event|4|||
30995938|NCT02224560|59181901|FG001|Overall Study|Adverse Event|1|||
30995939|NCT02224560|59181902|FG002|Overall Study|Adverse Event|1|||
30995940|NCT02224560|59181900|FG000|Overall Study|Withdrawn by Investigator|1|||
30995941|NCT02224560|59181901|FG001|Overall Study|Withdrawn by Investigator|1|||
30995942|NCT02224560|59181902|FG002|Overall Study|Withdrawn by Investigator|0|||
30995943|NCT02161458|59181914|FG000|Overall Study|Withdrawal by Subject|0|||
30995944|NCT02161458|59181915|FG001|Overall Study|Withdrawal by Subject|4|||
30995945|NCT02161458|59181916|FG002|Overall Study|Withdrawal by Subject|4|||
30995946|NCT02161458|59181917|FG003|Overall Study|Withdrawal by Subject|0|||
30995947|NCT02161458|59181914|FG000|Overall Study|Lost to Follow-up|0|||
30995948|NCT02161458|59181915|FG001|Overall Study|Lost to Follow-up|2|||
30995949|NCT02161458|59181916|FG002|Overall Study|Lost to Follow-up|1|||
30995950|NCT02161458|59181917|FG003|Overall Study|Lost to Follow-up|0|||
30995951|NCT02223858|59181929|FG000|Overall Study|Death|1|||
30995952|NCT02223858|59181930|FG001|Overall Study|Death|1|||
30995953|NCT02223858|59181929|FG000|Overall Study|Lost to Follow-up|6|||
30995954|NCT02223858|59181930|FG001|Overall Study|Lost to Follow-up|11|||
30995955|NCT02223858|59181929|FG000|Overall Study|Withdrawal by Subject|8|||
30995956|NCT02223858|59181930|FG001|Overall Study|Withdrawal by Subject|5|||
30995957|NCT02223858|59181929|FG000|Overall Study|Refused|9|||
30995958|NCT02223858|59181930|FG001|Overall Study|Refused|9|||
30995959|NCT02223390|59181938|FG000|Overall Study|Lost to Follow-up|9|||
30995960|NCT02223390|59181939|FG001|Overall Study|Lost to Follow-up|4|||
30995961|NCT04914000|59183842|FG000|Overall Study|Lost to Follow-up|8|||
30995962|NCT04914000|59183842|FG000|Overall Study|Withdrawal by Subject|1|||
30995963|NCT04530825|59183859|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
30995964|NCT04530825|59183860|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
30995965|NCT04530825|59183861|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
30995966|NCT04530825|59183862|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
30995967|NCT04530825|59183859|FG000|Overall Study|Did not complete follow-up|3|||
30995968|NCT04530825|59183860|FG001|Overall Study|Did not complete follow-up|0|||
30995969|NCT04530825|59183861|FG002|Overall Study|Did not complete follow-up|0|||
30995970|NCT04530825|59183862|FG003|Overall Study|Did not complete follow-up|0|||
30995971|NCT04169373|59183876|FG000|Week 1 to Week 14|Adverse Event|1|||
30995972|NCT04169373|59183877|FG001|Week 1 to Week 14|Adverse Event|0|||
30995973|NCT04169373|59183878|FG002|Week 1 to Week 14|Adverse Event|1|||
30995974|NCT04169373|59183879|FG003|Week 1 to Week 14|Adverse Event|2|||
30995975|NCT04169373|59183876|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
30995976|NCT04169373|59183877|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
30995977|NCT04169373|59183878|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
30995978|NCT04169373|59183879|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
30995979|NCT04169373|59183876|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
30995980|NCT04169373|59183877|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
30995981|NCT04169373|59183878|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
30995982|NCT04169373|59183879|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
30995983|NCT04169373|59183876|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
30995984|NCT04169373|59183877|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
30995985|NCT04169373|59183878|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
30995986|NCT04169373|59183879|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
30995987|NCT04169373|59183876|FG000|Week 1 to Week 14|Other|1|||
30995988|NCT04169373|59183877|FG001|Week 1 to Week 14|Other|3|||
30995989|NCT04169373|59183878|FG002|Week 1 to Week 14|Other|3|||
30995990|NCT04169373|59183879|FG003|Week 1 to Week 14|Other|5|||
30995991|NCT04169373|59183876|FG000|Week 14 to Week 52|Adverse Event|1|||
30995992|NCT04169373|59183877|FG001|Week 14 to Week 52|Adverse Event|0|||
30995993|NCT04169373|59183878|FG002|Week 14 to Week 52|Adverse Event|0|||
30995994|NCT04169373|59183879|FG003|Week 14 to Week 52|Adverse Event|1|||
30995995|NCT04169373|59183876|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
30995996|NCT04169373|59183877|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
30995997|NCT04169373|59183878|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
30995998|NCT04169373|59183879|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
30995999|NCT04169373|59183876|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
30996000|NCT04169373|59183877|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
30996001|NCT04169373|59183878|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
30996002|NCT04169373|59183879|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
30996003|NCT04169373|59183876|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
30996004|NCT04169373|59183877|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
30996005|NCT04169373|59183878|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
30996006|NCT04169373|59183879|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
30996007|NCT04169373|59183876|FG000|Week 14 to Week 52|Other|4|||
30996008|NCT04169373|59183877|FG001|Week 14 to Week 52|Other|5|||
30996009|NCT04169373|59183878|FG002|Week 14 to Week 52|Other|4|||
30996010|NCT04169373|59183879|FG003|Week 14 to Week 52|Other|5|||
30996011|NCT04169373|59183876|FG000|Week 14 to Week 52|Ongoing|0|||
30996012|NCT04169373|59183877|FG001|Week 14 to Week 52|Ongoing|1|||
30996013|NCT04169373|59183878|FG002|Week 14 to Week 52|Ongoing|0|||
30996014|NCT04169373|59183879|FG003|Week 14 to Week 52|Ongoing|0|||
30996015|NCT04154930|59183894|FG000|Overall Study|Withdrawal by Subject|15|||
30996016|NCT04154930|59183895|FG001|Overall Study|Withdrawal by Subject|6|||
30996017|NCT04154930|59183894|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
30996018|NCT04154930|59183895|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
30996019|NCT04154930|59183894|FG000|Overall Study|Lost to Follow-up|14|||
30996020|NCT04154930|59183895|FG001|Overall Study|Lost to Follow-up|6|||
30996021|NCT04154930|59183894|FG000|Overall Study|Other|6|||
30996022|NCT04154930|59183895|FG001|Overall Study|Other|0|||
30996023|NCT04124471|59183901|FG000|Overall Study|screen failure|1|||
30996024|NCT04093024|59183907|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
30996025|NCT04093024|59183908|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
30996026|NCT04093024|59183907|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
30996027|NCT04093024|59183908|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
30996028|NCT04093024|59183907|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
30996029|NCT04093024|59183908|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
30996030|NCT04093024|59183907|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
30996031|NCT04093024|59183908|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
30996032|NCT03971474|59183944|FG000|Overall Study|Adverse Event|11|||
30996033|NCT03971474|59183945|FG001|Overall Study|Adverse Event|7|||
30996034|NCT03971474|59183944|FG000|Overall Study|Refusal unrelated to adverse event|5|||
30996035|NCT03971474|59183945|FG001|Overall Study|Refusal unrelated to adverse event|1|||
30996036|NCT03971474|59183944|FG000|Overall Study|Progression/relapse|40|||
30996037|NCT03971474|59183945|FG001|Overall Study|Progression/relapse|47|||
30996038|NCT03971474|59183944|FG000|Overall Study|Death|6|||
30996039|NCT03971474|59183945|FG001|Overall Study|Death|3|||
30996040|NCT03971474|59183944|FG000|Overall Study|Other - not protocol specified|5|||
30996041|NCT03971474|59183945|FG001|Overall Study|Other - not protocol specified|4|||
30996042|NCT03971474|59183944|FG000|Overall Study|On treatment|0|||
30996043|NCT03971474|59183945|FG001|Overall Study|On treatment|7|||
30996044|NCT03633929|59183952|FG000|Overall Study|Lost to Follow-up|1|||
30996045|NCT03633929|59183952|FG000|Overall Study|Did not login to software. Did not participate|3|||
30996046|NCT03625687|59183956|FG000|Overall Study|Death|1|||
30996047|NCT02869633|59183979|FG000|Overall Study|Death|2|||
30996048|NCT02869633|59183980|FG001|Overall Study|Death|1|||
30996049|NCT02869633|59183979|FG000|Overall Study|Patient refused follow-up|1|||
30996050|NCT02869633|59183980|FG001|Overall Study|Patient refused follow-up|0|||
30996051|NCT02869633|59183979|FG000|Overall Study|Provider discretion|1|||
30996052|NCT02869633|59183980|FG001|Overall Study|Provider discretion|0|||
30996053|NCT02869633|59183979|FG000|Overall Study|Investigator decision|1|||
30996054|NCT02869633|59183980|FG001|Overall Study|Investigator decision|0|||
30996055|NCT02869633|59183979|FG000|Overall Study|Lost to Follow-up|0|||
30996056|NCT02869633|59183980|FG001|Overall Study|Lost to Follow-up|1|||
30996057|NCT02869633|59183979|FG000|Overall Study|Not eligible|6|||
30996058|NCT02869633|59183980|FG001|Overall Study|Not eligible|1|||
30996059|NCT02869633|59183979|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
30996060|NCT02869633|59183980|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
30996061|NCT02869633|59183979|FG000|Overall Study|Withdrawal by Subject|0|||
30996062|NCT02869633|59183980|FG001|Overall Study|Withdrawal by Subject|1|||
30996063|NCT02785952|59183990|FG000|Overall Study|Adverse Event|31|||
30996064|NCT02785952|59183991|FG001|Overall Study|Adverse Event|19|||
30996065|NCT02785952|59183990|FG000|Overall Study|Refusal unrelated to adverse events|10|||
30996066|NCT02785952|59183991|FG001|Overall Study|Refusal unrelated to adverse events|5|||
30996067|NCT02785952|59183990|FG000|Overall Study|Disease progression/relapse|61|||
30996068|NCT02785952|59183991|FG001|Overall Study|Disease progression/relapse|89|||
30996069|NCT02785952|59183990|FG000|Overall Study|Death|11|||
30996070|NCT02785952|59183991|FG001|Overall Study|Death|7|||
30996071|NCT02785952|59183990|FG000|Overall Study|Other- not protocol specified|6|||
30996072|NCT02785952|59183991|FG001|Overall Study|Other- not protocol specified|4|||
30996073|NCT02785952|59183990|FG000|Overall Study|On protocol treatment|6|||
30996074|NCT02785952|59183991|FG001|Overall Study|On protocol treatment|3|||
30996075|NCT02674685|59183999|FG000|Overall Study|Withdrawal by Subject|4|||
30996076|NCT02654236|59184006|FG000|Overall Study|Withdrawal by Subject|0|||
30996077|NCT02654236|59184007|FG001|Overall Study|Withdrawal by Subject|0|||
30996078|NCT02654236|59184008|FG002|Overall Study|Withdrawal by Subject|2|||
30996079|NCT02372136|59184018|FG000|Overall Study|Death|3|||
30996080|NCT02372136|59184019|FG001|Overall Study|Death|1|||
30996081|NCT02194829|59184029|FG000|Overall Study|Adverse Event|2|||
30996082|NCT02194829|59184030|FG001|Overall Study|Adverse Event|2|||
30996083|NCT02194829|59184029|FG000|Overall Study|Death|0|||
30996084|NCT02194829|59184030|FG001|Overall Study|Death|1|||
30996085|NCT02194829|59184029|FG000|Overall Study|Disease progression|0|||
30996086|NCT02194829|59184030|FG001|Overall Study|Disease progression|1|||
30996087|NCT02194829|59184029|FG000|Overall Study|Withdrawal by Subject|0|||
30996088|NCT02194829|59184030|FG001|Overall Study|Withdrawal by Subject|1|||
30996089|NCT02194829|59184029|FG000|Overall Study|Never started protocol therapy|0|||
30996090|NCT02194829|59184030|FG001|Overall Study|Never started protocol therapy|1|||
30996091|NCT02087046|59184037|FG000|Overall Study|Adverse Event|4|||
30996092|NCT02087046|59184037|FG000|Overall Study|Death|1|||
30996093|NCT02087046|59184037|FG000|Overall Study|Lost to Follow-up|3|||
30996094|NCT02087046|59184037|FG000|Overall Study|Withdrawal by Subject|2|||
30996095|NCT02087046|59184037|FG000|Overall Study|Physician Decision|1|||
30996096|NCT01390038|59184046|FG000|Overall Study|Death|1|||
30996097|NCT01390038|59184046|FG000|Overall Study|Lost to Follow-up|1|||
30996098|NCT01390038|59184046|FG000|Overall Study|Withdrawal by Subject|4|||
30996099|NCT01390038|59184046|FG000|Overall Study|Simpliciti System Removal|2|||
30996100|NCT00621192|59184064|FG000|Overall Study|Withdrawal by Subject|0|||
30996101|NCT00621192|59184065|FG001|Overall Study|Withdrawal by Subject|0|||
30996102|NCT00621192|59184066|FG002|Overall Study|Withdrawal by Subject|2|||
30996103|NCT00621192|59184067|FG003|Overall Study|Withdrawal by Subject|0|||
30996104|NCT00621192|59184064|FG000|Overall Study|Physician Decision|1|||
30996105|NCT00621192|59184065|FG001|Overall Study|Physician Decision|3|||
30996106|NCT00621192|59184066|FG002|Overall Study|Physician Decision|0|||
30996107|NCT00621192|59184067|FG003|Overall Study|Physician Decision|0|||
30996108|NCT00621192|59184064|FG000|Overall Study|Protocol Violation|1|||
30996109|NCT00621192|59184065|FG001|Overall Study|Protocol Violation|0|||
30996110|NCT00621192|59184066|FG002|Overall Study|Protocol Violation|0|||
30996111|NCT00621192|59184067|FG003|Overall Study|Protocol Violation|1|||
30996112|NCT00621192|59184064|FG000|Overall Study|Adverse Event|0|||
30996113|NCT00621192|59184065|FG001|Overall Study|Adverse Event|1|||
30996114|NCT00621192|59184066|FG002|Overall Study|Adverse Event|0|||
30996115|NCT00621192|59184067|FG003|Overall Study|Adverse Event|1|||
30996116|NCT00621192|59184064|FG000|Overall Study|Death|2|||
30996117|NCT00621192|59184065|FG001|Overall Study|Death|5|||
30996118|NCT00621192|59184066|FG002|Overall Study|Death|0|||
30996119|NCT00621192|59184067|FG003|Overall Study|Death|0|||
30996120|NCT00621192|59184064|FG000|Overall Study|Final Assessments not Completed|0|||
30996121|NCT00621192|59184065|FG001|Overall Study|Final Assessments not Completed|0|||
30996122|NCT00621192|59184066|FG002|Overall Study|Final Assessments not Completed|3|||
30996123|NCT00621192|59184067|FG003|Overall Study|Final Assessments not Completed|1|||
30996124|NCT00364286|59184077|FG000|Overall Study|Withdrawal by Subject|1|||
30996125|NCT00364286|59184077|FG000|Overall Study|Adverse Event|2|||
30996126|NCT00278200|59184083|FG000|Overall Study|Death|1|||
30996127|NCT00278200|59184084|FG001|Overall Study|Death|3|||
30996128|NCT00278200|59184083|FG000|Overall Study|Physician Decision|0|||
30996129|NCT00278200|59184084|FG001|Overall Study|Physician Decision|1|||
30996130|NCT00255346|59184095|FG000|Overall Study|Adverse Event|1|||
30996131|NCT00255346|59184096|FG001|Overall Study|Adverse Event|0|||
30996132|NCT00255346|59184097|FG002|Overall Study|Adverse Event|0|||
30996133|NCT00255346|59184098|FG003|Overall Study|Adverse Event|0|||
30996134|NCT00255346|59184099|FG004|Overall Study|Adverse Event|0|||
30996135|NCT02222922|59186249|FG000|Overall Study|Death|0|||
30996136|NCT02222922|59186250|FG001|Overall Study|Death|0|||
30996137|NCT02222922|59186251|FG002|Overall Study|Death|0|||
30891980|NCT02250651|58925283|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
30891981|NCT02250651|58925284|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
30996138|NCT02222922|59186252|FG003|Overall Study|Death|0|||
30996139|NCT02222922|59186253|FG004|Overall Study|Death|13|||
30996140|NCT02222922|59186254|FG005|Overall Study|Death|0|||
30996141|NCT02222922|59186255|FG006|Overall Study|Death|0|||
30996142|NCT02222922|59186256|FG007|Overall Study|Death|0|||
30996143|NCT02222922|59186257|FG008|Overall Study|Death|2|||
30996144|NCT02222922|59186249|FG000|Overall Study|Lost to Follow-up|0|||
30996145|NCT02222922|59186250|FG001|Overall Study|Lost to Follow-up|0|||
30996146|NCT02222922|59186251|FG002|Overall Study|Lost to Follow-up|1|||
30996147|NCT02222922|59186252|FG003|Overall Study|Lost to Follow-up|0|||
30996148|NCT02222922|59186253|FG004|Overall Study|Lost to Follow-up|9|||
30996149|NCT02222922|59186254|FG005|Overall Study|Lost to Follow-up|1|||
30996150|NCT02222922|59186255|FG006|Overall Study|Lost to Follow-up|0|||
30996151|NCT02222922|59186256|FG007|Overall Study|Lost to Follow-up|0|||
30996152|NCT02222922|59186257|FG008|Overall Study|Lost to Follow-up|0|||
30996153|NCT02222922|59186249|FG000|Overall Study|Other|0|||
30996154|NCT02222922|59186250|FG001|Overall Study|Other|0|||
30996155|NCT02222922|59186251|FG002|Overall Study|Other|0|||
30996156|NCT02222922|59186252|FG003|Overall Study|Other|2|||
30996157|NCT02222922|59186253|FG004|Overall Study|Other|10|||
30996158|NCT02222922|59186254|FG005|Overall Study|Other|2|||
30996159|NCT02222922|59186255|FG006|Overall Study|Other|2|||
30996160|NCT02222922|59186256|FG007|Overall Study|Other|4|||
30996161|NCT02222922|59186257|FG008|Overall Study|Other|1|||
30996162|NCT02222922|59186249|FG000|Overall Study|Participant refused further follow-up|1|||
30996163|NCT02222922|59186250|FG001|Overall Study|Participant refused further follow-up|0|||
30996164|NCT02222922|59186251|FG002|Overall Study|Participant refused further follow-up|0|||
30996165|NCT02222922|59186252|FG003|Overall Study|Participant refused further follow-up|1|||
30996166|NCT02222922|59186253|FG004|Overall Study|Participant refused further follow-up|6|||
30996167|NCT02222922|59186254|FG005|Overall Study|Participant refused further follow-up|0|||
30996168|NCT02222922|59186255|FG006|Overall Study|Participant refused further follow-up|0|||
30996169|NCT02222922|59186256|FG007|Overall Study|Participant refused further follow-up|0|||
30996170|NCT02222922|59186257|FG008|Overall Study|Participant refused further follow-up|3|||
30996171|NCT02161146|59186309|FG000|Overall Study|Adverse Event|1|||
30996172|NCT02161146|59186310|FG001|Overall Study|Adverse Event|1|||
30996173|NCT02161146|59186311|FG002|Overall Study|Adverse Event|0|||
30996174|NCT02161146|59186312|FG003|Overall Study|Adverse Event|1|||
30996175|NCT02161146|59186313|FG004|Overall Study|Adverse Event|0|||
30996176|NCT02161146|59186309|FG000|Overall Study|Lost to Follow-up|0|||
30996177|NCT02161146|59186310|FG001|Overall Study|Lost to Follow-up|1|||
30996178|NCT02161146|59186311|FG002|Overall Study|Lost to Follow-up|0|||
30996179|NCT02161146|59186312|FG003|Overall Study|Lost to Follow-up|0|||
30996180|NCT02161146|59186313|FG004|Overall Study|Lost to Follow-up|0|||
30996181|NCT02161146|59186309|FG000|Overall Study|Personal Reasons|0|||
30996182|NCT02161146|59186310|FG001|Overall Study|Personal Reasons|1|||
30996183|NCT02161146|59186311|FG002|Overall Study|Personal Reasons|0|||
30996184|NCT02161146|59186312|FG003|Overall Study|Personal Reasons|2|||
30996185|NCT02161146|59186313|FG004|Overall Study|Personal Reasons|1|||
30996186|NCT02161146|59186309|FG000|Overall Study|Other Miscellaneous Reasons|0|||
30996187|NCT02161146|59186310|FG001|Overall Study|Other Miscellaneous Reasons|1|||
30996188|NCT02161146|59186311|FG002|Overall Study|Other Miscellaneous Reasons|0|||
30996189|NCT02161146|59186312|FG003|Overall Study|Other Miscellaneous Reasons|0|||
30996190|NCT02161146|59186313|FG004|Overall Study|Other Miscellaneous Reasons|0|||
30996191|NCT02222688|59186548|FG000|Overall Study|Withdrawal by Subject|0|||
30996192|NCT02222688|59186549|FG001|Overall Study|Withdrawal by Subject|0|||
30996193|NCT02222688|59186550|FG002|Overall Study|Withdrawal by Subject|0|||
30996194|NCT02222688|59186551|FG003|Overall Study|Withdrawal by Subject|2|||
30996195|NCT02222688|59186552|FG004|Overall Study|Withdrawal by Subject|1|||
30996196|NCT02222688|59186553|FG005|Overall Study|Withdrawal by Subject|0|||
30996197|NCT02222688|59186554|FG006|Overall Study|Withdrawal by Subject|1|||
30996198|NCT02222688|59186548|FG000|Overall Study|Disease progression|1|||
30996199|NCT02222688|59186549|FG001|Overall Study|Disease progression|0|||
30996200|NCT02222688|59186550|FG002|Overall Study|Disease progression|0|||
30996201|NCT02222688|59186551|FG003|Overall Study|Disease progression|0|||
30996202|NCT02222688|59186552|FG004|Overall Study|Disease progression|0|||
30996203|NCT02222688|59186553|FG005|Overall Study|Disease progression|0|||
30996204|NCT02222688|59186554|FG006|Overall Study|Disease progression|0|||
30996205|NCT02159352|59186606|FG000|Overall Study|Adverse Event|3|||
30996206|NCT02159352|59186607|FG001|Overall Study|Adverse Event|1|||
30996207|NCT02159352|59186606|FG000|Overall Study|Withdrawal by Subject|0|||
30996208|NCT02159352|59186607|FG001|Overall Study|Withdrawal by Subject|1|||
30996209|NCT02187744|59186644|FG000|Study|Participant refused further follow-up|1|||
30996210|NCT02187744|59186645|FG001|Study|Participant refused further follow-up|0|||
30996211|NCT02187744|59186644|FG000|Study|Other|2|||
30996212|NCT02187744|59186645|FG001|Study|Other|1|||
30996213|NCT02187744|59186644|FG000|Study|Lost to Follow-up|0|||
30996214|NCT02187744|59186645|FG001|Study|Lost to Follow-up|2|||
30996215|NCT02187744|59186644|FG000|Study|Related adverse event, not serious|0|||
30996216|NCT02187744|59186645|FG001|Study|Related adverse event, not serious|2|||
30996217|NCT02187744|59186644|FG000|Study|Death|1|||
30996218|NCT02187744|59186645|FG001|Study|Death|0|||
30996219|NCT02187744|59186644|FG000|Study|Related adverse event, serious non-fatal|0|||
30996220|NCT02187744|59186645|FG001|Study|Related adverse event, serious non-fatal|1|||
30996221|NCT02187744|59186644|FG000|Treatment|Death|1|||
30996222|NCT02187744|59186645|FG001|Treatment|Death|0|||
30996223|NCT02187744|59186644|FG000|Treatment|Related adverse event, serious non-fatal|0|||
30996224|NCT02187744|59186645|FG001|Treatment|Related adverse event, serious non-fatal|1|||
30996225|NCT02187744|59186644|FG000|Treatment|Related adverse event, not serious|0|||
30996226|NCT02187744|59186645|FG001|Treatment|Related adverse event, not serious|2|||
30996227|NCT02187744|59186644|FG000|Treatment|Lost to Follow-up|0|||
30996228|NCT02187744|59186645|FG001|Treatment|Lost to Follow-up|1|||
30996229|NCT02187744|59186644|FG000|Treatment|Other|2|||
30996230|NCT02187744|59186645|FG001|Treatment|Other|0|||
30996231|NCT02187744|59186644|FG000|Treatment|Participant refused continued treatment|1|||
30996232|NCT02187744|59186645|FG001|Treatment|Participant refused continued treatment|1|||
30996233|NCT02186652|59186807|FG000|Overall Study|Lost to Follow-up|2|||
30996234|NCT02186652|59186808|FG001|Overall Study|Lost to Follow-up|0|||
30996235|NCT02185794|59186844|FG000|Overall Study|Enrolled but Never Dosed|1|||
30996236|NCT02185794|59186845|FG001|Overall Study|Enrolled but Never Dosed|6|||
30996237|NCT02185794|59186846|FG002|Overall Study|Enrolled but Never Dosed|3|||
30996238|NCT02185794|59186847|FG003|Overall Study|Enrolled but Never Dosed|1|||
30996239|NCT02185794|59186848|FG004|Overall Study|Enrolled but Never Dosed|1|||
30996240|NCT02185794|59186849|FG005|Overall Study|Enrolled but Never Dosed|0|||
30996241|NCT02185794|59186844|FG000|Overall Study|Investigator's Discretion|1|||
30996242|NCT02185794|59186845|FG001|Overall Study|Investigator's Discretion|0|||
30996243|NCT02185794|59186846|FG002|Overall Study|Investigator's Discretion|1|||
30996244|NCT02185794|59186847|FG003|Overall Study|Investigator's Discretion|2|||
30996245|NCT02185794|59186848|FG004|Overall Study|Investigator's Discretion|2|||
30996246|NCT02185794|59186849|FG005|Overall Study|Investigator's Discretion|15|||
30996247|NCT02185794|59186844|FG000|Overall Study|Withdrew Consent|2|||
30996248|NCT02185794|59186845|FG001|Overall Study|Withdrew Consent|5|||
30996249|NCT02185794|59186846|FG002|Overall Study|Withdrew Consent|10|||
30996250|NCT02185794|59186847|FG003|Overall Study|Withdrew Consent|2|||
30996251|NCT02185794|59186848|FG004|Overall Study|Withdrew Consent|0|||
30996252|NCT02185794|59186849|FG005|Overall Study|Withdrew Consent|0|||
30996253|NCT02185794|59186844|FG000|Overall Study|Lost to Follow-up|1|||
30996254|NCT02185794|59186845|FG001|Overall Study|Lost to Follow-up|2|||
30996255|NCT02185794|59186846|FG002|Overall Study|Lost to Follow-up|2|||
30996256|NCT02185794|59186847|FG003|Overall Study|Lost to Follow-up|3|||
30996257|NCT02185794|59186848|FG004|Overall Study|Lost to Follow-up|0|||
30996258|NCT02185794|59186849|FG005|Overall Study|Lost to Follow-up|1|||
30996259|NCT02221674|59186880|FG000|Overall Study|Lost to Follow-up|1|||
30996260|NCT02221674|59186881|FG001|Overall Study|Lost to Follow-up|0|||
30996261|NCT02221674|59186882|FG002|Overall Study|Lost to Follow-up|0|||
30996262|NCT02221284|59186897|FG000|Overall Study|Case Report Forms Uncollected|56|||
30996263|NCT02221284|59186897|FG000|Overall Study|Protocol Deviation|5|||
30996264|NCT02187042|59187058|FG000|Overall Study|Death|1|||
30996265|NCT02187042|59187059|FG001|Overall Study|Death|1|||
30996266|NCT02187042|59187058|FG000|Overall Study|Toxicity|6|||
30996267|NCT02187042|59187059|FG001|Overall Study|Toxicity|5|||
30996268|NCT02187042|59187058|FG000|Overall Study|Participant choice|1|||
30996269|NCT02187042|59187059|FG001|Overall Study|Participant choice|0|||
30996270|NCT02187042|59187058|FG000|Overall Study|Doctor choice|1|||
30996271|NCT02187042|59187059|FG001|Overall Study|Doctor choice|0|||
30996272|NCT02187042|59187058|FG000|Overall Study|Progressive disease|4|||
30996273|NCT02187042|59187059|FG001|Overall Study|Progressive disease|8|||
30996274|NCT02220894|59187233|FG000|Overall Study|Adverse Event|118|||
30996275|NCT02220894|59187234|FG001|Overall Study|Adverse Event|70|||
30996276|NCT02220894|59187233|FG000|Overall Study|Death|252|||
30996277|NCT02220894|59187234|FG001|Overall Study|Death|368|||
30996278|NCT02220894|59187233|FG000|Overall Study|Lost to Follow-up|0|||
30996279|NCT02220894|59187234|FG001|Overall Study|Lost to Follow-up|2|||
30996280|NCT02220894|59187233|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30996281|NCT02220894|59187234|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
30996282|NCT02220894|59187233|FG000|Overall Study|Withdrawal by Subject|2|||
30996283|NCT02220894|59187234|FG001|Overall Study|Withdrawal by Subject|13|||
30996284|NCT02220894|59187233|FG000|Overall Study|Ongoing in Study|265|||
30996285|NCT02220894|59187234|FG001|Overall Study|Ongoing in Study|183|||
30996286|NCT02219334|59187251|FG000|Overall Study|Withdrawal by Subject|1|||
30996287|NCT02219334|59187252|FG001|Overall Study|Withdrawal by Subject|0|||
30996288|NCT02219334|59187251|FG000|Overall Study|Protocol Violation|7|||
30996289|NCT02219334|59187252|FG001|Overall Study|Protocol Violation|3|||
30996290|NCT02159040|59187270|FG000|Overall Study|Death|1|||
30996291|NCT02218008|59187295|FG000|Stage 1 (S1)|Adverse Event|6|||
30996292|NCT02218008|59187296|FG001|Stage 1 (S1)|Adverse Event|5|||
30996293|NCT02218008|59187297|FG002|Stage 1 (S1)|Adverse Event|11|||
30996294|NCT02218008|59187298|FG003|Stage 1 (S1)|Adverse Event|0|||
30996295|NCT02218008|59187299|FG004|Stage 1 (S1)|Adverse Event|0|||
30996296|NCT02218008|59187300|FG005|Stage 1 (S1)|Adverse Event|0|||
30996297|NCT02218008|59187295|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
30996298|NCT02218008|59187296|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
30996299|NCT02218008|59187297|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
30996300|NCT02218008|59187298|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
30996301|NCT02218008|59187299|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
30996302|NCT02218008|59187300|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
30996303|NCT02218008|59187295|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
30996304|NCT02218008|59187296|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
30996305|NCT02218008|59187297|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
30996306|NCT02218008|59187298|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
30996307|NCT02218008|59187299|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
30996308|NCT02218008|59187300|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
30996309|NCT02218008|59187295|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
30996310|NCT02218008|59187296|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
30996311|NCT02218008|59187297|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
30996312|NCT02218008|59187298|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
30996313|NCT02218008|59187299|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
30996314|NCT02218008|59187300|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
30996315|NCT02218008|59187295|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
30996316|NCT02218008|59187296|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
30996317|NCT02218008|59187297|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
30996318|NCT02218008|59187298|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
30996319|NCT02218008|59187299|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
30996320|NCT02218008|59187300|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
30996321|NCT02218008|59187295|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
30996322|NCT02218008|59187296|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
30996323|NCT02218008|59187297|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
30996324|NCT02218008|59187298|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
30996325|NCT02218008|59187299|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
30996326|NCT02218008|59187300|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
30996327|NCT02218008|59187295|FG000|Stage 1 (S1)|Pregnancy|0|||
30996328|NCT02218008|59187296|FG001|Stage 1 (S1)|Pregnancy|0|||
30996329|NCT02218008|59187297|FG002|Stage 1 (S1)|Pregnancy|1|||
30996330|NCT02218008|59187298|FG003|Stage 1 (S1)|Pregnancy|0|||
30996331|NCT02218008|59187299|FG004|Stage 1 (S1)|Pregnancy|0|||
30996332|NCT02218008|59187300|FG005|Stage 1 (S1)|Pregnancy|0|||
30996333|NCT02218008|59187295|FG000|Stage 1 (S1)|Protocol Violation|0|||
30996334|NCT02218008|59187296|FG001|Stage 1 (S1)|Protocol Violation|0|||
30996335|NCT02218008|59187297|FG002|Stage 1 (S1)|Protocol Violation|1|||
30996336|NCT02218008|59187298|FG003|Stage 1 (S1)|Protocol Violation|0|||
30996337|NCT02218008|59187299|FG004|Stage 1 (S1)|Protocol Violation|0|||
30996338|NCT02218008|59187300|FG005|Stage 1 (S1)|Protocol Violation|0|||
30996339|NCT02218008|59187295|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
30996340|NCT02218008|59187296|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
30996341|NCT02218008|59187297|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
30996342|NCT02218008|59187298|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
30996343|NCT02218008|59187299|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
30996344|NCT02218008|59187300|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
30996345|NCT02218008|59187295|FG000|Stage 2 (S2)|Adverse Event|0|||
30996346|NCT02218008|59187296|FG001|Stage 2 (S2)|Adverse Event|0|||
30996347|NCT02218008|59187297|FG002|Stage 2 (S2)|Adverse Event|0|||
30996348|NCT02218008|59187298|FG003|Stage 2 (S2)|Adverse Event|2|||
30996349|NCT02218008|59187299|FG004|Stage 2 (S2)|Adverse Event|3|||
30996350|NCT02218008|59187300|FG005|Stage 2 (S2)|Adverse Event|3|||
30996351|NCT02218008|59187295|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
30996352|NCT02218008|59187296|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
30996353|NCT02218008|59187297|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
30996354|NCT02218008|59187298|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
30996355|NCT02218008|59187299|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
30996356|NCT02218008|59187300|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
30996357|NCT02218008|59187295|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
30996358|NCT02218008|59187296|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
30996359|NCT02218008|59187297|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
30996360|NCT02218008|59187298|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
30996361|NCT02218008|59187299|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
30996362|NCT02218008|59187300|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
30996363|NCT02218008|59187295|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
30996364|NCT02218008|59187296|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
30996365|NCT02218008|59187297|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
30996366|NCT02218008|59187298|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
30996367|NCT02218008|59187299|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
30996368|NCT02218008|59187300|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
30996369|NCT02218008|59187295|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
30996370|NCT02218008|59187296|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
30996371|NCT02218008|59187297|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
30996372|NCT02218008|59187298|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
30996373|NCT02218008|59187299|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
30996374|NCT02218008|59187300|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
30996375|NCT01632150|59187397|FG000|Overall Study|Disease progression|27|||
30996376|NCT01632150|59187397|FG000|Overall Study|Study drug toxicity|1|||
30996377|NCT01632150|59187397|FG000|Overall Study|Unrelated adverse event|7|||
30996378|NCT01632150|59187397|FG000|Overall Study|Withdrawal by Subject|2|||
30996379|NCT01632150|59187397|FG000|Overall Study|Patient underwent autologous transplant|1|||
30996380|NCT01632150|59187397|FG000|Overall Study|Moved to compassionate program|2|||
30996381|NCT02185014|59187422|FG000|Overall Study|Adverse Event|18|||
30996382|NCT02185014|59187422|FG000|Overall Study|Withdrew Consent|8|||
30996383|NCT02185014|59187422|FG000|Overall Study|Lost to Follow-up|4|||
30996384|NCT02185014|59187422|FG000|Overall Study|Lack of Efficacy|14|||
30996385|NCT02185014|59187422|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
30996386|NCT02185014|59187422|FG000|Overall Study|Subject Noncompliance|1|||
30996387|NCT02185014|59187422|FG000|Overall Study|Other|4|||
30996388|NCT02184156|59187472|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
30996389|NCT02184156|59187473|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
30996390|NCT02184156|59187472|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
30996391|NCT02184156|59187473|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
30996392|NCT02158884|59187496|FG000|Baseline Assessment|Missed performance assessment|3|||
30996393|NCT02158884|59187496|FG000|Baseline Assessment|Missed SMFA|1|||
30996394|NCT02158884|59187496|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
30996395|NCT02158884|59187496|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
30996396|NCT02158884|59187496|FG000|6 Month Assessment|Missed SMFA|20|||
30996397|NCT02158884|59187496|FG000|12 Month Assessment|Missed SMFA|17|||
30996398|NCT02158806|59187539|FG000|Overall Study|Death|2|||
30996399|NCT02158806|59187540|FG001|Overall Study|Death|0|||
30996400|NCT02158806|59187539|FG000|Overall Study|Withdrawal by Subject|2|||
30996401|NCT02158806|59187540|FG001|Overall Study|Withdrawal by Subject|0|||
30996402|NCT02158806|59187539|FG000|Overall Study|Lost to Follow-up|0|||
30996403|NCT02158806|59187540|FG001|Overall Study|Lost to Follow-up|3|||
30996404|NCT02158806|59187539|FG000|Overall Study|Moved out of area|0|||
30996405|NCT02158806|59187540|FG001|Overall Study|Moved out of area|1|||
30996406|NCT02158806|59187539|FG000|Overall Study|Transferred to palliative care|0|||
30996407|NCT02158806|59187540|FG001|Overall Study|Transferred to palliative care|1|||
30996408|NCT02158728|59187571|FG000|Overall Study|no procedure according to CIP done|3|||
30996409|NCT02158728|59187571|FG000|Overall Study|no qualified dataset|24|||
30996410|NCT02157948|59187616|FG000|Overall Study|Withdrawal by Subject|4|||
30996411|NCT02157948|59187617|FG001|Overall Study|Withdrawal by Subject|5|||
30996412|NCT02157948|59187616|FG000|Overall Study|Lost to Follow-up|3|||
30996413|NCT02157948|59187617|FG001|Overall Study|Lost to Follow-up|2|||
30996414|NCT02157948|59187616|FG000|Overall Study|Protocol Specified Criteria|2|||
30996415|NCT02157948|59187617|FG001|Overall Study|Protocol Specified Criteria|1|||
30996416|NCT02157948|59187616|FG000|Overall Study|Decision by Sponsor|0|||
30996417|NCT02157948|59187617|FG001|Overall Study|Decision by Sponsor|1|||
30996418|NCT02182830|59187658|FG000|Overall Study|Not Treated|1|||
30996419|NCT02182830|59187659|FG001|Overall Study|Not Treated|1|||
30996420|NCT02182830|59187658|FG000|Overall Study|Trial stopped, reason missing|3|||
30996421|NCT02182830|59187659|FG001|Overall Study|Trial stopped, reason missing|3|||
30996422|NCT02182830|59187658|FG000|Overall Study|Consent withdrawn|8|||
30996423|NCT02182830|59187659|FG001|Overall Study|Consent withdrawn|8|||
30996424|NCT02182830|59187658|FG000|Overall Study|Lost to Follow-up|3|||
30996425|NCT02182830|59187659|FG001|Overall Study|Lost to Follow-up|3|||
30996426|NCT02182440|59188233|FG000|Overall Study|Adverse Event|0|||
30996427|NCT02182440|59188234|FG001|Overall Study|Adverse Event|1|||
30996428|NCT02182440|59188235|FG002|Overall Study|Adverse Event|0|||
30996429|NCT02182440|59188236|FG003|Overall Study|Adverse Event|0|||
30996430|NCT02182440|59188233|FG000|Overall Study|Death|31|||
30996431|NCT02182440|59188234|FG001|Overall Study|Death|8|||
30996432|NCT02182440|59188235|FG002|Overall Study|Death|5|||
30996433|NCT02182440|59188236|FG003|Overall Study|Death|16|||
30996434|NCT02182440|59188233|FG000|Overall Study|Protocol Violation|0|||
30996435|NCT02182440|59188234|FG001|Overall Study|Protocol Violation|1|||
30996436|NCT02182440|59188235|FG002|Overall Study|Protocol Violation|0|||
30996437|NCT02182440|59188236|FG003|Overall Study|Protocol Violation|0|||
30996438|NCT02182440|59188233|FG000|Overall Study|Physician Decision|1|||
30996439|NCT02182440|59188234|FG001|Overall Study|Physician Decision|0|||
30996440|NCT02182440|59188235|FG002|Overall Study|Physician Decision|0|||
30996441|NCT02182440|59188236|FG003|Overall Study|Physician Decision|0|||
30996442|NCT02182440|59188233|FG000|Overall Study|Withdrawal by Subject|1|||
30996443|NCT02182440|59188234|FG001|Overall Study|Withdrawal by Subject|1|||
30996444|NCT02182440|59188235|FG002|Overall Study|Withdrawal by Subject|3|||
30996445|NCT02182440|59188236|FG003|Overall Study|Withdrawal by Subject|4|||
30996446|NCT02182440|59188233|FG000|Overall Study|different, e.g adm other hospital|12|||
30996447|NCT02182440|59188234|FG001|Overall Study|different, e.g adm other hospital|3|||
30996448|NCT02182440|59188235|FG002|Overall Study|different, e.g adm other hospital|3|||
30996449|NCT02182440|59188236|FG003|Overall Study|different, e.g adm other hospital|10|||
30996450|NCT02181816|59188278|FG000|Overall Study|Case Report Forms Uncollected|38|||
30996451|NCT02181816|59188278|FG000|Overall Study|Protocol Deviation|21|||
30996452|NCT02156466|59188434|FG000|Overall Study|Adverse Event|0|||
30996453|NCT02156466|59188435|FG001|Overall Study|Adverse Event|0|||
30996454|NCT02156466|59188436|FG002|Overall Study|Adverse Event|1|||
30996455|NCT02156466|59188437|FG003|Overall Study|Adverse Event|1|||
30996456|NCT02156466|59188438|FG004|Overall Study|Adverse Event|0|||
30996457|NCT02156466|59188434|FG000|Overall Study|Quantiferon Positivity|0|||
30996458|NCT02156466|59188435|FG001|Overall Study|Quantiferon Positivity|0|||
30996459|NCT02156466|59188436|FG002|Overall Study|Quantiferon Positivity|0|||
30996460|NCT02156466|59188437|FG003|Overall Study|Quantiferon Positivity|1|||
30996461|NCT02156466|59188438|FG004|Overall Study|Quantiferon Positivity|0|||
30996462|NCT02216526|59188477|FG000|Overall Study|Adverse Event|1|||
30996463|NCT02216526|59188478|FG001|Overall Study|Adverse Event|1|||
30996464|NCT02216526|59188479|FG002|Overall Study|Adverse Event|0|||
30996465|NCT02216526|59188477|FG000|Overall Study|Death|0|||
30996466|NCT02216526|59188478|FG001|Overall Study|Death|1|||
30996467|NCT02216526|59188479|FG002|Overall Study|Death|3|||
30996468|NCT02216526|59188477|FG000|Overall Study|Protocol Violation|2|||
30996469|NCT02216526|59188478|FG001|Overall Study|Protocol Violation|0|||
30996470|NCT02216526|59188479|FG002|Overall Study|Protocol Violation|2|||
30996471|NCT02216526|59188477|FG000|Overall Study|Hospitalization|2|||
30996472|NCT02216526|59188478|FG001|Overall Study|Hospitalization|1|||
30996473|NCT02216526|59188479|FG002|Overall Study|Hospitalization|3|||
30996474|NCT02216214|59188519|FG000|Overall Study|Randomized Never Received Study Drug|1|||
30996475|NCT02216214|59188520|FG001|Overall Study|Randomized Never Received Study Drug|0|||
30996476|NCT02216214|59188519|FG000|Overall Study|Adverse Event|10|||
30996477|NCT02216214|59188520|FG001|Overall Study|Adverse Event|8|||
30996478|NCT02216214|59188519|FG000|Overall Study|Lack of Efficacy|2|||
30996479|NCT02216214|59188520|FG001|Overall Study|Lack of Efficacy|2|||
30996480|NCT02216214|59188519|FG000|Overall Study|Lost to Follow-up|3|||
30996481|NCT02216214|59188520|FG001|Overall Study|Lost to Follow-up|2|||
30996482|NCT02216214|59188519|FG000|Overall Study|Protocol Violation|4|||
30996483|NCT02216214|59188520|FG001|Overall Study|Protocol Violation|2|||
30996484|NCT02216214|59188519|FG000|Overall Study|Withdrawal by Subject|22|||
30996485|NCT02216214|59188520|FG001|Overall Study|Withdrawal by Subject|20|||
30996486|NCT02216214|59188519|FG000|Overall Study|Study Terminated By Sponsor|0|||
30996487|NCT02216214|59188520|FG001|Overall Study|Study Terminated By Sponsor|1|||
30996488|NCT02216214|59188519|FG000|Overall Study|Miscellaneous|1|||
30996489|NCT02216214|59188520|FG001|Overall Study|Miscellaneous|1|||
30996490|NCT02214186|59188551|FG000|Overall Study|Lost to Follow-up|1|||
30996491|NCT02214186|59188552|FG001|Overall Study|Lost to Follow-up|1|||
30996492|NCT02214186|59188551|FG000|Overall Study|Protocol Violation|1|||
30996493|NCT02214186|59188552|FG001|Overall Study|Protocol Violation|1|||
30996494|NCT02181504|59188608|FG000|Overall Study|Adverse Event|1|||
30996495|NCT02181504|59188609|FG001|Overall Study|Adverse Event|1|||
30996496|NCT02181504|59188610|FG002|Overall Study|Adverse Event|1|||
30996497|NCT02179398|59188640|FG000|Overall Study|Lack of obligatory data|3|||
30996498|NCT02179398|59188641|FG001|Overall Study|Lack of obligatory data|3|||
30996499|NCT02179398|59188640|FG000|Overall Study|Lost to Follow-up|0|||
30996500|NCT02179398|59188641|FG001|Overall Study|Lost to Follow-up|1|||
30996501|NCT02156076|59188655|FG000|Treatment Period|no longer meets study criteria|0|||
30996502|NCT02156076|59188656|FG001|Treatment Period|no longer meets study criteria|0|||
30996503|NCT02156076|59188657|FG002|Treatment Period|no longer meets study criteria|1|||
30996504|NCT02156076|59188658|FG003|Treatment Period|no longer meets study criteria|0|||
30996505|NCT02156076|59188655|FG000|Treatment Period|Poor/non-compliance|0|||
30996506|NCT02156076|59188656|FG001|Treatment Period|Poor/non-compliance|1|||
30996507|NCT02156076|59188657|FG002|Treatment Period|Poor/non-compliance|0|||
30996508|NCT02156076|59188658|FG003|Treatment Period|Poor/non-compliance|0|||
30996509|NCT02156076|59188655|FG000|Treatment Period|Lost to Follow-up|0|||
30996510|NCT02156076|59188656|FG001|Treatment Period|Lost to Follow-up|0|||
30996511|NCT02156076|59188657|FG002|Treatment Period|Lost to Follow-up|0|||
30996512|NCT02156076|59188658|FG003|Treatment Period|Lost to Follow-up|1|||
30996513|NCT02156076|59188655|FG000|Treatment Period|Withdrawal by Subject|0|||
30996514|NCT02156076|59188656|FG001|Treatment Period|Withdrawal by Subject|0|||
30996515|NCT02156076|59188657|FG002|Treatment Period|Withdrawal by Subject|1|||
30996516|NCT02156076|59188658|FG003|Treatment Period|Withdrawal by Subject|0|||
30996517|NCT02156076|59188655|FG000|Treatment Period|Subject request to discontinue treatment|0|||
30996518|NCT02156076|59188656|FG001|Treatment Period|Subject request to discontinue treatment|1|||
30996519|NCT02156076|59188657|FG002|Treatment Period|Subject request to discontinue treatment|0|||
30996520|NCT02156076|59188658|FG003|Treatment Period|Subject request to discontinue treatment|0|||
30996521|NCT02156076|59188655|FG000|Treatment Period|Adverse Event|0|||
30996522|NCT02156076|59188656|FG001|Treatment Period|Adverse Event|0|||
30996523|NCT02156076|59188657|FG002|Treatment Period|Adverse Event|0|||
30996524|NCT02156076|59188658|FG003|Treatment Period|Adverse Event|1|||
30996525|NCT02156076|59188655|FG000|Follow-up Period|Withdrawal by Subject|1|||
30996526|NCT02156076|59188656|FG001|Follow-up Period|Withdrawal by Subject|0|||
30996527|NCT02156076|59188657|FG002|Follow-up Period|Withdrawal by Subject|0|||
30996528|NCT02156076|59188658|FG003|Follow-up Period|Withdrawal by Subject|0|||
30996529|NCT02213094|59188670|FG000|Overall Study|Adverse Event|1|||
30996530|NCT02213094|59188671|FG001|Overall Study|Adverse Event|0|||
30996531|NCT02155608|59188679|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
30996532|NCT02155608|59188680|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
30996533|NCT02155608|59188679|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
30996534|NCT02155608|59188680|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
30996535|NCT01629966|59188695|FG000|Overall Study|Pregnancy|0|||
30996536|NCT01629966|59188696|FG001|Overall Study|Pregnancy|1|||
30996537|NCT01629966|59188697|FG002|Overall Study|Pregnancy|0|||
30996538|NCT01629966|59188695|FG000|Overall Study|Lost to Follow-up|10|||
30996539|NCT01629966|59188696|FG001|Overall Study|Lost to Follow-up|13|||
30996540|NCT01629966|59188697|FG002|Overall Study|Lost to Follow-up|9|||
30996541|NCT01629966|59188695|FG000|Overall Study|Withdrawal by Subject|8|||
30996542|NCT01629966|59188696|FG001|Overall Study|Withdrawal by Subject|9|||
30996543|NCT01629966|59188697|FG002|Overall Study|Withdrawal by Subject|16|||
30996544|NCT01629966|59188695|FG000|Overall Study|Protocol Violation|7|||
30996545|NCT01629966|59188696|FG001|Overall Study|Protocol Violation|9|||
30996546|NCT01629966|59188697|FG002|Overall Study|Protocol Violation|7|||
30996547|NCT01629966|59188695|FG000|Overall Study|Lack of Efficacy|5|||
30996548|NCT01629966|59188696|FG001|Overall Study|Lack of Efficacy|2|||
30996549|NCT01629966|59188697|FG002|Overall Study|Lack of Efficacy|4|||
30996550|NCT01629966|59188695|FG000|Overall Study|Adverse Event|11|||
30996551|NCT01629966|59188696|FG001|Overall Study|Adverse Event|18|||
30996552|NCT01629966|59188697|FG002|Overall Study|Adverse Event|30|||
30996553|NCT02177838|59188737|FG000|Overall Study|Withdrawal by Subject|1|||
30996554|NCT02177838|59188737|FG000|Overall Study|Physician Decision|1|||
30996555|NCT02177838|59188737|FG000|Overall Study|Death|1|||
30996556|NCT02177136|59188834|FG000|DB Phase|Withdrawal by Subject|2|||
30996557|NCT02177136|59188835|FG001|DB Phase|Withdrawal by Subject|0|||
30996558|NCT02177136|59188836|FG002|DB Phase|Withdrawal by Subject|0|||
30996559|NCT02177136|59188837|FG003|DB Phase|Withdrawal by Subject|0|||
30996560|NCT02177136|59188834|FG000|DB Phase|Discontinued Due to Pruritus|1|||
30996561|NCT02177136|59188835|FG001|DB Phase|Discontinued Due to Pruritus|3|||
30996562|NCT02177136|59188836|FG002|DB Phase|Discontinued Due to Pruritus|0|||
30996563|NCT02177136|59188837|FG003|DB Phase|Discontinued Due to Pruritus|0|||
30996564|NCT02177136|59188834|FG000|DB Phase|Adverse Event|3|||
30996565|NCT02177136|59188835|FG001|DB Phase|Adverse Event|2|||
30996566|NCT02177136|59188836|FG002|DB Phase|Adverse Event|3|||
30996567|NCT02177136|59188837|FG003|DB Phase|Adverse Event|0|||
30996568|NCT02177136|59188834|FG000|DB Phase|Protocol Violation|0|||
30996569|NCT02177136|59188835|FG001|DB Phase|Protocol Violation|0|||
30996570|NCT02177136|59188836|FG002|DB Phase|Protocol Violation|1|||
30996571|NCT02177136|59188837|FG003|DB Phase|Protocol Violation|0|||
30996572|NCT02177136|59188834|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
30996573|NCT02177136|59188835|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
30996574|NCT02177136|59188836|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
30996575|NCT02177136|59188837|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
30996576|NCT02177136|59188834|FG000|LTSE Phase|Withdrawal by Subject|0|||
30996577|NCT02177136|59188835|FG001|LTSE Phase|Withdrawal by Subject|0|||
30996578|NCT02177136|59188836|FG002|LTSE Phase|Withdrawal by Subject|0|||
30996579|NCT02177136|59188837|FG003|LTSE Phase|Withdrawal by Subject|6|||
30996580|NCT02177136|59188834|FG000|LTSE Phase|Adverse Event|0|||
30996581|NCT02177136|59188835|FG001|LTSE Phase|Adverse Event|0|||
30996582|NCT02177136|59188836|FG002|LTSE Phase|Adverse Event|0|||
30996583|NCT02177136|59188837|FG003|LTSE Phase|Adverse Event|10|||
30996584|NCT02177136|59188834|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
30996585|NCT02177136|59188835|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
30996586|NCT02177136|59188836|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
30996587|NCT02177136|59188837|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
30996588|NCT02177136|59188834|FG000|LTSE Phase|Physician Decision|0|||
30996589|NCT02177136|59188835|FG001|LTSE Phase|Physician Decision|0|||
30996590|NCT02177136|59188836|FG002|LTSE Phase|Physician Decision|0|||
30996591|NCT02177136|59188837|FG003|LTSE Phase|Physician Decision|2|||
30996592|NCT02177136|59188834|FG000|LTSE Phase|Lost to Follow-up|0|||
30996593|NCT02177136|59188835|FG001|LTSE Phase|Lost to Follow-up|0|||
30996594|NCT02177136|59188836|FG002|LTSE Phase|Lost to Follow-up|0|||
30996595|NCT02177136|59188837|FG003|LTSE Phase|Lost to Follow-up|1|||
30996596|NCT02177136|59188834|FG000|LTSE Phase|Participant Moved|0|||
30996597|NCT02177136|59188835|FG001|LTSE Phase|Participant Moved|0|||
30996598|NCT02177136|59188836|FG002|LTSE Phase|Participant Moved|0|||
30996599|NCT02177136|59188837|FG003|LTSE Phase|Participant Moved|1|||
30996600|NCT02176356|59188865|FG000|Overall Study|Screen Failure|14|||
30996601|NCT02176356|59188865|FG000|Overall Study|Lost to Follow-up|4|||
30996602|NCT02176356|59188865|FG000|Overall Study|Personal Reasons|3|||
30996603|NCT02176356|59188865|FG000|Overall Study|Other Miscellaneous Reasons|2|||
30996604|NCT02210208|59188875|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
30996605|NCT02210208|59188875|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
30996606|NCT02210208|59188875|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
30996607|NCT02209506|59188895|FG000|Overall Study|Withdrawal by Subject|0|||
30996608|NCT02209506|59188896|FG001|Overall Study|Withdrawal by Subject|0|||
30996609|NCT02209506|59188897|FG002|Overall Study|Withdrawal by Subject|0|||
30996610|NCT02209506|59188898|FG003|Overall Study|Withdrawal by Subject|0|||
30996611|NCT02209506|59188899|FG004|Overall Study|Withdrawal by Subject|1|||
30996612|NCT02153736|59188916|FG000|Overall Study|Lost to Follow-up|1|||
30996613|NCT02153736|59188917|FG001|Overall Study|Lost to Follow-up|0|||
30996614|NCT02153736|59188916|FG000|Overall Study|Medical status change made ineligible|1|||
30996615|NCT02153736|59188917|FG001|Overall Study|Medical status change made ineligible|0|||
30996616|NCT02153736|59188916|FG000|Overall Study|Death|0|||
30996617|NCT02153736|59188917|FG001|Overall Study|Death|1|||
30996618|NCT02153736|59188916|FG000|Overall Study|Withdrawal by Subject|0|||
30996619|NCT02153736|59188917|FG001|Overall Study|Withdrawal by Subject|1|||
30996620|NCT02175966|59188925|FG000|Follow-up Period|Lack of Efficacy|10|||
30996621|NCT02175966|59188926|FG001|Follow-up Period|Lack of Efficacy|6|||
30996622|NCT02153346|59188932|FG000|Overall Study|Lost to Follow-up|11|||
30996623|NCT02174562|59188939|FG000|Overall Study|Withdrawal by Subject|7|||
30996624|NCT02174562|59188940|FG001|Overall Study|Withdrawal by Subject|2|||
30996625|NCT02174562|59188939|FG000|Overall Study|Death|2|||
30996626|NCT02174562|59188940|FG001|Overall Study|Death|0|||
30996627|NCT02174562|59188939|FG000|Overall Study|Lost to Follow-up|0|||
30996628|NCT02174562|59188940|FG001|Overall Study|Lost to Follow-up|3|||
30996629|NCT02136576|59188949|FG000|Overall Study|Lost to Follow-up|2|||
30996630|NCT02136576|59188950|FG001|Overall Study|Lost to Follow-up|0|||
30996631|NCT02136576|59188951|FG002|Overall Study|Lost to Follow-up|0|||
30996632|NCT02153112|59189208|FG000|Overall Study|Adverse Event|0|||
30996633|NCT02153112|59189209|FG001|Overall Study|Adverse Event|0|||
30996634|NCT02153112|59189210|FG002|Overall Study|Adverse Event|1|||
30996635|NCT02153112|59189211|FG003|Overall Study|Adverse Event|0|||
30996636|NCT02153112|59189212|FG004|Overall Study|Adverse Event|0|||
30996637|NCT02153112|59189213|FG005|Overall Study|Adverse Event|0|||
30996638|NCT02153112|59189214|FG006|Overall Study|Adverse Event|0|||
30996639|NCT02153112|59189215|FG007|Overall Study|Adverse Event|0|||
30996640|NCT02153112|59189216|FG008|Overall Study|Adverse Event|0|||
30996641|NCT02153112|59189217|FG009|Overall Study|Adverse Event|0|||
30996642|NCT02153112|59189208|FG000|Overall Study|Lost to Follow-up|1|||
30996643|NCT02153112|59189209|FG001|Overall Study|Lost to Follow-up|1|||
30996644|NCT02153112|59189210|FG002|Overall Study|Lost to Follow-up|0|||
30996645|NCT02153112|59189211|FG003|Overall Study|Lost to Follow-up|0|||
30996646|NCT02153112|59189212|FG004|Overall Study|Lost to Follow-up|2|||
30996647|NCT02153112|59189213|FG005|Overall Study|Lost to Follow-up|1|||
30996648|NCT02153112|59189214|FG006|Overall Study|Lost to Follow-up|1|||
30996649|NCT02153112|59189215|FG007|Overall Study|Lost to Follow-up|0|||
30996650|NCT02153112|59189216|FG008|Overall Study|Lost to Follow-up|1|||
30996651|NCT02153112|59189217|FG009|Overall Study|Lost to Follow-up|1|||
30996652|NCT02153112|59189208|FG000|Overall Study|Withdrawal by Subject|3|||
30996653|NCT02153112|59189209|FG001|Overall Study|Withdrawal by Subject|1|||
30996654|NCT02153112|59189210|FG002|Overall Study|Withdrawal by Subject|2|||
30996655|NCT02153112|59189211|FG003|Overall Study|Withdrawal by Subject|2|||
30996656|NCT02153112|59189212|FG004|Overall Study|Withdrawal by Subject|1|||
30996657|NCT02153112|59189213|FG005|Overall Study|Withdrawal by Subject|1|||
30996658|NCT02153112|59189214|FG006|Overall Study|Withdrawal by Subject|7|||
30996659|NCT02153112|59189215|FG007|Overall Study|Withdrawal by Subject|2|||
30996660|NCT02153112|59189216|FG008|Overall Study|Withdrawal by Subject|13|||
30996661|NCT02153112|59189217|FG009|Overall Study|Withdrawal by Subject|12|||
30996662|NCT02153112|59189208|FG000|Overall Study|Reason not Specified|0|||
30996663|NCT02153112|59189209|FG001|Overall Study|Reason not Specified|0|||
30996664|NCT02153112|59189210|FG002|Overall Study|Reason not Specified|0|||
30996665|NCT02153112|59189211|FG003|Overall Study|Reason not Specified|0|||
30996666|NCT02153112|59189212|FG004|Overall Study|Reason not Specified|0|||
30996667|NCT02153112|59189213|FG005|Overall Study|Reason not Specified|0|||
30996668|NCT02153112|59189214|FG006|Overall Study|Reason not Specified|0|||
30996669|NCT02153112|59189215|FG007|Overall Study|Reason not Specified|0|||
30996670|NCT02153112|59189216|FG008|Overall Study|Reason not Specified|1|||
30996671|NCT02153112|59189217|FG009|Overall Study|Reason not Specified|1|||
30996672|NCT02133924|59189267|FG000|Overall Study|Death|38|||
30996673|NCT02133924|59189267|FG000|Overall Study|Physician Decision|1|||
30996674|NCT02133924|59189267|FG000|Overall Study|Withdrawal by Subject|3|||
30996675|NCT02173704|59189358|FG000|Overall Study|Adverse Event|1|||
30996676|NCT02173704|59189359|FG001|Overall Study|Adverse Event|0|||
30996677|NCT02173704|59189358|FG000|Overall Study|Lost to Follow-up|1|||
30996678|NCT02173704|59189359|FG001|Overall Study|Lost to Follow-up|0|||
30996679|NCT02173704|59189358|FG000|Overall Study|Other|1|||
30996680|NCT02173704|59189359|FG001|Overall Study|Other|0|||
30996681|NCT02173704|59189358|FG000|Overall Study|Protocol Violation|1|||
30996682|NCT02173704|59189359|FG001|Overall Study|Protocol Violation|0|||
30996683|NCT02173704|59189358|FG000|Overall Study|Withdrawal by Subject|9|||
30996684|NCT02173704|59189359|FG001|Overall Study|Withdrawal by Subject|4|||
30996685|NCT02173548|59189380|FG000|Overall Study|Lost to Follow-up|0|||
30996686|NCT02173548|59189381|FG001|Overall Study|Lost to Follow-up|2|||
30996687|NCT02173548|59189380|FG000|Overall Study|Withdrawal by Subject|1|||
30996688|NCT02173548|59189381|FG001|Overall Study|Withdrawal by Subject|0|||
30996689|NCT02173158|59189397|FG000|Efficacy Phase|Adverse Event|1|||
30996690|NCT02152566|59189419|FG000|Overall Study|Lost to Follow-up|1|||
30996691|NCT02152566|59189419|FG000|Overall Study|Withdrawal by Subject|2|||
30996692|NCT02171130|59189448|FG000|Overall Study|Death|1|||
30996693|NCT02171130|59189448|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
30996694|NCT02171130|59189448|FG000|Overall Study|Discontinued; Site Termination|5|||
30996695|NCT02171130|59189448|FG000|Overall Study|Withdrawal by Subject|3|||
30996696|NCT02171130|59189448|FG000|Overall Study|Physician Decision|1|||
30996697|NCT02171130|59189448|FG000|Overall Study|Lost to Follow-up|1|||
30996698|NCT02171130|59189448|FG000|Overall Study|Met Exclusion Criteria|1|||
30996699|NCT03603314|59195329|FG000|Overall Study|Lost to Follow-up|0|||
30996700|NCT03603314|59195330|FG001|Overall Study|Lost to Follow-up|3|||
30996701|NCT03603314|59195331|FG002|Overall Study|Lost to Follow-up|0|||
30996702|NCT03603314|59195329|FG000|Overall Study|Protocol Violation|0|||
30996703|NCT03603314|59195330|FG001|Overall Study|Protocol Violation|1|||
30996704|NCT03603314|59195331|FG002|Overall Study|Protocol Violation|0|||
30996705|NCT03603314|59195329|FG000|Overall Study|Adverse Event|2|||
30996706|NCT03603314|59195330|FG001|Overall Study|Adverse Event|0|||
30996707|NCT03603314|59195331|FG002|Overall Study|Adverse Event|0|||
30996708|NCT03603314|59195329|FG000|Overall Study|Physician Decision|1|||
30996709|NCT03603314|59195330|FG001|Overall Study|Physician Decision|1|||
30996710|NCT03603314|59195331|FG002|Overall Study|Physician Decision|0|||
30996711|NCT03603314|59195329|FG000|Overall Study|Withdrawal by Subject|4|||
30996712|NCT03603314|59195330|FG001|Overall Study|Withdrawal by Subject|5|||
30996713|NCT03603314|59195331|FG002|Overall Study|Withdrawal by Subject|3|||
30996714|NCT03603314|59195329|FG000|Overall Study|Other|0|||
30996715|NCT03603314|59195330|FG001|Overall Study|Other|1|||
30996716|NCT03603314|59195331|FG002|Overall Study|Other|0|||
30996717|NCT04302350|59195346|FG000|Overall Study|Physician Decision|1|||
30996718|NCT04302350|59195347|FG001|Overall Study|Physician Decision|1|||
30996719|NCT04302350|59195348|FG002|Overall Study|Physician Decision|2|||
30996720|NCT04302350|59195346|FG000|Overall Study|Lack of Efficacy|1|||
30996721|NCT04302350|59195347|FG001|Overall Study|Lack of Efficacy|1|||
30996722|NCT04302350|59195348|FG002|Overall Study|Lack of Efficacy|4|||
30996723|NCT04302350|59195346|FG000|Overall Study|Adverse Event|0|||
30996724|NCT04302350|59195347|FG001|Overall Study|Adverse Event|1|||
30996725|NCT04302350|59195348|FG002|Overall Study|Adverse Event|2|||
30996726|NCT02335424|59195370|FG000|Overall Study|Withdrawal by Subject|19|||
30996727|NCT02335424|59195370|FG000|Overall Study|Adverse Event|25|||
30996728|NCT02335424|59195370|FG000|Overall Study|Death|273|||
30996729|NCT02335424|59195370|FG000|Overall Study|Lost to Follow-up|3|||
30996730|NCT02335424|59195370|FG000|Overall Study|Physician Decision|13|||
30996731|NCT02335424|59195370|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
30996732|NCT02335424|59195370|FG000|Overall Study|Protocol Violation|1|||
30996733|NCT02335424|59195370|FG000|Overall Study|Screen failure|1|||
30996734|NCT03805412|59195377|FG000|Overall Study|Lost to Follow-up|0|||
30996735|NCT03805412|59195378|FG001|Overall Study|Lost to Follow-up|1|||
30996736|NCT04791319|59195398|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
30996737|NCT04791319|59195399|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
30996738|NCT04791319|59195400|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
30996739|NCT04791319|59195401|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
30996740|NCT04791319|59195402|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
30996741|NCT04791319|59195403|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
30996742|NCT04791319|59195404|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
30996743|NCT04791319|59195405|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
30996744|NCT04791319|59195406|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
30996745|NCT04791319|59195407|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
30996746|NCT04791319|59195408|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
30996747|NCT04791319|59195398|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
30996748|NCT04791319|59195399|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
30996749|NCT04791319|59195400|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
30996750|NCT04791319|59195401|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
30996751|NCT04791319|59195402|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
30996752|NCT04791319|59195403|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
30996753|NCT04791319|59195404|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
30996754|NCT04791319|59195405|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
30996755|NCT04791319|59195406|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
30996756|NCT04791319|59195407|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
30996757|NCT04791319|59195408|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
30996758|NCT04791319|59195398|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
30996759|NCT04791319|59195399|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
30996760|NCT04791319|59195400|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
30996761|NCT04791319|59195401|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
30996762|NCT04791319|59195402|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
30996763|NCT04791319|59195403|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
30996764|NCT04791319|59195404|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
30996765|NCT04791319|59195405|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
30996766|NCT04791319|59195406|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
30996767|NCT04791319|59195407|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
30996768|NCT04791319|59195408|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
30996769|NCT04791319|59195398|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
30996770|NCT04791319|59195399|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
30996771|NCT04791319|59195400|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
30996772|NCT04791319|59195401|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
30996773|NCT04791319|59195402|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
30996774|NCT04791319|59195403|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
30996775|NCT04791319|59195404|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
30996776|NCT04791319|59195405|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
30996777|NCT04791319|59195406|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
30996778|NCT04791319|59195407|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
30996779|NCT04791319|59195408|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
30996780|NCT04791319|59195398|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
30996781|NCT04791319|59195399|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
30996782|NCT04791319|59195400|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
30996783|NCT04791319|59195401|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
30996784|NCT04791319|59195402|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
30996785|NCT04791319|59195403|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
30996786|NCT04791319|59195404|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
30996787|NCT04791319|59195405|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
30996788|NCT04791319|59195406|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
30996789|NCT04791319|59195407|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
30996790|NCT04791319|59195408|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
30996791|NCT04791319|59195398|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
30996792|NCT04791319|59195399|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
30996793|NCT04791319|59195400|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
30996794|NCT04791319|59195401|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
30996795|NCT04791319|59195402|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
30996796|NCT04791319|59195403|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
30996797|NCT04791319|59195404|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
30996798|NCT04791319|59195405|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
30996799|NCT04791319|59195406|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
30996800|NCT04791319|59195407|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
30996801|NCT04791319|59195408|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
30996802|NCT04791319|59195398|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
30996803|NCT04791319|59195399|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
30996804|NCT04791319|59195400|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
30996805|NCT04791319|59195401|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
30996806|NCT04791319|59195402|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
30996807|NCT04791319|59195403|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
30996808|NCT04791319|59195404|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
30996809|NCT04791319|59195405|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
30996810|NCT04791319|59195406|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
30996811|NCT04791319|59195407|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
30996812|NCT04791319|59195408|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
30996813|NCT04791319|59195398|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
30996814|NCT04791319|59195399|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
30996815|NCT04791319|59195400|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
30996816|NCT04791319|59195401|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
30996817|NCT04791319|59195402|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
30996818|NCT04791319|59195403|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
30996819|NCT04791319|59195404|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
30996820|NCT04791319|59195405|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
30891982|NCT02250651|58925285|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
30891983|NCT02250651|58925283|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
30891984|NCT02250651|58925284|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
30891985|NCT02250651|58925285|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
30891986|NCT02250651|58925283|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
30891987|NCT02250651|58925284|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
30891988|NCT02250651|58925285|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
30891989|NCT02377921|58925295|FG000|Overall Study|Subject non-compliance|1|||
30891990|NCT02377921|58925296|FG001|Overall Study|Subject non-compliance|1|||
30891991|NCT02311153|58925304|FG000|Overall Study|Lost to Follow-up|5|||
30891992|NCT02311153|58925305|FG001|Overall Study|Lost to Follow-up|7|||
30891993|NCT02195427|58925313|FG000|Overall Study|Did not consent to study extension|13|||
30891994|NCT02195427|58925314|FG001|Overall Study|Did not consent to study extension|9|||
30891995|NCT02195427|58925313|FG000|Overall Study|Withdrawal by Subject|4|||
30891996|NCT02195427|58925314|FG001|Overall Study|Withdrawal by Subject|2|||
30891997|NCT02195427|58925313|FG000|Overall Study|Lost to Follow-up|0|||
30891998|NCT02195427|58925314|FG001|Overall Study|Lost to Follow-up|1|||
30891999|NCT02195427|58925313|FG000|Overall Study|Protocol Violation|7|||
30892000|NCT02195427|58925314|FG001|Overall Study|Protocol Violation|14|||
30892001|NCT02195427|58925313|FG000|Overall Study|Conditional re-treatment at W52|2|||
30892002|NCT02195427|58925314|FG001|Overall Study|Conditional re-treatment at W52|1|||
30892003|NCT02214225|58925327|FG000|Overall Study|Lost to Follow-up|46|||
30892004|NCT02214225|58925328|FG001|Overall Study|Lost to Follow-up|18|||
30892005|NCT02214225|58925329|FG002|Overall Study|Lost to Follow-up|18|||
30892006|NCT02214225|58925327|FG000|Overall Study|Withdrawal by Subject|2|||
30892007|NCT02214225|58925328|FG001|Overall Study|Withdrawal by Subject|0|||
30892008|NCT02214225|58925329|FG002|Overall Study|Withdrawal by Subject|2|||
30892009|NCT02214225|58925327|FG000|Overall Study|Death|5|||
30892010|NCT02214225|58925328|FG001|Overall Study|Death|0|||
30892011|NCT02214225|58925329|FG002|Overall Study|Death|1|||
30892012|NCT02214225|58925327|FG000|Overall Study|randomized in error, not vaccinated|2|||
30892013|NCT02214225|58925328|FG001|Overall Study|randomized in error, not vaccinated|1|||
30892014|NCT02214225|58925329|FG002|Overall Study|randomized in error, not vaccinated|1|||
30892015|NCT02250183|58925360|FG000|Overall Study|Withdrawal by Subject|2|||
30892016|NCT02250183|58925360|FG000|Overall Study|Adverse Event|5|||
30892017|NCT02250183|58925360|FG000|Overall Study|Lost to Follow-up|1|||
30892018|NCT02249949|58925367|FG000|Overall Study|Cancelled prior to treatment|2|||
30892019|NCT02249091|58925373|FG000|Overall Study|Lack of Efficacy|8|||
30892020|NCT02249091|58925374|FG001|Overall Study|Lack of Efficacy|3|||
30892021|NCT02249091|58925373|FG000|Overall Study|Physician Decision|4|||
30892022|NCT02249091|58925374|FG001|Overall Study|Physician Decision|1|||
30892023|NCT02249091|58925373|FG000|Overall Study|Withdrawal by Subject|2|||
30892024|NCT02249091|58925374|FG001|Overall Study|Withdrawal by Subject|2|||
30892025|NCT02249091|58925373|FG000|Overall Study|Death|3|||
30892026|NCT02249091|58925374|FG001|Overall Study|Death|4|||
30892027|NCT02249091|58925373|FG000|Overall Study|Adverse Event|1|||
30892028|NCT02249091|58925374|FG001|Overall Study|Adverse Event|0|||
30892029|NCT02249091|58925373|FG000|Overall Study|Stable disease with following SCT|0|||
30892030|NCT02249091|58925374|FG001|Overall Study|Stable disease with following SCT|1|||
30892031|NCT02249091|58925373|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
30892032|NCT02249091|58925374|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
30892033|NCT02249091|58925373|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
30892034|NCT02249091|58925374|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
30892035|NCT02249091|58925373|FG000|Overall Study|Refractory AML|1|||
30892036|NCT02249091|58925374|FG001|Overall Study|Refractory AML|1|||
30892037|NCT02248857|58925383|FG000|3 Month|Withdrawal by Subject|9|||
30892038|NCT02248857|58925384|FG001|3 Month|Withdrawal by Subject|3|||
30892039|NCT02248857|58925385|FG002|3 Month|Withdrawal by Subject|4|||
30892040|NCT02248857|58925383|FG000|3 Month|Unable to reach for 3 month|35|||
30892041|NCT02248857|58925384|FG001|3 Month|Unable to reach for 3 month|29|||
30892042|NCT02248857|58925385|FG002|3 Month|Unable to reach for 3 month|26|||
30892043|NCT02248857|58925383|FG000|3 Month|Partially completed, unable to finish|2|||
30892044|NCT02248857|58925384|FG001|3 Month|Partially completed, unable to finish|2|||
30892045|NCT02248857|58925385|FG002|3 Month|Partially completed, unable to finish|1|||
30892046|NCT02248857|58925383|FG000|6 Month|Lost to Follow-up|27|||
30892047|NCT02248857|58925384|FG001|6 Month|Lost to Follow-up|26|||
30892048|NCT02248857|58925385|FG002|6 Month|Lost to Follow-up|15|||
30892049|NCT02248857|58925383|FG000|6 Month|Partially completed, unable to finish|0|||
30892050|NCT02248857|58925384|FG001|6 Month|Partially completed, unable to finish|1|||
30892051|NCT02248857|58925385|FG002|6 Month|Partially completed, unable to finish|0|||
30892052|NCT02248857|58925383|FG000|6 Month|Withdrawal by Subject|0|||
30892053|NCT02248857|58925384|FG001|6 Month|Withdrawal by Subject|2|||
30892054|NCT02248857|58925385|FG002|6 Month|Withdrawal by Subject|2|||
30892055|NCT02248857|58925383|FG000|6 Month|Death|1|||
30892056|NCT02248857|58925384|FG001|6 Month|Death|0|||
30892057|NCT02248857|58925385|FG002|6 Month|Death|0|||
30892058|NCT02213055|58925395|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
30892059|NCT02213055|58925396|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
30892060|NCT02213055|58925395|FG000|Overall Study|Protocol was not Followed during Study|1|||
30892061|NCT02213055|58925396|FG001|Overall Study|Protocol was not Followed during Study|0|||
30892062|NCT02213055|58925395|FG000|Overall Study|Documentation Issue at Enrollment|1|||
30892063|NCT02213055|58925396|FG001|Overall Study|Documentation Issue at Enrollment|0|||
30892064|NCT02213055|58925395|FG000|Overall Study|Documentation Issue during Study|10|||
30892065|NCT02213055|58925396|FG001|Overall Study|Documentation Issue during Study|0|||
30892066|NCT02213055|58925395|FG000|Overall Study|Did not have Live Lice|8|||
30892067|NCT02213055|58925396|FG001|Overall Study|Did not have Live Lice|0|||
30892068|NCT02213055|58925395|FG000|Overall Study|Had another Treatment during the Study|3|||
30892069|NCT02213055|58925396|FG001|Overall Study|Had another Treatment during the Study|0|||
30892070|NCT02213055|58925395|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
30892071|NCT02213055|58925396|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
30892072|NCT02213055|58925395|FG000|Overall Study|Did not Return to School|5|||
30892073|NCT02213055|58925396|FG001|Overall Study|Did not Return to School|0|||
30892074|NCT02310763|58925405|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
30892075|NCT02310763|58925406|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
30892076|NCT02310763|58925407|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
30892077|NCT02310763|58925405|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
30892078|NCT02310763|58925406|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
30892079|NCT02310763|58925407|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
30892080|NCT02310763|58925405|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
30892081|NCT02310763|58925406|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
30892082|NCT02310763|58925407|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
30892083|NCT02310763|58925405|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
30892084|NCT02310763|58925406|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
30892085|NCT02310763|58925407|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
30892086|NCT02310763|58925405|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
30892087|NCT02310763|58925406|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
30892088|NCT02310763|58925407|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
30892089|NCT02342743|58925433|FG000|Baseline Period|Withdrawal by Subject|3|||
30892090|NCT02342743|58925433|FG000|Baseline Period|Lost to Follow-up|2|||
30892091|NCT02342743|58925433|FG000|Baseline Period|Change in prophylactic medication|3|||
30892092|NCT02342743|58925433|FG000|Baseline Period|Screening failure regarding baseline|7|||
30892093|NCT02342743|58925433|FG000|Treatment Period|Withdrawal by Subject|2|||
30892094|NCT02342743|58925433|FG000|Treatment Period|Lost to Follow-up|8|||
30892095|NCT02342743|58925433|FG000|Treatment Period|Change in prophylactic medication|1|||
30892096|NCT02377063|58925437|FG000|Overall Study|Non-compliance|5|||
30892097|NCT02309515|58925443|FG000|Overall Study|Withdrawal by Subject|0|||
30996821|NCT04791319|59195406|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
30996822|NCT04791319|59195407|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
30996823|NCT04791319|59195408|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
30996824|NCT04791319|59195398|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
30996825|NCT04791319|59195399|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
30996826|NCT04791319|59195400|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
30996827|NCT04791319|59195401|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
30996828|NCT04791319|59195402|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
30996829|NCT04791319|59195403|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
30996830|NCT04791319|59195404|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
30996831|NCT04791319|59195405|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
30996832|NCT04791319|59195406|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
30996833|NCT04791319|59195407|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
30996834|NCT04791319|59195408|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
30996835|NCT03472495|59195465|FG000|Overall Study|Treatment no longer indicated|1|||
30996836|NCT03472495|59195466|FG001|Overall Study|Treatment no longer indicated|2|||
30996837|NCT03472495|59195465|FG000|Overall Study|Physician Decision|0|||
30996838|NCT03472495|59195466|FG001|Overall Study|Physician Decision|2|||
30790226|NCT00035555|58803456|FG000|Overall Study|Noncompliance|0|||
30996839|NCT03234907|59195474|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
30996840|NCT03234907|59195475|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
30996841|NCT03234907|59195476|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
30996842|NCT03234907|59195477|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
30996843|NCT03234907|59195478|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
30996844|NCT03234907|59195479|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
30996845|NCT03234907|59195474|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
30996846|NCT03234907|59195475|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
30996847|NCT03234907|59195476|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
30996848|NCT03234907|59195477|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
30996849|NCT03234907|59195478|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
30996850|NCT03234907|59195479|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
30996851|NCT03234907|59195474|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
30996852|NCT03234907|59195475|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
30996853|NCT03234907|59195476|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
30996854|NCT03234907|59195477|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
30996855|NCT03234907|59195478|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
30996856|NCT03234907|59195479|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
30996857|NCT03234907|59195474|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
30996858|NCT03234907|59195475|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
30996859|NCT03234907|59195476|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
30996860|NCT03234907|59195477|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
30996861|NCT03234907|59195478|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
30996862|NCT03234907|59195479|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
30996863|NCT03234907|59195474|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
30996864|NCT03234907|59195475|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
30996865|NCT03234907|59195476|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
30996866|NCT03234907|59195477|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
30996867|NCT03234907|59195478|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
30996868|NCT03234907|59195479|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
30996869|NCT03234907|59195474|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
30996870|NCT03234907|59195475|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
30996871|NCT03234907|59195476|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
30996872|NCT03234907|59195477|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
30996873|NCT03234907|59195478|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
30996874|NCT03234907|59195479|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
30996875|NCT03234907|59195474|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
30996876|NCT03234907|59195475|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
30996877|NCT03234907|59195476|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
30996878|NCT03234907|59195477|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
30996879|NCT03234907|59195478|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
30996880|NCT03234907|59195479|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
30996881|NCT03818581|59195493|FG000|Overall Study|Adverse Event|1|||
30996882|NCT03818581|59195494|FG001|Overall Study|Adverse Event|0|||
30996883|NCT03818581|59195495|FG002|Overall Study|Adverse Event|0|||
30996884|NCT03818581|59195496|FG003|Overall Study|Adverse Event|0|||
30996885|NCT03818581|59195497|FG004|Overall Study|Adverse Event|0|||
30996886|NCT03818581|59195493|FG000|Overall Study|Covid-19|2|||
30996887|NCT03818581|59195494|FG001|Overall Study|Covid-19|0|||
30996888|NCT03818581|59195495|FG002|Overall Study|Covid-19|0|||
30996889|NCT03818581|59195496|FG003|Overall Study|Covid-19|0|||
30996890|NCT03818581|59195497|FG004|Overall Study|Covid-19|1|||
30996891|NCT03818581|59195493|FG000|Overall Study|Withdrawal by Subject|0|||
30996892|NCT03818581|59195494|FG001|Overall Study|Withdrawal by Subject|0|||
30996893|NCT03818581|59195495|FG002|Overall Study|Withdrawal by Subject|0|||
30996894|NCT03818581|59195496|FG003|Overall Study|Withdrawal by Subject|0|||
30996895|NCT03818581|59195497|FG004|Overall Study|Withdrawal by Subject|1|||
30996896|NCT03818581|59195493|FG000|Overall Study|No longer met study criteria|1|||
30996897|NCT03818581|59195494|FG001|Overall Study|No longer met study criteria|0|||
30996898|NCT03818581|59195495|FG002|Overall Study|No longer met study criteria|0|||
30996899|NCT03818581|59195496|FG003|Overall Study|No longer met study criteria|0|||
30996900|NCT03818581|59195497|FG004|Overall Study|No longer met study criteria|2|||
30996901|NCT03736447|59195511|FG000|Overall Study|Adverse Event|5|||
30996902|NCT03736447|59195512|FG001|Overall Study|Adverse Event|1|||
30996903|NCT03736447|59195511|FG000|Overall Study|Withdrawal by Subject|5|||
30996904|NCT03736447|59195512|FG001|Overall Study|Withdrawal by Subject|1|||
30996905|NCT03736447|59195511|FG000|Overall Study|Lost to Follow-up|1|||
30996906|NCT03736447|59195512|FG001|Overall Study|Lost to Follow-up|0|||
30996907|NCT03736447|59195511|FG000|Overall Study|Physician Decision|1|||
30996908|NCT03736447|59195512|FG001|Overall Study|Physician Decision|0|||
30996909|NCT03736447|59195511|FG000|Overall Study|Continued commitment to study treatment|3|||
30996910|NCT03736447|59195512|FG001|Overall Study|Continued commitment to study treatment|0|||
30996911|NCT03736447|59195511|FG000|Overall Study|Taste aversion to study product|0|||
30996912|NCT03736447|59195512|FG001|Overall Study|Taste aversion to study product|1|||
30996913|NCT02132754|59195561|FG000|Overall Study|Adverse Event|0|||
30996914|NCT02132754|59195562|FG001|Overall Study|Adverse Event|0|||
30996915|NCT02132754|59195563|FG002|Overall Study|Adverse Event|0|||
30996916|NCT02132754|59195564|FG003|Overall Study|Adverse Event|0|||
30996917|NCT02132754|59195565|FG004|Overall Study|Adverse Event|0|||
30996918|NCT02132754|59195566|FG005|Overall Study|Adverse Event|0|||
30996919|NCT02132754|59195567|FG006|Overall Study|Adverse Event|0|||
30996920|NCT02132754|59195568|FG007|Overall Study|Adverse Event|0|||
30996921|NCT02132754|59195569|FG008|Overall Study|Adverse Event|0|||
30996922|NCT02132754|59195570|FG009|Overall Study|Adverse Event|0|||
30996923|NCT02132754|59195571|FG010|Overall Study|Adverse Event|0|||
30996924|NCT02132754|59195572|FG011|Overall Study|Adverse Event|0|||
30996925|NCT02132754|59195573|FG012|Overall Study|Adverse Event|0|||
30996926|NCT02132754|59195574|FG013|Overall Study|Adverse Event|0|||
30996927|NCT02132754|59195575|FG014|Overall Study|Adverse Event|0|||
30996928|NCT02132754|59195576|FG015|Overall Study|Adverse Event|0|||
30996929|NCT02132754|59195577|FG016|Overall Study|Adverse Event|0|||
30996930|NCT02132754|59195578|FG017|Overall Study|Adverse Event|1|||
30996931|NCT02132754|59195579|FG018|Overall Study|Adverse Event|0|||
30996932|NCT02132754|59195580|FG019|Overall Study|Adverse Event|0|||
30996933|NCT02132754|59195581|FG020|Overall Study|Adverse Event|0|||
30996934|NCT02132754|59195582|FG021|Overall Study|Adverse Event|0|||
30996935|NCT02132754|59195583|FG022|Overall Study|Adverse Event|0|||
30996936|NCT02132754|59195584|FG023|Overall Study|Adverse Event|0|||
30996937|NCT02132754|59195585|FG024|Overall Study|Adverse Event|0|||
30996938|NCT02132754|59195586|FG025|Overall Study|Adverse Event|1|||
30996939|NCT02132754|59195587|FG026|Overall Study|Adverse Event|1|||
30996940|NCT02132754|59195588|FG027|Overall Study|Adverse Event|0|||
30996941|NCT02132754|59195589|FG028|Overall Study|Adverse Event|0|||
30996942|NCT02132754|59195590|FG029|Overall Study|Adverse Event|0|||
30996943|NCT02132754|59195591|FG030|Overall Study|Adverse Event|1|||
30996944|NCT02132754|59195592|FG031|Overall Study|Adverse Event|0|||
30996945|NCT02132754|59195593|FG032|Overall Study|Adverse Event|1|||
30996946|NCT02132754|59195594|FG033|Overall Study|Adverse Event|1|||
30996947|NCT02132754|59195561|FG000|Overall Study|Clinical Progression|0|||
30996948|NCT02132754|59195562|FG001|Overall Study|Clinical Progression|0|||
30996949|NCT02132754|59195563|FG002|Overall Study|Clinical Progression|0|||
30996950|NCT02132754|59195564|FG003|Overall Study|Clinical Progression|0|||
30996951|NCT02132754|59195565|FG004|Overall Study|Clinical Progression|0|||
30996952|NCT02132754|59195566|FG005|Overall Study|Clinical Progression|0|||
30996953|NCT02132754|59195567|FG006|Overall Study|Clinical Progression|0|||
30996954|NCT02132754|59195568|FG007|Overall Study|Clinical Progression|0|||
30996955|NCT02132754|59195569|FG008|Overall Study|Clinical Progression|0|||
30996956|NCT02132754|59195570|FG009|Overall Study|Clinical Progression|1|||
30996957|NCT02132754|59195571|FG010|Overall Study|Clinical Progression|0|||
30996958|NCT02132754|59195572|FG011|Overall Study|Clinical Progression|0|||
30996959|NCT02132754|59195573|FG012|Overall Study|Clinical Progression|0|||
30996960|NCT02132754|59195574|FG013|Overall Study|Clinical Progression|0|||
30996961|NCT02132754|59195575|FG014|Overall Study|Clinical Progression|0|||
30996962|NCT02132754|59195576|FG015|Overall Study|Clinical Progression|0|||
30996963|NCT02132754|59195577|FG016|Overall Study|Clinical Progression|1|||
30996964|NCT02132754|59195578|FG017|Overall Study|Clinical Progression|1|||
30996965|NCT02132754|59195579|FG018|Overall Study|Clinical Progression|0|||
30996966|NCT02132754|59195580|FG019|Overall Study|Clinical Progression|1|||
30996967|NCT02132754|59195581|FG020|Overall Study|Clinical Progression|0|||
30996968|NCT02132754|59195582|FG021|Overall Study|Clinical Progression|0|||
30996969|NCT02132754|59195583|FG022|Overall Study|Clinical Progression|1|||
30996970|NCT02132754|59195584|FG023|Overall Study|Clinical Progression|0|||
30996971|NCT02132754|59195585|FG024|Overall Study|Clinical Progression|1|||
30996972|NCT02132754|59195586|FG025|Overall Study|Clinical Progression|1|||
30996973|NCT02132754|59195587|FG026|Overall Study|Clinical Progression|0|||
30996974|NCT02132754|59195588|FG027|Overall Study|Clinical Progression|1|||
30996975|NCT02132754|59195589|FG028|Overall Study|Clinical Progression|1|||
30996976|NCT02132754|59195590|FG029|Overall Study|Clinical Progression|0|||
30996977|NCT02132754|59195591|FG030|Overall Study|Clinical Progression|1|||
30996978|NCT02132754|59195592|FG031|Overall Study|Clinical Progression|0|||
30996979|NCT02132754|59195593|FG032|Overall Study|Clinical Progression|0|||
30996980|NCT02132754|59195594|FG033|Overall Study|Clinical Progression|2|||
30996981|NCT02132754|59195561|FG000|Overall Study|Death|0|||
30996982|NCT02132754|59195562|FG001|Overall Study|Death|0|||
30996983|NCT02132754|59195563|FG002|Overall Study|Death|0|||
30996984|NCT02132754|59195564|FG003|Overall Study|Death|0|||
30996985|NCT02132754|59195565|FG004|Overall Study|Death|0|||
30996986|NCT02132754|59195566|FG005|Overall Study|Death|0|||
30996987|NCT02132754|59195567|FG006|Overall Study|Death|0|||
30996988|NCT02132754|59195568|FG007|Overall Study|Death|0|||
30996989|NCT02132754|59195569|FG008|Overall Study|Death|0|||
30996990|NCT02132754|59195570|FG009|Overall Study|Death|0|||
30996991|NCT02132754|59195571|FG010|Overall Study|Death|0|||
30996992|NCT02132754|59195572|FG011|Overall Study|Death|0|||
30996993|NCT02132754|59195573|FG012|Overall Study|Death|0|||
30996994|NCT02132754|59195574|FG013|Overall Study|Death|0|||
30996995|NCT02132754|59195575|FG014|Overall Study|Death|0|||
30996996|NCT02132754|59195576|FG015|Overall Study|Death|1|||
30996997|NCT02132754|59195577|FG016|Overall Study|Death|0|||
30996998|NCT02132754|59195578|FG017|Overall Study|Death|0|||
30996999|NCT02132754|59195579|FG018|Overall Study|Death|0|||
30997000|NCT02132754|59195580|FG019|Overall Study|Death|1|||
30997001|NCT02132754|59195581|FG020|Overall Study|Death|0|||
30997002|NCT02132754|59195582|FG021|Overall Study|Death|1|||
30997003|NCT02132754|59195583|FG022|Overall Study|Death|0|||
30997004|NCT02132754|59195584|FG023|Overall Study|Death|0|||
30997005|NCT02132754|59195585|FG024|Overall Study|Death|0|||
30997006|NCT02132754|59195586|FG025|Overall Study|Death|0|||
30997007|NCT02132754|59195587|FG026|Overall Study|Death|1|||
30997008|NCT02132754|59195588|FG027|Overall Study|Death|0|||
30997009|NCT02132754|59195589|FG028|Overall Study|Death|0|||
30997010|NCT02132754|59195590|FG029|Overall Study|Death|0|||
30997011|NCT02132754|59195591|FG030|Overall Study|Death|0|||
30997012|NCT02132754|59195592|FG031|Overall Study|Death|0|||
30997013|NCT02132754|59195593|FG032|Overall Study|Death|0|||
30997014|NCT02132754|59195594|FG033|Overall Study|Death|2|||
30997015|NCT02132754|59195561|FG000|Overall Study|Excluded Medication|0|||
30997016|NCT02132754|59195562|FG001|Overall Study|Excluded Medication|0|||
30997017|NCT02132754|59195563|FG002|Overall Study|Excluded Medication|0|||
30997018|NCT02132754|59195564|FG003|Overall Study|Excluded Medication|0|||
30997019|NCT02132754|59195565|FG004|Overall Study|Excluded Medication|0|||
30997020|NCT02132754|59195566|FG005|Overall Study|Excluded Medication|0|||
30997021|NCT02132754|59195567|FG006|Overall Study|Excluded Medication|0|||
30997022|NCT02132754|59195568|FG007|Overall Study|Excluded Medication|0|||
30997023|NCT02132754|59195569|FG008|Overall Study|Excluded Medication|0|||
30997024|NCT02132754|59195570|FG009|Overall Study|Excluded Medication|0|||
30997025|NCT02132754|59195571|FG010|Overall Study|Excluded Medication|0|||
30997026|NCT02132754|59195572|FG011|Overall Study|Excluded Medication|0|||
30997027|NCT02132754|59195573|FG012|Overall Study|Excluded Medication|0|||
30997028|NCT02132754|59195574|FG013|Overall Study|Excluded Medication|0|||
30997029|NCT02132754|59195575|FG014|Overall Study|Excluded Medication|0|||
30997030|NCT02132754|59195576|FG015|Overall Study|Excluded Medication|0|||
30997031|NCT02132754|59195577|FG016|Overall Study|Excluded Medication|0|||
30997032|NCT02132754|59195578|FG017|Overall Study|Excluded Medication|0|||
30997033|NCT02132754|59195579|FG018|Overall Study|Excluded Medication|0|||
30997034|NCT02132754|59195580|FG019|Overall Study|Excluded Medication|0|||
30997035|NCT02132754|59195581|FG020|Overall Study|Excluded Medication|1|||
30997036|NCT02132754|59195582|FG021|Overall Study|Excluded Medication|0|||
30997037|NCT02132754|59195583|FG022|Overall Study|Excluded Medication|0|||
30997038|NCT02132754|59195584|FG023|Overall Study|Excluded Medication|0|||
30997039|NCT02132754|59195585|FG024|Overall Study|Excluded Medication|0|||
30997040|NCT02132754|59195586|FG025|Overall Study|Excluded Medication|0|||
30997041|NCT02132754|59195587|FG026|Overall Study|Excluded Medication|0|||
30997042|NCT02132754|59195588|FG027|Overall Study|Excluded Medication|0|||
30997043|NCT02132754|59195589|FG028|Overall Study|Excluded Medication|0|||
30997044|NCT02132754|59195590|FG029|Overall Study|Excluded Medication|0|||
30997045|NCT02132754|59195591|FG030|Overall Study|Excluded Medication|0|||
30997046|NCT02132754|59195592|FG031|Overall Study|Excluded Medication|0|||
30997047|NCT02132754|59195593|FG032|Overall Study|Excluded Medication|0|||
30997048|NCT02132754|59195594|FG033|Overall Study|Excluded Medication|1|||
30997049|NCT02132754|59195561|FG000|Overall Study|Physician Decision|0|||
30997050|NCT02132754|59195562|FG001|Overall Study|Physician Decision|0|||
30997051|NCT02132754|59195563|FG002|Overall Study|Physician Decision|0|||
30997052|NCT02132754|59195564|FG003|Overall Study|Physician Decision|0|||
30997053|NCT02132754|59195565|FG004|Overall Study|Physician Decision|0|||
30997054|NCT02132754|59195566|FG005|Overall Study|Physician Decision|0|||
30997055|NCT02132754|59195567|FG006|Overall Study|Physician Decision|0|||
30997056|NCT02132754|59195568|FG007|Overall Study|Physician Decision|0|||
30997057|NCT02132754|59195569|FG008|Overall Study|Physician Decision|0|||
30997058|NCT02132754|59195570|FG009|Overall Study|Physician Decision|1|||
30997059|NCT02132754|59195571|FG010|Overall Study|Physician Decision|0|||
30997060|NCT02132754|59195572|FG011|Overall Study|Physician Decision|1|||
30997061|NCT02132754|59195573|FG012|Overall Study|Physician Decision|1|||
30997062|NCT02132754|59195574|FG013|Overall Study|Physician Decision|0|||
30997063|NCT02132754|59195575|FG014|Overall Study|Physician Decision|0|||
30997064|NCT02132754|59195576|FG015|Overall Study|Physician Decision|1|||
30997065|NCT02132754|59195577|FG016|Overall Study|Physician Decision|0|||
30997066|NCT02132754|59195578|FG017|Overall Study|Physician Decision|0|||
30997067|NCT02132754|59195579|FG018|Overall Study|Physician Decision|0|||
30997068|NCT02132754|59195580|FG019|Overall Study|Physician Decision|0|||
30997069|NCT02132754|59195581|FG020|Overall Study|Physician Decision|0|||
30997070|NCT02132754|59195582|FG021|Overall Study|Physician Decision|0|||
30997071|NCT02132754|59195583|FG022|Overall Study|Physician Decision|0|||
30997072|NCT02132754|59195584|FG023|Overall Study|Physician Decision|0|||
30997073|NCT02132754|59195585|FG024|Overall Study|Physician Decision|1|||
30997074|NCT02132754|59195586|FG025|Overall Study|Physician Decision|0|||
30997075|NCT02132754|59195587|FG026|Overall Study|Physician Decision|0|||
30997076|NCT02132754|59195588|FG027|Overall Study|Physician Decision|0|||
30997077|NCT02132754|59195589|FG028|Overall Study|Physician Decision|0|||
30997078|NCT02132754|59195590|FG029|Overall Study|Physician Decision|0|||
30997079|NCT02132754|59195591|FG030|Overall Study|Physician Decision|0|||
30997080|NCT02132754|59195592|FG031|Overall Study|Physician Decision|1|||
30997081|NCT02132754|59195593|FG032|Overall Study|Physician Decision|0|||
30997082|NCT02132754|59195594|FG033|Overall Study|Physician Decision|3|||
30997083|NCT02132754|59195561|FG000|Overall Study|Progressive Disease|1|||
30997084|NCT02132754|59195562|FG001|Overall Study|Progressive Disease|1|||
30997085|NCT02132754|59195563|FG002|Overall Study|Progressive Disease|1|||
30997086|NCT02132754|59195564|FG003|Overall Study|Progressive Disease|1|||
30997087|NCT02132754|59195565|FG004|Overall Study|Progressive Disease|1|||
30997088|NCT02132754|59195566|FG005|Overall Study|Progressive Disease|1|||
30997089|NCT02132754|59195567|FG006|Overall Study|Progressive Disease|1|||
30997090|NCT02132754|59195568|FG007|Overall Study|Progressive Disease|1|||
30997091|NCT02132754|59195569|FG008|Overall Study|Progressive Disease|1|||
30997092|NCT02132754|59195570|FG009|Overall Study|Progressive Disease|3|||
30997093|NCT02132754|59195571|FG010|Overall Study|Progressive Disease|3|||
30997094|NCT02132754|59195572|FG011|Overall Study|Progressive Disease|2|||
30997095|NCT02132754|59195573|FG012|Overall Study|Progressive Disease|2|||
30997096|NCT02132754|59195574|FG013|Overall Study|Progressive Disease|3|||
30997097|NCT02132754|59195575|FG014|Overall Study|Progressive Disease|2|||
30997098|NCT02132754|59195576|FG015|Overall Study|Progressive Disease|1|||
30997099|NCT02132754|59195577|FG016|Overall Study|Progressive Disease|2|||
30997100|NCT02132754|59195578|FG017|Overall Study|Progressive Disease|1|||
30997101|NCT02132754|59195579|FG018|Overall Study|Progressive Disease|3|||
30997102|NCT02132754|59195580|FG019|Overall Study|Progressive Disease|1|||
30997103|NCT02132754|59195581|FG020|Overall Study|Progressive Disease|1|||
30997104|NCT02132754|59195582|FG021|Overall Study|Progressive Disease|3|||
30997105|NCT02132754|59195583|FG022|Overall Study|Progressive Disease|2|||
30997106|NCT02132754|59195584|FG023|Overall Study|Progressive Disease|3|||
30997107|NCT02132754|59195585|FG024|Overall Study|Progressive Disease|0|||
30997108|NCT02132754|59195586|FG025|Overall Study|Progressive Disease|1|||
30997109|NCT02132754|59195587|FG026|Overall Study|Progressive Disease|2|||
30997110|NCT02132754|59195588|FG027|Overall Study|Progressive Disease|1|||
30997111|NCT02132754|59195589|FG028|Overall Study|Progressive Disease|2|||
30997112|NCT02132754|59195590|FG029|Overall Study|Progressive Disease|3|||
30997113|NCT02132754|59195591|FG030|Overall Study|Progressive Disease|1|||
30997114|NCT02132754|59195592|FG031|Overall Study|Progressive Disease|1|||
30997115|NCT02132754|59195593|FG032|Overall Study|Progressive Disease|3|||
30997116|NCT02132754|59195594|FG033|Overall Study|Progressive Disease|6|||
30997117|NCT02132754|59195561|FG000|Overall Study|Screen Failure|0|||
30997118|NCT02132754|59195562|FG001|Overall Study|Screen Failure|0|||
30997119|NCT02132754|59195563|FG002|Overall Study|Screen Failure|0|||
30997120|NCT02132754|59195564|FG003|Overall Study|Screen Failure|0|||
30997121|NCT02132754|59195565|FG004|Overall Study|Screen Failure|0|||
30997122|NCT02132754|59195566|FG005|Overall Study|Screen Failure|0|||
30997123|NCT02132754|59195567|FG006|Overall Study|Screen Failure|0|||
30997124|NCT02132754|59195568|FG007|Overall Study|Screen Failure|0|||
30997125|NCT02132754|59195569|FG008|Overall Study|Screen Failure|0|||
30997126|NCT02132754|59195570|FG009|Overall Study|Screen Failure|0|||
30997127|NCT02132754|59195571|FG010|Overall Study|Screen Failure|0|||
30997128|NCT02132754|59195572|FG011|Overall Study|Screen Failure|0|||
30997129|NCT02132754|59195573|FG012|Overall Study|Screen Failure|0|||
30997130|NCT02132754|59195574|FG013|Overall Study|Screen Failure|0|||
30997131|NCT02132754|59195575|FG014|Overall Study|Screen Failure|0|||
30997132|NCT02132754|59195576|FG015|Overall Study|Screen Failure|0|||
30997133|NCT02132754|59195577|FG016|Overall Study|Screen Failure|0|||
30997134|NCT02132754|59195578|FG017|Overall Study|Screen Failure|0|||
30997135|NCT02132754|59195579|FG018|Overall Study|Screen Failure|0|||
30997136|NCT02132754|59195580|FG019|Overall Study|Screen Failure|1|||
30997137|NCT02132754|59195581|FG020|Overall Study|Screen Failure|0|||
30997138|NCT02132754|59195582|FG021|Overall Study|Screen Failure|1|||
30997139|NCT02132754|59195583|FG022|Overall Study|Screen Failure|0|||
30997140|NCT02132754|59195584|FG023|Overall Study|Screen Failure|0|||
30997141|NCT02132754|59195585|FG024|Overall Study|Screen Failure|0|||
30997142|NCT02132754|59195586|FG025|Overall Study|Screen Failure|0|||
30997143|NCT02132754|59195587|FG026|Overall Study|Screen Failure|0|||
30997144|NCT02132754|59195588|FG027|Overall Study|Screen Failure|0|||
30997145|NCT02132754|59195589|FG028|Overall Study|Screen Failure|0|||
30997146|NCT02132754|59195590|FG029|Overall Study|Screen Failure|0|||
30997147|NCT02132754|59195591|FG030|Overall Study|Screen Failure|0|||
30997148|NCT02132754|59195592|FG031|Overall Study|Screen Failure|0|||
30997149|NCT02132754|59195593|FG032|Overall Study|Screen Failure|0|||
30997150|NCT02132754|59195594|FG033|Overall Study|Screen Failure|0|||
30997151|NCT02132754|59195561|FG000|Overall Study|Transferred to Extension Study|0|||
30997152|NCT02132754|59195562|FG001|Overall Study|Transferred to Extension Study|0|||
30997153|NCT02132754|59195563|FG002|Overall Study|Transferred to Extension Study|0|||
30997154|NCT02132754|59195564|FG003|Overall Study|Transferred to Extension Study|0|||
30997155|NCT02132754|59195565|FG004|Overall Study|Transferred to Extension Study|0|||
30997156|NCT02132754|59195566|FG005|Overall Study|Transferred to Extension Study|0|||
30997157|NCT02132754|59195567|FG006|Overall Study|Transferred to Extension Study|0|||
30997158|NCT02132754|59195568|FG007|Overall Study|Transferred to Extension Study|0|||
30997159|NCT02132754|59195569|FG008|Overall Study|Transferred to Extension Study|0|||
30997160|NCT02132754|59195570|FG009|Overall Study|Transferred to Extension Study|0|||
30997161|NCT02132754|59195571|FG010|Overall Study|Transferred to Extension Study|0|||
30997162|NCT02132754|59195572|FG011|Overall Study|Transferred to Extension Study|0|||
30997163|NCT02132754|59195573|FG012|Overall Study|Transferred to Extension Study|0|||
30997164|NCT02132754|59195574|FG013|Overall Study|Transferred to Extension Study|0|||
30997165|NCT02132754|59195575|FG014|Overall Study|Transferred to Extension Study|0|||
30997166|NCT02132754|59195576|FG015|Overall Study|Transferred to Extension Study|0|||
30997167|NCT02132754|59195577|FG016|Overall Study|Transferred to Extension Study|0|||
30997168|NCT02132754|59195578|FG017|Overall Study|Transferred to Extension Study|0|||
30997169|NCT02132754|59195579|FG018|Overall Study|Transferred to Extension Study|0|||
30997170|NCT02132754|59195580|FG019|Overall Study|Transferred to Extension Study|0|||
30997171|NCT02132754|59195581|FG020|Overall Study|Transferred to Extension Study|0|||
30997172|NCT02132754|59195582|FG021|Overall Study|Transferred to Extension Study|0|||
30997173|NCT02132754|59195583|FG022|Overall Study|Transferred to Extension Study|0|||
30997174|NCT02132754|59195584|FG023|Overall Study|Transferred to Extension Study|0|||
30997175|NCT02132754|59195585|FG024|Overall Study|Transferred to Extension Study|0|||
30997176|NCT02132754|59195586|FG025|Overall Study|Transferred to Extension Study|0|||
30997177|NCT02132754|59195587|FG026|Overall Study|Transferred to Extension Study|0|||
30997178|NCT02132754|59195588|FG027|Overall Study|Transferred to Extension Study|0|||
30997179|NCT02132754|59195589|FG028|Overall Study|Transferred to Extension Study|0|||
30997180|NCT02132754|59195590|FG029|Overall Study|Transferred to Extension Study|0|||
30997181|NCT02132754|59195591|FG030|Overall Study|Transferred to Extension Study|0|||
30997182|NCT02132754|59195592|FG031|Overall Study|Transferred to Extension Study|0|||
30997183|NCT02132754|59195593|FG032|Overall Study|Transferred to Extension Study|0|||
30997184|NCT02132754|59195594|FG033|Overall Study|Transferred to Extension Study|6|||
30997185|NCT02132754|59195561|FG000|Overall Study|Withdrawal by Subject|0|||
30997186|NCT02132754|59195562|FG001|Overall Study|Withdrawal by Subject|0|||
30997187|NCT02132754|59195563|FG002|Overall Study|Withdrawal by Subject|0|||
30997188|NCT02132754|59195564|FG003|Overall Study|Withdrawal by Subject|0|||
30997189|NCT02132754|59195565|FG004|Overall Study|Withdrawal by Subject|0|||
30997190|NCT02132754|59195566|FG005|Overall Study|Withdrawal by Subject|0|||
30997191|NCT02132754|59195567|FG006|Overall Study|Withdrawal by Subject|0|||
30997192|NCT02132754|59195568|FG007|Overall Study|Withdrawal by Subject|0|||
30997193|NCT02132754|59195569|FG008|Overall Study|Withdrawal by Subject|0|||
30997194|NCT02132754|59195570|FG009|Overall Study|Withdrawal by Subject|1|||
30997195|NCT02132754|59195571|FG010|Overall Study|Withdrawal by Subject|0|||
30997196|NCT02132754|59195572|FG011|Overall Study|Withdrawal by Subject|0|||
30997197|NCT02132754|59195573|FG012|Overall Study|Withdrawal by Subject|1|||
30997198|NCT02132754|59195574|FG013|Overall Study|Withdrawal by Subject|0|||
30997199|NCT02132754|59195575|FG014|Overall Study|Withdrawal by Subject|1|||
30997200|NCT02132754|59195576|FG015|Overall Study|Withdrawal by Subject|2|||
30997201|NCT02132754|59195577|FG016|Overall Study|Withdrawal by Subject|1|||
30997202|NCT02132754|59195578|FG017|Overall Study|Withdrawal by Subject|0|||
30997203|NCT02132754|59195579|FG018|Overall Study|Withdrawal by Subject|0|||
30997204|NCT02132754|59195580|FG019|Overall Study|Withdrawal by Subject|0|||
30997205|NCT02132754|59195581|FG020|Overall Study|Withdrawal by Subject|1|||
30997206|NCT02132754|59195582|FG021|Overall Study|Withdrawal by Subject|0|||
30997207|NCT02132754|59195583|FG022|Overall Study|Withdrawal by Subject|0|||
30997208|NCT02132754|59195584|FG023|Overall Study|Withdrawal by Subject|0|||
30997209|NCT02132754|59195585|FG024|Overall Study|Withdrawal by Subject|1|||
30997210|NCT02132754|59195586|FG025|Overall Study|Withdrawal by Subject|0|||
30997211|NCT02132754|59195587|FG026|Overall Study|Withdrawal by Subject|0|||
30997212|NCT02132754|59195588|FG027|Overall Study|Withdrawal by Subject|1|||
30997213|NCT02132754|59195589|FG028|Overall Study|Withdrawal by Subject|0|||
30997214|NCT02132754|59195590|FG029|Overall Study|Withdrawal by Subject|0|||
30997215|NCT02132754|59195591|FG030|Overall Study|Withdrawal by Subject|0|||
30997216|NCT02132754|59195592|FG031|Overall Study|Withdrawal by Subject|1|||
30997217|NCT02132754|59195593|FG032|Overall Study|Withdrawal by Subject|0|||
30997218|NCT02132754|59195594|FG033|Overall Study|Withdrawal by Subject|2|||
30997219|NCT02151786|59195704|FG000|Overall Study|Unavailability of Case Report Form|26|||
30997220|NCT02151786|59195704|FG000|Overall Study|Outside the Contract Period|1|||
30997221|NCT02151786|59195704|FG000|Overall Study|Randomized, not Treated|1|||
30997222|NCT02151786|59195704|FG000|Overall Study|Unavailability of Information|8|||
30997223|NCT02132130|59195712|FG000|Overall Study|Lost to Follow-up|0|||
30997224|NCT02132130|59195713|FG001|Overall Study|Lost to Follow-up|2|||
30997225|NCT02132130|59195714|FG002|Overall Study|Lost to Follow-up|0|||
30997226|NCT02132130|59195715|FG003|Overall Study|Lost to Follow-up|0|||
30997227|NCT02132130|59195712|FG000|Overall Study|Withdrawal by Subject|0|||
30997228|NCT02132130|59195713|FG001|Overall Study|Withdrawal by Subject|0|||
30997229|NCT02132130|59195714|FG002|Overall Study|Withdrawal by Subject|0|||
30997230|NCT02132130|59195715|FG003|Overall Study|Withdrawal by Subject|1|||
30997231|NCT02131662|59195734|FG000|Overall Study|Protocol Violation|1|||
30997232|NCT02131662|59195735|FG001|Overall Study|Protocol Violation|0|||
30997233|NCT02131662|59195736|FG002|Overall Study|Protocol Violation|0|||
30997234|NCT02131662|59195737|FG003|Overall Study|Protocol Violation|0|||
30997235|NCT02131662|59195738|FG004|Overall Study|Protocol Violation|0|||
30997236|NCT02131662|59195734|FG000|Overall Study|Other|2|||
30997237|NCT02131662|59195735|FG001|Overall Study|Other|4|||
30997238|NCT02131662|59195736|FG002|Overall Study|Other|3|||
30997239|NCT02131662|59195737|FG003|Overall Study|Other|3|||
30997240|NCT02131662|59195738|FG004|Overall Study|Other|4|||
30997241|NCT02131662|59195734|FG000|Overall Study|Adverse Event|0|||
30997242|NCT02131662|59195735|FG001|Overall Study|Adverse Event|1|||
30997243|NCT02131662|59195736|FG002|Overall Study|Adverse Event|1|||
30997244|NCT02131662|59195737|FG003|Overall Study|Adverse Event|1|||
30997245|NCT02131662|59195738|FG004|Overall Study|Adverse Event|3|||
30997246|NCT02131662|59195734|FG000|Overall Study|Pregnancy|0|||
30997247|NCT02131662|59195735|FG001|Overall Study|Pregnancy|1|||
30997248|NCT02131662|59195736|FG002|Overall Study|Pregnancy|0|||
30997249|NCT02131662|59195737|FG003|Overall Study|Pregnancy|1|||
30997250|NCT02131662|59195738|FG004|Overall Study|Pregnancy|0|||
30997251|NCT02131662|59195734|FG000|Overall Study|Wish for pregnancy|0|||
30997252|NCT02131662|59195735|FG001|Overall Study|Wish for pregnancy|0|||
30997253|NCT02131662|59195736|FG002|Overall Study|Wish for pregnancy|0|||
30997254|NCT02131662|59195737|FG003|Overall Study|Wish for pregnancy|0|||
30997255|NCT02131662|59195738|FG004|Overall Study|Wish for pregnancy|1|||
30997256|NCT02131662|59195734|FG000|Overall Study|Lack of Efficacy|1|||
30997257|NCT02131662|59195735|FG001|Overall Study|Lack of Efficacy|0|||
30997258|NCT02131662|59195736|FG002|Overall Study|Lack of Efficacy|0|||
30997259|NCT02131662|59195737|FG003|Overall Study|Lack of Efficacy|0|||
30997260|NCT02131662|59195738|FG004|Overall Study|Lack of Efficacy|1|||
30997261|NCT02131662|59195734|FG000|Overall Study|Withdrawal by Subject|1|||
30997262|NCT02131662|59195735|FG001|Overall Study|Withdrawal by Subject|5|||
30997263|NCT02131662|59195736|FG002|Overall Study|Withdrawal by Subject|1|||
30997264|NCT02131662|59195737|FG003|Overall Study|Withdrawal by Subject|5|||
30997265|NCT02131662|59195738|FG004|Overall Study|Withdrawal by Subject|6|||
30997266|NCT02131662|59195734|FG000|Overall Study|Lost to Follow-up|1|||
30997267|NCT02131662|59195735|FG001|Overall Study|Lost to Follow-up|3|||
30997268|NCT02131662|59195736|FG002|Overall Study|Lost to Follow-up|0|||
30997269|NCT02131662|59195737|FG003|Overall Study|Lost to Follow-up|9|||
30997270|NCT02131662|59195738|FG004|Overall Study|Lost to Follow-up|0|||
30997271|NCT02131662|59195734|FG000|Overall Study|Not treated|2|||
30997272|NCT02131662|59195735|FG001|Overall Study|Not treated|0|||
30997273|NCT02131662|59195736|FG002|Overall Study|Not treated|2|||
30997274|NCT02131662|59195737|FG003|Overall Study|Not treated|2|||
30997275|NCT02131662|59195738|FG004|Overall Study|Not treated|3|||
30997276|NCT02106156|59195757|FG000|Overall Study|Patient Died|19|||
30997277|NCT02106156|59195758|FG001|Overall Study|Patient Died|0|||
30997278|NCT02106156|59195759|FG002|Overall Study|Patient Died|0|||
30997279|NCT02106156|59195757|FG000|Overall Study|Lack of Tolerability|305|||
30997280|NCT02106156|59195758|FG001|Overall Study|Lack of Tolerability|3|||
30997281|NCT02106156|59195759|FG002|Overall Study|Lack of Tolerability|0|||
30997282|NCT02106156|59195757|FG000|Overall Study|Lack of Virological Response|1044|||
30997283|NCT02106156|59195758|FG001|Overall Study|Lack of Virological Response|8|||
30997284|NCT02106156|59195759|FG002|Overall Study|Lack of Virological Response|0|||
30997285|NCT02106156|59195757|FG000|Overall Study|Concomitant Disease|74|||
30997286|NCT02106156|59195758|FG001|Overall Study|Concomitant Disease|2|||
30997287|NCT02106156|59195759|FG002|Overall Study|Concomitant Disease|0|||
30997288|NCT02106156|59195757|FG000|Overall Study|Lack of Compliance|211|||
30997289|NCT02106156|59195758|FG001|Overall Study|Lack of Compliance|7|||
30997290|NCT02106156|59195759|FG002|Overall Study|Lack of Compliance|0|||
30997291|NCT02106156|59195757|FG000|Overall Study|Patients Request|307|||
30997292|NCT02106156|59195758|FG001|Overall Study|Patients Request|9|||
30997293|NCT02106156|59195759|FG002|Overall Study|Patients Request|0|||
30997294|NCT02106156|59195757|FG000|Overall Study|Lost to Follow-up|451|||
30997295|NCT02106156|59195758|FG001|Overall Study|Lost to Follow-up|8|||
30997296|NCT02106156|59195759|FG002|Overall Study|Lost to Follow-up|0|||
30997297|NCT02106156|59195757|FG000|Overall Study|Unplanned Event|82|||
30997298|NCT02106156|59195758|FG001|Overall Study|Unplanned Event|2|||
30997299|NCT02106156|59195759|FG002|Overall Study|Unplanned Event|0|||
30997300|NCT02106156|59195757|FG000|Overall Study|Change of Laboratory Parameter|10|||
30997301|NCT02106156|59195758|FG001|Overall Study|Change of Laboratory Parameter|0|||
30997302|NCT02106156|59195759|FG002|Overall Study|Change of Laboratory Parameter|0|||
30997303|NCT02106156|59195757|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
30997304|NCT02106156|59195758|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
30997305|NCT02106156|59195759|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
30997306|NCT02106156|59195757|FG000|Overall Study|Relocation/Change of Physician|40|||
30997307|NCT02106156|59195758|FG001|Overall Study|Relocation/Change of Physician|1|||
30997308|NCT02106156|59195759|FG002|Overall Study|Relocation/Change of Physician|0|||
30997309|NCT01598610|59195785|FG000|Overall Study|Adverse Event|1|||
30997310|NCT01625988|59195791|FG000|Overall Study|Lost to Follow-up|5|||
30997311|NCT01625988|59195792|FG001|Overall Study|Lost to Follow-up|6|||
30997312|NCT01625988|59195791|FG000|Overall Study|Withdrawal by Subject|8|||
30997313|NCT01625988|59195792|FG001|Overall Study|Withdrawal by Subject|3|||
30997314|NCT01625988|59195791|FG000|Overall Study|Adverse Event|0|||
30997315|NCT01625988|59195792|FG001|Overall Study|Adverse Event|1|||
30997316|NCT01625988|59195791|FG000|Overall Study|Lack of Efficacy|0|||
30997317|NCT01625988|59195792|FG001|Overall Study|Lack of Efficacy|1|||
30997318|NCT01625988|59195791|FG000|Overall Study|Randomized Inappropriately|1|||
30997319|NCT01625988|59195792|FG001|Overall Study|Randomized Inappropriately|0|||
30997320|NCT01625988|59195791|FG000|Overall Study|Protocol Violation|0|||
30997321|NCT01625988|59195792|FG001|Overall Study|Protocol Violation|2|||
30997322|NCT02131272|59195803|FG000|Overall Study|Withdrawal by parent|0|||
30997323|NCT02131272|59195804|FG001|Overall Study|Withdrawal by parent|1|||
30997324|NCT02131272|59195803|FG000|Overall Study|Withdrawal by Subject|0|||
30997325|NCT02131272|59195804|FG001|Overall Study|Withdrawal by Subject|1|||
30997326|NCT02131272|59195803|FG000|Overall Study|Withdrawal Criteria|1|||
30997327|NCT02131272|59195804|FG001|Overall Study|Withdrawal Criteria|0|||
30997328|NCT02130882|59195812|FG000|Overall Study|Withdrawal by Subject|0|||
30997329|NCT02130882|59195813|FG001|Overall Study|Withdrawal by Subject|1|||
30997330|NCT02130570|59195821|FG000|Overall Study|Death|3|||
30997331|NCT02130570|59195822|FG001|Overall Study|Death|5|||
30997332|NCT02130570|59195821|FG000|Overall Study|Withdrawal by Subject|6|||
30997333|NCT02130570|59195822|FG001|Overall Study|Withdrawal by Subject|3|||
30997334|NCT02130570|59195821|FG000|Overall Study|Part of practice that discontinued study|0|||
30997335|NCT02130570|59195822|FG001|Overall Study|Part of practice that discontinued study|5|||
30997336|NCT02149836|59195829|FG000|Overall Study|Withdrawal by Subject|1|||
30997337|NCT02130024|59195835|FG000|Overall Study|Adverse Event|10|||
30997338|NCT02130024|59195836|FG001|Overall Study|Adverse Event|11|||
30997339|NCT02130024|59195835|FG000|Overall Study|Death|2|||
30997340|NCT02130024|59195836|FG001|Overall Study|Death|2|||
30997341|NCT02130024|59195835|FG000|Overall Study|Lost to Follow-up|1|||
30997342|NCT02130024|59195836|FG001|Overall Study|Lost to Follow-up|1|||
30997343|NCT02130024|59195835|FG000|Overall Study|Physician Decision|1|||
30997344|NCT02130024|59195836|FG001|Overall Study|Physician Decision|3|||
30997345|NCT02130024|59195835|FG000|Overall Study|Protocol Deviation|4|||
30997346|NCT02130024|59195836|FG001|Overall Study|Protocol Deviation|0|||
30997347|NCT02130024|59195835|FG000|Overall Study|Site Administration Problems|1|||
30997348|NCT02130024|59195836|FG001|Overall Study|Site Administration Problems|0|||
30997349|NCT02130024|59195835|FG000|Overall Study|Subject Withdrew Consent|6|||
30997350|NCT02130024|59195836|FG001|Overall Study|Subject Withdrew Consent|14|||
30997351|NCT02105688|59195844|FG000|Part A: Double-Blind|Adverse Event|1|||
30997352|NCT02105688|59195845|FG001|Part A: Double-Blind|Adverse Event|0|||
30997353|NCT02105688|59195844|FG000|Part A: Double-Blind|Death|0|||
30997354|NCT02105688|59195845|FG001|Part A: Double-Blind|Death|1|||
30997355|NCT02105688|59195844|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
30997356|NCT02105688|59195845|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
30997357|NCT02105688|59195844|FG000|Part A: Double-Blind|Physician Decision|0|||
30997358|NCT02105688|59195845|FG001|Part A: Double-Blind|Physician Decision|1|||
30997359|NCT02105688|59195844|FG000|Part A: Double-Blind|Status Unknown|0|||
30997360|NCT02105688|59195845|FG001|Part A: Double-Blind|Status Unknown|2|||
30997361|NCT02105688|59195844|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
30997362|NCT02105688|59195845|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
30997363|NCT02105688|59195844|FG000|Part B: Observational Follow-up|Death|2|||
30997364|NCT02105688|59195845|FG001|Part B: Observational Follow-up|Death|1|||
30997365|NCT02105688|59195844|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
30997366|NCT02105688|59195845|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
30997367|NCT02105688|59195844|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
30997368|NCT02105688|59195845|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
30997369|NCT02105688|59195844|FG000|Part B: Observational Follow-up|Physician Decision|3|||
30892098|NCT02309515|58925444|FG001|Overall Study|Withdrawal by Subject|1|||
30892099|NCT02309359|58925455|FG000|Overall Study|Adverse Event|4|||
30892100|NCT02309359|58925456|FG001|Overall Study|Adverse Event|5|||
30997370|NCT02105688|59195845|FG001|Part B: Observational Follow-up|Physician Decision|1|||
30997371|NCT02105454|59195852|FG000|Overall Study|Withdrawal by Subject|1|||
30997372|NCT01625910|59195858|FG000|Overall Study|Lost to Follow-up|3|||
30997373|NCT01625910|59195859|FG001|Overall Study|Lost to Follow-up|4|||
30997374|NCT02104752|59195869|FG000|Overall Study|Withdrawal by Subject|1|||
30997375|NCT02104752|59195870|FG001|Overall Study|Withdrawal by Subject|0|||
30997376|NCT02104752|59195869|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
30997377|NCT02104752|59195870|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
30997378|NCT02102724|59195878|FG000|Overall Study|Lost to Follow-up|1|||
30997379|NCT02102724|59195879|FG001|Overall Study|Lost to Follow-up|0|||
30997380|NCT02102724|59195878|FG000|Overall Study|surgery for brain aneurysm|1|||
30997381|NCT02102724|59195879|FG001|Overall Study|surgery for brain aneurysm|1|||
30997382|NCT02102490|59195885|FG000|Overall Study|Death|6|||
30997383|NCT02102490|59195885|FG000|Overall Study|Lost to Follow-up|1|||
30997384|NCT02101554|59195892|FG000|Overall Study|Protocol Violation|0|||
30892101|NCT02309359|58925457|FG002|Overall Study|Adverse Event|5|||
30997385|NCT02101554|59195893|FG001|Overall Study|Protocol Violation|1|||
30892102|NCT02309359|58925458|FG003|Overall Study|Adverse Event|4|||
30997386|NCT02101554|59195894|FG002|Overall Study|Protocol Violation|0|||
30997387|NCT02101554|59195892|FG000|Overall Study|Insufficient Clinical Response|0|||
30997388|NCT02101554|59195893|FG001|Overall Study|Insufficient Clinical Response|2|||
30997389|NCT02101554|59195894|FG002|Overall Study|Insufficient Clinical Response|0|||
30997390|NCT02101554|59195892|FG000|Overall Study|Adverse Event|2|||
30997391|NCT02101554|59195893|FG001|Overall Study|Adverse Event|1|||
30997392|NCT02101554|59195894|FG002|Overall Study|Adverse Event|1|||
30997393|NCT02101554|59195892|FG000|Overall Study|Lost to Follow-up|0|||
30997394|NCT02101554|59195893|FG001|Overall Study|Lost to Follow-up|1|||
30997395|NCT02101554|59195894|FG002|Overall Study|Lost to Follow-up|0|||
30997396|NCT02101554|59195892|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
30997397|NCT02101554|59195893|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
30997398|NCT02101554|59195894|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
30997399|NCT02128932|59195905|FG000|Overall Study|Withdrawal by Subject|11|||
30997400|NCT02128932|59195906|FG001|Overall Study|Withdrawal by Subject|7|||
30997401|NCT02128932|59195907|FG002|Overall Study|Withdrawal by Subject|8|||
30997402|NCT02128932|59195905|FG000|Overall Study|Death|2|||
30997403|NCT02128932|59195906|FG001|Overall Study|Death|0|||
30997404|NCT02128932|59195907|FG002|Overall Study|Death|2|||
30997405|NCT02128932|59195905|FG000|Overall Study|Lost to Follow-up|2|||
30997406|NCT02128932|59195906|FG001|Overall Study|Lost to Follow-up|1|||
30997407|NCT02128932|59195907|FG002|Overall Study|Lost to Follow-up|1|||
30997408|NCT02128932|59195905|FG000|Overall Study|No reason for withdrawal|12|||
30997409|NCT02128932|59195906|FG001|Overall Study|No reason for withdrawal|11|||
30997410|NCT02128932|59195907|FG002|Overall Study|No reason for withdrawal|7|||
30997411|NCT02128542|59195917|FG000|Overall Study|Lost to Follow-up|3|||
30997412|NCT02128542|59195918|FG001|Overall Study|Lost to Follow-up|0|||
30997413|NCT02128542|59195917|FG000|Overall Study|Withdrew Consent|1|||
30997414|NCT02128542|59195918|FG001|Overall Study|Withdrew Consent|0|||
30997415|NCT02127372|59195928|FG000|Overall Study|Withdrawal by Subject|1|||
30997416|NCT02127372|59195929|FG001|Overall Study|Withdrawal by Subject|0|||
30997417|NCT02126826|59195943|FG000|Overall Study|Withdrawal by Subject|0|||
30997418|NCT02126826|59195944|FG001|Overall Study|Withdrawal by Subject|0|||
30997419|NCT02126826|59195945|FG002|Overall Study|Withdrawal by Subject|0|||
30997420|NCT02126826|59195946|FG003|Overall Study|Withdrawal by Subject|1|||
30997421|NCT02126826|59195947|FG004|Overall Study|Withdrawal by Subject|0|||
30997422|NCT02126826|59195948|FG005|Overall Study|Withdrawal by Subject|0|||
30997423|NCT02126826|59195949|FG006|Overall Study|Withdrawal by Subject|0|||
30997424|NCT02126670|59195974|FG000|Overall Study|Withdrawal by Subject|1|||
30997425|NCT02126670|59195975|FG001|Overall Study|Withdrawal by Subject|0|||
30997426|NCT02126670|59195976|FG002|Overall Study|Withdrawal by Subject|0|||
30997427|NCT02126670|59195977|FG003|Overall Study|Withdrawal by Subject|1|||
30997428|NCT02125734|59195989|FG000|Period 2|Adverse Event|0|||
30997429|NCT02125734|59195990|FG001|Period 2|Adverse Event|1|||
30997430|NCT02124798|59195996|FG000|Overall Study|Adverse Event|3|||
30997431|NCT02124798|59195996|FG000|Overall Study|Lost to Follow-up|1|||
30997432|NCT02146326|59196004|FG000|Overall Study|Lost to Follow-up|3|||
30997433|NCT02146326|59196005|FG001|Overall Study|Lost to Follow-up|3|||
30997434|NCT02146326|59196006|FG002|Overall Study|Lost to Follow-up|11|||
30997435|NCT02146326|59196007|FG003|Overall Study|Lost to Follow-up|19|||
30997436|NCT02146326|59196004|FG000|Overall Study|Withdrawal by Subject|2|||
30997437|NCT02146326|59196005|FG001|Overall Study|Withdrawal by Subject|1|||
30997438|NCT02146326|59196006|FG002|Overall Study|Withdrawal by Subject|15|||
30997439|NCT02146326|59196007|FG003|Overall Study|Withdrawal by Subject|11|||
30997440|NCT02146326|59196004|FG000|Overall Study|Separated from mental health center|23|||
30997441|NCT02146326|59196005|FG001|Overall Study|Separated from mental health center|33|||
30997442|NCT02146326|59196006|FG002|Overall Study|Separated from mental health center|0|||
30997443|NCT02146326|59196007|FG003|Overall Study|Separated from mental health center|0|||
30997444|NCT02146326|59196004|FG000|Overall Study|Incarcerated|0|||
30997445|NCT02146326|59196005|FG001|Overall Study|Incarcerated|0|||
30997446|NCT02146326|59196006|FG002|Overall Study|Incarcerated|3|||
30997447|NCT02146326|59196007|FG003|Overall Study|Incarcerated|8|||
30997448|NCT02146326|59196004|FG000|Overall Study|Death|0|||
30997449|NCT02146326|59196005|FG001|Overall Study|Death|0|||
30997450|NCT02146326|59196006|FG002|Overall Study|Death|4|||
30997451|NCT02146326|59196007|FG003|Overall Study|Death|4|||
30997452|NCT02146326|59196004|FG000|Overall Study|Unable to complete interview|0|||
30997453|NCT02146326|59196005|FG001|Overall Study|Unable to complete interview|0|||
30997454|NCT02146326|59196006|FG002|Overall Study|Unable to complete interview|10|||
30997455|NCT02146326|59196007|FG003|Overall Study|Unable to complete interview|6|||
30997456|NCT02146248|59196023|FG000|Overall Study|Withdrawal by Subject|2|||
30997457|NCT02145468|59196033|FG000|Overall Study|Withdrawal by Subject|5|||
30997458|NCT02145468|59196034|FG001|Overall Study|Withdrawal by Subject|8|||
30997459|NCT02124564|59196040|FG000|Treatment Period|Adverse Event|2|||
30997460|NCT02124564|59196040|FG000|Treatment Period|Lack of Efficacy|3|||
30997461|NCT02124564|59196040|FG000|Treatment Period|Withdrawal by Subject|2|||
30997462|NCT02145390|59196045|FG000|Overall Study|Withdrawal by Subject|1|||
30997463|NCT02100696|59196055|FG000|Induction Phase|Adverse Event|0|||
30997464|NCT02100696|59196056|FG001|Induction Phase|Adverse Event|0|||
30997465|NCT02100696|59196057|FG002|Induction Phase|Adverse Event|1|||
30997466|NCT02100696|59196058|FG003|Induction Phase|Adverse Event|0|||
30997467|NCT02100696|59196059|FG004|Induction Phase|Adverse Event|0|||
30997468|NCT02100696|59196060|FG005|Induction Phase|Adverse Event|0|||
30997469|NCT02100696|59196055|FG000|Induction Phase|Lost to Follow-up|1|||
30997470|NCT02100696|59196056|FG001|Induction Phase|Lost to Follow-up|0|||
30997471|NCT02100696|59196057|FG002|Induction Phase|Lost to Follow-up|1|||
30997472|NCT02100696|59196058|FG003|Induction Phase|Lost to Follow-up|0|||
30997473|NCT02100696|59196059|FG004|Induction Phase|Lost to Follow-up|0|||
30997474|NCT02100696|59196060|FG005|Induction Phase|Lost to Follow-up|0|||
30997475|NCT02100696|59196055|FG000|Induction Phase|Protocol Violation|0|||
30997476|NCT02100696|59196056|FG001|Induction Phase|Protocol Violation|1|||
30997477|NCT02100696|59196057|FG002|Induction Phase|Protocol Violation|1|||
30997478|NCT02100696|59196058|FG003|Induction Phase|Protocol Violation|0|||
30997479|NCT02100696|59196059|FG004|Induction Phase|Protocol Violation|0|||
30997480|NCT02100696|59196060|FG005|Induction Phase|Protocol Violation|0|||
30997481|NCT02100696|59196055|FG000|Induction Phase|Withdrawal by Subject|8|||
30997482|NCT02100696|59196056|FG001|Induction Phase|Withdrawal by Subject|2|||
30997483|NCT02100696|59196057|FG002|Induction Phase|Withdrawal by Subject|13|||
30997484|NCT02100696|59196058|FG003|Induction Phase|Withdrawal by Subject|0|||
30997485|NCT02100696|59196059|FG004|Induction Phase|Withdrawal by Subject|0|||
30997486|NCT02100696|59196060|FG005|Induction Phase|Withdrawal by Subject|0|||
30997487|NCT02100696|59196055|FG000|Induction Phase|Physician Decision|1|||
30997488|NCT02100696|59196056|FG001|Induction Phase|Physician Decision|0|||
30997489|NCT02100696|59196057|FG002|Induction Phase|Physician Decision|2|||
30997490|NCT02100696|59196058|FG003|Induction Phase|Physician Decision|0|||
30997491|NCT02100696|59196059|FG004|Induction Phase|Physician Decision|0|||
30997492|NCT02100696|59196060|FG005|Induction Phase|Physician Decision|0|||
30997493|NCT02100696|59196055|FG000|Induction Phase|Multiple Reasons|5|||
30997494|NCT02100696|59196056|FG001|Induction Phase|Multiple Reasons|2|||
30997495|NCT02100696|59196057|FG002|Induction Phase|Multiple Reasons|8|||
30997496|NCT02100696|59196058|FG003|Induction Phase|Multiple Reasons|0|||
30997497|NCT02100696|59196059|FG004|Induction Phase|Multiple Reasons|0|||
30997498|NCT02100696|59196060|FG005|Induction Phase|Multiple Reasons|0|||
30997499|NCT02100696|59196055|FG000|Maintenance Phase|Adverse Event|0|||
30997500|NCT02100696|59196056|FG001|Maintenance Phase|Adverse Event|0|||
30997501|NCT02100696|59196057|FG002|Maintenance Phase|Adverse Event|0|||
30997502|NCT02100696|59196058|FG003|Maintenance Phase|Adverse Event|0|||
30997503|NCT02100696|59196059|FG004|Maintenance Phase|Adverse Event|0|||
30997504|NCT02100696|59196060|FG005|Maintenance Phase|Adverse Event|2|||
30997505|NCT02100696|59196055|FG000|Maintenance Phase|Lost to Follow-up|0|||
30997506|NCT02100696|59196056|FG001|Maintenance Phase|Lost to Follow-up|0|||
30997507|NCT02100696|59196057|FG002|Maintenance Phase|Lost to Follow-up|0|||
30997508|NCT02100696|59196058|FG003|Maintenance Phase|Lost to Follow-up|0|||
30997509|NCT02100696|59196059|FG004|Maintenance Phase|Lost to Follow-up|1|||
30997510|NCT02100696|59196060|FG005|Maintenance Phase|Lost to Follow-up|0|||
30997511|NCT02100696|59196055|FG000|Maintenance Phase|Protocol Violation|0|||
30997512|NCT02100696|59196056|FG001|Maintenance Phase|Protocol Violation|0|||
30997513|NCT02100696|59196057|FG002|Maintenance Phase|Protocol Violation|0|||
30997514|NCT02100696|59196058|FG003|Maintenance Phase|Protocol Violation|0|||
30997515|NCT02100696|59196059|FG004|Maintenance Phase|Protocol Violation|1|||
30997516|NCT02100696|59196060|FG005|Maintenance Phase|Protocol Violation|0|||
30997517|NCT02100696|59196055|FG000|Maintenance Phase|Withdrawal by Subject|0|||
30997518|NCT02100696|59196056|FG001|Maintenance Phase|Withdrawal by Subject|0|||
30997519|NCT02100696|59196057|FG002|Maintenance Phase|Withdrawal by Subject|0|||
30997520|NCT02100696|59196058|FG003|Maintenance Phase|Withdrawal by Subject|1|||
30997521|NCT02100696|59196059|FG004|Maintenance Phase|Withdrawal by Subject|4|||
30997522|NCT02100696|59196060|FG005|Maintenance Phase|Withdrawal by Subject|2|||
30997523|NCT02100696|59196055|FG000|Maintenance Phase|Physician Decision|0|||
30997524|NCT02100696|59196056|FG001|Maintenance Phase|Physician Decision|0|||
30997525|NCT02100696|59196057|FG002|Maintenance Phase|Physician Decision|0|||
30997526|NCT02100696|59196058|FG003|Maintenance Phase|Physician Decision|0|||
30997527|NCT02100696|59196059|FG004|Maintenance Phase|Physician Decision|1|||
30997528|NCT02100696|59196060|FG005|Maintenance Phase|Physician Decision|0|||
30997529|NCT02100696|59196055|FG000|Maintenance Phase|Multiple Reasons|0|||
30997530|NCT02100696|59196056|FG001|Maintenance Phase|Multiple Reasons|0|||
30997531|NCT02100696|59196057|FG002|Maintenance Phase|Multiple Reasons|0|||
30997532|NCT02100696|59196058|FG003|Maintenance Phase|Multiple Reasons|0|||
30997533|NCT02100696|59196059|FG004|Maintenance Phase|Multiple Reasons|2|||
30997534|NCT02100696|59196060|FG005|Maintenance Phase|Multiple Reasons|1|||
30997535|NCT02145156|59196084|FG000|Overall Study|No match to vaccination records|60|||
30997536|NCT02145156|59196085|FG001|Overall Study|No match to vaccination records|52|||
30997537|NCT02145156|59196086|FG002|Overall Study|No match to vaccination records|41|||
30997538|NCT02123472|59196094|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
30997539|NCT02123472|59196095|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
30997540|NCT02145078|59196101|FG000|Overall Study|Death|1|||
30997541|NCT02145078|59196101|FG000|Overall Study|Reason not given|3|||
30997542|NCT02144610|59196107|FG000|Overall Study|Physician Decision|1|||
30997543|NCT02144610|59196108|FG001|Overall Study|Physician Decision|0|||
30997544|NCT02144610|59196107|FG000|Overall Study|Withdrawal by Subject|1|||
30997545|NCT02144610|59196108|FG001|Overall Study|Withdrawal by Subject|5|||
30997546|NCT02144610|59196107|FG000|Overall Study|Death|2|||
30997547|NCT02144610|59196108|FG001|Overall Study|Death|2|||
30997548|NCT02144610|59196107|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
30997549|NCT02144610|59196108|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
30997550|NCT02144610|59196107|FG000|Overall Study|Other|0|||
30997551|NCT02144610|59196108|FG001|Overall Study|Other|1|||
30997552|NCT02100228|59196116|FG000|Overall Study|Other|19|||
30997553|NCT02100228|59196117|FG001|Overall Study|Other|19|||
30997554|NCT02100228|59196116|FG000|Overall Study|Administrative reason|0|||
30997555|NCT02100228|59196117|FG001|Overall Study|Administrative reason|1|||
30997556|NCT02100228|59196116|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
30997557|NCT02100228|59196117|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
30997558|NCT02100228|59196116|FG000|Overall Study|Non-compliance|0|||
30997559|NCT02100228|59196117|FG001|Overall Study|Non-compliance|3|||
30997560|NCT02100228|59196116|FG000|Overall Study|Lost to Follow-up|0|||
30997561|NCT02100228|59196117|FG001|Overall Study|Lost to Follow-up|1|||
30997562|NCT02100228|59196116|FG000|Overall Study|Withdrawal by Subject|27|||
30997563|NCT02100228|59196117|FG001|Overall Study|Withdrawal by Subject|37|||
30997564|NCT02100228|59196116|FG000|Overall Study|Adverse Event|16|||
30997565|NCT02100228|59196117|FG001|Overall Study|Adverse Event|12|||
30997566|NCT02100228|59196116|FG000|Overall Study|Death|1|||
30997567|NCT02100228|59196117|FG001|Overall Study|Death|1|||
30997568|NCT02099838|59196125|FG000|Overall Study|Death|1|||
30997569|NCT02099838|59196126|FG001|Overall Study|Death|0|||
30997570|NCT02099838|59196125|FG000|Overall Study|Lost to Follow-up|3|||
30997571|NCT02099838|59196126|FG001|Overall Study|Lost to Follow-up|1|||
30997572|NCT02099838|59196125|FG000|Overall Study|Withdrawal by Subject|0|||
30997573|NCT02099838|59196126|FG001|Overall Study|Withdrawal by Subject|1|||
30997574|NCT02144220|59196132|FG000|Overall Study|technology incompatibility|9|||
30997575|NCT02144220|59196132|FG000|Overall Study|Lack of Efficacy|4|||
30997576|NCT02144220|59196132|FG000|Overall Study|Physician Decision|3|||
30997577|NCT02144220|59196132|FG000|Overall Study|Withdrawal by Subject|2|||
30997578|NCT02144220|59196132|FG000|Overall Study|Protocol Violation|1|||
30997579|NCT02099682|59196136|FG000|Overall Study|Data Not Available|51|||
30997580|NCT02099682|59196136|FG000|Overall Study|Lost to Follow-up|31|||
30997581|NCT02099682|59196136|FG000|Overall Study|Other|29|||
30997582|NCT02142894|59196140|FG000|Overall Study|Protocol Violation|8|||
30997583|NCT02098746|59196144|FG000|Overall Study|Changes of Investigator|2|||
30997584|NCT02098746|59196144|FG000|Overall Study|Other Miscellaneous Reasons|1|||
30997585|NCT02098746|59196144|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
30997586|NCT02098746|59196144|FG000|Overall Study|Data Not Available After Treatment|1|||
30997587|NCT02122770|59196152|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
30997588|NCT02122770|59196153|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
30997589|NCT02122770|59196154|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
30997590|NCT02122770|59196155|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
30997591|NCT02122770|59196156|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
30997592|NCT02122770|59196157|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
30997593|NCT02122770|59196152|FG000|Part A: Drug-drug Interaction 2|Other|0|||
30997594|NCT02122770|59196153|FG001|Part A: Drug-drug Interaction 2|Other|0|||
30997595|NCT02122770|59196154|FG002|Part A: Drug-drug Interaction 2|Other|1|||
30790227|NCT00035555|58803457|FG001|Overall Study|Noncompliance|1|||
30997596|NCT02122770|59196155|FG003|Part A: Drug-drug Interaction 2|Other|0|||
30997597|NCT02122770|59196156|FG004|Part A: Drug-drug Interaction 2|Other|0|||
30997598|NCT02122770|59196157|FG005|Part A: Drug-drug Interaction 2|Other|0|||
30997599|NCT02122770|59196152|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
30997600|NCT02122770|59196153|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
30997601|NCT02122770|59196154|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
30997602|NCT02122770|59196155|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
30997603|NCT02122770|59196156|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
30997604|NCT02122770|59196157|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
30997605|NCT02122770|59196152|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
30997606|NCT02122770|59196153|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
30997607|NCT02122770|59196154|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
30997608|NCT02122770|59196155|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
30997609|NCT02122770|59196156|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
30997610|NCT02122770|59196157|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
30997611|NCT02122770|59196152|FG000|Part B: Standard of Care|Adverse Event|0|||
30997612|NCT02122770|59196153|FG001|Part B: Standard of Care|Adverse Event|0|||
30997613|NCT02122770|59196154|FG002|Part B: Standard of Care|Adverse Event|0|||
30997614|NCT02122770|59196155|FG003|Part B: Standard of Care|Adverse Event|0|||
30997615|NCT02122770|59196156|FG004|Part B: Standard of Care|Adverse Event|4|||
30997616|NCT02122770|59196157|FG005|Part B: Standard of Care|Adverse Event|1|||
30997617|NCT02122770|59196152|FG000|Part B: Standard of Care|Other|0|||
30997618|NCT02122770|59196153|FG001|Part B: Standard of Care|Other|0|||
30997619|NCT02122770|59196154|FG002|Part B: Standard of Care|Other|0|||
30997620|NCT02122770|59196155|FG003|Part B: Standard of Care|Other|0|||
30997621|NCT02122770|59196156|FG004|Part B: Standard of Care|Other|0|||
30997622|NCT02122770|59196157|FG005|Part B: Standard of Care|Other|2|||
30997623|NCT02122770|59196152|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
30997624|NCT02122770|59196153|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
30997625|NCT02122770|59196154|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
30997626|NCT02122770|59196155|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
30997627|NCT02122770|59196156|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
30997628|NCT02122770|59196157|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
30997629|NCT02122770|59196152|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
30997630|NCT02122770|59196153|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
30997631|NCT02122770|59196154|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
30997632|NCT02122770|59196155|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
30997633|NCT02122770|59196156|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
30997634|NCT02122770|59196157|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
30997635|NCT02122770|59196152|FG000|Part B: Standard of Care|Progressive Disease|0|||
30997636|NCT02122770|59196153|FG001|Part B: Standard of Care|Progressive Disease|0|||
30997637|NCT02122770|59196154|FG002|Part B: Standard of Care|Progressive Disease|0|||
30997638|NCT02122770|59196155|FG003|Part B: Standard of Care|Progressive Disease|0|||
30997639|NCT02122770|59196156|FG004|Part B: Standard of Care|Progressive Disease|10|||
30997640|NCT02122770|59196157|FG005|Part B: Standard of Care|Progressive Disease|8|||
30997641|NCT02122380|59196182|FG000|First Intervention (30 Days)|Adverse Event|1|||
30997642|NCT02122380|59196183|FG001|First Intervention (30 Days)|Adverse Event|0|||
30997643|NCT02122380|59196182|FG000|First Intervention (30 Days)|Physician Decision|0|||
30997644|NCT02122380|59196183|FG001|First Intervention (30 Days)|Physician Decision|1|||
30997645|NCT02122380|59196182|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
30997646|NCT02122380|59196183|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
30997647|NCT02122380|59196182|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
30997648|NCT02122380|59196183|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
30997649|NCT02122380|59196182|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
30997650|NCT02122380|59196183|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
30997651|NCT02122146|59196198|FG000|Part 1: Dose Escalation|Death|0|||
30997652|NCT02122146|59196199|FG001|Part 1: Dose Escalation|Death|1|||
30997653|NCT02122146|59196200|FG002|Part 1: Dose Escalation|Death|1|||
30997654|NCT02122146|59196201|FG003|Part 1: Dose Escalation|Death|0|||
30997655|NCT02122146|59196202|FG004|Part 1: Dose Escalation|Death|0|||
30997656|NCT02122146|59196203|FG005|Part 1: Dose Escalation|Death|0|||
30997657|NCT02122146|59196204|FG006|Part 1: Dose Escalation|Death|0|||
30997658|NCT02122146|59196205|FG007|Part 1: Dose Escalation|Death|0|||
30997659|NCT02122146|59196198|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
30997660|NCT02122146|59196199|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
30997661|NCT02122146|59196200|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
30997662|NCT02122146|59196201|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
30997663|NCT02122146|59196202|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
30997664|NCT02122146|59196203|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
30997665|NCT02122146|59196204|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
30997666|NCT02122146|59196205|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
30997667|NCT02122146|59196198|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30997668|NCT02122146|59196199|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30997669|NCT02122146|59196200|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30997670|NCT02122146|59196201|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
30997671|NCT02122146|59196202|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30997672|NCT02122146|59196203|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30997673|NCT02122146|59196204|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30997674|NCT02122146|59196205|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30997675|NCT02122146|59196198|FG000|Part 1: Dose Escalation|Other|1|||
30997676|NCT02122146|59196199|FG001|Part 1: Dose Escalation|Other|0|||
30997677|NCT02122146|59196200|FG002|Part 1: Dose Escalation|Other|0|||
30997678|NCT02122146|59196201|FG003|Part 1: Dose Escalation|Other|0|||
30997679|NCT02122146|59196202|FG004|Part 1: Dose Escalation|Other|0|||
30997680|NCT02122146|59196203|FG005|Part 1: Dose Escalation|Other|1|||
30997681|NCT02122146|59196204|FG006|Part 1: Dose Escalation|Other|1|||
30997682|NCT02122146|59196205|FG007|Part 1: Dose Escalation|Other|2|||
30997683|NCT02121834|59196231|FG000|Overall Study|Protocol Violation|0|||
30997684|NCT02121834|59196232|FG001|Overall Study|Protocol Violation|1|||
30997685|NCT02121834|59196233|FG002|Overall Study|Protocol Violation|0|||
30997686|NCT02121834|59196234|FG003|Overall Study|Protocol Violation|0|||
30997687|NCT02121834|59196235|FG004|Overall Study|Protocol Violation|0|||
30997688|NCT02121834|59196236|FG005|Overall Study|Protocol Violation|0|||
30997689|NCT02121834|59196237|FG006|Overall Study|Protocol Violation|0|||
30997690|NCT02121834|59196231|FG000|Overall Study|Withdrawal by Subject|0|||
30997691|NCT02121834|59196232|FG001|Overall Study|Withdrawal by Subject|1|||
30997692|NCT02121834|59196233|FG002|Overall Study|Withdrawal by Subject|1|||
30997693|NCT02121834|59196234|FG003|Overall Study|Withdrawal by Subject|0|||
30997694|NCT02121834|59196235|FG004|Overall Study|Withdrawal by Subject|0|||
30997695|NCT02121834|59196236|FG005|Overall Study|Withdrawal by Subject|0|||
30997696|NCT02121834|59196237|FG006|Overall Study|Withdrawal by Subject|0|||
30997697|NCT02121834|59196231|FG000|Overall Study|Lost to Follow-up|0|||
30997698|NCT02121834|59196232|FG001|Overall Study|Lost to Follow-up|0|||
30997699|NCT02121834|59196233|FG002|Overall Study|Lost to Follow-up|1|||
30997700|NCT02121834|59196234|FG003|Overall Study|Lost to Follow-up|0|||
30997701|NCT02121834|59196235|FG004|Overall Study|Lost to Follow-up|0|||
30997702|NCT02121834|59196236|FG005|Overall Study|Lost to Follow-up|0|||
30997703|NCT02121834|59196237|FG006|Overall Study|Lost to Follow-up|0|||
30997704|NCT02121756|59196265|FG000|Overall Study|Adverse Event|3|||
30997705|NCT02121756|59196266|FG001|Overall Study|Adverse Event|0|||
30997706|NCT02121756|59196265|FG000|Overall Study|Protocol Violation|1|||
30997707|NCT02121756|59196266|FG001|Overall Study|Protocol Violation|1|||
30997708|NCT02121756|59196265|FG000|Overall Study|Physician Decision|2|||
30997709|NCT02121756|59196266|FG001|Overall Study|Physician Decision|1|||
30997710|NCT02142504|59196278|FG000|Overall Study|Protocol Violation|2|||
30997711|NCT02142504|59196279|FG001|Overall Study|Protocol Violation|1|||
30997712|NCT02142504|59196280|FG002|Overall Study|Protocol Violation|2|||
30997713|NCT02142504|59196278|FG000|Overall Study|Adverse Event|2|||
30997714|NCT02142504|59196279|FG001|Overall Study|Adverse Event|3|||
30997715|NCT02142504|59196280|FG002|Overall Study|Adverse Event|4|||
30997716|NCT02142504|59196278|FG000|Overall Study|Lost to Follow-up|12|||
30997717|NCT02142504|59196279|FG001|Overall Study|Lost to Follow-up|19|||
30997718|NCT02142504|59196280|FG002|Overall Study|Lost to Follow-up|17|||
30997719|NCT02142504|59196278|FG000|Overall Study|Withdrawal by Subject|7|||
30997720|NCT02142504|59196279|FG001|Overall Study|Withdrawal by Subject|9|||
30997721|NCT02142504|59196280|FG002|Overall Study|Withdrawal by Subject|11|||
30997722|NCT02142504|59196278|FG000|Overall Study|Pregnancy|4|||
30997723|NCT02142504|59196279|FG001|Overall Study|Pregnancy|4|||
30997724|NCT02142504|59196280|FG002|Overall Study|Pregnancy|2|||
30997725|NCT02142504|59196278|FG000|Overall Study|Physician Decision|0|||
30997726|NCT02142504|59196279|FG001|Overall Study|Physician Decision|1|||
30997727|NCT02142504|59196280|FG002|Overall Study|Physician Decision|3|||
30997728|NCT02142504|59196278|FG000|Overall Study|Reason Not Specified|4|||
30997729|NCT02142504|59196279|FG001|Overall Study|Reason Not Specified|5|||
30997730|NCT02142504|59196280|FG002|Overall Study|Reason Not Specified|4|||
30997731|NCT02121522|59196288|FG000|Overall Study|Adverse Event|1|||
30997732|NCT02121210|59196294|FG000|Overall Study|Adverse Event|5|||
30997733|NCT02121210|59196295|FG001|Overall Study|Adverse Event|7|||
30997734|NCT02121210|59196294|FG000|Overall Study|Lack of Efficacy|2|||
30997735|NCT02121210|59196295|FG001|Overall Study|Lack of Efficacy|0|||
30997736|NCT02121210|59196294|FG000|Overall Study|Other than specified above|0|||
30997737|NCT02121210|59196295|FG001|Overall Study|Other than specified above|2|||
30997738|NCT02141490|59196304|FG000|Overall Study|Screening failures|4|||
30997739|NCT02141490|59196305|FG001|Overall Study|Screening failures|0|||
30997740|NCT02141490|59196306|FG002|Overall Study|Screening failures|0|||
30997741|NCT02097108|59196316|FG000|Overall Study|Adverse Event|1|||
30997742|NCT02097108|59196316|FG000|Overall Study|patient was abroad for 6 months|1|||
30997743|NCT02097030|59196322|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
30997744|NCT02097030|59196323|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
30997745|NCT02097030|59196322|FG000|First Intervention (3 Days)|Visual Acuity|0|||
30997746|NCT02097030|59196323|FG001|First Intervention (3 Days)|Visual Acuity|1|||
30997747|NCT02096952|59196333|FG000|Overall Study|Adverse Event|1|||
30997748|NCT02120898|59196340|FG000|Overall Study|Withdrawal by Subject|4|||
30997749|NCT02120898|59196341|FG001|Overall Study|Withdrawal by Subject|2|||
30997750|NCT02120898|59196342|FG002|Overall Study|Withdrawal by Subject|2|||
30997751|NCT02120898|59196340|FG000|Overall Study|Non-compliance with study drug|3|||
30997752|NCT02120898|59196341|FG001|Overall Study|Non-compliance with study drug|0|||
30997753|NCT02120898|59196342|FG002|Overall Study|Non-compliance with study drug|0|||
30997754|NCT02120898|59196340|FG000|Overall Study|Adverse Event|1|||
30997755|NCT02120898|59196341|FG001|Overall Study|Adverse Event|2|||
30997756|NCT02120898|59196342|FG002|Overall Study|Adverse Event|1|||
30997757|NCT02120898|59196340|FG000|Overall Study|Protocol Violation|1|||
30997758|NCT02120898|59196341|FG001|Overall Study|Protocol Violation|2|||
30997759|NCT02120898|59196342|FG002|Overall Study|Protocol Violation|0|||
30997760|NCT02120898|59196340|FG000|Overall Study|Lost to Follow-up|0|||
30997761|NCT02120898|59196341|FG001|Overall Study|Lost to Follow-up|0|||
30997762|NCT02120898|59196342|FG002|Overall Study|Lost to Follow-up|1|||
30997763|NCT02120664|59196355|FG000|Overall Study|Withdrawal by Subject|0|||
30997764|NCT02120664|59196356|FG001|Overall Study|Withdrawal by Subject|0|||
30997765|NCT02120664|59196357|FG002|Overall Study|Withdrawal by Subject|0|||
30997766|NCT02120664|59196358|FG003|Overall Study|Withdrawal by Subject|1|||
30997767|NCT02120664|59196359|FG004|Overall Study|Withdrawal by Subject|0|||
30997768|NCT01627860|59196374|FG000|Overall Study|Adverse Event|9|||
30997769|NCT01627860|59196375|FG001|Overall Study|Adverse Event|4|||
30997770|NCT01627860|59196374|FG000|Overall Study|Withdrawal by Subject|2|||
30997771|NCT01627860|59196375|FG001|Overall Study|Withdrawal by Subject|1|||
30997772|NCT01627860|59196374|FG000|Overall Study|Seizure frequency doubled|0|||
30997773|NCT01627860|59196375|FG001|Overall Study|Seizure frequency doubled|1|||
30997774|NCT01627860|59196374|FG000|Overall Study|Protocol Violation|1|||
30892103|NCT02309359|58925459|FG004|Overall Study|Adverse Event|4|||
30997775|NCT01627860|59196375|FG001|Overall Study|Protocol Violation|0|||
30997776|NCT01627782|59196385|FG000|Overall Study|Adverse Event|1|||
30997777|NCT01627782|59196386|FG001|Overall Study|Adverse Event|2|||
30997778|NCT01627782|59196387|FG002|Overall Study|Adverse Event|0|||
30997779|NCT01627782|59196388|FG003|Overall Study|Adverse Event|1|||
30892104|NCT02309359|58925455|FG000|Overall Study|Death|1|||
30892105|NCT02309359|58925456|FG001|Overall Study|Death|0|||
30997780|NCT01627782|59196385|FG000|Overall Study|Lack of Efficacy|11|||
30997781|NCT01627782|59196386|FG001|Overall Study|Lack of Efficacy|1|||
30997782|NCT01627782|59196387|FG002|Overall Study|Lack of Efficacy|15|||
30997783|NCT01627782|59196388|FG003|Overall Study|Lack of Efficacy|2|||
30997784|NCT01627782|59196385|FG000|Overall Study|Protocol Violation|1|||
30997785|NCT01627782|59196386|FG001|Overall Study|Protocol Violation|0|||
30997786|NCT01627782|59196387|FG002|Overall Study|Protocol Violation|0|||
30997787|NCT01627782|59196388|FG003|Overall Study|Protocol Violation|0|||
30997788|NCT01627782|59196385|FG000|Overall Study|Withdrawal by Subject|2|||
30997789|NCT01627782|59196386|FG001|Overall Study|Withdrawal by Subject|1|||
30997790|NCT01627782|59196387|FG002|Overall Study|Withdrawal by Subject|0|||
30997791|NCT01627782|59196388|FG003|Overall Study|Withdrawal by Subject|0|||
30997792|NCT01627782|59196385|FG000|Overall Study|Other|0|||
30997793|NCT01627782|59196386|FG001|Overall Study|Other|2|||
30997794|NCT01627782|59196387|FG002|Overall Study|Other|0|||
30997795|NCT01627782|59196388|FG003|Overall Study|Other|3|||
30997796|NCT01627782|59196385|FG000|Overall Study|Randomized But Not Treated|1|||
30997797|NCT01627782|59196386|FG001|Overall Study|Randomized But Not Treated|0|||
30997798|NCT01627782|59196387|FG002|Overall Study|Randomized But Not Treated|0|||
30997799|NCT01627782|59196388|FG003|Overall Study|Randomized But Not Treated|0|||
30997800|NCT01598532|59196400|FG000|Overall Study|Lost to Follow-up|3|||
30997801|NCT01598532|59196400|FG000|Overall Study|Did not meet inclusion criteria|8|||
30997802|NCT02119650|59196409|FG000|Overall Study|Adverse Event|3|||
30997803|NCT02119650|59196410|FG001|Overall Study|Adverse Event|4|||
30997804|NCT02119650|59196409|FG000|Overall Study|Subject decision|2|||
30997805|NCT02119650|59196410|FG001|Overall Study|Subject decision|3|||
30997806|NCT02119650|59196409|FG000|Overall Study|Disease progression|11|||
30997807|NCT02119650|59196410|FG001|Overall Study|Disease progression|14|||
30997808|NCT02119650|59196409|FG000|Overall Study|Death|5|||
30997809|NCT02119650|59196410|FG001|Overall Study|Death|1|||
30997810|NCT02119650|59196409|FG000|Overall Study|Noncompliance with study treatment|1|||
30997811|NCT02119650|59196410|FG001|Overall Study|Noncompliance with study treatment|1|||
30997812|NCT02119650|59196409|FG000|Overall Study|Study terminated by the sponsor|1|||
30997813|NCT02119650|59196410|FG001|Overall Study|Study terminated by the sponsor|0|||
30997814|NCT02119650|59196409|FG000|Overall Study|Physician Decision|0|||
30997815|NCT02119650|59196410|FG001|Overall Study|Physician Decision|2|||
30997816|NCT02119650|59196409|FG000|Overall Study|Multiple reasons for termination|2|||
30997817|NCT02119650|59196410|FG001|Overall Study|Multiple reasons for termination|1|||
30997818|NCT02119416|59196419|FG000|Overall Study|Protocol Violation|1|||
30997819|NCT02119416|59196420|FG001|Overall Study|Protocol Violation|1|||
30997820|NCT02119416|59196421|FG002|Overall Study|Protocol Violation|1|||
30997821|NCT02119416|59196419|FG000|Overall Study|wrong pubertal stage|1|||
30997822|NCT02119416|59196420|FG001|Overall Study|wrong pubertal stage|0|||
30997823|NCT02119416|59196421|FG002|Overall Study|wrong pubertal stage|1|||
30997824|NCT02140164|59196432|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
30997825|NCT02119260|59196443|FG000|Overall Study|Adverse Event|1|||
30997826|NCT02119260|59196444|FG001|Overall Study|Adverse Event|0|||
30997827|NCT02119260|59196445|FG002|Overall Study|Adverse Event|0|||
30997828|NCT02119260|59196446|FG003|Overall Study|Adverse Event|0|||
30997829|NCT02119260|59196447|FG004|Overall Study|Adverse Event|0|||
30997830|NCT02119260|59196448|FG005|Overall Study|Adverse Event|0|||
30997831|NCT02119260|59196449|FG006|Overall Study|Adverse Event|0|||
30997832|NCT02119260|59196443|FG000|Overall Study|Withdrew consent|0|||
30997833|NCT02119260|59196444|FG001|Overall Study|Withdrew consent|1|||
30997834|NCT02119260|59196445|FG002|Overall Study|Withdrew consent|1|||
30997835|NCT02119260|59196446|FG003|Overall Study|Withdrew consent|0|||
30997836|NCT02119260|59196447|FG004|Overall Study|Withdrew consent|0|||
30997837|NCT02119260|59196448|FG005|Overall Study|Withdrew consent|0|||
30997838|NCT02119260|59196449|FG006|Overall Study|Withdrew consent|0|||
30997839|NCT02119104|59196474|FG000|Overall Study|Protocol Violation|16|||
30997840|NCT02119026|59196480|FG000|1st-line Treatment|Adverse Event|9|||
30997841|NCT02119026|59196481|FG001|1st-line Treatment|Adverse Event|14|||
30997842|NCT02119026|59196480|FG000|1st-line Treatment|Physician Decision|3|||
30997843|NCT02119026|59196481|FG001|1st-line Treatment|Physician Decision|8|||
30997844|NCT02119026|59196480|FG000|1st-line Treatment|Withdrawal by Subject|4|||
30997845|NCT02119026|59196481|FG001|1st-line Treatment|Withdrawal by Subject|10|||
30997846|NCT02119026|59196480|FG000|1st-line Treatment|Patient condition or compliance|6|||
30997847|NCT02119026|59196481|FG001|1st-line Treatment|Patient condition or compliance|4|||
30997848|NCT02119026|59196480|FG000|1st-line Treatment|Surgery of metastases|2|||
30997849|NCT02119026|59196481|FG001|1st-line Treatment|Surgery of metastases|1|||
30997850|NCT02119026|59196480|FG000|1st-line Treatment|Death|2|||
30997851|NCT02119026|59196481|FG001|1st-line Treatment|Death|1|||
30997852|NCT02119026|59196480|FG000|2nd-line Treatment|Lost to Follow-up|2|||
30997853|NCT02119026|59196481|FG001|2nd-line Treatment|Lost to Follow-up|0|||
30997854|NCT02119026|59196480|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
30997855|NCT02119026|59196481|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
30997856|NCT02119026|59196480|FG000|2nd-line Treatment|Adverse Event|4|||
30997857|NCT02119026|59196481|FG001|2nd-line Treatment|Adverse Event|1|||
30997858|NCT02095158|59196487|FG000|Overall Study|Adverse Event|14|||
30997859|NCT02095158|59196487|FG000|Overall Study|Lack of Efficacy|3|||
30997860|NCT02095158|59196487|FG000|Overall Study|Pregnancy|1|||
30997861|NCT02095158|59196487|FG000|Overall Study|Lost to Follow-up|20|||
30997862|NCT02095158|59196487|FG000|Overall Study|Personal Reasons|35|||
30997863|NCT02095158|59196487|FG000|Overall Study|Protocol Violation|1|||
30997864|NCT02095158|59196487|FG000|Overall Study|Other Miscellaneous Reasons|1|||
30997865|NCT02094612|59196493|FG000|Overall Study|Lost to Follow-up|47|||
30997866|NCT02094612|59196494|FG001|Overall Study|Lost to Follow-up|47|||
30997867|NCT02094612|59196493|FG000|Overall Study|Never started ADHD medication|32|||
30997868|NCT02094612|59196494|FG001|Overall Study|Never started ADHD medication|23|||
30997869|NCT02139306|59196502|FG000|Overall Study|Withdrawal by Subject|4|||
30997870|NCT02139306|59196503|FG001|Overall Study|Withdrawal by Subject|6|||
30997871|NCT02139306|59196502|FG000|Overall Study|Adverse Event|3|||
30997872|NCT02139306|59196503|FG001|Overall Study|Adverse Event|4|||
30997873|NCT02139306|59196502|FG000|Overall Study|Physician Decision|0|||
30997874|NCT02139306|59196503|FG001|Overall Study|Physician Decision|1|||
30997875|NCT02139306|59196502|FG000|Overall Study|Other Unspecified|2|||
30997876|NCT02139306|59196503|FG001|Overall Study|Other Unspecified|3|||
30997877|NCT02139306|59196502|FG000|Overall Study|Protocol Violation|4|||
30997878|NCT02139306|59196503|FG001|Overall Study|Protocol Violation|0|||
30997879|NCT02094300|59196510|FG000|Overall Study|Death|7|||
30997880|NCT02094300|59196510|FG000|Overall Study|Lost to Follow-up|10|||
30997881|NCT02094300|59196510|FG000|Overall Study|Still be eligible for follow-up|3|||
30997882|NCT02118792|59196516|FG000|Overall Study|Withdrawal by Subject|6|||
30997883|NCT02118792|59196517|FG001|Overall Study|Withdrawal by Subject|3|||
30997884|NCT02118792|59196516|FG000|Overall Study|Lost to Follow-up|4|||
30997885|NCT02118792|59196517|FG001|Overall Study|Lost to Follow-up|4|||
30997886|NCT02118792|59196516|FG000|Overall Study|Adverse Event|5|||
30997887|NCT02118792|59196517|FG001|Overall Study|Adverse Event|4|||
30997888|NCT02118792|59196516|FG000|Overall Study|Withdrawal by parent/guardian|14|||
30997889|NCT02118792|59196517|FG001|Overall Study|Withdrawal by parent/guardian|20|||
30997890|NCT02118792|59196516|FG000|Overall Study|Other|1|||
30997891|NCT02118792|59196517|FG001|Overall Study|Other|6|||
30997892|NCT02118792|59196516|FG000|Overall Study|Randomised but not treated|1|||
30997893|NCT02118792|59196517|FG001|Overall Study|Randomised but not treated|0|||
30997894|NCT02118714|59196525|FG000|Overall Study|Lost to Follow-up|2|||
30997895|NCT02118714|59196525|FG000|Overall Study|Protocol Violation|1|||
30997896|NCT02138916|59196532|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
30997897|NCT02138916|59196533|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
30997898|NCT02138916|59196534|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
30997899|NCT02138916|59196532|FG000|Overall Study|Death|14|||
30997900|NCT02138916|59196533|FG001|Overall Study|Death|11|||
30997901|NCT02138916|59196534|FG002|Overall Study|Death|12|||
30997902|NCT02138916|59196532|FG000|Overall Study|Withdrawal by Subject|27|||
30997903|NCT02138916|59196533|FG001|Overall Study|Withdrawal by Subject|31|||
30997904|NCT02138916|59196534|FG002|Overall Study|Withdrawal by Subject|32|||
30997905|NCT02138916|59196532|FG000|Overall Study|Study specific withdrawal criteria|0|||
30997906|NCT02138916|59196533|FG001|Overall Study|Study specific withdrawal criteria|0|||
30997907|NCT02138916|59196534|FG002|Overall Study|Study specific withdrawal criteria|1|||
30997908|NCT02138916|59196532|FG000|Overall Study|incorrect enrolment|1|||
30997909|NCT02138916|59196533|FG001|Overall Study|incorrect enrolment|1|||
30997910|NCT02138916|59196534|FG002|Overall Study|incorrect enrolment|0|||
30997911|NCT02138916|59196532|FG000|Overall Study|Severe non-compliance|1|||
30997912|NCT02138916|59196533|FG001|Overall Study|Severe non-compliance|2|||
30997913|NCT02138916|59196534|FG002|Overall Study|Severe non-compliance|1|||
30997914|NCT02138916|59196532|FG000|Overall Study|Lost to Follow-up|4|||
30997915|NCT02138916|59196533|FG001|Overall Study|Lost to Follow-up|2|||
30997916|NCT02138916|59196534|FG002|Overall Study|Lost to Follow-up|3|||
30997917|NCT02138916|59196532|FG000|Overall Study|Adverse Event|4|||
30997918|NCT02138916|59196533|FG001|Overall Study|Adverse Event|4|||
30997919|NCT02138916|59196534|FG002|Overall Study|Adverse Event|3|||
30997920|NCT02118012|59196544|FG000|Overall Study|Adverse Event|0|||
30997921|NCT02118012|59196545|FG001|Overall Study|Adverse Event|1|||
30997922|NCT02118012|59196544|FG000|Overall Study|Physician Decision|0|||
30997923|NCT02118012|59196545|FG001|Overall Study|Physician Decision|1|||
30997924|NCT02093520|59196553|FG000|Overall Study|Not treated|6|||
30997925|NCT02093520|59196554|FG001|Overall Study|Not treated|22|||
30997926|NCT02138838|59196562|FG000|Overall Study|Study Closure|7|||
30997927|NCT02138838|59196563|FG001|Overall Study|Study Closure|6|||
30997928|NCT02138838|59196562|FG000|Overall Study|Withdrawal by Subject|1|||
30997929|NCT02138838|59196563|FG001|Overall Study|Withdrawal by Subject|5|||
30997930|NCT02138214|59196572|FG000|Overall Study|Withdrawal by Subject|0|||
30997931|NCT02138214|59196573|FG001|Overall Study|Withdrawal by Subject|1|||
30997932|NCT02138214|59196574|FG002|Overall Study|Withdrawal by Subject|0|||
30997933|NCT02138214|59196572|FG000|Overall Study|Lost to Follow-up|0|||
30997934|NCT02138214|59196573|FG001|Overall Study|Lost to Follow-up|2|||
30997935|NCT02138214|59196574|FG002|Overall Study|Lost to Follow-up|4|||
30997936|NCT02138214|59196572|FG000|Overall Study|Screen Failure|0|||
30997937|NCT02138214|59196573|FG001|Overall Study|Screen Failure|1|||
30997938|NCT02138214|59196574|FG002|Overall Study|Screen Failure|0|||
30997939|NCT02092662|59196583|FG000|Overall Study|Lost to Follow-up|13|||
30997940|NCT02092662|59196584|FG001|Overall Study|Lost to Follow-up|0|||
30997941|NCT02092350|59196593|FG000|Overall Study|Adverse Event|0|||
30997942|NCT02092350|59196594|FG001|Overall Study|Adverse Event|3|||
30997943|NCT02092350|59196593|FG000|Overall Study|Death|2|||
30997944|NCT02092350|59196594|FG001|Overall Study|Death|5|||
30997945|NCT02092350|59196593|FG000|Overall Study|Lost to Follow-up|3|||
30997946|NCT02092350|59196594|FG001|Overall Study|Lost to Follow-up|1|||
30892106|NCT02309359|58925457|FG002|Overall Study|Death|0|||
30892107|NCT02309359|58925458|FG003|Overall Study|Death|0|||
30892108|NCT02309359|58925459|FG004|Overall Study|Death|0|||
30892109|NCT02309359|58925455|FG000|Overall Study|Withdrawal by Subject|2|||
30892110|NCT02309359|58925456|FG001|Overall Study|Withdrawal by Subject|2|||
30892111|NCT02309359|58925457|FG002|Overall Study|Withdrawal by Subject|4|||
30892112|NCT02309359|58925458|FG003|Overall Study|Withdrawal by Subject|4|||
30892113|NCT02309359|58925459|FG004|Overall Study|Withdrawal by Subject|0|||
30892114|NCT02309359|58925455|FG000|Overall Study|Lack of Efficacy|3|||
30892115|NCT02309359|58925456|FG001|Overall Study|Lack of Efficacy|1|||
30892116|NCT02309359|58925457|FG002|Overall Study|Lack of Efficacy|0|||
30892117|NCT02309359|58925458|FG003|Overall Study|Lack of Efficacy|0|||
30892118|NCT02309359|58925459|FG004|Overall Study|Lack of Efficacy|3|||
30892119|NCT02309359|58925455|FG000|Overall Study|Lost to Follow-up|0|||
30997947|NCT02092350|59196593|FG000|Overall Study|Protocol Violation|1|||
30997948|NCT02092350|59196594|FG001|Overall Study|Protocol Violation|0|||
30997949|NCT02092350|59196593|FG000|Overall Study|Physician Decision|1|||
30997950|NCT02092350|59196594|FG001|Overall Study|Physician Decision|1|||
30997951|NCT02092350|59196593|FG000|Overall Study|Screen Failure|1|||
30997952|NCT02092350|59196594|FG001|Overall Study|Screen Failure|0|||
30997953|NCT02092350|59196593|FG000|Overall Study|Withdrawal by Subject|2|||
30997954|NCT02092350|59196594|FG001|Overall Study|Withdrawal by Subject|2|||
30997955|NCT02117544|59196602|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
30997956|NCT02117544|59196603|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
30997957|NCT02138136|59196610|FG000|Overall Study|Protocol Violation|4|||
30997958|NCT02138136|59196610|FG000|Overall Study|Physician Decision|7|||
30997959|NCT02138136|59196610|FG000|Overall Study|Lack of Efficacy|35|||
30997960|NCT02138136|59196610|FG000|Overall Study|Pregnancy|2|||
30997961|NCT02138136|59196610|FG000|Overall Study|Adverse Event|18|||
30997962|NCT02138136|59196610|FG000|Overall Study|Withdrawal by Subject|36|||
30997963|NCT02138136|59196610|FG000|Overall Study|Lost to Follow-up|32|||
30997964|NCT02138136|59196610|FG000|Overall Study|Withdrawn by Sponsor|5|||
30997965|NCT01626690|59196617|FG000|Overall Study|Protocol Violation|1|||
30997966|NCT01626690|59196618|FG001|Overall Study|Protocol Violation|0|||
30997967|NCT01626690|59196617|FG000|Overall Study|Adverse Event|1|||
30997968|NCT01626690|59196618|FG001|Overall Study|Adverse Event|0|||
30997969|NCT01626456|59196628|FG000|Overall Study|Withdrawal by Subject|21|||
30997970|NCT01626456|59196629|FG001|Overall Study|Withdrawal by Subject|46|||
30997971|NCT01626456|59196628|FG000|Overall Study|Adverse Event|2|||
30997972|NCT01626456|59196629|FG001|Overall Study|Adverse Event|27|||
30997973|NCT01626456|59196628|FG000|Overall Study|Lost to Follow-up|2|||
30997974|NCT01626456|59196629|FG001|Overall Study|Lost to Follow-up|27|||
30997975|NCT01626456|59196628|FG000|Overall Study|Lack of Efficacy|6|||
30997976|NCT01626456|59196629|FG001|Overall Study|Lack of Efficacy|7|||
30997977|NCT01626456|59196628|FG000|Overall Study|Physician Decision|1|||
30997978|NCT01626456|59196629|FG001|Overall Study|Physician Decision|4|||
30997979|NCT01626456|59196628|FG000|Overall Study|Protocol Violation|1|||
30997980|NCT01626456|59196629|FG001|Overall Study|Protocol Violation|1|||
30997981|NCT01626456|59196628|FG000|Overall Study|Site Closure|2|||
30997982|NCT01626456|59196629|FG001|Overall Study|Site Closure|3|||
30997983|NCT01626456|59196628|FG000|Overall Study|Incarceration|0|||
30997984|NCT01626456|59196629|FG001|Overall Study|Incarceration|2|||
30997985|NCT02116608|59196647|FG000|Overall Study|Lost to Follow-up|0|||
30997986|NCT02116608|59196648|FG001|Overall Study|Lost to Follow-up|0|||
30997987|NCT02116608|59196649|FG002|Overall Study|Lost to Follow-up|1|||
30997988|NCT02116608|59196647|FG000|Overall Study|Physician Decision|0|||
30997989|NCT02116608|59196648|FG001|Overall Study|Physician Decision|1|||
30997990|NCT02116608|59196649|FG002|Overall Study|Physician Decision|0|||
30997991|NCT02116608|59196647|FG000|Overall Study|Death|0|||
30997992|NCT02116608|59196648|FG001|Overall Study|Death|1|||
30997993|NCT02116608|59196649|FG002|Overall Study|Death|0|||
30997994|NCT02092116|59196659|FG000|Overall Study|Withdrawal by Subject|0|||
30997995|NCT02092116|59196660|FG001|Overall Study|Withdrawal by Subject|3|||
30997996|NCT02092116|59196659|FG000|Overall Study|Adverse Event|0|||
30997997|NCT02092116|59196660|FG001|Overall Study|Adverse Event|1|||
30997998|NCT02091726|59196666|FG000|Overall Study|Lost to Follow-up|6|||
30997999|NCT02091414|59196670|FG000|Overall Study|Withdrawal by Subject|2|||
30998000|NCT02091414|59196670|FG000|Overall Study|Death|2|||
30998001|NCT02116530|59196676|FG000|Overall Study|Withdrawal by Subject|1|||
30998002|NCT02116530|59196677|FG001|Overall Study|Withdrawal by Subject|2|||
30998003|NCT02116530|59196676|FG000|Overall Study|Adverse Event|4|||
30998004|NCT02116530|59196677|FG001|Overall Study|Adverse Event|0|||
30998005|NCT02116530|59196676|FG000|Overall Study|Physician Decision|1|||
30998006|NCT02116530|59196677|FG001|Overall Study|Physician Decision|0|||
30998007|NCT02116530|59196676|FG000|Overall Study|Lost to Follow-up|1|||
30998008|NCT02116530|59196677|FG001|Overall Study|Lost to Follow-up|0|||
30998009|NCT02116530|59196676|FG000|Overall Study|Other Medical Problems|2|||
30998010|NCT02116530|59196677|FG001|Overall Study|Other Medical Problems|2|||
30998011|NCT02072226|59196685|FG000|Overall Study|Lost to Follow-up|11|||
30998012|NCT02072226|59196686|FG001|Overall Study|Lost to Follow-up|7|||
30998013|NCT02072226|59196685|FG000|Overall Study|Patient Non-compliance|2|||
30998014|NCT02072226|59196686|FG001|Overall Study|Patient Non-compliance|3|||
30998015|NCT02072226|59196685|FG000|Overall Study|Death|1|||
30998016|NCT02072226|59196686|FG001|Overall Study|Death|0|||
30998017|NCT02072226|59196685|FG000|Overall Study|Patient Withdrawal of Consent|1|||
30998018|NCT02072226|59196686|FG001|Overall Study|Patient Withdrawal of Consent|0|||
30998019|NCT02090634|59196694|FG000|Overall Study|Lost to Follow-up|0|||
30998020|NCT02090634|59196695|FG001|Overall Study|Lost to Follow-up|1|||
30998021|NCT02090634|59196694|FG000|Overall Study|Death|0|||
30998022|NCT02090634|59196695|FG001|Overall Study|Death|1|||
30998023|NCT02090634|59196694|FG000|Overall Study|Protocol Violation|3|||
30998024|NCT02090634|59196695|FG001|Overall Study|Protocol Violation|1|||
30998025|NCT02090634|59196694|FG000|Overall Study|Adverse Event|2|||
30998026|NCT02090634|59196695|FG001|Overall Study|Adverse Event|0|||
30998027|NCT02114892|59196703|FG000|Overall Study|Lost to Follow-up|1|||
30998028|NCT02114892|59196704|FG001|Overall Study|Lost to Follow-up|2|||
30998029|NCT02070978|59196713|FG000|Overall Study|Adverse Event|6|||
30998030|NCT02070978|59196714|FG001|Overall Study|Adverse Event|2|||
30998031|NCT02070978|59196715|FG002|Overall Study|Adverse Event|0|||
30998032|NCT02070978|59196713|FG000|Overall Study|Lost to Follow-up|1|||
30998033|NCT02070978|59196714|FG001|Overall Study|Lost to Follow-up|3|||
30998034|NCT02070978|59196715|FG002|Overall Study|Lost to Follow-up|4|||
30998035|NCT02070978|59196713|FG000|Overall Study|Withdrawal by Subject|3|||
30998036|NCT02070978|59196714|FG001|Overall Study|Withdrawal by Subject|5|||
30998037|NCT02070978|59196715|FG002|Overall Study|Withdrawal by Subject|3|||
30998038|NCT02070978|59196713|FG000|Overall Study|Protocol Violation|1|||
30998039|NCT02070978|59196714|FG001|Overall Study|Protocol Violation|0|||
30998040|NCT02070978|59196715|FG002|Overall Study|Protocol Violation|3|||
30998041|NCT02070978|59196713|FG000|Overall Study|Lack of Efficacy|0|||
30998042|NCT02070978|59196714|FG001|Overall Study|Lack of Efficacy|1|||
30998043|NCT02070978|59196715|FG002|Overall Study|Lack of Efficacy|0|||
30998044|NCT02070978|59196713|FG000|Overall Study|Death|0|||
30998045|NCT02070978|59196714|FG001|Overall Study|Death|0|||
30998046|NCT02070978|59196715|FG002|Overall Study|Death|2|||
30998047|NCT02070978|59196713|FG000|Overall Study|Un-specified|3|||
30998048|NCT02070978|59196714|FG001|Overall Study|Un-specified|2|||
30998049|NCT02070978|59196715|FG002|Overall Study|Un-specified|2|||
30998050|NCT02070978|59196713|FG000|Overall Study|Terminated by Sponsor|33|||
30998051|NCT02070978|59196714|FG001|Overall Study|Terminated by Sponsor|40|||
30998052|NCT02070978|59196715|FG002|Overall Study|Terminated by Sponsor|39|||
30998053|NCT02114268|59196729|FG000|Overall Study|Lost to Follow-up|4|||
30998054|NCT02114268|59196730|FG001|Overall Study|Lost to Follow-up|1|||
30998055|NCT02114268|59196731|FG002|Overall Study|Lost to Follow-up|1|||
30998056|NCT02114268|59196732|FG003|Overall Study|Lost to Follow-up|0|||
30998057|NCT02114268|59196733|FG004|Overall Study|Lost to Follow-up|0|||
30998058|NCT02114268|59196734|FG005|Overall Study|Lost to Follow-up|2|||
30998059|NCT02114268|59196729|FG000|Overall Study|Withdrawal by Subject|1|||
30998060|NCT02114268|59196730|FG001|Overall Study|Withdrawal by Subject|0|||
30998061|NCT02114268|59196731|FG002|Overall Study|Withdrawal by Subject|0|||
30998062|NCT02114268|59196732|FG003|Overall Study|Withdrawal by Subject|0|||
30998063|NCT02114268|59196733|FG004|Overall Study|Withdrawal by Subject|0|||
30998064|NCT02114268|59196734|FG005|Overall Study|Withdrawal by Subject|1|||
30998065|NCT02114268|59196729|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
30998066|NCT02114268|59196730|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
30998067|NCT02114268|59196731|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
30998068|NCT02114268|59196732|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
30998069|NCT02114268|59196733|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
30998070|NCT02114268|59196734|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
30998071|NCT02089230|59196756|FG000|Overall Study|Death|0|||
30998072|NCT02089230|59196757|FG001|Overall Study|Death|0|||
30998073|NCT02089230|59196758|FG002|Overall Study|Death|2|||
30998074|NCT02089230|59196756|FG000|Overall Study|Seeking Alternative Therapy|0|||
30998075|NCT02089230|59196757|FG001|Overall Study|Seeking Alternative Therapy|0|||
30998076|NCT02089230|59196758|FG002|Overall Study|Seeking Alternative Therapy|4|||
30998077|NCT02070744|59196770|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
30998078|NCT02070744|59196771|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
30998079|NCT02070744|59196772|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
30998080|NCT02070744|59196773|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
30998081|NCT02070744|59196774|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
30998082|NCT02070744|59196770|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
30998083|NCT02070744|59196771|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
30998084|NCT02070744|59196772|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
30998085|NCT02070744|59196773|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
30998086|NCT02070744|59196774|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
30998087|NCT02070744|59196770|FG000|OLE Phase (48 Weeks)|Other|0|||
30998088|NCT02070744|59196771|FG001|OLE Phase (48 Weeks)|Other|0|||
30998089|NCT02070744|59196772|FG002|OLE Phase (48 Weeks)|Other|0|||
30998090|NCT02070744|59196773|FG003|OLE Phase (48 Weeks)|Other|0|||
30998091|NCT02070744|59196774|FG004|OLE Phase (48 Weeks)|Other|1|||
30998092|NCT02113956|59196791|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
30998093|NCT02113956|59196792|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
30998094|NCT02113956|59196791|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
30998095|NCT02113956|59196792|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
30998096|NCT02113956|59196791|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
30998097|NCT02113956|59196792|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
30998098|NCT02070588|59196801|FG000|Overall Study|Withdrawal by Subject|29|||
30998099|NCT02070588|59196802|FG001|Overall Study|Withdrawal by Subject|1|||
30998100|NCT02070588|59196803|FG002|Overall Study|Withdrawal by Subject|0|||
30998101|NCT02070588|59196801|FG000|Overall Study|Writhdrawal due to early termination|9|||
30998102|NCT02070588|59196802|FG001|Overall Study|Writhdrawal due to early termination|0|||
30998103|NCT02070588|59196803|FG002|Overall Study|Writhdrawal due to early termination|0|||
30998104|NCT02070588|59196801|FG000|Overall Study|Adverse Event|1|||
30998105|NCT02070588|59196802|FG001|Overall Study|Adverse Event|0|||
30998106|NCT02070588|59196803|FG002|Overall Study|Adverse Event|0|||
30998107|NCT02111850|59196822|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
30998108|NCT02111850|59196823|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
30998109|NCT02111850|59196824|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
30998110|NCT02111850|59196825|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
30998111|NCT02111850|59196826|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
30998112|NCT02111850|59196827|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
30998113|NCT02111850|59196828|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
30998114|NCT02111850|59196829|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
30998115|NCT02111850|59196830|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
30998116|NCT02111850|59196831|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
30998117|NCT02111850|59196832|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
30998118|NCT02087904|59196862|FG000|Overall Study|Did Not Receive Study Drug|0|||
30998119|NCT02087904|59196863|FG001|Overall Study|Did Not Receive Study Drug|0|||
30998120|NCT02087904|59196864|FG002|Overall Study|Did Not Receive Study Drug|2|||
30998121|NCT02087904|59196865|FG003|Overall Study|Did Not Receive Study Drug|1|||
30998122|NCT02087904|59196862|FG000|Overall Study|Adverse Event|8|||
30998123|NCT02087904|59196863|FG001|Overall Study|Adverse Event|4|||
30998124|NCT02087904|59196864|FG002|Overall Study|Adverse Event|4|||
30998125|NCT02087904|59196865|FG003|Overall Study|Adverse Event|12|||
30998126|NCT02087904|59196862|FG000|Overall Study|Lack of Efficacy|3|||
30998127|NCT02087904|59196863|FG001|Overall Study|Lack of Efficacy|6|||
30998128|NCT02087904|59196864|FG002|Overall Study|Lack of Efficacy|3|||
30998129|NCT02087904|59196865|FG003|Overall Study|Lack of Efficacy|2|||
30998130|NCT02087904|59196862|FG000|Overall Study|Other|6|||
30998131|NCT02087904|59196863|FG001|Overall Study|Other|2|||
30998132|NCT02087904|59196864|FG002|Overall Study|Other|4|||
30998133|NCT02087904|59196865|FG003|Overall Study|Other|4|||
30998134|NCT02087904|59196862|FG000|Overall Study|Withdrawal by Subject|8|||
30998135|NCT02087904|59196863|FG001|Overall Study|Withdrawal by Subject|3|||
30998136|NCT02087904|59196864|FG002|Overall Study|Withdrawal by Subject|7|||
30998137|NCT02087904|59196865|FG003|Overall Study|Withdrawal by Subject|4|||
30998138|NCT02087904|59196862|FG000|Overall Study|Lost to Follow-up|0|||
30998139|NCT02087904|59196863|FG001|Overall Study|Lost to Follow-up|4|||
30998140|NCT02087904|59196864|FG002|Overall Study|Lost to Follow-up|2|||
30998141|NCT02087904|59196865|FG003|Overall Study|Lost to Follow-up|2|||
30998142|NCT02087670|59196877|FG000|Overall Study|Withdrawal by Subject|3|||
30998143|NCT02087670|59196878|FG001|Overall Study|Withdrawal by Subject|2|||
30998144|NCT02086968|59196886|FG000|Overall Study|Adverse Event|1|||
30998145|NCT02086968|59196887|FG001|Overall Study|Adverse Event|5|||
30998146|NCT02086968|59196886|FG000|Overall Study|Lost to Follow-up|2|||
30998147|NCT02086968|59196887|FG001|Overall Study|Lost to Follow-up|3|||
30998148|NCT02086968|59196886|FG000|Overall Study|Study drug received outside protocol|0|||
30998149|NCT02086968|59196887|FG001|Overall Study|Study drug received outside protocol|1|||
30998150|NCT02086968|59196886|FG000|Overall Study|Physician Decision|4|||
30998151|NCT02086968|59196887|FG001|Overall Study|Physician Decision|0|||
30998152|NCT02086968|59196886|FG000|Overall Study|Withdrawal by Subject|1|||
30998153|NCT02086968|59196887|FG001|Overall Study|Withdrawal by Subject|4|||
30998154|NCT02086110|59196895|FG000|Overall Study|Withdrawal by Subject|1|||
30998155|NCT02086110|59196896|FG001|Overall Study|Withdrawal by Subject|1|||
30998156|NCT02085252|59196905|FG000|Overall Study|Withdrawal of Consent|1|||
30998157|NCT02085252|59196906|FG001|Overall Study|Withdrawal of Consent|0|||
30998158|NCT02085252|59196905|FG000|Overall Study|Adverse Event|0|||
30998159|NCT02085252|59196906|FG001|Overall Study|Adverse Event|1|||
30998160|NCT02085252|59196905|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
30998161|NCT02085252|59196906|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
30998162|NCT02085252|59196905|FG000|Overall Study|Reason Not Specified|0|||
30998163|NCT02085252|59196906|FG001|Overall Study|Reason Not Specified|1|||
30998164|NCT02085252|59196905|FG000|Overall Study|Reason Unknown|0|||
30998165|NCT02085252|59196906|FG001|Overall Study|Reason Unknown|1|||
30998166|NCT02084238|59196912|FG000|Overall Study|Lost to Follow-up|2|||
30998167|NCT02084082|59196925|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
30998168|NCT02084082|59196926|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
30998169|NCT02084082|59196927|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
30998170|NCT02084082|59196928|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
30998171|NCT02084082|59196925|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
30998172|NCT02084082|59196926|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
30998173|NCT02084082|59196927|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
30998174|NCT02084082|59196928|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
30998175|NCT02083926|59196940|FG000|Overall Study|Withdrawal by Subject|1|||
30998176|NCT02083926|59196941|FG001|Overall Study|Withdrawal by Subject|0|||
30998177|NCT02083380|59196951|FG000|Overall Study|Lack of Efficacy|68|||
30998178|NCT02083380|59196952|FG001|Overall Study|Lack of Efficacy|79|||
30998179|NCT02083380|59196953|FG002|Overall Study|Lack of Efficacy|64|||
30998180|NCT02083380|59196951|FG000|Overall Study|Withdrawal by Subject|9|||
30998181|NCT02083380|59196952|FG001|Overall Study|Withdrawal by Subject|3|||
30998182|NCT02083380|59196953|FG002|Overall Study|Withdrawal by Subject|7|||
30998183|NCT02083380|59196951|FG000|Overall Study|Physician Decision|1|||
30998184|NCT02083380|59196952|FG001|Overall Study|Physician Decision|6|||
30998185|NCT02083380|59196953|FG002|Overall Study|Physician Decision|3|||
30998186|NCT02083380|59196951|FG000|Overall Study|Adverse Event|0|||
30998187|NCT02083380|59196952|FG001|Overall Study|Adverse Event|0|||
30998188|NCT02083380|59196953|FG002|Overall Study|Adverse Event|1|||
30998189|NCT02083380|59196951|FG000|Overall Study|Lost to Follow-up|5|||
30998190|NCT02083380|59196952|FG001|Overall Study|Lost to Follow-up|3|||
30998191|NCT02083380|59196953|FG002|Overall Study|Lost to Follow-up|3|||
30998192|NCT02083380|59196951|FG000|Overall Study|Other|8|||
30998193|NCT02083380|59196952|FG001|Overall Study|Other|4|||
30998194|NCT02083380|59196953|FG002|Overall Study|Other|6|||
30998195|NCT02109744|59196968|FG000|Overall Study|Death|1|||
30998196|NCT02109744|59196969|FG001|Overall Study|Death|1|||
30998197|NCT02109744|59196968|FG000|Overall Study|no marrow exam|1|||
30998198|NCT02109744|59196969|FG001|Overall Study|no marrow exam|0|||
30998199|NCT02109432|59196975|FG000|Overall Study|Withdrawal by Subject|1|||
30998200|NCT02109042|59196979|FG000|Overall Study|Sponsor Decision|15|||
30998201|NCT02066922|59196984|FG000|Overall Study|Adverse Event|1|||
30998202|NCT02108262|59196995|FG000|Overall Study|Non-compliance|0|||
30998203|NCT02108262|59196996|FG001|Overall Study|Non-compliance|2|||
30998204|NCT02108262|59196997|FG002|Overall Study|Non-compliance|1|||
30998205|NCT02108262|59196998|FG003|Overall Study|Non-compliance|1|||
30998206|NCT02108262|59196995|FG000|Overall Study|Randomized by error/screen failure|0|||
30998207|NCT02108262|59196996|FG001|Overall Study|Randomized by error/screen failure|0|||
30998208|NCT02108262|59196997|FG002|Overall Study|Randomized by error/screen failure|1|||
30998209|NCT02108262|59196998|FG003|Overall Study|Randomized by error/screen failure|0|||
30998210|NCT02108262|59196995|FG000|Overall Study|Distance to center|0|||
30998211|NCT02108262|59196996|FG001|Overall Study|Distance to center|1|||
30998212|NCT02108262|59196997|FG002|Overall Study|Distance to center|1|||
30998213|NCT02108262|59196998|FG003|Overall Study|Distance to center|0|||
30998214|NCT02108262|59196995|FG000|Overall Study|Adverse Event|0|||
30998215|NCT02108262|59196996|FG001|Overall Study|Adverse Event|11|||
30998216|NCT02108262|59196997|FG002|Overall Study|Adverse Event|6|||
30998217|NCT02108262|59196998|FG003|Overall Study|Adverse Event|12|||
30998218|NCT02108262|59196995|FG000|Overall Study|Death|0|||
30998219|NCT02108262|59196996|FG001|Overall Study|Death|2|||
30998220|NCT02108262|59196997|FG002|Overall Study|Death|2|||
30998221|NCT02108262|59196998|FG003|Overall Study|Death|1|||
30998222|NCT02108262|59196995|FG000|Overall Study|Lost to Follow-up|0|||
30998223|NCT02108262|59196996|FG001|Overall Study|Lost to Follow-up|0|||
30998224|NCT02108262|59196997|FG002|Overall Study|Lost to Follow-up|1|||
30998225|NCT02108262|59196998|FG003|Overall Study|Lost to Follow-up|0|||
30998226|NCT02108262|59196995|FG000|Overall Study|Physician Decision|0|||
30998227|NCT02108262|59196996|FG001|Overall Study|Physician Decision|0|||
30998228|NCT02108262|59196997|FG002|Overall Study|Physician Decision|2|||
30998229|NCT02108262|59196998|FG003|Overall Study|Physician Decision|0|||
30998230|NCT02108262|59196995|FG000|Overall Study|Withdrawal by Subject|0|||
30998231|NCT02108262|59196996|FG001|Overall Study|Withdrawal by Subject|7|||
30998232|NCT02108262|59196997|FG002|Overall Study|Withdrawal by Subject|3|||
30998233|NCT02108262|59196998|FG003|Overall Study|Withdrawal by Subject|4|||
30998234|NCT02108262|59196995|FG000|Overall Study|Due to key hepatic values|0|||
30998235|NCT02108262|59196996|FG001|Overall Study|Due to key hepatic values|1|||
30998236|NCT02108262|59196997|FG002|Overall Study|Due to key hepatic values|0|||
30998237|NCT02108262|59196998|FG003|Overall Study|Due to key hepatic values|0|||
30998238|NCT02108262|59196995|FG000|Overall Study|Unable to contact patient|0|||
30998239|NCT02108262|59196996|FG001|Overall Study|Unable to contact patient|3|||
30998240|NCT02108262|59196997|FG002|Overall Study|Unable to contact patient|1|||
30998241|NCT02108262|59196998|FG003|Overall Study|Unable to contact patient|2|||
30998242|NCT02108262|59196995|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
30998243|NCT02108262|59196996|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
30998244|NCT02108262|59196997|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
30998245|NCT02108262|59196998|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
30998246|NCT02108262|59196995|FG000|Overall Study|Patient did not want another infusion|0|||
30998247|NCT02108262|59196996|FG001|Overall Study|Patient did not want another infusion|3|||
30998248|NCT02108262|59196997|FG002|Overall Study|Patient did not want another infusion|3|||
30998249|NCT02108262|59196998|FG003|Overall Study|Patient did not want another infusion|2|||
30998250|NCT02108262|59196995|FG000|Overall Study|Vacation|0|||
30998251|NCT02108262|59196996|FG001|Overall Study|Vacation|1|||
30998252|NCT02108262|59196997|FG002|Overall Study|Vacation|0|||
30998253|NCT02108262|59196998|FG003|Overall Study|Vacation|0|||
30998254|NCT02108262|59196995|FG000|Overall Study|Patient decision|0|||
30998255|NCT02108262|59196996|FG001|Overall Study|Patient decision|7|||
30998256|NCT02108262|59196997|FG002|Overall Study|Patient decision|9|||
30998257|NCT02108262|59196998|FG003|Overall Study|Patient decision|14|||
30998258|NCT02108262|59196995|FG000|Overall Study|Missed IV due to pharmacy error|0|||
30998259|NCT02108262|59196996|FG001|Overall Study|Missed IV due to pharmacy error|0|||
30998260|NCT02108262|59196997|FG002|Overall Study|Missed IV due to pharmacy error|1|||
30998261|NCT02108262|59196998|FG003|Overall Study|Missed IV due to pharmacy error|0|||
30998262|NCT02107482|59197007|FG000|Overall Study|inconveinence|2|||
30998263|NCT02107482|59197007|FG000|Overall Study|Lost to Follow-up|1|||
30998264|NCT02107482|59197007|FG000|Overall Study|Lack of Efficacy|1|||
30998265|NCT02066298|59197017|FG000|Overall Study|Lost to Follow-up|3|||
30998266|NCT02066298|59197018|FG001|Overall Study|Lost to Follow-up|2|||
30998267|NCT02066298|59197019|FG002|Overall Study|Lost to Follow-up|3|||
30998268|NCT02066298|59197020|FG003|Overall Study|Lost to Follow-up|2|||
30998269|NCT02066298|59197021|FG004|Overall Study|Lost to Follow-up|3|||
30998270|NCT02066298|59197022|FG005|Overall Study|Lost to Follow-up|4|||
30998271|NCT02066298|59197017|FG000|Overall Study|Withdrawal by Subject|6|||
30998272|NCT02066298|59197018|FG001|Overall Study|Withdrawal by Subject|6|||
30998273|NCT02066298|59197019|FG002|Overall Study|Withdrawal by Subject|6|||
30998274|NCT02066298|59197020|FG003|Overall Study|Withdrawal by Subject|4|||
30998275|NCT02066298|59197021|FG004|Overall Study|Withdrawal by Subject|5|||
30998276|NCT02066298|59197022|FG005|Overall Study|Withdrawal by Subject|8|||
30998277|NCT02066298|59197017|FG000|Overall Study|Physician Decision|0|||
30998278|NCT02066298|59197018|FG001|Overall Study|Physician Decision|0|||
30998279|NCT02066298|59197019|FG002|Overall Study|Physician Decision|1|||
30998280|NCT02066298|59197020|FG003|Overall Study|Physician Decision|0|||
30998281|NCT02066298|59197021|FG004|Overall Study|Physician Decision|1|||
30998282|NCT02066298|59197022|FG005|Overall Study|Physician Decision|0|||
30998283|NCT02082912|59197036|FG000|Overall Study|Physician Decision|0|||
30998284|NCT02082912|59197037|FG001|Overall Study|Physician Decision|1|||
30998285|NCT02082522|59197045|FG000|Overall Study|Sponsor termination|5|||
30998286|NCT02082522|59197046|FG001|Overall Study|Sponsor termination|3|||
30998287|NCT02082522|59197045|FG000|Overall Study|Withdrawal by Subject|2|||
30998288|NCT02082522|59197046|FG001|Overall Study|Withdrawal by Subject|4|||
30998289|NCT02082522|59197045|FG000|Overall Study|Death|1|||
30998290|NCT02082522|59197046|FG001|Overall Study|Death|0|||
30998291|NCT02082522|59197045|FG000|Overall Study|Lost to Follow-up|1|||
30998292|NCT02082522|59197046|FG001|Overall Study|Lost to Follow-up|0|||
30998293|NCT02082522|59197045|FG000|Overall Study|Physician Decision|3|||
30998294|NCT02082522|59197046|FG001|Overall Study|Physician Decision|1|||
30998295|NCT02082522|59197045|FG000|Overall Study|Disease progression|2|||
30998296|NCT02082522|59197046|FG001|Overall Study|Disease progression|2|||
30998297|NCT02082522|59197045|FG000|Overall Study|Chemotherapy change|1|||
30998298|NCT02082522|59197046|FG001|Overall Study|Chemotherapy change|3|||
30998299|NCT02082210|59197058|FG000|Overall Study|Death|0|||
30998300|NCT02082210|59197059|FG001|Overall Study|Death|0|||
30998301|NCT02082210|59197060|FG002|Overall Study|Death|1|||
30998302|NCT02082210|59197061|FG003|Overall Study|Death|1|||
30998303|NCT02082210|59197062|FG004|Overall Study|Death|1|||
30998304|NCT02082210|59197063|FG005|Overall Study|Death|0|||
30998305|NCT02082210|59197058|FG000|Overall Study|Withdrawal by Subject|0|||
30998306|NCT02082210|59197059|FG001|Overall Study|Withdrawal by Subject|0|||
30998307|NCT02082210|59197060|FG002|Overall Study|Withdrawal by Subject|0|||
30998308|NCT02082210|59197061|FG003|Overall Study|Withdrawal by Subject|1|||
30998309|NCT02082210|59197062|FG004|Overall Study|Withdrawal by Subject|2|||
30998310|NCT02082210|59197063|FG005|Overall Study|Withdrawal by Subject|2|||
30998311|NCT02082210|59197058|FG000|Overall Study|Clinical Progression|0|||
30998312|NCT02082210|59197059|FG001|Overall Study|Clinical Progression|0|||
30998313|NCT02082210|59197060|FG002|Overall Study|Clinical Progression|0|||
30998314|NCT02082210|59197061|FG003|Overall Study|Clinical Progression|1|||
30998315|NCT02082210|59197062|FG004|Overall Study|Clinical Progression|0|||
30998316|NCT02082210|59197063|FG005|Overall Study|Clinical Progression|0|||
30998317|NCT02082210|59197058|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
30998318|NCT02082210|59197059|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
30998319|NCT02082210|59197060|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
30998320|NCT02082210|59197061|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
30998321|NCT02082210|59197062|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
30998322|NCT02082210|59197063|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
30998323|NCT02082210|59197058|FG000|Overall Study|Physician Decision|0|||
30998324|NCT02082210|59197059|FG001|Overall Study|Physician Decision|0|||
30998325|NCT02082210|59197060|FG002|Overall Study|Physician Decision|1|||
30998326|NCT02082210|59197061|FG003|Overall Study|Physician Decision|1|||
30998327|NCT02082210|59197062|FG004|Overall Study|Physician Decision|0|||
30998328|NCT02082210|59197063|FG005|Overall Study|Physician Decision|0|||
30998329|NCT02107092|59197089|FG000|Overall Study|Miscellaneous|3|||
30998330|NCT02107092|59197089|FG000|Overall Study|Subject compliance|3|||
30998331|NCT02107092|59197089|FG000|Overall Study|Hypo-or hyperkalemia|2|||
30998332|NCT02107092|59197089|FG000|Overall Study|Met ECG withdrawal criteria|3|||
30998333|NCT02107092|59197089|FG000|Overall Study|Physician Decision|3|||
30998334|NCT02107092|59197089|FG000|Overall Study|Lost to Follow-up|2|||
30998335|NCT02107092|59197089|FG000|Overall Study|Withdrawal by Subject|9|||
30998336|NCT02107092|59197089|FG000|Overall Study|Adverse Event|7|||
30998337|NCT02107092|59197089|FG000|Overall Study|Expected progression of CKD|12|||
30998338|NCT02107014|59197093|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
30998339|NCT01624974|59197099|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
30998340|NCT01624974|59197100|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
30998341|NCT01624974|59197099|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
30998342|NCT01624974|59197100|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
30998343|NCT01624974|59197099|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
30998344|NCT01624974|59197100|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
30998345|NCT01624974|59197099|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
30998346|NCT01624974|59197100|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
30998347|NCT01624974|59197099|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
30998348|NCT01624974|59197100|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
30998349|NCT01624974|59197099|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
30998350|NCT01624974|59197100|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
30998351|NCT01624974|59197099|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
30998352|NCT01624974|59197100|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
30998353|NCT01624974|59197099|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
30998354|NCT01624974|59197100|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
30998355|NCT01624974|59197099|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
30998356|NCT01624974|59197100|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
30998357|NCT01624974|59197099|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
30998358|NCT01624974|59197100|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
30998359|NCT01624974|59197099|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
30998360|NCT01624974|59197100|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
30998361|NCT01624974|59197099|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
30998362|NCT01624974|59197100|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
30998363|NCT02065518|59197111|FG000|Overall Study|Lost to Follow-up|3|||
30998364|NCT02065518|59197112|FG001|Overall Study|Lost to Follow-up|4|||
30998365|NCT02065518|59197113|FG002|Overall Study|Lost to Follow-up|0|||
30998366|NCT02065518|59197114|FG003|Overall Study|Lost to Follow-up|3|||
30998367|NCT02065518|59197111|FG000|Overall Study|Withdrawal by Subject|3|||
30998368|NCT02065518|59197112|FG001|Overall Study|Withdrawal by Subject|4|||
30998369|NCT02065518|59197113|FG002|Overall Study|Withdrawal by Subject|9|||
30998370|NCT02065518|59197114|FG003|Overall Study|Withdrawal by Subject|2|||
30998371|NCT01624662|59197128|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
30998372|NCT01624662|59197129|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
30998373|NCT01624662|59197130|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
30998374|NCT01624662|59197131|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
30998375|NCT01624662|59197128|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
30998376|NCT01624662|59197129|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
30998377|NCT01624662|59197130|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
30998378|NCT01624662|59197131|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
30998379|NCT01624662|59197128|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
30998380|NCT01624662|59197129|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
30998381|NCT01624662|59197130|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
30998382|NCT01624662|59197131|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
30998383|NCT01624662|59197128|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
30998384|NCT01624662|59197129|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
30998385|NCT01624662|59197130|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
30998386|NCT01624662|59197131|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
30998387|NCT01624662|59197128|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
30998388|NCT01624662|59197129|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
30998389|NCT01624662|59197130|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
30998390|NCT01624662|59197131|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
30998391|NCT01624662|59197128|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
30998392|NCT01624662|59197129|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
30998393|NCT01624662|59197130|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
30998394|NCT01624662|59197131|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
30998395|NCT01624662|59197128|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
30998396|NCT01624662|59197129|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
30998397|NCT01624662|59197130|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
30998398|NCT01624662|59197131|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
30998399|NCT01624506|59197154|FG000|Overall Study|Lost to Follow-up|29|||
30998400|NCT01624506|59197155|FG001|Overall Study|Lost to Follow-up|15|||
30998401|NCT01624506|59197154|FG000|Overall Study|Withdrawal by Subject|9|||
30998402|NCT01624506|59197155|FG001|Overall Study|Withdrawal by Subject|2|||
30998403|NCT01624506|59197154|FG000|Overall Study|Death|1|||
30998404|NCT01624506|59197155|FG001|Overall Study|Death|0|||
30998405|NCT01624506|59197154|FG000|Overall Study|LINX explants|23|||
30998406|NCT01624506|59197155|FG001|Overall Study|LINX explants|0|||
30998407|NCT01624506|59197154|FG000|Overall Study|Adverse Event|3|||
30998408|NCT01624506|59197155|FG001|Overall Study|Adverse Event|0|||
30998409|NCT02106390|59197164|FG000|Overall Study|Withdrawal by Subject|15|||
30998410|NCT02106390|59197165|FG001|Overall Study|Withdrawal by Subject|16|||
30998411|NCT02106390|59197166|FG002|Overall Study|Withdrawal by Subject|15|||
30998412|NCT02106390|59197164|FG000|Overall Study|Lost to Follow-up|25|||
30998413|NCT02106390|59197165|FG001|Overall Study|Lost to Follow-up|20|||
30998414|NCT02106390|59197166|FG002|Overall Study|Lost to Follow-up|13|||
30998415|NCT02106390|59197164|FG000|Overall Study|Other: Administrative Reason|8|||
30998416|NCT02106390|59197165|FG001|Overall Study|Other: Administrative Reason|5|||
30998417|NCT02106390|59197166|FG002|Overall Study|Other: Administrative Reason|12|||
30998418|NCT02106390|59197164|FG000|Overall Study|Other: Unspecified|1|||
30998419|NCT02106390|59197165|FG001|Overall Study|Other: Unspecified|4|||
30998420|NCT02106390|59197166|FG002|Overall Study|Other: Unspecified|2|||
30998421|NCT02106390|59197164|FG000|Overall Study|Adverse Event|0|||
30998422|NCT02106390|59197165|FG001|Overall Study|Adverse Event|2|||
30998423|NCT02106390|59197166|FG002|Overall Study|Adverse Event|1|||
30998424|NCT02106390|59197164|FG000|Overall Study|Protocol Violation|0|||
30998425|NCT02106390|59197165|FG001|Overall Study|Protocol Violation|1|||
30998426|NCT02106390|59197166|FG002|Overall Study|Protocol Violation|0|||
30998427|NCT02064894|59197180|FG000|Overall Study|Withdrawal by Subject|43|||
30998428|NCT02064894|59197181|FG001|Overall Study|Withdrawal by Subject|102|||
30998429|NCT02064894|59197182|FG002|Overall Study|Withdrawal by Subject|115|||
30998430|NCT02081586|59197194|FG000|Overall Study|Lost to Follow-up|0|||
30998431|NCT02081586|59197195|FG001|Overall Study|Lost to Follow-up|1|||
30998432|NCT02081586|59197196|FG002|Overall Study|Lost to Follow-up|0|||
30998433|NCT02081586|59197197|FG003|Overall Study|Lost to Follow-up|1|||
30998434|NCT02081586|59197194|FG000|Overall Study|Head injury not related to study|0|||
30998435|NCT02081586|59197195|FG001|Overall Study|Head injury not related to study|0|||
30998436|NCT02081586|59197196|FG002|Overall Study|Head injury not related to study|1|||
30998437|NCT02081586|59197197|FG003|Overall Study|Head injury not related to study|0|||
30998438|NCT02081196|59197209|FG000|Overall Study|Lost to Follow-up|1|||
30998439|NCT02064816|59197217|FG000|Overall Study|Adverse Event|3|||
30998440|NCT02064816|59197218|FG001|Overall Study|Adverse Event|2|||
30998441|NCT02064816|59197217|FG000|Overall Study|Withdrawal by Subject|2|||
30998442|NCT02064816|59197218|FG001|Overall Study|Withdrawal by Subject|1|||
30998443|NCT02064816|59197217|FG000|Overall Study|Lost to Follow-up|2|||
30998444|NCT02064816|59197218|FG001|Overall Study|Lost to Follow-up|1|||
30998445|NCT02064816|59197217|FG000|Overall Study|Therapeutic failure|0|||
30998446|NCT02064816|59197218|FG001|Overall Study|Therapeutic failure|1|||
30998447|NCT02064816|59197217|FG000|Overall Study|Other|1|||
30998448|NCT02064816|59197218|FG001|Overall Study|Other|3|||
30998449|NCT02080260|59197224|FG000|Overall Study|Death|18|||
30998450|NCT02080260|59197224|FG000|Overall Study|Withdrawal by Subject|1|||
30998451|NCT01624194|59197230|FG000|Overall Study|Lost to Follow-up|1|||
30998452|NCT01624194|59197231|FG001|Overall Study|Lost to Follow-up|0|||
30998453|NCT01624194|59197230|FG000|Overall Study|Withdrawal by Subject|1|||
30998454|NCT01624194|59197231|FG001|Overall Study|Withdrawal by Subject|0|||
30998455|NCT02079636|59197253|FG000|Overall Study|Death|2|||
30998456|NCT02079636|59197254|FG001|Overall Study|Death|1|||
30998457|NCT02079636|59197255|FG002|Overall Study|Death|0|||
30998458|NCT02079636|59197256|FG003|Overall Study|Death|5|||
30998459|NCT02079636|59197257|FG004|Overall Study|Death|1|||
30998460|NCT02079636|59197258|FG005|Overall Study|Death|2|||
30998461|NCT02079636|59197259|FG006|Overall Study|Death|1|||
30998462|NCT02079636|59197260|FG007|Overall Study|Death|0|||
30998463|NCT02079636|59197261|FG008|Overall Study|Death|0|||
30998464|NCT02079636|59197262|FG009|Overall Study|Death|0|||
30892120|NCT02309359|58925456|FG001|Overall Study|Lost to Follow-up|0|||
30998465|NCT02079636|59197263|FG010|Overall Study|Death|0|||
30998466|NCT02079636|59197264|FG011|Overall Study|Death|1|||
30998467|NCT02079636|59197265|FG012|Overall Study|Death|1|||
30998468|NCT02079636|59197266|FG013|Overall Study|Death|0|||
30998469|NCT02079636|59197267|FG014|Overall Study|Death|2|||
30998470|NCT02079636|59197253|FG000|Overall Study|Adverse Event|1|||
30998471|NCT02079636|59197254|FG001|Overall Study|Adverse Event|1|||
30998472|NCT02079636|59197255|FG002|Overall Study|Adverse Event|0|||
30998473|NCT02079636|59197256|FG003|Overall Study|Adverse Event|1|||
30998474|NCT02079636|59197257|FG004|Overall Study|Adverse Event|1|||
30998475|NCT02079636|59197258|FG005|Overall Study|Adverse Event|2|||
30998476|NCT02079636|59197259|FG006|Overall Study|Adverse Event|0|||
30998477|NCT02079636|59197260|FG007|Overall Study|Adverse Event|0|||
30998478|NCT02079636|59197261|FG008|Overall Study|Adverse Event|0|||
30998479|NCT02079636|59197262|FG009|Overall Study|Adverse Event|0|||
30998480|NCT02079636|59197263|FG010|Overall Study|Adverse Event|0|||
30998481|NCT02079636|59197264|FG011|Overall Study|Adverse Event|0|||
30998482|NCT02079636|59197265|FG012|Overall Study|Adverse Event|0|||
30998483|NCT02079636|59197266|FG013|Overall Study|Adverse Event|0|||
30998484|NCT02079636|59197267|FG014|Overall Study|Adverse Event|0|||
30998485|NCT02079636|59197253|FG000|Overall Study|Progressive disease|0|||
30998486|NCT02079636|59197254|FG001|Overall Study|Progressive disease|0|||
30998487|NCT02079636|59197255|FG002|Overall Study|Progressive disease|0|||
30998488|NCT02079636|59197256|FG003|Overall Study|Progressive disease|2|||
30998489|NCT02079636|59197257|FG004|Overall Study|Progressive disease|0|||
30998490|NCT02079636|59197258|FG005|Overall Study|Progressive disease|0|||
30998491|NCT02079636|59197259|FG006|Overall Study|Progressive disease|0|||
30998492|NCT02079636|59197260|FG007|Overall Study|Progressive disease|0|||
30998493|NCT02079636|59197261|FG008|Overall Study|Progressive disease|0|||
30998494|NCT02079636|59197262|FG009|Overall Study|Progressive disease|0|||
30998495|NCT02079636|59197263|FG010|Overall Study|Progressive disease|0|||
30998496|NCT02079636|59197264|FG011|Overall Study|Progressive disease|0|||
30998497|NCT02079636|59197265|FG012|Overall Study|Progressive disease|1|||
30998498|NCT02079636|59197266|FG013|Overall Study|Progressive disease|0|||
30998499|NCT02079636|59197267|FG014|Overall Study|Progressive disease|0|||
30998500|NCT02079636|59197253|FG000|Overall Study|Withdrawal by Subject|0|||
30998501|NCT02079636|59197254|FG001|Overall Study|Withdrawal by Subject|0|||
30998502|NCT02079636|59197255|FG002|Overall Study|Withdrawal by Subject|0|||
30998503|NCT02079636|59197256|FG003|Overall Study|Withdrawal by Subject|4|||
30998504|NCT02079636|59197257|FG004|Overall Study|Withdrawal by Subject|0|||
30998505|NCT02079636|59197258|FG005|Overall Study|Withdrawal by Subject|1|||
30998506|NCT02079636|59197259|FG006|Overall Study|Withdrawal by Subject|0|||
30998507|NCT02079636|59197260|FG007|Overall Study|Withdrawal by Subject|0|||
30998508|NCT02079636|59197261|FG008|Overall Study|Withdrawal by Subject|0|||
30998509|NCT02079636|59197262|FG009|Overall Study|Withdrawal by Subject|2|||
30998510|NCT02079636|59197263|FG010|Overall Study|Withdrawal by Subject|1|||
30998511|NCT02079636|59197264|FG011|Overall Study|Withdrawal by Subject|1|||
30998512|NCT02079636|59197265|FG012|Overall Study|Withdrawal by Subject|1|||
30998513|NCT02079636|59197266|FG013|Overall Study|Withdrawal by Subject|0|||
30998514|NCT02079636|59197267|FG014|Overall Study|Withdrawal by Subject|2|||
30998515|NCT02079636|59197253|FG000|Overall Study|Physician Decision|0|||
30998516|NCT02079636|59197254|FG001|Overall Study|Physician Decision|0|||
30998517|NCT02079636|59197255|FG002|Overall Study|Physician Decision|0|||
30998518|NCT02079636|59197256|FG003|Overall Study|Physician Decision|0|||
30998519|NCT02079636|59197257|FG004|Overall Study|Physician Decision|0|||
30998520|NCT02079636|59197258|FG005|Overall Study|Physician Decision|1|||
30998521|NCT02079636|59197259|FG006|Overall Study|Physician Decision|0|||
30998522|NCT02079636|59197260|FG007|Overall Study|Physician Decision|0|||
30998523|NCT02079636|59197261|FG008|Overall Study|Physician Decision|0|||
30998524|NCT02079636|59197262|FG009|Overall Study|Physician Decision|1|||
30998525|NCT02079636|59197263|FG010|Overall Study|Physician Decision|1|||
30998526|NCT02079636|59197264|FG011|Overall Study|Physician Decision|0|||
30998527|NCT02079636|59197265|FG012|Overall Study|Physician Decision|0|||
30998528|NCT02079636|59197266|FG013|Overall Study|Physician Decision|0|||
30998529|NCT02079636|59197267|FG014|Overall Study|Physician Decision|1|||
30998530|NCT02079636|59197253|FG000|Overall Study|Lost to Follow-up|0|||
30998531|NCT02079636|59197254|FG001|Overall Study|Lost to Follow-up|0|||
30998532|NCT02079636|59197255|FG002|Overall Study|Lost to Follow-up|0|||
30998533|NCT02079636|59197256|FG003|Overall Study|Lost to Follow-up|0|||
30998534|NCT02079636|59197257|FG004|Overall Study|Lost to Follow-up|0|||
30998535|NCT02079636|59197258|FG005|Overall Study|Lost to Follow-up|0|||
30998536|NCT02079636|59197259|FG006|Overall Study|Lost to Follow-up|0|||
30998537|NCT02079636|59197260|FG007|Overall Study|Lost to Follow-up|1|||
30998538|NCT02079636|59197261|FG008|Overall Study|Lost to Follow-up|0|||
30998539|NCT02079636|59197262|FG009|Overall Study|Lost to Follow-up|0|||
30998540|NCT02079636|59197263|FG010|Overall Study|Lost to Follow-up|0|||
30998541|NCT02079636|59197264|FG011|Overall Study|Lost to Follow-up|0|||
30998542|NCT02079636|59197265|FG012|Overall Study|Lost to Follow-up|0|||
30998543|NCT02079636|59197266|FG013|Overall Study|Lost to Follow-up|0|||
30998544|NCT02079636|59197267|FG014|Overall Study|Lost to Follow-up|0|||
30998545|NCT02079246|59197331|FG000|OLEX|Withdrawal before treatment|1|||
30998546|NCT02079246|59197332|FG001|OLEX|Withdrawal before treatment|0|||
30998547|NCT02079246|59197331|FG000|OLEX|Death|11|||
30998548|NCT02079246|59197332|FG001|OLEX|Death|0|||
30998549|NCT02079246|59197331|FG000|OLEX|Adverse Event|66|||
30998550|NCT02079246|59197332|FG001|OLEX|Adverse Event|0|||
30998551|NCT02079246|59197331|FG000|OLEX|Withdrawal by Subject|60|||
30998552|NCT02079246|59197332|FG001|OLEX|Withdrawal by Subject|0|||
30998553|NCT02079246|59197331|FG000|OLEX|Lost to Follow-up|6|||
30998554|NCT02079246|59197332|FG001|OLEX|Lost to Follow-up|0|||
30998555|NCT02079246|59197331|FG000|OLEX|Protocol Violation|6|||
30998556|NCT02079246|59197332|FG001|OLEX|Protocol Violation|0|||
30998557|NCT02079246|59197331|FG000|OLEX|Lack of Efficacy|3|||
30998558|NCT02079246|59197332|FG001|OLEX|Lack of Efficacy|0|||
30998559|NCT02079246|59197331|FG000|OLEX|Results of the lead-in studies|58|||
30998560|NCT02079246|59197332|FG001|OLEX|Results of the lead-in studies|0|||
30998561|NCT02079246|59197331|FG000|OLEX|Other: Disallowed medication|8|||
30998562|NCT02079246|59197332|FG001|OLEX|Other: Disallowed medication|0|||
30998563|NCT02079246|59197331|FG000|OLEX|Other: Insufficient compliance|2|||
30998564|NCT02079246|59197332|FG001|OLEX|Other: Insufficient compliance|0|||
30998565|NCT02079246|59197331|FG000|OLEX|Other: Caregiver unavailable|3|||
30998566|NCT02079246|59197332|FG001|OLEX|Other: Caregiver unavailable|0|||
30998567|NCT02079246|59197331|FG000|OLEX|Other: Coordinator decision|1|||
30998568|NCT02079246|59197332|FG001|OLEX|Other: Coordinator decision|0|||
30998569|NCT02079246|59197331|FG000|OLEX|Other: Worsening of condition|1|||
30998570|NCT02079246|59197332|FG001|OLEX|Other: Worsening of condition|0|||
30998571|NCT02079246|59197331|FG000|OLEX|Other: Moved to nursing home|1|||
30998572|NCT02079246|59197332|FG001|OLEX|Other: Moved to nursing home|0|||
30998573|NCT02079246|59197331|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
30998574|NCT02079246|59197332|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
30998575|NCT02079246|59197331|FG000|OLEX-MEM|Adverse Event|0|||
30998576|NCT02079246|59197332|FG001|OLEX-MEM|Adverse Event|6|||
30998577|NCT02079246|59197331|FG000|OLEX-MEM|Withdrawal by Subject|0|||
30998578|NCT02079246|59197332|FG001|OLEX-MEM|Withdrawal by Subject|7|||
30998579|NCT02079246|59197331|FG000|OLEX-MEM|Protocol Violation|0|||
30998580|NCT02079246|59197332|FG001|OLEX-MEM|Protocol Violation|2|||
30998581|NCT02079246|59197331|FG000|OLEX-MEM|Lost to Follow-up|0|||
30998582|NCT02079246|59197332|FG001|OLEX-MEM|Lost to Follow-up|1|||
30998583|NCT02079246|59197331|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
30998584|NCT02079246|59197332|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
30998585|NCT02077374|59197343|FG000|Overall Study|Withdrawal by Subject|0|||
30998586|NCT02077374|59197344|FG001|Overall Study|Withdrawal by Subject|1|||
30998587|NCT02077374|59197343|FG000|Overall Study|Protocol Violation|0|||
30998588|NCT02077374|59197344|FG001|Overall Study|Protocol Violation|1|||
30998589|NCT02077140|59197358|FG000|Overall Study|Lost to Follow-up|4|||
30998590|NCT02077140|59197359|FG001|Overall Study|Lost to Follow-up|1|||
30998591|NCT02077140|59197360|FG002|Overall Study|Lost to Follow-up|2|||
30998592|NCT02077140|59197361|FG003|Overall Study|Lost to Follow-up|2|||
30998593|NCT02077140|59197362|FG004|Overall Study|Lost to Follow-up|3|||
30998594|NCT02077140|59197358|FG000|Overall Study|Withdrawal by Subject|0|||
30998595|NCT02077140|59197359|FG001|Overall Study|Withdrawal by Subject|1|||
30998596|NCT02077140|59197360|FG002|Overall Study|Withdrawal by Subject|0|||
30998597|NCT02077140|59197361|FG003|Overall Study|Withdrawal by Subject|2|||
30998598|NCT02077140|59197362|FG004|Overall Study|Withdrawal by Subject|2|||
30998599|NCT02047110|59197381|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
30998600|NCT02047110|59197382|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
30998601|NCT02047110|59197383|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
30998602|NCT02047110|59197384|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
30998603|NCT02047110|59197381|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
30998604|NCT02047110|59197382|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
30998605|NCT02047110|59197383|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
30998606|NCT02047110|59197384|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
30998607|NCT02047110|59197381|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
30998608|NCT02047110|59197382|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
30998609|NCT02047110|59197383|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
30998610|NCT02047110|59197384|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
30998611|NCT02047110|59197381|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
30998612|NCT02047110|59197382|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
30998613|NCT02047110|59197383|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
30998614|NCT02047110|59197384|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
30998615|NCT02047110|59197381|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
30998616|NCT02047110|59197382|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
30998617|NCT02047110|59197383|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
30998618|NCT02047110|59197384|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
30998619|NCT02047110|59197381|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
30998620|NCT02047110|59197382|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
30998621|NCT02047110|59197383|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
30998622|NCT02047110|59197384|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
30998623|NCT02047110|59197381|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
30998624|NCT02047110|59197382|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
30998625|NCT02047110|59197383|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
30998626|NCT02047110|59197384|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
30998627|NCT02047110|59197381|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
30998628|NCT02047110|59197382|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
30998629|NCT02047110|59197383|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
30998630|NCT02047110|59197384|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
30998631|NCT02047110|59197381|FG000|Escape Treatment Period|Adverse Event|1|||
30998632|NCT02047110|59197382|FG001|Escape Treatment Period|Adverse Event|2|||
30998633|NCT02047110|59197383|FG002|Escape Treatment Period|Adverse Event|2|||
30998634|NCT02047110|59197384|FG003|Escape Treatment Period|Adverse Event|0|||
30998635|NCT02047110|59197381|FG000|Escape Treatment Period|Other than specified|1|||
30998636|NCT02047110|59197382|FG001|Escape Treatment Period|Other than specified|2|||
30998637|NCT02047110|59197383|FG002|Escape Treatment Period|Other than specified|0|||
30998638|NCT02047110|59197384|FG003|Escape Treatment Period|Other than specified|1|||
30998639|NCT02047110|59197381|FG000|OLE Treatment Period|Other than specified|0|||
30998640|NCT02047110|59197382|FG001|OLE Treatment Period|Other than specified|0|||
30998641|NCT02047110|59197383|FG002|OLE Treatment Period|Other than specified|1|||
30998642|NCT02047110|59197384|FG003|OLE Treatment Period|Other than specified|0|||
30998643|NCT02046564|59197403|FG000|Overall Study|Adverse Event|6|||
30998644|NCT02046564|59197404|FG001|Overall Study|Adverse Event|3|||
30998645|NCT02046564|59197403|FG000|Overall Study|Physician Decision|0|||
30998646|NCT02046564|59197404|FG001|Overall Study|Physician Decision|1|||
30998647|NCT02046564|59197403|FG000|Overall Study|Protocol Violation|3|||
30998648|NCT02046564|59197404|FG001|Overall Study|Protocol Violation|1|||
30998649|NCT02046564|59197403|FG000|Overall Study|Withdrawal by Subject|4|||
30998650|NCT02046564|59197404|FG001|Overall Study|Withdrawal by Subject|10|||
30998651|NCT02046564|59197403|FG000|Overall Study|Subject met withdrawal criteria|2|||
30998652|NCT02046564|59197404|FG001|Overall Study|Subject met withdrawal criteria|5|||
30998653|NCT02046174|59197410|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
30998654|NCT02046174|59197411|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
30998655|NCT02045862|59197499|FG000|Overall Study|Death|0|||
30998656|NCT02045862|59197500|FG001|Overall Study|Death|0|||
30998657|NCT02045862|59197501|FG002|Overall Study|Death|1|||
30998658|NCT02045862|59197499|FG000|Overall Study|Miscellaneous|5|||
30998659|NCT02045862|59197500|FG001|Overall Study|Miscellaneous|0|||
30998660|NCT02045862|59197501|FG002|Overall Study|Miscellaneous|8|||
30998661|NCT02045862|59197499|FG000|Overall Study|Withdrawal by Patient|18|||
30998662|NCT02045862|59197500|FG001|Overall Study|Withdrawal by Patient|27|||
30998663|NCT02045862|59197501|FG002|Overall Study|Withdrawal by Patient|57|||
30998664|NCT02045862|59197499|FG000|Overall Study|Protocol Violation|0|||
30998665|NCT02045862|59197500|FG001|Overall Study|Protocol Violation|0|||
30998666|NCT02045862|59197501|FG002|Overall Study|Protocol Violation|6|||
30998667|NCT02045862|59197499|FG000|Overall Study|Lack of Efficacy|8|||
30998668|NCT02045862|59197500|FG001|Overall Study|Lack of Efficacy|4|||
30998669|NCT02045862|59197501|FG002|Overall Study|Lack of Efficacy|13|||
30998670|NCT02045862|59197499|FG000|Overall Study|Randomized but not Received Study Drug|0|||
30998671|NCT02045862|59197500|FG001|Overall Study|Randomized but not Received Study Drug|2|||
30998672|NCT02045862|59197501|FG002|Overall Study|Randomized but not Received Study Drug|8|||
30998673|NCT02045862|59197499|FG000|Overall Study|Adverse Event|7|||
30998674|NCT02045862|59197500|FG001|Overall Study|Adverse Event|5|||
30998675|NCT02045862|59197501|FG002|Overall Study|Adverse Event|27|||
30998676|NCT02045862|59197499|FG000|Overall Study|Lost to Follow-up|1|||
30998677|NCT02045862|59197500|FG001|Overall Study|Lost to Follow-up|2|||
30998678|NCT02045862|59197501|FG002|Overall Study|Lost to Follow-up|6|||
30998679|NCT02075658|59197511|FG000|Overall Study|Physician Decision|2|||
30998680|NCT02075658|59197512|FG001|Overall Study|Physician Decision|2|||
30998681|NCT02063880|59197520|FG000|Overall Study|Death|21|||
30998682|NCT02063880|59197521|FG001|Overall Study|Death|18|||
30998683|NCT02063880|59197520|FG000|Overall Study|Lost to Follow-up|7|||
30998684|NCT02063880|59197521|FG001|Overall Study|Lost to Follow-up|7|||
30998685|NCT02063880|59197520|FG000|Overall Study|Ineligible|0|||
30998686|NCT02063880|59197521|FG001|Overall Study|Ineligible|2|||
30998687|NCT02044848|59197529|FG000|Overall Study|Administrative Problems|2|||
30998688|NCT02044848|59197530|FG001|Overall Study|Administrative Problems|3|||
30998689|NCT02044458|59197538|FG000|Overall Study|Protocol Violation|3|||
30998690|NCT02044458|59197539|FG001|Overall Study|Protocol Violation|8|||
30998691|NCT02044302|59197547|FG000|Overall Study|study terminated|2|||
30998692|NCT02044302|59197548|FG001|Overall Study|study terminated|0|||
30998693|NCT02062944|59197552|FG000|Overall Study|Lost to Follow-up|1|||
30998694|NCT02062944|59197552|FG000|Overall Study|New hemotological disorder identified|1|||
30998695|NCT02062944|59197552|FG000|Overall Study|Uncontrolled Hypertension|1|||
30998696|NCT02062944|59197552|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
30998697|NCT02062632|59197557|FG000|Overall Study|No treatment data|1|||
30998698|NCT02062398|59197561|FG000|Overall Study|Implant removal|1|||
30998699|NCT02061540|59197565|FG000|Overall Study|Adverse Event|2|||
30998700|NCT02061540|59197565|FG000|Overall Study|Withdrawal by Subject|2|||
30998701|NCT02043366|59197580|FG000|Overall Study|Lost to Follow-up|2|||
30998702|NCT02043366|59197581|FG001|Overall Study|Lost to Follow-up|2|||
30998703|NCT02043366|59197582|FG002|Overall Study|Lost to Follow-up|2|||
30998704|NCT02043366|59197583|FG003|Overall Study|Lost to Follow-up|2|||
30998705|NCT02043366|59197584|FG004|Overall Study|Lost to Follow-up|2|||
30998706|NCT02043366|59197585|FG005|Overall Study|Lost to Follow-up|2|||
30998707|NCT02060370|59197601|FG000|Overall Study|Physician Decision|1|||
30998708|NCT01622088|59197605|FG000|Overall Study|Adverse Event|20|||
30998709|NCT01622088|59197605|FG000|Overall Study|Lost to Follow-up|1|||
30998710|NCT01622088|59197605|FG000|Overall Study|Withdrawal by Subject|20|||
30998711|NCT01622088|59197605|FG000|Overall Study|Investigator Decision|1|||
30998712|NCT01622088|59197605|FG000|Overall Study|Death|53|||
30998713|NCT01622088|59197605|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
30998714|NCT01621542|59197616|FG000|Overall Study|Adverse Event|0|||
30998715|NCT01621542|59197617|FG001|Overall Study|Adverse Event|0|||
30998716|NCT01621542|59197618|FG002|Overall Study|Adverse Event|1|||
30998717|NCT01621542|59197619|FG003|Overall Study|Adverse Event|3|||
30998718|NCT01621542|59197620|FG004|Overall Study|Adverse Event|0|||
30998719|NCT01621542|59197621|FG005|Overall Study|Adverse Event|0|||
30998720|NCT01621542|59197616|FG000|Overall Study|Death|0|||
30998721|NCT01621542|59197617|FG001|Overall Study|Death|1|||
30998722|NCT01621542|59197618|FG002|Overall Study|Death|0|||
30998723|NCT01621542|59197619|FG003|Overall Study|Death|0|||
30998724|NCT01621542|59197620|FG004|Overall Study|Death|0|||
30998725|NCT01621542|59197621|FG005|Overall Study|Death|0|||
30998726|NCT01621542|59197616|FG000|Overall Study|Physician Decision|1|||
30998727|NCT01621542|59197617|FG001|Overall Study|Physician Decision|0|||
30998728|NCT01621542|59197618|FG002|Overall Study|Physician Decision|1|||
30998729|NCT01621542|59197619|FG003|Overall Study|Physician Decision|13|||
30998730|NCT01621542|59197620|FG004|Overall Study|Physician Decision|3|||
30998731|NCT01621542|59197621|FG005|Overall Study|Physician Decision|1|||
30998732|NCT01621542|59197616|FG000|Overall Study|Withdrawal by Subject|2|||
30998733|NCT01621542|59197617|FG001|Overall Study|Withdrawal by Subject|0|||
30998734|NCT01621542|59197618|FG002|Overall Study|Withdrawal by Subject|1|||
30998735|NCT01621542|59197619|FG003|Overall Study|Withdrawal by Subject|3|||
30998736|NCT01621542|59197620|FG004|Overall Study|Withdrawal by Subject|3|||
30998737|NCT01621542|59197621|FG005|Overall Study|Withdrawal by Subject|3|||
30998738|NCT01621542|59197616|FG000|Overall Study|progression/treatment failure|2|||
30998739|NCT01621542|59197617|FG001|Overall Study|progression/treatment failure|4|||
30998740|NCT01621542|59197618|FG002|Overall Study|progression/treatment failure|3|||
30998741|NCT01621542|59197619|FG003|Overall Study|progression/treatment failure|7|||
30998742|NCT01621542|59197620|FG004|Overall Study|progression/treatment failure|3|||
30998743|NCT01621542|59197621|FG005|Overall Study|progression/treatment failure|5|||
30998744|NCT01621542|59197616|FG000|Overall Study|Protocol Violation|0|||
30998745|NCT01621542|59197617|FG001|Overall Study|Protocol Violation|0|||
30998746|NCT01621542|59197618|FG002|Overall Study|Protocol Violation|0|||
30998747|NCT01621542|59197619|FG003|Overall Study|Protocol Violation|1|||
30998748|NCT01621542|59197620|FG004|Overall Study|Protocol Violation|0|||
30998749|NCT01621542|59197621|FG005|Overall Study|Protocol Violation|0|||
30998750|NCT01621542|59197616|FG000|Overall Study|study stopped by sponsor|0|||
30998751|NCT01621542|59197617|FG001|Overall Study|study stopped by sponsor|0|||
30998752|NCT01621542|59197618|FG002|Overall Study|study stopped by sponsor|0|||
30998753|NCT01621542|59197619|FG003|Overall Study|study stopped by sponsor|1|||
30998754|NCT01621542|59197620|FG004|Overall Study|study stopped by sponsor|0|||
30998755|NCT01621542|59197621|FG005|Overall Study|study stopped by sponsor|0|||
30998756|NCT02021292|59197637|FG000|Overall Study|Physician Decision|0|||
30998757|NCT02021292|59197638|FG001|Overall Study|Physician Decision|1|||
30998758|NCT02021292|59197637|FG000|Overall Study|Lost to Follow-up|0|||
30998759|NCT02021292|59197638|FG001|Overall Study|Lost to Follow-up|1|||
30998760|NCT02021292|59197637|FG000|Overall Study|Death|0|||
30998761|NCT02021292|59197638|FG001|Overall Study|Death|1|||
30998762|NCT02059980|59197648|FG000|Overall Study|Lost to Follow-up|2|||
30998763|NCT02059980|59197649|FG001|Overall Study|Lost to Follow-up|1|||
30998764|NCT02043132|59197657|FG000|Overall Study|Lost to Follow-up|1|||
30998765|NCT02043132|59197658|FG001|Overall Study|Lost to Follow-up|1|||
30998766|NCT02043132|59197657|FG000|Overall Study|screen failures|4|||
30998767|NCT02043132|59197658|FG001|Overall Study|screen failures|8|||
30998768|NCT02059434|59197673|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
30998769|NCT02059434|59197674|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
30998770|NCT02059434|59197675|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
30998771|NCT02059434|59197676|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
30998772|NCT02059434|59197677|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
30998773|NCT02059434|59197678|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
30998774|NCT02059434|59197679|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
30998775|NCT02059434|59197680|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
30998776|NCT02059434|59197681|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
30998777|NCT02059434|59197673|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
30998778|NCT02059434|59197674|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
30998779|NCT02059434|59197675|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
30998780|NCT02059434|59197676|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
30998781|NCT02059434|59197677|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
30998782|NCT02059434|59197678|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
30998783|NCT02059434|59197679|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
30998784|NCT02059434|59197680|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
30998785|NCT02059434|59197681|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
30998786|NCT02059434|59197673|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
30998787|NCT02059434|59197674|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
30998788|NCT02059434|59197675|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
30998789|NCT02059434|59197676|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
30998790|NCT02059434|59197677|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
30998791|NCT02059434|59197678|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
30998792|NCT02059434|59197679|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
30998793|NCT02059434|59197680|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
30998794|NCT02059434|59197681|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
30998795|NCT02059434|59197673|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
30998796|NCT02059434|59197674|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
30998797|NCT02059434|59197675|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
30998798|NCT02059434|59197676|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
30998799|NCT02059434|59197677|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
30998800|NCT02059434|59197678|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
30998801|NCT02059434|59197679|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
30998802|NCT02059434|59197680|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
30998803|NCT02059434|59197681|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
30998804|NCT02059434|59197673|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
30998805|NCT02059434|59197674|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
30998806|NCT02059434|59197675|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
30998807|NCT02059434|59197676|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
30998808|NCT02059434|59197677|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
30998809|NCT02059434|59197678|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
30998810|NCT02059434|59197679|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
30998811|NCT02059434|59197680|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
30998812|NCT02059434|59197681|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
30998813|NCT02059278|59197711|FG000|Overall Study|Adverse Event|1|||
30998814|NCT02059278|59197712|FG001|Overall Study|Adverse Event|1|||
30998815|NCT02059278|59197711|FG000|Overall Study|Lost to Follow-up|1|||
30998816|NCT02059278|59197712|FG001|Overall Study|Lost to Follow-up|0|||
30998817|NCT02059278|59197711|FG000|Overall Study|Withdrawal by Subject|0|||
30998818|NCT02059278|59197712|FG001|Overall Study|Withdrawal by Subject|3|||
30998819|NCT02059278|59197711|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
30998820|NCT02059278|59197712|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
30998821|NCT02020512|59197718|FG000|Overall Study|Adverse Event|1|||
30998822|NCT02020512|59197718|FG000|Overall Study|Lost to Follow-up|3|||
30998823|NCT02020512|59197718|FG000|Overall Study|Protocol Violation|4|||
30998824|NCT02041962|59197724|FG000|Overall Study|Lost Aetna Coverage|43|||
30998825|NCT02041962|59197725|FG001|Overall Study|Lost Aetna Coverage|40|||
30998826|NCT02041962|59197724|FG000|Overall Study|Death|1|||
30998827|NCT02041962|59197725|FG001|Overall Study|Death|1|||
30998828|NCT02041962|59197724|FG000|Overall Study|Lost to Follow-up|37|||
30998829|NCT02041962|59197725|FG001|Overall Study|Lost to Follow-up|32|||
30998830|NCT02041962|59197724|FG000|Overall Study|Withdrawal by Subject|0|||
30998831|NCT02041962|59197725|FG001|Overall Study|Withdrawal by Subject|11|||
30998832|NCT02041494|59197733|FG000|Overall Study|Death|1|||
30998833|NCT02041494|59197734|FG001|Overall Study|Death|3|||
30998834|NCT02041494|59197733|FG000|Overall Study|Lost to Follow-up|2|||
30998835|NCT02041494|59197734|FG001|Overall Study|Lost to Follow-up|6|||
30998836|NCT02041494|59197733|FG000|Overall Study|study terminated|16|||
30998837|NCT02041494|59197734|FG001|Overall Study|study terminated|11|||
30998838|NCT02041104|59197765|FG000|Overall Study|Lost to Follow-up|1|||
30998839|NCT02041104|59197766|FG001|Overall Study|Lost to Follow-up|4|||
30998840|NCT02041104|59197765|FG000|Overall Study|discomfort during OGTT|0|||
30998841|NCT02041104|59197766|FG001|Overall Study|discomfort during OGTT|3|||
30998842|NCT02019420|59197776|FG000|Overall Study|Did not receive study drug|2|||
30998843|NCT02019420|59197777|FG001|Overall Study|Did not receive study drug|2|||
30998844|NCT02019420|59197776|FG000|Overall Study|Withdrawal by Subject|1|||
30998845|NCT02019420|59197777|FG001|Overall Study|Withdrawal by Subject|3|||
30998846|NCT02019420|59197776|FG000|Overall Study|At request of sponsor or investigator|0|||
30998847|NCT02019420|59197777|FG001|Overall Study|At request of sponsor or investigator|1|||
30998848|NCT02019420|59197776|FG000|Overall Study|Death|104|||
30998849|NCT02019420|59197777|FG001|Overall Study|Death|99|||
30998850|NCT02019420|59197776|FG000|Overall Study|Transferred to other care facility|1|||
30998851|NCT02019420|59197777|FG001|Overall Study|Transferred to other care facility|1|||
30998852|NCT02019264|59197785|FG000|Overall Study|Not treated|6|||
30998853|NCT02019264|59197786|FG001|Overall Study|Not treated|4|||
30998854|NCT02019264|59197785|FG000|Overall Study|Lost to Follow-up|50|||
30998855|NCT02019264|59197786|FG001|Overall Study|Lost to Follow-up|47|||
30998856|NCT02019264|59197785|FG000|Overall Study|Withdrawal by Subject|142|||
30998857|NCT02019264|59197786|FG001|Overall Study|Withdrawal by Subject|117|||
30998858|NCT02019264|59197785|FG000|Overall Study|Administrative reason|36|||
30998859|NCT02019264|59197786|FG001|Overall Study|Administrative reason|28|||
30998860|NCT02019264|59197785|FG000|Overall Study|Missing|14|||
30998861|NCT02019264|59197786|FG001|Overall Study|Missing|11|||
30998862|NCT02019108|59197794|FG000|Overall Study|Lost to Follow-up|5|||
30998863|NCT02019108|59197795|FG001|Overall Study|Lost to Follow-up|7|||
30998864|NCT02018562|59197803|FG000|Overall Study|Withdrawal by Subject|2|||
30998865|NCT02018562|59197804|FG001|Overall Study|Withdrawal by Subject|0|||
30998866|NCT02018562|59197803|FG000|Overall Study|Discharged prior to study completion|1|||
30998867|NCT02018562|59197804|FG001|Overall Study|Discharged prior to study completion|0|||
30998868|NCT02058966|59197810|FG000|Open-Label Methamphetamine|Adverse Event|1|||
30998869|NCT02058966|59197810|FG000|First Intervention|Withdrawal by Subject|1|||
30998870|NCT02017860|59197822|FG000|Overall Study|Adverse Event|1|||
30998871|NCT02017860|59197822|FG000|Overall Study|Withdrawal by Subject|1|||
30998872|NCT02040870|59197826|FG000|Overall Study|Completed treatment phase|6|||
30998873|NCT02040870|59197826|FG000|Overall Study|Adverse Event|7|||
30998874|NCT02040870|59197826|FG000|Overall Study|Progressive disease|58|||
30998875|NCT02040870|59197826|FG000|Overall Study|Physician Decision|6|||
30998876|NCT02040870|59197826|FG000|Overall Study|Subject/guardian decision|10|||
30998877|NCT02040870|59197826|FG000|Overall Study|Lost to Follow-up|3|||
30998878|NCT02040870|59197826|FG000|Overall Study|Death|13|||
30998879|NCT02016690|59197830|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
30998880|NCT02016690|59197830|FG000|Overall Study|Excluded from SAS: Duplication|2|||
30998881|NCT02016690|59197830|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
30998882|NCT02016690|59197830|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
30998883|NCT02016690|59197830|FG000|Overall Study|Did not meet inclusion criteria|13|||
30998884|NCT02016690|59197830|FG000|Overall Study|Hospitalized for RSV at study start|3|||
30998885|NCT02016300|59197836|FG000|Overall Study|Lost to Follow-up|0|||
30998886|NCT02016300|59197837|FG001|Overall Study|Lost to Follow-up|3|||
30998887|NCT02040090|59197845|FG000|Overall Study|Adverse Event|2|||
30998888|NCT02040090|59197846|FG001|Overall Study|Adverse Event|0|||
30998889|NCT02040090|59197845|FG000|Overall Study|Physician Decision|1|||
30998890|NCT02040090|59197846|FG001|Overall Study|Physician Decision|0|||
30998891|NCT02040090|59197845|FG000|Overall Study|Withdrawal by Subject|0|||
30998892|NCT02040090|59197846|FG001|Overall Study|Withdrawal by Subject|1|||
30998893|NCT02040090|59197845|FG000|Overall Study|Lost to Follow-up|0|||
30998894|NCT02040090|59197846|FG001|Overall Study|Lost to Follow-up|1|||
30998895|NCT02058498|59197852|FG000|Overall Study|Withdrawal by Subject|4|||
30998896|NCT02039778|59197856|FG000|Overall Study|Death|2|||
30998897|NCT02039778|59197856|FG000|Overall Study|Withdrawal by Subject|1|||
30998898|NCT02039778|59197856|FG000|Overall Study|Never started the protocol treatment|1|||
30998899|NCT02015754|59197860|FG000|Overall Study|Disease progression|5|||
30998900|NCT02015754|59197860|FG000|Overall Study|Change in treatment modality|5|||
30998901|NCT02015754|59197860|FG000|Overall Study|Lost to Follow-up|1|||
30998902|NCT02015676|59197867|FG000|Overall Study|Adverse Event|2|||
30998903|NCT02015676|59197868|FG001|Overall Study|Adverse Event|18|||
30998904|NCT02015676|59197869|FG002|Overall Study|Adverse Event|0|||
30998905|NCT02015676|59197867|FG000|Overall Study|Lack of Efficacy|2|||
30998906|NCT02015676|59197868|FG001|Overall Study|Lack of Efficacy|4|||
30998907|NCT02015676|59197869|FG002|Overall Study|Lack of Efficacy|0|||
30998908|NCT02015676|59197867|FG000|Overall Study|Protocol Violation|1|||
30998909|NCT02015676|59197868|FG001|Overall Study|Protocol Violation|0|||
30998910|NCT02015676|59197869|FG002|Overall Study|Protocol Violation|0|||
30998911|NCT02015676|59197867|FG000|Overall Study|Withdrawal by Subject|1|||
30998912|NCT02015676|59197868|FG001|Overall Study|Withdrawal by Subject|7|||
30998913|NCT02015676|59197869|FG002|Overall Study|Withdrawal by Subject|1|||
30998914|NCT02015676|59197867|FG000|Overall Study|Administrative reasons|0|||
30998915|NCT02015676|59197868|FG001|Overall Study|Administrative reasons|3|||
30998916|NCT02015676|59197869|FG002|Overall Study|Administrative reasons|1|||
30998917|NCT02015676|59197867|FG000|Overall Study|Death|0|||
30892121|NCT02309359|58925457|FG002|Overall Study|Lost to Follow-up|0|||
30998918|NCT02015676|59197868|FG001|Overall Study|Death|1|||
30998919|NCT02015676|59197869|FG002|Overall Study|Death|0|||
30998920|NCT02015676|59197867|FG000|Overall Study|Disease progression|3|||
30998921|NCT02015676|59197868|FG001|Overall Study|Disease progression|1|||
30998922|NCT02015676|59197869|FG002|Overall Study|Disease progression|1|||
30998923|NCT02015520|59197877|FG000|Overall Study|Lack of Efficacy|1|||
30998924|NCT02015520|59197878|FG001|Overall Study|Lack of Efficacy|0|||
30998925|NCT02015520|59197879|FG002|Overall Study|Lack of Efficacy|3|||
30998926|NCT02015520|59197880|FG003|Overall Study|Lack of Efficacy|2|||
30998927|NCT02015520|59197877|FG000|Overall Study|Adverse Event|0|||
30998928|NCT02015520|59197878|FG001|Overall Study|Adverse Event|0|||
30998929|NCT02015520|59197879|FG002|Overall Study|Adverse Event|0|||
30998930|NCT02015520|59197880|FG003|Overall Study|Adverse Event|1|||
30998931|NCT02015520|59197877|FG000|Overall Study|Withdrawal by Subject|2|||
30998932|NCT02015520|59197878|FG001|Overall Study|Withdrawal by Subject|2|||
30998933|NCT02015520|59197879|FG002|Overall Study|Withdrawal by Subject|1|||
30998934|NCT02015520|59197880|FG003|Overall Study|Withdrawal by Subject|0|||
30998935|NCT02015520|59197877|FG000|Overall Study|Death|1|||
30998936|NCT02015520|59197878|FG001|Overall Study|Death|0|||
30998937|NCT02015520|59197879|FG002|Overall Study|Death|0|||
30998938|NCT02015520|59197880|FG003|Overall Study|Death|0|||
30998939|NCT02015520|59197877|FG000|Overall Study|Lost to Follow-up|0|||
30998940|NCT02015520|59197878|FG001|Overall Study|Lost to Follow-up|0|||
30998941|NCT02015520|59197879|FG002|Overall Study|Lost to Follow-up|1|||
30998942|NCT02015520|59197880|FG003|Overall Study|Lost to Follow-up|0|||
30998943|NCT02015520|59197877|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
30998944|NCT02015520|59197878|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
30998945|NCT02015520|59197879|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
30998946|NCT02015520|59197880|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
30998947|NCT02015520|59197877|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
30998948|NCT02015520|59197878|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
30998949|NCT02015520|59197879|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
30998950|NCT02015520|59197880|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
30998951|NCT02058108|59197892|FG000|Overall Study|Abnormal Laboratory Values|0|||
30998952|NCT02058108|59197893|FG001|Overall Study|Abnormal Laboratory Values|1|||
30998953|NCT02058108|59197892|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
30998954|NCT02058108|59197893|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
30998955|NCT02058108|59197892|FG000|Overall Study|No longer requires study drug|0|||
30998956|NCT02058108|59197893|FG001|Overall Study|No longer requires study drug|1|||
30998957|NCT02058108|59197892|FG000|Overall Study|Withdrawal by Subject|1|||
30998958|NCT02058108|59197893|FG001|Overall Study|Withdrawal by Subject|0|||
30998959|NCT02058108|59197892|FG000|Overall Study|Administrative problems|3|||
30998960|NCT02058108|59197893|FG001|Overall Study|Administrative problems|3|||
30998961|NCT02058108|59197892|FG000|Overall Study|Protocol Violation|0|||
30998962|NCT02058108|59197893|FG001|Overall Study|Protocol Violation|1|||
30998963|NCT02057874|59197901|FG000|Overall Study|participant did not return for scan|1|||
30998964|NCT02038920|59197908|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
30998965|NCT02038920|59197909|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
30998966|NCT02038920|59197910|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
30998967|NCT02038920|59197911|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
30998968|NCT02038920|59197912|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
30998969|NCT02038920|59197913|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
30998970|NCT02038920|59197908|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
30998971|NCT02038920|59197909|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
30998972|NCT02038920|59197910|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
30998973|NCT02038920|59197911|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
30998974|NCT02038920|59197912|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
30998975|NCT02038920|59197913|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
30998976|NCT02038920|59197908|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
30998977|NCT02038920|59197909|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
30998978|NCT02038920|59197910|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
30998979|NCT02038920|59197911|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
30998980|NCT02038920|59197912|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
30998981|NCT02038920|59197913|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
30998982|NCT02038920|59197908|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
30998983|NCT02038920|59197909|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
30998984|NCT02038920|59197910|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
30998985|NCT02038920|59197911|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
30998986|NCT02038920|59197912|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
30998987|NCT02038920|59197913|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
30998988|NCT02038920|59197908|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
30998989|NCT02038920|59197909|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
30998990|NCT02038920|59197910|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
30998991|NCT02038920|59197911|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
30998992|NCT02038920|59197912|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
30998993|NCT02038920|59197913|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
30998994|NCT02038920|59197908|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
30998995|NCT02038920|59197909|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
30998996|NCT02038920|59197910|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
30998997|NCT02038920|59197911|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
30998998|NCT02038920|59197912|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
30998999|NCT02038920|59197913|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
30999000|NCT02038920|59197908|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
30999001|NCT02038920|59197909|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
30999002|NCT02038920|59197910|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
30999003|NCT02038920|59197911|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
30999004|NCT02038920|59197912|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
30999005|NCT02038920|59197913|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
30999006|NCT02038920|59197908|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
30999007|NCT02038920|59197909|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
30999008|NCT02038920|59197910|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
30999009|NCT02038920|59197911|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
30999010|NCT02038920|59197912|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
30999011|NCT02038920|59197913|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
30999012|NCT02038920|59197908|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
30999013|NCT02038920|59197909|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
30999014|NCT02038920|59197910|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
30999015|NCT02038920|59197911|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
30999016|NCT02038920|59197912|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
30999017|NCT02038920|59197913|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
30999018|NCT02038920|59197908|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
30999019|NCT02038920|59197909|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
30999020|NCT02038920|59197910|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
30999021|NCT02038920|59197911|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
30999022|NCT02038920|59197912|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
30999023|NCT02038920|59197913|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
30999024|NCT02038920|59197908|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
30999025|NCT02038920|59197909|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
30999026|NCT02038920|59197910|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
30999027|NCT02038920|59197911|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
30999028|NCT02038920|59197912|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
30999029|NCT02038920|59197913|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
30999030|NCT02038920|59197908|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
30999031|NCT02038920|59197909|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
30999032|NCT02038920|59197910|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
30999033|NCT02038920|59197911|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
30999034|NCT02038920|59197912|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
30999035|NCT02038920|59197913|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
30999036|NCT02038764|59197935|FG000|Overall Study|Adverse Event|0|||
30999037|NCT02038764|59197936|FG001|Overall Study|Adverse Event|0|||
30999038|NCT02038764|59197937|FG002|Overall Study|Adverse Event|1|||
30999039|NCT02038764|59197938|FG003|Overall Study|Adverse Event|0|||
30999040|NCT02038764|59197939|FG004|Overall Study|Adverse Event|0|||
30999041|NCT02038764|59197935|FG000|Overall Study|Lost to Follow-up|0|||
30999042|NCT02038764|59197936|FG001|Overall Study|Lost to Follow-up|1|||
30999043|NCT02038764|59197937|FG002|Overall Study|Lost to Follow-up|0|||
30999044|NCT02038764|59197938|FG003|Overall Study|Lost to Follow-up|0|||
30999045|NCT02038764|59197939|FG004|Overall Study|Lost to Follow-up|0|||
30999046|NCT02038764|59197935|FG000|Overall Study|Withdrawal by Subject|0|||
30999047|NCT02038764|59197936|FG001|Overall Study|Withdrawal by Subject|0|||
30999048|NCT02038764|59197937|FG002|Overall Study|Withdrawal by Subject|0|||
30999049|NCT02038764|59197938|FG003|Overall Study|Withdrawal by Subject|0|||
30999050|NCT02038764|59197939|FG004|Overall Study|Withdrawal by Subject|1|||
30999051|NCT02038764|59197935|FG000|Overall Study|Other|1|||
30999052|NCT02038764|59197936|FG001|Overall Study|Other|0|||
30999053|NCT02038764|59197937|FG002|Overall Study|Other|1|||
30999054|NCT02038764|59197938|FG003|Overall Study|Other|0|||
30999055|NCT02038764|59197939|FG004|Overall Study|Other|0|||
30999056|NCT02057718|59197957|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
30999057|NCT02057718|59197958|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
30999058|NCT02057718|59197957|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
30999059|NCT02057718|59197958|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
30999060|NCT02057718|59197957|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
30999061|NCT02057718|59197958|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
30999062|NCT02057718|59197957|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
30999063|NCT02057718|59197958|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
30999064|NCT02057718|59197957|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
30999065|NCT02057718|59197958|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
30999066|NCT02057718|59197957|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
30999067|NCT02057718|59197958|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
30999068|NCT02057718|59197957|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
30999069|NCT02057718|59197958|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
30999070|NCT02057718|59197957|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
30999071|NCT02057718|59197958|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
30999072|NCT02057718|59197957|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
30999073|NCT02057718|59197958|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
30999074|NCT02057718|59197957|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
30999075|NCT02057718|59197958|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
30999076|NCT02057718|59197957|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
30999077|NCT02057718|59197958|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
30999078|NCT01622868|59197966|FG000|Overall Study|Protocol Violation|7|||
30999079|NCT01622868|59197967|FG001|Overall Study|Protocol Violation|0|||
30999080|NCT02014740|59197975|FG000|Overall Study|Lost to Follow-up|4|||
30999081|NCT02014740|59197976|FG001|Overall Study|Lost to Follow-up|4|||
30999082|NCT02014740|59197975|FG000|Overall Study|Withdrawal by Subject|2|||
30999083|NCT02014740|59197976|FG001|Overall Study|Withdrawal by Subject|1|||
30999084|NCT02014584|59197984|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
30999085|NCT02014584|59197985|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
30999086|NCT02014584|59197986|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
30999087|NCT02014584|59197987|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
30999088|NCT02014584|59197988|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
30999089|NCT02014584|59197989|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
30999090|NCT02014584|59197984|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
30999091|NCT02014584|59197985|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
30999092|NCT02014584|59197986|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
30999093|NCT02014584|59197987|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
30999094|NCT02014584|59197988|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
30999095|NCT02014584|59197989|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
30999096|NCT02014584|59197984|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
30999097|NCT02014584|59197985|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
30999098|NCT02014584|59197986|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
30999099|NCT02014584|59197987|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
30999100|NCT02014584|59197988|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
30999101|NCT02014584|59197989|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
30999102|NCT02014584|59197984|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
30999103|NCT02014584|59197985|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
30999104|NCT02014584|59197986|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
30999105|NCT02014584|59197987|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
30999106|NCT02014584|59197988|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
30999107|NCT02014584|59197989|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
30999108|NCT02014584|59197984|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
30999109|NCT02014584|59197985|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
30999110|NCT02014584|59197986|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
30999111|NCT02014584|59197987|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
30999112|NCT02014584|59197988|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
30999113|NCT02014584|59197989|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
30999114|NCT02014272|59198001|FG000|Intervention Period 1|Withdrawal by Subject|1|||
30999115|NCT02014272|59198002|FG001|Intervention Period 1|Withdrawal by Subject|0|||
30999116|NCT02014272|59198001|FG000|Intervention Period 1|Adverse Event|0|||
30999117|NCT02014272|59198002|FG001|Intervention Period 1|Adverse Event|1|||
30999118|NCT02037984|59198016|FG000|Overall Study|Lack of Efficacy|0|||
30999119|NCT02037984|59198017|FG001|Overall Study|Lack of Efficacy|0|||
30999120|NCT02037984|59198018|FG002|Overall Study|Lack of Efficacy|3|||
30892122|NCT02309359|58925458|FG003|Overall Study|Lost to Follow-up|1|||
30892123|NCT02309359|58925459|FG004|Overall Study|Lost to Follow-up|0|||
30999121|NCT02037984|59198019|FG003|Overall Study|Lack of Efficacy|10|||
30999122|NCT02037984|59198020|FG004|Overall Study|Lack of Efficacy|2|||
30999123|NCT02037984|59198021|FG005|Overall Study|Lack of Efficacy|2|||
30892124|NCT02309359|58925455|FG000|Overall Study|Other|2|||
30999124|NCT02037984|59198022|FG006|Overall Study|Lack of Efficacy|4|||
30999125|NCT02037984|59198023|FG007|Overall Study|Lack of Efficacy|3|||
30999126|NCT02037984|59198016|FG000|Overall Study|Lost to Follow-up|1|||
30999127|NCT02037984|59198017|FG001|Overall Study|Lost to Follow-up|0|||
30999128|NCT02037984|59198018|FG002|Overall Study|Lost to Follow-up|3|||
30999129|NCT02037984|59198019|FG003|Overall Study|Lost to Follow-up|5|||
30999130|NCT02037984|59198020|FG004|Overall Study|Lost to Follow-up|2|||
30999131|NCT02037984|59198021|FG005|Overall Study|Lost to Follow-up|2|||
30999132|NCT02037984|59198022|FG006|Overall Study|Lost to Follow-up|2|||
30999133|NCT02037984|59198023|FG007|Overall Study|Lost to Follow-up|4|||
30999134|NCT02037984|59198016|FG000|Overall Study|Physician Decision|0|||
30999135|NCT02037984|59198017|FG001|Overall Study|Physician Decision|0|||
30999136|NCT02037984|59198018|FG002|Overall Study|Physician Decision|0|||
30999137|NCT02037984|59198019|FG003|Overall Study|Physician Decision|0|||
30999138|NCT02037984|59198020|FG004|Overall Study|Physician Decision|0|||
30999139|NCT02037984|59198021|FG005|Overall Study|Physician Decision|0|||
30999140|NCT02037984|59198022|FG006|Overall Study|Physician Decision|1|||
30999141|NCT02037984|59198023|FG007|Overall Study|Physician Decision|0|||
30999142|NCT02037984|59198016|FG000|Overall Study|Protocol Violation|0|||
30999143|NCT02037984|59198017|FG001|Overall Study|Protocol Violation|0|||
30999144|NCT02037984|59198018|FG002|Overall Study|Protocol Violation|0|||
30999145|NCT02037984|59198019|FG003|Overall Study|Protocol Violation|0|||
30999146|NCT02037984|59198020|FG004|Overall Study|Protocol Violation|0|||
30999147|NCT02037984|59198021|FG005|Overall Study|Protocol Violation|1|||
30999148|NCT02037984|59198022|FG006|Overall Study|Protocol Violation|2|||
30999149|NCT02037984|59198023|FG007|Overall Study|Protocol Violation|0|||
30999150|NCT02037984|59198016|FG000|Overall Study|Technical Problems|0|||
30999151|NCT02037984|59198017|FG001|Overall Study|Technical Problems|0|||
30999152|NCT02037984|59198018|FG002|Overall Study|Technical Problems|3|||
30999153|NCT02037984|59198019|FG003|Overall Study|Technical Problems|3|||
30999154|NCT02037984|59198020|FG004|Overall Study|Technical Problems|2|||
30999155|NCT02037984|59198021|FG005|Overall Study|Technical Problems|3|||
30999156|NCT02037984|59198022|FG006|Overall Study|Technical Problems|4|||
30999157|NCT02037984|59198023|FG007|Overall Study|Technical Problems|2|||
30999158|NCT02037984|59198016|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30999159|NCT02037984|59198017|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
30999160|NCT02037984|59198018|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
30999161|NCT02037984|59198019|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
30999162|NCT02037984|59198020|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
30999163|NCT02037984|59198021|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
30999164|NCT02037984|59198022|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
30999165|NCT02037984|59198023|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
30999166|NCT02037984|59198016|FG000|Overall Study|Withdrawal by Subject|0|||
30999167|NCT02037984|59198017|FG001|Overall Study|Withdrawal by Subject|0|||
30999168|NCT02037984|59198018|FG002|Overall Study|Withdrawal by Subject|0|||
30999169|NCT02037984|59198019|FG003|Overall Study|Withdrawal by Subject|1|||
30999170|NCT02037984|59198020|FG004|Overall Study|Withdrawal by Subject|1|||
30999171|NCT02037984|59198021|FG005|Overall Study|Withdrawal by Subject|3|||
30999172|NCT02037984|59198022|FG006|Overall Study|Withdrawal by Subject|0|||
30999173|NCT02037984|59198023|FG007|Overall Study|Withdrawal by Subject|1|||
30999174|NCT02057406|59198054|FG000|Overall Study|Physician Decision|0|||
30999175|NCT02057406|59198055|FG001|Overall Study|Physician Decision|0|||
30999176|NCT02057406|59198056|FG002|Overall Study|Physician Decision|2|||
30999177|NCT02057406|59198054|FG000|Overall Study|Withdrawal by Subject|0|||
30999178|NCT02057406|59198055|FG001|Overall Study|Withdrawal by Subject|2|||
30999179|NCT02057406|59198056|FG002|Overall Study|Withdrawal by Subject|0|||
30999180|NCT02057406|59198054|FG000|Overall Study|Lost to Follow-up|0|||
30999181|NCT02057406|59198055|FG001|Overall Study|Lost to Follow-up|0|||
30999182|NCT02057406|59198056|FG002|Overall Study|Lost to Follow-up|1|||
30999183|NCT02057406|59198054|FG000|Overall Study|Death|1|||
30999184|NCT02057406|59198055|FG001|Overall Study|Death|0|||
30999185|NCT02057406|59198056|FG002|Overall Study|Death|0|||
30999186|NCT02057406|59198054|FG000|Overall Study|Protocol Violation|0|||
30999187|NCT02057406|59198055|FG001|Overall Study|Protocol Violation|1|||
30999188|NCT02057406|59198056|FG002|Overall Study|Protocol Violation|0|||
30999189|NCT02057406|59198054|FG000|Overall Study|Patient transportation issues|0|||
30999190|NCT02057406|59198055|FG001|Overall Study|Patient transportation issues|0|||
30999191|NCT02057406|59198056|FG002|Overall Study|Patient transportation issues|1|||
30999192|NCT02036580|59198067|FG000|Overall Study|Withdrawal by Subject|0|||
30999193|NCT02036580|59198068|FG001|Overall Study|Withdrawal by Subject|1|||
30999194|NCT02036580|59198069|FG002|Overall Study|Withdrawal by Subject|0|||
30999195|NCT02036580|59198067|FG000|Overall Study|Adverse Event|1|||
30999196|NCT02036580|59198068|FG001|Overall Study|Adverse Event|0|||
30999197|NCT02036580|59198069|FG002|Overall Study|Adverse Event|0|||
30999198|NCT02014116|59198086|FG000|Overall Study|Progressive Disease|3|||
30999199|NCT02014116|59198087|FG001|Overall Study|Progressive Disease|4|||
30999200|NCT02014116|59198088|FG002|Overall Study|Progressive Disease|2|||
30999201|NCT02014116|59198089|FG003|Overall Study|Progressive Disease|6|||
30999202|NCT02014116|59198090|FG004|Overall Study|Progressive Disease|1|||
30999203|NCT02014116|59198091|FG005|Overall Study|Progressive Disease|13|||
30999204|NCT02014116|59198092|FG006|Overall Study|Progressive Disease|1|||
30999205|NCT02014116|59198093|FG007|Overall Study|Progressive Disease|3|||
30999206|NCT02014116|59198094|FG008|Overall Study|Progressive Disease|7|||
30999207|NCT02014116|59198086|FG000|Overall Study|Adverse Event|0|||
30999208|NCT02014116|59198087|FG001|Overall Study|Adverse Event|0|||
30999209|NCT02014116|59198088|FG002|Overall Study|Adverse Event|0|||
30999210|NCT02014116|59198089|FG003|Overall Study|Adverse Event|0|||
30999211|NCT02014116|59198090|FG004|Overall Study|Adverse Event|1|||
30999212|NCT02014116|59198091|FG005|Overall Study|Adverse Event|0|||
30999213|NCT02014116|59198092|FG006|Overall Study|Adverse Event|0|||
30999214|NCT02014116|59198093|FG007|Overall Study|Adverse Event|1|||
30999215|NCT02014116|59198094|FG008|Overall Study|Adverse Event|0|||
30999216|NCT02014116|59198086|FG000|Overall Study|Lost to Follow-up|0|||
30999217|NCT02014116|59198087|FG001|Overall Study|Lost to Follow-up|0|||
30999218|NCT02014116|59198088|FG002|Overall Study|Lost to Follow-up|0|||
30999219|NCT02014116|59198089|FG003|Overall Study|Lost to Follow-up|0|||
30999220|NCT02014116|59198090|FG004|Overall Study|Lost to Follow-up|0|||
30999221|NCT02014116|59198091|FG005|Overall Study|Lost to Follow-up|1|||
30999222|NCT02014116|59198092|FG006|Overall Study|Lost to Follow-up|0|||
30999223|NCT02014116|59198093|FG007|Overall Study|Lost to Follow-up|0|||
30999224|NCT02014116|59198094|FG008|Overall Study|Lost to Follow-up|1|||
30999225|NCT02014116|59198086|FG000|Overall Study|Death|0|||
30999226|NCT02014116|59198087|FG001|Overall Study|Death|0|||
30999227|NCT02014116|59198088|FG002|Overall Study|Death|0|||
30999228|NCT02014116|59198089|FG003|Overall Study|Death|0|||
30999229|NCT02014116|59198090|FG004|Overall Study|Death|0|||
30999230|NCT02014116|59198091|FG005|Overall Study|Death|0|||
30999231|NCT02014116|59198092|FG006|Overall Study|Death|0|||
30999232|NCT02014116|59198093|FG007|Overall Study|Death|1|||
30999233|NCT02014116|59198094|FG008|Overall Study|Death|1|||
30999234|NCT02014116|59198086|FG000|Overall Study|Withdrawal by Subject|0|||
30999235|NCT02014116|59198087|FG001|Overall Study|Withdrawal by Subject|0|||
30999236|NCT02014116|59198088|FG002|Overall Study|Withdrawal by Subject|1|||
30999237|NCT02014116|59198089|FG003|Overall Study|Withdrawal by Subject|1|||
30999238|NCT02014116|59198090|FG004|Overall Study|Withdrawal by Subject|0|||
30999239|NCT02014116|59198091|FG005|Overall Study|Withdrawal by Subject|1|||
30999240|NCT02014116|59198092|FG006|Overall Study|Withdrawal by Subject|0|||
30999241|NCT02014116|59198093|FG007|Overall Study|Withdrawal by Subject|0|||
30999242|NCT02014116|59198094|FG008|Overall Study|Withdrawal by Subject|0|||
30999243|NCT02014116|59198086|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
30999244|NCT02014116|59198087|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
30999245|NCT02014116|59198088|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
30999246|NCT02014116|59198089|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
30999247|NCT02014116|59198090|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
30999248|NCT02014116|59198091|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
30999249|NCT02014116|59198092|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
30999250|NCT02014116|59198093|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
30999251|NCT02014116|59198094|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
30999252|NCT02014116|59198086|FG000|Overall Study|Physician Decision|0|||
30999253|NCT02014116|59198087|FG001|Overall Study|Physician Decision|0|||
30999254|NCT02014116|59198088|FG002|Overall Study|Physician Decision|0|||
30999255|NCT02014116|59198089|FG003|Overall Study|Physician Decision|0|||
30999256|NCT02014116|59198090|FG004|Overall Study|Physician Decision|0|||
30999257|NCT02014116|59198091|FG005|Overall Study|Physician Decision|0|||
30999258|NCT02014116|59198092|FG006|Overall Study|Physician Decision|0|||
30892125|NCT02309359|58925456|FG001|Overall Study|Other|0|||
30999259|NCT02014116|59198093|FG007|Overall Study|Physician Decision|0|||
30999260|NCT02014116|59198094|FG008|Overall Study|Physician Decision|1|||
30999261|NCT02057250|59198121|FG000|AID Assessment Phase|Adverse Event|3|||
30999262|NCT02057250|59198122|FG001|AID Assessment Phase|Adverse Event|2|||
30999263|NCT02057250|59198123|FG002|AID Assessment Phase|Adverse Event|6|||
30999264|NCT02057250|59198124|FG003|AID Assessment Phase|Adverse Event|1|||
30999265|NCT02057250|59198125|FG004|AID Assessment Phase|Adverse Event|0|||
30999266|NCT02057250|59198121|FG000|AID Assessment Phase|Other than specified above|1|||
30999267|NCT02057250|59198122|FG001|AID Assessment Phase|Other than specified above|1|||
30999268|NCT02057250|59198123|FG002|AID Assessment Phase|Other than specified above|1|||
30999269|NCT02057250|59198124|FG003|AID Assessment Phase|Other than specified above|1|||
30999270|NCT02057250|59198125|FG004|AID Assessment Phase|Other than specified above|0|||
30999271|NCT02057250|59198121|FG000|Extension Phase|Adverse Event|0|||
30999272|NCT02057250|59198122|FG001|Extension Phase|Adverse Event|0|||
30999273|NCT02057250|59198123|FG002|Extension Phase|Adverse Event|0|||
30999274|NCT02057250|59198124|FG003|Extension Phase|Adverse Event|0|||
30999275|NCT02057250|59198125|FG004|Extension Phase|Adverse Event|15|||
30999276|NCT02057250|59198121|FG000|Extension Phase|Lack of Efficacy|0|||
30999277|NCT02057250|59198122|FG001|Extension Phase|Lack of Efficacy|0|||
30999278|NCT02057250|59198123|FG002|Extension Phase|Lack of Efficacy|0|||
30999279|NCT02057250|59198124|FG003|Extension Phase|Lack of Efficacy|0|||
30999280|NCT02057250|59198125|FG004|Extension Phase|Lack of Efficacy|10|||
30999281|NCT02057250|59198121|FG000|Extension Phase|Entered in this period but not treated|0|||
30999282|NCT02057250|59198122|FG001|Extension Phase|Entered in this period but not treated|0|||
30999283|NCT02057250|59198123|FG002|Extension Phase|Entered in this period but not treated|0|||
30999284|NCT02057250|59198124|FG003|Extension Phase|Entered in this period but not treated|0|||
30999285|NCT02057250|59198125|FG004|Extension Phase|Entered in this period but not treated|4|||
30999286|NCT02057250|59198121|FG000|Extension Phase|Other than specified above|0|||
30999287|NCT02057250|59198122|FG001|Extension Phase|Other than specified above|0|||
30999288|NCT02057250|59198123|FG002|Extension Phase|Other than specified above|0|||
30999289|NCT02057250|59198124|FG003|Extension Phase|Other than specified above|0|||
30999290|NCT02057250|59198125|FG004|Extension Phase|Other than specified above|7|||
30999291|NCT02036502|59198145|FG000|Part 1:Dose Determination/Escalation|Death|3|||
30999292|NCT02036502|59198146|FG001|Part 1:Dose Determination/Escalation|Death|2|||
30999293|NCT02036502|59198147|FG002|Part 1:Dose Determination/Escalation|Death|0|||
30999294|NCT02036502|59198148|FG003|Part 1:Dose Determination/Escalation|Death|0|||
30999295|NCT02036502|59198149|FG004|Part 1:Dose Determination/Escalation|Death|0|||
30999296|NCT02036502|59198150|FG005|Part 1:Dose Determination/Escalation|Death|0|||
30999297|NCT02036502|59198151|FG006|Part 1:Dose Determination/Escalation|Death|0|||
30999298|NCT02036502|59198152|FG007|Part 1:Dose Determination/Escalation|Death|0|||
30999299|NCT02036502|59198145|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
30999300|NCT02036502|59198146|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
30999301|NCT02036502|59198147|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
30999302|NCT02036502|59198148|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
30999303|NCT02036502|59198149|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
30999304|NCT02036502|59198150|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
30999305|NCT02036502|59198151|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
30999306|NCT02036502|59198152|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
30999307|NCT02036502|59198145|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
30999308|NCT02036502|59198146|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
30999309|NCT02036502|59198147|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
30999310|NCT02036502|59198148|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
30999311|NCT02036502|59198149|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
30999312|NCT02036502|59198150|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
30999313|NCT02036502|59198151|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
30999314|NCT02036502|59198152|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
30999315|NCT02036502|59198145|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
30999316|NCT02036502|59198146|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
30999317|NCT02036502|59198147|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
30999318|NCT02036502|59198148|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
30999319|NCT02036502|59198149|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
30999320|NCT02036502|59198150|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
30999321|NCT02036502|59198151|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
30999322|NCT02036502|59198152|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
30999323|NCT02036502|59198145|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
30999324|NCT02036502|59198146|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
30999325|NCT02036502|59198147|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
30999326|NCT02036502|59198148|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
30999327|NCT02036502|59198149|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
30999328|NCT02036502|59198150|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
30999329|NCT02036502|59198151|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
30999330|NCT02036502|59198152|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
30999331|NCT02036502|59198145|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
30999332|NCT02036502|59198146|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
30999333|NCT02036502|59198147|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
30999334|NCT02036502|59198148|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
30999335|NCT02036502|59198149|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
30999336|NCT02036502|59198150|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
30999337|NCT02036502|59198151|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
30999338|NCT02036502|59198152|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
30999339|NCT02036502|59198145|FG000|Part 2:Dose Confirmation|Death|0|||
30892126|NCT02309359|58925457|FG002|Overall Study|Other|2|||
30999340|NCT02036502|59198146|FG001|Part 2:Dose Confirmation|Death|0|||
30999341|NCT02036502|59198147|FG002|Part 2:Dose Confirmation|Death|1|||
30999342|NCT02036502|59198148|FG003|Part 2:Dose Confirmation|Death|0|||
30892127|NCT02309359|58925458|FG003|Overall Study|Other|3|||
30892128|NCT02309359|58925459|FG004|Overall Study|Other|2|||
30999343|NCT02036502|59198149|FG004|Part 2:Dose Confirmation|Death|0|||
30999344|NCT02036502|59198150|FG005|Part 2:Dose Confirmation|Death|0|||
30999345|NCT02036502|59198151|FG006|Part 2:Dose Confirmation|Death|0|||
30999346|NCT02036502|59198152|FG007|Part 2:Dose Confirmation|Death|0|||
30999347|NCT02036502|59198145|FG000|Part 2:Dose Confirmation|Not treated|0|||
30999348|NCT02036502|59198146|FG001|Part 2:Dose Confirmation|Not treated|0|||
30999349|NCT02036502|59198147|FG002|Part 2:Dose Confirmation|Not treated|0|||
30999350|NCT02036502|59198148|FG003|Part 2:Dose Confirmation|Not treated|1|||
30999351|NCT02036502|59198149|FG004|Part 2:Dose Confirmation|Not treated|0|||
30999352|NCT02036502|59198150|FG005|Part 2:Dose Confirmation|Not treated|0|||
30999353|NCT02036502|59198151|FG006|Part 2:Dose Confirmation|Not treated|0|||
30999354|NCT02036502|59198152|FG007|Part 2:Dose Confirmation|Not treated|0|||
30999355|NCT02036502|59198145|FG000|Part 3:Dose Expansion|Adverse Event|0|||
30999356|NCT02036502|59198146|FG001|Part 3:Dose Expansion|Adverse Event|0|||
30999357|NCT02036502|59198147|FG002|Part 3:Dose Expansion|Adverse Event|0|||
30999358|NCT02036502|59198148|FG003|Part 3:Dose Expansion|Adverse Event|0|||
30999359|NCT02036502|59198149|FG004|Part 3:Dose Expansion|Adverse Event|0|||
30999360|NCT02036502|59198150|FG005|Part 3:Dose Expansion|Adverse Event|4|||
30999361|NCT02036502|59198151|FG006|Part 3:Dose Expansion|Adverse Event|0|||
30999362|NCT02036502|59198152|FG007|Part 3:Dose Expansion|Adverse Event|2|||
30999363|NCT02036502|59198145|FG000|Part 3:Dose Expansion|Death|0|||
30999364|NCT02036502|59198146|FG001|Part 3:Dose Expansion|Death|0|||
30999365|NCT02036502|59198147|FG002|Part 3:Dose Expansion|Death|0|||
30999366|NCT02036502|59198148|FG003|Part 3:Dose Expansion|Death|0|||
30999367|NCT02036502|59198149|FG004|Part 3:Dose Expansion|Death|0|||
30999368|NCT02036502|59198150|FG005|Part 3:Dose Expansion|Death|24|||
30999369|NCT02036502|59198151|FG006|Part 3:Dose Expansion|Death|0|||
30999370|NCT02036502|59198152|FG007|Part 3:Dose Expansion|Death|3|||
30999371|NCT02036502|59198145|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
30999372|NCT02036502|59198146|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
30999373|NCT02036502|59198147|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
30999374|NCT02036502|59198148|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
30999375|NCT02036502|59198149|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
30999376|NCT02036502|59198150|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
30999377|NCT02036502|59198151|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
30999378|NCT02036502|59198152|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
30999379|NCT02036502|59198145|FG000|Part 3:Dose Expansion|Physician Decision|0|||
30999380|NCT02036502|59198146|FG001|Part 3:Dose Expansion|Physician Decision|0|||
30999381|NCT02036502|59198147|FG002|Part 3:Dose Expansion|Physician Decision|0|||
30999382|NCT02036502|59198148|FG003|Part 3:Dose Expansion|Physician Decision|0|||
30999383|NCT02036502|59198149|FG004|Part 3:Dose Expansion|Physician Decision|0|||
30999384|NCT02036502|59198150|FG005|Part 3:Dose Expansion|Physician Decision|1|||
30999385|NCT02036502|59198151|FG006|Part 3:Dose Expansion|Physician Decision|0|||
30999386|NCT02036502|59198152|FG007|Part 3:Dose Expansion|Physician Decision|0|||
30999387|NCT02036502|59198145|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
30999388|NCT02036502|59198146|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
30999389|NCT02036502|59198147|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
30999390|NCT02036502|59198148|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
30999391|NCT02036502|59198149|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
30999392|NCT02036502|59198150|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
30999393|NCT02036502|59198151|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
30999394|NCT02036502|59198152|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
30999395|NCT02036502|59198145|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
30999396|NCT02036502|59198146|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
30999397|NCT02036502|59198147|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
30999398|NCT02036502|59198148|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
30999399|NCT02036502|59198149|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
30999400|NCT02036502|59198150|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
30999401|NCT02036502|59198151|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
30999402|NCT02036502|59198152|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
30999403|NCT02036502|59198145|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
30999404|NCT02036502|59198146|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
30608998|NCT00963547|58619882|FG005|Overall Study|Adverse Event|0|||
30608999|NCT00963547|58619883|FG006|Overall Study|Adverse Event|0|||
30609000|NCT00963547|58619877|FG000|Overall Study|Physician Decision|1|||
30609001|NCT00963547|58619878|FG001|Overall Study|Physician Decision|1|||
30609002|NCT00963547|58619879|FG002|Overall Study|Physician Decision|0|||
30609003|NCT00963547|58619880|FG003|Overall Study|Physician Decision|0|||
30609004|NCT00963547|58619881|FG004|Overall Study|Physician Decision|0|||
30609005|NCT00963547|58619882|FG005|Overall Study|Physician Decision|0|||
30609006|NCT00963547|58619883|FG006|Overall Study|Physician Decision|0|||
30609007|NCT00963547|58619877|FG000|Overall Study|Progressive Disease|3|||
30609008|NCT00963547|58619878|FG001|Overall Study|Progressive Disease|8|||
30609009|NCT00963547|58619879|FG002|Overall Study|Progressive Disease|9|||
30609010|NCT00963547|58619880|FG003|Overall Study|Progressive Disease|5|||
30609011|NCT00963547|58619881|FG004|Overall Study|Progressive Disease|0|||
30609012|NCT00963547|58619882|FG005|Overall Study|Progressive Disease|0|||
30609013|NCT00963547|58619883|FG006|Overall Study|Progressive Disease|0|||
30609014|NCT00963547|58619877|FG000|Overall Study|Withdrawal by Subject|0|||
30609015|NCT00963547|58619878|FG001|Overall Study|Withdrawal by Subject|0|||
30609016|NCT00963547|58619879|FG002|Overall Study|Withdrawal by Subject|3|||
30609017|NCT00963547|58619880|FG003|Overall Study|Withdrawal by Subject|0|||
30609018|NCT00963547|58619881|FG004|Overall Study|Withdrawal by Subject|0|||
30609019|NCT00963547|58619882|FG005|Overall Study|Withdrawal by Subject|0|||
30609020|NCT00963547|58619883|FG006|Overall Study|Withdrawal by Subject|0|||
30609021|NCT00963547|58619877|FG000|Overall Study|Reason Unknown|0|||
30609022|NCT00963547|58619878|FG001|Overall Study|Reason Unknown|1|||
30609023|NCT00963547|58619879|FG002|Overall Study|Reason Unknown|0|||
30609024|NCT00963547|58619880|FG003|Overall Study|Reason Unknown|0|||
30892129|NCT02247531|58925475|FG000|Overall Study|Adverse Event|3|||
30999405|NCT02036502|59198147|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
30999406|NCT02036502|59198148|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
30999407|NCT02036502|59198149|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
30999408|NCT02036502|59198150|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
30999409|NCT02036502|59198151|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
30999410|NCT02036502|59198152|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
30999411|NCT02036502|59198145|FG000|Part 3:Dose Expansion|Not Treated|0|||
30999412|NCT02036502|59198146|FG001|Part 3:Dose Expansion|Not Treated|0|||
30999413|NCT02036502|59198147|FG002|Part 3:Dose Expansion|Not Treated|0|||
30999414|NCT02036502|59198148|FG003|Part 3:Dose Expansion|Not Treated|0|||
30999415|NCT02036502|59198149|FG004|Part 3:Dose Expansion|Not Treated|0|||
30999416|NCT02036502|59198150|FG005|Part 3:Dose Expansion|Not Treated|2|||
30999417|NCT02036502|59198151|FG006|Part 3:Dose Expansion|Not Treated|0|||
30999418|NCT02036502|59198152|FG007|Part 3:Dose Expansion|Not Treated|0|||
30999419|NCT02056626|59198176|FG000|Overall Study|patient did not follow directions|3|||
30999420|NCT02056626|59198177|FG001|Overall Study|patient did not follow directions|1|||
30999421|NCT02056626|59198178|FG002|Overall Study|patient did not follow directions|0|||
30999422|NCT02056626|59198179|FG003|Overall Study|patient did not follow directions|0|||
30999423|NCT02035332|59198189|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
30999424|NCT02056392|59198199|FG000|Overall Study|Lost to Follow-up|0|||
30999425|NCT02056392|59198200|FG001|Overall Study|Lost to Follow-up|1|||
30999426|NCT02056392|59198201|FG002|Overall Study|Lost to Follow-up|2|||
30999427|NCT02056392|59198202|FG003|Overall Study|Lost to Follow-up|0|||
30999428|NCT02056392|59198203|FG004|Overall Study|Lost to Follow-up|0|||
30999429|NCT02056392|59198204|FG005|Overall Study|Lost to Follow-up|0|||
30999430|NCT02056392|59198199|FG000|Overall Study|Protocol Violation|1|||
30999431|NCT02056392|59198200|FG001|Overall Study|Protocol Violation|0|||
30999432|NCT02056392|59198201|FG002|Overall Study|Protocol Violation|1|||
30999433|NCT02056392|59198202|FG003|Overall Study|Protocol Violation|0|||
30999434|NCT02056392|59198203|FG004|Overall Study|Protocol Violation|0|||
30999435|NCT02056392|59198204|FG005|Overall Study|Protocol Violation|0|||
30999436|NCT02056392|59198199|FG000|Overall Study|Withdrawal by Subject|1|||
30999437|NCT02056392|59198200|FG001|Overall Study|Withdrawal by Subject|0|||
30999438|NCT02056392|59198201|FG002|Overall Study|Withdrawal by Subject|0|||
30999439|NCT02056392|59198202|FG003|Overall Study|Withdrawal by Subject|0|||
30999440|NCT02056392|59198203|FG004|Overall Study|Withdrawal by Subject|1|||
30999441|NCT02056392|59198204|FG005|Overall Study|Withdrawal by Subject|0|||
30999442|NCT02034708|59198214|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
30999443|NCT02034708|59198215|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
30892130|NCT02247531|58925476|FG001|Overall Study|Adverse Event|4|||
30892131|NCT02247531|58925477|FG002|Overall Study|Adverse Event|9|||
30892132|NCT02247531|58925475|FG000|Overall Study|Death|8|||
30892133|NCT02247531|58925476|FG001|Overall Study|Death|9|||
30892134|NCT02247531|58925477|FG002|Overall Study|Death|5|||
30892135|NCT02247531|58925475|FG000|Overall Study|Lost to Follow-up|1|||
30892136|NCT02247531|58925476|FG001|Overall Study|Lost to Follow-up|8|||
30999444|NCT02034708|59198214|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
30999445|NCT02034708|59198215|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
30999446|NCT02034708|59198214|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
30999447|NCT02034708|59198215|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
30999448|NCT02034708|59198214|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
30999449|NCT02034708|59198215|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
30999450|NCT02034552|59198229|FG000|Overall Study|Never treated|3|||
30999451|NCT02034552|59198230|FG001|Overall Study|Never treated|2|||
30999452|NCT02034552|59198231|FG002|Overall Study|Never treated|0|||
30999453|NCT02034552|59198229|FG000|Overall Study|Radiological progression|3|||
30999454|NCT02034552|59198230|FG001|Overall Study|Radiological progression|5|||
30892137|NCT02247531|58925477|FG002|Overall Study|Lost to Follow-up|3|||
30999455|NCT02034552|59198231|FG002|Overall Study|Radiological progression|4|||
30999456|NCT02034552|59198229|FG000|Overall Study|AE not assoc. with disease progression|1|||
30999457|NCT02034552|59198230|FG001|Overall Study|AE not assoc. with disease progression|4|||
30999458|NCT02034552|59198231|FG002|Overall Study|AE not assoc. with disease progression|2|||
30999459|NCT02034552|59198229|FG000|Overall Study|AE associated with disease progression|0|||
30999460|NCT02034552|59198230|FG001|Overall Study|AE associated with disease progression|1|||
30999461|NCT02034552|59198231|FG002|Overall Study|AE associated with disease progression|0|||
30999462|NCT02034552|59198229|FG000|Overall Study|Withdrawal by Subject|2|||
30999463|NCT02034552|59198230|FG001|Overall Study|Withdrawal by Subject|1|||
30999464|NCT02034552|59198231|FG002|Overall Study|Withdrawal by Subject|1|||
30999465|NCT02034552|59198229|FG000|Overall Study|Non-compliance with study drug|0|||
30999466|NCT02034552|59198230|FG001|Overall Study|Non-compliance with study drug|0|||
30999467|NCT02034552|59198231|FG002|Overall Study|Non-compliance with study drug|1|||
30999468|NCT02034552|59198229|FG000|Overall Study|Clinical progression|5|||
30999469|NCT02034552|59198230|FG001|Overall Study|Clinical progression|7|||
30999470|NCT02034552|59198231|FG002|Overall Study|Clinical progression|9|||
30999471|NCT02034474|59198241|FG000|Overall Study|Adverse Event|3|||
30999472|NCT02034474|59198242|FG001|Overall Study|Adverse Event|2|||
30999473|NCT02034474|59198241|FG000|Overall Study|Withdrawal by Subject|1|||
30999474|NCT02034474|59198242|FG001|Overall Study|Withdrawal by Subject|2|||
30999475|NCT02011542|59198250|FG000|Overall Study|Physician Decision|1|||
30999476|NCT02011386|59198254|FG000|Overall Study|Non-compliance|2|||
30999477|NCT02011386|59198254|FG000|Overall Study|Lack of Efficacy|3|||
30999478|NCT02010684|59198260|FG000|Overall Study|Lost to Follow-up|8|||
30999479|NCT02010684|59198261|FG001|Overall Study|Lost to Follow-up|18|||
30999480|NCT02010684|59198260|FG000|Overall Study|Withdrawal by Subject|4|||
30999481|NCT02010684|59198261|FG001|Overall Study|Withdrawal by Subject|5|||
30999482|NCT02034162|59198269|FG000|Double-blind|Lost to Follow-up|3|||
30999483|NCT02034162|59198270|FG001|Double-blind|Lost to Follow-up|0|||
30999484|NCT02034162|59198271|FG002|Double-blind|Lost to Follow-up|0|||
30999485|NCT02034162|59198269|FG000|Double-blind|Physician Decision|1|||
30999486|NCT02034162|59198270|FG001|Double-blind|Physician Decision|0|||
30999487|NCT02034162|59198271|FG002|Double-blind|Physician Decision|0|||
30999488|NCT02034162|59198269|FG000|Double-blind|Protocol Violation|0|||
30999489|NCT02034162|59198270|FG001|Double-blind|Protocol Violation|1|||
30999490|NCT02034162|59198271|FG002|Double-blind|Protocol Violation|0|||
30999491|NCT02034162|59198269|FG000|Double-blind|Withdrawal by Subject|5|||
30999492|NCT02034162|59198270|FG001|Double-blind|Withdrawal by Subject|7|||
30999493|NCT02034162|59198271|FG002|Double-blind|Withdrawal by Subject|0|||
30999494|NCT02034006|59198284|FG000|Overall Study|Withdrawal by Subject|7|||
30999495|NCT02034006|59198284|FG000|Overall Study|Lost to Follow-up|5|||
30999496|NCT02034006|59198284|FG000|Overall Study|Death|1|||
30999497|NCT02034006|59198284|FG000|Overall Study|Pregnancy|1|||
30999498|NCT02054910|59198293|FG000|Overall Study|Lost to Follow-up|4|||
30999499|NCT02054910|59198294|FG001|Overall Study|Lost to Follow-up|1|||
30999500|NCT02033850|59198304|FG000|Overall Study|Death|1|||
30999501|NCT02033850|59198305|FG001|Overall Study|Death|0|||
30999502|NCT02033850|59198304|FG000|Overall Study|unrelated medical reason|1|||
30999503|NCT02033850|59198305|FG001|Overall Study|unrelated medical reason|1|||
30999504|NCT02054130|59198315|FG000|Overall Study|Withdrawal by Subject|4|||
30999505|NCT02054130|59198316|FG001|Overall Study|Withdrawal by Subject|4|||
30999506|NCT02054130|59198317|FG002|Overall Study|Withdrawal by Subject|7|||
30999507|NCT02054130|59198318|FG003|Overall Study|Withdrawal by Subject|10|||
30999508|NCT02054130|59198315|FG000|Overall Study|Death|0|||
30999509|NCT02054130|59198316|FG001|Overall Study|Death|1|||
30999510|NCT02054130|59198317|FG002|Overall Study|Death|0|||
30999511|NCT02054130|59198318|FG003|Overall Study|Death|0|||
30999512|NCT02054130|59198315|FG000|Overall Study|Lost to Follow-up|0|||
30999513|NCT02054130|59198316|FG001|Overall Study|Lost to Follow-up|0|||
30999514|NCT02054130|59198317|FG002|Overall Study|Lost to Follow-up|1|||
30999515|NCT02054130|59198318|FG003|Overall Study|Lost to Follow-up|2|||
30999516|NCT02054130|59198315|FG000|Overall Study|Missed dose|4|||
30999517|NCT02054130|59198316|FG001|Overall Study|Missed dose|6|||
30999518|NCT02054130|59198317|FG002|Overall Study|Missed dose|7|||
30999519|NCT02054130|59198318|FG003|Overall Study|Missed dose|10|||
30999520|NCT02009046|59198333|FG000|Overall Study|Lost to Follow-up|256|||
30999521|NCT02009046|59198334|FG001|Overall Study|Lost to Follow-up|206|||
30999522|NCT02052960|59198350|FG000|Overall Study|Adverse Event|19|||
30999523|NCT02052960|59198351|FG001|Overall Study|Adverse Event|17|||
30999524|NCT02052960|59198350|FG000|Overall Study|Protocol Violation|4|||
30999525|NCT02052960|59198351|FG001|Overall Study|Protocol Violation|3|||
30999526|NCT02052960|59198350|FG000|Overall Study|Withdrawal by Subject|6|||
30999527|NCT02052960|59198351|FG001|Overall Study|Withdrawal by Subject|11|||
30999528|NCT02052960|59198350|FG000|Overall Study|Other|25|||
30999529|NCT02052960|59198351|FG001|Overall Study|Other|15|||
30999530|NCT02008890|59198363|FG000|Period 1|Withdrawal by Subject|7|||
30999531|NCT02008890|59198364|FG001|Period 1|Withdrawal by Subject|7|||
30999532|NCT02008890|59198365|FG002|Period 1|Withdrawal by Subject|5|||
30999533|NCT02008890|59198366|FG003|Period 1|Withdrawal by Subject|0|||
30999534|NCT02008890|59198367|FG004|Period 1|Withdrawal by Subject|0|||
30999535|NCT02008890|59198363|FG000|Period 1|Pregnancy|1|||
30999536|NCT02008890|59198364|FG001|Period 1|Pregnancy|0|||
30999537|NCT02008890|59198365|FG002|Period 1|Pregnancy|0|||
30999538|NCT02008890|59198366|FG003|Period 1|Pregnancy|0|||
30999539|NCT02008890|59198367|FG004|Period 1|Pregnancy|0|||
30999540|NCT02008890|59198363|FG000|Period 1|Physician Decision|1|||
30999541|NCT02008890|59198364|FG001|Period 1|Physician Decision|0|||
30999542|NCT02008890|59198365|FG002|Period 1|Physician Decision|1|||
30999543|NCT02008890|59198366|FG003|Period 1|Physician Decision|0|||
30999544|NCT02008890|59198367|FG004|Period 1|Physician Decision|0|||
30999545|NCT02008890|59198363|FG000|Period 1|Adverse Event|6|||
30999546|NCT02008890|59198364|FG001|Period 1|Adverse Event|8|||
30999547|NCT02008890|59198365|FG002|Period 1|Adverse Event|6|||
30999548|NCT02008890|59198366|FG003|Period 1|Adverse Event|0|||
30999549|NCT02008890|59198367|FG004|Period 1|Adverse Event|0|||
30999550|NCT02008890|59198363|FG000|Period 2|Adverse Event|12|||
30790228|NCT00035555|58803458|FG002|Overall Study|Noncompliance|1|||
30999551|NCT02008890|59198364|FG001|Period 2|Adverse Event|7|||
30999552|NCT02008890|59198365|FG002|Period 2|Adverse Event|0|||
30999553|NCT02008890|59198366|FG003|Period 2|Adverse Event|5|||
30999554|NCT02008890|59198367|FG004|Period 2|Adverse Event|5|||
30999555|NCT02008890|59198363|FG000|Period 2|Withdrawal by Subject|11|||
30999556|NCT02008890|59198364|FG001|Period 2|Withdrawal by Subject|8|||
30999557|NCT02008890|59198365|FG002|Period 2|Withdrawal by Subject|0|||
30999558|NCT02008890|59198366|FG003|Period 2|Withdrawal by Subject|7|||
30999559|NCT02008890|59198367|FG004|Period 2|Withdrawal by Subject|2|||
30999560|NCT02008890|59198363|FG000|Period 2|Physician Decision|4|||
30999561|NCT02008890|59198364|FG001|Period 2|Physician Decision|0|||
30999562|NCT02008890|59198365|FG002|Period 2|Physician Decision|0|||
30999563|NCT02008890|59198366|FG003|Period 2|Physician Decision|2|||
30999564|NCT02008890|59198367|FG004|Period 2|Physician Decision|1|||
30999565|NCT02008890|59198363|FG000|Period 2|Lost to Follow-up|0|||
30999566|NCT02008890|59198364|FG001|Period 2|Lost to Follow-up|0|||
30999567|NCT02008890|59198365|FG002|Period 2|Lost to Follow-up|1|||
30999568|NCT02008890|59198366|FG003|Period 2|Lost to Follow-up|0|||
30999569|NCT02008890|59198367|FG004|Period 2|Lost to Follow-up|0|||
30999570|NCT02008890|59198363|FG000|Extension Period|Withdrawal by Subject|3|||
30999571|NCT02008890|59198364|FG001|Extension Period|Withdrawal by Subject|2|||
30999572|NCT02008890|59198365|FG002|Extension Period|Withdrawal by Subject|0|||
30999573|NCT02008890|59198366|FG003|Extension Period|Withdrawal by Subject|4|||
30999574|NCT02008890|59198367|FG004|Extension Period|Withdrawal by Subject|2|||
30999575|NCT02008890|59198363|FG000|Extension Period|Lost to Follow-up|1|||
30999576|NCT02008890|59198364|FG001|Extension Period|Lost to Follow-up|0|||
30999577|NCT02008890|59198365|FG002|Extension Period|Lost to Follow-up|0|||
30999578|NCT02008890|59198366|FG003|Extension Period|Lost to Follow-up|0|||
30999579|NCT02008890|59198367|FG004|Extension Period|Lost to Follow-up|0|||
30999580|NCT02008890|59198363|FG000|Extension Period|Adverse Event|1|||
30999581|NCT02008890|59198364|FG001|Extension Period|Adverse Event|3|||
30999582|NCT02008890|59198365|FG002|Extension Period|Adverse Event|0|||
30999583|NCT02008890|59198366|FG003|Extension Period|Adverse Event|0|||
30999584|NCT02008890|59198367|FG004|Extension Period|Adverse Event|2|||
30999585|NCT02052414|59198382|FG000|Overall Study|Adverse Event|12|||
30999586|NCT02052414|59198382|FG000|Overall Study|Lack of Efficacy|2|||
30999587|NCT02052414|59198382|FG000|Overall Study|Withdrawal by Subject|3|||
30999588|NCT02007954|59198387|FG000|Overall Study|Received liver transplant|3|||
30999589|NCT02007954|59198387|FG000|Overall Study|Switch in treatment modality|2|||
30999590|NCT02007954|59198387|FG000|Overall Study|Disease progression and unrelated AE|1|||
30999591|NCT02007954|59198387|FG000|Overall Study|Death|1|||
30999592|NCT02049450|59198391|FG000|Overall Study|Adverse Event|2|||
30999593|NCT02049450|59198391|FG000|Overall Study|Withdrawal by Subject|1|||
30999594|NCT02049450|59198391|FG000|Overall Study|Patients/guardian decision|1|||
30999595|NCT02031432|59198402|FG000|Overall Study|Protocol Violation|1|||
30999596|NCT02031432|59198402|FG000|Overall Study|Lack of Efficacy|5|||
30999597|NCT02031432|59198402|FG000|Overall Study|Cancer Progression|2|||
30999598|NCT02031432|59198402|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
30999599|NCT02031432|59198402|FG000|Overall Study|Adverse Event|8|||
30999600|NCT02031432|59198402|FG000|Overall Study|Withdrawal by Subject|5|||
30999601|NCT02031432|59198402|FG000|Overall Study|Lost to Follow-up|1|||
30999602|NCT02031432|59198402|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
30999603|NCT02031432|59198402|FG000|Overall Study|Death|10|||
30999604|NCT02031276|59198409|FG000|Period 1 Double-blind IV|Adverse Event|6|||
30999605|NCT02031276|59198410|FG001|Period 1 Double-blind IV|Adverse Event|5|||
30999606|NCT02031276|59198411|FG002|Period 1 Double-blind IV|Adverse Event|1|||
30999607|NCT02031276|59198409|FG000|Period 1 Double-blind IV|Other|0|||
30999608|NCT02031276|59198410|FG001|Period 1 Double-blind IV|Other|1|||
30999609|NCT02031276|59198411|FG002|Period 1 Double-blind IV|Other|0|||
30999610|NCT02031276|59198409|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
30999611|NCT02031276|59198410|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
30999612|NCT02031276|59198411|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
30999613|NCT02031276|59198409|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
30999614|NCT02031276|59198410|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
30999615|NCT02031276|59198411|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
30999616|NCT02031276|59198409|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
30999617|NCT02031276|59198410|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
30999618|NCT02031276|59198411|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
30999619|NCT02031276|59198409|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
30999620|NCT02031276|59198410|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
30999621|NCT02031276|59198411|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
30999622|NCT02031276|59198409|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
30999623|NCT02031276|59198410|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
30999624|NCT02031276|59198411|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
30999625|NCT02031276|59198409|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
30999626|NCT02031276|59198410|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
30999627|NCT02031276|59198411|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
30999628|NCT02031276|59198409|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
30999629|NCT02031276|59198410|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
30999630|NCT02031276|59198411|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
30999631|NCT02007720|59198425|FG000|Overall Study|Withdrawal by Subject|9|||
30999632|NCT02007720|59198426|FG001|Overall Study|Withdrawal by Subject|11|||
30999633|NCT02007720|59198425|FG000|Overall Study|study terminated by sponsor|58|||
30999634|NCT02007720|59198426|FG001|Overall Study|study terminated by sponsor|54|||
30999635|NCT02007720|59198425|FG000|Overall Study|technical problem|4|||
30999636|NCT02007720|59198426|FG001|Overall Study|technical problem|2|||
30999637|NCT02007720|59198425|FG000|Overall Study|patient followd less than 165 days|11|||
30999638|NCT02007720|59198426|FG001|Overall Study|patient followd less than 165 days|5|||
30999639|NCT01363440|59198436|FG000|Overall Study|Adverse Event|5|||
30999640|NCT01363440|59198437|FG001|Overall Study|Adverse Event|4|||
30999641|NCT01363440|59198438|FG002|Overall Study|Adverse Event|4|||
30999642|NCT01363440|59198436|FG000|Overall Study|Death|3|||
30999643|NCT01363440|59198437|FG001|Overall Study|Death|7|||
30999644|NCT01363440|59198438|FG002|Overall Study|Death|5|||
30999645|NCT01363440|59198436|FG000|Overall Study|Withdrawal by Subject|9|||
30999646|NCT01363440|59198437|FG001|Overall Study|Withdrawal by Subject|11|||
30999647|NCT01363440|59198438|FG002|Overall Study|Withdrawal by Subject|11|||
30999648|NCT01363440|59198436|FG000|Overall Study|Lost to Follow-up|2|||
30999649|NCT01363440|59198437|FG001|Overall Study|Lost to Follow-up|4|||
30999650|NCT01363440|59198438|FG002|Overall Study|Lost to Follow-up|5|||
30999651|NCT01363440|59198436|FG000|Overall Study|Other|4|||
30999652|NCT01363440|59198437|FG001|Overall Study|Other|5|||
30999653|NCT01363440|59198438|FG002|Overall Study|Other|2|||
30999654|NCT02007252|59198451|FG000|Overall Study|Administrative problems|3|||
30999655|NCT02007252|59198452|FG001|Overall Study|Administrative problems|7|||
30999656|NCT02007252|59198451|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30999657|NCT02007252|59198452|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30999658|NCT02007252|59198451|FG000|Overall Study|Adverse Event|7|||
30999659|NCT02007252|59198452|FG001|Overall Study|Adverse Event|4|||
30999660|NCT02007096|59198460|FG000|Overall Study|medication not available|2|||
30999661|NCT02007096|59198461|FG001|Overall Study|medication not available|0|||
30999662|NCT02007096|59198460|FG000|Overall Study|did not inject saline|0|||
30999663|NCT02007096|59198461|FG001|Overall Study|did not inject saline|3|||
30999664|NCT02007096|59198460|FG000|Overall Study|did not follow postoperative protocol|8|||
30999665|NCT02007096|59198461|FG001|Overall Study|did not follow postoperative protocol|11|||
30999666|NCT02007096|59198460|FG000|Overall Study|converted to open surgery|1|||
30999667|NCT02007096|59198461|FG001|Overall Study|converted to open surgery|1|||
30999668|NCT02007096|59198460|FG000|Overall Study|no mesh placed|0|||
30999669|NCT02007096|59198461|FG001|Overall Study|no mesh placed|1|||
30999670|NCT02006706|59198467|FG000|Overall Study|Lost to Follow-up|1|||
30999671|NCT02049138|59198474|FG000|Overall Study|Adverse Event|46|||
30999672|NCT02049138|59198475|FG001|Overall Study|Adverse Event|25|||
30999673|NCT02049138|59198476|FG002|Overall Study|Adverse Event|1|||
30999674|NCT02049138|59198474|FG000|Overall Study|Withdrawal by Subject|57|||
30999675|NCT02049138|59198475|FG001|Overall Study|Withdrawal by Subject|21|||
30999676|NCT02049138|59198476|FG002|Overall Study|Withdrawal by Subject|5|||
30999677|NCT02049138|59198474|FG000|Overall Study|Lost to Follow-up|18|||
30999678|NCT02049138|59198475|FG001|Overall Study|Lost to Follow-up|5|||
30999679|NCT02049138|59198476|FG002|Overall Study|Lost to Follow-up|1|||
30999680|NCT02049138|59198474|FG000|Overall Study|Lack of Efficacy|10|||
30999681|NCT02049138|59198475|FG001|Overall Study|Lack of Efficacy|26|||
30999682|NCT02049138|59198476|FG002|Overall Study|Lack of Efficacy|1|||
30999683|NCT02049138|59198474|FG000|Overall Study|Non-Compliance|15|||
30999684|NCT02049138|59198475|FG001|Overall Study|Non-Compliance|6|||
30999685|NCT02049138|59198476|FG002|Overall Study|Non-Compliance|0|||
30999686|NCT02049138|59198474|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
30999687|NCT02049138|59198475|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
30999688|NCT02049138|59198476|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
30999689|NCT02049138|59198474|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
30999690|NCT02049138|59198475|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
30999691|NCT02049138|59198476|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
30999692|NCT02049138|59198474|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
30999693|NCT02049138|59198475|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
30999694|NCT02049138|59198476|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
30999695|NCT02049138|59198474|FG000|Overall Study|Other|15|||
30999696|NCT02049138|59198475|FG001|Overall Study|Other|13|||
30999697|NCT02049138|59198476|FG002|Overall Study|Other|0|||
30999698|NCT02049138|59198474|FG000|Overall Study|Missing|0|||
30999699|NCT02049138|59198475|FG001|Overall Study|Missing|1|||
30999700|NCT02049138|59198476|FG002|Overall Study|Missing|0|||
30999701|NCT02048904|59198487|FG000|Overall Study|Withdrawal by Subject|7|||
30999702|NCT02048904|59198487|FG000|Overall Study|Physician Decision|70|||
30999703|NCT02006628|59198493|FG000|Overall Study|Adverse Event|1|||
30999704|NCT02006628|59198494|FG001|Overall Study|Adverse Event|1|||
30999705|NCT02006628|59198493|FG000|Overall Study|Withdrawal by Subject|2|||
30999706|NCT02006628|59198494|FG001|Overall Study|Withdrawal by Subject|1|||
30999707|NCT02048826|59198502|FG000|Overall Study|Withdrawal by Subject|1|||
30999708|NCT02048826|59198503|FG001|Overall Study|Withdrawal by Subject|0|||
30999709|NCT02006472|59198514|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
30999710|NCT02006472|59198515|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
30999711|NCT02006472|59198516|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
30999712|NCT02006472|59198517|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
30999713|NCT02006472|59198518|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
30999714|NCT02006472|59198514|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
30999715|NCT02006472|59198515|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
30999716|NCT02006472|59198516|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
30999717|NCT02006472|59198517|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
30999718|NCT02006472|59198518|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
30999719|NCT02006472|59198514|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
30999720|NCT02006472|59198515|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
30999721|NCT02006472|59198516|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
30999722|NCT02006472|59198517|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
30999723|NCT02006472|59198518|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
30999724|NCT02006472|59198514|FG000|Period 1 (Through Week 26)|Other|1|||
30999725|NCT02006472|59198515|FG001|Period 1 (Through Week 26)|Other|5|||
30999726|NCT02006472|59198516|FG002|Period 1 (Through Week 26)|Other|0|||
30999727|NCT02006472|59198517|FG003|Period 1 (Through Week 26)|Other|2|||
30999728|NCT02006472|59198518|FG004|Period 1 (Through Week 26)|Other|3|||
30999729|NCT02006472|59198514|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
30999730|NCT02006472|59198515|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
30999731|NCT02006472|59198516|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
30999732|NCT02006472|59198517|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
30999733|NCT02006472|59198518|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
30999734|NCT02006472|59198514|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
30999735|NCT02006472|59198515|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
30999736|NCT02006472|59198516|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
30999737|NCT02006472|59198517|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
30999738|NCT02006472|59198518|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
30999739|NCT02006472|59198514|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
30999740|NCT02006472|59198515|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
30999741|NCT02006472|59198516|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
30999742|NCT02006472|59198517|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
30999743|NCT02006472|59198518|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
30999744|NCT02006472|59198514|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
30999745|NCT02006472|59198515|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
30999746|NCT02006472|59198516|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
30999747|NCT02006472|59198517|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
30999748|NCT02006472|59198518|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
30999749|NCT02006472|59198514|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
30999750|NCT02006472|59198515|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
30999751|NCT02006472|59198516|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
30999752|NCT02006472|59198517|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
30999753|NCT02006472|59198518|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
30999754|NCT02006472|59198514|FG000|Period 2 (Through Week 52)|Other|0|||
30999755|NCT02006472|59198515|FG001|Period 2 (Through Week 52)|Other|1|||
30999756|NCT02006472|59198516|FG002|Period 2 (Through Week 52)|Other|0|||
30999757|NCT02006472|59198517|FG003|Period 2 (Through Week 52)|Other|1|||
30999758|NCT02006472|59198518|FG004|Period 2 (Through Week 52)|Other|0|||
30999759|NCT02006472|59198514|FG000|Period 2 (Through Week 52)|Not treated|0|||
30999760|NCT02006472|59198515|FG001|Period 2 (Through Week 52)|Not treated|0|||
30999761|NCT02006472|59198516|FG002|Period 2 (Through Week 52)|Not treated|2|||
30999762|NCT02006472|59198517|FG003|Period 2 (Through Week 52)|Not treated|0|||
30999763|NCT02006472|59198518|FG004|Period 2 (Through Week 52)|Not treated|0|||
30999764|NCT02006472|59198514|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
30999765|NCT02006472|59198515|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
30999766|NCT02006472|59198516|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
30999767|NCT02006472|59198517|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
30999768|NCT02006472|59198518|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
30999769|NCT02006472|59198514|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
30999770|NCT02006472|59198515|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
30999771|NCT02006472|59198516|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
30999772|NCT02006472|59198517|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
30999773|NCT02006472|59198518|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
30999774|NCT02005692|59198535|FG000|Overall Study|Protocol Violation|1|||
30999775|NCT02005692|59198535|FG000|Overall Study|Withdrawal by Subject|1|||
30999776|NCT02005692|59198535|FG000|Overall Study|Discharged earlier than anticipated|5|||
30999777|NCT02029638|59198543|FG000|Overall Study|Death|0|||
30999778|NCT02029638|59198544|FG001|Overall Study|Death|0|||
30999779|NCT02029638|59198545|FG002|Overall Study|Death|1|||
30999780|NCT02029638|59198543|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
30999781|NCT02029638|59198544|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
30999782|NCT02029638|59198545|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
30999783|NCT02047734|59198556|FG000|Overall Study|Adverse Event|18|||
30999784|NCT02047734|59198557|FG001|Overall Study|Adverse Event|13|||
30999785|NCT02047734|59198558|FG002|Overall Study|Adverse Event|13|||
30999786|NCT02047734|59198556|FG000|Overall Study|Lack of Efficacy|4|||
30999787|NCT02047734|59198557|FG001|Overall Study|Lack of Efficacy|5|||
30999788|NCT02047734|59198558|FG002|Overall Study|Lack of Efficacy|1|||
30999789|NCT02047734|59198556|FG000|Overall Study|Protocol Violation|3|||
30999790|NCT02047734|59198557|FG001|Overall Study|Protocol Violation|1|||
30999791|NCT02047734|59198558|FG002|Overall Study|Protocol Violation|1|||
30999792|NCT02047734|59198556|FG000|Overall Study|Lost to Follow-up|1|||
30999793|NCT02047734|59198557|FG001|Overall Study|Lost to Follow-up|4|||
30999794|NCT02047734|59198558|FG002|Overall Study|Lost to Follow-up|0|||
30999795|NCT02047734|59198556|FG000|Overall Study|Death|0|||
30999796|NCT02047734|59198557|FG001|Overall Study|Death|1|||
30999797|NCT02047734|59198558|FG002|Overall Study|Death|0|||
30999798|NCT02047734|59198556|FG000|Overall Study|Withdrawal by Subject|30|||
30999799|NCT02047734|59198557|FG001|Overall Study|Withdrawal by Subject|31|||
30999800|NCT02047734|59198558|FG002|Overall Study|Withdrawal by Subject|19|||
30999801|NCT02047734|59198556|FG000|Overall Study|Physician Decision|7|||
30999802|NCT02047734|59198557|FG001|Overall Study|Physician Decision|6|||
30999803|NCT02047734|59198558|FG002|Overall Study|Physician Decision|5|||
30999804|NCT02047734|59198556|FG000|Overall Study|Miscellaneous|2|||
30999805|NCT02047734|59198557|FG001|Overall Study|Miscellaneous|4|||
30999806|NCT02047734|59198558|FG002|Overall Study|Miscellaneous|6|||
30999807|NCT02047734|59198556|FG000|Overall Study|Did Not Receive Study Drug|2|||
30999808|NCT02047734|59198557|FG001|Overall Study|Did Not Receive Study Drug|4|||
30999809|NCT02047734|59198558|FG002|Overall Study|Did Not Receive Study Drug|1|||
30999810|NCT02053350|59198566|FG000|Overall Study|Withdrawal by Subject|1|||
30999811|NCT02053350|59198566|FG000|Overall Study|Adverse Event|4|||
30999812|NCT01994850|59198570|FG000|Overall Study|Physician Decision|1|||
30999813|NCT01994850|59198570|FG000|Overall Study|Withdrawal by Subject|1|||
30999814|NCT02027844|59198577|FG000|Overall Study|Withdrawal by Subject|3|||
30999815|NCT02027844|59198578|FG001|Overall Study|Withdrawal by Subject|2|||
30999816|NCT02027844|59198579|FG002|Overall Study|Withdrawal by Subject|1|||
30999817|NCT02027844|59198577|FG000|Overall Study|Lost to Follow-up|0|||
30999818|NCT02027844|59198578|FG001|Overall Study|Lost to Follow-up|2|||
30999819|NCT02027844|59198579|FG002|Overall Study|Lost to Follow-up|1|||
30999820|NCT02027844|59198577|FG000|Overall Study|Protocol Violation|0|||
30999821|NCT02027844|59198578|FG001|Overall Study|Protocol Violation|2|||
30892138|NCT02247531|58925475|FG000|Overall Study|Non-compliance|2|||
30892139|NCT02247531|58925476|FG001|Overall Study|Non-compliance|2|||
30892140|NCT02247531|58925477|FG002|Overall Study|Non-compliance|0|||
30892141|NCT02247531|58925475|FG000|Overall Study|Withdrawal by Subject|26|||
30892142|NCT02247531|58925476|FG001|Overall Study|Withdrawal by Subject|31|||
30892143|NCT02247531|58925477|FG002|Overall Study|Withdrawal by Subject|25|||
30892144|NCT02247531|58925475|FG000|Overall Study|Study Terminated by Sponsor|64|||
30892145|NCT02247531|58925476|FG001|Overall Study|Study Terminated by Sponsor|66|||
30892146|NCT02247531|58925477|FG002|Overall Study|Study Terminated by Sponsor|62|||
30892147|NCT02247531|58925475|FG000|Overall Study|Physician Decision|0|||
30892148|NCT02247531|58925476|FG001|Overall Study|Physician Decision|2|||
30892149|NCT02247531|58925477|FG002|Overall Study|Physician Decision|2|||
30892150|NCT02247531|58925475|FG000|Overall Study|Unspecified Reason|2|||
30892151|NCT02247531|58925476|FG001|Overall Study|Unspecified Reason|3|||
30892152|NCT02247531|58925477|FG002|Overall Study|Unspecified Reason|4|||
30892153|NCT02375971|58925488|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
30892154|NCT02375971|58925489|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
30892155|NCT02375971|58925490|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
30892156|NCT02375971|58925488|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
30892157|NCT02375971|58925489|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
30892158|NCT02375971|58925490|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
30892159|NCT02375971|58925488|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
30892160|NCT02375971|58925489|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
30892161|NCT02375971|58925490|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
30892162|NCT02375971|58925488|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
30892163|NCT02375971|58925489|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
30892164|NCT02375971|58925490|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
30892165|NCT02375971|58925488|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
30892166|NCT02375971|58925489|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
30892167|NCT02375971|58925490|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
30892168|NCT02375971|58925488|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
30892169|NCT02375971|58925489|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
30892170|NCT02375971|58925490|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
30892171|NCT02375971|58925488|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
30892172|NCT02375971|58925489|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
30892173|NCT02375971|58925490|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
30892174|NCT02375971|58925488|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
30892175|NCT02375971|58925489|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
30892176|NCT02375971|58925490|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
30892177|NCT02308735|58925502|FG000|Overall Study|Physician Decision|2|||
30892178|NCT02308735|58925503|FG001|Overall Study|Physician Decision|0|||
30892179|NCT02308735|58925504|FG002|Overall Study|Physician Decision|0|||
30892180|NCT02308735|58925505|FG003|Overall Study|Physician Decision|2|||
30999822|NCT02027844|59198579|FG002|Overall Study|Protocol Violation|0|||
30999823|NCT02027844|59198577|FG000|Overall Study|Incomlete data|2|||
30999824|NCT02027844|59198578|FG001|Overall Study|Incomlete data|0|||
30999825|NCT02027844|59198579|FG002|Overall Study|Incomlete data|0|||
30999826|NCT01994382|59198604|FG000|Overall Study|Informed consent withdrawn|0|||
30892181|NCT02212197|58925518|FG000|Overall Study|Need for radiotherapy|1|||
30892182|NCT02212197|58925519|FG001|Overall Study|Need for radiotherapy|0|||
30892183|NCT02212197|58925520|FG002|Overall Study|Need for radiotherapy|0|||
30892184|NCT02193165|58925531|FG000|4 Week Product Use|Lost to Follow-up|1|||
30892185|NCT02193165|58925532|FG001|4 Week Product Use|Lost to Follow-up|1|||
30892186|NCT02193165|58925533|FG002|4 Week Product Use|Lost to Follow-up|1|||
30892187|NCT02193165|58925531|FG000|6 Week Product Use|Lost to Follow-up|0|||
30892188|NCT02193165|58925532|FG001|6 Week Product Use|Lost to Follow-up|1|||
30892189|NCT02193165|58925533|FG002|6 Week Product Use|Lost to Follow-up|0|||
30892190|NCT01617460|58925541|FG000|Overall Study|Adverse Event|10|||
30892191|NCT01617460|58925541|FG000|Overall Study|Physician Decision|16|||
30892192|NCT01617460|58925541|FG000|Overall Study|Protocol Violation|5|||
30892193|NCT01617460|58925541|FG000|Overall Study|Withdrawal by Subject|9|||
30892194|NCT01890148|58925545|FG000|Overall Study|Adverse Event|1|||
30892195|NCT01889602|58925552|FG000|First Intervention|Adverse Event|1|||
30892196|NCT01889602|58925553|FG001|First Intervention|Adverse Event|1|||
30892197|NCT01889602|58925554|FG002|First Intervention|Adverse Event|1|||
30892198|NCT01889602|58925552|FG000|First Intervention|Protocol Violation|0|||
30892199|NCT01889602|58925553|FG001|First Intervention|Protocol Violation|1|||
30892200|NCT01889602|58925554|FG002|First Intervention|Protocol Violation|1|||
30892201|NCT01889602|58925552|FG000|First Intervention|Study ending|0|||
30892202|NCT01889602|58925553|FG001|First Intervention|Study ending|1|||
30892203|NCT01889602|58925554|FG002|First Intervention|Study ending|0|||
30892204|NCT01889602|58925552|FG000|Second Intervention|Adverse Event|0|||
30892205|NCT01889602|58925553|FG001|Second Intervention|Adverse Event|0|||
30892206|NCT01889602|58925554|FG002|Second Intervention|Adverse Event|1|||
30892207|NCT01889602|58925552|FG000|Second Intervention|Study ending|1|||
30892208|NCT01889602|58925553|FG001|Second Intervention|Study ending|0|||
30892209|NCT01889602|58925554|FG002|Second Intervention|Study ending|0|||
30892210|NCT01889602|58925552|FG000|Second Intervention|Withdrawal by Subject|0|||
30892211|NCT01889602|58925553|FG001|Second Intervention|Withdrawal by Subject|0|||
30892212|NCT01889602|58925554|FG002|Second Intervention|Withdrawal by Subject|1|||
30892213|NCT01889602|58925552|FG000|Third Intervention|Protocol Violation|1|||
30892214|NCT01889602|58925553|FG001|Third Intervention|Protocol Violation|0|||
30892215|NCT01889602|58925554|FG002|Third Intervention|Protocol Violation|0|||
30892216|NCT01889602|58925552|FG000|Third Intervention|Withdrawal by Subject|2|||
30892217|NCT01889602|58925553|FG001|Third Intervention|Withdrawal by Subject|2|||
30892218|NCT01889602|58925554|FG002|Third Intervention|Withdrawal by Subject|0|||
30892219|NCT01935700|58925572|FG000|Overall Study|Withdrawal by Subject|1|||
30892220|NCT01935700|58925573|FG001|Overall Study|Withdrawal by Subject|0|||
30892221|NCT01935700|58925572|FG000|Overall Study|Physician Decision|4|||
30892222|NCT01935700|58925573|FG001|Overall Study|Physician Decision|0|||
30892223|NCT01618162|58925583|FG000|Overall Study|Protocol Violation|13|||
30892224|NCT01618162|58925584|FG001|Overall Study|Protocol Violation|10|||
30892225|NCT01618162|58925583|FG000|Overall Study|Adverse Event|9|||
30892226|NCT01618162|58925584|FG001|Overall Study|Adverse Event|2|||
30892227|NCT01618162|58925583|FG000|Overall Study|Withdrawal Criteria|2|||
30892228|NCT01618162|58925584|FG001|Overall Study|Withdrawal Criteria|10|||
30892229|NCT01618162|58925583|FG000|Overall Study|Unclassified|14|||
30892230|NCT01618162|58925584|FG001|Overall Study|Unclassified|13|||
30892231|NCT02193087|58925594|FG000|Overall Study|Adverse Event|2|||
30892232|NCT02193087|58925595|FG001|Overall Study|Adverse Event|0|||
30892233|NCT02193087|58925596|FG002|Overall Study|Adverse Event|0|||
30892234|NCT02193087|58925597|FG003|Overall Study|Adverse Event|11|||
30892235|NCT02193087|58925594|FG000|Overall Study|Lost to Follow-up|14|||
30892236|NCT02193087|58925595|FG001|Overall Study|Lost to Follow-up|6|||
30892237|NCT02193087|58925596|FG002|Overall Study|Lost to Follow-up|4|||
30892238|NCT02193087|58925597|FG003|Overall Study|Lost to Follow-up|37|||
30892239|NCT02193087|58925594|FG000|Overall Study|Protocol Violation|2|||
30892240|NCT02193087|58925595|FG001|Overall Study|Protocol Violation|0|||
30892241|NCT02193087|58925596|FG002|Overall Study|Protocol Violation|1|||
30892242|NCT02193087|58925597|FG003|Overall Study|Protocol Violation|2|||
30892243|NCT02193087|58925594|FG000|Overall Study|Withdrawal by Subject|10|||
30892244|NCT02193087|58925595|FG001|Overall Study|Withdrawal by Subject|3|||
30892245|NCT02193087|58925596|FG002|Overall Study|Withdrawal by Subject|1|||
30892246|NCT02193087|58925597|FG003|Overall Study|Withdrawal by Subject|19|||
30892247|NCT02193087|58925594|FG000|Overall Study|Other Reason Not Specified|7|||
30892248|NCT02193087|58925595|FG001|Overall Study|Other Reason Not Specified|2|||
30892249|NCT02193087|58925596|FG002|Overall Study|Other Reason Not Specified|1|||
30892250|NCT02193087|58925597|FG003|Overall Study|Other Reason Not Specified|9|||
30892251|NCT02193087|58925594|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
30892252|NCT02193087|58925595|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
30892253|NCT02193087|58925596|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
30892254|NCT02193087|58925597|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
30892255|NCT01617070|58925614|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
30892256|NCT02341417|58925627|FG000|Overall Study|Withdrawal by Subject|0|||
30892257|NCT02341417|58925628|FG001|Overall Study|Withdrawal by Subject|2|||
30892258|NCT02341417|58925629|FG002|Overall Study|Withdrawal by Subject|0|||
30892259|NCT02341417|58925627|FG000|Overall Study|Decision by sponsor|2|||
30892260|NCT02341417|58925628|FG001|Overall Study|Decision by sponsor|0|||
30892261|NCT02341417|58925629|FG002|Overall Study|Decision by sponsor|0|||
30892262|NCT02341417|58925627|FG000|Overall Study|Death|0|||
30892263|NCT02341417|58925628|FG001|Overall Study|Death|0|||
30892264|NCT02341417|58925629|FG002|Overall Study|Death|1|||
30892265|NCT01888900|58925640|FG000|Overall Study|failed treatment|0|||
30892266|NCT01888900|58925641|FG001|Overall Study|failed treatment|2|||
30892267|NCT02340949|58925651|FG000|Overall Study|Adverse Event|4|||
30892268|NCT02340949|58925652|FG001|Overall Study|Adverse Event|2|||
30892269|NCT02340949|58925651|FG000|Overall Study|Withdrawal by Subject|2|||
30892270|NCT02340949|58925652|FG001|Overall Study|Withdrawal by Subject|0|||
30892271|NCT02340949|58925651|FG000|Overall Study|Progression disease|6|||
30892272|NCT02340949|58925652|FG001|Overall Study|Progression disease|2|||
30892273|NCT02340949|58925651|FG000|Overall Study|Death|3|||
30892274|NCT02340949|58925652|FG001|Overall Study|Death|0|||
30892275|NCT02340949|58925651|FG000|Overall Study|Physician Decision|1|||
30892276|NCT02340949|58925652|FG001|Overall Study|Physician Decision|0|||
30892277|NCT01646203|58925661|FG000|Overall Study|Adverse Event|2|||
30892278|NCT01646203|58925662|FG001|Overall Study|Adverse Event|0|||
30892279|NCT01646203|58925663|FG002|Overall Study|Adverse Event|1|||
30892280|NCT01646203|58925661|FG000|Overall Study|Withdrawal by Subject|0|||
30892281|NCT01646203|58925662|FG001|Overall Study|Withdrawal by Subject|1|||
30892282|NCT01646203|58925663|FG002|Overall Study|Withdrawal by Subject|0|||
30892283|NCT01646203|58925661|FG000|Overall Study|Physician's Decision|0|||
30892284|NCT01646203|58925662|FG001|Overall Study|Physician's Decision|1|||
30892285|NCT01646203|58925663|FG002|Overall Study|Physician's Decision|0|||
30892286|NCT02375347|58925676|FG000|Overall Study|Protocol Violation|1|||
30892287|NCT02374957|58925682|FG000|Overall Study|Patient did not complete forms correctly|1|||
30892288|NCT02374957|58925683|FG001|Overall Study|Patient did not complete forms correctly|0|||
30892289|NCT02374255|58925693|FG000|Overall Study|Withdrawal by Subject|2|||
30892290|NCT02374255|58925694|FG001|Overall Study|Withdrawal by Subject|0|||
30892291|NCT02374255|58925695|FG002|Overall Study|Withdrawal by Subject|0|||
30892292|NCT02374255|58925696|FG003|Overall Study|Withdrawal by Subject|0|||
30892293|NCT02308033|58925714|FG000|Overall Study|Normal Gram stain at Baseline|13|||
30892294|NCT02308033|58925715|FG001|Overall Study|Normal Gram stain at Baseline|10|||
30892295|NCT02308033|58925714|FG000|Overall Study|Positive for STD at Baseline|7|||
30892296|NCT02308033|58925715|FG001|Overall Study|Positive for STD at Baseline|4|||
30892297|NCT02308033|58925714|FG000|Overall Study|Lost to Follow-up|6|||
30892298|NCT02308033|58925715|FG001|Overall Study|Lost to Follow-up|5|||
30892299|NCT02339155|58925723|FG000|Overall Study|Adverse Event|0|||
30892300|NCT02339155|58925724|FG001|Overall Study|Adverse Event|6|||
30892301|NCT02339155|58925723|FG000|Overall Study|Death|1|||
30892302|NCT02339155|58925724|FG001|Overall Study|Death|1|||
30892303|NCT02339155|58925723|FG000|Overall Study|Lost to Follow-up|8|||
30892304|NCT02339155|58925724|FG001|Overall Study|Lost to Follow-up|9|||
30892305|NCT02339155|58925723|FG000|Overall Study|Physician Decision|2|||
30892306|NCT02339155|58925724|FG001|Overall Study|Physician Decision|1|||
30892307|NCT02339155|58925723|FG000|Overall Study|Withdrawal by Subject|4|||
30892308|NCT02339155|58925724|FG001|Overall Study|Withdrawal by Subject|4|||
30892309|NCT02211261|58925743|FG000|Overall Study|Withdrawal by Subject|0|||
30892310|NCT02211261|58925744|FG001|Overall Study|Withdrawal by Subject|0|||
30892311|NCT02211261|58925745|FG002|Overall Study|Withdrawal by Subject|1|||
30892312|NCT02211261|58925746|FG003|Overall Study|Withdrawal by Subject|0|||
30892313|NCT02211261|58925747|FG004|Overall Study|Withdrawal by Subject|2|||
30892314|NCT02211261|58925748|FG005|Overall Study|Withdrawal by Subject|0|||
30892315|NCT02211261|58925749|FG006|Overall Study|Withdrawal by Subject|0|||
30892316|NCT02211261|58925750|FG007|Overall Study|Withdrawal by Subject|0|||
30892317|NCT02211261|58925751|FG008|Overall Study|Withdrawal by Subject|0|||
30892318|NCT02211261|58925752|FG009|Overall Study|Withdrawal by Subject|0|||
30892319|NCT02211261|58925753|FG010|Overall Study|Withdrawal by Subject|0|||
30892320|NCT02211261|58925743|FG000|Overall Study|Other|0|||
30892321|NCT02211261|58925744|FG001|Overall Study|Other|0|||
30892322|NCT02211261|58925745|FG002|Overall Study|Other|0|||
30892323|NCT02211261|58925746|FG003|Overall Study|Other|0|||
30892324|NCT02211261|58925747|FG004|Overall Study|Other|0|||
30892325|NCT02211261|58925748|FG005|Overall Study|Other|1|||
30892326|NCT02211261|58925749|FG006|Overall Study|Other|0|||
30892327|NCT02211261|58925750|FG007|Overall Study|Other|0|||
30892328|NCT02211261|58925751|FG008|Overall Study|Other|0|||
30892329|NCT02211261|58925752|FG009|Overall Study|Other|2|||
30892330|NCT02211261|58925753|FG010|Overall Study|Other|0|||
30999827|NCT01994382|59198605|FG001|Overall Study|Informed consent withdrawn|0|||
30999828|NCT01994382|59198606|FG002|Overall Study|Informed consent withdrawn|0|||
30999829|NCT01994382|59198607|FG003|Overall Study|Informed consent withdrawn|0|||
30892331|NCT02211261|58925743|FG000|Overall Study|Lost to Follow-up|0|||
30892332|NCT02211261|58925744|FG001|Overall Study|Lost to Follow-up|0|||
30892333|NCT02211261|58925745|FG002|Overall Study|Lost to Follow-up|0|||
30892334|NCT02211261|58925746|FG003|Overall Study|Lost to Follow-up|0|||
30892335|NCT02211261|58925747|FG004|Overall Study|Lost to Follow-up|0|||
30892336|NCT02211261|58925748|FG005|Overall Study|Lost to Follow-up|0|||
30892337|NCT02211261|58925749|FG006|Overall Study|Lost to Follow-up|0|||
30892338|NCT02211261|58925750|FG007|Overall Study|Lost to Follow-up|1|||
30892339|NCT02211261|58925751|FG008|Overall Study|Lost to Follow-up|0|||
30892340|NCT02211261|58925752|FG009|Overall Study|Lost to Follow-up|0|||
30892341|NCT02211261|58925753|FG010|Overall Study|Lost to Follow-up|0|||
30892342|NCT02170077|58925789|FG000|Overall Study|Withdrawal by Subject|3|||
30892343|NCT02170077|58925790|FG001|Overall Study|Withdrawal by Subject|4|||
30892344|NCT02170077|58925791|FG002|Overall Study|Withdrawal by Subject|2|||
30892345|NCT02170077|58925789|FG000|Overall Study|Adverse Event|4|||
30892346|NCT02170077|58925790|FG001|Overall Study|Adverse Event|4|||
30892347|NCT02170077|58925791|FG002|Overall Study|Adverse Event|4|||
30892348|NCT02170077|58925789|FG000|Overall Study|Lost to Follow-up|0|||
30892349|NCT02170077|58925790|FG001|Overall Study|Lost to Follow-up|1|||
30892350|NCT02170077|58925791|FG002|Overall Study|Lost to Follow-up|0|||
30892351|NCT02170077|58925789|FG000|Overall Study|Exclusion criteria|2|||
30892352|NCT02170077|58925790|FG001|Overall Study|Exclusion criteria|2|||
30892353|NCT02170077|58925791|FG002|Overall Study|Exclusion criteria|5|||
30892354|NCT02170077|58925789|FG000|Overall Study|Exacerbation of seizures|0|||
30892355|NCT02170077|58925790|FG001|Overall Study|Exacerbation of seizures|2|||
30892356|NCT02170077|58925791|FG002|Overall Study|Exacerbation of seizures|1|||
30892357|NCT02210091|58925801|FG000|Overall Study|Physician Decision|0|||
30892358|NCT02210091|58925802|FG001|Overall Study|Physician Decision|1|||
30892359|NCT02210091|58925801|FG000|Overall Study|Withdrawal by Sponsor|0|||
30892360|NCT02210091|58925802|FG001|Overall Study|Withdrawal by Sponsor|1|||
30892361|NCT02338999|58925826|FG000|First Intervention|Withdrawal by Subject|3|||
30892362|NCT02338999|58925827|FG001|First Intervention|Withdrawal by Subject|1|||
30892363|NCT02338999|58925826|FG000|Washout Period|Withdrawal by Subject|0|||
30892364|NCT02338999|58925827|FG001|Washout Period|Withdrawal by Subject|2|||
30892365|NCT02338999|58925826|FG000|Second Intervention|Withdrawal by Subject|0|||
30892366|NCT02338999|58925827|FG001|Second Intervention|Withdrawal by Subject|2|||
30892367|NCT02169219|58925833|FG000|Overall Study|Lack of Efficacy|6|||
30892368|NCT02191605|58925847|FG000|Overall Study|Lost to Follow-up|9|||
30892369|NCT02191605|58925848|FG001|Overall Study|Lost to Follow-up|4|||
30892370|NCT02191605|58925849|FG002|Overall Study|Lost to Follow-up|7|||
30892371|NCT02191605|58925850|FG003|Overall Study|Lost to Follow-up|3|||
30892372|NCT02191605|58925851|FG004|Overall Study|Lost to Follow-up|4|||
30892373|NCT02191137|58925863|FG000|Treatment|Death|4|||
30892374|NCT02191137|58925863|FG000|Treatment|Withdrawal by Subject|3|||
30892375|NCT02191137|58925863|FG000|Treatment|Adverse Event|2|||
30892376|NCT02191137|58925863|FG000|Treatment|Other|1|||
30892377|NCT02191137|58925863|FG000|Follow-up|Lost to Follow-up|2|||
30892378|NCT02191137|58925863|FG000|Follow-up|Ongoing/unknown|2|||
30892379|NCT02191137|58925863|FG000|Follow-up|Adverse Event|1|||
30892380|NCT02168439|58925869|FG000|Overall Study|Protocol Violation|0|||
30892381|NCT02168439|58925870|FG001|Overall Study|Protocol Violation|2|||
30892382|NCT02190591|58925878|FG000|Overall Study|Withdrawal by Subject|1|||
30892383|NCT02190591|58925879|FG001|Overall Study|Withdrawal by Subject|8|||
30892384|NCT02190591|58925878|FG000|Overall Study|Protocol Violation|1|||
30892385|NCT02190591|58925879|FG001|Overall Study|Protocol Violation|0|||
30892386|NCT02190591|58925878|FG000|Overall Study|did not use peanut ball as instructed|0|||
30892387|NCT02190591|58925879|FG001|Overall Study|did not use peanut ball as instructed|2|||
30892388|NCT02190591|58925878|FG000|Overall Study|face presentation so she was ineligible|0|||
30892389|NCT02190591|58925879|FG001|Overall Study|face presentation so she was ineligible|1|||
30892390|NCT02190435|58925887|FG000|Overall Study|First 12 patients were lead-ins|12|||
30892391|NCT02190435|58925888|FG001|Overall Study|First 12 patients were lead-ins|0|||
30892392|NCT02190435|58925887|FG000|Overall Study|3 consented screen fails|3|||
30892393|NCT02190435|58925888|FG001|Overall Study|3 consented screen fails|0|||
30892394|NCT02338843|58925896|FG000|Overall Study|Adverse Event|2|||
30892395|NCT02338843|58925897|FG001|Overall Study|Adverse Event|1|||
30892396|NCT02338843|58925896|FG000|Overall Study|Death|40|||
30892397|NCT02338843|58925897|FG001|Overall Study|Death|53|||
30892398|NCT02338843|58925896|FG000|Overall Study|Physician Decision|1|||
30892399|NCT02338843|58925897|FG001|Overall Study|Physician Decision|0|||
30892400|NCT02338843|58925896|FG000|Overall Study|Withdrawal by Subject|0|||
30892401|NCT02338843|58925897|FG001|Overall Study|Withdrawal by Subject|2|||
30892402|NCT02338843|58925896|FG000|Overall Study|Subject Recovered|0|||
30892403|NCT02338843|58925897|FG001|Overall Study|Subject Recovered|2|||
30892404|NCT02338843|58925896|FG000|Overall Study|Discontinued prior to randomizat|1|||
30892405|NCT02338843|58925897|FG001|Overall Study|Discontinued prior to randomizat|0|||
30999830|NCT01994382|59198608|FG004|Overall Study|Informed consent withdrawn|0|||
30999831|NCT01994382|59198609|FG005|Overall Study|Informed consent withdrawn|0|||
30999832|NCT01994382|59198610|FG006|Overall Study|Informed consent withdrawn|1|||
30999833|NCT01994382|59198611|FG007|Overall Study|Informed consent withdrawn|0|||
30892406|NCT02190279|58925906|FG000|Overall Study|Withdrawal consent|1|||
30892407|NCT02190279|58925907|FG001|Overall Study|Withdrawal consent|0|||
30892408|NCT02190279|58925908|FG002|Overall Study|Withdrawal consent|1|||
30892409|NCT02190279|58925906|FG000|Overall Study|Lost to Follow-up|2|||
30892410|NCT02190279|58925907|FG001|Overall Study|Lost to Follow-up|0|||
30892411|NCT02190279|58925908|FG002|Overall Study|Lost to Follow-up|0|||
30892412|NCT02190279|58925906|FG000|Overall Study|Refused further treatment|0|||
30892413|NCT02190279|58925907|FG001|Overall Study|Refused further treatment|0|||
30892414|NCT02190279|58925908|FG002|Overall Study|Refused further treatment|1|||
30892415|NCT02190279|58925906|FG000|Overall Study|Screening failure|0|||
30892416|NCT02190279|58925907|FG001|Overall Study|Screening failure|0|||
30999834|NCT01994382|59198612|FG008|Overall Study|Informed consent withdrawn|0|||
30999835|NCT01994382|59198613|FG009|Overall Study|Informed consent withdrawn|0|||
30999836|NCT01994382|59198614|FG010|Overall Study|Informed consent withdrawn|0|||
30999837|NCT01994382|59198615|FG011|Overall Study|Informed consent withdrawn|0|||
30999838|NCT01994382|59198616|FG012|Overall Study|Informed consent withdrawn|0|||
30999839|NCT01994382|59198617|FG013|Overall Study|Informed consent withdrawn|0|||
30999840|NCT01994382|59198618|FG014|Overall Study|Informed consent withdrawn|0|||
30999841|NCT01994382|59198619|FG015|Overall Study|Informed consent withdrawn|0|||
30999842|NCT01994382|59198620|FG016|Overall Study|Informed consent withdrawn|0|||
30999843|NCT01994382|59198604|FG000|Overall Study|Progressive disease|3|||
30999844|NCT01994382|59198605|FG001|Overall Study|Progressive disease|4|||
30999845|NCT01994382|59198606|FG002|Overall Study|Progressive disease|4|||
30999846|NCT01994382|59198607|FG003|Overall Study|Progressive disease|3|||
30999847|NCT01994382|59198608|FG004|Overall Study|Progressive disease|2|||
30999848|NCT01994382|59198609|FG005|Overall Study|Progressive disease|3|||
30999849|NCT01994382|59198610|FG006|Overall Study|Progressive disease|3|||
30999850|NCT01994382|59198611|FG007|Overall Study|Progressive disease|6|||
30999851|NCT01994382|59198612|FG008|Overall Study|Progressive disease|2|||
30999852|NCT01994382|59198613|FG009|Overall Study|Progressive disease|2|||
30609025|NCT00963547|58619881|FG004|Overall Study|Reason Unknown|0|||
30999853|NCT01994382|59198614|FG010|Overall Study|Progressive disease|13|||
30999854|NCT01994382|59198615|FG011|Overall Study|Progressive disease|8|||
30999855|NCT01994382|59198616|FG012|Overall Study|Progressive disease|7|||
30999856|NCT01994382|59198617|FG013|Overall Study|Progressive disease|3|||
30999857|NCT01994382|59198618|FG014|Overall Study|Progressive disease|6|||
30999858|NCT01994382|59198619|FG015|Overall Study|Progressive disease|44|||
30999859|NCT01994382|59198620|FG016|Overall Study|Progressive disease|28|||
30999860|NCT01994382|59198604|FG000|Overall Study|Physician Decision|0|||
30999861|NCT01994382|59198605|FG001|Overall Study|Physician Decision|1|||
30999862|NCT01994382|59198606|FG002|Overall Study|Physician Decision|0|||
30999863|NCT01994382|59198607|FG003|Overall Study|Physician Decision|0|||
30999864|NCT01994382|59198608|FG004|Overall Study|Physician Decision|0|||
30999865|NCT01994382|59198609|FG005|Overall Study|Physician Decision|0|||
30999866|NCT01994382|59198610|FG006|Overall Study|Physician Decision|0|||
30999867|NCT01994382|59198611|FG007|Overall Study|Physician Decision|0|||
30999868|NCT01994382|59198612|FG008|Overall Study|Physician Decision|0|||
30999869|NCT01994382|59198613|FG009|Overall Study|Physician Decision|0|||
30999870|NCT01994382|59198614|FG010|Overall Study|Physician Decision|3|||
30999871|NCT01994382|59198615|FG011|Overall Study|Physician Decision|1|||
30999872|NCT01994382|59198616|FG012|Overall Study|Physician Decision|1|||
30999873|NCT01994382|59198617|FG013|Overall Study|Physician Decision|0|||
30999874|NCT01994382|59198618|FG014|Overall Study|Physician Decision|1|||
30999875|NCT01994382|59198619|FG015|Overall Study|Physician Decision|4|||
30999876|NCT01994382|59198620|FG016|Overall Study|Physician Decision|2|||
30999877|NCT01994382|59198604|FG000|Overall Study|Death|0|||
30999878|NCT01994382|59198605|FG001|Overall Study|Death|0|||
30999879|NCT01994382|59198606|FG002|Overall Study|Death|0|||
30999880|NCT01994382|59198607|FG003|Overall Study|Death|0|||
30999881|NCT01994382|59198608|FG004|Overall Study|Death|1|||
30999882|NCT01994382|59198609|FG005|Overall Study|Death|0|||
30999883|NCT01994382|59198610|FG006|Overall Study|Death|0|||
30999884|NCT01994382|59198611|FG007|Overall Study|Death|0|||
30999885|NCT01994382|59198612|FG008|Overall Study|Death|1|||
30999886|NCT01994382|59198613|FG009|Overall Study|Death|1|||
30999887|NCT01994382|59198614|FG010|Overall Study|Death|0|||
30999888|NCT01994382|59198615|FG011|Overall Study|Death|0|||
30999889|NCT01994382|59198616|FG012|Overall Study|Death|0|||
30999890|NCT01994382|59198617|FG013|Overall Study|Death|0|||
30999891|NCT01994382|59198618|FG014|Overall Study|Death|0|||
30999892|NCT01994382|59198619|FG015|Overall Study|Death|1|||
30999893|NCT01994382|59198620|FG016|Overall Study|Death|0|||
30999894|NCT01994382|59198604|FG000|Overall Study|Adverse Event|0|||
30999895|NCT01994382|59198605|FG001|Overall Study|Adverse Event|1|||
30999896|NCT01994382|59198606|FG002|Overall Study|Adverse Event|2|||
30999897|NCT01994382|59198607|FG003|Overall Study|Adverse Event|0|||
30999898|NCT01994382|59198608|FG004|Overall Study|Adverse Event|0|||
30609026|NCT00963547|58619882|FG005|Overall Study|Reason Unknown|0|||
30999899|NCT01994382|59198609|FG005|Overall Study|Adverse Event|0|||
30999900|NCT01994382|59198610|FG006|Overall Study|Adverse Event|0|||
30999901|NCT01994382|59198611|FG007|Overall Study|Adverse Event|0|||
30999902|NCT01994382|59198612|FG008|Overall Study|Adverse Event|0|||
30999903|NCT01994382|59198613|FG009|Overall Study|Adverse Event|0|||
30999904|NCT01994382|59198614|FG010|Overall Study|Adverse Event|15|||
30999905|NCT01994382|59198615|FG011|Overall Study|Adverse Event|2|||
30999906|NCT01994382|59198616|FG012|Overall Study|Adverse Event|7|||
30999907|NCT01994382|59198617|FG013|Overall Study|Adverse Event|3|||
30999908|NCT01994382|59198618|FG014|Overall Study|Adverse Event|17|||
30999909|NCT01994382|59198619|FG015|Overall Study|Adverse Event|6|||
30609027|NCT00963547|58619883|FG006|Overall Study|Reason Unknown|0|||
30999910|NCT01994382|59198620|FG016|Overall Study|Adverse Event|3|||
30999911|NCT01994382|59198604|FG000|Overall Study|Other than specified|0|||
30999912|NCT01994382|59198605|FG001|Overall Study|Other than specified|0|||
30999913|NCT01994382|59198606|FG002|Overall Study|Other than specified|0|||
30999914|NCT01994382|59198607|FG003|Overall Study|Other than specified|0|||
30999915|NCT01994382|59198608|FG004|Overall Study|Other than specified|0|||
30999916|NCT01994382|59198609|FG005|Overall Study|Other than specified|0|||
30999917|NCT01994382|59198610|FG006|Overall Study|Other than specified|0|||
30999918|NCT01994382|59198611|FG007|Overall Study|Other than specified|0|||
30999919|NCT01994382|59198612|FG008|Overall Study|Other than specified|0|||
30999920|NCT01994382|59198613|FG009|Overall Study|Other than specified|0|||
30999921|NCT01994382|59198614|FG010|Overall Study|Other than specified|2|||
30999922|NCT01994382|59198615|FG011|Overall Study|Other than specified|0|||
30999923|NCT01994382|59198616|FG012|Overall Study|Other than specified|2|||
30999924|NCT01994382|59198617|FG013|Overall Study|Other than specified|0|||
30999925|NCT01994382|59198618|FG014|Overall Study|Other than specified|0|||
30999926|NCT01994382|59198619|FG015|Overall Study|Other than specified|4|||
30999927|NCT01994382|59198620|FG016|Overall Study|Other than specified|4|||
30999928|NCT01994382|59198604|FG000|Overall Study|Withdrawal by Subject|0|||
30999929|NCT01994382|59198605|FG001|Overall Study|Withdrawal by Subject|0|||
30999930|NCT01994382|59198606|FG002|Overall Study|Withdrawal by Subject|0|||
30999931|NCT01994382|59198607|FG003|Overall Study|Withdrawal by Subject|0|||
30999932|NCT01994382|59198608|FG004|Overall Study|Withdrawal by Subject|0|||
30999933|NCT01994382|59198609|FG005|Overall Study|Withdrawal by Subject|0|||
30999934|NCT01994382|59198610|FG006|Overall Study|Withdrawal by Subject|0|||
30999935|NCT01994382|59198611|FG007|Overall Study|Withdrawal by Subject|0|||
30999936|NCT01994382|59198612|FG008|Overall Study|Withdrawal by Subject|0|||
30999937|NCT01994382|59198613|FG009|Overall Study|Withdrawal by Subject|0|||
30999938|NCT01994382|59198614|FG010|Overall Study|Withdrawal by Subject|6|||
30999939|NCT01994382|59198615|FG011|Overall Study|Withdrawal by Subject|0|||
30999940|NCT01994382|59198616|FG012|Overall Study|Withdrawal by Subject|2|||
30999941|NCT01994382|59198617|FG013|Overall Study|Withdrawal by Subject|0|||
30999942|NCT01994382|59198618|FG014|Overall Study|Withdrawal by Subject|4|||
30999943|NCT01994382|59198619|FG015|Overall Study|Withdrawal by Subject|3|||
30999944|NCT01994382|59198620|FG016|Overall Study|Withdrawal by Subject|0|||
30999945|NCT01994382|59198604|FG000|Overall Study|Lost to Follow-up|0|||
30999946|NCT01994382|59198605|FG001|Overall Study|Lost to Follow-up|0|||
30999947|NCT01994382|59198606|FG002|Overall Study|Lost to Follow-up|0|||
30999948|NCT01994382|59198607|FG003|Overall Study|Lost to Follow-up|0|||
30999949|NCT01994382|59198608|FG004|Overall Study|Lost to Follow-up|0|||
30999950|NCT01994382|59198609|FG005|Overall Study|Lost to Follow-up|0|||
30999951|NCT01994382|59198610|FG006|Overall Study|Lost to Follow-up|0|||
30999952|NCT01994382|59198611|FG007|Overall Study|Lost to Follow-up|0|||
30999953|NCT01994382|59198612|FG008|Overall Study|Lost to Follow-up|0|||
30999954|NCT01994382|59198613|FG009|Overall Study|Lost to Follow-up|0|||
30999955|NCT01994382|59198614|FG010|Overall Study|Lost to Follow-up|1|||
30999956|NCT01994382|59198615|FG011|Overall Study|Lost to Follow-up|0|||
30999957|NCT01994382|59198616|FG012|Overall Study|Lost to Follow-up|0|||
30999958|NCT01994382|59198617|FG013|Overall Study|Lost to Follow-up|0|||
30999959|NCT01994382|59198618|FG014|Overall Study|Lost to Follow-up|0|||
30999960|NCT01994382|59198619|FG015|Overall Study|Lost to Follow-up|0|||
30999961|NCT01994382|59198620|FG016|Overall Study|Lost to Follow-up|0|||
30999962|NCT01994382|59198604|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999963|NCT01994382|59198605|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999964|NCT01994382|59198606|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999965|NCT01994382|59198607|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999966|NCT01994382|59198608|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999967|NCT01994382|59198609|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999968|NCT01994382|59198610|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999969|NCT01994382|59198611|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999970|NCT01994382|59198612|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999971|NCT01994382|59198613|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999972|NCT01994382|59198614|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
30999973|NCT01994382|59198615|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999974|NCT01994382|59198616|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
30999975|NCT01994382|59198617|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999976|NCT01994382|59198618|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
30999977|NCT01994382|59198619|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
30999978|NCT01994382|59198620|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
30999979|NCT01994382|59198604|FG000|Overall Study|Protocol violation/noncompliance|0|||
30999980|NCT01994382|59198605|FG001|Overall Study|Protocol violation/noncompliance|0|||
30892417|NCT02190279|58925908|FG002|Overall Study|Screening failure|1|||
30892418|NCT02135445|58925920|FG000|Overall Study|Lost to Follow-up|1|||
30999981|NCT01994382|59198606|FG002|Overall Study|Protocol violation/noncompliance|0|||
30999982|NCT01994382|59198607|FG003|Overall Study|Protocol violation/noncompliance|0|||
30999983|NCT01994382|59198608|FG004|Overall Study|Protocol violation/noncompliance|0|||
30999984|NCT01994382|59198609|FG005|Overall Study|Protocol violation/noncompliance|0|||
30999985|NCT01994382|59198610|FG006|Overall Study|Protocol violation/noncompliance|0|||
30999986|NCT01994382|59198611|FG007|Overall Study|Protocol violation/noncompliance|0|||
30999987|NCT01994382|59198612|FG008|Overall Study|Protocol violation/noncompliance|0|||
30999988|NCT01994382|59198613|FG009|Overall Study|Protocol violation/noncompliance|0|||
30999989|NCT01994382|59198614|FG010|Overall Study|Protocol violation/noncompliance|0|||
30999990|NCT01994382|59198615|FG011|Overall Study|Protocol violation/noncompliance|1|||
30999991|NCT01994382|59198616|FG012|Overall Study|Protocol violation/noncompliance|0|||
30999992|NCT01994382|59198617|FG013|Overall Study|Protocol violation/noncompliance|0|||
30999993|NCT01994382|59198618|FG014|Overall Study|Protocol violation/noncompliance|0|||
30999994|NCT01994382|59198619|FG015|Overall Study|Protocol violation/noncompliance|0|||
30999995|NCT01994382|59198620|FG016|Overall Study|Protocol violation/noncompliance|2|||
30999996|NCT01994382|59198604|FG000|Overall Study|Rolled over to Phase 2a|0|||
30999997|NCT01994382|59198605|FG001|Overall Study|Rolled over to Phase 2a|0|||
30999998|NCT01994382|59198606|FG002|Overall Study|Rolled over to Phase 2a|1|||
30999999|NCT01994382|59198607|FG003|Overall Study|Rolled over to Phase 2a|0|||
31000000|NCT01994382|59198608|FG004|Overall Study|Rolled over to Phase 2a|0|||
31000001|NCT01994382|59198609|FG005|Overall Study|Rolled over to Phase 2a|0|||
31000002|NCT01994382|59198610|FG006|Overall Study|Rolled over to Phase 2a|0|||
31000003|NCT01994382|59198611|FG007|Overall Study|Rolled over to Phase 2a|0|||
31000004|NCT01994382|59198612|FG008|Overall Study|Rolled over to Phase 2a|0|||
31000005|NCT01994382|59198613|FG009|Overall Study|Rolled over to Phase 2a|2|||
31000006|NCT01994382|59198614|FG010|Overall Study|Rolled over to Phase 2a|0|||
31000007|NCT01994382|59198615|FG011|Overall Study|Rolled over to Phase 2a|0|||
31000008|NCT01994382|59198616|FG012|Overall Study|Rolled over to Phase 2a|0|||
31000009|NCT01994382|59198617|FG013|Overall Study|Rolled over to Phase 2a|0|||
31000010|NCT01994382|59198618|FG014|Overall Study|Rolled over to Phase 2a|0|||
31000011|NCT01994382|59198619|FG015|Overall Study|Rolled over to Phase 2a|0|||
31000012|NCT01994382|59198620|FG016|Overall Study|Rolled over to Phase 2a|0|||
31000013|NCT02003898|59198663|FG000|Overall Study|Death|3|||
31000014|NCT02003898|59198663|FG000|Overall Study|Lost to Follow-up|12|||
31000015|NCT02003898|59198663|FG000|Overall Study|Withdrawal by Subject|52|||
31000016|NCT01994226|59198669|FG000|Overall Study|Protocol Violation|13|||
31000017|NCT01994226|59198670|FG001|Overall Study|Protocol Violation|10|||
31000018|NCT01994226|59198669|FG000|Overall Study|Early Cessation of treatment|6|||
31000019|NCT01994226|59198670|FG001|Overall Study|Early Cessation of treatment|11|||
31000020|NCT02002884|59198679|FG000|Main Period (MP)|Other|0|||
31000021|NCT02002884|59198680|FG001|Main Period (MP)|Other|3|||
31000022|NCT02002884|59198681|FG002|Main Period (MP)|Other|3|||
31000023|NCT02002884|59198682|FG003|Main Period (MP)|Other|0|||
31000024|NCT02002884|59198679|FG000|Main Period (MP)|Adverse Event|0|||
31000025|NCT02002884|59198680|FG001|Main Period (MP)|Adverse Event|1|||
31000026|NCT02002884|59198681|FG002|Main Period (MP)|Adverse Event|1|||
31000027|NCT02002884|59198682|FG003|Main Period (MP)|Adverse Event|0|||
31000028|NCT02002884|59198679|FG000|Main Period (MP)|Withdrawal by Subject|6|||
31000029|NCT02002884|59198680|FG001|Main Period (MP)|Withdrawal by Subject|2|||
31000030|NCT02002884|59198681|FG002|Main Period (MP)|Withdrawal by Subject|2|||
31000031|NCT02002884|59198682|FG003|Main Period (MP)|Withdrawal by Subject|0|||
31000032|NCT02002884|59198679|FG000|Main Period (MP)|Lost to Follow-up|0|||
31000033|NCT02002884|59198680|FG001|Main Period (MP)|Lost to Follow-up|0|||
31000034|NCT02002884|59198681|FG002|Main Period (MP)|Lost to Follow-up|2|||
31000035|NCT02002884|59198682|FG003|Main Period (MP)|Lost to Follow-up|0|||
31000036|NCT02002884|59198679|FG000|Open-Label Extension Period (OLEX)|Other|0|||
31000037|NCT02002884|59198680|FG001|Open-Label Extension Period (OLEX)|Other|0|||
31000038|NCT02002884|59198681|FG002|Open-Label Extension Period (OLEX)|Other|0|||
31000039|NCT02002884|59198682|FG003|Open-Label Extension Period (OLEX)|Other|24|||
31000040|NCT02002884|59198679|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
31000041|NCT02002884|59198680|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
31000042|NCT02002884|59198681|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
31000043|NCT02002884|59198682|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
31000044|NCT02002884|59198679|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
31000045|NCT02002884|59198680|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
31000046|NCT02002884|59198681|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
31000047|NCT02002884|59198682|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
31000048|NCT02002884|59198679|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
31000049|NCT02002884|59198680|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
31000050|NCT02002884|59198681|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
31000051|NCT02002884|59198682|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
31000052|NCT02002884|59198679|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
31000053|NCT02002884|59198680|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
31000054|NCT02002884|59198681|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
31000055|NCT02002884|59198682|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
31000056|NCT02002182|59198694|FG000|Overall Study|Withdraw from study|3|||
31000057|NCT02002182|59198695|FG001|Overall Study|Withdraw from study|1|||
31000058|NCT02002182|59198694|FG000|Overall Study|Health Reasons|1|||
31000059|NCT02002182|59198695|FG001|Overall Study|Health Reasons|0|||
31000060|NCT02002182|59198694|FG000|Overall Study|Death|1|||
31000061|NCT02002182|59198695|FG001|Overall Study|Death|0|||
31000062|NCT01990950|59198701|FG000|Overall Study|Death|3|||
31000063|NCT01990950|59198701|FG000|Overall Study|Lost to Follow-up|2|||
31000064|NCT01990950|59198701|FG000|Overall Study|Withdrawal by Subject|6|||
31000065|NCT02001558|59198707|FG000|Overall Study|Lost to Follow-up|8|||
31000066|NCT02001558|59198708|FG001|Overall Study|Lost to Follow-up|14|||
31000067|NCT02023866|59198714|FG000|Overall Study|Non-compliance|2|||
31000068|NCT02023866|59198714|FG000|Overall Study|Adverse Event|3|||
31000069|NCT02023866|59198714|FG000|Overall Study|Withdrawal by Subject|1|||
31000070|NCT02023242|59198720|FG000|Overall Study|Lost to Follow-up|3|||
31000071|NCT02023242|59198721|FG001|Overall Study|Lost to Follow-up|1|||
31000072|NCT02023242|59198720|FG000|Overall Study|Death|0|||
31000073|NCT02023242|59198721|FG001|Overall Study|Death|1|||
31000074|NCT01967940|59198730|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
31000075|NCT01967940|59198731|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
31000076|NCT01967940|59198732|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
31000077|NCT01967940|59198733|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
31000078|NCT01967940|59198730|FG000|Part 2|Adverse Event|0|||
31000079|NCT01967940|59198731|FG001|Part 2|Adverse Event|0|||
31000080|NCT01967940|59198732|FG002|Part 2|Adverse Event|0|||
31000081|NCT01967940|59198733|FG003|Part 2|Adverse Event|1|||
31000082|NCT01967940|59198730|FG000|Part 2|Unknown Reason|0|||
31000083|NCT01967940|59198731|FG001|Part 2|Unknown Reason|0|||
31000084|NCT01967940|59198732|FG002|Part 2|Unknown Reason|0|||
31000085|NCT01967940|59198733|FG003|Part 2|Unknown Reason|1|||
31000086|NCT01990560|59198743|FG000|Overall Study|Withdrawal by Subject|1|||
31000087|NCT01998984|59198751|FG000|Overall Study|Adverse Event|0|||
31000088|NCT01998984|59198752|FG001|Overall Study|Adverse Event|0|||
31000089|NCT01998984|59198753|FG002|Overall Study|Adverse Event|0|||
31000090|NCT01998984|59198754|FG003|Overall Study|Adverse Event|1|||
31000091|NCT01998984|59198751|FG000|Overall Study|Lost to Follow-up|0|||
31000092|NCT01998984|59198752|FG001|Overall Study|Lost to Follow-up|1|||
31000093|NCT01998984|59198753|FG002|Overall Study|Lost to Follow-up|0|||
31000094|NCT01998984|59198754|FG003|Overall Study|Lost to Follow-up|1|||
31000095|NCT01998984|59198751|FG000|Overall Study|Withdrawal by Subject|0|||
31000096|NCT01998984|59198752|FG001|Overall Study|Withdrawal by Subject|0|||
31000097|NCT01998984|59198753|FG002|Overall Study|Withdrawal by Subject|1|||
31000098|NCT01998984|59198754|FG003|Overall Study|Withdrawal by Subject|0|||
31000099|NCT01998984|59198751|FG000|Overall Study|Other|0|||
31000100|NCT01998984|59198752|FG001|Overall Study|Other|0|||
31000101|NCT01998984|59198753|FG002|Overall Study|Other|0|||
31000102|NCT01998984|59198754|FG003|Overall Study|Other|1|||
31000103|NCT01967706|59198766|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
31000104|NCT01967706|59198767|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
31000105|NCT01967706|59198768|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
31000106|NCT01967706|59198769|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
31000107|NCT01967628|59198780|FG000|Overall Study|Withdrawal by Subject|2|||
31000108|NCT01967628|59198781|FG001|Overall Study|Withdrawal by Subject|0|||
31000109|NCT01967628|59198780|FG000|Overall Study|Unable to complete bronchoscopy|4|||
31000110|NCT01967628|59198781|FG001|Overall Study|Unable to complete bronchoscopy|6|||
31000111|NCT01967628|59198780|FG000|Overall Study|Lost to Follow-up|1|||
31000112|NCT01967628|59198781|FG001|Overall Study|Lost to Follow-up|0|||
31000113|NCT01967628|59198780|FG000|Overall Study|Low protein concentration in sample|20|||
31000114|NCT01967628|59198781|FG001|Overall Study|Low protein concentration in sample|25|||
31000115|NCT01998906|59198790|FG000|Overall Study|Participants ongoing in follow-up|77|||
31000116|NCT01998906|59198791|FG001|Overall Study|Participants ongoing in follow-up|60|||
31000117|NCT01998906|59198792|FG002|Overall Study|Participants ongoing in follow-up|58|||
31000118|NCT01998906|59198790|FG000|Overall Study|Death|21|||
31000119|NCT01998906|59198791|FG001|Overall Study|Death|30|||
31000120|NCT01998906|59198792|FG002|Overall Study|Death|17|||
31000121|NCT01998906|59198790|FG000|Overall Study|Lack of Efficacy|10|||
31000122|NCT01998906|59198791|FG001|Overall Study|Lack of Efficacy|9|||
31000123|NCT01998906|59198792|FG002|Overall Study|Lack of Efficacy|8|||
31000124|NCT01998906|59198790|FG000|Overall Study|Failure to return|0|||
31000125|NCT01998906|59198791|FG001|Overall Study|Failure to return|2|||
31000126|NCT01998906|59198792|FG002|Overall Study|Failure to return|4|||
31000127|NCT01998906|59198790|FG000|Overall Study|Violation of Selection Criteria|0|||
31000128|NCT01998906|59198791|FG001|Overall Study|Violation of Selection Criteria|0|||
31000129|NCT01998906|59198792|FG002|Overall Study|Violation of Selection Criteria|1|||
31000130|NCT01998906|59198790|FG000|Overall Study|Withdrawal by Subject|1|||
31000131|NCT01998906|59198791|FG001|Overall Study|Withdrawal by Subject|4|||
31000132|NCT01998906|59198792|FG002|Overall Study|Withdrawal by Subject|3|||
31000133|NCT01998906|59198790|FG000|Overall Study|Administrative/Other|2|||
31000134|NCT01998906|59198791|FG001|Overall Study|Administrative/Other|1|||
31000135|NCT01998906|59198792|FG002|Overall Study|Administrative/Other|3|||
31000136|NCT01998906|59198790|FG000|Overall Study|Other|3|||
31000137|NCT01998906|59198791|FG001|Overall Study|Other|8|||
31000138|NCT01998906|59198792|FG002|Overall Study|Other|4|||
31000139|NCT01967550|59198805|FG000|Overall Study|Withdrawal by Subject|1|||
31000140|NCT01967550|59198806|FG001|Overall Study|Withdrawal by Subject|0|||
31000141|NCT01967550|59198805|FG000|Overall Study|Adverse Event|2|||
31000142|NCT01967550|59198806|FG001|Overall Study|Adverse Event|0|||
31000143|NCT01967550|59198805|FG000|Overall Study|Protocol Violation|2|||
31000144|NCT01967550|59198806|FG001|Overall Study|Protocol Violation|1|||
31000145|NCT01967550|59198805|FG000|Overall Study|Non Compliance|0|||
31000146|NCT01967550|59198806|FG001|Overall Study|Non Compliance|1|||
31000147|NCT01989546|59198812|FG000|Overall Study|Clinical Progression|1|||
31000148|NCT01989546|59198812|FG000|Overall Study|Disease progression on study|8|||
31000149|NCT01997892|59198816|FG000|Overall Study|Physician Decision|2|||
31000150|NCT01997892|59198816|FG000|Overall Study|Lost to Follow-up|6|||
31000151|NCT01997892|59198816|FG000|Overall Study|Death|14|||
31000152|NCT01997892|59198816|FG000|Overall Study|Renal transplant|8|||
31000153|NCT01997892|59198816|FG000|Overall Study|Other|3|||
31000154|NCT01997892|59198816|FG000|Overall Study|Study completion data not recorded|35|||
31000155|NCT01989468|59198828|FG000|Overall Study|Adverse Event|10|||
31000156|NCT01989468|59198829|FG001|Overall Study|Adverse Event|15|||
31000157|NCT01989468|59198830|FG002|Overall Study|Adverse Event|4|||
31000158|NCT01989468|59198831|FG003|Overall Study|Adverse Event|5|||
31000159|NCT01989468|59198832|FG004|Overall Study|Adverse Event|4|||
31000160|NCT01989468|59198828|FG000|Overall Study|Lack of Efficacy|11|||
31000161|NCT01989468|59198829|FG001|Overall Study|Lack of Efficacy|11|||
31000162|NCT01989468|59198830|FG002|Overall Study|Lack of Efficacy|7|||
31000163|NCT01989468|59198831|FG003|Overall Study|Lack of Efficacy|4|||
31000164|NCT01989468|59198832|FG004|Overall Study|Lack of Efficacy|2|||
31000165|NCT01989468|59198828|FG000|Overall Study|Lost to Follow-up|5|||
31000166|NCT01989468|59198829|FG001|Overall Study|Lost to Follow-up|2|||
31000167|NCT01989468|59198830|FG002|Overall Study|Lost to Follow-up|0|||
31000168|NCT01989468|59198831|FG003|Overall Study|Lost to Follow-up|1|||
31000169|NCT01989468|59198832|FG004|Overall Study|Lost to Follow-up|1|||
31000170|NCT01989468|59198828|FG000|Overall Study|Physician Decision|4|||
31000171|NCT01989468|59198829|FG001|Overall Study|Physician Decision|1|||
31000172|NCT01989468|59198830|FG002|Overall Study|Physician Decision|0|||
31000173|NCT01989468|59198831|FG003|Overall Study|Physician Decision|1|||
31000174|NCT01989468|59198832|FG004|Overall Study|Physician Decision|0|||
31000175|NCT01989468|59198828|FG000|Overall Study|Pregnancy|0|||
31000176|NCT01989468|59198829|FG001|Overall Study|Pregnancy|1|||
31000177|NCT01989468|59198830|FG002|Overall Study|Pregnancy|0|||
31000178|NCT01989468|59198831|FG003|Overall Study|Pregnancy|0|||
31000179|NCT01989468|59198832|FG004|Overall Study|Pregnancy|0|||
31000180|NCT01989468|59198828|FG000|Overall Study|Technical Problems|3|||
31000181|NCT01989468|59198829|FG001|Overall Study|Technical Problems|1|||
31000182|NCT01989468|59198830|FG002|Overall Study|Technical Problems|3|||
31000183|NCT01989468|59198831|FG003|Overall Study|Technical Problems|1|||
31000184|NCT01989468|59198832|FG004|Overall Study|Technical Problems|0|||
31000185|NCT01989468|59198828|FG000|Overall Study|Subject Guardian Decision|11|||
31000186|NCT01989468|59198829|FG001|Overall Study|Subject Guardian Decision|6|||
31000187|NCT01989468|59198830|FG002|Overall Study|Subject Guardian Decision|4|||
31000188|NCT01989468|59198831|FG003|Overall Study|Subject Guardian Decision|4|||
31000189|NCT01989468|59198832|FG004|Overall Study|Subject Guardian Decision|1|||
31000190|NCT01989468|59198828|FG000|Overall Study|Death|3|||
31000191|NCT01989468|59198829|FG001|Overall Study|Death|0|||
31000192|NCT01989468|59198830|FG002|Overall Study|Death|1|||
31000193|NCT01989468|59198831|FG003|Overall Study|Death|0|||
31000194|NCT01989468|59198832|FG004|Overall Study|Death|0|||
31000195|NCT01989156|59198848|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
31000196|NCT01989156|59198849|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
31000197|NCT01989156|59198850|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
31000198|NCT01989156|59198848|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
31000199|NCT01989156|59198849|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
31000200|NCT01989156|59198850|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
31000201|NCT01989156|59198848|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
31000202|NCT01989156|59198849|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
31000203|NCT01989156|59198850|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
31000204|NCT01989156|59198848|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
31000205|NCT01989156|59198849|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
31000206|NCT01989156|59198850|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
31000207|NCT01989156|59198848|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
31000208|NCT01989156|59198849|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
31000209|NCT01989156|59198850|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
31000210|NCT01989156|59198848|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
31000211|NCT01989156|59198849|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
31000212|NCT01989156|59198850|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
31000213|NCT01989156|59198848|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
31000214|NCT01989156|59198849|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
31000215|NCT01989156|59198850|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
31000216|NCT01989156|59198848|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
31000217|NCT01989156|59198849|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
31000218|NCT01989156|59198850|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
31000219|NCT01620762|59198861|FG000|Overall Study|Protocol Violation|1|||
31000220|NCT01620762|59198862|FG001|Overall Study|Protocol Violation|1|||
31000221|NCT01620762|59198863|FG002|Overall Study|Protocol Violation|1|||
31000222|NCT01620762|59198861|FG000|Overall Study|Adverse Event|9|||
31000223|NCT01620762|59198862|FG001|Overall Study|Adverse Event|5|||
31000224|NCT01620762|59198863|FG002|Overall Study|Adverse Event|2|||
31000225|NCT01620762|59198861|FG000|Overall Study|Withdrawal by Subject|23|||
31000226|NCT01620762|59198862|FG001|Overall Study|Withdrawal by Subject|26|||
31000227|NCT01620762|59198863|FG002|Overall Study|Withdrawal by Subject|27|||
31000228|NCT01620762|59198861|FG000|Overall Study|Lost to Follow-up|11|||
31000229|NCT01620762|59198862|FG001|Overall Study|Lost to Follow-up|17|||
31000230|NCT01620762|59198863|FG002|Overall Study|Lost to Follow-up|10|||
31000231|NCT01620762|59198861|FG000|Overall Study|Protocol deviation|1|||
31000232|NCT01620762|59198862|FG001|Overall Study|Protocol deviation|1|||
31000233|NCT01620762|59198863|FG002|Overall Study|Protocol deviation|6|||
31000234|NCT01620762|59198861|FG000|Overall Study|Subject deterioration|0|||
31000235|NCT01620762|59198862|FG001|Overall Study|Subject deterioration|1|||
31000236|NCT01620762|59198863|FG002|Overall Study|Subject deterioration|1|||
31000237|NCT01620762|59198861|FG000|Overall Study|Non-specified|3|||
31000238|NCT01620762|59198862|FG001|Overall Study|Non-specified|6|||
31000239|NCT01620762|59198863|FG002|Overall Study|Non-specified|5|||
31000240|NCT01620762|59198861|FG000|Overall Study|Use of prohibted therapies|0|||
31000241|NCT01620762|59198862|FG001|Overall Study|Use of prohibted therapies|1|||
31000242|NCT01620762|59198863|FG002|Overall Study|Use of prohibted therapies|1|||
31000243|NCT01966068|59198873|FG000|Overall Study|Withdrawal by Subject|57|||
31000244|NCT01966068|59198873|FG000|Overall Study|Lost to Follow-up|81|||
31000245|NCT01620528|59198881|FG000|Treatment Period|Did Not Receive Study Drug|0|||
31000246|NCT01620528|59198882|FG001|Treatment Period|Did Not Receive Study Drug|0|||
31000247|NCT01620528|59198883|FG002|Treatment Period|Did Not Receive Study Drug|1|||
31000248|NCT01620528|59198881|FG000|Treatment Period|Withdrawal by Subject|35|||
31000249|NCT01620528|59198882|FG001|Treatment Period|Withdrawal by Subject|21|||
31000250|NCT01620528|59198883|FG002|Treatment Period|Withdrawal by Subject|16|||
31000251|NCT01620528|59198881|FG000|Treatment Period|Adverse Event|17|||
31000252|NCT01620528|59198882|FG001|Treatment Period|Adverse Event|13|||
31000253|NCT01620528|59198883|FG002|Treatment Period|Adverse Event|21|||
31000254|NCT01620528|59198881|FG000|Treatment Period|Lost to Follow-up|16|||
31000255|NCT01620528|59198882|FG001|Treatment Period|Lost to Follow-up|8|||
31000256|NCT01620528|59198883|FG002|Treatment Period|Lost to Follow-up|14|||
31000257|NCT01620528|59198881|FG000|Treatment Period|Other|9|||
31000258|NCT01620528|59198882|FG001|Treatment Period|Other|5|||
31000259|NCT01620528|59198883|FG002|Treatment Period|Other|7|||
31000260|NCT01620528|59198881|FG000|Treatment Period|Subject Noncompliant|11|||
31000261|NCT01620528|59198882|FG001|Treatment Period|Subject Noncompliant|2|||
31000262|NCT01620528|59198883|FG002|Treatment Period|Subject Noncompliant|2|||
31000263|NCT01620528|59198881|FG000|Treatment Period|Pregnancy|7|||
31000264|NCT01620528|59198882|FG001|Treatment Period|Pregnancy|2|||
31000265|NCT01620528|59198883|FG002|Treatment Period|Pregnancy|2|||
31000266|NCT01620528|59198881|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
31000267|NCT01620528|59198882|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
31000268|NCT01620528|59198883|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
31000269|NCT01620528|59198881|FG000|Treatment Period|Exclusionary Medication Received|0|||
31000270|NCT01620528|59198882|FG001|Treatment Period|Exclusionary Medication Received|1|||
31000271|NCT01620528|59198883|FG002|Treatment Period|Exclusionary Medication Received|0|||
31000272|NCT01620528|59198881|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
31000273|NCT01620528|59198882|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
31000274|NCT01620528|59198883|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
31000275|NCT01620528|59198881|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
31000276|NCT01620528|59198882|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
31000277|NCT01620528|59198883|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
31000278|NCT01620528|59198881|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
31000279|NCT01620528|59198882|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
31000280|NCT01620528|59198883|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
31000281|NCT01620528|59198881|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
31000282|NCT01620528|59198882|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
31000283|NCT01620528|59198883|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
31000284|NCT01620528|59198881|FG000|Post-Treatment Follow-Up Period|Other|6|||
31000285|NCT01620528|59198882|FG001|Post-Treatment Follow-Up Period|Other|4|||
31000286|NCT01620528|59198883|FG002|Post-Treatment Follow-Up Period|Other|2|||
31000287|NCT01965834|59198891|FG000|Overall Study|Lack of Efficacy|4|||
31000288|NCT01965600|59198895|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
31000289|NCT01965600|59198896|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
31000290|NCT01965600|59198897|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
31000291|NCT01965600|59198898|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
31000292|NCT01965600|59198895|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
31000293|NCT01965600|59198896|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
31000294|NCT01965600|59198897|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
31000295|NCT01965600|59198898|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
31000296|NCT01965600|59198895|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
31000297|NCT01965600|59198896|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
31000298|NCT01965600|59198897|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
31000299|NCT01965600|59198898|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
31000300|NCT01965600|59198895|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
31000301|NCT01965600|59198896|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
31000302|NCT01965600|59198897|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
31000303|NCT01965600|59198898|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
31000304|NCT01965600|59198895|FG000|Second Intervention|Study terminated by Sponsor|0|||
31000305|NCT01965600|59198896|FG001|Second Intervention|Study terminated by Sponsor|0|||
31000306|NCT01965600|59198897|FG002|Second Intervention|Study terminated by Sponsor|2|||
31000307|NCT01965600|59198898|FG003|Second Intervention|Study terminated by Sponsor|2|||
31000308|NCT01996332|59198906|FG000|Overall Study|Adverse Event|117|||
31000309|NCT01996332|59198906|FG000|Overall Study|Lack of Efficacy|1245|||
31000310|NCT01996332|59198906|FG000|Overall Study|Death|264|||
31000311|NCT01996332|59198906|FG000|Overall Study|Protocol Violation|9|||
31000312|NCT01996332|59198906|FG000|Overall Study|Withdrawal by Subject|71|||
31000313|NCT01996332|59198906|FG000|Overall Study|Other|20|||
31000314|NCT01996332|59198906|FG000|Overall Study|Clinical Deterioration|28|||
31000315|NCT01996332|59198906|FG000|Overall Study|Physician Decision|17|||
31000316|NCT01996332|59198906|FG000|Overall Study|Lost to Follow-up|34|||
31000317|NCT01996254|59198912|FG000|Overall Study|Change in Eligibility|0|||
31000318|NCT01996254|59198913|FG001|Overall Study|Change in Eligibility|2|||
31000319|NCT01996254|59198914|FG002|Overall Study|Change in Eligibility|0|||
31000320|NCT01996254|59198912|FG000|Overall Study|Withdrawal by Subject|0|||
31000321|NCT01996254|59198913|FG001|Overall Study|Withdrawal by Subject|3|||
31000322|NCT01996254|59198914|FG002|Overall Study|Withdrawal by Subject|4|||
31000323|NCT01996254|59198912|FG000|Overall Study|Lost to Follow-up|1|||
31000324|NCT01996254|59198913|FG001|Overall Study|Lost to Follow-up|0|||
31000325|NCT01996254|59198914|FG002|Overall Study|Lost to Follow-up|4|||
31000326|NCT01987986|59198928|FG000|Overall Study|Lost to Follow-up|1|||
31000327|NCT01987986|59198929|FG001|Overall Study|Lost to Follow-up|0|||
31000328|NCT01987986|59198930|FG002|Overall Study|Lost to Follow-up|0|||
31000329|NCT01987986|59198931|FG003|Overall Study|Lost to Follow-up|0|||
31000330|NCT01987986|59198928|FG000|Overall Study|Adverse Event|1|||
31000331|NCT01987986|59198929|FG001|Overall Study|Adverse Event|0|||
31000332|NCT01987986|59198930|FG002|Overall Study|Adverse Event|2|||
31000333|NCT01987986|59198931|FG003|Overall Study|Adverse Event|0|||
31000334|NCT01987908|59198941|FG000|Placebo Lead-in Period|Adverse Event|2|||
31000335|NCT01987908|59198942|FG001|Placebo Lead-in Period|Adverse Event|0|||
31000336|NCT01987908|59198943|FG002|Placebo Lead-in Period|Adverse Event|0|||
31000337|NCT01987908|59198941|FG000|Placebo Lead-in Period|Physician Decision|2|||
31000338|NCT01987908|59198942|FG001|Placebo Lead-in Period|Physician Decision|0|||
31000339|NCT01987908|59198943|FG002|Placebo Lead-in Period|Physician Decision|0|||
31000340|NCT01987908|59198941|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
31000341|NCT01987908|59198942|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
31000342|NCT01987908|59198943|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
31000343|NCT01987908|59198941|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
31000344|NCT01987908|59198942|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
31000345|NCT01987908|59198943|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
31000346|NCT01987908|59198941|FG000|Treatment Period|Adverse Event|0|||
31000347|NCT01987908|59198942|FG001|Treatment Period|Adverse Event|1|||
31000348|NCT01987908|59198943|FG002|Treatment Period|Adverse Event|1|||
31000349|NCT01987908|59198941|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
31000350|NCT01987908|59198942|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
31000351|NCT01987908|59198943|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
31000352|NCT01987908|59198941|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
31000353|NCT01987908|59198942|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
31000354|NCT01987908|59198943|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
31000355|NCT01995552|59198967|FG000|Overall Study|Protocol Violation|1|||
31000356|NCT01995552|59198967|FG000|Overall Study|Lack of Efficacy|15|||
31000357|NCT01995552|59198967|FG000|Overall Study|Death|1|||
31000358|NCT01987830|59198973|FG000|Overall Study|Never received baseline scan|1|||
31000359|NCT01987596|59198979|FG000|Overall Study|Physician Decision|1|||
31000360|NCT01987596|59198980|FG001|Overall Study|Physician Decision|0|||
31000361|NCT01987596|59198979|FG000|Overall Study|Progressive Disease; missing all period|0|||
31000362|NCT01987596|59198980|FG001|Overall Study|Progressive Disease; missing all period|1|||
31000363|NCT01964976|59198994|FG000|Overall Study|Protocol Violation|31|||
31000364|NCT01964898|59199003|FG000|Overall Study|ineligible post-randomization|1|||
31000365|NCT01964898|59199004|FG001|Overall Study|ineligible post-randomization|1|||
31000366|NCT01964898|59199003|FG000|Overall Study|did not receive the allocated interventi|2|||
31000367|NCT01964898|59199004|FG001|Overall Study|did not receive the allocated interventi|1|||
31000368|NCT01964898|59199003|FG000|Overall Study|Lost to Follow-up|3|||
31000369|NCT01964898|59199004|FG001|Overall Study|Lost to Follow-up|5|||
31000370|NCT01964898|59199003|FG000|Overall Study|Withdrawal by Subject|1|||
31000371|NCT01964898|59199004|FG001|Overall Study|Withdrawal by Subject|0|||
31000372|NCT01964352|59199014|FG000|Overall Study|Adverse Event|13|||
31000373|NCT01964352|59199015|FG001|Overall Study|Adverse Event|3|||
31000374|NCT01964352|59199016|FG002|Overall Study|Adverse Event|4|||
31000375|NCT01964352|59199017|FG003|Overall Study|Adverse Event|3|||
30843498|NCT02178098|58869604|FG001|Overall Study|Adverse Event|2|||
31000376|NCT01964352|59199014|FG000|Overall Study|Lack of Efficacy|6|||
31000377|NCT01964352|59199015|FG001|Overall Study|Lack of Efficacy|0|||
31000378|NCT01964352|59199016|FG002|Overall Study|Lack of Efficacy|0|||
31000379|NCT01964352|59199017|FG003|Overall Study|Lack of Efficacy|0|||
31000380|NCT01964352|59199014|FG000|Overall Study|Protocol Violation|2|||
31000381|NCT01964352|59199015|FG001|Overall Study|Protocol Violation|4|||
31000382|NCT01964352|59199016|FG002|Overall Study|Protocol Violation|0|||
31000383|NCT01964352|59199017|FG003|Overall Study|Protocol Violation|2|||
31000384|NCT01964352|59199014|FG000|Overall Study|Lost to Follow-up|1|||
31000385|NCT01964352|59199015|FG001|Overall Study|Lost to Follow-up|0|||
31000386|NCT01964352|59199016|FG002|Overall Study|Lost to Follow-up|0|||
31000387|NCT01964352|59199017|FG003|Overall Study|Lost to Follow-up|1|||
31000388|NCT01964352|59199014|FG000|Overall Study|Withdrawal by Subject|4|||
31000389|NCT01964352|59199015|FG001|Overall Study|Withdrawal by Subject|2|||
31000390|NCT01964352|59199016|FG002|Overall Study|Withdrawal by Subject|1|||
31000391|NCT01964352|59199017|FG003|Overall Study|Withdrawal by Subject|0|||
31000392|NCT01964352|59199014|FG000|Overall Study|Other than stated above|0|||
31000393|NCT01964352|59199015|FG001|Overall Study|Other than stated above|2|||
31000394|NCT01964352|59199016|FG002|Overall Study|Other than stated above|1|||
31000395|NCT01964352|59199017|FG003|Overall Study|Other than stated above|2|||
31000396|NCT01946412|59199027|FG000|Overall Study|Adverse Event|1|||
31000397|NCT01946412|59199027|FG000|Overall Study|Non-Compliance|1|||
31000398|NCT01946412|59199027|FG000|Overall Study|Continued with commercial Kalydeco|2|||
31000399|NCT01946412|59199027|FG000|Overall Study|Difficulty in swallowing|1|||
31000400|NCT01946178|59199033|FG000|Overall Study|Pregnancy|1|||
31000401|NCT01946178|59199033|FG000|Overall Study|Lost to Follow-up|1|||
31000402|NCT01945944|59199043|FG000|Overall Study|Adverse Event|0|||
31000403|NCT01945944|59199044|FG001|Overall Study|Adverse Event|2|||
31000404|NCT01945944|59199043|FG000|Overall Study|Physician Decision|1|||
31000405|NCT01945944|59199044|FG001|Overall Study|Physician Decision|0|||
31000406|NCT01945944|59199043|FG000|Overall Study|Withdrawal by Subject|0|||
31000407|NCT01945944|59199044|FG001|Overall Study|Withdrawal by Subject|1|||
31000408|NCT01945866|59199054|FG000|Overall Study|Eyes did not complete or were dropped|2|||
31000409|NCT01945866|59199055|FG001|Overall Study|Eyes did not complete or were dropped|0|||
31000410|NCT01986114|59199062|FG000|Overall Study|Adverse Event|59|||
31000411|NCT01986114|59199062|FG000|Overall Study|Lack of Efficacy|23|||
31000412|NCT01986114|59199062|FG000|Overall Study|Withdrawal by Subject|58|||
31000413|NCT01986114|59199062|FG000|Overall Study|Noncompliance|3|||
31000414|NCT01986114|59199062|FG000|Overall Study|Protocol Violation|1|||
31000415|NCT01986114|59199062|FG000|Overall Study|Lost to Follow-up|5|||
31000416|NCT01986114|59199062|FG000|Overall Study|Other reason|7|||
31000417|NCT01945710|59199075|FG000|Overall Study|Progressive Disease|5|||
31000418|NCT01945710|59199076|FG001|Overall Study|Progressive Disease|4|||
31000419|NCT01945710|59199077|FG002|Overall Study|Progressive Disease|3|||
31000420|NCT01945710|59199078|FG003|Overall Study|Progressive Disease|2|||
31000421|NCT01945710|59199079|FG004|Overall Study|Progressive Disease|7|||
31000422|NCT01945710|59199080|FG005|Overall Study|Progressive Disease|3|||
31000423|NCT01945710|59199081|FG006|Overall Study|Progressive Disease|19|||
31000424|NCT01945710|59199075|FG000|Overall Study|Adverse Event|0|||
31000425|NCT01945710|59199076|FG001|Overall Study|Adverse Event|1|||
31000426|NCT01945710|59199077|FG002|Overall Study|Adverse Event|0|||
31000427|NCT01945710|59199078|FG003|Overall Study|Adverse Event|0|||
31000428|NCT01945710|59199079|FG004|Overall Study|Adverse Event|0|||
31000429|NCT01945710|59199080|FG005|Overall Study|Adverse Event|0|||
31000430|NCT01945710|59199081|FG006|Overall Study|Adverse Event|0|||
31000431|NCT01945710|59199075|FG000|Overall Study|Other|2|||
31000432|NCT01945710|59199076|FG001|Overall Study|Other|0|||
31000433|NCT01945710|59199077|FG002|Overall Study|Other|3|||
31000434|NCT01945710|59199078|FG003|Overall Study|Other|1|||
31000435|NCT01945710|59199079|FG004|Overall Study|Other|1|||
31000436|NCT01945710|59199080|FG005|Overall Study|Other|0|||
31000437|NCT01945710|59199081|FG006|Overall Study|Other|4|||
31000438|NCT01945710|59199075|FG000|Overall Study|Withdrawal by Subject|0|||
31000439|NCT01945710|59199076|FG001|Overall Study|Withdrawal by Subject|1|||
31000440|NCT01945710|59199077|FG002|Overall Study|Withdrawal by Subject|1|||
31000441|NCT01945710|59199078|FG003|Overall Study|Withdrawal by Subject|0|||
31000442|NCT01945710|59199079|FG004|Overall Study|Withdrawal by Subject|1|||
31000443|NCT01945710|59199080|FG005|Overall Study|Withdrawal by Subject|0|||
31000444|NCT01945710|59199081|FG006|Overall Study|Withdrawal by Subject|0|||
31000445|NCT01945242|59199101|FG000|Overall Study|Physician Decision|3|||
31000446|NCT01945242|59199102|FG001|Overall Study|Physician Decision|3|||
31000447|NCT01945086|59199112|FG000|Overall Study|Withdrawal by Subject|1|||
31000448|NCT01945086|59199113|FG001|Overall Study|Withdrawal by Subject|0|||
31000449|NCT01945086|59199114|FG002|Overall Study|Withdrawal by Subject|1|||
31000450|NCT01945086|59199112|FG000|Overall Study|Adverse Event|0|||
31000451|NCT01945086|59199113|FG001|Overall Study|Adverse Event|0|||
31000452|NCT01945086|59199114|FG002|Overall Study|Adverse Event|1|||
31000453|NCT01963728|59199124|FG000|Overall Study|Study terminated early|0|||
31000454|NCT01963728|59199125|FG001|Overall Study|Study terminated early|1|||
31000455|NCT01963260|59199141|FG000|Overall Study|Withdrawal by Subject|2|||
31000456|NCT01963260|59199142|FG001|Overall Study|Withdrawal by Subject|0|||
31000457|NCT01963260|59199143|FG002|Overall Study|Withdrawal by Subject|0|||
31000458|NCT01963260|59199144|FG003|Overall Study|Withdrawal by Subject|1|||
31000459|NCT01963260|59199145|FG004|Overall Study|Withdrawal by Subject|2|||
31000460|NCT01963260|59199146|FG005|Overall Study|Withdrawal by Subject|0|||
31000461|NCT01963260|59199147|FG006|Overall Study|Withdrawal by Subject|0|||
31000462|NCT01963260|59199148|FG007|Overall Study|Withdrawal by Subject|0|||
31000463|NCT01963260|59199149|FG008|Overall Study|Withdrawal by Subject|0|||
31000464|NCT01963260|59199150|FG009|Overall Study|Withdrawal by Subject|0|||
31000465|NCT01962948|59199183|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
31000466|NCT01962948|59199184|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
31000467|NCT01962948|59199185|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
31000468|NCT01962948|59199186|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
31000469|NCT01985334|59199201|FG000|Overall Study|Administrative problems|1|||
31000470|NCT01985334|59199202|FG001|Overall Study|Administrative problems|1|||
31000471|NCT01985334|59199203|FG002|Overall Study|Administrative problems|0|||
31000472|NCT01985334|59199204|FG003|Overall Study|Administrative problems|2|||
31000473|NCT01985334|59199205|FG004|Overall Study|Administrative problems|0|||
31000474|NCT01985334|59199206|FG005|Overall Study|Administrative problems|1|||
31000475|NCT01985334|59199207|FG006|Overall Study|Administrative problems|1|||
31000476|NCT01985334|59199208|FG007|Overall Study|Administrative problems|3|||
31000477|NCT01985334|59199201|FG000|Overall Study|Death|1|||
31000478|NCT01985334|59199202|FG001|Overall Study|Death|0|||
31000479|NCT01985334|59199203|FG002|Overall Study|Death|0|||
31000480|NCT01985334|59199204|FG003|Overall Study|Death|3|||
31000481|NCT01985334|59199205|FG004|Overall Study|Death|0|||
31000482|NCT01985334|59199206|FG005|Overall Study|Death|0|||
31000483|NCT01985334|59199207|FG006|Overall Study|Death|1|||
31000484|NCT01985334|59199208|FG007|Overall Study|Death|2|||
31000485|NCT01985334|59199201|FG000|Overall Study|Worsening of disease|0|||
31000486|NCT01985334|59199202|FG001|Overall Study|Worsening of disease|0|||
31000487|NCT01985334|59199203|FG002|Overall Study|Worsening of disease|0|||
31000488|NCT01985334|59199204|FG003|Overall Study|Worsening of disease|1|||
31000489|NCT01985334|59199205|FG004|Overall Study|Worsening of disease|0|||
31000490|NCT01985334|59199206|FG005|Overall Study|Worsening of disease|3|||
31000491|NCT01985334|59199207|FG006|Overall Study|Worsening of disease|0|||
31000492|NCT01985334|59199208|FG007|Overall Study|Worsening of disease|1|||
31000493|NCT01985334|59199201|FG000|Overall Study|Other|2|||
31000494|NCT01985334|59199202|FG001|Overall Study|Other|9|||
31000495|NCT01985334|59199203|FG002|Overall Study|Other|7|||
31000496|NCT01985334|59199204|FG003|Overall Study|Other|17|||
31000497|NCT01985334|59199205|FG004|Overall Study|Other|4|||
31000498|NCT01985334|59199206|FG005|Overall Study|Other|8|||
31000499|NCT01985334|59199207|FG006|Overall Study|Other|4|||
31000500|NCT01985334|59199208|FG007|Overall Study|Other|7|||
31000501|NCT01985334|59199201|FG000|Overall Study|Protocol deviation|6|||
31000502|NCT01985334|59199202|FG001|Overall Study|Protocol deviation|31|||
31000503|NCT01985334|59199203|FG002|Overall Study|Protocol deviation|25|||
31000504|NCT01985334|59199204|FG003|Overall Study|Protocol deviation|84|||
31000505|NCT01985334|59199205|FG004|Overall Study|Protocol deviation|17|||
31000506|NCT01985334|59199206|FG005|Overall Study|Protocol deviation|47|||
31000507|NCT01985334|59199207|FG006|Overall Study|Protocol deviation|15|||
31000508|NCT01985334|59199208|FG007|Overall Study|Protocol deviation|42|||
31000509|NCT01985334|59199201|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
31000510|NCT01985334|59199202|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
31000511|NCT01985334|59199203|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
31000512|NCT01985334|59199204|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
31000513|NCT01985334|59199205|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
31000514|NCT01985334|59199206|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
31000515|NCT01985334|59199207|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
31000516|NCT01985334|59199208|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
31000517|NCT01985334|59199201|FG000|Overall Study|Subject withdrawal of consent|3|||
31000518|NCT01985334|59199202|FG001|Overall Study|Subject withdrawal of consent|6|||
31000519|NCT01985334|59199203|FG002|Overall Study|Subject withdrawal of consent|2|||
31000520|NCT01985334|59199204|FG003|Overall Study|Subject withdrawal of consent|28|||
31000521|NCT01985334|59199205|FG004|Overall Study|Subject withdrawal of consent|4|||
31000522|NCT01985334|59199206|FG005|Overall Study|Subject withdrawal of consent|19|||
31000523|NCT01985334|59199207|FG006|Overall Study|Subject withdrawal of consent|0|||
31000524|NCT01985334|59199208|FG007|Overall Study|Subject withdrawal of consent|20|||
31000525|NCT01985334|59199201|FG000|Overall Study|Adverse Event|0|||
31000526|NCT01985334|59199202|FG001|Overall Study|Adverse Event|8|||
31000527|NCT01985334|59199203|FG002|Overall Study|Adverse Event|2|||
31000528|NCT01985334|59199204|FG003|Overall Study|Adverse Event|26|||
31000529|NCT01985334|59199205|FG004|Overall Study|Adverse Event|3|||
31000530|NCT01985334|59199206|FG005|Overall Study|Adverse Event|18|||
31000531|NCT01985334|59199207|FG006|Overall Study|Adverse Event|3|||
31000532|NCT01985334|59199208|FG007|Overall Study|Adverse Event|15|||
31000533|NCT01985334|59199201|FG000|Overall Study|Other|4|||
31000534|NCT01985334|59199202|FG001|Overall Study|Other|2|||
31000535|NCT01985334|59199203|FG002|Overall Study|Other|3|||
31000536|NCT01985334|59199204|FG003|Overall Study|Other|10|||
31000537|NCT01985334|59199205|FG004|Overall Study|Other|1|||
31000538|NCT01985334|59199206|FG005|Overall Study|Other|6|||
31000539|NCT01985334|59199207|FG006|Overall Study|Other|2|||
31000540|NCT01985334|59199208|FG007|Overall Study|Other|2|||
31000541|NCT01985334|59199201|FG000|Overall Study|Medication non-compliance|0|||
31000542|NCT01985334|59199202|FG001|Overall Study|Medication non-compliance|4|||
31000543|NCT01985334|59199203|FG002|Overall Study|Medication non-compliance|1|||
31000544|NCT01985334|59199204|FG003|Overall Study|Medication non-compliance|6|||
31000545|NCT01985334|59199205|FG004|Overall Study|Medication non-compliance|2|||
31000546|NCT01985334|59199206|FG005|Overall Study|Medication non-compliance|3|||
31000547|NCT01985334|59199207|FG006|Overall Study|Medication non-compliance|1|||
31000548|NCT01985334|59199208|FG007|Overall Study|Medication non-compliance|3|||
31000549|NCT01985334|59199201|FG000|Overall Study|Use of prohibited treatment|1|||
31000550|NCT01985334|59199202|FG001|Overall Study|Use of prohibited treatment|4|||
31000551|NCT01985334|59199203|FG002|Overall Study|Use of prohibited treatment|1|||
31000552|NCT01985334|59199204|FG003|Overall Study|Use of prohibited treatment|2|||
31000553|NCT01985334|59199205|FG004|Overall Study|Use of prohibited treatment|1|||
31000554|NCT01985334|59199206|FG005|Overall Study|Use of prohibited treatment|6|||
31000555|NCT01985334|59199207|FG006|Overall Study|Use of prohibited treatment|2|||
31000556|NCT01985334|59199208|FG007|Overall Study|Use of prohibited treatment|0|||
31000557|NCT01985334|59199201|FG000|Overall Study|Investigator decision|0|||
31000558|NCT01985334|59199202|FG001|Overall Study|Investigator decision|3|||
31000559|NCT01985334|59199203|FG002|Overall Study|Investigator decision|0|||
31000560|NCT01985334|59199204|FG003|Overall Study|Investigator decision|7|||
31000561|NCT01985334|59199205|FG004|Overall Study|Investigator decision|1|||
31000562|NCT01985334|59199206|FG005|Overall Study|Investigator decision|1|||
31000563|NCT01985334|59199207|FG006|Overall Study|Investigator decision|0|||
31000564|NCT01985334|59199208|FG007|Overall Study|Investigator decision|4|||
31000565|NCT01985334|59199201|FG000|Overall Study|Lost to Follow-up|0|||
31000566|NCT01985334|59199202|FG001|Overall Study|Lost to Follow-up|2|||
31000567|NCT01985334|59199203|FG002|Overall Study|Lost to Follow-up|0|||
31000568|NCT01985334|59199204|FG003|Overall Study|Lost to Follow-up|3|||
31000569|NCT01985334|59199205|FG004|Overall Study|Lost to Follow-up|1|||
31000570|NCT01985334|59199206|FG005|Overall Study|Lost to Follow-up|4|||
31000571|NCT01985334|59199207|FG006|Overall Study|Lost to Follow-up|0|||
31000572|NCT01985334|59199208|FG007|Overall Study|Lost to Follow-up|3|||
31000573|NCT01944774|59199243|FG000|Overall Study|Withdrawal by Subject|2|||
31000574|NCT01944774|59199244|FG001|Overall Study|Withdrawal by Subject|3|||
31000575|NCT01944774|59199245|FG002|Overall Study|Withdrawal by Subject|3|||
31000576|NCT01944774|59199243|FG000|Overall Study|Adverse Event|3|||
31000577|NCT01944774|59199244|FG001|Overall Study|Adverse Event|2|||
31000578|NCT01944774|59199245|FG002|Overall Study|Adverse Event|3|||
31000579|NCT01944774|59199243|FG000|Overall Study|Lack of Efficacy|1|||
31000580|NCT01944774|59199244|FG001|Overall Study|Lack of Efficacy|2|||
31000581|NCT01944774|59199245|FG002|Overall Study|Lack of Efficacy|2|||
31000582|NCT01944774|59199243|FG000|Overall Study|Lost to Follow-up|0|||
31000583|NCT01944774|59199244|FG001|Overall Study|Lost to Follow-up|1|||
31000584|NCT01944774|59199245|FG002|Overall Study|Lost to Follow-up|0|||
31000585|NCT01944462|59199256|FG000|PPPP Educational Program|Lost to Follow-up|60|||
31000586|NCT01943292|59199264|FG000|Overall Study|Withdrawal by Subject|1|||
31000587|NCT01943292|59199265|FG001|Overall Study|Withdrawal by Subject|0|||
31000588|NCT01943292|59199266|FG002|Overall Study|Withdrawal by Subject|0|||
31000589|NCT01961544|59199274|FG000|Overall Study|Protocol Violation|1|||
31000590|NCT01961544|59199274|FG000|Overall Study|Withdrawal by Subject|7|||
31000591|NCT01961544|59199274|FG000|Overall Study|Adverse Event|1|||
31000592|NCT01961544|59199274|FG000|Overall Study|Physician Decision|2|||
31000593|NCT01961544|59199274|FG000|Overall Study|Poor Tolerance|1|||
31000594|NCT01961544|59199274|FG000|Overall Study|Aggravation of Steral Pain|1|||
31000595|NCT01942590|59199280|FG000|Overall Study|Withdrawal by Subject|0|||
31000596|NCT01942590|59199281|FG001|Overall Study|Withdrawal by Subject|1|||
31000597|NCT01942590|59199280|FG000|Overall Study|Adverse Event|1|||
31000598|NCT01942590|59199281|FG001|Overall Study|Adverse Event|0|||
31000599|NCT01984242|59199291|FG000|Overall Study|Death|52|||
31000600|NCT01984242|59199292|FG001|Overall Study|Death|50|||
31000601|NCT01984242|59199293|FG002|Overall Study|Death|52|||
31000602|NCT01984242|59199291|FG000|Overall Study|Withdrawal by Subject|5|||
31000603|NCT01984242|59199292|FG001|Overall Study|Withdrawal by Subject|3|||
31000604|NCT01984242|59199293|FG002|Overall Study|Withdrawal by Subject|10|||
31000605|NCT01984242|59199291|FG000|Overall Study|Physician Decision|0|||
31000606|NCT01984242|59199292|FG001|Overall Study|Physician Decision|0|||
31000607|NCT01984242|59199293|FG002|Overall Study|Physician Decision|1|||
31000608|NCT01984242|59199291|FG000|Overall Study|Lost to Follow-up|4|||
31000609|NCT01984242|59199292|FG001|Overall Study|Lost to Follow-up|0|||
31000610|NCT01984242|59199293|FG002|Overall Study|Lost to Follow-up|3|||
31000611|NCT01984242|59199291|FG000|Overall Study|Sponsor Decision|1|||
31000612|NCT01984242|59199292|FG001|Overall Study|Sponsor Decision|0|||
31000613|NCT01984242|59199293|FG002|Overall Study|Sponsor Decision|0|||
31000614|NCT01984242|59199291|FG000|Overall Study|Non-Compliance|1|||
31000615|NCT01984242|59199292|FG001|Overall Study|Non-Compliance|0|||
31000616|NCT01984242|59199293|FG002|Overall Study|Non-Compliance|0|||
31000617|NCT01984242|59199291|FG000|Overall Study|Study terminated by Sponsor|38|||
31000618|NCT01984242|59199292|FG001|Overall Study|Study terminated by Sponsor|50|||
31000619|NCT01984242|59199293|FG002|Overall Study|Study terminated by Sponsor|34|||
31000620|NCT01984242|59199291|FG000|Overall Study|Disease Progression|0|||
31000621|NCT01984242|59199292|FG001|Overall Study|Disease Progression|0|||
31000622|NCT01984242|59199293|FG002|Overall Study|Disease Progression|1|||
31000623|NCT01941498|59199309|FG000|Overall Study|Relocated out of state|1|||
31000624|NCT01960998|59199330|FG000|Overall Study|Lost to Follow-up|3|||
31000625|NCT01960998|59199331|FG001|Overall Study|Lost to Follow-up|7|||
31000626|NCT01960998|59199330|FG000|Overall Study|Death|0|||
31000627|NCT01960998|59199331|FG001|Overall Study|Death|1|||
31000628|NCT01960998|59199330|FG000|Overall Study|Withdrawal by Subject|8|||
31000629|NCT01960998|59199331|FG001|Overall Study|Withdrawal by Subject|2|||
31000630|NCT01960998|59199330|FG000|Overall Study|lost computer access|0|||
31000631|NCT01960998|59199331|FG001|Overall Study|lost computer access|1|||
31000632|NCT01941186|59199341|FG000|Follow-up|Lost to Follow-up|1|||
31000633|NCT01941186|59199342|FG001|Follow-up|Lost to Follow-up|0|||
31000634|NCT01960842|59199361|FG000|Overall Study|Adverse Event|1|||
31000635|NCT01960842|59199361|FG000|Overall Study|Withdrawal by Subject|2|||
31000636|NCT01984164|59199367|FG000|Overall Study|Withdrawal by Subject|4|||
31000637|NCT01984164|59199368|FG001|Overall Study|Withdrawal by Subject|3|||
31000638|NCT01984164|59199367|FG000|Overall Study|Adverse Event|5|||
31000639|NCT01984164|59199368|FG001|Overall Study|Adverse Event|19|||
31000640|NCT01984164|59199367|FG000|Overall Study|Lost to Follow-up|1|||
31000641|NCT01984164|59199368|FG001|Overall Study|Lost to Follow-up|3|||
31000642|NCT01983930|59199376|FG000|Overall Study|Withdrawal by Subject|9|||
31000643|NCT01983930|59199377|FG001|Overall Study|Withdrawal by Subject|8|||
31000644|NCT01983930|59199376|FG000|Overall Study|Adverse Event|0|||
31000645|NCT01983930|59199377|FG001|Overall Study|Adverse Event|1|||
31000646|NCT01983774|59199390|FG000|Overall Study|Lung Transplant|0|||
31000647|NCT01983774|59199391|FG001|Overall Study|Lung Transplant|1|||
31000648|NCT01983774|59199390|FG000|Overall Study|Lost to Follow-up|1|||
31000649|NCT01983774|59199391|FG001|Overall Study|Lost to Follow-up|0|||
31000650|NCT01982682|59199399|FG000|Overall Study|Physician Decision|1|||
31000651|NCT01940484|59199404|FG000|Overall Study|Withdrawal by Subject|3|||
31000652|NCT01940484|59199404|FG000|Overall Study|Underwent transplantation|4|||
31000653|NCT01940484|59199404|FG000|Overall Study|Death|2|||
31000654|NCT01940484|59199404|FG000|Overall Study|Adverse Event|1|||
31000655|NCT01939548|59199411|FG000|Overall Study|Non compliance|0|||
31000656|NCT01939548|59199412|FG001|Overall Study|Non compliance|2|||
31000657|NCT01939548|59199413|FG002|Overall Study|Non compliance|0|||
31000658|NCT01939548|59199411|FG000|Overall Study|Study Terminated by Sponsor|17|||
31000659|NCT01939548|59199412|FG001|Overall Study|Study Terminated by Sponsor|19|||
31000660|NCT01939548|59199413|FG002|Overall Study|Study Terminated by Sponsor|12|||
31000661|NCT01939548|59199411|FG000|Overall Study|Insufficient Clinical Response|1|||
31000662|NCT01939548|59199412|FG001|Overall Study|Insufficient Clinical Response|0|||
31000663|NCT01939548|59199413|FG002|Overall Study|Insufficient Clinical Response|0|||
31000664|NCT01939548|59199411|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
31000665|NCT01939548|59199412|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
31000666|NCT01939548|59199413|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
31000667|NCT01939548|59199411|FG000|Overall Study|Withdrawal by Subject|4|||
31000668|NCT01939548|59199412|FG001|Overall Study|Withdrawal by Subject|4|||
31000669|NCT01939548|59199413|FG002|Overall Study|Withdrawal by Subject|1|||
31000670|NCT01939548|59199411|FG000|Overall Study|Protocol Violation|7|||
31000671|NCT01939548|59199412|FG001|Overall Study|Protocol Violation|6|||
31000672|NCT01939548|59199413|FG002|Overall Study|Protocol Violation|5|||
31000673|NCT01939548|59199411|FG000|Overall Study|Lost to Follow-up|5|||
31000674|NCT01939548|59199412|FG001|Overall Study|Lost to Follow-up|5|||
31000675|NCT01939548|59199413|FG002|Overall Study|Lost to Follow-up|3|||
31000676|NCT01939548|59199411|FG000|Overall Study|Adverse Event|2|||
31000677|NCT01939548|59199412|FG001|Overall Study|Adverse Event|9|||
31000678|NCT01939548|59199413|FG002|Overall Study|Adverse Event|7|||
31000679|NCT01939548|59199411|FG000|Overall Study|Death|0|||
31000680|NCT01939548|59199412|FG001|Overall Study|Death|0|||
31000681|NCT01939548|59199413|FG002|Overall Study|Death|1|||
31000682|NCT01939548|59199411|FG000|Overall Study|Participant dropped|0|||
31000683|NCT01939548|59199412|FG001|Overall Study|Participant dropped|0|||
31000684|NCT01939548|59199413|FG002|Overall Study|Participant dropped|1|||
31000685|NCT01939548|59199411|FG000|Overall Study|Participant unwilling to continue|0|||
31000686|NCT01939548|59199412|FG001|Overall Study|Participant unwilling to continue|1|||
31000687|NCT01939548|59199413|FG002|Overall Study|Participant unwilling to continue|0|||
31000688|NCT01939548|59199411|FG000|Overall Study|Participant withdrew consent|0|||
31000689|NCT01939548|59199412|FG001|Overall Study|Participant withdrew consent|2|||
31000690|NCT01939548|59199413|FG002|Overall Study|Participant withdrew consent|0|||
31000691|NCT01939548|59199411|FG000|Overall Study|Did not complete follow-up|0|||
31000692|NCT01939548|59199412|FG001|Overall Study|Did not complete follow-up|1|||
31000693|NCT01939548|59199413|FG002|Overall Study|Did not complete follow-up|0|||
31000694|NCT01960296|59199423|FG000|Overall Study|Postponed surgery|1|||
31000695|NCT01960296|59199424|FG001|Overall Study|Postponed surgery|0|||
31000696|NCT01960296|59199423|FG000|Overall Study|Received different procedure|1|||
31000697|NCT01960296|59199424|FG001|Overall Study|Received different procedure|3|||
31000698|NCT01982292|59199432|FG000|Overall Study|Adverse Event|2|||
31000699|NCT01982292|59199433|FG001|Overall Study|Adverse Event|0|||
31000700|NCT01982292|59199432|FG000|Overall Study|Death|1|||
31000701|NCT01982292|59199433|FG001|Overall Study|Death|0|||
31000702|NCT01982292|59199432|FG000|Overall Study|Lost to Follow-up|2|||
31000703|NCT01982292|59199433|FG001|Overall Study|Lost to Follow-up|0|||
31000704|NCT01982292|59199432|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
31000705|NCT01982292|59199433|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
31000706|NCT01982292|59199432|FG000|Overall Study|Protocol Deviation|1|||
31000707|NCT01982292|59199433|FG001|Overall Study|Protocol Deviation|0|||
31000708|NCT01982292|59199432|FG000|Overall Study|Patient/Guardian Decision|3|||
31000709|NCT01982292|59199433|FG001|Overall Study|Patient/Guardian Decision|1|||
31000710|NCT01982292|59199432|FG000|Overall Study|Technical Problems|2|||
31000711|NCT01982292|59199433|FG001|Overall Study|Technical Problems|0|||
31000712|NCT01939314|59199441|FG000|Overall Study|Withdrawal by Subject|3|||
31000713|NCT01939314|59199442|FG001|Overall Study|Withdrawal by Subject|1|||
31000714|NCT01939314|59199441|FG000|Overall Study|Protocol Violation|1|||
31000715|NCT01939314|59199442|FG001|Overall Study|Protocol Violation|0|||
31000716|NCT01939314|59199441|FG000|Overall Study|Pregnancy|0|||
31000717|NCT01939314|59199442|FG001|Overall Study|Pregnancy|1|||
31000718|NCT01939314|59199441|FG000|Overall Study|Lost to Follow-up|5|||
31000719|NCT01939314|59199442|FG001|Overall Study|Lost to Follow-up|6|||
31000720|NCT01939158|59199454|FG000|Overall Study|Adverse Event|1|||
31000721|NCT01939158|59199455|FG001|Overall Study|Adverse Event|0|||
31000722|NCT01939158|59199456|FG002|Overall Study|Adverse Event|0|||
31000723|NCT01939158|59199457|FG003|Overall Study|Adverse Event|0|||
31000724|NCT01939158|59199454|FG000|Overall Study|Withdrawal by Subject|22|||
31000725|NCT01939158|59199455|FG001|Overall Study|Withdrawal by Subject|25|||
31000726|NCT01939158|59199456|FG002|Overall Study|Withdrawal by Subject|15|||
31000727|NCT01939158|59199457|FG003|Overall Study|Withdrawal by Subject|17|||
31000728|NCT01939158|59199454|FG000|Overall Study|Migrated/moved from study area|5|||
31000729|NCT01939158|59199455|FG001|Overall Study|Migrated/moved from study area|7|||
31000730|NCT01939158|59199456|FG002|Overall Study|Migrated/moved from study area|3|||
31000731|NCT01939158|59199457|FG003|Overall Study|Migrated/moved from study area|6|||
31000732|NCT01939158|59199454|FG000|Overall Study|Lost to Follow-up|18|||
31000733|NCT01939158|59199455|FG001|Overall Study|Lost to Follow-up|17|||
31000734|NCT01939158|59199456|FG002|Overall Study|Lost to Follow-up|17|||
31000735|NCT01939158|59199457|FG003|Overall Study|Lost to Follow-up|17|||
31000736|NCT01939158|59199454|FG000|Overall Study|Death|0|||
31000737|NCT01939158|59199455|FG001|Overall Study|Death|0|||
31000738|NCT01939158|59199456|FG002|Overall Study|Death|1|||
31000739|NCT01939158|59199457|FG003|Overall Study|Death|1|||
31000740|NCT01939158|59199454|FG000|Overall Study|No longer meets eligibility criteria|0|||
31000741|NCT01939158|59199455|FG001|Overall Study|No longer meets eligibility criteria|0|||
31000742|NCT01939158|59199456|FG002|Overall Study|No longer meets eligibility criteria|1|||
31000743|NCT01939158|59199457|FG003|Overall Study|No longer meets eligibility criteria|0|||
31000744|NCT01939158|59199454|FG000|Overall Study|Other|1|||
31000745|NCT01939158|59199455|FG001|Overall Study|Other|3|||
31000746|NCT01939158|59199456|FG002|Overall Study|Other|4|||
31000747|NCT01939158|59199457|FG003|Overall Study|Other|3|||
31000748|NCT01939002|59199473|FG000|Overall Study|Adverse Event|13|||
31000749|NCT01939002|59199474|FG001|Overall Study|Adverse Event|13|||
31000750|NCT01939002|59199473|FG000|Overall Study|Withdrawal by Subject|5|||
31000751|NCT01939002|59199474|FG001|Overall Study|Withdrawal by Subject|3|||
31000752|NCT01939002|59199473|FG000|Overall Study|Other|1|||
31000753|NCT01939002|59199474|FG001|Overall Study|Other|2|||
31000754|NCT01938846|59199488|FG000|Overall Study|Progressive disease|26|||
31000755|NCT01938846|59199489|FG001|Overall Study|Progressive disease|18|||
31000756|NCT01938846|59199490|FG002|Overall Study|Progressive disease|16|||
31000757|NCT01938846|59199488|FG000|Overall Study|Adverse Event|8|||
31000758|NCT01938846|59199489|FG001|Overall Study|Adverse Event|4|||
31000759|NCT01938846|59199490|FG002|Overall Study|Adverse Event|3|||
31000760|NCT01938846|59199488|FG000|Overall Study|Withdrawal by Subject|2|||
31000761|NCT01938846|59199489|FG001|Overall Study|Withdrawal by Subject|2|||
31000762|NCT01938846|59199490|FG002|Overall Study|Withdrawal by Subject|1|||
31000763|NCT01938846|59199488|FG000|Overall Study|Other than listed|5|||
31000764|NCT01938846|59199489|FG001|Overall Study|Other than listed|1|||
31000765|NCT01938846|59199490|FG002|Overall Study|Other than listed|4|||
31000766|NCT01960140|59199531|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
31000767|NCT01981356|59199541|FG000|Overall Study|Lost to Follow-up|4|||
31000768|NCT01981356|59199542|FG001|Overall Study|Lost to Follow-up|1|||
31000769|NCT01981356|59199541|FG000|Overall Study|Withdrawal by Subject|1|||
31000770|NCT01981356|59199542|FG001|Overall Study|Withdrawal by Subject|1|||
31000771|NCT01981356|59199541|FG000|Overall Study|Protocol Violation|2|||
31000772|NCT01981356|59199542|FG001|Overall Study|Protocol Violation|0|||
31000773|NCT01981122|59199551|FG000|Overall Study|Withdrawal by Subject|0|||
31000774|NCT01981122|59199552|FG001|Overall Study|Withdrawal by Subject|2|||
31000775|NCT01981122|59199551|FG000|Overall Study|Protocol Violation|0|||
31000776|NCT01981122|59199552|FG001|Overall Study|Protocol Violation|1|||
31000777|NCT01981122|59199551|FG000|Overall Study|Lost to Follow-up|0|||
31000778|NCT01981122|59199552|FG001|Overall Study|Lost to Follow-up|1|||
31000779|NCT01981122|59199551|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
31000780|NCT01981122|59199552|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
31000781|NCT01981122|59199551|FG000|Overall Study|Death|14|||
31000782|NCT01981122|59199552|FG001|Overall Study|Death|15|||
31000783|NCT01959672|59199558|FG000|Overall Study|Death|1|||
31000784|NCT01980888|59199567|FG000|Overall Study|Study Terminated by Sponsor|116|||
31000785|NCT01980888|59199568|FG001|Overall Study|Study Terminated by Sponsor|122|||
31000786|NCT01980888|59199567|FG000|Overall Study|Withdrew Consent|17|||
31000787|NCT01980888|59199568|FG001|Overall Study|Withdrew Consent|6|||
31000788|NCT01980888|59199567|FG000|Overall Study|Investigator's Discretion|8|||
31000789|NCT01980888|59199568|FG001|Overall Study|Investigator's Discretion|3|||
31000790|NCT01980888|59199567|FG000|Overall Study|Non-Compliance with Study Drug|3|||
31000791|NCT01980888|59199568|FG001|Overall Study|Non-Compliance with Study Drug|2|||
31000792|NCT01937364|59199585|FG000|Overall Study|Adverse Event|2|||
31000793|NCT01937364|59199586|FG001|Overall Study|Adverse Event|1|||
31000794|NCT01979952|59199594|FG000|Overall Study|Adverse Event|4|||
31000795|NCT01979952|59199595|FG001|Overall Study|Adverse Event|5|||
31000796|NCT01979952|59199594|FG000|Overall Study|Protocol Violation|1|||
31000797|NCT01979952|59199595|FG001|Overall Study|Protocol Violation|0|||
31000798|NCT01979952|59199594|FG000|Overall Study|Withdrawal by Subject|2|||
31000799|NCT01979952|59199595|FG001|Overall Study|Withdrawal by Subject|1|||
31000800|NCT01979952|59199594|FG000|Overall Study|Other than specified above|1|||
31000801|NCT01979952|59199595|FG001|Overall Study|Other than specified above|0|||
31000802|NCT01999218|59199604|FG000|Overall Study|Hyperglycemia|18|||
31000803|NCT01999218|59199605|FG001|Overall Study|Hyperglycemia|17|||
31000804|NCT01999218|59199606|FG002|Overall Study|Hyperglycemia|17|||
31000805|NCT01999218|59199604|FG000|Overall Study|Lack of Efficacy|1|||
31000806|NCT01999218|59199605|FG001|Overall Study|Lack of Efficacy|0|||
31000807|NCT01999218|59199606|FG002|Overall Study|Lack of Efficacy|1|||
31000808|NCT01999218|59199604|FG000|Overall Study|Lost to Follow-up|22|||
31000809|NCT01999218|59199605|FG001|Overall Study|Lost to Follow-up|17|||
31000810|NCT01999218|59199606|FG002|Overall Study|Lost to Follow-up|18|||
31000811|NCT01999218|59199604|FG000|Overall Study|Non-Compliance With Study Drug|6|||
31000812|NCT01999218|59199605|FG001|Overall Study|Non-Compliance With Study Drug|4|||
31000813|NCT01999218|59199606|FG002|Overall Study|Non-Compliance With Study Drug|1|||
31000814|NCT01999218|59199604|FG000|Overall Study|Physician Decision|1|||
31000815|NCT01999218|59199605|FG001|Overall Study|Physician Decision|4|||
31000816|NCT01999218|59199606|FG002|Overall Study|Physician Decision|6|||
31000817|NCT01999218|59199604|FG000|Overall Study|Protocol Violation|4|||
31000818|NCT01999218|59199605|FG001|Overall Study|Protocol Violation|5|||
31000819|NCT01999218|59199606|FG002|Overall Study|Protocol Violation|4|||
31000820|NCT01999218|59199604|FG000|Overall Study|Screen failure|0|||
31000821|NCT01999218|59199605|FG001|Overall Study|Screen failure|1|||
31000822|NCT01999218|59199606|FG002|Overall Study|Screen failure|0|||
31000823|NCT01999218|59199604|FG000|Overall Study|Study Terminated By Sponsor|7|||
31000824|NCT01999218|59199605|FG001|Overall Study|Study Terminated By Sponsor|5|||
31000825|NCT01999218|59199606|FG002|Overall Study|Study Terminated By Sponsor|12|||
31000826|NCT01999218|59199604|FG000|Overall Study|Participant moves|2|||
31000827|NCT01999218|59199605|FG001|Overall Study|Participant moves|5|||
31000828|NCT01999218|59199606|FG002|Overall Study|Participant moves|3|||
31000829|NCT01999218|59199604|FG000|Overall Study|Withdrawal by Subject|28|||
31000830|NCT01999218|59199605|FG001|Overall Study|Withdrawal by Subject|29|||
31000831|NCT01999218|59199606|FG002|Overall Study|Withdrawal by Subject|34|||
31000832|NCT01999218|59199604|FG000|Overall Study|Creatinine/eGFR|0|||
31000833|NCT01999218|59199605|FG001|Overall Study|Creatinine/eGFR|0|||
31000834|NCT01999218|59199606|FG002|Overall Study|Creatinine/eGFR|1|||
31000835|NCT01999218|59199604|FG000|Overall Study|Death|7|||
31000836|NCT01999218|59199605|FG001|Overall Study|Death|1|||
31000837|NCT01999218|59199606|FG002|Overall Study|Death|2|||
31000838|NCT01999218|59199604|FG000|Overall Study|Excluded Medication|1|||
31000839|NCT01999218|59199605|FG001|Overall Study|Excluded Medication|1|||
31000840|NCT01999218|59199606|FG002|Overall Study|Excluded Medication|2|||
31000841|NCT01999218|59199604|FG000|Overall Study|Adverse Event|9|||
31000842|NCT01999218|59199605|FG001|Overall Study|Adverse Event|7|||
31000843|NCT01999218|59199606|FG002|Overall Study|Adverse Event|7|||
31000844|NCT01999218|59199604|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
31000845|NCT01999218|59199605|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
31000846|NCT01999218|59199606|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
31000847|NCT01937130|59199618|FG000|Overall Study|Withdrawal by Subject|0|||
31000848|NCT01937130|59199619|FG001|Overall Study|Withdrawal by Subject|0|||
31000849|NCT01937130|59199620|FG002|Overall Study|Withdrawal by Subject|0|||
31000850|NCT01937130|59199621|FG003|Overall Study|Withdrawal by Subject|1|||
31000851|NCT01937130|59199618|FG000|Overall Study|Adverse Event|0|||
31000852|NCT01937130|59199619|FG001|Overall Study|Adverse Event|1|||
31000853|NCT01937130|59199620|FG002|Overall Study|Adverse Event|0|||
31000854|NCT01937130|59199621|FG003|Overall Study|Adverse Event|1|||
31000855|NCT01937130|59199618|FG000|Overall Study|Death|1|||
31000856|NCT01937130|59199619|FG001|Overall Study|Death|1|||
31000857|NCT01937130|59199620|FG002|Overall Study|Death|1|||
31000858|NCT01937130|59199621|FG003|Overall Study|Death|0|||
31000859|NCT01937130|59199618|FG000|Overall Study|Lost to Follow-up|2|||
31000860|NCT01937130|59199619|FG001|Overall Study|Lost to Follow-up|0|||
31000861|NCT01937130|59199620|FG002|Overall Study|Lost to Follow-up|2|||
31000862|NCT01937130|59199621|FG003|Overall Study|Lost to Follow-up|0|||
31000863|NCT01937130|59199618|FG000|Overall Study|Physician Decision|0|||
31000864|NCT01937130|59199619|FG001|Overall Study|Physician Decision|1|||
31000865|NCT01937130|59199620|FG002|Overall Study|Physician Decision|0|||
31000866|NCT01937130|59199621|FG003|Overall Study|Physician Decision|0|||
31000867|NCT01937130|59199618|FG000|Overall Study|Patients unable to swallow|0|||
31000868|NCT01937130|59199619|FG001|Overall Study|Patients unable to swallow|1|||
31000869|NCT01937130|59199620|FG002|Overall Study|Patients unable to swallow|0|||
31000870|NCT01937130|59199621|FG003|Overall Study|Patients unable to swallow|0|||
31000871|NCT01937130|59199618|FG000|Overall Study|Patient lost to FU due to death|2|||
31000872|NCT01937130|59199619|FG001|Overall Study|Patient lost to FU due to death|0|||
31000873|NCT01937130|59199620|FG002|Overall Study|Patient lost to FU due to death|0|||
31000874|NCT01937130|59199621|FG003|Overall Study|Patient lost to FU due to death|0|||
31000875|NCT01936974|59199633|FG000|Overall Study|Physician Decision|2|||
31000876|NCT01936974|59199634|FG001|Overall Study|Physician Decision|5|||
31000877|NCT01959516|59199640|FG000|Epoch 1|Adverse Event|4|||
31000878|NCT01959516|59199641|FG001|Epoch 1|Adverse Event|1|||
31000879|NCT01959516|59199640|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
31000880|NCT01959516|59199641|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
31000881|NCT01959516|59199640|FG000|Epoch 1|Subject withdrew consent|3|||
31000882|NCT01959516|59199641|FG001|Epoch 1|Subject withdrew consent|2|||
31000883|NCT01959516|59199640|FG000|Epoch 1|Administrative problems|1|||
31000884|NCT01959516|59199641|FG001|Epoch 1|Administrative problems|0|||
31000885|NCT01959516|59199640|FG000|Epoch 1|Use of prohibited treatment|1|||
31000886|NCT01959516|59199641|FG001|Epoch 1|Use of prohibited treatment|0|||
31000887|NCT01959516|59199640|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
31000888|NCT01959516|59199641|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
31000889|NCT01959516|59199640|FG000|Epoch 1|Protocol deviation|0|||
31000890|NCT01959516|59199641|FG001|Epoch 1|Protocol deviation|1|||
31000891|NCT01959516|59199640|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
31000892|NCT01959516|59199641|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
31000893|NCT01959516|59199640|FG000|Epoch 2|Subject withdrew consent|1|||
31000894|NCT01959516|59199641|FG001|Epoch 2|Subject withdrew consent|0|||
31000895|NCT01959516|59199640|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
31000896|NCT01959516|59199641|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
31000897|NCT01979016|59199649|FG000|Overall Study|Withdrawal by Subject|2|||
31000898|NCT01979016|59199650|FG001|Overall Study|Withdrawal by Subject|0|||
31000899|NCT01979016|59199649|FG000|Overall Study|Adverse Event|0|||
31000900|NCT01979016|59199650|FG001|Overall Study|Adverse Event|1|||
31000901|NCT01935336|59199660|FG000|Overall Study|Adverse Event|1|||
31000902|NCT01935336|59199661|FG001|Overall Study|Adverse Event|0|||
31000903|NCT01935336|59199662|FG002|Overall Study|Adverse Event|0|||
31000904|NCT01935336|59199663|FG003|Overall Study|Adverse Event|0|||
31000905|NCT01935336|59199660|FG000|Overall Study|Progressive disease|5|||
31000906|NCT01935336|59199661|FG001|Overall Study|Progressive disease|3|||
31000907|NCT01935336|59199662|FG002|Overall Study|Progressive disease|47|||
31000908|NCT01935336|59199663|FG003|Overall Study|Progressive disease|66|||
31000909|NCT01978236|59199679|FG000|Overall Study|Discontinued due to study close|2|||
31000910|NCT01977846|59199685|FG000|Total Study - Prospective|Death|0|||
31000911|NCT01977846|59199686|FG001|Total Study - Prospective|Death|1|||
31000912|NCT01977846|59199685|FG000|Total Study - Prospective|Lost to Follow-up|0|||
31000913|NCT01977846|59199686|FG001|Total Study - Prospective|Lost to Follow-up|8|||
31000914|NCT01977846|59199685|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
31000915|NCT01977846|59199686|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
31000916|NCT01977846|59199685|FG000|Total Study - Prospective|Not available at time of visit|0|||
31000917|NCT01977846|59199686|FG001|Total Study - Prospective|Not available at time of visit|5|||
31000918|NCT01977846|59199685|FG000|Total Study - Prospective|No show|0|||
31000919|NCT01977846|59199686|FG001|Total Study - Prospective|No show|1|||
31000920|NCT01977846|59199685|FG000|Total Study - Prospective|Protocol Violation|0|||
31000921|NCT01977846|59199686|FG001|Total Study - Prospective|Protocol Violation|1|||
31000922|NCT01934790|59199693|FG000|Treatment|Adverse Event|3|||
31000923|NCT01934790|59199693|FG000|Treatment|Clinical progression|6|||
31000924|NCT01934790|59199693|FG000|Treatment|Radiological progression|4|||
31000925|NCT01934790|59199693|FG000|Treatment|Withdrawal by Subject|2|||
31000926|NCT01934790|59199693|FG000|Treatment|Study drug never administered|1|||
31000927|NCT01934790|59199693|FG000|Active Follow up|Death|20|||
31000928|NCT01934790|59199693|FG000|Active Follow up|Physician Decision|2|||
31000929|NCT01934790|59199693|FG000|Active Follow up|Progressive disease|1|||
31000930|NCT01934790|59199693|FG000|Active Follow up|Other reason|1|||
31000931|NCT01934556|59199700|FG000|Overall Study|Withdrawal by Subject|0|||
31000932|NCT01934556|59199701|FG001|Overall Study|Withdrawal by Subject|1|||
31000933|NCT01934556|59199702|FG002|Overall Study|Withdrawal by Subject|1|||
31000934|NCT01934556|59199700|FG000|Overall Study|Lost to Follow-up|4|||
31000935|NCT01934556|59199701|FG001|Overall Study|Lost to Follow-up|10|||
31000936|NCT01934556|59199702|FG002|Overall Study|Lost to Follow-up|7|||
31000937|NCT01934556|59199700|FG000|Overall Study|Death|1|||
31000938|NCT01934556|59199701|FG001|Overall Study|Death|5|||
31000939|NCT01934556|59199702|FG002|Overall Study|Death|2|||
31000940|NCT01977690|59199712|FG000|Overall Study|Withdrawal by Subject|0|||
31000941|NCT01977690|59199713|FG001|Overall Study|Withdrawal by Subject|4|||
31000942|NCT01934010|59199788|FG000|Overall Study|Adverse Event|1|||
31000943|NCT01934010|59199789|FG001|Overall Study|Adverse Event|1|||
31000944|NCT01934010|59199790|FG002|Overall Study|Adverse Event|0|||
31000945|NCT01934010|59199788|FG000|Overall Study|Withdrawal by Subject|15|||
31000946|NCT01934010|59199789|FG001|Overall Study|Withdrawal by Subject|6|||
31000947|NCT01934010|59199790|FG002|Overall Study|Withdrawal by Subject|2|||
31000948|NCT01934010|59199788|FG000|Overall Study|Lost to Follow-up|7|||
31000949|NCT01934010|59199789|FG001|Overall Study|Lost to Follow-up|4|||
31000950|NCT01934010|59199790|FG002|Overall Study|Lost to Follow-up|0|||
31000951|NCT01620138|59199809|FG000|Overall Study|Withdrawal by Subject|3|||
31000952|NCT01620138|59199810|FG001|Overall Study|Withdrawal by Subject|0|||
31000953|NCT01620138|59199809|FG000|Overall Study|Lack of Efficacy|1|||
31000954|NCT01620138|59199810|FG001|Overall Study|Lack of Efficacy|0|||
31000955|NCT01620138|59199809|FG000|Overall Study|Adverse Event|2|||
31000956|NCT01620138|59199810|FG001|Overall Study|Adverse Event|0|||
31000957|NCT01977612|59199818|FG000|Overall Study|Lost to Follow-up|1|||
31000958|NCT01977612|59199819|FG001|Overall Study|Lost to Follow-up|1|||
31000959|NCT01932996|59199827|FG000|Overall Study|Protocol Violation|2|||
31000960|NCT01932996|59199828|FG001|Overall Study|Protocol Violation|0|||
31000961|NCT01932762|59199838|FG000|Overall Study|Withdrawal by Subject|1|||
31000962|NCT01932762|59199839|FG001|Overall Study|Withdrawal by Subject|2|||
31000963|NCT01932762|59199840|FG002|Overall Study|Withdrawal by Subject|0|||
31000964|NCT01932762|59199841|FG003|Overall Study|Withdrawal by Subject|0|||
31000965|NCT01932762|59199838|FG000|Overall Study|Lost to Follow-up|4|||
31000966|NCT01932762|59199839|FG001|Overall Study|Lost to Follow-up|0|||
31000967|NCT01932762|59199840|FG002|Overall Study|Lost to Follow-up|0|||
31000968|NCT01932762|59199841|FG003|Overall Study|Lost to Follow-up|1|||
31000969|NCT01932762|59199838|FG000|Overall Study|Physician Decision|1|||
31000970|NCT01932762|59199839|FG001|Overall Study|Physician Decision|0|||
31000971|NCT01932762|59199840|FG002|Overall Study|Physician Decision|0|||
31000972|NCT01932762|59199841|FG003|Overall Study|Physician Decision|0|||
31000973|NCT01618968|59199855|FG000|Overall Study|Adverse Event|1|||
31000974|NCT01618968|59199856|FG001|Overall Study|Adverse Event|0|||
31000975|NCT01618968|59199857|FG002|Overall Study|Adverse Event|0|||
31000976|NCT01618968|59199858|FG003|Overall Study|Adverse Event|0|||
31000977|NCT01618968|59199855|FG000|Overall Study|Death|0|||
31000978|NCT01618968|59199856|FG001|Overall Study|Death|0|||
31000979|NCT01618968|59199857|FG002|Overall Study|Death|0|||
31000980|NCT01618968|59199858|FG003|Overall Study|Death|1|||
31000981|NCT01932294|59199867|FG000|Overall Study|Death|43|||
31000982|NCT01932294|59199867|FG000|Overall Study|Lost to Follow-up|8|||
31000983|NCT01932294|59199867|FG000|Overall Study|VAD Implantation|20|||
31000984|NCT01932294|59199867|FG000|Overall Study|Heart Transplantation|16|||
31000985|NCT01932294|59199867|FG000|Overall Study|Transferred to other hospitals|12|||
31000986|NCT01931670|59199875|FG000|Treatment Period|Exclusionary Medication Received|1|||
31000987|NCT01931670|59199876|FG001|Treatment Period|Exclusionary Medication Received|1|||
31000988|NCT01931670|59199877|FG002|Treatment Period|Exclusionary Medication Received|1|||
31000989|NCT01931670|59199875|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
31000990|NCT01931670|59199876|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
31000991|NCT01931670|59199877|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
31000992|NCT01931670|59199875|FG000|Treatment Period|Subject Noncompliant|4|||
31000993|NCT01931670|59199876|FG001|Treatment Period|Subject Noncompliant|9|||
31000994|NCT01931670|59199877|FG002|Treatment Period|Subject Noncompliant|5|||
31000995|NCT01931670|59199875|FG000|Treatment Period|Adverse Event|19|||
31000996|NCT01931670|59199876|FG001|Treatment Period|Adverse Event|8|||
31000997|NCT01931670|59199877|FG002|Treatment Period|Adverse Event|21|||
31000998|NCT01931670|59199875|FG000|Treatment Period|Lack of Efficacy|11|||
31000999|NCT01931670|59199876|FG001|Treatment Period|Lack of Efficacy|2|||
31001000|NCT01931670|59199877|FG002|Treatment Period|Lack of Efficacy|2|||
31001001|NCT01931670|59199875|FG000|Treatment Period|Pregnancy|7|||
31001002|NCT01931670|59199876|FG001|Treatment Period|Pregnancy|2|||
31001003|NCT01931670|59199877|FG002|Treatment Period|Pregnancy|0|||
31001004|NCT01931670|59199875|FG000|Treatment Period|Other|8|||
31001005|NCT01931670|59199876|FG001|Treatment Period|Other|7|||
31001006|NCT01931670|59199877|FG002|Treatment Period|Other|2|||
31001007|NCT01931670|59199875|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
31001008|NCT01931670|59199876|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
31001009|NCT01931670|59199877|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
31001010|NCT01931670|59199875|FG000|Treatment Period|Lost to Follow-up|19|||
31001011|NCT01931670|59199876|FG001|Treatment Period|Lost to Follow-up|5|||
31001012|NCT01931670|59199877|FG002|Treatment Period|Lost to Follow-up|7|||
31001013|NCT01931670|59199875|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
31001014|NCT01931670|59199876|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
31001015|NCT01931670|59199877|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
31001016|NCT01931670|59199875|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
31001017|NCT01931670|59199876|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
31001018|NCT01931670|59199877|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
31001019|NCT01931670|59199875|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
31001020|NCT01931670|59199876|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
31001021|NCT01931670|59199877|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
31001022|NCT01931670|59199875|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
31001023|NCT01931670|59199876|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
30892419|NCT02135445|58925921|FG001|Overall Study|Lost to Follow-up|0|||
30892420|NCT02135445|58925920|FG000|Overall Study|Withdrawal by Subject|1|||
30892421|NCT02135445|58925921|FG001|Overall Study|Withdrawal by Subject|0|||
30892422|NCT02374099|58925929|FG000|Overall Study|Adverse Event|1|||
30892423|NCT02374099|58925930|FG001|Overall Study|Adverse Event|0|||
30892424|NCT02374099|58925929|FG000|Overall Study|Progressive Disease|35|||
30892425|NCT02374099|58925930|FG001|Overall Study|Progressive Disease|40|||
30892426|NCT02374099|58925929|FG000|Overall Study|Withdrawal by Subject|5|||
30892427|NCT02374099|58925930|FG001|Overall Study|Withdrawal by Subject|1|||
30892428|NCT02374099|58925929|FG000|Overall Study|Miscellaneous|2|||
30892429|NCT02374099|58925930|FG001|Overall Study|Miscellaneous|3|||
30892430|NCT02374099|58925929|FG000|Overall Study|Randomized, but not treated|2|||
30892431|NCT02374099|58925930|FG001|Overall Study|Randomized, but not treated|1|||
30892432|NCT02374099|58925929|FG000|Overall Study|Study Terminated by Sponsor|3|||
30892433|NCT02374099|58925930|FG001|Overall Study|Study Terminated by Sponsor|4|||
30892434|NCT02134977|58925936|FG000|Overall Study|Protocol Deviation|102|||
30892435|NCT02374021|58925942|FG000|Overall Study|Adverse Event|1|||
30892436|NCT02374021|58925943|FG001|Overall Study|Adverse Event|0|||
30892437|NCT02374021|58925942|FG000|Overall Study|Lost to Follow-up|3|||
30892438|NCT02374021|58925943|FG001|Overall Study|Lost to Follow-up|2|||
30892439|NCT02374021|58925942|FG000|Overall Study|Physician Decision|0|||
30892440|NCT02374021|58925943|FG001|Overall Study|Physician Decision|3|||
30892441|NCT02374021|58925942|FG000|Overall Study|Withdrawal by Subject|6|||
30892442|NCT02374021|58925943|FG001|Overall Study|Withdrawal by Subject|5|||
30892443|NCT02374021|58925942|FG000|Overall Study|Poor Adherence|0|||
30892444|NCT02374021|58925943|FG001|Overall Study|Poor Adherence|1|||
30892445|NCT02374021|58925942|FG000|Overall Study|Scan protocol not followed|0|||
30892446|NCT02374021|58925943|FG001|Overall Study|Scan protocol not followed|1|||
30892447|NCT02374021|58925942|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
30892448|NCT02374021|58925943|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
31001024|NCT01931670|59199877|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
31001025|NCT01931670|59199875|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
31001026|NCT01931670|59199876|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
31001027|NCT01931670|59199877|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
31001028|NCT01931670|59199875|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
31001029|NCT01931670|59199876|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
31001030|NCT01931670|59199877|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
31001031|NCT01977456|59199885|FG000|Overall Study|Death|5|||
31001032|NCT01957644|59199894|FG000|Overall Study|Adverse Event|4|||
31001033|NCT01957644|59199895|FG001|Overall Study|Adverse Event|2|||
31001034|NCT01957644|59199896|FG002|Overall Study|Adverse Event|0|||
31001035|NCT01957644|59199897|FG003|Overall Study|Adverse Event|0|||
31001036|NCT01957644|59199898|FG004|Overall Study|Adverse Event|1|||
31001037|NCT01957644|59199894|FG000|Overall Study|Progressive disease / relapse|0|||
31001038|NCT01957644|59199895|FG001|Overall Study|Progressive disease / relapse|1|||
31001039|NCT01957644|59199896|FG002|Overall Study|Progressive disease / relapse|0|||
31001040|NCT01957644|59199897|FG003|Overall Study|Progressive disease / relapse|1|||
31001041|NCT01957644|59199898|FG004|Overall Study|Progressive disease / relapse|0|||
31001042|NCT01957644|59199894|FG000|Overall Study|Other reason|1|||
31001043|NCT01957644|59199895|FG001|Overall Study|Other reason|2|||
31001044|NCT01957644|59199896|FG002|Overall Study|Other reason|1|||
31001045|NCT01957644|59199897|FG003|Overall Study|Other reason|1|||
31001046|NCT01957644|59199898|FG004|Overall Study|Other reason|0|||
31001047|NCT01957644|59199894|FG000|Overall Study|Withdrawal by Subject|1|||
31001048|NCT01957644|59199895|FG001|Overall Study|Withdrawal by Subject|0|||
31001049|NCT01957644|59199896|FG002|Overall Study|Withdrawal by Subject|0|||
31001050|NCT01957644|59199897|FG003|Overall Study|Withdrawal by Subject|0|||
31001051|NCT01957644|59199898|FG004|Overall Study|Withdrawal by Subject|0|||
31001052|NCT01957644|59199894|FG000|Overall Study|Protocol Violation|0|||
31001053|NCT01957644|59199895|FG001|Overall Study|Protocol Violation|1|||
31001054|NCT01957644|59199896|FG002|Overall Study|Protocol Violation|0|||
31001055|NCT01957644|59199897|FG003|Overall Study|Protocol Violation|0|||
31001056|NCT01957644|59199898|FG004|Overall Study|Protocol Violation|0|||
31001057|NCT01931202|59199915|FG000|Overall Study|Withdrawal by Subject|0|||
31001058|NCT01931202|59199916|FG001|Overall Study|Withdrawal by Subject|0|||
31001059|NCT01931202|59199917|FG002|Overall Study|Withdrawal by Subject|2|||
31001060|NCT01931202|59199915|FG000|Overall Study|Lost to Follow-up|0|||
31001061|NCT01931202|59199916|FG001|Overall Study|Lost to Follow-up|5|||
31001062|NCT01931202|59199917|FG002|Overall Study|Lost to Follow-up|2|||
31001063|NCT01930890|59199932|FG000|Overall Study|Study Termination|14|||
31001064|NCT01930890|59199933|FG001|Overall Study|Study Termination|28|||
31001065|NCT01930890|59199934|FG002|Overall Study|Study Termination|13|||
31001066|NCT01930890|59199935|FG003|Overall Study|Study Termination|25|||
31001067|NCT01930890|59199932|FG000|Overall Study|Death|0|||
31001068|NCT01930890|59199933|FG001|Overall Study|Death|0|||
31001069|NCT01930890|59199934|FG002|Overall Study|Death|0|||
31001070|NCT01930890|59199935|FG003|Overall Study|Death|1|||
31001071|NCT01930890|59199932|FG000|Overall Study|Investigator Decision|0|||
31001072|NCT01930890|59199933|FG001|Overall Study|Investigator Decision|1|||
31001073|NCT01930890|59199934|FG002|Overall Study|Investigator Decision|0|||
31001074|NCT01930890|59199935|FG003|Overall Study|Investigator Decision|0|||
31001075|NCT01930890|59199932|FG000|Overall Study|Consent Withdrawn|0|||
31001076|NCT01930890|59199933|FG001|Overall Study|Consent Withdrawn|3|||
31001077|NCT01930890|59199934|FG002|Overall Study|Consent Withdrawn|0|||
31001078|NCT01930890|59199935|FG003|Overall Study|Consent Withdrawn|1|||
31001079|NCT01930890|59199932|FG000|Overall Study|Adverse Event|0|||
31001080|NCT01930890|59199933|FG001|Overall Study|Adverse Event|1|||
31001081|NCT01930890|59199934|FG002|Overall Study|Adverse Event|0|||
31001082|NCT01930890|59199935|FG003|Overall Study|Adverse Event|0|||
31001083|NCT01930188|59199948|FG000|Overall Study|unclassified|4|||
31001084|NCT01930188|59199949|FG001|Overall Study|unclassified|5|||
31001085|NCT01930188|59199950|FG002|Overall Study|unclassified|3|||
31001086|NCT01930188|59199948|FG000|Overall Study|Missing follow-up information|2|||
31001087|NCT01930188|59199949|FG001|Overall Study|Missing follow-up information|2|||
31001088|NCT01930188|59199950|FG002|Overall Study|Missing follow-up information|3|||
31001089|NCT01930188|59199948|FG000|Overall Study|Lost to Follow-up|5|||
31001090|NCT01930188|59199949|FG001|Overall Study|Lost to Follow-up|2|||
31001091|NCT01930188|59199950|FG002|Overall Study|Lost to Follow-up|2|||
31001092|NCT01930188|59199948|FG000|Overall Study|Death|2|||
31001093|NCT01930188|59199949|FG001|Overall Study|Death|1|||
31001094|NCT01930188|59199950|FG002|Overall Study|Death|3|||
31001095|NCT01930188|59199948|FG000|Overall Study|Withdrawal by Subject|9|||
31001096|NCT01930188|59199949|FG001|Overall Study|Withdrawal by Subject|11|||
31001097|NCT01930188|59199950|FG002|Overall Study|Withdrawal by Subject|8|||
31001098|NCT01977222|59199959|FG000|Overall Study|Withdrawal by Subject|1|||
31001099|NCT01957488|59199963|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
31001100|NCT01957488|59199964|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
31001101|NCT01957488|59199965|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
31001102|NCT01957488|59199966|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
31001103|NCT01957488|59199967|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
31001104|NCT01957488|59199968|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
31001105|NCT01957488|59199963|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
31001106|NCT01957488|59199964|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
31001107|NCT01957488|59199965|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
31001108|NCT01957488|59199966|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
31001109|NCT01957488|59199967|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
31001110|NCT01957488|59199968|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
31001111|NCT01957488|59199963|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
31001112|NCT01957488|59199964|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
31001113|NCT01957488|59199965|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
31001114|NCT01957488|59199966|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
31001115|NCT01957488|59199967|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
31001116|NCT01957488|59199968|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
31001117|NCT01957488|59199963|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
31001118|NCT01957488|59199964|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
31001119|NCT01957488|59199965|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
31001120|NCT01957488|59199966|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
31001121|NCT01957488|59199967|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
31001122|NCT01957488|59199968|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
31001123|NCT01957488|59199963|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
31001124|NCT01957488|59199964|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
31001125|NCT01957488|59199965|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
31001126|NCT01957488|59199966|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
31001127|NCT01957488|59199967|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
31001128|NCT01957488|59199968|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
31001129|NCT01957488|59199963|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
31001130|NCT01957488|59199964|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
31001131|NCT01957488|59199965|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
31001132|NCT01957488|59199966|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
31001133|NCT01957488|59199967|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
31001134|NCT01957488|59199968|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
31001135|NCT01957488|59199963|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
31001136|NCT01957488|59199964|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
31001137|NCT01957488|59199965|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
31001138|NCT01957488|59199966|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
31001139|NCT01957488|59199967|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
31001140|NCT01957488|59199968|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
31001141|NCT01957488|59199963|FG000|Test Period 2 (2 Weeks)|Other|1|||
31001142|NCT01957488|59199964|FG001|Test Period 2 (2 Weeks)|Other|0|||
31001143|NCT01957488|59199965|FG002|Test Period 2 (2 Weeks)|Other|0|||
31001144|NCT01957488|59199966|FG003|Test Period 2 (2 Weeks)|Other|0|||
31001145|NCT01957488|59199967|FG004|Test Period 2 (2 Weeks)|Other|0|||
31001146|NCT01957488|59199968|FG005|Test Period 2 (2 Weeks)|Other|0|||
31001147|NCT01957488|59199963|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
31001148|NCT01957488|59199964|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
31001149|NCT01957488|59199965|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
31001150|NCT01957488|59199966|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
31001151|NCT01957488|59199967|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
31001152|NCT01957488|59199968|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
31001153|NCT01957488|59199963|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
31001154|NCT01957488|59199964|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
31001155|NCT01957488|59199965|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
31001156|NCT01957488|59199966|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
31001157|NCT01957488|59199967|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
31001158|NCT01957488|59199968|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
31001159|NCT01957488|59199963|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
31001160|NCT01957488|59199964|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
31001161|NCT01957488|59199965|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
31001162|NCT01957488|59199966|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
31001163|NCT01957488|59199967|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
31001164|NCT01957488|59199968|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
31001165|NCT01957488|59199963|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
31001166|NCT01957488|59199964|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
31001167|NCT01957488|59199965|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
31001168|NCT01957488|59199966|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
31001169|NCT01957488|59199967|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
31001170|NCT01957488|59199968|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
31001171|NCT01957488|59199963|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
31001172|NCT01957488|59199964|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
31001173|NCT01957488|59199965|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
31001174|NCT01957488|59199966|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
31001175|NCT01957488|59199967|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
31001176|NCT01957488|59199968|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
31001177|NCT01976364|59199976|FG000|Main Study (36 Months)|Adverse Event|63|||
31001178|NCT01976364|59199977|FG001|Main Study (36 Months)|Adverse Event|0|||
31001179|NCT01976364|59199978|FG002|Main Study (36 Months)|Adverse Event|0|||
31001180|NCT01976364|59199976|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
31001181|NCT01976364|59199977|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
31001182|NCT01976364|59199978|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
31001183|NCT01976364|59199976|FG000|Main Study (36 Months)|Other|13|||
31001184|NCT01976364|59199977|FG001|Main Study (36 Months)|Other|0|||
30892449|NCT02372383|58925951|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
31001185|NCT01976364|59199978|FG002|Main Study (36 Months)|Other|0|||
31001186|NCT01976364|59199976|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
31001187|NCT01976364|59199977|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
31001188|NCT01976364|59199978|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
31001189|NCT01976364|59199976|FG000|Main Study (36 Months)|Medication error|1|||
31001190|NCT01976364|59199977|FG001|Main Study (36 Months)|Medication error|0|||
31001191|NCT01976364|59199978|FG002|Main Study (36 Months)|Medication error|0|||
31001192|NCT01976364|59199976|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
31001193|NCT01976364|59199977|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
31001194|NCT01976364|59199978|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
31001195|NCT01976364|59199976|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
31001196|NCT01976364|59199977|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
31001197|NCT01976364|59199978|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
31001198|NCT01976364|59199976|FG000|Main Study (36 Months)|Protocol Violation|13|||
31001199|NCT01976364|59199977|FG001|Main Study (36 Months)|Protocol Violation|0|||
31001200|NCT01976364|59199978|FG002|Main Study (36 Months)|Protocol Violation|0|||
31001201|NCT01976364|59199976|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
31001202|NCT01976364|59199977|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
31001203|NCT01976364|59199978|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
31001204|NCT01976364|59199976|FG000|Main Study (36 Months)|Death|5|||
31001205|NCT01976364|59199977|FG001|Main Study (36 Months)|Death|0|||
31001206|NCT01976364|59199978|FG002|Main Study (36 Months)|Death|0|||
31001207|NCT01976364|59199976|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
31001208|NCT01976364|59199977|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
31001209|NCT01976364|59199978|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
31001210|NCT01976364|59199976|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
31001211|NCT01976364|59199977|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
31001212|NCT01976364|59199978|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
31001213|NCT01976364|59199976|FG000|Sub-study (12 Months)|Protocol Violation|0|||
31001214|NCT01976364|59199977|FG001|Sub-study (12 Months)|Protocol Violation|1|||
31001215|NCT01976364|59199978|FG002|Sub-study (12 Months)|Protocol Violation|1|||
31001216|NCT01976364|59199976|FG000|Sub-study (12 Months)|Adverse Event|0|||
31001217|NCT01976364|59199977|FG001|Sub-study (12 Months)|Adverse Event|4|||
31001218|NCT01976364|59199978|FG002|Sub-study (12 Months)|Adverse Event|3|||
31001219|NCT01956240|59199989|FG000|Overall Study|Lost to Follow-up|6|||
31001220|NCT01956240|59199990|FG001|Overall Study|Lost to Follow-up|20|||
31001221|NCT01956240|59199989|FG000|Overall Study|Adverse Event|17|||
31001222|NCT01956240|59199990|FG001|Overall Study|Adverse Event|4|||
31001223|NCT01929876|59199996|FG000|Period 2|Non-Compliance|1|||
31001224|NCT01929408|59200000|FG000|Overall Study|received HCT as initial treatment|8|||
31001225|NCT01929018|59200006|FG000|Overall Study|Lost to Follow-up|1|||
31001226|NCT01929018|59200007|FG001|Overall Study|Lost to Follow-up|0|||
31001227|NCT01929018|59200006|FG000|Overall Study|Hospitalization|0|||
31001228|NCT01929018|59200007|FG001|Overall Study|Hospitalization|1|||
31001229|NCT01928940|59200015|FG000|Overall Study|Adverse Event|0|||
31001230|NCT01928940|59200016|FG001|Overall Study|Adverse Event|1|||
31001231|NCT01928862|59200028|FG000|Overall Study|Lost to Follow-up|1|||
31001232|NCT01928862|59200029|FG001|Overall Study|Lost to Follow-up|0|||
31001233|NCT01928862|59200030|FG002|Overall Study|Lost to Follow-up|0|||
31001234|NCT01928862|59200031|FG003|Overall Study|Lost to Follow-up|0|||
31001235|NCT01928862|59200032|FG004|Overall Study|Lost to Follow-up|1|||
31001236|NCT01954056|59200047|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
31001237|NCT01954056|59200048|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
31001238|NCT01953354|59200056|FG000|Overall Study|Withdrawal by Subject|0|||
31001239|NCT01953354|59200057|FG001|Overall Study|Withdrawal by Subject|1|||
30892450|NCT02372383|58925952|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
30892451|NCT02372383|58925953|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
30892452|NCT01648699|58925963|FG000|Overall Study|Death|1|||
30892453|NCT01648699|58925963|FG000|Overall Study|Lost to Follow-up|2|||
30892454|NCT01648699|58925963|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
30892455|NCT02134353|58925978|FG000|Overall Study|Adverse Event|10|||
30892456|NCT02134353|58925979|FG001|Overall Study|Adverse Event|6|||
30892457|NCT02134353|58925978|FG000|Overall Study|Lost to Follow-up|1|||
30892458|NCT02134353|58925979|FG001|Overall Study|Lost to Follow-up|1|||
30892459|NCT02134353|58925978|FG000|Overall Study|Lack of Efficacy|2|||
30892460|NCT02134353|58925979|FG001|Overall Study|Lack of Efficacy|1|||
30892461|NCT02134353|58925978|FG000|Overall Study|Withdrawal by Subject|12|||
30892462|NCT02134353|58925979|FG001|Overall Study|Withdrawal by Subject|13|||
30892463|NCT02134353|58925978|FG000|Overall Study|Death|0|||
30892464|NCT02134353|58925979|FG001|Overall Study|Death|1|||
30892465|NCT02134353|58925978|FG000|Overall Study|Pregnancy|0|||
30892466|NCT02134353|58925979|FG001|Overall Study|Pregnancy|1|||
30892467|NCT02134353|58925978|FG000|Overall Study|Relocation|1|||
30892468|NCT02134353|58925979|FG001|Overall Study|Relocation|0|||
30892469|NCT02134353|58925978|FG000|Overall Study|Other - Patient's Choice|0|||
30892470|NCT02134353|58925979|FG001|Overall Study|Other - Patient's Choice|1|||
30892471|NCT01646125|58925987|FG000|Overall Study|Untreated|2|||
30892472|NCT01646125|58925988|FG001|Overall Study|Untreated|5|||
31001240|NCT01953354|59200056|FG000|Overall Study|Decision of Sponsor|0|||
31001241|NCT01953354|59200057|FG001|Overall Study|Decision of Sponsor|1|||
31001242|NCT01953354|59200056|FG000|Overall Study|Disease Exacerbation|1|||
31001243|NCT01953354|59200057|FG001|Overall Study|Disease Exacerbation|0|||
31001244|NCT01975272|59200066|FG000|Overall Study|Excluded after protocol amendment|1|||
31001245|NCT01975272|59200067|FG001|Overall Study|Excluded after protocol amendment|1|||
31001246|NCT01975272|59200068|FG002|Overall Study|Excluded after protocol amendment|2|||
31001247|NCT01951638|59200081|FG000|Treatment Period|Protocol Violation|0|||
31001248|NCT01951638|59200082|FG001|Treatment Period|Protocol Violation|0|||
31001249|NCT01951638|59200083|FG002|Treatment Period|Protocol Violation|0|||
31001250|NCT01951638|59200084|FG003|Treatment Period|Protocol Violation|2|||
31001251|NCT01951638|59200085|FG004|Treatment Period|Protocol Violation|0|||
31001252|NCT01951638|59200081|FG000|Treatment Period|Protocol-driven decision point|1|||
31001253|NCT01951638|59200082|FG001|Treatment Period|Protocol-driven decision point|3|||
31001254|NCT01951638|59200083|FG002|Treatment Period|Protocol-driven decision point|0|||
31001255|NCT01951638|59200084|FG003|Treatment Period|Protocol-driven decision point|0|||
31001256|NCT01951638|59200085|FG004|Treatment Period|Protocol-driven decision point|0|||
31001257|NCT01951638|59200081|FG000|Treatment Period|Logistical difficulties|0|||
31001258|NCT01951638|59200082|FG001|Treatment Period|Logistical difficulties|1|||
31001259|NCT01951638|59200083|FG002|Treatment Period|Logistical difficulties|1|||
31001260|NCT01951638|59200084|FG003|Treatment Period|Logistical difficulties|0|||
31001261|NCT01951638|59200085|FG004|Treatment Period|Logistical difficulties|0|||
31001262|NCT01951638|59200081|FG000|Treatment Period|Withdrawal by Subject|9|||
31001263|NCT01951638|59200082|FG001|Treatment Period|Withdrawal by Subject|6|||
31001264|NCT01951638|59200083|FG002|Treatment Period|Withdrawal by Subject|4|||
31001265|NCT01951638|59200084|FG003|Treatment Period|Withdrawal by Subject|5|||
31001266|NCT01951638|59200085|FG004|Treatment Period|Withdrawal by Subject|4|||
31001267|NCT01951638|59200081|FG000|Treatment Period|Death|0|||
31001268|NCT01951638|59200082|FG001|Treatment Period|Death|0|||
31001269|NCT01951638|59200083|FG002|Treatment Period|Death|0|||
31001270|NCT01951638|59200084|FG003|Treatment Period|Death|3|||
31001271|NCT01951638|59200085|FG004|Treatment Period|Death|1|||
31001272|NCT01951638|59200081|FG000|Treatment Period|Adverse Event|3|||
31001273|NCT01951638|59200082|FG001|Treatment Period|Adverse Event|4|||
31001274|NCT01951638|59200083|FG002|Treatment Period|Adverse Event|8|||
31001275|NCT01951638|59200084|FG003|Treatment Period|Adverse Event|6|||
31001276|NCT01951638|59200085|FG004|Treatment Period|Adverse Event|5|||
31001277|NCT01951638|59200081|FG000|Follow-up Period|Protocol Violation|0|||
31001278|NCT01951638|59200082|FG001|Follow-up Period|Protocol Violation|0|||
31001279|NCT01951638|59200083|FG002|Follow-up Period|Protocol Violation|0|||
31001280|NCT01951638|59200084|FG003|Follow-up Period|Protocol Violation|1|||
31001281|NCT01951638|59200085|FG004|Follow-up Period|Protocol Violation|0|||
31001282|NCT01951638|59200081|FG000|Follow-up Period|Logistical difficulties|0|||
31001283|NCT01951638|59200082|FG001|Follow-up Period|Logistical difficulties|2|||
31001284|NCT01951638|59200083|FG002|Follow-up Period|Logistical difficulties|0|||
31001285|NCT01951638|59200084|FG003|Follow-up Period|Logistical difficulties|0|||
31001286|NCT01951638|59200085|FG004|Follow-up Period|Logistical difficulties|1|||
31001287|NCT01951638|59200081|FG000|Follow-up Period|Withdrawal by Subject|1|||
31001288|NCT01951638|59200082|FG001|Follow-up Period|Withdrawal by Subject|5|||
31001289|NCT01951638|59200083|FG002|Follow-up Period|Withdrawal by Subject|2|||
31001290|NCT01951638|59200084|FG003|Follow-up Period|Withdrawal by Subject|1|||
31001291|NCT01951638|59200085|FG004|Follow-up Period|Withdrawal by Subject|2|||
31001292|NCT01951638|59200081|FG000|Follow-up Period|Lost to Follow-up|0|||
31001293|NCT01951638|59200082|FG001|Follow-up Period|Lost to Follow-up|1|||
31001294|NCT01951638|59200083|FG002|Follow-up Period|Lost to Follow-up|0|||
31001295|NCT01951638|59200084|FG003|Follow-up Period|Lost to Follow-up|1|||
30892473|NCT01646125|58925987|FG000|Overall Study|Adverse Event|2|||
30892474|NCT01646125|58925988|FG001|Overall Study|Adverse Event|1|||
30892475|NCT01646125|58925987|FG000|Overall Study|Death|1|||
30892476|NCT01646125|58925988|FG001|Overall Study|Death|1|||
30892477|NCT01646125|58925987|FG000|Overall Study|Physician Decision|1|||
30892478|NCT01646125|58925988|FG001|Overall Study|Physician Decision|3|||
30892479|NCT01646125|58925987|FG000|Overall Study|Progressive disease|22|||
30892480|NCT01646125|58925988|FG001|Overall Study|Progressive disease|16|||
30892481|NCT01646125|58925987|FG000|Overall Study|Study terminated by sponsor|2|||
30892482|NCT01646125|58925988|FG001|Overall Study|Study terminated by sponsor|1|||
30892483|NCT01646125|58925987|FG000|Overall Study|Subject/Guardian decision|1|||
30892484|NCT01646125|58925988|FG001|Overall Study|Subject/Guardian decision|1|||
30892485|NCT01362790|58926001|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
30892486|NCT01362790|58926002|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
30892487|NCT01362790|58926003|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
30892488|NCT01362790|58926004|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
30892489|NCT01362790|58926005|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
30892490|NCT01362790|58926006|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
30892491|NCT01362790|58926007|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
30892492|NCT01362790|58926001|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
31001296|NCT01951638|59200085|FG004|Follow-up Period|Lost to Follow-up|0|||
31001297|NCT01951638|59200081|FG000|Follow-up Period|Death|1|||
31001298|NCT01951638|59200082|FG001|Follow-up Period|Death|0|||
31001299|NCT01951638|59200083|FG002|Follow-up Period|Death|1|||
31001300|NCT01951638|59200084|FG003|Follow-up Period|Death|4|||
31001301|NCT01951638|59200085|FG004|Follow-up Period|Death|1|||
31001302|NCT01951638|59200081|FG000|Follow-up Period|Adverse Event|0|||
31001303|NCT01951638|59200082|FG001|Follow-up Period|Adverse Event|1|||
31001304|NCT01951638|59200083|FG002|Follow-up Period|Adverse Event|2|||
31001305|NCT01951638|59200084|FG003|Follow-up Period|Adverse Event|1|||
31001306|NCT01951638|59200085|FG004|Follow-up Period|Adverse Event|1|||
31001307|NCT01928472|59200101|FG000|Overall Study|Death|0|||
31001308|NCT01928472|59200102|FG001|Overall Study|Death|0|||
31001309|NCT01928472|59200103|FG002|Overall Study|Death|1|||
31001310|NCT01928472|59200104|FG003|Overall Study|Death|0|||
31001311|NCT01928472|59200101|FG000|Overall Study|Withdrawal by Subject|4|||
31001312|NCT01928472|59200102|FG001|Overall Study|Withdrawal by Subject|4|||
31001313|NCT01928472|59200103|FG002|Overall Study|Withdrawal by Subject|1|||
31001314|NCT01928472|59200104|FG003|Overall Study|Withdrawal by Subject|2|||
31001315|NCT01928472|59200101|FG000|Overall Study|Lost to Follow-up|2|||
31001316|NCT01928472|59200102|FG001|Overall Study|Lost to Follow-up|3|||
31001317|NCT01928472|59200103|FG002|Overall Study|Lost to Follow-up|4|||
31001318|NCT01928472|59200104|FG003|Overall Study|Lost to Follow-up|0|||
31001319|NCT01928472|59200101|FG000|Overall Study|Administrative Reason|2|||
31001320|NCT01928472|59200102|FG001|Overall Study|Administrative Reason|1|||
31001321|NCT01928472|59200103|FG002|Overall Study|Administrative Reason|0|||
31001322|NCT01928472|59200104|FG003|Overall Study|Administrative Reason|0|||
31001323|NCT01928472|59200101|FG000|Overall Study|Unclassified|0|||
31001324|NCT01928472|59200102|FG001|Overall Study|Unclassified|0|||
31001325|NCT01928472|59200103|FG002|Overall Study|Unclassified|1|||
31001326|NCT01928472|59200104|FG003|Overall Study|Unclassified|0|||
31001327|NCT01351415|59201965|FG000|Overall Study|Withdrawal by Subject|15|||
31001328|NCT01351415|59201966|FG001|Overall Study|Withdrawal by Subject|17|||
31001329|NCT01351415|59201965|FG000|Overall Study|Trial termination by the Sponsor|28|||
31001330|NCT01351415|59201966|FG001|Overall Study|Trial termination by the Sponsor|19|||
31001331|NCT01351415|59201965|FG000|Overall Study|Lost to Follow-up|5|||
31001332|NCT01351415|59201966|FG001|Overall Study|Lost to Follow-up|7|||
31001333|NCT01351415|59201965|FG000|Overall Study|Death|190|||
31001334|NCT01351415|59201966|FG001|Overall Study|Death|187|||
31001335|NCT01351415|59201965|FG000|Overall Study|Physician Decision|2|||
31001336|NCT01351415|59201966|FG001|Overall Study|Physician Decision|3|||
31001337|NCT01351415|59201965|FG000|Overall Study|Reason unknown|0|||
31001338|NCT01351415|59201966|FG001|Overall Study|Reason unknown|2|||
31001339|NCT01351415|59201965|FG000|Overall Study|Never Started|5|||
31001340|NCT01351415|59201966|FG001|Overall Study|Never Started|5|||
31001341|NCT04811339|59202074|FG000|Overall Study|lack of transportation not wanting to return|4|||
31001342|NCT04811339|59202075|FG001|Overall Study|lack of transportation not wanting to return|8|||
31001343|NCT04811339|59202076|FG002|Overall Study|lack of transportation not wanting to return|0|||
31001344|NCT04811339|59202074|FG000|Overall Study|Adverse Event|3|||
31001345|NCT04811339|59202075|FG001|Overall Study|Adverse Event|0|||
31001346|NCT04811339|59202076|FG002|Overall Study|Adverse Event|0|||
31001347|NCT04811339|59202074|FG000|Overall Study|Lost to Follow-up|1|||
31001348|NCT04811339|59202075|FG001|Overall Study|Lost to Follow-up|0|||
31001349|NCT04811339|59202076|FG002|Overall Study|Lost to Follow-up|0|||
31001350|NCT04811339|59202074|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
31001351|NCT04811339|59202075|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
31001352|NCT04811339|59202076|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
31001353|NCT04811339|59202074|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
31001354|NCT04811339|59202075|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
31001355|NCT04811339|59202076|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
31001356|NCT04811339|59202074|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
31001357|NCT04811339|59202075|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
31001358|NCT04811339|59202076|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
31001359|NCT04811339|59202074|FG000|Overall Study|Withdrawal by Subject|0|||
31001360|NCT04811339|59202075|FG001|Overall Study|Withdrawal by Subject|3|||
31001361|NCT04811339|59202076|FG002|Overall Study|Withdrawal by Subject|0|||
31001362|NCT04811339|59202074|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
31001363|NCT04811339|59202075|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
31001364|NCT04811339|59202076|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
31001365|NCT04811339|59202074|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
31001366|NCT04811339|59202075|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
31001367|NCT04811339|59202076|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
31001368|NCT04652453|59202089|FG000|Overall Study|Death|8|||
31001369|NCT04652453|59202090|FG001|Overall Study|Death|2|||
31001370|NCT04652453|59202091|FG002|Overall Study|Death|0|||
31001371|NCT04652453|59202089|FG000|Overall Study|Hospice|5|||
31001372|NCT04652453|59202090|FG001|Overall Study|Hospice|5|||
31001373|NCT04652453|59202091|FG002|Overall Study|Hospice|0|||
31001374|NCT04652453|59202089|FG000|Overall Study|Withdrawal by Subject|2|||
31001375|NCT04652453|59202090|FG001|Overall Study|Withdrawal by Subject|0|||
31001376|NCT04652453|59202091|FG002|Overall Study|Withdrawal by Subject|0|||
31001377|NCT04332107|59202099|FG000|Day 3|Lost to Follow-up|23|||
31001378|NCT04332107|59202100|FG001|Day 3|Lost to Follow-up|14|||
31001379|NCT04332107|59202099|FG000|Day 3|Missing outcome data|3|||
31001380|NCT04332107|59202100|FG001|Day 3|Missing outcome data|6|||
31001381|NCT04332107|59202099|FG000|Day 14|Lost to Follow-up|13|||
31001382|NCT04332107|59202100|FG001|Day 14|Lost to Follow-up|4|||
31001383|NCT04332107|59202099|FG000|Day 14|Missing outcome data|4|||
31001384|NCT04332107|59202100|FG001|Day 14|Missing outcome data|4|||
31001385|NCT04332107|59202099|FG000|Day 21|Lost to Follow-up|10|||
31001386|NCT04332107|59202100|FG001|Day 21|Lost to Follow-up|2|||
31001387|NCT03375203|59202115|FG000|Overall Study|Protocol Violation|0|||
31001388|NCT03375203|59202116|FG001|Overall Study|Protocol Violation|0|||
31001389|NCT03375203|59202117|FG002|Overall Study|Protocol Violation|1|||
31001390|NCT03375203|59202118|FG003|Overall Study|Protocol Violation|0|||
31001391|NCT03375203|59202119|FG004|Overall Study|Protocol Violation|0|||
31001392|NCT03375203|59202115|FG000|Overall Study|Adverse Event|2|||
31001393|NCT03375203|59202116|FG001|Overall Study|Adverse Event|3|||
31001394|NCT03375203|59202117|FG002|Overall Study|Adverse Event|0|||
31001395|NCT03375203|59202118|FG003|Overall Study|Adverse Event|2|||
31001396|NCT03375203|59202119|FG004|Overall Study|Adverse Event|2|||
31001397|NCT03375203|59202115|FG000|Overall Study|Withdrawal by Subject|3|||
31001398|NCT03375203|59202116|FG001|Overall Study|Withdrawal by Subject|0|||
31001399|NCT03375203|59202117|FG002|Overall Study|Withdrawal by Subject|1|||
31001400|NCT03375203|59202118|FG003|Overall Study|Withdrawal by Subject|0|||
31001401|NCT03375203|59202119|FG004|Overall Study|Withdrawal by Subject|2|||
31001402|NCT03375203|59202115|FG000|Overall Study|Non-compliance with study drug|1|||
31001403|NCT03375203|59202116|FG001|Overall Study|Non-compliance with study drug|0|||
31001404|NCT03375203|59202117|FG002|Overall Study|Non-compliance with study drug|0|||
31001405|NCT03375203|59202118|FG003|Overall Study|Non-compliance with study drug|0|||
31001406|NCT03375203|59202119|FG004|Overall Study|Non-compliance with study drug|0|||
31001407|NCT03375203|59202115|FG000|Overall Study|Randomized, not treated.|0|||
31001408|NCT03375203|59202116|FG001|Overall Study|Randomized, not treated.|1|||
31001409|NCT03375203|59202117|FG002|Overall Study|Randomized, not treated.|0|||
31001410|NCT03375203|59202118|FG003|Overall Study|Randomized, not treated.|0|||
31001411|NCT03375203|59202119|FG004|Overall Study|Randomized, not treated.|0|||
31001412|NCT03075839|59202141|FG000|Overall Study|Lost to Follow-up|4|||
31001413|NCT02919683|59202147|FG000|Post-Surgery Follow-Up|Death|2|||
31001414|NCT02919683|59202148|FG001|Post-Surgery Follow-Up|Death|2|||
31001415|NCT02919683|59202147|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
31001416|NCT02919683|59202148|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
31001417|NCT01928082|59202155|FG000|Overall Study|Study terminated.|1|||
31001418|NCT01972776|59202165|FG000|Part 1|Withdrawal by Subject|0|||
31001419|NCT01972776|59202166|FG001|Part 1|Withdrawal by Subject|0|||
31001420|NCT01972776|59202167|FG002|Part 1|Withdrawal by Subject|1|||
31001421|NCT01972776|59202168|FG003|Part 1|Withdrawal by Subject|0|||
31001422|NCT01972776|59202169|FG004|Part 1|Withdrawal by Subject|0|||
31001423|NCT01972776|59202170|FG005|Part 1|Withdrawal by Subject|0|||
31001424|NCT01972776|59202165|FG000|Part 1|Adverse Event|0|||
31001425|NCT01972776|59202166|FG001|Part 1|Adverse Event|0|||
31001426|NCT01972776|59202167|FG002|Part 1|Adverse Event|1|||
31001427|NCT01972776|59202168|FG003|Part 1|Adverse Event|1|||
31001428|NCT01972776|59202169|FG004|Part 1|Adverse Event|0|||
31001429|NCT01972776|59202170|FG005|Part 1|Adverse Event|0|||
31001430|NCT01972776|59202165|FG000|Part 2|Adverse Event|0|||
31001431|NCT01972776|59202166|FG001|Part 2|Adverse Event|0|||
31001432|NCT01972776|59202167|FG002|Part 2|Adverse Event|0|||
31001433|NCT01972776|59202168|FG003|Part 2|Adverse Event|0|||
31001434|NCT01972776|59202169|FG004|Part 2|Adverse Event|3|||
31001435|NCT01972776|59202170|FG005|Part 2|Adverse Event|0|||
31001436|NCT01972776|59202165|FG000|Part 2|Administrative problems|0|||
31001437|NCT01972776|59202166|FG001|Part 2|Administrative problems|0|||
30790229|NCT00035555|58803456|FG000|Overall Study|Prohibited medication|1|||
30790230|NCT00035555|58803457|FG001|Overall Study|Prohibited medication|1|||
31001438|NCT01972776|59202167|FG002|Part 2|Administrative problems|0|||
31001439|NCT01972776|59202168|FG003|Part 2|Administrative problems|0|||
31001440|NCT01972776|59202169|FG004|Part 2|Administrative problems|10|||
31001441|NCT01972776|59202170|FG005|Part 2|Administrative problems|7|||
31001442|NCT03763331|59202186|FG000|Overall Study|Lost to Follow-up|1|||
31001443|NCT03763331|59202187|FG001|Overall Study|Lost to Follow-up|0|||
31001444|NCT03763331|59202186|FG000|Overall Study|Withdrawal by Subject|1|||
31001445|NCT03763331|59202187|FG001|Overall Study|Withdrawal by Subject|0|||
31001446|NCT03763331|59202186|FG000|Overall Study|Non-compliance|0|||
31001447|NCT03763331|59202187|FG001|Overall Study|Non-compliance|3|||
31001448|NCT00001259|59202214|FG000|Study 2|Adverse Event|0|||
31001449|NCT00001259|59202215|FG001|Study 2|Adverse Event|0|||
31001450|NCT00001259|59202216|FG002|Study 2|Adverse Event|0|||
31001451|NCT00001259|59202217|FG003|Study 2|Adverse Event|0|||
31001452|NCT00001259|59202218|FG004|Study 2|Adverse Event|2|||
31001453|NCT00001259|59202219|FG005|Study 2|Adverse Event|0|||
31001454|NCT00001259|59202220|FG006|Study 2|Adverse Event|0|||
31001455|NCT01926444|59202234|FG000|Overall Study|Colonoscopy not performed|0|||
31001456|NCT01926444|59202235|FG001|Overall Study|Colonoscopy not performed|0|||
31001457|NCT01926444|59202236|FG002|Overall Study|Colonoscopy not performed|4|||
31001458|NCT01926444|59202237|FG003|Overall Study|Colonoscopy not performed|2|||
31001459|NCT05003167|59202247|FG000|Overall Study|Withdrawal by Subject|1|||
31001460|NCT04988035|59202253|FG000|Overall Study|Death|19|||
31001461|NCT04988035|59202254|FG001|Overall Study|Death|13|||
31001462|NCT04988035|59202253|FG000|Overall Study|Lost to Follow-up|12|||
31001463|NCT04988035|59202254|FG001|Overall Study|Lost to Follow-up|6|||
31001464|NCT04988035|59202253|FG000|Overall Study|Protocol Violation|0|||
31001465|NCT04988035|59202254|FG001|Overall Study|Protocol Violation|1|||
31001466|NCT04988035|59202253|FG000|Overall Study|Withdrawal by Subject|2|||
31001467|NCT04988035|59202254|FG001|Overall Study|Withdrawal by Subject|4|||
31001468|NCT04988035|59202253|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
31001469|NCT04988035|59202254|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
31001470|NCT04847674|59202272|FG000|Overall Study|Withdrawal by Subject|0|||
31001471|NCT04847674|59202273|FG001|Overall Study|Withdrawal by Subject|1|||
31001472|NCT04847674|59202274|FG002|Overall Study|Withdrawal by Subject|0|||
31001473|NCT04847674|59202272|FG000|Overall Study|Lost to Follow-up|0|||
31001474|NCT04847674|59202273|FG001|Overall Study|Lost to Follow-up|0|||
31001475|NCT04847674|59202274|FG002|Overall Study|Lost to Follow-up|2|||
31001476|NCT04847674|59202272|FG000|Overall Study|Other than specified|21|||
31001477|NCT04847674|59202273|FG001|Overall Study|Other than specified|20|||
31001478|NCT04847674|59202274|FG002|Overall Study|Other than specified|20|||
31001479|NCT04649060|59202286|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
31001480|NCT04649060|59202287|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
31001481|NCT04649060|59202286|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
31001482|NCT04649060|59202287|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
31001483|NCT04649060|59202286|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
31001484|NCT04649060|59202287|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
31001485|NCT04649060|59202286|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
31001486|NCT04649060|59202287|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
31001487|NCT04649060|59202286|FG000|Arm A/Arm B Treatment|Patient Request|1|||
31001488|NCT04649060|59202287|FG001|Arm A/Arm B Treatment|Patient Request|0|||
31001489|NCT04649060|59202286|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
31001490|NCT04649060|59202287|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
31001491|NCT04649060|59202286|FG000|Arm A/Arm B Treatment|Other|1|||
31001492|NCT04649060|59202287|FG001|Arm A/Arm B Treatment|Other|0|||
31001493|NCT04649060|59202286|FG000|Crossover (Arm B)|Adverse Event|0|||
31001494|NCT04649060|59202287|FG001|Crossover (Arm B)|Adverse Event|1|||
31001495|NCT04649060|59202286|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
31001496|NCT04649060|59202287|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
31001497|NCT04640272|59202294|FG000|Overall Study|Subject moved out of area|1|||
31001498|NCT04511650|59202301|FG000|Overall Study|Lost to Follow-up|1|||
31001499|NCT04511650|59202302|FG001|Overall Study|Lost to Follow-up|0|||
31001500|NCT04511650|59202303|FG002|Overall Study|Lost to Follow-up|0|||
31001501|NCT04511650|59202301|FG000|Overall Study|Withdrawal by Subject|1|||
31001502|NCT04511650|59202302|FG001|Overall Study|Withdrawal by Subject|0|||
31001503|NCT04511650|59202303|FG002|Overall Study|Withdrawal by Subject|0|||
31001504|NCT04511650|59202301|FG000|Overall Study|reason not provided|0|||
31001505|NCT04511650|59202302|FG001|Overall Study|reason not provided|0|||
31001506|NCT04511650|59202303|FG002|Overall Study|reason not provided|1|||
31001507|NCT04511650|59202301|FG000|Overall Study|Death|1|||
31001508|NCT04511650|59202302|FG001|Overall Study|Death|1|||
31001509|NCT04511650|59202303|FG002|Overall Study|Death|1|||
31001510|NCT04285580|59202335|FG000|Overall Study|Protocol Violation|0|||
31001511|NCT04285580|59202336|FG001|Overall Study|Protocol Violation|1|||
31001512|NCT04200248|59202354|FG000|Overall Study|Personal reasons|0|||
31001513|NCT04200248|59202355|FG001|Overall Study|Personal reasons|0|||
31001514|NCT04200248|59202356|FG002|Overall Study|Personal reasons|1|||
31001515|NCT04200248|59202354|FG000|Overall Study|Discontinued prior to treatment|3|||
31001516|NCT04200248|59202355|FG001|Overall Study|Discontinued prior to treatment|3|||
31001517|NCT04200248|59202356|FG002|Overall Study|Discontinued prior to treatment|2|||
31001518|NCT04137887|59202366|FG000|Overall Study|Death|102|||
31001519|NCT04137887|59202367|FG001|Overall Study|Death|92|||
31001520|NCT04137887|59202366|FG000|Overall Study|Withdrawal by Subject|2|||
31001521|NCT04137887|59202367|FG001|Overall Study|Withdrawal by Subject|3|||
31001522|NCT04137887|59202366|FG000|Overall Study|Randomized but not treated|0|||
31001523|NCT04137887|59202367|FG001|Overall Study|Randomized but not treated|1|||
31001524|NCT03557008|59202403|FG000|Overall Study|Withdrawal by Subject|2|||
31001525|NCT03557008|59202404|FG001|Overall Study|Withdrawal by Subject|2|||
31001526|NCT03557008|59202403|FG000|Overall Study|Early termination from study|3|||
31001527|NCT03557008|59202404|FG001|Overall Study|Early termination from study|1|||
31001528|NCT03040999|59202412|FG000|Overall Study|Lost to Follow-up|1|||
31001529|NCT03040999|59202413|FG001|Overall Study|Lost to Follow-up|0|||
31001530|NCT03040999|59202412|FG000|Overall Study|Withdrawal by Subject|7|||
31001531|NCT03040999|59202413|FG001|Overall Study|Withdrawal by Subject|12|||
31001532|NCT03040999|59202412|FG000|Overall Study|Death|128|||
31001533|NCT03040999|59202413|FG001|Overall Study|Death|138|||
31001534|NCT03040999|59202412|FG000|Overall Study|Participants Ongoing in Trial|266|||
31001535|NCT03040999|59202413|FG001|Overall Study|Participants Ongoing in Trial|252|||
31001536|NCT02990338|59202421|FG000|Overall Study|Ongoing|30|||
31001537|NCT02990338|59202422|FG001|Overall Study|Ongoing|36|||
31001538|NCT02366728|59202438|FG000|Overall Study|Death|0|||
31001539|NCT02366728|59202439|FG001|Overall Study|Death|0|||
31001540|NCT02366728|59202440|FG002|Overall Study|Death|1|||
31001541|NCT02366728|59202438|FG000|Overall Study|Adverse Event|1|||
31001542|NCT02366728|59202439|FG001|Overall Study|Adverse Event|0|||
31001543|NCT02366728|59202440|FG002|Overall Study|Adverse Event|0|||
31001544|NCT02366728|59202438|FG000|Overall Study|Screen Failure|2|||
31001545|NCT02366728|59202439|FG001|Overall Study|Screen Failure|1|||
31001546|NCT02366728|59202440|FG002|Overall Study|Screen Failure|0|||
31001547|NCT02366728|59202438|FG000|Overall Study|Only yielded 2 vaccines|1|||
31001548|NCT02366728|59202439|FG001|Overall Study|Only yielded 2 vaccines|0|||
31001549|NCT02366728|59202440|FG002|Overall Study|Only yielded 2 vaccines|0|||
31001550|NCT02355002|59202450|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
31001551|NCT02355002|59202451|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
31001552|NCT02355002|59202450|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
31001553|NCT02355002|59202451|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
31001554|NCT02355002|59202450|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
31001555|NCT02355002|59202451|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
31001556|NCT02355002|59202450|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
31001557|NCT02355002|59202451|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
31001558|NCT02355002|59202450|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
31001559|NCT02355002|59202451|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
31001560|NCT02355002|59202450|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
31001561|NCT02355002|59202451|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
31001562|NCT02355002|59202450|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
31001563|NCT02355002|59202451|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
31001564|NCT02246920|59202461|FG000|Overall Study|Adverse Event|3|||
31001565|NCT02246920|59202462|FG001|Overall Study|Adverse Event|1|||
31001566|NCT02246920|59202463|FG002|Overall Study|Adverse Event|1|||
31001567|NCT02246920|59202461|FG000|Overall Study|Lost to Follow-up|2|||
31001568|NCT02246920|59202462|FG001|Overall Study|Lost to Follow-up|1|||
31001569|NCT02246920|59202463|FG002|Overall Study|Lost to Follow-up|0|||
31001570|NCT02246920|59202461|FG000|Overall Study|Protocol Violation|2|||
31001571|NCT02246920|59202462|FG001|Overall Study|Protocol Violation|5|||
31001572|NCT02246920|59202463|FG002|Overall Study|Protocol Violation|1|||
31001573|NCT02246920|59202461|FG000|Overall Study|Withdrawal by Subject|0|||
31001574|NCT02246920|59202462|FG001|Overall Study|Withdrawal by Subject|0|||
31001575|NCT02246920|59202463|FG002|Overall Study|Withdrawal by Subject|1|||
31001576|NCT01832402|59202473|FG000|Overall Study|Lost to Follow-up|2|||
31001577|NCT01832402|59202474|FG001|Overall Study|Lost to Follow-up|0|||
31001578|NCT01832402|59202473|FG000|Overall Study|Withdrawal by Subject|3|||
31001579|NCT01832402|59202474|FG001|Overall Study|Withdrawal by Subject|3|||
31001580|NCT01832402|59202473|FG000|Overall Study|Declining Performance status|2|||
31001581|NCT01832402|59202474|FG001|Overall Study|Declining Performance status|1|||
31001582|NCT01661881|59202484|FG000|Overall Study|Disease Progression|1|||
31001583|NCT00667628|59202495|FG000|Overall Study|Lost to Follow-up|1|||
31001584|NCT00667628|59202496|FG001|Overall Study|Lost to Follow-up|0|||
31001585|NCT00667628|59202495|FG000|Overall Study|Death|6|||
31001586|NCT00667628|59202496|FG001|Overall Study|Death|6|||
31001587|NCT00667628|59202495|FG000|Overall Study|Investigator Considers in Best Interest|1|||
31001588|NCT00667628|59202496|FG001|Overall Study|Investigator Considers in Best Interest|0|||
31001589|NCT00667628|59202495|FG000|Overall Study|Sponsor Terminated Study|17|||
31001590|NCT00667628|59202496|FG001|Overall Study|Sponsor Terminated Study|21|||
31001591|NCT00321555|59202502|FG000|Overall Study|Developed antibodies|1|||
31001592|NCT00321555|59202502|FG000|Overall Study|Switched to alternative treatment|3|||
31001593|NCT00321555|59202502|FG000|Overall Study|Physician Decision|1|||
31001594|NCT00321555|59202502|FG000|Overall Study|Disease progression on study|1|||
31001595|NCT01597908|59202512|FG000|Randomized Phase|Death|217|||
31001596|NCT01597908|59202513|FG001|Randomized Phase|Death|238|||
31001597|NCT01597908|59202514|FG002|Randomized Phase|Death|0|||
31001598|NCT01597908|59202512|FG000|Randomized Phase|Sponsor Decision|93|||
31001599|NCT01597908|59202513|FG001|Randomized Phase|Sponsor Decision|39|||
31001600|NCT01597908|59202514|FG002|Randomized Phase|Sponsor Decision|0|||
31001601|NCT01597908|59202512|FG000|Randomized Phase|Lost to Follow-up|9|||
31001602|NCT01597908|59202513|FG001|Randomized Phase|Lost to Follow-up|16|||
31001603|NCT01597908|59202514|FG002|Randomized Phase|Lost to Follow-up|0|||
31001604|NCT01597908|59202512|FG000|Randomized Phase|Physician Decision|6|||
31001605|NCT01597908|59202513|FG001|Randomized Phase|Physician Decision|3|||
31001606|NCT01597908|59202514|FG002|Randomized Phase|Physician Decision|0|||
31001607|NCT01597908|59202512|FG000|Randomized Phase|Withdrawal by Subject|26|||
31001608|NCT01597908|59202513|FG001|Randomized Phase|Withdrawal by Subject|22|||
31001609|NCT01597908|59202514|FG002|Randomized Phase|Withdrawal by Subject|0|||
31001610|NCT01597908|59202512|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
31001611|NCT01597908|59202513|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
31001612|NCT01597908|59202514|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
31001613|NCT01597908|59202512|FG000|Crossover Phase|Death|0|||
31001614|NCT01597908|59202513|FG001|Crossover Phase|Death|0|||
31001615|NCT01597908|59202514|FG002|Crossover Phase|Death|11|||
31001616|NCT01597908|59202512|FG000|Crossover Phase|Withdrawal by Subject|0|||
31001617|NCT01597908|59202513|FG001|Crossover Phase|Withdrawal by Subject|0|||
31001618|NCT01597908|59202514|FG002|Crossover Phase|Withdrawal by Subject|3|||
31001619|NCT01597908|59202512|FG000|Crossover Phase|Sponsor Decision|0|||
31001620|NCT01597908|59202513|FG001|Crossover Phase|Sponsor Decision|0|||
31001621|NCT01597908|59202514|FG002|Crossover Phase|Sponsor Decision|20|||
31001622|NCT01951170|59202523|FG000|Overall Study|Investigator decision|1|||
31001623|NCT01951092|59202527|FG000|Overall Study|Lost to Follow-up|10|||
31001624|NCT01951092|59202527|FG000|Overall Study|Incarceration|1|||
31001625|NCT01951092|59202527|FG000|Overall Study|Transfer of Care|1|||
31001626|NCT01949532|59202533|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
31001627|NCT01949532|59202534|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
31001628|NCT01949142|59202542|FG000|Overall Study|Withdrawal of consent|1|||
31001629|NCT01949142|59202543|FG001|Overall Study|Withdrawal of consent|0|||
31001630|NCT01949142|59202542|FG000|Overall Study|Lost to Follow-up|1|||
31001631|NCT01949142|59202543|FG001|Overall Study|Lost to Follow-up|1|||
31001632|NCT01949142|59202542|FG000|Overall Study|Parent changed their mind|1|||
31001633|NCT01949142|59202543|FG001|Overall Study|Parent changed their mind|0|||
31001634|NCT01948908|59202553|FG000|Overall Study|Protocol Violation|1|||
31001635|NCT01948908|59202554|FG001|Overall Study|Protocol Violation|0|||
31001636|NCT01948908|59202555|FG002|Overall Study|Protocol Violation|2|||
31001637|NCT01925274|59202566|FG000|Overall Study|Death|1|||
31001638|NCT01925274|59202567|FG001|Overall Study|Death|0|||
31001639|NCT01925274|59202568|FG002|Overall Study|Death|0|||
31001640|NCT01925274|59202566|FG000|Overall Study|Lost to Follow-up|0|||
31001641|NCT01925274|59202567|FG001|Overall Study|Lost to Follow-up|1|||
31001642|NCT01925274|59202568|FG002|Overall Study|Lost to Follow-up|0|||
31001643|NCT01925274|59202566|FG000|Overall Study|Withdrawal by Subject|1|||
31001644|NCT01925274|59202567|FG001|Overall Study|Withdrawal by Subject|2|||
31001645|NCT01925274|59202568|FG002|Overall Study|Withdrawal by Subject|0|||
31001646|NCT01925274|59202566|FG000|Overall Study|Study terminated by sponsor|4|||
31001647|NCT01925274|59202567|FG001|Overall Study|Study terminated by sponsor|0|||
31001648|NCT01925274|59202568|FG002|Overall Study|Study terminated by sponsor|0|||
31001649|NCT01925274|59202566|FG000|Overall Study|Protocol amendment|1|||
31001650|NCT01925274|59202567|FG001|Overall Study|Protocol amendment|3|||
31001651|NCT01925274|59202568|FG002|Overall Study|Protocol amendment|6|||
31001652|NCT01948830|59202580|FG000|Overall Study|Physician Decision|1|||
31001653|NCT01948830|59202581|FG001|Overall Study|Physician Decision|3|||
31001654|NCT01948830|59202580|FG000|Overall Study|Protocol deviation|1|||
31001655|NCT01948830|59202581|FG001|Overall Study|Protocol deviation|2|||
31001656|NCT01948830|59202580|FG000|Overall Study|Lost to Follow-up|5|||
31001657|NCT01948830|59202581|FG001|Overall Study|Lost to Follow-up|4|||
31001658|NCT01948830|59202580|FG000|Overall Study|Withdrawal by Subject|14|||
31001659|NCT01948830|59202581|FG001|Overall Study|Withdrawal by Subject|17|||
31001660|NCT01948830|59202580|FG000|Overall Study|Adverse Event|9|||
31001661|NCT01948830|59202581|FG001|Overall Study|Adverse Event|2|||
31001662|NCT01948830|59202580|FG000|Overall Study|Death|3|||
31001663|NCT01948830|59202581|FG001|Overall Study|Death|4|||
31001664|NCT01972464|59202589|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
31001665|NCT01972464|59202590|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
31001666|NCT01972464|59202589|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
31001667|NCT01972464|59202590|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
31001668|NCT01972464|59202589|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
31001669|NCT01972464|59202590|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
31001670|NCT01972464|59202589|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
31001671|NCT01972464|59202590|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
31001672|NCT01948050|59202599|FG000|Overall Study|Withdrawal by Subject|0|||
31001673|NCT01948050|59202600|FG001|Overall Study|Withdrawal by Subject|1|||
31001674|NCT01947894|59202609|FG000|Overall Study|Other|3|||
31001675|NCT01947894|59202610|FG001|Overall Study|Other|4|||
31001676|NCT01947894|59202611|FG002|Overall Study|Other|3|||
31001677|NCT01947894|59202609|FG000|Overall Study|Withdrawal by Subject|12|||
31001678|NCT01947894|59202610|FG001|Overall Study|Withdrawal by Subject|4|||
31001679|NCT01947894|59202611|FG002|Overall Study|Withdrawal by Subject|1|||
31001680|NCT01947894|59202609|FG000|Overall Study|Death|12|||
31001681|NCT01947894|59202610|FG001|Overall Study|Death|1|||
31001682|NCT01947894|59202611|FG002|Overall Study|Death|0|||
31001683|NCT01947894|59202609|FG000|Overall Study|Physician Decision|2|||
31001684|NCT01947894|59202610|FG001|Overall Study|Physician Decision|0|||
31001685|NCT01947894|59202611|FG002|Overall Study|Physician Decision|0|||
31001686|NCT01947894|59202609|FG000|Overall Study|Adverse Event|5|||
31001687|NCT01947894|59202610|FG001|Overall Study|Adverse Event|1|||
31001688|NCT01947894|59202611|FG002|Overall Study|Adverse Event|0|||
31001689|NCT01947894|59202609|FG000|Overall Study|Switched to other growth hormone brand|53|||
31001690|NCT01947894|59202610|FG001|Overall Study|Switched to other growth hormone brand|8|||
31001691|NCT01947894|59202611|FG002|Overall Study|Switched to other growth hormone brand|23|||
31001692|NCT01947582|59202619|FG000|Overall Study|Withdrawal by Subject|1|||
31001693|NCT01924806|59202625|FG000|Overall Study|Physician Decision|2|||
31001694|NCT01924806|59202626|FG001|Overall Study|Physician Decision|1|||
31001695|NCT01924182|59202634|FG000|Overall Study|Withdrawal by Subject|1|||
31001696|NCT01924182|59202635|FG001|Overall Study|Withdrawal by Subject|0|||
31001697|NCT01972308|59202643|FG000|Overall Study|Withdrawal by Subject|0|||
31001698|NCT01972308|59202644|FG001|Overall Study|Withdrawal by Subject|1|||
31001699|NCT01972308|59202643|FG000|Overall Study|Lost to Follow-up|4|||
31001700|NCT01972308|59202644|FG001|Overall Study|Lost to Follow-up|6|||
31001701|NCT01972308|59202643|FG000|Overall Study|Death|4|||
31001702|NCT01972308|59202644|FG001|Overall Study|Death|1|||
31001703|NCT01946880|59202654|FG000|Overall Study|Lost to Follow-up|1|||
31001704|NCT01946880|59202655|FG001|Overall Study|Lost to Follow-up|0|||
31001705|NCT01946880|59202654|FG000|Overall Study|Physician Decision|1|||
31001706|NCT01946880|59202655|FG001|Overall Study|Physician Decision|1|||
31001707|NCT01946880|59202654|FG000|Overall Study|Withdrawal by Subject|3|||
31001708|NCT01946880|59202655|FG001|Overall Study|Withdrawal by Subject|2|||
31001709|NCT01946880|59202654|FG000|Overall Study|Met Primary Endpoint|1|||
31001710|NCT01946880|59202655|FG001|Overall Study|Met Primary Endpoint|0|||
31001711|NCT01946880|59202654|FG000|Overall Study|Personal and Family Issues|1|||
31001712|NCT01946880|59202655|FG001|Overall Study|Personal and Family Issues|0|||
31001713|NCT01972152|59202661|FG000|First Treatment Visit|Lost to Follow-up|0|||
31001714|NCT01972152|59202662|FG001|First Treatment Visit|Lost to Follow-up|1|||
31001715|NCT01972152|59202663|FG002|First Treatment Visit|Lost to Follow-up|0|||
31001716|NCT01972152|59202664|FG003|First Treatment Visit|Lost to Follow-up|0|||
31001717|NCT01972152|59202665|FG004|First Treatment Visit|Lost to Follow-up|0|||
31001718|NCT01972152|59202666|FG005|First Treatment Visit|Lost to Follow-up|0|||
31001719|NCT01972152|59202661|FG000|Second Treatment Visit|Protocol Violation|0|||
31001720|NCT01972152|59202662|FG001|Second Treatment Visit|Protocol Violation|1|||
31001721|NCT01972152|59202663|FG002|Second Treatment Visit|Protocol Violation|0|||
31001722|NCT01972152|59202664|FG003|Second Treatment Visit|Protocol Violation|0|||
31001723|NCT01972152|59202665|FG004|Second Treatment Visit|Protocol Violation|0|||
31001724|NCT01972152|59202666|FG005|Second Treatment Visit|Protocol Violation|0|||
31001725|NCT01972074|59202680|FG000|Overall Study|Adverse Event|4|||
31001726|NCT01972074|59202681|FG001|Overall Study|Adverse Event|1|||
31001727|NCT01972074|59202682|FG002|Overall Study|Adverse Event|0|||
31001728|NCT01972074|59202680|FG000|Overall Study|Lack of Efficacy|1|||
31001729|NCT01972074|59202681|FG001|Overall Study|Lack of Efficacy|1|||
31001730|NCT01972074|59202682|FG002|Overall Study|Lack of Efficacy|0|||
31001731|NCT01972074|59202680|FG000|Overall Study|Lost to Follow-up|0|||
31001732|NCT01972074|59202681|FG001|Overall Study|Lost to Follow-up|1|||
31001733|NCT01972074|59202682|FG002|Overall Study|Lost to Follow-up|1|||
31001734|NCT01972074|59202680|FG000|Overall Study|Withdrawal by Subject|1|||
31001735|NCT01972074|59202681|FG001|Overall Study|Withdrawal by Subject|1|||
31001736|NCT01972074|59202682|FG002|Overall Study|Withdrawal by Subject|1|||
31001737|NCT01972074|59202680|FG000|Overall Study|Scanner Unavailable|0|||
31001738|NCT01972074|59202681|FG001|Overall Study|Scanner Unavailable|0|||
31001739|NCT01972074|59202682|FG002|Overall Study|Scanner Unavailable|1|||
31001740|NCT01970982|59202692|FG000|Overall Study|Withdrawal by Subject|0|||
31001741|NCT01970982|59202693|FG001|Overall Study|Withdrawal by Subject|0|||
31001742|NCT01970982|59202694|FG002|Overall Study|Withdrawal by Subject|2|||
31001743|NCT01946802|59202703|FG000|Overall Study|Death|1|||
31001744|NCT01946802|59202703|FG000|Overall Study|Withdrawal by Subject|2|||
31001745|NCT01946802|59202703|FG000|Overall Study|Combined septic shock|1|||
31001746|NCT01946802|59202703|FG000|Overall Study|Protocol Violation|1|||
31001747|NCT01618266|59202707|FG000|Overall Study|Lost to Follow-up|9|||
31001748|NCT01618266|59202707|FG000|Overall Study|Treatment satisfaction|10|||
31001749|NCT01618266|59202707|FG000|Overall Study|Other reasons|11|||
31001750|NCT01618266|59202707|FG000|Overall Study|Lack of Efficacy|23|||
31001751|NCT01618266|59202707|FG000|Overall Study|Protocol Violation|43|||
31001752|NCT01919112|59202714|FG000|Secondary Analysis-day 30|Death|1|||
31001753|NCT01919112|59202715|FG001|Secondary Analysis-day 30|Death|1|||
31001754|NCT01919112|59202716|FG002|Secondary Analysis-day 30|Death|1|||
31001755|NCT01919112|59202714|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
31001756|NCT01919112|59202715|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
31001757|NCT01919112|59202716|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
31001758|NCT01918332|59202728|FG000|Overall Study|Adverse Event|0|||
31001759|NCT01918332|59202729|FG001|Overall Study|Adverse Event|0|||
31001760|NCT01918332|59202730|FG002|Overall Study|Adverse Event|0|||
31001761|NCT01918332|59202731|FG003|Overall Study|Adverse Event|1|||
31001762|NCT01918332|59202728|FG000|Overall Study|Withdrawal by Subject|2|||
31001763|NCT01918332|59202729|FG001|Overall Study|Withdrawal by Subject|3|||
31001764|NCT01918332|59202730|FG002|Overall Study|Withdrawal by Subject|2|||
31001765|NCT01918332|59202731|FG003|Overall Study|Withdrawal by Subject|3|||
31001766|NCT01918332|59202728|FG000|Overall Study|Protocol Violation|6|||
31001767|NCT01918332|59202729|FG001|Overall Study|Protocol Violation|2|||
31001768|NCT01918332|59202730|FG002|Overall Study|Protocol Violation|6|||
31001769|NCT01918332|59202731|FG003|Overall Study|Protocol Violation|3|||
31001770|NCT01918332|59202728|FG000|Overall Study|lipid result by central lab did not meet|0|||
31001771|NCT01918332|59202729|FG001|Overall Study|lipid result by central lab did not meet|0|||
31001772|NCT01918332|59202730|FG002|Overall Study|lipid result by central lab did not meet|1|||
31001773|NCT01918332|59202731|FG003|Overall Study|lipid result by central lab did not meet|0|||
31001774|NCT01922934|59202743|FG000|Eligible Patients|Death|0|||
31001775|NCT01922934|59202744|FG001|Eligible Patients|Death|7|||
31001776|NCT01922934|59202743|FG000|Eligible Patients|Physician Decision|17|||
31001777|NCT01922934|59202744|FG001|Eligible Patients|Physician Decision|0|||
31001778|NCT01922934|59202743|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
31001779|NCT01922934|59202744|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
31001780|NCT01922934|59202743|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
31001781|NCT01922934|59202744|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
31001782|NCT01922934|59202743|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
31001783|NCT01922934|59202744|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
31001784|NCT01922934|59202743|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
31001785|NCT01922934|59202744|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
31001786|NCT01970592|59202752|FG000|Overall Study|Withdrawal by Subject|4|||
31001787|NCT01970592|59202752|FG000|Overall Study|Physician Decision|1|||
31001788|NCT01970592|59202752|FG000|Overall Study|Adverse Event|1|||
31001789|NCT01920594|59202758|FG000|Overall Study|Adverse Event|4|||
31001790|NCT01920594|59202759|FG001|Overall Study|Adverse Event|2|||
31001791|NCT01920594|59202758|FG000|Overall Study|Lost to Follow-up|1|||
31001792|NCT01920594|59202759|FG001|Overall Study|Lost to Follow-up|0|||
31001793|NCT01920594|59202758|FG000|Overall Study|Recovery|2|||
31001794|NCT01920594|59202759|FG001|Overall Study|Recovery|0|||
31001795|NCT01920594|59202758|FG000|Overall Study|Investigator discretion|0|||
31001796|NCT01920594|59202759|FG001|Overall Study|Investigator discretion|1|||
31001797|NCT01917084|59202765|FG000|Overall Study|Withdrawal by Subject|1|||
31001798|NCT01917006|59202776|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
31001799|NCT01917006|59202777|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
31001800|NCT01917006|59202778|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
31001801|NCT01917006|59202779|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
31001802|NCT01917006|59202780|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
31001803|NCT01917006|59202781|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
31001804|NCT01917006|59202782|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
31001805|NCT01917006|59202783|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
31001806|NCT01917006|59202776|FG000|Randomized-treatment Period|Personal Reasons|0|||
31001807|NCT01917006|59202777|FG001|Randomized-treatment Period|Personal Reasons|0|||
31001808|NCT01917006|59202778|FG002|Randomized-treatment Period|Personal Reasons|0|||
31001809|NCT01917006|59202779|FG003|Randomized-treatment Period|Personal Reasons|0|||
31001810|NCT01917006|59202780|FG004|Randomized-treatment Period|Personal Reasons|0|||
31001811|NCT01917006|59202781|FG005|Randomized-treatment Period|Personal Reasons|1|||
31001812|NCT01917006|59202782|FG006|Randomized-treatment Period|Personal Reasons|0|||
31001813|NCT01917006|59202783|FG007|Randomized-treatment Period|Personal Reasons|0|||
31001814|NCT01917006|59202776|FG000|Randomized-treatment Period|Protocol Violation|1|||
31001815|NCT01917006|59202777|FG001|Randomized-treatment Period|Protocol Violation|0|||
31001816|NCT01917006|59202778|FG002|Randomized-treatment Period|Protocol Violation|0|||
31001817|NCT01917006|59202779|FG003|Randomized-treatment Period|Protocol Violation|0|||
31001818|NCT01917006|59202780|FG004|Randomized-treatment Period|Protocol Violation|0|||
31001819|NCT01917006|59202781|FG005|Randomized-treatment Period|Protocol Violation|0|||
31001820|NCT01917006|59202782|FG006|Randomized-treatment Period|Protocol Violation|0|||
31001821|NCT01917006|59202783|FG007|Randomized-treatment Period|Protocol Violation|0|||
31001822|NCT01917006|59202776|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
31001823|NCT01917006|59202777|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
31001824|NCT01917006|59202778|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
31001825|NCT01917006|59202779|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
31001826|NCT01917006|59202780|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
31001827|NCT01917006|59202781|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
31001828|NCT01917006|59202782|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
31001829|NCT01917006|59202783|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
31001830|NCT01917006|59202776|FG000|Open-label Period|Adverse Event|0|||
31001831|NCT01917006|59202777|FG001|Open-label Period|Adverse Event|0|||
31001832|NCT01917006|59202778|FG002|Open-label Period|Adverse Event|0|||
31001833|NCT01917006|59202779|FG003|Open-label Period|Adverse Event|0|||
31001834|NCT01917006|59202780|FG004|Open-label Period|Adverse Event|0|||
31001835|NCT01917006|59202781|FG005|Open-label Period|Adverse Event|0|||
31001836|NCT01917006|59202782|FG006|Open-label Period|Adverse Event|0|||
31001837|NCT01917006|59202783|FG007|Open-label Period|Adverse Event|1|||
31001838|NCT01917006|59202776|FG000|Open-label Period|Lost to Follow-up|0|||
31001839|NCT01917006|59202777|FG001|Open-label Period|Lost to Follow-up|0|||
31001840|NCT01917006|59202778|FG002|Open-label Period|Lost to Follow-up|0|||
31001841|NCT01917006|59202779|FG003|Open-label Period|Lost to Follow-up|0|||
31001842|NCT01917006|59202780|FG004|Open-label Period|Lost to Follow-up|0|||
31001843|NCT01917006|59202781|FG005|Open-label Period|Lost to Follow-up|0|||
31001844|NCT01917006|59202782|FG006|Open-label Period|Lost to Follow-up|0|||
31001845|NCT01917006|59202783|FG007|Open-label Period|Lost to Follow-up|1|||
31001846|NCT01916304|59202800|FG000|Overall Study|Screening failure|17|||
31001847|NCT01916226|59202808|FG000|Overall Study|Adverse Event|1|||
31001848|NCT01916226|59202809|FG001|Overall Study|Adverse Event|0|||
31001849|NCT01916226|59202810|FG002|Overall Study|Adverse Event|1|||
31001850|NCT01916226|59202811|FG003|Overall Study|Adverse Event|1|||
31001851|NCT01916226|59202808|FG000|Overall Study|Lack of Efficacy|0|||
31001852|NCT01916226|59202809|FG001|Overall Study|Lack of Efficacy|0|||
31001853|NCT01916226|59202810|FG002|Overall Study|Lack of Efficacy|2|||
31001854|NCT01916226|59202811|FG003|Overall Study|Lack of Efficacy|1|||
31001855|NCT01916226|59202808|FG000|Overall Study|Protocol Violation|0|||
31001856|NCT01916226|59202809|FG001|Overall Study|Protocol Violation|1|||
31001857|NCT01916226|59202810|FG002|Overall Study|Protocol Violation|0|||
31001858|NCT01916226|59202811|FG003|Overall Study|Protocol Violation|1|||
31001859|NCT01916226|59202808|FG000|Overall Study|Physician Decision|0|||
31001860|NCT01916226|59202809|FG001|Overall Study|Physician Decision|0|||
31001861|NCT01916226|59202810|FG002|Overall Study|Physician Decision|0|||
31001862|NCT01916226|59202811|FG003|Overall Study|Physician Decision|1|||
31001863|NCT01969500|59202824|FG000|Overall Study|Death|0|||
31001864|NCT01969500|59202825|FG001|Overall Study|Death|1|||
31001865|NCT01969500|59202824|FG000|Overall Study|extended hospitalization|1|||
31001866|NCT01969500|59202825|FG001|Overall Study|extended hospitalization|1|||
31001867|NCT01915914|59202831|FG000|Acute Phase|Withdrawal by Subject|4|||
31001868|NCT01915914|59202832|FG001|Acute Phase|Withdrawal by Subject|0|||
31001869|NCT01915914|59202833|FG002|Acute Phase|Withdrawal by Subject|0|||
31001870|NCT01915914|59202834|FG003|Acute Phase|Withdrawal by Subject|0|||
31001871|NCT01915914|59202831|FG000|Acute Phase|Lost to Follow-up|4|||
31001872|NCT01915914|59202832|FG001|Acute Phase|Lost to Follow-up|0|||
31001873|NCT01915914|59202833|FG002|Acute Phase|Lost to Follow-up|0|||
31001874|NCT01915914|59202834|FG003|Acute Phase|Lost to Follow-up|0|||
31001875|NCT01915914|59202831|FG000|Acute Phase|Physician Decision|1|||
31001876|NCT01915914|59202832|FG001|Acute Phase|Physician Decision|0|||
31001877|NCT01915914|59202833|FG002|Acute Phase|Physician Decision|0|||
31001878|NCT01915914|59202834|FG003|Acute Phase|Physician Decision|0|||
31001879|NCT01915914|59202831|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
31001880|NCT01915914|59202832|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
31001881|NCT01915914|59202833|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
31001882|NCT01915914|59202834|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
31001883|NCT01915914|59202831|FG000|Acute Phase|"Not Achieved treatment success"|1|||
31001884|NCT01915914|59202832|FG001|Acute Phase|"Not Achieved treatment success"|0|||
31001885|NCT01915914|59202833|FG002|Acute Phase|"Not Achieved treatment success"|0|||
31001886|NCT01915914|59202834|FG003|Acute Phase|"Not Achieved treatment success"|0|||
31001887|NCT01915914|59202831|FG000|Acute Phase|Missing|1|||
31001888|NCT01915914|59202832|FG001|Acute Phase|Missing|0|||
31001889|NCT01915914|59202833|FG002|Acute Phase|Missing|0|||
31001890|NCT01915914|59202834|FG003|Acute Phase|Missing|0|||
31001891|NCT01915914|59202831|FG000|Maintenance Phase|Withdrawal by Subject|0|||
31001892|NCT01915914|59202832|FG001|Maintenance Phase|Withdrawal by Subject|1|||
31001893|NCT01915914|59202833|FG002|Maintenance Phase|Withdrawal by Subject|1|||
31001894|NCT01915914|59202834|FG003|Maintenance Phase|Withdrawal by Subject|0|||
31001895|NCT01915914|59202831|FG000|Maintenance Phase|Lost to Follow-up|0|||
31001896|NCT01915914|59202832|FG001|Maintenance Phase|Lost to Follow-up|4|||
31001897|NCT01915914|59202833|FG002|Maintenance Phase|Lost to Follow-up|1|||
31001898|NCT01915914|59202834|FG003|Maintenance Phase|Lost to Follow-up|0|||
31001899|NCT01915914|59202831|FG000|Maintenance Phase|Missing|0|||
31001900|NCT01915914|59202832|FG001|Maintenance Phase|Missing|1|||
31001901|NCT01915914|59202833|FG002|Maintenance Phase|Missing|0|||
31001902|NCT01915914|59202834|FG003|Maintenance Phase|Missing|0|||
31001903|NCT01915914|59202831|FG000|Follow-up Phase|Withdrawal by Subject|0|||
31001904|NCT01915914|59202832|FG001|Follow-up Phase|Withdrawal by Subject|0|||
31001905|NCT01915914|59202833|FG002|Follow-up Phase|Withdrawal by Subject|0|||
31001906|NCT01915914|59202834|FG003|Follow-up Phase|Withdrawal by Subject|1|||
31001907|NCT01915914|59202831|FG000|Follow-up Phase|Physician Decision|0|||
31001908|NCT01915914|59202832|FG001|Follow-up Phase|Physician Decision|0|||
31001909|NCT01915914|59202833|FG002|Follow-up Phase|Physician Decision|0|||
31001910|NCT01915914|59202834|FG003|Follow-up Phase|Physician Decision|1|||
31001911|NCT01919970|59202854|FG000|Overall Study|Withdrawal by Subject|3|||
31001912|NCT01919970|59202855|FG001|Overall Study|Withdrawal by Subject|0|||
31001913|NCT01919814|59202861|FG000|Overall Study|Adverse Event|1|||
31001914|NCT01919814|59202862|FG001|Overall Study|Adverse Event|0|||
31001915|NCT01919814|59202861|FG000|Overall Study|Protocol Violation|1|||
31001916|NCT01919814|59202862|FG001|Overall Study|Protocol Violation|0|||
31001917|NCT01919814|59202861|FG000|Overall Study|Withdrawal by Subject|1|||
31001918|NCT01919814|59202862|FG001|Overall Study|Withdrawal by Subject|0|||
31001919|NCT01968954|59202870|FG000|Overall Study|Adverse Event|6|||
31001920|NCT01968954|59202871|FG001|Overall Study|Adverse Event|3|||
31001921|NCT01968954|59202870|FG000|Overall Study|Death|1|||
31001922|NCT01968954|59202871|FG001|Overall Study|Death|2|||
31001923|NCT01968954|59202870|FG000|Overall Study|Lost to Follow-up|6|||
31001924|NCT01968954|59202871|FG001|Overall Study|Lost to Follow-up|4|||
31001925|NCT01968954|59202870|FG000|Overall Study|Withdrawal by Subject|20|||
31001926|NCT01968954|59202871|FG001|Overall Study|Withdrawal by Subject|23|||
31001927|NCT01968954|59202870|FG000|Overall Study|Other|7|||
31001928|NCT01968954|59202871|FG001|Overall Study|Other|8|||
31001929|NCT01968954|59202870|FG000|Overall Study|Protocol Violation|0|||
31001930|NCT01968954|59202871|FG001|Overall Study|Protocol Violation|1|||
31001931|NCT01968954|59202870|FG000|Overall Study|Did not met inclusion criteria|0|||
31001932|NCT01968954|59202871|FG001|Overall Study|Did not met inclusion criteria|2|||
31001933|NCT01919190|59202880|FG000|Overall Study|Intra-op findings, etc.|3|||
31001934|NCT01919190|59202881|FG001|Overall Study|Intra-op findings, etc.|0|||
31001935|NCT01620060|59202888|FG000|Overall Study|Adverse Event|9|||
31001936|NCT01620060|59202888|FG000|Overall Study|Protocol Violation|1|||
31001937|NCT01620060|59202888|FG000|Overall Study|Withdrawal by Subject|1|||
31001938|NCT01620060|59202888|FG000|Overall Study|Did not comply with Study Produre|1|||
31001939|NCT01620060|59202888|FG000|Overall Study|Family emergency|1|||
31001940|NCT01620060|59202888|FG000|Overall Study|Per Sponsor Decision|2|||
31001941|NCT01914666|59202895|FG000|Treatment Period|Lack of Efficacy|0|||
31001942|NCT01914666|59202896|FG001|Treatment Period|Lack of Efficacy|0|||
31001943|NCT01914666|59202897|FG002|Treatment Period|Lack of Efficacy|2|||
31001944|NCT01914666|59202895|FG000|Treatment Period|Adverse Event|10|||
31001945|NCT01914666|59202896|FG001|Treatment Period|Adverse Event|4|||
31001946|NCT01914666|59202897|FG002|Treatment Period|Adverse Event|2|||
31001947|NCT01914666|59202895|FG000|Treatment Period|Withdrawal by Subject|3|||
31001948|NCT01914666|59202896|FG001|Treatment Period|Withdrawal by Subject|2|||
31001949|NCT01914666|59202897|FG002|Treatment Period|Withdrawal by Subject|2|||
31001950|NCT01914666|59202895|FG000|Treatment Period|Physician Decision|0|||
31001951|NCT01914666|59202896|FG001|Treatment Period|Physician Decision|0|||
31001952|NCT01914666|59202897|FG002|Treatment Period|Physician Decision|2|||
31001953|NCT01913340|59202905|FG000|Overall Study|Death|2|||
31001954|NCT01913340|59202906|FG001|Overall Study|Death|5|||
31001955|NCT01913340|59202905|FG000|Overall Study|Lost to Follow-up|1|||
31001956|NCT01913340|59202906|FG001|Overall Study|Lost to Follow-up|1|||
31001957|NCT01864200|59202914|FG000|Overall Study|Lost to Follow-up|1|||
31001958|NCT01864200|59202915|FG001|Overall Study|Lost to Follow-up|3|||
31001959|NCT01864200|59202914|FG000|Overall Study|Protocol Violation|1|||
31001960|NCT01864200|59202915|FG001|Overall Study|Protocol Violation|0|||
31001961|NCT01912872|59202925|FG000|Overall Study|Lost to Follow-up|2|||
31001962|NCT01912872|59202926|FG001|Overall Study|Lost to Follow-up|3|||
31001963|NCT01912872|59202927|FG002|Overall Study|Lost to Follow-up|5|||
31001964|NCT01912872|59202928|FG003|Overall Study|Lost to Follow-up|5|||
31001965|NCT01912872|59202925|FG000|Overall Study|Other unspecified|3|||
31001966|NCT01912872|59202926|FG001|Overall Study|Other unspecified|1|||
31001967|NCT01912872|59202927|FG002|Overall Study|Other unspecified|3|||
31001968|NCT01912872|59202928|FG003|Overall Study|Other unspecified|0|||
31001969|NCT01912872|59202925|FG000|Overall Study|Informed consent withdrawn|0|||
31001970|NCT01912872|59202926|FG001|Overall Study|Informed consent withdrawn|0|||
31001971|NCT01912872|59202927|FG002|Overall Study|Informed consent withdrawn|1|||
31001972|NCT01912872|59202928|FG003|Overall Study|Informed consent withdrawn|1|||
31001973|NCT01912872|59202925|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
31001974|NCT01912872|59202926|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
31001975|NCT01912872|59202927|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
31001976|NCT01912872|59202928|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
31001977|NCT01912872|59202925|FG000|Overall Study|Protocol Violation|0|||
31001978|NCT01912872|59202926|FG001|Overall Study|Protocol Violation|0|||
31001979|NCT01912872|59202927|FG002|Overall Study|Protocol Violation|1|||
31001980|NCT01912872|59202928|FG003|Overall Study|Protocol Violation|0|||
31001981|NCT01912872|59202925|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
31001982|NCT01912872|59202926|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
31001983|NCT01912872|59202927|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
31001984|NCT01912872|59202928|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
31001985|NCT01912872|59202925|FG000|Overall Study|Withdrawal of study medication|0|||
31001986|NCT01912872|59202926|FG001|Overall Study|Withdrawal of study medication|0|||
31001987|NCT01912872|59202927|FG002|Overall Study|Withdrawal of study medication|0|||
31001988|NCT01912872|59202928|FG003|Overall Study|Withdrawal of study medication|2|||
31001989|NCT01912872|59202925|FG000|Overall Study|Missing|0|||
31001990|NCT01912872|59202926|FG001|Overall Study|Missing|0|||
31001991|NCT01912872|59202927|FG002|Overall Study|Missing|0|||
31001992|NCT01912872|59202928|FG003|Overall Study|Missing|1|||
31001993|NCT01912404|59202941|FG000|Overall Study|Due to personal reasons|1|||
31001994|NCT01912404|59202942|FG001|Overall Study|Due to personal reasons|0|||
31001995|NCT01911780|59202950|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
31001996|NCT01911780|59202951|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
31001997|NCT01911780|59202950|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
31001998|NCT01911780|59202951|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
31001999|NCT01911780|59202950|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
31002000|NCT01911780|59202951|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
31002001|NCT01911780|59202950|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
31002002|NCT01911780|59202951|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
31002003|NCT01911780|59202950|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
31002004|NCT01911780|59202951|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
31002005|NCT01911780|59202950|FG000|Extension Period (52 Weeks)|Personal reason|1|||
31002006|NCT01911780|59202951|FG001|Extension Period (52 Weeks)|Personal reason|1|||
31002007|NCT01911546|59202961|FG000|Overall Study|Lost to Follow-up|1|||
31002008|NCT01911546|59202961|FG000|Overall Study|Everolimus was discontinued|5|||
31002009|NCT01910298|59202967|FG000|Overall Study|Adverse Event|1|||
31002010|NCT01910298|59202968|FG001|Overall Study|Adverse Event|0|||
31002011|NCT01910298|59202967|FG000|Overall Study|Withdrawal by Subject|2|||
31002012|NCT01910298|59202968|FG001|Overall Study|Withdrawal by Subject|7|||
31002013|NCT01910298|59202967|FG000|Overall Study|Protocol Deviation|0|||
31002014|NCT01910298|59202968|FG001|Overall Study|Protocol Deviation|5|||
31002015|NCT01910298|59202967|FG000|Overall Study|Lost to Follow-up|1|||
31002016|NCT01910298|59202968|FG001|Overall Study|Lost to Follow-up|1|||
31002017|NCT01910298|59202967|FG000|Overall Study|Study Terminated by Sponsor|1|||
31002018|NCT01910298|59202968|FG001|Overall Study|Study Terminated by Sponsor|17|||
31002019|NCT01910298|59202967|FG000|Overall Study|Other Miscellaneous Reasons|0|||
31002020|NCT01910298|59202968|FG001|Overall Study|Other Miscellaneous Reasons|2|||
31002021|NCT01909674|59202976|FG000|Overall Study|Withdrawal by Subject|5|||
31002022|NCT01909674|59202977|FG001|Overall Study|Withdrawal by Subject|2|||
31002023|NCT01908816|59202987|FG000|Overall Study|Subject's no longer requires study drug|0|||
31002024|NCT01908816|59202988|FG001|Overall Study|Subject's no longer requires study drug|0|||
31002025|NCT01908816|59202989|FG002|Overall Study|Subject's no longer requires study drug|0|||
31002026|NCT01908816|59202990|FG003|Overall Study|Subject's no longer requires study drug|1|||
31002027|NCT01908816|59202987|FG000|Overall Study|Protocol deviation|1|||
31002028|NCT01908816|59202988|FG001|Overall Study|Protocol deviation|2|||
31002029|NCT01908816|59202989|FG002|Overall Study|Protocol deviation|1|||
31002030|NCT01908816|59202990|FG003|Overall Study|Protocol deviation|1|||
31002031|NCT01908816|59202987|FG000|Overall Study|Withdrawal by Subject|0|||
31002032|NCT01908816|59202988|FG001|Overall Study|Withdrawal by Subject|4|||
31002033|NCT01908816|59202989|FG002|Overall Study|Withdrawal by Subject|2|||
31002034|NCT01908816|59202990|FG003|Overall Study|Withdrawal by Subject|2|||
31002035|NCT01908816|59202987|FG000|Overall Study|Lost to Follow-up|3|||
31002036|NCT01908816|59202988|FG001|Overall Study|Lost to Follow-up|5|||
31002037|NCT01908816|59202989|FG002|Overall Study|Lost to Follow-up|4|||
31002038|NCT01908816|59202990|FG003|Overall Study|Lost to Follow-up|2|||
31002039|NCT01908816|59202987|FG000|Overall Study|Death|1|||
31002040|NCT01908816|59202988|FG001|Overall Study|Death|0|||
31002041|NCT01908816|59202989|FG002|Overall Study|Death|7|||
31002042|NCT01908816|59202990|FG003|Overall Study|Death|1|||
31002043|NCT01908816|59202987|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
31002044|NCT01908816|59202988|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
31002045|NCT01908816|59202989|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
31002046|NCT01908816|59202990|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
31002047|NCT01908816|59202987|FG000|Overall Study|Early termination|87|||
31002048|NCT01908816|59202988|FG001|Overall Study|Early termination|60|||
31002049|NCT01908816|59202989|FG002|Overall Study|Early termination|43|||
31002050|NCT01908816|59202990|FG003|Overall Study|Early termination|28|||
31002051|NCT01908582|59203003|FG000|Period 2|Physician Decision|1|||
31002052|NCT01908582|59203003|FG000|Period 2|Withdrawal by Subject|1|||
31002053|NCT01908426|59203012|FG000|Overall Study|Adverse Event|98|||
31002054|NCT01908426|59203013|FG001|Overall Study|Adverse Event|11|||
31002055|NCT01908426|59203012|FG000|Overall Study|Clinical Deterioration|72|||
31002056|NCT01908426|59203013|FG001|Overall Study|Clinical Deterioration|38|||
31002057|NCT01908426|59203012|FG000|Overall Study|Lack of Efficacy|3|||
31002058|NCT01908426|59203013|FG001|Overall Study|Lack of Efficacy|0|||
31002059|NCT01908426|59203012|FG000|Overall Study|Lost to Follow-up|0|||
31002060|NCT01908426|59203013|FG001|Overall Study|Lost to Follow-up|1|||
31002061|NCT01908426|59203012|FG000|Overall Study|Physician Decision|3|||
30892493|NCT01362790|58926002|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
30892494|NCT01362790|58926003|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
30892495|NCT01362790|58926004|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
30892496|NCT01362790|58926005|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
30892497|NCT01362790|58926006|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
30892498|NCT01362790|58926007|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
30892499|NCT01362790|58926001|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
30892500|NCT01362790|58926002|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
30892501|NCT01362790|58926003|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
30892502|NCT01362790|58926004|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
30892503|NCT01362790|58926005|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
30892504|NCT01362790|58926006|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
30892505|NCT01362790|58926007|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
30892506|NCT01362790|58926001|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
30892507|NCT01362790|58926002|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
30892508|NCT01362790|58926003|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
30892509|NCT01362790|58926004|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
30892510|NCT01362790|58926005|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
30892511|NCT01362790|58926006|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
30892512|NCT01362790|58926007|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
30892513|NCT01362790|58926001|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
30892514|NCT01362790|58926002|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
30892515|NCT01362790|58926003|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
30892516|NCT01362790|58926004|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
30892517|NCT01362790|58926005|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
30892518|NCT01362790|58926006|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
30892519|NCT01362790|58926007|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
30892520|NCT01362790|58926001|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
30892521|NCT01362790|58926002|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
30892522|NCT01362790|58926003|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
30892523|NCT01362790|58926004|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
30892524|NCT01362790|58926005|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
30892525|NCT01362790|58926006|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
31002062|NCT01908426|59203013|FG001|Overall Study|Physician Decision|3|||
31002063|NCT01908426|59203012|FG000|Overall Study|Withdrawal by Subject|11|||
30609028|NCT01285310|58619899|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
30609029|NCT01285310|58619900|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
30609030|NCT01285310|58619901|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
30609031|NCT01285310|58619902|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
30609032|NCT01285310|58619903|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
30609033|NCT01285310|58619899|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
30843499|NCT02178098|58869603|FG000|Overall Study|Protocol Violation|1|||
31002064|NCT01908426|59203013|FG001|Overall Study|Withdrawal by Subject|6|||
31002065|NCT01908426|59203012|FG000|Overall Study|Progressive Disease|206|||
31002066|NCT01908426|59203013|FG001|Overall Study|Progressive Disease|152|||
31002067|NCT01908426|59203012|FG000|Overall Study|Protocol Violation|1|||
31002068|NCT01908426|59203013|FG001|Overall Study|Protocol Violation|0|||
31002069|NCT01908426|59203012|FG000|Overall Study|No Study Treatment Given|3|||
31002070|NCT01908426|59203013|FG001|Overall Study|No Study Treatment Given|0|||
31002071|NCT01907100|59203023|FG000|Overall Study|PD based on modified RECIST criteria|31|||
31002072|NCT01907100|59203024|FG001|Overall Study|PD based on modified RECIST criteria|32|||
31002073|NCT01907100|59203025|FG002|Overall Study|PD based on modified RECIST criteria|95|||
31002074|NCT01907100|59203026|FG003|Overall Study|PD based on modified RECIST criteria|92|||
31002075|NCT01907100|59203023|FG000|Overall Study|Withdrawal by Subject|2|||
31002076|NCT01907100|59203024|FG001|Overall Study|Withdrawal by Subject|5|||
31002077|NCT01907100|59203025|FG002|Overall Study|Withdrawal by Subject|10|||
31002078|NCT01907100|59203026|FG003|Overall Study|Withdrawal by Subject|13|||
31002079|NCT01907100|59203023|FG000|Overall Study|Protocol Violation|0|||
31002080|NCT01907100|59203024|FG001|Overall Study|Protocol Violation|0|||
31002081|NCT01907100|59203025|FG002|Overall Study|Protocol Violation|1|||
31002082|NCT01907100|59203026|FG003|Overall Study|Protocol Violation|1|||
31002083|NCT01907100|59203023|FG000|Overall Study|Lost to Follow-up|0|||
31002084|NCT01907100|59203024|FG001|Overall Study|Lost to Follow-up|0|||
31002085|NCT01907100|59203025|FG002|Overall Study|Lost to Follow-up|0|||
31002086|NCT01907100|59203026|FG003|Overall Study|Lost to Follow-up|1|||
31002087|NCT01907100|59203023|FG000|Overall Study|Not treated|2|||
31002088|NCT01907100|59203024|FG001|Overall Study|Not treated|0|||
31002089|NCT01907100|59203025|FG002|Overall Study|Not treated|1|||
31002090|NCT01907100|59203026|FG003|Overall Study|Not treated|2|||
31002091|NCT01907100|59203023|FG000|Overall Study|Other than reasons specified|1|||
31002092|NCT01907100|59203024|FG001|Overall Study|Other than reasons specified|0|||
31002093|NCT01907100|59203025|FG002|Overall Study|Other than reasons specified|10|||
31002094|NCT01907100|59203026|FG003|Overall Study|Other than reasons specified|6|||
31002095|NCT01907100|59203023|FG000|Overall Study|Adverse event (AE)|6|||
31002096|NCT01907100|59203024|FG001|Overall Study|Adverse event (AE)|3|||
31002097|NCT01907100|59203025|FG002|Overall Study|Adverse event (AE)|22|||
31002098|NCT01907100|59203026|FG003|Overall Study|Adverse event (AE)|23|||
31002099|NCT01907100|59203023|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
31002100|NCT01907100|59203024|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
31002101|NCT01907100|59203025|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
31002102|NCT01907100|59203026|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
31002103|NCT01889862|59203034|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
31002104|NCT01889862|59203035|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
31002105|NCT01889862|59203036|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
31002106|NCT01889862|59203037|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
31002107|NCT01889862|59203038|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
31002108|NCT01889862|59203034|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
31002109|NCT01889862|59203035|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
31002110|NCT01889862|59203036|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
31002111|NCT01889862|59203037|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
31002112|NCT01889862|59203038|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
31002113|NCT01889862|59203034|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
31002114|NCT01889862|59203035|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
31002115|NCT01889862|59203036|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
31002116|NCT01889862|59203037|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
31002117|NCT01889862|59203038|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
31002118|NCT01889862|59203034|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
31002119|NCT01889862|59203035|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
31002120|NCT01889862|59203036|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
31002121|NCT01889862|59203037|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
31002122|NCT01889862|59203038|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
31002123|NCT01889862|59203034|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
31002124|NCT01889862|59203035|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
31002125|NCT01889862|59203036|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
31002126|NCT01889862|59203037|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
31002127|NCT01889862|59203038|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
31002128|NCT01889862|59203034|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
31002129|NCT01889862|59203035|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
31002130|NCT01889862|59203036|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
31002131|NCT01889862|59203037|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
31002132|NCT01889862|59203038|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
31002133|NCT01889862|59203034|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
31002134|NCT01889862|59203035|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
31002135|NCT01889862|59203036|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
31002136|NCT01889862|59203037|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
31002137|NCT01889862|59203038|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
31002138|NCT01889862|59203034|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
31002139|NCT01889862|59203035|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
31002140|NCT01889862|59203036|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
31002141|NCT01889862|59203037|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
31002142|NCT01889862|59203038|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
31002143|NCT01889862|59203034|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
31002144|NCT01889862|59203035|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
31002145|NCT01889862|59203036|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
31002146|NCT01889862|59203037|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
31002147|NCT01889862|59203038|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
31002148|NCT01889862|59203034|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
31002149|NCT01889862|59203035|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
31002150|NCT01889862|59203036|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
31002151|NCT01889862|59203037|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
31002152|NCT01889862|59203038|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
31002153|NCT01887912|59203065|FG000|Overall Study|Serious adverse event|400|||
31002154|NCT01887912|59203066|FG001|Overall Study|Serious adverse event|198|||
31002155|NCT01887912|59203065|FG000|Overall Study|Other Adverse Event|34|||
31002156|NCT01887912|59203066|FG001|Overall Study|Other Adverse Event|15|||
31002157|NCT01887912|59203065|FG000|Overall Study|Protocol Violation|67|||
31002158|NCT01887912|59203066|FG001|Overall Study|Protocol Violation|37|||
31002159|NCT01887912|59203065|FG000|Overall Study|Lost to Follow-up|163|||
31002160|NCT01887912|59203066|FG001|Overall Study|Lost to Follow-up|74|||
31002161|NCT01887912|59203065|FG000|Overall Study|Withdrawal by Subject|606|||
31002162|NCT01887912|59203066|FG001|Overall Study|Withdrawal by Subject|349|||
31002163|NCT01887912|59203065|FG000|Overall Study|Other|122|||
31002164|NCT01887912|59203066|FG001|Overall Study|Other|58|||
31002165|NCT01887678|59203074|FG000|Overall Study|Adverse Event|4|||
31002166|NCT01887678|59203075|FG001|Overall Study|Adverse Event|6|||
31002167|NCT01887678|59203074|FG000|Overall Study|Exceeded rescue medication dosage|4|||
31002168|NCT01887678|59203075|FG001|Overall Study|Exceeded rescue medication dosage|5|||
31002169|NCT01887678|59203074|FG000|Overall Study|Withdrawal of consent|3|||
31002170|NCT01887678|59203075|FG001|Overall Study|Withdrawal of consent|4|||
31002171|NCT01887678|59203074|FG000|Overall Study|Lost to Follow-up|4|||
31002172|NCT01887678|59203075|FG001|Overall Study|Lost to Follow-up|2|||
31002173|NCT01887678|59203074|FG000|Overall Study|Deterioration of clinical condition|0|||
31002174|NCT01887678|59203075|FG001|Overall Study|Deterioration of clinical condition|4|||
31002175|NCT01887678|59203074|FG000|Overall Study|Lack of Efficacy|1|||
31002176|NCT01887678|59203075|FG001|Overall Study|Lack of Efficacy|2|||
31002177|NCT01887678|59203074|FG000|Overall Study|Non-compliance|0|||
31002178|NCT01887678|59203075|FG001|Overall Study|Non-compliance|3|||
31002179|NCT01887678|59203074|FG000|Overall Study|Specified|1|||
31002180|NCT01887678|59203075|FG001|Overall Study|Specified|2|||
31002181|NCT01887600|59203083|FG000|Overall Study|Death|39|||
31002182|NCT01887600|59203084|FG001|Overall Study|Death|16|||
31002183|NCT01887600|59203083|FG000|Overall Study|Lack of Efficacy|3|||
31002184|NCT01887600|59203084|FG001|Overall Study|Lack of Efficacy|26|||
31002185|NCT01887600|59203083|FG000|Overall Study|Lost to Follow-up|5|||
31002186|NCT01887600|59203084|FG001|Overall Study|Lost to Follow-up|1|||
31002187|NCT01887600|59203083|FG000|Overall Study|Physician Decision|7|||
31002188|NCT01887600|59203084|FG001|Overall Study|Physician Decision|8|||
31002189|NCT01887600|59203083|FG000|Overall Study|Protocol Deviation|3|||
31002190|NCT01887600|59203084|FG001|Overall Study|Protocol Deviation|0|||
31002191|NCT01887600|59203083|FG000|Overall Study|Withdrawal by Subject|58|||
31002192|NCT01887600|59203084|FG001|Overall Study|Withdrawal by Subject|52|||
31002193|NCT01887600|59203083|FG000|Overall Study|Adverse Event|21|||
31002194|NCT01887600|59203084|FG001|Overall Study|Adverse Event|9|||
31002195|NCT01887600|59203083|FG000|Overall Study|Non-compliance with study drug|3|||
31002196|NCT01887600|59203084|FG001|Overall Study|Non-compliance with study drug|0|||
31002197|NCT01887600|59203083|FG000|Overall Study|Miscellaneous|6|||
31002198|NCT01887600|59203084|FG001|Overall Study|Miscellaneous|2|||
31002199|NCT01887600|59203083|FG000|Overall Study|Progressive Disease|1|||
31002200|NCT01887600|59203084|FG001|Overall Study|Progressive Disease|0|||
31002201|NCT01887288|59203091|FG000|Overall Study|The study was terminated and the PI has|16|||
31002202|NCT01887210|59203097|FG000|Overall Study|Withdrawal by Subject|1|||
31002203|NCT01887210|59203098|FG001|Overall Study|Withdrawal by Subject|3|||
31002204|NCT01887210|59203097|FG000|Overall Study|Lost to Follow-up|0|||
31002205|NCT01887210|59203098|FG001|Overall Study|Lost to Follow-up|1|||
31002206|NCT01885182|59203129|FG000|Overall Study|Adverse Event|11|||
31002207|NCT01885182|59203130|FG001|Overall Study|Adverse Event|13|||
31002208|NCT01885182|59203129|FG000|Overall Study|Withdrawal by Subject|13|||
31002209|NCT01885182|59203130|FG001|Overall Study|Withdrawal by Subject|6|||
31002210|NCT01885182|59203129|FG000|Overall Study|Lost to Follow-up|2|||
31002211|NCT01885182|59203130|FG001|Overall Study|Lost to Follow-up|2|||
31002212|NCT01885182|59203129|FG000|Overall Study|Lack of Efficacy|8|||
31002213|NCT01885182|59203130|FG001|Overall Study|Lack of Efficacy|1|||
31002214|NCT01885104|59203140|FG000|Overall Study|Withdrawal of Consent|1|||
31002215|NCT01885104|59203141|FG001|Overall Study|Withdrawal of Consent|0|||
31002216|NCT01885104|59203140|FG000|Overall Study|Lost to Follow-up|0|||
31002217|NCT01885104|59203141|FG001|Overall Study|Lost to Follow-up|1|||
31002218|NCT01885104|59203140|FG000|Overall Study|Physician Decision|1|||
31002219|NCT01885104|59203141|FG001|Overall Study|Physician Decision|0|||
31002220|NCT01881750|59203149|FG000|Overall Study|Changes in concomitant therapies|2|||
31002221|NCT01881750|59203150|FG001|Overall Study|Changes in concomitant therapies|3|||
31002222|NCT01881750|59203149|FG000|Overall Study|Lost to Follow-up|0|||
31002223|NCT01881750|59203150|FG001|Overall Study|Lost to Follow-up|1|||
31002224|NCT01906008|59203160|FG000|Overall Study|Lost to Follow-up|2|||
31002225|NCT01906008|59203161|FG001|Overall Study|Lost to Follow-up|0|||
31002226|NCT01906008|59203160|FG000|Overall Study|Oxaliplatin toxicity|2|||
31002227|NCT01906008|59203161|FG001|Overall Study|Oxaliplatin toxicity|0|||
31002228|NCT01906008|59203160|FG000|Overall Study|Protocol Violation|0|||
31002229|NCT01906008|59203161|FG001|Overall Study|Protocol Violation|1|||
31002230|NCT01906008|59203160|FG000|Overall Study|Withdrawal by Subject|1|||
31002231|NCT01906008|59203161|FG001|Overall Study|Withdrawal by Subject|5|||
31002232|NCT01906008|59203160|FG000|Overall Study|Did not start study med|3|||
31002233|NCT01906008|59203161|FG001|Overall Study|Did not start study med|4|||
31002234|NCT01906008|59203160|FG000|Overall Study|Oxaliplatin stops|10|||
31002235|NCT01906008|59203161|FG001|Overall Study|Oxaliplatin stops|8|||
31002236|NCT01906008|59203160|FG000|Overall Study|Hospice|1|||
31002237|NCT01906008|59203161|FG001|Overall Study|Hospice|0|||
31002238|NCT01906008|59203160|FG000|Overall Study|Physician Decision|3|||
31002239|NCT01906008|59203161|FG001|Overall Study|Physician Decision|3|||
31002240|NCT01906008|59203160|FG000|Overall Study|Lack of compliance of study med|5|||
31002241|NCT01906008|59203161|FG001|Overall Study|Lack of compliance of study med|3|||
31002242|NCT01906008|59203160|FG000|Overall Study|Adverse Event|0|||
31002243|NCT01906008|59203161|FG001|Overall Study|Adverse Event|3|||
31002244|NCT01863732|59203171|FG000|Overall Study|Adverse Event|2|||
31002245|NCT01863732|59203172|FG001|Overall Study|Adverse Event|0|||
31002246|NCT01863732|59203173|FG002|Overall Study|Adverse Event|3|||
31002247|NCT01863732|59203174|FG003|Overall Study|Adverse Event|3|||
31002248|NCT01863732|59203171|FG000|Overall Study|Lack of Efficacy|1|||
31002249|NCT01863732|59203172|FG001|Overall Study|Lack of Efficacy|0|||
31002250|NCT01863732|59203173|FG002|Overall Study|Lack of Efficacy|2|||
31002251|NCT01863732|59203174|FG003|Overall Study|Lack of Efficacy|1|||
31002252|NCT01863732|59203171|FG000|Overall Study|Lost to Follow-up|2|||
31002253|NCT01863732|59203172|FG001|Overall Study|Lost to Follow-up|2|||
31002254|NCT01863732|59203173|FG002|Overall Study|Lost to Follow-up|1|||
31002255|NCT01863732|59203174|FG003|Overall Study|Lost to Follow-up|1|||
31002256|NCT01863732|59203171|FG000|Overall Study|Physician Decision|1|||
31002257|NCT01863732|59203172|FG001|Overall Study|Physician Decision|0|||
31002258|NCT01863732|59203173|FG002|Overall Study|Physician Decision|1|||
31002259|NCT01863732|59203174|FG003|Overall Study|Physician Decision|0|||
31002260|NCT01863732|59203171|FG000|Overall Study|Pregnancy|0|||
31002261|NCT01863732|59203172|FG001|Overall Study|Pregnancy|0|||
31002262|NCT01863732|59203173|FG002|Overall Study|Pregnancy|0|||
31002263|NCT01863732|59203174|FG003|Overall Study|Pregnancy|1|||
31002264|NCT01863732|59203171|FG000|Overall Study|Technical problems|0|||
31002265|NCT01863732|59203172|FG001|Overall Study|Technical problems|1|||
31002266|NCT01863732|59203173|FG002|Overall Study|Technical problems|1|||
31002267|NCT01863732|59203174|FG003|Overall Study|Technical problems|0|||
31002268|NCT01863732|59203171|FG000|Overall Study|Subject/guardian decision|6|||
31002269|NCT01863732|59203172|FG001|Overall Study|Subject/guardian decision|9|||
31002270|NCT01863732|59203173|FG002|Overall Study|Subject/guardian decision|3|||
31002271|NCT01863732|59203174|FG003|Overall Study|Subject/guardian decision|1|||
31002272|NCT01863732|59203171|FG000|Overall Study|Death|1|||
31002273|NCT01863732|59203172|FG001|Overall Study|Death|0|||
31002274|NCT01863732|59203173|FG002|Overall Study|Death|0|||
31002275|NCT01863732|59203174|FG003|Overall Study|Death|1|||
31002276|NCT01905540|59203187|FG000|Period 3|Other|1|||
31002277|NCT01905540|59203188|FG001|Period 3|Other|0|||
31002278|NCT01905540|59203189|FG002|Period 3|Other|1|||
31002279|NCT01905540|59203190|FG003|Period 3|Other|1|||
31002280|NCT01904760|59203202|FG000|Overall Study|Protocol Violation|1|||
31002281|NCT01904760|59203203|FG001|Overall Study|Protocol Violation|0|||
31002282|NCT01904604|59203212|FG000|Overall Study|Withdrew before receiving dosing|0|||
31002283|NCT01904604|59203213|FG001|Overall Study|Withdrew before receiving dosing|1|||
31002284|NCT01904604|59203214|FG002|Overall Study|Withdrew before receiving dosing|0|||
31002285|NCT01904604|59203212|FG000|Overall Study|Non-compliance|1|||
31002286|NCT01904604|59203213|FG001|Overall Study|Non-compliance|0|||
31002287|NCT01904604|59203214|FG002|Overall Study|Non-compliance|0|||
31002288|NCT01904604|59203212|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
31002289|NCT01904604|59203213|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
31002290|NCT01904604|59203214|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
31002291|NCT01904604|59203212|FG000|Overall Study|Patch site reactions|1|||
31002292|NCT01904604|59203213|FG001|Overall Study|Patch site reactions|1|||
31002293|NCT01904604|59203214|FG002|Overall Study|Patch site reactions|0|||
31002294|NCT01904604|59203212|FG000|Overall Study|Increased syncope|0|||
31002295|NCT01904604|59203213|FG001|Overall Study|Increased syncope|1|||
31002296|NCT01904604|59203214|FG002|Overall Study|Increased syncope|0|||
31002297|NCT01904604|59203212|FG000|Overall Study|Unrelated illness|0|||
31002298|NCT01904604|59203213|FG001|Overall Study|Unrelated illness|1|||
31002299|NCT01904604|59203214|FG002|Overall Study|Unrelated illness|0|||
31002300|NCT01904604|59203212|FG000|Overall Study|Passed Week 52 OFC|1|||
31002301|NCT01904604|59203213|FG001|Overall Study|Passed Week 52 OFC|0|||
30892526|NCT01362790|58926007|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
31002302|NCT01904604|59203214|FG002|Overall Study|Passed Week 52 OFC|0|||
31002303|NCT01904604|59203212|FG000|Overall Study|Withdrawal by Subject|1|||
31002304|NCT01904604|59203213|FG001|Overall Study|Withdrawal by Subject|2|||
31002305|NCT01904604|59203214|FG002|Overall Study|Withdrawal by Subject|0|||
31002306|NCT01904604|59203212|FG000|Overall Study|Participant Relocated|1|||
31002307|NCT01904604|59203213|FG001|Overall Study|Participant Relocated|1|||
31002308|NCT01904604|59203214|FG002|Overall Study|Participant Relocated|1|||
31002309|NCT01904604|59203212|FG000|Overall Study|Lost to Follow-up|0|||
31002310|NCT01904604|59203213|FG001|Overall Study|Lost to Follow-up|0|||
31002311|NCT01904604|59203214|FG002|Overall Study|Lost to Follow-up|1|||
31002312|NCT01904058|59203229|FG000|Overall Study|Adverse Event|2|||
31002313|NCT01904058|59203230|FG001|Overall Study|Adverse Event|0|||
31002314|NCT01904058|59203231|FG002|Overall Study|Adverse Event|0|||
31002315|NCT01904058|59203232|FG003|Overall Study|Adverse Event|0|||
31002316|NCT01904058|59203229|FG000|Overall Study|Withdrawal by Subject|1|||
31002317|NCT01904058|59203230|FG001|Overall Study|Withdrawal by Subject|0|||
31002318|NCT01904058|59203231|FG002|Overall Study|Withdrawal by Subject|1|||
31002319|NCT01904058|59203232|FG003|Overall Study|Withdrawal by Subject|0|||
31002320|NCT01904058|59203229|FG000|Overall Study|Pregnancy|0|||
31002321|NCT01904058|59203230|FG001|Overall Study|Pregnancy|0|||
31002322|NCT01904058|59203231|FG002|Overall Study|Pregnancy|0|||
31002323|NCT01904058|59203232|FG003|Overall Study|Pregnancy|1|||
31002324|NCT01881126|59203250|FG000|Overall Study|Non-compliance|1|||
31002325|NCT01881126|59203251|FG001|Overall Study|Non-compliance|1|||
31002326|NCT01881126|59203250|FG000|Overall Study|Adverse Event|0|||
31002327|NCT01881126|59203251|FG001|Overall Study|Adverse Event|1|||
31002328|NCT01614600|59203257|FG000|Overall Study|Unacceptable fit|1|||
31002329|NCT01614600|59203257|FG000|Overall Study|Discomfort|1|||
31002330|NCT01614600|59203257|FG000|Overall Study|Unable to remove lens at the end of day|1|||
31002331|NCT01614600|59203257|FG000|Overall Study|Protocol deviation|1|||
31002332|NCT01880736|59203265|FG000|Overall Study|Adverse Event|0|||
31002333|NCT01880736|59203266|FG001|Overall Study|Adverse Event|0|||
31002334|NCT01880736|59203267|FG002|Overall Study|Adverse Event|0|||
31002335|NCT01880736|59203268|FG003|Overall Study|Adverse Event|1|||
31002336|NCT01880736|59203265|FG000|Overall Study|Withdrawal Criteria|1|||
31002337|NCT01880736|59203266|FG001|Overall Study|Withdrawal Criteria|2|||
31002338|NCT01880736|59203267|FG002|Overall Study|Withdrawal Criteria|1|||
31002339|NCT01880736|59203268|FG003|Overall Study|Withdrawal Criteria|5|||
31002340|NCT01880424|59203280|FG000|Overall Study|Adverse Event|7|||
31002341|NCT01880424|59203281|FG001|Overall Study|Adverse Event|6|||
31002342|NCT01880424|59203280|FG000|Overall Study|Lack of Efficacy|1|||
31002343|NCT01880424|59203281|FG001|Overall Study|Lack of Efficacy|4|||
31002344|NCT01880424|59203280|FG000|Overall Study|Lost to Follow-up|3|||
31002345|NCT01880424|59203281|FG001|Overall Study|Lost to Follow-up|2|||
31002346|NCT01880424|59203280|FG000|Overall Study|Protocol Violation|11|||
31002347|NCT01880424|59203281|FG001|Overall Study|Protocol Violation|13|||
31002348|NCT01880424|59203280|FG000|Overall Study|Withdrawal by Subject|10|||
31002349|NCT01880424|59203281|FG001|Overall Study|Withdrawal by Subject|30|||
31002350|NCT01880424|59203280|FG000|Overall Study|Other|1|||
31002351|NCT01880424|59203281|FG001|Overall Study|Other|0|||
31002352|NCT01862874|59203289|FG000|Overall Study|Randomized not treated|1|||
31002353|NCT01862874|59203290|FG001|Overall Study|Randomized not treated|0|||
31002354|NCT01862874|59203289|FG000|Overall Study|Adverse Event|0|||
31002355|NCT01862874|59203290|FG001|Overall Study|Adverse Event|3|||
31002356|NCT01862874|59203289|FG000|Overall Study|Lost to Follow-up|26|||
31002357|NCT01862874|59203290|FG001|Overall Study|Lost to Follow-up|29|||
31002358|NCT01862874|59203289|FG000|Overall Study|Physician Decision|5|||
31002359|NCT01862874|59203290|FG001|Overall Study|Physician Decision|3|||
31002360|NCT01862874|59203289|FG000|Overall Study|Withdrawn by parent/guardian|1|||
31002361|NCT01862874|59203290|FG001|Overall Study|Withdrawn by parent/guardian|1|||
31002362|NCT01862874|59203289|FG000|Overall Study|Withdrawal by Subject|46|||
31002363|NCT01862874|59203290|FG001|Overall Study|Withdrawal by Subject|40|||
31002364|NCT01862874|59203289|FG000|Overall Study|Death|0|||
31002365|NCT01862874|59203290|FG001|Overall Study|Death|1|||
31002366|NCT01879722|59203306|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
31002367|NCT01879722|59203307|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
31002368|NCT01879722|59203308|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
31002369|NCT01879722|59203309|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
31002370|NCT01879722|59203310|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
31002371|NCT01879722|59203311|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
31002372|NCT01879722|59203312|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
31002373|NCT01879722|59203313|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
31002374|NCT01879722|59203314|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
31002375|NCT01879722|59203315|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
31002376|NCT01879722|59203306|FG000|Overall Study|Voluntary Withdrawal|0|||
31002377|NCT01879722|59203307|FG001|Overall Study|Voluntary Withdrawal|0|||
31002378|NCT01879722|59203308|FG002|Overall Study|Voluntary Withdrawal|0|||
31002379|NCT01879722|59203309|FG003|Overall Study|Voluntary Withdrawal|0|||
31002380|NCT01879722|59203310|FG004|Overall Study|Voluntary Withdrawal|0|||
31002381|NCT01879722|59203311|FG005|Overall Study|Voluntary Withdrawal|0|||
31002382|NCT01879722|59203312|FG006|Overall Study|Voluntary Withdrawal|0|||
31002383|NCT01879722|59203313|FG007|Overall Study|Voluntary Withdrawal|0|||
31002384|NCT01879722|59203314|FG008|Overall Study|Voluntary Withdrawal|1|||
31002385|NCT01879722|59203315|FG009|Overall Study|Voluntary Withdrawal|0|||
31002386|NCT01879410|59203342|FG000|Overall Study|Adverse Event|9|||
31002387|NCT01879410|59203343|FG001|Overall Study|Adverse Event|14|||
31002388|NCT01879410|59203342|FG000|Overall Study|Lack of Efficacy|4|||
31002389|NCT01879410|59203343|FG001|Overall Study|Lack of Efficacy|6|||
31002390|NCT01879410|59203342|FG000|Overall Study|Protocol Violation|1|||
31002391|NCT01879410|59203343|FG001|Overall Study|Protocol Violation|7|||
31002392|NCT01879410|59203342|FG000|Overall Study|Lost to Follow-up|2|||
31002393|NCT01879410|59203343|FG001|Overall Study|Lost to Follow-up|1|||
31002394|NCT01879410|59203342|FG000|Overall Study|Withdrawal by Subject|7|||
31002395|NCT01879410|59203343|FG001|Overall Study|Withdrawal by Subject|8|||
31002396|NCT01879410|59203342|FG000|Overall Study|Randomised in Error|1|||
31002397|NCT01879410|59203343|FG001|Overall Study|Randomised in Error|2|||
31002398|NCT01903434|59203349|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
31002399|NCT01903434|59203350|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
31002400|NCT01903434|59203349|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
31002401|NCT01903434|59203350|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
31002402|NCT01903356|59203356|FG000|Overall Study|Lost to Follow-up|7|||
31002403|NCT01903356|59203356|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
31002404|NCT01903356|59203356|FG000|Overall Study|Violated the dosage and administration|3|||
31002405|NCT01862796|59203363|FG000|Overall Study|Prohibited medications|0|||
31002406|NCT01862796|59203364|FG001|Overall Study|Prohibited medications|0|||
31002407|NCT01862796|59203365|FG002|Overall Study|Prohibited medications|1|||
31002408|NCT01878084|59203373|FG000|Overall Study|Physician Decision|2|||
31002409|NCT01862640|59203382|FG000|Overall Study|Adverse Event|4|||
31002410|NCT01862640|59203383|FG001|Overall Study|Adverse Event|10|||
31002411|NCT01862640|59203384|FG002|Overall Study|Adverse Event|6|||
31002412|NCT01862640|59203385|FG003|Overall Study|Adverse Event|8|||
31002413|NCT01862640|59203382|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
31002414|NCT01862640|59203383|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
31002415|NCT01862640|59203384|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
31002416|NCT01862640|59203385|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
31002417|NCT01862640|59203382|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
31002418|NCT01862640|59203383|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
31002419|NCT01862640|59203384|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
31002420|NCT01862640|59203385|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
31002421|NCT01862640|59203382|FG000|Overall Study|Withdrawal by Subject|2|||
31002422|NCT01862640|59203383|FG001|Overall Study|Withdrawal by Subject|4|||
31002423|NCT01862640|59203384|FG002|Overall Study|Withdrawal by Subject|8|||
31002424|NCT01862640|59203385|FG003|Overall Study|Withdrawal by Subject|5|||
31002425|NCT01862640|59203382|FG000|Overall Study|Protocol Deviation|0|||
31002426|NCT01862640|59203383|FG001|Overall Study|Protocol Deviation|0|||
31002427|NCT01862640|59203384|FG002|Overall Study|Protocol Deviation|1|||
31002428|NCT01862640|59203385|FG003|Overall Study|Protocol Deviation|0|||
31002429|NCT01902966|59203394|FG000|Overall Study|Death|1|||
31002430|NCT01902966|59203394|FG000|Overall Study|Physician Decision|1|||
31002431|NCT01902966|59203394|FG000|Overall Study|Withdrawal by Subject|1|||
31002432|NCT01862484|59203400|FG000|Overall Study|Lack of Efficacy|1|||
31002433|NCT01862484|59203401|FG001|Overall Study|Lack of Efficacy|1|||
31002434|NCT01862484|59203400|FG000|Overall Study|Lost to Follow-up|1|||
31002435|NCT01862484|59203401|FG001|Overall Study|Lost to Follow-up|2|||
31002436|NCT01862484|59203400|FG000|Overall Study|Protocol Violation|0|||
31002437|NCT01862484|59203401|FG001|Overall Study|Protocol Violation|2|||
31002438|NCT01862484|59203400|FG000|Overall Study|Withdrawal by Subject|0|||
31002439|NCT01862484|59203401|FG001|Overall Study|Withdrawal by Subject|3|||
31002440|NCT01902888|59203407|FG000|Overall Study|Study Terminated|3|||
31002441|NCT01862328|59203418|FG000|Overall Study|Progressive Disease|3|||
31002442|NCT01862328|59203419|FG001|Overall Study|Progressive Disease|11|||
31002443|NCT01862328|59203420|FG002|Overall Study|Progressive Disease|5|||
31002444|NCT01862328|59203421|FG003|Overall Study|Progressive Disease|6|||
31002445|NCT01862328|59203422|FG004|Overall Study|Progressive Disease|7|||
31002446|NCT01862328|59203423|FG005|Overall Study|Progressive Disease|4|||
31002447|NCT01862328|59203424|FG006|Overall Study|Progressive Disease|3|||
31002448|NCT01862328|59203418|FG000|Overall Study|Adverse Event|0|||
31002449|NCT01862328|59203419|FG001|Overall Study|Adverse Event|4|||
31002450|NCT01862328|59203420|FG002|Overall Study|Adverse Event|0|||
31002451|NCT01862328|59203421|FG003|Overall Study|Adverse Event|1|||
31002452|NCT01862328|59203422|FG004|Overall Study|Adverse Event|0|||
31002453|NCT01862328|59203423|FG005|Overall Study|Adverse Event|2|||
31002454|NCT01862328|59203424|FG006|Overall Study|Adverse Event|4|||
31002455|NCT01862328|59203418|FG000|Overall Study|Other|0|||
31002456|NCT01862328|59203419|FG001|Overall Study|Other|2|||
31002457|NCT01862328|59203420|FG002|Overall Study|Other|1|||
31002458|NCT01862328|59203421|FG003|Overall Study|Other|0|||
31002459|NCT01862328|59203422|FG004|Overall Study|Other|4|||
31002460|NCT01862328|59203423|FG005|Overall Study|Other|0|||
31002461|NCT01862328|59203424|FG006|Overall Study|Other|1|||
31002462|NCT01862328|59203418|FG000|Overall Study|Withdrawal by Subject|1|||
31002463|NCT01862328|59203419|FG001|Overall Study|Withdrawal by Subject|1|||
31002464|NCT01862328|59203420|FG002|Overall Study|Withdrawal by Subject|0|||
31002465|NCT01862328|59203421|FG003|Overall Study|Withdrawal by Subject|0|||
31002466|NCT01862328|59203422|FG004|Overall Study|Withdrawal by Subject|1|||
31002467|NCT01862328|59203423|FG005|Overall Study|Withdrawal by Subject|1|||
31002468|NCT01862328|59203424|FG006|Overall Study|Withdrawal by Subject|1|||
31002469|NCT01862328|59203418|FG000|Overall Study|Symptomatic Deterioration|0|||
31002470|NCT01862328|59203419|FG001|Overall Study|Symptomatic Deterioration|0|||
31002471|NCT01862328|59203420|FG002|Overall Study|Symptomatic Deterioration|0|||
31002472|NCT01862328|59203421|FG003|Overall Study|Symptomatic Deterioration|0|||
31002473|NCT01862328|59203422|FG004|Overall Study|Symptomatic Deterioration|0|||
31002474|NCT01862328|59203423|FG005|Overall Study|Symptomatic Deterioration|0|||
31002475|NCT01862328|59203424|FG006|Overall Study|Symptomatic Deterioration|1|||
31002476|NCT01862250|59203446|FG000|Overall Study|Adverse Event|4|||
31002477|NCT01860846|59203450|FG000|Overall Study|Lost to Follow-up|33|||
31002478|NCT01901874|59203454|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
31002479|NCT01901874|59203454|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
31002480|NCT01901874|59203454|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
31002481|NCT01901874|59203454|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
31002482|NCT01901874|59203454|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
31002483|NCT01901874|59203454|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
31002484|NCT01860534|59203460|FG000|ROP #1|Needed treatment for ROP|0|||
31002485|NCT01860534|59203461|FG001|ROP #1|Needed treatment for ROP|1|||
31002486|NCT01860534|59203460|FG000|ROP #2|discharged prior to ROP #2|1|||
31002487|NCT01860534|59203461|FG001|ROP #2|discharged prior to ROP #2|0|||
31002488|NCT01901328|59203471|FG000|Overall Study|Lost to Follow-up|1|||
31002489|NCT01901328|59203472|FG001|Overall Study|Lost to Follow-up|0|||
31002490|NCT01901328|59203471|FG000|Overall Study|Physician Decision|0|||
31002491|NCT01901328|59203472|FG001|Overall Study|Physician Decision|1|||
31002492|NCT01901328|59203471|FG000|Overall Study|Protocol Violation|1|||
31002493|NCT01901328|59203472|FG001|Overall Study|Protocol Violation|1|||
31002494|NCT01901328|59203471|FG000|Overall Study|Study Terminated by Sponsor|19|||
31002495|NCT01901328|59203472|FG001|Overall Study|Study Terminated by Sponsor|16|||
31002496|NCT01901328|59203471|FG000|Overall Study|Withdrawal by Subject|1|||
31002497|NCT01901328|59203472|FG001|Overall Study|Withdrawal by Subject|2|||
31002498|NCT01901328|59203471|FG000|Overall Study|Lack of Efficacy|0|||
31002499|NCT01901328|59203472|FG001|Overall Study|Lack of Efficacy|1|||
31002500|NCT01859988|59203485|FG000|Overall Study|Withdrawal by Subject|6|||
31002501|NCT01859988|59203486|FG001|Overall Study|Withdrawal by Subject|3|||
31002502|NCT01859988|59203487|FG002|Overall Study|Withdrawal by Subject|4|||
31002503|NCT01859988|59203488|FG003|Overall Study|Withdrawal by Subject|3|||
31002504|NCT01859988|59203489|FG004|Overall Study|Withdrawal by Subject|2|||
31002505|NCT01859988|59203490|FG005|Overall Study|Withdrawal by Subject|2|||
31002506|NCT01859988|59203485|FG000|Overall Study|Lack of Efficacy|1|||
31002507|NCT01859988|59203486|FG001|Overall Study|Lack of Efficacy|1|||
31002508|NCT01859988|59203487|FG002|Overall Study|Lack of Efficacy|5|||
31002509|NCT01859988|59203488|FG003|Overall Study|Lack of Efficacy|0|||
31002510|NCT01859988|59203489|FG004|Overall Study|Lack of Efficacy|7|||
31002511|NCT01859988|59203490|FG005|Overall Study|Lack of Efficacy|9|||
31002512|NCT01859988|59203485|FG000|Overall Study|Physician Decision|1|||
31002513|NCT01859988|59203486|FG001|Overall Study|Physician Decision|3|||
31002514|NCT01859988|59203487|FG002|Overall Study|Physician Decision|1|||
31002515|NCT01859988|59203488|FG003|Overall Study|Physician Decision|3|||
31002516|NCT01859988|59203489|FG004|Overall Study|Physician Decision|4|||
31002517|NCT01859988|59203490|FG005|Overall Study|Physician Decision|1|||
31002518|NCT01859988|59203485|FG000|Overall Study|Adverse Event|2|||
31002519|NCT01859988|59203486|FG001|Overall Study|Adverse Event|1|||
31002520|NCT01859988|59203487|FG002|Overall Study|Adverse Event|3|||
31002521|NCT01859988|59203488|FG003|Overall Study|Adverse Event|1|||
31002522|NCT01859988|59203489|FG004|Overall Study|Adverse Event|2|||
31002523|NCT01859988|59203490|FG005|Overall Study|Adverse Event|2|||
31002524|NCT01859988|59203485|FG000|Overall Study|Lost to Follow-up|1|||
31002525|NCT01859988|59203486|FG001|Overall Study|Lost to Follow-up|2|||
31002526|NCT01859988|59203487|FG002|Overall Study|Lost to Follow-up|3|||
31002527|NCT01859988|59203488|FG003|Overall Study|Lost to Follow-up|0|||
31002528|NCT01859988|59203489|FG004|Overall Study|Lost to Follow-up|3|||
31002529|NCT01859988|59203490|FG005|Overall Study|Lost to Follow-up|2|||
31002530|NCT01859988|59203485|FG000|Overall Study|Protocol Violation|0|||
31002531|NCT01859988|59203486|FG001|Overall Study|Protocol Violation|0|||
31002532|NCT01859988|59203487|FG002|Overall Study|Protocol Violation|1|||
31002533|NCT01859988|59203488|FG003|Overall Study|Protocol Violation|0|||
31002534|NCT01859988|59203489|FG004|Overall Study|Protocol Violation|0|||
31002535|NCT01859988|59203490|FG005|Overall Study|Protocol Violation|0|||
31002536|NCT01859988|59203485|FG000|Overall Study|Other than specified above|0|||
31002537|NCT01859988|59203486|FG001|Overall Study|Other than specified above|2|||
31002538|NCT01859988|59203487|FG002|Overall Study|Other than specified above|11|||
31002539|NCT01859988|59203488|FG003|Overall Study|Other than specified above|3|||
31002540|NCT01859988|59203489|FG004|Overall Study|Other than specified above|5|||
31002541|NCT01859988|59203490|FG005|Overall Study|Other than specified above|3|||
31002542|NCT01859598|59203504|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
31002543|NCT01876446|59203512|FG000|Overall Study|Death|0|||
31002544|NCT01876446|59203513|FG001|Overall Study|Death|1|||
31002545|NCT01876446|59203512|FG000|Overall Study|Withdrawal by Subject|1|||
31002546|NCT01876446|59203513|FG001|Overall Study|Withdrawal by Subject|2|||
31002547|NCT01876446|59203512|FG000|Overall Study|Physician Decision|1|||
31002548|NCT01876446|59203513|FG001|Overall Study|Physician Decision|3|||
31002549|NCT01900626|59203521|FG000|Overall Study|study was closed due to low enrollment|1|||
31002550|NCT01900626|59203522|FG001|Overall Study|study was closed due to low enrollment|1|||
31002551|NCT01900314|59203532|FG000|Overall Study|Lost to Follow-up|1|||
31002552|NCT01900314|59203533|FG001|Overall Study|Lost to Follow-up|0|||
31002553|NCT01900314|59203532|FG000|Overall Study|Protocol Violation|0|||
31002554|NCT01900314|59203533|FG001|Overall Study|Protocol Violation|1|||
31002555|NCT01900314|59203532|FG000|Overall Study|Withdrawal by Subject|3|||
31002556|NCT01900314|59203533|FG001|Overall Study|Withdrawal by Subject|3|||
31002557|NCT01899768|59203540|FG000|Part A|Adverse Event|2|||
31002558|NCT01899768|59203540|FG000|Part A|Withdrawal by Subject|1|||
31002559|NCT01899768|59203540|FG000|Part B|Adverse Event|1|||
31002560|NCT01899768|59203540|FG000|Part B|Withdrawal by Subject|1|||
31002561|NCT01898598|59203550|FG000|Overall Study|Adverse Event|1|||
31002562|NCT01898598|59203551|FG001|Overall Study|Adverse Event|0|||
31002563|NCT01898598|59203550|FG000|Overall Study|Withdrawal by Subject|3|||
31002564|NCT01898598|59203551|FG001|Overall Study|Withdrawal by Subject|0|||
31002565|NCT01898598|59203550|FG000|Overall Study|Lost to Follow-up|0|||
31002566|NCT01898598|59203551|FG001|Overall Study|Lost to Follow-up|1|||
31002567|NCT01898598|59203550|FG000|Overall Study|Other|0|||
31002568|NCT01898598|59203551|FG001|Overall Study|Other|1|||
31002569|NCT01898442|59203560|FG000|Overall Study|Hemolysis/technical problems|1|||
31002570|NCT01898442|59203561|FG001|Overall Study|Hemolysis/technical problems|2|||
31002571|NCT01898442|59203562|FG002|Overall Study|Hemolysis/technical problems|2|||
31002572|NCT01898442|59203560|FG000|Overall Study|Patient vomited pills|0|||
31002573|NCT01898442|59203561|FG001|Overall Study|Patient vomited pills|0|||
31002574|NCT01898442|59203562|FG002|Overall Study|Patient vomited pills|1|||
31002575|NCT01898286|59203570|FG000|Overall Study|Withdrawal by Subject|1|||
31002576|NCT01898286|59203570|FG000|Overall Study|Protocol Violation|1|||
31002577|NCT01898286|59203570|FG000|Overall Study|Lost to Follow-up|1|||
31002578|NCT01898208|59203577|FG000|Overall Study|Positive blood culture|17|||
31002579|NCT01898208|59203578|FG001|Overall Study|Positive blood culture|23|||
31002580|NCT01898208|59203579|FG002|Overall Study|Positive blood culture|15|||
31002581|NCT01898208|59203577|FG000|Overall Study|Death/comfort care within 24 hours|10|||
31002582|NCT01898208|59203578|FG001|Overall Study|Death/comfort care within 24 hours|9|||
31002583|NCT01898208|59203579|FG002|Overall Study|Death/comfort care within 24 hours|8|||
31002584|NCT01898208|59203577|FG000|Overall Study|Negative Gram Stain|6|||
31002585|NCT01898208|59203578|FG001|Overall Study|Negative Gram Stain|9|||
31002586|NCT01898208|59203579|FG002|Overall Study|Negative Gram Stain|6|||
31002587|NCT01898208|59203577|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
31002588|NCT01898208|59203578|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
31002589|NCT01898208|59203579|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
31002590|NCT01898208|59203577|FG000|Overall Study|System/Technical Error|1|||
31002591|NCT01898208|59203578|FG001|Overall Study|System/Technical Error|2|||
31002592|NCT01898208|59203579|FG002|Overall Study|System/Technical Error|3|||
31002593|NCT01898208|59203577|FG000|Overall Study|Lost to Follow-up|3|||
31002594|NCT01898208|59203578|FG001|Overall Study|Lost to Follow-up|1|||
31002595|NCT01898208|59203579|FG002|Overall Study|Lost to Follow-up|1|||
31002596|NCT01898130|59203587|FG000|Treatment|Withdrawal by Subject|2|||
31002597|NCT01898130|59203587|FG000|Treatment|Progressive Disease|4|||
31002598|NCT01898130|59203587|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
31002599|NCT01876368|59203593|FG000|Overall Study|Adverse Event|2|||
31002600|NCT01876368|59203594|FG001|Overall Study|Adverse Event|5|||
31002601|NCT01876368|59203593|FG000|Overall Study|Lack of Efficacy|1|||
31002602|NCT01876368|59203594|FG001|Overall Study|Lack of Efficacy|0|||
31002603|NCT01876368|59203593|FG000|Overall Study|Lost to Follow-up|0|||
31002604|NCT01876368|59203594|FG001|Overall Study|Lost to Follow-up|1|||
31002605|NCT01876368|59203593|FG000|Overall Study|Non-compliance with study treatment|0|||
31002606|NCT01876368|59203594|FG001|Overall Study|Non-compliance with study treatment|1|||
31002607|NCT01876368|59203593|FG000|Overall Study|Physician Decision|0|||
31002608|NCT01876368|59203594|FG001|Overall Study|Physician Decision|2|||
31002609|NCT01876368|59203593|FG000|Overall Study|Protocol deviation|3|||
31002610|NCT01876368|59203594|FG001|Overall Study|Protocol deviation|3|||
31002611|NCT01876368|59203593|FG000|Overall Study|Subject/guardian decision|3|||
31002612|NCT01876368|59203594|FG001|Overall Study|Subject/guardian decision|1|||
31002613|NCT01874340|59203604|FG000|Overall Study|Study terminated by Sponsor|6|||
31002614|NCT01874340|59203605|FG001|Overall Study|Study terminated by Sponsor|8|||
31002615|NCT01874340|59203606|FG002|Overall Study|Study terminated by Sponsor|8|||
31002616|NCT01874340|59203607|FG003|Overall Study|Study terminated by Sponsor|4|||
31002617|NCT01874340|59203604|FG000|Overall Study|Withdrawal by Subject|0|||
31002618|NCT01874340|59203605|FG001|Overall Study|Withdrawal by Subject|0|||
31002619|NCT01874340|59203606|FG002|Overall Study|Withdrawal by Subject|0|||
31002620|NCT01874340|59203607|FG003|Overall Study|Withdrawal by Subject|1|||
31002621|NCT01897896|59203619|FG000|Overall Study|Death|1|||
31002622|NCT01897896|59203620|FG001|Overall Study|Death|0|||
31002623|NCT01897896|59203619|FG000|Overall Study|Adverse Event|11|||
31002624|NCT01897896|59203620|FG001|Overall Study|Adverse Event|1|||
31002625|NCT01897896|59203619|FG000|Overall Study|Lost to Follow-up|1|||
31002626|NCT01897896|59203620|FG001|Overall Study|Lost to Follow-up|0|||
31002627|NCT01897896|59203619|FG000|Overall Study|Non-compliance with study drug dosing|1|||
31002628|NCT01897896|59203620|FG001|Overall Study|Non-compliance with study drug dosing|1|||
31002629|NCT01897896|59203619|FG000|Overall Study|Withdrawal by Subject|7|||
31002630|NCT01897896|59203620|FG001|Overall Study|Withdrawal by Subject|1|||
31002631|NCT01897896|59203619|FG000|Overall Study|Require drug that interfere with study|1|||
31002632|NCT01897896|59203620|FG001|Overall Study|Require drug that interfere with study|4|||
31002633|NCT01897896|59203619|FG000|Overall Study|Protocol Violation|1|||
31002634|NCT01897896|59203620|FG001|Overall Study|Protocol Violation|1|||
31002635|NCT01897896|59203619|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
31002636|NCT01897896|59203620|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
31002637|NCT01897896|59203619|FG000|Overall Study|Caregiver can no longer participate|0|||
31002638|NCT01897896|59203620|FG001|Overall Study|Caregiver can no longer participate|2|||
31002639|NCT01897896|59203619|FG000|Overall Study|Other than specified|2|||
31002640|NCT01897896|59203620|FG001|Overall Study|Other than specified|1|||
31002641|NCT01858194|59203630|FG000|Overall Study|Total Artificial Heart Implant|0|||
31002642|NCT01858194|59203631|FG001|Overall Study|Total Artificial Heart Implant|1|||
31002643|NCT01858194|59203630|FG000|Overall Study|Lost to Follow-up|0|||
31002644|NCT01858194|59203631|FG001|Overall Study|Lost to Follow-up|1|||
31002645|NCT01873950|59203639|FG000|Period 5|Withdrawal by Subject|0|||
31002646|NCT01873950|59203640|FG001|Period 5|Withdrawal by Subject|0|||
31002647|NCT01873950|59203641|FG002|Period 5|Withdrawal by Subject|0|||
31002648|NCT01873950|59203642|FG003|Period 5|Withdrawal by Subject|1|||
31002649|NCT01873950|59203643|FG004|Period 5|Withdrawal by Subject|0|||
31002650|NCT01857102|59203657|FG000|Period 1|No longer meets Eligibility Criteria|0|||
31002651|NCT01857102|59203658|FG001|Period 1|No longer meets Eligibility Criteria|2|||
31002652|NCT01857102|59203657|FG000|Period 1|Lost to Follow-up|0|||
31002653|NCT01857102|59203658|FG001|Period 1|Lost to Follow-up|3|||
31002654|NCT01857102|59203657|FG000|Period 1|Unsatisfactory Lens Fit|1|||
31002655|NCT01857102|59203658|FG001|Period 1|Unsatisfactory Lens Fit|0|||
31002656|NCT01857102|59203657|FG000|Period 1|Unsatisfactory Visual Response|1|||
31002657|NCT01857102|59203658|FG001|Period 1|Unsatisfactory Visual Response|0|||
31002658|NCT01857102|59203657|FG000|Period 1|Physician Decision|1|||
31002659|NCT01857102|59203658|FG001|Period 1|Physician Decision|0|||
31002660|NCT01857102|59203657|FG000|Period 2|Lens Discomfort|1|||
31002661|NCT01857102|59203658|FG001|Period 2|Lens Discomfort|0|||
31002662|NCT01857102|59203657|FG000|Period 2|Unsatisfactory Lens Fit|1|||
31002663|NCT01857102|59203658|FG001|Period 2|Unsatisfactory Lens Fit|0|||
31002664|NCT01872078|59203670|FG000|Overall Study|Adverse Event|0|||
31002665|NCT01872078|59203671|FG001|Overall Study|Adverse Event|0|||
31002666|NCT01872078|59203672|FG002|Overall Study|Adverse Event|1|||
31002667|NCT01872078|59203673|FG003|Overall Study|Adverse Event|0|||
31002668|NCT01872078|59203670|FG000|Overall Study|Dose administration non-compliance|0|||
31002669|NCT01872078|59203671|FG001|Overall Study|Dose administration non-compliance|0|||
31002670|NCT01872078|59203672|FG002|Overall Study|Dose administration non-compliance|0|||
31002671|NCT01872078|59203673|FG003|Overall Study|Dose administration non-compliance|1|||
31002672|NCT01872078|59203670|FG000|Overall Study|Protocol Violation|0|||
31002673|NCT01872078|59203671|FG001|Overall Study|Protocol Violation|0|||
31002674|NCT01872078|59203672|FG002|Overall Study|Protocol Violation|1|||
31002675|NCT01872078|59203673|FG003|Overall Study|Protocol Violation|0|||
31002676|NCT01872078|59203670|FG000|Overall Study|Withdrawal by Subject|0|||
31002677|NCT01872078|59203671|FG001|Overall Study|Withdrawal by Subject|0|||
31002678|NCT01872078|59203672|FG002|Overall Study|Withdrawal by Subject|1|||
31002679|NCT01872078|59203673|FG003|Overall Study|Withdrawal by Subject|0|||
31002680|NCT01872078|59203670|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
31002681|NCT01872078|59203671|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
31002682|NCT01872078|59203672|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
31002683|NCT01872078|59203673|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
31002684|NCT01896726|59203683|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
31002685|NCT01896726|59203683|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
30892527|NCT01362790|58926001|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
31002686|NCT01856790|59203690|FG000|Closed Loop Control|Withdrawal by Subject|2|||
31002687|NCT01856790|59203690|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
31002688|NCT01856322|59203704|FG000|Overall Study|off study due to lack of accrual|0|||
31002689|NCT01856322|59203705|FG001|Overall Study|off study due to lack of accrual|0|||
31002690|NCT01856322|59203706|FG002|Overall Study|off study due to lack of accrual|3|||
31002691|NCT01896102|59203713|FG000|Overall Study|Death|1|||
31002692|NCT01896102|59203713|FG000|Overall Study|Participant to receive allogenic transplant|2|||
31002693|NCT01871532|59203720|FG000|Overall Study|Withdrawal by Subject|1|||
31002694|NCT01871532|59203721|FG001|Overall Study|Withdrawal by Subject|2|||
31002695|NCT01855074|59203727|FG000|Overall Study|Adverse Event|1|||
31002696|NCT01855074|59203727|FG000|Overall Study|Lost to Follow-up|4|||
31002697|NCT01855074|59203727|FG000|Overall Study|Withdrawal by Subject|8|||
31002698|NCT01855074|59203727|FG000|Overall Study|Started but not treated|1|||
31002699|NCT01871142|59203731|FG000|Overall Study|Adverse Event|1|||
31002700|NCT01895322|59203745|FG000|Overall Study|Adverse Event|1|||
31002701|NCT01895322|59203745|FG000|Overall Study|Withdrawal by Subject|2|||
31002702|NCT01895322|59203745|FG000|Overall Study|Protocol Violation|10|||
31002703|NCT01894776|59203750|FG000|Overall Study|Withdrawal by Subject|1|||
31002704|NCT01894620|59203756|FG000|Overall Study|Withdrawal by Subject|0|||
31002705|NCT01894620|59203757|FG001|Overall Study|Withdrawal by Subject|1|||
31002706|NCT01854918|59203767|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
31002707|NCT01854918|59203768|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
31002708|NCT01854918|59203767|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
31002709|NCT01854918|59203768|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
31002710|NCT01854918|59203767|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
31002711|NCT01854918|59203768|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
31002712|NCT01854918|59203767|FG000|SOC-controlled Period (Year 1)|Death|5|||
31002713|NCT01854918|59203768|FG001|SOC-controlled Period (Year 1)|Death|5|||
31002714|NCT01854918|59203767|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
31002715|NCT01854918|59203768|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
31002716|NCT01854918|59203767|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
31002717|NCT01854918|59203768|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
31002718|NCT01854918|59203767|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
31002719|NCT01854918|59203768|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
31002720|NCT01854918|59203767|FG000|All-IP Period (Years 2 and 3)|Death|5|||
31002721|NCT01854918|59203768|FG001|All-IP Period (Years 2 and 3)|Death|16|||
31002722|NCT01894230|59203783|FG000|Overall Study|Lost to Follow-up|2|||
31002723|NCT01894230|59203784|FG001|Overall Study|Lost to Follow-up|2|||
31002724|NCT01894230|59203783|FG000|Overall Study|Withdrawal by Subject|4|||
31002725|NCT01894230|59203784|FG001|Overall Study|Withdrawal by Subject|4|||
31002726|NCT01894230|59203783|FG000|Overall Study|Non-adherent|0|||
31002727|NCT01894230|59203784|FG001|Overall Study|Non-adherent|1|||
31002728|NCT01894230|59203783|FG000|Overall Study|Death|1|||
31002729|NCT01894230|59203784|FG001|Overall Study|Death|0|||
31002730|NCT01894152|59203790|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
31002731|NCT01854528|59203796|FG000|Overall Study|Adverse Event|0|||
31002732|NCT01854528|59203797|FG001|Overall Study|Adverse Event|4|||
31002733|NCT01854528|59203796|FG000|Overall Study|Withdrawal by Subject|0|||
31002734|NCT01854528|59203797|FG001|Overall Study|Withdrawal by Subject|2|||
31002735|NCT01854528|59203796|FG000|Overall Study|Virologic Failure|0|||
31002736|NCT01854528|59203797|FG001|Overall Study|Virologic Failure|9|||
31002737|NCT01853982|59203805|FG000|Overall Study|Withdrawal by Subject|1|||
31002738|NCT01853982|59203806|FG001|Overall Study|Withdrawal by Subject|0|||
31002739|NCT01853982|59203805|FG000|Overall Study|Death|1|||
31002740|NCT01853982|59203806|FG001|Overall Study|Death|0|||
31002741|NCT01853982|59203805|FG000|Overall Study|Lost to Follow-up|0|||
31002742|NCT01853982|59203806|FG001|Overall Study|Lost to Follow-up|1|||
31002743|NCT01853280|59203814|FG000|Overall Study|Lack of Efficacy|2|||
31002744|NCT01853280|59203815|FG001|Overall Study|Lack of Efficacy|2|||
31002745|NCT01853280|59203814|FG000|Overall Study|Lost to Follow-up|0|||
31002746|NCT01853280|59203815|FG001|Overall Study|Lost to Follow-up|1|||
31002747|NCT01853280|59203814|FG000|Overall Study|Physician Decision|0|||
31002748|NCT01853280|59203815|FG001|Overall Study|Physician Decision|1|||
31002749|NCT01853280|59203814|FG000|Overall Study|Withdrawal by Subject|0|||
31002750|NCT01853280|59203815|FG001|Overall Study|Withdrawal by Subject|1|||
31002751|NCT01853280|59203814|FG000|Overall Study|Ineligible|0|||
31002752|NCT01853280|59203815|FG001|Overall Study|Ineligible|1|||
31002753|NCT01892436|59203825|FG000|Overall Study|Withdrawal by Subject|8|||
31002754|NCT01892436|59203826|FG001|Overall Study|Withdrawal by Subject|15|||
31002755|NCT01892436|59203827|FG002|Overall Study|Withdrawal by Subject|4|||
31002756|NCT01892436|59203828|FG003|Overall Study|Withdrawal by Subject|4|||
31002757|NCT01892436|59203825|FG000|Overall Study|Death|1|||
31002758|NCT01892436|59203826|FG001|Overall Study|Death|1|||
31002759|NCT01892436|59203827|FG002|Overall Study|Death|0|||
31002760|NCT01892436|59203828|FG003|Overall Study|Death|0|||
31002761|NCT01892436|59203825|FG000|Overall Study|Physician Decision|2|||
31002762|NCT01892436|59203826|FG001|Overall Study|Physician Decision|1|||
31002763|NCT01892436|59203827|FG002|Overall Study|Physician Decision|0|||
31002764|NCT01892436|59203828|FG003|Overall Study|Physician Decision|1|||
31002765|NCT01892436|59203825|FG000|Overall Study|Pregnancy|0|||
31002766|NCT01892436|59203826|FG001|Overall Study|Pregnancy|2|||
31002767|NCT01892436|59203827|FG002|Overall Study|Pregnancy|1|||
31002768|NCT01892436|59203828|FG003|Overall Study|Pregnancy|0|||
31002769|NCT01892436|59203825|FG000|Overall Study|Technical problems|2|||
31002770|NCT01892436|59203826|FG001|Overall Study|Technical problems|1|||
31002771|NCT01892436|59203827|FG002|Overall Study|Technical problems|1|||
31002772|NCT01892436|59203828|FG003|Overall Study|Technical problems|1|||
31002773|NCT01892436|59203825|FG000|Overall Study|Lack of Efficacy|1|||
31002774|NCT01892436|59203826|FG001|Overall Study|Lack of Efficacy|2|||
31002775|NCT01892436|59203827|FG002|Overall Study|Lack of Efficacy|2|||
31002776|NCT01892436|59203828|FG003|Overall Study|Lack of Efficacy|2|||
31002777|NCT01892436|59203825|FG000|Overall Study|Lost to Follow-up|1|||
31002778|NCT01892436|59203826|FG001|Overall Study|Lost to Follow-up|1|||
31002779|NCT01892436|59203827|FG002|Overall Study|Lost to Follow-up|1|||
31002780|NCT01892436|59203828|FG003|Overall Study|Lost to Follow-up|3|||
31002781|NCT01892436|59203825|FG000|Overall Study|non-compliance with treatment|1|||
31002782|NCT01892436|59203826|FG001|Overall Study|non-compliance with treatment|0|||
31002783|NCT01892436|59203827|FG002|Overall Study|non-compliance with treatment|0|||
31002784|NCT01892436|59203828|FG003|Overall Study|non-compliance with treatment|0|||
31002785|NCT01892436|59203825|FG000|Overall Study|Adverse Event|7|||
31002786|NCT01892436|59203826|FG001|Overall Study|Adverse Event|6|||
31002787|NCT01892436|59203827|FG002|Overall Study|Adverse Event|2|||
31002788|NCT01892436|59203828|FG003|Overall Study|Adverse Event|3|||
31002789|NCT01853046|59203840|FG000|Overall Study|Withdrawal by Subject|1|||
31002790|NCT01853046|59203841|FG001|Overall Study|Withdrawal by Subject|1|||
31002791|NCT01853046|59203840|FG000|Overall Study|Adverse Event|4|||
31002792|NCT01853046|59203841|FG001|Overall Study|Adverse Event|2|||
31002793|NCT01853046|59203840|FG000|Overall Study|Disease progression|13|||
31002794|NCT01853046|59203841|FG001|Overall Study|Disease progression|3|||
31002795|NCT01891890|59203851|FG000|Overall Study|Lost to Follow-up|0|||
31002796|NCT01891890|59203852|FG001|Overall Study|Lost to Follow-up|0|||
31002797|NCT01891890|59203853|FG002|Overall Study|Lost to Follow-up|1|||
31002798|NCT01891890|59203851|FG000|Overall Study|Study ended before endpoint reached|7|||
31002799|NCT01891890|59203852|FG001|Overall Study|Study ended before endpoint reached|3|||
31002800|NCT01891890|59203853|FG002|Overall Study|Study ended before endpoint reached|6|||
31002801|NCT01852812|59203864|FG000|Overall Study|Adverse Event|0|||
31002802|NCT01852812|59203865|FG001|Overall Study|Adverse Event|0|||
31002803|NCT01852812|59203866|FG002|Overall Study|Adverse Event|1|||
31002804|NCT01852812|59203864|FG000|Overall Study|Non-compliance With Study Drug|0|||
31002805|NCT01852812|59203865|FG001|Overall Study|Non-compliance With Study Drug|1|||
31002806|NCT01852812|59203866|FG002|Overall Study|Non-compliance With Study Drug|0|||
31002807|NCT01869348|59203876|FG000|Overall Study|Withdrawal by Subject|1|||
31002808|NCT01869348|59203877|FG001|Overall Study|Withdrawal by Subject|1|||
31002809|NCT01869192|59203885|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
31002810|NCT01869192|59203886|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
31002811|NCT01869192|59203885|FG000|Postoperative Chemotherapy|Physician Decision|0|||
31002812|NCT01869192|59203886|FG001|Postoperative Chemotherapy|Physician Decision|2|||
31002813|NCT01868646|59203894|FG000|Overall Study|Do not meet inclusion criteria|3|||
31002814|NCT01868646|59203895|FG001|Overall Study|Do not meet inclusion criteria|5|||
31002815|NCT01852110|59203903|FG000|Overall Study|Adverse Event|12|||
31002816|NCT01852110|59203904|FG001|Overall Study|Adverse Event|5|||
31002817|NCT01852110|59203905|FG002|Overall Study|Adverse Event|0|||
31002818|NCT01852110|59203906|FG003|Overall Study|Adverse Event|0|||
31002819|NCT01852110|59203907|FG004|Overall Study|Adverse Event|0|||
31002820|NCT01852110|59203908|FG005|Overall Study|Adverse Event|0|||
31002821|NCT01852110|59203903|FG000|Overall Study|Lost to Follow-up|1|||
31002822|NCT01852110|59203904|FG001|Overall Study|Lost to Follow-up|3|||
31002823|NCT01852110|59203905|FG002|Overall Study|Lost to Follow-up|0|||
31002824|NCT01852110|59203906|FG003|Overall Study|Lost to Follow-up|0|||
31002825|NCT01852110|59203907|FG004|Overall Study|Lost to Follow-up|0|||
31002826|NCT01852110|59203908|FG005|Overall Study|Lost to Follow-up|0|||
31002827|NCT01852110|59203903|FG000|Overall Study|Non-compliance with Study Drug|2|||
31002828|NCT01852110|59203904|FG001|Overall Study|Non-compliance with Study Drug|1|||
31002829|NCT01852110|59203905|FG002|Overall Study|Non-compliance with Study Drug|0|||
31002830|NCT01852110|59203906|FG003|Overall Study|Non-compliance with Study Drug|0|||
31002831|NCT01852110|59203907|FG004|Overall Study|Non-compliance with Study Drug|0|||
31002832|NCT01852110|59203908|FG005|Overall Study|Non-compliance with Study Drug|0|||
31002833|NCT01852110|59203903|FG000|Overall Study|Physician Decision|1|||
31002834|NCT01852110|59203904|FG001|Overall Study|Physician Decision|0|||
31002835|NCT01852110|59203905|FG002|Overall Study|Physician Decision|0|||
31002836|NCT01852110|59203906|FG003|Overall Study|Physician Decision|0|||
31002837|NCT01852110|59203907|FG004|Overall Study|Physician Decision|0|||
31002838|NCT01852110|59203908|FG005|Overall Study|Physician Decision|0|||
31002839|NCT01852110|59203903|FG000|Overall Study|Protocol Violation|0|||
31002840|NCT01852110|59203904|FG001|Overall Study|Protocol Violation|1|||
31002841|NCT01852110|59203905|FG002|Overall Study|Protocol Violation|0|||
31002842|NCT01852110|59203906|FG003|Overall Study|Protocol Violation|0|||
31002843|NCT01852110|59203907|FG004|Overall Study|Protocol Violation|0|||
31002844|NCT01852110|59203908|FG005|Overall Study|Protocol Violation|0|||
31002845|NCT01852110|59203903|FG000|Overall Study|Study Terminated by Sponsor|30|||
31002846|NCT01852110|59203904|FG001|Overall Study|Study Terminated by Sponsor|32|||
31002847|NCT01852110|59203905|FG002|Overall Study|Study Terminated by Sponsor|0|||
31002848|NCT01852110|59203906|FG003|Overall Study|Study Terminated by Sponsor|0|||
31002849|NCT01852110|59203907|FG004|Overall Study|Study Terminated by Sponsor|0|||
31002850|NCT01852110|59203908|FG005|Overall Study|Study Terminated by Sponsor|0|||
31002851|NCT01852110|59203903|FG000|Overall Study|Withdrawal by Subject|4|||
31002852|NCT01852110|59203904|FG001|Overall Study|Withdrawal by Subject|4|||
31002853|NCT01852110|59203905|FG002|Overall Study|Withdrawal by Subject|0|||
31002854|NCT01852110|59203906|FG003|Overall Study|Withdrawal by Subject|0|||
31002855|NCT01852110|59203907|FG004|Overall Study|Withdrawal by Subject|0|||
31002856|NCT01852110|59203908|FG005|Overall Study|Withdrawal by Subject|0|||
31002857|NCT01851720|59203924|FG000|Overall Study|Lost to Follow-up|0|||
31002858|NCT01851720|59203925|FG001|Overall Study|Lost to Follow-up|1|||
31002859|NCT01851330|59203934|FG000|Overall Study|Lack of Efficacy|10|||
31002860|NCT01851330|59203935|FG001|Overall Study|Lack of Efficacy|9|||
31002861|NCT01851330|59203936|FG002|Overall Study|Lack of Efficacy|2|||
31002862|NCT01851330|59203934|FG000|Overall Study|Lost to Follow-up|1|||
31002863|NCT01851330|59203935|FG001|Overall Study|Lost to Follow-up|6|||
31002864|NCT01851330|59203936|FG002|Overall Study|Lost to Follow-up|9|||
31002865|NCT01851330|59203934|FG000|Overall Study|Withdrew Consent|2|||
31002866|NCT01851330|59203935|FG001|Overall Study|Withdrew Consent|1|||
31002867|NCT01851330|59203936|FG002|Overall Study|Withdrew Consent|0|||
31002868|NCT01851330|59203934|FG000|Overall Study|Investigator's Discretion|0|||
31002869|NCT01851330|59203935|FG001|Overall Study|Investigator's Discretion|0|||
31002870|NCT01851330|59203936|FG002|Overall Study|Investigator's Discretion|1|||
31002871|NCT01868022|59203953|FG000|Overall Study|Withdrawal by Subject|0|||
31002872|NCT01868022|59203954|FG001|Overall Study|Withdrawal by Subject|0|||
31002873|NCT01868022|59203955|FG002|Overall Study|Withdrawal by Subject|1|||
31002874|NCT01868022|59203956|FG003|Overall Study|Withdrawal by Subject|1|||
31002875|NCT01868022|59203957|FG004|Overall Study|Withdrawal by Subject|0|||
31002876|NCT01868022|59203958|FG005|Overall Study|Withdrawal by Subject|0|||
31002877|NCT01868022|59203959|FG006|Overall Study|Withdrawal by Subject|0|||
31002878|NCT01868022|59203960|FG007|Overall Study|Withdrawal by Subject|1|||
31002879|NCT01868022|59203961|FG008|Overall Study|Withdrawal by Subject|0|||
31002880|NCT01868022|59203953|FG000|Overall Study|Adverse Event|0|||
31002881|NCT01868022|59203954|FG001|Overall Study|Adverse Event|0|||
31002882|NCT01868022|59203955|FG002|Overall Study|Adverse Event|0|||
31002883|NCT01868022|59203956|FG003|Overall Study|Adverse Event|0|||
31002884|NCT01868022|59203957|FG004|Overall Study|Adverse Event|2|||
31002885|NCT01868022|59203958|FG005|Overall Study|Adverse Event|0|||
31002886|NCT01868022|59203959|FG006|Overall Study|Adverse Event|0|||
31002887|NCT01868022|59203960|FG007|Overall Study|Adverse Event|2|||
31002888|NCT01868022|59203961|FG008|Overall Study|Adverse Event|2|||
31002889|NCT01868022|59203953|FG000|Overall Study|Physician Decision|0|||
31002890|NCT01868022|59203954|FG001|Overall Study|Physician Decision|0|||
31002891|NCT01868022|59203955|FG002|Overall Study|Physician Decision|0|||
31002892|NCT01868022|59203956|FG003|Overall Study|Physician Decision|0|||
31002893|NCT01868022|59203957|FG004|Overall Study|Physician Decision|0|||
31002894|NCT01868022|59203958|FG005|Overall Study|Physician Decision|1|||
31002895|NCT01868022|59203959|FG006|Overall Study|Physician Decision|0|||
31002896|NCT01868022|59203960|FG007|Overall Study|Physician Decision|2|||
31002897|NCT01868022|59203961|FG008|Overall Study|Physician Decision|0|||
31002898|NCT01868022|59203953|FG000|Overall Study|Study closed/terminated|0|||
31002899|NCT01868022|59203954|FG001|Overall Study|Study closed/terminated|0|||
31002900|NCT01868022|59203955|FG002|Overall Study|Study closed/terminated|0|||
31002901|NCT01868022|59203956|FG003|Overall Study|Study closed/terminated|0|||
31002902|NCT01868022|59203957|FG004|Overall Study|Study closed/terminated|0|||
31002903|NCT01868022|59203958|FG005|Overall Study|Study closed/terminated|0|||
31002904|NCT01868022|59203959|FG006|Overall Study|Study closed/terminated|0|||
31002905|NCT01868022|59203960|FG007|Overall Study|Study closed/terminated|1|||
31002906|NCT01868022|59203961|FG008|Overall Study|Study closed/terminated|0|||
31002907|NCT01868022|59203953|FG000|Overall Study|Ongoing|0|||
31002908|NCT01868022|59203954|FG001|Overall Study|Ongoing|0|||
31002909|NCT01868022|59203955|FG002|Overall Study|Ongoing|0|||
31002910|NCT01868022|59203956|FG003|Overall Study|Ongoing|0|||
31002911|NCT01868022|59203957|FG004|Overall Study|Ongoing|0|||
31002912|NCT01868022|59203958|FG005|Overall Study|Ongoing|0|||
31002913|NCT01868022|59203959|FG006|Overall Study|Ongoing|0|||
31002914|NCT01868022|59203960|FG007|Overall Study|Ongoing|3|||
31002915|NCT01868022|59203961|FG008|Overall Study|Ongoing|0|||
31002916|NCT01850004|59203987|FG000|Overall Study|Poor/Non-compliance|1|||
31002917|NCT01850004|59203987|FG000|Overall Study|Participant Withdrew Consent|9|||
31002918|NCT01850004|59203987|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
31002919|NCT01850004|59203987|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
31002920|NCT01850004|59203987|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
31002921|NCT01850004|59203987|FG000|Overall Study|Other Reasons|2|||
31002922|NCT01850004|59203987|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
31002923|NCT01850004|59203987|FG000|Overall Study|Maximum Clinical Benefit|4|||
31002924|NCT01867710|59203995|FG000|Overall Study|Death|25|||
31002925|NCT01867710|59203996|FG001|Overall Study|Death|15|||
31002926|NCT01867710|59203997|FG002|Overall Study|Death|27|||
31002927|NCT01867710|59203998|FG003|Overall Study|Death|20|||
31002928|NCT01867710|59203995|FG000|Overall Study|Lost to Follow-up|3|||
31002929|NCT01867710|59203996|FG001|Overall Study|Lost to Follow-up|4|||
31002930|NCT01867710|59203997|FG002|Overall Study|Lost to Follow-up|3|||
31002931|NCT01867710|59203998|FG003|Overall Study|Lost to Follow-up|2|||
31002932|NCT01867710|59203995|FG000|Overall Study|Withdrawal of consent|2|||
31002933|NCT01867710|59203996|FG001|Overall Study|Withdrawal of consent|5|||
31002934|NCT01867710|59203997|FG002|Overall Study|Withdrawal of consent|1|||
31002935|NCT01867710|59203998|FG003|Overall Study|Withdrawal of consent|2|||
31002936|NCT01867710|59203995|FG000|Overall Study|Study Terminated by Sponsor|9|||
31002937|NCT01867710|59203996|FG001|Overall Study|Study Terminated by Sponsor|13|||
31002938|NCT01867710|59203997|FG002|Overall Study|Study Terminated by Sponsor|8|||
31002939|NCT01867710|59203998|FG003|Overall Study|Study Terminated by Sponsor|16|||
31002940|NCT01867710|59203995|FG000|Overall Study|Biochemical progression|0|||
31002941|NCT01867710|59203996|FG001|Overall Study|Biochemical progression|1|||
31002942|NCT01867710|59203997|FG002|Overall Study|Biochemical progression|0|||
31002943|NCT01867710|59203998|FG003|Overall Study|Biochemical progression|0|||
31002944|NCT01867710|59203995|FG000|Overall Study|Clinical progression|0|||
31002945|NCT01867710|59203996|FG001|Overall Study|Clinical progression|0|||
31002946|NCT01867710|59203997|FG002|Overall Study|Clinical progression|1|||
31002947|NCT01867710|59203998|FG003|Overall Study|Clinical progression|0|||
31002948|NCT01867710|59203995|FG000|Overall Study|Disease progression|1|||
31002949|NCT01867710|59203996|FG001|Overall Study|Disease progression|0|||
31002950|NCT01867710|59203997|FG002|Overall Study|Disease progression|0|||
31002951|NCT01867710|59203998|FG003|Overall Study|Disease progression|0|||
31002952|NCT01867710|59203995|FG000|Overall Study|Patient decision|0|||
31002953|NCT01867710|59203996|FG001|Overall Study|Patient decision|0|||
31002954|NCT01867710|59203997|FG002|Overall Study|Patient decision|0|||
31002955|NCT01867710|59203998|FG003|Overall Study|Patient decision|1|||
31002956|NCT01867710|59203995|FG000|Overall Study|Patient to follow subsequent treatment|0|||
31002957|NCT01867710|59203996|FG001|Overall Study|Patient to follow subsequent treatment|1|||
31002958|NCT01867710|59203997|FG002|Overall Study|Patient to follow subsequent treatment|0|||
31002959|NCT01867710|59203998|FG003|Overall Study|Patient to follow subsequent treatment|0|||
31002960|NCT01867710|59203995|FG000|Overall Study|Progressive disease|1|||
31002961|NCT01867710|59203996|FG001|Overall Study|Progressive disease|0|||
31002962|NCT01867710|59203997|FG002|Overall Study|Progressive disease|0|||
31002963|NCT01867710|59203998|FG003|Overall Study|Progressive disease|0|||
31002964|NCT01867710|59203995|FG000|Overall Study|Protocol Violation|0|||
31002965|NCT01867710|59203996|FG001|Overall Study|Protocol Violation|0|||
31002966|NCT01867710|59203997|FG002|Overall Study|Protocol Violation|0|||
31002967|NCT01867710|59203998|FG003|Overall Study|Protocol Violation|1|||
31002968|NCT01867710|59203995|FG000|Overall Study|PSA-progression|0|||
31002969|NCT01867710|59203996|FG001|Overall Study|PSA-progression|1|||
31002970|NCT01867710|59203997|FG002|Overall Study|PSA-progression|0|||
31002971|NCT01867710|59203998|FG003|Overall Study|PSA-progression|0|||
31002972|NCT01867710|59203995|FG000|Overall Study|Study medication no longer effective|0|||
31002973|NCT01867710|59203996|FG001|Overall Study|Study medication no longer effective|1|||
31002974|NCT01867710|59203997|FG002|Overall Study|Study medication no longer effective|0|||
31002975|NCT01867710|59203998|FG003|Overall Study|Study medication no longer effective|0|||
31002976|NCT01849848|59204008|FG000|Overall Study|Physician Decision|1|||
31002977|NCT01849848|59204008|FG000|Overall Study|Progression of the primary disease|3|||
31002978|NCT01849458|59204012|FG000|Overall Study|Lost to Follow-up|4|||
31002979|NCT01832766|59204016|FG000|Washout|Lost to Follow-up|0|||
31002980|NCT01832766|59204017|FG001|Washout|Lost to Follow-up|1|||
31002981|NCT01832532|59204025|FG000|Overall Study|Withdrawal by Subject|5|||
31002982|NCT01832532|59204026|FG001|Overall Study|Withdrawal by Subject|2|||
30892528|NCT01362790|58926002|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
31002983|NCT01848990|59204035|FG000|Overall Study|Adverse Event|6|||
31002984|NCT01848990|59204036|FG001|Overall Study|Adverse Event|2|||
31002985|NCT01848990|59204037|FG002|Overall Study|Adverse Event|0|||
31002986|NCT01848990|59204035|FG000|Overall Study|Lost to Follow-up|6|||
31002987|NCT01848990|59204036|FG001|Overall Study|Lost to Follow-up|2|||
31002988|NCT01848990|59204037|FG002|Overall Study|Lost to Follow-up|2|||
31002989|NCT01848990|59204035|FG000|Overall Study|Protocol Violation|1|||
31002990|NCT01848990|59204036|FG001|Overall Study|Protocol Violation|1|||
31002991|NCT01848990|59204037|FG002|Overall Study|Protocol Violation|0|||
31002992|NCT01848990|59204035|FG000|Overall Study|Withdrawal by Subject|29|||
31002993|NCT01848990|59204036|FG001|Overall Study|Withdrawal by Subject|10|||
31002994|NCT01848990|59204037|FG002|Overall Study|Withdrawal by Subject|11|||
31002995|NCT01848990|59204035|FG000|Overall Study|Physician Decision|1|||
31002996|NCT01848990|59204036|FG001|Overall Study|Physician Decision|1|||
31002997|NCT01848990|59204037|FG002|Overall Study|Physician Decision|0|||
31002998|NCT01848990|59204035|FG000|Overall Study|Non Compliance|1|||
31002999|NCT01848990|59204036|FG001|Overall Study|Non Compliance|0|||
31003000|NCT01848990|59204037|FG002|Overall Study|Non Compliance|0|||
31003001|NCT01848990|59204035|FG000|Overall Study|Death|1|||
31003002|NCT01848990|59204036|FG001|Overall Study|Death|0|||
31003003|NCT01848990|59204037|FG002|Overall Study|Death|1|||
31003004|NCT01848990|59204035|FG000|Overall Study|Other|1|||
31003005|NCT01848990|59204036|FG001|Overall Study|Other|4|||
31003006|NCT01848990|59204037|FG002|Overall Study|Other|2|||
31003007|NCT01867086|59204049|FG000|Overall Study|Disease Progression|1|||
31003008|NCT01831596|59204053|FG000|Overall Study|Other|8|||
31003009|NCT01848834|59204062|FG000|Overall Study|Adverse Event|3|||
31003010|NCT01848834|59204063|FG001|Overall Study|Adverse Event|11|||
31003011|NCT01848834|59204064|FG002|Overall Study|Adverse Event|3|||
31003012|NCT01848834|59204065|FG003|Overall Study|Adverse Event|5|||
31003013|NCT01848834|59204066|FG004|Overall Study|Adverse Event|9|||
31003014|NCT01848834|59204062|FG000|Overall Study|Death|2|||
31003015|NCT01848834|59204063|FG001|Overall Study|Death|11|||
31003016|NCT01848834|59204064|FG002|Overall Study|Death|1|||
31003017|NCT01848834|59204065|FG003|Overall Study|Death|8|||
31003018|NCT01848834|59204066|FG004|Overall Study|Death|27|||
31003019|NCT01848834|59204062|FG000|Overall Study|Excluded Medication|5|||
31003020|NCT01848834|59204063|FG001|Overall Study|Excluded Medication|4|||
31003021|NCT01848834|59204064|FG002|Overall Study|Excluded Medication|3|||
31003022|NCT01848834|59204065|FG003|Overall Study|Excluded Medication|6|||
31003023|NCT01848834|59204066|FG004|Overall Study|Excluded Medication|6|||
31003024|NCT01848834|59204062|FG000|Overall Study|Lost to Follow-up|5|||
31003025|NCT01848834|59204063|FG001|Overall Study|Lost to Follow-up|5|||
31003026|NCT01848834|59204064|FG002|Overall Study|Lost to Follow-up|3|||
31003027|NCT01848834|59204065|FG003|Overall Study|Lost to Follow-up|0|||
31003028|NCT01848834|59204066|FG004|Overall Study|Lost to Follow-up|3|||
31003029|NCT01848834|59204062|FG000|Overall Study|Physician Decision|1|||
31003030|NCT01848834|59204063|FG001|Overall Study|Physician Decision|3|||
31003031|NCT01848834|59204064|FG002|Overall Study|Physician Decision|4|||
31003032|NCT01848834|59204065|FG003|Overall Study|Physician Decision|0|||
31003033|NCT01848834|59204066|FG004|Overall Study|Physician Decision|11|||
31003034|NCT01848834|59204062|FG000|Overall Study|Protocol Violation|0|||
31003035|NCT01848834|59204063|FG001|Overall Study|Protocol Violation|0|||
31003036|NCT01848834|59204064|FG002|Overall Study|Protocol Violation|0|||
31003037|NCT01848834|59204065|FG003|Overall Study|Protocol Violation|0|||
31003038|NCT01848834|59204066|FG004|Overall Study|Protocol Violation|1|||
31003039|NCT01848834|59204062|FG000|Overall Study|Sponsor Decision|1|||
31003040|NCT01848834|59204063|FG001|Overall Study|Sponsor Decision|1|||
31003041|NCT01848834|59204064|FG002|Overall Study|Sponsor Decision|0|||
31003042|NCT01848834|59204065|FG003|Overall Study|Sponsor Decision|1|||
31003043|NCT01848834|59204066|FG004|Overall Study|Sponsor Decision|1|||
31003044|NCT01848834|59204062|FG000|Overall Study|Withdrawal by Subject|2|||
31003045|NCT01848834|59204063|FG001|Overall Study|Withdrawal by Subject|13|||
31003046|NCT01848834|59204064|FG002|Overall Study|Withdrawal by Subject|10|||
31003047|NCT01848834|59204065|FG003|Overall Study|Withdrawal by Subject|6|||
31003048|NCT01848834|59204066|FG004|Overall Study|Withdrawal by Subject|36|||
31003049|NCT01867008|59204082|FG000|Overall Study|Withdrawal by Subject|1|||
31003050|NCT01848756|59204086|FG000|Overall Study|Adverse Event|1|||
31003051|NCT01848756|59204086|FG000|Overall Study|Withdrawal by Subject|1|||
31003052|NCT01848756|59204086|FG000|Overall Study|Enrolled in Error|1|||
31003053|NCT01830972|59204093|FG000|Part II|Withdrawal by Subject|2|||
31003054|NCT01830972|59204094|FG001|Part II|Withdrawal by Subject|2|||
31003055|NCT01830972|59204093|FG000|Part III|Withdrawal by Subject|1|||
31003056|NCT01830972|59204094|FG001|Part III|Withdrawal by Subject|0|||
31003057|NCT01830972|59204093|FG000|Part III|Noncompliance|1|||
31003058|NCT01830972|59204094|FG001|Part III|Noncompliance|0|||
31003059|NCT01830972|59204093|FG000|Part IV|Withdrawal by Subject|2|||
31003060|NCT01830972|59204094|FG001|Part IV|Withdrawal by Subject|1|||
31003061|NCT01830972|59204093|FG000|Part IV|Non-Compliance|1|||
31003062|NCT01830972|59204094|FG001|Part IV|Non-Compliance|0|||
31003063|NCT01848288|59204110|FG000|Overall Study|Death|1|||
31003064|NCT01848288|59204110|FG000|Overall Study|Protocol Violation|1|||
31003065|NCT01848288|59204110|FG000|Overall Study|Withdrawal by Subject|1|||
31003066|NCT01848210|59204117|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
31003067|NCT01848210|59204118|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
31003068|NCT01848210|59204117|FG000|Overall Study|Lost to Follow-up|24|||
31003069|NCT01848210|59204118|FG001|Overall Study|Lost to Follow-up|12|||
31003070|NCT01848210|59204117|FG000|Overall Study|Protocol Violation|3|||
31003071|NCT01848210|59204118|FG001|Overall Study|Protocol Violation|5|||
31003072|NCT01848210|59204117|FG000|Overall Study|Use of Forbidden Drugs|9|||
31003073|NCT01848210|59204118|FG001|Overall Study|Use of Forbidden Drugs|10|||
31003074|NCT01848210|59204117|FG000|Overall Study|Impedition Condition|5|||
31003075|NCT01848210|59204118|FG001|Overall Study|Impedition Condition|9|||
31003076|NCT01848210|59204117|FG000|Overall Study|Adverse Event|7|||
31003077|NCT01848210|59204118|FG001|Overall Study|Adverse Event|9|||
31003078|NCT01848210|59204117|FG000|Overall Study|Discontinuation Criterion|5|||
31003079|NCT01848210|59204118|FG001|Overall Study|Discontinuation Criterion|7|||
31003080|NCT01848210|59204117|FG000|Overall Study|Hypesensitivity|1|||
31003081|NCT01848210|59204118|FG001|Overall Study|Hypesensitivity|0|||
31003082|NCT01848210|59204117|FG000|Overall Study|Hepatic Function Alteration|4|||
31003083|NCT01848210|59204118|FG001|Overall Study|Hepatic Function Alteration|0|||
31003084|NCT01848210|59204117|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
31003085|NCT01848210|59204118|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
31003086|NCT01848210|59204117|FG000|Overall Study|Administrative|1|||
31003087|NCT01848210|59204118|FG001|Overall Study|Administrative|0|||
31003088|NCT01830816|59204127|FG000|Overall Study|Progressive Disease|12|||
31003089|NCT01830816|59204128|FG001|Overall Study|Progressive Disease|7|||
31003090|NCT01830816|59204129|FG002|Overall Study|Progressive Disease|7|||
31003091|NCT01830816|59204127|FG000|Overall Study|Adverse Event|3|||
31003092|NCT01830816|59204128|FG001|Overall Study|Adverse Event|4|||
31003093|NCT01830816|59204129|FG002|Overall Study|Adverse Event|0|||
31003094|NCT01830816|59204127|FG000|Overall Study|Study Terminated by Sponsor|1|||
31003095|NCT01830816|59204128|FG001|Overall Study|Study Terminated by Sponsor|1|||
31003096|NCT01830816|59204129|FG002|Overall Study|Study Terminated by Sponsor|0|||
31003097|NCT01830816|59204127|FG000|Overall Study|Withdrawal by Subject|1|||
31003098|NCT01830816|59204128|FG001|Overall Study|Withdrawal by Subject|1|||
31003099|NCT01830816|59204129|FG002|Overall Study|Withdrawal by Subject|0|||
31003100|NCT01830816|59204127|FG000|Overall Study|Lost to Follow-up|0|||
31003101|NCT01830816|59204128|FG001|Overall Study|Lost to Follow-up|1|||
31003102|NCT01830816|59204129|FG002|Overall Study|Lost to Follow-up|0|||
31003103|NCT01830816|59204127|FG000|Overall Study|Symptomatic Deterioration|1|||
31003104|NCT01830816|59204128|FG001|Overall Study|Symptomatic Deterioration|0|||
31003105|NCT01830816|59204129|FG002|Overall Study|Symptomatic Deterioration|0|||
31003106|NCT01830816|59204127|FG000|Overall Study|Reason not Specified|2|||
31003107|NCT01830816|59204128|FG001|Overall Study|Reason not Specified|0|||
31003108|NCT01830816|59204129|FG002|Overall Study|Reason not Specified|0|||
31003109|NCT01846416|59204143|FG000|Treatment Phase|Death|2|||
31003110|NCT01846416|59204144|FG001|Treatment Phase|Death|9|||
31003111|NCT01846416|59204145|FG002|Treatment Phase|Death|1|||
31003112|NCT01846416|59204143|FG000|Treatment Phase|Withdrawal by Subject|2|||
31003113|NCT01846416|59204144|FG001|Treatment Phase|Withdrawal by Subject|4|||
31003114|NCT01846416|59204145|FG002|Treatment Phase|Withdrawal by Subject|2|||
31003115|NCT01846416|59204143|FG000|Treatment Phase|Other|1|||
31003116|NCT01846416|59204144|FG001|Treatment Phase|Other|5|||
31003117|NCT01846416|59204145|FG002|Treatment Phase|Other|1|||
31003118|NCT01846416|59204143|FG000|Treatment Phase|Physician Decision|1|||
31003119|NCT01846416|59204144|FG001|Treatment Phase|Physician Decision|2|||
31003120|NCT01846416|59204145|FG002|Treatment Phase|Physician Decision|0|||
31003121|NCT01846416|59204143|FG000|Treatment Phase|Adverse Event|3|||
31003122|NCT01846416|59204144|FG001|Treatment Phase|Adverse Event|4|||
31003123|NCT01846416|59204145|FG002|Treatment Phase|Adverse Event|0|||
31003124|NCT01846416|59204143|FG000|Treatment Phase|Non-compliance|0|||
31003125|NCT01846416|59204144|FG001|Treatment Phase|Non-compliance|2|||
31003126|NCT01846416|59204145|FG002|Treatment Phase|Non-compliance|0|||
31003127|NCT01846416|59204143|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
31003128|NCT01846416|59204144|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
31003129|NCT01846416|59204145|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
31003130|NCT01846416|59204143|FG000|Treatment Phase|Progressive Disease|21|||
31003131|NCT01846416|59204144|FG001|Treatment Phase|Progressive Disease|63|||
31003132|NCT01846416|59204145|FG002|Treatment Phase|Progressive Disease|9|||
31003133|NCT01846416|59204143|FG000|Survival Follow-up|Death|21|||
31003134|NCT01846416|59204144|FG001|Survival Follow-up|Death|62|||
31003135|NCT01846416|59204145|FG002|Survival Follow-up|Death|9|||
31003136|NCT01846416|59204143|FG000|Survival Follow-up|Lost to Follow-up|0|||
31003137|NCT01846416|59204144|FG001|Survival Follow-up|Lost to Follow-up|2|||
31003138|NCT01846416|59204145|FG002|Survival Follow-up|Lost to Follow-up|2|||
31003139|NCT01846416|59204143|FG000|Survival Follow-up|Withdrawal by Subject|2|||
31003140|NCT01846416|59204144|FG001|Survival Follow-up|Withdrawal by Subject|7|||
31003141|NCT01846416|59204145|FG002|Survival Follow-up|Withdrawal by Subject|0|||
31003142|NCT01846416|59204143|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
31003143|NCT01846416|59204144|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
31003144|NCT01846416|59204145|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
31003145|NCT01846416|59204143|FG000|Survival Follow-up|Other|3|||
31003146|NCT01846416|59204144|FG001|Survival Follow-up|Other|1|||
31003147|NCT01846416|59204145|FG002|Survival Follow-up|Other|1|||
31003148|NCT01865448|59204156|FG000|Overall Study|Adverse Event|1|||
31003149|NCT01865448|59204157|FG001|Overall Study|Adverse Event|1|||
31003150|NCT01865448|59204156|FG000|Overall Study|Pregnancy|0|||
31003151|NCT01865448|59204157|FG001|Overall Study|Pregnancy|1|||
31003152|NCT01865448|59204156|FG000|Overall Study|dropout unrelated to study|1|||
31003153|NCT01865448|59204157|FG001|Overall Study|dropout unrelated to study|1|||
31003154|NCT01804140|59204164|FG000|Overall Study|No sampling or biopsy procedures done|114|||
31003155|NCT01846104|59204168|FG000|Overall Study|Withdrawal by Subject|1|||
31003156|NCT01803282|59204184|FG000|Overall Study|Progressive Disease|4|||
31003157|NCT01803282|59204185|FG001|Overall Study|Progressive Disease|3|||
31003158|NCT01803282|59204186|FG002|Overall Study|Progressive Disease|6|||
31003159|NCT01803282|59204187|FG003|Overall Study|Progressive Disease|22|||
31003160|NCT01803282|59204188|FG004|Overall Study|Progressive Disease|5|||
31003161|NCT01803282|59204189|FG005|Overall Study|Progressive Disease|8|||
31003162|NCT01803282|59204190|FG006|Overall Study|Progressive Disease|23|||
31003163|NCT01803282|59204191|FG007|Overall Study|Progressive Disease|24|||
31003164|NCT01803282|59204192|FG008|Overall Study|Progressive Disease|3|||
31003165|NCT01803282|59204193|FG009|Overall Study|Progressive Disease|29|||
31003166|NCT01803282|59204194|FG010|Overall Study|Progressive Disease|6|||
30892529|NCT01362790|58926003|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
31003167|NCT01803282|59204195|FG011|Overall Study|Progressive Disease|11|||
31003168|NCT01803282|59204184|FG000|Overall Study|Death|0|||
31003169|NCT01803282|59204185|FG001|Overall Study|Death|0|||
31003170|NCT01803282|59204186|FG002|Overall Study|Death|0|||
31003171|NCT01803282|59204187|FG003|Overall Study|Death|0|||
31003172|NCT01803282|59204188|FG004|Overall Study|Death|2|||
31003173|NCT01803282|59204189|FG005|Overall Study|Death|1|||
31003174|NCT01803282|59204190|FG006|Overall Study|Death|1|||
31003175|NCT01803282|59204191|FG007|Overall Study|Death|5|||
31003176|NCT01803282|59204192|FG008|Overall Study|Death|1|||
31003177|NCT01803282|59204193|FG009|Overall Study|Death|1|||
31003178|NCT01803282|59204194|FG010|Overall Study|Death|0|||
31003179|NCT01803282|59204195|FG011|Overall Study|Death|0|||
31003180|NCT01803282|59204184|FG000|Overall Study|Withdrew Consent|0|||
31003181|NCT01803282|59204185|FG001|Overall Study|Withdrew Consent|0|||
31003182|NCT01803282|59204186|FG002|Overall Study|Withdrew Consent|0|||
31003183|NCT01803282|59204187|FG003|Overall Study|Withdrew Consent|6|||
31003184|NCT01803282|59204188|FG004|Overall Study|Withdrew Consent|1|||
31003185|NCT01803282|59204189|FG005|Overall Study|Withdrew Consent|0|||
31003186|NCT01803282|59204190|FG006|Overall Study|Withdrew Consent|8|||
31003187|NCT01803282|59204191|FG007|Overall Study|Withdrew Consent|3|||
31003188|NCT01803282|59204192|FG008|Overall Study|Withdrew Consent|1|||
31003189|NCT01803282|59204193|FG009|Overall Study|Withdrew Consent|5|||
31003190|NCT01803282|59204194|FG010|Overall Study|Withdrew Consent|0|||
31003191|NCT01803282|59204195|FG011|Overall Study|Withdrew Consent|1|||
31003192|NCT01803282|59204184|FG000|Overall Study|Investigator's Discretion|0|||
31003193|NCT01803282|59204185|FG001|Overall Study|Investigator's Discretion|0|||
31003194|NCT01803282|59204186|FG002|Overall Study|Investigator's Discretion|0|||
31003195|NCT01803282|59204187|FG003|Overall Study|Investigator's Discretion|7|||
31003196|NCT01803282|59204188|FG004|Overall Study|Investigator's Discretion|2|||
31003197|NCT01803282|59204189|FG005|Overall Study|Investigator's Discretion|1|||
31003198|NCT01803282|59204190|FG006|Overall Study|Investigator's Discretion|7|||
31003199|NCT01803282|59204191|FG007|Overall Study|Investigator's Discretion|10|||
31003200|NCT01803282|59204192|FG008|Overall Study|Investigator's Discretion|6|||
31003201|NCT01803282|59204193|FG009|Overall Study|Investigator's Discretion|7|||
31003202|NCT01803282|59204194|FG010|Overall Study|Investigator's Discretion|1|||
31003203|NCT01803282|59204195|FG011|Overall Study|Investigator's Discretion|0|||
31003204|NCT01803282|59204184|FG000|Overall Study|Adverse Event|0|||
31003205|NCT01803282|59204185|FG001|Overall Study|Adverse Event|0|||
31003206|NCT01803282|59204186|FG002|Overall Study|Adverse Event|0|||
31003207|NCT01803282|59204187|FG003|Overall Study|Adverse Event|0|||
31003208|NCT01803282|59204188|FG004|Overall Study|Adverse Event|0|||
31003209|NCT01803282|59204189|FG005|Overall Study|Adverse Event|0|||
31003210|NCT01803282|59204190|FG006|Overall Study|Adverse Event|1|||
31003211|NCT01803282|59204191|FG007|Overall Study|Adverse Event|2|||
31003212|NCT01803282|59204192|FG008|Overall Study|Adverse Event|0|||
31003213|NCT01803282|59204193|FG009|Overall Study|Adverse Event|1|||
31003214|NCT01803282|59204194|FG010|Overall Study|Adverse Event|0|||
30892530|NCT01362790|58926004|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
30892531|NCT01362790|58926005|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
30892532|NCT01362790|58926006|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
31003215|NCT01803282|59204195|FG011|Overall Study|Adverse Event|3|||
31003216|NCT01803282|59204184|FG000|Overall Study|Non-Compliance with Study Drug|0|||
31003217|NCT01803282|59204185|FG001|Overall Study|Non-Compliance with Study Drug|0|||
31003218|NCT01803282|59204186|FG002|Overall Study|Non-Compliance with Study Drug|0|||
31003219|NCT01803282|59204187|FG003|Overall Study|Non-Compliance with Study Drug|1|||
30892533|NCT01362790|58926007|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
31003220|NCT01803282|59204188|FG004|Overall Study|Non-Compliance with Study Drug|0|||
31003221|NCT01803282|59204189|FG005|Overall Study|Non-Compliance with Study Drug|0|||
31003222|NCT01803282|59204190|FG006|Overall Study|Non-Compliance with Study Drug|0|||
31003223|NCT01803282|59204191|FG007|Overall Study|Non-Compliance with Study Drug|0|||
31003224|NCT01803282|59204192|FG008|Overall Study|Non-Compliance with Study Drug|0|||
31003225|NCT01803282|59204193|FG009|Overall Study|Non-Compliance with Study Drug|0|||
31003226|NCT01803282|59204194|FG010|Overall Study|Non-Compliance with Study Drug|0|||
31003227|NCT01803282|59204195|FG011|Overall Study|Non-Compliance with Study Drug|0|||
31003228|NCT01803282|59204184|FG000|Overall Study|Unknown Reason|0|||
31003229|NCT01803282|59204185|FG001|Overall Study|Unknown Reason|0|||
31003230|NCT01803282|59204186|FG002|Overall Study|Unknown Reason|0|||
31003231|NCT01803282|59204187|FG003|Overall Study|Unknown Reason|0|||
31003232|NCT01803282|59204188|FG004|Overall Study|Unknown Reason|0|||
31003233|NCT01803282|59204189|FG005|Overall Study|Unknown Reason|0|||
31003234|NCT01803282|59204190|FG006|Overall Study|Unknown Reason|0|||
31003235|NCT01803282|59204191|FG007|Overall Study|Unknown Reason|1|||
31003236|NCT01803282|59204192|FG008|Overall Study|Unknown Reason|0|||
31003237|NCT01803282|59204193|FG009|Overall Study|Unknown Reason|0|||
31003238|NCT01803282|59204194|FG010|Overall Study|Unknown Reason|0|||
31003239|NCT01803282|59204195|FG011|Overall Study|Unknown Reason|0|||
31003240|NCT01803282|59204184|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
31003241|NCT01803282|59204185|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
31003242|NCT01803282|59204186|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
31003243|NCT01803282|59204187|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
31003244|NCT01803282|59204188|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
31003245|NCT01803282|59204189|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
31003246|NCT01803282|59204190|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
31003247|NCT01803282|59204191|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
31003248|NCT01803282|59204192|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
31003249|NCT01803282|59204193|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
31003250|NCT01803282|59204194|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
31003251|NCT01803282|59204195|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
31003252|NCT01803282|59204184|FG000|Overall Study|Enrolled but Never Treated|0|||
31003253|NCT01803282|59204185|FG001|Overall Study|Enrolled but Never Treated|0|||
31003254|NCT01803282|59204186|FG002|Overall Study|Enrolled but Never Treated|0|||
31003255|NCT01803282|59204187|FG003|Overall Study|Enrolled but Never Treated|0|||
31003256|NCT01803282|59204188|FG004|Overall Study|Enrolled but Never Treated|1|||
31003257|NCT01803282|59204189|FG005|Overall Study|Enrolled but Never Treated|0|||
31003258|NCT01803282|59204190|FG006|Overall Study|Enrolled but Never Treated|1|||
31003259|NCT01803282|59204191|FG007|Overall Study|Enrolled but Never Treated|1|||
31003260|NCT01803282|59204192|FG008|Overall Study|Enrolled but Never Treated|0|||
31003261|NCT01803282|59204193|FG009|Overall Study|Enrolled but Never Treated|1|||
31003262|NCT01803282|59204194|FG010|Overall Study|Enrolled but Never Treated|0|||
31003263|NCT01803282|59204195|FG011|Overall Study|Enrolled but Never Treated|0|||
31003264|NCT01844778|59204224|FG000|Overall Study|Protocol deviation|0|||
31003265|NCT01844778|59204225|FG001|Overall Study|Protocol deviation|1|||
31003266|NCT01844778|59204226|FG002|Overall Study|Protocol deviation|2|||
31003267|NCT01844778|59204224|FG000|Overall Study|Withdrawal by Subject|2|||
31003268|NCT01844778|59204225|FG001|Overall Study|Withdrawal by Subject|0|||
31003269|NCT01844778|59204226|FG002|Overall Study|Withdrawal by Subject|0|||
31003270|NCT01844778|59204224|FG000|Overall Study|Adverse Event|0|||
31003271|NCT01844778|59204225|FG001|Overall Study|Adverse Event|2|||
31003272|NCT01844778|59204226|FG002|Overall Study|Adverse Event|2|||
31003273|NCT01802580|59204240|FG000|Overall Study|Physician Decision|1|||
31003274|NCT01802580|59204241|FG001|Overall Study|Physician Decision|0|||
31003275|NCT01802580|59204240|FG000|Overall Study|Protocol Violation|2|||
31003276|NCT01802580|59204241|FG001|Overall Study|Protocol Violation|0|||
31003277|NCT01802580|59204240|FG000|Overall Study|Withdrawal by Subject|5|||
31003278|NCT01802580|59204241|FG001|Overall Study|Withdrawal by Subject|6|||
31003279|NCT01802580|59204240|FG000|Overall Study|Other|1|||
31003280|NCT01802580|59204241|FG001|Overall Study|Other|3|||
31003281|NCT01802580|59204240|FG000|Overall Study|Lack of Efficacy|0|||
31003282|NCT01802580|59204241|FG001|Overall Study|Lack of Efficacy|2|||
31003283|NCT01611090|59204249|FG000|Randomized Period|Lost to Follow-up|8|||
31003284|NCT01611090|59204250|FG001|Randomized Period|Lost to Follow-up|3|||
31003285|NCT01611090|59204251|FG002|Randomized Period|Lost to Follow-up|0|||
31003286|NCT01611090|59204249|FG000|Randomized Period|Withdrawal by Subject|22|||
31003287|NCT01611090|59204250|FG001|Randomized Period|Withdrawal by Subject|26|||
31003288|NCT01611090|59204251|FG002|Randomized Period|Withdrawal by Subject|0|||
31003289|NCT01611090|59204249|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
31003290|NCT01611090|59204250|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
31003291|NCT01611090|59204251|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
31003292|NCT01611090|59204249|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
31003293|NCT01611090|59204250|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
31003294|NCT01611090|59204251|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
31003295|NCT01844700|59204260|FG000|Overall Study|Lack of Efficacy|1|||
31003296|NCT01844700|59204261|FG001|Overall Study|Lack of Efficacy|0|||
31003297|NCT01844700|59204260|FG000|Overall Study|refused medication switch|1|||
31003298|NCT01844700|59204261|FG001|Overall Study|refused medication switch|0|||
31003299|NCT01844700|59204260|FG000|Overall Study|Withdrawal by Subject|1|||
31003300|NCT01844700|59204261|FG001|Overall Study|Withdrawal by Subject|0|||
31003301|NCT01844700|59204260|FG000|Overall Study|stopped taking meds|0|||
31003302|NCT01844700|59204261|FG001|Overall Study|stopped taking meds|1|||
31003303|NCT01827384|59204281|FG000|Overall Study|Switched to alternative treatment|0|||
31003304|NCT01827384|59204282|FG001|Overall Study|Switched to alternative treatment|0|||
31003305|NCT01827384|59204283|FG002|Overall Study|Switched to alternative treatment|0|||
31003306|NCT01827384|59204284|FG003|Overall Study|Switched to alternative treatment|0|||
31003307|NCT01827384|59204285|FG004|Overall Study|Switched to alternative treatment|0|||
31003308|NCT01827384|59204286|FG005|Overall Study|Switched to alternative treatment|0|||
31003309|NCT01827384|59204287|FG006|Overall Study|Switched to alternative treatment|0|||
31003310|NCT01827384|59204288|FG007|Overall Study|Switched to alternative treatment|0|||
31003311|NCT01827384|59204289|FG008|Overall Study|Switched to alternative treatment|0|||
31003312|NCT01827384|59204290|FG009|Overall Study|Switched to alternative treatment|0|||
31003313|NCT01827384|59204291|FG010|Overall Study|Switched to alternative treatment|0|||
31003314|NCT01827384|59204292|FG011|Overall Study|Switched to alternative treatment|0|||
31003315|NCT01827384|59204293|FG012|Overall Study|Switched to alternative treatment|0|||
31003316|NCT01827384|59204294|FG013|Overall Study|Switched to alternative treatment|2|||
31003317|NCT01827384|59204281|FG000|Overall Study|Disease progression before treatment|0|||
31003318|NCT01827384|59204282|FG001|Overall Study|Disease progression before treatment|0|||
31003319|NCT01827384|59204283|FG002|Overall Study|Disease progression before treatment|0|||
31003320|NCT01827384|59204284|FG003|Overall Study|Disease progression before treatment|0|||
31003321|NCT01827384|59204285|FG004|Overall Study|Disease progression before treatment|0|||
31003322|NCT01827384|59204286|FG005|Overall Study|Disease progression before treatment|0|||
31003323|NCT01827384|59204287|FG006|Overall Study|Disease progression before treatment|0|||
31003324|NCT01827384|59204288|FG007|Overall Study|Disease progression before treatment|0|||
31003325|NCT01827384|59204289|FG008|Overall Study|Disease progression before treatment|0|||
31003326|NCT01827384|59204290|FG009|Overall Study|Disease progression before treatment|0|||
31003327|NCT01827384|59204291|FG010|Overall Study|Disease progression before treatment|0|||
31003328|NCT01827384|59204292|FG011|Overall Study|Disease progression before treatment|0|||
31003329|NCT01827384|59204293|FG012|Overall Study|Disease progression before treatment|0|||
31003330|NCT01827384|59204294|FG013|Overall Study|Disease progression before treatment|4|||
31003331|NCT01827384|59204281|FG000|Overall Study|Ineligible|0|||
31003332|NCT01827384|59204282|FG001|Overall Study|Ineligible|0|||
31003333|NCT01827384|59204283|FG002|Overall Study|Ineligible|0|||
31003334|NCT01827384|59204284|FG003|Overall Study|Ineligible|0|||
31003335|NCT01827384|59204285|FG004|Overall Study|Ineligible|0|||
31003336|NCT01827384|59204286|FG005|Overall Study|Ineligible|0|||
31003337|NCT01827384|59204287|FG006|Overall Study|Ineligible|0|||
31003338|NCT01827384|59204288|FG007|Overall Study|Ineligible|0|||
31003339|NCT01827384|59204289|FG008|Overall Study|Ineligible|0|||
31003340|NCT01827384|59204290|FG009|Overall Study|Ineligible|0|||
31003341|NCT01827384|59204291|FG010|Overall Study|Ineligible|0|||
31003342|NCT01827384|59204292|FG011|Overall Study|Ineligible|0|||
31003343|NCT01827384|59204293|FG012|Overall Study|Ineligible|0|||
31003344|NCT01827384|59204294|FG013|Overall Study|Ineligible|19|||
31003345|NCT01827384|59204281|FG000|Overall Study|Participant died before treatment|0|||
31003346|NCT01827384|59204282|FG001|Overall Study|Participant died before treatment|0|||
31003347|NCT01827384|59204283|FG002|Overall Study|Participant died before treatment|0|||
31003348|NCT01827384|59204284|FG003|Overall Study|Participant died before treatment|0|||
31003349|NCT01827384|59204285|FG004|Overall Study|Participant died before treatment|0|||
31003350|NCT01827384|59204286|FG005|Overall Study|Participant died before treatment|0|||
31003351|NCT01827384|59204287|FG006|Overall Study|Participant died before treatment|0|||
31003352|NCT01827384|59204288|FG007|Overall Study|Participant died before treatment|0|||
31003353|NCT01827384|59204289|FG008|Overall Study|Participant died before treatment|0|||
31003354|NCT01827384|59204290|FG009|Overall Study|Participant died before treatment|0|||
31003355|NCT01827384|59204291|FG010|Overall Study|Participant died before treatment|0|||
31003356|NCT01827384|59204292|FG011|Overall Study|Participant died before treatment|0|||
31003357|NCT01827384|59204293|FG012|Overall Study|Participant died before treatment|0|||
31003358|NCT01827384|59204294|FG013|Overall Study|Participant died before treatment|5|||
31003359|NCT01827384|59204281|FG000|Overall Study|Insufficient tumor cells|0|||
31003360|NCT01827384|59204282|FG001|Overall Study|Insufficient tumor cells|0|||
31003361|NCT01827384|59204283|FG002|Overall Study|Insufficient tumor cells|0|||
31003362|NCT01827384|59204284|FG003|Overall Study|Insufficient tumor cells|0|||
31003363|NCT01827384|59204285|FG004|Overall Study|Insufficient tumor cells|0|||
31003364|NCT01827384|59204286|FG005|Overall Study|Insufficient tumor cells|0|||
31003365|NCT01827384|59204287|FG006|Overall Study|Insufficient tumor cells|0|||
31003366|NCT01827384|59204288|FG007|Overall Study|Insufficient tumor cells|0|||
31003367|NCT01827384|59204289|FG008|Overall Study|Insufficient tumor cells|0|||
31003368|NCT01827384|59204290|FG009|Overall Study|Insufficient tumor cells|0|||
31003369|NCT01827384|59204291|FG010|Overall Study|Insufficient tumor cells|0|||
31003370|NCT01827384|59204292|FG011|Overall Study|Insufficient tumor cells|0|||
31003371|NCT01827384|59204293|FG012|Overall Study|Insufficient tumor cells|0|||
31003372|NCT01827384|59204294|FG013|Overall Study|Insufficient tumor cells|13|||
31003373|NCT01827384|59204281|FG000|Overall Study|No actionable mutation|0|||
31003374|NCT01827384|59204282|FG001|Overall Study|No actionable mutation|0|||
31003375|NCT01827384|59204283|FG002|Overall Study|No actionable mutation|0|||
31003376|NCT01827384|59204284|FG003|Overall Study|No actionable mutation|0|||
31003377|NCT01827384|59204285|FG004|Overall Study|No actionable mutation|0|||
31003378|NCT01827384|59204286|FG005|Overall Study|No actionable mutation|0|||
31003379|NCT01827384|59204287|FG006|Overall Study|No actionable mutation|0|||
31003380|NCT01827384|59204288|FG007|Overall Study|No actionable mutation|0|||
31003381|NCT01827384|59204289|FG008|Overall Study|No actionable mutation|0|||
31003382|NCT01827384|59204290|FG009|Overall Study|No actionable mutation|0|||
31003383|NCT01827384|59204291|FG010|Overall Study|No actionable mutation|0|||
31003384|NCT01827384|59204292|FG011|Overall Study|No actionable mutation|0|||
31003385|NCT01827384|59204293|FG012|Overall Study|No actionable mutation|0|||
31003386|NCT01827384|59204294|FG013|Overall Study|No actionable mutation|73|||
31003387|NCT01827384|59204281|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
31003388|NCT01827384|59204282|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
31003389|NCT01827384|59204283|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
31003390|NCT01827384|59204284|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
31003391|NCT01827384|59204285|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
31003392|NCT01827384|59204286|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
31003393|NCT01827384|59204287|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
31003394|NCT01827384|59204288|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
31003395|NCT01827384|59204289|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
31003396|NCT01827384|59204290|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
31003397|NCT01827384|59204291|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
31003398|NCT01827384|59204292|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
31003399|NCT01827384|59204293|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
31003400|NCT01827384|59204294|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
31003401|NCT01844076|59204328|FG000|Overall Study|Adverse Event|1|||
31003402|NCT01844076|59204329|FG001|Overall Study|Adverse Event|0|||
31003403|NCT01844076|59204330|FG002|Overall Study|Adverse Event|0|||
31003404|NCT01844076|59204331|FG003|Overall Study|Adverse Event|0|||
31003405|NCT01844076|59204328|FG000|Overall Study|Withdrawal by Subject|1|||
31003406|NCT01844076|59204329|FG001|Overall Study|Withdrawal by Subject|0|||
31003407|NCT01844076|59204330|FG002|Overall Study|Withdrawal by Subject|0|||
31003408|NCT01844076|59204331|FG003|Overall Study|Withdrawal by Subject|0|||
31003409|NCT01826604|59204343|FG000|Overall Study|Lost to Follow-up|8|||
31003410|NCT01826604|59204344|FG001|Overall Study|Lost to Follow-up|9|||
31003411|NCT01843842|59204352|FG000|Overall Study|Do not meet inclusion criteria|1|||
31003412|NCT01843842|59204353|FG001|Overall Study|Do not meet inclusion criteria|1|||
31003413|NCT01826448|59204361|FG000|Overall Study|Adverse Event|1|||
31003414|NCT01826448|59204362|FG001|Overall Study|Adverse Event|3|||
31003415|NCT01826448|59204361|FG000|Overall Study|Disease progression|2|||
31003416|NCT01826448|59204362|FG001|Overall Study|Disease progression|4|||
31003417|NCT01826448|59204361|FG000|Overall Study|Withdrawal by Subject|1|||
31003418|NCT01826448|59204362|FG001|Overall Study|Withdrawal by Subject|0|||
31003419|NCT01826448|59204361|FG000|Overall Study|Physician Decision|0|||
31003420|NCT01826448|59204362|FG001|Overall Study|Physician Decision|1|||
31003421|NCT01826448|59204361|FG000|Overall Study|2 active cancers|0|||
31003422|NCT01826448|59204362|FG001|Overall Study|2 active cancers|1|||
31003423|NCT01826370|59204368|FG000|Overall Study|Protocol Violation|6|||
31003424|NCT01826370|59204368|FG000|Overall Study|Lost to Follow-up|12|||
31003425|NCT01826370|59204368|FG000|Overall Study|Other reason not defined above|2|||
31003426|NCT01826214|59204374|FG000|Overall Study|Adverse Event|7|||
31003427|NCT01826214|59204375|FG001|Overall Study|Adverse Event|6|||
31003428|NCT01826214|59204374|FG000|Overall Study|Death|3|||
31003429|NCT01826214|59204375|FG001|Overall Study|Death|1|||
31003430|NCT01826214|59204374|FG000|Overall Study|Lost to Follow-up|1|||
31003431|NCT01826214|59204375|FG001|Overall Study|Lost to Follow-up|0|||
31003432|NCT01826214|59204374|FG000|Overall Study|Physician Decision|0|||
31003433|NCT01826214|59204375|FG001|Overall Study|Physician Decision|2|||
31003434|NCT01826214|59204374|FG000|Overall Study|Progressive disease|22|||
31003435|NCT01826214|59204375|FG001|Overall Study|Progressive disease|21|||
31003436|NCT01826214|59204374|FG000|Overall Study|Study terminated by Sponsor|0|||
31003437|NCT01826214|59204375|FG001|Overall Study|Study terminated by Sponsor|1|||
31003438|NCT01826214|59204374|FG000|Overall Study|Subject/guardian decision|2|||
31003439|NCT01826214|59204375|FG001|Overall Study|Subject/guardian decision|3|||
31003440|NCT01843062|59204383|FG000|Overall Study|Protocol Violation|1|||
31003441|NCT01843062|59204384|FG001|Overall Study|Protocol Violation|0|||
31003442|NCT01843062|59204383|FG000|Overall Study|New treatment following progression|2|||
31003443|NCT01843062|59204384|FG001|Overall Study|New treatment following progression|0|||
31003444|NCT01843062|59204383|FG000|Overall Study|Pregnancy|1|||
31003445|NCT01843062|59204384|FG001|Overall Study|Pregnancy|0|||
31003446|NCT01843062|59204383|FG000|Overall Study|Adverse Event|2|||
31003447|NCT01843062|59204384|FG001|Overall Study|Adverse Event|0|||
31003448|NCT01843062|59204383|FG000|Overall Study|Incorrect randomisation|1|||
31003449|NCT01843062|59204384|FG001|Overall Study|Incorrect randomisation|0|||
31003450|NCT01843062|59204383|FG000|Overall Study|Withdrawal by Subject|12|||
31003451|NCT01843062|59204384|FG001|Overall Study|Withdrawal by Subject|3|||
31003452|NCT01843062|59204383|FG000|Overall Study|Death|1|||
31003453|NCT01843062|59204384|FG001|Overall Study|Death|2|||
31003454|NCT01843062|59204383|FG000|Overall Study|Lost to Follow-up|2|||
31003455|NCT01843062|59204384|FG001|Overall Study|Lost to Follow-up|4|||
31003456|NCT01842438|59204392|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
31003457|NCT01842438|59204393|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
31003458|NCT01842438|59204392|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
31003459|NCT01842438|59204393|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
31003460|NCT01842438|59204392|FG000|T2: 6month Follow-up|Death|0|||
31003461|NCT01842438|59204393|FG001|T2: 6month Follow-up|Death|1|||
31003462|NCT01799226|59204405|FG000|Overall Study|Withdrawal by Subject|1|||
31003463|NCT01799226|59204406|FG001|Overall Study|Withdrawal by Subject|0|||
31003464|NCT01799226|59204405|FG000|Overall Study|Disqualified at Day 14|1|||
31003465|NCT01799226|59204406|FG001|Overall Study|Disqualified at Day 14|0|||
31003466|NCT01798992|59204416|FG000|Overall Study|Administrative withdrawal|0|||
31003467|NCT01798992|59204417|FG001|Overall Study|Administrative withdrawal|1|||
31003468|NCT01798992|59204418|FG002|Overall Study|Administrative withdrawal|0|||
31003469|NCT01798992|59204419|FG003|Overall Study|Administrative withdrawal|1|||
31003470|NCT01798992|59204416|FG000|Overall Study|Lost to Follow-up|0|||
31003471|NCT01798992|59204417|FG001|Overall Study|Lost to Follow-up|1|||
31003472|NCT01798992|59204418|FG002|Overall Study|Lost to Follow-up|1|||
31003473|NCT01798992|59204419|FG003|Overall Study|Lost to Follow-up|0|||
31003474|NCT01798992|59204416|FG000|Overall Study|Insufficient biopsy tissue|0|||
31003475|NCT01798992|59204417|FG001|Overall Study|Insufficient biopsy tissue|0|||
31003476|NCT01798992|59204418|FG002|Overall Study|Insufficient biopsy tissue|1|||
31003477|NCT01798992|59204419|FG003|Overall Study|Insufficient biopsy tissue|0|||
31003478|NCT01825200|59204430|FG000|Overall Study|Lost to Follow-up|5|||
31003479|NCT01825200|59204431|FG001|Overall Study|Lost to Follow-up|6|||
31003480|NCT01825200|59204430|FG000|Overall Study|Withdrawal by Subject|0|||
31003481|NCT01825200|59204431|FG001|Overall Study|Withdrawal by Subject|1|||
31003482|NCT01824576|59204437|FG000|Overall Study|Device deficiency|2|||
31003483|NCT01824498|59204447|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
31003484|NCT01824498|59204448|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
31003485|NCT01824498|59204449|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
31003486|NCT01824498|59204450|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
31003487|NCT01824498|59204451|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
31003488|NCT01824498|59204452|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
31003489|NCT01798134|59204460|FG000|Overall Study|Lost to Follow-up|1|||
31003490|NCT01798134|59204460|FG000|Overall Study|Withdrawal by Subject|3|||
31003491|NCT01798134|59204460|FG000|Overall Study|Death|2|||
31003492|NCT01798134|59204460|FG000|Overall Study|Adverse Event|3|||
31003493|NCT01798134|59204460|FG000|Overall Study|Physician Decision|3|||
31003494|NCT01798134|59204460|FG000|Overall Study|Liver transplant/surgery|4|||
31003495|NCT01798056|59204466|FG000|Overall Study|Serious Adverse Event|13|||
31003496|NCT01798056|59204467|FG001|Overall Study|Serious Adverse Event|12|||
31003497|NCT01798056|59204466|FG000|Overall Study|Withdrawal by Subject|12|||
31003498|NCT01798056|59204467|FG001|Overall Study|Withdrawal by Subject|9|||
31003499|NCT01798056|59204466|FG000|Overall Study|Migrated/moved from study area|1|||
31003500|NCT01798056|59204467|FG001|Overall Study|Migrated/moved from study area|1|||
31003501|NCT01798056|59204466|FG000|Overall Study|Lost to Follow-up|1|||
31003502|NCT01798056|59204467|FG001|Overall Study|Lost to Follow-up|1|||
31003503|NCT01798056|59204466|FG000|Overall Study|Other|0|||
31003504|NCT01798056|59204467|FG001|Overall Study|Other|2|||
31003505|NCT01824342|59204477|FG000|Overall Study|Withdrawal by Subject|0|||
31003506|NCT01824342|59204478|FG001|Overall Study|Withdrawal by Subject|3|||
31003507|NCT01824342|59204477|FG000|Overall Study|Adverse Event|1|||
31003508|NCT01824342|59204478|FG001|Overall Study|Adverse Event|1|||
31003509|NCT01824342|59204477|FG000|Overall Study|Disease Progression|1|||
31003510|NCT01824342|59204478|FG001|Overall Study|Disease Progression|1|||
31003511|NCT01824342|59204477|FG000|Overall Study|Physician Decision|5|||
31003512|NCT01824342|59204478|FG001|Overall Study|Physician Decision|0|||
31003513|NCT01824342|59204477|FG000|Overall Study|Death|2|||
31003514|NCT01824342|59204478|FG001|Overall Study|Death|0|||
31003515|NCT01841970|59204484|FG000|Overall Study|Withdrawal by Subject|1|||
31003516|NCT01841970|59204484|FG000|Overall Study|Physician Decision|2|||
31003517|NCT01841970|59204484|FG000|Overall Study|Lost to Follow-up|8|||
31003518|NCT01823328|59204493|FG000|Overall Study|Withdrawal by Subject|8|||
31003519|NCT01823328|59204494|FG001|Overall Study|Withdrawal by Subject|6|||
31003520|NCT01840410|59204502|FG000|Overall Study|Physician Decision|1|||
31003521|NCT01840410|59204503|FG001|Overall Study|Physician Decision|2|||
31003522|NCT01840410|59204502|FG000|Overall Study|Pregnancy|1|||
31003523|NCT01840410|59204503|FG001|Overall Study|Pregnancy|0|||
31003524|NCT01840410|59204502|FG000|Overall Study|Protocol deviation|1|||
31003525|NCT01840410|59204503|FG001|Overall Study|Protocol deviation|0|||
31003526|NCT01840410|59204502|FG000|Overall Study|Lost to Follow-up|1|||
31003527|NCT01840410|59204503|FG001|Overall Study|Lost to Follow-up|0|||
31003528|NCT01840410|59204502|FG000|Overall Study|Withdrawal by Subject|2|||
31003529|NCT01840410|59204503|FG001|Overall Study|Withdrawal by Subject|1|||
31003530|NCT01840410|59204502|FG000|Overall Study|Adverse Event|1|||
31003531|NCT01840410|59204503|FG001|Overall Study|Adverse Event|1|||
31003532|NCT01797432|59204511|FG000|Overall Study|Lost to Follow-up|1|||
31003533|NCT01797432|59204511|FG000|Overall Study|Adverse Event|1|||
31003534|NCT01797432|59204511|FG000|Overall Study|Withdrawal by Subject|1|||
31003535|NCT01797432|59204511|FG000|Overall Study|lived too far from study site|1|||
31003536|NCT01797120|59204517|FG000|Overall Study|Disesae progression|37|||
31003537|NCT01797120|59204518|FG001|Overall Study|Disesae progression|49|||
31003538|NCT01797120|59204517|FG000|Overall Study|Adverse Event|13|||
31003539|NCT01797120|59204518|FG001|Overall Study|Adverse Event|5|||
31003540|NCT01797120|59204517|FG000|Overall Study|Withdrawal by Subject|6|||
31003541|NCT01797120|59204518|FG001|Overall Study|Withdrawal by Subject|6|||
31003542|NCT01797120|59204517|FG000|Overall Study|Symptomatic progression|2|||
31003543|NCT01797120|59204518|FG001|Overall Study|Symptomatic progression|1|||
31003544|NCT01797120|59204517|FG000|Overall Study|Non-compliance|1|||
31003545|NCT01797120|59204518|FG001|Overall Study|Non-compliance|0|||
31003546|NCT01797120|59204517|FG000|Overall Study|Physician Decision|3|||
31003547|NCT01797120|59204518|FG001|Overall Study|Physician Decision|0|||
31003548|NCT01797120|59204517|FG000|Overall Study|still on treatment|2|||
31003549|NCT01797120|59204518|FG001|Overall Study|still on treatment|4|||
31003550|NCT01797120|59204517|FG000|Overall Study|never start protocol therapy|2|||
31003551|NCT01797120|59204518|FG001|Overall Study|never start protocol therapy|0|||
31003552|NCT01796964|59204526|FG000|Overall Study|Adverse Event|1|||
31003553|NCT01796964|59204527|FG001|Overall Study|Adverse Event|1|||
31003554|NCT01796964|59204526|FG000|Overall Study|Death|1|||
31003555|NCT01796964|59204527|FG001|Overall Study|Death|0|||
31003556|NCT01796964|59204526|FG000|Overall Study|Protocol Violation|0|||
31003557|NCT01796964|59204527|FG001|Overall Study|Protocol Violation|1|||
31003558|NCT01796964|59204526|FG000|Overall Study|Withdrawal by Subject|1|||
31003559|NCT01796964|59204527|FG001|Overall Study|Withdrawal by Subject|1|||
31003560|NCT01838694|59204536|FG000|Overall Study|Adverse Event|0|||
31003561|NCT01838694|59204537|FG001|Overall Study|Adverse Event|1|||
31003562|NCT01795638|59204548|FG000|Overall Study|Death|0|||
31003563|NCT01795638|59204549|FG001|Overall Study|Death|3|||
31003564|NCT01795638|59204548|FG000|Overall Study|transferred to quaternary hospital|2|||
31003565|NCT01795638|59204549|FG001|Overall Study|transferred to quaternary hospital|3|||
31003566|NCT01795638|59204548|FG000|Overall Study|Protocol Violation|3|||
31003567|NCT01795638|59204549|FG001|Overall Study|Protocol Violation|0|||
31003568|NCT01795638|59204548|FG000|Overall Study|discharged from hospital|7|||
31003569|NCT01795638|59204549|FG001|Overall Study|discharged from hospital|5|||
31003570|NCT01795638|59204548|FG000|Overall Study|Withdrawal by Subject|1|||
31003571|NCT01795638|59204549|FG001|Overall Study|Withdrawal by Subject|0|||
31003572|NCT01794780|59204563|FG000|Overall Study|Adverse Event|0|||
31003573|NCT01794780|59204564|FG001|Overall Study|Adverse Event|1|||
31003574|NCT01794780|59204565|FG002|Overall Study|Adverse Event|2|||
31003575|NCT01794780|59204566|FG003|Overall Study|Adverse Event|0|||
31003576|NCT01794780|59204567|FG004|Overall Study|Adverse Event|0|||
31003577|NCT01794780|59204568|FG005|Overall Study|Adverse Event|0|||
31003578|NCT01794780|59204569|FG006|Overall Study|Adverse Event|0|||
31003579|NCT01794780|59204570|FG007|Overall Study|Adverse Event|0|||
31003580|NCT01794780|59204563|FG000|Overall Study|Death|0|||
31003581|NCT01794780|59204564|FG001|Overall Study|Death|2|||
31003582|NCT01794780|59204565|FG002|Overall Study|Death|14|||
31003583|NCT01794780|59204566|FG003|Overall Study|Death|1|||
31003584|NCT01794780|59204567|FG004|Overall Study|Death|0|||
31003585|NCT01794780|59204568|FG005|Overall Study|Death|9|||
31003586|NCT01794780|59204569|FG006|Overall Study|Death|4|||
31003587|NCT01794780|59204570|FG007|Overall Study|Death|0|||
31003588|NCT01794780|59204563|FG000|Overall Study|Lost to Follow-up|10|||
31003589|NCT01794780|59204564|FG001|Overall Study|Lost to Follow-up|64|||
31003590|NCT01794780|59204565|FG002|Overall Study|Lost to Follow-up|165|||
31003591|NCT01794780|59204566|FG003|Overall Study|Lost to Follow-up|53|||
31003592|NCT01794780|59204567|FG004|Overall Study|Lost to Follow-up|2|||
31003593|NCT01794780|59204568|FG005|Overall Study|Lost to Follow-up|99|||
31003594|NCT01794780|59204569|FG006|Overall Study|Lost to Follow-up|30|||
31003595|NCT01794780|59204570|FG007|Overall Study|Lost to Follow-up|5|||
31003596|NCT01794780|59204563|FG000|Overall Study|Withdrew informed consent|7|||
31003597|NCT01794780|59204564|FG001|Overall Study|Withdrew informed consent|17|||
31003598|NCT01794780|59204565|FG002|Overall Study|Withdrew informed consent|36|||
31003599|NCT01794780|59204566|FG003|Overall Study|Withdrew informed consent|9|||
31003600|NCT01794780|59204567|FG004|Overall Study|Withdrew informed consent|0|||
31003601|NCT01794780|59204568|FG005|Overall Study|Withdrew informed consent|48|||
31003602|NCT01794780|59204569|FG006|Overall Study|Withdrew informed consent|4|||
31003603|NCT01794780|59204570|FG007|Overall Study|Withdrew informed consent|3|||
31003604|NCT01794780|59204563|FG000|Overall Study|Other|0|||
31003605|NCT01794780|59204564|FG001|Overall Study|Other|12|||
31003606|NCT01794780|59204565|FG002|Overall Study|Other|25|||
31003607|NCT01794780|59204566|FG003|Overall Study|Other|20|||
31003608|NCT01794780|59204567|FG004|Overall Study|Other|1|||
31003609|NCT01794780|59204568|FG005|Overall Study|Other|24|||
31003610|NCT01794780|59204569|FG006|Overall Study|Other|4|||
31003611|NCT01794780|59204570|FG007|Overall Study|Other|1|||
31003612|NCT01838616|59204597|FG000|Titration Period|Adverse Event|18|||
31003613|NCT01838616|59204598|FG001|Titration Period|Adverse Event|48|||
31003614|NCT01838616|59204597|FG000|Titration Period|Lack of Efficacy|5|||
31003615|NCT01838616|59204598|FG001|Titration Period|Lack of Efficacy|12|||
31003616|NCT01838616|59204597|FG000|Titration Period|Withdrawal by Subject|5|||
31003617|NCT01838616|59204598|FG001|Titration Period|Withdrawal by Subject|5|||
31003618|NCT01838616|59204597|FG000|Titration Period|Technical problems|1|||
31003619|NCT01838616|59204598|FG001|Titration Period|Technical problems|0|||
31003620|NCT01838616|59204597|FG000|Titration Period|Other|1|||
31003621|NCT01838616|59204598|FG001|Titration Period|Other|0|||
31003622|NCT01838616|59204597|FG000|Titration Period|Protocol Violation|0|||
31003623|NCT01838616|59204598|FG001|Titration Period|Protocol Violation|1|||
31003624|NCT01838616|59204597|FG000|Continuation Period|Lack of Efficacy|3|||
31003625|NCT01838616|59204598|FG001|Continuation Period|Lack of Efficacy|5|||
31003626|NCT01838616|59204597|FG000|Continuation Period|Adverse Event|8|||
31003627|NCT01838616|59204598|FG001|Continuation Period|Adverse Event|4|||
31003628|NCT01838616|59204597|FG000|Continuation Period|Protocol Violation|2|||
31003629|NCT01838616|59204598|FG001|Continuation Period|Protocol Violation|0|||
31003630|NCT01838616|59204597|FG000|Continuation Period|Lost to Follow-up|1|||
31003631|NCT01838616|59204598|FG001|Continuation Period|Lost to Follow-up|0|||
31003632|NCT01838616|59204597|FG000|Continuation Period|Withdrawal by Subject|0|||
31003633|NCT01838616|59204598|FG001|Continuation Period|Withdrawal by Subject|4|||
31003634|NCT01838616|59204597|FG000|Continuation Period|Technical problems|0|||
31003635|NCT01838616|59204598|FG001|Continuation Period|Technical problems|1|||
31003636|NCT01838616|59204597|FG000|Pick-up Arm|Lack of Efficacy|4|||
31003637|NCT01838616|59204598|FG001|Pick-up Arm|Lack of Efficacy|0|||
31003638|NCT01838616|59204597|FG000|Pick-up Arm|Adverse Event|9|||
31003639|NCT01838616|59204598|FG001|Pick-up Arm|Adverse Event|0|||
31003640|NCT01838616|59204597|FG000|Pick-up Arm|Withdrawal by Subject|1|||
31003641|NCT01838616|59204598|FG001|Pick-up Arm|Withdrawal by Subject|0|||
31003642|NCT01838616|59204597|FG000|Pick-up Arm|Technical problems|1|||
31003643|NCT01838616|59204598|FG001|Pick-up Arm|Technical problems|0|||
31003644|NCT01611792|59204611|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
31003645|NCT01611792|59204612|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
31003646|NCT01611792|59204611|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
31003647|NCT01611792|59204612|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
31003648|NCT01820364|59204619|FG000|Part I: LGX818|Death|1|||
31003649|NCT01820364|59204620|FG001|Part I: LGX818|Death|0|||
31003650|NCT01820364|59204619|FG000|Part I: LGX818|Administrative Problems|3|||
31003651|NCT01820364|59204620|FG001|Part I: LGX818|Administrative Problems|0|||
31003652|NCT01820364|59204619|FG000|Part I: LGX818|Adverse Event|6|||
31003653|NCT01820364|59204620|FG001|Part I: LGX818|Adverse Event|0|||
31003654|NCT01820364|59204619|FG000|Part I: LGX818|Disease Progression|4|||
31003655|NCT01820364|59204620|FG001|Part I: LGX818|Disease Progression|0|||
31003656|NCT01820364|59204619|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
31003657|NCT01820364|59204620|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
31003658|NCT01819506|59204628|FG000|Overall Study|Physician Decision|5|||
31003659|NCT01819506|59204629|FG001|Overall Study|Physician Decision|2|||
31003660|NCT01819506|59204628|FG000|Overall Study|Withdrawal by Subject|3|||
31003661|NCT01819506|59204629|FG001|Overall Study|Withdrawal by Subject|3|||
31003662|NCT01794000|59204637|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
31003663|NCT01794000|59204638|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
31003664|NCT01794000|59204637|FG000|Double-Blind Phase (DBP)|Death|1|||
31003665|NCT01794000|59204638|FG001|Double-Blind Phase (DBP)|Death|2|||
31003666|NCT01794000|59204637|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
31003667|NCT01794000|59204638|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
31003668|NCT01794000|59204637|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
31003669|NCT01794000|59204638|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
31003670|NCT01794000|59204637|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
31003671|NCT01794000|59204638|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
31003672|NCT01794000|59204637|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
31003673|NCT01794000|59204638|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
31003674|NCT01794000|59204637|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
31003675|NCT01794000|59204638|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
31003676|NCT01794000|59204637|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
31003677|NCT01794000|59204638|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
31003678|NCT01609296|59204645|FG000|Overall Study|Death|253|||
31003679|NCT01609296|59204645|FG000|Overall Study|Withdrawal by Subject|151|||
31003680|NCT01609296|59204645|FG000|Overall Study|Lost to Follow-up|21|||
31003681|NCT01609296|59204645|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
31003682|NCT01609296|59204645|FG000|Overall Study|missed visit but known to be alive|28|||
31003683|NCT01609218|59204653|FG000|Period 1|Adverse Event|3|||
31003684|NCT01609218|59204654|FG001|Period 1|Adverse Event|5|||
31003685|NCT01609218|59204653|FG000|Period 1|Sponsor Decision|0|||
31003686|NCT01609218|59204654|FG001|Period 1|Sponsor Decision|1|||
31003687|NCT01609218|59204653|FG000|Period 2|Adverse Event|1|||
30790231|NCT00035555|58803458|FG002|Overall Study|Prohibited medication|0|||
30790232|NCT00035555|58803456|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
30790233|NCT00035555|58803457|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
30790234|NCT00035555|58803458|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
30790235|NCT00035555|58803456|FG000|Overall Study|Withdrawal by Subject|2|||
30790236|NCT00035555|58803457|FG001|Overall Study|Withdrawal by Subject|0|||
30790237|NCT00035555|58803458|FG002|Overall Study|Withdrawal by Subject|2|||
30790238|NCT00035555|58803456|FG000|Overall Study|Investigator deemed not a good candidate|0|||
30790239|NCT00035555|58803457|FG001|Overall Study|Investigator deemed not a good candidate|0|||
30790240|NCT00035555|58803458|FG002|Overall Study|Investigator deemed not a good candidate|1|||
30790241|NCT00035555|58803456|FG000|Overall Study|Received cyclosporin in error|0|||
30790242|NCT00035555|58803457|FG001|Overall Study|Received cyclosporin in error|0|||
30790243|NCT00035555|58803458|FG002|Overall Study|Received cyclosporin in error|1|||
30790244|NCT03894046|58803470|FG000|Overall Study|Protocol Violation|1|||
30790245|NCT03894046|58803471|FG001|Overall Study|Protocol Violation|0|||
30790246|NCT03894046|58803472|FG002|Overall Study|Protocol Violation|0|||
30892534|NCT01362790|58926001|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
30892535|NCT01362790|58926002|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
31003688|NCT01609218|59204654|FG001|Period 2|Adverse Event|0|||
31003689|NCT01609062|59204662|FG000|Extension Phase|Terminated by Sponsor|14|||
31003690|NCT01609062|59204663|FG001|Extension Phase|Terminated by Sponsor|9|||
31003691|NCT01609062|59204662|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
31003692|NCT01609062|59204663|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
31003693|NCT01609062|59204662|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
31003694|NCT01609062|59204663|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
31003695|NCT01819272|59204676|FG000|Overall Study|Adverse Event|1|||
31003696|NCT01819272|59204677|FG001|Overall Study|Adverse Event|0|||
31003697|NCT01819272|59204678|FG002|Overall Study|Adverse Event|0|||
31003698|NCT01819272|59204679|FG003|Overall Study|Adverse Event|2|||
31003699|NCT01819272|59204680|FG004|Overall Study|Adverse Event|0|||
31003700|NCT01819272|59204681|FG005|Overall Study|Adverse Event|0|||
31003701|NCT01819272|59204676|FG000|Overall Study|Lost to Follow-up|3|||
30790247|NCT03894046|58803470|FG000|Overall Study|Adverse Event|0|||
30790248|NCT03894046|58803471|FG001|Overall Study|Adverse Event|1|||
30790249|NCT03894046|58803472|FG002|Overall Study|Adverse Event|0|||
30790250|NCT03894046|58803470|FG000|Overall Study|Withdrawal by Subject|2|||
30790251|NCT03894046|58803471|FG001|Overall Study|Withdrawal by Subject|3|||
30790252|NCT03894046|58803472|FG002|Overall Study|Withdrawal by Subject|1|||
30790253|NCT03894046|58803470|FG000|Overall Study|Death|15|||
30790254|NCT03894046|58803471|FG001|Overall Study|Death|21|||
30790255|NCT03894046|58803472|FG002|Overall Study|Death|4|||
30790256|NCT03894046|58803470|FG000|Overall Study|No growth of ABC|2|||
30790257|NCT03894046|58803471|FG001|Overall Study|No growth of ABC|1|||
30790258|NCT03894046|58803472|FG002|Overall Study|No growth of ABC|0|||
30790259|NCT03894046|58803470|FG000|Overall Study|Physician Decision|1|||
30790260|NCT03894046|58803471|FG001|Overall Study|Physician Decision|1|||
30790261|NCT03894046|58803472|FG002|Overall Study|Physician Decision|1|||
30790262|NCT03894046|58803470|FG000|Overall Study|Prohibited concomitant medication|1|||
30790263|NCT03894046|58803471|FG001|Overall Study|Prohibited concomitant medication|0|||
30790264|NCT03894046|58803472|FG002|Overall Study|Prohibited concomitant medication|0|||
30790265|NCT03894046|58803470|FG000|Overall Study|Transferred to other arm/group|1|||
30790266|NCT03894046|58803471|FG001|Overall Study|Transferred to other arm/group|1|||
30790267|NCT03894046|58803472|FG002|Overall Study|Transferred to other arm/group|0|||
30790268|NCT00033371|58803481|FG000|Overall Study|Adverse Event|1|||
30790269|NCT00033371|58803482|FG001|Overall Study|Adverse Event|5|||
30790270|NCT00033371|58803481|FG000|Overall Study|Lost to Follow-up|2|||
30790271|NCT00033371|58803482|FG001|Overall Study|Lost to Follow-up|1|||
30790272|NCT00033371|58803481|FG000|Overall Study|Withdrawal by Subject|3|||
30790273|NCT00033371|58803482|FG001|Overall Study|Withdrawal by Subject|3|||
30790274|NCT00033371|58803481|FG000|Overall Study|Disease Progression|0|||
30790275|NCT00033371|58803482|FG001|Overall Study|Disease Progression|1|||
30790276|NCT00081731|58803494|FG000|Overall Study|scientific integrity issue|8|||
30790277|NCT00081731|58803495|FG001|Overall Study|scientific integrity issue|8|||
30790278|NCT00079937|58803503|FG000|Overall Study|Adverse Event|2|||
30790279|NCT00079937|58803504|FG001|Overall Study|Adverse Event|1|||
30790280|NCT00079937|58803503|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30790281|NCT00079937|58803504|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30790282|NCT00079937|58803503|FG000|Overall Study|Subject no longer requires study drug|3|||
30790283|NCT00079937|58803504|FG001|Overall Study|Subject no longer requires study drug|0|||
30790284|NCT00079937|58803503|FG000|Overall Study|Protocol Violation|8|||
30790285|NCT00079937|58803504|FG001|Overall Study|Protocol Violation|6|||
30790286|NCT00079937|58803503|FG000|Overall Study|Withdrawal by Subject|21|||
30790287|NCT00079937|58803504|FG001|Overall Study|Withdrawal by Subject|7|||
30790288|NCT00079937|58803503|FG000|Overall Study|Lost to Follow-up|12|||
30790289|NCT00079937|58803504|FG001|Overall Study|Lost to Follow-up|5|||
30790290|NCT00079937|58803503|FG000|Overall Study|Administrative problems|22|||
30790291|NCT00079937|58803504|FG001|Overall Study|Administrative problems|11|||
30790292|NCT00909610|58803512|FG000|Period: First Intervention|Adverse Event|0|||
30790293|NCT00909610|58803513|FG001|Period: First Intervention|Adverse Event|1|||
30790294|NCT00909610|58803512|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
30790295|NCT00909610|58803513|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
30790296|NCT00909610|58803512|FG000|Period: Second Intervention|Adverse Event|1|||
30790297|NCT00909610|58803513|FG001|Period: Second Intervention|Adverse Event|0|||
30790298|NCT03126110|58803535|FG000|Phase 1|Death|2|||
30790299|NCT03126110|58803536|FG001|Phase 1|Death|2|||
30790300|NCT03126110|58803537|FG002|Phase 1|Death|4|||
30790301|NCT03126110|58803538|FG003|Phase 1|Death|3|||
30790302|NCT03126110|58803539|FG004|Phase 1|Death|4|||
30790303|NCT03126110|58803540|FG005|Phase 1|Death|4|||
31003702|NCT01819272|59204677|FG001|Overall Study|Lost to Follow-up|0|||
31003703|NCT01819272|59204678|FG002|Overall Study|Lost to Follow-up|1|||
30790304|NCT03126110|58803541|FG006|Phase 1|Death|3|||
30790305|NCT03126110|58803542|FG007|Phase 1|Death|4|||
30790306|NCT03126110|58803543|FG008|Phase 1|Death|5|||
30790307|NCT03126110|58803544|FG009|Phase 1|Death|2|||
30790308|NCT03126110|58803545|FG010|Phase 1|Death|6|||
30790309|NCT03126110|58803546|FG011|Phase 1|Death|0|||
30790310|NCT03126110|58803547|FG012|Phase 1|Death|0|||
30790311|NCT03126110|58803548|FG013|Phase 1|Death|0|||
30790312|NCT03126110|58803549|FG014|Phase 1|Death|0|||
30790313|NCT03126110|58803550|FG015|Phase 1|Death|0|||
30790314|NCT03126110|58803551|FG016|Phase 1|Death|0|||
30790315|NCT03126110|58803535|FG000|Phase 1|Lost to Follow-up|0|||
30790316|NCT03126110|58803536|FG001|Phase 1|Lost to Follow-up|1|||
30790317|NCT03126110|58803537|FG002|Phase 1|Lost to Follow-up|0|||
30790318|NCT03126110|58803538|FG003|Phase 1|Lost to Follow-up|0|||
30790319|NCT03126110|58803539|FG004|Phase 1|Lost to Follow-up|0|||
30790320|NCT03126110|58803540|FG005|Phase 1|Lost to Follow-up|0|||
30790321|NCT03126110|58803541|FG006|Phase 1|Lost to Follow-up|0|||
30790322|NCT03126110|58803542|FG007|Phase 1|Lost to Follow-up|0|||
30790323|NCT03126110|58803543|FG008|Phase 1|Lost to Follow-up|1|||
30790324|NCT03126110|58803544|FG009|Phase 1|Lost to Follow-up|0|||
30790325|NCT03126110|58803545|FG010|Phase 1|Lost to Follow-up|0|||
30790326|NCT03126110|58803546|FG011|Phase 1|Lost to Follow-up|0|||
31003704|NCT01819272|59204679|FG003|Overall Study|Lost to Follow-up|0|||
31003705|NCT01819272|59204680|FG004|Overall Study|Lost to Follow-up|0|||
31003706|NCT01819272|59204681|FG005|Overall Study|Lost to Follow-up|3|||
31003707|NCT01819272|59204676|FG000|Overall Study|Protocol Violation|0|||
31003708|NCT01819272|59204677|FG001|Overall Study|Protocol Violation|0|||
31003709|NCT01819272|59204678|FG002|Overall Study|Protocol Violation|0|||
31003710|NCT01819272|59204679|FG003|Overall Study|Protocol Violation|1|||
31003711|NCT01819272|59204680|FG004|Overall Study|Protocol Violation|2|||
31003712|NCT01819272|59204681|FG005|Overall Study|Protocol Violation|3|||
31003713|NCT01819272|59204676|FG000|Overall Study|Physician Decision|0|||
31003714|NCT01819272|59204677|FG001|Overall Study|Physician Decision|1|||
31003715|NCT01819272|59204678|FG002|Overall Study|Physician Decision|0|||
31003716|NCT01819272|59204679|FG003|Overall Study|Physician Decision|0|||
31003717|NCT01819272|59204680|FG004|Overall Study|Physician Decision|0|||
31003718|NCT01819272|59204681|FG005|Overall Study|Physician Decision|0|||
31003719|NCT01819272|59204676|FG000|Overall Study|Withdrawal of Consent|0|||
31003720|NCT01819272|59204677|FG001|Overall Study|Withdrawal of Consent|1|||
31003721|NCT01819272|59204678|FG002|Overall Study|Withdrawal of Consent|2|||
31003722|NCT01819272|59204679|FG003|Overall Study|Withdrawal of Consent|1|||
31003723|NCT01819272|59204680|FG004|Overall Study|Withdrawal of Consent|0|||
31003724|NCT01819272|59204681|FG005|Overall Study|Withdrawal of Consent|1|||
31003725|NCT01819272|59204676|FG000|Overall Study|Loss of Glucose Control|2|||
31003726|NCT01819272|59204677|FG001|Overall Study|Loss of Glucose Control|1|||
31003727|NCT01819272|59204678|FG002|Overall Study|Loss of Glucose Control|0|||
31003728|NCT01819272|59204679|FG003|Overall Study|Loss of Glucose Control|1|||
31003729|NCT01819272|59204680|FG004|Overall Study|Loss of Glucose Control|2|||
31003730|NCT01819272|59204681|FG005|Overall Study|Loss of Glucose Control|0|||
31003731|NCT01819194|59204695|FG000|Overall Study|Loss of study articles|2|||
31003732|NCT01611558|59204699|FG000|Induction Phase|Study drug toxicity|15|||
31003733|NCT01611558|59204699|FG000|Induction Phase|Disease progression|18|||
31003734|NCT01611558|59204699|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
31003735|NCT01611558|59204699|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
31003736|NCT01611558|59204699|FG000|Induction Phase|Death|1|||
31003737|NCT01611558|59204699|FG000|Maintenance Phase|Withdrawal by Subject|1|||
31003738|NCT01611558|59204699|FG000|Maintenance Phase|Elevated Uric acid|1|||
31003739|NCT01818726|59204706|FG000|Overall Study|Administrative reasons|5|||
31003740|NCT01818726|59204707|FG001|Overall Study|Administrative reasons|1|||
31003741|NCT01818726|59204706|FG000|Overall Study|Withdrawal by Subject|0|||
31003742|NCT01818726|59204707|FG001|Overall Study|Withdrawal by Subject|1|||
31003743|NCT01818726|59204706|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
31003744|NCT01818726|59204707|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
31003745|NCT01818336|59204713|FG000|Overall Study|Declined retest visit|0|||
31003746|NCT01818336|59204714|FG001|Overall Study|Declined retest visit|11|||
31003747|NCT01818336|59204713|FG000|Overall Study|Lost to Follow-up|0|||
31003748|NCT01818336|59204714|FG001|Overall Study|Lost to Follow-up|1|||
31003749|NCT01818258|59204722|FG000|Overall Study|Death|3|||
31003750|NCT01818258|59204723|FG001|Overall Study|Death|0|||
31003751|NCT01818258|59204722|FG000|Overall Study|Withdrawal by Subject|0|||
31003752|NCT01818258|59204723|FG001|Overall Study|Withdrawal by Subject|1|||
31003753|NCT01818258|59204722|FG000|Overall Study|Lost to Follow-up|0|||
31003754|NCT01818258|59204723|FG001|Overall Study|Lost to Follow-up|1|||
31003755|NCT01818258|59204722|FG000|Overall Study|Unable to Travel to Clinic|0|||
31003756|NCT01818258|59204723|FG001|Overall Study|Unable to Travel to Clinic|1|||
31003757|NCT01817790|59204732|FG000|Overall Study|Adverse Event|0|||
31003758|NCT01817790|59204733|FG001|Overall Study|Adverse Event|2|||
31003759|NCT01817790|59204732|FG000|Overall Study|Lost to Follow-up|0|||
30790327|NCT03126110|58803547|FG012|Phase 1|Lost to Follow-up|0|||
30790328|NCT03126110|58803548|FG013|Phase 1|Lost to Follow-up|0|||
30790329|NCT03126110|58803549|FG014|Phase 1|Lost to Follow-up|0|||
31003760|NCT01817790|59204733|FG001|Overall Study|Lost to Follow-up|1|||
31003761|NCT01817790|59204732|FG000|Overall Study|Protocol Violation|2|||
31003762|NCT01817790|59204733|FG001|Overall Study|Protocol Violation|1|||
31003763|NCT01817790|59204732|FG000|Overall Study|Withdrawal by Subject|1|||
31003764|NCT01817790|59204733|FG001|Overall Study|Withdrawal by Subject|3|||
31003765|NCT01817790|59204732|FG000|Overall Study|Other: Could not attend appointment|1|||
31003766|NCT01817790|59204733|FG001|Overall Study|Other: Could not attend appointment|1|||
31003767|NCT01793688|59204741|FG000|Overall Study|Protocol Violation|2|||
30790330|NCT03126110|58803550|FG015|Phase 1|Lost to Follow-up|0|||
30790331|NCT03126110|58803551|FG016|Phase 1|Lost to Follow-up|0|||
30790332|NCT03126110|58803535|FG000|Phase 1|Withdrawal by Subject|1|||
31003768|NCT01793142|59204745|FG000|Overall Study|Randomized not treated|7|||
31003769|NCT01792830|59204760|FG000|Overall Study|Withdrawal by Subject|22|||
31003770|NCT01792830|59204761|FG001|Overall Study|Withdrawal by Subject|0|||
31003771|NCT01792830|59204762|FG002|Overall Study|Withdrawal by Subject|0|||
31003772|NCT01792830|59204763|FG003|Overall Study|Withdrawal by Subject|2|||
31003773|NCT01792830|59204764|FG004|Overall Study|Withdrawal by Subject|1|||
31003774|NCT01792830|59204765|FG005|Overall Study|Withdrawal by Subject|1|||
31003775|NCT01792830|59204766|FG006|Overall Study|Withdrawal by Subject|1|||
31003776|NCT01792830|59204767|FG007|Overall Study|Withdrawal by Subject|1|||
31003777|NCT01792830|59204768|FG008|Overall Study|Withdrawal by Subject|7|||
31003778|NCT01792830|59204769|FG009|Overall Study|Withdrawal by Subject|0|||
31003779|NCT01792830|59204770|FG010|Overall Study|Withdrawal by Subject|2|||
31003780|NCT01792830|59204760|FG000|Overall Study|Death|3|||
31003781|NCT01792830|59204761|FG001|Overall Study|Death|0|||
31003782|NCT01792830|59204762|FG002|Overall Study|Death|0|||
31003783|NCT01792830|59204763|FG003|Overall Study|Death|1|||
31003784|NCT01792830|59204764|FG004|Overall Study|Death|0|||
31003785|NCT01792830|59204765|FG005|Overall Study|Death|0|||
31003786|NCT01792830|59204766|FG006|Overall Study|Death|1|||
31003787|NCT01792830|59204767|FG007|Overall Study|Death|0|||
31003788|NCT01792830|59204768|FG008|Overall Study|Death|1|||
31003789|NCT01792830|59204769|FG009|Overall Study|Death|0|||
31003790|NCT01792830|59204770|FG010|Overall Study|Death|1|||
31003791|NCT01792830|59204760|FG000|Overall Study|Adverse Event|0|||
31003792|NCT01792830|59204761|FG001|Overall Study|Adverse Event|0|||
31003793|NCT01792830|59204762|FG002|Overall Study|Adverse Event|0|||
31003794|NCT01792830|59204763|FG003|Overall Study|Adverse Event|0|||
31003795|NCT01792830|59204764|FG004|Overall Study|Adverse Event|0|||
31003796|NCT01792830|59204765|FG005|Overall Study|Adverse Event|0|||
31003797|NCT01792830|59204766|FG006|Overall Study|Adverse Event|0|||
31003798|NCT01792830|59204767|FG007|Overall Study|Adverse Event|0|||
31003799|NCT01792830|59204768|FG008|Overall Study|Adverse Event|1|||
31003800|NCT01792830|59204769|FG009|Overall Study|Adverse Event|0|||
31003801|NCT01792830|59204770|FG010|Overall Study|Adverse Event|0|||
31003802|NCT01792518|59204802|FG000|Overall Study|Adverse Event|3|||
31003803|NCT01792518|59204803|FG001|Overall Study|Adverse Event|4|||
31003804|NCT01792518|59204802|FG000|Overall Study|Protocol Violation|0|||
31003805|NCT01792518|59204803|FG001|Overall Study|Protocol Violation|1|||
31003806|NCT01792518|59204802|FG000|Overall Study|Lost to Follow-up|3|||
31003807|NCT01792518|59204803|FG001|Overall Study|Lost to Follow-up|1|||
31003808|NCT01792518|59204802|FG000|Overall Study|Withdrawal by Subject|2|||
31003809|NCT01792518|59204803|FG001|Overall Study|Withdrawal by Subject|0|||
31003810|NCT01792518|59204802|FG000|Overall Study|Other Reason|0|||
31003811|NCT01792518|59204803|FG001|Overall Study|Other Reason|1|||
31003812|NCT01792284|59204809|FG000|Lead-in Period|Adverse Event|15|||
31003813|NCT01792284|59204810|FG001|Lead-in Period|Adverse Event|0|||
31003814|NCT01792284|59204811|FG002|Lead-in Period|Adverse Event|0|||
31003815|NCT01792284|59204809|FG000|Lead-in Period|Lost to Follow-up|2|||
31003816|NCT01792284|59204810|FG001|Lead-in Period|Lost to Follow-up|0|||
31003817|NCT01792284|59204811|FG002|Lead-in Period|Lost to Follow-up|0|||
31003818|NCT01792284|59204809|FG000|Lead-in Period|Protocol Violation|1|||
31003819|NCT01792284|59204810|FG001|Lead-in Period|Protocol Violation|0|||
31003820|NCT01792284|59204811|FG002|Lead-in Period|Protocol Violation|0|||
31003821|NCT01792284|59204809|FG000|Lead-in Period|Withdrawal by Subject|10|||
31003822|NCT01792284|59204810|FG001|Lead-in Period|Withdrawal by Subject|0|||
31003823|NCT01792284|59204811|FG002|Lead-in Period|Withdrawal by Subject|0|||
31003824|NCT01792284|59204809|FG000|Lead-in Period|Physician Decision|1|||
31003825|NCT01792284|59204810|FG001|Lead-in Period|Physician Decision|0|||
31003826|NCT01792284|59204811|FG002|Lead-in Period|Physician Decision|0|||
31003827|NCT01792284|59204809|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
31003828|NCT01792284|59204810|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
31003829|NCT01792284|59204811|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
30892536|NCT01362790|58926003|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
30892537|NCT01362790|58926004|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
30892538|NCT01362790|58926005|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
30892539|NCT01362790|58926006|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
30892540|NCT01362790|58926007|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
30892541|NCT01362790|58926001|FG000|Pilot Phase & Phase 2|Death on study|0|||
30892542|NCT01362790|58926002|FG001|Pilot Phase & Phase 2|Death on study|0|||
30892543|NCT01362790|58926003|FG002|Pilot Phase & Phase 2|Death on study|0|||
30892544|NCT01362790|58926004|FG003|Pilot Phase & Phase 2|Death on study|1|||
30892545|NCT01362790|58926005|FG004|Pilot Phase & Phase 2|Death on study|0|||
30892546|NCT01362790|58926006|FG005|Pilot Phase & Phase 2|Death on study|0|||
30892547|NCT01362790|58926007|FG006|Pilot Phase & Phase 2|Death on study|0|||
30892548|NCT01362790|58926001|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
30892549|NCT01362790|58926002|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
31003830|NCT01792284|59204809|FG000|Randomization Period 1|Withdrawal by Subject|0|||
31003831|NCT01792284|59204810|FG001|Randomization Period 1|Withdrawal by Subject|1|||
31003832|NCT01792284|59204811|FG002|Randomization Period 1|Withdrawal by Subject|1|||
31003833|NCT01792284|59204809|FG000|Randomization Period 1|Physician Decision|0|||
31003834|NCT01792284|59204810|FG001|Randomization Period 1|Physician Decision|1|||
31003835|NCT01792284|59204811|FG002|Randomization Period 1|Physician Decision|1|||
31003836|NCT01792284|59204809|FG000|Randomization Period 1|Adverse Event|0|||
31003837|NCT01792284|59204810|FG001|Randomization Period 1|Adverse Event|0|||
31003838|NCT01792284|59204811|FG002|Randomization Period 1|Adverse Event|2|||
31003839|NCT01792284|59204809|FG000|Randomization Period 1|Lost to Follow-up|0|||
31003840|NCT01792284|59204810|FG001|Randomization Period 1|Lost to Follow-up|0|||
31003841|NCT01792284|59204811|FG002|Randomization Period 1|Lost to Follow-up|1|||
31003842|NCT01792284|59204809|FG000|Randomization Period 2|Protocol Violation|0|||
31003843|NCT01792284|59204810|FG001|Randomization Period 2|Protocol Violation|1|||
31003844|NCT01792284|59204811|FG002|Randomization Period 2|Protocol Violation|0|||
31003845|NCT01792284|59204809|FG000|Randomization Period 2|Withdrawal by Subject|0|||
31003846|NCT01792284|59204810|FG001|Randomization Period 2|Withdrawal by Subject|2|||
31003847|NCT01792284|59204811|FG002|Randomization Period 2|Withdrawal by Subject|0|||
31003848|NCT01791894|59204819|FG000|Overall Study|Adverse Event|1|||
31003849|NCT01837680|59204826|FG000|Overall Study|Lost to Follow-up|2|||
31003850|NCT01837680|59204827|FG001|Overall Study|Lost to Follow-up|2|||
31003851|NCT01837680|59204826|FG000|Overall Study|lack of insurance|0|||
31003852|NCT01837680|59204827|FG001|Overall Study|lack of insurance|2|||
31003853|NCT01837680|59204826|FG000|Overall Study|allergic reaction|6|||
31003854|NCT01837680|59204827|FG001|Overall Study|allergic reaction|0|||
31003855|NCT01837680|59204826|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
31003856|NCT01837680|59204827|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
31003857|NCT01836276|59204835|FG000|Overall Study|Lost to Follow-up|28|||
31003858|NCT01836276|59204836|FG001|Overall Study|Lost to Follow-up|51|||
31003859|NCT01790568|59204842|FG000|Overall Study|Progression prior to transplant|0|||
31003860|NCT01790568|59204843|FG001|Overall Study|Progression prior to transplant|1|||
31003861|NCT01610076|59204849|FG000|Overall Study|Technical issue with video|0|||
31003862|NCT01610076|59204850|FG001|Overall Study|Technical issue with video|1|||
31003863|NCT01610076|59204849|FG000|Overall Study|Lost to Follow-up|3|||
31003864|NCT01610076|59204850|FG001|Overall Study|Lost to Follow-up|4|||
31003865|NCT01836198|59204859|FG000|Part A, Period 2|Protocol Violation|0|||
31003866|NCT01836198|59204860|FG001|Part A, Period 2|Protocol Violation|1|||
31003867|NCT01836198|59204861|FG002|Part A, Period 2|Protocol Violation|0|||
31003868|NCT01816074|59204881|FG000|Phase 1|Time commitment issues|0|||
31003869|NCT01816074|59204882|FG001|Phase 1|Time commitment issues|0|||
31003870|NCT01816074|59204883|FG002|Phase 1|Time commitment issues|1|||
31003871|NCT01816074|59204884|FG003|Phase 1|Time commitment issues|0|||
31003872|NCT01816074|59204881|FG000|Phase 2|Time commitment Issues|0|||
31003873|NCT01816074|59204882|FG001|Phase 2|Time commitment Issues|2|||
31003874|NCT01816074|59204883|FG002|Phase 2|Time commitment Issues|0|||
31003875|NCT01816074|59204884|FG003|Phase 2|Time commitment Issues|0|||
31003876|NCT01816074|59204881|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
31003877|NCT01816074|59204882|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
31003878|NCT01816074|59204883|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
31003879|NCT01816074|59204884|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
31003880|NCT01816074|59204881|FG000|Phase 2|Physician Decision|0|||
31003881|NCT01816074|59204882|FG001|Phase 2|Physician Decision|0|||
31003882|NCT01816074|59204883|FG002|Phase 2|Physician Decision|0|||
31003883|NCT01816074|59204884|FG003|Phase 2|Physician Decision|1|||
31003884|NCT01816074|59204881|FG000|Phase 2|Withdrawal by Subject|1|||
31003885|NCT01816074|59204882|FG001|Phase 2|Withdrawal by Subject|0|||
31003886|NCT01816074|59204883|FG002|Phase 2|Withdrawal by Subject|0|||
31003887|NCT01816074|59204884|FG003|Phase 2|Withdrawal by Subject|0|||
31003888|NCT01815918|59204910|FG000|Overall Study|Patient samples not analyzable|3|||
31003889|NCT01815918|59204911|FG001|Overall Study|Patient samples not analyzable|4|||
31003890|NCT01815918|59204910|FG000|Overall Study|Lack of Efficacy|15|||
31003891|NCT01815918|59204911|FG001|Overall Study|Lack of Efficacy|15|||
31003892|NCT01789476|59204923|FG000|Overall Study|Lack of Efficacy|6|||
30892550|NCT01362790|58926003|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
31003893|NCT01789476|59204924|FG001|Overall Study|Lack of Efficacy|2|||
31003894|NCT01789476|59204923|FG000|Overall Study|Adverse Event|1|||
31003895|NCT01789476|59204924|FG001|Overall Study|Adverse Event|0|||
31003896|NCT01789476|59204923|FG000|Overall Study|Unable to get IV access|1|||
31003897|NCT01789476|59204924|FG001|Overall Study|Unable to get IV access|0|||
31003898|NCT01789320|59204930|FG000|Overall Study|Re-enrolled into study|1|||
31003899|NCT01789320|59204930|FG000|Overall Study|Lost to Follow-up|1|||
31003900|NCT01815840|59204936|FG000|Overall Study|Missing|1|||
31003901|NCT01815840|59204937|FG001|Overall Study|Missing|0|||
31003902|NCT01815840|59204936|FG000|Overall Study|Withdrew Consent|31|||
31003903|NCT01815840|59204937|FG001|Overall Study|Withdrew Consent|30|||
31003904|NCT01815840|59204936|FG000|Overall Study|Administrative/Other|1|||
31003905|NCT01815840|59204937|FG001|Overall Study|Administrative/Other|3|||
30892551|NCT01362790|58926004|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
31003906|NCT01815840|59204936|FG000|Overall Study|Adverse Event|10|||
31003907|NCT01815840|59204937|FG001|Overall Study|Adverse Event|16|||
31003908|NCT01815840|59204936|FG000|Overall Study|Death|2|||
31003909|NCT01815840|59204937|FG001|Overall Study|Death|2|||
31003910|NCT01815840|59204936|FG000|Overall Study|Disease progression|3|||
31003911|NCT01815840|59204937|FG001|Overall Study|Disease progression|2|||
31003912|NCT01815840|59204936|FG000|Overall Study|Investigators Decision|2|||
31003913|NCT01815840|59204937|FG001|Overall Study|Investigators Decision|3|||
31003914|NCT01815840|59204936|FG000|Overall Study|Lost to Follow-up|3|||
31003915|NCT01815840|59204937|FG001|Overall Study|Lost to Follow-up|6|||
31003916|NCT01815840|59204936|FG000|Overall Study|Refused Treatment|5|||
31003917|NCT01815840|59204937|FG001|Overall Study|Refused Treatment|1|||
31003918|NCT01815840|59204936|FG000|Overall Study|Sponsor Termination Treatment|1|||
31003919|NCT01815840|59204937|FG001|Overall Study|Sponsor Termination Treatment|0|||
31003920|NCT01774110|59204943|FG000|Overall Study|Lost to Follow-up|7|||
31003921|NCT01788228|59204950|FG000|Overall Study|Migrated/moved from study area|1|||
31003922|NCT01788228|59204951|FG001|Overall Study|Migrated/moved from study area|0|||
31003923|NCT01607346|59204960|FG000|Overall Study|Adverse Event|3|||
31003924|NCT01787838|59204964|FG000|Overall Study|refused|1413|||
31003925|NCT01787760|59204971|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
31003926|NCT01787760|59204972|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
31003927|NCT01787760|59204973|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
31003928|NCT01787760|59204971|FG000|Overall Study|Decompensated on left exotropia|0|||
31003929|NCT01787760|59204972|FG001|Overall Study|Decompensated on left exotropia|0|||
31003930|NCT01787760|59204973|FG002|Overall Study|Decompensated on left exotropia|1|||
31003931|NCT01787760|59204971|FG000|Overall Study|Dryness|0|||
31003932|NCT01787760|59204972|FG001|Overall Study|Dryness|1|||
31003933|NCT01787760|59204973|FG002|Overall Study|Dryness|0|||
31003934|NCT01787760|59204971|FG000|Overall Study|Relocation|1|||
31003935|NCT01787760|59204972|FG001|Overall Study|Relocation|1|||
31003936|NCT01787760|59204973|FG002|Overall Study|Relocation|0|||
31003937|NCT01787760|59204971|FG000|Overall Study|Lens discomfort|3|||
31003938|NCT01787760|59204972|FG001|Overall Study|Lens discomfort|0|||
31003939|NCT01787760|59204973|FG002|Overall Study|Lens discomfort|0|||
31003940|NCT01787760|59204971|FG000|Overall Study|Lens handling difficulty|1|||
31003941|NCT01787760|59204972|FG001|Overall Study|Lens handling difficulty|2|||
31003942|NCT01787760|59204973|FG002|Overall Study|Lens handling difficulty|0|||
31003943|NCT01787760|59204971|FG000|Overall Study|Protocol Violation|6|||
31003944|NCT01787760|59204972|FG001|Overall Study|Protocol Violation|0|||
31003945|NCT01787760|59204973|FG002|Overall Study|Protocol Violation|1|||
31003946|NCT01787760|59204971|FG000|Overall Study|Withdrawal by Subject|5|||
31003947|NCT01787760|59204972|FG001|Overall Study|Withdrawal by Subject|1|||
31003948|NCT01787760|59204973|FG002|Overall Study|Withdrawal by Subject|2|||
31003949|NCT01787760|59204971|FG000|Overall Study|Lost to Follow-up|1|||
31003950|NCT01787760|59204972|FG001|Overall Study|Lost to Follow-up|0|||
31003951|NCT01787760|59204973|FG002|Overall Study|Lost to Follow-up|1|||
31003952|NCT01787760|59204971|FG000|Overall Study|Stroke|1|||
31003953|NCT01787760|59204972|FG001|Overall Study|Stroke|0|||
31003954|NCT01787760|59204973|FG002|Overall Study|Stroke|0|||
31003955|NCT01787760|59204971|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
31003956|NCT01787760|59204972|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
31003957|NCT01787760|59204973|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
31003958|NCT01787760|59204971|FG000|Overall Study|Unsatisfactory physiological response|2|||
31003959|NCT01787760|59204972|FG001|Overall Study|Unsatisfactory physiological response|4|||
31003960|NCT01787760|59204973|FG002|Overall Study|Unsatisfactory physiological response|0|||
31003961|NCT01787760|59204971|FG000|Overall Study|Unsatisfactory visual response|1|||
31003962|NCT01787760|59204972|FG001|Overall Study|Unsatisfactory visual response|1|||
31003963|NCT01787760|59204973|FG002|Overall Study|Unsatisfactory visual response|0|||
31003964|NCT01787760|59204971|FG000|Overall Study|Near vision blur|1|||
31003965|NCT01787760|59204972|FG001|Overall Study|Near vision blur|0|||
31003966|NCT01787760|59204973|FG002|Overall Study|Near vision blur|0|||
31003967|NCT01815138|59204984|FG000|Overall Study|Withdrawal by Subject|0|||
31003968|NCT01815138|59204985|FG001|Overall Study|Withdrawal by Subject|1|||
31003969|NCT01815138|59204984|FG000|Overall Study|Physician Decision|8|||
31003970|NCT01815138|59204985|FG001|Overall Study|Physician Decision|5|||
31003971|NCT01606800|59204993|FG000|Overall Study|Adverse Event|3|||
31003972|NCT01606800|59204994|FG001|Overall Study|Adverse Event|1|||
31003973|NCT01606800|59204993|FG000|Overall Study|Participant withdrew consent|0|||
31003974|NCT01606800|59204994|FG001|Overall Study|Participant withdrew consent|1|||
31003975|NCT01606800|59204993|FG000|Overall Study|Missing completion status|2|||
31003976|NCT01606800|59204994|FG001|Overall Study|Missing completion status|0|||
31003977|NCT01772550|59205003|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
31003978|NCT01772550|59205004|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
31003979|NCT01772550|59205005|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
31003980|NCT01772550|59205003|FG000|Overall Study|Adverse Event|0|||
31003981|NCT01772550|59205004|FG001|Overall Study|Adverse Event|0|||
31003982|NCT01772550|59205005|FG002|Overall Study|Adverse Event|1|||
31003983|NCT01787292|59205013|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
31003984|NCT01787292|59205014|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
31003985|NCT01787292|59205013|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
31003986|NCT01787292|59205014|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
31003987|NCT01814748|59205027|FG000|Overall Study|Lost to Follow-up|1|||
31003988|NCT01814748|59205028|FG001|Overall Study|Lost to Follow-up|2|||
31003989|NCT01814748|59205027|FG000|Overall Study|Study site terminated by sponsor|1|||
31003990|NCT01814748|59205028|FG001|Overall Study|Study site terminated by sponsor|1|||
31003991|NCT01814748|59205027|FG000|Overall Study|Withdrawal by Subject|6|||
31003992|NCT01814748|59205028|FG001|Overall Study|Withdrawal by Subject|4|||
31003993|NCT01814670|59205034|FG000|Overall Study|Protocol Violation|12|||
31003994|NCT01814046|59205040|FG000|Drug Administration|Death due to complications of RSV|1|||
31003995|NCT01814046|59205041|FG001|Drug Administration|Death due to complications of RSV|0|||
31003996|NCT01814046|59205042|FG002|Drug Administration|Death due to complications of RSV|0|||
31003997|NCT01813890|59205052|FG000|Overall Study|Adverse Event|0|||
31003998|NCT01813890|59205053|FG001|Overall Study|Adverse Event|3|||
31003999|NCT01813890|59205054|FG002|Overall Study|Adverse Event|4|||
31004000|NCT01813890|59205052|FG000|Overall Study|Lack of Efficacy|9|||
31004001|NCT01813890|59205053|FG001|Overall Study|Lack of Efficacy|1|||
31004002|NCT01813890|59205054|FG002|Overall Study|Lack of Efficacy|2|||
31004003|NCT01772316|59205062|FG000|Overall Study|Serious adverse event|1|||
31004004|NCT01772316|59205062|FG000|Overall Study|Inform consent withdrawn|1|||
31004005|NCT01772316|59205062|FG000|Overall Study|Withdrawn by sponsor decision|5|||
31004006|NCT01813422|59205068|FG000|Overall Study|Withdrawal by Subject|14|||
31004007|NCT01813422|59205069|FG001|Overall Study|Withdrawal by Subject|8|||
31004008|NCT01813422|59205068|FG000|Overall Study|Death|2|||
31004009|NCT01813422|59205069|FG001|Overall Study|Death|3|||
31004010|NCT01813422|59205068|FG000|Overall Study|Sponsor Decision|2|||
31004011|NCT01813422|59205069|FG001|Overall Study|Sponsor Decision|1|||
31004012|NCT01813422|59205068|FG000|Overall Study|Lost to Follow-up|2|||
31004013|NCT01813422|59205069|FG001|Overall Study|Lost to Follow-up|4|||
31004014|NCT01786668|59205079|FG000|Overall Study|Adverse Event|0|||
31004015|NCT01786668|59205080|FG001|Overall Study|Adverse Event|1|||
31004016|NCT01786668|59205081|FG002|Overall Study|Adverse Event|1|||
31004017|NCT01786668|59205082|FG003|Overall Study|Adverse Event|2|||
31004018|NCT01786668|59205079|FG000|Overall Study|Withdrawal by Subject|0|||
31004019|NCT01786668|59205080|FG001|Overall Study|Withdrawal by Subject|0|||
31004020|NCT01786668|59205081|FG002|Overall Study|Withdrawal by Subject|3|||
31004021|NCT01786668|59205082|FG003|Overall Study|Withdrawal by Subject|1|||
31004022|NCT01786668|59205079|FG000|Overall Study|Pregnancy|0|||
31004023|NCT01786668|59205080|FG001|Overall Study|Pregnancy|0|||
31004024|NCT01786668|59205081|FG002|Overall Study|Pregnancy|0|||
31004025|NCT01786668|59205082|FG003|Overall Study|Pregnancy|1|||
31004026|NCT01786668|59205079|FG000|Overall Study|Lost to Follow-up|1|||
31004027|NCT01786668|59205080|FG001|Overall Study|Lost to Follow-up|0|||
31004028|NCT01786668|59205081|FG002|Overall Study|Lost to Follow-up|1|||
31004029|NCT01786668|59205082|FG003|Overall Study|Lost to Follow-up|0|||
31004030|NCT01786512|59205103|FG000|Overall Study|Lost to Follow-up|0|||
31004031|NCT01786512|59205104|FG001|Overall Study|Lost to Follow-up|0|||
31004032|NCT01786512|59205105|FG002|Overall Study|Lost to Follow-up|0|||
31004033|NCT01786512|59205106|FG003|Overall Study|Lost to Follow-up|0|||
31004034|NCT01786512|59205107|FG004|Overall Study|Lost to Follow-up|0|||
31004035|NCT01786512|59205108|FG005|Overall Study|Lost to Follow-up|0|||
31004036|NCT01786512|59205109|FG006|Overall Study|Lost to Follow-up|0|||
31004037|NCT01786512|59205110|FG007|Overall Study|Lost to Follow-up|0|||
31004038|NCT01786512|59205111|FG008|Overall Study|Lost to Follow-up|0|||
31004039|NCT01786512|59205112|FG009|Overall Study|Lost to Follow-up|1|||
31004040|NCT01786512|59205113|FG010|Overall Study|Lost to Follow-up|0|||
31004041|NCT01786512|59205103|FG000|Overall Study|Decision by sponsor|0|||
31004042|NCT01786512|59205104|FG001|Overall Study|Decision by sponsor|0|||
31004043|NCT01786512|59205105|FG002|Overall Study|Decision by sponsor|0|||
31004044|NCT01786512|59205106|FG003|Overall Study|Decision by sponsor|0|||
31004045|NCT01786512|59205107|FG004|Overall Study|Decision by sponsor|0|||
31004046|NCT01786512|59205108|FG005|Overall Study|Decision by sponsor|0|||
31004047|NCT01786512|59205109|FG006|Overall Study|Decision by sponsor|0|||
31004048|NCT01786512|59205110|FG007|Overall Study|Decision by sponsor|0|||
31004049|NCT01786512|59205111|FG008|Overall Study|Decision by sponsor|0|||
31004050|NCT01786512|59205112|FG009|Overall Study|Decision by sponsor|0|||
31004051|NCT01786512|59205113|FG010|Overall Study|Decision by sponsor|2|||
31004052|NCT01786512|59205103|FG000|Overall Study|Withdrawal by Subject|0|||
31004053|NCT01786512|59205104|FG001|Overall Study|Withdrawal by Subject|1|||
31004054|NCT01786512|59205105|FG002|Overall Study|Withdrawal by Subject|0|||
31004055|NCT01786512|59205106|FG003|Overall Study|Withdrawal by Subject|0|||
31004056|NCT01786512|59205107|FG004|Overall Study|Withdrawal by Subject|0|||
31004057|NCT01786512|59205108|FG005|Overall Study|Withdrawal by Subject|0|||
31004058|NCT01786512|59205109|FG006|Overall Study|Withdrawal by Subject|1|||
31004059|NCT01786512|59205110|FG007|Overall Study|Withdrawal by Subject|0|||
31004060|NCT01786512|59205111|FG008|Overall Study|Withdrawal by Subject|0|||
31004061|NCT01786512|59205112|FG009|Overall Study|Withdrawal by Subject|3|||
31004062|NCT01786512|59205113|FG010|Overall Study|Withdrawal by Subject|7|||
31004063|NCT01786512|59205103|FG000|Overall Study|Death|0|||
31004064|NCT01786512|59205104|FG001|Overall Study|Death|0|||
31004065|NCT01786512|59205105|FG002|Overall Study|Death|0|||
31004066|NCT01786512|59205106|FG003|Overall Study|Death|0|||
31004067|NCT01786512|59205107|FG004|Overall Study|Death|0|||
31004068|NCT01786512|59205108|FG005|Overall Study|Death|0|||
31004069|NCT01786512|59205109|FG006|Overall Study|Death|0|||
31004070|NCT01786512|59205110|FG007|Overall Study|Death|0|||
31004071|NCT01786512|59205111|FG008|Overall Study|Death|4|||
31004072|NCT01786512|59205112|FG009|Overall Study|Death|1|||
31004073|NCT01786512|59205113|FG010|Overall Study|Death|3|||
31004074|NCT01772160|59205145|FG000|Overall Study|Death|3|||
31004075|NCT01772160|59205145|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
31004076|NCT01772160|59205145|FG000|Overall Study|Consent withdrawal|3|||
31004077|NCT01772160|59205145|FG000|Overall Study|Migrated / moved from the study area|4|||
31004078|NCT01772160|59205145|FG000|Overall Study|Lost to Follow-up|30|||
31004079|NCT01772160|59205145|FG000|Overall Study|Other|5|||
31004080|NCT01770912|59205151|FG000|Overall Study|Lost to Follow-up|2|||
31004081|NCT01770912|59205152|FG001|Overall Study|Lost to Follow-up|0|||
31004082|NCT01811706|59205158|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
31004083|NCT01811706|59205159|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
31004084|NCT01811472|59205170|FG000|Overall Study|Adverse Event|1|||
31004085|NCT01811472|59205171|FG001|Overall Study|Adverse Event|0|||
31004086|NCT01811472|59205172|FG002|Overall Study|Adverse Event|4|||
31004087|NCT01811472|59205170|FG000|Overall Study|Lost to Follow-up|0|||
31004088|NCT01811472|59205171|FG001|Overall Study|Lost to Follow-up|0|||
31004089|NCT01811472|59205172|FG002|Overall Study|Lost to Follow-up|1|||
31004090|NCT01811472|59205170|FG000|Overall Study|Subject/guardian decision|1|||
31004091|NCT01811472|59205171|FG001|Overall Study|Subject/guardian decision|0|||
31004092|NCT01811472|59205172|FG002|Overall Study|Subject/guardian decision|0|||
31004093|NCT01811238|59205181|FG000|Overall Study|Withdrawal by Subject|42|||
31004094|NCT01811238|59205181|FG000|Overall Study|Adverse Event|25|||
31004095|NCT01811238|59205181|FG000|Overall Study|Protocol Violation|4|||
31004096|NCT01811238|59205181|FG000|Overall Study|Lack of Efficacy|4|||
31004097|NCT01811238|59205181|FG000|Overall Study|subject refused study medication|6|||
31004098|NCT01769508|59205186|FG000|Overall Study|Death|3|||
31004099|NCT01769508|59205186|FG000|Overall Study|Withdrawal by Subject|1|||
31004100|NCT01769508|59205186|FG000|Overall Study|Adverse Event|1|||
31004101|NCT01769508|59205186|FG000|Overall Study|Lost to Follow-up|1|||
31004102|NCT01810380|59205193|FG000|Overall Study|Randomised not treated|2|||
31004103|NCT01810380|59205194|FG001|Overall Study|Randomised not treated|1|||
31004104|NCT01810380|59205195|FG002|Overall Study|Randomised not treated|1|||
31004105|NCT01810380|59205193|FG000|Overall Study|Adverse Event|11|||
31004106|NCT01810380|59205194|FG001|Overall Study|Adverse Event|14|||
31004107|NCT01810380|59205195|FG002|Overall Study|Adverse Event|4|||
31004108|NCT01810380|59205193|FG000|Overall Study|Lack of Efficacy|24|||
31004109|NCT01810380|59205194|FG001|Overall Study|Lack of Efficacy|10|||
31004110|NCT01810380|59205195|FG002|Overall Study|Lack of Efficacy|11|||
31004111|NCT01810380|59205193|FG000|Overall Study|Protocol Violation|1|||
31004112|NCT01810380|59205194|FG001|Overall Study|Protocol Violation|0|||
31004113|NCT01810380|59205195|FG002|Overall Study|Protocol Violation|1|||
31004114|NCT01810380|59205193|FG000|Overall Study|Withdrawal by Subject|6|||
31004115|NCT01810380|59205194|FG001|Overall Study|Withdrawal by Subject|0|||
31004116|NCT01810380|59205195|FG002|Overall Study|Withdrawal by Subject|6|||
31004117|NCT01810380|59205193|FG000|Overall Study|Administrative or other reasons|11|||
31004118|NCT01810380|59205194|FG001|Overall Study|Administrative or other reasons|13|||
31004119|NCT01810380|59205195|FG002|Overall Study|Administrative or other reasons|9|||
31004120|NCT01769196|59205205|FG000|Overall Study|Adverse Event|24|||
31004121|NCT01769196|59205206|FG001|Overall Study|Adverse Event|20|||
31004122|NCT01769196|59205205|FG000|Overall Study|Death|21|||
31004123|NCT01769196|59205206|FG001|Overall Study|Death|26|||
31004124|NCT01769196|59205205|FG000|Overall Study|Investigator Discretion|7|||
31004125|NCT01769196|59205206|FG001|Overall Study|Investigator Discretion|3|||
31004126|NCT01769196|59205205|FG000|Overall Study|Lack of Efficacy|3|||
31004127|NCT01769196|59205206|FG001|Overall Study|Lack of Efficacy|2|||
31004128|NCT01769196|59205205|FG000|Overall Study|Progressive disease|11|||
31004129|NCT01769196|59205206|FG001|Overall Study|Progressive disease|6|||
31004130|NCT01769196|59205205|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
31004131|NCT01769196|59205206|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
31004132|NCT01769196|59205205|FG000|Overall Study|Protocol Violation|0|||
31004133|NCT01769196|59205206|FG001|Overall Study|Protocol Violation|3|||
31004134|NCT01769196|59205205|FG000|Overall Study|Study terminated by sponsor|160|||
31004135|NCT01769196|59205206|FG001|Overall Study|Study terminated by sponsor|161|||
31004136|NCT01769196|59205205|FG000|Overall Study|Participant never dosed with study drug|1|||
31004137|NCT01769196|59205206|FG001|Overall Study|Participant never dosed with study drug|0|||
31004138|NCT01769196|59205205|FG000|Overall Study|Withdrew consent|36|||
31004139|NCT01769196|59205206|FG001|Overall Study|Withdrew consent|40|||
31004140|NCT01810302|59205214|FG000|Overall Study|Death|1|||
31004141|NCT01810302|59205215|FG001|Overall Study|Death|0|||
31004142|NCT01810302|59205214|FG000|Overall Study|Physician Decision|0|||
31004143|NCT01810302|59205215|FG001|Overall Study|Physician Decision|1|||
31004144|NCT01783938|59205223|FG000|Overall Study|Disease Progression|18|||
31004145|NCT01783938|59205224|FG001|Overall Study|Disease Progression|41|||
31004146|NCT01783938|59205223|FG000|Overall Study|Study Drug Toxicity|27|||
31004147|NCT01783938|59205224|FG001|Overall Study|Study Drug Toxicity|14|||
31004148|NCT01783938|59205223|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
31004149|NCT01783938|59205224|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
31004150|NCT01783938|59205223|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
31004151|NCT01783938|59205224|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
31004152|NCT01783938|59205223|FG000|Overall Study|Participant Withdrew Consent|2|||
31004153|NCT01783938|59205224|FG001|Overall Study|Participant Withdrew Consent|0|||
31004154|NCT01783938|59205223|FG000|Overall Study|Maximum Clinical Benefit|1|||
31004155|NCT01783938|59205224|FG001|Overall Study|Maximum Clinical Benefit|0|||
31004156|NCT01783938|59205223|FG000|Overall Study|Other Reasons|3|||
31004157|NCT01783938|59205224|FG001|Overall Study|Other Reasons|1|||
31004158|NCT01768572|59205233|FG000|Overall Study|Adverse Event|7|||
31004159|NCT01768572|59205234|FG001|Overall Study|Adverse Event|8|||
31004160|NCT01768572|59205235|FG002|Overall Study|Adverse Event|4|||
31004161|NCT01768572|59205233|FG000|Overall Study|Lack of Efficacy|1|||
31004162|NCT01768572|59205234|FG001|Overall Study|Lack of Efficacy|3|||
31004163|NCT01768572|59205235|FG002|Overall Study|Lack of Efficacy|1|||
31004164|NCT01768572|59205233|FG000|Overall Study|Other, Not due to an adverse event|1|||
31004165|NCT01768572|59205234|FG001|Overall Study|Other, Not due to an adverse event|1|||
31004166|NCT01768572|59205235|FG002|Overall Study|Other, Not due to an adverse event|1|||
30892552|NCT01362790|58926005|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
30892553|NCT01362790|58926006|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
30892554|NCT01362790|58926007|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
30892555|NCT01362790|58926001|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
30892556|NCT01362790|58926002|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
30892557|NCT01362790|58926003|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
30892558|NCT01362790|58926004|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
30892559|NCT01362790|58926005|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
30892560|NCT01362790|58926006|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
30892561|NCT01362790|58926007|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
30892562|NCT01362790|58926001|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
30892563|NCT01362790|58926002|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
30892564|NCT01362790|58926003|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
31004167|NCT01783548|59205245|FG000|Overall Study|Adverse Event|8|||
31004168|NCT01783548|59205246|FG001|Overall Study|Adverse Event|4|||
31004169|NCT01783548|59205245|FG000|Overall Study|Withdrawal by Subject|11|||
31004170|NCT01783548|59205246|FG001|Overall Study|Withdrawal by Subject|8|||
31004171|NCT01783548|59205245|FG000|Overall Study|Non-compliance|4|||
31004172|NCT01783548|59205246|FG001|Overall Study|Non-compliance|0|||
31004173|NCT01783548|59205245|FG000|Overall Study|Protocol Violation|2|||
31004174|NCT01783548|59205246|FG001|Overall Study|Protocol Violation|2|||
31004175|NCT01783548|59205245|FG000|Overall Study|Lost to Follow-up|8|||
31004176|NCT01783548|59205246|FG001|Overall Study|Lost to Follow-up|3|||
31004177|NCT01783548|59205245|FG000|Overall Study|Lack of Efficacy|1|||
31004178|NCT01783548|59205246|FG001|Overall Study|Lack of Efficacy|1|||
31004179|NCT01809210|59205259|FG000|Overall Study|Withdrawal by Subject|0|||
31004180|NCT01809210|59205260|FG001|Overall Study|Withdrawal by Subject|0|||
31004181|NCT01809210|59205261|FG002|Overall Study|Withdrawal by Subject|1|||
31004182|NCT01809210|59205262|FG003|Overall Study|Withdrawal by Subject|1|||
31004183|NCT01809210|59205263|FG004|Overall Study|Withdrawal by Subject|1|||
31004184|NCT01809210|59205264|FG005|Overall Study|Withdrawal by Subject|0|||
31004185|NCT01809210|59205265|FG006|Overall Study|Withdrawal by Subject|4|||
31004186|NCT01809210|59205259|FG000|Overall Study|Death|1|||
31004187|NCT01809210|59205260|FG001|Overall Study|Death|1|||
31004188|NCT01809210|59205261|FG002|Overall Study|Death|2|||
31004189|NCT01809210|59205262|FG003|Overall Study|Death|0|||
31004190|NCT01809210|59205263|FG004|Overall Study|Death|1|||
31004191|NCT01809210|59205264|FG005|Overall Study|Death|3|||
31004192|NCT01809210|59205265|FG006|Overall Study|Death|1|||
31004193|NCT01809132|59205284|FG000|Overall Study|Withdrawal by Subject|0|||
31004194|NCT01809132|59205285|FG001|Overall Study|Withdrawal by Subject|0|||
31004195|NCT01809132|59205286|FG002|Overall Study|Withdrawal by Subject|1|||
31004196|NCT01808508|59205297|FG000|Overall Study|Lost to Follow-up|1|||
31004197|NCT01808508|59205298|FG001|Overall Study|Lost to Follow-up|0|||
31004198|NCT01808508|59205299|FG002|Overall Study|Lost to Follow-up|0|||
31004199|NCT01766778|59205309|FG000|Overall Study|Adverse Event|4|||
31004200|NCT01766778|59205310|FG001|Overall Study|Adverse Event|4|||
31004201|NCT01766778|59205309|FG000|Overall Study|Withdrawal by Subject|1|||
31004202|NCT01766778|59205310|FG001|Overall Study|Withdrawal by Subject|0|||
31004203|NCT01808196|59205316|FG000|Overall Study|Lost to Follow-up|1|||
31004204|NCT01808118|59205320|FG000|Period 1|Adverse Event|15|||
31004205|NCT01808118|59205321|FG001|Period 1|Adverse Event|0|||
31004206|NCT01808118|59205322|FG002|Period 1|Adverse Event|0|||
31004207|NCT01808118|59205320|FG000|Period 1|Withdrew consent|24|||
31004208|NCT01808118|59205321|FG001|Period 1|Withdrew consent|0|||
31004209|NCT01808118|59205322|FG002|Period 1|Withdrew consent|0|||
31004210|NCT01808118|59205320|FG000|Period 1|Lost to Follow-up|9|||
31004211|NCT01808118|59205321|FG001|Period 1|Lost to Follow-up|0|||
31004212|NCT01808118|59205322|FG002|Period 1|Lost to Follow-up|0|||
31004213|NCT01808118|59205320|FG000|Period 1|Did not meet criteria for remission|303|||
31004214|NCT01808118|59205321|FG001|Period 1|Did not meet criteria for remission|0|||
31004215|NCT01808118|59205322|FG002|Period 1|Did not meet criteria for remission|0|||
31004216|NCT01808118|59205320|FG000|Period 1|Enrolled in error|7|||
31004217|NCT01808118|59205321|FG001|Period 1|Enrolled in error|0|||
31004218|NCT01808118|59205322|FG002|Period 1|Enrolled in error|0|||
31004219|NCT01808118|59205320|FG000|Period 1|Did not meet inclusion criteria|3|||
31004220|NCT01808118|59205321|FG001|Period 1|Did not meet inclusion criteria|0|||
31004221|NCT01808118|59205322|FG002|Period 1|Did not meet inclusion criteria|0|||
31004222|NCT01808118|59205320|FG000|Period 1|Non-conformance with inclusion criteria|3|||
31004223|NCT01808118|59205321|FG001|Period 1|Non-conformance with inclusion criteria|0|||
31004224|NCT01808118|59205322|FG002|Period 1|Non-conformance with inclusion criteria|0|||
31004225|NCT01808118|59205320|FG000|Period 1|Investigator decision: site closure|2|||
31004226|NCT01808118|59205321|FG001|Period 1|Investigator decision: site closure|0|||
31004227|NCT01808118|59205322|FG002|Period 1|Investigator decision: site closure|0|||
31004228|NCT01808118|59205320|FG000|Period 1|Non-compliance per sponsor|1|||
31004229|NCT01808118|59205321|FG001|Period 1|Non-compliance per sponsor|0|||
31004230|NCT01808118|59205322|FG002|Period 1|Non-compliance per sponsor|0|||
31004231|NCT01808118|59205320|FG000|Period 1|Lack of Efficacy|1|||
31004232|NCT01808118|59205321|FG001|Period 1|Lack of Efficacy|0|||
31004233|NCT01808118|59205322|FG002|Period 1|Lack of Efficacy|0|||
31004234|NCT01808118|59205320|FG000|Period 2|Adverse Event|0|||
31004235|NCT01808118|59205321|FG001|Period 2|Adverse Event|4|||
31004236|NCT01808118|59205322|FG002|Period 2|Adverse Event|0|||
31004237|NCT01808118|59205320|FG000|Period 2|Withdrew consent|0|||
31004238|NCT01808118|59205321|FG001|Period 2|Withdrew consent|7|||
31004239|NCT01808118|59205322|FG002|Period 2|Withdrew consent|6|||
31004240|NCT01808118|59205320|FG000|Period 2|Lost to Follow-up|0|||
31004241|NCT01808118|59205321|FG001|Period 2|Lost to Follow-up|0|||
31004242|NCT01808118|59205322|FG002|Period 2|Lost to Follow-up|2|||
31004243|NCT01808118|59205320|FG000|Period 2|Investigator no longer conducting trials|0|||
31004244|NCT01808118|59205321|FG001|Period 2|Investigator no longer conducting trials|1|||
31004245|NCT01808118|59205322|FG002|Period 2|Investigator no longer conducting trials|0|||
31004246|NCT01808118|59205320|FG000|Period 2|Switched to other therapy|0|||
31004247|NCT01808118|59205321|FG001|Period 2|Switched to other therapy|1|||
31004248|NCT01808118|59205322|FG002|Period 2|Switched to other therapy|0|||
31004249|NCT01807650|59205336|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
31004250|NCT01807650|59205336|FG000|Overall Study|Adverse Event|5|||
31004251|NCT01807650|59205336|FG000|Overall Study|Other|2|||
31004252|NCT01782690|59205377|FG000|Overall Study|Not reported|7|||
31004253|NCT01782690|59205377|FG000|Overall Study|Toxicity of gemcitabine|1|||
31004254|NCT01782690|59205377|FG000|Overall Study|Toxicity of erlotinib|1|||
31004255|NCT01782690|59205377|FG000|Overall Study|Lost to Follow-up|31|||
31004256|NCT01782690|59205377|FG000|Overall Study|Withdrawal of informed consent|2|||
31004257|NCT01782690|59205377|FG000|Overall Study|Absent rash|9|||
31004258|NCT01782690|59205377|FG000|Overall Study|Physician Decision|13|||
31004259|NCT01782690|59205377|FG000|Overall Study|Patient's wish|21|||
31004260|NCT01782690|59205377|FG000|Overall Study|Tumor progression|74|||
31004261|NCT01782690|59205377|FG000|Overall Study|Death|133|||
31004262|NCT01782690|59205377|FG000|Overall Study|Study completion unknown|7|||
31004263|NCT01782378|59205383|FG000|First Series|Lost to Follow-up|7|||
31004264|NCT01782378|59205384|FG001|First Series|Lost to Follow-up|8|||
31004265|NCT01782378|59205383|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
31004266|NCT01782378|59205384|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
31004267|NCT01782378|59205383|FG000|Second Series|Lost to Follow-up|8|||
31004268|NCT01782378|59205384|FG001|Second Series|Lost to Follow-up|7|||
31004269|NCT01782378|59205383|FG000|Second Series|Did not choose to complete S2 Optional|18|||
31004270|NCT01782378|59205384|FG001|Second Series|Did not choose to complete S2 Optional|0|||
31004271|NCT01766310|59205392|FG000|Overall Study|Lost to Follow-up|1|||
31004272|NCT01766310|59205393|FG001|Overall Study|Lost to Follow-up|3|||
31004273|NCT01765920|59205401|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
31004274|NCT01765920|59205402|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
31004275|NCT01765920|59205401|FG000|Overall Study|Patient code disclosure|0|||
31004276|NCT01765920|59205402|FG001|Overall Study|Patient code disclosure|1|||
31004277|NCT01782222|59205411|FG000|Overall Study|Adverse Event|4|||
31004278|NCT01782222|59205412|FG001|Overall Study|Adverse Event|5|||
31004279|NCT01782222|59205413|FG002|Overall Study|Adverse Event|3|||
31004280|NCT01782222|59205411|FG000|Overall Study|Lack of Efficacy|2|||
31004281|NCT01782222|59205412|FG001|Overall Study|Lack of Efficacy|1|||
31004282|NCT01782222|59205413|FG002|Overall Study|Lack of Efficacy|0|||
31004283|NCT01782222|59205411|FG000|Overall Study|Protocol Violation|1|||
31004284|NCT01782222|59205412|FG001|Overall Study|Protocol Violation|0|||
31004285|NCT01782222|59205413|FG002|Overall Study|Protocol Violation|0|||
31004286|NCT01782222|59205411|FG000|Overall Study|Withdrawal by Subject|1|||
31004287|NCT01782222|59205412|FG001|Overall Study|Withdrawal by Subject|4|||
31004288|NCT01782222|59205413|FG002|Overall Study|Withdrawal by Subject|1|||
31004289|NCT01782222|59205411|FG000|Overall Study|Moved to other state|0|||
31004290|NCT01782222|59205412|FG001|Overall Study|Moved to other state|1|||
31004291|NCT01782222|59205413|FG002|Overall Study|Moved to other state|0|||
31004292|NCT01781832|59205421|FG000|Overall Study|Withdrawal by Subject|1|||
31004293|NCT01807182|59205425|FG000|Overall Study|Death|1|||
31004294|NCT01807182|59205425|FG000|Overall Study|New therapy|1|||
31004295|NCT01807182|59205425|FG000|Overall Study|Moved to hospice care|1|||
31004296|NCT01806714|59205431|FG000|Overall Study|No functioning phone number|200|||
31004297|NCT01806714|59205432|FG001|Overall Study|No functioning phone number|170|||
31004298|NCT01765764|59205441|FG000|Treatment Period|Adverse Event|1|||
31004299|NCT01765764|59205442|FG001|Treatment Period|Adverse Event|2|||
31004300|NCT01765764|59205443|FG002|Treatment Period|Adverse Event|1|||
31004301|NCT01765764|59205441|FG000|Treatment Period|Lost to Follow-up|0|||
31004302|NCT01765764|59205442|FG001|Treatment Period|Lost to Follow-up|3|||
31004303|NCT01765764|59205443|FG002|Treatment Period|Lost to Follow-up|2|||
31004304|NCT01765764|59205441|FG000|Treatment Period|Personal Reasons|1|||
31004305|NCT01765764|59205442|FG001|Treatment Period|Personal Reasons|2|||
31004306|NCT01765764|59205443|FG002|Treatment Period|Personal Reasons|1|||
31004307|NCT01765764|59205441|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
31004308|NCT01765764|59205442|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
31004309|NCT01765764|59205443|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
31004310|NCT01806168|59205454|FG000|Overall Study|Adverse Event|1|||
31004311|NCT01806168|59205455|FG001|Overall Study|Adverse Event|0|||
31004312|NCT01806168|59205456|FG002|Overall Study|Adverse Event|0|||
31004313|NCT01806168|59205454|FG000|Overall Study|Withdrawal by Subject|0|||
31004314|NCT01806168|59205455|FG001|Overall Study|Withdrawal by Subject|1|||
31004315|NCT01806168|59205456|FG002|Overall Study|Withdrawal by Subject|2|||
31004316|NCT01806168|59205454|FG000|Overall Study|Protocol Violation|0|||
31004317|NCT01806168|59205455|FG001|Overall Study|Protocol Violation|0|||
31004318|NCT01806168|59205456|FG002|Overall Study|Protocol Violation|1|||
31004319|NCT01804842|59205470|FG000|Overall Study|Adverse Event|1|||
31004320|NCT01804842|59205471|FG001|Overall Study|Adverse Event|1|||
31004321|NCT01804842|59205472|FG002|Overall Study|Adverse Event|0|||
31004322|NCT01804842|59205470|FG000|Overall Study|Lost to Follow-up|1|||
31004323|NCT01804842|59205471|FG001|Overall Study|Lost to Follow-up|0|||
31004324|NCT01804842|59205472|FG002|Overall Study|Lost to Follow-up|0|||
31004325|NCT01804842|59205470|FG000|Overall Study|Non-Compliance|1|||
31004326|NCT01804842|59205471|FG001|Overall Study|Non-Compliance|1|||
31004327|NCT01804842|59205472|FG002|Overall Study|Non-Compliance|0|||
31004328|NCT01804842|59205470|FG000|Overall Study|Personal Reason|0|||
31004329|NCT01804842|59205471|FG001|Overall Study|Personal Reason|0|||
31004330|NCT01804842|59205472|FG002|Overall Study|Personal Reason|1|||
31004331|NCT01781286|59205480|FG000|Overall Study|Lost to Follow-up|0|||
31004332|NCT01781286|59205481|FG001|Overall Study|Lost to Follow-up|0|||
31004333|NCT01781286|59205482|FG002|Overall Study|Lost to Follow-up|0|||
31004334|NCT01781286|59205483|FG003|Overall Study|Lost to Follow-up|0|||
31004335|NCT01781286|59205484|FG004|Overall Study|Lost to Follow-up|0|||
31004336|NCT01781286|59205485|FG005|Overall Study|Lost to Follow-up|1|||
31004337|NCT01781286|59205480|FG000|Overall Study|Time Constraints|2|||
31004338|NCT01781286|59205481|FG001|Overall Study|Time Constraints|0|||
31004339|NCT01781286|59205482|FG002|Overall Study|Time Constraints|2|||
31004340|NCT01781286|59205483|FG003|Overall Study|Time Constraints|0|||
31004341|NCT01781286|59205484|FG004|Overall Study|Time Constraints|0|||
31004342|NCT01781286|59205485|FG005|Overall Study|Time Constraints|0|||
31004343|NCT01781286|59205480|FG000|Overall Study|Noncompliance|0|||
31004344|NCT01781286|59205481|FG001|Overall Study|Noncompliance|0|||
31004345|NCT01781286|59205482|FG002|Overall Study|Noncompliance|0|||
31004346|NCT01781286|59205483|FG003|Overall Study|Noncompliance|1|||
31004347|NCT01781286|59205484|FG004|Overall Study|Noncompliance|0|||
31004348|NCT01781286|59205485|FG005|Overall Study|Noncompliance|0|||
31004349|NCT01780974|59205497|FG000|Overall Study|Death|1|||
31004350|NCT01780974|59205498|FG001|Overall Study|Death|0|||
31004351|NCT01780974|59205497|FG000|Overall Study|Adverse Event|1|||
31004352|NCT01780974|59205498|FG001|Overall Study|Adverse Event|3|||
31004353|NCT01780662|59205507|FG000|Overall Study|Adverse Event|1|||
31004354|NCT01780662|59205508|FG001|Overall Study|Adverse Event|0|||
31004355|NCT01780662|59205509|FG002|Overall Study|Adverse Event|2|||
31004356|NCT01780662|59205507|FG000|Overall Study|Physician Decision|0|||
31004357|NCT01780662|59205508|FG001|Overall Study|Physician Decision|5|||
31004358|NCT01780662|59205509|FG002|Overall Study|Physician Decision|7|||
31004359|NCT01780662|59205507|FG000|Overall Study|Protocol Violation|0|||
31004360|NCT01780662|59205508|FG001|Overall Study|Protocol Violation|1|||
31004361|NCT01780662|59205509|FG002|Overall Study|Protocol Violation|0|||
31004362|NCT01780662|59205507|FG000|Overall Study|Ineligible|0|||
31004363|NCT01780662|59205508|FG001|Overall Study|Ineligible|0|||
31004364|NCT01780662|59205509|FG002|Overall Study|Ineligible|1|||
31004365|NCT01780584|59205521|FG000|Overall Study|Death|1|||
31004366|NCT01780584|59205522|FG001|Overall Study|Death|0|||
31004367|NCT01780584|59205523|FG002|Overall Study|Death|1|||
31004368|NCT01780584|59205521|FG000|Overall Study|Adverse Event|0|||
31004369|NCT01780584|59205522|FG001|Overall Study|Adverse Event|1|||
31004370|NCT01780584|59205523|FG002|Overall Study|Adverse Event|0|||
31004371|NCT01780584|59205521|FG000|Overall Study|Protocol Violation|0|||
31004372|NCT01780584|59205522|FG001|Overall Study|Protocol Violation|0|||
31004373|NCT01780584|59205523|FG002|Overall Study|Protocol Violation|1|||
31004374|NCT01780506|59205533|FG000|Double-Blind Phase|Randomized but not Treated|3|||
31004375|NCT01780506|59205534|FG001|Double-Blind Phase|Randomized but not Treated|2|||
31004376|NCT01780506|59205533|FG000|Double-Blind Phase|Adverse Event|4|||
31004377|NCT01780506|59205534|FG001|Double-Blind Phase|Adverse Event|14|||
31004378|NCT01780506|59205533|FG000|Double-Blind Phase|Death|1|||
31004379|NCT01780506|59205534|FG001|Double-Blind Phase|Death|2|||
31004380|NCT01780506|59205533|FG000|Double-Blind Phase|Pregnancy|2|||
31004381|NCT01780506|59205534|FG001|Double-Blind Phase|Pregnancy|1|||
31004382|NCT01780506|59205533|FG000|Double-Blind Phase|Lack of Efficacy|1|||
31004383|NCT01780506|59205534|FG001|Double-Blind Phase|Lack of Efficacy|1|||
31004384|NCT01780506|59205533|FG000|Double-Blind Phase|Investigator's Discretion|5|||
31004385|NCT01780506|59205534|FG001|Double-Blind Phase|Investigator's Discretion|2|||
31004386|NCT01780506|59205533|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
31004387|NCT01780506|59205534|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
31004388|NCT01780506|59205533|FG000|Double-Blind Phase|Protocol Violation|4|||
31004389|NCT01780506|59205534|FG001|Double-Blind Phase|Protocol Violation|3|||
31004390|NCT01780506|59205533|FG000|Double-Blind Phase|Withdrew Consent|23|||
31004391|NCT01780506|59205534|FG001|Double-Blind Phase|Withdrew Consent|24|||
31004392|NCT01780506|59205533|FG000|Double-Blind Phase|Lost to Follow-up|23|||
31004393|NCT01780506|59205534|FG001|Double-Blind Phase|Lost to Follow-up|26|||
31004394|NCT01780506|59205533|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
31004395|NCT01780506|59205534|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
31004396|NCT01779648|59205544|FG000|Overall Study|Protocol Violation|1|||
31004397|NCT01779648|59205545|FG001|Overall Study|Protocol Violation|0|||
31004398|NCT01762800|59205553|FG000|Overall Study|Adverse Event|8|||
31004399|NCT01762800|59205554|FG001|Overall Study|Adverse Event|13|||
31004400|NCT01762800|59205553|FG000|Overall Study|Lack of Efficacy|3|||
31004401|NCT01762800|59205554|FG001|Overall Study|Lack of Efficacy|2|||
31004402|NCT01762800|59205553|FG000|Overall Study|Study Closed/Terminated|0|||
31004403|NCT01762800|59205554|FG001|Overall Study|Study Closed/Terminated|1|||
31004404|NCT01762800|59205553|FG000|Overall Study|Physician Decision|1|||
31004405|NCT01762800|59205554|FG001|Overall Study|Physician Decision|1|||
31004406|NCT01762800|59205553|FG000|Overall Study|Withdrawal by Subject|7|||
31004407|NCT01762800|59205554|FG001|Overall Study|Withdrawal by Subject|4|||
31004408|NCT01597596|59205568|FG000|Overall Study|Study terminated by sponsor|1|||
31004409|NCT01597596|59205569|FG001|Overall Study|Study terminated by sponsor|0|||
31004410|NCT01597596|59205568|FG000|Overall Study|Physician Decision|0|||
31004411|NCT01597596|59205569|FG001|Overall Study|Physician Decision|1|||
31004412|NCT01778556|59205577|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
31004413|NCT01778556|59205578|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
31004414|NCT01778556|59205577|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
31004415|NCT01778556|59205578|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
31004416|NCT01778556|59205577|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
31004417|NCT01778556|59205578|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
31004418|NCT01778556|59205577|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
31004419|NCT01778556|59205578|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
31004420|NCT01761162|59205587|FG000|Overall Study|Withdrawal by Subject|3|||
31004421|NCT01778010|59205591|FG000|Overall Study|Withdrawal by Subject|2|||
31004422|NCT01778010|59205591|FG000|Overall Study|abnormal ECG before meds|1|||
31004423|NCT01778010|59205591|FG000|Overall Study|Arrested|1|||
31004424|NCT01778010|59205591|FG000|Overall Study|rash while on placebo|1|||
31004425|NCT01777932|59205608|FG000|Overall Study|Disease progression|136|||
31004426|NCT01777932|59205608|FG000|Overall Study|Death|3|||
31004427|NCT01777932|59205608|FG000|Overall Study|Adverse Event|34|||
31004428|NCT01777932|59205608|FG000|Overall Study|Lost to Follow-up|3|||
31004429|NCT01777932|59205608|FG000|Overall Study|Investigator decision|10|||
31004430|NCT01777932|59205608|FG000|Overall Study|Reimbursement limit|9|||
31004431|NCT01777932|59205608|FG000|Overall Study|Patient refused further treatment|10|||
31004432|NCT01777854|59205612|FG000|Overall Study|Physician Decision|3|||
30892565|NCT01362790|58926004|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
30892566|NCT01362790|58926005|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
30892567|NCT01362790|58926006|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
30892568|NCT01362790|58926007|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
30892569|NCT02167893|58926027|FG000|Overall Study|Investigator transferred|85|||
30892570|NCT02167893|58926027|FG000|Overall Study|Investigator health reasons|10|||
30892571|NCT02167893|58926027|FG000|Overall Study|Case report forms not collected|68|||
30892572|NCT02167035|58926033|FG000|Overall Study|Adverse Event|2|||
30892573|NCT02167035|58926034|FG001|Overall Study|Adverse Event|2|||
30892574|NCT02167035|58926033|FG000|Overall Study|Lost to Follow-up|3|||
30892575|NCT02167035|58926034|FG001|Overall Study|Lost to Follow-up|3|||
30892576|NCT02167035|58926033|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
30892577|NCT02167035|58926034|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
30892578|NCT01615198|58926044|FG000|Overall Study|Withdrawal by Subject|5|||
30892579|NCT01615198|58926045|FG001|Overall Study|Withdrawal by Subject|5|||
30892580|NCT01615198|58926044|FG000|Overall Study|Protocol deviation|1|||
30892581|NCT01615198|58926045|FG001|Overall Study|Protocol deviation|1|||
30892582|NCT01615198|58926044|FG000|Overall Study|Physician Decision|5|||
30892583|NCT01615198|58926045|FG001|Overall Study|Physician Decision|1|||
30892584|NCT01615198|58926044|FG000|Overall Study|Lost to Follow-up|1|||
30892585|NCT01615198|58926045|FG001|Overall Study|Lost to Follow-up|1|||
30892586|NCT01615198|58926044|FG000|Overall Study|Lack of Efficacy|1|||
30892587|NCT01615198|58926045|FG001|Overall Study|Lack of Efficacy|6|||
30892588|NCT01615198|58926044|FG000|Overall Study|Adverse Event|11|||
30892589|NCT01615198|58926045|FG001|Overall Study|Adverse Event|5|||
30892590|NCT02337907|58926057|FG000|Overall Study|Other than listed|1|||
30892591|NCT02337907|58926058|FG001|Overall Study|Other than listed|0|||
30892592|NCT02337907|58926059|FG002|Overall Study|Other than listed|0|||
30892593|NCT02337907|58926060|FG003|Overall Study|Other than listed|1|||
30892594|NCT02337907|58926061|FG004|Overall Study|Other than listed|1|||
30892595|NCT02337907|58926062|FG005|Overall Study|Other than listed|0|||
30892596|NCT02337907|58926057|FG000|Overall Study|Withdrawal by Subject|2|||
30892597|NCT02337907|58926058|FG001|Overall Study|Withdrawal by Subject|3|||
30892598|NCT02337907|58926059|FG002|Overall Study|Withdrawal by Subject|0|||
30892599|NCT02337907|58926060|FG003|Overall Study|Withdrawal by Subject|2|||
30892600|NCT02337907|58926061|FG004|Overall Study|Withdrawal by Subject|5|||
31004433|NCT01777854|59205613|FG001|Overall Study|Physician Decision|3|||
31004434|NCT01777776|59205621|FG000|Overall Study|Adverse Event|2|||
31004435|NCT01777776|59205622|FG001|Overall Study|Adverse Event|4|||
31004436|NCT01777776|59205623|FG002|Overall Study|Adverse Event|0|||
31004437|NCT01777776|59205624|FG003|Overall Study|Adverse Event|0|||
31004438|NCT01777776|59205621|FG000|Overall Study|Disease Progression|4|||
31004439|NCT01777776|59205622|FG001|Overall Study|Disease Progression|8|||
31004440|NCT01777776|59205623|FG002|Overall Study|Disease Progression|6|||
31004441|NCT01777776|59205624|FG003|Overall Study|Disease Progression|3|||
31004442|NCT01777776|59205621|FG000|Overall Study|Withdrawal by Subject|0|||
31004443|NCT01777776|59205622|FG001|Overall Study|Withdrawal by Subject|0|||
31004444|NCT01777776|59205623|FG002|Overall Study|Withdrawal by Subject|0|||
31004445|NCT01777776|59205624|FG003|Overall Study|Withdrawal by Subject|1|||
31004446|NCT01777620|59205645|FG000|Overall Study|Subject Withdrawal|1|||
31004447|NCT01777620|59205646|FG001|Overall Study|Subject Withdrawal|0|||
31004448|NCT01777542|59205652|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
31004449|NCT01777542|59205653|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
31004450|NCT01736124|59205662|FG000|Post-intervention Assessment|Death|2|||
31004451|NCT01736124|59205663|FG001|Post-intervention Assessment|Death|2|||
31004452|NCT01736124|59205662|FG000|Post-intervention Assessment|lost computer access|1|||
31004453|NCT01736124|59205663|FG001|Post-intervention Assessment|lost computer access|1|||
31004454|NCT01736124|59205662|FG000|Post-intervention Assessment|Moved away|3|||
31004455|NCT01736124|59205663|FG001|Post-intervention Assessment|Moved away|1|||
31004456|NCT01736124|59205662|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
31004457|NCT01736124|59205663|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
31004458|NCT01736124|59205662|FG000|Post-intervention Assessment|Illness|3|||
31004459|NCT01736124|59205663|FG001|Post-intervention Assessment|Illness|2|||
31004460|NCT01736124|59205662|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
31004461|NCT01736124|59205663|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
31004462|NCT01736124|59205662|FG000|Post-intervention Assessment|Temporarily away|3|||
31004463|NCT01736124|59205663|FG001|Post-intervention Assessment|Temporarily away|1|||
31004464|NCT01736124|59205662|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
31004465|NCT01736124|59205663|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
31004466|NCT01736124|59205662|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
31004467|NCT01736124|59205663|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
31004468|NCT01736124|59205662|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
31004469|NCT01736124|59205663|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
31004470|NCT01736124|59205662|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
31004471|NCT01736124|59205663|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
31004472|NCT01736124|59205662|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
31004473|NCT01736124|59205663|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
31004474|NCT01736124|59205662|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
31004475|NCT01736124|59205663|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
31004476|NCT01736124|59205662|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
31004477|NCT01736124|59205663|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
31004478|NCT01736124|59205662|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
31004479|NCT01736124|59205663|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
31004480|NCT01736124|59205662|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
31004481|NCT01736124|59205663|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
31004482|NCT01759446|59205676|FG000|Overall Study|Protocol Violation|1|||
31004483|NCT01759446|59205677|FG001|Overall Study|Protocol Violation|0|||
31004484|NCT01759446|59205678|FG002|Overall Study|Protocol Violation|1|||
31004485|NCT01759446|59205679|FG003|Overall Study|Protocol Violation|0|||
31004486|NCT01759446|59205680|FG004|Overall Study|Protocol Violation|0|||
31004487|NCT01759446|59205676|FG000|Overall Study|Withdrawal by Subject|0|||
31004488|NCT01759446|59205677|FG001|Overall Study|Withdrawal by Subject|1|||
31004489|NCT01759446|59205678|FG002|Overall Study|Withdrawal by Subject|0|||
31004490|NCT01759446|59205679|FG003|Overall Study|Withdrawal by Subject|1|||
31004491|NCT01759446|59205680|FG004|Overall Study|Withdrawal by Subject|0|||
31004492|NCT01777308|59205694|FG000|Overall Study|Withdrawal by Subject|5|||
31004493|NCT01777308|59205695|FG001|Overall Study|Withdrawal by Subject|1|||
31004494|NCT01777308|59205694|FG000|Overall Study|Migrated/moved from study area|1|||
31004495|NCT01777308|59205695|FG001|Overall Study|Migrated/moved from study area|0|||
31004496|NCT01777308|59205694|FG000|Overall Study|Lost to Follow-up|7|||
31004497|NCT01777308|59205695|FG001|Overall Study|Lost to Follow-up|2|||
30609034|NCT01285310|58619900|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
30790333|NCT03126110|58803536|FG001|Phase 1|Withdrawal by Subject|0|||
31004498|NCT01777308|59205694|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
31004499|NCT01777308|59205695|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
31004500|NCT01759368|59205704|FG000|Overall Study|Lost to Follow-up|1|||
31004501|NCT01759368|59205705|FG001|Overall Study|Lost to Follow-up|0|||
31004502|NCT01777152|59205715|FG000|Overall Study|Withdrawal by Subject|22|||
31004503|NCT01777152|59205716|FG001|Overall Study|Withdrawal by Subject|16|||
31004504|NCT01777152|59205715|FG000|Overall Study|Lost to Follow-up|3|||
31004505|NCT01777152|59205716|FG001|Overall Study|Lost to Follow-up|5|||
31004506|NCT01777152|59205715|FG000|Overall Study|Death|68|||
31004507|NCT01777152|59205716|FG001|Overall Study|Death|89|||
31004508|NCT01777152|59205715|FG000|Overall Study|Not eligible, no study drug received|1|||
31004509|NCT01777152|59205716|FG001|Overall Study|Not eligible, no study drug received|0|||
31004510|NCT01777152|59205715|FG000|Overall Study|Change of diagnosis|1|||
31004511|NCT01777152|59205716|FG001|Overall Study|Change of diagnosis|0|||
31004512|NCT01759290|59205723|FG000|Overall Study|Subjects withdrawn consent|5|||
31004513|NCT01759290|59205723|FG000|Overall Study|Physician Decision|2|||
31004514|NCT01759290|59205723|FG000|Overall Study|Death|17|||
31004515|NCT01759290|59205723|FG000|Overall Study|Lost to Follow-up|53|||
31004516|NCT01759290|59205723|FG000|Overall Study|Unknown reason|4|||
31004517|NCT01758900|59205729|FG000|Overall Study|difficulty for further intubation|7|||
31004518|NCT01758900|59205730|FG001|Overall Study|difficulty for further intubation|8|||
31004519|NCT01757184|59205738|FG000|Double-blind Period|Adverse Event|1|||
31004520|NCT01757184|59205739|FG001|Double-blind Period|Adverse Event|0|||
31004521|NCT01757184|59205740|FG002|Double-blind Period|Adverse Event|0|||
31004522|NCT01757184|59205741|FG003|Double-blind Period|Adverse Event|0|||
31004523|NCT01757184|59205738|FG000|Open-label Period|Lost to Follow-up|0|||
31004524|NCT01757184|59205739|FG001|Open-label Period|Lost to Follow-up|0|||
31004525|NCT01757184|59205740|FG002|Open-label Period|Lost to Follow-up|2|||
31004526|NCT01757184|59205741|FG003|Open-label Period|Lost to Follow-up|0|||
31004527|NCT01757184|59205738|FG000|Open-label Period|Withdrawal by Subject|0|||
31004528|NCT01757184|59205739|FG001|Open-label Period|Withdrawal by Subject|0|||
31004529|NCT01757184|59205740|FG002|Open-label Period|Withdrawal by Subject|1|||
31004530|NCT01757184|59205741|FG003|Open-label Period|Withdrawal by Subject|1|||
31004531|NCT01757184|59205738|FG000|Open-label Period|Discontinued by Sponsor|0|||
31004532|NCT01757184|59205739|FG001|Open-label Period|Discontinued by Sponsor|0|||
31004533|NCT01757184|59205740|FG002|Open-label Period|Discontinued by Sponsor|1|||
31004534|NCT01757184|59205741|FG003|Open-label Period|Discontinued by Sponsor|2|||
31004535|NCT01775904|59205755|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
31004536|NCT01775904|59205755|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
31004537|NCT01775670|59205767|FG000|Overall Study|Lost to Follow-up|1|||
31004538|NCT01775670|59205768|FG001|Overall Study|Lost to Follow-up|1|||
31004539|NCT01775124|59205776|FG000|Core Period|Disease Progression|0|||
31004540|NCT01775124|59205777|FG001|Core Period|Disease Progression|1|||
31004541|NCT01775124|59205776|FG000|Core Period|Physician Decision|1|||
31004542|NCT01775124|59205777|FG001|Core Period|Physician Decision|1|||
31004543|NCT01775124|59205776|FG000|Core Period|Death|0|||
31004544|NCT01775124|59205777|FG001|Core Period|Death|1|||
31004545|NCT01775124|59205776|FG000|Core Period|Administrative problems|1|||
31004546|NCT01775124|59205777|FG001|Core Period|Administrative problems|0|||
31004547|NCT01775124|59205776|FG000|Core Period|Withdrawal by Subject|4|||
31004548|NCT01775124|59205777|FG001|Core Period|Withdrawal by Subject|2|||
31004549|NCT01775124|59205776|FG000|Core Period|Adverse Event|5|||
31004550|NCT01775124|59205777|FG001|Core Period|Adverse Event|5|||
31004551|NCT01775124|59205776|FG000|Extension Period|Adverse Event|3|||
31004552|NCT01775124|59205777|FG001|Extension Period|Adverse Event|2|||
31004553|NCT01775124|59205776|FG000|Extension Period|Physician Decision|0|||
31004554|NCT01775124|59205777|FG001|Extension Period|Physician Decision|2|||
31004555|NCT01775124|59205776|FG000|Extension Period|Administrative problems|0|||
31004556|NCT01775124|59205777|FG001|Extension Period|Administrative problems|1|||
31004557|NCT01775124|59205776|FG000|Extension Period|Lost to Follow-up|0|||
31004558|NCT01775124|59205777|FG001|Extension Period|Lost to Follow-up|1|||
31004559|NCT01775124|59205776|FG000|Extension Period|Withdrawal by Subject|9|||
31004560|NCT01775124|59205777|FG001|Extension Period|Withdrawal by Subject|12|||
31004561|NCT01733316|59205784|FG000|RP103 Phase|Non-compliance|1|||
31004562|NCT01733316|59205784|FG000|Long Term Extension Phase|Adverse Event|1|||
31004563|NCT01733316|59205784|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
31004564|NCT01733316|59205784|FG000|Long Term Extension Phase|Sponsor Decision|2|||
31004565|NCT01732926|59205797|FG000|Overall Study|Study Terminated by Sponsor|168|||
31004566|NCT01732926|59205798|FG001|Overall Study|Study Terminated by Sponsor|80|||
31004567|NCT01732926|59205797|FG000|Overall Study|Withdrawal by Subject|46|||
31004568|NCT01732926|59205798|FG001|Overall Study|Withdrawal by Subject|8|||
31004569|NCT01732926|59205797|FG000|Overall Study|Physician Decision|24|||
31004570|NCT01732926|59205798|FG001|Overall Study|Physician Decision|11|||
31004571|NCT01732926|59205797|FG000|Overall Study|Other Reason|21|||
31004572|NCT01732926|59205798|FG001|Overall Study|Other Reason|4|||
31004573|NCT01732926|59205797|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
31004574|NCT01732926|59205798|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
31004575|NCT01732926|59205797|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
31004576|NCT01732926|59205798|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
31004577|NCT01755858|59205806|FG000|Overall Study|Adverse Event|1|||
31004578|NCT01755858|59205807|FG001|Overall Study|Adverse Event|1|||
31004579|NCT01732770|59205817|FG000|Overall Study|Lost to Follow-up|2|||
31004580|NCT01732770|59205818|FG001|Overall Study|Lost to Follow-up|3|||
31004581|NCT01732770|59205817|FG000|Overall Study|Withdrawal by Subject|5|||
31004582|NCT01732770|59205818|FG001|Overall Study|Withdrawal by Subject|3|||
31004583|NCT01732770|59205817|FG000|Overall Study|Decision by Sponsor|2|||
31004584|NCT01732770|59205818|FG001|Overall Study|Decision by Sponsor|2|||
31004585|NCT01732770|59205817|FG000|Overall Study|Death|1|||
31004586|NCT01732770|59205818|FG001|Overall Study|Death|0|||
31004587|NCT01732692|59205826|FG000|Overall Study|Adverse Event|0|||
31004588|NCT01732692|59205827|FG001|Overall Study|Adverse Event|1|||
31004589|NCT01774968|59205835|FG000|Overall Study|Adverse Event|4|||
31004590|NCT01774968|59205836|FG001|Overall Study|Adverse Event|4|||
31004591|NCT01774968|59205835|FG000|Overall Study|Death|0|||
31004592|NCT01774968|59205836|FG001|Overall Study|Death|1|||
31004593|NCT01774968|59205835|FG000|Overall Study|Lost to Follow-up|1|||
31004594|NCT01774968|59205836|FG001|Overall Study|Lost to Follow-up|3|||
31004595|NCT01774968|59205835|FG000|Overall Study|Physician Decision|5|||
31004596|NCT01774968|59205836|FG001|Overall Study|Physician Decision|1|||
31004597|NCT01774968|59205835|FG000|Overall Study|Protocol Violation|14|||
31004598|NCT01774968|59205836|FG001|Overall Study|Protocol Violation|13|||
31004599|NCT01774968|59205835|FG000|Overall Study|Sponsor Decision|0|||
31004600|NCT01774968|59205836|FG001|Overall Study|Sponsor Decision|2|||
31004601|NCT01774968|59205835|FG000|Overall Study|Withdrawal by Subject|6|||
31004602|NCT01774968|59205836|FG001|Overall Study|Withdrawal by Subject|11|||
31004603|NCT01774344|59205844|FG000|Overall Study|Withdrawal by Subject|3|||
31004604|NCT01774344|59205845|FG001|Overall Study|Withdrawal by Subject|10|||
31004605|NCT01774344|59205844|FG000|Overall Study|Protocol Violation|0|||
31004606|NCT01774344|59205845|FG001|Overall Study|Protocol Violation|1|||
31004607|NCT01774344|59205844|FG000|Overall Study|Lost to Follow-up|4|||
31004608|NCT01774344|59205845|FG001|Overall Study|Lost to Follow-up|10|||
31004609|NCT01774344|59205844|FG000|Overall Study|End of survival follow-up not available|2|||
31004610|NCT01774344|59205845|FG001|Overall Study|End of survival follow-up not available|2|||
31004611|NCT01774344|59205844|FG000|Overall Study|Data collection finished|4|||
31004612|NCT01774344|59205845|FG001|Overall Study|Data collection finished|14|||
31004613|NCT01774344|59205844|FG000|Overall Study|Other|0|||
31004614|NCT01774344|59205845|FG001|Overall Study|Other|1|||
31004615|NCT01774344|59205844|FG000|Overall Study|Did not enter Survival Follow up|49|||
31004616|NCT01774344|59205845|FG001|Overall Study|Did not enter Survival Follow up|83|||
31004617|NCT01732536|59205853|FG000|Overall Study|Withdrawal by Subject|1|||
31004618|NCT01732536|59205854|FG001|Overall Study|Withdrawal by Subject|1|||
31004619|NCT01755702|59205863|FG000|Wash Out Period I|Other Reason|3|||
31004620|NCT01755702|59205863|FG000|Washout Period II|Other Reason|5|||
31004621|NCT01732458|59205877|FG000|Overall Study|Lost to Follow-up|0|||
31004622|NCT01732458|59205878|FG001|Overall Study|Lost to Follow-up|2|||
31004623|NCT01732458|59205879|FG002|Overall Study|Lost to Follow-up|0|||
31004624|NCT01732458|59205880|FG003|Overall Study|Lost to Follow-up|0|||
31004625|NCT01732458|59205877|FG000|Overall Study|Non-Compliance With Study Drug|0|||
31004626|NCT01732458|59205878|FG001|Overall Study|Non-Compliance With Study Drug|0|||
31004627|NCT01732458|59205879|FG002|Overall Study|Non-Compliance With Study Drug|1|||
31004628|NCT01732458|59205880|FG003|Overall Study|Non-Compliance With Study Drug|0|||
31004629|NCT01732458|59205877|FG000|Overall Study|Physician Decision|1|||
31004630|NCT01732458|59205878|FG001|Overall Study|Physician Decision|2|||
31004631|NCT01732458|59205879|FG002|Overall Study|Physician Decision|2|||
31004632|NCT01732458|59205880|FG003|Overall Study|Physician Decision|0|||
31004633|NCT01732458|59205877|FG000|Overall Study|Protocol Violation|2|||
31004634|NCT01732458|59205878|FG001|Overall Study|Protocol Violation|0|||
31004635|NCT01732458|59205879|FG002|Overall Study|Protocol Violation|0|||
31004636|NCT01732458|59205880|FG003|Overall Study|Protocol Violation|2|||
31004637|NCT01732458|59205877|FG000|Overall Study|Screen Failure|0|||
31004638|NCT01732458|59205878|FG001|Overall Study|Screen Failure|1|||
31004639|NCT01732458|59205879|FG002|Overall Study|Screen Failure|0|||
30609035|NCT01285310|58619901|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
30609036|NCT01285310|58619902|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
31004640|NCT01732458|59205880|FG003|Overall Study|Screen Failure|0|||
31004641|NCT01731990|59205904|FG000|Overall Study|Adverse Event|1|||
31004642|NCT01731990|59205905|FG001|Overall Study|Adverse Event|5|||
31004643|NCT01731990|59205904|FG000|Overall Study|Withdrawal by Subject|1|||
31004644|NCT01731990|59205905|FG001|Overall Study|Withdrawal by Subject|1|||
31004645|NCT01731990|59205904|FG000|Overall Study|Protocol deviation|1|||
31004646|NCT01731990|59205905|FG001|Overall Study|Protocol deviation|2|||
31004647|NCT01731990|59205904|FG000|Overall Study|Death|1|||
31004648|NCT01731990|59205905|FG001|Overall Study|Death|0|||
31004649|NCT01708902|59205918|FG000|Overall Study|Adverse Event|3|||
31004650|NCT01708902|59205919|FG001|Overall Study|Adverse Event|4|||
31004651|NCT01708902|59205920|FG002|Overall Study|Adverse Event|9|||
31004652|NCT01708902|59205921|FG003|Overall Study|Adverse Event|2|||
31004653|NCT01708902|59205922|FG004|Overall Study|Adverse Event|7|||
31004654|NCT01708902|59205923|FG005|Overall Study|Adverse Event|3|||
31004655|NCT01708902|59205924|FG006|Overall Study|Adverse Event|5|||
31004656|NCT01708902|59205918|FG000|Overall Study|Lack of Efficacy|3|||
31004657|NCT01708902|59205919|FG001|Overall Study|Lack of Efficacy|1|||
31004658|NCT01708902|59205920|FG002|Overall Study|Lack of Efficacy|0|||
31004659|NCT01708902|59205921|FG003|Overall Study|Lack of Efficacy|0|||
31004660|NCT01708902|59205922|FG004|Overall Study|Lack of Efficacy|0|||
31004661|NCT01708902|59205923|FG005|Overall Study|Lack of Efficacy|1|||
31004662|NCT01708902|59205924|FG006|Overall Study|Lack of Efficacy|0|||
31004663|NCT01708902|59205918|FG000|Overall Study|Non compliance with protocol|0|||
31004664|NCT01708902|59205919|FG001|Overall Study|Non compliance with protocol|2|||
31004665|NCT01708902|59205920|FG002|Overall Study|Non compliance with protocol|1|||
31004666|NCT01708902|59205921|FG003|Overall Study|Non compliance with protocol|3|||
31004667|NCT01708902|59205922|FG004|Overall Study|Non compliance with protocol|0|||
31004668|NCT01708902|59205923|FG005|Overall Study|Non compliance with protocol|0|||
31004669|NCT01708902|59205924|FG006|Overall Study|Non compliance with protocol|0|||
31004670|NCT01708902|59205918|FG000|Overall Study|Lost to Follow-up|2|||
31004671|NCT01708902|59205919|FG001|Overall Study|Lost to Follow-up|1|||
31004672|NCT01708902|59205920|FG002|Overall Study|Lost to Follow-up|2|||
31004673|NCT01708902|59205921|FG003|Overall Study|Lost to Follow-up|2|||
31004674|NCT01708902|59205922|FG004|Overall Study|Lost to Follow-up|0|||
31004675|NCT01708902|59205923|FG005|Overall Study|Lost to Follow-up|0|||
31004676|NCT01708902|59205924|FG006|Overall Study|Lost to Follow-up|1|||
31004677|NCT01708902|59205918|FG000|Overall Study|Refused to continue trial medication|8|||
31004678|NCT01708902|59205919|FG001|Overall Study|Refused to continue trial medication|0|||
31004679|NCT01708902|59205920|FG002|Overall Study|Refused to continue trial medication|4|||
31004680|NCT01708902|59205921|FG003|Overall Study|Refused to continue trial medication|2|||
31004681|NCT01708902|59205922|FG004|Overall Study|Refused to continue trial medication|8|||
31004682|NCT01708902|59205923|FG005|Overall Study|Refused to continue trial medication|1|||
31004683|NCT01708902|59205924|FG006|Overall Study|Refused to continue trial medication|1|||
31004684|NCT01708902|59205918|FG000|Overall Study|Other Reason|1|||
31004685|NCT01708902|59205919|FG001|Overall Study|Other Reason|0|||
31004686|NCT01708902|59205920|FG002|Overall Study|Other Reason|1|||
31004687|NCT01708902|59205921|FG003|Overall Study|Other Reason|1|||
31004688|NCT01708902|59205922|FG004|Overall Study|Other Reason|1|||
31004689|NCT01708902|59205923|FG005|Overall Study|Other Reason|2|||
31004690|NCT01708902|59205924|FG006|Overall Study|Other Reason|0|||
31004691|NCT01755546|59205943|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
31004692|NCT01755546|59205943|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
31004693|NCT01755546|59205943|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
31004694|NCT01755546|59205943|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
31004695|NCT01755546|59205943|FG000|Titration Phase|Adverse Event|11|||
31004696|NCT01755546|59205943|FG000|Titration Phase|Lack of Efficacy|18|||
31004697|NCT01755546|59205943|FG000|Titration Phase|Protocol Violation|9|||
31004698|NCT01755546|59205943|FG000|Titration Phase|Lost to Follow-up|2|||
31004699|NCT01755546|59205943|FG000|Titration Phase|Other and Continuing|22|||
31004700|NCT01755546|59205943|FG000|Titration Phase|Withdrawal by Subject|8|||
31004701|NCT01755546|59205943|FG000|Long Term Treatment|Adverse Event|12|||
31004702|NCT01755546|59205943|FG000|Long Term Treatment|Lack of Efficacy|6|||
31004703|NCT01755546|59205943|FG000|Long Term Treatment|Protocol Violation|10|||
31004704|NCT01755546|59205943|FG000|Long Term Treatment|Withdrawal by Subject|35|||
31004705|NCT01755546|59205943|FG000|Long Term Treatment|Lost to Follow-up|17|||
31004706|NCT01755546|59205943|FG000|Long Term Treatment|other and ongoing|41|||
31004707|NCT01755234|59205949|FG000|Overall Study|Lost to Follow-up|11|||
31004708|NCT01755234|59205950|FG001|Overall Study|Lost to Follow-up|6|||
31004709|NCT01755234|59205949|FG000|Overall Study|Change in surgical case|2|||
31004710|NCT01755234|59205950|FG001|Overall Study|Change in surgical case|1|||
31004711|NCT01755234|59205949|FG000|Overall Study|case cancelled|1|||
31004712|NCT01755234|59205950|FG001|Overall Study|case cancelled|0|||
31004713|NCT01755234|59205949|FG000|Overall Study|Withdrawal by Subject|0|||
31004714|NCT01755234|59205950|FG001|Overall Study|Withdrawal by Subject|1|||
31004715|NCT01755234|59205949|FG000|Overall Study|unblinded|1|||
31004716|NCT01755234|59205950|FG001|Overall Study|unblinded|0|||
31004717|NCT01731912|59205956|FG000|Overall Study|noncompliance|2|||
31004718|NCT01731678|59205960|FG000|Overall Study|Withdrawal by Subject|3|||
31004719|NCT01731678|59205960|FG000|Overall Study|Did not meet inclusion criteria|1|||
31004720|NCT01731678|59205960|FG000|Overall Study|RMT too high, making TMS difficult|3|||
31004721|NCT01731600|59205966|FG000|Overall Study|Adverse Event|2|||
31004722|NCT01731600|59205967|FG001|Overall Study|Adverse Event|0|||
31004723|NCT01731600|59205966|FG000|Overall Study|Withdrawal criteria|1|||
31004724|NCT01731600|59205967|FG001|Overall Study|Withdrawal criteria|0|||
31004725|NCT01731600|59205966|FG000|Overall Study|Other reasons|3|||
31004726|NCT01731600|59205967|FG001|Overall Study|Other reasons|0|||
31004727|NCT01730586|59205977|FG000|Overall Study|Progressive Disease|2|||
31004728|NCT01730586|59205977|FG000|Overall Study|Inadequate Trial|8|||
31004729|NCT01730586|59205977|FG000|Overall Study|Adverse Event|2|||
31004730|NCT01730586|59205977|FG000|Overall Study|Hospice|1|||
31004731|NCT01707030|59205985|FG000|Overall Study|Death|1|||
31004732|NCT01707030|59205986|FG001|Overall Study|Death|1|||
31004733|NCT01707030|59205985|FG000|Overall Study|Withdrawal by Subject|2|||
31004734|NCT01707030|59205986|FG001|Overall Study|Withdrawal by Subject|3|||
31004735|NCT01707030|59205985|FG000|Overall Study|Lost to Follow-up|8|||
31004736|NCT01707030|59205986|FG001|Overall Study|Lost to Follow-up|13|||
31004737|NCT01755156|59205998|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
31004738|NCT01755156|59205999|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
31004739|NCT01755156|59205998|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
31004740|NCT01755156|59205999|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
31004741|NCT01755156|59205998|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
31004742|NCT01755156|59205999|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
31004743|NCT01755156|59205998|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
31004744|NCT01755156|59205999|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
31004745|NCT01755156|59205998|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
31004746|NCT01755156|59205999|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
31004747|NCT01755156|59205998|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
31004748|NCT01755156|59205999|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
31004749|NCT01755156|59205998|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
31004750|NCT01755156|59205999|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
31004751|NCT01755156|59205998|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
31004752|NCT01755156|59205999|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
31004753|NCT01755156|59205998|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
31004754|NCT01755156|59205999|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
31004755|NCT01755156|59205998|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
31004756|NCT01755156|59205999|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
31004757|NCT01755156|59205998|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
31004758|NCT01755156|59205999|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
31004759|NCT01754922|59206011|FG000|Overall Study|Adverse Event|0|||
31004760|NCT01754922|59206012|FG001|Overall Study|Adverse Event|1|||
31004761|NCT01754766|59206022|FG000|Overall Study|Personal reasons|1|||
31004762|NCT01754766|59206023|FG001|Overall Study|Personal reasons|1|||
31004763|NCT01754766|59206024|FG002|Overall Study|Personal reasons|0|||
31004764|NCT01754376|59206032|FG000|Overall Study|Adverse Event|1|||
31004765|NCT01754376|59206032|FG000|Overall Study|Lack of Efficacy|2|||
31004766|NCT01605396|59206039|FG000|Overall Study|Adverse Event|5|||
31004767|NCT01605396|59206040|FG001|Overall Study|Adverse Event|3|||
31004768|NCT01605396|59206039|FG000|Overall Study|Lost to Follow-up|1|||
31004769|NCT01605396|59206040|FG001|Overall Study|Lost to Follow-up|0|||
31004770|NCT01605396|59206039|FG000|Overall Study|Non-Compliance With Study Drug|1|||
31004771|NCT01605396|59206040|FG001|Overall Study|Non-Compliance With Study Drug|1|||
31004772|NCT01605396|59206039|FG000|Overall Study|Physician Decision|2|||
31004773|NCT01605396|59206040|FG001|Overall Study|Physician Decision|2|||
31004774|NCT01605396|59206039|FG000|Overall Study|Progressive Disease|23|||
31004775|NCT01605396|59206040|FG001|Overall Study|Progressive Disease|27|||
31004776|NCT01605396|59206039|FG000|Overall Study|Withdrawal by Subject|4|||
31004777|NCT01605396|59206040|FG001|Overall Study|Withdrawal by Subject|2|||
31004778|NCT01605396|59206039|FG000|Overall Study|Transfer Off Study|4|||
31004779|NCT01605396|59206040|FG001|Overall Study|Transfer Off Study|5|||
31004780|NCT01730118|59206053|FG000|Dose Escalation|Death on study|5|||
31004781|NCT01730118|59206054|FG001|Dose Escalation|Death on study|7|||
31004782|NCT01730118|59206055|FG002|Dose Escalation|Death on study|2|||
31004783|NCT01730118|59206056|FG003|Dose Escalation|Death on study|6|||
31004784|NCT01730118|59206057|FG004|Dose Escalation|Death on study|0|||
31004785|NCT01730118|59206058|FG005|Dose Escalation|Death on study|0|||
31004786|NCT01730118|59206059|FG006|Dose Escalation|Death on study|0|||
31004787|NCT01730118|59206053|FG000|Dose Escalation|Died before treatment|0|||
31004788|NCT01730118|59206054|FG001|Dose Escalation|Died before treatment|0|||
31004789|NCT01730118|59206055|FG002|Dose Escalation|Died before treatment|0|||
31004790|NCT01730118|59206056|FG003|Dose Escalation|Died before treatment|0|||
31004791|NCT01730118|59206057|FG004|Dose Escalation|Died before treatment|0|||
31004792|NCT01730118|59206058|FG005|Dose Escalation|Died before treatment|0|||
31004793|NCT01730118|59206059|FG006|Dose Escalation|Died before treatment|1|||
31004794|NCT01730118|59206053|FG000|Dose Escalation|Chose to start a different treatment|1|||
31004795|NCT01730118|59206054|FG001|Dose Escalation|Chose to start a different treatment|0|||
31004796|NCT01730118|59206055|FG002|Dose Escalation|Chose to start a different treatment|0|||
31004797|NCT01730118|59206056|FG003|Dose Escalation|Chose to start a different treatment|0|||
31004798|NCT01730118|59206057|FG004|Dose Escalation|Chose to start a different treatment|0|||
31004799|NCT01730118|59206058|FG005|Dose Escalation|Chose to start a different treatment|0|||
31004800|NCT01730118|59206059|FG006|Dose Escalation|Chose to start a different treatment|0|||
31004801|NCT01730118|59206053|FG000|Dose Escalation|Withdrawal by Subject|0|||
31004802|NCT01730118|59206054|FG001|Dose Escalation|Withdrawal by Subject|0|||
31004803|NCT01730118|59206055|FG002|Dose Escalation|Withdrawal by Subject|1|||
31004804|NCT01730118|59206056|FG003|Dose Escalation|Withdrawal by Subject|0|||
31004805|NCT01730118|59206057|FG004|Dose Escalation|Withdrawal by Subject|0|||
31004806|NCT01730118|59206058|FG005|Dose Escalation|Withdrawal by Subject|0|||
31004807|NCT01730118|59206059|FG006|Dose Escalation|Withdrawal by Subject|0|||
31004808|NCT01730118|59206053|FG000|Dose Escalation|Disease progression prior to treatment|0|||
31004809|NCT01730118|59206054|FG001|Dose Escalation|Disease progression prior to treatment|0|||
31004810|NCT01730118|59206055|FG002|Dose Escalation|Disease progression prior to treatment|0|||
31004811|NCT01730118|59206056|FG003|Dose Escalation|Disease progression prior to treatment|0|||
31004812|NCT01730118|59206057|FG004|Dose Escalation|Disease progression prior to treatment|0|||
31004813|NCT01730118|59206058|FG005|Dose Escalation|Disease progression prior to treatment|0|||
31004814|NCT01730118|59206059|FG006|Dose Escalation|Disease progression prior to treatment|1|||
31004815|NCT01730118|59206053|FG000|Dose Expansion|Death|0|||
31004816|NCT01730118|59206054|FG001|Dose Expansion|Death|0|||
31004817|NCT01730118|59206055|FG002|Dose Expansion|Death|0|||
31004818|NCT01730118|59206056|FG003|Dose Expansion|Death|0|||
31004819|NCT01730118|59206057|FG004|Dose Expansion|Death|1|||
31004820|NCT01730118|59206058|FG005|Dose Expansion|Death|0|||
31004821|NCT01730118|59206059|FG006|Dose Expansion|Death|0|||
31004822|NCT01730118|59206053|FG000|Dose Expansion|Other medical condition|0|||
31004823|NCT01730118|59206054|FG001|Dose Expansion|Other medical condition|0|||
31004824|NCT01730118|59206055|FG002|Dose Expansion|Other medical condition|0|||
31004825|NCT01730118|59206056|FG003|Dose Expansion|Other medical condition|0|||
31004826|NCT01730118|59206057|FG004|Dose Expansion|Other medical condition|1|||
31004827|NCT01730118|59206058|FG005|Dose Expansion|Other medical condition|0|||
31004828|NCT01730118|59206059|FG006|Dose Expansion|Other medical condition|0|||
31004829|NCT01730118|59206053|FG000|Dose Expansion|Withdrawal by Subject|0|||
31004830|NCT01730118|59206054|FG001|Dose Expansion|Withdrawal by Subject|0|||
31004831|NCT01730118|59206055|FG002|Dose Expansion|Withdrawal by Subject|0|||
31004832|NCT01730118|59206056|FG003|Dose Expansion|Withdrawal by Subject|0|||
31004833|NCT01730118|59206057|FG004|Dose Expansion|Withdrawal by Subject|1|||
31004834|NCT01730118|59206058|FG005|Dose Expansion|Withdrawal by Subject|0|||
31004835|NCT01730118|59206059|FG006|Dose Expansion|Withdrawal by Subject|0|||
31004836|NCT01730118|59206053|FG000|Dose Expansion|Disease progression|0|||
31004837|NCT01730118|59206054|FG001|Dose Expansion|Disease progression|0|||
31004838|NCT01730118|59206055|FG002|Dose Expansion|Disease progression|0|||
31004839|NCT01730118|59206056|FG003|Dose Expansion|Disease progression|0|||
31004840|NCT01730118|59206057|FG004|Dose Expansion|Disease progression|0|||
31004841|NCT01730118|59206058|FG005|Dose Expansion|Disease progression|1|||
31004842|NCT01730118|59206059|FG006|Dose Expansion|Disease progression|0|||
31004843|NCT01730118|59206053|FG000|Dose Expansion|Inability to return|0|||
31004844|NCT01730118|59206054|FG001|Dose Expansion|Inability to return|0|||
31004845|NCT01730118|59206055|FG002|Dose Expansion|Inability to return|0|||
31004846|NCT01730118|59206056|FG003|Dose Expansion|Inability to return|0|||
31004847|NCT01730118|59206057|FG004|Dose Expansion|Inability to return|0|||
31004848|NCT01730118|59206058|FG005|Dose Expansion|Inability to return|1|||
31004849|NCT01730118|59206059|FG006|Dose Expansion|Inability to return|0|||
31004850|NCT01730118|59206053|FG000|Dose Expansion|Physician Decision|0|||
31004851|NCT01730118|59206054|FG001|Dose Expansion|Physician Decision|0|||
31004852|NCT01730118|59206055|FG002|Dose Expansion|Physician Decision|0|||
31004853|NCT01730118|59206056|FG003|Dose Expansion|Physician Decision|0|||
31004854|NCT01730118|59206057|FG004|Dose Expansion|Physician Decision|0|||
31004855|NCT01730118|59206058|FG005|Dose Expansion|Physician Decision|1|||
31004856|NCT01730118|59206059|FG006|Dose Expansion|Physician Decision|0|||
31004857|NCT01730040|59206083|FG000|Overall Study|Randomized but not treated|0|||
31004858|NCT01730040|59206084|FG001|Overall Study|Randomized but not treated|0|||
31004859|NCT01730040|59206085|FG002|Overall Study|Randomized but not treated|0|||
31004860|NCT01730040|59206086|FG003|Overall Study|Randomized but not treated|0|||
31004861|NCT01730040|59206087|FG004|Overall Study|Randomized but not treated|0|||
31004862|NCT01730040|59206088|FG005|Overall Study|Randomized but not treated|1|||
31004863|NCT01730040|59206089|FG006|Overall Study|Randomized but not treated|0|||
31004864|NCT01730040|59206083|FG000|Overall Study|Subject moved|0|||
31004865|NCT01730040|59206084|FG001|Overall Study|Subject moved|0|||
31004866|NCT01730040|59206085|FG002|Overall Study|Subject moved|1|||
31004867|NCT01730040|59206086|FG003|Overall Study|Subject moved|0|||
31004868|NCT01730040|59206087|FG004|Overall Study|Subject moved|0|||
31004869|NCT01730040|59206088|FG005|Overall Study|Subject moved|0|||
31004870|NCT01730040|59206089|FG006|Overall Study|Subject moved|1|||
31004871|NCT01730040|59206083|FG000|Overall Study|Physician Decision|0|||
31004872|NCT01730040|59206084|FG001|Overall Study|Physician Decision|0|||
31004873|NCT01730040|59206085|FG002|Overall Study|Physician Decision|0|||
31004874|NCT01730040|59206086|FG003|Overall Study|Physician Decision|0|||
31004875|NCT01730040|59206087|FG004|Overall Study|Physician Decision|0|||
31004876|NCT01730040|59206088|FG005|Overall Study|Physician Decision|1|||
31004877|NCT01730040|59206089|FG006|Overall Study|Physician Decision|1|||
31004878|NCT01730040|59206083|FG000|Overall Study|Other than specified|7|||
31004879|NCT01730040|59206084|FG001|Overall Study|Other than specified|8|||
31004880|NCT01730040|59206085|FG002|Overall Study|Other than specified|5|||
31004881|NCT01730040|59206086|FG003|Overall Study|Other than specified|5|||
31004882|NCT01730040|59206087|FG004|Overall Study|Other than specified|5|||
31004883|NCT01730040|59206088|FG005|Overall Study|Other than specified|4|||
31004884|NCT01730040|59206089|FG006|Overall Study|Other than specified|4|||
31004885|NCT01730040|59206083|FG000|Overall Study|Adverse Event|4|||
31004886|NCT01730040|59206084|FG001|Overall Study|Adverse Event|3|||
31004887|NCT01730040|59206085|FG002|Overall Study|Adverse Event|5|||
31004888|NCT01730040|59206086|FG003|Overall Study|Adverse Event|3|||
31004889|NCT01730040|59206087|FG004|Overall Study|Adverse Event|1|||
31004890|NCT01730040|59206088|FG005|Overall Study|Adverse Event|1|||
31004891|NCT01730040|59206089|FG006|Overall Study|Adverse Event|2|||
31004892|NCT01730040|59206083|FG000|Overall Study|Poor compliance to protocol|2|||
31004893|NCT01730040|59206084|FG001|Overall Study|Poor compliance to protocol|4|||
31004894|NCT01730040|59206085|FG002|Overall Study|Poor compliance to protocol|0|||
31004895|NCT01730040|59206086|FG003|Overall Study|Poor compliance to protocol|0|||
31004896|NCT01730040|59206087|FG004|Overall Study|Poor compliance to protocol|0|||
31004897|NCT01730040|59206088|FG005|Overall Study|Poor compliance to protocol|0|||
31004898|NCT01730040|59206089|FG006|Overall Study|Poor compliance to protocol|1|||
31004899|NCT01706328|59206107|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
31004900|NCT01706328|59206108|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
31004901|NCT01706328|59206109|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
31004902|NCT01706328|59206107|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
31004903|NCT01706328|59206108|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
31004904|NCT01706328|59206109|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
31004905|NCT01706328|59206107|FG000|2-week Run-in Period|Physician Decision|4|||
31004906|NCT01706328|59206108|FG001|2-week Run-in Period|Physician Decision|0|||
31004907|NCT01706328|59206109|FG002|2-week Run-in Period|Physician Decision|0|||
31004908|NCT01706328|59206107|FG000|2-week Run-in Period|Adverse Event|4|||
31004909|NCT01706328|59206108|FG001|2-week Run-in Period|Adverse Event|0|||
31004910|NCT01706328|59206109|FG002|2-week Run-in Period|Adverse Event|0|||
31004911|NCT01706328|59206107|FG000|2-week Run-in Period|Lost to Follow-up|2|||
31004912|NCT01706328|59206108|FG001|2-week Run-in Period|Lost to Follow-up|0|||
31004913|NCT01706328|59206109|FG002|2-week Run-in Period|Lost to Follow-up|0|||
31004914|NCT01706328|59206107|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
31004915|NCT01706328|59206108|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
31004916|NCT01706328|59206109|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
31004917|NCT01706328|59206107|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
31004918|NCT01706328|59206108|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
31004919|NCT01706328|59206109|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
31004920|NCT01706328|59206107|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
31004921|NCT01706328|59206108|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
31004922|NCT01706328|59206109|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
31004923|NCT01706328|59206107|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
31004924|NCT01706328|59206108|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
31004925|NCT01706328|59206109|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
31004926|NCT01706328|59206107|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
31004927|NCT01706328|59206108|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
31004928|NCT01706328|59206109|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
31004929|NCT01706328|59206107|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
31004930|NCT01706328|59206108|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
31004931|NCT01706328|59206109|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
31004932|NCT01706328|59206107|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
31004933|NCT01706328|59206108|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
31004934|NCT01706328|59206109|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
31004935|NCT01753518|59206117|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
31004936|NCT01753518|59206118|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
31004937|NCT01753518|59206117|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
31004938|NCT01753518|59206118|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
31004939|NCT01753518|59206117|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
31004940|NCT01753518|59206118|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
31004941|NCT01753518|59206117|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
31004942|NCT01753518|59206118|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
31004943|NCT01706250|59206124|FG000|Overall Study|Lost to Follow-up|2|||
31004944|NCT01729728|59206136|FG000|Overall Study|Adverse Event|0|||
31004945|NCT01729728|59206137|FG001|Overall Study|Adverse Event|6|||
31004946|NCT01729728|59206138|FG002|Overall Study|Adverse Event|0|||
31004947|NCT01729728|59206136|FG000|Overall Study|Protocol Violation|1|||
31004948|NCT01729728|59206137|FG001|Overall Study|Protocol Violation|0|||
31004949|NCT01729728|59206138|FG002|Overall Study|Protocol Violation|1|||
31004950|NCT01729026|59206271|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
31004951|NCT01729026|59206272|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
31004952|NCT01729026|59206271|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
31004953|NCT01729026|59206272|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
31004954|NCT01728792|59206286|FG000|Overall Study|Withdrawal of Consent|1|||
31004955|NCT01728792|59206287|FG001|Overall Study|Withdrawal of Consent|1|||
31004956|NCT01728792|59206288|FG002|Overall Study|Withdrawal of Consent|0|||
31004957|NCT01728792|59206289|FG003|Overall Study|Withdrawal of Consent|1|||
31004958|NCT01728792|59206290|FG004|Overall Study|Withdrawal of Consent|0|||
31004959|NCT01728792|59206286|FG000|Overall Study|Lost to Follow-up|2|||
31004960|NCT01728792|59206287|FG001|Overall Study|Lost to Follow-up|1|||
31004961|NCT01728792|59206288|FG002|Overall Study|Lost to Follow-up|4|||
31004962|NCT01728792|59206289|FG003|Overall Study|Lost to Follow-up|2|||
31004963|NCT01728792|59206290|FG004|Overall Study|Lost to Follow-up|0|||
31004964|NCT01752036|59206302|FG000|Overall Study|Death|2|||
31004965|NCT01728324|59206310|FG000|Termination of DBV|Adverse Event|14|||
31004966|NCT01728324|59206311|FG001|Termination of DBV|Adverse Event|13|||
31004967|NCT01728324|59206312|FG002|Termination of DBV|Adverse Event|4|||
31004968|NCT01728324|59206310|FG000|Termination of DBV|Lack of Efficacy|14|||
31004969|NCT01728324|59206311|FG001|Termination of DBV|Lack of Efficacy|12|||
31004970|NCT01728324|59206312|FG002|Termination of DBV|Lack of Efficacy|8|||
31004971|NCT01728324|59206310|FG000|Termination of DBV|Withdrawal by Subject|9|||
31004972|NCT01728324|59206311|FG001|Termination of DBV|Withdrawal by Subject|6|||
31004973|NCT01728324|59206312|FG002|Termination of DBV|Withdrawal by Subject|2|||
31004974|NCT01728324|59206310|FG000|Termination of DBV|Other than stated|1|||
31004975|NCT01728324|59206311|FG001|Termination of DBV|Other than stated|3|||
31004976|NCT01728324|59206312|FG002|Termination of DBV|Other than stated|0|||
31004977|NCT01728324|59206310|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
31004978|NCT01728324|59206311|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
31004979|NCT01728324|59206312|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
31004980|NCT01728324|59206310|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
31004981|NCT01728324|59206311|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
31004982|NCT01728324|59206312|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
31004983|NCT01728324|59206310|FG000|Termination of FDV|Adverse Event|14|||
31004984|NCT01728324|59206311|FG001|Termination of FDV|Adverse Event|13|||
31004985|NCT01728324|59206312|FG002|Termination of FDV|Adverse Event|4|||
31004986|NCT01728324|59206310|FG000|Termination of FDV|Lack of Efficacy|14|||
31004987|NCT01728324|59206311|FG001|Termination of FDV|Lack of Efficacy|12|||
31004988|NCT01728324|59206312|FG002|Termination of FDV|Lack of Efficacy|8|||
31004989|NCT01728324|59206310|FG000|Termination of FDV|Withdrawal by Subject|9|||
31004990|NCT01728324|59206311|FG001|Termination of FDV|Withdrawal by Subject|6|||
31004991|NCT01728324|59206312|FG002|Termination of FDV|Withdrawal by Subject|2|||
31004992|NCT01728324|59206310|FG000|Termination of FDV|Other than stated|1|||
31004993|NCT01728324|59206311|FG001|Termination of FDV|Other than stated|3|||
31004994|NCT01728324|59206312|FG002|Termination of FDV|Other than stated|0|||
31004995|NCT01728324|59206310|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
31004996|NCT01728324|59206311|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
31004997|NCT01728324|59206312|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
31004998|NCT01728324|59206310|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
31004999|NCT01728324|59206311|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
31005000|NCT01728324|59206312|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
31005001|NCT01728324|59206310|FG000|Termination of RBV|Adverse Event|15|||
31005002|NCT01728324|59206311|FG001|Termination of RBV|Adverse Event|16|||
31005003|NCT01728324|59206312|FG002|Termination of RBV|Adverse Event|5|||
31005004|NCT01728324|59206310|FG000|Termination of RBV|Lack of Efficacy|14|||
31005005|NCT01728324|59206311|FG001|Termination of RBV|Lack of Efficacy|11|||
31005006|NCT01728324|59206312|FG002|Termination of RBV|Lack of Efficacy|7|||
31005007|NCT01728324|59206310|FG000|Termination of RBV|Withdrawal by Subject|9|||
31005008|NCT01728324|59206311|FG001|Termination of RBV|Withdrawal by Subject|5|||
31005009|NCT01728324|59206312|FG002|Termination of RBV|Withdrawal by Subject|2|||
31005010|NCT01728324|59206310|FG000|Termination of RBV|Other than stated|1|||
31005011|NCT01728324|59206311|FG001|Termination of RBV|Other than stated|3|||
31005012|NCT01728324|59206312|FG002|Termination of RBV|Other than stated|1|||
31005013|NCT01728324|59206310|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
31005014|NCT01728324|59206311|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
31005015|NCT01728324|59206312|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
31005016|NCT01728324|59206310|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
31005017|NCT01728324|59206311|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
31005018|NCT01728324|59206312|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
31005019|NCT01728246|59206324|FG000|Overall Study|Participant needed rescue medication|1|||
31005020|NCT01728246|59206325|FG001|Overall Study|Participant needed rescue medication|5|||
31005021|NCT01728246|59206324|FG000|Overall Study|Protocol Violation|1|||
31005022|NCT01728246|59206325|FG001|Overall Study|Protocol Violation|0|||
31005023|NCT01728246|59206324|FG000|Overall Study|Withdrawal by Subject|2|||
31005024|NCT01728246|59206325|FG001|Overall Study|Withdrawal by Subject|3|||
31005025|NCT01728246|59206324|FG000|Overall Study|Lost to Follow-up|23|||
31005026|NCT01728246|59206325|FG001|Overall Study|Lost to Follow-up|22|||
31005027|NCT01728246|59206324|FG000|Overall Study|Lack of Efficacy|1|||
31005028|NCT01728246|59206325|FG001|Overall Study|Lack of Efficacy|1|||
31005029|NCT01728246|59206324|FG000|Overall Study|Adverse Event|8|||
31005030|NCT01728246|59206325|FG001|Overall Study|Adverse Event|5|||
31005031|NCT01705236|59206331|FG000|Overall Study|Lost to Follow-up|1|||
31005032|NCT01705236|59206331|FG000|Overall Study|Administrative problems|2|||
31005033|NCT01705236|59206331|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
31005034|NCT01705236|59206331|FG000|Overall Study|Protocol Violation|3|||
31005035|NCT01705236|59206331|FG000|Overall Study|Abnormal test procedure result(s)|4|||
31005036|NCT01705236|59206331|FG000|Overall Study|Abnormal laboratory value(s)|4|||
31005037|NCT01705236|59206331|FG000|Overall Study|Withdrawal by Subject|5|||
31005038|NCT01705236|59206331|FG000|Overall Study|Adverse Event|5|||
31005039|NCT01705080|59206338|FG000|Overall Study|Missed visit|10|||
31005040|NCT01705080|59206339|FG001|Overall Study|Missed visit|4|||
31005041|NCT01705080|59206340|FG002|Overall Study|Missed visit|1|||
31005042|NCT01705080|59206338|FG000|Overall Study|Death|4|||
31005043|NCT01705080|59206339|FG001|Overall Study|Death|4|||
31005044|NCT01705080|59206340|FG002|Overall Study|Death|6|||
31005045|NCT01705080|59206338|FG000|Overall Study|Withdrawal by Subject|61|||
31005046|NCT01705080|59206339|FG001|Overall Study|Withdrawal by Subject|44|||
31005047|NCT01705080|59206340|FG002|Overall Study|Withdrawal by Subject|9|||
31005048|NCT01704846|59206350|FG000|Treatment Period 2|Withdrawal by Subject|0|||
31005049|NCT01704846|59206351|FG001|Treatment Period 2|Withdrawal by Subject|1|||
31005050|NCT01751802|59206359|FG000|Overall Study|Adverse Event|4|||
31005051|NCT01751802|59206360|FG001|Overall Study|Adverse Event|2|||
31005052|NCT01704456|59206374|FG000|Overall Study|Lost to Follow-up|8|||
31005053|NCT01704456|59206375|FG001|Overall Study|Lost to Follow-up|14|||
31005054|NCT01703988|59206385|FG000|Overall Study|Investigator Judgment|0|||
31005055|NCT01703988|59206386|FG001|Overall Study|Investigator Judgment|0|||
31005056|NCT01703988|59206387|FG002|Overall Study|Investigator Judgment|0|||
31005057|NCT01703988|59206388|FG003|Overall Study|Investigator Judgment|1|||
31005058|NCT01703832|59206401|FG000|Overall Study|Withdrawal by Subject|1|||
31005059|NCT01703832|59206402|FG001|Overall Study|Withdrawal by Subject|0|||
31005060|NCT01703286|59206408|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
31005061|NCT01703286|59206409|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
31005062|NCT01703286|59206410|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
31005063|NCT01703286|59206411|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
31005064|NCT01703286|59206412|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
31005065|NCT01703286|59206413|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
31005066|NCT01703286|59206408|FG000|Period 2 Including Washout|Adverse Event|0|||
31005067|NCT01703286|59206409|FG001|Period 2 Including Washout|Adverse Event|0|||
31005068|NCT01703286|59206410|FG002|Period 2 Including Washout|Adverse Event|0|||
31005069|NCT01703286|59206411|FG003|Period 2 Including Washout|Adverse Event|1|||
31005070|NCT01703286|59206412|FG004|Period 2 Including Washout|Adverse Event|0|||
31005071|NCT01703286|59206413|FG005|Period 2 Including Washout|Adverse Event|0|||
31005072|NCT01703208|59206426|FG000|Overall Study|Death|61|||
31005073|NCT01703208|59206427|FG001|Overall Study|Death|48|||
31005074|NCT01703208|59206426|FG000|Overall Study|Lack of Efficacy|1|||
31005075|NCT01703208|59206427|FG001|Overall Study|Lack of Efficacy|2|||
31005076|NCT01703208|59206426|FG000|Overall Study|Lost to Follow-up|68|||
31005077|NCT01703208|59206427|FG001|Overall Study|Lost to Follow-up|62|||
31005078|NCT01703208|59206426|FG000|Overall Study|Non-Compliance with Study Drug|1|||
31005079|NCT01703208|59206427|FG001|Overall Study|Non-Compliance with Study Drug|0|||
31005080|NCT01703208|59206426|FG000|Overall Study|Excluded Medication|1|||
31005081|NCT01703208|59206427|FG001|Overall Study|Excluded Medication|2|||
31005082|NCT01703208|59206426|FG000|Overall Study|Site Discontinued Study Participation|23|||
31005083|NCT01703208|59206427|FG001|Overall Study|Site Discontinued Study Participation|27|||
31005084|NCT01703208|59206426|FG000|Overall Study|Physician Decision|11|||
31005085|NCT01703208|59206427|FG001|Overall Study|Physician Decision|13|||
31005086|NCT01703208|59206426|FG000|Overall Study|Progressive disease|2|||
31005087|NCT01703208|59206427|FG001|Overall Study|Progressive disease|2|||
31005088|NCT01703208|59206426|FG000|Overall Study|Protocol Violation|1|||
31005089|NCT01703208|59206427|FG001|Overall Study|Protocol Violation|1|||
31005090|NCT01703208|59206426|FG000|Overall Study|Study Terminated by Sponsor|1710|||
31005091|NCT01703208|59206427|FG001|Overall Study|Study Terminated by Sponsor|1716|||
31005092|NCT01703208|59206426|FG000|Overall Study|Withdrawal by Subject|205|||
31005093|NCT01703208|59206427|FG001|Overall Study|Withdrawal by Subject|209|||
31005094|NCT01703208|59206426|FG000|Overall Study|Adverse Event|14|||
31005095|NCT01703208|59206427|FG001|Overall Study|Adverse Event|19|||
31005096|NCT01703208|59206426|FG000|Overall Study|Technical Problems|0|||
31005097|NCT01703208|59206427|FG001|Overall Study|Technical Problems|1|||
31005098|NCT01703208|59206426|FG000|Overall Study|Protocol Deviation|2|||
31005099|NCT01703208|59206427|FG001|Overall Study|Protocol Deviation|0|||
31005100|NCT01727700|59206436|FG000|Overall Study|Adverse Event|0|||
31005101|NCT01727700|59206437|FG001|Overall Study|Adverse Event|7|||
31005102|NCT01727700|59206438|FG002|Overall Study|Adverse Event|1|||
31005103|NCT01727700|59206436|FG000|Overall Study|Particpant withdrew consent|0|||
31005104|NCT01727700|59206437|FG001|Overall Study|Particpant withdrew consent|3|||
31005105|NCT01727700|59206438|FG002|Overall Study|Particpant withdrew consent|1|||
31005106|NCT01727700|59206436|FG000|Overall Study|Protocol Violation|2|||
31005107|NCT01727700|59206437|FG001|Overall Study|Protocol Violation|0|||
31005108|NCT01727700|59206438|FG002|Overall Study|Protocol Violation|0|||
31005109|NCT01727154|59206446|FG000|Overall Study|Death|17|||
31005110|NCT01727154|59206446|FG000|Overall Study|Withdrawal by Subject|14|||
31005111|NCT01727154|59206446|FG000|Overall Study|Subject Withdrew Consent|18|||
31005112|NCT01727154|59206446|FG000|Overall Study|Study Terminated|6|||
31005113|NCT01727154|59206446|FG000|Overall Study|No Discontinuation Documentation|4|||
31005114|NCT01725750|59206452|FG000|Overall Study|Adverse Event|1|||
31005115|NCT01725750|59206453|FG001|Overall Study|Adverse Event|0|||
31005116|NCT01725750|59206452|FG000|Overall Study|Lost to Follow-up|1|||
31005117|NCT01725750|59206453|FG001|Overall Study|Lost to Follow-up|1|||
31005118|NCT01725750|59206452|FG000|Overall Study|Withdrawal by Subject|0|||
31005119|NCT01725750|59206453|FG001|Overall Study|Withdrawal by Subject|9|||
31005120|NCT01725282|59206465|FG000|Overall Study|Adverse Event|1|||
31005121|NCT01725282|59206466|FG001|Overall Study|Adverse Event|3|||
31005122|NCT01725282|59206467|FG002|Overall Study|Adverse Event|6|||
31005123|NCT01725282|59206468|FG003|Overall Study|Adverse Event|4|||
31005124|NCT01725282|59206465|FG000|Overall Study|Exacerbation of Target Disease|1|||
31005125|NCT01725282|59206466|FG001|Overall Study|Exacerbation of Target Disease|0|||
31005126|NCT01725282|59206467|FG002|Overall Study|Exacerbation of Target Disease|0|||
31005127|NCT01725282|59206468|FG003|Overall Study|Exacerbation of Target Disease|1|||
31005128|NCT01725282|59206465|FG000|Overall Study|Met Exclusion Criteria|0|||
31005129|NCT01725282|59206466|FG001|Overall Study|Met Exclusion Criteria|0|||
31005130|NCT01725282|59206467|FG002|Overall Study|Met Exclusion Criteria|1|||
31005131|NCT01725282|59206468|FG003|Overall Study|Met Exclusion Criteria|0|||
31005132|NCT01725282|59206465|FG000|Overall Study|Study Site Withdrawal|0|||
31005133|NCT01725282|59206466|FG001|Overall Study|Study Site Withdrawal|1|||
31005134|NCT01725282|59206467|FG002|Overall Study|Study Site Withdrawal|0|||
31005135|NCT01725282|59206468|FG003|Overall Study|Study Site Withdrawal|0|||
31005136|NCT01725282|59206465|FG000|Overall Study|Withdrawal by Subject|0|||
31005137|NCT01725282|59206466|FG001|Overall Study|Withdrawal by Subject|0|||
31005138|NCT01725282|59206467|FG002|Overall Study|Withdrawal by Subject|1|||
31005139|NCT01725282|59206468|FG003|Overall Study|Withdrawal by Subject|1|||
31005140|NCT01725282|59206465|FG000|Overall Study|Lack of Efficacy|0|||
31005141|NCT01725282|59206466|FG001|Overall Study|Lack of Efficacy|1|||
31005142|NCT01725282|59206467|FG002|Overall Study|Lack of Efficacy|0|||
31005143|NCT01725282|59206468|FG003|Overall Study|Lack of Efficacy|1|||
31005144|NCT01725126|59206484|FG000|Overall Study|Protocol Violation|0|||
31005145|NCT01725126|59206485|FG001|Overall Study|Protocol Violation|1|||
31005146|NCT01725126|59206486|FG002|Overall Study|Protocol Violation|0|||
31005147|NCT01725126|59206487|FG003|Overall Study|Protocol Violation|0|||
31005148|NCT01725126|59206488|FG004|Overall Study|Protocol Violation|0|||
31005149|NCT01725126|59206489|FG005|Overall Study|Protocol Violation|0|||
31005150|NCT01725126|59206484|FG000|Overall Study|Withdrawal by Subject|0|||
31005151|NCT01725126|59206485|FG001|Overall Study|Withdrawal by Subject|0|||
31005152|NCT01725126|59206486|FG002|Overall Study|Withdrawal by Subject|0|||
31005153|NCT01725126|59206487|FG003|Overall Study|Withdrawal by Subject|1|||
31005154|NCT01725126|59206488|FG004|Overall Study|Withdrawal by Subject|0|||
31005155|NCT01725126|59206489|FG005|Overall Study|Withdrawal by Subject|0|||
31005156|NCT01751724|59206514|FG000|Overall Study|extubated bef.start assigned treatment|1|||
31005157|NCT01751724|59206515|FG001|Overall Study|extubated bef.start assigned treatment|0|||
31005158|NCT01751724|59206514|FG000|Overall Study|withdrawn by parent|0|||
31005159|NCT01751724|59206515|FG001|Overall Study|withdrawn by parent|2|||
31005160|NCT01751646|59206523|FG000|Overall Study|Lost to Follow-up|5|||
31005161|NCT01751646|59206524|FG001|Overall Study|Lost to Follow-up|1|||
31005162|NCT01751646|59206523|FG000|Overall Study|Withdrawal by Subject|0|||
31005163|NCT01751646|59206524|FG001|Overall Study|Withdrawal by Subject|4|||
31005164|NCT01751646|59206523|FG000|Overall Study|Starting hormone therapy|1|||
31005165|NCT01751646|59206524|FG001|Overall Study|Starting hormone therapy|0|||
31005166|NCT01751646|59206523|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
31005167|NCT01751646|59206524|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
31005168|NCT01751646|59206523|FG000|Overall Study|Inadvertent enrollment|1|||
31005169|NCT01751646|59206524|FG001|Overall Study|Inadvertent enrollment|1|||
31005170|NCT01751646|59206523|FG000|Overall Study|Moved out of the area|1|||
31005171|NCT01751646|59206524|FG001|Overall Study|Moved out of the area|5|||
31005172|NCT01751646|59206523|FG000|Overall Study|Inability to attend required visits|0|||
31005173|NCT01751646|59206524|FG001|Overall Study|Inability to attend required visits|1|||
31005174|NCT01751646|59206523|FG000|Overall Study|Off study due to multiple obligations|0|||
31005175|NCT01751646|59206524|FG001|Overall Study|Off study due to multiple obligations|1|||
31005176|NCT01751646|59206523|FG000|Overall Study|Fails to comply with study requirements|0|||
31005177|NCT01751646|59206524|FG001|Overall Study|Fails to comply with study requirements|1|||
31005178|NCT01751646|59206523|FG000|Overall Study|Childcare issues|1|||
31005179|NCT01751646|59206524|FG001|Overall Study|Childcare issues|1|||
31005180|NCT01751568|59206537|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
31005181|NCT01751568|59206538|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
31005182|NCT01751568|59206539|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
31005183|NCT01751412|59206547|FG000|Overall Study|Disease Progression Before Treatment|1|||
31005184|NCT01751178|59206554|FG000|Overall Study|Adverse Event|2|||
31005185|NCT01751178|59206555|FG001|Overall Study|Adverse Event|0|||
31005186|NCT01751178|59206556|FG002|Overall Study|Adverse Event|0|||
31005187|NCT01751178|59206554|FG000|Overall Study|Other Reason (unknown)|1|||
31005188|NCT01751178|59206555|FG001|Overall Study|Other Reason (unknown)|0|||
31005189|NCT01751178|59206556|FG002|Overall Study|Other Reason (unknown)|2|||
31005190|NCT01606254|59206572|FG000|Overall Study|Withdrawal by Subject|1|||
31005191|NCT01606254|59206573|FG001|Overall Study|Withdrawal by Subject|3|||
31005192|NCT01606254|59206574|FG002|Overall Study|Withdrawal by Subject|0|||
31005193|NCT01606254|59206575|FG003|Overall Study|Withdrawal by Subject|2|||
31005194|NCT01606254|59206572|FG000|Overall Study|Adverse Event|1|||
31005195|NCT01606254|59206573|FG001|Overall Study|Adverse Event|1|||
31005196|NCT01606254|59206574|FG002|Overall Study|Adverse Event|0|||
31005197|NCT01606254|59206575|FG003|Overall Study|Adverse Event|1|||
31005198|NCT01750242|59206585|FG000|Overall Study|Unreadable Images|3|||
31005199|NCT01723254|59206598|FG000|Overall Study|Conflict with work schedule|0|||
31005200|NCT01723254|59206599|FG001|Overall Study|Conflict with work schedule|0|||
31005201|NCT01723254|59206600|FG002|Overall Study|Conflict with work schedule|0|||
31005202|NCT01723254|59206601|FG003|Overall Study|Conflict with work schedule|0|||
31005203|NCT01723254|59206602|FG004|Overall Study|Conflict with work schedule|0|||
31005204|NCT01723254|59206603|FG005|Overall Study|Conflict with work schedule|0|||
31005205|NCT01723254|59206604|FG006|Overall Study|Conflict with work schedule|0|||
31005206|NCT01723254|59206605|FG007|Overall Study|Conflict with work schedule|1|||
31005207|NCT01723254|59206598|FG000|Overall Study|Personal issues|0|||
31005208|NCT01723254|59206599|FG001|Overall Study|Personal issues|0|||
31005209|NCT01723254|59206600|FG002|Overall Study|Personal issues|0|||
31005210|NCT01723254|59206601|FG003|Overall Study|Personal issues|0|||
31005211|NCT01723254|59206602|FG004|Overall Study|Personal issues|0|||
31005212|NCT01723254|59206603|FG005|Overall Study|Personal issues|1|||
31005213|NCT01723254|59206604|FG006|Overall Study|Personal issues|0|||
31005214|NCT01723254|59206605|FG007|Overall Study|Personal issues|0|||
31005215|NCT01723254|59206598|FG000|Overall Study|No longer have time to participate|0|||
31005216|NCT01723254|59206599|FG001|Overall Study|No longer have time to participate|0|||
31005217|NCT01723254|59206600|FG002|Overall Study|No longer have time to participate|0|||
31005218|NCT01723254|59206601|FG003|Overall Study|No longer have time to participate|1|||
31005219|NCT01723254|59206602|FG004|Overall Study|No longer have time to participate|0|||
31005220|NCT01723254|59206603|FG005|Overall Study|No longer have time to participate|0|||
31005221|NCT01723254|59206604|FG006|Overall Study|No longer have time to participate|0|||
31005222|NCT01723254|59206605|FG007|Overall Study|No longer have time to participate|0|||
31005223|NCT01723254|59206598|FG000|Overall Study|Move/Left to another country/city|0|||
31005224|NCT01723254|59206599|FG001|Overall Study|Move/Left to another country/city|0|||
31005225|NCT01723254|59206600|FG002|Overall Study|Move/Left to another country/city|2|||
31005226|NCT01723254|59206601|FG003|Overall Study|Move/Left to another country/city|1|||
31005227|NCT01723254|59206602|FG004|Overall Study|Move/Left to another country/city|1|||
31005228|NCT01723254|59206603|FG005|Overall Study|Move/Left to another country/city|0|||
31005229|NCT01723254|59206604|FG006|Overall Study|Move/Left to another country/city|0|||
31005230|NCT01723254|59206605|FG007|Overall Study|Move/Left to another country/city|0|||
31005231|NCT01723254|59206598|FG000|Overall Study|Protocol Violation|0|||
31005232|NCT01723254|59206599|FG001|Overall Study|Protocol Violation|1|||
31005233|NCT01723254|59206600|FG002|Overall Study|Protocol Violation|0|||
31005234|NCT01723254|59206601|FG003|Overall Study|Protocol Violation|0|||
30609037|NCT01285310|58619903|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
31005235|NCT01723254|59206602|FG004|Overall Study|Protocol Violation|0|||
31005236|NCT01723254|59206603|FG005|Overall Study|Protocol Violation|0|||
31005237|NCT01723254|59206604|FG006|Overall Study|Protocol Violation|0|||
31005238|NCT01723254|59206605|FG007|Overall Study|Protocol Violation|0|||
31005239|NCT01723254|59206598|FG000|Overall Study|Withdrawal by Subject|1|||
31005240|NCT01723254|59206599|FG001|Overall Study|Withdrawal by Subject|2|||
31005241|NCT01723254|59206600|FG002|Overall Study|Withdrawal by Subject|1|||
31005242|NCT01723254|59206601|FG003|Overall Study|Withdrawal by Subject|0|||
31005243|NCT01723254|59206602|FG004|Overall Study|Withdrawal by Subject|1|||
31005244|NCT01723254|59206603|FG005|Overall Study|Withdrawal by Subject|1|||
31005245|NCT01723254|59206604|FG006|Overall Study|Withdrawal by Subject|1|||
31005246|NCT01723254|59206605|FG007|Overall Study|Withdrawal by Subject|2|||
31005247|NCT01722162|59206625|FG000|Overall Study|Withdrawal by Subject|1|||
31005248|NCT01722162|59206626|FG001|Overall Study|Withdrawal by Subject|1|||
31005249|NCT01722162|59206625|FG000|Overall Study|Found ineligible|1|||
31005250|NCT01722162|59206626|FG001|Overall Study|Found ineligible|0|||
31005251|NCT01722162|59206625|FG000|Overall Study|Unrelated to study adverse event|2|||
31005252|NCT01722162|59206626|FG001|Overall Study|Unrelated to study adverse event|2|||
31005253|NCT01722162|59206625|FG000|Overall Study|Adverse Event|1|||
31005254|NCT01722162|59206626|FG001|Overall Study|Adverse Event|1|||
31005255|NCT01722162|59206625|FG000|Overall Study|Insurance denial post enrollment|0|||
31005256|NCT01722162|59206626|FG001|Overall Study|Insurance denial post enrollment|1|||
31005257|NCT01722162|59206625|FG000|Overall Study|Noncompliance|0|||
31005258|NCT01722162|59206626|FG001|Overall Study|Noncompliance|1|||
31005259|NCT01721772|59206634|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
31005260|NCT01721772|59206635|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
31005261|NCT01721772|59206634|FG000|Pre-Treatment|Poor/non-compliance|0|||
31005262|NCT01721772|59206635|FG001|Pre-Treatment|Poor/non-compliance|1|||
31005263|NCT01721772|59206634|FG000|Pre-Treatment|Participant withdrew consent|0|||
31005264|NCT01721772|59206635|FG001|Pre-Treatment|Participant withdrew consent|1|||
31005265|NCT01721772|59206634|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
31005266|NCT01721772|59206635|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
31005267|NCT01721772|59206634|FG000|Treatment|Disease progression|119|||
31005268|NCT01721772|59206635|FG001|Treatment|Disease progression|168|||
31005269|NCT01721772|59206634|FG000|Treatment|Study drug toxicity|19|||
31005270|NCT01721772|59206635|FG001|Treatment|Study drug toxicity|10|||
31005271|NCT01721772|59206634|FG000|Treatment|Adverse event unrelated to study drug|7|||
31005272|NCT01721772|59206635|FG001|Treatment|Adverse event unrelated to study drug|7|||
31005273|NCT01721772|59206634|FG000|Treatment|Maximum clinical benefit|16|||
31005274|NCT01721772|59206635|FG001|Treatment|Maximum clinical benefit|4|||
31005275|NCT01721772|59206634|FG000|Treatment|Other|19|||
31005276|NCT01721772|59206635|FG001|Treatment|Other|2|||
31005277|NCT01721772|59206634|FG000|Treatment|Participant withdrew consent|2|||
31005278|NCT01721772|59206635|FG001|Treatment|Participant withdrew consent|5|||
31005279|NCT01721772|59206634|FG000|Treatment|Participant request to discontinue study treatment|21|||
31005280|NCT01721772|59206635|FG001|Treatment|Participant request to discontinue study treatment|8|||
31005281|NCT01721772|59206634|FG000|Treatment|Death|1|||
31005282|NCT01721772|59206635|FG001|Treatment|Death|0|||
31005283|NCT01721772|59206634|FG000|Treatment|Not reported|1|||
31005284|NCT01721772|59206635|FG001|Treatment|Not reported|0|||
31005285|NCT01721772|59206634|FG000|Treatment|Poor/non-compliance|1|||
31005286|NCT01721772|59206635|FG001|Treatment|Poor/non-compliance|0|||
31005287|NCT01721772|59206634|FG000|Treatment|Lost to Follow-up|0|||
31005288|NCT01721772|59206635|FG001|Treatment|Lost to Follow-up|1|||
31005289|NCT01702428|59206645|FG000|Overall Study|Adverse Event|2|||
31005290|NCT01702428|59206646|FG001|Overall Study|Adverse Event|0|||
31005291|NCT01702428|59206647|FG002|Overall Study|Adverse Event|0|||
31005292|NCT01702428|59206648|FG003|Overall Study|Adverse Event|0|||
31005293|NCT01702428|59206645|FG000|Overall Study|Lost to Follow-up|33|||
31005294|NCT01702428|59206646|FG001|Overall Study|Lost to Follow-up|41|||
31005295|NCT01702428|59206647|FG002|Overall Study|Lost to Follow-up|37|||
31005296|NCT01702428|59206648|FG003|Overall Study|Lost to Follow-up|44|||
31005297|NCT01702428|59206645|FG000|Overall Study|Parents cannot assist to site|1|||
31005298|NCT01702428|59206646|FG001|Overall Study|Parents cannot assist to site|0|||
31005299|NCT01702428|59206647|FG002|Overall Study|Parents cannot assist to site|1|||
31005300|NCT01702428|59206648|FG003|Overall Study|Parents cannot assist to site|0|||
31005301|NCT01702428|59206645|FG000|Overall Study|Lost Coverage|0|||
31005302|NCT01702428|59206646|FG001|Overall Study|Lost Coverage|0|||
31005303|NCT01702428|59206647|FG002|Overall Study|Lost Coverage|0|||
31005304|NCT01702428|59206648|FG003|Overall Study|Lost Coverage|1|||
31005305|NCT01702428|59206645|FG000|Overall Study|Lost Health Plan|3|||
31005306|NCT01702428|59206646|FG001|Overall Study|Lost Health Plan|5|||
31005307|NCT01702428|59206647|FG002|Overall Study|Lost Health Plan|0|||
31005308|NCT01702428|59206648|FG003|Overall Study|Lost Health Plan|2|||
31005309|NCT01702428|59206645|FG000|Overall Study|Mother transferred care|0|||
31005310|NCT01702428|59206646|FG001|Overall Study|Mother transferred care|1|||
31005311|NCT01702428|59206647|FG002|Overall Study|Mother transferred care|0|||
31005312|NCT01702428|59206648|FG003|Overall Study|Mother transferred care|0|||
31005313|NCT01702428|59206645|FG000|Overall Study|Parents too busy|1|||
31005314|NCT01702428|59206646|FG001|Overall Study|Parents too busy|0|||
31005315|NCT01702428|59206647|FG002|Overall Study|Parents too busy|0|||
31005316|NCT01702428|59206648|FG003|Overall Study|Parents too busy|0|||
31005317|NCT01702428|59206645|FG000|Overall Study|Protocol Violation|3|||
31005318|NCT01702428|59206646|FG001|Overall Study|Protocol Violation|0|||
31005319|NCT01702428|59206647|FG002|Overall Study|Protocol Violation|1|||
31005320|NCT01702428|59206648|FG003|Overall Study|Protocol Violation|0|||
31005321|NCT01702428|59206645|FG000|Overall Study|Withdrawal by Subject|21|||
31005322|NCT01702428|59206646|FG001|Overall Study|Withdrawal by Subject|23|||
31005323|NCT01702428|59206647|FG002|Overall Study|Withdrawal by Subject|14|||
31005324|NCT01702428|59206648|FG003|Overall Study|Withdrawal by Subject|10|||
31005325|NCT01701258|59206669|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
31005326|NCT01701258|59206670|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
31005327|NCT01701258|59206671|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
31005328|NCT01701258|59206672|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
31005329|NCT01701258|59206673|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
31005330|NCT01701258|59206674|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
31005331|NCT01701258|59206675|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
31005332|NCT01701258|59206676|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
31005333|NCT01701258|59206677|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
31005334|NCT01701258|59206678|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
31005335|NCT01701258|59206679|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
31005336|NCT01701258|59206680|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
31005337|NCT01701258|59206681|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
31005338|NCT01701258|59206669|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
31005339|NCT01701258|59206670|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
31005340|NCT01701258|59206671|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
31005341|NCT01701258|59206672|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
31005342|NCT01701258|59206673|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
31005343|NCT01701258|59206674|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
31005344|NCT01701258|59206675|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
31005345|NCT01701258|59206676|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
31005346|NCT01701258|59206677|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
31005347|NCT01701258|59206678|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
31005348|NCT01701258|59206679|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
31005349|NCT01701258|59206680|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
31005350|NCT01701258|59206681|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
31005351|NCT01701258|59206669|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
31005352|NCT01701258|59206670|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
31005353|NCT01701258|59206671|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
31005354|NCT01701258|59206672|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
31005355|NCT01701258|59206673|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
31005356|NCT01701258|59206674|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
31005357|NCT01701258|59206675|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
31005358|NCT01701258|59206676|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
31005359|NCT01701258|59206677|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
31005360|NCT01701258|59206678|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
31005361|NCT01701258|59206679|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
31005362|NCT01701258|59206680|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
31005363|NCT01701258|59206681|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
31005364|NCT01701258|59206669|FG000|Assessment and Scheduling|Investigator Terminated|2|||
31005365|NCT01701258|59206670|FG001|Assessment and Scheduling|Investigator Terminated|0|||
31005366|NCT01701258|59206671|FG002|Assessment and Scheduling|Investigator Terminated|0|||
31005367|NCT01701258|59206672|FG003|Assessment and Scheduling|Investigator Terminated|0|||
31005368|NCT01701258|59206673|FG004|Assessment and Scheduling|Investigator Terminated|0|||
31005369|NCT01701258|59206674|FG005|Assessment and Scheduling|Investigator Terminated|0|||
31005370|NCT01701258|59206675|FG006|Assessment and Scheduling|Investigator Terminated|0|||
31005371|NCT01701258|59206676|FG007|Assessment and Scheduling|Investigator Terminated|0|||
31005372|NCT01701258|59206677|FG008|Assessment and Scheduling|Investigator Terminated|0|||
31005373|NCT01701258|59206678|FG009|Assessment and Scheduling|Investigator Terminated|0|||
31005374|NCT01701258|59206679|FG010|Assessment and Scheduling|Investigator Terminated|0|||
31005375|NCT01701258|59206680|FG011|Assessment and Scheduling|Investigator Terminated|0|||
31005376|NCT01701258|59206681|FG012|Assessment and Scheduling|Investigator Terminated|0|||
31005377|NCT01700946|59206711|FG000|Overall Study|Lost to Follow-up|1|||
31005378|NCT01700946|59206712|FG001|Overall Study|Lost to Follow-up|0|||
31005379|NCT01700946|59206711|FG000|Overall Study|Physician Decision|7|||
31005380|NCT01700946|59206712|FG001|Overall Study|Physician Decision|12|||
31005381|NCT01700946|59206711|FG000|Overall Study|Withdrawal by Subject|0|||
31005382|NCT01700946|59206712|FG001|Overall Study|Withdrawal by Subject|2|||
31005383|NCT01700946|59206711|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
31005384|NCT01700946|59206712|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
31005385|NCT01700946|59206711|FG000|Overall Study|Relapse|2|||
31005386|NCT01700946|59206712|FG001|Overall Study|Relapse|1|||
31005387|NCT01700946|59206711|FG000|Overall Study|Unacceptable toxicity|1|||
31005388|NCT01700946|59206712|FG001|Overall Study|Unacceptable toxicity|0|||
31005389|NCT01748994|59206724|FG000|Overall Study|Lost to Follow-up|8|||
31005390|NCT01748994|59206725|FG001|Overall Study|Lost to Follow-up|6|||
31005391|NCT01721070|59206731|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
31005392|NCT01748760|59206740|FG000|Overall Study|Withdrawal by Subject|1|||
31005393|NCT01748760|59206741|FG001|Overall Study|Withdrawal by Subject|1|||
31005394|NCT01748760|59206740|FG000|Overall Study|Lost to Follow-up|5|||
31005395|NCT01748760|59206741|FG001|Overall Study|Lost to Follow-up|1|||
31005396|NCT01748292|59206749|FG000|Overall Study|Adverse Event|2|||
31005397|NCT01748292|59206750|FG001|Overall Study|Adverse Event|4|||
31005398|NCT01748292|59206749|FG000|Overall Study|Lost to Follow-up|0|||
31005399|NCT01748292|59206750|FG001|Overall Study|Lost to Follow-up|3|||
31005400|NCT01748292|59206749|FG000|Overall Study|Death|0|||
31005401|NCT01748292|59206750|FG001|Overall Study|Death|3|||
31005402|NCT01748292|59206749|FG000|Overall Study|Withdrawal by Subject|0|||
31005403|NCT01748292|59206750|FG001|Overall Study|Withdrawal by Subject|2|||
31005404|NCT01720602|59206756|FG000|Overall Study|Adverse Event|3|||
31005405|NCT01720602|59206756|FG000|Overall Study|Progressive disease on therapy|2|||
31005406|NCT01746732|59206760|FG000|Lead-In Period|Withdrawal by Subject|1|||
31005407|NCT01746732|59206761|FG001|Lead-In Period|Withdrawal by Subject|0|||
31005408|NCT01746732|59206762|FG002|Lead-In Period|Withdrawal by Subject|0|||
31005409|NCT01746732|59206760|FG000|Period 1|Physician Decision|0|||
31005410|NCT01746732|59206761|FG001|Period 1|Physician Decision|1|||
31005411|NCT01746732|59206762|FG002|Period 1|Physician Decision|0|||
31005412|NCT01746732|59206760|FG000|Period 2|Withdrawal by Subject|0|||
31005413|NCT01746732|59206761|FG001|Period 2|Withdrawal by Subject|0|||
31005414|NCT01746732|59206762|FG002|Period 2|Withdrawal by Subject|2|||
31005415|NCT01746732|59206760|FG000|Period 2|Adverse Event|0|||
31005416|NCT01746732|59206761|FG001|Period 2|Adverse Event|0|||
31005417|NCT01746732|59206762|FG002|Period 2|Adverse Event|1|||
31005418|NCT01746732|59206760|FG000|Period 2|Lost to Follow-up|0|||
31005419|NCT01746732|59206761|FG001|Period 2|Lost to Follow-up|0|||
31005420|NCT01746732|59206762|FG002|Period 2|Lost to Follow-up|1|||
31005421|NCT01720524|59206772|FG000|Part A|Insufficient Clinical Response|2|||
31005422|NCT01720524|59206773|FG001|Part A|Insufficient Clinical Response|4|||
31005423|NCT01720524|59206772|FG000|Part A|Adverse Event|2|||
31005424|NCT01720524|59206773|FG001|Part A|Adverse Event|2|||
31005425|NCT01720524|59206772|FG000|Part A|Death|2|||
31005426|NCT01720524|59206773|FG001|Part A|Death|1|||
31005427|NCT01720524|59206772|FG000|Part A|Lost to Follow-up|0|||
31005428|NCT01720524|59206773|FG001|Part A|Lost to Follow-up|1|||
31005429|NCT01720524|59206772|FG000|Part A|Missed 28 day follow-up visit|1|||
31005430|NCT01720524|59206773|FG001|Part A|Missed 28 day follow-up visit|1|||
31005431|NCT01720524|59206772|FG000|Part A|Withdrawal by Subject|0|||
31005432|NCT01720524|59206773|FG001|Part A|Withdrawal by Subject|1|||
31005433|NCT01720524|59206772|FG000|Part A|Other|0|||
31005434|NCT01720524|59206773|FG001|Part A|Other|1|||
31005435|NCT01720524|59206772|FG000|Part A|Lost to Follow-up|0|||
31005436|NCT01720524|59206773|FG001|Part A|Lost to Follow-up|1|||
31005437|NCT01720524|59206772|FG000|Part B|No longer willing to participate in study|1|||
31005438|NCT01720524|59206773|FG001|Part B|No longer willing to participate in study|4|||
31005439|NCT01720524|59206772|FG000|Part B|Other|2|||
31005440|NCT01720524|59206773|FG001|Part B|Other|0|||
31005441|NCT01720524|59206772|FG000|Part B|Lost to Follow-up|2|||
30609038|NCT01285310|58619899|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
30609039|NCT01285310|58619900|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
31005442|NCT01720524|59206773|FG001|Part B|Lost to Follow-up|3|||
31005443|NCT01720524|59206772|FG000|Part B|Death|0|||
31005444|NCT01720524|59206773|FG001|Part B|Death|2|||
31005445|NCT01720446|59206785|FG000|Overall Study|Lost to Follow-up|12|||
31005446|NCT01720446|59206786|FG001|Overall Study|Lost to Follow-up|6|||
31005447|NCT01720446|59206787|FG002|Overall Study|Lost to Follow-up|16|||
31005448|NCT01720446|59206788|FG003|Overall Study|Lost to Follow-up|16|||
31005449|NCT01720446|59206785|FG000|Overall Study|Withdrawal by Subject|2|||
31005450|NCT01720446|59206786|FG001|Overall Study|Withdrawal by Subject|5|||
31005451|NCT01720446|59206787|FG002|Overall Study|Withdrawal by Subject|4|||
31005452|NCT01720446|59206788|FG003|Overall Study|Withdrawal by Subject|4|||
31005453|NCT01746108|59206804|FG000|Overall Study|Migrated /moved from study area|0|||
31005454|NCT01746108|59206805|FG001|Overall Study|Migrated /moved from study area|1|||
31005455|NCT01746108|59206806|FG002|Overall Study|Migrated /moved from study area|0|||
31005456|NCT01746108|59206804|FG000|Overall Study|Adverse event, non-fatal|0|||
31005457|NCT01746108|59206805|FG001|Overall Study|Adverse event, non-fatal|1|||
31005458|NCT01746108|59206806|FG002|Overall Study|Adverse event, non-fatal|0|||
31005459|NCT01746108|59206804|FG000|Overall Study|Withdrawal by Subject|0|||
31005460|NCT01746108|59206805|FG001|Overall Study|Withdrawal by Subject|1|||
31005461|NCT01746108|59206806|FG002|Overall Study|Withdrawal by Subject|0|||
31005462|NCT01746108|59206804|FG000|Overall Study|Lost to Follow-up|0|||
31005463|NCT01746108|59206805|FG001|Overall Study|Lost to Follow-up|1|||
31005464|NCT01746108|59206806|FG002|Overall Study|Lost to Follow-up|0|||
31005465|NCT01717638|59206835|FG000|Overall Study|Lost to Follow-up|0|||
31005466|NCT01717638|59206836|FG001|Overall Study|Lost to Follow-up|0|||
31005467|NCT01717638|59206837|FG002|Overall Study|Lost to Follow-up|0|||
31005468|NCT01717638|59206838|FG003|Overall Study|Lost to Follow-up|0|||
31005469|NCT01717638|59206839|FG004|Overall Study|Lost to Follow-up|0|||
31005470|NCT01717638|59206840|FG005|Overall Study|Lost to Follow-up|1|||
31005471|NCT01717638|59206841|FG006|Overall Study|Lost to Follow-up|0|||
31005472|NCT01717638|59206842|FG007|Overall Study|Lost to Follow-up|0|||
31005473|NCT01717638|59206843|FG008|Overall Study|Lost to Follow-up|0|||
31005474|NCT01717638|59206844|FG009|Overall Study|Lost to Follow-up|0|||
31005475|NCT01717638|59206845|FG010|Overall Study|Lost to Follow-up|0|||
31005476|NCT01717638|59206846|FG011|Overall Study|Lost to Follow-up|0|||
31005477|NCT01717638|59206847|FG012|Overall Study|Lost to Follow-up|0|||
31005478|NCT01717638|59206835|FG000|Overall Study|Father in hospital|0|||
31005479|NCT01717638|59206836|FG001|Overall Study|Father in hospital|0|||
31005480|NCT01717638|59206837|FG002|Overall Study|Father in hospital|0|||
31005481|NCT01717638|59206838|FG003|Overall Study|Father in hospital|0|||
31005482|NCT01717638|59206839|FG004|Overall Study|Father in hospital|0|||
31005483|NCT01717638|59206840|FG005|Overall Study|Father in hospital|0|||
31005484|NCT01717638|59206841|FG006|Overall Study|Father in hospital|0|||
31005485|NCT01717638|59206842|FG007|Overall Study|Father in hospital|0|||
31005486|NCT01717638|59206843|FG008|Overall Study|Father in hospital|0|||
31005487|NCT01717638|59206844|FG009|Overall Study|Father in hospital|0|||
31005488|NCT01717638|59206845|FG010|Overall Study|Father in hospital|0|||
31005489|NCT01717638|59206846|FG011|Overall Study|Father in hospital|0|||
31005490|NCT01717638|59206847|FG012|Overall Study|Father in hospital|1|||
31005491|NCT01717638|59206835|FG000|Overall Study|Withdrawal by Subject|0|||
31005492|NCT01717638|59206836|FG001|Overall Study|Withdrawal by Subject|1|||
31005493|NCT01717638|59206837|FG002|Overall Study|Withdrawal by Subject|1|||
31005494|NCT01717638|59206838|FG003|Overall Study|Withdrawal by Subject|0|||
31005495|NCT01717638|59206839|FG004|Overall Study|Withdrawal by Subject|1|||
31005496|NCT01717638|59206840|FG005|Overall Study|Withdrawal by Subject|0|||
31005497|NCT01717638|59206841|FG006|Overall Study|Withdrawal by Subject|2|||
31005498|NCT01717638|59206842|FG007|Overall Study|Withdrawal by Subject|1|||
31005499|NCT01717638|59206843|FG008|Overall Study|Withdrawal by Subject|2|||
31005500|NCT01717638|59206844|FG009|Overall Study|Withdrawal by Subject|1|||
31005501|NCT01717638|59206845|FG010|Overall Study|Withdrawal by Subject|0|||
31005502|NCT01717638|59206846|FG011|Overall Study|Withdrawal by Subject|0|||
31005503|NCT01717638|59206847|FG012|Overall Study|Withdrawal by Subject|18|||
31005504|NCT01745094|59206885|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
31005505|NCT01745094|59206886|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
31005506|NCT01745094|59206887|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
31005507|NCT01745094|59206888|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
31005508|NCT01745094|59206885|FG000|Overall Study|Adverse Event|0|||
31005509|NCT01745094|59206886|FG001|Overall Study|Adverse Event|0|||
31005510|NCT01745094|59206887|FG002|Overall Study|Adverse Event|3|||
31005511|NCT01745094|59206888|FG003|Overall Study|Adverse Event|0|||
31005512|NCT01745094|59206885|FG000|Overall Study|Withdrawal by Subject|2|||
31005513|NCT01745094|59206886|FG001|Overall Study|Withdrawal by Subject|0|||
31005514|NCT01745094|59206887|FG002|Overall Study|Withdrawal by Subject|1|||
31005515|NCT01745094|59206888|FG003|Overall Study|Withdrawal by Subject|2|||
31005516|NCT01745094|59206885|FG000|Overall Study|Protocol Violation|1|||
31005517|NCT01745094|59206886|FG001|Overall Study|Protocol Violation|0|||
31005518|NCT01745094|59206887|FG002|Overall Study|Protocol Violation|3|||
31005519|NCT01745094|59206888|FG003|Overall Study|Protocol Violation|1|||
31005520|NCT01745094|59206885|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
31005521|NCT01745094|59206886|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
31005522|NCT01745094|59206887|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
31005523|NCT01745094|59206888|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
31005524|NCT01745094|59206885|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
31005525|NCT01745094|59206886|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
31005526|NCT01745094|59206887|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
31005527|NCT01745094|59206888|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
31005528|NCT01745094|59206885|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
31005529|NCT01745094|59206886|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
31005530|NCT01745094|59206887|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
31005531|NCT01745094|59206888|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
31005532|NCT01697748|59206903|FG000|Overall Study|ineligible skin incision|1|||
31005533|NCT01697748|59206904|FG001|Overall Study|ineligible skin incision|2|||
31005534|NCT01697748|59206903|FG000|Overall Study|ineligible uterine incision|4|||
31005535|NCT01697748|59206904|FG001|Overall Study|ineligible uterine incision|1|||
31005536|NCT01697748|59206903|FG000|Overall Study|Lost to Follow-up|53|||
31005537|NCT01697748|59206904|FG001|Overall Study|Lost to Follow-up|65|||
31005538|NCT01717326|59206930|FG000|Overall Study|Death|0|||
31005539|NCT01717326|59206931|FG001|Overall Study|Death|0|||
31005540|NCT01717326|59206932|FG002|Overall Study|Death|0|||
31005541|NCT01717326|59206933|FG003|Overall Study|Death|0|||
31005542|NCT01717326|59206934|FG004|Overall Study|Death|0|||
31005543|NCT01717326|59206935|FG005|Overall Study|Death|0|||
31005544|NCT01717326|59206936|FG006|Overall Study|Death|0|||
31005545|NCT01717326|59206937|FG007|Overall Study|Death|0|||
31005546|NCT01717326|59206938|FG008|Overall Study|Death|0|||
31005547|NCT01717326|59206939|FG009|Overall Study|Death|0|||
31005548|NCT01717326|59206940|FG010|Overall Study|Death|1|||
31005549|NCT01717326|59206941|FG011|Overall Study|Death|0|||
31005550|NCT01717326|59206942|FG012|Overall Study|Death|0|||
31005551|NCT01717326|59206943|FG013|Overall Study|Death|0|||
31005552|NCT01717326|59206944|FG014|Overall Study|Death|0|||
31005553|NCT01717326|59206945|FG015|Overall Study|Death|0|||
31005554|NCT01717326|59206946|FG016|Overall Study|Death|0|||
31005555|NCT01717326|59206947|FG017|Overall Study|Death|0|||
31005556|NCT01717326|59206948|FG018|Overall Study|Death|0|||
31005557|NCT01717326|59206949|FG019|Overall Study|Death|0|||
31005558|NCT01717326|59206930|FG000|Overall Study|Lost to Follow-up|3|||
31005559|NCT01717326|59206931|FG001|Overall Study|Lost to Follow-up|0|||
31005560|NCT01717326|59206932|FG002|Overall Study|Lost to Follow-up|0|||
31005561|NCT01717326|59206933|FG003|Overall Study|Lost to Follow-up|2|||
31005562|NCT01717326|59206934|FG004|Overall Study|Lost to Follow-up|1|||
31005563|NCT01717326|59206935|FG005|Overall Study|Lost to Follow-up|0|||
31005564|NCT01717326|59206936|FG006|Overall Study|Lost to Follow-up|1|||
31005565|NCT01717326|59206937|FG007|Overall Study|Lost to Follow-up|0|||
31005566|NCT01717326|59206938|FG008|Overall Study|Lost to Follow-up|0|||
31005567|NCT01717326|59206939|FG009|Overall Study|Lost to Follow-up|0|||
31005568|NCT01717326|59206940|FG010|Overall Study|Lost to Follow-up|1|||
31005569|NCT01717326|59206941|FG011|Overall Study|Lost to Follow-up|0|||
31005570|NCT01717326|59206942|FG012|Overall Study|Lost to Follow-up|0|||
31005571|NCT01717326|59206943|FG013|Overall Study|Lost to Follow-up|0|||
31005572|NCT01717326|59206944|FG014|Overall Study|Lost to Follow-up|0|||
31005573|NCT01717326|59206945|FG015|Overall Study|Lost to Follow-up|2|||
31005574|NCT01717326|59206946|FG016|Overall Study|Lost to Follow-up|1|||
31005575|NCT01717326|59206947|FG017|Overall Study|Lost to Follow-up|0|||
31005576|NCT01717326|59206948|FG018|Overall Study|Lost to Follow-up|2|||
31005577|NCT01717326|59206949|FG019|Overall Study|Lost to Follow-up|3|||
31005578|NCT01717326|59206930|FG000|Overall Study|Physician Decision|0|||
31005579|NCT01717326|59206931|FG001|Overall Study|Physician Decision|0|||
31005580|NCT01717326|59206932|FG002|Overall Study|Physician Decision|0|||
31005581|NCT01717326|59206933|FG003|Overall Study|Physician Decision|0|||
31005582|NCT01717326|59206934|FG004|Overall Study|Physician Decision|0|||
31005583|NCT01717326|59206935|FG005|Overall Study|Physician Decision|0|||
31005584|NCT01717326|59206936|FG006|Overall Study|Physician Decision|0|||
31005585|NCT01717326|59206937|FG007|Overall Study|Physician Decision|0|||
31005586|NCT01717326|59206938|FG008|Overall Study|Physician Decision|0|||
31005587|NCT01717326|59206939|FG009|Overall Study|Physician Decision|1|||
31005588|NCT01717326|59206940|FG010|Overall Study|Physician Decision|0|||
31005589|NCT01717326|59206941|FG011|Overall Study|Physician Decision|0|||
31005590|NCT01717326|59206942|FG012|Overall Study|Physician Decision|0|||
31005591|NCT01717326|59206943|FG013|Overall Study|Physician Decision|0|||
31005592|NCT01717326|59206944|FG014|Overall Study|Physician Decision|0|||
31005593|NCT01717326|59206945|FG015|Overall Study|Physician Decision|0|||
31005594|NCT01717326|59206946|FG016|Overall Study|Physician Decision|0|||
31005595|NCT01717326|59206947|FG017|Overall Study|Physician Decision|0|||
31005596|NCT01717326|59206948|FG018|Overall Study|Physician Decision|0|||
31005597|NCT01717326|59206949|FG019|Overall Study|Physician Decision|0|||
31005598|NCT01717326|59206930|FG000|Overall Study|Protocol Violation|0|||
31005599|NCT01717326|59206931|FG001|Overall Study|Protocol Violation|0|||
31005600|NCT01717326|59206932|FG002|Overall Study|Protocol Violation|0|||
31005601|NCT01717326|59206933|FG003|Overall Study|Protocol Violation|0|||
31005602|NCT01717326|59206934|FG004|Overall Study|Protocol Violation|1|||
31005603|NCT01717326|59206935|FG005|Overall Study|Protocol Violation|0|||
31005604|NCT01717326|59206936|FG006|Overall Study|Protocol Violation|0|||
31005605|NCT01717326|59206937|FG007|Overall Study|Protocol Violation|0|||
31005606|NCT01717326|59206938|FG008|Overall Study|Protocol Violation|0|||
31005607|NCT01717326|59206939|FG009|Overall Study|Protocol Violation|0|||
31005608|NCT01717326|59206940|FG010|Overall Study|Protocol Violation|0|||
31005609|NCT01717326|59206941|FG011|Overall Study|Protocol Violation|0|||
31005610|NCT01717326|59206942|FG012|Overall Study|Protocol Violation|0|||
31005611|NCT01717326|59206943|FG013|Overall Study|Protocol Violation|0|||
31005612|NCT01717326|59206944|FG014|Overall Study|Protocol Violation|0|||
31005613|NCT01717326|59206945|FG015|Overall Study|Protocol Violation|0|||
31005614|NCT01717326|59206946|FG016|Overall Study|Protocol Violation|0|||
31005615|NCT01717326|59206947|FG017|Overall Study|Protocol Violation|0|||
31005616|NCT01717326|59206948|FG018|Overall Study|Protocol Violation|0|||
31005617|NCT01717326|59206949|FG019|Overall Study|Protocol Violation|0|||
31005618|NCT01717326|59206930|FG000|Overall Study|Withdrawal by Subject|0|||
31005619|NCT01717326|59206931|FG001|Overall Study|Withdrawal by Subject|1|||
31005620|NCT01717326|59206932|FG002|Overall Study|Withdrawal by Subject|0|||
31005621|NCT01717326|59206933|FG003|Overall Study|Withdrawal by Subject|0|||
31005622|NCT01717326|59206934|FG004|Overall Study|Withdrawal by Subject|0|||
31005623|NCT01717326|59206935|FG005|Overall Study|Withdrawal by Subject|0|||
31005624|NCT01717326|59206936|FG006|Overall Study|Withdrawal by Subject|0|||
31005625|NCT01717326|59206937|FG007|Overall Study|Withdrawal by Subject|0|||
31005626|NCT01717326|59206938|FG008|Overall Study|Withdrawal by Subject|0|||
31005627|NCT01717326|59206939|FG009|Overall Study|Withdrawal by Subject|1|||
31005628|NCT01717326|59206940|FG010|Overall Study|Withdrawal by Subject|0|||
31005629|NCT01717326|59206941|FG011|Overall Study|Withdrawal by Subject|0|||
31005630|NCT01717326|59206942|FG012|Overall Study|Withdrawal by Subject|1|||
31005631|NCT01717326|59206943|FG013|Overall Study|Withdrawal by Subject|0|||
31005632|NCT01717326|59206944|FG014|Overall Study|Withdrawal by Subject|0|||
31005633|NCT01717326|59206945|FG015|Overall Study|Withdrawal by Subject|1|||
31005634|NCT01717326|59206946|FG016|Overall Study|Withdrawal by Subject|0|||
31005635|NCT01717326|59206947|FG017|Overall Study|Withdrawal by Subject|0|||
31005636|NCT01717326|59206948|FG018|Overall Study|Withdrawal by Subject|2|||
31005637|NCT01717326|59206949|FG019|Overall Study|Withdrawal by Subject|3|||
31005638|NCT01697592|59207001|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
31005639|NCT01697592|59207002|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
31005640|NCT01697592|59207003|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
31005641|NCT01697592|59207004|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
31005642|NCT01697592|59207005|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
31005643|NCT01697592|59207006|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
31005644|NCT01697592|59207007|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
31005645|NCT01697592|59207008|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
31005646|NCT01697592|59207009|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
31005647|NCT01697592|59207010|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
31005648|NCT01697592|59207001|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
31005649|NCT01697592|59207002|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
31005650|NCT01697592|59207003|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
31005651|NCT01697592|59207004|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
31005652|NCT01697592|59207005|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
31005653|NCT01697592|59207006|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
31005654|NCT01697592|59207007|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
31005655|NCT01697592|59207008|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
31005656|NCT01697592|59207009|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
31005657|NCT01697592|59207010|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
31005658|NCT01697592|59207001|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
31005659|NCT01697592|59207002|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
31005660|NCT01697592|59207003|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
31005661|NCT01697592|59207004|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
31005662|NCT01697592|59207005|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
31005663|NCT01697592|59207006|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
31005664|NCT01697592|59207007|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
31005665|NCT01697592|59207008|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
31005666|NCT01697592|59207009|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
31005667|NCT01697592|59207010|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
31005668|NCT01697592|59207001|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
31005669|NCT01697592|59207002|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
31005670|NCT01697592|59207003|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
31005671|NCT01697592|59207004|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
31005672|NCT01697592|59207005|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
31005673|NCT01697592|59207006|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
31005674|NCT01697592|59207007|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
31005675|NCT01697592|59207008|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
31005676|NCT01697592|59207009|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
31005677|NCT01697592|59207010|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
31005678|NCT01697592|59207001|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
31005679|NCT01697592|59207002|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
31005680|NCT01697592|59207003|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
31005681|NCT01697592|59207004|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
31005682|NCT01697592|59207005|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
31005683|NCT01697592|59207006|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
31005684|NCT01697592|59207007|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
31005685|NCT01697592|59207008|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
31005686|NCT01697592|59207009|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
31005687|NCT01697592|59207010|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
31005688|NCT01697592|59207001|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
31005689|NCT01697592|59207002|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
31005690|NCT01697592|59207003|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
31005691|NCT01697592|59207004|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
31005692|NCT01697592|59207005|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
31005693|NCT01697592|59207006|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
31005694|NCT01697592|59207007|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
31005695|NCT01697592|59207008|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
31005696|NCT01697592|59207009|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
31005697|NCT01697592|59207010|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
31005698|NCT01697592|59207001|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
31005699|NCT01697592|59207002|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
31005700|NCT01697592|59207003|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
31005701|NCT01697592|59207004|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
31005702|NCT01697592|59207005|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
31005703|NCT01697592|59207006|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
31005704|NCT01697592|59207007|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
31005705|NCT01697592|59207008|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
31005706|NCT01697592|59207009|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
31005707|NCT01697592|59207010|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
31005708|NCT01697592|59207001|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
31005709|NCT01697592|59207002|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
31005710|NCT01697592|59207003|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
31005711|NCT01697592|59207004|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
31005712|NCT01697592|59207005|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
31005713|NCT01697592|59207006|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
31005714|NCT01697592|59207007|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
31005715|NCT01697592|59207008|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
31005716|NCT01697592|59207009|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
31005717|NCT01697592|59207010|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
31005718|NCT01744782|59207046|FG000|Overall Study|Death|1|||
31005719|NCT01744392|59207050|FG000|Overall Study|Physician Decision|1|||
31005720|NCT01604850|59207057|FG000|Overall Study|Enrolled but never treated|0|||
31005721|NCT01604850|59207058|FG001|Overall Study|Enrolled but never treated|1|||
31005722|NCT01604850|59207057|FG000|Overall Study|Efficacy Failure|50|||
31005723|NCT01604850|59207058|FG001|Overall Study|Efficacy Failure|29|||
31005724|NCT01604850|59207057|FG000|Overall Study|Lost to Follow-up|1|||
31005725|NCT01604850|59207058|FG001|Overall Study|Lost to Follow-up|0|||
31005726|NCT01604850|59207057|FG000|Overall Study|Subject withdrew consent|1|||
31005727|NCT01604850|59207058|FG001|Overall Study|Subject withdrew consent|0|||
31005728|NCT01742286|59207071|FG000|Escalation Phase|Administrative problems|1|||
31005729|NCT01742286|59207072|FG001|Escalation Phase|Administrative problems|1|||
31005730|NCT01742286|59207073|FG002|Escalation Phase|Administrative problems|0|||
31005731|NCT01742286|59207074|FG003|Escalation Phase|Administrative problems|0|||
31005732|NCT01742286|59207075|FG004|Escalation Phase|Administrative problems|0|||
31005733|NCT01742286|59207076|FG005|Escalation Phase|Administrative problems|0|||
31005734|NCT01742286|59207077|FG006|Escalation Phase|Administrative problems|2|||
31005735|NCT01742286|59207071|FG000|Escalation Phase|Adverse Event|0|||
31005736|NCT01742286|59207072|FG001|Escalation Phase|Adverse Event|1|||
31005737|NCT01742286|59207073|FG002|Escalation Phase|Adverse Event|2|||
31005738|NCT01742286|59207074|FG003|Escalation Phase|Adverse Event|0|||
31005739|NCT01742286|59207075|FG004|Escalation Phase|Adverse Event|0|||
31005740|NCT01742286|59207076|FG005|Escalation Phase|Adverse Event|1|||
31005741|NCT01742286|59207077|FG006|Escalation Phase|Adverse Event|0|||
31005742|NCT01742286|59207071|FG000|Escalation Phase|Disease progression|3|||
31005743|NCT01742286|59207072|FG001|Escalation Phase|Disease progression|7|||
31005744|NCT01742286|59207073|FG002|Escalation Phase|Disease progression|4|||
31005745|NCT01742286|59207074|FG003|Escalation Phase|Disease progression|1|||
31005746|NCT01742286|59207075|FG004|Escalation Phase|Disease progression|4|||
31005747|NCT01742286|59207076|FG005|Escalation Phase|Disease progression|3|||
31005748|NCT01742286|59207077|FG006|Escalation Phase|Disease progression|2|||
31005749|NCT01742286|59207071|FG000|Escalation Phase|Death|0|||
31005750|NCT01742286|59207072|FG001|Escalation Phase|Death|0|||
31005751|NCT01742286|59207073|FG002|Escalation Phase|Death|0|||
31005752|NCT01742286|59207074|FG003|Escalation Phase|Death|0|||
31005753|NCT01742286|59207075|FG004|Escalation Phase|Death|0|||
31005754|NCT01742286|59207076|FG005|Escalation Phase|Death|1|||
31005755|NCT01742286|59207077|FG006|Escalation Phase|Death|0|||
31005756|NCT01742286|59207071|FG000|Escalation Phase|Physician Decision|0|||
31005757|NCT01742286|59207072|FG001|Escalation Phase|Physician Decision|3|||
31005758|NCT01742286|59207073|FG002|Escalation Phase|Physician Decision|0|||
31005759|NCT01742286|59207074|FG003|Escalation Phase|Physician Decision|1|||
31005760|NCT01742286|59207075|FG004|Escalation Phase|Physician Decision|0|||
31005761|NCT01742286|59207076|FG005|Escalation Phase|Physician Decision|0|||
31005762|NCT01742286|59207077|FG006|Escalation Phase|Physician Decision|2|||
31005763|NCT01742286|59207071|FG000|Escalation Phase|Subject/guardian decision|1|||
31005764|NCT01742286|59207072|FG001|Escalation Phase|Subject/guardian decision|0|||
31005765|NCT01742286|59207073|FG002|Escalation Phase|Subject/guardian decision|0|||
31005766|NCT01742286|59207074|FG003|Escalation Phase|Subject/guardian decision|0|||
31005767|NCT01742286|59207075|FG004|Escalation Phase|Subject/guardian decision|0|||
31005768|NCT01742286|59207076|FG005|Escalation Phase|Subject/guardian decision|0|||
31005769|NCT01742286|59207077|FG006|Escalation Phase|Subject/guardian decision|0|||
31005770|NCT01742286|59207071|FG000|Expansion Phase|Administrative problems|0|||
31005771|NCT01742286|59207072|FG001|Expansion Phase|Administrative problems|0|||
31005772|NCT01742286|59207073|FG002|Expansion Phase|Administrative problems|0|||
31005773|NCT01742286|59207074|FG003|Expansion Phase|Administrative problems|0|||
31005774|NCT01742286|59207075|FG004|Expansion Phase|Administrative problems|0|||
31005775|NCT01742286|59207076|FG005|Expansion Phase|Administrative problems|0|||
31005776|NCT01742286|59207077|FG006|Expansion Phase|Administrative problems|5|||
31005777|NCT01742286|59207071|FG000|Expansion Phase|Physician Decision|0|||
31005778|NCT01742286|59207072|FG001|Expansion Phase|Physician Decision|0|||
31005779|NCT01742286|59207073|FG002|Expansion Phase|Physician Decision|4|||
30892601|NCT02337907|58926062|FG005|Overall Study|Withdrawal by Subject|0|||
31005780|NCT01742286|59207074|FG003|Expansion Phase|Physician Decision|0|||
31005781|NCT01742286|59207075|FG004|Expansion Phase|Physician Decision|0|||
30790334|NCT03126110|58803537|FG002|Phase 1|Withdrawal by Subject|0|||
30790335|NCT03126110|58803538|FG003|Phase 1|Withdrawal by Subject|1|||
30790336|NCT03126110|58803539|FG004|Phase 1|Withdrawal by Subject|1|||
30790337|NCT03126110|58803540|FG005|Phase 1|Withdrawal by Subject|0|||
30790338|NCT03126110|58803541|FG006|Phase 1|Withdrawal by Subject|0|||
31005782|NCT01742286|59207076|FG005|Expansion Phase|Physician Decision|0|||
31005783|NCT01742286|59207077|FG006|Expansion Phase|Physician Decision|9|||
31005784|NCT01742286|59207071|FG000|Expansion Phase|Adverse Event|0|||
31005785|NCT01742286|59207072|FG001|Expansion Phase|Adverse Event|0|||
31005786|NCT01742286|59207073|FG002|Expansion Phase|Adverse Event|0|||
31005787|NCT01742286|59207074|FG003|Expansion Phase|Adverse Event|0|||
31005788|NCT01742286|59207075|FG004|Expansion Phase|Adverse Event|0|||
31005789|NCT01742286|59207076|FG005|Expansion Phase|Adverse Event|0|||
31005790|NCT01742286|59207077|FG006|Expansion Phase|Adverse Event|6|||
31005791|NCT01742286|59207071|FG000|Expansion Phase|Disease progression|0|||
31005792|NCT01742286|59207072|FG001|Expansion Phase|Disease progression|0|||
31005793|NCT01742286|59207073|FG002|Expansion Phase|Disease progression|3|||
31005794|NCT01742286|59207074|FG003|Expansion Phase|Disease progression|0|||
31005795|NCT01742286|59207075|FG004|Expansion Phase|Disease progression|0|||
31005796|NCT01742286|59207076|FG005|Expansion Phase|Disease progression|0|||
31005797|NCT01742286|59207077|FG006|Expansion Phase|Disease progression|15|||
31005798|NCT01742286|59207071|FG000|Expansion Phase|Withdrawal by Subject|0|||
31005799|NCT01742286|59207072|FG001|Expansion Phase|Withdrawal by Subject|0|||
31005800|NCT01742286|59207073|FG002|Expansion Phase|Withdrawal by Subject|0|||
31005801|NCT01742286|59207074|FG003|Expansion Phase|Withdrawal by Subject|0|||
31005802|NCT01742286|59207075|FG004|Expansion Phase|Withdrawal by Subject|0|||
31005803|NCT01742286|59207076|FG005|Expansion Phase|Withdrawal by Subject|0|||
31005804|NCT01742286|59207077|FG006|Expansion Phase|Withdrawal by Subject|1|||
31005805|NCT01697358|59207102|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
31005806|NCT01697358|59207103|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
31005807|NCT01697358|59207102|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
30892602|NCT02337907|58926057|FG000|Overall Study|Lost to Follow-up|0|||
30790339|NCT03126110|58803542|FG007|Phase 1|Withdrawal by Subject|0|||
31005808|NCT01697358|59207103|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
31005809|NCT01697358|59207102|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
31005810|NCT01697358|59207103|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
30892603|NCT02337907|58926058|FG001|Overall Study|Lost to Follow-up|0|||
31005811|NCT01697358|59207102|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
31005812|NCT01697358|59207103|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
31005813|NCT01697358|59207102|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
31005814|NCT01697358|59207103|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
31005815|NCT01697358|59207102|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
31005816|NCT01697358|59207103|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
31005817|NCT01697358|59207102|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
31005818|NCT01697358|59207103|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
31005819|NCT01697358|59207102|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
31005820|NCT01697358|59207103|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
31005821|NCT01697358|59207102|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
31005822|NCT01697358|59207103|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
31005823|NCT01697358|59207102|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
31005824|NCT01697358|59207103|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
31005825|NCT01716234|59207116|FG000|Overall Study|Protocol Violation|0|||
31005826|NCT01716234|59207117|FG001|Overall Study|Protocol Violation|0|||
31005827|NCT01716234|59207118|FG002|Overall Study|Protocol Violation|0|||
31005828|NCT01716234|59207119|FG003|Overall Study|Protocol Violation|1|||
31005829|NCT01716234|59207120|FG004|Overall Study|Protocol Violation|1|||
31005830|NCT01716234|59207121|FG005|Overall Study|Protocol Violation|1|||
31005831|NCT01716234|59207122|FG006|Overall Study|Protocol Violation|0|||
31005832|NCT01716234|59207116|FG000|Overall Study|Lack of Efficacy|0|||
31005833|NCT01716234|59207117|FG001|Overall Study|Lack of Efficacy|0|||
31005834|NCT01716234|59207118|FG002|Overall Study|Lack of Efficacy|0|||
31005835|NCT01716234|59207119|FG003|Overall Study|Lack of Efficacy|1|||
31005836|NCT01716234|59207120|FG004|Overall Study|Lack of Efficacy|0|||
31005837|NCT01716234|59207121|FG005|Overall Study|Lack of Efficacy|0|||
31005838|NCT01716234|59207122|FG006|Overall Study|Lack of Efficacy|0|||
31005839|NCT01716234|59207116|FG000|Overall Study|Did not meet protocol eligibility|0|||
31005840|NCT01716234|59207117|FG001|Overall Study|Did not meet protocol eligibility|0|||
31005841|NCT01716234|59207118|FG002|Overall Study|Did not meet protocol eligibility|1|||
31005842|NCT01716234|59207119|FG003|Overall Study|Did not meet protocol eligibility|0|||
31005843|NCT01716234|59207120|FG004|Overall Study|Did not meet protocol eligibility|0|||
31005844|NCT01716234|59207121|FG005|Overall Study|Did not meet protocol eligibility|4|||
31005845|NCT01716234|59207122|FG006|Overall Study|Did not meet protocol eligibility|0|||
31005846|NCT01716234|59207116|FG000|Overall Study|Adverse Event|7|||
31005847|NCT01716234|59207117|FG001|Overall Study|Adverse Event|10|||
31005848|NCT01716234|59207118|FG002|Overall Study|Adverse Event|2|||
31005849|NCT01716234|59207119|FG003|Overall Study|Adverse Event|8|||
31005850|NCT01716234|59207120|FG004|Overall Study|Adverse Event|3|||
31005851|NCT01716234|59207121|FG005|Overall Study|Adverse Event|6|||
31005852|NCT01716234|59207122|FG006|Overall Study|Adverse Event|0|||
31005853|NCT01716234|59207116|FG000|Overall Study|Withdrawal by Subject|3|||
31005854|NCT01716234|59207117|FG001|Overall Study|Withdrawal by Subject|0|||
31005855|NCT01716234|59207118|FG002|Overall Study|Withdrawal by Subject|2|||
31005856|NCT01716234|59207119|FG003|Overall Study|Withdrawal by Subject|2|||
31005857|NCT01716234|59207120|FG004|Overall Study|Withdrawal by Subject|1|||
31005858|NCT01716234|59207121|FG005|Overall Study|Withdrawal by Subject|3|||
31005859|NCT01716234|59207122|FG006|Overall Study|Withdrawal by Subject|0|||
30892604|NCT02337907|58926059|FG002|Overall Study|Lost to Follow-up|0|||
30892605|NCT02337907|58926060|FG003|Overall Study|Lost to Follow-up|0|||
30892606|NCT02337907|58926061|FG004|Overall Study|Lost to Follow-up|0|||
30892607|NCT02337907|58926062|FG005|Overall Study|Lost to Follow-up|1|||
30892608|NCT02337907|58926057|FG000|Overall Study|Adverse Event|1|||
30892609|NCT02337907|58926058|FG001|Overall Study|Adverse Event|1|||
30892610|NCT02337907|58926059|FG002|Overall Study|Adverse Event|1|||
30892611|NCT02337907|58926060|FG003|Overall Study|Adverse Event|1|||
30892612|NCT02337907|58926061|FG004|Overall Study|Adverse Event|4|||
30892613|NCT02337907|58926062|FG005|Overall Study|Adverse Event|0|||
30892614|NCT01913470|58926079|FG000|Overall Study|Lost to Follow-up|0|||
30892615|NCT01913470|58926080|FG001|Overall Study|Lost to Follow-up|1|||
30892616|NCT01913470|58926079|FG000|Overall Study|Physician Decision|0|||
30892617|NCT01913470|58926080|FG001|Overall Study|Physician Decision|1|||
30892618|NCT01913470|58926079|FG000|Overall Study|Withdrawal by Subject|0|||
30892619|NCT01913470|58926080|FG001|Overall Study|Withdrawal by Subject|1|||
30892620|NCT02372071|58926087|FG000|Overall Study|Protocol Violation|18|||
31005860|NCT01716156|59207141|FG000|Overall Study|Protocol Violation|1|||
31005861|NCT01716156|59207142|FG001|Overall Study|Protocol Violation|0|||
31005862|NCT01716156|59207143|FG002|Overall Study|Protocol Violation|0|||
31005863|NCT01716156|59207141|FG000|Overall Study|Withdrawal by Subject|0|||
31005864|NCT01716156|59207142|FG001|Overall Study|Withdrawal by Subject|1|||
30892621|NCT02337751|58926094|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
30892622|NCT02337751|58926095|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
30892623|NCT02337751|58926094|FG000|Overall Study|Voluntary Withdrawal|6|||
31005865|NCT01716156|59207143|FG002|Overall Study|Withdrawal by Subject|2|||
31005866|NCT01716156|59207141|FG000|Overall Study|Lost to Follow-up|1|||
31005867|NCT01716156|59207142|FG001|Overall Study|Lost to Follow-up|0|||
31005868|NCT01716156|59207143|FG002|Overall Study|Lost to Follow-up|0|||
31005869|NCT01739790|59207157|FG000|Overall Study|Early Trial Termination|2|||
31005870|NCT01739790|59207158|FG001|Overall Study|Early Trial Termination|4|||
31005871|NCT01696032|59207168|FG000|Overall Study|Withdrawal by Subject|0|||
31005872|NCT01696032|59207169|FG001|Overall Study|Withdrawal by Subject|0|||
31005873|NCT01696032|59207170|FG002|Overall Study|Withdrawal by Subject|1|||
31005874|NCT01696032|59207171|FG003|Overall Study|Withdrawal by Subject|2|||
31005875|NCT01696032|59207168|FG000|Overall Study|Death|14|||
31005876|NCT01696032|59207169|FG001|Overall Study|Death|4|||
31005877|NCT01696032|59207170|FG002|Overall Study|Death|43|||
31005878|NCT01696032|59207171|FG003|Overall Study|Death|18|||
31005879|NCT01696032|59207168|FG000|Overall Study|Lost to Follow-up|0|||
31005880|NCT01696032|59207169|FG001|Overall Study|Lost to Follow-up|1|||
31005881|NCT01696032|59207170|FG002|Overall Study|Lost to Follow-up|0|||
31005882|NCT01696032|59207171|FG003|Overall Study|Lost to Follow-up|0|||
31005883|NCT01696032|59207168|FG000|Overall Study|Database lock|0|||
31005884|NCT01696032|59207169|FG001|Overall Study|Database lock|1|||
31005885|NCT01696032|59207170|FG002|Overall Study|Database lock|7|||
31005886|NCT01696032|59207171|FG003|Overall Study|Database lock|2|||
31005887|NCT01695954|59207187|FG000|Overall Study|Withdrawal by Subject|4|||
31005888|NCT01695954|59207188|FG001|Overall Study|Withdrawal by Subject|0|||
31005889|NCT01695954|59207187|FG000|Overall Study|Adverse Event|0|||
31005890|NCT01695954|59207188|FG001|Overall Study|Adverse Event|2|||
31005891|NCT01694706|59207196|FG000|Overall Study|Adverse Event|0|||
31005892|NCT01694706|59207197|FG001|Overall Study|Adverse Event|1|||
31005893|NCT01694706|59207198|FG002|Overall Study|Adverse Event|0|||
31005894|NCT01694706|59207196|FG000|Overall Study|other reason not defined above|1|||
31005895|NCT01694706|59207197|FG001|Overall Study|other reason not defined above|0|||
31005896|NCT01694706|59207198|FG002|Overall Study|other reason not defined above|0|||
31005897|NCT01693692|59207210|FG000|Overall Study|Withdrawal by Subject|12|||
31005898|NCT01693692|59207211|FG001|Overall Study|Withdrawal by Subject|10|||
31005899|NCT01693692|59207212|FG002|Overall Study|Withdrawal by Subject|11|||
31005900|NCT01693692|59207210|FG000|Overall Study|Adverse Event|7|||
31005901|NCT01693692|59207211|FG001|Overall Study|Adverse Event|14|||
31005902|NCT01693692|59207212|FG002|Overall Study|Adverse Event|9|||
31005903|NCT01693692|59207210|FG000|Overall Study|Physician Decision|0|||
31005904|NCT01693692|59207211|FG001|Overall Study|Physician Decision|0|||
31005905|NCT01693692|59207212|FG002|Overall Study|Physician Decision|1|||
31005906|NCT01693692|59207210|FG000|Overall Study|Protocol Violation|5|||
31005907|NCT01693692|59207211|FG001|Overall Study|Protocol Violation|4|||
31005908|NCT01693692|59207212|FG002|Overall Study|Protocol Violation|6|||
31005909|NCT01693692|59207210|FG000|Overall Study|Lost to Follow-up|2|||
31005910|NCT01693692|59207211|FG001|Overall Study|Lost to Follow-up|2|||
31005911|NCT01693692|59207212|FG002|Overall Study|Lost to Follow-up|3|||
31005912|NCT01693692|59207210|FG000|Overall Study|Other|4|||
31005913|NCT01693692|59207211|FG001|Overall Study|Other|4|||
31005914|NCT01693692|59207212|FG002|Overall Study|Other|6|||
31005915|NCT01693614|59207223|FG000|Overall Study|Adverse Event|7|||
31005916|NCT01693614|59207224|FG001|Overall Study|Adverse Event|11|||
31005917|NCT01693614|59207225|FG002|Overall Study|Adverse Event|5|||
31005918|NCT01693614|59207223|FG000|Overall Study|Disease progression|11|||
31005919|NCT01693614|59207224|FG001|Overall Study|Disease progression|8|||
31005920|NCT01693614|59207225|FG002|Overall Study|Disease progression|7|||
31005921|NCT01693614|59207223|FG000|Overall Study|Protocol Violation|5|||
30892624|NCT02337751|58926095|FG001|Overall Study|Voluntary Withdrawal|8|||
30892625|NCT02337751|58926094|FG000|Overall Study|Lack of Efficacy|2|||
30892626|NCT02337751|58926095|FG001|Overall Study|Lack of Efficacy|5|||
30892627|NCT02337751|58926094|FG000|Overall Study|Investigator's Judgement|1|||
30892628|NCT02337751|58926095|FG001|Overall Study|Investigator's Judgement|0|||
30892629|NCT02166333|58926106|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
31005922|NCT01693614|59207224|FG001|Overall Study|Protocol Violation|2|||
31005923|NCT01693614|59207225|FG002|Overall Study|Protocol Violation|1|||
31005924|NCT01693614|59207223|FG000|Overall Study|Death|1|||
31005925|NCT01693614|59207224|FG001|Overall Study|Death|0|||
31005926|NCT01693614|59207225|FG002|Overall Study|Death|0|||
31005927|NCT01693614|59207223|FG000|Overall Study|Physician Decision|1|||
31005928|NCT01693614|59207224|FG001|Overall Study|Physician Decision|1|||
31005929|NCT01693614|59207225|FG002|Overall Study|Physician Decision|4|||
31005930|NCT01693614|59207223|FG000|Overall Study|Withdrawal by subject/guardian|0|||
31005931|NCT01693614|59207224|FG001|Overall Study|Withdrawal by subject/guardian|0|||
31005932|NCT01693614|59207225|FG002|Overall Study|Withdrawal by subject/guardian|2|||
31005933|NCT01693614|59207223|FG000|Overall Study|Withdrawal by Subject|1|||
31005934|NCT01693614|59207224|FG001|Overall Study|Withdrawal by Subject|0|||
31005935|NCT01693614|59207225|FG002|Overall Study|Withdrawal by Subject|5|||
31005936|NCT01715298|59207236|FG000|Overall Study|Lost to Follow-up|0|||
31005937|NCT01715298|59207237|FG001|Overall Study|Lost to Follow-up|2|||
31005938|NCT01715298|59207236|FG000|Overall Study|Patient/guardian decision|7|||
31005939|NCT01715298|59207237|FG001|Overall Study|Patient/guardian decision|9|||
31005940|NCT01713582|59207264|FG000|Overall Study|Disease progression|3|||
31005941|NCT01713582|59207265|FG001|Overall Study|Disease progression|3|||
31005942|NCT01713582|59207266|FG002|Overall Study|Disease progression|3|||
31005943|NCT01713582|59207267|FG003|Overall Study|Disease progression|2|||
31005944|NCT01713582|59207268|FG004|Overall Study|Disease progression|3|||
31005945|NCT01713582|59207269|FG005|Overall Study|Disease progression|3|||
31005946|NCT01713582|59207270|FG006|Overall Study|Disease progression|3|||
31005947|NCT01713582|59207271|FG007|Overall Study|Disease progression|3|||
31005948|NCT01713582|59207272|FG008|Overall Study|Disease progression|3|||
31005949|NCT01713582|59207273|FG009|Overall Study|Disease progression|11|||
31005950|NCT01713582|59207274|FG010|Overall Study|Disease progression|10|||
31005951|NCT01713582|59207275|FG011|Overall Study|Disease progression|5|||
31005952|NCT01713582|59207276|FG012|Overall Study|Disease progression|3|||
31005953|NCT01713582|59207277|FG013|Overall Study|Disease progression|3|||
31005954|NCT01713582|59207278|FG014|Overall Study|Disease progression|6|||
31005955|NCT01713582|59207279|FG015|Overall Study|Disease progression|6|||
31005956|NCT01713582|59207280|FG016|Overall Study|Disease progression|5|||
31005957|NCT01713582|59207281|FG017|Overall Study|Disease progression|2|||
31005958|NCT01713582|59207282|FG018|Overall Study|Disease progression|3|||
31005959|NCT01713582|59207283|FG019|Overall Study|Disease progression|5|||
31005960|NCT01713582|59207284|FG020|Overall Study|Disease progression|15|||
31005961|NCT01713582|59207264|FG000|Overall Study|Death|0|||
31005962|NCT01713582|59207265|FG001|Overall Study|Death|0|||
31005963|NCT01713582|59207266|FG002|Overall Study|Death|0|||
31005964|NCT01713582|59207267|FG003|Overall Study|Death|1|||
31005965|NCT01713582|59207268|FG004|Overall Study|Death|1|||
31005966|NCT01713582|59207269|FG005|Overall Study|Death|3|||
31005967|NCT01713582|59207270|FG006|Overall Study|Death|3|||
31005968|NCT01713582|59207271|FG007|Overall Study|Death|2|||
31005969|NCT01713582|59207272|FG008|Overall Study|Death|3|||
31005970|NCT01713582|59207273|FG009|Overall Study|Death|4|||
31005971|NCT01713582|59207274|FG010|Overall Study|Death|3|||
31005972|NCT01713582|59207275|FG011|Overall Study|Death|0|||
31005973|NCT01713582|59207276|FG012|Overall Study|Death|0|||
31005974|NCT01713582|59207277|FG013|Overall Study|Death|0|||
31005975|NCT01713582|59207278|FG014|Overall Study|Death|0|||
31005976|NCT01713582|59207279|FG015|Overall Study|Death|0|||
31005977|NCT01713582|59207280|FG016|Overall Study|Death|0|||
31005978|NCT01713582|59207281|FG017|Overall Study|Death|0|||
31005979|NCT01713582|59207282|FG018|Overall Study|Death|0|||
31005980|NCT01713582|59207283|FG019|Overall Study|Death|0|||
31005981|NCT01713582|59207284|FG020|Overall Study|Death|0|||
31005982|NCT01713582|59207264|FG000|Overall Study|Adverse event-related|0|||
31005983|NCT01713582|59207265|FG001|Overall Study|Adverse event-related|0|||
31005984|NCT01713582|59207266|FG002|Overall Study|Adverse event-related|0|||
31005985|NCT01713582|59207267|FG003|Overall Study|Adverse event-related|0|||
31005986|NCT01713582|59207268|FG004|Overall Study|Adverse event-related|0|||
31005987|NCT01713582|59207269|FG005|Overall Study|Adverse event-related|0|||
31005988|NCT01713582|59207270|FG006|Overall Study|Adverse event-related|0|||
31005989|NCT01713582|59207271|FG007|Overall Study|Adverse event-related|0|||
31005990|NCT01713582|59207272|FG008|Overall Study|Adverse event-related|0|||
31005991|NCT01713582|59207273|FG009|Overall Study|Adverse event-related|1|||
31005992|NCT01713582|59207274|FG010|Overall Study|Adverse event-related|1|||
31005993|NCT01713582|59207275|FG011|Overall Study|Adverse event-related|0|||
31005994|NCT01713582|59207276|FG012|Overall Study|Adverse event-related|0|||
31005995|NCT01713582|59207277|FG013|Overall Study|Adverse event-related|0|||
31005996|NCT01713582|59207278|FG014|Overall Study|Adverse event-related|0|||
31005997|NCT01713582|59207279|FG015|Overall Study|Adverse event-related|0|||
31005998|NCT01713582|59207280|FG016|Overall Study|Adverse event-related|0|||
31005999|NCT01713582|59207281|FG017|Overall Study|Adverse event-related|0|||
31006000|NCT01713582|59207282|FG018|Overall Study|Adverse event-related|1|||
31006001|NCT01713582|59207283|FG019|Overall Study|Adverse event-related|0|||
31006002|NCT01713582|59207284|FG020|Overall Study|Adverse event-related|0|||
31006003|NCT01713582|59207264|FG000|Overall Study|Adverse event-unrelated|0|||
31006004|NCT01713582|59207265|FG001|Overall Study|Adverse event-unrelated|0|||
31006005|NCT01713582|59207266|FG002|Overall Study|Adverse event-unrelated|0|||
31006006|NCT01713582|59207267|FG003|Overall Study|Adverse event-unrelated|0|||
31006007|NCT01713582|59207268|FG004|Overall Study|Adverse event-unrelated|0|||
31006008|NCT01713582|59207269|FG005|Overall Study|Adverse event-unrelated|1|||
31006009|NCT01713582|59207270|FG006|Overall Study|Adverse event-unrelated|1|||
31006010|NCT01713582|59207271|FG007|Overall Study|Adverse event-unrelated|1|||
31006011|NCT01713582|59207272|FG008|Overall Study|Adverse event-unrelated|0|||
31006012|NCT01713582|59207273|FG009|Overall Study|Adverse event-unrelated|0|||
31006013|NCT01713582|59207274|FG010|Overall Study|Adverse event-unrelated|0|||
31006014|NCT01713582|59207275|FG011|Overall Study|Adverse event-unrelated|0|||
31006015|NCT01713582|59207276|FG012|Overall Study|Adverse event-unrelated|0|||
31006016|NCT01713582|59207277|FG013|Overall Study|Adverse event-unrelated|1|||
31006017|NCT01713582|59207278|FG014|Overall Study|Adverse event-unrelated|1|||
31006018|NCT01713582|59207279|FG015|Overall Study|Adverse event-unrelated|0|||
31006019|NCT01713582|59207280|FG016|Overall Study|Adverse event-unrelated|0|||
31006020|NCT01713582|59207281|FG017|Overall Study|Adverse event-unrelated|0|||
31006021|NCT01713582|59207282|FG018|Overall Study|Adverse event-unrelated|0|||
31006022|NCT01713582|59207283|FG019|Overall Study|Adverse event-unrelated|0|||
31006023|NCT01713582|59207284|FG020|Overall Study|Adverse event-unrelated|0|||
31006024|NCT01713582|59207264|FG000|Overall Study|Withdrawal of consent|0|||
31006025|NCT01713582|59207265|FG001|Overall Study|Withdrawal of consent|0|||
31006026|NCT01713582|59207266|FG002|Overall Study|Withdrawal of consent|1|||
31006027|NCT01713582|59207267|FG003|Overall Study|Withdrawal of consent|0|||
31006028|NCT01713582|59207268|FG004|Overall Study|Withdrawal of consent|0|||
31006029|NCT01713582|59207269|FG005|Overall Study|Withdrawal of consent|1|||
31006030|NCT01713582|59207270|FG006|Overall Study|Withdrawal of consent|0|||
31006031|NCT01713582|59207271|FG007|Overall Study|Withdrawal of consent|0|||
31006032|NCT01713582|59207272|FG008|Overall Study|Withdrawal of consent|0|||
31006033|NCT01713582|59207273|FG009|Overall Study|Withdrawal of consent|1|||
31006034|NCT01713582|59207274|FG010|Overall Study|Withdrawal of consent|0|||
31006035|NCT01713582|59207275|FG011|Overall Study|Withdrawal of consent|0|||
31006036|NCT01713582|59207276|FG012|Overall Study|Withdrawal of consent|0|||
31006037|NCT01713582|59207277|FG013|Overall Study|Withdrawal of consent|0|||
31006038|NCT01713582|59207278|FG014|Overall Study|Withdrawal of consent|0|||
31006039|NCT01713582|59207279|FG015|Overall Study|Withdrawal of consent|0|||
31006040|NCT01713582|59207280|FG016|Overall Study|Withdrawal of consent|0|||
31006041|NCT01713582|59207281|FG017|Overall Study|Withdrawal of consent|0|||
31006042|NCT01713582|59207282|FG018|Overall Study|Withdrawal of consent|1|||
31006043|NCT01713582|59207283|FG019|Overall Study|Withdrawal of consent|0|||
31006044|NCT01713582|59207284|FG020|Overall Study|Withdrawal of consent|0|||
31006045|NCT01713582|59207264|FG000|Overall Study|Lack of Efficacy|0|||
31006046|NCT01713582|59207265|FG001|Overall Study|Lack of Efficacy|0|||
31006047|NCT01713582|59207266|FG002|Overall Study|Lack of Efficacy|0|||
31006048|NCT01713582|59207267|FG003|Overall Study|Lack of Efficacy|0|||
31006049|NCT01713582|59207268|FG004|Overall Study|Lack of Efficacy|0|||
31006050|NCT01713582|59207269|FG005|Overall Study|Lack of Efficacy|0|||
31006051|NCT01713582|59207270|FG006|Overall Study|Lack of Efficacy|0|||
31006052|NCT01713582|59207271|FG007|Overall Study|Lack of Efficacy|0|||
31006053|NCT01713582|59207272|FG008|Overall Study|Lack of Efficacy|0|||
31006054|NCT01713582|59207273|FG009|Overall Study|Lack of Efficacy|1|||
31006055|NCT01713582|59207274|FG010|Overall Study|Lack of Efficacy|2|||
31006056|NCT01713582|59207275|FG011|Overall Study|Lack of Efficacy|0|||
31006057|NCT01713582|59207276|FG012|Overall Study|Lack of Efficacy|0|||
31006058|NCT01713582|59207277|FG013|Overall Study|Lack of Efficacy|0|||
31006059|NCT01713582|59207278|FG014|Overall Study|Lack of Efficacy|0|||
31006060|NCT01713582|59207279|FG015|Overall Study|Lack of Efficacy|0|||
31006061|NCT01713582|59207280|FG016|Overall Study|Lack of Efficacy|0|||
31006062|NCT01713582|59207281|FG017|Overall Study|Lack of Efficacy|0|||
31006063|NCT01713582|59207282|FG018|Overall Study|Lack of Efficacy|0|||
31006064|NCT01713582|59207283|FG019|Overall Study|Lack of Efficacy|0|||
31006065|NCT01713582|59207284|FG020|Overall Study|Lack of Efficacy|0|||
31006066|NCT01713582|59207264|FG000|Overall Study|Withdrawal by Subject|0|||
31006067|NCT01713582|59207265|FG001|Overall Study|Withdrawal by Subject|0|||
31006068|NCT01713582|59207266|FG002|Overall Study|Withdrawal by Subject|0|||
31006069|NCT01713582|59207267|FG003|Overall Study|Withdrawal by Subject|0|||
31006070|NCT01713582|59207268|FG004|Overall Study|Withdrawal by Subject|0|||
31006071|NCT01713582|59207269|FG005|Overall Study|Withdrawal by Subject|0|||
31006072|NCT01713582|59207270|FG006|Overall Study|Withdrawal by Subject|0|||
31006073|NCT01713582|59207271|FG007|Overall Study|Withdrawal by Subject|0|||
31006074|NCT01713582|59207272|FG008|Overall Study|Withdrawal by Subject|0|||
31006075|NCT01713582|59207273|FG009|Overall Study|Withdrawal by Subject|0|||
31006076|NCT01713582|59207274|FG010|Overall Study|Withdrawal by Subject|0|||
31006077|NCT01713582|59207275|FG011|Overall Study|Withdrawal by Subject|0|||
31006078|NCT01713582|59207276|FG012|Overall Study|Withdrawal by Subject|0|||
31006079|NCT01713582|59207277|FG013|Overall Study|Withdrawal by Subject|0|||
31006080|NCT01713582|59207278|FG014|Overall Study|Withdrawal by Subject|0|||
31006081|NCT01713582|59207279|FG015|Overall Study|Withdrawal by Subject|0|||
31006082|NCT01713582|59207280|FG016|Overall Study|Withdrawal by Subject|0|||
31006083|NCT01713582|59207281|FG017|Overall Study|Withdrawal by Subject|1|||
31006084|NCT01713582|59207282|FG018|Overall Study|Withdrawal by Subject|0|||
31006085|NCT01713582|59207283|FG019|Overall Study|Withdrawal by Subject|0|||
31006086|NCT01713582|59207284|FG020|Overall Study|Withdrawal by Subject|0|||
31006087|NCT01713582|59207264|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
31006088|NCT01713582|59207265|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
31006089|NCT01713582|59207266|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
31006090|NCT01713582|59207267|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
31006091|NCT01713582|59207268|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
31006092|NCT01713582|59207269|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
31006093|NCT01713582|59207270|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
31006094|NCT01713582|59207271|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
31006095|NCT01713582|59207272|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
31006096|NCT01713582|59207273|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
31006097|NCT01713582|59207274|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
31006098|NCT01713582|59207275|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
31006099|NCT01713582|59207276|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
31006100|NCT01713582|59207277|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
31006101|NCT01713582|59207278|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
31006102|NCT01713582|59207279|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
31006103|NCT01713582|59207280|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
31006104|NCT01713582|59207281|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
31006105|NCT01713582|59207282|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
31006106|NCT01713582|59207283|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
31006107|NCT01713582|59207284|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
31006108|NCT01713582|59207264|FG000|Overall Study|Disease progression and adverse event|0|||
31006109|NCT01713582|59207265|FG001|Overall Study|Disease progression and adverse event|0|||
31006110|NCT01713582|59207266|FG002|Overall Study|Disease progression and adverse event|0|||
31006111|NCT01713582|59207267|FG003|Overall Study|Disease progression and adverse event|0|||
31006112|NCT01713582|59207268|FG004|Overall Study|Disease progression and adverse event|0|||
31006113|NCT01713582|59207269|FG005|Overall Study|Disease progression and adverse event|0|||
31006114|NCT01713582|59207270|FG006|Overall Study|Disease progression and adverse event|0|||
31006115|NCT01713582|59207271|FG007|Overall Study|Disease progression and adverse event|0|||
31006116|NCT01713582|59207272|FG008|Overall Study|Disease progression and adverse event|0|||
31006117|NCT01713582|59207273|FG009|Overall Study|Disease progression and adverse event|0|||
31006118|NCT01713582|59207274|FG010|Overall Study|Disease progression and adverse event|0|||
31006119|NCT01713582|59207275|FG011|Overall Study|Disease progression and adverse event|0|||
31006120|NCT01713582|59207276|FG012|Overall Study|Disease progression and adverse event|0|||
31006121|NCT01713582|59207277|FG013|Overall Study|Disease progression and adverse event|0|||
31006122|NCT01713582|59207278|FG014|Overall Study|Disease progression and adverse event|0|||
31006123|NCT01713582|59207279|FG015|Overall Study|Disease progression and adverse event|0|||
31006124|NCT01713582|59207280|FG016|Overall Study|Disease progression and adverse event|1|||
31006125|NCT01713582|59207281|FG017|Overall Study|Disease progression and adverse event|0|||
31006126|NCT01713582|59207282|FG018|Overall Study|Disease progression and adverse event|0|||
31006127|NCT01713582|59207283|FG019|Overall Study|Disease progression and adverse event|0|||
31006128|NCT01713582|59207284|FG020|Overall Study|Disease progression and adverse event|0|||
31006129|NCT01739400|59207344|FG000|Overall Study|Physician Decision|3|||
31006130|NCT01739400|59207345|FG001|Overall Study|Physician Decision|0|||
31006131|NCT01739400|59207344|FG000|Overall Study|Lost to Follow-up|2|||
31006132|NCT01739400|59207345|FG001|Overall Study|Lost to Follow-up|0|||
31006133|NCT01739400|59207344|FG000|Overall Study|Death|5|||
31006134|NCT01739400|59207345|FG001|Overall Study|Death|2|||
31006135|NCT01739400|59207344|FG000|Overall Study|Withdrawal by Subject|7|||
31006136|NCT01739400|59207345|FG001|Overall Study|Withdrawal by Subject|7|||
31006137|NCT01713348|59207354|FG000|Overall Study|Withdrawal by Subject|3|||
31006138|NCT01713348|59207355|FG001|Overall Study|Withdrawal by Subject|2|||
31006139|NCT01713348|59207356|FG002|Overall Study|Withdrawal by Subject|2|||
31006140|NCT01713348|59207357|FG003|Overall Study|Withdrawal by Subject|0|||
31006141|NCT01713348|59207354|FG000|Overall Study|Lost to Follow-up|1|||
31006142|NCT01713348|59207355|FG001|Overall Study|Lost to Follow-up|0|||
31006143|NCT01713348|59207356|FG002|Overall Study|Lost to Follow-up|0|||
31006144|NCT01713348|59207357|FG003|Overall Study|Lost to Follow-up|0|||
31006145|NCT01737996|59207370|FG000|Overall Study|Adverse Event|0|||
31006146|NCT01737996|59207371|FG001|Overall Study|Adverse Event|1|||
31006147|NCT01737996|59207372|FG002|Overall Study|Adverse Event|1|||
31006148|NCT01737996|59207370|FG000|Overall Study|Withdrawal by Subject|0|||
31006149|NCT01737996|59207371|FG001|Overall Study|Withdrawal by Subject|0|||
31006150|NCT01737996|59207372|FG002|Overall Study|Withdrawal by Subject|1|||
31006151|NCT01713036|59207380|FG000|Overall Study|Death|1|||
31006152|NCT01712334|59207390|FG000|Treatment Period 1|Randomized in Error|0|||
31006153|NCT01712334|59207391|FG001|Treatment Period 1|Randomized in Error|2|||
31006154|NCT01712256|59207397|FG000|Overall Study|Lost to Follow-up|1|||
31006155|NCT01712178|59207403|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
31006156|NCT01712178|59207404|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
31006157|NCT01712178|59207403|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
31006158|NCT01712178|59207404|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
31006159|NCT01712178|59207403|FG000|Overall Study|Lost to Follow-up|0|||
31006160|NCT01712178|59207404|FG001|Overall Study|Lost to Follow-up|1|||
31006161|NCT01693068|59207412|FG000|Randomization Period|On-study|2|||
31006162|NCT01693068|59207413|FG001|Randomization Period|On-study|5|||
31006163|NCT01693068|59207414|FG002|Randomization Period|On-study|0|||
31006164|NCT01693068|59207412|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
31006165|NCT01693068|59207413|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
31006166|NCT01693068|59207414|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
31006167|NCT01691898|59207428|FG000|Overall Study|Death|34|||
31006168|NCT01691898|59207429|FG001|Overall Study|Death|32|||
31006169|NCT01691898|59207430|FG002|Overall Study|Death|6|||
31006170|NCT01691898|59207431|FG003|Overall Study|Death|3|||
31006171|NCT01691898|59207432|FG004|Overall Study|Death|8|||
31006172|NCT01691898|59207433|FG005|Overall Study|Death|31|||
31006173|NCT01691898|59207428|FG000|Overall Study|Adverse Event|0|||
31006174|NCT01691898|59207429|FG001|Overall Study|Adverse Event|1|||
31006175|NCT01691898|59207430|FG002|Overall Study|Adverse Event|0|||
31006176|NCT01691898|59207431|FG003|Overall Study|Adverse Event|1|||
31006177|NCT01691898|59207432|FG004|Overall Study|Adverse Event|1|||
31006178|NCT01691898|59207433|FG005|Overall Study|Adverse Event|0|||
31006179|NCT01691898|59207428|FG000|Overall Study|Progression of Disease|1|||
31006180|NCT01691898|59207429|FG001|Overall Study|Progression of Disease|2|||
31006181|NCT01691898|59207430|FG002|Overall Study|Progression of Disease|1|||
30892630|NCT02166333|58926107|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
30892631|NCT02166333|58926108|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
30892632|NCT02166333|58926109|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
30892633|NCT02166333|58926110|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
30892634|NCT02166333|58926111|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
30892635|NCT02166333|58926106|FG000|Stage 1|Death|4|||
30892636|NCT02166333|58926107|FG001|Stage 1|Death|0|||
30892637|NCT02166333|58926108|FG002|Stage 1|Death|2|||
30892638|NCT02166333|58926109|FG003|Stage 1|Death|0|||
30892639|NCT02166333|58926110|FG004|Stage 1|Death|3|||
30892640|NCT02166333|58926111|FG005|Stage 1|Death|2|||
30892641|NCT02166333|58926106|FG000|Stage 1|Lost to Follow-up|12|||
30892642|NCT02166333|58926107|FG001|Stage 1|Lost to Follow-up|0|||
30892643|NCT02166333|58926108|FG002|Stage 1|Lost to Follow-up|6|||
30892644|NCT02166333|58926109|FG003|Stage 1|Lost to Follow-up|0|||
30892645|NCT02166333|58926110|FG004|Stage 1|Lost to Follow-up|3|||
30892646|NCT02166333|58926111|FG005|Stage 1|Lost to Follow-up|3|||
30892647|NCT02166333|58926106|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
30892648|NCT02166333|58926107|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
30892649|NCT02166333|58926108|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
30892650|NCT02166333|58926109|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
30892651|NCT02166333|58926110|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
30892652|NCT02166333|58926111|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
30892653|NCT02166333|58926106|FG000|Stage 2|Death|4|||
30892654|NCT02166333|58926107|FG001|Stage 2|Death|2|||
30892655|NCT02166333|58926108|FG002|Stage 2|Death|1|||
30892656|NCT02166333|58926109|FG003|Stage 2|Death|0|||
30892657|NCT02166333|58926110|FG004|Stage 2|Death|0|||
30892658|NCT02166333|58926111|FG005|Stage 2|Death|1|||
30892659|NCT02166333|58926106|FG000|Stage 2|Lost to Follow-up|23|||
30892660|NCT02166333|58926107|FG001|Stage 2|Lost to Follow-up|4|||
30892661|NCT02166333|58926108|FG002|Stage 2|Lost to Follow-up|11|||
30892662|NCT02166333|58926109|FG003|Stage 2|Lost to Follow-up|9|||
30892663|NCT02166333|58926110|FG004|Stage 2|Lost to Follow-up|3|||
30892664|NCT02166333|58926111|FG005|Stage 2|Lost to Follow-up|6|||
30892665|NCT02132949|58926125|FG000|Overall Study|Death|7|||
30892666|NCT02132949|58926126|FG001|Overall Study|Death|13|||
30892667|NCT02132949|58926125|FG000|Overall Study|Lost to Follow-up|14|||
30892668|NCT02132949|58926126|FG001|Overall Study|Lost to Follow-up|4|||
31006182|NCT01691898|59207431|FG003|Overall Study|Progression of Disease|0|||
31006183|NCT01691898|59207432|FG004|Overall Study|Progression of Disease|0|||
30892669|NCT02132949|58926125|FG000|Overall Study|Withdrawal by Subject|6|||
30892670|NCT02132949|58926126|FG001|Overall Study|Withdrawal by Subject|5|||
30892671|NCT02132949|58926125|FG000|Overall Study|Noncompliance|5|||
30892672|NCT02132949|58926126|FG001|Overall Study|Noncompliance|1|||
30892673|NCT02132949|58926125|FG000|Overall Study|Physician Decision|3|||
30892674|NCT02132949|58926126|FG001|Overall Study|Physician Decision|1|||
30892675|NCT02132949|58926125|FG000|Overall Study|Disease Progression|3|||
30892676|NCT02132949|58926126|FG001|Overall Study|Disease Progression|0|||
31006184|NCT01691898|59207433|FG005|Overall Study|Progression of Disease|1|||
31006185|NCT01691898|59207428|FG000|Overall Study|Lost to Follow-up|3|||
31006186|NCT01691898|59207429|FG001|Overall Study|Lost to Follow-up|1|||
31006187|NCT01691898|59207430|FG002|Overall Study|Lost to Follow-up|0|||
31006188|NCT01691898|59207431|FG003|Overall Study|Lost to Follow-up|0|||
31006189|NCT01691898|59207432|FG004|Overall Study|Lost to Follow-up|1|||
31006190|NCT01691898|59207433|FG005|Overall Study|Lost to Follow-up|0|||
31006191|NCT01691898|59207428|FG000|Overall Study|Withdrawal by Subject|9|||
31006192|NCT01691898|59207429|FG001|Overall Study|Withdrawal by Subject|8|||
31006193|NCT01691898|59207430|FG002|Overall Study|Withdrawal by Subject|2|||
31006194|NCT01691898|59207431|FG003|Overall Study|Withdrawal by Subject|1|||
31006195|NCT01691898|59207432|FG004|Overall Study|Withdrawal by Subject|3|||
31006196|NCT01691898|59207433|FG005|Overall Study|Withdrawal by Subject|3|||
31006197|NCT01691898|59207428|FG000|Overall Study|Non-Compliance|0|||
31006198|NCT01691898|59207429|FG001|Overall Study|Non-Compliance|0|||
31006199|NCT01691898|59207430|FG002|Overall Study|Non-Compliance|0|||
31006200|NCT01691898|59207431|FG003|Overall Study|Non-Compliance|0|||
31006201|NCT01691898|59207432|FG004|Overall Study|Non-Compliance|1|||
31006202|NCT01691898|59207433|FG005|Overall Study|Non-Compliance|0|||
31006203|NCT01737840|59207467|FG000|Overall Study|Diagnosed with an other pathology|2|||
31006204|NCT01737840|59207468|FG001|Overall Study|Diagnosed with an other pathology|2|||
31006205|NCT01691820|59207478|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
31006206|NCT01691820|59207479|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
31006207|NCT01691820|59207478|FG000|Overall Study|Migrated/moved from study area|7|||
30892677|NCT02132949|58926125|FG000|Overall Study|Adverse Event|2|||
30892678|NCT02132949|58926126|FG001|Overall Study|Adverse Event|1|||
30892679|NCT02132949|58926125|FG000|Overall Study|Withdrew Prior to Treatment|1|||
30892680|NCT02132949|58926126|FG001|Overall Study|Withdrew Prior to Treatment|2|||
30892681|NCT02132949|58926125|FG000|Overall Study|Reason Unspecified|0|||
31006208|NCT01691820|59207479|FG001|Overall Study|Migrated/moved from study area|4|||
31006209|NCT01691820|59207478|FG000|Overall Study|Lost to Follow-up|6|||
31006210|NCT01691820|59207479|FG001|Overall Study|Lost to Follow-up|17|||
30609040|NCT01285310|58619901|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
30609041|NCT01285310|58619902|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
30609042|NCT01285310|58619903|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
30609043|NCT01285310|58619899|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
30609044|NCT01285310|58619900|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
30609045|NCT01285310|58619901|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
30609046|NCT01285310|58619902|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
30609047|NCT01285310|58619903|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
30609048|NCT01285310|58619899|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
30609049|NCT01285310|58619900|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
30609050|NCT01285310|58619901|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
31006211|NCT01691820|59207478|FG000|Overall Study|Other (unspecified)|4|||
31006212|NCT01691820|59207479|FG001|Overall Study|Other (unspecified)|1|||
31006213|NCT01711866|59207489|FG000|Overall Study|Noncompliant|3|||
30609051|NCT01285310|58619902|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
30609052|NCT01285310|58619903|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
30609053|NCT01285310|58619899|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
30609054|NCT01285310|58619900|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
30609055|NCT01285310|58619901|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
30609056|NCT01285310|58619902|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
30609057|NCT01285310|58619903|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
30609058|NCT01285310|58619899|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
30609059|NCT01285310|58619900|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
30609060|NCT01285310|58619901|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
30609061|NCT01285310|58619902|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
30609062|NCT01285310|58619903|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
30609063|NCT01285310|58619899|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
30609064|NCT01285310|58619900|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
30609065|NCT01285310|58619901|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
30609066|NCT01285310|58619902|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
30609067|NCT01285310|58619903|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
30609068|NCT01285310|58619899|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
30609069|NCT01285310|58619900|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
30609070|NCT01285310|58619901|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
30609071|NCT01285310|58619902|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
30609072|NCT01285310|58619903|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
31006214|NCT01711866|59207489|FG000|Overall Study|Withdrawal by Subject|3|||
31006215|NCT01711866|59207489|FG000|Overall Study|Adverse Event|2|||
31006216|NCT01737762|59207495|FG000|Overall Study|Adverse Event|2|||
31006217|NCT01737762|59207496|FG001|Overall Study|Adverse Event|2|||
31006218|NCT01737762|59207495|FG000|Overall Study|Lost to Follow-up|1|||
31006219|NCT01737762|59207496|FG001|Overall Study|Lost to Follow-up|0|||
31006220|NCT01737762|59207495|FG000|Overall Study|Withdrawal by Subject|2|||
31006221|NCT01737762|59207496|FG001|Overall Study|Withdrawal by Subject|2|||
31006222|NCT01737762|59207495|FG000|Overall Study|Progressive disease|1|||
31006223|NCT01737762|59207496|FG001|Overall Study|Progressive disease|2|||
31006224|NCT01737762|59207495|FG000|Overall Study|Physician Decision|1|||
31006225|NCT01737762|59207496|FG001|Overall Study|Physician Decision|1|||
31006226|NCT01737762|59207495|FG000|Overall Study|Moved from area|2|||
31006227|NCT01737762|59207496|FG001|Overall Study|Moved from area|1|||
31006228|NCT01737762|59207495|FG000|Overall Study|Trial termination|11|||
31006229|NCT01737762|59207496|FG001|Overall Study|Trial termination|9|||
31006230|NCT01691508|59207504|FG000|Overall Study|Adverse Event|3|||
31006231|NCT01691508|59207505|FG001|Overall Study|Adverse Event|3|||
30609073|NCT01285310|58619899|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
30609074|NCT01285310|58619900|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
30609075|NCT01285310|58619901|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
30609076|NCT01285310|58619902|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
30609077|NCT01285310|58619903|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
30609078|NCT01285310|58619899|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
30609079|NCT01285310|58619900|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
30609080|NCT01285310|58619901|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
30609081|NCT01285310|58619902|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
30609082|NCT01285310|58619903|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
30609083|NCT01285310|58619899|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
30609084|NCT01285310|58619900|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
30609085|NCT01285310|58619901|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
30609086|NCT01285310|58619902|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
30609087|NCT01285310|58619903|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
30609088|NCT01254630|58619945|FG000|Overall Study|Adverse Event|36|||
30609089|NCT01254630|58619946|FG001|Overall Study|Adverse Event|15|||
30609090|NCT01254630|58619947|FG002|Overall Study|Adverse Event|40|||
30609091|NCT01254630|58619948|FG003|Overall Study|Adverse Event|8|||
30609092|NCT01254630|58619945|FG000|Overall Study|Death|461|||
30609093|NCT01254630|58619946|FG001|Overall Study|Death|151|||
30609094|NCT01254630|58619947|FG002|Overall Study|Death|478|||
30609095|NCT01254630|58619948|FG003|Overall Study|Death|139|||
30609096|NCT01254630|58619945|FG000|Overall Study|Lost to Follow-up|80|||
30609097|NCT01254630|58619946|FG001|Overall Study|Lost to Follow-up|26|||
30609098|NCT01254630|58619947|FG002|Overall Study|Lost to Follow-up|89|||
30609099|NCT01254630|58619948|FG003|Overall Study|Lost to Follow-up|32|||
30609100|NCT01254630|58619945|FG000|Overall Study|Physician Decision|24|||
30609101|NCT01254630|58619946|FG001|Overall Study|Physician Decision|8|||
30609102|NCT01254630|58619947|FG002|Overall Study|Physician Decision|16|||
30609103|NCT01254630|58619948|FG003|Overall Study|Physician Decision|7|||
30609104|NCT01254630|58619945|FG000|Overall Study|Withdrawal by Subject|201|||
30609105|NCT01254630|58619946|FG001|Overall Study|Withdrawal by Subject|94|||
30609106|NCT01254630|58619947|FG002|Overall Study|Withdrawal by Subject|188|||
30609107|NCT01254630|58619948|FG003|Overall Study|Withdrawal by Subject|89|||
30609108|NCT01254630|58619945|FG000|Overall Study|Study terminated by sponsor|0|||
30609109|NCT01254630|58619946|FG001|Overall Study|Study terminated by sponsor|994|||
30609110|NCT01254630|58619947|FG002|Overall Study|Study terminated by sponsor|0|||
30609111|NCT01254630|58619948|FG003|Overall Study|Study terminated by sponsor|1010|||
30609112|NCT01254630|58619945|FG000|Overall Study|Status not recorded|0|||
30609113|NCT01254630|58619946|FG001|Overall Study|Status not recorded|0|||
30609114|NCT01254630|58619947|FG002|Overall Study|Status not recorded|1|||
30609115|NCT01254630|58619948|FG003|Overall Study|Status not recorded|0|||
30609116|NCT01284140|58619958|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
30609117|NCT01284140|58619959|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
30609118|NCT01284140|58619958|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
30609119|NCT01284140|58619959|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
30609120|NCT01254318|58619965|FG000|Overall Study|Lost to Follow-up|5|||
30609121|NCT01254318|58619965|FG000|Overall Study|Death|47|||
30609122|NCT01284062|58619973|FG000|Overall Study|Adverse Event|4|||
30609123|NCT01284062|58619974|FG001|Overall Study|Adverse Event|5|||
30609124|NCT01284062|58619975|FG002|Overall Study|Adverse Event|0|||
30609125|NCT01284062|58619976|FG003|Overall Study|Adverse Event|5|||
30609126|NCT01284062|58619973|FG000|Overall Study|Lack of Efficacy|3|||
30609127|NCT01284062|58619974|FG001|Overall Study|Lack of Efficacy|2|||
30609128|NCT01284062|58619975|FG002|Overall Study|Lack of Efficacy|2|||
30609129|NCT01284062|58619976|FG003|Overall Study|Lack of Efficacy|1|||
30609130|NCT01284062|58619973|FG000|Overall Study|Medication error without adverse event|0|||
30609131|NCT01284062|58619974|FG001|Overall Study|Medication error without adverse event|0|||
30609132|NCT01284062|58619975|FG002|Overall Study|Medication error without adverse event|1|||
30609133|NCT01284062|58619976|FG003|Overall Study|Medication error without adverse event|0|||
30609134|NCT01284062|58619973|FG000|Overall Study|Protocol Violation|1|||
30609135|NCT01284062|58619974|FG001|Overall Study|Protocol Violation|0|||
30609136|NCT01284062|58619975|FG002|Overall Study|Protocol Violation|0|||
30609137|NCT01284062|58619976|FG003|Overall Study|Protocol Violation|2|||
30609138|NCT01284062|58619973|FG000|Overall Study|Withdrawal by Subject|3|||
30609139|NCT01284062|58619974|FG001|Overall Study|Withdrawal by Subject|1|||
30609140|NCT01284062|58619975|FG002|Overall Study|Withdrawal by Subject|2|||
30609141|NCT01284062|58619976|FG003|Overall Study|Withdrawal by Subject|5|||
30609142|NCT01284062|58619973|FG000|Overall Study|Other|0|||
30609143|NCT01284062|58619974|FG001|Overall Study|Other|0|||
30609144|NCT01284062|58619975|FG002|Overall Study|Other|0|||
30609145|NCT01284062|58619976|FG003|Overall Study|Other|1|||
30609146|NCT01284062|58619973|FG000|Overall Study|Site Closed|0|||
30609147|NCT01284062|58619974|FG001|Overall Study|Site Closed|0|||
30609148|NCT01284062|58619975|FG002|Overall Study|Site Closed|1|||
30609149|NCT01284062|58619976|FG003|Overall Study|Site Closed|0|||
30609150|NCT01253304|58619993|FG000|Overall Study|Adverse Event|0|||
30609151|NCT01253304|58619994|FG001|Overall Study|Adverse Event|0|||
30609152|NCT01253304|58619995|FG002|Overall Study|Adverse Event|0|||
30609153|NCT01253304|58619996|FG003|Overall Study|Adverse Event|1|||
30609154|NCT01253226|58620011|FG000|Overall Study|Adverse Event|0|||
30609155|NCT01253226|58620012|FG001|Overall Study|Adverse Event|0|||
30609156|NCT01253226|58620013|FG002|Overall Study|Adverse Event|1|||
30609157|NCT01253226|58620014|FG003|Overall Study|Adverse Event|0|||
30609158|NCT01253226|58620015|FG004|Overall Study|Adverse Event|0|||
30609159|NCT01253226|58620011|FG000|Overall Study|Death|0|||
30609160|NCT01253226|58620012|FG001|Overall Study|Death|1|||
30609161|NCT01253226|58620013|FG002|Overall Study|Death|0|||
30609162|NCT01253226|58620014|FG003|Overall Study|Death|0|||
30609163|NCT01253226|58620015|FG004|Overall Study|Death|0|||
30609164|NCT01253226|58620011|FG000|Overall Study|Physician Decision|0|||
30609165|NCT01253226|58620012|FG001|Overall Study|Physician Decision|0|||
30609166|NCT01253226|58620013|FG002|Overall Study|Physician Decision|0|||
30609167|NCT01253226|58620014|FG003|Overall Study|Physician Decision|0|||
30609168|NCT01253226|58620015|FG004|Overall Study|Physician Decision|2|||
30609169|NCT01253226|58620011|FG000|Overall Study|Withdrawal by Subject|0|||
30609170|NCT01253226|58620012|FG001|Overall Study|Withdrawal by Subject|0|||
30609171|NCT01253226|58620013|FG002|Overall Study|Withdrawal by Subject|0|||
30609172|NCT01253226|58620014|FG003|Overall Study|Withdrawal by Subject|1|||
30609173|NCT01253226|58620015|FG004|Overall Study|Withdrawal by Subject|0|||
30609174|NCT01252290|58620027|FG000|Overall Study|Withdrawal by Subject|1|||
30609175|NCT01252134|58620031|FG000|Period 1, 8 Hours|Personal Reasons|0|||
30609176|NCT01252134|58620032|FG001|Period 1, 8 Hours|Personal Reasons|1|||
30609177|NCT01252134|58620033|FG002|Period 1, 8 Hours|Personal Reasons|1|||
30609178|NCT01252134|58620034|FG003|Period 1, 8 Hours|Personal Reasons|0|||
30609179|NCT01252134|58620035|FG004|Period 1, 8 Hours|Personal Reasons|0|||
30609180|NCT01252134|58620036|FG005|Period 1, 8 Hours|Personal Reasons|0|||
30609181|NCT01251744|58620046|FG000|Overall Study|Lost to Follow-up|1|||
30609182|NCT01251744|58620047|FG001|Overall Study|Lost to Follow-up|0|||
30609183|NCT01251354|58620060|FG000|Overall Study|Adverse Event|1|||
30609184|NCT01251354|58620060|FG000|Overall Study|Investigator's Decision|1|||
30609185|NCT01251354|58620060|FG000|Overall Study|Disease Progression|4|||
30609186|NCT01251276|58620066|FG000|Overall Study|Protocol Violation|1|||
30609187|NCT01251276|58620067|FG001|Overall Study|Protocol Violation|0|||
30609188|NCT01251276|58620066|FG000|Overall Study|Lost to Follow-up|0|||
30609189|NCT01251276|58620067|FG001|Overall Study|Lost to Follow-up|1|||
30609190|NCT01251120|58620075|FG000|Overall Study|Lack of Efficacy|0|||
30609191|NCT01251120|58620076|FG001|Overall Study|Lack of Efficacy|1|||
30609192|NCT01250418|58620084|FG000|Overall Study|monitor data failure|1|||
30609193|NCT01250418|58620085|FG001|Overall Study|monitor data failure|1|||
30609194|NCT01292603|58620096|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
30609195|NCT01292603|58620097|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
30609196|NCT01292603|58620098|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
30609197|NCT01292603|58620099|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
30609198|NCT01292603|58620100|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
30609199|NCT01292603|58620101|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
30609200|NCT01292603|58620096|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
30609201|NCT01292603|58620097|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
30609202|NCT01292603|58620098|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
30609203|NCT01292603|58620099|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
30609204|NCT01292603|58620100|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
30609205|NCT01292603|58620101|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
30609206|NCT01292603|58620096|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
30609207|NCT01292603|58620097|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
30609208|NCT01292603|58620098|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
30609209|NCT01292603|58620099|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
30609210|NCT01292603|58620100|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
30609211|NCT01292603|58620101|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
30609212|NCT01292603|58620096|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
30609213|NCT01292603|58620097|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
30609214|NCT01292603|58620098|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
30790340|NCT03126110|58803543|FG008|Phase 1|Withdrawal by Subject|2|||
30609215|NCT01292603|58620099|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
30609216|NCT01292603|58620100|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
30609217|NCT01292603|58620101|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
30609218|NCT01292603|58620096|FG000|Part 1: Regular Follow-Up Period|Death|3|||
30609219|NCT01292603|58620097|FG001|Part 1: Regular Follow-Up Period|Death|1|||
30609220|NCT01292603|58620098|FG002|Part 1: Regular Follow-Up Period|Death|3|||
30609221|NCT01292603|58620099|FG003|Part 1: Regular Follow-Up Period|Death|1|||
30609222|NCT01292603|58620100|FG004|Part 1: Regular Follow-Up Period|Death|0|||
30609223|NCT01292603|58620101|FG005|Part 1: Regular Follow-Up Period|Death|0|||
30609224|NCT01292603|58620096|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
30609225|NCT01292603|58620097|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
30892682|NCT02132949|58926126|FG001|Overall Study|Reason Unspecified|1|||
31006232|NCT01691508|59207504|FG000|Overall Study|Withdrawal by Subject|1|||
31006233|NCT01691508|59207505|FG001|Overall Study|Withdrawal by Subject|0|||
31006234|NCT01682460|59207511|FG000|Overall Study|Withdrawal by Subject|2|||
30609226|NCT01292603|58620098|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
30609227|NCT01292603|58620099|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
30609228|NCT01292603|58620100|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
30609229|NCT01292603|58620101|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
30609230|NCT01292603|58620096|FG000|Part 2: Dose Confirmation Period|Death|0|||
30609231|NCT01292603|58620097|FG001|Part 2: Dose Confirmation Period|Death|0|||
30609232|NCT01292603|58620098|FG002|Part 2: Dose Confirmation Period|Death|0|||
30609233|NCT01292603|58620099|FG003|Part 2: Dose Confirmation Period|Death|0|||
30609234|NCT01292603|58620100|FG004|Part 2: Dose Confirmation Period|Death|1|||
30609235|NCT01292603|58620101|FG005|Part 2: Dose Confirmation Period|Death|0|||
30609236|NCT01292603|58620096|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
30609237|NCT01292603|58620097|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
30609238|NCT01292603|58620098|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
30609239|NCT01292603|58620099|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
30609240|NCT01292603|58620100|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
30609241|NCT01292603|58620101|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
30609242|NCT01292603|58620096|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
30609243|NCT01292603|58620097|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
30609244|NCT01292603|58620098|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
31006235|NCT01682460|59207511|FG000|Overall Study|Did not meet inclusion criteria|2|||
30609245|NCT01292603|58620099|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
30609246|NCT01292603|58620100|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
30609247|NCT01292603|58620101|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
30609248|NCT01292603|58620096|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
30609249|NCT01292603|58620097|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
30609250|NCT01292603|58620098|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
30609251|NCT01292603|58620099|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
30609252|NCT01292603|58620100|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
30609253|NCT01292603|58620101|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
30609254|NCT01292603|58620096|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
30609255|NCT01292603|58620097|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
30609256|NCT01292603|58620098|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
30609257|NCT01292603|58620099|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
30609258|NCT01292603|58620100|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
30609259|NCT01292603|58620101|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
30609260|NCT01292603|58620096|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
30609261|NCT01292603|58620097|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
30609262|NCT01292603|58620098|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
31006236|NCT01691430|59207517|FG000|Overall Study|Death|17|||
31006237|NCT01691430|59207518|FG001|Overall Study|Death|16|||
31006238|NCT01691430|59207517|FG000|Overall Study|Withdrawal by Subject|5|||
31006239|NCT01691430|59207518|FG001|Overall Study|Withdrawal by Subject|1|||
30609263|NCT01292603|58620099|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
30609264|NCT01292603|58620100|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
30609265|NCT01292603|58620101|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
30609266|NCT01292603|58620096|FG000|Part 2: Regular Follow-Up|Death|0|||
31006240|NCT01691430|59207517|FG000|Overall Study|Lost to Follow-up|0|||
30609267|NCT01292603|58620097|FG001|Part 2: Regular Follow-Up|Death|0|||
30609268|NCT01292603|58620098|FG002|Part 2: Regular Follow-Up|Death|0|||
30609269|NCT01292603|58620099|FG003|Part 2: Regular Follow-Up|Death|0|||
30609270|NCT01292603|58620100|FG004|Part 2: Regular Follow-Up|Death|6|||
30609271|NCT01292603|58620101|FG005|Part 2: Regular Follow-Up|Death|3|||
30790341|NCT03126110|58803544|FG009|Phase 1|Withdrawal by Subject|1|||
30790342|NCT03126110|58803545|FG010|Phase 1|Withdrawal by Subject|0|||
31006241|NCT01691430|59207518|FG001|Overall Study|Lost to Follow-up|3|||
30609272|NCT01292603|58620096|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
30609273|NCT01292603|58620097|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
30609274|NCT01292603|58620098|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
30609275|NCT01292603|58620099|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
30609276|NCT01292603|58620100|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
30609277|NCT01292603|58620101|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
30609278|NCT01292603|58620096|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
30609279|NCT01292603|58620097|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
30609280|NCT01292603|58620098|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
30609281|NCT01292603|58620099|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
30609282|NCT01292603|58620100|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
30609283|NCT01292603|58620101|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
30609284|NCT01292603|58620096|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
30609285|NCT01292603|58620097|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
30609286|NCT01292603|58620098|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
30609287|NCT01292603|58620099|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
30609288|NCT01292603|58620100|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
30609289|NCT01292603|58620101|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
30609290|NCT01292603|58620096|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
30609291|NCT01292603|58620097|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
30609292|NCT01292603|58620098|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
30609293|NCT01292603|58620099|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
30609294|NCT01292603|58620100|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
30609295|NCT01292603|58620101|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
30609296|NCT01292603|58620096|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
30609297|NCT01292603|58620097|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
30609298|NCT01292603|58620098|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
30609299|NCT01292603|58620099|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
30609300|NCT01292603|58620100|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
30609301|NCT01292603|58620101|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
30609302|NCT01292603|58620096|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
30609303|NCT01292603|58620097|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
30609304|NCT01292603|58620098|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
30609305|NCT01292603|58620099|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
30609306|NCT01292603|58620100|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
30609307|NCT01292603|58620101|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
30609308|NCT01292603|58620096|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
30609309|NCT01292603|58620097|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
30609310|NCT01292603|58620098|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
30609311|NCT01292603|58620099|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
30609312|NCT01292603|58620100|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
30609313|NCT01292603|58620101|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
30609314|NCT01292603|58620096|FG000|Overall Survival Status|Death|3|||
30609315|NCT01292603|58620097|FG001|Overall Survival Status|Death|1|||
30609316|NCT01292603|58620098|FG002|Overall Survival Status|Death|3|||
30609317|NCT01292603|58620099|FG003|Overall Survival Status|Death|1|||
30609318|NCT01292603|58620100|FG004|Overall Survival Status|Death|16|||
30609319|NCT01292603|58620101|FG005|Overall Survival Status|Death|10|||
30609320|NCT01292057|58620124|FG000|Overall Study|Protocol Violation|1|||
30609321|NCT01292057|58620125|FG001|Overall Study|Protocol Violation|1|||
30609322|NCT01292057|58620124|FG000|Overall Study|Lost to Follow-up|1|||
30609323|NCT01292057|58620125|FG001|Overall Study|Lost to Follow-up|1|||
30609324|NCT01291277|58620133|FG000|Overall Study|Death|2|||
31006242|NCT01709838|59207524|FG000|Overall Study|Withdrawal by Subject|21|||
31006243|NCT01709838|59207524|FG000|Overall Study|Lost to Follow-up|16|||
31006244|NCT01709838|59207524|FG000|Overall Study|Pregnancy|10|||
31006245|NCT01709838|59207524|FG000|Overall Study|Subject/guardian decision|8|||
31006246|NCT01709838|59207524|FG000|Overall Study|Adverse Event|4|||
31006247|NCT01709838|59207524|FG000|Overall Study|Physician Decision|4|||
31006248|NCT01709838|59207524|FG000|Overall Study|Death|3|||
31006249|NCT01709838|59207524|FG000|Overall Study|Protocol Violation|1|||
31006250|NCT01682226|59207530|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
30609325|NCT01291277|58620134|FG001|Overall Study|Death|2|||
31006251|NCT01682226|59207530|FG000|Overall Study|Participants did not receive treatment|2|||
30609326|NCT01291277|58620133|FG000|Overall Study|Lost to Follow-up|3|||
30609327|NCT01291277|58620134|FG001|Overall Study|Lost to Follow-up|1|||
30609328|NCT01290887|58620142|FG000|Overall Study|Adverse Event|6|||
30609329|NCT01290887|58620143|FG001|Overall Study|Adverse Event|11|||
30609330|NCT01290887|58620142|FG000|Overall Study|Lack of Efficacy|4|||
30609331|NCT01290887|58620143|FG001|Overall Study|Lack of Efficacy|5|||
30609332|NCT01290887|58620142|FG000|Overall Study|Withdrawal by Subject|26|||
30609333|NCT01290887|58620143|FG001|Overall Study|Withdrawal by Subject|32|||
30609334|NCT01290887|58620142|FG000|Overall Study|Protocol Violation|2|||
30609335|NCT01290887|58620143|FG001|Overall Study|Protocol Violation|1|||
30609336|NCT01290887|58620142|FG000|Overall Study|Lost to Follow-up|4|||
30609337|NCT01290887|58620143|FG001|Overall Study|Lost to Follow-up|4|||
30609338|NCT01290887|58620142|FG000|Overall Study|Non-compliance to study procedures|0|||
30609339|NCT01290887|58620143|FG001|Overall Study|Non-compliance to study procedures|1|||
30609340|NCT01290887|58620142|FG000|Overall Study|Non-compliance to study medications|1|||
30609341|NCT01290887|58620143|FG001|Overall Study|Non-compliance to study medications|0|||
30609342|NCT01290887|58620142|FG000|Overall Study|Sponsor closure of study|420|||
30609343|NCT01290887|58620143|FG001|Overall Study|Sponsor closure of study|476|||
30609344|NCT01290887|58620142|FG000|Overall Study|Other|3|||
30609345|NCT01290887|58620143|FG001|Overall Study|Other|6|||
30609346|NCT01290731|58620149|FG000|Overall Study|Withdrawal by Subject|1|||
30609347|NCT01290341|58620155|FG000|Overall Study|Protocol Violation|7|||
30609348|NCT01290341|58620156|FG001|Overall Study|Protocol Violation|3|||
30609349|NCT01290341|58620155|FG000|Overall Study|Adverse Event|1|||
30609350|NCT01290341|58620156|FG001|Overall Study|Adverse Event|0|||
30609351|NCT01290341|58620155|FG000|Overall Study|Lost to Follow-up|21|||
30609352|NCT01290341|58620156|FG001|Overall Study|Lost to Follow-up|10|||
30609353|NCT01290341|58620155|FG000|Overall Study|Withdrawal by Subject|19|||
30609354|NCT01290341|58620156|FG001|Overall Study|Withdrawal by Subject|5|||
30609355|NCT01290341|58620155|FG000|Overall Study|Negative baseline culture and others|44|||
30609356|NCT01290341|58620156|FG001|Overall Study|Negative baseline culture and others|11|||
30609357|NCT01290263|58620164|FG000|Overall Study|Adverse Event|0|||
30609358|NCT01290263|58620165|FG001|Overall Study|Adverse Event|0|||
30609359|NCT01290263|58620166|FG002|Overall Study|Adverse Event|0|||
30609360|NCT01290263|58620167|FG003|Overall Study|Adverse Event|1|||
30609361|NCT01290263|58620168|FG004|Overall Study|Adverse Event|1|||
30609362|NCT01290263|58620164|FG000|Overall Study|Lack of Efficacy|8|||
30609363|NCT01290263|58620165|FG001|Overall Study|Lack of Efficacy|2|||
30609364|NCT01290263|58620166|FG002|Overall Study|Lack of Efficacy|7|||
30609365|NCT01290263|58620167|FG003|Overall Study|Lack of Efficacy|24|||
30609366|NCT01290263|58620168|FG004|Overall Study|Lack of Efficacy|33|||
30609367|NCT01290263|58620164|FG000|Overall Study|Withdrawal by Subject|3|||
30609368|NCT01290263|58620165|FG001|Overall Study|Withdrawal by Subject|1|||
30609369|NCT01290263|58620166|FG002|Overall Study|Withdrawal by Subject|0|||
30609370|NCT01290263|58620167|FG003|Overall Study|Withdrawal by Subject|1|||
30609371|NCT01290263|58620168|FG004|Overall Study|Withdrawal by Subject|2|||
30609372|NCT01290263|58620164|FG000|Overall Study|Participant Non-Compliance|0|||
30609373|NCT01290263|58620165|FG001|Overall Study|Participant Non-Compliance|0|||
30609374|NCT01290263|58620166|FG002|Overall Study|Participant Non-Compliance|0|||
30609375|NCT01290263|58620167|FG003|Overall Study|Participant Non-Compliance|1|||
30609376|NCT01290263|58620168|FG004|Overall Study|Participant Non-Compliance|1|||
30609377|NCT01290029|58620176|FG000|Overall Study|Other|2|||
30609378|NCT01289639|58620183|FG000|Overall Study|Lost to Follow-up|1|||
30609379|NCT01289639|58620184|FG001|Overall Study|Lost to Follow-up|0|||
30609380|NCT01289639|58620185|FG002|Overall Study|Lost to Follow-up|0|||
30609381|NCT01289015|58620195|FG000|Overall Study|Protocol Violation|12|||
30609382|NCT01289015|58620196|FG001|Overall Study|Protocol Violation|9|||
30609383|NCT01289015|58620195|FG000|Overall Study|Adverse Event|3|||
30609384|NCT01289015|58620196|FG001|Overall Study|Adverse Event|0|||
30609385|NCT01289015|58620195|FG000|Overall Study|Lost to Follow-up|33|||
30609386|NCT01289015|58620196|FG001|Overall Study|Lost to Follow-up|17|||
30609387|NCT01289015|58620195|FG000|Overall Study|Withdrawal by Subject|17|||
30609388|NCT01289015|58620196|FG001|Overall Study|Withdrawal by Subject|8|||
30609389|NCT01289015|58620195|FG000|Overall Study|Disease progression|1|||
30609390|NCT01289015|58620196|FG001|Overall Study|Disease progression|0|||
30609391|NCT01289015|58620195|FG000|Overall Study|Negative baseline culture and others|33|||
30609392|NCT01289015|58620196|FG001|Overall Study|Negative baseline culture and others|20|||
30609393|NCT01288937|58620204|FG000|Overall Study|Adverse Event|1|||
30609394|NCT01288937|58620205|FG001|Overall Study|Adverse Event|0|||
30609395|NCT01288469|58620214|FG000|Overall Study|Adverse Event|4|||
30609396|NCT01288469|58620215|FG001|Overall Study|Adverse Event|1|||
30609397|NCT01288469|58620216|FG002|Overall Study|Adverse Event|1|||
30609398|NCT01288469|58620214|FG000|Overall Study|Poor compliance to protocol|0|||
30609399|NCT01288469|58620215|FG001|Overall Study|Poor compliance to protocol|1|||
30609400|NCT01288469|58620216|FG002|Overall Study|Poor compliance to protocol|0|||
30609401|NCT01288469|58620214|FG000|Overall Study|Participant Moved|1|||
30609402|NCT01288469|58620215|FG001|Overall Study|Participant Moved|0|||
30609403|NCT01288469|58620216|FG002|Overall Study|Participant Moved|0|||
30609404|NCT01288469|58620214|FG000|Overall Study|Consent withdrawn by subject|1|||
30609405|NCT01288469|58620215|FG001|Overall Study|Consent withdrawn by subject|1|||
30609406|NCT01288469|58620216|FG002|Overall Study|Consent withdrawn by subject|1|||
30609407|NCT01288469|58620214|FG000|Overall Study|Exclusion criteria finally met|1|||
30609408|NCT01288469|58620215|FG001|Overall Study|Exclusion criteria finally met|0|||
30609409|NCT01288469|58620216|FG002|Overall Study|Exclusion criteria finally met|0|||
30609410|NCT01288079|58620228|FG000|Overall Study|Withdrawal by Subject|2|||
30609411|NCT01288079|58620229|FG001|Overall Study|Withdrawal by Subject|4|||
30609412|NCT01288079|58620230|FG002|Overall Study|Withdrawal by Subject|1|||
30609413|NCT01288079|58620231|FG003|Overall Study|Withdrawal by Subject|0|||
30609414|NCT01288079|58620228|FG000|Overall Study|Adverse Event|2|||
30609415|NCT01288079|58620229|FG001|Overall Study|Adverse Event|1|||
30609416|NCT01288079|58620230|FG002|Overall Study|Adverse Event|2|||
30609417|NCT01288079|58620231|FG003|Overall Study|Adverse Event|3|||
30609418|NCT01288079|58620228|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
30609419|NCT01288079|58620229|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
30609420|NCT01288079|58620230|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
30609421|NCT01288079|58620231|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
30609422|NCT01288079|58620228|FG000|Overall Study|Condition under Investigation Worsened|0|||
30609423|NCT01288079|58620229|FG001|Overall Study|Condition under Investigation Worsened|0|||
30609424|NCT01288079|58620230|FG002|Overall Study|Condition under Investigation Worsened|0|||
30609425|NCT01288079|58620231|FG003|Overall Study|Condition under Investigation Worsened|1|||
30609426|NCT01288079|58620228|FG000|Overall Study|Lack of Efficacy|2|||
30609427|NCT01288079|58620229|FG001|Overall Study|Lack of Efficacy|2|||
30609428|NCT01288079|58620230|FG002|Overall Study|Lack of Efficacy|0|||
30609429|NCT01288079|58620231|FG003|Overall Study|Lack of Efficacy|2|||
30609430|NCT01288079|58620228|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
30609431|NCT01288079|58620229|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
30609432|NCT01288079|58620230|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
30609433|NCT01288079|58620231|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
30609434|NCT01288079|58620228|FG000|Overall Study|Lost to Follow-up|1|||
30609435|NCT01288079|58620229|FG001|Overall Study|Lost to Follow-up|1|||
30609436|NCT01288079|58620230|FG002|Overall Study|Lost to Follow-up|1|||
30609437|NCT01288079|58620231|FG003|Overall Study|Lost to Follow-up|0|||
30609438|NCT01288079|58620228|FG000|Overall Study|Other or Study Termination|11|||
30609439|NCT01288079|58620229|FG001|Overall Study|Other or Study Termination|15|||
30609440|NCT01288079|58620230|FG002|Overall Study|Other or Study Termination|14|||
30609441|NCT01288079|58620231|FG003|Overall Study|Other or Study Termination|8|||
30609442|NCT01287221|58620243|FG000|Overall Study|Lack of Perceived Benefit|1|||
30609443|NCT01287221|58620244|FG001|Overall Study|Lack of Perceived Benefit|1|||
30609444|NCT01287221|58620243|FG000|Overall Study|Adverse Event|3|||
30609445|NCT01287221|58620244|FG001|Overall Study|Adverse Event|3|||
30609446|NCT01287221|58620243|FG000|Overall Study|Withdrawal by Subject|0|||
30609447|NCT01287221|58620244|FG001|Overall Study|Withdrawal by Subject|1|||
30609448|NCT01168401|58620261|FG000|Overall Study|Lost to Follow-up|1|||
30609449|NCT01168401|58620262|FG001|Overall Study|Lost to Follow-up|1|||
30609450|NCT01168401|58620263|FG002|Overall Study|Lost to Follow-up|2|||
30609451|NCT01168401|58620264|FG003|Overall Study|Lost to Follow-up|1|||
30609452|NCT01168401|58620265|FG004|Overall Study|Lost to Follow-up|0|||
30609453|NCT01168401|58620266|FG005|Overall Study|Lost to Follow-up|0|||
30609454|NCT01168401|58620267|FG006|Overall Study|Lost to Follow-up|0|||
30609455|NCT01168401|58620268|FG007|Overall Study|Lost to Follow-up|0|||
30609456|NCT01168401|58620269|FG008|Overall Study|Lost to Follow-up|0|||
30609457|NCT01168401|58620270|FG009|Overall Study|Lost to Follow-up|0|||
30609458|NCT01168401|58620271|FG010|Overall Study|Lost to Follow-up|0|||
30609459|NCT01168401|58620261|FG000|Overall Study|Withdrawal by Subject|0|||
30609460|NCT01168401|58620262|FG001|Overall Study|Withdrawal by Subject|0|||
30609461|NCT01168401|58620263|FG002|Overall Study|Withdrawal by Subject|0|||
30609462|NCT01168401|58620264|FG003|Overall Study|Withdrawal by Subject|1|||
30609463|NCT01168401|58620265|FG004|Overall Study|Withdrawal by Subject|0|||
30609464|NCT01168401|58620266|FG005|Overall Study|Withdrawal by Subject|0|||
30609465|NCT01168401|58620267|FG006|Overall Study|Withdrawal by Subject|0|||
30609466|NCT01168401|58620268|FG007|Overall Study|Withdrawal by Subject|0|||
30609467|NCT01168401|58620269|FG008|Overall Study|Withdrawal by Subject|0|||
30609468|NCT01168401|58620270|FG009|Overall Study|Withdrawal by Subject|0|||
30609469|NCT01168401|58620271|FG010|Overall Study|Withdrawal by Subject|0|||
30609470|NCT01287065|58620295|FG000|Treatment Period 1|Adverse Event|0|||
30609471|NCT01287065|58620296|FG001|Treatment Period 1|Adverse Event|0|||
30609472|NCT01287065|58620297|FG002|Treatment Period 1|Adverse Event|0|||
30609473|NCT01287065|58620298|FG003|Treatment Period 1|Adverse Event|0|||
30609474|NCT01287065|58620299|FG004|Treatment Period 1|Adverse Event|1|||
30609475|NCT01287065|58620300|FG005|Treatment Period 1|Adverse Event|0|||
30609476|NCT01287065|58620295|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30609477|NCT01287065|58620296|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30609478|NCT01287065|58620297|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30609479|NCT01287065|58620298|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30609480|NCT01287065|58620299|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30609481|NCT01287065|58620300|FG005|Treatment Period 1|Withdrawal by Subject|1|||
30609482|NCT01167153|58620310|FG000|Overall Study|Non-effective therapy|1|||
30609483|NCT01167153|58620311|FG001|Overall Study|Non-effective therapy|4|||
30609484|NCT01167153|58620310|FG000|Overall Study|AE including clinical laboratory AE|2|||
30609485|NCT01167153|58620311|FG001|Overall Study|AE including clinical laboratory AE|8|||
30609486|NCT01167153|58620310|FG000|Overall Study|Hypotension|1|||
30609487|NCT01167153|58620311|FG001|Overall Study|Hypotension|0|||
30609488|NCT01167153|58620310|FG000|Overall Study|Lost to Follow-up|7|||
30609489|NCT01167153|58620311|FG001|Overall Study|Lost to Follow-up|9|||
30609490|NCT01167153|58620310|FG000|Overall Study|Non-compliance to concomitant medication|0|||
30609491|NCT01167153|58620311|FG001|Overall Study|Non-compliance to concomitant medication|2|||
30609492|NCT01167153|58620310|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
30609493|NCT01167153|58620311|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
30609494|NCT01167153|58620310|FG000|Overall Study|Withdrawal consent|1|||
30609495|NCT01167153|58620311|FG001|Overall Study|Withdrawal consent|1|||
30609496|NCT01167153|58620310|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
30609497|NCT01167153|58620311|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
30609498|NCT01166763|58620317|FG000|Overall Study|Withdrawal by Subject|3|||
30609499|NCT01166373|58620325|FG000|Overall Study|Lost to Follow-up|3|||
30609500|NCT01166373|58620326|FG001|Overall Study|Lost to Follow-up|2|||
30609501|NCT01166373|58620327|FG002|Overall Study|Lost to Follow-up|2|||
30609502|NCT01166373|58620328|FG003|Overall Study|Lost to Follow-up|2|||
30609503|NCT01166373|58620325|FG000|Overall Study|Withdrawal by Subject|1|||
30609504|NCT01166373|58620326|FG001|Overall Study|Withdrawal by Subject|2|||
30609505|NCT01166373|58620327|FG002|Overall Study|Withdrawal by Subject|2|||
30609506|NCT01166373|58620328|FG003|Overall Study|Withdrawal by Subject|3|||
30609507|NCT01166373|58620325|FG000|Overall Study|Physician Decision|1|||
30609508|NCT01166373|58620326|FG001|Overall Study|Physician Decision|0|||
30609509|NCT01166373|58620327|FG002|Overall Study|Physician Decision|0|||
30609510|NCT01166373|58620328|FG003|Overall Study|Physician Decision|0|||
30609511|NCT00963235|58620340|FG000|Overall Study|Withdrawal by Subject|22|||
30609512|NCT00963235|58620340|FG000|Overall Study|Lost to Follow-up|14|||
30609513|NCT00963235|58620340|FG000|Overall Study|Failed to return|9|||
30609514|NCT00963235|58620340|FG000|Overall Study|Protocol Violation|7|||
30609515|NCT00963235|58620340|FG000|Overall Study|Adverse Event|5|||
30609516|NCT00963235|58620340|FG000|Overall Study|Physician Decision|2|||
30609517|NCT00963235|58620340|FG000|Overall Study|Other|1|||
30609518|NCT01165281|58620349|FG000|Overall Study|Adverse Event|12|||
30609519|NCT01165281|58620350|FG001|Overall Study|Adverse Event|14|||
30609520|NCT01165281|58620349|FG000|Overall Study|Death|3|||
30609521|NCT01165281|58620350|FG001|Overall Study|Death|4|||
30609522|NCT01165281|58620349|FG000|Overall Study|Lack of Efficacy|4|||
30609523|NCT01165281|58620350|FG001|Overall Study|Lack of Efficacy|1|||
30609524|NCT01165281|58620349|FG000|Overall Study|Lost to Follow-up|0|||
30609525|NCT01165281|58620350|FG001|Overall Study|Lost to Follow-up|1|||
30609526|NCT01165281|58620349|FG000|Overall Study|Physician Decision|8|||
30609527|NCT01165281|58620350|FG001|Overall Study|Physician Decision|1|||
30609528|NCT01165281|58620349|FG000|Overall Study|Protocol Violation|6|||
30609529|NCT01165281|58620350|FG001|Overall Study|Protocol Violation|5|||
30609530|NCT01165281|58620349|FG000|Overall Study|Withdrawal by Subject|8|||
30609531|NCT01165281|58620350|FG001|Overall Study|Withdrawal by Subject|7|||
30609532|NCT01165281|58620349|FG000|Overall Study|Noncompliance with Study Drug|1|||
30609533|NCT01165281|58620350|FG001|Overall Study|Noncompliance with Study Drug|4|||
30609534|NCT01165281|58620349|FG000|Overall Study|Progressive Disease|10|||
30609535|NCT01165281|58620350|FG001|Overall Study|Progressive Disease|14|||
30609536|NCT01165281|58620349|FG000|Overall Study|Other|6|||
30609537|NCT01165281|58620350|FG001|Overall Study|Other|0|||
30609538|NCT01165203|58620358|FG000|Active Phase|Serious Adverse Event|1|||
30609539|NCT01165203|58620359|FG001|Active Phase|Serious Adverse Event|0|||
30609540|NCT01165203|58620358|FG000|Active Phase|Withdrawal by Subject|2|||
30609541|NCT01165203|58620359|FG001|Active Phase|Withdrawal by Subject|1|||
30609542|NCT01165203|58620358|FG000|Active Phase|Migrated/moved from study area|0|||
30609543|NCT01165203|58620359|FG001|Active Phase|Migrated/moved from study area|1|||
30609544|NCT01165203|58620358|FG000|Active Phase|Lost to Follow-up|2|||
30609545|NCT01165203|58620359|FG001|Active Phase|Lost to Follow-up|0|||
30609546|NCT01165203|58620358|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
30609547|NCT01165203|58620359|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
30609548|NCT01165203|58620358|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
30609549|NCT01165203|58620359|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
30609550|NCT01165203|58620358|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
30609551|NCT01165203|58620359|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
30609552|NCT01165203|58620358|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
30609553|NCT01165203|58620359|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
30609554|NCT01165203|58620358|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
30609555|NCT01165203|58620359|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
30609556|NCT00960661|58620374|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
30609557|NCT00960661|58620375|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
30609558|NCT00960661|58620376|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
30609559|NCT00960661|58620374|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
30609560|NCT00960661|58620375|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
30609561|NCT00960661|58620376|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
30609562|NCT00960661|58620374|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
30609563|NCT00960661|58620375|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
30609564|NCT00960661|58620376|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
30609565|NCT00960661|58620374|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
30609566|NCT00960661|58620375|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
30609567|NCT00960661|58620376|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
30609568|NCT00960661|58620374|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
30609569|NCT00960661|58620375|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
30609570|NCT00960661|58620376|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
30609571|NCT00960661|58620374|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
30609572|NCT00960661|58620375|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
30609573|NCT00960661|58620376|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
30609574|NCT00960661|58620374|FG000|Interventional Phase|Adverse Event|0|||
30609575|NCT00960661|58620375|FG001|Interventional Phase|Adverse Event|17|||
30609576|NCT00960661|58620376|FG002|Interventional Phase|Adverse Event|8|||
30609577|NCT00960661|58620374|FG000|Interventional Phase|Death|0|||
30609578|NCT00960661|58620375|FG001|Interventional Phase|Death|1|||
30609579|NCT00960661|58620376|FG002|Interventional Phase|Death|0|||
30609580|NCT00960661|58620374|FG000|Interventional Phase|Lost to Follow-up|0|||
30609581|NCT00960661|58620375|FG001|Interventional Phase|Lost to Follow-up|0|||
30609582|NCT00960661|58620376|FG002|Interventional Phase|Lost to Follow-up|2|||
30609583|NCT00960661|58620374|FG000|Interventional Phase|entry criteria not met|0|||
30609584|NCT00960661|58620375|FG001|Interventional Phase|entry criteria not met|3|||
30609585|NCT00960661|58620376|FG002|Interventional Phase|entry criteria not met|0|||
30609586|NCT00960661|58620374|FG000|Interventional Phase|Protocol Violation|0|||
30609587|NCT00960661|58620375|FG001|Interventional Phase|Protocol Violation|7|||
30609588|NCT00960661|58620376|FG002|Interventional Phase|Protocol Violation|2|||
30609589|NCT00960661|58620374|FG000|Interventional Phase|Withdrawal by Subject|0|||
30609590|NCT00960661|58620375|FG001|Interventional Phase|Withdrawal by Subject|18|||
30609591|NCT00960661|58620376|FG002|Interventional Phase|Withdrawal by Subject|29|||
30609592|NCT00960661|58620374|FG000|Interventional Phase|Physician Decision|0|||
30609593|NCT00960661|58620375|FG001|Interventional Phase|Physician Decision|3|||
30609594|NCT00960661|58620376|FG002|Interventional Phase|Physician Decision|5|||
30609595|NCT00960661|58620374|FG000|Interventional Phase|sponsor decision|0|||
30609596|NCT00960661|58620375|FG001|Interventional Phase|sponsor decision|1|||
30609597|NCT00960661|58620376|FG002|Interventional Phase|sponsor decision|0|||
30609598|NCT00960661|58620374|FG000|Interventional Phase|Lack of Efficacy|0|||
30609599|NCT00960661|58620375|FG001|Interventional Phase|Lack of Efficacy|2|||
30609600|NCT00960661|58620376|FG002|Interventional Phase|Lack of Efficacy|0|||
30609601|NCT00960193|58620382|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
30609602|NCT00960115|58620391|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
30609603|NCT00960115|58620392|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
30609604|NCT00959647|58620398|FG000|Overall Study|Adverse Event|2|||
30609605|NCT00959647|58620398|FG000|Overall Study|Progressive disease|6|||
30609606|NCT00959647|58620398|FG000|Overall Study|Study terminated by sponsor|4|||
30609607|NCT00959647|58620398|FG000|Overall Study|Withdrawal by Subject|7|||
30609608|NCT00957931|58620402|FG000|Overall Study|Death|4|||
30609609|NCT00957853|58620409|FG000|Overall Study|Withdrawal by Subject|1|||
30609610|NCT00957853|58620410|FG001|Overall Study|Withdrawal by Subject|0|||
30609611|NCT00957853|58620411|FG002|Overall Study|Withdrawal by Subject|0|||
30609612|NCT00957229|58620421|FG000|Study Start|Adverse Event|0|||
30609613|NCT00957229|58620422|FG001|Study Start|Adverse Event|3|||
30609614|NCT00957229|58620421|FG000|Study Start|Disease Progression|1|||
30609615|NCT00957229|58620422|FG001|Study Start|Disease Progression|0|||
30609616|NCT00957229|58620421|FG000|Reallocated to or Continued Vismodegib|Death|1|||
30609617|NCT00957229|58620422|FG001|Reallocated to or Continued Vismodegib|Death|1|||
30609618|NCT00957229|58620421|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
30609619|NCT00957229|58620422|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
30609620|NCT02604511|58620428|FG000|Overall Study|Adverse Event|3|||
30609621|NCT02604511|58620428|FG000|Overall Study|Disease Progression|4|||
30609622|NCT02604511|58620428|FG000|Overall Study|Withdrawal by Subject|3|||
30609623|NCT02604511|58620428|FG000|Overall Study|Participant ineligible|1|||
30609624|NCT02604511|58620428|FG000|Overall Study|Intercurrent illness|1|||
30609625|NCT00956839|58620436|FG000|Overall Study|Lost to Follow-up|3|||
30609626|NCT00956839|58620437|FG001|Overall Study|Lost to Follow-up|0|||
30609627|NCT00956839|58620438|FG002|Overall Study|Lost to Follow-up|3|||
30609628|NCT00956293|58620448|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
30609629|NCT00956293|58620449|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
30609630|NCT00956293|58620450|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
30609631|NCT00956293|58620448|FG000|Main Period (Pre-randomization)|Death|0|||
30609632|NCT00956293|58620449|FG001|Main Period (Pre-randomization)|Death|0|||
30609633|NCT00956293|58620450|FG002|Main Period (Pre-randomization)|Death|1|||
30609634|NCT00956293|58620448|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
30609635|NCT00956293|58620449|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
30609636|NCT00956293|58620450|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
30609637|NCT00956293|58620448|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
30609638|NCT00956293|58620449|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
30609639|NCT00956293|58620450|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
30609640|NCT00956293|58620448|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
30609641|NCT00956293|58620449|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
30609642|NCT00956293|58620450|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
30609643|NCT00956293|58620448|FG000|Main Period (Pre-randomization)|Graft loss|0|||
30609644|NCT00956293|58620449|FG001|Main Period (Pre-randomization)|Graft loss|0|||
30609645|NCT00956293|58620450|FG002|Main Period (Pre-randomization)|Graft loss|7|||
30609646|NCT00956293|58620448|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
30609647|NCT00956293|58620449|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
30609648|NCT00956293|58620450|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
30609649|NCT00956293|58620448|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
30609650|NCT00956293|58620449|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
30609651|NCT00956293|58620450|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
30609652|NCT00956293|58620448|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
30609653|NCT00956293|58620449|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
30609654|NCT00956293|58620450|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
30609655|NCT00956293|58620448|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
30609656|NCT00956293|58620449|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
30609657|NCT00956293|58620450|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
30609658|NCT00956293|58620448|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
30609659|NCT00956293|58620449|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
30609660|NCT00956293|58620450|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
30609661|NCT00956293|58620448|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
30609662|NCT00956293|58620449|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
30609663|NCT00956293|58620450|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
30609664|NCT00956293|58620448|FG000|Main Period (Randomization)|Adverse Event|0|||
30609665|NCT00956293|58620449|FG001|Main Period (Randomization)|Adverse Event|15|||
30609666|NCT00956293|58620450|FG002|Main Period (Randomization)|Adverse Event|0|||
30609667|NCT00956293|58620448|FG000|Follow-up Period|Follow-up period was terminated.|20|||
30609668|NCT00956293|58620449|FG001|Follow-up Period|Follow-up period was terminated.|32|||
30609669|NCT00956293|58620450|FG002|Follow-up Period|Follow-up period was terminated.|0|||
30609670|NCT00955825|58620458|FG000|Overall Study|Adverse Event|15|||
30609671|NCT00955825|58620459|FG001|Overall Study|Adverse Event|2|||
30609672|NCT00955825|58620458|FG000|Overall Study|Withdrawal by Subject|4|||
30609673|NCT00955825|58620459|FG001|Overall Study|Withdrawal by Subject|6|||
30609674|NCT00955825|58620458|FG000|Overall Study|Any other reason not above-mentioned|7|||
30609675|NCT00955825|58620459|FG001|Overall Study|Any other reason not above-mentioned|9|||
30609676|NCT01164579|58620468|FG000|Overall Study|Lack of Efficacy|0|||
30609677|NCT01164579|58620469|FG001|Overall Study|Lack of Efficacy|0|||
30609678|NCT01164579|58620470|FG002|Overall Study|Lack of Efficacy|6|||
30609679|NCT01164579|58620468|FG000|Overall Study|Lost to Follow-up|1|||
30609680|NCT01164579|58620469|FG001|Overall Study|Lost to Follow-up|1|||
30609681|NCT01164579|58620470|FG002|Overall Study|Lost to Follow-up|0|||
30609682|NCT01164579|58620468|FG000|Overall Study|Withdrawal by Subject|2|||
30609683|NCT01164579|58620469|FG001|Overall Study|Withdrawal by Subject|5|||
30609684|NCT01164579|58620470|FG002|Overall Study|Withdrawal by Subject|3|||
30609685|NCT01164579|58620468|FG000|Overall Study|Protocol Violation|0|||
30609686|NCT01164579|58620469|FG001|Overall Study|Protocol Violation|1|||
30609687|NCT01164579|58620470|FG002|Overall Study|Protocol Violation|2|||
30609688|NCT01164579|58620468|FG000|Overall Study|Adverse Event|4|||
30609689|NCT01164579|58620469|FG001|Overall Study|Adverse Event|2|||
30609690|NCT01164579|58620470|FG002|Overall Study|Adverse Event|5|||
30609691|NCT01164579|58620468|FG000|Overall Study|Reason not specified|1|||
30609692|NCT01164579|58620469|FG001|Overall Study|Reason not specified|0|||
30609693|NCT01164579|58620470|FG002|Overall Study|Reason not specified|0|||
30609694|NCT00958789|58620479|FG000|Overall Study|Death|5|||
30609695|NCT00958789|58620479|FG000|Overall Study|Lost to Follow-up|14|||
30609696|NCT00958789|58620479|FG000|Overall Study|Withdrawal by Subject|17|||
30609697|NCT00958789|58620479|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
30609698|NCT00958789|58620479|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
30609699|NCT00958789|58620479|FG000|Overall Study|Subject terminated|2|||
30609700|NCT00958789|58620479|FG000|Overall Study|Revision|7|||
30609701|NCT02445391|58620490|FG000|Overall Study|No active protocol treatment|3|||
30609702|NCT02445391|58620491|FG001|Overall Study|No active protocol treatment|0|||
30609703|NCT02445391|58620492|FG002|Overall Study|No active protocol treatment|0|||
30609704|NCT02445391|58620490|FG000|Overall Study|Adverse Event|0|||
30609705|NCT02445391|58620491|FG001|Overall Study|Adverse Event|21|||
30609706|NCT02445391|58620492|FG002|Overall Study|Adverse Event|12|||
30609707|NCT02445391|58620490|FG000|Overall Study|Alternative therapy|0|||
30609708|NCT02445391|58620491|FG001|Overall Study|Alternative therapy|0|||
30609709|NCT02445391|58620492|FG002|Overall Study|Alternative therapy|1|||
30609710|NCT02445391|58620490|FG000|Overall Study|Disease progression|0|||
30609711|NCT02445391|58620491|FG001|Overall Study|Disease progression|7|||
30609712|NCT02445391|58620492|FG002|Overall Study|Disease progression|22|||
30609713|NCT02445391|58620490|FG000|Overall Study|Complicating disease|0|||
30609714|NCT02445391|58620491|FG001|Overall Study|Complicating disease|2|||
30609715|NCT02445391|58620492|FG002|Overall Study|Complicating disease|1|||
30609716|NCT02445391|58620490|FG000|Overall Study|Withdrawal by Subject|0|||
31006252|NCT01682226|59207530|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
31006253|NCT01688466|59207536|FG000|Overall Study|Withdrawal by Subject|2|||
31006254|NCT01688466|59207537|FG001|Overall Study|Withdrawal by Subject|1|||
31006255|NCT01688466|59207536|FG000|Overall Study|Death|0|||
31006256|NCT01688466|59207537|FG001|Overall Study|Death|1|||
31006257|NCT01688466|59207536|FG000|Overall Study|Adverse Event|0|||
31006258|NCT01688466|59207537|FG001|Overall Study|Adverse Event|4|||
31006259|NCT01688466|59207536|FG000|Overall Study|Not evaluable|0|||
31006260|NCT01688466|59207537|FG001|Overall Study|Not evaluable|1|||
31006261|NCT01682148|59207545|FG000|Overall Study|Withdrawal by Subject|2|||
31006262|NCT01682148|59207546|FG001|Overall Study|Withdrawal by Subject|0|||
31006263|NCT01682148|59207545|FG000|Overall Study|Lost to Follow-up|1|||
31006264|NCT01682148|59207546|FG001|Overall Study|Lost to Follow-up|2|||
31006265|NCT01682148|59207545|FG000|Overall Study|Protocol Violation|1|||
31006266|NCT01682148|59207546|FG001|Overall Study|Protocol Violation|1|||
31006267|NCT01681992|59207560|FG000|Overall Study|Adverse Event|3|||
31006268|NCT01681992|59207561|FG001|Overall Study|Adverse Event|2|||
31006269|NCT01681992|59207562|FG002|Overall Study|Adverse Event|3|||
31006270|NCT01681992|59207560|FG000|Overall Study|Lost to Follow-up|36|||
31006271|NCT01681992|59207561|FG001|Overall Study|Lost to Follow-up|38|||
31006272|NCT01681992|59207562|FG002|Overall Study|Lost to Follow-up|53|||
31006273|NCT01681992|59207560|FG000|Overall Study|As Per Sponsor Decision|0|||
31006274|NCT01681992|59207561|FG001|Overall Study|As Per Sponsor Decision|0|||
30609717|NCT02445391|58620491|FG001|Overall Study|Withdrawal by Subject|4|||
30609718|NCT02445391|58620492|FG002|Overall Study|Withdrawal by Subject|9|||
30609719|NCT02445391|58620490|FG000|Overall Study|Financial issue|0|||
30609720|NCT02445391|58620491|FG001|Overall Study|Financial issue|0|||
30609721|NCT02445391|58620492|FG002|Overall Study|Financial issue|2|||
31006275|NCT01681992|59207562|FG002|Overall Study|As Per Sponsor Decision|1|||
31006276|NCT01681992|59207560|FG000|Overall Study|Protocol Violation|0|||
31006277|NCT01681992|59207561|FG001|Overall Study|Protocol Violation|0|||
31006278|NCT01681992|59207562|FG002|Overall Study|Protocol Violation|1|||
30609722|NCT02445391|58620490|FG000|Overall Study|Still on treatment|0|||
30609723|NCT02445391|58620491|FG001|Overall Study|Still on treatment|7|||
30609724|NCT02445391|58620492|FG002|Overall Study|Still on treatment|16|||
30609725|NCT02445391|58620490|FG000|Overall Study|Not start protocol therapy|0|||
30609726|NCT02445391|58620491|FG001|Overall Study|Not start protocol therapy|12|||
30609727|NCT02445391|58620492|FG002|Overall Study|Not start protocol therapy|9|||
30609728|NCT01246986|58620508|FG000|Overall Study|Lost to Follow-up|0|||
30609729|NCT01246986|58620509|FG001|Overall Study|Lost to Follow-up|1|||
30609730|NCT01246986|58620510|FG002|Overall Study|Lost to Follow-up|3|||
30609731|NCT01246986|58620511|FG003|Overall Study|Lost to Follow-up|0|||
30609732|NCT01246986|58620512|FG004|Overall Study|Lost to Follow-up|0|||
30609733|NCT01246986|58620513|FG005|Overall Study|Lost to Follow-up|1|||
30609734|NCT01246986|58620514|FG006|Overall Study|Lost to Follow-up|0|||
30609735|NCT01246986|58620508|FG000|Overall Study|Withdrawal by Subject|3|||
30609736|NCT01246986|58620509|FG001|Overall Study|Withdrawal by Subject|4|||
30609737|NCT01246986|58620510|FG002|Overall Study|Withdrawal by Subject|3|||
30609738|NCT01246986|58620511|FG003|Overall Study|Withdrawal by Subject|0|||
30609739|NCT01246986|58620512|FG004|Overall Study|Withdrawal by Subject|4|||
30609740|NCT01246986|58620513|FG005|Overall Study|Withdrawal by Subject|0|||
30609741|NCT01246986|58620514|FG006|Overall Study|Withdrawal by Subject|0|||
30609742|NCT01164501|58620548|FG000|Overall Study|Not treated|2|||
30609743|NCT01164501|58620549|FG001|Overall Study|Not treated|0|||
30609744|NCT01164501|58620550|FG002|Overall Study|Not treated|1|||
30609745|NCT01164501|58620548|FG000|Overall Study|Adverse Event|18|||
30609746|NCT01164501|58620549|FG001|Overall Study|Adverse Event|4|||
30609747|NCT01164501|58620550|FG002|Overall Study|Adverse Event|21|||
30609748|NCT01164501|58620548|FG000|Overall Study|Lack of Efficacy|0|||
30609749|NCT01164501|58620549|FG001|Overall Study|Lack of Efficacy|0|||
30609750|NCT01164501|58620550|FG002|Overall Study|Lack of Efficacy|1|||
30609751|NCT01164501|58620548|FG000|Overall Study|Non compliant with protocol|1|||
30609752|NCT01164501|58620549|FG001|Overall Study|Non compliant with protocol|1|||
30609753|NCT01164501|58620550|FG002|Overall Study|Non compliant with protocol|4|||
30609754|NCT01164501|58620548|FG000|Overall Study|Lost to Follow-up|3|||
30609755|NCT01164501|58620549|FG001|Overall Study|Lost to Follow-up|0|||
30609756|NCT01164501|58620550|FG002|Overall Study|Lost to Follow-up|3|||
30609757|NCT01164501|58620548|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
30609758|NCT01164501|58620549|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
30609759|NCT01164501|58620550|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
30609760|NCT01164501|58620548|FG000|Overall Study|Other reason not defined above|9|||
30609761|NCT01164501|58620549|FG001|Overall Study|Other reason not defined above|1|||
30609762|NCT01164501|58620550|FG002|Overall Study|Other reason not defined above|4|||
30609763|NCT00958711|58620562|FG000|Overall Study|Withdrawal by Subject|0|||
30609764|NCT00958711|58620563|FG001|Overall Study|Withdrawal by Subject|4|||
30609765|NCT00958711|58620562|FG000|Overall Study|Physician Decision|5|||
30609766|NCT00958711|58620563|FG001|Overall Study|Physician Decision|7|||
30609767|NCT00958711|58620562|FG000|Overall Study|Lost to Follow-up|4|||
30609768|NCT00958711|58620563|FG001|Overall Study|Lost to Follow-up|1|||
30609769|NCT00958711|58620562|FG000|Overall Study|Other|2|||
30609770|NCT00958711|58620563|FG001|Overall Study|Other|5|||
30609771|NCT00958711|58620562|FG000|Overall Study|Death|1|||
30892683|NCT02165397|58926135|FG000|Overall Study|Death|7|||
31006279|NCT01681992|59207560|FG000|Overall Study|Withdrawal by Subject|27|||
31006280|NCT01681992|59207561|FG001|Overall Study|Withdrawal by Subject|30|||
31006281|NCT01681992|59207562|FG002|Overall Study|Withdrawal by Subject|25|||
30609772|NCT00958711|58620563|FG001|Overall Study|Death|2|||
30609773|NCT00958711|58620562|FG000|Overall Study|Adverse Event|1|||
30892684|NCT02165397|58926136|FG001|Overall Study|Death|10|||
30892685|NCT02165397|58926137|FG002|Overall Study|Death|8|||
30892686|NCT02165397|58926135|FG000|Overall Study|Lost to Follow-up|1|||
31006282|NCT01687998|59207572|FG000|Overall Study|Withdrawal by Subject|49|||
31006283|NCT01687998|59207573|FG001|Overall Study|Withdrawal by Subject|51|||
31006284|NCT01687998|59207572|FG000|Overall Study|Known to be Alive at Study End|54|||
31006285|NCT01687998|59207573|FG001|Overall Study|Known to be Alive at Study End|62|||
31006286|NCT01687998|59207572|FG000|Overall Study|Lost to Follow-up|9|||
31006287|NCT01687998|59207573|FG001|Overall Study|Lost to Follow-up|7|||
30609774|NCT00958711|58620563|FG001|Overall Study|Adverse Event|2|||
30609775|NCT01163721|58620571|FG000|Overall Study|Adverse Event|5|||
30609776|NCT01163721|58620572|FG001|Overall Study|Adverse Event|6|||
30609777|NCT01163721|58620571|FG000|Overall Study|Withdrawal by Subject|3|||
30609778|NCT01163721|58620572|FG001|Overall Study|Withdrawal by Subject|4|||
30609779|NCT01163721|58620571|FG000|Overall Study|Lost to Follow-up|0|||
30609780|NCT01163721|58620572|FG001|Overall Study|Lost to Follow-up|1|||
30609781|NCT01163721|58620571|FG000|Overall Study|Physician Decision|0|||
31006288|NCT01681836|59207579|FG000|Second Intervention|Withdrawal by Subject|0|||
30609782|NCT01163721|58620572|FG001|Overall Study|Physician Decision|1|||
30609783|NCT00958243|58620584|FG000|Overall Study|Withdrawal by Subject|0|||
30609784|NCT00958243|58620585|FG001|Overall Study|Withdrawal by Subject|1|||
30892687|NCT02165397|58926136|FG001|Overall Study|Lost to Follow-up|3|||
30609785|NCT00958243|58620586|FG002|Overall Study|Withdrawal by Subject|3|||
30609786|NCT00958243|58620587|FG003|Overall Study|Withdrawal by Subject|1|||
30609787|NCT00958243|58620588|FG004|Overall Study|Withdrawal by Subject|1|||
30609788|NCT00958243|58620589|FG005|Overall Study|Withdrawal by Subject|5|||
30609789|NCT00958243|58620584|FG000|Overall Study|Lost to Follow-up|2|||
30609790|NCT00958243|58620585|FG001|Overall Study|Lost to Follow-up|5|||
30609791|NCT00958243|58620586|FG002|Overall Study|Lost to Follow-up|11|||
30609792|NCT00958243|58620587|FG003|Overall Study|Lost to Follow-up|2|||
30609793|NCT00958243|58620588|FG004|Overall Study|Lost to Follow-up|8|||
30609794|NCT00958243|58620589|FG005|Overall Study|Lost to Follow-up|5|||
30609795|NCT01241760|58620611|FG000|Overall Study|Adverse Event|1|||
30609796|NCT01241760|58620612|FG001|Overall Study|Adverse Event|0|||
30609797|NCT01241760|58620611|FG000|Overall Study|Lost to Follow-up|18|||
30609798|NCT01241760|58620612|FG001|Overall Study|Lost to Follow-up|22|||
30609799|NCT01241760|58620611|FG000|Overall Study|Withdrawal by Subject|13|||
30609800|NCT01241760|58620612|FG001|Overall Study|Withdrawal by Subject|13|||
30609801|NCT01241760|58620611|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
30609802|NCT01241760|58620612|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
30609803|NCT01241760|58620611|FG000|Overall Study|Other|1|||
30609804|NCT01241760|58620612|FG001|Overall Study|Other|1|||
30609805|NCT00958165|58620619|FG000|Overall Study|Lost to Follow-up|5|||
30609806|NCT00958165|58620619|FG000|Overall Study|Not eligible|9|||
30609807|NCT00958009|58620623|FG000|Overall Study|Adverse Event|1|||
30609808|NCT00958009|58620623|FG000|Overall Study|Subject found device difficult to use|1|||
30609809|NCT00953407|58620632|FG000|Overall Study|Failed inclusion criteria|1|||
30609810|NCT00953407|58620633|FG001|Overall Study|Failed inclusion criteria|1|||
30609811|NCT00953407|58620634|FG002|Overall Study|Failed inclusion criteria|1|||
30609812|NCT00953407|58620635|FG003|Overall Study|Failed inclusion criteria|1|||
30892688|NCT02165397|58926137|FG002|Overall Study|Lost to Follow-up|0|||
30892689|NCT02165397|58926135|FG000|Overall Study|Withdrawal by Subject|6|||
30892690|NCT02165397|58926136|FG001|Overall Study|Withdrawal by Subject|6|||
30892691|NCT02165397|58926137|FG002|Overall Study|Withdrawal by Subject|1|||
30892692|NCT02165397|58926135|FG000|Overall Study|Other, Not Specified|0|||
30892693|NCT02165397|58926136|FG001|Overall Study|Other, Not Specified|0|||
30892694|NCT02165397|58926137|FG002|Overall Study|Other, Not Specified|1|||
30892695|NCT02132637|58926149|FG000|Study Period 1|Withdrawal by Subject|0|||
30892696|NCT02132637|58926150|FG001|Study Period 1|Withdrawal by Subject|4|||
30609813|NCT00953407|58620636|FG004|Overall Study|Failed inclusion criteria|1|||
30609814|NCT00953407|58620632|FG000|Overall Study|Lost to Follow-up|0|||
30609815|NCT00953407|58620633|FG001|Overall Study|Lost to Follow-up|0|||
30609816|NCT00953407|58620634|FG002|Overall Study|Lost to Follow-up|0|||
30609817|NCT00953407|58620635|FG003|Overall Study|Lost to Follow-up|1|||
30609818|NCT00953407|58620636|FG004|Overall Study|Lost to Follow-up|0|||
30609819|NCT00953329|58620648|FG000|Overall Study|Lack of Efficacy|1|||
30609820|NCT00953017|58620656|FG000|Overall Study|DId not show up for colonoscopy|4|||
30609821|NCT00953017|58620657|FG001|Overall Study|DId not show up for colonoscopy|4|||
30609822|NCT00953017|58620658|FG002|Overall Study|DId not show up for colonoscopy|5|||
30609823|NCT00953017|58620659|FG003|Overall Study|DId not show up for colonoscopy|4|||
30609824|NCT00953017|58620656|FG000|Overall Study|Incomplete data|1|||
30609825|NCT00953017|58620657|FG001|Overall Study|Incomplete data|1|||
30609826|NCT00953017|58620658|FG002|Overall Study|Incomplete data|0|||
30609827|NCT00953017|58620659|FG003|Overall Study|Incomplete data|0|||
30609828|NCT00953017|58620656|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
30892697|NCT02132637|58926149|FG000|Study Period 1|Physician Decision|1|||
30892698|NCT02132637|58926150|FG001|Study Period 1|Physician Decision|0|||
30892699|NCT02132637|58926149|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
30892700|NCT02132637|58926150|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
30609829|NCT00953017|58620657|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
30609830|NCT00953017|58620658|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
30609831|NCT00953017|58620659|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
30609832|NCT00953017|58620656|FG000|Overall Study|Brown stool prior to procedure|0|||
30609833|NCT00953017|58620657|FG001|Overall Study|Brown stool prior to procedure|0|||
30609834|NCT00953017|58620658|FG002|Overall Study|Brown stool prior to procedure|1|||
30609835|NCT00953017|58620659|FG003|Overall Study|Brown stool prior to procedure|0|||
30609836|NCT00952705|58620672|FG000|Overall Study|Lost to Follow-up|24|||
30609837|NCT00952705|58620673|FG001|Overall Study|Lost to Follow-up|8|||
30609838|NCT00952705|58620674|FG002|Overall Study|Lost to Follow-up|9|||
30609839|NCT00952705|58620672|FG000|Overall Study|Withdrawal by Subject|2|||
30609840|NCT00952705|58620673|FG001|Overall Study|Withdrawal by Subject|1|||
30609841|NCT00952705|58620674|FG002|Overall Study|Withdrawal by Subject|1|||
30609842|NCT00952705|58620672|FG000|Overall Study|Death|2|||
30609843|NCT00952705|58620673|FG001|Overall Study|Death|0|||
30609844|NCT00952705|58620674|FG002|Overall Study|Death|0|||
30609845|NCT00952705|58620672|FG000|Overall Study|Incarcerated post dose|5|||
30609846|NCT00952705|58620673|FG001|Overall Study|Incarcerated post dose|0|||
30609847|NCT00952705|58620674|FG002|Overall Study|Incarcerated post dose|0|||
30609848|NCT00952705|58620672|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
30609849|NCT00952705|58620673|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
30609850|NCT00952705|58620674|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
30609851|NCT00955357|58620688|FG000|Titration Phase|Adverse Event|9|||
30609852|NCT00955357|58620689|FG001|Titration Phase|Adverse Event|46|||
30609853|NCT00955357|58620688|FG000|Titration Phase|Lack of Efficacy|0|||
30609854|NCT00955357|58620689|FG001|Titration Phase|Lack of Efficacy|2|||
30609855|NCT00955357|58620688|FG000|Titration Phase|Protocol Violation|3|||
30609856|NCT00955357|58620689|FG001|Titration Phase|Protocol Violation|7|||
30609857|NCT00955357|58620688|FG000|Titration Phase|Lost to Follow-up|1|||
30609858|NCT00955357|58620689|FG001|Titration Phase|Lost to Follow-up|3|||
30609859|NCT00955357|58620688|FG000|Titration Phase|Withdrawal by Subject|3|||
30609860|NCT00955357|58620689|FG001|Titration Phase|Withdrawal by Subject|5|||
30609861|NCT00955357|58620688|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
30609862|NCT00955357|58620689|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
30609863|NCT00955357|58620688|FG000|Titration Phase|Study medication not tolerated|0|||
30609864|NCT00955357|58620689|FG001|Titration Phase|Study medication not tolerated|1|||
30609865|NCT00955357|58620688|FG000|Titration Phase|Non compliance to study procedures|0|||
30609866|NCT00955357|58620689|FG001|Titration Phase|Non compliance to study procedures|1|||
30609867|NCT00955357|58620688|FG000|Maintenance Phase|Adverse Event|3|||
30609868|NCT00955357|58620689|FG001|Maintenance Phase|Adverse Event|23|||
30609869|NCT00955357|58620688|FG000|Maintenance Phase|Lack of Efficacy|0|||
30609870|NCT00955357|58620689|FG001|Maintenance Phase|Lack of Efficacy|4|||
30609871|NCT00955357|58620688|FG000|Maintenance Phase|Protocol Violation|2|||
30609872|NCT00955357|58620689|FG001|Maintenance Phase|Protocol Violation|6|||
30609873|NCT00955357|58620688|FG000|Maintenance Phase|Lost to Follow-up|2|||
30609874|NCT00955357|58620689|FG001|Maintenance Phase|Lost to Follow-up|7|||
30609875|NCT00955357|58620688|FG000|Maintenance Phase|Withdrawal by Subject|4|||
30609876|NCT00955357|58620689|FG001|Maintenance Phase|Withdrawal by Subject|4|||
30609877|NCT00955357|58620688|FG000|Maintenance Phase|Patient moving out of area|0|||
30609878|NCT00955357|58620689|FG001|Maintenance Phase|Patient moving out of area|1|||
30609879|NCT00955357|58620688|FG000|Maintenance Phase|Non compliance to study procedures|1|||
30609880|NCT00955357|58620689|FG001|Maintenance Phase|Non compliance to study procedures|0|||
30609881|NCT00955279|58620698|FG000|Overall Study|Other|0|||
30609882|NCT00955279|58620699|FG001|Overall Study|Other|0|||
30609883|NCT00955279|58620700|FG002|Overall Study|Other|3|||
30609884|NCT00955279|58620698|FG000|Overall Study|Death|1|||
30609885|NCT00955279|58620699|FG001|Overall Study|Death|1|||
30609886|NCT00955279|58620700|FG002|Overall Study|Death|1|||
30609887|NCT00955279|58620698|FG000|Overall Study|Lost to Follow-up|0|||
30609888|NCT00955279|58620699|FG001|Overall Study|Lost to Follow-up|3|||
30609889|NCT00955279|58620700|FG002|Overall Study|Lost to Follow-up|1|||
30609890|NCT00955279|58620698|FG000|Overall Study|Withdrawal by Subject|2|||
30609891|NCT00955279|58620699|FG001|Overall Study|Withdrawal by Subject|0|||
30892701|NCT02132637|58926149|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
30892702|NCT02132637|58926150|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
30892703|NCT02164929|58926160|FG000|Overall Study|Converted to open procedure|1|||
30892704|NCT02164929|58926161|FG001|Overall Study|Converted to open procedure|0|||
30609892|NCT00955279|58620700|FG002|Overall Study|Withdrawal by Subject|3|||
30609893|NCT00954733|58620708|FG000|Overall Study|blood gas machine did not work|1|||
30609894|NCT00954421|58620712|FG000|Screening|screen failures|3|||
30609895|NCT00954421|58620712|FG000|6 Months of DBS|Withdrawal by Subject|1|||
30609896|NCT00954421|58620712|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
30609897|NCT01241448|58620722|FG000|Overall Study|Adverse Event|1|||
30892705|NCT02164929|58926162|FG002|Overall Study|Converted to open procedure|0|||
30609898|NCT01241448|58620723|FG001|Overall Study|Adverse Event|0|||
30609899|NCT01241448|58620724|FG002|Overall Study|Adverse Event|2|||
30609900|NCT01241448|58620725|FG003|Overall Study|Adverse Event|2|||
30892706|NCT02164929|58926163|FG003|Overall Study|Converted to open procedure|2|||
30609901|NCT01241448|58620722|FG000|Overall Study|Lost to Follow-up|2|||
30609902|NCT01241448|58620723|FG001|Overall Study|Lost to Follow-up|1|||
30609903|NCT01241448|58620724|FG002|Overall Study|Lost to Follow-up|1|||
30609904|NCT01241448|58620725|FG003|Overall Study|Lost to Follow-up|1|||
30609905|NCT01241448|58620722|FG000|Overall Study|Physician Decision|0|||
30609906|NCT01241448|58620723|FG001|Overall Study|Physician Decision|2|||
30609907|NCT01241448|58620724|FG002|Overall Study|Physician Decision|0|||
30609908|NCT01241448|58620725|FG003|Overall Study|Physician Decision|0|||
30609909|NCT01241448|58620722|FG000|Overall Study|Protocol Violation|10|||
30609910|NCT01241448|58620723|FG001|Overall Study|Protocol Violation|5|||
30609911|NCT01241448|58620724|FG002|Overall Study|Protocol Violation|3|||
30609912|NCT01241448|58620725|FG003|Overall Study|Protocol Violation|6|||
30609913|NCT01241448|58620722|FG000|Overall Study|Sponsor Decision|17|||
31006289|NCT01681836|59207580|FG001|Second Intervention|Withdrawal by Subject|1|||
31006290|NCT01681368|59207586|FG000|Overall Study|Refused further treatment|1|||
31006291|NCT01681368|59207586|FG000|Overall Study|Refused further follow up|1|||
30609914|NCT01241448|58620723|FG001|Overall Study|Sponsor Decision|14|||
30609915|NCT01241448|58620724|FG002|Overall Study|Sponsor Decision|12|||
30609916|NCT01241448|58620725|FG003|Overall Study|Sponsor Decision|6|||
30609917|NCT01241448|58620722|FG000|Overall Study|Withdrawal by Subject|4|||
30609918|NCT01241448|58620723|FG001|Overall Study|Withdrawal by Subject|5|||
30609919|NCT01241448|58620724|FG002|Overall Study|Withdrawal by Subject|3|||
30609920|NCT01241448|58620725|FG003|Overall Study|Withdrawal by Subject|6|||
30609921|NCT01241448|58620722|FG000|Overall Study|Excluded due to data integrity issues|3|||
30609922|NCT01241448|58620723|FG001|Overall Study|Excluded due to data integrity issues|2|||
30609923|NCT01241448|58620724|FG002|Overall Study|Excluded due to data integrity issues|2|||
30609924|NCT01241448|58620725|FG003|Overall Study|Excluded due to data integrity issues|2|||
31006292|NCT01681212|59207590|FG000|Overall Study|No longer met study criteria|5|||
31006293|NCT01681212|59207590|FG000|Overall Study|Administrative reason by sponsor|1|||
31006294|NCT01687296|59207596|FG000|Overall Study|Lack of Efficacy|1|||
31006295|NCT01687296|59207597|FG001|Overall Study|Lack of Efficacy|1|||
31006296|NCT01687296|59207596|FG000|Overall Study|Protocol Violation|0|||
31006297|NCT01687296|59207597|FG001|Overall Study|Protocol Violation|1|||
31006298|NCT01687296|59207596|FG000|Overall Study|Withdrawal by Subject|6|||
31006299|NCT01687296|59207597|FG001|Overall Study|Withdrawal by Subject|3|||
31006300|NCT01568892|59207618|FG000|Open-label Phase|Adverse Event|2|||
31006301|NCT01568892|59207619|FG001|Open-label Phase|Adverse Event|0|||
31006302|NCT01568892|59207618|FG000|Open-label Phase|Lack of Efficacy|4|||
31006303|NCT01568892|59207619|FG001|Open-label Phase|Lack of Efficacy|2|||
31006304|NCT01568892|59207618|FG000|Open-label Phase|Lost to Follow-up|0|||
31006305|NCT01568892|59207619|FG001|Open-label Phase|Lost to Follow-up|1|||
31006306|NCT01568112|59207630|FG000|Overall Study|Randomized But Not Treated|0|||
31006307|NCT01568112|59207631|FG001|Overall Study|Randomized But Not Treated|1|||
31006308|NCT01568112|59207632|FG002|Overall Study|Randomized But Not Treated|0|||
31006309|NCT01568112|59207633|FG003|Overall Study|Randomized But Not Treated|0|||
31006310|NCT01568112|59207630|FG000|Overall Study|Withdrew due to Adverse Event|2|||
31006311|NCT01568112|59207631|FG001|Overall Study|Withdrew due to Adverse Event|4|||
31006312|NCT01568112|59207632|FG002|Overall Study|Withdrew due to Adverse Event|6|||
31006313|NCT01568112|59207633|FG003|Overall Study|Withdrew due to Adverse Event|3|||
31006314|NCT01568112|59207630|FG000|Overall Study|Lost to Follow-up|0|||
31006315|NCT01568112|59207631|FG001|Overall Study|Lost to Follow-up|0|||
31006316|NCT01568112|59207632|FG002|Overall Study|Lost to Follow-up|0|||
31006317|NCT01568112|59207633|FG003|Overall Study|Lost to Follow-up|1|||
31006318|NCT01568112|59207630|FG000|Overall Study|Withdrawal by Subject|2|||
31006319|NCT01568112|59207631|FG001|Overall Study|Withdrawal by Subject|3|||
31006320|NCT01568112|59207632|FG002|Overall Study|Withdrawal by Subject|0|||
31006321|NCT01568112|59207633|FG003|Overall Study|Withdrawal by Subject|7|||
31006322|NCT01568112|59207630|FG000|Overall Study|Withdrawal by Physician|1|||
31006323|NCT01568112|59207631|FG001|Overall Study|Withdrawal by Physician|0|||
31006324|NCT01568112|59207632|FG002|Overall Study|Withdrawal by Physician|1|||
31006325|NCT01568112|59207633|FG003|Overall Study|Withdrawal by Physician|1|||
31006326|NCT01568034|59207644|FG000|Overall Study|Withdrawal by Subject|1|||
31006327|NCT01568034|59207645|FG001|Overall Study|Withdrawal by Subject|0|||
31006328|NCT01568034|59207646|FG002|Overall Study|Withdrawal by Subject|0|||
31006329|NCT01568034|59207647|FG003|Overall Study|Withdrawal by Subject|0|||
31006330|NCT01687218|59207663|FG000|Overall Study|Withdrawal by Subject|2|||
31006331|NCT01687218|59207664|FG001|Overall Study|Withdrawal by Subject|3|||
30609925|NCT01240356|58620738|FG000|Overall Study|Withdrawal by Subject|2|||
30609926|NCT01240356|58620739|FG001|Overall Study|Withdrawal by Subject|0|||
30609927|NCT01240356|58620738|FG000|Overall Study|MRI contraindication|1|||
30609928|NCT01240356|58620739|FG001|Overall Study|MRI contraindication|0|||
30609929|NCT01239732|58620748|FG000|Overall Study|Termination of study per protocol|667|||
30609930|NCT01239732|58620748|FG000|Overall Study|Death|226|||
31006332|NCT01687218|59207665|FG002|Overall Study|Withdrawal by Subject|0|||
31006333|NCT01687218|59207666|FG003|Overall Study|Withdrawal by Subject|1|||
31006334|NCT01687218|59207667|FG004|Overall Study|Withdrawal by Subject|1|||
30609931|NCT01239732|58620748|FG000|Overall Study|Withdrawal by Subject|87|||
30609932|NCT01239732|58620748|FG000|Overall Study|Adverse Event|6|||
30609933|NCT01239732|58620748|FG000|Overall Study|Protocol Violation|3|||
30609934|NCT01239732|58620748|FG000|Overall Study|Participant non compliance|5|||
30609935|NCT01239732|58620748|FG000|Overall Study|Study termination by sponsor|2|||
30609936|NCT01239732|58620748|FG000|Overall Study|Investigator's decision|4|||
30609937|NCT01239732|58620748|FG000|Overall Study|Treatment failure|2|||
30609938|NCT01239732|58620748|FG000|Overall Study|Other|19|||
30609939|NCT02227147|58620754|FG000|Controlled Treatment Period|Adverse Event|4|||
30609940|NCT02227147|58620755|FG001|Controlled Treatment Period|Adverse Event|3|||
30609941|NCT02227147|58620754|FG000|Controlled Treatment Period|Other|2|||
30609942|NCT02227147|58620755|FG001|Controlled Treatment Period|Other|0|||
30609943|NCT02227147|58620754|FG000|Follow-up Period|Other|3|||
30609944|NCT02227147|58620755|FG001|Follow-up Period|Other|5|||
30609945|NCT00948025|58620767|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
30609946|NCT00948025|58620768|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
30609947|NCT00948025|58620767|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
30609948|NCT00948025|58620768|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
30609949|NCT00948025|58620767|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
30609950|NCT00948025|58620768|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
30609951|NCT00947011|58620775|FG000|Overall Study|Study was terminated,PI left institution|12|||
30609952|NCT01239342|58620783|FG000|Overall Study|Adverse Event|1|||
30609953|NCT01239342|58620784|FG001|Overall Study|Adverse Event|0|||
30609954|NCT01239342|58620783|FG000|Overall Study|Withdrawal by Subject|1|||
30609955|NCT01239342|58620784|FG001|Overall Study|Withdrawal by Subject|5|||
30609956|NCT01239342|58620783|FG000|Overall Study|Reason Unknown|1|||
30609957|NCT01239342|58620784|FG001|Overall Study|Reason Unknown|1|||
30609958|NCT00946309|58620792|FG000|Overall Study|Protocol Violation|1|||
30609959|NCT00946309|58620793|FG001|Overall Study|Protocol Violation|0|||
30609960|NCT00946309|58620792|FG000|Overall Study|Lost to Follow-up|0|||
30609961|NCT00946309|58620793|FG001|Overall Study|Lost to Follow-up|1|||
30609962|NCT00946309|58620792|FG000|Overall Study|Procedure cancelled/discontinued|0|||
30609963|NCT00946309|58620793|FG001|Overall Study|Procedure cancelled/discontinued|3|||
30609964|NCT01236534|58620802|FG000|Overall Study|Adverse Event|3|||
30609965|NCT01236534|58620803|FG001|Overall Study|Adverse Event|0|||
30609966|NCT01235598|58620811|FG000|Overall Study|Adverse Event|0|||
30609967|NCT01235598|58620812|FG001|Overall Study|Adverse Event|3|||
30609968|NCT01235598|58620811|FG000|Overall Study|Lack of Efficacy|0|||
30609969|NCT01235598|58620812|FG001|Overall Study|Lack of Efficacy|1|||
30609970|NCT01235598|58620811|FG000|Overall Study|Withdrawal by Subject|1|||
30609971|NCT01235598|58620812|FG001|Overall Study|Withdrawal by Subject|0|||
30609972|NCT01235442|58620821|FG000|Overall Study|Lost to Follow-up|12|||
30609973|NCT01235442|58620822|FG001|Overall Study|Lost to Follow-up|10|||
30609974|NCT01235442|58620821|FG000|Overall Study|Death|0|||
30609975|NCT01235442|58620822|FG001|Overall Study|Death|2|||
30609976|NCT01235442|58620821|FG000|Overall Study|Pregnancy|1|||
30609977|NCT01235442|58620822|FG001|Overall Study|Pregnancy|1|||
30609978|NCT01235442|58620821|FG000|Overall Study|Ineligibility determined|5|||
30609979|NCT01235442|58620822|FG001|Overall Study|Ineligibility determined|4|||
30609980|NCT01235442|58620821|FG000|Overall Study|Protocol Violation|3|||
30609981|NCT01235442|58620822|FG001|Overall Study|Protocol Violation|3|||
30609982|NCT01235442|58620821|FG000|Overall Study|Adverse Event|4|||
30609983|NCT01235442|58620822|FG001|Overall Study|Adverse Event|6|||
30609984|NCT01235442|58620821|FG000|Overall Study|Withdrawal by Subject|15|||
30609985|NCT01235442|58620822|FG001|Overall Study|Withdrawal by Subject|9|||
30609986|NCT01235442|58620821|FG000|Overall Study|Lack of Efficacy|1|||
31006335|NCT01687218|59207668|FG005|Overall Study|Withdrawal by Subject|0|||
31006336|NCT01687218|59207663|FG000|Overall Study|Relocated, no follow-up planned|1|||
31006337|NCT01687218|59207664|FG001|Overall Study|Relocated, no follow-up planned|0|||
31006338|NCT01687218|59207665|FG002|Overall Study|Relocated, no follow-up planned|1|||
31006339|NCT01687218|59207666|FG003|Overall Study|Relocated, no follow-up planned|1|||
31006340|NCT01687218|59207667|FG004|Overall Study|Relocated, no follow-up planned|0|||
31006341|NCT01687218|59207668|FG005|Overall Study|Relocated, no follow-up planned|0|||
31006342|NCT01686828|59207680|FG000|Overall Study|Physician Decision|1|||
31006343|NCT01686828|59207681|FG001|Overall Study|Physician Decision|0|||
31006344|NCT01686828|59207682|FG002|Overall Study|Physician Decision|0|||
30609987|NCT01235442|58620822|FG001|Overall Study|Lack of Efficacy|3|||
30609988|NCT01235442|58620821|FG000|Overall Study|Noncompliance|1|||
31006345|NCT01686828|59207683|FG003|Overall Study|Physician Decision|0|||
30609989|NCT01235442|58620822|FG001|Overall Study|Noncompliance|2|||
30609990|NCT01235442|58620821|FG000|Overall Study|Administrative decision|1|||
30609991|NCT01235442|58620822|FG001|Overall Study|Administrative decision|2|||
30609992|NCT01235442|58620821|FG000|Overall Study|Other unspecified|1|||
30609993|NCT01235442|58620822|FG001|Overall Study|Other unspecified|2|||
30609994|NCT01163253|58620830|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
30609995|NCT01163253|58620831|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
30609996|NCT01163253|58620830|FG000|Overall Study|Study Terminated by Sponsor|978|||
30609997|NCT01163253|58620831|FG001|Overall Study|Study Terminated by Sponsor|349|||
31006346|NCT01686828|59207680|FG000|Overall Study|New Job|0|||
31006347|NCT01686828|59207681|FG001|Overall Study|New Job|1|||
31006348|NCT01686828|59207682|FG002|Overall Study|New Job|0|||
31006349|NCT01686828|59207683|FG003|Overall Study|New Job|0|||
31006350|NCT01686828|59207680|FG000|Overall Study|Weight Loss|0|||
31006351|NCT01686828|59207681|FG001|Overall Study|Weight Loss|0|||
31006352|NCT01686828|59207682|FG002|Overall Study|Weight Loss|1|||
31006353|NCT01686828|59207683|FG003|Overall Study|Weight Loss|0|||
31006354|NCT01686438|59207700|FG000|Overall Study|Lost to Follow-up|8|||
31006355|NCT01686438|59207701|FG001|Overall Study|Lost to Follow-up|9|||
31006356|NCT01686438|59207702|FG002|Overall Study|Lost to Follow-up|10|||
31006357|NCT01686438|59207700|FG000|Overall Study|Adverse Event|0|||
31006358|NCT01686438|59207701|FG001|Overall Study|Adverse Event|0|||
31006359|NCT01686438|59207702|FG002|Overall Study|Adverse Event|1|||
31006360|NCT01686438|59207700|FG000|Overall Study|Protocol Violation|0|||
31006361|NCT01686438|59207701|FG001|Overall Study|Protocol Violation|0|||
31006362|NCT01686438|59207702|FG002|Overall Study|Protocol Violation|1|||
31006363|NCT01686438|59207700|FG000|Overall Study|Withdrawal by Subject|0|||
31006364|NCT01686438|59207701|FG001|Overall Study|Withdrawal by Subject|0|||
31006365|NCT01686438|59207702|FG002|Overall Study|Withdrawal by Subject|1|||
31006366|NCT01593696|59207716|FG000|Dose Escalation|Progressive Disease|2|||
31006367|NCT01593696|59207717|FG001|Dose Escalation|Progressive Disease|0|||
31006368|NCT01593696|59207718|FG002|Dose Escalation|Progressive Disease|0|||
31006369|NCT01593696|59207719|FG003|Dose Escalation|Progressive Disease|0|||
31006370|NCT01593696|59207716|FG000|Dose Expansion|Fungal infection|0|||
31006371|NCT01593696|59207717|FG001|Dose Expansion|Fungal infection|0|||
31006372|NCT01593696|59207718|FG002|Dose Expansion|Fungal infection|1|||
31006373|NCT01593696|59207719|FG003|Dose Expansion|Fungal infection|0|||
31006374|NCT01592760|59207732|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
31006375|NCT01592760|59207733|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
30609998|NCT01163253|58620830|FG000|Overall Study|Protocol Violation|43|||
30609999|NCT01163253|58620831|FG001|Overall Study|Protocol Violation|12|||
30610000|NCT01163253|58620830|FG000|Overall Study|Withdrawal by Subject|199|||
30610001|NCT01163253|58620831|FG001|Overall Study|Withdrawal by Subject|50|||
30610002|NCT01163253|58620830|FG000|Overall Study|Medication Error|1|||
30610003|NCT01163253|58620831|FG001|Overall Study|Medication Error|0|||
30610004|NCT01163253|58620830|FG000|Overall Study|Lost to Follow-up|125|||
30610005|NCT01163253|58620831|FG001|Overall Study|Lost to Follow-up|23|||
30610006|NCT01163253|58620830|FG000|Overall Study|Insufficient Clinical Response|423|||
30610007|NCT01163253|58620831|FG001|Overall Study|Insufficient Clinical Response|29|||
30610008|NCT01163253|58620830|FG000|Overall Study|Adverse Event|300|||
30610009|NCT01163253|58620831|FG001|Overall Study|Adverse Event|78|||
30610010|NCT01163253|58620830|FG000|Overall Study|Death|17|||
30610011|NCT01163253|58620831|FG001|Overall Study|Death|5|||
30610012|NCT01163253|58620830|FG000|Overall Study|Ongoing|13|||
30610013|NCT01163253|58620831|FG001|Overall Study|Ongoing|4|||
30610014|NCT01163253|58620830|FG000|Overall Study|Other Unspecified|170|||
30610015|NCT01163253|58620831|FG001|Overall Study|Other Unspecified|34|||
30610016|NCT01162863|58620840|FG000|Overall Study|Lack of Efficacy|1|||
30610017|NCT01162863|58620841|FG001|Overall Study|Lack of Efficacy|0|||
30610018|NCT01162863|58620842|FG002|Overall Study|Lack of Efficacy|0|||
30610019|NCT01162863|58620840|FG000|Overall Study|Adverse Event|0|||
30610020|NCT01162863|58620841|FG001|Overall Study|Adverse Event|1|||
30610021|NCT01162863|58620842|FG002|Overall Study|Adverse Event|0|||
30610022|NCT01162473|58620852|FG000|Overall Study|Adverse Event|2|||
30610023|NCT01162473|58620853|FG001|Overall Study|Adverse Event|1|||
30610024|NCT01162473|58620852|FG000|Overall Study|Withdrawal by Subject|0|||
30610025|NCT01162473|58620853|FG001|Overall Study|Withdrawal by Subject|4|||
30610026|NCT01162239|58620863|FG000|Treatment Phase|Withdrawal by Subject|1|||
30610027|NCT01162239|58620864|FG001|Treatment Phase|Withdrawal by Subject|3|||
30610028|NCT01162239|58620865|FG002|Treatment Phase|Withdrawal by Subject|2|||
30610029|NCT01162239|58620866|FG003|Treatment Phase|Withdrawal by Subject|3|||
30610030|NCT01162239|58620863|FG000|Treatment Phase|Death|0|||
30610031|NCT01162239|58620864|FG001|Treatment Phase|Death|0|||
30610032|NCT01162239|58620865|FG002|Treatment Phase|Death|0|||
30610033|NCT01162239|58620866|FG003|Treatment Phase|Death|1|||
31006376|NCT01592760|59207734|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
31006377|NCT01696188|59207747|FG000|Overall Study|Protocol Violation|1|||
31006378|NCT01696188|59207748|FG001|Overall Study|Protocol Violation|1|||
31006379|NCT01603602|59207757|FG000|Overall Study|Adverse Event|1|||
31006380|NCT01603602|59207758|FG001|Overall Study|Adverse Event|0|||
31006381|NCT01603602|59207759|FG002|Overall Study|Adverse Event|0|||
30610034|NCT01162239|58620863|FG000|Treatment Phase|Lost to Follow-up|5|||
30610035|NCT01162239|58620864|FG001|Treatment Phase|Lost to Follow-up|4|||
30610036|NCT01162239|58620865|FG002|Treatment Phase|Lost to Follow-up|2|||
30610037|NCT01162239|58620866|FG003|Treatment Phase|Lost to Follow-up|1|||
30610038|NCT01162239|58620863|FG000|Extended Follow-up|Lost to Follow-up|8|||
31006382|NCT01603602|59207757|FG000|Overall Study|Personal Reasons|1|||
30610039|NCT01162239|58620864|FG001|Extended Follow-up|Lost to Follow-up|13|||
31006383|NCT01603602|59207758|FG001|Overall Study|Personal Reasons|0|||
31006384|NCT01603602|59207759|FG002|Overall Study|Personal Reasons|1|||
30610040|NCT01162239|58620865|FG002|Extended Follow-up|Lost to Follow-up|8|||
30610041|NCT01162239|58620866|FG003|Extended Follow-up|Lost to Follow-up|6|||
30610042|NCT01161537|58620877|FG000|Part B|Withdrawal by Subject|2|||
30610043|NCT01234350|58620888|FG000|Overall Study|Adverse Event|277|||
30610044|NCT01234350|58620889|FG001|Overall Study|Adverse Event|92|||
30610045|NCT01234350|58620888|FG000|Overall Study|Withdrawal by Subject|61|||
30610046|NCT01234350|58620889|FG001|Overall Study|Withdrawal by Subject|36|||
30610047|NCT01234350|58620888|FG000|Overall Study|Lost to Follow-up|115|||
30610048|NCT01234350|58620889|FG001|Overall Study|Lost to Follow-up|47|||
30610049|NCT01234350|58620888|FG000|Overall Study|Covers a diverse set of reasons|234|||
30610050|NCT01234350|58620889|FG001|Overall Study|Covers a diverse set of reasons|92|||
30610051|NCT01233258|58620900|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
30610052|NCT01233258|58620901|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
30610053|NCT01233258|58620902|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
30610054|NCT01233258|58620903|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
30610055|NCT01233258|58620904|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
30610056|NCT01233258|58620905|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
30610057|NCT01233258|58620900|FG000|First Intervention (6 Months)|Protocol Violation|0|||
30610058|NCT01233258|58620901|FG001|First Intervention (6 Months)|Protocol Violation|0|||
30610059|NCT01233258|58620902|FG002|First Intervention (6 Months)|Protocol Violation|1|||
30610060|NCT01233258|58620903|FG003|First Intervention (6 Months)|Protocol Violation|0|||
30610061|NCT01233258|58620904|FG004|First Intervention (6 Months)|Protocol Violation|0|||
30610062|NCT01233258|58620905|FG005|First Intervention (6 Months)|Protocol Violation|0|||
30610063|NCT01233258|58620900|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
30610064|NCT01233258|58620901|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
30610065|NCT01233258|58620902|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
30610066|NCT01233258|58620903|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
30610067|NCT01233258|58620904|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
30610068|NCT01233258|58620905|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
30610069|NCT01232868|58620922|FG000|Overall Study|Lost to Follow-up|2|||
30610070|NCT01232868|58620923|FG001|Overall Study|Lost to Follow-up|4|||
30610071|NCT01232790|58620929|FG000|Randomization|Withdrawal by Subject|2|||
30610072|NCT01232790|58620930|FG001|Randomization|Withdrawal by Subject|0|||
30610073|NCT01232790|58620929|FG000|Randomization|Protocol Violation|0|||
30610074|NCT01232790|58620930|FG001|Randomization|Protocol Violation|1|||
31006385|NCT01684878|59207771|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
31006386|NCT01684878|59207772|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
31006387|NCT01684878|59207773|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
31006388|NCT01684878|59207774|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
31006389|NCT01684878|59207771|FG000|Part 1: Safety Run in Phase|Death|15|||
31006390|NCT01684878|59207772|FG001|Part 1: Safety Run in Phase|Death|20|||
31006391|NCT01684878|59207773|FG002|Part 1: Safety Run in Phase|Death|0|||
31006392|NCT01684878|59207774|FG003|Part 1: Safety Run in Phase|Death|0|||
31006393|NCT01684878|59207771|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
31006394|NCT01684878|59207772|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
31006395|NCT01684878|59207773|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
31006396|NCT01684878|59207774|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
31006397|NCT01684878|59207771|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
31006398|NCT01684878|59207772|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
31006399|NCT01684878|59207773|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
31006400|NCT01684878|59207774|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
31006401|NCT01684878|59207771|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
31006402|NCT01684878|59207772|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
31006403|NCT01684878|59207773|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
31006404|NCT01684878|59207774|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
31006405|NCT01684878|59207771|FG000|Part 2: Randomized Phase|Death|0|||
31006406|NCT01684878|59207772|FG001|Part 2: Randomized Phase|Death|0|||
31006407|NCT01684878|59207773|FG002|Part 2: Randomized Phase|Death|62|||
31006408|NCT01684878|59207774|FG003|Part 2: Randomized Phase|Death|68|||
31006409|NCT01684878|59207771|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
31006410|NCT01684878|59207772|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
30610075|NCT01232790|58620929|FG000|Randomization|Physician Decision|0|||
30610076|NCT01232790|58620930|FG001|Randomization|Physician Decision|1|||
30892707|NCT02164929|58926160|FG000|Overall Study|Failed regional block|0|||
31006411|NCT01684878|59207773|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
31006412|NCT01684878|59207774|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
31006413|NCT01684878|59207771|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
31006414|NCT01684878|59207772|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
31006415|NCT01684878|59207773|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
31006416|NCT01684878|59207774|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
30610077|NCT01232790|58620929|FG000|Initial Assessment|Withdrawal by Subject|0|||
30610078|NCT01232790|58620930|FG001|Initial Assessment|Withdrawal by Subject|1|||
30610079|NCT01232790|58620929|FG000|First Crossover|Withdrawal by Subject|1|||
30610080|NCT01232790|58620930|FG001|First Crossover|Withdrawal by Subject|0|||
30610081|NCT01232790|58620929|FG000|Second Crossover|Withdrawal by Subject|1|||
30610082|NCT01232790|58620930|FG001|Second Crossover|Withdrawal by Subject|2|||
30610083|NCT01232556|58620948|FG000|Overall Study|Withdrawal by Subject|21|||
30610084|NCT01232556|58620949|FG001|Overall Study|Withdrawal by Subject|17|||
30610085|NCT01232556|58620948|FG000|Overall Study|Death|97|||
30610086|NCT01232556|58620949|FG001|Overall Study|Death|97|||
30610087|NCT01232556|58620948|FG000|Overall Study|Lost to Follow-up|0|||
30610088|NCT01232556|58620949|FG001|Overall Study|Lost to Follow-up|2|||
30610089|NCT01232556|58620948|FG000|Overall Study|Terminated by Sponsor|35|||
30610090|NCT01232556|58620949|FG001|Overall Study|Terminated by Sponsor|51|||
30610091|NCT01232556|58620948|FG000|Overall Study|Other|6|||
30610092|NCT01232556|58620949|FG001|Overall Study|Other|4|||
30610093|NCT00946153|58620960|FG000|Phase 2|Adverse Event|0|||
30610094|NCT00946153|58620961|FG001|Phase 2|Adverse Event|0|||
30610095|NCT00946153|58620962|FG002|Phase 2|Adverse Event|0|||
30610096|NCT00946153|58620963|FG003|Phase 2|Adverse Event|0|||
30610097|NCT00946153|58620964|FG004|Phase 2|Adverse Event|6|||
30610098|NCT00946153|58620960|FG000|Phase 2|Need more reduction of dose|0|||
31006417|NCT01684722|59207788|FG000|Overall Study|Lost to Follow-up|78|||
31006418|NCT01684722|59207789|FG001|Overall Study|Lost to Follow-up|56|||
31006419|NCT01684722|59207790|FG002|Overall Study|Lost to Follow-up|75|||
31006420|NCT01684722|59207791|FG003|Overall Study|Lost to Follow-up|89|||
31006421|NCT01684722|59207788|FG000|Overall Study|Death|19|||
30610099|NCT00946153|58620961|FG001|Phase 2|Need more reduction of dose|0|||
30610100|NCT00946153|58620962|FG002|Phase 2|Need more reduction of dose|0|||
30610101|NCT00946153|58620963|FG003|Phase 2|Need more reduction of dose|0|||
30610102|NCT00946153|58620964|FG004|Phase 2|Need more reduction of dose|2|||
30610103|NCT00946153|58620960|FG000|Phase 2|Physician Decision|0|||
30610104|NCT00946153|58620961|FG001|Phase 2|Physician Decision|0|||
30610105|NCT00946153|58620962|FG002|Phase 2|Physician Decision|0|||
30610106|NCT00946153|58620963|FG003|Phase 2|Physician Decision|0|||
30610107|NCT00946153|58620964|FG004|Phase 2|Physician Decision|1|||
30610108|NCT00946153|58620960|FG000|Phase 2|14 days washout for recovery due to AE|0|||
30610109|NCT00946153|58620961|FG001|Phase 2|14 days washout for recovery due to AE|0|||
30610110|NCT00946153|58620962|FG002|Phase 2|14 days washout for recovery due to AE|0|||
30610111|NCT00946153|58620963|FG003|Phase 2|14 days washout for recovery due to AE|0|||
30610112|NCT00946153|58620964|FG004|Phase 2|14 days washout for recovery due to AE|4|||
30610113|NCT01160289|58620986|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
30610114|NCT01160289|58620987|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
31006422|NCT01684722|59207789|FG001|Overall Study|Death|21|||
31006423|NCT01684722|59207790|FG002|Overall Study|Death|19|||
31006424|NCT01684722|59207791|FG003|Overall Study|Death|21|||
31006425|NCT01592292|59207808|FG000|Overall Study|Follow-up loss|3|||
31006426|NCT01592292|59207809|FG001|Overall Study|Follow-up loss|3|||
31006427|NCT01592292|59207810|FG002|Overall Study|Follow-up loss|1|||
30610115|NCT01160289|58620988|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
30610116|NCT01160289|58620989|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
30610117|NCT01160289|58620990|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
31006428|NCT01592292|59207811|FG003|Overall Study|Follow-up loss|0|||
31006429|NCT01592292|59207808|FG000|Overall Study|Withdrew consent|2|||
30610118|NCT01160289|58620991|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
30610119|NCT01160289|58620986|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
30610120|NCT01160289|58620987|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
31006430|NCT01592292|59207809|FG001|Overall Study|Withdrew consent|1|||
30610121|NCT01160289|58620988|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
30610122|NCT01160289|58620989|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
30610123|NCT01160289|58620990|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
30610124|NCT01160289|58620991|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
30610125|NCT01160289|58620986|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
30610126|NCT01160289|58620987|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
30610127|NCT01160289|58620988|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
30610128|NCT01160289|58620989|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
30610129|NCT01160289|58620990|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
30610130|NCT01160289|58620991|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
30610131|NCT01160289|58620986|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
30610132|NCT01160289|58620987|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
30610133|NCT01160289|58620988|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
30610134|NCT01160289|58620989|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
30610135|NCT01160289|58620990|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
30610136|NCT01160289|58620991|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
30610137|NCT01160289|58620986|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
30610138|NCT01160289|58620987|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
30610139|NCT01160289|58620988|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
30610140|NCT01160289|58620989|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
30610141|NCT01160289|58620990|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
30610142|NCT01160289|58620991|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
31006431|NCT01592292|59207810|FG002|Overall Study|Withdrew consent|0|||
31006432|NCT01592292|59207811|FG003|Overall Study|Withdrew consent|0|||
31006433|NCT01592292|59207808|FG000|Overall Study|Other|1|||
31006434|NCT01592292|59207809|FG001|Overall Study|Other|1|||
31006435|NCT01592292|59207810|FG002|Overall Study|Other|2|||
31006436|NCT01592292|59207811|FG003|Overall Study|Other|1|||
30610143|NCT01160289|58620986|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
30610144|NCT01160289|58620987|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
31006437|NCT01590888|59207820|FG000|Overall Study|Adverse Event|3|||
31006438|NCT01590888|59207821|FG001|Overall Study|Adverse Event|0|||
31006439|NCT01590888|59207822|FG002|Overall Study|Adverse Event|1|||
31006440|NCT01590888|59207820|FG000|Overall Study|Lost to Follow-up|1|||
31006441|NCT01590888|59207821|FG001|Overall Study|Lost to Follow-up|0|||
31006442|NCT01590888|59207822|FG002|Overall Study|Lost to Follow-up|0|||
31006443|NCT01565928|59207830|FG000|Overall Study|Adverse Event|3|||
31006444|NCT01565928|59207830|FG000|Overall Study|Other|3|||
31006445|NCT01565928|59207830|FG000|Overall Study|Progressive Disease|13|||
31006446|NCT01565928|59207830|FG000|Overall Study|Withdrawal by Subject|1|||
31006447|NCT01565928|59207830|FG000|Overall Study|Death|2|||
31006448|NCT01565850|59207839|FG000|Overall Study|Adverse Event|0|||
31006449|NCT01565850|59207840|FG001|Overall Study|Adverse Event|1|||
31006450|NCT01565850|59207839|FG000|Overall Study|Lost to Follow-up|12|||
31006451|NCT01565850|59207840|FG001|Overall Study|Lost to Follow-up|4|||
31006452|NCT01565850|59207839|FG000|Overall Study|Investigator's Discretion|2|||
31006453|NCT01565850|59207840|FG001|Overall Study|Investigator's Discretion|1|||
31006454|NCT01565850|59207839|FG000|Overall Study|Participant noncompliance|2|||
31006455|NCT01565850|59207840|FG001|Overall Study|Participant noncompliance|0|||
31006456|NCT01565850|59207839|FG000|Overall Study|Withdrew Consent|4|||
31006457|NCT01565850|59207840|FG001|Overall Study|Withdrew Consent|2|||
31006458|NCT01565694|59207846|FG000|Dose-Titration Period|Adverse Event|4|||
31006459|NCT01565694|59207846|FG000|Dose-Titration Period|Protocol Violation|10|||
31006460|NCT01565694|59207846|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
31006461|NCT01543152|59207855|FG000|Overall Study|Withdrawal by Subject|0|||
30610145|NCT01160289|58620988|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
31006462|NCT01543152|59207856|FG001|Overall Study|Withdrawal by Subject|2|||
31006463|NCT01543152|59207857|FG002|Overall Study|Withdrawal by Subject|0|||
31006464|NCT01543152|59207858|FG003|Overall Study|Withdrawal by Subject|0|||
31006465|NCT01543152|59207859|FG004|Overall Study|Withdrawal by Subject|0|||
31006466|NCT01590810|59207876|FG000|Overall Study|Physician Decision|0|||
31006467|NCT01590810|59207877|FG001|Overall Study|Physician Decision|1|||
31006468|NCT01590810|59207878|FG002|Overall Study|Physician Decision|1|||
31006469|NCT01590810|59207879|FG003|Overall Study|Physician Decision|0|||
31006470|NCT01590810|59207880|FG004|Overall Study|Physician Decision|0|||
31006471|NCT01542528|59207915|FG000|Overall Study|Lost to Follow-up|2|||
31006472|NCT01542528|59207916|FG001|Overall Study|Lost to Follow-up|1|||
31006473|NCT01542528|59207915|FG000|Overall Study|Physician Decision|1|||
31006474|NCT01542528|59207916|FG001|Overall Study|Physician Decision|0|||
31006475|NCT01542528|59207915|FG000|Overall Study|Withdrawal by Subject|9|||
31006476|NCT01542528|59207916|FG001|Overall Study|Withdrawal by Subject|6|||
31006477|NCT01565148|59207926|FG000|Overall Study|Withdrawal by Subject|1|||
31006478|NCT01565148|59207927|FG001|Overall Study|Withdrawal by Subject|1|||
31006479|NCT01565148|59207928|FG002|Overall Study|Withdrawal by Subject|1|||
31006480|NCT01565148|59207929|FG003|Overall Study|Withdrawal by Subject|2|||
31006481|NCT01565148|59207926|FG000|Overall Study|Lost to Follow-up|4|||
31006482|NCT01565148|59207927|FG001|Overall Study|Lost to Follow-up|4|||
31006483|NCT01565148|59207928|FG002|Overall Study|Lost to Follow-up|0|||
31006484|NCT01565148|59207929|FG003|Overall Study|Lost to Follow-up|3|||
31006485|NCT01565148|59207926|FG000|Overall Study|Rescue Therapy|8|||
30610146|NCT01160289|58620989|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
30610147|NCT01160289|58620990|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
30610148|NCT01160289|58620991|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
30610149|NCT01160289|58620986|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
30610150|NCT01160289|58620987|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
30610151|NCT01160289|58620988|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
30892708|NCT02164929|58926161|FG001|Overall Study|Failed regional block|0|||
30892709|NCT02164929|58926162|FG002|Overall Study|Failed regional block|1|||
30892710|NCT02164929|58926163|FG003|Overall Study|Failed regional block|0|||
30892711|NCT01888432|58926175|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
30892712|NCT01888432|58926176|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
30892713|NCT01888432|58926175|FG000|12-month Analysis (FAS)|Physician Decision|1|||
30892714|NCT01888432|58926176|FG001|12-month Analysis (FAS)|Physician Decision|1|||
30892715|NCT01888432|58926175|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
30892716|NCT01888432|58926176|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
30892717|NCT01888432|58926175|FG000|12-month Analysis (FAS)|Death|4|||
30892718|NCT01888432|58926176|FG001|12-month Analysis (FAS)|Death|3|||
30892719|NCT01888432|58926175|FG000|24-month Analysis (FAS)|Graft loss|0|||
30892720|NCT01888432|58926176|FG001|24-month Analysis (FAS)|Graft loss|1|||
30892721|NCT01888432|58926175|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
30892722|NCT01888432|58926176|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
30892723|NCT01888432|58926175|FG000|24-month Analysis (FAS)|Physician Decision|2|||
30892724|NCT01888432|58926176|FG001|24-month Analysis (FAS)|Physician Decision|4|||
30892725|NCT01888432|58926175|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
30892726|NCT01888432|58926176|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
30892727|NCT01888432|58926175|FG000|24-month Analysis (FAS)|Death|8|||
30892728|NCT01888432|58926176|FG001|24-month Analysis (FAS)|Death|4|||
30892729|NCT01888432|58926175|FG000|36-month Analysis (Extension)|Death|1|||
30892730|NCT01888432|58926176|FG001|36-month Analysis (Extension)|Death|0|||
30892731|NCT02188719|58926188|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
30892732|NCT02188719|58926189|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
30892733|NCT02188719|58926190|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
30892734|NCT02188719|58926191|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
30892735|NCT01934140|58926201|FG000|Persistence Phase (Year 6-10)|Other|24|||
30892736|NCT01934140|58926202|FG001|Persistence Phase (Year 6-10)|Other|6|||
30892737|NCT01934140|58926201|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
30892738|NCT01934140|58926202|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
30892739|NCT01934140|58926201|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
30892740|NCT01934140|58926202|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
30892741|NCT01934140|58926201|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
30892742|NCT01934140|58926202|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
31006486|NCT01565148|59207927|FG001|Overall Study|Rescue Therapy|5|||
31006487|NCT01565148|59207928|FG002|Overall Study|Rescue Therapy|5|||
31006488|NCT01565148|59207929|FG003|Overall Study|Rescue Therapy|8|||
30790343|NCT03126110|58803546|FG011|Phase 1|Withdrawal by Subject|0|||
30892743|NCT01934140|58926201|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
30892744|NCT01934140|58926202|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
30892745|NCT01934140|58926201|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
30892746|NCT01934140|58926202|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
30892747|NCT01934140|58926201|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
30892748|NCT01934140|58926202|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
31006489|NCT01565148|59207926|FG000|Overall Study|Death|0|||
31006490|NCT01565148|59207927|FG001|Overall Study|Death|0|||
30610152|NCT01160289|58620989|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
30610153|NCT01160289|58620990|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
30610154|NCT01160289|58620991|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
30610155|NCT01160289|58620986|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
30610156|NCT01160289|58620987|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
30610157|NCT01160289|58620988|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
30610158|NCT01160289|58620989|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
30610159|NCT01160289|58620990|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
30610160|NCT01160289|58620991|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
30610161|NCT01160289|58620986|FG000|Post-Randomization Period|Adverse Event|0|||
30610162|NCT01160289|58620987|FG001|Post-Randomization Period|Adverse Event|4|||
30610163|NCT01160289|58620988|FG002|Post-Randomization Period|Adverse Event|4|||
30610164|NCT01160289|58620989|FG003|Post-Randomization Period|Adverse Event|2|||
30610165|NCT01160289|58620990|FG004|Post-Randomization Period|Adverse Event|0|||
30610166|NCT01160289|58620991|FG005|Post-Randomization Period|Adverse Event|0|||
30610167|NCT01160289|58620986|FG000|Post-Randomization Period|Death|0|||
30610168|NCT01160289|58620987|FG001|Post-Randomization Period|Death|0|||
30610169|NCT01160289|58620988|FG002|Post-Randomization Period|Death|0|||
30610170|NCT01160289|58620989|FG003|Post-Randomization Period|Death|1|||
30610171|NCT01160289|58620990|FG004|Post-Randomization Period|Death|0|||
30610172|NCT01160289|58620991|FG005|Post-Randomization Period|Death|0|||
30610173|NCT01160289|58620986|FG000|Post-Randomization Period|Lack of Efficacy|0|||
30610174|NCT01160289|58620987|FG001|Post-Randomization Period|Lack of Efficacy|1|||
30610175|NCT01160289|58620988|FG002|Post-Randomization Period|Lack of Efficacy|0|||
30610176|NCT01160289|58620989|FG003|Post-Randomization Period|Lack of Efficacy|3|||
30610177|NCT01160289|58620990|FG004|Post-Randomization Period|Lack of Efficacy|0|||
30610178|NCT01160289|58620991|FG005|Post-Randomization Period|Lack of Efficacy|0|||
30610179|NCT01160289|58620986|FG000|Post-Randomization Period|Lost to Follow-up|0|||
30610180|NCT01160289|58620987|FG001|Post-Randomization Period|Lost to Follow-up|3|||
30610181|NCT01160289|58620988|FG002|Post-Randomization Period|Lost to Follow-up|2|||
30610182|NCT01160289|58620989|FG003|Post-Randomization Period|Lost to Follow-up|5|||
30610183|NCT01160289|58620990|FG004|Post-Randomization Period|Lost to Follow-up|3|||
30610184|NCT01160289|58620991|FG005|Post-Randomization Period|Lost to Follow-up|4|||
30610185|NCT01160289|58620986|FG000|Post-Randomization Period|Physician Decision|0|||
30610186|NCT01160289|58620987|FG001|Post-Randomization Period|Physician Decision|0|||
30610187|NCT01160289|58620988|FG002|Post-Randomization Period|Physician Decision|1|||
30610188|NCT01160289|58620989|FG003|Post-Randomization Period|Physician Decision|0|||
30610189|NCT01160289|58620990|FG004|Post-Randomization Period|Physician Decision|0|||
30610190|NCT01160289|58620991|FG005|Post-Randomization Period|Physician Decision|0|||
30610191|NCT01160289|58620986|FG000|Post-Randomization Period|Protocol Violation|0|||
30610192|NCT01160289|58620987|FG001|Post-Randomization Period|Protocol Violation|4|||
30610193|NCT01160289|58620988|FG002|Post-Randomization Period|Protocol Violation|2|||
30610194|NCT01160289|58620989|FG003|Post-Randomization Period|Protocol Violation|0|||
30610195|NCT01160289|58620990|FG004|Post-Randomization Period|Protocol Violation|1|||
30610196|NCT01160289|58620991|FG005|Post-Randomization Period|Protocol Violation|3|||
30610197|NCT01160289|58620986|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
30610198|NCT01160289|58620987|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
30610199|NCT01160289|58620988|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
30610200|NCT01160289|58620989|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
30610201|NCT01160289|58620990|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
30610202|NCT01160289|58620991|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
30610203|NCT01160289|58620986|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
30610204|NCT01160289|58620987|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
30610205|NCT01160289|58620988|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
30610206|NCT01160289|58620989|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
30610207|NCT01160289|58620990|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
30610208|NCT01160289|58620991|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
30610209|NCT01160289|58620986|FG000|Post-Randomization Period|Sponsor Decision|0|||
30610210|NCT01160289|58620987|FG001|Post-Randomization Period|Sponsor Decision|1|||
30610211|NCT01160289|58620988|FG002|Post-Randomization Period|Sponsor Decision|0|||
30610212|NCT01160289|58620989|FG003|Post-Randomization Period|Sponsor Decision|0|||
30610213|NCT01160289|58620990|FG004|Post-Randomization Period|Sponsor Decision|0|||
30610214|NCT01160289|58620991|FG005|Post-Randomization Period|Sponsor Decision|0|||
30610215|NCT01159665|58621010|FG000|Overall Study|Withdrawal by Subject|0|||
30610216|NCT01159665|58621011|FG001|Overall Study|Withdrawal by Subject|1|||
30610217|NCT01159665|58621012|FG002|Overall Study|Withdrawal by Subject|0|||
30610218|NCT01159665|58621013|FG003|Overall Study|Withdrawal by Subject|0|||
30610219|NCT01159665|58621014|FG004|Overall Study|Withdrawal by Subject|0|||
30610220|NCT01159665|58621015|FG005|Overall Study|Withdrawal by Subject|0|||
30610221|NCT01159431|58621031|FG000|Overall Study|Adverse Event|1|||
30610222|NCT01159431|58621032|FG001|Overall Study|Adverse Event|2|||
30610223|NCT01159431|58621031|FG000|Overall Study|non-compliance|1|||
30610224|NCT01159431|58621032|FG001|Overall Study|non-compliance|1|||
30610225|NCT01159431|58621031|FG000|Overall Study|Lack of Efficacy|0|||
30610226|NCT01159431|58621032|FG001|Overall Study|Lack of Efficacy|3|||
30610227|NCT01158261|58621045|FG000|Overall Study|Lost to Follow-up|9|||
30610228|NCT01158261|58621045|FG000|Overall Study|Death|7|||
30610229|NCT01158261|58621045|FG000|Overall Study|Withdrawal by Subject|1|||
30610230|NCT01157169|58621051|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
30610231|NCT01157169|58621052|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
30610232|NCT01157169|58621051|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
30610233|NCT01157169|58621052|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
30610234|NCT01231620|58621061|FG000|Overall Study|Physician Decision|3|||
30610235|NCT01231620|58621062|FG001|Overall Study|Physician Decision|5|||
30610236|NCT01231620|58621063|FG002|Overall Study|Physician Decision|10|||
30610237|NCT01231620|58621061|FG000|Overall Study|Death|12|||
30610238|NCT01231620|58621062|FG001|Overall Study|Death|14|||
30610239|NCT01231620|58621063|FG002|Overall Study|Death|11|||
30610240|NCT01231620|58621061|FG000|Overall Study|Adverse Event|2|||
30610241|NCT01231620|58621062|FG001|Overall Study|Adverse Event|2|||
30610242|NCT01231620|58621063|FG002|Overall Study|Adverse Event|1|||
30610243|NCT01231620|58621061|FG000|Overall Study|Withdrawal by Subject|6|||
30610244|NCT01231620|58621062|FG001|Overall Study|Withdrawal by Subject|6|||
30610245|NCT01231620|58621063|FG002|Overall Study|Withdrawal by Subject|8|||
30610246|NCT01231620|58621061|FG000|Overall Study|Lost to Follow-up|3|||
30610247|NCT01231620|58621062|FG001|Overall Study|Lost to Follow-up|4|||
30610248|NCT01231620|58621063|FG002|Overall Study|Lost to Follow-up|9|||
30610249|NCT01231464|58621073|FG000|Overall Study|Adverse Event|0|||
30610250|NCT01231464|58621074|FG001|Overall Study|Adverse Event|1|||
30610251|NCT01231464|58621073|FG000|Overall Study|Protocol Violation|1|||
30610252|NCT01231464|58621074|FG001|Overall Study|Protocol Violation|2|||
30610253|NCT01231464|58621073|FG000|Overall Study|Lost to Follow-up|1|||
30610254|NCT01231464|58621074|FG001|Overall Study|Lost to Follow-up|2|||
30610255|NCT01231464|58621073|FG000|Overall Study|Withdrawal by Subject|3|||
30610256|NCT01231464|58621074|FG001|Overall Study|Withdrawal by Subject|2|||
30610257|NCT01156311|58621084|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
30610258|NCT01156311|58621085|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
30610259|NCT01156311|58621086|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
30610260|NCT01156311|58621087|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
30610261|NCT01156311|58621084|FG000|2-Month Monotherapy Period|Physician Decision|0|||
30610262|NCT01156311|58621085|FG001|2-Month Monotherapy Period|Physician Decision|1|||
30610263|NCT01156311|58621086|FG002|2-Month Monotherapy Period|Physician Decision|0|||
30610264|NCT01156311|58621087|FG003|2-Month Monotherapy Period|Physician Decision|0|||
30610265|NCT01156311|58621084|FG000|2-Month Monotherapy Period|Other|1|||
30610266|NCT01156311|58621085|FG001|2-Month Monotherapy Period|Other|0|||
30610267|NCT01156311|58621086|FG002|2-Month Monotherapy Period|Other|0|||
30610268|NCT01156311|58621087|FG003|2-Month Monotherapy Period|Other|0|||
30610269|NCT01156311|58621084|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
30610270|NCT01156311|58621085|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
30610271|NCT01156311|58621086|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
30610272|NCT01156311|58621087|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
30610273|NCT01156311|58621084|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
30610274|NCT01156311|58621085|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
30610275|NCT01156311|58621086|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
30610276|NCT01156311|58621087|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
30610277|NCT01156311|58621084|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
30610278|NCT01156311|58621085|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
30610279|NCT01156311|58621086|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
30610280|NCT01156311|58621087|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
30610281|NCT01156311|58621084|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
30610282|NCT01156311|58621085|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
30610283|NCT01156311|58621086|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
30610284|NCT01156311|58621087|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
30610285|NCT01156311|58621084|FG000|6-month Add-on Therapy Period|Other|0|||
30610286|NCT01156311|58621085|FG001|6-month Add-on Therapy Period|Other|0|||
30610287|NCT01156311|58621086|FG002|6-month Add-on Therapy Period|Other|1|||
30610288|NCT01156311|58621087|FG003|6-month Add-on Therapy Period|Other|2|||
30610289|NCT01230060|58621098|FG000|Overall Study|Withdrawal by Subject|1|||
30610290|NCT01155531|58621106|FG000|Overall Study|Adverse Event|0|||
30610291|NCT01155531|58621107|FG001|Overall Study|Adverse Event|0|||
30610292|NCT01155531|58621108|FG002|Overall Study|Adverse Event|1|||
31006491|NCT01565148|59207928|FG002|Overall Study|Death|1|||
31006492|NCT01565148|59207929|FG003|Overall Study|Death|0|||
30610293|NCT01155531|58621109|FG003|Overall Study|Adverse Event|0|||
30610294|NCT01155531|58621106|FG000|Overall Study|Lost to Follow-up|0|||
30610295|NCT01155531|58621107|FG001|Overall Study|Lost to Follow-up|0|||
30610296|NCT01155531|58621108|FG002|Overall Study|Lost to Follow-up|0|||
30610297|NCT01155531|58621109|FG003|Overall Study|Lost to Follow-up|1|||
30610298|NCT01155531|58621106|FG000|Overall Study|Withdrawal by Subject|1|||
30610299|NCT01155531|58621107|FG001|Overall Study|Withdrawal by Subject|0|||
30610300|NCT01155531|58621108|FG002|Overall Study|Withdrawal by Subject|1|||
31006493|NCT01565148|59207926|FG000|Overall Study|Physician Decision|2|||
30610301|NCT01155531|58621109|FG003|Overall Study|Withdrawal by Subject|0|||
30610302|NCT01155219|58621121|FG000|Overall Study|Adverse Event|3|||
30610303|NCT01155219|58621122|FG001|Overall Study|Adverse Event|1|||
30610304|NCT01155219|58621121|FG000|Overall Study|non-medical reason|1|||
30610305|NCT01155219|58621122|FG001|Overall Study|non-medical reason|2|||
30610306|NCT01229436|58621128|FG000|Overall Study|Withdrawal by Subject|2|||
30610307|NCT01229436|58621128|FG000|Overall Study|Lost to Follow-up|3|||
30610308|NCT01155141|58621132|FG000|Overall Study|Withdrawal by Subject|1|||
30610309|NCT01155141|58621132|FG000|Overall Study|Screen Failure|1|||
30610310|NCT01155063|58621136|FG000|Overall Study|Adverse Event|1|||
30610311|NCT01155063|58621136|FG000|Overall Study|Withdrawal by Subject|1|||
30610312|NCT01155063|58621136|FG000|Overall Study|Study terminated by sponsor|87|||
30610313|NCT01154673|58621142|FG000|Overall Study|Lost to Follow-up|1|||
30610314|NCT01154673|58621143|FG001|Overall Study|Lost to Follow-up|0|||
30610315|NCT01154673|58621142|FG000|Overall Study|moved out of province|1|||
30610316|NCT01154673|58621143|FG001|Overall Study|moved out of province|0|||
30610317|NCT01154283|58621151|FG000|0-6 Weeks|Withdrawal by Subject|7|||
30610318|NCT01154283|58621152|FG001|0-6 Weeks|Withdrawal by Subject|2|||
30610319|NCT01154283|58621151|FG000|0-6 Weeks|Death|0|||
30610320|NCT01154283|58621152|FG001|0-6 Weeks|Death|1|||
30610321|NCT01154283|58621151|FG000|7-12 Weeks|Death|1|||
30610322|NCT01154283|58621152|FG001|7-12 Weeks|Death|0|||
30610323|NCT01154283|58621151|FG000|7-12 Weeks|Withdrawal by Subject|0|||
30610324|NCT01154283|58621152|FG001|7-12 Weeks|Withdrawal by Subject|1|||
30610325|NCT00944125|58621158|FG000|3 to 6 Months|Withdrawal by Subject|0|||
30610326|NCT00944125|58621159|FG001|3 to 6 Months|Withdrawal by Subject|2|||
30610327|NCT00944125|58621158|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
30610328|NCT00944125|58621159|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
30610329|NCT00912223|58621165|FG000|Overall Study|Withdrawal by Subject|1|||
30610330|NCT00912223|58621165|FG000|Overall Study|Not transplanted|1|||
30610331|NCT00912223|58621165|FG000|Overall Study|Transformed disease|1|||
30610332|NCT01154127|58621171|FG000|Period 1 (21 Days)|Adverse Event|3|||
30610333|NCT01154127|58621172|FG001|Period 1 (21 Days)|Adverse Event|4|||
30610334|NCT01154127|58621171|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
30610335|NCT01154127|58621172|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
30610336|NCT01154127|58621171|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
30610337|NCT01154127|58621172|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
30610338|NCT01154127|58621171|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
30610339|NCT01154127|58621172|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
30610340|NCT01154127|58621171|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
30610341|NCT01154127|58621172|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
30610342|NCT01228734|58621180|FG000|Overall Study|Randomized, but not treated|0|||
30610343|NCT01228734|58621181|FG001|Overall Study|Randomized, but not treated|4|||
30610344|NCT01227954|58621187|FG000|Overall Study|Protocol Violation|6|||
30610345|NCT01227954|58621187|FG000|Overall Study|No protocol treatment|7|||
30610346|NCT01153971|58621191|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
30610347|NCT01153971|58621191|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
30610348|NCT01153971|58621191|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
30610349|NCT01153971|58621191|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
30610350|NCT01153971|58621191|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
30610351|NCT01153971|58621191|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
30610352|NCT01153971|58621191|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
30610353|NCT01153893|58621197|FG000|Overall Study|Adverse Event|1|||
30610354|NCT01153893|58621198|FG001|Overall Study|Adverse Event|0|||
30610355|NCT00951379|58621206|FG000|Overall Study|Adverse Event|4|||
30610356|NCT00951379|58621207|FG001|Overall Study|Adverse Event|1|||
30610357|NCT00951379|58621206|FG000|Overall Study|Withdrawal by Subject|1|||
30610358|NCT00951379|58621207|FG001|Overall Study|Withdrawal by Subject|0|||
30610359|NCT00951379|58621206|FG000|Overall Study|Noncompliance|1|||
30610360|NCT00951379|58621207|FG001|Overall Study|Noncompliance|0|||
30610361|NCT00951379|58621206|FG000|Overall Study|Disease Progression|0|||
30610362|NCT00951379|58621207|FG001|Overall Study|Disease Progression|1|||
30610363|NCT01153815|58621223|FG000|Overall Study|Adverse Event|3|||
30610364|NCT01153815|58621224|FG001|Overall Study|Adverse Event|1|||
30610365|NCT01153815|58621223|FG000|Overall Study|Withdrawal by Subject|6|||
31006494|NCT01565148|59207927|FG001|Overall Study|Physician Decision|5|||
30610366|NCT01153815|58621224|FG001|Overall Study|Withdrawal by Subject|4|||
30610367|NCT01153425|58621232|FG000|Overall Study|Withdrawal by Subject|3|||
30610368|NCT01153425|58621233|FG001|Overall Study|Withdrawal by Subject|3|||
30610369|NCT01153347|58621244|FG000|Overall Study|Withdrawal by Subject|7|||
31006495|NCT01565148|59207928|FG002|Overall Study|Physician Decision|0|||
30610370|NCT01153347|58621245|FG001|Overall Study|Withdrawal by Subject|7|||
30610371|NCT01153347|58621246|FG002|Overall Study|Withdrawal by Subject|7|||
30610372|NCT01153347|58621247|FG003|Overall Study|Withdrawal by Subject|7|||
30610373|NCT01153347|58621244|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30610374|NCT01153347|58621245|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
30610375|NCT01153347|58621246|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
30610376|NCT01153347|58621247|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
30610377|NCT01153347|58621244|FG000|Overall Study|Adverse Event|3|||
30610378|NCT01153347|58621245|FG001|Overall Study|Adverse Event|9|||
30610379|NCT01153347|58621246|FG002|Overall Study|Adverse Event|21|||
30610380|NCT01153347|58621247|FG003|Overall Study|Adverse Event|7|||
30610381|NCT01153347|58621244|FG000|Overall Study|Severe non-compliance to protocol|6|||
30610382|NCT01153347|58621245|FG001|Overall Study|Severe non-compliance to protocol|7|||
30610383|NCT01153347|58621246|FG002|Overall Study|Severe non-compliance to protocol|4|||
30610384|NCT01153347|58621247|FG003|Overall Study|Severe non-compliance to protocol|3|||
30610385|NCT01153347|58621244|FG000|Overall Study|Condition under investigation worsened|1|||
30610386|NCT01153347|58621245|FG001|Overall Study|Condition under investigation worsened|1|||
30610387|NCT01153347|58621246|FG002|Overall Study|Condition under investigation worsened|0|||
30610388|NCT01153347|58621247|FG003|Overall Study|Condition under investigation worsened|0|||
30610389|NCT01153347|58621244|FG000|Overall Study|Lack of Efficacy|2|||
30610390|NCT01153347|58621245|FG001|Overall Study|Lack of Efficacy|2|||
30610391|NCT01153347|58621246|FG002|Overall Study|Lack of Efficacy|0|||
30610392|NCT01153347|58621247|FG003|Overall Study|Lack of Efficacy|4|||
30610393|NCT01153347|58621244|FG000|Overall Study|Study-specific withdrawal criteria|4|||
30610394|NCT01153347|58621245|FG001|Overall Study|Study-specific withdrawal criteria|3|||
30610395|NCT01153347|58621246|FG002|Overall Study|Study-specific withdrawal criteria|1|||
30610396|NCT01153347|58621247|FG003|Overall Study|Study-specific withdrawal criteria|2|||
30610397|NCT01153347|58621244|FG000|Overall Study|Lost to Follow-up|4|||
30610398|NCT01153347|58621245|FG001|Overall Study|Lost to Follow-up|9|||
30610399|NCT01153347|58621246|FG002|Overall Study|Lost to Follow-up|11|||
30610400|NCT01153347|58621247|FG003|Overall Study|Lost to Follow-up|8|||
30610401|NCT01153347|58621244|FG000|Overall Study|Other|5|||
30610402|NCT01153347|58621245|FG001|Overall Study|Other|5|||
30610403|NCT01153347|58621246|FG002|Overall Study|Other|4|||
30610404|NCT01153347|58621247|FG003|Overall Study|Other|0|||
30610405|NCT01153347|58621244|FG000|Overall Study|Death|1|||
30610406|NCT01153347|58621245|FG001|Overall Study|Death|0|||
30610407|NCT01153347|58621246|FG002|Overall Study|Death|0|||
30610408|NCT01153347|58621247|FG003|Overall Study|Death|0|||
30610409|NCT01153269|58621257|FG000|Overall Study|Withdrawal by Subject|1|||
30610410|NCT01153269|58621257|FG000|Overall Study|Antiretroviral therapy break|1|||
30610411|NCT01152021|58621266|FG000|Overall Study|Adverse Event|4|||
30610412|NCT01152021|58621267|FG001|Overall Study|Adverse Event|4|||
30610413|NCT01152021|58621266|FG000|Overall Study|Study drug had expired|1|||
30610414|NCT01152021|58621267|FG001|Overall Study|Study drug had expired|0|||
30610415|NCT01152021|58621266|FG000|Overall Study|Physician Decision|1|||
30610416|NCT01152021|58621267|FG001|Overall Study|Physician Decision|1|||
30610417|NCT01152021|58621266|FG000|Overall Study|No access to study drug in Pharmacy|0|||
30610418|NCT01152021|58621267|FG001|Overall Study|No access to study drug in Pharmacy|1|||
30610419|NCT01151085|58621275|FG000|Overall Study|Lost to Follow-up|31|||
30610420|NCT01151085|58621275|FG000|Overall Study|Protocol Violation|25|||
30610421|NCT01149681|58621286|FG000|Overall Study|Withdrawal by Subject|7|||
30610422|NCT01149681|58621286|FG000|Overall Study|Progressive disease|1|||
30610423|NCT01149681|58621286|FG000|Overall Study|Physician Decision|2|||
30610424|NCT01149681|58621286|FG000|Overall Study|adverse events nonrelated study drug|2|||
30610425|NCT01149369|58621293|FG000|Overall Study|Adverse Event|6|||
30610426|NCT01149369|58621294|FG001|Overall Study|Adverse Event|3|||
30610427|NCT01740427|58621302|FG000|Overall Study|Ongoing|45|||
30610428|NCT01740427|58621303|FG001|Overall Study|Ongoing|5|||
30610429|NCT01740427|58621302|FG000|Overall Study|Objective Progression or Relapse|281|||
30610430|NCT01740427|58621303|FG001|Overall Study|Objective Progression or Relapse|171|||
30610431|NCT01740427|58621302|FG000|Overall Study|Adverse Event|31|||
30610432|NCT01740427|58621303|FG001|Overall Study|Adverse Event|9|||
30610433|NCT01740427|58621302|FG000|Overall Study|Global Deterioration of Health Status|28|||
30610434|NCT01740427|58621303|FG001|Overall Study|Global Deterioration of Health Status|12|||
30610435|NCT01740427|58621302|FG000|Overall Study|Participant Refused Continued Treatment|26|||
30610436|NCT01740427|58621303|FG001|Overall Study|Participant Refused Continued Treatment|15|||
30610437|NCT01740427|58621302|FG000|Overall Study|Unspecified reasons|15|||
30610438|NCT01740427|58621303|FG001|Overall Study|Unspecified reasons|4|||
30610439|NCT01740427|58621302|FG000|Overall Study|Death|10|||
30610440|NCT01740427|58621303|FG001|Overall Study|Death|3|||
30610441|NCT01740427|58621302|FG000|Overall Study|Protocol Violation|5|||
30610442|NCT01740427|58621303|FG001|Overall Study|Protocol Violation|3|||
30610443|NCT01740427|58621302|FG000|Overall Study|Lost to Follow-up|2|||
30610444|NCT01740427|58621303|FG001|Overall Study|Lost to Follow-up|0|||
30610445|NCT01740427|58621302|FG000|Overall Study|Site Terminated by Sponsor|1|||
30610446|NCT01740427|58621303|FG001|Overall Study|Site Terminated by Sponsor|0|||
30610447|NCT01149057|58621309|FG000|Overall Study|Lack of Efficacy|16|||
30610448|NCT01149057|58621309|FG000|Overall Study|Adverse Event|13|||
30610449|NCT01149057|58621309|FG000|Overall Study|Withdrawal by Subject|9|||
30610450|NCT01149057|58621309|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
30610451|NCT01149057|58621309|FG000|Overall Study|B Cell Depletion|4|||
30610452|NCT01149057|58621309|FG000|Overall Study|Participant Non-Compliance|2|||
30610453|NCT01149057|58621309|FG000|Overall Study|Lost to Follow-up|1|||
30610454|NCT01149057|58621309|FG000|Overall Study|High Parathyroid Hormone Value|1|||
30610455|NCT01149057|58621309|FG000|Overall Study|Other|6|||
30610456|NCT01227564|58621316|FG000|Overall Study|No Longer Willing to Participate|4|||
30610457|NCT01227564|58621317|FG001|Overall Study|No Longer Willing to Participate|2|||
30610458|NCT01227564|58621318|FG002|Overall Study|No Longer Willing to Participate|5|||
30610459|NCT01227564|58621316|FG000|Overall Study|Participant moved to another town|0|||
30610460|NCT01227564|58621317|FG001|Overall Study|Participant moved to another town|0|||
30610461|NCT01227564|58621318|FG002|Overall Study|Participant moved to another town|1|||
30610462|NCT01148979|58621334|FG000|Overall Study|Lost to Follow-up|0|||
30610463|NCT01148979|58621335|FG001|Overall Study|Lost to Follow-up|1|||
30610464|NCT01148511|58621343|FG000|Exposed to Study Drug|Protocol Violation|2|||
30610465|NCT01148511|58621344|FG001|Exposed to Study Drug|Protocol Violation|0|||
30610466|NCT01148511|58621345|FG002|Exposed to Study Drug|Protocol Violation|0|||
30610467|NCT01148511|58621343|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
30610468|NCT01148511|58621344|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
30610469|NCT01148511|58621345|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
30610470|NCT01148511|58621343|FG000|Randomized|Adverse Event|0|||
31006496|NCT01565148|59207929|FG003|Overall Study|Physician Decision|0|||
31006497|NCT01564758|59207943|FG000|Overall Study|Death|8|||
31006498|NCT01564758|59207943|FG000|Overall Study|Adverse Event|3|||
31006499|NCT01564758|59207943|FG000|Overall Study|Other|3|||
31006500|NCT01541826|59207950|FG000|Overall Study|Lost to Follow-up|2|||
31006501|NCT01541826|59207951|FG001|Overall Study|Lost to Follow-up|3|||
31006502|NCT01541826|59207952|FG002|Overall Study|Lost to Follow-up|0|||
30610471|NCT01148511|58621344|FG001|Randomized|Adverse Event|1|||
30610472|NCT01148511|58621345|FG002|Randomized|Adverse Event|0|||
30610473|NCT01148511|58621343|FG000|Randomized|Protocol Violation|0|||
30610474|NCT01148511|58621344|FG001|Randomized|Protocol Violation|2|||
30610475|NCT01148511|58621345|FG002|Randomized|Protocol Violation|1|||
30610476|NCT01148511|58621343|FG000|Randomized|Lost to Follow-up|0|||
30610477|NCT01148511|58621344|FG001|Randomized|Lost to Follow-up|1|||
30610478|NCT01148511|58621345|FG002|Randomized|Lost to Follow-up|1|||
30610479|NCT01148511|58621343|FG000|Randomized|Consent withdrawal|0|||
30610480|NCT01148511|58621344|FG001|Randomized|Consent withdrawal|5|||
30610481|NCT01148511|58621345|FG002|Randomized|Consent withdrawal|3|||
30610482|NCT01148511|58621343|FG000|Randomized|Other|0|||
30610483|NCT01148511|58621344|FG001|Randomized|Other|1|||
30610484|NCT01148511|58621345|FG002|Randomized|Other|1|||
30610485|NCT00547339|58621356|FG000|Overall Study|Physician Decision|0|||
30610486|NCT00547339|58621357|FG001|Overall Study|Physician Decision|0|||
30610487|NCT00547339|58621358|FG002|Overall Study|Physician Decision|1|||
30610488|NCT00547339|58621359|FG003|Overall Study|Physician Decision|0|||
30610489|NCT01227252|58621382|FG000|Overall Study|Sponsor Decision|0|||
30610490|NCT01227252|58621383|FG001|Overall Study|Sponsor Decision|1|||
31006503|NCT01541826|59207950|FG000|Overall Study|Withdrawal by Subject|2|||
31006504|NCT01541826|59207951|FG001|Overall Study|Withdrawal by Subject|0|||
31006505|NCT01541826|59207952|FG002|Overall Study|Withdrawal by Subject|0|||
31006506|NCT01541748|59207960|FG000|Overall Study|Lost to Follow-up|17|||
30610491|NCT01227252|58621384|FG002|Overall Study|Sponsor Decision|0|||
30610492|NCT01227252|58621385|FG003|Overall Study|Sponsor Decision|0|||
30610493|NCT01227252|58621382|FG000|Overall Study|Lost to Follow-up|0|||
30610494|NCT01227252|58621383|FG001|Overall Study|Lost to Follow-up|1|||
30610495|NCT01227252|58621384|FG002|Overall Study|Lost to Follow-up|0|||
30610496|NCT01227252|58621385|FG003|Overall Study|Lost to Follow-up|0|||
30610497|NCT01227252|58621382|FG000|Overall Study|Withdrawal by Subject|0|||
30610498|NCT01227252|58621383|FG001|Overall Study|Withdrawal by Subject|1|||
30610499|NCT01227252|58621384|FG002|Overall Study|Withdrawal by Subject|0|||
30610500|NCT01227252|58621385|FG003|Overall Study|Withdrawal by Subject|0|||
30610501|NCT01227018|58621398|FG000|Overall Study|Disease progression|9|||
30610502|NCT01227018|58621398|FG000|Overall Study|Toxicity|2|||
30610503|NCT01227018|58621398|FG000|Overall Study|Withdrew after beginning treatment|4|||
30610504|NCT01226472|58621412|FG000|Overall Study|Progressive Disease|1|||
30610505|NCT01225146|58621418|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
30610506|NCT01225146|58621419|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
30610507|NCT01223196|58621429|FG000|Overall Study|Lost to Follow-up|2|||
30610508|NCT01223196|58621430|FG001|Overall Study|Lost to Follow-up|0|||
30790344|NCT03126110|58803547|FG012|Phase 1|Withdrawal by Subject|0|||
31006507|NCT01541748|59207960|FG000|Overall Study|Moved out of state|1|||
31006508|NCT01541748|59207960|FG000|Overall Study|Withdrawal by Subject|7|||
30610509|NCT01223196|58621429|FG000|Overall Study|Physician Decision|1|||
30610510|NCT01223196|58621430|FG001|Overall Study|Physician Decision|0|||
30610511|NCT01223196|58621429|FG000|Overall Study|Withdrawal by Subject|1|||
30610512|NCT01223196|58621430|FG001|Overall Study|Withdrawal by Subject|0|||
30610513|NCT01222416|58621440|FG000|Overall Study|ineligible;metastasis|3|||
30610514|NCT01222416|58621441|FG001|Overall Study|ineligible;metastasis|0|||
30610515|NCT01222416|58621440|FG000|Overall Study|Adverse Event|4|||
30610516|NCT01222416|58621441|FG001|Overall Study|Adverse Event|0|||
30610517|NCT01222416|58621440|FG000|Overall Study|Withdrawal by Subject|5|||
30610518|NCT01222416|58621441|FG001|Overall Study|Withdrawal by Subject|0|||
30610519|NCT01222416|58621440|FG000|Overall Study|scheduling|6|||
30610520|NCT01222416|58621441|FG001|Overall Study|scheduling|0|||
30610521|NCT01222416|58621440|FG000|Overall Study|missed view/scan|1|||
30610522|NCT01222416|58621441|FG001|Overall Study|missed view/scan|0|||
30610523|NCT01222416|58621440|FG000|Overall Study|Death|1|||
30610524|NCT01222416|58621441|FG001|Overall Study|Death|0|||
30610525|NCT01222104|58621447|FG000|Overall Study|Lost to Follow-up|37|||
30610526|NCT01222104|58621447|FG000|Overall Study|Death|10|||
30610527|NCT01221948|58621457|FG000|Overall Study|Physician Decision|5|||
30610528|NCT01221948|58621457|FG000|Overall Study|Withdrawal by Subject|2|||
30610529|NCT01221948|58621457|FG000|Overall Study|not disclosed|2|||
30610530|NCT01221948|58621457|FG000|Overall Study|Death|1|||
30610531|NCT01221948|58621457|FG000|Overall Study|Protocol Violation|4|||
30610532|NCT01221090|58621465|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
30610533|NCT01221090|58621466|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
30610534|NCT01221090|58621467|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
30610535|NCT01221090|58621468|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
30610536|NCT01221090|58621465|FG000|Overall Study|Withdrawal by Subject|0|||
30610537|NCT01221090|58621466|FG001|Overall Study|Withdrawal by Subject|22|||
30610538|NCT01221090|58621467|FG002|Overall Study|Withdrawal by Subject|27|||
30610539|NCT01221090|58621468|FG003|Overall Study|Withdrawal by Subject|2|||
30610540|NCT00950911|58621480|FG000|Overall Study|Adverse Event|0|||
30610541|NCT00950911|58621481|FG001|Overall Study|Adverse Event|2|||
30610542|NCT00950911|58621480|FG000|Overall Study|Death|4|||
30610543|NCT00950911|58621481|FG001|Overall Study|Death|6|||
30610544|NCT00950911|58621480|FG000|Overall Study|Disease progression|2|||
30610545|NCT00950911|58621481|FG001|Overall Study|Disease progression|2|||
30610546|NCT00950911|58621480|FG000|Overall Study|Consent withdrawn|1|||
30610547|NCT00950911|58621481|FG001|Overall Study|Consent withdrawn|3|||
30610548|NCT00950911|58621480|FG000|Overall Study|Administrative decision|3|||
30610549|NCT00950911|58621481|FG001|Overall Study|Administrative decision|1|||
30610550|NCT00950911|58621480|FG000|Overall Study|Ineligibility determined|1|||
30610551|NCT00950911|58621481|FG001|Overall Study|Ineligibility determined|0|||
30610552|NCT00950911|58621480|FG000|Overall Study|Noncompliance|1|||
30610553|NCT00950911|58621481|FG001|Overall Study|Noncompliance|0|||
30610554|NCT00950911|58621480|FG000|Overall Study|Poor performance status|0|||
30610555|NCT00950911|58621481|FG001|Overall Study|Poor performance status|1|||
30610556|NCT01220856|58621489|FG000|Overall Study|graft loss|3|||
30610557|NCT01220856|58621490|FG001|Overall Study|graft loss|3|||
30610558|NCT01220856|58621489|FG000|Overall Study|Lost to Follow-up|1|||
30610559|NCT01220856|58621490|FG001|Overall Study|Lost to Follow-up|0|||
30610560|NCT01218594|58621499|FG000|Overall Study|Death|1|||
30610561|NCT01218594|58621499|FG000|Overall Study|Withdrawal by Subject|3|||
30610562|NCT01218594|58621499|FG000|Overall Study|Adverse Event|2|||
30610563|NCT01218594|58621499|FG000|Overall Study|Physician Decision|6|||
30610564|NCT01610557|58621507|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
30610565|NCT01610557|58621508|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
30610566|NCT01610557|58621509|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
30610567|NCT01610557|58621510|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
30610568|NCT01610557|58621511|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
30610569|NCT01610557|58621507|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
30610570|NCT01610557|58621508|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
30610571|NCT01610557|58621509|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
30610572|NCT01610557|58621510|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
30610573|NCT01610557|58621511|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
30610574|NCT00943735|58621522|FG000|Overall Study|Adverse Event|12|||
30610575|NCT00943735|58621522|FG000|Overall Study|Withdrawal by Subject|8|||
30610576|NCT00943735|58621522|FG000|Overall Study|Death|1|||
30610577|NCT00943735|58621522|FG000|Overall Study|Other|8|||
30610578|NCT00943735|58621522|FG000|Overall Study|Other|3|||
30610579|NCT00943579|58621528|FG000|Overall Study|Adverse Event|4|||
30610580|NCT00943579|58621529|FG001|Overall Study|Adverse Event|3|||
30610581|NCT00943579|58621528|FG000|Overall Study|Lack of Efficacy|2|||
30610582|NCT00943579|58621529|FG001|Overall Study|Lack of Efficacy|2|||
30610583|NCT01147809|58621544|FG000|Phase I (168 Days)|Adverse Event|0|||
30610584|NCT01147809|58621545|FG001|Phase I (168 Days)|Adverse Event|0|||
30610585|NCT01147809|58621546|FG002|Phase I (168 Days)|Adverse Event|0|||
30610586|NCT01147809|58621547|FG003|Phase I (168 Days)|Adverse Event|1|||
30610587|NCT01147809|58621548|FG004|Phase I (168 Days)|Adverse Event|0|||
30610588|NCT01147809|58621549|FG005|Phase I (168 Days)|Adverse Event|0|||
30610589|NCT01147809|58621544|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
30610590|NCT01147809|58621545|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
30610591|NCT01147809|58621546|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
30610592|NCT01147809|58621547|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
30610593|NCT01147809|58621548|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
30610594|NCT01147809|58621549|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
30610595|NCT01147809|58621544|FG000|Phase I (168 Days)|Physician Decision|0|||
30610596|NCT01147809|58621545|FG001|Phase I (168 Days)|Physician Decision|1|||
30610597|NCT01147809|58621546|FG002|Phase I (168 Days)|Physician Decision|2|||
30610598|NCT01147809|58621547|FG003|Phase I (168 Days)|Physician Decision|0|||
30610599|NCT01147809|58621548|FG004|Phase I (168 Days)|Physician Decision|0|||
30610600|NCT01147809|58621549|FG005|Phase I (168 Days)|Physician Decision|0|||
30610601|NCT01147809|58621544|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
30610602|NCT01147809|58621545|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
30610603|NCT01147809|58621546|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
30610604|NCT01147809|58621547|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
30610605|NCT01147809|58621548|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
30610606|NCT01147809|58621549|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
30610607|NCT01147809|58621544|FG000|Phase II (168 Days)|Adverse Event|0|||
30610608|NCT01147809|58621545|FG001|Phase II (168 Days)|Adverse Event|0|||
30610609|NCT01147809|58621546|FG002|Phase II (168 Days)|Adverse Event|0|||
30610610|NCT01147809|58621547|FG003|Phase II (168 Days)|Adverse Event|0|||
30610611|NCT01147809|58621548|FG004|Phase II (168 Days)|Adverse Event|3|||
30610612|NCT01147809|58621549|FG005|Phase II (168 Days)|Adverse Event|6|||
30610613|NCT01147809|58621544|FG000|Phase II (168 Days)|Protocol Violation|0|||
30610614|NCT01147809|58621545|FG001|Phase II (168 Days)|Protocol Violation|0|||
30610615|NCT01147809|58621546|FG002|Phase II (168 Days)|Protocol Violation|0|||
30610616|NCT01147809|58621547|FG003|Phase II (168 Days)|Protocol Violation|0|||
30610617|NCT01147809|58621548|FG004|Phase II (168 Days)|Protocol Violation|0|||
30610618|NCT01147809|58621549|FG005|Phase II (168 Days)|Protocol Violation|1|||
30610619|NCT01147809|58621544|FG000|Phase II (168 Days)|Physician Decision|0|||
30610620|NCT01147809|58621545|FG001|Phase II (168 Days)|Physician Decision|0|||
30610621|NCT01147809|58621546|FG002|Phase II (168 Days)|Physician Decision|0|||
30610622|NCT01147809|58621547|FG003|Phase II (168 Days)|Physician Decision|0|||
30610623|NCT01147809|58621548|FG004|Phase II (168 Days)|Physician Decision|5|||
30610624|NCT01147809|58621549|FG005|Phase II (168 Days)|Physician Decision|11|||
30610625|NCT01147809|58621544|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
30610626|NCT01147809|58621545|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
30610627|NCT01147809|58621546|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
30610628|NCT01147809|58621547|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
30610629|NCT01147809|58621548|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
30610630|NCT01147809|58621549|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
30610631|NCT01147809|58621544|FG000|Phase II (168 Days)|Ongoing|0|||
30610632|NCT01147809|58621545|FG001|Phase II (168 Days)|Ongoing|0|||
30610633|NCT01147809|58621546|FG002|Phase II (168 Days)|Ongoing|0|||
30610634|NCT01147809|58621547|FG003|Phase II (168 Days)|Ongoing|0|||
30610635|NCT01147809|58621548|FG004|Phase II (168 Days)|Ongoing|1|||
30610636|NCT01147809|58621549|FG005|Phase II (168 Days)|Ongoing|0|||
30610637|NCT00943111|58621566|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
30610638|NCT00943111|58621567|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
30610639|NCT00943111|58621568|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
30610640|NCT00943111|58621566|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
30610641|NCT00943111|58621567|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
30610642|NCT00943111|58621568|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
30610643|NCT00943111|58621566|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
30610644|NCT00943111|58621567|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
30610645|NCT00943111|58621568|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
30610646|NCT00943111|58621566|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
30610647|NCT00943111|58621567|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
30610648|NCT00943111|58621568|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
30610649|NCT00943111|58621566|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
30610650|NCT00943111|58621567|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
30610651|NCT00943111|58621568|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
30610652|NCT00943111|58621566|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
30610653|NCT00943111|58621567|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
30610654|NCT00943111|58621568|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
30610655|NCT00943111|58621566|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
30610656|NCT00943111|58621567|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
30610657|NCT00943111|58621568|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
30610658|NCT00943111|58621566|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
30610659|NCT00943111|58621567|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
30610660|NCT00943111|58621568|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
30610661|NCT01147497|58621577|FG000|Overall Study|failed insertion|2|||
30610662|NCT01147497|58621578|FG001|Overall Study|failed insertion|0|||
30610663|NCT01147341|58621586|FG000|Double Blind Period|Lack of Efficacy|1|||
30610664|NCT01147341|58621587|FG001|Double Blind Period|Lack of Efficacy|1|||
30610665|NCT01147341|58621586|FG000|Double Blind Period|Withdrawal by Subject|0|||
30790345|NCT03126110|58803548|FG013|Phase 1|Withdrawal by Subject|0|||
30790346|NCT03126110|58803549|FG014|Phase 1|Withdrawal by Subject|0|||
30892749|NCT01934140|58926201|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
30892750|NCT01934140|58926202|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
30892751|NCT01933672|58926210|FG000|Metformin Run-in Period|Adverse Event|1|||
30892752|NCT01933672|58926211|FG001|Metformin Run-in Period|Adverse Event|0|||
30892753|NCT01933672|58926212|FG002|Metformin Run-in Period|Adverse Event|0|||
30892754|NCT01933672|58926213|FG003|Metformin Run-in Period|Adverse Event|0|||
30892755|NCT01933672|58926214|FG004|Metformin Run-in Period|Adverse Event|0|||
30892756|NCT01933672|58926215|FG005|Metformin Run-in Period|Adverse Event|0|||
30892757|NCT01933672|58926216|FG006|Metformin Run-in Period|Adverse Event|0|||
30892758|NCT01933672|58926210|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
30892759|NCT01933672|58926211|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
30610666|NCT01147341|58621587|FG001|Double Blind Period|Withdrawal by Subject|1|||
30610667|NCT01147341|58621586|FG000|Open Label Period|Lack of Efficacy|3|||
30610668|NCT01147341|58621587|FG001|Open Label Period|Lack of Efficacy|0|||
30610669|NCT01147341|58621586|FG000|Open Label Period|Subject moved|1|||
30610670|NCT01147341|58621587|FG001|Open Label Period|Subject moved|0|||
30610671|NCT00950755|58621593|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
30610672|NCT00950755|58621593|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
30610673|NCT00950755|58621593|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
30610674|NCT00950755|58621593|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
30610675|NCT00950755|58621593|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
30610676|NCT00950755|58621593|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
30610677|NCT00950755|58621593|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
30610678|NCT00950755|58621593|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
30610679|NCT00950755|58621593|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
30610680|NCT00950755|58621593|FG000|Long-Term Follow-Up|Death|8|||
30610681|NCT01147107|58621599|FG000|Overall Study|Lack of Efficacy|5|||
30610682|NCT01147107|58621600|FG001|Overall Study|Lack of Efficacy|0|||
30610683|NCT01147107|58621599|FG000|Overall Study|Withdrawal by Subject|1|||
30610684|NCT01147107|58621600|FG001|Overall Study|Withdrawal by Subject|1|||
30610685|NCT00942409|58621606|FG000|Overall Study|Lack of Efficacy|1|||
30610686|NCT00942409|58621606|FG000|Overall Study|study drug unavailable|2|||
30610687|NCT01146951|58621612|FG000|Overall Study|Adverse Event|4|||
30610688|NCT01146951|58621613|FG001|Overall Study|Adverse Event|1|||
30610689|NCT01146873|58621621|FG000|Overall Study|Transfer out|0|||
30610690|NCT01146873|58621622|FG001|Overall Study|Transfer out|6|||
30610691|NCT01146795|58621628|FG000|Overall Study|Withdrawal by Subject|4|||
30610692|NCT01146795|58621628|FG000|Overall Study|Adverse Event|6|||
30610693|NCT01146795|58621628|FG000|Overall Study|Still in treatment at study closure|10|||
30610694|NCT01146561|58621632|FG000|Overall Study|Withdrawal by Subject|1|||
30610695|NCT01146561|58621632|FG000|Overall Study|Lost to Follow-up|1|||
30610696|NCT00942175|58621640|FG000|Overall Study|Adverse Event|2|||
30610697|NCT00942175|58621641|FG001|Overall Study|Adverse Event|1|||
30610698|NCT00942175|58621642|FG002|Overall Study|Adverse Event|0|||
30610699|NCT00942175|58621643|FG003|Overall Study|Adverse Event|0|||
30610700|NCT00942175|58621640|FG000|Overall Study|Protocol Violation|0|||
30610701|NCT00942175|58621641|FG001|Overall Study|Protocol Violation|1|||
30610702|NCT00942175|58621642|FG002|Overall Study|Protocol Violation|2|||
30610703|NCT00942175|58621643|FG003|Overall Study|Protocol Violation|0|||
30610704|NCT00942175|58621640|FG000|Overall Study|Pregnancy|0|||
30610705|NCT00942175|58621641|FG001|Overall Study|Pregnancy|0|||
30610706|NCT00942175|58621642|FG002|Overall Study|Pregnancy|0|||
30610707|NCT00942175|58621643|FG003|Overall Study|Pregnancy|1|||
30610708|NCT00942175|58621640|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
30610709|NCT00942175|58621641|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
30610710|NCT00942175|58621642|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
30610711|NCT00942175|58621643|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
30610712|NCT00942175|58621640|FG000|Overall Study|Low Platelet Count|0|||
30610713|NCT00942175|58621641|FG001|Overall Study|Low Platelet Count|2|||
30610714|NCT00942175|58621642|FG002|Overall Study|Low Platelet Count|0|||
30610715|NCT00942175|58621643|FG003|Overall Study|Low Platelet Count|0|||
30610716|NCT01145625|58621663|FG000|Overall Study|Lost to Follow-up|8|||
30610717|NCT01145625|58621664|FG001|Overall Study|Lost to Follow-up|9|||
30610718|NCT01145625|58621663|FG000|Overall Study|Adverse Event|6|||
30610719|NCT01145625|58621664|FG001|Overall Study|Adverse Event|4|||
30610720|NCT01145625|58621663|FG000|Overall Study|Protocol Violation|3|||
30610721|NCT01145625|58621664|FG001|Overall Study|Protocol Violation|1|||
30610722|NCT01145625|58621663|FG000|Overall Study|Withdrawal by Subject|7|||
30610723|NCT01145625|58621664|FG001|Overall Study|Withdrawal by Subject|16|||
30610724|NCT01145625|58621663|FG000|Overall Study|Pregnancy|0|||
30610725|NCT01145625|58621664|FG001|Overall Study|Pregnancy|1|||
30610726|NCT01144377|58621675|FG000|52 Week Treatment Period|Adverse Event|0|||
30610727|NCT01144377|58621676|FG001|52 Week Treatment Period|Adverse Event|0|||
30610728|NCT01144377|58621677|FG002|52 Week Treatment Period|Adverse Event|3|||
30610729|NCT01144377|58621678|FG003|52 Week Treatment Period|Adverse Event|2|||
30610730|NCT01144377|58621679|FG004|52 Week Treatment Period|Adverse Event|1|||
30610731|NCT01144377|58621675|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
30610732|NCT01144377|58621676|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
30610733|NCT01144377|58621677|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
30610734|NCT01144377|58621678|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
30610735|NCT01144377|58621679|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
30610736|NCT01144377|58621675|FG000|52 Week Treatment Period|Protocol Violation|0|||
30610737|NCT01144377|58621676|FG001|52 Week Treatment Period|Protocol Violation|0|||
30610738|NCT01144377|58621677|FG002|52 Week Treatment Period|Protocol Violation|0|||
30610739|NCT01144377|58621678|FG003|52 Week Treatment Period|Protocol Violation|0|||
30610740|NCT01144377|58621679|FG004|52 Week Treatment Period|Protocol Violation|1|||
30610741|NCT01144377|58621675|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
30610742|NCT01144377|58621676|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
30610743|NCT01144377|58621677|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
30610744|NCT01144377|58621678|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
30610745|NCT01144377|58621679|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
30610746|NCT01144377|58621675|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
30610747|NCT01144377|58621676|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
30610748|NCT01144377|58621677|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
30610749|NCT01144377|58621678|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
30610750|NCT01144377|58621679|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
30610751|NCT01144377|58621675|FG000|52 Week Treatment Period|Sponsor Decision|0|||
30610752|NCT01144377|58621676|FG001|52 Week Treatment Period|Sponsor Decision|0|||
30610753|NCT01144377|58621677|FG002|52 Week Treatment Period|Sponsor Decision|0|||
30610754|NCT01144377|58621678|FG003|52 Week Treatment Period|Sponsor Decision|0|||
30610755|NCT01144377|58621679|FG004|52 Week Treatment Period|Sponsor Decision|1|||
30610756|NCT01144377|58621675|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
30610757|NCT01144377|58621676|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
30610758|NCT01144377|58621677|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
30610759|NCT01144377|58621678|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
30610760|NCT01144377|58621679|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
30610761|NCT01144377|58621675|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
30610762|NCT01144377|58621676|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
30610763|NCT01144377|58621677|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
30610764|NCT01144377|58621678|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
30610765|NCT01144377|58621679|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
30610766|NCT01144377|58621675|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
30610767|NCT01144377|58621676|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
30610768|NCT01144377|58621677|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
30610769|NCT01144377|58621678|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
30610770|NCT01144377|58621679|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
30610771|NCT00950599|58621701|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
30610772|NCT00950599|58621702|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
30610773|NCT00950599|58621703|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
30610774|NCT00950599|58621704|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
30610775|NCT00950599|58621705|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
30610776|NCT00950599|58621706|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
30610777|NCT00950599|58621707|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
30610778|NCT00950599|58621708|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
30610779|NCT00950599|58621709|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
30610780|NCT00950599|58621710|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
30610781|NCT00950599|58621701|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30610782|NCT00950599|58621702|FG001|Double-Blind Treatment Period|Adverse Event|1|||
30610783|NCT00950599|58621703|FG002|Double-Blind Treatment Period|Adverse Event|1|||
30610784|NCT00950599|58621704|FG003|Double-Blind Treatment Period|Adverse Event|1|||
30610785|NCT00950599|58621705|FG004|Double-Blind Treatment Period|Adverse Event|1|||
30610786|NCT00950599|58621706|FG005|Double-Blind Treatment Period|Adverse Event|1|||
30610787|NCT00950599|58621707|FG006|Double-Blind Treatment Period|Adverse Event|0|||
30610788|NCT00950599|58621708|FG007|Double-Blind Treatment Period|Adverse Event|0|||
30610789|NCT00950599|58621709|FG008|Double-Blind Treatment Period|Adverse Event|0|||
30610790|NCT00950599|58621710|FG009|Double-Blind Treatment Period|Adverse Event|0|||
30610791|NCT00950599|58621701|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
30610792|NCT00950599|58621702|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
30610793|NCT00950599|58621703|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
30610794|NCT00950599|58621704|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
30610795|NCT00950599|58621705|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
30610796|NCT00950599|58621706|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
30610797|NCT00950599|58621707|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
30610798|NCT00950599|58621708|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
30610799|NCT00950599|58621709|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
30610800|NCT00950599|58621710|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
30610801|NCT00950599|58621701|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
30610802|NCT00950599|58621702|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
30610803|NCT00950599|58621703|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
30610804|NCT00950599|58621704|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
30610805|NCT00950599|58621705|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
30610806|NCT00950599|58621706|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
30610807|NCT00950599|58621707|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
30610808|NCT00950599|58621708|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
30610809|NCT00950599|58621709|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
30610810|NCT00950599|58621710|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
30610811|NCT00950599|58621701|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
30610812|NCT00950599|58621702|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
30610813|NCT00950599|58621703|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
30610814|NCT00950599|58621704|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
30610815|NCT00950599|58621705|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
30610816|NCT00950599|58621706|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
30610817|NCT00950599|58621707|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
30610818|NCT00950599|58621708|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
30610819|NCT00950599|58621709|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
30610820|NCT00950599|58621710|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
30610821|NCT00950599|58621701|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
30610822|NCT00950599|58621702|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
30610823|NCT00950599|58621703|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
30610824|NCT00950599|58621704|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
30610825|NCT00950599|58621705|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
30610826|NCT00950599|58621706|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
30610827|NCT00950599|58621707|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
30610828|NCT00950599|58621708|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
30610829|NCT00950599|58621709|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
30610830|NCT00950599|58621710|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
31006509|NCT01541748|59207960|FG000|Overall Study|Screen failure|5|||
31006510|NCT01541748|59207960|FG000|Overall Study|Did not receive study device|1|||
30610831|NCT00950599|58621701|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
30610832|NCT00950599|58621702|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
30610833|NCT00950599|58621703|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
30610834|NCT00950599|58621704|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
30610835|NCT00950599|58621705|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
30610836|NCT00950599|58621706|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
30610837|NCT00950599|58621707|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
30610838|NCT00950599|58621708|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
30610839|NCT00950599|58621709|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
30610840|NCT00950599|58621710|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
30610841|NCT00950599|58621701|FG000|Follow-Up Period|Adverse Event|0|||
30610842|NCT00950599|58621702|FG001|Follow-Up Period|Adverse Event|0|||
30610843|NCT00950599|58621703|FG002|Follow-Up Period|Adverse Event|0|||
30610844|NCT00950599|58621704|FG003|Follow-Up Period|Adverse Event|0|||
30610845|NCT00950599|58621705|FG004|Follow-Up Period|Adverse Event|0|||
30610846|NCT00950599|58621706|FG005|Follow-Up Period|Adverse Event|0|||
30610847|NCT00950599|58621707|FG006|Follow-Up Period|Adverse Event|0|||
30610848|NCT00950599|58621708|FG007|Follow-Up Period|Adverse Event|0|||
30610849|NCT00950599|58621709|FG008|Follow-Up Period|Adverse Event|1|||
30610850|NCT00950599|58621710|FG009|Follow-Up Period|Adverse Event|0|||
30610851|NCT00950599|58621701|FG000|Follow-Up Period|Lack of Efficacy|0|||
30610852|NCT00950599|58621702|FG001|Follow-Up Period|Lack of Efficacy|0|||
30610853|NCT00950599|58621703|FG002|Follow-Up Period|Lack of Efficacy|0|||
30610854|NCT00950599|58621704|FG003|Follow-Up Period|Lack of Efficacy|0|||
30610855|NCT00950599|58621705|FG004|Follow-Up Period|Lack of Efficacy|0|||
30610856|NCT00950599|58621706|FG005|Follow-Up Period|Lack of Efficacy|0|||
31006511|NCT01589094|59207973|FG000|Overall Study|Did not receive treatment|2|||
31006512|NCT01563978|59207979|FG000|Overall Study|Physician Decision|1|||
31006513|NCT01563978|59207980|FG001|Overall Study|Physician Decision|0|||
31006514|NCT01563978|59207979|FG000|Overall Study|Lost to Follow-up|1|||
31006515|NCT01563978|59207980|FG001|Overall Study|Lost to Follow-up|0|||
31006516|NCT01563978|59207979|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
31006517|NCT01563978|59207980|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
31006518|NCT01563978|59207979|FG000|Overall Study|Adverse Event|1|||
31006519|NCT01563978|59207980|FG001|Overall Study|Adverse Event|2|||
31006520|NCT01563354|59207989|FG000|Core Phase|Adverse Event|5|||
31006521|NCT01563354|59207990|FG001|Core Phase|Adverse Event|15|||
31006522|NCT01563354|59207991|FG002|Core Phase|Adverse Event|13|||
31006523|NCT01563354|59207989|FG000|Core Phase|Withdrawal by Subject|1|||
31006524|NCT01563354|59207990|FG001|Core Phase|Withdrawal by Subject|0|||
31006525|NCT01563354|59207991|FG002|Core Phase|Withdrawal by Subject|3|||
31006526|NCT01563354|59207989|FG000|Core Phase|Lost to Follow-up|1|||
31006527|NCT01563354|59207990|FG001|Core Phase|Lost to Follow-up|0|||
31006528|NCT01563354|59207991|FG002|Core Phase|Lost to Follow-up|0|||
31006529|NCT01563354|59207989|FG000|Core Phase|Death|1|||
31006530|NCT01563354|59207990|FG001|Core Phase|Death|5|||
31006531|NCT01563354|59207991|FG002|Core Phase|Death|2|||
31006532|NCT01563354|59207989|FG000|Core Phase|Diseasse progression|18|||
30610857|NCT00950599|58621707|FG006|Follow-Up Period|Lack of Efficacy|0|||
30610858|NCT00950599|58621708|FG007|Follow-Up Period|Lack of Efficacy|0|||
30610859|NCT00950599|58621709|FG008|Follow-Up Period|Lack of Efficacy|3|||
30610860|NCT00950599|58621710|FG009|Follow-Up Period|Lack of Efficacy|0|||
30610861|NCT00950599|58621701|FG000|Follow-Up Period|Lost to Follow-up|0|||
30610862|NCT00950599|58621702|FG001|Follow-Up Period|Lost to Follow-up|0|||
30610863|NCT00950599|58621703|FG002|Follow-Up Period|Lost to Follow-up|0|||
30610864|NCT00950599|58621704|FG003|Follow-Up Period|Lost to Follow-up|0|||
30610865|NCT00950599|58621705|FG004|Follow-Up Period|Lost to Follow-up|0|||
30610866|NCT00950599|58621706|FG005|Follow-Up Period|Lost to Follow-up|0|||
30610867|NCT00950599|58621707|FG006|Follow-Up Period|Lost to Follow-up|0|||
30610868|NCT00950599|58621708|FG007|Follow-Up Period|Lost to Follow-up|0|||
30610869|NCT00950599|58621709|FG008|Follow-Up Period|Lost to Follow-up|5|||
30610870|NCT00950599|58621710|FG009|Follow-Up Period|Lost to Follow-up|1|||
30610871|NCT00950599|58621701|FG000|Follow-Up Period|Physician Decision|0|||
30610872|NCT00950599|58621702|FG001|Follow-Up Period|Physician Decision|0|||
31006533|NCT01563354|59207990|FG001|Core Phase|Diseasse progression|7|||
31006534|NCT01563354|59207991|FG002|Core Phase|Diseasse progression|8|||
31006535|NCT01563354|59207989|FG000|Core Phase|Protocol deviation|2|||
31006536|NCT01563354|59207990|FG001|Core Phase|Protocol deviation|0|||
31006537|NCT01563354|59207991|FG002|Core Phase|Protocol deviation|0|||
30610873|NCT00950599|58621703|FG002|Follow-Up Period|Physician Decision|0|||
30610874|NCT00950599|58621704|FG003|Follow-Up Period|Physician Decision|0|||
30610875|NCT00950599|58621705|FG004|Follow-Up Period|Physician Decision|0|||
30610876|NCT00950599|58621706|FG005|Follow-Up Period|Physician Decision|0|||
30610877|NCT00950599|58621707|FG006|Follow-Up Period|Physician Decision|0|||
30610878|NCT00950599|58621708|FG007|Follow-Up Period|Physician Decision|0|||
30610879|NCT00950599|58621709|FG008|Follow-Up Period|Physician Decision|1|||
31006538|NCT01563354|59207989|FG000|Core Phase|PI decision - did not enter extension|0|||
30610880|NCT00950599|58621710|FG009|Follow-Up Period|Physician Decision|0|||
30610881|NCT00950599|58621701|FG000|Follow-Up Period|Poor/Noncompliance|0|||
30610882|NCT00950599|58621702|FG001|Follow-Up Period|Poor/Noncompliance|0|||
30610883|NCT00950599|58621703|FG002|Follow-Up Period|Poor/Noncompliance|0|||
30610884|NCT00950599|58621704|FG003|Follow-Up Period|Poor/Noncompliance|0|||
30610885|NCT00950599|58621705|FG004|Follow-Up Period|Poor/Noncompliance|0|||
30610886|NCT00950599|58621706|FG005|Follow-Up Period|Poor/Noncompliance|0|||
30610887|NCT00950599|58621707|FG006|Follow-Up Period|Poor/Noncompliance|0|||
30610888|NCT00950599|58621708|FG007|Follow-Up Period|Poor/Noncompliance|0|||
30610889|NCT00950599|58621709|FG008|Follow-Up Period|Poor/Noncompliance|1|||
30610890|NCT00950599|58621710|FG009|Follow-Up Period|Poor/Noncompliance|0|||
30610891|NCT00950599|58621701|FG000|Follow-Up Period|Subject withdrew Consent|0|||
30610892|NCT00950599|58621702|FG001|Follow-Up Period|Subject withdrew Consent|0|||
30610893|NCT00950599|58621703|FG002|Follow-Up Period|Subject withdrew Consent|0|||
30610894|NCT00950599|58621704|FG003|Follow-Up Period|Subject withdrew Consent|0|||
30610895|NCT00950599|58621705|FG004|Follow-Up Period|Subject withdrew Consent|0|||
30610896|NCT00950599|58621706|FG005|Follow-Up Period|Subject withdrew Consent|0|||
30610897|NCT00950599|58621707|FG006|Follow-Up Period|Subject withdrew Consent|0|||
30610898|NCT00950599|58621708|FG007|Follow-Up Period|Subject withdrew Consent|0|||
30610899|NCT00950599|58621709|FG008|Follow-Up Period|Subject withdrew Consent|2|||
30610900|NCT00950599|58621710|FG009|Follow-Up Period|Subject withdrew Consent|1|||
30610901|NCT01144299|58621735|FG000|Overall Study|Lost to Follow-up|1|||
30610902|NCT01144299|58621736|FG001|Overall Study|Lost to Follow-up|0|||
30610903|NCT01144299|58621735|FG000|Overall Study|Withdrawal by Subject|1|||
30610904|NCT01144299|58621736|FG001|Overall Study|Withdrawal by Subject|0|||
30610905|NCT01143207|58621742|FG000|Overall Study|Lost to Follow-up|2|||
30610906|NCT01143051|58621752|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
30610907|NCT01143051|58621753|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
30610908|NCT01143051|58621754|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
30610909|NCT01143051|58621755|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
30610910|NCT01143051|58621756|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
30610911|NCT01143051|58621757|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
30610912|NCT01143051|58621752|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
30610913|NCT01143051|58621753|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
30610914|NCT01143051|58621754|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
30610915|NCT01143051|58621755|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
30610916|NCT01143051|58621756|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
30610917|NCT01143051|58621757|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
30610918|NCT01142661|58621767|FG000|Overall Study|Adverse Event|2|||
30610919|NCT01142661|58621767|FG000|Overall Study|Withdrawal by Subject|1|||
30610920|NCT01142661|58621767|FG000|Overall Study|Physician Decision|1|||
30610921|NCT01142193|58621773|FG000|Overall Study|Adverse Event|12|||
30610922|NCT01142193|58621774|FG001|Overall Study|Adverse Event|4|||
30610923|NCT01142193|58621773|FG000|Overall Study|Lack of Efficacy|2|||
30610924|NCT01142193|58621774|FG001|Overall Study|Lack of Efficacy|1|||
30610925|NCT01142193|58621773|FG000|Overall Study|Physician Decision|1|||
30610926|NCT01142193|58621774|FG001|Overall Study|Physician Decision|1|||
30610927|NCT01142193|58621773|FG000|Overall Study|Withdrawal by Subject|4|||
30610928|NCT01142193|58621774|FG001|Overall Study|Withdrawal by Subject|3|||
30610929|NCT01142193|58621773|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
31006539|NCT01563354|59207990|FG001|Core Phase|PI decision - did not enter extension|1|||
31006540|NCT01563354|59207991|FG002|Core Phase|PI decision - did not enter extension|0|||
30610930|NCT01142193|58621774|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
30610931|NCT01142193|58621773|FG000|Overall Study|Other|1|||
30610932|NCT01142193|58621774|FG001|Overall Study|Other|2|||
30610933|NCT01142115|58621780|FG000|First Intervention|Lack of Efficacy|1|||
30610934|NCT01142115|58621781|FG001|First Intervention|Lack of Efficacy|1|||
30610935|NCT01142115|58621780|FG000|First Intervention|Adverse Event|1|||
31006541|NCT01563354|59207989|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
31006542|NCT01563354|59207990|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
31006543|NCT01563354|59207991|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
31006544|NCT01563354|59207989|FG000|Extension Phase|Adverse Event|0|||
31006545|NCT01563354|59207990|FG001|Extension Phase|Adverse Event|3|||
31006546|NCT01563354|59207991|FG002|Extension Phase|Adverse Event|2|||
31006547|NCT01563354|59207989|FG000|Extension Phase|Withdrawal by Subject|0|||
30610936|NCT01142115|58621781|FG001|First Intervention|Adverse Event|0|||
30610937|NCT01140477|58621788|FG000|Overall Study|Lost to Follow-up|4|||
30610938|NCT01140477|58621789|FG001|Overall Study|Lost to Follow-up|0|||
30610939|NCT01140477|58621788|FG000|Overall Study|Withdrawal by Subject|1|||
30610940|NCT01140477|58621789|FG001|Overall Study|Withdrawal by Subject|4|||
30610941|NCT01140477|58621788|FG000|Overall Study|Surgical complication preventing implant|2|||
30610942|NCT01140477|58621789|FG001|Overall Study|Surgical complication preventing implant|0|||
30610943|NCT01140477|58621788|FG000|Overall Study|Death|1|||
30610944|NCT01140477|58621789|FG001|Overall Study|Death|1|||
30610945|NCT01140477|58621788|FG000|Overall Study|Subject explanted|0|||
30610946|NCT01140477|58621789|FG001|Overall Study|Subject explanted|1|||
30610947|NCT01139775|58621798|FG000|Overall Study|Adverse Event|0|||
30610948|NCT01139775|58621799|FG001|Overall Study|Adverse Event|6|||
30610949|NCT01139775|58621800|FG002|Overall Study|Adverse Event|2|||
30610950|NCT01139775|58621798|FG000|Overall Study|Protocol Violation|0|||
30610951|NCT01139775|58621799|FG001|Overall Study|Protocol Violation|5|||
30610952|NCT01139775|58621800|FG002|Overall Study|Protocol Violation|0|||
30610953|NCT01139775|58621798|FG000|Overall Study|Withdrawal by Subject|1|||
30610954|NCT01139775|58621799|FG001|Overall Study|Withdrawal by Subject|0|||
30610955|NCT01139775|58621800|FG002|Overall Study|Withdrawal by Subject|2|||
30610956|NCT01139775|58621798|FG000|Overall Study|Physician Decision|0|||
30610957|NCT01139775|58621799|FG001|Overall Study|Physician Decision|2|||
30610958|NCT01139775|58621800|FG002|Overall Study|Physician Decision|2|||
30610959|NCT01283516|58621819|FG000|Overall Study|Adverse Event|0|||
30610960|NCT01283516|58621820|FG001|Overall Study|Adverse Event|0|||
30610961|NCT01283516|58621821|FG002|Overall Study|Adverse Event|0|||
30610962|NCT01283516|58621822|FG003|Overall Study|Adverse Event|0|||
30610963|NCT01283516|58621823|FG004|Overall Study|Adverse Event|0|||
30610964|NCT01283516|58621824|FG005|Overall Study|Adverse Event|0|||
30610965|NCT01283516|58621825|FG006|Overall Study|Adverse Event|2|||
30610966|NCT01283516|58621826|FG007|Overall Study|Adverse Event|0|||
30610967|NCT01283516|58621827|FG008|Overall Study|Adverse Event|28|||
30610968|NCT01283516|58621819|FG000|Overall Study|Death|0|||
30610969|NCT01283516|58621820|FG001|Overall Study|Death|0|||
30610970|NCT01283516|58621821|FG002|Overall Study|Death|0|||
30610971|NCT01283516|58621822|FG003|Overall Study|Death|0|||
30610972|NCT01283516|58621823|FG004|Overall Study|Death|0|||
30610973|NCT01283516|58621824|FG005|Overall Study|Death|1|||
30610974|NCT01283516|58621825|FG006|Overall Study|Death|0|||
30610975|NCT01283516|58621826|FG007|Overall Study|Death|1|||
30610976|NCT01283516|58621827|FG008|Overall Study|Death|12|||
30610977|NCT01283516|58621819|FG000|Overall Study|Disease Progression|2|||
30610978|NCT01283516|58621820|FG001|Overall Study|Disease Progression|2|||
30610979|NCT01283516|58621821|FG002|Overall Study|Disease Progression|3|||
30610980|NCT01283516|58621822|FG003|Overall Study|Disease Progression|3|||
30610981|NCT01283516|58621823|FG004|Overall Study|Disease Progression|13|||
30610982|NCT01283516|58621824|FG005|Overall Study|Disease Progression|8|||
30610983|NCT01283516|58621825|FG006|Overall Study|Disease Progression|6|||
30610984|NCT01283516|58621826|FG007|Overall Study|Disease Progression|3|||
30610985|NCT01283516|58621827|FG008|Overall Study|Disease Progression|139|||
30610986|NCT01283516|58621819|FG000|Overall Study|Withdrawal by Subject|0|||
30610987|NCT01283516|58621820|FG001|Overall Study|Withdrawal by Subject|0|||
30610988|NCT01283516|58621821|FG002|Overall Study|Withdrawal by Subject|0|||
30610989|NCT01283516|58621822|FG003|Overall Study|Withdrawal by Subject|0|||
30610990|NCT01283516|58621823|FG004|Overall Study|Withdrawal by Subject|1|||
30610991|NCT01283516|58621824|FG005|Overall Study|Withdrawal by Subject|0|||
30610992|NCT01283516|58621825|FG006|Overall Study|Withdrawal by Subject|1|||
30610993|NCT01283516|58621826|FG007|Overall Study|Withdrawal by Subject|0|||
30610994|NCT01283516|58621827|FG008|Overall Study|Withdrawal by Subject|36|||
30610995|NCT01283516|58621819|FG000|Overall Study|Administrative problems|0|||
30610996|NCT01283516|58621820|FG001|Overall Study|Administrative problems|0|||
30610997|NCT01283516|58621821|FG002|Overall Study|Administrative problems|0|||
30610998|NCT01283516|58621822|FG003|Overall Study|Administrative problems|0|||
30610999|NCT01283516|58621823|FG004|Overall Study|Administrative problems|0|||
30611000|NCT01283516|58621824|FG005|Overall Study|Administrative problems|1|||
30611001|NCT01283516|58621825|FG006|Overall Study|Administrative problems|1|||
30611002|NCT01283516|58621826|FG007|Overall Study|Administrative problems|1|||
30611003|NCT01283516|58621827|FG008|Overall Study|Administrative problems|39|||
30611004|NCT01283516|58621819|FG000|Overall Study|Lost to Follow-up|0|||
30611005|NCT01283516|58621820|FG001|Overall Study|Lost to Follow-up|0|||
30611006|NCT01283516|58621821|FG002|Overall Study|Lost to Follow-up|0|||
30611007|NCT01283516|58621822|FG003|Overall Study|Lost to Follow-up|0|||
30611008|NCT01283516|58621823|FG004|Overall Study|Lost to Follow-up|0|||
30611009|NCT01283516|58621824|FG005|Overall Study|Lost to Follow-up|0|||
30611010|NCT01283516|58621825|FG006|Overall Study|Lost to Follow-up|0|||
30611011|NCT01283516|58621826|FG007|Overall Study|Lost to Follow-up|0|||
30611012|NCT01283516|58621827|FG008|Overall Study|Lost to Follow-up|1|||
30611013|NCT01137435|58621855|FG000|Overall Study|Lost to Follow-up|24|||
30611014|NCT01137435|58621855|FG000|Overall Study|Off label usage|4|||
30611015|NCT01283282|58621859|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
30611016|NCT01283282|58621860|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
30611017|NCT01283282|58621859|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
30611018|NCT01283282|58621860|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
30611019|NCT01283282|58621859|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
30611020|NCT01283282|58621860|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
30611021|NCT01282814|58621869|FG000|First Intervention|Emesis During Dosing Interval|0|||
30611022|NCT01282814|58621870|FG001|First Intervention|Emesis During Dosing Interval|3|||
30611023|NCT01282814|58621869|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
30611024|NCT01282814|58621870|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
30611025|NCT00941863|58621881|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
30611026|NCT00941863|58621882|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
30611027|NCT00941863|58621883|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
30611028|NCT00941863|58621884|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
30611029|NCT00941863|58621885|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
30611030|NCT00941863|58621881|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
30611031|NCT00941863|58621882|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
30611032|NCT00941863|58621883|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
30611033|NCT00941863|58621884|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
30611034|NCT00941863|58621885|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
30611035|NCT00941863|58621881|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
30611036|NCT00941863|58621882|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
30611037|NCT00941863|58621883|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
30611038|NCT00941863|58621884|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
30611039|NCT00941863|58621885|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
30611040|NCT00941863|58621881|FG000|Until Primary Completion Date (PCD)|Death|0|||
30611041|NCT00941863|58621882|FG001|Until Primary Completion Date (PCD)|Death|0|||
30611042|NCT00941863|58621883|FG002|Until Primary Completion Date (PCD)|Death|1|||
30611043|NCT00941863|58621884|FG003|Until Primary Completion Date (PCD)|Death|2|||
30611044|NCT00941863|58621885|FG004|Until Primary Completion Date (PCD)|Death|7|||
30611045|NCT00941863|58621881|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
30611046|NCT00941863|58621882|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
30611047|NCT00941863|58621883|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
30611048|NCT00941863|58621884|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
30611049|NCT00941863|58621885|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
30611050|NCT00941863|58621881|FG000|Continued After PCD|Withdrawal by Subject|0|||
30611051|NCT00941863|58621882|FG001|Continued After PCD|Withdrawal by Subject|0|||
30892760|NCT01933672|58926212|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
30892761|NCT01933672|58926213|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
30892762|NCT01933672|58926214|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
31006548|NCT01563354|59207990|FG001|Extension Phase|Withdrawal by Subject|1|||
31006549|NCT01563354|59207991|FG002|Extension Phase|Withdrawal by Subject|0|||
31006550|NCT01563354|59207989|FG000|Extension Phase|Administration problems|3|||
31006551|NCT01563354|59207990|FG001|Extension Phase|Administration problems|2|||
31006552|NCT01563354|59207991|FG002|Extension Phase|Administration problems|3|||
31006553|NCT01563354|59207989|FG000|Extension Phase|Disease progression|9|||
31006554|NCT01563354|59207990|FG001|Extension Phase|Disease progression|8|||
31006555|NCT01563354|59207991|FG002|Extension Phase|Disease progression|10|||
30611052|NCT00941863|58621883|FG002|Continued After PCD|Withdrawal by Subject|0|||
30611053|NCT00941863|58621884|FG003|Continued After PCD|Withdrawal by Subject|0|||
30611054|NCT00941863|58621885|FG004|Continued After PCD|Withdrawal by Subject|1|||
31006556|NCT01588548|59208005|FG000|Overall Study|Withdrawal by Subject|0|||
31006557|NCT01588548|59208006|FG001|Overall Study|Withdrawal by Subject|1|||
31006558|NCT01588548|59208007|FG002|Overall Study|Withdrawal by Subject|1|||
31006559|NCT01588548|59208008|FG003|Overall Study|Withdrawal by Subject|1|||
31006560|NCT01588548|59208009|FG004|Overall Study|Withdrawal by Subject|2|||
30611055|NCT00941863|58621881|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
31006561|NCT01588548|59208010|FG005|Overall Study|Withdrawal by Subject|3|||
31006562|NCT01588548|59208005|FG000|Overall Study|Adverse Event|0|||
31006563|NCT01588548|59208006|FG001|Overall Study|Adverse Event|0|||
30790347|NCT03126110|58803550|FG015|Phase 1|Withdrawal by Subject|0|||
31006564|NCT01588548|59208007|FG002|Overall Study|Adverse Event|1|||
31006565|NCT01588548|59208008|FG003|Overall Study|Adverse Event|2|||
31006566|NCT01588548|59208009|FG004|Overall Study|Adverse Event|1|||
31006567|NCT01588548|59208010|FG005|Overall Study|Adverse Event|0|||
31006568|NCT01588548|59208005|FG000|Overall Study|Condition Under Investigation Worsened|3|||
31006569|NCT01588548|59208006|FG001|Overall Study|Condition Under Investigation Worsened|6|||
31006570|NCT01588548|59208007|FG002|Overall Study|Condition Under Investigation Worsened|4|||
31006571|NCT01588548|59208008|FG003|Overall Study|Condition Under Investigation Worsened|4|||
31006572|NCT01588548|59208009|FG004|Overall Study|Condition Under Investigation Worsened|3|||
31006573|NCT01588548|59208010|FG005|Overall Study|Condition Under Investigation Worsened|3|||
31006574|NCT01587924|59208028|FG000|Overall Study|Adverse Event|0|||
31006575|NCT01587924|59208029|FG001|Overall Study|Adverse Event|2|||
31006576|NCT01587924|59208030|FG002|Overall Study|Adverse Event|0|||
31006577|NCT01587924|59208031|FG003|Overall Study|Adverse Event|0|||
31006578|NCT01587924|59208028|FG000|Overall Study|Protocol Violation|2|||
31006579|NCT01587924|59208029|FG001|Overall Study|Protocol Violation|1|||
30892763|NCT01933672|58926215|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
31006580|NCT01587924|59208030|FG002|Overall Study|Protocol Violation|2|||
31006581|NCT01587924|59208031|FG003|Overall Study|Protocol Violation|1|||
31006582|NCT01587924|59208028|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
31006583|NCT01587924|59208029|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
31006584|NCT01587924|59208030|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
31006585|NCT01587924|59208031|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
31006586|NCT01587924|59208028|FG000|Overall Study|Withdrawal by Subject|0|||
31006587|NCT01587924|59208029|FG001|Overall Study|Withdrawal by Subject|1|||
31006588|NCT01587924|59208030|FG002|Overall Study|Withdrawal by Subject|1|||
31006589|NCT01587924|59208031|FG003|Overall Study|Withdrawal by Subject|0|||
31006590|NCT01539642|59208043|FG000|Overall Study|Lack of Efficacy|20|||
31006591|NCT01539642|59208044|FG001|Overall Study|Lack of Efficacy|18|||
31006592|NCT01539642|59208043|FG000|Overall Study|Patient ready for early discharge|8|||
31006593|NCT01539642|59208044|FG001|Overall Study|Patient ready for early discharge|7|||
31006594|NCT01539642|59208043|FG000|Overall Study|Adverse Event|6|||
31006595|NCT01539642|59208044|FG001|Overall Study|Adverse Event|4|||
31006596|NCT01539642|59208043|FG000|Overall Study|Withdrawal by Subject|2|||
31006597|NCT01539642|59208044|FG001|Overall Study|Withdrawal by Subject|2|||
31006598|NCT01586364|59208050|FG000|Overall Study|Withdrawal by Subject|40|||
31006599|NCT01586364|59208050|FG000|Overall Study|Adverse Event|37|||
31006600|NCT01586364|59208050|FG000|Overall Study|Lost to Follow-up|17|||
31006601|NCT01586364|59208050|FG000|Overall Study|Protocol Violation|16|||
30611056|NCT00941863|58621882|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
30611057|NCT00941863|58621883|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
30611058|NCT00941863|58621884|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
30790348|NCT03126110|58803551|FG016|Phase 1|Withdrawal by Subject|0|||
31006602|NCT01586364|59208050|FG000|Overall Study|Lack of Efficacy|1|||
31006603|NCT01586364|59208050|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
31006604|NCT01586364|59208050|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
31006605|NCT01586364|59208050|FG000|Overall Study|Other-Site closure due to PI illness|1|||
31006606|NCT01586364|59208050|FG000|Overall Study|Other-PI discretion, site closing|2|||
31006607|NCT01586364|59208050|FG000|Overall Study|Other-Not specified|1|||
31006608|NCT01538628|59208056|FG000|Overall Study|Withdrawal by Subject|1|||
31006609|NCT01538628|59208057|FG001|Overall Study|Withdrawal by Subject|1|||
31006610|NCT01538628|59208056|FG000|Overall Study|Lost to Follow-up|0|||
31006611|NCT01538628|59208057|FG001|Overall Study|Lost to Follow-up|1|||
30611059|NCT00941863|58621885|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
30611060|NCT01282424|58621901|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
30611061|NCT01282424|58621901|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
30611062|NCT01282424|58621901|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
30611063|NCT01282424|58621901|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
30611064|NCT01282424|58621901|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
30611065|NCT01282424|58621901|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
30611066|NCT01282424|58621901|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
30611067|NCT01282424|58621901|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
30611068|NCT01281956|58621905|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
30611069|NCT01281956|58621906|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
30611070|NCT01279850|58621915|FG000|Overall Study|Protocol Violation|50|||
30611071|NCT01279850|58621915|FG000|Overall Study|No Drug Administration Information|7|||
30611072|NCT01279850|58621915|FG000|Overall Study|No Visit After Treatment|34|||
30892764|NCT01933672|58926216|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
30892765|NCT01933672|58926210|FG000|Metformin Run-in Period|Other|5|||
30892766|NCT01933672|58926211|FG001|Metformin Run-in Period|Other|0|||
30892767|NCT01933672|58926212|FG002|Metformin Run-in Period|Other|0|||
30892768|NCT01933672|58926213|FG003|Metformin Run-in Period|Other|0|||
30892769|NCT01933672|58926214|FG004|Metformin Run-in Period|Other|0|||
30892770|NCT01933672|58926215|FG005|Metformin Run-in Period|Other|0|||
30892771|NCT01933672|58926216|FG006|Metformin Run-in Period|Other|0|||
30892772|NCT01933672|58926210|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
30892773|NCT01933672|58926211|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
30892774|NCT01933672|58926212|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
31006612|NCT01538472|59208064|FG000|Overall Study|Disease Progression|3|||
31006613|NCT01538472|59208064|FG000|Overall Study|Death|1|||
31006614|NCT01562028|59208070|FG000|Overall Study|Withdrawal by Subject|1|||
31006615|NCT01562028|59208071|FG001|Overall Study|Withdrawal by Subject|1|||
31006616|NCT01562028|59208070|FG000|Overall Study|Lost to Follow-up|2|||
31006617|NCT01562028|59208071|FG001|Overall Study|Lost to Follow-up|1|||
31006618|NCT01585584|59208077|FG000|Overall Study|Lack of Efficacy|1|||
31006619|NCT01585584|59208077|FG000|Overall Study|Withdrawal by Subject|1|||
31006620|NCT01585584|59208077|FG000|Overall Study|Physician Decision|2|||
31006621|NCT01561560|59208081|FG000|First Two Weeks of Wear|Time/job conflict|0|||
31006622|NCT01561560|59208082|FG001|First Two Weeks of Wear|Time/job conflict|1|||
31006623|NCT01561560|59208081|FG000|First Two Weeks of Wear|Adverse Event|0|||
31006624|NCT01561560|59208082|FG001|First Two Weeks of Wear|Adverse Event|1|||
31006625|NCT01561560|59208081|FG000|Second Two Weeks of Wear|Adverse Event|0|||
31006626|NCT01561560|59208082|FG001|Second Two Weeks of Wear|Adverse Event|1|||
31006627|NCT01537068|59208090|FG000|Overall Study|Lost to Follow-up|2|||
30611073|NCT00949975|58621923|FG000|Overall Study|Voluntary discontinuation|6|||
30892775|NCT01933672|58926213|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
31006628|NCT01537068|59208091|FG001|Overall Study|Lost to Follow-up|1|||
31006629|NCT01537068|59208090|FG000|Overall Study|Adverse Event|0|||
31006630|NCT01537068|59208091|FG001|Overall Study|Adverse Event|1|||
31006631|NCT01537068|59208090|FG000|Overall Study|Withdrawal by Subject|1|||
31006632|NCT01537068|59208091|FG001|Overall Study|Withdrawal by Subject|1|||
30611074|NCT00949975|58621924|FG001|Overall Study|Voluntary discontinuation|5|||
30611075|NCT00949975|58621925|FG002|Overall Study|Voluntary discontinuation|3|||
30611076|NCT00949975|58621926|FG003|Overall Study|Voluntary discontinuation|6|||
30611077|NCT00949975|58621923|FG000|Overall Study|Adverse Event|11|||
30611078|NCT00949975|58621924|FG001|Overall Study|Adverse Event|11|||
30611079|NCT00949975|58621925|FG002|Overall Study|Adverse Event|10|||
30611080|NCT00949975|58621926|FG003|Overall Study|Adverse Event|10|||
30611081|NCT00949975|58621923|FG000|Overall Study|Safety reason|0|||
30611082|NCT00949975|58621924|FG001|Overall Study|Safety reason|1|||
30611083|NCT00949975|58621925|FG002|Overall Study|Safety reason|0|||
30611084|NCT00949975|58621926|FG003|Overall Study|Safety reason|0|||
30611085|NCT00949975|58621923|FG000|Overall Study|Study-specific criteria|0|||
30611086|NCT00949975|58621924|FG001|Overall Study|Study-specific criteria|1|||
30611087|NCT00949975|58621925|FG002|Overall Study|Study-specific criteria|1|||
30611088|NCT00949975|58621926|FG003|Overall Study|Study-specific criteria|0|||
30611089|NCT00949975|58621923|FG000|Overall Study|Incorrect enrolment|5|||
30611090|NCT00949975|58621924|FG001|Overall Study|Incorrect enrolment|10|||
30611091|NCT00949975|58621925|FG002|Overall Study|Incorrect enrolment|4|||
30611092|NCT00949975|58621926|FG003|Overall Study|Incorrect enrolment|7|||
30611093|NCT00949975|58621923|FG000|Overall Study|Severe non-compliance|3|||
30611094|NCT00949975|58621924|FG001|Overall Study|Severe non-compliance|1|||
30611095|NCT00949975|58621925|FG002|Overall Study|Severe non-compliance|0|||
30611096|NCT00949975|58621926|FG003|Overall Study|Severe non-compliance|2|||
30611097|NCT00949975|58621923|FG000|Overall Study|Lost to Follow-up|1|||
30611098|NCT00949975|58621924|FG001|Overall Study|Lost to Follow-up|0|||
30611099|NCT00949975|58621925|FG002|Overall Study|Lost to Follow-up|1|||
30611100|NCT00949975|58621926|FG003|Overall Study|Lost to Follow-up|3|||
30611101|NCT00949975|58621923|FG000|Overall Study|Other|1|||
30611102|NCT00949975|58621924|FG001|Overall Study|Other|0|||
30611103|NCT00949975|58621925|FG002|Overall Study|Other|0|||
30892776|NCT01933672|58926214|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
30892777|NCT01933672|58926215|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
30892778|NCT01933672|58926216|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
30892779|NCT01933672|58926210|FG000|First Intervention Period (12-16 Days)|Other|0|||
30892780|NCT01933672|58926211|FG001|First Intervention Period (12-16 Days)|Other|0|||
30892781|NCT01933672|58926212|FG002|First Intervention Period (12-16 Days)|Other|1|||
30892782|NCT01933672|58926213|FG003|First Intervention Period (12-16 Days)|Other|0|||
30892783|NCT01933672|58926214|FG004|First Intervention Period (12-16 Days)|Other|0|||
30892784|NCT01933672|58926215|FG005|First Intervention Period (12-16 Days)|Other|1|||
30892785|NCT01933672|58926216|FG006|First Intervention Period (12-16 Days)|Other|0|||
30892786|NCT01933672|58926210|FG000|Second Intervention Period (12-16 Days)|Other|0|||
30611104|NCT00949975|58621926|FG003|Overall Study|Other|0|||
30611105|NCT00939055|58621938|FG000|Overall Study|Discontinuation prior to procedure|4|||
30611106|NCT00939055|58621939|FG001|Overall Study|Discontinuation prior to procedure|0|||
30611107|NCT01136967|58621948|FG000|Overall Study|Adverse Event|9|||
30611108|NCT01136967|58621949|FG001|Overall Study|Adverse Event|12|||
30611109|NCT01136967|58621948|FG000|Overall Study|Participant Choice|8|||
30611110|NCT01136967|58621949|FG001|Overall Study|Participant Choice|3|||
30611111|NCT01136967|58621948|FG000|Overall Study|Lost to Follow-up|0|||
30611112|NCT01136967|58621949|FG001|Overall Study|Lost to Follow-up|1|||
30611113|NCT01136967|58621948|FG000|Overall Study|Withdrawal by Subject|1|||
30611114|NCT01136967|58621949|FG001|Overall Study|Withdrawal by Subject|2|||
30611115|NCT01136967|58621948|FG000|Overall Study|Clinical Progression|3|||
30611116|NCT01136967|58621949|FG001|Overall Study|Clinical Progression|5|||
30611117|NCT01136967|58621948|FG000|Overall Study|Radiation|1|||
30611118|NCT01136967|58621949|FG001|Overall Study|Radiation|0|||
30611119|NCT01136967|58621948|FG000|Overall Study|Non-compliance|1|||
30611120|NCT01136967|58621949|FG001|Overall Study|Non-compliance|0|||
30611121|NCT01136967|58621948|FG000|Overall Study|Investigator's Choice|1|||
30892787|NCT01933672|58926211|FG001|Second Intervention Period (12-16 Days)|Other|1|||
31006633|NCT01537068|59208090|FG000|Overall Study|Lack of Efficacy|1|||
30611122|NCT01136967|58621949|FG001|Overall Study|Investigator's Choice|1|||
30611123|NCT01136967|58621948|FG000|Overall Study|Increase in Lesion Size|0|||
30611124|NCT01136967|58621949|FG001|Overall Study|Increase in Lesion Size|2|||
30611125|NCT01136967|58621948|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
30611126|NCT01136967|58621949|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
31006634|NCT01537068|59208091|FG001|Overall Study|Lack of Efficacy|0|||
31006635|NCT01585428|59208099|FG000|Overall Study|Death during treatment|1|||
31006636|NCT01585428|59208100|FG001|Overall Study|Death during treatment|0|||
31006637|NCT01585272|59208107|FG000|Overall Study|Adverse Event|22|||
31006638|NCT01585272|59208107|FG000|Overall Study|Protocol Violation|7|||
31006639|NCT01585272|59208107|FG000|Overall Study|Withdrawal by Subject|10|||
31006640|NCT01585194|59208111|FG000|Overall Study|Withdrawal by Subject|1|||
31006641|NCT01585194|59208111|FG000|Overall Study|Physician Decision|2|||
31006642|NCT01585194|59208111|FG000|Overall Study|Lack of insurance|1|||
31006643|NCT01560780|59208117|FG000|Overall Study|Death|2|||
31006644|NCT01560780|59208118|FG001|Overall Study|Death|1|||
31006645|NCT01560780|59208117|FG000|Overall Study|Patient Preference|11|||
31006646|NCT01560780|59208118|FG001|Overall Study|Patient Preference|11|||
31006647|NCT01585038|59208126|FG000|Overall Study|Adverse Event|2|||
31006648|NCT01585038|59208127|FG001|Overall Study|Adverse Event|2|||
31006649|NCT01560234|59208141|FG000|Overall Study|Lost to Follow-up|3|||
31006650|NCT01560234|59208142|FG001|Overall Study|Lost to Follow-up|0|||
31006651|NCT01560234|59208143|FG002|Overall Study|Lost to Follow-up|1|||
31006652|NCT01560234|59208144|FG003|Overall Study|Lost to Follow-up|0|||
31006653|NCT01560234|59208145|FG004|Overall Study|Lost to Follow-up|0|||
31006654|NCT01560234|59208146|FG005|Overall Study|Lost to Follow-up|2|||
31006655|NCT01560234|59208147|FG006|Overall Study|Lost to Follow-up|0|||
31006656|NCT01560234|59208148|FG007|Overall Study|Lost to Follow-up|2|||
31006657|NCT01559844|59208166|FG000|Overall Study|Consent Withdrawn|7|||
31006658|NCT01559844|59208166|FG000|Overall Study|Death|5|||
31006659|NCT01559844|59208166|FG000|Overall Study|Efficacy Failure|10|||
31006660|NCT01559844|59208166|FG000|Overall Study|No Longer A Transplant Candidate|3|||
31006661|NCT01584648|59208172|FG000|Overall Study|Death|136|||
31006662|NCT01584648|59208173|FG001|Overall Study|Death|146|||
31006663|NCT01584648|59208172|FG000|Overall Study|Lost to Follow-up|9|||
31006664|NCT01584648|59208173|FG001|Overall Study|Lost to Follow-up|9|||
31006665|NCT01584648|59208172|FG000|Overall Study|Investigator discretion|3|||
31006666|NCT01584648|59208173|FG001|Overall Study|Investigator discretion|2|||
31006667|NCT01584648|59208172|FG000|Overall Study|Withdrew consent|13|||
31006668|NCT01584648|59208173|FG001|Overall Study|Withdrew consent|4|||
31006669|NCT01584648|59208172|FG000|Overall Study|Study closed/terminated|50|||
31006670|NCT01584648|59208173|FG001|Overall Study|Study closed/terminated|23|||
31006671|NCT01584648|59208172|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
31006672|NCT01584648|59208173|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
31006673|NCT01559454|59208184|FG000|Overall Study|Lost to Follow-up|3|||
31006674|NCT01559454|59208185|FG001|Overall Study|Lost to Follow-up|2|||
31006675|NCT01559454|59208184|FG000|Overall Study|Withdrawal by Subject|0|||
31006676|NCT01559454|59208185|FG001|Overall Study|Withdrawal by Subject|1|||
31006677|NCT01559454|59208184|FG000|Overall Study|Physician Decision|0|||
31006678|NCT01559454|59208185|FG001|Overall Study|Physician Decision|1|||
31006679|NCT01559454|59208184|FG000|Overall Study|Protocol Violation|0|||
31006680|NCT01559454|59208185|FG001|Overall Study|Protocol Violation|1|||
31006681|NCT01559454|59208184|FG000|Overall Study|Lack of Efficacy|0|||
31006682|NCT01559454|59208185|FG001|Overall Study|Lack of Efficacy|1|||
30611127|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
30611128|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
30611129|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
31006683|NCT01584024|59208191|FG000|Overall Study|Lost to Follow-up|10|||
30611130|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
30611131|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
31006684|NCT01584024|59208191|FG000|Overall Study|Withdrawal by Subject|3|||
31006685|NCT01583166|59208198|FG000|Overall Study|Withdrawal by Subject|4|||
31006686|NCT01583166|59208199|FG001|Overall Study|Withdrawal by Subject|6|||
31006687|NCT01535274|59208207|FG000|Overall Study|Determined to be ineligible|0|||
31006688|NCT01535274|59208208|FG001|Overall Study|Determined to be ineligible|1|||
31006689|NCT01535274|59208207|FG000|Overall Study|Misallocated to propofol intervention|0|||
31006690|NCT01535274|59208208|FG001|Overall Study|Misallocated to propofol intervention|1|||
30611132|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
30611133|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
30611134|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
30611135|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
30611136|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
30611137|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
30611138|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
30611139|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
30611140|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
30611141|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
30611142|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
30611143|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
30611144|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
30611145|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
30611146|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
30611147|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
30611148|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
30611149|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
30611150|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
30611151|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
30611152|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
30611153|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
30611154|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
30611155|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
30611156|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
30611157|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
30611158|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
30611159|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
30611160|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
30611161|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
30611162|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
30611163|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
30611164|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
30611165|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
30611166|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
30611167|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
30611168|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
30611169|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
30611170|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
30611171|NCT01218516|58621957|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
30611172|NCT01218516|58621958|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
30611173|NCT01218516|58621959|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
30611174|NCT01218516|58621960|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
30611175|NCT00938431|58621973|FG000|Overall Study|Adverse Event|5|||
30611176|NCT00938431|58621974|FG001|Overall Study|Adverse Event|8|||
30611177|NCT00938431|58621975|FG002|Overall Study|Adverse Event|6|||
30611178|NCT00938431|58621973|FG000|Overall Study|Lack of Efficacy|0|||
30611179|NCT00938431|58621974|FG001|Overall Study|Lack of Efficacy|1|||
30611180|NCT00938431|58621975|FG002|Overall Study|Lack of Efficacy|0|||
30611181|NCT00938431|58621973|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
30611182|NCT00938431|58621974|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
30611183|NCT00938431|58621975|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
30611184|NCT00938431|58621973|FG000|Overall Study|Dosing compliance issue|0|||
30611185|NCT00938431|58621974|FG001|Overall Study|Dosing compliance issue|0|||
30611186|NCT00938431|58621975|FG002|Overall Study|Dosing compliance issue|1|||
30611187|NCT00938431|58621973|FG000|Overall Study|Reached maximum dose early|0|||
30611188|NCT00938431|58621974|FG001|Overall Study|Reached maximum dose early|0|||
30611189|NCT00938431|58621975|FG002|Overall Study|Reached maximum dose early|1|||
30611190|NCT01136811|58621987|FG000|Overall Study|Physician Decision|11|||
30611191|NCT00949117|58621993|FG000|Overall Study|Lack of Efficacy|2|||
30611192|NCT00949117|58621994|FG001|Overall Study|Lack of Efficacy|3|||
30611193|NCT00949117|58621993|FG000|Overall Study|Protocol Violation|1|||
30611194|NCT00949117|58621994|FG001|Overall Study|Protocol Violation|1|||
30611195|NCT00949117|58621993|FG000|Overall Study|Adverse Event|0|||
30611196|NCT00949117|58621994|FG001|Overall Study|Adverse Event|1|||
30611197|NCT00938041|58622002|FG000|Overall Study|Lost to Follow-up|6|||
30611198|NCT00938041|58622002|FG000|Overall Study|Received Alternative Therapy|1|||
30611199|NCT00938041|58622002|FG000|Overall Study|Progressive Disease|5|||
30611200|NCT00938041|58622002|FG000|Overall Study|Death|12|||
30611201|NCT00938041|58622002|FG000|Overall Study|Adrenal Insufficiency|3|||
30611202|NCT01218438|58622006|FG000|Epoch 1|Physician Decision|2|||
30611203|NCT01218438|58622006|FG000|Epoch 1|Adverse Event|1|||
30611204|NCT01218438|58622006|FG000|Epoch 3|Withdrawal by Subject|3|||
30611205|NCT01218438|58622006|FG000|Epoch 3|Adverse Event|1|||
30611206|NCT01218438|58622006|FG000|Epoch 4|Physician Decision|1|||
30611207|NCT01218438|58622006|FG000|Epoch 4|Withdrawal by Subject|2|||
30611208|NCT00935701|58622080|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
30611209|NCT01277510|58622087|FG000|Double-blind Phase|Non-compliance|0|||
30611210|NCT01277510|58622088|FG001|Double-blind Phase|Non-compliance|1|||
30611211|NCT01277510|58622087|FG000|Double-blind Phase|Adverse Event|1|||
30611212|NCT01277510|58622088|FG001|Double-blind Phase|Adverse Event|0|||
30611213|NCT01277510|58622087|FG000|Double-blind Phase|Withdrawal by Subject|2|||
30611214|NCT01277510|58622088|FG001|Double-blind Phase|Withdrawal by Subject|0|||
30611215|NCT01277510|58622087|FG000|Double-blind Phase|Administrative decision|7|||
30611216|NCT01277510|58622088|FG001|Double-blind Phase|Administrative decision|9|||
30611217|NCT01277510|58622087|FG000|Double-blind Phase|Death|0|||
30611218|NCT01277510|58622088|FG001|Double-blind Phase|Death|1|||
30611219|NCT01277510|58622087|FG000|Double-blind Phase|Protocol-specified criteria|2|||
30611220|NCT01277510|58622088|FG001|Double-blind Phase|Protocol-specified criteria|6|||
30611221|NCT01277510|58622087|FG000|Double-blind Phase|Other|1|||
30611222|NCT01277510|58622088|FG001|Double-blind Phase|Other|1|||
30611223|NCT01277510|58622087|FG000|Open-label Phase|Administrative decision|4|||
30611224|NCT01277510|58622088|FG001|Open-label Phase|Administrative decision|3|||
30611225|NCT01277510|58622087|FG000|Open-label Phase|Protocol-specified criteria|1|||
30611226|NCT01277510|58622088|FG001|Open-label Phase|Protocol-specified criteria|0|||
30611227|NCT01277510|58622087|FG000|Open-label Phase|Never received investigational product|2|||
30611228|NCT01277510|58622088|FG001|Open-label Phase|Never received investigational product|0|||
30611229|NCT00937495|58622096|FG000|Overall Study|Protocol Violation|2|||
30611230|NCT01268306|58622100|FG000|Overall Study|Lost to Follow-up|1|||
30611231|NCT00936715|58622104|FG000|Overall Study|Investigators Discretion|1|||
30611232|NCT00936715|58622104|FG000|Overall Study|Protocol Violation|1|||
30611233|NCT00936715|58622104|FG000|Overall Study|Safety or Tolerability Reasons|4|||
30611234|NCT01267994|58622108|FG000|Overall Study|Adverse Event|2|||
30611235|NCT00934843|58622115|FG000|Overall Study|Protocol Violation|0|||
30611236|NCT00934843|58622116|FG001|Overall Study|Protocol Violation|1|||
30611237|NCT01266902|58622124|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
30611238|NCT01266902|58622125|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
30611239|NCT01266902|58622126|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
30611240|NCT01266902|58622124|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
30611241|NCT01266902|58622125|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
30611242|NCT01266902|58622126|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
30611243|NCT01266902|58622124|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
30611244|NCT01266902|58622125|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
30611245|NCT01266902|58622126|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
30611246|NCT01266902|58622124|FG000|Period 1 (Main Study)|Adverse Event|3|||
30611247|NCT01266902|58622125|FG001|Period 1 (Main Study)|Adverse Event|11|||
30611248|NCT01266902|58622126|FG002|Period 1 (Main Study)|Adverse Event|0|||
30611249|NCT01266902|58622124|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
30611250|NCT01266902|58622125|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
30611251|NCT01266902|58622126|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
30611252|NCT01266902|58622124|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
30611253|NCT01266902|58622125|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
30611254|NCT01266902|58622126|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
30611255|NCT01266902|58622124|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
30611256|NCT01266902|58622125|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
30611257|NCT01266902|58622126|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
30611258|NCT01266902|58622124|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
30611259|NCT01266902|58622125|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
30611260|NCT01266902|58622126|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
30611261|NCT01266902|58622124|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
30611262|NCT01266902|58622125|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
30790349|NCT03126110|58803535|FG000|Phase 1|Safety follow-up no longer necessary|1|||
30790350|NCT03126110|58803536|FG001|Phase 1|Safety follow-up no longer necessary|0|||
30611263|NCT01266902|58622126|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
30611264|NCT01266902|58622124|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
30611265|NCT01266902|58622125|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
30611266|NCT01266902|58622126|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
30611267|NCT01266824|58622136|FG000|Overall Study|Study terminated prior to completion|2|||
30611268|NCT01266824|58622137|FG001|Overall Study|Study terminated prior to completion|3|||
30611269|NCT01266590|58622143|FG000|Overall Study|Adverse Event|3|||
30611270|NCT01266590|58622143|FG000|Overall Study|Lost to Follow-up|1|||
30611271|NCT01266590|58622143|FG000|Overall Study|Withdrawal by Subject|1|||
30611272|NCT01266590|58622143|FG000|Overall Study|Physician Decision|1|||
30611273|NCT01266122|58622152|FG000|Overall Study|Lost to Follow-up|6|||
30611274|NCT01266122|58622153|FG001|Overall Study|Lost to Follow-up|6|||
30611275|NCT01265498|58622161|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
30611276|NCT01265498|58622162|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
30611277|NCT01265420|58622168|FG000|Overall Study|Lost to Follow-up|1|||
30611278|NCT01264718|58622174|FG000|Overall Study|Lost to Follow-up|3|||
30611279|NCT01264718|58622175|FG001|Overall Study|Lost to Follow-up|2|||
30611280|NCT01264718|58622174|FG000|Overall Study|Withdrawal by Subject|9|||
30611281|NCT01264718|58622175|FG001|Overall Study|Withdrawal by Subject|15|||
30611282|NCT01264718|58622174|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
30611283|NCT01264718|58622175|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
30611284|NCT01264016|58622181|FG000|Overall Study|Withdrawal by Subject|1|||
30611285|NCT01264016|58622181|FG000|Overall Study|Felt faint at sight of blood|1|||
30611286|NCT01263782|58622190|FG000|Overall Study|Death|0|||
30611287|NCT01263782|58622191|FG001|Overall Study|Death|0|||
30611288|NCT01263782|58622192|FG002|Overall Study|Death|1|||
30611289|NCT01263782|58622193|FG003|Overall Study|Death|0|||
30611290|NCT01263782|58622190|FG000|Overall Study|Progressive disease|0|||
30611291|NCT01263782|58622191|FG001|Overall Study|Progressive disease|0|||
30611292|NCT01263782|58622192|FG002|Overall Study|Progressive disease|0|||
30611293|NCT01263782|58622193|FG003|Overall Study|Progressive disease|1|||
30611294|NCT01263782|58622190|FG000|Overall Study|Too early|0|||
30611295|NCT01263782|58622191|FG001|Overall Study|Too early|0|||
30611296|NCT01263782|58622192|FG002|Overall Study|Too early|1|||
30611297|NCT01263782|58622193|FG003|Overall Study|Too early|0|||
30611298|NCT01263782|58622190|FG000|Overall Study|Inevaluable|0|||
30611299|NCT01263782|58622191|FG001|Overall Study|Inevaluable|0|||
30611300|NCT01263782|58622192|FG002|Overall Study|Inevaluable|1|||
30611301|NCT01263782|58622193|FG003|Overall Study|Inevaluable|0|||
30611302|NCT01263704|58622203|FG000|Overall Study|Progressive disease|18|||
30611303|NCT01263704|58622203|FG000|Overall Study|Adverse Event|3|||
30611304|NCT01263704|58622203|FG000|Overall Study|Death|2|||
30611305|NCT01263704|58622203|FG000|Overall Study|Patient withdrew consent|2|||
30611306|NCT01263704|58622203|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
30611307|NCT01263704|58622203|FG000|Overall Study|Lost to Follow-up|1|||
30611308|NCT01263704|58622203|FG000|Overall Study|Colon metastases|1|||
30611309|NCT01263704|58622203|FG000|Overall Study|Principal Investigator (PI) decision|1|||
30611310|NCT01263470|58622213|FG000|Overall Study|Adverse Event|2|||
30611311|NCT01263470|58622214|FG001|Overall Study|Adverse Event|2|||
30611312|NCT01263470|58622215|FG002|Overall Study|Adverse Event|1|||
30611313|NCT01263470|58622216|FG003|Overall Study|Adverse Event|1|||
30611314|NCT01263470|58622217|FG004|Overall Study|Adverse Event|2|||
30611315|NCT01263470|58622218|FG005|Overall Study|Adverse Event|2|||
30611316|NCT01263470|58622213|FG000|Overall Study|Protocol Violation|0|||
30611317|NCT01263470|58622214|FG001|Overall Study|Protocol Violation|1|||
30611318|NCT01263470|58622215|FG002|Overall Study|Protocol Violation|0|||
30611319|NCT01263470|58622216|FG003|Overall Study|Protocol Violation|0|||
30611320|NCT01263470|58622217|FG004|Overall Study|Protocol Violation|0|||
30611321|NCT01263470|58622218|FG005|Overall Study|Protocol Violation|1|||
30611322|NCT01263470|58622213|FG000|Overall Study|Withdrawal by Subject|0|||
30611323|NCT01263470|58622214|FG001|Overall Study|Withdrawal by Subject|1|||
30892788|NCT01933672|58926212|FG002|Second Intervention Period (12-16 Days)|Other|1|||
30892789|NCT01933672|58926213|FG003|Second Intervention Period (12-16 Days)|Other|0|||
31006691|NCT01558752|59208218|FG000|Overall Study|Physician Decision|2|||
31006692|NCT01558752|59208219|FG001|Overall Study|Physician Decision|0|||
31006693|NCT01582854|59208227|FG000|Overall Study|Death|8|||
31006694|NCT01582854|59208228|FG001|Overall Study|Death|5|||
31006695|NCT01582854|59208227|FG000|Overall Study|Adverse Event|2|||
31006696|NCT01582854|59208228|FG001|Overall Study|Adverse Event|3|||
31006697|NCT01582854|59208227|FG000|Overall Study|Withdrawal by Participant|8|||
31006698|NCT01582854|59208228|FG001|Overall Study|Withdrawal by Participant|11|||
31006699|NCT01582854|59208227|FG000|Overall Study|Lost to Follow-up|1|||
31006700|NCT01582854|59208228|FG001|Overall Study|Lost to Follow-up|2|||
31006701|NCT01582854|59208227|FG000|Overall Study|Physician Decision|0|||
31006702|NCT01582854|59208228|FG001|Overall Study|Physician Decision|1|||
30611324|NCT01263470|58622215|FG002|Overall Study|Withdrawal by Subject|1|||
30611325|NCT01263470|58622216|FG003|Overall Study|Withdrawal by Subject|2|||
30611326|NCT01263470|58622217|FG004|Overall Study|Withdrawal by Subject|0|||
30611327|NCT01263470|58622218|FG005|Overall Study|Withdrawal by Subject|2|||
30611328|NCT01263470|58622213|FG000|Overall Study|Lack of Efficacy|0|||
30611329|NCT01263470|58622214|FG001|Overall Study|Lack of Efficacy|0|||
31006703|NCT01582854|59208227|FG000|Overall Study|Recurrent Stroke|13|||
31006704|NCT01582854|59208228|FG001|Overall Study|Recurrent Stroke|8|||
31006705|NCT01582854|59208227|FG000|Overall Study|Disallowed Concomitant Medication|3|||
30611330|NCT01263470|58622215|FG002|Overall Study|Lack of Efficacy|2|||
30611331|NCT01263470|58622216|FG003|Overall Study|Lack of Efficacy|0|||
30611332|NCT01263470|58622217|FG004|Overall Study|Lack of Efficacy|0|||
30611333|NCT01263470|58622218|FG005|Overall Study|Lack of Efficacy|0|||
30611334|NCT01263470|58622213|FG000|Overall Study|Participant Unavailability|0|||
30611335|NCT01263470|58622214|FG001|Overall Study|Participant Unavailability|1|||
30611336|NCT01263470|58622215|FG002|Overall Study|Participant Unavailability|0|||
30611337|NCT01263470|58622216|FG003|Overall Study|Participant Unavailability|0|||
30611338|NCT01263470|58622217|FG004|Overall Study|Participant Unavailability|0|||
30611339|NCT01263470|58622218|FG005|Overall Study|Participant Unavailability|0|||
30611340|NCT01263470|58622213|FG000|Overall Study|Study Drug Non-compliance|0|||
30611341|NCT01263470|58622214|FG001|Overall Study|Study Drug Non-compliance|0|||
30611342|NCT01263470|58622215|FG002|Overall Study|Study Drug Non-compliance|0|||
30611343|NCT01263470|58622216|FG003|Overall Study|Study Drug Non-compliance|0|||
30611344|NCT01263470|58622217|FG004|Overall Study|Study Drug Non-compliance|1|||
30611345|NCT01263470|58622218|FG005|Overall Study|Study Drug Non-compliance|0|||
30611346|NCT01262456|58622235|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
30611347|NCT01262456|58622236|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
30611348|NCT01262456|58622237|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
30611349|NCT01262456|58622235|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
30611350|NCT01262456|58622236|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
30611351|NCT01262456|58622237|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
30611352|NCT01262456|58622235|FG000|3-Month Double-Blind Period|Adverse Event|6|||
30611353|NCT01262456|58622236|FG001|3-Month Double-Blind Period|Adverse Event|4|||
30611354|NCT01262456|58622237|FG002|3-Month Double-Blind Period|Adverse Event|8|||
30611355|NCT01262456|58622235|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
30611356|NCT01262456|58622236|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
30611357|NCT01262456|58622237|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
30611358|NCT01262456|58622235|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
30611359|NCT01262456|58622236|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
30611360|NCT01262456|58622237|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
30611361|NCT01262456|58622235|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
30611362|NCT01262456|58622236|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
30611363|NCT01262456|58622237|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
30611364|NCT01262456|58622235|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
30611365|NCT01262456|58622236|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
30611366|NCT01262456|58622237|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
30611367|NCT01262456|58622235|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
30611368|NCT01262456|58622236|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
30611369|NCT01262456|58622237|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
30611370|NCT01262456|58622235|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
30611371|NCT01262456|58622236|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
30611372|NCT01262456|58622237|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
30611373|NCT00932893|58622255|FG000|Overall Study|Death|115|||
30790351|NCT03126110|58803537|FG002|Phase 1|Safety follow-up no longer necessary|0|||
30790352|NCT03126110|58803538|FG003|Phase 1|Safety follow-up no longer necessary|0|||
30790353|NCT03126110|58803539|FG004|Phase 1|Safety follow-up no longer necessary|0|||
30790354|NCT03126110|58803540|FG005|Phase 1|Safety follow-up no longer necessary|0|||
30790355|NCT03126110|58803541|FG006|Phase 1|Safety follow-up no longer necessary|0|||
30790356|NCT03126110|58803542|FG007|Phase 1|Safety follow-up no longer necessary|0|||
30790357|NCT03126110|58803543|FG008|Phase 1|Safety follow-up no longer necessary|0|||
30611374|NCT00932893|58622256|FG001|Overall Study|Death|24|||
30611375|NCT00932893|58622255|FG000|Overall Study|Lost to Follow-up|8|||
30611376|NCT00932893|58622256|FG001|Overall Study|Lost to Follow-up|0|||
30611377|NCT00932893|58622255|FG000|Overall Study|Withdrawal by Subject|5|||
30611378|NCT00932893|58622256|FG001|Overall Study|Withdrawal by Subject|2|||
30611379|NCT00932893|58622255|FG000|Overall Study|Other|5|||
30611380|NCT00932893|58622256|FG001|Overall Study|Other|144|||
30611381|NCT01260896|58622265|FG000|First Intervention|Withdrawn Due to Emesis|2|||
30611382|NCT01260896|58622266|FG001|First Intervention|Withdrawn Due to Emesis|0|||
30611383|NCT00932737|58622274|FG000|Overall Study|Not treated in second episode|1|||
30611384|NCT00932737|58622275|FG001|Overall Study|Not treated in second episode|0|||
30611385|NCT00932737|58622274|FG000|Overall Study|Adverse Event|0|||
30611386|NCT00932737|58622275|FG001|Overall Study|Adverse Event|1|||
30611387|NCT00939523|58622281|FG000|Overall Study|Lack of Efficacy|1|||
30611388|NCT00939523|58622281|FG000|Overall Study|Physician Decision|2|||
30611389|NCT01260584|58622289|FG000|Period 1|Protocol Violation|0|||
30611390|NCT01260584|58622290|FG001|Period 1|Protocol Violation|0|||
30611391|NCT01260584|58622291|FG002|Period 1|Protocol Violation|1|||
30611392|NCT01260584|58622292|FG003|Period 1|Protocol Violation|1|||
30611393|NCT01260584|58622289|FG000|Period 1|Adverse Event|0|||
30611394|NCT01260584|58622290|FG001|Period 1|Adverse Event|0|||
30611395|NCT01260584|58622291|FG002|Period 1|Adverse Event|1|||
30611396|NCT01260584|58622292|FG003|Period 1|Adverse Event|0|||
30611397|NCT01260584|58622289|FG000|Period 2|Protocol Violation|0|||
30611398|NCT01260584|58622290|FG001|Period 2|Protocol Violation|2|||
30611399|NCT01260584|58622291|FG002|Period 2|Protocol Violation|3|||
30611400|NCT01260584|58622292|FG003|Period 2|Protocol Violation|1|||
30611401|NCT01260584|58622289|FG000|Period 2|Adverse Event|1|||
30611402|NCT01260584|58622290|FG001|Period 2|Adverse Event|0|||
30611403|NCT01260584|58622291|FG002|Period 2|Adverse Event|2|||
30611404|NCT01260584|58622292|FG003|Period 2|Adverse Event|0|||
30611405|NCT01260584|58622289|FG000|Period 2|Withdrawal by Subject|0|||
30611406|NCT01260584|58622290|FG001|Period 2|Withdrawal by Subject|1|||
30611407|NCT01260584|58622291|FG002|Period 2|Withdrawal by Subject|0|||
30611408|NCT01260584|58622292|FG003|Period 2|Withdrawal by Subject|0|||
30611409|NCT00927589|58622302|FG000|Overall Study|Death|1|||
30611410|NCT00927589|58622302|FG000|Overall Study|Physician Decision|1|||
30611411|NCT00927589|58622302|FG000|Overall Study|Withdrawal by Subject|3|||
30611412|NCT00927589|58622302|FG000|Overall Study|Adverse Event|2|||
30611413|NCT00927589|58622302|FG000|Overall Study|Disease Progression|8|||
30611414|NCT00927589|58622302|FG000|Overall Study|Non-compliance|1|||
30611415|NCT00932425|58622308|FG000|Overall Study|Lost to Follow-up|0|||
30611416|NCT00932425|58622309|FG001|Overall Study|Lost to Follow-up|1|||
30611417|NCT00932425|58622308|FG000|Overall Study|Withdrawal by Subject|0|||
30611418|NCT00932425|58622309|FG001|Overall Study|Withdrawal by Subject|1|||
30611419|NCT05867342|58622315|FG000|Overall Study|Investigator Decision|3|||
30611420|NCT05867342|58622316|FG001|Overall Study|Investigator Decision|3|||
30611421|NCT04340362|58622351|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
30611422|NCT04024462|58622373|FG000|Overall Study|Withdrawal by Subject|6|||
30611423|NCT04024462|58622374|FG001|Overall Study|Withdrawal by Subject|7|||
30611424|NCT04024462|58622373|FG000|Overall Study|Progressive Disease|0|||
30611425|NCT04024462|58622374|FG001|Overall Study|Progressive Disease|1|||
30611426|NCT04024462|58622373|FG000|Overall Study|Adverse Event|0|||
30611427|NCT04024462|58622374|FG001|Overall Study|Adverse Event|1|||
30611428|NCT04024462|58622373|FG000|Overall Study|Death|0|||
30611429|NCT04024462|58622374|FG001|Overall Study|Death|1|||
30611430|NCT04024462|58622373|FG000|Overall Study|Lost to Follow-up|1|||
30611431|NCT04024462|58622374|FG001|Overall Study|Lost to Follow-up|0|||
30611432|NCT04024462|58622373|FG000|Overall Study|Ongoing in the Study|94|||
30611433|NCT04024462|58622374|FG001|Overall Study|Ongoing in the Study|89|||
30611434|NCT03980808|58622382|FG000|Overall Study|Lost to Follow-up|2|||
30611435|NCT03980808|58622383|FG001|Overall Study|Lost to Follow-up|2|||
30611436|NCT03943953|58622400|FG000|Trial of ITG 1|Lost to Follow-up|19|||
30611437|NCT03943953|58622401|FG001|Trial of ITG 1|Lost to Follow-up|1|||
30611438|NCT03943953|58622400|FG000|Trial of ITG 2|Lost to Follow-up|8|||
30611439|NCT03943953|58622401|FG001|Trial of ITG 2|Lost to Follow-up|0|||
30611440|NCT03943953|58622400|FG000|Trial of ITG 3|Lost to Follow-up|2|||
30611441|NCT03943953|58622401|FG001|Trial of ITG 3|Lost to Follow-up|0|||
30611442|NCT03943953|58622400|FG000|Trial of ITG 4|Lost to Follow-up|2|||
30611443|NCT03943953|58622401|FG001|Trial of ITG 4|Lost to Follow-up|0|||
30611444|NCT03670628|58622411|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
31006706|NCT01582854|59208228|FG001|Overall Study|Disallowed Concomitant Medication|2|||
30611445|NCT03670628|58622412|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
30611446|NCT03670628|58622411|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
30611447|NCT03670628|58622412|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
30611448|NCT03637764|58622422|FG000|Overall Study|Adverse Event|2|||
30611449|NCT03637764|58622423|FG001|Overall Study|Adverse Event|0|||
30611450|NCT03637764|58622424|FG002|Overall Study|Adverse Event|0|||
30611451|NCT03637764|58622425|FG003|Overall Study|Adverse Event|1|||
31006707|NCT01582854|59208227|FG000|Overall Study|Carotid or Neurosurgery|0|||
31006708|NCT01582854|59208228|FG001|Overall Study|Carotid or Neurosurgery|1|||
31006709|NCT01582854|59208227|FG000|Overall Study|General Anaesthesia|0|||
31006710|NCT01582854|59208228|FG001|Overall Study|General Anaesthesia|1|||
31006711|NCT01582854|59208227|FG000|Overall Study|Other Miscellaneous Reason|1|||
31006712|NCT01582854|59208228|FG001|Overall Study|Other Miscellaneous Reason|0|||
31006713|NCT01582308|59208234|FG000|Period 1|Withdrawal by Subject|0|||
31006714|NCT01582308|59208235|FG001|Period 1|Withdrawal by Subject|0|||
31006715|NCT01582308|59208236|FG002|Period 1|Withdrawal by Subject|0|||
31006716|NCT01582308|59208237|FG003|Period 1|Withdrawal by Subject|0|||
31006717|NCT01582308|59208238|FG004|Period 1|Withdrawal by Subject|0|||
31006718|NCT01582308|59208239|FG005|Period 1|Withdrawal by Subject|0|||
31006719|NCT01582308|59208240|FG006|Period 1|Withdrawal by Subject|1|||
30892790|NCT01933672|58926214|FG004|Second Intervention Period (12-16 Days)|Other|0|||
30892791|NCT01933672|58926215|FG005|Second Intervention Period (12-16 Days)|Other|0|||
30892792|NCT01933672|58926216|FG006|Second Intervention Period (12-16 Days)|Other|0|||
30892793|NCT01933672|58926210|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
30892794|NCT01933672|58926211|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
30892795|NCT01933672|58926212|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
30892796|NCT01933672|58926213|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
30892797|NCT01933672|58926214|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
30892798|NCT01933672|58926215|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
30892799|NCT01933672|58926216|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
30892800|NCT01933672|58926210|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
30892801|NCT01933672|58926211|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
30892802|NCT01933672|58926212|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
30892803|NCT01933672|58926213|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
30892804|NCT01933672|58926214|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
30892805|NCT01933672|58926215|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
30892806|NCT01933672|58926216|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
30892807|NCT02164539|58926235|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
30892808|NCT02164539|58926236|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
30892809|NCT02164539|58926237|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
30892810|NCT02164539|58926238|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
30892811|NCT02164539|58926239|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
30611452|NCT03637764|58622422|FG000|Overall Study|Progressive Disease|23|||
30611453|NCT03637764|58622423|FG001|Overall Study|Progressive Disease|23|||
30611454|NCT03637764|58622424|FG002|Overall Study|Progressive Disease|18|||
30611455|NCT03637764|58622425|FG003|Overall Study|Progressive Disease|31|||
30790358|NCT03126110|58803544|FG009|Phase 1|Safety follow-up no longer necessary|0|||
30790359|NCT03126110|58803545|FG010|Phase 1|Safety follow-up no longer necessary|0|||
30790360|NCT03126110|58803546|FG011|Phase 1|Safety follow-up no longer necessary|0|||
30790361|NCT03126110|58803547|FG012|Phase 1|Safety follow-up no longer necessary|0|||
30611456|NCT03637764|58622422|FG000|Overall Study|Withdrawal by Subject|1|||
30611457|NCT03637764|58622423|FG001|Overall Study|Withdrawal by Subject|3|||
30611458|NCT03637764|58622424|FG002|Overall Study|Withdrawal by Subject|0|||
30611459|NCT03637764|58622425|FG003|Overall Study|Withdrawal by Subject|1|||
30611460|NCT03483116|58622455|FG000|Overall Study|Adverse Event|0|||
30611461|NCT03483116|58622456|FG001|Overall Study|Adverse Event|1|||
30611462|NCT03483116|58622457|FG002|Overall Study|Adverse Event|0|||
30611463|NCT03483116|58622458|FG003|Overall Study|Adverse Event|1|||
30790362|NCT03126110|58803548|FG013|Phase 1|Safety follow-up no longer necessary|0|||
30790363|NCT03126110|58803549|FG014|Phase 1|Safety follow-up no longer necessary|0|||
30611464|NCT03483116|58622455|FG000|Overall Study|Protocol Violation|1|||
30611465|NCT03483116|58622456|FG001|Overall Study|Protocol Violation|0|||
30611466|NCT03483116|58622457|FG002|Overall Study|Protocol Violation|0|||
30611467|NCT03483116|58622458|FG003|Overall Study|Protocol Violation|7|||
30611468|NCT03483116|58622455|FG000|Overall Study|Lost to Follow-up|9|||
30611469|NCT03483116|58622456|FG001|Overall Study|Lost to Follow-up|4|||
30611470|NCT03483116|58622457|FG002|Overall Study|Lost to Follow-up|9|||
30611471|NCT03483116|58622458|FG003|Overall Study|Lost to Follow-up|5|||
30611472|NCT03483116|58622455|FG000|Overall Study|Death|1|||
30611473|NCT03483116|58622456|FG001|Overall Study|Death|0|||
30611474|NCT03483116|58622457|FG002|Overall Study|Death|2|||
30611475|NCT03483116|58622458|FG003|Overall Study|Death|1|||
30611476|NCT03483116|58622455|FG000|Overall Study|Withdrawal by Subject|14|||
30611477|NCT03483116|58622456|FG001|Overall Study|Withdrawal by Subject|16|||
30611478|NCT03483116|58622457|FG002|Overall Study|Withdrawal by Subject|14|||
30611479|NCT03483116|58622458|FG003|Overall Study|Withdrawal by Subject|16|||
30892812|NCT02164539|58926240|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
30892813|NCT02164539|58926241|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
30892814|NCT02164539|58926235|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
30892815|NCT02164539|58926236|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
30892816|NCT02164539|58926237|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
30611480|NCT03483116|58622455|FG000|Overall Study|Unknown other reason|3|||
30611481|NCT03483116|58622456|FG001|Overall Study|Unknown other reason|2|||
30611482|NCT03483116|58622457|FG002|Overall Study|Unknown other reason|1|||
30611483|NCT03483116|58622458|FG003|Overall Study|Unknown other reason|1|||
30611484|NCT03215706|58622488|FG000|Randomization|Adverse Event unrelated to study drug|1|||
30611485|NCT03215706|58622489|FG001|Randomization|Adverse Event unrelated to study drug|0|||
30611486|NCT03215706|58622488|FG000|Randomization|participant withdrew consent|1|||
30611487|NCT03215706|58622489|FG001|Randomization|participant withdrew consent|3|||
30611488|NCT03215706|58622488|FG000|Randomization|no longer meets study criteria|1|||
30611489|NCT03215706|58622489|FG001|Randomization|no longer meets study criteria|4|||
30611490|NCT03215706|58622488|FG000|Randomization|other reasons|0|||
30611491|NCT03215706|58622489|FG001|Randomization|other reasons|2|||
30611492|NCT03215706|58622488|FG000|Treatment Period|Disease Progression|150|||
30611493|NCT03215706|58622489|FG001|Treatment Period|Disease Progression|142|||
30611494|NCT03215706|58622488|FG000|Treatment Period|Study Drug Toxicity|53|||
30611495|NCT03215706|58622489|FG001|Treatment Period|Study Drug Toxicity|21|||
30611496|NCT03215706|58622488|FG000|Treatment Period|Death|2|||
30790364|NCT03126110|58803550|FG015|Phase 1|Safety follow-up no longer necessary|0|||
30790365|NCT03126110|58803551|FG016|Phase 1|Safety follow-up no longer necessary|0|||
30790366|NCT03126110|58803535|FG000|Phase 1|Survival follow-up no longer necessary|0|||
30790367|NCT03126110|58803536|FG001|Phase 1|Survival follow-up no longer necessary|0|||
31006720|NCT01582308|59208241|FG007|Period 1|Withdrawal by Subject|0|||
31006721|NCT01582308|59208242|FG008|Period 1|Withdrawal by Subject|0|||
31006722|NCT01582308|59208243|FG009|Period 1|Withdrawal by Subject|0|||
31006723|NCT01582308|59208234|FG000|10-day Washout Following Period 1|Physician Decision|0|||
31006724|NCT01582308|59208235|FG001|10-day Washout Following Period 1|Physician Decision|0|||
31006725|NCT01582308|59208236|FG002|10-day Washout Following Period 1|Physician Decision|0|||
30790368|NCT03126110|58803537|FG002|Phase 1|Survival follow-up no longer necessary|1|||
30790369|NCT03126110|58803538|FG003|Phase 1|Survival follow-up no longer necessary|0|||
31006726|NCT01582308|59208237|FG003|10-day Washout Following Period 1|Physician Decision|0|||
31006727|NCT01582308|59208238|FG004|10-day Washout Following Period 1|Physician Decision|1|||
31006728|NCT01582308|59208239|FG005|10-day Washout Following Period 1|Physician Decision|0|||
31006729|NCT01582308|59208240|FG006|10-day Washout Following Period 1|Physician Decision|0|||
31006730|NCT01582308|59208241|FG007|10-day Washout Following Period 1|Physician Decision|0|||
31006731|NCT01582308|59208242|FG008|10-day Washout Following Period 1|Physician Decision|0|||
31006732|NCT01582308|59208243|FG009|10-day Washout Following Period 1|Physician Decision|0|||
31006733|NCT01582308|59208234|FG000|Period 4|Physician Decision|1|||
31006734|NCT01582308|59208235|FG001|Period 4|Physician Decision|0|||
31006735|NCT01582308|59208236|FG002|Period 4|Physician Decision|0|||
31006736|NCT01582308|59208237|FG003|Period 4|Physician Decision|0|||
31006737|NCT01582308|59208238|FG004|Period 4|Physician Decision|0|||
31006738|NCT01582308|59208239|FG005|Period 4|Physician Decision|1|||
30790370|NCT03126110|58803539|FG004|Phase 1|Survival follow-up no longer necessary|0|||
30790371|NCT03126110|58803540|FG005|Phase 1|Survival follow-up no longer necessary|0|||
30790372|NCT03126110|58803541|FG006|Phase 1|Survival follow-up no longer necessary|0|||
30790373|NCT03126110|58803542|FG007|Phase 1|Survival follow-up no longer necessary|0|||
30611497|NCT03215706|58622489|FG001|Treatment Period|Death|1|||
30611498|NCT03215706|58622488|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
30611499|NCT03215706|58622489|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
30611500|NCT03215706|58622488|FG000|Treatment Period|Request to D/C treatment|1|||
30611501|NCT03215706|58622489|FG001|Treatment Period|Request to D/C treatment|6|||
30611502|NCT03215706|58622488|FG000|Treatment Period|Participant withdrew consent|3|||
30790374|NCT03126110|58803543|FG008|Phase 1|Survival follow-up no longer necessary|0|||
30790375|NCT03126110|58803544|FG009|Phase 1|Survival follow-up no longer necessary|0|||
30790376|NCT03126110|58803545|FG010|Phase 1|Survival follow-up no longer necessary|0|||
30790377|NCT03126110|58803546|FG011|Phase 1|Survival follow-up no longer necessary|0|||
30790378|NCT03126110|58803547|FG012|Phase 1|Survival follow-up no longer necessary|0|||
30790379|NCT03126110|58803548|FG013|Phase 1|Survival follow-up no longer necessary|0|||
30790380|NCT03126110|58803549|FG014|Phase 1|Survival follow-up no longer necessary|0|||
30790381|NCT03126110|58803550|FG015|Phase 1|Survival follow-up no longer necessary|0|||
30790382|NCT03126110|58803551|FG016|Phase 1|Survival follow-up no longer necessary|0|||
30790383|NCT03126110|58803535|FG000|Phase 2|Study terminated by the sponsor|0|||
30790384|NCT03126110|58803536|FG001|Phase 2|Study terminated by the sponsor|0|||
30790385|NCT03126110|58803537|FG002|Phase 2|Study terminated by the sponsor|0|||
31006739|NCT01582308|59208240|FG006|Period 4|Physician Decision|0|||
30611503|NCT03215706|58622489|FG001|Treatment Period|Participant withdrew consent|4|||
30611504|NCT03215706|58622488|FG000|Treatment Period|Lost to Follow-up|0|||
30611505|NCT03215706|58622489|FG001|Treatment Period|Lost to Follow-up|1|||
31006740|NCT01582308|59208241|FG007|Period 4|Physician Decision|0|||
30611506|NCT03215706|58622488|FG000|Treatment Period|Other Reasons|4|||
30611507|NCT03215706|58622489|FG001|Treatment Period|Other Reasons|5|||
30611508|NCT03215706|58622488|FG000|Treatment Period|Ongoing in the treatment period|105|||
30611509|NCT03215706|58622489|FG001|Treatment Period|Ongoing in the treatment period|43|||
30611510|NCT03141177|58622507|FG000|Overall Study|Death|62|||
30611511|NCT03141177|58622508|FG001|Overall Study|Death|13|||
30611512|NCT03141177|58622509|FG002|Overall Study|Death|84|||
30611513|NCT03141177|58622507|FG000|Overall Study|Participant withdrew consent|9|||
30611514|NCT03141177|58622508|FG001|Overall Study|Participant withdrew consent|2|||
30611515|NCT03141177|58622509|FG002|Overall Study|Participant withdrew consent|13|||
30611516|NCT03141177|58622507|FG000|Overall Study|Not reported|1|||
30611517|NCT03141177|58622508|FG001|Overall Study|Not reported|0|||
30790386|NCT03126110|58803538|FG003|Phase 2|Study terminated by the sponsor|0|||
30790387|NCT03126110|58803539|FG004|Phase 2|Study terminated by the sponsor|0|||
30790388|NCT03126110|58803540|FG005|Phase 2|Study terminated by the sponsor|0|||
30790389|NCT03126110|58803541|FG006|Phase 2|Study terminated by the sponsor|0|||
30790390|NCT03126110|58803542|FG007|Phase 2|Study terminated by the sponsor|0|||
30790391|NCT03126110|58803543|FG008|Phase 2|Study terminated by the sponsor|0|||
30790392|NCT03126110|58803544|FG009|Phase 2|Study terminated by the sponsor|0|||
30790393|NCT03126110|58803545|FG010|Phase 2|Study terminated by the sponsor|0|||
30790394|NCT03126110|58803546|FG011|Phase 2|Study terminated by the sponsor|0|||
30790395|NCT03126110|58803547|FG012|Phase 2|Study terminated by the sponsor|0|||
30790396|NCT03126110|58803548|FG013|Phase 2|Study terminated by the sponsor|4|||
30790397|NCT03126110|58803549|FG014|Phase 2|Study terminated by the sponsor|0|||
30790398|NCT03126110|58803550|FG015|Phase 2|Study terminated by the sponsor|0|||
30790399|NCT03126110|58803551|FG016|Phase 2|Study terminated by the sponsor|0|||
30790400|NCT03126110|58803535|FG000|Phase 2|Withdrawal by Subject|0|||
30790401|NCT03126110|58803536|FG001|Phase 2|Withdrawal by Subject|0|||
30790402|NCT03126110|58803537|FG002|Phase 2|Withdrawal by Subject|0|||
30790403|NCT03126110|58803538|FG003|Phase 2|Withdrawal by Subject|0|||
30790404|NCT03126110|58803539|FG004|Phase 2|Withdrawal by Subject|0|||
30790405|NCT03126110|58803540|FG005|Phase 2|Withdrawal by Subject|0|||
30790406|NCT03126110|58803541|FG006|Phase 2|Withdrawal by Subject|0|||
30790407|NCT03126110|58803542|FG007|Phase 2|Withdrawal by Subject|0|||
30790408|NCT03126110|58803543|FG008|Phase 2|Withdrawal by Subject|0|||
30892817|NCT02164539|58926238|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
30892818|NCT02164539|58926239|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
31006741|NCT01582308|59208242|FG008|Period 4|Physician Decision|0|||
31006742|NCT01582308|59208243|FG009|Period 4|Physician Decision|1|||
31006743|NCT01558674|59208258|FG000|Part 1|Study Terminated by Sponsor|10|||
31006744|NCT01558674|59208259|FG001|Part 1|Study Terminated by Sponsor|0|||
31006745|NCT01558674|59208258|FG000|Part 1|Withdrawal by Subject|1|||
31006746|NCT01558674|59208259|FG001|Part 1|Withdrawal by Subject|0|||
31006747|NCT01558596|59208280|FG000|Overall Study|Withdrawal by Subject|1|||
31006748|NCT01558596|59208281|FG001|Overall Study|Withdrawal by Subject|0|||
31006749|NCT01558596|59208280|FG000|Overall Study|surgery elsewhere or cancelled|1|||
31006750|NCT01558596|59208281|FG001|Overall Study|surgery elsewhere or cancelled|1|||
31006751|NCT01558596|59208280|FG000|Overall Study|Protocol Violation|1|||
31006752|NCT01558596|59208281|FG001|Overall Study|Protocol Violation|0|||
31006753|NCT01535040|59208289|FG000|Overall Study|Physician Decision|0|||
31006754|NCT01535040|59208290|FG001|Overall Study|Physician Decision|1|||
31006755|NCT01535040|59208289|FG000|Overall Study|Withdrawal by Subject|13|||
31006756|NCT01535040|59208290|FG001|Overall Study|Withdrawal by Subject|10|||
31006757|NCT01535040|59208289|FG000|Overall Study|Never Started|9|||
31006758|NCT01535040|59208290|FG001|Overall Study|Never Started|4|||
31006759|NCT01535040|59208289|FG000|Overall Study|Toxicity|7|||
31006760|NCT01535040|59208290|FG001|Overall Study|Toxicity|5|||
31006761|NCT01535040|59208289|FG000|Overall Study|Multiple Reasons|1|||
31006762|NCT01535040|59208290|FG001|Overall Study|Multiple Reasons|1|||
31006763|NCT01534962|59208300|FG000|Overall Study|Randomized but did not start treatment|2|||
31006764|NCT01534962|59208301|FG001|Overall Study|Randomized but did not start treatment|0|||
31006765|NCT01534962|59208302|FG002|Overall Study|Randomized but did not start treatment|0|||
31006766|NCT01534962|59208303|FG003|Overall Study|Randomized but did not start treatment|1|||
31006767|NCT01534962|59208300|FG000|Overall Study|Discontinued at AF recurrence|35|||
31006768|NCT01534962|59208301|FG001|Overall Study|Discontinued at AF recurrence|26|||
31006769|NCT01534962|59208302|FG002|Overall Study|Discontinued at AF recurrence|24|||
31006770|NCT01534962|59208303|FG003|Overall Study|Discontinued at AF recurrence|31|||
30790409|NCT03126110|58803544|FG009|Phase 2|Withdrawal by Subject|0|||
30790410|NCT03126110|58803545|FG010|Phase 2|Withdrawal by Subject|0|||
30790411|NCT03126110|58803546|FG011|Phase 2|Withdrawal by Subject|1|||
30790412|NCT03126110|58803547|FG012|Phase 2|Withdrawal by Subject|3|||
30790413|NCT03126110|58803548|FG013|Phase 2|Withdrawal by Subject|3|||
30790414|NCT03126110|58803549|FG014|Phase 2|Withdrawal by Subject|2|||
30790415|NCT03126110|58803550|FG015|Phase 2|Withdrawal by Subject|1|||
30790416|NCT03126110|58803551|FG016|Phase 2|Withdrawal by Subject|0|||
30892819|NCT02164539|58926240|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
31006771|NCT01582152|59208315|FG000|Overall Study|Disease Progression|4|||
31006772|NCT01582152|59208316|FG001|Overall Study|Disease Progression|5|||
30790417|NCT03126110|58803535|FG000|Phase 2|Lost to Follow-up|0|||
31006773|NCT01582152|59208315|FG000|Overall Study|Adverse Event|2|||
31006774|NCT01582152|59208316|FG001|Overall Study|Adverse Event|1|||
30790418|NCT03126110|58803536|FG001|Phase 2|Lost to Follow-up|0|||
30790419|NCT03126110|58803537|FG002|Phase 2|Lost to Follow-up|0|||
30790420|NCT03126110|58803538|FG003|Phase 2|Lost to Follow-up|0|||
30790421|NCT03126110|58803539|FG004|Phase 2|Lost to Follow-up|0|||
30790422|NCT03126110|58803540|FG005|Phase 2|Lost to Follow-up|0|||
30790423|NCT03126110|58803541|FG006|Phase 2|Lost to Follow-up|0|||
30790424|NCT03126110|58803542|FG007|Phase 2|Lost to Follow-up|0|||
30790425|NCT03126110|58803543|FG008|Phase 2|Lost to Follow-up|0|||
30611518|NCT03141177|58622509|FG002|Overall Study|Not reported|1|||
30611519|NCT03141177|58622507|FG000|Overall Study|Lost to Follow-up|2|||
30611520|NCT03141177|58622508|FG001|Overall Study|Lost to Follow-up|1|||
30611521|NCT03141177|58622509|FG002|Overall Study|Lost to Follow-up|1|||
30611522|NCT03141177|58622507|FG000|Overall Study|Other reasons|4|||
30611523|NCT03141177|58622508|FG001|Overall Study|Other reasons|0|||
30611524|NCT03141177|58622509|FG002|Overall Study|Other reasons|11|||
30611525|NCT03141177|58622507|FG000|Overall Study|Participants did not start treatment period|3|||
30611526|NCT03141177|58622508|FG001|Overall Study|Participants did not start treatment period|0|||
30611527|NCT03141177|58622509|FG002|Overall Study|Participants did not start treatment period|8|||
30611528|NCT02811861|58622526|FG000|Overall Study|Radiological Disease Progression|123|||
30611529|NCT02811861|58622527|FG001|Overall Study|Radiological Disease Progression|97|||
30611530|NCT02811861|58622528|FG002|Overall Study|Radiological Disease Progression|174|||
30611531|NCT02811861|58622526|FG000|Overall Study|Clinical Disease Progression|20|||
30611532|NCT02811861|58622527|FG001|Overall Study|Clinical Disease Progression|19|||
30611533|NCT02811861|58622528|FG002|Overall Study|Clinical Disease Progression|22|||
30611534|NCT02811861|58622526|FG000|Overall Study|Adverse Event|63|||
30611535|NCT02811861|58622527|FG001|Overall Study|Adverse Event|60|||
30611536|NCT02811861|58622528|FG002|Overall Study|Adverse Event|41|||
30611537|NCT02811861|58622526|FG000|Overall Study|Lost to Follow-up|0|||
30790426|NCT03126110|58803544|FG009|Phase 2|Lost to Follow-up|0|||
30790427|NCT03126110|58803545|FG010|Phase 2|Lost to Follow-up|0|||
30790428|NCT03126110|58803546|FG011|Phase 2|Lost to Follow-up|1|||
30790429|NCT03126110|58803547|FG012|Phase 2|Lost to Follow-up|1|||
30790430|NCT03126110|58803548|FG013|Phase 2|Lost to Follow-up|1|||
30790431|NCT03126110|58803549|FG014|Phase 2|Lost to Follow-up|2|||
30790432|NCT03126110|58803550|FG015|Phase 2|Lost to Follow-up|0|||
30790433|NCT03126110|58803551|FG016|Phase 2|Lost to Follow-up|0|||
30790434|NCT03126110|58803535|FG000|Phase 2|Death|0|||
30790435|NCT03126110|58803536|FG001|Phase 2|Death|0|||
30790436|NCT03126110|58803537|FG002|Phase 2|Death|0|||
30790437|NCT03126110|58803538|FG003|Phase 2|Death|0|||
30611538|NCT02811861|58622527|FG001|Overall Study|Lost to Follow-up|0|||
30611539|NCT02811861|58622528|FG002|Overall Study|Lost to Follow-up|1|||
30611540|NCT02811861|58622526|FG000|Overall Study|Subject Choice|29|||
30611541|NCT02811861|58622527|FG001|Overall Study|Subject Choice|17|||
30611542|NCT02811861|58622528|FG002|Overall Study|Subject Choice|23|||
30611543|NCT02811861|58622526|FG000|Overall Study|Withdrawal by Subject|4|||
30611544|NCT02811861|58622527|FG001|Overall Study|Withdrawal by Subject|4|||
30611545|NCT02811861|58622528|FG002|Overall Study|Withdrawal by Subject|9|||
30611546|NCT02811861|58622526|FG000|Overall Study|Other|4|||
30611547|NCT02811861|58622527|FG001|Overall Study|Other|13|||
30611548|NCT02811861|58622528|FG002|Overall Study|Other|3|||
30611549|NCT02811861|58622526|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
30611550|NCT02811861|58622527|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
30611551|NCT02811861|58622528|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
30611552|NCT02811861|58622526|FG000|Overall Study|Randomized but not treated|2|||
30611553|NCT02811861|58622527|FG001|Overall Study|Randomized but not treated|3|||
30611554|NCT02811861|58622528|FG002|Overall Study|Randomized but not treated|17|||
30611555|NCT02744612|58622538|FG000|Overall Study|Withdrawal by Subject|0|||
30611556|NCT02744612|58622539|FG001|Overall Study|Withdrawal by Subject|2|||
30611557|NCT02700451|58622548|FG000|Overall Study|Protocol Violation|2|||
30611558|NCT02700451|58622549|FG001|Overall Study|Protocol Violation|2|||
30611559|NCT02700451|58622550|FG002|Overall Study|Protocol Violation|3|||
30611560|NCT02700451|58622548|FG000|Overall Study|Discontinued intervention|14|||
30611561|NCT02700451|58622549|FG001|Overall Study|Discontinued intervention|15|||
30790438|NCT03126110|58803539|FG004|Phase 2|Death|0|||
30790439|NCT03126110|58803540|FG005|Phase 2|Death|0|||
30790440|NCT03126110|58803541|FG006|Phase 2|Death|0|||
31006775|NCT01581684|59208332|FG000|Overall Study|Other reason not defined|0|||
31006776|NCT01581684|59208333|FG001|Overall Study|Other reason not defined|0|||
30790441|NCT03126110|58803542|FG007|Phase 2|Death|0|||
31006777|NCT01581684|59208334|FG002|Overall Study|Other reason not defined|0|||
30611562|NCT02700451|58622550|FG002|Overall Study|Discontinued intervention|14|||
30611563|NCT02623426|58622561|FG000|Overall Study|Lost to Follow-up|0|||
30611564|NCT02623426|58622562|FG001|Overall Study|Lost to Follow-up|0|||
30611565|NCT02623426|58622563|FG002|Overall Study|Lost to Follow-up|1|||
30611566|NCT02623426|58622561|FG000|Overall Study|Withdrawal by Subject|1|||
30611567|NCT02623426|58622562|FG001|Overall Study|Withdrawal by Subject|2|||
30790442|NCT03126110|58803543|FG008|Phase 2|Death|0|||
30790443|NCT03126110|58803544|FG009|Phase 2|Death|0|||
30790444|NCT03126110|58803545|FG010|Phase 2|Death|0|||
30790445|NCT03126110|58803546|FG011|Phase 2|Death|6|||
30790446|NCT03126110|58803547|FG012|Phase 2|Death|12|||
30790447|NCT03126110|58803548|FG013|Phase 2|Death|25|||
30790448|NCT03126110|58803549|FG014|Phase 2|Death|11|||
30790449|NCT03126110|58803550|FG015|Phase 2|Death|3|||
30790450|NCT03126110|58803551|FG016|Phase 2|Death|2|||
30790451|NCT03126110|58803535|FG000|Phase 2|Progressive Disease|0|||
30790452|NCT03126110|58803536|FG001|Phase 2|Progressive Disease|0|||
30790453|NCT03126110|58803537|FG002|Phase 2|Progressive Disease|0|||
30790454|NCT03126110|58803538|FG003|Phase 2|Progressive Disease|0|||
30790455|NCT03126110|58803539|FG004|Phase 2|Progressive Disease|0|||
30790456|NCT03126110|58803540|FG005|Phase 2|Progressive Disease|0|||
30790457|NCT03126110|58803541|FG006|Phase 2|Progressive Disease|0|||
30790458|NCT03126110|58803542|FG007|Phase 2|Progressive Disease|0|||
30790459|NCT03126110|58803543|FG008|Phase 2|Progressive Disease|0|||
30790460|NCT03126110|58803544|FG009|Phase 2|Progressive Disease|0|||
30790461|NCT03126110|58803545|FG010|Phase 2|Progressive Disease|0|||
30790462|NCT03126110|58803546|FG011|Phase 2|Progressive Disease|0|||
30790463|NCT03126110|58803547|FG012|Phase 2|Progressive Disease|0|||
30790464|NCT03126110|58803548|FG013|Phase 2|Progressive Disease|1|||
30790465|NCT03126110|58803549|FG014|Phase 2|Progressive Disease|0|||
30790466|NCT03126110|58803550|FG015|Phase 2|Progressive Disease|0|||
30790467|NCT03126110|58803551|FG016|Phase 2|Progressive Disease|0|||
30790468|NCT03126110|58803535|FG000|Phase 2|Started new treatment|0|||
30790469|NCT03126110|58803536|FG001|Phase 2|Started new treatment|0|||
30790470|NCT03126110|58803537|FG002|Phase 2|Started new treatment|0|||
30790471|NCT03126110|58803538|FG003|Phase 2|Started new treatment|0|||
30790472|NCT03126110|58803539|FG004|Phase 2|Started new treatment|0|||
30790473|NCT03126110|58803540|FG005|Phase 2|Started new treatment|0|||
30790474|NCT03126110|58803541|FG006|Phase 2|Started new treatment|0|||
30790475|NCT03126110|58803542|FG007|Phase 2|Started new treatment|0|||
30790476|NCT03126110|58803543|FG008|Phase 2|Started new treatment|0|||
30790477|NCT03126110|58803544|FG009|Phase 2|Started new treatment|0|||
30790478|NCT03126110|58803545|FG010|Phase 2|Started new treatment|0|||
31006778|NCT01581684|59208335|FG003|Overall Study|Other reason not defined|0|||
30611568|NCT02623426|58622563|FG002|Overall Study|Withdrawal by Subject|2|||
30611569|NCT02580058|58622574|FG000|Overall Study|Adverse Event|16|||
30611570|NCT02580058|58622575|FG001|Overall Study|Adverse Event|30|||
30611571|NCT02580058|58622576|FG002|Overall Study|Adverse Event|20|||
30611572|NCT02580058|58622574|FG000|Overall Study|Death|4|||
30611573|NCT02580058|58622575|FG001|Overall Study|Death|4|||
30611574|NCT02580058|58622576|FG002|Overall Study|Death|5|||
31006779|NCT01581684|59208336|FG004|Overall Study|Other reason not defined|0|||
31006780|NCT01581684|59208337|FG005|Overall Study|Other reason not defined|0|||
31006781|NCT01581684|59208338|FG006|Overall Study|Other reason not defined|0|||
31006782|NCT01581684|59208339|FG007|Overall Study|Other reason not defined|0|||
31006783|NCT01581684|59208340|FG008|Overall Study|Other reason not defined|1|||
31006784|NCT01581684|59208341|FG009|Overall Study|Other reason not defined|0|||
31006785|NCT01557582|59208374|FG000|Overall Study|Protocol Violation|4|||
31006786|NCT01557582|59208374|FG000|Overall Study|Operator error|2|||
31006787|NCT01557504|59208380|FG000|Overall Study|Physician Decision|1|||
31006788|NCT01557504|59208381|FG001|Overall Study|Physician Decision|0|||
31006789|NCT01557348|59208395|FG000|Overall Study|Adverse Event|6|||
31006790|NCT01557348|59208396|FG001|Overall Study|Adverse Event|16|||
31006791|NCT01557348|59208395|FG000|Overall Study|Infusion reaction event|5|||
31006792|NCT01557348|59208396|FG001|Overall Study|Infusion reaction event|5|||
31006793|NCT01557348|59208395|FG000|Overall Study|Death|7|||
31006794|NCT01557348|59208396|FG001|Overall Study|Death|4|||
31006795|NCT01557348|59208395|FG000|Overall Study|Insufficient Therapeutic Response|13|||
30611575|NCT02580058|58622574|FG000|Overall Study|Physician Decision|1|||
30611576|NCT02580058|58622575|FG001|Overall Study|Physician Decision|3|||
30611577|NCT02580058|58622576|FG002|Overall Study|Physician Decision|11|||
30611578|NCT02580058|58622574|FG000|Overall Study|Other|5|||
30790479|NCT03126110|58803546|FG011|Phase 2|Started new treatment|0|||
30611579|NCT02580058|58622575|FG001|Overall Study|Other|1|||
30790480|NCT03126110|58803547|FG012|Phase 2|Started new treatment|0|||
30611580|NCT02580058|58622576|FG002|Overall Study|Other|3|||
30790481|NCT03126110|58803548|FG013|Phase 2|Started new treatment|0|||
30790482|NCT03126110|58803549|FG014|Phase 2|Started new treatment|1|||
30790483|NCT03126110|58803550|FG015|Phase 2|Started new treatment|0|||
31006796|NCT01557348|59208396|FG001|Overall Study|Insufficient Therapeutic Response|28|||
31006797|NCT01557348|59208395|FG000|Overall Study|Withdrawal by Subject|5|||
31006798|NCT01557348|59208396|FG001|Overall Study|Withdrawal by Subject|4|||
31006799|NCT01557348|59208395|FG000|Overall Study|Lost to Follow-up|26|||
31006800|NCT01557348|59208396|FG001|Overall Study|Lost to Follow-up|22|||
31006801|NCT01557348|59208395|FG000|Overall Study|Administrative|18|||
31006802|NCT01557348|59208396|FG001|Overall Study|Administrative|11|||
31006803|NCT01580670|59208403|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
31006804|NCT01580670|59208403|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
31006805|NCT01534260|59208409|FG000|Overall Study|Adverse Event|1|||
31006806|NCT01534260|59208410|FG001|Overall Study|Adverse Event|8|||
31006807|NCT01534260|59208409|FG000|Overall Study|Death|2|||
31006808|NCT01534260|59208410|FG001|Overall Study|Death|0|||
31006809|NCT01534260|59208409|FG000|Overall Study|Lack of Efficacy|1|||
31006810|NCT01534260|59208410|FG001|Overall Study|Lack of Efficacy|1|||
31006811|NCT01534260|59208409|FG000|Overall Study|Withdrawal by Subject|1|||
31006812|NCT01534260|59208410|FG001|Overall Study|Withdrawal by Subject|3|||
31006813|NCT01534260|59208409|FG000|Overall Study|Disease Progression|8|||
31006814|NCT01534260|59208410|FG001|Overall Study|Disease Progression|6|||
31006815|NCT01534260|59208409|FG000|Overall Study|Physician Decision|3|||
31006816|NCT01534260|59208410|FG001|Overall Study|Physician Decision|1|||
31006817|NCT01534260|59208409|FG000|Overall Study|No treatment, per protocol|0|||
31006818|NCT01534260|59208410|FG001|Overall Study|No treatment, per protocol|1|||
31006819|NCT01534182|59208418|FG000|Overall Study|Administrative problems|1|||
31006820|NCT01534182|59208419|FG001|Overall Study|Administrative problems|0|||
31006821|NCT01534182|59208418|FG000|Overall Study|Withdrawal by Subject|4|||
31006822|NCT01534182|59208419|FG001|Overall Study|Withdrawal by Subject|7|||
31006823|NCT01534182|59208418|FG000|Overall Study|Adverse Event|7|||
31006824|NCT01534182|59208419|FG001|Overall Study|Adverse Event|3|||
31006825|NCT01579812|59208426|FG000|Overall Study|Ineligible after treatment start|40|||
31006826|NCT01579812|59208426|FG000|Overall Study|Patient choice|3|||
31006827|NCT01579812|59208426|FG000|Overall Study|Noncompliance|3|||
31006828|NCT01579812|59208426|FG000|Overall Study|Withdrawal by Subject|6|||
31006829|NCT01533714|59208439|FG000|Overall Study|Adverse Event|0|||
31006830|NCT01533714|59208440|FG001|Overall Study|Adverse Event|1|||
31006831|NCT01533714|59208441|FG002|Overall Study|Adverse Event|2|||
31006832|NCT01533714|59208442|FG003|Overall Study|Adverse Event|2|||
31006833|NCT01533714|59208443|FG004|Overall Study|Adverse Event|2|||
31006834|NCT01533714|59208444|FG005|Overall Study|Adverse Event|1|||
31006835|NCT01533714|59208439|FG000|Overall Study|Lack of Efficacy|0|||
31006836|NCT01533714|59208440|FG001|Overall Study|Lack of Efficacy|0|||
31006837|NCT01533714|59208441|FG002|Overall Study|Lack of Efficacy|0|||
30611581|NCT02580058|58622574|FG000|Overall Study|Withdrawal by Subject|4|||
30611582|NCT02580058|58622575|FG001|Overall Study|Withdrawal by Subject|7|||
30790484|NCT03126110|58803551|FG016|Phase 2|Started new treatment|0|||
30790485|NCT00905164|58803601|FG000|Period 1|Protocol Violation|0|||
30790486|NCT00905164|58803602|FG001|Period 1|Protocol Violation|1|||
30790487|NCT03181958|58803609|FG000|Overall Study|Lost to Follow-up|17|||
30790488|NCT03181958|58803610|FG001|Overall Study|Lost to Follow-up|21|||
30790489|NCT03181958|58803611|FG002|Overall Study|Lost to Follow-up|15|||
30790490|NCT03165110|58803619|FG000|Overall Study|Anroid phone software incompatibility|1|||
30790491|NCT00079781|58803626|FG000|Pre-implant Period|Withdrawal by Subject|2|||
30790492|NCT00079781|58803627|FG001|Pre-implant Period|Withdrawal by Subject|0|||
30790493|NCT00079781|58803628|FG002|Pre-implant Period|Withdrawal by Subject|0|||
30790494|NCT00079781|58803626|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
30790495|NCT00079781|58803627|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
30790496|NCT00079781|58803628|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
30790497|NCT00079781|58803626|FG000|Follow-up Period|Withdrawal by Subject|3|||
30790498|NCT00079781|58803627|FG001|Follow-up Period|Withdrawal by Subject|0|||
30790499|NCT00079781|58803628|FG002|Follow-up Period|Withdrawal by Subject|1|||
30790500|NCT00079781|58803626|FG000|Follow-up Period|Lost to Follow-up|1|||
30790501|NCT00079781|58803627|FG001|Follow-up Period|Lost to Follow-up|0|||
30790502|NCT00079781|58803628|FG002|Follow-up Period|Lost to Follow-up|0|||
30790503|NCT00079781|58803626|FG000|Follow-up Period|Death|0|||
31006838|NCT01533714|59208442|FG003|Overall Study|Lack of Efficacy|0|||
31006839|NCT01533714|59208443|FG004|Overall Study|Lack of Efficacy|0|||
31006840|NCT01533714|59208444|FG005|Overall Study|Lack of Efficacy|1|||
31006841|NCT01533714|59208439|FG000|Overall Study|Withdrawal by Subject|0|||
30790504|NCT00079781|58803627|FG001|Follow-up Period|Death|0|||
30790505|NCT00079781|58803628|FG002|Follow-up Period|Death|1|||
30790506|NCT03176966|58803636|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
30790507|NCT03176966|58803637|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
30790508|NCT03176966|58803636|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
31006842|NCT01533714|59208440|FG001|Overall Study|Withdrawal by Subject|1|||
31006843|NCT01533714|59208441|FG002|Overall Study|Withdrawal by Subject|0|||
31006844|NCT01533714|59208442|FG003|Overall Study|Withdrawal by Subject|1|||
31006845|NCT01533714|59208443|FG004|Overall Study|Withdrawal by Subject|1|||
31006846|NCT01533714|59208444|FG005|Overall Study|Withdrawal by Subject|0|||
30790509|NCT03176966|58803637|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
30790510|NCT03176966|58803636|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
30790511|NCT03176966|58803637|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
30790512|NCT03176966|58803636|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
30790513|NCT03176966|58803637|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
30790514|NCT03176966|58803636|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
30790515|NCT03176966|58803637|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
30790516|NCT03176966|58803636|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
30790517|NCT03176966|58803637|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
30790518|NCT03176966|58803636|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
30790519|NCT03176966|58803637|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
30790520|NCT03175562|58803643|FG000|Overall Study|Adverse Event|1|||
30790521|NCT03175562|58803643|FG000|Overall Study|Lost to Follow-up|3|||
30790522|NCT03175562|58803643|FG000|Overall Study|Withdrawal by Subject|7|||
30790523|NCT03175562|58803643|FG000|Overall Study|Other (Not Specified)|5|||
30790524|NCT00079391|58803650|FG000|Overall Study|Withdrawal by Subject|1|||
30790525|NCT03209570|58803658|FG000|Overall Study|Death|1|||
30790526|NCT03209570|58803659|FG001|Overall Study|Death|0|||
30790527|NCT03209570|58803658|FG000|Overall Study|Incomplete Data|8|||
30790528|NCT03209570|58803659|FG001|Overall Study|Incomplete Data|10|||
30790529|NCT03209570|58803658|FG000|Overall Study|Protocol Violation|1|||
30790530|NCT03209570|58803659|FG001|Overall Study|Protocol Violation|0|||
30790531|NCT03209570|58803658|FG000|Overall Study|Withdrawal by Subject|0|||
30790532|NCT03209570|58803659|FG001|Overall Study|Withdrawal by Subject|3|||
30790533|NCT03209492|58803665|FG000|Overall Study|Case Report Forms Uncollected|5|||
30790534|NCT03208244|58803669|FG000|Overall Study|Death|1|||
30790535|NCT03175172|58803673|FG000|Overall Study|Death|3|||
30790536|NCT03175172|58803673|FG000|Overall Study|Withdrawal by Subject|3|||
30790537|NCT03175172|58803673|FG000|Overall Study|Lost to Follow-up|1|||
30790538|NCT03175172|58803673|FG000|Overall Study|Study Terminated by Sponsor|3|||
30790539|NCT03172364|58803679|FG000|Overall Study|Adverse Event|1|||
30790540|NCT03172364|58803680|FG001|Overall Study|Adverse Event|1|||
30790541|NCT03172364|58803679|FG000|Overall Study|Protocol Violation|1|||
30790542|NCT03172364|58803680|FG001|Overall Study|Protocol Violation|0|||
30790543|NCT00078767|58803688|FG000|Overall Study|Withdrawal by Subject|1|||
30790544|NCT00078767|58803689|FG001|Overall Study|Withdrawal by Subject|1|||
30790545|NCT03208088|58803695|FG000|Period 2|Withdrawal by Subject|0|||
30790546|NCT03208088|58803696|FG001|Period 2|Withdrawal by Subject|0|||
30790547|NCT03208088|58803697|FG002|Period 2|Withdrawal by Subject|0|||
30790548|NCT03208088|58803698|FG003|Period 2|Withdrawal by Subject|0|||
30790549|NCT03208088|58803699|FG004|Period 2|Withdrawal by Subject|0|||
30790550|NCT03208088|58803700|FG005|Period 2|Withdrawal by Subject|0|||
30790551|NCT03208088|58803701|FG006|Period 2|Withdrawal by Subject|0|||
30790552|NCT03208088|58803702|FG007|Period 2|Withdrawal by Subject|0|||
30790553|NCT03208088|58803703|FG008|Period 2|Withdrawal by Subject|1|||
30790554|NCT03208088|58803704|FG009|Period 2|Withdrawal by Subject|0|||
30790555|NCT03208088|58803695|FG000|Period 3|Unsatisfactory Test Article|0|||
30790556|NCT03208088|58803696|FG001|Period 3|Unsatisfactory Test Article|0|||
30790557|NCT03208088|58803697|FG002|Period 3|Unsatisfactory Test Article|0|||
30790558|NCT03208088|58803698|FG003|Period 3|Unsatisfactory Test Article|1|||
30790559|NCT03208088|58803699|FG004|Period 3|Unsatisfactory Test Article|0|||
30790560|NCT03208088|58803700|FG005|Period 3|Unsatisfactory Test Article|0|||
30790561|NCT03208088|58803701|FG006|Period 3|Unsatisfactory Test Article|0|||
30790562|NCT03208088|58803702|FG007|Period 3|Unsatisfactory Test Article|0|||
30790563|NCT03208088|58803703|FG008|Period 3|Unsatisfactory Test Article|0|||
30790564|NCT03208088|58803704|FG009|Period 3|Unsatisfactory Test Article|0|||
30790565|NCT03208088|58803695|FG000|Period 4|Unsatisfactory Test Article|0|||
30790566|NCT03208088|58803696|FG001|Period 4|Unsatisfactory Test Article|0|||
30790567|NCT03208088|58803697|FG002|Period 4|Unsatisfactory Test Article|0|||
30790568|NCT03208088|58803698|FG003|Period 4|Unsatisfactory Test Article|1|||
30790569|NCT03208088|58803699|FG004|Period 4|Unsatisfactory Test Article|0|||
30790570|NCT03208088|58803700|FG005|Period 4|Unsatisfactory Test Article|0|||
30790571|NCT03208088|58803701|FG006|Period 4|Unsatisfactory Test Article|0|||
30790572|NCT03208088|58803702|FG007|Period 4|Unsatisfactory Test Article|0|||
30790573|NCT03208088|58803703|FG008|Period 4|Unsatisfactory Test Article|0|||
30790574|NCT03208088|58803704|FG009|Period 4|Unsatisfactory Test Article|0|||
30790575|NCT00078377|58803719|FG000|Overall Study|Adverse Event|2|||
30790576|NCT00078377|58803720|FG001|Overall Study|Adverse Event|5|||
30790577|NCT00078377|58803721|FG002|Overall Study|Adverse Event|1|||
30790578|NCT00078377|58803719|FG000|Overall Study|Lack of Efficacy|2|||
30790579|NCT00078377|58803720|FG001|Overall Study|Lack of Efficacy|0|||
30790580|NCT00078377|58803721|FG002|Overall Study|Lack of Efficacy|2|||
30790581|NCT00078377|58803719|FG000|Overall Study|Lost to Follow-up|0|||
30790582|NCT00078377|58803720|FG001|Overall Study|Lost to Follow-up|1|||
30790583|NCT00078377|58803721|FG002|Overall Study|Lost to Follow-up|1|||
30790584|NCT00078377|58803719|FG000|Overall Study|Physician Decision|2|||
30790585|NCT00078377|58803720|FG001|Overall Study|Physician Decision|0|||
30790586|NCT00078377|58803721|FG002|Overall Study|Physician Decision|0|||
30790587|NCT00078377|58803719|FG000|Overall Study|Withdrawal by Subject|3|||
30790588|NCT00078377|58803720|FG001|Overall Study|Withdrawal by Subject|4|||
30790589|NCT00078377|58803721|FG002|Overall Study|Withdrawal by Subject|4|||
30790590|NCT00078377|58803719|FG000|Overall Study|Miscellaneous|2|||
30790591|NCT00078377|58803720|FG001|Overall Study|Miscellaneous|6|||
30790592|NCT00078377|58803721|FG002|Overall Study|Miscellaneous|1|||
30790593|NCT00886600|58803734|FG000|Double-blind Monotherapy|Adverse Event|1|||
30892820|NCT02164539|58926241|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
30892821|NCT02164539|58926235|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
30892822|NCT02164539|58926236|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
30892823|NCT02164539|58926237|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
30892824|NCT02164539|58926238|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
30892825|NCT02164539|58926239|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
30790594|NCT00886600|58803735|FG001|Double-blind Monotherapy|Adverse Event|1|||
30790595|NCT00886600|58803736|FG002|Double-blind Monotherapy|Adverse Event|1|||
30790596|NCT00886600|58803737|FG003|Double-blind Monotherapy|Adverse Event|1|||
30790597|NCT00886600|58803734|FG000|Double-blind Monotherapy|Protocol Violation|0|||
30790598|NCT00886600|58803735|FG001|Double-blind Monotherapy|Protocol Violation|0|||
30790599|NCT00886600|58803736|FG002|Double-blind Monotherapy|Protocol Violation|0|||
30790600|NCT00886600|58803737|FG003|Double-blind Monotherapy|Protocol Violation|1|||
30790601|NCT00886600|58803734|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
30790602|NCT00886600|58803735|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
30892826|NCT02164539|58926240|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
30892827|NCT02164539|58926241|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
30892828|NCT02164539|58926235|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
30892829|NCT02164539|58926236|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
30892830|NCT02164539|58926237|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
31006847|NCT01533714|59208439|FG000|Overall Study|Exclusion criteria|0|||
31006848|NCT01533714|59208440|FG001|Overall Study|Exclusion criteria|1|||
31006849|NCT01533714|59208441|FG002|Overall Study|Exclusion criteria|0|||
31006850|NCT01533714|59208442|FG003|Overall Study|Exclusion criteria|0|||
31006851|NCT01533714|59208443|FG004|Overall Study|Exclusion criteria|0|||
31006852|NCT01533714|59208444|FG005|Overall Study|Exclusion criteria|0|||
31006853|NCT01533714|59208439|FG000|Overall Study|Positive for purified protein derivative|0|||
31006854|NCT01533714|59208440|FG001|Overall Study|Positive for purified protein derivative|0|||
31006855|NCT01533714|59208441|FG002|Overall Study|Positive for purified protein derivative|1|||
31006856|NCT01533714|59208442|FG003|Overall Study|Positive for purified protein derivative|0|||
31006857|NCT01533714|59208443|FG004|Overall Study|Positive for purified protein derivative|1|||
31006858|NCT01533714|59208444|FG005|Overall Study|Positive for purified protein derivative|0|||
31006859|NCT01533714|59208439|FG000|Overall Study|Withdrawal criteria|0|||
31006860|NCT01533714|59208440|FG001|Overall Study|Withdrawal criteria|0|||
31006861|NCT01533714|59208441|FG002|Overall Study|Withdrawal criteria|1|||
31006862|NCT01533714|59208442|FG003|Overall Study|Withdrawal criteria|0|||
31006863|NCT01533714|59208443|FG004|Overall Study|Withdrawal criteria|3|||
31006864|NCT01533714|59208444|FG005|Overall Study|Withdrawal criteria|1|||
31006865|NCT01533714|59208439|FG000|Overall Study|Ineligibility reason|0|||
31006866|NCT01533714|59208440|FG001|Overall Study|Ineligibility reason|0|||
31006867|NCT01533714|59208441|FG002|Overall Study|Ineligibility reason|0|||
30790603|NCT00886600|58803736|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
30790604|NCT00886600|58803737|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
30790605|NCT00886600|58803734|FG000|Combination Therapy Period|Adverse Event|0|||
30790606|NCT00886600|58803735|FG001|Combination Therapy Period|Adverse Event|0|||
30790607|NCT00886600|58803736|FG002|Combination Therapy Period|Adverse Event|1|||
30790608|NCT00886600|58803737|FG003|Combination Therapy Period|Adverse Event|0|||
30892831|NCT02164539|58926238|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
31006868|NCT01533714|59208442|FG003|Overall Study|Ineligibility reason|1|||
31006869|NCT01533714|59208443|FG004|Overall Study|Ineligibility reason|0|||
31006870|NCT01533714|59208444|FG005|Overall Study|Ineligibility reason|0|||
31006871|NCT01533246|59208458|FG000|Overall Study|Adverse Event|1|||
31006872|NCT01533246|59208458|FG000|Overall Study|Withdrawal by Subject|1|||
31006873|NCT01579578|59208464|FG000|Overall Study|Death|4|||
31006874|NCT01579578|59208465|FG001|Overall Study|Death|1|||
31006875|NCT01579578|59208464|FG000|Overall Study|Lost to Follow-up|1|||
31006876|NCT01579578|59208465|FG001|Overall Study|Lost to Follow-up|1|||
31006877|NCT01579578|59208464|FG000|Overall Study|Withdrawal by Subject|2|||
31006878|NCT01579578|59208465|FG001|Overall Study|Withdrawal by Subject|1|||
31006879|NCT01579578|59208464|FG000|Overall Study|Eligibility criteria|3|||
31006880|NCT01579578|59208465|FG001|Overall Study|Eligibility criteria|9|||
31006881|NCT01579578|59208464|FG000|Overall Study|Ongoing|3|||
31006882|NCT01579578|59208465|FG001|Overall Study|Ongoing|0|||
31006883|NCT01578486|59208471|FG000|Overall Study|Physician Decision|3|||
31006884|NCT01578486|59208471|FG000|Overall Study|Withdrawal by Subject|2|||
31006885|NCT01532934|59208477|FG000|Overall Study|Lost to Follow-up|11|||
31006886|NCT01532934|59208478|FG001|Overall Study|Lost to Follow-up|11|||
31006887|NCT01532934|59208477|FG000|Overall Study|In controlled environment|3|||
31006888|NCT01532934|59208478|FG001|Overall Study|In controlled environment|2|||
31006889|NCT01532388|59208488|FG000|3-month Follow-up|Lost to Follow-up|68|||
31006890|NCT01532388|59208489|FG001|3-month Follow-up|Lost to Follow-up|68|||
31006891|NCT01532388|59208488|FG000|6-month Follow-up|Lost to Follow-up|74|||
31006892|NCT01532388|59208489|FG001|6-month Follow-up|Lost to Follow-up|66|||
31006893|NCT01532388|59208488|FG000|12-month Follow-up|Lost to Follow-up|69|||
31006894|NCT01532388|59208489|FG001|12-month Follow-up|Lost to Follow-up|67|||
31006895|NCT01555164|59208497|FG000|Overall Study|Adverse Event|5|||
31006896|NCT01555164|59208498|FG001|Overall Study|Adverse Event|7|||
31006897|NCT01555164|59208497|FG000|Overall Study|Hyperglycemia|0|||
31006898|NCT01555164|59208498|FG001|Overall Study|Hyperglycemia|1|||
31006899|NCT01555164|59208497|FG000|Overall Study|Investigator's Discretion|2|||
31006900|NCT01555164|59208498|FG001|Overall Study|Investigator's Discretion|2|||
31006901|NCT01555164|59208497|FG000|Overall Study|Lost to Follow-up|4|||
31006902|NCT01555164|59208498|FG001|Overall Study|Lost to Follow-up|3|||
31006903|NCT01555164|59208497|FG000|Overall Study|Protocol Violation|9|||
31006904|NCT01555164|59208498|FG001|Overall Study|Protocol Violation|5|||
30790609|NCT00886600|58803734|FG000|Combination Therapy Period|Protocol Violation|0|||
30790610|NCT00886600|58803735|FG001|Combination Therapy Period|Protocol Violation|0|||
30790611|NCT00886600|58803736|FG002|Combination Therapy Period|Protocol Violation|1|||
30790612|NCT00886600|58803737|FG003|Combination Therapy Period|Protocol Violation|0|||
30790613|NCT03172130|58803745|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
30790614|NCT03172130|58803746|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
30790615|NCT00870688|58803762|FG000|Overall Study|Lost to Follow-up|2|||
30790616|NCT00870688|58803762|FG000|Overall Study|Death, Unrelated|1|||
30790617|NCT00870688|58803762|FG000|Overall Study|Granules in the Stools|1|||
30790618|NCT00869128|58803765|FG000|Overall Study|lack of Compliance|6|||
30790619|NCT00869128|58803766|FG001|Overall Study|lack of Compliance|6|||
30790620|NCT00077675|58803772|FG000|Overall Study|Adverse Event|1|||
30790621|NCT00077675|58803773|FG001|Overall Study|Adverse Event|2|||
30790622|NCT00077675|58803772|FG000|Overall Study|Lost to Follow-up|6|||
30790623|NCT00077675|58803773|FG001|Overall Study|Lost to Follow-up|3|||
30790624|NCT00077675|58803772|FG000|Overall Study|Withdrawal by Subject|1|||
30790625|NCT00077675|58803773|FG001|Overall Study|Withdrawal by Subject|0|||
30790626|NCT00077675|58803772|FG000|Overall Study|Other|0|||
30790627|NCT00077675|58803773|FG001|Overall Study|Other|1|||
30892832|NCT02164539|58926239|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
30892833|NCT02164539|58926240|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
31006905|NCT01555164|59208497|FG000|Overall Study|Subject Non-compliance|14|||
31006906|NCT01555164|59208498|FG001|Overall Study|Subject Non-compliance|6|||
31006907|NCT01555164|59208497|FG000|Overall Study|Subject Withdrew Consent|6|||
31006908|NCT01555164|59208498|FG001|Overall Study|Subject Withdrew Consent|11|||
31006909|NCT01578330|59208504|FG000|Overall Study|Adverse Event|2|||
31006910|NCT01578330|59208504|FG000|Overall Study|Protocol Violation|5|||
31006911|NCT01577160|59208508|FG000|Overall Study|Adverse Event|9|||
31006912|NCT01577160|59208508|FG000|Overall Study|Lack of Efficacy|15|||
31006913|NCT01577160|59208508|FG000|Overall Study|Lost to Follow-up|40|||
31006914|NCT01577160|59208508|FG000|Overall Study|Withdrawal by Subject|18|||
31006915|NCT01577160|59208508|FG000|Overall Study|Subject Uncooperative|7|||
30790628|NCT00077675|58803772|FG000|Overall Study|Never received study treatment|3|||
30790629|NCT00077675|58803773|FG001|Overall Study|Never received study treatment|3|||
30790630|NCT02576444|58803790|FG000|Overall Study|Death|1|||
30790631|NCT02576444|58803791|FG001|Overall Study|Death|1|||
30790632|NCT02576444|58803792|FG002|Overall Study|Death|0|||
30790633|NCT02576444|58803793|FG003|Overall Study|Death|0|||
30892834|NCT02164539|58926241|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
30892835|NCT02164539|58926235|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
30892836|NCT02164539|58926236|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
30892837|NCT02164539|58926237|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
30892838|NCT02164539|58926238|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
30892839|NCT02164539|58926239|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
30892840|NCT02164539|58926240|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
30892841|NCT02164539|58926241|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
30892842|NCT02164539|58926235|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
30892843|NCT02164539|58926236|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
30892844|NCT02164539|58926237|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
30892845|NCT02164539|58926238|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
30892846|NCT02164539|58926239|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
30892847|NCT02164539|58926240|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
30892848|NCT02164539|58926241|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
30892849|NCT02188485|58926258|FG000|Overall Study|Withdrawal by Subject|2|||
30892850|NCT02188485|58926259|FG001|Overall Study|Withdrawal by Subject|1|||
30892851|NCT02188485|58926258|FG000|Overall Study|PI withdrew, lack of capacity|0|||
30892852|NCT02188485|58926259|FG001|Overall Study|PI withdrew, lack of capacity|2|||
30790634|NCT02576444|58803790|FG000|Overall Study|Withdrawal by Subject|0|||
30790635|NCT02576444|58803791|FG001|Overall Study|Withdrawal by Subject|0|||
30790636|NCT02576444|58803792|FG002|Overall Study|Withdrawal by Subject|2|||
30790637|NCT02576444|58803793|FG003|Overall Study|Withdrawal by Subject|0|||
30790638|NCT02576444|58803790|FG000|Overall Study|Adverse Event|0|||
30790639|NCT02576444|58803791|FG001|Overall Study|Adverse Event|0|||
30790640|NCT02576444|58803792|FG002|Overall Study|Adverse Event|1|||
30790641|NCT02576444|58803793|FG003|Overall Study|Adverse Event|0|||
30790642|NCT02576444|58803790|FG000|Overall Study|Physician Decision|0|||
30790643|NCT02576444|58803791|FG001|Overall Study|Physician Decision|0|||
30790644|NCT02576444|58803792|FG002|Overall Study|Physician Decision|1|||
30790645|NCT02576444|58803793|FG003|Overall Study|Physician Decision|0|||
30790646|NCT00850174|58803804|FG000|Washout: One Week|Withdrawal by Subject|0|||
30790647|NCT00850174|58803805|FG001|Washout: One Week|Withdrawal by Subject|2|||
30790648|NCT00850174|58803804|FG000|Second Intervention|Withdrawal by Subject|1|||
30611583|NCT02580058|58622576|FG002|Overall Study|Withdrawal by Subject|31|||
30790649|NCT00850174|58803805|FG001|Second Intervention|Withdrawal by Subject|0|||
30790650|NCT00077207|58803816|FG000|Overall Study|Adverse Event|5|||
30790651|NCT00077207|58803816|FG000|Overall Study|Lack of Efficacy|12|||
30790652|NCT00077207|58803816|FG000|Overall Study|Physician Decision|6|||
30790653|NCT00077207|58803816|FG000|Overall Study|Withdrawal by Subject|6|||
30790654|NCT00077207|58803816|FG000|Overall Study|Ineligible|1|||
30790655|NCT03206918|58803821|FG000|Overall Study|Death|11|||
30790656|NCT03206918|58803821|FG000|Overall Study|Withdrawal by Subject|5|||
30790657|NCT03206918|58803821|FG000|Overall Study|Study terminated by sponsor|12|||
30790658|NCT03206918|58803821|FG000|Overall Study|Lost to Follow-up|3|||
30790659|NCT03206918|58803821|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
30790660|NCT03206216|58803828|FG000|Overall Study|Withdrawal by Subject|0|||
30790661|NCT03206216|58803829|FG001|Overall Study|Withdrawal by Subject|1|||
30790662|NCT03169244|58803837|FG000|Overall Study|Lost to Follow-up|1|||
30790663|NCT03169244|58803838|FG001|Overall Study|Lost to Follow-up|2|||
30790664|NCT03169244|58803837|FG000|Overall Study|Adverse Event|1|||
30790665|NCT03169244|58803838|FG001|Overall Study|Adverse Event|0|||
30790666|NCT03169244|58803837|FG000|Overall Study|Withdrawal by Subject|2|||
30790667|NCT03169244|58803838|FG001|Overall Study|Withdrawal by Subject|2|||
30790668|NCT03169244|58803837|FG000|Overall Study|Physician Decision|1|||
30790669|NCT03169244|58803838|FG001|Overall Study|Physician Decision|0|||
30790670|NCT02486042|58803846|FG000|Overall Study|Physician Decision|1|||
30790671|NCT02486042|58803847|FG001|Overall Study|Physician Decision|7|||
30790672|NCT02486042|58803846|FG000|Overall Study|Hospital transfer|2|||
30790673|NCT02486042|58803847|FG001|Overall Study|Hospital transfer|2|||
30790674|NCT02486042|58803846|FG000|Overall Study|Withdrawal by Subject|0|||
30790675|NCT02486042|58803847|FG001|Overall Study|Withdrawal by Subject|2|||
30790676|NCT00057941|58803855|FG000|Overall Study|Death|1|||
30790677|NCT00057941|58803856|FG001|Overall Study|Death|2|||
30892853|NCT02132247|58926267|FG000|Overall Study|Protocol Violation|1|||
30892854|NCT02132247|58926268|FG001|Overall Study|Protocol Violation|0|||
30892855|NCT01629381|58926276|FG000|Overall Study|Withdrawal by Subject|2|||
30892856|NCT01629381|58926277|FG001|Overall Study|Withdrawal by Subject|5|||
30790678|NCT00057941|58803855|FG000|Overall Study|Adverse Event|7|||
30790679|NCT00057941|58803856|FG001|Overall Study|Adverse Event|9|||
30790680|NCT00057941|58803855|FG000|Overall Study|Lack of Efficacy|54|||
30790681|NCT00057941|58803856|FG001|Overall Study|Lack of Efficacy|53|||
30790682|NCT00057941|58803855|FG000|Overall Study|Withdrawal by Subject|6|||
30790683|NCT00057941|58803856|FG001|Overall Study|Withdrawal by Subject|1|||
30790684|NCT00057941|58803855|FG000|Overall Study|still on treatment|3|||
30790685|NCT00057941|58803856|FG001|Overall Study|still on treatment|1|||
30790686|NCT00057941|58803855|FG000|Overall Study|insurance, symptomatic deterioration|1|||
30790687|NCT00057941|58803856|FG001|Overall Study|insurance, symptomatic deterioration|3|||
30790688|NCT00057941|58803855|FG000|Overall Study|Ineligible|2|||
30790689|NCT00057941|58803856|FG001|Overall Study|Ineligible|5|||
30790690|NCT00075881|58803871|FG000|Overall Study|Lack of Efficacy|18|||
30790691|NCT00075881|58803871|FG000|Overall Study|Adverse Event|7|||
30790692|NCT00075881|58803871|FG000|Overall Study|Death|1|||
30790693|NCT00075881|58803871|FG000|Overall Study|Withdrawal by Subject|2|||
30790694|NCT00075881|58803871|FG000|Overall Study|Protocol Violation|4|||
30790695|NCT00075881|58803871|FG000|Overall Study|other complicating disease|3|||
30790696|NCT00075881|58803871|FG000|Overall Study|other|4|||
30790697|NCT00075881|58803871|FG000|Overall Study|missing data|2|||
30790698|NCT00075881|58803871|FG000|Overall Study|Ineligible|1|||
30790699|NCT00075881|58803871|FG000|Overall Study|never start protocol therapy|1|||
30790700|NCT00838630|58803879|FG000|First Intervention|Adverse Event|1|||
30790701|NCT00838630|58803880|FG001|First Intervention|Adverse Event|0|||
30790702|NCT00838630|58803879|FG000|Washout: 7 Days|Protocol Violation|1|||
30790703|NCT00838630|58803880|FG001|Washout: 7 Days|Protocol Violation|0|||
30790704|NCT02996474|58803884|FG000|Overall Study|Physician Decision|5|||
30790705|NCT03667924|58803891|FG000|Baseline Completed|Lost to Follow-up|0|||
30790706|NCT03667924|58803892|FG001|Baseline Completed|Lost to Follow-up|2|||
30790707|NCT03667924|58803893|FG002|Baseline Completed|Lost to Follow-up|0|||
30790708|NCT03667924|58803891|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
30790709|NCT03667924|58803892|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
30790710|NCT03667924|58803893|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
30790711|NCT03667924|58803891|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
30790712|NCT03667924|58803892|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
30790713|NCT03667924|58803893|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
30790714|NCT03667924|58803891|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
30892857|NCT02131311|58926287|FG000|Overall Study|Adverse Event|2|||
30892858|NCT02131311|58926287|FG000|Overall Study|Protocol Violation|1|||
30892859|NCT02131311|58926287|FG000|Overall Study|Lost to Follow-up|1|||
30892860|NCT01628913|58926294|FG000|Overall Study|Adverse Event|12|||
30892861|NCT01628913|58926295|FG001|Overall Study|Adverse Event|5|||
30892862|NCT01628913|58926294|FG000|Overall Study|Disease Progression|11|||
30892863|NCT01628913|58926295|FG001|Overall Study|Disease Progression|14|||
30892864|NCT01628913|58926294|FG000|Overall Study|Protocol Violation|1|||
30892865|NCT01628913|58926295|FG001|Overall Study|Protocol Violation|0|||
30892866|NCT01628913|58926294|FG000|Overall Study|Death|1|||
30892867|NCT01628913|58926295|FG001|Overall Study|Death|0|||
30790715|NCT03667924|58803892|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
30790716|NCT03667924|58803893|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
30790717|NCT03667924|58803891|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
30790718|NCT03667924|58803892|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
30611584|NCT02580058|58622574|FG000|Overall Study|Global Deterioration of Health Status|19|||
30611585|NCT02580058|58622575|FG001|Overall Study|Global Deterioration of Health Status|18|||
30611586|NCT02580058|58622576|FG002|Overall Study|Global Deterioration of Health Status|24|||
30611587|NCT02580058|58622574|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
30611588|NCT02580058|58622575|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
30611589|NCT02580058|58622576|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
30611590|NCT02580058|58622574|FG000|Overall Study|Progressive Disease|137|||
30611591|NCT02580058|58622575|FG001|Overall Study|Progressive Disease|125|||
30611592|NCT02580058|58622576|FG002|Overall Study|Progressive Disease|94|||
30611593|NCT02580058|58622574|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30611594|NCT02580058|58622575|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30611595|NCT02580058|58622576|FG002|Overall Study|Non-Compliance With Study Drug|0|||
30611596|NCT02539394|58622588|FG000|Overall Study|Protocol Violation|1|||
30611597|NCT02539394|58622589|FG001|Overall Study|Protocol Violation|3|||
30892868|NCT01628913|58926294|FG000|Overall Study|study terminated by Sponsor|4|||
30790719|NCT03667924|58803893|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
30892869|NCT01628913|58926295|FG001|Overall Study|study terminated by Sponsor|9|||
30611598|NCT02539394|58622588|FG000|Overall Study|Lost to Follow-up|1|||
30611599|NCT02539394|58622589|FG001|Overall Study|Lost to Follow-up|2|||
30611600|NCT02539394|58622588|FG000|Overall Study|Incomplete dataset|6|||
30611601|NCT02539394|58622589|FG001|Overall Study|Incomplete dataset|6|||
30892870|NCT01628913|58926294|FG000|Overall Study|Withdrawal by Subject|1|||
31006916|NCT01577160|59208508|FG000|Overall Study|Other|9|||
30611602|NCT02412670|58622603|FG000|Overall Study|Adverse Event|4|||
30611603|NCT02412670|58622604|FG001|Overall Study|Adverse Event|1|||
30611604|NCT02412670|58622603|FG000|Overall Study|Physician Decision|1|||
30611605|NCT02412670|58622604|FG001|Overall Study|Physician Decision|0|||
30611606|NCT02412670|58622603|FG000|Overall Study|Withdrawal by Subject|1|||
30611607|NCT02412670|58622604|FG001|Overall Study|Withdrawal by Subject|0|||
30611608|NCT02412670|58622603|FG000|Overall Study|Ineligible|1|||
30611609|NCT02412670|58622604|FG001|Overall Study|Ineligible|0|||
30611610|NCT01358877|58622612|FG000|Overall Study|Death|80|||
30611611|NCT01358877|58622613|FG001|Overall Study|Death|89|||
30611612|NCT01358877|58622612|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
30611613|NCT01358877|58622613|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
30611614|NCT01358877|58622612|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
30611615|NCT01358877|58622613|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
30611616|NCT01358877|58622612|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
30611617|NCT01358877|58622613|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
30611618|NCT01358877|58622612|FG000|Overall Study|Other|142|||
30611619|NCT01358877|58622613|FG001|Overall Study|Other|129|||
30790720|NCT03667924|58803891|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
30790721|NCT03667924|58803892|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
30790722|NCT03667924|58803893|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
30790723|NCT03667924|58803891|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
30790724|NCT03667924|58803892|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
30790725|NCT03667924|58803893|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
30790726|NCT03205046|58803905|FG000|Overall Study|Death|10|||
30790727|NCT03205046|58803906|FG001|Overall Study|Death|6|||
30790728|NCT03205046|58803905|FG000|Overall Study|Withdrawal by Subject|1|||
30611620|NCT01084252|58622640|FG000|Phase 1 (120 Weeks)|Adverse Event|0|||
30611621|NCT01084252|58622641|FG001|Phase 1 (120 Weeks)|Adverse Event|0|||
30611622|NCT01084252|58622642|FG002|Phase 1 (120 Weeks)|Adverse Event|1|||
30611623|NCT01084252|58622643|FG003|Phase 1 (120 Weeks)|Adverse Event|1|||
30611624|NCT01084252|58622644|FG004|Phase 1 (120 Weeks)|Adverse Event|1|||
30611625|NCT01084252|58622645|FG005|Phase 1 (120 Weeks)|Adverse Event|0|||
30611626|NCT01084252|58622646|FG006|Phase 1 (120 Weeks)|Adverse Event|1|||
30611627|NCT01084252|58622647|FG007|Phase 1 (120 Weeks)|Adverse Event|0|||
30790729|NCT03205046|58803906|FG001|Overall Study|Withdrawal by Subject|2|||
30790730|NCT03205046|58803905|FG000|Overall Study|Lost to Follow-up|0|||
30790731|NCT03205046|58803906|FG001|Overall Study|Lost to Follow-up|1|||
30790732|NCT03205046|58803905|FG000|Overall Study|Study terminated by sponsor|2|||
30790733|NCT03205046|58803906|FG001|Overall Study|Study terminated by sponsor|1|||
30790734|NCT03204812|58803912|FG000|Overall Study|Adverse Event|3|||
30790735|NCT02339090|58803918|FG000|Overall Study|Adverse Event|1|||
30790736|NCT02339090|58803919|FG001|Overall Study|Adverse Event|0|||
30790737|NCT02339090|58803918|FG000|Overall Study|Lost to Follow-up|0|||
30790738|NCT02339090|58803919|FG001|Overall Study|Lost to Follow-up|1|||
30790739|NCT02339090|58803918|FG000|Overall Study|Non-compliance With Study Drug|0|||
30790740|NCT02339090|58803919|FG001|Overall Study|Non-compliance With Study Drug|1|||
30790741|NCT02339090|58803918|FG000|Overall Study|Withdrawal by Subject|2|||
30790742|NCT02339090|58803919|FG001|Overall Study|Withdrawal by Subject|1|||
30790743|NCT02339090|58803918|FG000|Overall Study|Poor Growth|3|||
30611628|NCT01084252|58622648|FG008|Phase 1 (120 Weeks)|Adverse Event|0|||
30611629|NCT01084252|58622649|FG009|Phase 1 (120 Weeks)|Adverse Event|0|||
30611630|NCT01084252|58622650|FG010|Phase 1 (120 Weeks)|Adverse Event|0|||
30611631|NCT01084252|58622651|FG011|Phase 1 (120 Weeks)|Adverse Event|0|||
30611632|NCT01084252|58622652|FG012|Phase 1 (120 Weeks)|Adverse Event|0|||
30611633|NCT01084252|58622653|FG013|Phase 1 (120 Weeks)|Adverse Event|0|||
30611634|NCT01084252|58622640|FG000|Phase 1 (120 Weeks)|Progressive disease|15|||
30611635|NCT01084252|58622641|FG001|Phase 1 (120 Weeks)|Progressive disease|5|||
30611636|NCT01084252|58622642|FG002|Phase 1 (120 Weeks)|Progressive disease|2|||
30611637|NCT01084252|58622643|FG003|Phase 1 (120 Weeks)|Progressive disease|22|||
30611638|NCT01084252|58622644|FG004|Phase 1 (120 Weeks)|Progressive disease|16|||
30611639|NCT01084252|58622645|FG005|Phase 1 (120 Weeks)|Progressive disease|6|||
30611640|NCT01084252|58622646|FG006|Phase 1 (120 Weeks)|Progressive disease|5|||
30611641|NCT01084252|58622647|FG007|Phase 1 (120 Weeks)|Progressive disease|6|||
30611642|NCT01084252|58622648|FG008|Phase 1 (120 Weeks)|Progressive disease|0|||
30611643|NCT01084252|58622649|FG009|Phase 1 (120 Weeks)|Progressive disease|0|||
30611644|NCT01084252|58622650|FG010|Phase 1 (120 Weeks)|Progressive disease|0|||
30611645|NCT01084252|58622651|FG011|Phase 1 (120 Weeks)|Progressive disease|0|||
30611646|NCT01084252|58622652|FG012|Phase 1 (120 Weeks)|Progressive disease|0|||
30611647|NCT01084252|58622653|FG013|Phase 1 (120 Weeks)|Progressive disease|0|||
30611648|NCT01084252|58622640|FG000|Phase 1 (120 Weeks)|Other than specified above|1|||
30611649|NCT01084252|58622641|FG001|Phase 1 (120 Weeks)|Other than specified above|1|||
30611650|NCT01084252|58622642|FG002|Phase 1 (120 Weeks)|Other than specified above|0|||
30611651|NCT01084252|58622643|FG003|Phase 1 (120 Weeks)|Other than specified above|3|||
30611652|NCT01084252|58622644|FG004|Phase 1 (120 Weeks)|Other than specified above|1|||
30611653|NCT01084252|58622645|FG005|Phase 1 (120 Weeks)|Other than specified above|0|||
30611654|NCT01084252|58622646|FG006|Phase 1 (120 Weeks)|Other than specified above|1|||
30611655|NCT01084252|58622647|FG007|Phase 1 (120 Weeks)|Other than specified above|1|||
30611656|NCT01084252|58622648|FG008|Phase 1 (120 Weeks)|Other than specified above|0|||
30611657|NCT01084252|58622649|FG009|Phase 1 (120 Weeks)|Other than specified above|0|||
30611658|NCT01084252|58622650|FG010|Phase 1 (120 Weeks)|Other than specified above|0|||
30611659|NCT01084252|58622651|FG011|Phase 1 (120 Weeks)|Other than specified above|0|||
30611660|NCT01084252|58622652|FG012|Phase 1 (120 Weeks)|Other than specified above|0|||
30611661|NCT01084252|58622653|FG013|Phase 1 (120 Weeks)|Other than specified above|0|||
30611662|NCT01084252|58622640|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
30611663|NCT01084252|58622641|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
30611664|NCT01084252|58622642|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
30611665|NCT01084252|58622643|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
30611666|NCT01084252|58622644|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
30611667|NCT01084252|58622645|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
30611668|NCT01084252|58622646|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
30611669|NCT01084252|58622647|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
30611670|NCT01084252|58622648|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
30611671|NCT01084252|58622649|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
30611672|NCT01084252|58622650|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
30611673|NCT01084252|58622651|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1|||
30611674|NCT01084252|58622652|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
30611675|NCT01084252|58622653|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
30611676|NCT01084252|58622640|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
30611677|NCT01084252|58622641|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
30611678|NCT01084252|58622642|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
30611679|NCT01084252|58622643|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
30611680|NCT01084252|58622644|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
30611681|NCT01084252|58622645|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
30611682|NCT01084252|58622646|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
30611683|NCT01084252|58622647|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
30611684|NCT01084252|58622648|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20|||
30611685|NCT01084252|58622649|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18|||
30611686|NCT01084252|58622650|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17|||
30611687|NCT01084252|58622651|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19|||
30611688|NCT01084252|58622652|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
30611689|NCT01084252|58622653|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
30611690|NCT01084252|58622640|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
30611691|NCT01084252|58622641|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
30611692|NCT01084252|58622642|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
30611693|NCT01084252|58622643|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
30611694|NCT01084252|58622644|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
30611695|NCT01084252|58622645|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
30611696|NCT01084252|58622646|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
30611697|NCT01084252|58622647|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
30611698|NCT01084252|58622648|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2|||
30611699|NCT01084252|58622649|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
30611700|NCT01084252|58622650|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4|||
30611701|NCT01084252|58622651|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3|||
30611702|NCT01084252|58622652|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
30611703|NCT01084252|58622653|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
30611704|NCT01084252|58622640|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
30611705|NCT01084252|58622641|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
30611706|NCT01084252|58622642|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
30611707|NCT01084252|58622643|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
30611708|NCT01084252|58622644|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
30611709|NCT01084252|58622645|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
30611710|NCT01084252|58622646|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
30611711|NCT01084252|58622647|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
30611712|NCT01084252|58622648|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1|||
30611713|NCT01084252|58622649|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4|||
30611714|NCT01084252|58622650|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
30611715|NCT01084252|58622651|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
30790744|NCT02339090|58803919|FG001|Overall Study|Poor Growth|0|||
30790745|NCT02339090|58803918|FG000|Overall Study|Randomized but not treated|0|||
30611716|NCT01084252|58622652|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
30611717|NCT01084252|58622653|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
30611718|NCT01084252|58622640|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611719|NCT01084252|58622641|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611720|NCT01084252|58622642|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611721|NCT01084252|58622643|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611722|NCT01084252|58622644|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611723|NCT01084252|58622645|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611724|NCT01084252|58622646|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611725|NCT01084252|58622647|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611726|NCT01084252|58622648|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611727|NCT01084252|58622649|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611728|NCT01084252|58622650|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611729|NCT01084252|58622651|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
30611730|NCT01084252|58622652|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13|||
30611731|NCT01084252|58622653|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5|||
30611732|NCT01084252|58622640|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611733|NCT01084252|58622641|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611734|NCT01084252|58622642|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611735|NCT01084252|58622643|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611736|NCT01084252|58622644|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611737|NCT01084252|58622645|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611738|NCT01084252|58622646|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611739|NCT01084252|58622647|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611740|NCT01084252|58622648|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611741|NCT01084252|58622649|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611742|NCT01084252|58622650|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611743|NCT01084252|58622651|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
30611744|NCT01084252|58622652|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70|||
30611745|NCT01084252|58622653|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33|||
30611746|NCT01084252|58622640|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611747|NCT01084252|58622641|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611748|NCT01084252|58622642|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611749|NCT01084252|58622643|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611750|NCT01084252|58622644|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611751|NCT01084252|58622645|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611752|NCT01084252|58622646|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611753|NCT01084252|58622647|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611754|NCT01084252|58622648|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611755|NCT01084252|58622649|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611756|NCT01084252|58622650|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611757|NCT01084252|58622651|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611758|NCT01084252|58622652|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1|||
30611759|NCT01084252|58622653|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
30611760|NCT01084252|58622640|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611761|NCT01084252|58622641|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611762|NCT01084252|58622642|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611763|NCT01084252|58622643|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611764|NCT01084252|58622644|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611765|NCT01084252|58622645|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611766|NCT01084252|58622646|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611767|NCT01084252|58622647|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611768|NCT01084252|58622648|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611769|NCT01084252|58622649|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611770|NCT01084252|58622650|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611771|NCT01084252|58622651|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
30611772|NCT01084252|58622652|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12|||
30611773|NCT01084252|58622653|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2|||
30611774|NCT01084252|58622640|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30611775|NCT01084252|58622641|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30611776|NCT01084252|58622642|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30611777|NCT01084252|58622643|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30611778|NCT01084252|58622644|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30611779|NCT01084252|58622645|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30611780|NCT01084252|58622646|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30611781|NCT01084252|58622647|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30611782|NCT01084252|58622648|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30790746|NCT02339090|58803919|FG001|Overall Study|Randomized but not treated|2|||
30611783|NCT01084252|58622649|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30611784|NCT01084252|58622650|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30611785|NCT01084252|58622651|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
30611786|NCT01084252|58622652|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13|||
30611787|NCT01084252|58622653|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15|||
30611788|NCT01084252|58622640|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611789|NCT01084252|58622641|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611790|NCT01084252|58622642|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611791|NCT01084252|58622643|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611792|NCT01084252|58622644|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611793|NCT01084252|58622645|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611794|NCT01084252|58622646|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611795|NCT01084252|58622647|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611796|NCT01084252|58622648|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611797|NCT01084252|58622649|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611798|NCT01084252|58622650|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
31006917|NCT01554618|59208514|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
31006918|NCT01554618|59208515|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
31006919|NCT01554618|59208514|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
31006920|NCT01554618|59208515|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
31006921|NCT01554618|59208514|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
31006922|NCT01554618|59208515|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
31006923|NCT01554618|59208514|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
31006924|NCT01554618|59208515|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
31006925|NCT01554618|59208514|FG000|Open-Label Extension Period|Physician Decision|0|||
31006926|NCT01554618|59208515|FG001|Open-Label Extension Period|Physician Decision|1|||
31006927|NCT01554618|59208514|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
31006928|NCT01554618|59208515|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
31006929|NCT01531998|59208525|FG000|Overall Study|Withdrawal by Subject|3|||
31006930|NCT01576146|59208529|FG000|Extension Period 1|Adverse Event|2|||
31006931|NCT01576146|59208529|FG000|Extension Period 1|Death|2|||
31006932|NCT01576146|59208529|FG000|Extension Period 1|Physician Decision|2|||
31006933|NCT01576146|59208529|FG000|Extension Period 1|Withdrawal by Subject|1|||
31006934|NCT01576146|59208529|FG000|Extension Period 1|Lost to Follow-up|1|||
31006935|NCT01576146|59208529|FG000|Extension Period 1|Parathyroidectomy|1|||
31006936|NCT01576146|59208529|FG000|Extension Period 1|Renal Transplant|1|||
31006937|NCT01576146|59208529|FG000|Extension Period 2|Sponsor Decision|13|||
31006938|NCT01576146|59208529|FG000|Extension Period 2|Death|1|||
31006939|NCT01576146|59208529|FG000|Extension Period 2|Adverse Event|1|||
31006940|NCT01576146|59208529|FG000|Extension Period 2|Renal Transplant|1|||
31006941|NCT01576146|59208529|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
31006942|NCT01553916|59208533|FG000|Overall Study|Withdrawal by Subject|2|||
31006943|NCT01553916|59208533|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
31006944|NCT01553136|59208539|FG000|Overall Study|Adverse Event|3|||
31006945|NCT01553136|59208540|FG001|Overall Study|Adverse Event|2|||
30611799|NCT01084252|58622651|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611800|NCT01084252|58622652|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1|||
30611801|NCT01084252|58622653|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
30611802|NCT05111145|58622724|FG000|Overall Study|Commercial drug is available for participant|76|||
30611803|NCT05111145|58622724|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
30611804|NCT04823130|58622743|FG000|Overall Study|Withdrawal by Subject|2|||
30611805|NCT04823130|58622744|FG001|Overall Study|Withdrawal by Subject|3|||
30611806|NCT04823130|58622743|FG000|Overall Study|Failure to meet inclusion criteria|6|||
30611807|NCT04823130|58622744|FG001|Overall Study|Failure to meet inclusion criteria|4|||
30611808|NCT04823130|58622743|FG000|Overall Study|Other-unspecified|1|||
30611809|NCT04823130|58622744|FG001|Overall Study|Other-unspecified|0|||
30611810|NCT04402385|58622803|FG000|Overall Study|Withdrawal by Subject|4|||
30611811|NCT04402385|58622804|FG001|Overall Study|Withdrawal by Subject|4|||
30611812|NCT04402385|58622803|FG000|Overall Study|Lost to Follow-up|1|||
30611813|NCT04402385|58622804|FG001|Overall Study|Lost to Follow-up|1|||
30611814|NCT04402385|58622803|FG000|Overall Study|Physician Decision|0|||
30611815|NCT04402385|58622804|FG001|Overall Study|Physician Decision|1|||
30611816|NCT04060680|58622812|FG000|Overall Study|Unsuccessful implant|17|||
31006946|NCT01553136|59208539|FG000|Overall Study|Withdrawal by Subject|2|||
31006947|NCT01553136|59208540|FG001|Overall Study|Withdrawal by Subject|3|||
31006948|NCT01553136|59208539|FG000|Overall Study|Lost to Follow-up|4|||
31006949|NCT01553136|59208540|FG001|Overall Study|Lost to Follow-up|10|||
30611817|NCT04060680|58622812|FG000|Overall Study|Adverse Event|3|||
30790747|NCT03524092|58803940|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
31006950|NCT01553136|59208539|FG000|Overall Study|Physician Decision|2|||
30611818|NCT04060680|58622812|FG000|Overall Study|Death|2|||
30611819|NCT04060680|58622812|FG000|Overall Study|Study product no longer in use|1|||
30611820|NCT04060680|58622812|FG000|Overall Study|Withdrawal by Subject|1|||
30611821|NCT03785210|58622819|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
30611822|NCT03785210|58622820|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
30611823|NCT03750968|58622828|FG000|Overall Study|Adverse Event|2|||
30611824|NCT03750968|58622829|FG001|Overall Study|Adverse Event|0|||
30611825|NCT03750968|58622828|FG000|Overall Study|Lost to Follow-up|1|||
30611826|NCT03750968|58622829|FG001|Overall Study|Lost to Follow-up|3|||
30611827|NCT03690388|58622841|FG000|Overall Study|Adverse Event|8|||
30611828|NCT03690388|58622842|FG001|Overall Study|Adverse Event|1|||
30611829|NCT03690388|58622841|FG000|Overall Study|Radiographic Progression|14|||
30611830|NCT03690388|58622842|FG001|Overall Study|Radiographic Progression|29|||
30611831|NCT03690388|58622841|FG000|Overall Study|Clinical deterioration|10|||
30611832|NCT03690388|58622842|FG001|Overall Study|Clinical deterioration|6|||
30611833|NCT03690388|58622841|FG000|Overall Study|Withdrawal by Subject|2|||
30611834|NCT03690388|58622842|FG001|Overall Study|Withdrawal by Subject|0|||
30611835|NCT03690388|58622841|FG000|Overall Study|Lack of Efficacy|1|||
30611836|NCT03690388|58622842|FG001|Overall Study|Lack of Efficacy|0|||
30611837|NCT03690388|58622841|FG000|Overall Study|Lost to Follow-up|1|||
30611838|NCT03690388|58622842|FG001|Overall Study|Lost to Follow-up|0|||
30611839|NCT03619213|58622854|FG000|Overall Study|Lost to Follow-up|2|||
30611840|NCT03619213|58622855|FG001|Overall Study|Lost to Follow-up|1|||
30611841|NCT03619213|58622854|FG000|Overall Study|Withdrawal by Subject|8|||
30611842|NCT03619213|58622855|FG001|Overall Study|Withdrawal by Subject|10|||
30611843|NCT03342690|58622861|FG000|Overall Study|Missing Information|9|||
30611844|NCT03342690|58622861|FG000|Overall Study|Protocol Violation|16|||
30611845|NCT03257267|58622880|FG000|Overall Study|Adverse Event|9|||
30611846|NCT03257267|58622881|FG001|Overall Study|Adverse Event|7|||
30611847|NCT03257267|58622880|FG000|Overall Study|Death|92|||
30611848|NCT03257267|58622881|FG001|Overall Study|Death|95|||
30611849|NCT03257267|58622880|FG000|Overall Study|Lost to Follow-up|2|||
30611850|NCT03257267|58622881|FG001|Overall Study|Lost to Follow-up|2|||
30611851|NCT03257267|58622880|FG000|Overall Study|Non-compliance with Study Drug|0|||
30611852|NCT03257267|58622881|FG001|Overall Study|Non-compliance with Study Drug|1|||
30611853|NCT03257267|58622880|FG000|Overall Study|Participant Decision|34|||
30611854|NCT03257267|58622881|FG001|Overall Study|Participant Decision|42|||
30611855|NCT03257267|58622880|FG000|Overall Study|Physician Decision|1|||
30611856|NCT03257267|58622881|FG001|Overall Study|Physician Decision|3|||
30611857|NCT03257267|58622880|FG000|Overall Study|Disease Progression|98|||
30611858|NCT03257267|58622881|FG001|Overall Study|Disease Progression|117|||
30611859|NCT03257267|58622880|FG000|Overall Study|Withdrawal of Consent|8|||
30611860|NCT03257267|58622881|FG001|Overall Study|Withdrawal of Consent|26|||
30611861|NCT03257267|58622880|FG000|Overall Study|Study Ongoing|53|||
30611862|NCT03257267|58622881|FG001|Overall Study|Study Ongoing|11|||
30611863|NCT03064035|58622898|FG000|Overall Study|Did not receive allocated intervention|4|||
30611864|NCT03064035|58622899|FG001|Overall Study|Did not receive allocated intervention|2|||
30611865|NCT03064035|58622898|FG000|Overall Study|Lost to Follow-up|1|||
30611866|NCT03064035|58622899|FG001|Overall Study|Lost to Follow-up|1|||
30611867|NCT02991456|58622907|FG000|Overall Study|Adverse Event|2|||
30611868|NCT02991456|58622908|FG001|Overall Study|Adverse Event|0|||
30611869|NCT02991456|58622907|FG000|Overall Study|Lost to Follow-up|0|||
30611870|NCT02991456|58622908|FG001|Overall Study|Lost to Follow-up|2|||
30611871|NCT02991456|58622907|FG000|Overall Study|Withdrawal by Subject|1|||
30611872|NCT02991456|58622908|FG001|Overall Study|Withdrawal by Subject|0|||
30611873|NCT02842827|58622925|FG000|Overall Study|Adverse Event|0|||
30611874|NCT02842827|58622926|FG001|Overall Study|Adverse Event|1|||
30611875|NCT02842827|58622927|FG002|Overall Study|Adverse Event|0|||
30611876|NCT02842827|58622928|FG003|Overall Study|Adverse Event|1|||
30611877|NCT02842827|58622929|FG004|Overall Study|Adverse Event|0|||
30611878|NCT02842827|58622930|FG005|Overall Study|Adverse Event|1|||
30611879|NCT02842827|58622931|FG006|Overall Study|Adverse Event|0|||
30611880|NCT02842827|58622932|FG007|Overall Study|Adverse Event|0|||
30611881|NCT02842827|58622925|FG000|Overall Study|Death|1|||
30611882|NCT02842827|58622926|FG001|Overall Study|Death|0|||
30611883|NCT02842827|58622927|FG002|Overall Study|Death|2|||
30611884|NCT02842827|58622928|FG003|Overall Study|Death|3|||
30611885|NCT02842827|58622929|FG004|Overall Study|Death|2|||
30611886|NCT02842827|58622930|FG005|Overall Study|Death|1|||
30611887|NCT02842827|58622931|FG006|Overall Study|Death|0|||
30611888|NCT02842827|58622932|FG007|Overall Study|Death|4|||
30611889|NCT02842827|58622925|FG000|Overall Study|Physician Decision|1|||
30611890|NCT02842827|58622926|FG001|Overall Study|Physician Decision|3|||
30611891|NCT02842827|58622927|FG002|Overall Study|Physician Decision|0|||
30611892|NCT02842827|58622928|FG003|Overall Study|Physician Decision|0|||
30611893|NCT02842827|58622929|FG004|Overall Study|Physician Decision|1|||
30611894|NCT02842827|58622930|FG005|Overall Study|Physician Decision|4|||
30611895|NCT02842827|58622931|FG006|Overall Study|Physician Decision|2|||
30611896|NCT02842827|58622932|FG007|Overall Study|Physician Decision|1|||
30611897|NCT02842827|58622925|FG000|Overall Study|Protocol Defined Disease Progression|0|||
30611898|NCT02842827|58622926|FG001|Overall Study|Protocol Defined Disease Progression|0|||
30611899|NCT02842827|58622927|FG002|Overall Study|Protocol Defined Disease Progression|0|||
30611900|NCT02842827|58622928|FG003|Overall Study|Protocol Defined Disease Progression|0|||
30611901|NCT02842827|58622929|FG004|Overall Study|Protocol Defined Disease Progression|0|||
30611902|NCT02842827|58622930|FG005|Overall Study|Protocol Defined Disease Progression|1|||
30611903|NCT02842827|58622931|FG006|Overall Study|Protocol Defined Disease Progression|0|||
30611904|NCT02842827|58622932|FG007|Overall Study|Protocol Defined Disease Progression|0|||
30611905|NCT02842827|58622925|FG000|Overall Study|Participant Withdrawal of Consent|1|||
30611906|NCT02842827|58622926|FG001|Overall Study|Participant Withdrawal of Consent|2|||
30611907|NCT02842827|58622927|FG002|Overall Study|Participant Withdrawal of Consent|2|||
30611908|NCT02842827|58622928|FG003|Overall Study|Participant Withdrawal of Consent|2|||
30611909|NCT02842827|58622929|FG004|Overall Study|Participant Withdrawal of Consent|2|||
30611910|NCT02842827|58622930|FG005|Overall Study|Participant Withdrawal of Consent|1|||
30611911|NCT02842827|58622931|FG006|Overall Study|Participant Withdrawal of Consent|2|||
30611912|NCT02842827|58622932|FG007|Overall Study|Participant Withdrawal of Consent|1|||
30611913|NCT02432274|58622958|FG000|Overall Study|Death|2|||
30611914|NCT02432274|58622959|FG001|Overall Study|Death|6|||
30611915|NCT02432274|58622960|FG002|Overall Study|Death|7|||
30611916|NCT02432274|58622961|FG003|Overall Study|Death|0|||
30611917|NCT02432274|58622962|FG004|Overall Study|Death|27|||
30611918|NCT02432274|58622963|FG005|Overall Study|Death|7|||
30611919|NCT02432274|58622964|FG006|Overall Study|Death|9|||
30611920|NCT02432274|58622965|FG007|Overall Study|Death|14|||
30611921|NCT02432274|58622958|FG000|Overall Study|Withdrawal of Consent|0|||
30611922|NCT02432274|58622959|FG001|Overall Study|Withdrawal of Consent|0|||
30611923|NCT02432274|58622960|FG002|Overall Study|Withdrawal of Consent|0|||
30611924|NCT02432274|58622961|FG003|Overall Study|Withdrawal of Consent|0|||
30611925|NCT02432274|58622962|FG004|Overall Study|Withdrawal of Consent|2|||
30611926|NCT02432274|58622963|FG005|Overall Study|Withdrawal of Consent|0|||
30611927|NCT02432274|58622964|FG006|Overall Study|Withdrawal of Consent|1|||
30611928|NCT02432274|58622965|FG007|Overall Study|Withdrawal of Consent|2|||
30611929|NCT02393859|58623001|FG000|Overall Study|Decision by Sponsor|2|||
30611930|NCT02393859|58623002|FG001|Overall Study|Decision by Sponsor|4|||
30611931|NCT02393859|58623001|FG000|Overall Study|Withdrawal by Subject|11|||
30611932|NCT02393859|58623002|FG001|Overall Study|Withdrawal by Subject|6|||
30611933|NCT02393859|58623001|FG000|Overall Study|Death|27|||
30611934|NCT02393859|58623002|FG001|Overall Study|Death|10|||
30611935|NCT02393859|58623001|FG000|Overall Study|Lost to Follow-up|1|||
30611936|NCT02393859|58623002|FG001|Overall Study|Lost to Follow-up|1|||
30611937|NCT02197234|58623009|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
30843500|NCT02178098|58869604|FG001|Overall Study|Protocol Violation|1|||
30611938|NCT02197234|58623009|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1|||
30611939|NCT02197234|58623009|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
30611940|NCT02197234|58623009|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
30611941|NCT02197234|58623009|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
30611942|NCT02197234|58623009|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
30611943|NCT02197234|58623009|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
30611944|NCT02096588|58623018|FG000|Overall Study|Lack of Efficacy|2|||
30611945|NCT02096588|58623019|FG001|Overall Study|Lack of Efficacy|0|||
30611946|NCT02096588|58623018|FG000|Overall Study|Withdrawal by Subject|0|||
30611947|NCT02096588|58623019|FG001|Overall Study|Withdrawal by Subject|1|||
30611948|NCT01359592|58623025|FG000|Initial Registration|Adverse Event|1|||
30611949|NCT01359592|58623026|FG001|Initial Registration|Adverse Event|0|||
30611950|NCT01359592|58623027|FG002|Initial Registration|Adverse Event|0|||
30611951|NCT01359592|58623028|FG003|Initial Registration|Adverse Event|0|||
30892871|NCT01628913|58926295|FG001|Overall Study|Withdrawal by Subject|0|||
30611952|NCT01359592|58623025|FG000|Initial Registration|Death|1|||
30611953|NCT01359592|58623026|FG001|Initial Registration|Death|0|||
30611954|NCT01359592|58623027|FG002|Initial Registration|Death|0|||
30611955|NCT01359592|58623028|FG003|Initial Registration|Death|0|||
30611956|NCT01359592|58623025|FG000|Initial Registration|Other reason not protocol specified|1|||
30611957|NCT01359592|58623026|FG001|Initial Registration|Other reason not protocol specified|0|||
30611958|NCT01359592|58623027|FG002|Initial Registration|Other reason not protocol specified|0|||
30611959|NCT01359592|58623028|FG003|Initial Registration|Other reason not protocol specified|0|||
30611960|NCT01359592|58623025|FG000|Initial Registration|Ineligible|26|||
30611961|NCT01359592|58623026|FG001|Initial Registration|Ineligible|0|||
30611962|NCT01359592|58623027|FG002|Initial Registration|Ineligible|0|||
30611963|NCT01359592|58623028|FG003|Initial Registration|Ineligible|0|||
30611964|NCT01359592|58623025|FG000|PET-Directed Therapy|Adverse Event|0|||
30611965|NCT01359592|58623026|FG001|PET-Directed Therapy|Adverse Event|0|||
30611966|NCT01359592|58623027|FG002|PET-Directed Therapy|Adverse Event|1|||
30611967|NCT01359592|58623028|FG003|PET-Directed Therapy|Adverse Event|0|||
30611968|NCT01359592|58623025|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
30611969|NCT01359592|58623026|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
30611970|NCT01359592|58623027|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
30611971|NCT01359592|58623028|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
30611972|NCT01359592|58623025|FG000|PET-Directed Therapy|Ineligible|0|||
30892872|NCT01628913|58926294|FG000|Overall Study|Physician Decision|1|||
30892873|NCT01628913|58926295|FG001|Overall Study|Physician Decision|3|||
30892874|NCT02164383|58926303|FG000|Overall Study|Lost to Follow-up|1|||
30892875|NCT02164383|58926304|FG001|Overall Study|Lost to Follow-up|0|||
30892876|NCT02131233|58926312|FG000|Overall Study|Not Treated|2|||
30611973|NCT01359592|58623026|FG001|PET-Directed Therapy|Ineligible|0|||
30611974|NCT01359592|58623027|FG002|PET-Directed Therapy|Ineligible|24|||
30892877|NCT02131233|58926313|FG001|Overall Study|Not Treated|3|||
30892878|NCT02131233|58926312|FG000|Overall Study|Adverse Event|7|||
30892879|NCT02131233|58926313|FG001|Overall Study|Adverse Event|6|||
30892880|NCT02131233|58926312|FG000|Overall Study|Death|0|||
30611975|NCT01359592|58623028|FG003|PET-Directed Therapy|Ineligible|0|||
30611976|NCT00699816|58623045|FG000|Overall Study|Protocol Violation|1|||
30611977|NCT00699816|58623046|FG001|Overall Study|Protocol Violation|3|||
30611978|NCT00697073|58623052|FG000|Overall Study|Withdrawal by Subject|2|||
30611979|NCT00697073|58623052|FG000|Overall Study|Pregnancy|1|||
30611980|NCT00697073|58623052|FG000|Overall Study|non compliance and other|6|||
30611981|NCT00653432|58623058|FG000|Overall Study|Adverse Event|4|||
30611982|NCT00653432|58623059|FG001|Overall Study|Adverse Event|1|||
30892881|NCT02131233|58926313|FG001|Overall Study|Death|1|||
30892882|NCT02131233|58926312|FG000|Overall Study|Lack of Efficacy|6|||
30892883|NCT02131233|58926313|FG001|Overall Study|Lack of Efficacy|3|||
30892884|NCT02131233|58926312|FG000|Overall Study|Lost to Follow-up|14|||
30892885|NCT02131233|58926313|FG001|Overall Study|Lost to Follow-up|13|||
30611983|NCT00653432|58623058|FG000|Overall Study|Withdrawal by Subject|4|||
30611984|NCT00653432|58623059|FG001|Overall Study|Withdrawal by Subject|5|||
30611985|NCT00653432|58623058|FG000|Overall Study|Lost to Follow-up|7|||
30611986|NCT00653432|58623059|FG001|Overall Study|Lost to Follow-up|6|||
30611987|NCT00653432|58623058|FG000|Overall Study|Use/Need of Con Therapy|2|||
30892886|NCT02131233|58926312|FG000|Overall Study|Non-Compliance With Study Drug|8|||
30611988|NCT00653432|58623059|FG001|Overall Study|Use/Need of Con Therapy|1|||
30611989|NCT00653432|58623058|FG000|Overall Study|Other - Reason Not Provided|5|||
30611990|NCT00653432|58623059|FG001|Overall Study|Other - Reason Not Provided|3|||
30611991|NCT00446043|58623078|FG000|Overall Study|Adverse Event|9|||
30611992|NCT00446043|58623078|FG000|Overall Study|Withdrawal by Subject|70|||
30611993|NCT00446043|58623078|FG000|Overall Study|Protocol Violation|2|||
30698645|NCT03684928|58713120|FG001|Second Intervention|Soft Tissue Injury|0|||
30698646|NCT00777803|58713128|FG000|Overall Study|Lost to Follow-up|12|||
30892887|NCT02131233|58926313|FG001|Overall Study|Non-Compliance With Study Drug|5|||
30892888|NCT02131233|58926312|FG000|Overall Study|Physician Decision|7|||
30892889|NCT02131233|58926313|FG001|Overall Study|Physician Decision|0|||
30892890|NCT02131233|58926312|FG000|Overall Study|Pregnancy|4|||
30892891|NCT02131233|58926313|FG001|Overall Study|Pregnancy|0|||
30892892|NCT02131233|58926312|FG000|Overall Study|Withdrawal by Subject|18|||
30892893|NCT02131233|58926313|FG001|Overall Study|Withdrawal by Subject|11|||
30892894|NCT02131155|58926321|FG000|Overall Study|Adverse Event|1|||
30892895|NCT02131155|58926322|FG001|Overall Study|Adverse Event|0|||
30892896|NCT02131155|58926321|FG000|Overall Study|Treatment completed|1|||
30698647|NCT00777803|58713129|FG001|Overall Study|Lost to Follow-up|5|||
30698648|NCT00777803|58713128|FG000|Overall Study|Adverse Event|1|||
30698649|NCT00777803|58713129|FG001|Overall Study|Adverse Event|0|||
30698650|NCT00777803|58713128|FG000|Overall Study|Non-compliance|2|||
30698651|NCT00777803|58713129|FG001|Overall Study|Non-compliance|2|||
30698652|NCT00527488|58713139|FG000|Overall Study|Withdrawn prior to dosing|0|||
30698653|NCT00527488|58713140|FG001|Overall Study|Withdrawn prior to dosing|1|||
30698654|NCT00527488|58713141|FG002|Overall Study|Withdrawn prior to dosing|1|||
30698655|NCT00527488|58713142|FG003|Overall Study|Withdrawn prior to dosing|0|||
30698656|NCT00527332|58713154|FG000|Overall Study|Protocol Violation|4|||
30698657|NCT00527332|58713155|FG001|Overall Study|Protocol Violation|8|||
30698658|NCT00527332|58713154|FG000|Overall Study|Withdrew consent|5|||
30698659|NCT00527332|58713155|FG001|Overall Study|Withdrew consent|1|||
30698660|NCT00752609|58713163|FG000|Overall Study|Adverse Event|2|||
30698661|NCT00752609|58713164|FG001|Overall Study|Adverse Event|2|||
30698662|NCT00752609|58713163|FG000|Overall Study|Withdrawal by Subject|3|||
30698663|NCT00752609|58713164|FG001|Overall Study|Withdrawal by Subject|0|||
30698664|NCT00752609|58713163|FG000|Overall Study|Physician Decision|1|||
30698665|NCT00752609|58713164|FG001|Overall Study|Physician Decision|0|||
30698666|NCT00752609|58713163|FG000|Overall Study|Death|1|||
30698667|NCT00752609|58713164|FG001|Overall Study|Death|0|||
30698668|NCT00752609|58713163|FG000|Overall Study|Met exclusion criteria|1|||
30698669|NCT00752609|58713164|FG001|Overall Study|Met exclusion criteria|0|||
30698670|NCT00752609|58713163|FG000|Overall Study|Received Aranesp in error|1|||
30698671|NCT00752609|58713164|FG001|Overall Study|Received Aranesp in error|0|||
30698672|NCT03684304|58713175|FG000|Overall Study|Lost to Follow-up|19|||
30698673|NCT03684304|58713176|FG001|Overall Study|Lost to Follow-up|17|||
30698674|NCT00629772|58713184|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
30892897|NCT02131155|58926322|FG001|Overall Study|Treatment completed|0|||
30892898|NCT02131155|58926321|FG000|Overall Study|Primary tumour recurrence|2|||
30892899|NCT02131155|58926322|FG001|Overall Study|Primary tumour recurrence|1|||
30892900|NCT02131155|58926321|FG000|Overall Study|Refused to continue study medication|1|||
30892901|NCT02131155|58926322|FG001|Overall Study|Refused to continue study medication|0|||
30892902|NCT02131155|58926321|FG000|Overall Study|Study early termination|20|||
30892903|NCT02131155|58926322|FG001|Overall Study|Study early termination|10|||
30892904|NCT01933594|58926334|FG000|Overall Study|Lost to Follow-up|1|||
30892905|NCT01933594|58926335|FG001|Overall Study|Lost to Follow-up|0|||
30892906|NCT01933594|58926336|FG002|Overall Study|Lost to Follow-up|0|||
30892907|NCT01933594|58926337|FG003|Overall Study|Lost to Follow-up|0|||
30892908|NCT01933594|58926338|FG004|Overall Study|Lost to Follow-up|1|||
30892909|NCT01933594|58926339|FG005|Overall Study|Lost to Follow-up|0|||
30892910|NCT01933594|58926334|FG000|Overall Study|Ineligible for subsequent study step|0|||
30892911|NCT01933594|58926335|FG001|Overall Study|Ineligible for subsequent study step|0|||
30892912|NCT01933594|58926336|FG002|Overall Study|Ineligible for subsequent study step|0|||
30892913|NCT01933594|58926337|FG003|Overall Study|Ineligible for subsequent study step|0|||
31006951|NCT01553136|59208540|FG001|Overall Study|Physician Decision|3|||
30611994|NCT00446043|58623078|FG000|Overall Study|Lost to Follow-up|42|||
30611995|NCT00446043|58623078|FG000|Overall Study|Pregnancy|2|||
30611996|NCT00400725|58623085|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
30611997|NCT00400725|58623086|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
30611998|NCT00400725|58623087|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
30611999|NCT00400725|58623085|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
30612000|NCT00400725|58623086|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
30612001|NCT00400725|58623087|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
30612002|NCT00400725|58623085|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
30612003|NCT00400725|58623086|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
30698675|NCT00629772|58713185|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
30843501|NCT02178098|58869603|FG000|Overall Study|Lost to Follow-up|0|||
30843502|NCT02178098|58869604|FG001|Overall Study|Lost to Follow-up|1|||
30843503|NCT02178098|58869603|FG000|Overall Study|Sponsor Request|1|||
30843504|NCT02178098|58869604|FG001|Overall Study|Sponsor Request|0|||
30843505|NCT02178098|58869603|FG000|Overall Study|Other|2|||
30843506|NCT02178098|58869604|FG001|Overall Study|Other|2|||
30843507|NCT02101853|58869612|FG000|Block 1 Induction|Adverse Event|11|||
30843508|NCT02101853|58869613|FG001|Block 1 Induction|Adverse Event|0|||
30843509|NCT02101853|58869614|FG002|Block 1 Induction|Adverse Event|0|||
30843510|NCT02101853|58869615|FG003|Block 1 Induction|Adverse Event|0|||
30843511|NCT02101853|58869616|FG004|Block 1 Induction|Adverse Event|0|||
30843512|NCT02101853|58869617|FG005|Block 1 Induction|Adverse Event|0|||
30892914|NCT01933594|58926338|FG004|Overall Study|Ineligible for subsequent study step|1|||
30892915|NCT01933594|58926339|FG005|Overall Study|Ineligible for subsequent study step|0|||
30892916|NCT01932970|58926357|FG000|Overall Study|Withdrawal by Subject|5|||
30892917|NCT01932970|58926357|FG000|Overall Study|Death|1|||
30892918|NCT01932970|58926357|FG000|Overall Study|Lost to Follow-up|2|||
30892919|NCT01932970|58926357|FG000|Overall Study|Protocol Specified Criteria|10|||
30892920|NCT01912768|58926363|FG000|Overall Study|Adverse Event|2|||
30892921|NCT01912768|58926364|FG001|Overall Study|Adverse Event|0|||
30892922|NCT01912768|58926363|FG000|Overall Study|Lost to Follow-up|2|||
30892923|NCT01912768|58926364|FG001|Overall Study|Lost to Follow-up|1|||
30892924|NCT01912768|58926363|FG000|Overall Study|Withdrawal by Subject|5|||
30892925|NCT01912768|58926364|FG001|Overall Study|Withdrawal by Subject|3|||
30892926|NCT01912768|58926363|FG000|Overall Study|Randomized in error|1|||
30892927|NCT01912768|58926364|FG001|Overall Study|Randomized in error|0|||
30892928|NCT02305849|58926374|FG000|Overall Study|Adverse Event|10|||
30892929|NCT02305849|58926375|FG001|Overall Study|Adverse Event|12|||
30892930|NCT02305849|58926376|FG002|Overall Study|Adverse Event|7|||
30892931|NCT02305849|58926377|FG003|Overall Study|Adverse Event|3|||
30892932|NCT02305849|58926374|FG000|Overall Study|Lack of Efficacy|10|||
30892933|NCT02305849|58926375|FG001|Overall Study|Lack of Efficacy|6|||
30892934|NCT02305849|58926376|FG002|Overall Study|Lack of Efficacy|3|||
30892935|NCT02305849|58926377|FG003|Overall Study|Lack of Efficacy|9|||
30892936|NCT02305849|58926374|FG000|Overall Study|Withdrawal by Subject|2|||
30892937|NCT02305849|58926375|FG001|Overall Study|Withdrawal by Subject|2|||
30892938|NCT02305849|58926376|FG002|Overall Study|Withdrawal by Subject|1|||
30892939|NCT02305849|58926377|FG003|Overall Study|Withdrawal by Subject|4|||
30892940|NCT02305849|58926374|FG000|Overall Study|Lost to Follow-up|0|||
30892941|NCT02305849|58926375|FG001|Overall Study|Lost to Follow-up|2|||
30892942|NCT02305849|58926376|FG002|Overall Study|Lost to Follow-up|0|||
30892943|NCT02305849|58926377|FG003|Overall Study|Lost to Follow-up|0|||
30892944|NCT02305849|58926374|FG000|Overall Study|Protocol Violation|3|||
30892945|NCT02305849|58926375|FG001|Overall Study|Protocol Violation|2|||
30892946|NCT02305849|58926376|FG002|Overall Study|Protocol Violation|1|||
30892947|NCT02305849|58926377|FG003|Overall Study|Protocol Violation|1|||
30612004|NCT00400725|58623087|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
30612005|NCT00400725|58623085|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
30698676|NCT00629772|58713184|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
30698677|NCT00629772|58713185|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
30790748|NCT03524092|58803941|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
30892948|NCT02305849|58926374|FG000|Overall Study|Lab data met discontinuation criteria|0|||
30892949|NCT02305849|58926375|FG001|Overall Study|Lab data met discontinuation criteria|1|||
30892950|NCT02305849|58926376|FG002|Overall Study|Lab data met discontinuation criteria|2|||
30612006|NCT00400725|58623086|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
30612007|NCT00400725|58623087|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
30612008|NCT00400725|58623085|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
30612009|NCT00400725|58623086|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
30612010|NCT00400725|58623087|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
30612011|NCT00400725|58623085|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
30612012|NCT00400725|58623086|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
30612013|NCT00400725|58623087|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
30612014|NCT00400725|58623085|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
30612015|NCT00400725|58623086|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
30612016|NCT00400725|58623087|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
30612017|NCT00400725|58623085|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
30612018|NCT00400725|58623086|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
30612019|NCT00400725|58623087|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
30612020|NCT00400725|58623085|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
30612021|NCT00400725|58623086|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
30612022|NCT00400725|58623087|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
30612023|NCT00099437|58623103|FG000|Overall Study|Lost to Follow-up|30|||
30612024|NCT00099437|58623104|FG001|Overall Study|Lost to Follow-up|33|||
30612025|NCT00099437|58623103|FG000|Overall Study|Death|293|||
30612026|NCT00099437|58623104|FG001|Overall Study|Death|261|||
30892951|NCT02305849|58926377|FG003|Overall Study|Lab data met discontinuation criteria|1|||
30612027|NCT00099437|58623103|FG000|Overall Study|Withdrawal by Subject|6|||
30612028|NCT00099437|58623104|FG001|Overall Study|Withdrawal by Subject|10|||
30698678|NCT00526630|58713192|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
30698679|NCT00526630|58713193|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
30698680|NCT00526630|58713192|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
30790749|NCT03524092|58803942|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
30892952|NCT02305849|58926374|FG000|Overall Study|Miscellaneous|1|||
30892953|NCT02305849|58926375|FG001|Overall Study|Miscellaneous|2|||
30892954|NCT02305849|58926376|FG002|Overall Study|Miscellaneous|4|||
30892955|NCT02305849|58926377|FG003|Overall Study|Miscellaneous|1|||
31006952|NCT01553136|59208539|FG000|Overall Study|Scheduling Difficulties|5|||
31006953|NCT01553136|59208540|FG001|Overall Study|Scheduling Difficulties|4|||
31006954|NCT01552902|59208549|FG000|Overall Study|Adverse Event|1|||
31006955|NCT01552902|59208550|FG001|Overall Study|Adverse Event|15|||
31006956|NCT01552902|59208551|FG002|Overall Study|Adverse Event|14|||
31006957|NCT01552902|59208549|FG000|Overall Study|Protocol Violation|3|||
31006958|NCT01552902|59208550|FG001|Overall Study|Protocol Violation|3|||
31006959|NCT01552902|59208551|FG002|Overall Study|Protocol Violation|3|||
31006960|NCT01552902|59208549|FG000|Overall Study|Lack of Efficacy|4|||
31006961|NCT01552902|59208550|FG001|Overall Study|Lack of Efficacy|3|||
31006962|NCT01552902|59208551|FG002|Overall Study|Lack of Efficacy|1|||
31006963|NCT01552902|59208549|FG000|Overall Study|Withdrawal by Subject|1|||
31006964|NCT01552902|59208550|FG001|Overall Study|Withdrawal by Subject|9|||
31006965|NCT01552902|59208551|FG002|Overall Study|Withdrawal by Subject|6|||
31006966|NCT01552902|59208549|FG000|Overall Study|Lost to Follow-up|1|||
31006967|NCT01552902|59208550|FG001|Overall Study|Lost to Follow-up|3|||
31006968|NCT01552902|59208551|FG002|Overall Study|Lost to Follow-up|6|||
31006969|NCT01552902|59208549|FG000|Overall Study|Other|3|||
31006970|NCT01552902|59208550|FG001|Overall Study|Other|4|||
31006971|NCT01552902|59208551|FG002|Overall Study|Other|3|||
31006972|NCT01529346|59208577|FG000|Overall Study|Lost to Follow-up|2|||
31006973|NCT01529346|59208578|FG001|Overall Study|Lost to Follow-up|0|||
31006974|NCT01529346|59208579|FG002|Overall Study|Lost to Follow-up|1|||
31006975|NCT01529346|59208580|FG003|Overall Study|Lost to Follow-up|0|||
31006976|NCT01529346|59208581|FG004|Overall Study|Lost to Follow-up|0|||
31006977|NCT01529346|59208577|FG000|Overall Study|Other|0|||
31006978|NCT01529346|59208578|FG001|Overall Study|Other|1|||
31006979|NCT01529346|59208579|FG002|Overall Study|Other|1|||
31006980|NCT01529346|59208580|FG003|Overall Study|Other|0|||
31006981|NCT01529346|59208581|FG004|Overall Study|Other|0|||
31006982|NCT01529268|59208605|FG000|Overall Study|Lost to Follow-up|9|||
31006983|NCT01529268|59208606|FG001|Overall Study|Lost to Follow-up|3|||
31006984|NCT01529268|59208605|FG000|Overall Study|Moved|3|||
31006985|NCT01529268|59208606|FG001|Overall Study|Moved|0|||
31006986|NCT01529112|59208614|FG000|Overall Study|Adverse Event|2|||
31006987|NCT01529112|59208615|FG001|Overall Study|Adverse Event|0|||
31006988|NCT01529112|59208614|FG000|Overall Study|Death|59|||
31006989|NCT01529112|59208615|FG001|Overall Study|Death|38|||
31006990|NCT01529112|59208614|FG000|Overall Study|Protocol Violation|1|||
31006991|NCT01529112|59208615|FG001|Overall Study|Protocol Violation|0|||
31006992|NCT01529112|59208614|FG000|Overall Study|Withdrawal by Subject|7|||
31006993|NCT01529112|59208615|FG001|Overall Study|Withdrawal by Subject|3|||
31006994|NCT01551420|59208623|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
31006995|NCT01551420|59208624|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
31006996|NCT01551420|59208623|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
31006997|NCT01551420|59208624|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
31006998|NCT01551420|59208623|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
31006999|NCT01551420|59208624|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
31007000|NCT01551420|59208623|FG000|Screened for Part B Eligibility|Declined participation|8|||
31007001|NCT01551420|59208624|FG001|Screened for Part B Eligibility|Declined participation|1|||
31007002|NCT01551420|59208623|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
31007003|NCT01551420|59208624|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
31007004|NCT01551420|59208623|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
31007005|NCT01551420|59208624|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
31007006|NCT01551420|59208623|FG000|Home Use (Part B)|Withdrawal by staff|0|||
31007007|NCT01551420|59208624|FG001|Home Use (Part B)|Withdrawal by staff|1|||
31007008|NCT01575054|59208632|FG000|Overall Study|Other Reasons|5|||
31007009|NCT01575054|59208633|FG001|Overall Study|Other Reasons|3|||
31007010|NCT01575054|59208632|FG000|Overall Study|Protocol Violation|2|||
31007011|NCT01575054|59208633|FG001|Overall Study|Protocol Violation|1|||
31007012|NCT01575054|59208632|FG000|Overall Study|Personal Reasons|10|||
31007013|NCT01575054|59208633|FG001|Overall Study|Personal Reasons|11|||
31007014|NCT01575054|59208632|FG000|Overall Study|Lost to Follow-up|3|||
31007015|NCT01575054|59208633|FG001|Overall Study|Lost to Follow-up|3|||
31007016|NCT01575054|59208632|FG000|Overall Study|Adverse Event|9|||
31007017|NCT01575054|59208633|FG001|Overall Study|Adverse Event|8|||
31007018|NCT01528254|59208641|FG000|Overall Study|Administrative problems|96|||
31007019|NCT01528254|59208642|FG001|Overall Study|Administrative problems|94|||
30843513|NCT02101853|58869612|FG000|Block 1 Induction|Death|20|||
31007020|NCT01528254|59208641|FG000|Overall Study|Adverse Event|28|||
31007021|NCT01528254|59208642|FG001|Overall Study|Adverse Event|44|||
31007022|NCT01528254|59208641|FG000|Overall Study|Lost to Follow-up|17|||
31007023|NCT01528254|59208642|FG001|Overall Study|Lost to Follow-up|24|||
31007024|NCT01528254|59208641|FG000|Overall Study|Death|13|||
31007025|NCT01528254|59208642|FG001|Overall Study|Death|9|||
31007026|NCT01528254|59208641|FG000|Overall Study|Protocol deviation|9|||
31007027|NCT01528254|59208642|FG001|Overall Study|Protocol deviation|19|||
31007028|NCT01528254|59208641|FG000|Overall Study|New therapy for study indication|8|||
31007029|NCT01528254|59208642|FG001|Overall Study|New therapy for study indication|6|||
30612029|NCT00099437|58623103|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
30612030|NCT00099437|58623104|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
30612031|NCT00932113|58623112|FG000|Overall Study|Lost to Follow-up|1|||
30612032|NCT00932113|58623113|FG001|Overall Study|Lost to Follow-up|0|||
30612033|NCT00931801|58623122|FG000|Overall Study|Adverse Event|0|||
30612034|NCT00931801|58623123|FG001|Overall Study|Adverse Event|0|||
30612035|NCT00931801|58623124|FG002|Overall Study|Adverse Event|1|||
30612036|NCT00931801|58623122|FG000|Overall Study|Lost to Follow-up|0|||
30612037|NCT00931801|58623123|FG001|Overall Study|Lost to Follow-up|1|||
30612038|NCT00931801|58623124|FG002|Overall Study|Lost to Follow-up|0|||
30612039|NCT00931801|58623122|FG000|Overall Study|Withdrawal by Subject|1|||
30612040|NCT00931801|58623123|FG001|Overall Study|Withdrawal by Subject|0|||
30612041|NCT00931801|58623124|FG002|Overall Study|Withdrawal by Subject|0|||
30612042|NCT00931801|58623122|FG000|Overall Study|Confirmed Virologic Failure|0|||
30612043|NCT00931801|58623123|FG001|Overall Study|Confirmed Virologic Failure|0|||
30612044|NCT00931801|58623124|FG002|Overall Study|Confirmed Virologic Failure|3|||
30612045|NCT00931723|58623138|FG000|Overall Study|Withdrawal by Subject|11|||
30612046|NCT00931723|58623139|FG001|Overall Study|Withdrawal by Subject|13|||
30612047|NCT00931723|58623138|FG000|Overall Study|Adverse Event|6|||
30612048|NCT00931723|58623139|FG001|Overall Study|Adverse Event|13|||
30612049|NCT00931723|58623138|FG000|Overall Study|Lithium found in blood|0|||
30612050|NCT00931723|58623139|FG001|Overall Study|Lithium found in blood|1|||
30612051|NCT00931723|58623138|FG000|Overall Study|Condition under investigation worsened|1|||
30612052|NCT00931723|58623139|FG001|Overall Study|Condition under investigation worsened|2|||
30612053|NCT00931723|58623138|FG000|Overall Study|Lost to Follow-up|1|||
30612054|NCT00931723|58623139|FG001|Overall Study|Lost to Follow-up|2|||
30843514|NCT02101853|58869613|FG001|Block 1 Induction|Death|0|||
30892956|NCT02305849|58926374|FG000|Overall Study|Not fulfill eligibility criteria|1|||
30892957|NCT02305849|58926375|FG001|Overall Study|Not fulfill eligibility criteria|1|||
30892958|NCT02305849|58926376|FG002|Overall Study|Not fulfill eligibility criteria|0|||
30892959|NCT02305849|58926377|FG003|Overall Study|Not fulfill eligibility criteria|0|||
30892960|NCT02371759|58926416|FG000|Overall Study|Protocol Violation|3|||
30892961|NCT02371759|58926417|FG001|Overall Study|Protocol Violation|1|||
30892962|NCT02371759|58926418|FG002|Overall Study|Protocol Violation|1|||
30892963|NCT02371759|58926419|FG003|Overall Study|Protocol Violation|0|||
30892964|NCT02371759|58926420|FG004|Overall Study|Protocol Violation|3|||
30892965|NCT02371759|58926421|FG005|Overall Study|Protocol Violation|1|||
30612055|NCT00931723|58623138|FG000|Overall Study|Study-specific discontinuation criteria|1|||
30612056|NCT00931723|58623139|FG001|Overall Study|Study-specific discontinuation criteria|1|||
30612057|NCT00931723|58623138|FG000|Overall Study|Severe non-compliance to protocol|2|||
30612058|NCT00931723|58623139|FG001|Overall Study|Severe non-compliance to protocol|0|||
30612059|NCT00931723|58623138|FG000|Overall Study|Safety reasons|0|||
30612060|NCT00931723|58623139|FG001|Overall Study|Safety reasons|1|||
30843515|NCT02101853|58869614|FG002|Block 1 Induction|Death|0|||
30843516|NCT02101853|58869615|FG003|Block 1 Induction|Death|0|||
30843517|NCT02101853|58869616|FG004|Block 1 Induction|Death|0|||
30843518|NCT02101853|58869617|FG005|Block 1 Induction|Death|0|||
30843519|NCT02101853|58869612|FG000|Block 1 Induction|Lack of Efficacy|6|||
30843520|NCT02101853|58869613|FG001|Block 1 Induction|Lack of Efficacy|0|||
30843521|NCT02101853|58869614|FG002|Block 1 Induction|Lack of Efficacy|0|||
30843522|NCT02101853|58869615|FG003|Block 1 Induction|Lack of Efficacy|0|||
30843523|NCT02101853|58869616|FG004|Block 1 Induction|Lack of Efficacy|0|||
30843524|NCT02101853|58869617|FG005|Block 1 Induction|Lack of Efficacy|0|||
30843525|NCT02101853|58869612|FG000|Block 1 Induction|Physician Decision|61|||
30843526|NCT02101853|58869613|FG001|Block 1 Induction|Physician Decision|0|||
30843527|NCT02101853|58869614|FG002|Block 1 Induction|Physician Decision|0|||
30843528|NCT02101853|58869615|FG003|Block 1 Induction|Physician Decision|0|||
30843529|NCT02101853|58869616|FG004|Block 1 Induction|Physician Decision|0|||
30843530|NCT02101853|58869617|FG005|Block 1 Induction|Physician Decision|0|||
30843531|NCT02101853|58869612|FG000|Block 1 Induction|Protocol Violation|2|||
30843532|NCT02101853|58869613|FG001|Block 1 Induction|Protocol Violation|0|||
30843533|NCT02101853|58869614|FG002|Block 1 Induction|Protocol Violation|0|||
30843534|NCT02101853|58869615|FG003|Block 1 Induction|Protocol Violation|0|||
30843535|NCT02101853|58869616|FG004|Block 1 Induction|Protocol Violation|0|||
30843536|NCT02101853|58869617|FG005|Block 1 Induction|Protocol Violation|0|||
30843537|NCT02101853|58869612|FG000|Block 1 Induction|Withdrawal by Subject|65|||
30843538|NCT02101853|58869613|FG001|Block 1 Induction|Withdrawal by Subject|0|||
30843539|NCT02101853|58869614|FG002|Block 1 Induction|Withdrawal by Subject|0|||
30843540|NCT02101853|58869615|FG003|Block 1 Induction|Withdrawal by Subject|0|||
30843541|NCT02101853|58869616|FG004|Block 1 Induction|Withdrawal by Subject|0|||
30843542|NCT02101853|58869617|FG005|Block 1 Induction|Withdrawal by Subject|0|||
30843543|NCT02101853|58869612|FG000|Block 1 Induction|Ineligible|8|||
30843544|NCT02101853|58869613|FG001|Block 1 Induction|Ineligible|0|||
30843545|NCT02101853|58869614|FG002|Block 1 Induction|Ineligible|0|||
30843546|NCT02101853|58869615|FG003|Block 1 Induction|Ineligible|0|||
30612061|NCT00931723|58623138|FG000|Overall Study|Took prohibited concomitant medication|0|||
30612062|NCT00931723|58623139|FG001|Overall Study|Took prohibited concomitant medication|1|||
30612063|NCT00931723|58623138|FG000|Overall Study|Lack or insufficient theraputic response|2|||
30612064|NCT00931723|58623139|FG001|Overall Study|Lack or insufficient theraputic response|5|||
30612065|NCT00931723|58623138|FG000|Overall Study|Sponsor decision|1|||
30612066|NCT00931723|58623139|FG001|Overall Study|Sponsor decision|0|||
30612067|NCT00931723|58623138|FG000|Overall Study|Late hospital discharge|1|||
30612068|NCT00931723|58623139|FG001|Overall Study|Late hospital discharge|0|||
30612069|NCT00931411|58623147|FG000|First Intervention - 42 Days|Adverse Event|2|||
30612070|NCT00931411|58623148|FG001|First Intervention - 42 Days|Adverse Event|3|||
30612071|NCT00931411|58623147|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
30612072|NCT00931411|58623148|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
30612073|NCT00931411|58623147|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
30612074|NCT00931411|58623148|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
30612075|NCT00931255|58623160|FG000|Overall Study|Follow up biopsy not done|2|||
30612076|NCT00931255|58623161|FG001|Overall Study|Follow up biopsy not done|3|||
30612077|NCT00930553|58623167|FG000|Overall Study|Adverse Event|1|||
30612078|NCT00930553|58623167|FG000|Overall Study|Lack of Efficacy|7|||
30612079|NCT00930553|58623167|FG000|Overall Study|Physician Decision|39|||
30612080|NCT00930553|58623167|FG000|Overall Study|Protocol Violation|1|||
30612081|NCT00930553|58623167|FG000|Overall Study|Pregnancy|1|||
30612082|NCT00930553|58623167|FG000|Overall Study|Withdrawal by Subject|88|||
30612083|NCT00930553|58623167|FG000|Overall Study|Lost to Follow-up|25|||
30612084|NCT00930553|58623167|FG000|Overall Study|Death|9|||
30612085|NCT00930553|58623167|FG000|Overall Study|Study terminated by sponsor|24|||
30612086|NCT00930553|58623167|FG000|Overall Study|Other than specified above|28|||
30612087|NCT00929695|58623191|FG000|Overall Study|Death|2|||
30612088|NCT00929695|58623192|FG001|Overall Study|Death|1|||
30612089|NCT00929695|58623191|FG000|Overall Study|Withdrawal by Subject|0|||
30612090|NCT00929695|58623192|FG001|Overall Study|Withdrawal by Subject|2|||
30612091|NCT00929695|58623191|FG000|Overall Study|discharge home|4|||
30612092|NCT00929695|58623192|FG001|Overall Study|discharge home|3|||
30612093|NCT00929695|58623191|FG000|Overall Study|incorrect stratification|2|||
30612094|NCT00929695|58623192|FG001|Overall Study|incorrect stratification|0|||
30612095|NCT00927355|58623205|FG000|Overall Study|Adverse Event|1|||
30612096|NCT00927355|58623206|FG001|Overall Study|Adverse Event|1|||
30612097|NCT00923845|58623226|FG000|Induction Therapy|Poor performance status|0|||
30612098|NCT00923845|58623227|FG001|Induction Therapy|Poor performance status|2|||
30612099|NCT00922987|58623234|FG000|Overall Study|Insufficient clinical response|1|||
30612100|NCT00922987|58623234|FG000|Overall Study|Protocol Violation|2|||
30612101|NCT00922987|58623234|FG000|Overall Study|Adverse Event|1|||
30612102|NCT00928135|58623240|FG000|Overall Study|Withdrawal by Subject|1|||
30612103|NCT00928135|58623241|FG001|Overall Study|Withdrawal by Subject|0|||
30612104|NCT00928057|58623249|FG000|Overall Study|Adverse Event|1|||
30612105|NCT00928057|58623250|FG001|Overall Study|Adverse Event|2|||
30612106|NCT00928057|58623249|FG000|Overall Study|Withdrawal by Subject|1|||
30612107|NCT00928057|58623250|FG001|Overall Study|Withdrawal by Subject|0|||
30612108|NCT00928057|58623249|FG000|Overall Study|Lost to Follow-up|0|||
30612109|NCT00928057|58623250|FG001|Overall Study|Lost to Follow-up|1|||
30612110|NCT00928057|58623249|FG000|Overall Study|Protocol Violation|0|||
30612111|NCT00928057|58623250|FG001|Overall Study|Protocol Violation|1|||
30612112|NCT00927901|58623266|FG000|Treatment Period 1|Subject withdrew consent|0|||
30612113|NCT00927901|58623267|FG001|Treatment Period 1|Subject withdrew consent|0|||
30612114|NCT00927901|58623268|FG002|Treatment Period 1|Subject withdrew consent|1|||
30612115|NCT00927901|58623269|FG003|Treatment Period 1|Subject withdrew consent|0|||
30612116|NCT00927901|58623266|FG000|Treatment Period 4|Adverse Event|0|||
30612117|NCT00927901|58623267|FG001|Treatment Period 4|Adverse Event|0|||
30612118|NCT00927901|58623268|FG002|Treatment Period 4|Adverse Event|0|||
30612119|NCT00927901|58623269|FG003|Treatment Period 4|Adverse Event|1|||
30612120|NCT00927901|58623266|FG000|Treatment Period 4|Subject withdrew consent|0|||
30612121|NCT00927901|58623267|FG001|Treatment Period 4|Subject withdrew consent|0|||
31007030|NCT01528254|59208641|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
30612122|NCT00927901|58623268|FG002|Treatment Period 4|Subject withdrew consent|1|||
30612123|NCT00927901|58623269|FG003|Treatment Period 4|Subject withdrew consent|0|||
30612124|NCT01218204|58623284|FG000|Part B Washout|Adverse Event|0|||
30612125|NCT01218204|58623285|FG001|Part B Washout|Adverse Event|1|||
30612126|NCT01218204|58623286|FG002|Part B Washout|Adverse Event|0|||
30612127|NCT01218204|58623287|FG003|Part B Washout|Adverse Event|0|||
30612128|NCT01218204|58623284|FG000|Part B Washout|Lost to Follow-up|0|||
30612129|NCT01218204|58623285|FG001|Part B Washout|Lost to Follow-up|2|||
30843547|NCT02101853|58869616|FG004|Block 1 Induction|Ineligible|0|||
31007031|NCT01528254|59208642|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
30612130|NCT01218204|58623286|FG002|Part B Washout|Lost to Follow-up|0|||
30612131|NCT01218204|58623287|FG003|Part B Washout|Lost to Follow-up|0|||
30612132|NCT01218204|58623284|FG000|Part B Washout|Physician Decision|0|||
30612133|NCT01218204|58623285|FG001|Part B Washout|Physician Decision|14|||
30612134|NCT01218204|58623286|FG002|Part B Washout|Physician Decision|0|||
30612135|NCT01218204|58623287|FG003|Part B Washout|Physician Decision|0|||
30612136|NCT01218204|58623284|FG000|Part B Washout|Withdrawal by Subject|0|||
30612137|NCT01218204|58623285|FG001|Part B Washout|Withdrawal by Subject|14|||
30612138|NCT01218204|58623286|FG002|Part B Washout|Withdrawal by Subject|0|||
30612139|NCT01218204|58623287|FG003|Part B Washout|Withdrawal by Subject|0|||
30612140|NCT01218204|58623284|FG000|Part B Washout|Reached defined stopping criteria|0|||
30612141|NCT01218204|58623285|FG001|Part B Washout|Reached defined stopping criteria|2|||
30612142|NCT01218204|58623286|FG002|Part B Washout|Reached defined stopping criteria|0|||
30612143|NCT01218204|58623287|FG003|Part B Washout|Reached defined stopping criteria|0|||
30612144|NCT01218204|58623284|FG000|Part B Washout|Did not meet continuation criteria|0|||
30612145|NCT01218204|58623285|FG001|Part B Washout|Did not meet continuation criteria|112|||
30612146|NCT01218204|58623286|FG002|Part B Washout|Did not meet continuation criteria|0|||
30612147|NCT01218204|58623287|FG003|Part B Washout|Did not meet continuation criteria|0|||
30612148|NCT01218204|58623284|FG000|Part B Run-in|Adverse Event|0|||
30612149|NCT01218204|58623285|FG001|Part B Run-in|Adverse Event|0|||
30612150|NCT01218204|58623286|FG002|Part B Run-in|Adverse Event|1|||
30612151|NCT01218204|58623287|FG003|Part B Run-in|Adverse Event|0|||
30612152|NCT01218204|58623284|FG000|Part B Run-in|Protocol Violation|0|||
30612153|NCT01218204|58623285|FG001|Part B Run-in|Protocol Violation|0|||
30612154|NCT01218204|58623286|FG002|Part B Run-in|Protocol Violation|2|||
30612155|NCT01218204|58623287|FG003|Part B Run-in|Protocol Violation|0|||
30612156|NCT01218204|58623284|FG000|Part B Run-in|Withdrawal by Subject|0|||
30612157|NCT01218204|58623285|FG001|Part B Run-in|Withdrawal by Subject|0|||
31007032|NCT01528254|59208641|FG000|Overall Study|Withdrawal by Subject|5|||
31007033|NCT01528254|59208642|FG001|Overall Study|Withdrawal by Subject|4|||
31007034|NCT01528254|59208641|FG000|Overall Study|Abnormal laboratory value(s)|3|||
31007035|NCT01528254|59208642|FG001|Overall Study|Abnormal laboratory value(s)|7|||
31007036|NCT01528254|59208641|FG000|Overall Study|Abnormal test procedure result(s)|1|||
31007037|NCT01528254|59208642|FG001|Overall Study|Abnormal test procedure result(s)|0|||
31007038|NCT01528254|59208641|FG000|Overall Study|No longer requires study drug|1|||
31007039|NCT01528254|59208642|FG001|Overall Study|No longer requires study drug|1|||
31007040|NCT01574352|59208651|FG000|Overall Study|Withdrawal by Subject|6|||
31007041|NCT01574352|59208652|FG001|Overall Study|Withdrawal by Subject|13|||
31007042|NCT01574352|59208651|FG000|Overall Study|Injury in non-camp related sport|1|||
31007043|NCT01574352|59208652|FG001|Overall Study|Injury in non-camp related sport|0|||
31007044|NCT01527006|59208660|FG000|Core Study|Adverse Event|0|||
31007045|NCT01527006|59208661|FG001|Core Study|Adverse Event|2|||
31007046|NCT01527006|59208660|FG000|Core Study|Lost to Follow-up|0|||
31007047|NCT01527006|59208661|FG001|Core Study|Lost to Follow-up|1|||
31007048|NCT01527006|59208660|FG000|Core Study|Subject Choice|1|||
31007049|NCT01527006|59208661|FG001|Core Study|Subject Choice|0|||
31007050|NCT01527006|59208660|FG000|Core Study|Inadequate Therapeutic Effect|1|||
31007051|NCT01527006|59208661|FG001|Core Study|Inadequate Therapeutic Effect|0|||
31007052|NCT01527006|59208660|FG000|Core Study|Withdrawal by Subject|0|||
31007053|NCT01527006|59208661|FG001|Core Study|Withdrawal by Subject|1|||
31007054|NCT01527006|59208660|FG000|Core Study|Other|0|||
31007055|NCT01527006|59208661|FG001|Core Study|Other|2|||
31007056|NCT01527006|59208660|FG000|Extension Phase|Adverse Event|4|||
31007057|NCT01527006|59208661|FG001|Extension Phase|Adverse Event|2|||
31007058|NCT01527006|59208660|FG000|Extension Phase|Lost to Follow-up|0|||
31007059|NCT01527006|59208661|FG001|Extension Phase|Lost to Follow-up|1|||
31007060|NCT01527006|59208660|FG000|Extension Phase|Subject Choice|1|||
31007061|NCT01527006|59208661|FG001|Extension Phase|Subject Choice|1|||
31007062|NCT01527006|59208660|FG000|Extension Phase|Inadequate therapeutic effect|1|||
31007063|NCT01527006|59208661|FG001|Extension Phase|Inadequate therapeutic effect|1|||
31007064|NCT01527006|59208660|FG000|Extension Phase|Other|0|||
30612158|NCT01218204|58623286|FG002|Part B Run-in|Withdrawal by Subject|3|||
30612159|NCT01218204|58623287|FG003|Part B Run-in|Withdrawal by Subject|0|||
30612160|NCT01218204|58623284|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
30612161|NCT01218204|58623285|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
31007065|NCT01527006|59208661|FG001|Extension Phase|Other|3|||
31007066|NCT01526928|59208679|FG000|Overall Study|Progressive Disease|35|||
30612162|NCT01218204|58623286|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
30612163|NCT01218204|58623287|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
31007067|NCT01526928|59208680|FG001|Overall Study|Progressive Disease|17|||
31007068|NCT01526928|59208681|FG002|Overall Study|Progressive Disease|150|||
30612164|NCT01218204|58623284|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
30612165|NCT01218204|58623285|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
30612166|NCT01218204|58623286|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
30612167|NCT01218204|58623287|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
30612168|NCT00926575|58623336|FG000|Overall Study|Adverse Event|1|||
30612169|NCT00926575|58623337|FG001|Overall Study|Adverse Event|1|||
30612170|NCT00926575|58623336|FG000|Overall Study|Death|4|||
30612171|NCT00926575|58623337|FG001|Overall Study|Death|4|||
30612172|NCT00926575|58623336|FG000|Overall Study|Lost to Follow-up|1|||
30612173|NCT00926575|58623337|FG001|Overall Study|Lost to Follow-up|1|||
30612174|NCT00926575|58623336|FG000|Overall Study|Physician Decision|1|||
30612175|NCT00926575|58623337|FG001|Overall Study|Physician Decision|2|||
30612176|NCT00926575|58623336|FG000|Overall Study|Protocol Violation|1|||
30612177|NCT00926575|58623337|FG001|Overall Study|Protocol Violation|0|||
30612178|NCT00926575|58623336|FG000|Overall Study|Withdrawal by Subject|8|||
30612179|NCT00926575|58623337|FG001|Overall Study|Withdrawal by Subject|9|||
30612180|NCT01218126|58623347|FG000|Overall Study|Adverse Event|8|||
30612181|NCT01218126|58623348|FG001|Overall Study|Adverse Event|10|||
30612182|NCT01218126|58623349|FG002|Overall Study|Adverse Event|12|||
30612183|NCT01218126|58623350|FG003|Overall Study|Adverse Event|16|||
30612184|NCT01218126|58623347|FG000|Overall Study|Lack of Efficacy|7|||
30612185|NCT01218126|58623348|FG001|Overall Study|Lack of Efficacy|2|||
30612186|NCT01218126|58623349|FG002|Overall Study|Lack of Efficacy|2|||
30612187|NCT01218126|58623350|FG003|Overall Study|Lack of Efficacy|6|||
30612188|NCT01218126|58623347|FG000|Overall Study|Protocol Violation|5|||
30612189|NCT01218126|58623348|FG001|Overall Study|Protocol Violation|2|||
30612190|NCT01218126|58623349|FG002|Overall Study|Protocol Violation|2|||
30612191|NCT01218126|58623350|FG003|Overall Study|Protocol Violation|3|||
30612192|NCT01218126|58623347|FG000|Overall Study|Protocol-defined stopping criteria|1|||
30612193|NCT01218126|58623348|FG001|Overall Study|Protocol-defined stopping criteria|1|||
30612194|NCT01218126|58623349|FG002|Overall Study|Protocol-defined stopping criteria|0|||
30612195|NCT01218126|58623350|FG003|Overall Study|Protocol-defined stopping criteria|0|||
30612196|NCT01218126|58623347|FG000|Overall Study|Lost to Follow-up|0|||
30612197|NCT01218126|58623348|FG001|Overall Study|Lost to Follow-up|0|||
30612198|NCT01218126|58623349|FG002|Overall Study|Lost to Follow-up|0|||
30612199|NCT01218126|58623350|FG003|Overall Study|Lost to Follow-up|2|||
30612200|NCT01218126|58623347|FG000|Overall Study|Physician Decision|1|||
30790750|NCT03524092|58803943|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
30790751|NCT03524092|58803944|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
30790752|NCT03524092|58803945|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
30790753|NCT03524092|58803940|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
30790754|NCT03524092|58803941|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
30790755|NCT03524092|58803942|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
30790756|NCT03524092|58803943|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
30790757|NCT03524092|58803944|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
30790758|NCT03524092|58803945|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
30892966|NCT02371759|58926422|FG006|Overall Study|Protocol Violation|0|||
30612201|NCT01218126|58623348|FG001|Overall Study|Physician Decision|2|||
30612202|NCT01218126|58623349|FG002|Overall Study|Physician Decision|4|||
30612203|NCT01218126|58623350|FG003|Overall Study|Physician Decision|2|||
30698681|NCT00526630|58713193|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
30698682|NCT00755183|58713203|FG000|Overall Study|Adverse Event|5|||
30698683|NCT00755183|58713204|FG001|Overall Study|Adverse Event|2|||
30698684|NCT00755183|58713203|FG000|Overall Study|Protocol Violation|0|||
30698685|NCT00755183|58713204|FG001|Overall Study|Protocol Violation|1|||
30698686|NCT00755183|58713203|FG000|Overall Study|Withdrawal by Subject|0|||
30698687|NCT00755183|58713204|FG001|Overall Study|Withdrawal by Subject|2|||
30698688|NCT00755183|58713203|FG000|Overall Study|Administrative|2|||
30698689|NCT00755183|58713204|FG001|Overall Study|Administrative|1|||
30612204|NCT01218126|58623347|FG000|Overall Study|Withdrawal by Subject|2|||
30612205|NCT01218126|58623348|FG001|Overall Study|Withdrawal by Subject|5|||
30612206|NCT01218126|58623349|FG002|Overall Study|Withdrawal by Subject|4|||
30612207|NCT01218126|58623350|FG003|Overall Study|Withdrawal by Subject|6|||
30612208|NCT01217892|58623364|FG000|Overall Study|Adverse Event|1|||
30790759|NCT03524092|58803940|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
30790760|NCT03524092|58803941|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
30790761|NCT03524092|58803942|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
30790762|NCT03524092|58803943|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
30790763|NCT03524092|58803944|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
30790764|NCT03524092|58803945|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
30790765|NCT03524092|58803940|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
30790766|NCT03524092|58803941|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
30790767|NCT03524092|58803942|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
30790768|NCT03524092|58803943|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
30892967|NCT02371759|58926423|FG007|Overall Study|Protocol Violation|3|||
30892968|NCT02371759|58926416|FG000|Overall Study|Withdrawal by Subject|0|||
30892969|NCT02371759|58926417|FG001|Overall Study|Withdrawal by Subject|0|||
30698690|NCT00755105|58713215|FG000|Overall Study|Withdrawal by Subject|9|||
30698691|NCT00755105|58713216|FG001|Overall Study|Withdrawal by Subject|11|||
30698692|NCT00755105|58713217|FG002|Overall Study|Withdrawal by Subject|4|||
30698693|NCT00526162|58713225|FG000|Overall Study|Device not implanted|3|||
30698694|NCT03875482|58713235|FG000|Overall Study|Adverse Event|0|||
30698695|NCT03875482|58713236|FG001|Overall Study|Adverse Event|1|||
31007069|NCT01526928|59208682|FG003|Overall Study|Progressive Disease|182|||
31007070|NCT01526928|59208683|FG004|Overall Study|Progressive Disease|76|||
31007071|NCT01526928|59208684|FG005|Overall Study|Progressive Disease|4|||
31007072|NCT01526928|59208679|FG000|Overall Study|Adverse Event|2|||
31007073|NCT01526928|59208680|FG001|Overall Study|Adverse Event|1|||
31007074|NCT01526928|59208681|FG002|Overall Study|Adverse Event|29|||
31007075|NCT01526928|59208682|FG003|Overall Study|Adverse Event|40|||
31007076|NCT01526928|59208683|FG004|Overall Study|Adverse Event|13|||
31007077|NCT01526928|59208684|FG005|Overall Study|Adverse Event|2|||
31007078|NCT01526928|59208679|FG000|Overall Study|Death|0|||
31007079|NCT01526928|59208680|FG001|Overall Study|Death|0|||
31007080|NCT01526928|59208681|FG002|Overall Study|Death|3|||
31007081|NCT01526928|59208682|FG003|Overall Study|Death|0|||
31007082|NCT01526928|59208683|FG004|Overall Study|Death|0|||
31007083|NCT01526928|59208684|FG005|Overall Study|Death|0|||
31007084|NCT01526928|59208679|FG000|Overall Study|Withdrawal by Subject|1|||
31007085|NCT01526928|59208680|FG001|Overall Study|Withdrawal by Subject|0|||
31007086|NCT01526928|59208681|FG002|Overall Study|Withdrawal by Subject|13|||
31007087|NCT01526928|59208682|FG003|Overall Study|Withdrawal by Subject|11|||
31007088|NCT01526928|59208683|FG004|Overall Study|Withdrawal by Subject|3|||
31007089|NCT01526928|59208684|FG005|Overall Study|Withdrawal by Subject|0|||
31007090|NCT01526928|59208679|FG000|Overall Study|Physician Decision|0|||
30612209|NCT01217892|58623365|FG001|Overall Study|Adverse Event|1|||
30698696|NCT03875482|58713235|FG000|Overall Study|Withdrew consent|5|||
30698697|NCT03875482|58713236|FG001|Overall Study|Withdrew consent|6|||
30698698|NCT03875482|58713235|FG000|Overall Study|Lost to Follow-up|8|||
30698699|NCT03875482|58713236|FG001|Overall Study|Lost to Follow-up|2|||
30892970|NCT02371759|58926418|FG002|Overall Study|Withdrawal by Subject|0|||
31007091|NCT01526928|59208680|FG001|Overall Study|Physician Decision|0|||
31007092|NCT01526928|59208681|FG002|Overall Study|Physician Decision|2|||
30612210|NCT01217892|58623366|FG002|Overall Study|Adverse Event|1|||
30612211|NCT01217892|58623367|FG003|Overall Study|Adverse Event|0|||
30612212|NCT01217892|58623364|FG000|Overall Study|Withdrawal by Subject|0|||
30612213|NCT01217892|58623365|FG001|Overall Study|Withdrawal by Subject|2|||
30612214|NCT01217892|58623366|FG002|Overall Study|Withdrawal by Subject|1|||
30612215|NCT01217892|58623367|FG003|Overall Study|Withdrawal by Subject|0|||
30612216|NCT01217892|58623364|FG000|Overall Study|Lab value|1|||
30612217|NCT01217892|58623365|FG001|Overall Study|Lab value|0|||
30612218|NCT01217892|58623366|FG002|Overall Study|Lab value|1|||
30612219|NCT01217892|58623367|FG003|Overall Study|Lab value|0|||
30612220|NCT01217892|58623364|FG000|Overall Study|Subject no longer meets study criteria|5|||
30612221|NCT01217892|58623365|FG001|Overall Study|Subject no longer meets study criteria|2|||
30698700|NCT03875482|58713235|FG000|Overall Study|Lack of Efficacy|0|||
30698701|NCT03875482|58713236|FG001|Overall Study|Lack of Efficacy|11|||
30698702|NCT00754793|58713244|FG000|Overall Study|voluntary withdrawn from study|0|||
30698703|NCT00754793|58713245|FG001|Overall Study|voluntary withdrawn from study|1|||
30698704|NCT00586469|58713253|FG000|Overall Study|Adverse Event|0|||
30698705|NCT00586469|58713254|FG001|Overall Study|Adverse Event|1|||
30698706|NCT00626028|58713262|FG000|Overall Study|Adverse Event|1|||
30698707|NCT00626028|58713263|FG001|Overall Study|Adverse Event|1|||
30892971|NCT02371759|58926419|FG003|Overall Study|Withdrawal by Subject|0|||
31007093|NCT01526928|59208682|FG003|Overall Study|Physician Decision|5|||
31007094|NCT01526928|59208683|FG004|Overall Study|Physician Decision|0|||
31007095|NCT01526928|59208684|FG005|Overall Study|Physician Decision|0|||
30612222|NCT01217892|58623366|FG002|Overall Study|Subject no longer meets study criteria|4|||
31007096|NCT01526928|59208679|FG000|Overall Study|Other Reason|0|||
31007097|NCT01526928|59208680|FG001|Overall Study|Other Reason|1|||
30698708|NCT00626028|58713262|FG000|Overall Study|Device Failure|0|||
30698709|NCT00626028|58713263|FG001|Overall Study|Device Failure|1|||
30698710|NCT00626028|58713262|FG000|Overall Study|Physician Decision|2|||
30698711|NCT00626028|58713263|FG001|Overall Study|Physician Decision|1|||
30698712|NCT00626028|58713262|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
30698713|NCT00626028|58713263|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
30698714|NCT00777257|58713272|FG000|Overall Study|Adverse Event|3|||
30612223|NCT01217892|58623367|FG003|Overall Study|Subject no longer meets study criteria|8|||
30612224|NCT01217892|58623364|FG000|Overall Study|Incorrect enrollment|0|||
30612225|NCT01217892|58623365|FG001|Overall Study|Incorrect enrollment|1|||
30612226|NCT01217892|58623366|FG002|Overall Study|Incorrect enrollment|1|||
30612227|NCT01217892|58623367|FG003|Overall Study|Incorrect enrollment|0|||
30612228|NCT01217892|58623364|FG000|Overall Study|Poor/Non-Compliance|0|||
30612229|NCT01217892|58623365|FG001|Overall Study|Poor/Non-Compliance|0|||
30612230|NCT01217892|58623366|FG002|Overall Study|Poor/Non-Compliance|1|||
30612231|NCT01217892|58623367|FG003|Overall Study|Poor/Non-Compliance|0|||
30612232|NCT01217814|58623380|FG000|Overall Study|Adverse Event|1|||
30612233|NCT01217814|58623381|FG001|Overall Study|Adverse Event|1|||
30612234|NCT01217814|58623382|FG002|Overall Study|Adverse Event|0|||
30612235|NCT01217814|58623380|FG000|Overall Study|Lack of Efficacy|0|||
30612236|NCT01217814|58623381|FG001|Overall Study|Lack of Efficacy|0|||
30612237|NCT01217814|58623382|FG002|Overall Study|Lack of Efficacy|1|||
30612238|NCT01217190|58623393|FG000|Second Dosing|Withdrawal by Subject|0|||
30612239|NCT01217190|58623394|FG001|Second Dosing|Withdrawal by Subject|2|||
30612240|NCT01136733|58623410|FG000|Phase 1b|Adverse Event|0|||
30612241|NCT01136733|58623411|FG001|Phase 1b|Adverse Event|3|||
30698715|NCT00777257|58713273|FG001|Overall Study|Adverse Event|1|||
30698716|NCT00777257|58713274|FG002|Overall Study|Adverse Event|0|||
30698717|NCT00777257|58713272|FG000|Overall Study|Lost to Follow-up|3|||
30698718|NCT00777257|58713273|FG001|Overall Study|Lost to Follow-up|3|||
30698719|NCT00777257|58713274|FG002|Overall Study|Lost to Follow-up|2|||
30698720|NCT00777257|58713272|FG000|Overall Study|Protocol Violation|2|||
30698721|NCT00777257|58713273|FG001|Overall Study|Protocol Violation|2|||
30698722|NCT00777257|58713274|FG002|Overall Study|Protocol Violation|2|||
30698723|NCT00777257|58713272|FG000|Overall Study|Withdrawal by Subject|3|||
30698724|NCT00777257|58713273|FG001|Overall Study|Withdrawal by Subject|6|||
30698725|NCT00777257|58713274|FG002|Overall Study|Withdrawal by Subject|5|||
30698726|NCT00628758|58713284|FG000|Overall Study|Adverse Event|2|||
30698727|NCT00628758|58713285|FG001|Overall Study|Adverse Event|3|||
30698728|NCT00628758|58713284|FG000|Overall Study|Withdrawal by Subject|6|||
30698729|NCT00628758|58713285|FG001|Overall Study|Withdrawal by Subject|3|||
30698730|NCT00628758|58713284|FG000|Overall Study|Death|1|||
30698731|NCT00628758|58713285|FG001|Overall Study|Death|0|||
30698732|NCT00628758|58713284|FG000|Overall Study|Protocol Violation|5|||
30698733|NCT00628758|58713285|FG001|Overall Study|Protocol Violation|1|||
30698734|NCT00628758|58713284|FG000|Overall Study|Lost to Follow-up|25|||
30698735|NCT00628758|58713285|FG001|Overall Study|Lost to Follow-up|31|||
30698736|NCT00628758|58713284|FG000|Overall Study|Pregnancy|2|||
30698737|NCT00628758|58713285|FG001|Overall Study|Pregnancy|2|||
30698738|NCT00628758|58713284|FG000|Overall Study|Investigator Moved|3|||
30698739|NCT00628758|58713285|FG001|Overall Study|Investigator Moved|0|||
30698740|NCT00628758|58713284|FG000|Overall Study|Treatment Failure|0|||
30698741|NCT00628758|58713285|FG001|Overall Study|Treatment Failure|2|||
30698742|NCT04491604|58713293|FG000|Overall Study|Withdrawal by Subject|3|||
30698743|NCT00628446|58713298|FG000|Overall Study|Lost to Follow-up|3|||
30698744|NCT00628446|58713298|FG000|Overall Study|Withdrawal by Subject|1|||
30698745|NCT00628446|58713298|FG000|Overall Study|Protocol Violation|3|||
30698746|NCT00754559|58713303|FG000|Overall Study|Adverse Event|15|||
30698747|NCT00754559|58713303|FG000|Overall Study|Protocol Violation|11|||
30698748|NCT00754559|58713303|FG000|Overall Study|Lack of Efficacy|10|||
30698749|NCT00754559|58713303|FG000|Overall Study|Lost to Follow-up|2|||
30698750|NCT00754559|58713303|FG000|Overall Study|Administrative reason|1|||
30698751|NCT00754559|58713303|FG000|Overall Study|Other|5|||
30698752|NCT00754559|58713303|FG000|Overall Study|Withdrawal by Subject|3|||
30698753|NCT00525148|58713314|FG000|Overall Study|Other Adverse Event|3|||
30698754|NCT00525148|58713315|FG001|Overall Study|Other Adverse Event|5|||
30698755|NCT00525148|58713316|FG002|Overall Study|Other Adverse Event|1|||
30698756|NCT00525148|58713317|FG003|Overall Study|Other Adverse Event|8|||
30698757|NCT00525148|58713314|FG000|Overall Study|Progressive disease|18|||
30698758|NCT00525148|58713315|FG001|Overall Study|Progressive disease|30|||
30698759|NCT00525148|58713316|FG002|Overall Study|Progressive disease|6|||
30612242|NCT01136733|58623412|FG002|Phase 1b|Adverse Event|1|||
30612243|NCT01136733|58623413|FG003|Phase 1b|Adverse Event|0|||
30612244|NCT01136733|58623414|FG004|Phase 1b|Adverse Event|0|||
30612245|NCT01136733|58623415|FG005|Phase 1b|Adverse Event|0|||
30698760|NCT00525148|58713317|FG003|Overall Study|Progressive disease|49|||
30612246|NCT01136733|58623416|FG006|Phase 1b|Adverse Event|0|||
30612247|NCT01136733|58623410|FG000|Phase 1b|Participant Choice|0|||
30698761|NCT00525148|58713314|FG000|Overall Study|Refused continuation of study medication|0|||
30698762|NCT00525148|58713315|FG001|Overall Study|Refused continuation of study medication|2|||
30698763|NCT00525148|58713316|FG002|Overall Study|Refused continuation of study medication|0|||
30698764|NCT00525148|58713317|FG003|Overall Study|Refused continuation of study medication|1|||
30698765|NCT00525148|58713314|FG000|Overall Study|Other than stated|2|||
30698766|NCT00525148|58713315|FG001|Overall Study|Other than stated|1|||
30698767|NCT00525148|58713316|FG002|Overall Study|Other than stated|0|||
30698768|NCT00525148|58713317|FG003|Overall Study|Other than stated|3|||
30698769|NCT00754325|58713329|FG000|Initial Treatment|Continuing Active Treatment|4|||
30698770|NCT00754325|58713330|FG001|Initial Treatment|Continuing Active Treatment|5|||
30698771|NCT00754325|58713329|FG000|Initial Treatment|Adverse Event|7|||
30698772|NCT00754325|58713330|FG001|Initial Treatment|Adverse Event|6|||
30698773|NCT00754325|58713329|FG000|Initial Treatment|Withdrawal by Subject|2|||
30698774|NCT00754325|58713330|FG001|Initial Treatment|Withdrawal by Subject|2|||
30698775|NCT00754325|58713329|FG000|Initial Treatment|Physician Decision|2|||
30698776|NCT00754325|58713330|FG001|Initial Treatment|Physician Decision|0|||
30698777|NCT00754325|58713329|FG000|Initial Treatment|Sponsor Request|0|||
30698778|NCT00754325|58713330|FG001|Initial Treatment|Sponsor Request|1|||
30698779|NCT00754325|58713329|FG000|Initial Treatment|Disease Progression|35|||
30698780|NCT00754325|58713330|FG001|Initial Treatment|Disease Progression|35|||
30698781|NCT00524680|58713341|FG000|Overall Study|progression|0|||
30698782|NCT00524680|58713342|FG001|Overall Study|progression|0|||
30698783|NCT00524680|58713343|FG002|Overall Study|progression|0|||
30698784|NCT00524680|58713344|FG003|Overall Study|progression|1|||
30698785|NCT00524680|58713341|FG000|Overall Study|Adverse Event|2|||
30698786|NCT00524680|58713342|FG001|Overall Study|Adverse Event|0|||
30698787|NCT00524680|58713343|FG002|Overall Study|Adverse Event|0|||
30698788|NCT00524680|58713344|FG003|Overall Study|Adverse Event|1|||
30698789|NCT00524680|58713341|FG000|Overall Study|Other|0|||
30698790|NCT00524680|58713342|FG001|Overall Study|Other|1|||
30698791|NCT00524680|58713343|FG002|Overall Study|Other|2|||
30698792|NCT00524680|58713344|FG003|Overall Study|Other|3|||
30698793|NCT00524680|58713341|FG000|Overall Study|Withdrawal by Subject|1|||
30698794|NCT00524680|58713342|FG001|Overall Study|Withdrawal by Subject|0|||
30698795|NCT00524680|58713343|FG002|Overall Study|Withdrawal by Subject|1|||
30698796|NCT00524680|58713344|FG003|Overall Study|Withdrawal by Subject|1|||
30698797|NCT00628212|58713358|FG000|Overall Study|Adverse Event|2|||
30698798|NCT00628212|58713359|FG001|Overall Study|Adverse Event|0|||
30698799|NCT00628212|58713360|FG002|Overall Study|Adverse Event|1|||
30698800|NCT00628212|58713361|FG003|Overall Study|Adverse Event|2|||
30698801|NCT00628212|58713358|FG000|Overall Study|Physician Decision|1|||
30698802|NCT00628212|58713359|FG001|Overall Study|Physician Decision|1|||
30698803|NCT00628212|58713360|FG002|Overall Study|Physician Decision|2|||
30698804|NCT00628212|58713361|FG003|Overall Study|Physician Decision|3|||
30698805|NCT00298363|58713374|FG000|Overall Study|Lost to Follow-up|0|||
30698806|NCT00298363|58713375|FG001|Overall Study|Lost to Follow-up|0|||
30698807|NCT00298363|58713376|FG002|Overall Study|Lost to Follow-up|1|||
30698808|NCT00298363|58713374|FG000|Overall Study|Physician Decision|4|||
30698809|NCT00298363|58713375|FG001|Overall Study|Physician Decision|1|||
30698810|NCT00298363|58713376|FG002|Overall Study|Physician Decision|0|||
30698811|NCT00298363|58713374|FG000|Overall Study|Protocol Violation|1|||
30698812|NCT00298363|58713375|FG001|Overall Study|Protocol Violation|1|||
30698813|NCT00298363|58713376|FG002|Overall Study|Protocol Violation|0|||
30698814|NCT00298363|58713374|FG000|Overall Study|Withdrawal by Subject|5|||
30698815|NCT00298363|58713375|FG001|Overall Study|Withdrawal by Subject|1|||
30698816|NCT00298363|58713376|FG002|Overall Study|Withdrawal by Subject|3|||
30698817|NCT00298363|58713374|FG000|Overall Study|Adverse Event|5|||
30698818|NCT00298363|58713375|FG001|Overall Study|Adverse Event|2|||
30698819|NCT00298363|58713376|FG002|Overall Study|Adverse Event|2|||
30698820|NCT00298363|58713374|FG000|Overall Study|Lack of Efficacy|2|||
30698821|NCT00298363|58713375|FG001|Overall Study|Lack of Efficacy|3|||
30698822|NCT00298363|58713376|FG002|Overall Study|Lack of Efficacy|0|||
30698823|NCT00524368|58713392|FG000|Overall Study|Adverse Event|10|||
30698824|NCT00524368|58713393|FG001|Overall Study|Adverse Event|12|||
30698825|NCT00524368|58713392|FG000|Overall Study|Lost to Follow-up|9|||
30698826|NCT00524368|58713393|FG001|Overall Study|Lost to Follow-up|13|||
30698827|NCT00524368|58713392|FG000|Overall Study|Withdrawal by Subject|4|||
30698828|NCT00524368|58713393|FG001|Overall Study|Withdrawal by Subject|5|||
30698829|NCT00524368|58713392|FG000|Overall Study|Non-compliant|8|||
30698830|NCT00524368|58713393|FG001|Overall Study|Non-compliant|9|||
30698831|NCT00524368|58713392|FG000|Overall Study|Reached a Virologic Endpoint|3|||
30698832|NCT00524368|58713393|FG001|Overall Study|Reached a Virologic Endpoint|2|||
30698833|NCT00524368|58713392|FG000|Overall Study|Sponsor's Decision|2|||
30698834|NCT00524368|58713393|FG001|Overall Study|Sponsor's Decision|0|||
30892972|NCT02371759|58926420|FG004|Overall Study|Withdrawal by Subject|0|||
30698835|NCT00524368|58713392|FG000|Overall Study|Ineligible to Continue the study|2|||
30698836|NCT00524368|58713393|FG001|Overall Study|Ineligible to Continue the study|5|||
30698837|NCT00524368|58713392|FG000|Overall Study|Other|3|||
30698838|NCT00524368|58713393|FG001|Overall Study|Other|2|||
30698839|NCT00777101|58713401|FG000|Overall Study|Death|48|||
30698840|NCT00777101|58713402|FG001|Overall Study|Death|43|||
30698841|NCT00777101|58713401|FG000|Overall Study|Withdrawal by Subject|11|||
30892973|NCT02371759|58926421|FG005|Overall Study|Withdrawal by Subject|0|||
30698842|NCT00777101|58713402|FG001|Overall Study|Withdrawal by Subject|6|||
30698843|NCT00777101|58713401|FG000|Overall Study|Lost to Follow-up|2|||
30698844|NCT00777101|58713402|FG001|Overall Study|Lost to Follow-up|1|||
30698845|NCT00777101|58713401|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
30698846|NCT00777101|58713402|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
30698847|NCT00777101|58713401|FG000|Overall Study|Failed to Return|0|||
30698848|NCT00777101|58713402|FG001|Overall Study|Failed to Return|1|||
30698849|NCT00297427|58713411|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
30698850|NCT00297427|58713412|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
30698851|NCT00297427|58713411|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
30698852|NCT00297427|58713412|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
30698853|NCT00297427|58713411|FG000|Phase 1: Initial Intervention|Death|0|||
30612248|NCT01136733|58623411|FG001|Phase 1b|Participant Choice|0|||
30612249|NCT01136733|58623412|FG002|Phase 1b|Participant Choice|1|||
30612250|NCT01136733|58623413|FG003|Phase 1b|Participant Choice|0|||
30612251|NCT01136733|58623414|FG004|Phase 1b|Participant Choice|0|||
30612252|NCT01136733|58623415|FG005|Phase 1b|Participant Choice|0|||
30612253|NCT01136733|58623416|FG006|Phase 1b|Participant Choice|0|||
30698854|NCT00297427|58713412|FG001|Phase 1: Initial Intervention|Death|1|||
30698855|NCT00297427|58713411|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
30698856|NCT00297427|58713412|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
30698857|NCT00297427|58713411|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
30698858|NCT00297427|58713412|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
30698859|NCT00297427|58713411|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
30698860|NCT00297427|58713412|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
30698861|NCT00297427|58713411|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
30698862|NCT00297427|58713412|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
30843548|NCT02101853|58869617|FG005|Block 1 Induction|Ineligible|0|||
31007098|NCT01526928|59208681|FG002|Overall Study|Other Reason|11|||
31007099|NCT01526928|59208682|FG003|Overall Study|Other Reason|4|||
31007100|NCT01526928|59208683|FG004|Overall Study|Other Reason|1|||
31007101|NCT01526928|59208684|FG005|Overall Study|Other Reason|0|||
31007102|NCT01526928|59208679|FG000|Overall Study|Lost to Follow-up|0|||
31007103|NCT01526928|59208680|FG001|Overall Study|Lost to Follow-up|0|||
31007104|NCT01526928|59208681|FG002|Overall Study|Lost to Follow-up|0|||
31007105|NCT01526928|59208682|FG003|Overall Study|Lost to Follow-up|1|||
31007106|NCT01526928|59208683|FG004|Overall Study|Lost to Follow-up|0|||
31007107|NCT01526928|59208684|FG005|Overall Study|Lost to Follow-up|0|||
31007108|NCT01526928|59208679|FG000|Overall Study|Protocol Deviation|0|||
31007109|NCT01526928|59208680|FG001|Overall Study|Protocol Deviation|0|||
31007110|NCT01526928|59208681|FG002|Overall Study|Protocol Deviation|0|||
31007111|NCT01526928|59208682|FG003|Overall Study|Protocol Deviation|2|||
31007112|NCT01526928|59208683|FG004|Overall Study|Protocol Deviation|0|||
31007113|NCT01526928|59208684|FG005|Overall Study|Protocol Deviation|0|||
31007114|NCT01526928|59208679|FG000|Overall Study|Missing|0|||
31007115|NCT01526928|59208680|FG001|Overall Study|Missing|0|||
31007116|NCT01526928|59208681|FG002|Overall Study|Missing|1|||
30612254|NCT01136733|58623410|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
30612255|NCT01136733|58623411|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
30612256|NCT01136733|58623412|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
30612257|NCT01136733|58623413|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
30612258|NCT01136733|58623414|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
30612259|NCT01136733|58623415|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
30612260|NCT01136733|58623416|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
30612261|NCT01136733|58623410|FG000|Phase 1b|Clinical Progression|1|||
30612262|NCT01136733|58623411|FG001|Phase 1b|Clinical Progression|1|||
30612263|NCT01136733|58623412|FG002|Phase 1b|Clinical Progression|0|||
30612264|NCT01136733|58623413|FG003|Phase 1b|Clinical Progression|0|||
30612265|NCT01136733|58623414|FG004|Phase 1b|Clinical Progression|0|||
30612266|NCT01136733|58623415|FG005|Phase 1b|Clinical Progression|0|||
30612267|NCT01136733|58623416|FG006|Phase 1b|Clinical Progression|0|||
30612268|NCT01136733|58623410|FG000|Phase 2|Disease Progression|0|||
30612269|NCT01136733|58623411|FG001|Phase 2|Disease Progression|0|||
30612270|NCT01136733|58623412|FG002|Phase 2|Disease Progression|0|||
30612271|NCT01136733|58623413|FG003|Phase 2|Disease Progression|0|||
30612272|NCT01136733|58623414|FG004|Phase 2|Disease Progression|30|||
30698863|NCT00297427|58713411|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
30698864|NCT00297427|58713412|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
30698865|NCT00524134|58713426|FG000|Overall Study|Withdrawal by Subject|1|||
30698866|NCT00524134|58713426|FG000|Overall Study|Physician Decision|1|||
30698867|NCT00777023|58713433|FG000|Overall Study|Adverse Event|15|||
30698868|NCT00777023|58713434|FG001|Overall Study|Adverse Event|21|||
30698869|NCT00777023|58713435|FG002|Overall Study|Adverse Event|8|||
30698870|NCT00777023|58713433|FG000|Overall Study|Lack of Efficacy|1|||
30698871|NCT00777023|58713434|FG001|Overall Study|Lack of Efficacy|0|||
30698872|NCT00777023|58713435|FG002|Overall Study|Lack of Efficacy|14|||
30698873|NCT00777023|58713433|FG000|Overall Study|Protocol Violation|2|||
30698874|NCT00777023|58713434|FG001|Overall Study|Protocol Violation|1|||
30698875|NCT00777023|58713435|FG002|Overall Study|Protocol Violation|1|||
30698876|NCT00777023|58713433|FG000|Overall Study|Lost to Follow-up|2|||
30612273|NCT01136733|58623415|FG005|Phase 2|Disease Progression|32|||
30612274|NCT01136733|58623416|FG006|Phase 2|Disease Progression|38|||
30612275|NCT01136733|58623410|FG000|Phase 2|Adverse Event|0|||
30612276|NCT01136733|58623411|FG001|Phase 2|Adverse Event|0|||
30612277|NCT01136733|58623412|FG002|Phase 2|Adverse Event|0|||
30612278|NCT01136733|58623413|FG003|Phase 2|Adverse Event|0|||
30612279|NCT01136733|58623414|FG004|Phase 2|Adverse Event|11|||
30612280|NCT01136733|58623415|FG005|Phase 2|Adverse Event|13|||
30612281|NCT01136733|58623416|FG006|Phase 2|Adverse Event|5|||
30612282|NCT01136733|58623410|FG000|Phase 2|Participant Choice|0|||
30612283|NCT01136733|58623411|FG001|Phase 2|Participant Choice|0|||
30612284|NCT01136733|58623412|FG002|Phase 2|Participant Choice|0|||
30612285|NCT01136733|58623413|FG003|Phase 2|Participant Choice|0|||
30612286|NCT01136733|58623414|FG004|Phase 2|Participant Choice|3|||
30612287|NCT01136733|58623415|FG005|Phase 2|Participant Choice|0|||
30612288|NCT01136733|58623416|FG006|Phase 2|Participant Choice|1|||
30612289|NCT01136733|58623410|FG000|Phase 2|Administrative-Withdrew Consent|0|||
30612290|NCT01136733|58623411|FG001|Phase 2|Administrative-Withdrew Consent|0|||
30612291|NCT01136733|58623412|FG002|Phase 2|Administrative-Withdrew Consent|0|||
30612292|NCT01136733|58623413|FG003|Phase 2|Administrative-Withdrew Consent|0|||
30612293|NCT01136733|58623414|FG004|Phase 2|Administrative-Withdrew Consent|1|||
30612294|NCT01136733|58623415|FG005|Phase 2|Administrative-Withdrew Consent|0|||
30612295|NCT01136733|58623416|FG006|Phase 2|Administrative-Withdrew Consent|0|||
30612296|NCT01136733|58623410|FG000|Phase 2|Other|0|||
30612297|NCT01136733|58623411|FG001|Phase 2|Other|0|||
30612298|NCT01136733|58623412|FG002|Phase 2|Other|0|||
30612299|NCT01136733|58623413|FG003|Phase 2|Other|0|||
30698877|NCT00777023|58713434|FG001|Overall Study|Lost to Follow-up|3|||
30698878|NCT00777023|58713435|FG002|Overall Study|Lost to Follow-up|3|||
30698879|NCT00777023|58713433|FG000|Overall Study|Death|0|||
30698880|NCT00777023|58713434|FG001|Overall Study|Death|1|||
30698881|NCT00777023|58713435|FG002|Overall Study|Death|0|||
30698882|NCT00777023|58713433|FG000|Overall Study|Withdrawal by Subject|7|||
30698883|NCT00777023|58713434|FG001|Overall Study|Withdrawal by Subject|7|||
30698884|NCT00777023|58713435|FG002|Overall Study|Withdrawal by Subject|8|||
30698885|NCT00777023|58713433|FG000|Overall Study|Missing data|1|||
30698886|NCT00777023|58713434|FG001|Overall Study|Missing data|1|||
30698887|NCT00777023|58713435|FG002|Overall Study|Missing data|0|||
30698888|NCT00777023|58713433|FG000|Overall Study|Reasons not specified|4|||
30698889|NCT00777023|58713434|FG001|Overall Study|Reasons not specified|4|||
30698890|NCT00777023|58713435|FG002|Overall Study|Reasons not specified|2|||
30698891|NCT00777023|58713433|FG000|Overall Study|Last dose date unknown|3|||
30698892|NCT00777023|58713434|FG001|Overall Study|Last dose date unknown|3|||
30698893|NCT00777023|58713435|FG002|Overall Study|Last dose date unknown|1|||
31007117|NCT01526928|59208682|FG003|Overall Study|Missing|0|||
30612300|NCT01136733|58623414|FG004|Phase 2|Other|6|||
30612301|NCT01136733|58623415|FG005|Phase 2|Other|7|||
30612302|NCT01136733|58623416|FG006|Phase 2|Other|6|||
30612303|NCT01136655|58623446|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
30612304|NCT01136655|58623446|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
30612305|NCT01136655|58623446|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
30612306|NCT01136655|58623446|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
30612307|NCT01135017|58623461|FG000|Overall Study|Adverse Event|3|||
30612308|NCT01135017|58623462|FG001|Overall Study|Adverse Event|8|||
30612309|NCT01135017|58623461|FG000|Overall Study|Other than above|3|||
30612310|NCT01135017|58623462|FG001|Overall Study|Other than above|4|||
30612311|NCT01134939|58623476|FG000|Overall Study|Adverse Event|9|||
30612312|NCT01134939|58623477|FG001|Overall Study|Adverse Event|3|||
30612313|NCT01134939|58623478|FG002|Overall Study|Adverse Event|4|||
30612314|NCT01134939|58623479|FG003|Overall Study|Adverse Event|5|||
30612315|NCT01134939|58623480|FG004|Overall Study|Adverse Event|5|||
30612316|NCT01134939|58623481|FG005|Overall Study|Adverse Event|5|||
30612317|NCT01134939|58623482|FG006|Overall Study|Adverse Event|1|||
30612318|NCT01134939|58623483|FG007|Overall Study|Adverse Event|0|||
30612319|NCT01134939|58623476|FG000|Overall Study|Lack of Efficacy|2|||
30612320|NCT01134939|58623477|FG001|Overall Study|Lack of Efficacy|5|||
30612321|NCT01134939|58623478|FG002|Overall Study|Lack of Efficacy|1|||
30612322|NCT01134939|58623479|FG003|Overall Study|Lack of Efficacy|0|||
30612323|NCT01134939|58623480|FG004|Overall Study|Lack of Efficacy|3|||
30612324|NCT01134939|58623481|FG005|Overall Study|Lack of Efficacy|0|||
30612325|NCT01134939|58623482|FG006|Overall Study|Lack of Efficacy|1|||
30612326|NCT01134939|58623483|FG007|Overall Study|Lack of Efficacy|0|||
30612327|NCT01134939|58623476|FG000|Overall Study|Lost to Follow-up|2|||
30612328|NCT01134939|58623477|FG001|Overall Study|Lost to Follow-up|3|||
31007118|NCT01526928|59208683|FG004|Overall Study|Missing|2|||
31007119|NCT01526928|59208684|FG005|Overall Study|Missing|0|||
31007120|NCT01549860|59208742|FG000|Overall Study|Withdrawal by Subject|1|||
31007121|NCT01549860|59208743|FG001|Overall Study|Withdrawal by Subject|0|||
31007122|NCT01549860|59208742|FG000|Overall Study|Physician Decision|1|||
31007123|NCT01549860|59208743|FG001|Overall Study|Physician Decision|1|||
31007124|NCT01549392|59208751|FG000|Overall Study|Withdrawal by Subject|1|||
31007125|NCT01549392|59208752|FG001|Overall Study|Withdrawal by Subject|0|||
31007126|NCT01526148|59208760|FG000|Overall Study|Adverse Event|6|||
31007127|NCT01526148|59208761|FG001|Overall Study|Adverse Event|5|||
31007128|NCT01526148|59208760|FG000|Overall Study|Lost to Follow-up|3|||
30612329|NCT01134939|58623478|FG002|Overall Study|Lost to Follow-up|0|||
30612330|NCT01134939|58623479|FG003|Overall Study|Lost to Follow-up|1|||
30612331|NCT01134939|58623480|FG004|Overall Study|Lost to Follow-up|2|||
30612332|NCT01134939|58623481|FG005|Overall Study|Lost to Follow-up|1|||
30612333|NCT01134939|58623482|FG006|Overall Study|Lost to Follow-up|0|||
30612334|NCT01134939|58623483|FG007|Overall Study|Lost to Follow-up|0|||
30612335|NCT01134939|58623476|FG000|Overall Study|Death|0|||
30612336|NCT01134939|58623477|FG001|Overall Study|Death|1|||
30612337|NCT01134939|58623478|FG002|Overall Study|Death|0|||
30612338|NCT01134939|58623479|FG003|Overall Study|Death|0|||
30612339|NCT01134939|58623480|FG004|Overall Study|Death|0|||
30612340|NCT01134939|58623481|FG005|Overall Study|Death|0|||
30612341|NCT01134939|58623482|FG006|Overall Study|Death|0|||
30612342|NCT01134939|58623483|FG007|Overall Study|Death|0|||
30612343|NCT01134939|58623476|FG000|Overall Study|Termination page not available|4|||
30612344|NCT01134939|58623477|FG001|Overall Study|Termination page not available|6|||
30612345|NCT01134939|58623478|FG002|Overall Study|Termination page not available|5|||
30612346|NCT01134939|58623479|FG003|Overall Study|Termination page not available|8|||
30612347|NCT01134939|58623480|FG004|Overall Study|Termination page not available|0|||
30612348|NCT01134939|58623481|FG005|Overall Study|Termination page not available|3|||
30612349|NCT01134939|58623482|FG006|Overall Study|Termination page not available|7|||
30612350|NCT01134939|58623483|FG007|Overall Study|Termination page not available|0|||
30612351|NCT01134783|58623499|FG000|Overall Study|Pregnancy|16|||
30612352|NCT01134783|58623500|FG001|Overall Study|Pregnancy|8|||
30612353|NCT01134783|58623499|FG000|Overall Study|Withdrawal by Subject|15|||
30612354|NCT01134783|58623500|FG001|Overall Study|Withdrawal by Subject|9|||
30612355|NCT01134783|58623499|FG000|Overall Study|Lost to Follow-up|5|||
30612356|NCT01134783|58623500|FG001|Overall Study|Lost to Follow-up|20|||
30612357|NCT01134705|58623512|FG000|Overall Study|Adverse Event|1|||
30612358|NCT01134705|58623513|FG001|Overall Study|Adverse Event|7|||
30612359|NCT01134705|58623512|FG000|Overall Study|Withdrawal by Subject|6|||
30612360|NCT01134705|58623513|FG001|Overall Study|Withdrawal by Subject|6|||
30612361|NCT01134705|58623512|FG000|Overall Study|Pregnancy|1|||
31007129|NCT01526148|59208761|FG001|Overall Study|Lost to Follow-up|6|||
31007130|NCT01526148|59208760|FG000|Overall Study|Withdrawal by Subject|2|||
31007131|NCT01526148|59208761|FG001|Overall Study|Withdrawal by Subject|0|||
30612362|NCT01134705|58623513|FG001|Overall Study|Pregnancy|0|||
30612363|NCT01134705|58623512|FG000|Overall Study|Lost to Follow-up|5|||
30612364|NCT01134705|58623513|FG001|Overall Study|Lost to Follow-up|2|||
30612365|NCT01134705|58623512|FG000|Overall Study|Protocol Violation|1|||
30612366|NCT01134705|58623513|FG001|Overall Study|Protocol Violation|1|||
30612367|NCT01134705|58623512|FG000|Overall Study|Other|1|||
31007132|NCT01526148|59208760|FG000|Overall Study|Unstable Medical Condition|1|||
30612368|NCT01134705|58623513|FG001|Overall Study|Other|6|||
30612369|NCT00927823|58623519|FG000|Continuous Dosing Period|Death|0|||
30612370|NCT00927823|58623520|FG001|Continuous Dosing Period|Death|0|||
30612371|NCT00927823|58623521|FG002|Continuous Dosing Period|Death|6|||
30698894|NCT00297037|58713445|FG000|Overall Study|Withdrawal by Subject|2|||
30698895|NCT00297037|58713446|FG001|Overall Study|Withdrawal by Subject|0|||
30698896|NCT00292981|58713454|FG000|Overall Study|Adverse Event|1|||
30790769|NCT03524092|58803944|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
31007133|NCT01526148|59208761|FG001|Overall Study|Unstable Medical Condition|0|||
31007134|NCT01526148|59208760|FG000|Overall Study|Unable to discontinue concomitant med|1|||
31007135|NCT01526148|59208761|FG001|Overall Study|Unable to discontinue concomitant med|0|||
31007136|NCT01526148|59208760|FG000|Overall Study|Moved out of state|1|||
31007137|NCT01526148|59208761|FG001|Overall Study|Moved out of state|0|||
31007138|NCT01526148|59208760|FG000|Overall Study|Incarcerated|0|||
31007139|NCT01526148|59208761|FG001|Overall Study|Incarcerated|2|||
31007140|NCT01572948|59208769|FG000|Overall Study|Lost to Follow-up|1|||
31007141|NCT01572948|59208770|FG001|Overall Study|Lost to Follow-up|0|||
30612372|NCT00927823|58623522|FG003|Continuous Dosing Period|Death|0|||
30612373|NCT00927823|58623519|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
30612374|NCT00927823|58623520|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
30612375|NCT00927823|58623521|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
30612376|NCT00927823|58623522|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
30612377|NCT00927823|58623519|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
30612378|NCT00927823|58623520|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
30612379|NCT00927823|58623521|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
30612380|NCT00927823|58623522|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
30612381|NCT00927823|58623519|FG000|Continuous Dosing Period|Other|1|||
30612382|NCT00927823|58623520|FG001|Continuous Dosing Period|Other|2|||
30612383|NCT00927823|58623521|FG002|Continuous Dosing Period|Other|9|||
30612384|NCT00927823|58623522|FG003|Continuous Dosing Period|Other|3|||
30612385|NCT01134627|58623541|FG000|Overall Study|Adverse Event|47|||
30612386|NCT01134627|58623542|FG001|Overall Study|Adverse Event|31|||
30612387|NCT01134627|58623541|FG000|Overall Study|Lost to Follow-up|1|||
30612388|NCT01134627|58623542|FG001|Overall Study|Lost to Follow-up|2|||
30612389|NCT01134627|58623541|FG000|Overall Study|Protocol Violation|3|||
30612390|NCT01134627|58623542|FG001|Overall Study|Protocol Violation|5|||
30612391|NCT01134627|58623541|FG000|Overall Study|Lack of Efficacy|2|||
30612392|NCT01134627|58623542|FG001|Overall Study|Lack of Efficacy|12|||
30612393|NCT01134627|58623541|FG000|Overall Study|Withdrawal by Subject|4|||
30612394|NCT01134627|58623542|FG001|Overall Study|Withdrawal by Subject|3|||
30612395|NCT01134627|58623541|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
30612396|NCT01134627|58623542|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
30612397|NCT01134627|58623541|FG000|Overall Study|Other|11|||
30612398|NCT01134627|58623542|FG001|Overall Study|Other|14|||
30612399|NCT01134393|58623548|FG000|Overall Study|Adverse Event|18|||
30612400|NCT01134393|58623548|FG000|Overall Study|Lack of Efficacy|2|||
30612401|NCT01134393|58623548|FG000|Overall Study|Protocol Violation|12|||
30612402|NCT01134393|58623548|FG000|Overall Study|Lost to Follow-up|3|||
31007142|NCT01572948|59208769|FG000|Overall Study|unable to contact|0|||
31007143|NCT01572948|59208770|FG001|Overall Study|unable to contact|1|||
31007144|NCT01525602|59208788|FG000|Overall Study|Adverse Event|1|||
31007145|NCT01525602|59208789|FG001|Overall Study|Adverse Event|0|||
31007146|NCT01525602|59208790|FG002|Overall Study|Adverse Event|1|||
31007147|NCT01525602|59208791|FG003|Overall Study|Adverse Event|1|||
31007148|NCT01525602|59208792|FG004|Overall Study|Adverse Event|3|||
31007149|NCT01525602|59208793|FG005|Overall Study|Adverse Event|3|||
31007150|NCT01525602|59208794|FG006|Overall Study|Adverse Event|0|||
31007151|NCT01525602|59208795|FG007|Overall Study|Adverse Event|1|||
31007152|NCT01525602|59208788|FG000|Overall Study|Disease progression|6|||
31007153|NCT01525602|59208789|FG001|Overall Study|Disease progression|3|||
31007154|NCT01525602|59208790|FG002|Overall Study|Disease progression|2|||
31007155|NCT01525602|59208791|FG003|Overall Study|Disease progression|5|||
31007156|NCT01525602|59208792|FG004|Overall Study|Disease progression|22|||
31007157|NCT01525602|59208793|FG005|Overall Study|Disease progression|2|||
31007158|NCT01525602|59208794|FG006|Overall Study|Disease progression|3|||
31007159|NCT01525602|59208795|FG007|Overall Study|Disease progression|3|||
31007160|NCT01525602|59208788|FG000|Overall Study|Clinical progression|2|||
31007161|NCT01525602|59208789|FG001|Overall Study|Clinical progression|0|||
31007162|NCT01525602|59208790|FG002|Overall Study|Clinical progression|0|||
31007163|NCT01525602|59208791|FG003|Overall Study|Clinical progression|0|||
31007164|NCT01525602|59208792|FG004|Overall Study|Clinical progression|0|||
31007165|NCT01525602|59208793|FG005|Overall Study|Clinical progression|0|||
31007166|NCT01525602|59208794|FG006|Overall Study|Clinical progression|1|||
31007167|NCT01525602|59208795|FG007|Overall Study|Clinical progression|1|||
31007168|NCT01525602|59208788|FG000|Overall Study|Non-compliance|0|||
31007169|NCT01525602|59208789|FG001|Overall Study|Non-compliance|0|||
31007170|NCT01525602|59208790|FG002|Overall Study|Non-compliance|0|||
31007171|NCT01525602|59208791|FG003|Overall Study|Non-compliance|0|||
31007172|NCT01525602|59208792|FG004|Overall Study|Non-compliance|1|||
31007173|NCT01525602|59208793|FG005|Overall Study|Non-compliance|0|||
31007174|NCT01525602|59208794|FG006|Overall Study|Non-compliance|0|||
31007175|NCT01525602|59208795|FG007|Overall Study|Non-compliance|0|||
31007176|NCT01525602|59208788|FG000|Overall Study|Withdrawal by Subject|0|||
31007177|NCT01525602|59208789|FG001|Overall Study|Withdrawal by Subject|0|||
31007178|NCT01525602|59208790|FG002|Overall Study|Withdrawal by Subject|0|||
31007179|NCT01525602|59208791|FG003|Overall Study|Withdrawal by Subject|0|||
31007180|NCT01525602|59208792|FG004|Overall Study|Withdrawal by Subject|3|||
31007181|NCT01525602|59208793|FG005|Overall Study|Withdrawal by Subject|1|||
30612403|NCT01134393|58623548|FG000|Overall Study|Withdrawal by Subject|11|||
30612404|NCT01134393|58623548|FG000|Overall Study|Other|6|||
30612405|NCT00922441|58623556|FG000|Overall Study|Protocol Violation|0|||
30612406|NCT00922441|58623557|FG001|Overall Study|Protocol Violation|0|||
30612407|NCT00922441|58623558|FG002|Overall Study|Protocol Violation|2|||
30612408|NCT00922441|58623556|FG000|Overall Study|Withdrawal by Subject|0|||
30612409|NCT00922441|58623557|FG001|Overall Study|Withdrawal by Subject|0|||
30612410|NCT00922441|58623558|FG002|Overall Study|Withdrawal by Subject|1|||
30612411|NCT01217112|58623571|FG000|Overall Study|Adverse Event|0|||
30612412|NCT01217112|58623572|FG001|Overall Study|Adverse Event|2|||
30612413|NCT01217112|58623573|FG002|Overall Study|Adverse Event|0|||
30612414|NCT01217112|58623574|FG003|Overall Study|Adverse Event|2|||
30612415|NCT01217112|58623575|FG004|Overall Study|Adverse Event|0|||
30612416|NCT01217112|58623571|FG000|Overall Study|Withdrawal by Subject|0|||
30612417|NCT01217112|58623572|FG001|Overall Study|Withdrawal by Subject|0|||
30612418|NCT01217112|58623573|FG002|Overall Study|Withdrawal by Subject|1|||
30612419|NCT01217112|58623574|FG003|Overall Study|Withdrawal by Subject|0|||
30612420|NCT01217112|58623575|FG004|Overall Study|Withdrawal by Subject|0|||
30612421|NCT01217112|58623571|FG000|Overall Study|Physician Decision|0|||
30612422|NCT01217112|58623572|FG001|Overall Study|Physician Decision|0|||
30612423|NCT01217112|58623573|FG002|Overall Study|Physician Decision|0|||
30612424|NCT01217112|58623574|FG003|Overall Study|Physician Decision|0|||
30612425|NCT01217112|58623575|FG004|Overall Study|Physician Decision|1|||
30612426|NCT01216332|58623589|FG000|Overall Study|Withdrawal by Subject|4|||
30612427|NCT01216332|58623590|FG001|Overall Study|Withdrawal by Subject|0|||
30612428|NCT00922207|58623599|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
30612429|NCT00922207|58623600|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
31007182|NCT01525602|59208794|FG006|Overall Study|Withdrawal by Subject|0|||
31007183|NCT01525602|59208795|FG007|Overall Study|Withdrawal by Subject|1|||
31007184|NCT01525602|59208788|FG000|Overall Study|Physician Decision|0|||
31007185|NCT01525602|59208789|FG001|Overall Study|Physician Decision|0|||
30612430|NCT00922207|58623601|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
30612431|NCT00922207|58623599|FG000|Overall Study|Insufficient Therapeutic Response|0|||
31007186|NCT01525602|59208790|FG002|Overall Study|Physician Decision|0|||
31007187|NCT01525602|59208791|FG003|Overall Study|Physician Decision|0|||
31007188|NCT01525602|59208792|FG004|Overall Study|Physician Decision|3|||
31007189|NCT01525602|59208793|FG005|Overall Study|Physician Decision|0|||
30612432|NCT00922207|58623600|FG001|Overall Study|Insufficient Therapeutic Response|0|||
30612433|NCT00922207|58623601|FG002|Overall Study|Insufficient Therapeutic Response|1|||
31007190|NCT01525602|59208794|FG006|Overall Study|Physician Decision|1|||
31007191|NCT01525602|59208795|FG007|Overall Study|Physician Decision|0|||
31007192|NCT01525602|59208788|FG000|Overall Study|Death|0|||
30892974|NCT02371759|58926422|FG006|Overall Study|Withdrawal by Subject|0|||
30892975|NCT02371759|58926423|FG007|Overall Study|Withdrawal by Subject|1|||
30892976|NCT02531633|58926446|FG000|Part A (52 Weeks)|Sponsor request|24|||
30892977|NCT02531633|58926447|FG001|Part A (52 Weeks)|Sponsor request|24|||
30892978|NCT02531633|58926448|FG002|Part A (52 Weeks)|Sponsor request|18|||
30892979|NCT02531633|58926449|FG003|Part A (52 Weeks)|Sponsor request|18|||
30892980|NCT02531633|58926450|FG004|Part A (52 Weeks)|Sponsor request|19|||
30892981|NCT02531633|58926451|FG005|Part A (52 Weeks)|Sponsor request|0|||
30892982|NCT02531633|58926452|FG006|Part A (52 Weeks)|Sponsor request|0|||
30892983|NCT02531633|58926453|FG007|Part A (52 Weeks)|Sponsor request|0|||
30892984|NCT02531633|58926454|FG008|Part A (52 Weeks)|Sponsor request|0|||
30892985|NCT02531633|58926455|FG009|Part A (52 Weeks)|Sponsor request|0|||
30892986|NCT02531633|58926446|FG000|Part A (52 Weeks)|Protocol Violation|1|||
30892987|NCT02531633|58926447|FG001|Part A (52 Weeks)|Protocol Violation|0|||
30612434|NCT00922207|58623599|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
30612435|NCT00922207|58623600|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
30612436|NCT00922207|58623601|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
30612437|NCT00922207|58623599|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
30612438|NCT00922207|58623600|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
30612439|NCT00922207|58623601|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
30612440|NCT00922207|58623599|FG000|Overall Study|Withdrew Consent|2|||
30612441|NCT00922207|58623600|FG001|Overall Study|Withdrew Consent|5|||
30612442|NCT00922207|58623601|FG002|Overall Study|Withdrew Consent|2|||
30612443|NCT00922207|58623599|FG000|Overall Study|Abnormality of Laboratory Test|0|||
30612444|NCT00922207|58623600|FG001|Overall Study|Abnormality of Laboratory Test|1|||
30612445|NCT00922207|58623601|FG002|Overall Study|Abnormality of Laboratory Test|1|||
30612446|NCT01134315|58623611|FG000|Overall Study|Adverse Event|1|||
30612447|NCT01134315|58623612|FG001|Overall Study|Adverse Event|2|||
30612448|NCT01134315|58623611|FG000|Overall Study|Other Reason|8|||
30612449|NCT01134315|58623612|FG001|Overall Study|Other Reason|17|||
30612450|NCT01216176|58623621|FG000|Overall Study|Adverse Event|0|||
30612451|NCT01216176|58623622|FG001|Overall Study|Adverse Event|8|||
30612452|NCT01216176|58623623|FG002|Overall Study|Adverse Event|0|||
30612453|NCT01216176|58623621|FG000|Overall Study|Physician Decision|0|||
30612454|NCT01216176|58623622|FG001|Overall Study|Physician Decision|0|||
30612455|NCT01216176|58623623|FG002|Overall Study|Physician Decision|1|||
30612456|NCT01133847|58623635|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
30612457|NCT01133847|58623636|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
30612458|NCT01133847|58623637|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
30612459|NCT01133847|58623635|FG000|Follow-Up Phase|Lost to Follow-up|1|||
30612460|NCT01133847|58623636|FG001|Follow-Up Phase|Lost to Follow-up|3|||
30612461|NCT01133847|58623637|FG002|Follow-Up Phase|Lost to Follow-up|7|||
30612462|NCT01133379|58623649|FG000|Overall Study|Withdrawal by Subject|0|||
30612463|NCT01133379|58623650|FG001|Overall Study|Withdrawal by Subject|1|||
30612464|NCT01133379|58623651|FG002|Overall Study|Withdrawal by Subject|1|||
30612465|NCT01133379|58623649|FG000|Overall Study|Lost to Follow-up|1|||
30612466|NCT01133379|58623650|FG001|Overall Study|Lost to Follow-up|1|||
30612467|NCT01133379|58623651|FG002|Overall Study|Lost to Follow-up|1|||
30612468|NCT01133067|58623659|FG000|Overall Study|Death|136|||
30612469|NCT01133067|58623659|FG000|Overall Study|Lost to Follow-up|3|||
30612470|NCT01132755|58623663|FG000|Overall Study|Procedure not done due to medical reason|23|||
30612471|NCT01132755|58623663|FG000|Overall Study|Protocol Violation|15|||
30612472|NCT01132755|58623663|FG000|Overall Study|Withdrawal by Subject|4|||
30612473|NCT00919711|58623669|FG000|Overall Study|Withdrawal by Subject|15|||
30612474|NCT00919711|58623670|FG001|Overall Study|Withdrawal by Subject|7|||
30612475|NCT00919711|58623669|FG000|Overall Study|Adverse Event|13|||
30612476|NCT00919711|58623670|FG001|Overall Study|Adverse Event|3|||
30612477|NCT00919711|58623669|FG000|Overall Study|Other|1|||
30612478|NCT00919711|58623670|FG001|Overall Study|Other|2|||
30612479|NCT00919711|58623669|FG000|Overall Study|Administrative Decision|0|||
30612480|NCT00919711|58623670|FG001|Overall Study|Administrative Decision|1|||
30612481|NCT00919711|58623669|FG000|Overall Study|Lost to Follow-up|2|||
30612482|NCT00919711|58623670|FG001|Overall Study|Lost to Follow-up|0|||
30612483|NCT00919711|58623669|FG000|Overall Study|Death|1|||
30612484|NCT00919711|58623670|FG001|Overall Study|Death|0|||
30892988|NCT02531633|58926448|FG002|Part A (52 Weeks)|Protocol Violation|0|||
30612485|NCT00919711|58623669|FG000|Overall Study|Noncompliance|1|||
30612486|NCT00919711|58623670|FG001|Overall Study|Noncompliance|0|||
30612487|NCT01131585|58623678|FG000|Overall Study|Adverse Event|0|||
30612488|NCT01131585|58623679|FG001|Overall Study|Adverse Event|2|||
30612489|NCT01131585|58623678|FG000|Overall Study|Abnormal laboratory value|1|||
30612490|NCT01131585|58623679|FG001|Overall Study|Abnormal laboratory value|0|||
30892989|NCT02531633|58926449|FG003|Part A (52 Weeks)|Protocol Violation|0|||
30612491|NCT01131585|58623678|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30612492|NCT01131585|58623679|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
30892990|NCT02531633|58926450|FG004|Part A (52 Weeks)|Protocol Violation|0|||
30892991|NCT02531633|58926451|FG005|Part A (52 Weeks)|Protocol Violation|0|||
30612493|NCT01131585|58623678|FG000|Overall Study|Protocol Violation|2|||
30612494|NCT01131585|58623679|FG001|Overall Study|Protocol Violation|1|||
30612495|NCT01131585|58623678|FG000|Overall Study|Withdrawal by Subject|3|||
30612496|NCT01131585|58623679|FG001|Overall Study|Withdrawal by Subject|3|||
30612497|NCT01131585|58623678|FG000|Overall Study|Lost to Follow-up|0|||
30612498|NCT01131585|58623679|FG001|Overall Study|Lost to Follow-up|1|||
30612499|NCT01131585|58623678|FG000|Overall Study|Administrative problems|1|||
30612500|NCT01131585|58623679|FG001|Overall Study|Administrative problems|1|||
30612501|NCT01131585|58623678|FG000|Overall Study|Study termination|78|||
30612502|NCT01131585|58623679|FG001|Overall Study|Study termination|32|||
30612503|NCT01131507|58623685|FG000|Overall Study|Adverse Event|1|||
30612504|NCT01131507|58623685|FG000|Overall Study|Lost to Follow-up|1|||
30612505|NCT01131507|58623685|FG000|Overall Study|Withdrawal by Subject|1|||
30612506|NCT01131351|58623691|FG000|Overall Study|Adverse Event|0|||
30612507|NCT01131351|58623692|FG001|Overall Study|Adverse Event|2|||
30612508|NCT01131351|58623691|FG000|Overall Study|Protocol Deviation|0|||
30612509|NCT01131351|58623692|FG001|Overall Study|Protocol Deviation|1|||
30698897|NCT00292981|58713454|FG000|Overall Study|Lost to Follow-up|13|||
30698898|NCT00292981|58713454|FG000|Overall Study|Withdrawal by Subject|22|||
30698899|NCT00292981|58713454|FG000|Overall Study|Other|3|||
30698900|NCT00296725|58713458|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
30698901|NCT00296725|58713458|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
30698902|NCT00296725|58713458|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
30698903|NCT00625872|58713466|FG000|Overall Study|Withdrawal by Subject|1|||
30698904|NCT00625872|58713467|FG001|Overall Study|Withdrawal by Subject|0|||
30698905|NCT00625872|58713466|FG000|Overall Study|Does not meet inclusion criteria|1|||
30698906|NCT00625872|58713467|FG001|Overall Study|Does not meet inclusion criteria|0|||
30892992|NCT02531633|58926452|FG006|Part A (52 Weeks)|Protocol Violation|0|||
30698907|NCT00625872|58713466|FG000|Overall Study|Terminated by sponsor|2|||
30698908|NCT00625872|58713467|FG001|Overall Study|Terminated by sponsor|5|||
30698909|NCT00625872|58713466|FG000|Overall Study|Randomized but not treated|0|||
30698910|NCT00625872|58713467|FG001|Overall Study|Randomized but not treated|1|||
30698911|NCT00523978|58713475|FG000|Overall Study|Withdrawal by Subject|3|||
30698912|NCT00523978|58713476|FG001|Overall Study|Withdrawal by Subject|7|||
30698913|NCT00523978|58713475|FG000|Overall Study|Screen Failures|5|||
30698914|NCT00523978|58713476|FG001|Overall Study|Screen Failures|1|||
30698915|NCT00523978|58713475|FG000|Overall Study|Death|1|||
30698916|NCT00523978|58713476|FG001|Overall Study|Death|0|||
30698917|NCT00296647|58713488|FG000|Overall Study|Death|4|||
30698918|NCT00296647|58713489|FG001|Overall Study|Death|1|||
30698919|NCT00296647|58713490|FG002|Overall Study|Death|2|||
30698920|NCT00296647|58713491|FG003|Overall Study|Death|1|||
30892993|NCT02531633|58926453|FG007|Part A (52 Weeks)|Protocol Violation|0|||
30892994|NCT02531633|58926454|FG008|Part A (52 Weeks)|Protocol Violation|0|||
30892995|NCT02531633|58926455|FG009|Part A (52 Weeks)|Protocol Violation|0|||
30892996|NCT02531633|58926446|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
30892997|NCT02531633|58926447|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
30892998|NCT02531633|58926448|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
30892999|NCT02531633|58926449|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
30893000|NCT02531633|58926450|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
30893001|NCT02531633|58926451|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
30893002|NCT02531633|58926452|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
30893003|NCT02531633|58926453|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
30893004|NCT02531633|58926454|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
30893005|NCT02531633|58926455|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
30893006|NCT02531633|58926446|FG000|Part A (52 Weeks)|Physician Decision|1|||
30893007|NCT02531633|58926447|FG001|Part A (52 Weeks)|Physician Decision|4|||
30893008|NCT02531633|58926448|FG002|Part A (52 Weeks)|Physician Decision|3|||
30893009|NCT02531633|58926449|FG003|Part A (52 Weeks)|Physician Decision|1|||
30612510|NCT00919633|58623702|FG000|Overall Study|Adverse Event|1|||
30612511|NCT00919633|58623703|FG001|Overall Study|Adverse Event|9|||
30612512|NCT00919633|58623704|FG002|Overall Study|Adverse Event|12|||
30612513|NCT00919633|58623705|FG003|Overall Study|Adverse Event|10|||
30698921|NCT00296647|58713492|FG004|Overall Study|Death|1|||
30698922|NCT00296647|58713488|FG000|Overall Study|Withdrawal by Subject|28|||
30698923|NCT00296647|58713489|FG001|Overall Study|Withdrawal by Subject|27|||
30698924|NCT00296647|58713490|FG002|Overall Study|Withdrawal by Subject|32|||
30698925|NCT00296647|58713491|FG003|Overall Study|Withdrawal by Subject|16|||
30698926|NCT00296647|58713492|FG004|Overall Study|Withdrawal by Subject|19|||
30612514|NCT00919633|58623702|FG000|Overall Study|Death|0|||
30698927|NCT00754013|58713506|FG000|Overall Study|Lost to Follow-up|1|||
30893010|NCT02531633|58926450|FG004|Part A (52 Weeks)|Physician Decision|0|||
30893011|NCT02531633|58926451|FG005|Part A (52 Weeks)|Physician Decision|0|||
30893012|NCT02531633|58926452|FG006|Part A (52 Weeks)|Physician Decision|0|||
30893013|NCT02531633|58926453|FG007|Part A (52 Weeks)|Physician Decision|0|||
31007193|NCT01525602|59208789|FG001|Overall Study|Death|0|||
30698928|NCT00754013|58713507|FG001|Overall Study|Lost to Follow-up|1|||
30698929|NCT00754013|58713506|FG000|Overall Study|didn't return after study termed|3|||
30893014|NCT02531633|58926454|FG008|Part A (52 Weeks)|Physician Decision|0|||
30893015|NCT02531633|58926455|FG009|Part A (52 Weeks)|Physician Decision|0|||
31007194|NCT01525602|59208790|FG002|Overall Study|Death|0|||
31007195|NCT01525602|59208791|FG003|Overall Study|Death|0|||
31007196|NCT01525602|59208792|FG004|Overall Study|Death|1|||
31007197|NCT01525602|59208793|FG005|Overall Study|Death|1|||
31007198|NCT01525602|59208794|FG006|Overall Study|Death|0|||
31007199|NCT01525602|59208795|FG007|Overall Study|Death|0|||
30698930|NCT00754013|58713507|FG001|Overall Study|didn't return after study termed|4|||
30698931|NCT00523744|58713513|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
30698932|NCT00523744|58713513|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
30698933|NCT00523744|58713513|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
30698934|NCT00523744|58713513|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
30698935|NCT00523744|58713513|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
30698936|NCT00523744|58713513|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
30698937|NCT00752219|58713531|FG000|Overall Study|Clinical failure|0|||
30698938|NCT00752219|58713532|FG001|Overall Study|Clinical failure|1|||
30698939|NCT00752219|58713531|FG000|Overall Study|Adverse Event|5|||
30698940|NCT00752219|58713532|FG001|Overall Study|Adverse Event|3|||
30698941|NCT00752219|58713531|FG000|Overall Study|Protocol deviation|1|||
30698942|NCT00752219|58713532|FG001|Overall Study|Protocol deviation|0|||
30698943|NCT00752219|58713531|FG000|Overall Study|Lost to Follow-up|1|||
30698944|NCT00752219|58713532|FG001|Overall Study|Lost to Follow-up|2|||
30698945|NCT00752219|58713531|FG000|Overall Study|Randomized but not treated|1|||
30698946|NCT00752219|58713532|FG001|Overall Study|Randomized but not treated|0|||
30698947|NCT00752219|58713531|FG000|Overall Study|Other|3|||
30698948|NCT00752219|58713532|FG001|Overall Study|Other|0|||
30698949|NCT00622908|58713540|FG000|Overall Study|Protocol Violation|1|||
30698950|NCT00622908|58713541|FG001|Overall Study|Protocol Violation|0|||
30698951|NCT00622908|58713540|FG000|Overall Study|Adverse Event|0|||
30698952|NCT00622908|58713541|FG001|Overall Study|Adverse Event|1|||
30698953|NCT00622908|58713540|FG000|Overall Study|Lack of Efficacy|1|||
30698954|NCT00622908|58713541|FG001|Overall Study|Lack of Efficacy|7|||
30698955|NCT00622908|58713540|FG000|Overall Study|Lost to Follow-up|1|||
30698956|NCT00622908|58713541|FG001|Overall Study|Lost to Follow-up|0|||
30698957|NCT00622908|58713540|FG000|Overall Study|Refusal|0|||
30698958|NCT00622908|58713541|FG001|Overall Study|Refusal|1|||
30698959|NCT00622908|58713540|FG000|Overall Study|Termination by study sponser|0|||
30698960|NCT00622908|58713541|FG001|Overall Study|Termination by study sponser|1|||
30698961|NCT00296491|58713551|FG000|Overall Study|Low Pollen Counts|18|||
30698962|NCT00296491|58713552|FG001|Overall Study|Low Pollen Counts|26|||
30698963|NCT00296491|58713553|FG002|Overall Study|Low Pollen Counts|25|||
30698964|NCT00296491|58713554|FG003|Overall Study|Low Pollen Counts|16|||
30698965|NCT00296491|58713551|FG000|Overall Study|Protocol Violation|4|||
30698966|NCT00296491|58713552|FG001|Overall Study|Protocol Violation|6|||
30698967|NCT00296491|58713553|FG002|Overall Study|Protocol Violation|2|||
30698968|NCT00296491|58713554|FG003|Overall Study|Protocol Violation|3|||
30698969|NCT00296491|58713551|FG000|Overall Study|Adverse Event|1|||
30698970|NCT00296491|58713552|FG001|Overall Study|Adverse Event|3|||
30698971|NCT00296491|58713553|FG002|Overall Study|Adverse Event|1|||
30698972|NCT00296491|58713554|FG003|Overall Study|Adverse Event|4|||
30698973|NCT00296491|58713551|FG000|Overall Study|Withdrawn due to Asthma|0|||
30698974|NCT00296491|58713552|FG001|Overall Study|Withdrawn due to Asthma|0|||
30698975|NCT00296491|58713553|FG002|Overall Study|Withdrawn due to Asthma|0|||
30698976|NCT00296491|58713554|FG003|Overall Study|Withdrawn due to Asthma|4|||
30698977|NCT00296491|58713551|FG000|Overall Study|Withdrawal by Subject|7|||
31007200|NCT01525602|59208788|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
31007201|NCT01525602|59208789|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
31007202|NCT01525602|59208790|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
31007203|NCT01525602|59208791|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
31007204|NCT01525602|59208792|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
31007205|NCT01525602|59208793|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
31007206|NCT01525602|59208794|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
31007207|NCT01525602|59208795|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
30698978|NCT00296491|58713552|FG001|Overall Study|Withdrawal by Subject|3|||
30698979|NCT00296491|58713553|FG002|Overall Study|Withdrawal by Subject|3|||
30698980|NCT00296491|58713554|FG003|Overall Study|Withdrawal by Subject|2|||
30698981|NCT00296491|58713551|FG000|Overall Study|Non-Compliance|12|||
30698982|NCT00296491|58713552|FG001|Overall Study|Non-Compliance|13|||
30698983|NCT00296491|58713553|FG002|Overall Study|Non-Compliance|10|||
30698984|NCT00296491|58713554|FG003|Overall Study|Non-Compliance|14|||
30698985|NCT00296491|58713551|FG000|Overall Study|Lost to Follow-up|0|||
30698986|NCT00296491|58713552|FG001|Overall Study|Lost to Follow-up|2|||
30893016|NCT02531633|58926446|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
30698987|NCT00296491|58713553|FG002|Overall Study|Lost to Follow-up|2|||
30698988|NCT00296491|58713554|FG003|Overall Study|Lost to Follow-up|0|||
30698989|NCT00747617|58713573|FG000|Overall Study|Lost to Follow-up|3|||
30698990|NCT00747617|58713574|FG001|Overall Study|Lost to Follow-up|1|||
30698991|NCT00296335|58713582|FG000|Overall Study|Recurrence|3|||
30698992|NCT00296335|58713583|FG001|Overall Study|Recurrence|51|||
30698993|NCT00296335|58713582|FG000|Overall Study|Adverse Event|17|||
30698994|NCT00296335|58713583|FG001|Overall Study|Adverse Event|27|||
30698995|NCT00296335|58713582|FG000|Overall Study|Lost to Follow-up|7|||
30698996|NCT00296335|58713583|FG001|Overall Study|Lost to Follow-up|33|||
30698997|NCT00296335|58713582|FG000|Overall Study|Physician Decision|3|||
30698998|NCT00296335|58713583|FG001|Overall Study|Physician Decision|11|||
30698999|NCT00747461|58713591|FG000|Overall Study|study terminated by sponsor|5|||
30699000|NCT03683758|58713598|FG000|Overall Study|Non-study commitment conflict|1|||
30699001|NCT03683758|58713599|FG001|Overall Study|Non-study commitment conflict|3|||
30699002|NCT03683758|58713598|FG000|Overall Study|Illness preventing participation|1|||
30699003|NCT03683758|58713599|FG001|Overall Study|Illness preventing participation|0|||
30699004|NCT03683758|58713598|FG000|Overall Study|Adverse Event|1|||
30699005|NCT03683758|58713599|FG001|Overall Study|Adverse Event|0|||
30699006|NCT00522418|58713607|FG000|Overall Study|Local IRB Consent Violation|5|||
30699007|NCT00522418|58713608|FG001|Overall Study|Local IRB Consent Violation|5|||
30699008|NCT00522418|58713607|FG000|Overall Study|Early Study Termination|46|||
30699009|NCT00522418|58713608|FG001|Overall Study|Early Study Termination|47|||
31007208|NCT01549002|59208822|FG000|Overall Study|Excessive pain|0|||
31007209|NCT01549002|59208823|FG001|Overall Study|Excessive pain|2|||
31007210|NCT01549002|59208822|FG000|Overall Study|Moderate sedation required|0|||
31007211|NCT01549002|59208823|FG001|Overall Study|Moderate sedation required|2|||
31007212|NCT01548768|59208833|FG000|Overall Study|Withdrawal by Subject|0|||
31007213|NCT01548768|59208834|FG001|Overall Study|Withdrawal by Subject|2|||
31007214|NCT01548768|59208835|FG002|Overall Study|Withdrawal by Subject|1|||
31007215|NCT01548768|59208836|FG003|Overall Study|Withdrawal by Subject|0|||
31007216|NCT01548768|59208833|FG000|Overall Study|Physician Decision|1|||
31007217|NCT01548768|59208834|FG001|Overall Study|Physician Decision|0|||
31007218|NCT01548768|59208835|FG002|Overall Study|Physician Decision|0|||
31007219|NCT01548768|59208836|FG003|Overall Study|Physician Decision|0|||
31007220|NCT01548768|59208833|FG000|Overall Study|Adverse Event|0|||
31007221|NCT01548768|59208834|FG001|Overall Study|Adverse Event|0|||
31007222|NCT01548768|59208835|FG002|Overall Study|Adverse Event|0|||
31007223|NCT01548768|59208836|FG003|Overall Study|Adverse Event|1|||
31007224|NCT01548768|59208833|FG000|Overall Study|Non-Compliance|0|||
31007225|NCT01548768|59208834|FG001|Overall Study|Non-Compliance|0|||
31007226|NCT01548768|59208835|FG002|Overall Study|Non-Compliance|0|||
31007227|NCT01548768|59208836|FG003|Overall Study|Non-Compliance|3|||
31007228|NCT01572792|59208853|FG000|Lead-in Study|Lost to Follow-up|5|||
31007229|NCT01572792|59208854|FG001|Lead-in Study|Lost to Follow-up|9|||
30612515|NCT00919633|58623703|FG001|Overall Study|Death|0|||
30612516|NCT00919633|58623704|FG002|Overall Study|Death|2|||
30612517|NCT00919633|58623705|FG003|Overall Study|Death|0|||
30612518|NCT00919633|58623702|FG000|Overall Study|Lack of Efficacy|17|||
30612519|NCT00919633|58623703|FG001|Overall Study|Lack of Efficacy|3|||
30612520|NCT00919633|58623704|FG002|Overall Study|Lack of Efficacy|2|||
30612521|NCT00919633|58623705|FG003|Overall Study|Lack of Efficacy|3|||
30612522|NCT00919633|58623702|FG000|Overall Study|Withdrawal by Subject|1|||
30612523|NCT00919633|58623703|FG001|Overall Study|Withdrawal by Subject|2|||
30612524|NCT00919633|58623704|FG002|Overall Study|Withdrawal by Subject|4|||
30612525|NCT00919633|58623705|FG003|Overall Study|Withdrawal by Subject|3|||
30612526|NCT00919633|58623702|FG000|Overall Study|Lost to Follow-up|3|||
30612527|NCT00919633|58623703|FG001|Overall Study|Lost to Follow-up|1|||
30612528|NCT00919633|58623704|FG002|Overall Study|Lost to Follow-up|0|||
30612529|NCT00919633|58623705|FG003|Overall Study|Lost to Follow-up|2|||
30612530|NCT00919633|58623702|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
30612531|NCT00919633|58623703|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
30612532|NCT00919633|58623704|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
30699010|NCT00522418|58713607|FG000|Overall Study|Noncompliance|2|||
31007230|NCT01572792|59208855|FG002|Lead-in Study|Lost to Follow-up|4|||
31007231|NCT01572792|59208856|FG003|Lead-in Study|Lost to Follow-up|2|||
31007232|NCT01572792|59208857|FG004|Lead-in Study|Lost to Follow-up|4|||
30699011|NCT00522418|58713608|FG001|Overall Study|Noncompliance|2|||
30699012|NCT00522418|58713607|FG000|Overall Study|Reason Not Specified|3|||
30699013|NCT00522418|58713608|FG001|Overall Study|Reason Not Specified|1|||
31007233|NCT01572792|59208853|FG000|Lead-in Study|Withdrawal by Subject|22|||
31007234|NCT01572792|59208854|FG001|Lead-in Study|Withdrawal by Subject|11|||
31007235|NCT01572792|59208855|FG002|Lead-in Study|Withdrawal by Subject|12|||
31007236|NCT01572792|59208856|FG003|Lead-in Study|Withdrawal by Subject|24|||
30612533|NCT00919633|58623705|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
30612534|NCT00919633|58623702|FG000|Overall Study|Protocol Violation|0|||
30612535|NCT00919633|58623703|FG001|Overall Study|Protocol Violation|0|||
30699014|NCT00522418|58713607|FG000|Overall Study|Consent Withdraw|1|||
30699015|NCT00522418|58713608|FG001|Overall Study|Consent Withdraw|2|||
31007237|NCT01572792|59208857|FG004|Lead-in Study|Withdrawal by Subject|11|||
30699016|NCT00522418|58713607|FG000|Overall Study|Lack of Efficacy|0|||
30699017|NCT00522418|58713608|FG001|Overall Study|Lack of Efficacy|1|||
30699018|NCT00624780|58713622|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
30699019|NCT00624780|58713623|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
30699020|NCT00624780|58713624|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
30699021|NCT00624780|58713625|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
30699022|NCT00624780|58713626|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
30699023|NCT00624780|58713627|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
30699024|NCT00624780|58713622|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
30699025|NCT00624780|58713623|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
30699026|NCT00624780|58713624|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
30699027|NCT00624780|58713625|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
30699028|NCT00624780|58713626|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
30699029|NCT00624780|58713627|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
30699030|NCT00624780|58713622|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
30699031|NCT00624780|58713623|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
30699032|NCT00624780|58713624|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
30699033|NCT00624780|58713625|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
30699034|NCT00624780|58713626|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
30699035|NCT00624780|58713627|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
30699036|NCT00624780|58713622|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
30699037|NCT00624780|58713623|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
30699038|NCT00624780|58713624|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
30612536|NCT00919633|58623704|FG002|Overall Study|Protocol Violation|0|||
30612537|NCT00919633|58623705|FG003|Overall Study|Protocol Violation|1|||
30612538|NCT00919633|58623702|FG000|Overall Study|Physician Decision|0|||
30612539|NCT00919633|58623703|FG001|Overall Study|Physician Decision|0|||
30612540|NCT00919633|58623704|FG002|Overall Study|Physician Decision|0|||
30612541|NCT00919633|58623705|FG003|Overall Study|Physician Decision|1|||
30612542|NCT00919633|58623702|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
30612543|NCT00919633|58623703|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
30612544|NCT00919633|58623704|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
30612545|NCT00919633|58623705|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
30612546|NCT00919633|58623702|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
30612547|NCT00919633|58623703|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
30612548|NCT00919633|58623704|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
30612549|NCT00919633|58623705|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
30612550|NCT01130883|58623715|FG000|Overall Study|Patient Noncompliance|6|||
30612551|NCT01130883|58623715|FG000|Overall Study|Reason Unknown|1|||
30612552|NCT01130883|58623715|FG000|Overall Study|Adverse Event|3|||
30612553|NCT00926029|58623722|FG000|Overall Study|Lost to Follow-up|2|||
30612554|NCT00926029|58623723|FG001|Overall Study|Lost to Follow-up|1|||
30612555|NCT00926029|58623724|FG002|Overall Study|Lost to Follow-up|1|||
30612556|NCT01130493|58623734|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
30612557|NCT01130493|58623735|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
30612558|NCT01130493|58623736|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
30699039|NCT00624780|58713625|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
30790770|NCT03524092|58803945|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
30612559|NCT01130493|58623734|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
30612560|NCT01130493|58623735|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
30612561|NCT01130493|58623736|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
30699040|NCT00624780|58713626|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
30699041|NCT00624780|58713627|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
30699042|NCT00624780|58713622|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
30699043|NCT00624780|58713623|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
30699044|NCT00624780|58713624|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
30699045|NCT00624780|58713625|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
30699046|NCT00624780|58713626|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
30699047|NCT00624780|58713627|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
30699048|NCT00624780|58713622|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
30699049|NCT00624780|58713623|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
30699050|NCT00624780|58713624|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
30699051|NCT00624780|58713625|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
30699052|NCT00624780|58713626|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
30699053|NCT00624780|58713627|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
30699054|NCT00624780|58713622|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
30699055|NCT00624780|58713623|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
30699056|NCT00624780|58713624|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
30699057|NCT00624780|58713625|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
30699058|NCT00624780|58713626|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
30699059|NCT00624780|58713627|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
30699060|NCT00624780|58713622|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
30699061|NCT00624780|58713623|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
30699062|NCT00624780|58713624|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
30699063|NCT00624780|58713625|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
30699064|NCT00624780|58713626|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
30699065|NCT00624780|58713627|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
30699066|NCT00624780|58713622|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
30699067|NCT00624780|58713623|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
30699068|NCT00624780|58713624|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
30699069|NCT00624780|58713625|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
30699070|NCT00624780|58713626|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
30699071|NCT00624780|58713627|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
30699072|NCT00624780|58713622|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
30699073|NCT00624780|58713623|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
30699074|NCT00624780|58713624|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
30612562|NCT01130493|58623734|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
30612563|NCT01130493|58623735|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
30612564|NCT01130493|58623736|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
30612565|NCT01130493|58623734|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
30612566|NCT01130493|58623735|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
30612567|NCT01130493|58623736|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
30893017|NCT02531633|58926447|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
31007238|NCT01572792|59208853|FG000|Lead-in Study|Protocol Violation|19|||
30699075|NCT00624780|58713625|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
30699076|NCT00624780|58713626|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
30699077|NCT00624780|58713627|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
30699078|NCT00624780|58713622|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
30699079|NCT00624780|58713623|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
30699080|NCT00624780|58713624|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
30699081|NCT00624780|58713625|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
30699082|NCT00624780|58713626|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
30699083|NCT00624780|58713627|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
30699084|NCT00624780|58713622|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
30699085|NCT00624780|58713623|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
30699086|NCT00624780|58713624|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
30699087|NCT00624780|58713625|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
30699088|NCT00624780|58713626|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
30699089|NCT00624780|58713627|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
30699090|NCT00624780|58713622|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
30699091|NCT00624780|58713623|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
30699092|NCT00624780|58713624|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
30699093|NCT00624780|58713625|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
31007239|NCT01572792|59208854|FG001|Lead-in Study|Protocol Violation|10|||
31007240|NCT01572792|59208855|FG002|Lead-in Study|Protocol Violation|12|||
30612568|NCT01130493|58623734|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
30699094|NCT00624780|58713626|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
30893018|NCT02531633|58926448|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
30893019|NCT02531633|58926449|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
31007241|NCT01572792|59208856|FG003|Lead-in Study|Protocol Violation|13|||
30699095|NCT00624780|58713627|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
30699096|NCT00624780|58713622|FG000|Follow-up (Week 26)|Death|0|||
30699097|NCT00624780|58713623|FG001|Follow-up (Week 26)|Death|0|||
30699098|NCT00624780|58713624|FG002|Follow-up (Week 26)|Death|1|||
30699099|NCT00624780|58713625|FG003|Follow-up (Week 26)|Death|0|||
30699100|NCT00624780|58713626|FG004|Follow-up (Week 26)|Death|0|||
30699101|NCT00624780|58713627|FG005|Follow-up (Week 26)|Death|0|||
30699102|NCT00624780|58713622|FG000|Follow-up (Week 26)|Adverse Event|0|||
30699103|NCT00624780|58713623|FG001|Follow-up (Week 26)|Adverse Event|0|||
30699104|NCT00624780|58713624|FG002|Follow-up (Week 26)|Adverse Event|0|||
30699105|NCT00624780|58713625|FG003|Follow-up (Week 26)|Adverse Event|0|||
30699106|NCT00624780|58713626|FG004|Follow-up (Week 26)|Adverse Event|1|||
30699107|NCT00624780|58713627|FG005|Follow-up (Week 26)|Adverse Event|0|||
30699108|NCT00624780|58713622|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
30699109|NCT00624780|58713623|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
30699110|NCT00624780|58713624|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
30699111|NCT00624780|58713625|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
30699112|NCT00624780|58713626|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
30699113|NCT00624780|58713627|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
30699114|NCT00624780|58713622|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
30699115|NCT00624780|58713623|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
30699116|NCT00624780|58713624|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
30699117|NCT00624780|58713625|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
30699118|NCT00624780|58713626|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
30699119|NCT00624780|58713627|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
30699120|NCT00624780|58713622|FG000|Follow-up (Week 26)|Other|1|||
30699121|NCT00624780|58713623|FG001|Follow-up (Week 26)|Other|1|||
30699122|NCT00624780|58713624|FG002|Follow-up (Week 26)|Other|0|||
30699123|NCT00624780|58713625|FG003|Follow-up (Week 26)|Other|0|||
30699124|NCT00624780|58713626|FG004|Follow-up (Week 26)|Other|0|||
30699125|NCT00624780|58713627|FG005|Follow-up (Week 26)|Other|0|||
30699126|NCT00750893|58713644|FG000|Overall Study|Adverse Event|5|||
30699127|NCT00750893|58713644|FG000|Overall Study|Withdrawal by Subject|10|||
30699128|NCT00750893|58713644|FG000|Overall Study|Lost to Follow-up|510|||
30699129|NCT00750893|58713644|FG000|Overall Study|Other|17|||
30699130|NCT00753623|58713650|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
30699131|NCT00753623|58713651|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
30699132|NCT00753623|58713650|FG000|Phase I (14 Days)|Physician Decision|1|||
30699133|NCT00753623|58713651|FG001|Phase I (14 Days)|Physician Decision|2|||
30699134|NCT00753623|58713650|FG000|Phase I (14 Days)|Adverse Event|0|||
30699135|NCT00753623|58713651|FG001|Phase I (14 Days)|Adverse Event|1|||
30699136|NCT00753623|58713650|FG000|Washout (7 Days)|Physician Decision|1|||
30699137|NCT00753623|58713651|FG001|Washout (7 Days)|Physician Decision|0|||
30699138|NCT00753623|58713650|FG000|Phase II (14 Days)|Physician Decision|0|||
30699139|NCT00753623|58713651|FG001|Phase II (14 Days)|Physician Decision|1|||
30699140|NCT00750737|58713659|FG000|Overall Study|Withdrawal by Subject|3|||
30699141|NCT00750737|58713660|FG001|Overall Study|Withdrawal by Subject|3|||
30699142|NCT00622440|58713668|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
30699143|NCT00622440|58713669|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
30699144|NCT00622440|58713668|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
30699145|NCT00622440|58713669|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
30699146|NCT00622440|58713668|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
30699147|NCT00622440|58713669|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
30699148|NCT00622440|58713668|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
30699149|NCT00622440|58713669|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
30699150|NCT00744653|58713675|FG000|Overall Study|antineoplastic treatment|11|||
30699151|NCT00744653|58713675|FG000|Overall Study|Death|1|||
30699152|NCT00744653|58713675|FG000|Overall Study|Lost to Follow-up|1|||
30699153|NCT00744653|58713675|FG000|Overall Study|Physician Decision|3|||
30699154|NCT00311311|58713682|FG000|Overall Study|Adverse Event|3|||
30699155|NCT00311311|58713683|FG001|Overall Study|Adverse Event|2|||
30699156|NCT00311311|58713682|FG000|Overall Study|Withdrawal by Subject|1|||
30699157|NCT00311311|58713683|FG001|Overall Study|Withdrawal by Subject|1|||
30699158|NCT00311311|58713682|FG000|Overall Study|Noncompliance|0|||
30699159|NCT00311311|58713683|FG001|Overall Study|Noncompliance|1|||
30699160|NCT00311311|58713682|FG000|Overall Study|Study Termination by Sponsor|3|||
30699161|NCT00311311|58713683|FG001|Overall Study|Study Termination by Sponsor|4|||
30699162|NCT00311311|58713682|FG000|Overall Study|Death|1|||
30699163|NCT00311311|58713683|FG001|Overall Study|Death|0|||
30699164|NCT00311311|58713682|FG000|Overall Study|Lack of ancillary assistance|0|||
30699165|NCT00311311|58713683|FG001|Overall Study|Lack of ancillary assistance|1|||
30699166|NCT00521404|58713689|FG000|Overall Study|Adverse Event|13|||
30893020|NCT02531633|58926450|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
30699167|NCT00521404|58713689|FG000|Overall Study|Disease Progression|33|||
30699168|NCT00521404|58713689|FG000|Overall Study|Investigator decision|5|||
30699169|NCT00521404|58713689|FG000|Overall Study|Withdrawal of consent|3|||
30699170|NCT00521404|58713689|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
30699171|NCT00521404|58713689|FG000|Overall Study|Other|7|||
30699172|NCT00311155|58713693|FG000|Overall Study|Adverse Event|21|||
30699173|NCT00311155|58713693|FG000|Overall Study|Withdrawal by Subject|17|||
30699174|NCT00311155|58713693|FG000|Overall Study|Did not meet entry criteria|55|||
30699175|NCT00292045|58713697|FG000|Core Study (Through Week 13)|Adverse Event|1|||
30699176|NCT00292045|58713697|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
30612569|NCT01130493|58623735|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
30893021|NCT02531633|58926451|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
30893022|NCT02531633|58926452|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
30893023|NCT02531633|58926453|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
30893024|NCT02531633|58926454|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
30612570|NCT01130493|58623736|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
30612571|NCT01130493|58623734|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
30612572|NCT01130493|58623735|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
30612573|NCT01130493|58623736|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
30612574|NCT01130493|58623734|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
30612575|NCT01130493|58623735|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
30612576|NCT01130493|58623736|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
30612577|NCT01130493|58623734|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
30612578|NCT01130493|58623735|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
30612579|NCT01130493|58623736|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
30612580|NCT01130493|58623734|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
30612581|NCT01130493|58623735|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
30612582|NCT01130493|58623736|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
30612583|NCT01130493|58623734|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
30612584|NCT01130493|58623735|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
30612585|NCT01130493|58623736|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
30612586|NCT01130493|58623734|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
30612587|NCT01130493|58623735|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
30612588|NCT01130493|58623736|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
30612589|NCT01130493|58623734|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
30612590|NCT01130493|58623735|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
30612591|NCT01130493|58623736|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
30612592|NCT01130493|58623734|FG000|Part 2: OLE|Adverse Event|0|||
30612593|NCT01130493|58623735|FG001|Part 2: OLE|Adverse Event|2|||
30612594|NCT01130493|58623736|FG002|Part 2: OLE|Adverse Event|1|||
30612595|NCT01130493|58623734|FG000|Part 2: OLE|Withdrawal by Subject|0|||
30612596|NCT01130493|58623735|FG001|Part 2: OLE|Withdrawal by Subject|1|||
30612597|NCT01130493|58623736|FG002|Part 2: OLE|Withdrawal by Subject|4|||
30612598|NCT01130337|58623747|FG000|Overall Study|Withdrawal by Subject|3|||
30612599|NCT01130337|58623747|FG000|Overall Study|Principal investigator decision|1|||
30612600|NCT01130337|58623747|FG000|Overall Study|Death|1|||
30612601|NCT01130337|58623747|FG000|Overall Study|Disease progression|1|||
30612602|NCT01130337|58623747|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
30612603|NCT01130337|58623747|FG000|Overall Study|Surgical resection (R2)|1|||
30612604|NCT01130103|58623753|FG000|Randomized Treatment|Adverse Event|1|||
30612605|NCT01130103|58623754|FG001|Randomized Treatment|Adverse Event|1|||
30612606|NCT01130103|58623753|FG000|Randomized Treatment|Lost to Follow-up|1|||
30612607|NCT01130103|58623754|FG001|Randomized Treatment|Lost to Follow-up|0|||
30612608|NCT01130103|58623753|FG000|Randomized Treatment|Protocol Violation|3|||
30612609|NCT01130103|58623754|FG001|Randomized Treatment|Protocol Violation|2|||
30612610|NCT01130103|58623753|FG000|Randomized Treatment|Withdrawal by Subject|1|||
30612611|NCT01130103|58623754|FG001|Randomized Treatment|Withdrawal by Subject|2|||
30612612|NCT01130103|58623753|FG000|Maintenance Treatment|Lack of Efficacy|0|||
30612613|NCT01130103|58623754|FG001|Maintenance Treatment|Lack of Efficacy|1|||
30612614|NCT01130103|58623753|FG000|Maintenance Treatment|Lost to Follow-up|1|||
30699177|NCT00274651|58713703|FG000|Overall Study|Adverse Event|6|||
30699178|NCT00274651|58713704|FG001|Overall Study|Adverse Event|3|||
30893025|NCT02531633|58926455|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
30612615|NCT01130103|58623754|FG001|Maintenance Treatment|Lost to Follow-up|1|||
30612616|NCT01130103|58623753|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
30612617|NCT01130103|58623754|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
30612618|NCT01129557|58623763|FG000|Overall Study|Adverse Event|1|||
30612619|NCT01129557|58623764|FG001|Overall Study|Adverse Event|2|||
30699179|NCT00274651|58713703|FG000|Overall Study|Lack of Efficacy|13|||
30893026|NCT02531633|58926446|FG000|Part A (52 Weeks)|Other|2|||
30699180|NCT00274651|58713704|FG001|Overall Study|Lack of Efficacy|6|||
30893027|NCT02531633|58926447|FG001|Part A (52 Weeks)|Other|0|||
30893028|NCT02531633|58926448|FG002|Part A (52 Weeks)|Other|0|||
30893029|NCT02531633|58926449|FG003|Part A (52 Weeks)|Other|0|||
30893030|NCT02531633|58926450|FG004|Part A (52 Weeks)|Other|0|||
31007242|NCT01572792|59208857|FG004|Lead-in Study|Protocol Violation|21|||
31007243|NCT01572792|59208853|FG000|Lead-in Study|Lack of Efficacy|20|||
31007244|NCT01572792|59208854|FG001|Lead-in Study|Lack of Efficacy|5|||
31007245|NCT01572792|59208855|FG002|Lead-in Study|Lack of Efficacy|4|||
31007246|NCT01572792|59208856|FG003|Lead-in Study|Lack of Efficacy|8|||
31007247|NCT01572792|59208857|FG004|Lead-in Study|Lack of Efficacy|10|||
31007248|NCT01572792|59208853|FG000|Lead-in Study|Adverse Event|21|||
31007249|NCT01572792|59208854|FG001|Lead-in Study|Adverse Event|21|||
31007250|NCT01572792|59208855|FG002|Lead-in Study|Adverse Event|22|||
31007251|NCT01572792|59208856|FG003|Lead-in Study|Adverse Event|16|||
31007252|NCT01572792|59208857|FG004|Lead-in Study|Adverse Event|14|||
31007253|NCT01572792|59208853|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
31007254|NCT01572792|59208854|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
31007255|NCT01572792|59208855|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
31007256|NCT01572792|59208856|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
31007257|NCT01572792|59208857|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
31007258|NCT01572792|59208853|FG000|Extension Study|Lost to Follow-up|6|||
31007259|NCT01572792|59208854|FG001|Extension Study|Lost to Follow-up|2|||
31007260|NCT01572792|59208855|FG002|Extension Study|Lost to Follow-up|0|||
31007261|NCT01572792|59208856|FG003|Extension Study|Lost to Follow-up|3|||
31007262|NCT01572792|59208857|FG004|Extension Study|Lost to Follow-up|3|||
31007263|NCT01572792|59208853|FG000|Extension Study|Withdrawal by Subject|7|||
31007264|NCT01572792|59208854|FG001|Extension Study|Withdrawal by Subject|6|||
31007265|NCT01572792|59208855|FG002|Extension Study|Withdrawal by Subject|11|||
31007266|NCT01572792|59208856|FG003|Extension Study|Withdrawal by Subject|8|||
31007267|NCT01572792|59208857|FG004|Extension Study|Withdrawal by Subject|14|||
31007268|NCT01572792|59208853|FG000|Extension Study|Protocol Violation|0|||
31007269|NCT01572792|59208854|FG001|Extension Study|Protocol Violation|4|||
31007270|NCT01572792|59208855|FG002|Extension Study|Protocol Violation|3|||
31007271|NCT01572792|59208856|FG003|Extension Study|Protocol Violation|4|||
31007272|NCT01572792|59208857|FG004|Extension Study|Protocol Violation|3|||
31007273|NCT01572792|59208853|FG000|Extension Study|Lack of Efficacy|2|||
31007274|NCT01572792|59208854|FG001|Extension Study|Lack of Efficacy|3|||
31007275|NCT01572792|59208855|FG002|Extension Study|Lack of Efficacy|3|||
31007276|NCT01572792|59208856|FG003|Extension Study|Lack of Efficacy|2|||
31007277|NCT01572792|59208857|FG004|Extension Study|Lack of Efficacy|2|||
31007278|NCT01572792|59208853|FG000|Extension Study|Adverse Event|7|||
31007279|NCT01572792|59208854|FG001|Extension Study|Adverse Event|6|||
31007280|NCT01572792|59208855|FG002|Extension Study|Adverse Event|5|||
31007281|NCT01572792|59208856|FG003|Extension Study|Adverse Event|6|||
31007282|NCT01572792|59208857|FG004|Extension Study|Adverse Event|4|||
31007283|NCT01572792|59208853|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
31007284|NCT01572792|59208854|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
31007285|NCT01572792|59208855|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
31007286|NCT01572792|59208856|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
31007287|NCT01572792|59208857|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
31007288|NCT01547598|59208872|FG000|Overall Study|Withdrew consent|1|||
31007289|NCT01547598|59208873|FG001|Overall Study|Withdrew consent|1|||
31007290|NCT01547598|59208872|FG000|Overall Study|Lost to Follow-up|1|||
31007291|NCT01547598|59208873|FG001|Overall Study|Lost to Follow-up|1|||
31007292|NCT01547598|59208872|FG000|Overall Study|Adverse Event|1|||
31007293|NCT01547598|59208873|FG001|Overall Study|Adverse Event|1|||
31007294|NCT01547598|59208872|FG000|Overall Study|Protocol Violation|1|||
31007295|NCT01547598|59208873|FG001|Overall Study|Protocol Violation|1|||
31007296|NCT01547598|59208872|FG000|Overall Study|Other Miscellaneous Reasons|2|||
31007297|NCT01547598|59208873|FG001|Overall Study|Other Miscellaneous Reasons|1|||
31007298|NCT01547286|59208880|FG000|Overall Study|Did not meet all eligibility criteria|1|||
31007299|NCT01547286|59208880|FG000|Overall Study|Physician Decision|1|||
31007300|NCT01547130|59208887|FG000|Overall Study|Lost to Follow-up|9|||
31007301|NCT01547130|59208888|FG001|Overall Study|Lost to Follow-up|5|||
31007302|NCT01524978|59208913|FG000|Overall Study|Other|16|||
31007303|NCT01524978|59208914|FG001|Overall Study|Other|2|||
31007304|NCT01524978|59208915|FG002|Overall Study|Other|1|||
31007305|NCT01524978|59208916|FG003|Overall Study|Other|2|||
31007306|NCT01524978|59208917|FG004|Overall Study|Other|1|||
31007307|NCT01524978|59208918|FG005|Overall Study|Other|3|||
31007308|NCT01524978|59208919|FG006|Overall Study|Other|17|||
31007309|NCT01524978|59208920|FG007|Overall Study|Other|1|||
31007310|NCT01524978|59208921|FG008|Overall Study|Other|2|||
30612620|NCT01129557|58623765|FG002|Overall Study|Adverse Event|2|||
31007311|NCT01524978|59208922|FG009|Overall Study|Other|2|||
31007312|NCT01524978|59208923|FG010|Overall Study|Other|5|||
31007313|NCT01524978|59208913|FG000|Overall Study|Withdrawal by Subject|12|||
31007314|NCT01524978|59208914|FG001|Overall Study|Withdrawal by Subject|0|||
31007315|NCT01524978|59208915|FG002|Overall Study|Withdrawal by Subject|1|||
31007316|NCT01524978|59208916|FG003|Overall Study|Withdrawal by Subject|1|||
31007317|NCT01524978|59208917|FG004|Overall Study|Withdrawal by Subject|3|||
31007318|NCT01524978|59208918|FG005|Overall Study|Withdrawal by Subject|1|||
31007319|NCT01524978|59208919|FG006|Overall Study|Withdrawal by Subject|6|||
31007320|NCT01524978|59208920|FG007|Overall Study|Withdrawal by Subject|2|||
31007321|NCT01524978|59208921|FG008|Overall Study|Withdrawal by Subject|4|||
31007322|NCT01524978|59208922|FG009|Overall Study|Withdrawal by Subject|0|||
31007323|NCT01524978|59208923|FG010|Overall Study|Withdrawal by Subject|5|||
31007324|NCT01524978|59208913|FG000|Overall Study|Lost to Follow-up|0|||
31007325|NCT01524978|59208914|FG001|Overall Study|Lost to Follow-up|0|||
31007326|NCT01524978|59208915|FG002|Overall Study|Lost to Follow-up|3|||
31007327|NCT01524978|59208916|FG003|Overall Study|Lost to Follow-up|0|||
31007328|NCT01524978|59208917|FG004|Overall Study|Lost to Follow-up|1|||
31007329|NCT01524978|59208918|FG005|Overall Study|Lost to Follow-up|1|||
31007330|NCT01524978|59208919|FG006|Overall Study|Lost to Follow-up|2|||
31007331|NCT01524978|59208920|FG007|Overall Study|Lost to Follow-up|0|||
31007332|NCT01524978|59208921|FG008|Overall Study|Lost to Follow-up|1|||
31007333|NCT01524978|59208922|FG009|Overall Study|Lost to Follow-up|1|||
31007334|NCT01524978|59208923|FG010|Overall Study|Lost to Follow-up|1|||
31007335|NCT01524978|59208913|FG000|Overall Study|Death|34|||
31007336|NCT01524978|59208914|FG001|Overall Study|Death|2|||
31007337|NCT01524978|59208915|FG002|Overall Study|Death|5|||
31007338|NCT01524978|59208916|FG003|Overall Study|Death|24|||
31007339|NCT01524978|59208917|FG004|Overall Study|Death|4|||
31007340|NCT01524978|59208918|FG005|Overall Study|Death|4|||
31007341|NCT01524978|59208919|FG006|Overall Study|Death|1|||
31007342|NCT01524978|59208920|FG007|Overall Study|Death|9|||
31007343|NCT01524978|59208921|FG008|Overall Study|Death|5|||
31007344|NCT01524978|59208922|FG009|Overall Study|Death|6|||
31007345|NCT01524978|59208923|FG010|Overall Study|Death|17|||
31007346|NCT01524900|59208943|FG000|Overall Study|Lost to Follow-up|3|||
31007347|NCT01524900|59208944|FG001|Overall Study|Lost to Follow-up|12|||
31007348|NCT01524900|59208945|FG002|Overall Study|Lost to Follow-up|1|||
31007349|NCT01524900|59208946|FG003|Overall Study|Lost to Follow-up|0|||
31007350|NCT01524900|59208947|FG004|Overall Study|Lost to Follow-up|0|||
31007351|NCT01524900|59208943|FG000|Overall Study|Other reason than stated above|1|||
31007352|NCT01524900|59208944|FG001|Overall Study|Other reason than stated above|1|||
31007353|NCT01524900|59208945|FG002|Overall Study|Other reason than stated above|0|||
31007354|NCT01524900|59208946|FG003|Overall Study|Other reason than stated above|0|||
31007355|NCT01524900|59208947|FG004|Overall Study|Other reason than stated above|0|||
31007356|NCT01524900|59208943|FG000|Overall Study|No reason documented|2|||
31007357|NCT01524900|59208944|FG001|Overall Study|No reason documented|1|||
31007358|NCT01524900|59208945|FG002|Overall Study|No reason documented|0|||
31007359|NCT01524900|59208946|FG003|Overall Study|No reason documented|1|||
31007360|NCT01524900|59208947|FG004|Overall Study|No reason documented|0|||
31007361|NCT01524198|59208962|FG000|Overall Study|Protocol Violation|8|||
31007362|NCT01524198|59208963|FG001|Overall Study|Protocol Violation|6|||
31007363|NCT01524198|59208962|FG000|Overall Study|Withdrawal by Subject|15|||
31007364|NCT01524198|59208963|FG001|Overall Study|Withdrawal by Subject|10|||
31007365|NCT01523886|59208971|FG000|Overall Study|surgery cancelled|0|||
31007366|NCT01523886|59208972|FG001|Overall Study|surgery cancelled|1|||
31007367|NCT01546038|59208984|FG000|Overall Study|Death|15|||
31007368|NCT01546038|59208985|FG001|Overall Study|Death|6|||
31007369|NCT01546038|59208986|FG002|Overall Study|Death|4|||
31007370|NCT01546038|59208987|FG003|Overall Study|Death|2|||
31007371|NCT01546038|59208988|FG004|Overall Study|Death|9|||
31007372|NCT01546038|59208989|FG005|Overall Study|Death|3|||
31007373|NCT01546038|59208990|FG006|Overall Study|Death|46|||
31007374|NCT01546038|59208991|FG007|Overall Study|Death|76|||
31007375|NCT01546038|59208992|FG008|Overall Study|Death|39|||
31007376|NCT01546038|59208984|FG000|Overall Study|Lost to Follow-up|0|||
31007377|NCT01546038|59208985|FG001|Overall Study|Lost to Follow-up|0|||
31007378|NCT01546038|59208986|FG002|Overall Study|Lost to Follow-up|0|||
31007379|NCT01546038|59208987|FG003|Overall Study|Lost to Follow-up|0|||
31007380|NCT01546038|59208988|FG004|Overall Study|Lost to Follow-up|1|||
31007381|NCT01546038|59208989|FG005|Overall Study|Lost to Follow-up|0|||
31007382|NCT01546038|59208990|FG006|Overall Study|Lost to Follow-up|2|||
31007383|NCT01546038|59208991|FG007|Overall Study|Lost to Follow-up|1|||
31007384|NCT01546038|59208992|FG008|Overall Study|Lost to Follow-up|0|||
31007385|NCT01546038|59208984|FG000|Overall Study|Withdrawal by Subject|1|||
31007386|NCT01546038|59208985|FG001|Overall Study|Withdrawal by Subject|0|||
31007387|NCT01546038|59208986|FG002|Overall Study|Withdrawal by Subject|0|||
31007388|NCT01546038|59208987|FG003|Overall Study|Withdrawal by Subject|1|||
31007389|NCT01546038|59208988|FG004|Overall Study|Withdrawal by Subject|0|||
31007390|NCT01546038|59208989|FG005|Overall Study|Withdrawal by Subject|1|||
31007391|NCT01546038|59208990|FG006|Overall Study|Withdrawal by Subject|3|||
31007392|NCT01546038|59208991|FG007|Overall Study|Withdrawal by Subject|3|||
31007393|NCT01546038|59208992|FG008|Overall Study|Withdrawal by Subject|1|||
31007394|NCT01546038|59208984|FG000|Overall Study|: Randomized, not treated|0|||
31007395|NCT01546038|59208985|FG001|Overall Study|: Randomized, not treated|0|||
31007396|NCT01546038|59208986|FG002|Overall Study|: Randomized, not treated|0|||
31007397|NCT01546038|59208987|FG003|Overall Study|: Randomized, not treated|0|||
31007398|NCT01546038|59208988|FG004|Overall Study|: Randomized, not treated|0|||
31007399|NCT01546038|59208989|FG005|Overall Study|: Randomized, not treated|0|||
31007400|NCT01546038|59208990|FG006|Overall Study|: Randomized, not treated|2|||
31007401|NCT01546038|59208991|FG007|Overall Study|: Randomized, not treated|4|||
31007402|NCT01546038|59208992|FG008|Overall Study|: Randomized, not treated|3|||
31007403|NCT01571232|59209044|FG000|Overall Study|Lost to Follow-up|0|||
31007404|NCT01571232|59209045|FG001|Overall Study|Lost to Follow-up|1|||
31007405|NCT01571232|59209044|FG000|Overall Study|Withdrawal by Subject|1|||
31007406|NCT01571232|59209045|FG001|Overall Study|Withdrawal by Subject|0|||
31007407|NCT01544478|59209052|FG000|Overall Study|Adverse Event|1|||
31007408|NCT01544478|59209052|FG000|Overall Study|Death|1|||
31007409|NCT01544478|59209052|FG000|Overall Study|Lost to Follow-up|48|||
31007410|NCT01544478|59209052|FG000|Overall Study|Physician Decision|15|||
31007411|NCT01544478|59209052|FG000|Overall Study|Pregnancy|1|||
31007412|NCT01544478|59209052|FG000|Overall Study|Withdrawal by Subject|52|||
31007413|NCT01522950|59209059|FG000|Overall Study|Withdrawal by Subject|3|||
31007414|NCT01522950|59209060|FG001|Overall Study|Withdrawal by Subject|2|||
31007415|NCT01522950|59209061|FG002|Overall Study|Withdrawal by Subject|1|||
31007416|NCT01522950|59209059|FG000|Overall Study|Adverse Event|3|||
31007417|NCT01522950|59209060|FG001|Overall Study|Adverse Event|1|||
31007418|NCT01522950|59209061|FG002|Overall Study|Adverse Event|1|||
31007419|NCT01522950|59209059|FG000|Overall Study|Protocol Violation|0|||
31007420|NCT01522950|59209060|FG001|Overall Study|Protocol Violation|0|||
31007421|NCT01522950|59209061|FG002|Overall Study|Protocol Violation|2|||
31007422|NCT01522950|59209059|FG000|Overall Study|Death|0|||
31007423|NCT01522950|59209060|FG001|Overall Study|Death|1|||
31007424|NCT01522950|59209061|FG002|Overall Study|Death|1|||
31007425|NCT01522950|59209059|FG000|Overall Study|Study Medication Sensitivity|0|||
30612621|NCT01129557|58623763|FG000|Overall Study|Novartis terminated study early|3|||
30612622|NCT01129557|58623764|FG001|Overall Study|Novartis terminated study early|3|||
30612623|NCT01129557|58623765|FG002|Overall Study|Novartis terminated study early|2|||
30612624|NCT01129011|58623786|FG000|Overall Study|Adverse Event|20|||
30612625|NCT01129011|58623787|FG001|Overall Study|Adverse Event|30|||
30612626|NCT01129011|58623786|FG000|Overall Study|Withdrawal by Subject|24|||
30612627|NCT01129011|58623787|FG001|Overall Study|Withdrawal by Subject|8|||
30612628|NCT01129011|58623786|FG000|Overall Study|Lost to Follow-up|6|||
30612629|NCT01129011|58623787|FG001|Overall Study|Lost to Follow-up|7|||
30612630|NCT01129011|58623786|FG000|Overall Study|Duodenal Ulcer|2|||
30612631|NCT01129011|58623787|FG001|Overall Study|Duodenal Ulcer|8|||
30612632|NCT01129011|58623786|FG000|Overall Study|misc|7|||
30612633|NCT01129011|58623787|FG001|Overall Study|misc|4|||
30612634|NCT00919867|58623799|FG000|First Intervention|Withdrawal by Subject|0|||
30612635|NCT00919867|58623800|FG001|First Intervention|Withdrawal by Subject|0|||
30612636|NCT00919867|58623801|FG002|First Intervention|Withdrawal by Subject|1|||
30612637|NCT00919867|58623802|FG003|First Intervention|Withdrawal by Subject|0|||
30612638|NCT00919867|58623803|FG004|First Intervention|Withdrawal by Subject|0|||
30612639|NCT00919867|58623804|FG005|First Intervention|Withdrawal by Subject|0|||
30612640|NCT00919867|58623799|FG000|First Intervention|Physician Decision|0|||
30612641|NCT00919867|58623800|FG001|First Intervention|Physician Decision|0|||
30612642|NCT00919867|58623801|FG002|First Intervention|Physician Decision|0|||
30612643|NCT00919867|58623802|FG003|First Intervention|Physician Decision|0|||
30612644|NCT00919867|58623803|FG004|First Intervention|Physician Decision|0|||
30612645|NCT00919867|58623804|FG005|First Intervention|Physician Decision|1|||
30612646|NCT01215942|58623814|FG000|Treatment Period|Adverse Event|15|||
30612647|NCT01215942|58623815|FG001|Treatment Period|Adverse Event|26|||
30612648|NCT01215942|58623814|FG000|Treatment Period|Death|2|||
30612649|NCT01215942|58623815|FG001|Treatment Period|Death|4|||
30612650|NCT01215942|58623814|FG000|Treatment Period|Lack of Efficacy|23|||
30612651|NCT01215942|58623815|FG001|Treatment Period|Lack of Efficacy|62|||
31007426|NCT01522950|59209060|FG001|Overall Study|Study Medication Sensitivity|1|||
31007427|NCT01522950|59209061|FG002|Overall Study|Study Medication Sensitivity|0|||
31007428|NCT01522404|59209071|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
31007429|NCT01522404|59209072|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
30612652|NCT01215942|58623814|FG000|Treatment Period|Lost to Follow-up|3|||
30612653|NCT01215942|58623815|FG001|Treatment Period|Lost to Follow-up|4|||
31007430|NCT01522404|59209071|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
31007431|NCT01522404|59209072|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
30612654|NCT01215942|58623814|FG000|Treatment Period|Withdrawal by Subject|17|||
30612655|NCT01215942|58623815|FG001|Treatment Period|Withdrawal by Subject|40|||
30612656|NCT01215942|58623814|FG000|Treatment Period|Physician Decision|5|||
30612657|NCT01215942|58623815|FG001|Treatment Period|Physician Decision|5|||
31007432|NCT01522404|59209071|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
31007433|NCT01522404|59209072|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
31007434|NCT01570686|59209088|FG000|Overall Study|Abnormal test procedure result(s)|1|||
31007435|NCT01570686|59209089|FG001|Overall Study|Abnormal test procedure result(s)|1|||
31007436|NCT01570686|59209088|FG000|Overall Study|Administrative problems|0|||
31007437|NCT01570686|59209089|FG001|Overall Study|Administrative problems|1|||
31007438|NCT01570686|59209088|FG000|Overall Study|Adverse Event|8|||
31007439|NCT01570686|59209089|FG001|Overall Study|Adverse Event|6|||
31007440|NCT01570686|59209088|FG000|Overall Study|Lost to Follow-up|4|||
31007441|NCT01570686|59209089|FG001|Overall Study|Lost to Follow-up|3|||
31007442|NCT01570686|59209088|FG000|Overall Study|Protocol Deviation|3|||
31007443|NCT01570686|59209089|FG001|Overall Study|Protocol Deviation|0|||
31007444|NCT01570686|59209088|FG000|Overall Study|Withdrawal by Subject|4|||
31007445|NCT01570686|59209089|FG001|Overall Study|Withdrawal by Subject|4|||
31007446|NCT01570686|59209088|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
31007447|NCT01570686|59209089|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
31007448|NCT01522248|59209097|FG000|Overall Study|Lost to Follow-up|1|||
31007449|NCT01522248|59209098|FG001|Overall Study|Lost to Follow-up|0|||
31007450|NCT01543776|59209111|FG000|Overall Study|Withdrawal by Subject|2|||
31007451|NCT01543776|59209112|FG001|Overall Study|Withdrawal by Subject|2|||
31007452|NCT01518192|59209121|FG000|Overall Study|Lost to Follow-up|29|||
31007453|NCT01518192|59209122|FG001|Overall Study|Lost to Follow-up|26|||
31007454|NCT01518192|59209123|FG002|Overall Study|Lost to Follow-up|35|||
31007455|NCT01517802|59209137|FG000|Overall Study|Death|1|||
31007456|NCT01520922|59209143|FG000|Treatment Phase|Physician Decision|2|||
31007457|NCT01520922|59209144|FG001|Treatment Phase|Physician Decision|1|||
31007458|NCT01520922|59209143|FG000|Treatment Phase|Progression|0|||
31007459|NCT01520922|59209144|FG001|Treatment Phase|Progression|2|||
31007460|NCT01520922|59209143|FG000|Treatment Phase|Adverse Event|3|||
31007461|NCT01520922|59209144|FG001|Treatment Phase|Adverse Event|5|||
31007462|NCT01520922|59209143|FG000|Follow up|Lost to Follow-up|0|||
31007463|NCT01520922|59209144|FG001|Follow up|Lost to Follow-up|1|||
31007464|NCT01520922|59209143|FG000|Survival Follow-up|Withdrawal by Subject|1|||
31007465|NCT01520922|59209144|FG001|Survival Follow-up|Withdrawal by Subject|0|||
31007466|NCT01569438|59209152|FG000|Overall Study|Lack of Efficacy|1|||
31007467|NCT01569438|59209153|FG001|Overall Study|Lack of Efficacy|2|||
31007468|NCT01569438|59209152|FG000|Overall Study|Withdrawal by Subject|0|||
31007469|NCT01569438|59209153|FG001|Overall Study|Withdrawal by Subject|3|||
31007470|NCT01569438|59209152|FG000|Overall Study|Adverse Event|2|||
30612658|NCT01215942|58623814|FG000|Treatment Period|Protocol Violation|0|||
30612659|NCT01215942|58623815|FG001|Treatment Period|Protocol Violation|1|||
30612660|NCT01215942|58623814|FG000|Treatment Period|Sponsor Decision|349|||
30699181|NCT00274651|58713703|FG000|Overall Study|Death|1|||
30699182|NCT00274651|58713704|FG001|Overall Study|Death|3|||
30699183|NCT00274651|58713703|FG000|Overall Study|Withdrawal by Subject|0|||
30699184|NCT00274651|58713704|FG001|Overall Study|Withdrawal by Subject|1|||
30699185|NCT00274651|58713703|FG000|Overall Study|Physician Decision|8|||
30699186|NCT00274651|58713704|FG001|Overall Study|Physician Decision|7|||
30699187|NCT00274261|58713713|FG000|Overall Study|Adverse Event|19|||
30699188|NCT00274261|58713714|FG001|Overall Study|Adverse Event|11|||
30699189|NCT00274261|58713713|FG000|Overall Study|Pregnancy|114|||
30612661|NCT01215942|58623815|FG001|Treatment Period|Sponsor Decision|530|||
30612662|NCT01215942|58623814|FG000|Post-Treatment Follow-Up Period|Death|0|||
30612663|NCT01215942|58623815|FG001|Post-Treatment Follow-Up Period|Death|1|||
30612664|NCT01215942|58623814|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
30612665|NCT01215942|58623815|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
30612666|NCT01215942|58623814|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
30612667|NCT01215942|58623815|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
30699190|NCT00274261|58713714|FG001|Overall Study|Pregnancy|83|||
30699191|NCT00274261|58713713|FG000|Overall Study|Withdrawal by Subject|179|||
30699192|NCT00274261|58713714|FG001|Overall Study|Withdrawal by Subject|126|||
30699193|NCT00274261|58713713|FG000|Overall Study|Protocol Violation|71|||
30699194|NCT00274261|58713714|FG001|Overall Study|Protocol Violation|42|||
30699195|NCT00274261|58713713|FG000|Overall Study|Lost to Follow-up|106|||
30699196|NCT00274261|58713714|FG001|Overall Study|Lost to Follow-up|75|||
30699197|NCT00624468|58713724|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
30699198|NCT00624468|58713725|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
30699199|NCT00624468|58713726|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
31007471|NCT01569438|59209153|FG001|Overall Study|Adverse Event|15|||
31007472|NCT01569438|59209152|FG000|Overall Study|Protocol Violation|2|||
30612668|NCT01215942|58623814|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
30699200|NCT00624468|58713727|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
30790771|NCT03524092|58803940|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
31007473|NCT01569438|59209153|FG001|Overall Study|Protocol Violation|0|||
31007474|NCT01569438|59209152|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
30612669|NCT01215942|58623815|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
31007475|NCT01569438|59209153|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
31007476|NCT01569438|59209152|FG000|Overall Study|Sponsor/Physician decision|1|||
30699201|NCT00624468|58713724|FG000|Double-blind Period|Withdrew Prematurely|1|||
30699202|NCT00624468|58713725|FG001|Double-blind Period|Withdrew Prematurely|1|||
30699203|NCT00624468|58713726|FG002|Double-blind Period|Withdrew Prematurely|0|||
30699204|NCT00624468|58713727|FG003|Double-blind Period|Withdrew Prematurely|0|||
30699205|NCT00624468|58713724|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
30699206|NCT00624468|58713725|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
30699207|NCT00624468|58713726|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
30699208|NCT00624468|58713727|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
30699209|NCT00624468|58713724|FG000|Safety Follow-up (SFU) Period|Other|0|||
31007477|NCT01569438|59209153|FG001|Overall Study|Sponsor/Physician decision|1|||
31007478|NCT01569438|59209152|FG000|Overall Study|Unable to adhere to study schedule|0|||
31007479|NCT01569438|59209153|FG001|Overall Study|Unable to adhere to study schedule|1|||
31007480|NCT01517412|59209161|FG000|Overall Study|Adverse Event|10|||
31007481|NCT01517412|59209162|FG001|Overall Study|Adverse Event|11|||
31007482|NCT01517412|59209161|FG000|Overall Study|Lack of Efficacy|10|||
31007483|NCT01517412|59209162|FG001|Overall Study|Lack of Efficacy|5|||
31007484|NCT01517412|59209161|FG000|Overall Study|Poor compliance to protocol|8|||
31007485|NCT01517412|59209162|FG001|Overall Study|Poor compliance to protocol|3|||
31007486|NCT01517412|59209161|FG000|Overall Study|Other than specified above|8|||
31007487|NCT01517412|59209162|FG001|Overall Study|Other than specified above|5|||
31007488|NCT01517178|59209168|FG000|Period 1|Adverse Event|1|||
31007489|NCT01517178|59209169|FG001|Period 1|Adverse Event|2|||
31007490|NCT01517178|59209168|FG000|Period 1|Lack of Efficacy|0|||
31007491|NCT01517178|59209169|FG001|Period 1|Lack of Efficacy|1|||
31007492|NCT01517178|59209168|FG000|Period 1|E.g. study termination|3|||
31007493|NCT01517178|59209169|FG001|Period 1|E.g. study termination|1|||
31007494|NCT01517178|59209168|FG000|Period 1|Withdrawal by Subject|0|||
31007495|NCT01517178|59209169|FG001|Period 1|Withdrawal by Subject|1|||
31007496|NCT01517178|59209168|FG000|Period 2|Adverse Event|1|||
31007497|NCT01517178|59209169|FG001|Period 2|Adverse Event|0|||
31007498|NCT01517178|59209168|FG000|Period 2|Withdrawal by Subject|3|||
31007499|NCT01517178|59209169|FG001|Period 2|Withdrawal by Subject|0|||
31007500|NCT01517178|59209168|FG000|Period 2|E.g. study termination|2|||
31007501|NCT01517178|59209169|FG001|Period 2|E.g. study termination|2|||
31007502|NCT01489956|59209177|FG000|Overall Study|Lost to Follow-up|1|||
31007503|NCT01489956|59209178|FG001|Overall Study|Lost to Follow-up|0|||
31007504|NCT01489956|59209179|FG002|Overall Study|Lost to Follow-up|0|||
31007505|NCT01489956|59209177|FG000|Overall Study|Withdrawal by Subject|0|||
31007506|NCT01489956|59209178|FG001|Overall Study|Withdrawal by Subject|0|||
31007507|NCT01489956|59209179|FG002|Overall Study|Withdrawal by Subject|1|||
31007508|NCT01516008|59209190|FG000|Overall Study|Adverse Event|0|||
31007509|NCT01516008|59209191|FG001|Overall Study|Adverse Event|2|||
31007510|NCT01516008|59209192|FG002|Overall Study|Adverse Event|7|||
31007511|NCT01516008|59209190|FG000|Overall Study|Lack of Efficacy|44|||
31007512|NCT01516008|59209191|FG001|Overall Study|Lack of Efficacy|14|||
31007513|NCT01516008|59209192|FG002|Overall Study|Lack of Efficacy|10|||
31007514|NCT01516008|59209190|FG000|Overall Study|Protocol Violation|1|||
31007515|NCT01516008|59209191|FG001|Overall Study|Protocol Violation|0|||
31007516|NCT01516008|59209192|FG002|Overall Study|Protocol Violation|0|||
31007517|NCT01516008|59209190|FG000|Overall Study|Reason not specified|0|||
31007518|NCT01516008|59209191|FG001|Overall Study|Reason not specified|0|||
31007519|NCT01516008|59209192|FG002|Overall Study|Reason not specified|1|||
31007520|NCT01489254|59209203|FG000|Double-blind Part|Adverse Event|7|||
31007521|NCT01489254|59209204|FG001|Double-blind Part|Adverse Event|2|||
31007522|NCT01489254|59209205|FG002|Double-blind Part|Adverse Event|2|||
31007523|NCT01489254|59209206|FG003|Double-blind Part|Adverse Event|0|||
30612670|NCT01215942|58623814|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
30612671|NCT01215942|58623815|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
30612672|NCT01128621|58623834|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
30612673|NCT01128621|58623835|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
30612674|NCT00918463|58623857|FG000|Overall Study|Death|1|||
30612675|NCT00918463|58623857|FG000|Overall Study|Lack of Efficacy|1|||
30612676|NCT01128543|58623861|FG000|Overall Study|Withdrawal by Subject|3|||
30612677|NCT01128543|58623861|FG000|Overall Study|Protocol Violation|1|||
30612678|NCT01128387|58623867|FG000|Overall Study|Physician Decision|0|||
30612679|NCT01128387|58623868|FG001|Overall Study|Physician Decision|1|||
30612680|NCT01214850|58623877|FG000|Overall Study|Withdrawal by Subject|38|||
30699210|NCT00624468|58713725|FG001|Safety Follow-up (SFU) Period|Other|0|||
30699211|NCT00624468|58713726|FG002|Safety Follow-up (SFU) Period|Other|1|||
30699212|NCT00624468|58713727|FG003|Safety Follow-up (SFU) Period|Other|1|||
30699213|NCT00521014|58713735|FG000|Overall Study|Inevaluable, not treated|1|||
30612681|NCT01214850|58623878|FG001|Overall Study|Withdrawal by Subject|31|||
30699214|NCT00560235|58713742|FG000|Phase 1|Discontinued|8|||
31007524|NCT01489254|59209203|FG000|Double-blind Part|Pregnancy|1|||
31007525|NCT01489254|59209204|FG001|Double-blind Part|Pregnancy|3|||
31007526|NCT01489254|59209205|FG002|Double-blind Part|Pregnancy|0|||
31007527|NCT01489254|59209206|FG003|Double-blind Part|Pregnancy|0|||
31007528|NCT01489254|59209203|FG000|Double-blind Part|Withdrawal by Subject|12|||
31007529|NCT01489254|59209204|FG001|Double-blind Part|Withdrawal by Subject|20|||
31007530|NCT01489254|59209205|FG002|Double-blind Part|Withdrawal by Subject|1|||
31007531|NCT01489254|59209206|FG003|Double-blind Part|Withdrawal by Subject|0|||
31007532|NCT01489254|59209203|FG000|Double-blind Part|Lost to Follow-up|1|||
31007533|NCT01489254|59209204|FG001|Double-blind Part|Lost to Follow-up|2|||
31007534|NCT01489254|59209205|FG002|Double-blind Part|Lost to Follow-up|0|||
31007535|NCT01489254|59209206|FG003|Double-blind Part|Lost to Follow-up|0|||
31007536|NCT01489254|59209203|FG000|Double-blind Part|Other reasons for not completing study|4|||
31007537|NCT01489254|59209204|FG001|Double-blind Part|Other reasons for not completing study|6|||
31007538|NCT01489254|59209205|FG002|Double-blind Part|Other reasons for not completing study|0|||
31007539|NCT01489254|59209206|FG003|Double-blind Part|Other reasons for not completing study|0|||
31007540|NCT01489254|59209203|FG000|Open-label Extension Part|Adverse Event|0|||
31007541|NCT01489254|59209204|FG001|Open-label Extension Part|Adverse Event|0|||
31007542|NCT01489254|59209205|FG002|Open-label Extension Part|Adverse Event|0|||
31007543|NCT01489254|59209206|FG003|Open-label Extension Part|Adverse Event|10|||
31007544|NCT01489254|59209203|FG000|Open-label Extension Part|Pregnancy|0|||
31007545|NCT01489254|59209204|FG001|Open-label Extension Part|Pregnancy|0|||
31007546|NCT01489254|59209205|FG002|Open-label Extension Part|Pregnancy|0|||
31007547|NCT01489254|59209206|FG003|Open-label Extension Part|Pregnancy|3|||
31007548|NCT01489254|59209203|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
31007549|NCT01489254|59209204|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
31007550|NCT01489254|59209205|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
31007551|NCT01489254|59209206|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
31007552|NCT01489254|59209203|FG000|Open-label Extension Part|Protocol Violation|0|||
31007553|NCT01489254|59209204|FG001|Open-label Extension Part|Protocol Violation|0|||
31007554|NCT01489254|59209205|FG002|Open-label Extension Part|Protocol Violation|0|||
31007555|NCT01489254|59209206|FG003|Open-label Extension Part|Protocol Violation|1|||
31007556|NCT01489254|59209203|FG000|Open-label Extension Part|Lost to Follow-up|0|||
31007557|NCT01489254|59209204|FG001|Open-label Extension Part|Lost to Follow-up|0|||
31007558|NCT01489254|59209205|FG002|Open-label Extension Part|Lost to Follow-up|0|||
31007559|NCT01489254|59209206|FG003|Open-label Extension Part|Lost to Follow-up|9|||
31007560|NCT01489254|59209203|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
31007561|NCT01489254|59209204|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
31007562|NCT01489254|59209205|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
31007563|NCT01489254|59209206|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
31007564|NCT01489020|59209221|FG000|Overall Study|Withdrawal by Subject|1|||
31007565|NCT01489020|59209222|FG001|Overall Study|Withdrawal by Subject|0|||
31007566|NCT01489020|59209223|FG002|Overall Study|Withdrawal by Subject|0|||
31007567|NCT01489020|59209224|FG003|Overall Study|Withdrawal by Subject|0|||
31007568|NCT01489020|59209225|FG004|Overall Study|Withdrawal by Subject|0|||
31007569|NCT01489020|59209226|FG005|Overall Study|Withdrawal by Subject|0|||
31007570|NCT01489020|59209221|FG000|Overall Study|Adverse Event|0|||
31007571|NCT01489020|59209222|FG001|Overall Study|Adverse Event|0|||
31007572|NCT01489020|59209223|FG002|Overall Study|Adverse Event|3|||
31007573|NCT01489020|59209224|FG003|Overall Study|Adverse Event|0|||
30612682|NCT01214850|58623879|FG002|Overall Study|Withdrawal by Subject|28|||
30612683|NCT01214850|58623877|FG000|Overall Study|Lost to Follow-up|124|||
30612684|NCT01214850|58623878|FG001|Overall Study|Lost to Follow-up|98|||
30612685|NCT01214850|58623879|FG002|Overall Study|Lost to Follow-up|123|||
30612686|NCT01214850|58623877|FG000|Overall Study|Protocol Violation|5|||
30612687|NCT01214850|58623878|FG001|Overall Study|Protocol Violation|5|||
30612688|NCT01214850|58623879|FG002|Overall Study|Protocol Violation|6|||
30612689|NCT01214850|58623877|FG000|Overall Study|Adverse event or death|11|||
30612690|NCT01214850|58623878|FG001|Overall Study|Adverse event or death|8|||
30612691|NCT01214850|58623879|FG002|Overall Study|Adverse event or death|3|||
30612692|NCT01214850|58623877|FG000|Overall Study|Inappropriate enrollment|2|||
30612693|NCT01214850|58623878|FG001|Overall Study|Inappropriate enrollment|1|||
30612694|NCT01214850|58623879|FG002|Overall Study|Inappropriate enrollment|0|||
30612695|NCT01214850|58623877|FG000|Overall Study|Administrative reason|1|||
30612696|NCT01214850|58623878|FG001|Overall Study|Administrative reason|0|||
30612697|NCT01214850|58623879|FG002|Overall Study|Administrative reason|0|||
30612698|NCT01214850|58623877|FG000|Overall Study|Unable to classify|2|||
30612699|NCT01214850|58623878|FG001|Overall Study|Unable to classify|1|||
30699215|NCT00560235|58713743|FG001|Phase 1|Discontinued|0|||
31007574|NCT01489020|59209225|FG004|Overall Study|Adverse Event|3|||
31007575|NCT01489020|59209226|FG005|Overall Study|Adverse Event|0|||
31007576|NCT01489020|59209221|FG000|Overall Study|Concomitant disease|0|||
31007577|NCT01489020|59209222|FG001|Overall Study|Concomitant disease|0|||
31007578|NCT01489020|59209223|FG002|Overall Study|Concomitant disease|0|||
31007579|NCT01489020|59209224|FG003|Overall Study|Concomitant disease|0|||
30612700|NCT01214850|58623879|FG002|Overall Study|Unable to classify|1|||
30612701|NCT01128153|58623892|FG000|Overall Study|Adverse Event|1|||
30612702|NCT01128153|58623893|FG001|Overall Study|Adverse Event|3|||
30612703|NCT01128153|58623892|FG000|Overall Study|Condition under investigation worsened|8|||
31007580|NCT01489020|59209225|FG004|Overall Study|Concomitant disease|3|||
31007581|NCT01489020|59209226|FG005|Overall Study|Concomitant disease|0|||
31007582|NCT01514760|59209246|FG000|Overall Study|Lost to Follow-up|2|||
31007583|NCT01514682|59209252|FG000|Overall Study|Withdrawal by Subject|2|||
31007584|NCT01514682|59209253|FG001|Overall Study|Withdrawal by Subject|3|||
31007585|NCT01514682|59209252|FG000|Overall Study|Physician Decision|4|||
31007586|NCT01514682|59209253|FG001|Overall Study|Physician Decision|3|||
31007587|NCT01514448|59209261|FG000|Overall Study|Death|7|||
31007588|NCT01514448|59209262|FG001|Overall Study|Death|8|||
31007589|NCT01514448|59209261|FG000|Overall Study|Withdrawal by Subject|2|||
31007590|NCT01514448|59209262|FG001|Overall Study|Withdrawal by Subject|0|||
31007591|NCT01514448|59209261|FG000|Overall Study|Lost to Follow-up|2|||
31007592|NCT01514448|59209262|FG001|Overall Study|Lost to Follow-up|0|||
31007593|NCT01514448|59209261|FG000|Overall Study|New Cancer Therapy|1|||
31007594|NCT01514448|59209262|FG001|Overall Study|New Cancer Therapy|0|||
31007595|NCT01514370|59209271|FG000|Overall Study|Protocol Violation|2|||
31007596|NCT01514370|59209272|FG001|Overall Study|Protocol Violation|3|||
31007597|NCT01514370|59209271|FG000|Overall Study|Lost to Follow-up|0|||
31007598|NCT01514370|59209272|FG001|Overall Study|Lost to Follow-up|2|||
31007599|NCT01514370|59209271|FG000|Overall Study|Withdrawal by Subject|2|||
31007600|NCT01514370|59209272|FG001|Overall Study|Withdrawal by Subject|1|||
31007601|NCT01514370|59209271|FG000|Overall Study|Adverse Event|1|||
31007602|NCT01514370|59209272|FG001|Overall Study|Adverse Event|3|||
31007603|NCT01514370|59209271|FG000|Overall Study|Other|6|||
31007604|NCT01514370|59209272|FG001|Overall Study|Other|7|||
31007605|NCT01519674|59209282|FG000|Overall Study|Adverse Event|3|||
31007606|NCT01519674|59209283|FG001|Overall Study|Adverse Event|3|||
31007607|NCT01519674|59209284|FG002|Overall Study|Adverse Event|0|||
31007608|NCT01519674|59209282|FG000|Overall Study|Lack of Efficacy|1|||
31007609|NCT01519674|59209283|FG001|Overall Study|Lack of Efficacy|1|||
31007610|NCT01519674|59209284|FG002|Overall Study|Lack of Efficacy|1|||
31007611|NCT01519674|59209282|FG000|Overall Study|Protocol Violation|0|||
31007612|NCT01519674|59209283|FG001|Overall Study|Protocol Violation|3|||
31007613|NCT01519674|59209284|FG002|Overall Study|Protocol Violation|1|||
31007614|NCT01519674|59209282|FG000|Overall Study|Withdrawal Criteria|7|||
31007615|NCT01519674|59209283|FG001|Overall Study|Withdrawal Criteria|2|||
31007616|NCT01519674|59209284|FG002|Overall Study|Withdrawal Criteria|7|||
31007617|NCT01519674|59209282|FG000|Overall Study|Unsclassified|10|||
31007618|NCT01519674|59209283|FG001|Overall Study|Unsclassified|4|||
31007619|NCT01519674|59209284|FG002|Overall Study|Unsclassified|3|||
31007620|NCT01519518|59209294|FG000|Overall Study|Consent not available|7|||
31007621|NCT01519518|59209295|FG001|Overall Study|Consent not available|10|||
31007622|NCT01519206|59209301|FG000|Overall Study|Lost to Follow-up|3|||
31007623|NCT01519206|59209301|FG000|Overall Study|Missed Visit|2|||
31007624|NCT01518972|59209314|FG000|Overall Study|Lost to Follow-up|2|||
31007625|NCT01518972|59209315|FG001|Overall Study|Lost to Follow-up|1|||
31007626|NCT01518972|59209314|FG000|Overall Study|Withdrawal by Subject|1|||
31007627|NCT01518972|59209315|FG001|Overall Study|Withdrawal by Subject|0|||
31007628|NCT01518972|59209314|FG000|Overall Study|Moved from area|1|||
31007629|NCT01518972|59209315|FG001|Overall Study|Moved from area|0|||
31007630|NCT01518972|59209314|FG000|Overall Study|Transportation problems|1|||
31007631|NCT01518972|59209315|FG001|Overall Study|Transportation problems|0|||
31007632|NCT01518972|59209314|FG000|Overall Study|Exclusionary medical condition|1|||
31007633|NCT01518972|59209315|FG001|Overall Study|Exclusionary medical condition|0|||
31007634|NCT01518972|59209314|FG000|Overall Study|Missed safety visits|0|||
30893031|NCT02531633|58926451|FG005|Part A (52 Weeks)|Other|0|||
30893032|NCT02531633|58926452|FG006|Part A (52 Weeks)|Other|0|||
30893033|NCT02531633|58926453|FG007|Part A (52 Weeks)|Other|0|||
31007635|NCT01518972|59209315|FG001|Overall Study|Missed safety visits|1|||
31007636|NCT01518972|59209314|FG000|Overall Study|Exclusionary medication|0|||
31007637|NCT01518972|59209315|FG001|Overall Study|Exclusionary medication|1|||
31007638|NCT01518972|59209314|FG000|Overall Study|Declined medication starting on day 12|0|||
31007639|NCT01518972|59209315|FG001|Overall Study|Declined medication starting on day 12|1|||
31007640|NCT01514136|59209323|FG000|Test Period 1; Test A|Protocol Violation|1|||
31007641|NCT01514136|59209324|FG001|Test Period 1; Test A|Protocol Violation|0|||
31007642|NCT01514136|59209325|FG002|Test Period 1; Test A|Protocol Violation|0|||
31007643|NCT01514136|59209326|FG003|Test Period 1; Test A|Protocol Violation|0|||
31007644|NCT01514136|59209327|FG004|Test Period 1; Test A|Protocol Violation|0|||
30612704|NCT01128153|58623893|FG001|Overall Study|Condition under investigation worsened|7|||
30612705|NCT01128153|58623892|FG000|Overall Study|Withdrawal by Subject|2|||
30612706|NCT01128153|58623893|FG001|Overall Study|Withdrawal by Subject|3|||
30612707|NCT01128153|58623892|FG000|Overall Study|Incorrect enrolment to study|2|||
30612708|NCT01128153|58623893|FG001|Overall Study|Incorrect enrolment to study|1|||
30612709|NCT01128153|58623892|FG000|Overall Study|Protocol Violation|2|||
30612710|NCT01128153|58623893|FG001|Overall Study|Protocol Violation|0|||
30699216|NCT00560235|58713744|FG002|Phase 1|Discontinued|0|||
31007645|NCT01514136|59209328|FG005|Test Period 1; Test A|Protocol Violation|0|||
30893034|NCT02531633|58926454|FG008|Part A (52 Weeks)|Other|0|||
31007646|NCT01514136|59209329|FG006|Test Period 1; Test A|Protocol Violation|0|||
31007647|NCT01514136|59209330|FG007|Test Period 1; Test A|Protocol Violation|0|||
31007648|NCT01514136|59209323|FG000|Test Period 1; Test A|Break from study holiday|2|||
31007649|NCT01514136|59209324|FG001|Test Period 1; Test A|Break from study holiday|0|||
31007650|NCT01514136|59209325|FG002|Test Period 1; Test A|Break from study holiday|0|||
31007651|NCT01514136|59209326|FG003|Test Period 1; Test A|Break from study holiday|0|||
31007652|NCT01514136|59209327|FG004|Test Period 1; Test A|Break from study holiday|0|||
31007653|NCT01514136|59209328|FG005|Test Period 1; Test A|Break from study holiday|0|||
31007654|NCT01514136|59209329|FG006|Test Period 1; Test A|Break from study holiday|0|||
31007655|NCT01514136|59209330|FG007|Test Period 1; Test A|Break from study holiday|0|||
31007656|NCT01514136|59209323|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
31007657|NCT01514136|59209324|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
31007658|NCT01514136|59209325|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
31007659|NCT01514136|59209326|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
31007660|NCT01514136|59209327|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
31007661|NCT01514136|59209328|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
31007662|NCT01514136|59209329|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
31007663|NCT01514136|59209330|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
31007664|NCT01514136|59209323|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
31007665|NCT01514136|59209324|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
31007666|NCT01514136|59209325|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
31007667|NCT01514136|59209326|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
31007668|NCT01514136|59209327|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
31007669|NCT01514136|59209328|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
31007670|NCT01514136|59209329|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
31007671|NCT01514136|59209330|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
31007672|NCT01514136|59209323|FG000|Test Period 2; Test A*|Adverse Event|0|||
31007673|NCT01514136|59209324|FG001|Test Period 2; Test A*|Adverse Event|0|||
31007674|NCT01514136|59209325|FG002|Test Period 2; Test A*|Adverse Event|0|||
31007675|NCT01514136|59209326|FG003|Test Period 2; Test A*|Adverse Event|0|||
31007676|NCT01514136|59209327|FG004|Test Period 2; Test A*|Adverse Event|1|||
31007677|NCT01514136|59209328|FG005|Test Period 2; Test A*|Adverse Event|0|||
31007678|NCT01514136|59209329|FG006|Test Period 2; Test A*|Adverse Event|0|||
31007679|NCT01514136|59209330|FG007|Test Period 2; Test A*|Adverse Event|0|||
31007680|NCT01514136|59209323|FG000|Test Period 2; Test A*|Holiday|0|||
31007681|NCT01514136|59209324|FG001|Test Period 2; Test A*|Holiday|0|||
31007682|NCT01514136|59209325|FG002|Test Period 2; Test A*|Holiday|0|||
31007683|NCT01514136|59209326|FG003|Test Period 2; Test A*|Holiday|0|||
31007684|NCT01514136|59209327|FG004|Test Period 2; Test A*|Holiday|1|||
31007685|NCT01514136|59209328|FG005|Test Period 2; Test A*|Holiday|0|||
31007686|NCT01514136|59209329|FG006|Test Period 2; Test A*|Holiday|0|||
31007687|NCT01514136|59209330|FG007|Test Period 2; Test A*|Holiday|0|||
31007688|NCT01514136|59209323|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
31007689|NCT01514136|59209324|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
31007690|NCT01514136|59209325|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
31007691|NCT01514136|59209326|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
31007692|NCT01514136|59209327|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
31007693|NCT01514136|59209328|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
31007694|NCT01514136|59209329|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
31007695|NCT01514136|59209330|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
31007696|NCT01514136|59209323|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
31007697|NCT01514136|59209324|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
31007698|NCT01514136|59209325|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
31007699|NCT01514136|59209326|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
31007700|NCT01514136|59209327|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
31007701|NCT01514136|59209328|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
31007702|NCT01514136|59209329|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
31007703|NCT01514136|59209330|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
31007704|NCT01514136|59209323|FG000|Test Period 2; Test C*|holiday|0|||
30612711|NCT01128153|58623892|FG000|Overall Study|Developed discontinuation criteria|1|||
30612712|NCT01128153|58623893|FG001|Overall Study|Developed discontinuation criteria|1|||
30612713|NCT00925015|58623902|FG000|Overall Study|Adverse Event|1|||
30612714|NCT00925015|58623903|FG001|Overall Study|Adverse Event|2|||
30612715|NCT00925015|58623904|FG002|Overall Study|Adverse Event|1|||
30612716|NCT00925015|58623902|FG000|Overall Study|Physician Decision|0|||
30612717|NCT00925015|58623903|FG001|Overall Study|Physician Decision|1|||
30893035|NCT02531633|58926455|FG009|Part A (52 Weeks)|Other|0|||
31007705|NCT01514136|59209324|FG001|Test Period 2; Test C*|holiday|0|||
31007706|NCT01514136|59209325|FG002|Test Period 2; Test C*|holiday|0|||
30612718|NCT00925015|58623904|FG002|Overall Study|Physician Decision|0|||
31007707|NCT01514136|59209326|FG003|Test Period 2; Test C*|holiday|0|||
31007708|NCT01514136|59209327|FG004|Test Period 2; Test C*|holiday|0|||
30612719|NCT00925015|58623902|FG000|Overall Study|Progressive Disease|7|||
31007709|NCT01514136|59209328|FG005|Test Period 2; Test C*|holiday|0|||
31007710|NCT01514136|59209329|FG006|Test Period 2; Test C*|holiday|1|||
31007711|NCT01514136|59209330|FG007|Test Period 2; Test C*|holiday|0|||
31007712|NCT01514136|59209323|FG000|Test Period 2; Test C*|Protocol Violation|0|||
31007713|NCT01514136|59209324|FG001|Test Period 2; Test C*|Protocol Violation|0|||
31007714|NCT01514136|59209325|FG002|Test Period 2; Test C*|Protocol Violation|0|||
31007715|NCT01514136|59209326|FG003|Test Period 2; Test C*|Protocol Violation|0|||
31007716|NCT01514136|59209327|FG004|Test Period 2; Test C*|Protocol Violation|0|||
31007717|NCT01514136|59209328|FG005|Test Period 2; Test C*|Protocol Violation|0|||
31007718|NCT01514136|59209329|FG006|Test Period 2; Test C*|Protocol Violation|1|||
31007719|NCT01514136|59209330|FG007|Test Period 2; Test C*|Protocol Violation|0|||
31007720|NCT01513590|59209358|FG000|Overall Study|Adverse Event|2|||
31007721|NCT01513590|59209359|FG001|Overall Study|Adverse Event|3|||
31007722|NCT01513590|59209358|FG000|Overall Study|Withdrawal Criteria|3|||
31007723|NCT01513590|59209359|FG001|Overall Study|Withdrawal Criteria|0|||
31007724|NCT01513590|59209358|FG000|Overall Study|Unclassified|5|||
31007725|NCT01513590|59209359|FG001|Overall Study|Unclassified|10|||
31007726|NCT01512264|59209369|FG000|Overall Study|Lost to Follow-up|0|||
31007727|NCT01512264|59209370|FG001|Overall Study|Lost to Follow-up|0|||
31007728|NCT01512264|59209371|FG002|Overall Study|Lost to Follow-up|0|||
31007729|NCT01512264|59209372|FG003|Overall Study|Lost to Follow-up|1|||
31007730|NCT01512108|59209384|FG000|Overall Study|Adverse Event|9|||
31007731|NCT01512108|59209385|FG001|Overall Study|Adverse Event|4|||
31007732|NCT01512108|59209384|FG000|Overall Study|Protocol Violation|1|||
31007733|NCT01512108|59209385|FG001|Overall Study|Protocol Violation|2|||
31007734|NCT01512108|59209384|FG000|Overall Study|Withdrawal Criteria|1|||
31007735|NCT01512108|59209385|FG001|Overall Study|Withdrawal Criteria|0|||
31007736|NCT01512108|59209384|FG000|Overall Study|Unclassified|11|||
31007737|NCT01512108|59209385|FG001|Overall Study|Unclassified|3|||
31007738|NCT01486758|59209393|FG000|Overall Study|Lost to Follow-up|0|||
31007739|NCT01486758|59209394|FG001|Overall Study|Lost to Follow-up|1|||
31007740|NCT01463982|59209405|FG000|Overall Study|Withdrawal by Subject|0|||
31007741|NCT01463982|59209406|FG001|Overall Study|Withdrawal by Subject|1|||
31007742|NCT01463982|59209407|FG002|Overall Study|Withdrawal by Subject|1|||
31007743|NCT01463982|59209408|FG003|Overall Study|Withdrawal by Subject|0|||
31007744|NCT01463982|59209405|FG000|Overall Study|Treatment delay over 5 week|0|||
31007745|NCT01463982|59209406|FG001|Overall Study|Treatment delay over 5 week|0|||
31007746|NCT01463982|59209407|FG002|Overall Study|Treatment delay over 5 week|1|||
31007747|NCT01463982|59209408|FG003|Overall Study|Treatment delay over 5 week|0|||
31007748|NCT01486446|59209420|FG000|Overall Study|Adverse Event|1|||
31007749|NCT01486446|59209421|FG001|Overall Study|Adverse Event|0|||
31007750|NCT01485354|59209427|FG000|Overall Study|Withdrawal by Subject|5|||
31007751|NCT01510158|59209434|FG000|Overall Study|Adverse Event|7|||
31007752|NCT01510158|59209435|FG001|Overall Study|Adverse Event|8|||
31007753|NCT01510158|59209436|FG002|Overall Study|Adverse Event|5|||
31007754|NCT01510158|59209434|FG000|Overall Study|Gout flare|1|||
31007755|NCT01510158|59209435|FG001|Overall Study|Gout flare|0|||
31007756|NCT01510158|59209436|FG002|Overall Study|Gout flare|0|||
31007757|NCT01510158|59209434|FG000|Overall Study|Protocol Violation|17|||
31007758|NCT01510158|59209435|FG001|Overall Study|Protocol Violation|16|||
31007759|NCT01510158|59209436|FG002|Overall Study|Protocol Violation|24|||
31007760|NCT01510158|59209434|FG000|Overall Study|Sponsor terminated study.|2|||
31007761|NCT01510158|59209435|FG001|Overall Study|Sponsor terminated study.|0|||
31007762|NCT01510158|59209436|FG002|Overall Study|Sponsor terminated study.|2|||
31007763|NCT01510158|59209434|FG000|Overall Study|Lost to Follow-up|13|||
31007764|NCT01510158|59209435|FG001|Overall Study|Lost to Follow-up|16|||
31007765|NCT01510158|59209436|FG002|Overall Study|Lost to Follow-up|9|||
31007766|NCT01510158|59209434|FG000|Overall Study|Withdrawal by Subject|10|||
31007767|NCT01510158|59209435|FG001|Overall Study|Withdrawal by Subject|13|||
31007768|NCT01510158|59209436|FG002|Overall Study|Withdrawal by Subject|10|||
31007769|NCT01510158|59209434|FG000|Overall Study|Death|1|||
31007770|NCT01510158|59209435|FG001|Overall Study|Death|0|||
31007771|NCT01510158|59209436|FG002|Overall Study|Death|0|||
31007772|NCT01485120|59209453|FG000|Overall Study|Withdrawal by Subject|2|||
31007773|NCT01484496|59209460|FG000|Period 1|Protocol Violation|3|||
31007774|NCT01484496|59209461|FG001|Period 1|Protocol Violation|4|||
31007775|NCT01484496|59209462|FG002|Period 1|Protocol Violation|0|||
31007776|NCT01484496|59209463|FG003|Period 1|Protocol Violation|0|||
31007777|NCT01484496|59209460|FG000|Period 1|Physician Decision|5|||
31007778|NCT01484496|59209461|FG001|Period 1|Physician Decision|1|||
31007779|NCT01484496|59209462|FG002|Period 1|Physician Decision|0|||
31007780|NCT01484496|59209463|FG003|Period 1|Physician Decision|0|||
31007781|NCT01484496|59209460|FG000|Period 1|Lack of Efficacy|10|||
31007782|NCT01484496|59209461|FG001|Period 1|Lack of Efficacy|15|||
31007783|NCT01484496|59209462|FG002|Period 1|Lack of Efficacy|0|||
31007784|NCT01484496|59209463|FG003|Period 1|Lack of Efficacy|0|||
31007785|NCT01484496|59209460|FG000|Period 1|Adverse Event|25|||
31007786|NCT01484496|59209461|FG001|Period 1|Adverse Event|40|||
31007787|NCT01484496|59209462|FG002|Period 1|Adverse Event|0|||
31007788|NCT01484496|59209463|FG003|Period 1|Adverse Event|0|||
31007789|NCT01484496|59209460|FG000|Period 1|Withdrawal by Subject|15|||
31007790|NCT01484496|59209461|FG001|Period 1|Withdrawal by Subject|12|||
31007791|NCT01484496|59209462|FG002|Period 1|Withdrawal by Subject|0|||
31007792|NCT01484496|59209463|FG003|Period 1|Withdrawal by Subject|0|||
31007793|NCT01484496|59209460|FG000|Period 1|Lost to Follow-up|2|||
31007794|NCT01484496|59209461|FG001|Period 1|Lost to Follow-up|6|||
31007795|NCT01484496|59209462|FG002|Period 1|Lost to Follow-up|0|||
31007796|NCT01484496|59209463|FG003|Period 1|Lost to Follow-up|0|||
31007797|NCT01484496|59209460|FG000|Period 1|Positive Pregnancy|1|||
31007798|NCT01484496|59209461|FG001|Period 1|Positive Pregnancy|6|||
31007799|NCT01484496|59209462|FG002|Period 1|Positive Pregnancy|0|||
31007800|NCT01484496|59209463|FG003|Period 1|Positive Pregnancy|0|||
31007801|NCT01484496|59209460|FG000|Period 1|Treatment Failure|3|||
30612720|NCT00925015|58623903|FG001|Overall Study|Progressive Disease|3|||
30612721|NCT00925015|58623904|FG002|Overall Study|Progressive Disease|4|||
30612722|NCT00925015|58623902|FG000|Overall Study|Withdrawal by Subject|0|||
30612723|NCT00925015|58623903|FG001|Overall Study|Withdrawal by Subject|0|||
30612724|NCT00925015|58623904|FG002|Overall Study|Withdrawal by Subject|1|||
30612725|NCT01127763|58623916|FG000|Overall Study|Adverse Event|2|||
30612726|NCT01127763|58623916|FG000|Overall Study|Withdrawal by Subject|1|||
30612727|NCT01127763|58623916|FG000|Overall Study|Physician Decision|2|||
30612728|NCT01127607|58623926|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
30612729|NCT01127607|58623927|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
30612730|NCT01127607|58623926|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
30612731|NCT01127607|58623927|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
30612732|NCT00924781|58623954|FG000|Overall Study|Study terminated by sponsor|12|||
30612733|NCT00924781|58623955|FG001|Overall Study|Study terminated by sponsor|10|||
30612734|NCT01127451|58623973|FG000|Overall Study|Other|2|||
30612735|NCT01127451|58623974|FG001|Overall Study|Other|1|||
30612736|NCT01127451|58623973|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
30612737|NCT01127451|58623974|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
30612738|NCT01127451|58623973|FG000|Overall Study|Death|22|||
30612739|NCT01127451|58623974|FG001|Overall Study|Death|17|||
30612740|NCT01127451|58623973|FG000|Overall Study|Lost to Follow-up|3|||
30612741|NCT01127451|58623974|FG001|Overall Study|Lost to Follow-up|0|||
30612742|NCT01127451|58623973|FG000|Overall Study|Administrative Reason by Sponsor|2|||
30612743|NCT01127451|58623974|FG001|Overall Study|Administrative Reason by Sponsor|2|||
30612744|NCT01127373|58623980|FG000|Overall Study|Not Treated|3|||
30699217|NCT00560235|58713742|FG000|Phase 1B|Discontinued|0|||
31007802|NCT01484496|59209461|FG001|Period 1|Treatment Failure|6|||
31007803|NCT01484496|59209462|FG002|Period 1|Treatment Failure|0|||
31007804|NCT01484496|59209463|FG003|Period 1|Treatment Failure|0|||
31007805|NCT01484496|59209460|FG000|Period 1|Lack of Compliance|2|||
30612745|NCT01127373|58623980|FG000|Overall Study|Lost to Follow-up|7|||
30612746|NCT01127373|58623980|FG000|Overall Study|Withdrawal by Subject|1|||
30699218|NCT00560235|58713743|FG001|Phase 1B|Discontinued|19|||
30893036|NCT02531633|58926446|FG000|Part B (104 Weeks)|Sponsor request|0|||
30612747|NCT01127373|58623980|FG000|Overall Study|Disease progression|1|||
31007806|NCT01484496|59209461|FG001|Period 1|Lack of Compliance|1|||
31007807|NCT01484496|59209462|FG002|Period 1|Lack of Compliance|0|||
31007808|NCT01484496|59209463|FG003|Period 1|Lack of Compliance|0|||
31007809|NCT01484496|59209460|FG000|Period 1|Unable to Visit Site|0|||
31007810|NCT01484496|59209461|FG001|Period 1|Unable to Visit Site|2|||
31007811|NCT01484496|59209462|FG002|Period 1|Unable to Visit Site|0|||
31007812|NCT01484496|59209463|FG003|Period 1|Unable to Visit Site|0|||
31007813|NCT01484496|59209460|FG000|Period 2|Lack of Efficacy|0|||
31007814|NCT01484496|59209461|FG001|Period 2|Lack of Efficacy|0|||
31007815|NCT01484496|59209462|FG002|Period 2|Lack of Efficacy|1|||
31007816|NCT01484496|59209463|FG003|Period 2|Lack of Efficacy|3|||
31007817|NCT01484496|59209460|FG000|Period 2|Adverse Event|0|||
31007818|NCT01484496|59209461|FG001|Period 2|Adverse Event|0|||
31007819|NCT01484496|59209462|FG002|Period 2|Adverse Event|5|||
31007820|NCT01484496|59209463|FG003|Period 2|Adverse Event|13|||
31007821|NCT01484496|59209460|FG000|Period 2|Other|0|||
31007822|NCT01484496|59209461|FG001|Period 2|Other|0|||
31007823|NCT01484496|59209462|FG002|Period 2|Other|9|||
31007824|NCT01484496|59209463|FG003|Period 2|Other|6|||
31007825|NCT01509846|59209476|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
31007826|NCT01509846|59209477|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
31007827|NCT01509846|59209478|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
31007828|NCT01509846|59209479|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
30893037|NCT02531633|58926447|FG001|Part B (104 Weeks)|Sponsor request|0|||
30612748|NCT01127139|58623984|FG000|Overall Study|Adverse Event|40|||
30612749|NCT01127139|58623984|FG000|Overall Study|Incompliance|12|||
30612750|NCT01127139|58623984|FG000|Overall Study|Lack of Efficacy|4|||
30612751|NCT01127139|58623984|FG000|Overall Study|Reason not specified|1|||
30612752|NCT01214616|58623995|FG000|Overall Study|Progressive disease|2|||
30612753|NCT01214616|58623996|FG001|Overall Study|Progressive disease|2|||
30612754|NCT01214616|58623997|FG002|Overall Study|Progressive disease|2|||
30612755|NCT01214616|58623998|FG003|Overall Study|Progressive disease|4|||
30612756|NCT01214616|58623995|FG000|Overall Study|Dose limiting toxicity|0|||
30612757|NCT01214616|58623996|FG001|Overall Study|Dose limiting toxicity|2|||
30612758|NCT01214616|58623997|FG002|Overall Study|Dose limiting toxicity|0|||
30612759|NCT01214616|58623998|FG003|Overall Study|Dose limiting toxicity|0|||
30612760|NCT01214616|58623995|FG000|Overall Study|Other adverse events|0|||
30612761|NCT01214616|58623996|FG001|Overall Study|Other adverse events|1|||
30612762|NCT01214616|58623997|FG002|Overall Study|Other adverse events|1|||
30612763|NCT01214616|58623998|FG003|Overall Study|Other adverse events|1|||
30612764|NCT01214616|58623995|FG000|Overall Study|Withdrawal by Subject|1|||
30612765|NCT01214616|58623996|FG001|Overall Study|Withdrawal by Subject|0|||
30612766|NCT01214616|58623997|FG002|Overall Study|Withdrawal by Subject|0|||
30893038|NCT02531633|58926448|FG002|Part B (104 Weeks)|Sponsor request|0|||
30893039|NCT02531633|58926449|FG003|Part B (104 Weeks)|Sponsor request|0|||
30893040|NCT02531633|58926450|FG004|Part B (104 Weeks)|Sponsor request|0|||
30893041|NCT02531633|58926451|FG005|Part B (104 Weeks)|Sponsor request|8|||
30893042|NCT02531633|58926452|FG006|Part B (104 Weeks)|Sponsor request|5|||
30893043|NCT02531633|58926453|FG007|Part B (104 Weeks)|Sponsor request|3|||
31007829|NCT01509846|59209480|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
31007830|NCT01509846|59209476|FG000|Received Vaccination 2|Illness|0|||
30612767|NCT01214616|58623998|FG003|Overall Study|Withdrawal by Subject|1|||
31007831|NCT01509846|59209477|FG001|Received Vaccination 2|Illness|0|||
30612768|NCT01213836|58624018|FG000|Period 1, First Intervention|Adverse Event|2|||
31007832|NCT01509846|59209478|FG002|Received Vaccination 2|Illness|0|||
31007833|NCT01509846|59209479|FG003|Received Vaccination 2|Illness|0|||
31007834|NCT01509846|59209480|FG004|Received Vaccination 2|Illness|1|||
31007835|NCT01509846|59209476|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
31007836|NCT01509846|59209477|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
31007837|NCT01509846|59209478|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
31007838|NCT01509846|59209479|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
31007839|NCT01509846|59209480|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
31007840|NCT01509846|59209476|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
31007841|NCT01509846|59209477|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
31007842|NCT01509846|59209478|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
31007843|NCT01509846|59209479|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
31007844|NCT01509846|59209480|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
31007845|NCT01509846|59209476|FG000|Received Vaccination 3|Pregnancy|0|||
31007846|NCT01509846|59209477|FG001|Received Vaccination 3|Pregnancy|0|||
31007847|NCT01509846|59209478|FG002|Received Vaccination 3|Pregnancy|0|||
31007848|NCT01509846|59209479|FG003|Received Vaccination 3|Pregnancy|1|||
31007849|NCT01509846|59209480|FG004|Received Vaccination 3|Pregnancy|0|||
31007850|NCT01509846|59209476|FG000|Received Vaccination 3|Lost to Follow-up|0|||
31007851|NCT01509846|59209477|FG001|Received Vaccination 3|Lost to Follow-up|0|||
31007852|NCT01509846|59209478|FG002|Received Vaccination 3|Lost to Follow-up|1|||
31007853|NCT01509846|59209479|FG003|Received Vaccination 3|Lost to Follow-up|0|||
31007854|NCT01509846|59209480|FG004|Received Vaccination 3|Lost to Follow-up|0|||
31007855|NCT01462344|59209501|FG000|Overall Study|Withdrawal by Subject|245|||
31007856|NCT01462344|59209502|FG001|Overall Study|Withdrawal by Subject|226|||
31007857|NCT01462344|59209501|FG000|Overall Study|Adverse Event|24|||
31007858|NCT01462344|59209502|FG001|Overall Study|Adverse Event|23|||
31007859|NCT01462344|59209501|FG000|Overall Study|Asthma Exacerbation|34|||
31007860|NCT01462344|59209502|FG001|Overall Study|Asthma Exacerbation|35|||
31007861|NCT01462344|59209501|FG000|Overall Study|Lack of Efficacy|5|||
31007862|NCT01462344|59209502|FG001|Overall Study|Lack of Efficacy|6|||
31007863|NCT01462344|59209501|FG000|Overall Study|Protocol Violation|68|||
31007864|NCT01462344|59209502|FG001|Overall Study|Protocol Violation|53|||
31007865|NCT01462344|59209501|FG000|Overall Study|Lost to Follow-up|7|||
31007866|NCT01462344|59209502|FG001|Overall Study|Lost to Follow-up|7|||
31007867|NCT01484028|59209508|FG000|Period 1|Lost to Follow-up|0|||
31007868|NCT01484028|59209509|FG001|Period 1|Lost to Follow-up|1|||
31007869|NCT01484028|59209510|FG002|Period 1|Lost to Follow-up|0|||
31007870|NCT01484028|59209511|FG003|Period 1|Lost to Follow-up|0|||
31007871|NCT01484028|59209508|FG000|Period 1|Non-Compliance to Protocol|0|||
31007872|NCT01484028|59209509|FG001|Period 1|Non-Compliance to Protocol|1|||
31007873|NCT01484028|59209510|FG002|Period 1|Non-Compliance to Protocol|0|||
31007874|NCT01484028|59209511|FG003|Period 1|Non-Compliance to Protocol|1|||
31007875|NCT01484028|59209508|FG000|Period 1|Lens Discomfort|0|||
31007876|NCT01484028|59209509|FG001|Period 1|Lens Discomfort|1|||
31007877|NCT01484028|59209510|FG002|Period 1|Lens Discomfort|0|||
31007878|NCT01484028|59209511|FG003|Period 1|Lens Discomfort|0|||
31007879|NCT01462266|59209521|FG000|Overall Study|Adverse Event|7|||
31007880|NCT01462266|59209522|FG001|Overall Study|Adverse Event|6|||
31007881|NCT01462266|59209521|FG000|Overall Study|Death|2|||
31007882|NCT01462266|59209522|FG001|Overall Study|Death|1|||
31007883|NCT01462266|59209521|FG000|Overall Study|Lack of Efficacy|0|||
31007884|NCT01462266|59209522|FG001|Overall Study|Lack of Efficacy|2|||
31007885|NCT01462266|59209521|FG000|Overall Study|Lost to Follow-up|4|||
31007886|NCT01462266|59209522|FG001|Overall Study|Lost to Follow-up|3|||
31007887|NCT01462266|59209521|FG000|Overall Study|Non-compliance with study drug|3|||
31007888|NCT01462266|59209522|FG001|Overall Study|Non-compliance with study drug|0|||
31007889|NCT01462266|59209521|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
31007890|NCT01462266|59209522|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
31007891|NCT01462266|59209521|FG000|Overall Study|Physician Decision|2|||
31007892|NCT01462266|59209522|FG001|Overall Study|Physician Decision|5|||
31007893|NCT01462266|59209521|FG000|Overall Study|Protocol Violation|1|||
31007894|NCT01462266|59209522|FG001|Overall Study|Protocol Violation|3|||
31007895|NCT01462266|59209521|FG000|Overall Study|Withdrawal by Subject|7|||
31007896|NCT01462266|59209522|FG001|Overall Study|Withdrawal by Subject|2|||
31007897|NCT01462266|59209521|FG000|Overall Study|Screen failure|1|||
31007898|NCT01462266|59209522|FG001|Overall Study|Screen failure|1|||
31007899|NCT01508910|59209531|FG000|Treatment|Death|2|||
31007900|NCT01508910|59209532|FG001|Treatment|Death|3|||
31007901|NCT01508910|59209533|FG002|Treatment|Death|2|||
31007902|NCT01508910|59209534|FG003|Treatment|Death|0|||
31007903|NCT01508910|59209531|FG000|Treatment|Lost to Follow-up|0|||
31007904|NCT01508910|59209532|FG001|Treatment|Lost to Follow-up|0|||
31007905|NCT01508910|59209533|FG002|Treatment|Lost to Follow-up|2|||
31007906|NCT01508910|59209534|FG003|Treatment|Lost to Follow-up|1|||
31007907|NCT01508910|59209531|FG000|Treatment|Withdrawal by Subject|0|||
31007908|NCT01508910|59209532|FG001|Treatment|Withdrawal by Subject|1|||
31007909|NCT01508910|59209533|FG002|Treatment|Withdrawal by Subject|6|||
31007910|NCT01508910|59209534|FG003|Treatment|Withdrawal by Subject|1|||
31007911|NCT01508910|59209531|FG000|Treatment|Sponsor Decision|0|||
31007912|NCT01508910|59209532|FG001|Treatment|Sponsor Decision|0|||
31007913|NCT01508910|59209533|FG002|Treatment|Sponsor Decision|0|||
31007914|NCT01508910|59209534|FG003|Treatment|Sponsor Decision|1|||
31007915|NCT01462110|59209548|FG000|Overall Study|Adverse Event|1|||
31007916|NCT01462110|59209549|FG001|Overall Study|Adverse Event|0|||
31007917|NCT01508676|59209557|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
31007918|NCT01508676|59209558|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
31007919|NCT01508676|59209557|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
31007920|NCT01508676|59209558|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
31007921|NCT01508676|59209557|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
31007922|NCT01508676|59209558|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
31007923|NCT01508676|59209557|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
31007924|NCT01508676|59209558|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
31007925|NCT01508676|59209557|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
31007926|NCT01508676|59209558|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
31007927|NCT01508130|59209567|FG000|Overall Study|Adverse Event|81|||
31007928|NCT01508130|59209568|FG001|Overall Study|Adverse Event|28|||
31007929|NCT01508130|59209567|FG000|Overall Study|Death|3|||
31007930|NCT01508130|59209568|FG001|Overall Study|Death|1|||
31007931|NCT01508130|59209567|FG000|Overall Study|Protocol Violation|2|||
31007932|NCT01508130|59209568|FG001|Overall Study|Protocol Violation|0|||
31007933|NCT01508130|59209567|FG000|Overall Study|Lost to Follow-up|25|||
31007934|NCT01508130|59209568|FG001|Overall Study|Lost to Follow-up|2|||
31007935|NCT01508130|59209567|FG000|Overall Study|Withdrawal by Subject|3|||
31007936|NCT01508130|59209568|FG001|Overall Study|Withdrawal by Subject|3|||
31007937|NCT01508130|59209567|FG000|Overall Study|Subject's substantial non-compliance|25|||
31007938|NCT01508130|59209568|FG001|Overall Study|Subject's substantial non-compliance|9|||
31007939|NCT01508130|59209567|FG000|Overall Study|Insufficient therapeutic response|74|||
31007940|NCT01508130|59209568|FG001|Overall Study|Insufficient therapeutic response|23|||
31007941|NCT01508130|59209567|FG000|Overall Study|Administrative|14|||
31007942|NCT01508130|59209568|FG001|Overall Study|Administrative|3|||
31007943|NCT01482312|59209576|FG000|Period 1, 90 Minutes of Wear|Other|1|||
31007944|NCT01482312|59209577|FG001|Period 1, 90 Minutes of Wear|Other|0|||
31007945|NCT01482312|59209578|FG002|Period 1, 90 Minutes of Wear|Other|0|||
31007946|NCT01482312|59209576|FG000|Period 2, 90 Minutes of Wear|Other|1|||
31007947|NCT01482312|59209577|FG001|Period 2, 90 Minutes of Wear|Other|0|||
31007948|NCT01482312|59209578|FG002|Period 2, 90 Minutes of Wear|Other|0|||
31007949|NCT01461096|59209588|FG000|Overall Study|Death|3|||
31007950|NCT01461096|59209589|FG001|Overall Study|Death|6|||
31007951|NCT01461096|59209588|FG000|Overall Study|Severe debilitation, unable to continue|1|||
31007952|NCT01461096|59209589|FG001|Overall Study|Severe debilitation, unable to continue|1|||
31007953|NCT01461096|59209588|FG000|Overall Study|Subj not able to get to clinic|15|||
30699219|NCT00560235|58713744|FG002|Phase 1B|Discontinued|0|||
31007954|NCT01461096|59209589|FG001|Overall Study|Subj not able to get to clinic|13|||
31007955|NCT01461096|59209588|FG000|Overall Study|Site is closing|27|||
31007956|NCT01461096|59209589|FG001|Overall Study|Site is closing|30|||
31007957|NCT01461096|59209588|FG000|Overall Study|Withdrawal by Subject|5|||
31007958|NCT01461096|59209589|FG001|Overall Study|Withdrawal by Subject|3|||
31007959|NCT01461096|59209588|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
31007960|NCT01461096|59209589|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
31007961|NCT01461096|59209588|FG000|Overall Study|Lost to Follow-up|8|||
31007962|NCT01461096|59209589|FG001|Overall Study|Lost to Follow-up|4|||
31007963|NCT01507896|59209596|FG000|Overall Study|Withdrawal by Subject|1|||
31007964|NCT01507896|59209596|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
31007965|NCT01507662|59209611|FG000|Overall Study|Death|26|||
31007966|NCT01507662|59209612|FG001|Overall Study|Death|18|||
31007967|NCT01507662|59209611|FG000|Overall Study|Withdrawal by Subject|290|||
31007968|NCT01507662|59209612|FG001|Overall Study|Withdrawal by Subject|287|||
31007969|NCT01507662|59209611|FG000|Overall Study|Lost to Follow-up|498|||
31007970|NCT01507662|59209612|FG001|Overall Study|Lost to Follow-up|523|||
31007971|NCT01507662|59209611|FG000|Overall Study|Proxy interview done|2|||
31007972|NCT01507662|59209612|FG001|Overall Study|Proxy interview done|3|||
31007973|NCT01506960|59209618|FG000|Overall Study|Did not meet angiographic criteria|47|||
31007974|NCT01480674|59209624|FG000|Overall Study|Death|23|||
31007975|NCT01480674|59209624|FG000|Overall Study|Lost to Follow-up|2|||
31007976|NCT01480674|59209624|FG000|Overall Study|visit not done|10|||
31007977|NCT01506882|59209630|FG000|Overall Study|Lack of Efficacy|4|||
31007978|NCT01506882|59209631|FG001|Overall Study|Lack of Efficacy|3|||
31007979|NCT01506882|59209630|FG000|Overall Study|Lost to Follow-up|1|||
31007980|NCT01506882|59209631|FG001|Overall Study|Lost to Follow-up|0|||
31007981|NCT01506882|59209630|FG000|Overall Study|Withdrawal by Subject|9|||
31007982|NCT01506882|59209631|FG001|Overall Study|Withdrawal by Subject|3|||
31007983|NCT01506882|59209630|FG000|Overall Study|SAE, non-fatal|2|||
31007984|NCT01506882|59209631|FG001|Overall Study|SAE, non-fatal|0|||
31007985|NCT01506882|59209630|FG000|Overall Study|AE, non-serious non-fatal|3|||
31007986|NCT01506882|59209631|FG001|Overall Study|AE, non-serious non-fatal|1|||
31007987|NCT01506882|59209630|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
31007988|NCT01506882|59209631|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
31007989|NCT01506882|59209630|FG000|Overall Study|Other Reason|2|||
31007990|NCT01506882|59209631|FG001|Overall Study|Other Reason|0|||
31007991|NCT01506726|59209641|FG000|Overall Study|Adverse Event|1|||
31007992|NCT01506726|59209642|FG001|Overall Study|Adverse Event|2|||
31007993|NCT01505868|59209653|FG000|Overall Study|Withdrawal by Subject|1|||
31007994|NCT01505868|59209654|FG001|Overall Study|Withdrawal by Subject|0|||
31007995|NCT01505868|59209655|FG002|Overall Study|Withdrawal by Subject|0|||
31007996|NCT01505868|59209656|FG003|Overall Study|Withdrawal by Subject|0|||
30699220|NCT00560235|58713742|FG000|Phase 2|Discontinued|0|||
30699221|NCT00560235|58713743|FG001|Phase 2|Discontinued|0|||
30699222|NCT00560235|58713744|FG002|Phase 2|Discontinued|96|||
30699223|NCT00560235|58713742|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
31007997|NCT01505868|59209657|FG004|Overall Study|Withdrawal by Subject|0|||
31007998|NCT01505634|59209672|FG000|Overall Study|Withdrawal by Subject|2|||
31007999|NCT01505634|59209673|FG001|Overall Study|Withdrawal by Subject|5|||
31008000|NCT01505634|59209674|FG002|Overall Study|Withdrawal by Subject|1|||
31008001|NCT01505634|59209672|FG000|Overall Study|Physician Decision|1|||
31008002|NCT01505634|59209673|FG001|Overall Study|Physician Decision|1|||
31008003|NCT01505634|59209674|FG002|Overall Study|Physician Decision|0|||
31008004|NCT01505634|59209672|FG000|Overall Study|Adverse Event|1|||
31008005|NCT01505634|59209673|FG001|Overall Study|Adverse Event|0|||
31008006|NCT01505634|59209674|FG002|Overall Study|Adverse Event|0|||
31008007|NCT01505634|59209672|FG000|Overall Study|Insufficient supply of drug at site|1|||
31008008|NCT01505634|59209673|FG001|Overall Study|Insufficient supply of drug at site|0|||
31008009|NCT01505634|59209674|FG002|Overall Study|Insufficient supply of drug at site|0|||
31008010|NCT01505634|59209672|FG000|Overall Study|Protocol Violation|2|||
31008011|NCT01505634|59209673|FG001|Overall Study|Protocol Violation|0|||
31008012|NCT01505634|59209674|FG002|Overall Study|Protocol Violation|0|||
31008013|NCT01505634|59209672|FG000|Overall Study|Lost to Follow-up|1|||
31008014|NCT01505634|59209673|FG001|Overall Study|Lost to Follow-up|4|||
31008015|NCT01505634|59209674|FG002|Overall Study|Lost to Follow-up|4|||
31008016|NCT01505634|59209672|FG000|Overall Study|Death|1|||
31008017|NCT01505634|59209673|FG001|Overall Study|Death|0|||
31008018|NCT01505634|59209674|FG002|Overall Study|Death|0|||
31008019|NCT01505634|59209672|FG000|Overall Study|In a conflict zone|0|||
31008020|NCT01505634|59209673|FG001|Overall Study|In a conflict zone|0|||
31008021|NCT01505634|59209674|FG002|Overall Study|In a conflict zone|1|||
31008022|NCT01460628|59209682|FG000|Overall Study|Adverse Event|3|||
31008023|NCT01460628|59209682|FG000|Overall Study|Withdrawal by Subject|2|||
31008024|NCT01480596|59209688|FG000|Overall Study|Adverse Event|3|||
31008025|NCT01480596|59209689|FG001|Overall Study|Adverse Event|0|||
31008026|NCT01480596|59209688|FG000|Overall Study|MG exacerbation or change in medication|2|||
31008027|NCT01480596|59209689|FG001|Overall Study|MG exacerbation or change in medication|2|||
31008028|NCT01480284|59209697|FG000|Overall Study|Withdrawal by Subject|2|||
31008029|NCT01480284|59209698|FG001|Overall Study|Withdrawal by Subject|0|||
31008030|NCT01480284|59209697|FG000|Overall Study|Adverse Event|1|||
31008031|NCT01480284|59209698|FG001|Overall Study|Adverse Event|0|||
31008032|NCT01480284|59209697|FG000|Overall Study|Study closed/terminated|3|||
31008033|NCT01480284|59209698|FG001|Overall Study|Study closed/terminated|0|||
31008034|NCT01480284|59209697|FG000|Overall Study|Lost to Follow-up|1|||
31008035|NCT01480284|59209698|FG001|Overall Study|Lost to Follow-up|0|||
31008036|NCT01480284|59209697|FG000|Overall Study|Physician Decision|1|||
31008037|NCT01480284|59209698|FG001|Overall Study|Physician Decision|0|||
31008038|NCT01459614|59209706|FG000|Overall Study|Adverse Event|1|||
31008039|NCT01459614|59209707|FG001|Overall Study|Adverse Event|0|||
31008040|NCT01459068|59209715|FG000|Overall Study|Withdrawal by Subject|8|||
31008041|NCT01459068|59209716|FG001|Overall Study|Withdrawal by Subject|18|||
31008042|NCT01459068|59209715|FG000|Overall Study|Lost to Follow-up|31|||
31008043|NCT01459068|59209716|FG001|Overall Study|Lost to Follow-up|15|||
31008044|NCT01459068|59209715|FG000|Overall Study|Death|0|||
31008045|NCT01459068|59209716|FG001|Overall Study|Death|1|||
31008046|NCT01458522|59209724|FG000|Overall Study|Withdrawal by Subject|2|||
30790772|NCT03524092|58803941|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
31008047|NCT01458522|59209725|FG001|Overall Study|Withdrawal by Subject|2|||
31008048|NCT01458522|59209724|FG000|Overall Study|Physician Decision|1|||
31008049|NCT01458522|59209725|FG001|Overall Study|Physician Decision|9|||
31008050|NCT01505010|59209739|FG000|Overall Study|Protocol Violation|0|||
31008051|NCT01505010|59209740|FG001|Overall Study|Protocol Violation|1|||
31008052|NCT01505010|59209739|FG000|Overall Study|Lost to Follow-up|0|||
31008053|NCT01505010|59209740|FG001|Overall Study|Lost to Follow-up|1|||
31008054|NCT01458366|59209751|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
31008055|NCT01458366|59209752|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
30612769|NCT01213836|58624019|FG001|Period 1, First Intervention|Adverse Event|1|||
30612770|NCT01213836|58624018|FG000|Period 1, First Intervention|Protocol Violation|0|||
30612771|NCT01213836|58624019|FG001|Period 1, First Intervention|Protocol Violation|1|||
30612772|NCT01213836|58624018|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
30612773|NCT01213836|58624019|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
30612774|NCT01127061|58624030|FG000|Overall Study|Lost to Follow-up|7|||
30612775|NCT01127061|58624031|FG001|Overall Study|Lost to Follow-up|10|||
30612776|NCT01127061|58624030|FG000|Overall Study|Physician Decision|3|||
30612777|NCT01127061|58624031|FG001|Overall Study|Physician Decision|3|||
30612778|NCT00924703|58624037|FG000|Overall Study|Withdrawal by Subject|11|||
30612779|NCT00924703|58624037|FG000|Overall Study|Physician Decision|5|||
30612780|NCT00924703|58624037|FG000|Overall Study|Lost to Follow-up|3|||
30612781|NCT00924703|58624037|FG000|Overall Study|Adverse Event|2|||
30612782|NCT00924703|58624037|FG000|Overall Study|Withdrawal by Sponsor|1|||
30612783|NCT01213524|58624043|FG000|Baseline|Withdrawal by Subject|5|||
30612784|NCT01213524|58624043|FG000|Baseline|high breath alcohol levels|1|||
30612785|NCT01213524|58624043|FG000|Baseline|Physician Decision|1|||
30612786|NCT01213524|58624043|FG000|Session 2|Withdrawal by Subject|5|||
30612787|NCT01213524|58624043|FG000|Session 3|Withdrawal by Subject|4|||
30612788|NCT01213524|58624043|FG000|Session 4|Physician Decision|1|||
30612789|NCT01213524|58624043|FG000|Session 4|Withdrawal by Subject|2|||
30612790|NCT01212744|58624054|FG000|Overall Study|Withdrawal by Subject|1|||
30612791|NCT01212588|58624062|FG000|Overall Study|Physician Decision|0|||
30612792|NCT01212588|58624063|FG001|Overall Study|Physician Decision|1|||
30612793|NCT01212588|58624062|FG000|Overall Study|Protocol Violation|1|||
30612794|NCT01212588|58624063|FG001|Overall Study|Protocol Violation|1|||
30612795|NCT00918385|58624071|FG000|Monotherapy|Adverse Event|1|||
30612796|NCT00918385|58624072|FG001|Monotherapy|Adverse Event|6|||
30612797|NCT00918385|58624071|FG000|Monotherapy|Complicating illness|1|||
30612798|NCT00918385|58624072|FG001|Monotherapy|Complicating illness|0|||
30612799|NCT00918385|58624071|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
30612800|NCT00918385|58624072|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
30612801|NCT00918385|58624071|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
30612802|NCT00918385|58624072|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
30612803|NCT00918385|58624071|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
30612804|NCT00918385|58624072|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
30612805|NCT00918385|58624071|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
30612806|NCT00918385|58624072|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
30612807|NCT01211262|58624082|FG000|Overall Study|Progressive Disease|18|||
30612808|NCT01211262|58624083|FG001|Overall Study|Progressive Disease|9|||
30612809|NCT01211262|58624082|FG000|Overall Study|Adverse Event|4|||
30612810|NCT01211262|58624083|FG001|Overall Study|Adverse Event|0|||
30612811|NCT01211262|58624082|FG000|Overall Study|Withdrawal of Consent|1|||
30612812|NCT01211262|58624083|FG001|Overall Study|Withdrawal of Consent|0|||
31008056|NCT01458366|59209753|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
31008057|NCT01458366|59209754|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
31008058|NCT01458366|59209755|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
31008059|NCT01458366|59209751|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
31008060|NCT01458366|59209752|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
30612813|NCT01211262|58624082|FG000|Overall Study|Other|0|||
30612814|NCT01211262|58624083|FG001|Overall Study|Other|1|||
31008061|NCT01458366|59209753|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
31008062|NCT01458366|59209754|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
31008063|NCT01458366|59209755|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
31008064|NCT01458210|59209763|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
30612815|NCT01211184|58624095|FG000|Overall Study|Withdrawal by Subject|0|||
31008065|NCT01458210|59209763|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
30612816|NCT01211184|58624096|FG001|Overall Study|Withdrawal by Subject|2|||
30612817|NCT01211184|58624097|FG002|Overall Study|Withdrawal by Subject|1|||
30612818|NCT00924469|58624110|FG000|Overall Study|Adverse Event|2|||
30612819|NCT00924469|58624111|FG001|Overall Study|Adverse Event|0|||
30612820|NCT00924469|58624110|FG000|Overall Study|Withdrawal by Subject|0|||
30612821|NCT00924469|58624111|FG001|Overall Study|Withdrawal by Subject|1|||
30612822|NCT00924469|58624110|FG000|Overall Study|Lost to Follow-up|0|||
30612823|NCT00924469|58624111|FG001|Overall Study|Lost to Follow-up|1|||
30612824|NCT00924313|58624117|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
30612825|NCT01209780|58624125|FG000|Overall Study|Adverse Event|0|||
30612826|NCT01209780|58624126|FG001|Overall Study|Adverse Event|1|||
30612827|NCT01209780|58624127|FG002|Overall Study|Adverse Event|0|||
30612828|NCT01209780|58624128|FG003|Overall Study|Adverse Event|0|||
30612829|NCT01209780|58624129|FG004|Overall Study|Adverse Event|0|||
30612830|NCT01209780|58624125|FG000|Overall Study|Withdrawal by Subject|9|||
30612831|NCT01209780|58624126|FG001|Overall Study|Withdrawal by Subject|2|||
30612832|NCT01209780|58624127|FG002|Overall Study|Withdrawal by Subject|1|||
30612833|NCT01209780|58624128|FG003|Overall Study|Withdrawal by Subject|1|||
30612834|NCT01209780|58624129|FG004|Overall Study|Withdrawal by Subject|0|||
30612835|NCT01209780|58624125|FG000|Overall Study|Lost to Follow-up|17|||
30612836|NCT01209780|58624126|FG001|Overall Study|Lost to Follow-up|12|||
30612837|NCT01209780|58624127|FG002|Overall Study|Lost to Follow-up|3|||
30612838|NCT01209780|58624128|FG003|Overall Study|Lost to Follow-up|9|||
30612839|NCT01209780|58624129|FG004|Overall Study|Lost to Follow-up|4|||
30612840|NCT01209780|58624125|FG000|Overall Study|Protocol Violation|0|||
30612841|NCT01209780|58624126|FG001|Overall Study|Protocol Violation|1|||
30612842|NCT01209780|58624127|FG002|Overall Study|Protocol Violation|0|||
30612843|NCT01209780|58624128|FG003|Overall Study|Protocol Violation|0|||
30612844|NCT01209780|58624129|FG004|Overall Study|Protocol Violation|0|||
30612845|NCT01209780|58624125|FG000|Overall Study|Inappropriate enrollment|0|||
30612846|NCT01209780|58624126|FG001|Overall Study|Inappropriate enrollment|2|||
30612847|NCT01209780|58624127|FG002|Overall Study|Inappropriate enrollment|0|||
30612848|NCT01209780|58624128|FG003|Overall Study|Inappropriate enrollment|0|||
30612849|NCT01209780|58624129|FG004|Overall Study|Inappropriate enrollment|1|||
30612850|NCT00916357|58624142|FG000|Period 1|Withdrawal by Subject|1|||
30612851|NCT00916357|58624143|FG001|Period 1|Withdrawal by Subject|0|||
30612852|NCT00916357|58624144|FG002|Period 1|Withdrawal by Subject|0|||
30612853|NCT00916357|58624145|FG003|Period 1|Withdrawal by Subject|0|||
30612854|NCT00916357|58624146|FG004|Period 1|Withdrawal by Subject|0|||
30612855|NCT00916357|58624147|FG005|Period 1|Withdrawal by Subject|0|||
30612856|NCT00916357|58624142|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
30612857|NCT00916357|58624143|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
30612858|NCT00916357|58624144|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
30612859|NCT00916357|58624145|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
30612860|NCT00916357|58624146|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
30612861|NCT00916357|58624147|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
30612862|NCT01209624|58624156|FG000|Overall Study|Death|2|||
30612863|NCT01209624|58624156|FG000|Overall Study|Adverse Event|13|||
30612864|NCT01209624|58624156|FG000|Overall Study|Lack of Efficacy|17|||
30612865|NCT01209624|58624156|FG000|Overall Study|Lost to Follow-up|290|||
30612866|NCT01209624|58624156|FG000|Overall Study|Other|4|||
30612867|NCT00916279|58624160|FG000|Overall Study|Death|2|||
30612868|NCT00916279|58624160|FG000|Overall Study|Lost to Follow-up|2|||
30612869|NCT01209078|58624169|FG000|Overall Study|Adverse Event|5|||
30612870|NCT01209078|58624170|FG001|Overall Study|Adverse Event|0|||
30612871|NCT01209078|58624169|FG000|Overall Study|Lost to Follow-up|4|||
30612872|NCT01209078|58624170|FG001|Overall Study|Lost to Follow-up|0|||
30612873|NCT01209078|58624169|FG000|Overall Study|Physician Decision|5|||
30612874|NCT01209078|58624170|FG001|Overall Study|Physician Decision|2|||
30612875|NCT01209078|58624169|FG000|Overall Study|Withdrawal by Subject|2|||
30612876|NCT01209078|58624170|FG001|Overall Study|Withdrawal by Subject|1|||
30612877|NCT01207596|58624178|FG000|Overall Study|Physician Decision|4|||
30612878|NCT01207596|58624178|FG000|Overall Study|Lack of Efficacy|1|||
30612879|NCT01207596|58624178|FG000|Overall Study|Adverse Event|3|||
30612880|NCT01207596|58624178|FG000|Overall Study|Withdrawal by Subject|1|||
30612881|NCT00915343|58624182|FG000|Part B - Open Label Period|Treatment switch|0|||
30612882|NCT00915343|58624183|FG001|Part B - Open Label Period|Treatment switch|0|||
30612883|NCT00915343|58624184|FG002|Part B - Open Label Period|Treatment switch|1|||
30612884|NCT00915343|58624182|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
30612885|NCT00915343|58624183|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
30612886|NCT00915343|58624184|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
30612887|NCT00911989|58624196|FG000|Overall Study|Adverse Event|1|||
30612888|NCT00910273|58624202|FG000|Overall Study|Lack of Efficacy|6|||
30612889|NCT00910273|58624203|FG001|Overall Study|Lack of Efficacy|9|||
30612890|NCT00910273|58624202|FG000|Overall Study|Adverse Event|1|||
30612891|NCT00910273|58624203|FG001|Overall Study|Adverse Event|1|||
30612892|NCT00910273|58624202|FG000|Overall Study|Withdrawal by Subject|1|||
30612893|NCT00910273|58624203|FG001|Overall Study|Withdrawal by Subject|0|||
30612894|NCT00910273|58624202|FG000|Overall Study|Discontinuation of study by sponsor|8|||
30612895|NCT00910273|58624203|FG001|Overall Study|Discontinuation of study by sponsor|2|||
31008066|NCT01458210|59209763|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
31008067|NCT01458210|59209763|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
31008068|NCT01478958|59209773|FG000|Overall Study|Withdrawal by Subject|1|||
31008069|NCT01478958|59209774|FG001|Overall Study|Withdrawal by Subject|1|||
31008070|NCT01478958|59209775|FG002|Overall Study|Withdrawal by Subject|1|||
31008071|NCT01478958|59209773|FG000|Overall Study|Weight loss|1|||
31008072|NCT01478958|59209774|FG001|Overall Study|Weight loss|0|||
31008073|NCT01478958|59209775|FG002|Overall Study|Weight loss|0|||
31008074|NCT01478958|59209773|FG000|Overall Study|Re-located|0|||
31008075|NCT01478958|59209774|FG001|Overall Study|Re-located|1|||
31008076|NCT01478958|59209775|FG002|Overall Study|Re-located|0|||
30612896|NCT00910273|58624202|FG000|Overall Study|Protocol Violation|1|||
30612897|NCT00910273|58624203|FG001|Overall Study|Protocol Violation|0|||
30612898|NCT00910273|58624202|FG000|Overall Study|Lost to Follow-up|1|||
30612899|NCT00910273|58624203|FG001|Overall Study|Lost to Follow-up|1|||
30612900|NCT00910039|58624209|FG000|Overall Study|Physician Decision|1|||
30612901|NCT00909181|58624217|FG000|Overall Study|Lost to Follow-up|39|||
30612902|NCT00909181|58624218|FG001|Overall Study|Lost to Follow-up|18|||
30612903|NCT00909181|58624219|FG002|Overall Study|Lost to Follow-up|33|||
31008077|NCT01478958|59209773|FG000|Overall Study|Unable to comply|0|||
30612904|NCT01286987|58624242|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
30612905|NCT01286987|58624243|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
30612906|NCT01286987|58624244|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
30612907|NCT01286987|58624245|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
30612908|NCT01286987|58624246|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
30612909|NCT01286987|58624247|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
30612910|NCT01286987|58624248|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
30612911|NCT01286987|58624249|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
30612912|NCT01286987|58624250|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
30612913|NCT01286987|58624251|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
30612914|NCT01286987|58624252|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
30612915|NCT01286987|58624253|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
30612916|NCT01286987|58624254|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
30612917|NCT01286987|58624255|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
30612918|NCT01286987|58624256|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
30612919|NCT01286987|58624242|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
30612920|NCT01286987|58624243|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
30612921|NCT01286987|58624244|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
30612922|NCT01286987|58624245|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
30612923|NCT01286987|58624246|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
30612924|NCT01286987|58624247|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
30612925|NCT01286987|58624248|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
30612926|NCT01286987|58624249|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
30612927|NCT01286987|58624250|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
30612928|NCT01286987|58624251|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
30612929|NCT01286987|58624252|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
30612930|NCT01286987|58624253|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
30612931|NCT01286987|58624254|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
30612932|NCT01286987|58624255|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
30612933|NCT01286987|58624256|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
30612934|NCT01286987|58624242|FG000|Part 1: Dose Escalation|Physician Decision|0|||
30612935|NCT01286987|58624243|FG001|Part 1: Dose Escalation|Physician Decision|0|||
30612936|NCT01286987|58624244|FG002|Part 1: Dose Escalation|Physician Decision|0|||
30612937|NCT01286987|58624245|FG003|Part 1: Dose Escalation|Physician Decision|0|||
30612938|NCT01286987|58624246|FG004|Part 1: Dose Escalation|Physician Decision|1|||
30612939|NCT01286987|58624247|FG005|Part 1: Dose Escalation|Physician Decision|0|||
30612940|NCT01286987|58624248|FG006|Part 1: Dose Escalation|Physician Decision|0|||
30612941|NCT01286987|58624249|FG007|Part 1: Dose Escalation|Physician Decision|0|||
30612942|NCT01286987|58624250|FG008|Part 1: Dose Escalation|Physician Decision|0|||
30612943|NCT01286987|58624251|FG009|Part 1: Dose Escalation|Physician Decision|0|||
30612944|NCT01286987|58624252|FG010|Part 1: Dose Escalation|Physician Decision|0|||
30612945|NCT01286987|58624253|FG011|Part 1: Dose Escalation|Physician Decision|0|||
30612946|NCT01286987|58624254|FG012|Part 1: Dose Escalation|Physician Decision|0|||
30612947|NCT01286987|58624255|FG013|Part 1: Dose Escalation|Physician Decision|0|||
30612948|NCT01286987|58624256|FG014|Part 1: Dose Escalation|Physician Decision|0|||
30612949|NCT01286987|58624242|FG000|Part 2: Dose Expansion|Death|0|||
30612950|NCT01286987|58624243|FG001|Part 2: Dose Expansion|Death|0|||
30612951|NCT01286987|58624244|FG002|Part 2: Dose Expansion|Death|0|||
30612952|NCT01286987|58624245|FG003|Part 2: Dose Expansion|Death|0|||
30612953|NCT01286987|58624246|FG004|Part 2: Dose Expansion|Death|0|||
30612954|NCT01286987|58624247|FG005|Part 2: Dose Expansion|Death|0|||
30612955|NCT01286987|58624248|FG006|Part 2: Dose Expansion|Death|0|||
30612956|NCT01286987|58624249|FG007|Part 2: Dose Expansion|Death|0|||
30612957|NCT01286987|58624250|FG008|Part 2: Dose Expansion|Death|0|||
30612958|NCT01286987|58624251|FG009|Part 2: Dose Expansion|Death|0|||
30612959|NCT01286987|58624252|FG010|Part 2: Dose Expansion|Death|0|||
30612960|NCT01286987|58624253|FG011|Part 2: Dose Expansion|Death|0|||
30612961|NCT01286987|58624254|FG012|Part 2: Dose Expansion|Death|1|||
30612962|NCT01286987|58624255|FG013|Part 2: Dose Expansion|Death|1|||
30612963|NCT01286987|58624256|FG014|Part 2: Dose Expansion|Death|0|||
30612964|NCT01286987|58624242|FG000|Part 2: Dose Expansion|Physician Decision|0|||
30612965|NCT01286987|58624243|FG001|Part 2: Dose Expansion|Physician Decision|0|||
30612966|NCT01286987|58624244|FG002|Part 2: Dose Expansion|Physician Decision|0|||
30612967|NCT01286987|58624245|FG003|Part 2: Dose Expansion|Physician Decision|0|||
30612968|NCT01286987|58624246|FG004|Part 2: Dose Expansion|Physician Decision|0|||
30612969|NCT01286987|58624247|FG005|Part 2: Dose Expansion|Physician Decision|0|||
30612970|NCT01286987|58624248|FG006|Part 2: Dose Expansion|Physician Decision|0|||
30612971|NCT01286987|58624249|FG007|Part 2: Dose Expansion|Physician Decision|0|||
30612972|NCT01286987|58624250|FG008|Part 2: Dose Expansion|Physician Decision|0|||
30612973|NCT01286987|58624251|FG009|Part 2: Dose Expansion|Physician Decision|0|||
30612974|NCT01286987|58624252|FG010|Part 2: Dose Expansion|Physician Decision|1|||
30699224|NCT00560235|58713743|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
30612975|NCT01286987|58624253|FG011|Part 2: Dose Expansion|Physician Decision|1|||
30612976|NCT01286987|58624254|FG012|Part 2: Dose Expansion|Physician Decision|0|||
30612977|NCT01286987|58624255|FG013|Part 2: Dose Expansion|Physician Decision|1|||
30612978|NCT01286987|58624256|FG014|Part 2: Dose Expansion|Physician Decision|0|||
30612979|NCT01286987|58624242|FG000|Part 2: Dose Expansion|Other|0|||
30612980|NCT01286987|58624243|FG001|Part 2: Dose Expansion|Other|0|||
30612981|NCT01286987|58624244|FG002|Part 2: Dose Expansion|Other|0|||
30612982|NCT01286987|58624245|FG003|Part 2: Dose Expansion|Other|0|||
30612983|NCT01286987|58624246|FG004|Part 2: Dose Expansion|Other|0|||
30612984|NCT01286987|58624247|FG005|Part 2: Dose Expansion|Other|0|||
30612985|NCT01286987|58624248|FG006|Part 2: Dose Expansion|Other|0|||
30612986|NCT01286987|58624249|FG007|Part 2: Dose Expansion|Other|0|||
30612987|NCT01286987|58624250|FG008|Part 2: Dose Expansion|Other|0|||
30612988|NCT01286987|58624251|FG009|Part 2: Dose Expansion|Other|0|||
30612989|NCT01286987|58624252|FG010|Part 2: Dose Expansion|Other|0|||
30612990|NCT01286987|58624253|FG011|Part 2: Dose Expansion|Other|0|||
30612991|NCT01286987|58624254|FG012|Part 2: Dose Expansion|Other|0|||
31008078|NCT01478958|59209774|FG001|Overall Study|Unable to comply|0|||
31008079|NCT01478958|59209775|FG002|Overall Study|Unable to comply|2|||
31008080|NCT01458132|59209785|FG000|Overall Study|Other|15|||
31008081|NCT01458132|59209786|FG001|Overall Study|Other|3|||
31008082|NCT01457352|59209794|FG000|Period 1|Adverse Event|2|||
31008083|NCT01457352|59209795|FG001|Period 1|Adverse Event|0|||
31008084|NCT01457352|59209794|FG000|Period 1|Withdrawal by Subject|2|||
30612992|NCT01286987|58624255|FG013|Part 2: Dose Expansion|Other|1|||
30612993|NCT01286987|58624256|FG014|Part 2: Dose Expansion|Other|0|||
30612994|NCT01286987|58624242|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
30612995|NCT01286987|58624243|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
30612996|NCT01286987|58624244|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
30612997|NCT01286987|58624245|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
30612998|NCT01286987|58624246|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
30612999|NCT01286987|58624247|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
31008085|NCT01457352|59209795|FG001|Period 1|Withdrawal by Subject|0|||
31008086|NCT01457352|59209794|FG000|Period 1|Physician Decision|2|||
31008087|NCT01457352|59209795|FG001|Period 1|Physician Decision|0|||
31008088|NCT01457352|59209794|FG000|Period 1|MS related disease progression|1|||
31008089|NCT01457352|59209795|FG001|Period 1|MS related disease progression|0|||
30613000|NCT01286987|58624248|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
31008090|NCT01457352|59209794|FG000|Period 1|Withdrawn|1|||
31008091|NCT01457352|59209795|FG001|Period 1|Withdrawn|0|||
30613001|NCT01286987|58624249|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
30613002|NCT01286987|58624250|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
30613003|NCT01286987|58624251|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
30613004|NCT01286987|58624252|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
30613005|NCT01286987|58624253|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
30613006|NCT01286987|58624254|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
30613007|NCT01286987|58624255|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
30613008|NCT01286987|58624256|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
31008092|NCT01457352|59209794|FG000|Period 1|withdrew per sponsor|1|||
31008093|NCT01457352|59209795|FG001|Period 1|withdrew per sponsor|0|||
31008094|NCT01457352|59209794|FG000|Period 1|Protocol Violation|4|||
31008095|NCT01457352|59209795|FG001|Period 1|Protocol Violation|0|||
31008096|NCT01457352|59209794|FG000|Period 1|Did not meet eligibility criteria|3|||
31008097|NCT01457352|59209795|FG001|Period 1|Did not meet eligibility criteria|0|||
31008098|NCT01457352|59209794|FG000|Period 2|Withdrawal by Subject|23|||
31008099|NCT01457352|59209795|FG001|Period 2|Withdrawal by Subject|0|||
31008100|NCT01457352|59209794|FG000|Period 2|Adverse Event|22|||
31008101|NCT01457352|59209795|FG001|Period 2|Adverse Event|0|||
31008102|NCT01457352|59209794|FG000|Period 2|no analysis|10|||
31008103|NCT01457352|59209795|FG001|Period 2|no analysis|0|||
31008104|NCT01457352|59209794|FG000|Period 2|Lack of Efficacy|8|||
31008105|NCT01457352|59209795|FG001|Period 2|Lack of Efficacy|0|||
31008106|NCT01457352|59209794|FG000|Period 2|Protocol Violation|4|||
31008107|NCT01457352|59209795|FG001|Period 2|Protocol Violation|0|||
31008108|NCT01457352|59209794|FG000|Period 2|Sponsor's withdrawal|7|||
31008109|NCT01457352|59209795|FG001|Period 2|Sponsor's withdrawal|0|||
31008110|NCT01457352|59209794|FG000|Period 2|Lost to Follow-up|1|||
31008111|NCT01457352|59209795|FG001|Period 2|Lost to Follow-up|0|||
31008112|NCT01457352|59209794|FG000|Period 2|dose change|1|||
31008113|NCT01457352|59209795|FG001|Period 2|dose change|0|||
31008114|NCT01457352|59209794|FG000|Period 2|Physician Decision|1|||
31008115|NCT01457352|59209795|FG001|Period 2|Physician Decision|0|||
31008116|NCT01457352|59209794|FG000|Period 2|Did not meet eligibility criteria|3|||
31008117|NCT01457352|59209795|FG001|Period 2|Did not meet eligibility criteria|0|||
31008118|NCT01457352|59209794|FG000|Period 3|Adverse Event|1|||
31008119|NCT01457352|59209795|FG001|Period 3|Adverse Event|1|||
31008120|NCT01457352|59209794|FG000|Period 3|Withdrawal by Subject|0|||
31008121|NCT01457352|59209795|FG001|Period 3|Withdrawal by Subject|2|||
31008122|NCT01457352|59209794|FG000|Period 3|incorrect treatment|0|||
31008123|NCT01457352|59209795|FG001|Period 3|incorrect treatment|1|||
31008124|NCT01457352|59209794|FG000|Period 3|Sponsor's withdrawal|0|||
31008125|NCT01457352|59209795|FG001|Period 3|Sponsor's withdrawal|1|||
31008126|NCT01457118|59209809|FG000|Overall Study|Adverse Event|1|||
31008127|NCT01457118|59209810|FG001|Overall Study|Adverse Event|0|||
31008128|NCT01457118|59209811|FG002|Overall Study|Adverse Event|0|||
31008129|NCT01457118|59209812|FG003|Overall Study|Adverse Event|1|||
31008130|NCT01457118|59209809|FG000|Overall Study|Clinical Progression|0|||
31008131|NCT01457118|59209810|FG001|Overall Study|Clinical Progression|1|||
31008132|NCT01457118|59209811|FG002|Overall Study|Clinical Progression|0|||
31008133|NCT01457118|59209812|FG003|Overall Study|Clinical Progression|1|||
31008134|NCT01457118|59209809|FG000|Overall Study|Physician Decision|2|||
31008135|NCT01457118|59209810|FG001|Overall Study|Physician Decision|0|||
31008136|NCT01457118|59209811|FG002|Overall Study|Physician Decision|0|||
31008137|NCT01457118|59209812|FG003|Overall Study|Physician Decision|0|||
31008138|NCT01457118|59209809|FG000|Overall Study|Progressive Disease by RECIST|12|||
31008139|NCT01457118|59209810|FG001|Overall Study|Progressive Disease by RECIST|3|||
31008140|NCT01457118|59209811|FG002|Overall Study|Progressive Disease by RECIST|1|||
31008141|NCT01457118|59209812|FG003|Overall Study|Progressive Disease by RECIST|0|||
31008142|NCT01457118|59209809|FG000|Overall Study|Withdrawal by Subject|5|||
31008143|NCT01457118|59209810|FG001|Overall Study|Withdrawal by Subject|0|||
31008144|NCT01457118|59209811|FG002|Overall Study|Withdrawal by Subject|0|||
31008145|NCT01457118|59209812|FG003|Overall Study|Withdrawal by Subject|0|||
31008146|NCT01456962|59209824|FG000|Overall Study|Lost to Follow-up|2|||
31008147|NCT01456962|59209825|FG001|Overall Study|Lost to Follow-up|1|||
31008148|NCT01501110|59209833|FG000|Overall Study|Death|0|||
31008149|NCT01501110|59209834|FG001|Overall Study|Death|1|||
31008150|NCT01500720|59209842|FG000|Overall Study|Randomized But Not Treated|1|||
31008151|NCT01500720|59209843|FG001|Overall Study|Randomized But Not Treated|1|||
31008152|NCT01500720|59209842|FG000|Overall Study|Other|4|||
31008153|NCT01500720|59209843|FG001|Overall Study|Other|8|||
31008154|NCT01500252|59209851|FG000|Overall Study|Death|4|||
31008155|NCT01500252|59209852|FG001|Overall Study|Death|2|||
31008156|NCT01500252|59209851|FG000|Overall Study|Lost to Follow-up|5|||
31008157|NCT01500252|59209852|FG001|Overall Study|Lost to Follow-up|4|||
31008158|NCT01476696|59209859|FG000|Overall Study|Sponsor decision|2|||
31008159|NCT01476696|59209860|FG001|Overall Study|Sponsor decision|1|||
31008160|NCT01476696|59209861|FG002|Overall Study|Sponsor decision|0|||
31008161|NCT01476696|59209859|FG000|Overall Study|Withdrawal by Subject|1|||
31008162|NCT01476696|59209860|FG001|Overall Study|Withdrawal by Subject|0|||
31008163|NCT01476696|59209861|FG002|Overall Study|Withdrawal by Subject|0|||
31008164|NCT01500096|59209878|FG000|Overall Study|Lost to Follow-up|1|||
31008165|NCT01500096|59209879|FG001|Overall Study|Lost to Follow-up|0|||
31008166|NCT01500096|59209880|FG002|Overall Study|Lost to Follow-up|0|||
31008167|NCT01500096|59209881|FG003|Overall Study|Lost to Follow-up|2|||
31008168|NCT01455012|59209893|FG000|Overall Study|Adverse Event|0|||
31008169|NCT01455012|59209894|FG001|Overall Study|Adverse Event|2|||
31008170|NCT01455012|59209893|FG000|Overall Study|Lack of Efficacy|6|||
31008171|NCT01455012|59209894|FG001|Overall Study|Lack of Efficacy|1|||
31008172|NCT01455012|59209893|FG000|Overall Study|Withdrawal by Subject|3|||
31008173|NCT01455012|59209894|FG001|Overall Study|Withdrawal by Subject|1|||
31008174|NCT01455012|59209893|FG000|Overall Study|Unknown reason|2|||
31008175|NCT01455012|59209894|FG001|Overall Study|Unknown reason|0|||
31008176|NCT01454778|59209900|FG000|Overall Study|Lost to Follow-up|2|||
31008177|NCT01454778|59209900|FG000|Overall Study|Death|1|||
31008178|NCT01454076|59209909|FG000|Overall Study|Other|2|||
31008179|NCT01454076|59209910|FG001|Overall Study|Other|0|||
31008180|NCT01454076|59209911|FG002|Overall Study|Other|0|||
31008181|NCT01454076|59209912|FG003|Overall Study|Other|1|||
31008182|NCT01454076|59209913|FG004|Overall Study|Other|2|||
31008183|NCT01454076|59209909|FG000|Overall Study|Withdrawal by Subject|3|||
31008184|NCT01454076|59209910|FG001|Overall Study|Withdrawal by Subject|4|||
31008185|NCT01454076|59209911|FG002|Overall Study|Withdrawal by Subject|2|||
31008186|NCT01454076|59209912|FG003|Overall Study|Withdrawal by Subject|1|||
31008187|NCT01454076|59209913|FG004|Overall Study|Withdrawal by Subject|2|||
31008188|NCT01454076|59209909|FG000|Overall Study|Adverse Event|8|||
31008189|NCT01454076|59209910|FG001|Overall Study|Adverse Event|2|||
31008190|NCT01454076|59209911|FG002|Overall Study|Adverse Event|7|||
31008191|NCT01454076|59209912|FG003|Overall Study|Adverse Event|0|||
31008192|NCT01454076|59209913|FG004|Overall Study|Adverse Event|2|||
31008193|NCT01453998|59209937|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
31008194|NCT01453998|59209938|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
31008195|NCT01453998|59209939|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
31008196|NCT01453374|59209950|FG000|Overall Study|Adverse Event|7|||
31008197|NCT01453374|59209950|FG000|Overall Study|Lack of Efficacy|1|||
31008198|NCT01453374|59209950|FG000|Overall Study|Lost to Follow-up|3|||
31008199|NCT01453374|59209950|FG000|Overall Study|Withdrawal by Subject|5|||
31008200|NCT01453374|59209950|FG000|Overall Study|Incarcerated|2|||
31008201|NCT01453296|59209956|FG000|Treatment Period 1|Adverse Event|0|||
31008202|NCT01453296|59209957|FG001|Treatment Period 1|Adverse Event|1|||
31008203|NCT01453296|59209956|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
31008204|NCT01453296|59209957|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
31008205|NCT01453296|59209956|FG000|Treatment Period 2|Adverse Event|1|||
31008206|NCT01453296|59209957|FG001|Treatment Period 2|Adverse Event|0|||
31008207|NCT01453296|59209956|FG000|Treatment Period 2|Withdrawal by Subject|1|||
31008208|NCT01453296|59209957|FG001|Treatment Period 2|Withdrawal by Subject|0|||
31008209|NCT01453140|59209963|FG000|Overall Study|Adverse Event|3|||
31008210|NCT01499940|59209971|FG000|Overall Study|Study was withdrawn before completion.|9|||
31008211|NCT01499160|59209975|FG000|Overall Study|Adverse Event|1|||
31008212|NCT01499160|59209975|FG000|Overall Study|Withdrawal by Subject|1|||
30613009|NCT01286987|58624242|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
31008213|NCT01498692|59209980|FG000|Overall Study|Death|4|||
31008214|NCT01498692|59209980|FG000|Overall Study|Withdrawal by Subject|1|||
31008215|NCT01498692|59209980|FG000|Overall Study|Missed 12-month visit|3|||
31008216|NCT01498068|59209986|FG000|Overall Study|Withdrawal by Subject|1|||
31008217|NCT01498068|59209987|FG001|Overall Study|Withdrawal by Subject|1|||
31008218|NCT01497366|59209995|FG000|Overall Study|Virologic failure|2|||
31008219|NCT01497366|59209996|FG001|Overall Study|Virologic failure|50|||
31008220|NCT01497366|59209995|FG000|Overall Study|Lost to Follow-up|11|||
31008221|NCT01497366|59209996|FG001|Overall Study|Lost to Follow-up|10|||
31008222|NCT01497366|59209995|FG000|Overall Study|Withdrawal by Subject|6|||
31008223|NCT01497366|59209996|FG001|Overall Study|Withdrawal by Subject|6|||
31008224|NCT01497366|59209995|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
31008225|NCT01497366|59209996|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
31008226|NCT01497366|59209995|FG000|Overall Study|Other|5|||
31008227|NCT01497366|59209996|FG001|Overall Study|Other|0|||
31008228|NCT01497366|59209995|FG000|Overall Study|Death|1|||
31008229|NCT01497366|59209996|FG001|Overall Study|Death|1|||
31008230|NCT01497366|59209995|FG000|Overall Study|Randomized but not treated|7|||
31008231|NCT01497366|59209996|FG001|Overall Study|Randomized but not treated|21|||
31008232|NCT01475838|59210005|FG000|Randomized Phase|Randomized but Not Treated|0|||
31008233|NCT01475838|59210006|FG001|Randomized Phase|Randomized but Not Treated|5|||
31008234|NCT01475838|59210005|FG000|Randomized Phase|Adverse Event|6|||
31008235|NCT01475838|59210006|FG001|Randomized Phase|Adverse Event|1|||
31008236|NCT01475838|59210005|FG000|Randomized Phase|Pregnancy|0|||
31008237|NCT01475838|59210006|FG001|Randomized Phase|Pregnancy|1|||
31008238|NCT01475838|59210005|FG000|Randomized Phase|Investigators Discretion|1|||
31008239|NCT01475838|59210006|FG001|Randomized Phase|Investigators Discretion|2|||
31008240|NCT01475838|59210005|FG000|Randomized Phase|Withdrew Consent|10|||
31008241|NCT01475838|59210006|FG001|Randomized Phase|Withdrew Consent|14|||
31008242|NCT01475838|59210005|FG000|Randomized Phase|Lost to Follow-up|3|||
31008243|NCT01475838|59210006|FG001|Randomized Phase|Lost to Follow-up|4|||
30613010|NCT01286987|58624243|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
30613011|NCT01286987|58624244|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
30613012|NCT01286987|58624245|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
30613013|NCT01286987|58624246|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
30613014|NCT01286987|58624247|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
30613015|NCT01286987|58624248|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
30613016|NCT01286987|58624249|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
30613017|NCT01286987|58624250|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
30613018|NCT01286987|58624251|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
30613019|NCT01286987|58624252|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
30613020|NCT01286987|58624253|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
30613021|NCT01286987|58624254|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
30613022|NCT01286987|58624255|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
30613023|NCT01286987|58624256|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
30613024|NCT01286987|58624242|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613025|NCT01286987|58624243|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613026|NCT01286987|58624244|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613027|NCT01286987|58624245|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613028|NCT01286987|58624246|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613029|NCT01286987|58624247|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613030|NCT01286987|58624248|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613031|NCT01286987|58624249|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613032|NCT01286987|58624250|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613033|NCT01286987|58624251|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613034|NCT01286987|58624252|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
30613035|NCT01286987|58624253|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613036|NCT01286987|58624254|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613037|NCT01286987|58624255|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613038|NCT01286987|58624256|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
30613039|NCT01286753|58624299|FG000|Overall Study|Adverse Event|7|||
30613040|NCT01286753|58624300|FG001|Overall Study|Adverse Event|6|||
30613041|NCT01286753|58624299|FG000|Overall Study|Progression|11|||
30613042|NCT01286753|58624300|FG001|Overall Study|Progression|13|||
30613043|NCT01286753|58624299|FG000|Overall Study|Refused Treatment|1|||
30613044|NCT01286753|58624300|FG001|Overall Study|Refused Treatment|0|||
31008244|NCT01475838|59210005|FG000|Randomized Phase|Participant Noncompliance|1|||
30613045|NCT01286753|58624299|FG000|Overall Study|Withdrawal of Consent|0|||
30613046|NCT01286753|58624300|FG001|Overall Study|Withdrawal of Consent|2|||
30613047|NCT01286753|58624299|FG000|Overall Study|Discontinued to Join Extension Study|6|||
30613048|NCT01286753|58624300|FG001|Overall Study|Discontinued to Join Extension Study|4|||
30613049|NCT01286753|58624299|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
31008245|NCT01475838|59210006|FG001|Randomized Phase|Participant Noncompliance|5|||
31008246|NCT01475838|59210005|FG000|Randomized Phase|Protocol Violation|9|||
31008247|NCT01475838|59210006|FG001|Randomized Phase|Protocol Violation|4|||
31008248|NCT01475838|59210005|FG000|Extension Phase|Participant Noncompliance|1|||
30613050|NCT01286753|58624300|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
30613051|NCT01286129|58624309|FG000|Overall Study|Withdrawal by Subject|4|||
30613052|NCT01286129|58624310|FG001|Overall Study|Withdrawal by Subject|1|||
31008249|NCT01475838|59210006|FG001|Extension Phase|Participant Noncompliance|0|||
31008250|NCT01451814|59210015|FG000|Overall Study|Withdrawal by Subject|1|||
31008251|NCT01451814|59210016|FG001|Overall Study|Withdrawal by Subject|1|||
31008252|NCT01451814|59210015|FG000|Overall Study|Lost to Follow-up|5|||
31008253|NCT01451814|59210016|FG001|Overall Study|Lost to Follow-up|4|||
31008254|NCT01475370|59210025|FG000|Overall Study|Exacerbation of primary disease|2|||
31008255|NCT01475370|59210026|FG001|Overall Study|Exacerbation of primary disease|2|||
30613053|NCT01286129|58624309|FG000|Overall Study|Could not comply with study requirements|4|||
31008256|NCT01475370|59210027|FG002|Overall Study|Exacerbation of primary disease|2|||
31008257|NCT01475370|59210025|FG000|Overall Study|Study drug administration difficult|0|||
31008258|NCT01475370|59210026|FG001|Overall Study|Study drug administration difficult|1|||
30613054|NCT01286129|58624310|FG001|Overall Study|Could not comply with study requirements|4|||
30613055|NCT01285349|58624321|FG000|Overall Study|Lost to Follow-up|27|||
30613056|NCT01285349|58624322|FG001|Overall Study|Lost to Follow-up|20|||
30613057|NCT01285349|58624323|FG002|Overall Study|Lost to Follow-up|27|||
31008259|NCT01475370|59210027|FG002|Overall Study|Study drug administration difficult|1|||
31008260|NCT01475370|59210025|FG000|Overall Study|Other than specified|1|||
31008261|NCT01475370|59210026|FG001|Overall Study|Other than specified|0|||
31008262|NCT01475370|59210027|FG002|Overall Study|Other than specified|0|||
31008263|NCT01496430|59210038|FG000|Overall Study|Adverse Event|0|||
31008264|NCT01496430|59210039|FG001|Overall Study|Adverse Event|0|||
31008265|NCT01496430|59210040|FG002|Overall Study|Adverse Event|1|||
31008266|NCT01496430|59210038|FG000|Overall Study|Major Protocol Deviation|0|||
31008267|NCT01496430|59210039|FG001|Overall Study|Major Protocol Deviation|0|||
31008268|NCT01496430|59210040|FG002|Overall Study|Major Protocol Deviation|1|||
31008269|NCT01496430|59210038|FG000|Overall Study|Lost to Follow-up|2|||
31008270|NCT01496430|59210039|FG001|Overall Study|Lost to Follow-up|3|||
31008271|NCT01496430|59210040|FG002|Overall Study|Lost to Follow-up|1|||
31008272|NCT01496430|59210038|FG000|Overall Study|Voluntary Withdrawal|2|||
31008273|NCT01496430|59210039|FG001|Overall Study|Voluntary Withdrawal|1|||
31008274|NCT01496430|59210040|FG002|Overall Study|Voluntary Withdrawal|6|||
31008275|NCT01496430|59210038|FG000|Overall Study|Principal Investigator Discretion|0|||
31008276|NCT01496430|59210039|FG001|Overall Study|Principal Investigator Discretion|1|||
31008277|NCT01496430|59210040|FG002|Overall Study|Principal Investigator Discretion|1|||
31008278|NCT01496430|59210038|FG000|Overall Study|Other|2|||
31008279|NCT01496430|59210039|FG001|Overall Study|Other|0|||
31008280|NCT01496430|59210040|FG002|Overall Study|Other|0|||
31008281|NCT01451424|59210052|FG000|Overall Study|Withdrawal by Subject|1|||
31008282|NCT01451424|59210053|FG001|Overall Study|Withdrawal by Subject|1|||
31008283|NCT01451424|59210054|FG002|Overall Study|Withdrawal by Subject|0|||
31008284|NCT01451424|59210055|FG003|Overall Study|Withdrawal by Subject|2|||
31008285|NCT01451424|59210052|FG000|Overall Study|Lost to Follow-up|0|||
31008286|NCT01451424|59210053|FG001|Overall Study|Lost to Follow-up|1|||
31008287|NCT01451424|59210054|FG002|Overall Study|Lost to Follow-up|0|||
31008288|NCT01451424|59210055|FG003|Overall Study|Lost to Follow-up|1|||
31008289|NCT01451424|59210052|FG000|Overall Study|Physician Decision|0|||
31008290|NCT01451424|59210053|FG001|Overall Study|Physician Decision|0|||
31008291|NCT01451424|59210054|FG002|Overall Study|Physician Decision|1|||
31008292|NCT01451424|59210055|FG003|Overall Study|Physician Decision|1|||
31008293|NCT01451424|59210052|FG000|Overall Study|Adverse Event|0|||
31008294|NCT01451424|59210053|FG001|Overall Study|Adverse Event|0|||
31008295|NCT01451424|59210054|FG002|Overall Study|Adverse Event|0|||
31008296|NCT01451424|59210055|FG003|Overall Study|Adverse Event|1|||
31008297|NCT01475214|59210073|FG000|Overall Study|Lost to Follow-up|1|||
30613058|NCT01284959|58624335|FG000|Overall Study|Withdrawal by Subject|1|||
30613059|NCT01284959|58624336|FG001|Overall Study|Withdrawal by Subject|0|||
31008298|NCT01475214|59210074|FG001|Overall Study|Lost to Follow-up|0|||
31008299|NCT01475214|59210075|FG002|Overall Study|Lost to Follow-up|1|||
31008300|NCT01475214|59210073|FG000|Overall Study|Physician Decision|2|||
31008301|NCT01475214|59210074|FG001|Overall Study|Physician Decision|0|||
31008302|NCT01475214|59210075|FG002|Overall Study|Physician Decision|0|||
31008303|NCT01475214|59210073|FG000|Overall Study|Withdrawal by Subject|2|||
31008304|NCT01475214|59210074|FG001|Overall Study|Withdrawal by Subject|4|||
31008305|NCT01475214|59210075|FG002|Overall Study|Withdrawal by Subject|1|||
30613060|NCT01284959|58624337|FG002|Overall Study|Withdrawal by Subject|0|||
30613061|NCT01284959|58624335|FG000|Overall Study|Adverse Event|0|||
30613062|NCT01284959|58624336|FG001|Overall Study|Adverse Event|0|||
30613063|NCT01284959|58624337|FG002|Overall Study|Adverse Event|1|||
30613064|NCT01284491|58624345|FG000|Overall Study|Study termination|13|||
30613065|NCT01283009|58624353|FG000|Overall Study|Death|83|||
30613066|NCT01283009|58624354|FG001|Overall Study|Death|78|||
30613067|NCT01283009|58624353|FG000|Overall Study|Study ended early|23|||
30613068|NCT01283009|58624354|FG001|Overall Study|Study ended early|26|||
31008306|NCT01496274|59210086|FG000|Overall Study|Protocol Violation|0|||
31008307|NCT01496274|59210087|FG001|Overall Study|Protocol Violation|1|||
31008308|NCT01496274|59210086|FG000|Overall Study|Adverse Event|1|||
31008309|NCT01496274|59210087|FG001|Overall Study|Adverse Event|1|||
31008310|NCT01496274|59210086|FG000|Overall Study|Withdrawal by Subject|2|||
31008311|NCT01496274|59210087|FG001|Overall Study|Withdrawal by Subject|0|||
31008312|NCT01496274|59210086|FG000|Overall Study|Lost to Follow-up|0|||
31008313|NCT01496274|59210087|FG001|Overall Study|Lost to Follow-up|3|||
31008314|NCT01475136|59210112|FG000|Overall Study|Sponsor Decision|0|||
31008315|NCT01475136|59210113|FG001|Overall Study|Sponsor Decision|1|||
31008316|NCT01475136|59210114|FG002|Overall Study|Sponsor Decision|0|||
31008317|NCT01475136|59210115|FG003|Overall Study|Sponsor Decision|0|||
31008318|NCT01475136|59210112|FG000|Overall Study|Entry Criteria Not Met|0|||
31008319|NCT01475136|59210113|FG001|Overall Study|Entry Criteria Not Met|2|||
31008320|NCT01475136|59210114|FG002|Overall Study|Entry Criteria Not Met|3|||
31008321|NCT01475136|59210115|FG003|Overall Study|Entry Criteria Not Met|1|||
31008322|NCT01475136|59210112|FG000|Overall Study|Withdrawal by Subject|0|||
31008323|NCT01475136|59210113|FG001|Overall Study|Withdrawal by Subject|0|||
31008324|NCT01475136|59210114|FG002|Overall Study|Withdrawal by Subject|0|||
31008325|NCT01475136|59210115|FG003|Overall Study|Withdrawal by Subject|2|||
31008326|NCT01475136|59210112|FG000|Overall Study|Adverse Event|1|||
31008327|NCT01475136|59210113|FG001|Overall Study|Adverse Event|0|||
31008328|NCT01475136|59210114|FG002|Overall Study|Adverse Event|0|||
31008329|NCT01475136|59210115|FG003|Overall Study|Adverse Event|1|||
31008330|NCT01475136|59210112|FG000|Overall Study|Death|0|||
31008331|NCT01475136|59210113|FG001|Overall Study|Death|0|||
31008332|NCT01475136|59210114|FG002|Overall Study|Death|0|||
31008333|NCT01475136|59210115|FG003|Overall Study|Death|1|||
31008334|NCT01474746|59210127|FG000|Overall Study|Lost to Follow-up|1|||
31008335|NCT01474746|59210128|FG001|Overall Study|Lost to Follow-up|1|||
31008336|NCT01474746|59210127|FG000|Overall Study|Withdrawal by Subject|2|||
31008337|NCT01474746|59210128|FG001|Overall Study|Withdrawal by Subject|1|||
31008338|NCT01450800|59210136|FG000|Overall Study|Protocol Violation|1|||
31008339|NCT01450800|59210137|FG001|Overall Study|Protocol Violation|3|||
31008340|NCT01474512|59210148|FG000|Induction Period|Adverse Event|6|||
31008341|NCT01474512|59210149|FG001|Induction Period|Adverse Event|10|||
31008342|NCT01474512|59210150|FG002|Induction Period|Adverse Event|10|||
30613069|NCT01283009|58624353|FG000|Overall Study|Withdrawal by Subject|10|||
30613070|NCT01283009|58624354|FG001|Overall Study|Withdrawal by Subject|8|||
31008343|NCT01474512|59210151|FG003|Induction Period|Adverse Event|0|||
31008344|NCT01474512|59210152|FG004|Induction Period|Adverse Event|0|||
31008345|NCT01474512|59210153|FG005|Induction Period|Adverse Event|0|||
31008346|NCT01474512|59210154|FG006|Induction Period|Adverse Event|0|||
31008347|NCT01474512|59210155|FG007|Induction Period|Adverse Event|0|||
31008348|NCT01474512|59210156|FG008|Induction Period|Adverse Event|0|||
31008349|NCT01474512|59210157|FG009|Induction Period|Adverse Event|0|||
31008350|NCT01474512|59210158|FG010|Induction Period|Adverse Event|0|||
31008351|NCT01474512|59210159|FG011|Induction Period|Adverse Event|0|||
31008352|NCT01474512|59210160|FG012|Induction Period|Adverse Event|0|||
31008353|NCT01474512|59210161|FG013|Induction Period|Adverse Event|0|||
31008354|NCT01474512|59210162|FG014|Induction Period|Adverse Event|0|||
31008355|NCT01474512|59210163|FG015|Induction Period|Adverse Event|0|||
31008356|NCT01474512|59210164|FG016|Induction Period|Adverse Event|0|||
31008357|NCT01474512|59210165|FG017|Induction Period|Adverse Event|0|||
31008358|NCT01474512|59210148|FG000|Induction Period|Lack of Efficacy|7|||
31008359|NCT01474512|59210149|FG001|Induction Period|Lack of Efficacy|1|||
31008360|NCT01474512|59210150|FG002|Induction Period|Lack of Efficacy|0|||
31008361|NCT01474512|59210151|FG003|Induction Period|Lack of Efficacy|0|||
31008362|NCT01474512|59210152|FG004|Induction Period|Lack of Efficacy|0|||
31008363|NCT01474512|59210153|FG005|Induction Period|Lack of Efficacy|0|||
30613071|NCT01283009|58624353|FG000|Overall Study|Physician Decision|1|||
30613072|NCT01283009|58624354|FG001|Overall Study|Physician Decision|1|||
30613073|NCT01283009|58624353|FG000|Overall Study|Lost to Follow-up|1|||
30613074|NCT01283009|58624354|FG001|Overall Study|Lost to Follow-up|0|||
30613075|NCT01283009|58624353|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
30613076|NCT01283009|58624354|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
30613077|NCT01282463|58624363|FG000|Overall Study|Lost to Follow-up|1|||
30613078|NCT01282463|58624364|FG001|Overall Study|Lost to Follow-up|0|||
30613079|NCT01282463|58624365|FG002|Overall Study|Lost to Follow-up|0|||
30613080|NCT01282463|58624363|FG000|Overall Study|Withdrawal by Subject|6|||
30613081|NCT01282463|58624364|FG001|Overall Study|Withdrawal by Subject|2|||
30613082|NCT01282463|58624365|FG002|Overall Study|Withdrawal by Subject|3|||
30613083|NCT01282463|58624363|FG000|Overall Study|"Never Treated Death"|0|||
30613084|NCT01282463|58624364|FG001|Overall Study|"Never Treated Death"|1|||
30613085|NCT01282463|58624365|FG002|Overall Study|"Never Treated Death"|0|||
30613086|NCT01282463|58624363|FG000|Overall Study|"Never Treated PD"|0|||
30613087|NCT01282463|58624364|FG001|Overall Study|"Never Treated PD"|1|||
30613088|NCT01282463|58624365|FG002|Overall Study|"Never Treated PD"|0|||
30613089|NCT01282463|58624363|FG000|Overall Study|Protocol Violation|0|||
30613090|NCT01282463|58624364|FG001|Overall Study|Protocol Violation|0|||
30613091|NCT01282463|58624365|FG002|Overall Study|Protocol Violation|1|||
30613092|NCT01282463|58624363|FG000|Overall Study|Physician Decision|1|||
30613093|NCT01282463|58624364|FG001|Overall Study|Physician Decision|0|||
30613094|NCT01282463|58624365|FG002|Overall Study|Physician Decision|0|||
30613095|NCT01282229|58624381|FG000|Overall Study|Protocol Violation|2|||
30613096|NCT01281917|58624399|FG000|Overall Study|Withdrawal by Subject|1|||
30613097|NCT01281839|58624405|FG000|Overall Study|Lost to Follow-up|6|||
30613098|NCT01281839|58624406|FG001|Overall Study|Lost to Follow-up|3|||
30613099|NCT01281839|58624405|FG000|Overall Study|Withdrawal by Subject|4|||
30613100|NCT01281839|58624406|FG001|Overall Study|Withdrawal by Subject|10|||
30613101|NCT01281839|58624405|FG000|Overall Study|Reason not specified|0|||
30613102|NCT01281839|58624406|FG001|Overall Study|Reason not specified|1|||
30613103|NCT01281137|58624414|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
30613104|NCT01281137|58624415|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
30613105|NCT01281137|58624414|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
30613106|NCT01281137|58624415|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
30613107|NCT01281137|58624414|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
30613108|NCT01281137|58624415|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
30613109|NCT01281137|58624414|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
30613110|NCT01281137|58624415|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
30613111|NCT01281137|58624414|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
30613112|NCT01281137|58624415|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
30613113|NCT01280981|58624439|FG000|Overall Study|Withdrawal by Subject|11|||
30613114|NCT01280981|58624439|FG000|Overall Study|Protocol Violation|2|||
30613115|NCT01280981|58624439|FG000|Overall Study|Lack of Efficacy|13|||
30613116|NCT01280981|58624439|FG000|Overall Study|Lost to Follow-up|3|||
30613117|NCT01280981|58624439|FG000|Overall Study|Adverse Event|6|||
30613118|NCT01280981|58624439|FG000|Overall Study|Irregular or discontinued menses|3|||
30613119|NCT01280981|58624439|FG000|Overall Study|Failed to return|45|||
30613120|NCT01280981|58624439|FG000|Overall Study|Non-compliance with protocol|3|||
30613121|NCT01280981|58624439|FG000|Overall Study|Withdrawal of consent|3|||
30613122|NCT01280981|58624439|FG000|Overall Study|Elective surgery|2|||
30613123|NCT01280981|58624439|FG000|Overall Study|Study site closure|1|||
30613124|NCT01280903|58624445|FG000|Overall Study|Lost to Follow-up|23|||
30613125|NCT01280903|58624446|FG001|Overall Study|Lost to Follow-up|16|||
30699225|NCT00560235|58713744|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
31008364|NCT01474512|59210154|FG006|Induction Period|Lack of Efficacy|0|||
31008365|NCT01474512|59210155|FG007|Induction Period|Lack of Efficacy|0|||
31008366|NCT01474512|59210156|FG008|Induction Period|Lack of Efficacy|0|||
30613126|NCT01280591|58624456|FG000|Overall Study|Withdrawal by Subject|0|||
30613127|NCT01280591|58624457|FG001|Overall Study|Withdrawal by Subject|0|||
30613128|NCT01280591|58624458|FG002|Overall Study|Withdrawal by Subject|0|||
30613129|NCT01280591|58624459|FG003|Overall Study|Withdrawal by Subject|2|||
30613130|NCT01280591|58624456|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
30613131|NCT01280591|58624457|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
30613132|NCT01280591|58624458|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
30613133|NCT01280591|58624459|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
30613134|NCT01280357|58624469|FG000|Overall Study|Excluded no internal monitoring|14|||
30613135|NCT01280357|58624469|FG000|Overall Study|IInsufficient data/No data supplied|12|||
30613136|NCT01274351|58624476|FG000|Overall Study|Lost to Follow-up|1|||
30613137|NCT01274351|58624476|FG000|Overall Study|patient not compliant with the protocol|1|||
30613138|NCT01274351|58624476|FG000|Overall Study|Pregnancy|1|||
30613139|NCT01274351|58624476|FG000|Overall Study|Death|2|||
30613140|NCT01274351|58624476|FG000|Overall Study|Withdrawal by Subject|3|||
30613141|NCT01274351|58624476|FG000|Overall Study|Adverse Event|8|||
30613142|NCT01274351|58624476|FG000|Overall Study|progression of disease|3|||
30613143|NCT01274351|58624476|FG000|Overall Study|hospitalization|1|||
30613144|NCT01271933|58624480|FG000|Single-Blind Phase|Lack of Efficacy|37|||
30613145|NCT01271933|58624481|FG001|Single-Blind Phase|Lack of Efficacy|0|||
30613146|NCT01271933|58624482|FG002|Single-Blind Phase|Lack of Efficacy|0|||
30613147|NCT01271933|58624480|FG000|Single-Blind Phase|Lost to Follow-up|10|||
30613148|NCT01271933|58624481|FG001|Single-Blind Phase|Lost to Follow-up|0|||
30613149|NCT01271933|58624482|FG002|Single-Blind Phase|Lost to Follow-up|0|||
30613150|NCT01271933|58624480|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
30613151|NCT01271933|58624481|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
30613152|NCT01271933|58624482|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
30613153|NCT01271933|58624480|FG000|Single-Blind Phase|Protocol Violation|3|||
30613154|NCT01271933|58624481|FG001|Single-Blind Phase|Protocol Violation|0|||
30613155|NCT01271933|58624482|FG002|Single-Blind Phase|Protocol Violation|0|||
30613156|NCT01271933|58624480|FG000|Single-Blind Phase|Adverse Event|52|||
30613157|NCT01271933|58624481|FG001|Single-Blind Phase|Adverse Event|0|||
30613158|NCT01271933|58624482|FG002|Single-Blind Phase|Adverse Event|0|||
30613159|NCT01271933|58624480|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
30613160|NCT01271933|58624481|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
30613161|NCT01271933|58624482|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
30613162|NCT01271933|58624480|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
30613163|NCT01271933|58624481|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
30613164|NCT01271933|58624482|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
30613165|NCT01271933|58624480|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
30613166|NCT01271933|58624481|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
30613167|NCT01271933|58624482|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
30613168|NCT01271933|58624480|FG000|Double-Blind Phase|Randomized but not treated|0|||
30613169|NCT01271933|58624481|FG001|Double-Blind Phase|Randomized but not treated|0|||
30613170|NCT01271933|58624482|FG002|Double-Blind Phase|Randomized but not treated|1|||
30613171|NCT01271933|58624480|FG000|Double-Blind Phase|Lack of Efficacy|0|||
30613172|NCT01271933|58624481|FG001|Double-Blind Phase|Lack of Efficacy|6|||
31008367|NCT01474512|59210157|FG009|Induction Period|Lack of Efficacy|0|||
30613173|NCT01271933|58624482|FG002|Double-Blind Phase|Lack of Efficacy|9|||
30613174|NCT01271933|58624480|FG000|Double-Blind Phase|Lost to Follow-up|0|||
30613175|NCT01271933|58624481|FG001|Double-Blind Phase|Lost to Follow-up|1|||
30613176|NCT01271933|58624482|FG002|Double-Blind Phase|Lost to Follow-up|1|||
31008368|NCT01474512|59210158|FG010|Induction Period|Lack of Efficacy|0|||
31008369|NCT01474512|59210159|FG011|Induction Period|Lack of Efficacy|0|||
31008370|NCT01474512|59210160|FG012|Induction Period|Lack of Efficacy|0|||
31008371|NCT01474512|59210161|FG013|Induction Period|Lack of Efficacy|0|||
31008372|NCT01474512|59210162|FG014|Induction Period|Lack of Efficacy|0|||
31008373|NCT01474512|59210163|FG015|Induction Period|Lack of Efficacy|0|||
31008374|NCT01474512|59210164|FG016|Induction Period|Lack of Efficacy|0|||
31008375|NCT01474512|59210165|FG017|Induction Period|Lack of Efficacy|0|||
31008376|NCT01474512|59210148|FG000|Induction Period|Withdrawal by Subject|6|||
31008377|NCT01474512|59210149|FG001|Induction Period|Withdrawal by Subject|6|||
31008378|NCT01474512|59210150|FG002|Induction Period|Withdrawal by Subject|5|||
31008379|NCT01474512|59210151|FG003|Induction Period|Withdrawal by Subject|0|||
31008380|NCT01474512|59210152|FG004|Induction Period|Withdrawal by Subject|0|||
31008381|NCT01474512|59210153|FG005|Induction Period|Withdrawal by Subject|0|||
31008382|NCT01474512|59210154|FG006|Induction Period|Withdrawal by Subject|0|||
31008383|NCT01474512|59210155|FG007|Induction Period|Withdrawal by Subject|0|||
31008384|NCT01474512|59210156|FG008|Induction Period|Withdrawal by Subject|0|||
30613177|NCT01271933|58624480|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
30613178|NCT01271933|58624481|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
30613179|NCT01271933|58624482|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
31008385|NCT01474512|59210157|FG009|Induction Period|Withdrawal by Subject|0|||
31008386|NCT01474512|59210158|FG010|Induction Period|Withdrawal by Subject|0|||
31008387|NCT01474512|59210159|FG011|Induction Period|Withdrawal by Subject|0|||
30613180|NCT01271933|58624480|FG000|Double-Blind Phase|Adverse Event|0|||
30613181|NCT01271933|58624481|FG001|Double-Blind Phase|Adverse Event|3|||
30613182|NCT01271933|58624482|FG002|Double-Blind Phase|Adverse Event|0|||
30613183|NCT01271933|58624480|FG000|Double-Blind Phase|Participant request-personal reason|0|||
31008388|NCT01474512|59210160|FG012|Induction Period|Withdrawal by Subject|0|||
31008389|NCT01474512|59210161|FG013|Induction Period|Withdrawal by Subject|0|||
31008390|NCT01474512|59210162|FG014|Induction Period|Withdrawal by Subject|0|||
31008391|NCT01474512|59210163|FG015|Induction Period|Withdrawal by Subject|0|||
31008392|NCT01474512|59210164|FG016|Induction Period|Withdrawal by Subject|0|||
31008393|NCT01474512|59210165|FG017|Induction Period|Withdrawal by Subject|0|||
31008394|NCT01474512|59210148|FG000|Induction Period|Protocol Violation|3|||
31008395|NCT01474512|59210149|FG001|Induction Period|Protocol Violation|6|||
31008396|NCT01474512|59210150|FG002|Induction Period|Protocol Violation|0|||
31008397|NCT01474512|59210151|FG003|Induction Period|Protocol Violation|0|||
31008398|NCT01474512|59210152|FG004|Induction Period|Protocol Violation|0|||
31008399|NCT01474512|59210153|FG005|Induction Period|Protocol Violation|0|||
31008400|NCT01474512|59210154|FG006|Induction Period|Protocol Violation|0|||
30613184|NCT01271933|58624481|FG001|Double-Blind Phase|Participant request-personal reason|1|||
30613185|NCT01271933|58624482|FG002|Double-Blind Phase|Participant request-personal reason|0|||
30613186|NCT01269125|58624495|FG000|Overall Study|Adverse Event|3|||
30613187|NCT01269125|58624496|FG001|Overall Study|Adverse Event|5|||
30613188|NCT01269125|58624497|FG002|Overall Study|Adverse Event|0|||
30613189|NCT01269125|58624495|FG000|Overall Study|Lost to Follow-up|4|||
30613190|NCT01269125|58624496|FG001|Overall Study|Lost to Follow-up|0|||
30613191|NCT01269125|58624497|FG002|Overall Study|Lost to Follow-up|0|||
30613192|NCT01268891|58624507|FG000|Overall Study|Adverse Event|3|||
30613193|NCT01268891|58624508|FG001|Overall Study|Adverse Event|7|||
30613194|NCT01268891|58624507|FG000|Overall Study|Lack of Efficacy|1|||
30613195|NCT01268891|58624508|FG001|Overall Study|Lack of Efficacy|0|||
30613196|NCT01268891|58624507|FG000|Overall Study|Withdrawal of Consent|3|||
30613197|NCT01268891|58624508|FG001|Overall Study|Withdrawal of Consent|1|||
30613198|NCT01268891|58624507|FG000|Overall Study|Administrative or other reason(s)|1|||
30613199|NCT01268891|58624508|FG001|Overall Study|Administrative or other reason(s)|0|||
30613200|NCT01268501|58624514|FG000|Overall Study|Lost to Follow-up|1|||
30613201|NCT01268501|58624514|FG000|Overall Study|Withdrawal by Subject|3|||
30613202|NCT01268501|58624514|FG000|Overall Study|Unacceptable Subjective Vision|3|||
30613203|NCT01268501|58624514|FG000|Overall Study|Handling Difficulties|2|||
30613204|NCT01268267|58624518|FG000|Overall Study|Protocol Violation|1|||
30613205|NCT01267253|58624523|FG000|Overall Study|Ineligible - required test not done|1|||
30613206|NCT01267253|58624523|FG000|Overall Study|Inevaluable-never received study treatme|2|||
30613207|NCT01266317|58624527|FG000|Overall Study|Withdrawal by Subject|2|||
30613208|NCT01266161|58624533|FG000|Overall Study|Ineligible|1|||
30613209|NCT01266161|58624534|FG001|Overall Study|Ineligible|0|||
30613210|NCT01266161|58624533|FG000|Overall Study|Lack of Efficacy|0|||
30613211|NCT01266161|58624534|FG001|Overall Study|Lack of Efficacy|1|||
30613212|NCT01266161|58624533|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
30613213|NCT01266161|58624534|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
30613214|NCT01265849|58624543|FG000|Overall Study|Randomized//Treatment not initiated|1|||
30613215|NCT01265849|58624544|FG001|Overall Study|Randomized//Treatment not initiated|4|||
30613216|NCT01265849|58624545|FG002|Overall Study|Randomized//Treatment not initiated|0|||
30613217|NCT01265849|58624543|FG000|Overall Study|Physician Decision|1|||
30613218|NCT01265849|58624544|FG001|Overall Study|Physician Decision|2|||
30613219|NCT01265849|58624545|FG002|Overall Study|Physician Decision|0|||
30613220|NCT01265849|58624543|FG000|Overall Study|Lost to Follow-up|18|||
30613221|NCT01265849|58624544|FG001|Overall Study|Lost to Follow-up|15|||
30613222|NCT01265849|58624545|FG002|Overall Study|Lost to Follow-up|5|||
30613223|NCT01265849|58624543|FG000|Overall Study|Not otherwise specified|1|||
30613224|NCT01265849|58624544|FG001|Overall Study|Not otherwise specified|6|||
30613225|NCT01265849|58624545|FG002|Overall Study|Not otherwise specified|1|||
30893044|NCT02531633|58926454|FG008|Part B (104 Weeks)|Sponsor request|5|||
30613226|NCT01265849|58624543|FG000|Overall Study|Withdrawal by Subject|25|||
30613227|NCT01265849|58624544|FG001|Overall Study|Withdrawal by Subject|34|||
30613228|NCT01265849|58624545|FG002|Overall Study|Withdrawal by Subject|13|||
30613229|NCT01265615|58624561|FG000|Overall Study|Protocol Violation|2|||
30613230|NCT01265615|58624562|FG001|Overall Study|Protocol Violation|2|||
30613231|NCT01265615|58624563|FG002|Overall Study|Protocol Violation|4|||
30613232|NCT01265615|58624564|FG003|Overall Study|Protocol Violation|3|||
30613233|NCT01264835|58624574|FG000|Overall Study|Lost to Follow-up|1|||
30613234|NCT01264679|58624578|FG000|Overall Study|Participation in Another Clinical Trial|1|||
30613235|NCT01264679|58624578|FG000|Overall Study|Physician Decision|1|||
30613236|NCT01264679|58624578|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
30613237|NCT01264679|58624578|FG000|Overall Study|Withdrawal by Subject|1|||
30613238|NCT01263665|58624583|FG000|Overall Study|Withdrew Consent|1|||
30613239|NCT01263665|58624583|FG000|Overall Study|Lost to Follow-up|3|||
30613240|NCT01263665|58624583|FG000|Overall Study|Death|2|||
30613241|NCT01263665|58624583|FG000|Overall Study|Amputation above the ankle|1|||
30613242|NCT01263665|58624583|FG000|Overall Study|Surgical Bypass|2|||
30613243|NCT01263509|58624589|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
30613244|NCT01263509|58624590|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
30613245|NCT01263509|58624591|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
30613246|NCT01263509|58624592|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
30613247|NCT01263509|58624589|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
30613248|NCT01263509|58624590|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
30613249|NCT01263509|58624591|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
30613250|NCT01263509|58624592|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
30613251|NCT01263509|58624589|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
30613252|NCT01263509|58624590|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
30613253|NCT01263509|58624591|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
30613254|NCT01263509|58624592|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
30613255|NCT01263509|58624589|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
30613256|NCT01263509|58624590|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
30613257|NCT01263509|58624591|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
30613258|NCT01263509|58624592|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
30613259|NCT01263509|58624589|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
30613260|NCT01263509|58624590|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
30613261|NCT01263509|58624591|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
30613262|NCT01263509|58624592|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
30613263|NCT01263197|58624600|FG000|First Intervention (Period 1)|Adverse Event|0|||
30613264|NCT01263197|58624601|FG001|First Intervention (Period 1)|Adverse Event|0|||
30613265|NCT01263197|58624602|FG002|First Intervention (Period 1)|Adverse Event|0|||
30699226|NCT00291577|58713762|FG000|Overall Study|Adverse Event|1|||
30699227|NCT00291577|58713762|FG000|Overall Study|Other|4|||
30613266|NCT01263197|58624603|FG003|First Intervention (Period 1)|Adverse Event|0|||
30613267|NCT01263197|58624604|FG004|First Intervention (Period 1)|Adverse Event|0|||
30613268|NCT01263197|58624605|FG005|First Intervention (Period 1)|Adverse Event|1|||
30613269|NCT01263197|58624600|FG000|Washout Period 1|Protocol Violation|0|||
30613270|NCT01263197|58624601|FG001|Washout Period 1|Protocol Violation|0|||
30613271|NCT01263197|58624602|FG002|Washout Period 1|Protocol Violation|0|||
30613272|NCT01263197|58624603|FG003|Washout Period 1|Protocol Violation|0|||
30613273|NCT01263197|58624604|FG004|Washout Period 1|Protocol Violation|1|||
30613274|NCT01263197|58624605|FG005|Washout Period 1|Protocol Violation|0|||
30613275|NCT01263197|58624600|FG000|Washout Period 2|Physician Decision|0|||
30613276|NCT01263197|58624601|FG001|Washout Period 2|Physician Decision|0|||
30613277|NCT01263197|58624602|FG002|Washout Period 2|Physician Decision|0|||
30613278|NCT01263197|58624603|FG003|Washout Period 2|Physician Decision|0|||
30613279|NCT01263197|58624604|FG004|Washout Period 2|Physician Decision|0|||
30613280|NCT01263197|58624605|FG005|Washout Period 2|Physician Decision|1|||
30613281|NCT01263197|58624600|FG000|Washout Period 2|Protocol Violation|0|||
30613282|NCT01263197|58624601|FG001|Washout Period 2|Protocol Violation|0|||
30613283|NCT01263197|58624602|FG002|Washout Period 2|Protocol Violation|0|||
30613284|NCT01263197|58624603|FG003|Washout Period 2|Protocol Violation|1|||
30613285|NCT01263197|58624604|FG004|Washout Period 2|Protocol Violation|0|||
30613286|NCT01263197|58624605|FG005|Washout Period 2|Protocol Violation|0|||
30613287|NCT01263197|58624600|FG000|Third Intervention (Period 3)|Adverse Event|0|||
30613288|NCT01263197|58624601|FG001|Third Intervention (Period 3)|Adverse Event|1|||
30613289|NCT01263197|58624602|FG002|Third Intervention (Period 3)|Adverse Event|0|||
30613290|NCT01263197|58624603|FG003|Third Intervention (Period 3)|Adverse Event|0|||
30613291|NCT01263197|58624604|FG004|Third Intervention (Period 3)|Adverse Event|0|||
30613292|NCT01263197|58624605|FG005|Third Intervention (Period 3)|Adverse Event|0|||
30613293|NCT01263119|58624619|FG000|Period 1|Protocol Violation|2|||
30613294|NCT01263119|58624619|FG000|Period 2|Adverse Event|2|||
30613295|NCT01262651|58624629|FG000|Overall Study|Adverse Event|40|||
30613296|NCT01262651|58624630|FG001|Overall Study|Adverse Event|35|||
30613297|NCT01262651|58624629|FG000|Overall Study|Withdrawal by Subject|15|||
30699228|NCT00291577|58713762|FG000|Overall Study|Withdrawal by Subject|2|||
30613298|NCT01262651|58624630|FG001|Overall Study|Withdrawal by Subject|11|||
30699229|NCT00291577|58713762|FG000|Overall Study|Lack of Efficacy|14|||
30699230|NCT00520936|58713774|FG000|Overall Study|Physician Decision|0|||
30613299|NCT01262651|58624629|FG000|Overall Study|Withdrawal by Investigator|2|||
30613300|NCT01262651|58624630|FG001|Overall Study|Withdrawal by Investigator|2|||
30613301|NCT01262651|58624629|FG000|Overall Study|Met Withdrawal Criteria|1|||
30613302|NCT01262651|58624630|FG001|Overall Study|Met Withdrawal Criteria|0|||
30613303|NCT01262573|58624638|FG000|Overall Study|Withdrawal by Subject|0|||
30613304|NCT01262573|58624639|FG001|Overall Study|Withdrawal by Subject|1|||
30613305|NCT01262027|58624645|FG000|Overall Study|Adverse Event|1|||
30613306|NCT01262027|58624645|FG000|Overall Study|Withdrawal by Subject|3|||
30613307|NCT01262027|58624645|FG000|Overall Study|Protocol Violation|1|||
30613308|NCT01261793|58624652|FG000|Overall Study|Lack of Efficacy|44|||
30613309|NCT01261793|58624653|FG001|Overall Study|Lack of Efficacy|37|||
30613310|NCT01261793|58624654|FG002|Overall Study|Lack of Efficacy|32|||
30613311|NCT01261793|58624652|FG000|Overall Study|Protocol Violation|3|||
30613312|NCT01261793|58624653|FG001|Overall Study|Protocol Violation|5|||
30613313|NCT01261793|58624654|FG002|Overall Study|Protocol Violation|6|||
30613314|NCT01261793|58624652|FG000|Overall Study|Lost to Follow-up|10|||
30613315|NCT01261793|58624653|FG001|Overall Study|Lost to Follow-up|3|||
30613316|NCT01261793|58624654|FG002|Overall Study|Lost to Follow-up|7|||
30613317|NCT01261793|58624652|FG000|Overall Study|Withdrawal by Subject|12|||
30613318|NCT01261793|58624653|FG001|Overall Study|Withdrawal by Subject|14|||
30613319|NCT01261793|58624654|FG002|Overall Study|Withdrawal by Subject|14|||
30613320|NCT01261793|58624652|FG000|Overall Study|Death|3|||
30613321|NCT01261793|58624653|FG001|Overall Study|Death|1|||
30613322|NCT01261793|58624654|FG002|Overall Study|Death|0|||
30613323|NCT01261793|58624652|FG000|Overall Study|Adverse Event|9|||
30613324|NCT01261793|58624653|FG001|Overall Study|Adverse Event|24|||
30613325|NCT01261793|58624654|FG002|Overall Study|Adverse Event|19|||
30613326|NCT01261793|58624652|FG000|Overall Study|Patient non-availability|1|||
30613327|NCT01261793|58624653|FG001|Overall Study|Patient non-availability|1|||
30613328|NCT01261793|58624654|FG002|Overall Study|Patient non-availability|1|||
30613329|NCT01261793|58624652|FG000|Overall Study|Suspected pregnancy|1|||
30613330|NCT01261793|58624653|FG001|Overall Study|Suspected pregnancy|1|||
30613331|NCT01261793|58624654|FG002|Overall Study|Suspected pregnancy|0|||
30613332|NCT01261793|58624652|FG000|Overall Study|Patient non-compliance|1|||
30613333|NCT01261793|58624653|FG001|Overall Study|Patient non-compliance|0|||
30613334|NCT01261793|58624654|FG002|Overall Study|Patient non-compliance|1|||
30613335|NCT01261793|58624652|FG000|Overall Study|Patient pregnant|1|||
30613336|NCT01261793|58624653|FG001|Overall Study|Patient pregnant|0|||
30613337|NCT01261793|58624654|FG002|Overall Study|Patient pregnant|0|||
30613338|NCT01261793|58624652|FG000|Overall Study|Outside the study area|0|||
30613339|NCT01261793|58624653|FG001|Overall Study|Outside the study area|2|||
30613340|NCT01261793|58624654|FG002|Overall Study|Outside the study area|1|||
30613341|NCT01261793|58624652|FG000|Overall Study|Lack of efficacy & patient not available|0|||
30613342|NCT01261793|58624653|FG001|Overall Study|Lack of efficacy & patient not available|1|||
30613343|NCT01261793|58624654|FG002|Overall Study|Lack of efficacy & patient not available|0|||
30613344|NCT01261793|58624652|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
30613345|NCT01261793|58624653|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
30613346|NCT01261793|58624654|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
30613347|NCT01261793|58624652|FG000|Overall Study|Randomization error|0|||
30613348|NCT01261793|58624653|FG001|Overall Study|Randomization error|1|||
30613349|NCT01261793|58624654|FG002|Overall Study|Randomization error|0|||
30613350|NCT01261793|58624652|FG000|Overall Study|Patient unable to start IV line|0|||
30613351|NCT01261793|58624653|FG001|Overall Study|Patient unable to start IV line|0|||
30613352|NCT01261793|58624654|FG002|Overall Study|Patient unable to start IV line|1|||
30613353|NCT01261325|58624665|FG000|Overall Study|Lack of Efficacy|1|||
30613354|NCT01261325|58624666|FG001|Overall Study|Lack of Efficacy|1|||
30613355|NCT01261325|58624667|FG002|Overall Study|Lack of Efficacy|0|||
30613356|NCT01261325|58624665|FG000|Overall Study|Withdrawal by Subject|2|||
30613357|NCT01261325|58624666|FG001|Overall Study|Withdrawal by Subject|2|||
30613358|NCT01261325|58624667|FG002|Overall Study|Withdrawal by Subject|4|||
30613359|NCT01261325|58624665|FG000|Overall Study|SAE, non-fatal|1|||
30613360|NCT01261325|58624666|FG001|Overall Study|SAE, non-fatal|5|||
30613361|NCT01261325|58624667|FG002|Overall Study|SAE, non-fatal|1|||
30613362|NCT01261325|58624665|FG000|Overall Study|AE, non-serious non-fatal|9|||
30613363|NCT01261325|58624666|FG001|Overall Study|AE, non-serious non-fatal|15|||
30613364|NCT01261325|58624667|FG002|Overall Study|AE, non-serious non-fatal|13|||
30613365|NCT01261325|58624665|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
30613366|NCT01261325|58624666|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
30613367|NCT01261325|58624667|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
30613368|NCT01261325|58624665|FG000|Overall Study|Non Compliance|2|||
30613369|NCT01261325|58624666|FG001|Overall Study|Non Compliance|0|||
30613370|NCT01261325|58624667|FG002|Overall Study|Non Compliance|0|||
30613371|NCT01261325|58624665|FG000|Overall Study|Patient Randomized by Mistake|0|||
30613372|NCT01261325|58624666|FG001|Overall Study|Patient Randomized by Mistake|1|||
30613373|NCT01261325|58624667|FG002|Overall Study|Patient Randomized by Mistake|0|||
30613374|NCT01261325|58624665|FG000|Overall Study|Erroneously Randomized|1|||
31008401|NCT01474512|59210155|FG007|Induction Period|Protocol Violation|0|||
31008402|NCT01474512|59210156|FG008|Induction Period|Protocol Violation|0|||
31008403|NCT01474512|59210157|FG009|Induction Period|Protocol Violation|0|||
31008404|NCT01474512|59210158|FG010|Induction Period|Protocol Violation|0|||
31008405|NCT01474512|59210159|FG011|Induction Period|Protocol Violation|0|||
31008406|NCT01474512|59210160|FG012|Induction Period|Protocol Violation|0|||
31008407|NCT01474512|59210161|FG013|Induction Period|Protocol Violation|0|||
31008408|NCT01474512|59210162|FG014|Induction Period|Protocol Violation|0|||
31008409|NCT01474512|59210163|FG015|Induction Period|Protocol Violation|0|||
31008410|NCT01474512|59210164|FG016|Induction Period|Protocol Violation|0|||
31008411|NCT01474512|59210165|FG017|Induction Period|Protocol Violation|0|||
31008412|NCT01474512|59210148|FG000|Induction Period|Sponsor Decision|1|||
31008413|NCT01474512|59210149|FG001|Induction Period|Sponsor Decision|1|||
31008414|NCT01474512|59210150|FG002|Induction Period|Sponsor Decision|1|||
31008415|NCT01474512|59210151|FG003|Induction Period|Sponsor Decision|0|||
31008416|NCT01474512|59210152|FG004|Induction Period|Sponsor Decision|0|||
31008417|NCT01474512|59210153|FG005|Induction Period|Sponsor Decision|0|||
31008418|NCT01474512|59210154|FG006|Induction Period|Sponsor Decision|0|||
31008419|NCT01474512|59210155|FG007|Induction Period|Sponsor Decision|0|||
31008420|NCT01474512|59210156|FG008|Induction Period|Sponsor Decision|0|||
31008421|NCT01474512|59210157|FG009|Induction Period|Sponsor Decision|0|||
31008422|NCT01474512|59210158|FG010|Induction Period|Sponsor Decision|0|||
31008423|NCT01474512|59210159|FG011|Induction Period|Sponsor Decision|0|||
31008424|NCT01474512|59210160|FG012|Induction Period|Sponsor Decision|0|||
31008425|NCT01474512|59210161|FG013|Induction Period|Sponsor Decision|0|||
31008426|NCT01474512|59210162|FG014|Induction Period|Sponsor Decision|0|||
31008427|NCT01474512|59210163|FG015|Induction Period|Sponsor Decision|0|||
31008428|NCT01474512|59210164|FG016|Induction Period|Sponsor Decision|0|||
31008429|NCT01474512|59210165|FG017|Induction Period|Sponsor Decision|0|||
31008430|NCT01474512|59210148|FG000|Induction Period|Lost to Follow-up|1|||
31008431|NCT01474512|59210149|FG001|Induction Period|Lost to Follow-up|0|||
31008432|NCT01474512|59210150|FG002|Induction Period|Lost to Follow-up|2|||
30613375|NCT01261325|58624666|FG001|Overall Study|Erroneously Randomized|0|||
30893045|NCT02531633|58926455|FG009|Part B (104 Weeks)|Sponsor request|4|||
31008433|NCT01474512|59210151|FG003|Induction Period|Lost to Follow-up|0|||
31008434|NCT01474512|59210152|FG004|Induction Period|Lost to Follow-up|0|||
31008435|NCT01474512|59210153|FG005|Induction Period|Lost to Follow-up|0|||
30613376|NCT01261325|58624667|FG002|Overall Study|Erroneously Randomized|0|||
30613377|NCT01261325|58624665|FG000|Overall Study|Screen Failure|1|||
30613378|NCT01261325|58624666|FG001|Overall Study|Screen Failure|0|||
31008436|NCT01474512|59210154|FG006|Induction Period|Lost to Follow-up|0|||
31008437|NCT01474512|59210155|FG007|Induction Period|Lost to Follow-up|0|||
31008438|NCT01474512|59210156|FG008|Induction Period|Lost to Follow-up|0|||
31008439|NCT01474512|59210157|FG009|Induction Period|Lost to Follow-up|0|||
30613379|NCT01261325|58624667|FG002|Overall Study|Screen Failure|0|||
30613380|NCT01261325|58624665|FG000|Overall Study|Randomized in Error|0|||
31008440|NCT01474512|59210158|FG010|Induction Period|Lost to Follow-up|0|||
31008441|NCT01474512|59210159|FG011|Induction Period|Lost to Follow-up|0|||
31008442|NCT01474512|59210160|FG012|Induction Period|Lost to Follow-up|0|||
31008443|NCT01474512|59210161|FG013|Induction Period|Lost to Follow-up|0|||
31008444|NCT01474512|59210162|FG014|Induction Period|Lost to Follow-up|0|||
31008445|NCT01474512|59210163|FG015|Induction Period|Lost to Follow-up|0|||
31008446|NCT01474512|59210164|FG016|Induction Period|Lost to Follow-up|0|||
31008447|NCT01474512|59210165|FG017|Induction Period|Lost to Follow-up|0|||
31008448|NCT01474512|59210148|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008449|NCT01474512|59210149|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
30613381|NCT01261325|58624666|FG001|Overall Study|Randomized in Error|0|||
30613382|NCT01261325|58624667|FG002|Overall Study|Randomized in Error|1|||
30613383|NCT01261325|58624665|FG000|Overall Study|Protocol Violation|0|||
30613384|NCT01261325|58624666|FG001|Overall Study|Protocol Violation|3|||
30613385|NCT01261325|58624667|FG002|Overall Study|Protocol Violation|1|||
30613386|NCT01261325|58624665|FG000|Overall Study|Lost to Follow-up|0|||
30613387|NCT01261325|58624666|FG001|Overall Study|Lost to Follow-up|1|||
30613388|NCT01261325|58624667|FG002|Overall Study|Lost to Follow-up|3|||
30613389|NCT01261325|58624665|FG000|Overall Study|AE, serious fatal|0|||
30613390|NCT01261325|58624666|FG001|Overall Study|AE, serious fatal|0|||
30613391|NCT01261325|58624667|FG002|Overall Study|AE, serious fatal|2|||
30613392|NCT01260701|58624678|FG000|Overall Study|Adverse Event|9|||
30613393|NCT01260701|58624678|FG000|Overall Study|Withdrawal by Subject|2|||
30613394|NCT01260701|58624678|FG000|Overall Study|Progression|53|||
30613395|NCT01260701|58624678|FG000|Overall Study|Death|2|||
30613396|NCT01260701|58624678|FG000|Overall Study|Not protocol specified|3|||
30613397|NCT01260701|58624678|FG000|Overall Study|Under review|1|||
30613398|NCT01260701|58624678|FG000|Overall Study|Ineligible|4|||
30613399|NCT01260701|58624678|FG000|Overall Study|Did not begin protocol therapy|1|||
30613400|NCT01260467|58624682|FG000|Overall Study|Withdrawal by Subject|2|||
30613401|NCT01260311|58624688|FG000|Overall Study|Adverse Event|11|||
30613402|NCT01260311|58624688|FG000|Overall Study|Lack of Efficacy|4|||
30613403|NCT01260311|58624688|FG000|Overall Study|Lost to Follow-up|25|||
30613404|NCT01260311|58624688|FG000|Overall Study|Withdrawal by Subject|6|||
30613405|NCT01260311|58624688|FG000|Overall Study|Financial Constraints|77|||
30613406|NCT01260311|58624688|FG000|Overall Study|Gone to Province|2|||
30613407|NCT01260311|58624688|FG000|Overall Study|Medication Stopped|1|||
30613408|NCT01260311|58624688|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
30613409|NCT01259375|58624692|FG000|Overall Study|Adverse Event|1|||
30613410|NCT01940471|58624709|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
30613411|NCT01940471|58624710|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
30613412|NCT01940471|58624709|FG000|Double-Blind Phase|Withdrew Consent|13|||
30613413|NCT01940471|58624710|FG001|Double-Blind Phase|Withdrew Consent|7|||
30613414|NCT01940471|58624709|FG000|Double-Blind Phase|Adverse Event|1|||
30613415|NCT01940471|58624710|FG001|Double-Blind Phase|Adverse Event|2|||
30613416|NCT01940471|58624709|FG000|Double-Blind Phase|Lost to Follow-up|3|||
30613417|NCT01940471|58624710|FG001|Double-Blind Phase|Lost to Follow-up|2|||
30613418|NCT01940471|58624709|FG000|Double-Blind Phase|Pregnancy|2|||
30613419|NCT01940471|58624710|FG001|Double-Blind Phase|Pregnancy|1|||
30613420|NCT01940471|58624709|FG000|Double-Blind Phase|Investigator's Discretion|5|||
30613421|NCT01940471|58624710|FG001|Double-Blind Phase|Investigator's Discretion|0|||
30613422|NCT01940471|58624709|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
30613423|NCT01940471|58624710|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
30613424|NCT01940471|58624709|FG000|Double-Blind Phase|Protocol-Specified Criteria|1|||
30613425|NCT01940471|58624710|FG001|Double-Blind Phase|Protocol-Specified Criteria|0|||
31008450|NCT01474512|59210150|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
30613426|NCT01940471|58624709|FG000|Double-Blind Phase|Death|1|||
30613427|NCT01940471|58624710|FG001|Double-Blind Phase|Death|0|||
30613428|NCT01940471|58624709|FG000|Double-Blind Phase|Lack of Efficacy|1|||
30613429|NCT01940471|58624710|FG001|Double-Blind Phase|Lack of Efficacy|0|||
31008451|NCT01474512|59210151|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
30613430|NCT01940471|58624709|FG000|Double-Blind Phase|Protocol Violation|0|||
30613431|NCT01940471|58624710|FG001|Double-Blind Phase|Protocol Violation|1|||
30613432|NCT01940471|58624709|FG000|Double-Blind Phase|Still in Double-Blind Phase|539|||
30613433|NCT01940471|58624710|FG001|Double-Blind Phase|Still in Double-Blind Phase|270|||
30699231|NCT00520936|58713775|FG001|Overall Study|Physician Decision|2|||
30613434|NCT01940471|58624709|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14|||
30613435|NCT01940471|58624710|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8|||
30613436|NCT01321073|58624717|FG000|Overall Study|Did not attempt implant|4|||
30613437|NCT01321073|58624717|FG000|Overall Study|Death|3|||
30613438|NCT01259297|58624729|FG000|Double Blind Randomized Period|Death|1|||
30613439|NCT01259297|58624730|FG001|Double Blind Randomized Period|Death|1|||
30613440|NCT01259297|58624731|FG002|Double Blind Randomized Period|Death|1|||
30613441|NCT01259297|58624732|FG003|Double Blind Randomized Period|Death|2|||
30613442|NCT01259297|58624733|FG004|Double Blind Randomized Period|Death|1|||
30613443|NCT01259297|58624734|FG005|Double Blind Randomized Period|Death|5|||
30613444|NCT01259297|58624735|FG006|Double Blind Randomized Period|Death|2|||
30613445|NCT01259297|58624736|FG007|Double Blind Randomized Period|Death|1|||
30613446|NCT01259297|58624729|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
30613447|NCT01259297|58624730|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
30613448|NCT01259297|58624731|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
30613449|NCT01259297|58624732|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
30613450|NCT01259297|58624733|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
30613451|NCT01259297|58624734|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
30613452|NCT01259297|58624735|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
30613453|NCT01259297|58624736|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
30613454|NCT01259297|58624729|FG000|Double Blind Randomized Period|Other reasons|0|||
30613455|NCT01259297|58624730|FG001|Double Blind Randomized Period|Other reasons|1|||
30613456|NCT01259297|58624731|FG002|Double Blind Randomized Period|Other reasons|0|||
30613457|NCT01259297|58624732|FG003|Double Blind Randomized Period|Other reasons|0|||
30613458|NCT01259297|58624733|FG004|Double Blind Randomized Period|Other reasons|1|||
30613459|NCT01259297|58624734|FG005|Double Blind Randomized Period|Other reasons|2|||
30613460|NCT01259297|58624735|FG006|Double Blind Randomized Period|Other reasons|3|||
30613461|NCT01259297|58624736|FG007|Double Blind Randomized Period|Other reasons|1|||
30613462|NCT01126437|58624756|FG000|Overall Study|Not treated|11|||
30613463|NCT01126437|58624757|FG001|Overall Study|Not treated|18|||
30613464|NCT01126437|58624758|FG002|Overall Study|Not treated|19|||
30613465|NCT01126437|58624756|FG000|Overall Study|Sites with data irregularities/fraud|6|||
30613466|NCT01126437|58624757|FG001|Overall Study|Sites with data irregularities/fraud|6|||
30613467|NCT01126437|58624758|FG002|Overall Study|Sites with data irregularities/fraud|7|||
30613468|NCT01126437|58624756|FG000|Overall Study|Adverse Event|602|||
30613469|NCT01126437|58624757|FG001|Overall Study|Adverse Event|606|||
30613470|NCT01126437|58624758|FG002|Overall Study|Adverse Event|635|||
30613471|NCT01126437|58624756|FG000|Overall Study|Lack of Efficacy|65|||
30613472|NCT01126437|58624757|FG001|Overall Study|Lack of Efficacy|60|||
30613473|NCT01126437|58624758|FG002|Overall Study|Lack of Efficacy|59|||
30613474|NCT01126437|58624756|FG000|Overall Study|Protocol Violation|64|||
30613475|NCT01126437|58624757|FG001|Overall Study|Protocol Violation|66|||
30613476|NCT01126437|58624758|FG002|Overall Study|Protocol Violation|41|||
30613477|NCT01126437|58624756|FG000|Overall Study|Lost to Follow-up|52|||
30613478|NCT01126437|58624757|FG001|Overall Study|Lost to Follow-up|63|||
30613479|NCT01126437|58624758|FG002|Overall Study|Lost to Follow-up|55|||
30613480|NCT01126437|58624756|FG000|Overall Study|Withdrawal by Subject|331|||
30613481|NCT01126437|58624757|FG001|Overall Study|Withdrawal by Subject|335|||
30613482|NCT01126437|58624758|FG002|Overall Study|Withdrawal by Subject|319|||
30613483|NCT01126437|58624756|FG000|Overall Study|Other reason not specified|210|||
30613484|NCT01126437|58624757|FG001|Overall Study|Other reason not specified|176|||
30613485|NCT01126437|58624758|FG002|Overall Study|Other reason not specified|178|||
30790773|NCT03524092|58803942|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
30893046|NCT02531633|58926446|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
30893047|NCT02531633|58926447|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
30893048|NCT02531633|58926448|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
30893049|NCT02531633|58926449|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
30893050|NCT02531633|58926450|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
30893051|NCT02531633|58926451|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
30613486|NCT01258595|58624768|FG000|Overall Study|Lost to Follow-up|1|||
30613487|NCT01258595|58624769|FG001|Overall Study|Lost to Follow-up|0|||
30893052|NCT02531633|58926452|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
30613488|NCT01258595|58624768|FG000|Overall Study|Withdrawal by Subject|0|||
30613489|NCT01258595|58624769|FG001|Overall Study|Withdrawal by Subject|1|||
30613490|NCT01257737|58624777|FG000|Overall Study|Lost to Follow-up|1|||
30613491|NCT01257737|58624778|FG001|Overall Study|Lost to Follow-up|2|||
30613492|NCT01257737|58624777|FG000|Overall Study|Liver transplant|1|||
31008452|NCT01474512|59210152|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
31008453|NCT01474512|59210153|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
31008454|NCT01474512|59210154|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
31008455|NCT01474512|59210155|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008456|NCT01474512|59210156|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008457|NCT01474512|59210157|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008458|NCT01474512|59210158|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008459|NCT01474512|59210159|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008460|NCT01474512|59210160|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008461|NCT01474512|59210161|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008462|NCT01474512|59210162|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008463|NCT01474512|59210163|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008464|NCT01474512|59210164|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008465|NCT01474512|59210165|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
31008466|NCT01474512|59210148|FG000|Maintenance Period|Adverse Event|0|||
31008467|NCT01474512|59210149|FG001|Maintenance Period|Adverse Event|0|||
31008468|NCT01474512|59210150|FG002|Maintenance Period|Adverse Event|0|||
31008469|NCT01474512|59210151|FG003|Maintenance Period|Adverse Event|4|||
31008470|NCT01474512|59210152|FG004|Maintenance Period|Adverse Event|2|||
31008471|NCT01474512|59210153|FG005|Maintenance Period|Adverse Event|7|||
31008472|NCT01474512|59210154|FG006|Maintenance Period|Adverse Event|0|||
31008473|NCT01474512|59210155|FG007|Maintenance Period|Adverse Event|19|||
31008474|NCT01474512|59210156|FG008|Maintenance Period|Adverse Event|1|||
31008475|NCT01474512|59210157|FG009|Maintenance Period|Adverse Event|3|||
31008476|NCT01474512|59210158|FG010|Maintenance Period|Adverse Event|0|||
31008477|NCT01474512|59210159|FG011|Maintenance Period|Adverse Event|0|||
31008478|NCT01474512|59210160|FG012|Maintenance Period|Adverse Event|0|||
31008479|NCT01474512|59210161|FG013|Maintenance Period|Adverse Event|0|||
31008480|NCT01474512|59210162|FG014|Maintenance Period|Adverse Event|0|||
31008481|NCT01474512|59210163|FG015|Maintenance Period|Adverse Event|0|||
31008482|NCT01474512|59210164|FG016|Maintenance Period|Adverse Event|0|||
31008483|NCT01474512|59210165|FG017|Maintenance Period|Adverse Event|0|||
31008484|NCT01474512|59210148|FG000|Maintenance Period|Withdrawal by Subject|0|||
31008485|NCT01474512|59210149|FG001|Maintenance Period|Withdrawal by Subject|0|||
31008486|NCT01474512|59210150|FG002|Maintenance Period|Withdrawal by Subject|0|||
31008487|NCT01474512|59210151|FG003|Maintenance Period|Withdrawal by Subject|6|||
31008488|NCT01474512|59210152|FG004|Maintenance Period|Withdrawal by Subject|2|||
31008489|NCT01474512|59210153|FG005|Maintenance Period|Withdrawal by Subject|3|||
31008490|NCT01474512|59210154|FG006|Maintenance Period|Withdrawal by Subject|1|||
31008491|NCT01474512|59210155|FG007|Maintenance Period|Withdrawal by Subject|6|||
31008492|NCT01474512|59210156|FG008|Maintenance Period|Withdrawal by Subject|3|||
31008493|NCT01474512|59210157|FG009|Maintenance Period|Withdrawal by Subject|1|||
31008494|NCT01474512|59210158|FG010|Maintenance Period|Withdrawal by Subject|0|||
31008495|NCT01474512|59210159|FG011|Maintenance Period|Withdrawal by Subject|0|||
31008496|NCT01474512|59210160|FG012|Maintenance Period|Withdrawal by Subject|0|||
31008497|NCT01474512|59210161|FG013|Maintenance Period|Withdrawal by Subject|0|||
31008498|NCT01474512|59210162|FG014|Maintenance Period|Withdrawal by Subject|0|||
31008499|NCT01474512|59210163|FG015|Maintenance Period|Withdrawal by Subject|0|||
31008500|NCT01474512|59210164|FG016|Maintenance Period|Withdrawal by Subject|0|||
31008501|NCT01474512|59210165|FG017|Maintenance Period|Withdrawal by Subject|0|||
31008502|NCT01474512|59210148|FG000|Maintenance Period|Lost to Follow-up|0|||
31008503|NCT01474512|59210149|FG001|Maintenance Period|Lost to Follow-up|0|||
31008504|NCT01474512|59210150|FG002|Maintenance Period|Lost to Follow-up|0|||
31008505|NCT01474512|59210151|FG003|Maintenance Period|Lost to Follow-up|3|||
31008506|NCT01474512|59210152|FG004|Maintenance Period|Lost to Follow-up|3|||
31008507|NCT01474512|59210153|FG005|Maintenance Period|Lost to Follow-up|0|||
31008508|NCT01474512|59210154|FG006|Maintenance Period|Lost to Follow-up|0|||
31008509|NCT01474512|59210155|FG007|Maintenance Period|Lost to Follow-up|2|||
31008510|NCT01474512|59210156|FG008|Maintenance Period|Lost to Follow-up|1|||
31008511|NCT01474512|59210157|FG009|Maintenance Period|Lost to Follow-up|1|||
31008512|NCT01474512|59210158|FG010|Maintenance Period|Lost to Follow-up|0|||
31008513|NCT01474512|59210159|FG011|Maintenance Period|Lost to Follow-up|0|||
30613493|NCT01257737|58624778|FG001|Overall Study|Liver transplant|0|||
30699232|NCT00520936|58713776|FG002|Overall Study|Physician Decision|1|||
30699233|NCT00520936|58713777|FG003|Overall Study|Physician Decision|0|||
30699234|NCT00520936|58713778|FG004|Overall Study|Physician Decision|0|||
30699235|NCT00520936|58713779|FG005|Overall Study|Physician Decision|0|||
30699236|NCT00520936|58713780|FG006|Overall Study|Physician Decision|0|||
30699237|NCT00520936|58713781|FG007|Overall Study|Physician Decision|0|||
30699238|NCT00520936|58713774|FG000|Overall Study|Withdrawal by Subject|0|||
30613494|NCT01257737|58624777|FG000|Overall Study|Relocation out of the country|0|||
30613495|NCT01257737|58624778|FG001|Overall Study|Relocation out of the country|1|||
30613496|NCT01257737|58624777|FG000|Overall Study|Withdrew from study|0|||
30613497|NCT01257737|58624778|FG001|Overall Study|Withdrew from study|1|||
30613498|NCT01126359|58624785|FG000|First Intervention (20-minutes)|Physician Decision|0|||
30613499|NCT01126359|58624786|FG001|First Intervention (20-minutes)|Physician Decision|1|||
30613500|NCT01125813|58624796|FG000|Overall Study|Death|1|||
30613501|NCT01125813|58624796|FG000|Overall Study|Withdrawal by Subject|1|||
30613502|NCT01125813|58624796|FG000|Overall Study|Screen Failures|4|||
30613503|NCT00996892|58624800|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
30613504|NCT00996892|58624801|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
30613505|NCT00996892|58624802|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
30613506|NCT00996892|58624803|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
30613507|NCT00996892|58624804|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
30613508|NCT00996892|58624805|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
30613509|NCT00996892|58624806|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
30613510|NCT00996892|58624807|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
30613511|NCT00996892|58624808|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
30613512|NCT00996892|58624809|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
30613513|NCT00996892|58624810|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
30613514|NCT00996892|58624811|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
30613515|NCT00996892|58624812|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
30613516|NCT00996892|58624813|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
30613517|NCT00996892|58624814|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
30613518|NCT00996892|58624815|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
30613519|NCT00996892|58624816|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
30613520|NCT00996892|58624817|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
30613521|NCT00996892|58624818|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
30613522|NCT00996892|58624819|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
30613523|NCT00996892|58624800|FG000|Dose-Escalation Stage 1|Death|1|||
30613524|NCT00996892|58624801|FG001|Dose-Escalation Stage 1|Death|0|||
30613525|NCT00996892|58624802|FG002|Dose-Escalation Stage 1|Death|0|||
30613526|NCT00996892|58624803|FG003|Dose-Escalation Stage 1|Death|0|||
30613527|NCT00996892|58624804|FG004|Dose-Escalation Stage 1|Death|0|||
30613528|NCT00996892|58624805|FG005|Dose-Escalation Stage 1|Death|1|||
30613529|NCT00996892|58624806|FG006|Dose-Escalation Stage 1|Death|0|||
30613530|NCT00996892|58624807|FG007|Dose-Escalation Stage 1|Death|0|||
30613531|NCT00996892|58624808|FG008|Dose-Escalation Stage 1|Death|0|||
30613532|NCT00996892|58624809|FG009|Dose-Escalation Stage 1|Death|0|||
30613533|NCT00996892|58624810|FG010|Dose-Escalation Stage 1|Death|0|||
30613534|NCT00996892|58624811|FG011|Dose-Escalation Stage 1|Death|0|||
30613535|NCT00996892|58624812|FG012|Dose-Escalation Stage 1|Death|0|||
30613536|NCT00996892|58624813|FG013|Dose-Escalation Stage 1|Death|0|||
30613537|NCT00996892|58624814|FG014|Dose-Escalation Stage 1|Death|0|||
30613538|NCT00996892|58624815|FG015|Dose-Escalation Stage 1|Death|0|||
30613539|NCT00996892|58624816|FG016|Dose-Escalation Stage 1|Death|0|||
30613540|NCT00996892|58624817|FG017|Dose-Escalation Stage 1|Death|0|||
30613541|NCT00996892|58624818|FG018|Dose-Escalation Stage 1|Death|0|||
30613542|NCT00996892|58624819|FG019|Dose-Escalation Stage 1|Death|0|||
30613543|NCT00996892|58624800|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
30613544|NCT00996892|58624801|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
30613545|NCT00996892|58624802|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
30613546|NCT00996892|58624803|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
30613547|NCT00996892|58624804|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
30613548|NCT00996892|58624805|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
30613549|NCT00996892|58624806|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
30613550|NCT00996892|58624807|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
30613551|NCT00996892|58624808|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
30613552|NCT00996892|58624809|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
30613553|NCT00996892|58624810|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
30613554|NCT00996892|58624811|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
30613555|NCT00996892|58624812|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
30699239|NCT00520936|58713775|FG001|Overall Study|Withdrawal by Subject|0|||
30699240|NCT00520936|58713776|FG002|Overall Study|Withdrawal by Subject|0|||
30613556|NCT00996892|58624813|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
30613557|NCT00996892|58624814|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
30613558|NCT00996892|58624815|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
30699241|NCT00520936|58713777|FG003|Overall Study|Withdrawal by Subject|0|||
30613559|NCT00996892|58624816|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
30613560|NCT00996892|58624817|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
30613561|NCT00996892|58624818|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
30613562|NCT00996892|58624819|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
30613563|NCT00996892|58624800|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613564|NCT00996892|58624801|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
30613565|NCT00996892|58624802|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613566|NCT00996892|58624803|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
30613567|NCT00996892|58624804|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
30613568|NCT00996892|58624805|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
30613569|NCT00996892|58624806|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
30613570|NCT00996892|58624807|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613571|NCT00996892|58624808|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613572|NCT00996892|58624809|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613573|NCT00996892|58624810|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613574|NCT00996892|58624811|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613575|NCT00996892|58624812|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613576|NCT00996892|58624813|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613577|NCT00996892|58624814|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613578|NCT00996892|58624815|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613579|NCT00996892|58624816|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613580|NCT00996892|58624817|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613581|NCT00996892|58624818|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613582|NCT00996892|58624819|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
30613583|NCT00996892|58624800|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
30613584|NCT00996892|58624801|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
30613585|NCT00996892|58624802|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
30613586|NCT00996892|58624803|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
30613587|NCT00996892|58624804|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
30613588|NCT00996892|58624805|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
30613589|NCT00996892|58624806|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
30613590|NCT00996892|58624807|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
30613591|NCT00996892|58624808|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
30613592|NCT00996892|58624809|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
30613593|NCT00996892|58624810|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
30613594|NCT00996892|58624811|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
30613595|NCT00996892|58624812|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
30613596|NCT00996892|58624813|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
30613597|NCT00996892|58624814|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
30613598|NCT00996892|58624815|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
30613599|NCT00996892|58624816|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
30613600|NCT00996892|58624817|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
30613601|NCT00996892|58624818|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
30613602|NCT00996892|58624819|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
30613603|NCT00996892|58624800|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
30613604|NCT00996892|58624801|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
30613605|NCT00996892|58624802|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
30613606|NCT00996892|58624803|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
30613607|NCT00996892|58624804|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
30613608|NCT00996892|58624805|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
30613609|NCT00996892|58624806|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
30613610|NCT00996892|58624807|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
30613611|NCT00996892|58624808|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
30613612|NCT00996892|58624809|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
30613613|NCT00996892|58624810|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
30613614|NCT00996892|58624811|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
30613615|NCT00996892|58624812|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
30613616|NCT00996892|58624813|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
30613617|NCT00996892|58624814|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
30613618|NCT00996892|58624815|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
30613619|NCT00996892|58624816|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
30613620|NCT00996892|58624817|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
30613621|NCT00996892|58624818|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
30613622|NCT00996892|58624819|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
30613623|NCT00996892|58624800|FG000|Dose-Escalation Stage 1A|Death|0|||
30613624|NCT00996892|58624801|FG001|Dose-Escalation Stage 1A|Death|0|||
30613625|NCT00996892|58624802|FG002|Dose-Escalation Stage 1A|Death|0|||
30613626|NCT00996892|58624803|FG003|Dose-Escalation Stage 1A|Death|0|||
30613627|NCT00996892|58624804|FG004|Dose-Escalation Stage 1A|Death|0|||
30613628|NCT00996892|58624805|FG005|Dose-Escalation Stage 1A|Death|0|||
30613629|NCT00996892|58624806|FG006|Dose-Escalation Stage 1A|Death|0|||
30613630|NCT00996892|58624807|FG007|Dose-Escalation Stage 1A|Death|0|||
30613631|NCT00996892|58624808|FG008|Dose-Escalation Stage 1A|Death|0|||
30613632|NCT00996892|58624809|FG009|Dose-Escalation Stage 1A|Death|2|||
30613633|NCT00996892|58624810|FG010|Dose-Escalation Stage 1A|Death|0|||
30613634|NCT00996892|58624811|FG011|Dose-Escalation Stage 1A|Death|1|||
30613635|NCT00996892|58624812|FG012|Dose-Escalation Stage 1A|Death|1|||
30613636|NCT00996892|58624813|FG013|Dose-Escalation Stage 1A|Death|0|||
30613637|NCT00996892|58624814|FG014|Dose-Escalation Stage 1A|Death|0|||
30613638|NCT00996892|58624815|FG015|Dose-Escalation Stage 1A|Death|0|||
30613639|NCT00996892|58624816|FG016|Dose-Escalation Stage 1A|Death|0|||
30613640|NCT00996892|58624817|FG017|Dose-Escalation Stage 1A|Death|0|||
30613641|NCT00996892|58624818|FG018|Dose-Escalation Stage 1A|Death|0|||
30613642|NCT00996892|58624819|FG019|Dose-Escalation Stage 1A|Death|0|||
30613643|NCT00996892|58624800|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
30613644|NCT00996892|58624801|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
30613645|NCT00996892|58624802|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
30613646|NCT00996892|58624803|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
30613647|NCT00996892|58624804|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
30613648|NCT00996892|58624805|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
30613649|NCT00996892|58624806|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
30613650|NCT00996892|58624807|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
30613651|NCT00996892|58624808|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
30613652|NCT00996892|58624809|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
30613653|NCT00996892|58624810|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
30613654|NCT00996892|58624811|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
30613655|NCT00996892|58624812|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
30790774|NCT03524092|58803943|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
30790775|NCT03524092|58803944|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
31008514|NCT01474512|59210160|FG012|Maintenance Period|Lost to Follow-up|0|||
31008515|NCT01474512|59210161|FG013|Maintenance Period|Lost to Follow-up|0|||
31008516|NCT01474512|59210162|FG014|Maintenance Period|Lost to Follow-up|0|||
31008517|NCT01474512|59210163|FG015|Maintenance Period|Lost to Follow-up|0|||
31008518|NCT01474512|59210164|FG016|Maintenance Period|Lost to Follow-up|0|||
31008519|NCT01474512|59210165|FG017|Maintenance Period|Lost to Follow-up|0|||
31008520|NCT01474512|59210148|FG000|Maintenance Period|Death|0|||
31008521|NCT01474512|59210149|FG001|Maintenance Period|Death|0|||
31008522|NCT01474512|59210150|FG002|Maintenance Period|Death|0|||
31008523|NCT01474512|59210151|FG003|Maintenance Period|Death|0|||
31008524|NCT01474512|59210152|FG004|Maintenance Period|Death|0|||
31008525|NCT01474512|59210153|FG005|Maintenance Period|Death|2|||
31008526|NCT01474512|59210154|FG006|Maintenance Period|Death|0|||
31008527|NCT01474512|59210155|FG007|Maintenance Period|Death|0|||
31008528|NCT01474512|59210156|FG008|Maintenance Period|Death|0|||
31008529|NCT01474512|59210157|FG009|Maintenance Period|Death|0|||
31008530|NCT01474512|59210158|FG010|Maintenance Period|Death|0|||
31008531|NCT01474512|59210159|FG011|Maintenance Period|Death|0|||
31008532|NCT01474512|59210160|FG012|Maintenance Period|Death|0|||
31008533|NCT01474512|59210161|FG013|Maintenance Period|Death|0|||
31008534|NCT01474512|59210162|FG014|Maintenance Period|Death|0|||
31008535|NCT01474512|59210163|FG015|Maintenance Period|Death|0|||
31008536|NCT01474512|59210164|FG016|Maintenance Period|Death|0|||
31008537|NCT01474512|59210165|FG017|Maintenance Period|Death|0|||
31008538|NCT01474512|59210148|FG000|Maintenance Period|Physician Decision|0|||
31008539|NCT01474512|59210149|FG001|Maintenance Period|Physician Decision|0|||
31008540|NCT01474512|59210150|FG002|Maintenance Period|Physician Decision|0|||
31008541|NCT01474512|59210151|FG003|Maintenance Period|Physician Decision|0|||
31008542|NCT01474512|59210152|FG004|Maintenance Period|Physician Decision|0|||
31008543|NCT01474512|59210153|FG005|Maintenance Period|Physician Decision|1|||
31008544|NCT01474512|59210154|FG006|Maintenance Period|Physician Decision|0|||
31008545|NCT01474512|59210155|FG007|Maintenance Period|Physician Decision|2|||
30613656|NCT00996892|58624813|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
30613657|NCT00996892|58624814|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
30613658|NCT00996892|58624815|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
30613659|NCT00996892|58624816|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
30613660|NCT00996892|58624817|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
30613661|NCT00996892|58624818|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
31008546|NCT01474512|59210156|FG008|Maintenance Period|Physician Decision|0|||
31008547|NCT01474512|59210157|FG009|Maintenance Period|Physician Decision|0|||
31008548|NCT01474512|59210158|FG010|Maintenance Period|Physician Decision|0|||
30699242|NCT00520936|58713778|FG004|Overall Study|Withdrawal by Subject|0|||
30699243|NCT00520936|58713779|FG005|Overall Study|Withdrawal by Subject|0|||
30699244|NCT00520936|58713780|FG006|Overall Study|Withdrawal by Subject|0|||
30699245|NCT00520936|58713781|FG007|Overall Study|Withdrawal by Subject|1|||
30699246|NCT00520936|58713774|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
30699247|NCT00520936|58713775|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
30893053|NCT02531633|58926453|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
30613662|NCT00996892|58624819|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
30613663|NCT00996892|58624800|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613664|NCT00996892|58624801|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613665|NCT00996892|58624802|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613666|NCT00996892|58624803|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613667|NCT00996892|58624804|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613668|NCT00996892|58624805|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613669|NCT00996892|58624806|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613670|NCT00996892|58624807|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613671|NCT00996892|58624808|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613672|NCT00996892|58624809|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
30613673|NCT00996892|58624810|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
30613674|NCT00996892|58624811|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
30613675|NCT00996892|58624812|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
30613676|NCT00996892|58624813|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613677|NCT00996892|58624814|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613678|NCT00996892|58624815|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613679|NCT00996892|58624816|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613680|NCT00996892|58624817|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613681|NCT00996892|58624818|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613682|NCT00996892|58624819|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
30613683|NCT00996892|58624800|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
30613684|NCT00996892|58624801|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
30613685|NCT00996892|58624802|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
30613686|NCT00996892|58624803|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
30613687|NCT00996892|58624804|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
30613688|NCT00996892|58624805|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
30613689|NCT00996892|58624806|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
30613690|NCT00996892|58624807|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
30613691|NCT00996892|58624808|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
30613692|NCT00996892|58624809|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
30613693|NCT00996892|58624810|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
30613694|NCT00996892|58624811|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
30613695|NCT00996892|58624812|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
30613696|NCT00996892|58624813|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
30613697|NCT00996892|58624814|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
30613698|NCT00996892|58624815|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
30613699|NCT00996892|58624816|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
30613700|NCT00996892|58624817|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
30613701|NCT00996892|58624818|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
30613702|NCT00996892|58624819|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
30613703|NCT00996892|58624800|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
30613704|NCT00996892|58624801|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
30613705|NCT00996892|58624802|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
30613706|NCT00996892|58624803|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
30893054|NCT02531633|58926454|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
30893055|NCT02531633|58926455|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
30893056|NCT02536313|58926497|FG000|Overall Study|Lack of Efficacy|0|||
31008549|NCT01474512|59210159|FG011|Maintenance Period|Physician Decision|0|||
30613707|NCT00996892|58624804|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
30613708|NCT00996892|58624805|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
30613709|NCT00996892|58624806|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
30613710|NCT00996892|58624807|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
30613711|NCT00996892|58624808|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
30613712|NCT00996892|58624809|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
30613713|NCT00996892|58624810|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
31008550|NCT01474512|59210160|FG012|Maintenance Period|Physician Decision|0|||
31008551|NCT01474512|59210161|FG013|Maintenance Period|Physician Decision|0|||
31008552|NCT01474512|59210162|FG014|Maintenance Period|Physician Decision|0|||
31008553|NCT01474512|59210163|FG015|Maintenance Period|Physician Decision|0|||
31008554|NCT01474512|59210164|FG016|Maintenance Period|Physician Decision|0|||
30613714|NCT00996892|58624811|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
30613715|NCT00996892|58624812|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
30613716|NCT00996892|58624813|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
30613717|NCT00996892|58624814|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
30613718|NCT00996892|58624815|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
30613719|NCT00996892|58624816|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
30613720|NCT00996892|58624817|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
30613721|NCT00996892|58624818|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
30613722|NCT00996892|58624819|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
30613723|NCT00996892|58624800|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
30613724|NCT00996892|58624801|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
30613725|NCT00996892|58624802|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
30613726|NCT00996892|58624803|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
30613727|NCT00996892|58624804|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
30613728|NCT00996892|58624805|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
30613729|NCT00996892|58624806|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
30613730|NCT00996892|58624807|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
30613731|NCT00996892|58624808|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
30613732|NCT00996892|58624809|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
30613733|NCT00996892|58624810|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
30613734|NCT00996892|58624811|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
30613735|NCT00996892|58624812|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
30613736|NCT00996892|58624813|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
30613737|NCT00996892|58624814|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
30613738|NCT00996892|58624815|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
30613739|NCT00996892|58624816|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
30613740|NCT00996892|58624817|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
30699248|NCT00520936|58713776|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
31008555|NCT01474512|59210165|FG017|Maintenance Period|Physician Decision|0|||
31008556|NCT01474512|59210148|FG000|Maintenance Period|Clinical Relapse|0|||
31008557|NCT01474512|59210149|FG001|Maintenance Period|Clinical Relapse|0|||
31008558|NCT01474512|59210150|FG002|Maintenance Period|Clinical Relapse|0|||
31008559|NCT01474512|59210151|FG003|Maintenance Period|Clinical Relapse|1|||
31008560|NCT01474512|59210152|FG004|Maintenance Period|Clinical Relapse|0|||
31008561|NCT01474512|59210153|FG005|Maintenance Period|Clinical Relapse|0|||
31008562|NCT01474512|59210154|FG006|Maintenance Period|Clinical Relapse|0|||
31008563|NCT01474512|59210155|FG007|Maintenance Period|Clinical Relapse|0|||
31008564|NCT01474512|59210156|FG008|Maintenance Period|Clinical Relapse|0|||
31008565|NCT01474512|59210157|FG009|Maintenance Period|Clinical Relapse|0|||
31008566|NCT01474512|59210158|FG010|Maintenance Period|Clinical Relapse|0|||
31008567|NCT01474512|59210159|FG011|Maintenance Period|Clinical Relapse|0|||
31008568|NCT01474512|59210160|FG012|Maintenance Period|Clinical Relapse|0|||
31008569|NCT01474512|59210161|FG013|Maintenance Period|Clinical Relapse|0|||
31008570|NCT01474512|59210162|FG014|Maintenance Period|Clinical Relapse|0|||
31008571|NCT01474512|59210163|FG015|Maintenance Period|Clinical Relapse|0|||
31008572|NCT01474512|59210164|FG016|Maintenance Period|Clinical Relapse|0|||
31008573|NCT01474512|59210165|FG017|Maintenance Period|Clinical Relapse|0|||
31008574|NCT01474512|59210148|FG000|Maintenance Period|Lack of Efficacy|0|||
30613741|NCT00996892|58624818|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
30613742|NCT00996892|58624819|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
30613743|NCT00996892|58624800|FG000|Expansion Stage 2|Adverse Event|0|||
30613744|NCT00996892|58624801|FG001|Expansion Stage 2|Adverse Event|0|||
30613745|NCT00996892|58624802|FG002|Expansion Stage 2|Adverse Event|0|||
30613746|NCT00996892|58624803|FG003|Expansion Stage 2|Adverse Event|0|||
30613747|NCT00996892|58624804|FG004|Expansion Stage 2|Adverse Event|0|||
30613748|NCT00996892|58624805|FG005|Expansion Stage 2|Adverse Event|0|||
30613749|NCT00996892|58624806|FG006|Expansion Stage 2|Adverse Event|0|||
30613750|NCT00996892|58624807|FG007|Expansion Stage 2|Adverse Event|0|||
30613751|NCT00996892|58624808|FG008|Expansion Stage 2|Adverse Event|0|||
30613752|NCT00996892|58624809|FG009|Expansion Stage 2|Adverse Event|0|||
30613753|NCT00996892|58624810|FG010|Expansion Stage 2|Adverse Event|0|||
30613754|NCT00996892|58624811|FG011|Expansion Stage 2|Adverse Event|0|||
30613755|NCT00996892|58624812|FG012|Expansion Stage 2|Adverse Event|0|||
30613756|NCT00996892|58624813|FG013|Expansion Stage 2|Adverse Event|0|||
30613757|NCT00996892|58624814|FG014|Expansion Stage 2|Adverse Event|0|||
30613758|NCT00996892|58624815|FG015|Expansion Stage 2|Adverse Event|0|||
30613759|NCT00996892|58624816|FG016|Expansion Stage 2|Adverse Event|0|||
30613760|NCT00996892|58624817|FG017|Expansion Stage 2|Adverse Event|0|||
30613761|NCT00996892|58624818|FG018|Expansion Stage 2|Adverse Event|3|||
30613762|NCT00996892|58624819|FG019|Expansion Stage 2|Adverse Event|0|||
30613763|NCT00996892|58624800|FG000|Expansion Stage 2|Death|0|||
30613764|NCT00996892|58624801|FG001|Expansion Stage 2|Death|0|||
30613765|NCT00996892|58624802|FG002|Expansion Stage 2|Death|0|||
30613766|NCT00996892|58624803|FG003|Expansion Stage 2|Death|0|||
30613767|NCT00996892|58624804|FG004|Expansion Stage 2|Death|0|||
30613768|NCT00996892|58624805|FG005|Expansion Stage 2|Death|0|||
30613769|NCT00996892|58624806|FG006|Expansion Stage 2|Death|0|||
30613770|NCT00996892|58624807|FG007|Expansion Stage 2|Death|0|||
30613771|NCT00996892|58624808|FG008|Expansion Stage 2|Death|0|||
30613772|NCT00996892|58624809|FG009|Expansion Stage 2|Death|0|||
30613773|NCT00996892|58624810|FG010|Expansion Stage 2|Death|0|||
30613774|NCT00996892|58624811|FG011|Expansion Stage 2|Death|0|||
30613775|NCT00996892|58624812|FG012|Expansion Stage 2|Death|0|||
31008575|NCT01474512|59210149|FG001|Maintenance Period|Lack of Efficacy|0|||
31008576|NCT01474512|59210150|FG002|Maintenance Period|Lack of Efficacy|0|||
31008577|NCT01474512|59210151|FG003|Maintenance Period|Lack of Efficacy|1|||
31008578|NCT01474512|59210152|FG004|Maintenance Period|Lack of Efficacy|0|||
31008579|NCT01474512|59210153|FG005|Maintenance Period|Lack of Efficacy|0|||
31008580|NCT01474512|59210154|FG006|Maintenance Period|Lack of Efficacy|0|||
31008581|NCT01474512|59210155|FG007|Maintenance Period|Lack of Efficacy|11|||
31008582|NCT01474512|59210156|FG008|Maintenance Period|Lack of Efficacy|11|||
31008583|NCT01474512|59210157|FG009|Maintenance Period|Lack of Efficacy|12|||
31008584|NCT01474512|59210158|FG010|Maintenance Period|Lack of Efficacy|0|||
31008585|NCT01474512|59210159|FG011|Maintenance Period|Lack of Efficacy|0|||
31008586|NCT01474512|59210160|FG012|Maintenance Period|Lack of Efficacy|0|||
31008587|NCT01474512|59210161|FG013|Maintenance Period|Lack of Efficacy|0|||
31008588|NCT01474512|59210162|FG014|Maintenance Period|Lack of Efficacy|0|||
31008589|NCT01474512|59210163|FG015|Maintenance Period|Lack of Efficacy|0|||
31008590|NCT01474512|59210164|FG016|Maintenance Period|Lack of Efficacy|0|||
31008591|NCT01474512|59210165|FG017|Maintenance Period|Lack of Efficacy|0|||
31008592|NCT01474512|59210148|FG000|Maintenance Period|Protocol Violation|0|||
31008593|NCT01474512|59210149|FG001|Maintenance Period|Protocol Violation|0|||
31008594|NCT01474512|59210150|FG002|Maintenance Period|Protocol Violation|0|||
31008595|NCT01474512|59210151|FG003|Maintenance Period|Protocol Violation|1|||
31008596|NCT01474512|59210152|FG004|Maintenance Period|Protocol Violation|0|||
31008597|NCT01474512|59210153|FG005|Maintenance Period|Protocol Violation|0|||
31008598|NCT01474512|59210154|FG006|Maintenance Period|Protocol Violation|0|||
31008599|NCT01474512|59210155|FG007|Maintenance Period|Protocol Violation|1|||
31008600|NCT01474512|59210156|FG008|Maintenance Period|Protocol Violation|0|||
31008601|NCT01474512|59210157|FG009|Maintenance Period|Protocol Violation|1|||
31008602|NCT01474512|59210158|FG010|Maintenance Period|Protocol Violation|0|||
31008603|NCT01474512|59210159|FG011|Maintenance Period|Protocol Violation|0|||
30613776|NCT00996892|58624813|FG013|Expansion Stage 2|Death|0|||
31008604|NCT01474512|59210160|FG012|Maintenance Period|Protocol Violation|0|||
31008605|NCT01474512|59210161|FG013|Maintenance Period|Protocol Violation|0|||
31008606|NCT01474512|59210162|FG014|Maintenance Period|Protocol Violation|0|||
31008607|NCT01474512|59210163|FG015|Maintenance Period|Protocol Violation|0|||
31008608|NCT01474512|59210164|FG016|Maintenance Period|Protocol Violation|0|||
30613777|NCT00996892|58624814|FG014|Expansion Stage 2|Death|0|||
30613778|NCT00996892|58624815|FG015|Expansion Stage 2|Death|0|||
30613779|NCT00996892|58624816|FG016|Expansion Stage 2|Death|0|||
30613780|NCT00996892|58624817|FG017|Expansion Stage 2|Death|0|||
30613781|NCT00996892|58624818|FG018|Expansion Stage 2|Death|2|||
31008609|NCT01474512|59210165|FG017|Maintenance Period|Protocol Violation|0|||
30613782|NCT00996892|58624819|FG019|Expansion Stage 2|Death|0|||
30613783|NCT00996892|58624800|FG000|Expansion Stage 2|Physician Decision|0|||
30613784|NCT00996892|58624801|FG001|Expansion Stage 2|Physician Decision|0|||
31008610|NCT01474512|59210148|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
31008611|NCT01474512|59210149|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
31008612|NCT01474512|59210150|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
31008613|NCT01474512|59210151|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
31008614|NCT01474512|59210152|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
31008615|NCT01474512|59210153|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
31008616|NCT01474512|59210154|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
30613785|NCT00996892|58624802|FG002|Expansion Stage 2|Physician Decision|0|||
30613786|NCT00996892|58624803|FG003|Expansion Stage 2|Physician Decision|0|||
30613787|NCT00996892|58624804|FG004|Expansion Stage 2|Physician Decision|0|||
30613788|NCT00996892|58624805|FG005|Expansion Stage 2|Physician Decision|0|||
30613789|NCT00996892|58624806|FG006|Expansion Stage 2|Physician Decision|0|||
30613790|NCT00996892|58624807|FG007|Expansion Stage 2|Physician Decision|0|||
30613791|NCT00996892|58624808|FG008|Expansion Stage 2|Physician Decision|0|||
30613792|NCT00996892|58624809|FG009|Expansion Stage 2|Physician Decision|0|||
30613793|NCT00996892|58624810|FG010|Expansion Stage 2|Physician Decision|0|||
30613794|NCT00996892|58624811|FG011|Expansion Stage 2|Physician Decision|0|||
30613795|NCT00996892|58624812|FG012|Expansion Stage 2|Physician Decision|0|||
30613796|NCT00996892|58624813|FG013|Expansion Stage 2|Physician Decision|0|||
30613797|NCT00996892|58624814|FG014|Expansion Stage 2|Physician Decision|0|||
30613798|NCT00996892|58624815|FG015|Expansion Stage 2|Physician Decision|0|||
30613799|NCT00996892|58624816|FG016|Expansion Stage 2|Physician Decision|0|||
30613800|NCT00996892|58624817|FG017|Expansion Stage 2|Physician Decision|0|||
30613801|NCT00996892|58624818|FG018|Expansion Stage 2|Physician Decision|1|||
30613802|NCT00996892|58624819|FG019|Expansion Stage 2|Physician Decision|0|||
30613803|NCT00996892|58624800|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
30613804|NCT00996892|58624801|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
30613805|NCT00996892|58624802|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
30613806|NCT00996892|58624803|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
30613807|NCT00996892|58624804|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
30613808|NCT00996892|58624805|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
30613809|NCT00996892|58624806|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
30613810|NCT00996892|58624807|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
30613811|NCT00996892|58624808|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
30613812|NCT00996892|58624809|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
30613813|NCT00996892|58624810|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
30613814|NCT00996892|58624811|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
30613815|NCT00996892|58624812|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
30613816|NCT00996892|58624813|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
30613817|NCT00996892|58624814|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
30613818|NCT00996892|58624815|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
30613819|NCT00996892|58624816|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
31008617|NCT01474512|59210155|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
31008618|NCT01474512|59210156|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
31008619|NCT01474512|59210157|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
31008620|NCT01474512|59210158|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
31008621|NCT01474512|59210159|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
31008622|NCT01474512|59210160|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
31008623|NCT01474512|59210161|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
31008624|NCT01474512|59210162|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
31008625|NCT01474512|59210163|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
31008626|NCT01474512|59210164|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
31008627|NCT01474512|59210165|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
31008628|NCT01474512|59210148|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
31008629|NCT01474512|59210149|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
31008630|NCT01474512|59210150|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
31008631|NCT01474512|59210151|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
31008632|NCT01474512|59210152|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
31008633|NCT01474512|59210153|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
31008634|NCT01474512|59210154|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
31008635|NCT01474512|59210155|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
31008636|NCT01474512|59210156|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
31008637|NCT01474512|59210157|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
31008638|NCT01474512|59210158|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
30613820|NCT00996892|58624817|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
30613821|NCT00996892|58624818|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
30613822|NCT00996892|58624819|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
30613823|NCT00996892|58624800|FG000|Expansion Stage 2|Disease Progression|0|||
31008639|NCT01474512|59210159|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
31008640|NCT01474512|59210160|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
30613824|NCT00996892|58624801|FG001|Expansion Stage 2|Disease Progression|0|||
31008641|NCT01474512|59210161|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
31008642|NCT01474512|59210162|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
31008643|NCT01474512|59210163|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
31008644|NCT01474512|59210164|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
31008645|NCT01474512|59210165|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
31008646|NCT01474512|59210148|FG000|Long-Term Extension Period|Adverse Event|0|||
30613825|NCT00996892|58624802|FG002|Expansion Stage 2|Disease Progression|0|||
30613826|NCT00996892|58624803|FG003|Expansion Stage 2|Disease Progression|0|||
30613827|NCT00996892|58624804|FG004|Expansion Stage 2|Disease Progression|0|||
30613828|NCT00996892|58624805|FG005|Expansion Stage 2|Disease Progression|0|||
30613829|NCT00996892|58624806|FG006|Expansion Stage 2|Disease Progression|0|||
30613830|NCT00996892|58624807|FG007|Expansion Stage 2|Disease Progression|0|||
30613831|NCT00996892|58624808|FG008|Expansion Stage 2|Disease Progression|0|||
30613832|NCT00996892|58624809|FG009|Expansion Stage 2|Disease Progression|0|||
30613833|NCT00996892|58624810|FG010|Expansion Stage 2|Disease Progression|0|||
30613834|NCT00996892|58624811|FG011|Expansion Stage 2|Disease Progression|0|||
30613835|NCT00996892|58624812|FG012|Expansion Stage 2|Disease Progression|0|||
30613836|NCT00996892|58624813|FG013|Expansion Stage 2|Disease Progression|0|||
30613837|NCT00996892|58624814|FG014|Expansion Stage 2|Disease Progression|0|||
30613838|NCT00996892|58624815|FG015|Expansion Stage 2|Disease Progression|0|||
30613839|NCT00996892|58624816|FG016|Expansion Stage 2|Disease Progression|0|||
30613840|NCT00996892|58624817|FG017|Expansion Stage 2|Disease Progression|0|||
30613841|NCT00996892|58624818|FG018|Expansion Stage 2|Disease Progression|28|||
30613842|NCT00996892|58624819|FG019|Expansion Stage 2|Disease Progression|0|||
30613843|NCT00996892|58624800|FG000|Expansion Stage 2A|Adverse Event|0|||
30613844|NCT00996892|58624801|FG001|Expansion Stage 2A|Adverse Event|0|||
30613845|NCT00996892|58624802|FG002|Expansion Stage 2A|Adverse Event|0|||
30613846|NCT00996892|58624803|FG003|Expansion Stage 2A|Adverse Event|0|||
30613847|NCT00996892|58624804|FG004|Expansion Stage 2A|Adverse Event|0|||
30613848|NCT00996892|58624805|FG005|Expansion Stage 2A|Adverse Event|0|||
30613849|NCT00996892|58624806|FG006|Expansion Stage 2A|Adverse Event|0|||
30613850|NCT00996892|58624807|FG007|Expansion Stage 2A|Adverse Event|0|||
30613851|NCT00996892|58624808|FG008|Expansion Stage 2A|Adverse Event|0|||
30613852|NCT00996892|58624809|FG009|Expansion Stage 2A|Adverse Event|0|||
30613853|NCT00996892|58624810|FG010|Expansion Stage 2A|Adverse Event|0|||
30613854|NCT00996892|58624811|FG011|Expansion Stage 2A|Adverse Event|0|||
30613855|NCT00996892|58624812|FG012|Expansion Stage 2A|Adverse Event|0|||
30613856|NCT00996892|58624813|FG013|Expansion Stage 2A|Adverse Event|0|||
30613857|NCT00996892|58624814|FG014|Expansion Stage 2A|Adverse Event|0|||
30613858|NCT00996892|58624815|FG015|Expansion Stage 2A|Adverse Event|0|||
30613859|NCT00996892|58624816|FG016|Expansion Stage 2A|Adverse Event|0|||
30613860|NCT00996892|58624817|FG017|Expansion Stage 2A|Adverse Event|0|||
30613861|NCT00996892|58624818|FG018|Expansion Stage 2A|Adverse Event|0|||
30613862|NCT00996892|58624819|FG019|Expansion Stage 2A|Adverse Event|8|||
30613863|NCT00996892|58624800|FG000|Expansion Stage 2A|Physician Decision|0|||
30613864|NCT00996892|58624801|FG001|Expansion Stage 2A|Physician Decision|0|||
30613865|NCT00996892|58624802|FG002|Expansion Stage 2A|Physician Decision|0|||
30613866|NCT00996892|58624803|FG003|Expansion Stage 2A|Physician Decision|0|||
30613867|NCT00996892|58624804|FG004|Expansion Stage 2A|Physician Decision|0|||
30613868|NCT00996892|58624805|FG005|Expansion Stage 2A|Physician Decision|0|||
30613869|NCT00996892|58624806|FG006|Expansion Stage 2A|Physician Decision|0|||
30613870|NCT00996892|58624807|FG007|Expansion Stage 2A|Physician Decision|0|||
31008647|NCT01474512|59210149|FG001|Long-Term Extension Period|Adverse Event|0|||
31008648|NCT01474512|59210150|FG002|Long-Term Extension Period|Adverse Event|0|||
31008649|NCT01474512|59210151|FG003|Long-Term Extension Period|Adverse Event|0|||
31008650|NCT01474512|59210152|FG004|Long-Term Extension Period|Adverse Event|0|||
31008651|NCT01474512|59210153|FG005|Long-Term Extension Period|Adverse Event|0|||
31008652|NCT01474512|59210154|FG006|Long-Term Extension Period|Adverse Event|0|||
31008653|NCT01474512|59210155|FG007|Long-Term Extension Period|Adverse Event|0|||
31008654|NCT01474512|59210156|FG008|Long-Term Extension Period|Adverse Event|0|||
31008655|NCT01474512|59210157|FG009|Long-Term Extension Period|Adverse Event|0|||
31008656|NCT01474512|59210158|FG010|Long-Term Extension Period|Adverse Event|0|||
31008657|NCT01474512|59210159|FG011|Long-Term Extension Period|Adverse Event|1|||
31008658|NCT01474512|59210160|FG012|Long-Term Extension Period|Adverse Event|57|||
31008659|NCT01474512|59210161|FG013|Long-Term Extension Period|Adverse Event|58|||
31008660|NCT01474512|59210162|FG014|Long-Term Extension Period|Adverse Event|0|||
31008661|NCT01474512|59210163|FG015|Long-Term Extension Period|Adverse Event|0|||
31008662|NCT01474512|59210164|FG016|Long-Term Extension Period|Adverse Event|0|||
30613871|NCT00996892|58624808|FG008|Expansion Stage 2A|Physician Decision|0|||
30613872|NCT00996892|58624809|FG009|Expansion Stage 2A|Physician Decision|0|||
30613873|NCT00996892|58624810|FG010|Expansion Stage 2A|Physician Decision|0|||
30613874|NCT00996892|58624811|FG011|Expansion Stage 2A|Physician Decision|0|||
30613875|NCT00996892|58624812|FG012|Expansion Stage 2A|Physician Decision|0|||
30613876|NCT00996892|58624813|FG013|Expansion Stage 2A|Physician Decision|0|||
30613877|NCT00996892|58624814|FG014|Expansion Stage 2A|Physician Decision|0|||
30613878|NCT00996892|58624815|FG015|Expansion Stage 2A|Physician Decision|0|||
30613879|NCT00996892|58624816|FG016|Expansion Stage 2A|Physician Decision|0|||
30613880|NCT00996892|58624817|FG017|Expansion Stage 2A|Physician Decision|0|||
30613881|NCT00996892|58624818|FG018|Expansion Stage 2A|Physician Decision|0|||
30613882|NCT00996892|58624819|FG019|Expansion Stage 2A|Physician Decision|2|||
30613883|NCT00996892|58624800|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
30613884|NCT00996892|58624801|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
30613885|NCT00996892|58624802|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
30613886|NCT00996892|58624803|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
30613887|NCT00996892|58624804|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
30613888|NCT00996892|58624805|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
30613889|NCT00996892|58624806|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
30613890|NCT00996892|58624807|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
30613891|NCT00996892|58624808|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
30699249|NCT00520936|58713777|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
30699250|NCT00520936|58713778|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
30699251|NCT00520936|58713779|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
30699252|NCT00520936|58713780|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
30699253|NCT00520936|58713781|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
30699254|NCT00520936|58713774|FG000|Overall Study|Death|0|||
30699255|NCT00520936|58713775|FG001|Overall Study|Death|0|||
30699256|NCT00520936|58713776|FG002|Overall Study|Death|0|||
31008663|NCT01474512|59210165|FG017|Long-Term Extension Period|Adverse Event|0|||
31008664|NCT01474512|59210148|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
31008665|NCT01474512|59210149|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
31008666|NCT01474512|59210150|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
31008667|NCT01474512|59210151|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
31008668|NCT01474512|59210152|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
31008669|NCT01474512|59210153|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
31008670|NCT01474512|59210154|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
31008671|NCT01474512|59210155|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
31008672|NCT01474512|59210156|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
31008673|NCT01474512|59210157|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
31008674|NCT01474512|59210158|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
31008675|NCT01474512|59210159|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
31008676|NCT01474512|59210160|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
31008677|NCT01474512|59210161|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
31008678|NCT01474512|59210162|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
31008679|NCT01474512|59210163|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
31008680|NCT01474512|59210164|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
31008681|NCT01474512|59210165|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
31008682|NCT01474512|59210148|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
31008683|NCT01474512|59210149|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
31008684|NCT01474512|59210150|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
31008685|NCT01474512|59210151|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
31008686|NCT01474512|59210152|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
31008687|NCT01474512|59210153|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
31008688|NCT01474512|59210154|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
31008689|NCT01474512|59210155|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
31008690|NCT01474512|59210156|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
30699257|NCT00520936|58713777|FG003|Overall Study|Death|0|||
30699258|NCT00520936|58713778|FG004|Overall Study|Death|0|||
30699259|NCT00520936|58713779|FG005|Overall Study|Death|0|||
30699260|NCT00520936|58713780|FG006|Overall Study|Death|1|||
30699261|NCT00520936|58713781|FG007|Overall Study|Death|0|||
30699262|NCT00520936|58713774|FG000|Overall Study|Protocol Violation|0|||
30699263|NCT00520936|58713775|FG001|Overall Study|Protocol Violation|1|||
31008691|NCT01474512|59210157|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
30613892|NCT00996892|58624809|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
30613893|NCT00996892|58624810|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
30699264|NCT00520936|58713776|FG002|Overall Study|Protocol Violation|1|||
30699265|NCT00520936|58713777|FG003|Overall Study|Protocol Violation|0|||
31008692|NCT01474512|59210158|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
31008693|NCT01474512|59210159|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
31008694|NCT01474512|59210160|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
30699266|NCT00520936|58713778|FG004|Overall Study|Protocol Violation|1|||
30613894|NCT00996892|58624811|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
30613895|NCT00996892|58624812|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
30613896|NCT00996892|58624813|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
30613897|NCT00996892|58624814|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
30613898|NCT00996892|58624815|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
30613899|NCT00996892|58624816|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
30613900|NCT00996892|58624817|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
30613901|NCT00996892|58624818|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
30613902|NCT00996892|58624819|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
30613903|NCT00996892|58624800|FG000|Expansion Stage 2A|Disease Progression|0|||
30613904|NCT00996892|58624801|FG001|Expansion Stage 2A|Disease Progression|0|||
30613905|NCT00996892|58624802|FG002|Expansion Stage 2A|Disease Progression|0|||
30613906|NCT00996892|58624803|FG003|Expansion Stage 2A|Disease Progression|0|||
30613907|NCT00996892|58624804|FG004|Expansion Stage 2A|Disease Progression|0|||
30613908|NCT00996892|58624805|FG005|Expansion Stage 2A|Disease Progression|0|||
30613909|NCT00996892|58624806|FG006|Expansion Stage 2A|Disease Progression|0|||
30613910|NCT00996892|58624807|FG007|Expansion Stage 2A|Disease Progression|0|||
30613911|NCT00996892|58624808|FG008|Expansion Stage 2A|Disease Progression|0|||
30613912|NCT00996892|58624809|FG009|Expansion Stage 2A|Disease Progression|0|||
30613913|NCT00996892|58624810|FG010|Expansion Stage 2A|Disease Progression|0|||
30613914|NCT00996892|58624811|FG011|Expansion Stage 2A|Disease Progression|0|||
30613915|NCT00996892|58624812|FG012|Expansion Stage 2A|Disease Progression|0|||
30613916|NCT00996892|58624813|FG013|Expansion Stage 2A|Disease Progression|0|||
30613917|NCT00996892|58624814|FG014|Expansion Stage 2A|Disease Progression|0|||
30613918|NCT00996892|58624815|FG015|Expansion Stage 2A|Disease Progression|0|||
30613919|NCT00996892|58624816|FG016|Expansion Stage 2A|Disease Progression|0|||
30613920|NCT00996892|58624817|FG017|Expansion Stage 2A|Disease Progression|0|||
30613921|NCT00996892|58624818|FG018|Expansion Stage 2A|Disease Progression|0|||
30613922|NCT00996892|58624819|FG019|Expansion Stage 2A|Disease Progression|31|||
30613923|NCT01257581|58624883|FG000|Overall Study|Early Termination|3|||
30613924|NCT01257581|58624884|FG001|Overall Study|Early Termination|1|||
30613925|NCT01257581|58624885|FG002|Overall Study|Early Termination|2|||
30613926|NCT01257581|58624883|FG000|Overall Study|Death|2|||
30613927|NCT01257581|58624884|FG001|Overall Study|Death|2|||
30613928|NCT01257581|58624885|FG002|Overall Study|Death|4|||
30613929|NCT01257503|58624895|FG000|Overall Study|Lost to Follow-up|7|||
30613930|NCT01257503|58624896|FG001|Overall Study|Lost to Follow-up|10|||
30613931|NCT01257503|58624895|FG000|Overall Study|Over 5 years old at enrollment|0|||
30613932|NCT01257503|58624896|FG001|Overall Study|Over 5 years old at enrollment|1|||
30613933|NCT01257503|58624895|FG000|Overall Study|strep culture positive at enrollment|1|||
30613934|NCT01257503|58624896|FG001|Overall Study|strep culture positive at enrollment|0|||
30613935|NCT00995566|58624902|FG000|Overall Study|Adverse Event|2|||
30613936|NCT00995566|58624902|FG000|Overall Study|Early study termination|52|||
30613937|NCT01257425|58624908|FG000|Overall Study|Lack of Efficacy|3|||
30613938|NCT01257425|58624909|FG001|Overall Study|Lack of Efficacy|3|||
30613939|NCT01257425|58624908|FG000|Overall Study|Adverse Event|1|||
30613940|NCT01257425|58624909|FG001|Overall Study|Adverse Event|1|||
30613941|NCT01257425|58624908|FG000|Overall Study|Protocol Violation|1|||
30613942|NCT01257425|58624909|FG001|Overall Study|Protocol Violation|1|||
30613943|NCT01257425|58624908|FG000|Overall Study|Withdrawal by Subject|0|||
30613944|NCT01257425|58624909|FG001|Overall Study|Withdrawal by Subject|1|||
30613945|NCT01257425|58624908|FG000|Overall Study|Death|1|||
30613946|NCT01257425|58624909|FG001|Overall Study|Death|0|||
30613947|NCT00995488|58624915|FG000|Overall Study|Withdrawal by Subject|1|||
30613948|NCT01256879|58624919|FG000|Overall Study|Withdrawal by Subject|1|||
30613949|NCT01125189|58624932|FG000|Treatment Period|Lack of Efficacy|15|||
30613950|NCT01125189|58624933|FG001|Treatment Period|Lack of Efficacy|18|||
30613951|NCT01125189|58624934|FG002|Treatment Period|Lack of Efficacy|25|||
30613952|NCT01125189|58624932|FG000|Treatment Period|Adverse Event|7|||
30613953|NCT01125189|58624933|FG001|Treatment Period|Adverse Event|8|||
30613954|NCT01125189|58624934|FG002|Treatment Period|Adverse Event|8|||
30613955|NCT01125189|58624932|FG000|Treatment Period|Withdrawal by Subject|3|||
30613956|NCT01125189|58624933|FG001|Treatment Period|Withdrawal by Subject|1|||
30613957|NCT01125189|58624934|FG002|Treatment Period|Withdrawal by Subject|1|||
30613958|NCT01125189|58624932|FG000|Treatment Period|Death|1|||
30613959|NCT01125189|58624933|FG001|Treatment Period|Death|0|||
30613960|NCT01125189|58624934|FG002|Treatment Period|Death|0|||
30613961|NCT01125189|58624932|FG000|Treatment Period|Lost to Follow-up|1|||
30613962|NCT01125189|58624933|FG001|Treatment Period|Lost to Follow-up|2|||
30613963|NCT01125189|58624934|FG002|Treatment Period|Lost to Follow-up|1|||
30613964|NCT01125189|58624932|FG000|Treatment Period|Poor compliance/noncompliance|0|||
30613965|NCT01125189|58624933|FG001|Treatment Period|Poor compliance/noncompliance|1|||
30613966|NCT01125189|58624934|FG002|Treatment Period|Poor compliance/noncompliance|0|||
30613967|NCT01125189|58624932|FG000|Treatment Period|Participants requested to discontinue|1|||
30613968|NCT01125189|58624933|FG001|Treatment Period|Participants requested to discontinue|3|||
30613969|NCT01125189|58624934|FG002|Treatment Period|Participants requested to discontinue|4|||
30613970|NCT01125189|58624932|FG000|Treatment Period|Other reasons|1|||
30613971|NCT01125189|58624933|FG001|Treatment Period|Other reasons|1|||
30613972|NCT01125189|58624934|FG002|Treatment Period|Other reasons|0|||
30613973|NCT01125189|58624932|FG000|Treatment Period|Completed 24 week treatment period only|2|||
30613974|NCT01125189|58624933|FG001|Treatment Period|Completed 24 week treatment period only|1|||
30613975|NCT01125189|58624934|FG002|Treatment Period|Completed 24 week treatment period only|2|||
30613976|NCT01125189|58624932|FG000|Follow up Period|Withdrawal by Subject|3|||
30613977|NCT01125189|58624933|FG001|Follow up Period|Withdrawal by Subject|2|||
30613978|NCT01125189|58624934|FG002|Follow up Period|Withdrawal by Subject|5|||
30613979|NCT01125189|58624932|FG000|Follow up Period|Death|1|||
30613980|NCT01125189|58624933|FG001|Follow up Period|Death|0|||
30613981|NCT01125189|58624934|FG002|Follow up Period|Death|0|||
30613982|NCT01125189|58624932|FG000|Follow up Period|Lost to Follow-up|12|||
30613983|NCT01125189|58624933|FG001|Follow up Period|Lost to Follow-up|9|||
30613984|NCT01125189|58624934|FG002|Follow up Period|Lost to Follow-up|6|||
30613985|NCT01125189|58624932|FG000|Follow up Period|Other reasons|4|||
30613986|NCT01125189|58624933|FG001|Follow up Period|Other reasons|4|||
30613987|NCT01125189|58624934|FG002|Follow up Period|Other reasons|5|||
30613988|NCT01256567|58624945|FG000|Overall Study|Withdrawal by Subject|1|||
30613989|NCT00996736|58624952|FG000|Overall Study|Death|1|||
30613990|NCT00996736|58624953|FG001|Overall Study|Death|1|||
30613991|NCT00996736|58624952|FG000|Overall Study|Lost to Follow-up|15|||
30613992|NCT00996736|58624953|FG001|Overall Study|Lost to Follow-up|14|||
30613993|NCT00996736|58624952|FG000|Overall Study|Visit not within 3-month window|5|||
30613994|NCT00996736|58624953|FG001|Overall Study|Visit not within 3-month window|3|||
30613995|NCT00996658|58624961|FG000|Overall Study|Adverse Event|2|||
30613996|NCT00996658|58624962|FG001|Overall Study|Adverse Event|5|||
30613997|NCT00996658|58624961|FG000|Overall Study|Protocol Violation|0|||
30613998|NCT00996658|58624962|FG001|Overall Study|Protocol Violation|1|||
30613999|NCT00996658|58624961|FG000|Overall Study|Lost to Follow-up|2|||
30614000|NCT00996658|58624962|FG001|Overall Study|Lost to Follow-up|5|||
30614001|NCT00996658|58624961|FG000|Overall Study|Non-compliance issues|3|||
30614002|NCT00996658|58624962|FG001|Overall Study|Non-compliance issues|3|||
30614003|NCT00996658|58624961|FG000|Overall Study|Other|9|||
30614004|NCT00996658|58624962|FG001|Overall Study|Other|7|||
30614005|NCT01124643|58624968|FG000|Overall Study|Death|1|||
30614006|NCT01256411|58624976|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
30614007|NCT01256411|58624977|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
30614008|NCT01256411|58624978|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
30614009|NCT01256411|58624979|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
30614010|NCT01256411|58624980|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
30614011|NCT01256411|58624981|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
30614012|NCT01256411|58624976|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
30614013|NCT01256411|58624977|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
30614014|NCT01256411|58624978|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
30614015|NCT01256411|58624979|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
30614016|NCT01256411|58624980|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
30614017|NCT01256411|58624981|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
30614018|NCT01256411|58624976|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
30614019|NCT01256411|58624977|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
30614020|NCT01256411|58624978|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
30614021|NCT01256411|58624979|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
30614022|NCT01256411|58624980|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
30614023|NCT01256411|58624981|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
30614024|NCT01256411|58624976|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
30614025|NCT01256411|58624977|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
30614026|NCT01256411|58624978|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
30614027|NCT01256411|58624979|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
30614028|NCT01256411|58624980|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
31008695|NCT01474512|59210161|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
30614029|NCT01256411|58624981|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
30614030|NCT01256411|58624976|FG000|Extension by Maximum Treatment|Adverse Event|4|||
31008696|NCT01474512|59210162|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
31008697|NCT01474512|59210163|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
31008698|NCT01474512|59210164|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
31008699|NCT01474512|59210165|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
31008700|NCT01474512|59210148|FG000|Long-Term Extension Period|Physician Decision|0|||
31008701|NCT01474512|59210149|FG001|Long-Term Extension Period|Physician Decision|0|||
31008702|NCT01474512|59210150|FG002|Long-Term Extension Period|Physician Decision|0|||
31008703|NCT01474512|59210151|FG003|Long-Term Extension Period|Physician Decision|0|||
31008704|NCT01474512|59210152|FG004|Long-Term Extension Period|Physician Decision|0|||
31008705|NCT01474512|59210153|FG005|Long-Term Extension Period|Physician Decision|0|||
31008706|NCT01474512|59210154|FG006|Long-Term Extension Period|Physician Decision|0|||
31008707|NCT01474512|59210155|FG007|Long-Term Extension Period|Physician Decision|0|||
31008708|NCT01474512|59210156|FG008|Long-Term Extension Period|Physician Decision|0|||
31008709|NCT01474512|59210157|FG009|Long-Term Extension Period|Physician Decision|0|||
31008710|NCT01474512|59210158|FG010|Long-Term Extension Period|Physician Decision|0|||
31008711|NCT01474512|59210159|FG011|Long-Term Extension Period|Physician Decision|0|||
31008712|NCT01474512|59210160|FG012|Long-Term Extension Period|Physician Decision|21|||
31008713|NCT01474512|59210161|FG013|Long-Term Extension Period|Physician Decision|21|||
31008714|NCT01474512|59210162|FG014|Long-Term Extension Period|Physician Decision|0|||
31008715|NCT01474512|59210163|FG015|Long-Term Extension Period|Physician Decision|0|||
31008716|NCT01474512|59210164|FG016|Long-Term Extension Period|Physician Decision|0|||
31008717|NCT01474512|59210165|FG017|Long-Term Extension Period|Physician Decision|0|||
31008718|NCT01474512|59210148|FG000|Long-Term Extension Period|Clinical Relapse|0|||
31008719|NCT01474512|59210149|FG001|Long-Term Extension Period|Clinical Relapse|0|||
31008720|NCT01474512|59210150|FG002|Long-Term Extension Period|Clinical Relapse|0|||
31008721|NCT01474512|59210151|FG003|Long-Term Extension Period|Clinical Relapse|0|||
31008722|NCT01474512|59210152|FG004|Long-Term Extension Period|Clinical Relapse|0|||
31008723|NCT01474512|59210153|FG005|Long-Term Extension Period|Clinical Relapse|0|||
31008724|NCT01474512|59210154|FG006|Long-Term Extension Period|Clinical Relapse|0|||
31008725|NCT01474512|59210155|FG007|Long-Term Extension Period|Clinical Relapse|0|||
31008726|NCT01474512|59210156|FG008|Long-Term Extension Period|Clinical Relapse|0|||
31008727|NCT01474512|59210157|FG009|Long-Term Extension Period|Clinical Relapse|0|||
31008728|NCT01474512|59210158|FG010|Long-Term Extension Period|Clinical Relapse|0|||
31008729|NCT01474512|59210159|FG011|Long-Term Extension Period|Clinical Relapse|0|||
31008730|NCT01474512|59210160|FG012|Long-Term Extension Period|Clinical Relapse|9|||
31008731|NCT01474512|59210161|FG013|Long-Term Extension Period|Clinical Relapse|9|||
31008732|NCT01474512|59210162|FG014|Long-Term Extension Period|Clinical Relapse|0|||
31008733|NCT01474512|59210163|FG015|Long-Term Extension Period|Clinical Relapse|0|||
31008734|NCT01474512|59210164|FG016|Long-Term Extension Period|Clinical Relapse|0|||
31008735|NCT01474512|59210165|FG017|Long-Term Extension Period|Clinical Relapse|0|||
31008736|NCT01474512|59210148|FG000|Long-Term Extension Period|Death|0|||
31008737|NCT01474512|59210149|FG001|Long-Term Extension Period|Death|0|||
31008738|NCT01474512|59210150|FG002|Long-Term Extension Period|Death|0|||
31008739|NCT01474512|59210151|FG003|Long-Term Extension Period|Death|0|||
31008740|NCT01474512|59210152|FG004|Long-Term Extension Period|Death|0|||
31008741|NCT01474512|59210153|FG005|Long-Term Extension Period|Death|0|||
31008742|NCT01474512|59210154|FG006|Long-Term Extension Period|Death|0|||
31008743|NCT01474512|59210155|FG007|Long-Term Extension Period|Death|0|||
31008744|NCT01474512|59210156|FG008|Long-Term Extension Period|Death|0|||
31008745|NCT01474512|59210157|FG009|Long-Term Extension Period|Death|0|||
31008746|NCT01474512|59210158|FG010|Long-Term Extension Period|Death|0|||
31008747|NCT01474512|59210159|FG011|Long-Term Extension Period|Death|0|||
31008748|NCT01474512|59210160|FG012|Long-Term Extension Period|Death|9|||
31008749|NCT01474512|59210161|FG013|Long-Term Extension Period|Death|9|||
31008750|NCT01474512|59210162|FG014|Long-Term Extension Period|Death|0|||
31008751|NCT01474512|59210163|FG015|Long-Term Extension Period|Death|0|||
31008752|NCT01474512|59210164|FG016|Long-Term Extension Period|Death|0|||
31008753|NCT01474512|59210165|FG017|Long-Term Extension Period|Death|0|||
31008754|NCT01474512|59210148|FG000|Long-Term Extension Period|Sponsor Decision|0|||
31008755|NCT01474512|59210149|FG001|Long-Term Extension Period|Sponsor Decision|0|||
31008756|NCT01474512|59210150|FG002|Long-Term Extension Period|Sponsor Decision|0|||
31008757|NCT01474512|59210151|FG003|Long-Term Extension Period|Sponsor Decision|0|||
31008758|NCT01474512|59210152|FG004|Long-Term Extension Period|Sponsor Decision|0|||
31008759|NCT01474512|59210153|FG005|Long-Term Extension Period|Sponsor Decision|0|||
30614031|NCT01256411|58624977|FG001|Extension by Maximum Treatment|Adverse Event|2|||
31008760|NCT01474512|59210154|FG006|Long-Term Extension Period|Sponsor Decision|0|||
31008761|NCT01474512|59210155|FG007|Long-Term Extension Period|Sponsor Decision|0|||
31008762|NCT01474512|59210156|FG008|Long-Term Extension Period|Sponsor Decision|0|||
31008763|NCT01474512|59210157|FG009|Long-Term Extension Period|Sponsor Decision|0|||
31008764|NCT01474512|59210158|FG010|Long-Term Extension Period|Sponsor Decision|0|||
30614032|NCT01256411|58624978|FG002|Extension by Maximum Treatment|Adverse Event|1|||
30614033|NCT01256411|58624979|FG003|Extension by Maximum Treatment|Adverse Event|0|||
30614034|NCT01256411|58624980|FG004|Extension by Maximum Treatment|Adverse Event|0|||
31008765|NCT01474512|59210159|FG011|Long-Term Extension Period|Sponsor Decision|0|||
31008766|NCT01474512|59210160|FG012|Long-Term Extension Period|Sponsor Decision|6|||
31008767|NCT01474512|59210161|FG013|Long-Term Extension Period|Sponsor Decision|6|||
31008768|NCT01474512|59210162|FG014|Long-Term Extension Period|Sponsor Decision|0|||
31008769|NCT01474512|59210163|FG015|Long-Term Extension Period|Sponsor Decision|0|||
31008770|NCT01474512|59210164|FG016|Long-Term Extension Period|Sponsor Decision|0|||
30614035|NCT01256411|58624981|FG005|Extension by Maximum Treatment|Adverse Event|0|||
30614036|NCT01256411|58624976|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
30614037|NCT01256411|58624977|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
30614038|NCT01256411|58624978|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
30614039|NCT01256411|58624979|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
30614040|NCT01256411|58624980|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
30614041|NCT01256411|58624981|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
30614042|NCT01256411|58624976|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
30614043|NCT01256411|58624977|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
30614044|NCT01256411|58624978|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
30614045|NCT01256411|58624979|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
30614046|NCT01256411|58624980|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
30614047|NCT01256411|58624981|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
30614048|NCT01256411|58624976|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
30614049|NCT01256411|58624977|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
30614050|NCT01256411|58624978|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
30614051|NCT01256411|58624979|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
30614052|NCT01256411|58624980|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
30614053|NCT01256411|58624981|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
30614054|NCT01256411|58624976|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
30614055|NCT01256411|58624977|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
30614056|NCT01256411|58624978|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
30614057|NCT01256411|58624979|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
30614058|NCT01256411|58624980|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
30614059|NCT01256411|58624981|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
30614060|NCT01256411|58624976|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
30614061|NCT01256411|58624977|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
30614062|NCT01256411|58624978|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
30614063|NCT01256411|58624979|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
30614064|NCT01256411|58624980|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
30614065|NCT01256411|58624981|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
30614066|NCT00996580|58624995|FG000|Overall Study|Adverse Event|466|||
30614067|NCT00996580|58624995|FG000|Overall Study|Lost to Follow-up|480|||
30614068|NCT00996580|58624995|FG000|Overall Study|Noncompliance with the protocol|137|||
30614069|NCT00996580|58624995|FG000|Overall Study|Physician Decision|5|||
30614070|NCT00996580|58624995|FG000|Overall Study|Pregnancy|68|||
30614071|NCT00996580|58624995|FG000|Overall Study|Protocol Violation|16|||
30614072|NCT00996580|58624995|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
30614073|NCT00996580|58624995|FG000|Overall Study|Withdrawal by Subject|217|||
30614074|NCT00996580|58624995|FG000|Overall Study|Other|29|||
31008771|NCT01474512|59210165|FG017|Long-Term Extension Period|Sponsor Decision|0|||
31008772|NCT01474512|59210148|FG000|Long-Term Extension Period|Protocol Violation|0|||
30614075|NCT01124175|58625004|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
30614076|NCT01124175|58625005|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
30614077|NCT01256177|58625013|FG000|Overall Study|Withdrawal by Subject|23|||
30614078|NCT01256177|58625014|FG001|Overall Study|Withdrawal by Subject|22|||
30614079|NCT01256177|58625013|FG000|Overall Study|Lost to Follow-up|2|||
30614080|NCT01256177|58625014|FG001|Overall Study|Lost to Follow-up|2|||
30614081|NCT01256177|58625013|FG000|Overall Study|Adverse Event|8|||
30614082|NCT01256177|58625014|FG001|Overall Study|Adverse Event|9|||
30614083|NCT01256177|58625013|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
30614084|NCT01256177|58625014|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
30614085|NCT01256177|58625013|FG000|Overall Study|Condition under Investigation Worsened|1|||
30614086|NCT01256177|58625014|FG001|Overall Study|Condition under Investigation Worsened|0|||
30614087|NCT01256177|58625013|FG000|Overall Study|Lack of Efficacy|11|||
30614088|NCT01256177|58625014|FG001|Overall Study|Lack of Efficacy|2|||
30614089|NCT01256177|58625013|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
30614090|NCT01256177|58625014|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
30614091|NCT00999544|58625020|FG000|Overall Study|Withdrawal by Subject|1|||
30614092|NCT01124097|58625057|FG000|Overall Study|Withdrawal by Subject|4|||
30614093|NCT01124097|58625058|FG001|Overall Study|Withdrawal by Subject|3|||
30614094|NCT01124097|58625059|FG002|Overall Study|Withdrawal by Subject|2|||
30614095|NCT01124097|58625060|FG003|Overall Study|Withdrawal by Subject|3|||
30614096|NCT01124097|58625057|FG000|Overall Study|Lack of Efficacy|2|||
30614097|NCT01124097|58625058|FG001|Overall Study|Lack of Efficacy|3|||
30614098|NCT01124097|58625059|FG002|Overall Study|Lack of Efficacy|1|||
30614099|NCT01124097|58625060|FG003|Overall Study|Lack of Efficacy|3|||
30614100|NCT01124097|58625057|FG000|Overall Study|Adverse Event|24|||
30614101|NCT01124097|58625058|FG001|Overall Study|Adverse Event|15|||
30614102|NCT01124097|58625059|FG002|Overall Study|Adverse Event|15|||
30614103|NCT01124097|58625060|FG003|Overall Study|Adverse Event|7|||
30614104|NCT01124097|58625057|FG000|Overall Study|Protocol Violation|2|||
30614105|NCT01124097|58625058|FG001|Overall Study|Protocol Violation|0|||
30614106|NCT01124097|58625059|FG002|Overall Study|Protocol Violation|2|||
30614107|NCT01124097|58625060|FG003|Overall Study|Protocol Violation|1|||
30614108|NCT01124097|58625057|FG000|Overall Study|Physician Decision|2|||
30614109|NCT01124097|58625058|FG001|Overall Study|Physician Decision|1|||
30614110|NCT01124097|58625059|FG002|Overall Study|Physician Decision|0|||
30614111|NCT01124097|58625060|FG003|Overall Study|Physician Decision|0|||
30614112|NCT01123941|58625072|FG000|Overall Study|Lost to Follow-up|2|||
30614113|NCT01123941|58625073|FG001|Overall Study|Lost to Follow-up|1|||
30614114|NCT01123395|58625079|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
30614115|NCT01123395|58625080|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
30614116|NCT01255787|58625090|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
30614117|NCT01255787|58625091|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
30614118|NCT01255787|58625092|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
30614119|NCT01255787|58625093|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
30614120|NCT01255787|58625090|FG000|Overall Study|Major Protocol Deviation|1|||
30614121|NCT01255787|58625091|FG001|Overall Study|Major Protocol Deviation|1|||
30614122|NCT01255787|58625092|FG002|Overall Study|Major Protocol Deviation|0|||
30614123|NCT01255787|58625093|FG003|Overall Study|Major Protocol Deviation|4|||
30614124|NCT01255787|58625090|FG000|Overall Study|Lost to Follow-up|1|||
30614125|NCT01255787|58625091|FG001|Overall Study|Lost to Follow-up|2|||
30614126|NCT01255787|58625092|FG002|Overall Study|Lost to Follow-up|4|||
30614127|NCT01255787|58625093|FG003|Overall Study|Lost to Follow-up|2|||
30614128|NCT01255787|58625090|FG000|Overall Study|Withdrawal of Consent|3|||
30614129|NCT01255787|58625091|FG001|Overall Study|Withdrawal of Consent|9|||
30614130|NCT01255787|58625092|FG002|Overall Study|Withdrawal of Consent|3|||
30614131|NCT01255787|58625093|FG003|Overall Study|Withdrawal of Consent|4|||
30614132|NCT01255787|58625090|FG000|Overall Study|Pregnancy|0|||
30614133|NCT01255787|58625091|FG001|Overall Study|Pregnancy|0|||
30614134|NCT01255787|58625092|FG002|Overall Study|Pregnancy|0|||
30614135|NCT01255787|58625093|FG003|Overall Study|Pregnancy|1|||
30614136|NCT01255787|58625090|FG000|Overall Study|Lack of Efficacy|2|||
30614137|NCT01255787|58625091|FG001|Overall Study|Lack of Efficacy|2|||
30614138|NCT01255787|58625092|FG002|Overall Study|Lack of Efficacy|2|||
30614139|NCT01255787|58625093|FG003|Overall Study|Lack of Efficacy|2|||
30614140|NCT01255787|58625090|FG000|Overall Study|Noncompliance with Study Drug|3|||
30614141|NCT01255787|58625091|FG001|Overall Study|Noncompliance with Study Drug|1|||
30614142|NCT01255787|58625092|FG002|Overall Study|Noncompliance with Study Drug|0|||
30614143|NCT01255787|58625093|FG003|Overall Study|Noncompliance with Study Drug|0|||
30614144|NCT01123161|58625105|FG000|Overall Study|Lost to Follow-up|1|||
30614145|NCT01123161|58625106|FG001|Overall Study|Lost to Follow-up|0|||
30614146|NCT01123161|58625105|FG000|Overall Study|Withdrawal by Subject|1|||
30614147|NCT01123161|58625106|FG001|Overall Study|Withdrawal by Subject|0|||
30614148|NCT01255631|58625117|FG000|Overall Study|poor enrollment, no data analyzed|9|||
30614149|NCT01255631|58625118|FG001|Overall Study|poor enrollment, no data analyzed|6|||
30614150|NCT00999466|58625127|FG000|Main Part|Withdrawal by Subject|0|||
30614151|NCT00999466|58625128|FG001|Main Part|Withdrawal by Subject|0|||
30614152|NCT00999466|58625129|FG002|Main Part|Withdrawal by Subject|2|||
30614153|NCT00999466|58625127|FG000|Main Part|Adverse Event|0|||
30614154|NCT00999466|58625128|FG001|Main Part|Adverse Event|4|||
30614155|NCT00999466|58625129|FG002|Main Part|Adverse Event|2|||
30614156|NCT01255163|58625139|FG000|Overall Study|Withdrawal by Subject|1|||
30614157|NCT01255163|58625140|FG001|Overall Study|Withdrawal by Subject|0|||
30614158|NCT01255163|58625139|FG000|Overall Study|Lost to Follow-up|2|||
30614159|NCT01255163|58625140|FG001|Overall Study|Lost to Follow-up|0|||
30614160|NCT01255163|58625139|FG000|Overall Study|Adverse Event|0|||
30614161|NCT01255163|58625140|FG001|Overall Study|Adverse Event|2|||
30614162|NCT01255163|58625139|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
30614163|NCT01255163|58625140|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
30614164|NCT01123083|58625150|FG000|Overall Study|Investigator recommendation|1|||
30614165|NCT01123083|58625151|FG001|Overall Study|Investigator recommendation|1|||
30614166|NCT01123083|58625150|FG000|Overall Study|Administrative reasons|0|||
30614167|NCT01123083|58625151|FG001|Overall Study|Administrative reasons|4|||
30614168|NCT01123083|58625150|FG000|Overall Study|Lost to Follow-up|2|||
30614169|NCT01123083|58625151|FG001|Overall Study|Lost to Follow-up|6|||
30614170|NCT01123083|58625150|FG000|Overall Study|Adverse Event|1|||
30614171|NCT01123083|58625151|FG001|Overall Study|Adverse Event|0|||
30614172|NCT01123083|58625150|FG000|Overall Study|Withdrew for another reason not covered|0|||
30614173|NCT01123083|58625151|FG001|Overall Study|Withdrew for another reason not covered|1|||
30614174|NCT01123083|58625150|FG000|Overall Study|Participant/legal representative request|7|||
30614175|NCT01123083|58625151|FG001|Overall Study|Participant/legal representative request|3|||
30614176|NCT01254305|58625160|FG000|Overall Study|Adverse Event|6|||
30614177|NCT01254305|58625161|FG001|Overall Study|Adverse Event|3|||
30614178|NCT01254305|58625162|FG002|Overall Study|Adverse Event|2|||
30614179|NCT01254305|58625160|FG000|Overall Study|Lack of Efficacy|1|||
30614180|NCT01254305|58625161|FG001|Overall Study|Lack of Efficacy|0|||
30614181|NCT01254305|58625162|FG002|Overall Study|Lack of Efficacy|1|||
30614182|NCT01254305|58625160|FG000|Overall Study|Protocol Violation|1|||
30614183|NCT01254305|58625161|FG001|Overall Study|Protocol Violation|7|||
30614184|NCT01254305|58625162|FG002|Overall Study|Protocol Violation|3|||
30614185|NCT01254305|58625160|FG000|Overall Study|Withdrawal by Subject|4|||
30614186|NCT01254305|58625161|FG001|Overall Study|Withdrawal by Subject|2|||
30614187|NCT01254305|58625162|FG002|Overall Study|Withdrawal by Subject|4|||
30614188|NCT01254305|58625160|FG000|Overall Study|Lost to Follow-up|10|||
30614189|NCT01254305|58625161|FG001|Overall Study|Lost to Follow-up|6|||
30614190|NCT01254305|58625162|FG002|Overall Study|Lost to Follow-up|5|||
30614191|NCT01254305|58625160|FG000|Overall Study|Other Reasons|0|||
30614192|NCT01254305|58625161|FG001|Overall Study|Other Reasons|0|||
30614193|NCT01254305|58625162|FG002|Overall Study|Other Reasons|2|||
30614194|NCT01122927|58625173|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
30614195|NCT01122927|58625174|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
30614196|NCT01122927|58625173|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
30614197|NCT01122927|58625174|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
30614198|NCT01122927|58625173|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
30614199|NCT01122927|58625174|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
30614200|NCT01122927|58625173|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
30614201|NCT01122927|58625174|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
30614202|NCT01122927|58625173|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
30614203|NCT01122927|58625174|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
30614204|NCT01122927|58625173|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
30614205|NCT01122927|58625174|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
30614206|NCT01122927|58625173|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
30614207|NCT01122927|58625174|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
30614208|NCT01122927|58625173|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
30614209|NCT01122927|58625174|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
30614210|NCT01122927|58625173|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
30614211|NCT01122927|58625174|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
30614212|NCT01122927|58625173|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
30614213|NCT01122927|58625174|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
30614214|NCT01122927|58625173|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
30614215|NCT01122927|58625174|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
30614216|NCT01122927|58625173|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
30614217|NCT01122927|58625174|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
30614218|NCT01254227|58625184|FG000|Overall Study|Withdrawal by Subject|6|||
30614219|NCT01254227|58625184|FG000|Overall Study|Lost to Follow-up|6|||
30614220|NCT01254227|58625184|FG000|Overall Study|Adverse Event|5|||
30614221|NCT01254227|58625184|FG000|Overall Study|Abnormal test procedure result|5|||
30614222|NCT01254227|58625184|FG000|Overall Study|Administrative problems|2|||
30614223|NCT01254227|58625184|FG000|Overall Study|Death|1|||
30614224|NCT01254227|58625184|FG000|Overall Study|Protocol deviation|1|||
30614225|NCT00995410|58625188|FG000|Overall Study|Adverse Event|51|||
30614226|NCT00995410|58625188|FG000|Overall Study|Withdrawal by Subject|7|||
30614227|NCT00995410|58625188|FG000|Overall Study|Lost to Follow-up|2|||
31008773|NCT01474512|59210149|FG001|Long-Term Extension Period|Protocol Violation|0|||
30614228|NCT00995410|58625188|FG000|Overall Study|Misc|28|||
30614229|NCT00995020|58625194|FG000|Overall Study|margin analysis not performed|2|||
30614230|NCT00995020|58625195|FG001|Overall Study|margin analysis not performed|5|||
30614231|NCT00995020|58625194|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
30614232|NCT00995020|58625195|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
30614233|NCT01122381|58625205|FG000|Overall Study|study terminated early|0|||
30614234|NCT01122381|58625206|FG001|Overall Study|study terminated early|1|||
30614235|NCT00996034|58625212|FG000|Overall Study|Lost to Follow-up|2|||
30614236|NCT00996034|58625212|FG000|Overall Study|withdrawn by PI|1|||
30614237|NCT01253447|58625216|FG000|Overall Study|Adverse Event|2|||
30614238|NCT01121991|58625221|FG000|Overall Study|Lack of Ovarian Response|2|||
30614239|NCT01121991|58625221|FG000|Overall Study|No Oocytes Retrieved|3|||
30614240|NCT01121991|58625221|FG000|Overall Study|No Fertilization|1|||
30614241|NCT00994240|58625227|FG000|Overall Study|Lost to Follow-up|3|||
30614242|NCT00994240|58625228|FG001|Overall Study|Lost to Follow-up|2|||
31008774|NCT01474512|59210150|FG002|Long-Term Extension Period|Protocol Violation|0|||
31008775|NCT01474512|59210151|FG003|Long-Term Extension Period|Protocol Violation|0|||
31008776|NCT01474512|59210152|FG004|Long-Term Extension Period|Protocol Violation|0|||
31008777|NCT01474512|59210153|FG005|Long-Term Extension Period|Protocol Violation|0|||
31008778|NCT01474512|59210154|FG006|Long-Term Extension Period|Protocol Violation|0|||
31008779|NCT01474512|59210155|FG007|Long-Term Extension Period|Protocol Violation|0|||
31008780|NCT01474512|59210156|FG008|Long-Term Extension Period|Protocol Violation|0|||
31008781|NCT01474512|59210157|FG009|Long-Term Extension Period|Protocol Violation|0|||
31008782|NCT01474512|59210158|FG010|Long-Term Extension Period|Protocol Violation|0|||
31008783|NCT01474512|59210159|FG011|Long-Term Extension Period|Protocol Violation|0|||
31008784|NCT01474512|59210160|FG012|Long-Term Extension Period|Protocol Violation|5|||
31008785|NCT01474512|59210161|FG013|Long-Term Extension Period|Protocol Violation|5|||
31008786|NCT01474512|59210162|FG014|Long-Term Extension Period|Protocol Violation|0|||
31008787|NCT01474512|59210163|FG015|Long-Term Extension Period|Protocol Violation|0|||
31008788|NCT01474512|59210164|FG016|Long-Term Extension Period|Protocol Violation|0|||
31008789|NCT01474512|59210165|FG017|Long-Term Extension Period|Protocol Violation|0|||
31008790|NCT01474512|59210148|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008791|NCT01474512|59210149|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008792|NCT01474512|59210150|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008793|NCT01474512|59210151|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008794|NCT01474512|59210152|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008795|NCT01474512|59210153|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008796|NCT01474512|59210154|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008797|NCT01474512|59210155|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008798|NCT01474512|59210156|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008799|NCT01474512|59210157|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008800|NCT01474512|59210158|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008801|NCT01474512|59210159|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008802|NCT01474512|59210160|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
31008803|NCT01474512|59210161|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
31008804|NCT01474512|59210162|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008805|NCT01474512|59210163|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008806|NCT01474512|59210164|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008807|NCT01474512|59210165|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
31008808|NCT01474512|59210148|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008809|NCT01474512|59210149|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008810|NCT01474512|59210150|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008811|NCT01474512|59210151|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008812|NCT01474512|59210152|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008813|NCT01474512|59210153|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008814|NCT01474512|59210154|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008815|NCT01474512|59210155|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008816|NCT01474512|59210156|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
30614243|NCT00994240|58625227|FG000|Overall Study|Withdrawal by Subject|1|||
30614244|NCT00994240|58625228|FG001|Overall Study|Withdrawal by Subject|0|||
30614245|NCT00994240|58625227|FG000|Overall Study|study termination|2|||
30614246|NCT00994240|58625228|FG001|Overall Study|study termination|3|||
30614247|NCT01253369|58625234|FG000|Overall Study|Adverse Event|4|||
30614248|NCT01253369|58625234|FG000|Overall Study|Withdrawal by Subject|2|||
30614249|NCT01253369|58625234|FG000|Overall Study|Death|1|||
30614250|NCT01253369|58625234|FG000|Overall Study|Progressive disease|23|||
30614251|NCT01253369|58625234|FG000|Overall Study|Not Evaluable|3|||
30614252|NCT01121913|58625238|FG000|First Intervention Period|Adverse Event|0|||
30614253|NCT01121913|58625239|FG001|First Intervention Period|Adverse Event|0|||
30614254|NCT01121913|58625240|FG002|First Intervention Period|Adverse Event|1|||
31008817|NCT01474512|59210157|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
30699267|NCT00520936|58713779|FG005|Overall Study|Protocol Violation|0|||
30699268|NCT00520936|58713780|FG006|Overall Study|Protocol Violation|1|||
30699269|NCT00520936|58713781|FG007|Overall Study|Protocol Violation|0|||
30699270|NCT03867760|58713794|FG000|Overall Study|Lost to Follow-up|2|||
30699271|NCT03867760|58713795|FG001|Overall Study|Lost to Follow-up|3|||
30614255|NCT01121913|58625241|FG003|First Intervention Period|Adverse Event|0|||
30614256|NCT01121913|58625238|FG000|First Washout Period|Withdrawal by Subject|1|||
30614257|NCT01121913|58625239|FG001|First Washout Period|Withdrawal by Subject|0|||
30614258|NCT01121913|58625240|FG002|First Washout Period|Withdrawal by Subject|0|||
30614259|NCT01121913|58625241|FG003|First Washout Period|Withdrawal by Subject|0|||
30614260|NCT01121913|58625238|FG000|Second Intervention Period|Adverse Event|0|||
30614261|NCT01121913|58625239|FG001|Second Intervention Period|Adverse Event|0|||
30614262|NCT01121913|58625240|FG002|Second Intervention Period|Adverse Event|1|||
30614263|NCT01121913|58625241|FG003|Second Intervention Period|Adverse Event|0|||
30614264|NCT01121913|58625238|FG000|Second Washout Period|Withdrawal by Subject|0|||
30614265|NCT01121913|58625239|FG001|Second Washout Period|Withdrawal by Subject|0|||
30614266|NCT01121913|58625240|FG002|Second Washout Period|Withdrawal by Subject|1|||
30614267|NCT01121913|58625241|FG003|Second Washout Period|Withdrawal by Subject|0|||
30699272|NCT03867760|58713794|FG000|Overall Study|Withdrawal by Subject|1|||
30699273|NCT03867760|58713795|FG001|Overall Study|Withdrawal by Subject|2|||
30699274|NCT03867760|58713794|FG000|Overall Study|subject could not meet study logistics|3|||
31008818|NCT01474512|59210158|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008819|NCT01474512|59210159|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
31008820|NCT01474512|59210160|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008821|NCT01474512|59210161|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008822|NCT01474512|59210162|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
30614268|NCT01121913|58625238|FG000|Third Washout Period|Adverse Event|1|||
30699275|NCT03867760|58713795|FG001|Overall Study|subject could not meet study logistics|3|||
30614269|NCT01121913|58625239|FG001|Third Washout Period|Adverse Event|0|||
30614270|NCT01121913|58625240|FG002|Third Washout Period|Adverse Event|0|||
30614271|NCT01121913|58625241|FG003|Third Washout Period|Adverse Event|0|||
30614272|NCT00994162|58625253|FG000|Overall Study|Withdrawal by Subject|1|||
30614273|NCT00994162|58625253|FG000|Overall Study|Lost to Follow-up|2|||
30614274|NCT00994162|58625253|FG000|Overall Study|Product Complaint|1|||
30614275|NCT00994162|58625253|FG000|Overall Study|Poor Compliance|5|||
30614276|NCT00994162|58625253|FG000|Overall Study|Lack of Response|3|||
30614277|NCT00994162|58625253|FG000|Overall Study|Discharged from Hospital|4|||
30614278|NCT00994162|58625253|FG000|Overall Study|Death|2|||
30614279|NCT00994162|58625253|FG000|Overall Study|Care Transferred to Another Physician|2|||
30614280|NCT00994162|58625253|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
30614281|NCT00994162|58625253|FG000|Overall Study|Physician Decision|2|||
30614282|NCT00994162|58625253|FG000|Overall Study|Surrounding Wound Erythematous|1|||
30614283|NCT00994162|58625253|FG000|Overall Study|Machine Losing Vaccum|1|||
30614284|NCT00994162|58625253|FG000|Overall Study|Patient Lived Too Far Away|1|||
30614285|NCT00994162|58625253|FG000|Overall Study|Above Knee Amputation|1|||
30614286|NCT00994162|58625253|FG000|Overall Study|Reason Not Reported By Site|1|||
30614287|NCT00993928|58625260|FG000|Overall Study|Withdrawal by Subject|4|||
30614288|NCT00993928|58625261|FG001|Overall Study|Withdrawal by Subject|7|||
30614289|NCT00993928|58625260|FG000|Overall Study|ineligible|1|||
30614290|NCT00993928|58625261|FG001|Overall Study|ineligible|0|||
30614291|NCT01253291|58625276|FG000|Overall Study|Withdrawal by Subject|1|||
30614292|NCT01253291|58625277|FG001|Overall Study|Withdrawal by Subject|1|||
30614293|NCT01253291|58625278|FG002|Overall Study|Withdrawal by Subject|0|||
30614294|NCT01253291|58625279|FG003|Overall Study|Withdrawal by Subject|0|||
30614295|NCT01253291|58625280|FG004|Overall Study|Withdrawal by Subject|0|||
30614296|NCT01253291|58625276|FG000|Overall Study|Adverse Event|0|||
30614297|NCT01253291|58625277|FG001|Overall Study|Adverse Event|1|||
30614298|NCT01253291|58625278|FG002|Overall Study|Adverse Event|0|||
30614299|NCT01253291|58625279|FG003|Overall Study|Adverse Event|0|||
30614300|NCT01253291|58625280|FG004|Overall Study|Adverse Event|0|||
30614301|NCT01253291|58625276|FG000|Overall Study|Lack of Efficacy|1|||
30614302|NCT01253291|58625277|FG001|Overall Study|Lack of Efficacy|0|||
30614303|NCT01253291|58625278|FG002|Overall Study|Lack of Efficacy|0|||
30614304|NCT01253291|58625279|FG003|Overall Study|Lack of Efficacy|0|||
30614305|NCT01253291|58625280|FG004|Overall Study|Lack of Efficacy|0|||
30614306|NCT01253291|58625276|FG000|Overall Study|Physician Decision|2|||
30614307|NCT01253291|58625277|FG001|Overall Study|Physician Decision|0|||
30614308|NCT01253291|58625278|FG002|Overall Study|Physician Decision|0|||
30614309|NCT01253291|58625279|FG003|Overall Study|Physician Decision|0|||
30614310|NCT01253291|58625280|FG004|Overall Study|Physician Decision|2|||
30614311|NCT01121757|58625295|FG000|First Drug|Death|1|||
30614312|NCT01121757|58625296|FG001|First Drug|Death|0|||
30614313|NCT01121757|58625295|FG000|First Drug|Disease Progression|0|||
30614314|NCT01121757|58625296|FG001|First Drug|Disease Progression|2|||
30614315|NCT01121757|58625295|FG000|Combination|Physician Decision|0|||
30614316|NCT01121757|58625296|FG001|Combination|Physician Decision|1|||
30614317|NCT01121757|58625295|FG000|Combination|Disease Progression|2|||
30614318|NCT01121757|58625296|FG001|Combination|Disease Progression|0|||
30614319|NCT01253135|58625304|FG000|Original Protocol|Protocol Amendment|15|||
30614320|NCT01253135|58625304|FG000|Amended Protocol|Non-compliance|1|||
30614321|NCT00993616|58625312|FG000|Overall Study|No tumor at entry|1|||
30614322|NCT00993616|58625312|FG000|Overall Study|Never treated|1|||
30614323|NCT01120899|58625322|FG000|Overall Study|Withdrawal by Subject|3|||
30614324|NCT01120275|58625326|FG000|Overall Study|Adverse Event|3|||
30614325|NCT01120275|58625326|FG000|Overall Study|Progression|27|||
30614326|NCT01120275|58625326|FG000|Overall Study|Ineligible|3|||
30614327|NCT01120275|58625326|FG000|Overall Study|Withdrawal by Subject|1|||
30614328|NCT01120275|58625326|FG000|Overall Study|Refusal|1|||
30614329|NCT01120275|58625326|FG000|Overall Study|Not specific|1|||
30614330|NCT00991510|58625333|FG000|Period I (Days 1-14)|Adverse Event|1|||
30614331|NCT00991510|58625334|FG001|Period I (Days 1-14)|Adverse Event|0|||
30614332|NCT00991510|58625333|FG000|Period III (Days 29-112)|Adverse Event|1|||
30614333|NCT00991510|58625334|FG001|Period III (Days 29-112)|Adverse Event|1|||
30614334|NCT01119963|58625346|FG000|Overall Study|Lost to Follow-up|1|||
30614335|NCT01119963|58625347|FG001|Overall Study|Lost to Follow-up|1|||
30614336|NCT01252667|58625361|FG000|Overall Study|Transplant aborted post-conditioning|0|||
30614337|NCT01252667|58625362|FG001|Overall Study|Transplant aborted post-conditioning|0|||
30614338|NCT01252667|58625363|FG002|Overall Study|Transplant aborted post-conditioning|0|||
30614339|NCT01252667|58625364|FG003|Overall Study|Transplant aborted post-conditioning|0|||
30614340|NCT01252667|58625365|FG004|Overall Study|Transplant aborted post-conditioning|0|||
30614341|NCT01252667|58625366|FG005|Overall Study|Transplant aborted post-conditioning|1|||
30614342|NCT01119105|58625383|FG000|Overall Study|Withdrawal by Subject|1|||
30614343|NCT01119105|58625384|FG001|Overall Study|Withdrawal by Subject|1|||
30614344|NCT01119105|58625385|FG002|Overall Study|Withdrawal by Subject|1|||
30614345|NCT01119105|58625383|FG000|Overall Study|Lost to Follow-up|0|||
30614346|NCT01119105|58625384|FG001|Overall Study|Lost to Follow-up|2|||
30614347|NCT01119105|58625385|FG002|Overall Study|Lost to Follow-up|5|||
30614348|NCT01119105|58625383|FG000|Overall Study|Adverse Event|1|||
30614349|NCT01119105|58625384|FG001|Overall Study|Adverse Event|0|||
30614350|NCT01119105|58625385|FG002|Overall Study|Adverse Event|1|||
30614351|NCT01119105|58625383|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
30614352|NCT01119105|58625384|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
30614353|NCT01119105|58625385|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
30614354|NCT01119105|58625383|FG000|Overall Study|Other|1|||
30614355|NCT01119105|58625384|FG001|Overall Study|Other|1|||
30614356|NCT01119105|58625385|FG002|Overall Study|Other|0|||
30614357|NCT01118949|58625393|FG000|Overall Study|Adverse Event|5|||
30614358|NCT01118949|58625393|FG000|Overall Study|Withdrawal by Subject|4|||
30614359|NCT01252355|58625400|FG000|Overall Study|Adverse Event|9|||
30614360|NCT01252355|58625401|FG001|Overall Study|Adverse Event|17|||
30614361|NCT01252355|58625402|FG002|Overall Study|Adverse Event|22|||
30614362|NCT01252355|58625400|FG000|Overall Study|Lack of Efficacy|6|||
30614363|NCT01252355|58625401|FG001|Overall Study|Lack of Efficacy|4|||
30614364|NCT01252355|58625402|FG002|Overall Study|Lack of Efficacy|2|||
30614365|NCT01252355|58625400|FG000|Overall Study|Lost to Follow-up|0|||
31008823|NCT01474512|59210163|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008824|NCT01474512|59210164|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008825|NCT01474512|59210165|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
31008826|NCT01474512|59210148|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
31008827|NCT01474512|59210149|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
31008828|NCT01474512|59210150|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
31008829|NCT01474512|59210151|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
31008830|NCT01474512|59210152|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
31008831|NCT01474512|59210153|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
31008832|NCT01474512|59210154|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
31008833|NCT01474512|59210155|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
31008834|NCT01474512|59210156|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
30614366|NCT01252355|58625401|FG001|Overall Study|Lost to Follow-up|0|||
30614367|NCT01252355|58625402|FG002|Overall Study|Lost to Follow-up|1|||
30614368|NCT01252355|58625400|FG000|Overall Study|Poor Compliance to Protocol|1|||
30614369|NCT01252355|58625401|FG001|Overall Study|Poor Compliance to Protocol|1|||
30614370|NCT01252355|58625402|FG002|Overall Study|Poor Compliance to Protocol|1|||
30614371|NCT01252355|58625400|FG000|Overall Study|Progressive Disease|2|||
30614372|NCT01252355|58625401|FG001|Overall Study|Progressive Disease|0|||
30614373|NCT01252355|58625402|FG002|Overall Study|Progressive Disease|0|||
30614374|NCT01252355|58625400|FG000|Overall Study|Sponsor Early Termination of Study|149|||
30614375|NCT01252355|58625401|FG001|Overall Study|Sponsor Early Termination of Study|149|||
30614376|NCT01252355|58625402|FG002|Overall Study|Sponsor Early Termination of Study|146|||
30614377|NCT01252355|58625400|FG000|Overall Study|Randomized but not Treated|2|||
30614378|NCT01252355|58625401|FG001|Overall Study|Randomized but not Treated|0|||
30614379|NCT01252355|58625402|FG002|Overall Study|Randomized but not Treated|0|||
30614380|NCT01252355|58625400|FG000|Overall Study|Other Than Above|8|||
30614381|NCT01252355|58625401|FG001|Overall Study|Other Than Above|7|||
30614382|NCT01252355|58625402|FG002|Overall Study|Other Than Above|7|||
30614383|NCT01118325|58625413|FG000|Overall Study|Adverse Event|1|||
30614384|NCT01118325|58625414|FG001|Overall Study|Adverse Event|0|||
30614385|NCT01118325|58625415|FG002|Overall Study|Adverse Event|1|||
30614386|NCT01117857|58625436|FG000|Overall Study|Lost to Follow-up|4|||
30614387|NCT01117857|58625436|FG000|Overall Study|Withdrawal by Subject|4|||
30614388|NCT01117857|58625436|FG000|Overall Study|Physician Decision|1|||
30614389|NCT01251887|58625443|FG000|Overall Study|Scheduling conflict|1|||
30614390|NCT01251887|58625444|FG001|Overall Study|Scheduling conflict|2|||
30614391|NCT01251887|58625445|FG002|Overall Study|Scheduling conflict|2|||
30614392|NCT01251887|58625443|FG000|Overall Study|Physician Decision|0|||
30614393|NCT01251887|58625444|FG001|Overall Study|Physician Decision|1|||
30614394|NCT01251887|58625445|FG002|Overall Study|Physician Decision|0|||
30614395|NCT00991276|58625459|FG000|First Intervention Period|Adverse Event|0|||
30614396|NCT00991276|58625460|FG001|First Intervention Period|Adverse Event|1|||
30614397|NCT00991276|58625461|FG002|First Intervention Period|Adverse Event|0|||
30614398|NCT00991276|58625462|FG003|First Intervention Period|Adverse Event|1|||
30614399|NCT00991276|58625463|FG004|First Intervention Period|Adverse Event|0|||
31008835|NCT01474512|59210157|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
31008836|NCT01474512|59210158|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
31008837|NCT01474512|59210159|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
31008838|NCT01474512|59210160|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
30614400|NCT00991276|58625464|FG005|First Intervention Period|Adverse Event|0|||
30614401|NCT00991276|58625459|FG000|First Intervention Period|Protocol Violation|0|||
30614402|NCT00991276|58625460|FG001|First Intervention Period|Protocol Violation|0|||
30614403|NCT00991276|58625461|FG002|First Intervention Period|Protocol Violation|0|||
30614404|NCT00991276|58625462|FG003|First Intervention Period|Protocol Violation|0|||
30614405|NCT00991276|58625463|FG004|First Intervention Period|Protocol Violation|2|||
30614406|NCT00991276|58625464|FG005|First Intervention Period|Protocol Violation|0|||
30614407|NCT00991276|58625459|FG000|First Intervention Period|Insufficient clinical response|0|||
30614408|NCT00991276|58625460|FG001|First Intervention Period|Insufficient clinical response|0|||
30614409|NCT00991276|58625461|FG002|First Intervention Period|Insufficient clinical response|0|||
30614410|NCT00991276|58625462|FG003|First Intervention Period|Insufficient clinical response|0|||
30614411|NCT00991276|58625463|FG004|First Intervention Period|Insufficient clinical response|1|||
30614412|NCT00991276|58625464|FG005|First Intervention Period|Insufficient clinical response|0|||
30614413|NCT00991276|58625459|FG000|First Intervention Period|Other|0|||
30614414|NCT00991276|58625460|FG001|First Intervention Period|Other|0|||
30614415|NCT00991276|58625461|FG002|First Intervention Period|Other|0|||
30614416|NCT00991276|58625462|FG003|First Intervention Period|Other|1|||
30614417|NCT00991276|58625463|FG004|First Intervention Period|Other|1|||
30614418|NCT00991276|58625464|FG005|First Intervention Period|Other|0|||
30614419|NCT00991276|58625459|FG000|First Intervention Period|Withdrawal by Subject|0|||
30614420|NCT00991276|58625460|FG001|First Intervention Period|Withdrawal by Subject|1|||
30614421|NCT00991276|58625461|FG002|First Intervention Period|Withdrawal by Subject|0|||
30614422|NCT00991276|58625462|FG003|First Intervention Period|Withdrawal by Subject|1|||
30614423|NCT00991276|58625463|FG004|First Intervention Period|Withdrawal by Subject|0|||
30614424|NCT00991276|58625464|FG005|First Intervention Period|Withdrawal by Subject|1|||
30614425|NCT00991276|58625459|FG000|First Intervention Period|Lost to Follow-up|0|||
30614426|NCT00991276|58625460|FG001|First Intervention Period|Lost to Follow-up|1|||
30614427|NCT00991276|58625461|FG002|First Intervention Period|Lost to Follow-up|0|||
30614428|NCT00991276|58625462|FG003|First Intervention Period|Lost to Follow-up|1|||
30614429|NCT00991276|58625463|FG004|First Intervention Period|Lost to Follow-up|0|||
30614430|NCT00991276|58625464|FG005|First Intervention Period|Lost to Follow-up|0|||
30614431|NCT00991276|58625459|FG000|Second Intervention Period|Adverse Event|0|||
30614432|NCT00991276|58625460|FG001|Second Intervention Period|Adverse Event|2|||
30614433|NCT00991276|58625461|FG002|Second Intervention Period|Adverse Event|0|||
30614434|NCT00991276|58625462|FG003|Second Intervention Period|Adverse Event|1|||
30614435|NCT00991276|58625463|FG004|Second Intervention Period|Adverse Event|1|||
30614436|NCT00991276|58625464|FG005|Second Intervention Period|Adverse Event|0|||
30614437|NCT00991276|58625459|FG000|Second Intervention Period|Protocol Violation|1|||
30614438|NCT00991276|58625460|FG001|Second Intervention Period|Protocol Violation|0|||
30614439|NCT00991276|58625461|FG002|Second Intervention Period|Protocol Violation|0|||
30614440|NCT00991276|58625462|FG003|Second Intervention Period|Protocol Violation|0|||
30614441|NCT00991276|58625463|FG004|Second Intervention Period|Protocol Violation|0|||
30614442|NCT00991276|58625464|FG005|Second Intervention Period|Protocol Violation|0|||
30614443|NCT00991276|58625459|FG000|Second Intervention Period|Other|0|||
30614444|NCT00991276|58625460|FG001|Second Intervention Period|Other|0|||
30614445|NCT00991276|58625461|FG002|Second Intervention Period|Other|0|||
30614446|NCT00991276|58625462|FG003|Second Intervention Period|Other|1|||
30614447|NCT00991276|58625463|FG004|Second Intervention Period|Other|0|||
30614448|NCT00991276|58625464|FG005|Second Intervention Period|Other|1|||
30614449|NCT00991276|58625459|FG000|Third Intervention Period|Protocol Violation|1|||
30614450|NCT00991276|58625460|FG001|Third Intervention Period|Protocol Violation|0|||
30614451|NCT00991276|58625461|FG002|Third Intervention Period|Protocol Violation|0|||
30614452|NCT00991276|58625462|FG003|Third Intervention Period|Protocol Violation|0|||
30614453|NCT00991276|58625463|FG004|Third Intervention Period|Protocol Violation|0|||
30614454|NCT00991276|58625464|FG005|Third Intervention Period|Protocol Violation|0|||
30614455|NCT00991276|58625459|FG000|Third Intervention Period|Other|0|||
30614456|NCT00991276|58625460|FG001|Third Intervention Period|Other|0|||
30614457|NCT00991276|58625461|FG002|Third Intervention Period|Other|0|||
30614458|NCT00991276|58625462|FG003|Third Intervention Period|Other|0|||
30614459|NCT00991276|58625463|FG004|Third Intervention Period|Other|0|||
30614460|NCT00991276|58625464|FG005|Third Intervention Period|Other|1|||
30614461|NCT00991276|58625459|FG000|Third Intervention Period|Adverse Event|0|||
30614462|NCT00991276|58625460|FG001|Third Intervention Period|Adverse Event|0|||
30614463|NCT00991276|58625461|FG002|Third Intervention Period|Adverse Event|1|||
30614464|NCT00991276|58625462|FG003|Third Intervention Period|Adverse Event|0|||
30614465|NCT00991276|58625463|FG004|Third Intervention Period|Adverse Event|0|||
30614466|NCT00991276|58625464|FG005|Third Intervention Period|Adverse Event|0|||
30614467|NCT00991276|58625459|FG000|Third Intervention Period|Withdrawal by Subject|0|||
30614468|NCT00991276|58625460|FG001|Third Intervention Period|Withdrawal by Subject|0|||
30614469|NCT00991276|58625461|FG002|Third Intervention Period|Withdrawal by Subject|0|||
30614470|NCT00991276|58625462|FG003|Third Intervention Period|Withdrawal by Subject|1|||
31008839|NCT01474512|59210161|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
31008840|NCT01474512|59210162|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
31008841|NCT01474512|59210163|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
31008842|NCT01474512|59210164|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
31008843|NCT01474512|59210165|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
31008844|NCT01474512|59210148|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008845|NCT01474512|59210149|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008846|NCT01474512|59210150|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008847|NCT01474512|59210151|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008848|NCT01474512|59210152|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008849|NCT01474512|59210153|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008850|NCT01474512|59210154|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008851|NCT01474512|59210155|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008852|NCT01474512|59210156|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008853|NCT01474512|59210157|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008854|NCT01474512|59210158|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008855|NCT01474512|59210159|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008856|NCT01474512|59210160|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008857|NCT01474512|59210161|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
31008858|NCT01474512|59210162|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
31008859|NCT01474512|59210163|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
31008860|NCT01474512|59210164|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
31008861|NCT01474512|59210165|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
31008862|NCT01474512|59210148|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008863|NCT01474512|59210149|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008864|NCT01474512|59210150|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008865|NCT01474512|59210151|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008866|NCT01474512|59210152|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008867|NCT01474512|59210153|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008868|NCT01474512|59210154|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008869|NCT01474512|59210155|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008870|NCT01474512|59210156|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008871|NCT01474512|59210157|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008872|NCT01474512|59210158|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008873|NCT01474512|59210159|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008874|NCT01474512|59210160|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008875|NCT01474512|59210161|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
31008876|NCT01474512|59210162|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
31008877|NCT01474512|59210163|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
31008878|NCT01474512|59210164|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
31008879|NCT01474512|59210165|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
31008880|NCT01474512|59210148|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008881|NCT01474512|59210149|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008882|NCT01474512|59210150|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008883|NCT01474512|59210151|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008884|NCT01474512|59210152|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008885|NCT01474512|59210153|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008886|NCT01474512|59210154|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008887|NCT01474512|59210155|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008888|NCT01474512|59210156|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008889|NCT01474512|59210157|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008890|NCT01474512|59210158|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008891|NCT01474512|59210159|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008892|NCT01474512|59210160|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008893|NCT01474512|59210161|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008894|NCT01474512|59210162|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008895|NCT01474512|59210163|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
31008896|NCT01474512|59210164|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
31008897|NCT01474512|59210165|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
31008898|NCT01474512|59210148|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
31008899|NCT01474512|59210149|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
31008900|NCT01474512|59210150|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
31008901|NCT01474512|59210151|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
31008902|NCT01474512|59210152|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
31008903|NCT01474512|59210153|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
31008904|NCT01474512|59210154|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
31008905|NCT01474512|59210155|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
30614471|NCT00991276|58625463|FG004|Third Intervention Period|Withdrawal by Subject|0|||
31008906|NCT01474512|59210156|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
30614472|NCT00991276|58625464|FG005|Third Intervention Period|Withdrawal by Subject|0|||
31008907|NCT01474512|59210157|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
31008908|NCT01474512|59210158|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
31008909|NCT01474512|59210159|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
31008910|NCT01474512|59210160|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
31008911|NCT01474512|59210161|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
30614473|NCT00990652|58625473|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
30614474|NCT00990652|58625473|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
30614475|NCT00990340|58625480|FG000|First 14-day Treatment|Not Compliant|2|||
30614476|NCT00990340|58625481|FG001|First 14-day Treatment|Not Compliant|1|||
30614477|NCT00990340|58625480|FG000|First 14-day Treatment|Lost to Follow-up|2|||
30614478|NCT00990340|58625481|FG001|First 14-day Treatment|Lost to Follow-up|1|||
30614479|NCT00990340|58625480|FG000|First 14-day Treatment|Protocol Violation|2|||
30614480|NCT00990340|58625481|FG001|First 14-day Treatment|Protocol Violation|2|||
31008912|NCT01474512|59210162|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
31008913|NCT01474512|59210163|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
31008914|NCT01474512|59210164|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
31008915|NCT01474512|59210165|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
31008916|NCT01474512|59210148|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008917|NCT01474512|59210149|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008918|NCT01474512|59210150|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008919|NCT01474512|59210151|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008920|NCT01474512|59210152|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008921|NCT01474512|59210153|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008922|NCT01474512|59210154|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008923|NCT01474512|59210155|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008924|NCT01474512|59210156|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008925|NCT01474512|59210157|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008926|NCT01474512|59210158|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008927|NCT01474512|59210159|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008928|NCT01474512|59210160|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008929|NCT01474512|59210161|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008930|NCT01474512|59210162|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008931|NCT01474512|59210163|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
31008932|NCT01474512|59210164|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
31008933|NCT01474512|59210165|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
31008934|NCT01474512|59210148|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
31008935|NCT01474512|59210149|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
31008936|NCT01474512|59210150|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
31008937|NCT01474512|59210151|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
31008938|NCT01474512|59210152|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
31008939|NCT01474512|59210153|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
31008940|NCT01474512|59210154|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
31008941|NCT01474512|59210155|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
31008942|NCT01474512|59210156|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
31008943|NCT01474512|59210157|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
31008944|NCT01474512|59210158|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
31008945|NCT01474512|59210159|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
31008946|NCT01474512|59210160|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
31008947|NCT01474512|59210161|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
31008948|NCT01474512|59210162|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
31008949|NCT01474512|59210163|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
30614481|NCT01207440|58625496|FG000|Overall Study|Adverse Event|46|||
30614482|NCT01207440|58625497|FG001|Overall Study|Adverse Event|11|||
30614483|NCT01207440|58625498|FG002|Overall Study|Adverse Event|7|||
30614484|NCT01207440|58625499|FG003|Overall Study|Adverse Event|2|||
30614485|NCT01207440|58625500|FG004|Overall Study|Adverse Event|6|||
30614486|NCT01207440|58625501|FG005|Overall Study|Adverse Event|6|||
30614487|NCT01207440|58625502|FG006|Overall Study|Adverse Event|2|||
30614488|NCT01207440|58625496|FG000|Overall Study|Death|6|||
30614489|NCT01207440|58625497|FG001|Overall Study|Death|3|||
30614490|NCT01207440|58625498|FG002|Overall Study|Death|2|||
30614491|NCT01207440|58625499|FG003|Overall Study|Death|2|||
30614492|NCT01207440|58625500|FG004|Overall Study|Death|7|||
30614493|NCT01207440|58625501|FG005|Overall Study|Death|5|||
30614494|NCT01207440|58625502|FG006|Overall Study|Death|1|||
30614495|NCT01207440|58625496|FG000|Overall Study|Lack of Efficacy|13|||
30614496|NCT01207440|58625497|FG001|Overall Study|Lack of Efficacy|2|||
30614497|NCT01207440|58625498|FG002|Overall Study|Lack of Efficacy|5|||
31008950|NCT01474512|59210164|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
31008951|NCT01474512|59210165|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
31008952|NCT01474512|59210148|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
30614498|NCT01207440|58625499|FG003|Overall Study|Lack of Efficacy|1|||
30614499|NCT01207440|58625500|FG004|Overall Study|Lack of Efficacy|2|||
30614500|NCT01207440|58625501|FG005|Overall Study|Lack of Efficacy|3|||
30614501|NCT01207440|58625502|FG006|Overall Study|Lack of Efficacy|0|||
30614502|NCT01207440|58625496|FG000|Overall Study|Lost to Follow-up|0|||
30614503|NCT01207440|58625497|FG001|Overall Study|Lost to Follow-up|0|||
30614504|NCT01207440|58625498|FG002|Overall Study|Lost to Follow-up|2|||
30614505|NCT01207440|58625499|FG003|Overall Study|Lost to Follow-up|1|||
30614506|NCT01207440|58625500|FG004|Overall Study|Lost to Follow-up|0|||
30614507|NCT01207440|58625501|FG005|Overall Study|Lost to Follow-up|0|||
30614508|NCT01207440|58625502|FG006|Overall Study|Lost to Follow-up|0|||
31008953|NCT01474512|59210149|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008954|NCT01474512|59210150|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008955|NCT01474512|59210151|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008956|NCT01474512|59210152|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008957|NCT01474512|59210153|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008958|NCT01474512|59210154|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008959|NCT01474512|59210155|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008960|NCT01474512|59210156|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008961|NCT01474512|59210157|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008962|NCT01474512|59210158|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008963|NCT01474512|59210159|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008964|NCT01474512|59210160|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008965|NCT01474512|59210161|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008966|NCT01474512|59210162|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
31008967|NCT01474512|59210163|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008968|NCT01474512|59210164|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
31008969|NCT01474512|59210165|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
31008970|NCT01474512|59210148|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008971|NCT01474512|59210149|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008972|NCT01474512|59210150|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008973|NCT01474512|59210151|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008974|NCT01474512|59210152|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008975|NCT01474512|59210153|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008976|NCT01474512|59210154|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008977|NCT01474512|59210155|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008978|NCT01474512|59210156|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008979|NCT01474512|59210157|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008980|NCT01474512|59210158|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008981|NCT01474512|59210159|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008982|NCT01474512|59210160|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008983|NCT01474512|59210161|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008984|NCT01474512|59210162|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
31008985|NCT01474512|59210163|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008986|NCT01474512|59210164|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
31008987|NCT01474512|59210165|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
31008988|NCT01474512|59210148|FG000|Post-Treatment Follow-Up|Death|0|||
31008989|NCT01474512|59210149|FG001|Post-Treatment Follow-Up|Death|0|||
31008990|NCT01474512|59210150|FG002|Post-Treatment Follow-Up|Death|0|||
31008991|NCT01474512|59210151|FG003|Post-Treatment Follow-Up|Death|0|||
31008992|NCT01474512|59210152|FG004|Post-Treatment Follow-Up|Death|0|||
31008993|NCT01474512|59210153|FG005|Post-Treatment Follow-Up|Death|0|||
31008994|NCT01474512|59210154|FG006|Post-Treatment Follow-Up|Death|0|||
31008995|NCT01474512|59210155|FG007|Post-Treatment Follow-Up|Death|0|||
31008996|NCT01474512|59210156|FG008|Post-Treatment Follow-Up|Death|0|||
31008997|NCT01474512|59210157|FG009|Post-Treatment Follow-Up|Death|0|||
31008998|NCT01474512|59210158|FG010|Post-Treatment Follow-Up|Death|0|||
31008999|NCT01474512|59210159|FG011|Post-Treatment Follow-Up|Death|0|||
31009000|NCT01474512|59210160|FG012|Post-Treatment Follow-Up|Death|0|||
31009001|NCT01474512|59210161|FG013|Post-Treatment Follow-Up|Death|0|||
31009002|NCT01474512|59210162|FG014|Post-Treatment Follow-Up|Death|0|||
31009003|NCT01474512|59210163|FG015|Post-Treatment Follow-Up|Death|0|||
31009004|NCT01474512|59210164|FG016|Post-Treatment Follow-Up|Death|1|||
31009005|NCT01474512|59210165|FG017|Post-Treatment Follow-Up|Death|0|||
31009006|NCT01474434|59210199|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
31009007|NCT01474434|59210200|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
31009008|NCT01474434|59210201|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
31009009|NCT01474434|59210202|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
31009010|NCT01474434|59210199|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
31009011|NCT01474434|59210200|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
31009012|NCT01474434|59210201|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
31009013|NCT01474434|59210202|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
31009014|NCT01474434|59210199|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
31009015|NCT01474434|59210200|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
31009016|NCT01474434|59210201|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
30614509|NCT01207440|58625496|FG000|Overall Study|Non-compliance with Study Drug|3|||
30614510|NCT01207440|58625497|FG001|Overall Study|Non-compliance with Study Drug|0|||
30699276|NCT03865732|58713805|FG000|Overall Study|Adverse Event|0|||
31009017|NCT01474434|59210202|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
30614511|NCT01207440|58625498|FG002|Overall Study|Non-compliance with Study Drug|1|||
30614512|NCT01207440|58625499|FG003|Overall Study|Non-compliance with Study Drug|0|||
30614513|NCT01207440|58625500|FG004|Overall Study|Non-compliance with Study Drug|0|||
30614514|NCT01207440|58625501|FG005|Overall Study|Non-compliance with Study Drug|0|||
30614515|NCT01207440|58625502|FG006|Overall Study|Non-compliance with Study Drug|0|||
30614516|NCT01207440|58625496|FG000|Overall Study|Physician Decision|6|||
31009018|NCT01473732|59210218|FG000|Overall Study|Adverse Event|1|||
31009019|NCT01473732|59210219|FG001|Overall Study|Adverse Event|0|||
31009020|NCT01473732|59210218|FG000|Overall Study|Death|1|||
31009021|NCT01473732|59210219|FG001|Overall Study|Death|0|||
31009022|NCT01450098|59210227|FG000|Period 3|Protocol Violation|0|||
31009023|NCT01450098|59210228|FG001|Period 3|Protocol Violation|1|||
31009024|NCT01450098|59210227|FG000|Period 3|Withdrawal by Subject|0|||
31009025|NCT01450098|59210228|FG001|Period 3|Withdrawal by Subject|2|||
31009026|NCT01449708|59210243|FG000|Overall Study|Protocol Violation|0|||
31009027|NCT01449708|59210244|FG001|Overall Study|Protocol Violation|1|||
31009028|NCT01449708|59210243|FG000|Overall Study|surgical complication|1|||
31009029|NCT01449708|59210244|FG001|Overall Study|surgical complication|2|||
31009030|NCT01449708|59210243|FG000|Overall Study|respiratory failure|1|||
31009031|NCT01449708|59210244|FG001|Overall Study|respiratory failure|0|||
31009032|NCT01449630|59210262|FG000|Period 1|Physician Decision|1|||
31009033|NCT01449630|59210263|FG001|Period 1|Physician Decision|0|||
31009034|NCT01449630|59210264|FG002|Period 1|Physician Decision|0|||
31009035|NCT01449630|59210265|FG003|Period 1|Physician Decision|1|||
31009036|NCT01449630|59210266|FG004|Period 1|Physician Decision|0|||
31009037|NCT01449630|59210267|FG005|Period 1|Physician Decision|0|||
31009038|NCT01449630|59210268|FG006|Period 1|Physician Decision|0|||
31009039|NCT01449630|59210269|FG007|Period 1|Physician Decision|0|||
31009040|NCT01449630|59210270|FG008|Period 1|Physician Decision|0|||
31009041|NCT01449630|59210262|FG000|Period 1|Sponsor Decision|0|||
31009042|NCT01449630|59210263|FG001|Period 1|Sponsor Decision|0|||
31009043|NCT01449630|59210264|FG002|Period 1|Sponsor Decision|0|||
31009044|NCT01449630|59210265|FG003|Period 1|Sponsor Decision|0|||
31009045|NCT01449630|59210266|FG004|Period 1|Sponsor Decision|0|||
31009046|NCT01449630|59210267|FG005|Period 1|Sponsor Decision|1|||
31009047|NCT01449630|59210268|FG006|Period 1|Sponsor Decision|0|||
31009048|NCT01449630|59210269|FG007|Period 1|Sponsor Decision|0|||
31009049|NCT01449630|59210270|FG008|Period 1|Sponsor Decision|0|||
31009050|NCT01449630|59210262|FG000|Period 2|Sponsor Decision|0|||
31009051|NCT01449630|59210263|FG001|Period 2|Sponsor Decision|0|||
31009052|NCT01449630|59210264|FG002|Period 2|Sponsor Decision|0|||
31009053|NCT01449630|59210265|FG003|Period 2|Sponsor Decision|0|||
31009054|NCT01449630|59210266|FG004|Period 2|Sponsor Decision|0|||
31009055|NCT01449630|59210267|FG005|Period 2|Sponsor Decision|0|||
31009056|NCT01449630|59210268|FG006|Period 2|Sponsor Decision|1|||
31009057|NCT01449630|59210269|FG007|Period 2|Sponsor Decision|0|||
31009058|NCT01449630|59210270|FG008|Period 2|Sponsor Decision|0|||
31009059|NCT01493778|59210292|FG000|Overall Study|Withdrawal by Subject|8|||
31009060|NCT01473420|59210307|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
31009061|NCT01473420|59210308|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
31009062|NCT01473420|59210307|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
31009063|NCT01473420|59210308|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
31009064|NCT01473420|59210307|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
31009065|NCT01473420|59210308|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
31009066|NCT01473420|59210307|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
31009067|NCT01473420|59210308|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
31009068|NCT01473420|59210307|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
31009069|NCT01473420|59210308|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
31009070|NCT01473420|59210307|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
31009071|NCT01473420|59210308|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
31009072|NCT01473420|59210307|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
31009073|NCT01473420|59210308|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
31009074|NCT01473420|59210307|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
31009075|NCT01473420|59210308|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
30614517|NCT01207440|58625497|FG001|Overall Study|Physician Decision|5|||
30614518|NCT01207440|58625498|FG002|Overall Study|Physician Decision|5|||
30614519|NCT01207440|58625499|FG003|Overall Study|Physician Decision|0|||
31009076|NCT01473420|59210307|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
31009077|NCT01473420|59210308|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
31009078|NCT01473420|59210307|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
31009079|NCT01473420|59210308|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
31009080|NCT01473420|59210307|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
31009081|NCT01473420|59210308|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
31009082|NCT01473420|59210307|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
31009083|NCT01473420|59210308|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
31009084|NCT01473420|59210307|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
31009085|NCT01473420|59210308|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
30614520|NCT01207440|58625500|FG004|Overall Study|Physician Decision|1|||
30614521|NCT01207440|58625501|FG005|Overall Study|Physician Decision|0|||
30614522|NCT01207440|58625502|FG006|Overall Study|Physician Decision|0|||
30614523|NCT01207440|58625496|FG000|Overall Study|Progressive Disease|19|||
30614524|NCT01207440|58625497|FG001|Overall Study|Progressive Disease|10|||
30614525|NCT01207440|58625498|FG002|Overall Study|Progressive Disease|19|||
30614526|NCT01207440|58625499|FG003|Overall Study|Progressive Disease|7|||
30614527|NCT01207440|58625500|FG004|Overall Study|Progressive Disease|23|||
30614528|NCT01207440|58625501|FG005|Overall Study|Progressive Disease|27|||
30614529|NCT01207440|58625502|FG006|Overall Study|Progressive Disease|0|||
30614530|NCT01207440|58625496|FG000|Overall Study|Protocol Violation|2|||
30614531|NCT01207440|58625497|FG001|Overall Study|Protocol Violation|0|||
30614532|NCT01207440|58625498|FG002|Overall Study|Protocol Violation|0|||
30614533|NCT01207440|58625499|FG003|Overall Study|Protocol Violation|0|||
30614534|NCT01207440|58625500|FG004|Overall Study|Protocol Violation|0|||
30614535|NCT01207440|58625501|FG005|Overall Study|Protocol Violation|0|||
30614536|NCT01207440|58625502|FG006|Overall Study|Protocol Violation|0|||
30614537|NCT01207440|58625496|FG000|Overall Study|Site Terminated by Sponsor|69|||
30614538|NCT01207440|58625497|FG001|Overall Study|Site Terminated by Sponsor|19|||
30614539|NCT01207440|58625498|FG002|Overall Study|Site Terminated by Sponsor|12|||
30614540|NCT01207440|58625499|FG003|Overall Study|Site Terminated by Sponsor|2|||
30614541|NCT01207440|58625500|FG004|Overall Study|Site Terminated by Sponsor|3|||
31009086|NCT01492686|59210322|FG000|Double-blind Phase|Adverse Event|0|||
31009087|NCT01492686|59210323|FG001|Double-blind Phase|Adverse Event|2|||
31009088|NCT01492686|59210322|FG000|Double-blind Phase|Physician Decision|0|||
31009089|NCT01492686|59210323|FG001|Double-blind Phase|Physician Decision|1|||
31009090|NCT01492686|59210322|FG000|Double-blind Phase|Withdrawal by Subject|0|||
31009091|NCT01492686|59210323|FG001|Double-blind Phase|Withdrawal by Subject|2|||
31009092|NCT01492686|59210322|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
31009093|NCT01492686|59210323|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
31009094|NCT01492686|59210322|FG000|Open-label Phase|Adverse Event|1|||
31009095|NCT01492686|59210323|FG001|Open-label Phase|Adverse Event|2|||
31009096|NCT01492686|59210322|FG000|Open-label Phase|Physician Decision|1|||
31009097|NCT01492686|59210323|FG001|Open-label Phase|Physician Decision|0|||
31009098|NCT01492686|59210322|FG000|Open-label Phase|Withdrawal by Subject|6|||
31009099|NCT01492686|59210323|FG001|Open-label Phase|Withdrawal by Subject|7|||
31009100|NCT01492686|59210322|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
31009101|NCT01492686|59210323|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
31009102|NCT01449006|59210333|FG000|Overall Study|Lost to Follow-up|1|||
31009103|NCT01449006|59210334|FG001|Overall Study|Lost to Follow-up|0|||
31009104|NCT01449006|59210333|FG000|Overall Study|Withdrawal by Subject|1|||
31009105|NCT01449006|59210334|FG001|Overall Study|Withdrawal by Subject|0|||
31009106|NCT01449006|59210333|FG000|Overall Study|Protocol Violation|1|||
31009107|NCT01449006|59210334|FG001|Overall Study|Protocol Violation|0|||
31009108|NCT01448850|59210342|FG000|Overall Study|Death|3|||
31009109|NCT01448850|59210343|FG001|Overall Study|Death|6|||
31009110|NCT01448850|59210342|FG000|Overall Study|Withdrawal by Subject|13|||
31009111|NCT01448850|59210343|FG001|Overall Study|Withdrawal by Subject|21|||
31009112|NCT01448850|59210342|FG000|Overall Study|Lost to Follow-up|3|||
31009113|NCT01448850|59210343|FG001|Overall Study|Lost to Follow-up|1|||
31009114|NCT01448850|59210342|FG000|Overall Study|Other|15|||
31009115|NCT01448850|59210343|FG001|Overall Study|Other|12|||
31009116|NCT01491672|59210353|FG000|Overall Study|Lost to Follow-up|0|||
31009117|NCT01491672|59210354|FG001|Overall Study|Lost to Follow-up|4|||
31009118|NCT01491672|59210355|FG002|Overall Study|Lost to Follow-up|1|||
31009119|NCT01491672|59210353|FG000|Overall Study|Withdrawal by Subject|6|||
31009120|NCT01491672|59210354|FG001|Overall Study|Withdrawal by Subject|7|||
31009121|NCT01491672|59210355|FG002|Overall Study|Withdrawal by Subject|0|||
31009122|NCT01491672|59210353|FG000|Overall Study|Adverse Event|8|||
31009123|NCT01491672|59210354|FG001|Overall Study|Adverse Event|10|||
31009124|NCT01491672|59210355|FG002|Overall Study|Adverse Event|4|||
31009125|NCT01491672|59210353|FG000|Overall Study|Disease progression|42|||
31009126|NCT01491672|59210354|FG001|Overall Study|Disease progression|34|||
30614542|NCT01207440|58625501|FG005|Overall Study|Site Terminated by Sponsor|0|||
30614543|NCT01207440|58625502|FG006|Overall Study|Site Terminated by Sponsor|2|||
30614544|NCT01207440|58625496|FG000|Overall Study|Withdrawal by Subject|29|||
31009127|NCT01491672|59210355|FG002|Overall Study|Disease progression|6|||
31009128|NCT01491672|59210353|FG000|Overall Study|Protocol deviation|0|||
31009129|NCT01491672|59210354|FG001|Overall Study|Protocol deviation|1|||
31009130|NCT01491672|59210355|FG002|Overall Study|Protocol deviation|0|||
30614545|NCT01207440|58625497|FG001|Overall Study|Withdrawal by Subject|4|||
30614546|NCT01207440|58625498|FG002|Overall Study|Withdrawal by Subject|5|||
30614547|NCT01207440|58625499|FG003|Overall Study|Withdrawal by Subject|3|||
31009131|NCT01491672|59210353|FG000|Overall Study|Death|0|||
31009132|NCT01491672|59210354|FG001|Overall Study|Death|4|||
31009133|NCT01491672|59210355|FG002|Overall Study|Death|0|||
31009134|NCT01447446|59210371|FG000|Overall Study|Death|6|||
31009135|NCT01447446|59210372|FG001|Overall Study|Death|3|||
30614548|NCT01207440|58625500|FG004|Overall Study|Withdrawal by Subject|2|||
30614549|NCT01207440|58625501|FG005|Overall Study|Withdrawal by Subject|2|||
30614550|NCT01207440|58625502|FG006|Overall Study|Withdrawal by Subject|0|||
30614551|NCT01207440|58625496|FG000|Overall Study|Reason Not Specified|10|||
30614552|NCT01207440|58625497|FG001|Overall Study|Reason Not Specified|10|||
30614553|NCT01207440|58625498|FG002|Overall Study|Reason Not Specified|7|||
30614554|NCT01207440|58625499|FG003|Overall Study|Reason Not Specified|0|||
30614555|NCT01207440|58625500|FG004|Overall Study|Reason Not Specified|4|||
30614556|NCT01207440|58625501|FG005|Overall Study|Reason Not Specified|3|||
30614557|NCT01207440|58625502|FG006|Overall Study|Reason Not Specified|0|||
30614558|NCT00990184|58625524|FG000|Overall Study|Physician Decision|1|||
30614559|NCT00986830|58625530|FG000|Overall Study|Death|1|||
30614560|NCT00986830|58625530|FG000|Overall Study|Lost to Follow-up|1|||
30614561|NCT00986830|58625530|FG000|Overall Study|Lack of Efficacy|1|||
30614562|NCT00986830|58625530|FG000|Overall Study|Unable to access sinus with device|5|||
30614563|NCT00990106|58625536|FG000|Overall Study|"too busy to continue"|1|||
30614564|NCT00990106|58625537|FG001|Overall Study|"too busy to continue"|2|||
30614565|NCT00990106|58625536|FG000|Overall Study|Lost to Follow-up|1|||
30614566|NCT00990106|58625537|FG001|Overall Study|Lost to Follow-up|3|||
30614567|NCT00990106|58625536|FG000|Overall Study|Withdrawal by Subject|2|||
30614568|NCT00990106|58625537|FG001|Overall Study|Withdrawal by Subject|1|||
30614569|NCT00990106|58625536|FG000|Overall Study|opted for open label prazosin|1|||
30614570|NCT00990106|58625537|FG001|Overall Study|opted for open label prazosin|1|||
30614571|NCT00990106|58625536|FG000|Overall Study|relocation/deployment|4|||
30614572|NCT00990106|58625537|FG001|Overall Study|relocation/deployment|1|||
30614573|NCT00990106|58625536|FG000|Overall Study|started exclusionary medication|0|||
30614574|NCT00990106|58625537|FG001|Overall Study|started exclusionary medication|1|||
30614575|NCT00990106|58625536|FG000|Overall Study|planned major surgery|0|||
30614576|NCT00990106|58625537|FG001|Overall Study|planned major surgery|1|||
30614577|NCT00990106|58625536|FG000|Overall Study|scheduling conflicts|0|||
30614578|NCT00990106|58625537|FG001|Overall Study|scheduling conflicts|2|||
30614579|NCT00983476|58625546|FG000|Overall Study|Did not receive intervention|17|||
30614580|NCT00983476|58625547|FG001|Overall Study|Did not receive intervention|22|||
30614581|NCT00983476|58625548|FG002|Overall Study|Did not receive intervention|0|||
30614582|NCT00982228|58625592|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
30614583|NCT00982228|58625593|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
30614584|NCT00982228|58625592|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
30614585|NCT00982228|58625593|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
30614586|NCT00982228|58625592|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
30614587|NCT00982228|58625593|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
30614588|NCT00982228|58625592|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
30614589|NCT00982228|58625593|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
30614590|NCT00982228|58625592|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
30614591|NCT00982228|58625593|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
30614592|NCT00982228|58625592|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
30614593|NCT00982228|58625593|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
30614594|NCT00982228|58625592|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
30614595|NCT00982228|58625593|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
30614596|NCT00982228|58625592|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
30614597|NCT00982228|58625593|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
30614598|NCT00982228|58625592|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
30614599|NCT00982228|58625593|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
30614600|NCT00982228|58625592|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
30614601|NCT00982228|58625593|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
30614602|NCT01260350|58625619|FG000|Overall Study|Lack of Efficacy|0|||
30614603|NCT01260350|58625620|FG001|Overall Study|Lack of Efficacy|0|||
30614604|NCT01260350|58625621|FG002|Overall Study|Lack of Efficacy|0|||
30614605|NCT01260350|58625622|FG003|Overall Study|Lack of Efficacy|0|||
30614606|NCT01260350|58625623|FG004|Overall Study|Lack of Efficacy|0|||
30614607|NCT01260350|58625624|FG005|Overall Study|Lack of Efficacy|0|||
30614608|NCT01260350|58625625|FG006|Overall Study|Lack of Efficacy|0|||
30614609|NCT01260350|58625626|FG007|Overall Study|Lack of Efficacy|0|||
30614610|NCT01260350|58625627|FG008|Overall Study|Lack of Efficacy|0|||
30614611|NCT01260350|58625628|FG009|Overall Study|Lack of Efficacy|0|||
30614612|NCT01260350|58625629|FG010|Overall Study|Lack of Efficacy|0|||
30614613|NCT01260350|58625630|FG011|Overall Study|Lack of Efficacy|0|||
30614614|NCT01260350|58625631|FG012|Overall Study|Lack of Efficacy|0|||
30614615|NCT01260350|58625632|FG013|Overall Study|Lack of Efficacy|0|||
30614616|NCT01260350|58625633|FG014|Overall Study|Lack of Efficacy|0|||
30614617|NCT01260350|58625634|FG015|Overall Study|Lack of Efficacy|0|||
30614618|NCT01260350|58625635|FG016|Overall Study|Lack of Efficacy|0|||
30614619|NCT01260350|58625636|FG017|Overall Study|Lack of Efficacy|1|||
30614620|NCT01260350|58625637|FG018|Overall Study|Lack of Efficacy|0|||
31009136|NCT01447446|59210373|FG002|Overall Study|Death|2|||
30614621|NCT01260350|58625638|FG019|Overall Study|Lack of Efficacy|0|||
30614622|NCT01260350|58625639|FG020|Overall Study|Lack of Efficacy|3|||
30614623|NCT01260350|58625640|FG021|Overall Study|Lack of Efficacy|0|||
30614624|NCT01260350|58625619|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614625|NCT01260350|58625620|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614626|NCT01260350|58625621|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614627|NCT01260350|58625622|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614628|NCT01260350|58625623|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614629|NCT01260350|58625624|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614630|NCT01260350|58625625|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614631|NCT01260350|58625626|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614632|NCT01260350|58625627|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
30614633|NCT01260350|58625628|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614634|NCT01260350|58625629|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614635|NCT01260350|58625630|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614636|NCT01260350|58625631|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614637|NCT01260350|58625632|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614638|NCT01260350|58625633|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614639|NCT01260350|58625634|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614640|NCT01260350|58625635|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
31009137|NCT01447446|59210374|FG003|Overall Study|Death|1|||
31009138|NCT01447446|59210375|FG004|Overall Study|Death|7|||
31009139|NCT01447446|59210376|FG005|Overall Study|Death|0|||
31009140|NCT01447446|59210371|FG000|Overall Study|Adverse Event|3|||
31009141|NCT01447446|59210372|FG001|Overall Study|Adverse Event|0|||
31009142|NCT01447446|59210373|FG002|Overall Study|Adverse Event|1|||
31009143|NCT01447446|59210374|FG003|Overall Study|Adverse Event|0|||
31009144|NCT01447446|59210375|FG004|Overall Study|Adverse Event|2|||
31009145|NCT01447446|59210376|FG005|Overall Study|Adverse Event|0|||
31009146|NCT01447446|59210371|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
31009147|NCT01447446|59210372|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
31009148|NCT01447446|59210373|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
31009149|NCT01447446|59210374|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
31009150|NCT01447446|59210375|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
31009151|NCT01447446|59210376|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
31009152|NCT01447446|59210371|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
31009153|NCT01447446|59210372|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
31009154|NCT01447446|59210373|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
31009155|NCT01447446|59210374|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
31009156|NCT01447446|59210375|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
31009157|NCT01447446|59210376|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
31009158|NCT01447446|59210371|FG000|Overall Study|Administrative/Other|34|||
31009159|NCT01447446|59210372|FG001|Overall Study|Administrative/Other|9|||
31009160|NCT01447446|59210373|FG002|Overall Study|Administrative/Other|10|||
31009161|NCT01447446|59210374|FG003|Overall Study|Administrative/Other|2|||
31009162|NCT01447446|59210375|FG004|Overall Study|Administrative/Other|33|||
31009163|NCT01447446|59210376|FG005|Overall Study|Administrative/Other|4|||
31009164|NCT01447446|59210371|FG000|Overall Study|SVR12 Assessment|13|||
31009165|NCT01447446|59210372|FG001|Overall Study|SVR12 Assessment|1|||
31009166|NCT01447446|59210373|FG002|Overall Study|SVR12 Assessment|2|||
31009167|NCT01447446|59210374|FG003|Overall Study|SVR12 Assessment|1|||
31009168|NCT01447446|59210375|FG004|Overall Study|SVR12 Assessment|5|||
31009169|NCT01447446|59210376|FG005|Overall Study|SVR12 Assessment|5|||
31009170|NCT01447446|59210371|FG000|Overall Study|New Treatment Started|8|||
31009171|NCT01447446|59210372|FG001|Overall Study|New Treatment Started|2|||
31009172|NCT01447446|59210373|FG002|Overall Study|New Treatment Started|1|||
31009173|NCT01447446|59210374|FG003|Overall Study|New Treatment Started|0|||
31009174|NCT01447446|59210375|FG004|Overall Study|New Treatment Started|2|||
31009175|NCT01447446|59210376|FG005|Overall Study|New Treatment Started|0|||
31009176|NCT01447446|59210371|FG000|Overall Study|Reason not Specified|1|||
31009177|NCT01447446|59210372|FG001|Overall Study|Reason not Specified|1|||
31009178|NCT01447446|59210373|FG002|Overall Study|Reason not Specified|1|||
31009179|NCT01447446|59210374|FG003|Overall Study|Reason not Specified|1|||
30614641|NCT01260350|58625636|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
31009180|NCT01447446|59210375|FG004|Overall Study|Reason not Specified|1|||
31009181|NCT01447446|59210376|FG005|Overall Study|Reason not Specified|0|||
31009182|NCT01490814|59210398|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
31009183|NCT01490814|59210399|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
30614642|NCT01260350|58625637|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
31009184|NCT01490814|59210398|FG000|Overall Study|Physician Decision|1|||
30614643|NCT01260350|58625638|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614644|NCT01260350|58625639|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
30614645|NCT01260350|58625640|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
31009185|NCT01490814|59210399|FG001|Overall Study|Physician Decision|0|||
30614646|NCT01260194|58625694|FG000|Overall Study|Withdrawal of Consent|1|||
30614647|NCT01259726|58625702|FG000|Overall Study|Death|1|||
30614648|NCT01259726|58625703|FG001|Overall Study|Death|0|||
30614649|NCT01259726|58625704|FG002|Overall Study|Death|0|||
30614650|NCT01259726|58625705|FG003|Overall Study|Death|0|||
30614651|NCT01259726|58625702|FG000|Overall Study|Physician Decision|2|||
30614652|NCT01259726|58625703|FG001|Overall Study|Physician Decision|0|||
30893057|NCT02536313|58926498|FG001|Overall Study|Lack of Efficacy|1|||
30893058|NCT02187861|58926510|FG000|Overall Study|Adverse Event|2|||
30893059|NCT02187861|58926511|FG001|Overall Study|Adverse Event|1|||
30893060|NCT02187861|58926512|FG002|Overall Study|Adverse Event|2|||
30893061|NCT02187861|58926513|FG003|Overall Study|Adverse Event|1|||
30893062|NCT02187861|58926510|FG000|Overall Study|Death|0|||
30893063|NCT02187861|58926511|FG001|Overall Study|Death|3|||
30893064|NCT02187861|58926512|FG002|Overall Study|Death|1|||
30893065|NCT02187861|58926513|FG003|Overall Study|Death|2|||
30893066|NCT02187861|58926510|FG000|Overall Study|Physician Decision|0|||
30893067|NCT02187861|58926511|FG001|Overall Study|Physician Decision|1|||
30893068|NCT02187861|58926512|FG002|Overall Study|Physician Decision|0|||
30893069|NCT02187861|58926513|FG003|Overall Study|Physician Decision|3|||
30893070|NCT02187861|58926510|FG000|Overall Study|Progressive Disease|4|||
30893071|NCT02187861|58926511|FG001|Overall Study|Progressive Disease|42|||
30893072|NCT02187861|58926512|FG002|Overall Study|Progressive Disease|19|||
31009186|NCT01490814|59210398|FG000|Overall Study|Withdrawal by Subject|0|||
31009187|NCT01490814|59210399|FG001|Overall Study|Withdrawal by Subject|5|||
31009188|NCT01471782|59210411|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
31009189|NCT01471782|59210412|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
31009190|NCT01471782|59210413|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
31009191|NCT01471782|59210414|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
31009192|NCT01471782|59210415|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
31009193|NCT01471782|59210416|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
31009194|NCT01471782|59210411|FG000|Overall Study|Lack of Efficacy|1|||
31009195|NCT01471782|59210412|FG001|Overall Study|Lack of Efficacy|2|||
31009196|NCT01471782|59210413|FG002|Overall Study|Lack of Efficacy|1|||
31009197|NCT01471782|59210414|FG003|Overall Study|Lack of Efficacy|1|||
31009198|NCT01471782|59210415|FG004|Overall Study|Lack of Efficacy|5|||
31009199|NCT01471782|59210416|FG005|Overall Study|Lack of Efficacy|18|||
31009200|NCT01471782|59210411|FG000|Overall Study|Adverse Event|1|||
31009201|NCT01471782|59210412|FG001|Overall Study|Adverse Event|1|||
31009202|NCT01471782|59210413|FG002|Overall Study|Adverse Event|2|||
31009203|NCT01471782|59210414|FG003|Overall Study|Adverse Event|2|||
31009204|NCT01471782|59210415|FG004|Overall Study|Adverse Event|3|||
31009205|NCT01471782|59210416|FG005|Overall Study|Adverse Event|1|||
30614653|NCT01259726|58625704|FG002|Overall Study|Physician Decision|1|||
30614654|NCT01259726|58625705|FG003|Overall Study|Physician Decision|1|||
30614655|NCT01259726|58625702|FG000|Overall Study|Withdrawal by Subject|1|||
30893073|NCT02187861|58926513|FG003|Overall Study|Progressive Disease|22|||
30893074|NCT02187861|58926510|FG000|Overall Study|Withdrawal by Subject|0|||
30893075|NCT02187861|58926511|FG001|Overall Study|Withdrawal by Subject|0|||
30893076|NCT02187861|58926512|FG002|Overall Study|Withdrawal by Subject|3|||
31009206|NCT01471782|59210411|FG000|Overall Study|Other|0|||
30614656|NCT01259726|58625703|FG001|Overall Study|Withdrawal by Subject|3|||
30893077|NCT02187861|58926513|FG003|Overall Study|Withdrawal by Subject|3|||
30614657|NCT01259726|58625704|FG002|Overall Study|Withdrawal by Subject|2|||
30614658|NCT01259726|58625705|FG003|Overall Study|Withdrawal by Subject|1|||
30614659|NCT01259726|58625702|FG000|Overall Study|Lost to Follow-up|1|||
30614660|NCT01259726|58625703|FG001|Overall Study|Lost to Follow-up|1|||
30614661|NCT01259726|58625704|FG002|Overall Study|Lost to Follow-up|1|||
30614662|NCT01259726|58625705|FG003|Overall Study|Lost to Follow-up|3|||
30614663|NCT01259492|58625719|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
30614664|NCT01259492|58625720|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
30614665|NCT01259492|58625721|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
30614666|NCT01259492|58625722|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
30614667|NCT01259492|58625719|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
30614668|NCT01259492|58625720|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
30614669|NCT01259492|58625721|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
30614670|NCT01259492|58625722|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
30614671|NCT01259492|58625719|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
30614672|NCT01259492|58625720|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
30614673|NCT01259492|58625721|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
30614674|NCT01259492|58625722|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
30614675|NCT01259492|58625719|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
30614676|NCT01259492|58625720|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
30614677|NCT01259492|58625721|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
30614678|NCT01259492|58625722|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
30614679|NCT01259492|58625719|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
30614680|NCT01259492|58625720|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
30614681|NCT01259492|58625721|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
30614682|NCT01259492|58625722|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
30614683|NCT01259492|58625719|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
30614684|NCT01259492|58625720|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
30614685|NCT01259492|58625721|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
30614686|NCT01259492|58625722|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
30614687|NCT01259492|58625719|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
30614688|NCT01259492|58625720|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
30614689|NCT01259492|58625721|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
30614690|NCT01259492|58625722|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
30614691|NCT01259492|58625719|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
30614692|NCT01259492|58625720|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
30614693|NCT01259492|58625721|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
30614694|NCT01259492|58625722|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
30614695|NCT01259492|58625719|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
30614696|NCT01259492|58625720|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
30614697|NCT01259492|58625721|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
30614698|NCT01259492|58625722|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
30614699|NCT01259492|58625719|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
30614700|NCT01259492|58625720|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
30614701|NCT01259492|58625721|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
30614702|NCT01259492|58625722|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
30614703|NCT01259492|58625719|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
30614704|NCT01259492|58625720|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
30614705|NCT01259492|58625721|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
30614706|NCT01259492|58625722|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
30614707|NCT01259492|58625719|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
30614708|NCT01259492|58625720|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
30614709|NCT01259492|58625721|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
30614710|NCT01259492|58625722|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
30614711|NCT01259492|58625719|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
30614712|NCT01259492|58625720|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
30614713|NCT01259492|58625721|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
30614714|NCT01259492|58625722|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
30614715|NCT01259492|58625719|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
30614716|NCT01259492|58625720|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
30614717|NCT01259492|58625721|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
30614718|NCT01259492|58625722|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
30614719|NCT01259492|58625719|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
30614720|NCT01259492|58625720|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
30614721|NCT01259492|58625721|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
30614722|NCT01259492|58625722|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
30614723|NCT01259492|58625719|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
30614724|NCT01259492|58625720|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
30614725|NCT01259492|58625721|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
30614726|NCT01259492|58625722|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
30614727|NCT01259492|58625719|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
30614728|NCT01259492|58625720|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
31009207|NCT01471782|59210412|FG001|Overall Study|Other|0|||
31009208|NCT01471782|59210413|FG002|Overall Study|Other|1|||
31009209|NCT01471782|59210414|FG003|Overall Study|Other|1|||
31009210|NCT01471782|59210415|FG004|Overall Study|Other|6|||
31009211|NCT01471782|59210416|FG005|Overall Study|Other|5|||
31009212|NCT01471782|59210411|FG000|Overall Study|Change of Chemotherapy|1|||
31009213|NCT01471782|59210412|FG001|Overall Study|Change of Chemotherapy|1|||
31009214|NCT01471782|59210413|FG002|Overall Study|Change of Chemotherapy|0|||
31009215|NCT01471782|59210414|FG003|Overall Study|Change of Chemotherapy|0|||
31009216|NCT01471782|59210415|FG004|Overall Study|Change of Chemotherapy|1|||
31009217|NCT01471782|59210416|FG005|Overall Study|Change of Chemotherapy|4|||
31009218|NCT01471782|59210411|FG000|Overall Study|Disease Relapse|0|||
31009219|NCT01471782|59210412|FG001|Overall Study|Disease Relapse|0|||
31009220|NCT01471782|59210413|FG002|Overall Study|Disease Relapse|0|||
31009221|NCT01471782|59210414|FG003|Overall Study|Disease Relapse|1|||
31009222|NCT01471782|59210415|FG004|Overall Study|Disease Relapse|2|||
31009223|NCT01471782|59210416|FG005|Overall Study|Disease Relapse|1|||
31009224|NCT01471782|59210411|FG000|Overall Study|Physician Decision|0|||
31009225|NCT01471782|59210412|FG001|Overall Study|Physician Decision|0|||
31009226|NCT01471782|59210413|FG002|Overall Study|Physician Decision|0|||
31009227|NCT01471782|59210414|FG003|Overall Study|Physician Decision|0|||
31009228|NCT01471782|59210415|FG004|Overall Study|Physician Decision|3|||
31009229|NCT01471782|59210416|FG005|Overall Study|Physician Decision|8|||
31009230|NCT01471782|59210411|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
31009231|NCT01471782|59210412|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
31009232|NCT01471782|59210413|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
31009233|NCT01471782|59210414|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
31009234|NCT01471782|59210415|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
31009235|NCT01471782|59210416|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
31009236|NCT01471782|59210411|FG000|Overall Study|Death|0|||
31009237|NCT01471782|59210412|FG001|Overall Study|Death|0|||
31009238|NCT01471782|59210413|FG002|Overall Study|Death|0|||
31009239|NCT01471782|59210414|FG003|Overall Study|Death|0|||
31009240|NCT01471782|59210415|FG004|Overall Study|Death|0|||
31009241|NCT01471782|59210416|FG005|Overall Study|Death|1|||
31009242|NCT01490580|59210443|FG000|Overall Study|Parents withdrew consent|0|||
31009243|NCT01490580|59210444|FG001|Overall Study|Parents withdrew consent|2|||
31009244|NCT01490190|59210454|FG000|Overall Study|Withdrawal by Subject|9|||
31009245|NCT01490190|59210454|FG000|Overall Study|Adverse Event|17|||
31009246|NCT01490190|59210454|FG000|Overall Study|Protocol Violation|5|||
31009247|NCT01490190|59210454|FG000|Overall Study|Lost to Follow-up|13|||
31009248|NCT01490190|59210454|FG000|Overall Study|Relocation|1|||
31009249|NCT01490190|59210454|FG000|Overall Study|Inconvenience|1|||
31009250|NCT01490190|59210454|FG000|Overall Study|Ring expulsion|2|||
31009251|NCT01446042|59210461|FG000|Overall Study|Withdrawal by Subject|12|||
31009252|NCT01446042|59210462|FG001|Overall Study|Withdrawal by Subject|2|||
31009253|NCT01446042|59210463|FG002|Overall Study|Withdrawal by Subject|4|||
31009254|NCT01446042|59210461|FG000|Overall Study|Adverse Event|1|||
31009255|NCT01446042|59210462|FG001|Overall Study|Adverse Event|0|||
31009256|NCT01446042|59210463|FG002|Overall Study|Adverse Event|4|||
31009257|NCT01446042|59210461|FG000|Overall Study|Lost to Follow-up|5|||
31009258|NCT01446042|59210462|FG001|Overall Study|Lost to Follow-up|0|||
30614729|NCT01259492|58625721|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
30614730|NCT01259492|58625722|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
30614731|NCT01259492|58625719|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
30614732|NCT01259492|58625720|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
30614733|NCT01259492|58625721|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
30614734|NCT01259492|58625722|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
30614735|NCT01259492|58625719|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
30614736|NCT01259492|58625720|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
30614737|NCT01259492|58625721|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
30614738|NCT01259492|58625722|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
31009259|NCT01446042|59210463|FG002|Overall Study|Lost to Follow-up|0|||
30893078|NCT02187861|58926510|FG000|Overall Study|Other|0|||
31009260|NCT01446042|59210461|FG000|Overall Study|Other reasons|2|||
31009261|NCT01446042|59210462|FG001|Overall Study|Other reasons|1|||
30614739|NCT01259492|58625719|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
31009262|NCT01446042|59210463|FG002|Overall Study|Other reasons|1|||
31009263|NCT01445886|59210471|FG000|Overall Study|Lost to Follow-up|2|||
31009264|NCT01445886|59210471|FG000|Overall Study|Protocol Violation|3|||
31009265|NCT01470612|59210479|FG000|Overall Study|Adverse Event|20|||
30614740|NCT01259492|58625720|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
30614741|NCT01259492|58625721|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
30614742|NCT01259492|58625722|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
30614743|NCT01117623|58625739|FG000|Overall Study|Adverse Event|0|||
30614744|NCT01117623|58625740|FG001|Overall Study|Adverse Event|2|||
30614745|NCT01117623|58625741|FG002|Overall Study|Adverse Event|4|||
30614746|NCT01117623|58625742|FG003|Overall Study|Adverse Event|0|||
30614747|NCT01117623|58625743|FG004|Overall Study|Adverse Event|2|||
30614748|NCT01117623|58625744|FG005|Overall Study|Adverse Event|0|||
30614749|NCT01117623|58625745|FG006|Overall Study|Adverse Event|0|||
30614750|NCT01117623|58625746|FG007|Overall Study|Adverse Event|2|||
30614751|NCT01117623|58625739|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
30614752|NCT01117623|58625740|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
30614753|NCT01117623|58625741|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
30614754|NCT01117623|58625742|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
30614755|NCT01117623|58625743|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
30614756|NCT01117623|58625744|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
30614757|NCT01117623|58625745|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
30614758|NCT01117623|58625746|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
30614759|NCT01117623|58625739|FG000|Overall Study|Withdrawal by Subject|0|||
30614760|NCT01117623|58625740|FG001|Overall Study|Withdrawal by Subject|0|||
30614761|NCT01117623|58625741|FG002|Overall Study|Withdrawal by Subject|2|||
30614762|NCT01117623|58625742|FG003|Overall Study|Withdrawal by Subject|0|||
30614763|NCT01117623|58625743|FG004|Overall Study|Withdrawal by Subject|0|||
30614764|NCT01117623|58625744|FG005|Overall Study|Withdrawal by Subject|1|||
30614765|NCT01117623|58625745|FG006|Overall Study|Withdrawal by Subject|1|||
30614766|NCT01117623|58625746|FG007|Overall Study|Withdrawal by Subject|1|||
30614767|NCT01117623|58625739|FG000|Overall Study|Non-compliance with study medication|0|||
30614768|NCT01117623|58625740|FG001|Overall Study|Non-compliance with study medication|0|||
30614769|NCT01117623|58625741|FG002|Overall Study|Non-compliance with study medication|0|||
30614770|NCT01117623|58625742|FG003|Overall Study|Non-compliance with study medication|0|||
30614771|NCT01117623|58625743|FG004|Overall Study|Non-compliance with study medication|0|||
30614772|NCT01117623|58625744|FG005|Overall Study|Non-compliance with study medication|0|||
30614773|NCT01117623|58625745|FG006|Overall Study|Non-compliance with study medication|0|||
30614774|NCT01117623|58625746|FG007|Overall Study|Non-compliance with study medication|1|||
30614775|NCT01117623|58625739|FG000|Overall Study|Invest. text: completed all planned txs|0|||
30614776|NCT01117623|58625740|FG001|Overall Study|Invest. text: completed all planned txs|0|||
30614777|NCT01117623|58625741|FG002|Overall Study|Invest. text: completed all planned txs|0|||
30614778|NCT01117623|58625742|FG003|Overall Study|Invest. text: completed all planned txs|0|||
30614779|NCT01117623|58625743|FG004|Overall Study|Invest. text: completed all planned txs|0|||
30614780|NCT01117623|58625744|FG005|Overall Study|Invest. text: completed all planned txs|1|||
30614781|NCT01117623|58625745|FG006|Overall Study|Invest. text: completed all planned txs|0|||
30614782|NCT01117623|58625746|FG007|Overall Study|Invest. text: completed all planned txs|0|||
30614783|NCT01116687|58625766|FG000|Overall Study|Withdrawal by Subject|4|||
30614784|NCT01114737|58625772|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
30614785|NCT01114737|58625773|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
30614786|NCT01114737|58625772|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
30614787|NCT01114737|58625773|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
30614788|NCT01114737|58625772|FG000|Randomized Treatment Period|Pregnancy|1|||
30614789|NCT01114737|58625773|FG001|Randomized Treatment Period|Pregnancy|0|||
30614790|NCT01114737|58625772|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
30614791|NCT01114737|58625773|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
30614792|NCT01114737|58625772|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
30614793|NCT01114737|58625773|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
30614794|NCT01114737|58625772|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
30614795|NCT01114737|58625773|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
30614796|NCT01113879|58625796|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
30614797|NCT01113879|58625797|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
30614798|NCT00979576|58625808|FG000|Combination Treatment Phase|Progressive disease|3|||
30614799|NCT00979576|58625809|FG001|Combination Treatment Phase|Progressive disease|1|||
30614800|NCT00979576|58625810|FG002|Combination Treatment Phase|Progressive disease|5|||
30614801|NCT00979576|58625808|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
30614802|NCT00979576|58625809|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
30614803|NCT00979576|58625810|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
30614804|NCT00979576|58625808|FG000|Combination Treatment Phase|Adverse Event|0|||
30893079|NCT02187861|58926511|FG001|Overall Study|Other|1|||
30893080|NCT02187861|58926512|FG002|Overall Study|Other|7|||
30614805|NCT00979576|58625809|FG001|Combination Treatment Phase|Adverse Event|2|||
30614806|NCT00979576|58625810|FG002|Combination Treatment Phase|Adverse Event|2|||
30614807|NCT00979576|58625808|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
30614808|NCT00979576|58625809|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
30614809|NCT00979576|58625810|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
30614810|NCT00979420|58625823|FG000|Overall Study|Adverse Event|1|||
30614811|NCT00979420|58625824|FG001|Overall Study|Adverse Event|0|||
30614812|NCT00979420|58625825|FG002|Overall Study|Adverse Event|0|||
30614813|NCT00979420|58625826|FG003|Overall Study|Adverse Event|0|||
30614814|NCT00979420|58625823|FG000|Overall Study|Lack of Efficacy|3|||
30614815|NCT00979420|58625824|FG001|Overall Study|Lack of Efficacy|0|||
30614816|NCT00979420|58625825|FG002|Overall Study|Lack of Efficacy|1|||
30614817|NCT00979420|58625826|FG003|Overall Study|Lack of Efficacy|1|||
30614818|NCT00979420|58625823|FG000|Overall Study|Other reasons not related to Viramune|3|||
30614819|NCT00979420|58625824|FG001|Overall Study|Other reasons not related to Viramune|0|||
30614820|NCT00979420|58625825|FG002|Overall Study|Other reasons not related to Viramune|0|||
30614821|NCT00979420|58625826|FG003|Overall Study|Other reasons not related to Viramune|1|||
30614822|NCT02702180|58625837|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
30614823|NCT02702180|58625838|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
30614824|NCT02702180|58625839|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
30614825|NCT02702180|58625837|FG000|Double-blind Treatment Period|Adverse Event|0|||
30614826|NCT02702180|58625838|FG001|Double-blind Treatment Period|Adverse Event|0|||
30614827|NCT02702180|58625839|FG002|Double-blind Treatment Period|Adverse Event|1|||
30614828|NCT02702180|58625837|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
30614829|NCT02702180|58625838|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
30614830|NCT02702180|58625839|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
30614831|NCT02702180|58625837|FG000|Double-blind Treatment Period|Protocol Violation|0|||
30614832|NCT02702180|58625838|FG001|Double-blind Treatment Period|Protocol Violation|0|||
30614833|NCT02702180|58625839|FG002|Double-blind Treatment Period|Protocol Violation|2|||
30614834|NCT02702180|58625837|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
30614835|NCT02702180|58625838|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
30614836|NCT02702180|58625839|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
30614837|NCT02702180|58625837|FG000|Open-label Treatment Period|Withdrawn in error|0|||
30614838|NCT02702180|58625838|FG001|Open-label Treatment Period|Withdrawn in error|0|||
30614839|NCT02702180|58625839|FG002|Open-label Treatment Period|Withdrawn in error|1|||
30614840|NCT00980980|58625851|FG000|Overall Study|Withdrawal by Hospital|0|||
30614841|NCT00980980|58625852|FG001|Overall Study|Withdrawal by Hospital|1|||
30614842|NCT00980980|58625853|FG002|Overall Study|Withdrawal by Hospital|0|||
30614843|NCT00980200|58625864|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
30614844|NCT00980200|58625865|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
30614845|NCT00980200|58625866|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
30614846|NCT00980200|58625867|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
30614847|NCT00980200|58625868|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
30614848|NCT00980200|58625864|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
30614849|NCT00980200|58625865|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
30614850|NCT00980200|58625866|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
30614851|NCT00980200|58625867|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
30614852|NCT00980200|58625868|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
30614853|NCT00979654|58625880|FG000|Overall Study|Lost to Follow-up|1|||
30614854|NCT00979654|58625880|FG000|Overall Study|Withdrawal by Subject|22|||
30614855|NCT00979654|58625880|FG000|Overall Study|Death|1|||
30614856|NCT00979654|58625880|FG000|Overall Study|Lack of Efficacy|6|||
30614857|NCT00979654|58625880|FG000|Overall Study|Adverse Event|1|||
30614858|NCT00979654|58625880|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
30614859|NCT00979654|58625880|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
30614860|NCT00979654|58625880|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
30614861|NCT00979654|58625880|FG000|Overall Study|Serious Adverse Event|1|||
30614862|NCT00979654|58625880|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
30614863|NCT00978562|58625884|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
30614864|NCT02865460|58625892|FG000|Overall Study|Adverse Event|1|||
30614865|NCT02865460|58625893|FG001|Overall Study|Adverse Event|0|||
30614866|NCT02865460|58625892|FG000|Overall Study|Withdrawal by Subject|1|||
30614867|NCT02865460|58625893|FG001|Overall Study|Withdrawal by Subject|1|||
30614868|NCT02865460|58625892|FG000|Overall Study|Lost to Follow-up|7|||
30614869|NCT02865460|58625893|FG001|Overall Study|Lost to Follow-up|4|||
30614870|NCT02865460|58625892|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
30614871|NCT02865460|58625893|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
30614872|NCT01206816|58625906|FG000|Overall Study|Protocol Violation|0|||
30614873|NCT01206816|58625907|FG001|Overall Study|Protocol Violation|0|||
30614874|NCT01206816|58625908|FG002|Overall Study|Protocol Violation|1|||
30614875|NCT01206816|58625909|FG003|Overall Study|Protocol Violation|0|||
30614876|NCT01206816|58625910|FG004|Overall Study|Protocol Violation|0|||
30614877|NCT01206816|58625911|FG005|Overall Study|Protocol Violation|0|||
30614878|NCT01206816|58625912|FG006|Overall Study|Protocol Violation|0|||
30614879|NCT01206816|58625906|FG000|Overall Study|Withdrawal by Subject|0|||
30614880|NCT01206816|58625907|FG001|Overall Study|Withdrawal by Subject|0|||
30790776|NCT03524092|58803945|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
30893081|NCT02187861|58926513|FG003|Overall Study|Other|1|||
30614881|NCT01206816|58625908|FG002|Overall Study|Withdrawal by Subject|1|||
30614882|NCT01206816|58625909|FG003|Overall Study|Withdrawal by Subject|0|||
30614883|NCT01206816|58625910|FG004|Overall Study|Withdrawal by Subject|0|||
30614884|NCT01206816|58625911|FG005|Overall Study|Withdrawal by Subject|0|||
30614885|NCT01206816|58625912|FG006|Overall Study|Withdrawal by Subject|0|||
30614886|NCT01206816|58625906|FG000|Overall Study|Progressive disease|3|||
30614887|NCT01206816|58625907|FG001|Overall Study|Progressive disease|3|||
30614888|NCT01206816|58625908|FG002|Overall Study|Progressive disease|13|||
30614889|NCT01206816|58625909|FG003|Overall Study|Progressive disease|3|||
30614890|NCT01206816|58625910|FG004|Overall Study|Progressive disease|3|||
30614891|NCT01206816|58625911|FG005|Overall Study|Progressive disease|16|||
30614892|NCT01206816|58625912|FG006|Overall Study|Progressive disease|3|||
30614893|NCT01206816|58625906|FG000|Overall Study|Other AE|0|||
30614894|NCT01206816|58625907|FG001|Overall Study|Other AE|0|||
30614895|NCT01206816|58625908|FG002|Overall Study|Other AE|4|||
30614896|NCT01206816|58625909|FG003|Overall Study|Other AE|0|||
30614897|NCT01206816|58625910|FG004|Overall Study|Other AE|0|||
30614898|NCT01206816|58625911|FG005|Overall Study|Other AE|3|||
30614899|NCT01206816|58625912|FG006|Overall Study|Other AE|2|||
30614900|NCT01206816|58625906|FG000|Overall Study|other than stated above|0|||
30614901|NCT01206816|58625907|FG001|Overall Study|other than stated above|0|||
30614902|NCT01206816|58625908|FG002|Overall Study|other than stated above|1|||
30614903|NCT01206816|58625909|FG003|Overall Study|other than stated above|0|||
30614904|NCT01206816|58625910|FG004|Overall Study|other than stated above|0|||
30614905|NCT01206816|58625911|FG005|Overall Study|other than stated above|0|||
30614906|NCT01206816|58625912|FG006|Overall Study|other than stated above|1|||
30699277|NCT03865732|58713806|FG001|Overall Study|Adverse Event|1|||
30699278|NCT00520546|58713813|FG000|Overall Study|Withdrawal by Subject|1|||
30614907|NCT01206582|58625934|FG000|Overall Study|Withdrew prior to study|1|||
30614908|NCT01206582|58625935|FG001|Overall Study|Withdrew prior to study|0|||
30614909|NCT01206582|58625934|FG000|Overall Study|Discontinued intervention before week 8|1|||
30614910|NCT01206582|58625935|FG001|Overall Study|Discontinued intervention before week 8|2|||
30699279|NCT00520546|58713813|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
30614911|NCT01259102|58625946|FG000|Overall Study|Adverse Event|1|||
30614912|NCT01259102|58625947|FG001|Overall Study|Adverse Event|0|||
30614913|NCT01259102|58625948|FG002|Overall Study|Adverse Event|1|||
30614914|NCT01259102|58625949|FG003|Overall Study|Adverse Event|1|||
30614915|NCT01259102|58625950|FG004|Overall Study|Adverse Event|0|||
30614916|NCT01259102|58625946|FG000|Overall Study|Other|0|||
30614917|NCT01259102|58625947|FG001|Overall Study|Other|0|||
30614918|NCT01259102|58625948|FG002|Overall Study|Other|1|||
30614919|NCT01259102|58625949|FG003|Overall Study|Other|1|||
30614920|NCT01259102|58625950|FG004|Overall Study|Other|1|||
30614921|NCT00978250|58625966|FG000|Overall Study|Late determination of ineligibility|0|||
30614922|NCT00978250|58625967|FG001|Overall Study|Late determination of ineligibility|1|||
30614923|NCT00978250|58625968|FG002|Overall Study|Late determination of ineligibility|0|||
30614924|NCT00978250|58625969|FG003|Overall Study|Late determination of ineligibility|1|||
30614925|NCT01259024|58625981|FG000|Overall Study|Physician Decision|1|||
30614926|NCT01257698|58625987|FG000|Overall Study|Protocol Violation|4|||
30614927|NCT01257698|58625988|FG001|Overall Study|Protocol Violation|0|||
30614928|NCT01257542|58625996|FG000|Overall Study|Protocol Violation|3|||
30614929|NCT01257542|58625997|FG001|Overall Study|Protocol Violation|5|||
30614930|NCT01257542|58625996|FG000|Overall Study|Withdrawal by Subject|0|||
30614931|NCT01257542|58625997|FG001|Overall Study|Withdrawal by Subject|2|||
30614932|NCT01257230|58626006|FG000|Overall Study|Not Treated|0|||
30614933|NCT01257230|58626007|FG001|Overall Study|Not Treated|0|||
30614934|NCT01257230|58626008|FG002|Overall Study|Not Treated|1|||
30614935|NCT01257230|58626006|FG000|Overall Study|Adverse Event|2|||
30614936|NCT01257230|58626007|FG001|Overall Study|Adverse Event|0|||
30614937|NCT01257230|58626008|FG002|Overall Study|Adverse Event|0|||
30614938|NCT01257230|58626006|FG000|Overall Study|Lack of Efficacy|0|||
30614939|NCT01257230|58626007|FG001|Overall Study|Lack of Efficacy|1|||
30614940|NCT01257230|58626008|FG002|Overall Study|Lack of Efficacy|0|||
30614941|NCT01257230|58626006|FG000|Overall Study|Protocol Violation|3|||
30614942|NCT01257230|58626007|FG001|Overall Study|Protocol Violation|0|||
30614943|NCT01257230|58626008|FG002|Overall Study|Protocol Violation|1|||
30614944|NCT01257230|58626006|FG000|Overall Study|Withdrawal by Subject|0|||
30614945|NCT01257230|58626007|FG001|Overall Study|Withdrawal by Subject|4|||
30614946|NCT01257230|58626008|FG002|Overall Study|Withdrawal by Subject|1|||
30614947|NCT01257230|58626006|FG000|Overall Study|Other reason not defined above|1|||
30614948|NCT01257230|58626007|FG001|Overall Study|Other reason not defined above|5|||
30614949|NCT01257230|58626008|FG002|Overall Study|Other reason not defined above|3|||
30614950|NCT01113801|58626021|FG000|Overall Study|Adverse Event|4|||
30614951|NCT01113801|58626022|FG001|Overall Study|Adverse Event|0|||
30614952|NCT01113801|58626023|FG002|Overall Study|Adverse Event|2|||
30614953|NCT01113801|58626024|FG003|Overall Study|Adverse Event|6|||
30614954|NCT01113801|58626021|FG000|Overall Study|Death|4|||
30614955|NCT01113801|58626022|FG001|Overall Study|Death|5|||
30614956|NCT01113801|58626023|FG002|Overall Study|Death|3|||
30614957|NCT01113801|58626024|FG003|Overall Study|Death|4|||
30614958|NCT01113801|58626021|FG000|Overall Study|Protocol Violation|0|||
30614959|NCT01113801|58626022|FG001|Overall Study|Protocol Violation|1|||
30614960|NCT01113801|58626023|FG002|Overall Study|Protocol Violation|0|||
30614961|NCT01113801|58626024|FG003|Overall Study|Protocol Violation|0|||
30614962|NCT01113801|58626021|FG000|Overall Study|Withdrawal by Subject|9|||
30614963|NCT01113801|58626022|FG001|Overall Study|Withdrawal by Subject|7|||
30614964|NCT01113801|58626023|FG002|Overall Study|Withdrawal by Subject|7|||
30614965|NCT01113801|58626024|FG003|Overall Study|Withdrawal by Subject|8|||
30614966|NCT01113801|58626021|FG000|Overall Study|Physician Decision|2|||
30614967|NCT01113801|58626022|FG001|Overall Study|Physician Decision|2|||
30614968|NCT01113801|58626023|FG002|Overall Study|Physician Decision|3|||
30614969|NCT01113801|58626024|FG003|Overall Study|Physician Decision|3|||
30614970|NCT01113801|58626021|FG000|Overall Study|Sponsor Decision|15|||
30614971|NCT01113801|58626022|FG001|Overall Study|Sponsor Decision|21|||
30614972|NCT01113801|58626023|FG002|Overall Study|Sponsor Decision|20|||
30614973|NCT01113801|58626024|FG003|Overall Study|Sponsor Decision|15|||
30614974|NCT01113801|58626021|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
30614975|NCT01113801|58626022|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
30614976|NCT01113801|58626023|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
30614977|NCT01113801|58626024|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
30614978|NCT01256684|58626037|FG000|Overall Study|Adverse Event|1|||
30614979|NCT01256684|58626038|FG001|Overall Study|Adverse Event|4|||
30614980|NCT01256684|58626039|FG002|Overall Study|Adverse Event|2|||
30614981|NCT01256684|58626037|FG000|Overall Study|Withdrawal by Subject|4|||
30614982|NCT01256684|58626038|FG001|Overall Study|Withdrawal by Subject|0|||
30614983|NCT01256684|58626039|FG002|Overall Study|Withdrawal by Subject|2|||
30614984|NCT01256684|58626037|FG000|Overall Study|Physician Decision|0|||
30614985|NCT01256684|58626038|FG001|Overall Study|Physician Decision|1|||
30614986|NCT01256684|58626039|FG002|Overall Study|Physician Decision|0|||
30614987|NCT01256684|58626037|FG000|Overall Study|Lack of Efficacy|0|||
30614988|NCT01256684|58626038|FG001|Overall Study|Lack of Efficacy|1|||
30614989|NCT01256684|58626039|FG002|Overall Study|Lack of Efficacy|1|||
30614990|NCT01256684|58626037|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
30614991|NCT01256684|58626038|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
30614992|NCT01256684|58626039|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
30614993|NCT01204710|58626049|FG000|Randomization Treatment|Lost to Follow-up|1|||
30614994|NCT01204710|58626050|FG001|Randomization Treatment|Lost to Follow-up|0|||
30614995|NCT01204710|58626049|FG000|Randomization Treatment|Withdrawal by Subject|6|||
30614996|NCT01204710|58626050|FG001|Randomization Treatment|Withdrawal by Subject|5|||
30614997|NCT01204710|58626049|FG000|Randomization Treatment|Physician Decision|3|||
30614998|NCT01204710|58626050|FG001|Randomization Treatment|Physician Decision|2|||
30614999|NCT01204710|58626049|FG000|Randomization Treatment|Entry criteria not met|0|||
30615000|NCT01204710|58626050|FG001|Randomization Treatment|Entry criteria not met|1|||
30615001|NCT01204710|58626049|FG000|Randomization Treatment|Adverse Event|4|||
30615002|NCT01204710|58626050|FG001|Randomization Treatment|Adverse Event|2|||
30615003|NCT01204710|58626049|FG000|Randomization Treatment|Sponsor Decision|0|||
30615004|NCT01204710|58626050|FG001|Randomization Treatment|Sponsor Decision|1|||
30615005|NCT01204710|58626049|FG000|Randomization Treatment|Worsening of General condition|0|||
30615006|NCT01204710|58626050|FG001|Randomization Treatment|Worsening of General condition|1|||
30615007|NCT01204710|58626049|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
30615008|NCT01204710|58626050|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
30615009|NCT01204710|58626049|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
30615010|NCT01204710|58626050|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
30615011|NCT01204710|58626049|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
30615012|NCT01204710|58626050|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
30615013|NCT01204710|58626049|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
30615014|NCT01204710|58626050|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
30615015|NCT01256450|58626065|FG000|Open-label Titration|Adverse Event|39|||
30615016|NCT01256450|58626066|FG001|Open-label Titration|Adverse Event|0|||
30615017|NCT01256450|58626067|FG002|Open-label Titration|Adverse Event|0|||
30615018|NCT01256450|58626065|FG000|Open-label Titration|Lost to Follow-up|7|||
30615019|NCT01256450|58626066|FG001|Open-label Titration|Lost to Follow-up|0|||
30615020|NCT01256450|58626067|FG002|Open-label Titration|Lost to Follow-up|0|||
30615021|NCT01256450|58626065|FG000|Open-label Titration|Lack of analgesic effect|30|||
30615022|NCT01256450|58626066|FG001|Open-label Titration|Lack of analgesic effect|0|||
30615023|NCT01256450|58626067|FG002|Open-label Titration|Lack of analgesic effect|0|||
30615024|NCT01256450|58626065|FG000|Open-label Titration|Non-compliance|9|||
30615025|NCT01256450|58626066|FG001|Open-label Titration|Non-compliance|0|||
30615026|NCT01256450|58626067|FG002|Open-label Titration|Non-compliance|0|||
30615027|NCT01256450|58626065|FG000|Open-label Titration|Screen failure|1|||
30615028|NCT01256450|58626066|FG001|Open-label Titration|Screen failure|0|||
30615029|NCT01256450|58626067|FG002|Open-label Titration|Screen failure|0|||
30615030|NCT01256450|58626065|FG000|Open-label Titration|Other|13|||
30615031|NCT01256450|58626066|FG001|Open-label Titration|Other|0|||
30615032|NCT01256450|58626067|FG002|Open-label Titration|Other|0|||
30615033|NCT01256450|58626065|FG000|Double-blind Treatment|Adverse Event|0|||
30615034|NCT01256450|58626066|FG001|Double-blind Treatment|Adverse Event|8|||
30615035|NCT01256450|58626067|FG002|Double-blind Treatment|Adverse Event|6|||
30615036|NCT01256450|58626065|FG000|Double-blind Treatment|Lost to Follow-up|0|||
30615037|NCT01256450|58626066|FG001|Double-blind Treatment|Lost to Follow-up|1|||
30615038|NCT01256450|58626067|FG002|Double-blind Treatment|Lost to Follow-up|7|||
30615039|NCT01256450|58626065|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
30615040|NCT01256450|58626066|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
30615041|NCT01256450|58626067|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
30615042|NCT01256450|58626065|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
30615043|NCT01256450|58626066|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
30615044|NCT01256450|58626067|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
30615045|NCT01256450|58626065|FG000|Double-blind Treatment|Non-compliance|0|||
30615046|NCT01256450|58626066|FG001|Double-blind Treatment|Non-compliance|5|||
30615047|NCT01256450|58626067|FG002|Double-blind Treatment|Non-compliance|4|||
30615048|NCT01256450|58626065|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
30615049|NCT01256450|58626066|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
30615050|NCT01256450|58626067|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
30615051|NCT01256450|58626065|FG000|Double-blind Treatment|Other|0|||
30615052|NCT01256450|58626066|FG001|Double-blind Treatment|Other|9|||
30615053|NCT01256450|58626067|FG002|Double-blind Treatment|Other|12|||
30615054|NCT01204398|58626074|FG000|Overall Study|Adverse Event|1|||
30615055|NCT01111851|58626080|FG000|Overall Study|All planned PET scans were not obtained.|2|||
30615056|NCT01111851|58626081|FG001|Overall Study|All planned PET scans were not obtained.|0|||
30615057|NCT01256294|58626087|FG000|Overall Study|Adverse Event|1|||
30615058|NCT01256294|58626088|FG001|Overall Study|Adverse Event|0|||
30615059|NCT01256294|58626087|FG000|Overall Study|Withdrawal by Subject|1|||
30615060|NCT01256294|58626088|FG001|Overall Study|Withdrawal by Subject|1|||
30615061|NCT01256294|58626087|FG000|Overall Study|Protocol deviation|2|||
30615062|NCT01256294|58626088|FG001|Overall Study|Protocol deviation|1|||
30615063|NCT01256060|58626094|FG000|Overall Study|Lost to Follow-up|0|||
30615064|NCT01256060|58626095|FG001|Overall Study|Lost to Follow-up|1|||
30615065|NCT01256060|58626096|FG002|Overall Study|Lost to Follow-up|0|||
30615066|NCT01256060|58626097|FG003|Overall Study|Lost to Follow-up|0|||
30615067|NCT01255904|58626105|FG000|Overall Study|Physician Decision|1|||
30615068|NCT01255904|58626106|FG001|Overall Study|Physician Decision|4|||
30615069|NCT01255670|58626114|FG000|Overall Study|Adverse Event|10|||
30615070|NCT01255670|58626115|FG001|Overall Study|Adverse Event|10|||
30615071|NCT01255670|58626114|FG000|Overall Study|Lost to Follow-up|16|||
30615072|NCT01255670|58626115|FG001|Overall Study|Lost to Follow-up|10|||
30615073|NCT01255592|58626123|FG000|Overall Study|Adverse Event|5|||
30615074|NCT01255592|58626124|FG001|Overall Study|Adverse Event|0|||
30615075|NCT01255592|58626123|FG000|Overall Study|Withdrawal by Subject|1|||
30615076|NCT01255592|58626124|FG001|Overall Study|Withdrawal by Subject|0|||
30615077|NCT01255592|58626123|FG000|Overall Study|Other|0|||
30615078|NCT01255592|58626124|FG001|Overall Study|Other|1|||
30615079|NCT01255436|58626133|FG000|Overall Study|Lost to Follow-up|178|||
30615080|NCT01255436|58626134|FG001|Overall Study|Lost to Follow-up|191|||
30615081|NCT01255436|58626133|FG000|Overall Study|Death, stroke, or MI|4|||
31009266|NCT01470612|59210480|FG001|Overall Study|Adverse Event|80|||
31009267|NCT01470612|59210479|FG000|Overall Study|Death|0|||
31009268|NCT01470612|59210480|FG001|Overall Study|Death|1|||
31009269|NCT01470612|59210479|FG000|Overall Study|Lack of Efficacy|20|||
31009270|NCT01470612|59210480|FG001|Overall Study|Lack of Efficacy|326|||
31009271|NCT01470612|59210479|FG000|Overall Study|Lost to Follow-up|2|||
30615082|NCT01255436|58626134|FG001|Overall Study|Death, stroke, or MI|3|||
30615083|NCT01203930|58626142|FG000|Overall Study|Disease Progression|0|||
30615084|NCT01203930|58626143|FG001|Overall Study|Disease Progression|4|||
30615085|NCT01203930|58626142|FG000|Overall Study|Death|3|||
30615086|NCT01203930|58626143|FG001|Overall Study|Death|1|||
30615087|NCT01203930|58626142|FG000|Overall Study|Withdrew Consent|1|||
30615088|NCT01203930|58626143|FG001|Overall Study|Withdrew Consent|10|||
30615089|NCT01203930|58626142|FG000|Overall Study|Investigator Request|0|||
30615090|NCT01203930|58626143|FG001|Overall Study|Investigator Request|8|||
30615091|NCT01203930|58626142|FG000|Overall Study|Study Terminated by Sponsor|0|||
30615092|NCT01203930|58626143|FG001|Overall Study|Study Terminated by Sponsor|12|||
30615093|NCT01203930|58626142|FG000|Overall Study|Poor tolerance of study drug|0|||
30615094|NCT01203930|58626143|FG001|Overall Study|Poor tolerance of study drug|1|||
30615095|NCT01203930|58626142|FG000|Overall Study|Adverse Event|17|||
30615096|NCT01203930|58626143|FG001|Overall Study|Adverse Event|5|||
30615097|NCT01254890|58626153|FG000|Overall Study|Ineligible|0|||
30615098|NCT01254890|58626154|FG001|Overall Study|Ineligible|3|||
30615099|NCT01254890|58626153|FG000|Overall Study|Withdrawal by Subject|1|||
30615100|NCT01254890|58626154|FG001|Overall Study|Withdrawal by Subject|2|||
30615101|NCT01254890|58626153|FG000|Overall Study|Disease Progression|0|||
30615102|NCT01254890|58626154|FG001|Overall Study|Disease Progression|5|||
30615103|NCT01203852|58626159|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
30615104|NCT01203852|58626159|FG000|Washout 2 Weeks|Physician Decision|46|||
30615105|NCT01105533|58626166|FG000|Overall Study|Death|0|||
30615106|NCT01105533|58626167|FG001|Overall Study|Death|0|||
31009272|NCT01470612|59210480|FG001|Overall Study|Lost to Follow-up|5|||
30615107|NCT01105533|58626168|FG002|Overall Study|Death|0|||
30615108|NCT01105533|58626169|FG003|Overall Study|Death|0|||
31009273|NCT01470612|59210479|FG000|Overall Study|Did not meet entrance criteria|0|||
30615109|NCT01105533|58626170|FG004|Overall Study|Death|1|||
30615110|NCT01105533|58626171|FG005|Overall Study|Death|0|||
31009274|NCT01470612|59210480|FG001|Overall Study|Did not meet entrance criteria|1|||
30615111|NCT01105533|58626172|FG006|Overall Study|Death|0|||
30615112|NCT01105533|58626173|FG007|Overall Study|Death|0|||
30615113|NCT01105533|58626174|FG008|Overall Study|Death|0|||
30615114|NCT01105533|58626166|FG000|Overall Study|Lack of Efficacy|1|||
30615115|NCT01105533|58626167|FG001|Overall Study|Lack of Efficacy|1|||
30615116|NCT01105533|58626168|FG002|Overall Study|Lack of Efficacy|3|||
30615117|NCT01105533|58626169|FG003|Overall Study|Lack of Efficacy|3|||
30615118|NCT01105533|58626170|FG004|Overall Study|Lack of Efficacy|4|||
30615119|NCT01105533|58626171|FG005|Overall Study|Lack of Efficacy|5|||
30615120|NCT01105533|58626172|FG006|Overall Study|Lack of Efficacy|3|||
30615121|NCT01105533|58626173|FG007|Overall Study|Lack of Efficacy|2|||
30615122|NCT01105533|58626174|FG008|Overall Study|Lack of Efficacy|9|||
30615123|NCT01105533|58626166|FG000|Overall Study|Adverse Event|0|||
30615124|NCT01105533|58626167|FG001|Overall Study|Adverse Event|0|||
30615125|NCT01105533|58626168|FG002|Overall Study|Adverse Event|0|||
30615126|NCT01105533|58626169|FG003|Overall Study|Adverse Event|0|||
30615127|NCT01105533|58626170|FG004|Overall Study|Adverse Event|1|||
30615128|NCT01105533|58626171|FG005|Overall Study|Adverse Event|2|||
30615129|NCT01105533|58626172|FG006|Overall Study|Adverse Event|2|||
30615130|NCT01105533|58626173|FG007|Overall Study|Adverse Event|0|||
30615131|NCT01105533|58626174|FG008|Overall Study|Adverse Event|1|||
30615132|NCT01105533|58626166|FG000|Overall Study|Other|0|||
30615133|NCT01105533|58626167|FG001|Overall Study|Other|0|||
30615134|NCT01105533|58626168|FG002|Overall Study|Other|0|||
31009275|NCT01470612|59210479|FG000|Overall Study|Pregnancy|2|||
31009276|NCT01470612|59210480|FG001|Overall Study|Pregnancy|10|||
31009277|NCT01470612|59210479|FG000|Overall Study|Protocol Violation|2|||
31009278|NCT01470612|59210480|FG001|Overall Study|Protocol Violation|7|||
31009279|NCT01470612|59210479|FG000|Overall Study|Withdrawal by Subject|24|||
31009280|NCT01470612|59210480|FG001|Overall Study|Withdrawal by Subject|79|||
31009281|NCT01470612|59210479|FG000|Overall Study|Other|14|||
31009282|NCT01470612|59210480|FG001|Overall Study|Other|156|||
31009283|NCT01445730|59210486|FG000|Overall Study|Adverse Event|1|||
31009284|NCT01445730|59210486|FG000|Overall Study|For the advice of a dentist|1|||
31009285|NCT01445730|59210486|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
31009286|NCT01445652|59210492|FG000|Overall Study|Not comfortable in lenses|5|||
31009287|NCT01445652|59210493|FG001|Overall Study|Not comfortable in lenses|0|||
31009288|NCT01445652|59210492|FG000|Overall Study|Failed to attend scheduled visit|2|||
31009289|NCT01445652|59210493|FG001|Overall Study|Failed to attend scheduled visit|3|||
31009290|NCT01445652|59210492|FG000|Overall Study|Failed teach session|2|||
31009291|NCT01445652|59210493|FG001|Overall Study|Failed teach session|0|||
31009292|NCT01445652|59210492|FG000|Overall Study|Adverse Event|1|||
31009293|NCT01445652|59210493|FG001|Overall Study|Adverse Event|0|||
31009294|NCT01470144|59210499|FG000|Overall Study|Adverse Event|2|||
31009295|NCT01470144|59210499|FG000|Overall Study|Death|1|||
31009296|NCT01470144|59210499|FG000|Overall Study|Lung transplant|6|||
31009297|NCT01470144|59210499|FG000|Overall Study|Patient's and investigator's decision|1|||
31009298|NCT01443858|59210506|FG000|Overall Study|Withdrawal by Subject|9|||
31009299|NCT01443858|59210507|FG001|Overall Study|Withdrawal by Subject|8|||
31009300|NCT01443858|59210508|FG002|Overall Study|Withdrawal by Subject|5|||
31009301|NCT01443858|59210506|FG000|Overall Study|Lack of Efficacy|1|||
31009302|NCT01443858|59210507|FG001|Overall Study|Lack of Efficacy|0|||
31009303|NCT01443858|59210508|FG002|Overall Study|Lack of Efficacy|0|||
31009304|NCT01443858|59210506|FG000|Overall Study|Lost to Follow-up|5|||
31009305|NCT01443858|59210507|FG001|Overall Study|Lost to Follow-up|5|||
31009306|NCT01443858|59210508|FG002|Overall Study|Lost to Follow-up|2|||
31009307|NCT01443078|59210516|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
31009308|NCT01443078|59210516|FG000|Overall Study|Withdrawal by Subject|1|||
31009309|NCT01443078|59210516|FG000|Overall Study|Patient had brain mets|1|||
31009310|NCT01439880|59210522|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
31009311|NCT01439880|59210523|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
31009312|NCT01439880|59210522|FG000|SOC-controlled Period (Year 1)|Death|2|||
31009313|NCT01439880|59210523|FG001|SOC-controlled Period (Year 1)|Death|1|||
31009314|NCT01439880|59210522|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
30615135|NCT01105533|58626169|FG003|Overall Study|Other|0|||
30615136|NCT01105533|58626170|FG004|Overall Study|Other|1|||
30615137|NCT01105533|58626171|FG005|Overall Study|Other|0|||
30615138|NCT01105533|58626172|FG006|Overall Study|Other|3|||
30615139|NCT01105533|58626173|FG007|Overall Study|Other|1|||
30615140|NCT01105533|58626174|FG008|Overall Study|Other|2|||
30615141|NCT01105533|58626166|FG000|Overall Study|Physician Decision|0|||
31009315|NCT01439880|59210523|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
31009316|NCT01439880|59210522|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
30615142|NCT01105533|58626167|FG001|Overall Study|Physician Decision|0|||
30615143|NCT01105533|58626168|FG002|Overall Study|Physician Decision|0|||
30615144|NCT01105533|58626169|FG003|Overall Study|Physician Decision|0|||
31009317|NCT01439880|59210523|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
31009318|NCT01439880|59210522|FG000|SOC-controlled Period (Year 1)|Other|8|||
30615145|NCT01105533|58626170|FG004|Overall Study|Physician Decision|0|||
30615146|NCT01105533|58626171|FG005|Overall Study|Physician Decision|0|||
30615147|NCT01105533|58626172|FG006|Overall Study|Physician Decision|0|||
30615148|NCT01105533|58626173|FG007|Overall Study|Physician Decision|1|||
30615149|NCT01105533|58626174|FG008|Overall Study|Physician Decision|0|||
30615150|NCT01203072|58626192|FG000|Overall Study|Adverse Event|5|||
30615151|NCT01203072|58626193|FG001|Overall Study|Adverse Event|3|||
30615152|NCT01203072|58626194|FG002|Overall Study|Adverse Event|2|||
30615153|NCT01203072|58626195|FG003|Overall Study|Adverse Event|4|||
30615154|NCT01203072|58626196|FG004|Overall Study|Adverse Event|2|||
30615155|NCT01203072|58626192|FG000|Overall Study|Lack of Efficacy|1|||
30615156|NCT01203072|58626193|FG001|Overall Study|Lack of Efficacy|0|||
30615157|NCT01203072|58626194|FG002|Overall Study|Lack of Efficacy|0|||
30615158|NCT01203072|58626195|FG003|Overall Study|Lack of Efficacy|0|||
30615159|NCT01203072|58626196|FG004|Overall Study|Lack of Efficacy|0|||
30615160|NCT01203072|58626192|FG000|Overall Study|Lost to Follow-up|0|||
30615161|NCT01203072|58626193|FG001|Overall Study|Lost to Follow-up|1|||
30615162|NCT01203072|58626194|FG002|Overall Study|Lost to Follow-up|0|||
30615163|NCT01203072|58626195|FG003|Overall Study|Lost to Follow-up|0|||
30615164|NCT01203072|58626196|FG004|Overall Study|Lost to Follow-up|0|||
30615165|NCT01203072|58626192|FG000|Overall Study|Protocol Violation|2|||
30615166|NCT01203072|58626193|FG001|Overall Study|Protocol Violation|0|||
30615167|NCT01203072|58626194|FG002|Overall Study|Protocol Violation|0|||
30615168|NCT01203072|58626195|FG003|Overall Study|Protocol Violation|0|||
30615169|NCT01203072|58626196|FG004|Overall Study|Protocol Violation|1|||
30615170|NCT01203072|58626192|FG000|Overall Study|Withdrawal by Subject|2|||
30615171|NCT01203072|58626193|FG001|Overall Study|Withdrawal by Subject|2|||
30615172|NCT01203072|58626194|FG002|Overall Study|Withdrawal by Subject|1|||
30615173|NCT01203072|58626195|FG003|Overall Study|Withdrawal by Subject|2|||
30615174|NCT01203072|58626196|FG004|Overall Study|Withdrawal by Subject|3|||
30615175|NCT01105377|58626210|FG000|Overall Study|Withdrawal by Subject|0|||
30615176|NCT01105377|58626211|FG001|Overall Study|Withdrawal by Subject|1|||
30615177|NCT01105065|58626217|FG000|Overall Study|Adverse Event|5|||
30615178|NCT01105065|58626217|FG000|Overall Study|Technical Problems|1|||
30615179|NCT01111539|58626223|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
30615180|NCT01111539|58626224|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
30615181|NCT01111539|58626225|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
30615182|NCT01111539|58626226|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
30615183|NCT01111539|58626227|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
30615184|NCT01111539|58626223|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
30615185|NCT01111539|58626224|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
30615186|NCT01111539|58626225|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
30615187|NCT01111539|58626226|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
30615188|NCT01111539|58626227|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
30615189|NCT01111539|58626223|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
30615190|NCT01111539|58626224|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
30615191|NCT01111539|58626225|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
30615192|NCT01111539|58626226|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
30615193|NCT01111539|58626227|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
30615194|NCT01111539|58626223|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
30615195|NCT01111539|58626224|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
30615196|NCT01111539|58626225|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
30615197|NCT01111539|58626226|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
30615198|NCT01111539|58626227|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
30615199|NCT01111539|58626223|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
30615200|NCT01111539|58626224|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
30615201|NCT01111539|58626225|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
30615202|NCT01111539|58626226|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
30615203|NCT01111539|58626227|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
30615204|NCT01111539|58626223|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
30615205|NCT01111539|58626224|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
30615206|NCT01111539|58626225|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
30615207|NCT01111539|58626226|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
30615208|NCT01111539|58626227|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
30615209|NCT01111539|58626223|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
30615210|NCT01111539|58626224|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
30615211|NCT01111539|58626225|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
30615212|NCT01111539|58626226|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
30615213|NCT01111539|58626227|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
30615214|NCT01111539|58626223|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
30615215|NCT01111539|58626224|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
30790777|NCT03524092|58803940|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
30893082|NCT02163993|58926528|FG000|Treatment Period|Adverse Event|0|||
30893083|NCT02163993|58926529|FG001|Treatment Period|Adverse Event|1|||
30893084|NCT02163993|58926530|FG002|Treatment Period|Adverse Event|0|||
30893085|NCT02163993|58926531|FG003|Treatment Period|Adverse Event|0|||
30893086|NCT02163993|58926532|FG004|Treatment Period|Adverse Event|1|||
30893087|NCT02163993|58926528|FG000|Treatment Period|Lost to Follow-up|2|||
30893088|NCT02163993|58926529|FG001|Treatment Period|Lost to Follow-up|3|||
30893089|NCT02163993|58926530|FG002|Treatment Period|Lost to Follow-up|1|||
30893090|NCT02163993|58926531|FG003|Treatment Period|Lost to Follow-up|3|||
30893091|NCT02163993|58926532|FG004|Treatment Period|Lost to Follow-up|1|||
30893092|NCT02163993|58926528|FG000|Treatment Period|Physician Decision|1|||
30893093|NCT02163993|58926529|FG001|Treatment Period|Physician Decision|0|||
30893094|NCT02163993|58926530|FG002|Treatment Period|Physician Decision|0|||
30893095|NCT02163993|58926531|FG003|Treatment Period|Physician Decision|0|||
30893096|NCT02163993|58926532|FG004|Treatment Period|Physician Decision|0|||
30893097|NCT02163993|58926528|FG000|Treatment Period|Protocol Violation|2|||
30893098|NCT02163993|58926529|FG001|Treatment Period|Protocol Violation|1|||
30893099|NCT02163993|58926530|FG002|Treatment Period|Protocol Violation|0|||
30893100|NCT02163993|58926531|FG003|Treatment Period|Protocol Violation|1|||
30893101|NCT02163993|58926532|FG004|Treatment Period|Protocol Violation|2|||
30893102|NCT02163993|58926528|FG000|Treatment Period|Withdrawal by Subject|6|||
30893103|NCT02163993|58926529|FG001|Treatment Period|Withdrawal by Subject|4|||
30893104|NCT02163993|58926530|FG002|Treatment Period|Withdrawal by Subject|1|||
30893105|NCT02163993|58926531|FG003|Treatment Period|Withdrawal by Subject|4|||
31009319|NCT01439880|59210523|FG001|SOC-controlled Period (Year 1)|Other|13|||
31009320|NCT01439880|59210522|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
31009321|NCT01439880|59210523|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
31009322|NCT01439880|59210522|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
31009323|NCT01439880|59210523|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
31009324|NCT01439880|59210522|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
31009325|NCT01439880|59210523|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
30615216|NCT01111539|58626225|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
30615217|NCT01111539|58626226|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
30615218|NCT01111539|58626227|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
30615219|NCT01111539|58626223|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
30615220|NCT01111539|58626224|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
30615221|NCT01111539|58626225|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
30615222|NCT01111539|58626226|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
30615223|NCT01111539|58626227|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
30615224|NCT01111539|58626223|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
30615225|NCT01111539|58626224|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
30615226|NCT01111539|58626225|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
30615227|NCT01111539|58626226|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
30615228|NCT01111539|58626227|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
30615229|NCT01111539|58626223|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
30615230|NCT01111539|58626224|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
30615231|NCT01111539|58626225|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
30615232|NCT01111539|58626226|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
30615233|NCT01111539|58626227|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
30615234|NCT01111539|58626223|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
30615235|NCT01111539|58626224|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
30615236|NCT01111539|58626225|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
30893106|NCT02163993|58926532|FG004|Treatment Period|Withdrawal by Subject|1|||
30893107|NCT02163993|58926528|FG000|Treatment Period|Not treated|1|||
30893108|NCT02163993|58926529|FG001|Treatment Period|Not treated|0|||
30893109|NCT02163993|58926530|FG002|Treatment Period|Not treated|0|||
30893110|NCT02163993|58926531|FG003|Treatment Period|Not treated|1|||
30893111|NCT02163993|58926532|FG004|Treatment Period|Not treated|2|||
30893112|NCT02163993|58926528|FG000|Post-treatment Period|Adverse Event|0|||
30893113|NCT02163993|58926529|FG001|Post-treatment Period|Adverse Event|0|||
31009326|NCT01439880|59210522|FG000|All-IP Period (Years 2 to 5)|Death|3|||
31009327|NCT01439880|59210523|FG001|All-IP Period (Years 2 to 5)|Death|13|||
31009328|NCT01439880|59210522|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
31009329|NCT01439880|59210523|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
31009330|NCT01439880|59210522|FG000|All-IP Period (Years 2 to 5)|Other|14|||
31009331|NCT01439880|59210523|FG001|All-IP Period (Years 2 to 5)|Other|31|||
31009332|NCT01439880|59210522|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
31009333|NCT01439880|59210523|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
31009334|NCT01469364|59210540|FG000|Overall Study|Adverse Event|1|||
31009335|NCT01469364|59210540|FG000|Overall Study|Withdrawal by Subject|1|||
31009336|NCT01439724|59210546|FG000|Overall Study|missing consultation|9|||
31009337|NCT01439724|59210547|FG001|Overall Study|missing consultation|8|||
31009338|NCT01439568|59210555|FG000|Overall Study|Lost to Follow-up|1|||
31009339|NCT01439568|59210556|FG001|Overall Study|Lost to Follow-up|0|||
31009340|NCT01439568|59210555|FG000|Overall Study|Withdrawal by Subject|2|||
31009341|NCT01439568|59210556|FG001|Overall Study|Withdrawal by Subject|2|||
31009342|NCT01469052|59210568|FG000|Overall Study|Adverse Event|2|||
31009343|NCT01469052|59210569|FG001|Overall Study|Adverse Event|3|||
31009344|NCT01469052|59210570|FG002|Overall Study|Adverse Event|0|||
31009345|NCT01469052|59210571|FG003|Overall Study|Adverse Event|2|||
31009346|NCT01469052|59210572|FG004|Overall Study|Adverse Event|0|||
31009347|NCT01469052|59210573|FG005|Overall Study|Adverse Event|1|||
31009348|NCT01469052|59210568|FG000|Overall Study|Progressive disease|3|||
31009349|NCT01469052|59210569|FG001|Overall Study|Progressive disease|0|||
31009350|NCT01469052|59210570|FG002|Overall Study|Progressive disease|5|||
31009351|NCT01469052|59210571|FG003|Overall Study|Progressive disease|3|||
31009352|NCT01469052|59210572|FG004|Overall Study|Progressive disease|7|||
31009353|NCT01469052|59210573|FG005|Overall Study|Progressive disease|2|||
31009354|NCT01469052|59210568|FG000|Overall Study|Lack of Efficacy|0|||
31009355|NCT01469052|59210569|FG001|Overall Study|Lack of Efficacy|0|||
31009356|NCT01469052|59210570|FG002|Overall Study|Lack of Efficacy|0|||
31009357|NCT01469052|59210571|FG003|Overall Study|Lack of Efficacy|0|||
31009358|NCT01469052|59210572|FG004|Overall Study|Lack of Efficacy|0|||
31009359|NCT01469052|59210573|FG005|Overall Study|Lack of Efficacy|2|||
31009360|NCT01469052|59210568|FG000|Overall Study|Moved to rollover protocol|1|||
31009361|NCT01469052|59210569|FG001|Overall Study|Moved to rollover protocol|0|||
31009362|NCT01469052|59210570|FG002|Overall Study|Moved to rollover protocol|1|||
31009363|NCT01469052|59210571|FG003|Overall Study|Moved to rollover protocol|0|||
30699280|NCT00555009|58713824|FG000|Overall Study|Withdrawal by Subject|0|||
30699281|NCT00555009|58713825|FG001|Overall Study|Withdrawal by Subject|1|||
30699282|NCT00555009|58713824|FG000|Overall Study|Terminated by Sponsor|2|||
30699283|NCT00555009|58713825|FG001|Overall Study|Terminated by Sponsor|5|||
30699284|NCT00623766|58713833|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
30699285|NCT00623766|58713834|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
30699286|NCT00623766|58713833|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
31009364|NCT01469052|59210572|FG004|Overall Study|Moved to rollover protocol|0|||
31009365|NCT01469052|59210573|FG005|Overall Study|Moved to rollover protocol|1|||
31009366|NCT01469052|59210568|FG000|Overall Study|Other|0|||
31009367|NCT01469052|59210569|FG001|Overall Study|Other|1|||
31009368|NCT01469052|59210570|FG002|Overall Study|Other|0|||
31009369|NCT01469052|59210571|FG003|Overall Study|Other|0|||
31009370|NCT01469052|59210572|FG004|Overall Study|Other|1|||
31009371|NCT01469052|59210573|FG005|Overall Study|Other|0|||
31009372|NCT01468818|59210585|FG000|Overall Study|Death during treatment|2|||
31009373|NCT01442376|59210592|FG000|Overall Study|Adverse Event|0|||
31009374|NCT01442376|59210593|FG001|Overall Study|Adverse Event|3|||
30699287|NCT00623766|58713834|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
30790778|NCT03524092|58803941|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
31009375|NCT01442376|59210594|FG002|Overall Study|Adverse Event|2|||
31009376|NCT01442376|59210592|FG000|Overall Study|Death|0|||
31009377|NCT01442376|59210593|FG001|Overall Study|Death|1|||
31009378|NCT01442376|59210594|FG002|Overall Study|Death|1|||
31009379|NCT01442376|59210592|FG000|Overall Study|Withdrawal of consent|0|||
31009380|NCT01442376|59210593|FG001|Overall Study|Withdrawal of consent|0|||
31009381|NCT01442376|59210594|FG002|Overall Study|Withdrawal of consent|1|||
31009382|NCT01442376|59210592|FG000|Overall Study|Patients not treated|2|||
31009383|NCT01442376|59210593|FG001|Overall Study|Patients not treated|3|||
31009384|NCT01442376|59210594|FG002|Overall Study|Patients not treated|1|||
31009385|NCT01442376|59210592|FG000|Overall Study|Not eligible for subsequent cycles|1|||
31009386|NCT01442376|59210593|FG001|Overall Study|Not eligible for subsequent cycles|2|||
31009387|NCT01442376|59210594|FG002|Overall Study|Not eligible for subsequent cycles|0|||
31009388|NCT01442064|59210608|FG000|Overall Study|Adverse Event|2|||
31009389|NCT01442064|59210609|FG001|Overall Study|Adverse Event|2|||
31009390|NCT01442064|59210610|FG002|Overall Study|Adverse Event|2|||
31009391|NCT01442064|59210611|FG003|Overall Study|Adverse Event|1|||
31009392|NCT01442064|59210612|FG004|Overall Study|Adverse Event|2|||
31009393|NCT01442064|59210613|FG005|Overall Study|Adverse Event|0|||
31009394|NCT01442064|59210608|FG000|Overall Study|Death|0|||
31009395|NCT01442064|59210609|FG001|Overall Study|Death|1|||
31009396|NCT01442064|59210610|FG002|Overall Study|Death|3|||
31009397|NCT01442064|59210611|FG003|Overall Study|Death|3|||
31009398|NCT01442064|59210612|FG004|Overall Study|Death|1|||
31009399|NCT01442064|59210613|FG005|Overall Study|Death|3|||
31009400|NCT01442064|59210608|FG000|Overall Study|Lost to Follow-up|5|||
31009401|NCT01442064|59210609|FG001|Overall Study|Lost to Follow-up|5|||
31009402|NCT01442064|59210610|FG002|Overall Study|Lost to Follow-up|1|||
31009403|NCT01442064|59210611|FG003|Overall Study|Lost to Follow-up|1|||
31009404|NCT01442064|59210612|FG004|Overall Study|Lost to Follow-up|3|||
31009405|NCT01442064|59210613|FG005|Overall Study|Lost to Follow-up|3|||
31009406|NCT01442064|59210608|FG000|Overall Study|Physician Decision|1|||
31009407|NCT01442064|59210609|FG001|Overall Study|Physician Decision|1|||
31009408|NCT01442064|59210610|FG002|Overall Study|Physician Decision|2|||
31009409|NCT01442064|59210611|FG003|Overall Study|Physician Decision|3|||
31009410|NCT01442064|59210612|FG004|Overall Study|Physician Decision|3|||
31009411|NCT01442064|59210613|FG005|Overall Study|Physician Decision|1|||
31009412|NCT01442064|59210608|FG000|Overall Study|Withdrawal by Subject|6|||
31009413|NCT01442064|59210609|FG001|Overall Study|Withdrawal by Subject|3|||
31009414|NCT01442064|59210610|FG002|Overall Study|Withdrawal by Subject|2|||
31009415|NCT01442064|59210611|FG003|Overall Study|Withdrawal by Subject|2|||
31009416|NCT01442064|59210612|FG004|Overall Study|Withdrawal by Subject|2|||
31009417|NCT01442064|59210613|FG005|Overall Study|Withdrawal by Subject|1|||
31009418|NCT01442064|59210608|FG000|Overall Study|Sponsor decision|82|||
31009419|NCT01442064|59210609|FG001|Overall Study|Sponsor decision|88|||
31009420|NCT01442064|59210610|FG002|Overall Study|Sponsor decision|92|||
31009421|NCT01442064|59210611|FG003|Overall Study|Sponsor decision|88|||
31009422|NCT01442064|59210612|FG004|Overall Study|Sponsor decision|95|||
31009423|NCT01442064|59210613|FG005|Overall Study|Sponsor decision|87|||
31009424|NCT01442064|59210608|FG000|Overall Study|Subject non-compliance|0|||
31009425|NCT01442064|59210609|FG001|Overall Study|Subject non-compliance|0|||
31009426|NCT01442064|59210610|FG002|Overall Study|Subject non-compliance|0|||
31009427|NCT01442064|59210611|FG003|Overall Study|Subject non-compliance|0|||
31009428|NCT01442064|59210612|FG004|Overall Study|Subject non-compliance|0|||
31009429|NCT01442064|59210613|FG005|Overall Study|Subject non-compliance|2|||
31009430|NCT01442064|59210608|FG000|Overall Study|Condition mandated other intervention|1|||
31009431|NCT01442064|59210609|FG001|Overall Study|Condition mandated other intervention|1|||
31009432|NCT01442064|59210610|FG002|Overall Study|Condition mandated other intervention|2|||
31009433|NCT01442064|59210611|FG003|Overall Study|Condition mandated other intervention|0|||
31009434|NCT01442064|59210612|FG004|Overall Study|Condition mandated other intervention|0|||
31009435|NCT01442064|59210613|FG005|Overall Study|Condition mandated other intervention|2|||
31009436|NCT01467960|59210636|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
31009437|NCT01467960|59210637|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
31009438|NCT01467960|59210638|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
31009439|NCT01467960|59210639|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
31009440|NCT01467960|59210640|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
31009441|NCT01467960|59210641|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
31009442|NCT01441596|59210658|FG000|Overall Study|Other reason not defined below|0|||
31009443|NCT01441596|59210659|FG001|Overall Study|Other reason not defined below|2|||
31009444|NCT01441596|59210660|FG002|Overall Study|Other reason not defined below|1|||
31009445|NCT01441596|59210658|FG000|Overall Study|Withdrawal by Subject|4|||
31009446|NCT01441596|59210659|FG001|Overall Study|Withdrawal by Subject|0|||
31009447|NCT01441596|59210660|FG002|Overall Study|Withdrawal by Subject|2|||
31009448|NCT01441596|59210658|FG000|Overall Study|Not treated|0|||
31009449|NCT01441596|59210659|FG001|Overall Study|Not treated|1|||
31009450|NCT01441596|59210660|FG002|Overall Study|Not treated|1|||
31009451|NCT01441440|59210671|FG000|Overall Study|Death|1|||
31009452|NCT01441440|59210672|FG001|Overall Study|Death|0|||
31009453|NCT01441440|59210673|FG002|Overall Study|Death|1|||
31009454|NCT01441440|59210671|FG000|Overall Study|Adverse Event|2|||
31009455|NCT01441440|59210672|FG001|Overall Study|Adverse Event|9|||
31009456|NCT01441440|59210673|FG002|Overall Study|Adverse Event|9|||
31009457|NCT01441440|59210671|FG000|Overall Study|Lost to Follow-up|0|||
31009458|NCT01441440|59210672|FG001|Overall Study|Lost to Follow-up|2|||
30615237|NCT01111539|58626226|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
31009459|NCT01441440|59210673|FG002|Overall Study|Lost to Follow-up|1|||
31009460|NCT01441440|59210671|FG000|Overall Study|Withdrawal by Subject|11|||
31009461|NCT01441440|59210672|FG001|Overall Study|Withdrawal by Subject|9|||
31009462|NCT01441440|59210673|FG002|Overall Study|Withdrawal by Subject|9|||
31009463|NCT01441440|59210671|FG000|Overall Study|Pregnancy|1|||
31009464|NCT01441440|59210672|FG001|Overall Study|Pregnancy|0|||
31009465|NCT01441440|59210673|FG002|Overall Study|Pregnancy|0|||
31009466|NCT01441440|59210671|FG000|Overall Study|Lack of Efficacy|1|||
31009467|NCT01441440|59210672|FG001|Overall Study|Lack of Efficacy|0|||
31009468|NCT01441440|59210673|FG002|Overall Study|Lack of Efficacy|1|||
31009469|NCT01441440|59210671|FG000|Overall Study|Moving|0|||
31009470|NCT01441440|59210672|FG001|Overall Study|Moving|1|||
31009471|NCT01441440|59210673|FG002|Overall Study|Moving|1|||
31009472|NCT01441440|59210671|FG000|Overall Study|Work-related matter|0|||
31009473|NCT01441440|59210672|FG001|Overall Study|Work-related matter|1|||
31009474|NCT01441440|59210673|FG002|Overall Study|Work-related matter|0|||
31009475|NCT01441440|59210671|FG000|Overall Study|Difficllty in keeping the schedule|1|||
31009476|NCT01441440|59210672|FG001|Overall Study|Difficllty in keeping the schedule|1|||
31009477|NCT01441440|59210673|FG002|Overall Study|Difficllty in keeping the schedule|0|||
31009478|NCT01438476|59210683|FG000|Overall Study|Protocol Violation|1|||
31009479|NCT01438476|59210684|FG001|Overall Study|Protocol Violation|0|||
31009480|NCT01438476|59210683|FG000|Overall Study|Withdrawal by Subject|1|||
31009481|NCT01438476|59210684|FG001|Overall Study|Withdrawal by Subject|0|||
31009482|NCT01438476|59210683|FG000|Overall Study|No Surgery- Disease|8|||
31009483|NCT01438476|59210684|FG001|Overall Study|No Surgery- Disease|10|||
31009484|NCT01438476|59210683|FG000|Overall Study|Communication barrier|0|||
31009485|NCT01438476|59210684|FG001|Overall Study|Communication barrier|1|||
31009486|NCT01467570|59210692|FG000|Overall Study|Lost to Follow-up|8|||
31009487|NCT01467570|59210693|FG001|Overall Study|Lost to Follow-up|9|||
31009488|NCT01437540|59210703|FG000|Overall Study|Not listed below|7|||
31009489|NCT01437540|59210704|FG001|Overall Study|Not listed below|6|||
31009490|NCT01437540|59210703|FG000|Overall Study|COPD exacerbation|13|||
31009491|NCT01437540|59210704|FG001|Overall Study|COPD exacerbation|3|||
31009492|NCT01437540|59210703|FG000|Overall Study|Lost to Follow-up|3|||
31009493|NCT01437540|59210704|FG001|Overall Study|Lost to Follow-up|5|||
31009494|NCT01437540|59210703|FG000|Overall Study|Lack of Efficacy|23|||
31009495|NCT01437540|59210704|FG001|Overall Study|Lack of Efficacy|11|||
31009496|NCT01437540|59210703|FG000|Overall Study|Protocol Violation|24|||
31009497|NCT01437540|59210704|FG001|Overall Study|Protocol Violation|12|||
31009498|NCT01437540|59210703|FG000|Overall Study|Adverse Event|26|||
31009499|NCT01437540|59210704|FG001|Overall Study|Adverse Event|13|||
31009500|NCT01437540|59210703|FG000|Overall Study|Withdrawal by Subject|31|||
31009501|NCT01437540|59210704|FG001|Overall Study|Withdrawal by Subject|15|||
31009502|NCT01440972|59210712|FG000|Overall Study|Withdrawal by Subject|3|||
31009503|NCT01440972|59210713|FG001|Overall Study|Withdrawal by Subject|2|||
31009504|NCT01420536|59210721|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
31009505|NCT01420536|59210722|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
31009506|NCT01420068|59210732|FG000|Overall Study|Administrative problems|1|||
31009507|NCT01420068|59210733|FG001|Overall Study|Administrative problems|3|||
31009508|NCT01420068|59210732|FG000|Overall Study|Withdrawal by Subject|1|||
31009509|NCT01420068|59210733|FG001|Overall Study|Withdrawal by Subject|2|||
31009510|NCT01467492|59210741|FG000|Overall Study|Withdrawal by Subject|6|||
31009511|NCT01467492|59210742|FG001|Overall Study|Withdrawal by Subject|4|||
31009512|NCT01467492|59210741|FG000|Overall Study|Study Terminated by Sponsor|6|||
31009513|NCT01467492|59210742|FG001|Overall Study|Study Terminated by Sponsor|4|||
31009514|NCT01467492|59210741|FG000|Overall Study|Adverse Event|4|||
31009515|NCT01467492|59210742|FG001|Overall Study|Adverse Event|3|||
31009516|NCT01467492|59210741|FG000|Overall Study|Lost to Follow-up|3|||
31009517|NCT01467492|59210742|FG001|Overall Study|Lost to Follow-up|2|||
31009518|NCT01467492|59210741|FG000|Overall Study|Undefined|2|||
31009519|NCT01467492|59210742|FG001|Overall Study|Undefined|0|||
31009520|NCT01467492|59210741|FG000|Overall Study|Enrolled But Not Treated|1|||
31009521|NCT01467492|59210742|FG001|Overall Study|Enrolled But Not Treated|0|||
31009522|NCT01466790|59210757|FG000|Overall Study|Adverse Event|1|||
31009523|NCT01466790|59210758|FG001|Overall Study|Adverse Event|0|||
31009524|NCT01466790|59210759|FG002|Overall Study|Adverse Event|0|||
31009525|NCT01466790|59210760|FG003|Overall Study|Adverse Event|0|||
31009526|NCT01466790|59210761|FG004|Overall Study|Adverse Event|2|||
30615238|NCT01111539|58626227|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
30615239|NCT01111539|58626223|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
30615240|NCT01111539|58626224|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
31009527|NCT01466790|59210762|FG005|Overall Study|Adverse Event|0|||
30615241|NCT01111539|58626225|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
31009528|NCT01466790|59210763|FG006|Overall Study|Adverse Event|0|||
31009529|NCT01466790|59210764|FG007|Overall Study|Adverse Event|0|||
31009530|NCT01466790|59210757|FG000|Overall Study|Lost to Follow-up|2|||
31009531|NCT01466790|59210758|FG001|Overall Study|Lost to Follow-up|0|||
31009532|NCT01466790|59210759|FG002|Overall Study|Lost to Follow-up|0|||
31009533|NCT01466790|59210760|FG003|Overall Study|Lost to Follow-up|0|||
31009534|NCT01466790|59210761|FG004|Overall Study|Lost to Follow-up|0|||
31009535|NCT01466790|59210762|FG005|Overall Study|Lost to Follow-up|0|||
31009536|NCT01466790|59210763|FG006|Overall Study|Lost to Follow-up|0|||
31009537|NCT01466790|59210764|FG007|Overall Study|Lost to Follow-up|0|||
31009538|NCT01466790|59210757|FG000|Overall Study|Withdrawal by Subject|1|||
31009539|NCT01466790|59210758|FG001|Overall Study|Withdrawal by Subject|1|||
30615242|NCT01111539|58626226|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
30615243|NCT01111539|58626227|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
30615244|NCT01111539|58626223|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
30615245|NCT01111539|58626224|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
30615246|NCT01111539|58626225|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
30615247|NCT01111539|58626226|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
30615248|NCT01111539|58626227|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
30615249|NCT01111149|58626240|FG000|Overall Study|Protocol Violation|1|||
30615250|NCT01111149|58626241|FG001|Overall Study|Protocol Violation|1|||
30615251|NCT01111149|58626242|FG002|Overall Study|Protocol Violation|2|||
30615252|NCT01111149|58626240|FG000|Overall Study|Withdrawal by Subject|1|||
30615253|NCT01111149|58626241|FG001|Overall Study|Withdrawal by Subject|0|||
30615254|NCT01111149|58626242|FG002|Overall Study|Withdrawal by Subject|2|||
30615255|NCT01254656|58626253|FG000|Overall Study|Discontinued due to termination of study|40|||
30615256|NCT01254656|58626254|FG001|Overall Study|Discontinued due to termination of study|39|||
30615257|NCT01254656|58626255|FG002|Overall Study|Discontinued due to termination of study|13|||
30615258|NCT01254656|58626253|FG000|Overall Study|Lack of Efficacy|3|||
30615259|NCT01254656|58626254|FG001|Overall Study|Lack of Efficacy|0|||
30615260|NCT01254656|58626255|FG002|Overall Study|Lack of Efficacy|0|||
30615261|NCT01254656|58626253|FG000|Overall Study|Lost to Follow-up|1|||
30615262|NCT01254656|58626254|FG001|Overall Study|Lost to Follow-up|0|||
30615263|NCT01254656|58626255|FG002|Overall Study|Lost to Follow-up|2|||
30615264|NCT01254656|58626253|FG000|Overall Study|Withdrawal by Subject|2|||
30615265|NCT01254656|58626254|FG001|Overall Study|Withdrawal by Subject|2|||
30615266|NCT01254656|58626255|FG002|Overall Study|Withdrawal by Subject|1|||
30615267|NCT01254656|58626253|FG000|Overall Study|Pregnancy|0|||
30615268|NCT01254656|58626254|FG001|Overall Study|Pregnancy|0|||
30615269|NCT01254656|58626255|FG002|Overall Study|Pregnancy|2|||
30615270|NCT01254656|58626253|FG000|Overall Study|Adverse Event|1|||
30615271|NCT01254656|58626254|FG001|Overall Study|Adverse Event|1|||
30615272|NCT01254656|58626255|FG002|Overall Study|Adverse Event|0|||
30615273|NCT01254656|58626253|FG000|Overall Study|Death|0|||
30615274|NCT01254656|58626254|FG001|Overall Study|Death|1|||
30615275|NCT01254656|58626255|FG002|Overall Study|Death|0|||
30615276|NCT01110915|58626265|FG000|Overall Study|Death|2|||
30615277|NCT01110915|58626266|FG001|Overall Study|Death|1|||
30615278|NCT01110915|58626265|FG000|Overall Study|Lost to Follow-up|1|||
30615279|NCT01110915|58626266|FG001|Overall Study|Lost to Follow-up|0|||
30615280|NCT01110915|58626265|FG000|Overall Study|Withdrawal by Subject|7|||
30615281|NCT01110915|58626266|FG001|Overall Study|Withdrawal by Subject|1|||
30615282|NCT01254344|58626275|FG000|Overall Study|Adverse Event|2|||
30615283|NCT01254344|58626276|FG001|Overall Study|Adverse Event|5|||
30615284|NCT01254344|58626275|FG000|Overall Study|Physician Decision|7|||
30615285|NCT01254344|58626276|FG001|Overall Study|Physician Decision|4|||
30615286|NCT01254344|58626275|FG000|Overall Study|Protocol Violation|1|||
30615287|NCT01254344|58626276|FG001|Overall Study|Protocol Violation|4|||
30615288|NCT01254344|58626275|FG000|Overall Study|Withdrawal by Subject|3|||
30615289|NCT01254344|58626276|FG001|Overall Study|Withdrawal by Subject|6|||
30615290|NCT01102803|58626284|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
30615291|NCT01102803|58626285|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
30615292|NCT01102803|58626284|FG000|Post to Follow-Up|Lost to Follow-up|1|||
30615293|NCT01102803|58626285|FG001|Post to Follow-Up|Lost to Follow-up|3|||
30615294|NCT01254188|58626293|FG000|Overall Study|Disease Progression|6|||
30615295|NCT01254188|58626293|FG000|Overall Study|Protocol Violation|6|||
30615296|NCT01254188|58626293|FG000|Overall Study|Pregnancy|2|||
30615297|NCT01254188|58626293|FG000|Overall Study|Death|4|||
30615298|NCT01254188|58626293|FG000|Overall Study|Lost to Follow-up|5|||
30615299|NCT01254188|58626293|FG000|Overall Study|Withdrawal by Subject|7|||
30615300|NCT01254188|58626293|FG000|Overall Study|Adverse Event|43|||
30615301|NCT01254188|58626293|FG000|Overall Study|per investigator discretion|20|||
30615302|NCT01109979|58626299|FG000|Overall Study|Physician Decision|2|||
30615303|NCT01109979|58626300|FG001|Overall Study|Physician Decision|0|||
30615304|NCT01109979|58626299|FG000|Overall Study|Withdrawal by Subject|0|||
30615305|NCT01109979|58626300|FG001|Overall Study|Withdrawal by Subject|1|||
30615306|NCT01102491|58626308|FG000|Overall Study|Protocol Violation|11|||
30615307|NCT01102491|58626309|FG001|Overall Study|Protocol Violation|12|||
30615308|NCT01102257|58626317|FG000|Overall Study|Adverse Event|1|||
30615309|NCT01102257|58626318|FG001|Overall Study|Adverse Event|0|||
30615310|NCT01102257|58626317|FG000|Overall Study|Adverse Event|1|||
30893114|NCT02163993|58926530|FG002|Post-treatment Period|Adverse Event|1|||
30615311|NCT01102257|58626318|FG001|Overall Study|Adverse Event|0|||
30615312|NCT01253564|58626324|FG000|Overall Study|Disease Progression|22|||
30615313|NCT01253564|58626324|FG000|Overall Study|Withdrawal by Subject|1|||
30615314|NCT01253564|58626324|FG000|Overall Study|Serious Adverse Event|1|||
30615315|NCT01108809|58626328|FG000|Overall Study|Adverse Event|3|||
30615316|NCT01108809|58626328|FG000|Overall Study|Lost to Follow-up|1|||
30615317|NCT01253408|58626336|FG000|Overall Study|Adverse Event|0|||
31009540|NCT01466790|59210759|FG002|Overall Study|Withdrawal by Subject|0|||
31009541|NCT01466790|59210760|FG003|Overall Study|Withdrawal by Subject|0|||
31009542|NCT01466790|59210761|FG004|Overall Study|Withdrawal by Subject|1|||
31009543|NCT01466790|59210762|FG005|Overall Study|Withdrawal by Subject|0|||
31009544|NCT01466790|59210763|FG006|Overall Study|Withdrawal by Subject|1|||
31009545|NCT01466790|59210764|FG007|Overall Study|Withdrawal by Subject|1|||
31009546|NCT01418352|59210782|FG000|Overall Study|Lost to Follow-up|2|||
31009547|NCT01418352|59210783|FG001|Overall Study|Lost to Follow-up|0|||
31009548|NCT01418352|59210784|FG002|Overall Study|Lost to Follow-up|0|||
31009549|NCT01418352|59210785|FG003|Overall Study|Lost to Follow-up|0|||
31009550|NCT01418352|59210782|FG000|Overall Study|Adverse Event|0|||
31009551|NCT01418352|59210783|FG001|Overall Study|Adverse Event|1|||
30893115|NCT02163993|58926531|FG003|Post-treatment Period|Adverse Event|0|||
30893116|NCT02163993|58926532|FG004|Post-treatment Period|Adverse Event|0|||
30893117|NCT02163993|58926528|FG000|Post-treatment Period|Lost to Follow-up|2|||
30893118|NCT02163993|58926529|FG001|Post-treatment Period|Lost to Follow-up|2|||
30893119|NCT02163993|58926530|FG002|Post-treatment Period|Lost to Follow-up|3|||
30893120|NCT02163993|58926531|FG003|Post-treatment Period|Lost to Follow-up|1|||
30893121|NCT02163993|58926532|FG004|Post-treatment Period|Lost to Follow-up|0|||
30893122|NCT02163993|58926528|FG000|Post-treatment Period|Protocol Violation|0|||
30893123|NCT02163993|58926529|FG001|Post-treatment Period|Protocol Violation|0|||
30893124|NCT02163993|58926530|FG002|Post-treatment Period|Protocol Violation|0|||
30893125|NCT02163993|58926531|FG003|Post-treatment Period|Protocol Violation|0|||
30893126|NCT02163993|58926532|FG004|Post-treatment Period|Protocol Violation|1|||
30893127|NCT02163993|58926528|FG000|Post-treatment Period|Withdrawal by Subject|2|||
30893128|NCT02163993|58926529|FG001|Post-treatment Period|Withdrawal by Subject|4|||
30893129|NCT02163993|58926530|FG002|Post-treatment Period|Withdrawal by Subject|0|||
30893130|NCT02163993|58926531|FG003|Post-treatment Period|Withdrawal by Subject|1|||
30893131|NCT02163993|58926532|FG004|Post-treatment Period|Withdrawal by Subject|2|||
30893132|NCT02527421|58926555|FG000|Overall Study|Withdrawal by Subject|1|||
30893133|NCT02527421|58926556|FG001|Overall Study|Withdrawal by Subject|0|||
30893134|NCT02163915|58926567|FG000|Overall Study|Withdrawal by Subject|2|||
30893135|NCT02163915|58926568|FG001|Overall Study|Withdrawal by Subject|0|||
30893136|NCT02163915|58926569|FG002|Overall Study|Withdrawal by Subject|2|||
30893137|NCT02163915|58926570|FG003|Overall Study|Withdrawal by Subject|2|||
30893138|NCT02163915|58926571|FG004|Overall Study|Withdrawal by Subject|2|||
30893139|NCT02163915|58926567|FG000|Overall Study|Study termination|1|||
30893140|NCT02163915|58926568|FG001|Overall Study|Study termination|0|||
31009552|NCT01418352|59210784|FG002|Overall Study|Adverse Event|0|||
31009553|NCT01418352|59210785|FG003|Overall Study|Adverse Event|0|||
31009554|NCT01418352|59210782|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
31009555|NCT01418352|59210783|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
31009556|NCT01418352|59210784|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
31009557|NCT01418352|59210785|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
31009558|NCT01418352|59210782|FG000|Overall Study|Subject Withdrew Consent|0|||
31009559|NCT01418352|59210783|FG001|Overall Study|Subject Withdrew Consent|1|||
31009560|NCT01418352|59210784|FG002|Overall Study|Subject Withdrew Consent|2|||
31009561|NCT01418352|59210785|FG003|Overall Study|Subject Withdrew Consent|1|||
31009562|NCT01418352|59210782|FG000|Overall Study|Protocol Deviation|0|||
31009563|NCT01418352|59210783|FG001|Overall Study|Protocol Deviation|0|||
31009564|NCT01418352|59210784|FG002|Overall Study|Protocol Deviation|1|||
31009565|NCT01418352|59210785|FG003|Overall Study|Protocol Deviation|0|||
31009566|NCT01418352|59210782|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
31009567|NCT01418352|59210783|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
30760591|NCT03381274|58769070|FG000|Overall Study|Withdrawal by Subject|2|||
30893141|NCT02163915|58926569|FG002|Overall Study|Study termination|0|||
30893142|NCT02163915|58926570|FG003|Overall Study|Study termination|0|||
30893143|NCT02163915|58926571|FG004|Overall Study|Study termination|2|||
30893144|NCT02163915|58926567|FG000|Overall Study|Physician Decision|0|||
30893145|NCT02163915|58926568|FG001|Overall Study|Physician Decision|0|||
31009568|NCT01418352|59210784|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
31009569|NCT01418352|59210785|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
31009570|NCT01436370|59210803|FG000|Overall Study|Lost to Follow-up|0|||
31009571|NCT01436370|59210804|FG001|Overall Study|Lost to Follow-up|0|||
31009572|NCT01436370|59210805|FG002|Overall Study|Lost to Follow-up|0|||
31009573|NCT01436370|59210806|FG003|Overall Study|Lost to Follow-up|0|||
31009574|NCT01436370|59210807|FG004|Overall Study|Lost to Follow-up|1|||
31009575|NCT01436370|59210808|FG005|Overall Study|Lost to Follow-up|0|||
31009576|NCT01436370|59210809|FG006|Overall Study|Lost to Follow-up|0|||
31009577|NCT01436370|59210810|FG007|Overall Study|Lost to Follow-up|0|||
31009578|NCT01465464|59210838|FG000|Overall Study|Adverse Event|96|||
31009579|NCT01465464|59210839|FG001|Overall Study|Adverse Event|49|||
31009580|NCT01465464|59210838|FG000|Overall Study|Lack of Efficacy|139|||
30615318|NCT01253408|58626337|FG001|Overall Study|Adverse Event|1|||
30615319|NCT01253408|58626338|FG002|Overall Study|Adverse Event|0|||
30615320|NCT01253174|58626346|FG000|Period 1|Randomized but not treated|0|||
31009581|NCT01465464|59210839|FG001|Overall Study|Lack of Efficacy|190|||
31009582|NCT01465464|59210838|FG000|Overall Study|Physician Decision|13|||
31009583|NCT01465464|59210839|FG001|Overall Study|Physician Decision|5|||
31009584|NCT01465464|59210838|FG000|Overall Study|Protocol Violation|1|||
31009585|NCT01465464|59210839|FG001|Overall Study|Protocol Violation|1|||
31009586|NCT01465464|59210838|FG000|Overall Study|Withdrawal by Subject|46|||
31009587|NCT01465464|59210839|FG001|Overall Study|Withdrawal by Subject|30|||
31009588|NCT01465464|59210838|FG000|Overall Study|Other|9|||
31009589|NCT01465464|59210839|FG001|Overall Study|Other|3|||
31009590|NCT01465464|59210838|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
31009591|NCT01465464|59210839|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
31009592|NCT01417104|59210847|FG000|Overall Study|Withdrawal by Subject|5|||
31009593|NCT01417104|59210848|FG001|Overall Study|Withdrawal by Subject|1|||
31009594|NCT01417104|59210847|FG000|Overall Study|Failure to make contact|0|||
30615321|NCT01253174|58626347|FG001|Period 1|Randomized but not treated|1|||
31009595|NCT01417104|59210848|FG001|Overall Study|Failure to make contact|1|||
30615322|NCT01253174|58626348|FG002|Period 1|Randomized but not treated|1|||
30615323|NCT01253174|58626349|FG003|Period 1|Randomized but not treated|0|||
30615324|NCT01253174|58626350|FG004|Period 1|Randomized but not treated|1|||
30615325|NCT01253174|58626351|FG005|Period 1|Randomized but not treated|0|||
30615326|NCT01253174|58626346|FG000|Period 2|Adverse Event|0|||
30615327|NCT01253174|58626347|FG001|Period 2|Adverse Event|0|||
30615328|NCT01253174|58626348|FG002|Period 2|Adverse Event|1|||
30615329|NCT01253174|58626349|FG003|Period 2|Adverse Event|0|||
30615330|NCT01253174|58626350|FG004|Period 2|Adverse Event|0|||
30615331|NCT01253174|58626351|FG005|Period 2|Adverse Event|0|||
30615332|NCT01253174|58626346|FG000|Period 3|Withdrawal by Subject|0|||
30615333|NCT01253174|58626347|FG001|Period 3|Withdrawal by Subject|1|||
30615334|NCT01253174|58626348|FG002|Period 3|Withdrawal by Subject|0|||
30615335|NCT01253174|58626349|FG003|Period 3|Withdrawal by Subject|0|||
30615336|NCT01253174|58626350|FG004|Period 3|Withdrawal by Subject|1|||
30615337|NCT01253174|58626351|FG005|Period 3|Withdrawal by Subject|0|||
30615338|NCT01253174|58626346|FG000|Period 3|Pregnancy|0|||
30615339|NCT01253174|58626347|FG001|Period 3|Pregnancy|0|||
30615340|NCT01253174|58626348|FG002|Period 3|Pregnancy|1|||
30615341|NCT01253174|58626349|FG003|Period 3|Pregnancy|0|||
30615342|NCT01253174|58626350|FG004|Period 3|Pregnancy|0|||
30615343|NCT01253174|58626351|FG005|Period 3|Pregnancy|0|||
30615344|NCT01108731|58626362|FG000|Overall Study|Withdrawal by Subject|1|||
30615345|NCT01108731|58626363|FG001|Overall Study|Withdrawal by Subject|1|||
30615346|NCT01108731|58626362|FG000|Overall Study|Adverse Event|3|||
30615347|NCT01108731|58626363|FG001|Overall Study|Adverse Event|3|||
30615348|NCT01253018|58626371|FG000|Overall Study|Lost to Follow-up|1|||
30615349|NCT01253018|58626372|FG001|Overall Study|Lost to Follow-up|1|||
30615350|NCT01253018|58626371|FG000|Overall Study|Robot Repair Issues|2|||
30615351|NCT01253018|58626372|FG001|Overall Study|Robot Repair Issues|0|||
30615352|NCT01253018|58626371|FG000|Overall Study|Withdrawal by Subject|1|||
30893146|NCT02163915|58926569|FG002|Overall Study|Physician Decision|0|||
30893147|NCT02163915|58926570|FG003|Overall Study|Physician Decision|1|||
30893148|NCT02163915|58926571|FG004|Overall Study|Physician Decision|0|||
30893149|NCT02163759|58926590|FG000|Overall Study|Withdrawal by Subject|1|||
30893150|NCT02163759|58926591|FG001|Overall Study|Withdrawal by Subject|5|||
30893151|NCT02163759|58926592|FG002|Overall Study|Withdrawal by Subject|1|||
30893152|NCT02163759|58926590|FG000|Overall Study|Adverse Event|0|||
30893153|NCT02163759|58926591|FG001|Overall Study|Adverse Event|0|||
30893154|NCT02163759|58926592|FG002|Overall Study|Adverse Event|1|||
30893155|NCT02163759|58926590|FG000|Overall Study|Death|0|||
30893156|NCT02163759|58926591|FG001|Overall Study|Death|0|||
31009596|NCT01417104|59210847|FG000|Overall Study|Adverse Event|1|||
31009597|NCT01417104|59210848|FG001|Overall Study|Adverse Event|0|||
31009598|NCT01465386|59210854|FG000|Overall Study|Lack of Efficacy|3|||
31009599|NCT01465386|59210854|FG000|Overall Study|Adverse Event|1|||
31009600|NCT01465230|59210858|FG000|Overall Study|Withdrawal by Subject|2|||
30615353|NCT01253018|58626372|FG001|Overall Study|Withdrawal by Subject|1|||
30615354|NCT01108341|58626379|FG000|Overall Study|Death|2|||
30615355|NCT01108341|58626379|FG000|Overall Study|Withdrawal by Subject|1|||
30615356|NCT01108341|58626379|FG000|Overall Study|Lost to Follow-up|1|||
30615357|NCT01108341|58626379|FG000|Overall Study|Other|1|||
30615358|NCT01108263|58626385|FG000|Overall Study|Adverse Event|0|||
30615359|NCT01108263|58626386|FG001|Overall Study|Adverse Event|1|||
30615360|NCT01108185|58626392|FG000|Overall Study|Non-compliance|15|||
30615361|NCT01108185|58626392|FG000|Overall Study|Lost to Follow-up|12|||
30615362|NCT01252940|58626398|FG000|Main Study Phase|Randomized but not treated|4|||
30615363|NCT01252940|58626399|FG001|Main Study Phase|Randomized but not treated|2|||
30615364|NCT01252940|58626398|FG000|Main Study Phase|Adverse Event|3|||
30615365|NCT01252940|58626399|FG001|Main Study Phase|Adverse Event|1|||
30615366|NCT01252940|58626398|FG000|Main Study Phase|Lack of Efficacy|1|||
30615367|NCT01252940|58626399|FG001|Main Study Phase|Lack of Efficacy|0|||
30615368|NCT01252940|58626398|FG000|Main Study Phase|Lost to Follow-up|6|||
30615369|NCT01252940|58626399|FG001|Main Study Phase|Lost to Follow-up|1|||
30615370|NCT01252940|58626398|FG000|Main Study Phase|Physician Decision|1|||
30615371|NCT01252940|58626399|FG001|Main Study Phase|Physician Decision|0|||
30615372|NCT01252940|58626398|FG000|Main Study Phase|Protocol Violation|4|||
30615373|NCT01252940|58626399|FG001|Main Study Phase|Protocol Violation|2|||
30615374|NCT01252940|58626398|FG000|Main Study Phase|Withdrawal by Subject|6|||
30615375|NCT01252940|58626399|FG001|Main Study Phase|Withdrawal by Subject|5|||
30615376|NCT01252940|58626398|FG000|Main Study Phase|Subject Non-compliance|1|||
30615377|NCT01252940|58626399|FG001|Main Study Phase|Subject Non-compliance|1|||
30615378|NCT01252940|58626398|FG000|Extension Phase|Adverse Event|2|||
30615379|NCT01252940|58626399|FG001|Extension Phase|Adverse Event|1|||
30615380|NCT01252940|58626398|FG000|Extension Phase|Lack of Efficacy|1|||
30615381|NCT01252940|58626399|FG001|Extension Phase|Lack of Efficacy|0|||
30615382|NCT01252940|58626398|FG000|Extension Phase|Lost to Follow-up|5|||
30615383|NCT01252940|58626399|FG001|Extension Phase|Lost to Follow-up|0|||
30615384|NCT01252940|58626398|FG000|Extension Phase|Physician Decision|0|||
30615385|NCT01252940|58626399|FG001|Extension Phase|Physician Decision|1|||
30615386|NCT01252940|58626398|FG000|Extension Phase|Subject Non-compliance|1|||
30615387|NCT01252940|58626399|FG001|Extension Phase|Subject Non-compliance|0|||
30615388|NCT01252940|58626398|FG000|Extension Phase|Withdrawal by Subject|1|||
30615389|NCT01252940|58626399|FG001|Extension Phase|Withdrawal by Subject|1|||
30615390|NCT01252238|58626409|FG000|Overall Study|Sponsor terminated study|4|||
30615391|NCT01252238|58626410|FG001|Overall Study|Sponsor terminated study|4|||
30615392|NCT01252238|58626411|FG002|Overall Study|Sponsor terminated study|4|||
30615393|NCT01101477|58626425|FG000|Overall Study|Protocol Violation|5|||
30615394|NCT01101477|58626426|FG001|Overall Study|Protocol Violation|3|||
30615395|NCT01101477|58626427|FG002|Overall Study|Protocol Violation|1|||
30615396|NCT01251770|58626437|FG000|Overall Study|Protocol Violation|13|||
30615397|NCT01251770|58626438|FG001|Overall Study|Protocol Violation|7|||
30615398|NCT01101321|58626444|FG000|Period 1|Withdrawal by Subject|1|||
30615399|NCT01101321|58626445|FG001|Period 1|Withdrawal by Subject|1|||
30615400|NCT01101321|58626444|FG000|Period 1|Adverse Event|3|||
30615401|NCT01101321|58626445|FG001|Period 1|Adverse Event|3|||
30615402|NCT01101165|58626451|FG000|Period 1|Adverse Event|1|||
30615403|NCT01101165|58626452|FG001|Period 1|Adverse Event|2|||
30615404|NCT01101165|58626451|FG000|Period 1|Withdrawal by Subject|0|||
30615405|NCT01101165|58626452|FG001|Period 1|Withdrawal by Subject|2|||
30615406|NCT01101165|58626451|FG000|Period 1|Positive Drug Screen|0|||
30615407|NCT01101165|58626452|FG001|Period 1|Positive Drug Screen|1|||
30615408|NCT01101165|58626451|FG000|Period 1|Lost to Follow-up|1|||
30615409|NCT01101165|58626452|FG001|Period 1|Lost to Follow-up|0|||
30615410|NCT01101165|58626451|FG000|Period 2|Withdrawal by Subject|3|||
30615411|NCT01101165|58626452|FG001|Period 2|Withdrawal by Subject|1|||
30615412|NCT01101165|58626451|FG000|Period 2|Adverse Event|1|||
30615413|NCT01101165|58626452|FG001|Period 2|Adverse Event|0|||
30615414|NCT01100853|58626460|FG000|Overall Study|Lost to Follow-up|11|||
30615415|NCT01100853|58626461|FG001|Overall Study|Lost to Follow-up|6|||
30615416|NCT01100853|58626460|FG000|Overall Study|Received <4 study injections|10|||
30615417|NCT01100853|58626461|FG001|Overall Study|Received <4 study injections|13|||
30615418|NCT01100853|58626460|FG000|Overall Study|Withdrawal by Subject|6|||
30760592|NCT03381274|58769071|FG001|Overall Study|Withdrawal by Subject|1|||
30615419|NCT01100853|58626461|FG001|Overall Study|Withdrawal by Subject|4|||
30615420|NCT01100307|58626469|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
30615421|NCT01100307|58626470|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
30615422|NCT01100307|58626469|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
30615423|NCT01100307|58626470|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
30615424|NCT01100307|58626469|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
30615425|NCT01100307|58626470|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
30615426|NCT01100307|58626469|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
30615427|NCT01100307|58626470|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
30615428|NCT01100307|58626469|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
30615429|NCT01100307|58626470|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
30615430|NCT01100307|58626469|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
30615431|NCT01100307|58626470|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
30615432|NCT01100073|58626478|FG000|Overall Study|Lack of Efficacy|4|||
30615433|NCT01100073|58626478|FG000|Overall Study|Insufficient Tolerability|21|||
30615434|NCT01100073|58626478|FG000|Overall Study|Withdrawal by Subject|13|||
30615435|NCT01100073|58626478|FG000|Overall Study|Lost to Follow-up|39|||
30615436|NCT01100073|58626478|FG000|Overall Study|Lack of effect + patient's wish|2|||
30615437|NCT01100073|58626478|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
30615438|NCT01100073|58626478|FG000|Overall Study|Other|8|||
30615439|NCT01100073|58626478|FG000|Overall Study|Missing|5|||
30615440|NCT01099917|58626482|FG000|Overall Study|Adverse Event|3|||
30615441|NCT01099917|58626482|FG000|Overall Study|Not Treated|24|||
30615442|NCT01099215|58626488|FG000|Overall Study|Withdrawal by Subject|1|||
30615443|NCT01099215|58626489|FG001|Overall Study|Withdrawal by Subject|0|||
30615444|NCT01099215|58626488|FG000|Overall Study|Adverse Event|0|||
30615445|NCT01099215|58626489|FG001|Overall Study|Adverse Event|1|||
30615446|NCT01097655|58626495|FG000|Overall Study|Withdrawal by Subject|1|||
30615447|NCT01097655|58626495|FG000|Overall Study|Subject Documented Twice|1|||
30615448|NCT01097655|58626495|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
30615449|NCT01107405|58626504|FG000|Overall Study|Adverse Event|1|||
30615450|NCT01107405|58626505|FG001|Overall Study|Adverse Event|1|||
30615451|NCT01107405|58626506|FG002|Overall Study|Adverse Event|0|||
30615452|NCT01107405|58626507|FG003|Overall Study|Adverse Event|0|||
30615453|NCT01107405|58626508|FG004|Overall Study|Adverse Event|2|||
30615454|NCT01107405|58626504|FG000|Overall Study|Withdrawal by Subject|1|||
30615455|NCT01107405|58626505|FG001|Overall Study|Withdrawal by Subject|0|||
30615456|NCT01107405|58626506|FG002|Overall Study|Withdrawal by Subject|1|||
30615457|NCT01107405|58626507|FG003|Overall Study|Withdrawal by Subject|2|||
30615458|NCT01107405|58626508|FG004|Overall Study|Withdrawal by Subject|1|||
30615459|NCT01107405|58626504|FG000|Overall Study|Protocol Violation|0|||
30615460|NCT01107405|58626505|FG001|Overall Study|Protocol Violation|0|||
30615461|NCT01107405|58626506|FG002|Overall Study|Protocol Violation|1|||
30615462|NCT01107405|58626507|FG003|Overall Study|Protocol Violation|1|||
30615463|NCT01107405|58626508|FG004|Overall Study|Protocol Violation|0|||
30615464|NCT01097577|58626522|FG000|Overall Study|Adverse Event|0|||
30615465|NCT01097577|58626523|FG001|Overall Study|Adverse Event|1|||
30615466|NCT01097421|58626529|FG000|Overall Study|Adverse Event|8|||
30615467|NCT01097421|58626529|FG000|Overall Study|Protocol Violation|2|||
30615468|NCT01097421|58626529|FG000|Overall Study|Lost to Follow-up|1|||
30615469|NCT01097421|58626529|FG000|Overall Study|Withdrawal by Subject|3|||
30615470|NCT01251614|58626536|FG000|Overall Study|Adverse Event|1|||
30615471|NCT01251614|58626537|FG001|Overall Study|Adverse Event|0|||
30615472|NCT01251614|58626538|FG002|Overall Study|Adverse Event|1|||
30615473|NCT01251614|58626536|FG000|Overall Study|Lack of Efficacy|1|||
30615474|NCT01251614|58626537|FG001|Overall Study|Lack of Efficacy|9|||
30615475|NCT01251614|58626538|FG002|Overall Study|Lack of Efficacy|4|||
30615476|NCT01251614|58626536|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
30615477|NCT01251614|58626537|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
30615478|NCT01251614|58626538|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
30615479|NCT01251614|58626536|FG000|Overall Study|Pregnancy|0|||
30699288|NCT00623766|58713833|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
30893157|NCT02163759|58926592|FG002|Overall Study|Death|1|||
30893158|NCT02371369|58926605|FG000|Part 1|Physician Decision|0|||
30615480|NCT01251614|58626537|FG001|Overall Study|Pregnancy|0|||
30615481|NCT01251614|58626538|FG002|Overall Study|Pregnancy|2|||
30615482|NCT01251614|58626536|FG000|Overall Study|Loss of Disease Control|0|||
30615483|NCT01251614|58626537|FG001|Overall Study|Loss of Disease Control|1|||
30615484|NCT01251614|58626538|FG002|Overall Study|Loss of Disease Control|0|||
30893159|NCT02371369|58926606|FG001|Part 1|Physician Decision|3|||
30615485|NCT01251614|58626536|FG000|Overall Study|Withdrawal by Subject|0|||
30615486|NCT01251614|58626537|FG001|Overall Study|Withdrawal by Subject|2|||
30615487|NCT01251614|58626538|FG002|Overall Study|Withdrawal by Subject|1|||
30615488|NCT01251614|58626536|FG000|Overall Study|Lost to Follow-up|0|||
30893160|NCT02371369|58926605|FG000|Part 1|Adverse Event|8|||
30615489|NCT01251614|58626537|FG001|Overall Study|Lost to Follow-up|1|||
30615490|NCT01251614|58626538|FG002|Overall Study|Lost to Follow-up|0|||
30893161|NCT02371369|58926606|FG001|Part 1|Adverse Event|0|||
30615491|NCT01106625|58626559|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
30615492|NCT01106625|58626560|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
30615493|NCT01106625|58626561|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
30615494|NCT01106625|58626559|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
30615495|NCT01106625|58626560|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
30615496|NCT01106625|58626561|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
30615497|NCT01106625|58626559|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
30615498|NCT01106625|58626560|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
30615499|NCT01106625|58626561|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
30615500|NCT01106625|58626559|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
30615501|NCT01106625|58626560|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
30615502|NCT01106625|58626561|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
30615503|NCT01106625|58626559|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
30615504|NCT01106625|58626560|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
30615505|NCT01106625|58626561|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
30615506|NCT01106625|58626559|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
30615507|NCT01106625|58626560|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
30615508|NCT01106625|58626561|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
30615509|NCT01106625|58626559|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
30615510|NCT01106625|58626560|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
30615511|NCT01106625|58626561|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
30615512|NCT01106625|58626559|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
30615513|NCT01106625|58626560|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
30615514|NCT01106625|58626561|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
30615515|NCT01106625|58626559|FG000|Core Period: Baseline to Week 26|Other|8|||
30615516|NCT01106625|58626560|FG001|Core Period: Baseline to Week 26|Other|7|||
30615517|NCT01106625|58626561|FG002|Core Period: Baseline to Week 26|Other|4|||
30615518|NCT01106625|58626559|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
30615519|NCT01106625|58626560|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
30615520|NCT01106625|58626561|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
30615521|NCT01106625|58626559|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
30615522|NCT01106625|58626560|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
30615523|NCT01106625|58626561|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
30699289|NCT00623766|58713834|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
30699290|NCT00623766|58713833|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
30699291|NCT00623766|58713834|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
30699292|NCT00623766|58713833|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
30893162|NCT02371369|58926605|FG000|Part 1|Withdrawal by Subject|1|||
30893163|NCT02371369|58926606|FG001|Part 1|Withdrawal by Subject|6|||
30893164|NCT02371369|58926605|FG000|Part 1|Disease progression|0|||
31009601|NCT01435356|59210864|FG000|Overall Study|Adverse Event|2|||
31009602|NCT01435356|59210865|FG001|Overall Study|Adverse Event|0|||
31009603|NCT01435356|59210864|FG000|Overall Study|Disease progression/recurrence|17|||
31009604|NCT01435356|59210865|FG001|Overall Study|Disease progression/recurrence|10|||
31009605|NCT01435356|59210864|FG000|Overall Study|Protocol Violation|0|||
31009606|NCT01435356|59210865|FG001|Overall Study|Protocol Violation|1|||
31009607|NCT01435356|59210864|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
31009608|NCT01435356|59210865|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
31009609|NCT01435356|59210864|FG000|Overall Study|Withdrawal by Subject|1|||
31009610|NCT01435356|59210865|FG001|Overall Study|Withdrawal by Subject|1|||
31009611|NCT01435356|59210864|FG000|Overall Study|Facial palsy|1|||
31009612|NCT01435356|59210865|FG001|Overall Study|Facial palsy|0|||
31009613|NCT01435356|59210864|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
31009614|NCT01435356|59210865|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
31009615|NCT01435356|59210864|FG000|Overall Study|Physician Decision|1|||
31009616|NCT01435356|59210865|FG001|Overall Study|Physician Decision|0|||
31009617|NCT01435356|59210864|FG000|Overall Study|Patient decision|3|||
31009618|NCT01435356|59210865|FG001|Overall Study|Patient decision|0|||
31009619|NCT01435356|59210864|FG000|Overall Study|Patient moved to another city|1|||
31009620|NCT01435356|59210865|FG001|Overall Study|Patient moved to another city|1|||
31009621|NCT01435122|59210871|FG000|Overall Study|Early withdrawal due to toxicity|8|||
30615524|NCT01106625|58626559|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
30615525|NCT01106625|58626560|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
30615526|NCT01106625|58626561|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
30615527|NCT01106625|58626559|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
30615528|NCT01106625|58626560|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
30615529|NCT01106625|58626561|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
30615530|NCT01106625|58626559|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
30615531|NCT01106625|58626560|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
30615532|NCT01106625|58626561|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
30615533|NCT01106625|58626559|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
30615534|NCT01106625|58626560|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
30615535|NCT01106625|58626561|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
30615536|NCT01106625|58626559|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
30615537|NCT01106625|58626560|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
30615538|NCT01106625|58626561|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
30615539|NCT01106625|58626559|FG000|Extension Period: Week 26 to Week 52|Other|5|||
30615540|NCT01106625|58626560|FG001|Extension Period: Week 26 to Week 52|Other|5|||
30615541|NCT01106625|58626561|FG002|Extension Period: Week 26 to Week 52|Other|4|||
30615542|NCT01251380|58626572|FG000|Overall Study|Other (Not otherwise specified)|12|||
30615543|NCT01251380|58626572|FG000|Overall Study|Withdrawal by Subject|6|||
30615544|NCT01251380|58626572|FG000|Overall Study|Lack of Efficacy|1|||
30615545|NCT01251380|58626572|FG000|Overall Study|Adverse Event|1|||
30615546|NCT01251380|58626572|FG000|Overall Study|Lost to Follow-up|2|||
30615547|NCT01251146|58626583|FG000|Overall Study|Lost to Follow-up|3|||
30615548|NCT01251146|58626584|FG001|Overall Study|Lost to Follow-up|10|||
30615549|NCT01096017|58626590|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
30615550|NCT01096017|58626591|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
30615551|NCT01106157|58626599|FG000|Overall Study|Withdrawal by Subject|1|||
30615552|NCT01106157|58626600|FG001|Overall Study|Withdrawal by Subject|0|||
30615553|NCT01094301|58626606|FG000|Trial Stage|Withdrawal by Subject|1|||
30615554|NCT01094301|58626606|FG000|Implant Stage|Adverse Event|1|||
30615555|NCT01094301|58626606|FG000|Implant Stage|Protocol Violation|1|||
30615556|NCT01094301|58626606|FG000|Implant Stage|Withdrawal by Subject|2|||
30615557|NCT01094301|58626606|FG000|Implant Stage|No return of pain|4|||
30615558|NCT01093755|58626614|FG000|Overall Study|Withdrawal by Subject|3|||
30615559|NCT01093755|58626615|FG001|Overall Study|Withdrawal by Subject|4|||
30615560|NCT01093599|58626623|FG000|Overall Study|Lost to Follow-up|32|||
30615561|NCT01093599|58626624|FG001|Overall Study|Lost to Follow-up|46|||
30615562|NCT01092663|58626632|FG000|Overall Study|Withdrawal by Subject|3|||
30615563|NCT01092663|58626633|FG001|Overall Study|Withdrawal by Subject|2|||
30615564|NCT01092663|58626632|FG000|Overall Study|Glucose >300mg/dL|1|||
30615565|NCT01092663|58626633|FG001|Overall Study|Glucose >300mg/dL|0|||
30615566|NCT01092663|58626632|FG000|Overall Study|High fasting triglyceride|2|||
30615567|NCT01092663|58626633|FG001|Overall Study|High fasting triglyceride|0|||
30615568|NCT01092663|58626632|FG000|Overall Study|Adverse Event|1|||
30615569|NCT01092663|58626633|FG001|Overall Study|Adverse Event|1|||
30615570|NCT01092663|58626632|FG000|Overall Study|Protocol Violation|0|||
30615571|NCT01092663|58626633|FG001|Overall Study|Protocol Violation|1|||
30615572|NCT01078623|58626644|FG000|Treatment Period 1|Adverse Event|1|||
30615573|NCT01078623|58626645|FG001|Treatment Period 1|Adverse Event|1|||
30615574|NCT01078623|58626646|FG002|Treatment Period 1|Adverse Event|1|||
30615575|NCT01078623|58626647|FG003|Treatment Period 1|Adverse Event|0|||
30615576|NCT01078623|58626648|FG004|Treatment Period 1|Adverse Event|0|||
30615577|NCT01078623|58626649|FG005|Treatment Period 1|Adverse Event|0|||
30615578|NCT01078623|58626650|FG006|Treatment Period 1|Adverse Event|1|||
30615579|NCT01078623|58626651|FG007|Treatment Period 1|Adverse Event|0|||
30615580|NCT01078623|58626652|FG008|Treatment Period 1|Adverse Event|1|||
30615581|NCT01078623|58626653|FG009|Treatment Period 1|Adverse Event|1|||
30615582|NCT01078623|58626654|FG010|Treatment Period 1|Adverse Event|0|||
30615583|NCT01078623|58626655|FG011|Treatment Period 1|Adverse Event|0|||
30615584|NCT01078623|58626656|FG012|Treatment Period 1|Adverse Event|0|||
30615585|NCT01078623|58626657|FG013|Treatment Period 1|Adverse Event|0|||
30615586|NCT01078623|58626658|FG014|Treatment Period 1|Adverse Event|0|||
30615587|NCT01078623|58626659|FG015|Treatment Period 1|Adverse Event|0|||
30615588|NCT01078623|58626660|FG016|Treatment Period 1|Adverse Event|0|||
30615589|NCT01078623|58626661|FG017|Treatment Period 1|Adverse Event|0|||
30615590|NCT01078623|58626662|FG018|Treatment Period 1|Adverse Event|0|||
30615591|NCT01078623|58626663|FG019|Treatment Period 1|Adverse Event|0|||
31009622|NCT01434810|59210877|FG000|Overall Study|Did not receive treatment|11|||
30615592|NCT01078623|58626644|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30615593|NCT01078623|58626645|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30615594|NCT01078623|58626646|FG002|Treatment Period 1|Withdrawal by Subject|0|||
31009623|NCT01434810|59210878|FG001|Overall Study|Did not receive treatment|3|||
31009624|NCT01434810|59210877|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
30615595|NCT01078623|58626647|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30699293|NCT00623766|58713834|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
30699294|NCT00550407|58713846|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
30699295|NCT00550407|58713847|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
30699296|NCT00550407|58713848|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
30699297|NCT00550407|58713846|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
30699298|NCT00550407|58713847|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
30699299|NCT00550407|58713848|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
30699300|NCT00550407|58713846|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
30615596|NCT01078623|58626648|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30615597|NCT01078623|58626649|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30615598|NCT01078623|58626650|FG006|Treatment Period 1|Withdrawal by Subject|0|||
30615599|NCT01078623|58626651|FG007|Treatment Period 1|Withdrawal by Subject|1|||
30615600|NCT01078623|58626652|FG008|Treatment Period 1|Withdrawal by Subject|0|||
30615601|NCT01078623|58626653|FG009|Treatment Period 1|Withdrawal by Subject|0|||
30615602|NCT01078623|58626654|FG010|Treatment Period 1|Withdrawal by Subject|1|||
30615603|NCT01078623|58626655|FG011|Treatment Period 1|Withdrawal by Subject|0|||
30615604|NCT01078623|58626656|FG012|Treatment Period 1|Withdrawal by Subject|0|||
30615605|NCT01078623|58626657|FG013|Treatment Period 1|Withdrawal by Subject|0|||
30615606|NCT01078623|58626658|FG014|Treatment Period 1|Withdrawal by Subject|0|||
30615607|NCT01078623|58626659|FG015|Treatment Period 1|Withdrawal by Subject|0|||
30615608|NCT01078623|58626660|FG016|Treatment Period 1|Withdrawal by Subject|0|||
30615609|NCT01078623|58626661|FG017|Treatment Period 1|Withdrawal by Subject|0|||
30615610|NCT01078623|58626662|FG018|Treatment Period 1|Withdrawal by Subject|0|||
30615611|NCT01078623|58626663|FG019|Treatment Period 1|Withdrawal by Subject|0|||
30615612|NCT01078623|58626644|FG000|Treatment Period 1|Protocol Violation|0|||
30615613|NCT01078623|58626645|FG001|Treatment Period 1|Protocol Violation|0|||
30615614|NCT01078623|58626646|FG002|Treatment Period 1|Protocol Violation|0|||
30615615|NCT01078623|58626647|FG003|Treatment Period 1|Protocol Violation|0|||
30615616|NCT01078623|58626648|FG004|Treatment Period 1|Protocol Violation|0|||
30615617|NCT01078623|58626649|FG005|Treatment Period 1|Protocol Violation|1|||
30615618|NCT01078623|58626650|FG006|Treatment Period 1|Protocol Violation|0|||
30615619|NCT01078623|58626651|FG007|Treatment Period 1|Protocol Violation|0|||
30615620|NCT01078623|58626652|FG008|Treatment Period 1|Protocol Violation|0|||
30615621|NCT01078623|58626653|FG009|Treatment Period 1|Protocol Violation|0|||
30615622|NCT01078623|58626654|FG010|Treatment Period 1|Protocol Violation|0|||
30615623|NCT01078623|58626655|FG011|Treatment Period 1|Protocol Violation|0|||
30615624|NCT01078623|58626656|FG012|Treatment Period 1|Protocol Violation|0|||
30615625|NCT01078623|58626657|FG013|Treatment Period 1|Protocol Violation|0|||
30615626|NCT01078623|58626658|FG014|Treatment Period 1|Protocol Violation|0|||
30615627|NCT01078623|58626659|FG015|Treatment Period 1|Protocol Violation|0|||
30615628|NCT01078623|58626660|FG016|Treatment Period 1|Protocol Violation|0|||
30615629|NCT01078623|58626661|FG017|Treatment Period 1|Protocol Violation|0|||
30615630|NCT01078623|58626662|FG018|Treatment Period 1|Protocol Violation|0|||
30615631|NCT01078623|58626663|FG019|Treatment Period 1|Protocol Violation|0|||
30615632|NCT01078623|58626644|FG000|Treatment Period 2|Adverse Event|0|||
30615633|NCT01078623|58626645|FG001|Treatment Period 2|Adverse Event|0|||
30615634|NCT01078623|58626646|FG002|Treatment Period 2|Adverse Event|0|||
30615635|NCT01078623|58626647|FG003|Treatment Period 2|Adverse Event|0|||
30615636|NCT01078623|58626648|FG004|Treatment Period 2|Adverse Event|0|||
31009625|NCT01434810|59210878|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
31009626|NCT01393626|59210888|FG000|Overall Study|Adverse Event|2|||
31009627|NCT01393626|59210889|FG001|Overall Study|Adverse Event|1|||
31009628|NCT01393626|59210890|FG002|Overall Study|Adverse Event|5|||
31009629|NCT01393626|59210891|FG003|Overall Study|Adverse Event|0|||
31009630|NCT01393626|59210888|FG000|Overall Study|Did not meet entrance criteria|1|||
31009631|NCT01393626|59210889|FG001|Overall Study|Did not meet entrance criteria|0|||
31009632|NCT01393626|59210890|FG002|Overall Study|Did not meet entrance criteria|0|||
31009633|NCT01393626|59210891|FG003|Overall Study|Did not meet entrance criteria|0|||
31009634|NCT01393626|59210888|FG000|Overall Study|Lack of Efficacy|6|||
31009635|NCT01393626|59210889|FG001|Overall Study|Lack of Efficacy|6|||
31009636|NCT01393626|59210890|FG002|Overall Study|Lack of Efficacy|4|||
31009637|NCT01393626|59210891|FG003|Overall Study|Lack of Efficacy|1|||
30615637|NCT01078623|58626649|FG005|Treatment Period 2|Adverse Event|0|||
31009638|NCT01393626|59210888|FG000|Overall Study|Lost to Follow-up|1|||
31009639|NCT01393626|59210889|FG001|Overall Study|Lost to Follow-up|1|||
30615638|NCT01078623|58626650|FG006|Treatment Period 2|Adverse Event|1|||
30615639|NCT01078623|58626651|FG007|Treatment Period 2|Adverse Event|0|||
30615640|NCT01078623|58626652|FG008|Treatment Period 2|Adverse Event|0|||
30615641|NCT01078623|58626653|FG009|Treatment Period 2|Adverse Event|0|||
30615642|NCT01078623|58626654|FG010|Treatment Period 2|Adverse Event|0|||
30615643|NCT01078623|58626655|FG011|Treatment Period 2|Adverse Event|0|||
30615644|NCT01078623|58626656|FG012|Treatment Period 2|Adverse Event|0|||
30615645|NCT01078623|58626657|FG013|Treatment Period 2|Adverse Event|0|||
30615646|NCT01078623|58626658|FG014|Treatment Period 2|Adverse Event|0|||
30615647|NCT01078623|58626659|FG015|Treatment Period 2|Adverse Event|0|||
30615648|NCT01078623|58626660|FG016|Treatment Period 2|Adverse Event|0|||
30615649|NCT01078623|58626661|FG017|Treatment Period 2|Adverse Event|0|||
30615650|NCT01078623|58626662|FG018|Treatment Period 2|Adverse Event|1|||
30615651|NCT01078623|58626663|FG019|Treatment Period 2|Adverse Event|0|||
30615652|NCT01078623|58626644|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30615653|NCT01078623|58626645|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30615654|NCT01078623|58626646|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30615655|NCT01078623|58626647|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30615656|NCT01078623|58626648|FG004|Treatment Period 2|Withdrawal by Subject|0|||
30615657|NCT01078623|58626649|FG005|Treatment Period 2|Withdrawal by Subject|1|||
30615658|NCT01078623|58626650|FG006|Treatment Period 2|Withdrawal by Subject|0|||
30615659|NCT01078623|58626651|FG007|Treatment Period 2|Withdrawal by Subject|0|||
30615660|NCT01078623|58626652|FG008|Treatment Period 2|Withdrawal by Subject|0|||
30615661|NCT01078623|58626653|FG009|Treatment Period 2|Withdrawal by Subject|0|||
30615662|NCT01078623|58626654|FG010|Treatment Period 2|Withdrawal by Subject|0|||
30615663|NCT01078623|58626655|FG011|Treatment Period 2|Withdrawal by Subject|0|||
30615664|NCT01078623|58626656|FG012|Treatment Period 2|Withdrawal by Subject|0|||
30615665|NCT01078623|58626657|FG013|Treatment Period 2|Withdrawal by Subject|0|||
30615666|NCT01078623|58626658|FG014|Treatment Period 2|Withdrawal by Subject|0|||
30615667|NCT01078623|58626659|FG015|Treatment Period 2|Withdrawal by Subject|0|||
30615668|NCT01078623|58626660|FG016|Treatment Period 2|Withdrawal by Subject|0|||
30615669|NCT01078623|58626661|FG017|Treatment Period 2|Withdrawal by Subject|0|||
30615670|NCT01078623|58626662|FG018|Treatment Period 2|Withdrawal by Subject|0|||
30615671|NCT01078623|58626663|FG019|Treatment Period 2|Withdrawal by Subject|0|||
30615672|NCT01078623|58626644|FG000|Treatment Period 3|Adverse Event|0|||
30615673|NCT01078623|58626645|FG001|Treatment Period 3|Adverse Event|0|||
30615674|NCT01078623|58626646|FG002|Treatment Period 3|Adverse Event|0|||
30615675|NCT01078623|58626647|FG003|Treatment Period 3|Adverse Event|0|||
30615676|NCT01078623|58626648|FG004|Treatment Period 3|Adverse Event|1|||
30615677|NCT01078623|58626649|FG005|Treatment Period 3|Adverse Event|0|||
30615678|NCT01078623|58626650|FG006|Treatment Period 3|Adverse Event|0|||
30615679|NCT01078623|58626651|FG007|Treatment Period 3|Adverse Event|0|||
30615680|NCT01078623|58626652|FG008|Treatment Period 3|Adverse Event|0|||
30615681|NCT01078623|58626653|FG009|Treatment Period 3|Adverse Event|0|||
30615682|NCT01078623|58626654|FG010|Treatment Period 3|Adverse Event|0|||
30615683|NCT01078623|58626655|FG011|Treatment Period 3|Adverse Event|0|||
30615684|NCT01078623|58626656|FG012|Treatment Period 3|Adverse Event|0|||
30615685|NCT01078623|58626657|FG013|Treatment Period 3|Adverse Event|1|||
30615686|NCT01078623|58626658|FG014|Treatment Period 3|Adverse Event|0|||
30615687|NCT01078623|58626659|FG015|Treatment Period 3|Adverse Event|0|||
30615688|NCT01078623|58626660|FG016|Treatment Period 3|Adverse Event|0|||
30615689|NCT01078623|58626661|FG017|Treatment Period 3|Adverse Event|0|||
30615690|NCT01078623|58626662|FG018|Treatment Period 3|Adverse Event|0|||
30615691|NCT01078623|58626663|FG019|Treatment Period 3|Adverse Event|0|||
30615692|NCT01078623|58626644|FG000|Treatment Period 4|Adverse Event|0|||
30615693|NCT01078623|58626645|FG001|Treatment Period 4|Adverse Event|0|||
30615694|NCT01078623|58626646|FG002|Treatment Period 4|Adverse Event|1|||
30615695|NCT01078623|58626647|FG003|Treatment Period 4|Adverse Event|0|||
30615696|NCT01078623|58626648|FG004|Treatment Period 4|Adverse Event|0|||
30615697|NCT01078623|58626649|FG005|Treatment Period 4|Adverse Event|0|||
30615698|NCT01078623|58626650|FG006|Treatment Period 4|Adverse Event|0|||
30615699|NCT01078623|58626651|FG007|Treatment Period 4|Adverse Event|0|||
31009640|NCT01393626|59210890|FG002|Overall Study|Lost to Follow-up|1|||
30615700|NCT01078623|58626652|FG008|Treatment Period 4|Adverse Event|0|||
30615701|NCT01078623|58626653|FG009|Treatment Period 4|Adverse Event|0|||
31009641|NCT01393626|59210891|FG003|Overall Study|Lost to Follow-up|0|||
30615702|NCT01078623|58626654|FG010|Treatment Period 4|Adverse Event|0|||
30615703|NCT01078623|58626655|FG011|Treatment Period 4|Adverse Event|0|||
30615704|NCT01078623|58626656|FG012|Treatment Period 4|Adverse Event|0|||
30615705|NCT01078623|58626657|FG013|Treatment Period 4|Adverse Event|0|||
30893165|NCT02371369|58926606|FG001|Part 1|Disease progression|1|||
30615706|NCT01078623|58626658|FG014|Treatment Period 4|Adverse Event|0|||
30615707|NCT01078623|58626659|FG015|Treatment Period 4|Adverse Event|0|||
30615708|NCT01078623|58626660|FG016|Treatment Period 4|Adverse Event|0|||
30615709|NCT01078623|58626661|FG017|Treatment Period 4|Adverse Event|0|||
30615710|NCT01078623|58626662|FG018|Treatment Period 4|Adverse Event|0|||
30615711|NCT01078623|58626663|FG019|Treatment Period 4|Adverse Event|0|||
30893166|NCT02371369|58926605|FG000|Part 1|Protocol Violation|0|||
30615712|NCT01078623|58626644|FG000|Treatment Period 4|Withdrawal by Subject|0|||
30893167|NCT02371369|58926606|FG001|Part 1|Protocol Violation|1|||
30615713|NCT01078623|58626645|FG001|Treatment Period 4|Withdrawal by Subject|0|||
30615714|NCT01078623|58626646|FG002|Treatment Period 4|Withdrawal by Subject|0|||
30615715|NCT01078623|58626647|FG003|Treatment Period 4|Withdrawal by Subject|0|||
30615716|NCT01078623|58626648|FG004|Treatment Period 4|Withdrawal by Subject|0|||
30615717|NCT01078623|58626649|FG005|Treatment Period 4|Withdrawal by Subject|0|||
30615718|NCT01078623|58626650|FG006|Treatment Period 4|Withdrawal by Subject|0|||
30615719|NCT01078623|58626651|FG007|Treatment Period 4|Withdrawal by Subject|0|||
30615720|NCT01078623|58626652|FG008|Treatment Period 4|Withdrawal by Subject|0|||
30615721|NCT01078623|58626653|FG009|Treatment Period 4|Withdrawal by Subject|0|||
30615722|NCT01078623|58626654|FG010|Treatment Period 4|Withdrawal by Subject|0|||
30615723|NCT01078623|58626655|FG011|Treatment Period 4|Withdrawal by Subject|0|||
30615724|NCT01078623|58626656|FG012|Treatment Period 4|Withdrawal by Subject|0|||
30615725|NCT01078623|58626657|FG013|Treatment Period 4|Withdrawal by Subject|0|||
30615726|NCT01078623|58626658|FG014|Treatment Period 4|Withdrawal by Subject|0|||
30615727|NCT01078623|58626659|FG015|Treatment Period 4|Withdrawal by Subject|1|||
30615728|NCT01078623|58626660|FG016|Treatment Period 4|Withdrawal by Subject|0|||
30615729|NCT01078623|58626661|FG017|Treatment Period 4|Withdrawal by Subject|0|||
30615730|NCT01078623|58626662|FG018|Treatment Period 4|Withdrawal by Subject|0|||
30615731|NCT01078623|58626663|FG019|Treatment Period 4|Withdrawal by Subject|0|||
30615732|NCT01092507|58626677|FG000|Overall Study|Withdrawal by Subject|2|||
31009642|NCT01393626|59210888|FG000|Overall Study|Withdrawal by Subject|6|||
30615733|NCT01092507|58626678|FG001|Overall Study|Withdrawal by Subject|0|||
30615734|NCT01078545|58626684|FG000|Overall Study|Lost to Follow-up|13|||
30615735|NCT01078545|58626684|FG000|Overall Study|Physician Decision|6|||
30615736|NCT01078545|58626684|FG000|Overall Study|Withdrawal by Subject|3|||
30615737|NCT01078545|58626684|FG000|Overall Study|Death|3|||
30615738|NCT01078545|58626684|FG000|Overall Study|Participant moved to another physician|1|||
30615739|NCT01202760|58626691|FG000|Overall Study|Entry Criteria Not Met|0|||
30615740|NCT01202760|58626692|FG001|Overall Study|Entry Criteria Not Met|3|||
30615741|NCT01202760|58626693|FG002|Overall Study|Entry Criteria Not Met|1|||
30615742|NCT01202760|58626691|FG000|Overall Study|Adverse Event|11|||
30615743|NCT01202760|58626692|FG001|Overall Study|Adverse Event|9|||
30615744|NCT01202760|58626693|FG002|Overall Study|Adverse Event|10|||
30615745|NCT01202760|58626691|FG000|Overall Study|Death|2|||
30615746|NCT01202760|58626692|FG001|Overall Study|Death|1|||
30615747|NCT01202760|58626693|FG002|Overall Study|Death|0|||
30615748|NCT01202760|58626691|FG000|Overall Study|Lack of Efficacy|6|||
31009643|NCT01393626|59210889|FG001|Overall Study|Withdrawal by Subject|4|||
31009644|NCT01393626|59210890|FG002|Overall Study|Withdrawal by Subject|0|||
31009645|NCT01393626|59210891|FG003|Overall Study|Withdrawal by Subject|0|||
31009646|NCT01393626|59210888|FG000|Overall Study|Other|1|||
31009647|NCT01393626|59210889|FG001|Overall Study|Other|0|||
31009648|NCT01393626|59210890|FG002|Overall Study|Other|0|||
31009649|NCT01393626|59210891|FG003|Overall Study|Other|0|||
31009650|NCT01393626|59210888|FG000|Overall Study|Protocol Violation|1|||
31009651|NCT01393626|59210889|FG001|Overall Study|Protocol Violation|0|||
31009652|NCT01393626|59210890|FG002|Overall Study|Protocol Violation|2|||
31009653|NCT01393626|59210891|FG003|Overall Study|Protocol Violation|0|||
31009654|NCT01434654|59210910|FG000|Overall Study|Withdrawal by Subject|1|||
31009655|NCT01434654|59210911|FG001|Overall Study|Withdrawal by Subject|0|||
31009656|NCT01434654|59210910|FG000|Overall Study|Lost to Follow-up|1|||
31009657|NCT01434654|59210911|FG001|Overall Study|Lost to Follow-up|0|||
31009658|NCT01393158|59210921|FG000|Overall Study|Adverse Event|1|||
31009659|NCT01393158|59210922|FG001|Overall Study|Adverse Event|0|||
31009660|NCT01413360|59210934|FG000|Overall Study|Lost to Follow-up|2|||
31009661|NCT01413360|59210934|FG000|Overall Study|Adverse Event|1|||
31009662|NCT01413204|59210941|FG000|Overall Study|Adverse Event|1|||
30615749|NCT01202760|58626692|FG001|Overall Study|Lack of Efficacy|8|||
30615750|NCT01202760|58626693|FG002|Overall Study|Lack of Efficacy|7|||
30615751|NCT01202760|58626691|FG000|Overall Study|Lost to Follow-up|0|||
30615752|NCT01202760|58626692|FG001|Overall Study|Lost to Follow-up|2|||
30615753|NCT01202760|58626693|FG002|Overall Study|Lost to Follow-up|1|||
30615754|NCT01202760|58626691|FG000|Overall Study|Parent / Caregiver Decision|0|||
30615755|NCT01202760|58626692|FG001|Overall Study|Parent / Caregiver Decision|1|||
30615756|NCT01202760|58626693|FG002|Overall Study|Parent / Caregiver Decision|0|||
30615757|NCT01202760|58626691|FG000|Overall Study|Withdrawal by Subject|17|||
30615758|NCT01202760|58626692|FG001|Overall Study|Withdrawal by Subject|18|||
30615759|NCT01202760|58626693|FG002|Overall Study|Withdrawal by Subject|14|||
31009663|NCT01413204|59210942|FG001|Overall Study|Adverse Event|2|||
30893168|NCT02371369|58926605|FG000|Part 2|Adverse Event|6|||
31009664|NCT01413204|59210943|FG002|Overall Study|Adverse Event|2|||
31009665|NCT01413204|59210941|FG000|Overall Study|Physician Decision|3|||
31009666|NCT01413204|59210942|FG001|Overall Study|Physician Decision|0|||
31009667|NCT01413204|59210943|FG002|Overall Study|Physician Decision|2|||
31009668|NCT01413204|59210941|FG000|Overall Study|Withdrawal by Subject|1|||
30615760|NCT01202760|58626691|FG000|Overall Study|Physician Decision|0|||
30615761|NCT01202760|58626692|FG001|Overall Study|Physician Decision|1|||
30615762|NCT01202760|58626693|FG002|Overall Study|Physician Decision|0|||
30615763|NCT01202760|58626691|FG000|Overall Study|Protocol Violation|7|||
30615764|NCT01202760|58626692|FG001|Overall Study|Protocol Violation|5|||
30615765|NCT01202760|58626693|FG002|Overall Study|Protocol Violation|2|||
30615766|NCT01202760|58626691|FG000|Overall Study|Sponsor Decision|4|||
30615767|NCT01202760|58626692|FG001|Overall Study|Sponsor Decision|4|||
30615768|NCT01202760|58626693|FG002|Overall Study|Sponsor Decision|0|||
30615769|NCT01091259|58626713|FG000|Overall Study|Adverse Event|3|||
30615770|NCT01091259|58626713|FG000|Overall Study|Lack of Efficacy|2|||
30615771|NCT01091103|58626717|FG000|Overall Study|Adverse Event|1|||
30615772|NCT01091103|58626717|FG000|Overall Study|Progressive Disease|3|||
30615773|NCT01078389|58626725|FG000|Overall Study|Adverse Event|10|||
30615774|NCT01078389|58626726|FG001|Overall Study|Adverse Event|6|||
30615775|NCT01078389|58626725|FG000|Overall Study|Major Protocol Deviation|2|||
30615776|NCT01078389|58626726|FG001|Overall Study|Major Protocol Deviation|0|||
30615777|NCT01078389|58626725|FG000|Overall Study|Lost to Follow-up|23|||
30615778|NCT01078389|58626726|FG001|Overall Study|Lost to Follow-up|23|||
30615779|NCT01078389|58626725|FG000|Overall Study|Voluntary Withdrawal|20|||
30615780|NCT01078389|58626726|FG001|Overall Study|Voluntary Withdrawal|36|||
30615781|NCT01078389|58626725|FG000|Overall Study|Other|9|||
30615782|NCT01078389|58626726|FG001|Overall Study|Other|2|||
30615783|NCT01090323|58626734|FG000|Overall Study|Adverse Event|12|||
30615784|NCT01090323|58626735|FG001|Overall Study|Adverse Event|2|||
30615785|NCT01090323|58626734|FG000|Overall Study|Abnormal Lab Values|3|||
30615786|NCT01090323|58626735|FG001|Overall Study|Abnormal Lab Values|1|||
30615787|NCT01090323|58626734|FG000|Overall Study|Abnormal Test Procedure Results|2|||
30615788|NCT01090323|58626735|FG001|Overall Study|Abnormal Test Procedure Results|0|||
30615789|NCT01090323|58626734|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
30615790|NCT01090323|58626735|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30615791|NCT01090323|58626734|FG000|Overall Study|Condition no longer requires drug|5|||
30615792|NCT01090323|58626735|FG001|Overall Study|Condition no longer requires drug|4|||
30615793|NCT01090323|58626734|FG000|Overall Study|Protocol Violation|2|||
30615794|NCT01090323|58626735|FG001|Overall Study|Protocol Violation|1|||
30615795|NCT01090323|58626734|FG000|Overall Study|Withdrew consent|33|||
30615796|NCT01090323|58626735|FG001|Overall Study|Withdrew consent|11|||
30615797|NCT01090323|58626734|FG000|Overall Study|Lost to Follow-up|11|||
30615798|NCT01090323|58626735|FG001|Overall Study|Lost to Follow-up|6|||
30615799|NCT01090323|58626734|FG000|Overall Study|Administrative problems|6|||
30615800|NCT01090323|58626735|FG001|Overall Study|Administrative problems|4|||
30615801|NCT01090323|58626734|FG000|Overall Study|Death|1|||
30615802|NCT01090323|58626735|FG001|Overall Study|Death|2|||
30615803|NCT01090323|58626734|FG000|Overall Study|Stopped end of core|7|||
30615804|NCT01090323|58626735|FG001|Overall Study|Stopped end of core|0|||
30615805|NCT01090323|58626734|FG000|Overall Study|Stopped end of extension 1#|3|||
30615806|NCT01090323|58626735|FG001|Overall Study|Stopped end of extension 1#|1|||
30615807|NCT01078155|58626741|FG000|Overall Study|Adverse Event|7|||
30615808|NCT01078155|58626741|FG000|Overall Study|Lack of Efficacy|16|||
30615809|NCT01078155|58626741|FG000|Overall Study|Participant's Decision|6|||
30615810|NCT01078155|58626741|FG000|Overall Study|Lost to Follow-up|15|||
30615811|NCT01201356|58626745|FG000|Overall Study|Adverse Event|170|||
30615812|NCT01201356|58626745|FG000|Overall Study|Abnormal laboratory value(s)|51|||
31009669|NCT01413204|59210942|FG001|Overall Study|Withdrawal by Subject|4|||
30615813|NCT01201356|58626745|FG000|Overall Study|Abnormal test procedure result(s)|3|||
30615814|NCT01201356|58626745|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
30615815|NCT01201356|58626745|FG000|Overall Study|Condition no longer requires study drug|12|||
30615816|NCT01201356|58626745|FG000|Overall Study|Withdrawal by Subject|144|||
30615817|NCT01201356|58626745|FG000|Overall Study|Lost to Follow-up|50|||
30615818|NCT01201356|58626745|FG000|Overall Study|administrative problems|74|||
31009670|NCT01413204|59210943|FG002|Overall Study|Withdrawal by Subject|4|||
31009671|NCT01413204|59210941|FG000|Overall Study|Clearly not eligible for the study|0|||
31009672|NCT01413204|59210942|FG001|Overall Study|Clearly not eligible for the study|0|||
31009673|NCT01413204|59210943|FG002|Overall Study|Clearly not eligible for the study|1|||
31009674|NCT01413204|59210941|FG000|Overall Study|Fasting plasma glucose level increased|1|||
31009675|NCT01413204|59210942|FG001|Overall Study|Fasting plasma glucose level increased|0|||
31009676|NCT01413204|59210943|FG002|Overall Study|Fasting plasma glucose level increased|10|||
31009677|NCT01392378|59210956|FG000|Infant Series|Adverse Event|0|||
31009678|NCT01392378|59210957|FG001|Infant Series|Adverse Event|0|||
30615819|NCT01201356|58626745|FG000|Overall Study|Death|16|||
30615820|NCT01201356|58626745|FG000|Overall Study|Protocol Violation|12|||
30615821|NCT01200810|58626751|FG000|Overall Study|Physician Decision|1|||
30615822|NCT01200810|58626752|FG001|Overall Study|Physician Decision|0|||
31009679|NCT01392378|59210958|FG002|Infant Series|Adverse Event|0|||
31009680|NCT01392378|59210959|FG003|Infant Series|Adverse Event|1|||
30615823|NCT01200810|58626751|FG000|Overall Study|Withdrawal by Subject|1|||
30615824|NCT01200810|58626752|FG001|Overall Study|Withdrawal by Subject|2|||
30615825|NCT01200810|58626751|FG000|Overall Study|Sponsor stopped making study drug|3|||
30615826|NCT01200810|58626752|FG001|Overall Study|Sponsor stopped making study drug|3|||
30615827|NCT01200342|58626758|FG000|Overall Study|Disease Progression|1|||
30893169|NCT02371369|58926606|FG001|Part 2|Adverse Event|5|||
31009681|NCT01392378|59210960|FG004|Infant Series|Adverse Event|0|||
31009682|NCT01392378|59210956|FG000|Infant Series|Lost to Follow-up|0|||
31009683|NCT01392378|59210957|FG001|Infant Series|Lost to Follow-up|0|||
31009684|NCT01392378|59210958|FG002|Infant Series|Lost to Follow-up|0|||
31009685|NCT01392378|59210959|FG003|Infant Series|Lost to Follow-up|1|||
30615828|NCT01199016|58626762|FG000|Overall Study|No longer meets eligibility criteria|4|||
30615829|NCT01199016|58626762|FG000|Overall Study|Entrance criteria|5|||
30615830|NCT01199016|58626762|FG000|Overall Study|Protocol Violation|9|||
30615831|NCT01199016|58626762|FG000|Overall Study|Other|13|||
30615832|NCT01199016|58626762|FG000|Overall Study|Withdrawal by Subject|21|||
30615833|NCT01199016|58626762|FG000|Overall Study|Lost to Follow-up|25|||
30615834|NCT01198548|58626766|FG000|Overall Study|Disease Progression|9|||
30615835|NCT01198548|58626766|FG000|Overall Study|Administrative Decision|1|||
30615836|NCT01198470|58626770|FG000|Overall Study|Adverse Event|2|||
30615837|NCT00977938|58626778|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
30615838|NCT00977938|58626779|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
30615839|NCT00977938|58626780|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
30615840|NCT00977938|58626781|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
30615841|NCT00977938|58626778|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
30615842|NCT00977938|58626779|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
30615843|NCT00977938|58626780|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
30615844|NCT00977938|58626781|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
30615845|NCT00977938|58626778|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
30615846|NCT00977938|58626779|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
30615847|NCT00977938|58626780|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
30615848|NCT00977938|58626781|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
30615849|NCT00977938|58626778|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
30615850|NCT00977938|58626779|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
30615851|NCT00977938|58626780|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
30615852|NCT00977938|58626781|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
30615853|NCT00977938|58626778|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
31009686|NCT01392378|59210960|FG004|Infant Series|Lost to Follow-up|0|||
31009687|NCT01392378|59210956|FG000|Infant Series|Protocol Violation|0|||
31009688|NCT01392378|59210957|FG001|Infant Series|Protocol Violation|1|||
31009689|NCT01392378|59210958|FG002|Infant Series|Protocol Violation|0|||
31009690|NCT01392378|59210959|FG003|Infant Series|Protocol Violation|0|||
30615854|NCT00977938|58626779|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
30615855|NCT00977938|58626780|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
30615856|NCT00977938|58626781|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
30615857|NCT00977938|58626778|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
30615858|NCT00977938|58626779|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
30615859|NCT00977938|58626780|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
30615860|NCT00977938|58626781|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
30615861|NCT02716675|58626796|FG000|Overall Study|Death|2|||
30615862|NCT02716675|58626797|FG001|Overall Study|Death|3|||
30615863|NCT02716675|58626798|FG002|Overall Study|Death|0|||
30615864|NCT02716675|58626796|FG000|Overall Study|Physician Decision|2|||
30615865|NCT02716675|58626797|FG001|Overall Study|Physician Decision|1|||
30615866|NCT02716675|58626798|FG002|Overall Study|Physician Decision|1|||
30615867|NCT02716675|58626796|FG000|Overall Study|Lost to Follow-up|100|||
30615868|NCT02716675|58626797|FG001|Overall Study|Lost to Follow-up|87|||
30615869|NCT02716675|58626798|FG002|Overall Study|Lost to Follow-up|99|||
30615870|NCT02716675|58626796|FG000|Overall Study|Withdrawal by Subject|22|||
31009691|NCT01392378|59210960|FG004|Infant Series|Protocol Violation|0|||
30615871|NCT02716675|58626797|FG001|Overall Study|Withdrawal by Subject|25|||
30615872|NCT02716675|58626798|FG002|Overall Study|Withdrawal by Subject|20|||
30615873|NCT02716675|58626796|FG000|Overall Study|Protocol Violation|0|||
30615874|NCT02716675|58626797|FG001|Overall Study|Protocol Violation|3|||
30615875|NCT02716675|58626798|FG002|Overall Study|Protocol Violation|1|||
31009692|NCT01392378|59210956|FG000|Infant Series|Withdrawal by Parent|4|||
30615876|NCT02716675|58626796|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
30615877|NCT02716675|58626797|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
30615878|NCT02716675|58626798|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
30615879|NCT02716675|58626796|FG000|Overall Study|Other|38|||
30615880|NCT02716675|58626797|FG001|Overall Study|Other|47|||
30615881|NCT02716675|58626798|FG002|Overall Study|Other|48|||
30615882|NCT00977548|58626811|FG000|Overall Study|Ineligible|4|||
30615883|NCT00977548|58626811|FG000|Overall Study|Adverse Event|8|||
30615884|NCT00977548|58626811|FG000|Overall Study|Withdrawal by Subject|1|||
30615885|NCT01090011|58626815|FG000|Overall Study|Progressive disease|128|||
30615886|NCT01090011|58626815|FG000|Overall Study|Adverse Event|32|||
30615887|NCT01090011|58626815|FG000|Overall Study|Protocol Violation|1|||
30615888|NCT01090011|58626815|FG000|Overall Study|Refusal to start/continue medication|5|||
30615889|NCT01090011|58626815|FG000|Overall Study|Other reason not defined above|5|||
30615890|NCT01251653|58626836|FG000|Overall Study|Progressive Disease|1|||
30615891|NCT01251653|58626837|FG001|Overall Study|Progressive Disease|7|||
30615892|NCT01251653|58626838|FG002|Overall Study|Progressive Disease|16|||
30615893|NCT01251653|58626839|FG003|Overall Study|Progressive Disease|4|||
30615894|NCT01251653|58626840|FG004|Overall Study|Progressive Disease|0|||
30615895|NCT01251653|58626841|FG005|Overall Study|Progressive Disease|17|||
30615896|NCT01251653|58626842|FG006|Overall Study|Progressive Disease|14|||
30615897|NCT01251653|58626843|FG007|Overall Study|Progressive Disease|7|||
30615898|NCT01251653|58626844|FG008|Overall Study|Progressive Disease|5|||
30615899|NCT01251653|58626836|FG000|Overall Study|Dose-limiting toxicity|0|||
30615900|NCT01251653|58626837|FG001|Overall Study|Dose-limiting toxicity|1|||
30615901|NCT01251653|58626838|FG002|Overall Study|Dose-limiting toxicity|1|||
30615902|NCT01251653|58626839|FG003|Overall Study|Dose-limiting toxicity|1|||
30615903|NCT01251653|58626840|FG004|Overall Study|Dose-limiting toxicity|0|||
30615904|NCT01251653|58626841|FG005|Overall Study|Dose-limiting toxicity|0|||
30615905|NCT01251653|58626842|FG006|Overall Study|Dose-limiting toxicity|2|||
30615906|NCT01251653|58626843|FG007|Overall Study|Dose-limiting toxicity|0|||
30615907|NCT01251653|58626844|FG008|Overall Study|Dose-limiting toxicity|0|||
30615908|NCT01251653|58626836|FG000|Overall Study|Adverse Event|1|||
30615909|NCT01251653|58626837|FG001|Overall Study|Adverse Event|0|||
30615910|NCT01251653|58626838|FG002|Overall Study|Adverse Event|2|||
30615911|NCT01251653|58626839|FG003|Overall Study|Adverse Event|1|||
30615912|NCT01251653|58626840|FG004|Overall Study|Adverse Event|1|||
30615913|NCT01251653|58626841|FG005|Overall Study|Adverse Event|0|||
30615914|NCT01251653|58626842|FG006|Overall Study|Adverse Event|2|||
30615915|NCT01251653|58626843|FG007|Overall Study|Adverse Event|2|||
30615916|NCT01251653|58626844|FG008|Overall Study|Adverse Event|1|||
30615917|NCT01251653|58626836|FG000|Overall Study|Withdrawal by Subject|1|||
30615918|NCT01251653|58626837|FG001|Overall Study|Withdrawal by Subject|0|||
30615919|NCT01251653|58626838|FG002|Overall Study|Withdrawal by Subject|1|||
30615920|NCT01251653|58626839|FG003|Overall Study|Withdrawal by Subject|0|||
30615921|NCT01251653|58626840|FG004|Overall Study|Withdrawal by Subject|1|||
30699301|NCT00550407|58713847|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
30699302|NCT00550407|58713848|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
30893170|NCT02371369|58926605|FG000|Part 2|Withdrawal by Subject|16|||
31009693|NCT01392378|59210957|FG001|Infant Series|Withdrawal by Parent|1|||
31009694|NCT01392378|59210958|FG002|Infant Series|Withdrawal by Parent|0|||
31009695|NCT01392378|59210959|FG003|Infant Series|Withdrawal by Parent|0|||
31009696|NCT01392378|59210960|FG004|Infant Series|Withdrawal by Parent|0|||
31009697|NCT01392378|59210956|FG000|After Infant Series|Lost to Follow-up|0|||
31009698|NCT01392378|59210957|FG001|After Infant Series|Lost to Follow-up|0|||
31009699|NCT01392378|59210958|FG002|After Infant Series|Lost to Follow-up|1|||
31009700|NCT01392378|59210959|FG003|After Infant Series|Lost to Follow-up|0|||
31009701|NCT01392378|59210960|FG004|After Infant Series|Lost to Follow-up|0|||
31009702|NCT01392378|59210956|FG000|After Infant Series|Withdrawal by Parent|0|||
31009703|NCT01392378|59210957|FG001|After Infant Series|Withdrawal by Parent|1|||
31009704|NCT01392378|59210958|FG002|After Infant Series|Withdrawal by Parent|1|||
31009705|NCT01392378|59210959|FG003|After Infant Series|Withdrawal by Parent|0|||
31009706|NCT01392378|59210960|FG004|After Infant Series|Withdrawal by Parent|1|||
31009707|NCT01392378|59210956|FG000|Toddler Dose|Lost to Follow-up|0|||
30615922|NCT01251653|58626841|FG005|Overall Study|Withdrawal by Subject|1|||
30615923|NCT01251653|58626842|FG006|Overall Study|Withdrawal by Subject|0|||
30615924|NCT01251653|58626843|FG007|Overall Study|Withdrawal by Subject|1|||
30615925|NCT01251653|58626844|FG008|Overall Study|Withdrawal by Subject|0|||
30615926|NCT01251653|58626836|FG000|Overall Study|Other reason not mentioned above|0|||
30615927|NCT01251653|58626837|FG001|Overall Study|Other reason not mentioned above|0|||
30615928|NCT01251653|58626838|FG002|Overall Study|Other reason not mentioned above|0|||
30615929|NCT01251653|58626839|FG003|Overall Study|Other reason not mentioned above|0|||
30615930|NCT01251653|58626840|FG004|Overall Study|Other reason not mentioned above|0|||
30615931|NCT01251653|58626841|FG005|Overall Study|Other reason not mentioned above|0|||
31009708|NCT01392378|59210957|FG001|Toddler Dose|Lost to Follow-up|0|||
31009709|NCT01392378|59210958|FG002|Toddler Dose|Lost to Follow-up|0|||
31009710|NCT01392378|59210959|FG003|Toddler Dose|Lost to Follow-up|1|||
31009711|NCT01392378|59210960|FG004|Toddler Dose|Lost to Follow-up|0|||
31009712|NCT01392378|59210956|FG000|Toddler Dose|Withdrawal by Parent|0|||
31009713|NCT01392378|59210957|FG001|Toddler Dose|Withdrawal by Parent|1|||
31009714|NCT01392378|59210958|FG002|Toddler Dose|Withdrawal by Parent|0|||
31009715|NCT01392378|59210959|FG003|Toddler Dose|Withdrawal by Parent|1|||
31009716|NCT01392378|59210960|FG004|Toddler Dose|Withdrawal by Parent|1|||
31009717|NCT01412424|59210982|FG000|Core Treatment Period|Treatment Failure|24|||
31009718|NCT01412424|59210982|FG000|Core Treatment Period|Adverse Event|21|||
31009719|NCT01412424|59210982|FG000|Core Treatment Period|Patient Request|5|||
31009720|NCT01412424|59210982|FG000|Core Treatment Period|Lost to Follow-up|2|||
31009721|NCT01412424|59210982|FG000|Core Treatment Period|Sponsor Request|1|||
31009722|NCT01412424|59210982|FG000|Extension Treatment Period|Adverse Event|2|||
31009723|NCT01412424|59210982|FG000|Extension Treatment Period|Treatment Failure|2|||
31009724|NCT01412424|59210982|FG000|Extension Treatment Period|Patient Request|2|||
31009725|NCT01433250|59210994|FG000|Overall Study|Protocol Violation|0|||
31009726|NCT01433250|59210995|FG001|Overall Study|Protocol Violation|1|||
31009727|NCT01433250|59210994|FG000|Overall Study|Withdrawal by Subject|3|||
31009728|NCT01433250|59210995|FG001|Overall Study|Withdrawal by Subject|2|||
31009729|NCT01433172|59211004|FG000|Overall Study|Withdrawal by Subject|0|||
31009730|NCT01433172|59211005|FG001|Overall Study|Withdrawal by Subject|1|||
31009731|NCT01433172|59211006|FG002|Overall Study|Withdrawal by Subject|0|||
31009732|NCT01433172|59211004|FG000|Overall Study|Disease Progression|0|||
31009733|NCT01433172|59211005|FG001|Overall Study|Disease Progression|0|||
31009734|NCT01433172|59211006|FG002|Overall Study|Disease Progression|1|||
31009735|NCT01433172|59211004|FG000|Overall Study|Death|0|||
31009736|NCT01433172|59211005|FG001|Overall Study|Death|2|||
31009737|NCT01433172|59211006|FG002|Overall Study|Death|0|||
31009738|NCT01432938|59211014|FG000|First Intervention|Protocol Violation|1|||
31009739|NCT01432938|59211015|FG001|First Intervention|Protocol Violation|0|||
31009740|NCT01432938|59211014|FG000|First Intervention|Physician Decision|1|||
31009741|NCT01432938|59211015|FG001|First Intervention|Physician Decision|0|||
31009742|NCT01432938|59211014|FG000|Second Intervention|Adverse Event|1|||
31009743|NCT01432938|59211015|FG001|Second Intervention|Adverse Event|0|||
31009744|NCT01392300|59211024|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
31009745|NCT01392300|59211025|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
31009746|NCT01392300|59211026|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
31009747|NCT01392300|59211024|FG000|Main Period (MP)|Withdrawal by Subject|5|||
31009748|NCT01392300|59211025|FG001|Main Period (MP)|Withdrawal by Subject|1|||
31009749|NCT01392300|59211026|FG002|Main Period (MP)|Withdrawal by Subject|0|||
31009750|NCT01392300|59211024|FG000|Main Period (MP)|Lost to Follow-up|3|||
31009751|NCT01392300|59211025|FG001|Main Period (MP)|Lost to Follow-up|3|||
31009752|NCT01392300|59211026|FG002|Main Period (MP)|Lost to Follow-up|0|||
31009753|NCT01392300|59211024|FG000|Main Period (MP)|Non-compliance|1|||
31009754|NCT01392300|59211025|FG001|Main Period (MP)|Non-compliance|0|||
31009755|NCT01392300|59211026|FG002|Main Period (MP)|Non-compliance|0|||
31009756|NCT01392300|59211024|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
31009757|NCT01392300|59211025|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
31009758|NCT01392300|59211026|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
31009759|NCT01392300|59211024|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
31009760|NCT01392300|59211025|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
31009761|NCT01392300|59211026|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
31009762|NCT01392300|59211024|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
31009763|NCT01392300|59211025|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
30615932|NCT01251653|58626842|FG006|Overall Study|Other reason not mentioned above|0|||
30615933|NCT01251653|58626843|FG007|Overall Study|Other reason not mentioned above|2|||
30615934|NCT01251653|58626844|FG008|Overall Study|Other reason not mentioned above|0|||
30615935|NCT00910663|58626882|FG000|Period 1|Withdrawal by Subject|0|||
30615936|NCT00910663|58626883|FG001|Period 1|Withdrawal by Subject|1|||
30615937|NCT01077375|58626891|FG000|Overall Study|Adverse Event|2|||
30615938|NCT01077375|58626892|FG001|Overall Study|Adverse Event|15|||
31009764|NCT01392300|59211026|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
31009765|NCT01392300|59211024|FG000|Open Label Extension (OLEX) Period|Death|0|||
31009766|NCT01392300|59211025|FG001|Open Label Extension (OLEX) Period|Death|0|||
31009767|NCT01392300|59211026|FG002|Open Label Extension (OLEX) Period|Death|4|||
31009768|NCT01392300|59211024|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
31009769|NCT01392300|59211025|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
31009770|NCT01392300|59211026|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
31009771|NCT01392300|59211024|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
31009772|NCT01392300|59211025|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
31009773|NCT01392300|59211026|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
31009774|NCT01392300|59211024|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
31009775|NCT01392300|59211025|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
30615939|NCT01077375|58626891|FG000|Overall Study|Lack of Efficacy|6|||
30615940|NCT01077375|58626892|FG001|Overall Study|Lack of Efficacy|8|||
30615941|NCT01077375|58626891|FG000|Overall Study|Withdrawal by Subject|0|||
30615942|NCT01077375|58626892|FG001|Overall Study|Withdrawal by Subject|6|||
30615943|NCT01077375|58626891|FG000|Overall Study|Lost to Follow-up|2|||
30615944|NCT01077375|58626892|FG001|Overall Study|Lost to Follow-up|5|||
30615945|NCT01077375|58626891|FG000|Overall Study|Other Reason|0|||
30615946|NCT01077375|58626892|FG001|Overall Study|Other Reason|1|||
30615947|NCT01250873|58626900|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
30615948|NCT01250873|58626900|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
30615949|NCT01250171|58626909|FG000|Overall Study|Administrative reasons|1|||
30615950|NCT01250171|58626910|FG001|Overall Study|Administrative reasons|0|||
30615951|NCT01250171|58626911|FG002|Overall Study|Administrative reasons|0|||
30615952|NCT01077063|58626921|FG000|Overall Study|Adverse Event|3|||
30615953|NCT01077063|58626922|FG001|Overall Study|Adverse Event|0|||
30615954|NCT01077063|58626921|FG000|Overall Study|Death|1|||
30615955|NCT01077063|58626922|FG001|Overall Study|Death|1|||
30615956|NCT01077063|58626921|FG000|Overall Study|Withdrawal by Subject|0|||
30615957|NCT01077063|58626922|FG001|Overall Study|Withdrawal by Subject|2|||
30615958|NCT01248065|58626930|FG000|Overall Study|Lost to Follow-up|3|||
30615959|NCT01248065|58626931|FG001|Overall Study|Lost to Follow-up|5|||
30615960|NCT01248065|58626930|FG000|Overall Study|Withdrawal by Subject|14|||
30615961|NCT01248065|58626931|FG001|Overall Study|Withdrawal by Subject|11|||
30615962|NCT01248065|58626930|FG000|Overall Study|Adverse Event|3|||
30615963|NCT01248065|58626931|FG001|Overall Study|Adverse Event|0|||
30615964|NCT01248065|58626930|FG000|Overall Study|Third treatment failure event|3|||
31009776|NCT01392300|59211026|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
31009777|NCT01432626|59211033|FG000|Overall Study|LV function recovered|2|||
31009778|NCT01432626|59211033|FG000|Overall Study|Withdrawal by Subject|2|||
31009779|NCT01432626|59211033|FG000|Overall Study|Only 1 image competed|2|||
31009780|NCT01432626|59211033|FG000|Overall Study|Imaging agent not available|1|||
31009781|NCT01391832|59211039|FG000|Overall Study|Withdrawal by Subject|21|||
31009782|NCT01391832|59211040|FG001|Overall Study|Withdrawal by Subject|22|||
31009783|NCT01391832|59211039|FG000|Overall Study|Lost to Follow-up|0|||
31009784|NCT01391832|59211040|FG001|Overall Study|Lost to Follow-up|1|||
31009785|NCT01410474|59211048|FG000|Overall Study|Withdrawal by Subject|0|||
31009786|NCT01410474|59211049|FG001|Overall Study|Withdrawal by Subject|1|||
31009787|NCT01391130|59211064|FG000|Overall Study|Withdrawal by Subject|3|||
31009788|NCT01391130|59211065|FG001|Overall Study|Withdrawal by Subject|2|||
31009789|NCT01391130|59211064|FG000|Overall Study|Physician Decision|2|||
31009790|NCT01391130|59211065|FG001|Overall Study|Physician Decision|3|||
31009791|NCT01391130|59211064|FG000|Overall Study|Did not Receive Drug|1|||
31009792|NCT01391130|59211065|FG001|Overall Study|Did not Receive Drug|1|||
31009793|NCT01410240|59211074|FG000|Overall Study|Physician Decision|0|||
31009794|NCT01410240|59211075|FG001|Overall Study|Physician Decision|0|||
31009795|NCT01410240|59211076|FG002|Overall Study|Physician Decision|1|||
31009796|NCT01410240|59211074|FG000|Overall Study|Missed week 6 assessments|1|||
31009797|NCT01410240|59211075|FG001|Overall Study|Missed week 6 assessments|1|||
31009798|NCT01410240|59211076|FG002|Overall Study|Missed week 6 assessments|1|||
31009799|NCT01409928|59211085|FG000|Overall Study|Physician Decision|12|||
31009800|NCT01431534|59211092|FG000|Treatment Phase|Adverse Event|0|||
31009801|NCT01431534|59211093|FG001|Treatment Phase|Adverse Event|0|||
31009802|NCT01431534|59211094|FG002|Treatment Phase|Adverse Event|1|||
31009803|NCT01431534|59211092|FG000|Treatment Phase|Progressive Disease|4|||
31009804|NCT01431534|59211093|FG001|Treatment Phase|Progressive Disease|3|||
31009805|NCT01431534|59211094|FG002|Treatment Phase|Progressive Disease|10|||
31009806|NCT01409382|59211104|FG000|Overall Study|Lost to Follow-up|1|||
31009807|NCT01409382|59211105|FG001|Overall Study|Lost to Follow-up|1|||
31009808|NCT01409382|59211104|FG000|Overall Study|Protocol Violation|0|||
31009809|NCT01409382|59211105|FG001|Overall Study|Protocol Violation|3|||
31009810|NCT01409382|59211104|FG000|Overall Study|Multiple pregnancy|2|||
31009811|NCT01409382|59211105|FG001|Overall Study|Multiple pregnancy|4|||
31009812|NCT01409382|59211104|FG000|Overall Study|Still pregnant when study ended|13|||
30615965|NCT01248065|58626931|FG001|Overall Study|Third treatment failure event|1|||
30615966|NCT01248065|58626930|FG000|Overall Study|Other|3|||
31009813|NCT01409382|59211105|FG001|Overall Study|Still pregnant when study ended|2|||
31009814|NCT01409382|59211104|FG000|Overall Study|Did not manage to get pregnant|64|||
31009815|NCT01409382|59211105|FG001|Overall Study|Did not manage to get pregnant|70|||
31009816|NCT01409382|59211104|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
31009817|NCT01409382|59211105|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
31009818|NCT01408914|59211118|FG000|Overall Study|Could not complete tx in protocol period|5|||
30615967|NCT01248065|58626931|FG001|Overall Study|Other|5|||
30615968|NCT01250756|58626939|FG000|Infant Series|Withdrawal by Subject|4|||
30615969|NCT01250756|58626940|FG001|Infant Series|Withdrawal by Subject|5|||
30615970|NCT01250756|58626939|FG000|Infant Series|Randomized, Not Vaccinated|2|||
31009819|NCT01408914|59211119|FG001|Overall Study|Could not complete tx in protocol period|5|||
30615971|NCT01250756|58626940|FG001|Infant Series|Randomized, Not Vaccinated|2|||
30615972|NCT01250756|58626939|FG000|Infant Series|Other|22|||
30615973|NCT01250756|58626940|FG001|Infant Series|Other|0|||
30615974|NCT01250756|58626939|FG000|After Infant Series|Adverse Event|5|||
30615975|NCT01250756|58626940|FG001|After Infant Series|Adverse Event|2|||
30615976|NCT01250756|58626939|FG000|After Infant Series|Withdrawal by Subject|4|||
30615977|NCT01250756|58626940|FG001|After Infant Series|Withdrawal by Subject|1|||
30615978|NCT01250756|58626939|FG000|After Infant Series|Other|2|||
30615979|NCT01250756|58626940|FG001|After Infant Series|Other|1|||
30615980|NCT01250756|58626939|FG000|Toddler Dose|Adverse Event|0|||
30615981|NCT01250756|58626940|FG001|Toddler Dose|Adverse Event|1|||
30615982|NCT01250756|58626939|FG000|After Toddler Dose|Adverse Event|0|||
30615983|NCT01250756|58626940|FG001|After Toddler Dose|Adverse Event|1|||
30615984|NCT01250054|58626952|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
30615985|NCT01250054|58626953|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
30615986|NCT00977470|58626961|FG000|Overall Study|Lack of Efficacy|32|||
30615987|NCT00977470|58626962|FG001|Overall Study|Lack of Efficacy|30|||
30615988|NCT00977470|58626961|FG000|Overall Study|Physician Decision|2|||
30615989|NCT00977470|58626962|FG001|Overall Study|Physician Decision|0|||
30615990|NCT00977470|58626961|FG000|Overall Study|Adverse Event|1|||
30615991|NCT00977470|58626962|FG001|Overall Study|Adverse Event|2|||
30615992|NCT00977470|58626961|FG000|Overall Study|Protocol Violation|1|||
30615993|NCT00977470|58626962|FG001|Overall Study|Protocol Violation|0|||
30615994|NCT00977470|58626961|FG000|Overall Study|Withdrawal by Subject|0|||
30615995|NCT00977470|58626962|FG001|Overall Study|Withdrawal by Subject|2|||
30615996|NCT00977470|58626961|FG000|Overall Study|Death|0|||
30615997|NCT00977470|58626962|FG001|Overall Study|Death|2|||
30615998|NCT00977470|58626961|FG000|Overall Study|clinical decline|0|||
30615999|NCT00977470|58626962|FG001|Overall Study|clinical decline|1|||
30616000|NCT00977470|58626961|FG000|Overall Study|prolonged recovery post-surgery|0|||
30616001|NCT00977470|58626962|FG001|Overall Study|prolonged recovery post-surgery|1|||
30616002|NCT00977470|58626961|FG000|Overall Study|Still on-study|2|||
30616003|NCT00977470|58626962|FG001|Overall Study|Still on-study|0|||
30616004|NCT01245374|58626968|FG000|Overall Study|Protocol Violation|1|||
30616005|NCT01245374|58626968|FG000|Overall Study|Withdrawal by Subject|3|||
30616006|NCT00977314|58626975|FG000|Overall Study|Withdrawal by Subject|1|||
30616007|NCT00977314|58626976|FG001|Overall Study|Withdrawal by Subject|0|||
30616008|NCT00977314|58626975|FG000|Overall Study|Physician Decision|1|||
30616009|NCT00977314|58626976|FG001|Overall Study|Physician Decision|0|||
30616010|NCT01087203|58626984|FG000|Overall Study|Lost to Follow-up|2|||
30616011|NCT01087203|58626985|FG001|Overall Study|Lost to Follow-up|0|||
30616012|NCT01087203|58626984|FG000|Overall Study|Withdrawal by Subject|2|||
30616013|NCT01087203|58626985|FG001|Overall Study|Withdrawal by Subject|6|||
30616014|NCT01087203|58626984|FG000|Overall Study|Lack of Efficacy|1|||
30616015|NCT01087203|58626985|FG001|Overall Study|Lack of Efficacy|2|||
30616016|NCT01087203|58626984|FG000|Overall Study|Study terminated by sponsor|27|||
30616017|NCT01087203|58626985|FG001|Overall Study|Study terminated by sponsor|27|||
30616018|NCT01246583|58626996|FG000|Overall Study|Lost to Follow-up|0|||
30616019|NCT01246583|58626997|FG001|Overall Study|Lost to Follow-up|0|||
30616020|NCT01246583|58626998|FG002|Overall Study|Lost to Follow-up|0|||
30616021|NCT01246583|58626999|FG003|Overall Study|Lost to Follow-up|1|||
30616022|NCT01246583|58626996|FG000|Overall Study|Protocol Violation|0|||
30616023|NCT01246583|58626997|FG001|Overall Study|Protocol Violation|0|||
30616024|NCT01246583|58626998|FG002|Overall Study|Protocol Violation|1|||
30616025|NCT01246583|58626999|FG003|Overall Study|Protocol Violation|0|||
30616026|NCT01246583|58626996|FG000|Overall Study|Withdrawal by Subject|1|||
30616027|NCT01246583|58626997|FG001|Overall Study|Withdrawal by Subject|0|||
30616028|NCT01246583|58626998|FG002|Overall Study|Withdrawal by Subject|0|||
30616029|NCT01246583|58626999|FG003|Overall Study|Withdrawal by Subject|0|||
30616030|NCT01084239|58627012|FG000|28-Day Follow-up|Lost to Follow-up|4|||
30616031|NCT01084239|58627013|FG001|28-Day Follow-up|Lost to Follow-up|9|||
30616032|NCT01244906|58627021|FG000|Overall Study|Death|2|||
30616033|NCT01244906|58627021|FG000|Overall Study|Progression of disease post treatment|6|||
30616034|NCT01080807|58627027|FG000|Overall Study|Adverse Event|9|||
30616035|NCT01080807|58627028|FG001|Overall Study|Adverse Event|1|||
30616036|NCT01080807|58627027|FG000|Overall Study|Lack of Efficacy|0|||
30616037|NCT01080807|58627028|FG001|Overall Study|Lack of Efficacy|1|||
30699303|NCT00550407|58713846|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
30616038|NCT01080807|58627027|FG000|Overall Study|Withdrawal by Subject|7|||
30616039|NCT01080807|58627028|FG001|Overall Study|Withdrawal by Subject|2|||
30616040|NCT01080807|58627027|FG000|Overall Study|Protocol Violation|7|||
30616041|NCT01080807|58627028|FG001|Overall Study|Protocol Violation|6|||
30616042|NCT01080807|58627027|FG000|Overall Study|Lost to Follow-up|6|||
30616043|NCT01080807|58627028|FG001|Overall Study|Lost to Follow-up|4|||
30616044|NCT01080807|58627027|FG000|Overall Study|Noncompliance with drug administration|1|||
30616045|NCT01080807|58627028|FG001|Overall Study|Noncompliance with drug administration|1|||
30616046|NCT01080807|58627027|FG000|Overall Study|Noncompliance to study procedures|1|||
30616047|NCT01080807|58627028|FG001|Overall Study|Noncompliance to study procedures|1|||
30616048|NCT01080807|58627027|FG000|Overall Study|Began working day shift|0|||
30616049|NCT01080807|58627028|FG001|Overall Study|Began working day shift|2|||
30616050|NCT01080807|58627027|FG000|Overall Study|Laid off or terminated from job|1|||
30616051|NCT01080807|58627028|FG001|Overall Study|Laid off or terminated from job|2|||
30616052|NCT01080807|58627027|FG000|Overall Study|Stopped working consistent night shifts|0|||
30616053|NCT01080807|58627028|FG001|Overall Study|Stopped working consistent night shifts|1|||
30616054|NCT01080807|58627027|FG000|Overall Study|Work schedule changing|1|||
30616055|NCT01080807|58627028|FG001|Overall Study|Work schedule changing|1|||
30616056|NCT01080807|58627027|FG000|Overall Study|Work schedule and travel|0|||
30616057|NCT01080807|58627028|FG001|Overall Study|Work schedule and travel|1|||
31009820|NCT01408914|59211120|FG002|Overall Study|Could not complete tx in protocol period|6|||
31009821|NCT01408914|59211118|FG000|Overall Study|Lost to Follow-up|4|||
31009822|NCT01408914|59211119|FG001|Overall Study|Lost to Follow-up|1|||
31009823|NCT01408914|59211120|FG002|Overall Study|Lost to Follow-up|2|||
31009824|NCT01408914|59211118|FG000|Overall Study|Physician Decision|1|||
31009825|NCT01408914|59211119|FG001|Overall Study|Physician Decision|1|||
31009826|NCT01408914|59211120|FG002|Overall Study|Physician Decision|0|||
31009827|NCT01408914|59211118|FG000|Overall Study|Withdrawal by Subject|1|||
31009828|NCT01408914|59211119|FG001|Overall Study|Withdrawal by Subject|0|||
31009829|NCT01408914|59211120|FG002|Overall Study|Withdrawal by Subject|1|||
31009830|NCT01408914|59211118|FG000|Overall Study|Moved out of study jurisdiction|1|||
31009831|NCT01408914|59211119|FG001|Overall Study|Moved out of study jurisdiction|1|||
31009832|NCT01408914|59211120|FG002|Overall Study|Moved out of study jurisdiction|0|||
31009833|NCT01408914|59211118|FG000|Overall Study|Late exclusion|0|||
31009834|NCT01408914|59211119|FG001|Overall Study|Late exclusion|3|||
31009835|NCT01408914|59211120|FG002|Overall Study|Late exclusion|3|||
30616058|NCT01080807|58627027|FG000|Overall Study|Switched to first shift|1|||
30616059|NCT01080807|58627028|FG001|Overall Study|Switched to first shift|0|||
30616060|NCT01080807|58627027|FG000|Overall Study|Moved away without notifying center|1|||
30616061|NCT01080807|58627028|FG001|Overall Study|Moved away without notifying center|0|||
30616062|NCT01076361|58627034|FG000|Overall Study|22 leads were excluded from analysis|21|||
30616063|NCT01079949|58627040|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
30616064|NCT01079949|58627041|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
30616065|NCT01079949|58627040|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
30616066|NCT01079949|58627041|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
30616067|NCT01079949|58627040|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
30616068|NCT01079949|58627041|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
30616069|NCT01079949|58627040|FG000|Overall Study|Randomized but not treated|1|||
30616070|NCT01079949|58627041|FG001|Overall Study|Randomized but not treated|0|||
30616071|NCT00910429|58627049|FG000|Overall Study|Death|18|||
30616072|NCT00910429|58627050|FG001|Overall Study|Death|12|||
30616073|NCT00910429|58627049|FG000|Overall Study|Withdrawal by Subject|3|||
30616074|NCT00910429|58627050|FG001|Overall Study|Withdrawal by Subject|2|||
30616075|NCT00910429|58627049|FG000|Overall Study|Protocol Violation|1|||
30616076|NCT00910429|58627050|FG001|Overall Study|Protocol Violation|0|||
30616077|NCT00910429|58627049|FG000|Overall Study|Lost to Follow-up|2|||
30616078|NCT00910429|58627050|FG001|Overall Study|Lost to Follow-up|1|||
30616079|NCT00910429|58627049|FG000|Overall Study|Adverse Event|10|||
30616080|NCT00910429|58627050|FG001|Overall Study|Adverse Event|5|||
30616081|NCT00910429|58627049|FG000|Overall Study|Drug non-compliance|1|||
30616082|NCT00910429|58627050|FG001|Overall Study|Drug non-compliance|0|||
30616083|NCT00910429|58627049|FG000|Overall Study|Lack of Efficacy|4|||
30616084|NCT00910429|58627050|FG001|Overall Study|Lack of Efficacy|1|||
30616085|NCT00909727|58627058|FG000|Overall Study|Adverse Event|1|||
30616086|NCT00909727|58627059|FG001|Overall Study|Adverse Event|0|||
30616087|NCT00909727|58627058|FG000|Overall Study|Wrong Genotype|1|||
30616088|NCT00909727|58627059|FG001|Overall Study|Wrong Genotype|0|||
30616089|NCT00909727|58627058|FG000|Overall Study|Withdrawal of Consent|1|||
30616090|NCT00909727|58627059|FG001|Overall Study|Withdrawal of Consent|0|||
30616091|NCT00909727|58627058|FG000|Overall Study|Prohibited Medication|1|||
30616092|NCT00909727|58627059|FG001|Overall Study|Prohibited Medication|0|||
31009836|NCT01408914|59211118|FG000|Overall Study|Change in local TB/HIV norms|0|||
31009837|NCT01408914|59211119|FG001|Overall Study|Change in local TB/HIV norms|1|||
31009838|NCT01408914|59211120|FG002|Overall Study|Change in local TB/HIV norms|1|||
31009839|NCT01431144|59211130|FG000|Overall Study|Implant mobility and removal|2|||
31009840|NCT01431144|59211131|FG001|Overall Study|Implant mobility and removal|0|||
30616093|NCT00977080|58627069|FG000|Overall Study|Adverse Event|2|||
30616094|NCT00977080|58627070|FG001|Overall Study|Adverse Event|7|||
30616095|NCT00977080|58627071|FG002|Overall Study|Adverse Event|7|||
30616096|NCT00977080|58627072|FG003|Overall Study|Adverse Event|7|||
30616097|NCT00977080|58627069|FG000|Overall Study|Withdrawal by Subject|1|||
30616098|NCT00977080|58627070|FG001|Overall Study|Withdrawal by Subject|5|||
30790779|NCT03524092|58803942|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
30790780|NCT03524092|58803943|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
30893171|NCT02371369|58926606|FG001|Part 2|Withdrawal by Subject|6|||
30616099|NCT00977080|58627071|FG002|Overall Study|Withdrawal by Subject|1|||
30616100|NCT00977080|58627072|FG003|Overall Study|Withdrawal by Subject|5|||
30616101|NCT00977080|58627069|FG000|Overall Study|Protocol Violation|7|||
30616102|NCT00977080|58627070|FG001|Overall Study|Protocol Violation|3|||
30616103|NCT00977080|58627071|FG002|Overall Study|Protocol Violation|4|||
30616104|NCT00977080|58627072|FG003|Overall Study|Protocol Violation|3|||
30616105|NCT00977080|58627069|FG000|Overall Study|Noncompliance|0|||
30616106|NCT00977080|58627070|FG001|Overall Study|Noncompliance|2|||
30616107|NCT00977080|58627071|FG002|Overall Study|Noncompliance|1|||
30616108|NCT00977080|58627072|FG003|Overall Study|Noncompliance|0|||
30616109|NCT00977080|58627069|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
30616110|NCT00977080|58627070|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
30616111|NCT00977080|58627071|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
30616112|NCT00977080|58627072|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
30616113|NCT00977080|58627069|FG000|Overall Study|Required kidney transplantation|1|||
30616114|NCT00977080|58627070|FG001|Overall Study|Required kidney transplantation|3|||
30616115|NCT00977080|58627071|FG002|Overall Study|Required kidney transplantation|3|||
30616116|NCT00977080|58627072|FG003|Overall Study|Required kidney transplantation|1|||
30616117|NCT00977080|58627069|FG000|Overall Study|Travel for family reasons|1|||
30616118|NCT00977080|58627070|FG001|Overall Study|Travel for family reasons|0|||
30616119|NCT00977080|58627071|FG002|Overall Study|Travel for family reasons|0|||
30616120|NCT00977080|58627072|FG003|Overall Study|Travel for family reasons|0|||
30616121|NCT00975676|58627084|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
30616122|NCT00975676|58627085|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
30616123|NCT00975286|58627098|FG000|Overall Study|Adverse Event|9|||
30616124|NCT00975286|58627099|FG001|Overall Study|Adverse Event|19|||
30616125|NCT00975286|58627098|FG000|Overall Study|Protocol Violation|1|||
30616126|NCT00975286|58627099|FG001|Overall Study|Protocol Violation|2|||
30616127|NCT00975286|58627098|FG000|Overall Study|Withdrawal by Subject|0|||
30616128|NCT00975286|58627099|FG001|Overall Study|Withdrawal by Subject|2|||
30616129|NCT00975286|58627098|FG000|Overall Study|Familial and Personal Reasons|2|||
30616130|NCT00975286|58627099|FG001|Overall Study|Familial and Personal Reasons|2|||
30616131|NCT00975286|58627098|FG000|Overall Study|Poor Compliance to Protocol|0|||
30616132|NCT00975286|58627099|FG001|Overall Study|Poor Compliance to Protocol|2|||
30616133|NCT00975286|58627098|FG000|Overall Study|Sponsor Decision|0|||
30616134|NCT00975286|58627099|FG001|Overall Study|Sponsor Decision|2|||
30616135|NCT00907777|58627107|FG000|Overall Study|Withdrawal by Subject|0|||
30616136|NCT00907777|58627108|FG001|Overall Study|Withdrawal by Subject|1|||
30616137|NCT00908011|58627116|FG000|Overall Study|Withdrawal by Subject|2|||
30616138|NCT00908011|58627117|FG001|Overall Study|Withdrawal by Subject|2|||
30616139|NCT00976456|58627125|FG000|Overall Study|Adverse Event|17|||
30616140|NCT00976456|58627126|FG001|Overall Study|Adverse Event|22|||
30616141|NCT00976456|58627125|FG000|Overall Study|Death|7|||
30616142|NCT00976456|58627126|FG001|Overall Study|Death|9|||
31009841|NCT01430754|59211140|FG000|Run-In Phase|Circadian Period Ineligible|24|||
31009842|NCT01430754|59211141|FG001|Run-In Phase|Circadian Period Ineligible|0|||
31009843|NCT01430754|59211140|FG000|Run-In Phase|Protocol Violation|6|||
31009844|NCT01430754|59211141|FG001|Run-In Phase|Protocol Violation|0|||
31009845|NCT01430754|59211140|FG000|Run-In Phase|Adverse Event|2|||
31009846|NCT01430754|59211141|FG001|Run-In Phase|Adverse Event|0|||
31009847|NCT01430754|59211140|FG000|Run-In Phase|Other|2|||
31009848|NCT01430754|59211141|FG001|Run-In Phase|Other|0|||
31009849|NCT01430754|59211140|FG000|Run-In Phase|Withdrawal by Subject|2|||
31009850|NCT01430754|59211141|FG001|Run-In Phase|Withdrawal by Subject|0|||
31009851|NCT01430754|59211140|FG000|Run-In Phase|Lost to Follow-up|1|||
30616143|NCT00976456|58627125|FG000|Overall Study|Lack of Efficacy|5|||
30616144|NCT00976456|58627126|FG001|Overall Study|Lack of Efficacy|2|||
30616145|NCT00976456|58627125|FG000|Overall Study|Withdrawal by Subject|3|||
30616146|NCT00976456|58627126|FG001|Overall Study|Withdrawal by Subject|1|||
30616147|NCT00976456|58627125|FG000|Overall Study|screening failure, unknown|11|||
30616148|NCT00976456|58627126|FG001|Overall Study|screening failure, unknown|4|||
30616149|NCT01243151|58627137|FG000|Overall Study|Adverse Event|0|||
30616150|NCT01243151|58627138|FG001|Overall Study|Adverse Event|1|||
30616151|NCT01243151|58627139|FG002|Overall Study|Adverse Event|0|||
30616152|NCT01243151|58627140|FG003|Overall Study|Adverse Event|0|||
31009852|NCT01430754|59211141|FG001|Run-In Phase|Lost to Follow-up|0|||
31009853|NCT01390428|59211155|FG000|Overall Study|Elective Surgery|0|||
31009854|NCT01390428|59211156|FG001|Overall Study|Elective Surgery|0|||
30616153|NCT01243151|58627141|FG004|Overall Study|Adverse Event|0|||
30616154|NCT01243151|58627137|FG000|Overall Study|Protocol Violation|0|||
30616155|NCT01243151|58627138|FG001|Overall Study|Protocol Violation|0|||
30616156|NCT01243151|58627139|FG002|Overall Study|Protocol Violation|1|||
30616157|NCT01243151|58627140|FG003|Overall Study|Protocol Violation|0|||
30616158|NCT01243151|58627141|FG004|Overall Study|Protocol Violation|0|||
30616159|NCT01243151|58627137|FG000|Overall Study|Other|0|||
30616160|NCT01243151|58627138|FG001|Overall Study|Other|0|||
31009855|NCT01390428|59211157|FG002|Overall Study|Elective Surgery|0|||
30616161|NCT01243151|58627139|FG002|Overall Study|Other|0|||
30616162|NCT01243151|58627140|FG003|Overall Study|Other|1|||
30616163|NCT01243151|58627141|FG004|Overall Study|Other|0|||
30616164|NCT01243151|58627137|FG000|Overall Study|Randomized but not treated|0|||
30616165|NCT01243151|58627138|FG001|Overall Study|Randomized but not treated|0|||
30616166|NCT01243151|58627139|FG002|Overall Study|Randomized but not treated|0|||
30616167|NCT01243151|58627140|FG003|Overall Study|Randomized but not treated|1|||
30616168|NCT01243151|58627141|FG004|Overall Study|Randomized but not treated|0|||
30616169|NCT00993148|58627157|FG000|Overall Study|Lost to Follow-up|2|||
30616170|NCT00993148|58627157|FG000|Overall Study|never initiated treatment|1|||
30616171|NCT00907621|58627163|FG000|Overall Study|Lost to Follow-up|6|||
30616172|NCT00907621|58627164|FG001|Overall Study|Lost to Follow-up|3|||
30616173|NCT00907621|58627163|FG000|Overall Study|intercurrent febrile illness|1|||
30616174|NCT00907621|58627164|FG001|Overall Study|intercurrent febrile illness|1|||
30616175|NCT00907153|58627183|FG000|Overall Study|Lost to Follow-up|1|||
30616176|NCT00907153|58627184|FG001|Overall Study|Lost to Follow-up|1|||
30616177|NCT00907153|58627183|FG000|Overall Study|Withdrawal by Subject|1|||
30616178|NCT00907153|58627184|FG001|Overall Study|Withdrawal by Subject|3|||
30616179|NCT00904033|58627194|FG000|Overall Study|Withdrawal by Subject|1|||
30616180|NCT00904033|58627195|FG001|Overall Study|Withdrawal by Subject|1|||
30616181|NCT00904033|58627196|FG002|Overall Study|Withdrawal by Subject|0|||
30616182|NCT00904033|58627197|FG003|Overall Study|Withdrawal by Subject|0|||
30616183|NCT00904033|58627194|FG000|Overall Study|Physician Decision|0|||
30616184|NCT00904033|58627195|FG001|Overall Study|Physician Decision|0|||
30616185|NCT00904033|58627196|FG002|Overall Study|Physician Decision|1|||
30616186|NCT00904033|58627197|FG003|Overall Study|Physician Decision|0|||
30616187|NCT00904033|58627194|FG000|Overall Study|Unable to obtain final blood draw|0|||
30616188|NCT00904033|58627195|FG001|Overall Study|Unable to obtain final blood draw|0|||
30616189|NCT00904033|58627196|FG002|Overall Study|Unable to obtain final blood draw|0|||
30616190|NCT00904033|58627197|FG003|Overall Study|Unable to obtain final blood draw|2|||
30616191|NCT00903877|58627208|FG000|Overall Study|Did not meet study criteria|33|||
30616192|NCT00903877|58627208|FG000|Overall Study|Withdrawal by Subject|3|||
30616193|NCT00903877|58627208|FG000|Overall Study|Adverse Event|2|||
30616194|NCT00903877|58627208|FG000|Overall Study|Lost to Follow-up|1|||
30616195|NCT00903877|58627208|FG000|Overall Study|Participation put on hold|4|||
30616196|NCT01241591|58627216|FG000|Overall Study|Lack of Efficacy|5|||
30616197|NCT01241591|58627217|FG001|Overall Study|Lack of Efficacy|2|||
30616198|NCT01241591|58627218|FG002|Overall Study|Lack of Efficacy|2|||
30616199|NCT01241591|58627219|FG003|Overall Study|Lack of Efficacy|3|||
30616200|NCT01241591|58627216|FG000|Overall Study|Protocol Violation|5|||
31009856|NCT01390428|59211158|FG003|Overall Study|Elective Surgery|0|||
31009857|NCT01390428|59211159|FG004|Overall Study|Elective Surgery|1|||
31009858|NCT01390428|59211160|FG005|Overall Study|Elective Surgery|0|||
31009859|NCT01390428|59211155|FG000|Overall Study|Withdrawal by Subject|0|||
31009860|NCT01390428|59211156|FG001|Overall Study|Withdrawal by Subject|0|||
31009861|NCT01390428|59211157|FG002|Overall Study|Withdrawal by Subject|1|||
31009862|NCT01390428|59211158|FG003|Overall Study|Withdrawal by Subject|0|||
31009863|NCT01390428|59211159|FG004|Overall Study|Withdrawal by Subject|0|||
31009864|NCT01390428|59211160|FG005|Overall Study|Withdrawal by Subject|0|||
31009865|NCT01430130|59211174|FG000|Overall Study|Lost to Follow-up|1|||
31009866|NCT01430130|59211174|FG000|Overall Study|Infection on Control Side of Incision|1|||
31009867|NCT01407354|59211180|FG000|First Intervention|Withdrawal by Subject|0|||
30616201|NCT01241591|58627217|FG001|Overall Study|Protocol Violation|2|||
30616202|NCT01241591|58627218|FG002|Overall Study|Protocol Violation|3|||
30616203|NCT01241591|58627219|FG003|Overall Study|Protocol Violation|0|||
30616204|NCT01241591|58627216|FG000|Overall Study|Lost to Follow-up|1|||
30893172|NCT02371369|58926605|FG000|Part 2|Investigator decision|1|||
30893173|NCT02371369|58926606|FG001|Part 2|Investigator decision|2|||
30893174|NCT02371369|58926605|FG000|Part 2|Death|0|||
30893175|NCT02371369|58926606|FG001|Part 2|Death|1|||
30893176|NCT02371369|58926605|FG000|Part 2|Disease progression|1|||
30893177|NCT02371369|58926606|FG001|Part 2|Disease progression|0|||
30616205|NCT01241591|58627217|FG001|Overall Study|Lost to Follow-up|2|||
30616206|NCT01241591|58627218|FG002|Overall Study|Lost to Follow-up|2|||
30616207|NCT01241591|58627219|FG003|Overall Study|Lost to Follow-up|2|||
30616208|NCT01241591|58627216|FG000|Overall Study|Screen Failure|3|||
30616209|NCT01241591|58627217|FG001|Overall Study|Screen Failure|2|||
30616210|NCT01241591|58627218|FG002|Overall Study|Screen Failure|1|||
31009868|NCT01407354|59211181|FG001|First Intervention|Withdrawal by Subject|2|||
31009869|NCT01407354|59211180|FG000|First Intervention|Adverse Event|1|||
31009870|NCT01407354|59211181|FG001|First Intervention|Adverse Event|0|||
30790781|NCT03524092|58803944|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
30893178|NCT02371369|58926605|FG000|Part 2|Subject Noncompliance|1|||
30616211|NCT01241591|58627219|FG003|Overall Study|Screen Failure|0|||
30616212|NCT01241591|58627216|FG000|Overall Study|Withdrawal by Subject|6|||
30616213|NCT01241591|58627217|FG001|Overall Study|Withdrawal by Subject|4|||
30893179|NCT02371369|58926606|FG001|Part 2|Subject Noncompliance|0|||
30616214|NCT01241591|58627218|FG002|Overall Study|Withdrawal by Subject|2|||
30893180|NCT02371369|58926605|FG000|Part 2|Lost to Follow-up|1|||
30893181|NCT02371369|58926606|FG001|Part 2|Lost to Follow-up|1|||
30893182|NCT02371369|58926605|FG000|Part 2|Subject transitioned to commercial supply|6|||
30893183|NCT02371369|58926606|FG001|Part 2|Subject transitioned to commercial supply|4|||
30893184|NCT02371369|58926605|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
30893185|NCT02371369|58926606|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
30893186|NCT02371369|58926605|FG000|Part 2|Surgical resection of tumor|1|||
30893187|NCT02371369|58926606|FG001|Part 2|Surgical resection of tumor|1|||
30893188|NCT02371369|58926605|FG000|Part 2|Other|0|||
30616215|NCT01241591|58627219|FG003|Overall Study|Withdrawal by Subject|2|||
30616216|NCT01241591|58627216|FG000|Overall Study|Other|0|||
30616217|NCT01241591|58627217|FG001|Overall Study|Other|1|||
30616218|NCT01241591|58627218|FG002|Overall Study|Other|0|||
30616219|NCT01241591|58627219|FG003|Overall Study|Other|1|||
30616220|NCT01241591|58627216|FG000|Overall Study|Adverse Event|3|||
30616221|NCT01241591|58627217|FG001|Overall Study|Adverse Event|11|||
30616222|NCT01241591|58627218|FG002|Overall Study|Adverse Event|12|||
30616223|NCT01241591|58627219|FG003|Overall Study|Adverse Event|4|||
30616224|NCT00906373|58627231|FG000|Overall Study|Withdrawal by Subject|0|||
30616225|NCT00906373|58627232|FG001|Overall Study|Withdrawal by Subject|5|||
30616226|NCT00906373|58627231|FG000|Overall Study|Other|0|||
30616227|NCT00906373|58627232|FG001|Overall Study|Other|1|||
30616228|NCT00906373|58627231|FG000|Overall Study|Still on treatment at cutoff date|0|||
30616229|NCT00906373|58627232|FG001|Overall Study|Still on treatment at cutoff date|2|||
30616230|NCT00905437|58627245|FG000|Overall Study|Adverse Event|3|||
30616231|NCT00905437|58627246|FG001|Overall Study|Adverse Event|2|||
30616232|NCT00905437|58627245|FG000|Overall Study|Lost to Follow-up|0|||
30616233|NCT00905437|58627246|FG001|Overall Study|Lost to Follow-up|1|||
30616234|NCT00905437|58627245|FG000|Overall Study|Withdrawal by Subject|0|||
30616235|NCT00905437|58627246|FG001|Overall Study|Withdrawal by Subject|1|||
30616236|NCT00905437|58627245|FG000|Overall Study|Other|5|||
30616237|NCT00905437|58627246|FG001|Overall Study|Other|6|||
30616238|NCT01238861|58627258|FG000|Overall Study|Lost to Follow-up|4|||
30616239|NCT01238861|58627259|FG001|Overall Study|Lost to Follow-up|2|||
30616240|NCT01238861|58627260|FG002|Overall Study|Lost to Follow-up|3|||
30616241|NCT01238861|58627261|FG003|Overall Study|Lost to Follow-up|1|||
30616242|NCT01238861|58627262|FG004|Overall Study|Lost to Follow-up|1|||
30616243|NCT01238861|58627263|FG005|Overall Study|Lost to Follow-up|2|||
30616244|NCT01238861|58627258|FG000|Overall Study|Unplanned surgery|1|||
30616245|NCT01238861|58627259|FG001|Overall Study|Unplanned surgery|0|||
30616246|NCT01238861|58627260|FG002|Overall Study|Unplanned surgery|0|||
30616247|NCT01238861|58627261|FG003|Overall Study|Unplanned surgery|0|||
30616248|NCT01238861|58627262|FG004|Overall Study|Unplanned surgery|0|||
30616249|NCT01238861|58627263|FG005|Overall Study|Unplanned surgery|0|||
30616250|NCT01238861|58627258|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
30616251|NCT01238861|58627259|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
30616252|NCT01238861|58627260|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
30616253|NCT01238861|58627261|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
30616254|NCT01238861|58627262|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
30616255|NCT01238861|58627263|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
30616256|NCT01238861|58627258|FG000|Overall Study|Incorrect enrollment/randomization|0|||
30616257|NCT01238861|58627259|FG001|Overall Study|Incorrect enrollment/randomization|0|||
30616258|NCT01238861|58627260|FG002|Overall Study|Incorrect enrollment/randomization|1|||
30616259|NCT01238861|58627261|FG003|Overall Study|Incorrect enrollment/randomization|0|||
30616260|NCT01238861|58627262|FG004|Overall Study|Incorrect enrollment/randomization|1|||
30616261|NCT01238861|58627263|FG005|Overall Study|Incorrect enrollment/randomization|0|||
30616262|NCT01238861|58627258|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
30616263|NCT01238861|58627259|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
30616264|NCT01238861|58627260|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
30616265|NCT01238861|58627261|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
30616266|NCT01238861|58627262|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
30616267|NCT01238861|58627263|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
30616268|NCT01238861|58627258|FG000|Overall Study|Subject moved out of state/area|0|||
30616269|NCT01238861|58627259|FG001|Overall Study|Subject moved out of state/area|0|||
30616270|NCT01238861|58627260|FG002|Overall Study|Subject moved out of state/area|1|||
30616271|NCT01238861|58627261|FG003|Overall Study|Subject moved out of state/area|1|||
30616272|NCT01238861|58627262|FG004|Overall Study|Subject moved out of state/area|0|||
30616273|NCT01238861|58627263|FG005|Overall Study|Subject moved out of state/area|0|||
30616274|NCT01238861|58627258|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
30893189|NCT02371369|58926606|FG001|Part 2|Other|1|||
30616275|NCT01238861|58627259|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
30616276|NCT01238861|58627260|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
30893190|NCT02187783|58926628|FG000|Overall Study|Adverse Event|8|||
30893191|NCT02187783|58926628|FG000|Overall Study|Death|3|||
30893192|NCT02187783|58926628|FG000|Overall Study|Progressive disease|80|||
30893193|NCT02187783|58926628|FG000|Overall Study|Protocol Violation|3|||
30616277|NCT01238861|58627261|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
30616278|NCT01238861|58627262|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
30616279|NCT01238861|58627263|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
30616280|NCT01238861|58627258|FG000|Overall Study|Personal problems|0|||
30616281|NCT01238861|58627259|FG001|Overall Study|Personal problems|0|||
30616282|NCT01238861|58627260|FG002|Overall Study|Personal problems|0|||
30616283|NCT01238861|58627261|FG003|Overall Study|Personal problems|1|||
30616284|NCT01238861|58627262|FG004|Overall Study|Personal problems|0|||
30616285|NCT01238861|58627263|FG005|Overall Study|Personal problems|0|||
30616286|NCT01238861|58627258|FG000|Overall Study|Unable to continue visits|0|||
30616287|NCT01238861|58627259|FG001|Overall Study|Unable to continue visits|0|||
30616288|NCT01238861|58627260|FG002|Overall Study|Unable to continue visits|0|||
30616289|NCT01238861|58627261|FG003|Overall Study|Unable to continue visits|1|||
30616290|NCT01238861|58627262|FG004|Overall Study|Unable to continue visits|0|||
30616291|NCT01238861|58627263|FG005|Overall Study|Unable to continue visits|1|||
30616292|NCT01238861|58627258|FG000|Overall Study|Serious adverse event|0|||
30616293|NCT01238861|58627259|FG001|Overall Study|Serious adverse event|0|||
30616294|NCT01238861|58627260|FG002|Overall Study|Serious adverse event|0|||
30616295|NCT01238861|58627261|FG003|Overall Study|Serious adverse event|0|||
30616296|NCT01238861|58627262|FG004|Overall Study|Serious adverse event|0|||
30616297|NCT01238861|58627263|FG005|Overall Study|Serious adverse event|1|||
30616298|NCT01238861|58627258|FG000|Overall Study|Lack of compliance|0|||
30616299|NCT01238861|58627259|FG001|Overall Study|Lack of compliance|0|||
30616300|NCT01238861|58627260|FG002|Overall Study|Lack of compliance|0|||
30616301|NCT01238861|58627261|FG003|Overall Study|Lack of compliance|0|||
30616302|NCT01238861|58627262|FG004|Overall Study|Lack of compliance|0|||
30616303|NCT01238861|58627263|FG005|Overall Study|Lack of compliance|1|||
30616304|NCT01238861|58627258|FG000|Overall Study|Adverse Event|0|||
30616305|NCT01238861|58627259|FG001|Overall Study|Adverse Event|1|||
30616306|NCT01238861|58627260|FG002|Overall Study|Adverse Event|0|||
30616307|NCT01238861|58627261|FG003|Overall Study|Adverse Event|0|||
30616308|NCT01238861|58627262|FG004|Overall Study|Adverse Event|0|||
30616309|NCT01238861|58627263|FG005|Overall Study|Adverse Event|0|||
30616310|NCT01238861|58627258|FG000|Overall Study|Withdrawal by Subject|6|||
30616311|NCT01238861|58627259|FG001|Overall Study|Withdrawal by Subject|5|||
30616312|NCT01238861|58627260|FG002|Overall Study|Withdrawal by Subject|4|||
30616313|NCT01238861|58627261|FG003|Overall Study|Withdrawal by Subject|8|||
30616314|NCT01238861|58627262|FG004|Overall Study|Withdrawal by Subject|10|||
30616315|NCT01238861|58627263|FG005|Overall Study|Withdrawal by Subject|9|||
30616316|NCT00903409|58627286|FG000|Overall Study|Adverse Event|11|||
30616317|NCT00903409|58627287|FG001|Overall Study|Adverse Event|9|||
30616318|NCT00903409|58627286|FG000|Overall Study|Non-compliance with Protocol|1|||
30616319|NCT00903409|58627287|FG001|Overall Study|Non-compliance with Protocol|1|||
30616320|NCT00903409|58627286|FG000|Overall Study|Laboratory Abnormality|2|||
30616321|NCT00903409|58627287|FG001|Overall Study|Laboratory Abnormality|0|||
30616322|NCT00903409|58627286|FG000|Overall Study|Withdrawal by Subject|8|||
30616323|NCT00903409|58627287|FG001|Overall Study|Withdrawal by Subject|8|||
31009871|NCT01407354|59211180|FG000|First Intervention|Physician Decision|1|||
31009872|NCT01407354|59211181|FG001|First Intervention|Physician Decision|0|||
31009873|NCT01407276|59211196|FG000|Overall Study|Withdrawal by Subject|0|||
31009874|NCT01407276|59211197|FG001|Overall Study|Withdrawal by Subject|0|||
30616324|NCT00903409|58627286|FG000|Overall Study|Other|2|||
30616325|NCT00903409|58627287|FG001|Overall Study|Other|3|||
30616326|NCT00903409|58627286|FG000|Overall Study|Lost to Follow-up|2|||
30616327|NCT00903409|58627287|FG001|Overall Study|Lost to Follow-up|6|||
30616328|NCT01237223|58627301|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
30616329|NCT01237223|58627302|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
30616330|NCT01237223|58627303|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
30616331|NCT01237223|58627304|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
30616332|NCT01237223|58627305|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
30616333|NCT01237223|58627306|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
30616334|NCT01237223|58627301|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
30616335|NCT01237223|58627302|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
30616336|NCT01237223|58627303|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
30616337|NCT01237223|58627304|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
30616338|NCT01237223|58627305|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
30616339|NCT01237223|58627306|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
30616340|NCT01237223|58627301|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
30616341|NCT01237223|58627302|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
30616342|NCT01237223|58627303|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
30616343|NCT01237223|58627304|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
30616344|NCT01237223|58627305|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
31009875|NCT01407276|59211198|FG002|Overall Study|Withdrawal by Subject|0|||
30616345|NCT01237223|58627306|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
30616346|NCT01237223|58627301|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
30616347|NCT01237223|58627302|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
30616348|NCT01237223|58627303|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
30616349|NCT01237223|58627304|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
30616350|NCT01237223|58627305|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
30616351|NCT01237223|58627306|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
30616352|NCT01237223|58627301|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
30616353|NCT01237223|58627302|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
30616354|NCT01237223|58627303|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
30616355|NCT01237223|58627304|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
30616356|NCT01237223|58627305|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
30616357|NCT01237223|58627306|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
30616358|NCT01237223|58627301|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
30616359|NCT01237223|58627302|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
30616360|NCT01237223|58627303|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
30616361|NCT01237223|58627304|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
30616362|NCT01237223|58627305|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
30616363|NCT01237223|58627306|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
30616364|NCT01237223|58627301|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
30616365|NCT01237223|58627302|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
30616366|NCT01237223|58627303|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
30616367|NCT01237223|58627304|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
30616368|NCT01237223|58627305|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
30616369|NCT01237223|58627306|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
30616370|NCT01237223|58627301|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
30616371|NCT01237223|58627302|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
30616372|NCT01237223|58627303|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
30616373|NCT01237223|58627304|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
30616374|NCT01237223|58627305|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
30616375|NCT01237223|58627306|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
30616376|NCT01237223|58627301|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
30616377|NCT01237223|58627302|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
30616378|NCT01237223|58627303|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
30616379|NCT01237223|58627304|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
30616380|NCT01237223|58627305|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
30616381|NCT01237223|58627306|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
31009876|NCT01407276|59211199|FG003|Overall Study|Withdrawal by Subject|0|||
31009877|NCT01407276|59211200|FG004|Overall Study|Withdrawal by Subject|0|||
31009878|NCT01407276|59211201|FG005|Overall Study|Withdrawal by Subject|0|||
31009879|NCT01407276|59211202|FG006|Overall Study|Withdrawal by Subject|0|||
31009880|NCT01407276|59211203|FG007|Overall Study|Withdrawal by Subject|1|||
31009881|NCT01390272|59211230|FG000|Overall Study|Death|3|||
31009882|NCT01390272|59211231|FG001|Overall Study|Death|2|||
31009883|NCT01390272|59211230|FG000|Overall Study|Withdrawal by Subject|9|||
31009884|NCT01390272|59211231|FG001|Overall Study|Withdrawal by Subject|5|||
31009885|NCT01390272|59211230|FG000|Overall Study|Patient moved, no longer eligible|5|||
31009886|NCT01390272|59211231|FG001|Overall Study|Patient moved, no longer eligible|8|||
31009887|NCT01429584|59211239|FG000|Overall Study|Withdrawal by Subject|1|||
31009888|NCT01429584|59211240|FG001|Overall Study|Withdrawal by Subject|0|||
31009889|NCT01429584|59211239|FG000|Overall Study|Protocol Violation|0|||
31009890|NCT01429584|59211240|FG001|Overall Study|Protocol Violation|1|||
31009891|NCT01406652|59211248|FG000|Overall Study|Lost-to-follow-up|3|||
31009892|NCT01406652|59211249|FG001|Overall Study|Lost-to-follow-up|4|||
31009893|NCT01406652|59211248|FG000|Overall Study|Withdrawal by Subject|2|||
31009894|NCT01406652|59211249|FG001|Overall Study|Withdrawal by Subject|2|||
31009895|NCT01406652|59211248|FG000|Overall Study|Insufficient follow-up|5|||
31009896|NCT01406652|59211249|FG001|Overall Study|Insufficient follow-up|4|||
31009897|NCT01406652|59211248|FG000|Overall Study|Infection not sure|10|||
31009898|NCT01406652|59211249|FG001|Overall Study|Infection not sure|10|||
31009899|NCT01406574|59211257|FG000|Overall Study|Adverse Event|0|||
31009900|NCT01406574|59211258|FG001|Overall Study|Adverse Event|0|||
31009901|NCT01406574|59211259|FG002|Overall Study|Adverse Event|1|||
31009902|NCT01406574|59211260|FG003|Overall Study|Adverse Event|3|||
31009903|NCT01406574|59211257|FG000|Overall Study|Physician Decision|0|||
31009904|NCT01406574|59211258|FG001|Overall Study|Physician Decision|0|||
31009905|NCT01406574|59211259|FG002|Overall Study|Physician Decision|0|||
31009906|NCT01406574|59211260|FG003|Overall Study|Physician Decision|1|||
31009907|NCT01406574|59211257|FG000|Overall Study|Withdrawal by Subject|0|||
31009908|NCT01406574|59211258|FG001|Overall Study|Withdrawal by Subject|1|||
31009909|NCT01406574|59211259|FG002|Overall Study|Withdrawal by Subject|0|||
31009910|NCT01406574|59211260|FG003|Overall Study|Withdrawal by Subject|0|||
31009911|NCT01406574|59211257|FG000|Overall Study|Definite progression of primary disease|1|||
31009912|NCT01406574|59211258|FG001|Overall Study|Definite progression of primary disease|0|||
31009913|NCT01406574|59211259|FG002|Overall Study|Definite progression of primary disease|0|||
31009914|NCT01406574|59211260|FG003|Overall Study|Definite progression of primary disease|0|||
31009915|NCT01405950|59211273|FG000|Overall Study|Withdrawal by Subject|1|||
31009916|NCT01405950|59211274|FG001|Overall Study|Withdrawal by Subject|0|||
31009917|NCT01405950|59211275|FG002|Overall Study|Withdrawal by Subject|0|||
31009918|NCT01405950|59211276|FG003|Overall Study|Withdrawal by Subject|0|||
31009919|NCT01405560|59211284|FG000|Overall Study|Physician Decision|1|||
31009920|NCT01428882|59211290|FG000|Overall Study|Lack of Efficacy|2|||
31009921|NCT01428882|59211291|FG001|Overall Study|Lack of Efficacy|7|||
31009922|NCT01428882|59211290|FG000|Overall Study|Protocol Violation|4|||
31009923|NCT01428882|59211291|FG001|Overall Study|Protocol Violation|3|||
31009924|NCT01428258|59211299|FG000|Intervention 1|Withdrawal by Subject|2|||
31009925|NCT01428258|59211300|FG001|Intervention 1|Withdrawal by Subject|0|||
31009926|NCT01389882|59211316|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
31009927|NCT01389882|59211317|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
31009928|NCT01389882|59211316|FG000|Overall Study|Withdrawal by Subject|0|||
31009929|NCT01389882|59211317|FG001|Overall Study|Withdrawal by Subject|1|||
31009930|NCT01442688|59211325|FG000|First Intervention|Withdrawal by Subject|1|||
31009931|NCT01442688|59211326|FG001|First Intervention|Withdrawal by Subject|0|||
31009932|NCT01442688|59211325|FG000|First Intervention|subject incarcerated|1|||
31009933|NCT01442688|59211326|FG001|First Intervention|subject incarcerated|0|||
31009934|NCT01442688|59211325|FG000|Second Intervention|Adverse Event|1|||
31009935|NCT01442688|59211326|FG001|Second Intervention|Adverse Event|0|||
31009936|NCT01466166|59211332|FG000|Overall Study|Death|1|||
31009937|NCT01466166|59211332|FG000|Overall Study|Lost to Follow-up|7|||
31009938|NCT01466166|59211332|FG000|Overall Study|Infusion Reaction (IR)|27|||
31009939|NCT01466166|59211332|FG000|Overall Study|Adverse Event (Other than IR)|11|||
31009940|NCT01466166|59211332|FG000|Overall Study|Elevated Serum Uric Acid|78|||
31009941|NCT01466166|59211332|FG000|Overall Study|Withdrawal by Subject|13|||
31009942|NCT01466166|59211332|FG000|Overall Study|Sponsor Decision|4|||
31009943|NCT01466166|59211332|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
31009944|NCT01466166|59211332|FG000|Overall Study|Other|20|||
31009945|NCT01426854|59211338|FG000|Overall Study|Adverse Event|1|||
31009946|NCT01426854|59211339|FG001|Overall Study|Adverse Event|5|||
31009947|NCT01426854|59211338|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
31009948|NCT01426854|59211339|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
31009949|NCT01426854|59211338|FG000|Overall Study|Lost to Follow-up|3|||
31009950|NCT01426854|59211339|FG001|Overall Study|Lost to Follow-up|0|||
31009951|NCT01426854|59211338|FG000|Overall Study|Noncompliance|0|||
30616382|NCT01237223|58627301|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
30616383|NCT01237223|58627302|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
30616384|NCT01237223|58627303|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
30616385|NCT01237223|58627304|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
30616386|NCT01237223|58627305|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
30616387|NCT01237223|58627306|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
30616388|NCT01236755|58627322|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
30616389|NCT01236755|58627322|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
30616390|NCT01236755|58627322|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
30616391|NCT01236755|58627322|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
30616392|NCT01236365|58627329|FG000|Overall Study|Lost to Follow-up|0|||
30616393|NCT01236365|58627330|FG001|Overall Study|Lost to Follow-up|2|||
30616394|NCT01236365|58627329|FG000|Overall Study|Moved Out of State|1|||
30616395|NCT01236365|58627330|FG001|Overall Study|Moved Out of State|0|||
30616396|NCT01236365|58627329|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
30893194|NCT02187783|58926628|FG000|Overall Study|Physician Decision|2|||
31009952|NCT01426854|59211339|FG001|Overall Study|Noncompliance|1|||
31009953|NCT01426854|59211338|FG000|Overall Study|Treatment Failure|0|||
30616397|NCT01236365|58627330|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
30616398|NCT01235975|58627350|FG000|Overall Study|Serious Adverse Event|0|||
31009954|NCT01426854|59211339|FG001|Overall Study|Treatment Failure|16|||
31009955|NCT01426854|59211338|FG000|Overall Study|Protocol Deviation|0|||
31009956|NCT01426854|59211339|FG001|Overall Study|Protocol Deviation|1|||
31009957|NCT01426854|59211338|FG000|Overall Study|Other|3|||
31009958|NCT01426854|59211339|FG001|Overall Study|Other|2|||
31009959|NCT01426386|59211351|FG000|Overall Study|Adverse Event|0|||
30616399|NCT01235975|58627351|FG001|Overall Study|Serious Adverse Event|1|||
30616400|NCT01235975|58627350|FG000|Overall Study|Withdrawal by Subject|8|||
31009960|NCT01426386|59211352|FG001|Overall Study|Adverse Event|1|||
30616401|NCT01235975|58627351|FG001|Overall Study|Withdrawal by Subject|2|||
30616402|NCT01235975|58627350|FG000|Overall Study|Migrated/moved from study area|2|||
30616403|NCT01235975|58627351|FG001|Overall Study|Migrated/moved from study area|1|||
30616404|NCT01235975|58627350|FG000|Overall Study|Lost to Follow-up|7|||
30616405|NCT01235975|58627351|FG001|Overall Study|Lost to Follow-up|3|||
30616406|NCT00903331|58627359|FG000|Overall Study|Death|4|||
30616407|NCT00903331|58627360|FG001|Overall Study|Death|8|||
30616408|NCT00903331|58627359|FG000|Overall Study|Withdrawal of consent|1|||
30616409|NCT00903331|58627360|FG001|Overall Study|Withdrawal of consent|8|||
30616410|NCT00903331|58627359|FG000|Overall Study|Lung transplant|0|||
30616411|NCT00903331|58627360|FG001|Overall Study|Lung transplant|2|||
30616412|NCT01235741|58627369|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
30616413|NCT01235741|58627370|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
31009961|NCT01426386|59211353|FG002|Overall Study|Adverse Event|0|||
31009962|NCT01426386|59211354|FG003|Overall Study|Adverse Event|0|||
31009963|NCT01426386|59211355|FG004|Overall Study|Adverse Event|0|||
31009964|NCT01426386|59211356|FG005|Overall Study|Adverse Event|0|||
31009965|NCT01426386|59211351|FG000|Overall Study|Did not attend scheduled visit|1|||
31009966|NCT01426386|59211352|FG001|Overall Study|Did not attend scheduled visit|4|||
31009967|NCT01426386|59211353|FG002|Overall Study|Did not attend scheduled visit|0|||
31009968|NCT01426386|59211354|FG003|Overall Study|Did not attend scheduled visit|0|||
31009969|NCT01426386|59211355|FG004|Overall Study|Did not attend scheduled visit|2|||
31009970|NCT01426386|59211356|FG005|Overall Study|Did not attend scheduled visit|1|||
31009971|NCT01426386|59211351|FG000|Overall Study|Poor response|2|||
31009972|NCT01426386|59211352|FG001|Overall Study|Poor response|1|||
31009973|NCT01426386|59211353|FG002|Overall Study|Poor response|2|||
31009974|NCT01426386|59211354|FG003|Overall Study|Poor response|0|||
31009975|NCT01426386|59211355|FG004|Overall Study|Poor response|1|||
31009976|NCT01426386|59211356|FG005|Overall Study|Poor response|0|||
31009977|NCT01426386|59211351|FG000|Overall Study|Personal reasons|0|||
31009978|NCT01426386|59211352|FG001|Overall Study|Personal reasons|0|||
31009979|NCT01426386|59211353|FG002|Overall Study|Personal reasons|0|||
31009980|NCT01426386|59211354|FG003|Overall Study|Personal reasons|0|||
31009981|NCT01426386|59211355|FG004|Overall Study|Personal reasons|1|||
31009982|NCT01426386|59211356|FG005|Overall Study|Personal reasons|0|||
31009983|NCT01404234|59211370|FG000|Overall Study|Withdrawal by Subject|2|||
31009984|NCT01403610|59211378|FG000|Overall Study|Withdrawal by Subject|2|||
31009985|NCT01403610|59211379|FG001|Overall Study|Withdrawal by Subject|0|||
31009986|NCT01403610|59211380|FG002|Overall Study|Withdrawal by Subject|0|||
31009987|NCT01403610|59211381|FG003|Overall Study|Withdrawal by Subject|0|||
31009988|NCT01403610|59211378|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
31009989|NCT01403610|59211379|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
31009990|NCT01403610|59211380|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
31009991|NCT01403610|59211381|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
31009992|NCT01403064|59211395|FG000|Overall Study|Death|0|||
31009993|NCT01403064|59211396|FG001|Overall Study|Death|0|||
31009994|NCT01403064|59211397|FG002|Overall Study|Death|1|||
31009995|NCT01403064|59211398|FG003|Overall Study|Death|1|||
31009996|NCT01403064|59211395|FG000|Overall Study|Withdrawal by Subject|0|||
31009997|NCT01403064|59211396|FG001|Overall Study|Withdrawal by Subject|0|||
31009998|NCT01403064|59211397|FG002|Overall Study|Withdrawal by Subject|1|||
30616414|NCT01235741|58627371|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
30616415|NCT01235741|58627369|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
30616416|NCT01235741|58627370|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
30616417|NCT01235741|58627371|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
30616418|NCT01235741|58627369|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
30616419|NCT01235741|58627370|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
30616420|NCT01235741|58627371|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
30616421|NCT01235741|58627369|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
30616422|NCT01235741|58627370|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
30616423|NCT01235741|58627371|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
30616424|NCT01235741|58627369|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
30616425|NCT01235741|58627370|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
30616426|NCT01235741|58627371|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
30616427|NCT01235741|58627369|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
30616428|NCT01235741|58627370|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
31009999|NCT01403064|59211398|FG003|Overall Study|Withdrawal by Subject|1|||
31010000|NCT01403064|59211395|FG000|Overall Study|Other|1|||
30790782|NCT03524092|58803945|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
31010001|NCT01403064|59211396|FG001|Overall Study|Other|0|||
31010002|NCT01403064|59211397|FG002|Overall Study|Other|2|||
31010003|NCT01403064|59211398|FG003|Overall Study|Other|1|||
31010004|NCT01402986|59211417|FG000|Overall Study|Withdrawal by Subject|7|||
30616429|NCT01235741|58627371|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
30616430|NCT01235741|58627369|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
30616431|NCT01235741|58627370|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
30616432|NCT01235741|58627371|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
30616433|NCT01235741|58627369|FG000|Randomized to Treatment|Adverse Event|0|||
30616434|NCT01235741|58627370|FG001|Randomized to Treatment|Adverse Event|1|||
30616435|NCT01235741|58627371|FG002|Randomized to Treatment|Adverse Event|1|||
30616436|NCT01235741|58627369|FG000|Randomized to Treatment|Sponsor terminated study|0|||
30616437|NCT01235741|58627370|FG001|Randomized to Treatment|Sponsor terminated study|35|||
30616438|NCT01235741|58627371|FG002|Randomized to Treatment|Sponsor terminated study|34|||
30616439|NCT01235741|58627369|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
31010005|NCT01402986|59211418|FG001|Overall Study|Withdrawal by Subject|10|||
31010006|NCT01402986|59211419|FG002|Overall Study|Withdrawal by Subject|7|||
31010007|NCT01402986|59211420|FG003|Overall Study|Withdrawal by Subject|13|||
31010008|NCT01402986|59211417|FG000|Overall Study|Death|0|||
31010009|NCT01402986|59211418|FG001|Overall Study|Death|0|||
31010010|NCT01402986|59211419|FG002|Overall Study|Death|0|||
31010011|NCT01402986|59211420|FG003|Overall Study|Death|2|||
31010012|NCT01402986|59211417|FG000|Overall Study|Lost to Follow-up|0|||
31010013|NCT01402986|59211418|FG001|Overall Study|Lost to Follow-up|0|||
31010014|NCT01402986|59211419|FG002|Overall Study|Lost to Follow-up|0|||
31010015|NCT01402986|59211420|FG003|Overall Study|Lost to Follow-up|1|||
31010016|NCT01402986|59211417|FG000|Overall Study|Other|2|||
31010017|NCT01402986|59211418|FG001|Overall Study|Other|5|||
31010018|NCT01402986|59211419|FG002|Overall Study|Other|1|||
31010019|NCT01402986|59211420|FG003|Overall Study|Other|6|||
31010020|NCT01402908|59211432|FG000|Overall Study|Withdrawal by Subject|30|||
31010021|NCT01402908|59211433|FG001|Overall Study|Withdrawal by Subject|17|||
31010022|NCT01402908|59211432|FG000|Overall Study|Lost to Follow-up|3|||
31010023|NCT01402908|59211433|FG001|Overall Study|Lost to Follow-up|1|||
31010024|NCT01402908|59211432|FG000|Overall Study|Physician Decision|1|||
31010025|NCT01402908|59211433|FG001|Overall Study|Physician Decision|0|||
31010026|NCT01389258|59211439|FG000|Overall Study|Lost to Follow-up|5|||
31010027|NCT01389102|59211449|FG000|Overall Study|Adverse Event|1|||
31010028|NCT01389102|59211450|FG001|Overall Study|Adverse Event|3|||
31010029|NCT01389102|59211451|FG002|Overall Study|Adverse Event|2|||
31010030|NCT01389102|59211452|FG003|Overall Study|Adverse Event|2|||
31010031|NCT01389102|59211453|FG004|Overall Study|Adverse Event|2|||
31010032|NCT01389102|59211454|FG005|Overall Study|Adverse Event|2|||
31010033|NCT01389102|59211449|FG000|Overall Study|Hurricane Katrina|4|||
31010034|NCT01389102|59211450|FG001|Overall Study|Hurricane Katrina|2|||
31010035|NCT01389102|59211451|FG002|Overall Study|Hurricane Katrina|3|||
31010036|NCT01389102|59211452|FG003|Overall Study|Hurricane Katrina|0|||
31010037|NCT01389102|59211453|FG004|Overall Study|Hurricane Katrina|3|||
31010038|NCT01389102|59211454|FG005|Overall Study|Hurricane Katrina|1|||
31010039|NCT01389102|59211449|FG000|Overall Study|Lost to Follow-up|4|||
31010040|NCT01389102|59211450|FG001|Overall Study|Lost to Follow-up|1|||
31010041|NCT01389102|59211451|FG002|Overall Study|Lost to Follow-up|1|||
31010042|NCT01389102|59211452|FG003|Overall Study|Lost to Follow-up|2|||
31010043|NCT01389102|59211453|FG004|Overall Study|Lost to Follow-up|4|||
31010044|NCT01389102|59211454|FG005|Overall Study|Lost to Follow-up|1|||
30616440|NCT01235741|58627370|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
30616441|NCT01235741|58627371|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
30616442|NCT01235741|58627369|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
30616443|NCT01235741|58627370|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
30616444|NCT01235741|58627371|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
30616445|NCT01235741|58627369|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
30616446|NCT01235741|58627370|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
30616447|NCT01235741|58627371|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
30616448|NCT01235507|58627383|FG000|Overall Study|Adverse Event|1|||
30616449|NCT01235507|58627383|FG000|Overall Study|Withdrawal by Subject|1|||
30616450|NCT01235351|58627389|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
30616451|NCT01235351|58627390|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
30616452|NCT01076205|58627400|FG000|Overall Study|Adverse Drug Reaction|299|||
31010045|NCT01389102|59211449|FG000|Overall Study|Protocol Violation|0|||
31010046|NCT01389102|59211450|FG001|Overall Study|Protocol Violation|0|||
31010047|NCT01389102|59211451|FG002|Overall Study|Protocol Violation|3|||
31010048|NCT01389102|59211452|FG003|Overall Study|Protocol Violation|0|||
31010049|NCT01389102|59211453|FG004|Overall Study|Protocol Violation|1|||
31010050|NCT01389102|59211454|FG005|Overall Study|Protocol Violation|1|||
30616453|NCT01076205|58627400|FG000|Overall Study|Lack of Effectiveness|1423|||
31010051|NCT01389102|59211449|FG000|Overall Study|Withdrawal by Subject|7|||
31010052|NCT01389102|59211450|FG001|Overall Study|Withdrawal by Subject|4|||
30616454|NCT01076205|58627400|FG000|Overall Study|Other Reason|1075|||
31010053|NCT01389102|59211451|FG002|Overall Study|Withdrawal by Subject|9|||
31010054|NCT01389102|59211452|FG003|Overall Study|Withdrawal by Subject|2|||
31010055|NCT01389102|59211453|FG004|Overall Study|Withdrawal by Subject|3|||
31010056|NCT01389102|59211454|FG005|Overall Study|Withdrawal by Subject|3|||
31010057|NCT01389102|59211449|FG000|Overall Study|Subject Traveling Out of Country|0|||
31010058|NCT01389102|59211450|FG001|Overall Study|Subject Traveling Out of Country|0|||
31010059|NCT01389102|59211451|FG002|Overall Study|Subject Traveling Out of Country|0|||
31010060|NCT01389102|59211452|FG003|Overall Study|Subject Traveling Out of Country|1|||
31010061|NCT01389102|59211453|FG004|Overall Study|Subject Traveling Out of Country|0|||
31010062|NCT01389102|59211454|FG005|Overall Study|Subject Traveling Out of Country|0|||
31010063|NCT01389102|59211449|FG000|Overall Study|Subject Moved|2|||
31010064|NCT01389102|59211450|FG001|Overall Study|Subject Moved|0|||
31010065|NCT01389102|59211451|FG002|Overall Study|Subject Moved|1|||
31010066|NCT01389102|59211452|FG003|Overall Study|Subject Moved|0|||
31010067|NCT01389102|59211453|FG004|Overall Study|Subject Moved|0|||
31010068|NCT01389102|59211454|FG005|Overall Study|Subject Moved|0|||
31010069|NCT01389102|59211449|FG000|Overall Study|Unavailable due to husband's illness|0|||
31010070|NCT01389102|59211450|FG001|Overall Study|Unavailable due to husband's illness|1|||
31010071|NCT01389102|59211451|FG002|Overall Study|Unavailable due to husband's illness|0|||
31010072|NCT01389102|59211452|FG003|Overall Study|Unavailable due to husband's illness|0|||
31010073|NCT01389102|59211453|FG004|Overall Study|Unavailable due to husband's illness|0|||
31010074|NCT01389102|59211454|FG005|Overall Study|Unavailable due to husband's illness|0|||
31010075|NCT01389102|59211449|FG000|Overall Study|Investigator Judgement|0|||
31010076|NCT01389102|59211450|FG001|Overall Study|Investigator Judgement|1|||
31010077|NCT01389102|59211451|FG002|Overall Study|Investigator Judgement|0|||
31010078|NCT01389102|59211452|FG003|Overall Study|Investigator Judgement|0|||
31010079|NCT01389102|59211453|FG004|Overall Study|Investigator Judgement|0|||
31010080|NCT01389102|59211454|FG005|Overall Study|Investigator Judgement|0|||
31010081|NCT01402284|59211474|FG000|Overall Study|Withdrawal consent|2|||
31010082|NCT01402284|59211474|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
31010083|NCT01402284|59211474|FG000|Overall Study|Physician Decision|1|||
31010084|NCT01402284|59211474|FG000|Overall Study|Disease progression on study|10|||
31010085|NCT01388790|59211478|FG000|Overall Study|Ongoing at data cut-off date|8|||
31010086|NCT01388478|59211482|FG000|Overall Study|Adverse Event|4|||
31010087|NCT01388478|59211482|FG000|Overall Study|Withdrawal by Subject|1|||
31010088|NCT01424670|59211488|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
31010089|NCT01424670|59211489|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
31010090|NCT01424670|59211488|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
31010091|NCT01424670|59211489|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
31010092|NCT01424670|59211488|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
31010093|NCT01424670|59211489|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
31010094|NCT01424670|59211488|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
31010095|NCT01424670|59211489|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
31010096|NCT01424670|59211488|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
31010097|NCT01424670|59211489|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
31010098|NCT01424670|59211488|FG000|Continuation Period|Adverse Event|13|||
31010099|NCT01424670|59211489|FG001|Continuation Period|Adverse Event|5|||
31010100|NCT01424670|59211488|FG000|Continuation Period|Lost to Follow-up|2|||
31010101|NCT01424670|59211489|FG001|Continuation Period|Lost to Follow-up|0|||
31010102|NCT01424670|59211488|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
31010103|NCT01424670|59211489|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
31010104|NCT01424670|59211488|FG000|Continuation Period|Physician Decision|5|||
31010105|NCT01424670|59211489|FG001|Continuation Period|Physician Decision|4|||
31010106|NCT01424670|59211488|FG000|Continuation Period|Withdrawal by Subject|13|||
31010107|NCT01424670|59211489|FG001|Continuation Period|Withdrawal by Subject|4|||
31010108|NCT01424514|59211497|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
30616455|NCT01076205|58627400|FG000|Overall Study|Unknown Reason|71|||
30616456|NCT01076205|58627400|FG000|Overall Study|Lost to Follow-up|3151|||
30616457|NCT01234883|58627422|FG000|Overall Study|Early treatment release|8|||
30616458|NCT01234883|58627423|FG001|Overall Study|Early treatment release|10|||
30616459|NCT01234883|58627422|FG000|Overall Study|Parent/guardian withdrew consent|1|||
30616460|NCT01234883|58627423|FG001|Overall Study|Parent/guardian withdrew consent|2|||
30616461|NCT01234883|58627422|FG000|Overall Study|Technical difficulties with IV infusion|0|||
30616462|NCT01234883|58627423|FG001|Overall Study|Technical difficulties with IV infusion|1|||
30616463|NCT01234883|58627422|FG000|Overall Study|Inclusion/exclusion failure|1|||
30616464|NCT01234883|58627423|FG001|Overall Study|Inclusion/exclusion failure|0|||
30616465|NCT01234649|58627431|FG000|Overall Study|Withdrawal by Subject|32|||
30616466|NCT01234649|58627432|FG001|Overall Study|Withdrawal by Subject|26|||
31010109|NCT01424514|59211498|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
31010110|NCT01424514|59211497|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
30616467|NCT01234649|58627431|FG000|Overall Study|Pregnancy|6|||
30616468|NCT01234649|58627432|FG001|Overall Study|Pregnancy|6|||
30616469|NCT01234649|58627431|FG000|Overall Study|intolerant to side effects|4|||
31010111|NCT01424514|59211498|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
31010112|NCT01400958|59211511|FG000|Overall Study|Physician Decision|0|||
31010113|NCT01400958|59211512|FG001|Overall Study|Physician Decision|1|||
31010114|NCT01400958|59211511|FG000|Overall Study|Withdrawal by Subject|0|||
31010115|NCT01400958|59211512|FG001|Overall Study|Withdrawal by Subject|1|||
31010116|NCT01400958|59211511|FG000|Overall Study|Adverse Event|1|||
31010117|NCT01400958|59211512|FG001|Overall Study|Adverse Event|0|||
31010118|NCT01388166|59211518|FG000|Overall Study|Adverse Event|16|||
31010119|NCT01388166|59211518|FG000|Overall Study|Lost to Follow-up|30|||
31010120|NCT01388166|59211518|FG000|Overall Study|Others than specified above|13|||
31010121|NCT01400412|59211524|FG000|Overall Study|Lost to Follow-up|4|||
31010122|NCT01400412|59211525|FG001|Overall Study|Lost to Follow-up|7|||
31010123|NCT01400412|59211524|FG000|Overall Study|Withdrawal by Subject|3|||
31010124|NCT01400412|59211525|FG001|Overall Study|Withdrawal by Subject|4|||
31010125|NCT01400412|59211524|FG000|Overall Study|Unable to complete|3|||
31010126|NCT01400412|59211525|FG001|Overall Study|Unable to complete|3|||
31010127|NCT01400412|59211524|FG000|Overall Study|Never started study treatment|0|||
31010128|NCT01400412|59211525|FG001|Overall Study|Never started study treatment|3|||
31010129|NCT01422876|59211543|FG000|Week 24|Lost to Follow-up|1|||
31010130|NCT01422876|59211544|FG001|Week 24|Lost to Follow-up|1|||
31010131|NCT01422876|59211545|FG002|Week 24|Lost to Follow-up|2|||
31010132|NCT01422876|59211546|FG003|Week 24|Lost to Follow-up|4|||
31010133|NCT01422876|59211547|FG004|Week 24|Lost to Follow-up|2|||
31010134|NCT01422876|59211548|FG005|Week 24|Lost to Follow-up|0|||
31010135|NCT01422876|59211549|FG006|Week 24|Lost to Follow-up|1|||
31010136|NCT01422876|59211550|FG007|Week 24|Lost to Follow-up|3|||
31010137|NCT01422876|59211551|FG008|Week 24|Lost to Follow-up|3|||
31010138|NCT01422876|59211552|FG009|Week 24|Lost to Follow-up|4|||
31010139|NCT01422876|59211543|FG000|Week 24|Consent withdrawn|5|||
31010140|NCT01422876|59211544|FG001|Week 24|Consent withdrawn|1|||
31010141|NCT01422876|59211545|FG002|Week 24|Consent withdrawn|3|||
31010142|NCT01422876|59211546|FG003|Week 24|Consent withdrawn|4|||
31010143|NCT01422876|59211547|FG004|Week 24|Consent withdrawn|5|||
31010144|NCT01422876|59211548|FG005|Week 24|Consent withdrawn|6|||
31010145|NCT01422876|59211549|FG006|Week 24|Consent withdrawn|5|||
31010146|NCT01422876|59211550|FG007|Week 24|Consent withdrawn|4|||
31010147|NCT01422876|59211551|FG008|Week 24|Consent withdrawn|3|||
31010148|NCT01422876|59211552|FG009|Week 24|Consent withdrawn|6|||
31010149|NCT01422876|59211543|FG000|Week 24|Death|0|||
31010150|NCT01422876|59211544|FG001|Week 24|Death|1|||
31010151|NCT01422876|59211545|FG002|Week 24|Death|0|||
31010152|NCT01422876|59211546|FG003|Week 24|Death|0|||
31010153|NCT01422876|59211547|FG004|Week 24|Death|0|||
31010154|NCT01422876|59211548|FG005|Week 24|Death|0|||
31010155|NCT01422876|59211549|FG006|Week 24|Death|0|||
30616470|NCT01234649|58627432|FG001|Overall Study|intolerant to side effects|3|||
30616471|NCT01234649|58627431|FG000|Overall Study|Allergic reaction|1|||
30616472|NCT01234649|58627432|FG001|Overall Study|Allergic reaction|0|||
30616473|NCT01234649|58627431|FG000|Overall Study|Lack of Efficacy|0|||
30616474|NCT01234649|58627432|FG001|Overall Study|Lack of Efficacy|3|||
30616475|NCT01075815|58627440|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
30616476|NCT01075815|58627441|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
30616477|NCT01075815|58627440|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
30616478|NCT01075815|58627441|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
30616479|NCT01075815|58627440|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
30616480|NCT01075815|58627441|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
30616481|NCT01075191|58627447|FG000|Overall Study|Death|1|||
30616482|NCT01075191|58627447|FG000|Overall Study|Intensification|3|||
30616483|NCT01075191|58627447|FG000|Overall Study|Co-morbidities|1|||
30616484|NCT01075191|58627447|FG000|Overall Study|Adverse Event|4|||
30616485|NCT01075191|58627447|FG000|Overall Study|Noncompliance|3|||
30616486|NCT01075191|58627447|FG000|Overall Study|Therapy Break|3|||
31010156|NCT01422876|59211550|FG007|Week 24|Death|0|||
31010157|NCT01422876|59211551|FG008|Week 24|Death|0|||
31010158|NCT01422876|59211552|FG009|Week 24|Death|0|||
31010159|NCT01422876|59211543|FG000|Week 52|Lost to Follow-up|3|||
31010160|NCT01422876|59211544|FG001|Week 52|Lost to Follow-up|5|||
31010161|NCT01422876|59211545|FG002|Week 52|Lost to Follow-up|7|||
31010162|NCT01422876|59211546|FG003|Week 52|Lost to Follow-up|5|||
31010163|NCT01422876|59211547|FG004|Week 52|Lost to Follow-up|8|||
31010164|NCT01422876|59211548|FG005|Week 52|Lost to Follow-up|5|||
31010165|NCT01422876|59211549|FG006|Week 52|Lost to Follow-up|5|||
31010166|NCT01422876|59211550|FG007|Week 52|Lost to Follow-up|8|||
31010167|NCT01422876|59211551|FG008|Week 52|Lost to Follow-up|7|||
31010168|NCT01422876|59211552|FG009|Week 52|Lost to Follow-up|8|||
30616487|NCT01075191|58627447|FG000|Overall Study|Patient's Wish|2|||
30616488|NCT01075191|58627447|FG000|Overall Study|Unknown Reasons|1|||
30616489|NCT00905359|58627453|FG000|Overall Study|Lost to Follow-up|17|||
31010169|NCT01422876|59211543|FG000|Week 52|Consent withdrawn|9|||
31010170|NCT01422876|59211544|FG001|Week 52|Consent withdrawn|4|||
31010171|NCT01422876|59211545|FG002|Week 52|Consent withdrawn|6|||
31010172|NCT01422876|59211546|FG003|Week 52|Consent withdrawn|12|||
31010173|NCT01422876|59211547|FG004|Week 52|Consent withdrawn|7|||
30616490|NCT00905359|58627454|FG001|Overall Study|Lost to Follow-up|10|||
30616491|NCT00905359|58627453|FG000|Overall Study|Death|2|||
30616492|NCT00905359|58627454|FG001|Overall Study|Death|0|||
30616493|NCT00905359|58627453|FG000|Overall Study|Withdrawal consent|5|||
30616494|NCT00905359|58627454|FG001|Overall Study|Withdrawal consent|6|||
30616495|NCT01072149|58627460|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616496|NCT01072149|58627461|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
31010174|NCT01422876|59211548|FG005|Week 52|Consent withdrawn|12|||
31010175|NCT01422876|59211549|FG006|Week 52|Consent withdrawn|10|||
31010176|NCT01422876|59211550|FG007|Week 52|Consent withdrawn|12|||
31010177|NCT01422876|59211551|FG008|Week 52|Consent withdrawn|13|||
31010178|NCT01422876|59211552|FG009|Week 52|Consent withdrawn|9|||
31010179|NCT01422876|59211543|FG000|Week 52|Death|0|||
31010180|NCT01422876|59211544|FG001|Week 52|Death|1|||
31010181|NCT01422876|59211545|FG002|Week 52|Death|0|||
31010182|NCT01422876|59211546|FG003|Week 52|Death|1|||
31010183|NCT01422876|59211547|FG004|Week 52|Death|0|||
31010184|NCT01422876|59211548|FG005|Week 52|Death|0|||
31010185|NCT01422876|59211549|FG006|Week 52|Death|1|||
31010186|NCT01422876|59211550|FG007|Week 52|Death|3|||
31010187|NCT01422876|59211551|FG008|Week 52|Death|1|||
31010188|NCT01422876|59211552|FG009|Week 52|Death|0|||
31010189|NCT01422720|59211570|FG000|Overall Study|Adverse Event|16|||
31010190|NCT01422720|59211570|FG000|Overall Study|Lack of Efficacy|1|||
31010191|NCT01422720|59211570|FG000|Overall Study|Withdrawal by Subject|4|||
31010192|NCT01422720|59211570|FG000|Overall Study|Ineligibility|1|||
31010193|NCT01387932|59211580|FG000|Randomized and Treated|Physician Decision|3|||
31010194|NCT01387932|59211581|FG001|Randomized and Treated|Physician Decision|2|||
31010195|NCT01387932|59211580|FG000|Randomized and Treated|Withdrawal by Subject|4|||
31010196|NCT01387932|59211581|FG001|Randomized and Treated|Withdrawal by Subject|2|||
31010197|NCT01387932|59211580|FG000|Survival Follow-up|Liver Transplant|24|||
31010198|NCT01387932|59211581|FG001|Survival Follow-up|Liver Transplant|28|||
31010199|NCT01387932|59211580|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
31010200|NCT01387932|59211581|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
31010201|NCT01387932|59211580|FG000|Survival Follow-up|Withdrawal by Subject|2|||
31010202|NCT01387932|59211581|FG001|Survival Follow-up|Withdrawal by Subject|4|||
31010203|NCT01387932|59211580|FG000|Survival Follow-up|Lost to Follow-up|6|||
31010204|NCT01387932|59211581|FG001|Survival Follow-up|Lost to Follow-up|5|||
31010205|NCT01422408|59211589|FG000|Overall Study|Adverse Event|1|||
31010206|NCT01422408|59211589|FG000|Overall Study|Withdrawal by Subject|3|||
31010207|NCT01399788|59211593|FG000|First Intervention Period|Adverse Event|1|||
31010208|NCT01399788|59211594|FG001|First Intervention Period|Adverse Event|0|||
31010209|NCT01387542|59211600|FG000|Overall Study|Adverse Event|3|||
31010210|NCT01387542|59211600|FG000|Overall Study|Withdrawal by Subject|1|||
31010211|NCT01387542|59211600|FG000|Overall Study|Changed diagnosis|1|||
31010212|NCT01387542|59211600|FG000|Overall Study|Insufficient response|1|||
30616497|NCT01072149|58627462|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
30616498|NCT01072149|58627463|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616499|NCT01072149|58627464|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616500|NCT01072149|58627465|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616501|NCT01072149|58627466|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616502|NCT01072149|58627467|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616503|NCT01072149|58627468|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616504|NCT01072149|58627469|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616505|NCT01072149|58627470|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616506|NCT01072149|58627471|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616507|NCT01072149|58627472|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616508|NCT01072149|58627473|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616509|NCT01072149|58627474|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616510|NCT01072149|58627475|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30616511|NCT01072149|58627476|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30893195|NCT02187783|58926628|FG000|Overall Study|Withdrawal by Subject|9|||
31010213|NCT01387542|59211600|FG000|Overall Study|Non-compliant|1|||
31010214|NCT01387542|59211600|FG000|Overall Study|Lost to Follow-up|1|||
31010215|NCT01387230|59211607|FG000|Overall Study|Adverse Event|0|||
31010216|NCT01387230|59211608|FG001|Overall Study|Adverse Event|1|||
31010217|NCT01387230|59211609|FG002|Overall Study|Adverse Event|3|||
31010218|NCT01387230|59211607|FG000|Overall Study|Lack of Efficacy|8|||
31010219|NCT01387230|59211608|FG001|Overall Study|Lack of Efficacy|5|||
31010220|NCT01387230|59211609|FG002|Overall Study|Lack of Efficacy|4|||
31010221|NCT01387230|59211607|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
31010222|NCT01387230|59211608|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
30616512|NCT01072149|58627477|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
31010223|NCT01387230|59211609|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
31010224|NCT01387230|59211607|FG000|Overall Study|Lost to Follow-up|0|||
30616513|NCT01072149|58627460|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616514|NCT01072149|58627461|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616515|NCT01072149|58627462|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616516|NCT01072149|58627463|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616517|NCT01072149|58627464|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616518|NCT01072149|58627465|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616519|NCT01072149|58627466|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616520|NCT01072149|58627467|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616521|NCT01072149|58627468|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616522|NCT01072149|58627469|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616523|NCT01072149|58627470|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616524|NCT01072149|58627471|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616525|NCT01072149|58627472|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616526|NCT01072149|58627473|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616527|NCT01072149|58627474|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616528|NCT01072149|58627475|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
30616529|NCT01072149|58627476|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
31010225|NCT01387230|59211608|FG001|Overall Study|Lost to Follow-up|0|||
31010226|NCT01387230|59211609|FG002|Overall Study|Lost to Follow-up|1|||
31010227|NCT01387230|59211607|FG000|Overall Study|Withdrawal by Subject|4|||
31010228|NCT01387230|59211608|FG001|Overall Study|Withdrawal by Subject|1|||
31010229|NCT01387230|59211609|FG002|Overall Study|Withdrawal by Subject|0|||
31010230|NCT01387074|59211617|FG000|Overall Study|Lost to Follow-up|7|||
31010231|NCT01387074|59211617|FG000|Overall Study|Lack of Efficacy|1|||
31010232|NCT01386606|59211625|FG000|Overall Study|Adverse Event|0|||
31010233|NCT01386606|59211626|FG001|Overall Study|Adverse Event|1|||
31010234|NCT01386606|59211627|FG002|Overall Study|Adverse Event|0|||
31010235|NCT01386606|59211628|FG003|Overall Study|Adverse Event|0|||
31010236|NCT01386606|59211625|FG000|Overall Study|Withdrawal by Subject|0|||
31010237|NCT01386606|59211626|FG001|Overall Study|Withdrawal by Subject|1|||
31010238|NCT01386606|59211627|FG002|Overall Study|Withdrawal by Subject|1|||
31010239|NCT01386606|59211628|FG003|Overall Study|Withdrawal by Subject|0|||
31010240|NCT01386606|59211625|FG000|Overall Study|Protocol Violation|1|||
31010241|NCT01386606|59211626|FG001|Overall Study|Protocol Violation|0|||
31010242|NCT01386606|59211627|FG002|Overall Study|Protocol Violation|1|||
31010243|NCT01386606|59211628|FG003|Overall Study|Protocol Violation|1|||
31010244|NCT01386606|59211625|FG000|Overall Study|Lost to Follow-up|2|||
31010245|NCT01386606|59211626|FG001|Overall Study|Lost to Follow-up|0|||
31010246|NCT01386606|59211627|FG002|Overall Study|Lost to Follow-up|0|||
31010247|NCT01386606|59211628|FG003|Overall Study|Lost to Follow-up|0|||
31010248|NCT01386606|59211625|FG000|Overall Study|Subject incarcerated|0|||
31010249|NCT01386606|59211626|FG001|Overall Study|Subject incarcerated|1|||
31010250|NCT01386606|59211627|FG002|Overall Study|Subject incarcerated|0|||
31010251|NCT01386606|59211628|FG003|Overall Study|Subject incarcerated|0|||
31010252|NCT01386606|59211625|FG000|Overall Study|Unable to draw PK|1|||
31010253|NCT01386606|59211626|FG001|Overall Study|Unable to draw PK|0|||
31010254|NCT01386606|59211627|FG002|Overall Study|Unable to draw PK|0|||
30616530|NCT01072149|58627477|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
30616531|NCT01072149|58627460|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616532|NCT01072149|58627461|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616533|NCT01072149|58627462|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616534|NCT01072149|58627463|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616535|NCT01072149|58627464|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616536|NCT01072149|58627465|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616537|NCT01072149|58627466|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616538|NCT01072149|58627467|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616539|NCT01072149|58627468|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616540|NCT01072149|58627469|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616541|NCT01072149|58627470|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
30616542|NCT01072149|58627471|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616543|NCT01072149|58627472|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616544|NCT01072149|58627473|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616545|NCT01072149|58627474|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616546|NCT01072149|58627475|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30893196|NCT02187783|58926628|FG000|Overall Study|Study terminated by sponsor|1|||
30790783|NCT03524092|58803940|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
30893197|NCT02337361|58926634|FG000|3-month Follow-up|Lost to Follow-up|19|||
31010255|NCT01386606|59211628|FG003|Overall Study|Unable to draw PK|0|||
31010256|NCT01386606|59211625|FG000|Overall Study|T levels too high|0|||
31010257|NCT01386606|59211626|FG001|Overall Study|T levels too high|1|||
31010258|NCT01386606|59211627|FG002|Overall Study|T levels too high|1|||
31010259|NCT01386606|59211628|FG003|Overall Study|T levels too high|0|||
31010260|NCT01385748|59211645|FG000|Overall Study|Withdrawal by Subject|7|||
31010261|NCT01385748|59211646|FG001|Overall Study|Withdrawal by Subject|4|||
30616547|NCT01072149|58627476|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616548|NCT01072149|58627477|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30616549|NCT01072149|58627460|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616550|NCT01072149|58627461|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
30616551|NCT01072149|58627462|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616552|NCT01072149|58627463|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616553|NCT01072149|58627464|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616554|NCT01072149|58627465|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616555|NCT01072149|58627466|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616556|NCT01072149|58627467|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616557|NCT01072149|58627468|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616558|NCT01072149|58627469|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616559|NCT01072149|58627470|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616560|NCT01072149|58627471|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616561|NCT01072149|58627472|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616562|NCT01072149|58627473|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616563|NCT01072149|58627474|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616564|NCT01072149|58627475|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616565|NCT01072149|58627476|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616566|NCT01072149|58627477|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30616567|NCT01072149|58627460|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616568|NCT01072149|58627461|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616569|NCT01072149|58627462|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
30616570|NCT01072149|58627463|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616571|NCT01072149|58627464|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616572|NCT01072149|58627465|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616573|NCT01072149|58627466|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616574|NCT01072149|58627467|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616575|NCT01072149|58627468|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616576|NCT01072149|58627469|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616577|NCT01072149|58627470|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616578|NCT01072149|58627471|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616579|NCT01072149|58627472|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616580|NCT01072149|58627473|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616581|NCT01072149|58627474|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616582|NCT01072149|58627475|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616583|NCT01072149|58627476|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616584|NCT01072149|58627477|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30616585|NCT01072149|58627460|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616586|NCT01072149|58627461|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616587|NCT01072149|58627462|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616588|NCT01072149|58627463|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616589|NCT01072149|58627464|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616590|NCT01072149|58627465|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616591|NCT01072149|58627466|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616592|NCT01072149|58627467|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
30616593|NCT01072149|58627468|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616594|NCT01072149|58627469|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616595|NCT01072149|58627470|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616596|NCT01072149|58627471|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616597|NCT01072149|58627472|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616598|NCT01072149|58627473|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616599|NCT01072149|58627474|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616600|NCT01072149|58627475|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616601|NCT01072149|58627476|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616602|NCT01072149|58627477|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
30616603|NCT01072149|58627460|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
30616604|NCT01072149|58627461|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
30616605|NCT01072149|58627462|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
30616606|NCT01072149|58627463|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
30616607|NCT01072149|58627464|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
30616608|NCT01072149|58627465|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
30616609|NCT01072149|58627466|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
30616610|NCT01072149|58627467|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
30616611|NCT01072149|58627468|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
30616612|NCT01072149|58627469|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
30616613|NCT01072149|58627470|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
30616614|NCT01072149|58627471|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
30616615|NCT01072149|58627472|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
30616616|NCT01072149|58627473|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
30616617|NCT01072149|58627474|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
30616618|NCT01072149|58627475|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
30616619|NCT01072149|58627476|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
30616620|NCT01072149|58627477|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
30616621|NCT01072149|58627460|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616622|NCT01072149|58627461|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616623|NCT01072149|58627462|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616624|NCT01072149|58627463|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616625|NCT01072149|58627464|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616626|NCT01072149|58627465|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616627|NCT01072149|58627466|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616628|NCT01072149|58627467|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616629|NCT01072149|58627468|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616630|NCT01072149|58627469|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616631|NCT01072149|58627470|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616632|NCT01072149|58627471|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616633|NCT01072149|58627472|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616634|NCT01072149|58627473|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616635|NCT01072149|58627474|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616636|NCT01072149|58627475|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
30616637|NCT01072149|58627476|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
30616638|NCT01072149|58627477|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
31010262|NCT01385748|59211647|FG002|Overall Study|Withdrawal by Subject|5|||
31010263|NCT01385748|59211645|FG000|Overall Study|Noncompliance|3|||
31010264|NCT01385748|59211646|FG001|Overall Study|Noncompliance|1|||
31010265|NCT01385748|59211647|FG002|Overall Study|Noncompliance|6|||
31010266|NCT01385748|59211645|FG000|Overall Study|Other|1|||
31010267|NCT01385748|59211646|FG001|Overall Study|Other|7|||
31010268|NCT01385748|59211647|FG002|Overall Study|Other|1|||
31010269|NCT01385748|59211645|FG000|Overall Study|Adverse Event|4|||
31010270|NCT01385748|59211646|FG001|Overall Study|Adverse Event|2|||
31010271|NCT01385748|59211647|FG002|Overall Study|Adverse Event|1|||
31010272|NCT01397448|59211662|FG000|Overall Study|Adverse Event|4|||
31010273|NCT01397448|59211663|FG001|Overall Study|Adverse Event|4|||
31010274|NCT01397448|59211664|FG002|Overall Study|Adverse Event|6|||
31010275|NCT01397448|59211662|FG000|Overall Study|Withdrawal by Subject|4|||
31010276|NCT01397448|59211663|FG001|Overall Study|Withdrawal by Subject|4|||
31010277|NCT01397448|59211664|FG002|Overall Study|Withdrawal by Subject|3|||
31010278|NCT01397448|59211662|FG000|Overall Study|Lack of Efficacy|2|||
31010279|NCT01397448|59211663|FG001|Overall Study|Lack of Efficacy|0|||
31010280|NCT01397448|59211664|FG002|Overall Study|Lack of Efficacy|5|||
31010281|NCT01397448|59211662|FG000|Overall Study|Other|8|||
31010282|NCT01397448|59211663|FG001|Overall Study|Other|7|||
30616639|NCT01072149|58627460|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
30616640|NCT01072149|58627461|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
30616641|NCT01072149|58627462|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
30616642|NCT01072149|58627463|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
30616643|NCT01072149|58627464|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
30616644|NCT01072149|58627465|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
30616645|NCT01072149|58627466|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
30616646|NCT01072149|58627467|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
30616647|NCT01072149|58627468|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
31010283|NCT01397448|59211664|FG002|Overall Study|Other|4|||
31010284|NCT01385202|59211672|FG000|Overall Study|Lost to Follow-up|6|||
31010285|NCT01385202|59211672|FG000|Overall Study|Not Eligible|11|||
31010286|NCT01385202|59211672|FG000|Overall Study|Withdrawn|1|||
31010287|NCT01384734|59211683|FG000|Overall Study|Adverse Event|0|||
31010288|NCT01384734|59211684|FG001|Overall Study|Adverse Event|3|||
31010289|NCT01384734|59211685|FG002|Overall Study|Adverse Event|0|||
31010290|NCT01384734|59211686|FG003|Overall Study|Adverse Event|2|||
31010291|NCT01384734|59211687|FG004|Overall Study|Adverse Event|7|||
31010292|NCT01384734|59211683|FG000|Overall Study|Death|1|||
31010293|NCT01384734|59211684|FG001|Overall Study|Death|0|||
30616648|NCT01072149|58627469|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
31010294|NCT01384734|59211685|FG002|Overall Study|Death|1|||
31010295|NCT01384734|59211686|FG003|Overall Study|Death|0|||
30616649|NCT01072149|58627470|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
30616650|NCT01072149|58627471|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
31010296|NCT01384734|59211687|FG004|Overall Study|Death|0|||
31010297|NCT01384734|59211683|FG000|Overall Study|Continuation criteria not met|0|||
31010298|NCT01384734|59211684|FG001|Overall Study|Continuation criteria not met|0|||
31010299|NCT01384734|59211685|FG002|Overall Study|Continuation criteria not met|1|||
31010300|NCT01384734|59211686|FG003|Overall Study|Continuation criteria not met|1|||
31010301|NCT01384734|59211687|FG004|Overall Study|Continuation criteria not met|0|||
31010302|NCT01384734|59211683|FG000|Overall Study|Lack of Efficacy|3|||
31010303|NCT01384734|59211684|FG001|Overall Study|Lack of Efficacy|7|||
31010304|NCT01384734|59211685|FG002|Overall Study|Lack of Efficacy|4|||
31010305|NCT01384734|59211686|FG003|Overall Study|Lack of Efficacy|4|||
31010306|NCT01384734|59211687|FG004|Overall Study|Lack of Efficacy|2|||
31010307|NCT01384734|59211683|FG000|Overall Study|Lost to Follow-up|5|||
31010308|NCT01384734|59211684|FG001|Overall Study|Lost to Follow-up|3|||
31010309|NCT01384734|59211685|FG002|Overall Study|Lost to Follow-up|3|||
31010310|NCT01384734|59211686|FG003|Overall Study|Lost to Follow-up|8|||
31010311|NCT01384734|59211687|FG004|Overall Study|Lost to Follow-up|5|||
31010312|NCT01384734|59211683|FG000|Overall Study|Non-compliance with study drug|1|||
31010313|NCT01384734|59211684|FG001|Overall Study|Non-compliance with study drug|2|||
31010314|NCT01384734|59211685|FG002|Overall Study|Non-compliance with study drug|6|||
31010315|NCT01384734|59211686|FG003|Overall Study|Non-compliance with study drug|0|||
31010316|NCT01384734|59211687|FG004|Overall Study|Non-compliance with study drug|2|||
31010317|NCT01384734|59211683|FG000|Overall Study|Pregnancy|0|||
31010318|NCT01384734|59211684|FG001|Overall Study|Pregnancy|1|||
31010319|NCT01384734|59211685|FG002|Overall Study|Pregnancy|0|||
31010320|NCT01384734|59211686|FG003|Overall Study|Pregnancy|0|||
31010321|NCT01384734|59211687|FG004|Overall Study|Pregnancy|1|||
31010322|NCT01384734|59211683|FG000|Overall Study|Sponsor terminated|0|||
31010323|NCT01384734|59211684|FG001|Overall Study|Sponsor terminated|0|||
31010324|NCT01384734|59211685|FG002|Overall Study|Sponsor terminated|0|||
31010325|NCT01384734|59211686|FG003|Overall Study|Sponsor terminated|0|||
31010326|NCT01384734|59211687|FG004|Overall Study|Sponsor terminated|1|||
31010327|NCT01384734|59211683|FG000|Overall Study|Withdrawal by Subject|5|||
31010328|NCT01384734|59211684|FG001|Overall Study|Withdrawal by Subject|5|||
31010329|NCT01384734|59211685|FG002|Overall Study|Withdrawal by Subject|6|||
31010330|NCT01384734|59211686|FG003|Overall Study|Withdrawal by Subject|7|||
31010331|NCT01384734|59211687|FG004|Overall Study|Withdrawal by Subject|9|||
31010332|NCT01384734|59211683|FG000|Overall Study|Investigator relocating|0|||
31010333|NCT01384734|59211684|FG001|Overall Study|Investigator relocating|2|||
31010334|NCT01384734|59211685|FG002|Overall Study|Investigator relocating|0|||
31010335|NCT01384734|59211686|FG003|Overall Study|Investigator relocating|3|||
31010336|NCT01384734|59211687|FG004|Overall Study|Investigator relocating|1|||
31010337|NCT01384734|59211683|FG000|Overall Study|Unable to come back for visit|1|||
31010338|NCT01384734|59211684|FG001|Overall Study|Unable to come back for visit|0|||
31010339|NCT01384734|59211685|FG002|Overall Study|Unable to come back for visit|1|||
31010340|NCT01384734|59211686|FG003|Overall Study|Unable to come back for visit|1|||
31010341|NCT01384734|59211687|FG004|Overall Study|Unable to come back for visit|0|||
31010342|NCT01384734|59211683|FG000|Overall Study|Prison|0|||
31010343|NCT01384734|59211684|FG001|Overall Study|Prison|0|||
30616651|NCT01072149|58627472|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
30616652|NCT01072149|58627473|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
30616653|NCT01072149|58627474|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
30616654|NCT01072149|58627475|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
30616655|NCT01072149|58627476|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
30616656|NCT01072149|58627477|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
30616657|NCT01072149|58627460|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616658|NCT01072149|58627461|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616659|NCT01072149|58627462|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616660|NCT01072149|58627463|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616661|NCT01072149|58627464|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616662|NCT01072149|58627465|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616663|NCT01072149|58627466|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616664|NCT01072149|58627467|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616665|NCT01072149|58627468|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616666|NCT01072149|58627469|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616667|NCT01072149|58627470|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616668|NCT01072149|58627471|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616669|NCT01072149|58627472|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
30616670|NCT01072149|58627473|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616671|NCT01072149|58627474|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616672|NCT01072149|58627475|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616673|NCT01072149|58627476|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
31010344|NCT01384734|59211685|FG002|Overall Study|Prison|1|||
31010345|NCT01384734|59211686|FG003|Overall Study|Prison|0|||
31010346|NCT01384734|59211687|FG004|Overall Study|Prison|0|||
31010347|NCT01384734|59211683|FG000|Overall Study|As per Exclusion criteria|0|||
31010348|NCT01384734|59211684|FG001|Overall Study|As per Exclusion criteria|1|||
31010349|NCT01384734|59211685|FG002|Overall Study|As per Exclusion criteria|0|||
30616674|NCT01072149|58627477|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
30616675|NCT01072149|58627460|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
31010350|NCT01384734|59211686|FG003|Overall Study|As per Exclusion criteria|0|||
31010351|NCT01384734|59211687|FG004|Overall Study|As per Exclusion criteria|0|||
31010352|NCT01384734|59211683|FG000|Overall Study|Missed End of treatment visit|0|||
31010353|NCT01384734|59211684|FG001|Overall Study|Missed End of treatment visit|0|||
31010354|NCT01384734|59211685|FG002|Overall Study|Missed End of treatment visit|0|||
30616676|NCT01072149|58627461|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616677|NCT01072149|58627462|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
30616678|NCT01072149|58627463|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616679|NCT01072149|58627464|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616680|NCT01072149|58627465|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616681|NCT01072149|58627466|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616682|NCT01072149|58627467|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616683|NCT01072149|58627468|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616684|NCT01072149|58627469|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616685|NCT01072149|58627470|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616686|NCT01072149|58627471|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616687|NCT01072149|58627472|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616688|NCT01072149|58627473|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
30616689|NCT01072149|58627474|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616690|NCT01072149|58627475|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616691|NCT01072149|58627476|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616692|NCT01072149|58627477|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
30616693|NCT01071915|58627487|FG000|Overall Study|Adverse Event|3|||
30616694|NCT01071915|58627487|FG000|Overall Study|Physician Decision|2|||
30616695|NCT01071915|58627487|FG000|Overall Study|Withdrawal by Subject|2|||
30616696|NCT01071915|58627487|FG000|Overall Study|Miscellaneous Reasons|2|||
30616697|NCT00904969|58627491|FG000|Overall Study|Lost to Follow-up|4|||
30616698|NCT00904969|58627491|FG000|Overall Study|Withdrawal by Subject|3|||
30616699|NCT00904969|58627491|FG000|Overall Study|Additional Treatments|11|||
30616700|NCT00904969|58627491|FG000|Overall Study|Case Aborted; Subject Exited|1|||
30616701|NCT01070979|58627513|FG000|Overall Study|Adverse Event|2|||
30616702|NCT01070979|58627514|FG001|Overall Study|Adverse Event|3|||
30616703|NCT01070979|58627515|FG002|Overall Study|Adverse Event|3|||
30616704|NCT01070979|58627513|FG000|Overall Study|Lost to Follow-up|2|||
30616705|NCT01070979|58627514|FG001|Overall Study|Lost to Follow-up|1|||
30616706|NCT01070979|58627515|FG002|Overall Study|Lost to Follow-up|1|||
30616707|NCT01070979|58627513|FG000|Overall Study|Protocol Violation|0|||
30616708|NCT01070979|58627514|FG001|Overall Study|Protocol Violation|2|||
30616709|NCT01070979|58627515|FG002|Overall Study|Protocol Violation|6|||
30616710|NCT01070979|58627513|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
30616711|NCT01070979|58627514|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
30616712|NCT01070979|58627515|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
30616713|NCT01070979|58627513|FG000|Overall Study|Withdrawal by Subject|3|||
30616714|NCT01070979|58627514|FG001|Overall Study|Withdrawal by Subject|1|||
30616715|NCT01070979|58627515|FG002|Overall Study|Withdrawal by Subject|1|||
30616716|NCT01070979|58627513|FG000|Overall Study|No study drug taken|0|||
30616717|NCT01070979|58627514|FG001|Overall Study|No study drug taken|1|||
30616718|NCT01070979|58627515|FG002|Overall Study|No study drug taken|0|||
30616719|NCT01234337|58627525|FG000|Overall Study|Adverse Event|58|||
30616720|NCT01234337|58627526|FG001|Overall Study|Adverse Event|21|||
30616721|NCT01234337|58627525|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
30616722|NCT01234337|58627526|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
30616723|NCT01234337|58627525|FG000|Overall Study|Investi. decision not protocol driven|5|||
30616724|NCT01234337|58627526|FG001|Overall Study|Investi. decision not protocol driven|6|||
30616725|NCT01234337|58627525|FG000|Overall Study|Non-compliant with study medication|3|||
30616726|NCT01234337|58627526|FG001|Overall Study|Non-compliant with study medication|2|||
30616727|NCT01234337|58627525|FG000|Overall Study|Randomized but not treated|6|||
30616728|NCT01234337|58627526|FG001|Overall Study|Randomized but not treated|4|||
30616729|NCT01234337|58627525|FG000|Overall Study|Lost to Follow-up|0|||
30699304|NCT00550407|58713847|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
30699305|NCT00550407|58713848|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
30699306|NCT00550407|58713846|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
30699307|NCT00550407|58713847|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
30699308|NCT00550407|58713848|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
30699309|NCT00550407|58713846|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
30699310|NCT00550407|58713847|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
30699311|NCT00550407|58713848|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
30699312|NCT00550407|58713846|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
30699313|NCT00550407|58713847|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
30699314|NCT00550407|58713848|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
30616730|NCT01234337|58627526|FG001|Overall Study|Lost to Follow-up|1|||
30616731|NCT01234337|58627525|FG000|Overall Study|Protocol Violation|2|||
30616732|NCT01234337|58627526|FG001|Overall Study|Protocol Violation|3|||
30616733|NCT01234337|58627525|FG000|Overall Study|Withdrawal by Subject|11|||
30616734|NCT01234337|58627526|FG001|Overall Study|Withdrawal by Subject|9|||
30616735|NCT01234337|58627525|FG000|Overall Study|Death|0|||
30616736|NCT01234337|58627526|FG001|Overall Study|Death|1|||
30616737|NCT01234337|58627525|FG000|Overall Study|Switch to commercial drug|0|||
30616738|NCT01234337|58627526|FG001|Overall Study|Switch to commercial drug|1|||
30616739|NCT01070043|58627534|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
30616740|NCT01070043|58627535|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
30616741|NCT01070043|58627536|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
30616742|NCT01070043|58627534|FG000|Double-Blind Treatment|Adverse Event|0|||
30616743|NCT01070043|58627535|FG001|Double-Blind Treatment|Adverse Event|0|||
30616744|NCT01070043|58627536|FG002|Double-Blind Treatment|Adverse Event|2|||
30616745|NCT01074255|58627542|FG000|Overall Study|Did not receive EMEND|2|||
30616746|NCT01073943|58627548|FG000|Overall Study|Withdrawal by Subject|8|||
30616747|NCT01073943|58627549|FG001|Overall Study|Withdrawal by Subject|2|||
31010355|NCT01384734|59211686|FG003|Overall Study|Missed End of treatment visit|1|||
31010356|NCT01384734|59211687|FG004|Overall Study|Missed End of treatment visit|0|||
31010357|NCT01384734|59211683|FG000|Overall Study|Adhesion problem|0|||
31010358|NCT01384734|59211684|FG001|Overall Study|Adhesion problem|0|||
31010359|NCT01384734|59211685|FG002|Overall Study|Adhesion problem|0|||
31010360|NCT01384734|59211686|FG003|Overall Study|Adhesion problem|1|||
31010361|NCT01384734|59211687|FG004|Overall Study|Adhesion problem|0|||
31010362|NCT01384734|59211683|FG000|Overall Study|Early termination|0|||
31010363|NCT01384734|59211684|FG001|Overall Study|Early termination|0|||
31010364|NCT01384734|59211685|FG002|Overall Study|Early termination|0|||
31010365|NCT01384734|59211686|FG003|Overall Study|Early termination|0|||
31010366|NCT01384734|59211687|FG004|Overall Study|Early termination|1|||
31010367|NCT01384734|59211683|FG000|Overall Study|Physician Decision|1|||
31010368|NCT01384734|59211684|FG001|Overall Study|Physician Decision|0|||
31010369|NCT01384734|59211685|FG002|Overall Study|Physician Decision|0|||
31010370|NCT01384734|59211686|FG003|Overall Study|Physician Decision|0|||
31010371|NCT01384734|59211687|FG004|Overall Study|Physician Decision|0|||
31010372|NCT01396512|59211698|FG000|Overall Study|Withdrawal by Subject|0|||
31010373|NCT01396512|59211699|FG001|Overall Study|Withdrawal by Subject|1|||
31010374|NCT01396434|59211708|FG000|Overall Study|Lost to Follow-up|1|||
31010375|NCT01396434|59211709|FG001|Overall Study|Lost to Follow-up|0|||
31010376|NCT01396434|59211710|FG002|Overall Study|Lost to Follow-up|0|||
31010377|NCT01396434|59211708|FG000|Overall Study|Other|10|||
31010378|NCT01396434|59211709|FG001|Overall Study|Other|0|||
31010379|NCT01396434|59211710|FG002|Overall Study|Other|0|||
31010380|NCT01383954|59211718|FG000|Overall Study|Lack of Efficacy|2|||
31010381|NCT01383954|59211718|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
30616748|NCT01073943|58627548|FG000|Overall Study|Protocol Violation|2|||
30616749|NCT01073943|58627549|FG001|Overall Study|Protocol Violation|1|||
30616750|NCT01073943|58627548|FG000|Overall Study|Adverse Event|1|||
30616751|NCT01073943|58627549|FG001|Overall Study|Adverse Event|1|||
30616752|NCT01073943|58627548|FG000|Overall Study|Lost to Follow-up|0|||
30616753|NCT01073943|58627549|FG001|Overall Study|Lost to Follow-up|2|||
30616754|NCT01073943|58627548|FG000|Overall Study|Power outage; colonoscopy not done|1|||
30616755|NCT01073943|58627549|FG001|Overall Study|Power outage; colonoscopy not done|0|||
30616756|NCT01073943|58627548|FG000|Overall Study|Subject forgot|0|||
30616757|NCT01073943|58627549|FG001|Overall Study|Subject forgot|1|||
30616758|NCT01073943|58627548|FG000|Overall Study|Unable to return for follow-up|0|||
30616759|NCT01073943|58627549|FG001|Overall Study|Unable to return for follow-up|1|||
30616760|NCT01073943|58627548|FG000|Overall Study|Could not tolerate prep|1|||
30616761|NCT01073943|58627549|FG001|Overall Study|Could not tolerate prep|0|||
30616762|NCT01073865|58627557|FG000|Overall Study|Reasons other than below|19|||
30616763|NCT01073865|58627558|FG001|Overall Study|Reasons other than below|31|||
30616764|NCT01073865|58627557|FG000|Overall Study|Lost to Follow-up|1|||
30616765|NCT01073865|58627558|FG001|Overall Study|Lost to Follow-up|1|||
30616766|NCT01073865|58627557|FG000|Overall Study|Death|3|||
30699315|NCT00550407|58713846|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
31010382|NCT01383954|59211718|FG000|Overall Study|Adverse Event|1|||
31010383|NCT01383954|59211718|FG000|Overall Study|Reason Not Specified|9|||
31010384|NCT01383486|59211722|FG000|Overall Study|Lost to Follow-up|10|||
31010385|NCT01383486|59211722|FG000|Overall Study|Incomplete information for analysis|2|||
30616767|NCT01073865|58627558|FG001|Overall Study|Death|2|||
30616768|NCT01073865|58627557|FG000|Overall Study|Withdrawal by Subject|5|||
31010386|NCT01383486|59211722|FG000|Overall Study|Did not take any product|6|||
31010387|NCT01383174|59211729|FG000|3 Month Assessment|Death|0|||
31010388|NCT01383174|59211730|FG001|3 Month Assessment|Death|1|||
31010389|NCT01383174|59211729|FG000|3 Month Assessment|Lost to Follow-up|2|||
31010390|NCT01383174|59211730|FG001|3 Month Assessment|Lost to Follow-up|0|||
30616769|NCT01073865|58627558|FG001|Overall Study|Withdrawal by Subject|5|||
30616770|NCT04862065|58627567|FG000|Screening|Protocol Violation|54|||
30616771|NCT04862065|58627568|FG001|Screening|Protocol Violation|0|||
31010391|NCT01383174|59211729|FG000|3 Month Assessment|Refused to complete|4|||
30616772|NCT04862065|58627569|FG002|Screening|Protocol Violation|0|||
30616773|NCT04862065|58627567|FG000|Screening|Insufficient Sample|1|||
30616774|NCT04862065|58627568|FG001|Screening|Insufficient Sample|0|||
30616775|NCT04862065|58627569|FG002|Screening|Insufficient Sample|0|||
30616776|NCT04862065|58627567|FG000|Follow-Up|Lost to Follow-up|3|||
30616777|NCT04862065|58627568|FG001|Follow-Up|Lost to Follow-up|0|||
30616778|NCT04862065|58627569|FG002|Follow-Up|Lost to Follow-up|0|||
30616779|NCT01073631|58627575|FG000|Overall Study|Death|82|||
30616780|NCT01073631|58627575|FG000|Overall Study|Adverse Event|24|||
30616781|NCT01073631|58627575|FG000|Overall Study|Other|63|||
30616782|NCT01073163|58627579|FG000|Overall Study|Adverse Event|1|||
30616783|NCT01073163|58627579|FG000|Overall Study|Disease Progression|1|||
30616784|NCT01073163|58627579|FG000|Overall Study|Early termination|1|||
30616785|NCT01072929|58627590|FG000|Overall Study|Adverse Event|8|||
30616786|NCT01072929|58627591|FG001|Overall Study|Adverse Event|11|||
30616787|NCT01072929|58627592|FG002|Overall Study|Adverse Event|2|||
30616788|NCT01072929|58627590|FG000|Overall Study|Lack of Efficacy|7|||
30616789|NCT01072929|58627591|FG001|Overall Study|Lack of Efficacy|4|||
30616790|NCT01072929|58627592|FG002|Overall Study|Lack of Efficacy|0|||
30616791|NCT01072929|58627590|FG000|Overall Study|Withdrawal by Subject|7|||
30616792|NCT01072929|58627591|FG001|Overall Study|Withdrawal by Subject|15|||
30616793|NCT01072929|58627592|FG002|Overall Study|Withdrawal by Subject|3|||
30616794|NCT01072929|58627590|FG000|Overall Study|Protocol Violation|13|||
30616795|NCT01072929|58627591|FG001|Overall Study|Protocol Violation|11|||
30616796|NCT01072929|58627592|FG002|Overall Study|Protocol Violation|2|||
30616797|NCT01072929|58627590|FG000|Overall Study|Lost to Follow-up|8|||
30616798|NCT01072929|58627591|FG001|Overall Study|Lost to Follow-up|4|||
30616799|NCT01072929|58627592|FG002|Overall Study|Lost to Follow-up|1|||
30616800|NCT01072929|58627590|FG000|Overall Study|Noncompliance with study medication|0|||
30616801|NCT01072929|58627591|FG001|Overall Study|Noncompliance with study medication|3|||
30616802|NCT01072929|58627592|FG002|Overall Study|Noncompliance with study medication|0|||
30616803|NCT01072929|58627590|FG000|Overall Study|Noncompliance with study procedures|1|||
30616804|NCT01072929|58627591|FG001|Overall Study|Noncompliance with study procedures|0|||
30616805|NCT01072929|58627592|FG002|Overall Study|Noncompliance with study procedures|1|||
30616806|NCT01072929|58627590|FG000|Overall Study|Other|0|||
30616807|NCT01072929|58627591|FG001|Overall Study|Other|3|||
30616808|NCT01072929|58627592|FG002|Overall Study|Other|0|||
30616809|NCT01231607|58627606|FG000|Overall Study|Adverse Event|0|||
30616810|NCT01231607|58627607|FG001|Overall Study|Adverse Event|8|||
30616811|NCT01231607|58627608|FG002|Overall Study|Adverse Event|4|||
30616812|NCT01231607|58627609|FG003|Overall Study|Adverse Event|4|||
30616813|NCT01231607|58627610|FG004|Overall Study|Adverse Event|5|||
30616814|NCT01231607|58627606|FG000|Overall Study|Lost to Follow-up|13|||
30616815|NCT01231607|58627607|FG001|Overall Study|Lost to Follow-up|11|||
30616816|NCT01231607|58627608|FG002|Overall Study|Lost to Follow-up|10|||
30616817|NCT01231607|58627609|FG003|Overall Study|Lost to Follow-up|10|||
30616818|NCT01231607|58627610|FG004|Overall Study|Lost to Follow-up|4|||
30616819|NCT01231607|58627606|FG000|Overall Study|Physician Decision|4|||
30616820|NCT01231607|58627607|FG001|Overall Study|Physician Decision|4|||
30616821|NCT01231607|58627608|FG002|Overall Study|Physician Decision|3|||
30616822|NCT01231607|58627609|FG003|Overall Study|Physician Decision|5|||
30616823|NCT01231607|58627610|FG004|Overall Study|Physician Decision|4|||
30616824|NCT01231607|58627606|FG000|Overall Study|Protocol Violation|3|||
30616825|NCT01231607|58627607|FG001|Overall Study|Protocol Violation|2|||
30616826|NCT01231607|58627608|FG002|Overall Study|Protocol Violation|0|||
30616827|NCT01231607|58627609|FG003|Overall Study|Protocol Violation|2|||
30616828|NCT01231607|58627610|FG004|Overall Study|Protocol Violation|2|||
30616829|NCT01231607|58627606|FG000|Overall Study|Withdrawal by Subject|9|||
30616830|NCT01231607|58627607|FG001|Overall Study|Withdrawal by Subject|9|||
30616831|NCT01231607|58627608|FG002|Overall Study|Withdrawal by Subject|14|||
30616832|NCT01231607|58627609|FG003|Overall Study|Withdrawal by Subject|17|||
30616833|NCT01231607|58627610|FG004|Overall Study|Withdrawal by Subject|9|||
30616834|NCT01231373|58627629|FG000|Overall Study|Withdrew consent prior to randomization|2|||
30616835|NCT01231373|58627630|FG001|Overall Study|Withdrew consent prior to randomization|1|||
30616836|NCT01231373|58627631|FG002|Overall Study|Withdrew consent prior to randomization|0|||
30616837|NCT01231373|58627632|FG003|Overall Study|Withdrew consent prior to randomization|0|||
30616838|NCT01231373|58627629|FG000|Overall Study|Lost to Follow-up|0|||
30616839|NCT01231373|58627630|FG001|Overall Study|Lost to Follow-up|0|||
30616840|NCT01231373|58627631|FG002|Overall Study|Lost to Follow-up|0|||
30616841|NCT01231373|58627632|FG003|Overall Study|Lost to Follow-up|1|||
30616842|NCT01231373|58627629|FG000|Overall Study|Withdrew Consent|1|||
30616843|NCT01231373|58627630|FG001|Overall Study|Withdrew Consent|0|||
30616844|NCT01231373|58627631|FG002|Overall Study|Withdrew Consent|0|||
30616845|NCT01231373|58627632|FG003|Overall Study|Withdrew Consent|0|||
30616846|NCT00975130|58627644|FG000|Study Part 1|Adverse Event|150|||
30616847|NCT00975130|58627645|FG001|Study Part 1|Adverse Event|0|||
30893198|NCT02337361|58926635|FG001|3-month Follow-up|Lost to Follow-up|14|||
30616848|NCT00975130|58627646|FG002|Study Part 1|Adverse Event|0|||
30616849|NCT00975130|58627644|FG000|Study Part 1|Lost to Follow-up|19|||
31010392|NCT01383174|59211730|FG001|3 Month Assessment|Refused to complete|0|||
31010393|NCT01383174|59211729|FG000|6 Month Assessment|Lost to Follow-up|1|||
31010394|NCT01383174|59211730|FG001|6 Month Assessment|Lost to Follow-up|1|||
31010395|NCT01383174|59211729|FG000|6 Month Assessment|Refused to complete|4|||
31010396|NCT01383174|59211730|FG001|6 Month Assessment|Refused to complete|0|||
31010397|NCT01396278|59211741|FG000|Overall Study|Adverse Event|0|||
31010398|NCT01396278|59211742|FG001|Overall Study|Adverse Event|0|||
31010399|NCT01396278|59211743|FG002|Overall Study|Adverse Event|0|||
31010400|NCT01396278|59211744|FG003|Overall Study|Adverse Event|2|||
31010401|NCT01396278|59211745|FG004|Overall Study|Adverse Event|0|||
31010402|NCT01396278|59211741|FG000|Overall Study|Withdraw due to trial termination|2|||
31010403|NCT01396278|59211742|FG001|Overall Study|Withdraw due to trial termination|1|||
31010404|NCT01396278|59211743|FG002|Overall Study|Withdraw due to trial termination|1|||
31010405|NCT01396278|59211744|FG003|Overall Study|Withdraw due to trial termination|0|||
31010406|NCT01396278|59211745|FG004|Overall Study|Withdraw due to trial termination|2|||
31010407|NCT01383096|59211760|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
31010408|NCT01383096|59211761|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
31010409|NCT01383096|59211762|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
31010410|NCT01383096|59211760|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
31010411|NCT01383096|59211761|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
31010412|NCT01383096|59211762|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
31010413|NCT01383096|59211760|FG000|Third Intervention (8 Days)|Elevated AST|0|||
31010414|NCT01383096|59211761|FG001|Third Intervention (8 Days)|Elevated AST|1|||
31010415|NCT01383096|59211762|FG002|Third Intervention (8 Days)|Elevated AST|0|||
31010416|NCT01383096|59211760|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
31010417|NCT01383096|59211761|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
31010418|NCT01383096|59211762|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
31010419|NCT01383096|59211760|FG000|Third Intervention (8 Days)|Adverse Event|1|||
31010420|NCT01383096|59211761|FG001|Third Intervention (8 Days)|Adverse Event|0|||
31010421|NCT01383096|59211762|FG002|Third Intervention (8 Days)|Adverse Event|0|||
31010422|NCT01383096|59211760|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
31010423|NCT01383096|59211761|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
31010424|NCT01383096|59211762|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
31010425|NCT01383096|59211760|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
31010426|NCT01383096|59211761|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
31010427|NCT01383096|59211762|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
31010428|NCT01383096|59211760|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
31010429|NCT01383096|59211761|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
31010430|NCT01383096|59211762|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
31010431|NCT01383096|59211760|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
31010432|NCT01383096|59211761|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
31010433|NCT01383096|59211762|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
31010434|NCT01383096|59211760|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
31010435|NCT01383096|59211761|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
31010436|NCT01383096|59211762|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
31010437|NCT01383096|59211760|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
31010438|NCT01383096|59211761|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
31010439|NCT01383096|59211762|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
31010440|NCT01383018|59211799|FG000|Overall Study|Adverse Event|14|||
31010441|NCT01383018|59211799|FG000|Overall Study|Death|10|||
31010442|NCT01383018|59211799|FG000|Overall Study|Lost to Follow-up|5|||
31010443|NCT01383018|59211799|FG000|Overall Study|Physician Decision|5|||
31010444|NCT01383018|59211799|FG000|Overall Study|Withdrawal by Subject|9|||
31010445|NCT01383018|59211799|FG000|Overall Study|Subject not implanted|76|||
31010446|NCT01383018|59211799|FG000|Overall Study|Missed Visit|247|||
31010447|NCT01383018|59211799|FG000|Overall Study|Site closed early-not compliance related|7|||
31010448|NCT01383018|59211799|FG000|Overall Study|Patient moved away from site|1|||
31010449|NCT01383018|59211799|FG000|Overall Study|Subject Incarcerated|1|||
31010450|NCT01382940|59211813|FG000|Overall Study|Adverse Event|19|||
31010451|NCT01382940|59211813|FG000|Overall Study|Lost to Follow-up|4|||
31010452|NCT01382940|59211813|FG000|Overall Study|Physician Decision|7|||
31010453|NCT01382940|59211813|FG000|Overall Study|Withdrawal by Subject|23|||
31010454|NCT01382940|59211813|FG000|Overall Study|Protocol Violation|20|||
31010455|NCT01381926|59211819|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
31010456|NCT01381926|59211820|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
31010457|NCT01381926|59211819|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
31010458|NCT01381926|59211820|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
31010459|NCT01395888|59211830|FG000|2-week Run-in Period|Adverse Event|2|||
31010460|NCT01395888|59211831|FG001|2-week Run-in Period|Adverse Event|0|||
31010461|NCT01395888|59211832|FG002|2-week Run-in Period|Adverse Event|0|||
31010462|NCT01395888|59211830|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
31010463|NCT01395888|59211831|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
31010464|NCT01395888|59211832|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
31010465|NCT01395888|59211830|FG000|2-week Run-in Period|Lost to Follow-up|1|||
31010466|NCT01395888|59211831|FG001|2-week Run-in Period|Lost to Follow-up|0|||
31010467|NCT01395888|59211832|FG002|2-week Run-in Period|Lost to Follow-up|0|||
31010468|NCT01395888|59211830|FG000|2-week Run-in Period|Protocol Violation|2|||
31010469|NCT01395888|59211831|FG001|2-week Run-in Period|Protocol Violation|0|||
31010470|NCT01395888|59211832|FG002|2-week Run-in Period|Protocol Violation|0|||
31010471|NCT01395888|59211830|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
31010472|NCT01395888|59211831|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
31010473|NCT01395888|59211832|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
31010474|NCT01395888|59211830|FG000|Treatment Period (TP)|Adverse Event|0|||
31010475|NCT01395888|59211831|FG001|Treatment Period (TP)|Adverse Event|7|||
31010476|NCT01395888|59211832|FG002|Treatment Period (TP)|Adverse Event|6|||
31010477|NCT01395888|59211830|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
31010478|NCT01395888|59211831|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
31010479|NCT01395888|59211832|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
31010480|NCT01395888|59211830|FG000|Treatment Period (TP)|Protocol Violation|0|||
31010481|NCT01395888|59211831|FG001|Treatment Period (TP)|Protocol Violation|1|||
31010482|NCT01395888|59211832|FG002|Treatment Period (TP)|Protocol Violation|5|||
30699316|NCT00550407|58713847|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
30893199|NCT02337361|58926634|FG000|6-month Follow-up|Lost to Follow-up|2|||
30893200|NCT02337361|58926635|FG001|6-month Follow-up|Lost to Follow-up|4|||
30893201|NCT02336737|58926642|FG000|Overall Study|Withdrawal by Subject|5|||
30893202|NCT02336737|58926642|FG000|Overall Study|Physician Decision|8|||
31010483|NCT01395888|59211830|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
31010484|NCT01395888|59211831|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
30699317|NCT00550407|58713848|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
30699318|NCT00550407|58713846|FG000|26-Week Randomized Phase|Adverse Event|0|||
30699319|NCT00550407|58713847|FG001|26-Week Randomized Phase|Adverse Event|5|||
30699320|NCT00550407|58713848|FG002|26-Week Randomized Phase|Adverse Event|2|||
30699321|NCT00550407|58713846|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
30699322|NCT00550407|58713847|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
30699323|NCT00550407|58713848|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
30699324|NCT00550407|58713846|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
30699325|NCT00550407|58713847|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
30616850|NCT00975130|58627645|FG001|Study Part 1|Lost to Follow-up|0|||
30616851|NCT00975130|58627646|FG002|Study Part 1|Lost to Follow-up|0|||
30616852|NCT00975130|58627644|FG000|Study Part 1|Withdrawal by Subject|61|||
30616853|NCT00975130|58627645|FG001|Study Part 1|Withdrawal by Subject|0|||
30616854|NCT00975130|58627646|FG002|Study Part 1|Withdrawal by Subject|0|||
30616855|NCT00975130|58627644|FG000|Study Part 1|Protocol Violation|13|||
30616856|NCT00975130|58627645|FG001|Study Part 1|Protocol Violation|0|||
30616857|NCT00975130|58627646|FG002|Study Part 1|Protocol Violation|0|||
30616858|NCT00975130|58627644|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
30616859|NCT00975130|58627645|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
30616860|NCT00975130|58627646|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
30616861|NCT00975130|58627644|FG000|Study Part 1|Administrative|4|||
30616862|NCT00975130|58627645|FG001|Study Part 1|Administrative|0|||
30699326|NCT00550407|58713848|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
30699327|NCT00550407|58713846|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
30790784|NCT03524092|58803941|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
31010485|NCT01395888|59211832|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
31010486|NCT01395888|59211830|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
31010487|NCT01395888|59211831|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
31010488|NCT01395888|59211832|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
31010489|NCT01395810|59211842|FG000|Overall Study|Adverse Event|0|||
31010490|NCT01395810|59211843|FG001|Overall Study|Adverse Event|1|||
31010491|NCT01395810|59211844|FG002|Overall Study|Adverse Event|0|||
31010492|NCT01395810|59211845|FG003|Overall Study|Adverse Event|0|||
30616863|NCT00975130|58627646|FG002|Study Part 1|Administrative|0|||
30616864|NCT00975130|58627644|FG000|Study Part 1|Withdrew Consent|24|||
30616865|NCT00975130|58627645|FG001|Study Part 1|Withdrew Consent|0|||
30616866|NCT00975130|58627646|FG002|Study Part 1|Withdrew Consent|0|||
30893203|NCT02130765|58926651|FG000|Overall Study|Did not receive treatment|4|||
31010493|NCT01395810|59211842|FG000|Overall Study|Lack of Efficacy|0|||
31010494|NCT01395810|59211843|FG001|Overall Study|Lack of Efficacy|1|||
31010495|NCT01395810|59211844|FG002|Overall Study|Lack of Efficacy|0|||
31010496|NCT01395810|59211845|FG003|Overall Study|Lack of Efficacy|0|||
31010497|NCT01395810|59211842|FG000|Overall Study|Withdrawal criteria|0|||
31010498|NCT01395810|59211843|FG001|Overall Study|Withdrawal criteria|2|||
30616867|NCT00975130|58627644|FG000|Study Part 2|Adverse Event|0|||
30616868|NCT00975130|58627645|FG001|Study Part 2|Adverse Event|14|||
31010499|NCT01395810|59211844|FG002|Overall Study|Withdrawal criteria|0|||
31010500|NCT01395810|59211845|FG003|Overall Study|Withdrawal criteria|0|||
31010501|NCT01395810|59211842|FG000|Overall Study|Unclassified|2|||
31010502|NCT01395810|59211843|FG001|Overall Study|Unclassified|0|||
31010503|NCT01395810|59211844|FG002|Overall Study|Unclassified|0|||
31010504|NCT01395810|59211845|FG003|Overall Study|Unclassified|0|||
31010505|NCT01381692|59211858|FG000|Overall Study|Adverse Event|1|||
31010506|NCT01381692|59211859|FG001|Overall Study|Adverse Event|0|||
31010507|NCT01381692|59211860|FG002|Overall Study|Adverse Event|0|||
31010508|NCT01381692|59211861|FG003|Overall Study|Adverse Event|0|||
31010509|NCT01381692|59211862|FG004|Overall Study|Adverse Event|0|||
31010510|NCT01381692|59211863|FG005|Overall Study|Adverse Event|0|||
31010511|NCT01395030|59211871|FG000|Overall Study|Did not complete FCH PET/CT|7|||
31010512|NCT01381068|59211879|FG000|Overall Study|Death|1|||
31010513|NCT01381068|59211880|FG001|Overall Study|Death|0|||
31010514|NCT01394952|59211888|FG000|Overall Study|Lost to Follow-up|0|||
31010515|NCT01394952|59211889|FG001|Overall Study|Lost to Follow-up|5|||
31010516|NCT01394952|59211888|FG000|Overall Study|Withdrawal by Subject|10|||
31010517|NCT01394952|59211889|FG001|Overall Study|Withdrawal by Subject|5|||
31010518|NCT01394952|59211888|FG000|Overall Study|Physician Decision|2|||
31010519|NCT01394952|59211889|FG001|Overall Study|Physician Decision|0|||
31010520|NCT01394952|59211888|FG000|Overall Study|Sponsor Decision|5|||
31010521|NCT01394952|59211889|FG001|Overall Study|Sponsor Decision|7|||
31010522|NCT01394718|59211897|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
31010523|NCT01394718|59211898|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
31010524|NCT01394250|59211906|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
31010525|NCT01394250|59211907|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
31010526|NCT01394250|59211906|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
31010527|NCT01394250|59211907|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
31010528|NCT01380990|59211915|FG000|Overall Study|Treatment Failure|1|||
31010529|NCT01380990|59211916|FG001|Overall Study|Treatment Failure|0|||
31010530|NCT01380990|59211915|FG000|Overall Study|Death|0|||
31010531|NCT01380990|59211916|FG001|Overall Study|Death|1|||
30616869|NCT00975130|58627646|FG002|Study Part 2|Adverse Event|7|||
31010532|NCT01380834|59211928|FG000|Overall Study|Physician Decision|1|||
31010533|NCT01380834|59211929|FG001|Overall Study|Physician Decision|0|||
31010534|NCT00214422|59211938|FG000|Overall Study|Physician Decision|2|||
31010535|NCT00214422|59211939|FG001|Overall Study|Physician Decision|0|||
31010536|NCT00214422|59211940|FG002|Overall Study|Physician Decision|0|||
31010537|NCT00214422|59211938|FG000|Overall Study|Developed esophageal ca|1|||
31010538|NCT00214422|59211939|FG001|Overall Study|Developed esophageal ca|0|||
31010539|NCT00214422|59211940|FG002|Overall Study|Developed esophageal ca|0|||
31010540|NCT00214422|59211938|FG000|Overall Study|Pt taken off study|1|||
31010541|NCT00214422|59211939|FG001|Overall Study|Pt taken off study|1|||
31010542|NCT00214422|59211940|FG002|Overall Study|Pt taken off study|0|||
31010543|NCT00214422|59211938|FG000|Overall Study|Disease progression on study|1|||
31010544|NCT00214422|59211939|FG001|Overall Study|Disease progression on study|0|||
31010545|NCT00214422|59211940|FG002|Overall Study|Disease progression on study|0|||
31010546|NCT00214422|59211938|FG000|Overall Study|Unable to make a radiation treatment|0|||
31010547|NCT00214422|59211939|FG001|Overall Study|Unable to make a radiation treatment|0|||
31010548|NCT00214422|59211940|FG002|Overall Study|Unable to make a radiation treatment|1|||
31010549|NCT00218634|59211954|FG000|Overall Study|Lost to Follow-up|8|||
31010550|NCT00218634|59211955|FG001|Overall Study|Lost to Follow-up|15|||
31010551|NCT00217620|59211964|FG000|Overall Study|Adverse Event|2|||
31010552|NCT00217620|59211964|FG000|Overall Study|Progression|31|||
31010553|NCT00217620|59211964|FG000|Overall Study|Not Protocol Specified|4|||
31010554|NCT00217620|59211964|FG000|Overall Study|Ineligible|13|||
31010555|NCT00217620|59211964|FG000|Overall Study|Never received treatment|1|||
31010556|NCT00217464|59211972|FG000|Overall Study|Progression|15|||
31010557|NCT00217464|59211972|FG000|Overall Study|Other|2|||
31010558|NCT00214500|59211976|FG000|Treatment Period|Adverse Event|1|||
31010559|NCT00214500|59211976|FG000|Extension Period|Withdrawal by Subject|2|||
31010560|NCT00211536|59211985|FG000|Overall Study|Withdrawal by Subject|2|||
31010561|NCT00211536|59211986|FG001|Overall Study|Withdrawal by Subject|2|||
31010562|NCT00211536|59211985|FG000|Overall Study|Physician Decision|0|||
31010563|NCT00211536|59211986|FG001|Overall Study|Physician Decision|5|||
31010564|NCT00211536|59211985|FG000|Overall Study|Adverse Event|2|||
31010565|NCT00211536|59211986|FG001|Overall Study|Adverse Event|0|||
31010566|NCT03192462|59212049|FG000|Overall Study|Death|13|||
31010567|NCT03192462|59212050|FG001|Overall Study|Death|11|||
31010568|NCT03192462|59212051|FG002|Overall Study|Death|9|||
31010569|NCT03192462|59212049|FG000|Overall Study|Lost to Follow-up|0|||
31010570|NCT03192462|59212050|FG001|Overall Study|Lost to Follow-up|1|||
31010571|NCT03192462|59212051|FG002|Overall Study|Lost to Follow-up|0|||
31010572|NCT03192462|59212049|FG000|Overall Study|On follow up|0|||
31010573|NCT03192462|59212050|FG001|Overall Study|On follow up|0|||
31010574|NCT03192462|59212051|FG002|Overall Study|On follow up|3|||
31010575|NCT03028740|59212074|FG000|Overall Study|Did not Receive Study Drug|4|||
31010576|NCT03028740|59212075|FG001|Overall Study|Did not Receive Study Drug|5|||
31010577|NCT03028740|59212074|FG000|Overall Study|Adverse Event|8|||
31010578|NCT03028740|59212075|FG001|Overall Study|Adverse Event|26|||
31010579|NCT03028740|59212074|FG000|Overall Study|Lack of Efficacy|0|||
31010580|NCT03028740|59212075|FG001|Overall Study|Lack of Efficacy|1|||
31010581|NCT03028740|59212074|FG000|Overall Study|Withdrawal by Subject|48|||
31010582|NCT03028740|59212075|FG001|Overall Study|Withdrawal by Subject|101|||
31010583|NCT03028740|59212074|FG000|Overall Study|Lost to Follow-up|30|||
31010584|NCT03028740|59212075|FG001|Overall Study|Lost to Follow-up|54|||
31010585|NCT03028740|59212074|FG000|Overall Study|Physician Decision|4|||
31010586|NCT03028740|59212075|FG001|Overall Study|Physician Decision|11|||
31010587|NCT03028740|59212074|FG000|Overall Study|Protocol Violation|4|||
31010588|NCT03028740|59212075|FG001|Overall Study|Protocol Violation|8|||
30699328|NCT00550407|58713847|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
30699329|NCT00550407|58713848|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
30699330|NCT00531934|58713858|FG000|Overall Study|Adverse Event|4|||
30699331|NCT00531934|58713859|FG001|Overall Study|Adverse Event|8|||
30699332|NCT00531934|58713858|FG000|Overall Study|Progression|52|||
30699333|NCT00531934|58713859|FG001|Overall Study|Progression|42|||
30699334|NCT00531934|58713858|FG000|Overall Study|Death|7|||
30699335|NCT00531934|58713859|FG001|Overall Study|Death|10|||
30699336|NCT00531934|58713858|FG000|Overall Study|Withdrawal by Subject|1|||
30699337|NCT00531934|58713859|FG001|Overall Study|Withdrawal by Subject|1|||
30699338|NCT00531934|58713858|FG000|Overall Study|Other|2|||
30699339|NCT00531934|58713859|FG001|Overall Study|Other|2|||
30699340|NCT00549939|58713868|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
30699341|NCT00549939|58713869|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
30699342|NCT00549939|58713870|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
30699343|NCT00549939|58713868|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
30699344|NCT00549939|58713869|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
30699345|NCT00549939|58713870|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
30699346|NCT00549939|58713868|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
30699347|NCT00549939|58713869|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
30699348|NCT00549939|58713870|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
31010589|NCT03028740|59212074|FG000|Overall Study|Non-compliance with Study Drug|0|||
31010590|NCT03028740|59212075|FG001|Overall Study|Non-compliance with Study Drug|2|||
31010591|NCT03028740|59212074|FG000|Overall Study|Study Terminated by Sponsor|467|||
31010592|NCT03028740|59212075|FG001|Overall Study|Study Terminated by Sponsor|917|||
31010593|NCT03028740|59212074|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
31010594|NCT03028740|59212075|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
31010595|NCT03028740|59212074|FG000|Overall Study|Reason not Specified|1|||
30699349|NCT00549939|58713868|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
30699350|NCT00549939|58713869|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
30699351|NCT00549939|58713870|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
30699352|NCT00549939|58713868|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
30699353|NCT00549939|58713869|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
30699354|NCT00549939|58713870|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
30699355|NCT00549939|58713868|FG000|40-week Open Label Treatment Period|Other|0|||
30699356|NCT00549939|58713869|FG001|40-week Open Label Treatment Period|Other|1|||
31010596|NCT03028740|59212075|FG001|Overall Study|Reason not Specified|5|||
31010597|NCT02980692|59212098|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
31010598|NCT02980692|59212099|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
31010599|NCT02980692|59212100|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
31010600|NCT02980692|59212101|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
31010601|NCT02980692|59212102|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
31010602|NCT02980692|59212098|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
31010603|NCT02980692|59212099|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
31010604|NCT02980692|59212100|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
31010605|NCT02980692|59212101|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
31010606|NCT02980692|59212102|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
31010607|NCT02980692|59212098|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
31010608|NCT02980692|59212099|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
31010609|NCT02980692|59212100|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
31010610|NCT02980692|59212101|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
31010611|NCT02980692|59212102|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
31010612|NCT02980692|59212098|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
31010613|NCT02980692|59212099|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
31010614|NCT02980692|59212100|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
31010615|NCT02980692|59212101|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
31010616|NCT02980692|59212102|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
31010617|NCT02980692|59212098|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
31010618|NCT02980692|59212099|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
31010619|NCT02980692|59212100|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
31010620|NCT02980692|59212101|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
30616870|NCT00975130|58627644|FG000|Study Part 2|Lost to Follow-up|0|||
30616871|NCT00975130|58627645|FG001|Study Part 2|Lost to Follow-up|0|||
30616872|NCT00975130|58627646|FG002|Study Part 2|Lost to Follow-up|1|||
30616873|NCT00975130|58627644|FG000|Study Part 2|Withdrawal by Subject|0|||
30616874|NCT00975130|58627645|FG001|Study Part 2|Withdrawal by Subject|13|||
30616875|NCT00975130|58627646|FG002|Study Part 2|Withdrawal by Subject|5|||
30616876|NCT00975130|58627644|FG000|Study Part 2|Withdrew Consent|0|||
30616877|NCT00975130|58627645|FG001|Study Part 2|Withdrew Consent|6|||
30616878|NCT00975130|58627646|FG002|Study Part 2|Withdrew Consent|2|||
30616879|NCT00975130|58627644|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
30616880|NCT00975130|58627645|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
30616881|NCT00975130|58627646|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
30616882|NCT00975130|58627644|FG000|Study Part 2|Administrative|0|||
30616883|NCT00975130|58627645|FG001|Study Part 2|Administrative|1|||
30616884|NCT00975130|58627646|FG002|Study Part 2|Administrative|0|||
30616885|NCT00975130|58627644|FG000|Study Part 2|Protocol Violation|0|||
30616886|NCT00975130|58627645|FG001|Study Part 2|Protocol Violation|0|||
30616887|NCT00975130|58627646|FG002|Study Part 2|Protocol Violation|1|||
30616888|NCT01230827|58627663|FG000|Overall Study|Lost to Follow-up|0|||
30616889|NCT01230827|58627664|FG001|Overall Study|Lost to Follow-up|0|||
30616890|NCT01230827|58627665|FG002|Overall Study|Lost to Follow-up|1|||
30616891|NCT01230827|58627666|FG003|Overall Study|Lost to Follow-up|3|||
30616892|NCT01230827|58627663|FG000|Overall Study|Withdrawal by Subject|1|||
30616893|NCT01230827|58627664|FG001|Overall Study|Withdrawal by Subject|0|||
30616894|NCT01230827|58627665|FG002|Overall Study|Withdrawal by Subject|3|||
30699357|NCT00549939|58713870|FG002|40-week Open Label Treatment Period|Other|4|||
30699358|NCT00272779|58713882|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
30699359|NCT00272779|58713883|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
30699360|NCT00272779|58713882|FG000|Baseline Through Week 48|Death before Week 48|4|||
30699361|NCT00272779|58713883|FG001|Baseline Through Week 48|Death before Week 48|4|||
30699362|NCT00272779|58713882|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
30616895|NCT01230827|58627666|FG003|Overall Study|Withdrawal by Subject|2|||
30616896|NCT01230827|58627663|FG000|Overall Study|Lack of Efficacy|14|||
30699363|NCT00272779|58713883|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
30616897|NCT01230827|58627664|FG001|Overall Study|Lack of Efficacy|1|||
30616898|NCT01230827|58627665|FG002|Overall Study|Lack of Efficacy|2|||
30616899|NCT01230827|58627666|FG003|Overall Study|Lack of Efficacy|3|||
30616900|NCT01230827|58627663|FG000|Overall Study|Adverse Event|4|||
30616901|NCT01230827|58627664|FG001|Overall Study|Adverse Event|2|||
30616902|NCT01230827|58627665|FG002|Overall Study|Adverse Event|3|||
30616903|NCT01230827|58627666|FG003|Overall Study|Adverse Event|7|||
30616904|NCT01230827|58627663|FG000|Overall Study|Recovery|0|||
30616905|NCT01230827|58627664|FG001|Overall Study|Recovery|6|||
30616906|NCT01230827|58627665|FG002|Overall Study|Recovery|0|||
30790785|NCT03524092|58803942|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
30790786|NCT03524092|58803943|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
30790787|NCT03524092|58803944|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
30790788|NCT03524092|58803945|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
30790789|NCT03524092|58803940|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
30790790|NCT03524092|58803941|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
30790791|NCT03524092|58803942|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
30790792|NCT03524092|58803943|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
31010621|NCT02980692|59212102|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
31010622|NCT02980692|59212098|FG000|Double Blind Placebo Controlled Period|Other|1|||
31010623|NCT02980692|59212099|FG001|Double Blind Placebo Controlled Period|Other|0|||
31010624|NCT02980692|59212100|FG002|Double Blind Placebo Controlled Period|Other|0|||
31010625|NCT02980692|59212101|FG003|Double Blind Placebo Controlled Period|Other|0|||
31010626|NCT02980692|59212102|FG004|Double Blind Placebo Controlled Period|Other|1|||
31010627|NCT02980692|59212098|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
31010628|NCT02980692|59212099|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
31010629|NCT02980692|59212100|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
30616907|NCT01230827|58627666|FG003|Overall Study|Recovery|0|||
30616908|NCT01230827|58627663|FG000|Overall Study|Study terminated by Sponsor|0|||
30616909|NCT01230827|58627664|FG001|Overall Study|Study terminated by Sponsor|2|||
30616910|NCT01230827|58627665|FG002|Overall Study|Study terminated by Sponsor|56|||
30616911|NCT01230827|58627666|FG003|Overall Study|Study terminated by Sponsor|63|||
30616912|NCT01230749|58627678|FG000|Overall Study|Adverse Event|0|||
30616913|NCT01230749|58627679|FG001|Overall Study|Adverse Event|0|||
30616914|NCT01230749|58627680|FG002|Overall Study|Adverse Event|0|||
30616915|NCT01230749|58627681|FG003|Overall Study|Adverse Event|1|||
30616916|NCT01230749|58627678|FG000|Overall Study|Physician Decision|0|||
30616917|NCT01230749|58627679|FG001|Overall Study|Physician Decision|0|||
30616918|NCT01230749|58627680|FG002|Overall Study|Physician Decision|1|||
30616919|NCT01230749|58627681|FG003|Overall Study|Physician Decision|0|||
30616920|NCT01230749|58627678|FG000|Overall Study|Withdrawal by Subject|0|||
30616921|NCT01230749|58627679|FG001|Overall Study|Withdrawal by Subject|1|||
30616922|NCT01230749|58627680|FG002|Overall Study|Withdrawal by Subject|0|||
30616923|NCT01230749|58627681|FG003|Overall Study|Withdrawal by Subject|0|||
30616924|NCT01230749|58627678|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
30616925|NCT01230749|58627679|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
30616926|NCT01230749|58627680|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
30616927|NCT01230749|58627681|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
30616928|NCT00903175|58627696|FG000|Period 1 - First Line|Adverse Event|36|||
30616929|NCT00903175|58627697|FG001|Period 1 - First Line|Adverse Event|50|||
30616930|NCT00903175|58627696|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
30616931|NCT00903175|58627697|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
30616932|NCT00903175|58627696|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
30616933|NCT00903175|58627697|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
30616934|NCT00903175|58627696|FG000|Period 1 - First Line|Protocol Violation|3|||
30616935|NCT00903175|58627697|FG001|Period 1 - First Line|Protocol Violation|3|||
30616936|NCT00903175|58627696|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
30616937|NCT00903175|58627697|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
30616938|NCT00903175|58627696|FG000|Period 1 - First Line|Administrative problems|12|||
30616939|NCT00903175|58627697|FG001|Period 1 - First Line|Administrative problems|13|||
30699364|NCT00272779|58713882|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
30699365|NCT00272779|58713883|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
30699366|NCT00272779|58713882|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
30699367|NCT00272779|58713883|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
30699368|NCT00272779|58713882|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
30699369|NCT00272779|58713883|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
30699370|NCT00272779|58713882|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
30699371|NCT00272779|58713883|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
30699372|NCT00272779|58713882|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
30616940|NCT00903175|58627696|FG000|Period 1 - First Line|Death|17|||
30616941|NCT00903175|58627697|FG001|Period 1 - First Line|Death|10|||
30616942|NCT00903175|58627696|FG000|Period 2 - Second Line|Missing|1|||
30616943|NCT00903175|58627697|FG001|Period 2 - Second Line|Missing|0|||
30616944|NCT00903175|58627696|FG000|Period 2 - Second Line|Adverse Event|16|||
30616945|NCT00903175|58627697|FG001|Period 2 - Second Line|Adverse Event|20|||
30616946|NCT00903175|58627696|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
31010630|NCT02980692|59212101|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
31010631|NCT02980692|59212102|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
31010632|NCT02980692|59212098|FG000|Double-blind Follow-up Period|Adverse Event|0|||
31010633|NCT02980692|59212099|FG001|Double-blind Follow-up Period|Adverse Event|0|||
31010634|NCT02980692|59212100|FG002|Double-blind Follow-up Period|Adverse Event|0|||
31010635|NCT02980692|59212101|FG003|Double-blind Follow-up Period|Adverse Event|1|||
31010636|NCT02980692|59212102|FG004|Double-blind Follow-up Period|Adverse Event|1|||
31010637|NCT02980692|59212098|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
31010638|NCT02980692|59212099|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
31010639|NCT02980692|59212100|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
31010640|NCT02980692|59212101|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
31010641|NCT02980692|59212102|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
31010642|NCT02980692|59212098|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
31010643|NCT02980692|59212099|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
31010644|NCT02980692|59212100|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
31010645|NCT02980692|59212101|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
31010646|NCT02980692|59212102|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
31010647|NCT02980692|59212098|FG000|Double-blind Follow-up Period|Pregnancy|0|||
31010648|NCT02980692|59212099|FG001|Double-blind Follow-up Period|Pregnancy|0|||
31010649|NCT02980692|59212100|FG002|Double-blind Follow-up Period|Pregnancy|1|||
31010650|NCT02980692|59212101|FG003|Double-blind Follow-up Period|Pregnancy|1|||
31010651|NCT02980692|59212102|FG004|Double-blind Follow-up Period|Pregnancy|0|||
31010652|NCT02980692|59212098|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
31010653|NCT02980692|59212099|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
31010654|NCT02980692|59212100|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
31010655|NCT02980692|59212101|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
31010656|NCT02980692|59212102|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
31010657|NCT02980692|59212098|FG000|Double-blind Follow-up Period|Other|0|||
30616947|NCT00903175|58627697|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
30616948|NCT00903175|58627696|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
30616949|NCT00903175|58627697|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
30616950|NCT00903175|58627696|FG000|Period 2 - Second Line|Administrative problems|19|||
30616951|NCT00903175|58627697|FG001|Period 2 - Second Line|Administrative problems|9|||
30616952|NCT00903175|58627696|FG000|Period 2 - Second Line|Death|5|||
30616953|NCT00903175|58627697|FG001|Period 2 - Second Line|Death|2|||
30616954|NCT01229735|58627705|FG000|Overall Study|Lack of Efficacy|8|||
30616955|NCT01229735|58627706|FG001|Overall Study|Lack of Efficacy|8|||
30616956|NCT01229735|58627705|FG000|Overall Study|Protocol Violation|13|||
30616957|NCT01229735|58627706|FG001|Overall Study|Protocol Violation|8|||
30616958|NCT01229735|58627705|FG000|Overall Study|Lost to Follow-up|0|||
30616959|NCT01229735|58627706|FG001|Overall Study|Lost to Follow-up|2|||
30616960|NCT01229735|58627705|FG000|Overall Study|Withdrawal by Subject|18|||
30616961|NCT01229735|58627706|FG001|Overall Study|Withdrawal by Subject|17|||
30616962|NCT01229735|58627705|FG000|Overall Study|Other Reason|13|||
30616963|NCT01229735|58627706|FG001|Overall Study|Other Reason|10|||
30616964|NCT01229735|58627705|FG000|Overall Study|SAE, non-fatal|0|||
30616965|NCT01229735|58627706|FG001|Overall Study|SAE, non-fatal|4|||
30616966|NCT01229735|58627705|FG000|Overall Study|AE, non-serious non-fatal|13|||
30616967|NCT01229735|58627706|FG001|Overall Study|AE, non-serious non-fatal|17|||
30616968|NCT01229735|58627705|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
30616969|NCT01229735|58627706|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
30616970|NCT00974974|58627725|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
30616971|NCT00974974|58627726|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
30616972|NCT00974974|58627725|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
30616973|NCT00974974|58627726|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
30616974|NCT00974974|58627725|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
30616975|NCT00974974|58627726|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
31010658|NCT02980692|59212099|FG001|Double-blind Follow-up Period|Other|0|||
31010659|NCT02980692|59212100|FG002|Double-blind Follow-up Period|Other|1|||
30616976|NCT00974974|58627725|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
30616977|NCT00974974|58627726|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
30616978|NCT00974974|58627725|FG000|IR CD-LD Dose Adjustment|Various|0|||
30616979|NCT00974974|58627726|FG001|IR CD-LD Dose Adjustment|Various|9|||
30616980|NCT00974974|58627725|FG000|IPX066 Dose Conversion|Adverse Event|23|||
31010660|NCT02980692|59212101|FG003|Double-blind Follow-up Period|Other|1|||
31010661|NCT02980692|59212102|FG004|Double-blind Follow-up Period|Other|3|||
30616981|NCT00974974|58627726|FG001|IPX066 Dose Conversion|Adverse Event|0|||
30616982|NCT00974974|58627725|FG000|IPX066 Dose Conversion|Death|2|||
30616983|NCT00974974|58627726|FG001|IPX066 Dose Conversion|Death|0|||
30616984|NCT00974974|58627725|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
30616985|NCT00974974|58627726|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
30616986|NCT00974974|58627725|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
30616987|NCT00974974|58627726|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
30616988|NCT00974974|58627725|FG000|IPX066 Dose Conversion|Various|3|||
30616989|NCT00974974|58627726|FG001|IPX066 Dose Conversion|Various|0|||
30616990|NCT00974974|58627725|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
30616991|NCT00974974|58627726|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
30616992|NCT00974974|58627725|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
30616993|NCT00974974|58627726|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
30616994|NCT00974974|58627725|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
30616995|NCT00974974|58627726|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
30616996|NCT00974974|58627725|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
30616997|NCT00974974|58627726|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
30616998|NCT00974974|58627725|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
30616999|NCT00974974|58627726|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
30617000|NCT00974974|58627725|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
30617001|NCT00974974|58627726|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
30617002|NCT00974974|58627725|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
30617003|NCT00974974|58627726|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
30617004|NCT00974974|58627725|FG000|Maintenance - Double Blind Treatment|Various|4|||
30617005|NCT00974974|58627726|FG001|Maintenance - Double Blind Treatment|Various|0|||
30617006|NCT01233869|58627736|FG000|Initial Treatment Period (24 Months)|Death|1|||
30617007|NCT01233869|58627737|FG001|Initial Treatment Period (24 Months)|Death|0|||
30617008|NCT01233869|58627738|FG002|Initial Treatment Period (24 Months)|Death|0|||
30617009|NCT01233869|58627739|FG003|Initial Treatment Period (24 Months)|Death|0|||
30617010|NCT01233869|58627736|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
30617011|NCT01233869|58627737|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
30617012|NCT01233869|58627738|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
30617013|NCT01233869|58627739|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
30617014|NCT01233869|58627736|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
30617015|NCT01233869|58627737|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
30617016|NCT01233869|58627738|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
30617017|NCT01233869|58627739|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
30617018|NCT01233869|58627736|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
30617019|NCT01233869|58627737|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
30617020|NCT01233869|58627738|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
30617021|NCT01233869|58627739|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
30617022|NCT01233869|58627736|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
30617023|NCT01233869|58627737|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
30699373|NCT00272779|58713883|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
30699374|NCT00272779|58713882|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
30699375|NCT00272779|58713883|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
30699376|NCT00272779|58713882|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
30699377|NCT00272779|58713883|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
30699378|NCT00272779|58713882|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
30699379|NCT00272779|58713883|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
31010662|NCT00089778|59212408|FG000|Overall Study|Protocol Violation|0|||
31010663|NCT00089778|59212409|FG001|Overall Study|Protocol Violation|0|||
31010664|NCT00089778|59212410|FG002|Overall Study|Protocol Violation|1|||
31010665|NCT00089544|59212422|FG000|Overall Study|Ineligible|1|||
31010666|NCT00089544|59212423|FG001|Overall Study|Ineligible|0|||
31010667|NCT00089076|59212429|FG000|Overall Study|Alternate Therapy|1|||
31010668|NCT00089076|59212429|FG000|Overall Study|Withdrawal by Subject|2|||
31010669|NCT00089076|59212429|FG000|Overall Study|Progression|7|||
31010670|NCT00088374|59212433|FG000|Overall Study|patient did not receive any 17AAG|1|||
31010671|NCT00088374|59212433|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
30617024|NCT01233869|58627738|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
30617025|NCT01233869|58627739|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
30617026|NCT01233869|58627736|FG000|Extended Treatment Period (46 Months)|Other|3|||
30699380|NCT00272779|58713882|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
31010672|NCT00087594|59212439|FG000|Overall Study|Adverse Event|2|||
31010673|NCT00087594|59212440|FG001|Overall Study|Adverse Event|3|||
31010674|NCT00087594|59212439|FG000|Overall Study|Lost to Follow-up|0|||
31010675|NCT00087594|59212440|FG001|Overall Study|Lost to Follow-up|2|||
31010676|NCT00087594|59212439|FG000|Overall Study|Withdrawal by Subject|4|||
31010677|NCT00087594|59212440|FG001|Overall Study|Withdrawal by Subject|2|||
31010678|NCT00087594|59212439|FG000|Overall Study|Lack of Efficacy|2|||
31010679|NCT00087594|59212440|FG001|Overall Study|Lack of Efficacy|5|||
31010680|NCT00087516|59212449|FG000|Overall Study|Adverse Event|10|||
31010681|NCT00087516|59212450|FG001|Overall Study|Adverse Event|10|||
31010682|NCT00087516|59212451|FG002|Overall Study|Adverse Event|3|||
31010683|NCT00087516|59212452|FG003|Overall Study|Adverse Event|6|||
31010684|NCT00087516|59212449|FG000|Overall Study|Lack of Efficacy|82|||
31010685|NCT00087516|59212450|FG001|Overall Study|Lack of Efficacy|80|||
31010686|NCT00087516|59212451|FG002|Overall Study|Lack of Efficacy|39|||
31010687|NCT00087516|59212452|FG003|Overall Study|Lack of Efficacy|29|||
31010688|NCT00087516|59212449|FG000|Overall Study|Lost to Follow-up|8|||
31010689|NCT00087516|59212450|FG001|Overall Study|Lost to Follow-up|6|||
31010690|NCT00087516|59212451|FG002|Overall Study|Lost to Follow-up|5|||
31010691|NCT00087516|59212452|FG003|Overall Study|Lost to Follow-up|5|||
31010692|NCT00087516|59212449|FG000|Overall Study|Protocol Violation|4|||
31010693|NCT00087516|59212450|FG001|Overall Study|Protocol Violation|8|||
31010694|NCT00087516|59212451|FG002|Overall Study|Protocol Violation|3|||
31010695|NCT00087516|59212452|FG003|Overall Study|Protocol Violation|6|||
31010696|NCT00087516|59212449|FG000|Overall Study|Withdrawal by Subject|16|||
31010697|NCT00087516|59212450|FG001|Overall Study|Withdrawal by Subject|27|||
31010698|NCT00087516|59212451|FG002|Overall Study|Withdrawal by Subject|11|||
31010699|NCT00087516|59212452|FG003|Overall Study|Withdrawal by Subject|12|||
31010700|NCT00087516|59212449|FG000|Overall Study|Site terminated|0|||
31010701|NCT00087516|59212450|FG001|Overall Study|Site terminated|2|||
31010702|NCT00087516|59212451|FG002|Overall Study|Site terminated|1|||
31010703|NCT00087516|59212452|FG003|Overall Study|Site terminated|0|||
31010704|NCT00087516|59212449|FG000|Overall Study|Protocol specified discontinuation|35|||
31010705|NCT00087516|59212450|FG001|Overall Study|Protocol specified discontinuation|33|||
31010706|NCT00087516|59212451|FG002|Overall Study|Protocol specified discontinuation|33|||
31010707|NCT00087516|59212452|FG003|Overall Study|Protocol specified discontinuation|26|||
31010708|NCT00087516|59212449|FG000|Overall Study|Patient moved|3|||
31010709|NCT00087516|59212450|FG001|Overall Study|Patient moved|2|||
31010710|NCT00087516|59212451|FG002|Overall Study|Patient moved|1|||
31010711|NCT00087516|59212452|FG003|Overall Study|Patient moved|0|||
31010712|NCT00087516|59212449|FG000|Overall Study|Patient was non-compliant|3|||
31010713|NCT00087516|59212450|FG001|Overall Study|Patient was non-compliant|1|||
31010714|NCT00087516|59212451|FG002|Overall Study|Patient was non-compliant|0|||
31010715|NCT00087516|59212452|FG003|Overall Study|Patient was non-compliant|0|||
31010716|NCT00087516|59212449|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
31010717|NCT00087516|59212450|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
31010718|NCT00087516|59212451|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
31010719|NCT00087516|59212452|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
31010720|NCT00087516|59212449|FG000|Overall Study|Other|0|||
31010721|NCT00087516|59212450|FG001|Overall Study|Other|0|||
31010722|NCT00087516|59212451|FG002|Overall Study|Other|1|||
31010723|NCT00087516|59212452|FG003|Overall Study|Other|0|||
31010724|NCT00087126|59212466|FG000|Overall Study|Ineligible - second primary|1|||
31010725|NCT00087126|59212466|FG000|Overall Study|Never treated|1|||
31010726|NCT03490734|59212479|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
31010727|NCT03490734|59212480|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
31010728|NCT03490734|59212481|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
31010729|NCT03490734|59212482|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
31010730|NCT03490734|59212479|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
31010731|NCT03490734|59212480|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
31010732|NCT03490734|59212481|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
31010733|NCT03490734|59212482|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
31010734|NCT03490734|59212479|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
31010735|NCT03490734|59212480|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
31010736|NCT03490734|59212481|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
31010737|NCT03490734|59212482|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
31010738|NCT03490734|59212479|FG000|Post-intervention Scan Visit|Adverse Event|2|||
31010739|NCT03490734|59212480|FG001|Post-intervention Scan Visit|Adverse Event|0|||
31010740|NCT03490734|59212481|FG002|Post-intervention Scan Visit|Adverse Event|0|||
31010741|NCT03490734|59212482|FG003|Post-intervention Scan Visit|Adverse Event|0|||
31010742|NCT03490734|59212479|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
31010743|NCT03490734|59212480|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
31010744|NCT03490734|59212481|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
31010745|NCT03490734|59212482|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
31010746|NCT03490734|59212479|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
31010747|NCT03490734|59212480|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
31010748|NCT03490734|59212481|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
31010749|NCT03490734|59212482|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
31010750|NCT00086346|59212493|FG000|Randomization|Did not receive test article|4|||
31010751|NCT00086346|59212494|FG001|Randomization|Did not receive test article|4|||
31010752|NCT00086346|59212493|FG000|Patients Dosed With Test Article|Adverse Event|94|||
31010753|NCT00086346|59212494|FG001|Patients Dosed With Test Article|Adverse Event|11|||
31010754|NCT00086346|59212493|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
31010755|NCT00086346|59212494|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
31010756|NCT00086346|59212493|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
31010757|NCT00086346|59212494|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
31010758|NCT00086346|59212493|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
31010759|NCT00086346|59212494|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
31010760|NCT00086346|59212493|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
31010761|NCT00086346|59212494|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
31010762|NCT00086346|59212493|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
31010763|NCT00086346|59212494|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
31010764|NCT00085566|59212503|FG000|Overall Study|Adverse Event|0|||
31010765|NCT00085566|59212504|FG001|Overall Study|Adverse Event|0|||
31010766|NCT00085566|59212505|FG002|Overall Study|Adverse Event|10|||
31010767|NCT00085566|59212503|FG000|Overall Study|Patient Not treated|0|||
31010768|NCT00085566|59212504|FG001|Overall Study|Patient Not treated|0|||
31010769|NCT00085566|59212505|FG002|Overall Study|Patient Not treated|3|||
31010770|NCT00085566|59212503|FG000|Overall Study|Clinical progression|0|||
31010771|NCT00085566|59212504|FG001|Overall Study|Clinical progression|0|||
31010772|NCT00085566|59212505|FG002|Overall Study|Clinical progression|1|||
31010773|NCT00085098|59212515|FG000|Overall Study|Withdrawal by Subject|0|||
31010774|NCT00085098|59212516|FG001|Overall Study|Withdrawal by Subject|1|||
31010775|NCT00085098|59212515|FG000|Overall Study|Ineligible|1|||
31010776|NCT00085098|59212516|FG001|Overall Study|Ineligible|1|||
31010777|NCT00084864|59212529|FG000|Overall Study|Adverse Event|1|||
31010778|NCT00084864|59212530|FG001|Overall Study|Adverse Event|0|||
31010779|NCT00084864|59212531|FG002|Overall Study|Adverse Event|0|||
31010780|NCT00084864|59212532|FG003|Overall Study|Adverse Event|0|||
31010781|NCT00084318|59212544|FG000|Overall Study|Withdrawal by Subject|5|||
31010782|NCT00084318|59212545|FG001|Overall Study|Withdrawal by Subject|2|||
31010783|NCT00084318|59212544|FG000|Overall Study|Protocol Violation|15|||
31010784|NCT00084318|59212545|FG001|Overall Study|Protocol Violation|11|||
31010785|NCT00084318|59212544|FG000|Overall Study|No protocol treatment|2|||
31010786|NCT00084318|59212545|FG001|Overall Study|No protocol treatment|0|||
31010787|NCT00084084|59212553|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
30617027|NCT01233869|58627737|FG001|Extended Treatment Period (46 Months)|Other|0|||
30617028|NCT01233869|58627738|FG002|Extended Treatment Period (46 Months)|Other|0|||
30617029|NCT01233869|58627739|FG003|Extended Treatment Period (46 Months)|Other|3|||
30617030|NCT01233869|58627736|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
30617031|NCT01233869|58627737|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
30617032|NCT01233869|58627738|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
30617033|NCT01233869|58627739|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
30617034|NCT00992992|58627749|FG000|Overall Study|Lost to Follow-up|3|||
30617035|NCT00992992|58627749|FG000|Overall Study|Death|16|||
30617036|NCT00992992|58627749|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
30617037|NCT00992992|58627749|FG000|Overall Study|Sponsor Closed the Study|4|||
30617038|NCT00992836|58627753|FG000|Overall Study|Lost to Follow-up|1|||
30617039|NCT00992836|58627753|FG000|Overall Study|Withdrawal by Subject|2|||
30617040|NCT00992836|58627753|FG000|Overall Study|Protocol Violation|2|||
30617041|NCT00992446|58627763|FG000|Overall Study|Disease Progression|1|||
30617042|NCT00992446|58627763|FG000|Overall Study|Withdrawal by Subject|2|||
30617043|NCT00992446|58627763|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
30617044|NCT04344301|58627769|FG000|Overall Study|Withdrawal by Subject|1|||
30617045|NCT04344301|58627770|FG001|Overall Study|Withdrawal by Subject|0|||
30617046|NCT04344301|58627769|FG000|Overall Study|Death|0|||
30617047|NCT04344301|58627770|FG001|Overall Study|Death|1|||
30617048|NCT00970294|58627777|FG000|Overall Study|Physician Decision|4|||
31010788|NCT00084084|59212553|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
31010789|NCT00083616|59212558|FG000|Overall Study|Disease Progression|16|||
31010790|NCT00083616|59212558|FG000|Overall Study|Lost to Follow-up|1|||
30617049|NCT00970294|58627777|FG000|Overall Study|Withdrawal by Subject|1|||
30617050|NCT00969436|58627784|FG000|Overall Study|Protocol Violation|1|||
30617051|NCT00969436|58627785|FG001|Overall Study|Protocol Violation|3|||
30617052|NCT00969436|58627786|FG002|Overall Study|Protocol Violation|0|||
30617053|NCT00969436|58627784|FG000|Overall Study|Migrated/moved from study area|12|||
31010791|NCT00083616|59212558|FG000|Overall Study|Physician Decision|2|||
31010792|NCT00083616|59212558|FG000|Overall Study|Withdrawal by Subject|3|||
31010793|NCT00083616|59212558|FG000|Overall Study|Ineligibility determined|2|||
31010794|NCT00083616|59212558|FG000|Overall Study|Non-compliance|1|||
31010795|NCT00083616|59212558|FG000|Overall Study|Other|6|||
31010796|NCT00083226|59212562|FG000|Overall Study|Lack of Efficacy|19|||
31010797|NCT00083226|59212562|FG000|Overall Study|Adverse Event|9|||
31010798|NCT00083226|59212562|FG000|Overall Study|Death|4|||
31010799|NCT00083226|59212562|FG000|Overall Study|Withdrawal by Subject|4|||
31010800|NCT00083226|59212562|FG000|Overall Study|Other|2|||
31010801|NCT00083226|59212562|FG000|Overall Study|ineligible or not receiving treatment|4|||
31010802|NCT00082758|59212569|FG000|Overall Study|Adverse Event|0|||
31010803|NCT00082758|59212570|FG001|Overall Study|Adverse Event|2|||
31010804|NCT00082758|59212571|FG002|Overall Study|Adverse Event|0|||
31010805|NCT00082758|59212569|FG000|Overall Study|Lack of Efficacy|12|||
31010806|NCT00082758|59212570|FG001|Overall Study|Lack of Efficacy|13|||
31010807|NCT00082758|59212571|FG002|Overall Study|Lack of Efficacy|0|||
31010808|NCT00082758|59212569|FG000|Overall Study|Physician Decision|0|||
31010809|NCT00082758|59212570|FG001|Overall Study|Physician Decision|1|||
31010810|NCT00082758|59212571|FG002|Overall Study|Physician Decision|0|||
31010811|NCT00082758|59212569|FG000|Overall Study|Withdrawal by Subject|3|||
31010812|NCT00082758|59212570|FG001|Overall Study|Withdrawal by Subject|0|||
31010813|NCT00082758|59212571|FG002|Overall Study|Withdrawal by Subject|0|||
31010814|NCT00082758|59212569|FG000|Overall Study|Protocol Violation|0|||
31010815|NCT00082758|59212570|FG001|Overall Study|Protocol Violation|1|||
31010816|NCT00082758|59212571|FG002|Overall Study|Protocol Violation|0|||
31010817|NCT00088452|59212582|FG000|Overall Study|Did not receive intervention|1|||
31010818|NCT00088452|59212583|FG001|Overall Study|Did not receive intervention|0|||
31010819|NCT00088452|59212584|FG002|Overall Study|Did not receive intervention|1|||
31010820|NCT04686084|59212674|FG000|Overall Study|Lost to Follow-up|1|||
31010821|NCT04685538|59212681|FG000|Overall Study|Adverse Event|0|||
31010822|NCT04685538|59212682|FG001|Overall Study|Adverse Event|1|||
31010823|NCT04685538|59212681|FG000|Overall Study|Lost to Follow-up|0|||
31010824|NCT04685538|59212682|FG001|Overall Study|Lost to Follow-up|2|||
31010825|NCT04213326|59212694|FG000|Overall Study|Consent withdrawn|51|||
31010826|NCT04213326|59212695|FG001|Overall Study|Consent withdrawn|241|||
30617054|NCT00969436|58627785|FG001|Overall Study|Migrated/moved from study area|10|||
30617055|NCT00969436|58627786|FG002|Overall Study|Migrated/moved from study area|2|||
30617056|NCT00969436|58627784|FG000|Overall Study|Father - serious health problem|0|||
30617057|NCT00969436|58627785|FG001|Overall Study|Father - serious health problem|0|||
30617058|NCT00969436|58627786|FG002|Overall Study|Father - serious health problem|1|||
30617059|NCT00969436|58627784|FG000|Overall Study|Parents personal problem|0|||
30617060|NCT00969436|58627785|FG001|Overall Study|Parents personal problem|0|||
30617061|NCT00969436|58627786|FG002|Overall Study|Parents personal problem|1|||
30617062|NCT00969436|58627784|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
30617063|NCT00969436|58627785|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
30617064|NCT00969436|58627786|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
30617065|NCT00969436|58627784|FG000|Overall Study|Withdrawal by Subject|3|||
30617066|NCT00969436|58627785|FG001|Overall Study|Withdrawal by Subject|0|||
30617067|NCT00969436|58627786|FG002|Overall Study|Withdrawal by Subject|2|||
30617068|NCT00969436|58627784|FG000|Overall Study|Lost to Follow-up|8|||
30617069|NCT00969436|58627785|FG001|Overall Study|Lost to Follow-up|8|||
30617070|NCT00969436|58627786|FG002|Overall Study|Lost to Follow-up|5|||
30617071|NCT00900757|58627794|FG000|Overall Study|screen failure|19|||
30617072|NCT00969280|58627800|FG000|Overall Study|Protocol Violation|2|||
30617073|NCT00969280|58627801|FG001|Overall Study|Protocol Violation|1|||
30617074|NCT00969280|58627800|FG000|Overall Study|Withdrawal by Subject|0|||
30617075|NCT00969280|58627801|FG001|Overall Study|Withdrawal by Subject|1|||
30617076|NCT00969280|58627800|FG000|Overall Study|infection of influenza A(H1N1)|0|||
30617077|NCT00969280|58627801|FG001|Overall Study|infection of influenza A(H1N1)|1|||
30617078|NCT00969124|58627807|FG000|Overall Study|Protocol Violation|2|||
30617079|NCT00969124|58627807|FG000|Overall Study|Inadequate bowel preparation|15|||
30617080|NCT00969124|58627807|FG000|Overall Study|Inability to reach cecum|9|||
30617081|NCT00969124|58627807|FG000|Overall Study|Previously unrecognized disease|3|||
30617082|NCT00969124|58627807|FG000|Overall Study|Technical error|1|||
30617083|NCT00900601|58627812|FG000|Overall Study|Physician Decision|1|||
30617084|NCT00901927|58627839|FG000|Overall Study|Lack of Efficacy|1|||
30617085|NCT00901927|58627839|FG000|Overall Study|Protocol Violation|3|||
30617086|NCT00901927|58627839|FG000|Overall Study|Withdrawal by Subject|2|||
30617087|NCT00968968|58627845|FG000|Overall Study|Study closed/terminated|10|||
30617088|NCT00968968|58627846|FG001|Overall Study|Study closed/terminated|10|||
30617089|NCT00968968|58627845|FG000|Overall Study|Protocol defined stopping criteria|3|||
30617090|NCT00968968|58627846|FG001|Overall Study|Protocol defined stopping criteria|1|||
30617091|NCT00968968|58627845|FG000|Overall Study|Withdrawal by Subject|2|||
30617092|NCT00968968|58627846|FG001|Overall Study|Withdrawal by Subject|0|||
31010827|NCT04213326|59212694|FG000|Overall Study|Lost to Follow-up|50|||
31010828|NCT04213326|59212695|FG001|Overall Study|Lost to Follow-up|902|||
31010829|NCT04213326|59212694|FG000|Overall Study|Protocol Violation|3|||
31010830|NCT04213326|59212695|FG001|Overall Study|Protocol Violation|25|||
31010831|NCT04213326|59212694|FG000|Overall Study|Participant eligibility changed|106|||
31010832|NCT04213326|59212695|FG001|Overall Study|Participant eligibility changed|19|||
31010833|NCT04213326|59212694|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
31010834|NCT04213326|59212695|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
30617093|NCT00968968|58627845|FG000|Overall Study|Physician Decision|1|||
30617094|NCT00968968|58627846|FG001|Overall Study|Physician Decision|2|||
30617095|NCT00968968|58627845|FG000|Overall Study|Lost to Follow-up|0|||
30617096|NCT00968968|58627846|FG001|Overall Study|Lost to Follow-up|1|||
30617097|NCT00973102|58627855|FG000|Overall Study|Protocol Violation|1|||
30617098|NCT00973102|58627856|FG001|Overall Study|Protocol Violation|0|||
30617099|NCT00973102|58627855|FG000|Overall Study|Prisoner|0|||
30617100|NCT00973102|58627856|FG001|Overall Study|Prisoner|1|||
30617101|NCT00901459|58627862|FG000|Overall Study|Withdrawal by Subject|6|||
30617102|NCT00896233|58627873|FG000|Overall Study|Claustrophobia during MRI|1|||
30617103|NCT00899431|58627898|FG000|Overall Study|Physician Decision|1|||
30617104|NCT00899431|58627899|FG001|Overall Study|Physician Decision|0|||
30617105|NCT00899431|58627900|FG002|Overall Study|Physician Decision|0|||
30617106|NCT00899353|58627911|FG000|Overall Study|Adverse Event|2|||
30617107|NCT00899353|58627911|FG000|Overall Study|Lost to Follow-up|1|||
30617108|NCT00899353|58627911|FG000|Overall Study|Withdrawal by Subject|2|||
30617109|NCT00898807|58627934|FG000|Overall Study|Withdrawal by Subject|5|||
30617110|NCT00898807|58627935|FG001|Overall Study|Withdrawal by Subject|3|||
30617111|NCT00898807|58627934|FG000|Overall Study|Family pressure to discontinue|2|||
30617112|NCT00898807|58627935|FG001|Overall Study|Family pressure to discontinue|2|||
30617113|NCT00898807|58627934|FG000|Overall Study|Lost to Follow-up|1|||
30617114|NCT00898807|58627935|FG001|Overall Study|Lost to Follow-up|3|||
31010835|NCT04213326|59212694|FG000|Overall Study|Incomplete study visit|0|||
31010836|NCT04213326|59212695|FG001|Overall Study|Incomplete study visit|367|||
31010837|NCT01625286|59212708|FG000|Overall Study|Adverse Event|0|||
31010838|NCT01625286|59212709|FG001|Overall Study|Adverse Event|0|||
31010839|NCT01625286|59212710|FG002|Overall Study|Adverse Event|0|||
31010840|NCT01625286|59212711|FG003|Overall Study|Adverse Event|0|||
31010841|NCT01625286|59212712|FG004|Overall Study|Adverse Event|1|||
31010842|NCT01625286|59212713|FG005|Overall Study|Adverse Event|2|||
31010843|NCT01625286|59212714|FG006|Overall Study|Adverse Event|1|||
31010844|NCT01625286|59212708|FG000|Overall Study|Death|0|||
31010845|NCT01625286|59212709|FG001|Overall Study|Death|0|||
31010846|NCT01625286|59212710|FG002|Overall Study|Death|1|||
31010847|NCT01625286|59212711|FG003|Overall Study|Death|1|||
31010848|NCT01625286|59212712|FG004|Overall Study|Death|0|||
31010849|NCT01625286|59212713|FG005|Overall Study|Death|11|||
31010850|NCT01625286|59212714|FG006|Overall Study|Death|16|||
31010851|NCT01625286|59212708|FG000|Overall Study|Withdrawal by Subject|0|||
31010852|NCT01625286|59212709|FG001|Overall Study|Withdrawal by Subject|1|||
31010853|NCT01625286|59212710|FG002|Overall Study|Withdrawal by Subject|0|||
31010854|NCT01625286|59212711|FG003|Overall Study|Withdrawal by Subject|1|||
31010855|NCT01625286|59212712|FG004|Overall Study|Withdrawal by Subject|0|||
31010856|NCT01625286|59212713|FG005|Overall Study|Withdrawal by Subject|0|||
31010857|NCT01625286|59212714|FG006|Overall Study|Withdrawal by Subject|1|||
31010858|NCT01625286|59212708|FG000|Overall Study|Any reason not specifically recorded|0|||
31010859|NCT01625286|59212709|FG001|Overall Study|Any reason not specifically recorded|0|||
31010860|NCT01625286|59212710|FG002|Overall Study|Any reason not specifically recorded|0|||
31010861|NCT01625286|59212711|FG003|Overall Study|Any reason not specifically recorded|0|||
31010862|NCT01625286|59212712|FG004|Overall Study|Any reason not specifically recorded|0|||
31010863|NCT01625286|59212713|FG005|Overall Study|Any reason not specifically recorded|1|||
31010864|NCT01625286|59212714|FG006|Overall Study|Any reason not specifically recorded|0|||
31010865|NCT01625286|59212708|FG000|Overall Study|Progressive disease|6|||
31010866|NCT01625286|59212709|FG001|Overall Study|Progressive disease|3|||
31010867|NCT01625286|59212710|FG002|Overall Study|Progressive disease|4|||
31010868|NCT01625286|59212711|FG003|Overall Study|Progressive disease|5|||
31010869|NCT01625286|59212712|FG004|Overall Study|Progressive disease|5|||
31010870|NCT01625286|59212713|FG005|Overall Study|Progressive disease|0|||
31010871|NCT01625286|59212714|FG006|Overall Study|Progressive disease|0|||
31010872|NCT01625286|59212708|FG000|Overall Study|Lost to Follow-up|0|||
31010873|NCT01625286|59212709|FG001|Overall Study|Lost to Follow-up|0|||
31010874|NCT01625286|59212710|FG002|Overall Study|Lost to Follow-up|0|||
31010875|NCT01625286|59212711|FG003|Overall Study|Lost to Follow-up|0|||
30617115|NCT00898807|58627934|FG000|Overall Study|Death|0|||
30617116|NCT00898807|58627935|FG001|Overall Study|Death|1|||
30617117|NCT01229267|58627946|FG000|Overall Study|Adverse Event|4|||
30617118|NCT01229267|58627947|FG001|Overall Study|Adverse Event|6|||
30617119|NCT01229267|58627948|FG002|Overall Study|Adverse Event|3|||
30617120|NCT01229267|58627949|FG003|Overall Study|Adverse Event|2|||
31010876|NCT01625286|59212712|FG004|Overall Study|Lost to Follow-up|0|||
31010877|NCT01625286|59212713|FG005|Overall Study|Lost to Follow-up|0|||
31010878|NCT01625286|59212714|FG006|Overall Study|Lost to Follow-up|1|||
31010879|NCT04083222|59212759|FG000|Overall Study|Voluntary Withdrawal|0|||
31010880|NCT04083222|59212760|FG001|Overall Study|Voluntary Withdrawal|1|||
31010881|NCT04083222|59212759|FG000|Overall Study|Reason not Specified|0|||
31010882|NCT04083222|59212760|FG001|Overall Study|Reason not Specified|1|||
31010883|NCT03286842|59212766|FG000|Overall Study|Patients rolled over to another study|80|||
31010884|NCT03037476|59212774|FG000|Overall Study|Lost to Follow-up|63|||
31010885|NCT03037476|59212775|FG001|Overall Study|Lost to Follow-up|46|||
31010886|NCT00639678|59212790|FG000|Overall Study|Withdrawal by Subject|3|||
31010887|NCT00639678|59212791|FG001|Overall Study|Withdrawal by Subject|0|||
31010888|NCT00639678|59212792|FG002|Overall Study|Withdrawal by Subject|4|||
31010889|NCT00639678|59212793|FG003|Overall Study|Withdrawal by Subject|0|||
31010890|NCT00639678|59212790|FG000|Overall Study|Lost to Follow-up|1|||
31010891|NCT00639678|59212791|FG001|Overall Study|Lost to Follow-up|0|||
31010892|NCT00639678|59212792|FG002|Overall Study|Lost to Follow-up|6|||
31010893|NCT00639678|59212793|FG003|Overall Study|Lost to Follow-up|0|||
31010894|NCT00639678|59212790|FG000|Overall Study|Adverse Event|0|||
31010895|NCT00639678|59212791|FG001|Overall Study|Adverse Event|1|||
31010896|NCT00639678|59212792|FG002|Overall Study|Adverse Event|0|||
31010897|NCT00639678|59212793|FG003|Overall Study|Adverse Event|0|||
31010898|NCT00639678|59212790|FG000|Overall Study|Lack of Compliance|0|||
31010899|NCT00639678|59212791|FG001|Overall Study|Lack of Compliance|0|||
31010900|NCT00639678|59212792|FG002|Overall Study|Lack of Compliance|1|||
31010901|NCT00639678|59212793|FG003|Overall Study|Lack of Compliance|0|||
31010902|NCT00638508|59212818|FG000|Overall Study|Physician Decision|5|||
31010903|NCT00638508|59212819|FG001|Overall Study|Physician Decision|2|||
31010904|NCT00637806|59212832|FG000|Double-blind Phase|Study Discontinued|2|||
31010905|NCT00637806|59212833|FG001|Double-blind Phase|Study Discontinued|0|||
31010906|NCT00637806|59212834|FG002|Double-blind Phase|Study Discontinued|1|||
31010907|NCT00637806|59212835|FG003|Double-blind Phase|Study Discontinued|0|||
31010908|NCT00637806|59212832|FG000|Extension Phase|Study Discontinued|0|||
31010909|NCT00637806|59212833|FG001|Extension Phase|Study Discontinued|0|||
31010910|NCT00637806|59212834|FG002|Extension Phase|Study Discontinued|0|||
30617121|NCT01229267|58627950|FG004|Overall Study|Adverse Event|10|||
30617122|NCT01229267|58627946|FG000|Overall Study|Death|40|||
31010911|NCT00637806|59212835|FG003|Extension Phase|Study Discontinued|1|||
31010912|NCT00637728|59212846|FG000|Double-blind Phase|Adverse Event|1|||
31010913|NCT00637728|59212847|FG001|Double-blind Phase|Adverse Event|0|||
31010914|NCT00637728|59212848|FG002|Double-blind Phase|Adverse Event|0|||
30617123|NCT01229267|58627947|FG001|Overall Study|Death|37|||
30617124|NCT01229267|58627948|FG002|Overall Study|Death|35|||
30617125|NCT01229267|58627949|FG003|Overall Study|Death|13|||
30617126|NCT01229267|58627950|FG004|Overall Study|Death|103|||
30617127|NCT01229267|58627946|FG000|Overall Study|Withdrawal by Subject|23|||
30617128|NCT01229267|58627947|FG001|Overall Study|Withdrawal by Subject|22|||
30617129|NCT01229267|58627948|FG002|Overall Study|Withdrawal by Subject|32|||
30617130|NCT01229267|58627949|FG003|Overall Study|Withdrawal by Subject|14|||
30617131|NCT01229267|58627950|FG004|Overall Study|Withdrawal by Subject|59|||
30617132|NCT01229267|58627946|FG000|Overall Study|Protocol Violation|0|||
30617133|NCT01229267|58627947|FG001|Overall Study|Protocol Violation|1|||
30617134|NCT01229267|58627948|FG002|Overall Study|Protocol Violation|0|||
30617135|NCT01229267|58627949|FG003|Overall Study|Protocol Violation|0|||
30617136|NCT01229267|58627950|FG004|Overall Study|Protocol Violation|0|||
30617137|NCT01229267|58627946|FG000|Overall Study|Progressive disease|0|||
30617138|NCT01229267|58627947|FG001|Overall Study|Progressive disease|0|||
30617139|NCT01229267|58627948|FG002|Overall Study|Progressive disease|0|||
30617140|NCT01229267|58627949|FG003|Overall Study|Progressive disease|0|||
30617141|NCT01229267|58627950|FG004|Overall Study|Progressive disease|1|||
30617142|NCT01229267|58627946|FG000|Overall Study|Physician Decision|8|||
30617143|NCT01229267|58627947|FG001|Overall Study|Physician Decision|11|||
30617144|NCT01229267|58627948|FG002|Overall Study|Physician Decision|8|||
30617145|NCT01229267|58627949|FG003|Overall Study|Physician Decision|3|||
30617146|NCT01229267|58627950|FG004|Overall Study|Physician Decision|25|||
30617147|NCT01229267|58627946|FG000|Overall Study|Lost to Follow-up|6|||
30617148|NCT01229267|58627947|FG001|Overall Study|Lost to Follow-up|5|||
30617149|NCT01229267|58627948|FG002|Overall Study|Lost to Follow-up|8|||
30617150|NCT01229267|58627949|FG003|Overall Study|Lost to Follow-up|3|||
30617151|NCT01229267|58627950|FG004|Overall Study|Lost to Follow-up|22|||
30617152|NCT00897715|58627959|FG000|Overall Study|Lost to Follow-up|0|||
30617153|NCT00897715|58627960|FG001|Overall Study|Lost to Follow-up|1|||
30617154|NCT00897715|58627959|FG000|Overall Study|Physician Decision|1|||
30617155|NCT00897715|58627960|FG001|Overall Study|Physician Decision|0|||
30617156|NCT00897715|58627959|FG000|Overall Study|increased risk of infection|1|||
30617157|NCT00897715|58627960|FG001|Overall Study|increased risk of infection|0|||
31010915|NCT00637728|59212846|FG000|Double-blind Phase|Non-compliance|2|||
31010916|NCT00637728|59212847|FG001|Double-blind Phase|Non-compliance|0|||
31010917|NCT00637728|59212848|FG002|Double-blind Phase|Non-compliance|0|||
31010918|NCT00637728|59212846|FG000|Double-blind Phase|Study Discontinued|1|||
31010919|NCT00637728|59212847|FG001|Double-blind Phase|Study Discontinued|1|||
31010920|NCT00637728|59212848|FG002|Double-blind Phase|Study Discontinued|0|||
31010921|NCT00637572|59212857|FG000|Overall Study|Adverse Event|1|||
31010922|NCT00637572|59212858|FG001|Overall Study|Adverse Event|2|||
31010923|NCT00637572|59212857|FG000|Overall Study|Death|0|||
31010924|NCT00637572|59212858|FG001|Overall Study|Death|1|||
31010925|NCT00637572|59212857|FG000|Overall Study|Lost to Follow-up|0|||
30617158|NCT01229111|58627966|FG000|Overall Study|Death|1|||
30617159|NCT00894361|58627972|FG000|Overall Study|deaths and less than 2 years followup|24|||
30617160|NCT00894361|58627973|FG001|Overall Study|deaths and less than 2 years followup|64|||
30617161|NCT01228175|58627983|FG000|Overall Study|Lost to Follow-up|64|||
30617162|NCT01228175|58627984|FG001|Overall Study|Lost to Follow-up|50|||
30617163|NCT01228175|58627983|FG000|Overall Study|Withdrawal by Subject|1|||
30617164|NCT01228175|58627984|FG001|Overall Study|Withdrawal by Subject|2|||
30617165|NCT01228175|58627983|FG000|Overall Study|Physician Decision|1|||
30617166|NCT01228175|58627984|FG001|Overall Study|Physician Decision|1|||
30617167|NCT01228019|58627990|FG000|Overall Study|Dose Violation|70|||
30617168|NCT01228019|58627990|FG000|Overall Study|Duplicate enrollment|1|||
30617169|NCT01228019|58627990|FG000|Overall Study|Missing pre-treatment data|72|||
30617170|NCT01228019|58627990|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
30617171|NCT01228019|58627990|FG000|Overall Study|Violation of Entry Criterion|9|||
30617172|NCT02987959|58627994|FG000|Overall Study|Grantor stopped supply of drugs|6|||
30617173|NCT01227707|58627998|FG000|Overall Study|Adverse Event|10|||
30617174|NCT01227707|58627998|FG000|Overall Study|Progression of disease|3|||
30617175|NCT01227707|58627998|FG000|Overall Study|Withdrawal by Subject|1|||
30617176|NCT01227707|58627998|FG000|Overall Study|Patient non-compliance|3|||
30617177|NCT01227707|58627998|FG000|Overall Study|Medical decision|6|||
30617178|NCT01227707|58627998|FG000|Overall Study|Death|1|||
30617179|NCT00895843|58628004|FG000|Overall Study|Protocol Violation|12|||
30617180|NCT00895843|58628005|FG001|Overall Study|Protocol Violation|12|||
30617181|NCT00895453|58628014|FG000|Overall Study|Lost to Follow-up|25|||
30617182|NCT00895453|58628015|FG001|Overall Study|Lost to Follow-up|25|||
30617183|NCT00895453|58628016|FG002|Overall Study|Lost to Follow-up|23|||
30617184|NCT00893971|58628024|FG000|Overall Study|Physician Decision|3|||
30617185|NCT00893737|58628037|FG000|Overall Study|Adverse Event|4|||
30617186|NCT00893737|58628037|FG000|Overall Study|Withdrawal by Subject|2|||
30617187|NCT00893737|58628037|FG000|Overall Study|Lost to Follow-up|6|||
30617188|NCT00893113|58628043|FG000|Overall Study|Lost to Follow-up|4|||
30617189|NCT00893113|58628044|FG001|Overall Study|Lost to Follow-up|8|||
30617190|NCT00893113|58628043|FG000|Overall Study|Early Termination|1|||
30617191|NCT00893113|58628044|FG001|Overall Study|Early Termination|1|||
30617192|NCT00893113|58628043|FG000|Overall Study|Withdrew Consent|8|||
30617193|NCT00893113|58628044|FG001|Overall Study|Withdrew Consent|7|||
30617194|NCT00892957|58628052|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
30617195|NCT00892957|58628053|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
30617196|NCT00892957|58628052|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
30617197|NCT00892957|58628053|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
31010926|NCT00637572|59212858|FG001|Overall Study|Lost to Follow-up|1|||
31010927|NCT00637572|59212857|FG000|Overall Study|Physician Decision|1|||
31010928|NCT00637572|59212858|FG001|Overall Study|Physician Decision|1|||
31010929|NCT00637572|59212857|FG000|Overall Study|Withdrawal by Subject|0|||
31010930|NCT00637572|59212858|FG001|Overall Study|Withdrawal by Subject|2|||
31010931|NCT00637572|59212857|FG000|Overall Study|Illicit Drug Use|1|||
31010932|NCT00637572|59212858|FG001|Overall Study|Illicit Drug Use|0|||
30617198|NCT00968812|58628076|FG000|Overall Study|Adverse Event|30|||
30617199|NCT00968812|58628077|FG001|Overall Study|Adverse Event|46|||
30617200|NCT00968812|58628078|FG002|Overall Study|Adverse Event|33|||
30617201|NCT00968812|58628076|FG000|Overall Study|Death|2|||
30617202|NCT00968812|58628077|FG001|Overall Study|Death|2|||
30617203|NCT00968812|58628078|FG002|Overall Study|Death|1|||
30617204|NCT00968812|58628076|FG000|Overall Study|Lack of Efficacy|9|||
30617205|NCT00968812|58628077|FG001|Overall Study|Lack of Efficacy|7|||
30617206|NCT00968812|58628078|FG002|Overall Study|Lack of Efficacy|16|||
30617207|NCT00968812|58628076|FG000|Overall Study|Lost to Follow-up|17|||
30617208|NCT00968812|58628077|FG001|Overall Study|Lost to Follow-up|12|||
30617209|NCT00968812|58628078|FG002|Overall Study|Lost to Follow-up|11|||
30617210|NCT00968812|58628076|FG000|Overall Study|Physician Decision|8|||
30617211|NCT00968812|58628077|FG001|Overall Study|Physician Decision|5|||
30617212|NCT00968812|58628078|FG002|Overall Study|Physician Decision|9|||
30617213|NCT00968812|58628076|FG000|Overall Study|Protocol Violation|7|||
30617214|NCT00968812|58628077|FG001|Overall Study|Protocol Violation|4|||
30617215|NCT00968812|58628078|FG002|Overall Study|Protocol Violation|3|||
30843689|NCT01915498|58869653|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
31010933|NCT00637416|59212866|FG000|Overall Study|Lost to Follow-up|1|||
30617216|NCT00968812|58628076|FG000|Overall Study|Withdrawal by Subject|17|||
30617217|NCT00968812|58628077|FG001|Overall Study|Withdrawal by Subject|23|||
30617218|NCT00968812|58628078|FG002|Overall Study|Withdrawal by Subject|25|||
31010934|NCT00637416|59212867|FG001|Overall Study|Lost to Follow-up|1|||
31010935|NCT00637416|59212866|FG000|Overall Study|Unable to take study drug|0|||
30617219|NCT00968812|58628076|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
30617220|NCT00968812|58628077|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
30617221|NCT00968812|58628078|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
30617222|NCT00968812|58628076|FG000|Overall Study|Noncompliance with study drug|4|||
30617223|NCT00968812|58628077|FG001|Overall Study|Noncompliance with study drug|1|||
30617224|NCT00968812|58628078|FG002|Overall Study|Noncompliance with study drug|6|||
30617225|NCT00968812|58628076|FG000|Overall Study|Unable to take rescue therapy|12|||
30617226|NCT00968812|58628077|FG001|Overall Study|Unable to take rescue therapy|12|||
30617227|NCT00968812|58628078|FG002|Overall Study|Unable to take rescue therapy|17|||
30617228|NCT00968812|58628076|FG000|Overall Study|Other|25|||
30617229|NCT00968812|58628077|FG001|Overall Study|Other|37|||
30617230|NCT00968812|58628078|FG002|Overall Study|Other|40|||
30617231|NCT00992056|58628091|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
30617232|NCT00992056|58628092|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
30617233|NCT00992056|58628091|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
30617234|NCT00992056|58628092|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
30617235|NCT00972322|58628100|FG000|Overall Study|Adverse Event|2|||
30617236|NCT00972322|58628101|FG001|Overall Study|Adverse Event|1|||
30617237|NCT00972322|58628100|FG000|Overall Study|Positive drug screen|0|||
30617238|NCT00972322|58628101|FG001|Overall Study|Positive drug screen|1|||
30617239|NCT00972322|58628100|FG000|Overall Study|Lost to Follow-up|0|||
30617240|NCT00972322|58628101|FG001|Overall Study|Lost to Follow-up|1|||
30617241|NCT00972322|58628100|FG000|Overall Study|Consistently high glucose values|1|||
30617242|NCT00972322|58628101|FG001|Overall Study|Consistently high glucose values|0|||
30617243|NCT00967798|58628109|FG000|Overall Study|Withdrawal by Subject|5|||
30617244|NCT00967798|58628110|FG001|Overall Study|Withdrawal by Subject|2|||
30617245|NCT00967798|58628109|FG000|Overall Study|Lost to Follow-up|4|||
30617246|NCT00967798|58628110|FG001|Overall Study|Lost to Follow-up|1|||
30617247|NCT00965458|58628118|FG000|Overall Study|Adverse Event|1|||
30617248|NCT00965458|58628119|FG001|Overall Study|Adverse Event|0|||
30617249|NCT00965458|58628118|FG000|Overall Study|Lost to Follow-up|1|||
30617250|NCT00965458|58628119|FG001|Overall Study|Lost to Follow-up|3|||
30617251|NCT00965458|58628118|FG000|Overall Study|Withdrawal by Subject|0|||
30617252|NCT00965458|58628119|FG001|Overall Study|Withdrawal by Subject|1|||
30625550|NCT01185509|58637744|FG000|Overall Study|Withdrawal by Subject|0|||
30625551|NCT01185509|58637745|FG001|Overall Study|Withdrawal by Subject|1|||
30625552|NCT01185509|58637744|FG000|Overall Study|Death|0|||
30625553|NCT01185509|58637745|FG001|Overall Study|Death|1|||
30625554|NCT01185509|58637744|FG000|Overall Study|Intercurrent Illness|0|||
30625555|NCT01185509|58637745|FG001|Overall Study|Intercurrent Illness|1|||
30625556|NCT00891046|58637757|FG000|Overall Study|Protocol Violation|1|||
30625557|NCT00891046|58637758|FG001|Overall Study|Protocol Violation|1|||
30625558|NCT00891046|58637759|FG002|Overall Study|Protocol Violation|0|||
30625559|NCT00891046|58637760|FG003|Overall Study|Protocol Violation|0|||
30625560|NCT00891046|58637761|FG004|Overall Study|Protocol Violation|1|||
30625561|NCT00891046|58637757|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
30625562|NCT00891046|58637758|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30625563|NCT00891046|58637759|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
30625564|NCT00891046|58637760|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
30625565|NCT00891046|58637761|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
30625566|NCT00891046|58637757|FG000|Overall Study|Administrative problems|0|||
30625567|NCT00891046|58637758|FG001|Overall Study|Administrative problems|0|||
30625568|NCT00891046|58637759|FG002|Overall Study|Administrative problems|0|||
30625569|NCT00891046|58637760|FG003|Overall Study|Administrative problems|0|||
30625570|NCT00891046|58637761|FG004|Overall Study|Administrative problems|1|||
30625571|NCT00891046|58637757|FG000|Overall Study|Participant no longer required drug|0|||
30625572|NCT00891046|58637758|FG001|Overall Study|Participant no longer required drug|2|||
31010936|NCT00637416|59212867|FG001|Overall Study|Unable to take study drug|1|||
31010937|NCT00636792|59212873|FG000|Overall Study|Adverse Event|16|||
31010938|NCT00636792|59212873|FG000|Overall Study|Physician Decision|7|||
31010939|NCT00636792|59212873|FG000|Overall Study|Progressive Disease|4|||
31010940|NCT00636792|59212873|FG000|Overall Study|Withdrawal by Subject|3|||
31010941|NCT00636792|59212873|FG000|Overall Study|Other|3|||
31010942|NCT00636636|59212905|FG000|Overall Study|Other reason|4|||
31010943|NCT00636636|59212906|FG001|Overall Study|Other reason|6|||
30625573|NCT00891046|58637759|FG002|Overall Study|Participant no longer required drug|0|||
30625574|NCT00891046|58637760|FG003|Overall Study|Participant no longer required drug|0|||
30625575|NCT00891046|58637761|FG004|Overall Study|Participant no longer required drug|1|||
30625576|NCT00891046|58637757|FG000|Overall Study|Adverse Event|4|||
30625577|NCT00891046|58637758|FG001|Overall Study|Adverse Event|3|||
30625578|NCT00891046|58637759|FG002|Overall Study|Adverse Event|2|||
30625579|NCT00891046|58637760|FG003|Overall Study|Adverse Event|0|||
30625580|NCT00891046|58637761|FG004|Overall Study|Adverse Event|14|||
30893204|NCT02130765|58926652|FG001|Overall Study|Did not receive treatment|0|||
31010944|NCT00636636|59212905|FG000|Overall Study|Adverse Event|19|||
31010945|NCT00636636|59212906|FG001|Overall Study|Adverse Event|8|||
30625581|NCT00891046|58637757|FG000|Overall Study|Withdrawal by Subject|2|||
30625582|NCT00891046|58637758|FG001|Overall Study|Withdrawal by Subject|1|||
30625583|NCT00891046|58637759|FG002|Overall Study|Withdrawal by Subject|2|||
30625584|NCT00891046|58637760|FG003|Overall Study|Withdrawal by Subject|1|||
30625585|NCT00891046|58637761|FG004|Overall Study|Withdrawal by Subject|1|||
31010946|NCT00636636|59212905|FG000|Overall Study|Lack of Efficacy|7|||
31010947|NCT00636636|59212906|FG001|Overall Study|Lack of Efficacy|12|||
31010948|NCT00636636|59212905|FG000|Overall Study|Protocol Violation|2|||
31010949|NCT00636636|59212906|FG001|Overall Study|Protocol Violation|2|||
31010950|NCT00636636|59212905|FG000|Overall Study|Lost to Follow-up|0|||
31010951|NCT00636636|59212906|FG001|Overall Study|Lost to Follow-up|1|||
31010952|NCT00636636|59212905|FG000|Overall Study|Death|0|||
31010953|NCT00636636|59212906|FG001|Overall Study|Death|1|||
31010954|NCT00636636|59212905|FG000|Overall Study|Withdrawal by Subject|4|||
31010955|NCT00636636|59212906|FG001|Overall Study|Withdrawal by Subject|9|||
31010956|NCT00635778|59212919|FG000|Overall Study|Adverse Event|1|||
31010957|NCT00635778|59212920|FG001|Overall Study|Adverse Event|0|||
30617253|NCT00972244|58628132|FG000|Overall Study|Incorrect Enrolment|1|||
30617254|NCT00972244|58628133|FG001|Overall Study|Incorrect Enrolment|0|||
30617255|NCT00972244|58628134|FG002|Overall Study|Incorrect Enrolment|0|||
30617256|NCT00972244|58628135|FG003|Overall Study|Incorrect Enrolment|0|||
30617257|NCT00972244|58628136|FG004|Overall Study|Incorrect Enrolment|0|||
30617258|NCT00972244|58628132|FG000|Overall Study|Adverse Event|0|||
30617259|NCT00972244|58628133|FG001|Overall Study|Adverse Event|1|||
30617260|NCT00972244|58628134|FG002|Overall Study|Adverse Event|1|||
30617261|NCT00972244|58628135|FG003|Overall Study|Adverse Event|0|||
30617262|NCT00972244|58628136|FG004|Overall Study|Adverse Event|0|||
30617263|NCT00972244|58628132|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
30617264|NCT00972244|58628133|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
30617265|NCT00972244|58628134|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
31010958|NCT00635778|59212921|FG002|Overall Study|Adverse Event|0|||
31010959|NCT00635778|59212922|FG003|Overall Study|Adverse Event|3|||
31010960|NCT00635778|59212923|FG004|Overall Study|Adverse Event|3|||
31010961|NCT00635778|59212924|FG005|Overall Study|Adverse Event|6|||
31010962|NCT00635778|59212925|FG006|Overall Study|Adverse Event|1|||
31010963|NCT00635778|59212919|FG000|Overall Study|Withdrawal by Subject|0|||
31010964|NCT00635778|59212920|FG001|Overall Study|Withdrawal by Subject|0|||
31010965|NCT00635778|59212921|FG002|Overall Study|Withdrawal by Subject|0|||
31010966|NCT00635778|59212922|FG003|Overall Study|Withdrawal by Subject|1|||
31010967|NCT00635778|59212923|FG004|Overall Study|Withdrawal by Subject|0|||
31010968|NCT00635778|59212924|FG005|Overall Study|Withdrawal by Subject|1|||
31010969|NCT00635778|59212925|FG006|Overall Study|Withdrawal by Subject|1|||
31010970|NCT00635778|59212919|FG000|Overall Study|Progressive disease|0|||
31010971|NCT00635778|59212920|FG001|Overall Study|Progressive disease|3|||
31010972|NCT00635778|59212921|FG002|Overall Study|Progressive disease|3|||
31010973|NCT00635778|59212922|FG003|Overall Study|Progressive disease|4|||
31010974|NCT00635778|59212923|FG004|Overall Study|Progressive disease|5|||
31010975|NCT00635778|59212924|FG005|Overall Study|Progressive disease|14|||
31010976|NCT00635778|59212925|FG006|Overall Study|Progressive disease|4|||
31010977|NCT00634920|59212945|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
31010978|NCT00634920|59212946|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
31010979|NCT00634920|59212947|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
31010980|NCT00634920|59212945|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
31010981|NCT00634920|59212946|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
31010982|NCT00634920|59212947|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
31010983|NCT00634920|59212945|FG000|Period 1 - Pre-Randomization|Rejections|0|||
31010984|NCT00634920|59212946|FG001|Period 1 - Pre-Randomization|Rejections|0|||
31010985|NCT00634920|59212947|FG002|Period 1 - Pre-Randomization|Rejections|55|||
31010986|NCT00634920|59212945|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
31010987|NCT00634920|59212946|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
31010988|NCT00634920|59212947|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
31010989|NCT00634920|59212945|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
31010990|NCT00634920|59212946|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
31010991|NCT00634920|59212947|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
30617266|NCT00972244|58628135|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
30617267|NCT00972244|58628136|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
30617268|NCT00972244|58628132|FG000|Overall Study|Withdrawal by Subject|1|||
30617269|NCT00972244|58628133|FG001|Overall Study|Withdrawal by Subject|2|||
31010992|NCT00634920|59212945|FG000|Period 1 - Pre-Randomization|Other issues|0|||
31010993|NCT00634920|59212946|FG001|Period 1 - Pre-Randomization|Other issues|0|||
31010994|NCT00634920|59212947|FG002|Period 1 - Pre-Randomization|Other issues|6|||
31010995|NCT00634920|59212945|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
31010996|NCT00634920|59212946|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
31010997|NCT00634920|59212947|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
31010998|NCT00634920|59212945|FG000|Period 2 - Post-Randomization|Rejection|11|||
30617270|NCT00972244|58628134|FG002|Overall Study|Withdrawal by Subject|1|||
30617271|NCT00972244|58628135|FG003|Overall Study|Withdrawal by Subject|0|||
30617272|NCT00972244|58628136|FG004|Overall Study|Withdrawal by Subject|1|||
30617273|NCT00972244|58628132|FG000|Overall Study|Safety|0|||
31010999|NCT00634920|59212946|FG001|Period 2 - Post-Randomization|Rejection|5|||
31011000|NCT00634920|59212947|FG002|Period 2 - Post-Randomization|Rejection|0|||
31011001|NCT00634920|59212945|FG000|Period 2 - Post-Randomization|Death|2|||
31011002|NCT00634920|59212946|FG001|Period 2 - Post-Randomization|Death|5|||
31011003|NCT00634920|59212947|FG002|Period 2 - Post-Randomization|Death|0|||
31011004|NCT00634920|59212945|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
31011005|NCT00634920|59212946|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
31011006|NCT00634920|59212947|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
31011007|NCT00634920|59212945|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
31011008|NCT00634920|59212946|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
31011009|NCT00634920|59212947|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
31011010|NCT00634842|59212955|FG000|Overall Study|Adverse Event|2|||
31011011|NCT00634842|59212956|FG001|Overall Study|Adverse Event|3|||
31011012|NCT00634842|59212955|FG000|Overall Study|Protocol Violation|8|||
31011013|NCT00634842|59212956|FG001|Overall Study|Protocol Violation|4|||
31011014|NCT00634842|59212955|FG000|Overall Study|Move to another state|1|||
31011015|NCT00634842|59212956|FG001|Overall Study|Move to another state|0|||
31011016|NCT00634842|59212955|FG000|Overall Study|Inclusion criteria were not met|1|||
31011017|NCT00634842|59212956|FG001|Overall Study|Inclusion criteria were not met|0|||
31011018|NCT00634842|59212955|FG000|Overall Study|Lost to Follow-up|1|||
31011019|NCT00634842|59212956|FG001|Overall Study|Lost to Follow-up|2|||
31011020|NCT00634842|59212955|FG000|Overall Study|Physician Decision|1|||
31011021|NCT00634842|59212956|FG001|Overall Study|Physician Decision|0|||
31011022|NCT00634842|59212955|FG000|Overall Study|Withdrawal by Subject|1|||
31011023|NCT00634842|59212956|FG001|Overall Study|Withdrawal by Subject|3|||
31011024|NCT00634842|59212955|FG000|Overall Study|Lack of time and intolerance to drug|0|||
30617274|NCT00972244|58628133|FG001|Overall Study|Safety|0|||
30617275|NCT00972244|58628134|FG002|Overall Study|Safety|0|||
30617276|NCT00972244|58628135|FG003|Overall Study|Safety|0|||
30617277|NCT00972244|58628136|FG004|Overall Study|Safety|1|||
30617278|NCT00972244|58628132|FG000|Overall Study|Death|1|||
30617279|NCT00972244|58628133|FG001|Overall Study|Death|0|||
30617280|NCT00972244|58628134|FG002|Overall Study|Death|0|||
30617281|NCT00972244|58628135|FG003|Overall Study|Death|0|||
30617282|NCT00972244|58628136|FG004|Overall Study|Death|0|||
30617283|NCT00972244|58628132|FG000|Overall Study|Various|0|||
30617284|NCT00972244|58628133|FG001|Overall Study|Various|0|||
30617285|NCT00972244|58628134|FG002|Overall Study|Various|0|||
30617286|NCT00972244|58628135|FG003|Overall Study|Various|0|||
30617287|NCT00972244|58628136|FG004|Overall Study|Various|2|||
30617288|NCT00892723|58628151|FG000|Overall Study|Lost to Follow-up|1|||
30617289|NCT00892723|58628152|FG001|Overall Study|Lost to Follow-up|3|||
30617290|NCT00892723|58628153|FG002|Overall Study|Lost to Follow-up|1|||
30617291|NCT00892723|58628151|FG000|Overall Study|Withdrawal by Subject|1|||
30617292|NCT00892723|58628152|FG001|Overall Study|Withdrawal by Subject|1|||
30617293|NCT00892723|58628153|FG002|Overall Study|Withdrawal by Subject|1|||
30617294|NCT03811912|58628196|FG000|Overall Study|Withdrew Consent|4|||
30617295|NCT03811912|58628197|FG001|Overall Study|Withdrew Consent|2|||
30617296|NCT00971932|58628203|FG000|Overall Study|Withdrawal by Subject|1|||
30617297|NCT00971932|58628203|FG000|Overall Study|Investigator's decision|2|||
30617298|NCT00971932|58628203|FG000|Overall Study|Ongoing|4|||
30617299|NCT00970684|58628207|FG000|Overall Study|Lack of Efficacy|5|||
30617300|NCT00970684|58628207|FG000|Overall Study|Adverse Event|4|||
30617301|NCT00970684|58628207|FG000|Overall Study|Withdrawal by Subject|1|||
30617302|NCT00967330|58628213|FG000|Overall Study|Protocol Violation|3|||
30617303|NCT00967330|58628214|FG001|Overall Study|Protocol Violation|4|||
30617304|NCT00967330|58628213|FG000|Overall Study|Regular|10|||
30617305|NCT00967330|58628214|FG001|Overall Study|Regular|3|||
30617306|NCT00967330|58628213|FG000|Overall Study|Withdrawal by Subject|6|||
30617307|NCT00967330|58628214|FG001|Overall Study|Withdrawal by Subject|0|||
30617308|NCT00967330|58628213|FG000|Overall Study|Lost to Follow-up|1|||
30617309|NCT00967330|58628214|FG001|Overall Study|Lost to Follow-up|1|||
30617310|NCT00967330|58628213|FG000|Overall Study|Death|102|||
30617311|NCT00967330|58628214|FG001|Overall Study|Death|51|||
30617312|NCT00967330|58628213|FG000|Overall Study|Severe protocol deviation|0|||
30617313|NCT00967330|58628214|FG001|Overall Study|Severe protocol deviation|1|||
30617314|NCT00967018|58628220|FG000|Overall Study|Adverse Event|2|||
30617315|NCT00967018|58628220|FG000|Overall Study|Physician Decision|7|||
30617316|NCT00967018|58628220|FG000|Overall Study|Lost to Follow-up|2|||
30617317|NCT00967018|58628220|FG000|Overall Study|Withdrawal by Subject|1|||
30617318|NCT00967018|58628220|FG000|Overall Study|Miscellaneous Reasons|9|||
31011025|NCT00634842|59212956|FG001|Overall Study|Lack of time and intolerance to drug|1|||
30617319|NCT00965146|58628224|FG000|Overall Study|Death|7|||
30617320|NCT00965146|58628224|FG000|Overall Study|Lost to Follow-up|22|||
30617321|NCT00965146|58628224|FG000|Overall Study|Withdrawal by Subject|17|||
30617322|NCT00965146|58628224|FG000|Overall Study|Unable to return|1|||
30617323|NCT00965146|58628224|FG000|Overall Study|Unwilling to return|11|||
30617324|NCT00965146|58628224|FG000|Overall Study|Intercurrent illness|1|||
30617325|NCT00965146|58628224|FG000|Overall Study|Revision / Removal of Study Implant|6|||
30625586|NCT00891046|58637757|FG000|Overall Study|Lost to Follow-up|0|||
30617326|NCT00965146|58628224|FG000|Overall Study|Overall Study Termination|145|||
30617327|NCT00966940|58628230|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
30617328|NCT00966940|58628231|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
30617329|NCT00966940|58628230|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
30617330|NCT00966940|58628231|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
30617331|NCT00965848|58628237|FG000|Overall Study|Protocol Violation|3|||
30617332|NCT00965848|58628238|FG001|Overall Study|Protocol Violation|0|||
30617333|NCT00965848|58628239|FG002|Overall Study|Protocol Violation|1|||
30617334|NCT00965848|58628237|FG000|Overall Study|Death|11|||
30617335|NCT00965848|58628238|FG001|Overall Study|Death|1|||
30617336|NCT00965848|58628239|FG002|Overall Study|Death|5|||
30617337|NCT00965848|58628237|FG000|Overall Study|Lost to Follow-up|0|||
30617338|NCT00965848|58628238|FG001|Overall Study|Lost to Follow-up|0|||
30617339|NCT00965848|58628239|FG002|Overall Study|Lost to Follow-up|1|||
30617340|NCT00965848|58628237|FG000|Overall Study|Withdrawal by Subject|1|||
30617341|NCT00965848|58628238|FG001|Overall Study|Withdrawal by Subject|0|||
30617342|NCT00965848|58628239|FG002|Overall Study|Withdrawal by Subject|0|||
30617343|NCT00965848|58628237|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
30617344|NCT00965848|58628238|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
30617345|NCT00965848|58628239|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
30617346|NCT00965848|58628237|FG000|Overall Study|Not Clinically Evaluable|7|||
30617347|NCT00965848|58628238|FG001|Overall Study|Not Clinically Evaluable|1|||
30617348|NCT00965848|58628239|FG002|Overall Study|Not Clinically Evaluable|1|||
30617349|NCT00965848|58628237|FG000|Overall Study|Other|5|||
30617350|NCT00965848|58628238|FG001|Overall Study|Other|0|||
30617351|NCT00965848|58628239|FG002|Overall Study|Other|1|||
30617352|NCT00961636|58628250|FG000|Overall Study|Adverse Event|35|||
30617353|NCT00961636|58628251|FG001|Overall Study|Adverse Event|54|||
30699381|NCT00272779|58713883|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
30699382|NCT00272779|58713882|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
30699383|NCT00272779|58713883|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
30699384|NCT00272779|58713882|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
30699385|NCT00272779|58713883|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
30699386|NCT00272779|58713882|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
30699387|NCT00272779|58713883|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
30699388|NCT00272779|58713882|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
30699389|NCT00272779|58713883|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
30699390|NCT00272779|58713882|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
31011026|NCT00634842|59212955|FG000|Overall Study|Discontinued due to injection|0|||
31011027|NCT00634842|59212956|FG001|Overall Study|Discontinued due to injection|2|||
31011028|NCT00634842|59212955|FG000|Overall Study|No need of study drug to treat diabetes|0|||
31011029|NCT00634842|59212956|FG001|Overall Study|No need of study drug to treat diabetes|1|||
31011030|NCT00634842|59212955|FG000|Overall Study|No wish to keep taking Avandia|0|||
31011031|NCT00634842|59212956|FG001|Overall Study|No wish to keep taking Avandia|1|||
31011032|NCT00634842|59212955|FG000|Overall Study|Subject off study drug for too long|0|||
31011033|NCT00634842|59212956|FG001|Overall Study|Subject off study drug for too long|1|||
31011034|NCT00633984|59212964|FG000|Overall Study|Lost to Follow-up|0|||
31011035|NCT00633984|59212965|FG001|Overall Study|Lost to Follow-up|6|||
31011036|NCT00633984|59212964|FG000|Overall Study|Withdrawal by Subject|8|||
31011037|NCT00633984|59212965|FG001|Overall Study|Withdrawal by Subject|7|||
31011038|NCT00633984|59212964|FG000|Overall Study|Hospitalized|1|||
31011039|NCT00633984|59212965|FG001|Overall Study|Hospitalized|0|||
31011040|NCT01921218|59212993|FG000|Overall Study|Death|2|||
31011041|NCT01921218|59212994|FG001|Overall Study|Death|1|||
31011042|NCT01921218|59212993|FG000|Overall Study|Withdrawal by Subject|0|||
31011043|NCT01921218|59212994|FG001|Overall Study|Withdrawal by Subject|2|||
31011044|NCT01921218|59212993|FG000|Overall Study|Kidney transplant|1|||
31011045|NCT01921218|59212994|FG001|Overall Study|Kidney transplant|1|||
31011046|NCT00633750|59213000|FG000|Overall Study|Adverse Event|2|||
31011047|NCT00633750|59213000|FG000|Overall Study|Withdrawal by Subject|3|||
31011048|NCT00633360|59213008|FG000|Overall Study|Lost to Follow-up|1|||
31011049|NCT00633360|59213009|FG001|Overall Study|Lost to Follow-up|1|||
31011050|NCT00633360|59213008|FG000|Overall Study|Adverse Event|3|||
30699391|NCT00272779|58713883|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
30699392|NCT00272779|58713882|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
30617354|NCT00961636|58628252|FG002|Overall Study|Adverse Event|13|||
30617355|NCT00961636|58628250|FG000|Overall Study|Flushing Symptoms|29|||
30699393|NCT00272779|58713883|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
30699394|NCT00272779|58713882|FG000|Baseline Through Week 48|Continuing treatment|385|||
30699395|NCT00272779|58713883|FG001|Baseline Through Week 48|Continuing treatment|368|||
30699396|NCT00272779|58713882|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
31011051|NCT00633360|59213009|FG001|Overall Study|Adverse Event|1|||
31011052|NCT00633360|59213008|FG000|Overall Study|Protocol Violation|0|||
31011053|NCT00633360|59213009|FG001|Overall Study|Protocol Violation|1|||
31011054|NCT00633126|59213017|FG000|Overall Study|Did not receive full dose|1|||
31011055|NCT00989664|59213021|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
31011056|NCT00989664|59213021|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
31011057|NCT00989664|59213021|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
31011058|NCT00989664|59213021|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
31011059|NCT00989664|59213021|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
31011060|NCT00989664|59213021|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
31011061|NCT00989664|59213021|FG000|Long-Term Follow-Up|Death|3|||
31011062|NCT00632736|59213027|FG000|Overall Study|Adverse Event|104|||
31011063|NCT00632736|59213027|FG000|Overall Study|Lost to Follow-up|15|||
31011064|NCT00632736|59213027|FG000|Overall Study|Protocol Violation|14|||
30699397|NCT00272779|58713883|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
30699398|NCT00272779|58713882|FG000|Baseline Through Week 48|Never treated|2|||
30699399|NCT00272779|58713883|FG001|Baseline Through Week 48|Never treated|3|||
30699400|NCT00272779|58713882|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
30699401|NCT00272779|58713883|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
30699402|NCT00272779|58713882|FG000|Baseline Through Week 96|Death before Week 96|6|||
30699403|NCT00272779|58713883|FG001|Baseline Through Week 96|Death before Week 96|5|||
30699404|NCT00272779|58713882|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
30699405|NCT00272779|58713883|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
30699406|NCT00272779|58713882|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
30699407|NCT00272779|58713883|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
30699408|NCT00272779|58713882|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
30699409|NCT00272779|58713883|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
30699410|NCT00272779|58713882|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
30699411|NCT00272779|58713883|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
30699412|NCT00272779|58713882|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
31011065|NCT00632736|59213027|FG000|Overall Study|Withdrawal by Subject|99|||
31011066|NCT00632736|59213027|FG000|Overall Study|Lack of Efficacy|5|||
30617356|NCT00961636|58628251|FG001|Overall Study|Flushing Symptoms|46|||
30617357|NCT00961636|58628252|FG002|Overall Study|Flushing Symptoms|3|||
30617358|NCT00961636|58628250|FG000|Overall Study|Lost to Follow-up|2|||
30617359|NCT00961636|58628251|FG001|Overall Study|Lost to Follow-up|3|||
30617360|NCT00961636|58628252|FG002|Overall Study|Lost to Follow-up|1|||
30617361|NCT00961636|58628250|FG000|Overall Study|Physician Decision|3|||
30617362|NCT00961636|58628251|FG001|Overall Study|Physician Decision|1|||
30617363|NCT00961636|58628252|FG002|Overall Study|Physician Decision|1|||
30617364|NCT00961636|58628250|FG000|Overall Study|Protocol Violation|9|||
30617365|NCT00961636|58628251|FG001|Overall Study|Protocol Violation|5|||
30617366|NCT00961636|58628252|FG002|Overall Study|Protocol Violation|1|||
30617367|NCT00961636|58628250|FG000|Overall Study|Withdrawal by Subject|29|||
30617368|NCT00961636|58628251|FG001|Overall Study|Withdrawal by Subject|22|||
30617369|NCT00961636|58628252|FG002|Overall Study|Withdrawal by Subject|13|||
30617370|NCT00964678|58628260|FG000|Overall Study|Physician Decision|4|||
30617371|NCT00964366|58628267|FG000|Overall Study|Did not qualify at Day 1|1|||
30617372|NCT00964366|58628268|FG001|Overall Study|Did not qualify at Day 1|0|||
30617373|NCT00964366|58628267|FG000|Overall Study|Withdrawal by Subject|0|||
30617374|NCT00964366|58628268|FG001|Overall Study|Withdrawal by Subject|1|||
30617375|NCT00960154|58628276|FG000|Overall Study|Study termination|25|||
30617376|NCT00960154|58628277|FG001|Overall Study|Study termination|25|||
30617377|NCT00960076|58628285|FG000|Overall Study|Adverse Event|1|||
30617378|NCT00960076|58628286|FG001|Overall Study|Adverse Event|7|||
30617379|NCT00960076|58628285|FG000|Overall Study|No longer met study criteria|1|||
30617380|NCT00960076|58628286|FG001|Overall Study|No longer met study criteria|5|||
30617381|NCT00960076|58628285|FG000|Overall Study|Withdrawal by Subject|1|||
30617382|NCT00960076|58628286|FG001|Overall Study|Withdrawal by Subject|2|||
30617383|NCT00960076|58628285|FG000|Overall Study|Lost to Follow-up|3|||
30617384|NCT00960076|58628286|FG001|Overall Study|Lost to Follow-up|3|||
30617385|NCT00960076|58628285|FG000|Overall Study|Severe non-compliance to protocol|1|||
30617386|NCT00960076|58628286|FG001|Overall Study|Severe non-compliance to protocol|2|||
30617387|NCT00960076|58628285|FG000|Overall Study|Hyperglycemia|1|||
30617388|NCT00960076|58628286|FG001|Overall Study|Hyperglycemia|5|||
30617389|NCT00960076|58628285|FG000|Overall Study|Did not attend the termination visit|0|||
30617390|NCT00960076|58628286|FG001|Overall Study|Did not attend the termination visit|1|||
30617391|NCT01227629|58628302|FG000|Overall Study|Adverse Event|2|||
30617392|NCT01227629|58628303|FG001|Overall Study|Adverse Event|2|||
30617393|NCT01227629|58628304|FG002|Overall Study|Adverse Event|1|||
30617394|NCT01227629|58628305|FG003|Overall Study|Adverse Event|6|||
30617395|NCT01227629|58628306|FG004|Overall Study|Adverse Event|1|||
30617396|NCT01227629|58628307|FG005|Overall Study|Adverse Event|1|||
30617397|NCT01227629|58628308|FG006|Overall Study|Adverse Event|6|||
30617398|NCT01227629|58628309|FG007|Overall Study|Adverse Event|6|||
30617399|NCT01227629|58628310|FG008|Overall Study|Adverse Event|4|||
30617400|NCT01227629|58628311|FG009|Overall Study|Adverse Event|0|||
30617401|NCT01227629|58628302|FG000|Overall Study|Protocol Violation|0|||
30617402|NCT01227629|58628303|FG001|Overall Study|Protocol Violation|0|||
30617403|NCT01227629|58628304|FG002|Overall Study|Protocol Violation|0|||
30617404|NCT01227629|58628305|FG003|Overall Study|Protocol Violation|1|||
30617405|NCT01227629|58628306|FG004|Overall Study|Protocol Violation|0|||
30617406|NCT01227629|58628307|FG005|Overall Study|Protocol Violation|0|||
30617407|NCT01227629|58628308|FG006|Overall Study|Protocol Violation|0|||
30617408|NCT01227629|58628309|FG007|Overall Study|Protocol Violation|0|||
30617409|NCT01227629|58628310|FG008|Overall Study|Protocol Violation|0|||
30617410|NCT01227629|58628311|FG009|Overall Study|Protocol Violation|0|||
30617411|NCT01227629|58628302|FG000|Overall Study|Lost to Follow-up|0|||
30617412|NCT01227629|58628303|FG001|Overall Study|Lost to Follow-up|0|||
30617413|NCT01227629|58628304|FG002|Overall Study|Lost to Follow-up|0|||
30617414|NCT01227629|58628305|FG003|Overall Study|Lost to Follow-up|0|||
30617415|NCT01227629|58628306|FG004|Overall Study|Lost to Follow-up|1|||
30893205|NCT02130765|58926653|FG002|Overall Study|Did not receive treatment|0|||
31011067|NCT00632736|59213027|FG000|Overall Study|Sponsor terminated study|5|||
31011068|NCT00632736|59213027|FG000|Overall Study|Non-compliance|10|||
31011069|NCT00632736|59213027|FG000|Overall Study|Other|16|||
31011070|NCT00989196|59213031|FG000|Treatment Period|Lost to Follow-up|1|||
31011071|NCT00989196|59213032|FG001|Treatment Period|Lost to Follow-up|0|||
31011072|NCT00632502|59213040|FG000|Overall Study|Adverse Event|0|||
31011073|NCT00632502|59213041|FG001|Overall Study|Adverse Event|1|||
31011074|NCT00632502|59213040|FG000|Overall Study|Randomized not treated|3|||
31011075|NCT00632502|59213041|FG001|Overall Study|Randomized not treated|0|||
31011076|NCT00632424|59213051|FG000|Overall Study|Disease Progression|17|||
31011077|NCT00632424|59213051|FG000|Overall Study|Study Drug Toxicity|1|||
31011078|NCT00631488|59213068|FG000|Overall Study|Adverse Event|1|||
31011079|NCT00631488|59213069|FG001|Overall Study|Adverse Event|0|||
31011080|NCT00631488|59213070|FG002|Overall Study|Adverse Event|0|||
31011081|NCT00631488|59213068|FG000|Overall Study|Lost to Follow-up|2|||
31011082|NCT00631488|59213069|FG001|Overall Study|Lost to Follow-up|2|||
31011083|NCT00631488|59213070|FG002|Overall Study|Lost to Follow-up|0|||
31011084|NCT00631488|59213068|FG000|Overall Study|Physician Decision|1|||
31011085|NCT00631488|59213069|FG001|Overall Study|Physician Decision|0|||
31011086|NCT00631488|59213070|FG002|Overall Study|Physician Decision|1|||
31011087|NCT00631488|59213068|FG000|Overall Study|Protocol Violation|0|||
31011088|NCT00631488|59213069|FG001|Overall Study|Protocol Violation|0|||
31011089|NCT00631488|59213070|FG002|Overall Study|Protocol Violation|1|||
31011090|NCT00988884|59213080|FG000|Overall Study|Adverse Event|0|||
31011091|NCT00988884|59213081|FG001|Overall Study|Adverse Event|1|||
31011092|NCT00988884|59213080|FG000|Overall Study|Lost to Follow-up|20|||
31011093|NCT00988884|59213081|FG001|Overall Study|Lost to Follow-up|16|||
31011094|NCT00988884|59213080|FG000|Overall Study|Protocol Violation|0|||
31011095|NCT00988884|59213081|FG001|Overall Study|Protocol Violation|1|||
31011096|NCT00988884|59213080|FG000|Overall Study|Withdrawal by Subject|15|||
31011097|NCT00988884|59213081|FG001|Overall Study|Withdrawal by Subject|18|||
31011098|NCT00631020|59213087|FG000|Overall Study|Lost to Follow-up|7|||
31011099|NCT00631020|59213087|FG000|Overall Study|Incarcerated|1|||
31011100|NCT00987402|59213093|FG000|Overall Study|Insufficient data entry|86|||
31011101|NCT00987402|59213094|FG001|Overall Study|Insufficient data entry|98|||
31011102|NCT00630864|59213100|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
31011103|NCT00630864|59213100|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
31011104|NCT00630786|59213107|FG000|Overall Study|Physician Decision|0|||
31011105|NCT00630786|59213108|FG001|Overall Study|Physician Decision|0|||
31011106|NCT00630786|59213109|FG002|Overall Study|Physician Decision|1|||
31011107|NCT00630786|59213107|FG000|Overall Study|Withdrawal by Subject|0|||
31011108|NCT00630786|59213108|FG001|Overall Study|Withdrawal by Subject|1|||
31011109|NCT00630786|59213109|FG002|Overall Study|Withdrawal by Subject|1|||
31011110|NCT00630786|59213107|FG000|Overall Study|Lost to Follow-up|0|||
31011111|NCT00630786|59213108|FG001|Overall Study|Lost to Follow-up|1|||
31011112|NCT00630786|59213109|FG002|Overall Study|Lost to Follow-up|0|||
31011113|NCT00630786|59213107|FG000|Overall Study|Other|1|||
31011114|NCT00630786|59213108|FG001|Overall Study|Other|0|||
31011115|NCT00630786|59213109|FG002|Overall Study|Other|0|||
31011116|NCT00630396|59213115|FG000|Overall Study|Death|4|||
31011117|NCT00630396|59213115|FG000|Overall Study|Lost to Follow-up|3|||
31011118|NCT00985686|59213123|FG000|Overall Study|Lost to Follow-up|1|||
31011119|NCT00985686|59213124|FG001|Overall Study|Lost to Follow-up|1|||
31011120|NCT00985686|59213125|FG002|Overall Study|Lost to Follow-up|0|||
30617416|NCT01227629|58628307|FG005|Overall Study|Lost to Follow-up|0|||
30617417|NCT01227629|58628308|FG006|Overall Study|Lost to Follow-up|0|||
30617418|NCT01227629|58628309|FG007|Overall Study|Lost to Follow-up|0|||
30617419|NCT01227629|58628310|FG008|Overall Study|Lost to Follow-up|0|||
30893206|NCT02130765|58926654|FG003|Overall Study|Did not receive treatment|0|||
31011121|NCT00985686|59213126|FG003|Overall Study|Lost to Follow-up|2|||
31011122|NCT03098394|59213136|FG000|Overall Study|Pregnancy|0|||
31011123|NCT03098394|59213137|FG001|Overall Study|Pregnancy|1|||
31011124|NCT00984594|59213148|FG000|Overall Study|Lost to Follow-up|1|||
31011125|NCT00984594|59213149|FG001|Overall Study|Lost to Follow-up|0|||
31011126|NCT00984594|59213148|FG000|Overall Study|Withdrawal by Subject|0|||
31011127|NCT00984594|59213149|FG001|Overall Study|Withdrawal by Subject|1|||
31011128|NCT00984204|59213157|FG000|Overall Study|Death|1|||
31011129|NCT00984204|59213157|FG000|Overall Study|Lost to Follow-up|4|||
31011130|NCT00984204|59213157|FG000|Overall Study|Lack of Efficacy|10|||
31011131|NCT00983892|59213163|FG000|Overall Study|Withdrawal by Subject|10|||
31011132|NCT00983892|59213164|FG001|Overall Study|Withdrawal by Subject|12|||
31011133|NCT00983580|59213172|FG000|Overall Study|Cancel Prior to treatment|1|||
31011134|NCT00983580|59213173|FG001|Overall Study|Cancel Prior to treatment|3|||
31011135|NCT00983580|59213172|FG000|Overall Study|Protocol Violation|1|||
31011136|NCT00983580|59213173|FG001|Overall Study|Protocol Violation|1|||
31011137|NCT00983580|59213172|FG000|Overall Study|Ineligible|3|||
31011138|NCT00983580|59213173|FG001|Overall Study|Ineligible|0|||
31011139|NCT00982878|59213180|FG000|Overall Study|Physician Decision|1|||
31011140|NCT00982488|59213189|FG000|Overall Study|Administrative reason by sponsor|81|||
31011141|NCT00982488|59213190|FG001|Overall Study|Administrative reason by sponsor|3|||
31011142|NCT00982488|59213191|FG002|Overall Study|Administrative reason by sponsor|11|||
31011143|NCT00982488|59213192|FG003|Overall Study|Administrative reason by sponsor|0|||
31011144|NCT00982488|59213193|FG004|Overall Study|Administrative reason by sponsor|0|||
31011145|NCT00982488|59213189|FG000|Overall Study|Adverse event unrelated to study drug|5|||
31011146|NCT00982488|59213190|FG001|Overall Study|Adverse event unrelated to study drug|1|||
31011147|NCT00982488|59213191|FG002|Overall Study|Adverse event unrelated to study drug|0|||
31011148|NCT00982488|59213192|FG003|Overall Study|Adverse event unrelated to study drug|0|||
31011149|NCT00982488|59213193|FG004|Overall Study|Adverse event unrelated to study drug|0|||
31011150|NCT00982488|59213189|FG000|Overall Study|Death|11|||
31011151|NCT00982488|59213190|FG001|Overall Study|Death|0|||
31011152|NCT00982488|59213191|FG002|Overall Study|Death|2|||
30617420|NCT01227629|58628311|FG009|Overall Study|Lost to Follow-up|0|||
30617421|NCT01227629|58628302|FG000|Overall Study|Withdrawal by Subject|0|||
30617422|NCT01227629|58628303|FG001|Overall Study|Withdrawal by Subject|0|||
30617423|NCT01227629|58628304|FG002|Overall Study|Withdrawal by Subject|0|||
30617424|NCT01227629|58628305|FG003|Overall Study|Withdrawal by Subject|0|||
30617425|NCT01227629|58628306|FG004|Overall Study|Withdrawal by Subject|0|||
30617426|NCT01227629|58628307|FG005|Overall Study|Withdrawal by Subject|0|||
30617427|NCT01227629|58628308|FG006|Overall Study|Withdrawal by Subject|2|||
30617428|NCT01227629|58628309|FG007|Overall Study|Withdrawal by Subject|0|||
30617429|NCT01227629|58628310|FG008|Overall Study|Withdrawal by Subject|0|||
30617430|NCT01227629|58628311|FG009|Overall Study|Withdrawal by Subject|1|||
30617431|NCT01227629|58628302|FG000|Overall Study|Other|0|||
31011153|NCT00982488|59213192|FG003|Overall Study|Death|0|||
31011154|NCT00982488|59213193|FG004|Overall Study|Death|0|||
31011155|NCT00982488|59213189|FG000|Overall Study|Disease progression|30|||
31011156|NCT00982488|59213190|FG001|Overall Study|Disease progression|5|||
30617432|NCT01227629|58628303|FG001|Overall Study|Other|0|||
30617433|NCT01227629|58628304|FG002|Overall Study|Other|0|||
30617434|NCT01227629|58628305|FG003|Overall Study|Other|1|||
30617435|NCT01227629|58628306|FG004|Overall Study|Other|0|||
30617436|NCT01227629|58628307|FG005|Overall Study|Other|0|||
30617437|NCT01227629|58628308|FG006|Overall Study|Other|0|||
30617438|NCT01227629|58628309|FG007|Overall Study|Other|0|||
30617439|NCT01227629|58628310|FG008|Overall Study|Other|2|||
31011157|NCT00982488|59213191|FG002|Overall Study|Disease progression|10|||
31011158|NCT00982488|59213192|FG003|Overall Study|Disease progression|1|||
31011159|NCT00982488|59213193|FG004|Overall Study|Disease progression|1|||
31011160|NCT00982488|59213189|FG000|Overall Study|Lost to Follow-up|1|||
31011161|NCT00982488|59213190|FG001|Overall Study|Lost to Follow-up|0|||
31011162|NCT00982488|59213191|FG002|Overall Study|Lost to Follow-up|0|||
31011163|NCT00982488|59213192|FG003|Overall Study|Lost to Follow-up|0|||
31011164|NCT00982488|59213193|FG004|Overall Study|Lost to Follow-up|0|||
31011165|NCT00982488|59213189|FG000|Overall Study|Maximum clinical benefit|1|||
31011166|NCT00982488|59213190|FG001|Overall Study|Maximum clinical benefit|1|||
31011167|NCT00982488|59213191|FG002|Overall Study|Maximum clinical benefit|1|||
30617440|NCT01227629|58628311|FG009|Overall Study|Other|1|||
31011168|NCT00982488|59213192|FG003|Overall Study|Maximum clinical benefit|0|||
31011169|NCT00982488|59213193|FG004|Overall Study|Maximum clinical benefit|0|||
30617441|NCT00963820|58628357|FG000|Dose Escalation Phase|Progressive Disease|3|||
30617442|NCT00963820|58628358|FG001|Dose Escalation Phase|Progressive Disease|3|||
30617443|NCT00963820|58628359|FG002|Dose Escalation Phase|Progressive Disease|3|||
30893207|NCT02305381|58926669|FG000|Overall Study|Unclassified|5|||
31011170|NCT00982488|59213189|FG000|Overall Study|Other|15|||
31011171|NCT00982488|59213190|FG001|Overall Study|Other|1|||
30617444|NCT00963820|58628360|FG003|Dose Escalation Phase|Progressive Disease|3|||
30617445|NCT00963820|58628361|FG004|Dose Escalation Phase|Progressive Disease|4|||
31011172|NCT00982488|59213191|FG002|Overall Study|Other|3|||
31011173|NCT00982488|59213192|FG003|Overall Study|Other|1|||
31011174|NCT00982488|59213193|FG004|Overall Study|Other|0|||
31011175|NCT00982488|59213189|FG000|Overall Study|Poor compliance/noncompliance|0|||
31011176|NCT00982488|59213190|FG001|Overall Study|Poor compliance/noncompliance|1|||
31011177|NCT00982488|59213191|FG002|Overall Study|Poor compliance/noncompliance|0|||
31011178|NCT00982488|59213192|FG003|Overall Study|Poor compliance/noncompliance|0|||
31011179|NCT00982488|59213193|FG004|Overall Study|Poor compliance/noncompliance|0|||
31011180|NCT00982488|59213189|FG000|Overall Study|Stem cell transplant|2|||
31011181|NCT00982488|59213190|FG001|Overall Study|Stem cell transplant|0|||
31011182|NCT00982488|59213191|FG002|Overall Study|Stem cell transplant|0|||
31011183|NCT00982488|59213192|FG003|Overall Study|Stem cell transplant|1|||
31011184|NCT00982488|59213193|FG004|Overall Study|Stem cell transplant|0|||
31011185|NCT00982488|59213189|FG000|Overall Study|Study drug toxicity|34|||
31011186|NCT00982488|59213190|FG001|Overall Study|Study drug toxicity|1|||
31011187|NCT00982488|59213191|FG002|Overall Study|Study drug toxicity|6|||
31011188|NCT00982488|59213192|FG003|Overall Study|Study drug toxicity|0|||
31011189|NCT00982488|59213193|FG004|Overall Study|Study drug toxicity|0|||
31011190|NCT00982488|59213189|FG000|Overall Study|Withdrawal by Subject|5|||
31011191|NCT00982488|59213190|FG001|Overall Study|Withdrawal by Subject|1|||
31011192|NCT00982488|59213191|FG002|Overall Study|Withdrawal by Subject|1|||
31011193|NCT00982488|59213192|FG003|Overall Study|Withdrawal by Subject|0|||
31011194|NCT00982488|59213193|FG004|Overall Study|Withdrawal by Subject|0|||
31011195|NCT00982410|59213207|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
31011196|NCT00982410|59213208|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
31011197|NCT00982410|59213207|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
31011198|NCT00982410|59213208|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
31011199|NCT00982410|59213207|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
31011200|NCT00982410|59213208|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
31011201|NCT00982410|59213207|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
30617446|NCT00963820|58628362|FG005|Dose Escalation Phase|Progressive Disease|3|||
30617447|NCT00963820|58628363|FG006|Dose Escalation Phase|Progressive Disease|3|||
30617448|NCT00963820|58628364|FG007|Dose Escalation Phase|Progressive Disease|2|||
30617449|NCT00963820|58628365|FG008|Dose Escalation Phase|Progressive Disease|0|||
30617450|NCT00963820|58628366|FG009|Dose Escalation Phase|Progressive Disease|0|||
30617451|NCT00963820|58628367|FG010|Dose Escalation Phase|Progressive Disease|0|||
30617452|NCT00963820|58628368|FG011|Dose Escalation Phase|Progressive Disease|0|||
30617453|NCT00963820|58628357|FG000|Dose Escalation Phase|Adverse Event|0|||
30617454|NCT00963820|58628358|FG001|Dose Escalation Phase|Adverse Event|0|||
30617455|NCT00963820|58628359|FG002|Dose Escalation Phase|Adverse Event|0|||
31011202|NCT00982410|59213208|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
31011203|NCT00982410|59213207|FG000|6-month Follow-up Assessment|participant no transportation|1|||
31011204|NCT00982410|59213208|FG001|6-month Follow-up Assessment|participant no transportation|0|||
31011205|NCT00982410|59213207|FG000|6-month Follow-up Assessment|incarceration|0|||
31011206|NCT00982410|59213208|FG001|6-month Follow-up Assessment|incarceration|2|||
31011207|NCT00982410|59213207|FG000|6-month Follow-up Assessment|patent surgery|0|||
31011208|NCT00982410|59213208|FG001|6-month Follow-up Assessment|patent surgery|1|||
31011209|NCT00982410|59213207|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
31011210|NCT00982410|59213208|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
31011211|NCT00982410|59213207|FG000|12-month Follow-up Assessment|Death|0|||
31011212|NCT00982410|59213208|FG001|12-month Follow-up Assessment|Death|2|||
31011213|NCT00982410|59213207|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
31011214|NCT00982410|59213208|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
31011215|NCT00982410|59213207|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
31011216|NCT00982410|59213208|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
31011217|NCT00982410|59213207|FG000|12-month Follow-up Assessment|incarceration|2|||
31011218|NCT00982410|59213208|FG001|12-month Follow-up Assessment|incarceration|1|||
31011219|NCT00982410|59213207|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
31011220|NCT00982410|59213208|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
31011221|NCT00982020|59213217|FG000|Overall Study|Adverse Event|19|||
31011222|NCT00982020|59213218|FG001|Overall Study|Adverse Event|15|||
31011223|NCT00982020|59213217|FG000|Overall Study|Withdrawal by Subject|11|||
31011224|NCT00982020|59213218|FG001|Overall Study|Withdrawal by Subject|14|||
31011225|NCT00982020|59213217|FG000|Overall Study|Lost to Follow-up|5|||
30617456|NCT00963820|58628360|FG003|Dose Escalation Phase|Adverse Event|0|||
31011226|NCT00982020|59213218|FG001|Overall Study|Lost to Follow-up|11|||
30893208|NCT02305381|58926670|FG001|Overall Study|Unclassified|5|||
31011227|NCT00982020|59213217|FG000|Overall Study|Lack of Efficacy|10|||
31011228|NCT00982020|59213218|FG001|Overall Study|Lack of Efficacy|4|||
31011229|NCT00982020|59213217|FG000|Overall Study|Parent/Caregiver Decision|5|||
31011230|NCT00982020|59213218|FG001|Overall Study|Parent/Caregiver Decision|5|||
31011231|NCT00982020|59213217|FG000|Overall Study|Treatment Non-compliance|3|||
31011232|NCT00982020|59213218|FG001|Overall Study|Treatment Non-compliance|6|||
30617457|NCT00963820|58628361|FG004|Dose Escalation Phase|Adverse Event|0|||
30617458|NCT00963820|58628362|FG005|Dose Escalation Phase|Adverse Event|0|||
30625587|NCT00891046|58637758|FG001|Overall Study|Lost to Follow-up|0|||
31011233|NCT00982020|59213217|FG000|Overall Study|Physician Decision|2|||
31011234|NCT00982020|59213218|FG001|Overall Study|Physician Decision|5|||
31011235|NCT00982020|59213217|FG000|Overall Study|Entry Criteria Not Met|2|||
31011236|NCT00982020|59213218|FG001|Overall Study|Entry Criteria Not Met|1|||
31011237|NCT00982020|59213217|FG000|Overall Study|Protocol Violation|0|||
31011238|NCT00982020|59213218|FG001|Overall Study|Protocol Violation|2|||
31011239|NCT00982020|59213217|FG000|Overall Study|Clinical Relapse|0|||
31011240|NCT00982020|59213218|FG001|Overall Study|Clinical Relapse|1|||
31011241|NCT00981084|59213231|FG000|Post Intervention (Data Analysis)|poor effort|1|||
31011242|NCT00981084|59213232|FG001|Post Intervention (Data Analysis)|poor effort|1|||
31011243|NCT00981084|59213231|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
30617459|NCT00963820|58628363|FG006|Dose Escalation Phase|Adverse Event|3|||
30617460|NCT00963820|58628364|FG007|Dose Escalation Phase|Adverse Event|1|||
30617461|NCT00963820|58628365|FG008|Dose Escalation Phase|Adverse Event|0|||
30617462|NCT00963820|58628366|FG009|Dose Escalation Phase|Adverse Event|0|||
30617463|NCT00963820|58628367|FG010|Dose Escalation Phase|Adverse Event|0|||
30617464|NCT00963820|58628368|FG011|Dose Escalation Phase|Adverse Event|0|||
30617465|NCT00963820|58628357|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
30617466|NCT00963820|58628358|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
30617467|NCT00963820|58628359|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
30617468|NCT00963820|58628360|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
30617469|NCT00963820|58628361|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
30617470|NCT00963820|58628362|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
30617471|NCT00963820|58628363|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
30617472|NCT00963820|58628364|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
30617473|NCT00963820|58628365|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
30617474|NCT00963820|58628366|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
31011244|NCT00981084|59213232|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
31011245|NCT00980148|59213242|FG000|Overall Study|Discharged from facility|89|||
31011246|NCT00980148|59213243|FG001|Overall Study|Discharged from facility|96|||
31011247|NCT00980148|59213242|FG000|Overall Study|Received other antichlamydia treatment|20|||
31011248|NCT00980148|59213243|FG001|Overall Study|Received other antichlamydia treatment|14|||
31011249|NCT00980148|59213242|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
31011250|NCT00980148|59213243|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
31011251|NCT00980148|59213242|FG000|Overall Study|Various other reasons|8|||
31011252|NCT00980148|59213243|FG001|Overall Study|Various other reasons|9|||
31011253|NCT04553406|59213280|FG000|Overall Study|Study Discontinuation|0|||
31011254|NCT04553406|59213281|FG001|Overall Study|Study Discontinuation|1|||
31011255|NCT03033576|59213289|FG000|Overall Study|Ineligible|1|||
31011256|NCT03033576|59213290|FG001|Overall Study|Ineligible|1|||
31011257|NCT03033576|59213289|FG000|Overall Study|Adverse Event|4|||
31011258|NCT03033576|59213290|FG001|Overall Study|Adverse Event|20|||
31011259|NCT03033576|59213289|FG000|Overall Study|Progression/relapse|9|||
31011260|NCT03033576|59213290|FG001|Overall Study|Progression/relapse|36|||
30617475|NCT00963820|58628367|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
30617476|NCT00963820|58628368|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
30617477|NCT00963820|58628357|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30617478|NCT00963820|58628358|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30617479|NCT00963820|58628359|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30617480|NCT00963820|58628360|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30617481|NCT00963820|58628361|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30617482|NCT00963820|58628362|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30617483|NCT00963820|58628363|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
30617484|NCT00963820|58628364|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30617485|NCT00963820|58628365|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30617486|NCT00963820|58628366|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30617487|NCT00963820|58628367|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30617488|NCT00963820|58628368|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30617489|NCT00963820|58628357|FG000|Expansion Phase|Progressive Disease|0|||
30893209|NCT02305381|58926671|FG002|Overall Study|Unclassified|7|||
30617490|NCT00963820|58628358|FG001|Expansion Phase|Progressive Disease|0|||
30617491|NCT00963820|58628359|FG002|Expansion Phase|Progressive Disease|0|||
30617492|NCT00963820|58628360|FG003|Expansion Phase|Progressive Disease|0|||
30893210|NCT02336425|58926683|FG000|Overall Study|Study terminated.|2|||
30893211|NCT02336425|58926684|FG001|Overall Study|Study terminated.|2|||
30893212|NCT02336425|58926685|FG002|Overall Study|Study terminated.|3|||
31011261|NCT03033576|59213289|FG000|Overall Study|Death|1|||
31011262|NCT03033576|59213290|FG001|Overall Study|Death|1|||
31011263|NCT03033576|59213289|FG000|Overall Study|Patient refusal|1|||
31011264|NCT03033576|59213290|FG001|Overall Study|Patient refusal|6|||
31011265|NCT03033576|59213289|FG000|Overall Study|Other, unspecified reasons|0|||
31011266|NCT03033576|59213290|FG001|Overall Study|Other, unspecified reasons|4|||
31011267|NCT03033576|59213289|FG000|Overall Study|Currently on protocol therapy|0|||
31011268|NCT03033576|59213290|FG001|Overall Study|Currently on protocol therapy|2|||
31011269|NCT04129944|59213300|FG000|Overall Study|Death|0|||
31011270|NCT04129944|59213301|FG001|Overall Study|Death|0|||
31011271|NCT04129944|59213302|FG002|Overall Study|Death|0|||
31011272|NCT04129944|59213303|FG003|Overall Study|Death|1|||
30617493|NCT00963820|58628361|FG004|Expansion Phase|Progressive Disease|0|||
30617494|NCT00963820|58628362|FG005|Expansion Phase|Progressive Disease|0|||
30617495|NCT00963820|58628363|FG006|Expansion Phase|Progressive Disease|0|||
30617496|NCT00963820|58628364|FG007|Expansion Phase|Progressive Disease|0|||
30790793|NCT03524092|58803944|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
30790794|NCT03524092|58803945|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
30790795|NCT03524092|58803940|FG000|Loss of Response Rescue Period|Adverse Event|0|||
30790796|NCT03524092|58803941|FG001|Loss of Response Rescue Period|Adverse Event|0|||
30790797|NCT03524092|58803942|FG002|Loss of Response Rescue Period|Adverse Event|0|||
30790798|NCT03524092|58803943|FG003|Loss of Response Rescue Period|Adverse Event|2|||
30790799|NCT03524092|58803944|FG004|Loss of Response Rescue Period|Adverse Event|0|||
30790800|NCT03524092|58803945|FG005|Loss of Response Rescue Period|Adverse Event|0|||
30790801|NCT03524092|58803940|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
30790802|NCT03524092|58803941|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
30790803|NCT03524092|58803942|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
31011273|NCT04129944|59213300|FG000|Overall Study|Lost to Follow-up|1|||
31011274|NCT04129944|59213301|FG001|Overall Study|Lost to Follow-up|0|||
31011275|NCT04129944|59213302|FG002|Overall Study|Lost to Follow-up|0|||
30790804|NCT03524092|58803943|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
30790805|NCT03524092|58803944|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
30790806|NCT03524092|58803945|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
30790807|NCT03524092|58803940|FG000|Loss of Response Rescue Period|Pregnancy|0|||
30790808|NCT03524092|58803941|FG001|Loss of Response Rescue Period|Pregnancy|0|||
30790809|NCT03524092|58803942|FG002|Loss of Response Rescue Period|Pregnancy|0|||
30790810|NCT03524092|58803943|FG003|Loss of Response Rescue Period|Pregnancy|1|||
30790811|NCT03524092|58803944|FG004|Loss of Response Rescue Period|Pregnancy|0|||
30790812|NCT03524092|58803945|FG005|Loss of Response Rescue Period|Pregnancy|0|||
30790813|NCT03524092|58803940|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
30790814|NCT03524092|58803941|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
30790815|NCT03524092|58803942|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
30790816|NCT03524092|58803943|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
30790817|NCT03524092|58803944|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
30790818|NCT03524092|58803945|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
30790819|NCT03524092|58803940|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
30790820|NCT03524092|58803941|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
30790821|NCT03524092|58803942|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
30790822|NCT03524092|58803943|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
30790823|NCT03524092|58803944|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
30790824|NCT03524092|58803945|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
30790825|NCT03524092|58803940|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
30790826|NCT03524092|58803941|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
30790827|NCT03524092|58803942|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
30790828|NCT03524092|58803943|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
31011276|NCT04129944|59213303|FG003|Overall Study|Lost to Follow-up|0|||
31011277|NCT04129944|59213300|FG000|Overall Study|Withdrawal by Subject|1|||
31011278|NCT04129944|59213301|FG001|Overall Study|Withdrawal by Subject|0|||
31011279|NCT04129944|59213302|FG002|Overall Study|Withdrawal by Subject|1|||
31011280|NCT04129944|59213303|FG003|Overall Study|Withdrawal by Subject|2|||
31011281|NCT03829332|59213367|FG000|Overall Study|Death|145|||
31011282|NCT03829332|59213368|FG001|Overall Study|Death|135|||
31011283|NCT03829332|59213367|FG000|Overall Study|Withdrawal by Subject|10|||
31011284|NCT03829332|59213368|FG001|Overall Study|Withdrawal by Subject|4|||
30790829|NCT03524092|58803944|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
31011285|NCT03829332|59213367|FG000|Overall Study|Ongoing in Study|154|||
31011286|NCT03829332|59213368|FG001|Overall Study|Ongoing in Study|175|||
31011287|NCT01899144|59215002|FG000|Treatment Period 2|Other|1|||
31011288|NCT01899144|59215002|FG000|Treatment Period 3|Other|2|||
31011289|NCT01899144|59215002|FG000|Treatment Period 5|Other|1|||
31011290|NCT03821844|59215616|FG000|Overall Study|Death|37|||
31011291|NCT03821844|59215617|FG001|Overall Study|Death|31|||
31011292|NCT03821844|59215616|FG000|Overall Study|Discharged|10|||
31011293|NCT03821844|59215617|FG001|Overall Study|Discharged|14|||
31011294|NCT03821844|59215616|FG000|Overall Study|Not present in facility at followup|2|||
31011295|NCT03821844|59215617|FG001|Overall Study|Not present in facility at followup|3|||
31011296|NCT01796106|59217068|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
31011297|NCT01796106|59217069|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
31011298|NCT01168219|59218261|FG000|Overall Study|off study before starting treatment|2|||
31011299|NCT01168219|59218261|FG000|Overall Study|withdrew before transplant|1|||
31011300|NCT01168219|59218261|FG000|Overall Study|ineligible due to CML|2|||
31011301|NCT01115803|59218272|FG000|Overall Study|Withdrawal by Subject|0|||
31011302|NCT01115803|59218273|FG001|Overall Study|Withdrawal by Subject|0|||
31011303|NCT01115803|59218274|FG002|Overall Study|Withdrawal by Subject|0|||
31011304|NCT01115803|59218275|FG003|Overall Study|Withdrawal by Subject|0|||
31011305|NCT01115803|59218276|FG004|Overall Study|Withdrawal by Subject|0|||
31011306|NCT01115803|59218277|FG005|Overall Study|Withdrawal by Subject|0|||
31011307|NCT01115803|59218278|FG006|Overall Study|Withdrawal by Subject|1|||
31011308|NCT01115803|59218272|FG000|Overall Study|Lost to Follow-up|0|||
31011309|NCT01115803|59218273|FG001|Overall Study|Lost to Follow-up|0|||
31011310|NCT01115803|59218274|FG002|Overall Study|Lost to Follow-up|1|||
30790830|NCT03524092|58803945|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
30790831|NCT03524092|58803940|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
30790832|NCT03524092|58803941|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
30617497|NCT00963820|58628365|FG008|Expansion Phase|Progressive Disease|8|||
30617498|NCT00963820|58628366|FG009|Expansion Phase|Progressive Disease|6|||
30617499|NCT00963820|58628367|FG010|Expansion Phase|Progressive Disease|4|||
30617500|NCT00963820|58628368|FG011|Expansion Phase|Progressive Disease|2|||
30617501|NCT00963820|58628357|FG000|Expansion Phase|Adverse Event|0|||
30617502|NCT00963820|58628358|FG001|Expansion Phase|Adverse Event|0|||
30617503|NCT00963820|58628359|FG002|Expansion Phase|Adverse Event|0|||
30617504|NCT00963820|58628360|FG003|Expansion Phase|Adverse Event|0|||
30617505|NCT00963820|58628361|FG004|Expansion Phase|Adverse Event|0|||
30617506|NCT00963820|58628362|FG005|Expansion Phase|Adverse Event|0|||
30617507|NCT00963820|58628363|FG006|Expansion Phase|Adverse Event|0|||
30617508|NCT00963820|58628364|FG007|Expansion Phase|Adverse Event|0|||
30617509|NCT00963820|58628365|FG008|Expansion Phase|Adverse Event|1|||
30617510|NCT00963820|58628366|FG009|Expansion Phase|Adverse Event|3|||
30617511|NCT00963820|58628367|FG010|Expansion Phase|Adverse Event|0|||
30617512|NCT00963820|58628368|FG011|Expansion Phase|Adverse Event|0|||
30617513|NCT00963820|58628357|FG000|Expansion Phase|Withdrawal by Subject|0|||
30617514|NCT00963820|58628358|FG001|Expansion Phase|Withdrawal by Subject|0|||
30617515|NCT00963820|58628359|FG002|Expansion Phase|Withdrawal by Subject|0|||
30617516|NCT00963820|58628360|FG003|Expansion Phase|Withdrawal by Subject|0|||
30617517|NCT00963820|58628361|FG004|Expansion Phase|Withdrawal by Subject|0|||
30893213|NCT02336425|58926686|FG003|Overall Study|Study terminated.|3|||
30893214|NCT02163447|58926699|FG000|Overall Study|Withdrawal by Subject|2|||
30893215|NCT02163447|58926700|FG001|Overall Study|Withdrawal by Subject|0|||
30893216|NCT02163447|58926701|FG002|Overall Study|Withdrawal by Subject|1|||
30893217|NCT02163447|58926699|FG000|Overall Study|Lost to Follow-up|1|||
30893218|NCT02163447|58926700|FG001|Overall Study|Lost to Follow-up|3|||
30893219|NCT02163447|58926701|FG002|Overall Study|Lost to Follow-up|0|||
30893220|NCT02163447|58926699|FG000|Overall Study|Moved out of study area|2|||
30893221|NCT02163447|58926700|FG001|Overall Study|Moved out of study area|3|||
30893222|NCT02163447|58926701|FG002|Overall Study|Moved out of study area|2|||
30893223|NCT02163447|58926699|FG000|Overall Study|Became HIV infected at time of delivery|1|||
30893224|NCT02163447|58926700|FG001|Overall Study|Became HIV infected at time of delivery|0|||
30893225|NCT02163447|58926701|FG002|Overall Study|Became HIV infected at time of delivery|0|||
31011311|NCT01115803|59218275|FG003|Overall Study|Lost to Follow-up|0|||
31011312|NCT01115803|59218276|FG004|Overall Study|Lost to Follow-up|0|||
31011313|NCT01115803|59218277|FG005|Overall Study|Lost to Follow-up|0|||
31011314|NCT01115803|59218278|FG006|Overall Study|Lost to Follow-up|0|||
30617518|NCT00963820|58628362|FG005|Expansion Phase|Withdrawal by Subject|0|||
30617519|NCT00963820|58628363|FG006|Expansion Phase|Withdrawal by Subject|0|||
30617520|NCT00963820|58628364|FG007|Expansion Phase|Withdrawal by Subject|0|||
30617521|NCT00963820|58628365|FG008|Expansion Phase|Withdrawal by Subject|1|||
30617522|NCT00963820|58628366|FG009|Expansion Phase|Withdrawal by Subject|0|||
30617523|NCT00963820|58628367|FG010|Expansion Phase|Withdrawal by Subject|1|||
30617524|NCT00963820|58628368|FG011|Expansion Phase|Withdrawal by Subject|1|||
30617525|NCT00963820|58628357|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30617526|NCT00963820|58628358|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30617527|NCT00963820|58628359|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30617528|NCT00963820|58628360|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30617529|NCT00963820|58628361|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30617530|NCT00963820|58628362|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30617531|NCT00963820|58628363|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30617532|NCT00963820|58628364|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30617533|NCT00963820|58628365|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30617534|NCT00963820|58628366|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30617535|NCT00963820|58628367|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30617536|NCT00963820|58628368|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
30617537|NCT01227395|58628387|FG000|Overall Study|Protocol Violation|0|||
30617538|NCT01227395|58628388|FG001|Overall Study|Protocol Violation|1|||
30617539|NCT01226459|58628415|FG000|Overall Study|Adverse Event|2|||
30617540|NCT01226459|58628416|FG001|Overall Study|Adverse Event|8|||
30617541|NCT01226459|58628415|FG000|Overall Study|Protocol Violation|4|||
30617542|NCT01226459|58628416|FG001|Overall Study|Protocol Violation|3|||
30617543|NCT01226459|58628415|FG000|Overall Study|Withdrawal by Subject|10|||
30617544|NCT01226459|58628416|FG001|Overall Study|Withdrawal by Subject|13|||
30617545|NCT01226459|58628415|FG000|Overall Study|Lost to Follow-up|4|||
30617546|NCT01226459|58628416|FG001|Overall Study|Lost to Follow-up|8|||
30617547|NCT01226459|58628415|FG000|Overall Study|Pregnancy|1|||
30617548|NCT01226459|58628416|FG001|Overall Study|Pregnancy|0|||
30617549|NCT01225991|58628422|FG000|Overall Study|Withdrawal by Subject|6|||
30617550|NCT00959374|58628426|FG000|Overall Study|Withdrawal by Subject|2|||
30617551|NCT00959374|58628426|FG000|Overall Study|Lost to Follow-up|14|||
30617552|NCT00959374|58628426|FG000|Overall Study|Death|1|||
30617553|NCT00959374|58628426|FG000|Overall Study|Protocol Violation|1|||
30617554|NCT00959374|58628426|FG000|Overall Study|Implant Removed/Not Replaced|4|||
30617555|NCT00959374|58628426|FG000|Overall Study|Physician Decision|1|||
30617556|NCT01225835|58628436|FG000|Overall Study|Completed protocol|2|||
30617557|NCT01225835|58628437|FG001|Overall Study|Completed protocol|1|||
30617558|NCT01225835|58628436|FG000|Overall Study|Did not meet hCG criterion|2|||
30617559|NCT01225835|58628437|FG001|Overall Study|Did not meet hCG criterion|0|||
30617560|NCT01225835|58628436|FG000|Overall Study|Adverse Event|2|||
30617561|NCT01225835|58628437|FG001|Overall Study|Adverse Event|1|||
30617562|NCT01225835|58628436|FG000|Overall Study|Other|1|||
30617563|NCT01225835|58628437|FG001|Overall Study|Other|1|||
30617564|NCT02923180|58628449|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
30617565|NCT02923180|58628449|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
30617566|NCT00962650|58628453|FG000|Overall Study|Transgastric DP was not completed|2|||
30617567|NCT00958828|58628461|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
30617568|NCT00958828|58628462|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
30617569|NCT00958828|58628461|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
30617570|NCT00958828|58628462|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
31011315|NCT01115803|59218272|FG000|Overall Study|Progressive Disease during Cycle1|0|||
31011316|NCT01115803|59218273|FG001|Overall Study|Progressive Disease during Cycle1|0|||
31011317|NCT01115803|59218274|FG002|Overall Study|Progressive Disease during Cycle1|0|||
30617571|NCT00960934|58628474|FG000|Overall Study|Adverse Event|2|||
30617572|NCT00960934|58628475|FG001|Overall Study|Adverse Event|3|||
30617573|NCT00960934|58628476|FG002|Overall Study|Adverse Event|3|||
30617574|NCT00960934|58628477|FG003|Overall Study|Adverse Event|2|||
30617575|NCT00960934|58628478|FG004|Overall Study|Adverse Event|4|||
30617576|NCT00960934|58628479|FG005|Overall Study|Adverse Event|3|||
30617577|NCT00960934|58628474|FG000|Overall Study|Lack of Efficacy|1|||
30617578|NCT00960934|58628475|FG001|Overall Study|Lack of Efficacy|0|||
30617579|NCT00960934|58628476|FG002|Overall Study|Lack of Efficacy|0|||
30617580|NCT00960934|58628477|FG003|Overall Study|Lack of Efficacy|0|||
30617581|NCT00960934|58628478|FG004|Overall Study|Lack of Efficacy|0|||
30617582|NCT00960934|58628479|FG005|Overall Study|Lack of Efficacy|0|||
30617583|NCT00960934|58628474|FG000|Overall Study|Lost to Follow-up|0|||
30617584|NCT00960934|58628475|FG001|Overall Study|Lost to Follow-up|1|||
30617585|NCT00960934|58628476|FG002|Overall Study|Lost to Follow-up|0|||
30617586|NCT00960934|58628477|FG003|Overall Study|Lost to Follow-up|0|||
30617587|NCT00960934|58628478|FG004|Overall Study|Lost to Follow-up|0|||
31011318|NCT01115803|59218275|FG003|Overall Study|Progressive Disease during Cycle1|0|||
30617588|NCT00960934|58628479|FG005|Overall Study|Lost to Follow-up|0|||
30617589|NCT00960934|58628474|FG000|Overall Study|Other|2|||
30617590|NCT00960934|58628475|FG001|Overall Study|Other|1|||
30617591|NCT00960934|58628476|FG002|Overall Study|Other|5|||
30617592|NCT00960934|58628477|FG003|Overall Study|Other|4|||
30617593|NCT00960934|58628478|FG004|Overall Study|Other|2|||
30617594|NCT00960934|58628479|FG005|Overall Study|Other|2|||
30617595|NCT00960934|58628474|FG000|Overall Study|Physician Decision|0|||
30617596|NCT00960934|58628475|FG001|Overall Study|Physician Decision|1|||
30617597|NCT00960934|58628476|FG002|Overall Study|Physician Decision|0|||
30617598|NCT00960934|58628477|FG003|Overall Study|Physician Decision|0|||
30617599|NCT00960934|58628478|FG004|Overall Study|Physician Decision|0|||
30617600|NCT00960934|58628479|FG005|Overall Study|Physician Decision|0|||
30617601|NCT00960934|58628474|FG000|Overall Study|Progressive Disease|1|||
30617602|NCT00960934|58628475|FG001|Overall Study|Progressive Disease|1|||
30617603|NCT00960934|58628476|FG002|Overall Study|Progressive Disease|0|||
30617604|NCT00960934|58628477|FG003|Overall Study|Progressive Disease|0|||
30617605|NCT00960934|58628478|FG004|Overall Study|Progressive Disease|1|||
30617606|NCT00960934|58628479|FG005|Overall Study|Progressive Disease|1|||
30617607|NCT00960934|58628474|FG000|Overall Study|Protocol Violation|3|||
30617608|NCT00960934|58628475|FG001|Overall Study|Protocol Violation|4|||
30617609|NCT00960934|58628476|FG002|Overall Study|Protocol Violation|0|||
30617610|NCT00960934|58628477|FG003|Overall Study|Protocol Violation|3|||
30617611|NCT00960934|58628478|FG004|Overall Study|Protocol Violation|3|||
30617612|NCT00960934|58628479|FG005|Overall Study|Protocol Violation|2|||
30617613|NCT00960934|58628474|FG000|Overall Study|Withdrawal by Subject|5|||
30617614|NCT00960934|58628475|FG001|Overall Study|Withdrawal by Subject|6|||
30617615|NCT00960934|58628476|FG002|Overall Study|Withdrawal by Subject|4|||
30617616|NCT00960934|58628477|FG003|Overall Study|Withdrawal by Subject|5|||
30617617|NCT00960934|58628478|FG004|Overall Study|Withdrawal by Subject|5|||
30617618|NCT00960934|58628479|FG005|Overall Study|Withdrawal by Subject|7|||
30617619|NCT00960934|58628474|FG000|Overall Study|Study Terminated by Sponsor|50|||
30617620|NCT00960934|58628475|FG001|Overall Study|Study Terminated by Sponsor|46|||
30617621|NCT00960934|58628476|FG002|Overall Study|Study Terminated by Sponsor|52|||
30617622|NCT00960934|58628477|FG003|Overall Study|Study Terminated by Sponsor|50|||
30617623|NCT00960934|58628478|FG004|Overall Study|Study Terminated by Sponsor|49|||
30617624|NCT00960934|58628479|FG005|Overall Study|Study Terminated by Sponsor|49|||
30617625|NCT00892177|58628496|FG000|Phase II|Ineligible|0|||
30617626|NCT00892177|58628497|FG001|Phase II|Ineligible|0|||
30617627|NCT00892177|58628498|FG002|Phase II|Ineligible|0|||
30617628|NCT00892177|58628499|FG003|Phase II|Ineligible|0|||
30617629|NCT00892177|58628500|FG004|Phase II|Ineligible|1|||
30617630|NCT00892177|58628501|FG005|Phase II|Ineligible|1|||
30617631|NCT00892177|58628496|FG000|Phase II|Withdrawal by Subject|0|||
30617632|NCT00892177|58628497|FG001|Phase II|Withdrawal by Subject|0|||
30617633|NCT00892177|58628498|FG002|Phase II|Withdrawal by Subject|0|||
30617634|NCT00892177|58628499|FG003|Phase II|Withdrawal by Subject|0|||
30617635|NCT00892177|58628500|FG004|Phase II|Withdrawal by Subject|4|||
30617636|NCT00892177|58628501|FG005|Phase II|Withdrawal by Subject|1|||
30617637|NCT00962104|58628518|FG000|Overall Study|Adverse Event|10|||
30617638|NCT00962104|58628519|FG001|Overall Study|Adverse Event|3|||
30617639|NCT00962104|58628518|FG000|Overall Study|Entry Criteria Not Met|1|||
30617640|NCT00962104|58628519|FG001|Overall Study|Entry Criteria Not Met|2|||
30617641|NCT00962104|58628518|FG000|Overall Study|Lack of Efficacy|0|||
30617642|NCT00962104|58628519|FG001|Overall Study|Lack of Efficacy|1|||
30617643|NCT00962104|58628518|FG000|Overall Study|Lost to Follow-up|10|||
30617644|NCT00962104|58628519|FG001|Overall Study|Lost to Follow-up|4|||
30617645|NCT00962104|58628518|FG000|Overall Study|Physician Decision|1|||
30617646|NCT00962104|58628519|FG001|Overall Study|Physician Decision|0|||
30617647|NCT00962104|58628518|FG000|Overall Study|Protocol Violation|6|||
30617648|NCT00962104|58628519|FG001|Overall Study|Protocol Violation|8|||
30617649|NCT00962104|58628518|FG000|Overall Study|Sponsor Decision|0|||
30617650|NCT00962104|58628519|FG001|Overall Study|Sponsor Decision|1|||
30617651|NCT00962104|58628518|FG000|Overall Study|Withdrawal by Subject|10|||
30617652|NCT00962104|58628519|FG001|Overall Study|Withdrawal by Subject|6|||
30617653|NCT00962104|58628518|FG000|Overall Study|Other|2|||
30617654|NCT00962104|58628519|FG001|Overall Study|Other|0|||
30617655|NCT02821000|58628525|FG000|Overall Study|Death|44|||
30617656|NCT02821000|58628525|FG000|Overall Study|Withdrawal by Subject|1|||
30617657|NCT02821000|58628525|FG000|Overall Study|Ongoing in Study|58|||
30617658|NCT00892099|58628532|FG000|Overall Study|Death|1|||
30617659|NCT00892099|58628533|FG001|Overall Study|Death|0|||
30617660|NCT00892099|58628534|FG002|Overall Study|Death|1|||
30617661|NCT00892099|58628532|FG000|Overall Study|Adverse Event|1|||
30617662|NCT00892099|58628533|FG001|Overall Study|Adverse Event|0|||
30617663|NCT00892099|58628534|FG002|Overall Study|Adverse Event|0|||
30617664|NCT00892099|58628532|FG000|Overall Study|replocated|1|||
30617665|NCT00892099|58628533|FG001|Overall Study|replocated|0|||
30893226|NCT02370667|58926722|FG000|Overall Study|Lost to Follow-up|0|||
30617666|NCT00892099|58628534|FG002|Overall Study|replocated|2|||
30617667|NCT00892099|58628532|FG000|Overall Study|Prolonged hospitalization|1|||
30617668|NCT00892099|58628533|FG001|Overall Study|Prolonged hospitalization|0|||
30617669|NCT00892099|58628534|FG002|Overall Study|Prolonged hospitalization|1|||
30617670|NCT00892099|58628532|FG000|Overall Study|no further details|1|||
30617671|NCT00892099|58628533|FG001|Overall Study|no further details|0|||
30617672|NCT00892099|58628534|FG002|Overall Study|no further details|1|||
30617673|NCT00892099|58628532|FG000|Overall Study|kidney function recovered|0|||
30617674|NCT00892099|58628533|FG001|Overall Study|kidney function recovered|1|||
30617675|NCT00892099|58628534|FG002|Overall Study|kidney function recovered|0|||
30617676|NCT00892099|58628532|FG000|Overall Study|investigator decision|0|||
30617677|NCT00892099|58628533|FG001|Overall Study|investigator decision|0|||
30617678|NCT00892099|58628534|FG002|Overall Study|investigator decision|1|||
30617679|NCT00892099|58628532|FG000|Overall Study|Lost to Follow-up|0|||
30617680|NCT00892099|58628533|FG001|Overall Study|Lost to Follow-up|0|||
30617681|NCT00892099|58628534|FG002|Overall Study|Lost to Follow-up|1|||
30617682|NCT00960856|58628542|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
30617683|NCT00960856|58628543|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
30617684|NCT00960856|58628544|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
30617685|NCT00960856|58628545|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
30617686|NCT00960856|58628542|FG000|Washout Period of 7 Days|Adverse Event|0|||
30617687|NCT00960856|58628543|FG001|Washout Period of 7 Days|Adverse Event|0|||
30617688|NCT00960856|58628544|FG002|Washout Period of 7 Days|Adverse Event|1|||
30617689|NCT00960856|58628545|FG003|Washout Period of 7 Days|Adverse Event|0|||
30617690|NCT00958438|58628558|FG000|Overall Study|Protocol Violation|3|||
30617691|NCT00958438|58628559|FG001|Overall Study|Protocol Violation|2|||
30617692|NCT00958438|58628560|FG002|Overall Study|Protocol Violation|2|||
30617693|NCT00958438|58628558|FG000|Overall Study|Withdrawal by Subject|4|||
30617694|NCT00958438|58628559|FG001|Overall Study|Withdrawal by Subject|2|||
30617695|NCT00958438|58628560|FG002|Overall Study|Withdrawal by Subject|1|||
30617696|NCT00958438|58628558|FG000|Overall Study|Adverse Event|0|||
30617697|NCT00958438|58628559|FG001|Overall Study|Adverse Event|3|||
30617698|NCT00958438|58628560|FG002|Overall Study|Adverse Event|0|||
31011319|NCT01115803|59218276|FG004|Overall Study|Progressive Disease during Cycle1|0|||
31011320|NCT01115803|59218277|FG005|Overall Study|Progressive Disease during Cycle1|0|||
31011321|NCT01115803|59218278|FG006|Overall Study|Progressive Disease during Cycle1|1|||
31011322|NCT01115569|59218299|FG000|Conversion/Titration Phase|Adverse Event|59|||
31011323|NCT01115569|59218300|FG001|Conversion/Titration Phase|Adverse Event|0|||
31011324|NCT01115569|59218299|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
31011325|NCT01115569|59218300|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
31011326|NCT01115569|59218299|FG000|Conversion/Titration Phase|Physician Decision|5|||
31011327|NCT01115569|59218300|FG001|Conversion/Titration Phase|Physician Decision|0|||
31011328|NCT01115569|59218299|FG000|Conversion/Titration Phase|Protocol Violation|68|||
31011329|NCT01115569|59218300|FG001|Conversion/Titration Phase|Protocol Violation|0|||
31011330|NCT01115569|59218299|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
31011331|NCT01115569|59218300|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
31011332|NCT01115569|59218299|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
31011333|NCT01115569|59218300|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
31011334|NCT01115569|59218299|FG000|Maintenance Phase|Adverse Event|0|||
31011335|NCT01115569|59218300|FG001|Maintenance Phase|Adverse Event|43|||
31011336|NCT01115569|59218299|FG000|Maintenance Phase|Lost to Follow-up|0|||
31011337|NCT01115569|59218300|FG001|Maintenance Phase|Lost to Follow-up|8|||
31011338|NCT01115569|59218299|FG000|Maintenance Phase|Physician Decision|0|||
31011339|NCT01115569|59218300|FG001|Maintenance Phase|Physician Decision|3|||
31011340|NCT01115569|59218299|FG000|Maintenance Phase|Protocol Violation|0|||
31011341|NCT01115569|59218300|FG001|Maintenance Phase|Protocol Violation|9|||
31011342|NCT01115569|59218299|FG000|Maintenance Phase|Withdrawal by Subject|0|||
31011343|NCT01115569|59218300|FG001|Maintenance Phase|Withdrawal by Subject|27|||
31011344|NCT01115569|59218299|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
31011345|NCT01115569|59218300|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
31011346|NCT01115569|59218299|FG000|Maintenance Phase|Administrative|0|||
31011347|NCT01115569|59218300|FG001|Maintenance Phase|Administrative|1|||
31011348|NCT01107886|59218307|FG000|Overall Study|Lost to Follow-up|15|||
31011349|NCT01107886|59218308|FG001|Overall Study|Lost to Follow-up|13|||
31011350|NCT01107886|59218307|FG000|Overall Study|Withdrawal by Subject|180|||
31011351|NCT01107886|59218308|FG001|Overall Study|Withdrawal by Subject|196|||
31011352|NCT01107886|59218307|FG000|Overall Study|Administrative withdrawal of consent|7|||
31011353|NCT01107886|59218308|FG001|Overall Study|Administrative withdrawal of consent|5|||
31011354|NCT01107457|59218319|FG000|Part A|Adverse Event|1|||
31011355|NCT01107457|59218320|FG001|Part A|Adverse Event|2|||
31011356|NCT01107457|59218321|FG002|Part A|Adverse Event|1|||
30617699|NCT00958438|58628558|FG000|Overall Study|Physician Decision|1|||
30617700|NCT00958438|58628559|FG001|Overall Study|Physician Decision|0|||
30617701|NCT00958438|58628560|FG002|Overall Study|Physician Decision|1|||
30617702|NCT00958438|58628558|FG000|Overall Study|Other than specified above|2|||
30617703|NCT00958438|58628559|FG001|Overall Study|Other than specified above|3|||
30699413|NCT00272779|58713883|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
31011357|NCT01107457|59218322|FG003|Part A|Adverse Event|0|||
31011358|NCT01107457|59218323|FG004|Part A|Adverse Event|0|||
31011359|NCT01107457|59218324|FG005|Part A|Adverse Event|0|||
31011360|NCT01107457|59218319|FG000|Part A|Withdrawal by Subject|3|||
31011361|NCT01107457|59218320|FG001|Part A|Withdrawal by Subject|3|||
31011362|NCT01107457|59218321|FG002|Part A|Withdrawal by Subject|0|||
31011363|NCT01107457|59218322|FG003|Part A|Withdrawal by Subject|3|||
31011364|NCT01107457|59218323|FG004|Part A|Withdrawal by Subject|1|||
31011365|NCT01107457|59218324|FG005|Part A|Withdrawal by Subject|0|||
31011366|NCT01107457|59218319|FG000|Part A|Lost to Follow-up|0|||
31011367|NCT01107457|59218320|FG001|Part A|Lost to Follow-up|1|||
31011368|NCT01107457|59218321|FG002|Part A|Lost to Follow-up|0|||
31011369|NCT01107457|59218322|FG003|Part A|Lost to Follow-up|0|||
31011370|NCT01107457|59218323|FG004|Part A|Lost to Follow-up|0|||
31011371|NCT01107457|59218324|FG005|Part A|Lost to Follow-up|0|||
31011372|NCT01107457|59218319|FG000|Part A|Lack of Efficacy|1|||
31011373|NCT01107457|59218320|FG001|Part A|Lack of Efficacy|0|||
31011374|NCT01107457|59218321|FG002|Part A|Lack of Efficacy|0|||
31011375|NCT01107457|59218322|FG003|Part A|Lack of Efficacy|0|||
31011376|NCT01107457|59218323|FG004|Part A|Lack of Efficacy|0|||
31011377|NCT01107457|59218324|FG005|Part A|Lack of Efficacy|0|||
31011378|NCT01107457|59218319|FG000|Part A|Protocol Violation|0|||
31011379|NCT01107457|59218320|FG001|Part A|Protocol Violation|1|||
31011380|NCT01107457|59218321|FG002|Part A|Protocol Violation|0|||
31011381|NCT01107457|59218322|FG003|Part A|Protocol Violation|0|||
31011382|NCT01107457|59218323|FG004|Part A|Protocol Violation|0|||
31011383|NCT01107457|59218324|FG005|Part A|Protocol Violation|0|||
31011384|NCT01107457|59218319|FG000|Part B and C|Adverse Event|0|||
31011385|NCT01107457|59218320|FG001|Part B and C|Adverse Event|0|||
31011386|NCT01107457|59218321|FG002|Part B and C|Adverse Event|0|||
31011387|NCT01107457|59218322|FG003|Part B and C|Adverse Event|0|||
30617704|NCT00958438|58628560|FG002|Overall Study|Other than specified above|2|||
31011388|NCT01107457|59218323|FG004|Part B and C|Adverse Event|0|||
31011389|NCT01107457|59218324|FG005|Part B and C|Adverse Event|12|||
31011390|NCT01107457|59218319|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
31011391|NCT01107457|59218320|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
31011392|NCT01107457|59218321|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
31011393|NCT01107457|59218322|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
31011394|NCT01107457|59218323|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
31011395|NCT01107457|59218324|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
31011396|NCT01107457|59218319|FG000|Part B and C|Physician Decision|0|||
31011397|NCT01107457|59218320|FG001|Part B and C|Physician Decision|0|||
31011398|NCT01107457|59218321|FG002|Part B and C|Physician Decision|0|||
31011399|NCT01107457|59218322|FG003|Part B and C|Physician Decision|0|||
31011400|NCT01107457|59218323|FG004|Part B and C|Physician Decision|0|||
31011401|NCT01107457|59218324|FG005|Part B and C|Physician Decision|3|||
31011402|NCT01107457|59218319|FG000|Part B and C|Lack of Efficacy|0|||
31011403|NCT01107457|59218320|FG001|Part B and C|Lack of Efficacy|0|||
31011404|NCT01107457|59218321|FG002|Part B and C|Lack of Efficacy|0|||
31011405|NCT01107457|59218322|FG003|Part B and C|Lack of Efficacy|0|||
31011406|NCT01107457|59218323|FG004|Part B and C|Lack of Efficacy|0|||
31011407|NCT01107457|59218324|FG005|Part B and C|Lack of Efficacy|7|||
31011408|NCT01107457|59218319|FG000|Part B and C|Lost to Follow-up|0|||
31011409|NCT01107457|59218320|FG001|Part B and C|Lost to Follow-up|0|||
31011410|NCT01107457|59218321|FG002|Part B and C|Lost to Follow-up|0|||
31011411|NCT01107457|59218322|FG003|Part B and C|Lost to Follow-up|0|||
31011412|NCT01107457|59218323|FG004|Part B and C|Lost to Follow-up|0|||
31011413|NCT01107457|59218324|FG005|Part B and C|Lost to Follow-up|10|||
31011414|NCT01107457|59218319|FG000|Part B and C|Protocol Violation|0|||
31011415|NCT01107457|59218320|FG001|Part B and C|Protocol Violation|0|||
31011416|NCT01107457|59218321|FG002|Part B and C|Protocol Violation|0|||
31011417|NCT01107457|59218322|FG003|Part B and C|Protocol Violation|0|||
31011418|NCT01107457|59218323|FG004|Part B and C|Protocol Violation|0|||
31011419|NCT01107457|59218324|FG005|Part B and C|Protocol Violation|1|||
31011420|NCT01107457|59218319|FG000|Part B and C|Sponsor Decision|0|||
31011421|NCT01107457|59218320|FG001|Part B and C|Sponsor Decision|0|||
31011422|NCT01107457|59218321|FG002|Part B and C|Sponsor Decision|0|||
31011423|NCT01107457|59218322|FG003|Part B and C|Sponsor Decision|0|||
31011424|NCT01107457|59218323|FG004|Part B and C|Sponsor Decision|0|||
31011425|NCT01107457|59218324|FG005|Part B and C|Sponsor Decision|66|||
31011426|NCT01107457|59218319|FG000|Part B and C|Withdrawal by Subject|0|||
31011427|NCT01107457|59218320|FG001|Part B and C|Withdrawal by Subject|0|||
31011428|NCT01107457|59218321|FG002|Part B and C|Withdrawal by Subject|0|||
31011429|NCT01107457|59218322|FG003|Part B and C|Withdrawal by Subject|0|||
31011430|NCT01107457|59218323|FG004|Part B and C|Withdrawal by Subject|0|||
31011431|NCT01107457|59218324|FG005|Part B and C|Withdrawal by Subject|16|||
31011432|NCT01107457|59218319|FG000|Part B and C|Clinical Relapse|0|||
31011433|NCT01107457|59218320|FG001|Part B and C|Clinical Relapse|0|||
30617705|NCT00958360|58628570|FG000|Overall Study|Withdrawal by Subject|3|||
30617706|NCT00958360|58628571|FG001|Overall Study|Withdrawal by Subject|1|||
31011434|NCT01107457|59218321|FG002|Part B and C|Clinical Relapse|0|||
31011435|NCT01107457|59218322|FG003|Part B and C|Clinical Relapse|0|||
31011436|NCT01107457|59218323|FG004|Part B and C|Clinical Relapse|0|||
31011437|NCT01107457|59218324|FG005|Part B and C|Clinical Relapse|4|||
31011438|NCT04545385|59218354|FG000|Overall Study|Withdrawal by Subject|2|||
31011439|NCT04545385|59218355|FG001|Overall Study|Withdrawal by Subject|0|||
31011440|NCT04545385|59218354|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
30617707|NCT00958360|58628570|FG000|Overall Study|Death|6|||
30617708|NCT00958360|58628571|FG001|Overall Study|Death|7|||
30617709|NCT00958360|58628570|FG000|Overall Study|Physician Decision|2|||
30617710|NCT00958360|58628571|FG001|Overall Study|Physician Decision|1|||
30617711|NCT00958360|58628570|FG000|Overall Study|Lost to Follow-up|0|||
30617712|NCT00958360|58628571|FG001|Overall Study|Lost to Follow-up|1|||
30617713|NCT00888433|58628579|FG000|Overall Study|Withdrawal by Subject|1|||
30617714|NCT00888433|58628580|FG001|Overall Study|Withdrawal by Subject|2|||
30617715|NCT00888433|58628579|FG000|Overall Study|Missed Visit|2|||
30617716|NCT00888433|58628580|FG001|Overall Study|Missed Visit|1|||
30617717|NCT01243424|58628588|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
30617718|NCT01243424|58628589|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
30617719|NCT01243424|58628588|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
30617720|NCT01243424|58628589|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
30617721|NCT01243424|58628588|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
31011441|NCT04545385|59218355|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
31011442|NCT04545385|59218354|FG000|Overall Study|Study termination|10|||
31011443|NCT04545385|59218355|FG001|Overall Study|Study termination|10|||
31011444|NCT04545385|59218354|FG000|Overall Study|Sponsor decision|2|||
31011445|NCT04545385|59218355|FG001|Overall Study|Sponsor decision|2|||
31011446|NCT04545385|59218354|FG000|Overall Study|Other than specified|1|||
31011447|NCT04545385|59218355|FG001|Overall Study|Other than specified|0|||
31011448|NCT04099251|59218372|FG000|Pre-Treatment|Other reasons|1|||
31011449|NCT04099251|59218373|FG001|Pre-Treatment|Other reasons|0|||
31011450|NCT04099251|59218372|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
31011451|NCT04099251|59218373|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
31011452|NCT04099251|59218372|FG000|Blinded Treatment Phase|Other reasons|16|||
31011453|NCT04099251|59218373|FG001|Blinded Treatment Phase|Other reasons|7|||
31011454|NCT04099251|59218372|FG000|Blinded Treatment Phase|Disease recurrence|26|||
31011455|NCT04099251|59218373|FG001|Blinded Treatment Phase|Disease recurrence|41|||
31011456|NCT04099251|59218372|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
31011457|NCT04099251|59218373|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
31011458|NCT04099251|59218372|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
31011459|NCT04099251|59218373|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
31011460|NCT04099251|59218372|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
31011461|NCT04099251|59218373|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
31011462|NCT04099251|59218372|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
31011463|NCT04099251|59218373|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
31011464|NCT04099251|59218372|FG000|Blinded Treatment Phase|Death|6|||
31011465|NCT04099251|59218373|FG001|Blinded Treatment Phase|Death|2|||
31011466|NCT04099251|59218372|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
31011467|NCT04099251|59218373|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
31011468|NCT04099251|59218372|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
31011469|NCT04099251|59218373|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
31011470|NCT04099251|59218372|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
31011471|NCT04099251|59218373|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
31011472|NCT04099251|59218372|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
31011473|NCT04099251|59218373|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
31011474|NCT04099251|59218372|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
31011475|NCT04099251|59218373|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
31011476|NCT04099251|59218372|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
31011477|NCT04099251|59218373|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
31011478|NCT04099251|59218372|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
31011479|NCT04099251|59218373|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
31011480|NCT04099251|59218372|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
31011481|NCT04099251|59218373|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
31011482|NCT04099251|59218372|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
31011483|NCT04099251|59218373|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
31011484|NCT03783026|59218380|FG000|Treatment Phase|Adverse Event|15|||
31011485|NCT03783026|59218380|FG000|Treatment Phase|Lack of Efficacy|11|||
31011486|NCT03783026|59218380|FG000|Treatment Phase|Withdrawal by Subject|6|||
30617722|NCT01243424|58628589|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
30617723|NCT01243424|58628588|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
31011487|NCT03783026|59218380|FG000|Treatment Phase|Lost to Follow-up|2|||
31011488|NCT03783026|59218380|FG000|Treatment Phase|Protocol Deviation|8|||
31011489|NCT03783026|59218380|FG000|Treatment Phase|Did Not Receive Treatment|1|||
31011490|NCT03783026|59218380|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
31011491|NCT03635112|59218397|FG000|Overall Study|Adverse Event|5|||
31011492|NCT03635112|59218398|FG001|Overall Study|Adverse Event|9|||
31011493|NCT03635112|59218399|FG002|Overall Study|Adverse Event|14|||
31011494|NCT03635112|59218397|FG000|Overall Study|Lost to Follow-up|1|||
31011495|NCT03635112|59218398|FG001|Overall Study|Lost to Follow-up|0|||
31011496|NCT03635112|59218399|FG002|Overall Study|Lost to Follow-up|1|||
31011497|NCT03635112|59218397|FG000|Overall Study|Physician Decision|5|||
31011498|NCT03635112|59218398|FG001|Overall Study|Physician Decision|7|||
31011499|NCT03635112|59218399|FG002|Overall Study|Physician Decision|5|||
31011500|NCT03635112|59218397|FG000|Overall Study|Protocol Violation|0|||
31011501|NCT03635112|59218398|FG001|Overall Study|Protocol Violation|0|||
31011502|NCT03635112|59218399|FG002|Overall Study|Protocol Violation|1|||
31011503|NCT03635112|59218397|FG000|Overall Study|Study Terminated by Sponsor|11|||
31011504|NCT03635112|59218398|FG001|Overall Study|Study Terminated by Sponsor|17|||
31011505|NCT03635112|59218399|FG002|Overall Study|Study Terminated by Sponsor|21|||
31011506|NCT03635112|59218397|FG000|Overall Study|Withdrawal by Subject|4|||
31011507|NCT03635112|59218398|FG001|Overall Study|Withdrawal by Subject|9|||
31011508|NCT03635112|59218399|FG002|Overall Study|Withdrawal by Subject|7|||
31011509|NCT03635112|59218397|FG000|Overall Study|Miscellaneous|0|||
31011510|NCT03635112|59218398|FG001|Overall Study|Miscellaneous|0|||
31011511|NCT03635112|59218399|FG002|Overall Study|Miscellaneous|1|||
31011512|NCT03588728|59218412|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
31011513|NCT03588728|59218413|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
31011514|NCT03588728|59218414|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
31011515|NCT03588728|59218415|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
31011516|NCT03588728|59218412|FG000|Overall Study|Lab shut down due to COVID-19|0|||
31011517|NCT03588728|59218413|FG001|Overall Study|Lab shut down due to COVID-19|0|||
31011518|NCT03588728|59218414|FG002|Overall Study|Lab shut down due to COVID-19|0|||
31011519|NCT03588728|59218415|FG003|Overall Study|Lab shut down due to COVID-19|1|||
31011520|NCT03588728|59218412|FG000|Overall Study|multiple technical issues|1|||
31011521|NCT03588728|59218413|FG001|Overall Study|multiple technical issues|0|||
31011522|NCT03588728|59218414|FG002|Overall Study|multiple technical issues|0|||
31011523|NCT03588728|59218415|FG003|Overall Study|multiple technical issues|0|||
31011524|NCT03588728|59218412|FG000|Overall Study|Hospitalized for COVID|1|||
31011525|NCT03588728|59218413|FG001|Overall Study|Hospitalized for COVID|0|||
31011526|NCT03588728|59218414|FG002|Overall Study|Hospitalized for COVID|0|||
31011527|NCT03588728|59218415|FG003|Overall Study|Hospitalized for COVID|0|||
31011528|NCT03588728|59218412|FG000|Overall Study|Schedule change unable to attend sessions|1|||
31011529|NCT03588728|59218413|FG001|Overall Study|Schedule change unable to attend sessions|0|||
31011530|NCT03588728|59218414|FG002|Overall Study|Schedule change unable to attend sessions|0|||
31011531|NCT03588728|59218415|FG003|Overall Study|Schedule change unable to attend sessions|0|||
31011532|NCT02987543|59218437|FG000|Overall Study|Ongoing study at data cut off|49|||
31011533|NCT02987543|59218438|FG001|Overall Study|Ongoing study at data cut off|21|||
31011534|NCT02987543|59218439|FG002|Overall Study|Ongoing study at data cut off|19|||
31011535|NCT02987543|59218440|FG003|Overall Study|Ongoing study at data cut off|12|||
31011536|NCT02987543|59218437|FG000|Overall Study|Death|88|||
31011537|NCT02987543|59218438|FG001|Overall Study|Death|54|||
31011538|NCT02987543|59218439|FG002|Overall Study|Death|67|||
31011539|NCT02987543|59218440|FG003|Overall Study|Death|28|||
31011540|NCT02987543|59218437|FG000|Overall Study|Lost to Follow-up|3|||
31011541|NCT02987543|59218438|FG001|Overall Study|Lost to Follow-up|0|||
31011542|NCT02987543|59218439|FG002|Overall Study|Lost to Follow-up|1|||
31011543|NCT02987543|59218440|FG003|Overall Study|Lost to Follow-up|0|||
31011544|NCT02987543|59218437|FG000|Overall Study|Screen failure|0|||
31011545|NCT02987543|59218438|FG001|Overall Study|Screen failure|0|||
31011546|NCT02987543|59218439|FG002|Overall Study|Screen failure|0|||
31011547|NCT02987543|59218440|FG003|Overall Study|Screen failure|1|||
31011548|NCT02987543|59218437|FG000|Overall Study|Withdrawal by Subject|21|||
31011549|NCT02987543|59218438|FG001|Overall Study|Withdrawal by Subject|7|||
31011550|NCT02987543|59218439|FG002|Overall Study|Withdrawal by Subject|7|||
31011551|NCT02987543|59218440|FG003|Overall Study|Withdrawal by Subject|6|||
31011552|NCT02987543|59218437|FG000|Overall Study|Study terminated by sponsor|1|||
31011553|NCT02987543|59218438|FG001|Overall Study|Study terminated by sponsor|0|||
31011554|NCT02987543|59218439|FG002|Overall Study|Study terminated by sponsor|0|||
31011555|NCT02987543|59218440|FG003|Overall Study|Study terminated by sponsor|0|||
30790833|NCT03524092|58803942|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
31011556|NCT02987543|59218437|FG000|Overall Study|Investigator decision|0|||
31011557|NCT02987543|59218438|FG001|Overall Study|Investigator decision|1|||
31011558|NCT02987543|59218439|FG002|Overall Study|Investigator decision|0|||
31011559|NCT02987543|59218440|FG003|Overall Study|Investigator decision|0|||
31011560|NCT02987543|59218437|FG000|Overall Study|Disease progression|0|||
31011561|NCT02987543|59218438|FG001|Overall Study|Disease progression|0|||
31011562|NCT02987543|59218439|FG002|Overall Study|Disease progression|0|||
31011563|NCT02987543|59218440|FG003|Overall Study|Disease progression|1|||
31011564|NCT02983045|59218456|FG000|Overall Study|Withdrawal by Subject|0|||
31011565|NCT02983045|59218457|FG001|Overall Study|Withdrawal by Subject|1|||
31011566|NCT02983045|59218458|FG002|Overall Study|Withdrawal by Subject|0|||
31011567|NCT02983045|59218459|FG003|Overall Study|Withdrawal by Subject|5|||
31011568|NCT02983045|59218460|FG004|Overall Study|Withdrawal by Subject|0|||
31011569|NCT02983045|59218461|FG005|Overall Study|Withdrawal by Subject|72|||
31011570|NCT02983045|59218462|FG006|Overall Study|Withdrawal by Subject|0|||
31011571|NCT02983045|59218463|FG007|Overall Study|Withdrawal by Subject|0|||
31011572|NCT02983045|59218464|FG008|Overall Study|Withdrawal by Subject|0|||
31011573|NCT02983045|59218465|FG009|Overall Study|Withdrawal by Subject|2|||
31011574|NCT02983045|59218456|FG000|Overall Study|Lost to Follow-up|0|||
31011575|NCT02983045|59218457|FG001|Overall Study|Lost to Follow-up|0|||
31011576|NCT02983045|59218458|FG002|Overall Study|Lost to Follow-up|0|||
31011577|NCT02983045|59218459|FG003|Overall Study|Lost to Follow-up|0|||
31011578|NCT02983045|59218460|FG004|Overall Study|Lost to Follow-up|0|||
31011579|NCT02983045|59218461|FG005|Overall Study|Lost to Follow-up|10|||
31011580|NCT02983045|59218462|FG006|Overall Study|Lost to Follow-up|0|||
31011581|NCT02983045|59218463|FG007|Overall Study|Lost to Follow-up|0|||
31011582|NCT02983045|59218464|FG008|Overall Study|Lost to Follow-up|0|||
31011583|NCT02983045|59218465|FG009|Overall Study|Lost to Follow-up|0|||
31011584|NCT02564263|59218489|FG000|Overall Study|Adverse Event|31|||
31011585|NCT02564263|59218490|FG001|Overall Study|Adverse Event|29|||
31011586|NCT02564263|59218489|FG000|Overall Study|Death|270|||
30617724|NCT01243424|58628589|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
30617725|NCT01243424|58628588|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
30617726|NCT01243424|58628589|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
30617727|NCT01243424|58628588|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
30617728|NCT01243424|58628589|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
30617729|NCT01243424|58628588|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
30617730|NCT01243424|58628589|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
30617731|NCT01243424|58628588|FG000|Discontinuation From Treatment|Not treated|5|||
30617732|NCT01243424|58628589|FG001|Discontinuation From Treatment|Not treated|4|||
30617733|NCT01243424|58628588|FG000|Discontinuation From Treatment|Adverse Event|457|||
30617734|NCT01243424|58628589|FG001|Discontinuation From Treatment|Adverse Event|523|||
30617735|NCT01243424|58628588|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
30617736|NCT01243424|58628589|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
30617737|NCT01243424|58628588|FG000|Discontinuation From Treatment|Protocol Violation|46|||
31011587|NCT02564263|59218490|FG001|Overall Study|Death|262|||
31011588|NCT02564263|59218489|FG000|Overall Study|Withdrawal by Subject|4|||
31011589|NCT02564263|59218490|FG001|Overall Study|Withdrawal by Subject|19|||
31011590|NCT02564263|59218489|FG000|Overall Study|Sponsor's decision|9|||
31011591|NCT02564263|59218490|FG001|Overall Study|Sponsor's decision|4|||
31011592|NCT02379819|59218497|FG000|Overall Study|Withdrawal by Subject|10|||
31011593|NCT02379819|59218497|FG000|Overall Study|Death|2|||
31011594|NCT02379819|59218497|FG000|Overall Study|Lack of Efficacy|1|||
31011595|NCT02379819|59218497|FG000|Overall Study|Lost to Follow-up|1|||
31011596|NCT02368886|59218505|FG000|Overall Study|Cancel|1|||
31011597|NCT02368886|59218506|FG001|Overall Study|Cancel|1|||
31011598|NCT02368886|59218507|FG002|Overall Study|Cancel|1|||
31011599|NCT02368886|59218508|FG003|Overall Study|Cancel|3|||
31011600|NCT02368886|59218505|FG000|Overall Study|Ineligible|0|||
31011601|NCT02368886|59218506|FG001|Overall Study|Ineligible|0|||
31011602|NCT02368886|59218507|FG002|Overall Study|Ineligible|0|||
31011603|NCT02368886|59218508|FG003|Overall Study|Ineligible|1|||
31011604|NCT02227238|59218522|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
31011605|NCT02227238|59218523|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
31011606|NCT02227238|59218524|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
31011607|NCT02227238|59218522|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
31011608|NCT02227238|59218523|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
31011609|NCT02227238|59218524|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
31011610|NCT02227238|59218522|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
31011611|NCT02227238|59218523|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
31011612|NCT02227238|59218524|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
31011613|NCT02227238|59218522|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
31011614|NCT02227238|59218523|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
30617738|NCT01243424|58628589|FG001|Discontinuation From Treatment|Protocol Violation|47|||
30617739|NCT01243424|58628588|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
31011615|NCT02227238|59218524|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
31011616|NCT02227238|59218522|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
31011617|NCT02227238|59218523|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
31011618|NCT02227238|59218524|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
31011619|NCT02227238|59218522|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
31011620|NCT02227238|59218523|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
31011621|NCT02227238|59218524|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
31011622|NCT02227238|59218522|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
31011623|NCT02227238|59218523|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
30617740|NCT01243424|58628589|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
30617741|NCT01243424|58628588|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
30617742|NCT01243424|58628589|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
30617743|NCT01243424|58628588|FG000|Discontinuation From Treatment|Other than listed above|230|||
30617744|NCT01243424|58628589|FG001|Discontinuation From Treatment|Other than listed above|211|||
30617745|NCT00887809|58628598|FG000|Overall Study|Patient Not Treated|3|||
30617746|NCT00887809|58628599|FG001|Overall Study|Patient Not Treated|0|||
30617747|NCT00887809|58628598|FG000|Overall Study|Death|1|||
30617748|NCT00887809|58628599|FG001|Overall Study|Death|0|||
30617749|NCT00958126|58628613|FG000|Overall Study|Serious Adverse Event|0|||
30617750|NCT00958126|58628614|FG001|Overall Study|Serious Adverse Event|2|||
30617751|NCT00958126|58628615|FG002|Overall Study|Serious Adverse Event|0|||
30617752|NCT00958126|58628616|FG003|Overall Study|Serious Adverse Event|0|||
30617753|NCT00958126|58628617|FG004|Overall Study|Serious Adverse Event|0|||
30617754|NCT00958126|58628618|FG005|Overall Study|Serious Adverse Event|0|||
30617755|NCT00958126|58628619|FG006|Overall Study|Serious Adverse Event|1|||
30617756|NCT00958126|58628620|FG007|Overall Study|Serious Adverse Event|0|||
30617757|NCT00958126|58628613|FG000|Overall Study|Withdrawal by Subject|0|||
30617758|NCT00958126|58628614|FG001|Overall Study|Withdrawal by Subject|2|||
30617759|NCT00958126|58628615|FG002|Overall Study|Withdrawal by Subject|0|||
30617760|NCT00958126|58628616|FG003|Overall Study|Withdrawal by Subject|0|||
30617761|NCT00958126|58628617|FG004|Overall Study|Withdrawal by Subject|0|||
30617762|NCT00958126|58628618|FG005|Overall Study|Withdrawal by Subject|0|||
30617763|NCT00958126|58628619|FG006|Overall Study|Withdrawal by Subject|0|||
30617764|NCT00958126|58628620|FG007|Overall Study|Withdrawal by Subject|0|||
30617765|NCT00958126|58628613|FG000|Overall Study|Moved away from study area|0|||
30617766|NCT00958126|58628614|FG001|Overall Study|Moved away from study area|0|||
30699414|NCT00272779|58713882|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
30699415|NCT00272779|58713883|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
30699416|NCT00272779|58713882|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
30699417|NCT00272779|58713883|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
30699418|NCT00272779|58713882|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
31011624|NCT02227238|59218524|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
31011625|NCT02227238|59218522|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
31011626|NCT02227238|59218523|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
31011627|NCT02227238|59218524|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
31011628|NCT02227238|59218522|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
31011629|NCT02227238|59218523|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
31011630|NCT02227238|59218524|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
31011631|NCT02227238|59218522|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
31011632|NCT02227238|59218523|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
31011633|NCT02227238|59218524|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
31011634|NCT02227238|59218522|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
31011635|NCT02227238|59218523|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
31011636|NCT02227238|59218524|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
31011637|NCT02227238|59218522|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
31011638|NCT02227238|59218523|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
31011639|NCT02227238|59218524|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
31011640|NCT02227238|59218522|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
31011641|NCT02227238|59218523|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
31011642|NCT02227238|59218524|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
31011643|NCT02227238|59218522|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
31011644|NCT02227238|59218523|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
30699419|NCT00272779|58713883|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
30699420|NCT00272779|58713882|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
30699421|NCT00272779|58713883|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
30699422|NCT00272779|58713882|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
30699423|NCT00272779|58713883|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
31011645|NCT02227238|59218524|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
31011646|NCT02126969|59218545|FG000|Overall Study|Withdrawal by Subject|1|||
30699424|NCT00272779|58713882|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
30699425|NCT00272779|58713883|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
30617767|NCT00958126|58628615|FG002|Overall Study|Moved away from study area|1|||
30617768|NCT00958126|58628616|FG003|Overall Study|Moved away from study area|1|||
30617769|NCT00958126|58628617|FG004|Overall Study|Moved away from study area|0|||
30617770|NCT00958126|58628618|FG005|Overall Study|Moved away from study area|0|||
30617771|NCT00958126|58628619|FG006|Overall Study|Moved away from study area|0|||
30617772|NCT00958126|58628620|FG007|Overall Study|Moved away from study area|0|||
31011647|NCT02126969|59218546|FG001|Overall Study|Withdrawal by Subject|2|||
31011648|NCT01715285|59218554|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
31011649|NCT01715285|59218555|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
31011650|NCT01715285|59218556|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
31011651|NCT01715285|59218554|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
31011652|NCT01715285|59218555|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
31011653|NCT01715285|59218556|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
31011654|NCT01715285|59218554|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
31011655|NCT01715285|59218555|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
31011656|NCT01715285|59218556|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
31011657|NCT01715285|59218554|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
31011658|NCT01715285|59218555|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
31011659|NCT01715285|59218556|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
31011660|NCT01715285|59218554|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
31011661|NCT01715285|59218555|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
31011662|NCT01715285|59218556|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
30617773|NCT00958126|58628613|FG000|Overall Study|Lost to Follow-up|1|||
30617774|NCT00958126|58628614|FG001|Overall Study|Lost to Follow-up|5|||
30617775|NCT00958126|58628615|FG002|Overall Study|Lost to Follow-up|9|||
30617776|NCT00958126|58628616|FG003|Overall Study|Lost to Follow-up|8|||
30617777|NCT00958126|58628617|FG004|Overall Study|Lost to Follow-up|0|||
30617778|NCT00958126|58628618|FG005|Overall Study|Lost to Follow-up|0|||
30617779|NCT00958126|58628619|FG006|Overall Study|Lost to Follow-up|0|||
30617780|NCT00958126|58628620|FG007|Overall Study|Lost to Follow-up|0|||
30617781|NCT00958126|58628613|FG000|Overall Study|Sponsor/Investigator decision|0|||
30617782|NCT00958126|58628614|FG001|Overall Study|Sponsor/Investigator decision|0|||
30617783|NCT00958126|58628615|FG002|Overall Study|Sponsor/Investigator decision|0|||
30699426|NCT00272779|58713882|FG000|Baseline Through Week 96|Never treated|2|||
30699427|NCT00272779|58713883|FG001|Baseline Through Week 96|Never treated|3|||
30699428|NCT00272779|58713882|FG000|Baseline Through Week 96|Continuing on treatment|61|||
30699429|NCT00272779|58713883|FG001|Baseline Through Week 96|Continuing on treatment|38|||
31011663|NCT01715285|59218554|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
31011664|NCT01715285|59218555|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
31011665|NCT01715285|59218556|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
31011666|NCT01715285|59218554|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
31011667|NCT01715285|59218555|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
31011668|NCT01715285|59218556|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
31011669|NCT01715285|59218554|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
31011670|NCT01715285|59218555|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
31011671|NCT01715285|59218556|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
31011672|NCT01715285|59218554|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
31011673|NCT01715285|59218555|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
31011674|NCT01715285|59218556|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
31011675|NCT01715285|59218554|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
31011676|NCT01715285|59218555|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
31011677|NCT01715285|59218556|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
31011678|NCT01715285|59218554|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
31011679|NCT01715285|59218555|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
31011680|NCT01715285|59218556|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
31011681|NCT01715285|59218554|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
31011682|NCT01715285|59218555|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
31011683|NCT01715285|59218556|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
31011684|NCT01715285|59218554|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
31011685|NCT01715285|59218555|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
31011686|NCT01715285|59218556|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
31011687|NCT01715285|59218554|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
31011688|NCT01715285|59218555|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
31011689|NCT01715285|59218556|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
31011690|NCT01250496|59218565|FG000|Overall Study|Study terminated|124|||
31011691|NCT01250496|59218566|FG001|Overall Study|Study terminated|124|||
31011692|NCT01105975|59218582|FG000|Overall Study|Adverse Event|2|||
31011693|NCT01105975|59218583|FG001|Overall Study|Adverse Event|1|||
31011694|NCT01105975|59218584|FG002|Overall Study|Adverse Event|5|||
31011695|NCT01105975|59218585|FG003|Overall Study|Adverse Event|1|||
31011696|NCT01105975|59218586|FG004|Overall Study|Adverse Event|0|||
30699430|NCT00511810|58713892|FG000|Overall Study|Lost to Follow-up|1|||
30617784|NCT00958126|58628616|FG003|Overall Study|Sponsor/Investigator decision|1|||
30617785|NCT00958126|58628617|FG004|Overall Study|Sponsor/Investigator decision|0|||
30699431|NCT00511810|58713893|FG001|Overall Study|Lost to Follow-up|2|||
30699432|NCT00511810|58713892|FG000|Overall Study|Lack of Efficacy|0|||
30699433|NCT00511810|58713893|FG001|Overall Study|Lack of Efficacy|2|||
31011697|NCT01105975|59218587|FG005|Overall Study|Adverse Event|1|||
31011698|NCT01105975|59218588|FG006|Overall Study|Adverse Event|2|||
31011699|NCT01105975|59218589|FG007|Overall Study|Adverse Event|4|||
31011700|NCT01105975|59218590|FG008|Overall Study|Adverse Event|1|||
31011701|NCT01105975|59218591|FG009|Overall Study|Adverse Event|4|||
31011702|NCT01105975|59218582|FG000|Overall Study|Withdrawal by Subject|2|||
31011703|NCT01105975|59218583|FG001|Overall Study|Withdrawal by Subject|2|||
31011704|NCT01105975|59218584|FG002|Overall Study|Withdrawal by Subject|2|||
31011705|NCT01105975|59218585|FG003|Overall Study|Withdrawal by Subject|0|||
31011706|NCT01105975|59218586|FG004|Overall Study|Withdrawal by Subject|4|||
31011707|NCT01105975|59218587|FG005|Overall Study|Withdrawal by Subject|1|||
31011708|NCT01105975|59218588|FG006|Overall Study|Withdrawal by Subject|2|||
31011709|NCT01105975|59218589|FG007|Overall Study|Withdrawal by Subject|1|||
30617786|NCT00958126|58628618|FG005|Overall Study|Sponsor/Investigator decision|0|||
30617787|NCT00958126|58628619|FG006|Overall Study|Sponsor/Investigator decision|0|||
30617788|NCT00958126|58628620|FG007|Overall Study|Sponsor/Investigator decision|0|||
30617789|NCT00958126|58628613|FG000|Overall Study|Other Reason|0|||
30617790|NCT00958126|58628614|FG001|Overall Study|Other Reason|0|||
30617791|NCT00958126|58628615|FG002|Overall Study|Other Reason|0|||
30617792|NCT00958126|58628616|FG003|Overall Study|Other Reason|1|||
30617793|NCT00958126|58628617|FG004|Overall Study|Other Reason|0|||
30617794|NCT00958126|58628618|FG005|Overall Study|Other Reason|1|||
30617795|NCT00958126|58628619|FG006|Overall Study|Other Reason|0|||
30617796|NCT00958126|58628620|FG007|Overall Study|Other Reason|0|||
30617797|NCT00887341|58628644|FG000|Overall Study|Refused treatment|1|||
30617798|NCT00887341|58628645|FG001|Overall Study|Refused treatment|0|||
30617799|NCT00887341|58628644|FG000|Overall Study|Withdrawal by Subject|1|||
30617800|NCT00887341|58628645|FG001|Overall Study|Withdrawal by Subject|1|||
30617801|NCT00887341|58628644|FG000|Overall Study|Adverse Event|0|||
30617802|NCT00887341|58628645|FG001|Overall Study|Adverse Event|1|||
30617803|NCT00887341|58628644|FG000|Overall Study|Lost to Follow-up|0|||
30617804|NCT00887341|58628645|FG001|Overall Study|Lost to Follow-up|1|||
30617805|NCT00886795|58628651|FG000|Overall Study|Lack of Efficacy|1|||
30617806|NCT00889681|58628668|FG000|Overall Study|Not meeting qualification Criteria|2|||
30617807|NCT00889681|58628668|FG000|Overall Study|Insurance disapproval|1|||
30617808|NCT00957658|58628672|FG000|Overall Study|Death|1|||
30617809|NCT00957658|58628672|FG000|Overall Study|Lost to Follow-up|4|||
30617810|NCT00957658|58628672|FG000|Overall Study|Withdrawal by Subject|12|||
30617811|NCT00957658|58628672|FG000|Overall Study|Revision|1|||
30617812|NCT00957658|58628672|FG000|Overall Study|Incomplete 2 yr data|28|||
30617813|NCT00957658|58628672|FG000|Overall Study|Site termination|10|||
30617814|NCT00957658|58628672|FG000|Overall Study|unwilling/unable to return|2|||
30617815|NCT00957658|58628672|FG000|Overall Study|surgery cancelled|2|||
30617816|NCT00957658|58628672|FG000|Overall Study|Protocol Violation|5|||
30617817|NCT00953680|58628678|FG000|Period 1|Withdrawal by Subject|0|||
30617818|NCT00953680|58628679|FG001|Period 1|Withdrawal by Subject|1|||
30617819|NCT00890929|58628685|FG000|Overall Study|Death before treatment|2|||
30617820|NCT00890929|58628685|FG000|Overall Study|Withdrawal by Subject|3|||
30617821|NCT00890929|58628685|FG000|Overall Study|Physician Decision|1|||
30617822|NCT00886639|58628689|FG000|Overall Study|acute exacerbation|14|||
30617823|NCT00886639|58628689|FG000|Overall Study|non-compliance|2|||
30617824|NCT00889603|58628693|FG000|Overall Study|Adverse Event|7|||
30617825|NCT00889603|58628693|FG000|Overall Study|Death|3|||
30617826|NCT00889603|58628693|FG000|Overall Study|Lost to Follow-up|19|||
30617827|NCT00889603|58628693|FG000|Overall Study|No longer willing to participant in stud|4|||
30617828|NCT00889603|58628693|FG000|Overall Study|Other|4|||
30617829|NCT00886483|58628699|FG000|Overall Study|Lost to Follow-up|0|||
30617830|NCT00886483|58628700|FG001|Overall Study|Lost to Follow-up|1|||
30617831|NCT00886483|58628699|FG000|Overall Study|Pursue medications|1|||
30617832|NCT00886483|58628700|FG001|Overall Study|Pursue medications|2|||
30699434|NCT00511810|58713892|FG000|Overall Study|Refused second scn|0|||
30790834|NCT03524092|58803943|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
31011710|NCT01105975|59218590|FG008|Overall Study|Withdrawal by Subject|0|||
31011711|NCT01105975|59218591|FG009|Overall Study|Withdrawal by Subject|3|||
31011712|NCT01105975|59218582|FG000|Overall Study|Lost to Follow-up|1|||
31011713|NCT01105975|59218583|FG001|Overall Study|Lost to Follow-up|0|||
30617833|NCT00886483|58628699|FG000|Overall Study|Distance to center, poor grades|1|||
30617834|NCT00886483|58628700|FG001|Overall Study|Distance to center, poor grades|0|||
30617835|NCT00886015|58628716|FG000|Overall Study|Death|0|||
30617836|NCT00886015|58628717|FG001|Overall Study|Death|2|||
30617837|NCT00890695|58628725|FG000|Overall Study|Protocol Violation|1|||
30699435|NCT00511810|58713893|FG001|Overall Study|Refused second scn|1|||
31011714|NCT01105975|59218584|FG002|Overall Study|Lost to Follow-up|0|||
30617838|NCT00890695|58628726|FG001|Overall Study|Protocol Violation|0|||
30617839|NCT00957580|58628735|FG000|Overall Study|Ongoing at data cut-off|0|||
30617840|NCT00957580|58628736|FG001|Overall Study|Ongoing at data cut-off|1|||
30617841|NCT00957580|58628737|FG002|Overall Study|Ongoing at data cut-off|0|||
31011715|NCT01105975|59218585|FG003|Overall Study|Lost to Follow-up|1|||
30617842|NCT00957580|58628735|FG000|Overall Study|Enrolled but not treated|0|||
30617843|NCT00957580|58628736|FG001|Overall Study|Enrolled but not treated|1|||
30617844|NCT00957580|58628737|FG002|Overall Study|Enrolled but not treated|0|||
30617845|NCT00957424|58628758|FG000|Overall Study|Lost to Follow-up|19|||
30617846|NCT00957424|58628758|FG000|Overall Study|Protocol Violation|3|||
30617847|NCT00957424|58628758|FG000|Overall Study|Withdrawal by Subject|1|||
30617848|NCT01061151|58628766|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
30617849|NCT01061151|58628767|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
30617850|NCT01061151|58628768|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
30617851|NCT01061151|58628769|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
30617852|NCT01061151|58628766|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
30617853|NCT01061151|58628767|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
30617854|NCT01061151|58628768|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
30617855|NCT01061151|58628769|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
30617856|NCT01061151|58628766|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
30617857|NCT01061151|58628767|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
30617858|NCT01061151|58628768|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
30617859|NCT01061151|58628769|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
30617860|NCT01061151|58628766|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
30617861|NCT01061151|58628767|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
30617862|NCT01061151|58628768|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
30617863|NCT01061151|58628769|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
30617864|NCT01061151|58628766|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
30617865|NCT01061151|58628767|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
30617866|NCT01061151|58628768|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
30617867|NCT01061151|58628769|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
30617868|NCT01061151|58628766|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
30617869|NCT01061151|58628767|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
30617870|NCT01061151|58628768|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
30617871|NCT01061151|58628769|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
30617872|NCT01061151|58628766|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
30699436|NCT00291499|58713901|FG000|Overall Study|Adverse Event|3|||
30699437|NCT00291499|58713902|FG001|Overall Study|Adverse Event|8|||
30699438|NCT00291499|58713901|FG000|Overall Study|Change to other therapy|2|||
30699439|NCT00291499|58713902|FG001|Overall Study|Change to other therapy|1|||
30699440|NCT00291499|58713901|FG000|Overall Study|Intercurrent illness|1|||
30699441|NCT00291499|58713902|FG001|Overall Study|Intercurrent illness|0|||
30699442|NCT00291499|58713901|FG000|Overall Study|Protocol Violation|2|||
30699443|NCT00291499|58713902|FG001|Overall Study|Protocol Violation|2|||
30699444|NCT00291499|58713901|FG000|Overall Study|Other reasons|1|||
30699445|NCT00291499|58713902|FG001|Overall Study|Other reasons|4|||
30699446|NCT00553605|58713910|FG000|Overall Study|Did not meet entrance criteria|1|||
30699447|NCT00553605|58713911|FG001|Overall Study|Did not meet entrance criteria|3|||
30699448|NCT00553605|58713910|FG000|Overall Study|Did not receive full dose|1|||
30699449|NCT00553605|58713911|FG001|Overall Study|Did not receive full dose|0|||
30699450|NCT00553605|58713910|FG000|Overall Study|Randomized but not treated|2|||
30699451|NCT00553605|58713911|FG001|Overall Study|Randomized but not treated|0|||
30699452|NCT00621582|58713917|FG000|Overall Study|Adverse Event|7|||
30699453|NCT00621582|58713917|FG000|Overall Study|Protocol Violation|57|||
30699454|NCT00621582|58713917|FG000|Overall Study|Lost to Follow-up|24|||
30699455|NCT00621582|58713917|FG000|Overall Study|issues not identified by investigators|18|||
30699456|NCT00744497|58713923|FG000|Overall Study|Withdrawal by Subject|21|||
30699457|NCT00744497|58713924|FG001|Overall Study|Withdrawal by Subject|18|||
31011716|NCT01105975|59218586|FG004|Overall Study|Lost to Follow-up|1|||
31011717|NCT01105975|59218587|FG005|Overall Study|Lost to Follow-up|0|||
31011718|NCT01105975|59218588|FG006|Overall Study|Lost to Follow-up|0|||
31011719|NCT01105975|59218589|FG007|Overall Study|Lost to Follow-up|0|||
31011720|NCT01105975|59218590|FG008|Overall Study|Lost to Follow-up|1|||
31011721|NCT01105975|59218591|FG009|Overall Study|Lost to Follow-up|0|||
31011722|NCT01105975|59218582|FG000|Overall Study|Physician Decision|0|||
31011723|NCT01105975|59218583|FG001|Overall Study|Physician Decision|0|||
31011724|NCT01105975|59218584|FG002|Overall Study|Physician Decision|0|||
31011725|NCT01105975|59218585|FG003|Overall Study|Physician Decision|0|||
31011726|NCT01105975|59218586|FG004|Overall Study|Physician Decision|0|||
31011727|NCT01105975|59218587|FG005|Overall Study|Physician Decision|0|||
30617873|NCT01061151|58628767|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
30617874|NCT01061151|58628768|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
30699458|NCT00744497|58713923|FG000|Overall Study|Death|11|||
30699459|NCT00744497|58713924|FG001|Overall Study|Death|9|||
30699460|NCT00744497|58713923|FG000|Overall Study|Lost to Follow-up|4|||
30699461|NCT00744497|58713924|FG001|Overall Study|Lost to Follow-up|2|||
30699462|NCT00744497|58713923|FG000|Overall Study|Poor compliance/noncompliance|9|||
30617875|NCT01061151|58628769|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
30617876|NCT01061151|58628766|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
30617877|NCT01061151|58628767|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
30617878|NCT01061151|58628768|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
30617879|NCT01061151|58628769|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
30617880|NCT01061151|58628766|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
30617881|NCT01061151|58628767|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
30617882|NCT01061151|58628768|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
30617883|NCT01061151|58628769|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
30617884|NCT01061151|58628766|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
30617885|NCT01061151|58628767|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
30617886|NCT01061151|58628768|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
30617887|NCT01061151|58628769|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
30617888|NCT01061151|58628766|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
30617889|NCT01061151|58628767|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
30617890|NCT01061151|58628768|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
30617891|NCT01061151|58628769|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
30617892|NCT01061151|58628766|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
30617893|NCT01061151|58628767|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
30617894|NCT01061151|58628768|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
30617895|NCT01061151|58628769|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
30617896|NCT01061151|58628766|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
30617897|NCT01061151|58628767|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
30617898|NCT01061151|58628768|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
30617899|NCT01061151|58628769|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
30617900|NCT01061151|58628766|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
30617901|NCT01061151|58628767|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
30617902|NCT01061151|58628768|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
30617903|NCT01061151|58628769|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
30617904|NCT01061151|58628766|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
30617905|NCT01061151|58628767|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
30617906|NCT01061151|58628768|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
30617907|NCT01061151|58628769|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
30617908|NCT01241552|58628793|FG000|Overall Study|Lack of Efficacy|1|||
30617909|NCT01241552|58628794|FG001|Overall Study|Lack of Efficacy|0|||
30617910|NCT01241552|58628795|FG002|Overall Study|Lack of Efficacy|0|||
30617911|NCT01241552|58628796|FG003|Overall Study|Lack of Efficacy|0|||
30617912|NCT01241552|58628793|FG000|Overall Study|Death|26|||
30617913|NCT01241552|58628794|FG001|Overall Study|Death|30|||
30617914|NCT01241552|58628795|FG002|Overall Study|Death|20|||
30617915|NCT01241552|58628796|FG003|Overall Study|Death|25|||
30617916|NCT01241552|58628793|FG000|Overall Study|Adverse Event|1|||
30617917|NCT01241552|58628794|FG001|Overall Study|Adverse Event|1|||
30617918|NCT01241552|58628795|FG002|Overall Study|Adverse Event|0|||
30617919|NCT01241552|58628796|FG003|Overall Study|Adverse Event|0|||
30617920|NCT01241552|58628793|FG000|Overall Study|Technical Problems|2|||
30617921|NCT01241552|58628794|FG001|Overall Study|Technical Problems|0|||
30617922|NCT01241552|58628795|FG002|Overall Study|Technical Problems|2|||
30617923|NCT01241552|58628796|FG003|Overall Study|Technical Problems|2|||
30617924|NCT01241552|58628793|FG000|Overall Study|Progressive Disease|0|||
30617925|NCT01241552|58628794|FG001|Overall Study|Progressive Disease|0|||
30617926|NCT01241552|58628795|FG002|Overall Study|Progressive Disease|1|||
30617927|NCT01241552|58628796|FG003|Overall Study|Progressive Disease|2|||
30617928|NCT01241552|58628793|FG000|Overall Study|Protocol Violation|0|||
30617929|NCT01241552|58628794|FG001|Overall Study|Protocol Violation|2|||
30617930|NCT01241552|58628795|FG002|Overall Study|Protocol Violation|6|||
30617931|NCT01241552|58628796|FG003|Overall Study|Protocol Violation|1|||
30617932|NCT01241552|58628793|FG000|Overall Study|Withdrawal by Subject|7|||
30617933|NCT01241552|58628794|FG001|Overall Study|Withdrawal by Subject|15|||
30617934|NCT01241552|58628795|FG002|Overall Study|Withdrawal by Subject|14|||
30617935|NCT01241552|58628796|FG003|Overall Study|Withdrawal by Subject|15|||
30617936|NCT01241552|58628793|FG000|Overall Study|Physician Decision|2|||
30617937|NCT01241552|58628794|FG001|Overall Study|Physician Decision|4|||
30617938|NCT01241552|58628795|FG002|Overall Study|Physician Decision|2|||
30617939|NCT01241552|58628796|FG003|Overall Study|Physician Decision|3|||
30617940|NCT01241552|58628793|FG000|Overall Study|Lost to Follow-up|2|||
30617941|NCT01241552|58628794|FG001|Overall Study|Lost to Follow-up|11|||
30617942|NCT01241552|58628795|FG002|Overall Study|Lost to Follow-up|15|||
30617943|NCT01241552|58628796|FG003|Overall Study|Lost to Follow-up|16|||
30617944|NCT00948922|58628809|FG000|Overall Study|Did not start study treatment|2|||
30617945|NCT00948922|58628810|FG001|Overall Study|Did not start study treatment|5|||
30617946|NCT00948922|58628811|FG002|Overall Study|Did not start study treatment|0|||
30617947|NCT00948922|58628809|FG000|Overall Study|Withdrawal by Subject|0|||
30617948|NCT00948922|58628810|FG001|Overall Study|Withdrawal by Subject|2|||
30617949|NCT00948922|58628811|FG002|Overall Study|Withdrawal by Subject|1|||
30617950|NCT00948922|58628809|FG000|Overall Study|Death|3|||
30617951|NCT00948922|58628810|FG001|Overall Study|Death|0|||
30617952|NCT00948922|58628811|FG002|Overall Study|Death|0|||
30617953|NCT00948922|58628809|FG000|Overall Study|Disease progression|0|||
30617954|NCT00948922|58628810|FG001|Overall Study|Disease progression|1|||
30617955|NCT00948922|58628811|FG002|Overall Study|Disease progression|0|||
30617956|NCT00948922|58628809|FG000|Overall Study|Insurance issues|1|||
30617957|NCT00948922|58628810|FG001|Overall Study|Insurance issues|0|||
30617958|NCT00948922|58628811|FG002|Overall Study|Insurance issues|0|||
30617959|NCT00948922|58628809|FG000|Overall Study|Transplant eligibility issues|2|||
30617960|NCT00948922|58628810|FG001|Overall Study|Transplant eligibility issues|3|||
30617961|NCT00948922|58628811|FG002|Overall Study|Transplant eligibility issues|0|||
30617962|NCT00948922|58628809|FG000|Overall Study|Not evaluable at time of analysis|0|||
30617963|NCT00948922|58628810|FG001|Overall Study|Not evaluable at time of analysis|3|||
30617964|NCT00948922|58628811|FG002|Overall Study|Not evaluable at time of analysis|0|||
30617965|NCT01239992|58628823|FG000|Overall Study|Withdrawal by Subject|2|||
30617966|NCT01072539|58628827|FG000|Overall Study|Treated prior to the Site Initiation|1|||
30617967|NCT01072539|58628827|FG000|Overall Study|Protocol Violation|2|||
30617968|NCT01239680|58628833|FG000|Overall Study|Withdrawal by Subject|2|||
30617969|NCT01239680|58628834|FG001|Overall Study|Withdrawal by Subject|0|||
30617970|NCT01238900|58628840|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
30617971|NCT01238900|58628840|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
30617972|NCT01238822|58628845|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
30617973|NCT01238588|58628855|FG000|Overall Study|Withdrawal by Subject|1|||
30617974|NCT01238588|58628855|FG000|Overall Study|Physician Decision|2|||
30617975|NCT01047501|58628862|FG000|Overall Study|Adverse Event|7|||
30617976|NCT01047501|58628863|FG001|Overall Study|Adverse Event|8|||
30617977|NCT01047501|58628864|FG002|Overall Study|Adverse Event|5|||
30617978|NCT01047501|58628862|FG000|Overall Study|Withdrew Consent|6|||
30617979|NCT01047501|58628863|FG001|Overall Study|Withdrew Consent|2|||
30617980|NCT01047501|58628864|FG002|Overall Study|Withdrew Consent|4|||
30617981|NCT01047501|58628862|FG000|Overall Study|Lost to Follow-up|0|||
30617982|NCT01047501|58628863|FG001|Overall Study|Lost to Follow-up|1|||
30617983|NCT01047501|58628864|FG002|Overall Study|Lost to Follow-up|1|||
30617984|NCT01047501|58628862|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
30617985|NCT01047501|58628863|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
30617986|NCT01047501|58628864|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
30617987|NCT01047501|58628862|FG000|Overall Study|Death|1|||
30617988|NCT01047501|58628863|FG001|Overall Study|Death|0|||
30617989|NCT01047501|58628864|FG002|Overall Study|Death|0|||
30617990|NCT01047501|58628862|FG000|Overall Study|Other discontinuation|1|||
30617991|NCT01047501|58628863|FG001|Overall Study|Other discontinuation|0|||
30617992|NCT01047501|58628864|FG002|Overall Study|Other discontinuation|1|||
30617993|NCT01047501|58628862|FG000|Overall Study|Investigator judgement|0|||
30617994|NCT01047501|58628863|FG001|Overall Study|Investigator judgement|0|||
30617995|NCT01047501|58628864|FG002|Overall Study|Investigator judgement|1|||
31011728|NCT01105975|59218588|FG006|Overall Study|Physician Decision|2|||
31011729|NCT01105975|59218589|FG007|Overall Study|Physician Decision|0|||
31011730|NCT01105975|59218590|FG008|Overall Study|Physician Decision|0|||
31011731|NCT01105975|59218591|FG009|Overall Study|Physician Decision|0|||
31011732|NCT01105975|59218582|FG000|Overall Study|Protocol Violation|0|||
31011733|NCT01105975|59218583|FG001|Overall Study|Protocol Violation|2|||
31011734|NCT01105975|59218584|FG002|Overall Study|Protocol Violation|2|||
31011735|NCT01105975|59218585|FG003|Overall Study|Protocol Violation|0|||
31011736|NCT01105975|59218586|FG004|Overall Study|Protocol Violation|1|||
31011737|NCT01105975|59218587|FG005|Overall Study|Protocol Violation|1|||
31011738|NCT01105975|59218588|FG006|Overall Study|Protocol Violation|1|||
31011739|NCT01105975|59218589|FG007|Overall Study|Protocol Violation|1|||
31011740|NCT01105975|59218590|FG008|Overall Study|Protocol Violation|2|||
31011741|NCT01105975|59218591|FG009|Overall Study|Protocol Violation|2|||
31011742|NCT01105975|59218582|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
31011743|NCT01105975|59218583|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
31011744|NCT01105975|59218584|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
30617996|NCT01238120|58628876|FG000|Overall Study|Withdrawal by Subject|4|||
30617997|NCT01238120|58628877|FG001|Overall Study|Withdrawal by Subject|1|||
30617998|NCT01238120|58628878|FG002|Overall Study|Withdrawal by Subject|2|||
30617999|NCT01238120|58628879|FG003|Overall Study|Withdrawal by Subject|5|||
30618000|NCT01238120|58628876|FG000|Overall Study|Lost to Follow-up|2|||
30618001|NCT01238120|58628877|FG001|Overall Study|Lost to Follow-up|0|||
30618002|NCT01238120|58628878|FG002|Overall Study|Lost to Follow-up|1|||
30618003|NCT01238120|58628879|FG003|Overall Study|Lost to Follow-up|1|||
30618004|NCT01238120|58628876|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
31011745|NCT01105975|59218585|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
30618005|NCT01238120|58628877|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
31011746|NCT01105975|59218586|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
31011747|NCT01105975|59218587|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
31011748|NCT01105975|59218588|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
31011749|NCT01105975|59218589|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
31011750|NCT01105975|59218590|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
31011751|NCT01105975|59218591|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
31011752|NCT00831623|59218632|FG000|Overall Study|Withdrawal by Subject|9|||
31011753|NCT00831623|59218632|FG000|Overall Study|Lost to Follow-up|1|||
31011754|NCT00831623|59218632|FG000|Overall Study|Not 2 years post-treatment|12|||
31011755|NCT00079417|59218636|FG000|Overall Study|Physician Decision|2|||
31011756|NCT00079417|59218636|FG000|Overall Study|Ineligible|7|||
31011757|NCT05292755|59223664|FG000|Overall Study|Lost to Follow-up|5|||
31011758|NCT05292755|59223665|FG001|Overall Study|Lost to Follow-up|9|||
31011759|NCT04590781|59223679|FG000|Overall Study|Death|0|||
31011760|NCT04590781|59223680|FG001|Overall Study|Death|2|||
30618006|NCT01238120|58628878|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
30618007|NCT01238120|58628879|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
31011761|NCT04590781|59223679|FG000|Overall Study|Withdrawal by Subject|2|||
31011762|NCT04590781|59223680|FG001|Overall Study|Withdrawal by Subject|0|||
31011763|NCT04248868|59223687|FG000|Overall Study|Death|1|||
31011764|NCT04248868|59223687|FG000|Overall Study|Lost to Follow-up|3|||
31011765|NCT04248868|59223687|FG000|Overall Study|Protocol Violation|2|||
31011766|NCT04211831|59223694|FG000|Overall Study|Withdrawal by Subject|4|||
31011767|NCT04211831|59223695|FG001|Overall Study|Withdrawal by Subject|1|||
31011768|NCT04211831|59223696|FG002|Overall Study|Withdrawal by Subject|1|||
31011769|NCT04211831|59223694|FG000|Overall Study|Protocol Violation|0|||
31011770|NCT04211831|59223695|FG001|Overall Study|Protocol Violation|0|||
31011771|NCT04211831|59223696|FG002|Overall Study|Protocol Violation|1|||
31011772|NCT04211831|59223694|FG000|Overall Study|Adverse Event|0|||
31011773|NCT04211831|59223695|FG001|Overall Study|Adverse Event|1|||
31011774|NCT04211831|59223696|FG002|Overall Study|Adverse Event|0|||
31011775|NCT04211831|59223694|FG000|Overall Study|Lack of Efficacy|0|||
31011776|NCT04211831|59223695|FG001|Overall Study|Lack of Efficacy|0|||
31011777|NCT04211831|59223696|FG002|Overall Study|Lack of Efficacy|1|||
31011778|NCT04211831|59223694|FG000|Overall Study|Lost to Follow-up|0|||
31011779|NCT04211831|59223695|FG001|Overall Study|Lost to Follow-up|0|||
31011780|NCT04211831|59223696|FG002|Overall Study|Lost to Follow-up|2|||
31011781|NCT04211831|59223694|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
31011782|NCT04211831|59223695|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
31011783|NCT04211831|59223696|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
31011784|NCT04211831|59223694|FG000|Overall Study|Other|0|||
31011785|NCT04211831|59223695|FG001|Overall Study|Other|1|||
31011786|NCT04211831|59223696|FG002|Overall Study|Other|0|||
31011787|NCT04067518|59223754|FG000|Overall Study|Adverse Event|1|||
31011788|NCT04067518|59223755|FG001|Overall Study|Adverse Event|3|||
31011789|NCT04067518|59223754|FG000|Overall Study|Screen failures|0|||
31011790|NCT04067518|59223755|FG001|Overall Study|Screen failures|1|||
31011791|NCT04067518|59223754|FG000|Overall Study|Enrolled but not treated|0|||
31011792|NCT04067518|59223755|FG001|Overall Study|Enrolled but not treated|1|||
31011793|NCT03912233|59223796|FG000|Overall Study|Adverse Event|1|||
31011794|NCT03912233|59223797|FG001|Overall Study|Adverse Event|0|||
31011795|NCT03912233|59223798|FG002|Overall Study|Adverse Event|0|||
31011796|NCT03912233|59223799|FG003|Overall Study|Adverse Event|0|||
31011797|NCT03912233|59223800|FG004|Overall Study|Adverse Event|0|||
31011798|NCT03912233|59223801|FG005|Overall Study|Adverse Event|0|||
31011799|NCT03912233|59223796|FG000|Overall Study|Physician Decision|1|||
31011800|NCT03912233|59223797|FG001|Overall Study|Physician Decision|0|||
31011801|NCT03912233|59223798|FG002|Overall Study|Physician Decision|0|||
31011802|NCT03912233|59223799|FG003|Overall Study|Physician Decision|0|||
31011803|NCT03912233|59223800|FG004|Overall Study|Physician Decision|0|||
30618008|NCT01237340|58628889|FG000|Overall Study|Adverse Event|3|||
31011804|NCT03912233|59223801|FG005|Overall Study|Physician Decision|0|||
31011805|NCT03912233|59223796|FG000|Overall Study|Other|0|||
31011806|NCT03912233|59223797|FG001|Overall Study|Other|0|||
31011807|NCT03912233|59223798|FG002|Overall Study|Other|0|||
31011808|NCT03912233|59223799|FG003|Overall Study|Other|0|||
30618009|NCT01237340|58628889|FG000|Overall Study|Withdrawal by Subject|1|||
30618010|NCT01237340|58628889|FG000|Overall Study|Early termination of the trial|36|||
31011809|NCT03912233|59223800|FG004|Overall Study|Other|7|||
31011810|NCT03912233|59223801|FG005|Overall Study|Other|12|||
31011811|NCT03834519|59223825|FG000|Overall Study|Ongoing|234|||
31011812|NCT03834519|59223826|FG001|Overall Study|Ongoing|111|||
31011813|NCT03834519|59223825|FG000|Overall Study|Withdrawal by Subject|4|||
31011814|NCT03834519|59223826|FG001|Overall Study|Withdrawal by Subject|7|||
31011815|NCT03834519|59223825|FG000|Overall Study|Death|291|||
31011816|NCT03834519|59223826|FG001|Overall Study|Death|146|||
31011817|NCT03546062|59223853|FG000|Overall Study|Adverse Event|6|||
31011818|NCT03546062|59223854|FG001|Overall Study|Adverse Event|5|||
31011819|NCT03546062|59223855|FG002|Overall Study|Adverse Event|8|||
31011820|NCT03539952|59223865|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
31011821|NCT03539952|59223866|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
30618011|NCT01045707|58628898|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
30618012|NCT01045707|58628899|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
30618013|NCT01045707|58628898|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
30618014|NCT01045707|58628899|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
30618015|NCT01045707|58628898|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
30618016|NCT01045707|58628899|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
30618017|NCT01045707|58628898|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
30618018|NCT01045707|58628899|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
30618019|NCT01045707|58628898|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
30618020|NCT01045707|58628899|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
30618021|NCT01045707|58628898|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
31011822|NCT03539952|59223865|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
31011823|NCT03539952|59223866|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
31011824|NCT03539952|59223865|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
31011825|NCT03539952|59223866|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
31011826|NCT03539952|59223865|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
31011827|NCT03539952|59223866|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
31011828|NCT03539952|59223865|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
31011829|NCT03539952|59223866|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
31011830|NCT03539952|59223865|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
31011831|NCT03539952|59223866|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
31011832|NCT03539952|59223865|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
31011833|NCT03539952|59223866|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
31011834|NCT03471078|59223893|FG000|Overall Study|Withdrawal by Subject|9|||
31011835|NCT03471078|59223894|FG001|Overall Study|Withdrawal by Subject|1|||
31011836|NCT03471078|59223893|FG000|Overall Study|Adverse Event|4|||
31011837|NCT03471078|59223894|FG001|Overall Study|Adverse Event|1|||
31011838|NCT03471078|59223893|FG000|Overall Study|Physician Decision|3|||
31011839|NCT03471078|59223894|FG001|Overall Study|Physician Decision|2|||
30699463|NCT00744497|58713924|FG001|Overall Study|Poor compliance/noncompliance|5|||
30699464|NCT00744497|58713923|FG000|Overall Study|No longer meets study criteria|7|||
30699465|NCT00744497|58713924|FG001|Overall Study|No longer meets study criteria|3|||
30699466|NCT00744497|58713923|FG000|Overall Study|Administrative Reason By Sponsor|25|||
30699467|NCT00744497|58713924|FG001|Overall Study|Administrative Reason By Sponsor|8|||
30699468|NCT00744497|58713923|FG000|Overall Study|Disease progression|312|||
30699469|NCT00744497|58713924|FG001|Overall Study|Disease progression|219|||
30699470|NCT00744497|58713923|FG000|Overall Study|Study drug toxicity|68|||
30699471|NCT00744497|58713924|FG001|Overall Study|Study drug toxicity|141|||
30699472|NCT00744497|58713923|FG000|Overall Study|Adverse event unrelated to study drug|78|||
30699473|NCT00744497|58713924|FG001|Overall Study|Adverse event unrelated to study drug|122|||
30699474|NCT00744497|58713923|FG000|Overall Study|Patient requested to stop study drug|65|||
30699475|NCT00744497|58713924|FG001|Overall Study|Patient requested to stop study drug|80|||
30699476|NCT00744497|58713923|FG000|Overall Study|Maximum clinical benefit|141|||
30699477|NCT00744497|58713924|FG001|Overall Study|Maximum clinical benefit|142|||
30699478|NCT00744497|58713923|FG000|Overall Study|Not defined|19|||
30699479|NCT00744497|58713924|FG001|Overall Study|Not defined|13|||
30699480|NCT00747227|58713932|FG000|Overall Study|Death|3|||
30699481|NCT00747227|58713933|FG001|Overall Study|Death|1|||
30699482|NCT00747227|58713932|FG000|Overall Study|Withdrawal by Subject|1|||
30699483|NCT00747227|58713933|FG001|Overall Study|Withdrawal by Subject|0|||
30699484|NCT00747227|58713932|FG000|Overall Study|Lost to Follow-up|1|||
30699485|NCT00747227|58713933|FG001|Overall Study|Lost to Follow-up|2|||
30699486|NCT00747227|58713932|FG000|Overall Study|Illness|1|||
30699487|NCT00747227|58713933|FG001|Overall Study|Illness|1|||
30699488|NCT00747149|58713941|FG000|Overall Study|Adverse Event|0|||
30699489|NCT00747149|58713942|FG001|Overall Study|Adverse Event|15|||
30699490|NCT00747149|58713941|FG000|Overall Study|Lost to Follow-up|0|||
30699491|NCT00747149|58713942|FG001|Overall Study|Lost to Follow-up|10|||
31011840|NCT03471078|59223893|FG000|Overall Study|Death|2|||
31011841|NCT03471078|59223894|FG001|Overall Study|Death|0|||
31011842|NCT03471078|59223893|FG000|Overall Study|Other|3|||
30618022|NCT01045707|58628899|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
30699492|NCT00747149|58713941|FG000|Overall Study|Withdrawal by Subject|0|||
30699493|NCT00747149|58713942|FG001|Overall Study|Withdrawal by Subject|6|||
30699494|NCT00747149|58713941|FG000|Overall Study|Did not receive treatment|0|||
30699495|NCT00747149|58713942|FG001|Overall Study|Did not receive treatment|1|||
30699496|NCT00747149|58713941|FG000|Overall Study|Incorrect enrollment|0|||
30699497|NCT00747149|58713942|FG001|Overall Study|Incorrect enrollment|6|||
30893227|NCT02370667|58926723|FG001|Overall Study|Lost to Follow-up|1|||
31011843|NCT03471078|59223894|FG001|Overall Study|Other|2|||
30618023|NCT01045707|58628898|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
30618024|NCT01045707|58628899|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
30618025|NCT01045707|58628898|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
30618026|NCT01045707|58628899|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
30618027|NCT01045707|58628898|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
30618028|NCT01045707|58628899|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
30618029|NCT01054599|58628907|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
30618030|NCT01054599|58628908|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
30618031|NCT01054599|58628907|FG000|Overall Study|Protocol Violation|1|||
30618032|NCT01054599|58628908|FG001|Overall Study|Protocol Violation|0|||
30618033|NCT01054599|58628907|FG000|Overall Study|Spells/seizure-like episodes|1|||
30618034|NCT01054599|58628908|FG001|Overall Study|Spells/seizure-like episodes|1|||
30618035|NCT01054599|58628907|FG000|Overall Study|Timing/scheduling difficulties|1|||
30618036|NCT01054599|58628908|FG001|Overall Study|Timing/scheduling difficulties|1|||
30618037|NCT01054599|58628907|FG000|Overall Study|Visual impairment, WTAR <80|0|||
30618038|NCT01054599|58628908|FG001|Overall Study|Visual impairment, WTAR <80|1|||
31011844|NCT02929108|59223907|FG000|Overall Study|Hospice patient death|100|||
31011845|NCT02929108|59223908|FG001|Overall Study|Hospice patient death|64|||
31011846|NCT02929108|59223909|FG002|Overall Study|Hospice patient death|28|||
31011847|NCT02929108|59223910|FG003|Overall Study|Hospice patient death|46|||
31011848|NCT02929108|59223911|FG004|Overall Study|Hospice patient death|55|||
31011849|NCT02929108|59223912|FG005|Overall Study|Hospice patient death|28|||
31011850|NCT02929108|59223913|FG006|Overall Study|Hospice patient death|78|||
31011851|NCT02661295|59223921|FG000|Overall Study|Death|1|||
31011852|NCT02661295|59223921|FG000|Overall Study|Transferred Out|1|||
31011853|NCT02661295|59223921|FG000|Overall Study|Kidney Transplant|1|||
31011854|NCT02661295|59223921|FG000|Overall Study|Withdrawn due to side effects|8|||
31011855|NCT02661295|59223921|FG000|Overall Study|Withdrawn due to access type|1|||
31011856|NCT02661295|59223921|FG000|Overall Study|Withdrawn due to allergies|1|||
31011857|NCT02661295|59223921|FG000|Overall Study|Withdrawn due to non-compliance|1|||
30618039|NCT01054599|58628907|FG000|Overall Study|Lost to Follow-up|0|||
30618040|NCT01054599|58628908|FG001|Overall Study|Lost to Follow-up|2|||
30618041|NCT01054599|58628907|FG000|Overall Study|Adverse Event|0|||
30618042|NCT01054599|58628908|FG001|Overall Study|Adverse Event|1|||
30618043|NCT01054599|58628907|FG000|Overall Study|Withdrawal by Subject|0|||
30618044|NCT01054599|58628908|FG001|Overall Study|Withdrawal by Subject|1|||
30618045|NCT00948766|58628916|FG000|Core Study|Adverse Event|73|||
30618046|NCT00948766|58628917|FG001|Core Study|Adverse Event|51|||
30618047|NCT00948766|58628916|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
30618048|NCT00948766|58628917|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
30618049|NCT00948766|58628916|FG000|Core Study|Patient Withdrew Consent|27|||
30618050|NCT00948766|58628917|FG001|Core Study|Patient Withdrew Consent|46|||
30618051|NCT00948766|58628916|FG000|Core Study|Lost to Follow-up|3|||
30618052|NCT00948766|58628917|FG001|Core Study|Lost to Follow-up|2|||
30618053|NCT00948766|58628916|FG000|Core Study|Administrative Problems|2|||
30618054|NCT00948766|58628917|FG001|Core Study|Administrative Problems|2|||
30618055|NCT00948766|58628916|FG000|Core Study|Death|1|||
30618056|NCT00948766|58628917|FG001|Core Study|Death|1|||
30618057|NCT00948766|58628916|FG000|Core Study|Protocol Deviation|8|||
30618058|NCT00948766|58628917|FG001|Core Study|Protocol Deviation|10|||
30618059|NCT00948766|58628916|FG000|Extension Study|Adverse Event|43|||
30618060|NCT00948766|58628917|FG001|Extension Study|Adverse Event|0|||
30618061|NCT00948766|58628916|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
30618062|NCT00948766|58628917|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
30618063|NCT00948766|58628916|FG000|Extension Study|Study Drug No Longer Required|1|||
30618064|NCT00948766|58628917|FG001|Extension Study|Study Drug No Longer Required|0|||
30618065|NCT00948766|58628916|FG000|Extension Study|Patient Withdrew Consent|32|||
30618066|NCT00948766|58628917|FG001|Extension Study|Patient Withdrew Consent|0|||
30618067|NCT00948766|58628916|FG000|Extension Study|Lost to Follow-up|8|||
30618068|NCT00948766|58628917|FG001|Extension Study|Lost to Follow-up|0|||
30618069|NCT00948766|58628916|FG000|Extension Study|Administrative Problems|1|||
30790835|NCT03524092|58803944|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
31011858|NCT02661295|59223921|FG000|Overall Study|Withdrawal by Subject|3|||
31011859|NCT02661295|59223921|FG000|Overall Study|Failed screening|2|||
31011860|NCT02527434|59223928|FG000|Overall Study|Lost to Follow-up|2|||
30618070|NCT00948766|58628917|FG001|Extension Study|Administrative Problems|0|||
30618071|NCT00948766|58628916|FG000|Extension Study|Death|4|||
30618072|NCT00948766|58628917|FG001|Extension Study|Death|0|||
30618073|NCT01053663|58628927|FG000|Overall Study|Death|2|||
30618074|NCT01053663|58628927|FG000|Overall Study|Lost to Follow-up|1|||
30618075|NCT01053663|58628927|FG000|Overall Study|Poor IV Access|1|||
30618076|NCT01053663|58628927|FG000|Overall Study|Transferred to Another Hospital|1|||
30618077|NCT01053663|58628927|FG000|Overall Study|Negative Influenza Diagnosis|1|||
30618078|NCT01235546|58628939|FG000|Overall Study|Staff error, medication not administered|1|||
30618079|NCT01235546|58628940|FG001|Overall Study|Staff error, medication not administered|0|||
30618080|NCT01235546|58628939|FG000|Overall Study|Protocol Violation|1|||
30618081|NCT01235546|58628940|FG001|Overall Study|Protocol Violation|1|||
31011861|NCT02527434|59223929|FG001|Overall Study|Lost to Follow-up|2|||
31011862|NCT02527434|59223930|FG002|Overall Study|Lost to Follow-up|0|||
31011863|NCT02527434|59223928|FG000|Overall Study|Death|19|||
31011864|NCT02527434|59223929|FG001|Overall Study|Death|6|||
31011865|NCT02527434|59223930|FG002|Overall Study|Death|17|||
31011866|NCT02527434|59223928|FG000|Overall Study|Withdrawal by Subject|5|||
31011867|NCT02527434|59223929|FG001|Overall Study|Withdrawal by Subject|3|||
31011868|NCT02527434|59223930|FG002|Overall Study|Withdrawal by Subject|3|||
31011869|NCT02527434|59223928|FG000|Overall Study|Reason Not Specified|1|||
31011870|NCT02527434|59223929|FG001|Overall Study|Reason Not Specified|0|||
31011871|NCT02527434|59223930|FG002|Overall Study|Reason Not Specified|0|||
31011872|NCT02527434|59223928|FG000|Overall Study|Site closure|1|||
31011873|NCT02527434|59223929|FG001|Overall Study|Site closure|0|||
31011874|NCT02527434|59223930|FG002|Overall Study|Site closure|0|||
31011875|NCT02412748|59223959|FG000|Overall Study|Lost to Follow-up|38|||
31011876|NCT02412748|59223960|FG001|Overall Study|Lost to Follow-up|39|||
31011877|NCT01844726|59223985|FG000|Overall Study|Withdrawal by Subject|0|||
31011878|NCT01844726|59223986|FG001|Overall Study|Withdrawal by Subject|1|||
31011879|NCT01844726|59223985|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
31011880|NCT01844726|59223986|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
31011881|NCT03180840|59229555|FG000|Overall Study|Withdrawal by Subject|1|||
31011882|NCT02538666|59229567|FG000|Pre-Treatment|Disease progression|1|||
31011883|NCT02538666|59229568|FG001|Pre-Treatment|Disease progression|0|||
31011884|NCT02538666|59229569|FG002|Pre-Treatment|Disease progression|0|||
31011885|NCT02538666|59229567|FG000|Pre-Treatment|no longer meets study criteria|1|||
31011886|NCT02538666|59229568|FG001|Pre-Treatment|no longer meets study criteria|0|||
31011887|NCT02538666|59229569|FG002|Pre-Treatment|no longer meets study criteria|0|||
31011888|NCT02538666|59229567|FG000|Pre-Treatment|Withdrew Consent|0|||
31011889|NCT02538666|59229568|FG001|Pre-Treatment|Withdrew Consent|1|||
31011890|NCT02538666|59229569|FG002|Pre-Treatment|Withdrew Consent|1|||
31011891|NCT02538666|59229567|FG000|Treatment|Disease progression|270|||
31011892|NCT02538666|59229568|FG001|Treatment|Disease progression|227|||
31011893|NCT02538666|59229569|FG002|Treatment|Disease progression|165|||
31011894|NCT02538666|59229567|FG000|Treatment|Study drug toxicity|1|||
31011895|NCT02538666|59229568|FG001|Treatment|Study drug toxicity|29|||
31011896|NCT02538666|59229569|FG002|Treatment|Study drug toxicity|92|||
31011897|NCT02538666|59229567|FG000|Treatment|Death|0|||
31011898|NCT02538666|59229568|FG001|Treatment|Death|2|||
31011899|NCT02538666|59229569|FG002|Treatment|Death|3|||
31011900|NCT02538666|59229567|FG000|Treatment|Adverse event unrelated to study drug|8|||
31011901|NCT02538666|59229568|FG001|Treatment|Adverse event unrelated to study drug|10|||
31011902|NCT02538666|59229569|FG002|Treatment|Adverse event unrelated to study drug|15|||
31011903|NCT02538666|59229567|FG000|Treatment|Participant request to discontinue study treatment|3|||
31011904|NCT02538666|59229568|FG001|Treatment|Participant request to discontinue study treatment|6|||
31011905|NCT02538666|59229569|FG002|Treatment|Participant request to discontinue study treatment|11|||
31011906|NCT02538666|59229567|FG000|Treatment|Participant withdrew consent|2|||
31011907|NCT02538666|59229568|FG001|Treatment|Participant withdrew consent|5|||
31011908|NCT02538666|59229569|FG002|Treatment|Participant withdrew consent|3|||
31011909|NCT02538666|59229567|FG000|Treatment|Lost to Follow-up|0|||
31011910|NCT02538666|59229568|FG001|Treatment|Lost to Follow-up|1|||
31011911|NCT02538666|59229569|FG002|Treatment|Lost to Follow-up|1|||
31011912|NCT02538666|59229567|FG000|Treatment|Maximum clinical benefit|4|||
31011913|NCT02538666|59229568|FG001|Treatment|Maximum clinical benefit|3|||
31011914|NCT02538666|59229569|FG002|Treatment|Maximum clinical benefit|4|||
31011915|NCT02538666|59229567|FG000|Treatment|Poor/non-compliance|0|||
31011916|NCT02538666|59229568|FG001|Treatment|Poor/non-compliance|1|||
31011917|NCT02538666|59229569|FG002|Treatment|Poor/non-compliance|0|||
31011918|NCT02538666|59229567|FG000|Treatment|Participant no longer meets study criteria|0|||
31011919|NCT02538666|59229568|FG001|Treatment|Participant no longer meets study criteria|2|||
31011920|NCT02538666|59229569|FG002|Treatment|Participant no longer meets study criteria|0|||
31011921|NCT02538666|59229567|FG000|Treatment|Administrative reason by sponsor|0|||
31011922|NCT02538666|59229568|FG001|Treatment|Administrative reason by sponsor|0|||
31011923|NCT02538666|59229569|FG002|Treatment|Administrative reason by sponsor|1|||
31011924|NCT02538666|59229567|FG000|Treatment|Other reasons|8|||
31011925|NCT02538666|59229568|FG001|Treatment|Other reasons|15|||
31011926|NCT02538666|59229569|FG002|Treatment|Other reasons|5|||
30618082|NCT01053429|58628955|FG000|Overall Study|Adverse Event|64|||
31011927|NCT02538666|59229567|FG000|Treatment|Not reported|2|||
31011928|NCT02538666|59229568|FG001|Treatment|Not reported|2|||
31011929|NCT02538666|59229569|FG002|Treatment|Not reported|2|||
31011930|NCT02407236|59229623|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
31011931|NCT02407236|59229624|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
30618083|NCT01053429|58628955|FG000|Overall Study|Other|309|||
31011932|NCT02407236|59229625|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
31011933|NCT02407236|59229626|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
31011934|NCT02407236|59229627|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
31011935|NCT02407236|59229628|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
31011936|NCT02407236|59229629|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
31011937|NCT02407236|59229630|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
31011938|NCT02407236|59229631|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
31011939|NCT02407236|59229632|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
31011940|NCT02407236|59229633|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
31011941|NCT02407236|59229634|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
31011942|NCT02407236|59229635|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
31011943|NCT02407236|59229623|FG000|Induction Study (8 Weeks)|Death|0|||
31011944|NCT02407236|59229624|FG001|Induction Study (8 Weeks)|Death|0|||
31011945|NCT02407236|59229625|FG002|Induction Study (8 Weeks)|Death|1|||
31011946|NCT02407236|59229626|FG003|Induction Study (8 Weeks)|Death|0|||
31011947|NCT02407236|59229627|FG004|Induction Study (8 Weeks)|Death|0|||
31011948|NCT02407236|59229628|FG005|Induction Study (8 Weeks)|Death|0|||
31011949|NCT02407236|59229629|FG006|Induction Study (8 Weeks)|Death|0|||
31011950|NCT02407236|59229630|FG007|Induction Study (8 Weeks)|Death|0|||
31011951|NCT02407236|59229631|FG008|Induction Study (8 Weeks)|Death|0|||
31011952|NCT02407236|59229632|FG009|Induction Study (8 Weeks)|Death|0|||
31011953|NCT02407236|59229633|FG010|Induction Study (8 Weeks)|Death|0|||
31011954|NCT02407236|59229634|FG011|Induction Study (8 Weeks)|Death|0|||
31011955|NCT02407236|59229635|FG012|Induction Study (8 Weeks)|Death|0|||
31011956|NCT02407236|59229623|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
31011957|NCT02407236|59229624|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
31011958|NCT02407236|59229625|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
31011959|NCT02407236|59229626|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
31011960|NCT02407236|59229627|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
31011961|NCT02407236|59229628|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
31011962|NCT02407236|59229629|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
31011963|NCT02407236|59229630|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
31011964|NCT02407236|59229631|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
31011965|NCT02407236|59229632|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
31011966|NCT02407236|59229633|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
31011967|NCT02407236|59229634|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
31011968|NCT02407236|59229635|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
31011969|NCT02407236|59229623|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011970|NCT02407236|59229624|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011971|NCT02407236|59229625|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
31011972|NCT02407236|59229626|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011973|NCT02407236|59229627|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011974|NCT02407236|59229628|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011975|NCT02407236|59229629|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011976|NCT02407236|59229630|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011977|NCT02407236|59229631|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011978|NCT02407236|59229632|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011979|NCT02407236|59229633|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011980|NCT02407236|59229634|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011981|NCT02407236|59229635|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
31011982|NCT02407236|59229623|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
31011983|NCT02407236|59229624|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
31011984|NCT02407236|59229625|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
31011985|NCT02407236|59229626|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
31011986|NCT02407236|59229627|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
30618084|NCT01233284|58628959|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
30618085|NCT01233284|58628960|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
30625588|NCT00891046|58637759|FG002|Overall Study|Lost to Follow-up|0|||
30893228|NCT02370667|58926724|FG002|Overall Study|Lost to Follow-up|0|||
31011987|NCT02407236|59229628|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
31011988|NCT02407236|59229629|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
31011989|NCT02407236|59229630|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
31011990|NCT02407236|59229631|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
31011991|NCT02407236|59229632|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
31011992|NCT02407236|59229633|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
31011993|NCT02407236|59229634|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
31011994|NCT02407236|59229635|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
31011995|NCT02407236|59229623|FG000|Induction Study (8 Weeks)|Other|2|||
31011996|NCT02407236|59229624|FG001|Induction Study (8 Weeks)|Other|1|||
30618086|NCT01233284|58628961|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
30618087|NCT01233284|58628962|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
30618088|NCT01233284|58628963|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
30618089|NCT01233284|58628959|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
30618090|NCT01233284|58628960|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
30618091|NCT01233284|58628961|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
31011997|NCT02407236|59229625|FG002|Induction Study (8 Weeks)|Other|5|||
31011998|NCT02407236|59229626|FG003|Induction Study (8 Weeks)|Other|0|||
31011999|NCT02407236|59229627|FG004|Induction Study (8 Weeks)|Other|0|||
31012000|NCT02407236|59229628|FG005|Induction Study (8 Weeks)|Other|0|||
31012001|NCT02407236|59229629|FG006|Induction Study (8 Weeks)|Other|0|||
31012002|NCT02407236|59229630|FG007|Induction Study (8 Weeks)|Other|0|||
31012003|NCT02407236|59229631|FG008|Induction Study (8 Weeks)|Other|0|||
31012004|NCT02407236|59229632|FG009|Induction Study (8 Weeks)|Other|0|||
31012005|NCT02407236|59229633|FG010|Induction Study (8 Weeks)|Other|0|||
31012006|NCT02407236|59229634|FG011|Induction Study (8 Weeks)|Other|0|||
31012007|NCT02407236|59229635|FG012|Induction Study (8 Weeks)|Other|0|||
31012008|NCT02407236|59229623|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
31012009|NCT02407236|59229624|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
31012010|NCT02407236|59229625|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
31012011|NCT02407236|59229626|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
31012012|NCT02407236|59229627|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
31012013|NCT02407236|59229628|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
31012014|NCT02407236|59229629|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
31012015|NCT02407236|59229630|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
31012016|NCT02407236|59229631|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
31012017|NCT02407236|59229632|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
31012018|NCT02407236|59229633|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
31012019|NCT02407236|59229634|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
31012020|NCT02407236|59229635|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
31012021|NCT02407236|59229623|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
31012022|NCT02407236|59229624|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
31012023|NCT02407236|59229625|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
31012024|NCT02407236|59229626|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
31012025|NCT02407236|59229627|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
31012026|NCT02407236|59229628|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
31012027|NCT02407236|59229629|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
31012028|NCT02407236|59229630|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
31012029|NCT02407236|59229631|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
31012030|NCT02407236|59229632|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
31012031|NCT02407236|59229633|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
31012032|NCT02407236|59229634|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
31012033|NCT02407236|59229635|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
31012034|NCT02407236|59229623|FG000|Maintenance Study (44 Weeks)|Other|0|||
31012035|NCT02407236|59229624|FG001|Maintenance Study (44 Weeks)|Other|0|||
31012036|NCT02407236|59229625|FG002|Maintenance Study (44 Weeks)|Other|0|||
31012037|NCT02407236|59229626|FG003|Maintenance Study (44 Weeks)|Other|5|||
31012038|NCT02407236|59229627|FG004|Maintenance Study (44 Weeks)|Other|7|||
31012039|NCT02407236|59229628|FG005|Maintenance Study (44 Weeks)|Other|8|||
31012040|NCT02407236|59229629|FG006|Maintenance Study (44 Weeks)|Other|4|||
31012041|NCT02407236|59229630|FG007|Maintenance Study (44 Weeks)|Other|6|||
31012042|NCT02407236|59229631|FG008|Maintenance Study (44 Weeks)|Other|0|||
31012043|NCT02407236|59229632|FG009|Maintenance Study (44 Weeks)|Other|0|||
31012044|NCT02407236|59229633|FG010|Maintenance Study (44 Weeks)|Other|0|||
31012045|NCT02407236|59229634|FG011|Maintenance Study (44 Weeks)|Other|0|||
31012046|NCT02407236|59229635|FG012|Maintenance Study (44 Weeks)|Other|0|||
31012047|NCT02407236|59229623|FG000|Maintenance Study (44 Weeks)|Death|0|||
30618092|NCT01233284|58628962|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
30618093|NCT01233284|58628963|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
31012048|NCT02407236|59229624|FG001|Maintenance Study (44 Weeks)|Death|0|||
31012049|NCT02407236|59229625|FG002|Maintenance Study (44 Weeks)|Death|0|||
31012050|NCT02407236|59229626|FG003|Maintenance Study (44 Weeks)|Death|0|||
31012051|NCT02407236|59229627|FG004|Maintenance Study (44 Weeks)|Death|0|||
31012052|NCT02407236|59229628|FG005|Maintenance Study (44 Weeks)|Death|0|||
31012053|NCT02407236|59229629|FG006|Maintenance Study (44 Weeks)|Death|0|||
31012054|NCT02407236|59229630|FG007|Maintenance Study (44 Weeks)|Death|1|||
31012055|NCT02407236|59229631|FG008|Maintenance Study (44 Weeks)|Death|0|||
31012056|NCT02407236|59229632|FG009|Maintenance Study (44 Weeks)|Death|0|||
31012057|NCT02407236|59229633|FG010|Maintenance Study (44 Weeks)|Death|0|||
31012058|NCT02407236|59229634|FG011|Maintenance Study (44 Weeks)|Death|0|||
31012059|NCT02407236|59229635|FG012|Maintenance Study (44 Weeks)|Death|0|||
31012060|NCT02407236|59229623|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
31012061|NCT02407236|59229624|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
31012062|NCT02407236|59229625|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
31012063|NCT02407236|59229626|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
31012064|NCT02407236|59229627|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
31012065|NCT02407236|59229628|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
31012066|NCT02407236|59229629|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
31012067|NCT02407236|59229630|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
31012068|NCT02407236|59229631|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
31012069|NCT02407236|59229632|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
31012070|NCT02407236|59229633|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
31012071|NCT02407236|59229634|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
31012072|NCT02407236|59229635|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
31012073|NCT02407236|59229623|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012074|NCT02407236|59229624|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012075|NCT02407236|59229625|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012076|NCT02407236|59229626|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012077|NCT02407236|59229627|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012078|NCT02407236|59229628|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012079|NCT02407236|59229629|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012080|NCT02407236|59229630|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012081|NCT02407236|59229631|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012082|NCT02407236|59229632|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012083|NCT02407236|59229633|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
31012084|NCT02407236|59229634|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012085|NCT02407236|59229635|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
31012086|NCT02407236|59229623|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
31012087|NCT02407236|59229624|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
31012088|NCT02407236|59229625|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
31012089|NCT02407236|59229626|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
31012090|NCT02407236|59229627|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
31012091|NCT02407236|59229628|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
31012092|NCT02407236|59229629|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
31012093|NCT02407236|59229630|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
31012094|NCT02407236|59229631|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
31012095|NCT02407236|59229632|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
31012096|NCT02407236|59229633|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
31012097|NCT02407236|59229634|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
31012098|NCT02407236|59229635|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
31012099|NCT02407236|59229623|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
31012100|NCT02407236|59229624|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
31012101|NCT02407236|59229625|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
31012102|NCT02407236|59229626|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
31012103|NCT02407236|59229627|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
31012104|NCT02407236|59229628|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
31012105|NCT02407236|59229629|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
31012106|NCT02407236|59229630|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
31012107|NCT02407236|59229631|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
31012108|NCT02407236|59229632|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
31012109|NCT02407236|59229633|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
31012110|NCT02407236|59229634|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
31012111|NCT02407236|59229635|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
31012112|NCT01893138|59229663|FG000|Double-Blind Period|Withdrawal by Subject|1|||
31012113|NCT01893138|59229664|FG001|Double-Blind Period|Withdrawal by Subject|1|||
31012114|NCT01893138|59229663|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
31012115|NCT01893138|59229664|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
31012116|NCT01893138|59229663|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
31012117|NCT01893138|59229664|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
31012118|NCT01893138|59229663|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
31012119|NCT01893138|59229664|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
31012120|NCT01893138|59229663|FG000|Open Label - Unblinded Period|Adverse Event|1|||
31012121|NCT01893138|59229664|FG001|Open Label - Unblinded Period|Adverse Event|0|||
31012122|NCT04309500|59229676|FG000|Overall Study|Lost to Follow-up|1|||
31012123|NCT04309500|59229677|FG001|Overall Study|Lost to Follow-up|0|||
31012124|NCT04309500|59229678|FG002|Overall Study|Lost to Follow-up|0|||
31012125|NCT04309500|59229679|FG003|Overall Study|Lost to Follow-up|0|||
31012126|NCT03671304|59231014|FG000|Overall Study|study terminated|7|||
31012127|NCT03517722|59231020|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
31012128|NCT03517722|59231021|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
31012129|NCT03517722|59231020|FG000|Double Blind Period: Week 0-52|Death|0|||
31012130|NCT03517722|59231021|FG001|Double Blind Period: Week 0-52|Death|4|||
31012131|NCT03517722|59231020|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
31012132|NCT03517722|59231021|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
31012133|NCT03517722|59231020|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
31012134|NCT03517722|59231021|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
31012135|NCT03517722|59231020|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
31012136|NCT03517722|59231021|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
31012137|NCT03517722|59231020|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
31012138|NCT03517722|59231021|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
31012139|NCT03517722|59231020|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
31012140|NCT03517722|59231021|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
31012141|NCT03517722|59231020|FG000|Double Blind Period: Week 0-52|Other|4|||
31012142|NCT03517722|59231021|FG001|Double Blind Period: Week 0-52|Other|3|||
31012143|NCT03517722|59231020|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
31012144|NCT03517722|59231021|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
31012145|NCT03517722|59231020|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
31012146|NCT03517722|59231021|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
31012147|NCT03517722|59231020|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
31012148|NCT03517722|59231021|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
31012149|NCT03517722|59231020|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
31012150|NCT03517722|59231021|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
31012151|NCT03517722|59231020|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
31012152|NCT03517722|59231021|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
31012153|NCT03447990|59231035|FG000|Overall Study|Withdrawal by Subject|0|||
31012154|NCT03447990|59231036|FG001|Overall Study|Withdrawal by Subject|0|||
31012155|NCT03447990|59231037|FG002|Overall Study|Withdrawal by Subject|0|||
31012156|NCT03447990|59231038|FG003|Overall Study|Withdrawal by Subject|0|||
31012157|NCT03447990|59231039|FG004|Overall Study|Withdrawal by Subject|0|||
31012158|NCT03447990|59231040|FG005|Overall Study|Withdrawal by Subject|0|||
31012159|NCT03447990|59231041|FG006|Overall Study|Withdrawal by Subject|1|||
31012160|NCT01376778|59231093|FG000|Overall Study|Lost to Follow-up|3|||
31012161|NCT01376778|59231094|FG001|Overall Study|Lost to Follow-up|2|||
31012162|NCT01074294|59231103|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
31012163|NCT01074294|59231104|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
31012164|NCT01074294|59231105|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
31012165|NCT01074294|59231106|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
31012166|NCT01074294|59231103|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
31012167|NCT01074294|59231104|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
31012168|NCT01074294|59231105|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
31012169|NCT01074294|59231106|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
31012170|NCT01074294|59231103|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
31012171|NCT01074294|59231104|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
31012172|NCT01074294|59231105|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
31012173|NCT01074294|59231106|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
31012174|NCT01074294|59231103|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
31012175|NCT01074294|59231104|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
31012176|NCT01074294|59231105|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
31012177|NCT01074294|59231106|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
31012178|NCT01074294|59231103|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
31012179|NCT01074294|59231104|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
31012180|NCT01074294|59231105|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
31012181|NCT01074294|59231106|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
31012182|NCT01074294|59231103|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
31012183|NCT01074294|59231104|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
31012184|NCT01074294|59231105|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
31012185|NCT01074294|59231106|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
31012186|NCT01074294|59231103|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
31012187|NCT01074294|59231104|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
31012188|NCT01074294|59231105|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
31012189|NCT01074294|59231106|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
31012190|NCT01074294|59231103|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
30618094|NCT01233284|58628959|FG000|Period 1 (4 Weeks)|Other|0|||
30618095|NCT01233284|58628960|FG001|Period 1 (4 Weeks)|Other|0|||
30618096|NCT01233284|58628961|FG002|Period 1 (4 Weeks)|Other|1|||
31012191|NCT01074294|59231104|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
31012192|NCT01074294|59231105|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
31012193|NCT01074294|59231106|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
31012194|NCT01074294|59231103|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
31012195|NCT01074294|59231104|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
31012196|NCT01074294|59231105|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
31012197|NCT01074294|59231106|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
31012198|NCT01074294|59231103|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
31012199|NCT01074294|59231104|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
31012200|NCT01074294|59231105|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
31012201|NCT01074294|59231106|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
31012202|NCT01074294|59231103|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
31012203|NCT01074294|59231104|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
31012204|NCT01074294|59231105|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
31012205|NCT01074294|59231106|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
31012206|NCT01074294|59231103|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
31012207|NCT01074294|59231104|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
31012208|NCT01074294|59231105|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
31012209|NCT01074294|59231106|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
31012210|NCT01074294|59231103|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
31012211|NCT01074294|59231104|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
31012212|NCT01074294|59231105|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
31012213|NCT01074294|59231106|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
31012214|NCT04753437|59232095|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
31012215|NCT04753437|59232096|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
31012216|NCT04753437|59232095|FG000|Overall Study|Liver Function Test Abnormalities|2|||
31012217|NCT04753437|59232096|FG001|Overall Study|Liver Function Test Abnormalities|4|||
31012218|NCT04605094|59232104|FG000|Overall Study|Adverse Event|2|||
31012219|NCT04605094|59232105|FG001|Overall Study|Adverse Event|2|||
31012220|NCT04605094|59232104|FG000|Overall Study|Lost to Follow-up|1|||
31012221|NCT04605094|59232105|FG001|Overall Study|Lost to Follow-up|4|||
31012222|NCT04605094|59232104|FG000|Overall Study|Physician Decision|2|||
31012223|NCT04605094|59232105|FG001|Overall Study|Physician Decision|2|||
31012224|NCT04605094|59232104|FG000|Overall Study|Study terminated by Sponsor|31|||
31012225|NCT04605094|59232105|FG001|Overall Study|Study terminated by Sponsor|33|||
31012226|NCT04605094|59232104|FG000|Overall Study|Withdrawal by Subject|22|||
31012227|NCT04605094|59232105|FG001|Overall Study|Withdrawal by Subject|19|||
31012228|NCT04605094|59232104|FG000|Overall Study|Other|1|||
31012229|NCT04605094|59232105|FG001|Overall Study|Other|1|||
31012230|NCT04526210|59232114|FG000|Overall Study|Sponsor decision|7|||
30618097|NCT01233284|58628962|FG003|Period 1 (4 Weeks)|Other|0|||
30618098|NCT01233284|58628963|FG004|Period 1 (4 Weeks)|Other|0|||
30618099|NCT01233284|58628959|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30618100|NCT01233284|58628960|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
31012231|NCT04526210|59232115|FG001|Overall Study|Sponsor decision|5|||
31012232|NCT04526210|59232114|FG000|Overall Study|Withdrawal by Subject|3|||
31012233|NCT04526210|59232115|FG001|Overall Study|Withdrawal by Subject|2|||
31012234|NCT04149964|59232133|FG000|Overall Study|Lost to Follow-up|19|||
31012235|NCT04149964|59232134|FG001|Overall Study|Lost to Follow-up|18|||
31012236|NCT03842969|59232160|FG000|Overall Study|Participant declined follow-up visit|0|||
31012237|NCT03842969|59232161|FG001|Overall Study|Participant declined follow-up visit|1|||
30618101|NCT01233284|58628961|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
30618102|NCT01233284|58628962|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30618103|NCT01233284|58628963|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30618104|NCT01233284|58628959|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
30618105|NCT01233284|58628960|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
30618106|NCT01233284|58628961|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
30618107|NCT01233284|58628962|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
30618108|NCT01233284|58628963|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
30618109|NCT01233284|58628959|FG000|Period 3 (4 Weeks)|Other|0|||
30618110|NCT01233284|58628960|FG001|Period 3 (4 Weeks)|Other|0|||
30699498|NCT00747149|58713941|FG000|Overall Study|Severe non-compliance to protocol|0|||
31012238|NCT03842969|59232162|FG002|Overall Study|Participant declined follow-up visit|0|||
30618111|NCT01233284|58628961|FG002|Period 3 (4 Weeks)|Other|0|||
30618112|NCT01233284|58628962|FG003|Period 3 (4 Weeks)|Other|1|||
31012239|NCT03842969|59232160|FG000|Overall Study|Sponsor's decision|12|||
30618113|NCT01233284|58628963|FG004|Period 3 (4 Weeks)|Other|0|||
30618114|NCT01233284|58628959|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
30618115|NCT01233284|58628960|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
30618116|NCT01233284|58628961|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
30699499|NCT00747149|58713942|FG001|Overall Study|Severe non-compliance to protocol|1|||
30618117|NCT01233284|58628962|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
30618118|NCT01233284|58628963|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
30618119|NCT01233284|58628959|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
30618120|NCT01233284|58628960|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
30618121|NCT01233284|58628961|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
30618122|NCT01233284|58628962|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
30618123|NCT01233284|58628963|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
30618124|NCT00948688|58628973|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
30618125|NCT00948688|58628974|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
31012240|NCT03842969|59232161|FG001|Overall Study|Sponsor's decision|99|||
31012241|NCT03842969|59232162|FG002|Overall Study|Sponsor's decision|61|||
31012242|NCT03842969|59232160|FG000|Overall Study|Pregnancy|0|||
31012243|NCT03842969|59232161|FG001|Overall Study|Pregnancy|0|||
31012244|NCT03842969|59232162|FG002|Overall Study|Pregnancy|1|||
31012245|NCT03842969|59232160|FG000|Overall Study|Death|1|||
31012246|NCT03842969|59232161|FG001|Overall Study|Death|0|||
31012247|NCT03842969|59232162|FG002|Overall Study|Death|1|||
31012248|NCT03842969|59232160|FG000|Overall Study|Withdrawal by Subject|3|||
31012249|NCT03842969|59232161|FG001|Overall Study|Withdrawal by Subject|30|||
31012250|NCT03842969|59232162|FG002|Overall Study|Withdrawal by Subject|18|||
31012251|NCT03842969|59232160|FG000|Overall Study|Protocol Violation|1|||
31012252|NCT03842969|59232161|FG001|Overall Study|Protocol Violation|1|||
31012253|NCT03842969|59232162|FG002|Overall Study|Protocol Violation|0|||
31012254|NCT03842969|59232160|FG000|Overall Study|Physician Decision|0|||
31012255|NCT03842969|59232161|FG001|Overall Study|Physician Decision|3|||
31012256|NCT03842969|59232162|FG002|Overall Study|Physician Decision|0|||
31012257|NCT03842969|59232160|FG000|Overall Study|Lost to Follow-up|0|||
31012258|NCT03842969|59232161|FG001|Overall Study|Lost to Follow-up|2|||
31012259|NCT03842969|59232162|FG002|Overall Study|Lost to Follow-up|0|||
31012260|NCT03842969|59232160|FG000|Overall Study|Adverse Event|0|||
31012261|NCT03842969|59232161|FG001|Overall Study|Adverse Event|2|||
31012262|NCT03842969|59232162|FG002|Overall Study|Adverse Event|0|||
31012263|NCT03122106|59232179|FG000|Overall Study|Not enough tissue|1|||
31012264|NCT03122106|59232179|FG000|Overall Study|Disease progression during screening|2|||
31012265|NCT03122106|59232179|FG000|Overall Study|Poor RNA quality for vaccine|1|||
31012266|NCT02938520|59232189|FG000|Overall Study|On-going at the time of analysis|258|||
31012267|NCT02938520|59232190|FG001|Overall Study|On-going at the time of analysis|261|||
31012268|NCT02938520|59232189|FG000|Overall Study|Physician Decision|2|||
31012269|NCT02938520|59232190|FG001|Overall Study|Physician Decision|5|||
31012270|NCT02938520|59232189|FG000|Overall Study|Lost to Follow-up|2|||
31012271|NCT02938520|59232190|FG001|Overall Study|Lost to Follow-up|2|||
31012272|NCT02938520|59232189|FG000|Overall Study|Withdrawal by Subject|7|||
30618126|NCT00948688|58628973|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
30618127|NCT00948688|58628974|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
30618128|NCT00948688|58628973|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
30618129|NCT00948688|58628974|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
30618130|NCT01233050|58628983|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
30618131|NCT01233050|58628984|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
30618132|NCT01232894|58628992|FG000|Overall Study|Lost to Follow-up|0|||
30618133|NCT01232894|58628993|FG001|Overall Study|Lost to Follow-up|1|||
30618134|NCT01232894|58628992|FG000|Overall Study|Death|1|||
30618135|NCT01232894|58628993|FG001|Overall Study|Death|0|||
30618136|NCT01232894|58628992|FG000|Overall Study|Protocol Violation|1|||
30618137|NCT01232894|58628993|FG001|Overall Study|Protocol Violation|1|||
30618138|NCT01232894|58628992|FG000|Overall Study|Withdrawal by Subject|8|||
30618139|NCT01232894|58628993|FG001|Overall Study|Withdrawal by Subject|5|||
30618140|NCT01232894|58628992|FG000|Overall Study|Physician Decision|2|||
30618141|NCT01232894|58628993|FG001|Overall Study|Physician Decision|1|||
30618142|NCT01049217|58629001|FG000|Overall Study|Adverse Event|2|||
30618143|NCT01049217|58629002|FG001|Overall Study|Adverse Event|1|||
30618144|NCT01049217|58629001|FG000|Overall Study|Lack of Efficacy|1|||
30618145|NCT01049217|58629002|FG001|Overall Study|Lack of Efficacy|1|||
30618146|NCT01049217|58629001|FG000|Overall Study|Lost to Follow-up|3|||
30618147|NCT01049217|58629002|FG001|Overall Study|Lost to Follow-up|8|||
30618148|NCT01049217|58629001|FG000|Overall Study|Withdrawal by Subject|4|||
30618149|NCT01049217|58629002|FG001|Overall Study|Withdrawal by Subject|3|||
30618150|NCT01049217|58629001|FG000|Overall Study|Protocol Violation|1|||
30618151|NCT01049217|58629002|FG001|Overall Study|Protocol Violation|3|||
30618152|NCT01049217|58629001|FG000|Overall Study|Pregnancy|1|||
30618153|NCT01049217|58629002|FG001|Overall Study|Pregnancy|0|||
30618154|NCT01049217|58629001|FG000|Overall Study|Study Terminated by Sponsor|43|||
30699500|NCT00747149|58713941|FG000|Overall Study|Not reported|1|||
31012273|NCT02938520|59232190|FG001|Overall Study|Withdrawal by Subject|7|||
31012274|NCT02938520|59232189|FG000|Overall Study|Protocol Violation|0|||
31012275|NCT02938520|59232190|FG001|Overall Study|Protocol Violation|1|||
31012276|NCT02938520|59232189|FG000|Overall Study|Lack of Efficacy|5|||
30790836|NCT03524092|58803945|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
31012277|NCT02938520|59232190|FG001|Overall Study|Lack of Efficacy|3|||
31012278|NCT02938520|59232189|FG000|Overall Study|Adverse Event|9|||
30618155|NCT01049217|58629002|FG001|Overall Study|Study Terminated by Sponsor|43|||
30618156|NCT01049217|58629001|FG000|Overall Study|Other|1|||
30618157|NCT01049217|58629002|FG001|Overall Study|Other|2|||
30618158|NCT01049217|58629001|FG000|Overall Study|Randomized but not Treated|0|||
30618159|NCT01049217|58629002|FG001|Overall Study|Randomized but not Treated|2|||
30618160|NCT01232738|58629008|FG000|Overall Study|Death|3|||
30618161|NCT01232738|58629008|FG000|Overall Study|Physician Decision|2|||
30618162|NCT01232738|58629008|FG000|Overall Study|Lost to Follow-up|1|||
31012279|NCT02938520|59232190|FG001|Overall Study|Adverse Event|4|||
31012280|NCT02764541|59232207|FG000|Overall Study|Withdrawal by Subject|0|||
31012281|NCT02764541|59232208|FG001|Overall Study|Withdrawal by Subject|0|||
31012282|NCT02764541|59232209|FG002|Overall Study|Withdrawal by Subject|0|||
31012283|NCT02764541|59232210|FG003|Overall Study|Withdrawal by Subject|0|||
31012284|NCT02764541|59232211|FG004|Overall Study|Withdrawal by Subject|1|||
31012285|NCT02764541|59232212|FG005|Overall Study|Withdrawal by Subject|1|||
31012286|NCT02764541|59232213|FG006|Overall Study|Withdrawal by Subject|0|||
31012287|NCT02764541|59232214|FG007|Overall Study|Withdrawal by Subject|1|||
31012288|NCT02764541|59232207|FG000|Overall Study|Adverse Event|1|||
31012289|NCT02764541|59232208|FG001|Overall Study|Adverse Event|0|||
31012290|NCT02764541|59232209|FG002|Overall Study|Adverse Event|0|||
31012291|NCT02764541|59232210|FG003|Overall Study|Adverse Event|0|||
31012292|NCT02764541|59232211|FG004|Overall Study|Adverse Event|0|||
31012293|NCT02764541|59232212|FG005|Overall Study|Adverse Event|0|||
31012294|NCT02764541|59232213|FG006|Overall Study|Adverse Event|1|||
31012295|NCT02764541|59232214|FG007|Overall Study|Adverse Event|0|||
31012296|NCT02764541|59232207|FG000|Overall Study|Metastasis|1|||
31012297|NCT02764541|59232208|FG001|Overall Study|Metastasis|0|||
31012298|NCT02764541|59232209|FG002|Overall Study|Metastasis|0|||
31012299|NCT02764541|59232210|FG003|Overall Study|Metastasis|0|||
31012300|NCT02764541|59232211|FG004|Overall Study|Metastasis|0|||
31012301|NCT02764541|59232212|FG005|Overall Study|Metastasis|0|||
31012302|NCT02764541|59232213|FG006|Overall Study|Metastasis|0|||
31012303|NCT02764541|59232214|FG007|Overall Study|Metastasis|0|||
31012304|NCT02764541|59232207|FG000|Overall Study|Disease progression|1|||
31012305|NCT02764541|59232208|FG001|Overall Study|Disease progression|1|||
31012306|NCT02764541|59232209|FG002|Overall Study|Disease progression|0|||
31012307|NCT02764541|59232210|FG003|Overall Study|Disease progression|0|||
31012308|NCT02764541|59232211|FG004|Overall Study|Disease progression|0|||
31012309|NCT02764541|59232212|FG005|Overall Study|Disease progression|0|||
31012310|NCT02764541|59232213|FG006|Overall Study|Disease progression|0|||
31012311|NCT02764541|59232214|FG007|Overall Study|Disease progression|1|||
31012312|NCT02764541|59232207|FG000|Overall Study|Protocol Violation|0|||
31012313|NCT02764541|59232208|FG001|Overall Study|Protocol Violation|0|||
31012314|NCT02764541|59232209|FG002|Overall Study|Protocol Violation|0|||
31012315|NCT02764541|59232210|FG003|Overall Study|Protocol Violation|1|||
31012316|NCT02764541|59232211|FG004|Overall Study|Protocol Violation|0|||
31012317|NCT02764541|59232212|FG005|Overall Study|Protocol Violation|1|||
31012318|NCT02764541|59232213|FG006|Overall Study|Protocol Violation|0|||
31012319|NCT02764541|59232214|FG007|Overall Study|Protocol Violation|0|||
31012320|NCT02764541|59232207|FG000|Overall Study|Physician Decision|0|||
31012321|NCT02764541|59232208|FG001|Overall Study|Physician Decision|0|||
31012322|NCT02764541|59232209|FG002|Overall Study|Physician Decision|0|||
31012323|NCT02764541|59232210|FG003|Overall Study|Physician Decision|1|||
31012324|NCT02764541|59232211|FG004|Overall Study|Physician Decision|0|||
31012325|NCT02764541|59232212|FG005|Overall Study|Physician Decision|0|||
31012326|NCT02764541|59232213|FG006|Overall Study|Physician Decision|0|||
31012327|NCT02764541|59232214|FG007|Overall Study|Physician Decision|1|||
31012328|NCT02764541|59232207|FG000|Overall Study|Three Cycles completed before surgery|0|||
31012329|NCT02764541|59232208|FG001|Overall Study|Three Cycles completed before surgery|0|||
31012330|NCT02764541|59232209|FG002|Overall Study|Three Cycles completed before surgery|0|||
31012331|NCT02764541|59232210|FG003|Overall Study|Three Cycles completed before surgery|1|||
31012332|NCT02764541|59232211|FG004|Overall Study|Three Cycles completed before surgery|0|||
31012333|NCT02764541|59232212|FG005|Overall Study|Three Cycles completed before surgery|0|||
31012334|NCT02764541|59232213|FG006|Overall Study|Three Cycles completed before surgery|0|||
30618163|NCT01232738|58629008|FG000|Overall Study|Withdrawal by Subject|2|||
30618164|NCT01232738|58629008|FG000|Overall Study|Adverse Event|5|||
30618165|NCT00957268|58629021|FG000|Overall Study|Voluntary Withdrawal|0|||
30699501|NCT00747149|58713942|FG001|Overall Study|Not reported|4|||
31012335|NCT02764541|59232214|FG007|Overall Study|Three Cycles completed before surgery|0|||
31012336|NCT02764541|59232207|FG000|Overall Study|Patient Compliance|0|||
31012337|NCT02764541|59232208|FG001|Overall Study|Patient Compliance|0|||
31012338|NCT02764541|59232209|FG002|Overall Study|Patient Compliance|1|||
31012339|NCT02764541|59232210|FG003|Overall Study|Patient Compliance|0|||
31012340|NCT02764541|59232211|FG004|Overall Study|Patient Compliance|0|||
30618166|NCT00957268|58629022|FG001|Overall Study|Voluntary Withdrawal|0|||
30618167|NCT00957268|58629023|FG002|Overall Study|Voluntary Withdrawal|1|||
31012341|NCT02764541|59232212|FG005|Overall Study|Patient Compliance|0|||
31012342|NCT02764541|59232213|FG006|Overall Study|Patient Compliance|0|||
31012343|NCT02764541|59232214|FG007|Overall Study|Patient Compliance|0|||
31012344|NCT02764541|59232207|FG000|Overall Study|Death|0|||
31012345|NCT02764541|59232208|FG001|Overall Study|Death|0|||
31012346|NCT02764541|59232209|FG002|Overall Study|Death|0|||
31012347|NCT02764541|59232210|FG003|Overall Study|Death|0|||
31012348|NCT02764541|59232211|FG004|Overall Study|Death|0|||
31012349|NCT02764541|59232212|FG005|Overall Study|Death|0|||
31012350|NCT02764541|59232213|FG006|Overall Study|Death|1|||
31012351|NCT02764541|59232214|FG007|Overall Study|Death|0|||
31012352|NCT02764541|59232207|FG000|Overall Study|Insurance reasons|0|||
31012353|NCT02764541|59232208|FG001|Overall Study|Insurance reasons|0|||
31012354|NCT02764541|59232209|FG002|Overall Study|Insurance reasons|0|||
31012355|NCT02764541|59232210|FG003|Overall Study|Insurance reasons|0|||
31012356|NCT02764541|59232211|FG004|Overall Study|Insurance reasons|0|||
31012357|NCT02764541|59232212|FG005|Overall Study|Insurance reasons|0|||
31012358|NCT02764541|59232213|FG006|Overall Study|Insurance reasons|1|||
31012359|NCT02764541|59232214|FG007|Overall Study|Insurance reasons|0|||
31012360|NCT02667587|59232236|FG000|Pre-Treatment|Not reported|1|||
31012361|NCT02667587|59232237|FG001|Pre-Treatment|Not reported|0|||
31012362|NCT02667587|59232236|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
31012363|NCT02667587|59232237|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
31012364|NCT02667587|59232236|FG000|Pre-Treatment|Participant withdrew consent|0|||
31012365|NCT02667587|59232237|FG001|Pre-Treatment|Participant withdrew consent|1|||
31012366|NCT02667587|59232236|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
31012367|NCT02667587|59232237|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
31012368|NCT02667587|59232236|FG000|End of Treatment|Other reasons|11|||
31012369|NCT02667587|59232237|FG001|End of Treatment|Other reasons|8|||
31012370|NCT02667587|59232236|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
31012371|NCT02667587|59232237|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
31012372|NCT02667587|59232236|FG000|End of Treatment|Poor/Non-Compliance|0|||
31012373|NCT02667587|59232237|FG001|End of Treatment|Poor/Non-Compliance|1|||
31012374|NCT02667587|59232236|FG000|End of Treatment|Maximum Clinical Benefit|3|||
31012375|NCT02667587|59232237|FG001|End of Treatment|Maximum Clinical Benefit|3|||
31012376|NCT02667587|59232236|FG000|End of Treatment|Participant Withdrew Consent|5|||
31012377|NCT02667587|59232237|FG001|End of Treatment|Participant Withdrew Consent|6|||
31012378|NCT02667587|59232236|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
30618168|NCT00957268|58629024|FG003|Overall Study|Voluntary Withdrawal|0|||
30618169|NCT00957268|58629025|FG004|Overall Study|Voluntary Withdrawal|0|||
30618170|NCT01230788|58629037|FG000|Overall Study|Prescribed exclusion drug|1|||
30618171|NCT01230710|58629041|FG000|Overall Study|Disease Progression|41|||
30618172|NCT01230710|58629041|FG000|Overall Study|Lost to Follow-up|3|||
30618173|NCT01230710|58629041|FG000|Overall Study|Death|4|||
30618174|NCT01230710|58629041|FG000|Overall Study|Withdrawal of Consent|1|||
30618175|NCT01230554|58629045|FG000|Overall Study|Lost to Follow-up|2|||
30618176|NCT01230554|58629045|FG000|Overall Study|Inability to maintain visit schedule|1|||
30618177|NCT01040793|58629049|FG000|Overall Study|Adverse Event|5|||
30618178|NCT01040793|58629050|FG001|Overall Study|Adverse Event|3|||
30618179|NCT01040793|58629051|FG002|Overall Study|Adverse Event|0|||
30618180|NCT01040793|58629052|FG003|Overall Study|Adverse Event|2|||
30618181|NCT01040793|58629053|FG004|Overall Study|Adverse Event|2|||
30618182|NCT01040793|58629054|FG005|Overall Study|Adverse Event|1|||
30618183|NCT01040793|58629049|FG000|Overall Study|Protocol Violation|1|||
30618184|NCT01040793|58629050|FG001|Overall Study|Protocol Violation|1|||
30618185|NCT01040793|58629051|FG002|Overall Study|Protocol Violation|1|||
30618186|NCT01040793|58629052|FG003|Overall Study|Protocol Violation|0|||
30618187|NCT01040793|58629053|FG004|Overall Study|Protocol Violation|1|||
30618188|NCT01040793|58629054|FG005|Overall Study|Protocol Violation|0|||
30618189|NCT01040793|58629049|FG000|Overall Study|Lost to Follow-up|0|||
30618190|NCT01040793|58629050|FG001|Overall Study|Lost to Follow-up|1|||
30618191|NCT01040793|58629051|FG002|Overall Study|Lost to Follow-up|1|||
30618192|NCT01040793|58629052|FG003|Overall Study|Lost to Follow-up|0|||
31012379|NCT02667587|59232237|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
31012380|NCT02667587|59232236|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
31012381|NCT02667587|59232237|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
30618193|NCT01040793|58629053|FG004|Overall Study|Lost to Follow-up|0|||
30618194|NCT01040793|58629054|FG005|Overall Study|Lost to Follow-up|0|||
30618195|NCT01040793|58629049|FG000|Overall Study|Withdrawal by Subject|0|||
31012382|NCT02667587|59232236|FG000|End of Treatment|Death|2|||
31012383|NCT02667587|59232237|FG001|End of Treatment|Death|1|||
31012384|NCT02667587|59232236|FG000|End of Treatment|Study Drug Toxicity|74|||
31012385|NCT02667587|59232237|FG001|End of Treatment|Study Drug Toxicity|18|||
31012386|NCT02667587|59232236|FG000|End of Treatment|Disease progression|177|||
31012387|NCT02667587|59232237|FG001|End of Treatment|Disease progression|222|||
30618196|NCT01040793|58629050|FG001|Overall Study|Withdrawal by Subject|0|||
30618197|NCT01040793|58629051|FG002|Overall Study|Withdrawal by Subject|0|||
30699502|NCT00271609|58713956|FG000|Overall Study|Adverse Event|11|||
30618198|NCT01040793|58629052|FG003|Overall Study|Withdrawal by Subject|2|||
30618199|NCT01040793|58629053|FG004|Overall Study|Withdrawal by Subject|0|||
30618200|NCT01040793|58629054|FG005|Overall Study|Withdrawal by Subject|0|||
30618201|NCT01040793|58629049|FG000|Overall Study|Other reasons not listed above|0|||
30618202|NCT01040793|58629050|FG001|Overall Study|Other reasons not listed above|0|||
30618203|NCT01040793|58629051|FG002|Overall Study|Other reasons not listed above|1|||
30618204|NCT01040793|58629052|FG003|Overall Study|Other reasons not listed above|0|||
30618205|NCT01040793|58629053|FG004|Overall Study|Other reasons not listed above|1|||
30618206|NCT01040793|58629054|FG005|Overall Study|Other reasons not listed above|0|||
30618207|NCT00948064|58629067|FG000|Phase I|No treatment received|1|||
30618208|NCT00948064|58629068|FG001|Phase I|No treatment received|0|||
31012388|NCT02667587|59232236|FG000|End of Treatment|Lost to Follow-up|1|||
31012389|NCT02667587|59232237|FG001|End of Treatment|Lost to Follow-up|3|||
31012390|NCT02587065|59232243|FG000|Overall Study|Adverse Event|14|||
31012391|NCT02587065|59232243|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
31012392|NCT02587065|59232243|FG000|Overall Study|Non-adherence to the Protocol|3|||
31012393|NCT02587065|59232243|FG000|Overall Study|Discontinuation of Study Medication|2|||
31012394|NCT02587065|59232243|FG000|Overall Study|Reason not Specified|3|||
31012395|NCT02544503|59232253|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
31012396|NCT02544503|59232254|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
31012397|NCT02544503|59232253|FG000|Overall Study|Lost to Follow-up|9|||
31012398|NCT02544503|59232254|FG001|Overall Study|Lost to Follow-up|0|||
31012399|NCT02544503|59232253|FG000|Overall Study|Withdrawal by Subject|1|||
31012400|NCT02544503|59232254|FG001|Overall Study|Withdrawal by Subject|0|||
31012401|NCT02426658|59232260|FG000|Overall Study|Withdrawal by Subject|1|||
31012402|NCT02426658|59232260|FG000|Overall Study|Patient expired before treatment|2|||
31012403|NCT01705977|59232266|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
31012404|NCT01705977|59232267|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
31012405|NCT01705977|59232266|FG000|Treatment Period (Year 1)|Adverse Event|57|||
31012406|NCT01705977|59232267|FG001|Treatment Period (Year 1)|Adverse Event|49|||
31012407|NCT01705977|59232266|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
31012408|NCT01705977|59232267|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
31012409|NCT01705977|59232266|FG000|Treatment Period (Year 1)|Site closure|3|||
31012410|NCT01705977|59232267|FG001|Treatment Period (Year 1)|Site closure|2|||
31012411|NCT01705977|59232266|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
31012412|NCT01705977|59232267|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
31012413|NCT01705977|59232266|FG000|Treatment Period (Year 1)|Physician Decision|48|||
31012414|NCT01705977|59232267|FG001|Treatment Period (Year 1)|Physician Decision|38|||
31012415|NCT01705977|59232266|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
31012416|NCT01705977|59232267|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
31012417|NCT01705977|59232266|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
31012418|NCT01705977|59232267|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
31012419|NCT01705977|59232266|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
31012420|NCT01705977|59232267|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
31012421|NCT01705977|59232266|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
31012422|NCT01705977|59232267|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
31012423|NCT01705977|59232266|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
31012424|NCT01705977|59232267|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
31012425|NCT01705977|59232266|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
31012426|NCT01705977|59232267|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
31012427|NCT01474889|59232276|FG000|Overall Study|Physician Decision|1|||
31012428|NCT01474889|59232277|FG001|Overall Study|Physician Decision|0|||
31012429|NCT01474889|59232278|FG002|Overall Study|Physician Decision|0|||
31012430|NCT01474889|59232276|FG000|Overall Study|Did not meet inclusion|1|||
31012431|NCT01474889|59232277|FG001|Overall Study|Did not meet inclusion|0|||
31012432|NCT01474889|59232278|FG002|Overall Study|Did not meet inclusion|0|||
31012433|NCT01474889|59232276|FG000|Overall Study|Withdrawal by Subject|0|||
31012434|NCT01474889|59232277|FG001|Overall Study|Withdrawal by Subject|1|||
31012435|NCT01474889|59232278|FG002|Overall Study|Withdrawal by Subject|0|||
31012436|NCT01236560|59232290|FG000|Overall Study|Adverse Event|0|||
31012437|NCT01236560|59232291|FG001|Overall Study|Adverse Event|2|||
31012438|NCT01236560|59232292|FG002|Overall Study|Adverse Event|1|||
31012439|NCT01236560|59232293|FG003|Overall Study|Adverse Event|3|||
31012440|NCT01236560|59232294|FG004|Overall Study|Adverse Event|0|||
31012441|NCT01236560|59232295|FG005|Overall Study|Adverse Event|0|||
31012442|NCT01236560|59232290|FG000|Overall Study|Death|0|||
31012443|NCT01236560|59232291|FG001|Overall Study|Death|1|||
31012444|NCT01236560|59232292|FG002|Overall Study|Death|0|||
31012445|NCT01236560|59232293|FG003|Overall Study|Death|1|||
31012446|NCT01236560|59232294|FG004|Overall Study|Death|0|||
31012447|NCT01236560|59232295|FG005|Overall Study|Death|0|||
31012448|NCT01236560|59232290|FG000|Overall Study|Lost to Follow-up|0|||
31012449|NCT01236560|59232291|FG001|Overall Study|Lost to Follow-up|1|||
31012450|NCT01236560|59232292|FG002|Overall Study|Lost to Follow-up|1|||
31012451|NCT01236560|59232293|FG003|Overall Study|Lost to Follow-up|0|||
30618209|NCT00948064|58629069|FG002|Phase I|No treatment received|0|||
31012452|NCT01236560|59232294|FG004|Overall Study|Lost to Follow-up|0|||
31012453|NCT01236560|59232295|FG005|Overall Study|Lost to Follow-up|0|||
31012454|NCT01236560|59232290|FG000|Overall Study|Physician Decision|0|||
31012455|NCT01236560|59232291|FG001|Overall Study|Physician Decision|1|||
31012456|NCT01236560|59232292|FG002|Overall Study|Physician Decision|8|||
31012457|NCT01236560|59232293|FG003|Overall Study|Physician Decision|0|||
31012458|NCT01236560|59232294|FG004|Overall Study|Physician Decision|0|||
31012459|NCT01236560|59232295|FG005|Overall Study|Physician Decision|0|||
31012460|NCT01236560|59232290|FG000|Overall Study|Withdrawal by Subject|0|||
31012461|NCT01236560|59232291|FG001|Overall Study|Withdrawal by Subject|0|||
31012462|NCT01236560|59232292|FG002|Overall Study|Withdrawal by Subject|1|||
31012463|NCT01236560|59232293|FG003|Overall Study|Withdrawal by Subject|2|||
31012464|NCT01236560|59232294|FG004|Overall Study|Withdrawal by Subject|0|||
31012465|NCT01236560|59232295|FG005|Overall Study|Withdrawal by Subject|0|||
31012466|NCT01236560|59232290|FG000|Overall Study|Progressive disease|5|||
31012467|NCT01236560|59232291|FG001|Overall Study|Progressive disease|19|||
31012468|NCT01236560|59232292|FG002|Overall Study|Progressive disease|9|||
31012469|NCT01236560|59232293|FG003|Overall Study|Progressive disease|16|||
31012470|NCT01236560|59232294|FG004|Overall Study|Progressive disease|0|||
30618210|NCT00948064|58629067|FG000|Phase II|Physician Decision|0|||
30618211|NCT00948064|58629068|FG001|Phase II|Physician Decision|0|||
30618212|NCT00948064|58629069|FG002|Phase II|Physician Decision|1|||
30618213|NCT00948064|58629067|FG000|Phase II|Withdrawal by Subject|0|||
30618214|NCT00948064|58629068|FG001|Phase II|Withdrawal by Subject|1|||
30618215|NCT00948064|58629069|FG002|Phase II|Withdrawal by Subject|0|||
30618216|NCT00953524|58629083|FG000|Overall Study|Adverse Event|2|||
30618217|NCT00953524|58629084|FG001|Overall Study|Adverse Event|0|||
30618218|NCT00953524|58629085|FG002|Overall Study|Adverse Event|1|||
30618219|NCT00953524|58629086|FG003|Overall Study|Adverse Event|2|||
30618220|NCT00953524|58629083|FG000|Overall Study|Protocol Violation|18|||
30618221|NCT00953524|58629084|FG001|Overall Study|Protocol Violation|10|||
30618222|NCT00953524|58629085|FG002|Overall Study|Protocol Violation|11|||
30618223|NCT00953524|58629086|FG003|Overall Study|Protocol Violation|6|||
30618224|NCT00953524|58629083|FG000|Overall Study|Lost to Follow-up|0|||
30618225|NCT00953524|58629084|FG001|Overall Study|Lost to Follow-up|1|||
30618226|NCT00953524|58629085|FG002|Overall Study|Lost to Follow-up|1|||
30618227|NCT00953524|58629086|FG003|Overall Study|Lost to Follow-up|0|||
30699503|NCT00271609|58713957|FG001|Overall Study|Adverse Event|3|||
30699504|NCT00271609|58713956|FG000|Overall Study|Withdrawal by Subject|2|||
30618228|NCT00953524|58629083|FG000|Overall Study|Withdrawal by Subject|2|||
30618229|NCT00953524|58629084|FG001|Overall Study|Withdrawal by Subject|4|||
30618230|NCT00953524|58629085|FG002|Overall Study|Withdrawal by Subject|1|||
30618231|NCT00953524|58629086|FG003|Overall Study|Withdrawal by Subject|0|||
30618232|NCT01040403|58629105|FG000|Overall Study|Adverse Event|10|||
30618233|NCT01040403|58629105|FG000|Overall Study|Protocol Violation|2|||
30618234|NCT01040403|58629105|FG000|Overall Study|Lost to Follow-up|1|||
30618235|NCT01040403|58629105|FG000|Overall Study|Not treated|1|||
30618236|NCT01040403|58629105|FG000|Overall Study|Other reason not defined above|6|||
30618237|NCT00957034|58629127|FG000|Overall Study|Adverse Event|0|||
30618238|NCT00957034|58629128|FG001|Overall Study|Adverse Event|1|||
30618239|NCT00957034|58629129|FG002|Overall Study|Adverse Event|1|||
30618240|NCT00957034|58629127|FG000|Overall Study|Sponsor Terminated Study|6|||
30618241|NCT00957034|58629128|FG001|Overall Study|Sponsor Terminated Study|1|||
30618242|NCT00957034|58629129|FG002|Overall Study|Sponsor Terminated Study|5|||
30618243|NCT00957034|58629127|FG000|Overall Study|Withdrawal by Subject|0|||
30618244|NCT00957034|58629128|FG001|Overall Study|Withdrawal by Subject|2|||
30618245|NCT00957034|58629129|FG002|Overall Study|Withdrawal by Subject|0|||
30618246|NCT00953056|58629143|FG000|Overall Study|Withdrew Consent|0|||
30618247|NCT00953056|58629144|FG001|Overall Study|Withdrew Consent|0|||
30618248|NCT00953056|58629145|FG002|Overall Study|Withdrew Consent|0|||
30618249|NCT00953056|58629146|FG003|Overall Study|Withdrew Consent|0|||
30618250|NCT00953056|58629147|FG004|Overall Study|Withdrew Consent|2|||
30618251|NCT00953056|58629148|FG005|Overall Study|Withdrew Consent|3|||
30618252|NCT00953056|58629143|FG000|Overall Study|Serious Adverse Event|0|||
30618253|NCT00953056|58629144|FG001|Overall Study|Serious Adverse Event|0|||
30618254|NCT00953056|58629145|FG002|Overall Study|Serious Adverse Event|0|||
31012471|NCT01236560|59232295|FG005|Overall Study|Progressive disease|0|||
31012472|NCT01231906|59232307|FG000|Overall Study|Lack of Efficacy|75|||
31012473|NCT01231906|59232308|FG001|Overall Study|Lack of Efficacy|68|||
31012474|NCT01231906|59232307|FG000|Overall Study|Lost to Follow-up|1|||
31012475|NCT01231906|59232308|FG001|Overall Study|Lost to Follow-up|0|||
30618255|NCT00953056|58629146|FG003|Overall Study|Serious Adverse Event|0|||
31012476|NCT01231906|59232307|FG000|Overall Study|Physician Decision|34|||
31012477|NCT01231906|59232308|FG001|Overall Study|Physician Decision|24|||
30618256|NCT00953056|58629147|FG004|Overall Study|Serious Adverse Event|0|||
30618257|NCT00953056|58629148|FG005|Overall Study|Serious Adverse Event|1|||
30699505|NCT00271609|58713957|FG001|Overall Study|Withdrawal by Subject|0|||
30618258|NCT00952822|58629173|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
30618259|NCT00952822|58629174|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
30618260|NCT00952822|58629175|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
30618261|NCT00952822|58629176|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
30618262|NCT00952822|58629173|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
30618263|NCT00952822|58629174|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
30618264|NCT00952822|58629175|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
30618265|NCT00952822|58629176|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
30618266|NCT01038297|58629190|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
30618267|NCT01038297|58629191|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
30618268|NCT01038297|58629192|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
30618269|NCT00955708|58629209|FG000|Overall Study|Death|269|||
31012478|NCT01231906|59232307|FG000|Overall Study|Withdrawal by Subject|0|||
31012479|NCT01231906|59232308|FG001|Overall Study|Withdrawal by Subject|4|||
31012480|NCT01231906|59232307|FG000|Overall Study|Ineligible|10|||
31012481|NCT01231906|59232308|FG001|Overall Study|Ineligible|3|||
31012482|NCT01231906|59232307|FG000|Overall Study|No treatment|1|||
31012483|NCT01231906|59232308|FG001|Overall Study|No treatment|2|||
31012484|NCT00724048|59232335|FG000|Overall Study|Adverse Event|1|||
31012485|NCT00724048|59232336|FG001|Overall Study|Adverse Event|1|||
31012486|NCT00724048|59232337|FG002|Overall Study|Adverse Event|1|||
31012487|NCT00724048|59232338|FG003|Overall Study|Adverse Event|0|||
31012488|NCT00724048|59232335|FG000|Overall Study|Lost to Follow-up|0|||
31012489|NCT00724048|59232336|FG001|Overall Study|Lost to Follow-up|1|||
31012490|NCT00724048|59232337|FG002|Overall Study|Lost to Follow-up|0|||
31012491|NCT00724048|59232338|FG003|Overall Study|Lost to Follow-up|0|||
31012492|NCT00724048|59232335|FG000|Overall Study|Withdrawal by Subject|1|||
31012493|NCT00724048|59232336|FG001|Overall Study|Withdrawal by Subject|2|||
31012494|NCT00724048|59232337|FG002|Overall Study|Withdrawal by Subject|1|||
31012495|NCT00724048|59232338|FG003|Overall Study|Withdrawal by Subject|2|||
31012496|NCT00724048|59232335|FG000|Overall Study|Investigator decision|0|||
31012497|NCT00724048|59232336|FG001|Overall Study|Investigator decision|0|||
31012498|NCT00724048|59232337|FG002|Overall Study|Investigator decision|1|||
31012499|NCT00724048|59232338|FG003|Overall Study|Investigator decision|0|||
31012500|NCT00724048|59232335|FG000|Overall Study|Did not tolerate study drug|0|||
31012501|NCT00724048|59232336|FG001|Overall Study|Did not tolerate study drug|0|||
31012502|NCT00724048|59232337|FG002|Overall Study|Did not tolerate study drug|0|||
31012503|NCT00724048|59232338|FG003|Overall Study|Did not tolerate study drug|1|||
31012504|NCT00724048|59232335|FG000|Overall Study|Other than specified|1|||
31012505|NCT00724048|59232336|FG001|Overall Study|Other than specified|1|||
31012506|NCT00724048|59232337|FG002|Overall Study|Other than specified|0|||
31012507|NCT00724048|59232338|FG003|Overall Study|Other than specified|0|||
31012508|NCT00304070|59232351|FG000|Overall Study|Death|0|||
31012509|NCT00304070|59232352|FG001|Overall Study|Death|0|||
31012510|NCT00304070|59232353|FG002|Overall Study|Death|3|||
30618270|NCT00955708|58629209|FG000|Overall Study|Lost to Follow-up|72|||
30618271|NCT00955708|58629209|FG000|Overall Study|Physician Decision|36|||
30618272|NCT00955708|58629209|FG000|Overall Study|Protocol Violation|134|||
30618273|NCT00955708|58629209|FG000|Overall Study|Registry Conclusion|186|||
30618274|NCT00955708|58629209|FG000|Overall Study|Product removed from service|94|||
30618275|NCT00955708|58629209|FG000|Overall Study|Patient Refused to participate further|116|||
30618276|NCT00955708|58629209|FG000|Overall Study|Closure of study location|60|||
30618277|NCT00955708|58629209|FG000|Overall Study|Patient changed care provider/moved|91|||
30618278|NCT01037985|58629213|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
30618279|NCT01037985|58629214|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
30618280|NCT01037985|58629213|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
30618281|NCT01037985|58629214|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
30618282|NCT01037985|58629213|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
30618283|NCT01037985|58629214|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
30618284|NCT01037985|58629213|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
30618285|NCT01037985|58629214|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
30618286|NCT00955474|58629226|FG000|Overall Study|Physician Decision|7|||
30699506|NCT00548847|58713963|FG000|Overall Study|Disease progression|7|||
31012511|NCT00304070|59232351|FG000|Overall Study|Lost to Follow-up|0|||
30618287|NCT00955474|58629227|FG001|Overall Study|Physician Decision|5|||
30618288|NCT01229150|58629239|FG000|Overall Study|Toxicity|2|||
30618289|NCT01229150|58629240|FG001|Overall Study|Toxicity|2|||
30618290|NCT01229150|58629241|FG002|Overall Study|Toxicity|0|||
30618291|NCT01229150|58629242|FG003|Overall Study|Toxicity|0|||
30618292|NCT00952588|58629258|FG000|Overall Study|Death|28|||
30618293|NCT00952588|58629259|FG001|Overall Study|Death|13|||
30699507|NCT00290407|58713967|FG000|Overall Study|Physician Decision|2|||
30618294|NCT00952588|58629258|FG000|Overall Study|Withdrawal by Subject|2|||
30699508|NCT00749411|58713973|FG000|Overall Study|Adverse Event|0|||
31012512|NCT00304070|59232352|FG001|Overall Study|Lost to Follow-up|0|||
31012513|NCT00304070|59232353|FG002|Overall Study|Lost to Follow-up|1|||
31012514|NCT00304070|59232351|FG000|Overall Study|Physician Decision|0|||
31012515|NCT00304070|59232352|FG001|Overall Study|Physician Decision|0|||
30618295|NCT00952588|58629259|FG001|Overall Study|Withdrawal by Subject|5|||
30618296|NCT00952588|58629258|FG000|Overall Study|Adverse Event|2|||
30618297|NCT00952588|58629259|FG001|Overall Study|Adverse Event|3|||
30618298|NCT00952588|58629258|FG000|Overall Study|Lost to Follow-up|2|||
30618299|NCT00952588|58629259|FG001|Overall Study|Lost to Follow-up|0|||
30618300|NCT00952588|58629258|FG000|Overall Study|Physician Decision|0|||
30618301|NCT00952588|58629259|FG001|Overall Study|Physician Decision|1|||
30618302|NCT00952588|58629258|FG000|Overall Study|Lack of Efficacy|2|||
31012516|NCT00304070|59232353|FG002|Overall Study|Physician Decision|3|||
31012517|NCT00304070|59232351|FG000|Overall Study|Withdrawal by Subject|0|||
31012518|NCT00304070|59232352|FG001|Overall Study|Withdrawal by Subject|0|||
31012519|NCT00304070|59232353|FG002|Overall Study|Withdrawal by Subject|1|||
31012520|NCT00304070|59232351|FG000|Overall Study|Progressive Disease|3|||
31012521|NCT00304070|59232352|FG001|Overall Study|Progressive Disease|7|||
31012522|NCT00304070|59232353|FG002|Overall Study|Progressive Disease|4|||
31012523|NCT00160680|59232367|FG000|Overall Study|Adverse Event|0|||
31012524|NCT00160680|59232368|FG001|Overall Study|Adverse Event|1|||
31012525|NCT00160680|59232367|FG000|Overall Study|Lack of Efficacy|2|||
31012526|NCT00160680|59232368|FG001|Overall Study|Lack of Efficacy|1|||
31012527|NCT00160680|59232367|FG000|Overall Study|Lost to Follow-up|3|||
31012528|NCT00160680|59232368|FG001|Overall Study|Lost to Follow-up|2|||
31012529|NCT00160680|59232367|FG000|Overall Study|Withdrawal by Subject|4|||
31012530|NCT00160680|59232368|FG001|Overall Study|Withdrawal by Subject|9|||
30618303|NCT00952588|58629259|FG001|Overall Study|Lack of Efficacy|2|||
30618304|NCT01227902|58629269|FG000|Overall Study|Adverse Event|12|||
30618305|NCT01227902|58629270|FG001|Overall Study|Adverse Event|8|||
30618306|NCT01227902|58629271|FG002|Overall Study|Adverse Event|11|||
30618307|NCT01227902|58629272|FG003|Overall Study|Adverse Event|4|||
30618308|NCT01227902|58629269|FG000|Overall Study|Lack of Efficacy|1|||
30618309|NCT01227902|58629270|FG001|Overall Study|Lack of Efficacy|2|||
30618310|NCT01227902|58629271|FG002|Overall Study|Lack of Efficacy|2|||
30618311|NCT01227902|58629272|FG003|Overall Study|Lack of Efficacy|1|||
30618312|NCT01227902|58629269|FG000|Overall Study|Protocol Violation|1|||
30618313|NCT01227902|58629270|FG001|Overall Study|Protocol Violation|0|||
30790837|NCT03524092|58803940|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
30618314|NCT01227902|58629271|FG002|Overall Study|Protocol Violation|0|||
30618315|NCT01227902|58629272|FG003|Overall Study|Protocol Violation|0|||
30618316|NCT01227902|58629269|FG000|Overall Study|Lost to Follow-up|0|||
30618317|NCT01227902|58629270|FG001|Overall Study|Lost to Follow-up|0|||
30618318|NCT01227902|58629271|FG002|Overall Study|Lost to Follow-up|1|||
30618319|NCT01227902|58629272|FG003|Overall Study|Lost to Follow-up|2|||
30618320|NCT01227902|58629269|FG000|Overall Study|Physician Decision|0|||
30618321|NCT01227902|58629270|FG001|Overall Study|Physician Decision|1|||
30618322|NCT01227902|58629271|FG002|Overall Study|Physician Decision|1|||
30618323|NCT01227902|58629272|FG003|Overall Study|Physician Decision|0|||
30618324|NCT01227902|58629269|FG000|Overall Study|Withdrawal by Subject|4|||
30618325|NCT01227902|58629270|FG001|Overall Study|Withdrawal by Subject|2|||
30618326|NCT01227902|58629271|FG002|Overall Study|Withdrawal by Subject|4|||
30618327|NCT01227902|58629272|FG003|Overall Study|Withdrawal by Subject|3|||
30618328|NCT00946192|58629286|FG000|Overall Study|Lost to Follow-up|6|||
30618329|NCT00946192|58629287|FG001|Overall Study|Lost to Follow-up|11|||
30618330|NCT00946192|58629288|FG002|Overall Study|Lost to Follow-up|9|||
30618331|NCT00946192|58629286|FG000|Overall Study|Withdrawal by Subject|10|||
30618332|NCT00946192|58629287|FG001|Overall Study|Withdrawal by Subject|7|||
30625589|NCT00891046|58637760|FG003|Overall Study|Lost to Follow-up|0|||
30618333|NCT00946192|58629288|FG002|Overall Study|Withdrawal by Subject|3|||
30618334|NCT00946192|58629286|FG000|Overall Study|Did not start medication|2|||
30618335|NCT00946192|58629287|FG001|Overall Study|Did not start medication|0|||
30618336|NCT00946192|58629288|FG002|Overall Study|Did not start medication|0|||
30618337|NCT01037127|58629298|FG000|Overall Study|Lost to Follow-up|2|||
30618338|NCT01037127|58629299|FG001|Overall Study|Lost to Follow-up|4|||
30618339|NCT01037127|58629298|FG000|Overall Study|Physician Decision|1|||
30618340|NCT01037127|58629299|FG001|Overall Study|Physician Decision|0|||
30618341|NCT01037127|58629298|FG000|Overall Study|Study Closed Terminated|2|||
30618342|NCT01037127|58629299|FG001|Overall Study|Study Closed Terminated|17|||
30618343|NCT00946114|58629317|FG000|Overall Study|Death|5|||
30618344|NCT00946114|58629318|FG001|Overall Study|Death|2|||
30618345|NCT00946114|58629317|FG000|Overall Study|Other|1|||
30618346|NCT00946114|58629318|FG001|Overall Study|Other|0|||
30618347|NCT00946114|58629317|FG000|Overall Study|Withdrawal by Subject|2|||
30618348|NCT00946114|58629318|FG001|Overall Study|Withdrawal by Subject|0|||
30618349|NCT01038921|58629326|FG000|Overall Study|Withdrawal by Subject|1|||
30618350|NCT01038921|58629327|FG001|Overall Study|Withdrawal by Subject|0|||
30618351|NCT01038921|58629326|FG000|Overall Study|Physician Decision|1|||
30618352|NCT01038921|58629327|FG001|Overall Study|Physician Decision|0|||
30618353|NCT01038687|58629336|FG000|Overall Study|Adverse Event|0|||
30618354|NCT01038687|58629337|FG001|Overall Study|Adverse Event|2|||
30618355|NCT01038687|58629338|FG002|Overall Study|Adverse Event|1|||
30618356|NCT01081912|58629346|FG000|Conversion/Titration|Adverse Event|47|||
30618357|NCT01081912|58629347|FG001|Conversion/Titration|Adverse Event|0|||
30618358|NCT01081912|58629348|FG002|Conversion/Titration|Adverse Event|0|||
30618359|NCT01081912|58629346|FG000|Conversion/Titration|Lack of Efficacy|17|||
30618360|NCT01081912|58629347|FG001|Conversion/Titration|Lack of Efficacy|0|||
30618361|NCT01081912|58629348|FG002|Conversion/Titration|Lack of Efficacy|0|||
30618362|NCT01081912|58629346|FG000|Conversion/Titration|Lost to Follow-up|5|||
30618363|NCT01081912|58629347|FG001|Conversion/Titration|Lost to Follow-up|0|||
30618364|NCT01081912|58629348|FG002|Conversion/Titration|Lost to Follow-up|0|||
30618365|NCT01081912|58629346|FG000|Conversion/Titration|Physician Decision|2|||
30618366|NCT01081912|58629347|FG001|Conversion/Titration|Physician Decision|0|||
30618367|NCT01081912|58629348|FG002|Conversion/Titration|Physician Decision|0|||
30618368|NCT01081912|58629346|FG000|Conversion/Titration|Protocol Violation|67|||
30618369|NCT01081912|58629347|FG001|Conversion/Titration|Protocol Violation|0|||
30618370|NCT01081912|58629348|FG002|Conversion/Titration|Protocol Violation|0|||
30618371|NCT01081912|58629346|FG000|Conversion/Titration|Withdrawal by Subject|23|||
30618372|NCT01081912|58629347|FG001|Conversion/Titration|Withdrawal by Subject|0|||
30618373|NCT01081912|58629348|FG002|Conversion/Titration|Withdrawal by Subject|0|||
30618374|NCT01081912|58629346|FG000|Conversion/Titration|Non-Compliance|47|||
30618375|NCT01081912|58629347|FG001|Conversion/Titration|Non-Compliance|0|||
30618376|NCT01081912|58629348|FG002|Conversion/Titration|Non-Compliance|0|||
30618377|NCT01081912|58629346|FG000|Maintenance Treatment|Adverse Event|0|||
30618378|NCT01081912|58629347|FG001|Maintenance Treatment|Adverse Event|2|||
30618379|NCT01081912|58629348|FG002|Maintenance Treatment|Adverse Event|12|||
30618380|NCT01081912|58629346|FG000|Maintenance Treatment|Lack of Efficacy|0|||
30618381|NCT01081912|58629347|FG001|Maintenance Treatment|Lack of Efficacy|14|||
30618382|NCT01081912|58629348|FG002|Maintenance Treatment|Lack of Efficacy|64|||
30618383|NCT01081912|58629346|FG000|Maintenance Treatment|Lost to Follow-up|0|||
30618384|NCT01081912|58629347|FG001|Maintenance Treatment|Lost to Follow-up|1|||
30618385|NCT01081912|58629348|FG002|Maintenance Treatment|Lost to Follow-up|0|||
30618386|NCT01081912|58629346|FG000|Maintenance Treatment|Physician Decision|0|||
30618387|NCT01081912|58629347|FG001|Maintenance Treatment|Physician Decision|0|||
30618388|NCT01081912|58629348|FG002|Maintenance Treatment|Physician Decision|1|||
30618389|NCT01081912|58629346|FG000|Maintenance Treatment|Protocol Violation|0|||
30618390|NCT01081912|58629347|FG001|Maintenance Treatment|Protocol Violation|1|||
30618391|NCT01081912|58629348|FG002|Maintenance Treatment|Protocol Violation|2|||
30618392|NCT01081912|58629346|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
30618393|NCT01081912|58629347|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
30618394|NCT01081912|58629348|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
30618395|NCT01081912|58629346|FG000|Maintenance Treatment|Non-Compliance|0|||
30618396|NCT01081912|58629347|FG001|Maintenance Treatment|Non-Compliance|4|||
30618397|NCT01081912|58629348|FG002|Maintenance Treatment|Non-Compliance|7|||
30618398|NCT01081912|58629346|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
30618399|NCT01081912|58629347|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
30618400|NCT01081912|58629348|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
30618401|NCT01038609|58629360|FG000|Overall Study|Adverse Event|0|||
30618402|NCT01038609|58629361|FG001|Overall Study|Adverse Event|0|||
30618403|NCT01038609|58629362|FG002|Overall Study|Adverse Event|1|||
30618404|NCT01038609|58629363|FG003|Overall Study|Adverse Event|0|||
30618405|NCT01038609|58629364|FG004|Overall Study|Adverse Event|0|||
30618406|NCT01038609|58629360|FG000|Overall Study|Dosing Error|0|||
30618407|NCT01038609|58629361|FG001|Overall Study|Dosing Error|0|||
30618408|NCT01038609|58629362|FG002|Overall Study|Dosing Error|0|||
30618409|NCT01038609|58629363|FG003|Overall Study|Dosing Error|1|||
30618410|NCT01038609|58629364|FG004|Overall Study|Dosing Error|1|||
30618411|NCT01038609|58629360|FG000|Overall Study|Death in the Family|1|||
30618412|NCT01038609|58629361|FG001|Overall Study|Death in the Family|0|||
30618413|NCT01038609|58629362|FG002|Overall Study|Death in the Family|0|||
30618414|NCT01038609|58629363|FG003|Overall Study|Death in the Family|0|||
30618415|NCT01038609|58629364|FG004|Overall Study|Death in the Family|0|||
30618416|NCT01038609|58629360|FG000|Overall Study|Refusal of Blood Draws|0|||
30618417|NCT01038609|58629361|FG001|Overall Study|Refusal of Blood Draws|1|||
30699509|NCT00749411|58713974|FG001|Overall Study|Adverse Event|2|||
30618418|NCT01038609|58629362|FG002|Overall Study|Refusal of Blood Draws|0|||
30618419|NCT01038609|58629363|FG003|Overall Study|Refusal of Blood Draws|0|||
30618420|NCT01038609|58629364|FG004|Overall Study|Refusal of Blood Draws|0|||
30618421|NCT02357134|58629380|FG000|Overall Study|Lost to Follow-up|1|||
30618422|NCT02357134|58629381|FG001|Overall Study|Lost to Follow-up|0|||
30618423|NCT02357134|58629382|FG002|Overall Study|Lost to Follow-up|0|||
30618424|NCT02357134|58629383|FG003|Overall Study|Lost to Follow-up|0|||
30618425|NCT00745420|58629393|FG000|Overall Study|Ineligible|1|||
30618426|NCT02853370|58629397|FG000|Overall Study|Physician Decision|1|||
30618427|NCT02853370|58629397|FG000|Overall Study|Lack of Efficacy|2|||
30618428|NCT02853370|58629397|FG000|Overall Study|Death|1|||
30618429|NCT02853370|58629397|FG000|Overall Study|Adverse Event|4|||
30618430|NCT02853370|58629397|FG000|Overall Study|Withdrawal by Subject|3|||
30618431|NCT01879072|58629402|FG000|Overall Study|Withdrawal by Subject|121|||
30618432|NCT01879072|58629402|FG000|Overall Study|Not Transplanted|30|||
30618433|NCT00954538|58629408|FG000|Part III|Withdrawal by Subject|0|||
30618434|NCT00954538|58629409|FG001|Part III|Withdrawal by Subject|0|||
30618435|NCT00954538|58629410|FG002|Part III|Withdrawal by Subject|0|||
30618436|NCT00954538|58629411|FG003|Part III|Withdrawal by Subject|0|||
30618437|NCT00954538|58629412|FG004|Part III|Withdrawal by Subject|1|||
30618438|NCT00954538|58629413|FG005|Part III|Withdrawal by Subject|0|||
30618439|NCT00943852|58629422|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
30618440|NCT00943852|58629423|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
30618441|NCT00943852|58629424|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
30618442|NCT00943852|58629425|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
30618443|NCT00943852|58629426|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
30618444|NCT00943852|58629427|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
30618445|NCT00943852|58629428|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
30618446|NCT00943852|58629429|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
30618447|NCT00943852|58629430|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
30618448|NCT00943852|58629431|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
30618449|NCT00943852|58629422|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
30618450|NCT00943852|58629423|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
30618451|NCT00943852|58629424|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
30618452|NCT00943852|58629425|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
30618453|NCT00943852|58629426|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
30618454|NCT00943852|58629427|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
30618455|NCT00943852|58629428|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
30618456|NCT00943852|58629429|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
30618457|NCT00943852|58629430|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
30618458|NCT00943852|58629431|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
30618459|NCT00943852|58629422|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
30618460|NCT00943852|58629423|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
30618461|NCT00943852|58629424|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
30618462|NCT00943852|58629425|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
30618463|NCT00943852|58629426|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
30618464|NCT00943852|58629427|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
30618465|NCT00943852|58629428|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
30618466|NCT00943852|58629429|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
30618467|NCT00943852|58629430|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
30618468|NCT00943852|58629431|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
30618469|NCT00943852|58629422|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
30618470|NCT00943852|58629423|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
30618471|NCT00943852|58629424|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
30618472|NCT00943852|58629425|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
30618473|NCT00943852|58629426|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
30618474|NCT00943852|58629427|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
30618475|NCT00943852|58629428|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
30618476|NCT00943852|58629429|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
30618477|NCT00943852|58629430|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
30618478|NCT00943852|58629431|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
30618479|NCT00943852|58629422|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
30699510|NCT00749411|58713973|FG000|Overall Study|Lack of Efficacy|0|||
30618480|NCT00943852|58629423|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
30618481|NCT00943852|58629424|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
30618482|NCT00943852|58629425|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
30618483|NCT00943852|58629426|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
30618484|NCT00943852|58629427|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
30618485|NCT00943852|58629428|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
30699511|NCT00749411|58713974|FG001|Overall Study|Lack of Efficacy|1|||
30699512|NCT00749411|58713973|FG000|Overall Study|Protocol Violation|1|||
30699513|NCT00749411|58713974|FG001|Overall Study|Protocol Violation|1|||
30699514|NCT00749411|58713973|FG000|Overall Study|Protocol-defined stopping criteria|0|||
30699515|NCT00749411|58713974|FG001|Overall Study|Protocol-defined stopping criteria|1|||
30699516|NCT03958149|58713982|FG000|Overall Study|Withdrawal by Subject|0|||
30618486|NCT00943852|58629429|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
30618487|NCT00943852|58629430|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
30618488|NCT00943852|58629431|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
30618489|NCT00952276|58629446|FG000|Overall Study|Withdrawal by Subject|1|||
30618490|NCT00952276|58629447|FG001|Overall Study|Withdrawal by Subject|0|||
30618491|NCT00952276|58629448|FG002|Overall Study|Withdrawal by Subject|0|||
30618492|NCT00952276|58629449|FG003|Overall Study|Withdrawal by Subject|1|||
30618493|NCT00952276|58629450|FG004|Overall Study|Withdrawal by Subject|0|||
30618494|NCT00943384|58629462|FG000|Overall Study|Dispositioned prior to treatment|23|||
30618495|NCT00943384|58629462|FG000|Overall Study|Treated off protocol-protocol violation|5|||
30618496|NCT00943384|58629462|FG000|Overall Study|Lost to Follow-up|16|||
30618497|NCT00943384|58629462|FG000|Overall Study|Withdrawal by Subject|5|||
30618498|NCT00943306|58629466|FG000|Overall Study|Physician Decision|1|||
30618499|NCT00943306|58629466|FG000|Overall Study|Death|1|||
30618500|NCT00943306|58629466|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
30618501|NCT01198002|58629473|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
30618502|NCT01198002|58629474|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
30893229|NCT02130297|58926732|FG000|Overall Study|Lost to Follow-up|4|||
30618503|NCT01198002|58629475|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
30618504|NCT01198002|58629473|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
30618505|NCT01198002|58629474|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
30618506|NCT01198002|58629475|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
30618507|NCT01198002|58629473|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
30618508|NCT01198002|58629474|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
30618509|NCT01198002|58629475|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
30618510|NCT01198002|58629473|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
30618511|NCT01198002|58629474|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
30618512|NCT01198002|58629475|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
30618513|NCT01198002|58629473|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
30618514|NCT01198002|58629474|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
30618515|NCT01198002|58629475|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
30618516|NCT01198002|58629473|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
30618517|NCT01198002|58629474|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
30618518|NCT01198002|58629475|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
30618519|NCT01198002|58629473|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
30618520|NCT01198002|58629474|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
30618521|NCT01198002|58629475|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
30618522|NCT01198002|58629473|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
30618523|NCT01198002|58629474|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
30618524|NCT01198002|58629475|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
30618525|NCT01198002|58629473|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
30618526|NCT01198002|58629474|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
30618527|NCT01198002|58629475|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
30618528|NCT01198002|58629473|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
30618529|NCT01198002|58629474|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
30618530|NCT01198002|58629475|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
30618531|NCT01198002|58629473|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
30618532|NCT01198002|58629474|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
30618533|NCT01198002|58629475|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
30618534|NCT01198002|58629473|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
30618535|NCT01198002|58629474|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
30618536|NCT01198002|58629475|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
30618537|NCT01198002|58629473|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
30699517|NCT03958149|58713983|FG001|Overall Study|Withdrawal by Subject|1|||
30699518|NCT00549549|58713997|FG000|Overall Study|Adverse Event|5|||
30618538|NCT01198002|58629474|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
30618539|NCT01198002|58629475|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
30618540|NCT01198002|58629473|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
30618541|NCT01198002|58629474|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
30618542|NCT01198002|58629475|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
30618543|NCT01198002|58629473|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
30618544|NCT01198002|58629474|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
30618545|NCT01198002|58629475|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
30618546|NCT01197534|58629508|FG000|Overall Study|Not reported|16|||
30618547|NCT01197534|58629509|FG001|Overall Study|Not reported|10|||
30618548|NCT01197534|58629510|FG002|Overall Study|Not reported|16|||
30618549|NCT01197534|58629508|FG000|Overall Study|Enrolment in long term extension|57|||
30618550|NCT01197534|58629509|FG001|Overall Study|Enrolment in long term extension|66|||
30618551|NCT01197534|58629510|FG002|Overall Study|Enrolment in long term extension|119|||
30618552|NCT01197534|58629508|FG000|Overall Study|Severe non-compliance to protocol|3|||
30618553|NCT01197534|58629509|FG001|Overall Study|Severe non-compliance to protocol|4|||
30618554|NCT01197534|58629510|FG002|Overall Study|Severe non-compliance to protocol|1|||
30618555|NCT01197534|58629508|FG000|Overall Study|Lack of therapeutic response|9|||
30618556|NCT01197534|58629509|FG001|Overall Study|Lack of therapeutic response|4|||
30618557|NCT01197534|58629510|FG002|Overall Study|Lack of therapeutic response|9|||
30618558|NCT01197534|58629508|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
30618559|NCT01197534|58629509|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
30618560|NCT01197534|58629510|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
30618561|NCT01197534|58629508|FG000|Overall Study|Lost to Follow-up|1|||
30618562|NCT01197534|58629509|FG001|Overall Study|Lost to Follow-up|4|||
30618563|NCT01197534|58629510|FG002|Overall Study|Lost to Follow-up|2|||
30618564|NCT01197534|58629508|FG000|Overall Study|Adverse Event|35|||
30618565|NCT01197534|58629509|FG001|Overall Study|Adverse Event|36|||
30618566|NCT01197534|58629510|FG002|Overall Study|Adverse Event|24|||
30618567|NCT01197378|58629521|FG000|Overall Study|Adverse Event|3|||
30618568|NCT01197378|58629521|FG000|Overall Study|Withdrawal by Subject|1|||
30618569|NCT01197378|58629521|FG000|Overall Study|Physician Decision|1|||
30618570|NCT01197378|58629521|FG000|Overall Study|Other|2|||
30618571|NCT01197300|58629527|FG000|Overall Study|Lost to Follow-up|0|||
30618572|NCT01197300|58629528|FG001|Overall Study|Lost to Follow-up|1|||
30618573|NCT01197300|58629527|FG000|Overall Study|Protocol Violation|0|||
30893230|NCT01931956|58926740|FG000|Overall Study|Death|42|||
30893231|NCT01931956|58926741|FG001|Overall Study|Death|7|||
30893232|NCT01931956|58926742|FG002|Overall Study|Death|379|||
30893233|NCT01931956|58926743|FG003|Overall Study|Death|96|||
30893234|NCT01931956|58926740|FG000|Overall Study|Withdrawal by Subject|5|||
30893235|NCT01931956|58926741|FG001|Overall Study|Withdrawal by Subject|0|||
30893236|NCT01931956|58926742|FG002|Overall Study|Withdrawal by Subject|70|||
30893237|NCT01931956|58926743|FG003|Overall Study|Withdrawal by Subject|30|||
30893238|NCT01931956|58926740|FG000|Overall Study|Lost to Follow-up|2|||
30893239|NCT01931956|58926741|FG001|Overall Study|Lost to Follow-up|0|||
30893240|NCT01931956|58926742|FG002|Overall Study|Lost to Follow-up|11|||
30893241|NCT01931956|58926743|FG003|Overall Study|Lost to Follow-up|7|||
30893242|NCT01931956|58926740|FG000|Overall Study|Expected|2|||
30893243|NCT01931956|58926741|FG001|Overall Study|Expected|0|||
30893244|NCT01931956|58926742|FG002|Overall Study|Expected|6|||
30893245|NCT01931956|58926743|FG003|Overall Study|Expected|0|||
30893246|NCT01931956|58926740|FG000|Overall Study|Not due|0|||
30893247|NCT01931956|58926741|FG001|Overall Study|Not due|0|||
30893248|NCT01931956|58926742|FG002|Overall Study|Not due|21|||
30893249|NCT01931956|58926743|FG003|Overall Study|Not due|0|||
30893250|NCT01887418|58926769|FG000|Overall Study|Travelling difficulties|0|||
30893251|NCT01887418|58926770|FG001|Overall Study|Travelling difficulties|0|||
30893252|NCT01887418|58926771|FG002|Overall Study|Travelling difficulties|1|||
30893253|NCT01886716|58926783|FG000|Week 1|Lost to Follow-up|0|||
30893254|NCT01886716|58926784|FG001|Week 1|Lost to Follow-up|0|||
30893255|NCT01886716|58926785|FG002|Week 1|Lost to Follow-up|2|||
30893256|NCT01886716|58926786|FG003|Week 1|Lost to Follow-up|2|||
30893257|NCT01886716|58926783|FG000|Week 2|Lost to Follow-up|3|||
30893258|NCT01886716|58926784|FG001|Week 2|Lost to Follow-up|2|||
30893259|NCT01886716|58926785|FG002|Week 2|Lost to Follow-up|1|||
30893260|NCT01886716|58926786|FG003|Week 2|Lost to Follow-up|3|||
30893261|NCT01886716|58926783|FG000|Week 3|Lost to Follow-up|1|||
30893262|NCT01886716|58926784|FG001|Week 3|Lost to Follow-up|1|||
30893263|NCT01886716|58926785|FG002|Week 3|Lost to Follow-up|0|||
30893264|NCT01886716|58926786|FG003|Week 3|Lost to Follow-up|1|||
30893265|NCT01912612|58926798|FG000|Overall Study|Adverse Event|4|||
30893266|NCT01912612|58926799|FG001|Overall Study|Adverse Event|0|||
30893267|NCT01912612|58926800|FG002|Overall Study|Adverse Event|0|||
30893268|NCT01912612|58926798|FG000|Overall Study|Withdrew consent|1|||
30893269|NCT01912612|58926799|FG001|Overall Study|Withdrew consent|0|||
30893270|NCT01912612|58926800|FG002|Overall Study|Withdrew consent|0|||
30893271|NCT01912612|58926798|FG000|Overall Study|Study design change|0|||
30893272|NCT01912612|58926799|FG001|Overall Study|Study design change|0|||
30893273|NCT01912612|58926800|FG002|Overall Study|Study design change|3|||
30790838|NCT03524092|58803941|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
30618574|NCT01197300|58629528|FG001|Overall Study|Protocol Violation|1|||
30618575|NCT01196988|58629543|FG000|Overall Study|Adverse Event|1|||
30618576|NCT01196988|58629544|FG001|Overall Study|Adverse Event|2|||
30618577|NCT01196988|58629545|FG002|Overall Study|Adverse Event|0|||
30618578|NCT01196988|58629546|FG003|Overall Study|Adverse Event|0|||
30618579|NCT01196988|58629543|FG000|Overall Study|Withdrawal by Subject|5|||
30618580|NCT01196988|58629544|FG001|Overall Study|Withdrawal by Subject|1|||
30618581|NCT01196988|58629545|FG002|Overall Study|Withdrawal by Subject|4|||
30618582|NCT01196988|58629546|FG003|Overall Study|Withdrawal by Subject|0|||
30618583|NCT01196988|58629543|FG000|Overall Study|Lost to Follow-up|16|||
30618584|NCT01196988|58629544|FG001|Overall Study|Lost to Follow-up|29|||
30618585|NCT01196988|58629545|FG002|Overall Study|Lost to Follow-up|21|||
30618586|NCT01196988|58629546|FG003|Overall Study|Lost to Follow-up|1|||
30618587|NCT01196988|58629543|FG000|Overall Study|Other|2|||
30618588|NCT01196988|58629544|FG001|Overall Study|Other|0|||
30618589|NCT01196988|58629545|FG002|Overall Study|Other|0|||
30618590|NCT01196988|58629546|FG003|Overall Study|Other|0|||
30618591|NCT01196052|58629557|FG000|Overall Study|Adverse Event|9|||
30618592|NCT01196052|58629557|FG000|Overall Study|Lost to Follow-up|1|||
30618593|NCT01196052|58629557|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
30618594|NCT01196052|58629557|FG000|Overall Study|Reason not Specified|5|||
30618595|NCT01196052|58629557|FG000|Overall Study|Withdrawal by Subject|6|||
30618596|NCT01195662|58629564|FG000|Double Blind Treatment Period|Adverse Event|4|||
30618597|NCT01195662|58629565|FG001|Double Blind Treatment Period|Adverse Event|1|||
30618598|NCT01195662|58629566|FG002|Double Blind Treatment Period|Adverse Event|2|||
30618599|NCT01195662|58629564|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
30618600|NCT01195662|58629565|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
30618601|NCT01195662|58629566|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
30618602|NCT01195662|58629564|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
30618603|NCT01195662|58629565|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
30618604|NCT01195662|58629566|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
30618605|NCT01195662|58629564|FG000|Double Blind Treatment Period|Administrative reason|2|||
30618606|NCT01195662|58629565|FG001|Double Blind Treatment Period|Administrative reason|1|||
30618607|NCT01195662|58629566|FG002|Double Blind Treatment Period|Administrative reason|1|||
30618608|NCT01195662|58629564|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
30618609|NCT01195662|58629565|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
30618610|NCT01195662|58629566|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
30618611|NCT01195662|58629564|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
30618612|NCT01195662|58629565|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
30618613|NCT01195662|58629566|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
30618614|NCT01195662|58629564|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
30618615|NCT01195662|58629565|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
30618616|NCT01195662|58629566|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
30618617|NCT01195662|58629564|FG000|Double Blind Treatment Period|Non-specified|3|||
30618618|NCT01195662|58629565|FG001|Double Blind Treatment Period|Non-specified|0|||
30618619|NCT01195662|58629566|FG002|Double Blind Treatment Period|Non-specified|0|||
30618620|NCT01195662|58629564|FG000|Double Blind Treatment Period|Missing disposition information|0|||
30618621|NCT01195662|58629565|FG001|Double Blind Treatment Period|Missing disposition information|1|||
30618622|NCT01195662|58629566|FG002|Double Blind Treatment Period|Missing disposition information|1|||
30618623|NCT01195662|58629564|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
30618624|NCT01195662|58629565|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
30618625|NCT01195662|58629566|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
30618626|NCT01195662|58629564|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
30618627|NCT01195662|58629565|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
30618628|NCT01195662|58629566|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
30618629|NCT01195272|58629575|FG000|Overall Study|Adverse Event|1|||
30618630|NCT01195272|58629575|FG000|Overall Study|Lack of Efficacy|3|||
30618631|NCT01194804|58629579|FG000|Overall Study|Withdrawal by Subject|1|||
30618632|NCT01194414|58629603|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
30618633|NCT01194414|58629604|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
30618634|NCT01194414|58629605|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
30618635|NCT01194414|58629606|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
30618636|NCT01194414|58629603|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
30618637|NCT01194414|58629604|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
30618638|NCT01194414|58629605|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
30618639|NCT01194414|58629606|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
30618640|NCT01194414|58629603|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
30618641|NCT01194414|58629604|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
30618642|NCT01194414|58629605|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
30618643|NCT01194414|58629606|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
30618644|NCT01194414|58629603|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
30618645|NCT01194414|58629604|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
30618646|NCT01194414|58629605|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
30618647|NCT01194414|58629606|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
30618648|NCT01194414|58629603|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
30618649|NCT01194414|58629604|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
30618650|NCT01194414|58629605|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
30618651|NCT01194414|58629606|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
30618652|NCT01194414|58629603|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
30618653|NCT01194414|58629604|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
30618654|NCT01194414|58629605|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
30618655|NCT01194414|58629606|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
30618656|NCT01194414|58629603|FG000|24 Weeks Double Blind Period|Other|0|||
30618657|NCT01194414|58629604|FG001|24 Weeks Double Blind Period|Other|1|||
30618658|NCT01194414|58629605|FG002|24 Weeks Double Blind Period|Other|0|||
30618659|NCT01194414|58629606|FG003|24 Weeks Double Blind Period|Other|0|||
30618660|NCT01194414|58629603|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
30618661|NCT01194414|58629604|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
30618662|NCT01194414|58629605|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
30618663|NCT01194414|58629606|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
30618664|NCT01194414|58629603|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
30618665|NCT01194414|58629604|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
30618666|NCT01194414|58629605|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
30618667|NCT01194414|58629606|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
30618668|NCT01194414|58629603|FG000|24 Weeks Double Blind Period|Death|0|||
30618669|NCT01194414|58629604|FG001|24 Weeks Double Blind Period|Death|1|||
30618670|NCT01194414|58629605|FG002|24 Weeks Double Blind Period|Death|0|||
30618671|NCT01194414|58629606|FG003|24 Weeks Double Blind Period|Death|0|||
30618672|NCT01194414|58629603|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
30618673|NCT01194414|58629604|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
30618674|NCT01194414|58629605|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
30618675|NCT01194414|58629606|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
30618676|NCT01194414|58629603|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
30618677|NCT01194414|58629604|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
30618678|NCT01194414|58629605|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
30618679|NCT01194414|58629606|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
30618680|NCT01194414|58629603|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
30618681|NCT01194414|58629604|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
30618682|NCT01194414|58629605|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
30618683|NCT01194414|58629606|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
30618684|NCT01194414|58629603|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
30618685|NCT01194414|58629604|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
30618686|NCT01194414|58629605|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
30618687|NCT01194414|58629606|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
30618688|NCT01194414|58629603|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
30618689|NCT01194414|58629604|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
30618690|NCT01194414|58629605|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
30618691|NCT01194414|58629606|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
30618692|NCT01194414|58629603|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
30618693|NCT01194414|58629604|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
30618694|NCT01194414|58629605|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
30618695|NCT01194414|58629606|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
30618696|NCT01194414|58629603|FG000|72 Weeks Open Label Extension|Other|2|||
30618697|NCT01194414|58629604|FG001|72 Weeks Open Label Extension|Other|1|||
30618698|NCT01194414|58629605|FG002|72 Weeks Open Label Extension|Other|0|||
30618699|NCT01194414|58629606|FG003|72 Weeks Open Label Extension|Other|0|||
30618700|NCT01194414|58629603|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
30618701|NCT01194414|58629604|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
30618702|NCT01194414|58629605|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
30618703|NCT01194414|58629606|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
30618704|NCT01194414|58629603|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
30618705|NCT01194414|58629604|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
30618706|NCT01194414|58629605|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
30618707|NCT01194414|58629606|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
30618708|NCT01194414|58629603|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
30618709|NCT01194414|58629604|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
30618710|NCT01194414|58629605|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
30618711|NCT01194414|58629606|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
30618712|NCT01194414|58629603|FG000|72 Weeks Open Label Extension|Death|1|||
30618713|NCT01194414|58629604|FG001|72 Weeks Open Label Extension|Death|2|||
30618714|NCT01194414|58629605|FG002|72 Weeks Open Label Extension|Death|0|||
30618715|NCT01194414|58629606|FG003|72 Weeks Open Label Extension|Death|2|||
30618716|NCT01194258|58629618|FG000|Titration Period|Withdrawal by Subject|6|||
30618717|NCT01194258|58629619|FG001|Titration Period|Withdrawal by Subject|0|||
30618718|NCT01194258|58629620|FG002|Titration Period|Withdrawal by Subject|0|||
30618719|NCT01194258|58629621|FG003|Titration Period|Withdrawal by Subject|0|||
30618720|NCT01194258|58629622|FG004|Titration Period|Withdrawal by Subject|0|||
30618721|NCT01194258|58629618|FG000|Titration Period|Lost to Follow-up|2|||
30618722|NCT01194258|58629619|FG001|Titration Period|Lost to Follow-up|0|||
30618723|NCT01194258|58629620|FG002|Titration Period|Lost to Follow-up|0|||
30618724|NCT01194258|58629621|FG003|Titration Period|Lost to Follow-up|0|||
30618725|NCT01194258|58629622|FG004|Titration Period|Lost to Follow-up|0|||
30618726|NCT01194258|58629618|FG000|Titration Period|Titration failure|3|||
30618727|NCT01194258|58629619|FG001|Titration Period|Titration failure|0|||
30790839|NCT03524092|58803942|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
30790840|NCT03524092|58803943|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
30618728|NCT01194258|58629620|FG002|Titration Period|Titration failure|0|||
30618729|NCT01194258|58629621|FG003|Titration Period|Titration failure|0|||
30618730|NCT01194258|58629622|FG004|Titration Period|Titration failure|0|||
30618731|NCT01194258|58629618|FG000|Period 1 (12 Weeks)|Death|0|||
30618732|NCT01194258|58629619|FG001|Period 1 (12 Weeks)|Death|0|||
30618733|NCT01194258|58629620|FG002|Period 1 (12 Weeks)|Death|0|||
30618734|NCT01194258|58629621|FG003|Period 1 (12 Weeks)|Death|0|||
30618735|NCT01194258|58629622|FG004|Period 1 (12 Weeks)|Death|1|||
30618736|NCT01194258|58629618|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
30618737|NCT01194258|58629619|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
30618738|NCT01194258|58629620|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
30618739|NCT01194258|58629621|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
30618740|NCT01194258|58629622|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
30618741|NCT01194258|58629618|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
30618742|NCT01194258|58629619|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
30618743|NCT01194258|58629620|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
30618744|NCT01194258|58629621|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
30618745|NCT01194258|58629622|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
30618746|NCT01194258|58629618|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30618747|NCT01194258|58629619|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
30618748|NCT01194258|58629620|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
30618749|NCT01194258|58629621|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30618750|NCT01194258|58629622|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30618751|NCT01193556|58629635|FG000|Overall Study|Study termination|26|||
30618752|NCT01193556|58629636|FG001|Overall Study|Study termination|25|||
30618753|NCT00951496|58629649|FG000|Overall Study|Did not initiate study treatment|10|||
30618754|NCT00951496|58629650|FG001|Overall Study|Did not initiate study treatment|8|||
30618755|NCT00951496|58629651|FG002|Overall Study|Did not initiate study treatment|13|||
30618756|NCT01193244|58629664|FG000|Overall Study|Withdrawal by Subject|79|||
30618757|NCT01193244|58629665|FG001|Overall Study|Withdrawal by Subject|97|||
30618758|NCT01193244|58629664|FG000|Overall Study|Other|303|||
30618759|NCT01193244|58629665|FG001|Overall Study|Other|278|||
30618760|NCT01193244|58629664|FG000|Overall Study|Lost to Follow-up|6|||
30618761|NCT01193244|58629665|FG001|Overall Study|Lost to Follow-up|15|||
30618762|NCT01192152|58629671|FG000|Period 1|left prematurely (while on treatment B)|0|||
30618763|NCT01192152|58629672|FG001|Period 1|left prematurely (while on treatment B)|1|||
30618764|NCT01192152|58629671|FG000|Period 3|family emergency|1|||
30618765|NCT01192152|58629672|FG001|Period 3|family emergency|0|||
30618766|NCT01191840|58629682|FG000|Overall Study|withdrew consent|2|||
30618767|NCT01191840|58629683|FG001|Overall Study|withdrew consent|1|||
30618768|NCT01191840|58629682|FG000|Overall Study|Subject discontinued treatment|1|||
30618769|NCT01191840|58629683|FG001|Overall Study|Subject discontinued treatment|2|||
30618770|NCT01191840|58629682|FG000|Overall Study|Lost to Follow-up|4|||
30618771|NCT01191840|58629683|FG001|Overall Study|Lost to Follow-up|6|||
30618772|NCT01191840|58629682|FG000|Overall Study|Non Staph Infection|4|||
30618773|NCT01191840|58629683|FG001|Overall Study|Non Staph Infection|3|||
30618774|NCT01191840|58629682|FG000|Overall Study|ineligible at enrollment|1|||
30618775|NCT01191840|58629683|FG001|Overall Study|ineligible at enrollment|0|||
30618776|NCT01191840|58629682|FG000|Overall Study|IRB approval lapse|0|||
30618777|NCT01191840|58629683|FG001|Overall Study|IRB approval lapse|2|||
30618778|NCT01191840|58629682|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
30618779|NCT01191840|58629683|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
30618780|NCT01191840|58629682|FG000|Overall Study|Withdrawal by Subject|2|||
30618781|NCT01191840|58629683|FG001|Overall Study|Withdrawal by Subject|0|||
30618782|NCT00943072|58629695|FG000|Overall Study|Adverse Event|0|||
30618783|NCT00943072|58629696|FG001|Overall Study|Adverse Event|3|||
30618784|NCT00943072|58629695|FG000|Overall Study|Death|0|||
30618785|NCT00943072|58629696|FG001|Overall Study|Death|2|||
30618786|NCT00943072|58629695|FG000|Overall Study|Withdrawal by Subject|3|||
30618787|NCT00943072|58629696|FG001|Overall Study|Withdrawal by Subject|1|||
30618788|NCT00943072|58629695|FG000|Overall Study|Protocol Violation|0|||
30618789|NCT00943072|58629696|FG001|Overall Study|Protocol Violation|1|||
30618790|NCT00943072|58629695|FG000|Overall Study|Lost to Follow-up|1|||
30618791|NCT00943072|58629696|FG001|Overall Study|Lost to Follow-up|2|||
30618792|NCT00943072|58629695|FG000|Overall Study|Lack of Efficacy|0|||
30618793|NCT00943072|58629696|FG001|Overall Study|Lack of Efficacy|4|||
30618794|NCT00943072|58629695|FG000|Overall Study|Other|1|||
30618795|NCT00943072|58629696|FG001|Overall Study|Other|1|||
30618796|NCT00942994|58629706|FG000|Overall Study|Adverse Event|7|||
30618797|NCT00942994|58629707|FG001|Overall Study|Adverse Event|4|||
30618798|NCT00942994|58629706|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30618799|NCT00942994|58629707|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30618800|NCT00942994|58629706|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30618801|NCT00942994|58629707|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30618802|NCT00942994|58629706|FG000|Overall Study|Patient withdrew consent|5|||
30618803|NCT00942994|58629707|FG001|Overall Study|Patient withdrew consent|8|||
30618804|NCT00942994|58629706|FG000|Overall Study|Lost to Follow-up|1|||
30618805|NCT00942994|58629707|FG001|Overall Study|Lost to Follow-up|4|||
30618806|NCT00942994|58629706|FG000|Overall Study|Protocol deviation|1|||
30618807|NCT00942994|58629707|FG001|Overall Study|Protocol deviation|2|||
30618808|NCT00942604|58629715|FG000|Overall Study|Protocol Violation|1|||
30618809|NCT00942604|58629716|FG001|Overall Study|Protocol Violation|1|||
30618810|NCT00942604|58629715|FG000|Overall Study|Adverse Event|0|||
30618811|NCT00942604|58629716|FG001|Overall Study|Adverse Event|1|||
30618812|NCT00942604|58629715|FG000|Overall Study|Withdrawal by Subject|0|||
30618813|NCT00942604|58629716|FG001|Overall Study|Withdrawal by Subject|1|||
30618814|NCT00942604|58629715|FG000|Overall Study|Patient relocation|1|||
30618815|NCT00942604|58629716|FG001|Overall Study|Patient relocation|1|||
30618816|NCT01188564|58629724|FG000|Double-blind Phase|randomized not treated|1|||
30618817|NCT01188564|58629725|FG001|Double-blind Phase|randomized not treated|0|||
30618818|NCT01187550|58629733|FG000|Overall Study|Protocol Violation|3|||
30618819|NCT01187550|58629734|FG001|Overall Study|Protocol Violation|1|||
30618820|NCT01187550|58629733|FG000|Overall Study|Other|3|||
30618821|NCT01187550|58629734|FG001|Overall Study|Other|0|||
30618822|NCT01187550|58629733|FG000|Overall Study|Randomized but not treated|8|||
30618823|NCT01187550|58629734|FG001|Overall Study|Randomized but not treated|0|||
30618824|NCT01186770|58629744|FG000|Overall Study|Ineligibility|0|||
30618825|NCT01186770|58629745|FG001|Overall Study|Ineligibility|0|||
30618826|NCT01186770|58629746|FG002|Overall Study|Ineligibility|2|||
30618827|NCT01186770|58629747|FG003|Overall Study|Ineligibility|0|||
30618828|NCT01186770|58629744|FG000|Overall Study|Protocol Violation|7|||
30618829|NCT01186770|58629745|FG001|Overall Study|Protocol Violation|9|||
30618830|NCT01186770|58629746|FG002|Overall Study|Protocol Violation|12|||
30618831|NCT01186770|58629747|FG003|Overall Study|Protocol Violation|14|||
30618832|NCT01186770|58629744|FG000|Overall Study|Adverse Event|2|||
30893274|NCT02370511|58926809|FG000|Overall Study|Death|10|||
30618833|NCT01186770|58629745|FG001|Overall Study|Adverse Event|9|||
30618834|NCT01186770|58629746|FG002|Overall Study|Adverse Event|7|||
30618835|NCT01186770|58629747|FG003|Overall Study|Adverse Event|9|||
30790841|NCT03524092|58803944|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
30618836|NCT01186770|58629744|FG000|Overall Study|Withdrawal by Subject|15|||
30618837|NCT01186770|58629745|FG001|Overall Study|Withdrawal by Subject|13|||
30618838|NCT01186770|58629746|FG002|Overall Study|Withdrawal by Subject|11|||
30618839|NCT01186770|58629747|FG003|Overall Study|Withdrawal by Subject|17|||
30618840|NCT01186770|58629744|FG000|Overall Study|Lost to Follow-up|10|||
30618841|NCT01186770|58629745|FG001|Overall Study|Lost to Follow-up|6|||
30618842|NCT01186770|58629746|FG002|Overall Study|Lost to Follow-up|14|||
30618843|NCT01186770|58629747|FG003|Overall Study|Lost to Follow-up|9|||
30618844|NCT01186770|58629744|FG000|Overall Study|Insufficient response to treatment|7|||
30618845|NCT01186770|58629745|FG001|Overall Study|Insufficient response to treatment|8|||
30618846|NCT01186770|58629746|FG002|Overall Study|Insufficient response to treatment|5|||
30618847|NCT01186770|58629747|FG003|Overall Study|Insufficient response to treatment|7|||
30618848|NCT01186770|58629744|FG000|Overall Study|Other than specified|0|||
30618849|NCT01186770|58629745|FG001|Overall Study|Other than specified|1|||
30618850|NCT01186770|58629746|FG002|Overall Study|Other than specified|1|||
30618851|NCT01186770|58629747|FG003|Overall Study|Other than specified|2|||
30618852|NCT01186692|58629757|FG000|Overall Study|Not Catheterized|11|||
30618853|NCT01186692|58629757|FG000|Overall Study|Futher testing contraindicated implant|19|||
30618854|NCT01186692|58629757|FG000|Overall Study|Adverse Event|2|||
30618855|NCT01186458|58629765|FG000|Overall Study|Adverse Event|1|||
30618856|NCT01185834|58629769|FG000|Overall Study|Lost to Follow-up|2|||
30618857|NCT01185834|58629769|FG000|Overall Study|Discomfort|4|||
30618858|NCT01185834|58629769|FG000|Overall Study|Biomicroscopy|4|||
30618859|NCT01185834|58629769|FG000|Overall Study|Time/Job Conflict|2|||
30618860|NCT01185834|58629769|FG000|Overall Study|Early exit - Site error|2|||
30618861|NCT01185600|58629775|FG000|Overall Study|Adverse Event|1|||
30618862|NCT01185600|58629776|FG001|Overall Study|Adverse Event|1|||
30790842|NCT03524092|58803945|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
30893275|NCT02370511|58926810|FG001|Overall Study|Death|7|||
30618863|NCT01185600|58629775|FG000|Overall Study|Death|0|||
30893276|NCT02370511|58926811|FG002|Overall Study|Death|1|||
30893277|NCT02370511|58926809|FG000|Overall Study|Withdrawal by Subject|2|||
30893278|NCT02370511|58926810|FG001|Overall Study|Withdrawal by Subject|0|||
30893279|NCT02370511|58926811|FG002|Overall Study|Withdrawal by Subject|0|||
30893280|NCT02370511|58926809|FG000|Overall Study|Lost to Follow-up|0|||
30893281|NCT02370511|58926810|FG001|Overall Study|Lost to Follow-up|4|||
30893282|NCT02370511|58926811|FG002|Overall Study|Lost to Follow-up|0|||
30893283|NCT02303041|58926821|FG000|Overall Study|Adverse Event|1|||
30893284|NCT02303041|58926822|FG001|Overall Study|Adverse Event|2|||
30893285|NCT02302807|58926830|FG000|Overall Study|Withdrawal by Subject|28|||
30893286|NCT02302807|58926831|FG001|Overall Study|Withdrawal by Subject|11|||
30893287|NCT02302807|58926830|FG000|Overall Study|Lost to Follow-up|4|||
30893288|NCT02302807|58926831|FG001|Overall Study|Lost to Follow-up|6|||
30893289|NCT02302807|58926830|FG000|Overall Study|Death|397|||
30893290|NCT02302807|58926831|FG001|Overall Study|Death|385|||
30790843|NCT03524092|58803940|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
30699519|NCT00549549|58713998|FG001|Overall Study|Adverse Event|3|||
30699520|NCT00549549|58713999|FG002|Overall Study|Adverse Event|1|||
30699521|NCT00549549|58714000|FG003|Overall Study|Adverse Event|9|||
30618864|NCT01185600|58629776|FG001|Overall Study|Death|1|||
30618865|NCT01185600|58629775|FG000|Overall Study|Lost to Follow-up|0|||
30618866|NCT01185600|58629776|FG001|Overall Study|Lost to Follow-up|5|||
30618867|NCT01185600|58629775|FG000|Overall Study|Physician Decision|29|||
30618868|NCT01185600|58629776|FG001|Overall Study|Physician Decision|35|||
30618869|NCT01185600|58629775|FG000|Overall Study|Withdrawal by Subject|1|||
30618870|NCT01185600|58629776|FG001|Overall Study|Withdrawal by Subject|1|||
30618871|NCT01185600|58629775|FG000|Overall Study|Hold by DSMB|1|||
30618872|NCT01185600|58629776|FG001|Overall Study|Hold by DSMB|2|||
30618873|NCT01185522|58629785|FG000|Overall Study|Lack of Efficacy|28|||
30618874|NCT01185522|58629785|FG000|Overall Study|Lost to Follow-up|19|||
30618875|NCT01185522|58629785|FG000|Overall Study|Withdrawal by Subject|10|||
30618876|NCT01185522|58629785|FG000|Overall Study|Poor tolerance|39|||
30618877|NCT01185522|58629785|FG000|Overall Study|Other reasons|12|||
30618878|NCT01185366|58629792|FG000|First Line Therapy|Insurance Coverage Denied|1|||
30618879|NCT01185366|58629793|FG001|First Line Therapy|Insurance Coverage Denied|1|||
30618880|NCT01185366|58629792|FG000|First Line Therapy|Withdrawal by Subject|1|||
30618881|NCT01185366|58629793|FG001|First Line Therapy|Withdrawal by Subject|0|||
30618882|NCT01185366|58629792|FG000|First Line Therapy|Lack of Metastatic Site|1|||
30618883|NCT01185366|58629793|FG001|First Line Therapy|Lack of Metastatic Site|0|||
30618884|NCT01185366|58629792|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
30618885|NCT01185366|58629793|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
30618886|NCT01185366|58629792|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
30618887|NCT01185366|58629793|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
30618888|NCT01185366|58629792|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
30618889|NCT01185366|58629793|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
30618890|NCT01185366|58629792|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
30618891|NCT01185366|58629793|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
30618892|NCT01185288|58629803|FG000|Overall Study|Adverse Event|7|||
30618893|NCT01185288|58629804|FG001|Overall Study|Adverse Event|6|||
30618894|NCT01185288|58629803|FG000|Overall Study|Withdrawal by Subject|6|||
30618895|NCT01185288|58629804|FG001|Overall Study|Withdrawal by Subject|4|||
30618896|NCT01185288|58629803|FG000|Overall Study|Lost to Follow-up|2|||
30699522|NCT00549549|58713997|FG000|Overall Study|Lack of Efficacy|9|||
30699523|NCT00549549|58713998|FG001|Overall Study|Lack of Efficacy|6|||
30699524|NCT00549549|58713999|FG002|Overall Study|Lack of Efficacy|4|||
30699525|NCT00549549|58714000|FG003|Overall Study|Lack of Efficacy|2|||
30699526|NCT00549549|58713997|FG000|Overall Study|Lost to Follow-up|1|||
30699527|NCT00549549|58713998|FG001|Overall Study|Lost to Follow-up|0|||
30699528|NCT00549549|58713999|FG002|Overall Study|Lost to Follow-up|1|||
30699529|NCT00549549|58714000|FG003|Overall Study|Lost to Follow-up|2|||
30699530|NCT00549549|58713997|FG000|Overall Study|Withdrawal by Subject|0|||
30699531|NCT00549549|58713998|FG001|Overall Study|Withdrawal by Subject|4|||
30618897|NCT01185288|58629804|FG001|Overall Study|Lost to Follow-up|5|||
30699532|NCT00549549|58713999|FG002|Overall Study|Withdrawal by Subject|1|||
30618898|NCT01185288|58629803|FG000|Overall Study|Lack of Efficacy|2|||
30699533|NCT00549549|58714000|FG003|Overall Study|Withdrawal by Subject|0|||
30618899|NCT01185288|58629804|FG001|Overall Study|Lack of Efficacy|0|||
30618900|NCT01185288|58629803|FG000|Overall Study|Investigator discretion|1|||
30699534|NCT00549549|58713997|FG000|Overall Study|Other|9|||
30699535|NCT00549549|58713998|FG001|Overall Study|Other|9|||
30699536|NCT00549549|58713999|FG002|Overall Study|Other|9|||
30625590|NCT00891046|58637761|FG004|Overall Study|Lost to Follow-up|1|||
30699537|NCT00549549|58714000|FG003|Overall Study|Other|11|||
30893291|NCT02302807|58926830|FG000|Overall Study|Study Terminated By Sponsor|35|||
30893292|NCT02302807|58926831|FG001|Overall Study|Study Terminated By Sponsor|64|||
30893293|NCT02302807|58926830|FG000|Overall Study|Physician Decision|0|||
30893294|NCT02302807|58926831|FG001|Overall Study|Physician Decision|1|||
30618901|NCT01185288|58629804|FG001|Overall Study|Investigator discretion|0|||
30618902|NCT01185288|58629803|FG000|Overall Study|Did not meet inclusion criteria|1|||
30618903|NCT01185288|58629804|FG001|Overall Study|Did not meet inclusion criteria|0|||
30618904|NCT01185288|58629803|FG000|Overall Study|Noncompliance|0|||
30618905|NCT01185288|58629804|FG001|Overall Study|Noncompliance|1|||
30618906|NCT01184508|58629812|FG000|Overall Study|Adverse Event|4|||
30618907|NCT01184508|58629813|FG001|Overall Study|Adverse Event|6|||
30618908|NCT01184508|58629812|FG000|Overall Study|Lack of Efficacy|1|||
30618909|NCT01184508|58629813|FG001|Overall Study|Lack of Efficacy|1|||
30618910|NCT01184508|58629812|FG000|Overall Study|Lost to Follow-up|1|||
30618911|NCT01184508|58629813|FG001|Overall Study|Lost to Follow-up|1|||
30618912|NCT01184508|58629812|FG000|Overall Study|Physician Decision|1|||
30618913|NCT01184508|58629813|FG001|Overall Study|Physician Decision|0|||
30618914|NCT01184508|58629812|FG000|Overall Study|Protocol Violation|3|||
30618915|NCT01184508|58629813|FG001|Overall Study|Protocol Violation|1|||
30618916|NCT01184508|58629812|FG000|Overall Study|Sponsor Decision|5|||
30618917|NCT01184508|58629813|FG001|Overall Study|Sponsor Decision|2|||
30618918|NCT01184508|58629812|FG000|Overall Study|Withdrawal by Subject|1|||
30618919|NCT01184508|58629813|FG001|Overall Study|Withdrawal by Subject|3|||
30618920|NCT01184508|58629812|FG000|Overall Study|Randomized, Not Treated|0|||
30618921|NCT01184508|58629813|FG001|Overall Study|Randomized, Not Treated|1|||
30618922|NCT01184118|58629820|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
30618923|NCT01184118|58629820|FG000|Overall Study|No physiologic confirmation of asthma|8|||
30618924|NCT01184118|58629820|FG000|Overall Study|FEV1 <60% predicted|2|||
30618925|NCT01184118|58629820|FG000|Overall Study|Exclusionary medical condition|2|||
30618926|NCT01184118|58629820|FG000|Overall Study|Withdrawal by Subject|5|||
30893295|NCT02335489|58926850|FG000|Overall Study|Sponsor terminated study|4|||
30618927|NCT01183884|58629824|FG000|Overall Study|Progressive Disease|26|||
30618928|NCT01183884|58629824|FG000|Overall Study|Adverse Event|3|||
30618929|NCT01183884|58629824|FG000|Overall Study|Withdrawal by Subject|1|||
30618930|NCT01183884|58629824|FG000|Overall Study|Other Complicating Disease|3|||
30618931|NCT01183884|58629824|FG000|Overall Study|Not Treated|1|||
30618932|NCT01183884|58629824|FG000|Overall Study|Other|4|||
30893296|NCT02335489|58926850|FG000|Overall Study|Lost to Follow-up|1|||
30893297|NCT02335489|58926850|FG000|Overall Study|Withdrawal by Subject|2|||
30893298|NCT02335489|58926850|FG000|Overall Study|Physician Decision|2|||
30893299|NCT02335489|58926850|FG000|Overall Study|Lack of Efficacy|1|||
30893300|NCT02527343|58926856|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
30893301|NCT02527343|58926857|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
30893302|NCT02527343|58926858|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
30893303|NCT02527343|58926859|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
30893304|NCT02527343|58926860|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
30893305|NCT02527343|58926861|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
30893306|NCT02527343|58926856|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
30893307|NCT02527343|58926857|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
30893308|NCT02527343|58926858|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
30893309|NCT02527343|58926859|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
30893310|NCT02527343|58926860|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
30893311|NCT02527343|58926861|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
30893312|NCT02527343|58926856|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
30893313|NCT02527343|58926857|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
30893314|NCT02527343|58926858|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
30893315|NCT02527343|58926859|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
30893316|NCT02527343|58926860|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
30893317|NCT02527343|58926861|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
30893318|NCT02527343|58926856|FG000|RT Period: Weeks 1 to 52|Other|4|||
30893319|NCT02527343|58926857|FG001|RT Period: Weeks 1 to 52|Other|3|||
30893320|NCT02527343|58926858|FG002|RT Period: Weeks 1 to 52|Other|0|||
30893321|NCT02527343|58926859|FG003|RT Period: Weeks 1 to 52|Other|0|||
30893322|NCT02527343|58926860|FG004|RT Period: Weeks 1 to 52|Other|0|||
30893323|NCT02527343|58926861|FG005|RT Period: Weeks 1 to 52|Other|0|||
30893324|NCT02527343|58926856|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
30893325|NCT02527343|58926857|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
30893326|NCT02527343|58926858|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
30893327|NCT02527343|58926859|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
30893328|NCT02527343|58926860|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
30893329|NCT02527343|58926861|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
30893330|NCT02527343|58926856|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
30893331|NCT02527343|58926857|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
30893332|NCT02527343|58926858|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
30618933|NCT01183260|58629830|FG000|Overall Study|Intraop screen failure|2|||
30618934|NCT01183260|58629831|FG001|Overall Study|Intraop screen failure|0|||
30618935|NCT01183260|58629830|FG000|Overall Study|Withdrawal by Subject|1|||
30618936|NCT01183260|58629831|FG001|Overall Study|Withdrawal by Subject|1|||
30618937|NCT01183260|58629830|FG000|Overall Study|Revised within 30 days|0|||
30618938|NCT01183260|58629831|FG001|Overall Study|Revised within 30 days|1|||
30618939|NCT01183260|58629830|FG000|Overall Study|Death|1|||
30618940|NCT01183260|58629831|FG001|Overall Study|Death|0|||
30618941|NCT01191762|58629839|FG000|Overall Study|Adverse Event|1|||
30618942|NCT01191762|58629840|FG001|Overall Study|Adverse Event|0|||
30618943|NCT01723774|58629849|FG000|Neoadjuvant|Ki67 > 10%|4|||
30618944|NCT01723774|58629850|FG001|Neoadjuvant|Ki67 > 10%|0|||
30618945|NCT01723774|58629851|FG002|Neoadjuvant|Ki67 > 10%|10|||
30618946|NCT01723774|58629852|FG003|Neoadjuvant|Ki67 > 10%|0|||
30618947|NCT01723774|58629849|FG000|Neoadjuvant|Withdrawal by Subject|3|||
30618948|NCT01723774|58629850|FG001|Neoadjuvant|Withdrawal by Subject|1|||
30618949|NCT01723774|58629851|FG002|Neoadjuvant|Withdrawal by Subject|0|||
30618950|NCT01723774|58629852|FG003|Neoadjuvant|Withdrawal by Subject|0|||
30618951|NCT01723774|58629849|FG000|Neoadjuvant|Disease progression|0|||
30618952|NCT01723774|58629850|FG001|Neoadjuvant|Disease progression|1|||
30618953|NCT01723774|58629851|FG002|Neoadjuvant|Disease progression|1|||
30618954|NCT01723774|58629852|FG003|Neoadjuvant|Disease progression|0|||
30618955|NCT01723774|58629849|FG000|Neoadjuvant|Adverse Event|0|||
30618956|NCT01723774|58629850|FG001|Neoadjuvant|Adverse Event|1|||
30618957|NCT01723774|58629851|FG002|Neoadjuvant|Adverse Event|2|||
30618958|NCT01723774|58629852|FG003|Neoadjuvant|Adverse Event|0|||
30618959|NCT01723774|58629849|FG000|Neoadjuvant|High estradiol|0|||
30618960|NCT01723774|58629850|FG001|Neoadjuvant|High estradiol|1|||
30618961|NCT01723774|58629851|FG002|Neoadjuvant|High estradiol|0|||
30618962|NCT01723774|58629852|FG003|Neoadjuvant|High estradiol|0|||
30618963|NCT01723774|58629849|FG000|Adjuvant|Still on active treatment|0|||
30618964|NCT01723774|58629850|FG001|Adjuvant|Still on active treatment|0|||
30618965|NCT01723774|58629851|FG002|Adjuvant|Still on active treatment|0|||
30618966|NCT01723774|58629852|FG003|Adjuvant|Still on active treatment|1|||
30618967|NCT01190514|58629861|FG000|First Intervention (Period 1)|Adverse Event|1|||
30618968|NCT01190514|58629862|FG001|First Intervention (Period 1)|Adverse Event|0|||
30618969|NCT01190514|58629863|FG002|First Intervention (Period 1)|Adverse Event|0|||
30618970|NCT01190514|58629864|FG003|First Intervention (Period 1)|Adverse Event|0|||
30618971|NCT01190514|58629861|FG000|Third Intervention (Period 3)|Adverse Event|1|||
30618972|NCT01190514|58629862|FG001|Third Intervention (Period 3)|Adverse Event|0|||
30618973|NCT01190514|58629863|FG002|Third Intervention (Period 3)|Adverse Event|0|||
30618974|NCT01190514|58629864|FG003|Third Intervention (Period 3)|Adverse Event|0|||
30618975|NCT01190436|58629874|FG000|Overall Study|Lost to Follow-up|35|||
30618976|NCT01190436|58629874|FG000|Overall Study|Other|4|||
30618977|NCT01035255|58629881|FG000|Overall Study|Death|724|||
30618978|NCT01035255|58629882|FG001|Overall Study|Death|844|||
30618979|NCT01035255|58629881|FG000|Overall Study|Lost to Follow-up|2|||
30618980|NCT01035255|58629882|FG001|Overall Study|Lost to Follow-up|5|||
30618981|NCT01035255|58629881|FG000|Overall Study|patient's request|15|||
30618982|NCT01035255|58629882|FG001|Overall Study|patient's request|13|||
30618983|NCT01190124|58629891|FG000|Overall Study|Death|3|||
30618984|NCT01190124|58629892|FG001|Overall Study|Death|0|||
30618985|NCT01190124|58629893|FG002|Overall Study|Death|0|||
30618986|NCT01190124|58629891|FG000|Overall Study|Therapeutic Failure|12|||
30618987|NCT01190124|58629892|FG001|Overall Study|Therapeutic Failure|0|||
30618988|NCT01190124|58629893|FG002|Overall Study|Therapeutic Failure|1|||
30618989|NCT01190124|58629891|FG000|Overall Study|Lost to Follow-up|2|||
30618990|NCT01190124|58629892|FG001|Overall Study|Lost to Follow-up|0|||
30618991|NCT01190124|58629893|FG002|Overall Study|Lost to Follow-up|0|||
30618992|NCT01189890|58629906|FG000|Overall Study|Adverse Event|3|||
30618993|NCT01189890|58629907|FG001|Overall Study|Adverse Event|4|||
30893333|NCT02527343|58926859|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
30618994|NCT01189890|58629906|FG000|Overall Study|Lack of Efficacy|7|||
30618995|NCT01189890|58629907|FG001|Overall Study|Lack of Efficacy|2|||
30618996|NCT01189890|58629906|FG000|Overall Study|Lost to Follow-up|1|||
30618997|NCT01189890|58629907|FG001|Overall Study|Lost to Follow-up|7|||
30618998|NCT01189890|58629906|FG000|Overall Study|Protocol Violation|1|||
30618999|NCT01189890|58629907|FG001|Overall Study|Protocol Violation|5|||
30619000|NCT01189890|58629906|FG000|Overall Study|Withdrawal by Subject|15|||
30619001|NCT01189890|58629907|FG001|Overall Study|Withdrawal by Subject|11|||
30619002|NCT01189890|58629906|FG000|Overall Study|Non Compliance|0|||
30619003|NCT01189890|58629907|FG001|Overall Study|Non Compliance|1|||
30619004|NCT01189890|58629906|FG000|Overall Study|Physician Decision|5|||
30619005|NCT01189890|58629907|FG001|Overall Study|Physician Decision|4|||
30619006|NCT01189890|58629906|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
30619007|NCT01189890|58629907|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
30619008|NCT01189812|58629915|FG000|Overall Study|Withdrawal by Subject|2|||
30619009|NCT01189812|58629916|FG001|Overall Study|Withdrawal by Subject|3|||
30619010|NCT01189812|58629915|FG000|Overall Study|Adverse Event|1|||
30619011|NCT01189812|58629916|FG001|Overall Study|Adverse Event|0|||
30619012|NCT01189812|58629915|FG000|Overall Study|Out of Window|4|||
30619013|NCT01189812|58629916|FG001|Overall Study|Out of Window|3|||
30619014|NCT01189812|58629915|FG000|Overall Study|Moved out of State|1|||
30619015|NCT01189812|58629916|FG001|Overall Study|Moved out of State|2|||
30619016|NCT00950950|58629924|FG000|Overall Study|Adverse Event|1|||
30619017|NCT00950950|58629925|FG001|Overall Study|Adverse Event|0|||
30619018|NCT00950950|58629924|FG000|Overall Study|Withdrawal by Subject|0|||
30619019|NCT00950950|58629925|FG001|Overall Study|Withdrawal by Subject|1|||
30619020|NCT00950872|58629932|FG000|Overall Study|Withdrawal by Subject|1|||
30619021|NCT00950872|58629932|FG000|Overall Study|Did not have surgery|2|||
30619022|NCT01189500|58629936|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
30619023|NCT01189500|58629936|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
30619024|NCT00938860|58629945|FG000|Overall Study|Adverse Event|2|||
30619025|NCT00938860|58629946|FG001|Overall Study|Adverse Event|1|||
30619026|NCT00938860|58629945|FG000|Overall Study|Abnormal laboratory values|2|||
30619027|NCT00938860|58629946|FG001|Overall Study|Abnormal laboratory values|2|||
30619028|NCT00938860|58629945|FG000|Overall Study|Withdrawal by Subject|11|||
30619029|NCT00938860|58629946|FG001|Overall Study|Withdrawal by Subject|8|||
30619030|NCT00938860|58629945|FG000|Overall Study|Lost to Follow-up|4|||
30619031|NCT00938860|58629946|FG001|Overall Study|Lost to Follow-up|4|||
30619032|NCT00938860|58629945|FG000|Overall Study|Administration problems|2|||
30619033|NCT00938860|58629946|FG001|Overall Study|Administration problems|0|||
30619034|NCT00938860|58629945|FG000|Overall Study|Death|1|||
30619035|NCT00938860|58629946|FG001|Overall Study|Death|1|||
30619036|NCT00938860|58629945|FG000|Overall Study|Protocol Violation|3|||
30619037|NCT00938860|58629946|FG001|Overall Study|Protocol Violation|1|||
30619038|NCT00938470|58629954|FG000|Overall Study|Disease Progression|3|||
30619039|NCT00938470|58629955|FG001|Overall Study|Disease Progression|0|||
30619040|NCT00938470|58629954|FG000|Overall Study|Alternate Treatment|1|||
30619041|NCT00938470|58629955|FG001|Overall Study|Alternate Treatment|0|||
30619042|NCT00938470|58629954|FG000|Overall Study|Death|3|||
30619043|NCT00938470|58629955|FG001|Overall Study|Death|2|||
30619044|NCT00938470|58629954|FG000|Overall Study|Other Reason|0|||
30619045|NCT00938470|58629955|FG001|Overall Study|Other Reason|1|||
30619046|NCT00938392|58629963|FG000|Overall Study|Adverse Event|0|||
30619047|NCT00938392|58629964|FG001|Overall Study|Adverse Event|1|||
30619048|NCT00938392|58629963|FG000|Overall Study|Withdrawal by Subject|0|||
30619049|NCT00938392|58629964|FG001|Overall Study|Withdrawal by Subject|1|||
30619050|NCT00938392|58629963|FG000|Overall Study|Lost to Follow-up|2|||
30619051|NCT00938392|58629964|FG001|Overall Study|Lost to Follow-up|2|||
30619052|NCT01022853|58629975|FG000|Overall Study|Progressive disease|2|||
30619053|NCT01022853|58629976|FG001|Overall Study|Progressive disease|3|||
30619054|NCT01022853|58629977|FG002|Overall Study|Progressive disease|11|||
30619055|NCT01022853|58629978|FG003|Overall Study|Progressive disease|7|||
30619056|NCT01022853|58629979|FG004|Overall Study|Progressive disease|1|||
30893334|NCT02527343|58926860|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
30893335|NCT02527343|58926861|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
30893336|NCT02527343|58926856|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
30893337|NCT02527343|58926857|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
30619057|NCT01022853|58629975|FG000|Overall Study|Dose-limiting toxicity|0|||
30619058|NCT01022853|58629976|FG001|Overall Study|Dose-limiting toxicity|0|||
30619059|NCT01022853|58629977|FG002|Overall Study|Dose-limiting toxicity|0|||
30619060|NCT01022853|58629978|FG003|Overall Study|Dose-limiting toxicity|0|||
30699538|NCT00549549|58713997|FG000|Overall Study|Randomized but not treated|0|||
30699539|NCT00549549|58713998|FG001|Overall Study|Randomized but not treated|0|||
30699540|NCT00549549|58713999|FG002|Overall Study|Randomized but not treated|1|||
30699541|NCT00549549|58714000|FG003|Overall Study|Randomized but not treated|1|||
30699542|NCT00270205|58714014|FG000|Overall Study|Lost to Follow-up|1|||
30699543|NCT00270205|58714015|FG001|Overall Study|Lost to Follow-up|0|||
30699544|NCT00270205|58714016|FG002|Overall Study|Lost to Follow-up|0|||
30699545|NCT00270205|58714017|FG003|Overall Study|Lost to Follow-up|1|||
30699546|NCT00622284|58714029|FG000|Overall Study|Lack of Efficacy|45|||
30699547|NCT00622284|58714030|FG001|Overall Study|Lack of Efficacy|15|||
30699548|NCT00622284|58714029|FG000|Overall Study|Adverse Event|61|||
30699549|NCT00622284|58714030|FG001|Overall Study|Adverse Event|90|||
30699550|NCT00622284|58714029|FG000|Overall Study|Protocol Violation|12|||
30699551|NCT00622284|58714030|FG001|Overall Study|Protocol Violation|5|||
30619061|NCT01022853|58629979|FG004|Overall Study|Dose-limiting toxicity|1|||
30619062|NCT01022853|58629975|FG000|Overall Study|Withdrawal by Subject|0|||
30619063|NCT01022853|58629976|FG001|Overall Study|Withdrawal by Subject|1|||
30619064|NCT01022853|58629977|FG002|Overall Study|Withdrawal by Subject|1|||
30619065|NCT01022853|58629978|FG003|Overall Study|Withdrawal by Subject|1|||
30619066|NCT01022853|58629979|FG004|Overall Study|Withdrawal by Subject|0|||
30619067|NCT01022853|58629975|FG000|Overall Study|Other not stated above|1|||
30619068|NCT01022853|58629976|FG001|Overall Study|Other not stated above|0|||
30619069|NCT01022853|58629977|FG002|Overall Study|Other not stated above|1|||
30619070|NCT01022853|58629978|FG003|Overall Study|Other not stated above|0|||
30619071|NCT01022853|58629979|FG004|Overall Study|Other not stated above|0|||
30619072|NCT01034709|58629996|FG000|Overall Study|Protocol Violation|9|||
30619073|NCT01034709|58629997|FG001|Overall Study|Protocol Violation|16|||
30619074|NCT00937768|58630005|FG000|Overall Study|Refused Further Treatment|3|||
30619075|NCT00937768|58630006|FG001|Overall Study|Refused Further Treatment|2|||
30619076|NCT00937768|58630005|FG000|Overall Study|Disease Progression|1|||
30699552|NCT00622284|58714029|FG000|Overall Study|Lost to Follow-up|11|||
30619077|NCT00937768|58630006|FG001|Overall Study|Disease Progression|1|||
30619078|NCT00937768|58630005|FG000|Overall Study|Alternate Treatment|0|||
30699553|NCT00622284|58714030|FG001|Overall Study|Lost to Follow-up|13|||
30699554|NCT00622284|58714029|FG000|Overall Study|Withdrawal by Subject|27|||
30619079|NCT00937768|58630006|FG001|Overall Study|Alternate Treatment|1|||
30619080|NCT00937768|58630005|FG000|Overall Study|No Further Funding|4|||
30619081|NCT00937768|58630006|FG001|Overall Study|No Further Funding|4|||
30619082|NCT00940888|58630012|FG000|Overall Study|Unsuccessful Implant|4|||
30619083|NCT00940888|58630012|FG000|Overall Study|Death|461|||
30619084|NCT00940888|58630012|FG000|Overall Study|Withdrawn - Non-Death|364|||
30619085|NCT00940888|58630012|FG000|Overall Study|Lost to Follow-up|6|||
30619086|NCT01189266|58630019|FG000|Overall Study|Adverse Event|1|||
30619087|NCT01189266|58630020|FG001|Overall Study|Adverse Event|0|||
30619088|NCT01189266|58630021|FG002|Overall Study|Adverse Event|5|||
30619089|NCT01189266|58630019|FG000|Overall Study|Death|0|||
30619090|NCT01189266|58630020|FG001|Overall Study|Death|0|||
30619091|NCT01189266|58630021|FG002|Overall Study|Death|5|||
30619092|NCT01189266|58630019|FG000|Overall Study|Lack of Efficacy|4|||
30619093|NCT01189266|58630020|FG001|Overall Study|Lack of Efficacy|5|||
30619094|NCT01189266|58630021|FG002|Overall Study|Lack of Efficacy|44|||
30619095|NCT01189266|58630019|FG000|Overall Study|Physician Decision|0|||
30619096|NCT01189266|58630020|FG001|Overall Study|Physician Decision|0|||
30619097|NCT01189266|58630021|FG002|Overall Study|Physician Decision|1|||
30619098|NCT01189266|58630019|FG000|Overall Study|Protocol Violation|0|||
30619099|NCT01189266|58630020|FG001|Overall Study|Protocol Violation|1|||
30619100|NCT01189266|58630021|FG002|Overall Study|Protocol Violation|1|||
30619101|NCT01189266|58630019|FG000|Overall Study|Withdrawal by Subject|0|||
30619102|NCT01189266|58630020|FG001|Overall Study|Withdrawal by Subject|0|||
30619103|NCT01189266|58630021|FG002|Overall Study|Withdrawal by Subject|1|||
30619104|NCT01189266|58630019|FG000|Overall Study|Patient refuses further therapy|1|||
30619105|NCT01189266|58630020|FG001|Overall Study|Patient refuses further therapy|0|||
30619106|NCT01189266|58630021|FG002|Overall Study|Patient refuses further therapy|7|||
30619107|NCT01189266|58630019|FG000|Overall Study|No treatment|0|||
30619108|NCT01189266|58630020|FG001|Overall Study|No treatment|0|||
30699555|NCT00622284|58714030|FG001|Overall Study|Withdrawal by Subject|24|||
30699556|NCT00622284|58714029|FG000|Overall Study|Other reason (not specified)|33|||
30699557|NCT00622284|58714030|FG001|Overall Study|Other reason (not specified)|24|||
30699558|NCT00269113|58714038|FG000|Overall Study|Adverse Event|14|||
30699559|NCT00269113|58714039|FG001|Overall Study|Adverse Event|7|||
30699560|NCT00269113|58714038|FG000|Overall Study|Lack of Efficacy|35|||
30699561|NCT00269113|58714039|FG001|Overall Study|Lack of Efficacy|18|||
30699562|NCT00269113|58714038|FG000|Overall Study|Early Improvement|2|||
30699563|NCT00269113|58714039|FG001|Overall Study|Early Improvement|0|||
30699564|NCT00269113|58714038|FG000|Overall Study|Withdrawal by Subject|0|||
30699565|NCT00269113|58714039|FG001|Overall Study|Withdrawal by Subject|2|||
30699566|NCT00269113|58714038|FG000|Overall Study|Death|6|||
30699567|NCT00269113|58714039|FG001|Overall Study|Death|2|||
30699568|NCT00269113|58714038|FG000|Overall Study|Lost to Follow-up|2|||
30699569|NCT00269113|58714039|FG001|Overall Study|Lost to Follow-up|1|||
30619109|NCT01189266|58630021|FG002|Overall Study|No treatment|1|||
30619110|NCT01189032|58630033|FG000|Overall Study|Adverse Event|1|||
30619111|NCT01189032|58630034|FG001|Overall Study|Adverse Event|3|||
30619112|NCT01189032|58630035|FG002|Overall Study|Adverse Event|4|||
30699570|NCT00269113|58714038|FG000|Overall Study|Protocol Violation|15|||
30790844|NCT03524092|58803941|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
30619113|NCT01189032|58630033|FG000|Overall Study|Lack of Efficacy|2|||
30619114|NCT01189032|58630034|FG001|Overall Study|Lack of Efficacy|3|||
30619115|NCT01189032|58630035|FG002|Overall Study|Lack of Efficacy|0|||
30619116|NCT01189032|58630033|FG000|Overall Study|Withdrawal by Subject|1|||
30699571|NCT00269113|58714039|FG001|Overall Study|Protocol Violation|5|||
30699572|NCT00269113|58714038|FG000|Overall Study|Other|0|||
30699573|NCT00269113|58714039|FG001|Overall Study|Other|2|||
30699574|NCT00291187|58714049|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
30699575|NCT00291187|58714050|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
30699576|NCT00291187|58714051|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
30699577|NCT00291187|58714052|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
30619117|NCT01189032|58630034|FG001|Overall Study|Withdrawal by Subject|0|||
30619118|NCT01189032|58630035|FG002|Overall Study|Withdrawal by Subject|1|||
30619119|NCT01189032|58630033|FG000|Overall Study|Protocol Violation|1|||
30619120|NCT01189032|58630034|FG001|Overall Study|Protocol Violation|1|||
30619121|NCT01189032|58630035|FG002|Overall Study|Protocol Violation|1|||
30619122|NCT01188798|58630045|FG000|Overall Study|Death|0|||
30619123|NCT01188798|58630046|FG001|Overall Study|Death|1|||
30619124|NCT01188798|58630045|FG000|Overall Study|Required additional transplant|1|||
30619125|NCT01188798|58630046|FG001|Overall Study|Required additional transplant|1|||
30619126|NCT01188798|58630045|FG000|Overall Study|Protocol closure|1|||
30619127|NCT01188798|58630046|FG001|Overall Study|Protocol closure|1|||
30619128|NCT01183104|58630055|FG000|Overall Study|Adverse Event|8|||
30619129|NCT01183104|58630056|FG001|Overall Study|Adverse Event|6|||
30619130|NCT01183104|58630055|FG000|Overall Study|Death|0|||
30619131|NCT01183104|58630056|FG001|Overall Study|Death|1|||
30619132|NCT01183104|58630055|FG000|Overall Study|Lost to Follow-up|14|||
30699578|NCT00546819|58714068|FG000|Overall Study|Adverse Event|2|||
30619133|NCT01183104|58630056|FG001|Overall Study|Lost to Follow-up|7|||
30619134|NCT01183104|58630055|FG000|Overall Study|Physician Decision|5|||
30619135|NCT01183104|58630056|FG001|Overall Study|Physician Decision|8|||
30619136|NCT01183104|58630055|FG000|Overall Study|Withdrawal by Subject|6|||
30619137|NCT01183104|58630056|FG001|Overall Study|Withdrawal by Subject|11|||
30619138|NCT01183104|58630055|FG000|Overall Study|Nonparticipation in Extension Study|39|||
30619139|NCT01183104|58630056|FG001|Overall Study|Nonparticipation in Extension Study|50|||
30619140|NCT01183104|58630055|FG000|Overall Study|Did not receive study drug|5|||
30619141|NCT01183104|58630056|FG001|Overall Study|Did not receive study drug|9|||
30619142|NCT01163292|58630064|FG000|Overall Study|Lack of Efficacy|9|||
30619143|NCT01163292|58630065|FG001|Overall Study|Lack of Efficacy|0|||
30790845|NCT03524092|58803942|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
30619144|NCT01163292|58630064|FG000|Overall Study|Adverse Event|6|||
30619145|NCT01163292|58630065|FG001|Overall Study|Adverse Event|0|||
30619146|NCT01163292|58630064|FG000|Overall Study|Initiation of biological therapy|0|||
30619147|NCT01163292|58630065|FG001|Overall Study|Initiation of biological therapy|15|||
30619148|NCT01163292|58630064|FG000|Overall Study|Sufficient response to adalimumab|8|||
30619149|NCT01163292|58630065|FG001|Overall Study|Sufficient response to adalimumab|0|||
30619150|NCT01163292|58630064|FG000|Overall Study|Refusal to receive adalimumab|7|||
30619151|NCT01163292|58630065|FG001|Overall Study|Refusal to receive adalimumab|0|||
30619152|NCT01163292|58630064|FG000|Overall Study|Economic reasons|6|||
30619153|NCT01163292|58630065|FG001|Overall Study|Economic reasons|0|||
30619154|NCT01163292|58630064|FG000|Overall Study|No further visits|5|||
30619155|NCT01163292|58630065|FG001|Overall Study|No further visits|7|||
30619156|NCT00950248|58630073|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
30619157|NCT00950248|58630074|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
30619158|NCT00950248|58630075|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
30619159|NCT00950248|58630073|FG000|Year 1: Baseline|worsening of symptoms|2|||
30619160|NCT00950248|58630074|FG001|Year 1: Baseline|worsening of symptoms|0|||
30619161|NCT00950248|58630075|FG002|Year 1: Baseline|worsening of symptoms|0|||
30619162|NCT00950248|58630073|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
30619163|NCT00950248|58630074|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
30619164|NCT00950248|58630075|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
30619165|NCT00950248|58630073|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
30619166|NCT00950248|58630074|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
30619167|NCT00950248|58630075|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
30619168|NCT00950248|58630073|FG000|Year 2&3 Treatment Randomization|Death|0|||
30619169|NCT00950248|58630074|FG001|Year 2&3 Treatment Randomization|Death|0|||
30619170|NCT00950248|58630075|FG002|Year 2&3 Treatment Randomization|Death|1|||
30619171|NCT00950248|58630073|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
30619172|NCT00950248|58630074|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
30619173|NCT00950248|58630075|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
30619174|NCT00950170|58630082|FG000|Overall Study|Parent/Legal Guardian Request|1|||
30619175|NCT00950170|58630082|FG000|Overall Study|Adverse Event|2|||
30619176|NCT00950170|58630082|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
30619177|NCT01227824|58630106|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
30619178|NCT01227824|58630107|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
30619179|NCT01227824|58630108|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
30619180|NCT01227824|58630106|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
30619181|NCT01227824|58630107|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
30619182|NCT01227824|58630108|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
30619183|NCT01227824|58630106|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
30619184|NCT01227824|58630107|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
30619185|NCT01227824|58630108|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
30619186|NCT01227824|58630106|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
30619187|NCT01227824|58630107|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
30619188|NCT01227824|58630108|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
30619189|NCT01227824|58630106|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
30619190|NCT01227824|58630107|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
30619191|NCT01227824|58630108|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
30619192|NCT01227824|58630106|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
30619193|NCT01227824|58630107|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
30619194|NCT01227824|58630108|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
30619195|NCT01227824|58630106|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
30619196|NCT01227824|58630107|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
30619197|NCT01227824|58630108|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
30619198|NCT01227824|58630106|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
30619199|NCT01227824|58630107|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
30619200|NCT01227824|58630108|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
30619201|NCT01227824|58630106|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
30619202|NCT01227824|58630107|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
30619203|NCT01227824|58630108|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
30619204|NCT01227824|58630106|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
30619205|NCT01227824|58630107|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
30619206|NCT01227824|58630108|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
30893338|NCT02527343|58926858|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
30619207|NCT01227824|58630106|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
30619208|NCT01227824|58630107|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
30893339|NCT02527343|58926859|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
30893340|NCT02527343|58926860|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
30893341|NCT02527343|58926861|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
30893342|NCT02527343|58926856|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
30893343|NCT02527343|58926857|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
30893344|NCT02527343|58926858|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
30893345|NCT02527343|58926859|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
30893346|NCT02527343|58926860|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
30893347|NCT02527343|58926861|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
30893348|NCT02527343|58926856|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
30893349|NCT02527343|58926857|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
30893350|NCT02527343|58926858|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
30893351|NCT02527343|58926859|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
30893352|NCT02527343|58926860|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
30893353|NCT02527343|58926861|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
30893354|NCT02527343|58926856|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
30893355|NCT02527343|58926857|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
30893356|NCT02527343|58926858|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
30893357|NCT02527343|58926859|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
30893358|NCT02527343|58926860|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
30893359|NCT02527343|58926861|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
30893360|NCT02527343|58926856|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
30893361|NCT02527343|58926857|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
30893362|NCT02527343|58926858|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
30893363|NCT02527343|58926859|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
30893364|NCT02527343|58926860|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
30893365|NCT02527343|58926861|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
30893366|NCT02527343|58926856|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
30893367|NCT02527343|58926857|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
30893368|NCT02527343|58926858|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
30893369|NCT02527343|58926859|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
30893370|NCT02527343|58926860|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
30893371|NCT02527343|58926861|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
30893372|NCT02527343|58926856|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
30619209|NCT01227824|58630108|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
30619210|NCT01227824|58630106|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
30619211|NCT01227824|58630107|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
30619212|NCT01227824|58630108|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
30619213|NCT01227824|58630106|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
30619214|NCT01227824|58630107|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
30619215|NCT01227824|58630108|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
30619216|NCT01227824|58630106|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
30619217|NCT01227824|58630107|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
30619218|NCT01227824|58630108|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
30619219|NCT01227824|58630106|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
30619220|NCT01227824|58630107|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
30619221|NCT01227824|58630108|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
30619222|NCT00949702|58630115|FG000|Overall Study|Death|40|||
30619223|NCT00949702|58630115|FG000|Overall Study|Disease progression|7|||
30699579|NCT00546819|58714069|FG001|Overall Study|Adverse Event|3|||
30699580|NCT00546819|58714068|FG000|Overall Study|Lost to Follow-up|2|||
30699581|NCT00546819|58714069|FG001|Overall Study|Lost to Follow-up|1|||
30699582|NCT00546819|58714068|FG000|Overall Study|Withdrawal by Subject|4|||
30699583|NCT00546819|58714069|FG001|Overall Study|Withdrawal by Subject|2|||
30699584|NCT00621504|58714077|FG000|Overall Study|Adverse Event|1|||
30699585|NCT00621504|58714078|FG001|Overall Study|Adverse Event|3|||
30699586|NCT00621504|58714077|FG000|Overall Study|At the request of sponsor/investigator|1|||
30699587|NCT00621504|58714078|FG001|Overall Study|At the request of sponsor/investigator|0|||
30699588|NCT00621504|58714077|FG000|Overall Study|Withdrew consent|9|||
30699589|NCT00621504|58714078|FG001|Overall Study|Withdrew consent|6|||
30619224|NCT00949702|58630115|FG000|Overall Study|Withdrawal of consent|1|||
30619225|NCT01034631|58630122|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
30699590|NCT00621504|58714077|FG000|Overall Study|Lost to Follow-up|8|||
30699591|NCT00621504|58714078|FG001|Overall Study|Lost to Follow-up|10|||
30893373|NCT02527343|58926857|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
30893374|NCT02527343|58926858|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
30893375|NCT02527343|58926859|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
30893376|NCT02527343|58926860|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
30893377|NCT02527343|58926861|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
30893378|NCT01931566|58926879|FG000|Overall Study|Randomized But Not Treated|6|||
30893379|NCT01931566|58926880|FG001|Overall Study|Randomized But Not Treated|9|||
30893380|NCT01931566|58926881|FG002|Overall Study|Randomized But Not Treated|14|||
30893381|NCT01931566|58926879|FG000|Overall Study|Adverse Event|37|||
30893382|NCT01931566|58926880|FG001|Overall Study|Adverse Event|167|||
30893383|NCT01931566|58926881|FG002|Overall Study|Adverse Event|132|||
30893384|NCT01931566|58926879|FG000|Overall Study|Major Protocol Deviation|5|||
30619226|NCT01034631|58630123|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
30619227|NCT01034631|58630124|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
30619228|NCT01034631|58630122|FG000|Phase II|Not Evaluable per protocol|0|||
30619229|NCT01034631|58630123|FG001|Phase II|Not Evaluable per protocol|0|||
30619230|NCT01034631|58630124|FG002|Phase II|Not Evaluable per protocol|2|||
30619231|NCT01034631|58630122|FG000|Phase II|Determined Ineligible per protocol|0|||
30619232|NCT01034631|58630123|FG001|Phase II|Determined Ineligible per protocol|1|||
30619233|NCT01034631|58630124|FG002|Phase II|Determined Ineligible per protocol|0|||
30619234|NCT01227668|58630136|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
30619235|NCT01227668|58630137|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
30619236|NCT01227668|58630136|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
30619237|NCT01227668|58630137|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
30619238|NCT01227668|58630136|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
30619239|NCT01227668|58630137|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
30619240|NCT01227668|58630136|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
30619241|NCT01227668|58630137|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
30619242|NCT01227668|58630136|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
30619243|NCT01227668|58630137|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
30619244|NCT01227668|58630136|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
30619245|NCT01227668|58630137|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
30619246|NCT01227668|58630136|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
30619247|NCT01227668|58630137|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
30619248|NCT01227668|58630136|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
30619249|NCT01227668|58630137|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
30619250|NCT01227668|58630136|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
30619251|NCT01227668|58630137|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
30619252|NCT01227668|58630136|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
30699592|NCT00621504|58714077|FG000|Overall Study|Other|1|||
30699593|NCT00621504|58714078|FG001|Overall Study|Other|0|||
30699594|NCT00621504|58714077|FG000|Overall Study|Death|6|||
30699595|NCT00621504|58714078|FG001|Overall Study|Death|6|||
30699596|NCT00548145|58714086|FG000|Overall Study|Death|0|||
30699597|NCT00548145|58714087|FG001|Overall Study|Death|1|||
30699598|NCT00548145|58714086|FG000|Overall Study|Withdrawal by Subject|0|||
30699599|NCT00548145|58714087|FG001|Overall Study|Withdrawal by Subject|2|||
30699600|NCT00548145|58714086|FG000|Overall Study|Physician Decision|1|||
30699601|NCT00548145|58714087|FG001|Overall Study|Physician Decision|1|||
30699602|NCT00547911|58714097|FG000|Overall Study|Adverse Event|0|||
30699603|NCT00547911|58714098|FG001|Overall Study|Adverse Event|0|||
30699604|NCT00547911|58714099|FG002|Overall Study|Adverse Event|0|||
30699605|NCT00547911|58714100|FG003|Overall Study|Adverse Event|1|||
30699606|NCT00547911|58714101|FG004|Overall Study|Adverse Event|0|||
30699607|NCT00547911|58714102|FG005|Overall Study|Adverse Event|0|||
30699608|NCT00289783|58714117|FG000|Primary Phase|Adverse Event|10|||
30699609|NCT00289783|58714118|FG001|Primary Phase|Adverse Event|1|||
30619253|NCT01227668|58630137|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
30619254|NCT01227668|58630136|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
30619255|NCT01227668|58630137|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
30699610|NCT00289783|58714117|FG000|Primary Phase|Protocol Violation|27|||
30699611|NCT00289783|58714118|FG001|Primary Phase|Protocol Violation|6|||
30699612|NCT00289783|58714117|FG000|Primary Phase|Withdrawal by Subject|93|||
30699613|NCT00289783|58714118|FG001|Primary Phase|Withdrawal by Subject|40|||
30699614|NCT00289783|58714117|FG000|Primary Phase|Lost to Follow-up|60|||
30699615|NCT00289783|58714118|FG001|Primary Phase|Lost to Follow-up|14|||
30619256|NCT01227668|58630136|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
30619257|NCT01227668|58630137|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
30619258|NCT01227512|58630149|FG000|Overall Study|Physician Decision|6|||
30699616|NCT00289783|58714117|FG000|Primary Phase|Migration from the study area|26|||
30699617|NCT00289783|58714118|FG001|Primary Phase|Migration from the study area|10|||
30699618|NCT00289783|58714117|FG000|Primary Phase|Other|32|||
30699619|NCT00289783|58714118|FG001|Primary Phase|Other|12|||
30699620|NCT00289783|58714117|FG000|Fourth Dose Phase|Adverse Event|1|||
30699621|NCT00289783|58714118|FG001|Fourth Dose Phase|Adverse Event|0|||
30699622|NCT00289783|58714117|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
30699623|NCT00289783|58714118|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
30699624|NCT00289783|58714117|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
30699625|NCT00289783|58714118|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
30699626|NCT00289783|58714117|FG000|Fourth Dose Phase|Migration from the study area|1|||
30699627|NCT00289783|58714118|FG001|Fourth Dose Phase|Migration from the study area|1|||
30699628|NCT00289783|58714117|FG000|Fourth Dose Phase|Other|22|||
30699629|NCT00289783|58714118|FG001|Fourth Dose Phase|Other|10|||
30699630|NCT00574080|58714134|FG000|Overall Study|Death|10|||
30699631|NCT00574080|58714135|FG001|Overall Study|Death|10|||
30699632|NCT00546351|58714141|FG000|Overall Study|Adverse Event|76|||
30699633|NCT00546351|58714141|FG000|Overall Study|Lack of Efficacy|15|||
30699634|NCT00546351|58714141|FG000|Overall Study|Withdrawal by Subject|109|||
30699635|NCT00546351|58714141|FG000|Overall Study|Lost to Follow-up|9|||
30699636|NCT00546351|58714141|FG000|Overall Study|Protocol Deviation|1|||
30699637|NCT00546351|58714141|FG000|Overall Study|Unsatisfactory compliance|9|||
30699638|NCT00546351|58714141|FG000|Overall Study|Other reasons for premature termination|17|||
30699639|NCT00267865|58714145|FG000|Induction Treatment|Died before completing.|2|||
30893385|NCT01931566|58926880|FG001|Overall Study|Major Protocol Deviation|14|||
30893386|NCT01931566|58926881|FG002|Overall Study|Major Protocol Deviation|21|||
30699640|NCT00267865|58714145|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
30699641|NCT00546117|58714151|FG000|Overall Study|Withdrawal by Subject|3|||
30699642|NCT00546117|58714152|FG001|Overall Study|Withdrawal by Subject|0|||
30699643|NCT00546117|58714151|FG000|Overall Study|Inability to schedule follow-up visit|1|||
30699644|NCT00546117|58714152|FG001|Overall Study|Inability to schedule follow-up visit|0|||
30699645|NCT00251719|58714163|FG000|Overall Study|Adverse Event|14|||
30699646|NCT00251719|58714164|FG001|Overall Study|Adverse Event|8|||
30699647|NCT00251719|58714165|FG002|Overall Study|Adverse Event|7|||
30699648|NCT00251719|58714163|FG000|Overall Study|Protocol Violation|1|||
30699649|NCT00251719|58714164|FG001|Overall Study|Protocol Violation|1|||
30699650|NCT00251719|58714165|FG002|Overall Study|Protocol Violation|1|||
30699651|NCT00251719|58714163|FG000|Overall Study|Lost to Follow-up|5|||
30699652|NCT00251719|58714164|FG001|Overall Study|Lost to Follow-up|11|||
30699653|NCT00251719|58714165|FG002|Overall Study|Lost to Follow-up|8|||
30699654|NCT00251719|58714163|FG000|Overall Study|Withdrawal by Subject|14|||
30699655|NCT00251719|58714164|FG001|Overall Study|Withdrawal by Subject|12|||
30699656|NCT00251719|58714165|FG002|Overall Study|Withdrawal by Subject|11|||
30699657|NCT00251719|58714163|FG000|Overall Study|Lack of Efficacy|2|||
30699658|NCT00251719|58714164|FG001|Overall Study|Lack of Efficacy|1|||
30699659|NCT00251719|58714165|FG002|Overall Study|Lack of Efficacy|0|||
30699660|NCT00251719|58714163|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
30699661|NCT00251719|58714164|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
30699662|NCT00251719|58714165|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
30699663|NCT00251719|58714163|FG000|Overall Study|Investigator decision|1|||
30699664|NCT00251719|58714164|FG001|Overall Study|Investigator decision|1|||
30699665|NCT00251719|58714165|FG002|Overall Study|Investigator decision|0|||
30699666|NCT00251719|58714163|FG000|Overall Study|Noncompliance|2|||
30699667|NCT00251719|58714164|FG001|Overall Study|Noncompliance|3|||
30699668|NCT00251719|58714165|FG002|Overall Study|Noncompliance|1|||
30699669|NCT00251719|58714163|FG000|Overall Study|Barrett's esophagus|2|||
30699670|NCT00251719|58714164|FG001|Overall Study|Barrett's esophagus|2|||
30699671|NCT00251719|58714165|FG002|Overall Study|Barrett's esophagus|0|||
30699672|NCT03952143|58714175|FG000|Lead-In Period|Adverse Event|2|||
30699673|NCT03952143|58714176|FG001|Lead-In Period|Adverse Event|0|||
30699674|NCT03952143|58714177|FG002|Lead-In Period|Adverse Event|0|||
30699675|NCT03952143|58714175|FG000|Lead-In Period|Lack of Efficacy|2|||
30699676|NCT03952143|58714176|FG001|Lead-In Period|Lack of Efficacy|0|||
30699677|NCT03952143|58714177|FG002|Lead-In Period|Lack of Efficacy|0|||
30699678|NCT03952143|58714175|FG000|Lead-In Period|Physician Decision|5|||
30699679|NCT03952143|58714176|FG001|Lead-In Period|Physician Decision|0|||
30699680|NCT03952143|58714177|FG002|Lead-In Period|Physician Decision|0|||
30699681|NCT03952143|58714175|FG000|Lead-In Period|Protocol Violation|5|||
30699682|NCT03952143|58714176|FG001|Lead-In Period|Protocol Violation|0|||
30699683|NCT03952143|58714177|FG002|Lead-In Period|Protocol Violation|0|||
30699684|NCT03952143|58714175|FG000|Lead-In Period|Withdrawal by Subject|19|||
30699685|NCT03952143|58714176|FG001|Lead-In Period|Withdrawal by Subject|0|||
30699686|NCT03952143|58714177|FG002|Lead-In Period|Withdrawal by Subject|0|||
30699687|NCT03952143|58714175|FG000|Treatment Period|Adverse Event|0|||
30699688|NCT03952143|58714176|FG001|Treatment Period|Adverse Event|0|||
30699689|NCT03952143|58714177|FG002|Treatment Period|Adverse Event|1|||
30699690|NCT03952143|58714175|FG000|Treatment Period|Lost to Follow-up|0|||
30699691|NCT03952143|58714176|FG001|Treatment Period|Lost to Follow-up|2|||
30699692|NCT03952143|58714177|FG002|Treatment Period|Lost to Follow-up|0|||
30699693|NCT03952143|58714175|FG000|Treatment Period|Physician Decision|0|||
30790846|NCT03524092|58803943|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
30699694|NCT03952143|58714176|FG001|Treatment Period|Physician Decision|0|||
30699695|NCT03952143|58714177|FG002|Treatment Period|Physician Decision|2|||
30699696|NCT03952143|58714175|FG000|Treatment Period|Protocol Violation|0|||
30893387|NCT01931566|58926879|FG000|Overall Study|Lost to Follow-up|3|||
30893388|NCT01931566|58926880|FG001|Overall Study|Lost to Follow-up|26|||
30893389|NCT01931566|58926881|FG002|Overall Study|Lost to Follow-up|23|||
30893390|NCT01931566|58926879|FG000|Overall Study|Voluntary Withdrawal|78|||
30893391|NCT01931566|58926880|FG001|Overall Study|Voluntary Withdrawal|245|||
30893392|NCT01931566|58926881|FG002|Overall Study|Voluntary Withdrawal|225|||
30893393|NCT01931566|58926879|FG000|Overall Study|Study Termination|289|||
30893394|NCT01931566|58926880|FG001|Overall Study|Study Termination|968|||
30893395|NCT01931566|58926881|FG002|Overall Study|Study Termination|1037|||
30893396|NCT01931566|58926879|FG000|Overall Study|Reason Not Specified|11|||
30893397|NCT01931566|58926880|FG001|Overall Study|Reason Not Specified|47|||
30893398|NCT01931566|58926881|FG002|Overall Study|Reason Not Specified|53|||
30619259|NCT01227512|58630150|FG001|Overall Study|Physician Decision|6|||
30619260|NCT01227512|58630149|FG000|Overall Study|Adverse Event|4|||
30699697|NCT03952143|58714176|FG001|Treatment Period|Protocol Violation|0|||
30699698|NCT03952143|58714177|FG002|Treatment Period|Protocol Violation|1|||
30699699|NCT03952143|58714175|FG000|Treatment Period|Withdrawal by Subject|0|||
30699700|NCT03952143|58714176|FG001|Treatment Period|Withdrawal by Subject|5|||
30699701|NCT03952143|58714177|FG002|Treatment Period|Withdrawal by Subject|26|||
30699702|NCT03952143|58714175|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
30699703|NCT03952143|58714176|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
30893399|NCT01931566|58926879|FG000|Overall Study|Missing|0|||
30893400|NCT01931566|58926880|FG001|Overall Study|Missing|0|||
30893401|NCT01931566|58926881|FG002|Overall Study|Missing|1|||
30619261|NCT01227512|58630150|FG001|Overall Study|Adverse Event|3|||
30619262|NCT01227512|58630149|FG000|Overall Study|Withdrawal by Subject|3|||
30619263|NCT01227512|58630150|FG001|Overall Study|Withdrawal by Subject|0|||
30619264|NCT01227512|58630149|FG000|Overall Study|Participant met withdrawal criteria|0|||
30619265|NCT01227512|58630150|FG001|Overall Study|Participant met withdrawal criteria|1|||
30619266|NCT01227278|58630160|FG000|Overall Study|Withdrawal by Subject|4|||
30619267|NCT01227278|58630161|FG001|Overall Study|Withdrawal by Subject|4|||
30619268|NCT01227278|58630160|FG000|Overall Study|Death|0|||
30619269|NCT01227278|58630161|FG001|Overall Study|Death|2|||
30619270|NCT01227278|58630160|FG000|Overall Study|Other|1|||
30619271|NCT01227278|58630161|FG001|Overall Study|Other|2|||
30619272|NCT01034397|58630169|FG000|Overall Study|Lack of compliance|0|||
30619273|NCT01034397|58630170|FG001|Overall Study|Lack of compliance|1|||
30619274|NCT01034397|58630169|FG000|Overall Study|Lack of Efficacy|3|||
30619275|NCT01034397|58630170|FG001|Overall Study|Lack of Efficacy|0|||
30699704|NCT03952143|58714177|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
30893402|NCT01912456|58926892|FG000|Period 1|Physician Decision|0|||
30893403|NCT01912456|58926893|FG001|Period 1|Physician Decision|0|||
30893404|NCT01912456|58926894|FG002|Period 1|Physician Decision|1|||
30893405|NCT01912456|58926895|FG003|Period 1|Physician Decision|0|||
30893406|NCT01912456|58926892|FG000|Period 1|non-compliance|1|||
30893407|NCT01912456|58926893|FG001|Period 1|non-compliance|0|||
30893408|NCT01912456|58926894|FG002|Period 1|non-compliance|0|||
30893409|NCT01912456|58926895|FG003|Period 1|non-compliance|1|||
30893410|NCT01912456|58926892|FG000|Period 1|Adverse Event|1|||
30893411|NCT01912456|58926893|FG001|Period 1|Adverse Event|0|||
30893412|NCT01912456|58926894|FG002|Period 1|Adverse Event|0|||
30893413|NCT01912456|58926895|FG003|Period 1|Adverse Event|1|||
30893414|NCT01912456|58926892|FG000|Period 1|Withdrawal by Subject|0|||
30893415|NCT01912456|58926893|FG001|Period 1|Withdrawal by Subject|1|||
30893416|NCT01912456|58926894|FG002|Period 1|Withdrawal by Subject|1|||
30893417|NCT01912456|58926895|FG003|Period 1|Withdrawal by Subject|1|||
30893418|NCT01912456|58926892|FG000|Period 2|Lack of Efficacy|0|||
30893419|NCT01912456|58926893|FG001|Period 2|Lack of Efficacy|2|||
30893420|NCT01912456|58926894|FG002|Period 2|Lack of Efficacy|0|||
30893421|NCT01912456|58926895|FG003|Period 2|Lack of Efficacy|0|||
30893422|NCT01912456|58926892|FG000|Period 2|Adverse Event|0|||
30619276|NCT01034397|58630169|FG000|Overall Study|Adverse Event|4|||
30619277|NCT01034397|58630170|FG001|Overall Study|Adverse Event|0|||
30699705|NCT03952143|58714175|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
30699706|NCT03952143|58714176|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
30699707|NCT03952143|58714177|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
30699708|NCT00267007|58714186|FG000|Overall Study|Withdrawal by Subject|6|||
30699709|NCT00267007|58714187|FG001|Overall Study|Withdrawal by Subject|0|||
30699710|NCT00267007|58714186|FG000|Overall Study|Lost to Follow-up|1|||
30699711|NCT00267007|58714187|FG001|Overall Study|Lost to Follow-up|0|||
30699712|NCT00267007|58714186|FG000|Overall Study|Non-compliance|0|||
30699713|NCT00267007|58714187|FG001|Overall Study|Non-compliance|1|||
30699714|NCT00267007|58714186|FG000|Overall Study|Adverse Event|1|||
30699715|NCT00267007|58714187|FG001|Overall Study|Adverse Event|0|||
30699716|NCT03943095|58714195|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
30699717|NCT03943095|58714196|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
30699718|NCT03943095|58714195|FG000|Overall Study|Withdrawal by Subject|1|||
30699719|NCT03943095|58714196|FG001|Overall Study|Withdrawal by Subject|0|||
30619278|NCT01034397|58630169|FG000|Overall Study|Other|0|||
30619279|NCT01034397|58630170|FG001|Overall Study|Other|1|||
30699720|NCT00251641|58714205|FG000|Overall Study|Adverse Event|80|||
30699721|NCT00251641|58714206|FG001|Overall Study|Adverse Event|8|||
30699722|NCT00251641|58714205|FG000|Overall Study|Lack of Efficacy|2|||
30699723|NCT00251641|58714206|FG001|Overall Study|Lack of Efficacy|1|||
30699724|NCT00251641|58714205|FG000|Overall Study|Progression of Disease|0|||
30699725|NCT00251641|58714206|FG001|Overall Study|Progression of Disease|2|||
30699726|NCT00251641|58714205|FG000|Overall Study|Lost to Follow-up|3|||
30699727|NCT00251641|58714206|FG001|Overall Study|Lost to Follow-up|3|||
30699728|NCT00251641|58714205|FG000|Overall Study|Withdrawal by Subject|6|||
30699729|NCT00251641|58714206|FG001|Overall Study|Withdrawal by Subject|8|||
30699730|NCT00251641|58714205|FG000|Overall Study|Protocol Violation|10|||
30699731|NCT00251641|58714206|FG001|Overall Study|Protocol Violation|2|||
30699732|NCT00251641|58714205|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
30619280|NCT01227044|58630187|FG000|Overall Study|Lost to Follow-up|5|||
30619281|NCT01227044|58630188|FG001|Overall Study|Lost to Follow-up|7|||
30619282|NCT01227044|58630187|FG000|Overall Study|Discontinued Intervention|1|||
30619283|NCT01227044|58630188|FG001|Overall Study|Discontinued Intervention|2|||
30619284|NCT01225952|58630197|FG000|Overall Study|Lost to Follow-up|1|||
30619285|NCT01225952|58630198|FG001|Overall Study|Lost to Follow-up|0|||
30699733|NCT00251641|58714206|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
30699734|NCT00251641|58714205|FG000|Overall Study|Switched Treatment|9|||
30699735|NCT00251641|58714206|FG001|Overall Study|Switched Treatment|63|||
30699736|NCT00250705|58714214|FG000|Overall Study|Lack of Efficacy|2|||
30699737|NCT00266695|58714220|FG000|Overall Study|Adverse Event|1|||
30699738|NCT00266695|58714220|FG000|Overall Study|Death|9|||
30699739|NCT00266695|58714220|FG000|Overall Study|Physician Decision|1|||
30699740|NCT00266695|58714220|FG000|Overall Study|Lost to Follow-up|3|||
30699741|NCT00266695|58714220|FG000|Overall Study|Withdrawal by Subject|15|||
30699742|NCT00620022|58714224|FG000|Treatment Period 1|Adverse Event|4|||
30699743|NCT00620022|58714225|FG001|Treatment Period 1|Adverse Event|6|||
30699744|NCT00620022|58714224|FG000|Treatment Period 1|Subject withdrew consent|1|||
30699745|NCT00620022|58714225|FG001|Treatment Period 1|Subject withdrew consent|0|||
30699746|NCT00620022|58714224|FG000|Treatment Period 2|Adverse Event|2|||
30699747|NCT00620022|58714225|FG001|Treatment Period 2|Adverse Event|2|||
30699748|NCT00547521|58714233|FG000|Short Term Study (4 Months)|Adverse Event|1|||
30699749|NCT00547521|58714234|FG001|Short Term Study (4 Months)|Adverse Event|0|||
30699750|NCT00547521|58714233|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
30699751|NCT00547521|58714234|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
30699752|NCT00547521|58714233|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
30699753|NCT00547521|58714234|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
30699754|NCT00547521|58714233|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
30699755|NCT00547521|58714234|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
30699756|NCT00547521|58714233|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
30699757|NCT00547521|58714234|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
30699758|NCT00547521|58714233|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
30699759|NCT00547521|58714234|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
30699760|NCT00547521|58714233|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
30699761|NCT00547521|58714234|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
30699762|NCT00547521|58714233|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
30699763|NCT00547521|58714234|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
30699764|NCT00547521|58714233|FG000|Long Term Extension (LTE) Study|Other|0|||
30699765|NCT00547521|58714234|FG001|Long Term Extension (LTE) Study|Other|2|||
30699766|NCT00547521|58714233|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
30619286|NCT01225952|58630199|FG002|Overall Study|Lost to Follow-up|0|||
30619287|NCT01225952|58630197|FG000|Overall Study|Study Eye Explanted|0|||
30619288|NCT01225952|58630198|FG001|Overall Study|Study Eye Explanted|0|||
30619289|NCT01225952|58630199|FG002|Overall Study|Study Eye Explanted|1|||
30619290|NCT01225952|58630197|FG000|Overall Study|Withdrawal by Subject|4|||
30619291|NCT01225952|58630198|FG001|Overall Study|Withdrawal by Subject|4|||
30619292|NCT01225952|58630199|FG002|Overall Study|Withdrawal by Subject|5|||
30619293|NCT01225952|58630197|FG000|Overall Study|Surgical complications|1|||
30619294|NCT01225952|58630198|FG001|Overall Study|Surgical complications|0|||
30619295|NCT01225952|58630199|FG002|Overall Study|Surgical complications|0|||
30619296|NCT01034163|58630209|FG000|Overall Study|Treatment completed as per protocol|8|||
30619297|NCT01034163|58630210|FG001|Overall Study|Treatment completed as per protocol|7|||
30619298|NCT01034163|58630209|FG000|Overall Study|Withdrawal by Subject|8|||
30619299|NCT01034163|58630210|FG001|Overall Study|Withdrawal by Subject|2|||
30619300|NCT01034163|58630209|FG000|Overall Study|Protocol deviation|1|||
30619301|NCT01034163|58630210|FG001|Overall Study|Protocol deviation|0|||
30619302|NCT01034163|58630209|FG000|Overall Study|Disease progression|3|||
30619303|NCT01034163|58630210|FG001|Overall Study|Disease progression|4|||
30619304|NCT01034163|58630209|FG000|Overall Study|Adverse Event|6|||
30619305|NCT01034163|58630210|FG001|Overall Study|Adverse Event|0|||
30619306|NCT01034163|58630209|FG000|Overall Study|Administrative problems|0|||
30699767|NCT00547521|58714234|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
30699768|NCT00266227|58714249|FG000|Initial Treatment|Adverse Event|0|||
30699769|NCT00266227|58714250|FG001|Initial Treatment|Adverse Event|0|||
30699770|NCT00266227|58714251|FG002|Initial Treatment|Adverse Event|13|||
30699771|NCT00266227|58714249|FG000|Initial Treatment|Lost to Follow-up|0|||
30699772|NCT00266227|58714250|FG001|Initial Treatment|Lost to Follow-up|0|||
30619307|NCT01034163|58630210|FG001|Overall Study|Administrative problems|1|||
30619308|NCT01034163|58630209|FG000|Overall Study|Abnormal laboratory value|1|||
30893423|NCT01912456|58926893|FG001|Period 2|Adverse Event|0|||
30619309|NCT01034163|58630210|FG001|Overall Study|Abnormal laboratory value|0|||
30699773|NCT00266227|58714251|FG002|Initial Treatment|Lost to Follow-up|6|||
30699774|NCT00266227|58714249|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
30699775|NCT00266227|58714250|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
30699776|NCT00266227|58714251|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
30699777|NCT00266227|58714249|FG000|Initial Treatment|Physician decision to withdraw|0|||
30699778|NCT00266227|58714250|FG001|Initial Treatment|Physician decision to withdraw|0|||
30699779|NCT00266227|58714251|FG002|Initial Treatment|Physician decision to withdraw|12|||
30699780|NCT00266227|58714249|FG000|Initial Treatment|Pregnancy|0|||
30699781|NCT00266227|58714250|FG001|Initial Treatment|Pregnancy|0|||
30699782|NCT00266227|58714251|FG002|Initial Treatment|Pregnancy|1|||
30699783|NCT00266227|58714249|FG000|Retreatment: Up to Week 48|Death|1|||
30699784|NCT00266227|58714250|FG001|Retreatment: Up to Week 48|Death|0|||
30699785|NCT00266227|58714251|FG002|Retreatment: Up to Week 48|Death|0|||
30699786|NCT00266227|58714249|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
30699787|NCT00266227|58714250|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
30699788|NCT00266227|58714251|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
30699789|NCT00266227|58714249|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
30699790|NCT00266227|58714250|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
30699791|NCT00266227|58714251|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
30699792|NCT00266227|58714249|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
30699793|NCT00266227|58714250|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
30699794|NCT00266227|58714251|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
30699795|NCT00266227|58714249|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
30699796|NCT00266227|58714250|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
30699797|NCT00266227|58714251|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
30699798|NCT00266227|58714249|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
30699799|NCT00266227|58714250|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
30699800|NCT00266227|58714251|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
30699801|NCT00266227|58714249|FG000|Retreatment: Week 48 to Week 72|Death|1|||
30699802|NCT00266227|58714250|FG001|Retreatment: Week 48 to Week 72|Death|1|||
30699803|NCT00266227|58714251|FG002|Retreatment: Week 48 to Week 72|Death|0|||
30699804|NCT00266227|58714249|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
30699805|NCT00266227|58714250|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
30699806|NCT00266227|58714251|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
30699807|NCT00266227|58714249|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
30619310|NCT01033851|58630218|FG000|Overall Study|Withdrawal by Subject|3|||
30619311|NCT01033851|58630219|FG001|Overall Study|Withdrawal by Subject|7|||
30619312|NCT01162122|58630227|FG000|Overall Study|Withdrawal by Subject|52|||
30619313|NCT01162122|58630228|FG001|Overall Study|Withdrawal by Subject|43|||
30619314|NCT01162122|58630227|FG000|Overall Study|Lost to Follow-up|73|||
30619315|NCT01162122|58630228|FG001|Overall Study|Lost to Follow-up|91|||
30619316|NCT01162122|58630227|FG000|Overall Study|Adverse Event|3|||
30619317|NCT01162122|58630228|FG001|Overall Study|Adverse Event|2|||
30619318|NCT01162122|58630227|FG000|Overall Study|Death|51|||
30619319|NCT01162122|58630228|FG001|Overall Study|Death|46|||
30619320|NCT01162122|58630227|FG000|Overall Study|Protocol Violation|2|||
30619321|NCT01162122|58630228|FG001|Overall Study|Protocol Violation|2|||
30699808|NCT00266227|58714250|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
30619322|NCT01162122|58630227|FG000|Overall Study|Inappropriate enrollment|5|||
30699809|NCT00266227|58714251|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
30699810|NCT00266227|58714249|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
30619323|NCT01162122|58630228|FG001|Overall Study|Inappropriate enrollment|4|||
30619324|NCT01162122|58630227|FG000|Overall Study|Administrative reason|1|||
30699811|NCT00266227|58714250|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
30699812|NCT00266227|58714251|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
30699813|NCT00266227|58714249|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
30699814|NCT00266227|58714250|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
30699815|NCT00266227|58714251|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
30699816|NCT00287365|58714260|FG000|Overall Study|sample not acquired|13|||
30699817|NCT00573768|58714268|FG000|Overall Study|Adverse Event|1|||
30699818|NCT00573768|58714269|FG001|Overall Study|Adverse Event|1|||
30699819|NCT00573768|58714270|FG002|Overall Study|Adverse Event|2|||
30699820|NCT00573768|58714268|FG000|Overall Study|Protocol Violation|1|||
30699821|NCT00573768|58714269|FG001|Overall Study|Protocol Violation|0|||
30699822|NCT00573768|58714270|FG002|Overall Study|Protocol Violation|1|||
30699823|NCT00573768|58714268|FG000|Overall Study|Withdrawal by Subject|0|||
30699824|NCT00573768|58714269|FG001|Overall Study|Withdrawal by Subject|1|||
30699825|NCT00573768|58714270|FG002|Overall Study|Withdrawal by Subject|0|||
30699826|NCT00573768|58714268|FG000|Overall Study|Lost to Follow-up|0|||
30699827|NCT00573768|58714269|FG001|Overall Study|Lost to Follow-up|0|||
30699828|NCT00573768|58714270|FG002|Overall Study|Lost to Follow-up|1|||
30699829|NCT00547365|58714278|FG000|Overall Study|Physician Decision|1|||
30699830|NCT00547365|58714278|FG000|Overall Study|Lost to Follow-up|1|||
30699831|NCT00547365|58714278|FG000|Overall Study|Protocol Violation|2|||
30699832|NCT00547365|58714278|FG000|Overall Study|death (not related to study)|4|||
30699833|NCT00619866|58714286|FG000|Weeks 1 - 12|Adverse Event|0|||
30699834|NCT00619866|58714287|FG001|Weeks 1 - 12|Adverse Event|1|||
30699835|NCT00619866|58714288|FG002|Weeks 1 - 12|Adverse Event|2|||
30699836|NCT00619866|58714289|FG003|Weeks 1 - 12|Adverse Event|0|||
30699837|NCT00619866|58714290|FG004|Weeks 1 - 12|Adverse Event|0|||
30699838|NCT00619866|58714286|FG000|Weeks 1 - 12|Non-compliance|0|||
30699839|NCT00619866|58714287|FG001|Weeks 1 - 12|Non-compliance|0|||
30699840|NCT00619866|58714288|FG002|Weeks 1 - 12|Non-compliance|1|||
30699841|NCT00619866|58714289|FG003|Weeks 1 - 12|Non-compliance|0|||
30699842|NCT00619866|58714290|FG004|Weeks 1 - 12|Non-compliance|0|||
30699843|NCT00619866|58714286|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
30699844|NCT00619866|58714287|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
30699845|NCT00619866|58714288|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
30699846|NCT00619866|58714289|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
30699847|NCT00619866|58714290|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
30699848|NCT00619866|58714286|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
30699849|NCT00619866|58714287|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
30699850|NCT00619866|58714288|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
30699851|NCT00619866|58714289|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
30699852|NCT00619866|58714290|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
30699853|NCT00619866|58714286|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
30699854|NCT00619866|58714287|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
30699855|NCT00619866|58714288|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
30699856|NCT00619866|58714289|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
30699857|NCT00619866|58714290|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
30699858|NCT00619866|58714286|FG000|Weeks 1 - 12|Sponsor Decision|0|||
30699859|NCT00619866|58714287|FG001|Weeks 1 - 12|Sponsor Decision|1|||
30699860|NCT00619866|58714288|FG002|Weeks 1 - 12|Sponsor Decision|0|||
30699861|NCT00619866|58714289|FG003|Weeks 1 - 12|Sponsor Decision|0|||
30619325|NCT01162122|58630228|FG001|Overall Study|Administrative reason|1|||
30619326|NCT01162122|58630227|FG000|Overall Study|Unable to classify|3|||
30619327|NCT01162122|58630228|FG001|Overall Study|Unable to classify|7|||
30619328|NCT01162122|58630227|FG000|Overall Study|Missing primary reason|1|||
30619329|NCT01162122|58630228|FG001|Overall Study|Missing primary reason|0|||
30619330|NCT01033071|58630240|FG000|Overall Study|Adverse Event|28|||
30619331|NCT01033071|58630241|FG001|Overall Study|Adverse Event|51|||
30619332|NCT01033071|58630242|FG002|Overall Study|Adverse Event|26|||
30699862|NCT00619866|58714290|FG004|Weeks 1 - 12|Sponsor Decision|0|||
30699863|NCT00619866|58714286|FG000|Weeks 13 - 24|Adverse Event|0|||
30699864|NCT00619866|58714287|FG001|Weeks 13 - 24|Adverse Event|0|||
30699865|NCT00619866|58714288|FG002|Weeks 13 - 24|Adverse Event|2|||
30699866|NCT00619866|58714289|FG003|Weeks 13 - 24|Adverse Event|1|||
30699867|NCT00619866|58714290|FG004|Weeks 13 - 24|Adverse Event|0|||
30699868|NCT00619866|58714286|FG000|Weeks 13 - 24|Protocol Deviation|0|||
30699869|NCT00619866|58714287|FG001|Weeks 13 - 24|Protocol Deviation|0|||
30699870|NCT00619866|58714288|FG002|Weeks 13 - 24|Protocol Deviation|0|||
30699871|NCT00619866|58714289|FG003|Weeks 13 - 24|Protocol Deviation|1|||
30699872|NCT00619866|58714290|FG004|Weeks 13 - 24|Protocol Deviation|0|||
30699873|NCT00619866|58714286|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
30699874|NCT00619866|58714287|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
30699875|NCT00619866|58714288|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
30699876|NCT00619866|58714289|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
30699877|NCT00619866|58714290|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
30699878|NCT00619866|58714286|FG000|Weeks 13 - 24|Non-compliance|0|||
30699879|NCT00619866|58714287|FG001|Weeks 13 - 24|Non-compliance|1|||
30699880|NCT00619866|58714288|FG002|Weeks 13 - 24|Non-compliance|1|||
30699881|NCT00619866|58714289|FG003|Weeks 13 - 24|Non-compliance|0|||
30699882|NCT00619866|58714290|FG004|Weeks 13 - 24|Non-compliance|0|||
30699883|NCT00619866|58714286|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
30699884|NCT00619866|58714287|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
30699885|NCT00619866|58714288|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
30699886|NCT00619866|58714289|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
30699887|NCT00619866|58714290|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
30699888|NCT03937479|58714318|FG000|Overall Study|Adverse Event|2|||
30699889|NCT03937479|58714319|FG001|Overall Study|Adverse Event|3|||
30699890|NCT03937479|58714320|FG002|Overall Study|Adverse Event|0|||
30699891|NCT03937479|58714321|FG003|Overall Study|Adverse Event|0|||
30699892|NCT03937479|58714322|FG004|Overall Study|Adverse Event|1|||
30699893|NCT03937479|58714318|FG000|Overall Study|Withdrawal by Subject|3|||
30699894|NCT03937479|58714319|FG001|Overall Study|Withdrawal by Subject|5|||
30699895|NCT03937479|58714320|FG002|Overall Study|Withdrawal by Subject|2|||
30699896|NCT03937479|58714321|FG003|Overall Study|Withdrawal by Subject|2|||
30699897|NCT03937479|58714322|FG004|Overall Study|Withdrawal by Subject|1|||
30699898|NCT03937479|58714318|FG000|Overall Study|Protocol Violation|5|||
30699899|NCT03937479|58714319|FG001|Overall Study|Protocol Violation|6|||
30699900|NCT03937479|58714320|FG002|Overall Study|Protocol Violation|4|||
30699901|NCT03937479|58714321|FG003|Overall Study|Protocol Violation|3|||
30699902|NCT03937479|58714322|FG004|Overall Study|Protocol Violation|2|||
30699903|NCT03937479|58714318|FG000|Overall Study|Lost to Follow-up|0|||
30699904|NCT03937479|58714319|FG001|Overall Study|Lost to Follow-up|1|||
30699905|NCT03937479|58714320|FG002|Overall Study|Lost to Follow-up|0|||
30699906|NCT03937479|58714321|FG003|Overall Study|Lost to Follow-up|1|||
30699907|NCT03937479|58714322|FG004|Overall Study|Lost to Follow-up|0|||
30699908|NCT03937479|58714318|FG000|Overall Study|Physician Decision|0|||
30699909|NCT03937479|58714319|FG001|Overall Study|Physician Decision|0|||
30699910|NCT03937479|58714320|FG002|Overall Study|Physician Decision|1|||
30699911|NCT03937479|58714321|FG003|Overall Study|Physician Decision|0|||
30699912|NCT03937479|58714322|FG004|Overall Study|Physician Decision|1|||
30699913|NCT00619476|58714338|FG000|Overall Study|Adverse Event|12|||
30699914|NCT00619476|58714339|FG001|Overall Study|Adverse Event|6|||
30699915|NCT00619476|58714340|FG002|Overall Study|Adverse Event|12|||
30699916|NCT00619476|58714341|FG003|Overall Study|Adverse Event|16|||
30699917|NCT00619476|58714338|FG000|Overall Study|Lack of Efficacy|6|||
30699918|NCT00619476|58714339|FG001|Overall Study|Lack of Efficacy|1|||
30893424|NCT01912456|58926894|FG002|Period 2|Adverse Event|0|||
30699919|NCT00619476|58714340|FG002|Overall Study|Lack of Efficacy|1|||
30699920|NCT00619476|58714341|FG003|Overall Study|Lack of Efficacy|4|||
30699921|NCT00619476|58714338|FG000|Overall Study|Protocol Violation|5|||
30699922|NCT00619476|58714339|FG001|Overall Study|Protocol Violation|4|||
30699923|NCT00619476|58714340|FG002|Overall Study|Protocol Violation|4|||
30699924|NCT00619476|58714341|FG003|Overall Study|Protocol Violation|9|||
30699925|NCT00619476|58714338|FG000|Overall Study|Lost to Follow-up|1|||
30699926|NCT00619476|58714339|FG001|Overall Study|Lost to Follow-up|2|||
30699927|NCT00619476|58714340|FG002|Overall Study|Lost to Follow-up|0|||
30699928|NCT00619476|58714341|FG003|Overall Study|Lost to Follow-up|1|||
30699929|NCT00619476|58714338|FG000|Overall Study|Investigator Discretion|2|||
30699930|NCT00619476|58714339|FG001|Overall Study|Investigator Discretion|2|||
30699931|NCT00619476|58714340|FG002|Overall Study|Investigator Discretion|2|||
30699932|NCT00619476|58714341|FG003|Overall Study|Investigator Discretion|0|||
30699933|NCT00619476|58714338|FG000|Overall Study|Withdrawal by Subject|5|||
30699934|NCT00619476|58714339|FG001|Overall Study|Withdrawal by Subject|7|||
30699935|NCT00619476|58714340|FG002|Overall Study|Withdrawal by Subject|5|||
30699936|NCT00619476|58714341|FG003|Overall Study|Withdrawal by Subject|4|||
30699937|NCT00618072|58714354|FG000|Overall Study|Lost to Follow-up|2|||
30699938|NCT00618072|58714355|FG001|Overall Study|Lost to Follow-up|0|||
30699939|NCT00618072|58714356|FG002|Overall Study|Lost to Follow-up|3|||
30699940|NCT00618072|58714354|FG000|Overall Study|Physician Decision|0|||
30699941|NCT00618072|58714355|FG001|Overall Study|Physician Decision|1|||
30619333|NCT01033071|58630240|FG000|Overall Study|Protocol Violation|0|||
30619334|NCT01033071|58630241|FG001|Overall Study|Protocol Violation|2|||
30619335|NCT01033071|58630242|FG002|Overall Study|Protocol Violation|1|||
30619336|NCT01033071|58630240|FG000|Overall Study|Lost to Follow-up|4|||
30619337|NCT01033071|58630241|FG001|Overall Study|Lost to Follow-up|5|||
30619338|NCT01033071|58630242|FG002|Overall Study|Lost to Follow-up|5|||
30619339|NCT01033071|58630240|FG000|Overall Study|Withdrawal by Subject|17|||
30619340|NCT01033071|58630241|FG001|Overall Study|Withdrawal by Subject|14|||
30619341|NCT01033071|58630242|FG002|Overall Study|Withdrawal by Subject|11|||
30619342|NCT01033071|58630240|FG000|Overall Study|Lack of Efficacy|0|||
30619343|NCT01033071|58630241|FG001|Overall Study|Lack of Efficacy|1|||
30619344|NCT01033071|58630242|FG002|Overall Study|Lack of Efficacy|1|||
30619345|NCT01033071|58630240|FG000|Overall Study|Other|6|||
30619346|NCT01033071|58630241|FG001|Overall Study|Other|4|||
30893425|NCT01912456|58926895|FG003|Period 2|Adverse Event|1|||
30699942|NCT00618072|58714356|FG002|Overall Study|Physician Decision|1|||
30699943|NCT00666926|58714364|FG000|Overall Study|Adverse Event|0|||
30699944|NCT00666926|58714365|FG001|Overall Study|Adverse Event|0|||
30699945|NCT00666926|58714366|FG002|Overall Study|Adverse Event|0|||
30699946|NCT00666926|58714367|FG003|Overall Study|Adverse Event|0|||
30699947|NCT00666926|58714368|FG004|Overall Study|Adverse Event|0|||
30699948|NCT00666926|58714369|FG005|Overall Study|Adverse Event|0|||
30699949|NCT00666926|58714370|FG006|Overall Study|Adverse Event|0|||
30699950|NCT00666926|58714371|FG007|Overall Study|Adverse Event|0|||
30699951|NCT00666926|58714372|FG008|Overall Study|Adverse Event|0|||
30699952|NCT00666926|58714373|FG009|Overall Study|Adverse Event|2|||
30699953|NCT00666926|58714374|FG010|Overall Study|Adverse Event|2|||
30699954|NCT00666926|58714375|FG011|Overall Study|Adverse Event|2|||
30699955|NCT00666926|58714376|FG012|Overall Study|Adverse Event|0|||
30699956|NCT00666926|58714377|FG013|Overall Study|Adverse Event|1|||
30699957|NCT00666926|58714378|FG014|Overall Study|Adverse Event|0|||
30699958|NCT00666926|58714379|FG015|Overall Study|Adverse Event|0|||
30699959|NCT00666926|58714364|FG000|Overall Study|Laboratory abnormality|0|||
30699960|NCT00666926|58714365|FG001|Overall Study|Laboratory abnormality|0|||
30699961|NCT00666926|58714366|FG002|Overall Study|Laboratory abnormality|0|||
30699962|NCT00666926|58714367|FG003|Overall Study|Laboratory abnormality|0|||
30699963|NCT00666926|58714368|FG004|Overall Study|Laboratory abnormality|0|||
30699964|NCT00666926|58714369|FG005|Overall Study|Laboratory abnormality|0|||
30699965|NCT00666926|58714370|FG006|Overall Study|Laboratory abnormality|0|||
30699966|NCT00666926|58714371|FG007|Overall Study|Laboratory abnormality|0|||
30699967|NCT00666926|58714372|FG008|Overall Study|Laboratory abnormality|0|||
30699968|NCT00666926|58714373|FG009|Overall Study|Laboratory abnormality|0|||
30619347|NCT01033071|58630242|FG002|Overall Study|Other|3|||
30619348|NCT01032915|58630254|FG000|Overall Study|Adverse Event|2|||
30619349|NCT01032915|58630255|FG001|Overall Study|Adverse Event|2|||
30619350|NCT01032915|58630256|FG002|Overall Study|Adverse Event|1|||
30619351|NCT01032915|58630257|FG003|Overall Study|Adverse Event|1|||
30619352|NCT01032915|58630254|FG000|Overall Study|Abnormal test procedure result|0|||
30619353|NCT01032915|58630255|FG001|Overall Study|Abnormal test procedure result|0|||
30619354|NCT01032915|58630256|FG002|Overall Study|Abnormal test procedure result|1|||
30619355|NCT01032915|58630257|FG003|Overall Study|Abnormal test procedure result|0|||
30619356|NCT01032915|58630254|FG000|Overall Study|Withdrawal by Subject|0|||
30619357|NCT01032915|58630255|FG001|Overall Study|Withdrawal by Subject|3|||
30619358|NCT01032915|58630256|FG002|Overall Study|Withdrawal by Subject|1|||
30619359|NCT01032915|58630257|FG003|Overall Study|Withdrawal by Subject|1|||
30619360|NCT01032915|58630254|FG000|Overall Study|Administrative reasons|5|||
30619361|NCT01032915|58630255|FG001|Overall Study|Administrative reasons|6|||
30699969|NCT00666926|58714374|FG010|Overall Study|Laboratory abnormality|1|||
30699970|NCT00666926|58714375|FG011|Overall Study|Laboratory abnormality|0|||
30699971|NCT00666926|58714376|FG012|Overall Study|Laboratory abnormality|0|||
30699972|NCT00666926|58714377|FG013|Overall Study|Laboratory abnormality|0|||
30699973|NCT00666926|58714378|FG014|Overall Study|Laboratory abnormality|0|||
30699974|NCT00666926|58714379|FG015|Overall Study|Laboratory abnormality|1|||
30699975|NCT00666926|58714364|FG000|Overall Study|Lack of Efficacy|0|||
30699976|NCT00666926|58714365|FG001|Overall Study|Lack of Efficacy|0|||
30699977|NCT00666926|58714366|FG002|Overall Study|Lack of Efficacy|0|||
30699978|NCT00666926|58714367|FG003|Overall Study|Lack of Efficacy|0|||
30699979|NCT00666926|58714368|FG004|Overall Study|Lack of Efficacy|0|||
30699980|NCT00666926|58714369|FG005|Overall Study|Lack of Efficacy|1|||
30699981|NCT00666926|58714370|FG006|Overall Study|Lack of Efficacy|0|||
30699982|NCT00666926|58714371|FG007|Overall Study|Lack of Efficacy|0|||
30699983|NCT00666926|58714372|FG008|Overall Study|Lack of Efficacy|0|||
30699984|NCT00666926|58714373|FG009|Overall Study|Lack of Efficacy|0|||
30699985|NCT00666926|58714374|FG010|Overall Study|Lack of Efficacy|0|||
30699986|NCT00666926|58714375|FG011|Overall Study|Lack of Efficacy|1|||
30699987|NCT00666926|58714376|FG012|Overall Study|Lack of Efficacy|0|||
30699988|NCT00666926|58714377|FG013|Overall Study|Lack of Efficacy|0|||
30699989|NCT00666926|58714378|FG014|Overall Study|Lack of Efficacy|0|||
30699990|NCT00666926|58714379|FG015|Overall Study|Lack of Efficacy|0|||
30699991|NCT00666926|58714364|FG000|Overall Study|Lost to Follow-up|0|||
30699992|NCT00666926|58714365|FG001|Overall Study|Lost to Follow-up|0|||
30699993|NCT00666926|58714366|FG002|Overall Study|Lost to Follow-up|0|||
30699994|NCT00666926|58714367|FG003|Overall Study|Lost to Follow-up|1|||
30699995|NCT00666926|58714368|FG004|Overall Study|Lost to Follow-up|0|||
30893426|NCT01885936|58926907|FG000|Overall Study|Withdrawal by Subject|1|||
30893427|NCT01885936|58926908|FG001|Overall Study|Withdrawal by Subject|0|||
30893428|NCT01912222|58926917|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
30893429|NCT01912222|58926918|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
30619362|NCT01032915|58630256|FG002|Overall Study|Administrative reasons|4|||
30619363|NCT01032915|58630257|FG003|Overall Study|Administrative reasons|4|||
30619364|NCT01032915|58630254|FG000|Overall Study|Protocol Violation|1|||
30619365|NCT01032915|58630255|FG001|Overall Study|Protocol Violation|0|||
30619366|NCT01032915|58630256|FG002|Overall Study|Protocol Violation|0|||
30619367|NCT01032915|58630257|FG003|Overall Study|Protocol Violation|1|||
30619368|NCT01161498|58630269|FG000|Overall Study|Disease Progression|0|||
30619369|NCT01161498|58630270|FG001|Overall Study|Disease Progression|1|||
30619370|NCT01180998|58630279|FG000|Overall Study|Poor Vision|0|||
30619371|NCT01180998|58630280|FG001|Overall Study|Poor Vision|2|||
30619372|NCT01180998|58630281|FG002|Overall Study|Poor Vision|2|||
30619373|NCT01180998|58630279|FG000|Overall Study|Lost to Follow-up|0|||
30893430|NCT01912222|58926919|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
30893431|NCT01912222|58926917|FG000|Part B: Treatment Period|Progressive disease|10|||
30619374|NCT01180998|58630280|FG001|Overall Study|Lost to Follow-up|0|||
30619375|NCT01180998|58630281|FG002|Overall Study|Lost to Follow-up|1|||
30619376|NCT01180998|58630279|FG000|Overall Study|Protocol Violation|1|||
30619377|NCT01180998|58630280|FG001|Overall Study|Protocol Violation|2|||
30619378|NCT01180998|58630281|FG002|Overall Study|Protocol Violation|0|||
30619379|NCT01180998|58630279|FG000|Overall Study|Withdrawal by Subject|0|||
30619380|NCT01180998|58630280|FG001|Overall Study|Withdrawal by Subject|0|||
30619381|NCT01180998|58630281|FG002|Overall Study|Withdrawal by Subject|1|||
30619382|NCT01180998|58630279|FG000|Overall Study|Poor comfort|3|||
30619383|NCT01180998|58630280|FG001|Overall Study|Poor comfort|0|||
30619384|NCT01180998|58630281|FG002|Overall Study|Poor comfort|4|||
30619385|NCT01180998|58630279|FG000|Overall Study|Poor lens handling|0|||
30893432|NCT01912222|58926918|FG001|Part B: Treatment Period|Progressive disease|12|||
30893433|NCT01912222|58926919|FG002|Part B: Treatment Period|Progressive disease|15|||
30893434|NCT01912222|58926917|FG000|Part B: Treatment Period|Adverse Event|1|||
30893435|NCT01912222|58926918|FG001|Part B: Treatment Period|Adverse Event|2|||
30893436|NCT01912222|58926919|FG002|Part B: Treatment Period|Adverse Event|3|||
30893437|NCT01912222|58926917|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
30893438|NCT01912222|58926918|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
30893439|NCT01912222|58926919|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
30893440|NCT02525861|58926930|FG000|Overall Study|Adverse Event|1|||
30893441|NCT02525861|58926931|FG001|Overall Study|Adverse Event|0|||
30619386|NCT01180998|58630280|FG001|Overall Study|Poor lens handling|0|||
30619387|NCT01180998|58630281|FG002|Overall Study|Poor lens handling|2|||
30619388|NCT01029795|58630292|FG000|Overall Study|Entry Criteria Not Met|2|||
30619389|NCT01029795|58630293|FG001|Overall Study|Entry Criteria Not Met|1|||
30619390|NCT01029795|58630292|FG000|Overall Study|Physician Decision|2|||
30619391|NCT01029795|58630293|FG001|Overall Study|Physician Decision|1|||
30699996|NCT00666926|58714369|FG005|Overall Study|Lost to Follow-up|0|||
30699997|NCT00666926|58714370|FG006|Overall Study|Lost to Follow-up|0|||
30699998|NCT00666926|58714371|FG007|Overall Study|Lost to Follow-up|0|||
30699999|NCT00666926|58714372|FG008|Overall Study|Lost to Follow-up|0|||
30700000|NCT00666926|58714373|FG009|Overall Study|Lost to Follow-up|0|||
30700001|NCT00666926|58714374|FG010|Overall Study|Lost to Follow-up|0|||
30700002|NCT00666926|58714375|FG011|Overall Study|Lost to Follow-up|0|||
30700003|NCT00666926|58714376|FG012|Overall Study|Lost to Follow-up|0|||
30700004|NCT00666926|58714377|FG013|Overall Study|Lost to Follow-up|0|||
30700005|NCT00666926|58714378|FG014|Overall Study|Lost to Follow-up|0|||
30700006|NCT00666926|58714379|FG015|Overall Study|Lost to Follow-up|0|||
30700007|NCT00666926|58714364|FG000|Overall Study|Other|2|||
30700008|NCT00666926|58714365|FG001|Overall Study|Other|4|||
30700009|NCT00666926|58714366|FG002|Overall Study|Other|3|||
30700010|NCT00666926|58714367|FG003|Overall Study|Other|3|||
30700011|NCT00666926|58714368|FG004|Overall Study|Other|3|||
30700012|NCT00666926|58714369|FG005|Overall Study|Other|3|||
30700013|NCT00666926|58714370|FG006|Overall Study|Other|4|||
30700014|NCT00666926|58714371|FG007|Overall Study|Other|0|||
30700015|NCT00666926|58714372|FG008|Overall Study|Other|3|||
30700016|NCT00666926|58714373|FG009|Overall Study|Other|5|||
30700017|NCT00666926|58714374|FG010|Overall Study|Other|3|||
30700018|NCT00666926|58714375|FG011|Overall Study|Other|26|||
30700019|NCT00666926|58714376|FG012|Overall Study|Other|3|||
30700020|NCT00666926|58714377|FG013|Overall Study|Other|2|||
30700021|NCT00666926|58714378|FG014|Overall Study|Other|4|||
30700022|NCT00666926|58714379|FG015|Overall Study|Other|4|||
30700023|NCT00666926|58714364|FG000|Overall Study|Withdrawal by Subject|0|||
30700024|NCT00666926|58714365|FG001|Overall Study|Withdrawal by Subject|0|||
30700025|NCT00666926|58714366|FG002|Overall Study|Withdrawal by Subject|0|||
30700026|NCT00666926|58714367|FG003|Overall Study|Withdrawal by Subject|0|||
30700027|NCT00666926|58714368|FG004|Overall Study|Withdrawal by Subject|0|||
30700028|NCT00666926|58714369|FG005|Overall Study|Withdrawal by Subject|0|||
30700029|NCT00666926|58714370|FG006|Overall Study|Withdrawal by Subject|0|||
30700030|NCT00666926|58714371|FG007|Overall Study|Withdrawal by Subject|1|||
30700031|NCT00666926|58714372|FG008|Overall Study|Withdrawal by Subject|0|||
30700032|NCT00666926|58714373|FG009|Overall Study|Withdrawal by Subject|3|||
30700033|NCT00666926|58714374|FG010|Overall Study|Withdrawal by Subject|0|||
30700034|NCT00666926|58714375|FG011|Overall Study|Withdrawal by Subject|3|||
30700035|NCT00666926|58714376|FG012|Overall Study|Withdrawal by Subject|0|||
30700036|NCT00666926|58714377|FG013|Overall Study|Withdrawal by Subject|1|||
30700037|NCT00666926|58714378|FG014|Overall Study|Withdrawal by Subject|3|||
30700038|NCT00666926|58714379|FG015|Overall Study|Withdrawal by Subject|3|||
30700039|NCT00666926|58714364|FG000|Overall Study|Death|0|||
30700040|NCT00666926|58714365|FG001|Overall Study|Death|0|||
30700041|NCT00666926|58714366|FG002|Overall Study|Death|0|||
30700042|NCT00666926|58714367|FG003|Overall Study|Death|0|||
30700043|NCT00666926|58714368|FG004|Overall Study|Death|0|||
30700044|NCT00666926|58714369|FG005|Overall Study|Death|0|||
30619392|NCT01029795|58630292|FG000|Overall Study|Sponsor Decision|11|||
30700045|NCT00666926|58714370|FG006|Overall Study|Death|0|||
30700046|NCT00666926|58714371|FG007|Overall Study|Death|0|||
30700047|NCT00666926|58714372|FG008|Overall Study|Death|0|||
30619393|NCT01029795|58630293|FG001|Overall Study|Sponsor Decision|17|||
30619394|NCT01029795|58630292|FG000|Overall Study|Withdrawal by Subject|1|||
30619395|NCT01029795|58630293|FG001|Overall Study|Withdrawal by Subject|3|||
30619396|NCT01032837|58630303|FG000|Overall Study|Adverse event/internal illness|0|||
30619397|NCT01032837|58630304|FG001|Overall Study|Adverse event/internal illness|1|||
30619398|NCT01032837|58630305|FG002|Overall Study|Adverse event/internal illness|0|||
30619399|NCT01032837|58630306|FG003|Overall Study|Adverse event/internal illness|1|||
30619400|NCT01032837|58630303|FG000|Overall Study|Withdrew consent|0|||
30700048|NCT00666926|58714373|FG009|Overall Study|Death|0|||
30700049|NCT00666926|58714374|FG010|Overall Study|Death|0|||
30700050|NCT00666926|58714375|FG011|Overall Study|Death|1|||
30700051|NCT00666926|58714376|FG012|Overall Study|Death|0|||
30619401|NCT01032837|58630304|FG001|Overall Study|Withdrew consent|2|||
30700052|NCT00666926|58714377|FG013|Overall Study|Death|0|||
30619402|NCT01032837|58630305|FG002|Overall Study|Withdrew consent|0|||
30700053|NCT00666926|58714378|FG014|Overall Study|Death|0|||
30700054|NCT00666926|58714379|FG015|Overall Study|Death|0|||
30700055|NCT03861052|58714434|FG000|Overall Study|Adverse Event|1|||
30700056|NCT03861052|58714435|FG001|Overall Study|Adverse Event|1|||
30700057|NCT03861052|58714436|FG002|Overall Study|Adverse Event|2|||
30700058|NCT03861052|58714437|FG003|Overall Study|Adverse Event|4|||
30700059|NCT03861052|58714434|FG000|Overall Study|Lost to Follow-up|0|||
30700060|NCT03861052|58714435|FG001|Overall Study|Lost to Follow-up|0|||
30700061|NCT03861052|58714436|FG002|Overall Study|Lost to Follow-up|0|||
30700062|NCT03861052|58714437|FG003|Overall Study|Lost to Follow-up|1|||
30700063|NCT03861052|58714434|FG000|Overall Study|Physician Decision|0|||
30700064|NCT03861052|58714435|FG001|Overall Study|Physician Decision|1|||
30700065|NCT03861052|58714436|FG002|Overall Study|Physician Decision|0|||
30700066|NCT03861052|58714437|FG003|Overall Study|Physician Decision|0|||
30619403|NCT01032837|58630306|FG003|Overall Study|Withdrew consent|1|||
30619404|NCT01032837|58630303|FG000|Overall Study|Failed to return|0|||
30619405|NCT01032837|58630304|FG001|Overall Study|Failed to return|0|||
30619406|NCT01032837|58630305|FG002|Overall Study|Failed to return|1|||
30619407|NCT01032837|58630306|FG003|Overall Study|Failed to return|0|||
30619408|NCT01032837|58630303|FG000|Overall Study|Refused treatment|0|||
30619409|NCT01032837|58630304|FG001|Overall Study|Refused treatment|0|||
30700067|NCT03861052|58714434|FG000|Overall Study|Withdrawal by Subject|2|||
30700068|NCT03861052|58714435|FG001|Overall Study|Withdrawal by Subject|5|||
30700069|NCT03861052|58714436|FG002|Overall Study|Withdrawal by Subject|3|||
30700070|NCT03861052|58714437|FG003|Overall Study|Withdrawal by Subject|0|||
30700071|NCT03861052|58714434|FG000|Overall Study|Relocation to other city|1|||
30700072|NCT03861052|58714435|FG001|Overall Study|Relocation to other city|0|||
30700073|NCT03861052|58714436|FG002|Overall Study|Relocation to other city|0|||
30700074|NCT03861052|58714437|FG003|Overall Study|Relocation to other city|0|||
30700075|NCT00664742|58714452|FG000|Overall Study|Withdrawn due to adverse events|3|||
30700076|NCT00664742|58714452|FG000|Overall Study|Withdrawal by Subject|31|||
30700077|NCT00664742|58714452|FG000|Overall Study|Lost to Follow-up|92|||
30700078|NCT00511342|58714458|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
30700079|NCT00511342|58714459|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
30700080|NCT00511342|58714458|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
30700081|NCT00511342|58714459|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
30700082|NCT00511342|58714458|FG000|Overall Study|Pregnancy|0|||
30700083|NCT00511342|58714459|FG001|Overall Study|Pregnancy|1|||
30700084|NCT00511342|58714458|FG000|Overall Study|Pregnancy wish|0|||
30700085|NCT00511342|58714459|FG001|Overall Study|Pregnancy wish|1|||
30700086|NCT00511342|58714458|FG000|Overall Study|Lost to Follow-up|1|||
30700087|NCT00511342|58714459|FG001|Overall Study|Lost to Follow-up|5|||
30700088|NCT00511342|58714458|FG000|Overall Study|Other Reason|2|||
30700089|NCT00511342|58714459|FG001|Overall Study|Other Reason|2|||
30700090|NCT03931785|58714469|FG000|Overall Study|Lost to Follow-up|4|||
30893442|NCT02525861|58926930|FG000|Overall Study|Withdrawal by Subject|0|||
30893443|NCT02525861|58926931|FG001|Overall Study|Withdrawal by Subject|1|||
30893444|NCT02525861|58926930|FG000|Overall Study|Physician Decision|0|||
30893445|NCT02525861|58926931|FG001|Overall Study|Physician Decision|1|||
30893446|NCT02524847|58926939|FG000|Overall Study|Adverse Event|4|||
30893447|NCT02524847|58926939|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
30893448|NCT02524847|58926939|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
30893449|NCT02524847|58926939|FG000|Overall Study|Death|1|||
30700091|NCT03931785|58714470|FG001|Overall Study|Lost to Follow-up|1|||
30700092|NCT03931785|58714471|FG002|Overall Study|Lost to Follow-up|4|||
30700093|NCT03931785|58714472|FG003|Overall Study|Lost to Follow-up|3|||
30619410|NCT01032837|58630305|FG002|Overall Study|Refused treatment|0|||
30619411|NCT01032837|58630306|FG003|Overall Study|Refused treatment|1|||
30893450|NCT02524847|58926939|FG000|Overall Study|Reason not Specified|1|||
30619412|NCT01180296|58630318|FG000|Overall Study|Protocol Violation|1|||
30700094|NCT03931785|58714469|FG000|Overall Study|Adverse Event|1|||
30700095|NCT03931785|58714470|FG001|Overall Study|Adverse Event|0|||
30700096|NCT03931785|58714471|FG002|Overall Study|Adverse Event|3|||
30700097|NCT03931785|58714472|FG003|Overall Study|Adverse Event|4|||
30700098|NCT03931785|58714469|FG000|Overall Study|Protocol Violation|0|||
30700099|NCT03931785|58714470|FG001|Overall Study|Protocol Violation|1|||
30700100|NCT03931785|58714471|FG002|Overall Study|Protocol Violation|0|||
30700101|NCT03931785|58714472|FG003|Overall Study|Protocol Violation|0|||
30700102|NCT03931785|58714469|FG000|Overall Study|Noncompliance With Study drug|0|||
30700103|NCT03931785|58714470|FG001|Overall Study|Noncompliance With Study drug|1|||
30700104|NCT03931785|58714471|FG002|Overall Study|Noncompliance With Study drug|0|||
30700105|NCT03931785|58714472|FG003|Overall Study|Noncompliance With Study drug|0|||
30700106|NCT03931785|58714469|FG000|Overall Study|Other Not specified|0|||
30700107|NCT03931785|58714470|FG001|Overall Study|Other Not specified|2|||
30700108|NCT03931785|58714471|FG002|Overall Study|Other Not specified|2|||
30700109|NCT03931785|58714472|FG003|Overall Study|Other Not specified|2|||
30700110|NCT03931785|58714469|FG000|Overall Study|Withdrawal by Subject|0|||
30700111|NCT03931785|58714470|FG001|Overall Study|Withdrawal by Subject|2|||
30700112|NCT03931785|58714471|FG002|Overall Study|Withdrawal by Subject|4|||
30700113|NCT03931785|58714472|FG003|Overall Study|Withdrawal by Subject|1|||
30700114|NCT03931785|58714469|FG000|Overall Study|Pregnancy|0|||
30700115|NCT03931785|58714470|FG001|Overall Study|Pregnancy|0|||
30700116|NCT03931785|58714471|FG002|Overall Study|Pregnancy|0|||
30893451|NCT02525627|58926946|FG000|Overall Study|Revision|1|||
30893452|NCT02525627|58926947|FG001|Overall Study|Revision|1|||
30893453|NCT02525627|58926946|FG000|Overall Study|Withdrawal by Subject|1|||
30700117|NCT03931785|58714472|FG003|Overall Study|Pregnancy|1|||
30700118|NCT00666536|58714484|FG000|Overall Study|Adverse Event|9|||
30700119|NCT00666536|58714485|FG001|Overall Study|Adverse Event|19|||
30700120|NCT00666536|58714484|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30700121|NCT00666536|58714485|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30700122|NCT00666536|58714484|FG000|Overall Study|Protocol deviation(s)|8|||
30700123|NCT00666536|58714485|FG001|Overall Study|Protocol deviation(s)|6|||
30700124|NCT00666536|58714484|FG000|Overall Study|Withdrawal by Subject|10|||
30700125|NCT00666536|58714485|FG001|Overall Study|Withdrawal by Subject|9|||
30700126|NCT00666536|58714484|FG000|Overall Study|Lost to Follow-up|4|||
30700127|NCT00666536|58714485|FG001|Overall Study|Lost to Follow-up|3|||
30700128|NCT00519532|58714491|FG000|Overall Study|Adverse Event|11|||
30700129|NCT00519532|58714491|FG000|Overall Study|Withdrawal by Subject|5|||
30700130|NCT00519532|58714491|FG000|Overall Study|Lost to Follow-up|2|||
30700131|NCT00666458|58714497|FG000|Overall Study|Adverse Event|8|||
30700132|NCT00666458|58714498|FG001|Overall Study|Adverse Event|7|||
30700133|NCT00666458|58714497|FG000|Overall Study|Withdrawal by Subject|5|||
30700134|NCT00666458|58714498|FG001|Overall Study|Withdrawal by Subject|4|||
30700135|NCT00666458|58714497|FG000|Overall Study|Lost to Follow-up|0|||
30700136|NCT00666458|58714498|FG001|Overall Study|Lost to Follow-up|3|||
30700137|NCT00666458|58714497|FG000|Overall Study|Administrative reason by sponsor|1|||
30700138|NCT00666458|58714498|FG001|Overall Study|Administrative reason by sponsor|1|||
30700139|NCT00666458|58714497|FG000|Overall Study|Incorrect enrollment|7|||
30700140|NCT00666458|58714498|FG001|Overall Study|Incorrect enrollment|1|||
30893454|NCT02525627|58926947|FG001|Overall Study|Withdrawal by Subject|2|||
30619413|NCT01180296|58630319|FG001|Overall Study|Protocol Violation|2|||
30700141|NCT00666458|58714497|FG000|Overall Study|Study specific discontinuation criteria|14|||
30700142|NCT00666458|58714498|FG001|Overall Study|Study specific discontinuation criteria|7|||
30700143|NCT00666458|58714497|FG000|Overall Study|Severe non-compliance to the protocol|1|||
30700144|NCT00666458|58714498|FG001|Overall Study|Severe non-compliance to the protocol|1|||
30700145|NCT00666458|58714497|FG000|Overall Study|Safety reasons|1|||
30700146|NCT00666458|58714498|FG001|Overall Study|Safety reasons|0|||
30700147|NCT00666458|58714497|FG000|Overall Study|Medical history of anemia|1|||
30700148|NCT00666458|58714498|FG001|Overall Study|Medical history of anemia|0|||
30700149|NCT00511108|58714508|FG000|Overall Study|Adverse Event|2|||
30700150|NCT00511108|58714509|FG001|Overall Study|Adverse Event|0|||
30700151|NCT00511108|58714510|FG002|Overall Study|Adverse Event|1|||
30700152|NCT00511108|58714511|FG003|Overall Study|Adverse Event|2|||
30700153|NCT00511108|58714508|FG000|Overall Study|Lost to Follow-up|0|||
30700154|NCT00511108|58714509|FG001|Overall Study|Lost to Follow-up|2|||
30700155|NCT00511108|58714510|FG002|Overall Study|Lost to Follow-up|1|||
30700156|NCT00511108|58714511|FG003|Overall Study|Lost to Follow-up|0|||
30700157|NCT00511108|58714508|FG000|Overall Study|Physician Decision|0|||
30700158|NCT00511108|58714509|FG001|Overall Study|Physician Decision|0|||
30700159|NCT00511108|58714510|FG002|Overall Study|Physician Decision|0|||
30700160|NCT00511108|58714511|FG003|Overall Study|Physician Decision|1|||
30700161|NCT00511108|58714508|FG000|Overall Study|Withdrawal by Subject|4|||
30700162|NCT00511108|58714509|FG001|Overall Study|Withdrawal by Subject|0|||
30700163|NCT00511108|58714510|FG002|Overall Study|Withdrawal by Subject|3|||
30700164|NCT00511108|58714511|FG003|Overall Study|Withdrawal by Subject|2|||
30700165|NCT00510952|58714523|FG000|Overall Study|Adverse Event|1|||
30700166|NCT00510952|58714524|FG001|Overall Study|Adverse Event|0|||
30700167|NCT00510952|58714523|FG000|Overall Study|Entry Criteria Not Met|3|||
30700168|NCT00510952|58714524|FG001|Overall Study|Entry Criteria Not Met|1|||
30700169|NCT00510952|58714523|FG000|Overall Study|Lost to Follow-up|5|||
30700170|NCT00510952|58714524|FG001|Overall Study|Lost to Follow-up|3|||
30700171|NCT00510952|58714523|FG000|Overall Study|Physician Decision|1|||
30700172|NCT00510952|58714524|FG001|Overall Study|Physician Decision|1|||
30700173|NCT00510952|58714523|FG000|Overall Study|Protocol Violation|7|||
30700174|NCT00510952|58714524|FG001|Overall Study|Protocol Violation|4|||
30700175|NCT00510952|58714523|FG000|Overall Study|Sponsor Decision|1|||
30700176|NCT00510952|58714524|FG001|Overall Study|Sponsor Decision|0|||
30700177|NCT00510952|58714523|FG000|Overall Study|Withdrawal by Subject|6|||
30700178|NCT00510952|58714524|FG001|Overall Study|Withdrawal by Subject|7|||
30619414|NCT01160640|58630329|FG000|Overall Study|Physician Decision|3|||
30619415|NCT01160640|58630330|FG001|Overall Study|Physician Decision|3|||
30619416|NCT01160640|58630329|FG000|Overall Study|Incarceration|1|||
30619417|NCT01160640|58630330|FG001|Overall Study|Incarceration|0|||
30619418|NCT01160640|58630329|FG000|Overall Study|Withdrawal by Subject|0|||
30619419|NCT01160640|58630330|FG001|Overall Study|Withdrawal by Subject|3|||
30619420|NCT01160484|58630338|FG000|Overall Study|Lack of Efficacy|9|||
30619421|NCT01160484|58630338|FG000|Overall Study|Adverse Event|6|||
30619422|NCT01160484|58630338|FG000|Overall Study|Withdrawal by Subject|2|||
30700179|NCT00510952|58714523|FG000|Overall Study|Did Not Receive Study Drug|2|||
30700180|NCT00510952|58714524|FG001|Overall Study|Did Not Receive Study Drug|0|||
30700181|NCT00617604|58714532|FG000|Overall Study|Death|2|||
30700182|NCT00617604|58714533|FG001|Overall Study|Death|1|||
30619423|NCT01160484|58630338|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
30700183|NCT00617604|58714532|FG000|Overall Study|Lost to Follow-up|1|||
30619424|NCT01032291|58630345|FG000|Safety Lead-in|Adverse Event|1|||
30700184|NCT00617604|58714533|FG001|Overall Study|Lost to Follow-up|0|||
30700185|NCT00617604|58714532|FG000|Overall Study|Miscellaneous Reasons|8|||
30700186|NCT00617604|58714533|FG001|Overall Study|Miscellaneous Reasons|10|||
30700187|NCT00617604|58714532|FG000|Overall Study|Withdrawal by Subject|4|||
30700188|NCT00617604|58714533|FG001|Overall Study|Withdrawal by Subject|6|||
30700189|NCT00617604|58714532|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
30700190|NCT00617604|58714533|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
30700191|NCT00661622|58714541|FG000|Overall Study|Protocol Violation|1|||
30700192|NCT00661622|58714542|FG001|Overall Study|Protocol Violation|0|||
30700193|NCT04093752|58714553|FG000|Overall Study|Adverse Event|7|||
30700194|NCT04093752|58714554|FG001|Overall Study|Adverse Event|19|||
30700195|NCT04093752|58714555|FG002|Overall Study|Adverse Event|18|||
30700196|NCT04093752|58714556|FG003|Overall Study|Adverse Event|4|||
30700197|NCT04093752|58714553|FG000|Overall Study|Withdrawal by Subject|6|||
30700198|NCT04093752|58714554|FG001|Overall Study|Withdrawal by Subject|6|||
30700199|NCT04093752|58714555|FG002|Overall Study|Withdrawal by Subject|8|||
30700200|NCT04093752|58714556|FG003|Overall Study|Withdrawal by Subject|20|||
30700201|NCT04093752|58714553|FG000|Overall Study|Lost to Follow-up|2|||
30700202|NCT04093752|58714554|FG001|Overall Study|Lost to Follow-up|1|||
30700203|NCT04093752|58714555|FG002|Overall Study|Lost to Follow-up|1|||
30700204|NCT04093752|58714556|FG003|Overall Study|Lost to Follow-up|1|||
30700205|NCT04093752|58714553|FG000|Overall Study|Death|0|||
30700206|NCT04093752|58714554|FG001|Overall Study|Death|0|||
30700207|NCT04093752|58714555|FG002|Overall Study|Death|1|||
30700208|NCT04093752|58714556|FG003|Overall Study|Death|2|||
30700209|NCT04093752|58714553|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
30700210|NCT04093752|58714554|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
30700211|NCT04093752|58714555|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
30700212|NCT04093752|58714556|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
30700213|NCT04093752|58714553|FG000|Overall Study|Covid 19|0|||
30700214|NCT04093752|58714554|FG001|Overall Study|Covid 19|0|||
30700215|NCT04093752|58714555|FG002|Overall Study|Covid 19|0|||
30700216|NCT04093752|58714556|FG003|Overall Study|Covid 19|1|||
30700217|NCT04093752|58714553|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
30700218|NCT04093752|58714554|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
30700219|NCT04093752|58714555|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
30700220|NCT04093752|58714556|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
30700221|NCT04093752|58714553|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
30700222|NCT04093752|58714554|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
30700223|NCT04093752|58714555|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
30700224|NCT04093752|58714556|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
30700225|NCT04093752|58714553|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
30700226|NCT04093752|58714554|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
30700227|NCT04093752|58714555|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
30893455|NCT02525627|58926946|FG000|Overall Study|Death|1|||
30700228|NCT04093752|58714556|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
30700229|NCT03928821|58714574|FG000|Overall Study|Death|0|||
30700230|NCT03928821|58714575|FG001|Overall Study|Death|1|||
30700231|NCT03928821|58714576|FG002|Overall Study|Death|0|||
30700232|NCT03928821|58714577|FG003|Overall Study|Death|0|||
30700233|NCT03928821|58714574|FG000|Overall Study|Lost to Follow-up|0|||
30700234|NCT03928821|58714575|FG001|Overall Study|Lost to Follow-up|2|||
30700235|NCT03928821|58714576|FG002|Overall Study|Lost to Follow-up|3|||
30700236|NCT03928821|58714577|FG003|Overall Study|Lost to Follow-up|0|||
30700237|NCT03928821|58714574|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
30700238|NCT03928821|58714575|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
30700239|NCT03928821|58714576|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
30700240|NCT03928821|58714577|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
30700241|NCT00666224|58714589|FG000|Double-Blind|Adverse Event|15|||
30700242|NCT00666224|58714590|FG001|Double-Blind|Adverse Event|5|||
30700243|NCT00666224|58714589|FG000|Double-Blind|Lost to Follow-up|2|||
30700244|NCT00666224|58714590|FG001|Double-Blind|Lost to Follow-up|2|||
30700245|NCT00666224|58714589|FG000|Double-Blind|Withdrawal by Subject|18|||
30700246|NCT00666224|58714590|FG001|Double-Blind|Withdrawal by Subject|14|||
30619425|NCT01032291|58630346|FG001|Safety Lead-in|Adverse Event|0|||
30700247|NCT00666224|58714589|FG000|Double-Blind|Physician Decision|0|||
30700248|NCT00666224|58714590|FG001|Double-Blind|Physician Decision|3|||
30700249|NCT00666224|58714589|FG000|Double-Blind|Sponsor decision|1|||
30700250|NCT00666224|58714590|FG001|Double-Blind|Sponsor decision|0|||
30700251|NCT00666224|58714589|FG000|Double-Blind|Pregnancy|3|||
30700252|NCT00666224|58714590|FG001|Double-Blind|Pregnancy|2|||
30700253|NCT00666224|58714589|FG000|Double-Blind|Noncompliance|1|||
30700254|NCT00666224|58714590|FG001|Double-Blind|Noncompliance|0|||
30700255|NCT00666224|58714589|FG000|Double-Blind|Death|1|||
30700256|NCT00666224|58714590|FG001|Double-Blind|Death|0|||
30700257|NCT00666224|58714589|FG000|Double-Blind|Undefined/Unknown|4|||
30700258|NCT00666224|58714590|FG001|Double-Blind|Undefined/Unknown|1|||
30700259|NCT00666224|58714589|FG000|Open-Label|Adverse Event|8|||
30700260|NCT00666224|58714590|FG001|Open-Label|Adverse Event|43|||
30700261|NCT00666224|58714589|FG000|Open-Label|Lost to Follow-up|4|||
30700262|NCT00666224|58714590|FG001|Open-Label|Lost to Follow-up|5|||
30700263|NCT00666224|58714589|FG000|Open-Label|Withdrawal by Subject|12|||
30700264|NCT00666224|58714590|FG001|Open-Label|Withdrawal by Subject|25|||
30700265|NCT00666224|58714589|FG000|Open-Label|Physician Decision|7|||
30700266|NCT00666224|58714590|FG001|Open-Label|Physician Decision|5|||
30893456|NCT02525627|58926947|FG001|Overall Study|Death|0|||
30893457|NCT02525627|58926946|FG000|Overall Study|Site terminated|11|||
30619426|NCT01032291|58630347|FG002|Safety Lead-in|Adverse Event|0|||
30619427|NCT01032291|58630345|FG000|Safety Lead-in|Death|1|||
30619428|NCT01032291|58630346|FG001|Safety Lead-in|Death|0|||
30619429|NCT01032291|58630347|FG002|Safety Lead-in|Death|0|||
30619430|NCT01032291|58630345|FG000|Proof of Concept|Adverse Event|0|||
30619431|NCT01032291|58630346|FG001|Proof of Concept|Adverse Event|5|||
30619432|NCT01032291|58630347|FG002|Proof of Concept|Adverse Event|1|||
30700267|NCT00666224|58714589|FG000|Open-Label|Pregnancy|1|||
30700268|NCT00666224|58714590|FG001|Open-Label|Pregnancy|5|||
30700269|NCT00666224|58714589|FG000|Open-Label|Noncompliance|2|||
30619433|NCT01032291|58630345|FG000|Proof of Concept|Death|0|||
30619434|NCT01032291|58630346|FG001|Proof of Concept|Death|1|||
30700270|NCT00666224|58714590|FG001|Open-Label|Noncompliance|1|||
30700271|NCT00666224|58714589|FG000|Open-Label|Undefined/Unknown|1|||
30700272|NCT00666224|58714590|FG001|Open-Label|Undefined/Unknown|1|||
30700273|NCT00663962|58714599|FG000|Overall Study|somnolence|1|||
30700274|NCT00663962|58714600|FG001|Overall Study|somnolence|0|||
30700275|NCT00265759|58714612|FG000|Overall Study|Withdrawal by Subject|0|||
30700276|NCT00265759|58714613|FG001|Overall Study|Withdrawal by Subject|1|||
30700277|NCT00265759|58714614|FG002|Overall Study|Withdrawal by Subject|2|||
30700278|NCT00265759|58714615|FG003|Overall Study|Withdrawal by Subject|2|||
30700279|NCT00265759|58714612|FG000|Overall Study|Cancel|0|||
30700280|NCT00265759|58714613|FG001|Overall Study|Cancel|0|||
30700281|NCT00265759|58714614|FG002|Overall Study|Cancel|0|||
30700282|NCT00265759|58714615|FG003|Overall Study|Cancel|3|||
30700283|NCT00265759|58714612|FG000|Overall Study|Ineligible|0|||
30700284|NCT00265759|58714613|FG001|Overall Study|Ineligible|0|||
30700285|NCT00265759|58714614|FG002|Overall Study|Ineligible|0|||
30700286|NCT00265759|58714615|FG003|Overall Study|Ineligible|1|||
30700287|NCT00265759|58714612|FG000|Overall Study|Bilateral disease|0|||
30700288|NCT00265759|58714613|FG001|Overall Study|Bilateral disease|0|||
30700289|NCT00265759|58714614|FG002|Overall Study|Bilateral disease|0|||
30619435|NCT01032291|58630347|FG002|Proof of Concept|Death|2|||
30619436|NCT01032291|58630345|FG000|Proof of Concept|Lack of Efficacy|0|||
30619437|NCT01032291|58630346|FG001|Proof of Concept|Lack of Efficacy|1|||
30619438|NCT01032291|58630347|FG002|Proof of Concept|Lack of Efficacy|0|||
30619439|NCT01032291|58630345|FG000|Proof of Concept|Never Received Study Drug|0|||
30619440|NCT01032291|58630346|FG001|Proof of Concept|Never Received Study Drug|1|||
30619441|NCT01032291|58630347|FG002|Proof of Concept|Never Received Study Drug|0|||
30619442|NCT01159938|58630361|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
30619443|NCT01159938|58630362|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
30619444|NCT01159938|58630363|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
30619445|NCT01159938|58630364|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
30619446|NCT01159938|58630365|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
30619447|NCT01029405|58630390|FG000|Overall Study|Withdrawal by Subject|0|||
30619448|NCT01029405|58630391|FG001|Overall Study|Withdrawal by Subject|1|||
30619449|NCT01029405|58630392|FG002|Overall Study|Withdrawal by Subject|2|||
30700290|NCT00265759|58714615|FG003|Overall Study|Bilateral disease|2|||
30700291|NCT00265759|58714612|FG000|Overall Study|Discontinued due to intolerability|0|||
30700292|NCT00265759|58714613|FG001|Overall Study|Discontinued due to intolerability|0|||
30700293|NCT00265759|58714614|FG002|Overall Study|Discontinued due to intolerability|0|||
30700294|NCT00265759|58714615|FG003|Overall Study|Discontinued due to intolerability|1|||
30700295|NCT00744263|58714628|FG000|Overall Study|Death|3006|||
30700296|NCT00744263|58714629|FG001|Overall Study|Death|3005|||
30700297|NCT00744263|58714628|FG000|Overall Study|Lost to Follow-up|2038|||
30700298|NCT00744263|58714629|FG001|Overall Study|Lost to Follow-up|2135|||
30700299|NCT00744263|58714628|FG000|Overall Study|Withdrawal by Subject|166|||
30700300|NCT00744263|58714629|FG001|Overall Study|Withdrawal by Subject|150|||
30700301|NCT00744263|58714628|FG000|Overall Study|Physician Decision|20|||
30619450|NCT01029405|58630393|FG003|Overall Study|Withdrawal by Subject|0|||
30619451|NCT01029405|58630390|FG000|Overall Study|Protocol Violation|0|||
30619452|NCT01029405|58630391|FG001|Overall Study|Protocol Violation|0|||
30619453|NCT01029405|58630392|FG002|Overall Study|Protocol Violation|0|||
30893458|NCT02525627|58926947|FG001|Overall Study|Site terminated|10|||
30893459|NCT02129205|58926963|FG000|Overall Study|Withdrawal by Subject|0|||
30893460|NCT02129205|58926964|FG001|Overall Study|Withdrawal by Subject|0|||
30893461|NCT02129205|58926965|FG002|Overall Study|Withdrawal by Subject|0|||
30893462|NCT02129205|58926966|FG003|Overall Study|Withdrawal by Subject|0|||
30893463|NCT02129205|58926967|FG004|Overall Study|Withdrawal by Subject|1|||
30893464|NCT02129205|58926968|FG005|Overall Study|Withdrawal by Subject|1|||
30893465|NCT02129205|58926969|FG006|Overall Study|Withdrawal by Subject|1|||
30893466|NCT02129205|58926970|FG007|Overall Study|Withdrawal by Subject|0|||
30893467|NCT02129205|58926971|FG008|Overall Study|Withdrawal by Subject|1|||
30893468|NCT02129205|58926972|FG009|Overall Study|Withdrawal by Subject|0|||
30619454|NCT01029405|58630393|FG003|Overall Study|Protocol Violation|1|||
30893469|NCT02129205|58926963|FG000|Overall Study|Other|1|||
30893470|NCT02129205|58926964|FG001|Overall Study|Other|0|||
30893471|NCT02129205|58926965|FG002|Overall Study|Other|0|||
30893472|NCT02129205|58926966|FG003|Overall Study|Other|0|||
30893473|NCT02129205|58926967|FG004|Overall Study|Other|2|||
30893474|NCT02129205|58926968|FG005|Overall Study|Other|3|||
30893475|NCT02129205|58926969|FG006|Overall Study|Other|3|||
30893476|NCT02129205|58926970|FG007|Overall Study|Other|2|||
30893477|NCT02129205|58926971|FG008|Overall Study|Other|1|||
30893478|NCT02129205|58926972|FG009|Overall Study|Other|0|||
30893479|NCT02128269|58926996|FG000|Treatment Period|Adverse Event|1|||
30893480|NCT02128269|58926996|FG000|Treatment Period|Physician Decision|1|||
30893481|NCT01626885|58927000|FG000|Overall Study|Adverse Event|8|||
30893482|NCT01626885|58927000|FG000|Overall Study|Withdrawal by Subject|4|||
30619455|NCT01029405|58630390|FG000|Overall Study|Adverse Event|0|||
30893483|NCT02524379|58927004|FG000|Overall Study|Death|1|||
30893484|NCT02524145|58927011|FG000|Overall Study|Withdrawal by Subject|2|||
30619456|NCT01029405|58630391|FG001|Overall Study|Adverse Event|0|||
30619457|NCT01029405|58630392|FG002|Overall Study|Adverse Event|1|||
30619458|NCT01029405|58630393|FG003|Overall Study|Adverse Event|1|||
30619459|NCT01029405|58630390|FG000|Overall Study|Lost to Follow-up|2|||
30619460|NCT01029405|58630391|FG001|Overall Study|Lost to Follow-up|1|||
30619461|NCT01029405|58630392|FG002|Overall Study|Lost to Follow-up|1|||
30619462|NCT01029405|58630393|FG003|Overall Study|Lost to Follow-up|2|||
30619463|NCT01029405|58630390|FG000|Overall Study|Other|0|||
30619464|NCT01029405|58630391|FG001|Overall Study|Other|1|||
30893485|NCT02524145|58927012|FG001|Overall Study|Withdrawal by Subject|2|||
30619465|NCT01029405|58630392|FG002|Overall Study|Other|0|||
30619466|NCT01029405|58630393|FG003|Overall Study|Other|1|||
30893486|NCT02524145|58927013|FG002|Overall Study|Withdrawal by Subject|3|||
30893487|NCT01658813|58927021|FG000|Overall Study|Disease progression|3|||
30893488|NCT02187471|58927033|FG000|Overall Study|Protocol Violation|4|||
30893489|NCT02187471|58927034|FG001|Overall Study|Protocol Violation|5|||
30893490|NCT02187471|58927035|FG002|Overall Study|Protocol Violation|4|||
30893491|NCT02187471|58927036|FG003|Overall Study|Protocol Violation|4|||
30893492|NCT02187471|58927033|FG000|Overall Study|Missing|0|||
30893493|NCT02187471|58927034|FG001|Overall Study|Missing|0|||
30619467|NCT01021683|58630403|FG000|Overall Study|Lack of Efficacy|12|||
30619468|NCT01021683|58630403|FG000|Overall Study|Recovery of neutrophil count|51|||
30619469|NCT01021683|58630403|FG000|Overall Study|Other|8|||
30619470|NCT01021293|58630409|FG000|Overall Study|Serious Adverse Event|2|||
30619471|NCT01021293|58630410|FG001|Overall Study|Serious Adverse Event|1|||
30619472|NCT01021293|58630409|FG000|Overall Study|Adverse Event|2|||
30619473|NCT01021293|58630410|FG001|Overall Study|Adverse Event|1|||
30619474|NCT01021293|58630409|FG000|Overall Study|Withdrawal by Subject|1|||
30619475|NCT01021293|58630410|FG001|Overall Study|Withdrawal by Subject|3|||
30619476|NCT01021293|58630409|FG000|Overall Study|Migrated/moved from study area|6|||
30893494|NCT02187471|58927035|FG002|Overall Study|Missing|0|||
30619477|NCT01021293|58630410|FG001|Overall Study|Migrated/moved from study area|18|||
30619478|NCT01021293|58630409|FG000|Overall Study|Lost to Follow-up|1|||
30619479|NCT01021293|58630410|FG001|Overall Study|Lost to Follow-up|1|||
30619480|NCT04625725|58630419|FG000|Overall Study|Death|4|||
30619481|NCT04625725|58630420|FG001|Overall Study|Death|4|||
30619482|NCT04625725|58630419|FG000|Overall Study|Lost to Follow-up|11|||
30619483|NCT04625725|58630420|FG001|Overall Study|Lost to Follow-up|8|||
30619484|NCT04625725|58630419|FG000|Overall Study|Physician Decision|1|||
30619485|NCT04625725|58630420|FG001|Overall Study|Physician Decision|0|||
30700302|NCT00744263|58714629|FG001|Overall Study|Physician Decision|23|||
30700303|NCT00744263|58714628|FG000|Overall Study|Protocol Violation|3|||
30700304|NCT00744263|58714629|FG001|Overall Study|Protocol Violation|5|||
30700305|NCT00744263|58714628|FG000|Overall Study|Adverse Event|1|||
30700306|NCT00744263|58714629|FG001|Overall Study|Adverse Event|0|||
30700307|NCT00744263|58714628|FG000|Overall Study|Other|2|||
30700308|NCT00744263|58714629|FG001|Overall Study|Other|2|||
30700309|NCT00618774|58714639|FG000|Overall Study|Adverse Event|5|||
30700310|NCT00618774|58714640|FG001|Overall Study|Adverse Event|3|||
30700311|NCT00618774|58714639|FG000|Overall Study|Withdrawal by Subject|1|||
30700312|NCT00618774|58714640|FG001|Overall Study|Withdrawal by Subject|0|||
30700313|NCT00545571|58714646|FG000|Overall Study|Administrative Reasons|1|||
30700314|NCT00545571|58714646|FG000|Overall Study|Adverse Event|2|||
30700315|NCT00545571|58714646|FG000|Overall Study|Death|5|||
30619486|NCT04625725|58630419|FG000|Overall Study|Withdrawal by Subject|56|||
30619487|NCT04625725|58630420|FG001|Overall Study|Withdrawal by Subject|32|||
30619488|NCT04625725|58630419|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|18|||
30619489|NCT04625725|58630420|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|10|||
30619490|NCT04625725|58630419|FG000|Overall Study|Ongoing in study|3409|||
30619491|NCT04625725|58630420|FG001|Overall Study|Ongoing in study|1700|||
30619492|NCT04625725|58630419|FG000|Overall Study|Protocol Deviation|1|||
30619493|NCT04625725|58630420|FG001|Overall Study|Protocol Deviation|0|||
30619494|NCT01021215|58630428|FG000|Overall Study|Lost to Follow-up|3|||
30619495|NCT01021215|58630429|FG001|Overall Study|Lost to Follow-up|0|||
30619496|NCT01021137|58630439|FG000|Overall Study|Lost to Follow-up|9|||
30619497|NCT01021137|58630440|FG001|Overall Study|Lost to Follow-up|4|||
30619498|NCT01021137|58630441|FG002|Overall Study|Lost to Follow-up|2|||
30619499|NCT01021137|58630442|FG003|Overall Study|Lost to Follow-up|6|||
30619500|NCT01021137|58630439|FG000|Overall Study|Withdrawal by Subject|1|||
30619501|NCT01021137|58630440|FG001|Overall Study|Withdrawal by Subject|0|||
30619502|NCT01021137|58630441|FG002|Overall Study|Withdrawal by Subject|0|||
30619503|NCT01021137|58630442|FG003|Overall Study|Withdrawal by Subject|3|||
30619504|NCT01020981|58630455|FG000|Overall Study|Did not return mailed survey|74|||
30619505|NCT01020981|58630456|FG001|Overall Study|Did not return mailed survey|58|||
30619506|NCT01020981|58630455|FG000|Overall Study|Survey returned undeliverable|8|||
30619507|NCT01020981|58630456|FG001|Overall Study|Survey returned undeliverable|32|||
30619508|NCT01020981|58630455|FG000|Overall Study|Participant declined to complete survey|2|||
30619509|NCT01020981|58630456|FG001|Overall Study|Participant declined to complete survey|0|||
30619510|NCT01020747|58630464|FG000|Overall Study|Withdrawal by Subject|1|||
30619511|NCT01020435|58630471|FG000|Overall Study|Lost to Follow-up|0|||
30619512|NCT01020435|58630472|FG001|Overall Study|Lost to Follow-up|1|||
30700316|NCT00545571|58714646|FG000|Overall Study|Lack of Efficacy|1|||
30700317|NCT00545571|58714646|FG000|Overall Study|Protocol Violation|2|||
30619513|NCT01031979|58630481|FG000|Overall Study|Lost to Follow-up|5|||
30619514|NCT01031979|58630482|FG001|Overall Study|Lost to Follow-up|4|||
30619515|NCT01020123|58630495|FG000|Main Period|Withdrawal by Subject|6|||
30700318|NCT00545571|58714646|FG000|Overall Study|Refused Treatment|1|||
30619516|NCT01020123|58630496|FG001|Main Period|Withdrawal by Subject|5|||
30619517|NCT01020123|58630497|FG002|Main Period|Withdrawal by Subject|3|||
30619518|NCT01020123|58630498|FG003|Main Period|Withdrawal by Subject|1|||
30619519|NCT01020123|58630499|FG004|Main Period|Withdrawal by Subject|6|||
30619520|NCT01020123|58630500|FG005|Main Period|Withdrawal by Subject|3|||
30619521|NCT01020123|58630501|FG006|Main Period|Withdrawal by Subject|2|||
30619522|NCT01020123|58630495|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
30619523|NCT01020123|58630496|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
30619524|NCT01020123|58630497|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
30619525|NCT01020123|58630498|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
30619526|NCT01020123|58630499|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
30619527|NCT01020123|58630500|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
30619528|NCT01020123|58630501|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
30619529|NCT01020123|58630495|FG000|Main Period|Adverse Event|5|||
30619530|NCT01020123|58630496|FG001|Main Period|Adverse Event|2|||
30619531|NCT01020123|58630497|FG002|Main Period|Adverse Event|2|||
30619532|NCT01020123|58630498|FG003|Main Period|Adverse Event|1|||
30619533|NCT01020123|58630499|FG004|Main Period|Adverse Event|1|||
30619534|NCT01020123|58630500|FG005|Main Period|Adverse Event|2|||
30619535|NCT01020123|58630501|FG006|Main Period|Adverse Event|1|||
30619536|NCT01020123|58630495|FG000|Main Period|Protocol Violation|4|||
30619537|NCT01020123|58630496|FG001|Main Period|Protocol Violation|4|||
30619538|NCT01020123|58630497|FG002|Main Period|Protocol Violation|2|||
30619539|NCT01020123|58630498|FG003|Main Period|Protocol Violation|5|||
30619540|NCT01020123|58630499|FG004|Main Period|Protocol Violation|2|||
30619541|NCT01020123|58630500|FG005|Main Period|Protocol Violation|3|||
30700319|NCT00545571|58714646|FG000|Overall Study|Screen Failure|16|||
30619542|NCT01020123|58630501|FG006|Main Period|Protocol Violation|2|||
30619543|NCT01020123|58630495|FG000|Main Period|Lost to Follow-up|0|||
30619544|NCT01020123|58630496|FG001|Main Period|Lost to Follow-up|2|||
30619545|NCT01020123|58630497|FG002|Main Period|Lost to Follow-up|0|||
30700320|NCT00545571|58714646|FG000|Overall Study|Transfusion|12|||
30700321|NCT00545571|58714646|FG000|Overall Study|Early Termination of Study|24|||
30700322|NCT00545571|58714646|FG000|Overall Study|Kidney Transplantation|3|||
30700323|NCT00748709|58714650|FG000|Overall Study|Progressive disease|15|||
30700324|NCT00748709|58714650|FG000|Overall Study|Drug reducing Toxity|2|||
30700325|NCT00748709|58714650|FG000|Overall Study|Other Adverse Event|1|||
30700326|NCT00748709|58714650|FG000|Overall Study|Withdrawal by Subject|1|||
30700327|NCT00748709|58714650|FG000|Overall Study|Other Reasons|1|||
30700328|NCT00263887|58714656|FG000|Overall Study|Withdrawal by Subject|1|||
30700329|NCT00263887|58714657|FG001|Overall Study|Withdrawal by Subject|1|||
30700330|NCT00263887|58714656|FG000|Overall Study|Lung transplantation|1|||
30700331|NCT00263887|58714657|FG001|Overall Study|Lung transplantation|2|||
30700332|NCT00263887|58714656|FG000|Overall Study|Too ill to attend visit|1|||
30700333|NCT00263887|58714657|FG001|Overall Study|Too ill to attend visit|0|||
30700334|NCT00263887|58714656|FG000|Overall Study|Adverse Event|0|||
30700335|NCT00263887|58714657|FG001|Overall Study|Adverse Event|2|||
30700336|NCT00263887|58714656|FG000|Overall Study|Disease progression|0|||
30700337|NCT00263887|58714657|FG001|Overall Study|Disease progression|1|||
30700338|NCT00263887|58714656|FG000|Overall Study|Lack of Efficacy|0|||
30700339|NCT00263887|58714657|FG001|Overall Study|Lack of Efficacy|1|||
30700340|NCT00748553|58714665|FG000|Overall Study|Adverse Event|0|||
30700341|NCT00748553|58714666|FG001|Overall Study|Adverse Event|1|||
30700342|NCT00748553|58714665|FG000|Overall Study|disease progression|2|||
30700343|NCT00748553|58714666|FG001|Overall Study|disease progression|0|||
30700344|NCT00748553|58714665|FG000|Overall Study|noncompliance|1|||
30700345|NCT00748553|58714666|FG001|Overall Study|noncompliance|0|||
30700346|NCT00661388|58714671|FG000|Overall Study|Adverse Event|14|||
30700347|NCT00661388|58714671|FG000|Overall Study|Protocol Violation|7|||
30700348|NCT00661388|58714671|FG000|Overall Study|Renal transplantation|1|||
30700349|NCT00661388|58714671|FG000|Overall Study|Dialysis initiation|1|||
30700350|NCT00661388|58714671|FG000|Overall Study|Administrative reasons|1|||
30700351|NCT00743483|58714675|FG000|Baseline Period|Physician Decision|1|||
30700352|NCT00743483|58714675|FG000|Treatment Period|Adverse Event|1|||
30700353|NCT00263575|58714679|FG000|Titration Period|Adverse Event|14|||
30700354|NCT00263575|58714679|FG000|Titration Period|Withdrawal by Subject|10|||
30700355|NCT00263575|58714679|FG000|Titration Period|Protocol Violation|9|||
30700356|NCT00263575|58714679|FG000|Titration Period|Sponsor Decision|2|||
30700357|NCT00263575|58714679|FG000|Titration Period|Other|2|||
30700358|NCT00263575|58714679|FG000|Titration Period|Lack of Efficacy|6|||
30619546|NCT01020123|58630498|FG003|Main Period|Lost to Follow-up|0|||
30619547|NCT01020123|58630499|FG004|Main Period|Lost to Follow-up|0|||
30700359|NCT00263575|58714679|FG000|Maintence Period|Adverse Event|23|||
30700360|NCT00263575|58714679|FG000|Maintence Period|Withdrawal by Subject|8|||
30700361|NCT00263575|58714679|FG000|Maintence Period|Protocol Violation|4|||
30700362|NCT00263575|58714679|FG000|Maintence Period|Lack of Efficacy|4|||
30700363|NCT00263575|58714679|FG000|Maintence Period|Physician Decision|6|||
30700364|NCT00263575|58714679|FG000|Maintence Period|Lost to Follow-up|1|||
30700365|NCT00263575|58714679|FG000|Maintence Period|Sponsor Decision|24|||
30700366|NCT00263575|58714679|FG000|Maintence Period|Other|7|||
30619548|NCT01020123|58630500|FG005|Main Period|Lost to Follow-up|0|||
30619549|NCT01020123|58630501|FG006|Main Period|Lost to Follow-up|0|||
30619550|NCT01020123|58630495|FG000|Main Period|Unclasified|2|||
30619551|NCT01020123|58630496|FG001|Main Period|Unclasified|0|||
30619552|NCT01020123|58630497|FG002|Main Period|Unclasified|1|||
30619553|NCT01020123|58630498|FG003|Main Period|Unclasified|0|||
30700367|NCT00748241|58714685|FG000|Overall Study|Implant failure|1|||
30619554|NCT01020123|58630499|FG004|Main Period|Unclasified|1|||
30619555|NCT01020123|58630500|FG005|Main Period|Unclasified|3|||
30619556|NCT01020123|58630501|FG006|Main Period|Unclasified|6|||
30700368|NCT00748241|58714685|FG000|Overall Study|Lost to Follow-up|5|||
30700369|NCT00748241|58714685|FG000|Overall Study|Death|2|||
30700370|NCT00570128|58714691|FG000|Overall Study|Adverse Event|1|||
30700371|NCT00570128|58714692|FG001|Overall Study|Adverse Event|0|||
30700372|NCT00570128|58714691|FG000|Overall Study|Lost to Follow-up|1|||
30893495|NCT02187471|58927036|FG003|Overall Study|Missing|1|||
30893496|NCT02187471|58927033|FG000|Overall Study|Lack of Efficacy|18|||
30893497|NCT02187471|58927034|FG001|Overall Study|Lack of Efficacy|9|||
30893498|NCT02187471|58927035|FG002|Overall Study|Lack of Efficacy|13|||
30893499|NCT02187471|58927036|FG003|Overall Study|Lack of Efficacy|11|||
30893500|NCT02187471|58927033|FG000|Overall Study|Adverse Event|24|||
30893501|NCT02187471|58927034|FG001|Overall Study|Adverse Event|34|||
30893502|NCT02187471|58927035|FG002|Overall Study|Adverse Event|44|||
30893503|NCT02187471|58927036|FG003|Overall Study|Adverse Event|36|||
30893504|NCT02187471|58927033|FG000|Overall Study|Withdrawal by Subject|23|||
30893505|NCT02187471|58927034|FG001|Overall Study|Withdrawal by Subject|29|||
30619557|NCT01020123|58630495|FG000|Extention Period|Withdrawal by Subject|2|||
30619558|NCT01020123|58630496|FG001|Extention Period|Withdrawal by Subject|1|||
30619559|NCT01020123|58630497|FG002|Extention Period|Withdrawal by Subject|1|||
30619560|NCT01020123|58630498|FG003|Extention Period|Withdrawal by Subject|0|||
30619561|NCT01020123|58630499|FG004|Extention Period|Withdrawal by Subject|0|||
30619562|NCT01020123|58630500|FG005|Extention Period|Withdrawal by Subject|0|||
30619563|NCT01020123|58630501|FG006|Extention Period|Withdrawal by Subject|0|||
30619564|NCT01020123|58630495|FG000|Extention Period|Adverse Event|0|||
30619565|NCT01020123|58630496|FG001|Extention Period|Adverse Event|0|||
30619566|NCT01020123|58630497|FG002|Extention Period|Adverse Event|0|||
30619567|NCT01020123|58630498|FG003|Extention Period|Adverse Event|1|||
30619568|NCT01020123|58630499|FG004|Extention Period|Adverse Event|0|||
30619569|NCT01020123|58630500|FG005|Extention Period|Adverse Event|0|||
30619570|NCT01020123|58630501|FG006|Extention Period|Adverse Event|0|||
30619571|NCT01020123|58630495|FG000|Extention Period|Protocol Violation|1|||
30893506|NCT02187471|58927035|FG002|Overall Study|Withdrawal by Subject|22|||
30893507|NCT02187471|58927036|FG003|Overall Study|Withdrawal by Subject|24|||
30700373|NCT00570128|58714692|FG001|Overall Study|Lost to Follow-up|0|||
30700374|NCT00570128|58714691|FG000|Overall Study|Withdrawal by Subject|2|||
30700375|NCT00570128|58714692|FG001|Overall Study|Withdrawal by Subject|0|||
30700376|NCT00743249|58714700|FG000|Overall Study|Adverse Event|0|||
30700377|NCT00743249|58714701|FG001|Overall Study|Adverse Event|4|||
30700378|NCT00743249|58714700|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
30700379|NCT00743249|58714701|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
30700380|NCT00743249|58714700|FG000|Overall Study|Unsuccessful insertion of stent|2|||
30700381|NCT00743249|58714701|FG001|Overall Study|Unsuccessful insertion of stent|1|||
30700382|NCT00262951|58714707|FG000|Overall Study|Progressive disease/relapse|3|||
30700383|NCT00262951|58714707|FG000|Overall Study|Adverse Event|7|||
30700384|NCT00262951|58714707|FG000|Overall Study|Death|1|||
30700385|NCT00262951|58714707|FG000|Overall Study|Withdrawal by Subject|1|||
30700386|NCT00262951|58714707|FG000|Overall Study|Alternative treatment|3|||
30700387|NCT00262951|58714707|FG000|Overall Study|Off treatment for other disease|1|||
30700388|NCT00262873|58714711|FG000|Overall Study|Adverse Event|3|||
30700389|NCT00262873|58714711|FG000|Overall Study|Withdrawal by Subject|5|||
30700390|NCT00573534|58714715|FG000|Overall Study|oppositional behavior|3|||
30700391|NCT00260533|58714722|FG000|Overall Study|Other|3|||
30700392|NCT00260533|58714723|FG001|Overall Study|Other|3|||
30700393|NCT03945981|58714729|FG000|Overall Study|Lost to Follow-up|12|||
30700394|NCT03945981|58714729|FG000|Overall Study|Physician Decision|4|||
30700395|NCT03945981|58714729|FG000|Overall Study|Withdrawal by Subject|6|||
30700396|NCT03945981|58714729|FG000|Overall Study|Protocol Violation|1|||
30700397|NCT00745901|58714756|FG000|Overall Study|Adverse Event|3|||
30700398|NCT00745901|58714757|FG001|Overall Study|Adverse Event|4|||
30619572|NCT01020123|58630496|FG001|Extention Period|Protocol Violation|1|||
30619573|NCT01020123|58630497|FG002|Extention Period|Protocol Violation|1|||
30619574|NCT01020123|58630498|FG003|Extention Period|Protocol Violation|0|||
30619575|NCT01020123|58630499|FG004|Extention Period|Protocol Violation|0|||
30619576|NCT01020123|58630500|FG005|Extention Period|Protocol Violation|0|||
30619577|NCT01020123|58630501|FG006|Extention Period|Protocol Violation|1|||
30619578|NCT01020123|58630495|FG000|Extention Period|Lost to Follow-up|0|||
30619579|NCT01020123|58630496|FG001|Extention Period|Lost to Follow-up|0|||
30619580|NCT01020123|58630497|FG002|Extention Period|Lost to Follow-up|0|||
30619581|NCT01020123|58630498|FG003|Extention Period|Lost to Follow-up|0|||
30619582|NCT01020123|58630499|FG004|Extention Period|Lost to Follow-up|0|||
30619583|NCT01020123|58630500|FG005|Extention Period|Lost to Follow-up|2|||
30619584|NCT01020123|58630501|FG006|Extention Period|Lost to Follow-up|0|||
30619585|NCT01028391|58630542|FG000|Overall Study|Adverse Event|4|||
30619586|NCT01028391|58630543|FG001|Overall Study|Adverse Event|0|||
30619587|NCT01028391|58630542|FG000|Overall Study|Lack of Efficacy|0|||
30619588|NCT01028391|58630543|FG001|Overall Study|Lack of Efficacy|2|||
30619589|NCT01028391|58630542|FG000|Overall Study|Lost to Follow-up|3|||
30619590|NCT01028391|58630543|FG001|Overall Study|Lost to Follow-up|4|||
30619591|NCT01028391|58630542|FG000|Overall Study|Physician Decision|0|||
30619592|NCT01028391|58630543|FG001|Overall Study|Physician Decision|1|||
30619593|NCT01028391|58630542|FG000|Overall Study|Withdrawal by Subject|6|||
30619594|NCT01028391|58630543|FG001|Overall Study|Withdrawal by Subject|3|||
30619595|NCT01028391|58630542|FG000|Overall Study|Needed excluded medication|1|||
30700399|NCT00745901|58714756|FG000|Overall Study|Protocol Violation|0|||
30700400|NCT00745901|58714757|FG001|Overall Study|Protocol Violation|1|||
30700401|NCT00745901|58714756|FG000|Overall Study|Withdrawal by Subject|1|||
30700402|NCT00745901|58714757|FG001|Overall Study|Withdrawal by Subject|0|||
30700403|NCT00745901|58714756|FG000|Overall Study|Lost to Follow-up|7|||
30700404|NCT00745901|58714757|FG001|Overall Study|Lost to Follow-up|4|||
30700405|NCT00745901|58714756|FG000|Overall Study|Pregnancy|2|||
30619596|NCT01028391|58630543|FG001|Overall Study|Needed excluded medication|1|||
30619597|NCT01179672|58630551|FG000|Overall Study|Adverse Event|17|||
30619598|NCT01179672|58630552|FG001|Overall Study|Adverse Event|8|||
30700406|NCT00745901|58714757|FG001|Overall Study|Pregnancy|4|||
30619599|NCT01179672|58630551|FG000|Overall Study|Withdrawal by Subject|10|||
30700407|NCT00745901|58714756|FG000|Overall Study|Lack of compliance|2|||
30700408|NCT00745901|58714757|FG001|Overall Study|Lack of compliance|2|||
30700409|NCT00745901|58714756|FG000|Overall Study|Patient's next menses did not start with|1|||
30700410|NCT00745901|58714757|FG001|Overall Study|Patient's next menses did not start with|0|||
30700411|NCT00745901|58714756|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
30700412|NCT00745901|58714757|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
30700413|NCT00745901|58714756|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
30700414|NCT00745901|58714757|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
30700415|NCT00745901|58714756|FG000|Overall Study|Patient didn't take any study medication|7|||
30619600|NCT01179672|58630552|FG001|Overall Study|Withdrawal by Subject|12|||
30619601|NCT01179672|58630551|FG000|Overall Study|Entry Criteria Not Met|0|||
30619602|NCT01179672|58630552|FG001|Overall Study|Entry Criteria Not Met|2|||
30619603|NCT01179672|58630551|FG000|Overall Study|Lost to Follow-up|0|||
30619604|NCT01179672|58630552|FG001|Overall Study|Lost to Follow-up|1|||
30619605|NCT01179672|58630551|FG000|Overall Study|Protocol Violation|2|||
30619606|NCT01179672|58630552|FG001|Overall Study|Protocol Violation|2|||
30619607|NCT01179672|58630551|FG000|Overall Study|Physician Decision|1|||
30619608|NCT01179672|58630552|FG001|Overall Study|Physician Decision|1|||
30619609|NCT01030965|58630566|FG000|Overall Study|Lack of Efficacy|3|||
30619610|NCT01030965|58630567|FG001|Overall Study|Lack of Efficacy|2|||
30619611|NCT01030965|58630568|FG002|Overall Study|Lack of Efficacy|0|||
30619612|NCT01030965|58630569|FG003|Overall Study|Lack of Efficacy|3|||
30619613|NCT01030965|58630566|FG000|Overall Study|Protocol Violation|1|||
30619614|NCT01030965|58630567|FG001|Overall Study|Protocol Violation|1|||
30619615|NCT01030965|58630568|FG002|Overall Study|Protocol Violation|1|||
30619616|NCT01030965|58630569|FG003|Overall Study|Protocol Violation|1|||
30700416|NCT00745901|58714757|FG001|Overall Study|Patient didn't take any study medication|3|||
30700417|NCT00286429|58714766|FG000|Overall Study|Adverse Event|4|||
30619617|NCT01030965|58630566|FG000|Overall Study|Adverse Event|0|||
30619618|NCT01030965|58630567|FG001|Overall Study|Adverse Event|1|||
30893508|NCT02187471|58927033|FG000|Overall Study|Other|7|||
30893509|NCT02187471|58927034|FG001|Overall Study|Other|5|||
30893510|NCT02187471|58927035|FG002|Overall Study|Other|3|||
30893511|NCT02187471|58927036|FG003|Overall Study|Other|4|||
30893512|NCT02525471|58927047|FG000|Overall Study|Screen Failure|6|||
30893513|NCT02525471|58927047|FG000|Overall Study|Withdrawal by Subject|4|||
30893514|NCT02525471|58927047|FG000|Overall Study|Death|1|||
30893515|NCT01658735|58927055|FG000|Overall Study|Lack of Efficacy|1|||
30893516|NCT01658735|58927056|FG001|Overall Study|Lack of Efficacy|0|||
30893517|NCT01658735|58927057|FG002|Overall Study|Lack of Efficacy|1|||
30893518|NCT01658735|58927055|FG000|Overall Study|Lost to Follow-up|1|||
30893519|NCT01658735|58927056|FG001|Overall Study|Lost to Follow-up|1|||
30893520|NCT01658735|58927057|FG002|Overall Study|Lost to Follow-up|0|||
30893521|NCT01658735|58927055|FG000|Overall Study|Protocol Violation|0|||
30893522|NCT01658735|58927056|FG001|Overall Study|Protocol Violation|1|||
30893523|NCT01658735|58927057|FG002|Overall Study|Protocol Violation|0|||
30893524|NCT01658735|58927055|FG000|Overall Study|Withdrawal by Subject|3|||
30893525|NCT01658735|58927056|FG001|Overall Study|Withdrawal by Subject|5|||
30893526|NCT01658735|58927057|FG002|Overall Study|Withdrawal by Subject|3|||
30893527|NCT02523599|58927067|FG000|Overall Study|Adverse Event|1|||
30893528|NCT02523599|58927068|FG001|Overall Study|Adverse Event|0|||
30893529|NCT02523599|58927067|FG000|Overall Study|Physician Decision|1|||
30893530|NCT02523599|58927068|FG001|Overall Study|Physician Decision|0|||
30893531|NCT02523599|58927067|FG000|Overall Study|Lost to Follow-up|4|||
30893532|NCT02523599|58927068|FG001|Overall Study|Lost to Follow-up|1|||
30893533|NCT02523599|58927067|FG000|Overall Study|Did not return for Day 30 visit|2|||
30893534|NCT02523599|58927068|FG001|Overall Study|Did not return for Day 30 visit|0|||
30893535|NCT02187159|58927078|FG000|Overall Study|Protocol Violation|4|||
30893536|NCT02187159|58927079|FG001|Overall Study|Protocol Violation|6|||
30893537|NCT02187159|58927080|FG002|Overall Study|Protocol Violation|3|||
30893538|NCT02187159|58927081|FG003|Overall Study|Protocol Violation|4|||
30893539|NCT02187159|58927078|FG000|Overall Study|Lack of Efficacy|10|||
30893540|NCT02187159|58927079|FG001|Overall Study|Lack of Efficacy|5|||
30893541|NCT02187159|58927080|FG002|Overall Study|Lack of Efficacy|4|||
30893542|NCT02187159|58927081|FG003|Overall Study|Lack of Efficacy|7|||
30893543|NCT02187159|58927078|FG000|Overall Study|Adverse Event|28|||
30893544|NCT02187159|58927079|FG001|Overall Study|Adverse Event|33|||
30893545|NCT02187159|58927080|FG002|Overall Study|Adverse Event|42|||
30893546|NCT02187159|58927081|FG003|Overall Study|Adverse Event|50|||
30893547|NCT02187159|58927078|FG000|Overall Study|Withdrawal by Subject|24|||
30893548|NCT02187159|58927079|FG001|Overall Study|Withdrawal by Subject|28|||
30893549|NCT02187159|58927080|FG002|Overall Study|Withdrawal by Subject|25|||
30893550|NCT02187159|58927081|FG003|Overall Study|Withdrawal by Subject|26|||
30893551|NCT02187159|58927078|FG000|Overall Study|Other|3|||
30893552|NCT02187159|58927079|FG001|Overall Study|Other|7|||
30893553|NCT02187159|58927080|FG002|Overall Study|Other|3|||
30893554|NCT02187159|58927081|FG003|Overall Study|Other|9|||
30893555|NCT02335411|58927094|FG000|Overall Study|Death|223|||
30893556|NCT02335411|58927095|FG001|Overall Study|Death|22|||
30893557|NCT02335411|58927096|FG002|Overall Study|Death|26|||
30893558|NCT02335411|58927094|FG000|Overall Study|Physician Decision|3|||
30893559|NCT02335411|58927095|FG001|Overall Study|Physician Decision|0|||
30893560|NCT02335411|58927096|FG002|Overall Study|Physician Decision|0|||
30893561|NCT02335411|58927094|FG000|Overall Study|Protocol Violation|1|||
30893562|NCT02335411|58927095|FG001|Overall Study|Protocol Violation|0|||
30893563|NCT02335411|58927096|FG002|Overall Study|Protocol Violation|0|||
30893564|NCT02335411|58927094|FG000|Overall Study|Withdrawal by Subject|11|||
30893565|NCT02335411|58927095|FG001|Overall Study|Withdrawal by Subject|0|||
30893566|NCT02335411|58927096|FG002|Overall Study|Withdrawal by Subject|3|||
30893567|NCT02335411|58927094|FG000|Overall Study|Sponsor Decision|12|||
30893568|NCT02335411|58927095|FG001|Overall Study|Sponsor Decision|3|||
30893569|NCT02335411|58927096|FG002|Overall Study|Sponsor Decision|2|||
30893570|NCT02335411|58927094|FG000|Overall Study|Adverse Event|9|||
30893571|NCT02335411|58927095|FG001|Overall Study|Adverse Event|0|||
30893572|NCT02335411|58927096|FG002|Overall Study|Adverse Event|0|||
30893573|NCT02186301|58927110|FG000|Overall Study|Progressive Disease|7|||
30893574|NCT02186301|58927111|FG001|Overall Study|Progressive Disease|22|||
30893575|NCT02186301|58927112|FG002|Overall Study|Progressive Disease|27|||
30893576|NCT02186301|58927110|FG000|Overall Study|Adverse Event|5|||
30893577|NCT02186301|58927111|FG001|Overall Study|Adverse Event|5|||
30893578|NCT02186301|58927112|FG002|Overall Study|Adverse Event|5|||
30893579|NCT02186301|58927110|FG000|Overall Study|Death|1|||
30893580|NCT02186301|58927111|FG001|Overall Study|Death|0|||
30893581|NCT02186301|58927112|FG002|Overall Study|Death|0|||
30893582|NCT02186301|58927110|FG000|Overall Study|Withdrawal by Subject|5|||
30893583|NCT02186301|58927111|FG001|Overall Study|Withdrawal by Subject|1|||
30893584|NCT02186301|58927112|FG002|Overall Study|Withdrawal by Subject|3|||
30893585|NCT02186301|58927110|FG000|Overall Study|Physician Decision|1|||
30700418|NCT00286429|58714767|FG001|Overall Study|Adverse Event|1|||
30619619|NCT01030965|58630568|FG002|Overall Study|Adverse Event|2|||
30619620|NCT01030965|58630569|FG003|Overall Study|Adverse Event|1|||
30619621|NCT01030965|58630566|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
30619622|NCT01030965|58630567|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
30619623|NCT01030965|58630568|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
30619624|NCT01030965|58630569|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
30619625|NCT01030965|58630566|FG000|Overall Study|Withdrawal by Subject|0|||
30700419|NCT00286429|58714768|FG002|Overall Study|Adverse Event|6|||
30700420|NCT00286429|58714766|FG000|Overall Study|Lack of Efficacy|52|||
30893586|NCT02186301|58927111|FG001|Overall Study|Physician Decision|0|||
30619626|NCT01030965|58630567|FG001|Overall Study|Withdrawal by Subject|1|||
30700421|NCT00286429|58714767|FG001|Overall Study|Lack of Efficacy|27|||
30700422|NCT00286429|58714768|FG002|Overall Study|Lack of Efficacy|25|||
30700423|NCT00286429|58714766|FG000|Overall Study|Lost to Follow-up|2|||
30700424|NCT00286429|58714767|FG001|Overall Study|Lost to Follow-up|4|||
30700425|NCT00286429|58714768|FG002|Overall Study|Lost to Follow-up|3|||
30700426|NCT00286429|58714766|FG000|Overall Study|Physician Decision|10|||
30700427|NCT00286429|58714767|FG001|Overall Study|Physician Decision|7|||
30700428|NCT00286429|58714768|FG002|Overall Study|Physician Decision|7|||
30700429|NCT00286429|58714766|FG000|Overall Study|Protocol Violation|3|||
30700430|NCT00286429|58714767|FG001|Overall Study|Protocol Violation|5|||
30700431|NCT00286429|58714768|FG002|Overall Study|Protocol Violation|4|||
30700432|NCT00286429|58714766|FG000|Overall Study|Withdrawal by Subject|3|||
30700433|NCT00286429|58714767|FG001|Overall Study|Withdrawal by Subject|2|||
30700434|NCT00286429|58714768|FG002|Overall Study|Withdrawal by Subject|6|||
30700435|NCT00286429|58714766|FG000|Overall Study|Administrative Error|1|||
30700436|NCT00286429|58714767|FG001|Overall Study|Administrative Error|1|||
30700437|NCT00286429|58714768|FG002|Overall Study|Administrative Error|1|||
30700438|NCT00286429|58714766|FG000|Overall Study|Administrative Decision|0|||
30700439|NCT00286429|58714767|FG001|Overall Study|Administrative Decision|1|||
30700440|NCT00286429|58714768|FG002|Overall Study|Administrative Decision|0|||
30700441|NCT00665444|58714776|FG000|Overall Study|Physician Decision|1|||
30700442|NCT00665444|58714776|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
30700443|NCT03926169|58714783|FG000|Period A|Adverse Event|2|||
30700444|NCT03926169|58714784|FG001|Period A|Adverse Event|2|||
30700445|NCT03926169|58714785|FG002|Period A|Adverse Event|1|||
30700446|NCT03926169|58714783|FG000|Period A|Withdrawal by Subject|2|||
30700447|NCT03926169|58714784|FG001|Period A|Withdrawal by Subject|2|||
30700448|NCT03926169|58714785|FG002|Period A|Withdrawal by Subject|2|||
30700449|NCT03926169|58714783|FG000|Period A|Lost to Follow-up|3|||
30700450|NCT03926169|58714784|FG001|Period A|Lost to Follow-up|1|||
30700451|NCT03926169|58714785|FG002|Period A|Lost to Follow-up|0|||
30700452|NCT03926169|58714783|FG000|Period A|Lack of Efficacy|0|||
30700453|NCT03926169|58714784|FG001|Period A|Lack of Efficacy|2|||
30700454|NCT03926169|58714785|FG002|Period A|Lack of Efficacy|2|||
30700455|NCT03926169|58714783|FG000|Period A|COVID-19 Infection|0|||
30700456|NCT03926169|58714784|FG001|Period A|COVID-19 Infection|1|||
30700457|NCT03926169|58714785|FG002|Period A|COVID-19 Infection|0|||
30700458|NCT03926169|58714783|FG000|Period A|COVID-19 Logistical Restrictions|0|||
30700459|NCT03926169|58714784|FG001|Period A|COVID-19 Logistical Restrictions|2|||
30700460|NCT03926169|58714785|FG002|Period A|COVID-19 Logistical Restrictions|1|||
30700461|NCT03926169|58714783|FG000|Period A|Other, Not Specified|1|||
30700462|NCT03926169|58714784|FG001|Period A|Other, Not Specified|0|||
30700463|NCT03926169|58714785|FG002|Period A|Other, Not Specified|0|||
30700464|NCT03926169|58714783|FG000|Period B|Adverse Event|3|||
30700465|NCT03926169|58714784|FG001|Period B|Adverse Event|1|||
30790847|NCT03524092|58803944|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
30619627|NCT01030965|58630568|FG002|Overall Study|Withdrawal by Subject|0|||
30619628|NCT01030965|58630569|FG003|Overall Study|Withdrawal by Subject|2|||
30619629|NCT01179516|58630582|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
30619630|NCT01179516|58630583|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
30619631|NCT01179516|58630584|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
30619632|NCT01179516|58630582|FG000|Overall Study|Lack of Efficacy|4|||
30619633|NCT01179516|58630583|FG001|Overall Study|Lack of Efficacy|2|||
30619634|NCT01179516|58630584|FG002|Overall Study|Lack of Efficacy|0|||
30700466|NCT03926169|58714785|FG002|Period B|Adverse Event|1|||
30700467|NCT03926169|58714783|FG000|Period B|Withdrawal by Subject|1|||
30700468|NCT03926169|58714784|FG001|Period B|Withdrawal by Subject|3|||
30700469|NCT03926169|58714785|FG002|Period B|Withdrawal by Subject|0|||
30700470|NCT03926169|58714783|FG000|Period B|Lack of Efficacy|3|||
30700471|NCT03926169|58714784|FG001|Period B|Lack of Efficacy|1|||
30700472|NCT03926169|58714785|FG002|Period B|Lack of Efficacy|1|||
30700473|NCT03926169|58714783|FG000|Period B|Lost to Follow-up|1|||
30700474|NCT03926169|58714784|FG001|Period B|Lost to Follow-up|1|||
30700475|NCT03926169|58714785|FG002|Period B|Lost to Follow-up|4|||
30619635|NCT01179516|58630582|FG000|Overall Study|Noncompliance with Study Drug|2|||
30619636|NCT01179516|58630583|FG001|Overall Study|Noncompliance with Study Drug|0|||
30619637|NCT01179516|58630584|FG002|Overall Study|Noncompliance with Study Drug|1|||
30619638|NCT01179516|58630582|FG000|Overall Study|Protocol Deviations|4|||
30619639|NCT01179516|58630583|FG001|Overall Study|Protocol Deviations|3|||
30619640|NCT01179516|58630584|FG002|Overall Study|Protocol Deviations|3|||
30619641|NCT01179516|58630582|FG000|Overall Study|Withdrawal of Consent|2|||
30619642|NCT01179516|58630583|FG001|Overall Study|Withdrawal of Consent|6|||
30619643|NCT01179516|58630584|FG002|Overall Study|Withdrawal of Consent|10|||
30619644|NCT01179516|58630582|FG000|Overall Study|Lost to Follow-up|7|||
30619645|NCT01179516|58630583|FG001|Overall Study|Lost to Follow-up|7|||
30700476|NCT03926169|58714783|FG000|Period B|Other, Not Specified|62|||
30700477|NCT03926169|58714784|FG001|Period B|Other, Not Specified|57|||
30700478|NCT03926169|58714785|FG002|Period B|Other, Not Specified|65|||
30700479|NCT00285649|58714799|FG000|Overall Study|Lost to Follow-up|6|||
30700480|NCT00285649|58714800|FG001|Overall Study|Lost to Follow-up|4|||
30619646|NCT01179516|58630584|FG002|Overall Study|Lost to Follow-up|3|||
30700481|NCT00285649|58714801|FG002|Overall Study|Lost to Follow-up|4|||
30700482|NCT00285649|58714799|FG000|Overall Study|Withdrawal by Subject|3|||
30700483|NCT00285649|58714800|FG001|Overall Study|Withdrawal by Subject|2|||
30700484|NCT00285649|58714801|FG002|Overall Study|Withdrawal by Subject|2|||
30700485|NCT00745823|58714811|FG000|Overall Study|Adverse Event|5|||
30700486|NCT00745823|58714812|FG001|Overall Study|Adverse Event|3|||
30700487|NCT00745823|58714811|FG000|Overall Study|Lack of Efficacy|20|||
30700488|NCT00745823|58714812|FG001|Overall Study|Lack of Efficacy|6|||
30700489|NCT00745823|58714811|FG000|Overall Study|Lost to Follow-up|10|||
30700490|NCT00745823|58714812|FG001|Overall Study|Lost to Follow-up|11|||
30700491|NCT00745823|58714811|FG000|Overall Study|Physician Decision|10|||
30700492|NCT00745823|58714812|FG001|Overall Study|Physician Decision|5|||
30700493|NCT00745823|58714811|FG000|Overall Study|Pregnancy|0|||
30700494|NCT00745823|58714812|FG001|Overall Study|Pregnancy|4|||
30700495|NCT00745823|58714811|FG000|Overall Study|Withdrawal by Subject|14|||
30700496|NCT00745823|58714812|FG001|Overall Study|Withdrawal by Subject|8|||
30700497|NCT00745823|58714811|FG000|Overall Study|Study Terminated by Sponsor|326|||
30700498|NCT00745823|58714812|FG001|Overall Study|Study Terminated by Sponsor|349|||
30700499|NCT00663260|58714823|FG000|Overall Study|Lack of Efficacy|2|||
30700500|NCT00663260|58714824|FG001|Overall Study|Lack of Efficacy|0|||
30700501|NCT00663260|58714825|FG002|Overall Study|Lack of Efficacy|0|||
30700502|NCT00663260|58714823|FG000|Overall Study|Adverse Event|12|||
30700503|NCT00663260|58714824|FG001|Overall Study|Adverse Event|7|||
30700504|NCT00663260|58714825|FG002|Overall Study|Adverse Event|6|||
30700505|NCT00663260|58714823|FG000|Overall Study|Withdrawal by Subject|3|||
30700506|NCT00663260|58714824|FG001|Overall Study|Withdrawal by Subject|1|||
30700507|NCT00663260|58714825|FG002|Overall Study|Withdrawal by Subject|6|||
30700508|NCT00663260|58714823|FG000|Overall Study|Death|1|||
30700509|NCT00663260|58714824|FG001|Overall Study|Death|0|||
30700510|NCT00663260|58714825|FG002|Overall Study|Death|1|||
30700511|NCT00663260|58714823|FG000|Overall Study|Lost to Follow-up|0|||
30700512|NCT00663260|58714824|FG001|Overall Study|Lost to Follow-up|1|||
30700513|NCT00663260|58714825|FG002|Overall Study|Lost to Follow-up|0|||
30700514|NCT00663260|58714823|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
30700515|NCT00663260|58714824|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
30700516|NCT00663260|58714825|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
30700517|NCT00740597|58714833|FG000|Overall Study|insurance would not cover treatment|1|||
30700518|NCT00284089|58714841|FG000|Multiple Dose Phase|Adverse Event|1|||
30700519|NCT00284089|58714842|FG001|Multiple Dose Phase|Adverse Event|0|||
30700520|NCT00284089|58714843|FG002|Multiple Dose Phase|Adverse Event|1|||
30700521|NCT00284089|58714844|FG003|Multiple Dose Phase|Adverse Event|1|||
30700522|NCT00284089|58714841|FG000|Multiple Dose Phase|Protocol Violation|0|||
30700523|NCT00284089|58714842|FG001|Multiple Dose Phase|Protocol Violation|0|||
30700524|NCT00284089|58714843|FG002|Multiple Dose Phase|Protocol Violation|1|||
30700525|NCT00284089|58714844|FG003|Multiple Dose Phase|Protocol Violation|0|||
30700526|NCT00284089|58714841|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
30700527|NCT00284089|58714842|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
30700528|NCT00284089|58714843|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
30700529|NCT00284089|58714844|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
30700530|NCT00284089|58714841|FG000|Multiple Dose Phase|Death|0|||
30700531|NCT00284089|58714842|FG001|Multiple Dose Phase|Death|0|||
30700532|NCT00284089|58714843|FG002|Multiple Dose Phase|Death|1|||
30700533|NCT00284089|58714844|FG003|Multiple Dose Phase|Death|1|||
30700534|NCT00284089|58714841|FG000|Extension Phase|Adverse Event|0|||
30700535|NCT00284089|58714842|FG001|Extension Phase|Adverse Event|0|||
30700536|NCT00284089|58714843|FG002|Extension Phase|Adverse Event|2|||
30700537|NCT00284089|58714844|FG003|Extension Phase|Adverse Event|2|||
30700538|NCT00284089|58714841|FG000|Extension Phase|condition no longer requires study drug|2|||
30700539|NCT00284089|58714842|FG001|Extension Phase|condition no longer requires study drug|0|||
30700540|NCT00284089|58714843|FG002|Extension Phase|condition no longer requires study drug|2|||
30700541|NCT00284089|58714844|FG003|Extension Phase|condition no longer requires study drug|7|||
30700542|NCT00284089|58714841|FG000|Extension Phase|Protocol Violation|0|||
30700543|NCT00284089|58714842|FG001|Extension Phase|Protocol Violation|0|||
30700544|NCT00284089|58714843|FG002|Extension Phase|Protocol Violation|1|||
30700545|NCT00284089|58714844|FG003|Extension Phase|Protocol Violation|0|||
30700546|NCT00284089|58714841|FG000|Extension Phase|Withdrawal by Subject|0|||
30700547|NCT00284089|58714842|FG001|Extension Phase|Withdrawal by Subject|0|||
30700548|NCT00284089|58714843|FG002|Extension Phase|Withdrawal by Subject|1|||
30893587|NCT02186301|58927112|FG002|Overall Study|Physician Decision|1|||
30619647|NCT01179516|58630582|FG000|Overall Study|Other|2|||
30619648|NCT01179516|58630583|FG001|Overall Study|Other|0|||
30619649|NCT01179516|58630584|FG002|Overall Study|Other|2|||
30619650|NCT01018953|58630592|FG000|Overall Study|Adverse Event|2|||
30619651|NCT01018953|58630592|FG000|Overall Study|Withdrawal by Subject|1|||
30619652|NCT01018953|58630592|FG000|Overall Study|Study termination by sponsor|5|||
30619653|NCT01158924|58630599|FG000|Overall Study|Withdrawal by Subject|1|||
30700549|NCT00284089|58714844|FG003|Extension Phase|Withdrawal by Subject|3|||
30700550|NCT00659984|58714854|FG000|Overall Study|Adverse Event|1|||
30700551|NCT00283387|58714868|FG000|First Intervention|Subject non-compliant|1|||
30700552|NCT00283387|58714869|FG001|First Intervention|Subject non-compliant|1|||
30700553|NCT00283387|58714868|FG000|First Intervention|Withdrawal by Subject|0|||
30700554|NCT00283387|58714869|FG001|First Intervention|Withdrawal by Subject|1|||
30700555|NCT00282919|58714875|FG000|Overall Study|Lack of Efficacy|4|||
30700556|NCT00282919|58714875|FG000|Overall Study|Withdrawal by Subject|1|||
30700557|NCT00282919|58714875|FG000|Overall Study|Asymptomatic Parasitemia|2|||
30700558|NCT00282295|58714882|FG000|Overall Study|Adverse Event|0|||
30700559|NCT00282295|58714883|FG001|Overall Study|Adverse Event|1|||
30700560|NCT00282295|58714884|FG002|Overall Study|Adverse Event|0|||
30700561|NCT00282295|58714882|FG000|Overall Study|Serious Adverse Events|0|||
30700562|NCT00282295|58714883|FG001|Overall Study|Serious Adverse Events|0|||
30700563|NCT00282295|58714884|FG002|Overall Study|Serious Adverse Events|1|||
30700564|NCT00282295|58714882|FG000|Overall Study|Protocol Violation|0|||
30700565|NCT00282295|58714883|FG001|Overall Study|Protocol Violation|2|||
30700566|NCT00282295|58714884|FG002|Overall Study|Protocol Violation|1|||
30700567|NCT00282295|58714882|FG000|Overall Study|Withdrawal by Subject|2|||
30700568|NCT00282295|58714883|FG001|Overall Study|Withdrawal by Subject|6|||
30700569|NCT00282295|58714884|FG002|Overall Study|Withdrawal by Subject|4|||
30700570|NCT00282295|58714882|FG000|Overall Study|Lost to Follow-up|1|||
30700571|NCT00282295|58714883|FG001|Overall Study|Lost to Follow-up|7|||
30700572|NCT00282295|58714884|FG002|Overall Study|Lost to Follow-up|2|||
30700573|NCT00282295|58714882|FG000|Overall Study|Other|0|||
30619654|NCT01158924|58630600|FG001|Overall Study|Withdrawal by Subject|2|||
30619655|NCT01158924|58630599|FG000|Overall Study|Lost to Follow-up|0|||
30619656|NCT01158924|58630600|FG001|Overall Study|Lost to Follow-up|1|||
30619657|NCT01027845|58630608|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
30619658|NCT01027845|58630609|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
30619659|NCT01027845|58630610|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
30619660|NCT01027845|58630611|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
30619661|NCT01027845|58630608|FG000|Primary Vaccination Phase|Adverse Event|1|||
30700574|NCT00282295|58714883|FG001|Overall Study|Other|1|||
30700575|NCT00282295|58714884|FG002|Overall Study|Other|0|||
30893588|NCT02186301|58927110|FG000|Overall Study|Study Terminated by Sponsor|1|||
30619662|NCT01027845|58630609|FG001|Primary Vaccination Phase|Adverse Event|0|||
30700576|NCT00742781|58714897|FG000|Overall Study|Withdrawal by Subject|3|||
30619663|NCT01027845|58630610|FG002|Primary Vaccination Phase|Adverse Event|0|||
30700577|NCT00663026|58714905|FG000|Overall Study|Lost to Follow-up|1|||
30619664|NCT01027845|58630611|FG003|Primary Vaccination Phase|Adverse Event|0|||
30619665|NCT01027845|58630608|FG000|Primary Vaccination Phase|Protocol Violation|1|||
30619666|NCT01027845|58630609|FG001|Primary Vaccination Phase|Protocol Violation|0|||
30619667|NCT01027845|58630610|FG002|Primary Vaccination Phase|Protocol Violation|0|||
30619668|NCT01027845|58630611|FG003|Primary Vaccination Phase|Protocol Violation|0|||
30619669|NCT01027845|58630608|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
30619670|NCT01027845|58630609|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
30619671|NCT01027845|58630610|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
30700578|NCT00663026|58714906|FG001|Overall Study|Lost to Follow-up|0|||
30700579|NCT00663026|58714907|FG002|Overall Study|Lost to Follow-up|0|||
30700580|NCT00663026|58714905|FG000|Overall Study|Other|1|||
30700581|NCT00663026|58714906|FG001|Overall Study|Other|2|||
30700582|NCT00663026|58714907|FG002|Overall Study|Other|0|||
30700583|NCT00663026|58714905|FG000|Overall Study|Adverse Event|0|||
30700584|NCT00663026|58714906|FG001|Overall Study|Adverse Event|2|||
30700585|NCT00663026|58714907|FG002|Overall Study|Adverse Event|3|||
30700586|NCT00663026|58714905|FG000|Overall Study|Caregiver Request|0|||
30700587|NCT00663026|58714906|FG001|Overall Study|Caregiver Request|2|||
30700588|NCT00663026|58714907|FG002|Overall Study|Caregiver Request|0|||
30700589|NCT00663026|58714905|FG000|Overall Study|Withdrawal by Subject|0|||
30700590|NCT00663026|58714906|FG001|Overall Study|Withdrawal by Subject|0|||
30700591|NCT00663026|58714907|FG002|Overall Study|Withdrawal by Subject|1|||
30700592|NCT00280735|58714917|FG000|Overall Study|Adverse Event|5|||
30700593|NCT00280735|58714917|FG000|Overall Study|Lack of Efficacy|3|||
30700594|NCT00280735|58714917|FG000|Overall Study|Withdrawal by Subject|8|||
30700595|NCT00280735|58714917|FG000|Overall Study|Intercurrent Illness|2|||
30700596|NCT00260065|58714925|FG000|Overall Study|Progressive Disease|22|||
30700597|NCT00260065|58714925|FG000|Overall Study|Adverse Event|17|||
30700598|NCT00260065|58714925|FG000|Overall Study|Death|13|||
30700599|NCT00260065|58714925|FG000|Overall Study|Withdrawal by Subject|13|||
30700600|NCT00260065|58714925|FG000|Overall Study|Physician Decision|19|||
30700601|NCT00260065|58714925|FG000|Overall Study|Not otherwise specified|8|||
30700602|NCT00260065|58714925|FG000|Overall Study|Medication Noncompliance|1|||
30700603|NCT00506350|58714938|FG000|Overall Study|Serious Adverse Event|1|||
30700604|NCT00506350|58714939|FG001|Overall Study|Serious Adverse Event|0|||
30700605|NCT00506350|58714940|FG002|Overall Study|Serious Adverse Event|0|||
30700606|NCT00506350|58714941|FG003|Overall Study|Serious Adverse Event|0|||
30700607|NCT00506350|58714942|FG004|Overall Study|Serious Adverse Event|0|||
30700608|NCT00506350|58714943|FG005|Overall Study|Serious Adverse Event|0|||
30700609|NCT00506350|58714944|FG006|Overall Study|Serious Adverse Event|0|||
30700610|NCT00506350|58714945|FG007|Overall Study|Serious Adverse Event|0|||
30700611|NCT00506350|58714946|FG008|Overall Study|Serious Adverse Event|0|||
30700612|NCT00506350|58714938|FG000|Overall Study|Adverse Event|0|||
30700613|NCT00506350|58714939|FG001|Overall Study|Adverse Event|0|||
30700614|NCT00506350|58714940|FG002|Overall Study|Adverse Event|0|||
30700615|NCT00506350|58714941|FG003|Overall Study|Adverse Event|0|||
30700616|NCT00506350|58714942|FG004|Overall Study|Adverse Event|0|||
30700617|NCT00506350|58714943|FG005|Overall Study|Adverse Event|0|||
30700618|NCT00506350|58714944|FG006|Overall Study|Adverse Event|0|||
30700619|NCT00506350|58714945|FG007|Overall Study|Adverse Event|1|||
30700620|NCT00506350|58714946|FG008|Overall Study|Adverse Event|1|||
30700621|NCT00506350|58714938|FG000|Overall Study|Protocol Violation|0|||
30619672|NCT01027845|58630611|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
30619673|NCT01027845|58630608|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
30619674|NCT01027845|58630609|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
30619675|NCT01027845|58630610|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
30619676|NCT01027845|58630611|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
30619677|NCT01027845|58630608|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
30619678|NCT01027845|58630609|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
30619679|NCT01027845|58630610|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
30619680|NCT01027845|58630611|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
30619681|NCT01017549|58630620|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
30700622|NCT00506350|58714939|FG001|Overall Study|Protocol Violation|0|||
30700623|NCT00506350|58714940|FG002|Overall Study|Protocol Violation|1|||
30700624|NCT00506350|58714941|FG003|Overall Study|Protocol Violation|0|||
30700625|NCT00506350|58714942|FG004|Overall Study|Protocol Violation|0|||
30700626|NCT00506350|58714943|FG005|Overall Study|Protocol Violation|0|||
30700627|NCT00506350|58714944|FG006|Overall Study|Protocol Violation|1|||
30700628|NCT00506350|58714945|FG007|Overall Study|Protocol Violation|0|||
30700629|NCT00506350|58714946|FG008|Overall Study|Protocol Violation|0|||
30700630|NCT00506350|58714938|FG000|Overall Study|Withdrawal by Subject|0|||
30700631|NCT00506350|58714939|FG001|Overall Study|Withdrawal by Subject|1|||
30700632|NCT00506350|58714940|FG002|Overall Study|Withdrawal by Subject|1|||
30619682|NCT01017549|58630620|FG000|One-year Follow-up|Lost to Follow-up|2|||
30619683|NCT01017549|58630620|FG000|One-year Follow-up|Withdrawal by Subject|5|||
30619684|NCT01017549|58630620|FG000|5 Year Follow-up|Lost to Follow-up|9|||
30619685|NCT01017549|58630620|FG000|5 Year Follow-up|Mastectomy|3|||
30619686|NCT01030341|58630624|FG000|Overall Study|Withdrawal by Subject|1|||
30619687|NCT01030341|58630624|FG000|Overall Study|Lost to Follow-up|2|||
30619688|NCT01026831|58630630|FG000|Overall Study|Adverse Event|4|||
30619689|NCT01026831|58630631|FG001|Overall Study|Adverse Event|3|||
30619690|NCT01026831|58630630|FG000|Overall Study|Lost to Follow-up|2|||
30619691|NCT01026831|58630631|FG001|Overall Study|Lost to Follow-up|0|||
30619692|NCT01026831|58630630|FG000|Overall Study|Physician Decision|1|||
30619693|NCT01026831|58630631|FG001|Overall Study|Physician Decision|1|||
30619694|NCT01026831|58630630|FG000|Overall Study|Protocol Violation|0|||
30619695|NCT01026831|58630631|FG001|Overall Study|Protocol Violation|2|||
30619696|NCT01026831|58630630|FG000|Overall Study|Withdrawal by Subject|7|||
30619697|NCT01026831|58630631|FG001|Overall Study|Withdrawal by Subject|5|||
30619698|NCT01016067|58630639|FG000|Overall Study|Lost to Follow-up|1|||
30619699|NCT01016067|58630640|FG001|Overall Study|Lost to Follow-up|2|||
30619700|NCT01016067|58630639|FG000|Overall Study|Physician Decision|1|||
30619701|NCT01016067|58630640|FG001|Overall Study|Physician Decision|1|||
30619702|NCT01016067|58630639|FG000|Overall Study|Withdrew due to Relocation|0|||
30700633|NCT00506350|58714941|FG003|Overall Study|Withdrawal by Subject|1|||
30700634|NCT00506350|58714942|FG004|Overall Study|Withdrawal by Subject|4|||
30700635|NCT00506350|58714943|FG005|Overall Study|Withdrawal by Subject|1|||
30700636|NCT00506350|58714944|FG006|Overall Study|Withdrawal by Subject|1|||
30700637|NCT00506350|58714945|FG007|Overall Study|Withdrawal by Subject|2|||
30700638|NCT00506350|58714946|FG008|Overall Study|Withdrawal by Subject|0|||
30700639|NCT00506350|58714938|FG000|Overall Study|Lost to Follow-up|1|||
30700640|NCT00506350|58714939|FG001|Overall Study|Lost to Follow-up|1|||
30700641|NCT00506350|58714940|FG002|Overall Study|Lost to Follow-up|1|||
30700642|NCT00506350|58714941|FG003|Overall Study|Lost to Follow-up|1|||
30700643|NCT00506350|58714942|FG004|Overall Study|Lost to Follow-up|2|||
30700644|NCT00506350|58714943|FG005|Overall Study|Lost to Follow-up|1|||
30700645|NCT00506350|58714944|FG006|Overall Study|Lost to Follow-up|0|||
30700646|NCT00506350|58714945|FG007|Overall Study|Lost to Follow-up|0|||
30700647|NCT00506350|58714946|FG008|Overall Study|Lost to Follow-up|2|||
30700648|NCT00506350|58714938|FG000|Overall Study|Medical Reason|0|||
30619703|NCT01016067|58630640|FG001|Overall Study|Withdrew due to Relocation|1|||
30700649|NCT00506350|58714939|FG001|Overall Study|Medical Reason|0|||
30700650|NCT00506350|58714940|FG002|Overall Study|Medical Reason|0|||
30700651|NCT00506350|58714941|FG003|Overall Study|Medical Reason|0|||
30619704|NCT01015833|58630648|FG000|Overall Study|Death|1|||
30619705|NCT01015833|58630649|FG001|Overall Study|Death|0|||
30619706|NCT01015833|58630648|FG000|Overall Study|Withdrawal by Subject|3|||
30619707|NCT01015833|58630649|FG001|Overall Study|Withdrawal by Subject|2|||
30619708|NCT01015833|58630648|FG000|Overall Study|Adverse Event|0|||
30619709|NCT01015833|58630649|FG001|Overall Study|Adverse Event|1|||
30619710|NCT01015833|58630648|FG000|Overall Study|Physician Decision|2|||
30619711|NCT01015833|58630649|FG001|Overall Study|Physician Decision|0|||
30619712|NCT01015833|58630648|FG000|Overall Study|Symptomatic deterioration|0|||
30619713|NCT01015833|58630649|FG001|Overall Study|Symptomatic deterioration|1|||
30619714|NCT01015833|58630648|FG000|Overall Study|Other|5|||
30619715|NCT01015833|58630649|FG001|Overall Study|Other|1|||
30619716|NCT01015833|58630648|FG000|Overall Study|Motor Vehicle Accidents|1|||
30619717|NCT01015833|58630649|FG001|Overall Study|Motor Vehicle Accidents|0|||
30619718|NCT01015833|58630648|FG000|Overall Study|Did not start treatment|1|||
30619719|NCT01015833|58630649|FG001|Overall Study|Did not start treatment|0|||
30619720|NCT01015677|58630667|FG000|Overall Study|Adverse Event|0|||
30619721|NCT01015677|58630668|FG001|Overall Study|Adverse Event|1|||
30619722|NCT01015677|58630669|FG002|Overall Study|Adverse Event|0|||
30619723|NCT01015677|58630667|FG000|Overall Study|Lack of Efficacy|0|||
30619724|NCT01015677|58630668|FG001|Overall Study|Lack of Efficacy|1|||
30619725|NCT01015677|58630669|FG002|Overall Study|Lack of Efficacy|0|||
30619726|NCT01015677|58630667|FG000|Overall Study|Protocol Violation|0|||
30619727|NCT01015677|58630668|FG001|Overall Study|Protocol Violation|1|||
30619728|NCT01015677|58630669|FG002|Overall Study|Protocol Violation|0|||
30619729|NCT01015677|58630667|FG000|Overall Study|Withdrawal by Subject|1|||
30619730|NCT01015677|58630668|FG001|Overall Study|Withdrawal by Subject|1|||
30619731|NCT01015677|58630669|FG002|Overall Study|Withdrawal by Subject|0|||
30619732|NCT01225211|58630709|FG000|Overall Study|Adverse Event|0|||
30619733|NCT01225211|58630710|FG001|Overall Study|Adverse Event|0|||
30619734|NCT01225211|58630711|FG002|Overall Study|Adverse Event|1|||
30619735|NCT01225211|58630712|FG003|Overall Study|Adverse Event|0|||
30619736|NCT01225211|58630713|FG004|Overall Study|Adverse Event|0|||
30619737|NCT01225211|58630714|FG005|Overall Study|Adverse Event|0|||
30700652|NCT00506350|58714942|FG004|Overall Study|Medical Reason|1|||
30619738|NCT01225211|58630715|FG006|Overall Study|Adverse Event|0|||
30619739|NCT01225211|58630716|FG007|Overall Study|Adverse Event|0|||
30700653|NCT00506350|58714943|FG005|Overall Study|Medical Reason|0|||
30700654|NCT00506350|58714944|FG006|Overall Study|Medical Reason|0|||
30700655|NCT00506350|58714945|FG007|Overall Study|Medical Reason|0|||
30700656|NCT00506350|58714946|FG008|Overall Study|Medical Reason|0|||
30700657|NCT00506350|58714938|FG000|Overall Study|Other|1|||
30700658|NCT00506350|58714939|FG001|Overall Study|Other|1|||
30700659|NCT00506350|58714940|FG002|Overall Study|Other|3|||
30700660|NCT00506350|58714941|FG003|Overall Study|Other|0|||
30700661|NCT00506350|58714942|FG004|Overall Study|Other|3|||
30700662|NCT00506350|58714943|FG005|Overall Study|Other|0|||
30700663|NCT00506350|58714944|FG006|Overall Study|Other|0|||
30700664|NCT00506350|58714945|FG007|Overall Study|Other|2|||
30700665|NCT00506350|58714946|FG008|Overall Study|Other|2|||
30700666|NCT00258895|58714975|FG000|Overall Study|Lost to Follow-up|3|||
30700667|NCT00258895|58714976|FG001|Overall Study|Lost to Follow-up|1|||
30700668|NCT00258895|58714975|FG000|Overall Study|Protocol Violation|6|||
30700669|NCT00258895|58714976|FG001|Overall Study|Protocol Violation|2|||
30700670|NCT00258895|58714975|FG000|Overall Study|Withdrawal by Subject|1|||
30700671|NCT00258895|58714976|FG001|Overall Study|Withdrawal by Subject|0|||
30700672|NCT00742625|58714982|FG000|Remission Induction|Progression|6|||
30700673|NCT00742625|58714982|FG000|Remission Induction|Failed induction|8|||
30700674|NCT00742625|58714982|FG000|Remission Induction|Adverse Event|3|||
30619740|NCT01225211|58630717|FG008|Overall Study|Adverse Event|0|||
30619741|NCT01225211|58630718|FG009|Overall Study|Adverse Event|1|||
30619742|NCT01225211|58630709|FG000|Overall Study|Withdrawal by Subject|0|||
30619743|NCT01225211|58630710|FG001|Overall Study|Withdrawal by Subject|0|||
30619744|NCT01225211|58630711|FG002|Overall Study|Withdrawal by Subject|0|||
30619745|NCT01225211|58630712|FG003|Overall Study|Withdrawal by Subject|0|||
30619746|NCT01225211|58630713|FG004|Overall Study|Withdrawal by Subject|0|||
30619747|NCT01225211|58630714|FG005|Overall Study|Withdrawal by Subject|0|||
30619748|NCT01225211|58630715|FG006|Overall Study|Withdrawal by Subject|1|||
30619749|NCT01225211|58630716|FG007|Overall Study|Withdrawal by Subject|0|||
30619750|NCT01225211|58630717|FG008|Overall Study|Withdrawal by Subject|1|||
30619751|NCT01225211|58630718|FG009|Overall Study|Withdrawal by Subject|3|||
30619752|NCT01225211|58630709|FG000|Overall Study|Other|0|||
30619753|NCT01225211|58630710|FG001|Overall Study|Other|0|||
30619754|NCT01225211|58630711|FG002|Overall Study|Other|0|||
30619755|NCT01225211|58630712|FG003|Overall Study|Other|0|||
30619756|NCT01225211|58630713|FG004|Overall Study|Other|0|||
30619757|NCT01225211|58630714|FG005|Overall Study|Other|0|||
30619758|NCT01225211|58630715|FG006|Overall Study|Other|0|||
30619759|NCT01225211|58630716|FG007|Overall Study|Other|0|||
30619760|NCT01225211|58630717|FG008|Overall Study|Other|0|||
30619761|NCT01225211|58630718|FG009|Overall Study|Other|1|||
30619762|NCT01224821|58630801|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
30619763|NCT01224821|58630801|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
30619764|NCT01224821|58630801|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
30619765|NCT01224821|58630801|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
30619766|NCT01224821|58630801|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
30619767|NCT01224821|58630801|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
30619768|NCT01224821|58630801|FG000|Long-Term Follow-Up|Death|2|||
30619769|NCT01224821|58630801|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
30619770|NCT01224431|58630818|FG000|Overall Study|not randomized|0|||
30619771|NCT01224431|58630819|FG001|Overall Study|not randomized|4|||
30700675|NCT00742625|58714982|FG000|Remission Induction|Death|10|||
30700676|NCT00742625|58714982|FG000|Remission Induction|Refusal|5|||
30700677|NCT00742625|58714982|FG000|Remission Induction|Non protocol treatment|17|||
30619772|NCT01224431|58630818|FG000|Overall Study|no video record|0|||
30619773|NCT01224431|58630819|FG001|Overall Study|no video record|1|||
30619774|NCT01223183|58630829|FG000|Imaging Day 1|Physician Decision|0|||
30619775|NCT01223183|58630830|FG001|Imaging Day 1|Physician Decision|1|||
30619776|NCT01223183|58630829|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
30619777|NCT01223183|58630830|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
30700678|NCT00742625|58714982|FG000|Remission Induction|Other, not specified|5|||
30700679|NCT00742625|58714982|FG000|Consolidation|Progression|5|||
30700680|NCT00742625|58714982|FG000|Consolidation|Adverse Event|1|||
30700681|NCT00742625|58714982|FG000|Consolidation|Death|1|||
30700682|NCT00742625|58714982|FG000|Consolidation|Refused|1|||
30700683|NCT00742625|58714982|FG000|Consolidation|Non protocol therapy|13|||
30700684|NCT00618618|58714993|FG000|Overall Study|Patient Request|0|||
30700685|NCT00618618|58714994|FG001|Overall Study|Patient Request|0|||
30700686|NCT00618618|58714995|FG002|Overall Study|Patient Request|2|||
30700687|NCT00618618|58714996|FG003|Overall Study|Patient Request|0|||
30700688|NCT00618618|58714993|FG000|Overall Study|Inability to Complete Study Procedures|0|||
30700689|NCT00618618|58714994|FG001|Overall Study|Inability to Complete Study Procedures|1|||
30700690|NCT00618618|58714995|FG002|Overall Study|Inability to Complete Study Procedures|0|||
30700691|NCT00618618|58714996|FG003|Overall Study|Inability to Complete Study Procedures|0|||
30700692|NCT00618618|58714993|FG000|Overall Study|Lost to Follow-up|3|||
30700693|NCT00618618|58714994|FG001|Overall Study|Lost to Follow-up|0|||
30700694|NCT00618618|58714995|FG002|Overall Study|Lost to Follow-up|0|||
30700695|NCT00618618|58714996|FG003|Overall Study|Lost to Follow-up|1|||
30700696|NCT00618618|58714993|FG000|Overall Study|Non-compliance|1|||
30700697|NCT00618618|58714994|FG001|Overall Study|Non-compliance|1|||
30700698|NCT00618618|58714995|FG002|Overall Study|Non-compliance|0|||
30700699|NCT00618618|58714996|FG003|Overall Study|Non-compliance|0|||
30700700|NCT00618618|58714993|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
30700701|NCT00618618|58714994|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
30700702|NCT00618618|58714995|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
30700703|NCT00618618|58714996|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
30700704|NCT00618618|58714993|FG000|Overall Study|Death|0|||
30700705|NCT00618618|58714994|FG001|Overall Study|Death|1|||
30700706|NCT00618618|58714995|FG002|Overall Study|Death|0|||
30700707|NCT00618618|58714996|FG003|Overall Study|Death|0|||
30700708|NCT00246805|58715009|FG000|Phase 1|Lost to Follow-up|1|||
30700709|NCT00246805|58715010|FG001|Phase 1|Lost to Follow-up|0|||
30700710|NCT00519376|58715016|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700711|NCT00519376|58715017|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700712|NCT00519376|58715018|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700713|NCT00519376|58715019|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700714|NCT00519376|58715020|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700715|NCT00519376|58715021|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700716|NCT00519376|58715022|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700717|NCT00519376|58715023|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700718|NCT00519376|58715024|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700719|NCT00519376|58715025|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700720|NCT00519376|58715026|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700721|NCT00519376|58715027|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700722|NCT00519376|58715028|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
30700723|NCT00519376|58715029|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700724|NCT00519376|58715030|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700725|NCT00519376|58715031|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
30700726|NCT00519376|58715016|FG000|Treatment Period 4|Lost to Follow-up|0|||
30700727|NCT00519376|58715017|FG001|Treatment Period 4|Lost to Follow-up|0|||
30700728|NCT00519376|58715018|FG002|Treatment Period 4|Lost to Follow-up|1|||
30700729|NCT00519376|58715019|FG003|Treatment Period 4|Lost to Follow-up|0|||
30700730|NCT00519376|58715020|FG004|Treatment Period 4|Lost to Follow-up|0|||
30700731|NCT00519376|58715021|FG005|Treatment Period 4|Lost to Follow-up|0|||
30700732|NCT00519376|58715022|FG006|Treatment Period 4|Lost to Follow-up|0|||
30700733|NCT00519376|58715023|FG007|Treatment Period 4|Lost to Follow-up|0|||
30700734|NCT00519376|58715024|FG008|Treatment Period 4|Lost to Follow-up|0|||
30700735|NCT00519376|58715025|FG009|Treatment Period 4|Lost to Follow-up|0|||
30700736|NCT00519376|58715026|FG010|Treatment Period 4|Lost to Follow-up|0|||
30700737|NCT00519376|58715027|FG011|Treatment Period 4|Lost to Follow-up|0|||
30700738|NCT00519376|58715028|FG012|Treatment Period 4|Lost to Follow-up|0|||
30700739|NCT00519376|58715029|FG013|Treatment Period 4|Lost to Follow-up|0|||
30700740|NCT00519376|58715030|FG014|Treatment Period 4|Lost to Follow-up|0|||
30619778|NCT01223183|58630829|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
30619779|NCT01223183|58630830|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
30619780|NCT01223027|58630839|FG000|Overall Study|Adverse Event|20|||
30700741|NCT00519376|58715031|FG015|Treatment Period 4|Lost to Follow-up|0|||
30700742|NCT00745121|58715045|FG000|Overall Study|Death|3|||
30619781|NCT01223027|58630840|FG001|Overall Study|Adverse Event|10|||
30619782|NCT01223027|58630839|FG000|Overall Study|Death|42|||
30619783|NCT01223027|58630840|FG001|Overall Study|Death|42|||
30619784|NCT01223027|58630839|FG000|Overall Study|Lost to Follow-up|2|||
30700743|NCT00745121|58715046|FG001|Overall Study|Death|0|||
30700744|NCT00745121|58715045|FG000|Overall Study|Adverse Event|1|||
30700745|NCT00745121|58715046|FG001|Overall Study|Adverse Event|0|||
30700746|NCT00745121|58715045|FG000|Overall Study|Lost to Follow-up|1|||
30700747|NCT00745121|58715046|FG001|Overall Study|Lost to Follow-up|0|||
30700748|NCT00745121|58715045|FG000|Overall Study|Withdrawal by Subject|4|||
30700749|NCT00745121|58715046|FG001|Overall Study|Withdrawal by Subject|2|||
30700750|NCT00740051|58715054|FG000|Overall Study|Lack of Efficacy|2|||
30619785|NCT01223027|58630840|FG001|Overall Study|Lost to Follow-up|1|||
30619786|NCT01223027|58630839|FG000|Overall Study|Physician Decision|4|||
30700751|NCT00740051|58715055|FG001|Overall Study|Lack of Efficacy|5|||
30700752|NCT00740051|58715054|FG000|Overall Study|Adverse Event|1|||
30700753|NCT00740051|58715055|FG001|Overall Study|Adverse Event|4|||
30700754|NCT00740051|58715054|FG000|Overall Study|Protocol Violation|2|||
30700755|NCT00740051|58715055|FG001|Overall Study|Protocol Violation|6|||
30700756|NCT00740051|58715054|FG000|Overall Study|Lost to Follow-up|3|||
30700757|NCT00740051|58715055|FG001|Overall Study|Lost to Follow-up|8|||
30700758|NCT00740051|58715054|FG000|Overall Study|Withdrawal by Subject|6|||
30700759|NCT00740051|58715055|FG001|Overall Study|Withdrawal by Subject|8|||
30700760|NCT00740051|58715054|FG000|Overall Study|Other reason (not specified)|4|||
30700761|NCT00740051|58715055|FG001|Overall Study|Other reason (not specified)|1|||
30700762|NCT00518986|58715064|FG000|Overall Study|Adverse Event|12|||
30700763|NCT00518986|58715065|FG001|Overall Study|Adverse Event|7|||
30700764|NCT00518986|58715064|FG000|Overall Study|Lack of Efficacy|0|||
30700765|NCT00518986|58715065|FG001|Overall Study|Lack of Efficacy|2|||
30700766|NCT00518986|58715064|FG000|Overall Study|Lost to Follow-up|3|||
30700767|NCT00518986|58715065|FG001|Overall Study|Lost to Follow-up|2|||
30700768|NCT00518986|58715064|FG000|Overall Study|Physician Decision|0|||
30700769|NCT00518986|58715065|FG001|Overall Study|Physician Decision|3|||
30700770|NCT00518986|58715064|FG000|Overall Study|Protocol Violation|5|||
30700771|NCT00518986|58715065|FG001|Overall Study|Protocol Violation|7|||
30700772|NCT00518986|58715064|FG000|Overall Study|Withdrawal by Subject|4|||
30700773|NCT00518986|58715065|FG001|Overall Study|Withdrawal by Subject|4|||
30700774|NCT00518986|58715064|FG000|Overall Study|Non-Specific|2|||
30700775|NCT00518986|58715065|FG001|Overall Study|Non-Specific|1|||
30700776|NCT00742391|58715073|FG000|Overall Study|Adverse Event|2|||
30700777|NCT00742391|58715074|FG001|Overall Study|Adverse Event|1|||
30700778|NCT00742391|58715073|FG000|Overall Study|Lost to Follow-up|1|||
30700779|NCT00742391|58715074|FG001|Overall Study|Lost to Follow-up|0|||
30700780|NCT00742391|58715073|FG000|Overall Study|Protocol Violation|1|||
30700781|NCT00742391|58715074|FG001|Overall Study|Protocol Violation|0|||
30700782|NCT00742235|58715082|FG000|Overall Study|Lost to Follow-up|0|||
30700783|NCT00742235|58715083|FG001|Overall Study|Lost to Follow-up|31|||
30700784|NCT00742079|58715091|FG000|Overall Study|Lost to Follow-up|0|||
30700785|NCT00742079|58715092|FG001|Overall Study|Lost to Follow-up|1|||
30700786|NCT00662792|58715098|FG000|Period 1|Personal Reasons|0|||
30700787|NCT00662792|58715099|FG001|Period 1|Personal Reasons|0|||
30700788|NCT00662792|58715100|FG002|Period 1|Personal Reasons|1|||
30700789|NCT00662792|58715101|FG003|Period 1|Personal Reasons|0|||
30700790|NCT00662792|58715098|FG000|Period 1|Refused continuing medication|0|||
30700791|NCT00662792|58715099|FG001|Period 1|Refused continuing medication|1|||
30700792|NCT00662792|58715100|FG002|Period 1|Refused continuing medication|1|||
30700793|NCT00662792|58715101|FG003|Period 1|Refused continuing medication|0|||
30700794|NCT00662792|58715098|FG000|Period 1|Lost to Follow-up|1|||
30700795|NCT00662792|58715099|FG001|Period 1|Lost to Follow-up|0|||
30700796|NCT00662792|58715100|FG002|Period 1|Lost to Follow-up|0|||
30700797|NCT00662792|58715101|FG003|Period 1|Lost to Follow-up|0|||
30700798|NCT00662792|58715098|FG000|Period 1|Other adverse event (AE)|0|||
30700799|NCT00662792|58715099|FG001|Period 1|Other adverse event (AE)|2|||
30700800|NCT00662792|58715100|FG002|Period 1|Other adverse event (AE)|0|||
30700801|NCT00662792|58715101|FG003|Period 1|Other adverse event (AE)|0|||
30700802|NCT00662792|58715098|FG000|Period 1|Worsening of disease under study (AE)|1|||
30700803|NCT00662792|58715099|FG001|Period 1|Worsening of disease under study (AE)|3|||
30700804|NCT00662792|58715100|FG002|Period 1|Worsening of disease under study (AE)|2|||
30700805|NCT00662792|58715101|FG003|Period 1|Worsening of disease under study (AE)|0|||
30700806|NCT00662792|58715098|FG000|Period 1|Not treated|0|||
30700807|NCT00662792|58715099|FG001|Period 1|Not treated|1|||
30700808|NCT00662792|58715100|FG002|Period 1|Not treated|0|||
30700809|NCT00662792|58715101|FG003|Period 1|Not treated|0|||
30700810|NCT00662792|58715098|FG000|Period 2|Worsening of disease under study|1|||
30700811|NCT00662792|58715099|FG001|Period 2|Worsening of disease under study|0|||
30700812|NCT00662792|58715100|FG002|Period 2|Worsening of disease under study|0|||
30700813|NCT00662792|58715101|FG003|Period 2|Worsening of disease under study|3|||
30700814|NCT00662792|58715098|FG000|Period 3|Refused continuing medication|1|||
30700815|NCT00662792|58715099|FG001|Period 3|Refused continuing medication|0|||
30700816|NCT00662792|58715100|FG002|Period 3|Refused continuing medication|1|||
30700817|NCT00662792|58715101|FG003|Period 3|Refused continuing medication|0|||
30700818|NCT00662792|58715098|FG000|Period 3|Other adverse event (AE)|0|||
30700819|NCT00662792|58715099|FG001|Period 3|Other adverse event (AE)|0|||
30700820|NCT00662792|58715100|FG002|Period 3|Other adverse event (AE)|1|||
30700821|NCT00662792|58715101|FG003|Period 3|Other adverse event (AE)|1|||
30700822|NCT00662792|58715098|FG000|Period 4|Refused continuing medication|0|||
30700823|NCT00662792|58715099|FG001|Period 4|Refused continuing medication|1|||
30700824|NCT00662792|58715100|FG002|Period 4|Refused continuing medication|0|||
30700825|NCT00662792|58715101|FG003|Period 4|Refused continuing medication|0|||
30700826|NCT00662792|58715098|FG000|Period 4|Other adverse event (AE)|1|||
30700827|NCT00662792|58715099|FG001|Period 4|Other adverse event (AE)|0|||
30619787|NCT01223027|58630840|FG001|Overall Study|Physician Decision|8|||
30619788|NCT01223027|58630839|FG000|Overall Study|Progressive Disease|167|||
30619789|NCT01223027|58630840|FG001|Overall Study|Progressive Disease|183|||
30619790|NCT01223027|58630839|FG000|Overall Study|Protocol Violation|2|||
30619791|NCT01223027|58630840|FG001|Overall Study|Protocol Violation|1|||
30619792|NCT01223027|58630839|FG000|Overall Study|Subject/guardian decicion|18|||
30619793|NCT01223027|58630840|FG001|Overall Study|Subject/guardian decicion|16|||
30619794|NCT01223027|58630839|FG000|Overall Study|New therapy for study indication|17|||
30619795|NCT01223027|58630840|FG001|Overall Study|New therapy for study indication|8|||
30619796|NCT01223027|58630839|FG000|Overall Study|Study terminated by sponsor|2|||
30619797|NCT01223027|58630840|FG001|Overall Study|Study terminated by sponsor|8|||
30619798|NCT01015287|58630848|FG000|Overall Study|Death|21|||
30619799|NCT01015287|58630849|FG001|Overall Study|Death|16|||
30619800|NCT01015287|58630848|FG000|Overall Study|Adverse Event|1|||
30619801|NCT01015287|58630849|FG001|Overall Study|Adverse Event|0|||
30619802|NCT01015287|58630848|FG000|Overall Study|Sponsor Decision|3|||
30619803|NCT01015287|58630849|FG001|Overall Study|Sponsor Decision|7|||
30700828|NCT00662792|58715100|FG002|Period 4|Other adverse event (AE)|0|||
30700829|NCT00662792|58715101|FG003|Period 4|Other adverse event (AE)|0|||
30700830|NCT00662792|58715098|FG000|Period 4|Worsening of disease under study (AE)|0|||
30700831|NCT00662792|58715099|FG001|Period 4|Worsening of disease under study (AE)|0|||
30700832|NCT00662792|58715100|FG002|Period 4|Worsening of disease under study (AE)|0|||
30619804|NCT01015287|58630848|FG000|Overall Study|Physician Decision|19|||
30619805|NCT01015287|58630849|FG001|Overall Study|Physician Decision|21|||
30700833|NCT00662792|58715101|FG003|Period 4|Worsening of disease under study (AE)|1|||
30700834|NCT00742001|58715116|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
30700835|NCT00742001|58715117|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
30700836|NCT00742001|58715118|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
30700837|NCT00616902|58715131|FG000|Overall Study|Termination of study|6|||
30700838|NCT00616902|58715132|FG001|Overall Study|Termination of study|6|||
30700839|NCT00741611|58715141|FG000|Overall Study|Death|0|||
30700840|NCT00741611|58715142|FG001|Overall Study|Death|0|||
30700841|NCT00741611|58715143|FG002|Overall Study|Death|1|||
30700842|NCT00741611|58715141|FG000|Overall Study|Withdrawal by Subject|0|||
30700843|NCT00741611|58715142|FG001|Overall Study|Withdrawal by Subject|2|||
30700844|NCT00741611|58715143|FG002|Overall Study|Withdrawal by Subject|2|||
30700845|NCT00662558|58715154|FG000|Overall Study|Adverse Event|21|||
30700846|NCT00662558|58715155|FG001|Overall Study|Adverse Event|59|||
30700847|NCT00662558|58715154|FG000|Overall Study|Lack of Efficacy|4|||
30700848|NCT00662558|58715155|FG001|Overall Study|Lack of Efficacy|7|||
30700849|NCT00662558|58715154|FG000|Overall Study|Lost to Follow-up|13|||
30700850|NCT00662558|58715155|FG001|Overall Study|Lost to Follow-up|10|||
30700851|NCT00662558|58715154|FG000|Overall Study|Other|9|||
30700852|NCT00662558|58715155|FG001|Overall Study|Other|14|||
30700853|NCT00662558|58715154|FG000|Overall Study|Withdrawal by Subject|7|||
30700854|NCT00662558|58715155|FG001|Overall Study|Withdrawal by Subject|12|||
30700855|NCT00662558|58715154|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
30700856|NCT00662558|58715155|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
30700857|NCT00739973|58715170|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
30619806|NCT01015287|58630848|FG000|Overall Study|Withdrawal by Subject|14|||
30619807|NCT01015287|58630849|FG001|Overall Study|Withdrawal by Subject|19|||
30619808|NCT01015287|58630848|FG000|Overall Study|Entry Criteria not Met|11|||
30619809|NCT01015287|58630849|FG001|Overall Study|Entry Criteria not Met|14|||
30619810|NCT01015287|58630848|FG000|Overall Study|Lost to Follow-up|2|||
30619811|NCT01015287|58630849|FG001|Overall Study|Lost to Follow-up|1|||
30619812|NCT01015287|58630848|FG000|Overall Study|Protocol Violation|1|||
30619813|NCT01015287|58630849|FG001|Overall Study|Protocol Violation|1|||
30619814|NCT01015131|58630857|FG000|Overall Study|Physician Decision|1|||
30619815|NCT01015131|58630857|FG000|Overall Study|Protocol Violation|1|||
30619816|NCT01015131|58630857|FG000|Overall Study|Withdrawal by Subject|2|||
30619817|NCT01015131|58630857|FG000|Overall Study|Other Protocol Specified Criteria|4|||
30619818|NCT01222715|58630863|FG000|Overall Study|Adverse Event|0|||
30619819|NCT01222715|58630864|FG001|Overall Study|Adverse Event|4|||
30700858|NCT00739973|58715171|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
30700859|NCT00739973|58715172|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
30700860|NCT00739973|58715173|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
30700861|NCT00739973|58715174|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
30700862|NCT00739973|58715175|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
30700863|NCT00739973|58715176|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
30700864|NCT00739973|58715177|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
30700865|NCT00739973|58715178|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
30700866|NCT00739973|58715170|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
30700867|NCT00739973|58715171|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
30700868|NCT00739973|58715172|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
30700869|NCT00739973|58715173|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
30700870|NCT00739973|58715174|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
30700871|NCT00739973|58715175|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
30700872|NCT00739973|58715176|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
30700873|NCT00739973|58715177|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
30700874|NCT00739973|58715178|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
30700875|NCT00739973|58715170|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
30700876|NCT00739973|58715171|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
30700877|NCT00739973|58715172|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
30700878|NCT00739973|58715173|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
30700879|NCT00739973|58715174|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
30700880|NCT00739973|58715175|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
30700881|NCT00739973|58715176|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
30700882|NCT00739973|58715177|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
30700883|NCT00739973|58715178|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
30700884|NCT00739973|58715170|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
30700885|NCT00739973|58715171|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
30700886|NCT00739973|58715172|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
30700887|NCT00739973|58715173|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
30700888|NCT00739973|58715174|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
30700889|NCT00739973|58715175|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
30700890|NCT00739973|58715176|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
30700891|NCT00739973|58715177|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
30700892|NCT00739973|58715178|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
30700893|NCT00739973|58715170|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
30700894|NCT00739973|58715171|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
30700895|NCT00739973|58715172|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
30700896|NCT00739973|58715173|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
30700897|NCT00739973|58715174|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
30700898|NCT00739973|58715175|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
30700899|NCT00739973|58715176|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
30700900|NCT00739973|58715177|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
30700901|NCT00739973|58715178|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
30700902|NCT00739973|58715170|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
30700903|NCT00739973|58715171|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
30700904|NCT00739973|58715172|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
30700905|NCT00739973|58715173|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
30700906|NCT00739973|58715174|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
30700907|NCT00739973|58715175|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
30700908|NCT00739973|58715176|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
30700909|NCT00739973|58715177|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
30700910|NCT00739973|58715178|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
30700911|NCT00739973|58715170|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
30700912|NCT00739973|58715171|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
30700913|NCT00739973|58715172|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
30700914|NCT00739973|58715173|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
30619820|NCT01222715|58630863|FG000|Overall Study|Death|0|||
30619821|NCT01222715|58630864|FG001|Overall Study|Death|1|||
30619822|NCT01222715|58630863|FG000|Overall Study|Lack of Efficacy|22|||
30619823|NCT01222715|58630864|FG001|Overall Study|Lack of Efficacy|14|||
30619824|NCT01222715|58630863|FG000|Overall Study|Physician Decision|12|||
30619825|NCT01222715|58630864|FG001|Overall Study|Physician Decision|2|||
30619826|NCT01222715|58630863|FG000|Overall Study|Refusal of further protocol therapy|0|||
30619827|NCT01222715|58630864|FG001|Overall Study|Refusal of further protocol therapy|4|||
30619828|NCT01222715|58630863|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
30619829|NCT01222715|58630864|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
30619830|NCT01222715|58630863|FG000|Overall Study|Ineligible|0|||
30619831|NCT01222715|58630864|FG001|Overall Study|Ineligible|1|||
30619832|NCT01222715|58630863|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
30619833|NCT01222715|58630864|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
30619834|NCT01222403|58630872|FG000|Overall Study|Inappropriate enrollment|0|||
30619835|NCT01222403|58630873|FG001|Overall Study|Inappropriate enrollment|2|||
30619836|NCT01222247|58630881|FG000|Overall Study|Lost to Follow-up|2|||
30619837|NCT01222247|58630882|FG001|Overall Study|Lost to Follow-up|2|||
30619838|NCT01014975|58630888|FG000|Overall Study|Withdrawal by Subject|1|||
30619839|NCT01014975|58630889|FG001|Overall Study|Withdrawal by Subject|0|||
30619840|NCT01014975|58630890|FG002|Overall Study|Withdrawal by Subject|1|||
30619841|NCT01014975|58630888|FG000|Overall Study|Death|3|||
30619842|NCT01014975|58630889|FG001|Overall Study|Death|3|||
30700915|NCT00739973|58715174|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
30700916|NCT00739973|58715175|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
30700917|NCT00739973|58715176|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
30700918|NCT00739973|58715177|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
30700919|NCT00739973|58715178|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
30700920|NCT00739973|58715170|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
30700921|NCT00739973|58715171|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
30700922|NCT00739973|58715172|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
30700923|NCT00739973|58715173|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
30700924|NCT00739973|58715174|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
30700925|NCT00739973|58715175|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
30700926|NCT00739973|58715176|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
30700927|NCT00739973|58715177|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
30700928|NCT00739973|58715178|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
30700929|NCT00739973|58715170|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
30700930|NCT00739973|58715171|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
30700931|NCT00739973|58715172|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
30700932|NCT00739973|58715173|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
30700933|NCT00739973|58715174|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
30700934|NCT00739973|58715175|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
30700935|NCT00739973|58715176|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
30700936|NCT00739973|58715177|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
30700937|NCT00739973|58715178|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
30700938|NCT00739973|58715170|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
30700939|NCT00739973|58715171|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
30700940|NCT00739973|58715172|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
30700941|NCT00739973|58715173|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
30700942|NCT00739973|58715174|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
30700943|NCT00739973|58715175|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
30700944|NCT00739973|58715176|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
30700945|NCT00739973|58715177|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
30700946|NCT00739973|58715178|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
30619843|NCT01014975|58630890|FG002|Overall Study|Death|4|||
30619844|NCT01014975|58630888|FG000|Overall Study|Lost to Follow-up|0|||
30619845|NCT01014975|58630889|FG001|Overall Study|Lost to Follow-up|0|||
30619846|NCT01014975|58630890|FG002|Overall Study|Lost to Follow-up|1|||
30619847|NCT01221623|58630900|FG000|Overall Study|Withdrawal by Subject|19|||
30619848|NCT01221623|58630901|FG001|Overall Study|Withdrawal by Subject|8|||
30619849|NCT01221623|58630900|FG000|Overall Study|Lost to Follow-up|7|||
30619850|NCT01221623|58630901|FG001|Overall Study|Lost to Follow-up|1|||
30619851|NCT01221623|58630900|FG000|Overall Study|Adverse Event|6|||
30619852|NCT01221623|58630901|FG001|Overall Study|Adverse Event|3|||
30619853|NCT01221623|58630900|FG000|Overall Study|Death|1|||
30619854|NCT01221623|58630901|FG001|Overall Study|Death|0|||
30700947|NCT00739973|58715170|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
30700948|NCT00739973|58715171|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
30700949|NCT00739973|58715172|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
30700950|NCT00739973|58715173|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
30700951|NCT00739973|58715174|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
30700952|NCT00739973|58715175|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
30700953|NCT00739973|58715176|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
30700954|NCT00739973|58715177|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
30700955|NCT00739973|58715178|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
30700956|NCT00739973|58715170|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
30700957|NCT00739973|58715171|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
30700958|NCT00739973|58715172|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
30700959|NCT00739973|58715173|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
30700960|NCT00739973|58715174|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
30700961|NCT00739973|58715175|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
30700962|NCT00739973|58715176|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
30700963|NCT00739973|58715177|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
30619855|NCT01221623|58630900|FG000|Overall Study|Other|5|||
30619856|NCT01221623|58630901|FG001|Overall Study|Other|2|||
30619857|NCT01014585|58630911|FG000|Overall Study|Adverse Event|0|||
30619858|NCT01014585|58630912|FG001|Overall Study|Adverse Event|2|||
30619859|NCT01014585|58630913|FG002|Overall Study|Adverse Event|0|||
30619860|NCT01014585|58630914|FG003|Overall Study|Adverse Event|3|||
30619861|NCT01014585|58630911|FG000|Overall Study|Withdrawal by Subject|2|||
30619862|NCT01014585|58630912|FG001|Overall Study|Withdrawal by Subject|0|||
30619863|NCT01014585|58630913|FG002|Overall Study|Withdrawal by Subject|1|||
30619864|NCT01014585|58630914|FG003|Overall Study|Withdrawal by Subject|3|||
30619865|NCT01014585|58630911|FG000|Overall Study|Lost to Follow-up|0|||
30619866|NCT01014585|58630912|FG001|Overall Study|Lost to Follow-up|0|||
30619867|NCT01014585|58630913|FG002|Overall Study|Lost to Follow-up|0|||
30619868|NCT01014585|58630914|FG003|Overall Study|Lost to Follow-up|2|||
30619869|NCT01014585|58630911|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
30619870|NCT01014585|58630912|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
30619871|NCT01014585|58630913|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
30619872|NCT01014585|58630914|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
30619873|NCT01221233|58630926|FG000|Overall Study|Withdrawal by Subject|3|||
30700964|NCT00739973|58715178|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
30700965|NCT00739973|58715170|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
30700966|NCT00739973|58715171|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
30700967|NCT00739973|58715172|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
30700968|NCT00739973|58715173|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
30700969|NCT00739973|58715174|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
30700970|NCT00739973|58715175|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
30700971|NCT00739973|58715176|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
30700972|NCT00739973|58715177|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
30700973|NCT00739973|58715178|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
30700974|NCT00739973|58715170|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
30700975|NCT00739973|58715171|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
30700976|NCT00739973|58715172|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
30700977|NCT00739973|58715173|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
30700978|NCT00739973|58715174|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
30790848|NCT03524092|58803945|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
30700979|NCT00739973|58715175|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
30700980|NCT00739973|58715176|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
30700981|NCT00739973|58715177|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
30700982|NCT00739973|58715178|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
30700983|NCT00739973|58715170|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
30700984|NCT00739973|58715171|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
30700985|NCT00739973|58715172|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
30700986|NCT00739973|58715173|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
30700987|NCT00739973|58715174|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
30700988|NCT00739973|58715175|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
30700989|NCT00739973|58715176|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
30700990|NCT00739973|58715177|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
30700991|NCT00739973|58715178|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
30700992|NCT00739973|58715170|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
30700993|NCT00739973|58715171|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
30700994|NCT00739973|58715172|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
30700995|NCT00739973|58715173|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
30700996|NCT00739973|58715174|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
30700997|NCT00739973|58715175|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
30700998|NCT00739973|58715176|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
30700999|NCT00739973|58715177|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
30701000|NCT00739973|58715178|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
30701001|NCT00739973|58715170|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
30701002|NCT00739973|58715171|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
30701003|NCT00739973|58715172|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
30701004|NCT00739973|58715173|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
30701005|NCT00739973|58715174|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
30701006|NCT00739973|58715175|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
30701007|NCT00739973|58715176|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
30701008|NCT00739973|58715177|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
30701009|NCT00739973|58715178|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
30701010|NCT00510874|58715213|FG000|Overall Study|Withdrawal by Subject|1|||
30701011|NCT00510874|58715214|FG001|Overall Study|Withdrawal by Subject|1|||
30701012|NCT00510874|58715215|FG002|Overall Study|Withdrawal by Subject|0|||
30701013|NCT00510874|58715216|FG003|Overall Study|Withdrawal by Subject|0|||
30701014|NCT00510874|58715217|FG004|Overall Study|Withdrawal by Subject|3|||
30893589|NCT02186301|58927111|FG001|Overall Study|Study Terminated by Sponsor|0|||
30893590|NCT02186301|58927112|FG002|Overall Study|Study Terminated by Sponsor|11|||
30893591|NCT02186301|58927110|FG000|Overall Study|Protocol Deviation|0|||
30619874|NCT01221233|58630927|FG001|Overall Study|Withdrawal by Subject|1|||
30619875|NCT01220609|58630933|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
30619876|NCT01220609|58630933|FG000|Overall Study|Ineligible- Wrong cell type|1|||
30619877|NCT01220609|58630933|FG000|Overall Study|Ineligible-Never treated|1|||
30619878|NCT01220297|58630945|FG000|Overall Study|Death|2|||
30619879|NCT01220297|58630945|FG000|Overall Study|Lost to Follow-up|1|||
30619880|NCT01219985|58630951|FG000|Overall Study|Physician Decision|20|||
30619881|NCT01218659|58630959|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
30619882|NCT01218659|58630960|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
30619883|NCT01218659|58630961|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
30619884|NCT01218659|58630959|FG000|18-Month Randomized Period|Did not receive study drug|0|||
30619885|NCT01218659|58630960|FG001|18-Month Randomized Period|Did not receive study drug|3|||
30619886|NCT01218659|58630961|FG002|18-Month Randomized Period|Did not receive study drug|0|||
30619887|NCT01218659|58630959|FG000|12-Month OLE|Withdrawal by Subject|0|||
30619888|NCT01218659|58630960|FG001|12-Month OLE|Withdrawal by Subject|0|||
30701015|NCT00510874|58715218|FG005|Overall Study|Withdrawal by Subject|0|||
30701016|NCT00510874|58715219|FG006|Overall Study|Withdrawal by Subject|0|||
30701017|NCT00510874|58715213|FG000|Overall Study|Lost to Follow-up|2|||
30701018|NCT00510874|58715214|FG001|Overall Study|Lost to Follow-up|3|||
30701019|NCT00510874|58715215|FG002|Overall Study|Lost to Follow-up|1|||
30701020|NCT00510874|58715216|FG003|Overall Study|Lost to Follow-up|3|||
30701021|NCT00510874|58715217|FG004|Overall Study|Lost to Follow-up|4|||
30701022|NCT00510874|58715218|FG005|Overall Study|Lost to Follow-up|0|||
30701023|NCT00510874|58715219|FG006|Overall Study|Lost to Follow-up|1|||
30701024|NCT00739661|58715238|FG000|Overall Study|Adverse Event|2|||
30701025|NCT00739661|58715239|FG001|Overall Study|Adverse Event|0|||
30701026|NCT00739661|58715238|FG000|Overall Study|Physician decision to withdraw patient|1|||
30701027|NCT00739661|58715239|FG001|Overall Study|Physician decision to withdraw patient|0|||
30701028|NCT00739661|58715238|FG000|Overall Study|Patient decision to withdraw|9|||
30701029|NCT00739661|58715239|FG001|Overall Study|Patient decision to withdraw|4|||
30701030|NCT00739661|58715238|FG000|Overall Study|Disease progression, radiographic|33|||
30701031|NCT00739661|58715239|FG001|Overall Study|Disease progression, radiographic|37|||
30701032|NCT00739661|58715238|FG000|Overall Study|Reason for discontinuation not available|1|||
30701033|NCT00739661|58715239|FG001|Overall Study|Reason for discontinuation not available|1|||
30701034|NCT00615030|58715245|FG000|Period I|Administrative problem|0|||
30701035|NCT00615030|58715246|FG001|Period I|Administrative problem|0|||
30701036|NCT00615030|58715247|FG002|Period I|Administrative problem|0|||
30701037|NCT00615030|58715248|FG003|Period I|Administrative problem|0|||
30701038|NCT00615030|58715249|FG004|Period I|Administrative problem|1|||
30701039|NCT00615030|58715250|FG005|Period I|Administrative problem|0|||
30701040|NCT00615030|58715251|FG006|Period I|Administrative problem|0|||
30701041|NCT00615030|58715252|FG007|Period I|Administrative problem|0|||
30701042|NCT00615030|58715253|FG008|Period I|Administrative problem|0|||
30701043|NCT00615030|58715254|FG009|Period I|Administrative problem|0|||
30701044|NCT00615030|58715255|FG010|Period I|Administrative problem|0|||
30701045|NCT00615030|58715256|FG011|Period I|Administrative problem|0|||
30701046|NCT00615030|58715245|FG000|Period I|Protocol deviation|1|||
30701047|NCT00615030|58715246|FG001|Period I|Protocol deviation|0|||
30701048|NCT00615030|58715247|FG002|Period I|Protocol deviation|0|||
30701049|NCT00615030|58715248|FG003|Period I|Protocol deviation|0|||
30701050|NCT00615030|58715249|FG004|Period I|Protocol deviation|0|||
30701051|NCT00615030|58715250|FG005|Period I|Protocol deviation|0|||
30701052|NCT00615030|58715251|FG006|Period I|Protocol deviation|0|||
30701053|NCT00615030|58715252|FG007|Period I|Protocol deviation|0|||
30701054|NCT00615030|58715253|FG008|Period I|Protocol deviation|0|||
30701055|NCT00615030|58715254|FG009|Period I|Protocol deviation|0|||
30701056|NCT00615030|58715255|FG010|Period I|Protocol deviation|0|||
30701057|NCT00615030|58715256|FG011|Period I|Protocol deviation|0|||
30701058|NCT00615030|58715245|FG000|Period I|Subject withdrew consent|0|||
30701059|NCT00615030|58715246|FG001|Period I|Subject withdrew consent|0|||
30701060|NCT00615030|58715247|FG002|Period I|Subject withdrew consent|0|||
30701061|NCT00615030|58715248|FG003|Period I|Subject withdrew consent|0|||
30701062|NCT00615030|58715249|FG004|Period I|Subject withdrew consent|0|||
30701063|NCT00615030|58715250|FG005|Period I|Subject withdrew consent|0|||
30701064|NCT00615030|58715251|FG006|Period I|Subject withdrew consent|0|||
30701065|NCT00615030|58715252|FG007|Period I|Subject withdrew consent|0|||
30701066|NCT00615030|58715253|FG008|Period I|Subject withdrew consent|1|||
30701067|NCT00615030|58715254|FG009|Period I|Subject withdrew consent|0|||
30701068|NCT00615030|58715255|FG010|Period I|Subject withdrew consent|1|||
30701069|NCT00615030|58715256|FG011|Period I|Subject withdrew consent|1|||
30701070|NCT00615030|58715245|FG000|Period I|Abnormal laboratory value(s)|0|||
30701071|NCT00615030|58715246|FG001|Period I|Abnormal laboratory value(s)|0|||
30701072|NCT00615030|58715247|FG002|Period I|Abnormal laboratory value(s)|0|||
30701073|NCT00615030|58715248|FG003|Period I|Abnormal laboratory value(s)|0|||
30701074|NCT00615030|58715249|FG004|Period I|Abnormal laboratory value(s)|0|||
30701075|NCT00615030|58715250|FG005|Period I|Abnormal laboratory value(s)|1|||
30701076|NCT00615030|58715251|FG006|Period I|Abnormal laboratory value(s)|0|||
30701077|NCT00615030|58715252|FG007|Period I|Abnormal laboratory value(s)|0|||
30701078|NCT00615030|58715253|FG008|Period I|Abnormal laboratory value(s)|0|||
30701079|NCT00615030|58715254|FG009|Period I|Abnormal laboratory value(s)|0|||
30619889|NCT01218659|58630961|FG002|12-Month OLE|Withdrawal by Subject|2|||
30619890|NCT01218659|58630959|FG000|12-Month OLE|Physician Decision|0|||
30619891|NCT01218659|58630960|FG001|12-Month OLE|Physician Decision|0|||
30619892|NCT01218659|58630961|FG002|12-Month OLE|Physician Decision|1|||
30619893|NCT01218659|58630959|FG000|12-Month OLE|Lost to Follow-up|0|||
30619894|NCT01218659|58630960|FG001|12-Month OLE|Lost to Follow-up|0|||
30619895|NCT01218659|58630961|FG002|12-Month OLE|Lost to Follow-up|1|||
30619896|NCT01218659|58630959|FG000|12-Month OLE|Pregnancy|0|||
30701080|NCT00615030|58715255|FG010|Period I|Abnormal laboratory value(s)|0|||
30701081|NCT00615030|58715256|FG011|Period I|Abnormal laboratory value(s)|0|||
30619897|NCT01218659|58630960|FG001|12-Month OLE|Pregnancy|0|||
30619898|NCT01218659|58630961|FG002|12-Month OLE|Pregnancy|1|||
30701082|NCT00615030|58715245|FG000|Period II|Adverse Event|0|||
30701083|NCT00615030|58715246|FG001|Period II|Adverse Event|0|||
30701084|NCT00615030|58715247|FG002|Period II|Adverse Event|1|||
30701085|NCT00615030|58715248|FG003|Period II|Adverse Event|0|||
30701086|NCT00615030|58715249|FG004|Period II|Adverse Event|0|||
30701087|NCT00615030|58715250|FG005|Period II|Adverse Event|0|||
30701088|NCT00615030|58715251|FG006|Period II|Adverse Event|0|||
30701089|NCT00615030|58715252|FG007|Period II|Adverse Event|0|||
30701090|NCT00615030|58715253|FG008|Period II|Adverse Event|1|||
30701091|NCT00615030|58715254|FG009|Period II|Adverse Event|0|||
30701092|NCT00615030|58715255|FG010|Period II|Adverse Event|0|||
30701093|NCT00615030|58715256|FG011|Period II|Adverse Event|0|||
30701094|NCT00615030|58715245|FG000|Period II|Subject withdrew consent|0|||
30701095|NCT00615030|58715246|FG001|Period II|Subject withdrew consent|0|||
30701096|NCT00615030|58715247|FG002|Period II|Subject withdrew consent|0|||
30701097|NCT00615030|58715248|FG003|Period II|Subject withdrew consent|1|||
30701098|NCT00615030|58715249|FG004|Period II|Subject withdrew consent|0|||
30701099|NCT00615030|58715250|FG005|Period II|Subject withdrew consent|0|||
30701100|NCT00615030|58715251|FG006|Period II|Subject withdrew consent|1|||
30701101|NCT00615030|58715252|FG007|Period II|Subject withdrew consent|0|||
30701102|NCT00615030|58715253|FG008|Period II|Subject withdrew consent|0|||
30701103|NCT00615030|58715254|FG009|Period II|Subject withdrew consent|0|||
30701104|NCT00615030|58715255|FG010|Period II|Subject withdrew consent|0|||
30893592|NCT02186301|58927111|FG001|Overall Study|Protocol Deviation|2|||
30893593|NCT02186301|58927112|FG002|Overall Study|Protocol Deviation|0|||
30893594|NCT02186301|58927110|FG000|Overall Study|Missing|0|||
30893595|NCT02186301|58927111|FG001|Overall Study|Missing|0|||
30893596|NCT02186301|58927112|FG002|Overall Study|Missing|2|||
30893597|NCT02186301|58927110|FG000|Overall Study|Other|0|||
30893598|NCT02186301|58927111|FG001|Overall Study|Other|0|||
30893599|NCT02186301|58927112|FG002|Overall Study|Other|1|||
30893600|NCT02186223|58927122|FG000|Overall Study|Not eligible for device placement|6|||
30893601|NCT02186223|58927122|FG000|Overall Study|Unable to obtain femoral access|3|||
30893602|NCT02186223|58927122|FG000|Overall Study|Death|3|||
30893603|NCT02186223|58927122|FG000|Overall Study|Device in place less than 48 hours|9|||
30893604|NCT02163057|58927129|FG000|Overall Study|Participant Refusal to Continue|2|||
30893605|NCT02163057|58927130|FG001|Overall Study|Participant Refusal to Continue|2|||
30893606|NCT02163057|58927129|FG000|Overall Study|Participant Significant Noncompliance|0|||
30893607|NCT02163057|58927130|FG001|Overall Study|Participant Significant Noncompliance|1|||
30893608|NCT02163057|58927129|FG000|Overall Study|Progression of Disease|1|||
30893609|NCT02163057|58927130|FG001|Overall Study|Progression of Disease|2|||
30893610|NCT02185521|58927138|FG000|Overall Study|Withdrawal by Subject|1|||
30893611|NCT02185521|58927138|FG000|Overall Study|Protocol Violation|1|||
30893612|NCT01599585|58927145|FG000|Overall Study|Withdrawal by Subject|16|||
30893613|NCT01599585|58927146|FG001|Overall Study|Withdrawal by Subject|9|||
30893614|NCT01599585|58927145|FG000|Overall Study|Lost to Follow-up|3|||
30893615|NCT01599585|58927146|FG001|Overall Study|Lost to Follow-up|5|||
30701105|NCT00615030|58715256|FG011|Period II|Subject withdrew consent|0|||
30701106|NCT00615030|58715245|FG000|Period III|Administrative problems|1|||
30701107|NCT00615030|58715246|FG001|Period III|Administrative problems|0|||
30701108|NCT00615030|58715247|FG002|Period III|Administrative problems|0|||
30701109|NCT00615030|58715248|FG003|Period III|Administrative problems|1|||
30893616|NCT01599585|58927145|FG000|Overall Study|randomized did not start treatment|3|||
30893617|NCT01599585|58927146|FG001|Overall Study|randomized did not start treatment|3|||
30701110|NCT00615030|58715249|FG004|Period III|Administrative problems|0|||
30701111|NCT00615030|58715250|FG005|Period III|Administrative problems|0|||
30701112|NCT00615030|58715251|FG006|Period III|Administrative problems|0|||
30701113|NCT00615030|58715252|FG007|Period III|Administrative problems|0|||
30701114|NCT00615030|58715253|FG008|Period III|Administrative problems|0|||
30701115|NCT00615030|58715254|FG009|Period III|Administrative problems|0|||
30701116|NCT00615030|58715255|FG010|Period III|Administrative problems|0|||
30701117|NCT00615030|58715256|FG011|Period III|Administrative problems|0|||
30701118|NCT00518284|58715274|FG000|Overall Study|Adverse Event|0|||
30701119|NCT00518284|58715275|FG001|Overall Study|Adverse Event|1|||
30701120|NCT00518284|58715276|FG002|Overall Study|Adverse Event|0|||
30701121|NCT00518284|58715277|FG003|Overall Study|Adverse Event|0|||
30701122|NCT00518284|58715274|FG000|Overall Study|Study Termination|0|||
30701123|NCT00518284|58715275|FG001|Overall Study|Study Termination|2|||
30701124|NCT00518284|58715276|FG002|Overall Study|Study Termination|1|||
30701125|NCT00518284|58715277|FG003|Overall Study|Study Termination|2|||
30701126|NCT00614874|58715287|FG000|Overall Study|Protocol Violation|1|||
30701127|NCT00614874|58715287|FG000|Overall Study|Withdrawal by Subject|1|||
30701128|NCT00727415|58715291|FG000|Phase I|Dose Limiting Toxicity|2|||
30790849|NCT03524092|58803940|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
30619899|NCT01218659|58630959|FG000|12-Month OLE|Lack of Efficacy|0|||
30619900|NCT01218659|58630960|FG001|12-Month OLE|Lack of Efficacy|0|||
30619901|NCT01218659|58630961|FG002|12-Month OLE|Lack of Efficacy|1|||
30619902|NCT01218659|58630959|FG000|12-Month OLE|Declined to participate in the OLE|0|||
30619903|NCT01218659|58630960|FG001|12-Month OLE|Declined to participate in the OLE|0|||
30701129|NCT00544557|58715295|FG000|Overall Study|Adverse Event|140|||
30701130|NCT00544557|58715295|FG000|Overall Study|Lack of Efficacy|196|||
30701131|NCT00544557|58715295|FG000|Overall Study|Other|98|||
30701132|NCT00727259|58715299|FG000|Overall Study|Not all questionnaires completed|1055|||
30701133|NCT00735371|58715308|FG000|Overall Study|Adverse Event|3|||
30701134|NCT00735371|58715309|FG001|Overall Study|Adverse Event|3|||
30701135|NCT00735371|58715310|FG002|Overall Study|Adverse Event|4|||
30701136|NCT00735371|58715311|FG003|Overall Study|Adverse Event|1|||
30701137|NCT00735371|58715308|FG000|Overall Study|Protocol Violation|2|||
30701138|NCT00735371|58715309|FG001|Overall Study|Protocol Violation|2|||
30701139|NCT00735371|58715310|FG002|Overall Study|Protocol Violation|0|||
30701140|NCT00735371|58715311|FG003|Overall Study|Protocol Violation|3|||
30701141|NCT00735371|58715308|FG000|Overall Study|Withdrawal by Subject|0|||
30701142|NCT00735371|58715309|FG001|Overall Study|Withdrawal by Subject|2|||
30701143|NCT00735371|58715310|FG002|Overall Study|Withdrawal by Subject|2|||
30701144|NCT00735371|58715311|FG003|Overall Study|Withdrawal by Subject|0|||
30701145|NCT00735371|58715308|FG000|Overall Study|Lost to Follow-up|1|||
30701146|NCT00735371|58715309|FG001|Overall Study|Lost to Follow-up|1|||
30701147|NCT00735371|58715310|FG002|Overall Study|Lost to Follow-up|3|||
30701148|NCT00735371|58715311|FG003|Overall Study|Lost to Follow-up|1|||
30701149|NCT00735371|58715308|FG000|Overall Study|Lack of Efficacy|4|||
30701150|NCT00735371|58715309|FG001|Overall Study|Lack of Efficacy|2|||
30701151|NCT00735371|58715310|FG002|Overall Study|Lack of Efficacy|0|||
30701152|NCT00735371|58715311|FG003|Overall Study|Lack of Efficacy|4|||
30701153|NCT00735371|58715308|FG000|Overall Study|Sponsor Decision|3|||
30701154|NCT00735371|58715309|FG001|Overall Study|Sponsor Decision|1|||
30701155|NCT00735371|58715310|FG002|Overall Study|Sponsor Decision|0|||
30701156|NCT00735371|58715311|FG003|Overall Study|Sponsor Decision|1|||
30701157|NCT00735371|58715308|FG000|Overall Study|Protocol Violation|0|||
30701158|NCT00735371|58715309|FG001|Overall Study|Protocol Violation|1|||
30701159|NCT00735371|58715310|FG002|Overall Study|Protocol Violation|2|||
30701160|NCT00735371|58715311|FG003|Overall Study|Protocol Violation|0|||
30701161|NCT00735371|58715308|FG000|Overall Study|Prior Vyvanse Exposure|1|||
30701162|NCT00735371|58715309|FG001|Overall Study|Prior Vyvanse Exposure|1|||
30701163|NCT00735371|58715310|FG002|Overall Study|Prior Vyvanse Exposure|0|||
30701164|NCT00735371|58715311|FG003|Overall Study|Prior Vyvanse Exposure|0|||
30701165|NCT00735371|58715308|FG000|Overall Study|Exclusion criteria|1|||
30701166|NCT00735371|58715309|FG001|Overall Study|Exclusion criteria|0|||
30701167|NCT00735371|58715310|FG002|Overall Study|Exclusion criteria|0|||
30701168|NCT00735371|58715311|FG003|Overall Study|Exclusion criteria|0|||
30701169|NCT00518206|58715323|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
30701170|NCT00518206|58715324|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
30701171|NCT00518206|58715323|FG000|Overall Study|Withdrawal by Subject|2|||
30701172|NCT00518206|58715324|FG001|Overall Study|Withdrawal by Subject|0|||
30701173|NCT00518206|58715323|FG000|Overall Study|Drug Supply Issue|1|||
30701174|NCT00518206|58715324|FG001|Overall Study|Drug Supply Issue|0|||
30701175|NCT00518206|58715323|FG000|Overall Study|Reason Unknown|1|||
30701176|NCT00518206|58715324|FG001|Overall Study|Reason Unknown|0|||
30701177|NCT00518206|58715323|FG000|Overall Study|Completion Status Unknown|1|||
30701178|NCT00518206|58715324|FG001|Overall Study|Completion Status Unknown|0|||
30701179|NCT00586313|58715330|FG000|Overall Study|Lack of Efficacy|2|||
30701180|NCT00727025|58715334|FG000|Overall Study|Physician Decision|23|||
30701181|NCT00734747|58715342|FG000|SRS Procedure|No staples placed|3|||
30701182|NCT00734747|58715342|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
30701183|NCT00726557|58715346|FG000|Overall Study|Screening failure|4|||
30701184|NCT00726557|58715346|FG000|Overall Study|No end of treatment documentation|37|||
30701185|NCT00726557|58715346|FG000|Overall Study|No follow-up documentation available|55|||
30701186|NCT00726557|58715346|FG000|Overall Study|Treatment less than 3 months|17|||
30701187|NCT00726557|58715346|FG000|Overall Study|Inclusion criteria not met|15|||
30701188|NCT00738881|58715353|FG000|Overall Study|Withdrawal by Subject|0|||
30701189|NCT00738881|58715354|FG001|Overall Study|Withdrawal by Subject|2|||
30701190|NCT00657020|58715360|FG000|PERIOD 1|Adverse Event|0|||
30701191|NCT00657020|58715361|FG001|PERIOD 1|Adverse Event|1|||
30701192|NCT03921723|58715373|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
30701193|NCT03921723|58715373|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
30701194|NCT00544167|58715381|FG000|Overall Study|Adverse Event|21|||
30701195|NCT00544167|58715381|FG000|Overall Study|Physician Decision|8|||
30701196|NCT00659438|58715387|FG000|Overall Study|Withdrawal by Subject|2|||
30701197|NCT00659438|58715388|FG001|Overall Study|Withdrawal by Subject|2|||
30701198|NCT00659438|58715387|FG000|Overall Study|Death|11|||
30701199|NCT00659438|58715388|FG001|Overall Study|Death|6|||
30701200|NCT00659438|58715387|FG000|Overall Study|Lost to Follow-up|1|||
30701201|NCT00659438|58715388|FG001|Overall Study|Lost to Follow-up|0|||
30701202|NCT00543855|58715398|FG000|Overall Study|Adverse Event|3|||
30701203|NCT00543855|58715399|FG001|Overall Study|Adverse Event|1|||
30701204|NCT00543855|58715400|FG002|Overall Study|Adverse Event|3|||
30701205|NCT00543855|58715401|FG003|Overall Study|Adverse Event|4|||
30701206|NCT00543855|58715398|FG000|Overall Study|Lost to Follow-up|0|||
30701207|NCT00543855|58715399|FG001|Overall Study|Lost to Follow-up|0|||
30701208|NCT00543855|58715400|FG002|Overall Study|Lost to Follow-up|1|||
30701209|NCT00543855|58715401|FG003|Overall Study|Lost to Follow-up|0|||
30701210|NCT00543855|58715398|FG000|Overall Study|Withdrawal by Subject|0|||
30701211|NCT00543855|58715399|FG001|Overall Study|Withdrawal by Subject|1|||
30701212|NCT00543855|58715400|FG002|Overall Study|Withdrawal by Subject|2|||
30701213|NCT00543855|58715401|FG003|Overall Study|Withdrawal by Subject|0|||
30701214|NCT00543855|58715398|FG000|Overall Study|Protocol Violation|1|||
30701215|NCT00543855|58715399|FG001|Overall Study|Protocol Violation|0|||
30701216|NCT00543855|58715400|FG002|Overall Study|Protocol Violation|0|||
30701217|NCT00543855|58715401|FG003|Overall Study|Protocol Violation|0|||
30701218|NCT00656474|58715411|FG000|Overall Study|Other Reason|1|||
30701219|NCT00656084|58715416|FG000|Overall Study|Adverse Event|4|||
30701220|NCT00656084|58715416|FG000|Overall Study|Withdrawal by Subject|1|||
30701221|NCT00656084|58715416|FG000|Overall Study|Patient Request|1|||
30701222|NCT00656084|58715416|FG000|Overall Study|Investigator Request|1|||
30701223|NCT00613938|58715424|FG000|Overall Study|Withdrawal by Subject|2|||
30701224|NCT00613938|58715425|FG001|Overall Study|Withdrawal by Subject|4|||
30701225|NCT00613938|58715426|FG002|Overall Study|Withdrawal by Subject|9|||
30701226|NCT00613938|58715427|FG003|Overall Study|Withdrawal by Subject|9|||
30701227|NCT00613938|58715424|FG000|Overall Study|Adverse Event|1|||
30701228|NCT00613938|58715425|FG001|Overall Study|Adverse Event|4|||
30701229|NCT00613938|58715426|FG002|Overall Study|Adverse Event|8|||
30701230|NCT00613938|58715427|FG003|Overall Study|Adverse Event|5|||
30701231|NCT00613938|58715424|FG000|Overall Study|Lack of Efficacy|16|||
30701232|NCT00613938|58715425|FG001|Overall Study|Lack of Efficacy|18|||
30701233|NCT00613938|58715426|FG002|Overall Study|Lack of Efficacy|5|||
30701234|NCT00613938|58715427|FG003|Overall Study|Lack of Efficacy|9|||
30701235|NCT00613938|58715424|FG000|Overall Study|Other|1|||
30701236|NCT00613938|58715425|FG001|Overall Study|Other|2|||
30701237|NCT00613938|58715426|FG002|Overall Study|Other|1|||
30701238|NCT00613938|58715427|FG003|Overall Study|Other|3|||
30701239|NCT00655928|58715439|FG000|Overall Study|Withdrawal by Subject|2|||
30701240|NCT00655928|58715440|FG001|Overall Study|Withdrawal by Subject|1|||
30701241|NCT00655928|58715439|FG000|Overall Study|Physician Decision|1|||
30701242|NCT00655928|58715440|FG001|Overall Study|Physician Decision|1|||
30701243|NCT00655850|58715446|FG000|Overall Study|Death|2|||
30701244|NCT00655850|58715446|FG000|Overall Study|Withdrawal by Subject|1|||
30701245|NCT00726323|58715454|FG000|Overall Study|Withdrawal by Subject|3|||
30701246|NCT00726323|58715455|FG001|Overall Study|Withdrawal by Subject|1|||
30701247|NCT00726323|58715454|FG000|Overall Study|Physician Decision|1|||
30701248|NCT00726323|58715455|FG001|Overall Study|Physician Decision|0|||
30701249|NCT00726323|58715454|FG000|Overall Study|Progressive disease|23|||
30701250|NCT00726323|58715455|FG001|Overall Study|Progressive disease|16|||
30701251|NCT00726323|58715454|FG000|Overall Study|Clinical progression|0|||
30701252|NCT00726323|58715455|FG001|Overall Study|Clinical progression|3|||
30701253|NCT00726323|58715454|FG000|Overall Study|Adverse Event|9|||
30701254|NCT00726323|58715455|FG001|Overall Study|Adverse Event|9|||
30701255|NCT00726323|58715454|FG000|Overall Study|Death|1|||
30701256|NCT00726323|58715455|FG001|Overall Study|Death|0|||
30701257|NCT00726323|58715454|FG000|Overall Study|Participant wished to discontinue|0|||
30701258|NCT00726323|58715455|FG001|Overall Study|Participant wished to discontinue|1|||
30701259|NCT00726323|58715454|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
30701260|NCT00726323|58715455|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
30701261|NCT00246571|58715463|FG000|Overall Study|Adverse Event|7|||
30701262|NCT00246571|58715464|FG001|Overall Study|Adverse Event|0|||
30701263|NCT00246571|58715463|FG000|Overall Study|Protocol Violation|0|||
30701264|NCT00246571|58715464|FG001|Overall Study|Protocol Violation|1|||
30701265|NCT00246571|58715463|FG000|Overall Study|Withdrawal by Subject|2|||
30701266|NCT00246571|58715464|FG001|Overall Study|Withdrawal by Subject|3|||
30701267|NCT00246571|58715463|FG000|Overall Study|Lack of Efficacy|84|||
30701268|NCT00246571|58715464|FG001|Overall Study|Lack of Efficacy|21|||
30701269|NCT00246571|58715463|FG000|Overall Study|Death|17|||
30701270|NCT00246571|58715464|FG001|Overall Study|Death|3|||
30701271|NCT00246571|58715463|FG000|Overall Study|Sponsor|0|||
30701272|NCT00246571|58715464|FG001|Overall Study|Sponsor|1|||
30701273|NCT00246571|58715463|FG000|Overall Study|Did not meet entrance criteria|2|||
30701274|NCT00246571|58715464|FG001|Overall Study|Did not meet entrance criteria|1|||
30701275|NCT00246571|58715463|FG000|Overall Study|Laboratory abnormalities|1|||
30893618|NCT02185053|58927152|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
30893619|NCT02185053|58927153|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
30701276|NCT00246571|58715464|FG001|Overall Study|Laboratory abnormalities|0|||
30701277|NCT00246571|58715463|FG000|Overall Study|Crossover participants|0|||
30893620|NCT02185053|58927154|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
30893621|NCT02185053|58927152|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
30701278|NCT00246571|58715464|FG001|Overall Study|Crossover participants|74|||
30701279|NCT00734591|58715472|FG000|Screening for Prospective Period|Site did not participate|1604|||
30701280|NCT00734591|58715473|FG001|Screening for Prospective Period|Site did not participate|1488|||
30760593|NCT03381274|58769072|FG002|Overall Study|Withdrawal by Subject|3|||
30701281|NCT00734591|58715472|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
30701282|NCT00734591|58715473|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
30701283|NCT00734591|58715472|FG000|Prospective Period|Withdrawal by Subject|11|||
30701284|NCT00734591|58715473|FG001|Prospective Period|Withdrawal by Subject|9|||
30701285|NCT00734591|58715472|FG000|Prospective Period|Lost to Follow-up|37|||
30701286|NCT00734591|58715473|FG001|Prospective Period|Lost to Follow-up|33|||
30701287|NCT00734591|58715472|FG000|Prospective Period|Study Terminated|1|||
30701288|NCT00734591|58715473|FG001|Prospective Period|Study Terminated|0|||
30701289|NCT00734591|58715472|FG000|Prospective Period|Other|2|||
30701290|NCT00734591|58715473|FG001|Prospective Period|Other|2|||
30701291|NCT00569270|58715479|FG000|Period: First Intervention|Protocol Violation|0|||
30701292|NCT00569270|58715480|FG001|Period: First Intervention|Protocol Violation|1|||
30701293|NCT00545103|58715499|FG000|Overall Study|Lack of Efficacy|48|||
30701294|NCT00545103|58715500|FG001|Overall Study|Lack of Efficacy|45|||
30701295|NCT00545103|58715501|FG002|Overall Study|Lack of Efficacy|31|||
30701296|NCT00545103|58715502|FG003|Overall Study|Lack of Efficacy|27|||
30701297|NCT00545103|58715499|FG000|Overall Study|Withdrawal by Subject|6|||
30701298|NCT00545103|58715500|FG001|Overall Study|Withdrawal by Subject|10|||
30701299|NCT00545103|58715501|FG002|Overall Study|Withdrawal by Subject|18|||
30701300|NCT00545103|58715502|FG003|Overall Study|Withdrawal by Subject|22|||
30701301|NCT00545103|58715499|FG000|Overall Study|Adverse Event|11|||
30701302|NCT00545103|58715500|FG001|Overall Study|Adverse Event|12|||
30701303|NCT00545103|58715501|FG002|Overall Study|Adverse Event|17|||
30701304|NCT00545103|58715502|FG003|Overall Study|Adverse Event|10|||
30701305|NCT00545103|58715499|FG000|Overall Study|Lost to Follow-up|4|||
30701306|NCT00545103|58715500|FG001|Overall Study|Lost to Follow-up|6|||
30701307|NCT00545103|58715501|FG002|Overall Study|Lost to Follow-up|3|||
30701308|NCT00545103|58715502|FG003|Overall Study|Lost to Follow-up|4|||
30701309|NCT00545103|58715499|FG000|Overall Study|Protocol Violation|1|||
30701310|NCT00545103|58715500|FG001|Overall Study|Protocol Violation|2|||
30701311|NCT00545103|58715501|FG002|Overall Study|Protocol Violation|3|||
30701312|NCT00545103|58715502|FG003|Overall Study|Protocol Violation|0|||
30701313|NCT00545103|58715499|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
30701314|NCT00545103|58715500|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
30701315|NCT00545103|58715501|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
30701316|NCT00545103|58715502|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
30701317|NCT00545103|58715499|FG000|Overall Study|Difficult to open package|0|||
30701318|NCT00545103|58715500|FG001|Overall Study|Difficult to open package|0|||
30701319|NCT00545103|58715501|FG002|Overall Study|Difficult to open package|0|||
30701320|NCT00545103|58715502|FG003|Overall Study|Difficult to open package|1|||
30701321|NCT00545103|58715499|FG000|Overall Study|Investigational product not taken|1|||
30701322|NCT00545103|58715500|FG001|Overall Study|Investigational product not taken|0|||
30701323|NCT00545103|58715501|FG002|Overall Study|Investigational product not taken|0|||
30701324|NCT00545103|58715502|FG003|Overall Study|Investigational product not taken|1|||
30701325|NCT00545103|58715499|FG000|Overall Study|Wish to start a family|0|||
30701326|NCT00545103|58715500|FG001|Overall Study|Wish to start a family|0|||
30701327|NCT00545103|58715501|FG002|Overall Study|Wish to start a family|0|||
30701328|NCT00545103|58715502|FG003|Overall Study|Wish to start a family|1|||
30701329|NCT00545103|58715499|FG000|Overall Study|Diverticulitis crisis|0|||
30701330|NCT00545103|58715500|FG001|Overall Study|Diverticulitis crisis|0|||
30701331|NCT00545103|58715501|FG002|Overall Study|Diverticulitis crisis|0|||
30701332|NCT00545103|58715502|FG003|Overall Study|Diverticulitis crisis|1|||
30701333|NCT00545103|58715499|FG000|Overall Study|Personal reasons|1|||
30701334|NCT00545103|58715500|FG001|Overall Study|Personal reasons|0|||
30701335|NCT00545103|58715501|FG002|Overall Study|Personal reasons|0|||
30701336|NCT00545103|58715502|FG003|Overall Study|Personal reasons|0|||
30701337|NCT00545103|58715499|FG000|Overall Study|Subject's decision|1|||
30701338|NCT00545103|58715500|FG001|Overall Study|Subject's decision|0|||
30701339|NCT00545103|58715501|FG002|Overall Study|Subject's decision|0|||
30701340|NCT00545103|58715502|FG003|Overall Study|Subject's decision|0|||
30701341|NCT00545103|58715499|FG000|Overall Study|Noncompliance|0|||
30701342|NCT00545103|58715500|FG001|Overall Study|Noncompliance|1|||
30948463|NCT01719224|58994410|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
30701343|NCT00545103|58715501|FG002|Overall Study|Noncompliance|0|||
30701344|NCT00545103|58715502|FG003|Overall Study|Noncompliance|0|||
30701345|NCT00545103|58715499|FG000|Overall Study|Investigator decision|0|||
30701346|NCT00545103|58715500|FG001|Overall Study|Investigator decision|0|||
30701347|NCT00545103|58715501|FG002|Overall Study|Investigator decision|1|||
30701348|NCT00545103|58715502|FG003|Overall Study|Investigator decision|0|||
30701349|NCT00545103|58715499|FG000|Overall Study|Subject moved|0|||
30701350|NCT00545103|58715500|FG001|Overall Study|Subject moved|1|||
30701351|NCT00545103|58715501|FG002|Overall Study|Subject moved|0|||
30790850|NCT03524092|58803941|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
30948464|NCT01719224|58994411|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
30948465|NCT01717976|58994422|FG000|Overall Study|Protocol Violation|0|||
30948466|NCT01717976|58994423|FG001|Overall Study|Protocol Violation|1|||
30948467|NCT01740440|58994429|FG000|Overall Study|Lost to Follow-up|3|||
30948468|NCT01740128|58994436|FG000|Overall Study|Pregnancy|0|||
30948469|NCT01740128|58994437|FG001|Overall Study|Pregnancy|1|||
30948470|NCT01740128|58994436|FG000|Overall Study|Protocol Violation|1|||
30948471|NCT01740128|58994437|FG001|Overall Study|Protocol Violation|2|||
30948472|NCT01740128|58994436|FG000|Overall Study|Lost to Follow-up|2|||
30948473|NCT01740128|58994437|FG001|Overall Study|Lost to Follow-up|2|||
30948474|NCT01740128|58994436|FG000|Overall Study|Withdrawal by Subject|1|||
30948475|NCT01740128|58994437|FG001|Overall Study|Withdrawal by Subject|0|||
30948476|NCT01740128|58994436|FG000|Overall Study|Insufficient protocol compliance|2|||
30948477|NCT01740128|58994437|FG001|Overall Study|Insufficient protocol compliance|2|||
30948478|NCT01976741|58994453|FG000|Overall Study|Withdrawal by Subject|1|||
30948479|NCT01976741|58994454|FG001|Overall Study|Withdrawal by Subject|0|||
30701352|NCT00545103|58715502|FG003|Overall Study|Subject moved|0|||
30701353|NCT00545103|58715499|FG000|Overall Study|Use of prohibited medication|0|||
30701354|NCT00545103|58715500|FG001|Overall Study|Use of prohibited medication|0|||
30701355|NCT00545103|58715501|FG002|Overall Study|Use of prohibited medication|1|||
30701356|NCT00545103|58715502|FG003|Overall Study|Use of prohibited medication|0|||
30701357|NCT00545103|58715499|FG000|Overall Study|Does not want to take study drug anymore|1|||
30701358|NCT00545103|58715500|FG001|Overall Study|Does not want to take study drug anymore|0|||
30701359|NCT00545103|58715501|FG002|Overall Study|Does not want to take study drug anymore|1|||
30701360|NCT00545103|58715502|FG003|Overall Study|Does not want to take study drug anymore|0|||
30701361|NCT00545103|58715499|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
30701362|NCT00545103|58715500|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
30701363|NCT00545103|58715501|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
30701364|NCT00545103|58715502|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
30701365|NCT00545103|58715499|FG000|Overall Study|Death|0|||
30701366|NCT00545103|58715500|FG001|Overall Study|Death|1|||
30701367|NCT00545103|58715501|FG002|Overall Study|Death|0|||
30701368|NCT00545103|58715502|FG003|Overall Study|Death|0|||
30701369|NCT00586157|58715512|FG000|First Intervention|Worsening behavior|1|||
30701370|NCT00586157|58715513|FG001|First Intervention|Worsening behavior|0|||
30701371|NCT00586157|58715512|FG000|Second Intervention|Withdrawal by Subject|1|||
30701372|NCT00586157|58715513|FG001|Second Intervention|Withdrawal by Subject|0|||
30701373|NCT00586157|58715512|FG000|Second Intervention|Worsening behavior|1|||
30701374|NCT00586157|58715513|FG001|Second Intervention|Worsening behavior|0|||
30701375|NCT00586157|58715512|FG000|Second Intervention|Adverse Event|0|||
30701376|NCT00586157|58715513|FG001|Second Intervention|Adverse Event|1|||
30701377|NCT00246337|58715528|FG000|Overall Study|Lost to Follow-up|3|||
30701378|NCT00246337|58715529|FG001|Overall Study|Lost to Follow-up|0|||
30701379|NCT00246337|58715530|FG002|Overall Study|Lost to Follow-up|0|||
30701380|NCT00246337|58715531|FG003|Overall Study|Lost to Follow-up|0|||
30701381|NCT00246337|58715532|FG004|Overall Study|Lost to Follow-up|2|||
30701382|NCT00246337|58715533|FG005|Overall Study|Lost to Follow-up|2|||
30701383|NCT00246337|58715534|FG006|Overall Study|Lost to Follow-up|1|||
30701384|NCT00246337|58715535|FG007|Overall Study|Lost to Follow-up|2|||
30701385|NCT00246337|58715536|FG008|Overall Study|Lost to Follow-up|0|||
30701386|NCT00246337|58715528|FG000|Overall Study|Protocol Violation|1|||
30701387|NCT00246337|58715529|FG001|Overall Study|Protocol Violation|0|||
30701388|NCT00246337|58715530|FG002|Overall Study|Protocol Violation|0|||
30701389|NCT00246337|58715531|FG003|Overall Study|Protocol Violation|0|||
30701390|NCT00246337|58715532|FG004|Overall Study|Protocol Violation|1|||
30701391|NCT00246337|58715533|FG005|Overall Study|Protocol Violation|0|||
30701392|NCT00246337|58715534|FG006|Overall Study|Protocol Violation|1|||
30701393|NCT00246337|58715535|FG007|Overall Study|Protocol Violation|1|||
30701394|NCT00246337|58715536|FG008|Overall Study|Protocol Violation|0|||
30701395|NCT00246337|58715528|FG000|Overall Study|Withdrawal by Subject|2|||
30701396|NCT00246337|58715529|FG001|Overall Study|Withdrawal by Subject|0|||
30701397|NCT00246337|58715530|FG002|Overall Study|Withdrawal by Subject|0|||
30701398|NCT00246337|58715531|FG003|Overall Study|Withdrawal by Subject|0|||
30701399|NCT00246337|58715532|FG004|Overall Study|Withdrawal by Subject|0|||
30701400|NCT00246337|58715533|FG005|Overall Study|Withdrawal by Subject|0|||
30701401|NCT00246337|58715534|FG006|Overall Study|Withdrawal by Subject|1|||
30701402|NCT00246337|58715535|FG007|Overall Study|Withdrawal by Subject|1|||
30701403|NCT00246337|58715536|FG008|Overall Study|Withdrawal by Subject|0|||
30701404|NCT00246337|58715528|FG000|Overall Study|Lack of Qualifying Event|8|||
30701405|NCT00246337|58715529|FG001|Overall Study|Lack of Qualifying Event|2|||
30701406|NCT00246337|58715530|FG002|Overall Study|Lack of Qualifying Event|1|||
30701407|NCT00246337|58715531|FG003|Overall Study|Lack of Qualifying Event|1|||
30701408|NCT00246337|58715532|FG004|Overall Study|Lack of Qualifying Event|1|||
30701409|NCT00246337|58715533|FG005|Overall Study|Lack of Qualifying Event|3|||
30701410|NCT00246337|58715534|FG006|Overall Study|Lack of Qualifying Event|3|||
30701411|NCT00246337|58715535|FG007|Overall Study|Lack of Qualifying Event|2|||
30701412|NCT00246337|58715536|FG008|Overall Study|Lack of Qualifying Event|5|||
30701413|NCT00246337|58715528|FG000|Overall Study|Site Terminated|10|||
30701414|NCT00246337|58715529|FG001|Overall Study|Site Terminated|0|||
30701415|NCT00246337|58715530|FG002|Overall Study|Site Terminated|0|||
30701416|NCT00246337|58715531|FG003|Overall Study|Site Terminated|0|||
30701417|NCT00246337|58715532|FG004|Overall Study|Site Terminated|0|||
30701418|NCT00246337|58715533|FG005|Overall Study|Site Terminated|7|||
30701419|NCT00246337|58715534|FG006|Overall Study|Site Terminated|1|||
30701420|NCT00246337|58715535|FG007|Overall Study|Site Terminated|6|||
30701421|NCT00246337|58715536|FG008|Overall Study|Site Terminated|2|||
30701422|NCT00246337|58715528|FG000|Overall Study|Abnormal baseline lab values|7|||
30701423|NCT00246337|58715529|FG001|Overall Study|Abnormal baseline lab values|0|||
30701424|NCT00246337|58715530|FG002|Overall Study|Abnormal baseline lab values|2|||
30701425|NCT00246337|58715531|FG003|Overall Study|Abnormal baseline lab values|0|||
30701426|NCT00246337|58715532|FG004|Overall Study|Abnormal baseline lab values|0|||
30701427|NCT00246337|58715533|FG005|Overall Study|Abnormal baseline lab values|2|||
30701428|NCT00246337|58715534|FG006|Overall Study|Abnormal baseline lab values|2|||
30701429|NCT00246337|58715535|FG007|Overall Study|Abnormal baseline lab values|0|||
30701430|NCT00246337|58715536|FG008|Overall Study|Abnormal baseline lab values|4|||
30701431|NCT00246337|58715528|FG000|Overall Study|Overwhelmed|0|||
30701432|NCT00246337|58715529|FG001|Overall Study|Overwhelmed|0|||
30701433|NCT00246337|58715530|FG002|Overall Study|Overwhelmed|0|||
30701434|NCT00246337|58715531|FG003|Overall Study|Overwhelmed|0|||
30701435|NCT00246337|58715532|FG004|Overall Study|Overwhelmed|0|||
30701436|NCT00246337|58715533|FG005|Overall Study|Overwhelmed|1|||
30701437|NCT00246337|58715534|FG006|Overall Study|Overwhelmed|0|||
30701438|NCT00246337|58715535|FG007|Overall Study|Overwhelmed|0|||
30701439|NCT00246337|58715536|FG008|Overall Study|Overwhelmed|0|||
30701440|NCT00246337|58715528|FG000|Overall Study|Protocol Violator|1|||
30701441|NCT00246337|58715529|FG001|Overall Study|Protocol Violator|0|||
30619904|NCT01218659|58630961|FG002|12-Month OLE|Declined to participate in the OLE|4|||
30619905|NCT00940498|58630976|FG000|Overall Study|Death|2|||
30619906|NCT00940498|58630977|FG001|Overall Study|Death|0|||
30619907|NCT00940498|58630978|FG002|Overall Study|Death|0|||
30619908|NCT00940498|58630979|FG003|Overall Study|Death|1|||
30619909|NCT00940498|58630980|FG004|Overall Study|Death|5|||
30619910|NCT00940498|58630981|FG005|Overall Study|Death|0|||
30619911|NCT00940498|58630982|FG006|Overall Study|Death|1|||
30619912|NCT00940498|58630983|FG007|Overall Study|Death|0|||
30619913|NCT00940498|58630976|FG000|Overall Study|Lost to Follow-up|1|||
30619914|NCT00940498|58630977|FG001|Overall Study|Lost to Follow-up|1|||
30701442|NCT00246337|58715530|FG002|Overall Study|Protocol Violator|0|||
30701443|NCT00246337|58715531|FG003|Overall Study|Protocol Violator|0|||
30701444|NCT00246337|58715532|FG004|Overall Study|Protocol Violator|0|||
30701445|NCT00246337|58715533|FG005|Overall Study|Protocol Violator|0|||
30701446|NCT00246337|58715534|FG006|Overall Study|Protocol Violator|0|||
30701447|NCT00246337|58715535|FG007|Overall Study|Protocol Violator|0|||
30701448|NCT00246337|58715536|FG008|Overall Study|Protocol Violator|0|||
30701449|NCT00246337|58715528|FG000|Overall Study|Reported as completing trial in error|0|||
30701450|NCT00246337|58715529|FG001|Overall Study|Reported as completing trial in error|0|||
30701451|NCT00246337|58715530|FG002|Overall Study|Reported as completing trial in error|0|||
30701452|NCT00246337|58715531|FG003|Overall Study|Reported as completing trial in error|0|||
30701453|NCT00246337|58715532|FG004|Overall Study|Reported as completing trial in error|0|||
30701454|NCT00246337|58715533|FG005|Overall Study|Reported as completing trial in error|0|||
30701455|NCT00246337|58715534|FG006|Overall Study|Reported as completing trial in error|0|||
30701456|NCT00246337|58715535|FG007|Overall Study|Reported as completing trial in error|1|||
30701457|NCT00246337|58715536|FG008|Overall Study|Reported as completing trial in error|0|||
30701458|NCT00243919|58715559|FG000|Overall Study|Death|3|||
30701459|NCT00243919|58715560|FG001|Overall Study|Death|4|||
30701460|NCT00243919|58715561|FG002|Overall Study|Death|6|||
30701461|NCT00243919|58715559|FG000|Overall Study|Withdrawal by Subject|6|||
30701462|NCT00243919|58715560|FG001|Overall Study|Withdrawal by Subject|6|||
30701463|NCT00243919|58715561|FG002|Overall Study|Withdrawal by Subject|2|||
30701464|NCT00243919|58715559|FG000|Overall Study|Lost to Follow-up|6|||
30701465|NCT00243919|58715560|FG001|Overall Study|Lost to Follow-up|7|||
30701466|NCT00243919|58715561|FG002|Overall Study|Lost to Follow-up|3|||
30701467|NCT00243919|58715559|FG000|Overall Study|Administrative Error|1|||
30701468|NCT00243919|58715560|FG001|Overall Study|Administrative Error|0|||
30701469|NCT00243919|58715561|FG002|Overall Study|Administrative Error|0|||
30701470|NCT00243919|58715559|FG000|Overall Study|Physician Decision|1|||
30701471|NCT00243919|58715560|FG001|Overall Study|Physician Decision|1|||
30701472|NCT00243919|58715561|FG002|Overall Study|Physician Decision|0|||
30701473|NCT00725621|58715569|FG000|Overall Study|Adverse Event|25|||
30701474|NCT00725621|58715569|FG000|Overall Study|Lack of Efficacy|46|||
30701475|NCT00725621|58715569|FG000|Overall Study|Withdrawal by Subject|57|||
30701476|NCT00725621|58715569|FG000|Overall Study|Physician Decision|19|||
30701477|NCT00725621|58715569|FG000|Overall Study|Lost to Follow-up|52|||
30701478|NCT00725621|58715569|FG000|Overall Study|Non-compliance|8|||
30701479|NCT00725621|58715569|FG000|Overall Study|Continued treatment by other physician|6|||
30701480|NCT00725621|58715569|FG000|Overall Study|Switched to other study|1|||
30701481|NCT00725621|58715569|FG000|Overall Study|Switched to other drug|1|||
30701482|NCT00725621|58715569|FG000|Overall Study|Prepared for elective surgery|1|||
30701483|NCT00725621|58715569|FG000|Overall Study|Reason not specified|55|||
30701484|NCT00613626|58715580|FG000|Overall Study|Ineligible|0|||
30701485|NCT00613626|58715581|FG001|Overall Study|Ineligible|1|||
30701486|NCT00613626|58715582|FG002|Overall Study|Ineligible|0|||
30701487|NCT00725543|58715589|FG000|Overall Study|Adverse Event|10|||
30701488|NCT00725543|58715589|FG000|Overall Study|Lack of Efficacy|3|||
30701489|NCT00725543|58715589|FG000|Overall Study|Withdrawal by Subject|10|||
30701490|NCT00725543|58715589|FG000|Overall Study|Physician Decision|5|||
30701491|NCT00725543|58715589|FG000|Overall Study|Lost to Follow-up|4|||
30701492|NCT00725543|58715589|FG000|Overall Study|Non-compliance|2|||
30701493|NCT00725543|58715589|FG000|Overall Study|Other|119|||
30701494|NCT00239005|58715595|FG000|Overall Study|Adverse Event|6|||
30701495|NCT00239005|58715596|FG001|Overall Study|Adverse Event|6|||
30701496|NCT00239005|58715595|FG000|Overall Study|Withdrawal by Subject|3|||
30701497|NCT00239005|58715596|FG001|Overall Study|Withdrawal by Subject|4|||
30701498|NCT00239005|58715595|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
30701499|NCT00239005|58715596|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
30701500|NCT00239005|58715595|FG000|Overall Study|Protocol Violation|1|||
30701501|NCT00239005|58715596|FG001|Overall Study|Protocol Violation|0|||
30701502|NCT00239005|58715595|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
30701503|NCT00239005|58715596|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
30701504|NCT00239005|58715595|FG000|Overall Study|Lost to Follow-up|0|||
30701505|NCT00239005|58715596|FG001|Overall Study|Lost to Follow-up|1|||
30701506|NCT00616434|58715604|FG000|Overall Study|Adverse Event|5|||
30701507|NCT00616434|58715605|FG001|Overall Study|Adverse Event|2|||
30701508|NCT00616434|58715604|FG000|Overall Study|Physician Decision|0|||
30701509|NCT00616434|58715605|FG001|Overall Study|Physician Decision|4|||
30701510|NCT00616434|58715604|FG000|Overall Study|Withdrawal by Subject|1|||
30701511|NCT00616434|58715605|FG001|Overall Study|Withdrawal by Subject|1|||
30701512|NCT00616434|58715604|FG000|Overall Study|Protocol deviation|0|||
30701513|NCT00616434|58715605|FG001|Overall Study|Protocol deviation|1|||
30701514|NCT00652340|58715613|FG000|Overall Study|Had not progressed.|4|||
30701515|NCT00652340|58715614|FG001|Overall Study|Had not progressed.|3|||
30701516|NCT00613314|58715620|FG000|Overall Study|Adverse Event|5|||
30701517|NCT00613314|58715620|FG000|Overall Study|Protocol Violation|14|||
30701518|NCT00613314|58715620|FG000|Overall Study|Lost to Follow-up|46|||
30701519|NCT00613314|58715620|FG000|Overall Study|Other reason not defined above|90|||
30701520|NCT00257725|58715624|FG000|Overall Study|Adverse Event|3|||
30701521|NCT00544869|58715632|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
30701522|NCT00544869|58715633|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
30701523|NCT00544869|58715634|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
30701524|NCT00544869|58715632|FG000|Overall Study|Adverse Event|6|||
30701525|NCT00544869|58715633|FG001|Overall Study|Adverse Event|1|||
30701526|NCT00544869|58715634|FG002|Overall Study|Adverse Event|0|||
30701527|NCT00544869|58715632|FG000|Overall Study|Lack of Efficacy|1|||
30701528|NCT00544869|58715633|FG001|Overall Study|Lack of Efficacy|1|||
30701529|NCT00544869|58715634|FG002|Overall Study|Lack of Efficacy|0|||
30701530|NCT00544869|58715632|FG000|Overall Study|Physician Decision|2|||
30701531|NCT00544869|58715633|FG001|Overall Study|Physician Decision|0|||
30701532|NCT00544869|58715634|FG002|Overall Study|Physician Decision|0|||
30701533|NCT00725075|58715645|FG000|Overall Study|Use of Excluded Medication|0|||
30701534|NCT00725075|58715646|FG001|Overall Study|Use of Excluded Medication|1|||
30701535|NCT00725075|58715647|FG002|Overall Study|Use of Excluded Medication|0|||
30701536|NCT00725075|58715645|FG000|Overall Study|Protocol Violation|0|||
30701537|NCT00725075|58715646|FG001|Overall Study|Protocol Violation|0|||
30701538|NCT00725075|58715647|FG002|Overall Study|Protocol Violation|1|||
30790851|NCT03524092|58803942|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
30701539|NCT00725075|58715645|FG000|Overall Study|Lost to Follow-up|1|||
30701540|NCT00725075|58715646|FG001|Overall Study|Lost to Follow-up|0|||
30701541|NCT00725075|58715647|FG002|Overall Study|Lost to Follow-up|0|||
30701542|NCT00725075|58715645|FG000|Overall Study|Withdrawal by Subject|4|||
30701543|NCT00725075|58715646|FG001|Overall Study|Withdrawal by Subject|5|||
30701544|NCT00725075|58715647|FG002|Overall Study|Withdrawal by Subject|4|||
30701545|NCT00725075|58715645|FG000|Overall Study|Adverse Event|2|||
30701546|NCT00725075|58715646|FG001|Overall Study|Adverse Event|1|||
30701547|NCT00725075|58715647|FG002|Overall Study|Adverse Event|1|||
30701548|NCT00725075|58715645|FG000|Overall Study|Worsening of Disease|2|||
30701549|NCT00725075|58715646|FG001|Overall Study|Worsening of Disease|1|||
30701550|NCT00725075|58715647|FG002|Overall Study|Worsening of Disease|2|||
30701551|NCT00725075|58715645|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
30701552|NCT00725075|58715646|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
30701553|NCT00725075|58715647|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
30701554|NCT00725075|58715645|FG000|Overall Study|Other|1|||
30701555|NCT00725075|58715646|FG001|Overall Study|Other|0|||
30701556|NCT00725075|58715647|FG002|Overall Study|Other|0|||
30701557|NCT00733499|58715657|FG000|Pre-operative|Protocol Violation|0|||
30701558|NCT00733499|58715658|FG001|Pre-operative|Protocol Violation|1|||
30701559|NCT00733499|58715657|FG000|3 Months Follow-up|Death|1|||
30701560|NCT00733499|58715658|FG001|3 Months Follow-up|Death|2|||
30701561|NCT00733499|58715657|FG000|6 Months Follow-up|Death|0|||
30701562|NCT00733499|58715658|FG001|6 Months Follow-up|Death|2|||
30701563|NCT00733499|58715657|FG000|6 Months Follow-up|Adverse Event|0|||
30701564|NCT00733499|58715658|FG001|6 Months Follow-up|Adverse Event|1|||
30701565|NCT00733499|58715657|FG000|12 Months Follow-up|Death|2|||
30701566|NCT00733499|58715658|FG001|12 Months Follow-up|Death|1|||
30701567|NCT00733499|58715657|FG000|24 Months Follow-up|Death|0|||
30701568|NCT00733499|58715658|FG001|24 Months Follow-up|Death|1|||
30701569|NCT00733499|58715657|FG000|5 Year Followup|Adverse Event|2|||
30701570|NCT00733499|58715658|FG001|5 Year Followup|Adverse Event|2|||
30701571|NCT00733499|58715657|FG000|5 Year Followup|Non device related AE|0|||
30701572|NCT00733499|58715658|FG001|5 Year Followup|Non device related AE|1|||
30701573|NCT00733499|58715657|FG000|5 Year Followup|Revision of Study Implant|0|||
30701574|NCT00733499|58715658|FG001|5 Year Followup|Revision of Study Implant|1|||
30701575|NCT00733499|58715657|FG000|5 Year Followup|Lost to Follow-up|2|||
30893622|NCT02185053|58927153|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
30701576|NCT00733499|58715658|FG001|5 Year Followup|Lost to Follow-up|0|||
30701577|NCT00733499|58715657|FG000|5 Year Followup|Death|13|||
30701578|NCT00733499|58715658|FG001|5 Year Followup|Death|19|||
30701579|NCT00733499|58715657|FG000|5 Year Followup|missing, unable to locate|0|||
30701580|NCT00733499|58715658|FG001|5 Year Followup|missing, unable to locate|1|||
30893623|NCT02185053|58927154|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
30701581|NCT00733499|58715657|FG000|5 Year Followup|Withdrawal by Subject|4|||
30701582|NCT00733499|58715658|FG001|5 Year Followup|Withdrawal by Subject|1|||
30701583|NCT00733499|58715657|FG000|10 Year Followup|Death|9|||
30701584|NCT00733499|58715658|FG001|10 Year Followup|Death|7|||
30701585|NCT00733499|58715657|FG000|10 Year Followup|Adverse Event|3|||
30701586|NCT00733499|58715658|FG001|10 Year Followup|Adverse Event|3|||
30701587|NCT00733499|58715657|FG000|10 Year Followup|Lost to Follow-up|3|||
30893624|NCT02185053|58927152|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
30893625|NCT02185053|58927153|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
30893626|NCT02185053|58927154|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
30701588|NCT00733499|58715658|FG001|10 Year Followup|Lost to Follow-up|2|||
30701589|NCT00733499|58715657|FG000|10 Year Followup|Withdrawal by Subject|5|||
30701590|NCT00733499|58715658|FG001|10 Year Followup|Withdrawal by Subject|5|||
30701591|NCT00733499|58715657|FG000|10 Year Followup|missing, unable to locate|0|||
30701592|NCT00733499|58715658|FG001|10 Year Followup|missing, unable to locate|2|||
30701593|NCT00652028|58715668|FG000|Overall Study|Adverse Event|1|||
30701594|NCT00652028|58715669|FG001|Overall Study|Adverse Event|0|||
30701595|NCT00652028|58715670|FG002|Overall Study|Adverse Event|0|||
30701596|NCT00652028|58715671|FG003|Overall Study|Adverse Event|0|||
30701597|NCT00652028|58715668|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
30701598|NCT00652028|58715669|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
30701599|NCT00652028|58715670|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
30701600|NCT00652028|58715671|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
30701601|NCT00652028|58715668|FG000|Overall Study|Physician Decision|0|||
30701602|NCT00652028|58715669|FG001|Overall Study|Physician Decision|0|||
30701603|NCT00652028|58715670|FG002|Overall Study|Physician Decision|1|||
30701604|NCT00652028|58715671|FG003|Overall Study|Physician Decision|0|||
30701605|NCT00738101|58715681|FG000|Overall Study|Physician Decision|5|||
30701606|NCT00738101|58715681|FG000|Overall Study|Death|1|||
30701607|NCT00738101|58715681|FG000|Overall Study|Repeat enrollment|1|||
30701608|NCT00733421|58715687|FG000|Overall Study|Withdrawal by Subject|1|||
30701609|NCT00733421|58715688|FG001|Overall Study|Withdrawal by Subject|1|||
30701610|NCT00613080|58715694|FG000|Overall Study|Ineligible / no protocol treatment|11|||
30893627|NCT02185053|58927152|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
30701611|NCT00732875|58715698|FG000|Overall Study|Adverse Event|16|||
30701612|NCT00732875|58715698|FG000|Overall Study|Withdrawal by Subject|6|||
30701613|NCT00732875|58715698|FG000|Overall Study|Lack of Efficacy|13|||
30701614|NCT00615264|58715708|FG000|Overall Study|Withdrawal by Subject|17|||
30701615|NCT00615264|58715709|FG001|Overall Study|Withdrawal by Subject|19|||
30701616|NCT00615264|58715708|FG000|Overall Study|Lost to Follow-up|6|||
30701617|NCT00615264|58715709|FG001|Overall Study|Lost to Follow-up|13|||
30701618|NCT00615264|58715708|FG000|Overall Study|Adverse Event|8|||
30701619|NCT00615264|58715709|FG001|Overall Study|Adverse Event|5|||
30701620|NCT00615264|58715708|FG000|Overall Study|Death|1|||
30701621|NCT00615264|58715709|FG001|Overall Study|Death|1|||
30701622|NCT00615264|58715708|FG000|Overall Study|Protocol Violation|11|||
30701623|NCT00615264|58715709|FG001|Overall Study|Protocol Violation|7|||
30701624|NCT00615264|58715708|FG000|Overall Study|Not defined|7|||
30701625|NCT00615264|58715709|FG001|Overall Study|Not defined|4|||
30701626|NCT00615264|58715708|FG000|Overall Study|Dermal Hypersensitivity|0|||
30701627|NCT00615264|58715709|FG001|Overall Study|Dermal Hypersensitivity|3|||
30701628|NCT00732641|58715717|FG000|Overall Study|Relapse or Progressive Disease|65|||
30701629|NCT00732641|58715718|FG001|Overall Study|Relapse or Progressive Disease|101|||
30701630|NCT00732641|58715717|FG000|Overall Study|Serious Adverse Events|12|||
30701631|NCT00732641|58715718|FG001|Overall Study|Serious Adverse Events|3|||
30701632|NCT00732641|58715717|FG000|Overall Study|Physician Decision|6|||
30701633|NCT00732641|58715718|FG001|Overall Study|Physician Decision|0|||
30701634|NCT00732641|58715717|FG000|Overall Study|Withdrawal by Subject|4|||
30893628|NCT02185053|58927153|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
30701635|NCT00732641|58715718|FG001|Overall Study|Withdrawal by Subject|2|||
30701636|NCT00732641|58715717|FG000|Overall Study|Unable to Complete|1|||
30893629|NCT02185053|58927154|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
30701637|NCT00732641|58715718|FG001|Overall Study|Unable to Complete|1|||
30701638|NCT00732641|58715717|FG000|Overall Study|Other|18|||
30701639|NCT00732641|58715718|FG001|Overall Study|Other|5|||
30701640|NCT00737711|58715724|FG000|Overall Study|Adverse Event|2|||
30701641|NCT00737711|58715724|FG000|Overall Study|Death|8|||
30701642|NCT00737711|58715724|FG000|Overall Study|Failure to return|4|||
30701643|NCT00737711|58715724|FG000|Overall Study|Protocol Violation|1|||
30701644|NCT00737711|58715724|FG000|Overall Study|Withdrawal by Subject|5|||
30701645|NCT00737711|58715724|FG000|Overall Study|Blood transfusion|6|||
30701646|NCT00737711|58715724|FG000|Overall Study|Other|5|||
30701647|NCT00615108|58715728|FG000|Overall Study|Adverse Event|122|||
30701648|NCT00615108|58715728|FG000|Overall Study|Other|370|||
30701649|NCT00615108|58715728|FG000|Overall Study|Lost to Follow-up|15|||
30701650|NCT00238303|58715737|FG000|Overall Study|Withdrawal by Subject|11|||
30701651|NCT00238303|58715738|FG001|Overall Study|Withdrawal by Subject|1|||
30701652|NCT00238303|58715739|FG002|Overall Study|Withdrawal by Subject|2|||
30701653|NCT00238303|58715737|FG000|Overall Study|Death|1|||
30701654|NCT00238303|58715738|FG001|Overall Study|Death|0|||
30701655|NCT00238303|58715739|FG002|Overall Study|Death|1|||
30701656|NCT00238303|58715737|FG000|Overall Study|Other Medical Problems|2|||
30701657|NCT00238303|58715738|FG001|Overall Study|Other Medical Problems|0|||
30701658|NCT00238303|58715739|FG002|Overall Study|Other Medical Problems|2|||
30701659|NCT00238303|58715737|FG000|Overall Study|Poor tolerance of study treatment|1|||
30701660|NCT00238303|58715738|FG001|Overall Study|Poor tolerance of study treatment|0|||
30701661|NCT00238303|58715739|FG002|Overall Study|Poor tolerance of study treatment|1|||
30701662|NCT00238303|58715737|FG000|Overall Study|Adverse Event|0|||
30701663|NCT00238303|58715738|FG001|Overall Study|Adverse Event|1|||
30701664|NCT00238303|58715739|FG002|Overall Study|Adverse Event|3|||
30701665|NCT00737633|58715750|FG000|Overall Study|Study terminated by sponsor|44|||
30701666|NCT00737633|58715751|FG001|Overall Study|Study terminated by sponsor|55|||
30701667|NCT00737633|58715750|FG000|Overall Study|Lost to Follow-up|0|||
30701668|NCT00737633|58715751|FG001|Overall Study|Lost to Follow-up|1|||
30701669|NCT00737633|58715750|FG000|Overall Study|protocol non-compliance|0|||
30701670|NCT00737633|58715751|FG001|Overall Study|protocol non-compliance|1|||
30701671|NCT00732251|58715757|FG000|Overall Study|Lost to Follow-up|3|||
30701672|NCT00732251|58715757|FG000|Overall Study|Withdrawal by Subject|3|||
30701673|NCT00732251|58715757|FG000|Overall Study|Early Term due to Site Closure|1|||
30701674|NCT00737477|58715761|FG000|Overall Study|Adverse Event|9|||
30701675|NCT00737477|58715761|FG000|Overall Study|Death|9|||
30701676|NCT00737477|58715761|FG000|Overall Study|Treatment Refusal|1|||
30701677|NCT00737477|58715761|FG000|Overall Study|Withdrawal by Subject|1|||
30701678|NCT00737477|58715761|FG000|Overall Study|Renal Transplantation|10|||
30701679|NCT00737477|58715761|FG000|Overall Study|Other|4|||
30701680|NCT00256867|58715773|FG000|Overall Study|Adverse Event|0|||
30701681|NCT00256867|58715774|FG001|Overall Study|Adverse Event|1|||
30701682|NCT00256867|58715775|FG002|Overall Study|Adverse Event|1|||
30701683|NCT00256867|58715776|FG003|Overall Study|Adverse Event|1|||
30701684|NCT00256867|58715777|FG004|Overall Study|Adverse Event|2|||
30701685|NCT00256867|58715778|FG005|Overall Study|Adverse Event|2|||
30701686|NCT00256867|58715779|FG006|Overall Study|Adverse Event|1|||
30701687|NCT00256867|58715780|FG007|Overall Study|Adverse Event|4|||
30701688|NCT00256867|58715773|FG000|Overall Study|Lost to Follow-up|2|||
30701689|NCT00256867|58715774|FG001|Overall Study|Lost to Follow-up|2|||
30701690|NCT00256867|58715775|FG002|Overall Study|Lost to Follow-up|2|||
30701691|NCT00256867|58715776|FG003|Overall Study|Lost to Follow-up|3|||
30701692|NCT00256867|58715777|FG004|Overall Study|Lost to Follow-up|2|||
30701693|NCT00256867|58715778|FG005|Overall Study|Lost to Follow-up|0|||
30701694|NCT00256867|58715779|FG006|Overall Study|Lost to Follow-up|1|||
30701695|NCT00256867|58715780|FG007|Overall Study|Lost to Follow-up|2|||
30701696|NCT00256867|58715773|FG000|Overall Study|Protocol Violation|0|||
30701697|NCT00256867|58715774|FG001|Overall Study|Protocol Violation|0|||
30701698|NCT00256867|58715775|FG002|Overall Study|Protocol Violation|0|||
30701699|NCT00256867|58715776|FG003|Overall Study|Protocol Violation|1|||
30701700|NCT00256867|58715777|FG004|Overall Study|Protocol Violation|0|||
30701701|NCT00256867|58715778|FG005|Overall Study|Protocol Violation|1|||
30701702|NCT00256867|58715779|FG006|Overall Study|Protocol Violation|0|||
30701703|NCT00256867|58715780|FG007|Overall Study|Protocol Violation|1|||
30701704|NCT00256867|58715773|FG000|Overall Study|Withdrawal by Subject|0|||
30701705|NCT00256867|58715774|FG001|Overall Study|Withdrawal by Subject|0|||
30701706|NCT00256867|58715775|FG002|Overall Study|Withdrawal by Subject|1|||
30701707|NCT00256867|58715776|FG003|Overall Study|Withdrawal by Subject|1|||
30701708|NCT00256867|58715777|FG004|Overall Study|Withdrawal by Subject|2|||
30701709|NCT00256867|58715778|FG005|Overall Study|Withdrawal by Subject|2|||
30701710|NCT00256867|58715779|FG006|Overall Study|Withdrawal by Subject|3|||
30701711|NCT00256867|58715780|FG007|Overall Study|Withdrawal by Subject|2|||
30701712|NCT00256867|58715773|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
30701713|NCT00256867|58715774|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
30701714|NCT00256867|58715775|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
30701715|NCT00256867|58715776|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
30701716|NCT00256867|58715777|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
30701717|NCT00256867|58715778|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
30701718|NCT00256867|58715779|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
30701719|NCT00256867|58715780|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
30701720|NCT00256867|58715773|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
30701721|NCT00256867|58715774|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
30701722|NCT00256867|58715775|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
30701723|NCT00256867|58715776|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
30701724|NCT00256867|58715777|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
30701725|NCT00256867|58715778|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
30701726|NCT00256867|58715779|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
30701727|NCT00256867|58715780|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
30701728|NCT00256867|58715773|FG000|Overall Study|Investigator's Decision|0|||
30701729|NCT00256867|58715774|FG001|Overall Study|Investigator's Decision|0|||
30701730|NCT00256867|58715775|FG002|Overall Study|Investigator's Decision|0|||
30701731|NCT00256867|58715776|FG003|Overall Study|Investigator's Decision|0|||
30701732|NCT00256867|58715777|FG004|Overall Study|Investigator's Decision|1|||
30701733|NCT00256867|58715778|FG005|Overall Study|Investigator's Decision|0|||
30701734|NCT00256867|58715779|FG006|Overall Study|Investigator's Decision|0|||
30701735|NCT00256867|58715780|FG007|Overall Study|Investigator's Decision|0|||
30701736|NCT00256867|58715773|FG000|Overall Study|Non-compliance with study medication|0|||
30701737|NCT00256867|58715774|FG001|Overall Study|Non-compliance with study medication|0|||
30701738|NCT00256867|58715775|FG002|Overall Study|Non-compliance with study medication|0|||
30701739|NCT00256867|58715776|FG003|Overall Study|Non-compliance with study medication|0|||
30701740|NCT00256867|58715777|FG004|Overall Study|Non-compliance with study medication|0|||
30701741|NCT00256867|58715778|FG005|Overall Study|Non-compliance with study medication|0|||
30701742|NCT00256867|58715779|FG006|Overall Study|Non-compliance with study medication|0|||
30701743|NCT00256867|58715780|FG007|Overall Study|Non-compliance with study medication|1|||
30701744|NCT00256867|58715773|FG000|Overall Study|Participant travelled Overseas|0|||
30701745|NCT00256867|58715774|FG001|Overall Study|Participant travelled Overseas|1|||
30701746|NCT00256867|58715775|FG002|Overall Study|Participant travelled Overseas|0|||
30701747|NCT00256867|58715776|FG003|Overall Study|Participant travelled Overseas|0|||
30701748|NCT00256867|58715777|FG004|Overall Study|Participant travelled Overseas|0|||
30701749|NCT00256867|58715778|FG005|Overall Study|Participant travelled Overseas|0|||
30701750|NCT00256867|58715779|FG006|Overall Study|Participant travelled Overseas|0|||
30701751|NCT00256867|58715780|FG007|Overall Study|Participant travelled Overseas|0|||
30701752|NCT00256867|58715773|FG000|Overall Study|Participant out of assessment window|0|||
30701753|NCT00256867|58715774|FG001|Overall Study|Participant out of assessment window|0|||
30701754|NCT00256867|58715775|FG002|Overall Study|Participant out of assessment window|1|||
30701755|NCT00256867|58715776|FG003|Overall Study|Participant out of assessment window|0|||
30701756|NCT00256867|58715777|FG004|Overall Study|Participant out of assessment window|0|||
30701757|NCT00256867|58715778|FG005|Overall Study|Participant out of assessment window|0|||
30701758|NCT00256867|58715779|FG006|Overall Study|Participant out of assessment window|0|||
30701759|NCT00256867|58715780|FG007|Overall Study|Participant out of assessment window|0|||
30701760|NCT00256867|58715773|FG000|Overall Study|Withdrawal by participant|0|||
30701761|NCT00256867|58715774|FG001|Overall Study|Withdrawal by participant|0|||
30701762|NCT00256867|58715775|FG002|Overall Study|Withdrawal by participant|0|||
30701763|NCT00256867|58715776|FG003|Overall Study|Withdrawal by participant|0|||
30701764|NCT00256867|58715777|FG004|Overall Study|Withdrawal by participant|0|||
30701765|NCT00256867|58715778|FG005|Overall Study|Withdrawal by participant|1|||
30701766|NCT00256867|58715779|FG006|Overall Study|Withdrawal by participant|0|||
30701767|NCT00256867|58715780|FG007|Overall Study|Withdrawal by participant|0|||
30701768|NCT00731939|58715803|FG000|Overall Study|Adverse Event|6|||
30701769|NCT00731939|58715803|FG000|Overall Study|Lost to Follow-up|15|||
30701770|NCT00731939|58715803|FG000|Overall Study|Not implanted with study device|9|||
30701771|NCT00731939|58715803|FG000|Overall Study|Withdrawal by Subject|2|||
30701772|NCT00731939|58715803|FG000|Overall Study|Did not meet enrollment criteria|2|||
30701773|NCT00731783|58715809|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
30701774|NCT00731783|58715810|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
30701775|NCT00731783|58715809|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
30701776|NCT00731783|58715810|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
30701777|NCT00731783|58715809|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
30701778|NCT00731783|58715810|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
30701779|NCT00731783|58715809|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
30701780|NCT00731783|58715810|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
30701781|NCT00724451|58715816|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
30701782|NCT00724451|58715816|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
30701783|NCT00724451|58715816|FG000|Overall Study|Not Eligible for Treatment|431|||
30701784|NCT00724451|58715816|FG000|Overall Study|Participant Refused Treatment|89|||
30701785|NCT00724451|58715816|FG000|Overall Study|Never Started Treatment|89|||
30701786|NCT00724451|58715816|FG000|Overall Study|Unknown; No Data Sources Available|9|||
30701787|NCT00724451|58715816|FG000|Overall Study|Physician Decision|116|||
30701788|NCT00724451|58715816|FG000|Overall Study|Withdrawal by Subject|45|||
30701789|NCT00724451|58715816|FG000|Overall Study|Investigator + Participant Decision|13|||
30701790|NCT00724373|58715820|FG000|Overall Study|Adverse Event|41|||
30701791|NCT00724373|58715820|FG000|Overall Study|Lack of Efficacy|82|||
30701792|NCT00724373|58715820|FG000|Overall Study|Lost to Follow-up|7|||
30701793|NCT00724373|58715820|FG000|Overall Study|Non-compliance|2|||
30701794|NCT00724373|58715820|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
30701795|NCT00724373|58715820|FG000|Overall Study|Participant moved away|1|||
30701796|NCT00724373|58715820|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
30701797|NCT00724373|58715820|FG000|Overall Study|Only to have 24 week regimen|1|||
30701798|NCT00724373|58715820|FG000|Overall Study|Viral Relapse|1|||
30701799|NCT00724373|58715820|FG000|Overall Study|Acute HCV infection|1|||
30701800|NCT00724373|58715820|FG000|Overall Study|Drug Relapse|1|||
30701801|NCT00724373|58715820|FG000|Overall Study|Tolerability|23|||
30701802|NCT00724061|58715824|FG000|Dose Escalation Phase|Adverse Event|2|||
30701803|NCT00724061|58715824|FG000|Dose Escalation Phase|Disease Progression|3|||
30701804|NCT00731549|58715828|FG000|Overall Study|Lost to Follow-up|19|||
30701805|NCT00731549|58715828|FG000|Overall Study|Met withdrawal criteria|24|||
30701806|NCT00731549|58715828|FG000|Overall Study|Physician Decision|16|||
30701807|NCT00731549|58715828|FG000|Overall Study|Withdrawal by Subject|89|||
30701808|NCT00731549|58715828|FG000|Overall Study|Protocol deviation|1|||
30701809|NCT00731549|58715828|FG000|Overall Study|Adverse Event|31|||
30701810|NCT00731549|58715828|FG000|Overall Study|Lack of efficacy with AE|37|||
30701811|NCT00731549|58715828|FG000|Overall Study|Lack of efficacy without AE|6|||
30701812|NCT00730925|58715873|FG000|Overall Study|Progressive Disease|21|||
30701813|NCT00730925|58715873|FG000|Overall Study|Dose reducing Event|2|||
30701814|NCT00730925|58715873|FG000|Overall Study|Other Averse Event|7|||
30701815|NCT00730925|58715873|FG000|Overall Study|Protocol Violation|1|||
30701816|NCT00730925|58715873|FG000|Overall Study|Withdrawal by Subject|1|||
30701817|NCT00730925|58715873|FG000|Overall Study|Switch to combination therapy|8|||
30701818|NCT00730925|58715873|FG000|Overall Study|Other|1|||
30701819|NCT00236899|58715881|FG000|Overall Study|Adverse Event (Study Related)|1|||
30701820|NCT00236899|58715882|FG001|Overall Study|Adverse Event (Study Related)|1|||
30701821|NCT00236899|58715883|FG002|Overall Study|Adverse Event (Study Related)|2|||
30701822|NCT00236899|58715884|FG003|Overall Study|Adverse Event (Study Related)|1|||
30701823|NCT00236899|58715881|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
30701824|NCT00236899|58715882|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
30701825|NCT00236899|58715883|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
30701826|NCT00236899|58715884|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
30701827|NCT00236899|58715881|FG000|Overall Study|Death (Study Disease)|1|||
30701828|NCT00236899|58715882|FG001|Overall Study|Death (Study Disease)|4|||
30701829|NCT00236899|58715883|FG002|Overall Study|Death (Study Disease)|0|||
30701830|NCT00236899|58715884|FG003|Overall Study|Death (Study Disease)|0|||
30701831|NCT00236899|58715881|FG000|Overall Study|Death (Not Study Related)|2|||
30701832|NCT00236899|58715882|FG001|Overall Study|Death (Not Study Related)|0|||
30701833|NCT00236899|58715883|FG002|Overall Study|Death (Not Study Related)|0|||
30701834|NCT00236899|58715884|FG003|Overall Study|Death (Not Study Related)|0|||
30701835|NCT00236899|58715881|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
30701836|NCT00236899|58715882|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
30701837|NCT00236899|58715883|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
30701838|NCT00236899|58715884|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
30701839|NCT00236899|58715881|FG000|Overall Study|Lost to Follow-up|0|||
30701840|NCT00236899|58715882|FG001|Overall Study|Lost to Follow-up|1|||
30701841|NCT00236899|58715883|FG002|Overall Study|Lost to Follow-up|0|||
30701842|NCT00236899|58715884|FG003|Overall Study|Lost to Follow-up|0|||
30701843|NCT00236899|58715881|FG000|Overall Study|Entry Criteria Exclusion|0|||
30701844|NCT00236899|58715882|FG001|Overall Study|Entry Criteria Exclusion|1|||
30701845|NCT00236899|58715883|FG002|Overall Study|Entry Criteria Exclusion|1|||
30701846|NCT00236899|58715884|FG003|Overall Study|Entry Criteria Exclusion|0|||
30701847|NCT00236899|58715881|FG000|Overall Study|Protocol Violation|1|||
30701848|NCT00236899|58715882|FG001|Overall Study|Protocol Violation|0|||
30701849|NCT00236899|58715883|FG002|Overall Study|Protocol Violation|0|||
30701850|NCT00236899|58715884|FG003|Overall Study|Protocol Violation|0|||
30701851|NCT00236899|58715881|FG000|Overall Study|Withdrawal by Subject|6|||
30701852|NCT00236899|58715882|FG001|Overall Study|Withdrawal by Subject|4|||
30701853|NCT00236899|58715883|FG002|Overall Study|Withdrawal by Subject|5|||
30701854|NCT00236899|58715884|FG003|Overall Study|Withdrawal by Subject|2|||
30701855|NCT00236899|58715881|FG000|Overall Study|Physician Decision|7|||
30701856|NCT00236899|58715882|FG001|Overall Study|Physician Decision|8|||
30701857|NCT00236899|58715883|FG002|Overall Study|Physician Decision|7|||
30701858|NCT00236899|58715884|FG003|Overall Study|Physician Decision|6|||
30701859|NCT00236899|58715881|FG000|Overall Study|Satisfactory Response|2|||
30701860|NCT00236899|58715882|FG001|Overall Study|Satisfactory Response|0|||
30701861|NCT00236899|58715883|FG002|Overall Study|Satisfactory Response|0|||
30701862|NCT00236899|58715884|FG003|Overall Study|Satisfactory Response|1|||
30701863|NCT00236899|58715881|FG000|Overall Study|Lack of Efficacy|18|||
30701864|NCT00236899|58715882|FG001|Overall Study|Lack of Efficacy|18|||
30701865|NCT00236899|58715883|FG002|Overall Study|Lack of Efficacy|25|||
30701866|NCT00236899|58715884|FG003|Overall Study|Lack of Efficacy|23|||
30701867|NCT00611130|58715903|FG000|Overall Study|Lost to Follow-up|25|||
30701868|NCT00611130|58715904|FG001|Overall Study|Lost to Follow-up|29|||
30701869|NCT00611130|58715903|FG000|Overall Study|Protocol noncompliance|7|||
30701870|NCT00611130|58715904|FG001|Overall Study|Protocol noncompliance|6|||
30701871|NCT00611130|58715903|FG000|Overall Study|Withdrawal by Subject|6|||
30701872|NCT00611130|58715904|FG001|Overall Study|Withdrawal by Subject|5|||
30701873|NCT00611130|58715903|FG000|Overall Study|Other|5|||
30701874|NCT00611130|58715904|FG001|Overall Study|Other|4|||
30701875|NCT00611130|58715903|FG000|Overall Study|Incarceration|3|||
30701876|NCT00611130|58715904|FG001|Overall Study|Incarceration|2|||
30701877|NCT00611130|58715903|FG000|Overall Study|Administrative|1|||
30701878|NCT00611130|58715904|FG001|Overall Study|Administrative|1|||
30701879|NCT00611130|58715903|FG000|Overall Study|Adverse Event|1|||
30701880|NCT00611130|58715904|FG001|Overall Study|Adverse Event|0|||
30701881|NCT00611130|58715903|FG000|Overall Study|Death|1|||
30701882|NCT00611130|58715904|FG001|Overall Study|Death|0|||
30701883|NCT00256243|58715911|FG000|Overall Study|Lost to Follow-up|2|||
30701884|NCT00256243|58715911|FG000|Overall Study|Death|7|||
30701885|NCT00256243|58715911|FG000|Overall Study|Not treated|1|||
30893630|NCT02185053|58927152|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
30893631|NCT02185053|58927153|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
30893632|NCT02185053|58927154|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
30893633|NCT02185053|58927152|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
30893634|NCT02185053|58927153|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
30893635|NCT02185053|58927154|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
30893636|NCT02185053|58927152|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
30893637|NCT02185053|58927153|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
30893638|NCT02185053|58927154|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
30893639|NCT02185053|58927152|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
30893640|NCT02185053|58927153|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
30893641|NCT02185053|58927154|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
30893642|NCT02161731|58927163|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
30893643|NCT02161731|58927164|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
30893644|NCT02161731|58927163|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
30893645|NCT02161731|58927164|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
30893646|NCT02124759|58927174|FG000|Overall Study|Withdrawal by Subject|3|||
30893647|NCT02124759|58927175|FG001|Overall Study|Withdrawal by Subject|1|||
30893648|NCT02124759|58927176|FG002|Overall Study|Withdrawal by Subject|1|||
30893649|NCT02124759|58927174|FG000|Overall Study|Screen Fail|2|||
30893650|NCT02124759|58927175|FG001|Overall Study|Screen Fail|2|||
30893651|NCT02124759|58927176|FG002|Overall Study|Screen Fail|3|||
30893652|NCT02302339|58927193|FG000|Overall Study|Lost to Follow-up|1|||
30893653|NCT02302339|58927194|FG001|Overall Study|Lost to Follow-up|0|||
30893654|NCT02302339|58927195|FG002|Overall Study|Lost to Follow-up|0|||
30893655|NCT02302339|58927196|FG003|Overall Study|Lost to Follow-up|0|||
30893656|NCT02302339|58927193|FG000|Overall Study|Withdrawal by Subject|0|||
30893657|NCT02302339|58927194|FG001|Overall Study|Withdrawal by Subject|2|||
30893658|NCT02302339|58927195|FG002|Overall Study|Withdrawal by Subject|1|||
30893659|NCT02302339|58927196|FG003|Overall Study|Withdrawal by Subject|0|||
30893660|NCT02161575|58927207|FG000|Overall Study|Protocol Violation|8|||
30893661|NCT02161575|58927207|FG000|Overall Study|Lack of Efficacy|1|||
30893662|NCT02161575|58927207|FG000|Overall Study|Adverse Event|2|||
30893663|NCT02370121|58927213|FG000|Overall Study|Lost to Follow-up|1|||
30701886|NCT00236197|58715918|FG000|Overall Study|Withdrawal by Subject|3|||
30893664|NCT02370121|58927214|FG001|Overall Study|Lost to Follow-up|1|||
30701887|NCT00236197|58715919|FG001|Overall Study|Withdrawal by Subject|2|||
30701888|NCT00236197|58715918|FG000|Overall Study|Lost to Follow-up|1|||
30701889|NCT00236197|58715919|FG001|Overall Study|Lost to Follow-up|5|||
30701890|NCT00236197|58715918|FG000|Overall Study|Protocol Violation|0|||
30701891|NCT00236197|58715919|FG001|Overall Study|Protocol Violation|3|||
30701892|NCT00236197|58715918|FG000|Overall Study|Medication non-compliance|1|||
30701893|NCT00236197|58715919|FG001|Overall Study|Medication non-compliance|2|||
30701894|NCT00236197|58715918|FG000|Overall Study|Other|0|||
30701895|NCT00236197|58715919|FG001|Overall Study|Other|2|||
30701896|NCT00278629|58715925|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
30701897|NCT00612690|58715932|FG000|Overall Study|Lost to Follow-up|72|||
30701898|NCT00612690|58715933|FG001|Overall Study|Lost to Follow-up|98|||
30701899|NCT00612690|58715932|FG000|Overall Study|Withdrawal by Subject|32|||
30701900|NCT00612690|58715933|FG001|Overall Study|Withdrawal by Subject|20|||
30701901|NCT00612690|58715932|FG000|Overall Study|Withdrawal by Site|11|||
30701902|NCT00612690|58715933|FG001|Overall Study|Withdrawal by Site|0|||
30701903|NCT00278473|58715943|FG000|Overall Study|drop out|4|||
30701904|NCT00278473|58715944|FG001|Overall Study|drop out|3|||
30701905|NCT00278395|58715950|FG000|Overall Study|Adverse Event|2|||
30701906|NCT00278395|58715950|FG000|Overall Study|Nonevaluable|1|||
30701907|NCT00612534|58715961|FG000|Overall Study|Adverse Event|0|||
30701908|NCT00612534|58715962|FG001|Overall Study|Adverse Event|4|||
30701909|NCT00612534|58715963|FG002|Overall Study|Adverse Event|2|||
30701910|NCT00612534|58715964|FG003|Overall Study|Adverse Event|1|||
30701911|NCT00612534|58715961|FG000|Overall Study|Lack of Efficacy|13|||
30701912|NCT00612534|58715962|FG001|Overall Study|Lack of Efficacy|12|||
30701913|NCT00612534|58715963|FG002|Overall Study|Lack of Efficacy|5|||
30701914|NCT00612534|58715964|FG003|Overall Study|Lack of Efficacy|16|||
30701915|NCT00612534|58715961|FG000|Overall Study|Other Reason|0|||
30701916|NCT00612534|58715962|FG001|Overall Study|Other Reason|1|||
30701917|NCT00612534|58715963|FG002|Overall Study|Other Reason|0|||
30701918|NCT00612534|58715964|FG003|Overall Study|Other Reason|0|||
30701919|NCT00736853|58715974|FG000|Open-Label Period|Physician Decision|2|||
30701920|NCT00736853|58715975|FG001|Open-Label Period|Physician Decision|0|||
30701921|NCT00736853|58715976|FG002|Open-Label Period|Physician Decision|0|||
30701922|NCT00736853|58715974|FG000|Open-Label Period|Adverse Event|31|||
30701923|NCT00736853|58715975|FG001|Open-Label Period|Adverse Event|0|||
30701924|NCT00736853|58715976|FG002|Open-Label Period|Adverse Event|0|||
30701925|NCT00736853|58715974|FG000|Open-Label Period|Withdrawal by Subject|16|||
30701926|NCT00736853|58715975|FG001|Open-Label Period|Withdrawal by Subject|0|||
30701927|NCT00736853|58715976|FG002|Open-Label Period|Withdrawal by Subject|0|||
30701928|NCT00736853|58715974|FG000|Open-Label Period|Started but not treated|42|||
30701929|NCT00736853|58715975|FG001|Open-Label Period|Started but not treated|0|||
30701930|NCT00736853|58715976|FG002|Open-Label Period|Started but not treated|0|||
30701931|NCT00736853|58715974|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
30701932|NCT00736853|58715975|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
30701933|NCT00736853|58715976|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
30701934|NCT00736853|58715974|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
30701935|NCT00736853|58715975|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
30701936|NCT00736853|58715976|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
30701937|NCT00736853|58715974|FG000|Double-Blind Period|Lack of Efficacy|0|||
30701938|NCT00736853|58715975|FG001|Double-Blind Period|Lack of Efficacy|19|||
30701939|NCT00736853|58715976|FG002|Double-Blind Period|Lack of Efficacy|42|||
30701940|NCT00736853|58715974|FG000|Double-Blind Period|Adverse Event|0|||
30701941|NCT00736853|58715975|FG001|Double-Blind Period|Adverse Event|3|||
30701942|NCT00736853|58715976|FG002|Double-Blind Period|Adverse Event|2|||
30701943|NCT00736853|58715974|FG000|Double-Blind Period|Withdrawal by Subject|0|||
30701944|NCT00736853|58715975|FG001|Double-Blind Period|Withdrawal by Subject|1|||
30701945|NCT00736853|58715976|FG002|Double-Blind Period|Withdrawal by Subject|4|||
30701946|NCT00736853|58715974|FG000|Double-Blind Period|Ineligible to participate the study|0|||
30701947|NCT00736853|58715975|FG001|Double-Blind Period|Ineligible to participate the study|1|||
30701948|NCT00736853|58715976|FG002|Double-Blind Period|Ineligible to participate the study|0|||
30701949|NCT00730847|58715985|FG000|Overall Study|Adverse Event|1|||
30701950|NCT00730847|58715985|FG000|Overall Study|Protocol Violation|2|||
30701951|NCT00730847|58715985|FG000|Overall Study|Withdrawal by Subject|16|||
30701952|NCT00730847|58715985|FG000|Overall Study|Lost to Follow-up|67|||
30701953|NCT00730847|58715985|FG000|Overall Study|Unknown completion status|21|||
30701954|NCT00730847|58715985|FG000|Overall Study|Other|24|||
30701955|NCT00573066|58715989|FG000|Overall Study|Exclusion criteria|18|||
30701956|NCT00573066|58715989|FG000|Overall Study|IV malfunction|1|||
30701957|NCT00573066|58715989|FG000|Overall Study|Postoperative bleeding|1|||
30701958|NCT00612456|58715996|FG000|Overall Study|Adverse Event|1|||
30701959|NCT00612456|58715997|FG001|Overall Study|Adverse Event|0|||
30701960|NCT00612456|58715998|FG002|Overall Study|Adverse Event|0|||
30701961|NCT00612456|58715996|FG000|Overall Study|Lack of Efficacy|1|||
30701962|NCT00612456|58715997|FG001|Overall Study|Lack of Efficacy|1|||
30701963|NCT00612456|58715998|FG002|Overall Study|Lack of Efficacy|0|||
30701964|NCT00612456|58715996|FG000|Overall Study|Withdrawal by Subject|0|||
30701965|NCT00612456|58715997|FG001|Overall Study|Withdrawal by Subject|1|||
30701966|NCT00612456|58715998|FG002|Overall Study|Withdrawal by Subject|0|||
30701967|NCT00730691|58716013|FG000|Overall Study|Adverse Event|4|||
30701968|NCT00730691|58716014|FG001|Overall Study|Adverse Event|8|||
30701969|NCT00730691|58716015|FG002|Overall Study|Adverse Event|11|||
30701970|NCT00730691|58716016|FG003|Overall Study|Adverse Event|11|||
30701971|NCT00730691|58716017|FG004|Overall Study|Adverse Event|23|||
30701972|NCT00730691|58716013|FG000|Overall Study|Lack of Efficacy|4|||
30701973|NCT00730691|58716014|FG001|Overall Study|Lack of Efficacy|4|||
30701974|NCT00730691|58716015|FG002|Overall Study|Lack of Efficacy|2|||
30619915|NCT00940498|58630978|FG002|Overall Study|Lost to Follow-up|2|||
30701975|NCT00730691|58716016|FG003|Overall Study|Lack of Efficacy|1|||
30701976|NCT00730691|58716017|FG004|Overall Study|Lack of Efficacy|1|||
30701977|NCT00730691|58716013|FG000|Overall Study|Non-compliance with Study Drug|6|||
30701978|NCT00730691|58716014|FG001|Overall Study|Non-compliance with Study Drug|1|||
30701979|NCT00730691|58716015|FG002|Overall Study|Non-compliance with Study Drug|6|||
30619916|NCT00940498|58630979|FG003|Overall Study|Lost to Follow-up|0|||
30619917|NCT00940498|58630980|FG004|Overall Study|Lost to Follow-up|1|||
30619918|NCT00940498|58630981|FG005|Overall Study|Lost to Follow-up|0|||
30619919|NCT00940498|58630982|FG006|Overall Study|Lost to Follow-up|0|||
30619920|NCT00940498|58630983|FG007|Overall Study|Lost to Follow-up|1|||
30619921|NCT00940498|58630976|FG000|Overall Study|Disease Progression|0|||
30619922|NCT00940498|58630977|FG001|Overall Study|Disease Progression|0|||
30619923|NCT00940498|58630978|FG002|Overall Study|Disease Progression|1|||
30619924|NCT00940498|58630979|FG003|Overall Study|Disease Progression|1|||
30701980|NCT00730691|58716016|FG003|Overall Study|Non-compliance with Study Drug|3|||
30701981|NCT00730691|58716017|FG004|Overall Study|Non-compliance with Study Drug|3|||
30701982|NCT00730691|58716013|FG000|Overall Study|Protocol Deviations|3|||
30701983|NCT00730691|58716014|FG001|Overall Study|Protocol Deviations|5|||
30701984|NCT00730691|58716015|FG002|Overall Study|Protocol Deviations|3|||
30701985|NCT00730691|58716016|FG003|Overall Study|Protocol Deviations|7|||
30701986|NCT00730691|58716017|FG004|Overall Study|Protocol Deviations|5|||
30701987|NCT00730691|58716013|FG000|Overall Study|Withdrawal of Consent|7|||
30701988|NCT00730691|58716014|FG001|Overall Study|Withdrawal of Consent|9|||
30701989|NCT00730691|58716015|FG002|Overall Study|Withdrawal of Consent|3|||
30701990|NCT00730691|58716016|FG003|Overall Study|Withdrawal of Consent|6|||
30701991|NCT00730691|58716017|FG004|Overall Study|Withdrawal of Consent|3|||
30701992|NCT00730691|58716013|FG000|Overall Study|Lost to Follow-up|11|||
30701993|NCT00730691|58716014|FG001|Overall Study|Lost to Follow-up|8|||
30701994|NCT00730691|58716015|FG002|Overall Study|Lost to Follow-up|13|||
30701995|NCT00730691|58716016|FG003|Overall Study|Lost to Follow-up|15|||
30701996|NCT00730691|58716017|FG004|Overall Study|Lost to Follow-up|13|||
30701997|NCT00730691|58716013|FG000|Overall Study|Other|1|||
30701998|NCT00730691|58716014|FG001|Overall Study|Other|1|||
30701999|NCT00730691|58716015|FG002|Overall Study|Other|1|||
30702000|NCT00730691|58716016|FG003|Overall Study|Other|2|||
30702001|NCT00730691|58716017|FG004|Overall Study|Other|2|||
30702002|NCT00235495|58716031|FG000|Overall Study|Death|52|||
30702003|NCT00235495|58716032|FG001|Overall Study|Death|42|||
30702004|NCT00235495|58716031|FG000|Overall Study|Withdrawal by Subject|5|||
30702005|NCT00235495|58716032|FG001|Overall Study|Withdrawal by Subject|3|||
30702006|NCT00235495|58716031|FG000|Overall Study|Lost to Follow-up|11|||
30702007|NCT00235495|58716032|FG001|Overall Study|Lost to Follow-up|13|||
30702008|NCT00235495|58716031|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
30702009|NCT00235495|58716032|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
30702010|NCT00278161|58716038|FG000|Overall Study|Death|11|||
30702011|NCT00255151|58716045|FG000|Overall Study|Adverse Event|10|||
30702012|NCT00255151|58716046|FG001|Overall Study|Adverse Event|6|||
30702013|NCT00255151|58716047|FG002|Overall Study|Adverse Event|9|||
30702014|NCT00255151|58716045|FG000|Overall Study|Lost to Follow-up|4|||
30702015|NCT00255151|58716046|FG001|Overall Study|Lost to Follow-up|3|||
30702016|NCT00255151|58716047|FG002|Overall Study|Lost to Follow-up|4|||
30702017|NCT00255151|58716045|FG000|Overall Study|Withdrawal by Subject|18|||
30702018|NCT00255151|58716046|FG001|Overall Study|Withdrawal by Subject|17|||
30702019|NCT00255151|58716047|FG002|Overall Study|Withdrawal by Subject|8|||
30702020|NCT00255151|58716045|FG000|Overall Study|Noncompliance|0|||
30702021|NCT00255151|58716046|FG001|Overall Study|Noncompliance|1|||
30702022|NCT00255151|58716047|FG002|Overall Study|Noncompliance|2|||
30702023|NCT00255151|58716045|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
30702024|NCT00255151|58716046|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
30702025|NCT00255151|58716047|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
30702026|NCT00255151|58716045|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
30702027|NCT00255151|58716046|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
30702028|NCT00255151|58716047|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
30702029|NCT00255151|58716045|FG000|Overall Study|Possible Barrett's Esophagus|1|||
30702030|NCT00255151|58716046|FG001|Overall Study|Possible Barrett's Esophagus|3|||
30702031|NCT00255151|58716047|FG002|Overall Study|Possible Barrett's Esophagus|8|||
30702032|NCT00255151|58716045|FG000|Overall Study|Esophageal Stricture|0|||
30702033|NCT00255151|58716046|FG001|Overall Study|Esophageal Stricture|0|||
30702034|NCT00255151|58716047|FG002|Overall Study|Esophageal Stricture|1|||
30702035|NCT00255151|58716045|FG000|Overall Study|Therapeutic Failure|11|||
30702036|NCT00255151|58716046|FG001|Overall Study|Therapeutic Failure|2|||
30702037|NCT00255151|58716047|FG002|Overall Study|Therapeutic Failure|3|||
30702038|NCT00658658|58716060|FG000|Overall Study|Withdrawal by Subject|0|||
30702039|NCT00658658|58716061|FG001|Overall Study|Withdrawal by Subject|1|||
30702040|NCT00658658|58716062|FG002|Overall Study|Withdrawal by Subject|0|||
30702041|NCT00658658|58716063|FG003|Overall Study|Withdrawal by Subject|0|||
30702042|NCT00658658|58716064|FG004|Overall Study|Withdrawal by Subject|0|||
30702043|NCT00658658|58716060|FG000|Overall Study|Death|4|||
30702044|NCT00658658|58716061|FG001|Overall Study|Death|0|||
30702045|NCT00658658|58716062|FG002|Overall Study|Death|0|||
30702046|NCT00658658|58716063|FG003|Overall Study|Death|1|||
30702047|NCT00658658|58716064|FG004|Overall Study|Death|1|||
30702048|NCT00658658|58716060|FG000|Overall Study|Disease Progression|0|||
30702049|NCT00658658|58716061|FG001|Overall Study|Disease Progression|1|||
30702050|NCT00658658|58716062|FG002|Overall Study|Disease Progression|0|||
30702051|NCT00658658|58716063|FG003|Overall Study|Disease Progression|1|||
30702052|NCT00658658|58716064|FG004|Overall Study|Disease Progression|3|||
30702053|NCT00658658|58716060|FG000|Overall Study|Protocol-specified Criteria|1|||
30702054|NCT00658658|58716061|FG001|Overall Study|Protocol-specified Criteria|0|||
30702055|NCT00658658|58716062|FG002|Overall Study|Protocol-specified Criteria|0|||
30702056|NCT00658658|58716063|FG003|Overall Study|Protocol-specified Criteria|0|||
30702057|NCT00658658|58716064|FG004|Overall Study|Protocol-specified Criteria|0|||
30702058|NCT00658658|58716060|FG000|Overall Study|Other|0|||
30702059|NCT00658658|58716061|FG001|Overall Study|Other|0|||
30702060|NCT00658658|58716062|FG002|Overall Study|Other|0|||
30702061|NCT00658658|58716063|FG003|Overall Study|Other|0|||
30702062|NCT00658658|58716064|FG004|Overall Study|Other|1|||
30702063|NCT00723203|58716076|FG000|Overall Study|Withdrawal by Subject|3|||
30702064|NCT00233389|58716082|FG000|Overall Study|Adverse Event|5|||
30702065|NCT00233389|58716083|FG001|Overall Study|Adverse Event|5|||
30702066|NCT00233389|58716082|FG000|Overall Study|Lack of Efficacy|11|||
30619925|NCT00940498|58630980|FG004|Overall Study|Disease Progression|0|||
30619926|NCT00940498|58630981|FG005|Overall Study|Disease Progression|1|||
30619927|NCT00940498|58630982|FG006|Overall Study|Disease Progression|0|||
30702067|NCT00233389|58716083|FG001|Overall Study|Lack of Efficacy|8|||
30702068|NCT00233389|58716082|FG000|Overall Study|Lost to Follow-up|1|||
30702069|NCT00233389|58716083|FG001|Overall Study|Lost to Follow-up|1|||
30702070|NCT00233389|58716082|FG000|Overall Study|Physician Decision|1|||
30702071|NCT00233389|58716083|FG001|Overall Study|Physician Decision|0|||
30702072|NCT00233389|58716082|FG000|Overall Study|Protocol Violation|0|||
30702073|NCT00233389|58716083|FG001|Overall Study|Protocol Violation|1|||
30702074|NCT00233389|58716082|FG000|Overall Study|Withdrawal by Subject|0|||
30702075|NCT00233389|58716083|FG001|Overall Study|Withdrawal by Subject|1|||
30702076|NCT00649220|58716089|FG000|Overall Study|Adverse Event|2|||
30702077|NCT00649220|58716089|FG000|Overall Study|Withdrawal by Subject|1|||
30702078|NCT00654368|58716096|FG000|Overall Study|Ineligibility determined|6|||
30702079|NCT00654368|58716097|FG001|Overall Study|Ineligibility determined|0|||
30702080|NCT00654368|58716098|FG002|Overall Study|Ineligibility determined|0|||
30702081|NCT00654368|58716096|FG000|Overall Study|Protocol deviation|3|||
30619928|NCT00940498|58630983|FG007|Overall Study|Disease Progression|0|||
30619929|NCT00940498|58630976|FG000|Overall Study|Physician Decision|0|||
30619930|NCT00940498|58630977|FG001|Overall Study|Physician Decision|0|||
30619931|NCT00940498|58630978|FG002|Overall Study|Physician Decision|0|||
30619932|NCT00940498|58630979|FG003|Overall Study|Physician Decision|0|||
30619933|NCT00940498|58630980|FG004|Overall Study|Physician Decision|2|||
30619934|NCT00940498|58630981|FG005|Overall Study|Physician Decision|0|||
30619935|NCT00940498|58630982|FG006|Overall Study|Physician Decision|0|||
30619936|NCT00940498|58630983|FG007|Overall Study|Physician Decision|0|||
30619937|NCT00940498|58630976|FG000|Overall Study|Not treated due to disease related pain|0|||
30619938|NCT00940498|58630977|FG001|Overall Study|Not treated due to disease related pain|0|||
30619939|NCT00940498|58630978|FG002|Overall Study|Not treated due to disease related pain|0|||
30619940|NCT00940498|58630979|FG003|Overall Study|Not treated due to disease related pain|0|||
30619941|NCT00940498|58630980|FG004|Overall Study|Not treated due to disease related pain|1|||
30619942|NCT00940498|58630981|FG005|Overall Study|Not treated due to disease related pain|0|||
30619943|NCT00940498|58630982|FG006|Overall Study|Not treated due to disease related pain|0|||
30619944|NCT00940498|58630983|FG007|Overall Study|Not treated due to disease related pain|0|||
30619945|NCT00940342|58631010|FG000|Overall Study|Adverse Event|0|||
30702082|NCT00654368|58716097|FG001|Overall Study|Protocol deviation|2|||
30702083|NCT00654368|58716098|FG002|Overall Study|Protocol deviation|1|||
30702084|NCT00654368|58716096|FG000|Overall Study|Non-compliance|2|||
30702085|NCT00654368|58716097|FG001|Overall Study|Non-compliance|1|||
30702086|NCT00654368|58716098|FG002|Overall Study|Non-compliance|2|||
30702087|NCT00654368|58716096|FG000|Overall Study|Withdrawal by Subject|5|||
30702088|NCT00654368|58716097|FG001|Overall Study|Withdrawal by Subject|2|||
30702089|NCT00654368|58716098|FG002|Overall Study|Withdrawal by Subject|2|||
30702090|NCT00654368|58716096|FG000|Overall Study|Disease progression|21|||
30702091|NCT00654368|58716097|FG001|Overall Study|Disease progression|31|||
30702092|NCT00654368|58716098|FG002|Overall Study|Disease progression|13|||
30702093|NCT00654368|58716096|FG000|Overall Study|Requirement for alternative therapy|1|||
30702094|NCT00654368|58716097|FG001|Overall Study|Requirement for alternative therapy|1|||
30702095|NCT00654368|58716098|FG002|Overall Study|Requirement for alternative therapy|1|||
30702096|NCT00654368|58716096|FG000|Overall Study|Physician Decision|0|||
30702097|NCT00654368|58716097|FG001|Overall Study|Physician Decision|0|||
30702098|NCT00654368|58716098|FG002|Overall Study|Physician Decision|2|||
30702099|NCT00654368|58716096|FG000|Overall Study|Death|1|||
30702100|NCT00654368|58716097|FG001|Overall Study|Death|0|||
30702101|NCT00654368|58716098|FG002|Overall Study|Death|0|||
30702102|NCT00654368|58716096|FG000|Overall Study|Pregnancy|0|||
30702103|NCT00654368|58716097|FG001|Overall Study|Pregnancy|0|||
30702104|NCT00654368|58716098|FG002|Overall Study|Pregnancy|2|||
30702105|NCT00654368|58716096|FG000|Overall Study|Other|0|||
30702106|NCT00654368|58716097|FG001|Overall Study|Other|2|||
30702107|NCT00654368|58716098|FG002|Overall Study|Other|3|||
30702108|NCT00654368|58716096|FG000|Overall Study|Adverse Event|14|||
30702109|NCT00654368|58716097|FG001|Overall Study|Adverse Event|9|||
30702110|NCT00654368|58716098|FG002|Overall Study|Adverse Event|6|||
30702111|NCT00647426|58716105|FG000|Overall Study|Withdrawal by Subject|2|||
30702112|NCT00647348|58716112|FG000|Overall Study|Lost to Follow-up|3|||
30702113|NCT00647348|58716113|FG001|Overall Study|Lost to Follow-up|6|||
30702114|NCT00647270|58716122|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
30702115|NCT00647270|58716123|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
30702116|NCT00647270|58716124|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
30702117|NCT00647270|58716122|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
30702118|NCT00647270|58716123|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
30702119|NCT00647270|58716124|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
30702120|NCT00647270|58716122|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
30702121|NCT00647270|58716123|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
30702122|NCT00647270|58716124|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
30702123|NCT00647270|58716122|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
30702124|NCT00647270|58716123|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
30702125|NCT00647270|58716124|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
30702126|NCT00647270|58716122|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
30702127|NCT00647270|58716123|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
30702128|NCT00647270|58716124|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
30702129|NCT00647270|58716122|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
30702130|NCT00647270|58716123|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
30702131|NCT00647270|58716124|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
30702132|NCT00647270|58716122|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
30702133|NCT00647270|58716123|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
30702134|NCT00647270|58716124|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
30702135|NCT00645944|58716137|FG000|Randomized|Withdrawal by Subject|1|||
30702136|NCT00645944|58716138|FG001|Randomized|Withdrawal by Subject|2|||
30702137|NCT00645944|58716137|FG000|Received Medication|Adverse Event|2|||
30702138|NCT00645944|58716138|FG001|Received Medication|Adverse Event|1|||
30702139|NCT00645944|58716137|FG000|Received Medication|Withdrawal by Subject|1|||
30702140|NCT00645944|58716138|FG001|Received Medication|Withdrawal by Subject|1|||
30702141|NCT00645944|58716137|FG000|Received Medication|Lost to Follow-up|1|||
30702142|NCT00645944|58716138|FG001|Received Medication|Lost to Follow-up|0|||
30702143|NCT00645944|58716137|FG000|Received Medication|Protocol Violation|2|||
30702144|NCT00645944|58716138|FG001|Received Medication|Protocol Violation|1|||
30702145|NCT00646958|58716147|FG000|Overall Study|Lack of Efficacy|1|||
30702146|NCT00646958|58716148|FG001|Overall Study|Lack of Efficacy|0|||
30702147|NCT00646958|58716149|FG002|Overall Study|Lack of Efficacy|0|||
30702148|NCT00646958|58716147|FG000|Overall Study|Adverse Event|4|||
30702149|NCT00646958|58716148|FG001|Overall Study|Adverse Event|0|||
30790852|NCT03524092|58803943|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
30790853|NCT03524092|58803944|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
30619946|NCT00940342|58631011|FG001|Overall Study|Adverse Event|2|||
30619947|NCT00940342|58631012|FG002|Overall Study|Adverse Event|1|||
30619948|NCT00936910|58631020|FG000|Overall Study|Lack of Efficacy|3|||
30619949|NCT00940108|58631029|FG000|Overall Study|Adverse Event|2|||
30619950|NCT00940108|58631030|FG001|Overall Study|Adverse Event|4|||
30619951|NCT00940108|58631031|FG002|Overall Study|Adverse Event|0|||
30619952|NCT00940108|58631032|FG003|Overall Study|Adverse Event|2|||
30619953|NCT00940108|58631029|FG000|Overall Study|Withdrew Consent|2|||
30619954|NCT00940108|58631030|FG001|Overall Study|Withdrew Consent|1|||
30619955|NCT00940108|58631031|FG002|Overall Study|Withdrew Consent|0|||
30619956|NCT00940108|58631032|FG003|Overall Study|Withdrew Consent|1|||
30619957|NCT00940108|58631029|FG000|Overall Study|Dose 2 contraindicated|1|||
30619958|NCT00940108|58631030|FG001|Overall Study|Dose 2 contraindicated|1|||
30619959|NCT00940108|58631031|FG002|Overall Study|Dose 2 contraindicated|0|||
30619960|NCT00940108|58631032|FG003|Overall Study|Dose 2 contraindicated|1|||
30619961|NCT00940108|58631029|FG000|Overall Study|Declined further vaccination|0|||
30619962|NCT00940108|58631030|FG001|Overall Study|Declined further vaccination|1|||
30619963|NCT00940108|58631031|FG002|Overall Study|Declined further vaccination|3|||
30619964|NCT00940108|58631032|FG003|Overall Study|Declined further vaccination|0|||
30619965|NCT00940108|58631029|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
30619966|NCT00940108|58631030|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
30702150|NCT00646958|58716149|FG002|Overall Study|Adverse Event|0|||
30702151|NCT00646958|58716147|FG000|Overall Study|Lost to Follow-up|1|||
30702152|NCT00646958|58716148|FG001|Overall Study|Lost to Follow-up|5|||
30790854|NCT03524092|58803945|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
30702153|NCT00646958|58716149|FG002|Overall Study|Lost to Follow-up|7|||
30702154|NCT00646958|58716147|FG000|Overall Study|Protocol Violation|1|||
30702155|NCT00646958|58716148|FG001|Overall Study|Protocol Violation|1|||
30702156|NCT00646958|58716149|FG002|Overall Study|Protocol Violation|0|||
30702157|NCT00646958|58716147|FG000|Overall Study|Abnormal screening lab tests|1|||
30702158|NCT00646958|58716148|FG001|Overall Study|Abnormal screening lab tests|1|||
30702159|NCT00646958|58716149|FG002|Overall Study|Abnormal screening lab tests|0|||
30702160|NCT00646958|58716147|FG000|Overall Study|Withdrawal by Subject|1|||
30702161|NCT00646958|58716148|FG001|Overall Study|Withdrawal by Subject|2|||
30702162|NCT00646958|58716149|FG002|Overall Study|Withdrawal by Subject|0|||
30702163|NCT00646958|58716147|FG000|Overall Study|Did not receive study drug|2|||
30702164|NCT00646958|58716148|FG001|Overall Study|Did not receive study drug|0|||
30702165|NCT00646958|58716149|FG002|Overall Study|Did not receive study drug|2|||
30702166|NCT00642746|58716159|FG000|Overall Study|Patient unevaluable|1|||
30702167|NCT00642746|58716160|FG001|Overall Study|Patient unevaluable|0|||
30702168|NCT00642668|58716166|FG000|Overall Study|Lost to Follow-up|1|||
30702169|NCT00642668|58716166|FG000|Overall Study|Adverse Event|2|||
30702170|NCT00642668|58716166|FG000|Overall Study|Death|2|||
30702171|NCT00642668|58716166|FG000|Overall Study|Insufficient Therapeutic Response|1|||
30702172|NCT00642668|58716166|FG000|Overall Study|Failure to Return|1|||
30702173|NCT00642668|58716166|FG000|Overall Study|Dialysis Initiation|5|||
30702174|NCT00642668|58716166|FG000|Overall Study|Blood Transfusion|2|||
30702175|NCT00729833|58716170|FG000|Overall Study|Death|5|||
30702176|NCT00729833|58716171|FG001|Overall Study|Death|1|||
30702177|NCT00729833|58716172|FG002|Overall Study|Death|3|||
30702178|NCT00729833|58716173|FG003|Overall Study|Death|5|||
30702179|NCT00729833|58716170|FG000|Overall Study|Study Terminated by Sponsor|0|||
30702180|NCT00729833|58716171|FG001|Overall Study|Study Terminated by Sponsor|0|||
30702181|NCT00729833|58716172|FG002|Overall Study|Study Terminated by Sponsor|1|||
30702182|NCT00729833|58716173|FG003|Overall Study|Study Terminated by Sponsor|0|||
30702183|NCT00729833|58716170|FG000|Overall Study|Lost to Follow-up|1|||
30702184|NCT00729833|58716171|FG001|Overall Study|Lost to Follow-up|0|||
30702185|NCT00729833|58716172|FG002|Overall Study|Lost to Follow-up|0|||
30702186|NCT00729833|58716173|FG003|Overall Study|Lost to Follow-up|0|||
30702187|NCT00729833|58716170|FG000|Overall Study|Withdrawal by Subject|3|||
30702188|NCT00729833|58716171|FG001|Overall Study|Withdrawal by Subject|1|||
30702189|NCT00729833|58716172|FG002|Overall Study|Withdrawal by Subject|3|||
30702190|NCT00729833|58716173|FG003|Overall Study|Withdrawal by Subject|0|||
30702191|NCT00729833|58716170|FG000|Overall Study|Unspecified Reasons|11|||
30702192|NCT00729833|58716171|FG001|Overall Study|Unspecified Reasons|5|||
30702193|NCT00729833|58716172|FG002|Overall Study|Unspecified Reasons|5|||
30702194|NCT00729833|58716173|FG003|Overall Study|Unspecified Reasons|1|||
30702195|NCT00645788|58716188|FG000|Overall Study|Did not receive study drug|1|||
30702196|NCT00645788|58716189|FG001|Overall Study|Did not receive study drug|1|||
30702197|NCT00645788|58716190|FG002|Overall Study|Did not receive study drug|0|||
30702198|NCT00645788|58716191|FG003|Overall Study|Did not receive study drug|0|||
30702199|NCT00645788|58716188|FG000|Overall Study|Adverse Event|4|||
30702200|NCT00645788|58716189|FG001|Overall Study|Adverse Event|9|||
30702201|NCT00645788|58716190|FG002|Overall Study|Adverse Event|5|||
30702202|NCT00645788|58716191|FG003|Overall Study|Adverse Event|3|||
30702203|NCT00645788|58716188|FG000|Overall Study|Lost to Follow-up|1|||
30702204|NCT00645788|58716189|FG001|Overall Study|Lost to Follow-up|0|||
30702205|NCT00645788|58716190|FG002|Overall Study|Lost to Follow-up|0|||
30702206|NCT00645788|58716191|FG003|Overall Study|Lost to Follow-up|0|||
30702207|NCT00645788|58716188|FG000|Overall Study|Protocol Violation|1|||
30702208|NCT00645788|58716189|FG001|Overall Study|Protocol Violation|0|||
30702209|NCT00645788|58716190|FG002|Overall Study|Protocol Violation|2|||
30702210|NCT00645788|58716191|FG003|Overall Study|Protocol Violation|0|||
30702211|NCT00645788|58716188|FG000|Overall Study|Withdrawal by Subject|0|||
30702212|NCT00645788|58716189|FG001|Overall Study|Withdrawal by Subject|1|||
30702213|NCT00645788|58716190|FG002|Overall Study|Withdrawal by Subject|0|||
30702214|NCT00645788|58716191|FG003|Overall Study|Withdrawal by Subject|2|||
30702215|NCT00645788|58716188|FG000|Overall Study|Pulmonary exacerbation|13|||
30702216|NCT00645788|58716189|FG001|Overall Study|Pulmonary exacerbation|16|||
30702217|NCT00645788|58716190|FG002|Overall Study|Pulmonary exacerbation|11|||
30702218|NCT00645788|58716191|FG003|Overall Study|Pulmonary exacerbation|9|||
30702219|NCT00642356|58716203|FG000|Overall Study|Adverse Event|1|||
30702220|NCT00642356|58716204|FG001|Overall Study|Adverse Event|0|||
30702221|NCT00642356|58716203|FG000|Overall Study|Protocol Violation|0|||
30702222|NCT00642356|58716204|FG001|Overall Study|Protocol Violation|3|||
30702223|NCT00642356|58716203|FG000|Overall Study|Lack of Efficacy|1|||
30702224|NCT00642356|58716204|FG001|Overall Study|Lack of Efficacy|0|||
30702225|NCT00642278|58716217|FG000|Overall Study|Adverse Event|2|||
30702226|NCT00642278|58716218|FG001|Overall Study|Adverse Event|1|||
30702227|NCT00642278|58716219|FG002|Overall Study|Adverse Event|3|||
30702228|NCT00642278|58716220|FG003|Overall Study|Adverse Event|1|||
30702229|NCT00642278|58716221|FG004|Overall Study|Adverse Event|2|||
30702230|NCT00642278|58716222|FG005|Overall Study|Adverse Event|2|||
30702231|NCT00642278|58716223|FG006|Overall Study|Adverse Event|0|||
30702232|NCT00642278|58716217|FG000|Overall Study|Lack of Efficacy|0|||
30702233|NCT00642278|58716218|FG001|Overall Study|Lack of Efficacy|1|||
30702234|NCT00642278|58716219|FG002|Overall Study|Lack of Efficacy|0|||
30702235|NCT00642278|58716220|FG003|Overall Study|Lack of Efficacy|0|||
30702236|NCT00642278|58716221|FG004|Overall Study|Lack of Efficacy|0|||
30702237|NCT00642278|58716222|FG005|Overall Study|Lack of Efficacy|0|||
30702238|NCT00642278|58716223|FG006|Overall Study|Lack of Efficacy|0|||
30702239|NCT00642278|58716217|FG000|Overall Study|Lost to Follow-up|5|||
30702240|NCT00642278|58716218|FG001|Overall Study|Lost to Follow-up|1|||
30702241|NCT00642278|58716219|FG002|Overall Study|Lost to Follow-up|0|||
30702242|NCT00642278|58716220|FG003|Overall Study|Lost to Follow-up|1|||
30702243|NCT00642278|58716221|FG004|Overall Study|Lost to Follow-up|0|||
30702244|NCT00642278|58716222|FG005|Overall Study|Lost to Follow-up|1|||
30702245|NCT00642278|58716223|FG006|Overall Study|Lost to Follow-up|1|||
30702246|NCT00642278|58716217|FG000|Overall Study|Physician Decision|0|||
30702247|NCT00642278|58716218|FG001|Overall Study|Physician Decision|0|||
30702248|NCT00642278|58716219|FG002|Overall Study|Physician Decision|0|||
30702249|NCT00642278|58716220|FG003|Overall Study|Physician Decision|1|||
30702250|NCT00642278|58716221|FG004|Overall Study|Physician Decision|0|||
30702251|NCT00642278|58716222|FG005|Overall Study|Physician Decision|0|||
30702252|NCT00642278|58716223|FG006|Overall Study|Physician Decision|0|||
30702253|NCT00642278|58716217|FG000|Overall Study|Protocol Violation|0|||
30702254|NCT00642278|58716218|FG001|Overall Study|Protocol Violation|0|||
30702255|NCT00642278|58716219|FG002|Overall Study|Protocol Violation|1|||
30702256|NCT00642278|58716220|FG003|Overall Study|Protocol Violation|1|||
30702257|NCT00642278|58716221|FG004|Overall Study|Protocol Violation|0|||
30702258|NCT00642278|58716222|FG005|Overall Study|Protocol Violation|1|||
30702259|NCT00642278|58716223|FG006|Overall Study|Protocol Violation|2|||
30702260|NCT00642278|58716217|FG000|Overall Study|Withdrawal by Subject|1|||
30702261|NCT00642278|58716218|FG001|Overall Study|Withdrawal by Subject|1|||
30702262|NCT00642278|58716219|FG002|Overall Study|Withdrawal by Subject|1|||
30702263|NCT00642278|58716220|FG003|Overall Study|Withdrawal by Subject|3|||
30702264|NCT00642278|58716221|FG004|Overall Study|Withdrawal by Subject|6|||
30702265|NCT00642278|58716222|FG005|Overall Study|Withdrawal by Subject|2|||
30702266|NCT00642278|58716223|FG006|Overall Study|Withdrawal by Subject|2|||
30702267|NCT00642278|58716217|FG000|Overall Study|Noncompliance with study drug regimen|0|||
30702268|NCT00642278|58716218|FG001|Overall Study|Noncompliance with study drug regimen|0|||
30702269|NCT00642278|58716219|FG002|Overall Study|Noncompliance with study drug regimen|0|||
30702270|NCT00642278|58716220|FG003|Overall Study|Noncompliance with study drug regimen|1|||
30702271|NCT00642278|58716221|FG004|Overall Study|Noncompliance with study drug regimen|0|||
30702272|NCT00642278|58716222|FG005|Overall Study|Noncompliance with study drug regimen|0|||
30702273|NCT00642278|58716223|FG006|Overall Study|Noncompliance with study drug regimen|0|||
30702274|NCT00642278|58716217|FG000|Overall Study|Other|2|||
30702275|NCT00642278|58716218|FG001|Overall Study|Other|1|||
30702276|NCT00642278|58716219|FG002|Overall Study|Other|0|||
30702277|NCT00642278|58716220|FG003|Overall Study|Other|1|||
30702278|NCT00642278|58716221|FG004|Overall Study|Other|0|||
30702279|NCT00642278|58716222|FG005|Overall Study|Other|1|||
30702280|NCT00642278|58716223|FG006|Overall Study|Other|0|||
30702281|NCT00543543|58716243|FG000|Base Study|Adverse Event|1|||
30702282|NCT00543543|58716244|FG001|Base Study|Adverse Event|11|||
30702283|NCT00543543|58716245|FG002|Base Study|Adverse Event|0|||
30702284|NCT00543543|58716246|FG003|Base Study|Adverse Event|5|||
30702285|NCT00543543|58716243|FG000|Base Study|Lost to Follow-up|12|||
30702286|NCT00543543|58716244|FG001|Base Study|Lost to Follow-up|749|||
30702287|NCT00543543|58716245|FG002|Base Study|Lost to Follow-up|9|||
30702288|NCT00543543|58716246|FG003|Base Study|Lost to Follow-up|701|||
30702289|NCT00543543|58716243|FG000|Base Study|Physician Decision|0|||
30702290|NCT00543543|58716244|FG001|Base Study|Physician Decision|4|||
30702291|NCT00543543|58716245|FG002|Base Study|Physician Decision|0|||
30702292|NCT00543543|58716246|FG003|Base Study|Physician Decision|7|||
30702293|NCT00543543|58716243|FG000|Base Study|Protocol Violation|0|||
30702294|NCT00543543|58716244|FG001|Base Study|Protocol Violation|6|||
30702295|NCT00543543|58716245|FG002|Base Study|Protocol Violation|0|||
30702296|NCT00543543|58716246|FG003|Base Study|Protocol Violation|6|||
30702297|NCT00543543|58716243|FG000|Base Study|Withdrawal by Subject|7|||
30702298|NCT00543543|58716244|FG001|Base Study|Withdrawal by Subject|482|||
30702299|NCT00543543|58716245|FG002|Base Study|Withdrawal by Subject|5|||
30702300|NCT00543543|58716246|FG003|Base Study|Withdrawal by Subject|503|||
30702301|NCT00543543|58716243|FG000|Extension Study|Adverse Event|0|||
30702302|NCT00543543|58716244|FG001|Extension Study|Adverse Event|0|||
30702303|NCT00543543|58716245|FG002|Extension Study|Adverse Event|0|||
30702304|NCT00543543|58716246|FG003|Extension Study|Adverse Event|5|||
30702305|NCT00543543|58716243|FG000|Extension Study|Lost to Follow-up|0|||
30702306|NCT00543543|58716244|FG001|Extension Study|Lost to Follow-up|0|||
30702307|NCT00543543|58716245|FG002|Extension Study|Lost to Follow-up|0|||
30702308|NCT00543543|58716246|FG003|Extension Study|Lost to Follow-up|77|||
30702309|NCT00543543|58716243|FG000|Extension Study|Physician Decision|0|||
30702310|NCT00543543|58716244|FG001|Extension Study|Physician Decision|0|||
30702311|NCT00543543|58716245|FG002|Extension Study|Physician Decision|0|||
30702312|NCT00543543|58716246|FG003|Extension Study|Physician Decision|7|||
30702313|NCT00543543|58716243|FG000|Extension Study|Pregnancy|0|||
30702314|NCT00543543|58716244|FG001|Extension Study|Pregnancy|0|||
30702315|NCT00543543|58716245|FG002|Extension Study|Pregnancy|0|||
30702316|NCT00543543|58716246|FG003|Extension Study|Pregnancy|6|||
30702317|NCT00543543|58716243|FG000|Extension Study|Protocol Violation|0|||
30702318|NCT00543543|58716244|FG001|Extension Study|Protocol Violation|0|||
30702319|NCT00543543|58716245|FG002|Extension Study|Protocol Violation|0|||
30702320|NCT00543543|58716246|FG003|Extension Study|Protocol Violation|11|||
30702321|NCT00543543|58716243|FG000|Extension Study|Withdrawal by Subject|0|||
30702322|NCT00543543|58716244|FG001|Extension Study|Withdrawal by Subject|0|||
30702323|NCT00543543|58716245|FG002|Extension Study|Withdrawal by Subject|0|||
30702324|NCT00543543|58716246|FG003|Extension Study|Withdrawal by Subject|120|||
30702325|NCT00645164|58716261|FG000|Overall Study|Lost to Follow-up|2|||
30702326|NCT00645164|58716261|FG000|Overall Study|Withdrawal by Subject|4|||
30702327|NCT00645164|58716261|FG000|Overall Study|Protocol Violation|1|||
30702328|NCT00723125|58716267|FG000|Overall Study|Met Dx|1|||
30702329|NCT00723125|58716268|FG001|Overall Study|Met Dx|0|||
30702330|NCT00723125|58716267|FG000|Overall Study|Withdrawal by Subject|15|||
30702331|NCT00723125|58716268|FG001|Overall Study|Withdrawal by Subject|6|||
30702332|NCT00723125|58716267|FG000|Overall Study|Adverse Event|2|||
30702333|NCT00723125|58716268|FG001|Overall Study|Adverse Event|0|||
30702334|NCT00722423|58716282|FG000|Overall Study|Protocol Violation|0|||
30702335|NCT00722423|58716283|FG001|Overall Study|Protocol Violation|1|||
30702336|NCT00640562|58716293|FG000|Overall Study|Adverse Event|8|||
30702337|NCT00640562|58716294|FG001|Overall Study|Adverse Event|5|||
30702338|NCT00640562|58716293|FG000|Overall Study|Lack of Efficacy|1|||
30702339|NCT00640562|58716294|FG001|Overall Study|Lack of Efficacy|4|||
30702340|NCT00640562|58716293|FG000|Overall Study|Protocol Violation|2|||
30702341|NCT00640562|58716294|FG001|Overall Study|Protocol Violation|4|||
30702342|NCT00640562|58716293|FG000|Overall Study|Withdrawal by Subject|6|||
30702343|NCT00640562|58716294|FG001|Overall Study|Withdrawal by Subject|10|||
30702344|NCT00640562|58716293|FG000|Overall Study|Known risperidone intolerance|0|||
30702345|NCT00640562|58716294|FG001|Overall Study|Known risperidone intolerance|1|||
30702346|NCT00640562|58716293|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
30702347|NCT00640562|58716294|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
30702348|NCT00640562|58716293|FG000|Overall Study|Low study drug dose|0|||
30702349|NCT00640562|58716294|FG001|Overall Study|Low study drug dose|1|||
30702350|NCT00640562|58716293|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
30702351|NCT00640562|58716294|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
30702352|NCT00585923|58716302|FG000|Overall Study|Physician decided not to continue|31|||
30702353|NCT00585923|58716303|FG001|Overall Study|Physician decided not to continue|33|||
30702354|NCT00721955|58716312|FG000|Overall Study|Adverse Event|0|||
30702355|NCT00721955|58716313|FG001|Overall Study|Adverse Event|0|||
30702356|NCT00721955|58716314|FG002|Overall Study|Adverse Event|2|||
30702357|NCT00585689|58716322|FG000|Overall Study|Received different ABI-007 schedule|3|||
30702358|NCT00585689|58716322|FG000|Overall Study|Adverse Event|1|||
30702359|NCT00585689|58716322|FG000|Overall Study|Patient Declined Surgery|1|||
30702360|NCT00585689|58716322|FG000|Overall Study|Patient had unresectable disease|1|||
30702361|NCT00585689|58716322|FG000|Overall Study|Death|1|||
30702362|NCT00721799|58716326|FG000|Overall Study|Withdrawal by Subject|7|||
30702363|NCT00721799|58716326|FG000|Overall Study|withdraw by subject after scan 1|1|||
30702364|NCT00729365|58716333|FG000|Overall Study|Physician Decision|33|||
30702365|NCT00729365|58716334|FG001|Overall Study|Physician Decision|6|||
30702366|NCT00729365|58716335|FG002|Overall Study|Physician Decision|7|||
30702367|NCT00254293|58716351|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
30702368|NCT00254293|58716352|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
30702369|NCT00254293|58716353|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
30702370|NCT00254293|58716354|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
30702371|NCT00254293|58716355|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
30702372|NCT00254293|58716356|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
30702373|NCT00254293|58716357|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
30702374|NCT00254293|58716351|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
30702375|NCT00254293|58716352|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
30702376|NCT00254293|58716353|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
30702377|NCT00254293|58716354|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
30702378|NCT00254293|58716355|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
30702379|NCT00254293|58716356|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
30702380|NCT00254293|58716357|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
30702381|NCT00254293|58716351|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
30702382|NCT00254293|58716352|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
30702383|NCT00254293|58716353|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
30702384|NCT00254293|58716354|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
30702385|NCT00254293|58716355|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
30702386|NCT00254293|58716356|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
30702387|NCT00254293|58716357|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
30702388|NCT00254293|58716351|FG000|LTE Open Label Variable SC Dosing|Death|0|||
30702389|NCT00254293|58716352|FG001|LTE Open Label Variable SC Dosing|Death|0|||
30702390|NCT00254293|58716353|FG002|LTE Open Label Variable SC Dosing|Death|1|||
30702391|NCT00254293|58716354|FG003|LTE Open Label Variable SC Dosing|Death|0|||
30702392|NCT00254293|58716355|FG004|LTE Open Label Variable SC Dosing|Death|0|||
30702393|NCT00254293|58716356|FG005|LTE Open Label Variable SC Dosing|Death|0|||
30702394|NCT00254293|58716357|FG006|LTE Open Label Variable SC Dosing|Death|0|||
30702395|NCT00254293|58716351|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
30702396|NCT00254293|58716352|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
30702397|NCT00254293|58716353|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
30702398|NCT00254293|58716354|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
30702399|NCT00254293|58716355|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
30702400|NCT00254293|58716356|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
30702401|NCT00254293|58716357|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
30702402|NCT00254293|58716351|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
30702403|NCT00254293|58716352|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
30702404|NCT00254293|58716353|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
30702405|NCT00254293|58716354|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
30702406|NCT00254293|58716355|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
30702407|NCT00254293|58716356|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
30702408|NCT00254293|58716357|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
30702409|NCT00254293|58716351|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
30702410|NCT00254293|58716352|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
30702411|NCT00254293|58716353|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
30702412|NCT00254293|58716354|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
30702413|NCT00254293|58716355|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
30702414|NCT00254293|58716356|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
30702415|NCT00254293|58716357|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
30702416|NCT00254293|58716351|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
30702417|NCT00254293|58716352|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
30702418|NCT00254293|58716353|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
30702419|NCT00254293|58716354|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
30702420|NCT00254293|58716355|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
30702421|NCT00254293|58716356|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
30702422|NCT00254293|58716357|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
30702423|NCT00254293|58716351|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
30702424|NCT00254293|58716352|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
30702425|NCT00254293|58716353|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
30702426|NCT00254293|58716354|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
30702427|NCT00254293|58716355|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
30702428|NCT00254293|58716356|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
30702429|NCT00254293|58716357|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
30702430|NCT00254293|58716351|FG000|LTE Open Label Variable SC Dosing|Other|0|||
30702431|NCT00254293|58716352|FG001|LTE Open Label Variable SC Dosing|Other|0|||
30702432|NCT00254293|58716353|FG002|LTE Open Label Variable SC Dosing|Other|2|||
30702433|NCT00254293|58716354|FG003|LTE Open Label Variable SC Dosing|Other|0|||
30702434|NCT00254293|58716355|FG004|LTE Open Label Variable SC Dosing|Other|0|||
30702435|NCT00254293|58716356|FG005|LTE Open Label Variable SC Dosing|Other|0|||
30702436|NCT00254293|58716357|FG006|LTE Open Label Variable SC Dosing|Other|0|||
30702437|NCT00254293|58716351|FG000|LTE Open Label Fixed Dosing|Death|0|||
30702438|NCT00254293|58716352|FG001|LTE Open Label Fixed Dosing|Death|0|||
30702439|NCT00254293|58716353|FG002|LTE Open Label Fixed Dosing|Death|0|||
30702440|NCT00254293|58716354|FG003|LTE Open Label Fixed Dosing|Death|0|||
30702441|NCT00254293|58716355|FG004|LTE Open Label Fixed Dosing|Death|0|||
30702442|NCT00254293|58716356|FG005|LTE Open Label Fixed Dosing|Death|0|||
30702443|NCT00254293|58716357|FG006|LTE Open Label Fixed Dosing|Death|3|||
30702444|NCT00254293|58716351|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
30702445|NCT00254293|58716352|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
30702446|NCT00254293|58716353|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
30702447|NCT00254293|58716354|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
30702448|NCT00254293|58716355|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
30702449|NCT00254293|58716356|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
30702450|NCT00254293|58716357|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
30702451|NCT00254293|58716351|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
30702452|NCT00254293|58716352|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
30702453|NCT00254293|58716353|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
30702454|NCT00254293|58716354|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
30702455|NCT00254293|58716355|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
30702456|NCT00254293|58716356|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
30702457|NCT00254293|58716357|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
30702458|NCT00254293|58716351|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
30702459|NCT00254293|58716352|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
30702460|NCT00254293|58716353|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
30702461|NCT00254293|58716354|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
30702462|NCT00254293|58716355|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
30702463|NCT00254293|58716356|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
30702464|NCT00254293|58716357|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
30702465|NCT00254293|58716351|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
30702466|NCT00254293|58716352|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
30702467|NCT00254293|58716353|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
30702468|NCT00254293|58716354|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
30702469|NCT00254293|58716355|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
30702470|NCT00254293|58716356|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
30702471|NCT00254293|58716357|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
30702472|NCT00254293|58716351|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
30702473|NCT00254293|58716352|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
30702474|NCT00254293|58716353|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
30702475|NCT00254293|58716354|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
30702476|NCT00254293|58716355|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
30702477|NCT00254293|58716356|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
30702478|NCT00254293|58716357|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
30702479|NCT00254293|58716351|FG000|LTE Open Label Fixed Dosing|Other|0|||
30702480|NCT00254293|58716352|FG001|LTE Open Label Fixed Dosing|Other|0|||
30702481|NCT00254293|58716353|FG002|LTE Open Label Fixed Dosing|Other|0|||
30702482|NCT00254293|58716354|FG003|LTE Open Label Fixed Dosing|Other|0|||
30702483|NCT00254293|58716355|FG004|LTE Open Label Fixed Dosing|Other|0|||
30702484|NCT00254293|58716356|FG005|LTE Open Label Fixed Dosing|Other|0|||
30702485|NCT00254293|58716357|FG006|LTE Open Label Fixed Dosing|Other|1|||
30702486|NCT00736385|58716402|FG000|Overall Study|Withdrawal by Subject|2|||
30702487|NCT00736385|58716403|FG001|Overall Study|Withdrawal by Subject|2|||
30702488|NCT00736385|58716402|FG000|Overall Study|Adverse Event|0|||
30702489|NCT00736385|58716403|FG001|Overall Study|Adverse Event|1|||
30702490|NCT00585221|58716409|FG000|Overall Study|Protocol Violation|8|||
30702491|NCT00253747|58716415|FG000|Overall Study|Lost to Follow-up|13|||
30702492|NCT00253747|58716416|FG001|Overall Study|Lost to Follow-up|14|||
30702493|NCT00253747|58716415|FG000|Overall Study|Withdrawal by Subject|10|||
30702494|NCT00253747|58716416|FG001|Overall Study|Withdrawal by Subject|11|||
30702495|NCT00253747|58716415|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
30702496|NCT00253747|58716416|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
30702497|NCT00252733|58716434|FG000|Overall Study|Withdrawal by Subject|73|||
30702498|NCT00252733|58716435|FG001|Overall Study|Withdrawal by Subject|67|||
30702499|NCT00252733|58716434|FG000|Overall Study|Death|7|||
30702500|NCT00252733|58716435|FG001|Overall Study|Death|5|||
30702501|NCT00252733|58716434|FG000|Overall Study|Lost to Follow-up|12|||
30702502|NCT00252733|58716435|FG001|Overall Study|Lost to Follow-up|6|||
30702503|NCT00252733|58716434|FG000|Overall Study|Multiple Reasons|14|||
30702504|NCT00252733|58716435|FG001|Overall Study|Multiple Reasons|14|||
30702505|NCT00275821|58716444|FG000|Overall Study|Adverse Event|4|||
30702506|NCT00275821|58716445|FG001|Overall Study|Adverse Event|12|||
30702507|NCT00275821|58716446|FG002|Overall Study|Adverse Event|5|||
30702508|NCT00275821|58716444|FG000|Overall Study|Administrative problems|3|||
30702509|NCT00275821|58716445|FG001|Overall Study|Administrative problems|4|||
30702510|NCT00275821|58716446|FG002|Overall Study|Administrative problems|4|||
30702511|NCT00275821|58716444|FG000|Overall Study|Withdrawal by Subject|0|||
30702512|NCT00275821|58716445|FG001|Overall Study|Withdrawal by Subject|2|||
30702513|NCT00275821|58716446|FG002|Overall Study|Withdrawal by Subject|1|||
30702514|NCT00275821|58716444|FG000|Overall Study|Lost to Follow-up|0|||
30702515|NCT00275821|58716445|FG001|Overall Study|Lost to Follow-up|1|||
30702516|NCT00275821|58716446|FG002|Overall Study|Lost to Follow-up|1|||
30702517|NCT00275821|58716444|FG000|Overall Study|Death|0|||
30702518|NCT00275821|58716445|FG001|Overall Study|Death|2|||
30702519|NCT00275821|58716446|FG002|Overall Study|Death|1|||
30702520|NCT00275821|58716444|FG000|Overall Study|Lack of Efficacy|2|||
30702521|NCT00275821|58716445|FG001|Overall Study|Lack of Efficacy|1|||
30702522|NCT00275821|58716446|FG002|Overall Study|Lack of Efficacy|0|||
30702523|NCT00275821|58716444|FG000|Overall Study|Protocol Violation|5|||
30702524|NCT00275821|58716445|FG001|Overall Study|Protocol Violation|1|||
30702525|NCT00275821|58716446|FG002|Overall Study|Protocol Violation|0|||
30702526|NCT00275509|58716456|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
30702527|NCT00275509|58716457|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
30702528|NCT00252577|58716463|FG000|Overall Study|Lost to Follow-up|20|||
30702529|NCT00252499|58716470|FG000|Overall Study|Lost to Follow-up|1|||
30702530|NCT00252499|58716471|FG001|Overall Study|Lost to Follow-up|0|||
30702531|NCT00252499|58716472|FG002|Overall Study|Lost to Follow-up|0|||
30702532|NCT00252187|58716482|FG000|Overall Study|Adverse Event|3|||
30702533|NCT00252187|58716483|FG001|Overall Study|Adverse Event|1|||
30702534|NCT00252187|58716482|FG000|Overall Study|Withdrawal by Subject|1|||
30702535|NCT00252187|58716483|FG001|Overall Study|Withdrawal by Subject|0|||
30702536|NCT00572910|58716495|FG000|Overall Study|Adverse Event|1|||
30702537|NCT00572910|58716496|FG001|Overall Study|Adverse Event|2|||
30702538|NCT00572910|58716497|FG002|Overall Study|Adverse Event|0|||
30702539|NCT00572910|58716498|FG003|Overall Study|Adverse Event|2|||
30702540|NCT00572910|58716499|FG004|Overall Study|Adverse Event|0|||
30702541|NCT00572910|58716500|FG005|Overall Study|Adverse Event|0|||
30702542|NCT00572910|58716501|FG006|Overall Study|Adverse Event|4|||
30702543|NCT00572910|58716502|FG007|Overall Study|Adverse Event|2|||
30702544|NCT00572910|58716503|FG008|Overall Study|Adverse Event|1|||
30702545|NCT00572910|58716504|FG009|Overall Study|Adverse Event|3|||
30702546|NCT00572910|58716505|FG010|Overall Study|Adverse Event|2|||
30702547|NCT00572910|58716495|FG000|Overall Study|Lost to Follow-up|0|||
30702548|NCT00572910|58716496|FG001|Overall Study|Lost to Follow-up|1|||
30702549|NCT00572910|58716497|FG002|Overall Study|Lost to Follow-up|1|||
30702550|NCT00572910|58716498|FG003|Overall Study|Lost to Follow-up|2|||
30702551|NCT00572910|58716499|FG004|Overall Study|Lost to Follow-up|1|||
30702552|NCT00572910|58716500|FG005|Overall Study|Lost to Follow-up|0|||
30702553|NCT00572910|58716501|FG006|Overall Study|Lost to Follow-up|0|||
30702554|NCT00572910|58716502|FG007|Overall Study|Lost to Follow-up|0|||
30702555|NCT00572910|58716503|FG008|Overall Study|Lost to Follow-up|0|||
30702556|NCT00572910|58716504|FG009|Overall Study|Lost to Follow-up|1|||
30893665|NCT02161185|58927220|FG000|Treatment Phase|Administrative/Other|7|||
30702557|NCT00572910|58716505|FG010|Overall Study|Lost to Follow-up|0|||
30702558|NCT00572910|58716495|FG000|Overall Study|Withdrawal by Subject|3|||
30702559|NCT00572910|58716496|FG001|Overall Study|Withdrawal by Subject|0|||
30702560|NCT00572910|58716497|FG002|Overall Study|Withdrawal by Subject|1|||
30702561|NCT00572910|58716498|FG003|Overall Study|Withdrawal by Subject|0|||
30702562|NCT00572910|58716499|FG004|Overall Study|Withdrawal by Subject|1|||
30893666|NCT02159469|58927224|FG000|Overall Study|Missing Completion status|1|||
30702563|NCT00572910|58716500|FG005|Overall Study|Withdrawal by Subject|3|||
30702564|NCT00572910|58716501|FG006|Overall Study|Withdrawal by Subject|0|||
30702565|NCT00572910|58716502|FG007|Overall Study|Withdrawal by Subject|2|||
30702566|NCT00572910|58716503|FG008|Overall Study|Withdrawal by Subject|2|||
30702567|NCT00572910|58716504|FG009|Overall Study|Withdrawal by Subject|2|||
30702568|NCT00572910|58716505|FG010|Overall Study|Withdrawal by Subject|1|||
30702569|NCT00163657|58716543|FG000|Overall Study|Death|12|||
30702570|NCT00163657|58716544|FG001|Overall Study|Death|14|||
30702571|NCT00163657|58716545|FG002|Overall Study|Death|19|||
30702572|NCT00163657|58716543|FG000|Overall Study|graft loss|4|||
30702573|NCT00163657|58716544|FG001|Overall Study|graft loss|1|||
30702574|NCT00163657|58716545|FG002|Overall Study|graft loss|2|||
30702575|NCT00163657|58716543|FG000|Overall Study|Withdrawal by Subject|2|||
30702576|NCT00163657|58716544|FG001|Overall Study|Withdrawal by Subject|3|||
30702577|NCT00163657|58716545|FG002|Overall Study|Withdrawal by Subject|2|||
30702578|NCT00163657|58716543|FG000|Overall Study|Physician Decision|0|||
30702579|NCT00163657|58716544|FG001|Overall Study|Physician Decision|1|||
30702580|NCT00163657|58716545|FG002|Overall Study|Physician Decision|1|||
30702581|NCT00163657|58716543|FG000|Overall Study|Non Compliance|1|||
30702582|NCT00163657|58716544|FG001|Overall Study|Non Compliance|0|||
30702583|NCT00163657|58716545|FG002|Overall Study|Non Compliance|0|||
30702584|NCT00163657|58716543|FG000|Overall Study|Lost to Follow-up|1|||
30702585|NCT00163657|58716544|FG001|Overall Study|Lost to Follow-up|3|||
30702586|NCT00163657|58716545|FG002|Overall Study|Lost to Follow-up|10|||
30702587|NCT00163657|58716543|FG000|Overall Study|Other reason|0|||
30702588|NCT00163657|58716544|FG001|Overall Study|Other reason|1|||
30702589|NCT00163657|58716545|FG002|Overall Study|Other reason|3|||
30702590|NCT00609492|58716556|FG000|Overall Study|Withdrawal by Subject|0|||
30702591|NCT00609492|58716557|FG001|Overall Study|Withdrawal by Subject|2|||
30702592|NCT00609492|58716558|FG002|Overall Study|Withdrawal by Subject|3|||
30702593|NCT00609492|58716556|FG000|Overall Study|Lost to Follow-up|1|||
30702594|NCT00609492|58716557|FG001|Overall Study|Lost to Follow-up|1|||
30702595|NCT00609492|58716558|FG002|Overall Study|Lost to Follow-up|4|||
30702596|NCT00230971|58716570|FG000|Randomization|No study drug administered|3|||
30702597|NCT00230971|58716571|FG001|Randomization|No study drug administered|3|||
30702598|NCT00230971|58716570|FG000|Baseline Participants|Lost to Follow-up|5|||
30702599|NCT00230971|58716571|FG001|Baseline Participants|Lost to Follow-up|12|||
30702600|NCT00230971|58716570|FG000|Baseline Participants|Death|6|||
30702601|NCT00230971|58716571|FG001|Baseline Participants|Death|5|||
30702602|NCT00230971|58716570|FG000|Baseline Participants|Withdrawal by Subject|7|||
30702603|NCT00230971|58716571|FG001|Baseline Participants|Withdrawal by Subject|1|||
30702604|NCT00230971|58716570|FG000|Baseline Participants|Adverse Event|1|||
30702605|NCT00230971|58716571|FG001|Baseline Participants|Adverse Event|0|||
30702606|NCT00230971|58716570|FG000|Baseline Participants|No bacteria observed|1|||
30702607|NCT00230971|58716571|FG001|Baseline Participants|No bacteria observed|0|||
30702608|NCT00230971|58716570|FG000|Baseline Participants|Failure to return|1|||
30702609|NCT00230971|58716571|FG001|Baseline Participants|Failure to return|1|||
30702610|NCT00230971|58716570|FG000|Baseline Participants|Reintervention|1|||
30702611|NCT00230971|58716571|FG001|Baseline Participants|Reintervention|0|||
30702612|NCT00211081|58716577|FG000|Overall Study|Withdrawal by Subject|2|||
30702613|NCT00609336|58716581|FG000|Overall Study|Protocol Violation|3|||
30702614|NCT00609336|58716581|FG000|Overall Study|Death|1|||
30702615|NCT00609336|58716581|FG000|Overall Study|LA or Met at Surgery|9|||
30702616|NCT00612066|58716586|FG000|Overall Study|Adverse Event|1|||
30702617|NCT00573144|58716592|FG000|Overall Study|Withdrawal by Subject|2|||
30702618|NCT00573144|58716593|FG001|Overall Study|Withdrawal by Subject|3|||
30702619|NCT00640328|58716605|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
30702620|NCT00640328|58716606|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
30702621|NCT00640328|58716607|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
30702622|NCT00640328|58716608|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
30702623|NCT00640328|58716609|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
30702624|NCT00640328|58716610|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
30702625|NCT00640328|58716605|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
30702626|NCT00640328|58716606|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
30702627|NCT00640328|58716607|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
30702628|NCT00640328|58716608|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
30702629|NCT00640328|58716609|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
30702630|NCT00640328|58716610|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
30702631|NCT00640328|58716605|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
30843690|NCT01915498|58869654|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
30702632|NCT00640328|58716606|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
30702633|NCT00640328|58716607|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
30702634|NCT00640328|58716608|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
30702635|NCT00640328|58716609|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
30702636|NCT00640328|58716610|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
30702637|NCT00640328|58716605|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
30702638|NCT00640328|58716606|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
30702639|NCT00640328|58716607|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
30702640|NCT00640328|58716608|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
30702641|NCT00640328|58716609|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
30702642|NCT00640328|58716610|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
30702643|NCT00163189|58716631|FG000|Overall Study|Other|6|||
30702644|NCT00163189|58716631|FG000|Overall Study|Lost to Follow-up|1|||
30702645|NCT00163189|58716631|FG000|Overall Study|Protocol Violation|2|||
30702646|NCT00163189|58716631|FG000|Overall Study|Death|3|||
30702647|NCT00163189|58716631|FG000|Overall Study|Adverse Event|6|||
30702648|NCT00163189|58716631|FG000|Overall Study|Lack of Efficacy|7|||
30702649|NCT00163189|58716631|FG000|Overall Study|Study terminated by sponsor|11|||
30702650|NCT00163189|58716631|FG000|Overall Study|Withdrawal by Subject|11|||
30702651|NCT00163189|58716631|FG000|Overall Study|Did not meet continuation criterion|16|||
30702652|NCT00162097|58716639|FG000|Overall Study|Participant no longer met study criteria|0|||
30702653|NCT00162097|58716640|FG001|Overall Study|Participant no longer met study criteria|0|||
30702654|NCT00162097|58716641|FG002|Overall Study|Participant no longer met study criteria|0|||
30702655|NCT00162097|58716642|FG003|Overall Study|Participant no longer met study criteria|1|||
30702656|NCT00640016|58716662|FG000|Overall Study|Withdrawal by Subject|0|||
30702657|NCT00640016|58716663|FG001|Overall Study|Withdrawal by Subject|1|||
30702658|NCT00640016|58716664|FG002|Overall Study|Withdrawal by Subject|0|||
30702659|NCT00640016|58716665|FG003|Overall Study|Withdrawal by Subject|0|||
30702660|NCT00640016|58716662|FG000|Overall Study|Study termination|2|||
30702661|NCT00640016|58716663|FG001|Overall Study|Study termination|1|||
30702662|NCT00640016|58716664|FG002|Overall Study|Study termination|3|||
30702663|NCT00640016|58716665|FG003|Overall Study|Study termination|2|||
30702664|NCT00640016|58716662|FG000|Overall Study|Adverse Event|0|||
30702665|NCT00640016|58716663|FG001|Overall Study|Adverse Event|0|||
30702666|NCT00640016|58716664|FG002|Overall Study|Adverse Event|0|||
30702667|NCT00640016|58716665|FG003|Overall Study|Adverse Event|1|||
30702668|NCT00608868|58716682|FG000|Overall Study|Withdrawal by Subject|7|||
30702669|NCT00608868|58716682|FG000|Overall Study|Protocol Violation|3|||
30702670|NCT00608868|58716682|FG000|Overall Study|Lost to Follow-up|2|||
30702671|NCT00608868|58716682|FG000|Overall Study|Adverse Event|1|||
30702672|NCT00608868|58716682|FG000|Overall Study|Physician Decision|2|||
30702673|NCT00608322|58716688|FG000|Overall Study|Death|2|||
30702674|NCT00608322|58716689|FG001|Overall Study|Death|1|||
30702675|NCT00608244|58716695|FG000|Overall Study|Adverse Event|1|||
30702676|NCT00608244|58716695|FG000|Overall Study|Low trough levels|1|||
30702677|NCT00605280|58716705|FG000|Year 1|Protocol Violation|0|||
30702678|NCT00605280|58716706|FG001|Year 1|Protocol Violation|0|||
30702679|NCT00605280|58716707|FG002|Year 1|Protocol Violation|0|||
30702680|NCT00605280|58716708|FG003|Year 1|Protocol Violation|1|||
30702681|NCT00605280|58716705|FG000|Year 1|Adverse Event|3|||
30702682|NCT00605280|58716706|FG001|Year 1|Adverse Event|1|||
30702683|NCT00605280|58716707|FG002|Year 1|Adverse Event|1|||
30702684|NCT00605280|58716708|FG003|Year 1|Adverse Event|5|||
30702685|NCT00605280|58716705|FG000|Year 1|Physician Decision|7|||
30702686|NCT00605280|58716706|FG001|Year 1|Physician Decision|4|||
30702687|NCT00605280|58716707|FG002|Year 1|Physician Decision|0|||
30702688|NCT00605280|58716708|FG003|Year 1|Physician Decision|6|||
30702689|NCT00605280|58716705|FG000|Year 1|Withdrawal by Subject|2|||
30702690|NCT00605280|58716706|FG001|Year 1|Withdrawal by Subject|4|||
30702691|NCT00605280|58716707|FG002|Year 1|Withdrawal by Subject|0|||
30702692|NCT00605280|58716708|FG003|Year 1|Withdrawal by Subject|4|||
30702693|NCT00605280|58716705|FG000|Year 1|Other|2|||
30702694|NCT00605280|58716706|FG001|Year 1|Other|1|||
30702695|NCT00605280|58716707|FG002|Year 1|Other|0|||
30702696|NCT00605280|58716708|FG003|Year 1|Other|1|||
30702697|NCT00605280|58716705|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
30702698|NCT00605280|58716706|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
30702699|NCT00605280|58716707|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
30702700|NCT00605280|58716708|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
30702701|NCT00605280|58716705|FG000|Year 2|Adverse Event|4|||
30702702|NCT00605280|58716706|FG001|Year 2|Adverse Event|0|||
30702703|NCT00605280|58716707|FG002|Year 2|Adverse Event|2|||
30702704|NCT00605280|58716708|FG003|Year 2|Adverse Event|4|||
30702705|NCT00605280|58716705|FG000|Year 2|Physician Decision|11|||
30702706|NCT00605280|58716706|FG001|Year 2|Physician Decision|6|||
30702707|NCT00605280|58716707|FG002|Year 2|Physician Decision|4|||
30702708|NCT00605280|58716708|FG003|Year 2|Physician Decision|11|||
30702709|NCT00605280|58716705|FG000|Year 2|Withdrawal by Subject|4|||
30702710|NCT00605280|58716706|FG001|Year 2|Withdrawal by Subject|0|||
30702711|NCT00605280|58716707|FG002|Year 2|Withdrawal by Subject|0|||
30702712|NCT00605280|58716708|FG003|Year 2|Withdrawal by Subject|4|||
30702713|NCT00605280|58716705|FG000|Year 2|Other|1|||
30702714|NCT00605280|58716706|FG001|Year 2|Other|0|||
30702715|NCT00605280|58716707|FG002|Year 2|Other|0|||
30702716|NCT00605280|58716708|FG003|Year 2|Other|1|||
30702717|NCT00605280|58716705|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
30702718|NCT00605280|58716706|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
30702719|NCT00605280|58716707|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
30702720|NCT00605280|58716708|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
30702721|NCT00605280|58716705|FG000|Year 3 Extension|Adverse Event|2|||
30702722|NCT00605280|58716706|FG001|Year 3 Extension|Adverse Event|0|||
30702723|NCT00605280|58716707|FG002|Year 3 Extension|Adverse Event|0|||
30702724|NCT00605280|58716708|FG003|Year 3 Extension|Adverse Event|2|||
30702725|NCT00605280|58716705|FG000|Year 3 Extension|Physician Decision|0|||
30702726|NCT00605280|58716706|FG001|Year 3 Extension|Physician Decision|0|||
30702727|NCT00605280|58716707|FG002|Year 3 Extension|Physician Decision|0|||
30702728|NCT00605280|58716708|FG003|Year 3 Extension|Physician Decision|2|||
30702729|NCT00605280|58716705|FG000|Year 3 Extension|Withdrawal by Subject|2|||
30702730|NCT00605280|58716706|FG001|Year 3 Extension|Withdrawal by Subject|0|||
30702731|NCT00605280|58716707|FG002|Year 3 Extension|Withdrawal by Subject|0|||
30702732|NCT00605280|58716708|FG003|Year 3 Extension|Withdrawal by Subject|5|||
30702733|NCT00605280|58716705|FG000|Year 3 Extension|Other|2|||
30702734|NCT00605280|58716706|FG001|Year 3 Extension|Other|0|||
30702735|NCT00605280|58716707|FG002|Year 3 Extension|Other|0|||
30702736|NCT00605280|58716708|FG003|Year 3 Extension|Other|0|||
30702737|NCT00605280|58716705|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
30702738|NCT00605280|58716706|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
30702739|NCT00605280|58716707|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
30702740|NCT00605280|58716708|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
30702741|NCT00607386|58716718|FG000|Overall Study|Physician Decision|1|||
30702742|NCT00638690|58716724|FG000|Overall Study|Death|655|||
30702743|NCT00638690|58716725|FG001|Overall Study|Death|335|||
30702744|NCT00638690|58716724|FG000|Overall Study|Withdrawal by Subject|22|||
30702745|NCT00638690|58716725|FG001|Overall Study|Withdrawal by Subject|5|||
30702746|NCT00638690|58716724|FG000|Overall Study|Lost to Follow-up|4|||
30702747|NCT00638690|58716725|FG001|Overall Study|Lost to Follow-up|2|||
30702748|NCT00543387|58716741|FG000|Panel 1 + Panel 2|Adverse Event|0|||
30702749|NCT00543387|58716742|FG001|Panel 1 + Panel 2|Adverse Event|1|||
30702750|NCT00543387|58716743|FG002|Panel 1 + Panel 2|Adverse Event|0|||
30702751|NCT00543387|58716744|FG003|Panel 1 + Panel 2|Adverse Event|0|||
30702752|NCT00543387|58716745|FG004|Panel 1 + Panel 2|Adverse Event|0|||
30702753|NCT00543387|58716746|FG005|Panel 1 + Panel 2|Adverse Event|0|||
30702754|NCT00543387|58716747|FG006|Panel 1 + Panel 2|Adverse Event|0|||
30702755|NCT00543387|58716748|FG007|Panel 1 + Panel 2|Adverse Event|1|||
30702756|NCT00543387|58716749|FG008|Panel 1 + Panel 2|Adverse Event|1|||
30702757|NCT00543387|58716750|FG009|Panel 1 + Panel 2|Adverse Event|0|||
30702758|NCT00543387|58716751|FG010|Panel 1 + Panel 2|Adverse Event|0|||
30702759|NCT00543387|58716741|FG000|Panel 1 + Panel 2|Physician Decision|0|||
30702760|NCT00543387|58716742|FG001|Panel 1 + Panel 2|Physician Decision|0|||
30702761|NCT00543387|58716743|FG002|Panel 1 + Panel 2|Physician Decision|1|||
30702762|NCT00543387|58716744|FG003|Panel 1 + Panel 2|Physician Decision|0|||
30702763|NCT00543387|58716745|FG004|Panel 1 + Panel 2|Physician Decision|0|||
30702764|NCT00543387|58716746|FG005|Panel 1 + Panel 2|Physician Decision|0|||
30893667|NCT02159469|58927224|FG000|Overall Study|Adverse Event|5|||
30702765|NCT00543387|58716747|FG006|Panel 1 + Panel 2|Physician Decision|0|||
30702766|NCT00543387|58716748|FG007|Panel 1 + Panel 2|Physician Decision|1|||
30702767|NCT00543387|58716749|FG008|Panel 1 + Panel 2|Physician Decision|0|||
30702768|NCT00543387|58716750|FG009|Panel 1 + Panel 2|Physician Decision|0|||
30702769|NCT00543387|58716751|FG010|Panel 1 + Panel 2|Physician Decision|0|||
30702770|NCT00543387|58716741|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
30702771|NCT00543387|58716742|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
30702772|NCT00543387|58716743|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
30702773|NCT00543387|58716744|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
30702774|NCT00543387|58716745|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
30702775|NCT00543387|58716746|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
30702776|NCT00543387|58716747|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
30702777|NCT00543387|58716748|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
30702778|NCT00543387|58716749|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
30702779|NCT00543387|58716750|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
30702780|NCT00543387|58716751|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
30702781|NCT00543387|58716741|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
30702782|NCT00543387|58716742|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
30702783|NCT00543387|58716743|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
30702784|NCT00543387|58716744|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
30702785|NCT00543387|58716745|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
30702786|NCT00543387|58716746|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
30702787|NCT00543387|58716747|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
30702788|NCT00543387|58716748|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
30702789|NCT00543387|58716749|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
30702790|NCT00543387|58716750|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
30702791|NCT00543387|58716751|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
30702792|NCT00543387|58716741|FG000|Crossover Participants|Progressive Disease|0|||
30702793|NCT00543387|58716742|FG001|Crossover Participants|Progressive Disease|0|||
30702794|NCT00543387|58716743|FG002|Crossover Participants|Progressive Disease|0|||
30702795|NCT00543387|58716744|FG003|Crossover Participants|Progressive Disease|0|||
30702796|NCT00543387|58716745|FG004|Crossover Participants|Progressive Disease|0|||
30702797|NCT00543387|58716746|FG005|Crossover Participants|Progressive Disease|0|||
30702798|NCT00543387|58716747|FG006|Crossover Participants|Progressive Disease|0|||
30702799|NCT00543387|58716748|FG007|Crossover Participants|Progressive Disease|0|||
30702800|NCT00543387|58716749|FG008|Crossover Participants|Progressive Disease|0|||
30702801|NCT00543387|58716750|FG009|Crossover Participants|Progressive Disease|1|||
30702802|NCT00543387|58716751|FG010|Crossover Participants|Progressive Disease|2|||
30702803|NCT00543387|58716741|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
30702804|NCT00543387|58716742|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
30702805|NCT00543387|58716743|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
30702806|NCT00543387|58716744|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
30702807|NCT00543387|58716745|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
30702808|NCT00543387|58716746|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
30702809|NCT00543387|58716747|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
30702810|NCT00543387|58716748|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
30702811|NCT00543387|58716749|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
30702812|NCT00543387|58716750|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
30702813|NCT00543387|58716751|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
30702814|NCT00635570|58716781|FG000|Overall Study|Lost to Follow-up|8|||
30702815|NCT00635570|58716782|FG001|Overall Study|Lost to Follow-up|8|||
30702816|NCT00635570|58716781|FG000|Overall Study|Withdrawal by Subject|1|||
30702817|NCT00635570|58716782|FG001|Overall Study|Withdrawal by Subject|1|||
30702818|NCT00635570|58716781|FG000|Overall Study|Adverse Event|2|||
30702819|NCT00635570|58716782|FG001|Overall Study|Adverse Event|0|||
30702820|NCT00635570|58716781|FG000|Overall Study|Physician Decision|1|||
30702821|NCT00635570|58716782|FG001|Overall Study|Physician Decision|0|||
30702822|NCT00635570|58716781|FG000|Overall Study|Did not complete survey|2|||
30702823|NCT00635570|58716782|FG001|Overall Study|Did not complete survey|1|||
30702824|NCT00635570|58716781|FG000|Overall Study|Early termination(No sexual activity)|1|||
30702825|NCT00635570|58716782|FG001|Overall Study|Early termination(No sexual activity)|1|||
30702826|NCT00635492|58716790|FG000|Overall Study|Death|12|||
30702827|NCT00635492|58716791|FG001|Overall Study|Death|40|||
30702828|NCT00635492|58716790|FG000|Overall Study|Lost to Follow-up|151|||
30702829|NCT00635492|58716791|FG001|Overall Study|Lost to Follow-up|172|||
30702830|NCT00635492|58716790|FG000|Overall Study|Physician Decision|32|||
30702831|NCT00635492|58716791|FG001|Overall Study|Physician Decision|22|||
30702832|NCT00635492|58716790|FG000|Overall Study|Sponsor decision|2|||
30702833|NCT00635492|58716791|FG001|Overall Study|Sponsor decision|3|||
30702834|NCT00635492|58716790|FG000|Overall Study|Withdrawal by Subject|82|||
30702835|NCT00635492|58716791|FG001|Overall Study|Withdrawal by Subject|45|||
30702836|NCT00543309|58716804|FG000|Overall Study|Physician Decision|0|||
30702837|NCT00543309|58716805|FG001|Overall Study|Physician Decision|1|||
30702838|NCT00543309|58716806|FG002|Overall Study|Physician Decision|0|||
30702839|NCT00569582|58716815|FG000|Overall Study|Withdrawal by Subject|5|||
30702840|NCT00569582|58716815|FG000|Overall Study|Death|2|||
30702841|NCT00569582|58716815|FG000|Overall Study|Adverse Event|7|||
30702842|NCT00569582|58716815|FG000|Overall Study|Subject was too ill to travel.|1|||
30702843|NCT00569582|58716815|FG000|Overall Study|Subject was non-compliant.|1|||
30702844|NCT00721409|58716822|FG000|Overall Study|Global deterioration of health status|2|||
30702845|NCT00721409|58716823|FG001|Overall Study|Global deterioration of health status|6|||
30702846|NCT00721409|58716824|FG002|Overall Study|Global deterioration of health status|3|||
30702847|NCT00721409|58716822|FG000|Overall Study|Death|0|||
30702848|NCT00721409|58716823|FG001|Overall Study|Death|1|||
30702849|NCT00721409|58716824|FG002|Overall Study|Death|0|||
30702850|NCT00721409|58716822|FG000|Overall Study|Randomized not Treated|0|||
30702851|NCT00721409|58716823|FG001|Overall Study|Randomized not Treated|1|||
30702852|NCT00721409|58716824|FG002|Overall Study|Randomized not Treated|4|||
30702853|NCT00721409|58716822|FG000|Overall Study|Reason not specified|1|||
30702854|NCT00721409|58716823|FG001|Overall Study|Reason not specified|0|||
30702855|NCT00721409|58716824|FG002|Overall Study|Reason not specified|2|||
30702856|NCT00721409|58716822|FG000|Overall Study|Adverse Event|0|||
30702857|NCT00721409|58716823|FG001|Overall Study|Adverse Event|13|||
30702858|NCT00721409|58716824|FG002|Overall Study|Adverse Event|2|||
30702859|NCT00721409|58716822|FG000|Overall Study|Lost to Follow-up|0|||
30702860|NCT00721409|58716823|FG001|Overall Study|Lost to Follow-up|0|||
30702861|NCT00721409|58716824|FG002|Overall Study|Lost to Follow-up|1|||
30702862|NCT00721409|58716822|FG000|Overall Study|Withdrawal by Subject|1|||
30702863|NCT00721409|58716823|FG001|Overall Study|Withdrawal by Subject|6|||
30702864|NCT00721409|58716824|FG002|Overall Study|Withdrawal by Subject|5|||
30702865|NCT00721409|58716822|FG000|Overall Study|Objective progression or relapse|8|||
30702866|NCT00721409|58716823|FG001|Overall Study|Objective progression or relapse|55|||
30702867|NCT00721409|58716824|FG002|Overall Study|Objective progression or relapse|62|||
30702868|NCT00542997|58716848|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
30702869|NCT00542997|58716848|FG000|Wash in / Wash Out Period|Adverse Event|3|||
30702870|NCT00542997|58716848|FG000|Efficacy Period|Adverse Event|3|||
30702871|NCT00572832|58716857|FG000|Overall Study|Lost to Follow-up|0|||
30702872|NCT00572832|58716858|FG001|Overall Study|Lost to Follow-up|11|||
30702873|NCT00572832|58716857|FG000|Overall Study|Pregnancy|0|||
30702874|NCT00572832|58716858|FG001|Overall Study|Pregnancy|1|||
30702875|NCT03917823|58716866|FG000|Overall Study|Lost to Follow-up|1|||
30702876|NCT03917823|58716867|FG001|Overall Study|Lost to Follow-up|1|||
30702877|NCT03917823|58716866|FG000|Overall Study|Withdrawal by Subject|0|||
30702878|NCT03917823|58716867|FG001|Overall Study|Withdrawal by Subject|1|||
30702879|NCT00229723|58716880|FG000|Concomitant Phase|Adverse Event|4|||
30702880|NCT00229723|58716881|FG001|Concomitant Phase|Adverse Event|2|||
30702881|NCT00229723|58716882|FG002|Concomitant Phase|Adverse Event|5|||
30702882|NCT00229723|58716883|FG003|Concomitant Phase|Adverse Event|2|||
30702883|NCT00229723|58716884|FG004|Concomitant Phase|Adverse Event|0|||
30702884|NCT00229723|58716885|FG005|Concomitant Phase|Adverse Event|1|||
30702885|NCT00229723|58716886|FG006|Concomitant Phase|Adverse Event|2|||
30702886|NCT00229723|58716880|FG000|Concomitant Phase|Objective disease progression|0|||
30702887|NCT00229723|58716881|FG001|Concomitant Phase|Objective disease progression|0|||
30702888|NCT00229723|58716882|FG002|Concomitant Phase|Objective disease progression|0|||
30702889|NCT00229723|58716883|FG003|Concomitant Phase|Objective disease progression|0|||
30702890|NCT00229723|58716884|FG004|Concomitant Phase|Objective disease progression|0|||
30702891|NCT00229723|58716885|FG005|Concomitant Phase|Objective disease progression|0|||
30702892|NCT00229723|58716886|FG006|Concomitant Phase|Objective disease progression|0|||
30702893|NCT00229723|58716880|FG000|Concomitant Phase|Clinical progression|0|||
30702894|NCT00229723|58716881|FG001|Concomitant Phase|Clinical progression|0|||
30702895|NCT00229723|58716882|FG002|Concomitant Phase|Clinical progression|0|||
30702896|NCT00229723|58716883|FG003|Concomitant Phase|Clinical progression|0|||
30702897|NCT00229723|58716884|FG004|Concomitant Phase|Clinical progression|0|||
30702898|NCT00229723|58716885|FG005|Concomitant Phase|Clinical progression|0|||
30702899|NCT00229723|58716886|FG006|Concomitant Phase|Clinical progression|1|||
30702900|NCT00229723|58716880|FG000|Concomitant Phase|Lost to Follow-up|0|||
30702901|NCT00229723|58716881|FG001|Concomitant Phase|Lost to Follow-up|0|||
30702902|NCT00229723|58716882|FG002|Concomitant Phase|Lost to Follow-up|0|||
30702903|NCT00229723|58716883|FG003|Concomitant Phase|Lost to Follow-up|0|||
30702904|NCT00229723|58716884|FG004|Concomitant Phase|Lost to Follow-up|1|||
30893668|NCT02159469|58927224|FG000|Overall Study|Non-compliance|2|||
30893669|NCT02159469|58927224|FG000|Overall Study|Withdrawal by Subject|9|||
30702905|NCT00229723|58716885|FG005|Concomitant Phase|Lost to Follow-up|0|||
30702906|NCT00229723|58716886|FG006|Concomitant Phase|Lost to Follow-up|0|||
30702907|NCT00229723|58716880|FG000|Concomitant Phase|Informed consent withdrawn|3|||
30702908|NCT00229723|58716881|FG001|Concomitant Phase|Informed consent withdrawn|2|||
30702909|NCT00229723|58716882|FG002|Concomitant Phase|Informed consent withdrawn|0|||
30702910|NCT00229723|58716883|FG003|Concomitant Phase|Informed consent withdrawn|2|||
30702911|NCT00229723|58716884|FG004|Concomitant Phase|Informed consent withdrawn|0|||
30702912|NCT00229723|58716885|FG005|Concomitant Phase|Informed consent withdrawn|0|||
30702913|NCT00229723|58716886|FG006|Concomitant Phase|Informed consent withdrawn|0|||
30893670|NCT02159469|58927224|FG000|Overall Study|Lost to Follow-up|1|||
30702914|NCT00229723|58716880|FG000|Concomitant Phase|Severe non-compliance|0|||
30702915|NCT00229723|58716881|FG001|Concomitant Phase|Severe non-compliance|1|||
30702916|NCT00229723|58716882|FG002|Concomitant Phase|Severe non-compliance|0|||
30702917|NCT00229723|58716883|FG003|Concomitant Phase|Severe non-compliance|0|||
30702918|NCT00229723|58716884|FG004|Concomitant Phase|Severe non-compliance|1|||
30702919|NCT00229723|58716885|FG005|Concomitant Phase|Severe non-compliance|0|||
30702920|NCT00229723|58716886|FG006|Concomitant Phase|Severe non-compliance|0|||
30702921|NCT00229723|58716880|FG000|Concomitant Phase|Other|3|||
30702922|NCT00229723|58716881|FG001|Concomitant Phase|Other|0|||
30702923|NCT00229723|58716882|FG002|Concomitant Phase|Other|1|||
30702924|NCT00229723|58716883|FG003|Concomitant Phase|Other|1|||
30702925|NCT00229723|58716884|FG004|Concomitant Phase|Other|0|||
30702926|NCT00229723|58716885|FG005|Concomitant Phase|Other|2|||
30702927|NCT00229723|58716886|FG006|Concomitant Phase|Other|0|||
30702928|NCT00229723|58716880|FG000|Maintenance Phase|Adverse Event|7|||
30702929|NCT00229723|58716881|FG001|Maintenance Phase|Adverse Event|2|||
30702930|NCT00229723|58716882|FG002|Maintenance Phase|Adverse Event|1|||
30702931|NCT00229723|58716883|FG003|Maintenance Phase|Adverse Event|4|||
30702932|NCT00229723|58716884|FG004|Maintenance Phase|Adverse Event|7|||
30702933|NCT00229723|58716885|FG005|Maintenance Phase|Adverse Event|5|||
30702934|NCT00229723|58716886|FG006|Maintenance Phase|Adverse Event|2|||
30702935|NCT00229723|58716880|FG000|Maintenance Phase|Objective disease progression|5|||
30702936|NCT00229723|58716881|FG001|Maintenance Phase|Objective disease progression|5|||
30702937|NCT00229723|58716882|FG002|Maintenance Phase|Objective disease progression|3|||
30702938|NCT00229723|58716883|FG003|Maintenance Phase|Objective disease progression|6|||
30702939|NCT00229723|58716884|FG004|Maintenance Phase|Objective disease progression|2|||
30702940|NCT00229723|58716885|FG005|Maintenance Phase|Objective disease progression|9|||
30702941|NCT00229723|58716886|FG006|Maintenance Phase|Objective disease progression|5|||
30702942|NCT00229723|58716880|FG000|Maintenance Phase|Clinical progression|4|||
30702943|NCT00229723|58716881|FG001|Maintenance Phase|Clinical progression|1|||
30702944|NCT00229723|58716882|FG002|Maintenance Phase|Clinical progression|2|||
30702945|NCT00229723|58716883|FG003|Maintenance Phase|Clinical progression|2|||
30702946|NCT00229723|58716884|FG004|Maintenance Phase|Clinical progression|1|||
30702947|NCT00229723|58716885|FG005|Maintenance Phase|Clinical progression|1|||
30702948|NCT00229723|58716886|FG006|Maintenance Phase|Clinical progression|1|||
30702949|NCT00229723|58716880|FG000|Maintenance Phase|Lost to Follow-up|0|||
30702950|NCT00229723|58716881|FG001|Maintenance Phase|Lost to Follow-up|1|||
30702951|NCT00229723|58716882|FG002|Maintenance Phase|Lost to Follow-up|2|||
30702952|NCT00229723|58716883|FG003|Maintenance Phase|Lost to Follow-up|2|||
30702953|NCT00229723|58716884|FG004|Maintenance Phase|Lost to Follow-up|0|||
30702954|NCT00229723|58716885|FG005|Maintenance Phase|Lost to Follow-up|0|||
30702955|NCT00229723|58716886|FG006|Maintenance Phase|Lost to Follow-up|1|||
30702956|NCT00229723|58716880|FG000|Maintenance Phase|Informed consent withdrawn|1|||
30702957|NCT00229723|58716881|FG001|Maintenance Phase|Informed consent withdrawn|0|||
30702958|NCT00229723|58716882|FG002|Maintenance Phase|Informed consent withdrawn|0|||
30702959|NCT00229723|58716883|FG003|Maintenance Phase|Informed consent withdrawn|1|||
30702960|NCT00229723|58716884|FG004|Maintenance Phase|Informed consent withdrawn|1|||
30702961|NCT00229723|58716885|FG005|Maintenance Phase|Informed consent withdrawn|1|||
30702962|NCT00229723|58716886|FG006|Maintenance Phase|Informed consent withdrawn|0|||
30702963|NCT00229723|58716880|FG000|Maintenance Phase|Severe non-compliance|3|||
30702964|NCT00229723|58716881|FG001|Maintenance Phase|Severe non-compliance|1|||
30702965|NCT00229723|58716882|FG002|Maintenance Phase|Severe non-compliance|0|||
30702966|NCT00229723|58716883|FG003|Maintenance Phase|Severe non-compliance|0|||
30702967|NCT00229723|58716884|FG004|Maintenance Phase|Severe non-compliance|1|||
30702968|NCT00229723|58716885|FG005|Maintenance Phase|Severe non-compliance|0|||
30702969|NCT00229723|58716886|FG006|Maintenance Phase|Severe non-compliance|0|||
30702970|NCT00229723|58716880|FG000|Maintenance Phase|Other|5|||
30702971|NCT00229723|58716881|FG001|Maintenance Phase|Other|4|||
30702972|NCT00229723|58716882|FG002|Maintenance Phase|Other|1|||
30702973|NCT00229723|58716883|FG003|Maintenance Phase|Other|2|||
30702974|NCT00229723|58716884|FG004|Maintenance Phase|Other|3|||
30702975|NCT00229723|58716885|FG005|Maintenance Phase|Other|3|||
30702976|NCT00229723|58716886|FG006|Maintenance Phase|Other|1|||
30702977|NCT00606684|58716908|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
30702978|NCT00606684|58716909|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
30893671|NCT02159469|58927224|FG000|Overall Study|Sponsor's request|2|||
30893672|NCT02159469|58927224|FG000|Overall Study|Met Stopping Criteria|3|||
30893673|NCT02159469|58927224|FG000|Overall Study|Other|1|||
30702979|NCT00606684|58716910|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
30702980|NCT00606684|58716911|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
30702981|NCT00606684|58716912|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
30702982|NCT00606684|58716913|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
30702983|NCT00606684|58716914|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
30702984|NCT00606684|58716908|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
30893674|NCT02159469|58927224|FG000|Overall Study|Multiple|29|||
30702985|NCT00606684|58716909|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
30702986|NCT00606684|58716910|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
30702987|NCT00606684|58716911|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
30702988|NCT00606684|58716912|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
30702989|NCT00606684|58716913|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
30702990|NCT00606684|58716914|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
30702991|NCT00606684|58716908|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
30702992|NCT00606684|58716909|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
30702993|NCT00606684|58716910|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
30702994|NCT00606684|58716911|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
30702995|NCT00606684|58716912|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
30702996|NCT00606684|58716913|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
30702997|NCT00606684|58716914|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
30702998|NCT00606684|58716908|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
30702999|NCT00606684|58716909|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
30703000|NCT00606684|58716910|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
30703001|NCT00606684|58716911|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
30703002|NCT00606684|58716912|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
30703003|NCT00606684|58716913|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
30703004|NCT00606684|58716914|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
30703005|NCT00606684|58716908|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
30703006|NCT00606684|58716909|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
30703007|NCT00606684|58716910|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
30703008|NCT00606684|58716911|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
30703009|NCT00606684|58716912|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
30703010|NCT00606684|58716913|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
30703011|NCT00606684|58716914|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
30703012|NCT00606684|58716908|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
30703013|NCT00606684|58716909|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
30703014|NCT00606684|58716910|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
30703015|NCT00606684|58716911|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
30703016|NCT00606684|58716912|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
30703017|NCT00606684|58716913|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
30703018|NCT00606684|58716914|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
30703019|NCT00606684|58716908|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
30703020|NCT00606684|58716909|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
30703021|NCT00606684|58716910|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
30703022|NCT00606684|58716911|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
30703023|NCT00606684|58716912|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
30703024|NCT00606684|58716913|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
30703025|NCT00606684|58716914|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
30703026|NCT00606684|58716908|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30703027|NCT00606684|58716909|FG001|Double-Blind Treatment Period|Adverse Event|3|||
30703028|NCT00606684|58716910|FG002|Double-Blind Treatment Period|Adverse Event|2|||
30703029|NCT00606684|58716911|FG003|Double-Blind Treatment Period|Adverse Event|4|||
30703030|NCT00606684|58716912|FG004|Double-Blind Treatment Period|Adverse Event|2|||
30703031|NCT00606684|58716913|FG005|Double-Blind Treatment Period|Adverse Event|0|||
30703032|NCT00606684|58716914|FG006|Double-Blind Treatment Period|Adverse Event|1|||
30703033|NCT00606684|58716908|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
30703034|NCT00606684|58716909|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
30703035|NCT00606684|58716910|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
30703036|NCT00606684|58716911|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
30703037|NCT00606684|58716912|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
30703038|NCT00606684|58716913|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
30703039|NCT00606684|58716914|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
30703040|NCT00606684|58716908|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
30703041|NCT00606684|58716909|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
30703042|NCT00606684|58716910|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
30703043|NCT00606684|58716911|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
30703044|NCT00606684|58716912|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
30703045|NCT00606684|58716913|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
30703046|NCT00606684|58716914|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
30893675|NCT02123511|58927231|FG000|Overall Study|Cancelled treatment|1|||
30893676|NCT02123511|58927232|FG001|Overall Study|Cancelled treatment|0|||
30893677|NCT02123511|58927231|FG000|Overall Study|Incomplete data|1|||
30893678|NCT02123511|58927232|FG001|Overall Study|Incomplete data|3|||
30893679|NCT02123511|58927231|FG000|Overall Study|Ineligible|0|||
30893680|NCT02123511|58927232|FG001|Overall Study|Ineligible|1|||
30703047|NCT00606684|58716908|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
30703048|NCT00606684|58716909|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
30703049|NCT00606684|58716910|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
30703050|NCT00606684|58716911|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
30703051|NCT00606684|58716912|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
30703052|NCT00606684|58716913|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
30703053|NCT00606684|58716914|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
30703054|NCT00606684|58716908|FG000|Double-Blind Treatment Period|Physician Decision|0|||
30703055|NCT00606684|58716909|FG001|Double-Blind Treatment Period|Physician Decision|5|||
30703056|NCT00606684|58716910|FG002|Double-Blind Treatment Period|Physician Decision|1|||
30703057|NCT00606684|58716911|FG003|Double-Blind Treatment Period|Physician Decision|0|||
30703058|NCT00606684|58716912|FG004|Double-Blind Treatment Period|Physician Decision|3|||
30703059|NCT00606684|58716913|FG005|Double-Blind Treatment Period|Physician Decision|1|||
30703060|NCT00606684|58716914|FG006|Double-Blind Treatment Period|Physician Decision|2|||
30703061|NCT00606684|58716908|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30703062|NCT00606684|58716909|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
30703063|NCT00606684|58716910|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
30703064|NCT00606684|58716911|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
30703065|NCT00606684|58716912|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
30703066|NCT00606684|58716913|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
30703067|NCT00606684|58716914|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30703068|NCT00627926|58716931|FG000|Overall Study|Adverse Event|26|||
30703069|NCT00627926|58716932|FG001|Overall Study|Adverse Event|37|||
30703070|NCT00627926|58716933|FG002|Overall Study|Adverse Event|36|||
30703071|NCT00627926|58716931|FG000|Overall Study|Death|1|||
30703072|NCT00627926|58716932|FG001|Overall Study|Death|0|||
30703073|NCT00627926|58716933|FG002|Overall Study|Death|0|||
30703074|NCT00627926|58716931|FG000|Overall Study|Lost to Follow-up|4|||
30703075|NCT00627926|58716932|FG001|Overall Study|Lost to Follow-up|3|||
30703076|NCT00627926|58716933|FG002|Overall Study|Lost to Follow-up|4|||
30703077|NCT00627926|58716931|FG000|Overall Study|Withdrawal by Subject|2|||
30703078|NCT00627926|58716932|FG001|Overall Study|Withdrawal by Subject|1|||
30703079|NCT00627926|58716933|FG002|Overall Study|Withdrawal by Subject|0|||
30703080|NCT00627926|58716931|FG000|Overall Study|Lack of Efficacy|118|||
30703081|NCT00627926|58716932|FG001|Overall Study|Lack of Efficacy|40|||
30703082|NCT00627926|58716933|FG002|Overall Study|Lack of Efficacy|38|||
30703083|NCT00627926|58716931|FG000|Overall Study|Noncompliance/unspecified|8|||
30703084|NCT00627926|58716932|FG001|Overall Study|Noncompliance/unspecified|23|||
30703085|NCT00627926|58716933|FG002|Overall Study|Noncompliance/unspecified|17|||
30703086|NCT00228553|58716941|FG000|Overall Study|Adverse Event|112|||
30703087|NCT00228553|58716941|FG000|Overall Study|Lack of Efficacy|34|||
30703088|NCT00228553|58716941|FG000|Overall Study|Lost to Follow-up|67|||
30703089|NCT00228553|58716941|FG000|Overall Study|Physician Decision|48|||
30703090|NCT00228553|58716941|FG000|Overall Study|Protocol Violation|6|||
30703091|NCT00228553|58716941|FG000|Overall Study|Withdrawal by Subject|115|||
30703092|NCT00228553|58716941|FG000|Overall Study|Pregnancy|2|||
30703093|NCT00228553|58716941|FG000|Overall Study|Miscellaneous|46|||
30703094|NCT00643916|58716951|FG000|Overall Study|Protocol Violation|0|||
30703095|NCT00643916|58716952|FG001|Overall Study|Protocol Violation|1|||
30703096|NCT00643916|58716953|FG002|Overall Study|Protocol Violation|1|||
30703097|NCT00643916|58716954|FG003|Overall Study|Protocol Violation|1|||
30703098|NCT00643916|58716955|FG004|Overall Study|Protocol Violation|0|||
30703099|NCT00643916|58716956|FG005|Overall Study|Protocol Violation|0|||
30703100|NCT00643916|58716951|FG000|Overall Study|Lost to Follow-up|0|||
30703101|NCT00643916|58716952|FG001|Overall Study|Lost to Follow-up|1|||
30703102|NCT00643916|58716953|FG002|Overall Study|Lost to Follow-up|0|||
30703103|NCT00643916|58716954|FG003|Overall Study|Lost to Follow-up|0|||
30703104|NCT00643916|58716955|FG004|Overall Study|Lost to Follow-up|0|||
30703105|NCT00643916|58716956|FG005|Overall Study|Lost to Follow-up|0|||
30703106|NCT00643916|58716951|FG000|Overall Study|Withdrawal by Subject|2|||
30703107|NCT00643916|58716952|FG001|Overall Study|Withdrawal by Subject|2|||
30703108|NCT00643916|58716953|FG002|Overall Study|Withdrawal by Subject|2|||
30703109|NCT00643916|58716954|FG003|Overall Study|Withdrawal by Subject|1|||
30703110|NCT00643916|58716955|FG004|Overall Study|Withdrawal by Subject|0|||
30703111|NCT00643916|58716956|FG005|Overall Study|Withdrawal by Subject|1|||
30703112|NCT00643916|58716951|FG000|Overall Study|Not Vaccinated|2|||
30703113|NCT00643916|58716952|FG001|Overall Study|Not Vaccinated|2|||
30703114|NCT00643916|58716953|FG002|Overall Study|Not Vaccinated|3|||
30703115|NCT00643916|58716954|FG003|Overall Study|Not Vaccinated|0|||
30703116|NCT00643916|58716955|FG004|Overall Study|Not Vaccinated|2|||
30703117|NCT00643916|58716956|FG005|Overall Study|Not Vaccinated|0|||
30703118|NCT00160693|58716970|FG000|Overall Study|Adverse Event|97|||
30703119|NCT00160693|58716970|FG000|Overall Study|Lack of Efficacy|30|||
30703120|NCT00160693|58716970|FG000|Overall Study|Protocol Violation|24|||
30703121|NCT00160693|58716970|FG000|Overall Study|Lost to Follow-up|15|||
30703122|NCT00160693|58716970|FG000|Overall Study|Withdrawal by Subject|54|||
30703123|NCT00160693|58716970|FG000|Overall Study|Study terminated by sponsor|15|||
30703124|NCT00643760|58716979|FG000|Overall Study|Adverse Event|11|||
30703125|NCT00643760|58716980|FG001|Overall Study|Adverse Event|5|||
30703126|NCT00643760|58716981|FG002|Overall Study|Adverse Event|12|||
30703127|NCT00643760|58716982|FG003|Overall Study|Adverse Event|21|||
30703128|NCT00643760|58716983|FG004|Overall Study|Adverse Event|6|||
30703129|NCT00643760|58716979|FG000|Overall Study|Lack of Efficacy|3|||
30703130|NCT00643760|58716980|FG001|Overall Study|Lack of Efficacy|1|||
30703131|NCT00643760|58716981|FG002|Overall Study|Lack of Efficacy|0|||
30703132|NCT00643760|58716982|FG003|Overall Study|Lack of Efficacy|4|||
30703133|NCT00643760|58716983|FG004|Overall Study|Lack of Efficacy|3|||
30703134|NCT00643760|58716979|FG000|Overall Study|Protocol Violation|7|||
30703135|NCT00643760|58716980|FG001|Overall Study|Protocol Violation|6|||
30703136|NCT00643760|58716981|FG002|Overall Study|Protocol Violation|4|||
30703137|NCT00643760|58716982|FG003|Overall Study|Protocol Violation|4|||
30703138|NCT00643760|58716983|FG004|Overall Study|Protocol Violation|6|||
30703139|NCT00643760|58716979|FG000|Overall Study|Lost to Follow-up|6|||
30703140|NCT00643760|58716980|FG001|Overall Study|Lost to Follow-up|2|||
30703141|NCT00643760|58716981|FG002|Overall Study|Lost to Follow-up|1|||
30703142|NCT00643760|58716982|FG003|Overall Study|Lost to Follow-up|3|||
30703143|NCT00643760|58716983|FG004|Overall Study|Lost to Follow-up|3|||
30703144|NCT00643760|58716979|FG000|Overall Study|Investigator Discretion|0|||
30703145|NCT00643760|58716980|FG001|Overall Study|Investigator Discretion|0|||
30703146|NCT00643760|58716981|FG002|Overall Study|Investigator Discretion|0|||
30703147|NCT00643760|58716982|FG003|Overall Study|Investigator Discretion|2|||
30703148|NCT00643760|58716983|FG004|Overall Study|Investigator Discretion|0|||
30703149|NCT00643760|58716979|FG000|Overall Study|Withdrawal by Subject|3|||
30703150|NCT00643760|58716980|FG001|Overall Study|Withdrawal by Subject|1|||
30703151|NCT00643760|58716981|FG002|Overall Study|Withdrawal by Subject|2|||
30703152|NCT00643760|58716982|FG003|Overall Study|Withdrawal by Subject|4|||
30703153|NCT00643760|58716983|FG004|Overall Study|Withdrawal by Subject|1|||
30703154|NCT00643682|58716997|FG000|Overall Study|did not keep appointment|522|||
30703155|NCT00643682|58716998|FG001|Overall Study|did not keep appointment|509|||
30703156|NCT00643604|58717004|FG000|Overall Study|Death|1|||
30703157|NCT00603798|58717011|FG000|Overall Study|Adverse Event|4|||
30703158|NCT00603798|58717012|FG001|Overall Study|Adverse Event|2|||
30703159|NCT00603798|58717013|FG002|Overall Study|Adverse Event|1|||
30703160|NCT00603798|58717011|FG000|Overall Study|Withdrawal by Subject|4|||
30703161|NCT00603798|58717012|FG001|Overall Study|Withdrawal by Subject|3|||
30703162|NCT00603798|58717013|FG002|Overall Study|Withdrawal by Subject|4|||
30703163|NCT00603798|58717011|FG000|Overall Study|Lost to Follow-up|1|||
30703164|NCT00603798|58717012|FG001|Overall Study|Lost to Follow-up|0|||
30703165|NCT00603798|58717013|FG002|Overall Study|Lost to Follow-up|1|||
30703166|NCT00603798|58717011|FG000|Overall Study|Non-compliance with study procedures|0|||
30703167|NCT00603798|58717012|FG001|Overall Study|Non-compliance with study procedures|1|||
30703168|NCT00603798|58717013|FG002|Overall Study|Non-compliance with study procedures|0|||
30703169|NCT00603798|58717011|FG000|Overall Study|Not due to AE|1|||
30703170|NCT00603798|58717012|FG001|Overall Study|Not due to AE|1|||
30703171|NCT00603798|58717013|FG002|Overall Study|Not due to AE|4|||
30703172|NCT00630812|58717023|FG000|Randomisation to First Dose|Adverse Event|1|||
30703173|NCT00630812|58717024|FG001|Randomisation to First Dose|Adverse Event|1|||
30703174|NCT00630812|58717023|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
30619967|NCT00940108|58631031|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
30619968|NCT00940108|58631032|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
30619969|NCT00940108|58631029|FG000|Overall Study|Viral illness after Dose 1|0|||
30619970|NCT00940108|58631030|FG001|Overall Study|Viral illness after Dose 1|1|||
30619971|NCT00940108|58631031|FG002|Overall Study|Viral illness after Dose 1|0|||
30619972|NCT00940108|58631032|FG003|Overall Study|Viral illness after Dose 1|0|||
30619973|NCT00940108|58631029|FG000|Overall Study|Diagnosed with H1N1|0|||
30619974|NCT00940108|58631030|FG001|Overall Study|Diagnosed with H1N1|0|||
30619975|NCT00940108|58631031|FG002|Overall Study|Diagnosed with H1N1|0|||
30619976|NCT00940108|58631032|FG003|Overall Study|Diagnosed with H1N1|1|||
30703175|NCT00630812|58717024|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
30703176|NCT00630812|58717023|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
30703177|NCT00630812|58717024|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
30703178|NCT00630812|58717023|FG000|Randomisation to First Dose|Protocol Violation|4|||
30703179|NCT00630812|58717024|FG001|Randomisation to First Dose|Protocol Violation|1|||
30619977|NCT00936598|58631044|FG000|Overall Study|Withdrawal by Subject|1|||
30619978|NCT00936598|58631045|FG001|Overall Study|Withdrawal by Subject|0|||
30619979|NCT00936598|58631044|FG000|Overall Study|Ineligible after consent|1|||
30703180|NCT00630812|58717023|FG000|Double Blind Treatment Period|Adverse Event|13|||
30703181|NCT00630812|58717024|FG001|Double Blind Treatment Period|Adverse Event|5|||
30703182|NCT00630812|58717023|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
30703183|NCT00630812|58717024|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
30703184|NCT00630812|58717023|FG000|Double Blind Treatment Period|Physician Decision|2|||
30703185|NCT00630812|58717024|FG001|Double Blind Treatment Period|Physician Decision|1|||
30703186|NCT00630812|58717023|FG000|Double Blind Treatment Period|Protocol Violation|1|||
30703187|NCT00630812|58717024|FG001|Double Blind Treatment Period|Protocol Violation|0|||
30703188|NCT00630812|58717023|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
30703189|NCT00630812|58717024|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
30703190|NCT00630812|58717023|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
30703191|NCT00630812|58717024|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
30703192|NCT00630812|58717023|FG000|Double Blind Treatment Period|Non-compliance|0|||
30703193|NCT00630812|58717024|FG001|Double Blind Treatment Period|Non-compliance|1|||
30703194|NCT00629798|58717030|FG000|Overall Study|Not Treated|4|||
30703195|NCT00160615|58717036|FG000|Overall Study|Adverse Event|5|||
30703196|NCT00160615|58717037|FG001|Overall Study|Adverse Event|12|||
30703197|NCT00160615|58717036|FG000|Overall Study|Withdrawal by Subject|0|||
30703198|NCT00160615|58717037|FG001|Overall Study|Withdrawal by Subject|2|||
30703199|NCT00160615|58717036|FG000|Overall Study|Lack of Efficacy|11|||
30703200|NCT00160615|58717037|FG001|Overall Study|Lack of Efficacy|23|||
30703201|NCT00160615|58717036|FG000|Overall Study|Patient decision|1|||
30703202|NCT00160615|58717037|FG001|Overall Study|Patient decision|2|||
30703203|NCT00160615|58717036|FG000|Overall Study|Investigator decision|1|||
30703204|NCT00160615|58717037|FG001|Overall Study|Investigator decision|1|||
30703205|NCT00160615|58717036|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
30703206|NCT00160615|58717037|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
30703207|NCT00160615|58717036|FG000|Overall Study|Switch to surgical treatment|0|||
30703208|NCT00160615|58717037|FG001|Overall Study|Switch to surgical treatment|2|||
30703209|NCT00160615|58717036|FG000|Overall Study|Non-compliance was suspected|0|||
30703210|NCT00160615|58717037|FG001|Overall Study|Non-compliance was suspected|1|||
30703211|NCT00160615|58717036|FG000|Overall Study|Poor compliance|0|||
30703212|NCT00160615|58717037|FG001|Overall Study|Poor compliance|1|||
30703213|NCT00643448|58717048|FG000|Overall Study|Lack of Efficacy|2|||
30703214|NCT00643448|58717049|FG001|Overall Study|Lack of Efficacy|0|||
30703215|NCT00643448|58717050|FG002|Overall Study|Lack of Efficacy|4|||
30703216|NCT00643448|58717048|FG000|Overall Study|Adverse Event|2|||
30703217|NCT00643448|58717049|FG001|Overall Study|Adverse Event|2|||
30703218|NCT00643448|58717050|FG002|Overall Study|Adverse Event|2|||
30703219|NCT00643448|58717048|FG000|Overall Study|QTcF>550 ms|0|||
30703220|NCT00643448|58717049|FG001|Overall Study|QTcF>550 ms|3|||
30703221|NCT00643448|58717050|FG002|Overall Study|QTcF>550 ms|0|||
30703222|NCT00604500|58717060|FG000|Overall Study|Adverse Event|2|||
30703223|NCT00604500|58717060|FG000|Overall Study|Protocol Violation|2|||
30703224|NCT00604500|58717060|FG000|Overall Study|Treatment Failure|1|||
30703225|NCT00604500|58717060|FG000|Overall Study|Withdrawal by Subject|4|||
30703226|NCT00604500|58717060|FG000|Overall Study|Administrative|1|||
30703227|NCT00604500|58717060|FG000|Overall Study|Did not meet protocol eligibility|1|||
30703228|NCT00627458|58717067|FG000|Overall Study|Migrated from study area|1|||
30703229|NCT00627458|58717068|FG001|Overall Study|Migrated from study area|0|||
30703230|NCT00627458|58717069|FG002|Overall Study|Migrated from study area|1|||
30703231|NCT00627458|58717067|FG000|Overall Study|Withdrawal by Subject|2|||
30703232|NCT00627458|58717068|FG001|Overall Study|Withdrawal by Subject|6|||
30703233|NCT00627458|58717069|FG002|Overall Study|Withdrawal by Subject|5|||
30703234|NCT00627458|58717067|FG000|Overall Study|Lost to Follow-up|1|||
30703235|NCT00627458|58717068|FG001|Overall Study|Lost to Follow-up|1|||
30703236|NCT00627458|58717069|FG002|Overall Study|Lost to Follow-up|0|||
30703237|NCT00542919|58717081|FG000|Overall Study|Adverse Event|1|||
30703238|NCT00542919|58717082|FG001|Overall Study|Adverse Event|5|||
30893681|NCT02122887|58927240|FG000|Overall Study|Withdrawal by Subject|20|||
30619980|NCT00936598|58631045|FG001|Overall Study|Ineligible after consent|0|||
30619981|NCT01025817|58631053|FG000|Completed Study Medication|Adverse Event|66|||
30619982|NCT01025817|58631054|FG001|Completed Study Medication|Adverse Event|39|||
30619983|NCT01025817|58631053|FG000|Completed Study Medication|Protocol Deviation|9|||
30619984|NCT01025817|58631054|FG001|Completed Study Medication|Protocol Deviation|8|||
30619985|NCT01025817|58631053|FG000|Completed Study Medication|Withdrawal by Subject|8|||
30619986|NCT01025817|58631054|FG001|Completed Study Medication|Withdrawal by Subject|9|||
30619987|NCT01025817|58631053|FG000|Completed Study Medication|Administrative problems|7|||
30619988|NCT01025817|58631054|FG001|Completed Study Medication|Administrative problems|5|||
30619989|NCT01025817|58631053|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
30703239|NCT00542919|58717083|FG002|Overall Study|Adverse Event|1|||
30703240|NCT00542919|58717081|FG000|Overall Study|Withdrawal by Subject|1|||
30703241|NCT00542919|58717082|FG001|Overall Study|Withdrawal by Subject|0|||
30703242|NCT00542919|58717083|FG002|Overall Study|Withdrawal by Subject|3|||
30703243|NCT00542919|58717081|FG000|Overall Study|Physician Decision|2|||
30703244|NCT00542919|58717082|FG001|Overall Study|Physician Decision|2|||
30703245|NCT00542919|58717083|FG002|Overall Study|Physician Decision|1|||
30703246|NCT00542919|58717081|FG000|Overall Study|Sponsor Decision|1|||
30703247|NCT00542919|58717082|FG001|Overall Study|Sponsor Decision|0|||
30703248|NCT00542919|58717083|FG002|Overall Study|Sponsor Decision|0|||
30703249|NCT00542919|58717081|FG000|Overall Study|Lost to Follow-up|2|||
30703250|NCT00542919|58717082|FG001|Overall Study|Lost to Follow-up|0|||
30703251|NCT00542919|58717083|FG002|Overall Study|Lost to Follow-up|1|||
30703252|NCT00159913|58717110|FG000|Overall Study|Adverse Event|1|||
30703253|NCT00159913|58717111|FG001|Overall Study|Adverse Event|0|||
30703254|NCT00159913|58717112|FG002|Overall Study|Adverse Event|1|||
30703255|NCT00159913|58717113|FG003|Overall Study|Adverse Event|0|||
30703256|NCT00159913|58717110|FG000|Overall Study|Withdrawal by Subject|0|||
30703257|NCT00159913|58717111|FG001|Overall Study|Withdrawal by Subject|0|||
30703258|NCT00159913|58717112|FG002|Overall Study|Withdrawal by Subject|0|||
30703259|NCT00159913|58717113|FG003|Overall Study|Withdrawal by Subject|1|||
30703260|NCT00159913|58717110|FG000|Overall Study|Lost to Follow-up|0|||
30703261|NCT00159913|58717111|FG001|Overall Study|Lost to Follow-up|0|||
30703262|NCT00159913|58717112|FG002|Overall Study|Lost to Follow-up|0|||
30703263|NCT00159913|58717113|FG003|Overall Study|Lost to Follow-up|1|||
30703264|NCT00159913|58717110|FG000|Overall Study|Protocol Violation|1|||
30703265|NCT00159913|58717111|FG001|Overall Study|Protocol Violation|0|||
30703266|NCT00159913|58717112|FG002|Overall Study|Protocol Violation|1|||
30703267|NCT00159913|58717113|FG003|Overall Study|Protocol Violation|0|||
30703268|NCT00604188|58717127|FG000|Overall Study|Adverse Event|1|||
30703269|NCT00604188|58717128|FG001|Overall Study|Adverse Event|4|||
30703270|NCT00604188|58717127|FG000|Overall Study|Lost to Follow-up|17|||
30703271|NCT00604188|58717128|FG001|Overall Study|Lost to Follow-up|15|||
30703272|NCT00604188|58717127|FG000|Overall Study|Withdrawal by Subject|5|||
30703273|NCT00604188|58717128|FG001|Overall Study|Withdrawal by Subject|1|||
30703274|NCT00604188|58717127|FG000|Overall Study|Non-compliance with protocol|4|||
30703275|NCT00604188|58717128|FG001|Overall Study|Non-compliance with protocol|4|||
30703276|NCT00604188|58717127|FG000|Overall Study|Did not receive study drug|0|||
30703277|NCT00604188|58717128|FG001|Overall Study|Did not receive study drug|1|||
30703278|NCT03913377|58717136|FG000|Period 1|Test Article no longer available|0|||
30703279|NCT03913377|58717137|FG001|Period 1|Test Article no longer available|1|||
30703280|NCT03913377|58717138|FG002|Period 1|Test Article no longer available|0|||
30703281|NCT03913377|58717136|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
30703282|NCT03913377|58717137|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
30703283|NCT03913377|58717138|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
30703284|NCT00227539|58717145|FG000|Overall Study|Protocol Violation|1|||
30703285|NCT00227305|58717149|FG000|Overall Study|Adverse Event|40|||
30703286|NCT00227305|58717149|FG000|Overall Study|Withdrawal by Subject|42|||
30703287|NCT00227305|58717149|FG000|Overall Study|Lost to Follow-up|33|||
30703288|NCT00227305|58717149|FG000|Overall Study|Study specific discontinuation|13|||
30703289|NCT00227305|58717149|FG000|Overall Study|MOVED OUT OF AREA|3|||
30703290|NCT00227305|58717149|FG000|Overall Study|Lack of Efficacy|7|||
30703291|NCT00227305|58717149|FG000|Overall Study|Physician Decision|3|||
30703292|NCT00227305|58717149|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
30703293|NCT00227305|58717149|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
30703294|NCT00227305|58717149|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
30703295|NCT00720941|58717155|FG000|Overall Study|Death|334|||
30703296|NCT00720941|58717156|FG001|Overall Study|Death|335|||
30703297|NCT00720941|58717155|FG000|Overall Study|Protocol Violation|0|||
30703298|NCT00720941|58717156|FG001|Overall Study|Protocol Violation|2|||
30703299|NCT00720941|58717155|FG000|Overall Study|Lost to Follow-up|17|||
30703300|NCT00720941|58717156|FG001|Overall Study|Lost to Follow-up|15|||
30703301|NCT00720941|58717155|FG000|Overall Study|Physician Decision|1|||
30703302|NCT00720941|58717156|FG001|Overall Study|Physician Decision|5|||
30703303|NCT00720941|58717155|FG000|Overall Study|Withdrawal by Subject|27|||
30703304|NCT00720941|58717156|FG001|Overall Study|Withdrawal by Subject|35|||
30703305|NCT00720941|58717155|FG000|Overall Study|Ongoing|34|||
30703306|NCT00720941|58717156|FG001|Overall Study|Ongoing|23|||
30703307|NCT00585533|58717162|FG000|Overall Study|objective or symptomatic progression|9|||
30703308|NCT00628862|58717169|FG000|Overall Study|Adverse Event|6|||
30703309|NCT00628862|58717170|FG001|Overall Study|Adverse Event|8|||
30703310|NCT00628862|58717171|FG002|Overall Study|Adverse Event|10|||
30703311|NCT00628862|58717169|FG000|Overall Study|Withdrawal by Subject|4|||
30703312|NCT00628862|58717170|FG001|Overall Study|Withdrawal by Subject|6|||
30703313|NCT00628862|58717171|FG002|Overall Study|Withdrawal by Subject|11|||
30703314|NCT00628862|58717169|FG000|Overall Study|Lost to Follow-up|0|||
30703315|NCT00628862|58717170|FG001|Overall Study|Lost to Follow-up|2|||
30703316|NCT00628862|58717171|FG002|Overall Study|Lost to Follow-up|1|||
30703317|NCT00628862|58717169|FG000|Overall Study|Protocol Violation|1|||
30703318|NCT00628862|58717170|FG001|Overall Study|Protocol Violation|0|||
30703319|NCT00628862|58717171|FG002|Overall Study|Protocol Violation|0|||
30703320|NCT00628862|58717169|FG000|Overall Study|COPD Exacerbation|0|||
30703321|NCT00628862|58717170|FG001|Overall Study|COPD Exacerbation|1|||
30703322|NCT00628862|58717171|FG002|Overall Study|COPD Exacerbation|0|||
30703323|NCT00584987|58717183|FG000|Overall Study|Protocol Violation|1|||
30703324|NCT00584987|58717184|FG001|Overall Study|Protocol Violation|1|||
30703325|NCT00584987|58717185|FG002|Overall Study|Protocol Violation|1|||
30703326|NCT00584987|58717186|FG003|Overall Study|Protocol Violation|0|||
30703327|NCT00584987|58717183|FG000|Overall Study|Adverse Event|0|||
30703328|NCT00584987|58717184|FG001|Overall Study|Adverse Event|0|||
30703329|NCT00584987|58717185|FG002|Overall Study|Adverse Event|0|||
30703330|NCT00584987|58717186|FG003|Overall Study|Adverse Event|1|||
30703331|NCT00727961|58717196|FG000|Overall Study|Lost to Follow-up|1|||
30703332|NCT00727961|58717196|FG000|Overall Study|Adverse Event|4|||
30703333|NCT00727961|58717196|FG000|Overall Study|Patient's refusal|2|||
30703334|NCT00727961|58717196|FG000|Overall Study|Progression|30|||
30703335|NCT00568958|58717202|FG000|Allocation|Withdrawal by Subject|7|||
30703336|NCT00568958|58717203|FG001|Allocation|Withdrawal by Subject|3|||
30703337|NCT00568958|58717202|FG000|Allocation|Physician Decision|2|||
30703338|NCT00568958|58717203|FG001|Allocation|Physician Decision|0|||
30703339|NCT00568958|58717202|FG000|Follow-Up|Withdrawal by Subject|6|||
30703340|NCT00568958|58717203|FG001|Follow-Up|Withdrawal by Subject|6|||
30703341|NCT00568958|58717202|FG000|Follow-Up|Physician Decision|1|||
30703342|NCT00568958|58717203|FG001|Follow-Up|Physician Decision|1|||
30703343|NCT00568958|58717202|FG000|Follow-Up|Family Emergency|1|||
30703344|NCT00568958|58717203|FG001|Follow-Up|Family Emergency|0|||
30703345|NCT00568958|58717202|FG000|Follow-Up|Adverse Event|1|||
30703346|NCT00568958|58717203|FG001|Follow-Up|Adverse Event|0|||
30703347|NCT00727649|58717211|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
30703348|NCT00727649|58717212|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
30703349|NCT00727649|58717211|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
30703350|NCT00727649|58717212|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
30703351|NCT00727649|58717211|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
30703352|NCT00727649|58717212|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
30703353|NCT00727649|58717211|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
30703354|NCT00727649|58717212|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
30703355|NCT00727649|58717211|FG000|Second Intervention (4-weeks)|Death|1|||
30703356|NCT00727649|58717212|FG001|Second Intervention (4-weeks)|Death|0|||
30703357|NCT00727649|58717211|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
30703358|NCT00727649|58717212|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
30703359|NCT00727649|58717211|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
30703360|NCT00727649|58717212|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
30703361|NCT00568334|58717222|FG000|Overall Study|Withdrawal by Subject|0|||
30703362|NCT00568334|58717223|FG001|Overall Study|Withdrawal by Subject|1|||
30703363|NCT00568334|58717222|FG000|Overall Study|Lost to Follow-up|1|||
30703364|NCT00568334|58717223|FG001|Overall Study|Lost to Follow-up|0|||
30703365|NCT00727571|58717233|FG000|Overall Study|Ineligibility determined|1|||
30703366|NCT00727571|58717234|FG001|Overall Study|Ineligibility determined|1|||
30703367|NCT00727571|58717235|FG002|Overall Study|Ineligibility determined|1|||
30703368|NCT00727571|58717236|FG003|Overall Study|Ineligibility determined|0|||
30703369|NCT00727571|58717233|FG000|Overall Study|Death|0|||
30703370|NCT00727571|58717234|FG001|Overall Study|Death|19|||
30703371|NCT00727571|58717235|FG002|Overall Study|Death|5|||
30703372|NCT00727571|58717236|FG003|Overall Study|Death|1|||
30703373|NCT00727571|58717233|FG000|Overall Study|Physician Decision|0|||
30703374|NCT00727571|58717234|FG001|Overall Study|Physician Decision|5|||
30703375|NCT00727571|58717235|FG002|Overall Study|Physician Decision|0|||
30703376|NCT00727571|58717236|FG003|Overall Study|Physician Decision|0|||
30703377|NCT00727571|58717233|FG000|Overall Study|Withdrawal by Subject|0|||
30703378|NCT00727571|58717234|FG001|Overall Study|Withdrawal by Subject|10|||
30703379|NCT00727571|58717235|FG002|Overall Study|Withdrawal by Subject|11|||
30703380|NCT00727571|58717236|FG003|Overall Study|Withdrawal by Subject|0|||
30703381|NCT00727571|58717233|FG000|Overall Study|Subject Non Compliance|0|||
30703382|NCT00727571|58717234|FG001|Overall Study|Subject Non Compliance|6|||
30703383|NCT00727571|58717235|FG002|Overall Study|Subject Non Compliance|0|||
30703384|NCT00727571|58717236|FG003|Overall Study|Subject Non Compliance|4|||
30703385|NCT00727571|58717233|FG000|Overall Study|Dismissed from nursing home|0|||
30703386|NCT00727571|58717234|FG001|Overall Study|Dismissed from nursing home|9|||
30703387|NCT00727571|58717235|FG002|Overall Study|Dismissed from nursing home|5|||
30703388|NCT00727571|58717236|FG003|Overall Study|Dismissed from nursing home|0|||
30703389|NCT00727571|58717233|FG000|Overall Study|Hospitalization|0|||
30703390|NCT00727571|58717234|FG001|Overall Study|Hospitalization|1|||
30703391|NCT00727571|58717235|FG002|Overall Study|Hospitalization|0|||
30703392|NCT00727571|58717236|FG003|Overall Study|Hospitalization|1|||
30703393|NCT00727571|58717233|FG000|Overall Study|AE not leading to hospitalization|0|||
30703394|NCT00727571|58717234|FG001|Overall Study|AE not leading to hospitalization|0|||
30703395|NCT00727571|58717235|FG002|Overall Study|AE not leading to hospitalization|2|||
30703396|NCT00727571|58717236|FG003|Overall Study|AE not leading to hospitalization|0|||
30703397|NCT00727571|58717233|FG000|Overall Study|Other|0|||
30703398|NCT00727571|58717234|FG001|Overall Study|Other|4|||
30703399|NCT00727571|58717235|FG002|Overall Study|Other|6|||
30703400|NCT00727571|58717236|FG003|Overall Study|Other|0|||
30703401|NCT00225277|58717248|FG000|Overall Study|Adverse Event|30|||
30703402|NCT00225277|58717249|FG001|Overall Study|Adverse Event|34|||
30703403|NCT00225277|58717248|FG000|Overall Study|Lack of Efficacy|4|||
30703404|NCT00225277|58717249|FG001|Overall Study|Lack of Efficacy|1|||
30703405|NCT00225277|58717248|FG000|Overall Study|Lost to Follow-up|4|||
30703406|NCT00225277|58717249|FG001|Overall Study|Lost to Follow-up|6|||
30703407|NCT00225277|58717248|FG000|Overall Study|Physician Decision|6|||
30703408|NCT00225277|58717249|FG001|Overall Study|Physician Decision|8|||
30703409|NCT00225277|58717248|FG000|Overall Study|Protocol Violation|6|||
30703410|NCT00225277|58717249|FG001|Overall Study|Protocol Violation|3|||
30703411|NCT00225277|58717248|FG000|Overall Study|Withdrawal by Subject|40|||
30703412|NCT00225277|58717249|FG001|Overall Study|Withdrawal by Subject|34|||
30703413|NCT00225277|58717248|FG000|Overall Study|Other|7|||
30703414|NCT00225277|58717249|FG001|Overall Study|Other|9|||
30703415|NCT00567996|58717258|FG000|Overall Study|Adverse Event|18|||
30703416|NCT00567996|58717259|FG001|Overall Study|Adverse Event|16|||
30703417|NCT00567996|58717260|FG002|Overall Study|Adverse Event|13|||
30703418|NCT00567996|58717258|FG000|Overall Study|Protocol Deviation|9|||
30703419|NCT00567996|58717259|FG001|Overall Study|Protocol Deviation|11|||
30703420|NCT00567996|58717260|FG002|Overall Study|Protocol Deviation|13|||
30703421|NCT00567996|58717258|FG000|Overall Study|Withdrawal by Subject|8|||
30703422|NCT00567996|58717259|FG001|Overall Study|Withdrawal by Subject|12|||
30703423|NCT00567996|58717260|FG002|Overall Study|Withdrawal by Subject|22|||
30703424|NCT00567996|58717258|FG000|Overall Study|Abnormal Lab value(s)|2|||
30703425|NCT00567996|58717259|FG001|Overall Study|Abnormal Lab value(s)|1|||
30703426|NCT00567996|58717260|FG002|Overall Study|Abnormal Lab value(s)|2|||
30703427|NCT00567996|58717258|FG000|Overall Study|Abnormal test procedure result(s)|2|||
30703428|NCT00567996|58717259|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30703429|NCT00567996|58717260|FG002|Overall Study|Abnormal test procedure result(s)|1|||
30703430|NCT00567996|58717258|FG000|Overall Study|Lost to Follow-up|2|||
30703431|NCT00567996|58717259|FG001|Overall Study|Lost to Follow-up|5|||
30703432|NCT00567996|58717260|FG002|Overall Study|Lost to Follow-up|2|||
30703433|NCT00567996|58717258|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30703434|NCT00567996|58717259|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30703435|NCT00567996|58717260|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
30703436|NCT00567996|58717258|FG000|Overall Study|Administrative problems|1|||
30703437|NCT00567996|58717259|FG001|Overall Study|Administrative problems|1|||
30703438|NCT00567996|58717260|FG002|Overall Study|Administrative problems|0|||
30703439|NCT00567996|58717258|FG000|Overall Study|Death|1|||
30703440|NCT00567996|58717259|FG001|Overall Study|Death|0|||
30703441|NCT00567996|58717260|FG002|Overall Study|Death|2|||
30703442|NCT00567996|58717258|FG000|Overall Study|Patient's inability to use the device|0|||
30703443|NCT00567996|58717259|FG001|Overall Study|Patient's inability to use the device|1|||
30703444|NCT00567996|58717260|FG002|Overall Study|Patient's inability to use the device|0|||
30703445|NCT00224887|58717274|FG000|Overall Study|Pregnancy|6|||
30703446|NCT00224887|58717275|FG001|Overall Study|Pregnancy|6|||
30703447|NCT00148759|58717283|FG000|Overall Study|Withdrawal by Subject|1|||
30703448|NCT00148759|58717284|FG001|Overall Study|Withdrawal by Subject|1|||
30703449|NCT00148759|58717283|FG000|Overall Study|Lost to Follow-up|1|||
30703450|NCT00148759|58717284|FG001|Overall Study|Lost to Follow-up|0|||
30703451|NCT00717275|58717290|FG000|Overall Study|Premature study termination.|3|||
30703452|NCT00584909|58717294|FG000|Overall Study|Adverse Event|4|||
30703453|NCT00147823|58717300|FG000|Overall Study|Lost to Follow-up|6|||
30703454|NCT00147823|58717301|FG001|Overall Study|Lost to Follow-up|12|||
30703455|NCT00147823|58717300|FG000|Overall Study|Physician Decision|1|||
30703456|NCT00147823|58717301|FG001|Overall Study|Physician Decision|0|||
30703457|NCT00147823|58717300|FG000|Overall Study|Withdrawal by Subject|0|||
30703458|NCT00147823|58717301|FG001|Overall Study|Withdrawal by Subject|1|||
30703459|NCT00147823|58717300|FG000|Overall Study|Did not receive vitoss due to infection|6|||
30703460|NCT00147823|58717301|FG001|Overall Study|Did not receive vitoss due to infection|2|||
30703461|NCT00717197|58717307|FG000|Overall Study|Unable to purchase study drug|5|||
30703462|NCT00717197|58717307|FG000|Overall Study|Tumor Progression|1|||
30703463|NCT00717197|58717307|FG000|Overall Study|Physician Decision|1|||
30703464|NCT00147745|58717314|FG000|Overall Study|Withdrawal by Subject|1|||
30703465|NCT00147745|58717315|FG001|Overall Study|Withdrawal by Subject|0|||
30703466|NCT00147745|58717316|FG002|Overall Study|Withdrawal by Subject|0|||
30703467|NCT00642902|58717328|FG000|Overall Study|Adverse Event|0|||
30703468|NCT00642902|58717329|FG001|Overall Study|Adverse Event|1|||
30703469|NCT00642902|58717330|FG002|Overall Study|Adverse Event|3|||
30703470|NCT00642902|58717331|FG003|Overall Study|Adverse Event|1|||
30703471|NCT00642902|58717328|FG000|Overall Study|Lost to Follow-up|1|||
30703472|NCT00642902|58717329|FG001|Overall Study|Lost to Follow-up|1|||
30703473|NCT00642902|58717330|FG002|Overall Study|Lost to Follow-up|0|||
30703474|NCT00642902|58717331|FG003|Overall Study|Lost to Follow-up|0|||
30703475|NCT00642902|58717328|FG000|Overall Study|Lack of Efficacy|0|||
30703476|NCT00642902|58717329|FG001|Overall Study|Lack of Efficacy|3|||
30703477|NCT00642902|58717330|FG002|Overall Study|Lack of Efficacy|3|||
30703478|NCT00642902|58717331|FG003|Overall Study|Lack of Efficacy|0|||
30703479|NCT00642902|58717328|FG000|Overall Study|Death|1|||
30703480|NCT00642902|58717329|FG001|Overall Study|Death|0|||
30703481|NCT00642902|58717330|FG002|Overall Study|Death|0|||
30703482|NCT00642902|58717331|FG003|Overall Study|Death|0|||
30703483|NCT00642902|58717328|FG000|Overall Study|Premature termination of clinical trial|37|||
30703484|NCT00642902|58717329|FG001|Overall Study|Premature termination of clinical trial|32|||
30703485|NCT00642902|58717330|FG002|Overall Study|Premature termination of clinical trial|35|||
30703486|NCT00642902|58717331|FG003|Overall Study|Premature termination of clinical trial|35|||
30703487|NCT00642902|58717328|FG000|Overall Study|Randomized, but not treated|0|||
30703488|NCT00642902|58717329|FG001|Overall Study|Randomized, but not treated|0|||
30703489|NCT00642902|58717330|FG002|Overall Study|Randomized, but not treated|1|||
30703490|NCT00642902|58717331|FG003|Overall Study|Randomized, but not treated|0|||
30703491|NCT00642902|58717328|FG000|Overall Study|Other|1|||
30703492|NCT00642902|58717329|FG001|Overall Study|Other|5|||
30703493|NCT00642902|58717330|FG002|Overall Study|Other|1|||
30703494|NCT00642902|58717331|FG003|Overall Study|Other|4|||
30703495|NCT00224107|58717343|FG000|Overall Study|Adverse Event|20|||
30703496|NCT00224107|58717344|FG001|Overall Study|Adverse Event|6|||
30703497|NCT00224107|58717343|FG000|Overall Study|Protocol Violation|2|||
30703498|NCT00224107|58717344|FG001|Overall Study|Protocol Violation|3|||
30703499|NCT00224107|58717343|FG000|Overall Study|Withdrawal by Subject|1|||
30703500|NCT00224107|58717344|FG001|Overall Study|Withdrawal by Subject|4|||
30703501|NCT00224107|58717343|FG000|Overall Study|Lack of Efficacy|2|||
30703502|NCT00224107|58717344|FG001|Overall Study|Lack of Efficacy|0|||
30703503|NCT00224107|58717343|FG000|Overall Study|Lost to Follow-up|4|||
30703504|NCT00224107|58717344|FG001|Overall Study|Lost to Follow-up|0|||
30703505|NCT00224107|58717343|FG000|Overall Study|Physician Decision|1|||
30703506|NCT00224107|58717344|FG001|Overall Study|Physician Decision|0|||
30703507|NCT00224107|58717343|FG000|Overall Study|Other|1|||
30703508|NCT00224107|58717344|FG001|Overall Study|Other|1|||
30703509|NCT00720083|58717352|FG000|Overall Study|Ineligible|1|||
30703510|NCT00720083|58717353|FG001|Overall Study|Ineligible|2|||
30703511|NCT00209131|58717361|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
30703512|NCT00209131|58717362|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
30703513|NCT00224029|58717368|FG000|Overall Study|Lost to Follow-up|1|||
30703514|NCT00224029|58717368|FG000|Overall Study|Withdrawal by Subject|4|||
30703515|NCT00224029|58717368|FG000|Overall Study|Other|1|||
30703516|NCT00223795|58717372|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
30703517|NCT00223795|58717373|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
30703518|NCT00223795|58717372|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
30703519|NCT00223795|58717373|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
30703520|NCT00719849|58717382|FG000|Overall Study|Death|0|||
30703521|NCT00719849|58717383|FG001|Overall Study|Death|1|||
30703522|NCT03907683|58717389|FG000|Overall Study|Pregnancy|1|||
30703523|NCT03907683|58717389|FG000|Overall Study|Withdrawal by Subject|1|||
30703524|NCT00626522|58717399|FG000|Overall Study|Protocol Violation|0|||
30703525|NCT00626522|58717400|FG001|Overall Study|Protocol Violation|0|||
30703526|NCT00626522|58717401|FG002|Overall Study|Protocol Violation|0|||
30703527|NCT00626522|58717402|FG003|Overall Study|Protocol Violation|0|||
30703528|NCT00626522|58717403|FG004|Overall Study|Protocol Violation|1|||
30703529|NCT00626522|58717404|FG005|Overall Study|Protocol Violation|0|||
30703530|NCT00626522|58717399|FG000|Overall Study|Adverse Event|2|||
30703531|NCT00626522|58717400|FG001|Overall Study|Adverse Event|1|||
30703532|NCT00626522|58717401|FG002|Overall Study|Adverse Event|2|||
30703533|NCT00626522|58717402|FG003|Overall Study|Adverse Event|0|||
30703534|NCT00626522|58717403|FG004|Overall Study|Adverse Event|1|||
30703535|NCT00626522|58717404|FG005|Overall Study|Adverse Event|1|||
30703536|NCT00626522|58717399|FG000|Overall Study|Withdrawal by Subject|2|||
30703537|NCT00626522|58717400|FG001|Overall Study|Withdrawal by Subject|5|||
30703538|NCT00626522|58717401|FG002|Overall Study|Withdrawal by Subject|5|||
30703539|NCT00626522|58717402|FG003|Overall Study|Withdrawal by Subject|0|||
30703540|NCT00626522|58717403|FG004|Overall Study|Withdrawal by Subject|4|||
30703541|NCT00626522|58717404|FG005|Overall Study|Withdrawal by Subject|1|||
30703542|NCT00626522|58717399|FG000|Overall Study|COPD exacerbation|0|||
30703543|NCT00626522|58717400|FG001|Overall Study|COPD exacerbation|0|||
30703544|NCT00626522|58717401|FG002|Overall Study|COPD exacerbation|0|||
30893682|NCT02122887|58927241|FG001|Overall Study|Withdrawal by Subject|2|||
30893683|NCT02182947|58927247|FG000|Overall Study|Withdrawal by Subject|7|||
30893684|NCT02182947|58927247|FG000|Overall Study|Lost to Follow-up|3|||
30893685|NCT02182947|58927247|FG000|Overall Study|Failed screening activities|8|||
30893686|NCT02370043|58927251|FG000|Overall Study|Withdrawal by Subject|0|||
30893687|NCT02370043|58927252|FG001|Overall Study|Withdrawal by Subject|0|||
30893688|NCT02370043|58927253|FG002|Overall Study|Withdrawal by Subject|0|||
30893689|NCT02370043|58927254|FG003|Overall Study|Withdrawal by Subject|0|||
30893690|NCT02370043|58927255|FG004|Overall Study|Withdrawal by Subject|1|||
30893691|NCT02370043|58927256|FG005|Overall Study|Withdrawal by Subject|1|||
30703545|NCT00626522|58717402|FG003|Overall Study|COPD exacerbation|1|||
30619990|NCT01025817|58631054|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
30703546|NCT00626522|58717403|FG004|Overall Study|COPD exacerbation|1|||
30703547|NCT00626522|58717404|FG005|Overall Study|COPD exacerbation|0|||
30703548|NCT00626522|58717399|FG000|Overall Study|Lost to Follow-up|0|||
30893692|NCT02301403|58927286|FG000|Overall Study|Withdrawal by Subject|28|||
30619991|NCT01025817|58631053|FG000|Completed Study Medication|Abnormal test procedure|4|||
30619992|NCT01025817|58631054|FG001|Completed Study Medication|Abnormal test procedure|0|||
30619993|NCT01025817|58631053|FG000|Completed Study Medication|Graft loss|2|||
30619994|NCT01025817|58631054|FG001|Completed Study Medication|Graft loss|5|||
30619995|NCT01025817|58631053|FG000|Completed Study Medication|Death|2|||
30619996|NCT01025817|58631054|FG001|Completed Study Medication|Death|2|||
30619997|NCT01025817|58631053|FG000|Completed Study Medication|Abnormal lab values|0|||
30703549|NCT00626522|58717400|FG001|Overall Study|Lost to Follow-up|1|||
30703550|NCT00626522|58717401|FG002|Overall Study|Lost to Follow-up|0|||
30893693|NCT02301403|58927287|FG001|Overall Study|Withdrawal by Subject|41|||
30703551|NCT00626522|58717402|FG003|Overall Study|Lost to Follow-up|0|||
30703552|NCT00626522|58717403|FG004|Overall Study|Lost to Follow-up|0|||
30703553|NCT00626522|58717404|FG005|Overall Study|Lost to Follow-up|0|||
30703554|NCT00626522|58717399|FG000|Overall Study|Inconsistent reason reported|1|||
30703555|NCT00626522|58717400|FG001|Overall Study|Inconsistent reason reported|0|||
30703556|NCT00626522|58717401|FG002|Overall Study|Inconsistent reason reported|0|||
30703557|NCT00626522|58717402|FG003|Overall Study|Inconsistent reason reported|0|||
30703558|NCT00626522|58717403|FG004|Overall Study|Inconsistent reason reported|0|||
30703559|NCT00626522|58717404|FG005|Overall Study|Inconsistent reason reported|0|||
30703560|NCT00626522|58717399|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
30703561|NCT00626522|58717400|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
30703562|NCT00626522|58717401|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
30703563|NCT00626522|58717402|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
30703564|NCT00626522|58717403|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
30703565|NCT00626522|58717404|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
30703566|NCT00540423|58717429|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30703567|NCT00540423|58717430|FG001|Double-Blind Treatment Period|Adverse Event|1|||
30703568|NCT00540423|58717431|FG002|Double-Blind Treatment Period|Adverse Event|0|||
30703569|NCT00540423|58717429|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
30703570|NCT00540423|58717430|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
30703571|NCT00540423|58717431|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
30703572|NCT00566982|58717451|FG000|Overall Study|Adverse Event|6|||
30703573|NCT00566982|58717452|FG001|Overall Study|Adverse Event|48|||
30703574|NCT00566982|58717451|FG000|Overall Study|Withdrawal by Subject|1|||
30703575|NCT00566982|58717452|FG001|Overall Study|Withdrawal by Subject|14|||
30703576|NCT00566982|58717451|FG000|Overall Study|Protocol Violation|1|||
30703577|NCT00566982|58717452|FG001|Overall Study|Protocol Violation|4|||
30703578|NCT00566982|58717451|FG000|Overall Study|Lost to Follow-up|0|||
30703579|NCT00566982|58717452|FG001|Overall Study|Lost to Follow-up|1|||
30703580|NCT00566982|58717451|FG000|Overall Study|Other-family problems & doctor's request|0|||
30703581|NCT00566982|58717452|FG001|Overall Study|Other-family problems & doctor's request|2|||
30703582|NCT00624338|58717464|FG000|Overall Study|Adverse Event|14|||
30703583|NCT00624338|58717465|FG001|Overall Study|Adverse Event|14|||
30703584|NCT00624338|58717466|FG002|Overall Study|Adverse Event|18|||
30703585|NCT00624338|58717464|FG000|Overall Study|Lost to Follow-up|1|||
30703586|NCT00624338|58717465|FG001|Overall Study|Lost to Follow-up|0|||
30703587|NCT00624338|58717466|FG002|Overall Study|Lost to Follow-up|0|||
30703588|NCT00624338|58717464|FG000|Overall Study|Lack of Efficacy|11|||
30703589|NCT00624338|58717465|FG001|Overall Study|Lack of Efficacy|3|||
30703590|NCT00624338|58717466|FG002|Overall Study|Lack of Efficacy|14|||
30703591|NCT00624338|58717464|FG000|Overall Study|Protocol Violation|3|||
30703592|NCT00624338|58717465|FG001|Overall Study|Protocol Violation|3|||
30703593|NCT00624338|58717466|FG002|Overall Study|Protocol Violation|2|||
30703594|NCT00624338|58717464|FG000|Overall Study|Death|0|||
30703595|NCT00624338|58717465|FG001|Overall Study|Death|2|||
30703596|NCT00624338|58717466|FG002|Overall Study|Death|0|||
30703597|NCT00624338|58717464|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
30703598|NCT00624338|58717465|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
30703599|NCT00624338|58717466|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
30703600|NCT00624338|58717464|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
30703601|NCT00624338|58717465|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
30703602|NCT00624338|58717466|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
30703603|NCT00624338|58717464|FG000|Overall Study|Other|15|||
30703604|NCT00624338|58717465|FG001|Overall Study|Other|5|||
30703605|NCT00624338|58717466|FG002|Overall Study|Other|9|||
30703606|NCT00624338|58717464|FG000|Overall Study|Randomized but not treated|2|||
30703607|NCT00624338|58717465|FG001|Overall Study|Randomized but not treated|1|||
30703608|NCT00624338|58717466|FG002|Overall Study|Randomized but not treated|3|||
30703609|NCT03977454|58717476|FG000|Overall Study|immediate postoperative revision|2|||
30703610|NCT03977454|58717477|FG001|Overall Study|immediate postoperative revision|2|||
30703611|NCT00538785|58717485|FG000|Overall Study|Death|9|||
30703612|NCT00538785|58717486|FG001|Overall Study|Death|10|||
30703613|NCT00538785|58717485|FG000|Overall Study|Withdrawal of consent|9|||
30703614|NCT00538785|58717486|FG001|Overall Study|Withdrawal of consent|7|||
30703615|NCT00538785|58717485|FG000|Overall Study|Lost to Follow-up|1|||
30703616|NCT00538785|58717486|FG001|Overall Study|Lost to Follow-up|0|||
30703617|NCT00538629|58717492|FG000|Overall Study|At subject's request|1|||
30703618|NCT00538629|58717492|FG000|Overall Study|Adverse Event|2|||
30703619|NCT00538629|58717492|FG000|Overall Study|Lack of Efficacy|12|||
30703620|NCT00538629|58717492|FG000|Overall Study|Lost to Follow-up|6|||
30703621|NCT00538629|58717492|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
30703622|NCT00622700|58717499|FG000|Core Treatment Period|Randomized but Not Treated|0|||
30703623|NCT00622700|58717500|FG001|Core Treatment Period|Randomized but Not Treated|2|||
30703624|NCT00622700|58717501|FG002|Core Treatment Period|Randomized but Not Treated|2|||
30703625|NCT00622700|58717502|FG003|Core Treatment Period|Randomized but Not Treated|0|||
30703626|NCT00622700|58717503|FG004|Core Treatment Period|Randomized but Not Treated|0|||
30703627|NCT00622700|58717504|FG005|Core Treatment Period|Randomized but Not Treated|0|||
30703628|NCT00622700|58717505|FG006|Core Treatment Period|Randomized but Not Treated|0|||
30703629|NCT00622700|58717499|FG000|Core Treatment Period|Adverse Event|18|||
30703630|NCT00622700|58717500|FG001|Core Treatment Period|Adverse Event|25|||
30703631|NCT00622700|58717501|FG002|Core Treatment Period|Adverse Event|18|||
30703632|NCT00622700|58717502|FG003|Core Treatment Period|Adverse Event|0|||
30703633|NCT00622700|58717503|FG004|Core Treatment Period|Adverse Event|0|||
30703634|NCT00622700|58717504|FG005|Core Treatment Period|Adverse Event|0|||
30703635|NCT00622700|58717505|FG006|Core Treatment Period|Adverse Event|0|||
30703636|NCT00622700|58717499|FG000|Core Treatment Period|Lack of Efficacy|19|||
30703637|NCT00622700|58717500|FG001|Core Treatment Period|Lack of Efficacy|6|||
30703638|NCT00622700|58717501|FG002|Core Treatment Period|Lack of Efficacy|12|||
30703639|NCT00622700|58717502|FG003|Core Treatment Period|Lack of Efficacy|0|||
30703640|NCT00622700|58717503|FG004|Core Treatment Period|Lack of Efficacy|0|||
30703641|NCT00622700|58717504|FG005|Core Treatment Period|Lack of Efficacy|0|||
30703642|NCT00622700|58717505|FG006|Core Treatment Period|Lack of Efficacy|0|||
30703643|NCT00622700|58717499|FG000|Core Treatment Period|Lost to Follow-up|1|||
30703644|NCT00622700|58717500|FG001|Core Treatment Period|Lost to Follow-up|1|||
30703645|NCT00622700|58717501|FG002|Core Treatment Period|Lost to Follow-up|1|||
30703646|NCT00622700|58717502|FG003|Core Treatment Period|Lost to Follow-up|0|||
30703647|NCT00622700|58717503|FG004|Core Treatment Period|Lost to Follow-up|0|||
30703648|NCT00622700|58717504|FG005|Core Treatment Period|Lost to Follow-up|0|||
30703649|NCT00622700|58717505|FG006|Core Treatment Period|Lost to Follow-up|0|||
30703650|NCT00622700|58717499|FG000|Core Treatment Period|Death|1|||
30703651|NCT00622700|58717500|FG001|Core Treatment Period|Death|0|||
30703652|NCT00622700|58717501|FG002|Core Treatment Period|Death|0|||
30703653|NCT00622700|58717502|FG003|Core Treatment Period|Death|0|||
30703654|NCT00622700|58717503|FG004|Core Treatment Period|Death|0|||
30703655|NCT00622700|58717504|FG005|Core Treatment Period|Death|0|||
30703656|NCT00622700|58717505|FG006|Core Treatment Period|Death|0|||
30703657|NCT00622700|58717499|FG000|Core Treatment Period|Progressive Disease|3|||
30703658|NCT00622700|58717500|FG001|Core Treatment Period|Progressive Disease|1|||
30703659|NCT00622700|58717501|FG002|Core Treatment Period|Progressive Disease|0|||
30703660|NCT00622700|58717502|FG003|Core Treatment Period|Progressive Disease|0|||
30703661|NCT00622700|58717503|FG004|Core Treatment Period|Progressive Disease|0|||
30703662|NCT00622700|58717504|FG005|Core Treatment Period|Progressive Disease|0|||
30703663|NCT00622700|58717505|FG006|Core Treatment Period|Progressive Disease|0|||
30703664|NCT00622700|58717499|FG000|Core Treatment Period|Withdrawal by Subject|12|||
30703665|NCT00622700|58717500|FG001|Core Treatment Period|Withdrawal by Subject|18|||
30703666|NCT00622700|58717501|FG002|Core Treatment Period|Withdrawal by Subject|15|||
30703667|NCT00622700|58717502|FG003|Core Treatment Period|Withdrawal by Subject|0|||
30703668|NCT00622700|58717503|FG004|Core Treatment Period|Withdrawal by Subject|0|||
30703669|NCT00622700|58717504|FG005|Core Treatment Period|Withdrawal by Subject|0|||
30703670|NCT00622700|58717505|FG006|Core Treatment Period|Withdrawal by Subject|0|||
30703671|NCT00622700|58717499|FG000|Core Treatment Period|Other than specified above|2|||
30703672|NCT00622700|58717500|FG001|Core Treatment Period|Other than specified above|2|||
30703673|NCT00622700|58717501|FG002|Core Treatment Period|Other than specified above|5|||
30703674|NCT00622700|58717502|FG003|Core Treatment Period|Other than specified above|0|||
30703675|NCT00622700|58717503|FG004|Core Treatment Period|Other than specified above|0|||
30703676|NCT00622700|58717504|FG005|Core Treatment Period|Other than specified above|0|||
30703677|NCT00622700|58717505|FG006|Core Treatment Period|Other than specified above|0|||
30703678|NCT00622700|58717499|FG000|Extension Treatment Period|Adverse Event|0|||
30703679|NCT00622700|58717500|FG001|Extension Treatment Period|Adverse Event|0|||
30703680|NCT00622700|58717501|FG002|Extension Treatment Period|Adverse Event|0|||
30703681|NCT00622700|58717502|FG003|Extension Treatment Period|Adverse Event|5|||
30703682|NCT00622700|58717503|FG004|Extension Treatment Period|Adverse Event|9|||
30703683|NCT00622700|58717504|FG005|Extension Treatment Period|Adverse Event|6|||
30703684|NCT00622700|58717505|FG006|Extension Treatment Period|Adverse Event|8|||
30703685|NCT00622700|58717499|FG000|Extension Treatment Period|Lack of Efficacy|0|||
30703686|NCT00622700|58717500|FG001|Extension Treatment Period|Lack of Efficacy|0|||
30703687|NCT00622700|58717501|FG002|Extension Treatment Period|Lack of Efficacy|0|||
30703688|NCT00622700|58717502|FG003|Extension Treatment Period|Lack of Efficacy|2|||
30703689|NCT00622700|58717503|FG004|Extension Treatment Period|Lack of Efficacy|8|||
30703690|NCT00622700|58717504|FG005|Extension Treatment Period|Lack of Efficacy|1|||
30703691|NCT00622700|58717505|FG006|Extension Treatment Period|Lack of Efficacy|9|||
30703692|NCT00622700|58717499|FG000|Extension Treatment Period|Protocol Violation|0|||
30703693|NCT00622700|58717500|FG001|Extension Treatment Period|Protocol Violation|0|||
30703694|NCT00622700|58717501|FG002|Extension Treatment Period|Protocol Violation|0|||
30703695|NCT00622700|58717502|FG003|Extension Treatment Period|Protocol Violation|0|||
30703696|NCT00622700|58717503|FG004|Extension Treatment Period|Protocol Violation|0|||
30703697|NCT00622700|58717504|FG005|Extension Treatment Period|Protocol Violation|2|||
30703698|NCT00622700|58717505|FG006|Extension Treatment Period|Protocol Violation|0|||
30703699|NCT00622700|58717499|FG000|Extension Treatment Period|Lost to Follow-up|0|||
30703700|NCT00622700|58717500|FG001|Extension Treatment Period|Lost to Follow-up|0|||
30703701|NCT00622700|58717501|FG002|Extension Treatment Period|Lost to Follow-up|0|||
30703702|NCT00622700|58717502|FG003|Extension Treatment Period|Lost to Follow-up|0|||
30703703|NCT00622700|58717503|FG004|Extension Treatment Period|Lost to Follow-up|1|||
30703704|NCT00622700|58717504|FG005|Extension Treatment Period|Lost to Follow-up|0|||
30703705|NCT00622700|58717505|FG006|Extension Treatment Period|Lost to Follow-up|0|||
30703706|NCT00622700|58717499|FG000|Extension Treatment Period|Progressive Disease|0|||
30703707|NCT00622700|58717500|FG001|Extension Treatment Period|Progressive Disease|0|||
30703708|NCT00622700|58717501|FG002|Extension Treatment Period|Progressive Disease|0|||
30703709|NCT00622700|58717502|FG003|Extension Treatment Period|Progressive Disease|1|||
30703710|NCT00622700|58717503|FG004|Extension Treatment Period|Progressive Disease|2|||
30703711|NCT00622700|58717504|FG005|Extension Treatment Period|Progressive Disease|0|||
30703712|NCT00622700|58717505|FG006|Extension Treatment Period|Progressive Disease|2|||
30703713|NCT00622700|58717499|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
30703714|NCT00622700|58717500|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
30703715|NCT00622700|58717501|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
30703716|NCT00622700|58717502|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
30703717|NCT00622700|58717503|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
30703718|NCT00622700|58717504|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
30703719|NCT00622700|58717505|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
30703720|NCT00622700|58717499|FG000|Extension Treatment Period|Missing|0|||
30703721|NCT00622700|58717500|FG001|Extension Treatment Period|Missing|0|||
30703722|NCT00622700|58717501|FG002|Extension Treatment Period|Missing|0|||
30703723|NCT00622700|58717502|FG003|Extension Treatment Period|Missing|2|||
30703724|NCT00622700|58717503|FG004|Extension Treatment Period|Missing|3|||
30703725|NCT00622700|58717504|FG005|Extension Treatment Period|Missing|1|||
30703726|NCT00622700|58717505|FG006|Extension Treatment Period|Missing|0|||
30703727|NCT00622700|58717499|FG000|Extension Treatment Period|Other than specified above|0|||
30703728|NCT00622700|58717500|FG001|Extension Treatment Period|Other than specified above|0|||
30703729|NCT00622700|58717501|FG002|Extension Treatment Period|Other than specified above|0|||
30703730|NCT00622700|58717502|FG003|Extension Treatment Period|Other than specified above|0|||
30703731|NCT00622700|58717503|FG004|Extension Treatment Period|Other than specified above|0|||
30703732|NCT00622700|58717504|FG005|Extension Treatment Period|Other than specified above|1|||
30703733|NCT00622700|58717505|FG006|Extension Treatment Period|Other than specified above|1|||
30703734|NCT00538473|58717524|FG000|Overall Study|Adverse Event|1|||
30703735|NCT00538473|58717525|FG001|Overall Study|Adverse Event|0|||
30893694|NCT02301169|58927295|FG000|Overall Study|Adverse Event|1|||
30893695|NCT02301169|58927296|FG001|Overall Study|Adverse Event|0|||
30893696|NCT02333383|58927302|FG000|Overall Study|Adalimumab discontinuation|21|||
30893697|NCT02333383|58927302|FG000|Overall Study|Lost to Follow-up|15|||
30893698|NCT02333383|58927302|FG000|Overall Study|Withdrawal by Subject|3|||
30893699|NCT02333383|58927302|FG000|Overall Study|Transfer to another hospital|2|||
30893700|NCT02332915|58927308|FG000|Overall Study|Moved out of region|3|||
30893701|NCT02332915|58927309|FG001|Overall Study|Moved out of region|0|||
30893702|NCT02332915|58927308|FG000|Overall Study|Unrelated illness|1|||
30893703|NCT02332915|58927309|FG001|Overall Study|Unrelated illness|1|||
30893704|NCT02332915|58927308|FG000|Overall Study|Travel distance prohibitive|0|||
30893705|NCT02332915|58927309|FG001|Overall Study|Travel distance prohibitive|1|||
30893706|NCT02332915|58927308|FG000|Overall Study|did not meet inclusion criteria|2|||
30893707|NCT02332915|58927309|FG001|Overall Study|did not meet inclusion criteria|4|||
30893708|NCT02369341|58927322|FG000|Overall Study|Migrated/moved from study area|1|||
30893709|NCT02369341|58927323|FG001|Overall Study|Migrated/moved from study area|0|||
30893710|NCT02121795|58927335|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
30893711|NCT02121795|58927336|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
30703736|NCT00622466|58717531|FG000|Overall Study|Death|1|||
30703737|NCT00622466|58717531|FG000|Overall Study|Adverse Event|1|||
30703738|NCT00622466|58717531|FG000|Overall Study|Withdrawal by Subject|2|||
30893712|NCT02121795|58927335|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
30893713|NCT02121795|58927336|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
30893714|NCT02121795|58927335|FG000|Double-Blind Phase|Lost to Follow-up|7|||
30893715|NCT02121795|58927336|FG001|Double-Blind Phase|Lost to Follow-up|4|||
30703739|NCT00537771|58717537|FG000|Overall Study|Withdrawal by Subject|6|||
30703740|NCT00537771|58717538|FG001|Overall Study|Withdrawal by Subject|23|||
30703741|NCT00537771|58717537|FG000|Overall Study|Adverse Event|8|||
30703742|NCT00537771|58717538|FG001|Overall Study|Adverse Event|15|||
30703743|NCT00537771|58717537|FG000|Overall Study|Lost to Follow-up|9|||
30703744|NCT00537771|58717538|FG001|Overall Study|Lost to Follow-up|15|||
30703745|NCT00537771|58717537|FG000|Overall Study|Protocol Violation|2|||
30703746|NCT00537771|58717538|FG001|Overall Study|Protocol Violation|6|||
30703747|NCT00537771|58717537|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
30703748|NCT00537771|58717538|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
30703749|NCT00623480|58717546|FG000|Overall Study|Lost to Follow-up|0|||
30703750|NCT00623480|58717547|FG001|Overall Study|Lost to Follow-up|1|||
30703751|NCT00623480|58717546|FG000|Overall Study|Withdrawal by Subject|2|||
30703752|NCT00623480|58717547|FG001|Overall Study|Withdrawal by Subject|4|||
30703753|NCT00623480|58717546|FG000|Overall Study|Lack of Efficacy|1|||
30703754|NCT00623480|58717547|FG001|Overall Study|Lack of Efficacy|0|||
30703755|NCT00623480|58717546|FG000|Overall Study|Non-compliant with study medication|4|||
30703756|NCT00623480|58717547|FG001|Overall Study|Non-compliant with study medication|0|||
30703757|NCT00623480|58717546|FG000|Overall Study|Protocol Violation|0|||
30703758|NCT00623480|58717547|FG001|Overall Study|Protocol Violation|1|||
30703759|NCT00623480|58717546|FG000|Overall Study|Site closed by sponsor|0|||
30703760|NCT00623480|58717547|FG001|Overall Study|Site closed by sponsor|1|||
30703761|NCT02513667|58717555|FG000|Overall Study|Withdrawal by Subject|0|||
30703762|NCT02513667|58717556|FG001|Overall Study|Withdrawal by Subject|1|||
30703763|NCT03823911|58717565|FG000|Overall Study|Lost to Follow-up|1|||
30703764|NCT03823911|58717566|FG001|Overall Study|Lost to Follow-up|5|||
30703765|NCT03823911|58717567|FG002|Overall Study|Lost to Follow-up|2|||
30703766|NCT03823911|58717565|FG000|Overall Study|Did not meet eligibility criteria|13|||
30703767|NCT03823911|58717566|FG001|Overall Study|Did not meet eligibility criteria|7|||
30703768|NCT03823911|58717567|FG002|Overall Study|Did not meet eligibility criteria|4|||
30703769|NCT03823911|58717565|FG000|Overall Study|Death|0|||
30703770|NCT03823911|58717566|FG001|Overall Study|Death|1|||
30703771|NCT03823911|58717567|FG002|Overall Study|Death|0|||
30703772|NCT00621764|58717578|FG000|Overall Study|Protocol Violation|0|||
30703773|NCT00621764|58717579|FG001|Overall Study|Protocol Violation|0|||
30703774|NCT00621764|58717580|FG002|Overall Study|Protocol Violation|0|||
30703775|NCT00621764|58717581|FG003|Overall Study|Protocol Violation|1|||
30703776|NCT00510718|58717599|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
30703777|NCT00510718|58717600|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
30703778|NCT00510718|58717599|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
30703779|NCT00510718|58717600|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
30703780|NCT00510718|58717599|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
30703781|NCT00510718|58717600|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
30703782|NCT00510718|58717599|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
30703783|NCT00510718|58717600|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
30703784|NCT00510718|58717599|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
30703785|NCT00510718|58717600|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
30703786|NCT00510718|58717599|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
30703787|NCT00510718|58717600|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
30703788|NCT00537381|58717621|FG000|Overall Study|Adverse Event|13|||
30703789|NCT00537381|58717622|FG001|Overall Study|Adverse Event|9|||
30703790|NCT00537381|58717621|FG000|Overall Study|Death|3|||
30703791|NCT00537381|58717622|FG001|Overall Study|Death|3|||
30703792|NCT00537381|58717621|FG000|Overall Study|Withdrawal by Subject|5|||
30703793|NCT00537381|58717622|FG001|Overall Study|Withdrawal by Subject|14|||
30703794|NCT00537381|58717621|FG000|Overall Study|Physician Decision|7|||
30703795|NCT00537381|58717622|FG001|Overall Study|Physician Decision|6|||
30703796|NCT00537381|58717621|FG000|Overall Study|Disease Progression|9|||
30703797|NCT00537381|58717622|FG001|Overall Study|Disease Progression|18|||
30703798|NCT00537381|58717621|FG000|Overall Study|Sponsor decision|14|||
30703799|NCT00537381|58717622|FG001|Overall Study|Sponsor decision|9|||
30703800|NCT00537381|58717621|FG000|Overall Study|Other|5|||
30703801|NCT00537381|58717622|FG001|Overall Study|Other|3|||
30703802|NCT03791398|58717633|FG000|Overall Study|Progression of Disease Under Study|2|||
30703803|NCT03791398|58717634|FG001|Overall Study|Progression of Disease Under Study|0|||
30703804|NCT03791398|58717635|FG002|Overall Study|Progression of Disease Under Study|0|||
30703805|NCT00517192|58717641|FG000|Overall Study|Adverse Event|1|||
30703806|NCT00517192|58717642|FG001|Overall Study|Adverse Event|1|||
30703807|NCT00517192|58717641|FG000|Overall Study|Lost to Follow-up|1|||
30703808|NCT00517192|58717642|FG001|Overall Study|Lost to Follow-up|1|||
30703809|NCT00517192|58717641|FG000|Overall Study|Withdrawal by Subject|1|||
30703810|NCT00517192|58717642|FG001|Overall Study|Withdrawal by Subject|0|||
30703811|NCT00517192|58717641|FG000|Overall Study|Early termination of the trial|16|||
30703812|NCT00517192|58717642|FG001|Overall Study|Early termination of the trial|18|||
30703813|NCT00625820|58717648|FG000|Overall Study|Withdrawal by Subject|1|||
30703814|NCT00145327|58717656|FG000|Overall Study|Withdrawal by Subject|77|||
30703815|NCT00145327|58717657|FG001|Overall Study|Withdrawal by Subject|72|||
30703816|NCT00145327|58717658|FG002|Overall Study|Withdrawal by Subject|164|||
30703817|NCT00145327|58717656|FG000|Overall Study|Death|26|||
30703818|NCT00145327|58717657|FG001|Overall Study|Death|18|||
30703819|NCT00145327|58717658|FG002|Overall Study|Death|30|||
30703820|NCT00145327|58717656|FG000|Overall Study|Adverse Event|14|||
30703821|NCT00145327|58717657|FG001|Overall Study|Adverse Event|11|||
30703822|NCT00145327|58717658|FG002|Overall Study|Adverse Event|22|||
30703823|NCT00145327|58717656|FG000|Overall Study|Lost to Follow-up|9|||
30703824|NCT00145327|58717657|FG001|Overall Study|Lost to Follow-up|14|||
30703825|NCT00145327|58717658|FG002|Overall Study|Lost to Follow-up|14|||
30703826|NCT00145327|58717656|FG000|Overall Study|Administrative problems|12|||
30703827|NCT00145327|58717657|FG001|Overall Study|Administrative problems|9|||
30703828|NCT00145327|58717658|FG002|Overall Study|Administrative problems|13|||
30703829|NCT00145327|58717656|FG000|Overall Study|Protocol Violation|2|||
30703830|NCT00145327|58717657|FG001|Overall Study|Protocol Violation|0|||
30703831|NCT00145327|58717658|FG002|Overall Study|Protocol Violation|2|||
30703832|NCT00145327|58717656|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30703833|NCT00145327|58717657|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30703834|NCT00145327|58717658|FG002|Overall Study|Abnormal laboratory value(s)|2|||
30703835|NCT00145327|58717656|FG000|Overall Study|Missing - not stated|1|||
30703836|NCT00145327|58717657|FG001|Overall Study|Missing - not stated|0|||
30703837|NCT00145327|58717658|FG002|Overall Study|Missing - not stated|1|||
30703838|NCT00510484|58717668|FG000|Wash-out Period|Adverse Event|0|||
30703839|NCT00510484|58717669|FG001|Wash-out Period|Adverse Event|1|||
30703840|NCT00622388|58717675|FG000|Overall Study|Disease Progression|47|||
30703841|NCT00622388|58717675|FG000|Overall Study|Adverse Event|6|||
30703842|NCT00622388|58717675|FG000|Overall Study|Protocol Violation|3|||
30703843|NCT00622388|58717675|FG000|Overall Study|Participant Refusal|1|||
30703844|NCT00622388|58717675|FG000|Overall Study|Death|3|||
30703845|NCT00622388|58717675|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
30703846|NCT00622388|58717675|FG000|Overall Study|Took Prohibited Medication|2|||
30703847|NCT00622388|58717675|FG000|Overall Study|Withdrew Consent|1|||
30703848|NCT00622388|58717675|FG000|Overall Study|Insurance Expired|1|||
30703849|NCT01156389|58717682|FG000|Overall Study|Elevated liver enzymes|4|||
30703850|NCT01156389|58717683|FG001|Overall Study|Elevated liver enzymes|0|||
30703851|NCT01156389|58717682|FG000|Overall Study|Vomiting|0|||
30703852|NCT01156389|58717683|FG001|Overall Study|Vomiting|1|||
30703853|NCT01105767|58717692|FG000|Overall Study|Lost to Follow-up|1160|||
30703854|NCT01105767|58717693|FG001|Overall Study|Lost to Follow-up|1614|||
30703855|NCT01105767|58717694|FG002|Overall Study|Lost to Follow-up|1184|||
30703856|NCT03693430|58717704|FG000|Overall Study|Lost to Follow-up|3|||
30703857|NCT03693430|58717705|FG001|Overall Study|Lost to Follow-up|14|||
30703858|NCT03693430|58717704|FG000|Overall Study|Death|1|||
30703859|NCT03693430|58717705|FG001|Overall Study|Death|0|||
30703860|NCT03693430|58717704|FG000|Overall Study|Withdrawal by Subject|0|||
30703861|NCT03693430|58717705|FG001|Overall Study|Withdrawal by Subject|4|||
30703862|NCT00625742|58717711|FG000|Overall Study|Disease Progression|2|||
30703863|NCT00625742|58717711|FG000|Overall Study|Withdrawal by Subject|1|||
30703864|NCT00625742|58717711|FG000|Overall Study|Adverse Event|4|||
30703865|NCT00625742|58717711|FG000|Overall Study|Lost to Follow-up|4|||
30703866|NCT00625742|58717711|FG000|Overall Study|Ineligible|1|||
30703867|NCT00621296|58717724|FG000|Overall Study|Adverse Event|2|||
30703868|NCT00621296|58717724|FG000|Overall Study|Lack of Efficacy|1|||
30703869|NCT00621296|58717724|FG000|Overall Study|Physician Decision|7|||
30703870|NCT00621296|58717724|FG000|Overall Study|Unmatch Criteria|1|||
30703871|NCT00621296|58717724|FG000|Overall Study|Stopping Criteria|3|||
30703872|NCT00537303|58717730|FG000|Overall Study|Adverse Event|1|||
30703873|NCT00537303|58717731|FG001|Overall Study|Adverse Event|4|||
30703874|NCT00537303|58717730|FG000|Overall Study|Lack of Efficacy|6|||
30703875|NCT00537303|58717731|FG001|Overall Study|Lack of Efficacy|7|||
30703876|NCT00537303|58717730|FG000|Overall Study|Protocol Violation|8|||
30703877|NCT00537303|58717731|FG001|Overall Study|Protocol Violation|4|||
30703878|NCT00537303|58717730|FG000|Overall Study|Withdrawal criteria|3|||
30703879|NCT00537303|58717731|FG001|Overall Study|Withdrawal criteria|3|||
30703880|NCT00537303|58717730|FG000|Overall Study|Unclassified|8|||
30703881|NCT00537303|58717731|FG001|Overall Study|Unclassified|7|||
30703882|NCT00505414|58717739|FG000|Titration Phase|Adverse Event|0|||
30703883|NCT00505414|58717740|FG001|Titration Phase|Adverse Event|0|||
30703884|NCT00505414|58717741|FG002|Titration Phase|Adverse Event|0|||
30703885|NCT00505414|58717742|FG003|Titration Phase|Adverse Event|8|||
30703886|NCT00505414|58717743|FG004|Titration Phase|Adverse Event|3|||
30703887|NCT00505414|58717739|FG000|Titration Phase|Death|0|||
30703888|NCT00505414|58717740|FG001|Titration Phase|Death|0|||
30703889|NCT00505414|58717741|FG002|Titration Phase|Death|0|||
30703890|NCT00505414|58717742|FG003|Titration Phase|Death|2|||
30703891|NCT00505414|58717743|FG004|Titration Phase|Death|0|||
30703892|NCT00505414|58717739|FG000|Titration Phase|Lack of Efficacy|0|||
30703893|NCT00505414|58717740|FG001|Titration Phase|Lack of Efficacy|0|||
30703894|NCT00505414|58717741|FG002|Titration Phase|Lack of Efficacy|0|||
30703895|NCT00505414|58717742|FG003|Titration Phase|Lack of Efficacy|10|||
30703896|NCT00505414|58717743|FG004|Titration Phase|Lack of Efficacy|1|||
30703897|NCT00505414|58717739|FG000|Titration Phase|Protocol Violation|0|||
30703898|NCT00505414|58717740|FG001|Titration Phase|Protocol Violation|0|||
30703899|NCT00505414|58717741|FG002|Titration Phase|Protocol Violation|0|||
30703900|NCT00505414|58717742|FG003|Titration Phase|Protocol Violation|0|||
30703901|NCT00505414|58717743|FG004|Titration Phase|Protocol Violation|1|||
30703902|NCT00505414|58717739|FG000|Titration Phase|Withdrawal by Subject|0|||
30703903|NCT00505414|58717740|FG001|Titration Phase|Withdrawal by Subject|0|||
30703904|NCT00505414|58717741|FG002|Titration Phase|Withdrawal by Subject|0|||
30703905|NCT00505414|58717742|FG003|Titration Phase|Withdrawal by Subject|3|||
30703906|NCT00505414|58717743|FG004|Titration Phase|Withdrawal by Subject|4|||
30703907|NCT00505414|58717739|FG000|Titration Phase|Underlying disease and therapy required|0|||
30703908|NCT00505414|58717740|FG001|Titration Phase|Underlying disease and therapy required|0|||
30703909|NCT00505414|58717741|FG002|Titration Phase|Underlying disease and therapy required|0|||
30703910|NCT00505414|58717742|FG003|Titration Phase|Underlying disease and therapy required|7|||
30703911|NCT00505414|58717743|FG004|Titration Phase|Underlying disease and therapy required|3|||
30703912|NCT00505414|58717739|FG000|Maintenance Phase|Adverse Event|2|||
30703913|NCT00505414|58717740|FG001|Maintenance Phase|Adverse Event|2|||
30703914|NCT00505414|58717741|FG002|Maintenance Phase|Adverse Event|3|||
30703915|NCT00505414|58717742|FG003|Maintenance Phase|Adverse Event|0|||
30703916|NCT00505414|58717743|FG004|Maintenance Phase|Adverse Event|0|||
30703917|NCT00505414|58717739|FG000|Maintenance Phase|Death|2|||
30703918|NCT00505414|58717740|FG001|Maintenance Phase|Death|0|||
30703919|NCT00505414|58717741|FG002|Maintenance Phase|Death|1|||
30703920|NCT00505414|58717742|FG003|Maintenance Phase|Death|0|||
30703921|NCT00505414|58717743|FG004|Maintenance Phase|Death|0|||
30703922|NCT00505414|58717739|FG000|Maintenance Phase|Lack of Efficacy|2|||
30703923|NCT00505414|58717740|FG001|Maintenance Phase|Lack of Efficacy|1|||
30703924|NCT00505414|58717741|FG002|Maintenance Phase|Lack of Efficacy|1|||
30703925|NCT00505414|58717742|FG003|Maintenance Phase|Lack of Efficacy|0|||
30703926|NCT00505414|58717743|FG004|Maintenance Phase|Lack of Efficacy|0|||
30703927|NCT00505414|58717739|FG000|Maintenance Phase|Withdrawal by Subject|0|||
30703928|NCT00505414|58717740|FG001|Maintenance Phase|Withdrawal by Subject|0|||
30703929|NCT00505414|58717741|FG002|Maintenance Phase|Withdrawal by Subject|1|||
30703930|NCT00505414|58717742|FG003|Maintenance Phase|Withdrawal by Subject|0|||
30703931|NCT00505414|58717743|FG004|Maintenance Phase|Withdrawal by Subject|0|||
30703932|NCT00505414|58717739|FG000|Maintenance Phase|underlying disease and therapy required|0|||
30703933|NCT00505414|58717740|FG001|Maintenance Phase|underlying disease and therapy required|2|||
30703934|NCT00505414|58717741|FG002|Maintenance Phase|underlying disease and therapy required|2|||
30703935|NCT00505414|58717742|FG003|Maintenance Phase|underlying disease and therapy required|0|||
30703936|NCT00505414|58717743|FG004|Maintenance Phase|underlying disease and therapy required|0|||
30703937|NCT00625586|58717759|FG000|Overall Study|Adverse Event|1|||
30703938|NCT00144781|58717781|FG000|Overall Study|Adverse Event|0|||
30703939|NCT00144781|58717782|FG001|Overall Study|Adverse Event|1|||
30703940|NCT00144781|58717783|FG002|Overall Study|Adverse Event|0|||
30703941|NCT00144781|58717784|FG003|Overall Study|Adverse Event|0|||
30703942|NCT00144781|58717781|FG000|Overall Study|Non-compliant|0|||
30703943|NCT00144781|58717782|FG001|Overall Study|Non-compliant|1|||
30703944|NCT00144781|58717783|FG002|Overall Study|Non-compliant|0|||
30703945|NCT00144781|58717784|FG003|Overall Study|Non-compliant|0|||
30703946|NCT00621140|58717800|FG000|Overall Study|Adverse Event|4|||
30703947|NCT00621140|58717801|FG001|Overall Study|Adverse Event|5|||
30703948|NCT00621140|58717800|FG000|Overall Study|Lost to Follow-up|1|||
30703949|NCT00621140|58717801|FG001|Overall Study|Lost to Follow-up|2|||
30703950|NCT00621140|58717800|FG000|Overall Study|Withdrawal by Subject|4|||
30703951|NCT00621140|58717801|FG001|Overall Study|Withdrawal by Subject|6|||
30703952|NCT00621140|58717800|FG000|Overall Study|Other incl. lack of efficacy|6|||
30703953|NCT00621140|58717801|FG001|Overall Study|Other incl. lack of efficacy|5|||
30703954|NCT00207727|58717812|FG000|Overall Study|Withdrawal by Subject|0|||
30703955|NCT00207727|58717813|FG001|Overall Study|Withdrawal by Subject|0|||
30703956|NCT00207727|58717814|FG002|Overall Study|Withdrawal by Subject|0|||
30703957|NCT00207727|58717815|FG003|Overall Study|Withdrawal by Subject|0|||
30703958|NCT00207727|58717816|FG004|Overall Study|Withdrawal by Subject|1|||
30703959|NCT00207727|58717812|FG000|Overall Study|Lost to Follow-up|0|||
30703960|NCT00207727|58717813|FG001|Overall Study|Lost to Follow-up|1|||
30703961|NCT00207727|58717814|FG002|Overall Study|Lost to Follow-up|0|||
30703962|NCT00207727|58717815|FG003|Overall Study|Lost to Follow-up|0|||
30703963|NCT00207727|58717816|FG004|Overall Study|Lost to Follow-up|0|||
30703964|NCT00207727|58717812|FG000|Overall Study|Other|38|||
30703965|NCT00207727|58717813|FG001|Overall Study|Other|41|||
30703966|NCT00207727|58717814|FG002|Overall Study|Other|41|||
30703967|NCT00207727|58717815|FG003|Overall Study|Other|37|||
30703968|NCT00207727|58717816|FG004|Overall Study|Other|33|||
30703969|NCT00504556|58717833|FG000|Overall Study|Adverse Event|11|||
30703970|NCT00504556|58717834|FG001|Overall Study|Adverse Event|11|||
30703971|NCT00504556|58717835|FG002|Overall Study|Adverse Event|14|||
30703972|NCT00504556|58717836|FG003|Overall Study|Adverse Event|13|||
30703973|NCT00504556|58717837|FG004|Overall Study|Adverse Event|5|||
30703974|NCT00504556|58717833|FG000|Overall Study|Death|3|||
30703975|NCT00504556|58717834|FG001|Overall Study|Death|3|||
30703976|NCT00504556|58717835|FG002|Overall Study|Death|1|||
30703977|NCT00504556|58717836|FG003|Overall Study|Death|0|||
30703978|NCT00504556|58717837|FG004|Overall Study|Death|2|||
30703979|NCT00504556|58717833|FG000|Overall Study|Protocol Violation|1|||
30703980|NCT00504556|58717834|FG001|Overall Study|Protocol Violation|3|||
30703981|NCT00504556|58717835|FG002|Overall Study|Protocol Violation|2|||
30703982|NCT00504556|58717836|FG003|Overall Study|Protocol Violation|1|||
30703983|NCT00504556|58717837|FG004|Overall Study|Protocol Violation|2|||
30703984|NCT00504556|58717833|FG000|Overall Study|Lost to Follow-up|0|||
30703985|NCT00504556|58717834|FG001|Overall Study|Lost to Follow-up|0|||
30703986|NCT00504556|58717835|FG002|Overall Study|Lost to Follow-up|1|||
30703987|NCT00504556|58717836|FG003|Overall Study|Lost to Follow-up|1|||
30703988|NCT00504556|58717837|FG004|Overall Study|Lost to Follow-up|1|||
30703989|NCT00504556|58717833|FG000|Overall Study|Withdrawal by Subject|16|||
30703990|NCT00504556|58717834|FG001|Overall Study|Withdrawal by Subject|16|||
30703991|NCT00504556|58717835|FG002|Overall Study|Withdrawal by Subject|7|||
30703992|NCT00504556|58717836|FG003|Overall Study|Withdrawal by Subject|8|||
30703993|NCT00504556|58717837|FG004|Overall Study|Withdrawal by Subject|12|||
30703994|NCT00504556|58717833|FG000|Overall Study|administrative reasons|0|||
30703995|NCT00504556|58717834|FG001|Overall Study|administrative reasons|2|||
30703996|NCT00504556|58717835|FG002|Overall Study|administrative reasons|2|||
30703997|NCT00504556|58717836|FG003|Overall Study|administrative reasons|1|||
30703998|NCT00504556|58717837|FG004|Overall Study|administrative reasons|2|||
30703999|NCT00504556|58717833|FG000|Overall Study|did not meet entry criteria|2|||
30704000|NCT00504556|58717834|FG001|Overall Study|did not meet entry criteria|0|||
30704001|NCT00504556|58717835|FG002|Overall Study|did not meet entry criteria|1|||
30704002|NCT00504556|58717836|FG003|Overall Study|did not meet entry criteria|1|||
30704003|NCT00504556|58717837|FG004|Overall Study|did not meet entry criteria|0|||
30704004|NCT00504556|58717833|FG000|Overall Study|data monitor committee decision|0|||
30704005|NCT00504556|58717834|FG001|Overall Study|data monitor committee decision|0|||
30704006|NCT00504556|58717835|FG002|Overall Study|data monitor committee decision|0|||
30704007|NCT00504556|58717836|FG003|Overall Study|data monitor committee decision|100|||
30704008|NCT00504556|58717837|FG004|Overall Study|data monitor committee decision|0|||
30704009|NCT00504556|58717833|FG000|Overall Study|Other|2|||
30704010|NCT00504556|58717834|FG001|Overall Study|Other|2|||
30704011|NCT00504556|58717835|FG002|Overall Study|Other|2|||
30704012|NCT00504556|58717836|FG003|Overall Study|Other|3|||
30704013|NCT00504556|58717837|FG004|Overall Study|Other|0|||
30704014|NCT00504556|58717833|FG000|Overall Study|not in safety analysis set|0|||
30704015|NCT00504556|58717834|FG001|Overall Study|not in safety analysis set|1|||
30704016|NCT00504556|58717835|FG002|Overall Study|not in safety analysis set|1|||
30704017|NCT00504556|58717836|FG003|Overall Study|not in safety analysis set|0|||
30704018|NCT00504556|58717837|FG004|Overall Study|not in safety analysis set|1|||
30704019|NCT00206323|58717851|FG000|Overall Study|Lack of Efficacy|4|||
30704020|NCT00206323|58717852|FG001|Overall Study|Lack of Efficacy|1|||
30704021|NCT00206323|58717851|FG000|Overall Study|Adverse Event|1|||
30704022|NCT00206323|58717852|FG001|Overall Study|Adverse Event|1|||
30704023|NCT00206323|58717851|FG000|Overall Study|Lost to Follow-up|1|||
30704024|NCT00206323|58717852|FG001|Overall Study|Lost to Follow-up|1|||
30704025|NCT03903159|58717858|FG000|Overall Study|Discharged with Staff Approval|2|||
30704026|NCT03903159|58717858|FG000|Overall Study|Discharged at Staff Request|2|||
30704027|NCT03903159|58717858|FG000|Overall Study|Discharged Against Staff Advice|1|||
30704028|NCT00205855|58717862|FG000|Overall Study|Only received temporary implants|16|||
30704029|NCT00205855|58717862|FG000|Overall Study|Withdrawal by Subject|5|||
30704030|NCT00536991|58717866|FG000|Overall Study|Withdrawal by Subject|10|||
30704031|NCT00536991|58717866|FG000|Overall Study|Physician Decision|1|||
30704032|NCT00536991|58717866|FG000|Overall Study|patient ineligible|2|||
30704033|NCT03902613|58717871|FG000|Overall Study|Physician Decision|1|||
30704034|NCT00504166|58717877|FG000|Overall Study|Adverse Event|1|||
30704035|NCT00504166|58717878|FG001|Overall Study|Adverse Event|4|||
30704036|NCT00504166|58717877|FG000|Overall Study|Withdrawal by Subject|3|||
30704037|NCT00504166|58717878|FG001|Overall Study|Withdrawal by Subject|6|||
30704038|NCT00504166|58717877|FG000|Overall Study|Physician Decision|1|||
30704039|NCT00504166|58717878|FG001|Overall Study|Physician Decision|1|||
30704040|NCT00504166|58717877|FG000|Overall Study|Lost to Follow-up|1|||
30704041|NCT00504166|58717878|FG001|Overall Study|Lost to Follow-up|3|||
30704042|NCT00509236|58717886|FG000|Overall Study|Adverse Event|7|||
30704043|NCT00509236|58717887|FG001|Overall Study|Adverse Event|9|||
30704044|NCT00509236|58717886|FG000|Overall Study|Withdrawal by Subject|5|||
30704045|NCT00509236|58717887|FG001|Overall Study|Withdrawal by Subject|10|||
30704046|NCT00509236|58717886|FG000|Overall Study|Protocol Violation|3|||
30704047|NCT00509236|58717887|FG001|Overall Study|Protocol Violation|0|||
30704048|NCT00509236|58717886|FG000|Overall Study|Excluded Medication|1|||
30704049|NCT00509236|58717887|FG001|Overall Study|Excluded Medication|1|||
30704050|NCT00509236|58717886|FG000|Overall Study|Scheduled Kidney Transplant|1|||
30704051|NCT00509236|58717887|FG001|Overall Study|Scheduled Kidney Transplant|0|||
30704052|NCT00508924|58717897|FG000|Overall Study|Protocol Violation|0|||
30704053|NCT00508924|58717898|FG001|Overall Study|Protocol Violation|0|||
30704054|NCT00508924|58717899|FG002|Overall Study|Protocol Violation|1|||
30704055|NCT00508924|58717900|FG003|Overall Study|Protocol Violation|1|||
30704056|NCT00620750|58717910|FG000|Overall Study|Lost to Follow-up|25|||
30704057|NCT00508144|58717914|FG000|Overall Study|Not eligible|6|||
30704058|NCT00508144|58717914|FG000|Overall Study|Death|5|||
30704059|NCT00621842|58717918|FG000|Overall Study|Adverse Event|6|||
30704060|NCT00621842|58717918|FG000|Overall Study|Withdrawal by Subject|7|||
30704061|NCT00621842|58717918|FG000|Overall Study|Protocol Violation|4|||
30704062|NCT00621842|58717918|FG000|Overall Study|Lack of Efficacy|2|||
30704063|NCT00503776|58717926|FG000|Overall Study|Withdrawal by Subject|1|||
30704064|NCT00503776|58717927|FG001|Overall Study|Withdrawal by Subject|0|||
30704065|NCT00503776|58717928|FG002|Overall Study|Withdrawal by Subject|1|||
30704066|NCT00503776|58717929|FG003|Overall Study|Withdrawal by Subject|1|||
30704067|NCT00503776|58717926|FG000|Overall Study|Physician Decision|0|||
30704068|NCT00503776|58717927|FG001|Overall Study|Physician Decision|0|||
30704069|NCT00503776|58717928|FG002|Overall Study|Physician Decision|1|||
30704070|NCT00503776|58717929|FG003|Overall Study|Physician Decision|1|||
30704071|NCT00619112|58717946|FG000|Overall Study|Adverse Event|1|||
30704072|NCT00619112|58717947|FG001|Overall Study|Adverse Event|2|||
30704073|NCT00619502|58717958|FG000|Overall Study|Lost to Follow-up|8|||
30704074|NCT00619502|58717959|FG001|Overall Study|Lost to Follow-up|10|||
30704075|NCT00618956|58717969|FG000|Overall Study|Adverse Event|10|||
30704076|NCT00618956|58717970|FG001|Overall Study|Adverse Event|34|||
30704077|NCT00618956|58717969|FG000|Overall Study|Lack of Efficacy|2|||
30704078|NCT00618956|58717970|FG001|Overall Study|Lack of Efficacy|1|||
30704079|NCT00618956|58717969|FG000|Overall Study|Withdrawal by Subject|5|||
30704080|NCT00618956|58717970|FG001|Overall Study|Withdrawal by Subject|7|||
30704081|NCT00618956|58717969|FG000|Overall Study|Lost to Follow-up|4|||
30704082|NCT00618956|58717970|FG001|Overall Study|Lost to Follow-up|5|||
30704083|NCT00618956|58717969|FG000|Overall Study|Protocol Violation|2|||
30704084|NCT00618956|58717970|FG001|Overall Study|Protocol Violation|2|||
30704085|NCT00618956|58717969|FG000|Overall Study|did not meet criteria, non-compliance|2|||
30704086|NCT00618956|58717970|FG001|Overall Study|did not meet criteria, non-compliance|1|||
30704087|NCT00716417|58717992|FG000|Overall Study|Adverse Event|0|||
30704088|NCT00716417|58717993|FG001|Overall Study|Adverse Event|0|||
30704089|NCT00716417|58717994|FG002|Overall Study|Adverse Event|2|||
30704090|NCT00716417|58717995|FG003|Overall Study|Adverse Event|1|||
30704091|NCT00716417|58717996|FG004|Overall Study|Adverse Event|0|||
30704092|NCT00716417|58717997|FG005|Overall Study|Adverse Event|0|||
30704093|NCT00716417|58717998|FG006|Overall Study|Adverse Event|3|||
30704094|NCT00716417|58717999|FG007|Overall Study|Adverse Event|1|||
30704095|NCT00716417|58718000|FG008|Overall Study|Adverse Event|0|||
30704096|NCT00716417|58718001|FG009|Overall Study|Adverse Event|3|||
30704097|NCT00716417|58717992|FG000|Overall Study|Withdrawal by Subject|0|||
30704098|NCT00716417|58717993|FG001|Overall Study|Withdrawal by Subject|1|||
30704099|NCT00716417|58717994|FG002|Overall Study|Withdrawal by Subject|0|||
30704100|NCT00716417|58717995|FG003|Overall Study|Withdrawal by Subject|2|||
30704101|NCT00716417|58717996|FG004|Overall Study|Withdrawal by Subject|0|||
30704102|NCT00716417|58717997|FG005|Overall Study|Withdrawal by Subject|0|||
30704103|NCT00716417|58717998|FG006|Overall Study|Withdrawal by Subject|1|||
30704104|NCT00716417|58717999|FG007|Overall Study|Withdrawal by Subject|0|||
30704105|NCT00716417|58718000|FG008|Overall Study|Withdrawal by Subject|0|||
30704106|NCT00716417|58718001|FG009|Overall Study|Withdrawal by Subject|0|||
30704107|NCT00716417|58717992|FG000|Overall Study|Progressive disease|3|||
30704108|NCT00716417|58717993|FG001|Overall Study|Progressive disease|5|||
30704109|NCT00716417|58717994|FG002|Overall Study|Progressive disease|3|||
30704110|NCT00716417|58717995|FG003|Overall Study|Progressive disease|8|||
30704111|NCT00716417|58717996|FG004|Overall Study|Progressive disease|0|||
30704112|NCT00716417|58717997|FG005|Overall Study|Progressive disease|3|||
30704113|NCT00716417|58717998|FG006|Overall Study|Progressive disease|3|||
30704114|NCT00716417|58717999|FG007|Overall Study|Progressive disease|1|||
30704115|NCT00716417|58718000|FG008|Overall Study|Progressive disease|5|||
30704116|NCT00716417|58718001|FG009|Overall Study|Progressive disease|0|||
30704117|NCT00716417|58717992|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
30704118|NCT00716417|58717993|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
30704119|NCT00716417|58717994|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
30704120|NCT00716417|58717995|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
30704121|NCT00716417|58717996|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
30704122|NCT00716417|58717997|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
30704123|NCT00716417|58717998|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
30704124|NCT00716417|58717999|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
30704125|NCT00716417|58718000|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
30704126|NCT00716417|58718001|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
30704127|NCT00716417|58717992|FG000|Overall Study|On patient request due to toxicities|0|||
30704128|NCT00716417|58717993|FG001|Overall Study|On patient request due to toxicities|0|||
30704129|NCT00716417|58717994|FG002|Overall Study|On patient request due to toxicities|0|||
30704130|NCT00716417|58717995|FG003|Overall Study|On patient request due to toxicities|0|||
30704131|NCT00716417|58717996|FG004|Overall Study|On patient request due to toxicities|0|||
30704132|NCT00716417|58717997|FG005|Overall Study|On patient request due to toxicities|0|||
30704133|NCT00716417|58717998|FG006|Overall Study|On patient request due to toxicities|0|||
30704134|NCT00716417|58717999|FG007|Overall Study|On patient request due to toxicities|1|||
30704135|NCT00716417|58718000|FG008|Overall Study|On patient request due to toxicities|0|||
30704136|NCT00716417|58718001|FG009|Overall Study|On patient request due to toxicities|0|||
30704137|NCT00719537|58718027|FG000|Overall Study|Withdrawal by Subject|1|||
30704138|NCT00719537|58718028|FG001|Overall Study|Withdrawal by Subject|0|||
30704139|NCT00719537|58718027|FG000|Overall Study|Lost to Follow-up|0|||
30704140|NCT00719537|58718028|FG001|Overall Study|Lost to Follow-up|1|||
30704141|NCT00715949|58718034|FG000|Overall Study|could not finish first test|4|||
30704142|NCT00503698|58718040|FG000|Overall Study|Protocol Violation|5|||
30704143|NCT00503698|58718041|FG001|Overall Study|Protocol Violation|6|||
30704144|NCT00503698|58718040|FG000|Overall Study|Adverse Event|52|||
30704145|NCT00503698|58718041|FG001|Overall Study|Adverse Event|41|||
30704146|NCT00503698|58718040|FG000|Overall Study|Death|1|||
30704147|NCT00503698|58718041|FG001|Overall Study|Death|0|||
30704148|NCT00503698|58718040|FG000|Overall Study|Lack of Efficacy|3|||
30704149|NCT00503698|58718041|FG001|Overall Study|Lack of Efficacy|4|||
30704150|NCT00503698|58718040|FG000|Overall Study|Trial terminated|216|||
30704151|NCT00503698|58718041|FG001|Overall Study|Trial terminated|253|||
30704152|NCT00503698|58718040|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
30704153|NCT00503698|58718041|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
30704154|NCT00503698|58718040|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
30704155|NCT00503698|58718041|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
30704156|NCT00503698|58718040|FG000|Overall Study|Any condition in exclusion criteria|4|||
30704157|NCT00503698|58718041|FG001|Overall Study|Any condition in exclusion criteria|6|||
30704158|NCT00503698|58718040|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
30704159|NCT00503698|58718041|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
30704160|NCT00503698|58718040|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
30704161|NCT00503698|58718041|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
30704162|NCT00503698|58718040|FG000|Overall Study|Critically ill|2|||
30704163|NCT00503698|58718041|FG001|Overall Study|Critically ill|0|||
30704164|NCT00503698|58718040|FG000|Overall Study|Unclassified|48|||
30704165|NCT00503698|58718041|FG001|Overall Study|Unclassified|32|||
30704166|NCT00503698|58718040|FG000|Overall Study|Not exposed to trial drug|11|||
30704167|NCT00503698|58718041|FG001|Overall Study|Not exposed to trial drug|6|||
30704168|NCT00573794|58718056|FG000|Overall Study|Adverse Event|81|||
30704169|NCT00573794|58718056|FG000|Overall Study|Withdrew Consent|90|||
30704170|NCT00573794|58718056|FG000|Overall Study|Lost to Follow-up|13|||
30704171|NCT00573794|58718056|FG000|Overall Study|Protocol Violation|6|||
30704172|NCT00573794|58718056|FG000|Overall Study|Lack of Efficacy|94|||
30704173|NCT00573794|58718056|FG000|Overall Study|Other|46|||
30704174|NCT00715793|58718060|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
30704175|NCT00715793|58718061|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
30704176|NCT00715793|58718060|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
30704177|NCT00715793|58718061|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
30704178|NCT00718523|58718070|FG000|Overall Study|Withdrawal by Subject|5|||
30704179|NCT00718523|58718071|FG001|Overall Study|Withdrawal by Subject|7|||
30704180|NCT00718523|58718070|FG000|Overall Study|Death|13|||
30704181|NCT00718523|58718071|FG001|Overall Study|Death|17|||
30704182|NCT00715559|58718077|FG000|Overall Study|medication not tolerated - nausea|1|||
30704183|NCT00620282|58718093|FG000|Overall Study|Adverse Event|0|||
30704184|NCT00620282|58718094|FG001|Overall Study|Adverse Event|1|||
30704185|NCT00620282|58718095|FG002|Overall Study|Adverse Event|0|||
30704186|NCT00620282|58718093|FG000|Overall Study|Arterial line unable to be placed|0|||
30704187|NCT00620282|58718094|FG001|Overall Study|Arterial line unable to be placed|0|||
30704188|NCT00620282|58718095|FG002|Overall Study|Arterial line unable to be placed|1|||
30704189|NCT00620282|58718093|FG000|Overall Study|Withdrawal by Subject|0|||
30704190|NCT00620282|58718094|FG001|Overall Study|Withdrawal by Subject|1|||
30704191|NCT00620282|58718095|FG002|Overall Study|Withdrawal by Subject|0|||
30704192|NCT00515086|58718107|FG000|Overall Study|Adverse Event|1|||
30704193|NCT00515086|58718108|FG001|Overall Study|Adverse Event|1|||
30704194|NCT00515086|58718109|FG002|Overall Study|Adverse Event|2|||
30704195|NCT00515086|58718110|FG003|Overall Study|Adverse Event|3|||
30704196|NCT00515086|58718107|FG000|Overall Study|Administrative|1|||
30704197|NCT00515086|58718108|FG001|Overall Study|Administrative|1|||
30704198|NCT00515086|58718109|FG002|Overall Study|Administrative|0|||
30704199|NCT00515086|58718110|FG003|Overall Study|Administrative|0|||
30704200|NCT00515086|58718107|FG000|Overall Study|Withdrawal by Subject|1|||
30704201|NCT00515086|58718108|FG001|Overall Study|Withdrawal by Subject|0|||
30704202|NCT00515086|58718109|FG002|Overall Study|Withdrawal by Subject|0|||
30704203|NCT00515086|58718110|FG003|Overall Study|Withdrawal by Subject|1|||
30704204|NCT00515086|58718107|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
30704205|NCT00515086|58718108|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
30704206|NCT00515086|58718109|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
30704207|NCT00515086|58718110|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
30704208|NCT00515086|58718107|FG000|Overall Study|Lost to Follow-up|1|||
30704209|NCT00515086|58718108|FG001|Overall Study|Lost to Follow-up|0|||
30704210|NCT00515086|58718109|FG002|Overall Study|Lost to Follow-up|0|||
30704211|NCT00515086|58718110|FG003|Overall Study|Lost to Follow-up|0|||
30704212|NCT00515086|58718107|FG000|Overall Study|Study drug no longer required|0|||
30704213|NCT00515086|58718108|FG001|Overall Study|Study drug no longer required|1|||
30704214|NCT00515086|58718109|FG002|Overall Study|Study drug no longer required|0|||
30704215|NCT00515086|58718110|FG003|Overall Study|Study drug no longer required|0|||
30704216|NCT00515086|58718107|FG000|Overall Study|Death|2|||
30704217|NCT00515086|58718108|FG001|Overall Study|Death|0|||
30704218|NCT00515086|58718109|FG002|Overall Study|Death|0|||
30704219|NCT00515086|58718110|FG003|Overall Study|Death|0|||
30704220|NCT00618410|58718126|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
30704221|NCT00618410|58718127|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
30704222|NCT00618722|58718137|FG000|Overall Study|Refusal of Treatment|0|||
30704223|NCT00618722|58718138|FG001|Overall Study|Refusal of Treatment|0|||
30704224|NCT00618722|58718139|FG002|Overall Study|Refusal of Treatment|1|||
30704225|NCT00618722|58718140|FG003|Overall Study|Refusal of Treatment|0|||
30704226|NCT00618722|58718137|FG000|Overall Study|Patient Request|1|||
30704227|NCT00618722|58718138|FG001|Overall Study|Patient Request|1|||
30704228|NCT00618722|58718139|FG002|Overall Study|Patient Request|1|||
30704229|NCT00618722|58718140|FG003|Overall Study|Patient Request|1|||
30704230|NCT00618722|58718137|FG000|Overall Study|Inability to Complete Study Procedure|0|||
30704231|NCT00618722|58718138|FG001|Overall Study|Inability to Complete Study Procedure|1|||
30704232|NCT00618722|58718139|FG002|Overall Study|Inability to Complete Study Procedure|0|||
30704233|NCT00618722|58718140|FG003|Overall Study|Inability to Complete Study Procedure|0|||
30704234|NCT00618722|58718137|FG000|Overall Study|Lost to Follow-up|2|||
30704235|NCT00618722|58718138|FG001|Overall Study|Lost to Follow-up|0|||
30704236|NCT00618722|58718139|FG002|Overall Study|Lost to Follow-up|0|||
30704237|NCT00618722|58718140|FG003|Overall Study|Lost to Follow-up|2|||
30704238|NCT00618722|58718137|FG000|Overall Study|Miscellaneous Reasons|0|||
30704239|NCT00618722|58718138|FG001|Overall Study|Miscellaneous Reasons|0|||
30704240|NCT00618722|58718139|FG002|Overall Study|Miscellaneous Reasons|1|||
30704241|NCT00618722|58718140|FG003|Overall Study|Miscellaneous Reasons|1|||
30704242|NCT00507442|58718154|FG000|Overall Study|Adverse Event|8|||
30704243|NCT00507442|58718155|FG001|Overall Study|Adverse Event|11|||
30704244|NCT00507442|58718156|FG002|Overall Study|Adverse Event|4|||
30704245|NCT00507442|58718157|FG003|Overall Study|Adverse Event|1|||
30704246|NCT00507442|58718154|FG000|Overall Study|Protocol Violation|0|||
30704247|NCT00507442|58718155|FG001|Overall Study|Protocol Violation|1|||
30704248|NCT00507442|58718156|FG002|Overall Study|Protocol Violation|0|||
30704249|NCT00507442|58718157|FG003|Overall Study|Protocol Violation|0|||
30704250|NCT00507442|58718154|FG000|Overall Study|Lost to Follow-up|0|||
30704251|NCT00507442|58718155|FG001|Overall Study|Lost to Follow-up|0|||
30704252|NCT00507442|58718156|FG002|Overall Study|Lost to Follow-up|1|||
30619998|NCT01025817|58631054|FG001|Completed Study Medication|Abnormal lab values|2|||
30619999|NCT01025817|58631053|FG000|Completed Study Medication|Subject no longer required study drug|0|||
30620000|NCT01025817|58631054|FG001|Completed Study Medication|Subject no longer required study drug|1|||
30620001|NCT01025817|58631053|FG000|Completed Study Medication|Lost to Follow-up|0|||
30620002|NCT01025817|58631054|FG001|Completed Study Medication|Lost to Follow-up|1|||
30620003|NCT01025817|58631053|FG000|Completed Study|Withdrawal by Subject|8|||
30620004|NCT01025817|58631054|FG001|Completed Study|Withdrawal by Subject|16|||
30620005|NCT01025817|58631053|FG000|Completed Study|Death|6|||
30620006|NCT01025817|58631054|FG001|Completed Study|Death|5|||
30620007|NCT01025817|58631053|FG000|Completed Study|Missing|2|||
30704253|NCT00507442|58718157|FG003|Overall Study|Lost to Follow-up|0|||
30704254|NCT00507442|58718154|FG000|Overall Study|Physician Decision|0|||
30704255|NCT00507442|58718155|FG001|Overall Study|Physician Decision|2|||
30704256|NCT00507442|58718156|FG002|Overall Study|Physician Decision|4|||
30704257|NCT00507442|58718157|FG003|Overall Study|Physician Decision|1|||
30704258|NCT00507442|58718154|FG000|Overall Study|Progressive Disease|2|||
30704259|NCT00507442|58718155|FG001|Overall Study|Progressive Disease|4|||
30790855|NCT03524092|58803940|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
30704260|NCT00507442|58718156|FG002|Overall Study|Progressive Disease|2|||
30704261|NCT00507442|58718157|FG003|Overall Study|Progressive Disease|0|||
30704262|NCT00507442|58718154|FG000|Overall Study|Withdrawal by Subject|4|||
30704263|NCT00507442|58718155|FG001|Overall Study|Withdrawal by Subject|4|||
30704264|NCT00507442|58718156|FG002|Overall Study|Withdrawal by Subject|2|||
30704265|NCT00507442|58718157|FG003|Overall Study|Withdrawal by Subject|1|||
30704266|NCT00507442|58718154|FG000|Overall Study|Other|2|||
30704267|NCT00507442|58718155|FG001|Overall Study|Other|5|||
30704268|NCT00507442|58718156|FG002|Overall Study|Other|2|||
30704269|NCT00507442|58718157|FG003|Overall Study|Other|2|||
30704270|NCT00619892|58718173|FG000|Overall Study|Adverse Event|3|||
30704271|NCT00619892|58718174|FG001|Overall Study|Adverse Event|0|||
30704272|NCT00619892|58718173|FG000|Overall Study|Lost to Follow-up|0|||
30704273|NCT00619892|58718174|FG001|Overall Study|Lost to Follow-up|1|||
30704274|NCT00619892|58718173|FG000|Overall Study|Intercurrent illness|0|||
30704275|NCT00619892|58718174|FG001|Overall Study|Intercurrent illness|1|||
30704276|NCT00507130|58718186|FG000|Overall Study|Lost to Follow-up|0|||
30704277|NCT00507130|58718187|FG001|Overall Study|Lost to Follow-up|0|||
30704278|NCT00507130|58718188|FG002|Overall Study|Lost to Follow-up|1|||
30704279|NCT00507130|58718189|FG003|Overall Study|Lost to Follow-up|1|||
30704280|NCT00507130|58718186|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
30704281|NCT00507130|58718187|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
30704282|NCT00507130|58718188|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
30704283|NCT00507130|58718189|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
30704284|NCT00503308|58718201|FG000|Overall Study|Protocol Violation|2|||
30704285|NCT00503308|58718202|FG001|Overall Study|Protocol Violation|1|||
30704286|NCT03893565|58718213|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
30704287|NCT03893565|58718214|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
30704288|NCT03893565|58718215|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
30704289|NCT03893565|58718216|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
30704290|NCT03893565|58718217|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
30704291|NCT03893565|58718218|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
30704292|NCT03893565|58718219|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
30704293|NCT03893565|58718220|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
30704294|NCT03893565|58718221|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
30704295|NCT03893565|58718213|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
30704296|NCT03893565|58718214|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
30704297|NCT03893565|58718215|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
30704298|NCT03893565|58718216|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
30704299|NCT03893565|58718217|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
30704300|NCT03893565|58718218|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
30704301|NCT03893565|58718219|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
30704302|NCT03893565|58718220|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
30704303|NCT03893565|58718221|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
30704304|NCT03893565|58718213|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704305|NCT03893565|58718214|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
30704306|NCT03893565|58718215|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704307|NCT03893565|58718216|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
30704308|NCT03893565|58718217|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704309|NCT03893565|58718218|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704310|NCT03893565|58718219|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704311|NCT03893565|58718220|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704312|NCT03893565|58718221|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704313|NCT03893565|58718213|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
30704314|NCT03893565|58718214|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
30704315|NCT03893565|58718215|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
30704316|NCT03893565|58718216|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
30704317|NCT03893565|58718217|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
30704318|NCT03893565|58718218|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
30704319|NCT03893565|58718219|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
30704320|NCT03893565|58718220|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
30704321|NCT03893565|58718221|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
30704322|NCT03893565|58718213|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
30704323|NCT03893565|58718214|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
30704324|NCT03893565|58718215|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
30704325|NCT03893565|58718216|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704326|NCT03893565|58718217|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
30704327|NCT03893565|58718218|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704328|NCT03893565|58718219|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704329|NCT03893565|58718220|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704330|NCT03893565|58718221|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704331|NCT03893565|58718213|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
30704332|NCT03893565|58718214|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
30704333|NCT03893565|58718215|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
30704334|NCT03893565|58718216|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
30704335|NCT03893565|58718217|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
30704336|NCT03893565|58718218|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
30704337|NCT03893565|58718219|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
30704338|NCT03893565|58718220|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
30704339|NCT03893565|58718221|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
30704340|NCT03893565|58718213|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704341|NCT03893565|58718214|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704342|NCT03893565|58718215|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704343|NCT03893565|58718216|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
30704344|NCT03893565|58718217|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704345|NCT03893565|58718218|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704346|NCT03893565|58718219|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704347|NCT03893565|58718220|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704348|NCT03893565|58718221|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704349|NCT03893565|58718213|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
30704350|NCT03893565|58718214|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
30704351|NCT03893565|58718215|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
30704352|NCT03893565|58718216|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
30704353|NCT03893565|58718217|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
30704354|NCT03893565|58718218|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
30704355|NCT03893565|58718219|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
30704356|NCT03893565|58718220|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
30704357|NCT03893565|58718221|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
30704358|NCT03893565|58718213|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
30704359|NCT03893565|58718214|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
30704360|NCT03893565|58718215|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
30704361|NCT03893565|58718216|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
30704362|NCT03893565|58718217|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
30704363|NCT03893565|58718218|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
30704364|NCT03893565|58718219|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
30704365|NCT03893565|58718220|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
30704366|NCT03893565|58718221|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
30704367|NCT03893565|58718213|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
30704368|NCT03893565|58718214|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
30704369|NCT03893565|58718215|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
30704370|NCT03893565|58718216|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
30704371|NCT03893565|58718217|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
30704372|NCT03893565|58718218|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
30704373|NCT03893565|58718219|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
30704374|NCT03893565|58718220|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
30704375|NCT03893565|58718221|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
30620008|NCT01025817|58631054|FG001|Completed Study|Missing|0|||
30620009|NCT01025817|58631053|FG000|Completed Study|Lost to Follow-up|0|||
30620010|NCT01025817|58631054|FG001|Completed Study|Lost to Follow-up|1|||
30620011|NCT00939640|58631060|FG000|Overall Study|Physician Decision|1|||
30620012|NCT01218113|58631072|FG000|Overall Study|Withdrawal by Subject|1|||
30620013|NCT01218113|58631073|FG001|Overall Study|Withdrawal by Subject|0|||
30620014|NCT01218113|58631074|FG002|Overall Study|Withdrawal by Subject|1|||
30704376|NCT03893565|58718213|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
30704377|NCT03893565|58718214|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
30620015|NCT01218113|58631072|FG000|Overall Study|Lost to Follow-up|4|||
30620016|NCT01218113|58631073|FG001|Overall Study|Lost to Follow-up|1|||
30620017|NCT01218113|58631074|FG002|Overall Study|Lost to Follow-up|4|||
30704378|NCT03893565|58718215|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
30620018|NCT01218113|58631072|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
30704379|NCT03893565|58718216|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
30704380|NCT03893565|58718217|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
30704381|NCT03893565|58718218|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
30704382|NCT03893565|58718219|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
30704383|NCT03893565|58718220|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
30704384|NCT03893565|58718221|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
30704385|NCT03893565|58718213|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
30704386|NCT03893565|58718214|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
30704387|NCT03893565|58718215|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
30704388|NCT03893565|58718216|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
30704389|NCT03893565|58718217|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
30704390|NCT03893565|58718218|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
30704391|NCT03893565|58718219|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
30704392|NCT03893565|58718220|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
30704393|NCT03893565|58718221|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
30704394|NCT03893565|58718213|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704395|NCT03893565|58718214|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704396|NCT03893565|58718215|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704397|NCT03893565|58718216|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704398|NCT03893565|58718217|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704399|NCT03893565|58718218|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704400|NCT03893565|58718219|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704401|NCT03893565|58718220|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
30704402|NCT03893565|58718221|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
30704403|NCT03893565|58718213|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704404|NCT03893565|58718214|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704405|NCT03893565|58718215|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704406|NCT03893565|58718216|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704407|NCT03893565|58718217|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704408|NCT03893565|58718218|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704409|NCT03893565|58718219|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704410|NCT03893565|58718220|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
30704411|NCT03893565|58718221|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
30704412|NCT03893565|58718213|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704413|NCT03893565|58718214|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704414|NCT03893565|58718215|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704415|NCT03893565|58718216|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704416|NCT03893565|58718217|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704417|NCT03893565|58718218|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704418|NCT03893565|58718219|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704419|NCT03893565|58718220|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
30704420|NCT03893565|58718221|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
30704421|NCT03893565|58718213|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
30704422|NCT03893565|58718214|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
30704423|NCT03893565|58718215|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
30704424|NCT03893565|58718216|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
30704425|NCT03893565|58718217|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
30704426|NCT03893565|58718218|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
30704427|NCT03893565|58718219|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
30704428|NCT03893565|58718220|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
30704429|NCT03893565|58718221|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
30704430|NCT00502996|58718240|FG000|Overall Study|Lost to Follow-up|9|||
30704431|NCT00502996|58718240|FG000|Overall Study|Protocol Violation|2|||
30704432|NCT00502996|58718240|FG000|Overall Study|Treatment failure|25|||
30704433|NCT00502996|58718240|FG000|Overall Study|Withdrawal Informed Consent|6|||
30704434|NCT00502996|58718240|FG000|Overall Study|Adverse Event|2|||
30704435|NCT00715403|58718251|FG000|Overall Study|Progressive disease|0|||
30704436|NCT00715403|58718252|FG001|Overall Study|Progressive disease|1|||
30704437|NCT00715403|58718253|FG002|Overall Study|Progressive disease|3|||
30704438|NCT00715403|58718254|FG003|Overall Study|Progressive disease|9|||
30704439|NCT00715403|58718255|FG004|Overall Study|Progressive disease|5|||
30704440|NCT00715403|58718256|FG005|Overall Study|Progressive disease|14|||
30704441|NCT00715403|58718257|FG006|Overall Study|Progressive disease|1|||
30704442|NCT00715403|58718251|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
30704443|NCT00715403|58718252|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
30704444|NCT00715403|58718253|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
30704445|NCT00715403|58718254|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
30704446|NCT00715403|58718255|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
30704447|NCT00715403|58718256|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
30704448|NCT00715403|58718257|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
30704449|NCT00715403|58718251|FG000|Overall Study|Other Adverse Event than DLT|1|||
30704450|NCT00715403|58718252|FG001|Overall Study|Other Adverse Event than DLT|0|||
30620019|NCT01218113|58631073|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
30620020|NCT01218113|58631074|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
30620021|NCT03873493|58631089|FG000|Overall Study|Withdrawal by Subject|1|||
30620022|NCT03873493|58631089|FG000|Overall Study|Death|9|||
30620023|NCT03873493|58631089|FG000|Overall Study|Lost to Follow-up|1|||
30620024|NCT03873493|58631089|FG000|Overall Study|Study Terminated by Sponsor|1|||
30620025|NCT03873493|58631089|FG000|Overall Study|Other|2|||
30620026|NCT00939484|58631109|FG000|Overall Study|Progression/Relapse|8|||
30620027|NCT00939484|58631110|FG001|Overall Study|Progression/Relapse|20|||
30620028|NCT00939484|58631111|FG002|Overall Study|Progression/Relapse|3|||
30620029|NCT01010217|58631126|FG000|Overall Study|Lost to Follow-up|4|||
30620030|NCT01010217|58631127|FG001|Overall Study|Lost to Follow-up|5|||
30620031|NCT01010217|58631128|FG002|Overall Study|Lost to Follow-up|1|||
30620032|NCT01010217|58631129|FG003|Overall Study|Lost to Follow-up|0|||
30620033|NCT01010217|58631130|FG004|Overall Study|Lost to Follow-up|0|||
30620034|NCT01010217|58631126|FG000|Overall Study|Withdrawal by Subject|1|||
30620035|NCT01010217|58631127|FG001|Overall Study|Withdrawal by Subject|0|||
30620036|NCT01010217|58631128|FG002|Overall Study|Withdrawal by Subject|0|||
30620037|NCT01010217|58631129|FG003|Overall Study|Withdrawal by Subject|0|||
30620038|NCT01010217|58631130|FG004|Overall Study|Withdrawal by Subject|0|||
30620039|NCT01010217|58631126|FG000|Overall Study|Physician Decision|0|||
30620040|NCT01010217|58631127|FG001|Overall Study|Physician Decision|0|||
30620041|NCT01010217|58631128|FG002|Overall Study|Physician Decision|0|||
30620042|NCT01010217|58631129|FG003|Overall Study|Physician Decision|6|||
30620043|NCT01010217|58631130|FG004|Overall Study|Physician Decision|3|||
30620044|NCT01217957|58631147|FG000|Phase 1|Withdrawal by Patient|1|||
30620045|NCT01217957|58631148|FG001|Phase 1|Withdrawal by Patient|0|||
30620046|NCT01217957|58631149|FG002|Phase 1|Withdrawal by Patient|1|||
30620047|NCT01217957|58631150|FG003|Phase 1|Withdrawal by Patient|1|||
30620048|NCT01217957|58631151|FG004|Phase 1|Withdrawal by Patient|0|||
30620049|NCT01217957|58631147|FG000|Phase 2|Withdrawal by Patient|0|||
30620050|NCT01217957|58631148|FG001|Phase 2|Withdrawal by Patient|0|||
30620051|NCT01217957|58631149|FG002|Phase 2|Withdrawal by Patient|0|||
30620052|NCT01217957|58631150|FG003|Phase 2|Withdrawal by Patient|0|||
30620053|NCT01217957|58631151|FG004|Phase 2|Withdrawal by Patient|1|||
30620054|NCT00939094|58631174|FG000|Overall Study|Adverse Event|9|||
30620055|NCT00939094|58631175|FG001|Overall Study|Adverse Event|0|||
30620056|NCT00939094|58631174|FG000|Overall Study|Withdrawal by Subject|1|||
30620057|NCT00939094|58631175|FG001|Overall Study|Withdrawal by Subject|6|||
30620058|NCT00939094|58631174|FG000|Overall Study|Lost to Follow-up|1|||
30620059|NCT00939094|58631175|FG001|Overall Study|Lost to Follow-up|1|||
30620060|NCT00939094|58631174|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
30620061|NCT00939094|58631175|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30790856|NCT03524092|58803941|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
30790857|NCT03524092|58803942|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
30790858|NCT03524092|58803943|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
30620062|NCT00939094|58631174|FG000|Overall Study|Severe non-compliance to protocol|0|||
30620063|NCT00939094|58631175|FG001|Overall Study|Severe non-compliance to protocol|1|||
30620064|NCT00939094|58631174|FG000|Overall Study|Study stopped by sponsor|0|||
30620065|NCT00939094|58631175|FG001|Overall Study|Study stopped by sponsor|2|||
30620066|NCT00939094|58631174|FG000|Overall Study|Abnormal ECG findings|1|||
30620067|NCT00939094|58631175|FG001|Overall Study|Abnormal ECG findings|0|||
30620068|NCT01217801|58631183|FG000|Period 1|Protocol Violation|1|||
30620069|NCT01217801|58631184|FG001|Period 1|Protocol Violation|1|||
30620070|NCT01217801|58631183|FG000|Period 1|Withdrawal by Subject|0|||
30620071|NCT01217801|58631184|FG001|Period 1|Withdrawal by Subject|1|||
30620072|NCT00935818|58631192|FG000|Overall Study|Withdrawal by Subject|45|||
30704451|NCT00715403|58718253|FG002|Overall Study|Other Adverse Event than DLT|0|||
30620073|NCT00935818|58631193|FG001|Overall Study|Withdrawal by Subject|50|||
30620074|NCT00935818|58631192|FG000|Overall Study|Lost to Follow-up|40|||
30620075|NCT00935818|58631193|FG001|Overall Study|Lost to Follow-up|42|||
30620076|NCT00935818|58631192|FG000|Overall Study|Adverse Event|6|||
30620077|NCT00935818|58631193|FG001|Overall Study|Adverse Event|7|||
30620078|NCT00935818|58631192|FG000|Overall Study|Physician Decision|0|||
30620079|NCT00935818|58631193|FG001|Overall Study|Physician Decision|1|||
30620080|NCT01216319|58631199|FG000|Overall Study|Lost to Follow-up|2|||
30620081|NCT01216319|58631199|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
30620082|NCT00936208|58631205|FG000|Overall Study|Protocol Violation|37|||
30620083|NCT00936208|58631206|FG001|Overall Study|Protocol Violation|22|||
30620084|NCT01216163|58631215|FG000|Overall Study|Withdrawal by Subject|1|||
30620085|NCT01216163|58631216|FG001|Overall Study|Withdrawal by Subject|1|||
30620086|NCT01216163|58631217|FG002|Overall Study|Withdrawal by Subject|0|||
30620087|NCT00933244|58631228|FG000|Overall Study|Withdrawal by Subject|5|||
30620088|NCT00933244|58631229|FG001|Overall Study|Withdrawal by Subject|1|||
30620089|NCT00933244|58631230|FG002|Overall Study|Withdrawal by Subject|3|||
30620090|NCT00930046|58631240|FG000|Overall Study|Wound catheter malfunctioned|1|||
30620091|NCT00930046|58631241|FG001|Overall Study|Wound catheter malfunctioned|2|||
30620092|NCT00935584|58631249|FG000|Overall Study|Withdrawal by Subject|9|||
30620093|NCT00935584|58631250|FG001|Overall Study|Withdrawal by Subject|0|||
30704452|NCT00715403|58718254|FG003|Overall Study|Other Adverse Event than DLT|0|||
30704453|NCT00715403|58718255|FG004|Overall Study|Other Adverse Event than DLT|0|||
30704454|NCT00715403|58718256|FG005|Overall Study|Other Adverse Event than DLT|2|||
30704455|NCT00715403|58718257|FG006|Overall Study|Other Adverse Event than DLT|0|||
30704456|NCT00715403|58718251|FG000|Overall Study|Protocol Violation|0|||
30704457|NCT00715403|58718252|FG001|Overall Study|Protocol Violation|0|||
30704458|NCT00715403|58718253|FG002|Overall Study|Protocol Violation|0|||
30704459|NCT00715403|58718254|FG003|Overall Study|Protocol Violation|0|||
30704460|NCT00715403|58718255|FG004|Overall Study|Protocol Violation|0|||
30704461|NCT00715403|58718256|FG005|Overall Study|Protocol Violation|1|||
30704462|NCT00715403|58718257|FG006|Overall Study|Protocol Violation|0|||
30704463|NCT00715403|58718251|FG000|Overall Study|Other reason not defined above|0|||
30704464|NCT00715403|58718252|FG001|Overall Study|Other reason not defined above|0|||
30704465|NCT00715403|58718253|FG002|Overall Study|Other reason not defined above|1|||
30704466|NCT00715403|58718254|FG003|Overall Study|Other reason not defined above|0|||
30704467|NCT00715403|58718255|FG004|Overall Study|Other reason not defined above|1|||
30704468|NCT00715403|58718256|FG005|Overall Study|Other reason not defined above|1|||
30704469|NCT00715403|58718257|FG006|Overall Study|Other reason not defined above|0|||
30704470|NCT00502840|58718273|FG000|Overall Study|Adverse Event|5|||
30704471|NCT00502840|58718273|FG000|Overall Study|Additional or changed therapy|48|||
30704472|NCT00502840|58718273|FG000|Overall Study|Lack of Efficacy|11|||
30704473|NCT00502840|58718273|FG000|Overall Study|Protocol Violation|4|||
30704474|NCT00502840|58718273|FG000|Overall Study|Withdrawal by Subject|5|||
30704475|NCT00502840|58718273|FG000|Overall Study|Lost to Follow-up|6|||
30704476|NCT00502840|58718273|FG000|Overall Study|Administrative problems|1|||
30704477|NCT00502840|58718273|FG000|Overall Study|Other|20|||
30704478|NCT00515008|58718280|FG000|Overall Study|Lost to Follow-up|1|||
30704479|NCT00515008|58718281|FG001|Overall Study|Lost to Follow-up|0|||
30704480|NCT00515008|58718280|FG000|Overall Study|Declined|0|||
30704481|NCT00515008|58718281|FG001|Overall Study|Declined|3|||
30620094|NCT00935584|58631249|FG000|Overall Study|Death|3|||
30704482|NCT00515008|58718280|FG000|Overall Study|Left the Boston Area|1|||
30704483|NCT00515008|58718281|FG001|Overall Study|Left the Boston Area|1|||
30704484|NCT00515008|58718280|FG000|Overall Study|Scheduling conflict|1|||
30704485|NCT00515008|58718281|FG001|Overall Study|Scheduling conflict|0|||
30704486|NCT00514540|58718290|FG000|First-Line Chemo|Withdrawal by Subject|1|||
30704487|NCT00514540|58718290|FG000|First-Line Chemo|Protocol Violation|7|||
30704488|NCT00514540|58718290|FG000|Second-Line|Physician/Patient Decision|31|||
30704489|NCT00713609|58718308|FG000|Overall Study|Adverse Event|2|||
30893716|NCT02121795|58927335|FG000|Double-Blind Phase|Physician Decision|2|||
30893717|NCT02121795|58927336|FG001|Double-Blind Phase|Physician Decision|5|||
30893718|NCT02121795|58927335|FG000|Double-Blind Phase|Adverse Event|5|||
30893719|NCT02121795|58927336|FG001|Double-Blind Phase|Adverse Event|0|||
30893720|NCT02121795|58927335|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
30893721|NCT02121795|58927336|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
30893722|NCT02121795|58927335|FG000|Double-Blind Phase|Protocol Violation|0|||
30893723|NCT02121795|58927336|FG001|Double-Blind Phase|Protocol Violation|3|||
30893724|NCT02121795|58927335|FG000|Double-Blind Phase|Death|1|||
30893725|NCT02121795|58927336|FG001|Double-Blind Phase|Death|1|||
30893726|NCT02121795|58927335|FG000|Open-Label Phase|Physician Decision|8|||
30893727|NCT02121795|58927336|FG001|Open-Label Phase|Physician Decision|8|||
30893728|NCT02121795|58927335|FG000|Open-Label Phase|Withdrawal by Subject|3|||
30893729|NCT02121795|58927336|FG001|Open-Label Phase|Withdrawal by Subject|2|||
30893730|NCT02121795|58927335|FG000|Open-Label Phase|Lost to Follow-up|1|||
30893731|NCT02121795|58927336|FG001|Open-Label Phase|Lost to Follow-up|0|||
30893732|NCT02158533|58927347|FG000|Stage 1|Adverse Event|6|||
30893733|NCT02158533|58927348|FG001|Stage 1|Adverse Event|4|||
30893734|NCT02158533|58927349|FG002|Stage 1|Adverse Event|7|||
30893735|NCT02158533|58927350|FG003|Stage 1|Adverse Event|0|||
30893736|NCT02158533|58927351|FG004|Stage 1|Adverse Event|0|||
30893737|NCT02158533|58927352|FG005|Stage 1|Adverse Event|0|||
30620095|NCT00935584|58631250|FG001|Overall Study|Death|0|||
30620096|NCT00935584|58631249|FG000|Overall Study|Lost to Follow-up|8|||
30620097|NCT00935584|58631250|FG001|Overall Study|Lost to Follow-up|0|||
30620098|NCT00935584|58631249|FG000|Overall Study|No show|9|||
30893738|NCT02158533|58927347|FG000|Stage 1|Withdrawal by Subject|3|||
30893739|NCT02158533|58927348|FG001|Stage 1|Withdrawal by Subject|2|||
30893740|NCT02158533|58927349|FG002|Stage 1|Withdrawal by Subject|1|||
30893741|NCT02158533|58927350|FG003|Stage 1|Withdrawal by Subject|0|||
30893742|NCT02158533|58927351|FG004|Stage 1|Withdrawal by Subject|0|||
30893743|NCT02158533|58927352|FG005|Stage 1|Withdrawal by Subject|0|||
30893744|NCT02158533|58927347|FG000|Stage 1|Lack of Efficacy|1|||
30893745|NCT02158533|58927348|FG001|Stage 1|Lack of Efficacy|0|||
30893746|NCT02158533|58927349|FG002|Stage 1|Lack of Efficacy|0|||
30893747|NCT02158533|58927350|FG003|Stage 1|Lack of Efficacy|0|||
30893748|NCT02158533|58927351|FG004|Stage 1|Lack of Efficacy|0|||
30893749|NCT02158533|58927352|FG005|Stage 1|Lack of Efficacy|0|||
30893750|NCT02158533|58927347|FG000|Stage 1|Lost to Follow-up|3|||
30893751|NCT02158533|58927348|FG001|Stage 1|Lost to Follow-up|1|||
30893752|NCT02158533|58927349|FG002|Stage 1|Lost to Follow-up|0|||
30893753|NCT02158533|58927350|FG003|Stage 1|Lost to Follow-up|0|||
30620099|NCT00935584|58631250|FG001|Overall Study|No show|0|||
30620100|NCT00935584|58631249|FG000|Overall Study|Relocated|3|||
30620101|NCT00935584|58631250|FG001|Overall Study|Relocated|0|||
30620102|NCT00935584|58631249|FG000|Overall Study|Patient changed provider|3|||
30620103|NCT00935584|58631250|FG001|Overall Study|Patient changed provider|0|||
30620104|NCT00935584|58631249|FG000|Overall Study|Provider dropped out of study|14|||
30620105|NCT00935584|58631250|FG001|Overall Study|Provider dropped out of study|4|||
30620106|NCT01215851|58631260|FG000|Treatment Period|Adverse Event|1|||
30620107|NCT01215851|58631261|FG001|Treatment Period|Adverse Event|1|||
30620108|NCT01215851|58631262|FG002|Treatment Period|Adverse Event|1|||
30620109|NCT01215851|58631263|FG003|Treatment Period|Adverse Event|3|||
30620110|NCT01215851|58631264|FG004|Treatment Period|Adverse Event|0|||
30620111|NCT01215851|58631265|FG005|Treatment Period|Adverse Event|1|||
30620112|NCT01215851|58631260|FG000|Follow up Period|Lost to Follow-up|0|||
30620113|NCT01215851|58631261|FG001|Follow up Period|Lost to Follow-up|0|||
30620114|NCT01215851|58631262|FG002|Follow up Period|Lost to Follow-up|0|||
30620115|NCT01215851|58631263|FG003|Follow up Period|Lost to Follow-up|0|||
30620116|NCT01215851|58631264|FG004|Follow up Period|Lost to Follow-up|0|||
30620117|NCT01215851|58631265|FG005|Follow up Period|Lost to Follow-up|1|||
30620118|NCT00933166|58631280|FG000|Overall Study|Lost to Follow-up|4|||
30620119|NCT00933166|58631280|FG000|Overall Study|Lack of Efficacy|9|||
30620120|NCT00933166|58631280|FG000|Overall Study|Unavailable|4|||
30893754|NCT02158533|58927351|FG004|Stage 1|Lost to Follow-up|0|||
30893755|NCT02158533|58927352|FG005|Stage 1|Lost to Follow-up|0|||
30620121|NCT00933166|58631280|FG000|Overall Study|Withdrawal by Subject|1|||
30620122|NCT00935272|58631286|FG000|Overall Study|Lost to Follow-up|10|||
30620123|NCT00935272|58631287|FG001|Overall Study|Lost to Follow-up|3|||
30893756|NCT02158533|58927347|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
30893757|NCT02158533|58927348|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
30893758|NCT02158533|58927349|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
30893759|NCT02158533|58927350|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
30893760|NCT02158533|58927351|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
30893761|NCT02158533|58927352|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
30893762|NCT02158533|58927347|FG000|Stage 1|Non-compliance with study visits|1|||
30893763|NCT02158533|58927348|FG001|Stage 1|Non-compliance with study visits|0|||
30893764|NCT02158533|58927349|FG002|Stage 1|Non-compliance with study visits|0|||
30704490|NCT00713609|58718309|FG001|Overall Study|Adverse Event|0|||
30704491|NCT00713609|58718310|FG002|Overall Study|Adverse Event|2|||
30704492|NCT00713609|58718311|FG003|Overall Study|Adverse Event|2|||
30704493|NCT00713609|58718312|FG004|Overall Study|Adverse Event|3|||
30704494|NCT00713609|58718313|FG005|Overall Study|Adverse Event|1|||
30704495|NCT00713609|58718308|FG000|Overall Study|Lost to Follow-up|5|||
30704496|NCT00713609|58718309|FG001|Overall Study|Lost to Follow-up|7|||
30704497|NCT00713609|58718310|FG002|Overall Study|Lost to Follow-up|5|||
30704498|NCT00713609|58718311|FG003|Overall Study|Lost to Follow-up|5|||
30704499|NCT00713609|58718312|FG004|Overall Study|Lost to Follow-up|7|||
30704500|NCT00713609|58718313|FG005|Overall Study|Lost to Follow-up|0|||
30704501|NCT00713609|58718308|FG000|Overall Study|Lack of Efficacy|1|||
30704502|NCT00713609|58718309|FG001|Overall Study|Lack of Efficacy|3|||
30704503|NCT00713609|58718310|FG002|Overall Study|Lack of Efficacy|0|||
30704504|NCT00713609|58718311|FG003|Overall Study|Lack of Efficacy|0|||
30704505|NCT00713609|58718312|FG004|Overall Study|Lack of Efficacy|1|||
30704506|NCT00713609|58718313|FG005|Overall Study|Lack of Efficacy|0|||
30704507|NCT00713609|58718308|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
30704508|NCT00713609|58718309|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
30704509|NCT00713609|58718310|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
30704510|NCT00713609|58718311|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
30704511|NCT00713609|58718312|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
30704512|NCT00713609|58718313|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
30704513|NCT00713609|58718308|FG000|Overall Study|Withdrawal by Subject|6|||
30704514|NCT00713609|58718309|FG001|Overall Study|Withdrawal by Subject|1|||
30704515|NCT00713609|58718310|FG002|Overall Study|Withdrawal by Subject|5|||
30704516|NCT00713609|58718311|FG003|Overall Study|Withdrawal by Subject|1|||
30704517|NCT00713609|58718312|FG004|Overall Study|Withdrawal by Subject|5|||
30704518|NCT00713609|58718313|FG005|Overall Study|Withdrawal by Subject|7|||
30704519|NCT00713609|58718308|FG000|Overall Study|Protocol Violation|6|||
30704520|NCT00713609|58718309|FG001|Overall Study|Protocol Violation|3|||
30704521|NCT00713609|58718310|FG002|Overall Study|Protocol Violation|1|||
30704522|NCT00713609|58718311|FG003|Overall Study|Protocol Violation|1|||
30704523|NCT00713609|58718312|FG004|Overall Study|Protocol Violation|2|||
30704524|NCT00713609|58718313|FG005|Overall Study|Protocol Violation|0|||
30704525|NCT00513682|58718327|FG000|Washout Phase|Adverse Event|2|||
30704526|NCT00493012|58718336|FG000|Overall Study|Lost to Follow-up|18|||
30704527|NCT00493012|58718337|FG001|Overall Study|Lost to Follow-up|17|||
30704528|NCT05144477|58718345|FG000|Overall Study|Withdrawal by Subject|1|||
30704529|NCT05144477|58718346|FG001|Overall Study|Withdrawal by Subject|1|||
30704530|NCT00617708|58718362|FG000|Overall Study|Adverse Event|0|||
30704531|NCT00617708|58718363|FG001|Overall Study|Adverse Event|6|||
30704532|NCT00617708|58718364|FG002|Overall Study|Adverse Event|9|||
30704533|NCT00617708|58718362|FG000|Overall Study|Withdrawal by Subject|1|||
30704534|NCT00617708|58718363|FG001|Overall Study|Withdrawal by Subject|1|||
30704535|NCT00617708|58718364|FG002|Overall Study|Withdrawal by Subject|7|||
30704536|NCT00617708|58718362|FG000|Overall Study|Death|0|||
30704537|NCT00617708|58718363|FG001|Overall Study|Death|6|||
30704538|NCT00617708|58718364|FG002|Overall Study|Death|5|||
30704539|NCT00617708|58718362|FG000|Overall Study|Progression/Relapse|7|||
30704540|NCT00617708|58718363|FG001|Overall Study|Progression/Relapse|40|||
30704541|NCT00617708|58718364|FG002|Overall Study|Progression/Relapse|36|||
30704542|NCT00617708|58718362|FG000|Overall Study|Not protocol specified|1|||
30704543|NCT00617708|58718363|FG001|Overall Study|Not protocol specified|4|||
30704544|NCT00617708|58718364|FG002|Overall Study|Not protocol specified|2|||
30704545|NCT00617708|58718362|FG000|Overall Study|Not eligible|1|||
30704546|NCT00617708|58718363|FG001|Overall Study|Not eligible|3|||
30704547|NCT00617708|58718364|FG002|Overall Study|Not eligible|5|||
30704548|NCT03894969|58718379|FG000|Overall Study|Adverse Event|0|||
30704549|NCT03894969|58718380|FG001|Overall Study|Adverse Event|2|||
30704550|NCT03894969|58718381|FG002|Overall Study|Adverse Event|0|||
30704551|NCT03894969|58718382|FG003|Overall Study|Adverse Event|1|||
30704552|NCT03894969|58718383|FG004|Overall Study|Adverse Event|2|||
30704553|NCT03894969|58718379|FG000|Overall Study|Lost to Follow-up|3|||
30704554|NCT03894969|58718380|FG001|Overall Study|Lost to Follow-up|1|||
30704555|NCT03894969|58718381|FG002|Overall Study|Lost to Follow-up|1|||
30704556|NCT03894969|58718382|FG003|Overall Study|Lost to Follow-up|0|||
30704557|NCT03894969|58718383|FG004|Overall Study|Lost to Follow-up|0|||
30704558|NCT03894969|58718379|FG000|Overall Study|Withdrawal by Subject|2|||
30704559|NCT03894969|58718380|FG001|Overall Study|Withdrawal by Subject|1|||
30704560|NCT03894969|58718381|FG002|Overall Study|Withdrawal by Subject|3|||
30704561|NCT03894969|58718382|FG003|Overall Study|Withdrawal by Subject|4|||
30704562|NCT03894969|58718383|FG004|Overall Study|Withdrawal by Subject|8|||
30704563|NCT03894969|58718379|FG000|Overall Study|Other|0|||
30704564|NCT03894969|58718380|FG001|Overall Study|Other|0|||
30704565|NCT03894969|58718381|FG002|Overall Study|Other|0|||
30704566|NCT03894969|58718382|FG003|Overall Study|Other|0|||
30704567|NCT03894969|58718383|FG004|Overall Study|Other|3|||
30704568|NCT03894969|58718379|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
30704569|NCT03894969|58718380|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
30704570|NCT03894969|58718381|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
30704571|NCT03894969|58718382|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
30704572|NCT03894969|58718383|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
30704573|NCT03894969|58718379|FG000|Overall Study|Solicited Adverse Event|0|||
30704574|NCT03894969|58718380|FG001|Overall Study|Solicited Adverse Event|1|||
30704575|NCT03894969|58718381|FG002|Overall Study|Solicited Adverse Event|0|||
30704576|NCT03894969|58718382|FG003|Overall Study|Solicited Adverse Event|0|||
30704577|NCT03894969|58718383|FG004|Overall Study|Solicited Adverse Event|0|||
30704578|NCT03894813|58718399|FG000|Overall Study|Adverse Event|1|||
30704579|NCT03894813|58718400|FG001|Overall Study|Adverse Event|1|||
30704580|NCT03894813|58718399|FG000|Overall Study|Lack of Efficacy|3|||
30704581|NCT03894813|58718400|FG001|Overall Study|Lack of Efficacy|3|||
30704582|NCT03894813|58718399|FG000|Overall Study|Lost to Follow-up|1|||
30704583|NCT03894813|58718400|FG001|Overall Study|Lost to Follow-up|0|||
30704584|NCT03894813|58718399|FG000|Overall Study|Pregnancy|2|||
30704585|NCT03894813|58718400|FG001|Overall Study|Pregnancy|1|||
30704586|NCT03894813|58718399|FG000|Overall Study|Protocol Violation|3|||
30704587|NCT03894813|58718400|FG001|Overall Study|Protocol Violation|7|||
30704588|NCT03894813|58718399|FG000|Overall Study|Withdrawal by Subject|1|||
30704589|NCT03894813|58718400|FG001|Overall Study|Withdrawal by Subject|3|||
30704590|NCT03894813|58718399|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
30704591|NCT03894813|58718400|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
30704592|NCT00615992|58718406|FG000|Overall Study|Protocol Violation|67|||
30704593|NCT03892707|58718412|FG000|Overall Study|Screen failure|6|||
30704594|NCT03892707|58718413|FG001|Overall Study|Screen failure|0|||
30704595|NCT03892707|58718412|FG000|Overall Study|Pain resolution|0|||
30704596|NCT03892707|58718413|FG001|Overall Study|Pain resolution|4|||
30704597|NCT03892707|58718412|FG000|Overall Study|Withdrawal by Subject|0|||
30704598|NCT03892707|58718413|FG001|Overall Study|Withdrawal by Subject|1|||
30704599|NCT03892707|58718412|FG000|Overall Study|Other (long business trip)|0|||
30704600|NCT03892707|58718413|FG001|Overall Study|Other (long business trip)|1|||
30704601|NCT00615914|58718420|FG000|Overall Study|Adverse Event|274|||
30704602|NCT00615914|58718420|FG000|Overall Study|Death|20|||
30704603|NCT00615914|58718420|FG000|Overall Study|Lack of Efficacy|59|||
30704604|NCT00615914|58718420|FG000|Overall Study|Lost to Follow-up|187|||
30704605|NCT00615914|58718420|FG000|Overall Study|Withdrawal by Subject|16|||
30704606|NCT00615914|58718420|FG000|Overall Study|Physician Decision|4|||
30704607|NCT00615914|58718420|FG000|Overall Study|No data was collected.|65|||
30704608|NCT00615914|58718420|FG000|Overall Study|No treatment|2|||
30704609|NCT00615914|58718420|FG000|Overall Study|Irregularly enrolled patients|10|||
30704610|NCT00513604|58718430|FG000|Overall Study|Not treated|2|||
30704611|NCT00513604|58718431|FG001|Overall Study|Not treated|0|||
30704612|NCT00513604|58718432|FG002|Overall Study|Not treated|1|||
30704613|NCT00513604|58718433|FG003|Overall Study|Not treated|0|||
30704614|NCT00513604|58718434|FG004|Overall Study|Not treated|0|||
30704615|NCT00513604|58718430|FG000|Overall Study|Death during treatment|0|||
30704616|NCT00513604|58718431|FG001|Overall Study|Death during treatment|3|||
30704617|NCT00513604|58718432|FG002|Overall Study|Death during treatment|2|||
30704618|NCT00513604|58718433|FG003|Overall Study|Death during treatment|0|||
30704619|NCT00513604|58718434|FG004|Overall Study|Death during treatment|0|||
30704620|NCT00534105|58718448|FG000|Overall Study|Lost to Follow-up|23|||
30704621|NCT00534105|58718449|FG001|Overall Study|Lost to Follow-up|39|||
30704622|NCT00573248|58718464|FG000|Overall Study|scheduling conflicts|15|||
30704623|NCT00573248|58718465|FG001|Overall Study|scheduling conflicts|11|||
30704624|NCT00532935|58718473|FG000|Overall Study|Adverse Event|11|||
30704625|NCT00532935|58718474|FG001|Overall Study|Adverse Event|12|||
30704626|NCT00532935|58718473|FG000|Overall Study|Lack of Efficacy|0|||
30704627|NCT00532935|58718474|FG001|Overall Study|Lack of Efficacy|3|||
30704628|NCT00532935|58718473|FG000|Overall Study|Lost to Follow-up|10|||
30704629|NCT00532935|58718474|FG001|Overall Study|Lost to Follow-up|6|||
30704630|NCT00532935|58718473|FG000|Overall Study|Physician Decision|4|||
30704631|NCT00532935|58718474|FG001|Overall Study|Physician Decision|5|||
30704632|NCT00532935|58718473|FG000|Overall Study|Pregnancy|1|||
30704633|NCT00532935|58718474|FG001|Overall Study|Pregnancy|0|||
30704634|NCT00532935|58718473|FG000|Overall Study|Protocol Violation|4|||
30704635|NCT00532935|58718474|FG001|Overall Study|Protocol Violation|2|||
30704636|NCT00532935|58718473|FG000|Overall Study|Withdrawal by Subject|10|||
30704637|NCT00532935|58718474|FG001|Overall Study|Withdrawal by Subject|9|||
30704638|NCT00532935|58718473|FG000|Overall Study|Protocol Specific Criteria|11|||
30704639|NCT00532935|58718474|FG001|Overall Study|Protocol Specific Criteria|15|||
30704640|NCT03016312|58718482|FG000|Overall Study|Death|194|||
30704641|NCT03016312|58718483|FG001|Overall Study|Death|164|||
30704642|NCT03016312|58718482|FG000|Overall Study|Lost to Follow-up|11|||
30893765|NCT02158533|58927350|FG003|Stage 1|Non-compliance with study visits|0|||
30893766|NCT02158533|58927351|FG004|Stage 1|Non-compliance with study visits|0|||
30893767|NCT02158533|58927352|FG005|Stage 1|Non-compliance with study visits|0|||
30893768|NCT02158533|58927347|FG000|Stage 2|Adverse Event|0|||
30893769|NCT02158533|58927348|FG001|Stage 2|Adverse Event|0|||
30893770|NCT02158533|58927349|FG002|Stage 2|Adverse Event|0|||
30893771|NCT02158533|58927350|FG003|Stage 2|Adverse Event|0|||
30893772|NCT02158533|58927351|FG004|Stage 2|Adverse Event|0|||
30893773|NCT02158533|58927352|FG005|Stage 2|Adverse Event|1|||
30893774|NCT02158533|58927347|FG000|Stage 2|Lack of Efficacy|0|||
30704643|NCT03016312|58718483|FG001|Overall Study|Lost to Follow-up|12|||
30704644|NCT03016312|58718482|FG000|Overall Study|Started new therapy, loss of contact|2|||
30704645|NCT03016312|58718483|FG001|Overall Study|Started new therapy, loss of contact|1|||
30704646|NCT03016312|58718482|FG000|Overall Study|Physician Decision|0|||
30704647|NCT03016312|58718483|FG001|Overall Study|Physician Decision|2|||
30704648|NCT03016312|58718482|FG000|Overall Study|Withdrawal by Subject|34|||
30704649|NCT03016312|58718483|FG001|Overall Study|Withdrawal by Subject|39|||
30704650|NCT00512902|58718489|FG000|Overall Study|Adverse Event|7|||
30704651|NCT00512902|58718489|FG000|Overall Study|Lost to Follow-up|1|||
30704652|NCT00492232|58718495|FG000|Placebo Run-in|Adverse Event|0|||
30704653|NCT00492232|58718496|FG001|Placebo Run-in|Adverse Event|2|||
30704654|NCT00492232|58718495|FG000|Placebo Run-in|Protocol Violation|0|||
30704655|NCT00492232|58718496|FG001|Placebo Run-in|Protocol Violation|3|||
30704656|NCT00492232|58718495|FG000|Placebo Run-in|Lost to Follow-up|0|||
30704657|NCT00492232|58718496|FG001|Placebo Run-in|Lost to Follow-up|3|||
30704658|NCT00492232|58718495|FG000|Placebo Run-in|Withdrawal by Subject|0|||
30704659|NCT00492232|58718496|FG001|Placebo Run-in|Withdrawal by Subject|8|||
30704660|NCT00492232|58718495|FG000|Placebo Run-in|Pregnancy|0|||
30704661|NCT00492232|58718496|FG001|Placebo Run-in|Pregnancy|1|||
30704662|NCT00492232|58718495|FG000|Placebo Run-in|Entrance criteria not met|0|||
30704663|NCT00492232|58718496|FG001|Placebo Run-in|Entrance criteria not met|45|||
30704664|NCT00492232|58718495|FG000|Placebo Run-in|Other|0|||
30704665|NCT00492232|58718496|FG001|Placebo Run-in|Other|6|||
30704666|NCT00492232|58718495|FG000|Placebo Run-in|Missing|0|||
30704667|NCT00492232|58718496|FG001|Placebo Run-in|Missing|2|||
30704668|NCT00492232|58718495|FG000|Double-Blind Treatment|Adverse Event|1|||
30704669|NCT00492232|58718496|FG001|Double-Blind Treatment|Adverse Event|2|||
30704670|NCT00492232|58718495|FG000|Double-Blind Treatment|Protocol Violation|3|||
30704671|NCT00492232|58718496|FG001|Double-Blind Treatment|Protocol Violation|7|||
30704672|NCT00492232|58718495|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
30704673|NCT00492232|58718496|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
30704674|NCT00492232|58718495|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
30704675|NCT00492232|58718496|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
30704676|NCT00492232|58718495|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
30704677|NCT00492232|58718496|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
30704678|NCT00492232|58718495|FG000|Double-Blind Treatment|Other|6|||
30704679|NCT00492232|58718496|FG001|Double-Blind Treatment|Other|5|||
30704680|NCT00492232|58718495|FG000|Double-Blind Treatment|Randomized not treated|1|||
30704681|NCT00492232|58718496|FG001|Double-Blind Treatment|Randomized not treated|0|||
30704682|NCT00492232|58718495|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
30704683|NCT00492232|58718496|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
30704684|NCT00491764|58718508|FG000|Overall Study|Adverse Event|1|||
30704685|NCT00491764|58718509|FG001|Overall Study|Adverse Event|2|||
30704686|NCT00491764|58718510|FG002|Overall Study|Adverse Event|4|||
30704687|NCT00491764|58718511|FG003|Overall Study|Adverse Event|4|||
30704688|NCT00491764|58718512|FG004|Overall Study|Adverse Event|0|||
30704689|NCT00491764|58718513|FG005|Overall Study|Adverse Event|1|||
30704690|NCT00491764|58718508|FG000|Overall Study|Lost to Follow-up|0|||
30704691|NCT00491764|58718509|FG001|Overall Study|Lost to Follow-up|1|||
30704692|NCT00491764|58718510|FG002|Overall Study|Lost to Follow-up|0|||
30704693|NCT00491764|58718511|FG003|Overall Study|Lost to Follow-up|1|||
30704694|NCT00491764|58718512|FG004|Overall Study|Lost to Follow-up|0|||
30704695|NCT00491764|58718513|FG005|Overall Study|Lost to Follow-up|3|||
30704696|NCT00491764|58718508|FG000|Overall Study|Withdrawal by Subject|2|||
30704697|NCT00491764|58718509|FG001|Overall Study|Withdrawal by Subject|3|||
30704698|NCT00491764|58718510|FG002|Overall Study|Withdrawal by Subject|1|||
30704699|NCT00491764|58718511|FG003|Overall Study|Withdrawal by Subject|2|||
30704700|NCT00491764|58718512|FG004|Overall Study|Withdrawal by Subject|2|||
30704701|NCT00491764|58718513|FG005|Overall Study|Withdrawal by Subject|4|||
30704702|NCT00491764|58718508|FG000|Overall Study|Non Compliance with the Protocol|1|||
30704703|NCT00491764|58718509|FG001|Overall Study|Non Compliance with the Protocol|0|||
30893775|NCT02158533|58927348|FG001|Stage 2|Lack of Efficacy|0|||
30893776|NCT02158533|58927349|FG002|Stage 2|Lack of Efficacy|0|||
30893777|NCT02158533|58927350|FG003|Stage 2|Lack of Efficacy|0|||
30704704|NCT00491764|58718510|FG002|Overall Study|Non Compliance with the Protocol|0|||
30704705|NCT00491764|58718511|FG003|Overall Study|Non Compliance with the Protocol|0|||
30704706|NCT00491764|58718512|FG004|Overall Study|Non Compliance with the Protocol|0|||
30893778|NCT02158533|58927351|FG004|Stage 2|Lack of Efficacy|1|||
30893779|NCT02158533|58927352|FG005|Stage 2|Lack of Efficacy|0|||
30704707|NCT00491764|58718513|FG005|Overall Study|Non Compliance with the Protocol|0|||
30704708|NCT00491764|58718508|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
30704709|NCT00491764|58718509|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
30704710|NCT00491764|58718510|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
30704711|NCT00491764|58718511|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
30704712|NCT00491764|58718512|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
30704713|NCT00491764|58718513|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
30704714|NCT00491764|58718508|FG000|Overall Study|Administrative|1|||
30704715|NCT00491764|58718509|FG001|Overall Study|Administrative|0|||
30704716|NCT00491764|58718510|FG002|Overall Study|Administrative|2|||
30704717|NCT00491764|58718511|FG003|Overall Study|Administrative|1|||
30704718|NCT00491764|58718512|FG004|Overall Study|Administrative|0|||
30704719|NCT00491764|58718513|FG005|Overall Study|Administrative|0|||
30704720|NCT00491608|58718527|FG000|Overall Study|Death|2|||
30704721|NCT00491608|58718527|FG000|Overall Study|Withdrawal by Subject|1|||
30704722|NCT00615836|58718535|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
30704723|NCT00615836|58718536|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
30704724|NCT00615836|58718537|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
30704725|NCT00615836|58718538|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
30704726|NCT00615836|58718539|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
30704727|NCT00615836|58718535|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
30704728|NCT00615836|58718536|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
30704729|NCT00615836|58718537|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
30620124|NCT00935272|58631286|FG000|Overall Study|Withdrawal by Subject|8|||
30704730|NCT00615836|58718538|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
30704731|NCT00615836|58718539|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
30704732|NCT00615836|58718535|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
30704733|NCT00615836|58718536|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
30704734|NCT00615836|58718537|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
30704735|NCT00615836|58718538|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
30704736|NCT00615836|58718539|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
30704737|NCT00615836|58718535|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
30704738|NCT00615836|58718536|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
30704739|NCT00615836|58718537|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
30704740|NCT00615836|58718538|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
30704741|NCT00615836|58718539|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
30704742|NCT00615836|58718535|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
30704743|NCT00615836|58718536|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
30704744|NCT00615836|58718537|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
30704745|NCT00615836|58718538|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
30704746|NCT00615836|58718539|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
30704747|NCT00615836|58718535|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
30620125|NCT00935272|58631287|FG001|Overall Study|Withdrawal by Subject|2|||
30620126|NCT00935272|58631286|FG000|Overall Study|Physician Decision|1|||
30620127|NCT00935272|58631287|FG001|Overall Study|Physician Decision|0|||
30620128|NCT00935272|58631286|FG000|Overall Study|Protocol Violation|0|||
30620129|NCT00935272|58631287|FG001|Overall Study|Protocol Violation|1|||
30620130|NCT01010061|58631296|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
30620131|NCT01010061|58631297|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
30620132|NCT01010061|58631296|FG000|Overall Study|Disease Progression|2|||
30620133|NCT01010061|58631297|FG001|Overall Study|Disease Progression|8|||
30704748|NCT00615836|58718536|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
30704749|NCT00615836|58718537|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
30704750|NCT00615836|58718538|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
30704751|NCT00615836|58718539|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
30704752|NCT00615836|58718535|FG000|Extension Study (FE992026 CS31)|Other|10|||
30704753|NCT00615836|58718536|FG001|Extension Study (FE992026 CS31)|Other|7|||
30704754|NCT00615836|58718537|FG002|Extension Study (FE992026 CS31)|Other|8|||
30704755|NCT00615836|58718538|FG003|Extension Study (FE992026 CS31)|Other|8|||
30704756|NCT00615836|58718539|FG004|Extension Study (FE992026 CS31)|Other|0|||
30704757|NCT00615836|58718535|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
30704758|NCT00615836|58718536|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
30704759|NCT00615836|58718537|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
30704760|NCT00615836|58718538|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
30704761|NCT00615836|58718539|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
30704762|NCT00615836|58718535|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
30704763|NCT00615836|58718536|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
30704764|NCT00615836|58718537|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
30704765|NCT00615836|58718538|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
30704766|NCT00615836|58718539|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
30704767|NCT00491530|58718558|FG000|Overall Study|Adverse Event|6|||
30704768|NCT00491530|58718559|FG001|Overall Study|Adverse Event|1|||
30704769|NCT00491530|58718560|FG002|Overall Study|Adverse Event|2|||
30704770|NCT00491530|58718558|FG000|Overall Study|Withdrawal by Subject|3|||
30704771|NCT00491530|58718559|FG001|Overall Study|Withdrawal by Subject|0|||
30704772|NCT00491530|58718560|FG002|Overall Study|Withdrawal by Subject|0|||
30704773|NCT00491530|58718558|FG000|Overall Study|Lost to Follow-up|3|||
30704774|NCT00491530|58718559|FG001|Overall Study|Lost to Follow-up|2|||
30704775|NCT00491530|58718560|FG002|Overall Study|Lost to Follow-up|2|||
30704776|NCT00491530|58718558|FG000|Overall Study|Lack of Efficacy|0|||
30704777|NCT00491530|58718559|FG001|Overall Study|Lack of Efficacy|1|||
30704778|NCT00491530|58718560|FG002|Overall Study|Lack of Efficacy|0|||
30704779|NCT00491530|58718558|FG000|Overall Study|Investigator Discretion|0|||
30704780|NCT00491530|58718559|FG001|Overall Study|Investigator Discretion|1|||
30704781|NCT00491530|58718560|FG002|Overall Study|Investigator Discretion|0|||
30704782|NCT00491530|58718558|FG000|Overall Study|Patient Request|0|||
30704783|NCT00491530|58718559|FG001|Overall Study|Patient Request|1|||
30704784|NCT00491530|58718560|FG002|Overall Study|Patient Request|0|||
30704785|NCT00491530|58718558|FG000|Overall Study|Use of Prohibited Medication|0|||
30704786|NCT00491530|58718559|FG001|Overall Study|Use of Prohibited Medication|0|||
30704787|NCT00491530|58718560|FG002|Overall Study|Use of Prohibited Medication|1|||
30704788|NCT00617240|58718570|FG000|Overall Study|Lack of Efficacy|1|||
30704789|NCT00617240|58718571|FG001|Overall Study|Lack of Efficacy|0|||
30704790|NCT00615290|58718577|FG000|Overall Study|Adverse Event|2|||
30704791|NCT00615290|58718577|FG000|Overall Study|Lost to Follow-up|3|||
30704792|NCT00615290|58718577|FG000|Overall Study|Withdrawal by Subject|1|||
30704793|NCT00615290|58718577|FG000|Overall Study|Other|2|||
30704794|NCT00501046|58718583|FG000|Overall Study|Adverse Event|21|||
30704795|NCT00501046|58718584|FG001|Overall Study|Adverse Event|25|||
30704796|NCT00501046|58718583|FG000|Overall Study|Death|23|||
30704797|NCT00501046|58718584|FG001|Overall Study|Death|30|||
30704798|NCT00501046|58718583|FG000|Overall Study|Lost to Follow-up|14|||
30704799|NCT00501046|58718584|FG001|Overall Study|Lost to Follow-up|13|||
30704800|NCT00501046|58718583|FG000|Overall Study|Physician Decision|7|||
30704801|NCT00501046|58718584|FG001|Overall Study|Physician Decision|2|||
30704802|NCT00501046|58718583|FG000|Overall Study|Pregnancy|0|||
30704803|NCT00501046|58718584|FG001|Overall Study|Pregnancy|3|||
30704804|NCT00501046|58718583|FG000|Overall Study|Protocol Violation|2|||
30704805|NCT00501046|58718584|FG001|Overall Study|Protocol Violation|1|||
30704806|NCT00501046|58718583|FG000|Overall Study|Withdrawal by Subject|84|||
30704807|NCT00501046|58718584|FG001|Overall Study|Withdrawal by Subject|83|||
30704808|NCT00501046|58718583|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
30704809|NCT00501046|58718584|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
30704810|NCT00533949|58718594|FG000|Overall Study|Protocol Violation|12|||
30704811|NCT00533949|58718595|FG001|Overall Study|Protocol Violation|12|||
30704812|NCT00533949|58718596|FG002|Overall Study|Protocol Violation|9|||
30704813|NCT00533949|58718597|FG003|Overall Study|Protocol Violation|9|||
30704814|NCT00533949|58718594|FG000|Overall Study|Withdrawal by Subject|3|||
30704815|NCT00533949|58718595|FG001|Overall Study|Withdrawal by Subject|2|||
30704816|NCT00533949|58718596|FG002|Overall Study|Withdrawal by Subject|1|||
30704817|NCT00533949|58718597|FG003|Overall Study|Withdrawal by Subject|1|||
30704818|NCT00485134|58718623|FG000|Overall Study|Lost to Follow-up|1|||
30704819|NCT00485134|58718624|FG001|Overall Study|Lost to Follow-up|0|||
30704820|NCT00485134|58718625|FG002|Overall Study|Lost to Follow-up|0|||
30704821|NCT00485134|58718626|FG003|Overall Study|Lost to Follow-up|0|||
30704822|NCT00485134|58718627|FG004|Overall Study|Lost to Follow-up|0|||
30704823|NCT00485134|58718628|FG005|Overall Study|Lost to Follow-up|0|||
30704824|NCT00485134|58718629|FG006|Overall Study|Lost to Follow-up|0|||
30704825|NCT00485134|58718630|FG007|Overall Study|Lost to Follow-up|0|||
30704826|NCT00485134|58718623|FG000|Overall Study|Withdrawal by Subject|0|||
30893780|NCT02158533|58927347|FG000|Stage 2|Lost to Follow-up|0|||
30893781|NCT02158533|58927348|FG001|Stage 2|Lost to Follow-up|0|||
30893782|NCT02158533|58927349|FG002|Stage 2|Lost to Follow-up|0|||
30893783|NCT02158533|58927350|FG003|Stage 2|Lost to Follow-up|1|||
30893784|NCT02158533|58927351|FG004|Stage 2|Lost to Follow-up|1|||
30704827|NCT00485134|58718624|FG001|Overall Study|Withdrawal by Subject|1|||
30704828|NCT00485134|58718625|FG002|Overall Study|Withdrawal by Subject|0|||
30704829|NCT00485134|58718626|FG003|Overall Study|Withdrawal by Subject|0|||
30704830|NCT00485134|58718627|FG004|Overall Study|Withdrawal by Subject|0|||
30704831|NCT00485134|58718628|FG005|Overall Study|Withdrawal by Subject|0|||
30704832|NCT00485134|58718629|FG006|Overall Study|Withdrawal by Subject|0|||
30704833|NCT00485134|58718630|FG007|Overall Study|Withdrawal by Subject|0|||
30704834|NCT00485134|58718623|FG000|Overall Study|Change in health status|0|||
30704835|NCT00485134|58718624|FG001|Overall Study|Change in health status|1|||
30704836|NCT00485134|58718625|FG002|Overall Study|Change in health status|2|||
30704837|NCT00485134|58718626|FG003|Overall Study|Change in health status|1|||
30704838|NCT00485134|58718627|FG004|Overall Study|Change in health status|0|||
30704839|NCT00485134|58718628|FG005|Overall Study|Change in health status|1|||
30704840|NCT00485134|58718629|FG006|Overall Study|Change in health status|0|||
30893785|NCT02158533|58927352|FG005|Stage 2|Lost to Follow-up|2|||
30893786|NCT02158533|58927347|FG000|Stage 2|Withdrawal by Subject|0|||
30893787|NCT02158533|58927348|FG001|Stage 2|Withdrawal by Subject|0|||
30704841|NCT00485134|58718630|FG007|Overall Study|Change in health status|0|||
30704842|NCT00485134|58718623|FG000|Overall Study|Withdrew for adverse event|0|||
30893788|NCT02158533|58927349|FG002|Stage 2|Withdrawal by Subject|0|||
30704843|NCT00485134|58718624|FG001|Overall Study|Withdrew for adverse event|0|||
30704844|NCT00485134|58718625|FG002|Overall Study|Withdrew for adverse event|1|||
30704845|NCT00485134|58718626|FG003|Overall Study|Withdrew for adverse event|0|||
30704846|NCT00485134|58718627|FG004|Overall Study|Withdrew for adverse event|0|||
30704847|NCT00485134|58718628|FG005|Overall Study|Withdrew for adverse event|0|||
30704848|NCT00485134|58718629|FG006|Overall Study|Withdrew for adverse event|0|||
30704849|NCT00485134|58718630|FG007|Overall Study|Withdrew for adverse event|0|||
30704850|NCT00485134|58718623|FG000|Overall Study|Positive drug test|0|||
30704851|NCT00485134|58718624|FG001|Overall Study|Positive drug test|0|||
30704852|NCT00485134|58718625|FG002|Overall Study|Positive drug test|0|||
30704853|NCT00485134|58718626|FG003|Overall Study|Positive drug test|0|||
30704854|NCT00485134|58718627|FG004|Overall Study|Positive drug test|2|||
30704855|NCT00485134|58718628|FG005|Overall Study|Positive drug test|1|||
30704856|NCT00485134|58718629|FG006|Overall Study|Positive drug test|0|||
30704857|NCT00485134|58718630|FG007|Overall Study|Positive drug test|0|||
30704858|NCT00485134|58718623|FG000|Overall Study|Non-compliance|0|||
30704859|NCT00485134|58718624|FG001|Overall Study|Non-compliance|0|||
30704860|NCT00485134|58718625|FG002|Overall Study|Non-compliance|0|||
30704861|NCT00485134|58718626|FG003|Overall Study|Non-compliance|0|||
30704862|NCT00485134|58718627|FG004|Overall Study|Non-compliance|1|||
30704863|NCT00485134|58718628|FG005|Overall Study|Non-compliance|2|||
30704864|NCT00485134|58718629|FG006|Overall Study|Non-compliance|2|||
30704865|NCT00485134|58718630|FG007|Overall Study|Non-compliance|0|||
30704866|NCT00485134|58718623|FG000|Overall Study|Unable to comply with study schedule|0|||
30704867|NCT00485134|58718624|FG001|Overall Study|Unable to comply with study schedule|0|||
30704868|NCT00485134|58718625|FG002|Overall Study|Unable to comply with study schedule|0|||
30704869|NCT00485134|58718626|FG003|Overall Study|Unable to comply with study schedule|0|||
30704870|NCT00485134|58718627|FG004|Overall Study|Unable to comply with study schedule|0|||
30704871|NCT00485134|58718628|FG005|Overall Study|Unable to comply with study schedule|0|||
30704872|NCT00485134|58718629|FG006|Overall Study|Unable to comply with study schedule|0|||
30704873|NCT00485134|58718630|FG007|Overall Study|Unable to comply with study schedule|1|||
30893789|NCT02158533|58927350|FG003|Stage 2|Withdrawal by Subject|0|||
30893790|NCT02158533|58927351|FG004|Stage 2|Withdrawal by Subject|1|||
30704874|NCT00485134|58718623|FG000|Overall Study|Pregnancy|0|||
30704875|NCT00485134|58718624|FG001|Overall Study|Pregnancy|0|||
30704876|NCT00485134|58718625|FG002|Overall Study|Pregnancy|0|||
30704877|NCT00485134|58718626|FG003|Overall Study|Pregnancy|0|||
30704878|NCT00485134|58718627|FG004|Overall Study|Pregnancy|0|||
30704879|NCT00485134|58718628|FG005|Overall Study|Pregnancy|0|||
30704880|NCT00485134|58718629|FG006|Overall Study|Pregnancy|1|||
30704881|NCT00485134|58718630|FG007|Overall Study|Pregnancy|0|||
30704882|NCT03890367|58718645|FG000|Overall Study|Withdrawal by parent/guardian|1|||
30704883|NCT03890367|58718646|FG001|Overall Study|Withdrawal by parent/guardian|3|||
30704884|NCT03890367|58718647|FG002|Overall Study|Withdrawal by parent/guardian|0|||
30704885|NCT03890367|58718645|FG000|Overall Study|Protocol deviation|2|||
30704886|NCT03890367|58718646|FG001|Overall Study|Protocol deviation|2|||
30704887|NCT03890367|58718647|FG002|Overall Study|Protocol deviation|1|||
30704888|NCT03890367|58718645|FG000|Overall Study|Lost to Follow-up|1|||
30704889|NCT03890367|58718646|FG001|Overall Study|Lost to Follow-up|1|||
30704890|NCT03890367|58718647|FG002|Overall Study|Lost to Follow-up|0|||
30704891|NCT00583115|58718655|FG000|Overall Study|Death|1|||
30704892|NCT00532779|58718662|FG000|Overall Study|Adverse Event|122|||
30704893|NCT00532779|58718663|FG001|Overall Study|Adverse Event|112|||
30704894|NCT00532779|58718664|FG002|Overall Study|Adverse Event|56|||
30704895|NCT00532779|58718662|FG000|Overall Study|Lost to Follow-up|76|||
30704896|NCT00532779|58718663|FG001|Overall Study|Lost to Follow-up|65|||
30704897|NCT00532779|58718664|FG002|Overall Study|Lost to Follow-up|66|||
30704898|NCT00532779|58718662|FG000|Overall Study|Withdrawal by Subject|63|||
30704899|NCT00532779|58718663|FG001|Overall Study|Withdrawal by Subject|60|||
30704900|NCT00532779|58718664|FG002|Overall Study|Withdrawal by Subject|90|||
30704901|NCT00532779|58718662|FG000|Overall Study|Lack of Efficacy|12|||
30704902|NCT00532779|58718663|FG001|Overall Study|Lack of Efficacy|12|||
30704903|NCT00532779|58718664|FG002|Overall Study|Lack of Efficacy|40|||
30704904|NCT00532779|58718662|FG000|Overall Study|Protocol Violation|5|||
30704905|NCT00532779|58718663|FG001|Overall Study|Protocol Violation|9|||
30893791|NCT02158533|58927352|FG005|Stage 2|Withdrawal by Subject|2|||
30704906|NCT00532779|58718664|FG002|Overall Study|Protocol Violation|7|||
30704907|NCT00532779|58718662|FG000|Overall Study|Pregnancy|2|||
30704908|NCT00532779|58718663|FG001|Overall Study|Pregnancy|5|||
30704909|NCT00532779|58718664|FG002|Overall Study|Pregnancy|3|||
30893792|NCT02158533|58927347|FG000|Stage 2|Physician Decision|0|||
30704910|NCT00532779|58718662|FG000|Overall Study|Death|0|||
30704911|NCT00532779|58718663|FG001|Overall Study|Death|1|||
30704912|NCT00532779|58718664|FG002|Overall Study|Death|0|||
30704913|NCT00532779|58718662|FG000|Overall Study|Drug noncompliance, moved, other|14|||
30704914|NCT00532779|58718663|FG001|Overall Study|Drug noncompliance, moved, other|23|||
30704915|NCT00532779|58718664|FG002|Overall Study|Drug noncompliance, moved, other|29|||
30893793|NCT02158533|58927348|FG001|Stage 2|Physician Decision|0|||
30704916|NCT00500266|58718672|FG000|Overall Study|Death|3|||
30704917|NCT00500266|58718672|FG000|Overall Study|Lost to Follow-up|3|||
30704918|NCT00500266|58718672|FG000|Overall Study|Withdrawal by Subject|3|||
30704919|NCT00500266|58718672|FG000|Overall Study|Assigned, not treated|4|||
30704920|NCT00500110|58718677|FG000|Overall Study|Withdrawal by Subject|3|||
30704921|NCT00534495|58718683|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
30704922|NCT00534495|58718684|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
30704923|NCT00534495|58718685|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
30704924|NCT00534495|58718683|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
30704925|NCT00534495|58718684|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
30704926|NCT00534495|58718685|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
30704927|NCT00534495|58718683|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
30704928|NCT00534495|58718684|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
30704929|NCT00534495|58718685|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
30704930|NCT00534495|58718683|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
30704931|NCT00534495|58718684|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
30704932|NCT00534495|58718685|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
30704933|NCT00534495|58718683|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
30704934|NCT00534495|58718684|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
30704935|NCT00534495|58718685|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
30704936|NCT00534495|58718683|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
30704937|NCT00534495|58718684|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
30893794|NCT02158533|58927349|FG002|Stage 2|Physician Decision|0|||
30893795|NCT02158533|58927350|FG003|Stage 2|Physician Decision|0|||
30893796|NCT02158533|58927351|FG004|Stage 2|Physician Decision|1|||
30893797|NCT02158533|58927352|FG005|Stage 2|Physician Decision|0|||
30893798|NCT02158533|58927347|FG000|Stage 2|Pregnancy|0|||
30893799|NCT02158533|58927348|FG001|Stage 2|Pregnancy|0|||
30893800|NCT02158533|58927349|FG002|Stage 2|Pregnancy|0|||
30893801|NCT02158533|58927350|FG003|Stage 2|Pregnancy|1|||
30893802|NCT02158533|58927351|FG004|Stage 2|Pregnancy|0|||
30893803|NCT02158533|58927352|FG005|Stage 2|Pregnancy|0|||
30893804|NCT02158533|58927347|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
30893805|NCT02158533|58927348|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
30893806|NCT02158533|58927349|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
30893807|NCT02158533|58927350|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
30893808|NCT02158533|58927351|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
30893809|NCT02158533|58927352|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
30893810|NCT02158533|58927347|FG000|Stage 2|Non-adherence with study visits|0|||
30893811|NCT02158533|58927348|FG001|Stage 2|Non-adherence with study visits|0|||
30893812|NCT02158533|58927349|FG002|Stage 2|Non-adherence with study visits|0|||
30893813|NCT02158533|58927350|FG003|Stage 2|Non-adherence with study visits|0|||
30893814|NCT02158533|58927351|FG004|Stage 2|Non-adherence with study visits|0|||
30893815|NCT02158533|58927352|FG005|Stage 2|Non-adherence with study visits|1|||
30893816|NCT02120781|58927368|FG000|Overall Study|Physician Decision|2|||
30893817|NCT02120781|58927369|FG001|Overall Study|Physician Decision|0|||
30893818|NCT02120781|58927368|FG000|Overall Study|Completion not documented|2|||
30893819|NCT02120781|58927369|FG001|Overall Study|Completion not documented|1|||
30893820|NCT02120625|58927375|FG000|Overall Study|Physician Decision|2|||
30893821|NCT02120469|58927382|FG000|Overall Study|HER-2/neu-amplified|1|||
30893822|NCT02120469|58927383|FG001|Overall Study|HER-2/neu-amplified|0|||
30893823|NCT02120469|58927384|FG002|Overall Study|HER-2/neu-amplified|1|||
30893824|NCT02157519|58927397|FG000|Overall Study|Death|3|||
30893825|NCT02157519|58927398|FG001|Overall Study|Death|1|||
30893826|NCT02157519|58927397|FG000|Overall Study|Withdrawal by Subject|7|||
30704938|NCT00534495|58718685|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
30704939|NCT00534495|58718683|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
30704940|NCT00534495|58718684|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
30704941|NCT00534495|58718685|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
30704942|NCT00534495|58718683|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
30704943|NCT00534495|58718684|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
30704944|NCT00534495|58718685|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
30704945|NCT00534495|58718683|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
30704946|NCT00534495|58718684|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
30704947|NCT00534495|58718685|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
30704948|NCT00484198|58718709|FG000|Overall Study|Participant Withdrew Consent|12|||
30704949|NCT00484198|58718710|FG001|Overall Study|Participant Withdrew Consent|21|||
30704950|NCT00484198|58718711|FG002|Overall Study|Participant Withdrew Consent|47|||
30704951|NCT00484198|58718712|FG003|Overall Study|Participant Withdrew Consent|59|||
30704952|NCT00484198|58718709|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
30704953|NCT00484198|58718710|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
30704954|NCT00484198|58718711|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
30704955|NCT00484198|58718712|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
30704956|NCT00484198|58718709|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
30704957|NCT00484198|58718710|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
30704958|NCT00484198|58718711|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
30704959|NCT00484198|58718712|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
30704960|NCT00484198|58718709|FG000|Overall Study|Adverse Event|3|||
30704961|NCT00484198|58718710|FG001|Overall Study|Adverse Event|11|||
30704962|NCT00484198|58718711|FG002|Overall Study|Adverse Event|32|||
30704963|NCT00484198|58718712|FG003|Overall Study|Adverse Event|31|||
30704964|NCT00484198|58718709|FG000|Overall Study|Protocol Violation|0|||
30704965|NCT00484198|58718710|FG001|Overall Study|Protocol Violation|5|||
30704966|NCT00484198|58718711|FG002|Overall Study|Protocol Violation|6|||
30704967|NCT00484198|58718712|FG003|Overall Study|Protocol Violation|8|||
30704968|NCT00484198|58718709|FG000|Overall Study|Other|7|||
30704969|NCT00484198|58718710|FG001|Overall Study|Other|10|||
30704970|NCT00484198|58718711|FG002|Overall Study|Other|31|||
30704971|NCT00484198|58718712|FG003|Overall Study|Other|28|||
30704972|NCT00499486|58718727|FG000|Overall Study|Withdrawal by Subject|16|||
30704973|NCT00499252|58718731|FG000|Overall Study|Adverse Event|3|||
30704974|NCT00499252|58718731|FG000|Overall Study|Refused further treatment|2|||
30704975|NCT00499252|58718731|FG000|Overall Study|Ineligible|4|||
30893827|NCT02157519|58927398|FG001|Overall Study|Withdrawal by Subject|0|||
30893828|NCT02157519|58927397|FG000|Overall Study|Lost to Follow-up|1|||
30893829|NCT02157519|58927398|FG001|Overall Study|Lost to Follow-up|0|||
30704976|NCT00499252|58718731|FG000|Overall Study|<no further label>|3|||
30704977|NCT00499174|58718741|FG000|Overall Study|Physician Decision|78|||
30704978|NCT00499174|58718742|FG001|Overall Study|Physician Decision|9|||
30704979|NCT03775421|58718750|FG000|Overall Study|Lost to Follow-up|2|||
30704980|NCT03775421|58718750|FG000|Overall Study|Withdrawal by Subject|10|||
30704981|NCT03775421|58718750|FG000|Overall Study|Physician Decision|3|||
30704982|NCT03775421|58718750|FG000|Overall Study|Death|1|||
30704983|NCT03775421|58718750|FG000|Overall Study|Study Terminated by Sponsor|94|||
30704984|NCT00532155|58718756|FG000|Overall Study|Adverse Event|66|||
30704985|NCT00532155|58718757|FG001|Overall Study|Adverse Event|123|||
30704986|NCT00532155|58718756|FG000|Overall Study|Lack of Efficacy|332|||
30704987|NCT00532155|58718757|FG001|Overall Study|Lack of Efficacy|255|||
30704988|NCT00532155|58718756|FG000|Overall Study|Protocol Violation|1|||
30704989|NCT00532155|58718757|FG001|Overall Study|Protocol Violation|3|||
30704990|NCT00532155|58718756|FG000|Overall Study|Lost to Follow-up|2|||
30704991|NCT00532155|58718757|FG001|Overall Study|Lost to Follow-up|0|||
30704992|NCT00532155|58718756|FG000|Overall Study|Physician Decision|16|||
30704993|NCT00532155|58718757|FG001|Overall Study|Physician Decision|15|||
30704994|NCT00532155|58718756|FG000|Overall Study|Withdrawal by Subject|23|||
30704995|NCT00532155|58718757|FG001|Overall Study|Withdrawal by Subject|44|||
30704996|NCT00532155|58718756|FG000|Overall Study|Consent withdrawn|5|||
30704997|NCT00532155|58718757|FG001|Overall Study|Consent withdrawn|7|||
30704998|NCT00532155|58718756|FG000|Overall Study|Moved|1|||
30704999|NCT00532155|58718757|FG001|Overall Study|Moved|0|||
30705000|NCT00532155|58718756|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
30705001|NCT00532155|58718757|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
30705002|NCT00532155|58718756|FG000|Overall Study|Occurence of a second cancer|0|||
30705003|NCT00532155|58718757|FG001|Overall Study|Occurence of a second cancer|1|||
30705004|NCT00532155|58718756|FG000|Overall Study|Occurence of a secondary cancer|0|||
30620134|NCT01010061|58631296|FG000|Overall Study|Withdrew Consent|5|||
30620135|NCT01010061|58631297|FG001|Overall Study|Withdrew Consent|1|||
30620136|NCT01010061|58631296|FG000|Overall Study|Death|3|||
30620137|NCT01010061|58631297|FG001|Overall Study|Death|6|||
30620138|NCT01010061|58631296|FG000|Overall Study|Administrative/Other|0|||
30620139|NCT01010061|58631297|FG001|Overall Study|Administrative/Other|1|||
30705005|NCT00532155|58718757|FG001|Overall Study|Occurence of a secondary cancer|1|||
30705006|NCT00532155|58718756|FG000|Overall Study|Promotor ended study|1|||
30705007|NCT00532155|58718757|FG001|Overall Study|Promotor ended study|0|||
30705008|NCT00532155|58718756|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
30705009|NCT00532155|58718757|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
30705010|NCT00532155|58718756|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
30705011|NCT00532155|58718757|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
30705012|NCT00532155|58718756|FG000|Overall Study|Study stopped|1|||
30705013|NCT00532155|58718757|FG001|Overall Study|Study stopped|0|||
30705014|NCT00532155|58718756|FG000|Overall Study|Study terminated by sponsor|1|||
30705015|NCT00532155|58718757|FG001|Overall Study|Study terminated by sponsor|0|||
30705016|NCT00532155|58718756|FG000|Overall Study|Study termination stop further treatment|4|||
30705017|NCT00532155|58718757|FG001|Overall Study|Study termination stop further treatment|0|||
30705018|NCT00532155|58718756|FG000|Overall Study|Did not receive study medication|2|||
30705019|NCT00532155|58718757|FG001|Overall Study|Did not receive study medication|6|||
30705020|NCT00205777|58718767|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
30705021|NCT00205777|58718768|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
30705022|NCT00205777|58718769|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
30705023|NCT00205777|58718770|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
30893830|NCT02180061|58927406|FG000|Overall Study|Adverse Event|4|||
30893831|NCT02180061|58927407|FG001|Overall Study|Adverse Event|2|||
30893832|NCT02180061|58927406|FG000|Overall Study|Clinical Progression|5|||
30893833|NCT02180061|58927407|FG001|Overall Study|Clinical Progression|1|||
30893834|NCT02180061|58927406|FG000|Overall Study|Progressive Disease|15|||
30620140|NCT01010061|58631296|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
30620141|NCT01010061|58631297|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
30620142|NCT01010061|58631296|FG000|Overall Study|Insufficient Therapeutic Response|1|||
30620143|NCT01010061|58631297|FG001|Overall Study|Insufficient Therapeutic Response|5|||
30620144|NCT01010061|58631296|FG000|Overall Study|Violation of Selection Criteria|0|||
30620145|NCT01010061|58631297|FG001|Overall Study|Violation of Selection Criteria|1|||
30620146|NCT01010061|58631296|FG000|Overall Study|Did Not Receive Treatment|2|||
30620147|NCT01010061|58631297|FG001|Overall Study|Did Not Receive Treatment|2|||
30620148|NCT00929734|58631317|FG000|Overall Study|Lost to Follow-up|2|||
30620149|NCT00929734|58631318|FG001|Overall Study|Lost to Follow-up|1|||
30620150|NCT00929734|58631317|FG000|Overall Study|Withdrawal by Subject|0|||
30705024|NCT00205777|58718771|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
30705025|NCT00205777|58718772|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
30705026|NCT00205777|58718767|FG000|Core Study (Up to 3 Years)|Death|9|||
30705027|NCT00205777|58718768|FG001|Core Study (Up to 3 Years)|Death|7|||
30705028|NCT00205777|58718769|FG002|Core Study (Up to 3 Years)|Death|14|||
30705029|NCT00205777|58718770|FG003|Core Study (Up to 3 Years)|Death|7|||
30893835|NCT02180061|58927407|FG001|Overall Study|Progressive Disease|5|||
30893836|NCT02180061|58927406|FG000|Overall Study|Physician Decision|1|||
30893837|NCT02180061|58927407|FG001|Overall Study|Physician Decision|0|||
30893838|NCT02179515|58927416|FG000|Overall Study|switched to alternative treatment|0|||
30893839|NCT02179515|58927417|FG001|Overall Study|switched to alternative treatment|1|||
30893840|NCT02179515|58927418|FG002|Overall Study|switched to alternative treatment|1|||
30893841|NCT02179515|58927416|FG000|Overall Study|Death|0|||
30893842|NCT02179515|58927417|FG001|Overall Study|Death|1|||
30893843|NCT02179515|58927418|FG002|Overall Study|Death|1|||
30893844|NCT02179515|58927416|FG000|Overall Study|refused further treatment|0|||
30893845|NCT02179515|58927417|FG001|Overall Study|refused further treatment|3|||
30893846|NCT02179515|58927418|FG002|Overall Study|refused further treatment|4|||
30893847|NCT02179515|58927416|FG000|Overall Study|Disease progression on study|2|||
30893848|NCT02179515|58927417|FG001|Overall Study|Disease progression on study|11|||
30893849|NCT02179515|58927418|FG002|Overall Study|Disease progression on study|8|||
30893850|NCT02120157|58927430|FG000|Overall Study|Death|8|||
30893851|NCT02119299|58927436|FG000|Overall Study|Withdrawal by Subject|7|||
30893852|NCT02119299|58927436|FG000|Overall Study|Lack of Efficacy|1|||
30893853|NCT02119299|58927436|FG000|Overall Study|Pregnancy|1|||
30893854|NCT02156271|58927442|FG000|Overall Study|Physician Decision|4|||
30893855|NCT02156271|58927443|FG001|Overall Study|Physician Decision|3|||
30893856|NCT01365455|58927452|FG000|Induction Period|Adverse Event|5|||
30893857|NCT01365455|58927453|FG001|Induction Period|Adverse Event|3|||
30893858|NCT01365455|58927454|FG002|Induction Period|Adverse Event|4|||
30893859|NCT01365455|58927455|FG003|Induction Period|Adverse Event|0|||
30893860|NCT01365455|58927456|FG004|Induction Period|Adverse Event|0|||
30893861|NCT01365455|58927452|FG000|Induction Period|Lack of Efficacy|1|||
30893862|NCT01365455|58927453|FG001|Induction Period|Lack of Efficacy|1|||
30893863|NCT01365455|58927454|FG002|Induction Period|Lack of Efficacy|0|||
30893864|NCT01365455|58927455|FG003|Induction Period|Lack of Efficacy|0|||
30893865|NCT01365455|58927456|FG004|Induction Period|Lack of Efficacy|0|||
30893866|NCT01365455|58927452|FG000|Induction Period|Pregnancy|0|||
30705030|NCT00205777|58718771|FG004|Core Study (Up to 3 Years)|Death|0|||
30705031|NCT00205777|58718772|FG005|Core Study (Up to 3 Years)|Death|0|||
30705032|NCT00205777|58718767|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
30705033|NCT00205777|58718768|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
30705034|NCT00205777|58718769|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
30705035|NCT00205777|58718770|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
30705036|NCT00205777|58718771|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
30705037|NCT00205777|58718772|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
30705038|NCT00205777|58718767|FG000|Core Study (Up to 3 Years)|Other Event|49|||
30705039|NCT00205777|58718768|FG001|Core Study (Up to 3 Years)|Other Event|52|||
30705040|NCT00205777|58718769|FG002|Core Study (Up to 3 Years)|Other Event|41|||
30705041|NCT00205777|58718770|FG003|Core Study (Up to 3 Years)|Other Event|58|||
30705042|NCT00205777|58718771|FG004|Core Study (Up to 3 Years)|Other Event|0|||
30705043|NCT00205777|58718772|FG005|Core Study (Up to 3 Years)|Other Event|0|||
30705044|NCT00205777|58718767|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
30705045|NCT00205777|58718768|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
30705046|NCT00205777|58718769|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
30705047|NCT00205777|58718770|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
30705048|NCT00205777|58718771|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
30705049|NCT00205777|58718772|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
30705050|NCT00205777|58718767|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
30705051|NCT00205777|58718768|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
30705052|NCT00205777|58718769|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
30705053|NCT00205777|58718770|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
30705054|NCT00205777|58718771|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
30705055|NCT00205777|58718772|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
30705056|NCT00205777|58718767|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
30893867|NCT01365455|58927453|FG001|Induction Period|Pregnancy|1|||
30893868|NCT01365455|58927454|FG002|Induction Period|Pregnancy|0|||
30893869|NCT01365455|58927455|FG003|Induction Period|Pregnancy|0|||
30893870|NCT01365455|58927456|FG004|Induction Period|Pregnancy|0|||
30893871|NCT01365455|58927452|FG000|Induction Period|Protocol deviation|0|||
30705057|NCT00205777|58718768|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
30705058|NCT00205777|58718769|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
30705059|NCT00205777|58718770|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
30705060|NCT00205777|58718771|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
30893872|NCT01365455|58927453|FG001|Induction Period|Protocol deviation|1|||
30893873|NCT01365455|58927454|FG002|Induction Period|Protocol deviation|1|||
30893874|NCT01365455|58927455|FG003|Induction Period|Protocol deviation|0|||
30893875|NCT01365455|58927456|FG004|Induction Period|Protocol deviation|0|||
30893876|NCT01365455|58927452|FG000|Induction Period|Subject/guardian decision|9|||
30893877|NCT01365455|58927453|FG001|Induction Period|Subject/guardian decision|1|||
30893878|NCT01365455|58927454|FG002|Induction Period|Subject/guardian decision|8|||
30893879|NCT01365455|58927455|FG003|Induction Period|Subject/guardian decision|0|||
30893880|NCT01365455|58927456|FG004|Induction Period|Subject/guardian decision|0|||
30893881|NCT01365455|58927452|FG000|Induction Period|Lost to Follow-up|0|||
30893882|NCT01365455|58927453|FG001|Induction Period|Lost to Follow-up|0|||
30893883|NCT01365455|58927454|FG002|Induction Period|Lost to Follow-up|3|||
30893884|NCT01365455|58927455|FG003|Induction Period|Lost to Follow-up|0|||
30893885|NCT01365455|58927456|FG004|Induction Period|Lost to Follow-up|0|||
30893886|NCT01365455|58927452|FG000|Maintenance Period|Adverse Event|12|||
30893887|NCT01365455|58927453|FG001|Maintenance Period|Adverse Event|5|||
30893888|NCT01365455|58927454|FG002|Maintenance Period|Adverse Event|1|||
30893889|NCT01365455|58927455|FG003|Maintenance Period|Adverse Event|2|||
30893890|NCT01365455|58927456|FG004|Maintenance Period|Adverse Event|4|||
30893891|NCT01365455|58927452|FG000|Maintenance Period|Lack of Efficacy|10|||
30893892|NCT01365455|58927453|FG001|Maintenance Period|Lack of Efficacy|2|||
30893893|NCT01365455|58927454|FG002|Maintenance Period|Lack of Efficacy|0|||
30893894|NCT01365455|58927455|FG003|Maintenance Period|Lack of Efficacy|2|||
30893895|NCT01365455|58927456|FG004|Maintenance Period|Lack of Efficacy|2|||
30893896|NCT01365455|58927452|FG000|Maintenance Period|Lost to Follow-up|2|||
30893897|NCT01365455|58927453|FG001|Maintenance Period|Lost to Follow-up|4|||
30893898|NCT01365455|58927454|FG002|Maintenance Period|Lost to Follow-up|0|||
30893899|NCT01365455|58927455|FG003|Maintenance Period|Lost to Follow-up|0|||
30893900|NCT01365455|58927456|FG004|Maintenance Period|Lost to Follow-up|3|||
30893901|NCT01365455|58927452|FG000|Maintenance Period|Non-compliance with study treatment|0|||
30893902|NCT01365455|58927453|FG001|Maintenance Period|Non-compliance with study treatment|0|||
30893903|NCT01365455|58927454|FG002|Maintenance Period|Non-compliance with study treatment|0|||
30893904|NCT01365455|58927455|FG003|Maintenance Period|Non-compliance with study treatment|1|||
30893905|NCT01365455|58927456|FG004|Maintenance Period|Non-compliance with study treatment|0|||
30893906|NCT01365455|58927452|FG000|Maintenance Period|Physician Decision|0|||
30893907|NCT01365455|58927453|FG001|Maintenance Period|Physician Decision|1|||
30893908|NCT01365455|58927454|FG002|Maintenance Period|Physician Decision|0|||
30893909|NCT01365455|58927455|FG003|Maintenance Period|Physician Decision|0|||
30893910|NCT01365455|58927456|FG004|Maintenance Period|Physician Decision|1|||
30893911|NCT01365455|58927452|FG000|Maintenance Period|Pregnancy|0|||
30893912|NCT01365455|58927453|FG001|Maintenance Period|Pregnancy|4|||
30893913|NCT01365455|58927454|FG002|Maintenance Period|Pregnancy|0|||
30893914|NCT01365455|58927455|FG003|Maintenance Period|Pregnancy|0|||
30893915|NCT01365455|58927456|FG004|Maintenance Period|Pregnancy|2|||
30893916|NCT01365455|58927452|FG000|Maintenance Period|Protocol deviation|1|||
30893917|NCT01365455|58927453|FG001|Maintenance Period|Protocol deviation|1|||
30893918|NCT01365455|58927454|FG002|Maintenance Period|Protocol deviation|0|||
30893919|NCT01365455|58927455|FG003|Maintenance Period|Protocol deviation|0|||
30893920|NCT01365455|58927456|FG004|Maintenance Period|Protocol deviation|0|||
30893921|NCT01365455|58927452|FG000|Maintenance Period|Subject/guardian decision|4|||
30893922|NCT01365455|58927453|FG001|Maintenance Period|Subject/guardian decision|6|||
30893923|NCT01365455|58927454|FG002|Maintenance Period|Subject/guardian decision|2|||
30893924|NCT01365455|58927455|FG003|Maintenance Period|Subject/guardian decision|4|||
30893925|NCT01365455|58927456|FG004|Maintenance Period|Subject/guardian decision|1|||
30893926|NCT02155881|58927476|FG000|Overall Study|Withdrawal by Subject|0|||
30893927|NCT02155881|58927477|FG001|Overall Study|Withdrawal by Subject|2|||
30893928|NCT02155881|58927476|FG000|Overall Study|Inappropriately randomized|2|||
30620151|NCT00929734|58631318|FG001|Overall Study|Withdrawal by Subject|2|||
30620152|NCT01013883|58631326|FG000|Overall Study|Lost to Follow-up|2|||
30620153|NCT01013883|58631327|FG001|Overall Study|Lost to Follow-up|2|||
30620154|NCT01009983|58631333|FG000|Overall Study|necessary scans not completed|1|||
30620155|NCT01215227|58631347|FG000|Overall Study|Adverse Event|11|||
30620156|NCT01215227|58631348|FG001|Overall Study|Adverse Event|11|||
30620157|NCT01215227|58631349|FG002|Overall Study|Adverse Event|4|||
30620158|NCT01215227|58631350|FG003|Overall Study|Adverse Event|8|||
30620159|NCT01215227|58631351|FG004|Overall Study|Adverse Event|7|||
30620160|NCT01215227|58631352|FG005|Overall Study|Adverse Event|6|||
30620161|NCT01215227|58631347|FG000|Overall Study|Treatment Failure|8|||
30620162|NCT01215227|58631348|FG001|Overall Study|Treatment Failure|4|||
30620163|NCT01215227|58631349|FG002|Overall Study|Treatment Failure|1|||
30620164|NCT01215227|58631350|FG003|Overall Study|Treatment Failure|5|||
30620165|NCT01215227|58631351|FG004|Overall Study|Treatment Failure|1|||
30893929|NCT02155881|58927477|FG001|Overall Study|Inappropriately randomized|2|||
30893930|NCT01658579|58927487|FG000|Treatment Period A|Other|0|||
30893931|NCT01658579|58927488|FG001|Treatment Period A|Other|0|||
30893932|NCT01658579|58927489|FG002|Treatment Period A|Other|1|||
30893933|NCT01658579|58927490|FG003|Treatment Period A|Other|1|||
30893934|NCT01658579|58927487|FG000|Treatment Period A|Adverse Event|1|||
30620166|NCT01215227|58631352|FG005|Overall Study|Treatment Failure|1|||
30705061|NCT00205777|58718772|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
30705062|NCT00205777|58718767|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
30705063|NCT00205777|58718768|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
30705064|NCT00205777|58718769|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
30705065|NCT00205777|58718770|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
30705066|NCT00205777|58718771|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
30705067|NCT00205777|58718772|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
30705068|NCT00205777|58718767|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
30705069|NCT00205777|58718768|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
30705070|NCT00205777|58718769|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
30705071|NCT00205777|58718770|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
30705072|NCT00205777|58718771|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
30705073|NCT00205777|58718772|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
30705074|NCT00205777|58718767|FG000|Completed Core Study, Entered SE I|Other Event|52|||
30705075|NCT00205777|58718768|FG001|Completed Core Study, Entered SE I|Other Event|46|||
30705076|NCT00205777|58718769|FG002|Completed Core Study, Entered SE I|Other Event|47|||
30705077|NCT00205777|58718770|FG003|Completed Core Study, Entered SE I|Other Event|50|||
30705078|NCT00205777|58718771|FG004|Completed Core Study, Entered SE I|Other Event|0|||
30705079|NCT00205777|58718772|FG005|Completed Core Study, Entered SE I|Other Event|0|||
30705080|NCT00205777|58718767|FG000|Study Extension I|Adverse Event|57|||
30705081|NCT00205777|58718768|FG001|Study Extension I|Adverse Event|0|||
30705082|NCT00205777|58718769|FG002|Study Extension I|Adverse Event|0|||
30705083|NCT00205777|58718770|FG003|Study Extension I|Adverse Event|61|||
30705084|NCT00205777|58718771|FG004|Study Extension I|Adverse Event|58|||
30705085|NCT00205777|58718772|FG005|Study Extension I|Adverse Event|0|||
30705086|NCT00205777|58718767|FG000|Study Extension I|Death|5|||
30705087|NCT00205777|58718768|FG001|Study Extension I|Death|0|||
30705088|NCT00205777|58718769|FG002|Study Extension I|Death|0|||
30705089|NCT00205777|58718770|FG003|Study Extension I|Death|1|||
30705090|NCT00205777|58718771|FG004|Study Extension I|Death|2|||
30705091|NCT00205777|58718772|FG005|Study Extension I|Death|0|||
30705092|NCT00205777|58718767|FG000|Study Extension I|Withdrawal by Subject|99|||
30705093|NCT00205777|58718768|FG001|Study Extension I|Withdrawal by Subject|0|||
30705094|NCT00205777|58718769|FG002|Study Extension I|Withdrawal by Subject|0|||
30705095|NCT00205777|58718770|FG003|Study Extension I|Withdrawal by Subject|106|||
30705096|NCT00205777|58718771|FG004|Study Extension I|Withdrawal by Subject|89|||
30705097|NCT00205777|58718772|FG005|Study Extension I|Withdrawal by Subject|0|||
30705098|NCT00205777|58718767|FG000|Study Extension I|Protocol Violation|4|||
30705099|NCT00205777|58718768|FG001|Study Extension I|Protocol Violation|0|||
30705100|NCT00205777|58718769|FG002|Study Extension I|Protocol Violation|0|||
30705101|NCT00205777|58718770|FG003|Study Extension I|Protocol Violation|8|||
30705102|NCT00205777|58718771|FG004|Study Extension I|Protocol Violation|8|||
30705103|NCT00205777|58718772|FG005|Study Extension I|Protocol Violation|0|||
30705104|NCT00205777|58718767|FG000|Study Extension I|Lack of Efficacy|0|||
30705105|NCT00205777|58718768|FG001|Study Extension I|Lack of Efficacy|0|||
30705106|NCT00205777|58718769|FG002|Study Extension I|Lack of Efficacy|0|||
30705107|NCT00205777|58718770|FG003|Study Extension I|Lack of Efficacy|1|||
30705108|NCT00205777|58718771|FG004|Study Extension I|Lack of Efficacy|2|||
30705109|NCT00205777|58718772|FG005|Study Extension I|Lack of Efficacy|0|||
30705110|NCT00205777|58718767|FG000|Study Extension I|Failed to return|15|||
30620167|NCT01215227|58631347|FG000|Overall Study|Lost to Follow-up|1|||
30620168|NCT01215227|58631348|FG001|Overall Study|Lost to Follow-up|4|||
30620169|NCT01215227|58631349|FG002|Overall Study|Lost to Follow-up|1|||
30620170|NCT01215227|58631350|FG003|Overall Study|Lost to Follow-up|1|||
30620171|NCT01215227|58631351|FG004|Overall Study|Lost to Follow-up|1|||
30620172|NCT01215227|58631352|FG005|Overall Study|Lost to Follow-up|2|||
30620173|NCT01215227|58631347|FG000|Overall Study|Subject Withdrew Consent|16|||
30620174|NCT01215227|58631348|FG001|Overall Study|Subject Withdrew Consent|20|||
30620175|NCT01215227|58631349|FG002|Overall Study|Subject Withdrew Consent|7|||
30620176|NCT01215227|58631350|FG003|Overall Study|Subject Withdrew Consent|10|||
30620177|NCT01215227|58631351|FG004|Overall Study|Subject Withdrew Consent|11|||
30620178|NCT01215227|58631352|FG005|Overall Study|Subject Withdrew Consent|8|||
30620179|NCT01215227|58631347|FG000|Overall Study|Non-Compliance With Protocol|2|||
30620180|NCT01215227|58631348|FG001|Overall Study|Non-Compliance With Protocol|6|||
30620181|NCT01215227|58631349|FG002|Overall Study|Non-Compliance With Protocol|1|||
30620182|NCT01215227|58631350|FG003|Overall Study|Non-Compliance With Protocol|0|||
30620183|NCT01215227|58631351|FG004|Overall Study|Non-Compliance With Protocol|0|||
30620184|NCT01215227|58631352|FG005|Overall Study|Non-Compliance With Protocol|0|||
30620185|NCT01215227|58631347|FG000|Overall Study|Administrative|83|||
30705111|NCT00205777|58718768|FG001|Study Extension I|Failed to return|0|||
30620186|NCT01215227|58631348|FG001|Overall Study|Administrative|73|||
30620187|NCT01215227|58631349|FG002|Overall Study|Administrative|42|||
30705112|NCT00205777|58718769|FG002|Study Extension I|Failed to return|0|||
30705113|NCT00205777|58718770|FG003|Study Extension I|Failed to return|17|||
30705114|NCT00205777|58718771|FG004|Study Extension I|Failed to return|13|||
30705115|NCT00205777|58718772|FG005|Study Extension I|Failed to return|0|||
30705116|NCT00205777|58718767|FG000|Study Extension I|Other Event|34|||
30705117|NCT00205777|58718768|FG001|Study Extension I|Other Event|0|||
30705118|NCT00205777|58718769|FG002|Study Extension I|Other Event|0|||
30705119|NCT00205777|58718770|FG003|Study Extension I|Other Event|34|||
30705120|NCT00205777|58718771|FG004|Study Extension I|Other Event|29|||
30705121|NCT00205777|58718772|FG005|Study Extension I|Other Event|0|||
30705122|NCT00205777|58718767|FG000|Study Extension I|Withdrawn as per protocol|0|||
30705123|NCT00205777|58718768|FG001|Study Extension I|Withdrawn as per protocol|0|||
30705124|NCT00205777|58718769|FG002|Study Extension I|Withdrawn as per protocol|1070|||
30705125|NCT00205777|58718770|FG003|Study Extension I|Withdrawn as per protocol|0|||
30705126|NCT00205777|58718771|FG004|Study Extension I|Withdrawn as per protocol|0|||
30705127|NCT00205777|58718772|FG005|Study Extension I|Withdrawn as per protocol|0|||
30705128|NCT00205777|58718767|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
30705129|NCT00205777|58718768|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
30705130|NCT00205777|58718769|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
30705131|NCT00205777|58718770|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
30705132|NCT00205777|58718771|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
30705133|NCT00205777|58718772|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
30705134|NCT00205777|58718767|FG000|Study Extension II|Adverse Event|0|||
30705135|NCT00205777|58718768|FG001|Study Extension II|Adverse Event|0|||
30705136|NCT00205777|58718769|FG002|Study Extension II|Adverse Event|0|||
30705137|NCT00205777|58718770|FG003|Study Extension II|Adverse Event|14|||
30705138|NCT00205777|58718771|FG004|Study Extension II|Adverse Event|0|||
30705139|NCT00205777|58718772|FG005|Study Extension II|Adverse Event|30|||
30705140|NCT00205777|58718767|FG000|Study Extension II|Death|0|||
30705141|NCT00205777|58718768|FG001|Study Extension II|Death|0|||
30705142|NCT00205777|58718769|FG002|Study Extension II|Death|0|||
30705143|NCT00205777|58718770|FG003|Study Extension II|Death|2|||
30705144|NCT00205777|58718771|FG004|Study Extension II|Death|0|||
30705145|NCT00205777|58718772|FG005|Study Extension II|Death|5|||
30705146|NCT00205777|58718767|FG000|Study Extension II|Withdrawal by Subject|0|||
30705147|NCT00205777|58718768|FG001|Study Extension II|Withdrawal by Subject|0|||
30705148|NCT00205777|58718769|FG002|Study Extension II|Withdrawal by Subject|0|||
30705149|NCT00205777|58718770|FG003|Study Extension II|Withdrawal by Subject|35|||
30705150|NCT00205777|58718771|FG004|Study Extension II|Withdrawal by Subject|0|||
30705151|NCT00205777|58718772|FG005|Study Extension II|Withdrawal by Subject|59|||
30705152|NCT00205777|58718767|FG000|Study Extension II|Protocol Violation|0|||
30705153|NCT00205777|58718768|FG001|Study Extension II|Protocol Violation|0|||
30705154|NCT00205777|58718769|FG002|Study Extension II|Protocol Violation|0|||
30705155|NCT00205777|58718770|FG003|Study Extension II|Protocol Violation|1|||
30705156|NCT00205777|58718771|FG004|Study Extension II|Protocol Violation|0|||
30705157|NCT00205777|58718772|FG005|Study Extension II|Protocol Violation|10|||
30705158|NCT00205777|58718767|FG000|Study Extension II|Lack of Efficacy|0|||
30705159|NCT00205777|58718768|FG001|Study Extension II|Lack of Efficacy|0|||
30705160|NCT00205777|58718769|FG002|Study Extension II|Lack of Efficacy|0|||
30705161|NCT00205777|58718770|FG003|Study Extension II|Lack of Efficacy|0|||
30705162|NCT00205777|58718771|FG004|Study Extension II|Lack of Efficacy|0|||
30705163|NCT00205777|58718772|FG005|Study Extension II|Lack of Efficacy|1|||
30705164|NCT00205777|58718767|FG000|Study Extension II|Failed to return|0|||
30705165|NCT00205777|58718768|FG001|Study Extension II|Failed to return|0|||
30705166|NCT00205777|58718769|FG002|Study Extension II|Failed to return|0|||
30705167|NCT00205777|58718770|FG003|Study Extension II|Failed to return|14|||
30705168|NCT00205777|58718771|FG004|Study Extension II|Failed to return|0|||
30705169|NCT00205777|58718772|FG005|Study Extension II|Failed to return|26|||
30705170|NCT00205777|58718767|FG000|Study Extension II|Other Event|0|||
30705171|NCT00205777|58718768|FG001|Study Extension II|Other Event|0|||
30705172|NCT00205777|58718769|FG002|Study Extension II|Other Event|0|||
30705173|NCT00205777|58718770|FG003|Study Extension II|Other Event|12|||
30893935|NCT01658579|58927488|FG001|Treatment Period A|Adverse Event|0|||
30893936|NCT01658579|58927489|FG002|Treatment Period A|Adverse Event|0|||
30620188|NCT01215227|58631350|FG003|Overall Study|Administrative|24|||
30620189|NCT01215227|58631351|FG004|Overall Study|Administrative|28|||
30620190|NCT01215227|58631352|FG005|Overall Study|Administrative|40|||
30620191|NCT01215227|58631347|FG000|Overall Study|Missing Status|0|||
30620192|NCT01215227|58631348|FG001|Overall Study|Missing Status|1|||
30620193|NCT01215227|58631349|FG002|Overall Study|Missing Status|0|||
30620194|NCT01215227|58631350|FG003|Overall Study|Missing Status|0|||
30620195|NCT01215227|58631351|FG004|Overall Study|Missing Status|0|||
30620196|NCT01215227|58631352|FG005|Overall Study|Missing Status|0|||
30620197|NCT01215227|58631347|FG000|Overall Study|Randomized but not treated|0|||
30893937|NCT01658579|58927490|FG003|Treatment Period A|Adverse Event|0|||
30893938|NCT01658579|58927487|FG000|Treatment Period B|Other|0|||
30893939|NCT01658579|58927488|FG001|Treatment Period B|Other|0|||
30620198|NCT01215227|58631348|FG001|Overall Study|Randomized but not treated|0|||
30620199|NCT01215227|58631349|FG002|Overall Study|Randomized but not treated|1|||
30620200|NCT01215227|58631350|FG003|Overall Study|Randomized but not treated|1|||
30620201|NCT01215227|58631351|FG004|Overall Study|Randomized but not treated|0|||
30620202|NCT01215227|58631352|FG005|Overall Study|Randomized but not treated|1|||
30620203|NCT01009515|58631366|FG000|Overall Study|Withdrawal by Subject|3|||
30620204|NCT01214915|58631370|FG000|Overall Study|Adverse Event|8|||
30620205|NCT01214915|58631370|FG000|Overall Study|Lack of Efficacy|3|||
30620206|NCT01009281|58631374|FG000|Overall Study|Administrative problems|7|||
30620207|NCT01009203|58631378|FG000|Overall Study|Withdrawal by Subject|1|||
30620208|NCT01009203|58631378|FG000|Overall Study|Adverse Event|5|||
30620209|NCT01009203|58631378|FG000|Overall Study|Treatment-unrelated death|1|||
30620210|NCT01009047|58631384|FG000|Overall Study|Adverse Event|5|||
30620211|NCT01009047|58631385|FG001|Overall Study|Adverse Event|0|||
30620212|NCT01009047|58631384|FG000|Overall Study|Lost to Follow-up|0|||
30620213|NCT01009047|58631385|FG001|Overall Study|Lost to Follow-up|2|||
30620214|NCT01009047|58631384|FG000|Overall Study|Lack of Efficacy|4|||
30620215|NCT01009047|58631385|FG001|Overall Study|Lack of Efficacy|11|||
30620216|NCT01009047|58631384|FG000|Overall Study|Withdrawal by consent|16|||
30620217|NCT01009047|58631385|FG001|Overall Study|Withdrawal by consent|11|||
30620218|NCT01009047|58631384|FG000|Overall Study|Other|3|||
30620219|NCT01009047|58631385|FG001|Overall Study|Other|2|||
30620220|NCT01025193|58631391|FG000|Overall Study|Protocol Violation|1|||
30620221|NCT01025193|58631391|FG000|Overall Study|Adverse Event|3|||
30620222|NCT01025037|58631399|FG000|Overall Study|Adverse Event|3|||
30620223|NCT01025037|58631399|FG000|Overall Study|Lost to Follow-up|7|||
30620224|NCT01025037|58631399|FG000|Overall Study|Withdrawal by Subject|1|||
30620225|NCT01214837|58631406|FG000|Overall Study|Death|0|||
30620226|NCT01214837|58631407|FG001|Overall Study|Death|0|||
30620227|NCT01214837|58631408|FG002|Overall Study|Death|1|||
30620228|NCT01214837|58631406|FG000|Overall Study|Adverse Event|1|||
30620229|NCT01214837|58631407|FG001|Overall Study|Adverse Event|2|||
30620230|NCT01214837|58631408|FG002|Overall Study|Adverse Event|1|||
30620231|NCT01214837|58631406|FG000|Overall Study|Withdrawal by Subject|27|||
30620232|NCT01214837|58631407|FG001|Overall Study|Withdrawal by Subject|36|||
30620233|NCT01214837|58631408|FG002|Overall Study|Withdrawal by Subject|28|||
30620234|NCT01214837|58631406|FG000|Overall Study|Lost to Follow-up|20|||
30620235|NCT01214837|58631407|FG001|Overall Study|Lost to Follow-up|15|||
30705174|NCT00205777|58718771|FG004|Study Extension II|Other Event|0|||
30705175|NCT00205777|58718772|FG005|Study Extension II|Other Event|20|||
30705176|NCT00205777|58718767|FG000|Study Extension II|Enrolled but not treated|0|||
30705177|NCT00205777|58718768|FG001|Study Extension II|Enrolled but not treated|0|||
30705178|NCT00205777|58718769|FG002|Study Extension II|Enrolled but not treated|0|||
30705179|NCT00205777|58718770|FG003|Study Extension II|Enrolled but not treated|71|||
30705180|NCT00205777|58718771|FG004|Study Extension II|Enrolled but not treated|0|||
30705181|NCT00205777|58718772|FG005|Study Extension II|Enrolled but not treated|131|||
30893940|NCT01658579|58927489|FG002|Treatment Period B|Other|0|||
30893941|NCT01658579|58927490|FG003|Treatment Period B|Other|1|||
30620236|NCT01214837|58631408|FG002|Overall Study|Lost to Follow-up|21|||
30705182|NCT00483652|58718789|FG000|Double-blind Treatment Period|Protocol Violation|2|||
30705183|NCT00483652|58718790|FG001|Double-blind Treatment Period|Protocol Violation|1|||
30705184|NCT00483652|58718789|FG000|Double-blind Treatment Period|Adverse Event|3|||
30705185|NCT00483652|58718790|FG001|Double-blind Treatment Period|Adverse Event|4|||
30705186|NCT00483652|58718789|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
30705187|NCT00483652|58718790|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
30705188|NCT00483652|58718789|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
30705189|NCT00483652|58718790|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
30893942|NCT02154087|58927496|FG000|Overall Study|Study Termination|1|||
30893943|NCT02118597|58927500|FG000|Overall Study|Sponsor terminated the study|14|||
30893944|NCT02118597|58927500|FG000|Overall Study|Serious Adverse Event|1|||
30620237|NCT01214837|58631406|FG000|Overall Study|Inappropriate Enrolment|0|||
30620238|NCT01214837|58631407|FG001|Overall Study|Inappropriate Enrolment|1|||
30620239|NCT01214837|58631408|FG002|Overall Study|Inappropriate Enrolment|2|||
30620240|NCT01214837|58631406|FG000|Overall Study|Administrative Reason|2|||
30620241|NCT01214837|58631407|FG001|Overall Study|Administrative Reason|6|||
30620242|NCT01214837|58631408|FG002|Overall Study|Administrative Reason|4|||
30620243|NCT01214837|58631406|FG000|Overall Study|Protocol Violation|3|||
30620244|NCT01214837|58631407|FG001|Overall Study|Protocol Violation|1|||
30705190|NCT00483574|58718798|FG000|Overall Study|Adverse Event|6|||
30705191|NCT00483574|58718799|FG001|Overall Study|Adverse Event|0|||
30705192|NCT00483574|58718798|FG000|Overall Study|Protocol Violation|28|||
30705193|NCT00483574|58718799|FG001|Overall Study|Protocol Violation|9|||
30705194|NCT00483574|58718798|FG000|Overall Study|Lost to Follow-up|16|||
30705195|NCT00483574|58718799|FG001|Overall Study|Lost to Follow-up|4|||
30705196|NCT00483574|58718798|FG000|Overall Study|Withdrawal by Subject|52|||
30705197|NCT00483574|58718799|FG001|Overall Study|Withdrawal by Subject|0|||
30705198|NCT00483184|58718810|FG000|Overall Study|Withdrawal by Subject|2|||
30705199|NCT00483184|58718811|FG001|Overall Study|Withdrawal by Subject|2|||
30705200|NCT00483184|58718812|FG002|Overall Study|Withdrawal by Subject|0|||
30705201|NCT00483184|58718810|FG000|Overall Study|Lost to Follow-up|1|||
30705202|NCT00483184|58718811|FG001|Overall Study|Lost to Follow-up|0|||
30705203|NCT00483184|58718812|FG002|Overall Study|Lost to Follow-up|0|||
30705204|NCT00483184|58718810|FG000|Overall Study|Adverse Event|1|||
30705205|NCT00483184|58718811|FG001|Overall Study|Adverse Event|2|||
30620245|NCT01214837|58631408|FG002|Overall Study|Protocol Violation|5|||
30620246|NCT01214837|58631406|FG000|Overall Study|Unable to Classify|1|||
30620247|NCT01214837|58631407|FG001|Overall Study|Unable to Classify|3|||
30620248|NCT01214837|58631408|FG002|Overall Study|Unable to Classify|0|||
30620249|NCT01024959|58631417|FG000|Overall Study|ineligible|12|||
30705206|NCT00483184|58718812|FG002|Overall Study|Adverse Event|2|||
30705207|NCT00483184|58718810|FG000|Overall Study|Protocol Violation|1|||
30705208|NCT00483184|58718811|FG001|Overall Study|Protocol Violation|0|||
30705209|NCT00483184|58718812|FG002|Overall Study|Protocol Violation|1|||
30705210|NCT00482170|58718822|FG000|Overall Study|Adverse Event|5|||
30705211|NCT00482170|58718823|FG001|Overall Study|Adverse Event|14|||
30705212|NCT00482170|58718822|FG000|Overall Study|Withdrawal by Subject|6|||
30705213|NCT00482170|58718823|FG001|Overall Study|Withdrawal by Subject|1|||
30705214|NCT00482170|58718822|FG000|Overall Study|Protocol Violation|2|||
30705215|NCT00482170|58718823|FG001|Overall Study|Protocol Violation|3|||
30705216|NCT00482170|58718822|FG000|Overall Study|Lost to Follow-up|2|||
30705217|NCT00482170|58718823|FG001|Overall Study|Lost to Follow-up|0|||
30705218|NCT00482170|58718822|FG000|Overall Study|Unspecified reason|0|||
30705219|NCT00482170|58718823|FG001|Overall Study|Unspecified reason|2|||
30705220|NCT03883113|58718831|FG000|Overall Study|Physician Decision|4|||
30705221|NCT03883113|58718832|FG001|Overall Study|Physician Decision|2|||
30705222|NCT03883113|58718831|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
30705223|NCT03883113|58718832|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
30705224|NCT03883113|58718831|FG000|Overall Study|Pregnancy|1|||
30705225|NCT03883113|58718832|FG001|Overall Study|Pregnancy|0|||
30705226|NCT03883113|58718831|FG000|Overall Study|Adverse Event|0|||
30705227|NCT03883113|58718832|FG001|Overall Study|Adverse Event|1|||
30705228|NCT03883113|58718831|FG000|Overall Study|Withdrawal by Subject|1|||
30705229|NCT03883113|58718832|FG001|Overall Study|Withdrawal by Subject|2|||
30705230|NCT03883113|58718831|FG000|Overall Study|Lost to Follow-up|1|||
30620250|NCT01024959|58631417|FG000|Overall Study|results not evaluable|12|||
30620251|NCT01024959|58631417|FG000|Overall Study|missing results required for analysis|17|||
30620252|NCT03672175|58631429|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
30620253|NCT03672175|58631430|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
30620254|NCT03672175|58631431|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
30620255|NCT03672175|58631429|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
30705231|NCT03883113|58718832|FG001|Overall Study|Lost to Follow-up|0|||
30705232|NCT04218695|58718854|FG000|Overall Study|Adverse Event|1|||
30705233|NCT04218695|58718855|FG001|Overall Study|Adverse Event|0|||
30705234|NCT00490282|58718861|FG000|Overall Study|Withdrawal by Subject|3|||
30705235|NCT00615056|58718870|FG000|Overall Study|Death|31|||
30620256|NCT03672175|58631430|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
30705236|NCT00615056|58718871|FG001|Overall Study|Death|31|||
30705237|NCT00615056|58718872|FG002|Overall Study|Death|21|||
30705238|NCT00615056|58718873|FG003|Overall Study|Death|23|||
30705239|NCT00615056|58718870|FG000|Overall Study|Lost to Follow-up|1|||
30705240|NCT00615056|58718871|FG001|Overall Study|Lost to Follow-up|2|||
30705241|NCT00615056|58718872|FG002|Overall Study|Lost to Follow-up|4|||
30705242|NCT00615056|58718873|FG003|Overall Study|Lost to Follow-up|5|||
30705243|NCT00615056|58718870|FG000|Overall Study|Other|13|||
30705244|NCT00615056|58718871|FG001|Overall Study|Other|15|||
30705245|NCT00615056|58718872|FG002|Overall Study|Other|10|||
30705246|NCT00615056|58718873|FG003|Overall Study|Other|7|||
30705247|NCT00615056|58718870|FG000|Overall Study|Objective progression or relapse|0|||
30705248|NCT00615056|58718871|FG001|Overall Study|Objective progression or relapse|2|||
30705249|NCT00615056|58718872|FG002|Overall Study|Objective progression or relapse|0|||
30705250|NCT00615056|58718873|FG003|Overall Study|Objective progression or relapse|0|||
30705251|NCT00615056|58718870|FG000|Overall Study|Withdrawal by Subject|0|||
30705252|NCT00615056|58718871|FG001|Overall Study|Withdrawal by Subject|1|||
30705253|NCT00615056|58718872|FG002|Overall Study|Withdrawal by Subject|1|||
30705254|NCT00615056|58718873|FG003|Overall Study|Withdrawal by Subject|0|||
30705255|NCT00615056|58718870|FG000|Overall Study|Discontinued by Sponsor|1|||
30705256|NCT00615056|58718871|FG001|Overall Study|Discontinued by Sponsor|0|||
30705257|NCT00615056|58718872|FG002|Overall Study|Discontinued by Sponsor|0|||
30705258|NCT00615056|58718873|FG003|Overall Study|Discontinued by Sponsor|0|||
30705259|NCT00615056|58718870|FG000|Overall Study|Randomized but not treated|3|||
30705260|NCT00615056|58718871|FG001|Overall Study|Randomized but not treated|0|||
30705261|NCT00615056|58718872|FG002|Overall Study|Randomized but not treated|0|||
30705262|NCT00615056|58718873|FG003|Overall Study|Randomized but not treated|0|||
30705263|NCT00482014|58718887|FG000|Overall Study|Withdrawal by Subject|1|||
30705264|NCT00482014|58718888|FG001|Overall Study|Withdrawal by Subject|2|||
30705265|NCT00482014|58718889|FG002|Overall Study|Withdrawal by Subject|3|||
30705266|NCT00482014|58718890|FG003|Overall Study|Withdrawal by Subject|4|||
30705267|NCT00482014|58718887|FG000|Overall Study|Adverse Event|3|||
30705268|NCT00482014|58718888|FG001|Overall Study|Adverse Event|0|||
30705269|NCT00482014|58718889|FG002|Overall Study|Adverse Event|2|||
30705270|NCT00482014|58718890|FG003|Overall Study|Adverse Event|8|||
30705271|NCT00482014|58718887|FG000|Overall Study|Death|1|||
30705272|NCT00482014|58718888|FG001|Overall Study|Death|2|||
30705273|NCT00482014|58718889|FG002|Overall Study|Death|1|||
30705274|NCT00482014|58718890|FG003|Overall Study|Death|4|||
30705275|NCT00482014|58718887|FG000|Overall Study|Lack of Efficacy|1|||
30705276|NCT00482014|58718888|FG001|Overall Study|Lack of Efficacy|0|||
30705277|NCT00482014|58718889|FG002|Overall Study|Lack of Efficacy|4|||
30705278|NCT00482014|58718890|FG003|Overall Study|Lack of Efficacy|6|||
30705279|NCT00482014|58718887|FG000|Overall Study|Sponsor Decision|1|||
30705280|NCT00482014|58718888|FG001|Overall Study|Sponsor Decision|2|||
30893945|NCT02118597|58927500|FG000|Overall Study|Investigator's decision|1|||
30705281|NCT00482014|58718889|FG002|Overall Study|Sponsor Decision|1|||
30705282|NCT00482014|58718890|FG003|Overall Study|Sponsor Decision|1|||
30705283|NCT03595553|58718904|FG000|Overall Study|Withdrawal by Subject|20|||
30705284|NCT03595553|58718905|FG001|Overall Study|Withdrawal by Subject|8|||
30705285|NCT03595553|58718904|FG000|Overall Study|Physician Decision|3|||
30705286|NCT03595553|58718905|FG001|Overall Study|Physician Decision|2|||
30705287|NCT03595553|58718904|FG000|Overall Study|Adverse Event|2|||
30705288|NCT03595553|58718905|FG001|Overall Study|Adverse Event|5|||
30705289|NCT03595553|58718904|FG000|Overall Study|Death|24|||
30705290|NCT03595553|58718905|FG001|Overall Study|Death|22|||
30705291|NCT03595553|58718904|FG000|Overall Study|Lost to Follow-up|6|||
30705292|NCT03595553|58718905|FG001|Overall Study|Lost to Follow-up|7|||
30893946|NCT01659125|58927504|FG000|Overall Study|Withdrawal by Subject|2|||
30893947|NCT01659125|58927504|FG000|Overall Study|Lost to Follow-up|7|||
30893948|NCT01659125|58927504|FG000|Overall Study|Technical Problem|1|||
30893949|NCT01659125|58927504|FG000|Overall Study|Time Constraints|2|||
30893950|NCT01659125|58927504|FG000|Overall Study|Failed to Start Treatment|2|||
30893951|NCT01657253|58927510|FG000|Overall Study|Lost to Follow-up|6|||
30893952|NCT01657253|58927511|FG001|Overall Study|Lost to Follow-up|5|||
30705293|NCT03595553|58718904|FG000|Overall Study|Other as indicated in CSR|3|||
30705294|NCT03595553|58718905|FG001|Overall Study|Other as indicated in CSR|3|||
30705295|NCT03595553|58718904|FG000|Overall Study|Sponsor Decision|0|||
30705296|NCT03595553|58718905|FG001|Overall Study|Sponsor Decision|1|||
30705297|NCT00614822|58718911|FG000|Overall Study|Adverse Event|3|||
30705298|NCT00529659|58718918|FG000|Overall Study|Adverse Event|8|||
30705299|NCT00529659|58718919|FG001|Overall Study|Adverse Event|7|||
30893953|NCT01657253|58927510|FG000|Overall Study|Withdrawal by Subject|11|||
30705300|NCT00529659|58718918|FG000|Overall Study|Lost to Follow-up|0|||
30893954|NCT01657253|58927511|FG001|Overall Study|Withdrawal by Subject|12|||
30893955|NCT01657253|58927510|FG000|Overall Study|Adverse Event|0|||
30705301|NCT00529659|58718919|FG001|Overall Study|Lost to Follow-up|2|||
30705302|NCT00529659|58718918|FG000|Overall Study|Physician Decision|0|||
30705303|NCT00529659|58718919|FG001|Overall Study|Physician Decision|2|||
30705304|NCT00529659|58718918|FG000|Overall Study|Protocol Violation|2|||
30705305|NCT00529659|58718919|FG001|Overall Study|Protocol Violation|6|||
30705306|NCT00529659|58718918|FG000|Overall Study|Withdrawal by Subject|1|||
30705307|NCT00529659|58718919|FG001|Overall Study|Withdrawal by Subject|6|||
30705308|NCT03569891|58718925|FG000|Lead-in|Ineligible during lead-in|8|||
30705309|NCT03569891|58718925|FG000|Lead-in|Withdrawal by Subject|3|||
30705310|NCT03569891|58718925|FG000|Lead-in|Risks related to COVID-19|2|||
30705311|NCT03569891|58718925|FG000|AMT-061|Adverse Event|1|||
30705312|NCT00143455|58718938|FG000|Cohort 1|Adverse Event|8|||
30705313|NCT00143455|58718939|FG001|Cohort 1|Adverse Event|4|||
30705314|NCT00143455|58718940|FG002|Cohort 1|Adverse Event|0|||
30705315|NCT00143455|58718941|FG003|Cohort 1|Adverse Event|0|||
30705316|NCT00143455|58718938|FG000|Cohort 1|Death|5|||
30705317|NCT00143455|58718939|FG001|Cohort 1|Death|2|||
30705318|NCT00143455|58718940|FG002|Cohort 1|Death|0|||
30705319|NCT00143455|58718941|FG003|Cohort 1|Death|0|||
30705320|NCT00143455|58718938|FG000|Cohort 1|Progressive Disease|0|||
30705321|NCT00143455|58718939|FG001|Cohort 1|Progressive Disease|6|||
30705322|NCT00143455|58718940|FG002|Cohort 1|Progressive Disease|0|||
30705323|NCT00143455|58718941|FG003|Cohort 1|Progressive Disease|0|||
30705324|NCT00143455|58718938|FG000|Cohort 1|Withdrawal by Subject|1|||
30705325|NCT00143455|58718939|FG001|Cohort 1|Withdrawal by Subject|4|||
30705326|NCT00143455|58718940|FG002|Cohort 1|Withdrawal by Subject|0|||
30705327|NCT00143455|58718941|FG003|Cohort 1|Withdrawal by Subject|0|||
30705328|NCT00143455|58718938|FG000|Cohort 1|Randomized But Not Treated|0|||
30705329|NCT00143455|58718939|FG001|Cohort 1|Randomized But Not Treated|1|||
30705330|NCT00143455|58718940|FG002|Cohort 1|Randomized But Not Treated|0|||
30705331|NCT00143455|58718941|FG003|Cohort 1|Randomized But Not Treated|0|||
30705332|NCT00143455|58718938|FG000|Cohort 2|Adverse Event|0|||
30705333|NCT00143455|58718939|FG001|Cohort 2|Adverse Event|0|||
30705334|NCT00143455|58718940|FG002|Cohort 2|Adverse Event|42|||
30705335|NCT00143455|58718941|FG003|Cohort 2|Adverse Event|30|||
30705336|NCT00143455|58718938|FG000|Cohort 2|No Longer Required Study Treatment|0|||
30705337|NCT00143455|58718939|FG001|Cohort 2|No Longer Required Study Treatment|0|||
30705338|NCT00143455|58718940|FG002|Cohort 2|No Longer Required Study Treatment|1|||
30705339|NCT00143455|58718941|FG003|Cohort 2|No Longer Required Study Treatment|0|||
30705340|NCT00143455|58718938|FG000|Cohort 2|Protocol Violation|0|||
30705341|NCT00143455|58718939|FG001|Cohort 2|Protocol Violation|0|||
30705342|NCT00143455|58718940|FG002|Cohort 2|Protocol Violation|1|||
30705343|NCT00143455|58718941|FG003|Cohort 2|Protocol Violation|1|||
30705344|NCT00143455|58718938|FG000|Cohort 2|Lost to Follow-up|0|||
30705345|NCT00143455|58718939|FG001|Cohort 2|Lost to Follow-up|0|||
30705346|NCT00143455|58718940|FG002|Cohort 2|Lost to Follow-up|1|||
30705347|NCT00143455|58718941|FG003|Cohort 2|Lost to Follow-up|4|||
30705348|NCT00143455|58718938|FG000|Cohort 2|Death|0|||
30705349|NCT00143455|58718939|FG001|Cohort 2|Death|0|||
30705350|NCT00143455|58718940|FG002|Cohort 2|Death|20|||
30705351|NCT00143455|58718941|FG003|Cohort 2|Death|12|||
30705352|NCT00143455|58718938|FG000|Cohort 2|Progressive Disease|0|||
30705353|NCT00143455|58718939|FG001|Cohort 2|Progressive Disease|0|||
30705354|NCT00143455|58718940|FG002|Cohort 2|Progressive Disease|20|||
30705355|NCT00143455|58718941|FG003|Cohort 2|Progressive Disease|27|||
30705356|NCT00143455|58718938|FG000|Cohort 2|Withdrawal by Subject|0|||
30705357|NCT00143455|58718939|FG001|Cohort 2|Withdrawal by Subject|0|||
30705358|NCT00143455|58718940|FG002|Cohort 2|Withdrawal by Subject|13|||
30705359|NCT00143455|58718941|FG003|Cohort 2|Withdrawal by Subject|12|||
30705360|NCT00143455|58718938|FG000|Cohort 2|Other|0|||
30705361|NCT00143455|58718939|FG001|Cohort 2|Other|0|||
30705362|NCT00143455|58718940|FG002|Cohort 2|Other|7|||
30705363|NCT00143455|58718941|FG003|Cohort 2|Other|6|||
30705364|NCT00143455|58718938|FG000|Cohort 2|Randomized But Not Treated|0|||
30705365|NCT00143455|58718939|FG001|Cohort 2|Randomized But Not Treated|0|||
30705366|NCT00143455|58718940|FG002|Cohort 2|Randomized But Not Treated|1|||
30705367|NCT00143455|58718941|FG003|Cohort 2|Randomized But Not Treated|1|||
30705368|NCT03529955|58718953|FG000|Overall Study|Adverse Event|1|||
30705369|NCT03529955|58718953|FG000|Overall Study|Lack of Efficacy|1|||
30705370|NCT00142909|58718969|FG000|Randomization|Various Reasons|7|||
30705371|NCT00142909|58718970|FG001|Randomization|Various Reasons|10|||
30705372|NCT00142909|58718969|FG000|Medications Begin|Protocol Violation|2|||
30705373|NCT00142909|58718970|FG001|Medications Begin|Protocol Violation|0|||
30705374|NCT00142909|58718969|FG000|Medications Begin|Withdrawal by Subject|5|||
30705375|NCT00142909|58718970|FG001|Medications Begin|Withdrawal by Subject|3|||
30705376|NCT00142909|58718969|FG000|Medications Begin|Withdrawal by Subject|2|||
30705377|NCT00142909|58718970|FG001|Medications Begin|Withdrawal by Subject|0|||
30893956|NCT01657253|58927511|FG001|Overall Study|Adverse Event|1|||
30893957|NCT02117427|58927520|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
30893958|NCT02117427|58927521|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
30893959|NCT02117427|58927522|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
30893960|NCT02117427|58927520|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
30893961|NCT02117427|58927521|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
30893962|NCT02117427|58927522|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
30893963|NCT02117427|58927520|FG000|Overall Study|Physician Decision|0|||
30893964|NCT02117427|58927521|FG001|Overall Study|Physician Decision|2|||
30705378|NCT00205699|58718979|FG000|Overall Study|Lost to Follow-up|1|||
30893965|NCT02117427|58927522|FG002|Overall Study|Physician Decision|0|||
30893966|NCT02117427|58927520|FG000|Overall Study|No longer meets inclusion criteria|0|||
30893967|NCT02117427|58927521|FG001|Overall Study|No longer meets inclusion criteria|1|||
30705379|NCT00205699|58718980|FG001|Overall Study|Lost to Follow-up|3|||
30705380|NCT00205699|58718981|FG002|Overall Study|Lost to Follow-up|5|||
30705381|NCT00205699|58718979|FG000|Overall Study|Adverse Event|1|||
30705382|NCT00205699|58718980|FG001|Overall Study|Adverse Event|0|||
30705383|NCT00205699|58718981|FG002|Overall Study|Adverse Event|0|||
30705384|NCT00205699|58718979|FG000|Overall Study|Withdrawal by Subject|1|||
30705385|NCT00205699|58718980|FG001|Overall Study|Withdrawal by Subject|2|||
30705386|NCT00205699|58718981|FG002|Overall Study|Withdrawal by Subject|1|||
30705387|NCT00205699|58718979|FG000|Overall Study|Lack of Efficacy|0|||
30705388|NCT00205699|58718980|FG001|Overall Study|Lack of Efficacy|1|||
30705389|NCT00205699|58718981|FG002|Overall Study|Lack of Efficacy|0|||
30705390|NCT03882801|58718994|FG000|Period 1|Adverse Event|0|||
30705391|NCT03882801|58718995|FG001|Period 1|Adverse Event|1|||
30705392|NCT03882801|58718994|FG000|Period 1|Non-compliance with study drug|1|||
30705393|NCT03882801|58718995|FG001|Period 1|Non-compliance with study drug|1|||
30705394|NCT03882801|58718994|FG000|Period 1|Never treated with study drug|1|||
30705395|NCT03882801|58718995|FG001|Period 1|Never treated with study drug|0|||
30705396|NCT03882801|58718994|FG000|Washout Period|Physician Decision|0|||
30705397|NCT03882801|58718995|FG001|Washout Period|Physician Decision|1|||
30705398|NCT03882801|58718994|FG000|Period 2|Non-compliance with study drug|0|||
30705399|NCT03882801|58718995|FG001|Period 2|Non-compliance with study drug|1|||
30705400|NCT03880227|58719005|FG000|First Visit|Withdrawal by Subject|1|||
30705401|NCT03880227|58719006|FG001|First Visit|Withdrawal by Subject|0|||
30705402|NCT03880227|58719007|FG002|First Visit|Withdrawal by Subject|0|||
30705403|NCT03880227|58719008|FG003|First Visit|Withdrawal by Subject|0|||
30705404|NCT03880227|58719005|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
30705405|NCT03880227|58719006|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
30705406|NCT03880227|58719007|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
30705407|NCT03880227|58719008|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
30705408|NCT03880227|58719005|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
30705409|NCT03880227|58719006|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
30705410|NCT03880227|58719007|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
30705411|NCT03880227|58719008|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
30705412|NCT03880227|58719005|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
30893968|NCT02117427|58927522|FG002|Overall Study|No longer meets inclusion criteria|0|||
30893969|NCT02117427|58927520|FG000|Overall Study|Death|0|||
30705413|NCT03880227|58719006|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
30705414|NCT03880227|58719007|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
30705415|NCT03880227|58719008|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
30705416|NCT00530439|58719032|FG000|Overall Study|GDM|9|||
30705417|NCT00530439|58719033|FG001|Overall Study|GDM|3|||
30893970|NCT02117427|58927521|FG001|Overall Study|Death|1|||
30893971|NCT02117427|58927522|FG002|Overall Study|Death|0|||
30893972|NCT02117349|58927530|FG000|Overall Study|Withdrawal by Subject|1|||
30705418|NCT00530439|58719032|FG000|Overall Study|Withdraw|18|||
30705419|NCT00530439|58719033|FG001|Overall Study|Withdraw|14|||
30705420|NCT00530439|58719032|FG000|Overall Study|Missed abortion|1|||
30705421|NCT00530439|58719033|FG001|Overall Study|Missed abortion|4|||
30705422|NCT00530439|58719032|FG000|Overall Study|Misclassification|2|||
30705423|NCT00530439|58719033|FG001|Overall Study|Misclassification|0|||
30705424|NCT00530439|58719032|FG000|Overall Study|Twin pregnancy|0|||
30705425|NCT00530439|58719033|FG001|Overall Study|Twin pregnancy|2|||
30705426|NCT00530439|58719032|FG000|Overall Study|Severe malformation/abortion|0|||
30705427|NCT00530439|58719033|FG001|Overall Study|Severe malformation/abortion|3|||
30705428|NCT00497146|58719041|FG000|Treatment Period|Adverse Event|6|||
30705429|NCT00497146|58719042|FG001|Treatment Period|Adverse Event|2|||
30705430|NCT00497146|58719041|FG000|Treatment Period|Withdrawal by Subject|5|||
30705431|NCT00497146|58719042|FG001|Treatment Period|Withdrawal by Subject|9|||
30705432|NCT00497146|58719041|FG000|Treatment Period|Lost to Follow-up|1|||
30705433|NCT00497146|58719042|FG001|Treatment Period|Lost to Follow-up|3|||
30705434|NCT00497146|58719041|FG000|Treatment Period|Required dialysis|4|||
30705435|NCT00497146|58719042|FG001|Treatment Period|Required dialysis|1|||
30705436|NCT00497146|58719041|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
30705437|NCT00497146|58719042|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
30705438|NCT00497146|58719041|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
30705439|NCT00497146|58719042|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
30705440|NCT00497146|58719041|FG000|Treatment Period|Other Reason|2|||
30705441|NCT00497146|58719042|FG001|Treatment Period|Other Reason|3|||
30705442|NCT00497146|58719041|FG000|Long-term Follow-up Period|Adverse Event|2|||
30705443|NCT00497146|58719042|FG001|Long-term Follow-up Period|Adverse Event|2|||
30620257|NCT03672175|58631431|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
30620258|NCT03672175|58631429|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
30620259|NCT03672175|58631430|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
30705444|NCT00497146|58719041|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
30705445|NCT00497146|58719042|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
30705446|NCT00497146|58719041|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
30705447|NCT00497146|58719042|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
30705448|NCT00497146|58719041|FG000|Long-term Follow-up Period|Other|0|||
30705449|NCT00497146|58719042|FG001|Long-term Follow-up Period|Other|1|||
30705450|NCT00489970|58719053|FG000|Persistence Year 9|Lost to Follow-up|2|||
30705451|NCT00489970|58719054|FG001|Persistence Year 9|Lost to Follow-up|2|||
30705452|NCT00489970|58719055|FG002|Persistence Year 9|Lost to Follow-up|3|||
30893973|NCT02117349|58927531|FG001|Overall Study|Withdrawal by Subject|0|||
30893974|NCT02117349|58927530|FG000|Overall Study|Lost to Follow-up|1|||
30620260|NCT03672175|58631431|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
30620261|NCT03672175|58631429|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
30620262|NCT03672175|58631430|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
30620263|NCT03672175|58631431|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
30620264|NCT03672175|58631429|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
30620265|NCT03672175|58631430|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
30620266|NCT03672175|58631431|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
30620267|NCT03672175|58631429|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
30620268|NCT03672175|58631430|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
30620269|NCT03672175|58631431|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
30620270|NCT03672175|58631429|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
30620271|NCT03672175|58631430|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
30620272|NCT03672175|58631431|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
30620273|NCT03672175|58631429|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
30620274|NCT03672175|58631430|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
30620275|NCT03672175|58631431|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
30620276|NCT03672175|58631429|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
30620277|NCT03672175|58631430|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
30620278|NCT03672175|58631431|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
30705453|NCT00489970|58719053|FG000|Persistence Year 9|Other|1|||
30705454|NCT00489970|58719054|FG001|Persistence Year 9|Other|0|||
30705455|NCT00489970|58719055|FG002|Persistence Year 9|Other|2|||
30705456|NCT02798471|58719068|FG000|Overall Study|Adverse Event|7|||
30705457|NCT02798471|58719069|FG001|Overall Study|Adverse Event|2|||
30705458|NCT02798471|58719068|FG000|Overall Study|Physician Decision|3|||
30893975|NCT02117349|58927531|FG001|Overall Study|Lost to Follow-up|1|||
30705459|NCT02798471|58719069|FG001|Overall Study|Physician Decision|7|||
30705460|NCT02798471|58719068|FG000|Overall Study|Death|2|||
30705461|NCT02798471|58719069|FG001|Overall Study|Death|3|||
30705462|NCT02798471|58719068|FG000|Overall Study|Lost to Follow-up|0|||
30705463|NCT02798471|58719069|FG001|Overall Study|Lost to Follow-up|1|||
30705464|NCT02798471|58719068|FG000|Overall Study|Other|5|||
30705465|NCT02798471|58719069|FG001|Overall Study|Other|3|||
30705466|NCT02798471|58719068|FG000|Overall Study|Subject withdrew consent|0|||
30705467|NCT02798471|58719069|FG001|Overall Study|Subject withdrew consent|6|||
30705468|NCT02798471|58719068|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
30705469|NCT02798471|58719069|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
30705470|NCT02798471|58719068|FG000|Overall Study|Randomized, but not treated|0|||
30705471|NCT02798471|58719069|FG001|Overall Study|Randomized, but not treated|2|||
30705472|NCT00489736|58719077|FG000|Overall Study|Lack of Efficacy|53|||
30705473|NCT00489736|58719078|FG001|Overall Study|Lack of Efficacy|14|||
30705474|NCT00489736|58719077|FG000|Overall Study|Adverse Event|32|||
30705475|NCT00489736|58719078|FG001|Overall Study|Adverse Event|45|||
30705476|NCT00489736|58719077|FG000|Overall Study|Poor compliance|6|||
30705477|NCT00489736|58719078|FG001|Overall Study|Poor compliance|2|||
30705478|NCT00489736|58719077|FG000|Overall Study|Not coded/ Not pre-specified|5|||
30705479|NCT00489736|58719078|FG001|Overall Study|Not coded/ Not pre-specified|8|||
30705480|NCT00617084|58719086|FG000|Overall Study|Withdrawal by Subject|5|||
30705481|NCT00617084|58719087|FG001|Overall Study|Withdrawal by Subject|7|||
30705482|NCT00617084|58719086|FG000|Overall Study|Missed 12 Months visit|16|||
30705483|NCT00617084|58719087|FG001|Overall Study|Missed 12 Months visit|19|||
30705484|NCT00489424|58719096|FG000|Overall Study|Adverse Event|3|||
30705485|NCT00489424|58719097|FG001|Overall Study|Adverse Event|3|||
30705486|NCT00489424|58719098|FG002|Overall Study|Adverse Event|4|||
30705487|NCT00489424|58719096|FG000|Overall Study|Lack of Efficacy|1|||
30705488|NCT00489424|58719097|FG001|Overall Study|Lack of Efficacy|0|||
30705489|NCT00489424|58719098|FG002|Overall Study|Lack of Efficacy|0|||
30705490|NCT00489424|58719096|FG000|Overall Study|Administrative problems|0|||
30705491|NCT00489424|58719097|FG001|Overall Study|Administrative problems|2|||
30705492|NCT00489424|58719098|FG002|Overall Study|Administrative problems|1|||
30705493|NCT00614744|58719108|FG000|Overall Study|Lost to Follow-up|5|||
30705494|NCT00614744|58719109|FG001|Overall Study|Lost to Follow-up|4|||
30705495|NCT00614744|58719108|FG000|Overall Study|Incomplete for Behavior Issues|0|||
30705496|NCT00614744|58719109|FG001|Overall Study|Incomplete for Behavior Issues|2|||
30705497|NCT00565812|58719118|FG000|Overall Study|Death|2|||
30705498|NCT00565812|58719119|FG001|Overall Study|Death|1|||
30705499|NCT00565812|58719120|FG002|Overall Study|Death|3|||
30705500|NCT00565812|58719118|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
30705501|NCT00565812|58719119|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
30620279|NCT03672175|58631429|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
30620280|NCT03672175|58631430|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
30620281|NCT03672175|58631431|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
30620282|NCT03672175|58631429|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
30620283|NCT03672175|58631430|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
30620284|NCT03672175|58631431|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
30620285|NCT03672175|58631429|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
30620286|NCT03672175|58631430|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
30620287|NCT03672175|58631431|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
30620288|NCT01008423|58631459|FG000|Overall Study|Adverse Event|13|||
30620289|NCT01008423|58631460|FG001|Overall Study|Adverse Event|6|||
30620290|NCT01008423|58631459|FG000|Overall Study|Withdrawal by Subject|4|||
30620291|NCT01008423|58631460|FG001|Overall Study|Withdrawal by Subject|7|||
30620292|NCT01008423|58631459|FG000|Overall Study|Lost to Follow-up|0|||
30620293|NCT01008423|58631460|FG001|Overall Study|Lost to Follow-up|2|||
30705502|NCT00565812|58719120|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
30705503|NCT00565812|58719118|FG000|Overall Study|Lost to Follow-up|10|||
30705504|NCT00565812|58719119|FG001|Overall Study|Lost to Follow-up|8|||
30705505|NCT00565812|58719120|FG002|Overall Study|Lost to Follow-up|8|||
30705506|NCT00565812|58719118|FG000|Overall Study|Withdrawal by Subject|58|||
30705507|NCT00565812|58719119|FG001|Overall Study|Withdrawal by Subject|47|||
30705508|NCT00565812|58719120|FG002|Overall Study|Withdrawal by Subject|48|||
30705509|NCT00565812|58719118|FG000|Overall Study|Work Schedule|5|||
30705510|NCT00565812|58719119|FG001|Overall Study|Work Schedule|3|||
30705511|NCT00565812|58719120|FG002|Overall Study|Work Schedule|1|||
30705512|NCT00565812|58719118|FG000|Overall Study|Protocol Violation|2|||
30705513|NCT00565812|58719119|FG001|Overall Study|Protocol Violation|6|||
30705514|NCT00565812|58719120|FG002|Overall Study|Protocol Violation|4|||
30705515|NCT00565812|58719118|FG000|Overall Study|Adverse Event|41|||
30705516|NCT00565812|58719119|FG001|Overall Study|Adverse Event|54|||
30705517|NCT00565812|58719120|FG002|Overall Study|Adverse Event|40|||
30705518|NCT00565812|58719118|FG000|Overall Study|Jury Duty|1|||
30705519|NCT00565812|58719119|FG001|Overall Study|Jury Duty|0|||
30705520|NCT00565812|58719120|FG002|Overall Study|Jury Duty|0|||
30705521|NCT00565812|58719118|FG000|Overall Study|Relocated Out of Area|5|||
30705522|NCT00565812|58719119|FG001|Overall Study|Relocated Out of Area|8|||
30705523|NCT00565812|58719120|FG002|Overall Study|Relocated Out of Area|9|||
30705524|NCT00565812|58719118|FG000|Overall Study|Sponsor Decision|1|||
30705525|NCT00565812|58719119|FG001|Overall Study|Sponsor Decision|5|||
30705526|NCT00565812|58719120|FG002|Overall Study|Sponsor Decision|1|||
30705527|NCT00565812|58719118|FG000|Overall Study|Domestic Reasons|7|||
30705528|NCT00565812|58719119|FG001|Overall Study|Domestic Reasons|1|||
30705529|NCT00565812|58719120|FG002|Overall Study|Domestic Reasons|3|||
30705530|NCT00565812|58719118|FG000|Overall Study|Research Site Closure|6|||
30705531|NCT00565812|58719119|FG001|Overall Study|Research Site Closure|1|||
30705532|NCT00565812|58719120|FG002|Overall Study|Research Site Closure|8|||
30705533|NCT00565812|58719118|FG000|Overall Study|Surgical Intervention|0|||
30705534|NCT00565812|58719119|FG001|Overall Study|Surgical Intervention|1|||
30705535|NCT00565812|58719120|FG002|Overall Study|Surgical Intervention|2|||
30705536|NCT00565812|58719118|FG000|Overall Study|Low Compliance|1|||
30705537|NCT00565812|58719119|FG001|Overall Study|Low Compliance|0|||
30705538|NCT00565812|58719120|FG002|Overall Study|Low Compliance|1|||
30705539|NCT00565812|58719118|FG000|Overall Study|Follow-up Visit Not Completed|2|||
30705540|NCT00565812|58719119|FG001|Overall Study|Follow-up Visit Not Completed|0|||
30705541|NCT00565812|58719120|FG002|Overall Study|Follow-up Visit Not Completed|1|||
30705542|NCT00565812|58719118|FG000|Overall Study|Physician Decision|2|||
30705543|NCT00565812|58719119|FG001|Overall Study|Physician Decision|0|||
30893976|NCT02117349|58927530|FG000|Overall Study|Death|1|||
30893977|NCT02117349|58927531|FG001|Overall Study|Death|0|||
30893978|NCT01626495|58927537|FG000|Overall Study|Adverse Event|3|||
30893979|NCT01626495|58927537|FG000|Overall Study|Disease progression|27|||
30893980|NCT01626495|58927537|FG000|Overall Study|Withdrawal by Subject|1|||
30893981|NCT01626495|58927537|FG000|Overall Study|Administrative problem|1|||
30893982|NCT01626495|58927537|FG000|Overall Study|Death|2|||
30893983|NCT01626495|58927537|FG000|Overall Study|Physician Decision|1|||
30893984|NCT01626495|58927537|FG000|Overall Study|New cancer therapy|16|||
30893985|NCT01626495|58927537|FG000|Overall Study|Manufacturing failure|1|||
30893986|NCT02177175|58927543|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
30893987|NCT02177175|58927544|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
30893988|NCT02153073|58927550|FG000|Overall Study|Case Report Forms Uncollected|230|||
30893989|NCT02153073|58927550|FG000|Overall Study|Protocol Deviation|68|||
30893990|NCT01657877|58927554|FG000|Overall Study|Withdrawal by Subject|4|||
30893991|NCT01657877|58927554|FG000|Overall Study|Protocol Violation|6|||
30893992|NCT01657877|58927554|FG000|Overall Study|Adverse Event|2|||
30893993|NCT01657877|58927554|FG000|Overall Study|Other Reason|2|||
30893994|NCT02175771|58927579|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
30893995|NCT02175771|58927580|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30893996|NCT02175771|58927581|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30893997|NCT02175771|58927582|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30893998|NCT02175771|58927583|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30893999|NCT02175771|58927584|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30894000|NCT02175771|58927585|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30894001|NCT02175771|58927586|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30894002|NCT02175771|58927587|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30894003|NCT02175771|58927579|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
30705544|NCT00565812|58719120|FG002|Overall Study|Physician Decision|0|||
30705545|NCT03974334|58719128|FG000|Overall Study|Lost to Follow-up|1|||
30705546|NCT03970824|58719135|FG000|Overall Study|Withdrawal by Subject|1|||
30705547|NCT03970824|58719136|FG001|Overall Study|Withdrawal by Subject|1|||
30705548|NCT03970824|58719137|FG002|Overall Study|Withdrawal by Subject|3|||
30705549|NCT03970824|58719135|FG000|Overall Study|Lost to Follow-up|0|||
30705550|NCT03970824|58719136|FG001|Overall Study|Lost to Follow-up|2|||
30705551|NCT03970824|58719137|FG002|Overall Study|Lost to Follow-up|1|||
30705552|NCT03970824|58719135|FG000|Overall Study|Adverse Event|1|||
30705553|NCT03970824|58719136|FG001|Overall Study|Adverse Event|0|||
30705554|NCT03970824|58719137|FG002|Overall Study|Adverse Event|0|||
30705555|NCT00564486|58719148|FG000|Overall Study|Adverse Event|0|||
30705556|NCT00564486|58719149|FG001|Overall Study|Adverse Event|1|||
30705557|NCT00564486|58719150|FG002|Overall Study|Adverse Event|0|||
30705558|NCT00564486|58719151|FG003|Overall Study|Adverse Event|0|||
30705559|NCT00564486|58719148|FG000|Overall Study|Withdrawal by Subject|4|||
30705560|NCT00564486|58719149|FG001|Overall Study|Withdrawal by Subject|0|||
30705561|NCT00564486|58719150|FG002|Overall Study|Withdrawal by Subject|0|||
30705562|NCT00564486|58719151|FG003|Overall Study|Withdrawal by Subject|5|||
30705563|NCT00564486|58719148|FG000|Overall Study|Subject refused to have blood drawn|0|||
30705564|NCT00564486|58719149|FG001|Overall Study|Subject refused to have blood drawn|0|||
30705565|NCT00564486|58719150|FG002|Overall Study|Subject refused to have blood drawn|1|||
30705566|NCT00564486|58719151|FG003|Overall Study|Subject refused to have blood drawn|0|||
30705567|NCT00564486|58719148|FG000|Overall Study|Lost to Follow-up|3|||
30705568|NCT00564486|58719149|FG001|Overall Study|Lost to Follow-up|0|||
30894004|NCT02175771|58927580|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30894005|NCT02175771|58927581|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30705569|NCT00564486|58719150|FG002|Overall Study|Lost to Follow-up|2|||
30894006|NCT02175771|58927582|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30705570|NCT00564486|58719151|FG003|Overall Study|Lost to Follow-up|2|||
30705571|NCT00481078|58719167|FG000|Overall Study|Progression of disease|11|||
30705572|NCT00481078|58719168|FG001|Overall Study|Progression of disease|11|||
30705573|NCT00481078|58719167|FG000|Overall Study|Adverse Event|15|||
30705574|NCT00481078|58719168|FG001|Overall Study|Adverse Event|3|||
30705575|NCT00481078|58719167|FG000|Overall Study|Death|5|||
30705576|NCT00481078|58719168|FG001|Overall Study|Death|3|||
30705577|NCT00481078|58719167|FG000|Overall Study|Intercurrent illness|1|||
30705578|NCT00481078|58719168|FG001|Overall Study|Intercurrent illness|0|||
30705579|NCT00481078|58719167|FG000|Overall Study|Withdrawal by Subject|7|||
30705580|NCT00481078|58719168|FG001|Overall Study|Withdrawal by Subject|1|||
30705581|NCT00481078|58719167|FG000|Overall Study|Information not available|1|||
30705582|NCT00481078|58719168|FG001|Overall Study|Information not available|0|||
30705583|NCT00481078|58719167|FG000|Overall Study|Received other treatment|2|||
30705584|NCT00481078|58719168|FG001|Overall Study|Received other treatment|1|||
30705585|NCT00481078|58719167|FG000|Overall Study|Brain metastasis|0|||
30705586|NCT00481078|58719168|FG001|Overall Study|Brain metastasis|1|||
30705587|NCT00480532|58719178|FG000|Overall Study|Withdrawal by Subject|2|||
30705588|NCT00480532|58719179|FG001|Overall Study|Withdrawal by Subject|4|||
30705589|NCT00480532|58719180|FG002|Overall Study|Withdrawal by Subject|3|||
30705590|NCT00480532|58719181|FG003|Overall Study|Withdrawal by Subject|1|||
30705591|NCT00480532|58719178|FG000|Overall Study|Protocol Violation|0|||
30705592|NCT00480532|58719179|FG001|Overall Study|Protocol Violation|0|||
30705593|NCT00480532|58719180|FG002|Overall Study|Protocol Violation|1|||
30705594|NCT00480532|58719181|FG003|Overall Study|Protocol Violation|0|||
30705595|NCT00496366|58719191|FG000|Overall Study|Death|1|||
30705596|NCT00488644|58719195|FG000|Overall Study|Not Eligible|1|||
30843691|NCT01915498|58869655|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
30705597|NCT00488644|58719195|FG000|Overall Study|Not Evaluable|1|||
30705598|NCT00564018|58719202|FG000|Overall Study|Withdrawal by Subject|2|||
30705599|NCT00564018|58719203|FG001|Overall Study|Withdrawal by Subject|3|||
30843692|NCT01915498|58869656|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
30843693|NCT01915498|58869657|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
30843694|NCT01915498|58869658|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
30843695|NCT01915498|58869659|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
30843696|NCT01915498|58869660|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
30843697|NCT01915498|58869661|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
30843698|NCT01915498|58869662|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
30843699|NCT01915498|58869663|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
30843700|NCT01915498|58869664|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
30705600|NCT00564018|58719204|FG002|Overall Study|Withdrawal by Subject|1|||
30705601|NCT03381287|58719216|FG000|Overall Study|Withdrawal by Subject|0|||
30705602|NCT03381287|58719217|FG001|Overall Study|Withdrawal by Subject|1|||
30705603|NCT03381287|58719218|FG002|Overall Study|Withdrawal by Subject|0|||
30705604|NCT03381287|58719219|FG003|Overall Study|Withdrawal by Subject|0|||
30705605|NCT03381287|58719216|FG000|Overall Study|Adverse Event|0|||
30705606|NCT03381287|58719217|FG001|Overall Study|Adverse Event|0|||
30705607|NCT03381287|58719218|FG002|Overall Study|Adverse Event|0|||
30705608|NCT03381287|58719219|FG003|Overall Study|Adverse Event|1|||
30705609|NCT03381287|58719216|FG000|Overall Study|Physician Decision|0|||
30705610|NCT03381287|58719217|FG001|Overall Study|Physician Decision|0|||
30705611|NCT03381287|58719218|FG002|Overall Study|Physician Decision|0|||
30705612|NCT03381287|58719219|FG003|Overall Study|Physician Decision|1|||
30705613|NCT00616928|58719243|FG000|Overall Study|Adverse Event|6|||
30705614|NCT00616928|58719244|FG001|Overall Study|Adverse Event|3|||
30705615|NCT00616928|58719245|FG002|Overall Study|Adverse Event|2|||
30705616|NCT00616928|58719246|FG003|Overall Study|Adverse Event|2|||
30705617|NCT00616928|58719243|FG000|Overall Study|Other|51|||
30705618|NCT00616928|58719244|FG001|Overall Study|Other|8|||
30705619|NCT00616928|58719245|FG002|Overall Study|Other|15|||
30705620|NCT00616928|58719246|FG003|Overall Study|Other|5|||
30705621|NCT00616928|58719243|FG000|Overall Study|Lost to Follow-up|5|||
30705622|NCT00616928|58719244|FG001|Overall Study|Lost to Follow-up|7|||
30705623|NCT00616928|58719245|FG002|Overall Study|Lost to Follow-up|0|||
30705624|NCT00616928|58719246|FG003|Overall Study|Lost to Follow-up|0|||
30705625|NCT00563784|58719268|FG000|Overall Study|Withdrawal by Subject|2|||
30705626|NCT00563784|58719268|FG000|Overall Study|Screen Failures|20|||
30705627|NCT00203047|58719283|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
30705628|NCT00203047|58719284|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
30705629|NCT00203047|58719283|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
30705630|NCT00203047|58719284|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
30705631|NCT00203047|58719283|FG000|Overall Study|Withdrawal by Subject|13|||
30705632|NCT00203047|58719284|FG001|Overall Study|Withdrawal by Subject|47|||
30705633|NCT00203047|58719283|FG000|Overall Study|Teva requested participant withdrawal|1|||
30705634|NCT00203047|58719284|FG001|Overall Study|Teva requested participant withdrawal|1|||
30705635|NCT00203047|58719283|FG000|Overall Study|Physician Decision|8|||
30705636|NCT00203047|58719284|FG001|Overall Study|Physician Decision|7|||
30705637|NCT00203047|58719283|FG000|Overall Study|Non-compliance|4|||
30705638|NCT00203047|58719284|FG001|Overall Study|Non-compliance|8|||
30705639|NCT00203047|58719283|FG000|Overall Study|Protocol Violation|1|||
30705640|NCT00203047|58719284|FG001|Overall Study|Protocol Violation|0|||
30705641|NCT00203047|58719283|FG000|Overall Study|Lost to Follow-up|11|||
30705642|NCT00203047|58719284|FG001|Overall Study|Lost to Follow-up|5|||
30705643|NCT00203047|58719283|FG000|Overall Study|Adverse Event|8|||
30705644|NCT00203047|58719284|FG001|Overall Study|Adverse Event|18|||
30705645|NCT00203047|58719283|FG000|Overall Study|Death|1|||
30705646|NCT00203047|58719284|FG001|Overall Study|Death|2|||
30705647|NCT00203047|58719283|FG000|Overall Study|Pregnancy|3|||
30705648|NCT00203047|58719284|FG001|Overall Study|Pregnancy|0|||
30705649|NCT00203047|58719283|FG000|Overall Study|Other|5|||
30705650|NCT00203047|58719284|FG001|Overall Study|Other|5|||
30705651|NCT00142519|58719292|FG000|Overall Study|Not Treated|7|||
30705652|NCT00142519|58719293|FG001|Overall Study|Not Treated|9|||
30705653|NCT00142519|58719292|FG000|Overall Study|Protocol Violation|1|||
30705654|NCT00142519|58719293|FG001|Overall Study|Protocol Violation|0|||
30705655|NCT00142519|58719292|FG000|Overall Study|Withdrawal by Subject|10|||
30705656|NCT00142519|58719293|FG001|Overall Study|Withdrawal by Subject|7|||
30705657|NCT00141817|58719312|FG000|Overall Study|Protocol Violation|0|||
30705658|NCT00141817|58719313|FG001|Overall Study|Protocol Violation|0|||
30705659|NCT00141817|58719314|FG002|Overall Study|Protocol Violation|1|||
30705660|NCT00141817|58719315|FG003|Overall Study|Protocol Violation|0|||
30705661|NCT00141817|58719312|FG000|Overall Study|Parent request|1|||
30705662|NCT00141817|58719313|FG001|Overall Study|Parent request|0|||
30705663|NCT00141817|58719314|FG002|Overall Study|Parent request|0|||
30705664|NCT00141817|58719315|FG003|Overall Study|Parent request|0|||
30705665|NCT00573170|58719325|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
30705666|NCT00573170|58719326|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
30705667|NCT00573170|58719327|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
30705668|NCT00573170|58719328|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
30705669|NCT00573170|58719329|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
30705670|NCT00573170|58719330|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
30705671|NCT00573170|58719325|FG000|First Washout Period|Adverse Event|1|||
30705672|NCT00573170|58719326|FG001|First Washout Period|Adverse Event|1|||
30705673|NCT00573170|58719327|FG002|First Washout Period|Adverse Event|0|||
30705674|NCT00573170|58719328|FG003|First Washout Period|Adverse Event|0|||
30705675|NCT00573170|58719329|FG004|First Washout Period|Adverse Event|0|||
30705676|NCT00573170|58719330|FG005|First Washout Period|Adverse Event|1|||
30705677|NCT00573170|58719325|FG000|First Washout Period|Lack of Efficacy|0|||
30705678|NCT00573170|58719326|FG001|First Washout Period|Lack of Efficacy|0|||
30705679|NCT00573170|58719327|FG002|First Washout Period|Lack of Efficacy|0|||
30705680|NCT00573170|58719328|FG003|First Washout Period|Lack of Efficacy|0|||
30705681|NCT00573170|58719329|FG004|First Washout Period|Lack of Efficacy|0|||
30705682|NCT00573170|58719330|FG005|First Washout Period|Lack of Efficacy|1|||
30705683|NCT00573170|58719325|FG000|First Washout Period|Lost to Follow-up|1|||
30705684|NCT00573170|58719326|FG001|First Washout Period|Lost to Follow-up|1|||
30705685|NCT00573170|58719327|FG002|First Washout Period|Lost to Follow-up|0|||
30705686|NCT00573170|58719328|FG003|First Washout Period|Lost to Follow-up|2|||
30705687|NCT00573170|58719329|FG004|First Washout Period|Lost to Follow-up|0|||
30705688|NCT00573170|58719330|FG005|First Washout Period|Lost to Follow-up|2|||
30705689|NCT00573170|58719325|FG000|First Washout Period|Withdrawal by Subject|2|||
30705690|NCT00573170|58719326|FG001|First Washout Period|Withdrawal by Subject|0|||
30705691|NCT00573170|58719327|FG002|First Washout Period|Withdrawal by Subject|0|||
30894007|NCT02175771|58927583|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30894008|NCT02175771|58927584|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30894009|NCT02175771|58927585|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30894010|NCT02175771|58927586|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30894011|NCT02175771|58927587|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30894012|NCT02175771|58927579|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
30894013|NCT02175771|58927580|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30894014|NCT02175771|58927581|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30894015|NCT02175771|58927582|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30894016|NCT02175771|58927583|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30894017|NCT02175771|58927584|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30705692|NCT00573170|58719328|FG003|First Washout Period|Withdrawal by Subject|2|||
30705693|NCT00573170|58719329|FG004|First Washout Period|Withdrawal by Subject|3|||
30705694|NCT00573170|58719330|FG005|First Washout Period|Withdrawal by Subject|3|||
30705695|NCT00573170|58719325|FG000|First Washout Period|Other|4|||
30705696|NCT00573170|58719326|FG001|First Washout Period|Other|0|||
30705697|NCT00573170|58719327|FG002|First Washout Period|Other|1|||
30705698|NCT00573170|58719328|FG003|First Washout Period|Other|1|||
30705699|NCT00573170|58719329|FG004|First Washout Period|Other|0|||
30705700|NCT00573170|58719330|FG005|First Washout Period|Other|0|||
30705701|NCT00573170|58719325|FG000|Second Washout Period|Adverse Event|1|||
30705702|NCT00573170|58719326|FG001|Second Washout Period|Adverse Event|0|||
30705703|NCT00573170|58719327|FG002|Second Washout Period|Adverse Event|0|||
30705704|NCT00573170|58719328|FG003|Second Washout Period|Adverse Event|0|||
30705705|NCT00573170|58719329|FG004|Second Washout Period|Adverse Event|1|||
30705706|NCT00573170|58719330|FG005|Second Washout Period|Adverse Event|0|||
30705707|NCT00573170|58719325|FG000|Second Washout Period|Protocol Violation|2|||
30705708|NCT00573170|58719326|FG001|Second Washout Period|Protocol Violation|1|||
30705709|NCT00573170|58719327|FG002|Second Washout Period|Protocol Violation|1|||
30705710|NCT00573170|58719328|FG003|Second Washout Period|Protocol Violation|0|||
30705711|NCT00573170|58719329|FG004|Second Washout Period|Protocol Violation|0|||
30705712|NCT00573170|58719330|FG005|Second Washout Period|Protocol Violation|0|||
30705713|NCT00573170|58719325|FG000|Second Washout Period|Withdrawal by Subject|1|||
30705714|NCT00573170|58719326|FG001|Second Washout Period|Withdrawal by Subject|1|||
30705715|NCT00573170|58719327|FG002|Second Washout Period|Withdrawal by Subject|2|||
30705716|NCT00573170|58719328|FG003|Second Washout Period|Withdrawal by Subject|0|||
30705717|NCT00573170|58719329|FG004|Second Washout Period|Withdrawal by Subject|1|||
30705718|NCT00573170|58719330|FG005|Second Washout Period|Withdrawal by Subject|0|||
30705719|NCT00573170|58719325|FG000|Second Washout Period|Lost to Follow-up|0|||
30894018|NCT02175771|58927585|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30705720|NCT00573170|58719326|FG001|Second Washout Period|Lost to Follow-up|0|||
30705721|NCT00573170|58719327|FG002|Second Washout Period|Lost to Follow-up|0|||
30894019|NCT02175771|58927586|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30705722|NCT00573170|58719328|FG003|Second Washout Period|Lost to Follow-up|1|||
30705723|NCT00573170|58719329|FG004|Second Washout Period|Lost to Follow-up|0|||
30705724|NCT00573170|58719330|FG005|Second Washout Period|Lost to Follow-up|0|||
30705725|NCT00573170|58719325|FG000|Second Washout Period|Other|1|||
30705726|NCT00573170|58719326|FG001|Second Washout Period|Other|2|||
30705727|NCT00573170|58719327|FG002|Second Washout Period|Other|1|||
30705728|NCT00573170|58719328|FG003|Second Washout Period|Other|4|||
30705729|NCT00573170|58719329|FG004|Second Washout Period|Other|6|||
30705730|NCT00573170|58719330|FG005|Second Washout Period|Other|2|||
30705731|NCT00573170|58719325|FG000|Third Treatment Period|Withdrawal by Subject|1|||
30705732|NCT00573170|58719326|FG001|Third Treatment Period|Withdrawal by Subject|0|||
30705733|NCT00573170|58719327|FG002|Third Treatment Period|Withdrawal by Subject|0|||
30705734|NCT00573170|58719328|FG003|Third Treatment Period|Withdrawal by Subject|0|||
30705735|NCT00573170|58719329|FG004|Third Treatment Period|Withdrawal by Subject|0|||
30705736|NCT00573170|58719330|FG005|Third Treatment Period|Withdrawal by Subject|0|||
30705737|NCT00573170|58719325|FG000|Third Treatment Period|Lost to Follow-up|0|||
30705738|NCT00573170|58719326|FG001|Third Treatment Period|Lost to Follow-up|0|||
30705739|NCT00573170|58719327|FG002|Third Treatment Period|Lost to Follow-up|0|||
30705740|NCT00573170|58719328|FG003|Third Treatment Period|Lost to Follow-up|0|||
30705741|NCT00573170|58719329|FG004|Third Treatment Period|Lost to Follow-up|0|||
30705742|NCT00573170|58719330|FG005|Third Treatment Period|Lost to Follow-up|2|||
30705743|NCT00201643|58719349|FG000|Overall Study|Withdrawal by Subject|5|||
30620294|NCT01008423|58631459|FG000|Overall Study|Low Cortisol|0|||
30620295|NCT01008423|58631460|FG001|Overall Study|Low Cortisol|1|||
30620296|NCT01008423|58631459|FG000|Overall Study|Lack of Efficacy|0|||
30620297|NCT01008423|58631460|FG001|Overall Study|Lack of Efficacy|5|||
30620298|NCT01008423|58631459|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
30620299|NCT01008423|58631460|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
30620300|NCT01008423|58631459|FG000|Overall Study|Personal Conflict|1|||
30620301|NCT01008423|58631460|FG001|Overall Study|Personal Conflict|0|||
30705744|NCT00201643|58719350|FG001|Overall Study|Withdrawal by Subject|4|||
30620302|NCT01008423|58631459|FG000|Overall Study|Other|0|||
30620303|NCT01008423|58631460|FG001|Overall Study|Other|1|||
30620304|NCT01012947|58631471|FG000|Overall Study|Lost to Follow-up|131|||
30620305|NCT01012947|58631472|FG001|Overall Study|Lost to Follow-up|135|||
30620306|NCT01012947|58631473|FG002|Overall Study|Lost to Follow-up|130|||
30705745|NCT00130039|58719358|FG000|Overall Study|Withdrawal by Subject|15|||
30705746|NCT00130039|58719359|FG001|Overall Study|Withdrawal by Subject|11|||
30705747|NCT00130039|58719358|FG000|Overall Study|Lost to Follow-up|3|||
30705748|NCT00130039|58719359|FG001|Overall Study|Lost to Follow-up|1|||
30790859|NCT03524092|58803944|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
30705749|NCT00130039|58719358|FG000|Overall Study|Adverse Event|4|||
30705750|NCT00130039|58719359|FG001|Overall Study|Adverse Event|2|||
30705751|NCT00130039|58719358|FG000|Overall Study|Physician Decision|3|||
30705752|NCT00130039|58719359|FG001|Overall Study|Physician Decision|0|||
30705753|NCT00130039|58719358|FG000|Overall Study|clinical events without follow up MRI|5|||
30705754|NCT00130039|58719359|FG001|Overall Study|clinical events without follow up MRI|4|||
30705755|NCT00475852|58719367|FG000|Overall Study|Death|444|||
30705756|NCT00475852|58719368|FG001|Overall Study|Death|456|||
30705757|NCT00475852|58719367|FG000|Overall Study|Withdrawal by Subject|19|||
30705758|NCT00475852|58719368|FG001|Overall Study|Withdrawal by Subject|24|||
30705759|NCT00475852|58719367|FG000|Overall Study|Lost to Follow-up|54|||
30705760|NCT00475852|58719368|FG001|Overall Study|Lost to Follow-up|68|||
30705761|NCT00141271|58719377|FG000|Overall Study|Adverse Event|31|||
30705762|NCT00141271|58719378|FG001|Overall Study|Adverse Event|19|||
30705763|NCT00141271|58719379|FG002|Overall Study|Adverse Event|17|||
30705764|NCT00141271|58719377|FG000|Overall Study|Laboratory Abnormality|2|||
30705765|NCT00141271|58719378|FG001|Overall Study|Laboratory Abnormality|1|||
30705766|NCT00141271|58719379|FG002|Overall Study|Laboratory Abnormality|1|||
30705767|NCT00141271|58719377|FG000|Overall Study|Lack of Efficacy|7|||
30705768|NCT00141271|58719378|FG001|Overall Study|Lack of Efficacy|7|||
30705769|NCT00141271|58719379|FG002|Overall Study|Lack of Efficacy|3|||
30705770|NCT00141271|58719377|FG000|Overall Study|Lost to Follow-up|15|||
30705771|NCT00141271|58719378|FG001|Overall Study|Lost to Follow-up|15|||
30705772|NCT00141271|58719379|FG002|Overall Study|Lost to Follow-up|21|||
30705773|NCT00141271|58719377|FG000|Overall Study|Withdrawal by Subject|14|||
30705774|NCT00141271|58719378|FG001|Overall Study|Withdrawal by Subject|9|||
30705775|NCT00141271|58719379|FG002|Overall Study|Withdrawal by Subject|10|||
30705776|NCT00141271|58719377|FG000|Overall Study|Other|11|||
30705777|NCT00141271|58719378|FG001|Overall Study|Other|12|||
30705778|NCT00141271|58719379|FG002|Overall Study|Other|5|||
30705779|NCT00614120|58719391|FG000|Overall Study|Adverse Event|9|||
30705780|NCT00614120|58719392|FG001|Overall Study|Adverse Event|22|||
30705781|NCT00614120|58719393|FG002|Overall Study|Adverse Event|30|||
30705782|NCT00614120|58719394|FG003|Overall Study|Adverse Event|3|||
30705783|NCT00614120|58719391|FG000|Overall Study|Lack of Efficacy|3|||
30705784|NCT00614120|58719392|FG001|Overall Study|Lack of Efficacy|3|||
30705785|NCT00614120|58719393|FG002|Overall Study|Lack of Efficacy|2|||
30705786|NCT00614120|58719394|FG003|Overall Study|Lack of Efficacy|2|||
30705787|NCT00614120|58719391|FG000|Overall Study|Protocol Violation|2|||
30705788|NCT00614120|58719392|FG001|Overall Study|Protocol Violation|5|||
30705789|NCT00614120|58719393|FG002|Overall Study|Protocol Violation|3|||
30705790|NCT00614120|58719394|FG003|Overall Study|Protocol Violation|1|||
30705791|NCT00614120|58719391|FG000|Overall Study|Withdrawal criteria|1|||
30705792|NCT00614120|58719392|FG001|Overall Study|Withdrawal criteria|0|||
30705793|NCT00614120|58719393|FG002|Overall Study|Withdrawal criteria|0|||
30705794|NCT00614120|58719394|FG003|Overall Study|Withdrawal criteria|0|||
30705795|NCT00614120|58719391|FG000|Overall Study|Withdrawal by Subject|9|||
30705796|NCT00614120|58719392|FG001|Overall Study|Withdrawal by Subject|10|||
30705797|NCT00614120|58719393|FG002|Overall Study|Withdrawal by Subject|16|||
30705798|NCT00614120|58719394|FG003|Overall Study|Withdrawal by Subject|3|||
30705799|NCT00614120|58719391|FG000|Overall Study|Did not meet trial criteria|0|||
30705800|NCT00614120|58719392|FG001|Overall Study|Did not meet trial criteria|1|||
30705801|NCT00614120|58719393|FG002|Overall Study|Did not meet trial criteria|1|||
30705802|NCT00614120|58719394|FG003|Overall Study|Did not meet trial criteria|1|||
30705803|NCT00614120|58719391|FG000|Overall Study|hCG positive (not pregnant)|0|||
30705804|NCT00614120|58719392|FG001|Overall Study|hCG positive (not pregnant)|0|||
30705805|NCT00614120|58719393|FG002|Overall Study|hCG positive (not pregnant)|1|||
30705806|NCT00614120|58719394|FG003|Overall Study|hCG positive (not pregnant)|0|||
30705807|NCT00614120|58719391|FG000|Overall Study|Hypoglycaemia|0|||
30705808|NCT00614120|58719392|FG001|Overall Study|Hypoglycaemia|0|||
30705809|NCT00614120|58719393|FG002|Overall Study|Hypoglycaemia|0|||
30705810|NCT00614120|58719394|FG003|Overall Study|Hypoglycaemia|1|||
30705811|NCT00614120|58719391|FG000|Overall Study|Lack of trial product|3|||
30705812|NCT00614120|58719392|FG001|Overall Study|Lack of trial product|3|||
30705813|NCT00614120|58719393|FG002|Overall Study|Lack of trial product|2|||
30705814|NCT00614120|58719394|FG003|Overall Study|Lack of trial product|0|||
30705815|NCT00614120|58719391|FG000|Overall Study|Late syphilis, latent|1|||
30705816|NCT00614120|58719392|FG001|Overall Study|Late syphilis, latent|0|||
30705817|NCT00614120|58719393|FG002|Overall Study|Late syphilis, latent|0|||
30705818|NCT00614120|58719394|FG003|Overall Study|Late syphilis, latent|0|||
30705819|NCT00614120|58719391|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
30705820|NCT00614120|58719392|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
30705821|NCT00614120|58719393|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
30705822|NCT00614120|58719394|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
30705823|NCT00614120|58719391|FG000|Overall Study|Lost to Follow-up|1|||
30705824|NCT00614120|58719392|FG001|Overall Study|Lost to Follow-up|2|||
30705825|NCT00614120|58719393|FG002|Overall Study|Lost to Follow-up|3|||
30705826|NCT00614120|58719394|FG003|Overall Study|Lost to Follow-up|4|||
30705827|NCT00496054|58719404|FG000|Overall Study|Adverse Event|1|||
30705828|NCT00496054|58719404|FG000|Overall Study|Lost to Follow-up|7|||
30705829|NCT00495820|58719410|FG000|Overall Study|Adverse Event|1|||
30705830|NCT00495820|58719411|FG001|Overall Study|Adverse Event|1|||
30705831|NCT00495586|58719419|FG000|Overall Study|Withdrawal by Subject|4|||
30705832|NCT00495586|58719420|FG001|Overall Study|Withdrawal by Subject|4|||
30705833|NCT00613730|58719428|FG000|Overall Study|Disease progression|2|||
30705834|NCT00613730|58719428|FG000|Overall Study|Administrative decision|1|||
30705835|NCT00613574|58719432|FG000|Overall Study|Adverse Event|3|||
30705836|NCT00613574|58719432|FG000|Overall Study|Lost to Follow-up|2|||
30705837|NCT00613574|58719432|FG000|Overall Study|Other|1|||
30705838|NCT00613106|58719438|FG000|Overall Study|Adverse Event|3|||
30705839|NCT00613106|58719439|FG001|Overall Study|Adverse Event|1|||
30705840|NCT00613106|58719438|FG000|Overall Study|Withdrawal by Subject|6|||
30705841|NCT00613106|58719439|FG001|Overall Study|Withdrawal by Subject|3|||
30705842|NCT00613106|58719438|FG000|Overall Study|Lost to Follow-up|7|||
30705843|NCT00613106|58719439|FG001|Overall Study|Lost to Follow-up|2|||
30705844|NCT00613106|58719438|FG000|Overall Study|misc|4|||
30705845|NCT00613106|58719439|FG001|Overall Study|misc|3|||
30705846|NCT00141037|58719447|FG000|Overall Study|Physician Decision|1|||
30705847|NCT00141037|58719448|FG001|Overall Study|Physician Decision|2|||
30705848|NCT00141037|58719447|FG000|Overall Study|Lost to Follow-up|3|||
30705849|NCT00141037|58719448|FG001|Overall Study|Lost to Follow-up|1|||
30705850|NCT00141037|58719447|FG000|Overall Study|Protocol Violation|0|||
30705851|NCT00141037|58719448|FG001|Overall Study|Protocol Violation|2|||
30705852|NCT00141037|58719447|FG000|Overall Study|Withdrawal by Subject|2|||
30705853|NCT00141037|58719448|FG001|Overall Study|Withdrawal by Subject|1|||
30705854|NCT00141037|58719447|FG000|Overall Study|Other|0|||
30705855|NCT00141037|58719448|FG001|Overall Study|Other|1|||
30705856|NCT00141037|58719447|FG000|Overall Study|Moved from area|1|||
30705857|NCT00141037|58719448|FG001|Overall Study|Moved from area|7|||
30705858|NCT00141037|58719447|FG000|Overall Study|Graft Failure|3|||
30705859|NCT00141037|58719448|FG001|Overall Study|Graft Failure|4|||
30705860|NCT00140413|58719457|FG000|Overall Study|Lost to Follow-up|1|||
30705861|NCT00140413|58719458|FG001|Overall Study|Lost to Follow-up|0|||
30705862|NCT00140413|58719457|FG000|Overall Study|Withdrawal by Subject|2|||
30705863|NCT00140413|58719458|FG001|Overall Study|Withdrawal by Subject|0|||
30705864|NCT00563706|58719474|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
30705865|NCT00563706|58719475|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
30705866|NCT00563706|58719476|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
30705867|NCT00563706|58719477|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
30705868|NCT00563706|58719478|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
30705869|NCT00563706|58719479|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
30705870|NCT00563706|58719480|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
30705871|NCT00563706|58719481|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
30705872|NCT00563706|58719482|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
30705873|NCT00563706|58719474|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
30705874|NCT00563706|58719475|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
30705875|NCT00563706|58719476|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
30705876|NCT00563706|58719477|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
30705877|NCT00563706|58719478|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
30705878|NCT00563706|58719479|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
30705879|NCT00563706|58719480|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
30705880|NCT00563706|58719481|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
30705881|NCT00563706|58719482|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
30705882|NCT00563706|58719474|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
30705883|NCT00563706|58719475|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
30705884|NCT00563706|58719476|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
30705885|NCT00563706|58719477|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
30705886|NCT00563706|58719478|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
30705887|NCT00563706|58719479|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
30705888|NCT00563706|58719480|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
30705889|NCT00563706|58719481|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
30705890|NCT00563706|58719482|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
30705891|NCT00563706|58719474|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
30705892|NCT00563706|58719475|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
30705893|NCT00563706|58719476|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
30705894|NCT00563706|58719477|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
30705895|NCT00563706|58719478|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
30705896|NCT00563706|58719479|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
30705897|NCT00563706|58719480|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
30705898|NCT00563706|58719481|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
30705899|NCT00563706|58719482|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
30705900|NCT00563706|58719474|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
30705901|NCT00563706|58719475|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
30705902|NCT00563706|58719476|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
30705903|NCT00563706|58719477|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
30705904|NCT00563706|58719478|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
30705905|NCT00563706|58719479|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
30705906|NCT00563706|58719480|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
30705907|NCT00563706|58719481|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
30705908|NCT00563706|58719482|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
30705909|NCT00129961|58719504|FG000|Overall Study|Adverse Event|1|||
30705910|NCT00129961|58719505|FG001|Overall Study|Adverse Event|0|||
30705911|NCT00129961|58719504|FG000|Overall Study|Death|1|||
30705912|NCT00129961|58719505|FG001|Overall Study|Death|1|||
30705913|NCT00129961|58719504|FG000|Overall Study|Withdrawal by Sponsor|14|||
30705914|NCT00129961|58719505|FG001|Overall Study|Withdrawal by Sponsor|20|||
30705915|NCT00129961|58719504|FG000|Overall Study|Physician Decision|1|||
30705916|NCT00129961|58719505|FG001|Overall Study|Physician Decision|0|||
30705917|NCT00129961|58719504|FG000|Overall Study|Withdrawal by Subject|2|||
30705918|NCT00129961|58719505|FG001|Overall Study|Withdrawal by Subject|1|||
30705919|NCT00129961|58719504|FG000|Overall Study|Missing Record|0|||
30705920|NCT00129961|58719505|FG001|Overall Study|Missing Record|1|||
30705921|NCT00528567|58719513|FG000|Overall Study|Death|4|||
30705922|NCT00528567|58719514|FG001|Overall Study|Death|5|||
30705923|NCT00528567|58719513|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
30705924|NCT00528567|58719514|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
30705925|NCT00528567|58719513|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
30705926|NCT00528567|58719514|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
30705927|NCT00528567|58719513|FG000|Overall Study|Violation Criteria at Entry|3|||
30705928|NCT00528567|58719514|FG001|Overall Study|Violation Criteria at Entry|17|||
30705929|NCT00528567|58719513|FG000|Overall Study|Withdrew Consent|59|||
30705930|NCT00528567|58719514|FG001|Overall Study|Withdrew Consent|55|||
30705931|NCT00528567|58719513|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
30705932|NCT00528567|58719514|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
30705933|NCT00528567|58719513|FG000|Overall Study|Failure to Return|1|||
30705934|NCT00528567|58719514|FG001|Overall Study|Failure to Return|4|||
30705935|NCT00528567|58719513|FG000|Overall Study|Other Protocol Violation|5|||
30705936|NCT00528567|58719514|FG001|Overall Study|Other Protocol Violation|21|||
30705937|NCT00528567|58719513|FG000|Overall Study|Administrative/Other|22|||
30705938|NCT00528567|58719514|FG001|Overall Study|Administrative/Other|75|||
30705939|NCT00138151|58719527|FG000|Overall Study|Withdrawal by Subject|3|||
30705940|NCT00138151|58719527|FG000|Overall Study|Physician Decision|1|||
30705941|NCT00138073|58719531|FG000|Overall Study|lack of resources|55|||
30705942|NCT02581631|58719540|FG000|Overall Study|Disease progression|29|||
30705943|NCT02581631|58719541|FG001|Overall Study|Disease progression|19|||
30705944|NCT02581631|58719542|FG002|Overall Study|Disease progression|13|||
30705945|NCT02581631|58719543|FG003|Overall Study|Disease progression|5|||
30705946|NCT02581631|58719544|FG004|Overall Study|Disease progression|8|||
30705947|NCT02581631|58719540|FG000|Overall Study|Study drug toxicity|4|||
30705948|NCT02581631|58719541|FG001|Overall Study|Study drug toxicity|6|||
30705949|NCT02581631|58719542|FG002|Overall Study|Study drug toxicity|7|||
30705950|NCT02581631|58719543|FG003|Overall Study|Study drug toxicity|0|||
30705951|NCT02581631|58719544|FG004|Overall Study|Study drug toxicity|3|||
30705952|NCT02581631|58719540|FG000|Overall Study|AE unrelated to study drug|3|||
30705953|NCT02581631|58719541|FG001|Overall Study|AE unrelated to study drug|1|||
30705954|NCT02581631|58719542|FG002|Overall Study|AE unrelated to study drug|1|||
30705955|NCT02581631|58719543|FG003|Overall Study|AE unrelated to study drug|0|||
30705956|NCT02581631|58719544|FG004|Overall Study|AE unrelated to study drug|2|||
30705957|NCT02581631|58719540|FG000|Overall Study|Request to discontinue|1|||
30705958|NCT02581631|58719541|FG001|Overall Study|Request to discontinue|0|||
30705959|NCT02581631|58719542|FG002|Overall Study|Request to discontinue|3|||
30705960|NCT02581631|58719543|FG003|Overall Study|Request to discontinue|0|||
30705961|NCT02581631|58719544|FG004|Overall Study|Request to discontinue|1|||
30705962|NCT02581631|58719540|FG000|Overall Study|participant withdrew consent|3|||
30705963|NCT02581631|58719541|FG001|Overall Study|participant withdrew consent|0|||
30705964|NCT02581631|58719542|FG002|Overall Study|participant withdrew consent|1|||
30705965|NCT02581631|58719543|FG003|Overall Study|participant withdrew consent|0|||
30705966|NCT02581631|58719544|FG004|Overall Study|participant withdrew consent|0|||
30705967|NCT02581631|58719540|FG000|Overall Study|Maximum clinical benefit|1|||
30705968|NCT02581631|58719541|FG001|Overall Study|Maximum clinical benefit|7|||
30705969|NCT02581631|58719542|FG002|Overall Study|Maximum clinical benefit|1|||
30705970|NCT02581631|58719543|FG003|Overall Study|Maximum clinical benefit|3|||
30705971|NCT02581631|58719544|FG004|Overall Study|Maximum clinical benefit|13|||
30705972|NCT02581631|58719540|FG000|Overall Study|Other Reasons|1|||
30705973|NCT02581631|58719541|FG001|Overall Study|Other Reasons|0|||
30705974|NCT02581631|58719542|FG002|Overall Study|Other Reasons|2|||
30705975|NCT02581631|58719543|FG003|Overall Study|Other Reasons|2|||
30705976|NCT02581631|58719544|FG004|Overall Study|Other Reasons|3|||
30705977|NCT02581631|58719540|FG000|Overall Study|Poor/Non-Compliance|0|||
30705978|NCT02581631|58719541|FG001|Overall Study|Poor/Non-Compliance|0|||
30705979|NCT02581631|58719542|FG002|Overall Study|Poor/Non-Compliance|1|||
30705980|NCT02581631|58719543|FG003|Overall Study|Poor/Non-Compliance|0|||
30705981|NCT02581631|58719544|FG004|Overall Study|Poor/Non-Compliance|0|||
30705982|NCT00529035|58719556|FG000|Overall Study|Withdrawal by Subject|1|||
30705983|NCT00609674|58719569|FG000|Overall Study|Adverse Event|1|||
30705984|NCT00609674|58719570|FG001|Overall Study|Adverse Event|1|||
30705985|NCT00609674|58719569|FG000|Overall Study|Protocol Violation|3|||
30705986|NCT00609674|58719570|FG001|Overall Study|Protocol Violation|5|||
30705987|NCT00609674|58719569|FG000|Overall Study|Lost to Follow-up|1|||
30705988|NCT00609674|58719570|FG001|Overall Study|Lost to Follow-up|0|||
30705989|NCT00609674|58719569|FG000|Overall Study|Withdrew consent|2|||
30705990|NCT00609674|58719570|FG001|Overall Study|Withdrew consent|1|||
30705991|NCT00137839|58719576|FG000|Overall Study|Adverse Event|7|||
30705992|NCT00137839|58719576|FG000|Overall Study|Physician Decision|7|||
30705993|NCT00137839|58719576|FG000|Overall Study|Death|8|||
30705994|NCT00137839|58719576|FG000|Overall Study|Disease Progression|60|||
30705995|NCT00137839|58719576|FG000|Overall Study|Not Start Treatment|1|||
30705996|NCT00137839|58719576|FG000|Overall Study|Prolonged Treatment Delay|1|||
30705997|NCT00563316|58719583|FG000|Overall Study|Adverse Event|2|||
30705998|NCT00563316|58719583|FG000|Overall Study|Physician Decision|1|||
30705999|NCT00563316|58719583|FG000|Overall Study|Lost to Follow-up|2|||
30706000|NCT00563316|58719583|FG000|Overall Study|Death|1|||
30706001|NCT00563316|58719583|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
30706002|NCT00563316|58719583|FG000|Overall Study|Other|1|||
30706003|NCT03178487|58719593|FG000|Period 1|Adverse Event|1|||
30706004|NCT03178487|58719594|FG001|Period 1|Adverse Event|2|||
30706005|NCT03178487|58719593|FG000|Period 1|Withdrawal by Subject|2|||
30706006|NCT03178487|58719594|FG001|Period 1|Withdrawal by Subject|1|||
30706007|NCT03178487|58719593|FG000|Period 1|Lost to Follow-up|1|||
30706008|NCT03178487|58719594|FG001|Period 1|Lost to Follow-up|0|||
30706009|NCT03178487|58719593|FG000|Period 1|Other|0|||
30706010|NCT03178487|58719594|FG001|Period 1|Other|1|||
30706011|NCT03178487|58719593|FG000|Period 2|Adverse Event|4|||
30706012|NCT03178487|58719594|FG001|Period 2|Adverse Event|4|||
30706013|NCT03178487|58719593|FG000|Period 2|Withdrawal by Subject|6|||
30706014|NCT03178487|58719594|FG001|Period 2|Withdrawal by Subject|6|||
30706015|NCT03178487|58719593|FG000|Period 2|Lost to Follow-up|2|||
30706016|NCT03178487|58719594|FG001|Period 2|Lost to Follow-up|2|||
30706017|NCT03178487|58719593|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
30706018|NCT03178487|58719594|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
30706019|NCT03178487|58719593|FG000|Period 2|Other|8|||
30706020|NCT03178487|58719594|FG001|Period 2|Other|7|||
30706021|NCT00528957|58719603|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
30706022|NCT00528957|58719604|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
30706023|NCT00528957|58719603|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
30706024|NCT00528957|58719604|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
30706025|NCT00528957|58719603|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
30706026|NCT00528957|58719604|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
30706027|NCT00528957|58719603|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
30706028|NCT00528957|58719604|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
30706029|NCT00528957|58719603|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
30706030|NCT00528957|58719604|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
30706031|NCT00528957|58719603|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
30706032|NCT00528957|58719604|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
30706033|NCT00528957|58719603|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
30706034|NCT00528957|58719604|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
30706035|NCT00528957|58719603|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
30706036|NCT00528957|58719604|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
30706037|NCT00528957|58719603|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
30706038|NCT00528957|58719604|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
30706039|NCT00528957|58719603|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
30706040|NCT00528957|58719604|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
30706041|NCT00528957|58719603|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
30706042|NCT00528957|58719604|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
30706043|NCT00528957|58719603|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
30706044|NCT00528957|58719604|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
30706045|NCT00528957|58719603|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
30706046|NCT00528957|58719604|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
30706047|NCT00528957|58719603|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
30706048|NCT00528957|58719604|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
30706049|NCT00528957|58719603|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
30706050|NCT00528957|58719604|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
30706051|NCT00528957|58719603|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
30706052|NCT00528957|58719604|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
30706053|NCT00560508|58719622|FG000|12 Week Double-blind Period|Adverse Event|3|||
30706054|NCT00560508|58719623|FG001|12 Week Double-blind Period|Adverse Event|2|||
30706055|NCT00560508|58719622|FG000|12 Week Double-blind Period|Protocol Violation|1|||
30706056|NCT00560508|58719623|FG001|12 Week Double-blind Period|Protocol Violation|0|||
30706057|NCT00560508|58719622|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
30706058|NCT00560508|58719623|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
30706059|NCT00560508|58719622|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
30706060|NCT00560508|58719623|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
30706061|NCT00560508|58719622|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
30706062|NCT00560508|58719623|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
30706063|NCT00560508|58719622|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
30706064|NCT00560508|58719623|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
30706065|NCT00560508|58719622|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
30706066|NCT00560508|58719623|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
30706067|NCT03962790|58719634|FG000|Period 1|Adverse Event|0|||
30706068|NCT03962790|58719635|FG001|Period 1|Adverse Event|1|||
30706069|NCT03962790|58719634|FG000|Period 1|Failed to meet all eligibility criteria|1|||
30706070|NCT03962790|58719635|FG001|Period 1|Failed to meet all eligibility criteria|1|||
30706071|NCT03962790|58719634|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
30706072|NCT03962790|58719635|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
30706073|NCT03962790|58719634|FG000|Period 1|Withdrawal by Subject|1|||
30894020|NCT02175771|58927587|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30706074|NCT03962790|58719635|FG001|Period 1|Withdrawal by Subject|0|||
30706075|NCT00609518|58719643|FG000|Overall Study|Death from Study Disease|32|||
30706076|NCT00609518|58719644|FG001|Overall Study|Death from Study Disease|32|||
30706077|NCT00609518|58719643|FG000|Overall Study|Withdrawal by Subject|5|||
30894021|NCT02175771|58927579|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
30894022|NCT02175771|58927580|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
30894023|NCT02175771|58927581|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
30894024|NCT02175771|58927582|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
30894025|NCT02175771|58927583|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
30894026|NCT02175771|58927584|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
30894027|NCT02175771|58927585|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
30894028|NCT02175771|58927586|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
30894029|NCT02175771|58927587|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
30894030|NCT02175771|58927579|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
30894031|NCT02175771|58927580|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30894032|NCT02175771|58927581|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30894033|NCT02175771|58927582|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30894034|NCT02175771|58927583|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30894035|NCT02175771|58927584|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30894036|NCT02175771|58927585|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30894037|NCT02175771|58927586|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30894038|NCT02175771|58927587|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30894039|NCT02175771|58927579|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
30894040|NCT02175771|58927580|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30894041|NCT02175771|58927581|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30894042|NCT02175771|58927582|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30894043|NCT02175771|58927583|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30894044|NCT02175771|58927584|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30894045|NCT02175771|58927585|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30894046|NCT02175771|58927586|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30894047|NCT02175771|58927587|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30894048|NCT02175771|58927579|FG000|Run-In Period (Pre-assignment)|Other|8|||
30894049|NCT02175771|58927580|FG001|Run-In Period (Pre-assignment)|Other|0|||
30894050|NCT02175771|58927581|FG002|Run-In Period (Pre-assignment)|Other|0|||
30894051|NCT02175771|58927582|FG003|Run-In Period (Pre-assignment)|Other|0|||
30894052|NCT02175771|58927583|FG004|Run-In Period (Pre-assignment)|Other|0|||
30894053|NCT02175771|58927584|FG005|Run-In Period (Pre-assignment)|Other|0|||
30894054|NCT02175771|58927585|FG006|Run-In Period (Pre-assignment)|Other|0|||
30894055|NCT02175771|58927586|FG007|Run-In Period (Pre-assignment)|Other|0|||
30894056|NCT02175771|58927587|FG008|Run-In Period (Pre-assignment)|Other|0|||
30894057|NCT02175771|58927579|FG000|Treatment Period|Adverse Event|0|||
30894058|NCT02175771|58927580|FG001|Treatment Period|Adverse Event|2|||
30706078|NCT00609518|58719644|FG001|Overall Study|Withdrawal by Subject|3|||
30706079|NCT00609518|58719643|FG000|Overall Study|Lost to Follow-up|3|||
30706080|NCT00609518|58719644|FG001|Overall Study|Lost to Follow-up|0|||
30706081|NCT00609518|58719643|FG000|Overall Study|Physician Decision|1|||
30706082|NCT00609518|58719644|FG001|Overall Study|Physician Decision|3|||
30706083|NCT00609518|58719643|FG000|Overall Study|Death from Adverse Event|2|||
30706084|NCT00609518|58719644|FG001|Overall Study|Death from Adverse Event|2|||
30706085|NCT00609362|58719652|FG000|Overall Study|Withdrawal by Subject|2|||
30706086|NCT00609362|58719653|FG001|Overall Study|Withdrawal by Subject|1|||
30706087|NCT00609362|58719652|FG000|Overall Study|Adverse Event|1|||
30706088|NCT00609362|58719653|FG001|Overall Study|Adverse Event|0|||
30706089|NCT00611858|58719659|FG000|Overall Study|Adverse Event|2|||
30706090|NCT00611858|58719659|FG000|Overall Study|Withdrawal by Subject|2|||
30706091|NCT00137449|58719667|FG000|Overall Study|Disease Progression|8|||
30706092|NCT00137449|58719668|FG001|Overall Study|Disease Progression|13|||
30706093|NCT00137449|58719667|FG000|Overall Study|Death|4|||
30706094|NCT00137449|58719668|FG001|Overall Study|Death|3|||
30706095|NCT00137449|58719667|FG000|Overall Study|Adverse Event|3|||
30706096|NCT00137449|58719668|FG001|Overall Study|Adverse Event|1|||
30706097|NCT00137449|58719667|FG000|Overall Study|Withdrawal by Subject|1|||
30706098|NCT00137449|58719668|FG001|Overall Study|Withdrawal by Subject|1|||
30706099|NCT00528879|58719679|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
30706100|NCT00528879|58719680|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
30894059|NCT02175771|58927581|FG002|Treatment Period|Adverse Event|1|||
30894060|NCT02175771|58927582|FG003|Treatment Period|Adverse Event|1|||
30706101|NCT00528879|58719681|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
30706102|NCT00528879|58719682|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
30894061|NCT02175771|58927583|FG004|Treatment Period|Adverse Event|1|||
30706103|NCT00528879|58719679|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
30706104|NCT00528879|58719680|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
30706105|NCT00528879|58719681|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
30706106|NCT00528879|58719682|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
30706107|NCT00528879|58719679|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
30706108|NCT00528879|58719680|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
30706109|NCT00528879|58719681|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
30706110|NCT00528879|58719682|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
30706111|NCT00528879|58719679|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
30706112|NCT00528879|58719680|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
30706113|NCT00528879|58719681|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
30706114|NCT00528879|58719682|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
30706115|NCT00528879|58719679|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
30706116|NCT00528879|58719680|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
30706117|NCT00528879|58719681|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
30706118|NCT00528879|58719682|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
30706119|NCT00528879|58719679|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
30706120|NCT00528879|58719680|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
30706121|NCT00528879|58719681|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
30706122|NCT00528879|58719682|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
30706123|NCT00528879|58719679|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
30706124|NCT00528879|58719680|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
30706125|NCT00528879|58719681|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
30706126|NCT00528879|58719682|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
30706127|NCT00528879|58719679|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
30706128|NCT00528879|58719680|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
30706129|NCT00528879|58719681|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
30706130|NCT00528879|58719682|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
30706131|NCT00528879|58719679|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
30706132|NCT00528879|58719680|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
30706133|NCT00528879|58719681|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
30706134|NCT00528879|58719682|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
30706135|NCT00528879|58719679|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
30706136|NCT00528879|58719680|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
30706137|NCT00528879|58719681|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
30706138|NCT00528879|58719682|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
30706139|NCT00528879|58719679|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
30706140|NCT00528879|58719680|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
30706141|NCT00528879|58719681|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
30706142|NCT00528879|58719682|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
30706143|NCT00528879|58719679|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
30706144|NCT00528879|58719680|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
30706145|NCT00528879|58719681|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
30706146|NCT00528879|58719682|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
30706147|NCT00528879|58719679|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
30706148|NCT00528879|58719680|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
30706149|NCT00528879|58719681|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
30706150|NCT00528879|58719682|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
30706151|NCT00528879|58719679|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
30706152|NCT00528879|58719680|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
30706153|NCT00528879|58719681|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
30706154|NCT00528879|58719682|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
30706155|NCT00528879|58719679|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
30706156|NCT00528879|58719680|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
30706157|NCT00528879|58719681|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
30706158|NCT00528879|58719682|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
30706159|NCT00528879|58719679|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
30706160|NCT00528879|58719680|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
30706161|NCT00528879|58719681|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
30706162|NCT00528879|58719682|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
30706163|NCT00608894|58719694|FG000|Overall Study|Withdrawal by Subject|0|||
30706164|NCT00608894|58719695|FG001|Overall Study|Withdrawal by Subject|2|||
30706165|NCT00557856|58719703|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
30706166|NCT00557856|58719704|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
30706167|NCT00557856|58719705|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
30894062|NCT02175771|58927584|FG005|Treatment Period|Adverse Event|3|||
30894063|NCT02175771|58927585|FG006|Treatment Period|Adverse Event|2|||
30894064|NCT02175771|58927586|FG007|Treatment Period|Adverse Event|0|||
30706168|NCT00557856|58719706|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
30706169|NCT00557856|58719707|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
30706170|NCT00557856|58719708|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
30706171|NCT00557856|58719709|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
30706172|NCT00557856|58719710|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
30706173|NCT00557856|58719711|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
30706174|NCT00557856|58719703|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
30706175|NCT00557856|58719704|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
30706176|NCT00557856|58719705|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
30706177|NCT00557856|58719706|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
30706178|NCT00557856|58719707|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
30706179|NCT00557856|58719708|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
30894065|NCT02175771|58927587|FG008|Treatment Period|Adverse Event|1|||
30894066|NCT02175771|58927579|FG000|Treatment Period|Withdrawal by Subject|0|||
30894067|NCT02175771|58927580|FG001|Treatment Period|Withdrawal by Subject|9|||
30706180|NCT00557856|58719709|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
30706181|NCT00557856|58719710|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
30706182|NCT00557856|58719711|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
30706183|NCT00557856|58719703|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
30706184|NCT00557856|58719704|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
30706185|NCT00557856|58719705|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
30706186|NCT00557856|58719706|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
30706187|NCT00557856|58719707|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
30706188|NCT00557856|58719708|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
30706189|NCT00557856|58719709|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
30706190|NCT00557856|58719710|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
30706191|NCT00557856|58719711|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
30706192|NCT00557856|58719703|FG000|Part 1: Dose Escalation Phase|Other|0|||
30706193|NCT00557856|58719704|FG001|Part 1: Dose Escalation Phase|Other|0|||
30706194|NCT00557856|58719705|FG002|Part 1: Dose Escalation Phase|Other|1|||
30706195|NCT00557856|58719706|FG003|Part 1: Dose Escalation Phase|Other|1|||
30706196|NCT00557856|58719707|FG004|Part 1: Dose Escalation Phase|Other|0|||
30706197|NCT00557856|58719708|FG005|Part 1: Dose Escalation Phase|Other|0|||
30706198|NCT00557856|58719709|FG006|Part 1: Dose Escalation Phase|Other|0|||
30706199|NCT00557856|58719710|FG007|Part 1: Dose Escalation Phase|Other|1|||
30706200|NCT00557856|58719711|FG008|Part 1: Dose Escalation Phase|Other|0|||
30706201|NCT00557856|58719703|FG000|Part 1: Dose Escalation Phase|Death|0|||
30706202|NCT00557856|58719704|FG001|Part 1: Dose Escalation Phase|Death|0|||
30706203|NCT00557856|58719705|FG002|Part 1: Dose Escalation Phase|Death|0|||
30706204|NCT00557856|58719706|FG003|Part 1: Dose Escalation Phase|Death|0|||
30706205|NCT00557856|58719707|FG004|Part 1: Dose Escalation Phase|Death|0|||
30706206|NCT00557856|58719708|FG005|Part 1: Dose Escalation Phase|Death|1|||
30706207|NCT00557856|58719709|FG006|Part 1: Dose Escalation Phase|Death|0|||
30706208|NCT00557856|58719710|FG007|Part 1: Dose Escalation Phase|Death|0|||
30706209|NCT00557856|58719711|FG008|Part 1: Dose Escalation Phase|Death|0|||
30706210|NCT00557856|58719703|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
30706211|NCT00557856|58719704|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
30706212|NCT00557856|58719705|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
30706213|NCT00557856|58719706|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
30706214|NCT00557856|58719707|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
30706215|NCT00557856|58719708|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
30706216|NCT00557856|58719709|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
30706217|NCT00557856|58719710|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
30706218|NCT00557856|58719711|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
30706219|NCT00557856|58719703|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
30706220|NCT00557856|58719704|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
30706221|NCT00557856|58719705|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
30706222|NCT00557856|58719706|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
30706223|NCT00557856|58719707|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
30706224|NCT00557856|58719708|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
30894068|NCT02175771|58927581|FG002|Treatment Period|Withdrawal by Subject|3|||
30894069|NCT02175771|58927582|FG003|Treatment Period|Withdrawal by Subject|6|||
30894070|NCT02175771|58927583|FG004|Treatment Period|Withdrawal by Subject|2|||
30894071|NCT02175771|58927584|FG005|Treatment Period|Withdrawal by Subject|4|||
30894072|NCT02175771|58927585|FG006|Treatment Period|Withdrawal by Subject|2|||
30894073|NCT02175771|58927586|FG007|Treatment Period|Withdrawal by Subject|9|||
30894074|NCT02175771|58927587|FG008|Treatment Period|Withdrawal by Subject|2|||
30894075|NCT02175771|58927579|FG000|Treatment Period|Noncompliance|0|||
30706225|NCT00557856|58719709|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
30706226|NCT00557856|58719710|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
30706227|NCT00557856|58719711|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
30706228|NCT00557856|58719703|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
30706229|NCT00557856|58719704|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
30706230|NCT00557856|58719705|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
30706231|NCT00557856|58719706|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
30706232|NCT00557856|58719707|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
30706233|NCT00557856|58719708|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
30706234|NCT00557856|58719709|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
30706235|NCT00557856|58719710|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
30706236|NCT00557856|58719711|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
30706237|NCT00557856|58719703|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
30706238|NCT00557856|58719704|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
30706239|NCT00557856|58719705|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
30706240|NCT00557856|58719706|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
30706241|NCT00557856|58719707|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
30706242|NCT00557856|58719708|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
30706243|NCT00557856|58719709|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
30706244|NCT00557856|58719710|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
30706245|NCT00557856|58719711|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
30706246|NCT00557856|58719703|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
30706247|NCT00557856|58719704|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
30706248|NCT00557856|58719705|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
30706249|NCT00557856|58719706|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
30706250|NCT00557856|58719707|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
30706251|NCT00557856|58719708|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
30706252|NCT00557856|58719709|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
30706253|NCT00557856|58719710|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
30706254|NCT00557856|58719711|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
30706255|NCT00557856|58719703|FG000|Part 2: Exploratory Phase|Other|0|||
30706256|NCT00557856|58719704|FG001|Part 2: Exploratory Phase|Other|0|||
30706257|NCT00557856|58719705|FG002|Part 2: Exploratory Phase|Other|0|||
30706258|NCT00557856|58719706|FG003|Part 2: Exploratory Phase|Other|0|||
30706259|NCT00557856|58719707|FG004|Part 2: Exploratory Phase|Other|0|||
30706260|NCT00557856|58719708|FG005|Part 2: Exploratory Phase|Other|0|||
30706261|NCT00557856|58719709|FG006|Part 2: Exploratory Phase|Other|0|||
30706262|NCT00557856|58719710|FG007|Part 2: Exploratory Phase|Other|0|||
30706263|NCT00557856|58719711|FG008|Part 2: Exploratory Phase|Other|1|||
30706264|NCT00557856|58719703|FG000|Part 2: Exploratory Phase|Death|0|||
30706265|NCT00557856|58719704|FG001|Part 2: Exploratory Phase|Death|0|||
30706266|NCT00557856|58719705|FG002|Part 2: Exploratory Phase|Death|0|||
30706267|NCT00557856|58719706|FG003|Part 2: Exploratory Phase|Death|0|||
30706268|NCT00557856|58719707|FG004|Part 2: Exploratory Phase|Death|0|||
30706269|NCT00557856|58719708|FG005|Part 2: Exploratory Phase|Death|0|||
30706270|NCT00557856|58719709|FG006|Part 2: Exploratory Phase|Death|0|||
30706271|NCT00557856|58719710|FG007|Part 2: Exploratory Phase|Death|0|||
30706272|NCT00557856|58719711|FG008|Part 2: Exploratory Phase|Death|2|||
30706273|NCT00557856|58719703|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
30894076|NCT02175771|58927580|FG001|Treatment Period|Noncompliance|1|||
30894077|NCT02175771|58927581|FG002|Treatment Period|Noncompliance|2|||
30894078|NCT02175771|58927582|FG003|Treatment Period|Noncompliance|0|||
30894079|NCT02175771|58927583|FG004|Treatment Period|Noncompliance|0|||
30894080|NCT02175771|58927584|FG005|Treatment Period|Noncompliance|0|||
30894081|NCT02175771|58927585|FG006|Treatment Period|Noncompliance|0|||
30894082|NCT02175771|58927586|FG007|Treatment Period|Noncompliance|0|||
30894083|NCT02175771|58927587|FG008|Treatment Period|Noncompliance|1|||
30706274|NCT00557856|58719704|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
30706275|NCT00557856|58719705|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
30706276|NCT00557856|58719706|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
30894084|NCT02175771|58927579|FG000|Treatment Period|Protocol Violation|0|||
30706277|NCT00557856|58719707|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
30706278|NCT00557856|58719708|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
30706279|NCT00557856|58719709|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
30706280|NCT00557856|58719710|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
30706281|NCT00557856|58719711|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
30706282|NCT00191113|58719728|FG000|Core Study|Withdrawal by Subject|25|||
30706283|NCT00191113|58719729|FG001|Core Study|Withdrawal by Subject|9|||
30706284|NCT00191113|58719728|FG000|Core Study|Protocol Violation|6|||
30706285|NCT00191113|58719729|FG001|Core Study|Protocol Violation|2|||
30706286|NCT00191113|58719728|FG000|Core Study|Lost to Follow-up|3|||
30706287|NCT00191113|58719729|FG001|Core Study|Lost to Follow-up|0|||
30706288|NCT00191113|58719728|FG000|Core Study|Adverse Event|0|||
30706289|NCT00191113|58719729|FG001|Core Study|Adverse Event|2|||
30706290|NCT00191113|58719728|FG000|Core Study|Lack of Efficacy|0|||
30706291|NCT00191113|58719729|FG001|Core Study|Lack of Efficacy|2|||
30706292|NCT00191113|58719728|FG000|Core Study|Death|1|||
30706293|NCT00191113|58719729|FG001|Core Study|Death|0|||
30706294|NCT00608582|58719743|FG000|Overall Study|Lost to Follow-up|2|||
30706295|NCT00608582|58719744|FG001|Overall Study|Lost to Follow-up|0|||
30706296|NCT00608582|58719743|FG000|Overall Study|No Best Response in Phase 1 located|1|||
30894085|NCT02175771|58927580|FG001|Treatment Period|Protocol Violation|0|||
30894086|NCT02175771|58927581|FG002|Treatment Period|Protocol Violation|0|||
30706297|NCT00608582|58719744|FG001|Overall Study|No Best Response in Phase 1 located|1|||
30706298|NCT00608582|58719743|FG000|Overall Study|Illicit Drug Use|1|||
30706299|NCT00608582|58719744|FG001|Overall Study|Illicit Drug Use|0|||
30706300|NCT00608582|58719743|FG000|Overall Study|Early stage Design Change|0|||
30706301|NCT00608582|58719744|FG001|Overall Study|Early stage Design Change|3|||
30706302|NCT03965052|58719754|FG000|Overall Study|Protocol Violation|1|||
30706303|NCT03965052|58719755|FG001|Overall Study|Protocol Violation|0|||
30706304|NCT03964974|58719763|FG000|Overall Study|Lost to Follow-up|3|||
30706305|NCT03964974|58719764|FG001|Overall Study|Lost to Follow-up|2|||
30706306|NCT03964974|58719763|FG000|Overall Study|Withdrawal by Subject|0|||
30706307|NCT03964974|58719764|FG001|Overall Study|Withdrawal by Subject|3|||
30706308|NCT00606320|58719770|FG000|Overall Study|Adverse Event|3|||
30706309|NCT00606320|58719770|FG000|Overall Study|Lack of Efficacy|5|||
30706310|NCT00606320|58719770|FG000|Overall Study|Physician Decision|7|||
30706311|NCT00606320|58719770|FG000|Overall Study|Protocol Violation|8|||
30706312|NCT00606320|58719770|FG000|Overall Study|Withdrawal by Subject|10|||
30706313|NCT00606320|58719770|FG000|Overall Study|Progression to depressive phase|4|||
30706314|NCT00528411|58719777|FG000|Overall Study|Adverse Event|4|||
30706315|NCT00528411|58719778|FG001|Overall Study|Adverse Event|0|||
30706316|NCT00528411|58719779|FG002|Overall Study|Adverse Event|1|||
30706317|NCT00528411|58719777|FG000|Overall Study|Incorrect Enrolment|1|||
30706318|NCT00528411|58719778|FG001|Overall Study|Incorrect Enrolment|1|||
30706319|NCT00528411|58719779|FG002|Overall Study|Incorrect Enrolment|0|||
30706320|NCT00528411|58719777|FG000|Overall Study|Severe non-compliance to protocol|0|||
30706321|NCT00528411|58719778|FG001|Overall Study|Severe non-compliance to protocol|1|||
30706322|NCT00528411|58719779|FG002|Overall Study|Severe non-compliance to protocol|0|||
30706323|NCT00528411|58719777|FG000|Overall Study|Prior commitment medication|0|||
30706324|NCT00528411|58719778|FG001|Overall Study|Prior commitment medication|1|||
30706325|NCT00528411|58719779|FG002|Overall Study|Prior commitment medication|0|||
30706326|NCT00136357|58719789|FG000|Overall Study|Withdrawal by Subject|3|||
30706327|NCT00136357|58719790|FG001|Overall Study|Withdrawal by Subject|2|||
30894087|NCT02175771|58927582|FG003|Treatment Period|Protocol Violation|0|||
30706328|NCT00129649|58719798|FG000|Overall Study|Withdrawal by Subject|76|||
30706329|NCT00129649|58719799|FG001|Overall Study|Withdrawal by Subject|65|||
30706330|NCT00187135|58719811|FG000|Visit One|Withdrawal by Subject|1|||
30706331|NCT00187135|58719812|FG001|Visit One|Withdrawal by Subject|0|||
30706332|NCT00187135|58719813|FG002|Visit One|Withdrawal by Subject|0|||
30706333|NCT00187135|58719814|FG003|Visit One|Withdrawal by Subject|0|||
30706334|NCT00187135|58719815|FG004|Visit One|Withdrawal by Subject|0|||
30706335|NCT00187135|58719816|FG005|Visit One|Withdrawal by Subject|1|||
30706336|NCT00187135|58719811|FG000|Visit One|Physician Decision|3|||
30706337|NCT00187135|58719812|FG001|Visit One|Physician Decision|1|||
30706338|NCT00187135|58719813|FG002|Visit One|Physician Decision|0|||
30706339|NCT00187135|58719814|FG003|Visit One|Physician Decision|0|||
30706340|NCT00187135|58719815|FG004|Visit One|Physician Decision|0|||
30706341|NCT00187135|58719816|FG005|Visit One|Physician Decision|1|||
30706342|NCT00187135|58719811|FG000|Visit Two|Death|0|||
30706343|NCT00187135|58719812|FG001|Visit Two|Death|0|||
30706344|NCT00187135|58719813|FG002|Visit Two|Death|0|||
30706345|NCT00187135|58719814|FG003|Visit Two|Death|1|||
30706346|NCT00187135|58719815|FG004|Visit Two|Death|0|||
30706347|NCT00187135|58719816|FG005|Visit Two|Death|1|||
30706348|NCT00187135|58719811|FG000|Visit Two|Physician Decision|1|||
30706349|NCT00187135|58719812|FG001|Visit Two|Physician Decision|0|||
30706350|NCT00187135|58719813|FG002|Visit Two|Physician Decision|0|||
30706351|NCT00187135|58719814|FG003|Visit Two|Physician Decision|0|||
30706352|NCT00187135|58719815|FG004|Visit Two|Physician Decision|0|||
30706353|NCT00187135|58719816|FG005|Visit Two|Physician Decision|0|||
30706354|NCT00187135|58719811|FG000|Visit Two|Withdrawal by Subject|1|||
30706355|NCT00187135|58719812|FG001|Visit Two|Withdrawal by Subject|1|||
30706356|NCT00187135|58719813|FG002|Visit Two|Withdrawal by Subject|1|||
30706357|NCT00187135|58719814|FG003|Visit Two|Withdrawal by Subject|0|||
30706358|NCT00187135|58719815|FG004|Visit Two|Withdrawal by Subject|1|||
30706359|NCT00187135|58719816|FG005|Visit Two|Withdrawal by Subject|1|||
30706360|NCT00187135|58719811|FG000|Visit Two|Study Discontinued|3|||
30706361|NCT00187135|58719812|FG001|Visit Two|Study Discontinued|2|||
30706362|NCT00187135|58719813|FG002|Visit Two|Study Discontinued|1|||
30706363|NCT00187135|58719814|FG003|Visit Two|Study Discontinued|7|||
30706364|NCT00187135|58719815|FG004|Visit Two|Study Discontinued|5|||
30706365|NCT00187135|58719816|FG005|Visit Two|Study Discontinued|6|||
30706366|NCT00187135|58719811|FG000|Visit Three|Death|0|||
30706367|NCT00187135|58719812|FG001|Visit Three|Death|0|||
30706368|NCT00187135|58719813|FG002|Visit Three|Death|1|||
30706369|NCT00187135|58719814|FG003|Visit Three|Death|0|||
30706370|NCT00187135|58719815|FG004|Visit Three|Death|1|||
30706371|NCT00187135|58719816|FG005|Visit Three|Death|0|||
30706372|NCT00187135|58719811|FG000|Visit Three|Withdrawal by Subject|0|||
30706373|NCT00187135|58719812|FG001|Visit Three|Withdrawal by Subject|1|||
30706374|NCT00187135|58719813|FG002|Visit Three|Withdrawal by Subject|1|||
30706375|NCT00187135|58719814|FG003|Visit Three|Withdrawal by Subject|2|||
30706376|NCT00187135|58719815|FG004|Visit Three|Withdrawal by Subject|0|||
30706377|NCT00187135|58719816|FG005|Visit Three|Withdrawal by Subject|0|||
30706378|NCT00187135|58719811|FG000|Visit Three|Study Discontinued|7|||
30706379|NCT00187135|58719812|FG001|Visit Three|Study Discontinued|6|||
30706380|NCT00187135|58719813|FG002|Visit Three|Study Discontinued|7|||
30706381|NCT00187135|58719814|FG003|Visit Three|Study Discontinued|7|||
30706382|NCT00187135|58719815|FG004|Visit Three|Study Discontinued|7|||
30706383|NCT00187135|58719816|FG005|Visit Three|Study Discontinued|6|||
30706384|NCT00528021|58719832|FG000|Overall Study|Lack of Efficacy|17|||
30706385|NCT00528021|58719833|FG001|Overall Study|Lack of Efficacy|13|||
30706386|NCT00528021|58719834|FG002|Overall Study|Lack of Efficacy|7|||
30706387|NCT00528021|58719835|FG003|Overall Study|Lack of Efficacy|9|||
30706388|NCT00560352|58719848|FG000|Overall Study|Adverse event unrelated to study drug|2|||
30706389|NCT00560352|58719849|FG001|Overall Study|Adverse event unrelated to study drug|1|||
30706390|NCT00560352|58719850|FG002|Overall Study|Adverse event unrelated to study drug|1|||
30706391|NCT00560352|58719848|FG000|Overall Study|Study drug toxicity|3|||
30706392|NCT00560352|58719849|FG001|Overall Study|Study drug toxicity|0|||
30706393|NCT00560352|58719850|FG002|Overall Study|Study drug toxicity|1|||
30706394|NCT00560352|58719848|FG000|Overall Study|Disease progression|0|||
30706395|NCT00560352|58719849|FG001|Overall Study|Disease progression|1|||
30706396|NCT00560352|58719850|FG002|Overall Study|Disease progression|1|||
30706397|NCT00560352|58719848|FG000|Overall Study|Withdrawal by Subject|1|||
30706398|NCT00560352|58719849|FG001|Overall Study|Withdrawal by Subject|1|||
30706399|NCT00560352|58719850|FG002|Overall Study|Withdrawal by Subject|1|||
30706400|NCT00560352|58719848|FG000|Overall Study|Maximum clinical benefit|1|||
30706401|NCT00560352|58719849|FG001|Overall Study|Maximum clinical benefit|0|||
30706402|NCT00560352|58719850|FG002|Overall Study|Maximum clinical benefit|0|||
30706403|NCT00527787|58719864|FG000|Overall Study|Adverse Event|14|||
30706404|NCT00527787|58719865|FG001|Overall Study|Adverse Event|24|||
30706405|NCT00527787|58719864|FG000|Overall Study|Withdrawal by Subject|13|||
30706406|NCT00527787|58719865|FG001|Overall Study|Withdrawal by Subject|25|||
30706407|NCT00527787|58719864|FG000|Overall Study|Lost to Follow-up|5|||
30706408|NCT00527787|58719865|FG001|Overall Study|Lost to Follow-up|2|||
30706409|NCT00527787|58719864|FG000|Overall Study|Duodenal Ulcer|1|||
30706410|NCT00527787|58719865|FG001|Overall Study|Duodenal Ulcer|10|||
30706411|NCT00527787|58719864|FG000|Overall Study|misc|5|||
30706412|NCT00527787|58719865|FG001|Overall Study|misc|2|||
30706413|NCT00608426|58719873|FG000|Overall Study|Death|32|||
30706414|NCT00608426|58719874|FG001|Overall Study|Death|36|||
30706415|NCT00608426|58719873|FG000|Overall Study|Lost to Follow-up|485|||
30706416|NCT00608426|58719874|FG001|Overall Study|Lost to Follow-up|521|||
30706417|NCT00608426|58719873|FG000|Overall Study|refused, health issues, wrong address|319|||
30706418|NCT00608426|58719874|FG001|Overall Study|refused, health issues, wrong address|348|||
30706419|NCT00557076|58719882|FG000|Overall Study|Unblinding|0|||
30706420|NCT00557076|58719883|FG001|Overall Study|Unblinding|1|||
30706421|NCT00129259|58719891|FG000|Overall Study|Lost to Follow-up|1|||
30706422|NCT00129259|58719892|FG001|Overall Study|Lost to Follow-up|1|||
30706423|NCT00129259|58719891|FG000|Overall Study|Withdrawal by Subject|2|||
30706424|NCT00129259|58719892|FG001|Overall Study|Withdrawal by Subject|1|||
30706425|NCT00129259|58719891|FG000|Overall Study|Only available minimal phone assessments|0|||
30706426|NCT00129259|58719892|FG001|Overall Study|Only available minimal phone assessments|1|||
30706427|NCT00186901|58719901|FG000|Overall Study|Pregnancy|6|||
30706428|NCT00186901|58719902|FG001|Overall Study|Pregnancy|3|||
30706429|NCT00186901|58719903|FG002|Overall Study|Pregnancy|0|||
30706430|NCT00186901|58719901|FG000|Overall Study|Lost to Follow-up|6|||
30706431|NCT00186901|58719902|FG001|Overall Study|Lost to Follow-up|3|||
30706432|NCT00186901|58719903|FG002|Overall Study|Lost to Follow-up|0|||
30706433|NCT00186901|58719901|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
30706434|NCT00186901|58719902|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
30706435|NCT00186901|58719903|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
30706436|NCT00186901|58719901|FG000|Overall Study|ALL relapse or second malignancy|1|||
30706437|NCT00186901|58719902|FG001|Overall Study|ALL relapse or second malignancy|2|||
30706438|NCT00186901|58719903|FG002|Overall Study|ALL relapse or second malignancy|0|||
30706439|NCT00186901|58719901|FG000|Overall Study|Withdrawal by Subject|4|||
30706440|NCT00186901|58719902|FG001|Overall Study|Withdrawal by Subject|5|||
30706441|NCT00186901|58719903|FG002|Overall Study|Withdrawal by Subject|0|||
30706442|NCT00186901|58719901|FG000|Overall Study|Open label|3|||
30706443|NCT00186901|58719902|FG001|Overall Study|Open label|2|||
30706444|NCT00186901|58719903|FG002|Overall Study|Open label|0|||
30706445|NCT00186901|58719901|FG000|Overall Study|Limited adherence to study requirements|20|||
30706446|NCT00186901|58719902|FG001|Overall Study|Limited adherence to study requirements|23|||
30706447|NCT00186901|58719903|FG002|Overall Study|Limited adherence to study requirements|0|||
30706448|NCT00186901|58719901|FG000|Overall Study|Bone Mineral Density > 0|0|||
30706449|NCT00186901|58719902|FG001|Overall Study|Bone Mineral Density > 0|0|||
30706450|NCT00186901|58719903|FG002|Overall Study|Bone Mineral Density > 0|149|||
30706451|NCT00186121|58719940|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
30706452|NCT00186121|58719940|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
30706453|NCT00186121|58719940|FG000|Overall Study|Not eligible (no treatment)|1|||
30706454|NCT00186043|58719946|FG000|Overall Study|Lack of Efficacy|1|||
30706455|NCT00186043|58719947|FG001|Overall Study|Lack of Efficacy|3|||
30706456|NCT00186043|58719946|FG000|Overall Study|Lost to Follow-up|4|||
30706457|NCT00186043|58719947|FG001|Overall Study|Lost to Follow-up|6|||
30706458|NCT00186043|58719946|FG000|Overall Study|Withdrawal by Subject|1|||
30706459|NCT00186043|58719947|FG001|Overall Study|Withdrawal by Subject|0|||
30706460|NCT00186043|58719946|FG000|Overall Study|Adverse Event|7|||
30706461|NCT00186043|58719947|FG001|Overall Study|Adverse Event|3|||
30706462|NCT00186043|58719946|FG000|Overall Study|Protocol Violation|2|||
30706463|NCT00186043|58719947|FG001|Overall Study|Protocol Violation|1|||
30706464|NCT00185965|58719955|FG000|Overall Study|Adverse Event|0|||
30706465|NCT00185965|58719956|FG001|Overall Study|Adverse Event|1|||
30706466|NCT00607880|58719964|FG000|Overall Study|Unable to place port due to occlusion|1|||
30706467|NCT00607880|58719965|FG001|Overall Study|Unable to place port due to occlusion|0|||
30706468|NCT00127933|58719973|FG000|Overall Study|Randomized but not dosed|1|||
30706469|NCT00127933|58719974|FG001|Overall Study|Randomized but not dosed|0|||
30706470|NCT03875313|58719985|FG000|Overall Study|Withdrawal by Subject|1|||
30706471|NCT03875313|58719986|FG001|Overall Study|Withdrawal by Subject|3|||
30706472|NCT03875313|58719987|FG002|Overall Study|Withdrawal by Subject|0|||
30706473|NCT03875313|58719988|FG003|Overall Study|Withdrawal by Subject|0|||
30706474|NCT03875313|58719989|FG004|Overall Study|Withdrawal by Subject|0|||
30706475|NCT03875313|58719985|FG000|Overall Study|Death|0|||
30706476|NCT03875313|58719986|FG001|Overall Study|Death|0|||
30706477|NCT03875313|58719987|FG002|Overall Study|Death|0|||
30706478|NCT03875313|58719988|FG003|Overall Study|Death|0|||
30706479|NCT03875313|58719989|FG004|Overall Study|Death|1|||
30706480|NCT03875313|58719985|FG000|Overall Study|Lost to Follow-up|0|||
30706481|NCT03875313|58719986|FG001|Overall Study|Lost to Follow-up|0|||
30706482|NCT03875313|58719987|FG002|Overall Study|Lost to Follow-up|0|||
30706483|NCT03875313|58719988|FG003|Overall Study|Lost to Follow-up|0|||
30706484|NCT03875313|58719989|FG004|Overall Study|Lost to Follow-up|1|||
30894088|NCT02175771|58927583|FG004|Treatment Period|Protocol Violation|0|||
30894089|NCT02175771|58927584|FG005|Treatment Period|Protocol Violation|0|||
30894090|NCT02175771|58927585|FG006|Treatment Period|Protocol Violation|0|||
30894091|NCT02175771|58927586|FG007|Treatment Period|Protocol Violation|1|||
30894092|NCT02175771|58927587|FG008|Treatment Period|Protocol Violation|0|||
30894093|NCT02175771|58927579|FG000|Treatment Period|Disease progression|0|||
30706485|NCT03875313|58719985|FG000|Overall Study|Study Termination by Sponsor|0|||
30706486|NCT03875313|58719986|FG001|Overall Study|Study Termination by Sponsor|1|||
30706487|NCT03875313|58719987|FG002|Overall Study|Study Termination by Sponsor|1|||
30706488|NCT03875313|58719988|FG003|Overall Study|Study Termination by Sponsor|0|||
30706489|NCT03875313|58719989|FG004|Overall Study|Study Termination by Sponsor|1|||
30706490|NCT03875313|58719985|FG000|Overall Study|New Anticancer Treatment|0|||
30706491|NCT03875313|58719986|FG001|Overall Study|New Anticancer Treatment|1|||
30706492|NCT03875313|58719987|FG002|Overall Study|New Anticancer Treatment|2|||
30706493|NCT03875313|58719988|FG003|Overall Study|New Anticancer Treatment|1|||
30706494|NCT03875313|58719989|FG004|Overall Study|New Anticancer Treatment|0|||
30706495|NCT03875313|58719985|FG000|Overall Study|Other, Not Specified|2|||
30706496|NCT03875313|58719986|FG001|Overall Study|Other, Not Specified|11|||
30706497|NCT03875313|58719987|FG002|Overall Study|Other, Not Specified|3|||
30706498|NCT03875313|58719988|FG003|Overall Study|Other, Not Specified|3|||
30706499|NCT03875313|58719989|FG004|Overall Study|Other, Not Specified|1|||
30706500|NCT00556998|58720001|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
30706501|NCT00556998|58720001|FG000|Voriconazole Intravenous (IV)|Other|4|||
30706502|NCT00556998|58720001|FG000|Voriconazole Oral|Adverse Event|1|||
30706503|NCT00556998|58720001|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
30706504|NCT00528801|58720011|FG000|Overall Study|Withdrawal by Subject|1|||
30706505|NCT00528801|58720012|FG001|Overall Study|Withdrawal by Subject|1|||
30706506|NCT00528801|58720011|FG000|Overall Study|Protocol Violation|11|||
30706507|NCT00528801|58720012|FG001|Overall Study|Protocol Violation|5|||
30706508|NCT00528801|58720011|FG000|Overall Study|Lost to Follow-up|15|||
30706509|NCT00528801|58720012|FG001|Overall Study|Lost to Follow-up|4|||
30706510|NCT00528801|58720011|FG000|Overall Study|Administrative Reasons|0|||
30706511|NCT00528801|58720012|FG001|Overall Study|Administrative Reasons|1|||
30706512|NCT00527397|58720018|FG000|Overall Study|Adverse Event|3|||
30706513|NCT00527397|58720018|FG000|Overall Study|Lack of Efficacy|1|||
30706514|NCT00527397|58720018|FG000|Overall Study|Protocol Violation|1|||
30706515|NCT00527397|58720018|FG000|Overall Study|Withdrawal by Subject|6|||
30706516|NCT00527397|58720018|FG000|Overall Study|Study terminated by sponsor|13|||
30706517|NCT00527319|58720028|FG000|Overall Study|Withdrawal by Subject|5|||
30706518|NCT00527319|58720029|FG001|Overall Study|Withdrawal by Subject|0|||
30706519|NCT00527319|58720030|FG002|Overall Study|Withdrawal by Subject|1|||
30706520|NCT00527319|58720028|FG000|Overall Study|Lost to Follow-up|1|||
30706521|NCT00527319|58720029|FG001|Overall Study|Lost to Follow-up|0|||
30706522|NCT00527319|58720030|FG002|Overall Study|Lost to Follow-up|0|||
30706523|NCT00527319|58720028|FG000|Overall Study|Death|0|||
30706524|NCT00527319|58720029|FG001|Overall Study|Death|3|||
30706525|NCT00527319|58720030|FG002|Overall Study|Death|1|||
30706526|NCT00527319|58720028|FG000|Overall Study|Intercurrent Medical Illness|0|||
30706527|NCT00527319|58720029|FG001|Overall Study|Intercurrent Medical Illness|1|||
30706528|NCT00527319|58720030|FG002|Overall Study|Intercurrent Medical Illness|3|||
30706529|NCT00527319|58720028|FG000|Overall Study|Adverse Event|0|||
30706530|NCT00527319|58720029|FG001|Overall Study|Adverse Event|0|||
30706531|NCT00527319|58720030|FG002|Overall Study|Adverse Event|1|||
30706532|NCT00562302|58720040|FG000|Overall Study|Lost to Follow-up|3|||
30706533|NCT00562302|58720041|FG001|Overall Study|Lost to Follow-up|3|||
30706534|NCT00562302|58720040|FG000|Overall Study|Adverse Event|0|||
30706535|NCT00562302|58720041|FG001|Overall Study|Adverse Event|6|||
30706536|NCT00562302|58720040|FG000|Overall Study|Non-compliance|1|||
30706537|NCT00562302|58720041|FG001|Overall Study|Non-compliance|2|||
30706538|NCT00562302|58720040|FG000|Overall Study|Withdrawal by Subject|7|||
30706539|NCT00562302|58720041|FG001|Overall Study|Withdrawal by Subject|8|||
30706540|NCT00562302|58720040|FG000|Overall Study|Death|1|||
30706541|NCT00562302|58720041|FG001|Overall Study|Death|2|||
30620307|NCT01012947|58631474|FG003|Overall Study|Lost to Follow-up|118|||
30706542|NCT00562302|58720040|FG000|Overall Study|Lung resection prior to study completion|7|||
30706543|NCT00562302|58720041|FG001|Overall Study|Lung resection prior to study completion|7|||
30706544|NCT00562302|58720040|FG000|Overall Study|Not stated|1|||
30620308|NCT01012947|58631475|FG004|Overall Study|Lost to Follow-up|142|||
30620309|NCT01214603|58631507|FG000|Overall Study|Adverse Event|0|||
30620310|NCT01214603|58631508|FG001|Overall Study|Adverse Event|0|||
30620311|NCT01214603|58631509|FG002|Overall Study|Adverse Event|1|||
30620312|NCT01214603|58631507|FG000|Overall Study|Death|1|||
30620313|NCT01214603|58631508|FG001|Overall Study|Death|0|||
30620314|NCT01214603|58631509|FG002|Overall Study|Death|0|||
30706545|NCT00562302|58720041|FG001|Overall Study|Not stated|4|||
30706546|NCT00134719|58720050|FG000|Primary Vaccination Phase|Adverse Event|4|||
30706547|NCT00134719|58720051|FG001|Primary Vaccination Phase|Adverse Event|0|||
30706548|NCT00134719|58720052|FG002|Primary Vaccination Phase|Adverse Event|0|||
30706549|NCT00134719|58720050|FG000|Primary Vaccination Phase|Protocol Violation|1|||
30706550|NCT00134719|58720051|FG001|Primary Vaccination Phase|Protocol Violation|0|||
30706551|NCT00134719|58720052|FG002|Primary Vaccination Phase|Protocol Violation|0|||
30706552|NCT00134719|58720050|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
30706553|NCT00134719|58720051|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
30706554|NCT00134719|58720052|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
30706555|NCT00134719|58720050|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
30706556|NCT00134719|58720051|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
30706557|NCT00134719|58720052|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
30706558|NCT00134719|58720050|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
30706559|NCT00134719|58720051|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
30706560|NCT00134719|58720052|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
30706561|NCT00134719|58720050|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
30706562|NCT00134719|58720051|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
30706563|NCT00134719|58720052|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
30706564|NCT00526071|58720060|FG000|Overall Study|Adverse Event|1|||
30706565|NCT00526071|58720060|FG000|Overall Study|Withdrawal by Subject|1|||
30706566|NCT00526071|58720060|FG000|Overall Study|Lack of Response to Study Drug|4|||
30706567|NCT00525915|58720070|FG000|Overall Study|Non-Compliance|0|||
30706568|NCT00525915|58720071|FG001|Overall Study|Non-Compliance|1|||
30706569|NCT00525915|58720070|FG000|Overall Study|Disease Progression|5|||
30706570|NCT00525915|58720071|FG001|Overall Study|Disease Progression|6|||
30706571|NCT00525915|58720070|FG000|Overall Study|Withdrawal by Subject|1|||
30706572|NCT00525915|58720071|FG001|Overall Study|Withdrawal by Subject|0|||
30706573|NCT00525915|58720070|FG000|Overall Study|Refused Surgery|1|||
30706574|NCT00525915|58720071|FG001|Overall Study|Refused Surgery|2|||
30706575|NCT00525915|58720070|FG000|Overall Study|Unrelated illness|1|||
30706576|NCT00525915|58720071|FG001|Overall Study|Unrelated illness|0|||
30706577|NCT00521079|58720079|FG000|Overall Study|Adverse Event|7|||
30706578|NCT00521079|58720080|FG001|Overall Study|Adverse Event|1|||
30706579|NCT00521079|58720079|FG000|Overall Study|Lost to Follow-up|2|||
30706580|NCT00521079|58720080|FG001|Overall Study|Lost to Follow-up|1|||
30706581|NCT00521079|58720079|FG000|Overall Study|Withdrawal by Subject|5|||
30706582|NCT00521079|58720080|FG001|Overall Study|Withdrawal by Subject|3|||
30706583|NCT00521001|58720086|FG000|Overall Study|Ineligible|1|||
30706584|NCT00134563|58720093|FG000|Overall Study|Not treated due to protocol violation|0|||
30706585|NCT00134563|58720094|FG001|Overall Study|Not treated due to protocol violation|1|||
30706586|NCT00134563|58720095|FG002|Overall Study|Not treated due to protocol violation|1|||
30706587|NCT00134563|58720093|FG000|Overall Study|Adverse Event|29|||
30706588|NCT00134563|58720094|FG001|Overall Study|Adverse Event|37|||
30706589|NCT00134563|58720095|FG002|Overall Study|Adverse Event|38|||
30706590|NCT00134563|58720093|FG000|Overall Study|Lack of Efficacy|24|||
30706591|NCT00134563|58720094|FG001|Overall Study|Lack of Efficacy|14|||
30894094|NCT02175771|58927580|FG001|Treatment Period|Disease progression|0|||
30894095|NCT02175771|58927581|FG002|Treatment Period|Disease progression|0|||
30894096|NCT02175771|58927582|FG003|Treatment Period|Disease progression|0|||
30894097|NCT02175771|58927583|FG004|Treatment Period|Disease progression|0|||
30894098|NCT02175771|58927584|FG005|Treatment Period|Disease progression|0|||
30894099|NCT02175771|58927585|FG006|Treatment Period|Disease progression|0|||
30894100|NCT02175771|58927586|FG007|Treatment Period|Disease progression|2|||
30894101|NCT02175771|58927587|FG008|Treatment Period|Disease progression|0|||
30706592|NCT00134563|58720095|FG002|Overall Study|Lack of Efficacy|17|||
30706593|NCT00134563|58720093|FG000|Overall Study|Protocol Violation|3|||
30706594|NCT00134563|58720094|FG001|Overall Study|Protocol Violation|2|||
30706595|NCT00134563|58720095|FG002|Overall Study|Protocol Violation|5|||
30894102|NCT02175771|58927579|FG000|Treatment Period|Lost to Follow-up|0|||
30706596|NCT00134563|58720093|FG000|Overall Study|Lost to Follow-up|4|||
30706597|NCT00134563|58720094|FG001|Overall Study|Lost to Follow-up|0|||
30706598|NCT00134563|58720095|FG002|Overall Study|Lost to Follow-up|2|||
30706599|NCT00134563|58720093|FG000|Overall Study|progressive disease|11|||
30706600|NCT00134563|58720094|FG001|Overall Study|progressive disease|4|||
30706601|NCT00134563|58720095|FG002|Overall Study|progressive disease|2|||
30706602|NCT00134563|58720093|FG000|Overall Study|did not wish to continue|33|||
30706603|NCT00134563|58720094|FG001|Overall Study|did not wish to continue|32|||
30706604|NCT00134563|58720095|FG002|Overall Study|did not wish to continue|26|||
30706605|NCT00134563|58720093|FG000|Overall Study|Reason other than above|0|||
30706606|NCT00134563|58720094|FG001|Overall Study|Reason other than above|2|||
30706607|NCT00134563|58720095|FG002|Overall Study|Reason other than above|5|||
30706608|NCT00520845|58720103|FG000|Overall Study|Death|3|||
30706609|NCT00520845|58720103|FG000|Overall Study|Adverse Event|4|||
30706610|NCT00520845|58720103|FG000|Overall Study|Disease Progression, relapse|13|||
30706611|NCT00520845|58720103|FG000|Overall Study|Withdrawal by Subject|1|||
30706612|NCT00520845|58720103|FG000|Overall Study|Alternative Therapy|1|||
30706613|NCT00185731|58720107|FG000|Overall Study|Withdrawal by Subject|1|||
30706614|NCT00185731|58720107|FG000|Overall Study|Not Eligible|1|||
30706615|NCT00582491|58720115|FG000|Overall Study|Withdrawal by Subject|1|||
30706616|NCT00582491|58720116|FG001|Overall Study|Withdrawal by Subject|0|||
30706617|NCT00520767|58720122|FG000|Overall Study|Death|2|||
30706618|NCT04679051|58720128|FG000|Overall Study|felt tired after restricted time in bed|3|||
30706619|NCT04679051|58720129|FG001|Overall Study|felt tired after restricted time in bed|0|||
30706620|NCT04679051|58720128|FG000|Overall Study|discomfort with blood pressure cuff|2|||
30706621|NCT04679051|58720129|FG001|Overall Study|discomfort with blood pressure cuff|0|||
30706622|NCT04679051|58720128|FG000|Overall Study|scheduling conflict|1|||
30706623|NCT04679051|58720129|FG001|Overall Study|scheduling conflict|1|||
30706624|NCT04679051|58720128|FG000|Overall Study|Protocol Violation|0|||
30706625|NCT04679051|58720129|FG001|Overall Study|Protocol Violation|4|||
30706626|NCT03873987|58720140|FG000|Overall Study|Adverse Event|1|||
30706627|NCT03873987|58720141|FG001|Overall Study|Adverse Event|0|||
30706628|NCT03873987|58720140|FG000|Overall Study|staff was unable to start a new IV line|1|||
30706629|NCT03873987|58720141|FG001|Overall Study|staff was unable to start a new IV line|0|||
30706630|NCT03873987|58720140|FG000|Overall Study|Lost to Follow-up|0|||
30706631|NCT03873987|58720141|FG001|Overall Study|Lost to Follow-up|1|||
30706632|NCT00474760|58720159|FG000|Overall Study|Death|0|||
30706633|NCT00474760|58720160|FG001|Overall Study|Death|0|||
30706634|NCT00474760|58720161|FG002|Overall Study|Death|0|||
30706635|NCT00474760|58720162|FG003|Overall Study|Death|0|||
30706636|NCT00474760|58720163|FG004|Overall Study|Death|2|||
30706637|NCT00474760|58720164|FG005|Overall Study|Death|0|||
30706638|NCT00474760|58720165|FG006|Overall Study|Death|0|||
30894103|NCT02175771|58927580|FG001|Treatment Period|Lost to Follow-up|3|||
30894104|NCT02175771|58927581|FG002|Treatment Period|Lost to Follow-up|1|||
30894105|NCT02175771|58927582|FG003|Treatment Period|Lost to Follow-up|3|||
30620315|NCT01214603|58631507|FG000|Overall Study|Progressive Disease|4|||
30620316|NCT01214603|58631508|FG001|Overall Study|Progressive Disease|1|||
30620317|NCT01214603|58631509|FG002|Overall Study|Progressive Disease|3|||
30620318|NCT01212185|58631520|FG000|Overall Study|Protocol Violation|2|||
30620319|NCT01212185|58631521|FG001|Overall Study|Protocol Violation|1|||
30620320|NCT01995175|58631527|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
30620321|NCT01995175|58631527|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
30620322|NCT01995175|58631527|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
30620323|NCT01995175|58631527|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
30620324|NCT01995175|58631527|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
30620325|NCT01995175|58631527|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
30620326|NCT01995175|58631527|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
30620327|NCT01995175|58631527|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
30620328|NCT01995175|58631527|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
30706639|NCT00474760|58720159|FG000|Overall Study|Adverse Event|0|||
30706640|NCT00474760|58720160|FG001|Overall Study|Adverse Event|0|||
30706641|NCT00474760|58720161|FG002|Overall Study|Adverse Event|0|||
30706642|NCT00474760|58720162|FG003|Overall Study|Adverse Event|0|||
30706643|NCT00474760|58720163|FG004|Overall Study|Adverse Event|1|||
30894106|NCT02175771|58927583|FG004|Treatment Period|Lost to Follow-up|1|||
30894107|NCT02175771|58927584|FG005|Treatment Period|Lost to Follow-up|2|||
30894108|NCT02175771|58927585|FG006|Treatment Period|Lost to Follow-up|1|||
30894109|NCT02175771|58927586|FG007|Treatment Period|Lost to Follow-up|2|||
30894110|NCT02175771|58927587|FG008|Treatment Period|Lost to Follow-up|2|||
30894111|NCT02175771|58927579|FG000|Treatment Period|Lack of Efficacy|0|||
30894112|NCT02175771|58927580|FG001|Treatment Period|Lack of Efficacy|0|||
30894113|NCT02175771|58927581|FG002|Treatment Period|Lack of Efficacy|0|||
30894114|NCT02175771|58927582|FG003|Treatment Period|Lack of Efficacy|0|||
30894115|NCT02175771|58927583|FG004|Treatment Period|Lack of Efficacy|0|||
30894116|NCT02175771|58927584|FG005|Treatment Period|Lack of Efficacy|1|||
30894117|NCT02175771|58927585|FG006|Treatment Period|Lack of Efficacy|0|||
30894118|NCT02175771|58927586|FG007|Treatment Period|Lack of Efficacy|1|||
30894119|NCT02175771|58927587|FG008|Treatment Period|Lack of Efficacy|0|||
30894120|NCT02175771|58927579|FG000|Treatment Period|Other|0|||
30894121|NCT02175771|58927580|FG001|Treatment Period|Other|1|||
30894122|NCT02175771|58927581|FG002|Treatment Period|Other|0|||
30894123|NCT02175771|58927582|FG003|Treatment Period|Other|3|||
30894124|NCT02175771|58927583|FG004|Treatment Period|Other|1|||
30894125|NCT02175771|58927584|FG005|Treatment Period|Other|0|||
30894126|NCT02175771|58927585|FG006|Treatment Period|Other|0|||
30894127|NCT02175771|58927586|FG007|Treatment Period|Other|2|||
30894128|NCT02175771|58927587|FG008|Treatment Period|Other|0|||
30706644|NCT00474760|58720164|FG005|Overall Study|Adverse Event|7|||
30706645|NCT00474760|58720165|FG006|Overall Study|Adverse Event|0|||
30706646|NCT00474760|58720159|FG000|Overall Study|Laboratory abnormality|0|||
30706647|NCT00474760|58720160|FG001|Overall Study|Laboratory abnormality|0|||
30706648|NCT00474760|58720161|FG002|Overall Study|Laboratory abnormality|0|||
30706649|NCT00474760|58720162|FG003|Overall Study|Laboratory abnormality|0|||
30706650|NCT00474760|58720163|FG004|Overall Study|Laboratory abnormality|0|||
30706651|NCT00474760|58720164|FG005|Overall Study|Laboratory abnormality|1|||
30706652|NCT00474760|58720165|FG006|Overall Study|Laboratory abnormality|0|||
30706653|NCT00474760|58720159|FG000|Overall Study|Withdrawal by Subject|0|||
30706654|NCT00474760|58720160|FG001|Overall Study|Withdrawal by Subject|0|||
30706655|NCT00474760|58720161|FG002|Overall Study|Withdrawal by Subject|0|||
30706656|NCT00474760|58720162|FG003|Overall Study|Withdrawal by Subject|1|||
30706657|NCT00474760|58720163|FG004|Overall Study|Withdrawal by Subject|0|||
30706658|NCT00474760|58720164|FG005|Overall Study|Withdrawal by Subject|1|||
30706659|NCT00474760|58720165|FG006|Overall Study|Withdrawal by Subject|1|||
30706660|NCT00474760|58720159|FG000|Overall Study|Other|0|||
30706661|NCT00474760|58720160|FG001|Overall Study|Other|1|||
30706662|NCT00474760|58720161|FG002|Overall Study|Other|0|||
30706663|NCT00474760|58720162|FG003|Overall Study|Other|0|||
30706664|NCT00474760|58720163|FG004|Overall Study|Other|1|||
30706665|NCT00474760|58720164|FG005|Overall Study|Other|0|||
30706666|NCT00474760|58720165|FG006|Overall Study|Other|0|||
30706667|NCT00474760|58720159|FG000|Overall Study|Progressive disease|3|||
30894129|NCT01657799|58927608|FG000|Overall Study|Adverse Event Related to progression|6|||
30894130|NCT01657799|58927609|FG001|Overall Study|Adverse Event Related to progression|8|||
30894131|NCT01657799|58927610|FG002|Overall Study|Adverse Event Related to progression|12|||
30894132|NCT01657799|58927608|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
30894133|NCT01657799|58927609|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
30894134|NCT01657799|58927610|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
30706668|NCT00474760|58720160|FG001|Overall Study|Progressive disease|2|||
30706669|NCT00474760|58720161|FG002|Overall Study|Progressive disease|3|||
30706670|NCT00474760|58720162|FG003|Overall Study|Progressive disease|2|||
30706671|NCT00474760|58720163|FG004|Overall Study|Progressive disease|8|||
30894135|NCT01657799|58927608|FG000|Overall Study|Withdrawal by Subject|13|||
30894136|NCT01657799|58927609|FG001|Overall Study|Withdrawal by Subject|10|||
30894137|NCT01657799|58927610|FG002|Overall Study|Withdrawal by Subject|10|||
30894138|NCT01657799|58927608|FG000|Overall Study|Lost to Follow-up|1|||
30894139|NCT01657799|58927609|FG001|Overall Study|Lost to Follow-up|0|||
30894140|NCT01657799|58927610|FG002|Overall Study|Lost to Follow-up|1|||
30894141|NCT01657799|58927608|FG000|Overall Study|Disease Progression|2|||
30894142|NCT01657799|58927609|FG001|Overall Study|Disease Progression|4|||
30706672|NCT00474760|58720164|FG005|Overall Study|Progressive disease|20|||
30706673|NCT00474760|58720165|FG006|Overall Study|Progressive disease|7|||
30706674|NCT00474760|58720159|FG000|Overall Study|Terminated by sponsor|0|||
30706675|NCT00474760|58720160|FG001|Overall Study|Terminated by sponsor|0|||
30706676|NCT00474760|58720161|FG002|Overall Study|Terminated by sponsor|0|||
30706677|NCT00474760|58720162|FG003|Overall Study|Terminated by sponsor|0|||
30706678|NCT00474760|58720163|FG004|Overall Study|Terminated by sponsor|0|||
30706679|NCT00474760|58720164|FG005|Overall Study|Terminated by sponsor|0|||
30706680|NCT00474760|58720165|FG006|Overall Study|Terminated by sponsor|2|||
30706681|NCT00528645|58720188|FG000|Overall Study|Adverse Event|3|||
30706682|NCT00524745|58720197|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
30706683|NCT00524745|58720198|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
30706684|NCT00524745|58720199|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
30706685|NCT00524745|58720200|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
30706686|NCT00495040|58720210|FG000|Overall Study|Withdrawal by Subject|3|||
30706687|NCT00494026|58720218|FG000|Overall Study|Sponsor Decision|4|||
30706688|NCT00524589|58720222|FG000|Overall Study|Withdrawal by Subject|2|||
30706689|NCT00524589|58720222|FG000|Overall Study|Disease Progression|16|||
30706690|NCT00472030|58720228|FG000|Overall Study|Physician Decision|1|||
30706691|NCT00472030|58720229|FG001|Overall Study|Physician Decision|0|||
30620329|NCT02243605|58631607|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
30620330|NCT02243605|58631608|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
30620331|NCT02243605|58631607|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
30620332|NCT02243605|58631608|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
30620333|NCT02243605|58631607|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
30620334|NCT02243605|58631608|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
30620335|NCT02243605|58631607|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
30620336|NCT02243605|58631608|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
30620337|NCT02243605|58631607|FG000|Stage 2 - Final Analysis Population|Progression|0|||
30620338|NCT02243605|58631608|FG001|Stage 2 - Final Analysis Population|Progression|1|||
30620339|NCT01752907|58631625|FG000|Overall Study|Withdrawal by Subject|4|||
30620340|NCT01752907|58631626|FG001|Overall Study|Withdrawal by Subject|10|||
30620341|NCT01752907|58631625|FG000|Overall Study|Lost to Follow-up|2|||
30620342|NCT01752907|58631626|FG001|Overall Study|Lost to Follow-up|1|||
30620343|NCT01752907|58631625|FG000|Overall Study|Decision by Sponsor|6|||
30620344|NCT01752907|58631626|FG001|Overall Study|Decision by Sponsor|9|||
30894143|NCT01657799|58927610|FG002|Overall Study|Disease Progression|4|||
30620345|NCT03439189|58631632|FG000|Overall Study|Protocol Violation|19|||
30620346|NCT03439189|58631632|FG000|Overall Study|Lack of Efficacy|63|||
30620347|NCT01211483|58631641|FG000|Phase 1b|Death|6|||
30620348|NCT01211483|58631642|FG001|Phase 1b|Death|0|||
30620349|NCT01211483|58631643|FG002|Phase 1b|Death|0|||
30706692|NCT00127855|58720244|FG000|Primary Vaccination Course|Adverse Event|0|||
30706693|NCT00127855|58720245|FG001|Primary Vaccination Course|Adverse Event|0|||
30706694|NCT00127855|58720246|FG002|Primary Vaccination Course|Adverse Event|1|||
30706695|NCT00127855|58720247|FG003|Primary Vaccination Course|Adverse Event|0|||
30706696|NCT00127855|58720248|FG004|Primary Vaccination Course|Adverse Event|0|||
30706697|NCT00127855|58720244|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
30706698|NCT00127855|58720245|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
30894144|NCT01657799|58927608|FG000|Overall Study|Progressive Disease Clinical|7|||
30894145|NCT01657799|58927609|FG001|Overall Study|Progressive Disease Clinical|4|||
30894146|NCT01657799|58927610|FG002|Overall Study|Progressive Disease Clinical|7|||
30894147|NCT01657799|58927608|FG000|Overall Study|Radiographic & Clinical Progression|16|||
30894148|NCT01657799|58927609|FG001|Overall Study|Radiographic & Clinical Progression|11|||
30894149|NCT01657799|58927610|FG002|Overall Study|Radiographic & Clinical Progression|15|||
30706699|NCT00127855|58720246|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
30706700|NCT00127855|58720247|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
30706701|NCT00127855|58720248|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
30706702|NCT00127855|58720244|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
30706703|NCT00127855|58720245|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
30706704|NCT00127855|58720246|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
30706705|NCT00127855|58720247|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
30706706|NCT00127855|58720248|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
30706707|NCT00127855|58720244|FG000|Primary Vaccination Course|Other|0|||
30706708|NCT00127855|58720245|FG001|Primary Vaccination Course|Other|0|||
30706709|NCT00127855|58720246|FG002|Primary Vaccination Course|Other|0|||
30706710|NCT00127855|58720247|FG003|Primary Vaccination Course|Other|0|||
30706711|NCT00127855|58720248|FG004|Primary Vaccination Course|Other|1|||
30706712|NCT00493636|58720262|FG000|Overall Study|Withdrawal by Subject|1|||
30706713|NCT00493636|58720263|FG001|Overall Study|Withdrawal by Subject|0|||
30706714|NCT00493636|58720262|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
30706715|NCT00493636|58720263|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
30706716|NCT00493636|58720262|FG000|Overall Study|Mis-randomization|1|||
30706717|NCT00493636|58720263|FG001|Overall Study|Mis-randomization|1|||
30706718|NCT00524121|58720269|FG000|Overall Study|Disease progression|6|||
30706719|NCT00524121|58720269|FG000|Overall Study|Adverse Event|4|||
30706720|NCT00524121|58720269|FG000|Overall Study|Patient refused|2|||
30706721|NCT00524121|58720269|FG000|Overall Study|Other|1|||
30706722|NCT00524121|58720269|FG000|Overall Study|Death|1|||
30706723|NCT00524121|58720269|FG000|Overall Study|Not treated (became ineligible)|4|||
30706724|NCT00524121|58720269|FG000|Overall Study|Not treated (changed mind)|1|||
30706725|NCT00470626|58720284|FG000|Overall Study|Lost to Follow-up|10|||
30706726|NCT00470626|58720284|FG000|Overall Study|Withdrawal by Subject|7|||
30706727|NCT00133705|58720290|FG000|Overall Study|Withdrawal by Subject|2|||
30706728|NCT00133705|58720291|FG001|Overall Study|Withdrawal by Subject|3|||
30706729|NCT00132769|58720299|FG000|Overall Study|Withdrawal by Subject|1|||
30706730|NCT00132769|58720300|FG001|Overall Study|Withdrawal by Subject|3|||
30706731|NCT00132769|58720299|FG000|Overall Study|Lack of Efficacy|7|||
30706732|NCT00132769|58720300|FG001|Overall Study|Lack of Efficacy|6|||
30706733|NCT00132769|58720299|FG000|Overall Study|Adverse Event|2|||
30706734|NCT00132769|58720300|FG001|Overall Study|Adverse Event|1|||
30706735|NCT00132769|58720299|FG000|Overall Study|Protocol Violation|1|||
30706736|NCT00132769|58720300|FG001|Overall Study|Protocol Violation|1|||
30706737|NCT00520299|58720309|FG000|Overall Study|Withdrawal by Subject|0|||
30706738|NCT00520299|58720310|FG001|Overall Study|Withdrawal by Subject|0|||
30706739|NCT00520299|58720311|FG002|Overall Study|Withdrawal by Subject|2|||
30706740|NCT00520299|58720309|FG000|Overall Study|Progressive disease|0|||
30894150|NCT01657799|58927608|FG000|Overall Study|Other|52|||
30894151|NCT01657799|58927609|FG001|Overall Study|Other|62|||
30894152|NCT01657799|58927610|FG002|Overall Study|Other|49|||
30894153|NCT02116803|58927620|FG000|Overall Study|Adverse Event|2|||
30894154|NCT02116803|58927621|FG001|Overall Study|Adverse Event|1|||
30706741|NCT00520299|58720310|FG001|Overall Study|Progressive disease|3|||
30706742|NCT00520299|58720311|FG002|Overall Study|Progressive disease|4|||
30894155|NCT02116803|58927620|FG000|Overall Study|Physician Decision|1|||
30706743|NCT02478255|58720321|FG000|Overall Study|Physician Decision|6|||
30706744|NCT02478255|58720322|FG001|Overall Study|Physician Decision|0|||
30894156|NCT02116803|58927621|FG001|Overall Study|Physician Decision|0|||
30790860|NCT03524092|58803945|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
30894157|NCT02116803|58927620|FG000|Overall Study|Progressive disease|4|||
30894158|NCT02116803|58927621|FG001|Overall Study|Progressive disease|0|||
30894159|NCT02116803|58927620|FG000|Overall Study|Study terminated by sponsor|2|||
30894160|NCT02116803|58927621|FG001|Overall Study|Study terminated by sponsor|1|||
30790861|NCT03524092|58803940|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
30790862|NCT03524092|58803941|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
30790863|NCT03524092|58803942|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
30790864|NCT03524092|58803943|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
30790865|NCT03524092|58803944|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
30894161|NCT02116803|58927620|FG000|Overall Study|Death|1|||
30894162|NCT02116803|58927621|FG001|Overall Study|Death|0|||
30894163|NCT02115321|58927629|FG000|Overall Study|Death|1|||
30894164|NCT02115321|58927630|FG001|Overall Study|Death|0|||
30894165|NCT02367781|58927638|FG000|Overall Study|Withdrawal by Subject|20|||
30894166|NCT02367781|58927639|FG001|Overall Study|Withdrawal by Subject|13|||
30894167|NCT02367781|58927638|FG000|Overall Study|Protocol Violation|0|||
30894168|NCT02367781|58927639|FG001|Overall Study|Protocol Violation|1|||
30894169|NCT02367781|58927638|FG000|Overall Study|Physician Decision|7|||
30894170|NCT02367781|58927639|FG001|Overall Study|Physician Decision|0|||
30894171|NCT02367781|58927638|FG000|Overall Study|Randomized in Error|5|||
30894172|NCT02367781|58927639|FG001|Overall Study|Randomized in Error|4|||
30894173|NCT02367781|58927638|FG000|Overall Study|Non-Compliance|1|||
30894174|NCT02367781|58927639|FG001|Overall Study|Non-Compliance|0|||
30894175|NCT02367781|58927638|FG000|Overall Study|Lost to Follow-up|1|||
30706745|NCT02478255|58720321|FG000|Overall Study|Withdrawal by Subject|2|||
30706746|NCT02478255|58720322|FG001|Overall Study|Withdrawal by Subject|0|||
30706747|NCT00132691|58720330|FG000|Overall Study|Lost to Follow-up|5|||
30706748|NCT00132691|58720331|FG001|Overall Study|Lost to Follow-up|8|||
30706749|NCT00132691|58720330|FG000|Overall Study|Missed 2-year visit|4|||
30706750|NCT00132691|58720331|FG001|Overall Study|Missed 2-year visit|4|||
30706751|NCT00132691|58720330|FG000|Overall Study|Death|2|||
30894176|NCT02367781|58927639|FG001|Overall Study|Lost to Follow-up|2|||
30894177|NCT02367781|58927638|FG000|Overall Study|Death|330|||
30894178|NCT02367781|58927639|FG001|Overall Study|Death|176|||
30894179|NCT02367781|58927638|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
30894180|NCT02367781|58927639|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
30894181|NCT02367781|58927638|FG000|Overall Study|Prolonged Hospitalization|1|||
30706752|NCT00132691|58720331|FG001|Overall Study|Death|0|||
30706753|NCT00125359|58720342|FG000|Overall Study|Death|4|||
30706754|NCT00125359|58720342|FG000|Overall Study|Adverse Event|5|||
30706755|NCT00125359|58720342|FG000|Overall Study|Physician Decision|14|||
30706756|NCT00524043|58720349|FG000|Overall Study|Lack of Efficacy|15|||
30706757|NCT00524043|58720350|FG001|Overall Study|Lack of Efficacy|13|||
30706758|NCT00524043|58720351|FG002|Overall Study|Lack of Efficacy|14|||
30706759|NCT00524043|58720349|FG000|Overall Study|Withdrawal by Subject|5|||
30706760|NCT00524043|58720350|FG001|Overall Study|Withdrawal by Subject|7|||
30706761|NCT00524043|58720351|FG002|Overall Study|Withdrawal by Subject|7|||
30706762|NCT00524043|58720349|FG000|Overall Study|Adverse Event|5|||
30706763|NCT00524043|58720350|FG001|Overall Study|Adverse Event|2|||
30706764|NCT00524043|58720351|FG002|Overall Study|Adverse Event|7|||
30706765|NCT00524043|58720349|FG000|Overall Study|Lost to Follow-up|3|||
30706766|NCT00524043|58720350|FG001|Overall Study|Lost to Follow-up|5|||
30706767|NCT00524043|58720351|FG002|Overall Study|Lost to Follow-up|3|||
30706768|NCT00524043|58720349|FG000|Overall Study|Various (eg, incarceration)|2|||
30706769|NCT00524043|58720350|FG001|Overall Study|Various (eg, incarceration)|1|||
30706770|NCT00524043|58720351|FG002|Overall Study|Various (eg, incarceration)|0|||
30706771|NCT00523419|58720359|FG000|Overall Study|Adverse Event|1|||
30894182|NCT02367781|58927639|FG001|Overall Study|Prolonged Hospitalization|0|||
30894183|NCT02367781|58927638|FG000|Overall Study|Death Prior First Dose|1|||
30706772|NCT00523419|58720359|FG000|Overall Study|Withdrawal by Subject|1|||
30894184|NCT02367781|58927639|FG001|Overall Study|Death Prior First Dose|0|||
30894185|NCT02367781|58927638|FG000|Overall Study|Administrative-Change Facility|1|||
30706773|NCT00523419|58720359|FG000|Overall Study|Physician Decision|2|||
30706774|NCT00523419|58720359|FG000|Overall Study|Progressive Disease|22|||
30706775|NCT00523419|58720359|FG000|Overall Study|Death due to Study Disease|4|||
30706776|NCT00523419|58720359|FG000|Overall Study|Death due to Adverse Event|2|||
30706777|NCT03868059|58720363|FG000|Overall Study|Adverse Event|3|||
30894186|NCT02367781|58927639|FG001|Overall Study|Administrative-Change Facility|0|||
30706778|NCT03868059|58720363|FG000|Overall Study|Lost to Follow-up|3|||
30706779|NCT03868059|58720363|FG000|Overall Study|Withdrawal by Subject|6|||
30706780|NCT00522951|58720367|FG000|Period 1|body motion|0|||
30706781|NCT00522951|58720368|FG001|Period 1|body motion|1|||
30706782|NCT00522951|58720367|FG000|Washout Period|Adverse Event|0|||
30706783|NCT00522951|58720368|FG001|Washout Period|Adverse Event|1|||
30706784|NCT00522951|58720367|FG000|Washout Period|Death|0|||
30706785|NCT00522951|58720368|FG001|Washout Period|Death|1|||
30706786|NCT00522951|58720367|FG000|Period 2|Withdrawal by Subject|1|||
30706787|NCT00522951|58720368|FG001|Period 2|Withdrawal by Subject|0|||
30706788|NCT00522951|58720367|FG000|Period 2|residual contrast medium|1|||
30706789|NCT00522951|58720368|FG001|Period 2|residual contrast medium|1|||
30706790|NCT03865953|58720380|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
30706791|NCT03865953|58720381|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
30706792|NCT03865953|58720380|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
30706793|NCT03865953|58720381|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
30706794|NCT03865953|58720380|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
30706795|NCT03865953|58720381|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
30706796|NCT03865407|58720389|FG000|Overall Study|Adverse Event|1|||
30706797|NCT03865407|58720390|FG001|Overall Study|Adverse Event|0|||
30706798|NCT03865407|58720389|FG000|Overall Study|Withdrawal by Subject|1|||
30706799|NCT03865407|58720390|FG001|Overall Study|Withdrawal by Subject|0|||
30706800|NCT03865407|58720389|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
30706801|NCT03865407|58720390|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
30706802|NCT00487942|58720400|FG000|Overall Study|Adverse Event|1|||
30706803|NCT00487942|58720401|FG001|Overall Study|Adverse Event|1|||
30706804|NCT00487942|58720402|FG002|Overall Study|Adverse Event|1|||
30706805|NCT00487942|58720403|FG003|Overall Study|Adverse Event|1|||
30706806|NCT00487942|58720400|FG000|Overall Study|Lost to Follow-up|1|||
30706807|NCT00487942|58720401|FG001|Overall Study|Lost to Follow-up|0|||
30706808|NCT00487942|58720402|FG002|Overall Study|Lost to Follow-up|0|||
30706809|NCT00487942|58720403|FG003|Overall Study|Lost to Follow-up|1|||
30706810|NCT00487942|58720400|FG000|Overall Study|Protocol Violation|1|||
30706811|NCT00487942|58720401|FG001|Overall Study|Protocol Violation|1|||
30706812|NCT00487942|58720402|FG002|Overall Study|Protocol Violation|0|||
30894187|NCT02367781|58927638|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
30894188|NCT02367781|58927639|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
30894189|NCT02367781|58927638|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
30894190|NCT02367781|58927639|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
30894191|NCT02367781|58927638|FG000|Overall Study|Study Terminated by Sponsor|3|||
30706813|NCT00487942|58720403|FG003|Overall Study|Protocol Violation|0|||
30706814|NCT00487942|58720400|FG000|Overall Study|Withdrawal by Subject|0|||
30706815|NCT00487942|58720401|FG001|Overall Study|Withdrawal by Subject|1|||
30706816|NCT00487942|58720402|FG002|Overall Study|Withdrawal by Subject|2|||
30706817|NCT00487942|58720403|FG003|Overall Study|Withdrawal by Subject|0|||
30706818|NCT00132301|58720415|FG000|Overall Study|Death|7|||
30894192|NCT02367781|58927639|FG001|Overall Study|Study Terminated by Sponsor|1|||
30894193|NCT02367781|58927638|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
30894194|NCT02367781|58927639|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
30894195|NCT02367781|58927638|FG000|Overall Study|Sponsor Decision|2|||
30894196|NCT02367781|58927639|FG001|Overall Study|Sponsor Decision|0|||
30894197|NCT02367781|58927638|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
30894198|NCT02367781|58927639|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
30894199|NCT02152761|58927651|FG000|Epoch: Treatment Epoch|Technical problems|0|||
30894200|NCT02152761|58927652|FG001|Epoch: Treatment Epoch|Technical problems|0|||
30894201|NCT02152761|58927653|FG002|Epoch: Treatment Epoch|Technical problems|0|||
30894202|NCT02152761|58927654|FG003|Epoch: Treatment Epoch|Technical problems|1|||
30894203|NCT02152761|58927651|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
30894204|NCT02152761|58927652|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
30894205|NCT02152761|58927653|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
30894206|NCT02152761|58927654|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
30894207|NCT02152761|58927651|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
30894208|NCT02152761|58927652|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
30894209|NCT02152761|58927653|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
30894210|NCT02152761|58927654|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
30894211|NCT02152761|58927651|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
30894212|NCT02152761|58927652|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
30706819|NCT00132301|58720416|FG001|Overall Study|Death|6|||
30706820|NCT00132301|58720415|FG000|Overall Study|Withdrawal by Subject|5|||
30706821|NCT00132301|58720416|FG001|Overall Study|Withdrawal by Subject|2|||
30706822|NCT00132301|58720415|FG000|Overall Study|Physician Decision|1|||
30706823|NCT00132301|58720416|FG001|Overall Study|Physician Decision|1|||
30706824|NCT00132301|58720415|FG000|Overall Study|Lost to Follow-up|5|||
30706825|NCT00132301|58720416|FG001|Overall Study|Lost to Follow-up|3|||
30706826|NCT00132301|58720415|FG000|Overall Study|Other|1|||
30706827|NCT00132301|58720416|FG001|Overall Study|Other|1|||
30706828|NCT00132301|58720415|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
30706829|NCT00132301|58720416|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
30706830|NCT00522873|58720424|FG000|Overall Study|Adverse Event|41|||
30706831|NCT00522873|58720425|FG001|Overall Study|Adverse Event|26|||
30706832|NCT00522873|58720424|FG000|Overall Study|Withdrawal by Subject|20|||
30706833|NCT00522873|58720425|FG001|Overall Study|Withdrawal by Subject|9|||
30706834|NCT00522873|58720424|FG000|Overall Study|Protocol Violation|14|||
30706835|NCT00522873|58720425|FG001|Overall Study|Protocol Violation|4|||
30706836|NCT00522873|58720424|FG000|Overall Study|Lost to Follow-up|11|||
30706837|NCT00522873|58720425|FG001|Overall Study|Lost to Follow-up|3|||
30706838|NCT00522873|58720424|FG000|Overall Study|Personal Reasons|8|||
30706839|NCT00522873|58720425|FG001|Overall Study|Personal Reasons|1|||
30706840|NCT00522873|58720424|FG000|Overall Study|Medication Errors|1|||
30706841|NCT00522873|58720425|FG001|Overall Study|Medication Errors|1|||
30706842|NCT00522873|58720424|FG000|Overall Study|Never Received Medication|1|||
30706843|NCT00522873|58720425|FG001|Overall Study|Never Received Medication|0|||
30894213|NCT02152761|58927653|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
30894214|NCT02152761|58927654|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
30894215|NCT02152761|58927651|FG000|Epoch: Treatment Epoch|Death|0|||
30894216|NCT02152761|58927652|FG001|Epoch: Treatment Epoch|Death|3|||
30620350|NCT01211483|58631644|FG003|Phase 1b|Death|0|||
30620351|NCT01211483|58631641|FG000|Phase 1b|Withdrawal by Subject|1|||
30620352|NCT01211483|58631642|FG001|Phase 1b|Withdrawal by Subject|0|||
30620353|NCT01211483|58631643|FG002|Phase 1b|Withdrawal by Subject|0|||
30620354|NCT01211483|58631644|FG003|Phase 1b|Withdrawal by Subject|0|||
30620355|NCT01211483|58631641|FG000|Phase 2|Lost to Follow-up|0|||
30620356|NCT01211483|58631642|FG001|Phase 2|Lost to Follow-up|1|||
30620357|NCT01211483|58631643|FG002|Phase 2|Lost to Follow-up|1|||
30620358|NCT01211483|58631644|FG003|Phase 2|Lost to Follow-up|2|||
30620359|NCT01211483|58631641|FG000|Phase 2|Death|0|||
30706844|NCT03684057|58720433|FG000|Overall Study|Withdrawal by Subject|4|||
30706845|NCT03684057|58720434|FG001|Overall Study|Withdrawal by Subject|5|||
30706846|NCT03864627|58720443|FG000|Overall Study|Adverse Event|0|||
30706847|NCT03864627|58720444|FG001|Overall Study|Adverse Event|1|||
30706848|NCT03864627|58720443|FG000|Overall Study|Lack of Efficacy|0|||
30706849|NCT03864627|58720444|FG001|Overall Study|Lack of Efficacy|1|||
30706850|NCT03864627|58720443|FG000|Overall Study|Lost to Follow-up|0|||
30706851|NCT03864627|58720444|FG001|Overall Study|Lost to Follow-up|1|||
30706852|NCT03864627|58720443|FG000|Overall Study|Withdrawal by Subject|4|||
30706853|NCT03864627|58720444|FG001|Overall Study|Withdrawal by Subject|8|||
30706854|NCT03864627|58720443|FG000|Overall Study|Study terminated by sponsor|0|||
30706855|NCT03864627|58720444|FG001|Overall Study|Study terminated by sponsor|1|||
30706856|NCT00519831|58720451|FG000|Overall Study|Adverse Event|3|||
30706857|NCT00131911|58720461|FG000|Overall Study|Withdrawal by Subject|1|||
30706858|NCT00131911|58720462|FG001|Overall Study|Withdrawal by Subject|0|||
30706859|NCT00184093|58720467|FG000|Overall Study|Adverse Event|3|||
30706860|NCT00184093|58720467|FG000|Overall Study|Lost to Follow-up|3|||
30706861|NCT00184093|58720467|FG000|Overall Study|Physician Decision|1|||
30706862|NCT00184093|58720467|FG000|Overall Study|Withdrawal by Subject|2|||
30706863|NCT00183625|58720473|FG000|Overall Study|Withdrawal by Subject|18|||
30706864|NCT00183625|58720474|FG001|Overall Study|Withdrawal by Subject|18|||
30706865|NCT00183625|58720475|FG002|Overall Study|Withdrawal by Subject|19|||
30706866|NCT00183625|58720476|FG003|Overall Study|Withdrawal by Subject|14|||
30706867|NCT00511875|58720486|FG000|Overall Study|Lost to Follow-up|4|||
30706868|NCT00511875|58720487|FG001|Overall Study|Lost to Follow-up|0|||
30706869|NCT00511875|58720486|FG000|Overall Study|Missing variables|1|||
30706870|NCT00511875|58720487|FG001|Overall Study|Missing variables|0|||
30706871|NCT00183391|58720495|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
30706872|NCT00183391|58720496|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
30706873|NCT00183391|58720495|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
30706874|NCT00183391|58720496|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
30706875|NCT00493246|58720512|FG000|Overall Study|Withdrawal by Subject|0|||
30706876|NCT00493246|58720513|FG001|Overall Study|Withdrawal by Subject|0|||
30706877|NCT00493246|58720514|FG002|Overall Study|Withdrawal by Subject|0|||
30706878|NCT00493246|58720515|FG003|Overall Study|Withdrawal by Subject|0|||
30894217|NCT02152761|58927653|FG002|Epoch: Treatment Epoch|Death|1|||
30894218|NCT02152761|58927654|FG003|Epoch: Treatment Epoch|Death|0|||
30894219|NCT02152761|58927651|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
30894220|NCT02152761|58927652|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
30894221|NCT02152761|58927653|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
30894222|NCT02152761|58927654|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
30894223|NCT02152761|58927651|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
30894224|NCT02152761|58927652|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
30620360|NCT01211483|58631642|FG001|Phase 2|Death|64|||
30620361|NCT01211483|58631643|FG002|Phase 2|Death|53|||
30706879|NCT00493246|58720516|FG004|Overall Study|Withdrawal by Subject|1|||
30706880|NCT00493246|58720517|FG005|Overall Study|Withdrawal by Subject|0|||
30706881|NCT00493246|58720518|FG006|Overall Study|Withdrawal by Subject|0|||
30706882|NCT00493246|58720519|FG007|Overall Study|Withdrawal by Subject|0|||
30620362|NCT01211483|58631644|FG003|Phase 2|Death|53|||
30620363|NCT01211483|58631641|FG000|Phase 2|Withdrawal by Subject|0|||
30620364|NCT01211483|58631642|FG001|Phase 2|Withdrawal by Subject|1|||
30620365|NCT01211483|58631643|FG002|Phase 2|Withdrawal by Subject|10|||
30620366|NCT01211483|58631644|FG003|Phase 2|Withdrawal by Subject|5|||
30620367|NCT01211483|58631641|FG000|Phase 2|Study terminated by Sponsor|0|||
30620368|NCT01211483|58631642|FG001|Phase 2|Study terminated by Sponsor|6|||
30620369|NCT01211483|58631643|FG002|Phase 2|Study terminated by Sponsor|8|||
30620370|NCT01211483|58631644|FG003|Phase 2|Study terminated by Sponsor|11|||
30620371|NCT01210001|58631661|FG000|Overall Study|Not treated|1|||
30620372|NCT01210001|58631662|FG001|Overall Study|Not treated|0|||
30706883|NCT00493246|58720512|FG000|Overall Study|No access to draw blood|0|||
30706884|NCT00493246|58720513|FG001|Overall Study|No access to draw blood|0|||
30620373|NCT01210001|58631663|FG002|Overall Study|Not treated|0|||
30620374|NCT01210001|58631661|FG000|Overall Study|Adverse Event|4|||
30620375|NCT01210001|58631662|FG001|Overall Study|Adverse Event|2|||
30706885|NCT00493246|58720514|FG002|Overall Study|No access to draw blood|0|||
30706886|NCT00493246|58720515|FG003|Overall Study|No access to draw blood|0|||
30706887|NCT00493246|58720516|FG004|Overall Study|No access to draw blood|0|||
30706888|NCT00493246|58720517|FG005|Overall Study|No access to draw blood|1|||
30706889|NCT00493246|58720518|FG006|Overall Study|No access to draw blood|0|||
30706890|NCT00493246|58720519|FG007|Overall Study|No access to draw blood|0|||
30620376|NCT01210001|58631663|FG002|Overall Study|Adverse Event|5|||
30706891|NCT00493246|58720512|FG000|Overall Study|Lost to Follow-up|0|||
30706892|NCT00493246|58720513|FG001|Overall Study|Lost to Follow-up|0|||
30706893|NCT00493246|58720514|FG002|Overall Study|Lost to Follow-up|0|||
30706894|NCT00493246|58720515|FG003|Overall Study|Lost to Follow-up|0|||
30706895|NCT00493246|58720516|FG004|Overall Study|Lost to Follow-up|0|||
30706896|NCT00493246|58720517|FG005|Overall Study|Lost to Follow-up|0|||
30706897|NCT00493246|58720518|FG006|Overall Study|Lost to Follow-up|1|||
30706898|NCT00493246|58720519|FG007|Overall Study|Lost to Follow-up|0|||
30706899|NCT02281955|58720537|FG000|Overall Study|Death|1|||
30706900|NCT00511797|58720545|FG000|Overall Study|Adverse Event|1|||
30706901|NCT00511797|58720546|FG001|Overall Study|Adverse Event|2|||
30706902|NCT00511797|58720547|FG002|Overall Study|Adverse Event|2|||
30706903|NCT00511797|58720548|FG003|Overall Study|Adverse Event|2|||
30706904|NCT00511797|58720545|FG000|Overall Study|Lost to Follow-up|1|||
30706905|NCT00511797|58720546|FG001|Overall Study|Lost to Follow-up|0|||
30706906|NCT00511797|58720547|FG002|Overall Study|Lost to Follow-up|0|||
30706907|NCT00511797|58720548|FG003|Overall Study|Lost to Follow-up|1|||
30706908|NCT00511797|58720545|FG000|Overall Study|Pregnancy|0|||
30706909|NCT00511797|58720546|FG001|Overall Study|Pregnancy|0|||
30706910|NCT00511797|58720547|FG002|Overall Study|Pregnancy|0|||
30706911|NCT00511797|58720548|FG003|Overall Study|Pregnancy|1|||
30706912|NCT00511797|58720545|FG000|Overall Study|Protocol Violation|0|||
30706913|NCT00511797|58720546|FG001|Overall Study|Protocol Violation|2|||
30706914|NCT00511797|58720547|FG002|Overall Study|Protocol Violation|2|||
30706915|NCT00511797|58720548|FG003|Overall Study|Protocol Violation|3|||
30706916|NCT00511797|58720545|FG000|Overall Study|Withdrawal by Subject|3|||
30706917|NCT00511797|58720546|FG001|Overall Study|Withdrawal by Subject|3|||
30706918|NCT00511797|58720547|FG002|Overall Study|Withdrawal by Subject|4|||
30620377|NCT01210001|58631661|FG000|Overall Study|Non compliant with protocol|2|||
30620378|NCT01210001|58631662|FG001|Overall Study|Non compliant with protocol|2|||
30620379|NCT01210001|58631663|FG002|Overall Study|Non compliant with protocol|3|||
30706919|NCT00511797|58720548|FG003|Overall Study|Withdrawal by Subject|2|||
30706920|NCT00511797|58720545|FG000|Overall Study|Never dispensed|1|||
30706921|NCT00511797|58720546|FG001|Overall Study|Never dispensed|0|||
30706922|NCT00511797|58720547|FG002|Overall Study|Never dispensed|1|||
30706923|NCT00511797|58720548|FG003|Overall Study|Never dispensed|3|||
30706924|NCT00511797|58720545|FG000|Overall Study|Study drug not taken|0|||
30706925|NCT00511797|58720546|FG001|Overall Study|Study drug not taken|1|||
30706926|NCT00511797|58720547|FG002|Overall Study|Study drug not taken|0|||
30706927|NCT00511797|58720548|FG003|Overall Study|Study drug not taken|1|||
30706928|NCT00511797|58720545|FG000|Overall Study|Partially missing diary|0|||
30706929|NCT00511797|58720546|FG001|Overall Study|Partially missing diary|0|||
30706930|NCT00511797|58720547|FG002|Overall Study|Partially missing diary|1|||
30706931|NCT00511797|58720548|FG003|Overall Study|Partially missing diary|0|||
30706932|NCT00511797|58720545|FG000|Overall Study|Other (moving etc)|1|||
30706933|NCT00511797|58720546|FG001|Overall Study|Other (moving etc)|0|||
30706934|NCT00511797|58720547|FG002|Overall Study|Other (moving etc)|1|||
30706935|NCT00511797|58720548|FG003|Overall Study|Other (moving etc)|2|||
30706936|NCT00487552|58720558|FG000|Overall Study|Unsuccessful magnet placements|3|||
30706937|NCT00487552|58720558|FG000|Overall Study|Death due to progressive malignancy|2|||
30706938|NCT00487552|58720558|FG000|Overall Study|Stent not placed|1|||
30706939|NCT00182689|58720565|FG000|Overall Study|Adverse Event|8|||
30706940|NCT00182689|58720566|FG001|Overall Study|Adverse Event|11|||
30706941|NCT00182689|58720565|FG000|Overall Study|Withdrawal by Subject|2|||
30706942|NCT00182689|58720566|FG001|Overall Study|Withdrawal by Subject|2|||
30706943|NCT00182689|58720565|FG000|Overall Study|Progression|27|||
30620380|NCT01210001|58631661|FG000|Overall Study|Lost to Follow-up|4|||
30620381|NCT01210001|58631662|FG001|Overall Study|Lost to Follow-up|3|||
30620382|NCT01210001|58631663|FG002|Overall Study|Lost to Follow-up|2|||
30620383|NCT01210001|58631661|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
30620384|NCT01210001|58631662|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
30620385|NCT01210001|58631663|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
30620386|NCT01210001|58631661|FG000|Overall Study|Other reason not defined above|2|||
30620387|NCT01210001|58631662|FG001|Overall Study|Other reason not defined above|2|||
30620388|NCT01210001|58631663|FG002|Overall Study|Other reason not defined above|1|||
30620389|NCT01209689|58631704|FG000|Overall Study|Insufficient Therapeutic Response|7|||
30620390|NCT01209689|58631705|FG001|Overall Study|Insufficient Therapeutic Response|2|||
30706944|NCT00182689|58720566|FG001|Overall Study|Progression|29|||
30706945|NCT00182689|58720565|FG000|Overall Study|Death|1|||
30706946|NCT00182689|58720566|FG001|Overall Study|Death|0|||
30706947|NCT00182689|58720565|FG000|Overall Study|not protocol specified|0|||
30706948|NCT00182689|58720566|FG001|Overall Study|not protocol specified|3|||
30706949|NCT00182689|58720565|FG000|Overall Study|Ineligible|1|||
30706950|NCT00182689|58720566|FG001|Overall Study|Ineligible|4|||
30706951|NCT00182689|58720565|FG000|Overall Study|Never received treatment|1|||
30706952|NCT00182689|58720566|FG001|Overall Study|Never received treatment|0|||
30760594|NCT03381274|58769073|FG003|Overall Study|Withdrawal by Subject|1|||
30760595|NCT03381274|58769074|FG004|Overall Study|Withdrawal by Subject|0|||
30760596|NCT03381274|58769070|FG000|Overall Study|Other|1|||
30760597|NCT03381274|58769071|FG001|Overall Study|Other|11|||
30706953|NCT03860259|58720578|FG000|Overall Study|Lost to Follow-up|5|||
30706954|NCT03860259|58720579|FG001|Overall Study|Lost to Follow-up|5|||
30706955|NCT03860259|58720578|FG000|Overall Study|Protocol Violation|1|||
30706956|NCT03860259|58720579|FG001|Overall Study|Protocol Violation|0|||
30706957|NCT00131365|58720585|FG000|Overall Study|Withdrawal by Subject|1|||
30706958|NCT00131365|58720585|FG000|Overall Study|Alternative treatment|3|||
30620391|NCT01209689|58631704|FG000|Overall Study|Refused Treatment|8|||
30620392|NCT01209689|58631705|FG001|Overall Study|Refused Treatment|3|||
30620393|NCT01209689|58631704|FG000|Overall Study|Adverse Event|4|||
30894225|NCT02152761|58927653|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
30894226|NCT02152761|58927654|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
30894227|NCT02152761|58927651|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
30894228|NCT02152761|58927652|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
30894229|NCT02152761|58927653|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
30894230|NCT02152761|58927654|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
30894231|NCT02152761|58927651|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
30894232|NCT02152761|58927652|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
30894233|NCT02152761|58927653|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
30894234|NCT02152761|58927654|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
30894235|NCT02152761|58927651|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
30894236|NCT02152761|58927652|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
30894237|NCT02152761|58927653|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
30894238|NCT02152761|58927654|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
30894239|NCT02152605|58927676|FG000|Overall Study|Adverse Event|6|||
30894240|NCT02152605|58927677|FG001|Overall Study|Adverse Event|8|||
30894241|NCT02152605|58927676|FG000|Overall Study|Lack of Efficacy|7|||
30894242|NCT02152605|58927677|FG001|Overall Study|Lack of Efficacy|4|||
30894243|NCT02152605|58927676|FG000|Overall Study|Protocol deviation|1|||
30894244|NCT02152605|58927677|FG001|Overall Study|Protocol deviation|4|||
30706959|NCT00487240|58720592|FG000|Overall Study|Withdrawal by Subject|12|||
30706960|NCT00487240|58720593|FG001|Overall Study|Withdrawal by Subject|6|||
30706961|NCT00487240|58720592|FG000|Overall Study|Lost to Follow-up|7|||
30706962|NCT00487240|58720593|FG001|Overall Study|Lost to Follow-up|6|||
30706963|NCT00487240|58720592|FG000|Overall Study|Adverse Event|0|||
30706964|NCT00487240|58720593|FG001|Overall Study|Adverse Event|4|||
30706965|NCT00487240|58720592|FG000|Overall Study|Protocol Violation|5|||
30706966|NCT00487240|58720593|FG001|Overall Study|Protocol Violation|5|||
30706967|NCT00487240|58720592|FG000|Overall Study|Entry Criteria Not Met|3|||
30706968|NCT00487240|58720593|FG001|Overall Study|Entry Criteria Not Met|4|||
30706969|NCT00487240|58720592|FG000|Overall Study|Sponsor Decision|2|||
30706970|NCT00487240|58720593|FG001|Overall Study|Sponsor Decision|1|||
30706971|NCT00487240|58720592|FG000|Overall Study|Physician Decision|2|||
30706972|NCT00487240|58720593|FG001|Overall Study|Physician Decision|0|||
30706973|NCT02224391|58720601|FG000|Overall Study|Lost to Follow-up|26|||
30706974|NCT02224391|58720602|FG001|Overall Study|Lost to Follow-up|19|||
30706975|NCT02224391|58720601|FG000|Overall Study|Withdrawal by Subject|6|||
30706976|NCT02224391|58720602|FG001|Overall Study|Withdrawal by Subject|5|||
30706977|NCT00487162|58720610|FG000|Overall Study|Adverse Event|0|||
30706978|NCT00487162|58720611|FG001|Overall Study|Adverse Event|1|||
30706979|NCT00487162|58720610|FG000|Overall Study|Physician Decision|0|||
30706980|NCT00487162|58720611|FG001|Overall Study|Physician Decision|1|||
30706981|NCT00487162|58720610|FG000|Overall Study|Withdrawal by Subject|2|||
30894245|NCT02152605|58927676|FG000|Overall Study|Lost to Follow-up|1|||
30894246|NCT02152605|58927677|FG001|Overall Study|Lost to Follow-up|0|||
30620394|NCT01209689|58631705|FG001|Overall Study|Adverse Event|0|||
30620395|NCT01209689|58631704|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
30620396|NCT01209689|58631705|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
30620397|NCT01209689|58631704|FG000|Overall Study|Failure to Return|3|||
30620398|NCT01209689|58631705|FG001|Overall Study|Failure to Return|0|||
30706982|NCT00487162|58720611|FG001|Overall Study|Withdrawal by Subject|3|||
30706983|NCT00487084|58720620|FG000|Overall Study|Did not receive intervention|4|||
30706984|NCT00487084|58720621|FG001|Overall Study|Did not receive intervention|3|||
30706985|NCT00487084|58720622|FG002|Overall Study|Did not receive intervention|5|||
30706986|NCT00466726|58720630|FG000|Overall Study|Not evaluable for response|14|||
30706987|NCT01721291|58720636|FG000|Overall Study|Withdrawal by Subject|1|||
30706988|NCT01721291|58720637|FG001|Overall Study|Withdrawal by Subject|0|||
30706989|NCT01721291|58720636|FG000|Overall Study|did not like the treatment|1|||
30706990|NCT01721291|58720637|FG001|Overall Study|did not like the treatment|0|||
30706991|NCT00486226|58720663|FG000|Overall Study|Death|3|||
30620399|NCT01209689|58631704|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
30706992|NCT00486226|58720663|FG000|Overall Study|Adverse Event|1|||
30706993|NCT00486226|58720663|FG000|Overall Study|Withdrawal by Subject|1|||
30790866|NCT03524092|58803945|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
30706994|NCT00486226|58720663|FG000|Overall Study|Lost to Follow-up|8|||
30706995|NCT00485758|58720672|FG000|Overall Study|Adverse Event|102|||
30706996|NCT00485758|58720673|FG001|Overall Study|Adverse Event|31|||
30706997|NCT00485758|58720672|FG000|Overall Study|Death|0|||
30706998|NCT00485758|58720673|FG001|Overall Study|Death|1|||
30706999|NCT00485758|58720672|FG000|Overall Study|Lost to Follow-up|5|||
30707000|NCT00485758|58720673|FG001|Overall Study|Lost to Follow-up|1|||
30707001|NCT00485758|58720672|FG000|Overall Study|Physician Decision|3|||
30707002|NCT00485758|58720673|FG001|Overall Study|Physician Decision|3|||
30707003|NCT00485758|58720672|FG000|Overall Study|Protocol Violation|11|||
30707004|NCT00485758|58720673|FG001|Overall Study|Protocol Violation|2|||
30707005|NCT00485758|58720672|FG000|Overall Study|Withdrawal by Subject|32|||
30707006|NCT00485758|58720673|FG001|Overall Study|Withdrawal by Subject|27|||
30707007|NCT00485758|58720672|FG000|Overall Study|Study Terminated by Sponsor|3|||
30707008|NCT00485758|58720673|FG001|Overall Study|Study Terminated by Sponsor|0|||
30707009|NCT03850444|58720681|FG000|Overall Study|Adverse Event|12|||
30707010|NCT03850444|58720682|FG001|Overall Study|Adverse Event|9|||
30707011|NCT03850444|58720681|FG000|Overall Study|Death|38|||
30707012|NCT03850444|58720682|FG001|Overall Study|Death|64|||
30707013|NCT03850444|58720681|FG000|Overall Study|Lost to Follow-up|0|||
30707014|NCT03850444|58720682|FG001|Overall Study|Lost to Follow-up|1|||
30707015|NCT03850444|58720681|FG000|Overall Study|Withdrawal by Subject|0|||
30707016|NCT03850444|58720682|FG001|Overall Study|Withdrawal by Subject|1|||
30707017|NCT03850444|58720681|FG000|Overall Study|Ongoing in Study|78|||
30707018|NCT03850444|58720682|FG001|Overall Study|Ongoing in Study|59|||
30707019|NCT00469612|58720690|FG000|Overall Study|Study terminated before data collected|2|||
30707020|NCT00469612|58720691|FG001|Overall Study|Study terminated before data collected|0|||
30707021|NCT00469456|58720699|FG000|Overall Study|Adverse Event|4|||
30707022|NCT00469456|58720700|FG001|Overall Study|Adverse Event|3|||
30707023|NCT00469456|58720699|FG000|Overall Study|Protocol Violation|1|||
30707024|NCT00469456|58720700|FG001|Overall Study|Protocol Violation|0|||
30707025|NCT00469456|58720699|FG000|Overall Study|Withdrawal by Subject|4|||
30707026|NCT00469456|58720700|FG001|Overall Study|Withdrawal by Subject|1|||
30707027|NCT00581555|58720708|FG000|Overall Study|Adverse Event|4|||
30707028|NCT00581555|58720709|FG001|Overall Study|Adverse Event|3|||
30707029|NCT00581555|58720708|FG000|Overall Study|Physician Decision|3|||
30707030|NCT00581555|58720709|FG001|Overall Study|Physician Decision|2|||
30707031|NCT00581555|58720708|FG000|Overall Study|Withdrawal by Subject|18|||
30707032|NCT00581555|58720709|FG001|Overall Study|Withdrawal by Subject|9|||
30707033|NCT00581555|58720708|FG000|Overall Study|Lost to Follow-up|2|||
30894247|NCT02152605|58927676|FG000|Overall Study|Withdrew consent|4|||
30894248|NCT02152605|58927677|FG001|Overall Study|Withdrew consent|2|||
30707034|NCT00581555|58720709|FG001|Overall Study|Lost to Follow-up|2|||
30707035|NCT00581555|58720708|FG000|Overall Study|Other reasons|16|||
30707036|NCT00581555|58720709|FG001|Overall Study|Other reasons|4|||
30707037|NCT00469144|58720717|FG000|Overall Study|Death|0|||
30707038|NCT00469144|58720718|FG001|Overall Study|Death|1|||
30707039|NCT00469144|58720717|FG000|Overall Study|No Response|5|||
30707040|NCT00469144|58720718|FG001|Overall Study|No Response|5|||
30707041|NCT00469144|58720717|FG000|Overall Study|Progressive Disease|1|||
30707042|NCT00469144|58720718|FG001|Overall Study|Progressive Disease|0|||
30707043|NCT00468910|58720730|FG000|Overall Study|Lost to Follow-up|2|||
30707044|NCT00468910|58720731|FG001|Overall Study|Lost to Follow-up|1|||
30707045|NCT00468910|58720730|FG000|Overall Study|Withdrawal by Subject|2|||
30707046|NCT00468910|58720731|FG001|Overall Study|Withdrawal by Subject|1|||
30707047|NCT00468910|58720730|FG000|Overall Study|Medical Contraindication|0|||
30707048|NCT00468910|58720731|FG001|Overall Study|Medical Contraindication|1|||
30707049|NCT01412333|58720740|FG000|Overall Study|Death|1|||
30707050|NCT01412333|58720741|FG001|Overall Study|Death|1|||
30707051|NCT01412333|58720740|FG000|Overall Study|Physician Decision|0|||
30707052|NCT01412333|58720741|FG001|Overall Study|Physician Decision|1|||
30707053|NCT01412333|58720740|FG000|Overall Study|Reason not specified|16|||
30707054|NCT01412333|58720741|FG001|Overall Study|Reason not specified|10|||
30707055|NCT01412333|58720740|FG000|Overall Study|Non-compliance with study drug|1|||
30707056|NCT01412333|58720741|FG001|Overall Study|Non-compliance with study drug|1|||
30707057|NCT01412333|58720740|FG000|Overall Study|Protocol Violation|1|||
30707058|NCT01412333|58720741|FG001|Overall Study|Protocol Violation|1|||
30707059|NCT01412333|58720740|FG000|Overall Study|Non-compliance|1|||
30707060|NCT01412333|58720741|FG001|Overall Study|Non-compliance|3|||
30894249|NCT02152371|58927686|FG000|Overall Study|Adverse Event|6|||
30894250|NCT02152371|58927687|FG001|Overall Study|Adverse Event|2|||
30707061|NCT01412333|58720740|FG000|Overall Study|Lack of Efficacy|15|||
30894251|NCT02152371|58927686|FG000|Overall Study|Withdrawal by Subject|3|||
30707062|NCT01412333|58720741|FG001|Overall Study|Lack of Efficacy|6|||
30894252|NCT02152371|58927687|FG001|Overall Study|Withdrawal by Subject|7|||
30707063|NCT01412333|58720740|FG000|Overall Study|Pregnancy|3|||
30707064|NCT01412333|58720741|FG001|Overall Study|Pregnancy|0|||
30707065|NCT01412333|58720740|FG000|Overall Study|Consent withdrawn by participant|25|||
30707066|NCT01412333|58720741|FG001|Overall Study|Consent withdrawn by participant|12|||
30707067|NCT01412333|58720740|FG000|Overall Study|Adverse Event|25|||
30707068|NCT01412333|58720741|FG001|Overall Study|Adverse Event|16|||
30707069|NCT01412333|58720740|FG000|Overall Study|Lost to Follow-up|10|||
30707070|NCT01412333|58720741|FG001|Overall Study|Lost to Follow-up|6|||
30707071|NCT00519285|58720750|FG000|Overall Study|Adverse Event|127|||
30707072|NCT00519285|58720751|FG001|Overall Study|Adverse Event|266|||
30707073|NCT00519285|58720750|FG000|Overall Study|Disease progression|334|||
30707074|NCT00519285|58720751|FG001|Overall Study|Disease progression|186|||
30707075|NCT00519285|58720750|FG000|Overall Study|Physician Decision|75|||
30707076|NCT00519285|58720751|FG001|Overall Study|Physician Decision|47|||
30707077|NCT00519285|58720750|FG000|Overall Study|Participant's request|53|||
30707078|NCT00519285|58720751|FG001|Overall Study|Participant's request|84|||
30707079|NCT00519285|58720750|FG000|Overall Study|Consent withdrawn|4|||
30707080|NCT00519285|58720751|FG001|Overall Study|Consent withdrawn|5|||
30707081|NCT00519285|58720750|FG000|Overall Study|Poor compliance to protocol|5|||
30707082|NCT00519285|58720751|FG001|Overall Study|Poor compliance to protocol|7|||
30707083|NCT00519285|58720750|FG000|Overall Study|Reason unspecified|5|||
30707084|NCT00519285|58720751|FG001|Overall Study|Reason unspecified|8|||
30707085|NCT00519285|58720750|FG000|Overall Study|Not treated|8|||
30707086|NCT00519285|58720751|FG001|Overall Study|Not treated|7|||
30894253|NCT02152371|58927686|FG000|Overall Study|Protocol Violation|2|||
30894254|NCT02152371|58927687|FG001|Overall Study|Protocol Violation|3|||
30894255|NCT02152371|58927686|FG000|Overall Study|Lost to Follow-up|1|||
30894256|NCT02152371|58927687|FG001|Overall Study|Lost to Follow-up|0|||
30894257|NCT02152371|58927686|FG000|Overall Study|Lack of Efficacy|0|||
30894258|NCT02152371|58927687|FG001|Overall Study|Lack of Efficacy|1|||
30894259|NCT02152371|58927686|FG000|Overall Study|Physician Decision|0|||
30894260|NCT02152371|58927687|FG001|Overall Study|Physician Decision|2|||
30894261|NCT02152371|58927686|FG000|Overall Study|Reason Not Given|0|||
30894262|NCT02152371|58927687|FG001|Overall Study|Reason Not Given|1|||
30894263|NCT02332291|58927695|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
30894264|NCT02332291|58927696|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
30894265|NCT02332291|58927695|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
30894266|NCT02332291|58927696|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
30894267|NCT02332291|58927695|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
30894268|NCT02332291|58927696|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
30894269|NCT02332291|58927695|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
30894270|NCT02332291|58927696|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
30894271|NCT02332291|58927695|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
30894272|NCT02332291|58927696|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
30894273|NCT02332291|58927695|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
30894274|NCT02332291|58927696|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
30894275|NCT01656395|58927712|FG000|Overall Study|Adverse Event|1|||
30894276|NCT01656395|58927713|FG001|Overall Study|Adverse Event|14|||
30894277|NCT01656395|58927714|FG002|Overall Study|Adverse Event|5|||
30894278|NCT01656395|58927715|FG003|Overall Study|Adverse Event|4|||
30894279|NCT01656395|58927716|FG004|Overall Study|Adverse Event|5|||
30894280|NCT01656395|58927717|FG005|Overall Study|Adverse Event|7|||
30894281|NCT01656395|58927718|FG006|Overall Study|Adverse Event|0|||
30894282|NCT01656395|58927719|FG007|Overall Study|Adverse Event|0|||
30894283|NCT01656395|58927712|FG000|Overall Study|Lack of Efficacy|1|||
30894284|NCT01656395|58927713|FG001|Overall Study|Lack of Efficacy|8|||
30894285|NCT01656395|58927714|FG002|Overall Study|Lack of Efficacy|6|||
30894286|NCT01656395|58927715|FG003|Overall Study|Lack of Efficacy|1|||
30894287|NCT01656395|58927716|FG004|Overall Study|Lack of Efficacy|1|||
30894288|NCT01656395|58927717|FG005|Overall Study|Lack of Efficacy|6|||
30894289|NCT01656395|58927718|FG006|Overall Study|Lack of Efficacy|0|||
30894290|NCT01656395|58927719|FG007|Overall Study|Lack of Efficacy|0|||
30894291|NCT01656395|58927712|FG000|Overall Study|Lost to Follow-up|1|||
30894292|NCT01656395|58927713|FG001|Overall Study|Lost to Follow-up|0|||
30894293|NCT01656395|58927714|FG002|Overall Study|Lost to Follow-up|0|||
30894294|NCT01656395|58927715|FG003|Overall Study|Lost to Follow-up|0|||
30894295|NCT01656395|58927716|FG004|Overall Study|Lost to Follow-up|0|||
30894296|NCT01656395|58927717|FG005|Overall Study|Lost to Follow-up|0|||
30894297|NCT01656395|58927718|FG006|Overall Study|Lost to Follow-up|0|||
30894298|NCT01656395|58927719|FG007|Overall Study|Lost to Follow-up|0|||
30894299|NCT01656395|58927712|FG000|Overall Study|Non-Compliance with Study Drug|1|||
30894300|NCT01656395|58927713|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30894301|NCT01656395|58927714|FG002|Overall Study|Non-Compliance with Study Drug|0|||
30707087|NCT00519285|58720750|FG000|Overall Study|Treatment ongoing|1|||
30707088|NCT00519285|58720751|FG001|Overall Study|Treatment ongoing|2|||
30707089|NCT00464620|58720757|FG000|Overall Study|Physician Decision|1|||
30707090|NCT00464620|58720758|FG001|Overall Study|Physician Decision|0|||
30707091|NCT00464620|58720759|FG002|Overall Study|Physician Decision|0|||
30707092|NCT00464620|58720757|FG000|Overall Study|Withdrawal by Subject|1|||
30894302|NCT01656395|58927715|FG003|Overall Study|Non-Compliance with Study Drug|0|||
30894303|NCT01656395|58927716|FG004|Overall Study|Non-Compliance with Study Drug|1|||
30894304|NCT01656395|58927717|FG005|Overall Study|Non-Compliance with Study Drug|1|||
30894305|NCT01656395|58927718|FG006|Overall Study|Non-Compliance with Study Drug|0|||
30894306|NCT01656395|58927719|FG007|Overall Study|Non-Compliance with Study Drug|0|||
30894307|NCT01656395|58927712|FG000|Overall Study|Other|0|||
30894308|NCT01656395|58927713|FG001|Overall Study|Other|0|||
30894309|NCT01656395|58927714|FG002|Overall Study|Other|1|||
30894310|NCT01656395|58927715|FG003|Overall Study|Other|0|||
30707093|NCT00464620|58720758|FG001|Overall Study|Withdrawal by Subject|0|||
30707094|NCT00464620|58720759|FG002|Overall Study|Withdrawal by Subject|3|||
30707095|NCT00464620|58720757|FG000|Overall Study|Ineligible sarcoma subtype|0|||
30707096|NCT00464620|58720758|FG001|Overall Study|Ineligible sarcoma subtype|2|||
30707097|NCT00464620|58720759|FG002|Overall Study|Ineligible sarcoma subtype|2|||
30707098|NCT00464620|58720757|FG000|Overall Study|Use of prohibited concomitant medication|0|||
30707099|NCT00464620|58720758|FG001|Overall Study|Use of prohibited concomitant medication|0|||
30707100|NCT00464620|58720759|FG002|Overall Study|Use of prohibited concomitant medication|2|||
30707101|NCT00464542|58720772|FG000|Pre-treatment|Withdrawal by Subject|2|||
30707102|NCT00468676|58720778|FG000|Overall Study|Lost to Follow-up|14|||
30707103|NCT00468676|58720779|FG001|Overall Study|Lost to Follow-up|11|||
30707104|NCT00468676|58720778|FG000|Overall Study|Death|2|||
30707105|NCT00468676|58720779|FG001|Overall Study|Death|1|||
30707106|NCT00464308|58720790|FG000|Overall Study|Adverse Event|22|||
30707107|NCT00464308|58720791|FG001|Overall Study|Adverse Event|27|||
30707108|NCT00464308|58720792|FG002|Overall Study|Adverse Event|16|||
30707109|NCT00464308|58720790|FG000|Overall Study|Lost to Follow-up|29|||
30707110|NCT00464308|58720791|FG001|Overall Study|Lost to Follow-up|19|||
30707111|NCT00464308|58720792|FG002|Overall Study|Lost to Follow-up|20|||
30707112|NCT00464308|58720790|FG000|Overall Study|Patient discontinued and other reasons|17|||
30707113|NCT00464308|58720791|FG001|Overall Study|Patient discontinued and other reasons|17|||
30707114|NCT00464308|58720792|FG002|Overall Study|Patient discontinued and other reasons|23|||
30707115|NCT00464308|58720790|FG000|Overall Study|Physician Decision|1|||
30707116|NCT00464308|58720791|FG001|Overall Study|Physician Decision|0|||
30707117|NCT00464308|58720792|FG002|Overall Study|Physician Decision|0|||
30707118|NCT00468286|58720802|FG000|Overall Study|Adverse Event|1|||
30707119|NCT00468286|58720803|FG001|Overall Study|Adverse Event|6|||
30707120|NCT00468286|58720802|FG000|Overall Study|Protocol Violation|2|||
30707121|NCT00468286|58720803|FG001|Overall Study|Protocol Violation|2|||
30707122|NCT00468286|58720802|FG000|Overall Study|Withdrawal by Subject|4|||
30707123|NCT00468286|58720803|FG001|Overall Study|Withdrawal by Subject|3|||
30843701|NCT01915498|58869665|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
30707124|NCT00468286|58720802|FG000|Overall Study|Physician Decision|0|||
30707125|NCT00468286|58720803|FG001|Overall Study|Physician Decision|1|||
30707126|NCT00463840|58720809|FG000|Overall Study|Disease progression|7|||
30707127|NCT00463840|58720809|FG000|Overall Study|Withdrawal by Subject|2|||
30707128|NCT00463840|58720809|FG000|Overall Study|Adverse Event|3|||
30707129|NCT00129389|58720815|FG000|Overall Study|Adverse Event|19|||
30707130|NCT00129389|58720816|FG001|Overall Study|Adverse Event|87|||
30707131|NCT00129389|58720815|FG000|Overall Study|Death|0|||
30843702|NCT01915498|58869647|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843703|NCT01915498|58869648|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843704|NCT01915498|58869649|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843705|NCT01915498|58869650|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843706|NCT01915498|58869651|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843707|NCT01915498|58869652|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843708|NCT01915498|58869653|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843709|NCT01915498|58869654|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843710|NCT01915498|58869655|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843711|NCT01915498|58869656|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843712|NCT01915498|58869657|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
30843713|NCT01915498|58869658|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30707132|NCT00129389|58720816|FG001|Overall Study|Death|1|||
30707133|NCT00129389|58720815|FG000|Overall Study|Lost to Follow-up|2|||
30707134|NCT00129389|58720816|FG001|Overall Study|Lost to Follow-up|1|||
30707135|NCT00129389|58720815|FG000|Overall Study|Physician Decision|0|||
30707136|NCT00129389|58720816|FG001|Overall Study|Physician Decision|4|||
30707137|NCT00129389|58720815|FG000|Overall Study|Protocol Violation|0|||
30707138|NCT00129389|58720816|FG001|Overall Study|Protocol Violation|6|||
30707139|NCT00129389|58720815|FG000|Overall Study|Withdrawal by Subject|9|||
30707140|NCT00129389|58720816|FG001|Overall Study|Withdrawal by Subject|23|||
30707141|NCT00129389|58720815|FG000|Overall Study|Relapse|1|||
30707142|NCT00129389|58720816|FG001|Overall Study|Relapse|0|||
30707143|NCT00129389|58720815|FG000|Overall Study|Not eligible|1|||
30707144|NCT00129389|58720816|FG001|Overall Study|Not eligible|2|||
30707145|NCT00129389|58720815|FG000|Overall Study|Crossed to the other arm|1|||
30707146|NCT00129389|58720816|FG001|Overall Study|Crossed to the other arm|16|||
30707147|NCT00468052|58720824|FG000|Overall Study|Protocol Violation|7|||
30707148|NCT00468052|58720825|FG001|Overall Study|Protocol Violation|8|||
30707149|NCT00453310|58720833|FG000|Overall Study|Progression of Disease|10|||
30707150|NCT00124657|58720840|FG000|Overall Study|Toxicity|0|||
30707151|NCT00124657|58720841|FG001|Overall Study|Toxicity|0|||
30707152|NCT00124657|58720842|FG002|Overall Study|Toxicity|1|||
30707153|NCT00124657|58720840|FG000|Overall Study|Non-compliance|1|||
30707154|NCT00124657|58720841|FG001|Overall Study|Non-compliance|0|||
30894311|NCT01656395|58927716|FG004|Overall Study|Other|0|||
30894312|NCT01656395|58927717|FG005|Overall Study|Other|1|||
30894313|NCT01656395|58927718|FG006|Overall Study|Other|0|||
30894314|NCT01656395|58927719|FG007|Overall Study|Other|0|||
30894315|NCT01656395|58927712|FG000|Overall Study|Physician Decision|2|||
30894316|NCT01656395|58927713|FG001|Overall Study|Physician Decision|3|||
30894317|NCT01656395|58927714|FG002|Overall Study|Physician Decision|3|||
30894318|NCT01656395|58927715|FG003|Overall Study|Physician Decision|2|||
30894319|NCT01656395|58927716|FG004|Overall Study|Physician Decision|3|||
30894320|NCT01656395|58927717|FG005|Overall Study|Physician Decision|3|||
30894321|NCT01656395|58927718|FG006|Overall Study|Physician Decision|0|||
30894322|NCT01656395|58927719|FG007|Overall Study|Physician Decision|0|||
30894323|NCT01656395|58927712|FG000|Overall Study|Pregnancy|0|||
30894324|NCT01656395|58927713|FG001|Overall Study|Pregnancy|0|||
30894325|NCT01656395|58927714|FG002|Overall Study|Pregnancy|1|||
30894326|NCT01656395|58927715|FG003|Overall Study|Pregnancy|0|||
30894327|NCT01656395|58927716|FG004|Overall Study|Pregnancy|0|||
30707155|NCT00124657|58720842|FG002|Overall Study|Non-compliance|4|||
30894328|NCT01656395|58927717|FG005|Overall Study|Pregnancy|0|||
30894329|NCT01656395|58927718|FG006|Overall Study|Pregnancy|0|||
30707156|NCT00124657|58720840|FG000|Overall Study|Progressive disease|14|||
30707157|NCT00124657|58720841|FG001|Overall Study|Progressive disease|5|||
30707158|NCT00124657|58720842|FG002|Overall Study|Progressive disease|27|||
30707159|NCT00124657|58720840|FG000|Overall Study|Intercurrent illness|1|||
30707160|NCT00124657|58720841|FG001|Overall Study|Intercurrent illness|0|||
30894330|NCT01656395|58927719|FG007|Overall Study|Pregnancy|0|||
30894331|NCT01656395|58927712|FG000|Overall Study|Progressive Disease|0|||
30894332|NCT01656395|58927713|FG001|Overall Study|Progressive Disease|0|||
30707161|NCT00124657|58720842|FG002|Overall Study|Intercurrent illness|0|||
30707162|NCT00581945|58720865|FG000|Overall Study|Adverse Event|4|||
30894333|NCT01656395|58927714|FG002|Overall Study|Progressive Disease|0|||
30894334|NCT01656395|58927715|FG003|Overall Study|Progressive Disease|0|||
30894335|NCT01656395|58927716|FG004|Overall Study|Progressive Disease|0|||
30894336|NCT01656395|58927717|FG005|Overall Study|Progressive Disease|1|||
30894337|NCT01656395|58927718|FG006|Overall Study|Progressive Disease|0|||
30894338|NCT01656395|58927719|FG007|Overall Study|Progressive Disease|0|||
30894339|NCT01656395|58927712|FG000|Overall Study|Protocol Violation|6|||
30894340|NCT01656395|58927713|FG001|Overall Study|Protocol Violation|6|||
30894341|NCT01656395|58927714|FG002|Overall Study|Protocol Violation|9|||
30894342|NCT01656395|58927715|FG003|Overall Study|Protocol Violation|2|||
30894343|NCT01656395|58927716|FG004|Overall Study|Protocol Violation|4|||
30894344|NCT01656395|58927717|FG005|Overall Study|Protocol Violation|10|||
30894345|NCT01656395|58927718|FG006|Overall Study|Protocol Violation|0|||
30894346|NCT01656395|58927719|FG007|Overall Study|Protocol Violation|0|||
30894347|NCT01656395|58927712|FG000|Overall Study|Screen Failure|2|||
30894348|NCT01656395|58927713|FG001|Overall Study|Screen Failure|1|||
30894349|NCT01656395|58927714|FG002|Overall Study|Screen Failure|7|||
30894350|NCT01656395|58927715|FG003|Overall Study|Screen Failure|1|||
30894351|NCT01656395|58927716|FG004|Overall Study|Screen Failure|0|||
30707163|NCT00581945|58720866|FG001|Overall Study|Adverse Event|4|||
30707164|NCT00581945|58720865|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30707165|NCT00581945|58720866|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30707166|NCT00581945|58720865|FG000|Overall Study|Withdrawal by Subject|2|||
30707167|NCT00581945|58720866|FG001|Overall Study|Withdrawal by Subject|6|||
30707168|NCT00581945|58720865|FG000|Overall Study|Death|1|||
30707169|NCT00581945|58720866|FG001|Overall Study|Death|0|||
30707170|NCT00555906|58720875|FG000|Phase 1|Objective Progression or Relapse|3|||
30707171|NCT00555906|58720876|FG001|Phase 1|Objective Progression or Relapse|5|||
30707172|NCT00555906|58720877|FG002|Phase 1|Objective Progression or Relapse|3|||
30707173|NCT00555906|58720878|FG003|Phase 1|Objective Progression or Relapse|1|||
30707174|NCT00555906|58720879|FG004|Phase 1|Objective Progression or Relapse|0|||
30707175|NCT00555906|58720875|FG000|Phase 1|Global Deterioration of Health Status|0|||
30707176|NCT00555906|58720876|FG001|Phase 1|Global Deterioration of Health Status|1|||
30707177|NCT00555906|58720877|FG002|Phase 1|Global Deterioration of Health Status|1|||
30707178|NCT00555906|58720878|FG003|Phase 1|Global Deterioration of Health Status|1|||
30707179|NCT00555906|58720879|FG004|Phase 1|Global Deterioration of Health Status|0|||
30707180|NCT00555906|58720875|FG000|Phase 1|Adverse Event|0|||
30707181|NCT00555906|58720876|FG001|Phase 1|Adverse Event|0|||
30707182|NCT00555906|58720877|FG002|Phase 1|Adverse Event|3|||
30707183|NCT00555906|58720878|FG003|Phase 1|Adverse Event|2|||
30707184|NCT00555906|58720879|FG004|Phase 1|Adverse Event|0|||
30707185|NCT00555906|58720875|FG000|Phase 1|Withdrawal by Subject|0|||
30707186|NCT00555906|58720876|FG001|Phase 1|Withdrawal by Subject|0|||
30707187|NCT00555906|58720877|FG002|Phase 1|Withdrawal by Subject|0|||
30707188|NCT00555906|58720878|FG003|Phase 1|Withdrawal by Subject|1|||
30707189|NCT00555906|58720879|FG004|Phase 1|Withdrawal by Subject|0|||
30707190|NCT00555906|58720875|FG000|Phase 2|Adverse Event|0|||
30707191|NCT00555906|58720876|FG001|Phase 2|Adverse Event|0|||
30894352|NCT01656395|58927717|FG005|Overall Study|Screen Failure|8|||
30894353|NCT01656395|58927718|FG006|Overall Study|Screen Failure|0|||
30894354|NCT01656395|58927719|FG007|Overall Study|Screen Failure|0|||
30894355|NCT01656395|58927712|FG000|Overall Study|Withdrawal by Subject|3|||
30894356|NCT01656395|58927713|FG001|Overall Study|Withdrawal by Subject|1|||
30894357|NCT01656395|58927714|FG002|Overall Study|Withdrawal by Subject|4|||
30707192|NCT00555906|58720877|FG002|Phase 2|Adverse Event|0|||
30707193|NCT00555906|58720878|FG003|Phase 2|Adverse Event|0|||
30707194|NCT00555906|58720879|FG004|Phase 2|Adverse Event|4|||
30707195|NCT00555906|58720875|FG000|Phase 2|Global Deterioration of Health Status|0|||
30707196|NCT00555906|58720876|FG001|Phase 2|Global Deterioration of Health Status|0|||
30894358|NCT01656395|58927715|FG003|Overall Study|Withdrawal by Subject|2|||
30894359|NCT01656395|58927716|FG004|Overall Study|Withdrawal by Subject|0|||
30894360|NCT01656395|58927717|FG005|Overall Study|Withdrawal by Subject|3|||
30894361|NCT01656395|58927718|FG006|Overall Study|Withdrawal by Subject|0|||
30894362|NCT01656395|58927719|FG007|Overall Study|Withdrawal by Subject|0|||
30894363|NCT02114931|58927735|FG000|Overall Study|Withdrawal by Subject|15|||
30894364|NCT02114931|58927736|FG001|Overall Study|Withdrawal by Subject|18|||
30707197|NCT00555906|58720877|FG002|Phase 2|Global Deterioration of Health Status|0|||
30707198|NCT00555906|58720878|FG003|Phase 2|Global Deterioration of Health Status|0|||
30707199|NCT00555906|58720879|FG004|Phase 2|Global Deterioration of Health Status|2|||
30707200|NCT00555906|58720875|FG000|Phase 2|Objective Progression or Relapse|0|||
30707201|NCT00555906|58720876|FG001|Phase 2|Objective Progression or Relapse|0|||
30707202|NCT00555906|58720877|FG002|Phase 2|Objective Progression or Relapse|0|||
30707203|NCT00555906|58720878|FG003|Phase 2|Objective Progression or Relapse|0|||
30707204|NCT00555906|58720879|FG004|Phase 2|Objective Progression or Relapse|16|||
30707205|NCT00555906|58720875|FG000|Phase 2|Withdrawal by Subject|0|||
30707206|NCT00555906|58720876|FG001|Phase 2|Withdrawal by Subject|0|||
30707207|NCT00555906|58720877|FG002|Phase 2|Withdrawal by Subject|0|||
30707208|NCT00555906|58720878|FG003|Phase 2|Withdrawal by Subject|0|||
30707209|NCT00555906|58720879|FG004|Phase 2|Withdrawal by Subject|2|||
30707210|NCT00555906|58720875|FG000|Phase 2|Other|0|||
30707211|NCT00555906|58720876|FG001|Phase 2|Other|0|||
30707212|NCT00555906|58720877|FG002|Phase 2|Other|0|||
30707213|NCT00555906|58720878|FG003|Phase 2|Other|0|||
30707214|NCT00555906|58720879|FG004|Phase 2|Other|6|||
30707215|NCT00555906|58720875|FG000|Phase 2|Randomized but not Treated|0|||
30707216|NCT00555906|58720876|FG001|Phase 2|Randomized but not Treated|0|||
30707217|NCT00555906|58720877|FG002|Phase 2|Randomized but not Treated|0|||
30707218|NCT00555906|58720878|FG003|Phase 2|Randomized but not Treated|0|||
30707219|NCT00555906|58720879|FG004|Phase 2|Randomized but not Treated|2|||
30707220|NCT03817879|58720896|FG000|Overall Study|Drop out|5|||
30707221|NCT03817879|58720897|FG001|Overall Study|Drop out|12|||
30707222|NCT03817879|58720896|FG000|Overall Study|Withdrawal by Subject|0|||
30707223|NCT03817879|58720897|FG001|Overall Study|Withdrawal by Subject|1|||
30707224|NCT00555672|58720905|FG000|Overall Study|Death|0|||
30707225|NCT00555672|58720906|FG001|Overall Study|Death|2|||
30707226|NCT00555672|58720905|FG000|Overall Study|Adverse Event|8|||
30707227|NCT00555672|58720906|FG001|Overall Study|Adverse Event|2|||
30707228|NCT00555672|58720905|FG000|Overall Study|Objective progression or relapse|11|||
30707229|NCT00555672|58720906|FG001|Overall Study|Objective progression or relapse|5|||
30707230|NCT00555672|58720905|FG000|Overall Study|Other|3|||
30707231|NCT00555672|58720906|FG001|Overall Study|Other|1|||
30707232|NCT00555672|58720905|FG000|Overall Study|Participant refused|2|||
30707233|NCT00555672|58720906|FG001|Overall Study|Participant refused|0|||
30707234|NCT03958656|58720916|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
30707235|NCT03958656|58720917|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
30707236|NCT03958656|58720918|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
30707237|NCT03958656|58720919|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
30707238|NCT03958656|58720916|FG000|Overall Study|No longer meets eligibility criteria|0|||
30707239|NCT03958656|58720917|FG001|Overall Study|No longer meets eligibility criteria|0|||
30707240|NCT03958656|58720918|FG002|Overall Study|No longer meets eligibility criteria|1|||
30894365|NCT02114931|58927735|FG000|Overall Study|Adverse Event|4|||
30894366|NCT02114931|58927736|FG001|Overall Study|Adverse Event|6|||
30707241|NCT03958656|58720919|FG003|Overall Study|No longer meets eligibility criteria|0|||
30707242|NCT03958656|58720916|FG000|Overall Study|Started anti-cancer treatment|0|||
30707243|NCT03958656|58720917|FG001|Overall Study|Started anti-cancer treatment|0|||
30894367|NCT02114931|58927735|FG000|Overall Study|Lost to Follow-up|3|||
30894368|NCT02114931|58927736|FG001|Overall Study|Lost to Follow-up|3|||
30707244|NCT03958656|58720918|FG002|Overall Study|Started anti-cancer treatment|1|||
30707245|NCT03958656|58720919|FG003|Overall Study|Started anti-cancer treatment|0|||
30707246|NCT00561912|58720929|FG000|Overall Study|ineligible|1|||
30760598|NCT03381274|58769072|FG002|Overall Study|Other|0|||
30707247|NCT00561678|58720935|FG000|Overall Study|Withdrawal by Subject|4|||
30707248|NCT00561678|58720936|FG001|Overall Study|Withdrawal by Subject|3|||
30707249|NCT00561678|58720935|FG000|Overall Study|surgery cancelled|1|||
30707250|NCT00561678|58720936|FG001|Overall Study|surgery cancelled|1|||
30707251|NCT00561678|58720935|FG000|Overall Study|surgery rescheduled to different site|2|||
30707252|NCT00561678|58720936|FG001|Overall Study|surgery rescheduled to different site|2|||
30707253|NCT00561678|58720935|FG000|Overall Study|anesthesia provider refusal|1|||
30707254|NCT00561678|58720936|FG001|Overall Study|anesthesia provider refusal|0|||
30707255|NCT00463684|58720942|FG000|Overall Study|Withdrawal by Subject|1|||
30707256|NCT00463684|58720942|FG000|Overall Study|Lost to Follow-up|3|||
30707257|NCT00463606|58720949|FG000|Overall Study|Adverse Event|21|||
30707258|NCT00463606|58720950|FG001|Overall Study|Adverse Event|18|||
30707259|NCT00463606|58720951|FG002|Overall Study|Adverse Event|11|||
30707260|NCT00463606|58720949|FG000|Overall Study|Withdrawal by Subject|11|||
30707261|NCT00463606|58720950|FG001|Overall Study|Withdrawal by Subject|11|||
30707262|NCT00463606|58720951|FG002|Overall Study|Withdrawal by Subject|5|||
30707263|NCT00463606|58720949|FG000|Overall Study|Lost to Follow-up|2|||
30707264|NCT00463606|58720950|FG001|Overall Study|Lost to Follow-up|2|||
30707265|NCT00463606|58720951|FG002|Overall Study|Lost to Follow-up|3|||
30707266|NCT00463606|58720949|FG000|Overall Study|Subject noncompliance|1|||
30707267|NCT00463606|58720950|FG001|Overall Study|Subject noncompliance|1|||
30707268|NCT00463606|58720951|FG002|Overall Study|Subject noncompliance|0|||
30707269|NCT00463606|58720949|FG000|Overall Study|Subject moved out of town|1|||
30707270|NCT00463606|58720950|FG001|Overall Study|Subject moved out of town|0|||
30707271|NCT00463606|58720951|FG002|Overall Study|Subject moved out of town|0|||
30707272|NCT00463606|58720949|FG000|Overall Study|Physician Decision|0|||
30707273|NCT00463606|58720950|FG001|Overall Study|Physician Decision|1|||
30707274|NCT00463606|58720951|FG002|Overall Study|Physician Decision|0|||
30707275|NCT00463606|58720949|FG000|Overall Study|Sponsor request|0|||
30707276|NCT00463606|58720950|FG001|Overall Study|Sponsor request|1|||
30707277|NCT00463606|58720951|FG002|Overall Study|Sponsor request|0|||
30707278|NCT00463606|58720949|FG000|Overall Study|Exclusion criteria violation|2|||
30707279|NCT00463606|58720950|FG001|Overall Study|Exclusion criteria violation|0|||
30707280|NCT00463606|58720951|FG002|Overall Study|Exclusion criteria violation|0|||
30707281|NCT00463606|58720949|FG000|Overall Study|Coordinator error|1|||
30707282|NCT00463606|58720950|FG001|Overall Study|Coordinator error|0|||
30707283|NCT00463606|58720951|FG002|Overall Study|Coordinator error|0|||
30707284|NCT00463606|58720949|FG000|Overall Study|Patient randomized in error|1|||
30707285|NCT00463606|58720950|FG001|Overall Study|Patient randomized in error|0|||
30707286|NCT00463606|58720951|FG002|Overall Study|Patient randomized in error|0|||
30707287|NCT00463606|58720949|FG000|Overall Study|Participation in another ABT-335 trial|1|||
30707288|NCT00463606|58720950|FG001|Overall Study|Participation in another ABT-335 trial|0|||
30707289|NCT00463606|58720951|FG002|Overall Study|Participation in another ABT-335 trial|0|||
30707290|NCT00463606|58720949|FG000|Overall Study|Protocol Violation|0|||
30707291|NCT00463606|58720950|FG001|Overall Study|Protocol Violation|0|||
30707292|NCT00463606|58720951|FG002|Overall Study|Protocol Violation|1|||
30707293|NCT03961308|58720961|FG000|Overall Study|Withdrawal by Subject|1|||
30707294|NCT03961308|58720962|FG001|Overall Study|Withdrawal by Subject|0|||
30707295|NCT03961308|58720961|FG000|Overall Study|Other|1|||
30707296|NCT03961308|58720962|FG001|Overall Study|Other|0|||
30707297|NCT03961308|58720961|FG000|Overall Study|Lost to Follow-up|0|||
30707298|NCT03961308|58720962|FG001|Overall Study|Lost to Follow-up|1|||
30707299|NCT03961308|58720961|FG000|Overall Study|Adverse Event|0|||
30707300|NCT03961308|58720962|FG001|Overall Study|Adverse Event|1|||
30707301|NCT00174187|58720970|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
30707302|NCT00174187|58720971|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
30707303|NCT00174187|58720972|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
30707304|NCT00174187|58720970|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
30707305|NCT00174187|58720971|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
30707306|NCT00174187|58720972|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
30707307|NCT00174187|58720970|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
30707308|NCT00174187|58720971|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
30707309|NCT00174187|58720972|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
30894369|NCT02114931|58927735|FG000|Overall Study|Physician Decision|1|||
30620400|NCT01209689|58631705|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
30620401|NCT01209143|58631713|FG000|Overall Study|Adverse Event|2|||
30707310|NCT00174187|58720970|FG000|Period 1 (up to 3 Years)|Other|0|||
30707311|NCT00174187|58720971|FG001|Period 1 (up to 3 Years)|Other|1|||
30707312|NCT00174187|58720972|FG002|Period 1 (up to 3 Years)|Other|0|||
30707313|NCT00174187|58720970|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
30707314|NCT00174187|58720971|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
30707315|NCT00174187|58720972|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
30707316|NCT00174187|58720970|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
30707317|NCT00174187|58720971|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
30707318|NCT00174187|58720972|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
30707319|NCT00174187|58720970|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
30707320|NCT00174187|58720971|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
30707321|NCT00174187|58720972|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
30707322|NCT00174187|58720970|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
30707323|NCT00174187|58720971|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
30707324|NCT00174187|58720972|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
30707325|NCT00174187|58720970|FG000|Period 2 (After 3 Years)|Other|0|||
30707326|NCT00174187|58720971|FG001|Period 2 (After 3 Years)|Other|0|||
30707327|NCT00174187|58720972|FG002|Period 2 (After 3 Years)|Other|5|||
30707328|NCT01011335|58720984|FG000|Overall Study|Lost to Follow-up|0|||
30707329|NCT01011335|58720985|FG001|Overall Study|Lost to Follow-up|0|||
30707330|NCT01011335|58720986|FG002|Overall Study|Lost to Follow-up|1|||
30707331|NCT01011335|58720987|FG003|Overall Study|Lost to Follow-up|1|||
30620402|NCT01209143|58631714|FG001|Overall Study|Adverse Event|1|||
30620403|NCT01209143|58631713|FG000|Overall Study|Death|0|||
30620404|NCT01209143|58631714|FG001|Overall Study|Death|1|||
30620405|NCT01209143|58631713|FG000|Overall Study|Physician Decision|3|||
30620406|NCT01209143|58631714|FG001|Overall Study|Physician Decision|1|||
30620407|NCT01209143|58631713|FG000|Overall Study|Lost to Follow-up|1|||
30620408|NCT01209143|58631714|FG001|Overall Study|Lost to Follow-up|0|||
30620409|NCT01209143|58631713|FG000|Overall Study|Withdrawal by Subject|2|||
30620410|NCT01209143|58631714|FG001|Overall Study|Withdrawal by Subject|1|||
30620411|NCT01209143|58631713|FG000|Overall Study|Disease progression|11|||
30620412|NCT01209143|58631714|FG001|Overall Study|Disease progression|16|||
30620413|NCT01023789|58631720|FG000|3 - Year Visit|Death|29|||
30620414|NCT01023789|58631720|FG000|3 - Year Visit|Withdrawal of consent|1|||
30620415|NCT01023789|58631720|FG000|3 - Year Visit|Lost to Follow-up|13|||
30620416|NCT01208207|58631727|FG000|Part I|Adverse Event|19|||
30620417|NCT01208207|58631728|FG001|Part I|Adverse Event|2|||
30707332|NCT01011335|58720988|FG004|Overall Study|Lost to Follow-up|1|||
30707333|NCT01011335|58720989|FG005|Overall Study|Lost to Follow-up|1|||
30707334|NCT01011335|58720990|FG006|Overall Study|Lost to Follow-up|2|||
30707335|NCT01011335|58720991|FG007|Overall Study|Lost to Follow-up|2|||
30707336|NCT01011335|58720992|FG008|Overall Study|Lost to Follow-up|1|||
30620418|NCT01208207|58631729|FG002|Part I|Adverse Event|6|||
30620419|NCT01208207|58631730|FG003|Part I|Adverse Event|0|||
30620420|NCT01208207|58631731|FG004|Part I|Adverse Event|0|||
30620421|NCT01208207|58631732|FG005|Part I|Adverse Event|0|||
30620422|NCT01208207|58631733|FG006|Part I|Adverse Event|0|||
30620423|NCT01208207|58631727|FG000|Part I|Lack of Efficacy|21|||
30620424|NCT01208207|58631728|FG001|Part I|Lack of Efficacy|3|||
30620425|NCT01208207|58631729|FG002|Part I|Lack of Efficacy|2|||
30620426|NCT01208207|58631730|FG003|Part I|Lack of Efficacy|0|||
30620427|NCT01208207|58631731|FG004|Part I|Lack of Efficacy|0|||
30620428|NCT01208207|58631732|FG005|Part I|Lack of Efficacy|0|||
30620429|NCT01208207|58631733|FG006|Part I|Lack of Efficacy|0|||
30620430|NCT01208207|58631727|FG000|Part I|Lost to Follow-up|6|||
30620431|NCT01208207|58631728|FG001|Part I|Lost to Follow-up|1|||
30620432|NCT01208207|58631729|FG002|Part I|Lost to Follow-up|0|||
30620433|NCT01208207|58631730|FG003|Part I|Lost to Follow-up|0|||
30620434|NCT01208207|58631731|FG004|Part I|Lost to Follow-up|0|||
30620435|NCT01208207|58631732|FG005|Part I|Lost to Follow-up|0|||
30620436|NCT01208207|58631733|FG006|Part I|Lost to Follow-up|0|||
30620437|NCT01208207|58631727|FG000|Part I|Non-Compliance With Study Drug|1|||
30620438|NCT01208207|58631728|FG001|Part I|Non-Compliance With Study Drug|0|||
30620439|NCT01208207|58631729|FG002|Part I|Non-Compliance With Study Drug|1|||
30620440|NCT01208207|58631730|FG003|Part I|Non-Compliance With Study Drug|0|||
30620441|NCT01208207|58631731|FG004|Part I|Non-Compliance With Study Drug|0|||
30620442|NCT01208207|58631732|FG005|Part I|Non-Compliance With Study Drug|0|||
30620443|NCT01208207|58631733|FG006|Part I|Non-Compliance With Study Drug|0|||
30620444|NCT01208207|58631727|FG000|Part I|Physician Decision|0|||
30620445|NCT01208207|58631728|FG001|Part I|Physician Decision|1|||
30620446|NCT01208207|58631729|FG002|Part I|Physician Decision|0|||
30620447|NCT01208207|58631730|FG003|Part I|Physician Decision|0|||
30620448|NCT01208207|58631731|FG004|Part I|Physician Decision|0|||
30620449|NCT01208207|58631732|FG005|Part I|Physician Decision|0|||
30620450|NCT01208207|58631733|FG006|Part I|Physician Decision|0|||
30620451|NCT01208207|58631727|FG000|Part I|Progressive Disease|1|||
30620452|NCT01208207|58631728|FG001|Part I|Progressive Disease|0|||
30620453|NCT01208207|58631729|FG002|Part I|Progressive Disease|0|||
30620454|NCT01208207|58631730|FG003|Part I|Progressive Disease|0|||
30620455|NCT01208207|58631731|FG004|Part I|Progressive Disease|0|||
30620456|NCT01208207|58631732|FG005|Part I|Progressive Disease|0|||
30620457|NCT01208207|58631733|FG006|Part I|Progressive Disease|0|||
30620458|NCT01208207|58631727|FG000|Part I|Protocol Violation|8|||
30620459|NCT01208207|58631728|FG001|Part I|Protocol Violation|0|||
30620460|NCT01208207|58631729|FG002|Part I|Protocol Violation|2|||
30790867|NCT03524092|58803940|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
30620461|NCT01208207|58631730|FG003|Part I|Protocol Violation|0|||
30620462|NCT01208207|58631731|FG004|Part I|Protocol Violation|0|||
30620463|NCT01208207|58631732|FG005|Part I|Protocol Violation|0|||
30620464|NCT01208207|58631733|FG006|Part I|Protocol Violation|0|||
30620465|NCT01208207|58631727|FG000|Part I|Withdrawal by Subject|14|||
30707337|NCT01011335|58720993|FG009|Overall Study|Lost to Follow-up|0|||
30707338|NCT01011335|58720994|FG010|Overall Study|Lost to Follow-up|0|||
30707339|NCT01011335|58720995|FG011|Overall Study|Lost to Follow-up|1|||
30707340|NCT01011335|58720996|FG012|Overall Study|Lost to Follow-up|2|||
30707341|NCT01011335|58720984|FG000|Overall Study|Protocol Violation|0|||
30707342|NCT01011335|58720985|FG001|Overall Study|Protocol Violation|1|||
30707343|NCT01011335|58720986|FG002|Overall Study|Protocol Violation|0|||
30707344|NCT01011335|58720987|FG003|Overall Study|Protocol Violation|0|||
30707345|NCT01011335|58720988|FG004|Overall Study|Protocol Violation|0|||
30707346|NCT01011335|58720989|FG005|Overall Study|Protocol Violation|0|||
30707347|NCT01011335|58720990|FG006|Overall Study|Protocol Violation|0|||
30707348|NCT01011335|58720991|FG007|Overall Study|Protocol Violation|0|||
30707349|NCT01011335|58720992|FG008|Overall Study|Protocol Violation|0|||
30707350|NCT01011335|58720993|FG009|Overall Study|Protocol Violation|0|||
30707351|NCT01011335|58720994|FG010|Overall Study|Protocol Violation|0|||
30707352|NCT01011335|58720995|FG011|Overall Study|Protocol Violation|0|||
30707353|NCT01011335|58720996|FG012|Overall Study|Protocol Violation|0|||
30707354|NCT01011335|58720984|FG000|Overall Study|Moved/deployed or no booster|1|||
30707355|NCT01011335|58720985|FG001|Overall Study|Moved/deployed or no booster|0|||
30707356|NCT01011335|58720986|FG002|Overall Study|Moved/deployed or no booster|0|||
30707357|NCT01011335|58720987|FG003|Overall Study|Moved/deployed or no booster|1|||
30707358|NCT01011335|58720988|FG004|Overall Study|Moved/deployed or no booster|0|||
30707359|NCT01011335|58720989|FG005|Overall Study|Moved/deployed or no booster|0|||
30707360|NCT01011335|58720990|FG006|Overall Study|Moved/deployed or no booster|1|||
30707361|NCT01011335|58720991|FG007|Overall Study|Moved/deployed or no booster|0|||
30707362|NCT01011335|58720992|FG008|Overall Study|Moved/deployed or no booster|1|||
30707363|NCT01011335|58720993|FG009|Overall Study|Moved/deployed or no booster|0|||
30707364|NCT01011335|58720994|FG010|Overall Study|Moved/deployed or no booster|2|||
30707365|NCT01011335|58720995|FG011|Overall Study|Moved/deployed or no booster|0|||
30707366|NCT01011335|58720996|FG012|Overall Study|Moved/deployed or no booster|0|||
30707367|NCT01011335|58720984|FG000|Overall Study|Adverse Event|0|||
30707368|NCT01011335|58720985|FG001|Overall Study|Adverse Event|0|||
30707369|NCT01011335|58720986|FG002|Overall Study|Adverse Event|0|||
30707370|NCT01011335|58720987|FG003|Overall Study|Adverse Event|0|||
30707371|NCT01011335|58720988|FG004|Overall Study|Adverse Event|0|||
30707372|NCT01011335|58720989|FG005|Overall Study|Adverse Event|0|||
30707373|NCT01011335|58720990|FG006|Overall Study|Adverse Event|0|||
30707374|NCT01011335|58720991|FG007|Overall Study|Adverse Event|0|||
30707375|NCT01011335|58720992|FG008|Overall Study|Adverse Event|0|||
30707376|NCT01011335|58720993|FG009|Overall Study|Adverse Event|0|||
30707377|NCT01011335|58720994|FG010|Overall Study|Adverse Event|4|||
30707378|NCT01011335|58720995|FG011|Overall Study|Adverse Event|0|||
30707379|NCT01011335|58720996|FG012|Overall Study|Adverse Event|1|||
30707380|NCT00467896|58721033|FG000|Overall Study|Consent Withdrawal|18|||
30707381|NCT00467896|58721033|FG000|Overall Study|Adverse Event|7|||
30707382|NCT00467896|58721033|FG000|Overall Study|Serious Adverse Event|13|||
30707383|NCT00467896|58721033|FG000|Overall Study|Non-compliance|3|||
30707384|NCT00467896|58721033|FG000|Overall Study|Changed therapy|2|||
30707385|NCT00467896|58721033|FG000|Overall Study|Patient received transplant|2|||
30707386|NCT00467896|58721033|FG000|Overall Study|Patient had atrial septostomy|1|||
30707387|NCT00467896|58721033|FG000|Overall Study|Patient weaned off iloprost|1|||
30707388|NCT00467896|58721033|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
30707389|NCT00467896|58721033|FG000|Overall Study|Started intravenous prostacyclin|1|||
30707390|NCT00467896|58721033|FG000|Overall Study|Started inhaled Remodulin|1|||
30707391|NCT00467896|58721033|FG000|Overall Study|Patient had no improvement|1|||
30707392|NCT00579059|58721041|FG000|Overall Study|Study Canceled at 1 Year|21|||
30707393|NCT00579059|58721042|FG001|Overall Study|Study Canceled at 1 Year|10|||
30707394|NCT00467818|58721050|FG000|Overall Study|Adverse Event|1|||
30707395|NCT00467818|58721051|FG001|Overall Study|Adverse Event|0|||
30707396|NCT00467818|58721050|FG000|Overall Study|Lost to Follow-up|2|||
30707397|NCT00467818|58721051|FG001|Overall Study|Lost to Follow-up|2|||
30707398|NCT00467740|58721064|FG000|Overall Study|Adverse Event|0|||
30707399|NCT00467740|58721065|FG001|Overall Study|Adverse Event|0|||
30707400|NCT00467740|58721066|FG002|Overall Study|Adverse Event|1|||
30707401|NCT00467740|58721067|FG003|Overall Study|Adverse Event|0|||
30707402|NCT00467740|58721068|FG004|Overall Study|Adverse Event|0|||
30707403|NCT00467740|58721064|FG000|Overall Study|Protocol Violation|0|||
30707404|NCT00467740|58721065|FG001|Overall Study|Protocol Violation|0|||
30707405|NCT00467740|58721066|FG002|Overall Study|Protocol Violation|1|||
30707406|NCT00467740|58721067|FG003|Overall Study|Protocol Violation|0|||
30707407|NCT00467740|58721068|FG004|Overall Study|Protocol Violation|0|||
30707408|NCT00467740|58721064|FG000|Overall Study|Lost to Follow-up|0|||
30707409|NCT00467740|58721065|FG001|Overall Study|Lost to Follow-up|1|||
30707410|NCT00467740|58721066|FG002|Overall Study|Lost to Follow-up|0|||
30707411|NCT00467740|58721067|FG003|Overall Study|Lost to Follow-up|0|||
30707412|NCT00467740|58721068|FG004|Overall Study|Lost to Follow-up|0|||
30707413|NCT00467740|58721064|FG000|Overall Study|Withdrawal by Subject|1|||
30707414|NCT00467740|58721065|FG001|Overall Study|Withdrawal by Subject|1|||
30707415|NCT00467740|58721066|FG002|Overall Study|Withdrawal by Subject|0|||
30707416|NCT00467740|58721067|FG003|Overall Study|Withdrawal by Subject|1|||
30707417|NCT00467740|58721068|FG004|Overall Study|Withdrawal by Subject|0|||
30707418|NCT00467740|58721064|FG000|Overall Study|Lack of Efficacy|0|||
30707419|NCT00467740|58721065|FG001|Overall Study|Lack of Efficacy|1|||
30707420|NCT00467740|58721066|FG002|Overall Study|Lack of Efficacy|0|||
30707421|NCT00467740|58721067|FG003|Overall Study|Lack of Efficacy|0|||
30707422|NCT00467740|58721068|FG004|Overall Study|Lack of Efficacy|0|||
30707423|NCT00553254|58721082|FG000|Overall Study|Death|3|||
30707424|NCT00553254|58721083|FG001|Overall Study|Death|6|||
30707425|NCT00553254|58721084|FG002|Overall Study|Death|25|||
30707426|NCT00553254|58721082|FG000|Overall Study|Lost to Follow-up|0|||
30707427|NCT00553254|58721083|FG001|Overall Study|Lost to Follow-up|0|||
30707428|NCT00553254|58721084|FG002|Overall Study|Lost to Follow-up|2|||
30707429|NCT00553254|58721082|FG000|Overall Study|Withdrawal by Subject|2|||
30707430|NCT00553254|58721083|FG001|Overall Study|Withdrawal by Subject|0|||
30707431|NCT00553254|58721084|FG002|Overall Study|Withdrawal by Subject|2|||
30707432|NCT00553254|58721082|FG000|Overall Study|Study terminated by Sponsor|0|||
30707433|NCT00553254|58721083|FG001|Overall Study|Study terminated by Sponsor|0|||
30707434|NCT00553254|58721084|FG002|Overall Study|Study terminated by Sponsor|1|||
30707435|NCT00553254|58721082|FG000|Overall Study|Other|1|||
30707436|NCT00553254|58721083|FG001|Overall Study|Other|0|||
30707437|NCT00553254|58721084|FG002|Overall Study|Other|13|||
30707438|NCT00168805|58721099|FG000|Overall Study|Adverse Event|7|||
30707439|NCT00168805|58721100|FG001|Overall Study|Adverse Event|11|||
30707440|NCT00168805|58721101|FG002|Overall Study|Adverse Event|16|||
30707441|NCT00168805|58721099|FG000|Overall Study|Protocol Violation|12|||
30707442|NCT00168805|58721100|FG001|Overall Study|Protocol Violation|11|||
30707443|NCT00168805|58721101|FG002|Overall Study|Protocol Violation|8|||
30707444|NCT00168805|58721099|FG000|Overall Study|Lost to Follow-up|12|||
30707445|NCT00168805|58721100|FG001|Overall Study|Lost to Follow-up|17|||
30707446|NCT00168805|58721101|FG002|Overall Study|Lost to Follow-up|11|||
30707447|NCT00168805|58721099|FG000|Overall Study|Withdrawal by Subject|16|||
30707448|NCT00168805|58721100|FG001|Overall Study|Withdrawal by Subject|18|||
30707449|NCT00168805|58721101|FG002|Overall Study|Withdrawal by Subject|21|||
30707450|NCT00168805|58721099|FG000|Overall Study|Other|24|||
30707451|NCT00168805|58721100|FG001|Overall Study|Other|21|||
30707452|NCT00168805|58721101|FG002|Overall Study|Other|22|||
30894370|NCT02114931|58927736|FG001|Overall Study|Physician Decision|2|||
30707453|NCT00168805|58721099|FG000|Treatment|Adverse Event|25|||
30707454|NCT00168805|58721100|FG001|Treatment|Adverse Event|26|||
30707455|NCT00168805|58721101|FG002|Treatment|Adverse Event|32|||
30707456|NCT00168805|58721099|FG000|Treatment|Protocol Violation|3|||
30707457|NCT00168805|58721100|FG001|Treatment|Protocol Violation|5|||
30707458|NCT00168805|58721101|FG002|Treatment|Protocol Violation|5|||
30707459|NCT00168805|58721099|FG000|Treatment|Withdrawal by Subject|3|||
30707460|NCT00168805|58721100|FG001|Treatment|Withdrawal by Subject|7|||
30707461|NCT00168805|58721101|FG002|Treatment|Withdrawal by Subject|8|||
30707462|NCT00168805|58721099|FG000|Treatment|Other|18|||
30707463|NCT00168805|58721100|FG001|Treatment|Other|18|||
30707464|NCT00168805|58721101|FG002|Treatment|Other|17|||
30707465|NCT00467584|58721112|FG000|Overall Study|Withdrawal by Subject|4|||
30707466|NCT00467584|58721113|FG001|Overall Study|Withdrawal by Subject|5|||
30707467|NCT00467584|58721114|FG002|Overall Study|Withdrawal by Subject|1|||
30707468|NCT03839212|58721122|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
30707469|NCT00168103|58721129|FG000|Overall Study|Withdrawal by Subject|1|||
30707470|NCT00168103|58721130|FG001|Overall Study|Withdrawal by Subject|2|||
30707471|NCT00168103|58721131|FG002|Overall Study|Withdrawal by Subject|1|||
30707472|NCT00168103|58721132|FG003|Overall Study|Withdrawal by Subject|0|||
30707473|NCT00168103|58721129|FG000|Overall Study|Lost to Follow-up|1|||
30707474|NCT00168103|58721130|FG001|Overall Study|Lost to Follow-up|3|||
30707475|NCT00168103|58721131|FG002|Overall Study|Lost to Follow-up|0|||
30707476|NCT00168103|58721132|FG003|Overall Study|Lost to Follow-up|0|||
30707477|NCT00463060|58721142|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
30707478|NCT00463060|58721142|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
30707479|NCT00462982|58721151|FG000|Overall Study|Adverse Event|1|||
30707480|NCT00462982|58721151|FG000|Overall Study|Patient Not Treated|2|||
30707481|NCT00462904|58721172|FG000|Overall Study|Lost to Follow-up|1|||
30707482|NCT00467272|58721176|FG000|Overall Study|Pneumonia|2|||
30707483|NCT00467272|58721176|FG000|Overall Study|Thrombophlebitis|1|||
30707484|NCT00462826|58721180|FG000|Overall Study|Ineligible - second primary|1|||
30707485|NCT00462826|58721180|FG000|Overall Study|Ineligible - wrong cell type|1|||
30707486|NCT00462826|58721180|FG000|Overall Study|Ineligible - wrong primary|2|||
30707487|NCT00462826|58721180|FG000|Overall Study|Never treated|1|||
30707488|NCT00551616|58721192|FG000|Overall Study|Lost to Follow-up|48|||
30707489|NCT00551616|58721193|FG001|Overall Study|Lost to Follow-up|40|||
30707490|NCT00452530|58721201|FG000|Overall Study|Death|1|||
30707491|NCT00452530|58721202|FG001|Overall Study|Death|0|||
30707492|NCT00452530|58721201|FG000|Overall Study|Adverse Event|40|||
30707493|NCT00452530|58721202|FG001|Overall Study|Adverse Event|44|||
30707494|NCT00452530|58721201|FG000|Overall Study|Withdrawal by Subject|68|||
30707495|NCT00452530|58721202|FG001|Overall Study|Withdrawal by Subject|57|||
30707496|NCT00452530|58721201|FG000|Overall Study|Lost to Follow-up|1|||
30707497|NCT00452530|58721202|FG001|Overall Study|Lost to Follow-up|0|||
30707498|NCT00452530|58721201|FG000|Overall Study|Poor compliance/noncompliance|1|||
30707499|NCT00452530|58721202|FG001|Overall Study|Poor compliance/noncompliance|2|||
30707500|NCT00452530|58721201|FG000|Overall Study|No longer met study criteria|18|||
30707501|NCT00452530|58721202|FG001|Overall Study|No longer met study criteria|22|||
30707502|NCT00452530|58721201|FG000|Overall Study|Other|7|||
30707503|NCT00452530|58721202|FG001|Overall Study|Other|11|||
30707504|NCT00549198|58721214|FG000|Overall Study|Adverse Event|28|||
30707505|NCT00549198|58721215|FG001|Overall Study|Adverse Event|26|||
30707506|NCT00549198|58721214|FG000|Overall Study|Insufficient Viral Load Response|4|||
30707507|NCT00549198|58721215|FG001|Overall Study|Insufficient Viral Load Response|2|||
30707508|NCT00549198|58721214|FG000|Overall Study|Protocol-defined Virological Failure|7|||
30707509|NCT00549198|58721215|FG001|Overall Study|Protocol-defined Virological Failure|0|||
30707510|NCT00549198|58721214|FG000|Overall Study|Non-compliance|2|||
30707511|NCT00549198|58721215|FG001|Overall Study|Non-compliance|4|||
30707512|NCT00549198|58721214|FG000|Overall Study|Lost to Follow-up|7|||
30707513|NCT00549198|58721215|FG001|Overall Study|Lost to Follow-up|8|||
30707514|NCT00549198|58721214|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
30707515|NCT00549198|58721215|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
30707516|NCT00549198|58721214|FG000|Overall Study|Protocol Violation|7|||
30707517|NCT00549198|58721215|FG001|Overall Study|Protocol Violation|2|||
30707518|NCT00549198|58721214|FG000|Overall Study|Investigator Decision|4|||
30707519|NCT00549198|58721215|FG001|Overall Study|Investigator Decision|3|||
30707520|NCT00549198|58721214|FG000|Overall Study|Withdrawal by Subject|7|||
30707521|NCT00549198|58721215|FG001|Overall Study|Withdrawal by Subject|7|||
30707522|NCT00549198|58721214|FG000|Overall Study|Disease Progression|1|||
30707523|NCT00549198|58721215|FG001|Overall Study|Disease Progression|0|||
30707524|NCT00549198|58721214|FG000|Overall Study|Participant Moved|2|||
30707525|NCT00549198|58721215|FG001|Overall Study|Participant Moved|0|||
30707526|NCT00549198|58721214|FG000|Overall Study|Participant not able to perform Week 96|1|||
30707527|NCT00549198|58721215|FG001|Overall Study|Participant not able to perform Week 96|0|||
30620466|NCT01208207|58631728|FG001|Part I|Withdrawal by Subject|4|||
30620467|NCT01208207|58631729|FG002|Part I|Withdrawal by Subject|4|||
30894371|NCT02114931|58927735|FG000|Overall Study|Other|2|||
30620468|NCT01208207|58631730|FG003|Part I|Withdrawal by Subject|0|||
30620469|NCT01208207|58631731|FG004|Part I|Withdrawal by Subject|0|||
30620470|NCT01208207|58631732|FG005|Part I|Withdrawal by Subject|0|||
30620471|NCT01208207|58631733|FG006|Part I|Withdrawal by Subject|0|||
30620472|NCT01208207|58631727|FG000|Part II|Withdrawal by Subject|0|||
30620473|NCT01208207|58631728|FG001|Part II|Withdrawal by Subject|0|||
30620474|NCT01208207|58631729|FG002|Part II|Withdrawal by Subject|0|||
30620475|NCT01208207|58631730|FG003|Part II|Withdrawal by Subject|10|||
30620476|NCT01208207|58631731|FG004|Part II|Withdrawal by Subject|9|||
30760599|NCT03381274|58769073|FG003|Overall Study|Other|2|||
30620477|NCT01208207|58631732|FG005|Part II|Withdrawal by Subject|3|||
30620478|NCT01208207|58631733|FG006|Part II|Withdrawal by Subject|5|||
30707528|NCT00549198|58721214|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
30707529|NCT00549198|58721215|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
30707530|NCT00549198|58721214|FG000|Overall Study|Prohibited Medication|1|||
30707531|NCT00549198|58721215|FG001|Overall Study|Prohibited Medication|2|||
30620479|NCT01208207|58631727|FG000|Part II|Adverse Event|0|||
30620480|NCT01208207|58631728|FG001|Part II|Adverse Event|0|||
30620481|NCT01208207|58631729|FG002|Part II|Adverse Event|0|||
30620482|NCT01208207|58631730|FG003|Part II|Adverse Event|5|||
30620483|NCT01208207|58631731|FG004|Part II|Adverse Event|9|||
30620484|NCT01208207|58631732|FG005|Part II|Adverse Event|4|||
30894372|NCT02114931|58927736|FG001|Overall Study|Other|1|||
30620485|NCT01208207|58631733|FG006|Part II|Adverse Event|2|||
30620486|NCT01208207|58631727|FG000|Part II|Lack of Efficacy|0|||
30620487|NCT01208207|58631728|FG001|Part II|Lack of Efficacy|0|||
30620488|NCT01208207|58631729|FG002|Part II|Lack of Efficacy|0|||
30707532|NCT00549198|58721214|FG000|Overall Study|Participant planning pregnancy|1|||
30707533|NCT00549198|58721215|FG001|Overall Study|Participant planning pregnancy|0|||
30707534|NCT00549198|58721214|FG000|Overall Study|Participant overweight, no scan possible|1|||
30707535|NCT00549198|58721215|FG001|Overall Study|Participant overweight, no scan possible|0|||
30707536|NCT00549198|58721214|FG000|Overall Study|No scan facilities|0|||
30707537|NCT00549198|58721215|FG001|Overall Study|No scan facilities|2|||
30707538|NCT00549198|58721214|FG000|Overall Study|Pregnancy|0|||
30707539|NCT00549198|58721215|FG001|Overall Study|Pregnancy|3|||
30707540|NCT00549198|58721214|FG000|Overall Study|Not Exposed to Study Drug|3|||
30707541|NCT00549198|58721215|FG001|Overall Study|Not Exposed to Study Drug|4|||
30707542|NCT00607724|58721228|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
30707543|NCT00607724|58721229|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
30707544|NCT00607724|58721230|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
30707545|NCT00607724|58721231|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
30707546|NCT00607724|58721232|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
30707547|NCT00607724|58721233|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
30707548|NCT00607724|58721234|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
30707549|NCT00607724|58721228|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
30707550|NCT00607724|58721229|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
30707551|NCT00607724|58721230|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
30707552|NCT00607724|58721231|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
30707553|NCT00607724|58721232|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
30707554|NCT00607724|58721233|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
30707555|NCT00607724|58721234|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
30707556|NCT00607724|58721228|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
30707557|NCT00607724|58721229|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
30707558|NCT00607724|58721230|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
30707559|NCT00607724|58721231|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
30707560|NCT00607724|58721232|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
30707561|NCT00607724|58721233|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
30707562|NCT00607724|58721234|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
30707563|NCT00607724|58721228|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
30707564|NCT00607724|58721229|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
30707565|NCT00607724|58721230|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
30707566|NCT00607724|58721231|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
30707567|NCT00607724|58721232|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
30707568|NCT00607724|58721233|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
30707569|NCT00607724|58721234|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
30707570|NCT00607724|58721228|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
30707571|NCT00607724|58721229|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
30707572|NCT00607724|58721230|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
30707573|NCT00607724|58721231|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
30707574|NCT00607724|58721232|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
30707575|NCT00607724|58721233|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
30707576|NCT00607724|58721234|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
30707577|NCT00506415|58721258|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
30707578|NCT00506415|58721259|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
30707579|NCT00506415|58721260|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
30707580|NCT00506415|58721261|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
30707581|NCT00506415|58721258|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
30707582|NCT00506415|58721259|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
30707583|NCT00506415|58721260|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
30707584|NCT00506415|58721261|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
30707585|NCT00506415|58721258|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
30707586|NCT00506415|58721259|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
30707587|NCT00506415|58721260|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
30707588|NCT00506415|58721261|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
30707589|NCT00506415|58721258|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
30707590|NCT00506415|58721259|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
30707591|NCT00506415|58721260|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
30707592|NCT00506415|58721261|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
30707593|NCT00506415|58721258|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
30707594|NCT00506415|58721259|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
30707595|NCT00506415|58721260|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
30707596|NCT00506415|58721261|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
30707597|NCT00506415|58721258|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
30707598|NCT00506415|58721259|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
30707599|NCT00506415|58721260|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
30707600|NCT00506415|58721261|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
30707601|NCT00506415|58721258|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
30707602|NCT00506415|58721259|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
30707603|NCT00506415|58721260|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
30707604|NCT00506415|58721261|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
30707605|NCT00506415|58721258|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
30707606|NCT00506415|58721259|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
30707607|NCT00506415|58721260|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
30707608|NCT00506415|58721261|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
30707609|NCT00506415|58721258|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
30707610|NCT00506415|58721259|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
30707611|NCT00506415|58721260|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
30707612|NCT00506415|58721261|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
30707613|NCT00506415|58721258|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
30707614|NCT00506415|58721259|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
30707615|NCT00506415|58721260|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
30707616|NCT00506415|58721261|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
30707617|NCT00506415|58721258|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
30707618|NCT00506415|58721259|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
30707619|NCT00506415|58721260|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
30707620|NCT00506415|58721261|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
30707621|NCT00506415|58721258|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
30707622|NCT00506415|58721259|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
30707623|NCT00506415|58721260|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
30707624|NCT00506415|58721261|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
30707625|NCT00506415|58721258|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
30707626|NCT00506415|58721259|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
30707627|NCT00506415|58721260|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
30707628|NCT00506415|58721261|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
30707629|NCT00506415|58721258|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
30707630|NCT00506415|58721259|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
30707631|NCT00506415|58721260|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
30707632|NCT00506415|58721261|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
30707633|NCT00506415|58721258|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
30707634|NCT00506415|58721259|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
30707635|NCT00506415|58721260|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
30707636|NCT00506415|58721261|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
30707637|NCT00506415|58721258|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
30707638|NCT00506415|58721259|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
30707639|NCT00506415|58721260|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
30707640|NCT00506415|58721261|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
30707641|NCT00506415|58721258|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
30707642|NCT00506415|58721259|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
30707643|NCT00506415|58721260|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
30707644|NCT00506415|58721261|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
30707645|NCT00506415|58721258|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
30707646|NCT00506415|58721259|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
30707647|NCT00506415|58721260|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
30707648|NCT00506415|58721261|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
30707649|NCT00506415|58721258|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
30707650|NCT00506415|58721259|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
30707651|NCT00506415|58721260|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
30707652|NCT00506415|58721261|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
30707653|NCT00506415|58721258|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
30707654|NCT00506415|58721259|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
30707655|NCT00506415|58721260|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
30707656|NCT00506415|58721261|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
30707657|NCT00506415|58721258|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
30707658|NCT00506415|58721259|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
30707659|NCT00506415|58721260|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
30707660|NCT00506415|58721261|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
30707661|NCT00506415|58721258|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
30707662|NCT00506415|58721259|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
30707663|NCT00506415|58721260|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
30707664|NCT00506415|58721261|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
30707665|NCT00506415|58721258|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
30707666|NCT00506415|58721259|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
30707667|NCT00506415|58721260|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
30707668|NCT00506415|58721261|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
30707669|NCT00506415|58721258|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
30707670|NCT00506415|58721259|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
30707671|NCT00506415|58721260|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
30707672|NCT00506415|58721261|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
30707673|NCT00452452|58721277|FG000|Overall Study|Protocol Violation|0|||
30707674|NCT00452452|58721278|FG001|Overall Study|Protocol Violation|0|||
30707675|NCT00452452|58721279|FG002|Overall Study|Protocol Violation|1|||
30707676|NCT00452452|58721277|FG000|Overall Study|Withdrawal by Subject|1|||
30707677|NCT00452452|58721278|FG001|Overall Study|Withdrawal by Subject|0|||
30707678|NCT00452452|58721279|FG002|Overall Study|Withdrawal by Subject|0|||
30707679|NCT00452452|58721277|FG000|Overall Study|Lost to Follow-up|1|||
30707680|NCT00452452|58721278|FG001|Overall Study|Lost to Follow-up|0|||
30707681|NCT00452452|58721279|FG002|Overall Study|Lost to Follow-up|0|||
30707682|NCT00510783|58721295|FG000|Overall Study|Lost to Follow-up|29|||
30707683|NCT00510783|58721296|FG001|Overall Study|Lost to Follow-up|25|||
30707684|NCT00510783|58721295|FG000|Overall Study|Withdrawal by Subject|2|||
30707685|NCT00510783|58721296|FG001|Overall Study|Withdrawal by Subject|3|||
30707686|NCT00510783|58721295|FG000|Overall Study|Protocol Violation|0|||
30707687|NCT00510783|58721296|FG001|Overall Study|Protocol Violation|1|||
30707688|NCT00518973|58721304|FG000|Overall Study|Withdrawal by Subject|3|||
30707689|NCT00518973|58721305|FG001|Overall Study|Withdrawal by Subject|2|||
30707690|NCT00462670|58721313|FG000|Overall Study|Adverse Event|3|||
30707691|NCT00462670|58721314|FG001|Overall Study|Adverse Event|5|||
30707692|NCT00462670|58721313|FG000|Overall Study|Lack of Efficacy|1|||
30707693|NCT00462670|58721314|FG001|Overall Study|Lack of Efficacy|0|||
30707694|NCT00462670|58721313|FG000|Overall Study|Protocol Violation|1|||
30707695|NCT00462670|58721314|FG001|Overall Study|Protocol Violation|0|||
30707696|NCT00462670|58721313|FG000|Overall Study|Resolution of signs and symptoms|0|||
30707697|NCT00462670|58721314|FG001|Overall Study|Resolution of signs and symptoms|2|||
30707698|NCT00606086|58721322|FG000|Overall Study|Adverse Event|1|||
30707699|NCT00606086|58721323|FG001|Overall Study|Adverse Event|1|||
30707700|NCT00606086|58721322|FG000|Overall Study|Lost to Follow-up|4|||
30707701|NCT00606086|58721323|FG001|Overall Study|Lost to Follow-up|8|||
30707702|NCT00606086|58721322|FG000|Overall Study|Protocol Violation|1|||
30707703|NCT00606086|58721323|FG001|Overall Study|Protocol Violation|0|||
30707704|NCT00606086|58721322|FG000|Overall Study|Withdrawal by Subject|5|||
30707705|NCT00606086|58721323|FG001|Overall Study|Withdrawal by Subject|3|||
30707706|NCT00606086|58721322|FG000|Overall Study|Non-compliance|0|||
30707707|NCT00606086|58721323|FG001|Overall Study|Non-compliance|1|||
30707708|NCT00606086|58721322|FG000|Overall Study|Randomized, not treated|1|||
30707709|NCT00606086|58721323|FG001|Overall Study|Randomized, not treated|2|||
30707710|NCT00609986|58721331|FG000|Overall Study|Did not receive transplant or treatment|8|||
30707711|NCT00609986|58721332|FG001|Overall Study|Did not receive transplant or treatment|3|||
30707712|NCT00451906|58721338|FG000|Overall Study|Adverse Event|515|||
30707713|NCT00451906|58721338|FG000|Overall Study|Lost to Follow-up|31|||
30707714|NCT00451906|58721338|FG000|Overall Study|Withdrawal by Subject|111|||
30707715|NCT00451906|58721338|FG000|Overall Study|Protocol Violation|21|||
30707716|NCT00451906|58721338|FG000|Overall Study|Progressive disease|1328|||
30707717|NCT00451906|58721338|FG000|Overall Study|Termination of the study|108|||
30707718|NCT00451906|58721338|FG000|Overall Study|Other Reasons|121|||
30707719|NCT00451906|58721338|FG000|Overall Study|Did not complete final visit|4|||
30707720|NCT00451282|58721344|FG000|Overall Study|Lost to Follow-up|6|||
30707721|NCT00451282|58721345|FG001|Overall Study|Lost to Follow-up|5|||
30707722|NCT03838198|58721353|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
30707723|NCT03838198|58721354|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
30707724|NCT03838198|58721355|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
30707725|NCT03838198|58721356|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
30707726|NCT03838198|58721353|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
30707727|NCT03838198|58721354|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
30707728|NCT03838198|58721355|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
30707729|NCT03838198|58721356|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
30707730|NCT00115765|58721371|FG000|Overall Study|Withdrawal by Subject|22|||
30707731|NCT00115765|58721372|FG001|Overall Study|Withdrawal by Subject|53|||
30707732|NCT00115765|58721373|FG002|Overall Study|Withdrawal by Subject|76|||
30707733|NCT00115765|58721374|FG003|Overall Study|Withdrawal by Subject|15|||
30707734|NCT00115765|58721371|FG000|Overall Study|Physician Decision|4|||
30707735|NCT00115765|58721372|FG001|Overall Study|Physician Decision|15|||
30707736|NCT00115765|58721373|FG002|Overall Study|Physician Decision|18|||
30707737|NCT00115765|58721374|FG003|Overall Study|Physician Decision|13|||
30707738|NCT00115765|58721371|FG000|Overall Study|Lost to Follow-up|3|||
30707739|NCT00115765|58721372|FG001|Overall Study|Lost to Follow-up|20|||
30707740|NCT00115765|58721373|FG002|Overall Study|Lost to Follow-up|18|||
30707741|NCT00115765|58721374|FG003|Overall Study|Lost to Follow-up|1|||
30707742|NCT00115765|58721371|FG000|Overall Study|Other|6|||
30707743|NCT00115765|58721372|FG001|Overall Study|Other|12|||
30707744|NCT00115765|58721373|FG002|Overall Study|Other|9|||
30707745|NCT00115765|58721374|FG003|Overall Study|Other|2|||
30707746|NCT00606008|58721382|FG000|Overall Study|Adverse Event|1|||
30707747|NCT00606008|58721382|FG000|Overall Study|Withdrawal by Subject|4|||
30707748|NCT00461812|58721394|FG000|Overall Study|study terminated|10|||
30707749|NCT00123955|58721401|FG000|Overall Study|Adverse Event|1|||
30707750|NCT00123955|58721402|FG001|Overall Study|Adverse Event|0|||
30707751|NCT00123955|58721401|FG000|Overall Study|Withdrawal by Subject|4|||
30707752|NCT00123955|58721402|FG001|Overall Study|Withdrawal by Subject|3|||
30707753|NCT00123955|58721401|FG000|Overall Study|Death|0|||
30707754|NCT00123955|58721402|FG001|Overall Study|Death|1|||
30707755|NCT03837028|58721412|FG000|Overall Study|Lost to Follow-up|4|||
30707756|NCT03837028|58721413|FG001|Overall Study|Lost to Follow-up|0|||
30707757|NCT03837028|58721414|FG002|Overall Study|Lost to Follow-up|2|||
30707758|NCT03837028|58721415|FG003|Overall Study|Lost to Follow-up|0|||
30707759|NCT03837028|58721412|FG000|Overall Study|Withdrawal by Subject|12|||
30707760|NCT03837028|58721413|FG001|Overall Study|Withdrawal by Subject|11|||
30707761|NCT03837028|58721414|FG002|Overall Study|Withdrawal by Subject|11|||
30707762|NCT03837028|58721415|FG003|Overall Study|Withdrawal by Subject|7|||
30707763|NCT00115063|58721427|FG000|Overall Study|Lost to Follow-up|98|||
30707764|NCT00115063|58721428|FG001|Overall Study|Lost to Follow-up|104|||
30707765|NCT00115063|58721427|FG000|Overall Study|Death|1|||
30707766|NCT00115063|58721428|FG001|Overall Study|Death|0|||
30707767|NCT00461500|58721436|FG000|Overall Study|Adverse Event|1|||
30707768|NCT00461500|58721437|FG001|Overall Study|Adverse Event|0|||
30707769|NCT00461500|58721436|FG000|Overall Study|Lack of Efficacy|0|||
30707770|NCT00461500|58721437|FG001|Overall Study|Lack of Efficacy|1|||
30707771|NCT00461500|58721436|FG000|Overall Study|Expired Drug Treatment|1|||
30707772|NCT00461500|58721437|FG001|Overall Study|Expired Drug Treatment|1|||
30707773|NCT00461500|58721436|FG000|Overall Study|Study Stopped|1|||
30707774|NCT00461500|58721437|FG001|Overall Study|Study Stopped|2|||
30707775|NCT00461500|58721436|FG000|Overall Study|Drug Treatment Misuse|1|||
30707776|NCT00461500|58721437|FG001|Overall Study|Drug Treatment Misuse|0|||
30707777|NCT00461500|58721436|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
30707778|NCT00461500|58721437|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
30707779|NCT00461500|58721436|FG000|Overall Study|Lost to Follow-up|2|||
30707780|NCT00461500|58721437|FG001|Overall Study|Lost to Follow-up|2|||
30707781|NCT00167245|58721445|FG000|Overall Study|Lost to Follow-up|20|||
30707782|NCT00167245|58721446|FG001|Overall Study|Lost to Follow-up|31|||
30707783|NCT00167245|58721445|FG000|Overall Study|Withdrawal by Subject|5|||
30707784|NCT00167245|58721446|FG001|Overall Study|Withdrawal by Subject|8|||
30707785|NCT00167245|58721445|FG000|Overall Study|Incarcerated|3|||
30707786|NCT00167245|58721446|FG001|Overall Study|Incarcerated|2|||
30707787|NCT00167245|58721445|FG000|Overall Study|Drowsy|1|||
30707788|NCT00167245|58721446|FG001|Overall Study|Drowsy|0|||
30707789|NCT00443560|58721457|FG000|Overall Study|No intrathecal dose|58|||
30707790|NCT00443560|58721458|FG001|Overall Study|No intrathecal dose|26|||
30707791|NCT00443560|58721457|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
30707792|NCT00443560|58721458|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
30707793|NCT00451204|58721466|FG000|Overall Study|Adverse Event|4|||
30707794|NCT00451204|58721467|FG001|Overall Study|Adverse Event|6|||
30707795|NCT00451204|58721466|FG000|Overall Study|Lack of Efficacy|4|||
30707796|NCT00451204|58721467|FG001|Overall Study|Lack of Efficacy|4|||
30707797|NCT00451204|58721466|FG000|Overall Study|Lost to Follow-up|4|||
30707798|NCT00451204|58721467|FG001|Overall Study|Lost to Follow-up|4|||
30707799|NCT00451204|58721466|FG000|Overall Study|Protocol Violation|1|||
30707800|NCT00451204|58721467|FG001|Overall Study|Protocol Violation|0|||
30707801|NCT00451204|58721466|FG000|Overall Study|Patient refusal|8|||
30707802|NCT00451204|58721467|FG001|Overall Study|Patient refusal|4|||
30707803|NCT00451204|58721466|FG000|Overall Study|Other|1|||
30707804|NCT00451204|58721467|FG001|Overall Study|Other|2|||
30707805|NCT00605540|58721476|FG000|Overall Study|Death|15|||
30707806|NCT00605540|58721476|FG000|Overall Study|Lost to Follow-up|23|||
30707807|NCT00605306|58721482|FG000|Overall Study|Adverse Event|0|||
30707808|NCT00605306|58721483|FG001|Overall Study|Adverse Event|1|||
30707809|NCT00607022|58721492|FG000|Overall Study|Withdrawal by Subject|1|||
30707810|NCT00607022|58721493|FG001|Overall Study|Withdrawal by Subject|0|||
30707811|NCT00607022|58721494|FG002|Overall Study|Withdrawal by Subject|0|||
30707812|NCT00606632|58721502|FG000|Overall Study|Withdrawal by Subject|13|||
30707813|NCT00606632|58721502|FG000|Overall Study|Miscellaneous reasons|9|||
30707814|NCT00450814|58721521|FG000|Overall Study|Failed to complete the initial therapy|0|||
30707815|NCT00450814|58721522|FG001|Overall Study|Failed to complete the initial therapy|0|||
30707816|NCT00450814|58721523|FG002|Overall Study|Failed to complete the initial therapy|0|||
30707817|NCT00450814|58721524|FG003|Overall Study|Failed to complete the initial therapy|1|||
30707818|NCT00450814|58721525|FG004|Overall Study|Failed to complete the initial therapy|1|||
30707819|NCT00450814|58721526|FG005|Overall Study|Failed to complete the initial therapy|1|||
30707820|NCT00450814|58721527|FG006|Overall Study|Failed to complete the initial therapy|0|||
30707821|NCT00450814|58721528|FG007|Overall Study|Failed to complete the initial therapy|0|||
30707822|NCT00450814|58721529|FG008|Overall Study|Failed to complete the initial therapy|0|||
30707823|NCT00450814|58721530|FG009|Overall Study|Failed to complete the initial therapy|0|||
30707824|NCT00450814|58721531|FG010|Overall Study|Failed to complete the initial therapy|0|||
30707825|NCT00450814|58721521|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
30707826|NCT00450814|58721522|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
30707827|NCT00450814|58721523|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
30707828|NCT00450814|58721524|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
30707829|NCT00450814|58721525|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
30707830|NCT00450814|58721526|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
30707831|NCT00450814|58721527|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
30707832|NCT00450814|58721528|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
30707833|NCT00450814|58721529|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
30707834|NCT00450814|58721530|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
30707835|NCT00450814|58721531|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
30707836|NCT00518115|58721566|FG000|Overall Study|Adverse Event|6|||
30707837|NCT00518115|58721567|FG001|Overall Study|Adverse Event|1|||
30707838|NCT00518115|58721568|FG002|Overall Study|Adverse Event|5|||
30707839|NCT00518115|58721569|FG003|Overall Study|Adverse Event|6|||
30707840|NCT00518115|58721570|FG004|Overall Study|Adverse Event|5|||
30707841|NCT00518115|58721571|FG005|Overall Study|Adverse Event|5|||
30707842|NCT00518115|58721572|FG006|Overall Study|Adverse Event|5|||
30707843|NCT00518115|58721573|FG007|Overall Study|Adverse Event|10|||
30707844|NCT00518115|58721574|FG008|Overall Study|Adverse Event|2|||
30707845|NCT00518115|58721575|FG009|Overall Study|Adverse Event|9|||
30707846|NCT00518115|58721566|FG000|Overall Study|Lost to Follow-up|0|||
30707847|NCT00518115|58721567|FG001|Overall Study|Lost to Follow-up|0|||
30707848|NCT00518115|58721568|FG002|Overall Study|Lost to Follow-up|2|||
30707849|NCT00518115|58721569|FG003|Overall Study|Lost to Follow-up|3|||
30707850|NCT00518115|58721570|FG004|Overall Study|Lost to Follow-up|1|||
30707851|NCT00518115|58721571|FG005|Overall Study|Lost to Follow-up|3|||
30707852|NCT00518115|58721572|FG006|Overall Study|Lost to Follow-up|0|||
30707853|NCT00518115|58721573|FG007|Overall Study|Lost to Follow-up|1|||
30707854|NCT00518115|58721574|FG008|Overall Study|Lost to Follow-up|1|||
30707855|NCT00518115|58721575|FG009|Overall Study|Lost to Follow-up|1|||
30707856|NCT00518115|58721566|FG000|Overall Study|Protocol Violation|1|||
30843714|NCT01915498|58869659|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30707857|NCT00518115|58721567|FG001|Overall Study|Protocol Violation|3|||
30707858|NCT00518115|58721568|FG002|Overall Study|Protocol Violation|1|||
30707859|NCT00518115|58721569|FG003|Overall Study|Protocol Violation|0|||
30707860|NCT00518115|58721570|FG004|Overall Study|Protocol Violation|0|||
30707861|NCT00518115|58721571|FG005|Overall Study|Protocol Violation|0|||
30707862|NCT00518115|58721572|FG006|Overall Study|Protocol Violation|0|||
30707863|NCT00518115|58721573|FG007|Overall Study|Protocol Violation|0|||
30707864|NCT00518115|58721574|FG008|Overall Study|Protocol Violation|0|||
30707865|NCT00518115|58721575|FG009|Overall Study|Protocol Violation|0|||
30707866|NCT00518115|58721566|FG000|Overall Study|Withdrawal by Subject|1|||
30707867|NCT00518115|58721567|FG001|Overall Study|Withdrawal by Subject|1|||
30707868|NCT00518115|58721568|FG002|Overall Study|Withdrawal by Subject|5|||
30707869|NCT00518115|58721569|FG003|Overall Study|Withdrawal by Subject|0|||
30707870|NCT00518115|58721570|FG004|Overall Study|Withdrawal by Subject|2|||
30707871|NCT00518115|58721571|FG005|Overall Study|Withdrawal by Subject|1|||
30707872|NCT00518115|58721572|FG006|Overall Study|Withdrawal by Subject|0|||
30707873|NCT00518115|58721573|FG007|Overall Study|Withdrawal by Subject|2|||
30707874|NCT00518115|58721574|FG008|Overall Study|Withdrawal by Subject|1|||
30707875|NCT00518115|58721575|FG009|Overall Study|Withdrawal by Subject|3|||
30707876|NCT00518115|58721566|FG000|Overall Study|Lack of Efficacy|1|||
30707877|NCT00518115|58721567|FG001|Overall Study|Lack of Efficacy|0|||
30707878|NCT00518115|58721568|FG002|Overall Study|Lack of Efficacy|1|||
30707879|NCT00518115|58721569|FG003|Overall Study|Lack of Efficacy|1|||
30707880|NCT00518115|58721570|FG004|Overall Study|Lack of Efficacy|0|||
30707881|NCT00518115|58721571|FG005|Overall Study|Lack of Efficacy|0|||
30707882|NCT00518115|58721572|FG006|Overall Study|Lack of Efficacy|0|||
30707883|NCT00518115|58721573|FG007|Overall Study|Lack of Efficacy|1|||
30707884|NCT00518115|58721574|FG008|Overall Study|Lack of Efficacy|0|||
30707885|NCT00518115|58721575|FG009|Overall Study|Lack of Efficacy|0|||
30707886|NCT00518115|58721566|FG000|Overall Study|Non-Compliance|1|||
30707887|NCT00518115|58721567|FG001|Overall Study|Non-Compliance|0|||
30707888|NCT00518115|58721568|FG002|Overall Study|Non-Compliance|1|||
30707889|NCT00518115|58721569|FG003|Overall Study|Non-Compliance|0|||
30707890|NCT00518115|58721570|FG004|Overall Study|Non-Compliance|1|||
30707891|NCT00518115|58721571|FG005|Overall Study|Non-Compliance|1|||
30707892|NCT00518115|58721572|FG006|Overall Study|Non-Compliance|1|||
30707893|NCT00518115|58721573|FG007|Overall Study|Non-Compliance|1|||
30707894|NCT00518115|58721574|FG008|Overall Study|Non-Compliance|0|||
30707895|NCT00518115|58721575|FG009|Overall Study|Non-Compliance|1|||
30707896|NCT00518115|58721566|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
30707897|NCT00518115|58721567|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
30707898|NCT00518115|58721568|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
30707899|NCT00518115|58721569|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
30707900|NCT00518115|58721570|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
30707901|NCT00518115|58721571|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
30707902|NCT00518115|58721572|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
30707903|NCT00518115|58721573|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
30707904|NCT00518115|58721574|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
30707905|NCT00518115|58721575|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
30707906|NCT00518115|58721566|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
30707907|NCT00518115|58721567|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
30707908|NCT00518115|58721568|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
30707909|NCT00518115|58721569|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
30707910|NCT00518115|58721570|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
30620489|NCT01208207|58631730|FG003|Part II|Lack of Efficacy|6|||
30620490|NCT01208207|58631731|FG004|Part II|Lack of Efficacy|4|||
30620491|NCT01208207|58631732|FG005|Part II|Lack of Efficacy|3|||
30620492|NCT01208207|58631733|FG006|Part II|Lack of Efficacy|3|||
30620493|NCT01208207|58631727|FG000|Part II|Lost to Follow-up|0|||
30620494|NCT01208207|58631728|FG001|Part II|Lost to Follow-up|0|||
30620495|NCT01208207|58631729|FG002|Part II|Lost to Follow-up|0|||
30620496|NCT01208207|58631730|FG003|Part II|Lost to Follow-up|4|||
30620497|NCT01208207|58631731|FG004|Part II|Lost to Follow-up|0|||
30620498|NCT01208207|58631732|FG005|Part II|Lost to Follow-up|2|||
30707911|NCT00518115|58721571|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
30707912|NCT00518115|58721572|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
30707913|NCT00518115|58721573|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
30707914|NCT00518115|58721574|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
30707915|NCT00518115|58721575|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
30707916|NCT00518115|58721566|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
30707917|NCT00518115|58721567|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
30707918|NCT00518115|58721568|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
30760600|NCT03381274|58769074|FG004|Overall Study|Other|2|||
30620499|NCT01208207|58631733|FG006|Part II|Lost to Follow-up|1|||
30620500|NCT01208207|58631727|FG000|Part II|Non-Compliance With Study Drug|0|||
30620501|NCT01208207|58631728|FG001|Part II|Non-Compliance With Study Drug|0|||
30707919|NCT00518115|58721569|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
30707920|NCT00518115|58721570|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
30707921|NCT00518115|58721571|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
30707922|NCT00518115|58721572|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
30707923|NCT00518115|58721573|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
30707924|NCT00518115|58721574|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
30707925|NCT00518115|58721575|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
30707926|NCT00518115|58721566|FG000|Overall Study|Wrong Monotherapy Administered|0|||
30707927|NCT00518115|58721567|FG001|Overall Study|Wrong Monotherapy Administered|0|||
30707928|NCT00518115|58721568|FG002|Overall Study|Wrong Monotherapy Administered|1|||
30707929|NCT00518115|58721569|FG003|Overall Study|Wrong Monotherapy Administered|0|||
30707930|NCT00518115|58721570|FG004|Overall Study|Wrong Monotherapy Administered|0|||
30707931|NCT00518115|58721571|FG005|Overall Study|Wrong Monotherapy Administered|0|||
30707932|NCT00518115|58721572|FG006|Overall Study|Wrong Monotherapy Administered|1|||
30707933|NCT00518115|58721573|FG007|Overall Study|Wrong Monotherapy Administered|0|||
30707934|NCT00518115|58721574|FG008|Overall Study|Wrong Monotherapy Administered|0|||
30707935|NCT00518115|58721575|FG009|Overall Study|Wrong Monotherapy Administered|0|||
30707936|NCT00518115|58721566|FG000|Overall Study|Violation of Exclusion Criteria|0|||
30620502|NCT01208207|58631729|FG002|Part II|Non-Compliance With Study Drug|0|||
30620503|NCT01208207|58631730|FG003|Part II|Non-Compliance With Study Drug|4|||
30620504|NCT01208207|58631731|FG004|Part II|Non-Compliance With Study Drug|1|||
30620505|NCT01208207|58631732|FG005|Part II|Non-Compliance With Study Drug|1|||
30620506|NCT01208207|58631733|FG006|Part II|Non-Compliance With Study Drug|0|||
30620507|NCT01208207|58631727|FG000|Part II|Physician Decision|0|||
30620508|NCT01208207|58631728|FG001|Part II|Physician Decision|0|||
30620509|NCT01208207|58631729|FG002|Part II|Physician Decision|0|||
30620510|NCT01208207|58631730|FG003|Part II|Physician Decision|1|||
30620511|NCT01208207|58631731|FG004|Part II|Physician Decision|0|||
30620512|NCT01208207|58631732|FG005|Part II|Physician Decision|2|||
30620513|NCT01208207|58631733|FG006|Part II|Physician Decision|0|||
30620514|NCT01208207|58631727|FG000|Part II|Protocol Violation|0|||
30620515|NCT01208207|58631728|FG001|Part II|Protocol Violation|0|||
30620516|NCT01208207|58631729|FG002|Part II|Protocol Violation|0|||
30620517|NCT01208207|58631730|FG003|Part II|Protocol Violation|1|||
30620518|NCT01208207|58631731|FG004|Part II|Protocol Violation|0|||
30620519|NCT01208207|58631732|FG005|Part II|Protocol Violation|0|||
30620520|NCT01208207|58631733|FG006|Part II|Protocol Violation|0|||
30620521|NCT01208207|58631727|FG000|Part II|Technical Problems|0|||
30620522|NCT01208207|58631728|FG001|Part II|Technical Problems|0|||
30620523|NCT01208207|58631729|FG002|Part II|Technical Problems|0|||
30620524|NCT01208207|58631730|FG003|Part II|Technical Problems|1|||
30620525|NCT01208207|58631731|FG004|Part II|Technical Problems|0|||
30620526|NCT01208207|58631732|FG005|Part II|Technical Problems|1|||
30620527|NCT01208207|58631733|FG006|Part II|Technical Problems|0|||
30620528|NCT01012713|58631764|FG000|Overall Study|Lack of Efficacy|3|||
30620529|NCT01007253|58631769|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
30620530|NCT01007253|58631770|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
30620531|NCT01007253|58631771|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
30620532|NCT01007253|58631772|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
30620533|NCT01006707|58631782|FG000|Study Session 1|Lost to Follow-up|2|||
30620534|NCT01006707|58631783|FG001|Study Session 1|Lost to Follow-up|0|||
30620535|NCT01006707|58631784|FG002|Study Session 1|Lost to Follow-up|0|||
30620536|NCT01006707|58631782|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
30620537|NCT01006707|58631783|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
30620538|NCT01006707|58631784|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
30707937|NCT00518115|58721567|FG001|Overall Study|Violation of Exclusion Criteria|0|||
30760601|NCT03298022|58769090|FG000|Overall Study|Lack of Efficacy|4|||
30760602|NCT03298022|58769090|FG000|Overall Study|Withdrawal by Subject|7|||
30760603|NCT03298022|58769090|FG000|Overall Study|Adverse Event|1|||
30760604|NCT03298022|58769090|FG000|Overall Study|disease relapse|1|||
30760605|NCT03264404|58769100|FG000|Overall Study|Death|2|||
30760606|NCT03264404|58769100|FG000|Overall Study|Physician Decision|1|||
30707938|NCT00518115|58721568|FG002|Overall Study|Violation of Exclusion Criteria|0|||
30707939|NCT00518115|58721569|FG003|Overall Study|Violation of Exclusion Criteria|1|||
30707940|NCT00518115|58721570|FG004|Overall Study|Violation of Exclusion Criteria|0|||
30707941|NCT00518115|58721571|FG005|Overall Study|Violation of Exclusion Criteria|0|||
30707942|NCT00518115|58721572|FG006|Overall Study|Violation of Exclusion Criteria|1|||
30707943|NCT00518115|58721573|FG007|Overall Study|Violation of Exclusion Criteria|0|||
30707944|NCT00518115|58721574|FG008|Overall Study|Violation of Exclusion Criteria|0|||
30707945|NCT00518115|58721575|FG009|Overall Study|Violation of Exclusion Criteria|0|||
30707946|NCT00518115|58721566|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
30707947|NCT00518115|58721567|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
30707948|NCT00518115|58721568|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
30707949|NCT00518115|58721569|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
30707950|NCT00518115|58721570|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
30707951|NCT00518115|58721571|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
30707952|NCT00518115|58721572|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
30707953|NCT00518115|58721573|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
30707954|NCT00518115|58721574|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
30707955|NCT00518115|58721575|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
30707956|NCT00518115|58721566|FG000|Overall Study|Withdrew Consent|0|||
30707957|NCT00518115|58721567|FG001|Overall Study|Withdrew Consent|0|||
30707958|NCT00518115|58721568|FG002|Overall Study|Withdrew Consent|0|||
30707959|NCT00518115|58721569|FG003|Overall Study|Withdrew Consent|0|||
30707960|NCT00518115|58721570|FG004|Overall Study|Withdrew Consent|0|||
30707961|NCT00518115|58721571|FG005|Overall Study|Withdrew Consent|1|||
30707962|NCT00518115|58721572|FG006|Overall Study|Withdrew Consent|0|||
30707963|NCT00518115|58721573|FG007|Overall Study|Withdrew Consent|0|||
30707964|NCT00518115|58721574|FG008|Overall Study|Withdrew Consent|0|||
30707965|NCT00518115|58721575|FG009|Overall Study|Withdrew Consent|0|||
30707966|NCT00518115|58721566|FG000|Overall Study|Moved Out of State|0|||
30707967|NCT00518115|58721567|FG001|Overall Study|Moved Out of State|0|||
30707968|NCT00518115|58721568|FG002|Overall Study|Moved Out of State|0|||
30707969|NCT00518115|58721569|FG003|Overall Study|Moved Out of State|0|||
30707970|NCT00518115|58721570|FG004|Overall Study|Moved Out of State|0|||
30707971|NCT00518115|58721571|FG005|Overall Study|Moved Out of State|0|||
30707972|NCT00518115|58721572|FG006|Overall Study|Moved Out of State|0|||
30707973|NCT00518115|58721573|FG007|Overall Study|Moved Out of State|0|||
30707974|NCT00518115|58721574|FG008|Overall Study|Moved Out of State|0|||
30707975|NCT00518115|58721575|FG009|Overall Study|Moved Out of State|1|||
30707976|NCT00450658|58721600|FG000|Overall Study|Adverse Event|24|||
30707977|NCT00450658|58721601|FG001|Overall Study|Adverse Event|15|||
30707978|NCT00450658|58721600|FG000|Overall Study|Withdrawal by Subject|43|||
30707979|NCT00450658|58721601|FG001|Overall Study|Withdrawal by Subject|26|||
30707980|NCT00450658|58721600|FG000|Overall Study|Lost to Follow-up|22|||
30707981|NCT00450658|58721601|FG001|Overall Study|Lost to Follow-up|5|||
30707982|NCT00450658|58721600|FG000|Overall Study|UGI ulcer|33|||
30707983|NCT00450658|58721601|FG001|Overall Study|UGI ulcer|34|||
30707984|NCT00450658|58721600|FG000|Overall Study|misc|21|||
30707985|NCT00450658|58721601|FG001|Overall Study|misc|10|||
30707986|NCT00517881|58721607|FG000|Overall Study|Protocol Violation|2|||
30707987|NCT00517881|58721607|FG000|Overall Study|Adverse Event|1|||
30707988|NCT00517881|58721607|FG000|Overall Study|Renal transplantation|2|||
30707989|NCT00517413|58721628|FG000|Overall Study|Adverse Event|7|||
30707990|NCT00517413|58721628|FG000|Overall Study|Death|13|||
30707991|NCT00517413|58721628|FG000|Overall Study|Protocol Violation|15|||
30707992|NCT00517413|58721628|FG000|Overall Study|Withdrawal by Subject|2|||
30707993|NCT00517413|58721628|FG000|Overall Study|Failure to return|1|||
30707994|NCT00517413|58721628|FG000|Overall Study|Other-Reasons|23|||
30707995|NCT00604214|58721642|FG000|Baseline to Day 28|Death|223|||
30707996|NCT00604214|58721643|FG001|Baseline to Day 28|Death|202|||
30707997|NCT00604214|58721642|FG000|Baseline to Day 28|Lost to Follow-up|2|||
30707998|NCT00604214|58721643|FG001|Baseline to Day 28|Lost to Follow-up|4|||
30707999|NCT00604214|58721642|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
30708000|NCT00604214|58721643|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
30708001|NCT00604214|58721642|FG000|Day 29 to Day 90|Death|64|||
30708002|NCT00604214|58721643|FG001|Day 29 to Day 90|Death|67|||
30708003|NCT00604214|58721642|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
30708004|NCT00604214|58721643|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
30708005|NCT00604214|58721642|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
30708006|NCT00604214|58721643|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
30708007|NCT00604214|58721642|FG000|Day 91 to Day 180|Death|19|||
30708008|NCT00604214|58721643|FG001|Day 91 to Day 180|Death|23|||
30708009|NCT00604214|58721642|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
30708010|NCT00604214|58721643|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
30708011|NCT00604214|58721642|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
30708012|NCT00604214|58721643|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
30708013|NCT00450580|58721651|FG000|Overall Study|Adverse Event|5|||
30708014|NCT00450580|58721652|FG001|Overall Study|Adverse Event|7|||
30708015|NCT00450580|58721651|FG000|Overall Study|Lost to Follow-up|4|||
30708016|NCT00450580|58721652|FG001|Overall Study|Lost to Follow-up|5|||
30708017|NCT00450580|58721651|FG000|Overall Study|Withdrawal by Subject|2|||
30708018|NCT00450580|58721652|FG001|Overall Study|Withdrawal by Subject|2|||
30708019|NCT00450580|58721651|FG000|Overall Study|Protocol Violation|1|||
30708020|NCT00450580|58721652|FG001|Overall Study|Protocol Violation|1|||
30708021|NCT00450580|58721651|FG000|Overall Study|Protocol-defined virologic failure|1|||
30708022|NCT00450580|58721652|FG001|Overall Study|Protocol-defined virologic failure|0|||
30708023|NCT00450580|58721651|FG000|Overall Study|Could not comply with scheduled visits|1|||
30708024|NCT00450580|58721652|FG001|Overall Study|Could not comply with scheduled visits|0|||
30708025|NCT00450580|58721651|FG000|Overall Study|Patient went to Brazil|1|||
30708026|NCT00450580|58721652|FG001|Overall Study|Patient went to Brazil|0|||
30708027|NCT00450580|58721651|FG000|Overall Study|Patient could not swallow Norvir|1|||
30708028|NCT00450580|58721652|FG001|Overall Study|Patient could not swallow Norvir|0|||
30708029|NCT00450580|58721651|FG000|Overall Study|Withdrawal due to pregnancy|0|||
30708030|NCT00450580|58721652|FG001|Overall Study|Withdrawal due to pregnancy|1|||
30708031|NCT00123487|58721660|FG000|Randomized|Death prior to starting treatment|0|||
30708032|NCT00123487|58721661|FG001|Randomized|Death prior to starting treatment|1|||
30708033|NCT00123487|58721660|FG000|Randomized|SAE prior to starting treatment|1|||
30708034|NCT00123487|58721661|FG001|Randomized|SAE prior to starting treatment|0|||
30708035|NCT00123487|58721660|FG000|Treated With Study Drug|Adverse Event|23|||
30708036|NCT00123487|58721661|FG001|Treated With Study Drug|Adverse Event|22|||
30708037|NCT00123487|58721660|FG000|Treated With Study Drug|Disease Progression|141|||
30708038|NCT00123487|58721661|FG001|Treated With Study Drug|Disease Progression|122|||
30708039|NCT00123487|58721660|FG000|Treated With Study Drug|Physician Decision|8|||
30708040|NCT00123487|58721661|FG001|Treated With Study Drug|Physician Decision|9|||
30708041|NCT00123487|58721660|FG000|Treated With Study Drug|Other|59|||
30708042|NCT00123487|58721661|FG001|Treated With Study Drug|Other|58|||
30708043|NCT00123487|58721660|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
30708044|NCT00123487|58721661|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
30708045|NCT00123487|58721660|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
30708046|NCT00123487|58721661|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
30708047|NCT00123487|58721660|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
30708048|NCT00123487|58721661|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
30708049|NCT00509925|58721668|FG000|Overall Study|Personal reasons|0|||
30708050|NCT00509925|58721669|FG001|Overall Study|Personal reasons|1|||
30708051|NCT00504777|58721677|FG000|Overall Study|Adverse Event|1|||
30708052|NCT00509769|58721681|FG000|Overall Study|Progressive disease|77|||
30708053|NCT00509769|58721681|FG000|Overall Study|Adverse Event|4|||
30790868|NCT03524092|58803941|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
30708054|NCT00509769|58721681|FG000|Overall Study|Patient's decision|1|||
30708055|NCT00509769|58721681|FG000|Overall Study|Physician Decision|8|||
30708056|NCT00509769|58721681|FG000|Overall Study|Use of prohibited therapies during study|1|||
30708057|NCT00114127|58721687|FG000|Overall Study|Adverse Event|2|||
30708058|NCT00114127|58721688|FG001|Overall Study|Adverse Event|1|||
30708059|NCT00114127|58721687|FG000|Overall Study|Lost to Follow-up|1|||
30708060|NCT00114127|58721688|FG001|Overall Study|Lost to Follow-up|0|||
30708061|NCT00114127|58721687|FG000|Overall Study|Withdrawal by Subject|1|||
30708062|NCT00114127|58721688|FG001|Overall Study|Withdrawal by Subject|3|||
30708063|NCT00572624|58721696|FG000|Overall Study|Lost to Follow-up|10|||
30708064|NCT00572624|58721697|FG001|Overall Study|Lost to Follow-up|4|||
30708065|NCT00572624|58721696|FG000|Overall Study|Wanted to do a different diet program|1|||
30708066|NCT00572624|58721697|FG001|Overall Study|Wanted to do a different diet program|0|||
30708067|NCT00572624|58721696|FG000|Overall Study|Medication change|1|||
30708068|NCT00572624|58721697|FG001|Overall Study|Medication change|0|||
30708069|NCT00572624|58721696|FG000|Overall Study|Started a new job-- no time for study|1|||
30708070|NCT00572624|58721697|FG001|Overall Study|Started a new job-- no time for study|0|||
30708071|NCT00572624|58721696|FG000|Overall Study|Admitted to being a smoker|1|||
30708072|NCT00572624|58721697|FG001|Overall Study|Admitted to being a smoker|0|||
30708073|NCT00572624|58721696|FG000|Overall Study|Refused to do the stress test|1|||
30708074|NCT00572624|58721697|FG001|Overall Study|Refused to do the stress test|0|||
30708075|NCT00572624|58721696|FG000|Overall Study|Problem with vascular access|1|||
30708076|NCT00572624|58721697|FG001|Overall Study|Problem with vascular access|0|||
30708077|NCT00572624|58721696|FG000|Overall Study|Health issues unrelated to the study|1|||
30708078|NCT00572624|58721697|FG001|Overall Study|Health issues unrelated to the study|0|||
30708079|NCT00122317|58721703|FG000|Overall Study|Death|3|||
30708080|NCT00122317|58721703|FG000|Overall Study|Adverse Event|4|||
30708081|NCT00122317|58721703|FG000|Overall Study|Physician Decision|2|||
30708082|NCT00122317|58721703|FG000|Overall Study|patient non-compliance|1|||
30708083|NCT00122317|58721703|FG000|Overall Study|Withdrawal by Subject|1|||
30708084|NCT03870555|58721710|FG000|Period 3 (2 Days)|Adverse Event|1|||
30708085|NCT03870555|58721711|FG001|Period 3 (2 Days)|Adverse Event|0|||
30708086|NCT03870555|58721712|FG002|Period 3 (2 Days)|Adverse Event|0|||
30708087|NCT03870477|58721723|FG000|Overall Study|Early Study Termination|1|||
30708088|NCT00165841|58721729|FG000|Overall Study|Adverse Event|2|||
30708089|NCT00165841|58721730|FG001|Overall Study|Adverse Event|3|||
30708090|NCT00165841|58721729|FG000|Overall Study|Lack of Efficacy|6|||
30708091|NCT00165841|58721730|FG001|Overall Study|Lack of Efficacy|33|||
30708092|NCT00165841|58721729|FG000|Overall Study|Lost to Follow-up|4|||
30708093|NCT00165841|58721730|FG001|Overall Study|Lost to Follow-up|4|||
30708094|NCT00165841|58721729|FG000|Overall Study|Withdrawal by Subject|7|||
30708095|NCT00165841|58721730|FG001|Overall Study|Withdrawal by Subject|8|||
30708096|NCT00165841|58721729|FG000|Overall Study|Physician Decision|1|||
30708097|NCT00165841|58721730|FG001|Overall Study|Physician Decision|0|||
30708098|NCT00165841|58721729|FG000|Overall Study|Protocol Violation|6|||
30708099|NCT00165841|58721730|FG001|Overall Study|Protocol Violation|8|||
30708100|NCT00165841|58721729|FG000|Overall Study|Other|3|||
30708101|NCT00165841|58721730|FG001|Overall Study|Other|5|||
30708102|NCT00165841|58721729|FG000|Overall Study|Medication Noncompliance|1|||
30708103|NCT00165841|58721730|FG001|Overall Study|Medication Noncompliance|1|||
30708104|NCT00509223|58721738|FG000|Overall Study|Lost to Follow-up|1|||
30708105|NCT00509223|58721739|FG001|Overall Study|Lost to Follow-up|1|||
30708106|NCT00509223|58721738|FG000|Overall Study|Adverse Event|1|||
30708107|NCT00509223|58721739|FG001|Overall Study|Adverse Event|1|||
30708108|NCT00509223|58721738|FG000|Overall Study|Withdrawal by Subject|25|||
30708109|NCT00509223|58721739|FG001|Overall Study|Withdrawal by Subject|6|||
30708110|NCT00509223|58721738|FG000|Overall Study|Including: subject change of address|5|||
30708111|NCT00509223|58721739|FG001|Overall Study|Including: subject change of address|2|||
30708112|NCT00509223|58721738|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
30708113|NCT00509223|58721739|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
30708114|NCT00460798|58721745|FG000|Overall Study|Death|59|||
30708115|NCT00460798|58721745|FG000|Overall Study|Adverse Event|27|||
30708116|NCT00460798|58721745|FG000|Overall Study|Lost to Follow-up|19|||
30708117|NCT00460798|58721745|FG000|Overall Study|Progressive Disease|99|||
30708118|NCT00460798|58721745|FG000|Overall Study|Other|27|||
30708119|NCT00460798|58721745|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
30708120|NCT00460798|58721745|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
30708121|NCT00603980|58721749|FG000|Study Qualification|Protocol Violation|3|||
30708122|NCT00603980|58721749|FG000|Study Qualification|Inconsistent data reporting|13|||
30708123|NCT00603980|58721749|FG000|Main Study|14th subject completed trial|1|||
30708124|NCT00450190|58721769|FG000|Overall Study|Withdrawal by Subject|2|||
30708125|NCT00450112|58721775|FG000|Overall Study|Other Treatment Required|5|||
30708126|NCT00450112|58721776|FG001|Overall Study|Other Treatment Required|1|||
30708127|NCT00450112|58721775|FG000|Overall Study|Withdrawal by Subject|4|||
30708128|NCT00450112|58721776|FG001|Overall Study|Withdrawal by Subject|1|||
30708129|NCT00450112|58721775|FG000|Overall Study|Lost to Follow-up|2|||
30708130|NCT00450112|58721776|FG001|Overall Study|Lost to Follow-up|1|||
30708131|NCT00450112|58721775|FG000|Overall Study|Others|2|||
30708132|NCT00450112|58721776|FG001|Overall Study|Others|3|||
30708133|NCT00449956|58721785|FG000|Overall Study|Adverse Event|7|||
30708134|NCT00449956|58721786|FG001|Overall Study|Adverse Event|1|||
30708135|NCT00449956|58721787|FG002|Overall Study|Adverse Event|6|||
30708136|NCT00449956|58721785|FG000|Overall Study|Lack of Efficacy|0|||
30708137|NCT00449956|58721786|FG001|Overall Study|Lack of Efficacy|0|||
30708138|NCT00449956|58721787|FG002|Overall Study|Lack of Efficacy|1|||
30708139|NCT00449956|58721785|FG000|Overall Study|Protocol Violation|1|||
30708140|NCT00449956|58721786|FG001|Overall Study|Protocol Violation|1|||
30708141|NCT00449956|58721787|FG002|Overall Study|Protocol Violation|1|||
30708142|NCT00449956|58721785|FG000|Overall Study|Withdrawal by Subject|0|||
30708143|NCT00449956|58721786|FG001|Overall Study|Withdrawal by Subject|1|||
30708144|NCT00449956|58721787|FG002|Overall Study|Withdrawal by Subject|0|||
30708145|NCT00449956|58721785|FG000|Overall Study|Physician Decision|2|||
30708146|NCT00449956|58721786|FG001|Overall Study|Physician Decision|1|||
30708147|NCT00449956|58721787|FG002|Overall Study|Physician Decision|1|||
30708148|NCT00509145|58721797|FG000|Overall Study|Death|0|||
30708149|NCT00509145|58721798|FG001|Overall Study|Death|2|||
30708150|NCT00509145|58721797|FG000|Overall Study|Adverse Event|42|||
30708151|NCT00509145|58721798|FG001|Overall Study|Adverse Event|28|||
30708152|NCT00509145|58721797|FG000|Overall Study|Withdrawal by Subject|32|||
30708153|NCT00509145|58721798|FG001|Overall Study|Withdrawal by Subject|38|||
30708154|NCT00509145|58721797|FG000|Overall Study|Physician Decision|11|||
30708155|NCT00509145|58721798|FG001|Overall Study|Physician Decision|14|||
30708156|NCT00509145|58721797|FG000|Overall Study|Protocol Violation|1|||
30708157|NCT00509145|58721798|FG001|Overall Study|Protocol Violation|6|||
30708158|NCT00509145|58721797|FG000|Overall Study|Pregnancy|3|||
30708159|NCT00509145|58721798|FG001|Overall Study|Pregnancy|8|||
30708160|NCT00509145|58721797|FG000|Overall Study|Lost to Follow-up|6|||
30708161|NCT00509145|58721798|FG001|Overall Study|Lost to Follow-up|5|||
30708162|NCT00509145|58721797|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
30708163|NCT00509145|58721798|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
30708164|NCT00509145|58721797|FG000|Overall Study|Other|6|||
30620539|NCT01006629|58631792|FG000|Overall Study|Adverse Event|1|||
30620540|NCT01006629|58631792|FG000|Overall Study|Parent refused to continue participation|1|||
30620541|NCT01006629|58631792|FG000|Overall Study|Parent unable to perform site visit|4|||
30620542|NCT01012323|58631796|FG000|Overall Study|Investigator Judgment|1|||
30620543|NCT01011933|58631800|FG000|Overall Study|Wrong cell type|1|||
30620544|NCT01011933|58631800|FG000|Overall Study|Improper pre-protocol Rx|1|||
30620545|NCT01011933|58631800|FG000|Overall Study|Inadequate pathology|1|||
30620546|NCT01011933|58631800|FG000|Overall Study|Never treated|1|||
30620547|NCT01011465|58631822|FG000|Overall Study|Withdrawal by Subject|2|||
30620548|NCT01011465|58631823|FG001|Overall Study|Withdrawal by Subject|1|||
30620549|NCT01011465|58631824|FG002|Overall Study|Withdrawal by Subject|0|||
30620550|NCT01011465|58631825|FG003|Overall Study|Withdrawal by Subject|0|||
30620551|NCT01011465|58631826|FG004|Overall Study|Withdrawal by Subject|1|||
30620552|NCT01011465|58631827|FG005|Overall Study|Withdrawal by Subject|0|||
30620553|NCT01011465|58631828|FG006|Overall Study|Withdrawal by Subject|1|||
30620554|NCT01011465|58631829|FG007|Overall Study|Withdrawal by Subject|0|||
30620555|NCT01011387|58631854|FG000|Overall Study|Withdrawal by Subject|3|||
30620556|NCT01011387|58631854|FG000|Overall Study|Adverse Event|2|||
30620557|NCT01011387|58631854|FG000|Overall Study|Protocol Violation|1|||
30620558|NCT01011309|58631861|FG000|Overall Study|Adverse Event|2|||
30620559|NCT01011309|58631862|FG001|Overall Study|Adverse Event|1|||
30708165|NCT00509145|58721798|FG001|Overall Study|Other|6|||
30708166|NCT00509067|58721806|FG000|Overall Study|Lost to Follow-up|1|||
30708167|NCT00509067|58721807|FG001|Overall Study|Lost to Follow-up|1|||
30708168|NCT00509067|58721806|FG000|Overall Study|Adverse Event|3|||
30708169|NCT00509067|58721807|FG001|Overall Study|Adverse Event|1|||
30708170|NCT00509067|58721806|FG000|Overall Study|Protocol Violation|0|||
30708171|NCT00509067|58721807|FG001|Overall Study|Protocol Violation|3|||
30708172|NCT00504309|58721823|FG000|Overall Study|Death|0|||
30708173|NCT00504309|58721824|FG001|Overall Study|Death|0|||
30708174|NCT00504309|58721825|FG002|Overall Study|Death|0|||
30708175|NCT00504309|58721826|FG003|Overall Study|Death|0|||
30708176|NCT00504309|58721827|FG004|Overall Study|Death|1|||
30708177|NCT00504309|58721828|FG005|Overall Study|Death|0|||
30708178|NCT00504309|58721823|FG000|Overall Study|Withdrawal by Subject|0|||
30708179|NCT00504309|58721824|FG001|Overall Study|Withdrawal by Subject|0|||
30708180|NCT00504309|58721825|FG002|Overall Study|Withdrawal by Subject|1|||
30708181|NCT00504309|58721826|FG003|Overall Study|Withdrawal by Subject|0|||
30708182|NCT00504309|58721827|FG004|Overall Study|Withdrawal by Subject|0|||
30708183|NCT00504309|58721828|FG005|Overall Study|Withdrawal by Subject|0|||
30708184|NCT00508755|58721840|FG000|Overall Study|Withdrawal by Subject|1|||
30708185|NCT00504231|58721850|FG000|Overall Study|Discrepant chart documentation re route|0|||
30708186|NCT00504231|58721851|FG001|Overall Study|Discrepant chart documentation re route|0|||
30708187|NCT00504231|58721852|FG002|Overall Study|Discrepant chart documentation re route|1|||
30708188|NCT00504231|58721853|FG003|Overall Study|Discrepant chart documentation re route|0|||
30708189|NCT00568178|58721905|FG000|Double Blind Base Study|Adverse Event|0|||
30708190|NCT00568178|58721906|FG001|Double Blind Base Study|Adverse Event|2|||
30708191|NCT00568178|58721907|FG002|Double Blind Base Study|Adverse Event|1|||
30708192|NCT00568178|58721908|FG003|Double Blind Base Study|Adverse Event|2|||
30708193|NCT00568178|58721909|FG004|Double Blind Base Study|Adverse Event|0|||
30708194|NCT00568178|58721910|FG005|Double Blind Base Study|Adverse Event|0|||
30708195|NCT00568178|58721905|FG000|Double Blind Base Study|Lost to Follow-up|1|||
30708196|NCT00568178|58721906|FG001|Double Blind Base Study|Lost to Follow-up|0|||
30708197|NCT00568178|58721907|FG002|Double Blind Base Study|Lost to Follow-up|0|||
30894373|NCT01657019|58927742|FG000|Overall Study|Withdrawal by Subject|65|||
30894374|NCT01657019|58927742|FG000|Overall Study|Adverse Event|55|||
30894375|NCT01657019|58927742|FG000|Overall Study|Lost to Follow-up|48|||
30894376|NCT01657019|58927742|FG000|Overall Study|Protocol Violation|6|||
30894377|NCT01657019|58927742|FG000|Overall Study|Lack of Efficacy|3|||
30894378|NCT01657019|58927742|FG000|Overall Study|Other|58|||
30894379|NCT02329327|58927748|FG000|Overall Study|Death|78|||
30894380|NCT02329327|58927749|FG001|Overall Study|Death|0|||
30894381|NCT02329327|58927748|FG000|Overall Study|Withdrawal by Subject|3|||
30894382|NCT02329327|58927749|FG001|Overall Study|Withdrawal by Subject|0|||
30894383|NCT02329327|58927748|FG000|Overall Study|Lost to Follow-up|4|||
30894384|NCT02329327|58927749|FG001|Overall Study|Lost to Follow-up|0|||
30894385|NCT02328937|58927768|FG000|Period 1|Lost to Follow-up|0|||
30894386|NCT02328937|58927769|FG001|Period 1|Lost to Follow-up|0|||
30894387|NCT02328937|58927770|FG002|Period 1|Lost to Follow-up|0|||
30894388|NCT02328937|58927771|FG003|Period 1|Lost to Follow-up|1|||
30894389|NCT02328937|58927772|FG004|Period 1|Lost to Follow-up|0|||
30894390|NCT02328937|58927773|FG005|Period 1|Lost to Follow-up|0|||
30894391|NCT02328937|58927768|FG000|Period 2|Adverse Event|0|||
30894392|NCT02328937|58927769|FG001|Period 2|Adverse Event|0|||
30894393|NCT02328937|58927770|FG002|Period 2|Adverse Event|1|||
30620560|NCT01011309|58631863|FG002|Overall Study|Adverse Event|2|||
30620561|NCT01011309|58631861|FG000|Overall Study|Lack of Efficacy|0|||
30620562|NCT01011309|58631862|FG001|Overall Study|Lack of Efficacy|1|||
30620563|NCT01011309|58631863|FG002|Overall Study|Lack of Efficacy|0|||
30620564|NCT01011309|58631861|FG000|Overall Study|Protocol Violation|0|||
30620565|NCT01011309|58631862|FG001|Overall Study|Protocol Violation|1|||
30620566|NCT01011309|58631863|FG002|Overall Study|Protocol Violation|3|||
30620567|NCT01011153|58631874|FG000|Overall Study|Less than 78 cases completed|8|||
30620568|NCT01011153|58631875|FG001|Overall Study|Less than 78 cases completed|11|||
30620569|NCT01011153|58631876|FG002|Overall Study|Less than 78 cases completed|9|||
30620570|NCT00997893|58631908|FG000|Overall Study|Adverse Event|1|||
30620571|NCT00997893|58631909|FG001|Overall Study|Adverse Event|0|||
30620572|NCT00997893|58631910|FG002|Overall Study|Adverse Event|0|||
30894394|NCT02328937|58927771|FG003|Period 2|Adverse Event|0|||
30708198|NCT00568178|58721908|FG003|Double Blind Base Study|Lost to Follow-up|1|||
30708199|NCT00568178|58721909|FG004|Double Blind Base Study|Lost to Follow-up|0|||
30708200|NCT00568178|58721910|FG005|Double Blind Base Study|Lost to Follow-up|0|||
30708201|NCT00568178|58721905|FG000|Double Blind Base Study|Physician Decision|1|||
30708202|NCT00568178|58721906|FG001|Double Blind Base Study|Physician Decision|1|||
30894395|NCT02328937|58927772|FG004|Period 2|Adverse Event|0|||
30894396|NCT02328937|58927773|FG005|Period 2|Adverse Event|0|||
30894397|NCT02328547|58927783|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
30894398|NCT02328547|58927784|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
30894399|NCT02328547|58927783|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
30894400|NCT02328547|58927784|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
30894401|NCT02300311|58927798|FG000|Overall Study|Other than the reason specified|1|||
30894402|NCT02300311|58927799|FG001|Overall Study|Other than the reason specified|0|||
30894403|NCT02300311|58927798|FG000|Overall Study|Refused to continue taking medication|18|||
30894404|NCT02300311|58927799|FG001|Overall Study|Refused to continue taking medication|0|||
30894405|NCT02300233|58927808|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
30894406|NCT02300233|58927809|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
30894407|NCT02300233|58927810|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
30894408|NCT02300233|58927808|FG000|Overall Study|Withdrawal by Subject|1|||
30894409|NCT02300233|58927809|FG001|Overall Study|Withdrawal by Subject|0|||
30894410|NCT02300233|58927810|FG002|Overall Study|Withdrawal by Subject|3|||
30894411|NCT02300233|58927808|FG000|Overall Study|Investigator Judgement|0|||
30894412|NCT02300233|58927809|FG001|Overall Study|Investigator Judgement|0|||
30894413|NCT02300233|58927810|FG002|Overall Study|Investigator Judgement|1|||
30894414|NCT02300233|58927808|FG000|Overall Study|Reason Not Specified|0|||
30894415|NCT02300233|58927809|FG001|Overall Study|Reason Not Specified|0|||
30894416|NCT02300233|58927810|FG002|Overall Study|Reason Not Specified|5|||
30894417|NCT02175225|58927821|FG000|Overall Study|Withdrawal by Subject|1|||
30894418|NCT02175225|58927822|FG001|Overall Study|Withdrawal by Subject|2|||
30894419|NCT02175225|58927821|FG000|Overall Study|Lost to Follow-up|6|||
30894420|NCT02175225|58927822|FG001|Overall Study|Lost to Follow-up|7|||
30894421|NCT02175225|58927821|FG000|Overall Study|Study drug not administered|1|||
30894422|NCT02175225|58927822|FG001|Overall Study|Study drug not administered|2|||
30708203|NCT00568178|58721907|FG002|Double Blind Base Study|Physician Decision|0|||
30708204|NCT00568178|58721908|FG003|Double Blind Base Study|Physician Decision|1|||
30708205|NCT00568178|58721909|FG004|Double Blind Base Study|Physician Decision|0|||
30708206|NCT00568178|58721910|FG005|Double Blind Base Study|Physician Decision|0|||
30708207|NCT00568178|58721905|FG000|Double Blind Base Study|Protocol Violation|3|||
30708208|NCT00568178|58721906|FG001|Double Blind Base Study|Protocol Violation|2|||
30894423|NCT02299375|58927830|FG000|Overall Study|Adverse Event, serious fatal|1|||
30894424|NCT02299375|58927831|FG001|Overall Study|Adverse Event, serious fatal|3|||
30894425|NCT02299375|58927830|FG000|Overall Study|Adverse Event, non-fatal|8|||
30894426|NCT02299375|58927831|FG001|Overall Study|Adverse Event, non-fatal|9|||
30894427|NCT02299375|58927830|FG000|Overall Study|Lack of Efficacy|1|||
30894428|NCT02299375|58927831|FG001|Overall Study|Lack of Efficacy|3|||
30894429|NCT02299375|58927830|FG000|Overall Study|Protocol Violation|1|||
30894430|NCT02299375|58927831|FG001|Overall Study|Protocol Violation|3|||
30894431|NCT02299375|58927830|FG000|Overall Study|Other: Met stopping criteria|1|||
30894432|NCT02299375|58927831|FG001|Overall Study|Other: Met stopping criteria|0|||
30894433|NCT02299375|58927830|FG000|Overall Study|Other: Study closed/terminated|66|||
30620573|NCT00997893|58631908|FG000|Overall Study|Unable to meet study timelines|1|||
30620574|NCT00997893|58631909|FG001|Overall Study|Unable to meet study timelines|0|||
30620575|NCT00997893|58631910|FG002|Overall Study|Unable to meet study timelines|0|||
30620576|NCT00997893|58631908|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
30620577|NCT00997893|58631909|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
30620578|NCT00997893|58631910|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
30620579|NCT02905825|58631927|FG000|Overall Study|Protocol Violation|11|||
30620580|NCT02905825|58631927|FG000|Overall Study|Device Malfunction|1|||
30620581|NCT01208051|58631936|FG000|Total Enrollment|Withdrawal by Subject|0|||
30620582|NCT01208051|58631937|FG001|Total Enrollment|Withdrawal by Subject|1|||
30620583|NCT01208051|58631938|FG002|Total Enrollment|Withdrawal by Subject|0|||
30708209|NCT00568178|58721907|FG002|Double Blind Base Study|Protocol Violation|0|||
30708210|NCT00568178|58721908|FG003|Double Blind Base Study|Protocol Violation|0|||
30708211|NCT00568178|58721909|FG004|Double Blind Base Study|Protocol Violation|0|||
30708212|NCT00568178|58721910|FG005|Double Blind Base Study|Protocol Violation|0|||
30894434|NCT02299375|58927831|FG001|Overall Study|Other: Study closed/terminated|55|||
30894435|NCT02299375|58927830|FG000|Overall Study|Lost to Follow-up|0|||
30894436|NCT02299375|58927831|FG001|Overall Study|Lost to Follow-up|2|||
30894437|NCT02299375|58927830|FG000|Overall Study|Physician Decision|1|||
30894438|NCT02299375|58927831|FG001|Overall Study|Physician Decision|1|||
30708213|NCT00568178|58721905|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
30708214|NCT00568178|58721906|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
30708215|NCT00568178|58721907|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
30708216|NCT00568178|58721908|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
30708217|NCT00568178|58721909|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
30708218|NCT00568178|58721910|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
30708219|NCT00568178|58721905|FG000|Double Blind Base Study|Progressive Disease|0|||
30708220|NCT00568178|58721906|FG001|Double Blind Base Study|Progressive Disease|0|||
30708221|NCT00568178|58721907|FG002|Double Blind Base Study|Progressive Disease|0|||
30708222|NCT00568178|58721908|FG003|Double Blind Base Study|Progressive Disease|1|||
30708223|NCT00568178|58721909|FG004|Double Blind Base Study|Progressive Disease|0|||
30708224|NCT00568178|58721910|FG005|Double Blind Base Study|Progressive Disease|0|||
30708225|NCT00568178|58721905|FG000|Open Label Extension|Adverse Event|0|||
30708226|NCT00568178|58721906|FG001|Open Label Extension|Adverse Event|0|||
30708227|NCT00568178|58721907|FG002|Open Label Extension|Adverse Event|0|||
30708228|NCT00568178|58721908|FG003|Open Label Extension|Adverse Event|0|||
30708229|NCT00568178|58721909|FG004|Open Label Extension|Adverse Event|11|||
30708230|NCT00568178|58721910|FG005|Open Label Extension|Adverse Event|8|||
30708231|NCT00568178|58721905|FG000|Open Label Extension|Protocol Violation|0|||
30708232|NCT00568178|58721906|FG001|Open Label Extension|Protocol Violation|0|||
30708233|NCT00568178|58721907|FG002|Open Label Extension|Protocol Violation|0|||
30708234|NCT00568178|58721908|FG003|Open Label Extension|Protocol Violation|0|||
30708235|NCT00568178|58721909|FG004|Open Label Extension|Protocol Violation|1|||
30708236|NCT00568178|58721910|FG005|Open Label Extension|Protocol Violation|0|||
30708237|NCT00568178|58721905|FG000|Open Label Extension|Lost to Follow-up|0|||
30708238|NCT00568178|58721906|FG001|Open Label Extension|Lost to Follow-up|0|||
30708239|NCT00568178|58721907|FG002|Open Label Extension|Lost to Follow-up|0|||
30708240|NCT00568178|58721908|FG003|Open Label Extension|Lost to Follow-up|0|||
30708241|NCT00568178|58721909|FG004|Open Label Extension|Lost to Follow-up|6|||
30708242|NCT00568178|58721910|FG005|Open Label Extension|Lost to Follow-up|11|||
30708243|NCT00568178|58721905|FG000|Open Label Extension|Physician Decision|0|||
30708244|NCT00568178|58721906|FG001|Open Label Extension|Physician Decision|0|||
30708245|NCT00568178|58721907|FG002|Open Label Extension|Physician Decision|0|||
30708246|NCT00568178|58721908|FG003|Open Label Extension|Physician Decision|0|||
30708247|NCT00568178|58721909|FG004|Open Label Extension|Physician Decision|9|||
30708248|NCT00568178|58721910|FG005|Open Label Extension|Physician Decision|8|||
30708249|NCT00568178|58721905|FG000|Open Label Extension|Pregnancy|0|||
30708250|NCT00568178|58721906|FG001|Open Label Extension|Pregnancy|0|||
30708251|NCT00568178|58721907|FG002|Open Label Extension|Pregnancy|0|||
30708252|NCT00568178|58721908|FG003|Open Label Extension|Pregnancy|0|||
30708253|NCT00568178|58721909|FG004|Open Label Extension|Pregnancy|0|||
30708254|NCT00568178|58721910|FG005|Open Label Extension|Pregnancy|1|||
30708255|NCT00568178|58721905|FG000|Open Label Extension|Progressive Disease|0|||
30708256|NCT00568178|58721906|FG001|Open Label Extension|Progressive Disease|0|||
30708257|NCT00568178|58721907|FG002|Open Label Extension|Progressive Disease|0|||
30708258|NCT00568178|58721908|FG003|Open Label Extension|Progressive Disease|0|||
30708259|NCT00568178|58721909|FG004|Open Label Extension|Progressive Disease|3|||
30708260|NCT00568178|58721910|FG005|Open Label Extension|Progressive Disease|1|||
30708261|NCT00568178|58721905|FG000|Open Label Extension|Termination of Trial|0|||
30708262|NCT00568178|58721906|FG001|Open Label Extension|Termination of Trial|0|||
30708263|NCT00568178|58721907|FG002|Open Label Extension|Termination of Trial|0|||
30708264|NCT00568178|58721908|FG003|Open Label Extension|Termination of Trial|0|||
30708265|NCT00568178|58721909|FG004|Open Label Extension|Termination of Trial|45|||
30708266|NCT00568178|58721910|FG005|Open Label Extension|Termination of Trial|47|||
30708267|NCT00568178|58721905|FG000|Open Label Extension|Withdrawal by Subject|0|||
30708268|NCT00568178|58721906|FG001|Open Label Extension|Withdrawal by Subject|0|||
30708269|NCT00568178|58721907|FG002|Open Label Extension|Withdrawal by Subject|0|||
30708270|NCT00568178|58721908|FG003|Open Label Extension|Withdrawal by Subject|0|||
30708271|NCT00568178|58721909|FG004|Open Label Extension|Withdrawal by Subject|4|||
30708272|NCT00568178|58721910|FG005|Open Label Extension|Withdrawal by Subject|4|||
30708273|NCT00577889|58721927|FG000|Overall Study|Withdrawal by Subject|1|||
30708274|NCT00577889|58721928|FG001|Overall Study|Withdrawal by Subject|0|||
30708275|NCT00577889|58721929|FG002|Overall Study|Withdrawal by Subject|0|||
30708276|NCT00460564|58721941|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
30708277|NCT00460564|58721942|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
30708278|NCT00460564|58721943|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
30708279|NCT00460564|58721944|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
30708280|NCT00460564|58721945|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
30708281|NCT00460564|58721946|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
30894439|NCT02299375|58927830|FG000|Overall Study|Withdrawal by Subject|1|||
30894440|NCT02299375|58927831|FG001|Overall Study|Withdrawal by Subject|4|||
30894441|NCT02151903|58927840|FG000|Overall Study|Withdrawal by Subject|1|||
30894442|NCT02151903|58927841|FG001|Overall Study|Withdrawal by Subject|0|||
30894443|NCT02151903|58927840|FG000|Overall Study|Progressive disease|2|||
30894444|NCT02151903|58927841|FG001|Overall Study|Progressive disease|1|||
30708282|NCT00460564|58721947|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
30708283|NCT00460564|58721948|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
30708284|NCT00460564|58721941|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
30708285|NCT00460564|58721942|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
30708286|NCT00460564|58721943|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
30708287|NCT00460564|58721944|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
30708288|NCT00460564|58721945|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
30708289|NCT00460564|58721946|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
30708290|NCT00460564|58721947|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
30708291|NCT00460564|58721948|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
30708292|NCT00460564|58721941|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
30708293|NCT00460564|58721942|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
30708294|NCT00460564|58721943|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
30708295|NCT00460564|58721944|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
30708296|NCT00460564|58721945|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
30708297|NCT00460564|58721946|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
30708298|NCT00460564|58721947|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
30708299|NCT00460564|58721948|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
30708300|NCT00460564|58721941|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
30708301|NCT00460564|58721942|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
30708302|NCT00460564|58721943|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
30708303|NCT00460564|58721944|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
30708304|NCT00460564|58721945|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
30708305|NCT00460564|58721946|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
30708306|NCT00460564|58721947|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
30708307|NCT00460564|58721948|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
30708308|NCT00460564|58721941|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
30708309|NCT00460564|58721942|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
30708310|NCT00460564|58721943|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
30708311|NCT00460564|58721944|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
30708312|NCT00460564|58721945|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
30708313|NCT00460564|58721946|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
30708314|NCT00460564|58721947|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
30708315|NCT00460564|58721948|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
30708316|NCT00567476|58721970|FG000|Overall Study|Adverse Event|2|||
30708317|NCT00567476|58721971|FG001|Overall Study|Adverse Event|0|||
30708318|NCT00567476|58721970|FG000|Overall Study|Pregnancy|1|||
30708319|NCT00567476|58721971|FG001|Overall Study|Pregnancy|0|||
30708320|NCT00567476|58721970|FG000|Overall Study|Protocol Violation|4|||
30708321|NCT00567476|58721971|FG001|Overall Study|Protocol Violation|1|||
30708322|NCT00567476|58721970|FG000|Overall Study|Lost to Follow-up|0|||
30708323|NCT00567476|58721971|FG001|Overall Study|Lost to Follow-up|1|||
30708324|NCT00567476|58721970|FG000|Overall Study|Administrative issues|1|||
30708325|NCT00567476|58721971|FG001|Overall Study|Administrative issues|0|||
30708326|NCT00567476|58721970|FG000|Overall Study|Medical Decision|0|||
30708327|NCT00567476|58721971|FG001|Overall Study|Medical Decision|1|||
30708328|NCT00567476|58721970|FG000|Overall Study|Non-adherence to protocol|0|||
30708329|NCT00567476|58721971|FG001|Overall Study|Non-adherence to protocol|1|||
30708330|NCT00516321|58721979|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
30708331|NCT00516321|58721980|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
30708332|NCT00516321|58721981|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
30708333|NCT00516321|58721979|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
30708334|NCT00516321|58721980|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
30708335|NCT00516321|58721981|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
30708336|NCT00516321|58721979|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
30708337|NCT00516321|58721980|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
30708338|NCT00516321|58721981|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
30708339|NCT00516321|58721979|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
30894445|NCT02151591|58927849|FG000|Overall Study|Lost to Follow-up|6|||
30894446|NCT02151591|58927850|FG001|Overall Study|Lost to Follow-up|3|||
30760607|NCT03264404|58769100|FG000|Overall Study|Disease Progression|28|||
30894447|NCT02174523|58927858|FG000|Overall Study|Withdrawal by Subject|1|||
30894448|NCT02174523|58927859|FG001|Overall Study|Withdrawal by Subject|0|||
30894449|NCT02297815|58927866|FG000|Overall Study|Lost to Follow-up|236|||
30708340|NCT00516321|58721980|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
30708341|NCT00516321|58721981|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
30708342|NCT00516321|58721979|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
30708343|NCT00516321|58721980|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
30620584|NCT01208051|58631939|FG003|Total Enrollment|Withdrawal by Subject|0|||
30620585|NCT01208051|58631940|FG004|Total Enrollment|Withdrawal by Subject|2|||
30620586|NCT01208051|58631936|FG000|Total Enrollment|Brain metastases|0|||
30620587|NCT01208051|58631937|FG001|Total Enrollment|Brain metastases|0|||
30620588|NCT01208051|58631938|FG002|Total Enrollment|Brain metastases|1|||
30620589|NCT01208051|58631939|FG003|Total Enrollment|Brain metastases|0|||
30708344|NCT00516321|58721981|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
30708345|NCT00516321|58721979|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
30708346|NCT00516321|58721980|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
30708347|NCT00516321|58721981|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
30708348|NCT00516321|58721979|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
30708349|NCT00516321|58721980|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
30708350|NCT00516321|58721981|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
30708351|NCT00516321|58721979|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
30708352|NCT00516321|58721980|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
30708353|NCT00516321|58721981|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
30708354|NCT00516321|58721979|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
30708355|NCT00516321|58721980|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
30708356|NCT00516321|58721981|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
30708357|NCT00516321|58721979|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
30708358|NCT00516321|58721980|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
30708359|NCT00516321|58721981|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
30708360|NCT00516321|58721979|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
30708361|NCT00516321|58721980|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
30708362|NCT00516321|58721981|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
30708363|NCT00460408|58721993|FG000|Overall Study|Adverse Event|1|||
30708364|NCT00460408|58721994|FG001|Overall Study|Adverse Event|0|||
30708365|NCT00460408|58721995|FG002|Overall Study|Adverse Event|0|||
30708366|NCT00460408|58721996|FG003|Overall Study|Adverse Event|0|||
30708367|NCT00460408|58721993|FG000|Overall Study|Death|7|||
30708368|NCT00460408|58721994|FG001|Overall Study|Death|0|||
30708369|NCT00460408|58721995|FG002|Overall Study|Death|0|||
30708370|NCT00460408|58721996|FG003|Overall Study|Death|0|||
30708371|NCT00460408|58721993|FG000|Overall Study|Lost to Follow-up|11|||
30708372|NCT00460408|58721994|FG001|Overall Study|Lost to Follow-up|0|||
30708373|NCT00460408|58721995|FG002|Overall Study|Lost to Follow-up|1|||
30708374|NCT00460408|58721996|FG003|Overall Study|Lost to Follow-up|0|||
30708375|NCT00460408|58721993|FG000|Overall Study|Withdrawal by Subject|31|||
30708376|NCT00460408|58721994|FG001|Overall Study|Withdrawal by Subject|0|||
30708377|NCT00460408|58721995|FG002|Overall Study|Withdrawal by Subject|0|||
30708378|NCT00460408|58721996|FG003|Overall Study|Withdrawal by Subject|0|||
30708379|NCT00460408|58721993|FG000|Overall Study|Insufficient clinical response|5|||
30708380|NCT00460408|58721994|FG001|Overall Study|Insufficient clinical response|1|||
30708381|NCT00460408|58721995|FG002|Overall Study|Insufficient clinical response|5|||
30708382|NCT00460408|58721996|FG003|Overall Study|Insufficient clinical response|0|||
30708383|NCT00460408|58721993|FG000|Overall Study|Other|12|||
30708384|NCT00460408|58721994|FG001|Overall Study|Other|2|||
30708385|NCT00460408|58721995|FG002|Overall Study|Other|0|||
30708386|NCT00460408|58721996|FG003|Overall Study|Other|0|||
30708387|NCT00507819|58722006|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
30708388|NCT00507819|58722007|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
30708389|NCT00442936|58722037|FG000|Overall Study|Protocol Violation|1|||
30708390|NCT00442936|58722038|FG001|Overall Study|Protocol Violation|0|||
30708391|NCT00442936|58722039|FG002|Overall Study|Protocol Violation|1|||
30708392|NCT00442936|58722040|FG003|Overall Study|Protocol Violation|1|||
30620590|NCT01208051|58631940|FG004|Total Enrollment|Brain metastases|0|||
30620591|NCT01207583|58631959|FG000|Overall Study|Withdrawal by Subject|0|||
30620592|NCT01207583|58631960|FG001|Overall Study|Withdrawal by Subject|3|||
30708393|NCT00577655|58722052|FG000|Overall Study|Patient Request|0|||
30708394|NCT00577655|58722053|FG001|Overall Study|Patient Request|2|||
30708395|NCT00577655|58722052|FG000|Overall Study|Protocol Violation|0|||
30708396|NCT00577655|58722053|FG001|Overall Study|Protocol Violation|1|||
30708397|NCT00577655|58722052|FG000|Overall Study|Lost to Follow-up|1|||
30708398|NCT00577655|58722053|FG001|Overall Study|Lost to Follow-up|1|||
30708399|NCT00113269|58722064|FG000|Overall Study|Not transplanted, donor issues|4|||
30708400|NCT00113269|58722065|FG001|Overall Study|Not transplanted, donor issues|0|||
30708401|NCT00113269|58722066|FG002|Overall Study|Not transplanted, donor issues|2|||
30708402|NCT00113269|58722067|FG003|Overall Study|Not transplanted, donor issues|2|||
30708403|NCT00113269|58722064|FG000|Overall Study|Not transplanted, recipient issues|2|||
30894450|NCT02297815|58927867|FG001|Overall Study|Lost to Follow-up|140|||
30894451|NCT02114385|58927877|FG000|Overall Study|Withdrawal by Subject|3|||
30894452|NCT02114385|58927878|FG001|Overall Study|Withdrawal by Subject|2|||
30894453|NCT02114385|58927877|FG000|Overall Study|Lost to Follow-up|0|||
30708404|NCT00113269|58722065|FG001|Overall Study|Not transplanted, recipient issues|1|||
30708405|NCT00113269|58722066|FG002|Overall Study|Not transplanted, recipient issues|7|||
30708406|NCT00113269|58722067|FG003|Overall Study|Not transplanted, recipient issues|4|||
30708407|NCT00113269|58722064|FG000|Overall Study|Early graft loss, technical|0|||
30708408|NCT00113269|58722065|FG001|Overall Study|Early graft loss, technical|0|||
30708409|NCT00113269|58722066|FG002|Overall Study|Early graft loss, technical|2|||
30708410|NCT00113269|58722067|FG003|Overall Study|Early graft loss, technical|0|||
30708411|NCT00113269|58722064|FG000|Overall Study|Death in operating room|0|||
30708412|NCT00113269|58722065|FG001|Overall Study|Death in operating room|0|||
30708413|NCT00113269|58722066|FG002|Overall Study|Death in operating room|0|||
30708414|NCT00113269|58722067|FG003|Overall Study|Death in operating room|1|||
30708415|NCT00113269|58722064|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
30708416|NCT00113269|58722065|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
30708417|NCT00113269|58722066|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
30708418|NCT00113269|58722067|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
30708419|NCT00113269|58722064|FG000|Overall Study|Adverse Event|2|||
30708420|NCT00113269|58722065|FG001|Overall Study|Adverse Event|7|||
30708421|NCT00113269|58722066|FG002|Overall Study|Adverse Event|11|||
30708422|NCT00113269|58722067|FG003|Overall Study|Adverse Event|7|||
30708423|NCT00113269|58722064|FG000|Overall Study|Withdrawal by Subject|4|||
30708424|NCT00113269|58722065|FG001|Overall Study|Withdrawal by Subject|3|||
30708425|NCT00113269|58722066|FG002|Overall Study|Withdrawal by Subject|4|||
30708426|NCT00113269|58722067|FG003|Overall Study|Withdrawal by Subject|2|||
30708427|NCT00113269|58722064|FG000|Overall Study|Graft loss|6|||
30708428|NCT00113269|58722065|FG001|Overall Study|Graft loss|6|||
30708429|NCT00113269|58722066|FG002|Overall Study|Graft loss|4|||
30708430|NCT00113269|58722067|FG003|Overall Study|Graft loss|9|||
30708431|NCT00113269|58722064|FG000|Overall Study|Protocol Violation|1|||
30708432|NCT00113269|58722065|FG001|Overall Study|Protocol Violation|0|||
30708433|NCT00113269|58722066|FG002|Overall Study|Protocol Violation|4|||
30708434|NCT00113269|58722067|FG003|Overall Study|Protocol Violation|2|||
30708435|NCT00113269|58722064|FG000|Overall Study|Lost to Follow-up|2|||
30708436|NCT00113269|58722065|FG001|Overall Study|Lost to Follow-up|3|||
30708437|NCT00113269|58722066|FG002|Overall Study|Lost to Follow-up|6|||
30708438|NCT00113269|58722067|FG003|Overall Study|Lost to Follow-up|3|||
30708439|NCT00113269|58722064|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
30708440|NCT00113269|58722065|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
30708441|NCT00113269|58722066|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
30708442|NCT00113269|58722067|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
30708443|NCT00113269|58722064|FG000|Overall Study|Discontinued due to rejection|0|||
30708444|NCT00113269|58722065|FG001|Overall Study|Discontinued due to rejection|0|||
30708445|NCT00113269|58722066|FG002|Overall Study|Discontinued due to rejection|1|||
30708446|NCT00113269|58722067|FG003|Overall Study|Discontinued due to rejection|0|||
30708447|NCT00113269|58722064|FG000|Overall Study|Moved|0|||
30708448|NCT00113269|58722065|FG001|Overall Study|Moved|1|||
30708449|NCT00113269|58722066|FG002|Overall Study|Moved|0|||
30708450|NCT00113269|58722067|FG003|Overall Study|Moved|3|||
30708451|NCT00113269|58722064|FG000|Overall Study|Received pancreas transplant|0|||
30708452|NCT00113269|58722065|FG001|Overall Study|Received pancreas transplant|0|||
30708453|NCT00113269|58722066|FG002|Overall Study|Received pancreas transplant|0|||
30708454|NCT00113269|58722067|FG003|Overall Study|Received pancreas transplant|2|||
30708455|NCT00113269|58722064|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
30708456|NCT00113269|58722065|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
30708457|NCT00113269|58722066|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
30708458|NCT00113269|58722067|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
30894454|NCT02114385|58927878|FG001|Overall Study|Lost to Follow-up|6|||
30894455|NCT02114151|58927884|FG000|Overall Study|Death|1|||
30894456|NCT02114151|58927884|FG000|Overall Study|Lost to Follow-up|1|||
30708459|NCT00113269|58722064|FG000|Overall Study|Did not meet eligibility criteria|1|||
30708460|NCT00113269|58722065|FG001|Overall Study|Did not meet eligibility criteria|0|||
30708461|NCT00113269|58722066|FG002|Overall Study|Did not meet eligibility criteria|0|||
30708462|NCT00113269|58722067|FG003|Overall Study|Did not meet eligibility criteria|1|||
30708463|NCT00113269|58722064|FG000|Overall Study|Unable to return for follow up|2|||
30708464|NCT00113269|58722065|FG001|Overall Study|Unable to return for follow up|1|||
30790869|NCT03524092|58803942|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
30894457|NCT02114151|58927884|FG000|Overall Study|Withdrawal by Subject|5|||
30894458|NCT02297503|58927890|FG000|Overall Study|Withdrawal by Subject|1|||
30894459|NCT02297503|58927891|FG001|Overall Study|Withdrawal by Subject|1|||
30708465|NCT00113269|58722066|FG002|Overall Study|Unable to return for follow up|0|||
30708466|NCT00113269|58722067|FG003|Overall Study|Unable to return for follow up|0|||
30708467|NCT00515619|58722077|FG000|Overall Study|Adverse Event|34|||
30620593|NCT01207583|58631961|FG002|Overall Study|Withdrawal by Subject|1|||
30620594|NCT01207583|58631959|FG000|Overall Study|Participant failed to return|1|||
30620595|NCT01207583|58631960|FG001|Overall Study|Participant failed to return|0|||
30620596|NCT01207583|58631961|FG002|Overall Study|Participant failed to return|0|||
30620597|NCT01207583|58631959|FG000|Overall Study|Lost to Follow-up|0|||
30620598|NCT01207583|58631960|FG001|Overall Study|Lost to Follow-up|2|||
30620599|NCT01207583|58631961|FG002|Overall Study|Lost to Follow-up|0|||
30620600|NCT01207427|58631985|FG000|Double-blind Treatment Period|Adverse Event|0|||
30620601|NCT01207427|58631986|FG001|Double-blind Treatment Period|Adverse Event|1|||
30620602|NCT01207427|58631987|FG002|Double-blind Treatment Period|Adverse Event|0|||
30620603|NCT01207427|58631985|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
30620604|NCT01207427|58631986|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
30620605|NCT01207427|58631987|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
30620606|NCT01207427|58631985|FG000|Double-blind Treatment Period|Protocol Violation|2|||
30620607|NCT01207427|58631986|FG001|Double-blind Treatment Period|Protocol Violation|1|||
30620608|NCT01207427|58631987|FG002|Double-blind Treatment Period|Protocol Violation|1|||
30620609|NCT01207427|58631985|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
30620610|NCT01207427|58631986|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
30620611|NCT01207427|58631987|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
30620612|NCT04713553|58632000|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
30620613|NCT04713553|58632001|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
30620614|NCT04713553|58632002|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
30620615|NCT04713553|58632003|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
30620616|NCT04713553|58632004|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
30620617|NCT04713553|58632005|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
30620618|NCT04713553|58632006|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
30620619|NCT04713553|58632000|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
30620620|NCT04713553|58632001|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
30620621|NCT04713553|58632002|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
30620622|NCT04713553|58632003|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
30620623|NCT04713553|58632004|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
30620624|NCT04713553|58632005|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
30620625|NCT04713553|58632006|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
30620626|NCT04713553|58632000|FG000|Primary Study (2 Months)|Other|1|||
30620627|NCT04713553|58632001|FG001|Primary Study (2 Months)|Other|2|||
30620628|NCT04713553|58632002|FG002|Primary Study (2 Months)|Other|0|||
30620629|NCT04713553|58632003|FG003|Primary Study (2 Months)|Other|0|||
30620630|NCT04713553|58632004|FG004|Primary Study (2 Months)|Other|1|||
30620631|NCT04713553|58632005|FG005|Primary Study (2 Months)|Other|0|||
30620632|NCT04713553|58632006|FG006|Primary Study (2 Months)|Other|0|||
30620633|NCT04713553|58632000|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
30620634|NCT04713553|58632001|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
30620635|NCT04713553|58632002|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
30620636|NCT04713553|58632003|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
30620637|NCT04713553|58632004|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
30620638|NCT04713553|58632005|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
30620639|NCT04713553|58632006|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
30620640|NCT04713553|58632000|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
30620641|NCT04713553|58632001|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
30620642|NCT04713553|58632002|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
30620643|NCT04713553|58632003|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
30620644|NCT04713553|58632004|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
30620645|NCT04713553|58632005|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
30620646|NCT04713553|58632006|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
30620647|NCT01206101|58632029|FG000|Overall Study|Adverse Event|1|||
30620648|NCT01206101|58632030|FG001|Overall Study|Adverse Event|0|||
30620649|NCT01206101|58632029|FG000|Overall Study|Physician Decision|0|||
30620650|NCT01206101|58632030|FG001|Overall Study|Physician Decision|1|||
30620651|NCT01206101|58632029|FG000|Overall Study|Unclassified|1|||
30620652|NCT01206101|58632030|FG001|Overall Study|Unclassified|0|||
30620653|NCT01205165|58632036|FG000|Overall Study|Lost to Follow-up|2|||
30620654|NCT00997503|58632041|FG000|Overall Study|Death|53|||
30620655|NCT00997503|58632041|FG000|Overall Study|Withdrawal by Subject|76|||
30620656|NCT00997503|58632041|FG000|Overall Study|Lost to Follow-up|33|||
30620657|NCT00997503|58632041|FG000|Overall Study|Adverse Event|3|||
30620658|NCT00997503|58632041|FG000|Overall Study|Physician Decision|10|||
30620659|NCT00997503|58632041|FG000|Overall Study|Missed 12-month follow-up|85|||
30620660|NCT00997503|58632041|FG000|Overall Study|Other reason|13|||
30620661|NCT01204775|58632050|FG000|Overall Study|Poor/non-compliance|0|||
30708468|NCT00515619|58722077|FG000|Overall Study|Lack of Efficacy|92|||
30708469|NCT00515619|58722077|FG000|Overall Study|Withdrawal by Subject|66|||
30708470|NCT00515619|58722077|FG000|Overall Study|Protocol Violation|3|||
30708471|NCT00515619|58722077|FG000|Overall Study|Lost to Follow-up|4|||
30708472|NCT00515619|58722077|FG000|Overall Study|Unsatisfactory compliance|6|||
30708473|NCT00515619|58722077|FG000|Overall Study|Other: Site discontinuing trials|2|||
30708474|NCT00515619|58722077|FG000|Overall Study|Other: Subject cannot attend visits|2|||
30708475|NCT00515619|58722077|FG000|Overall Study|Other: Subject required surgery|1|||
30708476|NCT00515619|58722077|FG000|Overall Study|Other: Subject moved to another country|1|||
30708477|NCT00515619|58722077|FG000|Overall Study|Other: Investigator decision|1|||
30708478|NCT00515619|58722077|FG000|Overall Study|Other: Subject became pregnant|1|||
30708479|NCT00515619|58722077|FG000|Overall Study|Other: Request from sponsor|1|||
30708480|NCT00515619|58722077|FG000|Overall Study|Other: Drug available on license|1|||
30708481|NCT00515619|58722077|FG000|Overall Study|Other: Subject interested in other AED|1|||
30708482|NCT00449644|58722085|FG000|Overall Study|Adverse Event|0|||
30708483|NCT00449644|58722086|FG001|Overall Study|Adverse Event|0|||
30708484|NCT00449644|58722087|FG002|Overall Study|Adverse Event|3|||
30708485|NCT00449644|58722088|FG003|Overall Study|Adverse Event|5|||
30708486|NCT00449644|58722085|FG000|Overall Study|Death|1|||
30708487|NCT00449644|58722086|FG001|Overall Study|Death|0|||
30708488|NCT00449644|58722087|FG002|Overall Study|Death|6|||
30708489|NCT00449644|58722088|FG003|Overall Study|Death|1|||
30708490|NCT00449644|58722085|FG000|Overall Study|Lost to Follow-up|1|||
30708491|NCT00449644|58722086|FG001|Overall Study|Lost to Follow-up|1|||
30708492|NCT00449644|58722087|FG002|Overall Study|Lost to Follow-up|5|||
30708493|NCT00449644|58722088|FG003|Overall Study|Lost to Follow-up|3|||
30708494|NCT00449644|58722085|FG000|Overall Study|Pregnancy|0|||
30708495|NCT00449644|58722086|FG001|Overall Study|Pregnancy|0|||
30708496|NCT00449644|58722087|FG002|Overall Study|Pregnancy|3|||
30708497|NCT00449644|58722088|FG003|Overall Study|Pregnancy|2|||
30708498|NCT00449644|58722085|FG000|Overall Study|Protocol Violation|4|||
30708499|NCT00449644|58722086|FG001|Overall Study|Protocol Violation|4|||
30708500|NCT00449644|58722087|FG002|Overall Study|Protocol Violation|3|||
30708501|NCT00449644|58722088|FG003|Overall Study|Protocol Violation|7|||
30708502|NCT00449644|58722085|FG000|Overall Study|Withdrawal by Subject|3|||
30708503|NCT00449644|58722086|FG001|Overall Study|Withdrawal by Subject|4|||
30708504|NCT00449644|58722087|FG002|Overall Study|Withdrawal by Subject|6|||
30708505|NCT00449644|58722088|FG003|Overall Study|Withdrawal by Subject|7|||
30708506|NCT00449644|58722085|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
30708507|NCT00449644|58722086|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
30708508|NCT00449644|58722087|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
30708509|NCT00449644|58722088|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
30894460|NCT02297503|58927890|FG000|Overall Study|Protocol Violation|1|||
30894461|NCT02297503|58927891|FG001|Overall Study|Protocol Violation|0|||
30894462|NCT02297503|58927890|FG000|Overall Study|Pregnancy|0|||
30708510|NCT00449644|58722085|FG000|Overall Study|Other|1|||
30708511|NCT00449644|58722086|FG001|Overall Study|Other|4|||
30708512|NCT00449644|58722087|FG002|Overall Study|Other|1|||
30894463|NCT02297503|58927891|FG001|Overall Study|Pregnancy|1|||
30894464|NCT02297503|58927890|FG000|Overall Study|Lost to Follow-up|0|||
30894465|NCT02297503|58927891|FG001|Overall Study|Lost to Follow-up|1|||
30894466|NCT02297503|58927890|FG000|Overall Study|Medical reason|0|||
30894467|NCT02297503|58927891|FG001|Overall Study|Medical reason|1|||
30894468|NCT02113449|58927906|FG000|Overall Study|Adverse Event|4|||
30894469|NCT02366923|58927914|FG000|Overall Study|Withdrawal by Subject|1|||
30894470|NCT02366923|58927914|FG000|Overall Study|Positive Slit Lamp Findings|2|||
30894471|NCT02366923|58927914|FG000|Overall Study|High Astigmatism|3|||
30894472|NCT02326597|58927921|FG000|Overall Study|Lost to Follow-up|42|||
30894473|NCT02326597|58927922|FG001|Overall Study|Lost to Follow-up|32|||
30894474|NCT02366767|58927932|FG000|Overall Study|left for home after 1 day at camp|1|||
30894475|NCT02366767|58927933|FG001|Overall Study|left for home after 1 day at camp|0|||
30894476|NCT02150343|58927943|FG000|Overall Study|Adverse Event|2|||
30894477|NCT02150343|58927944|FG001|Overall Study|Adverse Event|0|||
30894478|NCT02150343|58927945|FG002|Overall Study|Adverse Event|1|||
30894479|NCT02150343|58927946|FG003|Overall Study|Adverse Event|1|||
30708513|NCT00449644|58722088|FG003|Overall Study|Other|0|||
30708514|NCT00449644|58722085|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
30708515|NCT00449644|58722086|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
30894480|NCT02150343|58927943|FG000|Overall Study|Withdrawal by Subject|13|||
30894481|NCT02150343|58927944|FG001|Overall Study|Withdrawal by Subject|10|||
30894482|NCT02150343|58927945|FG002|Overall Study|Withdrawal by Subject|9|||
30894483|NCT02150343|58927946|FG003|Overall Study|Withdrawal by Subject|4|||
30708516|NCT00449644|58722087|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
30708517|NCT00449644|58722088|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
30894484|NCT02150343|58927943|FG000|Overall Study|Lost to Follow-up|4|||
30708518|NCT00515541|58722105|FG000|Overall Study|Physician Decision|0|||
30708519|NCT00515541|58722106|FG001|Overall Study|Physician Decision|2|||
30708520|NCT00515541|58722107|FG002|Overall Study|Physician Decision|0|||
30708521|NCT00515541|58722108|FG003|Overall Study|Physician Decision|1|||
30708522|NCT00515541|58722105|FG000|Overall Study|No show for appointments|0|||
30708523|NCT00515541|58722106|FG001|Overall Study|No show for appointments|1|||
30708524|NCT00515541|58722107|FG002|Overall Study|No show for appointments|0|||
30708525|NCT00515541|58722108|FG003|Overall Study|No show for appointments|2|||
30708526|NCT00515541|58722105|FG000|Overall Study|Withdrawal by Subject|0|||
30708527|NCT00515541|58722106|FG001|Overall Study|Withdrawal by Subject|2|||
30708528|NCT00515541|58722107|FG002|Overall Study|Withdrawal by Subject|0|||
30708529|NCT00515541|58722108|FG003|Overall Study|Withdrawal by Subject|2|||
30708530|NCT00112489|58722118|FG000|Overall Study|Refused further treatment|8|||
30708531|NCT00112489|58722118|FG000|Overall Study|Adverse Event|12|||
30708532|NCT00112489|58722118|FG000|Overall Study|Death|2|||
30708533|NCT00112489|58722118|FG000|Overall Study|Other, Not Specified|9|||
30708534|NCT00112489|58722118|FG000|Overall Study|Patient never treated|2|||
30708535|NCT00112489|58722118|FG000|Overall Study|Ineligible|7|||
30708536|NCT00711971|58722131|FG000|Overall Study|Lost to Follow-up|3|||
30708537|NCT00711971|58722132|FG001|Overall Study|Lost to Follow-up|4|||
30708538|NCT00711971|58722133|FG002|Overall Study|Lost to Follow-up|1|||
30708539|NCT00515463|58722147|FG000|Overall Study|Physician Decision|4|||
30708540|NCT00515463|58722148|FG001|Overall Study|Physician Decision|2|||
30708541|NCT00515463|58722147|FG000|Overall Study|Adverse Event|1|||
30708542|NCT00515463|58722148|FG001|Overall Study|Adverse Event|2|||
30708543|NCT00515463|58722147|FG000|Overall Study|Withdrawal by Subject|3|||
30708544|NCT00515463|58722148|FG001|Overall Study|Withdrawal by Subject|4|||
30708545|NCT00515463|58722147|FG000|Overall Study|Lost to Follow-up|6|||
30708546|NCT00515463|58722148|FG001|Overall Study|Lost to Follow-up|5|||
30708547|NCT00515463|58722147|FG000|Overall Study|Other|0|||
30708548|NCT00515463|58722148|FG001|Overall Study|Other|1|||
30708549|NCT00507507|58722157|FG000|Treatment Period|Lost to Follow-up|0|||
30708550|NCT00507507|58722158|FG001|Treatment Period|Lost to Follow-up|2|||
30708551|NCT00507507|58722157|FG000|Treatment Period|Physician Decision|4|||
30708552|NCT00507507|58722158|FG001|Treatment Period|Physician Decision|1|||
30708553|NCT00507507|58722157|FG000|Treatment Period|Protocol Violation|1|||
30708554|NCT00507507|58722158|FG001|Treatment Period|Protocol Violation|2|||
30708555|NCT00507507|58722157|FG000|Treatment Period|Adverse Event|1|||
30708556|NCT00507507|58722158|FG001|Treatment Period|Adverse Event|1|||
30894485|NCT02150343|58927944|FG001|Overall Study|Lost to Follow-up|4|||
30620662|NCT01204775|58632051|FG001|Overall Study|Poor/non-compliance|1|||
30620663|NCT01204775|58632050|FG000|Overall Study|Withdrawal by Subject|1|||
30620664|NCT01204775|58632051|FG001|Overall Study|Withdrawal by Subject|0|||
30620665|NCT00997035|58632059|FG000|3-week Followup Visit|Lost to Follow-up|9|||
30620666|NCT00997035|58632060|FG001|3-week Followup Visit|Lost to Follow-up|6|||
30620667|NCT00997035|58632059|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
30620668|NCT00997035|58632060|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
30620669|NCT01204697|58632078|FG000|Overall Study|Death|26|||
30620670|NCT01204697|58632079|FG001|Overall Study|Death|27|||
30620671|NCT01204697|58632078|FG000|Overall Study|Lost to Follow-up|3|||
30708557|NCT00507507|58722157|FG000|Treatment Period|Withdrawal by Subject|46|||
30708558|NCT00507507|58722158|FG001|Treatment Period|Withdrawal by Subject|47|||
30708559|NCT00507507|58722157|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
30708560|NCT00507507|58722158|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
30708561|NCT00507507|58722157|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
30708562|NCT00507507|58722158|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
30708563|NCT00507507|58722157|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
30708564|NCT00507507|58722158|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
30708565|NCT00459706|58722168|FG000|Overall Study|Adverse Event|19|||
30708566|NCT00459706|58722169|FG001|Overall Study|Adverse Event|13|||
30708567|NCT00459706|58722168|FG000|Overall Study|Withdrawal by Subject|1|||
30708568|NCT00459706|58722169|FG001|Overall Study|Withdrawal by Subject|6|||
30708569|NCT00459706|58722168|FG000|Overall Study|Physician Decision|2|||
30708570|NCT00459706|58722169|FG001|Overall Study|Physician Decision|0|||
30708571|NCT00459706|58722168|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
30708572|NCT00459706|58722169|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
30708573|NCT00459706|58722168|FG000|Overall Study|Protocol Violation|2|||
30708574|NCT00459706|58722169|FG001|Overall Study|Protocol Violation|1|||
30708575|NCT00459706|58722168|FG000|Overall Study|Failed to Return|1|||
30708576|NCT00459706|58722169|FG001|Overall Study|Failed to Return|0|||
30708577|NCT00459706|58722168|FG000|Overall Study|Other|0|||
30708578|NCT00459706|58722169|FG001|Overall Study|Other|1|||
30708579|NCT00507429|58722177|FG000|Treatment Phase|Disease Progression|12|||
30708580|NCT00507429|58722178|FG001|Treatment Phase|Disease Progression|5|||
30708581|NCT00507429|58722177|FG000|Treatment Phase|Adverse Event|12|||
30708582|NCT00507429|58722178|FG001|Treatment Phase|Adverse Event|5|||
30708583|NCT00507429|58722177|FG000|Treatment Phase|Withdrawal by Subject|3|||
30708584|NCT00507429|58722178|FG001|Treatment Phase|Withdrawal by Subject|3|||
30708585|NCT00507429|58722177|FG000|Treatment Phase|Physician Decision|4|||
30708586|NCT00507429|58722178|FG001|Treatment Phase|Physician Decision|2|||
30708587|NCT00507429|58722177|FG000|Treatment Phase|Other|6|||
30708588|NCT00507429|58722178|FG001|Treatment Phase|Other|3|||
30708589|NCT00507429|58722177|FG000|Maintenance Phase|Progressive Disease|14|||
30708590|NCT00507429|58722178|FG001|Maintenance Phase|Progressive Disease|0|||
30708591|NCT00449176|58722189|FG000|Overall Study|Withdrawal by Subject|39|||
30708592|NCT00449176|58722190|FG001|Overall Study|Withdrawal by Subject|43|||
30708593|NCT00449176|58722191|FG002|Overall Study|Withdrawal by Subject|59|||
30708594|NCT00449176|58722189|FG000|Overall Study|Lost to Follow-up|13|||
30708595|NCT00449176|58722190|FG001|Overall Study|Lost to Follow-up|8|||
30708596|NCT00449176|58722191|FG002|Overall Study|Lost to Follow-up|12|||
30708597|NCT00449176|58722189|FG000|Overall Study|Adverse Event|51|||
30708598|NCT00449176|58722190|FG001|Overall Study|Adverse Event|107|||
30708599|NCT00449176|58722191|FG002|Overall Study|Adverse Event|15|||
30708600|NCT00449176|58722189|FG000|Overall Study|Lack of Efficacy|13|||
30708601|NCT00449176|58722190|FG001|Overall Study|Lack of Efficacy|7|||
30708602|NCT00449176|58722191|FG002|Overall Study|Lack of Efficacy|50|||
30708603|NCT00449176|58722189|FG000|Overall Study|Study drug non-compliant|14|||
30708604|NCT00449176|58722190|FG001|Overall Study|Study drug non-compliant|11|||
30708605|NCT00449176|58722191|FG002|Overall Study|Study drug non-compliant|11|||
30708606|NCT00449176|58722189|FG000|Overall Study|all other|22|||
30708607|NCT00449176|58722190|FG001|Overall Study|all other|19|||
30790870|NCT03524092|58803943|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
30843715|NCT01915498|58869660|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30708608|NCT00449176|58722191|FG002|Overall Study|all other|20|||
30708609|NCT00515073|58722199|FG000|Overall Study|Withdrawal by Subject|1|||
30708610|NCT00515073|58722199|FG000|Overall Study|Physician Decision|1|||
30708611|NCT00710021|58722206|FG000|Overall Study|Lost to Follow-up|1|||
30708612|NCT00710021|58722207|FG001|Overall Study|Lost to Follow-up|0|||
30708613|NCT00710021|58722208|FG002|Overall Study|Lost to Follow-up|0|||
30708614|NCT00710021|58722206|FG000|Overall Study|Subject's Decision|0|||
30843716|NCT01915498|58869661|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30708615|NCT00710021|58722207|FG001|Overall Study|Subject's Decision|1|||
30708616|NCT00710021|58722208|FG002|Overall Study|Subject's Decision|0|||
30708617|NCT00710021|58722206|FG000|Overall Study|Subject misrandomized|0|||
30708618|NCT00710021|58722207|FG001|Overall Study|Subject misrandomized|1|||
30708619|NCT00710021|58722208|FG002|Overall Study|Subject misrandomized|1|||
30708620|NCT00710021|58722206|FG000|Overall Study|Physician Decision|0|||
30708621|NCT00710021|58722207|FG001|Overall Study|Physician Decision|1|||
30708622|NCT00710021|58722208|FG002|Overall Study|Physician Decision|0|||
30708623|NCT00504153|58722217|FG000|Overall Study|Withdrawal by Subject|1|||
30708624|NCT00504153|58722217|FG000|Overall Study|Adverse Event|4|||
30708625|NCT00504153|58722217|FG000|Overall Study|Death|1|||
30708626|NCT00442702|58722223|FG000|Titration Period|Adverse Event|2|||
30708627|NCT00442702|58722224|FG001|Titration Period|Adverse Event|0|||
30708628|NCT00442702|58722223|FG000|Titration Period|Death|3|||
30708629|NCT00442702|58722224|FG001|Titration Period|Death|2|||
30708630|NCT00442702|58722223|FG000|Titration Period|Insufficient Therapeutic Response|1|||
30708631|NCT00442702|58722224|FG001|Titration Period|Insufficient Therapeutic Response|0|||
30708632|NCT00442702|58722223|FG000|Titration Period|Refused Treatment|4|||
30708633|NCT00442702|58722224|FG001|Titration Period|Refused Treatment|1|||
30708634|NCT00442702|58722223|FG000|Titration Period|Failure to return|1|||
30708635|NCT00442702|58722224|FG001|Titration Period|Failure to return|0|||
30708636|NCT00442702|58722223|FG000|Titration Period|Hospitalized in another hospital|1|||
30708637|NCT00442702|58722224|FG001|Titration Period|Hospitalized in another hospital|0|||
30708638|NCT00442702|58722223|FG000|Evaluation Period|Adverse Event|1|||
30708639|NCT00442702|58722224|FG001|Evaluation Period|Adverse Event|0|||
30708640|NCT00442702|58722223|FG000|Evaluation Period|Death|1|||
30708641|NCT00442702|58722224|FG001|Evaluation Period|Death|1|||
30708642|NCT00442702|58722223|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
30708643|NCT00442702|58722224|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
30708644|NCT00442702|58722223|FG000|Evaluation Period|Refused treatment|1|||
30708645|NCT00442702|58722224|FG001|Evaluation Period|Refused treatment|1|||
30708646|NCT00442702|58722223|FG000|Evaluation Period|Renal transplant|0|||
30708647|NCT00442702|58722224|FG001|Evaluation Period|Renal transplant|1|||
30708648|NCT00442702|58722223|FG000|Evaluation Period|Failure to return|1|||
30708649|NCT00442702|58722224|FG001|Evaluation Period|Failure to return|0|||
30708650|NCT00442702|58722223|FG000|Evaluation Period|Site closure|0|||
30708651|NCT00442702|58722224|FG001|Evaluation Period|Site closure|1|||
30708652|NCT00514917|58722232|FG000|Overall Study|Death|4|||
30708653|NCT00514917|58722233|FG001|Overall Study|Death|10|||
30708654|NCT00514917|58722232|FG000|Overall Study|Protocol Violation|1|||
30708655|NCT00514917|58722233|FG001|Overall Study|Protocol Violation|0|||
30708656|NCT00514917|58722232|FG000|Overall Study|Lost to Follow-up|4|||
30708657|NCT00514917|58722233|FG001|Overall Study|Lost to Follow-up|3|||
30708658|NCT00514917|58722232|FG000|Overall Study|Withdrawal by Subject|18|||
30708659|NCT00514917|58722233|FG001|Overall Study|Withdrawal by Subject|16|||
30708660|NCT00514917|58722232|FG000|Overall Study|Discontinued due to study closure|88|||
30708661|NCT00514917|58722233|FG001|Overall Study|Discontinued due to study closure|81|||
30708662|NCT00514917|58722232|FG000|Overall Study|Undefined|11|||
30708663|NCT00514917|58722233|FG001|Overall Study|Undefined|5|||
30708664|NCT00711425|58722241|FG000|Overall Study|Protocol Violation|1|||
30708665|NCT00711425|58722241|FG000|Overall Study|Death|2|||
30708666|NCT00711425|58722241|FG000|Overall Study|Lost to Follow-up|1|||
30708667|NCT00504075|58722245|FG000|Overall Study|Adverse Event|1|||
30894486|NCT02150343|58927945|FG002|Overall Study|Lost to Follow-up|2|||
30894487|NCT02150343|58927946|FG003|Overall Study|Lost to Follow-up|3|||
30894488|NCT02150343|58927943|FG000|Overall Study|Other|2|||
30894489|NCT02150343|58927944|FG001|Overall Study|Other|6|||
30708668|NCT00504075|58722245|FG000|Overall Study|Lost to Follow-up|5|||
30708669|NCT00504075|58722245|FG000|Overall Study|Withdrawal by Subject|1|||
30708670|NCT00504075|58722245|FG000|Overall Study|Required other therapeutic intervention|1|||
30708671|NCT00503997|58722250|FG000|Overall Study|disease progression|1|||
30708672|NCT00503997|58722250|FG000|Overall Study|Adverse Event|5|||
30708673|NCT00503997|58722250|FG000|Overall Study|Death|1|||
30708674|NCT00503997|58722250|FG000|Overall Study|Withdrawal by Subject|1|||
30708675|NCT00096265|58722257|FG000|Overall Study|Ineligible|1|||
30708676|NCT00096265|58722258|FG001|Overall Study|Ineligible|0|||
30708677|NCT00096265|58722259|FG002|Overall Study|Ineligible|0|||
30708678|NCT00711191|58722271|FG000|Overall Study|Adverse Event|1|||
30894490|NCT02150343|58927945|FG002|Overall Study|Other|0|||
30708679|NCT00711191|58722272|FG001|Overall Study|Adverse Event|1|||
30708680|NCT00711191|58722273|FG002|Overall Study|Adverse Event|2|||
30708681|NCT00711191|58722271|FG000|Overall Study|Objective progression or relapse|2|||
30708682|NCT00711191|58722272|FG001|Overall Study|Objective progression or relapse|3|||
30708683|NCT00711191|58722273|FG002|Overall Study|Objective progression or relapse|7|||
30708684|NCT00711191|58722271|FG000|Overall Study|Withdrawal by Subject|0|||
30708685|NCT00711191|58722272|FG001|Overall Study|Withdrawal by Subject|1|||
30708686|NCT00711191|58722273|FG002|Overall Study|Withdrawal by Subject|3|||
30708687|NCT00706511|58722288|FG000|Overall Study|Withdrawal by Subject|1|||
30708688|NCT00706511|58722289|FG001|Overall Study|Withdrawal by Subject|0|||
30708689|NCT00706511|58722290|FG002|Overall Study|Withdrawal by Subject|0|||
30708690|NCT00706511|58722291|FG003|Overall Study|Withdrawal by Subject|0|||
30708691|NCT00448864|58722302|FG000|Overall Study|Death|1|||
30708692|NCT00448864|58722303|FG001|Overall Study|Death|0|||
30708693|NCT00448864|58722304|FG002|Overall Study|Death|0|||
30708694|NCT00448864|58722302|FG000|Overall Study|Lost to Follow-up|3|||
30708695|NCT00448864|58722303|FG001|Overall Study|Lost to Follow-up|1|||
30708696|NCT00448864|58722304|FG002|Overall Study|Lost to Follow-up|0|||
30708697|NCT00448864|58722302|FG000|Overall Study|Physician Decision|1|||
30708698|NCT00448864|58722303|FG001|Overall Study|Physician Decision|0|||
30708699|NCT00448864|58722304|FG002|Overall Study|Physician Decision|1|||
30708700|NCT00448864|58722302|FG000|Overall Study|Withdrawal by Subject|0|||
30708701|NCT00448864|58722303|FG001|Overall Study|Withdrawal by Subject|2|||
30708702|NCT00448864|58722304|FG002|Overall Study|Withdrawal by Subject|0|||
30708703|NCT00448864|58722302|FG000|Overall Study|Protocol Violation|0|||
30708704|NCT00448864|58722303|FG001|Overall Study|Protocol Violation|2|||
30708705|NCT00448864|58722304|FG002|Overall Study|Protocol Violation|0|||
30708706|NCT00567398|58722316|FG000|Overall Study|Adverse Event|6|||
30708707|NCT00567398|58722317|FG001|Overall Study|Adverse Event|14|||
30708708|NCT00567398|58722316|FG000|Overall Study|Physician Decision|0|||
30708709|NCT00567398|58722317|FG001|Overall Study|Physician Decision|4|||
30708710|NCT00567398|58722316|FG000|Overall Study|Withdrawal by Subject|0|||
30708711|NCT00567398|58722317|FG001|Overall Study|Withdrawal by Subject|2|||
30708712|NCT00567398|58722316|FG000|Overall Study|Renal Transplantation|0|||
30708713|NCT00567398|58722317|FG001|Overall Study|Renal Transplantation|3|||
30708714|NCT00567398|58722316|FG000|Overall Study|Other|1|||
30708715|NCT00567398|58722317|FG001|Overall Study|Other|0|||
30708716|NCT00448708|58722325|FG000|Overall Study|Death|21|||
30708717|NCT00448708|58722326|FG001|Overall Study|Death|17|||
30708718|NCT00448708|58722325|FG000|Overall Study|Withdrawal by Subject|8|||
30708719|NCT00448708|58722326|FG001|Overall Study|Withdrawal by Subject|4|||
30708720|NCT00448708|58722325|FG000|Overall Study|Lost to Follow-up|6|||
30708721|NCT00448708|58722326|FG001|Overall Study|Lost to Follow-up|8|||
30708722|NCT00448708|58722325|FG000|Overall Study|not listed|0|||
30708723|NCT00448708|58722326|FG001|Overall Study|not listed|2|||
30708724|NCT00706355|58722336|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
30708725|NCT00706355|58722337|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
30708726|NCT00706355|58722338|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
30708727|NCT00706355|58722339|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
30708728|NCT00706355|58722336|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
30708729|NCT00706355|58722337|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
30708730|NCT00706355|58722338|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
30708731|NCT00706355|58722339|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
30708732|NCT00706355|58722336|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
30708733|NCT00706355|58722337|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
30708734|NCT00706355|58722338|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
30708735|NCT00706355|58722339|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
30708736|NCT00706355|58722336|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
30708737|NCT00706355|58722337|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
30708738|NCT00706355|58722338|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
30708739|NCT00706355|58722339|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
30708740|NCT00706355|58722336|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
30708741|NCT00706355|58722337|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
30708742|NCT00706355|58722338|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
30708743|NCT00706355|58722339|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
30708744|NCT00706355|58722336|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
30708745|NCT00706355|58722337|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
30708746|NCT00706355|58722338|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
30708747|NCT00706355|58722339|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
30708748|NCT00706355|58722336|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
30708749|NCT00706355|58722337|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
30708750|NCT00706355|58722338|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
30708751|NCT00706355|58722339|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
30708752|NCT00706355|58722336|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
30708753|NCT00706355|58722337|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
30708754|NCT00706355|58722338|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
30708755|NCT00706355|58722339|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
30708756|NCT00706355|58722336|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
30708757|NCT00706355|58722337|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
30708758|NCT00706355|58722338|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
30708759|NCT00706355|58722339|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
30708760|NCT00711113|58722351|FG000|Overall Study|Lost to Follow-up|9|||
30708761|NCT00711113|58722351|FG000|Overall Study|Implant lost|2|||
30708762|NCT00710879|58722361|FG000|Overall Study|Lost to Follow-up|2|||
30708763|NCT00710879|58722362|FG001|Overall Study|Lost to Follow-up|1|||
30708764|NCT00710879|58722361|FG000|Overall Study|Protocol Violation|0|||
30708765|NCT00710879|58722362|FG001|Overall Study|Protocol Violation|3|||
30708766|NCT03979274|58722368|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30708767|NCT03979274|58722369|FG001|Treatment Period 2|Withdrawal by Subject|1|||
30708768|NCT00459316|58722379|FG000|Steps 1 & 2|Other eligibility failure|1|||
30708769|NCT00459316|58722380|FG001|Steps 1 & 2|Other eligibility failure|1|||
30708770|NCT00459316|58722381|FG002|Steps 1 & 2|Other eligibility failure|0|||
30708771|NCT00459316|58722379|FG000|Steps 1 & 2|Death|1|||
30708772|NCT00459316|58722380|FG001|Steps 1 & 2|Death|1|||
30708773|NCT00459316|58722381|FG002|Steps 1 & 2|Death|0|||
30708774|NCT00459316|58722379|FG000|Steps 1 & 2|Not able to get to clinic|7|||
30708775|NCT00459316|58722380|FG001|Steps 1 & 2|Not able to get to clinic|4|||
30708776|NCT00459316|58722381|FG002|Steps 1 & 2|Not able to get to clinic|0|||
30708777|NCT00459316|58722379|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
30708778|NCT00459316|58722380|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
30708779|NCT00459316|58722381|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
30620672|NCT01204697|58632079|FG001|Overall Study|Lost to Follow-up|4|||
30620673|NCT01204697|58632078|FG000|Overall Study|Withdrawal by Subject|2|||
30620674|NCT01204697|58632079|FG001|Overall Study|Withdrawal by Subject|4|||
30620675|NCT01204697|58632078|FG000|Overall Study|Randomized, but not treated|0|||
30620676|NCT01204697|58632079|FG001|Overall Study|Randomized, but not treated|1|||
30620677|NCT01001325|58632087|FG000|Overall Study|Lost to Follow-up|16|||
30620678|NCT01001325|58632088|FG001|Overall Study|Lost to Follow-up|10|||
30620679|NCT01001325|58632087|FG000|Overall Study|Protocol Violation|2|||
30620680|NCT01001325|58632088|FG001|Overall Study|Protocol Violation|0|||
30620681|NCT01203917|58632094|FG000|Overall Study|Death|29|||
30620682|NCT01203917|58632094|FG000|Overall Study|Lost to Follow-up|2|||
30620683|NCT01203917|58632094|FG000|Overall Study|Withdrawal by Subject|3|||
30620684|NCT01203917|58632094|FG000|Overall Study|Due to objective disease progression|1|||
30620685|NCT01203917|58632094|FG000|Overall Study|Due to EGFR M+I patient|1|||
30620686|NCT01202903|58632100|FG000|Overall Study|Administrative Probelms|1|||
30620687|NCT01202903|58632101|FG001|Overall Study|Administrative Probelms|4|||
30620688|NCT01202903|58632100|FG000|Overall Study|Protocol Violation|0|||
30620689|NCT01202903|58632101|FG001|Overall Study|Protocol Violation|1|||
30620690|NCT01202903|58632100|FG000|Overall Study|Death|1|||
30620691|NCT01202903|58632101|FG001|Overall Study|Death|0|||
30708780|NCT00459316|58722379|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
30708781|NCT00459316|58722380|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
30708782|NCT00459316|58722381|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
30708783|NCT00459316|58722379|FG000|Steps 1 & 2|Lost to Follow-up|5|||
30708784|NCT00459316|58722380|FG001|Steps 1 & 2|Lost to Follow-up|0|||
30708785|NCT00459316|58722381|FG002|Steps 1 & 2|Lost to Follow-up|2|||
30708786|NCT00459316|58722379|FG000|Step 3|Withdrawal by Subject|3|||
30708787|NCT00459316|58722380|FG001|Step 3|Withdrawal by Subject|0|||
30708788|NCT00459316|58722381|FG002|Step 3|Withdrawal by Subject|1|||
30708789|NCT00567164|58722407|FG000|Overall Study|Withdrawal by Subject|171|||
30708790|NCT00567164|58722408|FG001|Overall Study|Withdrawal by Subject|21|||
30708791|NCT00567164|58722409|FG002|Overall Study|Withdrawal by Subject|17|||
30708792|NCT00567164|58722407|FG000|Overall Study|Protocol Violation|23|||
30708793|NCT00567164|58722408|FG001|Overall Study|Protocol Violation|4|||
30708794|NCT00567164|58722409|FG002|Overall Study|Protocol Violation|2|||
30708795|NCT00567164|58722407|FG000|Overall Study|Adverse Event|92|||
30708796|NCT00567164|58722408|FG001|Overall Study|Adverse Event|13|||
30708797|NCT00567164|58722409|FG002|Overall Study|Adverse Event|9|||
30708798|NCT00567164|58722407|FG000|Overall Study|Death|0|||
30708799|NCT00567164|58722408|FG001|Overall Study|Death|0|||
30708800|NCT00567164|58722409|FG002|Overall Study|Death|1|||
30708801|NCT00567164|58722407|FG000|Overall Study|Lost to Follow-up|202|||
30708802|NCT00567164|58722408|FG001|Overall Study|Lost to Follow-up|23|||
30708803|NCT00567164|58722409|FG002|Overall Study|Lost to Follow-up|21|||
30708804|NCT00567164|58722407|FG000|Overall Study|Pregnancy|20|||
30708805|NCT00567164|58722408|FG001|Overall Study|Pregnancy|4|||
30708806|NCT00567164|58722409|FG002|Overall Study|Pregnancy|6|||
30708807|NCT00567164|58722407|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
30708808|NCT00567164|58722408|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
30708809|NCT00567164|58722409|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
30708810|NCT00567164|58722407|FG000|Overall Study|Missing|1|||
30708811|NCT00567164|58722408|FG001|Overall Study|Missing|0|||
30708812|NCT00567164|58722409|FG002|Overall Study|Missing|0|||
30708813|NCT00713219|58722421|FG000|Overall Study|Death|1|||
30708814|NCT00713219|58722421|FG000|Overall Study|Protocol Violation|1|||
30708815|NCT00712985|58722425|FG000|Overall Study|1 withdrew prior to start of drug|1|||
30708816|NCT00712985|58722425|FG000|Overall Study|1 patient moved out of state|1|||
30708817|NCT00712985|58722425|FG000|Overall Study|Lack of Efficacy|3|||
30708818|NCT00700115|58722431|FG000|Overall Study|Withdrawal by Subject|1|||
30708819|NCT00700115|58722432|FG001|Overall Study|Withdrawal by Subject|0|||
30708820|NCT00700115|58722431|FG000|Overall Study|Lost to Follow-up|0|||
30708821|NCT00700115|58722432|FG001|Overall Study|Lost to Follow-up|1|||
30708822|NCT00566852|58722440|FG000|Overall Study|Protocol Violation|22|||
30708823|NCT00566852|58722441|FG001|Overall Study|Protocol Violation|24|||
30708824|NCT00566852|58722440|FG000|Overall Study|Death|95|||
30708825|NCT00566852|58722441|FG001|Overall Study|Death|78|||
30708826|NCT00566852|58722440|FG000|Overall Study|Withdrawal by Subject|30|||
30708827|NCT00566852|58722441|FG001|Overall Study|Withdrawal by Subject|25|||
30708828|NCT00566852|58722440|FG000|Overall Study|Patient refusal|37|||
30708829|NCT00566852|58722441|FG001|Overall Study|Patient refusal|37|||
30708830|NCT00566852|58722440|FG000|Overall Study|Not tested due to disability|6|||
30708831|NCT00566852|58722441|FG001|Overall Study|Not tested due to disability|12|||
30708832|NCT00566852|58722440|FG000|Overall Study|Missing reason not specified|1|||
30708833|NCT00566852|58722441|FG001|Overall Study|Missing reason not specified|2|||
30708834|NCT00566852|58722440|FG000|Overall Study|Missing reason not reported|16|||
30708835|NCT00566852|58722441|FG001|Overall Study|Missing reason not reported|20|||
30708836|NCT00442546|58722450|FG000|Overall Study|Adverse Event|11|||
30708837|NCT00442546|58722451|FG001|Overall Study|Adverse Event|17|||
30708838|NCT00442546|58722452|FG002|Overall Study|Adverse Event|13|||
30708839|NCT00442546|58722450|FG000|Overall Study|Lost to Follow-up|1|||
30708840|NCT00442546|58722451|FG001|Overall Study|Lost to Follow-up|2|||
30708841|NCT00442546|58722452|FG002|Overall Study|Lost to Follow-up|1|||
30708842|NCT00442546|58722450|FG000|Overall Study|Other|4|||
30708843|NCT00442546|58722451|FG001|Overall Study|Other|9|||
30708844|NCT00442546|58722452|FG002|Overall Study|Other|6|||
30708845|NCT00442546|58722450|FG000|Overall Study|Withdrawal by Subject|5|||
30708846|NCT00442546|58722451|FG001|Overall Study|Withdrawal by Subject|5|||
30708847|NCT00442546|58722452|FG002|Overall Study|Withdrawal by Subject|7|||
30708848|NCT00442546|58722450|FG000|Overall Study|Randomized But Not Treated|5|||
30708849|NCT00442546|58722451|FG001|Overall Study|Randomized But Not Treated|4|||
30708850|NCT00442546|58722452|FG002|Overall Study|Randomized But Not Treated|6|||
30708851|NCT00514683|58722467|FG000|Overall Study|Not treated|2|||
30708852|NCT00514683|58722468|FG001|Overall Study|Not treated|1|||
30708853|NCT00514683|58722469|FG002|Overall Study|Not treated|0|||
30708854|NCT00514683|58722470|FG003|Overall Study|Not treated|0|||
30708855|NCT00514683|58722471|FG004|Overall Study|Not treated|1|||
30708856|NCT00514683|58722467|FG000|Overall Study|Adverse Event|21|||
30708857|NCT00514683|58722468|FG001|Overall Study|Adverse Event|20|||
30708858|NCT00514683|58722469|FG002|Overall Study|Adverse Event|15|||
30708859|NCT00514683|58722470|FG003|Overall Study|Adverse Event|13|||
30708860|NCT00514683|58722471|FG004|Overall Study|Adverse Event|27|||
30708861|NCT00514683|58722467|FG000|Overall Study|Protocol Violation|1|||
30708862|NCT00514683|58722468|FG001|Overall Study|Protocol Violation|1|||
30708863|NCT00514683|58722469|FG002|Overall Study|Protocol Violation|0|||
30708864|NCT00514683|58722470|FG003|Overall Study|Protocol Violation|1|||
30708865|NCT00514683|58722471|FG004|Overall Study|Protocol Violation|0|||
30708866|NCT00514683|58722467|FG000|Overall Study|Withdrawal by Subject|2|||
30708867|NCT00514683|58722468|FG001|Overall Study|Withdrawal by Subject|2|||
30708868|NCT00514683|58722469|FG002|Overall Study|Withdrawal by Subject|1|||
30708869|NCT00514683|58722470|FG003|Overall Study|Withdrawal by Subject|0|||
30708870|NCT00514683|58722471|FG004|Overall Study|Withdrawal by Subject|4|||
30708871|NCT00514683|58722467|FG000|Overall Study|Reason other than listed above|0|||
30708872|NCT00514683|58722468|FG001|Overall Study|Reason other than listed above|1|||
30708873|NCT00514683|58722469|FG002|Overall Study|Reason other than listed above|2|||
30708874|NCT00514683|58722470|FG003|Overall Study|Reason other than listed above|0|||
30708875|NCT00514683|58722471|FG004|Overall Study|Reason other than listed above|1|||
30708876|NCT00566696|58722487|FG000|Overall Study|Met Exclusion Criteria|2|||
30708877|NCT00566696|58722487|FG000|Overall Study|Muromonab not available|1|||
30708878|NCT00566696|58722487|FG000|Overall Study|Health Status Change|1|||
30708879|NCT00566696|58722487|FG000|Overall Study|Physician Decision|1|||
30708880|NCT00566696|58722487|FG000|Overall Study|Non-Patient Donors|37|||
30708881|NCT00503841|58722491|FG000|Overall Study|All screen failures|44|||
30708882|NCT00442468|58722497|FG000|Overall Study|Adverse Event|4|||
30708883|NCT00442468|58722497|FG000|Overall Study|Withdrawal by Subject|91|||
30708884|NCT00442468|58722497|FG000|Overall Study|Did not complete all study procedures|88|||
30708885|NCT00506883|58722504|FG000|Overall Study|Lost to Follow-up|1|||
30708886|NCT00506883|58722505|FG001|Overall Study|Lost to Follow-up|1|||
30708887|NCT00506883|58722506|FG002|Overall Study|Lost to Follow-up|1|||
30708888|NCT00506883|58722504|FG000|Overall Study|Withdrawal by Subject|1|||
30708889|NCT00506883|58722505|FG001|Overall Study|Withdrawal by Subject|0|||
30708890|NCT00506883|58722506|FG002|Overall Study|Withdrawal by Subject|1|||
30708891|NCT00506883|58722504|FG000|Overall Study|Lack of Efficacy|0|||
30708892|NCT00506883|58722505|FG001|Overall Study|Lack of Efficacy|1|||
30708893|NCT00506883|58722506|FG002|Overall Study|Lack of Efficacy|1|||
30708894|NCT00506883|58722504|FG000|Overall Study|Other|5|||
30708895|NCT00506883|58722505|FG001|Overall Study|Other|1|||
30708896|NCT00506883|58722506|FG002|Overall Study|Other|1|||
30708897|NCT00503685|58722517|FG000|Overall Study|Adverse Event|0|||
30708898|NCT00503685|58722518|FG001|Overall Study|Adverse Event|0|||
30708899|NCT00503685|58722519|FG002|Overall Study|Adverse Event|2|||
30708900|NCT00503685|58722517|FG000|Overall Study|Withdrawal by Subject|0|||
30708901|NCT00503685|58722518|FG001|Overall Study|Withdrawal by Subject|1|||
30708902|NCT00503685|58722519|FG002|Overall Study|Withdrawal by Subject|0|||
30708903|NCT00503685|58722517|FG000|Overall Study|Protocol Violation|0|||
30708904|NCT00503685|58722518|FG001|Overall Study|Protocol Violation|1|||
30708905|NCT00503685|58722519|FG002|Overall Study|Protocol Violation|0|||
30708906|NCT00503685|58722517|FG000|Overall Study|Eligibility Criteria Not Met|0|||
30708907|NCT00503685|58722518|FG001|Overall Study|Eligibility Criteria Not Met|1|||
30708908|NCT00503685|58722519|FG002|Overall Study|Eligibility Criteria Not Met|0|||
30708909|NCT00712673|58722531|FG000|Overall Study|Adverse Event|3|||
30708910|NCT00712673|58722532|FG001|Overall Study|Adverse Event|3|||
30843717|NCT01915498|58869662|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30708911|NCT00712673|58722533|FG002|Overall Study|Adverse Event|21|||
30708912|NCT00712673|58722534|FG003|Overall Study|Adverse Event|26|||
30708913|NCT00712673|58722531|FG000|Overall Study|Lack of Efficacy|2|||
30708914|NCT00712673|58722532|FG001|Overall Study|Lack of Efficacy|8|||
30708915|NCT00712673|58722533|FG002|Overall Study|Lack of Efficacy|8|||
30708916|NCT00712673|58722534|FG003|Overall Study|Lack of Efficacy|6|||
30708917|NCT00712673|58722531|FG000|Overall Study|Poor Compliance to Protocol|3|||
30708918|NCT00712673|58722532|FG001|Overall Study|Poor Compliance to Protocol|3|||
30708919|NCT00712673|58722533|FG002|Overall Study|Poor Compliance to Protocol|4|||
30708920|NCT00712673|58722534|FG003|Overall Study|Poor Compliance to Protocol|16|||
30708921|NCT00712673|58722531|FG000|Overall Study|Lost to Follow-up|1|||
30708922|NCT00712673|58722532|FG001|Overall Study|Lost to Follow-up|0|||
30708923|NCT00712673|58722533|FG002|Overall Study|Lost to Follow-up|2|||
30708924|NCT00712673|58722534|FG003|Overall Study|Lost to Follow-up|0|||
30708925|NCT00712673|58722531|FG000|Overall Study|Withdrawal by Subject|6|||
30708926|NCT00712673|58722532|FG001|Overall Study|Withdrawal by Subject|7|||
30708927|NCT00712673|58722533|FG002|Overall Study|Withdrawal by Subject|15|||
30708928|NCT00712673|58722534|FG003|Overall Study|Withdrawal by Subject|20|||
30708929|NCT00712673|58722531|FG000|Overall Study|Familial and Personal Reasons|5|||
30708930|NCT00712673|58722532|FG001|Overall Study|Familial and Personal Reasons|0|||
30708931|NCT00712673|58722533|FG002|Overall Study|Familial and Personal Reasons|5|||
30708932|NCT00712673|58722534|FG003|Overall Study|Familial and Personal Reasons|2|||
30708933|NCT00712673|58722531|FG000|Overall Study|Investigator's Decision|1|||
30708934|NCT00712673|58722532|FG001|Overall Study|Investigator's Decision|0|||
30708935|NCT00712673|58722533|FG002|Overall Study|Investigator's Decision|0|||
30708936|NCT00712673|58722534|FG003|Overall Study|Investigator's Decision|0|||
30708937|NCT00712673|58722531|FG000|Overall Study|Protocol Violation|0|||
30708938|NCT00712673|58722532|FG001|Overall Study|Protocol Violation|0|||
30708939|NCT00712673|58722533|FG002|Overall Study|Protocol Violation|2|||
30708940|NCT00712673|58722534|FG003|Overall Study|Protocol Violation|0|||
30708941|NCT03976466|58722555|FG000|Overall Study|Lost to Follow-up|1|||
30708942|NCT03976466|58722556|FG001|Overall Study|Lost to Follow-up|3|||
30894491|NCT02150343|58927946|FG003|Overall Study|Other|2|||
30894492|NCT02149875|58927959|FG000|Overall Study|Lost to Follow-up|3|||
30894493|NCT02149875|58927960|FG001|Overall Study|Lost to Follow-up|4|||
30894494|NCT02149875|58927961|FG002|Overall Study|Lost to Follow-up|5|||
30894495|NCT02149875|58927959|FG000|Overall Study|Withdrawal by Subject|3|||
30894496|NCT02149875|58927960|FG001|Overall Study|Withdrawal by Subject|2|||
30894497|NCT02149875|58927961|FG002|Overall Study|Withdrawal by Subject|2|||
30894498|NCT02149875|58927959|FG000|Overall Study|Physician Decision|1|||
30620692|NCT01202903|58632100|FG000|Overall Study|Lost to Follow-up|1|||
30620693|NCT01202903|58632101|FG001|Overall Study|Lost to Follow-up|1|||
30620694|NCT01202903|58632100|FG000|Overall Study|Lack of Efficacy|1|||
30620695|NCT01202903|58632101|FG001|Overall Study|Lack of Efficacy|3|||
30620696|NCT01202903|58632100|FG000|Overall Study|Adverse Event|3|||
30620697|NCT01202903|58632101|FG001|Overall Study|Adverse Event|3|||
30620698|NCT01202903|58632100|FG000|Overall Study|Withdrawal by Subject|4|||
30620699|NCT01202903|58632101|FG001|Overall Study|Withdrawal by Subject|4|||
30620700|NCT01001169|58632109|FG000|Overall Study|Withdrawal by Subject|2|||
30620701|NCT01001169|58632110|FG001|Overall Study|Withdrawal by Subject|1|||
30620702|NCT01202747|58632124|FG000|Overall Study|Withdrawal by Subject|1|||
30620703|NCT00996801|58632134|FG000|Overall Study|Adverse Event|6|||
30620704|NCT00996801|58632135|FG001|Overall Study|Adverse Event|4|||
30620705|NCT00996801|58632136|FG002|Overall Study|Adverse Event|12|||
30620706|NCT00996801|58632137|FG003|Overall Study|Adverse Event|17|||
30620707|NCT00996801|58632138|FG004|Overall Study|Adverse Event|31|||
30620708|NCT00996801|58632139|FG005|Overall Study|Adverse Event|3|||
30620709|NCT00996801|58632134|FG000|Overall Study|Lack of Efficacy|3|||
30620710|NCT00996801|58632135|FG001|Overall Study|Lack of Efficacy|0|||
30620711|NCT00996801|58632136|FG002|Overall Study|Lack of Efficacy|1|||
30620712|NCT00996801|58632137|FG003|Overall Study|Lack of Efficacy|3|||
30620713|NCT00996801|58632138|FG004|Overall Study|Lack of Efficacy|0|||
30620714|NCT00996801|58632139|FG005|Overall Study|Lack of Efficacy|1|||
30620715|NCT00996801|58632134|FG000|Overall Study|Lost to Follow-up|0|||
30620716|NCT00996801|58632135|FG001|Overall Study|Lost to Follow-up|0|||
30620717|NCT00996801|58632136|FG002|Overall Study|Lost to Follow-up|0|||
30620718|NCT00996801|58632137|FG003|Overall Study|Lost to Follow-up|3|||
30620719|NCT00996801|58632138|FG004|Overall Study|Lost to Follow-up|3|||
30620720|NCT00996801|58632139|FG005|Overall Study|Lost to Follow-up|2|||
30620721|NCT00996801|58632134|FG000|Overall Study|Physician Decision|0|||
30620722|NCT00996801|58632135|FG001|Overall Study|Physician Decision|0|||
30620723|NCT00996801|58632136|FG002|Overall Study|Physician Decision|0|||
30620724|NCT00996801|58632137|FG003|Overall Study|Physician Decision|1|||
30620725|NCT00996801|58632138|FG004|Overall Study|Physician Decision|0|||
30620726|NCT00996801|58632139|FG005|Overall Study|Physician Decision|0|||
30620727|NCT00996801|58632134|FG000|Overall Study|Progressive Disease|0|||
30620728|NCT00996801|58632135|FG001|Overall Study|Progressive Disease|1|||
30620729|NCT00996801|58632136|FG002|Overall Study|Progressive Disease|0|||
30708943|NCT02536755|58722564|FG000|Overall Study|Adverse Event|4|||
30708944|NCT03303105|58722573|FG000|Overall Study|Adverse Event|0|||
30708945|NCT03303105|58722574|FG001|Overall Study|Adverse Event|2|||
30708946|NCT03303105|58722573|FG000|Overall Study|Lack of Efficacy|1|||
30708947|NCT03303105|58722574|FG001|Overall Study|Lack of Efficacy|0|||
30708948|NCT03303105|58722573|FG000|Overall Study|Protocol Violation|1|||
30708949|NCT03303105|58722574|FG001|Overall Study|Protocol Violation|0|||
30708950|NCT03303105|58722573|FG000|Overall Study|Withdrawal by Subject|0|||
30708951|NCT03303105|58722574|FG001|Overall Study|Withdrawal by Subject|2|||
30708952|NCT00447694|58722580|FG000|Overall Study|Adverse Event|2|||
30708953|NCT00447694|58722580|FG000|Overall Study|Abnormal laboratory value|1|||
30708954|NCT00447694|58722580|FG000|Overall Study|Abnormal test procedure result|1|||
30708955|NCT00447694|58722580|FG000|Overall Study|Withdrawal by Subject|2|||
30708956|NCT00564278|58722586|FG000|Overall Study|Lost to Follow-up|35|||
30708957|NCT00564278|58722587|FG001|Overall Study|Lost to Follow-up|33|||
30708958|NCT00564278|58722586|FG000|Overall Study|Physician Decision|1|||
30708959|NCT00564278|58722587|FG001|Overall Study|Physician Decision|2|||
30708960|NCT00564278|58722586|FG000|Overall Study|Withdrawal by Subject|11|||
30708961|NCT00564278|58722587|FG001|Overall Study|Withdrawal by Subject|7|||
30708962|NCT00565604|58722593|FG000|Overall Study|Failure to treat|2|||
30708963|NCT00565604|58722593|FG000|Overall Study|Lost to Follow-up|2|||
30708964|NCT00447382|58722599|FG000|Overall Study|Adverse Event|1|||
30708965|NCT00447382|58722600|FG001|Overall Study|Adverse Event|1|||
30708966|NCT00447382|58722599|FG000|Overall Study|Lack of Efficacy|1|||
30620730|NCT00996801|58632137|FG003|Overall Study|Progressive Disease|0|||
30620731|NCT00996801|58632138|FG004|Overall Study|Progressive Disease|0|||
30620732|NCT00996801|58632139|FG005|Overall Study|Progressive Disease|0|||
30620733|NCT00996801|58632134|FG000|Overall Study|Protocol Violation|3|||
30620734|NCT00996801|58632135|FG001|Overall Study|Protocol Violation|4|||
30620735|NCT00996801|58632136|FG002|Overall Study|Protocol Violation|1|||
30620736|NCT00996801|58632137|FG003|Overall Study|Protocol Violation|2|||
30620737|NCT00996801|58632138|FG004|Overall Study|Protocol Violation|3|||
30620738|NCT00996801|58632139|FG005|Overall Study|Protocol Violation|4|||
30620739|NCT00996801|58632134|FG000|Overall Study|Study Terminated by Sponsor|0|||
30620740|NCT00996801|58632135|FG001|Overall Study|Study Terminated by Sponsor|1|||
30620741|NCT00996801|58632136|FG002|Overall Study|Study Terminated by Sponsor|0|||
30620742|NCT00996801|58632137|FG003|Overall Study|Study Terminated by Sponsor|0|||
30620743|NCT00996801|58632138|FG004|Overall Study|Study Terminated by Sponsor|46|||
30620744|NCT00996801|58632139|FG005|Overall Study|Study Terminated by Sponsor|0|||
30620745|NCT00996801|58632134|FG000|Overall Study|Withdrawal by Subject|8|||
30620746|NCT00996801|58632135|FG001|Overall Study|Withdrawal by Subject|6|||
30620747|NCT00996801|58632136|FG002|Overall Study|Withdrawal by Subject|9|||
30620748|NCT00996801|58632137|FG003|Overall Study|Withdrawal by Subject|5|||
30620749|NCT00996801|58632138|FG004|Overall Study|Withdrawal by Subject|5|||
30620750|NCT00996801|58632139|FG005|Overall Study|Withdrawal by Subject|9|||
30620751|NCT00996489|58632155|FG000|Overall Study|Device failure|45|||
30620752|NCT00996489|58632155|FG000|Overall Study|Discontinued|116|||
30620753|NCT01000311|58632161|FG000|Overall Study|Adverse Event|2|||
30620754|NCT01000311|58632162|FG001|Overall Study|Adverse Event|5|||
30620755|NCT01000311|58632161|FG000|Overall Study|Withdrawal by Subject|16|||
30620756|NCT01000311|58632162|FG001|Overall Study|Withdrawal by Subject|24|||
30620757|NCT01000311|58632161|FG000|Overall Study|Lost to Follow-up|15|||
30620758|NCT01000311|58632162|FG001|Overall Study|Lost to Follow-up|24|||
30620759|NCT01000311|58632161|FG000|Overall Study|Protocol Violation|1|||
30620760|NCT01000311|58632162|FG001|Overall Study|Protocol Violation|2|||
30620761|NCT01000311|58632161|FG000|Overall Study|Inappropriate enrollment|2|||
30620762|NCT01000311|58632162|FG001|Overall Study|Inappropriate enrollment|0|||
30708967|NCT00447382|58722600|FG001|Overall Study|Lack of Efficacy|0|||
30708968|NCT00447382|58722599|FG000|Overall Study|Protocol Violation|2|||
30708969|NCT00447382|58722600|FG001|Overall Study|Protocol Violation|0|||
30620763|NCT01000311|58632161|FG000|Overall Study|Administrative reason|9|||
30620764|NCT01000311|58632162|FG001|Overall Study|Administrative reason|15|||
30620765|NCT01003899|58632168|FG000|Overall Study|Other Adverse Event|8|||
30620766|NCT01003899|58632168|FG000|Overall Study|Not entered|4|||
30708970|NCT00447382|58722599|FG000|Overall Study|Unclassified|2|||
30708971|NCT00447382|58722600|FG001|Overall Study|Unclassified|5|||
30708972|NCT00447226|58722606|FG000|12-Week Open-label Phase|Adverse Event|0|||
30708973|NCT00447226|58722607|FG001|12-Week Open-label Phase|Adverse Event|3|||
30708974|NCT00447226|58722606|FG000|12-Week Open-label Phase|Protocol Violation|0|||
30708975|NCT00447226|58722607|FG001|12-Week Open-label Phase|Protocol Violation|1|||
30708976|NCT00447226|58722606|FG000|12-Week Open-label Phase|Disease Progression|0|||
30708977|NCT00447226|58722607|FG001|12-Week Open-label Phase|Disease Progression|20|||
30708978|NCT00447226|58722606|FG000|12-Week Open-label Phase|Physician Decision|0|||
30708979|NCT00447226|58722607|FG001|12-Week Open-label Phase|Physician Decision|1|||
30708980|NCT00447226|58722606|FG000|Double-blind Phase|Disease Progression|4|||
30708981|NCT00447226|58722607|FG001|Double-blind Phase|Disease Progression|3|||
30708982|NCT00446992|58722622|FG000|Overall Study|Adverse Event|11|||
30708983|NCT00446992|58722622|FG000|Overall Study|Lost to Follow-up|5|||
30708984|NCT00503139|58722626|FG000|Overall Study|Case Report Forms were not collected|4|||
30708985|NCT00503139|58722626|FG000|Overall Study|Protocol Violation|4|||
30708986|NCT00577031|58722630|FG000|Overall Study|Adverse Event|52|||
30708987|NCT00577031|58722630|FG000|Overall Study|Progression of disease|93|||
30708988|NCT00577031|58722630|FG000|Overall Study|Protocol Violation|5|||
30708989|NCT00577031|58722630|FG000|Overall Study|Participant withdrew consent|13|||
30708990|NCT00577031|58722630|FG000|Overall Study|Participant non-compliance|5|||
30708991|NCT00577031|58722630|FG000|Overall Study|Need for surgery|17|||
30708992|NCT00577031|58722630|FG000|Overall Study|Medical decision|14|||
30708993|NCT00577031|58722630|FG000|Overall Study|Death|6|||
30708994|NCT00565448|58722639|FG000|Overall Study|Adverse Event|1|||
30708995|NCT00565448|58722640|FG001|Overall Study|Adverse Event|2|||
30708996|NCT00565448|58722639|FG000|Overall Study|Disease progression|1|||
30708997|NCT00565448|58722640|FG001|Overall Study|Disease progression|0|||
30708998|NCT00565448|58722639|FG000|Overall Study|Withdrawal by Subject|1|||
30708999|NCT00565448|58722640|FG001|Overall Study|Withdrawal by Subject|0|||
30709000|NCT00446446|58722649|FG000|Overall Study|Death|10|||
30709001|NCT00446446|58722649|FG000|Overall Study|Withdrawal by Subject|6|||
30709002|NCT00446446|58722649|FG000|Overall Study|Other|4|||
30709003|NCT00446446|58722649|FG000|Overall Study|Disease Progession|2|||
30709004|NCT00446446|58722649|FG000|Overall Study|Adverse Event|1|||
30709005|NCT00446446|58722649|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
30709006|NCT00506493|58722653|FG000|Overall Study|Death|6|||
30709007|NCT00506493|58722653|FG000|Overall Study|Withdrawal by Subject|5|||
30709008|NCT00514449|58722661|FG000|Overall Study|Withdrawal by Subject|1|||
30709009|NCT00514449|58722662|FG001|Overall Study|Withdrawal by Subject|2|||
30709010|NCT00514449|58722661|FG000|Overall Study|Protocol Violation|1|||
30709011|NCT00514449|58722662|FG001|Overall Study|Protocol Violation|2|||
30709012|NCT00514449|58722661|FG000|Overall Study|Lost to Follow-up|1|||
30709013|NCT00514449|58722662|FG001|Overall Study|Lost to Follow-up|0|||
30709014|NCT00565136|58722671|FG000|Overall Study|Lost to Follow-up|1|||
30709015|NCT00565136|58722671|FG000|Overall Study|Withdrawal by Subject|1|||
30709016|NCT00565136|58722671|FG000|Overall Study|Protocol Violation|1|||
30709017|NCT00492921|58722675|FG000|Overall Study|Death|1|||
30709018|NCT00492921|58722676|FG001|Overall Study|Death|0|||
30709019|NCT00492921|58722677|FG002|Overall Study|Death|1|||
30709020|NCT00502671|58722685|FG000|Overall Study|Disease Progression|13|||
30709021|NCT00502671|58722685|FG000|Overall Study|Personal Reasons|22|||
30709022|NCT00502671|58722685|FG000|Overall Study|Lost to Follow-up|7|||
30709023|NCT00502671|58722685|FG000|Overall Study|Protocol Violation|16|||
30709024|NCT00502671|58722685|FG000|Overall Study|Adverse Event|19|||
30709025|NCT00697463|58722689|FG000|Overall Study|Withdrawal by Subject|1|||
30709026|NCT00492531|58722695|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
30709027|NCT00492531|58722696|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
30709028|NCT00111475|58722712|FG000|Overall Study|Lost to Follow-up|0|||
30709029|NCT00111475|58722713|FG001|Overall Study|Lost to Follow-up|0|||
30709030|NCT00111475|58722714|FG002|Overall Study|Lost to Follow-up|0|||
30709031|NCT00111475|58722715|FG003|Overall Study|Lost to Follow-up|0|||
30709032|NCT00111475|58722716|FG004|Overall Study|Lost to Follow-up|0|||
30709033|NCT00111475|58722717|FG005|Overall Study|Lost to Follow-up|1|||
30709034|NCT00111475|58722718|FG006|Overall Study|Lost to Follow-up|0|||
30709035|NCT00111475|58722719|FG007|Overall Study|Lost to Follow-up|0|||
30709036|NCT00111475|58722720|FG008|Overall Study|Lost to Follow-up|0|||
30709037|NCT00111475|58722721|FG009|Overall Study|Lost to Follow-up|0|||
30709038|NCT00111241|58722750|FG000|Overall Study|Lost to Follow-up|1|||
30709039|NCT00111241|58722751|FG001|Overall Study|Lost to Follow-up|0|||
30709040|NCT00111241|58722750|FG000|Overall Study|Withdrawal by Subject|4|||
30709041|NCT00111241|58722751|FG001|Overall Study|Withdrawal by Subject|0|||
30709042|NCT00111241|58722750|FG000|Overall Study|Protocol Violation|9|||
30709043|NCT00111241|58722751|FG001|Overall Study|Protocol Violation|8|||
30709044|NCT00111241|58722750|FG000|Overall Study|Adverse Event|1|||
30709045|NCT00111241|58722751|FG001|Overall Study|Adverse Event|0|||
30709046|NCT00492297|58722759|FG000|Treatment|Death|2|||
30709047|NCT00492297|58722759|FG000|Treatment|Study terminated by sponsor|3|||
30709048|NCT00492297|58722759|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
30709049|NCT00492297|58722759|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
30894499|NCT02149875|58927960|FG001|Overall Study|Physician Decision|2|||
30894500|NCT02149875|58927961|FG002|Overall Study|Physician Decision|2|||
30894501|NCT02112045|58927971|FG000|Overall Study|Withdrawal by Subject|1|||
30894502|NCT02112045|58927972|FG001|Overall Study|Withdrawal by Subject|0|||
30894503|NCT01629693|58927980|FG000|Overall Study|Lost to Follow-up|2|||
30894504|NCT01629693|58927981|FG001|Overall Study|Lost to Follow-up|4|||
30894505|NCT01629693|58927980|FG000|Overall Study|Withdrawal by Subject|2|||
30894506|NCT01629693|58927981|FG001|Overall Study|Withdrawal by Subject|2|||
30894507|NCT01629693|58927980|FG000|Overall Study|Adverse Event|1|||
30894508|NCT01629693|58927981|FG001|Overall Study|Adverse Event|0|||
30894509|NCT01629693|58927980|FG000|Overall Study|Investigator decision|0|||
30894510|NCT01629693|58927981|FG001|Overall Study|Investigator decision|1|||
30894511|NCT01629693|58927980|FG000|Overall Study|Poor comfort of study lenses|0|||
30894512|NCT01629693|58927981|FG001|Overall Study|Poor comfort of study lenses|2|||
30894513|NCT01629693|58927980|FG000|Overall Study|Subject decision unrelated to AE|0|||
30894514|NCT01629693|58927981|FG001|Overall Study|Subject decision unrelated to AE|1|||
30894515|NCT02147691|58927989|FG000|Overall Study|Withdrawal by Subject|2|||
30894516|NCT02147691|58927990|FG001|Overall Study|Withdrawal by Subject|0|||
30894517|NCT02147691|58927989|FG000|Overall Study|Adverse Event|2|||
30894518|NCT02147691|58927990|FG001|Overall Study|Adverse Event|0|||
30894519|NCT02147691|58927989|FG000|Overall Study|Lost to Follow-up|0|||
30894520|NCT02147691|58927990|FG001|Overall Study|Lost to Follow-up|1|||
30894521|NCT02111811|58927998|FG000|Treatment Phase|Lost to Follow-up|22|||
30894522|NCT02111811|58927999|FG001|Treatment Phase|Lost to Follow-up|18|||
30894523|NCT02111811|58927998|FG000|Treatment Phase|Death|2|||
30894524|NCT02111811|58927999|FG001|Treatment Phase|Death|0|||
30894525|NCT02111811|58927998|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
30894526|NCT02111811|58927999|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
30894527|NCT02111811|58927998|FG000|Follow up Period (Aim 2)|Death|2|||
30894528|NCT02111811|58927999|FG001|Follow up Period (Aim 2)|Death|0|||
30894529|NCT01655693|58928008|FG000|Overall Study|Progression of Disease|92|||
30894530|NCT01655693|58928009|FG001|Overall Study|Progression of Disease|76|||
30709050|NCT00492297|58722759|FG000|Survival Only Follow-up|Death|46|||
30709051|NCT00492297|58722759|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
30709052|NCT00492297|58722759|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
30709053|NCT00565058|58722765|FG000|Overall Study|Adverse Event|1|||
30709054|NCT00565058|58722766|FG001|Overall Study|Adverse Event|0|||
30709055|NCT00564902|58722775|FG000|Overall Study|Withdrawal by Subject|0|||
30709056|NCT00564902|58722776|FG001|Overall Study|Withdrawal by Subject|3|||
30709057|NCT00564902|58722777|FG002|Overall Study|Withdrawal by Subject|4|||
30709058|NCT00564902|58722775|FG000|Overall Study|Death|1|||
30709059|NCT00564902|58722776|FG001|Overall Study|Death|1|||
30709060|NCT00564902|58722777|FG002|Overall Study|Death|0|||
30709061|NCT00446134|58722789|FG000|Overall Study|Adverse Event|7|||
30709062|NCT00446134|58722790|FG001|Overall Study|Adverse Event|17|||
30709063|NCT00446134|58722791|FG002|Overall Study|Adverse Event|13|||
30709064|NCT00446134|58722792|FG003|Overall Study|Adverse Event|18|||
30709065|NCT00446134|58722789|FG000|Overall Study|Lack of Efficacy|19|||
30709066|NCT00446134|58722790|FG001|Overall Study|Lack of Efficacy|19|||
30709067|NCT00446134|58722791|FG002|Overall Study|Lack of Efficacy|24|||
30709068|NCT00446134|58722792|FG003|Overall Study|Lack of Efficacy|19|||
30709069|NCT00446134|58722789|FG000|Overall Study|Protocol Violation|0|||
30709070|NCT00446134|58722790|FG001|Overall Study|Protocol Violation|2|||
30709071|NCT00446134|58722791|FG002|Overall Study|Protocol Violation|1|||
30709072|NCT00446134|58722792|FG003|Overall Study|Protocol Violation|0|||
30709073|NCT00446134|58722789|FG000|Overall Study|Lost to Follow-up|1|||
30894531|NCT01655693|58928010|FG002|Overall Study|Progression of Disease|58|||
30894532|NCT01655693|58928008|FG000|Overall Study|Death|8|||
30894533|NCT01655693|58928009|FG001|Overall Study|Death|9|||
30894534|NCT01655693|58928010|FG002|Overall Study|Death|12|||
30894535|NCT01655693|58928008|FG000|Overall Study|Serious Adverse Event|3|||
30894536|NCT01655693|58928009|FG001|Overall Study|Serious Adverse Event|15|||
30894537|NCT01655693|58928010|FG002|Overall Study|Serious Adverse Event|11|||
30894538|NCT01655693|58928008|FG000|Overall Study|Withdrawal by Subject|3|||
30894539|NCT01655693|58928009|FG001|Overall Study|Withdrawal by Subject|2|||
30894540|NCT01655693|58928010|FG002|Overall Study|Withdrawal by Subject|20|||
30894541|NCT01655693|58928008|FG000|Overall Study|Adverse Event|3|||
30709074|NCT00446134|58722790|FG001|Overall Study|Lost to Follow-up|3|||
30709075|NCT00446134|58722791|FG002|Overall Study|Lost to Follow-up|1|||
30709076|NCT00446134|58722792|FG003|Overall Study|Lost to Follow-up|1|||
30709077|NCT00446134|58722789|FG000|Overall Study|Withdrawal by Subject|3|||
30894542|NCT01655693|58928009|FG001|Overall Study|Adverse Event|11|||
30894543|NCT01655693|58928010|FG002|Overall Study|Adverse Event|3|||
30894544|NCT01655693|58928008|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
30709078|NCT00446134|58722790|FG001|Overall Study|Withdrawal by Subject|3|||
30709079|NCT00446134|58722791|FG002|Overall Study|Withdrawal by Subject|1|||
30709080|NCT00446134|58722792|FG003|Overall Study|Withdrawal by Subject|3|||
30894545|NCT01655693|58928009|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
30709081|NCT00446134|58722789|FG000|Overall Study|Physician Decision|0|||
30709082|NCT00446134|58722790|FG001|Overall Study|Physician Decision|0|||
30709083|NCT00446134|58722791|FG002|Overall Study|Physician Decision|0|||
30709084|NCT00446134|58722792|FG003|Overall Study|Physician Decision|2|||
30709085|NCT00446134|58722789|FG000|Overall Study|Adverse Event-Diarrhea|1|||
30709086|NCT00446134|58722790|FG001|Overall Study|Adverse Event-Diarrhea|1|||
30709087|NCT00446134|58722791|FG002|Overall Study|Adverse Event-Diarrhea|2|||
30709088|NCT00446134|58722792|FG003|Overall Study|Adverse Event-Diarrhea|0|||
30709089|NCT00446134|58722789|FG000|Overall Study|Reason Not Completed|3|||
30709090|NCT00446134|58722790|FG001|Overall Study|Reason Not Completed|0|||
30709091|NCT00446134|58722791|FG002|Overall Study|Reason Not Completed|1|||
30709092|NCT00446134|58722792|FG003|Overall Study|Reason Not Completed|2|||
30709093|NCT00563186|58722804|FG000|Overall Study|LOS<48 hours|97|||
30709094|NCT00563186|58722805|FG001|Overall Study|LOS<48 hours|74|||
30709095|NCT00563186|58722804|FG000|Overall Study|Incomplete data|1|||
30709096|NCT00563186|58722805|FG001|Overall Study|Incomplete data|1|||
30709097|NCT00699413|58722816|FG000|Overall Study|Withdrawal by Subject|0|||
30709098|NCT00699413|58722817|FG001|Overall Study|Withdrawal by Subject|2|||
30709099|NCT00699413|58722816|FG000|Overall Study|Study terminated by sponsor|4|||
30709100|NCT00699413|58722817|FG001|Overall Study|Study terminated by sponsor|2|||
30709101|NCT04808609|58722825|FG000|Overall Study|Lost to Follow-up|0|||
30709102|NCT04808609|58722826|FG001|Overall Study|Lost to Follow-up|2|||
30709103|NCT04808609|58722825|FG000|Overall Study|Administrative Withdrawal|0|||
30709104|NCT04808609|58722826|FG001|Overall Study|Administrative Withdrawal|1|||
30709105|NCT00111007|58722834|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
30709106|NCT00111007|58722835|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
30709107|NCT00111007|58722834|FG000|Double-blind (DB) Treatment|Death|5|||
30709108|NCT00111007|58722835|FG001|Double-blind (DB) Treatment|Death|2|||
30709109|NCT00111007|58722834|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
30709110|NCT00111007|58722835|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
30709111|NCT00111007|58722834|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
30709112|NCT00111007|58722835|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
30709113|NCT00111007|58722834|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
30709114|NCT00111007|58722835|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
30709115|NCT00111007|58722834|FG000|Double-blind (DB) Treatment|Relapse|1|||
30894546|NCT01655693|58928010|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
30894547|NCT01655693|58928008|FG000|Overall Study|Non-Compliance|0|||
30894548|NCT01655693|58928009|FG001|Overall Study|Non-Compliance|0|||
30894549|NCT01655693|58928010|FG002|Overall Study|Non-Compliance|7|||
30894550|NCT01655693|58928008|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
30894551|NCT01655693|58928009|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
30894552|NCT01655693|58928010|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
30894553|NCT01655693|58928008|FG000|Overall Study|Protocol Violation|1|||
30709116|NCT00111007|58722835|FG001|Double-blind (DB) Treatment|Relapse|0|||
30709117|NCT00111007|58722834|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
30709118|NCT00111007|58722835|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
30894554|NCT01655693|58928009|FG001|Overall Study|Protocol Violation|0|||
30894555|NCT01655693|58928010|FG002|Overall Study|Protocol Violation|3|||
30620767|NCT01003899|58632168|FG000|Overall Study|Not treated|1|||
30620768|NCT01003899|58632168|FG000|Overall Study|Progressive disease|34|||
30620769|NCT01000155|58632172|FG000|Overall Study|Withdrawal by Subject|1|||
30620770|NCT01000155|58632172|FG000|Overall Study|Adverse Event|1|||
30620771|NCT00999921|58632178|FG000|Overall Study|Lost to Follow-up|10|||
30620772|NCT00999921|58632179|FG001|Overall Study|Lost to Follow-up|19|||
30620773|NCT01002573|58632190|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
30620774|NCT01002573|58632191|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
30709119|NCT00111007|58722834|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
30709120|NCT00111007|58722835|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
30709121|NCT00111007|58722834|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
30709122|NCT00111007|58722835|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
30709123|NCT00111007|58722834|FG000|Active Follow-up|Adverse Event|1|||
30894556|NCT01655693|58928008|FG000|Overall Study|Lost to Follow-up|1|||
30894557|NCT01655693|58928009|FG001|Overall Study|Lost to Follow-up|0|||
30894558|NCT01655693|58928010|FG002|Overall Study|Lost to Follow-up|1|||
30894559|NCT01655693|58928008|FG000|Overall Study|Screening Failure|1|||
30894560|NCT01655693|58928009|FG001|Overall Study|Screening Failure|0|||
30709124|NCT00111007|58722835|FG001|Active Follow-up|Adverse Event|0|||
30894561|NCT01655693|58928010|FG002|Overall Study|Screening Failure|0|||
30620775|NCT00999687|58632197|FG000|First Intervention|Withdrawal by Subject|1|||
30894562|NCT01655693|58928008|FG000|Overall Study|Other|8|||
30709125|NCT00111007|58722834|FG000|Active Follow-up|Death|2|||
30709126|NCT00111007|58722835|FG001|Active Follow-up|Death|0|||
30709127|NCT00111007|58722834|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
30709128|NCT00111007|58722835|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
30709129|NCT00111007|58722834|FG000|Long Term Follow-up|Death|34|||
30709130|NCT00111007|58722835|FG001|Long Term Follow-up|Death|39|||
30709131|NCT00111007|58722834|FG000|Long Term Follow-up|Lost to Follow-up|1|||
30709132|NCT00111007|58722835|FG001|Long Term Follow-up|Lost to Follow-up|1|||
30709133|NCT00111007|58722834|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
30709134|NCT00111007|58722835|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
30709135|NCT00111007|58722834|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
30894563|NCT01655693|58928009|FG001|Overall Study|Other|6|||
30894564|NCT01655693|58928010|FG002|Overall Study|Other|15|||
30894565|NCT01655381|58928028|FG000|Overall Study|Investigator Decision|1|||
30894566|NCT01655381|58928028|FG000|Overall Study|Moved to Another City|1|||
30894567|NCT01655381|58928028|FG000|Overall Study|Insufficient Treatment Response|1|||
30894568|NCT01656161|58928033|FG000|Overall Study|Death|3|||
30894569|NCT01656161|58928033|FG000|Overall Study|Adverse Event|2|||
30894570|NCT01656161|58928033|FG000|Overall Study|Protocol Violation|1|||
30894571|NCT01656161|58928033|FG000|Overall Study|Withdrawal by Subject|1|||
30894572|NCT02111577|58928042|FG000|Overall Study|Protocol Violation|2|||
30894573|NCT02111577|58928043|FG001|Overall Study|Protocol Violation|0|||
30894574|NCT02111577|58928042|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
30894575|NCT02111577|58928043|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
30894576|NCT02111577|58928042|FG000|Overall Study|Failure to produce study treatment|6|||
30894577|NCT02111577|58928043|FG001|Overall Study|Failure to produce study treatment|0|||
30894578|NCT02111577|58928042|FG000|Overall Study|Death|518|||
30894579|NCT02111577|58928043|FG001|Overall Study|Death|254|||
30894580|NCT02111577|58928042|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
30894581|NCT02111577|58928043|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
30894582|NCT02111577|58928042|FG000|Overall Study|Adverse Event|1|||
30894583|NCT02111577|58928043|FG001|Overall Study|Adverse Event|1|||
30620776|NCT00999687|58632197|FG000|Second Intervention|Withdrawal by Subject|2|||
30620777|NCT00999687|58632197|FG000|Second Intervention|Lack of Efficacy|1|||
30620778|NCT00996333|58632203|FG000|Overall Study|Screen failure|1|||
30620779|NCT00996333|58632203|FG000|Overall Study|Withdrawal by Subject|1|||
30620780|NCT00996333|58632203|FG000|Overall Study|Death|4|||
30620781|NCT00996333|58632203|FG000|Overall Study|Adverse Event|1|||
30620782|NCT00996333|58632203|FG000|Overall Study|Physician Decision|1|||
30620783|NCT00996333|58632203|FG000|Overall Study|Other|5|||
30620784|NCT00995865|58632210|FG000|Overall Study|Protocol Violation|2|||
30620785|NCT00995865|58632211|FG001|Overall Study|Protocol Violation|0|||
30620786|NCT00995865|58632212|FG002|Overall Study|Protocol Violation|0|||
30620787|NCT00995865|58632210|FG000|Overall Study|Lost to Follow-up|0|||
30620788|NCT00995865|58632211|FG001|Overall Study|Lost to Follow-up|0|||
30620789|NCT00995865|58632212|FG002|Overall Study|Lost to Follow-up|1|||
30620790|NCT00995709|58632228|FG000|Overall Study|Adverse Event|4|||
30620791|NCT00995709|58632229|FG001|Overall Study|Adverse Event|2|||
30620792|NCT00995709|58632230|FG002|Overall Study|Adverse Event|0|||
30620793|NCT00995709|58632228|FG000|Overall Study|Lack of Efficacy|0|||
30620794|NCT00995709|58632229|FG001|Overall Study|Lack of Efficacy|1|||
30620795|NCT00995709|58632230|FG002|Overall Study|Lack of Efficacy|4|||
30620796|NCT00995709|58632228|FG000|Overall Study|Withdrawal by Subject|0|||
30620797|NCT00995709|58632229|FG001|Overall Study|Withdrawal by Subject|4|||
30620798|NCT00995709|58632230|FG002|Overall Study|Withdrawal by Subject|1|||
30620799|NCT00995709|58632228|FG000|Overall Study|Lost to Follow-up|1|||
30620800|NCT00995709|58632229|FG001|Overall Study|Lost to Follow-up|0|||
30620801|NCT00995709|58632230|FG002|Overall Study|Lost to Follow-up|0|||
30620802|NCT00995709|58632228|FG000|Overall Study|Death|0|||
30620803|NCT00995709|58632229|FG001|Overall Study|Death|1|||
30620804|NCT00995709|58632230|FG002|Overall Study|Death|0|||
30709136|NCT00111007|58722835|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
30894584|NCT02111577|58928042|FG000|Overall Study|Withdrawal by Subject|51|||
30894585|NCT02111577|58928043|FG001|Overall Study|Withdrawal by Subject|23|||
30894586|NCT02111577|58928042|FG000|Overall Study|Disease progression|0|||
30894587|NCT02111577|58928043|FG001|Overall Study|Disease progression|1|||
30894588|NCT02111577|58928042|FG000|Overall Study|Lost to Follow-up|19|||
30894589|NCT02111577|58928043|FG001|Overall Study|Lost to Follow-up|10|||
30620805|NCT00995709|58632228|FG000|Overall Study|Protocol Violation|2|||
30620806|NCT00995709|58632229|FG001|Overall Study|Protocol Violation|1|||
30620807|NCT00995709|58632230|FG002|Overall Study|Protocol Violation|0|||
30620808|NCT00998985|58632252|FG000|Overall Study|Withdrawal by Subject|0|||
30620809|NCT00998985|58632253|FG001|Overall Study|Withdrawal by Subject|0|||
30620810|NCT00998985|58632254|FG002|Overall Study|Withdrawal by Subject|0|||
30709137|NCT00111007|58722834|FG000|Long Term Follow-up|Missing|10|||
30709138|NCT00111007|58722835|FG001|Long Term Follow-up|Missing|3|||
30894590|NCT02170779|58928053|FG000|Overall Study|Withdrawal by Subject|1|||
30620811|NCT00998985|58632255|FG003|Overall Study|Withdrawal by Subject|0|||
30894591|NCT02170779|58928054|FG001|Overall Study|Withdrawal by Subject|0|||
30894592|NCT02170779|58928053|FG000|Overall Study|Lost to Follow-up|0|||
30894593|NCT02170779|58928054|FG001|Overall Study|Lost to Follow-up|1|||
30894594|NCT02147067|58928062|FG000|Overall Study|Withdrawal by Subject|2|||
30894595|NCT02147067|58928063|FG001|Overall Study|Withdrawal by Subject|2|||
30894596|NCT02170389|58928069|FG000|Overall Study|Study terminated prior to start of treat|1|||
30894597|NCT02146599|58928073|FG000|Overall Study|Failed to meet inclusion criteria|5|||
30894598|NCT02146365|58928083|FG000|Overall Study|Lost to Follow-up|2|||
30894599|NCT02146365|58928084|FG001|Overall Study|Lost to Follow-up|1|||
30894600|NCT02146365|58928085|FG002|Overall Study|Lost to Follow-up|3|||
30894601|NCT02146365|58928086|FG003|Overall Study|Lost to Follow-up|3|||
30894602|NCT02146365|58928087|FG004|Overall Study|Lost to Follow-up|1|||
30894603|NCT02146365|58928088|FG005|Overall Study|Lost to Follow-up|1|||
30894604|NCT02146365|58928089|FG006|Overall Study|Lost to Follow-up|0|||
30894605|NCT02146365|58928090|FG007|Overall Study|Lost to Follow-up|1|||
30709139|NCT03975920|58722843|FG000|Overall Study|Lost to Follow-up|1|||
30709140|NCT03975920|58722844|FG001|Overall Study|Lost to Follow-up|2|||
30709141|NCT03975920|58722843|FG000|Overall Study|Protocol Violation|1|||
30709142|NCT03975920|58722844|FG001|Overall Study|Protocol Violation|1|||
30709143|NCT03975920|58722843|FG000|Overall Study|Did not complete survey|2|||
30709144|NCT03975920|58722844|FG001|Overall Study|Did not complete survey|1|||
30709145|NCT00699335|58722850|FG000|Overall Study|Combination of multiple reasons|176|||
30709146|NCT00699335|58722850|FG000|Overall Study|Missing data|52|||
30709147|NCT00445978|58722857|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
30709148|NCT00445978|58722857|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
30709149|NCT00445978|58722857|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
30709150|NCT00445978|58722857|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
30709151|NCT00445978|58722857|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
30709152|NCT00445978|58722857|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
30709153|NCT00445978|58722857|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
30709154|NCT00445978|58722857|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
30709155|NCT00445978|58722857|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
30709156|NCT00566228|58722870|FG000|Overall Study|Withdrawal by Subject|1|||
30709157|NCT00566228|58722871|FG001|Overall Study|Withdrawal by Subject|0|||
30709158|NCT00566228|58722870|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
30709159|NCT00566228|58722871|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
30709160|NCT00566228|58722870|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
30709161|NCT00566228|58722871|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
30709162|NCT00566228|58722870|FG000|Overall Study|progressed before infusion could occur|0|||
30709163|NCT00566228|58722871|FG001|Overall Study|progressed before infusion could occur|1|||
30709164|NCT00698009|58722877|FG000|Overall Study|Withdrawal by Subject|1|||
30709165|NCT03968978|58722883|FG000|Overall Study|Adverse Event|1|||
30709166|NCT03968978|58722884|FG001|Overall Study|Adverse Event|0|||
30709167|NCT00562718|58722890|FG000|Overall Study|Death|1|||
30709168|NCT00562718|58722890|FG000|Overall Study|Withdrawal by Subject|3|||
30709169|NCT00562718|58722890|FG000|Overall Study|Adverse Event|4|||
30709170|NCT00562718|58722890|FG000|Overall Study|Lack of Efficacy|2|||
30709171|NCT00562718|58722890|FG000|Overall Study|not stated|1|||
30709172|NCT00697619|58722896|FG000|Overall Study|Lack of Efficacy|2|||
30709173|NCT00697619|58722897|FG001|Overall Study|Lack of Efficacy|2|||
30709174|NCT00697619|58722896|FG000|Overall Study|Adverse Event|4|||
30709175|NCT00697619|58722897|FG001|Overall Study|Adverse Event|6|||
30709176|NCT00445432|58722906|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
30709177|NCT00445432|58722907|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
30790871|NCT03524092|58803944|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
30790872|NCT03524092|58803945|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
30790873|NCT03524092|58803940|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
30790874|NCT03524092|58803941|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
30790875|NCT03524092|58803942|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
30709178|NCT00445432|58722908|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
30709179|NCT00445432|58722909|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
30790876|NCT03524092|58803943|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
30790877|NCT03524092|58803944|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
30790878|NCT03524092|58803945|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
30790879|NCT03524092|58803940|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
30894606|NCT02146365|58928083|FG000|Overall Study|Withdrawal by Subject|1|||
30709180|NCT00445432|58722906|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
30709181|NCT00445432|58722907|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
30709182|NCT00445432|58722908|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
30709183|NCT00445432|58722909|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
30894607|NCT02146365|58928084|FG001|Overall Study|Withdrawal by Subject|2|||
30894608|NCT02146365|58928085|FG002|Overall Study|Withdrawal by Subject|1|||
30894609|NCT02146365|58928086|FG003|Overall Study|Withdrawal by Subject|5|||
30894610|NCT02146365|58928087|FG004|Overall Study|Withdrawal by Subject|1|||
30894611|NCT02146365|58928088|FG005|Overall Study|Withdrawal by Subject|0|||
30894612|NCT02146365|58928089|FG006|Overall Study|Withdrawal by Subject|0|||
30894613|NCT02146365|58928090|FG007|Overall Study|Withdrawal by Subject|0|||
30894614|NCT02146365|58928083|FG000|Overall Study|Unable to Comply with Protocol|0|||
30894615|NCT02146365|58928084|FG001|Overall Study|Unable to Comply with Protocol|1|||
30894616|NCT02146365|58928085|FG002|Overall Study|Unable to Comply with Protocol|1|||
30894617|NCT02146365|58928086|FG003|Overall Study|Unable to Comply with Protocol|0|||
30894618|NCT02146365|58928087|FG004|Overall Study|Unable to Comply with Protocol|0|||
30894619|NCT02146365|58928088|FG005|Overall Study|Unable to Comply with Protocol|0|||
30894620|NCT02146365|58928089|FG006|Overall Study|Unable to Comply with Protocol|0|||
30894621|NCT02146365|58928090|FG007|Overall Study|Unable to Comply with Protocol|0|||
30894622|NCT02146365|58928083|FG000|Overall Study|Other|1|||
30894623|NCT02146365|58928084|FG001|Overall Study|Other|0|||
30894624|NCT02146365|58928085|FG002|Overall Study|Other|2|||
30894625|NCT02146365|58928086|FG003|Overall Study|Other|1|||
30894626|NCT02146365|58928087|FG004|Overall Study|Other|0|||
30894627|NCT02146365|58928088|FG005|Overall Study|Other|0|||
30894628|NCT02146365|58928089|FG006|Overall Study|Other|0|||
30894629|NCT02146365|58928090|FG007|Overall Study|Other|0|||
30894630|NCT02146131|58928110|FG000|Overall Study|Physician Decision|61|||
30894631|NCT02146131|58928111|FG001|Overall Study|Physician Decision|56|||
30894632|NCT02107131|58928119|FG000|Overall Study|Lost to Follow-up|4|||
30894633|NCT02107131|58928120|FG001|Overall Study|Lost to Follow-up|4|||
30894634|NCT02107131|58928119|FG000|Overall Study|Physician Decision|1|||
30894635|NCT02107131|58928120|FG001|Overall Study|Physician Decision|0|||
30894636|NCT02107131|58928119|FG000|Overall Study|Withdrawal by Subject|2|||
30894637|NCT02107131|58928120|FG001|Overall Study|Withdrawal by Subject|0|||
30894638|NCT02107131|58928119|FG000|Overall Study|mental instability|1|||
30894639|NCT02107131|58928120|FG001|Overall Study|mental instability|0|||
30894640|NCT02107131|58928119|FG000|Overall Study|Death|0|||
30894641|NCT02107131|58928120|FG001|Overall Study|Death|1|||
30894642|NCT02107131|58928119|FG000|Overall Study|Protocol Violation|0|||
30894643|NCT02107131|58928120|FG001|Overall Study|Protocol Violation|4|||
30894644|NCT02106975|58928130|FG000|Overall Study|Death|25|||
30894645|NCT02106975|58928131|FG001|Overall Study|Death|39|||
30894646|NCT02145429|58928139|FG000|Overall Study|Death|4|||
30894647|NCT02145429|58928140|FG001|Overall Study|Death|5|||
30894648|NCT02145429|58928139|FG000|Overall Study|Lost to Follow-up|4|||
30894649|NCT02145429|58928140|FG001|Overall Study|Lost to Follow-up|3|||
30894650|NCT02145429|58928139|FG000|Overall Study|Withdrawal by Subject|8|||
30894651|NCT02145429|58928140|FG001|Overall Study|Withdrawal by Subject|3|||
30894652|NCT02144337|58928148|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
30894653|NCT02144337|58928149|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
30894654|NCT02144337|58928148|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
30894655|NCT02144337|58928149|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
30894656|NCT02144337|58928148|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
30894657|NCT02144337|58928149|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
30894658|NCT02144337|58928148|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
30894659|NCT02144337|58928149|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
30894660|NCT02144337|58928148|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
30894661|NCT02144337|58928149|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
30894662|NCT02520011|58928159|FG000|Overall Study|Adverse Event|0|||
30894663|NCT02520011|58928160|FG001|Overall Study|Adverse Event|1|||
30894664|NCT02520011|58928161|FG002|Overall Study|Adverse Event|2|||
30894665|NCT02520011|58928159|FG000|Overall Study|Death|0|||
30894666|NCT02520011|58928160|FG001|Overall Study|Death|8|||
30894667|NCT02520011|58928161|FG002|Overall Study|Death|1|||
30894668|NCT02520011|58928159|FG000|Overall Study|Lack of Efficacy|4|||
30894669|NCT02520011|58928160|FG001|Overall Study|Lack of Efficacy|26|||
30894670|NCT02520011|58928161|FG002|Overall Study|Lack of Efficacy|4|||
30894671|NCT02520011|58928159|FG000|Overall Study|Physician Decision|0|||
30894672|NCT02520011|58928160|FG001|Overall Study|Physician Decision|2|||
30894673|NCT02520011|58928161|FG002|Overall Study|Physician Decision|0|||
30894674|NCT02520011|58928159|FG000|Overall Study|Withdrawal by Subject|1|||
30894675|NCT02520011|58928160|FG001|Overall Study|Withdrawal by Subject|3|||
30894676|NCT02520011|58928161|FG002|Overall Study|Withdrawal by Subject|0|||
30894677|NCT02520011|58928159|FG000|Overall Study|Protocol Deviation|0|||
30894678|NCT02520011|58928160|FG001|Overall Study|Protocol Deviation|1|||
30894679|NCT02520011|58928161|FG002|Overall Study|Protocol Deviation|0|||
30894680|NCT02520011|58928159|FG000|Overall Study|Patient went to hospice|0|||
30894681|NCT02520011|58928160|FG001|Overall Study|Patient went to hospice|1|||
30894682|NCT02520011|58928161|FG002|Overall Study|Patient went to hospice|0|||
30894683|NCT02520011|58928159|FG000|Overall Study|Progressive disease following response|0|||
30894684|NCT02520011|58928160|FG001|Overall Study|Progressive disease following response|4|||
30894685|NCT02520011|58928161|FG002|Overall Study|Progressive disease following response|2|||
30894686|NCT02519231|58928176|FG000|Overall Study|Lost to Follow-up|2|||
30894687|NCT02519231|58928177|FG001|Overall Study|Lost to Follow-up|5|||
30894688|NCT02519231|58928176|FG000|Overall Study|Withdrawal by Subject|0|||
30894689|NCT02519231|58928177|FG001|Overall Study|Withdrawal by Subject|1|||
30894690|NCT02106351|58928188|FG000|Treatment Cycle 1|Adverse Event|2|||
30894691|NCT02106351|58928189|FG001|Treatment Cycle 1|Adverse Event|0|||
30894692|NCT02106351|58928190|FG002|Treatment Cycle 1|Adverse Event|0|||
30894693|NCT02106351|58928188|FG000|Treatment Cycle 1|Consent withdrawn|1|||
30709184|NCT00445432|58722906|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
30894694|NCT02106351|58928189|FG001|Treatment Cycle 1|Consent withdrawn|0|||
30894695|NCT02106351|58928190|FG002|Treatment Cycle 1|Consent withdrawn|2|||
30894696|NCT02106351|58928188|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
30894697|NCT02106351|58928189|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
30894698|NCT02106351|58928190|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
30894699|NCT02106351|58928188|FG000|Treatment Cycle 1|Other|0|||
30894700|NCT02106351|58928189|FG001|Treatment Cycle 1|Other|3|||
30894701|NCT02106351|58928190|FG002|Treatment Cycle 1|Other|1|||
30894702|NCT02106351|58928188|FG000|Treatment Cycle 1|Randomised but not treated|1|||
30894703|NCT02106351|58928189|FG001|Treatment Cycle 1|Randomised but not treated|0|||
30894704|NCT02106351|58928190|FG002|Treatment Cycle 1|Randomised but not treated|1|||
30894705|NCT02106351|58928188|FG000|Treatment Cycle 2|Adverse Event|0|||
30894706|NCT02106351|58928189|FG001|Treatment Cycle 2|Adverse Event|2|||
30894707|NCT02106351|58928190|FG002|Treatment Cycle 2|Adverse Event|0|||
30894708|NCT02106351|58928188|FG000|Treatment Cycle 2|Consent withdrawn|0|||
30894709|NCT02106351|58928189|FG001|Treatment Cycle 2|Consent withdrawn|1|||
30894710|NCT02106351|58928190|FG002|Treatment Cycle 2|Consent withdrawn|1|||
30894711|NCT02106351|58928188|FG000|Treatment Cycle 2|Other|0|||
30894712|NCT02106351|58928189|FG001|Treatment Cycle 2|Other|2|||
30894713|NCT02106351|58928190|FG002|Treatment Cycle 2|Other|2|||
30894714|NCT02106351|58928188|FG000|Treatment Cycle 3|Adverse Event|0|||
30894715|NCT02106351|58928189|FG001|Treatment Cycle 3|Adverse Event|1|||
30894716|NCT02106351|58928190|FG002|Treatment Cycle 3|Adverse Event|0|||
30894717|NCT02106351|58928188|FG000|Treatment Cycle 3|Consent withdrawn|0|||
30894718|NCT02106351|58928189|FG001|Treatment Cycle 3|Consent withdrawn|0|||
30894719|NCT02106351|58928190|FG002|Treatment Cycle 3|Consent withdrawn|2|||
30894720|NCT02106351|58928188|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
30894721|NCT02106351|58928189|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
30894722|NCT02106351|58928190|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
30894723|NCT02106351|58928188|FG000|Treatment Cycle 3|Other|0|||
30894724|NCT02106351|58928189|FG001|Treatment Cycle 3|Other|2|||
30894725|NCT02106351|58928190|FG002|Treatment Cycle 3|Other|3|||
30894726|NCT02106351|58928188|FG000|Treatment Cycle 4|Consent withdrawn|0|||
30894727|NCT02106351|58928189|FG001|Treatment Cycle 4|Consent withdrawn|0|||
30894728|NCT02106351|58928190|FG002|Treatment Cycle 4|Consent withdrawn|2|||
30894729|NCT02106351|58928188|FG000|Treatment Cycle 4|Other|0|||
30894730|NCT02106351|58928189|FG001|Treatment Cycle 4|Other|1|||
30894731|NCT02106351|58928190|FG002|Treatment Cycle 4|Other|0|||
30894732|NCT02143947|58928206|FG000|Overall Study|Lost to Follow-up|4|||
30894733|NCT02143947|58928207|FG001|Overall Study|Lost to Follow-up|2|||
30894734|NCT02075073|58928218|FG000|Overall Study|Withdrawal by Subject|0|||
30894735|NCT02075073|58928219|FG001|Overall Study|Withdrawal by Subject|1|||
30894736|NCT02075073|58928220|FG002|Overall Study|Withdrawal by Subject|0|||
30894737|NCT02074059|58928234|FG000|Overall Study|Death|0|||
30894738|NCT02074059|58928235|FG001|Overall Study|Death|0|||
30894739|NCT02074059|58928236|FG002|Overall Study|Death|0|||
30894740|NCT02074059|58928237|FG003|Overall Study|Death|0|||
30894741|NCT02074059|58928238|FG004|Overall Study|Death|1|||
30894742|NCT02074059|58928239|FG005|Overall Study|Death|1|||
30894743|NCT01364597|58928258|FG000|Overall Study|Adverse Event|4|||
30894744|NCT01364597|58928259|FG001|Overall Study|Adverse Event|5|||
30894745|NCT01364597|58928260|FG002|Overall Study|Adverse Event|16|||
30894746|NCT01364597|58928261|FG003|Overall Study|Adverse Event|7|||
30894747|NCT01364597|58928258|FG000|Overall Study|Lack of Efficacy|4|||
30894748|NCT01364597|58928259|FG001|Overall Study|Lack of Efficacy|4|||
30894749|NCT01364597|58928260|FG002|Overall Study|Lack of Efficacy|23|||
30894750|NCT01364597|58928261|FG003|Overall Study|Lack of Efficacy|8|||
30894751|NCT01364597|58928258|FG000|Overall Study|Protocol Violation|0|||
30894752|NCT01364597|58928259|FG001|Overall Study|Protocol Violation|0|||
30894753|NCT01364597|58928260|FG002|Overall Study|Protocol Violation|2|||
30894754|NCT01364597|58928261|FG003|Overall Study|Protocol Violation|0|||
30894755|NCT01364597|58928258|FG000|Overall Study|Lost to Follow-up|0|||
30894756|NCT01364597|58928259|FG001|Overall Study|Lost to Follow-up|0|||
30894757|NCT01364597|58928260|FG002|Overall Study|Lost to Follow-up|5|||
30894758|NCT01364597|58928261|FG003|Overall Study|Lost to Follow-up|3|||
30894759|NCT01364597|58928258|FG000|Overall Study|Withdrawal by Subject|4|||
30894760|NCT01364597|58928259|FG001|Overall Study|Withdrawal by Subject|1|||
30894761|NCT01364597|58928260|FG002|Overall Study|Withdrawal by Subject|18|||
30894762|NCT01364597|58928261|FG003|Overall Study|Withdrawal by Subject|6|||
30894763|NCT01364597|58928258|FG000|Overall Study|Non compliance|1|||
30894764|NCT01364597|58928259|FG001|Overall Study|Non compliance|0|||
30894765|NCT01364597|58928260|FG002|Overall Study|Non compliance|1|||
30894766|NCT01364597|58928261|FG003|Overall Study|Non compliance|0|||
30894767|NCT01364597|58928258|FG000|Overall Study|Lack of compliance|1|||
30894768|NCT01364597|58928259|FG001|Overall Study|Lack of compliance|0|||
30894769|NCT01364597|58928260|FG002|Overall Study|Lack of compliance|0|||
30894770|NCT01364597|58928261|FG003|Overall Study|Lack of compliance|0|||
30894771|NCT01364597|58928258|FG000|Overall Study|End of treatment epilepsy|1|||
30894772|NCT01364597|58928259|FG001|Overall Study|End of treatment epilepsy|0|||
30894773|NCT01364597|58928260|FG002|Overall Study|End of treatment epilepsy|0|||
30894774|NCT01364597|58928261|FG003|Overall Study|End of treatment epilepsy|0|||
30709185|NCT00445432|58722907|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
30709186|NCT00445432|58722908|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
30709187|NCT00445432|58722909|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
30709188|NCT00445432|58722906|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
30709189|NCT00445432|58722907|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
30709190|NCT00445432|58722908|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
30709191|NCT00445432|58722909|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
30709192|NCT00445432|58722906|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
30709193|NCT00445432|58722907|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
30709194|NCT00445432|58722908|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
30709195|NCT00445432|58722909|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
30709196|NCT00445432|58722906|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
30709197|NCT00445432|58722907|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
30709198|NCT00445432|58722908|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
30709199|NCT00445432|58722909|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
30709200|NCT00445432|58722906|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
30709201|NCT00445432|58722907|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
30709202|NCT00445432|58722908|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
30709203|NCT00445432|58722909|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
30709204|NCT03370133|58722923|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
30709205|NCT03370133|58722924|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
30709206|NCT03370133|58722925|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
30709207|NCT03370133|58722926|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
30709208|NCT03370133|58722927|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
30709209|NCT03370133|58722928|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
30709210|NCT03370133|58722923|FG000|Initial Treatment Period (WK 16)|Death|1|||
30709211|NCT03370133|58722924|FG001|Initial Treatment Period (WK 16)|Death|1|||
30709212|NCT03370133|58722925|FG002|Initial Treatment Period (WK 16)|Death|1|||
30709213|NCT03370133|58722926|FG003|Initial Treatment Period (WK 16)|Death|0|||
30709214|NCT03370133|58722927|FG004|Initial Treatment Period (WK 16)|Death|0|||
30709215|NCT03370133|58722928|FG005|Initial Treatment Period (WK 16)|Death|0|||
30709216|NCT03370133|58722923|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
30709217|NCT03370133|58722924|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
30709218|NCT03370133|58722925|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
30709219|NCT03370133|58722926|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
30709220|NCT03370133|58722927|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
30709221|NCT03370133|58722928|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
30709222|NCT03370133|58722923|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
30709223|NCT03370133|58722924|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
30709224|NCT03370133|58722925|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
30709225|NCT03370133|58722926|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
30709226|NCT03370133|58722927|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
30709227|NCT03370133|58722928|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
30709228|NCT03370133|58722923|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
30709229|NCT03370133|58722924|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
30709230|NCT03370133|58722925|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
30709231|NCT03370133|58722926|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
30709232|NCT03370133|58722927|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
30709233|NCT03370133|58722928|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
30709234|NCT03370133|58722923|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
30709235|NCT03370133|58722924|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
30709236|NCT03370133|58722925|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
30709237|NCT03370133|58722926|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
30709238|NCT03370133|58722927|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
30709239|NCT03370133|58722928|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
30709240|NCT03370133|58722923|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
30709241|NCT03370133|58722924|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
30709242|NCT03370133|58722925|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
30709243|NCT03370133|58722926|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
30709244|NCT03370133|58722927|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
30709245|NCT03370133|58722928|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
30709246|NCT03370133|58722923|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
30709247|NCT03370133|58722924|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
30709248|NCT03370133|58722925|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
30709249|NCT03370133|58722926|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
30709250|NCT03370133|58722927|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
30709251|NCT03370133|58722928|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
30709252|NCT03370133|58722923|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
30709253|NCT03370133|58722924|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
30709254|NCT03370133|58722925|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
30709255|NCT03370133|58722926|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
30709256|NCT03370133|58722927|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
30709257|NCT03370133|58722928|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
30709258|NCT03370133|58722923|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
30709259|NCT03370133|58722924|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
30709260|NCT03370133|58722925|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
30709261|NCT03370133|58722926|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
30709262|NCT03370133|58722927|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
30709263|NCT03370133|58722928|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
30709264|NCT03370133|58722923|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
30709265|NCT03370133|58722924|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
30709266|NCT03370133|58722925|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
30620812|NCT00998985|58632256|FG004|Overall Study|Withdrawal by Subject|0|||
30620813|NCT00998985|58632257|FG005|Overall Study|Withdrawal by Subject|0|||
30709267|NCT03370133|58722926|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
30709268|NCT03370133|58722927|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
30709269|NCT03370133|58722928|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
30709270|NCT03370133|58722923|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
30709271|NCT03370133|58722924|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
30709272|NCT03370133|58722925|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
30709273|NCT03370133|58722926|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
30709274|NCT03370133|58722927|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
30709275|NCT03370133|58722928|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
30709276|NCT03370133|58722923|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
30709277|NCT03370133|58722924|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
30709278|NCT03370133|58722925|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
30709279|NCT03370133|58722926|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
30709280|NCT03370133|58722927|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
30709281|NCT03370133|58722928|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
30709282|NCT03370133|58722923|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
30709283|NCT03370133|58722924|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
30709284|NCT03370133|58722925|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
30709285|NCT03370133|58722926|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
30709286|NCT03370133|58722927|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
30709287|NCT03370133|58722928|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
30709288|NCT03370133|58722923|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
30709289|NCT03370133|58722924|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
30709290|NCT03370133|58722925|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
30709291|NCT03370133|58722926|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
30709292|NCT03370133|58722927|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
30709293|NCT03370133|58722928|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
30709294|NCT00696137|58722946|FG000|Overall Study|Withdrawal by Subject|2|||
30709295|NCT00441142|58722954|FG000|Overall Study|Adverse Event|2|||
30709296|NCT00441142|58722955|FG001|Overall Study|Adverse Event|3|||
30709297|NCT00441142|58722956|FG002|Overall Study|Adverse Event|3|||
30709298|NCT00441142|58722957|FG003|Overall Study|Adverse Event|22|||
30709299|NCT00441142|58722954|FG000|Overall Study|Lack of Efficacy|3|||
30709300|NCT00441142|58722955|FG001|Overall Study|Lack of Efficacy|3|||
30620814|NCT00998985|58632258|FG006|Overall Study|Withdrawal by Subject|0|||
30620815|NCT00998985|58632259|FG007|Overall Study|Withdrawal by Subject|0|||
30620816|NCT00998985|58632260|FG008|Overall Study|Withdrawal by Subject|1|||
30620817|NCT00998985|58632261|FG009|Overall Study|Withdrawal by Subject|0|||
30620818|NCT00998985|58632262|FG010|Overall Study|Withdrawal by Subject|0|||
30620819|NCT00998985|58632263|FG011|Overall Study|Withdrawal by Subject|0|||
30620820|NCT00998985|58632264|FG012|Overall Study|Withdrawal by Subject|0|||
30709301|NCT00441142|58722956|FG002|Overall Study|Lack of Efficacy|17|||
30709302|NCT00441142|58722957|FG003|Overall Study|Lack of Efficacy|32|||
30620821|NCT00998985|58632265|FG013|Overall Study|Withdrawal by Subject|0|||
30709303|NCT00441142|58722954|FG000|Overall Study|Withdrawal by Subject|0|||
30709304|NCT00441142|58722955|FG001|Overall Study|Withdrawal by Subject|0|||
30709305|NCT00441142|58722956|FG002|Overall Study|Withdrawal by Subject|2|||
30709306|NCT00441142|58722957|FG003|Overall Study|Withdrawal by Subject|10|||
30709307|NCT00441142|58722954|FG000|Overall Study|Patient still receiving active study tx|1|||
30709308|NCT00441142|58722955|FG001|Overall Study|Patient still receiving active study tx|0|||
30709309|NCT00441142|58722956|FG002|Overall Study|Patient still receiving active study tx|0|||
30709310|NCT00441142|58722957|FG003|Overall Study|Patient still receiving active study tx|2|||
30709311|NCT00441142|58722954|FG000|Overall Study|Physician Decision|0|||
30709312|NCT00441142|58722955|FG001|Overall Study|Physician Decision|1|||
30709313|NCT00441142|58722956|FG002|Overall Study|Physician Decision|0|||
30709314|NCT00441142|58722957|FG003|Overall Study|Physician Decision|1|||
30709315|NCT00441142|58722954|FG000|Overall Study|Death|0|||
30709316|NCT00441142|58722955|FG001|Overall Study|Death|0|||
30709317|NCT00441142|58722956|FG002|Overall Study|Death|0|||
30709318|NCT00441142|58722957|FG003|Overall Study|Death|1|||
30709319|NCT04025021|58722971|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
30709320|NCT04025021|58722972|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
30709321|NCT03848416|58722982|FG000|Overall Study|Withdrawal by Subject|1|||
30709322|NCT03848416|58722983|FG001|Overall Study|Withdrawal by Subject|0|||
30709323|NCT03848416|58722984|FG002|Overall Study|Withdrawal by Subject|0|||
30709324|NCT03848416|58722982|FG000|Overall Study|Death|0|||
30709325|NCT03848416|58722983|FG001|Overall Study|Death|0|||
30709326|NCT03848416|58722984|FG002|Overall Study|Death|1|||
30709327|NCT00458302|58722994|FG000|Overall Study|Adverse Event|4|||
30709328|NCT00458302|58722995|FG001|Overall Study|Adverse Event|14|||
30709329|NCT00458302|58722994|FG000|Overall Study|Pregnancy|2|||
30709330|NCT00458302|58722995|FG001|Overall Study|Pregnancy|1|||
30709331|NCT00458302|58722994|FG000|Overall Study|Protocol Violation|0|||
30709332|NCT00458302|58722995|FG001|Overall Study|Protocol Violation|2|||
30709333|NCT00458302|58722994|FG000|Overall Study|Withdrawal by Subject|6|||
30709334|NCT00458302|58722995|FG001|Overall Study|Withdrawal by Subject|4|||
30709335|NCT00458302|58722994|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
30709336|NCT00458302|58722995|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
30709337|NCT00458302|58722994|FG000|Overall Study|Study Termination By Sponsor|1|||
30709338|NCT00458302|58722995|FG001|Overall Study|Study Termination By Sponsor|0|||
30709339|NCT00458302|58722994|FG000|Overall Study|Lost to Follow-up|2|||
30709340|NCT00458302|58722995|FG001|Overall Study|Lost to Follow-up|0|||
30709341|NCT00458302|58722994|FG000|Overall Study|Other|4|||
30709342|NCT00458302|58722995|FG001|Overall Study|Other|2|||
30709343|NCT00444106|58723005|FG000|Overall Study|Lost to Follow-up|2|||
30709344|NCT00444106|58723006|FG001|Overall Study|Lost to Follow-up|1|||
30709345|NCT00444106|58723007|FG002|Overall Study|Lost to Follow-up|0|||
30709346|NCT00444106|58723005|FG000|Overall Study|Abnormal Test Procedure Results|0|||
30709347|NCT00444106|58723006|FG001|Overall Study|Abnormal Test Procedure Results|0|||
30709348|NCT00444106|58723007|FG002|Overall Study|Abnormal Test Procedure Results|1|||
30709349|NCT00561470|58723020|FG000|Overall Study|Adverse Event|74|||
30709350|NCT00561470|58723021|FG001|Overall Study|Adverse Event|163|||
30894775|NCT01364597|58928258|FG000|Overall Study|No Seizures|1|||
30894776|NCT01364597|58928259|FG001|Overall Study|No Seizures|0|||
30894777|NCT01364597|58928260|FG002|Overall Study|No Seizures|0|||
30894778|NCT01364597|58928261|FG003|Overall Study|No Seizures|0|||
30894779|NCT01364597|58928258|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
30894780|NCT01364597|58928259|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
30709351|NCT00561470|58723020|FG000|Overall Study|Disease progression|437|||
30709352|NCT00561470|58723021|FG001|Overall Study|Disease progression|305|||
30709353|NCT00561470|58723020|FG000|Overall Study|poor compliance to protocol|4|||
30894781|NCT01364597|58928260|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
30894782|NCT01364597|58928261|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
30894783|NCT01364597|58928258|FG000|Overall Study|Cure|1|||
30894784|NCT01364597|58928259|FG001|Overall Study|Cure|0|||
30709354|NCT00561470|58723021|FG001|Overall Study|poor compliance to protocol|4|||
30894785|NCT01364597|58928260|FG002|Overall Study|Cure|0|||
30894786|NCT01364597|58928261|FG003|Overall Study|Cure|0|||
30894787|NCT01364597|58928258|FG000|Overall Study|Patient was moving|0|||
30894788|NCT01364597|58928259|FG001|Overall Study|Patient was moving|1|||
30894789|NCT01364597|58928260|FG002|Overall Study|Patient was moving|0|||
30894790|NCT01364597|58928261|FG003|Overall Study|Patient was moving|0|||
30709355|NCT00561470|58723020|FG000|Overall Study|Lost to Follow-up|2|||
30709356|NCT00561470|58723021|FG001|Overall Study|Lost to Follow-up|0|||
30709357|NCT00561470|58723020|FG000|Overall Study|Physician Decision|21|||
30709358|NCT00561470|58723021|FG001|Overall Study|Physician Decision|20|||
30709359|NCT00561470|58723020|FG000|Overall Study|Consent Withdrawn|2|||
30709360|NCT00561470|58723021|FG001|Overall Study|Consent Withdrawn|6|||
30709361|NCT00561470|58723020|FG000|Overall Study|Subject request|43|||
30709362|NCT00561470|58723021|FG001|Overall Study|Subject request|77|||
30709363|NCT00561470|58723020|FG000|Overall Study|Metastatic surgery|10|||
30709364|NCT00561470|58723021|FG001|Overall Study|Metastatic surgery|12|||
30709365|NCT00561470|58723020|FG000|Overall Study|Unauthorized procedure|3|||
30709366|NCT00561470|58723021|FG001|Overall Study|Unauthorized procedure|1|||
30709367|NCT00561470|58723020|FG000|Overall Study|Randomized but not treated|5|||
30709368|NCT00561470|58723021|FG001|Overall Study|Randomized but not treated|5|||
30709369|NCT00561470|58723020|FG000|Overall Study|Missed visit window|1|||
30709370|NCT00561470|58723021|FG001|Overall Study|Missed visit window|4|||
30709371|NCT00561470|58723020|FG000|Overall Study|Planning surgery|1|||
30709372|NCT00561470|58723021|FG001|Overall Study|Planning surgery|1|||
30709373|NCT00561470|58723020|FG000|Overall Study|Ongoing Treatment|11|||
30709374|NCT00561470|58723021|FG001|Overall Study|Ongoing Treatment|14|||
30709375|NCT00443872|58723029|FG000|Overall Study|Protocol Violation|7|||
30620822|NCT00998985|58632252|FG000|Overall Study|Protocol Violation|0|||
30620823|NCT00998985|58632253|FG001|Overall Study|Protocol Violation|0|||
30620824|NCT00998985|58632254|FG002|Overall Study|Protocol Violation|0|||
30620825|NCT00998985|58632255|FG003|Overall Study|Protocol Violation|0|||
30620826|NCT00998985|58632256|FG004|Overall Study|Protocol Violation|0|||
30620827|NCT00998985|58632257|FG005|Overall Study|Protocol Violation|1|||
30620828|NCT00998985|58632258|FG006|Overall Study|Protocol Violation|0|||
30620829|NCT00998985|58632259|FG007|Overall Study|Protocol Violation|0|||
30620830|NCT00998985|58632260|FG008|Overall Study|Protocol Violation|0|||
30620831|NCT00998985|58632261|FG009|Overall Study|Protocol Violation|0|||
30620832|NCT00998985|58632262|FG010|Overall Study|Protocol Violation|0|||
30620833|NCT00998985|58632263|FG011|Overall Study|Protocol Violation|0|||
30709376|NCT00443872|58723029|FG000|Overall Study|Lost to Follow-up|2|||
30709377|NCT00443872|58723029|FG000|Overall Study|Adverse Event|8|||
30620834|NCT00998985|58632264|FG012|Overall Study|Protocol Violation|0|||
30620835|NCT00998985|58632265|FG013|Overall Study|Protocol Violation|0|||
30620836|NCT00995553|58632312|FG000|Overall Study|Withdrawal by Subject|2|||
30620837|NCT00995553|58632313|FG001|Overall Study|Withdrawal by Subject|6|||
30620838|NCT00991887|58632321|FG000|Overall Study|Lost to Follow-up|2|||
30709378|NCT00441064|58723044|FG000|Overall Study|Adverse Event|1|||
30709379|NCT00441064|58723045|FG001|Overall Study|Adverse Event|0|||
30709380|NCT00441064|58723044|FG000|Overall Study|Abnormal laboratory values|0|||
30709381|NCT00441064|58723045|FG001|Overall Study|Abnormal laboratory values|2|||
30709382|NCT00441064|58723044|FG000|Overall Study|Abnormal test procedure results|0|||
30709383|NCT00441064|58723045|FG001|Overall Study|Abnormal test procedure results|1|||
30709384|NCT00441064|58723044|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30709385|NCT00441064|58723045|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30709386|NCT00441064|58723044|FG000|Overall Study|Protocol Deviation|3|||
30709387|NCT00441064|58723045|FG001|Overall Study|Protocol Deviation|2|||
30709388|NCT00441064|58723044|FG000|Overall Study|Patient withdrew consent|5|||
30709389|NCT00441064|58723045|FG001|Overall Study|Patient withdrew consent|2|||
30709390|NCT03962738|58723055|FG000|Overall Study|Protocol Deviation|3|||
30709391|NCT03962738|58723056|FG001|Overall Study|Protocol Deviation|0|||
30709392|NCT03962738|58723057|FG002|Overall Study|Protocol Deviation|1|||
30709393|NCT03962738|58723058|FG003|Overall Study|Protocol Deviation|1|||
30709394|NCT03962738|58723055|FG000|Overall Study|Withdrawal by Subject|4|||
30709395|NCT03962738|58723056|FG001|Overall Study|Withdrawal by Subject|0|||
30709396|NCT03962738|58723057|FG002|Overall Study|Withdrawal by Subject|0|||
30709397|NCT03962738|58723058|FG003|Overall Study|Withdrawal by Subject|0|||
30709398|NCT03962738|58723055|FG000|Overall Study|Lost to Follow-up|0|||
30709399|NCT03962738|58723056|FG001|Overall Study|Lost to Follow-up|0|||
30709400|NCT03962738|58723057|FG002|Overall Study|Lost to Follow-up|1|||
30709401|NCT03962738|58723058|FG003|Overall Study|Lost to Follow-up|0|||
30709402|NCT00561392|58723076|FG000|Overall Study|Adverse Event|38|||
30709403|NCT00561392|58723076|FG000|Overall Study|Lack of Efficacy|2|||
30709404|NCT00561392|58723076|FG000|Overall Study|Protocol Violation|1|||
30709405|NCT00561392|58723076|FG000|Overall Study|Withdrawal by Subject|8|||
30709406|NCT00561392|58723076|FG000|Overall Study|Administrative problems|4|||
30709407|NCT00694109|58723080|FG000|Overall Study|Physician Decision|3|||
30709408|NCT00694109|58723080|FG000|Overall Study|Adverse Event|74|||
30620839|NCT00991887|58632322|FG001|Overall Study|Lost to Follow-up|1|||
30620840|NCT01002339|58632331|FG000|Overall Study|Withdrawal by Subject|0|||
30620841|NCT01002339|58632332|FG001|Overall Study|Withdrawal by Subject|1|||
30620842|NCT01002339|58632333|FG002|Overall Study|Withdrawal by Subject|0|||
30620843|NCT01002339|58632331|FG000|Overall Study|Incorrect treatment assignment|0|||
30620844|NCT01002339|58632332|FG001|Overall Study|Incorrect treatment assignment|0|||
30620845|NCT01002339|58632333|FG002|Overall Study|Incorrect treatment assignment|1|||
30620846|NCT01002339|58632331|FG000|Overall Study|Protocol Violation|0|||
30620847|NCT01002339|58632332|FG001|Overall Study|Protocol Violation|0|||
30620848|NCT01002339|58632333|FG002|Overall Study|Protocol Violation|2|||
30709409|NCT00694109|58723080|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
30709410|NCT00694109|58723080|FG000|Overall Study|Lack of Efficacy|2|||
30709411|NCT00694109|58723080|FG000|Overall Study|Withdrawal by Subject|13|||
30709412|NCT00694109|58723080|FG000|Overall Study|Pregnancy|1|||
30709413|NCT00694109|58723080|FG000|Overall Study|Enrolled but not treated|1|||
30709414|NCT00694109|58723080|FG000|Overall Study|Other|2|||
30894791|NCT01364597|58928258|FG000|Overall Study|Seizures resolved|0|||
30894792|NCT01364597|58928259|FG001|Overall Study|Seizures resolved|0|||
30894793|NCT01364597|58928260|FG002|Overall Study|Seizures resolved|1|||
30894794|NCT01364597|58928261|FG003|Overall Study|Seizures resolved|0|||
30894795|NCT01364597|58928258|FG000|Overall Study|Patient became seizure-free after surgery|0|||
30894796|NCT01364597|58928259|FG001|Overall Study|Patient became seizure-free after surgery|0|||
30894797|NCT01364597|58928260|FG002|Overall Study|Patient became seizure-free after surgery|1|||
30894798|NCT01364597|58928261|FG003|Overall Study|Patient became seizure-free after surgery|0|||
30894799|NCT01364597|58928258|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
30894800|NCT01364597|58928259|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
30894801|NCT01364597|58928260|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
30894802|NCT01364597|58928261|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
30894803|NCT01364597|58928258|FG000|Overall Study|Patient cured from Epilepsy|0|||
30894804|NCT01364597|58928259|FG001|Overall Study|Patient cured from Epilepsy|0|||
30894805|NCT01364597|58928260|FG002|Overall Study|Patient cured from Epilepsy|1|||
30894806|NCT01364597|58928261|FG003|Overall Study|Patient cured from Epilepsy|0|||
30894807|NCT01364597|58928258|FG000|Overall Study|Investigator decision|0|||
30894808|NCT01364597|58928259|FG001|Overall Study|Investigator decision|0|||
30894809|NCT01364597|58928260|FG002|Overall Study|Investigator decision|1|||
30894810|NCT01364597|58928261|FG003|Overall Study|Investigator decision|0|||
30894811|NCT01364597|58928258|FG000|Overall Study|Sponsor recommended discontinuation|0|||
30894812|NCT01364597|58928259|FG001|Overall Study|Sponsor recommended discontinuation|0|||
30894813|NCT01364597|58928260|FG002|Overall Study|Sponsor recommended discontinuation|0|||
30894814|NCT01364597|58928261|FG003|Overall Study|Sponsor recommended discontinuation|1|||
30894815|NCT01364597|58928258|FG000|Overall Study|Parents went abroad with the patient|0|||
30894816|NCT01364597|58928259|FG001|Overall Study|Parents went abroad with the patient|0|||
30894817|NCT01364597|58928260|FG002|Overall Study|Parents went abroad with the patient|1|||
30894818|NCT01364597|58928261|FG003|Overall Study|Parents went abroad with the patient|0|||
30894819|NCT01364597|58928258|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
30894820|NCT01364597|58928259|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
30894821|NCT01364597|58928260|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
30894822|NCT01364597|58928261|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
30894823|NCT01364597|58928258|FG000|Overall Study|BRV administration dropout|0|||
30894824|NCT01364597|58928259|FG001|Overall Study|BRV administration dropout|0|||
30894825|NCT01364597|58928260|FG002|Overall Study|BRV administration dropout|1|||
30620849|NCT01002339|58632331|FG000|Overall Study|Lung cancer detected before transplant|0|||
30620850|NCT01002339|58632332|FG001|Overall Study|Lung cancer detected before transplant|0|||
30620851|NCT01002339|58632333|FG002|Overall Study|Lung cancer detected before transplant|1|||
30620852|NCT01002339|58632331|FG000|Overall Study|Randomized. Not transplanted|0|||
30620853|NCT01002339|58632332|FG001|Overall Study|Randomized. Not transplanted|0|||
30620854|NCT01002339|58632333|FG002|Overall Study|Randomized. Not transplanted|1|||
30894826|NCT01364597|58928261|FG003|Overall Study|BRV administration dropout|0|||
30894827|NCT01364597|58928258|FG000|Overall Study|Dropout|0|||
30894828|NCT01364597|58928259|FG001|Overall Study|Dropout|0|||
30894829|NCT01364597|58928260|FG002|Overall Study|Dropout|3|||
30894830|NCT01364597|58928261|FG003|Overall Study|Dropout|1|||
30894831|NCT01364597|58928258|FG000|Overall Study|Unreliable subject|0|||
30894832|NCT01364597|58928259|FG001|Overall Study|Unreliable subject|0|||
30894833|NCT01364597|58928260|FG002|Overall Study|Unreliable subject|0|||
30894834|NCT01364597|58928261|FG003|Overall Study|Unreliable subject|1|||
30894835|NCT01364597|58928258|FG000|Overall Study|Other|0|||
30894836|NCT01364597|58928259|FG001|Overall Study|Other|0|||
30709415|NCT00694109|58723080|FG000|Overall Study|Consented but no additional treatment|3|||
30709416|NCT00562484|58723091|FG000|Overall Study|Adverse Event|6|||
30894837|NCT01364597|58928260|FG002|Overall Study|Other|0|||
30894838|NCT01364597|58928261|FG003|Overall Study|Other|1|||
30894839|NCT02143713|58928278|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
30894840|NCT02143713|58928279|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
30894841|NCT02143713|58928280|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
30894842|NCT02143713|58928281|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
30894843|NCT02143713|58928278|FG000|Treatment Period (6 Months)|Adverse Event|7|||
30894844|NCT02143713|58928279|FG001|Treatment Period (6 Months)|Adverse Event|8|||
30894845|NCT02143713|58928280|FG002|Treatment Period (6 Months)|Adverse Event|8|||
30894846|NCT02143713|58928281|FG003|Treatment Period (6 Months)|Adverse Event|9|||
30894847|NCT02143713|58928278|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
30894848|NCT02143713|58928279|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
30894849|NCT02143713|58928280|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
30894850|NCT02143713|58928281|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
30894851|NCT02143713|58928278|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
30894852|NCT02143713|58928279|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
30894853|NCT02143713|58928280|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
30894854|NCT02143713|58928281|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
30894855|NCT02143713|58928278|FG000|Treatment Period (6 Months)|Pregnancy|0|||
30894856|NCT02143713|58928279|FG001|Treatment Period (6 Months)|Pregnancy|2|||
30894857|NCT02143713|58928280|FG002|Treatment Period (6 Months)|Pregnancy|2|||
30894858|NCT02143713|58928281|FG003|Treatment Period (6 Months)|Pregnancy|0|||
30894859|NCT02143713|58928278|FG000|Treatment Period (6 Months)|Non-compliance|1|||
30894860|NCT02143713|58928279|FG001|Treatment Period (6 Months)|Non-compliance|0|||
30894861|NCT02143713|58928280|FG002|Treatment Period (6 Months)|Non-compliance|0|||
30894862|NCT02143713|58928281|FG003|Treatment Period (6 Months)|Non-compliance|3|||
30894863|NCT02143713|58928278|FG000|Treatment Period (6 Months)|Other|3|||
30894864|NCT02143713|58928279|FG001|Treatment Period (6 Months)|Other|0|||
30894865|NCT02143713|58928280|FG002|Treatment Period (6 Months)|Other|3|||
30894866|NCT02143713|58928281|FG003|Treatment Period (6 Months)|Other|2|||
30894867|NCT02143713|58928278|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
30894868|NCT02143713|58928279|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
30894869|NCT02143713|58928280|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
30894870|NCT02143713|58928281|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
30894871|NCT02143713|58928278|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
30894872|NCT02143713|58928279|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
30894873|NCT02143713|58928280|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
30894874|NCT02143713|58928281|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
30894875|NCT02143713|58928278|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
30894876|NCT02143713|58928279|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
30894877|NCT02143713|58928280|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
30894878|NCT02143713|58928281|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
30894879|NCT02143713|58928278|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
30894880|NCT02143713|58928279|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
30894881|NCT02143713|58928280|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
30894882|NCT02143713|58928281|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
30894883|NCT02143713|58928278|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
30894884|NCT02143713|58928279|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
30894885|NCT02143713|58928280|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
30894886|NCT02143713|58928281|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
30894887|NCT02143713|58928278|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
30894888|NCT02143713|58928279|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
30894889|NCT02143713|58928280|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
30894890|NCT02143713|58928281|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
30894891|NCT02143713|58928278|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
30894892|NCT02143713|58928279|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
30894893|NCT02143713|58928280|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
30894894|NCT02143713|58928281|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
30709417|NCT00562484|58723092|FG001|Overall Study|Adverse Event|1|||
30790880|NCT03524092|58803941|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
30790881|NCT03524092|58803942|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
30894895|NCT02143713|58928278|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
30894896|NCT02143713|58928279|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
30894897|NCT02143713|58928280|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
30894898|NCT02143713|58928281|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
30894899|NCT02143713|58928278|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
30894900|NCT02143713|58928279|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
30894901|NCT02143713|58928280|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
30894902|NCT02143713|58928281|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
30894903|NCT02519855|58928294|FG000|Overall Study|Adverse Event|0|||
30894904|NCT02519855|58928295|FG001|Overall Study|Adverse Event|1|||
30894905|NCT02519855|58928294|FG000|Overall Study|Lost to Follow-up|3|||
30894906|NCT02519855|58928295|FG001|Overall Study|Lost to Follow-up|3|||
30894907|NCT02142387|58928303|FG000|Overall Study|<19 years old|49|||
30894908|NCT02142387|58928304|FG001|Overall Study|<19 years old|326|||
30894909|NCT02142387|58928303|FG000|Overall Study|non-cardiac etiology|504|||
30894910|NCT02142387|58928304|FG001|Overall Study|non-cardiac etiology|3431|||
30894911|NCT02142387|58928303|FG000|Overall Study|CPR not performed|74|||
30894912|NCT02142387|58928304|FG001|Overall Study|CPR not performed|473|||
30894913|NCT02142387|58928303|FG000|Overall Study|witnessed by paramedic|139|||
30894914|NCT02142387|58928304|FG001|Overall Study|witnessed by paramedic|917|||
30894915|NCT02142387|58928303|FG000|Overall Study|incomplete data|1|||
30894916|NCT02142387|58928304|FG001|Overall Study|incomplete data|9|||
30894917|NCT02142387|58928303|FG000|Overall Study|occurred not at home|298|||
30894918|NCT02142387|58928304|FG001|Overall Study|occurred not at home|2474|||
30894919|NCT02518919|58928313|FG000|Overall Study|Protocol Violation|1|||
30894920|NCT02518919|58928314|FG001|Overall Study|Protocol Violation|1|||
30894921|NCT02518919|58928315|FG002|Overall Study|Protocol Violation|2|||
30894922|NCT02518685|58928325|FG000|Overall Study|Adverse Event|29|||
30894923|NCT02518685|58928326|FG001|Overall Study|Adverse Event|1|||
30894924|NCT02518685|58928325|FG000|Overall Study|Withdrawal by Subject|10|||
30894925|NCT02518685|58928326|FG001|Overall Study|Withdrawal by Subject|3|||
30894926|NCT02518685|58928325|FG000|Overall Study|relocation, study fatigue|7|||
30894927|NCT02518685|58928326|FG001|Overall Study|relocation, study fatigue|2|||
30894928|NCT02518685|58928325|FG000|Overall Study|Pregnancy|1|||
30894929|NCT02518685|58928326|FG001|Overall Study|Pregnancy|0|||
30894930|NCT02518685|58928325|FG000|Overall Study|Physician Decision|1|||
30709418|NCT00562484|58723091|FG000|Overall Study|Protocol Violation|11|||
30709419|NCT00562484|58723092|FG001|Overall Study|Protocol Violation|2|||
30894931|NCT02518685|58928326|FG001|Overall Study|Physician Decision|0|||
30894932|NCT02518685|58928325|FG000|Overall Study|Lost to Follow-up|1|||
30894933|NCT02518685|58928326|FG001|Overall Study|Lost to Follow-up|4|||
30894934|NCT02520089|58928335|FG000|Overall Study|Lost to Follow-up|3|||
30894935|NCT02520089|58928336|FG001|Overall Study|Lost to Follow-up|4|||
30894936|NCT02105961|58928345|FG000|Overall Study|Adverse Event|18|||
30894937|NCT02105961|58928346|FG001|Overall Study|Adverse Event|7|||
30894938|NCT02105961|58928347|FG002|Overall Study|Adverse Event|13|||
30894939|NCT02105961|58928345|FG000|Overall Study|Lack of Efficacy|3|||
30894940|NCT02105961|58928346|FG001|Overall Study|Lack of Efficacy|0|||
30894941|NCT02105961|58928347|FG002|Overall Study|Lack of Efficacy|3|||
30894942|NCT02105961|58928345|FG000|Overall Study|Lost to Follow-up|2|||
30894943|NCT02105961|58928346|FG001|Overall Study|Lost to Follow-up|0|||
30709420|NCT00562484|58723091|FG000|Overall Study|Withdrawal by Subject|12|||
30709421|NCT00562484|58723092|FG001|Overall Study|Withdrawal by Subject|9|||
30709422|NCT00562484|58723091|FG000|Overall Study|Moved away from the study area|20|||
30709423|NCT00562484|58723092|FG001|Overall Study|Moved away from the study area|9|||
30709424|NCT00562484|58723091|FG000|Overall Study|Lost to Follow-up|132|||
30709425|NCT00562484|58723092|FG001|Overall Study|Lost to Follow-up|71|||
30709426|NCT00562484|58723091|FG000|Overall Study|Reason not provided or not specified|25|||
30709427|NCT00562484|58723092|FG001|Overall Study|Reason not provided or not specified|12|||
30709428|NCT00561080|58723101|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
30709429|NCT00561080|58723102|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
30709430|NCT00561080|58723103|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
30709431|NCT00561080|58723101|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
30709432|NCT00561080|58723102|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
30709433|NCT00561080|58723103|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
30709434|NCT00561080|58723101|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
30709435|NCT00561080|58723102|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
30709436|NCT00561080|58723103|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
30709437|NCT00561080|58723101|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
30709438|NCT00561080|58723102|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
30894944|NCT02105961|58928347|FG002|Overall Study|Lost to Follow-up|1|||
30894945|NCT02105961|58928345|FG000|Overall Study|Physician Decision|3|||
30894946|NCT02105961|58928346|FG001|Overall Study|Physician Decision|3|||
30709439|NCT00561080|58723103|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
30894947|NCT02105961|58928347|FG002|Overall Study|Physician Decision|2|||
30894948|NCT02105961|58928345|FG000|Overall Study|Withdrawal by Subject|15|||
30894949|NCT02105961|58928346|FG001|Overall Study|Withdrawal by Subject|7|||
30894950|NCT02105961|58928347|FG002|Overall Study|Withdrawal by Subject|11|||
30894951|NCT02141997|58928360|FG000|Overall Study|Adverse Event|0|||
30894952|NCT02141997|58928361|FG001|Overall Study|Adverse Event|2|||
30894953|NCT02141997|58928362|FG002|Overall Study|Adverse Event|0|||
30894954|NCT02141997|58928363|FG003|Overall Study|Adverse Event|1|||
30894955|NCT02141997|58928360|FG000|Overall Study|Participant noncompliance|1|||
30894956|NCT02141997|58928361|FG001|Overall Study|Participant noncompliance|0|||
30894957|NCT02141997|58928362|FG002|Overall Study|Participant noncompliance|0|||
30894958|NCT02141997|58928363|FG003|Overall Study|Participant noncompliance|0|||
30894959|NCT02141997|58928360|FG000|Overall Study|Withdrew consent|1|||
30894960|NCT02141997|58928361|FG001|Overall Study|Withdrew consent|0|||
30894961|NCT02141997|58928362|FG002|Overall Study|Withdrew consent|3|||
30894962|NCT02141997|58928363|FG003|Overall Study|Withdrew consent|0|||
30894963|NCT02141997|58928360|FG000|Overall Study|Other|1|||
30894964|NCT02141997|58928361|FG001|Overall Study|Other|4|||
30894965|NCT02141997|58928362|FG002|Overall Study|Other|0|||
30894966|NCT02141997|58928363|FG003|Overall Study|Other|0|||
30894967|NCT01628367|58928375|FG000|Overall Study|Adverse Event|1|||
30894968|NCT01628367|58928376|FG001|Overall Study|Adverse Event|0|||
30894969|NCT01627899|58928382|FG000|Overall Study|Study terminated early by sponsor.|5|||
30894970|NCT02519777|58928389|FG000|Overall Study|Death|1|||
30894971|NCT02519777|58928390|FG001|Overall Study|Death|0|||
30894972|NCT02519777|58928391|FG002|Overall Study|Death|0|||
30894973|NCT02519777|58928389|FG000|Overall Study|Lost to Follow-up|0|||
30894974|NCT02519777|58928390|FG001|Overall Study|Lost to Follow-up|4|||
30894975|NCT02519777|58928391|FG002|Overall Study|Lost to Follow-up|2|||
30894976|NCT02519777|58928389|FG000|Overall Study|Withdrawal by Subject|3|||
30894977|NCT02519777|58928390|FG001|Overall Study|Withdrawal by Subject|1|||
30894978|NCT02519777|58928391|FG002|Overall Study|Withdrawal by Subject|0|||
30894979|NCT02519777|58928389|FG000|Overall Study|Severe Debilitation|1|||
30894980|NCT02519777|58928390|FG001|Overall Study|Severe Debilitation|1|||
30894981|NCT02519777|58928391|FG002|Overall Study|Severe Debilitation|1|||
30894982|NCT02519777|58928389|FG000|Overall Study|Not able to get to clinic|1|||
30894983|NCT02519777|58928390|FG001|Overall Study|Not able to get to clinic|2|||
30894984|NCT02519777|58928391|FG002|Overall Study|Not able to get to clinic|1|||
30894985|NCT02515331|58928402|FG000|Overall Study|Withdrawal by Subject|0|||
30894986|NCT02515331|58928403|FG001|Overall Study|Withdrawal by Subject|0|||
30894987|NCT02515331|58928404|FG002|Overall Study|Withdrawal by Subject|1|||
30894988|NCT02515331|58928402|FG000|Overall Study|Protocol deviation|0|||
30894989|NCT02515331|58928403|FG001|Overall Study|Protocol deviation|0|||
30894990|NCT02515331|58928404|FG002|Overall Study|Protocol deviation|3|||
30894991|NCT02515331|58928402|FG000|Overall Study|Adverse Event|2|||
30894992|NCT02515331|58928403|FG001|Overall Study|Adverse Event|0|||
30894993|NCT02515331|58928404|FG002|Overall Study|Adverse Event|0|||
30894994|NCT02515097|58928414|FG000|Overall Study|Lost to Follow-up|4|||
30894995|NCT02515097|58928415|FG001|Overall Study|Lost to Follow-up|2|||
30894996|NCT02515097|58928414|FG000|Overall Study|Withdrawal by Subject|1|||
30894997|NCT02515097|58928415|FG001|Overall Study|Withdrawal by Subject|3|||
30894998|NCT02515097|58928414|FG000|Overall Study|Adverse Event|2|||
30894999|NCT02515097|58928415|FG001|Overall Study|Adverse Event|1|||
30895000|NCT02141295|58928424|FG000|Overall Study|Adverse Event|1|||
30895001|NCT02141295|58928425|FG001|Overall Study|Adverse Event|18|||
30895002|NCT02141295|58928426|FG002|Overall Study|Adverse Event|11|||
30895003|NCT02141295|58928424|FG000|Overall Study|Physician Decision|2|||
30620855|NCT01002105|58632343|FG000|Overall Study|Lost to Follow-up|10|||
30620856|NCT01002105|58632344|FG001|Overall Study|Lost to Follow-up|16|||
30895004|NCT02141295|58928425|FG001|Overall Study|Physician Decision|19|||
30895005|NCT02141295|58928426|FG002|Overall Study|Physician Decision|14|||
30895006|NCT02141295|58928424|FG000|Overall Study|Study terminated by sponsor|0|||
30895007|NCT02141295|58928425|FG001|Overall Study|Study terminated by sponsor|6|||
30895008|NCT02141295|58928426|FG002|Overall Study|Study terminated by sponsor|6|||
30895009|NCT02141295|58928424|FG000|Overall Study|Non-compliance|0|||
30895010|NCT02141295|58928425|FG001|Overall Study|Non-compliance|1|||
30895011|NCT02141295|58928426|FG002|Overall Study|Non-compliance|0|||
30895012|NCT02141295|58928424|FG000|Overall Study|Progressive disease|3|||
30895013|NCT02141295|58928425|FG001|Overall Study|Progressive disease|32|||
30895014|NCT02141295|58928426|FG002|Overall Study|Progressive disease|50|||
30895015|NCT02141295|58928424|FG000|Overall Study|Reason not specified|0|||
30895016|NCT02141295|58928425|FG001|Overall Study|Reason not specified|9|||
30895017|NCT02141295|58928426|FG002|Overall Study|Reason not specified|10|||
30895018|NCT02141295|58928424|FG000|Overall Study|Withdrawal by Subject|0|||
30895019|NCT02141295|58928425|FG001|Overall Study|Withdrawal by Subject|9|||
30895020|NCT02141295|58928426|FG002|Overall Study|Withdrawal by Subject|4|||
30895021|NCT02514551|58928438|FG000|Overall Study|Lost to Follow-up|0|||
30895022|NCT02514551|58928439|FG001|Overall Study|Lost to Follow-up|1|||
30895023|NCT02514551|58928438|FG000|Overall Study|Participant Never Treated|0|||
30895024|NCT02514551|58928439|FG001|Overall Study|Participant Never Treated|2|||
30895025|NCT02141217|58928448|FG000|Overall Study|Adverse Event|1|||
30895026|NCT02141217|58928449|FG001|Overall Study|Adverse Event|2|||
30895027|NCT02141217|58928448|FG000|Overall Study|Protocol Violation|1|||
30895028|NCT02141217|58928449|FG001|Overall Study|Protocol Violation|4|||
30895029|NCT02141217|58928448|FG000|Overall Study|Withdrawal by Subject|6|||
30709440|NCT00561080|58723101|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
30709441|NCT00561080|58723102|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
30709442|NCT00561080|58723103|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
30709443|NCT00561080|58723101|FG000|Vaccination Period (up to Month 4)|Other|0|||
30709444|NCT00561080|58723102|FG001|Vaccination Period (up to Month 4)|Other|2|||
30709445|NCT00561080|58723103|FG002|Vaccination Period (up to Month 4)|Other|1|||
30709446|NCT00561080|58723101|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
30895030|NCT02141217|58928449|FG001|Overall Study|Withdrawal by Subject|0|||
30895031|NCT02141217|58928448|FG000|Overall Study|Lost to Follow-up|1|||
30895032|NCT02141217|58928449|FG001|Overall Study|Lost to Follow-up|1|||
30895033|NCT02141217|58928448|FG000|Overall Study|Physician Decision|1|||
30895034|NCT02141217|58928449|FG001|Overall Study|Physician Decision|0|||
30895035|NCT02141217|58928448|FG000|Overall Study|Surgical Intervention|1|||
30895036|NCT02141217|58928449|FG001|Overall Study|Surgical Intervention|1|||
30895037|NCT02138253|58928460|FG000|Overall Study|Adverse Event|3|||
30895038|NCT02138253|58928461|FG001|Overall Study|Adverse Event|3|||
30895039|NCT02138253|58928460|FG000|Overall Study|Lost to Follow-up|2|||
30895040|NCT02138253|58928461|FG001|Overall Study|Lost to Follow-up|1|||
30895041|NCT02138253|58928460|FG000|Overall Study|Physician Decision|2|||
30895042|NCT02138253|58928461|FG001|Overall Study|Physician Decision|0|||
30895043|NCT02138253|58928460|FG000|Overall Study|Non compliance|1|||
30895044|NCT02138253|58928461|FG001|Overall Study|Non compliance|0|||
30895045|NCT02138253|58928460|FG000|Overall Study|Withdrawal by Subject|1|||
30895046|NCT02138253|58928461|FG001|Overall Study|Withdrawal by Subject|0|||
30895047|NCT02514473|58928469|FG000|Overall Study|Adverse Event|0|||
30895048|NCT02514473|58928470|FG001|Overall Study|Adverse Event|2|||
30895049|NCT02514473|58928469|FG000|Overall Study|Withdrawal by Subject|2|||
30895050|NCT02514473|58928470|FG001|Overall Study|Withdrawal by Subject|1|||
30895051|NCT02514473|58928469|FG000|Overall Study|Lost to Follow-up|0|||
30895052|NCT02514473|58928470|FG001|Overall Study|Lost to Follow-up|1|||
30895053|NCT02514473|58928469|FG000|Overall Study|Other|1|||
30895054|NCT02514473|58928470|FG001|Overall Study|Other|1|||
30895055|NCT02513771|58928479|FG000|Overall Study|Lost to Follow-up|1|||
30895056|NCT02513771|58928480|FG001|Overall Study|Lost to Follow-up|1|||
30895057|NCT02513771|58928479|FG000|Overall Study|Not being able to get to clinic|1|||
30895058|NCT02513771|58928480|FG001|Overall Study|Not being able to get to clinic|0|||
30895059|NCT02104947|58928488|FG000|Overall Study|Withdrawal by Subject|10|||
30895060|NCT02104947|58928489|FG001|Overall Study|Withdrawal by Subject|3|||
30895061|NCT02104947|58928488|FG000|Overall Study|Lost to Follow-up|4|||
30895062|NCT02104947|58928489|FG001|Overall Study|Lost to Follow-up|4|||
30895063|NCT02104947|58928488|FG000|Overall Study|Protocol Violation|6|||
30895064|NCT02104947|58928489|FG001|Overall Study|Protocol Violation|8|||
30895065|NCT02104947|58928488|FG000|Overall Study|Adverse Event|57|||
30709447|NCT00561080|58723102|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
30895066|NCT02104947|58928489|FG001|Overall Study|Adverse Event|38|||
30895067|NCT02104947|58928488|FG000|Overall Study|Other than stated above|2|||
30895068|NCT02104947|58928489|FG001|Overall Study|Other than stated above|3|||
30895069|NCT02513459|58928499|FG000|Overall Study|Adverse Event|7|||
30895070|NCT02513459|58928499|FG000|Overall Study|Withdrew consent|5|||
30895071|NCT02513459|58928499|FG000|Overall Study|Loss of efficacy|2|||
30895072|NCT02513459|58928499|FG000|Overall Study|Pregnancy|2|||
30895073|NCT02513459|58928499|FG000|Overall Study|Subject decision|2|||
30895074|NCT02513459|58928499|FG000|Overall Study|Lack of response|1|||
30895075|NCT02513459|58928499|FG000|Overall Study|Reproductive plans|1|||
30895076|NCT02513459|58928499|FG000|Overall Study|Surgery planned-- not done|1|||
30895077|NCT02104557|58928508|FG000|Overall Study|Adverse Event|24|||
30895078|NCT02104557|58928508|FG000|Overall Study|Lost to Follow-up|34|||
30895079|NCT02104557|58928508|FG000|Overall Study|Violated the usage and dosage|14|||
30895080|NCT02104557|58928508|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
30895081|NCT02104557|58928508|FG000|Overall Study|Administered Sayana prior to the contract|1|||
30895082|NCT02104557|58928508|FG000|Overall Study|Other|17|||
30895083|NCT02104557|58928508|FG000|Overall Study|Change to other contraception methods|5|||
30895084|NCT02104557|58928508|FG000|Overall Study|Discontinuation due to no pain|1|||
30895085|NCT02104557|58928508|FG000|Overall Study|Withdrawal consent|2|||
30895086|NCT02104557|58928508|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
30895087|NCT02104557|58928508|FG000|Overall Study|Discontinuation of contraception|9|||
30895088|NCT02069379|58928514|FG000|Baseline Measurements|Lost to Follow-up|1|||
30895089|NCT02069379|58928515|FG001|Baseline Measurements|Lost to Follow-up|0|||
30895090|NCT02069379|58928516|FG002|Baseline Measurements|Lost to Follow-up|0|||
30895091|NCT02069379|58928517|FG003|Baseline Measurements|Lost to Follow-up|0|||
30895092|NCT02069379|58928514|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
30895093|NCT02069379|58928515|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
30895094|NCT02069379|58928516|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
30895095|NCT02069379|58928517|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
30895096|NCT02069379|58928514|FG000|First Treatment Arm|Lost to Follow-up|0|||
30895097|NCT02069379|58928515|FG001|First Treatment Arm|Lost to Follow-up|1|||
30895098|NCT02069379|58928516|FG002|First Treatment Arm|Lost to Follow-up|1|||
30895099|NCT02069379|58928517|FG003|First Treatment Arm|Lost to Follow-up|0|||
30895100|NCT02069379|58928514|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
30895101|NCT02069379|58928515|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
30895102|NCT02069379|58928516|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
30895103|NCT02069379|58928517|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
30895104|NCT02069379|58928514|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
30895105|NCT02069379|58928515|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
30895106|NCT02069379|58928516|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
30895107|NCT02069379|58928517|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
30895108|NCT02069379|58928514|FG000|Second Treatment Arm|Lost to Follow-up|0|||
30895109|NCT02069379|58928515|FG001|Second Treatment Arm|Lost to Follow-up|0|||
30895110|NCT02069379|58928516|FG002|Second Treatment Arm|Lost to Follow-up|1|||
30895111|NCT02069379|58928517|FG003|Second Treatment Arm|Lost to Follow-up|0|||
30895112|NCT02511431|58928533|FG000|Treatment|Lost to Follow-up|0|||
30895113|NCT02511431|58928534|FG001|Treatment|Lost to Follow-up|0|||
30895114|NCT02511431|58928535|FG002|Treatment|Lost to Follow-up|1|||
30895115|NCT02511431|58928536|FG003|Treatment|Lost to Follow-up|0|||
30895116|NCT02511431|58928537|FG004|Treatment|Lost to Follow-up|0|||
30620857|NCT01002105|58632343|FG000|Overall Study|non compliance|5|||
30620858|NCT01002105|58632344|FG001|Overall Study|non compliance|3|||
30895117|NCT02511431|58928538|FG005|Treatment|Lost to Follow-up|1|||
30895118|NCT02137785|58928555|FG000|Overall Study|Lost to Follow-up|1|||
30895119|NCT02137785|58928556|FG001|Overall Study|Lost to Follow-up|0|||
30895120|NCT02137785|58928555|FG000|Overall Study|Withdrawal by Subject|1|||
30895121|NCT02137785|58928556|FG001|Overall Study|Withdrawal by Subject|4|||
30895122|NCT02137785|58928555|FG000|Overall Study|subject moved out of state|1|||
30895123|NCT02137785|58928556|FG001|Overall Study|subject moved out of state|0|||
30895124|NCT01655069|58928566|FG000|Overall Study|Physician Decision|0|||
30895125|NCT01655069|58928567|FG001|Overall Study|Physician Decision|0|||
30895126|NCT01655069|58928568|FG002|Overall Study|Physician Decision|0|||
30895127|NCT01655069|58928569|FG003|Overall Study|Physician Decision|1|||
30620859|NCT01002105|58632343|FG000|Overall Study|condition worsened|4|||
30620860|NCT01002105|58632344|FG001|Overall Study|condition worsened|2|||
30895128|NCT01655069|58928566|FG000|Overall Study|Adverse Event|6|||
30895129|NCT01655069|58928567|FG001|Overall Study|Adverse Event|7|||
30895130|NCT01655069|58928568|FG002|Overall Study|Adverse Event|2|||
30895131|NCT01655069|58928569|FG003|Overall Study|Adverse Event|3|||
30760608|NCT03264404|58769100|FG000|Overall Study|Adverse Event|1|||
30895132|NCT01655069|58928566|FG000|Overall Study|Lack of Efficacy|0|||
30895133|NCT01655069|58928567|FG001|Overall Study|Lack of Efficacy|1|||
30895134|NCT01655069|58928568|FG002|Overall Study|Lack of Efficacy|0|||
30895135|NCT01655069|58928569|FG003|Overall Study|Lack of Efficacy|0|||
30895136|NCT01655069|58928566|FG000|Overall Study|No Treatment Needed|0|||
30895137|NCT01655069|58928567|FG001|Overall Study|No Treatment Needed|1|||
30895138|NCT01655069|58928568|FG002|Overall Study|No Treatment Needed|0|||
30895139|NCT01655069|58928569|FG003|Overall Study|No Treatment Needed|0|||
30895140|NCT01655069|58928566|FG000|Overall Study|Withdrawal by Subject|2|||
30895141|NCT01655069|58928567|FG001|Overall Study|Withdrawal by Subject|3|||
30895142|NCT01655069|58928568|FG002|Overall Study|Withdrawal by Subject|0|||
30895143|NCT01655069|58928569|FG003|Overall Study|Withdrawal by Subject|0|||
30895144|NCT02068599|58928580|FG000|Overall Study|Adverse Event|4|||
30895145|NCT02068599|58928581|FG001|Overall Study|Adverse Event|1|||
30895146|NCT02068599|58928582|FG002|Overall Study|Adverse Event|1|||
30895147|NCT02068599|58928580|FG000|Overall Study|Withdrawal by Subject|2|||
30895148|NCT02068599|58928581|FG001|Overall Study|Withdrawal by Subject|7|||
30895149|NCT02068599|58928582|FG002|Overall Study|Withdrawal by Subject|5|||
30895150|NCT02068599|58928580|FG000|Overall Study|Protocol Violation|4|||
30895151|NCT02068599|58928581|FG001|Overall Study|Protocol Violation|2|||
30895152|NCT02068599|58928582|FG002|Overall Study|Protocol Violation|3|||
30895153|NCT02068599|58928580|FG000|Overall Study|Lost to Follow-up|1|||
30895154|NCT02068599|58928581|FG001|Overall Study|Lost to Follow-up|0|||
30895155|NCT02068599|58928582|FG002|Overall Study|Lost to Follow-up|0|||
30895156|NCT02068599|58928580|FG000|Overall Study|Lack of Efficacy|0|||
30895157|NCT02068599|58928581|FG001|Overall Study|Lack of Efficacy|0|||
30895158|NCT02068599|58928582|FG002|Overall Study|Lack of Efficacy|3|||
30895159|NCT02068599|58928580|FG000|Overall Study|Noncompliance|0|||
30895160|NCT02068599|58928581|FG001|Overall Study|Noncompliance|0|||
30895161|NCT02068599|58928582|FG002|Overall Study|Noncompliance|1|||
30895162|NCT01654601|58928592|FG000|1st Administration|Withdrawal by Subject|2|||
30895163|NCT01654601|58928593|FG001|1st Administration|Withdrawal by Subject|0|||
30895164|NCT01654601|58928592|FG000|1st Administration|Protocol Violation|0|||
30895165|NCT01654601|58928593|FG001|1st Administration|Protocol Violation|2|||
30895166|NCT01654601|58928592|FG000|2nd Administration|Adverse Event|1|||
30895167|NCT01654601|58928593|FG001|2nd Administration|Adverse Event|0|||
30895168|NCT01654601|58928592|FG000|2nd Administration|Protocol Violation|0|||
30895169|NCT01654601|58928593|FG001|2nd Administration|Protocol Violation|1|||
30895170|NCT01654523|58928599|FG000|Overall Study|Withdrawal by Subject|1|||
30895171|NCT02068443|58928606|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
30895172|NCT02068443|58928607|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
30895173|NCT02068443|58928608|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
30895174|NCT02068443|58928606|FG000|Overall Study|Voluntary Withdrawal|4|||
30895175|NCT02068443|58928607|FG001|Overall Study|Voluntary Withdrawal|0|||
30895176|NCT02068443|58928608|FG002|Overall Study|Voluntary Withdrawal|1|||
30895177|NCT02068443|58928606|FG000|Overall Study|Lack of Efficacy|2|||
30895178|NCT02068443|58928607|FG001|Overall Study|Lack of Efficacy|1|||
30895179|NCT02068443|58928608|FG002|Overall Study|Lack of Efficacy|0|||
30895180|NCT02068443|58928606|FG000|Overall Study|Other Reason Not Specified|1|||
30895181|NCT02068443|58928607|FG001|Overall Study|Other Reason Not Specified|0|||
30895182|NCT02068443|58928608|FG002|Overall Study|Other Reason Not Specified|0|||
30895183|NCT02508935|58928616|FG000|Overall Study|Withdrawal by Subject|1|||
30895184|NCT02508935|58928616|FG000|Overall Study|Withdrawal by Caregiver|8|||
30895185|NCT02508935|58928616|FG000|Overall Study|Pain Score <4|1|||
30895186|NCT02508935|58928616|FG000|Overall Study|Emesis|3|||
30895187|NCT02508935|58928616|FG000|Overall Study|Adverse Event|3|||
30895188|NCT02508935|58928616|FG000|Overall Study|Protocol Violation|1|||
30895189|NCT02508935|58928616|FG000|Overall Study|Physician Decision|1|||
30895190|NCT02508935|58928616|FG000|Overall Study|Trial terminated by sponsor|5|||
30895191|NCT02508701|58928626|FG000|Overall Study|Lost to Follow-up|9|||
30895192|NCT02508701|58928627|FG001|Overall Study|Lost to Follow-up|5|||
30895193|NCT02508701|58928628|FG002|Overall Study|Lost to Follow-up|5|||
30895194|NCT02508701|58928629|FG003|Overall Study|Lost to Follow-up|3|||
30895195|NCT02507375|58928645|FG000|Overall Study|Progressive Disease|4|||
30895196|NCT02507375|58928646|FG001|Overall Study|Progressive Disease|5|||
30895197|NCT02507375|58928645|FG000|Overall Study|Death|0|||
30895198|NCT02507375|58928646|FG001|Overall Study|Death|1|||
30709448|NCT00561080|58723103|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
30709449|NCT00561080|58723101|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
30709450|NCT00561080|58723102|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
30709451|NCT00561080|58723103|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
30709452|NCT00561080|58723101|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
30709453|NCT00561080|58723102|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
30709454|NCT00561080|58723103|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
30895199|NCT02507375|58928645|FG000|Overall Study|Refused treatment|0|||
30895200|NCT02507375|58928646|FG001|Overall Study|Refused treatment|1|||
30895201|NCT02507375|58928645|FG000|Overall Study|Adverse Event|0|||
30895202|NCT02507375|58928646|FG001|Overall Study|Adverse Event|1|||
30895203|NCT02507219|58928656|FG000|Overall Study|Physician Decision|1|||
30895204|NCT02507219|58928657|FG001|Overall Study|Physician Decision|0|||
30895205|NCT02507219|58928658|FG002|Overall Study|Physician Decision|0|||
30895206|NCT02507219|58928659|FG003|Overall Study|Physician Decision|0|||
30895207|NCT02507219|58928660|FG004|Overall Study|Physician Decision|0|||
30895208|NCT02507219|58928661|FG005|Overall Study|Physician Decision|0|||
30895209|NCT02507219|58928656|FG000|Overall Study|Withdrawal by Subject|0|||
30895210|NCT02507219|58928657|FG001|Overall Study|Withdrawal by Subject|0|||
30895211|NCT02507219|58928658|FG002|Overall Study|Withdrawal by Subject|0|||
30895212|NCT02507219|58928659|FG003|Overall Study|Withdrawal by Subject|0|||
30895213|NCT02507219|58928660|FG004|Overall Study|Withdrawal by Subject|1|||
30895214|NCT02507219|58928661|FG005|Overall Study|Withdrawal by Subject|0|||
30895215|NCT02483975|58928671|FG000|Overall Study|Adverse Event|0|||
30895216|NCT02483975|58928672|FG001|Overall Study|Adverse Event|1|||
30895217|NCT02483975|58928671|FG000|Overall Study|Lost to Follow-up|0|||
30895218|NCT02483975|58928672|FG001|Overall Study|Lost to Follow-up|1|||
30895219|NCT02483975|58928671|FG000|Overall Study|Physician Decision|2|||
30895220|NCT02483975|58928672|FG001|Overall Study|Physician Decision|0|||
30895221|NCT02047227|58928683|FG000|Overall Study|Adverse Event|2|||
30895222|NCT02047227|58928684|FG001|Overall Study|Adverse Event|4|||
30895223|NCT02047227|58928683|FG000|Overall Study|Lost to Follow-up|0|||
30895224|NCT02047227|58928684|FG001|Overall Study|Lost to Follow-up|3|||
30895225|NCT02047227|58928683|FG000|Overall Study|Protocol Violation|1|||
30895226|NCT02047227|58928684|FG001|Overall Study|Protocol Violation|0|||
30895227|NCT02047227|58928683|FG000|Overall Study|Spontaneous pregnancy|1|||
30895228|NCT02047227|58928684|FG001|Overall Study|Spontaneous pregnancy|0|||
30895229|NCT02047227|58928683|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
30895230|NCT02047227|58928684|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
30895231|NCT02047227|58928683|FG000|Overall Study|No oocytes retrieved|21|||
30895232|NCT02047227|58928684|FG001|Overall Study|No oocytes retrieved|20|||
30895233|NCT02047227|58928683|FG000|Overall Study|No fertilization|61|||
30895234|NCT02047227|58928684|FG001|Overall Study|No fertilization|51|||
30895235|NCT02047227|58928683|FG000|Overall Study|Intention to freeze all embryos|1|||
30895236|NCT02047227|58928684|FG001|Overall Study|Intention to freeze all embryos|0|||
30895237|NCT02047227|58928683|FG000|Overall Study|All embryos discarded|12|||
30895238|NCT02047227|58928684|FG001|Overall Study|All embryos discarded|11|||
30895239|NCT02047227|58928683|FG000|Overall Study|Other|10|||
30620861|NCT02605993|58632357|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
30620862|NCT02605993|58632358|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
30620863|NCT02605993|58632359|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
30620864|NCT02605993|58632360|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
30620865|NCT00995085|58632370|FG000|Overall Study|Withdrawal by Subject|5|||
30620866|NCT00603733|58632376|FG000|Active Phase ITT|Adverse Event|8|||
30620867|NCT00603733|58632377|FG001|Active Phase ITT|Adverse Event|7|||
30620868|NCT00603733|58632376|FG000|Active Phase ITT|Withdrawal by Subject|0|||
30620869|NCT00603733|58632377|FG001|Active Phase ITT|Withdrawal by Subject|3|||
30620870|NCT00603733|58632376|FG000|Active Phase ITT|Lost to Follow-up|0|||
30895240|NCT02047227|58928684|FG001|Overall Study|Other|9|||
30895241|NCT02483585|58928692|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
30895242|NCT02483585|58928693|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
30895243|NCT02483585|58928692|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
30895244|NCT02483585|58928693|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
30895245|NCT02483585|58928692|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
30895246|NCT02483585|58928693|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
30620871|NCT00603733|58632377|FG001|Active Phase ITT|Lost to Follow-up|1|||
30620872|NCT00603733|58632376|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
30620873|NCT00603733|58632377|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
30620874|NCT00603733|58632376|FG000|Active Phase ITT|Lack of Efficacy|1|||
30620875|NCT00603733|58632377|FG001|Active Phase ITT|Lack of Efficacy|2|||
30620876|NCT00603733|58632376|FG000|Active Phase ITT|Subject moved, site closed|1|||
30620877|NCT00603733|58632377|FG001|Active Phase ITT|Subject moved, site closed|1|||
30620878|NCT00603733|58632376|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
30620879|NCT00603733|58632377|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
30620880|NCT00603733|58632376|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
30620881|NCT00603733|58632377|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
30620882|NCT00603733|58632376|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
30620883|NCT00603733|58632377|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
30895247|NCT02483585|58928692|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
30895248|NCT02483585|58928693|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
30709455|NCT00561080|58723101|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
30709456|NCT00561080|58723102|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
30709457|NCT00561080|58723103|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
30709458|NCT00562094|58723113|FG000|Overall Study|Lost to Follow-up|62|||
30709459|NCT03817853|58723121|FG000|Induction Phase|Adverse Event|5|||
30709460|NCT03817853|58723122|FG001|Induction Phase|Adverse Event|0|||
30709461|NCT03817853|58723123|FG002|Induction Phase|Adverse Event|0|||
30709462|NCT03817853|58723121|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
30709463|NCT03817853|58723122|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
30709464|NCT03817853|58723123|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
30709465|NCT03817853|58723121|FG000|Induction Phase|Physician Decision|2|||
30709466|NCT03817853|58723122|FG001|Induction Phase|Physician Decision|0|||
30709467|NCT03817853|58723123|FG002|Induction Phase|Physician Decision|0|||
30709468|NCT03817853|58723121|FG000|Induction Phase|Progressive Disease|4|||
30709469|NCT03817853|58723122|FG001|Induction Phase|Progressive Disease|0|||
30709470|NCT03817853|58723123|FG002|Induction Phase|Progressive Disease|0|||
30709471|NCT03817853|58723121|FG000|Induction Phase|Withdrawal by Subject|3|||
30709472|NCT03817853|58723122|FG001|Induction Phase|Withdrawal by Subject|0|||
30709473|NCT03817853|58723123|FG002|Induction Phase|Withdrawal by Subject|0|||
30709474|NCT03817853|58723121|FG000|Induction Phase|Continuing on Study|34|||
30709475|NCT03817853|58723122|FG001|Induction Phase|Continuing on Study|0|||
30709476|NCT03817853|58723123|FG002|Induction Phase|Continuing on Study|0|||
30709477|NCT03817853|58723121|FG000|Maintenance/ Follow-up Phase|Adverse Event|0|||
30709478|NCT03817853|58723122|FG001|Maintenance/ Follow-up Phase|Adverse Event|1|||
30709479|NCT03817853|58723123|FG002|Maintenance/ Follow-up Phase|Adverse Event|0|||
30709480|NCT03817853|58723121|FG000|Maintenance/ Follow-up Phase|Death|0|||
30709481|NCT03817853|58723122|FG001|Maintenance/ Follow-up Phase|Death|1|||
30709482|NCT03817853|58723123|FG002|Maintenance/ Follow-up Phase|Death|1|||
30709483|NCT03817853|58723121|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0|||
30709484|NCT03817853|58723122|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1|||
30709485|NCT03817853|58723123|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3|||
30709486|NCT03817853|58723121|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
30709487|NCT03817853|58723122|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1|||
30709488|NCT03817853|58723123|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
30709489|NCT03817853|58723121|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0|||
30709490|NCT03817853|58723122|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52|||
30709491|NCT03817853|58723123|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2|||
30709492|NCT00439270|58723136|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
30709493|NCT00439270|58723137|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
30709494|NCT00439270|58723138|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
30709495|NCT00439270|58723139|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
30709496|NCT00439270|58723140|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
30709497|NCT00439270|58723136|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
30709498|NCT00439270|58723137|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
30620884|NCT00603733|58632376|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
30620885|NCT00603733|58632377|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
30620886|NCT00603733|58632376|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
30620887|NCT00603733|58632377|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
30620888|NCT00603733|58632376|FG000|Maintenance Phase ITT|Adverse Event|3|||
30620889|NCT00603733|58632377|FG001|Maintenance Phase ITT|Adverse Event|6|||
30709499|NCT00439270|58723138|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
30709500|NCT00439270|58723139|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
30709501|NCT00439270|58723140|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
30709502|NCT00439270|58723136|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
30709503|NCT00439270|58723137|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
30709504|NCT00439270|58723138|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
30709505|NCT00439270|58723139|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
30709506|NCT00439270|58723140|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
30709507|NCT00439270|58723136|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
30709508|NCT00439270|58723137|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
30709509|NCT00439270|58723138|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
30709510|NCT00439270|58723139|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
30709511|NCT00439270|58723140|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
30709512|NCT00439270|58723136|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
30709513|NCT00439270|58723137|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
30709514|NCT00439270|58723138|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
30709515|NCT00439270|58723139|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
30895249|NCT02483585|58928692|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
30895250|NCT02483585|58928693|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
30895251|NCT02483585|58928692|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
30895252|NCT02483585|58928693|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
30895253|NCT02483585|58928692|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
30895254|NCT02483585|58928693|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
30895255|NCT02046993|58928705|FG000|Overall Study|Withdrawal by Subject|2|||
30895256|NCT02046993|58928706|FG001|Overall Study|Withdrawal by Subject|10|||
30895257|NCT02046993|58928705|FG000|Overall Study|Lost to Follow-up|1|||
30895258|NCT02046993|58928706|FG001|Overall Study|Lost to Follow-up|1|||
30895259|NCT02101983|58928716|FG000|Overall Study|Physician Decision|1|||
30895260|NCT02101983|58928717|FG001|Overall Study|Physician Decision|0|||
30895261|NCT02482805|58928726|FG000|Overall Study|Lost to Follow-up|4|||
30895262|NCT02482805|58928727|FG001|Overall Study|Lost to Follow-up|4|||
30895263|NCT02482805|58928728|FG002|Overall Study|Lost to Follow-up|0|||
30895264|NCT02503865|58928739|FG000|Overall Study|Moved out of area|1|||
30895265|NCT02503865|58928740|FG001|Overall Study|Moved out of area|8|||
30895266|NCT02503865|58928741|FG002|Overall Study|Moved out of area|0|||
30895267|NCT02503865|58928739|FG000|Overall Study|Refused treatment|4|||
30895268|NCT02503865|58928740|FG001|Overall Study|Refused treatment|39|||
30895269|NCT02503865|58928741|FG002|Overall Study|Refused treatment|2|||
30895270|NCT01623531|58928752|FG000|Overall Study|Death|1|||
30895271|NCT01623531|58928753|FG001|Overall Study|Death|0|||
30895272|NCT01623531|58928752|FG000|Overall Study|Protocol Violation|2|||
30895273|NCT01623531|58928753|FG001|Overall Study|Protocol Violation|1|||
30895274|NCT01623531|58928752|FG000|Overall Study|Missing data at primary outcome time poi|1|||
30895275|NCT01623531|58928753|FG001|Overall Study|Missing data at primary outcome time poi|1|||
30895276|NCT02503787|58928762|FG000|Enrollment|Withdrawal by Subject|6|||
30895277|NCT02503787|58928762|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
30895278|NCT02503787|58928762|FG000|Enrollment|Physician Decision|2|||
30895279|NCT02503787|58928762|FG000|Enrollment|Insurance issue|2|||
30895280|NCT02503787|58928762|FG000|Enrollment|Lost to Follow-up|1|||
30895281|NCT02503787|58928762|FG000|Enrollment|Study closure|1|||
30895282|NCT02503787|58928762|FG000|Enrollment|Adverse Event|1|||
30895283|NCT02503787|58928762|FG000|Enrollment|Protocol Violation|1|||
30895284|NCT02503787|58928762|FG000|Enrollment|Inability to implant system|1|||
30895285|NCT02503787|58928762|FG000|Enrollment|Unable to be programmed|1|||
30895286|NCT02503787|58928762|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
30895287|NCT02503787|58928762|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
30895288|NCT02503787|58928762|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
30895289|NCT02503787|58928762|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
30895290|NCT02503787|58928762|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
30895291|NCT02503787|58928762|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
30895292|NCT02482571|58928766|FG000|Overall Study|Adverse Event|1|||
30895293|NCT02482571|58928766|FG000|Overall Study|Scanner or Respiract failure|3|||
30895294|NCT02482571|58928766|FG000|Overall Study|Withdrawal by Subject|4|||
30895295|NCT02481947|58928773|FG000|Overall Study|Withdrawal by Subject|24|||
30895296|NCT02481947|58928774|FG001|Overall Study|Withdrawal by Subject|10|||
30895297|NCT02481947|58928773|FG000|Overall Study|Lost to Follow-up|11|||
30895298|NCT02481947|58928774|FG001|Overall Study|Lost to Follow-up|5|||
30895299|NCT02481947|58928773|FG000|Overall Study|Adverse Event|6|||
30895300|NCT02481947|58928774|FG001|Overall Study|Adverse Event|11|||
30709516|NCT00439270|58723140|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
30709517|NCT00439270|58723136|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
30709518|NCT00439270|58723137|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
30895301|NCT02481947|58928773|FG000|Overall Study|Physician Decision|4|||
30895302|NCT02481947|58928774|FG001|Overall Study|Physician Decision|5|||
30895303|NCT02481947|58928773|FG000|Overall Study|Protocol Violation|1|||
30895304|NCT02481947|58928774|FG001|Overall Study|Protocol Violation|5|||
30895305|NCT02503085|58928780|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
30895306|NCT02503085|58928781|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
30895307|NCT02503085|58928782|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
30895308|NCT02503085|58928783|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
30895309|NCT02481869|58928792|FG000|Overall Study|Lost to Follow-up|3|||
30895310|NCT02481869|58928793|FG001|Overall Study|Lost to Follow-up|4|||
30895311|NCT02481869|58928792|FG000|Overall Study|Withdrawal by Subject|2|||
30895312|NCT02481869|58928793|FG001|Overall Study|Withdrawal by Subject|0|||
30895313|NCT02502149|58928800|FG000|Intermediate|Discontinued prematurely|1|||
30895314|NCT02502149|58928801|FG001|Intermediate|Discontinued prematurely|0|||
30895315|NCT02502149|58928802|FG002|Intermediate|Discontinued prematurely|0|||
30895316|NCT02502149|58928803|FG003|Intermediate|Discontinued prematurely|0|||
30895317|NCT02502149|58928804|FG004|Intermediate|Discontinued prematurely|0|||
30895318|NCT02480621|58928823|FG000|Randomization|Withdrawal by Subject|1|||
30895319|NCT02480621|58928824|FG001|Randomization|Withdrawal by Subject|0|||
30895320|NCT02480621|58928823|FG000|Randomization|Surgeon did not give intervention|0|||
30895321|NCT02480621|58928824|FG001|Randomization|Surgeon did not give intervention|1|||
30895322|NCT02480621|58928823|FG000|Follow Up|Lost to Follow-up|4|||
30895323|NCT02480621|58928824|FG001|Follow Up|Lost to Follow-up|2|||
30895324|NCT02046603|58928832|FG000|Overall Study|Other|11|||
30895325|NCT02046603|58928833|FG001|Overall Study|Other|66|||
30895326|NCT02046603|58928832|FG000|Overall Study|Protocol Violation|0|||
30895327|NCT02046603|58928833|FG001|Overall Study|Protocol Violation|1|||
30895328|NCT02046603|58928832|FG000|Overall Study|Participant/legal guardian decision|1|||
30895329|NCT02046603|58928833|FG001|Overall Study|Participant/legal guardian decision|3|||
30895330|NCT02046603|58928832|FG000|Overall Study|Physician Decision|2|||
30895331|NCT02046603|58928833|FG001|Overall Study|Physician Decision|1|||
30895332|NCT02046603|58928832|FG000|Overall Study|Lost to Follow-up|1|||
30895333|NCT02046603|58928833|FG001|Overall Study|Lost to Follow-up|2|||
30895334|NCT02046603|58928832|FG000|Overall Study|Death|0|||
30895335|NCT02046603|58928833|FG001|Overall Study|Death|1|||
30895336|NCT02046603|58928832|FG000|Overall Study|Adverse Event|0|||
30895337|NCT02046603|58928833|FG001|Overall Study|Adverse Event|1|||
30895338|NCT01885078|58928848|FG000|Treatment Period|Adverse Event|52|||
30895339|NCT01885078|58928849|FG001|Treatment Period|Adverse Event|136|||
30895340|NCT01885078|58928850|FG002|Treatment Period|Adverse Event|30|||
30895341|NCT01885078|58928851|FG003|Treatment Period|Adverse Event|73|||
30895342|NCT01885078|58928852|FG004|Treatment Period|Adverse Event|17|||
30895343|NCT01885078|58928853|FG005|Treatment Period|Adverse Event|72|||
30895344|NCT01885078|58928854|FG006|Treatment Period|Adverse Event|24|||
30895345|NCT01885078|58928855|FG007|Treatment Period|Adverse Event|5|||
30895346|NCT01885078|58928856|FG008|Treatment Period|Adverse Event|0|||
30895347|NCT01885078|58928857|FG009|Treatment Period|Adverse Event|0|||
30895348|NCT01885078|58928848|FG000|Treatment Period|Death|13|||
30895349|NCT01885078|58928849|FG001|Treatment Period|Death|33|||
30895350|NCT01885078|58928850|FG002|Treatment Period|Death|5|||
30895351|NCT01885078|58928851|FG003|Treatment Period|Death|9|||
30895352|NCT01885078|58928852|FG004|Treatment Period|Death|2|||
30895353|NCT01885078|58928853|FG005|Treatment Period|Death|10|||
30895354|NCT01885078|58928854|FG006|Treatment Period|Death|3|||
30895355|NCT01885078|58928855|FG007|Treatment Period|Death|2|||
30895356|NCT01885078|58928856|FG008|Treatment Period|Death|0|||
30895357|NCT01885078|58928857|FG009|Treatment Period|Death|0|||
30895358|NCT01885078|58928848|FG000|Treatment Period|Lack of Efficacy|12|||
30895359|NCT01885078|58928849|FG001|Treatment Period|Lack of Efficacy|33|||
30895360|NCT01885078|58928850|FG002|Treatment Period|Lack of Efficacy|10|||
30895361|NCT01885078|58928851|FG003|Treatment Period|Lack of Efficacy|23|||
30895362|NCT01885078|58928852|FG004|Treatment Period|Lack of Efficacy|24|||
30895363|NCT01885078|58928853|FG005|Treatment Period|Lack of Efficacy|58|||
30895364|NCT01885078|58928854|FG006|Treatment Period|Lack of Efficacy|9|||
30895365|NCT01885078|58928855|FG007|Treatment Period|Lack of Efficacy|5|||
30895366|NCT01885078|58928856|FG008|Treatment Period|Lack of Efficacy|0|||
30895367|NCT01885078|58928857|FG009|Treatment Period|Lack of Efficacy|0|||
30895368|NCT01885078|58928848|FG000|Treatment Period|Lost to Follow-up|16|||
30895369|NCT01885078|58928849|FG001|Treatment Period|Lost to Follow-up|19|||
30620890|NCT00603733|58632376|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
30709519|NCT00439270|58723138|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
30895370|NCT01885078|58928850|FG002|Treatment Period|Lost to Follow-up|7|||
30895371|NCT01885078|58928851|FG003|Treatment Period|Lost to Follow-up|9|||
30895372|NCT01885078|58928852|FG004|Treatment Period|Lost to Follow-up|2|||
30895373|NCT01885078|58928853|FG005|Treatment Period|Lost to Follow-up|8|||
30895374|NCT01885078|58928854|FG006|Treatment Period|Lost to Follow-up|2|||
30895375|NCT01885078|58928855|FG007|Treatment Period|Lost to Follow-up|0|||
30895376|NCT01885078|58928856|FG008|Treatment Period|Lost to Follow-up|0|||
30895377|NCT01885078|58928857|FG009|Treatment Period|Lost to Follow-up|0|||
30895378|NCT01885078|58928848|FG000|Treatment Period|Physician Decision|19|||
30895379|NCT01885078|58928849|FG001|Treatment Period|Physician Decision|21|||
30895380|NCT01885078|58928850|FG002|Treatment Period|Physician Decision|5|||
30895381|NCT01885078|58928851|FG003|Treatment Period|Physician Decision|12|||
30895382|NCT01885078|58928852|FG004|Treatment Period|Physician Decision|9|||
30709520|NCT00439270|58723139|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
30709521|NCT00439270|58723140|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
30709522|NCT00439270|58723136|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
30709523|NCT00439270|58723137|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
30709524|NCT00439270|58723138|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
30709525|NCT00439270|58723139|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
30709526|NCT00439270|58723140|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
30709527|NCT00439270|58723136|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
30709528|NCT00439270|58723137|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
30709529|NCT00439270|58723138|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
30709530|NCT00439270|58723139|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
30709531|NCT00439270|58723140|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
30709532|NCT00439270|58723136|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
30709533|NCT00439270|58723137|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
30709534|NCT00439270|58723138|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
30709535|NCT00439270|58723139|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
30709536|NCT00439270|58723140|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
30709537|NCT00439270|58723136|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
30709538|NCT00439270|58723137|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
30709539|NCT00439270|58723138|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
30620891|NCT00603733|58632377|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
30620892|NCT00603733|58632376|FG000|Maintenance Phase ITT|Protocol Violation|1|||
30620893|NCT00603733|58632377|FG001|Maintenance Phase ITT|Protocol Violation|1|||
30620894|NCT00603733|58632376|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
30620895|NCT00603733|58632377|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
30620896|NCT00603733|58632376|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
30709540|NCT00439270|58723139|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
30709541|NCT00439270|58723140|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
30709542|NCT00553280|58723159|FG000|Overall Study|Adverse Event|19|||
30709543|NCT00553280|58723159|FG000|Overall Study|Lack of Efficacy|3|||
30895383|NCT01885078|58928853|FG005|Treatment Period|Physician Decision|24|||
30620897|NCT00603733|58632377|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
30620898|NCT00603733|58632376|FG000|Maintenance Phase ITT|Physician Decision|0|||
30620899|NCT00603733|58632377|FG001|Maintenance Phase ITT|Physician Decision|1|||
30620900|NCT00603733|58632376|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
30620901|NCT00603733|58632377|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
30620902|NCT04631107|58632383|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
30620903|NCT04631107|58632383|FG000|Second Intervention (1 Night)|Adverse Event|1|||
30620904|NCT04631107|58632383|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
30620905|NCT04631107|58632383|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
30620906|NCT00995007|58632393|FG000|Overall Study|Withdrew consent|1|||
30620907|NCT00995007|58632394|FG001|Overall Study|Withdrew consent|0|||
30620908|NCT00995007|58632393|FG000|Overall Study|Refused further treatment|8|||
30620909|NCT00995007|58632394|FG001|Overall Study|Refused further treatment|2|||
30620910|NCT00995007|58632393|FG000|Overall Study|Toxicity|8|||
30709544|NCT00553280|58723159|FG000|Overall Study|Withdrawal by Subject|3|||
30709545|NCT00553280|58723159|FG000|Overall Study|Physician Decision|1|||
30790882|NCT03524092|58803943|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
30895384|NCT01885078|58928854|FG006|Treatment Period|Physician Decision|4|||
30895385|NCT01885078|58928855|FG007|Treatment Period|Physician Decision|3|||
30895386|NCT01885078|58928856|FG008|Treatment Period|Physician Decision|0|||
30895387|NCT01885078|58928857|FG009|Treatment Period|Physician Decision|0|||
30895388|NCT01885078|58928848|FG000|Treatment Period|Protocol Violation|3|||
30895389|NCT01885078|58928849|FG001|Treatment Period|Protocol Violation|5|||
30895390|NCT01885078|58928850|FG002|Treatment Period|Protocol Violation|0|||
30895391|NCT01885078|58928851|FG003|Treatment Period|Protocol Violation|3|||
30895392|NCT01885078|58928852|FG004|Treatment Period|Protocol Violation|1|||
30895393|NCT01885078|58928853|FG005|Treatment Period|Protocol Violation|6|||
30895394|NCT01885078|58928854|FG006|Treatment Period|Protocol Violation|0|||
30895395|NCT01885078|58928855|FG007|Treatment Period|Protocol Violation|0|||
30895396|NCT01885078|58928856|FG008|Treatment Period|Protocol Violation|0|||
30895397|NCT01885078|58928857|FG009|Treatment Period|Protocol Violation|0|||
30895398|NCT01885078|58928848|FG000|Treatment Period|Sponsor Decision|245|||
30895399|NCT01885078|58928849|FG001|Treatment Period|Sponsor Decision|648|||
30895400|NCT01885078|58928850|FG002|Treatment Period|Sponsor Decision|49|||
30895401|NCT01885078|58928851|FG003|Treatment Period|Sponsor Decision|90|||
30895402|NCT01885078|58928852|FG004|Treatment Period|Sponsor Decision|20|||
30895403|NCT01885078|58928853|FG005|Treatment Period|Sponsor Decision|38|||
30895404|NCT01885078|58928854|FG006|Treatment Period|Sponsor Decision|162|||
30895405|NCT01885078|58928855|FG007|Treatment Period|Sponsor Decision|3|||
30895406|NCT01885078|58928856|FG008|Treatment Period|Sponsor Decision|0|||
30895407|NCT01885078|58928857|FG009|Treatment Period|Sponsor Decision|0|||
30895408|NCT01885078|58928848|FG000|Treatment Period|Withdrawal by Subject|72|||
30895409|NCT01885078|58928849|FG001|Treatment Period|Withdrawal by Subject|132|||
30895410|NCT01885078|58928850|FG002|Treatment Period|Withdrawal by Subject|25|||
30895411|NCT01885078|58928851|FG003|Treatment Period|Withdrawal by Subject|63|||
30895412|NCT01885078|58928852|FG004|Treatment Period|Withdrawal by Subject|15|||
30895413|NCT01885078|58928853|FG005|Treatment Period|Withdrawal by Subject|34|||
30895414|NCT01885078|58928854|FG006|Treatment Period|Withdrawal by Subject|17|||
30895415|NCT01885078|58928855|FG007|Treatment Period|Withdrawal by Subject|10|||
30895416|NCT01885078|58928856|FG008|Treatment Period|Withdrawal by Subject|0|||
30895417|NCT01885078|58928857|FG009|Treatment Period|Withdrawal by Subject|0|||
30895418|NCT01885078|58928848|FG000|Treatment Period|Other|0|||
30895419|NCT01885078|58928849|FG001|Treatment Period|Other|0|||
30895420|NCT01885078|58928850|FG002|Treatment Period|Other|0|||
30895421|NCT01885078|58928851|FG003|Treatment Period|Other|1|||
30895422|NCT01885078|58928852|FG004|Treatment Period|Other|0|||
30895423|NCT01885078|58928853|FG005|Treatment Period|Other|0|||
30895424|NCT01885078|58928854|FG006|Treatment Period|Other|0|||
30895425|NCT01885078|58928855|FG007|Treatment Period|Other|0|||
30895426|NCT01885078|58928856|FG008|Treatment Period|Other|0|||
30895427|NCT01885078|58928857|FG009|Treatment Period|Other|0|||
30895428|NCT01885078|58928848|FG000|Step-down Period|Sponsor Decision|0|||
30895429|NCT01885078|58928849|FG001|Step-down Period|Sponsor Decision|0|||
30895430|NCT01885078|58928850|FG002|Step-down Period|Sponsor Decision|0|||
30895431|NCT01885078|58928851|FG003|Step-down Period|Sponsor Decision|0|||
30895432|NCT01885078|58928852|FG004|Step-down Period|Sponsor Decision|0|||
30895433|NCT01885078|58928853|FG005|Step-down Period|Sponsor Decision|0|||
30895434|NCT01885078|58928854|FG006|Step-down Period|Sponsor Decision|0|||
30895435|NCT01885078|58928855|FG007|Step-down Period|Sponsor Decision|0|||
30895436|NCT01885078|58928856|FG008|Step-down Period|Sponsor Decision|1|||
30620911|NCT00995007|58632394|FG001|Overall Study|Toxicity|0|||
30620912|NCT00994461|58632412|FG000|Overall Study|Adverse Event|2|||
30709546|NCT00440518|58723166|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
30790883|NCT03524092|58803944|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
30790884|NCT03524092|58803945|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
30790885|NCT03331562|58803958|FG000|Overall Study|Adverse Event|2|||
30790886|NCT03331562|58803959|FG001|Overall Study|Adverse Event|0|||
30790887|NCT03331562|58803958|FG000|Overall Study|Death|1|||
30790888|NCT03331562|58803959|FG001|Overall Study|Death|0|||
30895437|NCT01885078|58928857|FG009|Step-down Period|Sponsor Decision|1|||
30895438|NCT01885078|58928848|FG000|Step-down Period|Adverse Event|0|||
30895439|NCT01885078|58928849|FG001|Step-down Period|Adverse Event|0|||
30895440|NCT01885078|58928850|FG002|Step-down Period|Adverse Event|0|||
30895441|NCT01885078|58928851|FG003|Step-down Period|Adverse Event|0|||
30895442|NCT01885078|58928852|FG004|Step-down Period|Adverse Event|0|||
30895443|NCT01885078|58928853|FG005|Step-down Period|Adverse Event|0|||
30895444|NCT01885078|58928854|FG006|Step-down Period|Adverse Event|0|||
30895445|NCT01885078|58928855|FG007|Step-down Period|Adverse Event|0|||
30895446|NCT01885078|58928856|FG008|Step-down Period|Adverse Event|29|||
30620913|NCT00994461|58632413|FG001|Overall Study|Adverse Event|1|||
30620914|NCT00994461|58632414|FG002|Overall Study|Adverse Event|0|||
30620915|NCT00993915|58632422|FG000|Overall Study|Insufficient clinical response|3|||
30620916|NCT00993915|58632422|FG000|Overall Study|Withdrawal by Subject|2|||
30620917|NCT00993915|58632422|FG000|Overall Study|Other|1|||
30620918|NCT00993915|58632422|FG000|Overall Study|Ongoing|3|||
30620919|NCT01202591|58632432|FG000|Overall Study|Adverse Event|2|||
30620920|NCT01202591|58632433|FG001|Overall Study|Adverse Event|1|||
30620921|NCT01202591|58632434|FG002|Overall Study|Adverse Event|4|||
30620922|NCT01202591|58632435|FG003|Overall Study|Adverse Event|4|||
30620923|NCT01202591|58632436|FG004|Overall Study|Adverse Event|0|||
30620924|NCT01202591|58632437|FG005|Overall Study|Adverse Event|0|||
30620925|NCT01202591|58632432|FG000|Overall Study|Other reason as per investigator|3|||
30620926|NCT01202591|58632433|FG001|Overall Study|Other reason as per investigator|4|||
30620927|NCT01202591|58632434|FG002|Overall Study|Other reason as per investigator|7|||
30709547|NCT00440518|58723167|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
30709548|NCT00440518|58723168|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
30709549|NCT00440518|58723166|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
30709550|NCT00440518|58723167|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
30895447|NCT01885078|58928857|FG009|Step-down Period|Adverse Event|38|||
30895448|NCT01885078|58928848|FG000|Step-down Period|Withdrawal by Subject|0|||
30895449|NCT01885078|58928849|FG001|Step-down Period|Withdrawal by Subject|0|||
30895450|NCT01885078|58928850|FG002|Step-down Period|Withdrawal by Subject|0|||
30895451|NCT01885078|58928851|FG003|Step-down Period|Withdrawal by Subject|0|||
30895452|NCT01885078|58928852|FG004|Step-down Period|Withdrawal by Subject|0|||
30895453|NCT01885078|58928853|FG005|Step-down Period|Withdrawal by Subject|0|||
30895454|NCT01885078|58928854|FG006|Step-down Period|Withdrawal by Subject|0|||
30895455|NCT01885078|58928855|FG007|Step-down Period|Withdrawal by Subject|0|||
30895456|NCT01885078|58928856|FG008|Step-down Period|Withdrawal by Subject|25|||
30895457|NCT01885078|58928857|FG009|Step-down Period|Withdrawal by Subject|15|||
30895458|NCT01885078|58928848|FG000|Step-down Period|Physician Decision|0|||
30895459|NCT01885078|58928849|FG001|Step-down Period|Physician Decision|0|||
30895460|NCT01885078|58928850|FG002|Step-down Period|Physician Decision|0|||
30895461|NCT01885078|58928851|FG003|Step-down Period|Physician Decision|0|||
30895462|NCT01885078|58928852|FG004|Step-down Period|Physician Decision|0|||
30895463|NCT01885078|58928853|FG005|Step-down Period|Physician Decision|0|||
30895464|NCT01885078|58928854|FG006|Step-down Period|Physician Decision|0|||
30895465|NCT01885078|58928855|FG007|Step-down Period|Physician Decision|0|||
30895466|NCT01885078|58928856|FG008|Step-down Period|Physician Decision|7|||
30895467|NCT01885078|58928857|FG009|Step-down Period|Physician Decision|2|||
30895468|NCT01885078|58928848|FG000|Step-down Period|Death|0|||
30895469|NCT01885078|58928849|FG001|Step-down Period|Death|0|||
30895470|NCT01885078|58928850|FG002|Step-down Period|Death|0|||
30895471|NCT01885078|58928851|FG003|Step-down Period|Death|0|||
30895472|NCT01885078|58928852|FG004|Step-down Period|Death|0|||
30895473|NCT01885078|58928853|FG005|Step-down Period|Death|0|||
30895474|NCT01885078|58928854|FG006|Step-down Period|Death|0|||
30895475|NCT01885078|58928855|FG007|Step-down Period|Death|0|||
30895476|NCT01885078|58928856|FG008|Step-down Period|Death|4|||
30895477|NCT01885078|58928857|FG009|Step-down Period|Death|3|||
30895478|NCT01885078|58928848|FG000|Step-down Period|Lost to Follow-up|0|||
30895479|NCT01885078|58928849|FG001|Step-down Period|Lost to Follow-up|0|||
30895480|NCT01885078|58928850|FG002|Step-down Period|Lost to Follow-up|0|||
30895481|NCT01885078|58928851|FG003|Step-down Period|Lost to Follow-up|0|||
30895482|NCT01885078|58928852|FG004|Step-down Period|Lost to Follow-up|0|||
30895483|NCT01885078|58928853|FG005|Step-down Period|Lost to Follow-up|0|||
30895484|NCT01885078|58928854|FG006|Step-down Period|Lost to Follow-up|0|||
30895485|NCT01885078|58928855|FG007|Step-down Period|Lost to Follow-up|0|||
30895486|NCT01885078|58928856|FG008|Step-down Period|Lost to Follow-up|1|||
30620928|NCT01202591|58632435|FG003|Overall Study|Other reason as per investigator|3|||
30620929|NCT01202591|58632436|FG004|Overall Study|Other reason as per investigator|1|||
30620930|NCT01202591|58632437|FG005|Overall Study|Other reason as per investigator|3|||
30620931|NCT01202591|58632432|FG000|Overall Study|Withdrawal by Subject|0|||
30790889|NCT02038634|58803971|FG000|Overall Study|Lost to Follow-up|0|||
30895487|NCT01885078|58928857|FG009|Step-down Period|Lost to Follow-up|1|||
30895488|NCT01885078|58928848|FG000|Step-down Period|Lack of Efficacy|0|||
30895489|NCT01885078|58928849|FG001|Step-down Period|Lack of Efficacy|0|||
30895490|NCT01885078|58928850|FG002|Step-down Period|Lack of Efficacy|0|||
30895491|NCT01885078|58928851|FG003|Step-down Period|Lack of Efficacy|0|||
30620932|NCT01202591|58632433|FG001|Overall Study|Withdrawal by Subject|0|||
30620933|NCT01202591|58632434|FG002|Overall Study|Withdrawal by Subject|0|||
30620934|NCT01202591|58632435|FG003|Overall Study|Withdrawal by Subject|0|||
30895492|NCT01885078|58928852|FG004|Step-down Period|Lack of Efficacy|0|||
30895493|NCT01885078|58928853|FG005|Step-down Period|Lack of Efficacy|0|||
30895494|NCT01885078|58928854|FG006|Step-down Period|Lack of Efficacy|0|||
30895495|NCT01885078|58928855|FG007|Step-down Period|Lack of Efficacy|0|||
30895496|NCT01885078|58928856|FG008|Step-down Period|Lack of Efficacy|1|||
30895497|NCT01885078|58928857|FG009|Step-down Period|Lack of Efficacy|0|||
30895498|NCT01885078|58928848|FG000|Step-down Period|Protocol Violation|0|||
30895499|NCT01885078|58928849|FG001|Step-down Period|Protocol Violation|0|||
30895500|NCT01885078|58928850|FG002|Step-down Period|Protocol Violation|0|||
30895501|NCT01885078|58928851|FG003|Step-down Period|Protocol Violation|0|||
30895502|NCT01885078|58928852|FG004|Step-down Period|Protocol Violation|0|||
30895503|NCT01885078|58928853|FG005|Step-down Period|Protocol Violation|0|||
30895504|NCT01885078|58928854|FG006|Step-down Period|Protocol Violation|0|||
30895505|NCT01885078|58928855|FG007|Step-down Period|Protocol Violation|0|||
30895506|NCT01885078|58928856|FG008|Step-down Period|Protocol Violation|1|||
30895507|NCT01885078|58928857|FG009|Step-down Period|Protocol Violation|1|||
30895508|NCT02046369|58928880|FG000|Overall Study|Adverse Event|3|||
30895509|NCT02046369|58928881|FG001|Overall Study|Adverse Event|3|||
30895510|NCT02046369|58928880|FG000|Overall Study|Lack of Efficacy|3|||
30895511|NCT02046369|58928881|FG001|Overall Study|Lack of Efficacy|3|||
30895512|NCT02046369|58928880|FG000|Overall Study|Lost to Follow-up|3|||
30895513|NCT02046369|58928881|FG001|Overall Study|Lost to Follow-up|3|||
30895514|NCT02046369|58928880|FG000|Overall Study|Protocol Violation|1|||
30895515|NCT02046369|58928881|FG001|Overall Study|Protocol Violation|2|||
30895516|NCT02046369|58928880|FG000|Overall Study|Withdrawal by Subject|3|||
30895517|NCT02046369|58928881|FG001|Overall Study|Withdrawal by Subject|6|||
30895518|NCT02046369|58928880|FG000|Overall Study|never received study drug|0|||
30895519|NCT02046369|58928881|FG001|Overall Study|never received study drug|1|||
30895520|NCT02046369|58928880|FG000|Overall Study|non compliance|1|||
30895521|NCT02046369|58928881|FG001|Overall Study|non compliance|0|||
30895522|NCT02101359|58928889|FG000|Overall Study|Not included|23|||
30895523|NCT02101359|58928890|FG001|Overall Study|Not included|13|||
30895524|NCT02101359|58928889|FG000|Overall Study|Withdrawal by Subject|5|||
30895525|NCT02101359|58928890|FG001|Overall Study|Withdrawal by Subject|4|||
30895526|NCT02101359|58928889|FG000|Overall Study|Lost to Follow-up|1|||
30895527|NCT02101359|58928890|FG001|Overall Study|Lost to Follow-up|0|||
30895528|NCT02101359|58928889|FG000|Overall Study|Protocol Violation|0|||
30895529|NCT02101359|58928890|FG001|Overall Study|Protocol Violation|2|||
30895530|NCT02100969|58928896|FG000|Overall Study|Did not pass screening phase|1|||
30895531|NCT01885000|58928903|FG000|Overall Study|Adverse Event|1|||
30895532|NCT01885000|58928904|FG001|Overall Study|Adverse Event|0|||
30895533|NCT01885000|58928903|FG000|Overall Study|Withdrawal by Subject|1|||
30895534|NCT01885000|58928904|FG001|Overall Study|Withdrawal by Subject|1|||
30895535|NCT01885000|58928903|FG000|Overall Study|Protocol Violation|0|||
30895536|NCT01885000|58928904|FG001|Overall Study|Protocol Violation|1|||
30895537|NCT01884688|58928910|FG000|Overall Study|Screen Failure|2|||
30895538|NCT01883362|58928916|FG000|Treatment|Adverse Event|1|||
30709551|NCT00440518|58723168|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
30709552|NCT00440518|58723166|FG000|Randomized /Titration Period|Protocol Deviation|1|||
30709553|NCT00440518|58723167|FG001|Randomized /Titration Period|Protocol Deviation|0|||
30709554|NCT00440518|58723168|FG002|Randomized /Titration Period|Protocol Deviation|0|||
30709555|NCT00440518|58723166|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
30709556|NCT00440518|58723167|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
30709557|NCT00440518|58723168|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
30709558|NCT00440518|58723166|FG000|Randomized /Titration Period|Other|1|||
30709559|NCT00440518|58723167|FG001|Randomized /Titration Period|Other|0|||
30709560|NCT00440518|58723168|FG002|Randomized /Titration Period|Other|0|||
30709561|NCT00440518|58723166|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
30709562|NCT00440518|58723167|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
30709563|NCT00440518|58723168|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
30709564|NCT00440518|58723166|FG000|Randomized /Titration Period|Adverse Event|2|||
30709565|NCT00440518|58723167|FG001|Randomized /Titration Period|Adverse Event|3|||
30709566|NCT00440518|58723168|FG002|Randomized /Titration Period|Adverse Event|0|||
30709567|NCT00440518|58723166|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
30709568|NCT00440518|58723167|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
30709569|NCT00440518|58723168|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
30709570|NCT00440518|58723166|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
30709571|NCT00440518|58723167|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
30709572|NCT00440518|58723168|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
30709573|NCT00440518|58723166|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
30709574|NCT00440518|58723167|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
30709575|NCT00440518|58723168|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
30895539|NCT01883362|58928917|FG001|Treatment|Adverse Event|8|||
30895540|NCT01883362|58928916|FG000|Treatment|Withdrawal by Subject|6|||
30709576|NCT00440518|58723166|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
30895541|NCT01883362|58928917|FG001|Treatment|Withdrawal by Subject|2|||
30895542|NCT01883362|58928916|FG000|Treatment|Administrative problems|4|||
30895543|NCT01883362|58928917|FG001|Treatment|Administrative problems|1|||
30895544|NCT01883362|58928916|FG000|Treatment|Relapse|4|||
30895545|NCT01883362|58928917|FG001|Treatment|Relapse|2|||
30895546|NCT01883362|58928916|FG000|Treatment|Randomized, not treated|1|||
30895547|NCT01883362|58928917|FG001|Treatment|Randomized, not treated|1|||
30895548|NCT01883362|58928916|FG000|Post Treatment Follow-up|Protocol Violation|0|||
30895549|NCT01883362|58928917|FG001|Post Treatment Follow-up|Protocol Violation|1|||
30895550|NCT01883362|58928916|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
30895551|NCT01883362|58928917|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
30895552|NCT01883362|58928916|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
30895553|NCT01883362|58928917|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
30895554|NCT01883362|58928916|FG000|Post Treatment Follow-up|Administrative problems|2|||
30895555|NCT01883362|58928917|FG001|Post Treatment Follow-up|Administrative problems|0|||
30895556|NCT01883362|58928916|FG000|Post Treatment Follow-up|Death|8|||
30895557|NCT01883362|58928917|FG001|Post Treatment Follow-up|Death|4|||
30895558|NCT01883362|58928916|FG000|Post Treatment Follow-up|Relapse|1|||
30895559|NCT01883362|58928917|FG001|Post Treatment Follow-up|Relapse|2|||
30895560|NCT02100813|58928935|FG000|Overall Study|Adverse Event|0|||
30895561|NCT02100813|58928936|FG001|Overall Study|Adverse Event|0|||
30895562|NCT02100813|58928937|FG002|Overall Study|Adverse Event|0|||
30895563|NCT02100813|58928938|FG003|Overall Study|Adverse Event|0|||
30895564|NCT02100813|58928939|FG004|Overall Study|Adverse Event|0|||
30895565|NCT02100813|58928940|FG005|Overall Study|Adverse Event|0|||
30895566|NCT02100813|58928941|FG006|Overall Study|Adverse Event|0|||
30790890|NCT02038634|58803972|FG001|Overall Study|Lost to Follow-up|1|||
30709577|NCT00440518|58723167|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
30895567|NCT02100813|58928942|FG007|Overall Study|Adverse Event|1|||
30895568|NCT01930162|58928964|FG000|Overall Study|Abnormal test procedure result(s)|4|||
30895569|NCT01930162|58928964|FG000|Overall Study|Death|1|||
30895570|NCT02045979|58928972|FG000|Overall Study|Informed Consent Withdrawn|2|||
30895571|NCT02045979|58928973|FG001|Overall Study|Informed Consent Withdrawn|0|||
30709578|NCT00440518|58723168|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
30709579|NCT00440518|58723166|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
30709580|NCT00440518|58723167|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
30709581|NCT00440518|58723168|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
30709582|NCT00440518|58723166|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
30709583|NCT00440518|58723167|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
30709584|NCT00440518|58723168|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
30709585|NCT00438256|58723176|FG000|Overall Study|Ineligible for Resection|2|||
30709586|NCT00438256|58723177|FG001|Overall Study|Ineligible for Resection|1|||
30709587|NCT00438256|58723178|FG002|Overall Study|Ineligible for Resection|1|||
30709588|NCT00438256|58723179|FG003|Overall Study|Ineligible for Resection|7|||
30709589|NCT00438256|58723176|FG000|Overall Study|Excluded final Diagnosis|0|||
30709590|NCT00438256|58723177|FG001|Overall Study|Excluded final Diagnosis|0|||
30709591|NCT00438256|58723178|FG002|Overall Study|Excluded final Diagnosis|0|||
30709592|NCT00438256|58723179|FG003|Overall Study|Excluded final Diagnosis|2|||
30709593|NCT00436852|58723198|FG000|Overall Study|Death|23|||
30709594|NCT00436852|58723199|FG001|Overall Study|Death|34|||
30709595|NCT00436852|58723198|FG000|Overall Study|Lack of Efficacy|9|||
30709596|NCT00436852|58723199|FG001|Overall Study|Lack of Efficacy|7|||
30709597|NCT00436852|58723198|FG000|Overall Study|Withdrawal by Subject|2|||
30709598|NCT00436852|58723199|FG001|Overall Study|Withdrawal by Subject|4|||
30709599|NCT00436852|58723198|FG000|Overall Study|Ineligible|1|||
30709600|NCT00436852|58723199|FG001|Overall Study|Ineligible|0|||
30709601|NCT00120289|58723210|FG000|Overall Study|Death|96|||
30709602|NCT00120289|58723211|FG001|Overall Study|Death|82|||
30709603|NCT00120289|58723210|FG000|Overall Study|Lost to Follow-up|11|||
30709604|NCT00120289|58723211|FG001|Overall Study|Lost to Follow-up|14|||
30709605|NCT00120289|58723210|FG000|Overall Study|Withdrawal by Subject|14|||
30709606|NCT00120289|58723211|FG001|Overall Study|Withdrawal by Subject|13|||
30709607|NCT00550446|58723224|FG000|Up To Week 12|Adverse Event|2|||
30709608|NCT00550446|58723225|FG001|Up To Week 12|Adverse Event|2|||
30709609|NCT00550446|58723226|FG002|Up To Week 12|Adverse Event|0|||
30709610|NCT00550446|58723227|FG003|Up To Week 12|Adverse Event|0|||
30709611|NCT00550446|58723228|FG004|Up To Week 12|Adverse Event|2|||
30709612|NCT00550446|58723229|FG005|Up To Week 12|Adverse Event|2|||
30709613|NCT00550446|58723230|FG006|Up To Week 12|Adverse Event|1|||
30709614|NCT00550446|58723231|FG007|Up To Week 12|Adverse Event|0|||
30709615|NCT00550446|58723232|FG008|Up To Week 12|Adverse Event|0|||
30709616|NCT00550446|58723233|FG009|Up To Week 12|Adverse Event|0|||
30895572|NCT02045979|58928974|FG002|Overall Study|Informed Consent Withdrawn|1|||
30895573|NCT02045979|58928972|FG000|Overall Study|not specified above|0|||
30620935|NCT01202591|58632436|FG004|Overall Study|Withdrawal by Subject|2|||
30620936|NCT01202591|58632437|FG005|Overall Study|Withdrawal by Subject|1|||
30620937|NCT01202591|58632432|FG000|Overall Study|Objective Disease Progression|0|||
30620938|NCT01202591|58632433|FG001|Overall Study|Objective Disease Progression|0|||
30620939|NCT01202591|58632434|FG002|Overall Study|Objective Disease Progression|0|||
30620940|NCT01202591|58632435|FG003|Overall Study|Objective Disease Progression|0|||
30620941|NCT01202591|58632436|FG004|Overall Study|Objective Disease Progression|2|||
30620942|NCT01202591|58632437|FG005|Overall Study|Objective Disease Progression|0|||
30620943|NCT01202279|58632453|FG000|Overall Study|Adverse Event|8|||
30709617|NCT00550446|58723234|FG010|Up To Week 12|Adverse Event|0|||
30709618|NCT00550446|58723224|FG000|Up To Week 12|Lack of Efficacy|3|||
30709619|NCT00550446|58723225|FG001|Up To Week 12|Lack of Efficacy|1|||
30709620|NCT00550446|58723226|FG002|Up To Week 12|Lack of Efficacy|0|||
30709621|NCT00550446|58723227|FG003|Up To Week 12|Lack of Efficacy|1|||
30709622|NCT00550446|58723228|FG004|Up To Week 12|Lack of Efficacy|0|||
30709623|NCT00550446|58723229|FG005|Up To Week 12|Lack of Efficacy|3|||
30895574|NCT02045979|58928973|FG001|Overall Study|not specified above|1|||
30895575|NCT02045979|58928974|FG002|Overall Study|not specified above|0|||
30895576|NCT01929226|58928984|FG000|Overall Study|Lost to Follow-up|4|||
30895577|NCT01929226|58928985|FG001|Overall Study|Lost to Follow-up|0|||
30895578|NCT01929226|58928984|FG000|Overall Study|Withdrawal by Subject|1|||
30895579|NCT01929226|58928985|FG001|Overall Study|Withdrawal by Subject|1|||
30895580|NCT02045433|58928992|FG000|Overall Study|Withdrawal by Subject|1|||
30895581|NCT01911442|58928999|FG000|Overall Study|Adverse Event|2|||
30895582|NCT01911442|58929000|FG001|Overall Study|Adverse Event|2|||
30895583|NCT01911442|58929001|FG002|Overall Study|Adverse Event|4|||
30895584|NCT01911442|58928999|FG000|Overall Study|Lack of Efficacy|1|||
30895585|NCT01911442|58929000|FG001|Overall Study|Lack of Efficacy|1|||
30895586|NCT01911442|58929001|FG002|Overall Study|Lack of Efficacy|1|||
30895587|NCT01911442|58928999|FG000|Overall Study|Lost to Follow-up|2|||
30895588|NCT01911442|58929000|FG001|Overall Study|Lost to Follow-up|0|||
30895589|NCT01911442|58929001|FG002|Overall Study|Lost to Follow-up|1|||
30895590|NCT01911442|58928999|FG000|Overall Study|Withdrawal by Subject|1|||
30895591|NCT01911442|58929000|FG001|Overall Study|Withdrawal by Subject|0|||
30895592|NCT01911442|58929001|FG002|Overall Study|Withdrawal by Subject|6|||
30895593|NCT01911442|58928999|FG000|Overall Study|Mother's Work Schedule|0|||
30895594|NCT01911442|58929000|FG001|Overall Study|Mother's Work Schedule|1|||
30895595|NCT01911442|58929001|FG002|Overall Study|Mother's Work Schedule|0|||
30895596|NCT01928758|58929015|FG000|Overall Study|Lost to Follow-up|14|||
30895597|NCT01928758|58929016|FG001|Overall Study|Lost to Follow-up|9|||
30895598|NCT01928758|58929015|FG000|Overall Study|Withdrawal by Subject|5|||
30895599|NCT01928758|58929016|FG001|Overall Study|Withdrawal by Subject|2|||
30895600|NCT01928758|58929015|FG000|Overall Study|Adverse Event|3|||
30895601|NCT01928758|58929016|FG001|Overall Study|Adverse Event|5|||
30895602|NCT01928758|58929015|FG000|Overall Study|Protocol Violation|3|||
30895603|NCT01928758|58929016|FG001|Overall Study|Protocol Violation|4|||
30895604|NCT01910116|58929025|FG000|Overall Study|Adverse Event|0|||
30895605|NCT01910116|58929026|FG001|Overall Study|Adverse Event|3|||
30895606|NCT01910116|58929025|FG000|Overall Study|Lack of Efficacy|3|||
30895607|NCT01910116|58929026|FG001|Overall Study|Lack of Efficacy|4|||
30895608|NCT01910116|58929025|FG000|Overall Study|Lost to Follow-up|1|||
30895609|NCT01910116|58929026|FG001|Overall Study|Lost to Follow-up|0|||
30895610|NCT01910116|58929025|FG000|Overall Study|Protocol Violation|1|||
30895611|NCT01910116|58929026|FG001|Overall Study|Protocol Violation|2|||
30895612|NCT01910116|58929025|FG000|Overall Study|Withdrawal by Subject|8|||
30895613|NCT01910116|58929026|FG001|Overall Study|Withdrawal by Subject|3|||
30895614|NCT01910116|58929025|FG000|Overall Study|uncertain allocation|1|||
30895615|NCT01910116|58929026|FG001|Overall Study|uncertain allocation|3|||
30895616|NCT01910116|58929025|FG000|Overall Study|incomplete data|0|||
30895617|NCT01910116|58929026|FG001|Overall Study|incomplete data|1|||
30895618|NCT01614886|58929034|FG000|Overall Study|Adverse Event|15|||
30895619|NCT01614886|58929035|FG001|Overall Study|Adverse Event|20|||
30895620|NCT01614886|58929034|FG000|Overall Study|Withdrawal by Subject|4|||
30895621|NCT01614886|58929035|FG001|Overall Study|Withdrawal by Subject|4|||
30895622|NCT01614886|58929034|FG000|Overall Study|Death|1|||
30895623|NCT01614886|58929035|FG001|Overall Study|Death|0|||
30895624|NCT01614886|58929034|FG000|Overall Study|Protocol deviation|0|||
30895625|NCT01614886|58929035|FG001|Overall Study|Protocol deviation|2|||
30895626|NCT01880554|58929041|FG000|Overall Study|Protocol Violation|14|||
30895627|NCT01880554|58929041|FG000|Overall Study|Simon's design requirements|2|||
30895628|NCT02100657|58929049|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
30895629|NCT02100657|58929050|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
30895630|NCT02100657|58929051|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
30620944|NCT01202279|58632454|FG001|Overall Study|Adverse Event|6|||
30895631|NCT02100657|58929049|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
30895632|NCT02100657|58929050|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
30895633|NCT02100657|58929051|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
30895634|NCT02100657|58929049|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
30895635|NCT02100657|58929050|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
30895636|NCT02100657|58929051|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
30895637|NCT02100657|58929049|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
30895638|NCT02100657|58929050|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
30895639|NCT02100657|58929051|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
30895640|NCT02100657|58929049|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
30895641|NCT02100657|58929050|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
30895642|NCT02100657|58929051|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
30895643|NCT02100657|58929049|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
30895644|NCT02100657|58929050|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
30895645|NCT02100657|58929051|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
30895646|NCT02100657|58929049|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
30895647|NCT02100657|58929050|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
30895648|NCT02100657|58929051|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
30895649|NCT02100657|58929049|FG000|Cohort 3: Dose Level 3|Death|0|||
30709624|NCT00550446|58723230|FG006|Up To Week 12|Lack of Efficacy|3|||
30709625|NCT00550446|58723231|FG007|Up To Week 12|Lack of Efficacy|0|||
30709626|NCT00550446|58723232|FG008|Up To Week 12|Lack of Efficacy|0|||
30709627|NCT00550446|58723233|FG009|Up To Week 12|Lack of Efficacy|0|||
30709628|NCT00550446|58723234|FG010|Up To Week 12|Lack of Efficacy|0|||
30709629|NCT00550446|58723224|FG000|Up To Week 12|Lost to Follow-up|0|||
30709630|NCT00550446|58723225|FG001|Up To Week 12|Lost to Follow-up|1|||
30709631|NCT00550446|58723226|FG002|Up To Week 12|Lost to Follow-up|0|||
30709632|NCT00550446|58723227|FG003|Up To Week 12|Lost to Follow-up|0|||
30709633|NCT00550446|58723228|FG004|Up To Week 12|Lost to Follow-up|1|||
30709634|NCT00550446|58723229|FG005|Up To Week 12|Lost to Follow-up|1|||
30709635|NCT00550446|58723230|FG006|Up To Week 12|Lost to Follow-up|2|||
30709636|NCT00550446|58723231|FG007|Up To Week 12|Lost to Follow-up|0|||
30709637|NCT00550446|58723232|FG008|Up To Week 12|Lost to Follow-up|0|||
30709638|NCT00550446|58723233|FG009|Up To Week 12|Lost to Follow-up|0|||
30709639|NCT00550446|58723234|FG010|Up To Week 12|Lost to Follow-up|0|||
30709640|NCT00550446|58723224|FG000|Up To Week 12|Withdrawal by Subject|2|||
30709641|NCT00550446|58723225|FG001|Up To Week 12|Withdrawal by Subject|0|||
30709642|NCT00550446|58723226|FG002|Up To Week 12|Withdrawal by Subject|3|||
30709643|NCT00550446|58723227|FG003|Up To Week 12|Withdrawal by Subject|2|||
30709644|NCT00550446|58723228|FG004|Up To Week 12|Withdrawal by Subject|0|||
30709645|NCT00550446|58723229|FG005|Up To Week 12|Withdrawal by Subject|1|||
30709646|NCT00550446|58723230|FG006|Up To Week 12|Withdrawal by Subject|3|||
30709647|NCT00550446|58723231|FG007|Up To Week 12|Withdrawal by Subject|0|||
30709648|NCT00550446|58723232|FG008|Up To Week 12|Withdrawal by Subject|0|||
30709649|NCT00550446|58723233|FG009|Up To Week 12|Withdrawal by Subject|0|||
30709650|NCT00550446|58723234|FG010|Up To Week 12|Withdrawal by Subject|0|||
30709651|NCT00550446|58723224|FG000|Up To Week 12|Other|3|||
30709652|NCT00550446|58723225|FG001|Up To Week 12|Other|0|||
30709653|NCT00550446|58723226|FG002|Up To Week 12|Other|0|||
30709654|NCT00550446|58723227|FG003|Up To Week 12|Other|0|||
30709655|NCT00550446|58723228|FG004|Up To Week 12|Other|0|||
30709656|NCT00550446|58723229|FG005|Up To Week 12|Other|1|||
30709657|NCT00550446|58723230|FG006|Up To Week 12|Other|4|||
30709658|NCT00550446|58723231|FG007|Up To Week 12|Other|0|||
30709659|NCT00550446|58723232|FG008|Up To Week 12|Other|0|||
30709660|NCT00550446|58723233|FG009|Up To Week 12|Other|0|||
30709661|NCT00550446|58723234|FG010|Up To Week 12|Other|0|||
30709662|NCT00550446|58723224|FG000|Up To Week 12|Randomized not treated|0|||
30709663|NCT00550446|58723225|FG001|Up To Week 12|Randomized not treated|1|||
30709664|NCT00550446|58723226|FG002|Up To Week 12|Randomized not treated|1|||
30709665|NCT00550446|58723227|FG003|Up To Week 12|Randomized not treated|0|||
30709666|NCT00550446|58723228|FG004|Up To Week 12|Randomized not treated|0|||
30709667|NCT00550446|58723229|FG005|Up To Week 12|Randomized not treated|0|||
30709668|NCT00550446|58723230|FG006|Up To Week 12|Randomized not treated|0|||
30709669|NCT00550446|58723231|FG007|Up To Week 12|Randomized not treated|0|||
30709670|NCT00550446|58723232|FG008|Up To Week 12|Randomized not treated|0|||
30709671|NCT00550446|58723233|FG009|Up To Week 12|Randomized not treated|0|||
30709672|NCT00550446|58723234|FG010|Up To Week 12|Randomized not treated|0|||
30709673|NCT00550446|58723224|FG000|Post Week 12|Adverse Event|2|||
30709674|NCT00550446|58723225|FG001|Post Week 12|Adverse Event|1|||
30709675|NCT00550446|58723226|FG002|Post Week 12|Adverse Event|1|||
30895650|NCT02100657|58929050|FG001|Cohort 3: Dose Level 3|Death|0|||
30895651|NCT02100657|58929051|FG002|Cohort 3: Dose Level 3|Death|1|||
30895652|NCT02100657|58929049|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
30895653|NCT02100657|58929050|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
30895654|NCT02100657|58929051|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
30895655|NCT02100657|58929049|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
30895656|NCT02100657|58929050|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
30895657|NCT02100657|58929051|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
30895658|NCT02100657|58929049|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
30895659|NCT02100657|58929050|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
30895660|NCT02100657|58929051|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
30895661|NCT02100657|58929049|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
30895662|NCT02100657|58929050|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
30895663|NCT02100657|58929051|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
30895664|NCT02100657|58929049|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
30895665|NCT02100657|58929050|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
30895666|NCT02100657|58929051|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
30895667|NCT02067663|58929062|FG000|Overall Study|Lost to Follow-up|13|||
30895668|NCT02067663|58929063|FG001|Overall Study|Lost to Follow-up|14|||
30895669|NCT01909804|58929081|FG000|Overall Study|Randomized but Never Treated|0|||
30895670|NCT01909804|58929082|FG001|Overall Study|Randomized but Never Treated|0|||
30895671|NCT01909804|58929083|FG002|Overall Study|Randomized but Never Treated|0|||
30895672|NCT01909804|58929084|FG003|Overall Study|Randomized but Never Treated|0|||
30895673|NCT01909804|58929085|FG004|Overall Study|Randomized but Never Treated|0|||
30895674|NCT01909804|58929086|FG005|Overall Study|Randomized but Never Treated|0|||
30895675|NCT01909804|58929087|FG006|Overall Study|Randomized but Never Treated|1|||
30895676|NCT01909804|58929088|FG007|Overall Study|Randomized but Never Treated|0|||
30895677|NCT01909804|58929089|FG008|Overall Study|Randomized but Never Treated|0|||
30895678|NCT01909804|58929090|FG009|Overall Study|Randomized but Never Treated|0|||
30895679|NCT01909804|58929091|FG010|Overall Study|Randomized but Never Treated|0|||
30895680|NCT01909804|58929092|FG011|Overall Study|Randomized but Never Treated|1|||
30895681|NCT01909804|58929081|FG000|Overall Study|Death|0|||
30895682|NCT01909804|58929082|FG001|Overall Study|Death|0|||
30895683|NCT01909804|58929083|FG002|Overall Study|Death|0|||
30895684|NCT01909804|58929084|FG003|Overall Study|Death|0|||
30895685|NCT01909804|58929085|FG004|Overall Study|Death|0|||
30895686|NCT01909804|58929086|FG005|Overall Study|Death|0|||
30895687|NCT01909804|58929087|FG006|Overall Study|Death|0|||
30895688|NCT01909804|58929088|FG007|Overall Study|Death|0|||
30895689|NCT01909804|58929089|FG008|Overall Study|Death|0|||
30895690|NCT01909804|58929090|FG009|Overall Study|Death|0|||
30895691|NCT01909804|58929091|FG010|Overall Study|Death|1|||
30895692|NCT01909804|58929092|FG011|Overall Study|Death|0|||
30895693|NCT01909804|58929081|FG000|Overall Study|Lack of Efficacy|4|||
30895694|NCT01909804|58929082|FG001|Overall Study|Lack of Efficacy|1|||
30895695|NCT01909804|58929083|FG002|Overall Study|Lack of Efficacy|0|||
30895696|NCT01909804|58929084|FG003|Overall Study|Lack of Efficacy|0|||
30895697|NCT01909804|58929085|FG004|Overall Study|Lack of Efficacy|7|||
30895698|NCT01909804|58929086|FG005|Overall Study|Lack of Efficacy|3|||
30895699|NCT01909804|58929087|FG006|Overall Study|Lack of Efficacy|1|||
30895700|NCT01909804|58929088|FG007|Overall Study|Lack of Efficacy|1|||
30895701|NCT01909804|58929089|FG008|Overall Study|Lack of Efficacy|0|||
30895702|NCT01909804|58929090|FG009|Overall Study|Lack of Efficacy|1|||
30895703|NCT01909804|58929091|FG010|Overall Study|Lack of Efficacy|0|||
30895704|NCT01909804|58929092|FG011|Overall Study|Lack of Efficacy|1|||
30895705|NCT01909804|58929081|FG000|Overall Study|Withdrew Consent|0|||
30895706|NCT01909804|58929082|FG001|Overall Study|Withdrew Consent|0|||
30895707|NCT01909804|58929083|FG002|Overall Study|Withdrew Consent|0|||
30895708|NCT01909804|58929084|FG003|Overall Study|Withdrew Consent|0|||
30895709|NCT01909804|58929085|FG004|Overall Study|Withdrew Consent|1|||
30895710|NCT01909804|58929086|FG005|Overall Study|Withdrew Consent|1|||
30895711|NCT01909804|58929087|FG006|Overall Study|Withdrew Consent|0|||
30895712|NCT01909804|58929088|FG007|Overall Study|Withdrew Consent|0|||
30895713|NCT01909804|58929089|FG008|Overall Study|Withdrew Consent|0|||
30895714|NCT01909804|58929090|FG009|Overall Study|Withdrew Consent|0|||
30895715|NCT01909804|58929091|FG010|Overall Study|Withdrew Consent|0|||
30895716|NCT01909804|58929092|FG011|Overall Study|Withdrew Consent|0|||
30895717|NCT01909804|58929081|FG000|Overall Study|Protocol Violation|0|||
30895718|NCT01909804|58929082|FG001|Overall Study|Protocol Violation|0|||
30895719|NCT01909804|58929083|FG002|Overall Study|Protocol Violation|0|||
30895720|NCT01909804|58929084|FG003|Overall Study|Protocol Violation|0|||
30895721|NCT01909804|58929085|FG004|Overall Study|Protocol Violation|0|||
30895722|NCT01909804|58929086|FG005|Overall Study|Protocol Violation|0|||
30895723|NCT01909804|58929087|FG006|Overall Study|Protocol Violation|0|||
30895724|NCT01909804|58929088|FG007|Overall Study|Protocol Violation|0|||
30895725|NCT01909804|58929089|FG008|Overall Study|Protocol Violation|0|||
30895726|NCT01909804|58929090|FG009|Overall Study|Protocol Violation|0|||
30895727|NCT01909804|58929091|FG010|Overall Study|Protocol Violation|0|||
30895728|NCT01909804|58929092|FG011|Overall Study|Protocol Violation|1|||
30895729|NCT01880086|58929116|FG000|Overall Study|Lost to Follow-up|1|||
30895730|NCT01880086|58929117|FG001|Overall Study|Lost to Follow-up|1|||
30895731|NCT01879852|58929125|FG000|Overall Study|Withdrawal by Subject|2|||
30895732|NCT01879852|58929126|FG001|Overall Study|Withdrawal by Subject|0|||
30895733|NCT01879618|58929132|FG000|Overall Study|Does not meet entrance criteria|1|||
30895734|NCT01879618|58929132|FG000|Overall Study|Withdrawal by Subject|1|||
30895735|NCT01879618|58929132|FG000|Overall Study|Surgery;changed schedule; not available|8|||
30895736|NCT01879618|58929132|FG000|Overall Study|Protocol Violation|6|||
30895737|NCT01879618|58929132|FG000|Overall Study|Adverse Event|5|||
30895738|NCT01926886|58929136|FG000|Overall Study|Administrative/other|1|||
30895739|NCT01926886|58929137|FG001|Overall Study|Administrative/other|0|||
30895740|NCT01926886|58929136|FG000|Overall Study|Adverse event/intercurrent illness|4|||
30895741|NCT01926886|58929137|FG001|Overall Study|Adverse event/intercurrent illness|0|||
30895742|NCT01926886|58929136|FG000|Overall Study|Disease progression/recurrence|4|||
30895743|NCT01926886|58929137|FG001|Overall Study|Disease progression/recurrence|0|||
30895744|NCT01926886|58929136|FG000|Overall Study|Withdrawal by Subject|15|||
30895745|NCT01926886|58929137|FG001|Overall Study|Withdrawal by Subject|0|||
30895746|NCT01926886|58929136|FG000|Overall Study|Failure to return|3|||
30895747|NCT01926886|58929137|FG001|Overall Study|Failure to return|0|||
30895748|NCT01926886|58929136|FG000|Overall Study|Recurrence of disease|1|||
30895749|NCT01926886|58929137|FG001|Overall Study|Recurrence of disease|0|||
30895750|NCT01926886|58929136|FG000|Overall Study|Progression of disease|2|||
30895751|NCT01926886|58929137|FG001|Overall Study|Progression of disease|0|||
30895752|NCT01926886|58929136|FG000|Overall Study|Death|1|||
30895753|NCT01926886|58929137|FG001|Overall Study|Death|0|||
30895754|NCT01926886|58929136|FG000|Overall Study|Did not cooperate|1|||
30895755|NCT01926886|58929137|FG001|Overall Study|Did not cooperate|0|||
30895756|NCT01909336|58929146|FG000|Overall Study|Lost to Follow-up|4|||
30895757|NCT01909336|58929147|FG001|Overall Study|Lost to Follow-up|2|||
30895758|NCT01909336|58929148|FG002|Overall Study|Lost to Follow-up|2|||
30895759|NCT01909336|58929146|FG000|Overall Study|Physician Decision|0|||
30895760|NCT01909336|58929147|FG001|Overall Study|Physician Decision|1|||
30895761|NCT01909336|58929148|FG002|Overall Study|Physician Decision|1|||
30895762|NCT01926028|58929159|FG000|Overall Study|Lost to Follow-up|7|||
30895763|NCT01926028|58929160|FG001|Overall Study|Lost to Follow-up|6|||
30895764|NCT01926028|58929161|FG002|Overall Study|Lost to Follow-up|0|||
30895765|NCT01926028|58929159|FG000|Overall Study|Physician Decision|1|||
30895766|NCT01926028|58929160|FG001|Overall Study|Physician Decision|5|||
30895767|NCT01926028|58929161|FG002|Overall Study|Physician Decision|0|||
30895768|NCT01926028|58929159|FG000|Overall Study|Withdrawal by Subject|9|||
30895769|NCT01926028|58929160|FG001|Overall Study|Withdrawal by Subject|9|||
30895770|NCT01926028|58929161|FG002|Overall Study|Withdrawal by Subject|2|||
30895771|NCT01926028|58929159|FG000|Overall Study|Non compliance or other reasons|4|||
30895772|NCT01926028|58929160|FG001|Overall Study|Non compliance or other reasons|2|||
30895773|NCT01926028|58929161|FG002|Overall Study|Non compliance or other reasons|0|||
30895774|NCT01925950|58929172|FG000|Part 2|Withdrawal by Subject|1|||
30895775|NCT01925950|58929173|FG001|Part 2|Withdrawal by Subject|0|||
30895776|NCT01878292|58929182|FG000|Randomized|Protocol Violation|1|||
30895777|NCT01878292|58929183|FG001|Randomized|Protocol Violation|0|||
30895778|NCT01878292|58929184|FG002|Randomized|Protocol Violation|0|||
30895779|NCT01878292|58929182|FG000|Randomized|Lost to Follow-up|1|||
30895780|NCT01878292|58929183|FG001|Randomized|Lost to Follow-up|0|||
30895781|NCT01878292|58929184|FG002|Randomized|Lost to Follow-up|0|||
30895782|NCT01878292|58929182|FG000|Randomized|Adverse Event|1|||
30895783|NCT01878292|58929183|FG001|Randomized|Adverse Event|0|||
30895784|NCT01878292|58929184|FG002|Randomized|Adverse Event|0|||
30895785|NCT01878292|58929182|FG000|Double-blind Treatment Period|Other Reasons|2|||
30895786|NCT01878292|58929183|FG001|Double-blind Treatment Period|Other Reasons|0|||
30895787|NCT01878292|58929184|FG002|Double-blind Treatment Period|Other Reasons|0|||
30895788|NCT01878292|58929182|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
30895789|NCT01878292|58929183|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
30895790|NCT01878292|58929184|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
30895791|NCT01878292|58929182|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
30895792|NCT01878292|58929183|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
30895793|NCT01878292|58929184|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
30895794|NCT01878292|58929182|FG000|Double-blind Treatment Period|Protocol Violation|3|||
30895795|NCT01878292|58929183|FG001|Double-blind Treatment Period|Protocol Violation|4|||
30895796|NCT01878292|58929184|FG002|Double-blind Treatment Period|Protocol Violation|2|||
30895797|NCT01878292|58929182|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
30895798|NCT01878292|58929183|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
30895799|NCT01878292|58929184|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
30895800|NCT01878292|58929182|FG000|Double-blind Treatment Period|Adverse Event|4|||
30895801|NCT01878292|58929183|FG001|Double-blind Treatment Period|Adverse Event|9|||
30895802|NCT01878292|58929184|FG002|Double-blind Treatment Period|Adverse Event|8|||
30895803|NCT01878292|58929182|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
30895804|NCT01878292|58929183|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
30895805|NCT01878292|58929184|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
30709676|NCT00550446|58723227|FG003|Post Week 12|Adverse Event|1|||
30895806|NCT01908634|58929192|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
30895807|NCT01908634|58929192|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
30895808|NCT01878214|58929202|FG000|Overall Study|Withdrawal by Subject|18|||
30709677|NCT00550446|58723228|FG004|Post Week 12|Adverse Event|1|||
30709678|NCT00550446|58723229|FG005|Post Week 12|Adverse Event|1|||
30895809|NCT01878214|58929203|FG001|Overall Study|Withdrawal by Subject|7|||
30895810|NCT01878214|58929202|FG000|Overall Study|Death|0|||
30895811|NCT01878214|58929203|FG001|Overall Study|Death|1|||
30895812|NCT01878214|58929202|FG000|Overall Study|Lost to Follow-up|35|||
30895813|NCT01878214|58929203|FG001|Overall Study|Lost to Follow-up|36|||
30895814|NCT01907854|58929211|FG000|Overall Study|Protocol Violation|1|||
30895815|NCT01907854|58929212|FG001|Overall Study|Protocol Violation|1|||
30895816|NCT01907854|58929211|FG000|Overall Study|Withdrawal by Subject|9|||
30620945|NCT01202279|58632453|FG000|Overall Study|Withdrawal by Subject|13|||
30709679|NCT00550446|58723230|FG006|Post Week 12|Adverse Event|0|||
30709680|NCT00550446|58723231|FG007|Post Week 12|Adverse Event|0|||
30709681|NCT00550446|58723232|FG008|Post Week 12|Adverse Event|0|||
30709682|NCT00550446|58723233|FG009|Post Week 12|Adverse Event|4|||
30709683|NCT00550446|58723234|FG010|Post Week 12|Adverse Event|0|||
30709684|NCT00550446|58723224|FG000|Post Week 12|Lack of Efficacy|0|||
30709685|NCT00550446|58723225|FG001|Post Week 12|Lack of Efficacy|0|||
30709686|NCT00550446|58723226|FG002|Post Week 12|Lack of Efficacy|1|||
30709687|NCT00550446|58723227|FG003|Post Week 12|Lack of Efficacy|0|||
30709688|NCT00550446|58723228|FG004|Post Week 12|Lack of Efficacy|0|||
30709689|NCT00550446|58723229|FG005|Post Week 12|Lack of Efficacy|0|||
30709690|NCT00550446|58723230|FG006|Post Week 12|Lack of Efficacy|0|||
30709691|NCT00550446|58723231|FG007|Post Week 12|Lack of Efficacy|1|||
30709692|NCT00550446|58723232|FG008|Post Week 12|Lack of Efficacy|1|||
30709693|NCT00550446|58723233|FG009|Post Week 12|Lack of Efficacy|2|||
30709694|NCT00550446|58723234|FG010|Post Week 12|Lack of Efficacy|1|||
30709695|NCT00550446|58723224|FG000|Post Week 12|Lost to Follow-up|0|||
30709696|NCT00550446|58723225|FG001|Post Week 12|Lost to Follow-up|0|||
30709697|NCT00550446|58723226|FG002|Post Week 12|Lost to Follow-up|1|||
30709698|NCT00550446|58723227|FG003|Post Week 12|Lost to Follow-up|1|||
30709699|NCT00550446|58723228|FG004|Post Week 12|Lost to Follow-up|0|||
30709700|NCT00550446|58723229|FG005|Post Week 12|Lost to Follow-up|0|||
30709701|NCT00550446|58723230|FG006|Post Week 12|Lost to Follow-up|1|||
30709702|NCT00550446|58723231|FG007|Post Week 12|Lost to Follow-up|0|||
30709703|NCT00550446|58723232|FG008|Post Week 12|Lost to Follow-up|0|||
30709704|NCT00550446|58723233|FG009|Post Week 12|Lost to Follow-up|0|||
30709705|NCT00550446|58723234|FG010|Post Week 12|Lost to Follow-up|0|||
30709706|NCT00550446|58723224|FG000|Post Week 12|Withdrawal by Subject|0|||
30709707|NCT00550446|58723225|FG001|Post Week 12|Withdrawal by Subject|0|||
30709708|NCT00550446|58723226|FG002|Post Week 12|Withdrawal by Subject|0|||
30709709|NCT00550446|58723227|FG003|Post Week 12|Withdrawal by Subject|0|||
30709710|NCT00550446|58723228|FG004|Post Week 12|Withdrawal by Subject|1|||
30709711|NCT00550446|58723229|FG005|Post Week 12|Withdrawal by Subject|0|||
30620946|NCT01202279|58632454|FG001|Overall Study|Withdrawal by Subject|10|||
30620947|NCT01202279|58632453|FG000|Overall Study|Physician Decision|0|||
30620948|NCT01202279|58632454|FG001|Overall Study|Physician Decision|1|||
30620949|NCT01202279|58632453|FG000|Overall Study|Lost to Follow-up|10|||
30620950|NCT01202279|58632454|FG001|Overall Study|Lost to Follow-up|7|||
30620951|NCT01202279|58632453|FG000|Overall Study|Protocol Violation|1|||
30620952|NCT01202279|58632454|FG001|Overall Study|Protocol Violation|1|||
30620953|NCT01202279|58632453|FG000|Overall Study|study compliance|5|||
30620954|NCT01202279|58632454|FG001|Overall Study|study compliance|2|||
30620955|NCT01201967|58632462|FG000|Overall Study|Lost to Follow-up|6|||
30620956|NCT01201967|58632463|FG001|Overall Study|Lost to Follow-up|5|||
30620957|NCT01201811|58632479|FG000|Overall Study|Adverse Event|6|||
30620958|NCT01201811|58632479|FG000|Overall Study|Disease progression|3|||
30620959|NCT01201811|58632479|FG000|Overall Study|Withdrawal by Subject|3|||
30620960|NCT01201811|58632479|FG000|Overall Study|Death|4|||
30620961|NCT01201811|58632479|FG000|Overall Study|Treatment Failure|2|||
30620962|NCT01201811|58632479|FG000|Overall Study|Physician Decision|1|||
30620963|NCT01201343|58632483|FG000|Overall Study|Adverse Event|6|||
30620964|NCT01201343|58632483|FG000|Overall Study|Withdrawal by Subject|5|||
30620965|NCT01201343|58632483|FG000|Overall Study|Lost to Follow-up|2|||
30620966|NCT01201343|58632483|FG000|Overall Study|Lack of Efficacy|2|||
30620967|NCT01201343|58632483|FG000|Overall Study|Participant wrongly included in trial|1|||
30620968|NCT01201343|58632483|FG000|Overall Study|Randomized, not treated|3|||
30620969|NCT01201265|58632487|FG000|Overall Study|Death|14|||
30620970|NCT01201265|58632487|FG000|Overall Study|Insufficient Therapeutic Response|3|||
30620971|NCT01201265|58632487|FG000|Overall Study|Lost to Follow-up|10|||
30620972|NCT01201265|58632487|FG000|Overall Study|Withdrawal by Subject|7|||
30709712|NCT00550446|58723230|FG006|Post Week 12|Withdrawal by Subject|0|||
30709713|NCT00550446|58723231|FG007|Post Week 12|Withdrawal by Subject|0|||
30709714|NCT00550446|58723232|FG008|Post Week 12|Withdrawal by Subject|0|||
30709715|NCT00550446|58723233|FG009|Post Week 12|Withdrawal by Subject|0|||
30895817|NCT01907854|58929212|FG001|Overall Study|Withdrawal by Subject|7|||
30895818|NCT01907854|58929211|FG000|Overall Study|Lost to Follow-up|2|||
30620973|NCT01201265|58632487|FG000|Overall Study|Disease Progression|4|||
30620974|NCT04246801|58632493|FG000|Overall Study|Adverse Event|1|||
30620975|NCT04246801|58632494|FG001|Overall Study|Adverse Event|1|||
30620976|NCT04246801|58632493|FG000|Overall Study|Protocol Violation|1|||
30709716|NCT00550446|58723234|FG010|Post Week 12|Withdrawal by Subject|0|||
30620977|NCT04246801|58632494|FG001|Overall Study|Protocol Violation|1|||
30620978|NCT04246801|58632493|FG000|Overall Study|Lack of Efficacy|0|||
30620979|NCT04246801|58632494|FG001|Overall Study|Lack of Efficacy|2|||
30709717|NCT00550446|58723224|FG000|Post Week 12|Other|1|||
30709718|NCT00550446|58723225|FG001|Post Week 12|Other|1|||
30895819|NCT01907854|58929212|FG001|Overall Study|Lost to Follow-up|2|||
30895820|NCT01907854|58929211|FG000|Overall Study|Unclassified|4|||
30895821|NCT01907854|58929212|FG001|Overall Study|Unclassified|3|||
30895822|NCT02480153|58929220|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
30895823|NCT02480153|58929221|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
30895824|NCT02480153|58929222|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
30895825|NCT02480153|58929220|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
30895826|NCT02480153|58929221|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
30895827|NCT02480153|58929222|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
30895828|NCT02480153|58929220|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
30895829|NCT02480153|58929221|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
30895830|NCT02480153|58929222|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
30895831|NCT02480153|58929220|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
30895832|NCT02480153|58929221|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
30895833|NCT02480153|58929222|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
30895834|NCT02480153|58929220|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
30895835|NCT02480153|58929221|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
30895836|NCT02480153|58929222|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
30895837|NCT02480153|58929220|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
30895838|NCT02480153|58929221|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
30895839|NCT02480153|58929222|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
30895840|NCT02480153|58929220|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
30895841|NCT02480153|58929221|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
30895842|NCT02480153|58929222|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
30895843|NCT02480153|58929220|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
30895844|NCT02480153|58929221|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
30895845|NCT02480153|58929222|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
30895846|NCT02480153|58929220|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
30895847|NCT02480153|58929221|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
30895848|NCT02480153|58929222|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
30895849|NCT02480153|58929220|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
30895850|NCT02480153|58929221|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
30895851|NCT02480153|58929222|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
30895852|NCT02480153|58929220|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
30895853|NCT02480153|58929221|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
30895854|NCT02480153|58929222|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
30895855|NCT02480153|58929220|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
30895856|NCT02480153|58929221|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
30895857|NCT02480153|58929222|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
30895858|NCT02480153|58929220|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
30895859|NCT02480153|58929221|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
30895860|NCT02480153|58929222|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
30895861|NCT02480153|58929220|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
30895862|NCT02480153|58929221|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
30895863|NCT02480153|58929222|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
30895864|NCT02480153|58929220|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
30895865|NCT02480153|58929221|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
30895866|NCT02480153|58929222|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
30895867|NCT02480153|58929220|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
30895868|NCT02480153|58929221|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
30895869|NCT02480153|58929222|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
30895870|NCT02480153|58929220|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
30709719|NCT00550446|58723226|FG002|Post Week 12|Other|0|||
30620980|NCT04246801|58632493|FG000|Overall Study|Lost to Follow-up|1|||
30895871|NCT02480153|58929221|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
30895872|NCT02480153|58929222|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
30895873|NCT02480153|58929220|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
30895874|NCT02480153|58929221|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
30895875|NCT02480153|58929222|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
30895876|NCT02500979|58929247|FG000|Period 1|Hyperglycemia|1|||
30895877|NCT02500979|58929248|FG001|Period 1|Hyperglycemia|0|||
30895878|NCT02500979|58929247|FG000|Period 1|Severe non-compliance to protocol|0|||
30895879|NCT02500979|58929248|FG001|Period 1|Severe non-compliance to protocol|1|||
30895880|NCT02500979|58929247|FG000|Period 1|Adverse Event|1|||
30895881|NCT02500979|58929248|FG001|Period 1|Adverse Event|0|||
30895882|NCT02500979|58929247|FG000|Period 1|Subject decision|2|||
30895883|NCT02500979|58929248|FG001|Period 1|Subject decision|0|||
30895884|NCT02500979|58929247|FG000|Period 2|Change in risk|1|||
30895885|NCT02500979|58929248|FG001|Period 2|Change in risk|0|||
30895886|NCT02500901|58929254|FG000|Overall Study|Disease ProgressionDD|2|||
30895887|NCT02479139|58929264|FG000|Overall Study|Lost to Follow-up|2|||
30895888|NCT02479139|58929265|FG001|Overall Study|Lost to Follow-up|4|||
30895889|NCT02479139|58929266|FG002|Overall Study|Lost to Follow-up|4|||
30895890|NCT02479139|58929267|FG003|Overall Study|Lost to Follow-up|2|||
30895891|NCT02479139|58929268|FG004|Overall Study|Lost to Follow-up|3|||
30895892|NCT02479139|58929269|FG005|Overall Study|Lost to Follow-up|5|||
30895893|NCT02479139|58929264|FG000|Overall Study|Withdrew Consent|5|||
30895894|NCT02479139|58929265|FG001|Overall Study|Withdrew Consent|6|||
30895895|NCT02479139|58929266|FG002|Overall Study|Withdrew Consent|1|||
30895896|NCT02479139|58929267|FG003|Overall Study|Withdrew Consent|4|||
30895897|NCT02479139|58929268|FG004|Overall Study|Withdrew Consent|1|||
30895898|NCT02479139|58929269|FG005|Overall Study|Withdrew Consent|1|||
30895899|NCT02479139|58929264|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
30895900|NCT02479139|58929265|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
30895901|NCT02479139|58929266|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
30895902|NCT02479139|58929267|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
30895903|NCT02479139|58929268|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
30895904|NCT02479139|58929269|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
30895905|NCT02479139|58929264|FG000|Overall Study|Other Miscellaneous Reasons|1|||
30895906|NCT02479139|58929265|FG001|Overall Study|Other Miscellaneous Reasons|0|||
30895907|NCT02479139|58929266|FG002|Overall Study|Other Miscellaneous Reasons|1|||
30895908|NCT02479139|58929267|FG003|Overall Study|Other Miscellaneous Reasons|1|||
30895909|NCT02479139|58929268|FG004|Overall Study|Other Miscellaneous Reasons|1|||
30895910|NCT02479139|58929269|FG005|Overall Study|Other Miscellaneous Reasons|0|||
30895911|NCT02478359|58929285|FG000|Overall Study|Disenrolled from health plan|106|||
30895912|NCT02478359|58929286|FG001|Overall Study|Disenrolled from health plan|65|||
30895913|NCT01877668|58929299|FG000|Overall Study|Death|0|||
30895914|NCT01877668|58929300|FG001|Overall Study|Death|0|||
30895915|NCT01877668|58929301|FG002|Overall Study|Death|0|||
30895916|NCT01877668|58929302|FG003|Overall Study|Death|1|||
30895917|NCT01877668|58929303|FG004|Overall Study|Death|0|||
30895918|NCT01877668|58929299|FG000|Overall Study|No longer met study criteria|1|||
30895919|NCT01877668|58929300|FG001|Overall Study|No longer met study criteria|0|||
30895920|NCT01877668|58929301|FG002|Overall Study|No longer met study criteria|1|||
30895921|NCT01877668|58929302|FG003|Overall Study|No longer met study criteria|0|||
30895922|NCT01877668|58929303|FG004|Overall Study|No longer met study criteria|0|||
30620981|NCT04246801|58632494|FG001|Overall Study|Lost to Follow-up|1|||
30895923|NCT01877668|58929299|FG000|Overall Study|Insufficient clinical response|0|||
30895924|NCT01877668|58929300|FG001|Overall Study|Insufficient clinical response|1|||
30895925|NCT01877668|58929301|FG002|Overall Study|Insufficient clinical response|2|||
30895926|NCT01877668|58929302|FG003|Overall Study|Insufficient clinical response|2|||
30895927|NCT01877668|58929303|FG004|Overall Study|Insufficient clinical response|0|||
30895928|NCT01877668|58929299|FG000|Overall Study|Lost to Follow-up|0|||
30895929|NCT01877668|58929300|FG001|Overall Study|Lost to Follow-up|2|||
30895930|NCT01877668|58929301|FG002|Overall Study|Lost to Follow-up|1|||
30895931|NCT01877668|58929302|FG003|Overall Study|Lost to Follow-up|0|||
30895932|NCT01877668|58929303|FG004|Overall Study|Lost to Follow-up|0|||
30895933|NCT01877668|58929299|FG000|Overall Study|Withdrawal by Subject|2|||
30895934|NCT01877668|58929300|FG001|Overall Study|Withdrawal by Subject|0|||
30895935|NCT01877668|58929301|FG002|Overall Study|Withdrawal by Subject|3|||
30895936|NCT01877668|58929302|FG003|Overall Study|Withdrawal by Subject|2|||
30895937|NCT01877668|58929303|FG004|Overall Study|Withdrawal by Subject|2|||
30895938|NCT01877668|58929299|FG000|Overall Study|Other|1|||
30895939|NCT01877668|58929300|FG001|Overall Study|Other|1|||
30709720|NCT00550446|58723227|FG003|Post Week 12|Other|1|||
30895940|NCT01877668|58929301|FG002|Overall Study|Other|1|||
30895941|NCT01877668|58929302|FG003|Overall Study|Other|1|||
30895942|NCT01877668|58929303|FG004|Overall Study|Other|3|||
30895943|NCT01877668|58929299|FG000|Overall Study|Protocol Violation|1|||
30895944|NCT01877668|58929300|FG001|Overall Study|Protocol Violation|1|||
30895945|NCT01877668|58929301|FG002|Overall Study|Protocol Violation|0|||
30895946|NCT01877668|58929302|FG003|Overall Study|Protocol Violation|0|||
30895947|NCT01877668|58929303|FG004|Overall Study|Protocol Violation|3|||
30895948|NCT01877668|58929299|FG000|Overall Study|Adverse event related to study drug|2|||
30895949|NCT01877668|58929300|FG001|Overall Study|Adverse event related to study drug|2|||
30895950|NCT01877668|58929301|FG002|Overall Study|Adverse event related to study drug|2|||
30895951|NCT01877668|58929302|FG003|Overall Study|Adverse event related to study drug|2|||
30895952|NCT01877668|58929303|FG004|Overall Study|Adverse event related to study drug|1|||
30895953|NCT01877668|58929299|FG000|Overall Study|Adverse event unrelated to study drug|4|||
30895954|NCT01877668|58929300|FG001|Overall Study|Adverse event unrelated to study drug|1|||
30895955|NCT01877668|58929301|FG002|Overall Study|Adverse event unrelated to study drug|2|||
30895956|NCT01877668|58929302|FG003|Overall Study|Adverse event unrelated to study drug|0|||
30895957|NCT01877668|58929303|FG004|Overall Study|Adverse event unrelated to study drug|1|||
30895958|NCT01877278|58929321|FG000|Overall Study|Lost to Follow-up|3|||
30895959|NCT01877278|58929322|FG001|Overall Study|Lost to Follow-up|3|||
30895960|NCT01906372|58929328|FG000|Overall Study|Withdrawal by Subject|2|||
30895961|NCT01925170|58929333|FG000|Overall Study|Unverified cancer status|53|||
30895962|NCT01925014|58929341|FG000|Overall Study|Inappropriate enrollment|4|||
30895963|NCT01925014|58929342|FG001|Overall Study|Inappropriate enrollment|6|||
30895964|NCT01925014|58929341|FG000|Overall Study|Withdrawal by Subject|5|||
30895965|NCT01925014|58929342|FG001|Overall Study|Withdrawal by Subject|13|||
30895966|NCT01876810|58929348|FG000|Overall Study|Physician Decision|0|||
30895967|NCT01876810|58929349|FG001|Overall Study|Physician Decision|1|||
30895968|NCT01876732|58929358|FG000|Overall Study|MMA was not over 800mg/dL|75|||
30895969|NCT01905592|58929365|FG000|Overall Study|Disease Progression|51|||
30895970|NCT01905592|58929366|FG001|Overall Study|Disease Progression|110|||
30895971|NCT01905592|58929365|FG000|Overall Study|Toxicity|1|||
30895972|NCT01905592|58929366|FG001|Overall Study|Toxicity|16|||
30895973|NCT01905592|58929365|FG000|Overall Study|Physician Decision|0|||
30895974|NCT01905592|58929366|FG001|Overall Study|Physician Decision|2|||
30895975|NCT01905592|58929365|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
30895976|NCT01905592|58929366|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
30895977|NCT01905592|58929365|FG000|Overall Study|Protocol Violation|0|||
30895978|NCT01905592|58929366|FG001|Overall Study|Protocol Violation|1|||
30895979|NCT01905592|58929365|FG000|Overall Study|Sponsor's decision|1|||
30895980|NCT01905592|58929366|FG001|Overall Study|Sponsor's decision|1|||
30895981|NCT01905592|58929365|FG000|Overall Study|Not treated|7|||
30895982|NCT01905592|58929366|FG001|Overall Study|Not treated|3|||
30895983|NCT01905592|58929365|FG000|Overall Study|Withdrawal by Subject|10|||
30895984|NCT01905592|58929366|FG001|Overall Study|Withdrawal by Subject|2|||
30895985|NCT01876420|58929372|FG000|Overall Study|Missed 30 day visit|1|||
30895986|NCT01875874|58929376|FG000|Overall Study|Death|3|||
30895987|NCT02500121|58929383|FG000|Overall Study|Lost to Follow-up|0|||
30895988|NCT02500121|58929384|FG001|Overall Study|Lost to Follow-up|1|||
30895989|NCT02500121|58929383|FG000|Overall Study|Withdrawal by Subject|1|||
30895990|NCT02500121|58929384|FG001|Overall Study|Withdrawal by Subject|1|||
30895991|NCT02500121|58929383|FG000|Overall Study|Death|26|||
30895992|NCT02500121|58929384|FG001|Overall Study|Death|24|||
30895993|NCT01875250|58929394|FG000|Overall Study|Adverse Event|2|||
30895994|NCT01875250|58929395|FG001|Overall Study|Adverse Event|0|||
30895995|NCT01904032|58929405|FG000|Overall Study|Adverse Event|3|||
30895996|NCT01904032|58929406|FG001|Overall Study|Adverse Event|1|||
30895997|NCT01904032|58929405|FG000|Overall Study|Lost to Follow-up|4|||
30709721|NCT00550446|58723228|FG004|Post Week 12|Other|0|||
30709722|NCT00550446|58723229|FG005|Post Week 12|Other|0|||
30709723|NCT00550446|58723230|FG006|Post Week 12|Other|1|||
30709724|NCT00550446|58723231|FG007|Post Week 12|Other|0|||
30709725|NCT00550446|58723232|FG008|Post Week 12|Other|1|||
30709726|NCT00550446|58723233|FG009|Post Week 12|Other|1|||
30709727|NCT00550446|58723234|FG010|Post Week 12|Other|0|||
30709728|NCT00436618|58723275|FG000|Overall Study|Withdrawal by Subject|5|||
30709729|NCT00436618|58723276|FG001|Overall Study|Withdrawal by Subject|8|||
30895998|NCT01904032|58929406|FG001|Overall Study|Lost to Follow-up|2|||
30895999|NCT01903876|58929414|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
30896000|NCT01903876|58929415|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
30896001|NCT01903876|58929414|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
30896002|NCT01903876|58929415|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
30709730|NCT00436618|58723277|FG002|Overall Study|Withdrawal by Subject|11|||
30896003|NCT01921348|58929423|FG000|Overall Study|Withdrawal by Subject|1|||
30896004|NCT01921348|58929424|FG001|Overall Study|Withdrawal by Subject|0|||
30896005|NCT01921348|58929423|FG000|Overall Study|Lost to Follow-up|0|||
30896006|NCT01921348|58929424|FG001|Overall Study|Lost to Follow-up|2|||
30896007|NCT01921270|58929430|FG000|Overall Study|Withdrawal by Subject|1|||
30896008|NCT02325739|58929445|FG000|Phase I Part|Adverse Event|1|||
30896009|NCT02325739|58929446|FG001|Phase I Part|Adverse Event|0|||
30896010|NCT02325739|58929447|FG002|Phase I Part|Adverse Event|1|||
30896011|NCT02325739|58929448|FG003|Phase I Part|Adverse Event|2|||
30896012|NCT02325739|58929449|FG004|Phase I Part|Adverse Event|3|||
30896013|NCT02325739|58929450|FG005|Phase I Part|Adverse Event|1|||
30896014|NCT02325739|58929451|FG006|Phase I Part|Adverse Event|0|||
30896015|NCT02325739|58929452|FG007|Phase I Part|Adverse Event|2|||
30896016|NCT02325739|58929453|FG008|Phase I Part|Adverse Event|0|||
30896017|NCT02325739|58929454|FG009|Phase I Part|Adverse Event|0|||
30896018|NCT02325739|58929455|FG010|Phase I Part|Adverse Event|0|||
30896019|NCT02325739|58929445|FG000|Phase I Part|Progressive disease|9|||
30896020|NCT02325739|58929446|FG001|Phase I Part|Progressive disease|6|||
30896021|NCT02325739|58929447|FG002|Phase I Part|Progressive disease|3|||
30896022|NCT02325739|58929448|FG003|Phase I Part|Progressive disease|23|||
30896023|NCT02325739|58929449|FG004|Phase I Part|Progressive disease|14|||
30896024|NCT02325739|58929450|FG005|Phase I Part|Progressive disease|6|||
30896025|NCT02325739|58929451|FG006|Phase I Part|Progressive disease|6|||
30896026|NCT02325739|58929452|FG007|Phase I Part|Progressive disease|3|||
30896027|NCT02325739|58929453|FG008|Phase I Part|Progressive disease|0|||
30896028|NCT02325739|58929454|FG009|Phase I Part|Progressive disease|0|||
30896029|NCT02325739|58929455|FG010|Phase I Part|Progressive disease|0|||
30896030|NCT02325739|58929445|FG000|Phase I Part|Subject/guardian decision|1|||
30896031|NCT02325739|58929446|FG001|Phase I Part|Subject/guardian decision|0|||
30896032|NCT02325739|58929447|FG002|Phase I Part|Subject/guardian decision|1|||
30896033|NCT02325739|58929448|FG003|Phase I Part|Subject/guardian decision|1|||
30896034|NCT02325739|58929449|FG004|Phase I Part|Subject/guardian decision|0|||
30896035|NCT02325739|58929450|FG005|Phase I Part|Subject/guardian decision|0|||
30896036|NCT02325739|58929451|FG006|Phase I Part|Subject/guardian decision|0|||
30896037|NCT02325739|58929452|FG007|Phase I Part|Subject/guardian decision|1|||
30896038|NCT02325739|58929453|FG008|Phase I Part|Subject/guardian decision|0|||
30896039|NCT02325739|58929454|FG009|Phase I Part|Subject/guardian decision|0|||
30896040|NCT02325739|58929455|FG010|Phase I Part|Subject/guardian decision|0|||
30896041|NCT02325739|58929445|FG000|Phase I Part|Death|0|||
30896042|NCT02325739|58929446|FG001|Phase I Part|Death|0|||
30896043|NCT02325739|58929447|FG002|Phase I Part|Death|0|||
30896044|NCT02325739|58929448|FG003|Phase I Part|Death|0|||
30896045|NCT02325739|58929449|FG004|Phase I Part|Death|2|||
30896046|NCT02325739|58929450|FG005|Phase I Part|Death|0|||
30896047|NCT02325739|58929451|FG006|Phase I Part|Death|0|||
30896048|NCT02325739|58929452|FG007|Phase I Part|Death|0|||
30896049|NCT02325739|58929453|FG008|Phase I Part|Death|0|||
30896050|NCT02325739|58929454|FG009|Phase I Part|Death|0|||
30896051|NCT02325739|58929455|FG010|Phase I Part|Death|0|||
30896052|NCT02325739|58929445|FG000|Phase II Part|Adverse Event|0|||
30896053|NCT02325739|58929446|FG001|Phase II Part|Adverse Event|0|||
30896054|NCT02325739|58929447|FG002|Phase II Part|Adverse Event|0|||
30896055|NCT02325739|58929448|FG003|Phase II Part|Adverse Event|0|||
30896056|NCT02325739|58929449|FG004|Phase II Part|Adverse Event|0|||
30896057|NCT02325739|58929450|FG005|Phase II Part|Adverse Event|0|||
30620982|NCT04246801|58632493|FG000|Overall Study|Withdrawal by Subject|2|||
30896058|NCT02325739|58929451|FG006|Phase II Part|Adverse Event|0|||
30896059|NCT02325739|58929452|FG007|Phase II Part|Adverse Event|0|||
30896060|NCT02325739|58929453|FG008|Phase II Part|Adverse Event|4|||
30896061|NCT02325739|58929454|FG009|Phase II Part|Adverse Event|5|||
30896062|NCT02325739|58929455|FG010|Phase II Part|Adverse Event|1|||
30896063|NCT02325739|58929445|FG000|Phase II Part|Physician Decision|0|||
30896064|NCT02325739|58929446|FG001|Phase II Part|Physician Decision|0|||
30896065|NCT02325739|58929447|FG002|Phase II Part|Physician Decision|0|||
30896066|NCT02325739|58929448|FG003|Phase II Part|Physician Decision|0|||
30896067|NCT02325739|58929449|FG004|Phase II Part|Physician Decision|0|||
30896068|NCT02325739|58929450|FG005|Phase II Part|Physician Decision|0|||
30896069|NCT02325739|58929451|FG006|Phase II Part|Physician Decision|0|||
30896070|NCT02325739|58929452|FG007|Phase II Part|Physician Decision|0|||
30896071|NCT02325739|58929453|FG008|Phase II Part|Physician Decision|0|||
30896072|NCT02325739|58929454|FG009|Phase II Part|Physician Decision|1|||
30896073|NCT02325739|58929455|FG010|Phase II Part|Physician Decision|0|||
30896074|NCT02325739|58929445|FG000|Phase II Part|Progressive disease|0|||
30896075|NCT02325739|58929446|FG001|Phase II Part|Progressive disease|0|||
30896076|NCT02325739|58929447|FG002|Phase II Part|Progressive disease|0|||
30896077|NCT02325739|58929448|FG003|Phase II Part|Progressive disease|0|||
30896078|NCT02325739|58929449|FG004|Phase II Part|Progressive disease|0|||
30896079|NCT02325739|58929450|FG005|Phase II Part|Progressive disease|0|||
30896080|NCT02325739|58929451|FG006|Phase II Part|Progressive disease|0|||
30896081|NCT02325739|58929452|FG007|Phase II Part|Progressive disease|0|||
30896082|NCT02325739|58929453|FG008|Phase II Part|Progressive disease|22|||
30896083|NCT02325739|58929454|FG009|Phase II Part|Progressive disease|29|||
30896084|NCT02325739|58929455|FG010|Phase II Part|Progressive disease|18|||
30896085|NCT02325739|58929445|FG000|Phase II Part|Subject/guardian decision|0|||
30896086|NCT02325739|58929446|FG001|Phase II Part|Subject/guardian decision|0|||
30896087|NCT02325739|58929447|FG002|Phase II Part|Subject/guardian decision|0|||
30896088|NCT02325739|58929448|FG003|Phase II Part|Subject/guardian decision|0|||
30896089|NCT02325739|58929449|FG004|Phase II Part|Subject/guardian decision|0|||
30896090|NCT02325739|58929450|FG005|Phase II Part|Subject/guardian decision|0|||
30896091|NCT02325739|58929451|FG006|Phase II Part|Subject/guardian decision|0|||
30896092|NCT02325739|58929452|FG007|Phase II Part|Subject/guardian decision|0|||
30896093|NCT02325739|58929453|FG008|Phase II Part|Subject/guardian decision|4|||
30896094|NCT02325739|58929454|FG009|Phase II Part|Subject/guardian decision|1|||
30896095|NCT02325739|58929455|FG010|Phase II Part|Subject/guardian decision|1|||
30896096|NCT01903720|58929500|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
30896097|NCT01903720|58929500|FG000|Overall Study|Adverse Event|1|||
30896098|NCT01903720|58929500|FG000|Overall Study|Rescinding of informed consent|2|||
30709731|NCT00436618|58723275|FG000|Overall Study|Adverse Event|8|||
30709732|NCT00436618|58723276|FG001|Overall Study|Adverse Event|8|||
30709733|NCT00436618|58723277|FG002|Overall Study|Adverse Event|9|||
30709734|NCT00436618|58723275|FG000|Overall Study|Alternate Treatment|3|||
30709735|NCT00436618|58723276|FG001|Overall Study|Alternate Treatment|4|||
30709736|NCT00436618|58723277|FG002|Overall Study|Alternate Treatment|12|||
30709737|NCT00436618|58723275|FG000|Overall Study|Other Medical Problems|3|||
30709738|NCT00436618|58723276|FG001|Overall Study|Other Medical Problems|1|||
30709739|NCT00436618|58723277|FG002|Overall Study|Other Medical Problems|7|||
30709740|NCT00436618|58723275|FG000|Overall Study|Death|4|||
30709741|NCT00436618|58723276|FG001|Overall Study|Death|2|||
30709742|NCT00436618|58723277|FG002|Overall Study|Death|3|||
30709743|NCT00436618|58723275|FG000|Overall Study|New Primary or Other Reasons|6|||
30709744|NCT00436618|58723276|FG001|Overall Study|New Primary or Other Reasons|2|||
30709745|NCT00436618|58723277|FG002|Overall Study|New Primary or Other Reasons|12|||
30709746|NCT00436618|58723275|FG000|Overall Study|Still on treatment|1|||
30709747|NCT00436618|58723276|FG001|Overall Study|Still on treatment|2|||
30709748|NCT00436618|58723277|FG002|Overall Study|Still on treatment|7|||
30709749|NCT00548808|58723314|FG000|Overall Study|Lost to Follow-up|9|||
30709750|NCT00548808|58723315|FG001|Overall Study|Lost to Follow-up|3|||
30709751|NCT00548808|58723314|FG000|Overall Study|Protocol Violation|8|||
30709752|NCT00548808|58723315|FG001|Overall Study|Protocol Violation|8|||
30709753|NCT00548808|58723314|FG000|Overall Study|Withdrawal by Subject|8|||
30709754|NCT00548808|58723315|FG001|Overall Study|Withdrawal by Subject|4|||
30709755|NCT00548808|58723314|FG000|Overall Study|Physician Decision|6|||
30709756|NCT00548808|58723315|FG001|Overall Study|Physician Decision|3|||
30709757|NCT00548808|58723314|FG000|Overall Study|Adverse Event|4|||
30709758|NCT00548808|58723315|FG001|Overall Study|Adverse Event|5|||
30709759|NCT00548808|58723314|FG000|Overall Study|Death|2|||
30709760|NCT00548808|58723315|FG001|Overall Study|Death|0|||
30709761|NCT00548808|58723314|FG000|Overall Study|Entry Criteria Not Met|2|||
30709762|NCT00548808|58723315|FG001|Overall Study|Entry Criteria Not Met|2|||
30709763|NCT00548808|58723314|FG000|Overall Study|Lack of Efficacy|2|||
30709764|NCT00548808|58723315|FG001|Overall Study|Lack of Efficacy|0|||
30896099|NCT01903720|58929500|FG000|Overall Study|Lost to Follow-up|2|||
30709765|NCT00548808|58723314|FG000|Overall Study|Sponsor Decision|1|||
30709766|NCT00548808|58723315|FG001|Overall Study|Sponsor Decision|1|||
30709767|NCT00110617|58723323|FG000|Overall Study|Adverse Event|2|||
30709768|NCT00110617|58723324|FG001|Overall Study|Adverse Event|4|||
30709769|NCT00110617|58723323|FG000|Overall Study|Abnormal Laboratory Value|4|||
30709770|NCT00110617|58723324|FG001|Overall Study|Abnormal Laboratory Value|2|||
30709771|NCT00110617|58723323|FG000|Overall Study|Lack of Efficacy|1|||
30709772|NCT00110617|58723324|FG001|Overall Study|Lack of Efficacy|0|||
30896100|NCT01903720|58929500|FG000|Overall Study|Treatment with alternative drug|1|||
30896101|NCT02366689|58929507|FG000|Overall Study|Withdrawal by Subject|1|||
30896102|NCT02366689|58929508|FG001|Overall Study|Withdrawal by Subject|0|||
30896103|NCT02366689|58929509|FG002|Overall Study|Withdrawal by Subject|1|||
30896104|NCT02366689|58929507|FG000|Overall Study|Lost to Follow-up|3|||
30896105|NCT02366689|58929508|FG001|Overall Study|Lost to Follow-up|2|||
30896106|NCT02366689|58929509|FG002|Overall Study|Lost to Follow-up|0|||
30896107|NCT02366689|58929507|FG000|Overall Study|Pregnancy|0|||
30896108|NCT02366689|58929508|FG001|Overall Study|Pregnancy|1|||
30896109|NCT02366689|58929509|FG002|Overall Study|Pregnancy|1|||
30896110|NCT01903252|58929519|FG000|Double-Blind Induction|Adverse Event|20|||
30896111|NCT01903252|58929520|FG001|Double-Blind Induction|Adverse Event|18|||
30896112|NCT01903252|58929521|FG002|Double-Blind Induction|Adverse Event|0|||
30896113|NCT01903252|58929522|FG003|Double-Blind Induction|Adverse Event|0|||
30896114|NCT01903252|58929523|FG004|Double-Blind Induction|Adverse Event|0|||
30896115|NCT01903252|58929524|FG005|Double-Blind Induction|Adverse Event|0|||
30896116|NCT01903252|58929519|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
30896117|NCT01903252|58929520|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
30896118|NCT01903252|58929521|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
30896119|NCT01903252|58929522|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
30896120|NCT01903252|58929523|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
30896121|NCT01903252|58929524|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
30896122|NCT01903252|58929519|FG000|Double-Blind Induction|Physician Decision|2|||
30896123|NCT01903252|58929520|FG001|Double-Blind Induction|Physician Decision|3|||
30896124|NCT01903252|58929521|FG002|Double-Blind Induction|Physician Decision|0|||
30896125|NCT01903252|58929522|FG003|Double-Blind Induction|Physician Decision|0|||
30896126|NCT01903252|58929523|FG004|Double-Blind Induction|Physician Decision|0|||
30896127|NCT01903252|58929524|FG005|Double-Blind Induction|Physician Decision|0|||
30896128|NCT01903252|58929519|FG000|Double-Blind Induction|non-compliance,|7|||
30896129|NCT01903252|58929520|FG001|Double-Blind Induction|non-compliance,|7|||
30896130|NCT01903252|58929521|FG002|Double-Blind Induction|non-compliance,|0|||
30896131|NCT01903252|58929522|FG003|Double-Blind Induction|non-compliance,|0|||
30896132|NCT01903252|58929523|FG004|Double-Blind Induction|non-compliance,|0|||
30896133|NCT01903252|58929524|FG005|Double-Blind Induction|non-compliance,|0|||
30896134|NCT01903252|58929519|FG000|Extended Induction, Open-Label|Adverse Event|0|||
30896135|NCT01903252|58929520|FG001|Extended Induction, Open-Label|Adverse Event|0|||
30896136|NCT01903252|58929521|FG002|Extended Induction, Open-Label|Adverse Event|17|||
30709773|NCT00110617|58723323|FG000|Overall Study|Patient no longer requires study drug|1|||
30709774|NCT00110617|58723324|FG001|Overall Study|Patient no longer requires study drug|0|||
30709775|NCT00110617|58723323|FG000|Overall Study|Protocol Violation|5|||
30709776|NCT00110617|58723324|FG001|Overall Study|Protocol Violation|0|||
30709777|NCT00110617|58723323|FG000|Overall Study|Withdrawal by Subject|10|||
30709778|NCT00110617|58723324|FG001|Overall Study|Withdrawal by Subject|4|||
30709779|NCT00110617|58723323|FG000|Overall Study|Lost to Follow-up|9|||
30709780|NCT00110617|58723324|FG001|Overall Study|Lost to Follow-up|1|||
30709781|NCT00110617|58723323|FG000|Overall Study|Administrative problems|6|||
30709782|NCT00110617|58723324|FG001|Overall Study|Administrative problems|5|||
30709783|NCT00110617|58723323|FG000|Overall Study|Death|1|||
30709784|NCT00110617|58723324|FG001|Overall Study|Death|1|||
30709785|NCT00110617|58723323|FG000|Overall Study|Did not receive study drug|0|||
30709786|NCT00110617|58723324|FG001|Overall Study|Did not receive study drug|12|||
30709787|NCT03956862|58723334|FG000|Overall Study|Lost to Follow-up|1|||
30709788|NCT03956862|58723335|FG001|Overall Study|Lost to Follow-up|1|||
30896137|NCT01903252|58929522|FG003|Extended Induction, Open-Label|Adverse Event|0|||
30620983|NCT04246801|58632494|FG001|Overall Study|Withdrawal by Subject|1|||
30620984|NCT01200797|58632500|FG000|Overall Study|symptomatic deterioration|2|||
30620985|NCT01200797|58632500|FG000|Overall Study|Adverse Event|4|||
30620986|NCT01200797|58632500|FG000|Overall Study|Disease Progression|13|||
30620987|NCT01200485|58632505|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
30620988|NCT01200485|58632506|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
30620989|NCT01200485|58632507|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
30620990|NCT01200485|58632505|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
30620991|NCT01200485|58632506|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
30620992|NCT01200485|58632507|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
30620993|NCT01200407|58632514|FG000|Overall Study|Lost to Follow-up|56|||
30620994|NCT01200407|58632514|FG000|Overall Study|Adverse Event|3|||
30620995|NCT01200407|58632514|FG000|Overall Study|Withdrawal by Subject|4|||
30620996|NCT01200407|58632514|FG000|Overall Study|Other|19|||
30620997|NCT01200329|58632518|FG000|Overall Study|Lack of financial coverage|2|||
30896138|NCT01903252|58929523|FG004|Extended Induction, Open-Label|Adverse Event|0|||
30896139|NCT01903252|58929524|FG005|Extended Induction, Open-Label|Adverse Event|0|||
30896140|NCT01903252|58929519|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
30896141|NCT01903252|58929520|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
30896142|NCT01903252|58929521|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
30896143|NCT01903252|58929522|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
30896144|NCT01903252|58929523|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
30896145|NCT01903252|58929524|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
30896146|NCT01903252|58929519|FG000|Extended Induction, Open-Label|Physician Decision|0|||
30896147|NCT01903252|58929520|FG001|Extended Induction, Open-Label|Physician Decision|0|||
30896148|NCT01903252|58929521|FG002|Extended Induction, Open-Label|Physician Decision|1|||
30896149|NCT01903252|58929522|FG003|Extended Induction, Open-Label|Physician Decision|0|||
30896150|NCT01903252|58929523|FG004|Extended Induction, Open-Label|Physician Decision|0|||
30896151|NCT01903252|58929524|FG005|Extended Induction, Open-Label|Physician Decision|0|||
30896152|NCT01903252|58929519|FG000|Maintenance, Open-Label|Adverse Event|0|||
30896153|NCT01903252|58929520|FG001|Maintenance, Open-Label|Adverse Event|0|||
30896154|NCT01903252|58929521|FG002|Maintenance, Open-Label|Adverse Event|0|||
30896155|NCT01903252|58929522|FG003|Maintenance, Open-Label|Adverse Event|3|||
30896156|NCT01903252|58929523|FG004|Maintenance, Open-Label|Adverse Event|9|||
30896157|NCT01903252|58929524|FG005|Maintenance, Open-Label|Adverse Event|14|||
30896158|NCT01903252|58929519|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
30896159|NCT01903252|58929520|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
30896160|NCT01903252|58929521|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
30896161|NCT01903252|58929522|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
30896162|NCT01903252|58929523|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
30896163|NCT01903252|58929524|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
30896164|NCT01903252|58929519|FG000|Maintenance, Open-Label|Other|0|||
30896165|NCT01903252|58929520|FG001|Maintenance, Open-Label|Other|0|||
30896166|NCT01903252|58929521|FG002|Maintenance, Open-Label|Other|0|||
30896167|NCT01903252|58929522|FG003|Maintenance, Open-Label|Other|2|||
30896168|NCT01903252|58929523|FG004|Maintenance, Open-Label|Other|6|||
30896169|NCT01903252|58929524|FG005|Maintenance, Open-Label|Other|2|||
30896170|NCT01920958|58929542|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
30896171|NCT01613716|58929546|FG000|Overall Study|screen failures|3|||
30896172|NCT01613716|58929546|FG000|Overall Study|Lost to Follow-up|4|||
30896173|NCT01872910|58929556|FG000|Overall Study|Lost to Follow-up|2|||
30896174|NCT01872910|58929557|FG001|Overall Study|Lost to Follow-up|0|||
30896175|NCT01872910|58929558|FG002|Overall Study|Lost to Follow-up|2|||
30896176|NCT01872910|58929559|FG003|Overall Study|Lost to Follow-up|0|||
30896177|NCT01872910|58929560|FG004|Overall Study|Lost to Follow-up|0|||
30896178|NCT01872910|58929561|FG005|Overall Study|Lost to Follow-up|0|||
30896179|NCT01920568|58929576|FG000|Overall Study|Adverse Event|27|||
30896180|NCT01920568|58929577|FG001|Overall Study|Adverse Event|8|||
30896181|NCT01920568|58929576|FG000|Overall Study|Protocol Violation|5|||
30896182|NCT01920568|58929577|FG001|Overall Study|Protocol Violation|3|||
30896183|NCT01920568|58929576|FG000|Overall Study|Lost to Follow-up|2|||
30896184|NCT01920568|58929577|FG001|Overall Study|Lost to Follow-up|2|||
30896185|NCT01920568|58929576|FG000|Overall Study|Physician Decision|13|||
30896186|NCT01920568|58929577|FG001|Overall Study|Physician Decision|4|||
30896187|NCT01920568|58929576|FG000|Overall Study|Withdrawal by Subject|79|||
30896188|NCT01920568|58929577|FG001|Overall Study|Withdrawal by Subject|55|||
30896189|NCT01920568|58929576|FG000|Overall Study|Death due to disease progression|25|||
30896190|NCT01920568|58929577|FG001|Overall Study|Death due to disease progression|12|||
30896191|NCT01902628|58929584|FG000|Overall Study|Withdrawal of participant's consent|7|||
30896192|NCT01902628|58929584|FG000|Overall Study|Adverse Event|41|||
30896193|NCT01902628|58929584|FG000|Overall Study|Lost to Follow-up|35|||
30896194|NCT01920178|58929590|FG000|Overall Study|Lost to Follow-up|2|||
30896195|NCT01920178|58929591|FG001|Overall Study|Lost to Follow-up|1|||
30896196|NCT01901848|58929599|FG000|Randomized and Treated|Lost to Follow-up|3|||
30896197|NCT01901848|58929600|FG001|Randomized and Treated|Lost to Follow-up|6|||
30709789|NCT03956862|58723334|FG000|Overall Study|Withdrawal by Subject|1|||
30709790|NCT03956862|58723335|FG001|Overall Study|Withdrawal by Subject|1|||
30790891|NCT00836056|58803980|FG000|First Intervention|Adverse Event|1|||
30709791|NCT00550238|58723341|FG000|Overall Study|Adverse Event|88|||
30896198|NCT01901848|58929599|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
30896199|NCT01901848|58929600|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
30896200|NCT01901614|58929608|FG000|Overall Study|Adverse Event|0|||
30896201|NCT01901614|58929609|FG001|Overall Study|Adverse Event|1|||
30896202|NCT01901614|58929608|FG000|Overall Study|Lost to Follow-up|1|||
30896203|NCT01901614|58929609|FG001|Overall Study|Lost to Follow-up|0|||
30896204|NCT01901614|58929608|FG000|Overall Study|Screen Fail|1|||
30896205|NCT01901614|58929609|FG001|Overall Study|Screen Fail|0|||
30896206|NCT01901302|58929617|FG000|Overall Study|Adverse Event|2|||
30896207|NCT01901302|58929618|FG001|Overall Study|Adverse Event|1|||
30896208|NCT01901302|58929617|FG000|Overall Study|Lack of Efficacy|0|||
30896209|NCT01901302|58929618|FG001|Overall Study|Lack of Efficacy|2|||
30896210|NCT01901302|58929617|FG000|Overall Study|Study Terminated by Sponsor|23|||
30896211|NCT01901302|58929618|FG001|Overall Study|Study Terminated by Sponsor|20|||
30896212|NCT01901302|58929617|FG000|Overall Study|Withdrawal by Subject|2|||
30896213|NCT01901302|58929618|FG001|Overall Study|Withdrawal by Subject|0|||
30896214|NCT01919398|58929627|FG000|Overall Study|Progressive Disease|0|||
30896215|NCT01919398|58929628|FG001|Overall Study|Progressive Disease|0|||
30896216|NCT01919398|58929629|FG002|Overall Study|Progressive Disease|4|||
30896217|NCT02500043|58929639|FG000|Overall Study|Randomized, but not Treated|2|||
30896218|NCT02500043|58929640|FG001|Overall Study|Randomized, but not Treated|2|||
30896219|NCT02500043|58929639|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
30896220|NCT02500043|58929640|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
30896221|NCT02500043|58929639|FG000|Overall Study|Adverse Event|33|||
30896222|NCT02500043|58929640|FG001|Overall Study|Adverse Event|11|||
30896223|NCT02500043|58929639|FG000|Overall Study|Clinical Progression|54|||
30896224|NCT02500043|58929640|FG001|Overall Study|Clinical Progression|35|||
30896225|NCT02500043|58929639|FG000|Overall Study|Radiological Progression|192|||
30896226|NCT02500043|58929640|FG001|Overall Study|Radiological Progression|110|||
30896227|NCT02500043|58929639|FG000|Overall Study|Physician's Decision|11|||
30896228|NCT02500043|58929640|FG001|Overall Study|Physician's Decision|3|||
30896229|NCT02500043|58929639|FG000|Overall Study|Withdrawal by Subject|14|||
30896230|NCT02500043|58929640|FG001|Overall Study|Withdrawal by Subject|4|||
30896231|NCT02500043|58929639|FG000|Overall Study|Death|11|||
30896232|NCT02500043|58929640|FG001|Overall Study|Death|2|||
30896233|NCT02500043|58929639|FG000|Overall Study|Protocol Deviation|1|||
30896234|NCT02500043|58929640|FG001|Overall Study|Protocol Deviation|0|||
30896235|NCT02499575|58929648|FG000|Overall Study|Protocol Violation|0|||
30896236|NCT02499575|58929649|FG001|Overall Study|Protocol Violation|1|||
30896237|NCT02065791|58929657|FG000|Overall Study|Closed Site|1|||
30896238|NCT02065791|58929658|FG001|Overall Study|Closed Site|1|||
30896239|NCT02065791|58929657|FG000|Overall Study|Withdrawal by Subject|11|||
30896240|NCT02065791|58929658|FG001|Overall Study|Withdrawal by Subject|5|||
30896241|NCT02065791|58929657|FG000|Overall Study|Lost to Follow-up|13|||
30896242|NCT02065791|58929658|FG001|Overall Study|Lost to Follow-up|9|||
30896243|NCT02499263|58929664|FG000|Overall Study|Lost to Follow-up|9|||
30896244|NCT02499263|58929664|FG000|Overall Study|Participant's withdrawal of consent|4|||
30896245|NCT02499263|58929664|FG000|Overall Study|Lack of Efficacy|22|||
30896246|NCT02499263|58929664|FG000|Overall Study|investigator's judgment|12|||
30896247|NCT02499263|58929664|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
30709792|NCT00550238|58723341|FG000|Overall Study|Death|34|||
30709793|NCT00550238|58723341|FG000|Overall Study|Disease progression|46|||
30709794|NCT00550238|58723341|FG000|Overall Study|Withdrawal by Subject|167|||
30709795|NCT00550238|58723341|FG000|Overall Study|Physician Decision|31|||
30709796|NCT00550238|58723341|FG000|Overall Study|Patient noncompliance|25|||
30709797|NCT00550238|58723341|FG000|Overall Study|Lost to Follow-up|13|||
30709798|NCT00550238|58723341|FG000|Overall Study|Sponsor decision|55|||
30709799|NCT03956550|58723348|FG000|Overall Study|Sponsor decision|65|||
30709800|NCT03956550|58723349|FG001|Overall Study|Sponsor decision|66|||
30709801|NCT03956550|58723350|FG002|Overall Study|Sponsor decision|64|||
30709802|NCT03956550|58723348|FG000|Overall Study|Adverse Event|0|||
30709803|NCT03956550|58723349|FG001|Overall Study|Adverse Event|1|||
30709804|NCT03956550|58723350|FG002|Overall Study|Adverse Event|0|||
30709805|NCT03956550|58723348|FG000|Overall Study|Withdrawal by Subject|5|||
30709806|NCT03956550|58723349|FG001|Overall Study|Withdrawal by Subject|5|||
30709807|NCT03956550|58723350|FG002|Overall Study|Withdrawal by Subject|6|||
30709808|NCT00110305|58723362|FG000|Overall Study|Adverse Event|46|||
30709809|NCT00110305|58723363|FG001|Overall Study|Adverse Event|13|||
30709810|NCT00110305|58723362|FG000|Overall Study|Sponsors Decision|1|||
30709811|NCT00110305|58723363|FG001|Overall Study|Sponsors Decision|0|||
30709812|NCT00110305|58723362|FG000|Overall Study|Subject Non-Compliant|9|||
30709813|NCT00110305|58723363|FG001|Overall Study|Subject Non-Compliant|2|||
30709814|NCT00110305|58723362|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
30709815|NCT00110305|58723363|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
30709816|NCT00110305|58723362|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
30709817|NCT00110305|58723363|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
30709818|NCT00110305|58723362|FG000|Overall Study|Protocol Violation|0|||
30709819|NCT00110305|58723363|FG001|Overall Study|Protocol Violation|1|||
30709820|NCT00110305|58723362|FG000|Overall Study|Withdrawal by Subject|7|||
30709821|NCT00110305|58723363|FG001|Overall Study|Withdrawal by Subject|7|||
30709822|NCT00110305|58723362|FG000|Overall Study|Lost to Follow-up|20|||
30709823|NCT00110305|58723363|FG001|Overall Study|Lost to Follow-up|3|||
30709824|NCT00110305|58723362|FG000|Overall Study|Other|8|||
30709825|NCT00110305|58723363|FG001|Overall Study|Other|2|||
30709826|NCT00428116|58723382|FG000|Overall Study|Death|1|||
30709827|NCT00428116|58723383|FG001|Overall Study|Death|0|||
30709828|NCT00428116|58723382|FG000|Overall Study|Withdrawal by Subject|1|||
30709829|NCT00428116|58723383|FG001|Overall Study|Withdrawal by Subject|0|||
30709830|NCT00428116|58723382|FG000|Overall Study|Lost to Follow-up|1|||
30709831|NCT00428116|58723383|FG001|Overall Study|Lost to Follow-up|0|||
30709832|NCT00560066|58723392|FG000|Overall Study|Death|2|||
30709833|NCT00560066|58723393|FG001|Overall Study|Death|1|||
30709834|NCT00560066|58723392|FG000|Overall Study|Withdrawal by Subject|0|||
30709835|NCT00560066|58723393|FG001|Overall Study|Withdrawal by Subject|3|||
30709836|NCT00560066|58723392|FG000|Overall Study|Lost to Follow-up|4|||
30709837|NCT00560066|58723393|FG001|Overall Study|Lost to Follow-up|10|||
30709838|NCT00560066|58723392|FG000|Overall Study|Protocol Violation|0|||
30709839|NCT00560066|58723393|FG001|Overall Study|Protocol Violation|1|||
30709840|NCT00560066|58723392|FG000|Overall Study|Administrative reason|0|||
30709841|NCT00560066|58723393|FG001|Overall Study|Administrative reason|5|||
30709842|NCT00560066|58723392|FG000|Overall Study|Missing primary reason|0|||
30709843|NCT00560066|58723393|FG001|Overall Study|Missing primary reason|2|||
30709844|NCT00549900|58723404|FG000|Overall Study|Adverse Event|1|||
30709845|NCT00435994|58723411|FG000|Overall Study|Lost to Follow-up|7|||
30709846|NCT00435994|58723412|FG001|Overall Study|Lost to Follow-up|0|||
30709847|NCT00435994|58723413|FG002|Overall Study|Lost to Follow-up|0|||
30896248|NCT02499263|58929664|FG000|Overall Study|Participant's decision|3|||
30896249|NCT02499263|58929664|FG000|Overall Study|Pregnancy|1|||
30709848|NCT00435370|58723424|FG000|Overall Study|Adverse Event|8|||
30709849|NCT00435370|58723425|FG001|Overall Study|Adverse Event|8|||
30709850|NCT00435370|58723424|FG000|Overall Study|Withdrawal by Subject|10|||
30709851|NCT00435370|58723425|FG001|Overall Study|Withdrawal by Subject|10|||
30709852|NCT00435370|58723424|FG000|Overall Study|Antipsychotic medication changed|4|||
30709853|NCT00435370|58723425|FG001|Overall Study|Antipsychotic medication changed|2|||
30709854|NCT00096031|58723431|FG000|Overall Study|Adverse Event|3|||
30709855|NCT00096031|58723431|FG000|Overall Study|Lack of Efficacy|42|||
30709856|NCT00096031|58723431|FG000|Overall Study|Death|4|||
30709857|NCT00096031|58723431|FG000|Overall Study|Withdrawal by Subject|1|||
30709858|NCT00096031|58723431|FG000|Overall Study|Ineligible|8|||
30709859|NCT00096031|58723431|FG000|Overall Study|Not protocol specified|5|||
30709860|NCT00118417|58723435|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
30709861|NCT00118417|58723436|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
30709862|NCT00118417|58723435|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
30709863|NCT00118417|58723436|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
30896250|NCT01654289|58929671|FG000|Overall Study|Withdrawal by Subject|10|||
30896251|NCT01654289|58929672|FG001|Overall Study|Withdrawal by Subject|8|||
30896252|NCT01654289|58929673|FG002|Overall Study|Withdrawal by Subject|5|||
30896253|NCT01654289|58929671|FG000|Overall Study|Withdrew from intervention only|17|||
30896254|NCT01654289|58929672|FG001|Overall Study|Withdrew from intervention only|20|||
30896255|NCT01654289|58929673|FG002|Overall Study|Withdrew from intervention only|0|||
30896256|NCT02499029|58929683|FG000|Overall Study|Lost to Follow-up|2|||
30896257|NCT02499029|58929684|FG001|Overall Study|Lost to Follow-up|2|||
30896258|NCT02499029|58929683|FG000|Overall Study|Physician Decision|2|||
30896259|NCT02499029|58929684|FG001|Overall Study|Physician Decision|1|||
30896260|NCT02499029|58929683|FG000|Overall Study|Death|1|||
30896261|NCT02499029|58929684|FG001|Overall Study|Death|0|||
30896262|NCT04968353|58929694|FG000|Overall Study|Non-compliance|1|||
30896263|NCT04968353|58929695|FG001|Overall Study|Non-compliance|0|||
30896264|NCT04968353|58929696|FG002|Overall Study|Non-compliance|2|||
30896265|NCT04968353|58929697|FG003|Overall Study|Non-compliance|0|||
30896266|NCT02065713|58929709|FG000|Overall Study|Adverse Event|0|||
30896267|NCT02065713|58929710|FG001|Overall Study|Adverse Event|1|||
30896268|NCT02065713|58929709|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30896269|NCT02065713|58929710|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30896270|NCT02497781|58929718|FG000|Overall Study|Withdrawal by Subject|2|||
30896271|NCT02497781|58929719|FG001|Overall Study|Withdrawal by Subject|0|||
30896272|NCT02497781|58929718|FG000|Overall Study|Lack of Efficacy|0|||
30896273|NCT02497781|58929719|FG001|Overall Study|Lack of Efficacy|1|||
30896274|NCT02497781|58929718|FG000|Overall Study|Randomised but not treated|1|||
30896275|NCT02497781|58929719|FG001|Overall Study|Randomised but not treated|1|||
30896276|NCT02497781|58929718|FG000|Overall Study|Lost to Follow-up|1|||
30896277|NCT02497781|58929719|FG001|Overall Study|Lost to Follow-up|1|||
30896278|NCT02497469|58929727|FG000|Overall Study|Randomized but not Treated|0|||
30896279|NCT02497469|58929728|FG001|Overall Study|Randomized but not Treated|2|||
30896280|NCT02497469|58929727|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
30896281|NCT02497469|58929728|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
30896282|NCT02497469|58929727|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
30896283|NCT02497469|58929728|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
30896284|NCT02497469|58929727|FG000|Overall Study|Significant Protocol Deviation|4|||
30896285|NCT02497469|58929728|FG001|Overall Study|Significant Protocol Deviation|5|||
30896286|NCT02497469|58929727|FG000|Overall Study|Lost to Follow-up|14|||
30896287|NCT02497469|58929728|FG001|Overall Study|Lost to Follow-up|4|||
30896288|NCT02497469|58929727|FG000|Overall Study|Voluntary Withdrawal|39|||
30896289|NCT02497469|58929728|FG001|Overall Study|Voluntary Withdrawal|41|||
30896290|NCT02497469|58929727|FG000|Overall Study|Pregnancy|1|||
30896291|NCT02497469|58929728|FG001|Overall Study|Pregnancy|1|||
30896292|NCT02497469|58929727|FG000|Overall Study|Lack of Efficacy|86|||
30896293|NCT02497469|58929728|FG001|Overall Study|Lack of Efficacy|40|||
30896294|NCT02497469|58929727|FG000|Overall Study|Reason not Specified|6|||
30896295|NCT02497469|58929728|FG001|Overall Study|Reason not Specified|6|||
30896296|NCT02497391|58929734|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
30896297|NCT02497391|58929735|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
30896298|NCT02497391|58929736|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
30896299|NCT02497391|58929737|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
30896300|NCT02497391|58929738|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
30896301|NCT02497391|58929739|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
30896302|NCT02497391|58929734|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
30896303|NCT02497391|58929735|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
30896304|NCT02497391|58929736|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
30896305|NCT02497391|58929737|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
30896306|NCT02497391|58929738|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
30896307|NCT02497391|58929739|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
30896308|NCT02497391|58929734|FG000|Period 3 (14 Days)|Adverse Event|0|||
30709864|NCT00118417|58723435|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
30896309|NCT02497391|58929735|FG001|Period 3 (14 Days)|Adverse Event|1|||
30896310|NCT02497391|58929736|FG002|Period 3 (14 Days)|Adverse Event|0|||
30896311|NCT02497391|58929737|FG003|Period 3 (14 Days)|Adverse Event|0|||
30896312|NCT02497391|58929738|FG004|Period 3 (14 Days)|Adverse Event|0|||
30896313|NCT02497391|58929739|FG005|Period 3 (14 Days)|Adverse Event|0|||
30896314|NCT02497391|58929734|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
30620998|NCT01200329|58632518|FG000|Overall Study|Progressive disease|1|||
30620999|NCT01199939|58632522|FG000|Overall Study|Adverse Event|4|||
30621000|NCT01199939|58632522|FG000|Overall Study|Protocol Violation|3|||
30621001|NCT01199939|58632522|FG000|Overall Study|Lost to Follow-up|2|||
30621002|NCT01199939|58632522|FG000|Overall Study|Reached a virologic endpoint|4|||
30621003|NCT01199861|58632528|FG000|Overall Study|Administrative problems|1|||
30709865|NCT00118417|58723436|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
30621004|NCT01199861|58632529|FG001|Overall Study|Administrative problems|0|||
30896315|NCT02497391|58929735|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
30896316|NCT02497391|58929736|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
30896317|NCT02497391|58929737|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
30896318|NCT02497391|58929738|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
30896319|NCT02497391|58929739|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
30896320|NCT02497391|58929734|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
30896321|NCT02497391|58929735|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
30896322|NCT02497391|58929736|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
30896323|NCT02497391|58929737|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
30896324|NCT02497391|58929738|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
30896325|NCT02497391|58929739|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
30896326|NCT02476175|58929747|FG000|Overall Study|Adverse Event|2|||
30896327|NCT02065557|58929754|FG000|Induction Period|Withdrawal by Subject|2|||
30896328|NCT02065557|58929755|FG001|Induction Period|Withdrawal by Subject|1|||
30896329|NCT02065557|58929756|FG002|Induction Period|Withdrawal by Subject|0|||
30896330|NCT02065557|58929757|FG003|Induction Period|Withdrawal by Subject|0|||
30896331|NCT02065557|58929758|FG004|Induction Period|Withdrawal by Subject|0|||
30896332|NCT02065557|58929759|FG005|Induction Period|Withdrawal by Subject|0|||
30896333|NCT02065557|58929754|FG000|Induction Period|Lack of Efficacy|2|||
30896334|NCT02065557|58929755|FG001|Induction Period|Lack of Efficacy|1|||
30896335|NCT02065557|58929756|FG002|Induction Period|Lack of Efficacy|1|||
30896336|NCT02065557|58929757|FG003|Induction Period|Lack of Efficacy|0|||
30896337|NCT02065557|58929758|FG004|Induction Period|Lack of Efficacy|0|||
30896338|NCT02065557|58929759|FG005|Induction Period|Lack of Efficacy|0|||
30896339|NCT02065557|58929754|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
30896340|NCT02065557|58929755|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
30896341|NCT02065557|58929756|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
30896342|NCT02065557|58929757|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
30896343|NCT02065557|58929758|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
30896344|NCT02065557|58929759|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
30896345|NCT02065557|58929754|FG000|Induction Period|Non-Responder at Week 8|4|||
30896346|NCT02065557|58929755|FG001|Induction Period|Non-Responder at Week 8|4|||
30896347|NCT02065557|58929756|FG002|Induction Period|Non-Responder at Week 8|0|||
30896348|NCT02065557|58929757|FG003|Induction Period|Non-Responder at Week 8|0|||
30896349|NCT02065557|58929758|FG004|Induction Period|Non-Responder at Week 8|0|||
30896350|NCT02065557|58929759|FG005|Induction Period|Non-Responder at Week 8|0|||
30896351|NCT02065557|58929754|FG000|Induction Period|Adverse Event|1|||
30896352|NCT02065557|58929755|FG001|Induction Period|Adverse Event|1|||
30896353|NCT02065557|58929756|FG002|Induction Period|Adverse Event|0|||
30896354|NCT02065557|58929757|FG003|Induction Period|Adverse Event|0|||
30896355|NCT02065557|58929758|FG004|Induction Period|Adverse Event|0|||
30896356|NCT02065557|58929759|FG005|Induction Period|Adverse Event|0|||
30896357|NCT02065557|58929754|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
30896358|NCT02065557|58929755|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
30896359|NCT02065557|58929756|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
30896360|NCT02065557|58929757|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
30896361|NCT02065557|58929758|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
30896362|NCT02065557|58929759|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
30709866|NCT00118417|58723435|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
30709867|NCT00118417|58723436|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
30709868|NCT00118417|58723435|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
30709869|NCT00118417|58723436|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
30709870|NCT00549848|58723449|FG000|Overall Study|Death|1|||
30709871|NCT00549848|58723450|FG001|Overall Study|Death|4|||
30709872|NCT00549848|58723451|FG002|Overall Study|Death|13|||
30709873|NCT00549848|58723449|FG000|Overall Study|Physician Decision|0|||
30709874|NCT00549848|58723450|FG001|Overall Study|Physician Decision|0|||
30709875|NCT00549848|58723451|FG002|Overall Study|Physician Decision|4|||
30709876|NCT00549848|58723449|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
30709877|NCT00549848|58723450|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
30709878|NCT00549848|58723451|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
30709879|NCT00549848|58723449|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
30709880|NCT00549848|58723450|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
30709881|NCT00549848|58723451|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
30709882|NCT00549848|58723449|FG000|Overall Study|Participant/Family Withdraw|2|||
30896363|NCT02065557|58929754|FG000|Maintenance Period|Withdrawal by Subject|0|||
30896364|NCT02065557|58929755|FG001|Maintenance Period|Withdrawal by Subject|0|||
30896365|NCT02065557|58929756|FG002|Maintenance Period|Withdrawal by Subject|0|||
30896366|NCT02065557|58929757|FG003|Maintenance Period|Withdrawal by Subject|0|||
30896367|NCT02065557|58929758|FG004|Maintenance Period|Withdrawal by Subject|2|||
30896368|NCT02065557|58929759|FG005|Maintenance Period|Withdrawal by Subject|1|||
30896369|NCT02065557|58929754|FG000|Maintenance Period|Lack of Efficacy|0|||
30896370|NCT02065557|58929755|FG001|Maintenance Period|Lack of Efficacy|0|||
30896371|NCT02065557|58929756|FG002|Maintenance Period|Lack of Efficacy|0|||
30709883|NCT00549848|58723450|FG001|Overall Study|Participant/Family Withdraw|3|||
30709884|NCT00549848|58723451|FG002|Overall Study|Participant/Family Withdraw|5|||
30709885|NCT00549848|58723449|FG000|Overall Study|Second Malignancy|1|||
30709886|NCT00549848|58723450|FG001|Overall Study|Second Malignancy|0|||
30709887|NCT00549848|58723451|FG002|Overall Study|Second Malignancy|0|||
30709888|NCT00549848|58723449|FG000|Overall Study|Transplant|3|||
30709889|NCT00549848|58723450|FG001|Overall Study|Transplant|3|||
30709890|NCT00549848|58723451|FG002|Overall Study|Transplant|18|||
30709891|NCT00549848|58723449|FG000|Overall Study|Unacceptable Toxicity|1|||
30709892|NCT00549848|58723450|FG001|Overall Study|Unacceptable Toxicity|6|||
30709893|NCT00549848|58723451|FG002|Overall Study|Unacceptable Toxicity|6|||
30709894|NCT00549770|58723475|FG000|Overall Study|Protocol deviation|1|||
30709895|NCT00549770|58723476|FG001|Overall Study|Protocol deviation|1|||
30709896|NCT00549770|58723477|FG002|Overall Study|Protocol deviation|1|||
30709897|NCT00549770|58723478|FG003|Overall Study|Protocol deviation|2|||
30709898|NCT00549770|58723479|FG004|Overall Study|Protocol deviation|2|||
30709899|NCT00549770|58723480|FG005|Overall Study|Protocol deviation|2|||
30709900|NCT00549770|58723481|FG006|Overall Study|Protocol deviation|1|||
30709901|NCT00549770|58723482|FG007|Overall Study|Protocol deviation|2|||
30709902|NCT00549770|58723475|FG000|Overall Study|Administrative problems|0|||
30709903|NCT00549770|58723476|FG001|Overall Study|Administrative problems|1|||
30709904|NCT00549770|58723477|FG002|Overall Study|Administrative problems|0|||
30709905|NCT00549770|58723478|FG003|Overall Study|Administrative problems|0|||
30709906|NCT00549770|58723479|FG004|Overall Study|Administrative problems|0|||
30709907|NCT00549770|58723480|FG005|Overall Study|Administrative problems|0|||
30709908|NCT00549770|58723481|FG006|Overall Study|Administrative problems|0|||
30709909|NCT00549770|58723482|FG007|Overall Study|Administrative problems|1|||
30709910|NCT00549770|58723475|FG000|Overall Study|Lost to Follow-up|0|||
30709911|NCT00549770|58723476|FG001|Overall Study|Lost to Follow-up|0|||
30709912|NCT00549770|58723477|FG002|Overall Study|Lost to Follow-up|2|||
30709913|NCT00549770|58723478|FG003|Overall Study|Lost to Follow-up|2|||
30709914|NCT00549770|58723479|FG004|Overall Study|Lost to Follow-up|3|||
30709915|NCT00549770|58723480|FG005|Overall Study|Lost to Follow-up|2|||
30709916|NCT00549770|58723481|FG006|Overall Study|Lost to Follow-up|0|||
30709917|NCT00549770|58723482|FG007|Overall Study|Lost to Follow-up|0|||
30709918|NCT00549770|58723475|FG000|Overall Study|Withdrawal by Subject|4|||
30709919|NCT00549770|58723476|FG001|Overall Study|Withdrawal by Subject|6|||
30709920|NCT00549770|58723477|FG002|Overall Study|Withdrawal by Subject|4|||
30709921|NCT00549770|58723478|FG003|Overall Study|Withdrawal by Subject|5|||
30709922|NCT00549770|58723479|FG004|Overall Study|Withdrawal by Subject|6|||
30709923|NCT00549770|58723480|FG005|Overall Study|Withdrawal by Subject|6|||
30709924|NCT00549770|58723481|FG006|Overall Study|Withdrawal by Subject|4|||
30709925|NCT00549770|58723482|FG007|Overall Study|Withdrawal by Subject|9|||
30709926|NCT00549770|58723475|FG000|Overall Study|Lack of Efficacy|1|||
30709927|NCT00549770|58723476|FG001|Overall Study|Lack of Efficacy|0|||
30709928|NCT00549770|58723477|FG002|Overall Study|Lack of Efficacy|2|||
30896372|NCT02065557|58929757|FG003|Maintenance Period|Lack of Efficacy|0|||
30896373|NCT02065557|58929758|FG004|Maintenance Period|Lack of Efficacy|5|||
30896374|NCT02065557|58929759|FG005|Maintenance Period|Lack of Efficacy|2|||
30896375|NCT02065557|58929754|FG000|Maintenance Period|Subject Non-Compliance|0|||
30896376|NCT02065557|58929755|FG001|Maintenance Period|Subject Non-Compliance|0|||
30896377|NCT02065557|58929756|FG002|Maintenance Period|Subject Non-Compliance|0|||
30896378|NCT02065557|58929757|FG003|Maintenance Period|Subject Non-Compliance|0|||
30896379|NCT02065557|58929758|FG004|Maintenance Period|Subject Non-Compliance|0|||
30896380|NCT02065557|58929759|FG005|Maintenance Period|Subject Non-Compliance|1|||
30896381|NCT02065245|58929791|FG000|Infusion 1|Lost to Follow-up|0|||
30896382|NCT02065245|58929792|FG001|Infusion 1|Lost to Follow-up|0|||
30896383|NCT02065245|58929793|FG002|Infusion 1|Lost to Follow-up|0|||
30896384|NCT02065245|58929794|FG003|Infusion 1|Lost to Follow-up|0|||
30709929|NCT00549770|58723478|FG003|Overall Study|Lack of Efficacy|3|||
30709930|NCT00549770|58723479|FG004|Overall Study|Lack of Efficacy|5|||
30709931|NCT00549770|58723480|FG005|Overall Study|Lack of Efficacy|1|||
30709932|NCT00549770|58723481|FG006|Overall Study|Lack of Efficacy|3|||
30896385|NCT02065245|58929795|FG004|Infusion 1|Lost to Follow-up|0|||
30709933|NCT00549770|58723482|FG007|Overall Study|Lack of Efficacy|8|||
30709934|NCT00549770|58723475|FG000|Overall Study|Abnormal test procedure results|0|||
30896386|NCT02065245|58929796|FG005|Infusion 1|Lost to Follow-up|0|||
30896387|NCT02065245|58929797|FG006|Infusion 1|Lost to Follow-up|1|||
30896388|NCT02065245|58929791|FG000|Infusion 1|Death|0|||
30709935|NCT00549770|58723476|FG001|Overall Study|Abnormal test procedure results|0|||
30709936|NCT00549770|58723477|FG002|Overall Study|Abnormal test procedure results|0|||
30709937|NCT00549770|58723478|FG003|Overall Study|Abnormal test procedure results|2|||
30709938|NCT00549770|58723479|FG004|Overall Study|Abnormal test procedure results|0|||
30709939|NCT00549770|58723480|FG005|Overall Study|Abnormal test procedure results|1|||
30709940|NCT00549770|58723481|FG006|Overall Study|Abnormal test procedure results|1|||
30709941|NCT00549770|58723482|FG007|Overall Study|Abnormal test procedure results|1|||
30709942|NCT00549770|58723475|FG000|Overall Study|Abnormal laboratory values|0|||
30709943|NCT00549770|58723476|FG001|Overall Study|Abnormal laboratory values|0|||
30709944|NCT00549770|58723477|FG002|Overall Study|Abnormal laboratory values|0|||
30896389|NCT02065245|58929792|FG001|Infusion 1|Death|0|||
30896390|NCT02065245|58929793|FG002|Infusion 1|Death|1|||
30896391|NCT02065245|58929794|FG003|Infusion 1|Death|0|||
30896392|NCT02065245|58929795|FG004|Infusion 1|Death|1|||
30896393|NCT02065245|58929796|FG005|Infusion 1|Death|0|||
30896394|NCT02065245|58929797|FG006|Infusion 1|Death|0|||
30896395|NCT02065245|58929791|FG000|Infusion 2|Death|0|||
30896396|NCT02065245|58929792|FG001|Infusion 2|Death|0|||
30896397|NCT02065245|58929793|FG002|Infusion 2|Death|0|||
30896398|NCT02065245|58929794|FG003|Infusion 2|Death|0|||
30896399|NCT02065245|58929795|FG004|Infusion 2|Death|0|||
30896400|NCT02065245|58929796|FG005|Infusion 2|Death|0|||
30896401|NCT02065245|58929797|FG006|Infusion 2|Death|1|||
30896402|NCT02065245|58929791|FG000|Infusion 3|Lost to Follow-up|1|||
30896403|NCT02065245|58929792|FG001|Infusion 3|Lost to Follow-up|1|||
30621005|NCT01199861|58632528|FG000|Overall Study|Adverse Event|1|||
30621006|NCT01199861|58632529|FG001|Overall Study|Adverse Event|0|||
30621007|NCT01199705|58632549|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
30621008|NCT01199471|58632564|FG000|Overall Study|Protocol Violation|4|||
30621009|NCT01199471|58632564|FG000|Overall Study|Withdrawal by Subject|1|||
30621010|NCT01199471|58632564|FG000|Overall Study|Physician Decision|1|||
30621011|NCT01198145|58632571|FG000|Overall Study|Withdrawal by Subject|1|||
30621012|NCT01198145|58632572|FG001|Overall Study|Withdrawal by Subject|1|||
30621013|NCT01197911|58632582|FG000|Overall Study|Adverse Event|0|||
30621014|NCT01197911|58632583|FG001|Overall Study|Adverse Event|0|||
30621015|NCT01197911|58632584|FG002|Overall Study|Adverse Event|1|||
30621016|NCT01197755|58632596|FG000|Overall Study|Adverse Event|8|||
30621017|NCT01197755|58632597|FG001|Overall Study|Adverse Event|10|||
30709945|NCT00549770|58723478|FG003|Overall Study|Abnormal laboratory values|0|||
30709946|NCT00549770|58723479|FG004|Overall Study|Abnormal laboratory values|0|||
30709947|NCT00549770|58723480|FG005|Overall Study|Abnormal laboratory values|1|||
30709948|NCT00549770|58723481|FG006|Overall Study|Abnormal laboratory values|0|||
30709949|NCT00549770|58723482|FG007|Overall Study|Abnormal laboratory values|0|||
30709950|NCT00549770|58723475|FG000|Overall Study|Adverse Event|1|||
30709951|NCT00549770|58723476|FG001|Overall Study|Adverse Event|3|||
30709952|NCT00549770|58723477|FG002|Overall Study|Adverse Event|1|||
30709953|NCT00549770|58723478|FG003|Overall Study|Adverse Event|2|||
30709954|NCT00549770|58723479|FG004|Overall Study|Adverse Event|1|||
30709955|NCT00549770|58723480|FG005|Overall Study|Adverse Event|0|||
30709956|NCT00549770|58723481|FG006|Overall Study|Adverse Event|5|||
30709957|NCT00549770|58723482|FG007|Overall Study|Adverse Event|4|||
30709958|NCT00548184|58723500|FG000|Overall Study|Adverse Event|3|||
30709959|NCT00548184|58723500|FG000|Overall Study|took other drug|1|||
30709960|NCT00548184|58723500|FG000|Overall Study|Found Her2 negative|1|||
30709961|NCT00454636|58723508|FG000|Overall Study|Adverse Event|10|||
30709962|NCT00454636|58723509|FG001|Overall Study|Adverse Event|6|||
30709963|NCT00454636|58723510|FG002|Overall Study|Adverse Event|9|||
30709964|NCT00454636|58723511|FG003|Overall Study|Adverse Event|15|||
30709965|NCT00454636|58723508|FG000|Overall Study|Disease Progression|11|||
30621018|NCT01197755|58632598|FG002|Overall Study|Adverse Event|10|||
30709966|NCT00454636|58723509|FG001|Overall Study|Disease Progression|12|||
30896404|NCT02065245|58929793|FG002|Infusion 3|Lost to Follow-up|0|||
30896405|NCT02065245|58929794|FG003|Infusion 3|Lost to Follow-up|0|||
30896406|NCT02065245|58929795|FG004|Infusion 3|Lost to Follow-up|0|||
30896407|NCT02065245|58929796|FG005|Infusion 3|Lost to Follow-up|0|||
30896408|NCT02065245|58929797|FG006|Infusion 3|Lost to Follow-up|0|||
30896409|NCT02043015|58929813|FG000|Overall Study|Lost to Follow-up|4|||
30896410|NCT02043015|58929813|FG000|Overall Study|Withdrawal by Subject|4|||
30896411|NCT02043015|58929813|FG000|Overall Study|Removed once target enrollment reached|15|||
30896412|NCT02043015|58929813|FG000|Overall Study|Participant moved away from study city|4|||
30896413|NCT02043015|58929813|FG000|Overall Study|Incarceration|1|||
30896414|NCT02064231|58929819|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
30621019|NCT01197755|58632596|FG000|Overall Study|Study-specific discontinuation criteria|2|||
30709967|NCT00454636|58723510|FG002|Overall Study|Disease Progression|4|||
30709968|NCT00454636|58723511|FG003|Overall Study|Disease Progression|11|||
30709969|NCT00454636|58723508|FG000|Overall Study|Protocol Violation|3|||
30709970|NCT00454636|58723509|FG001|Overall Study|Protocol Violation|2|||
30709971|NCT00454636|58723510|FG002|Overall Study|Protocol Violation|3|||
30896415|NCT02064231|58929820|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
30896416|NCT02064231|58929821|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
30896417|NCT02064231|58929822|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
30896418|NCT02064231|58929819|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
30896419|NCT02064231|58929820|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
30896420|NCT02064231|58929821|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
30896421|NCT02064231|58929822|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
30896422|NCT02064231|58929819|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
30896423|NCT02064231|58929820|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
30896424|NCT02064231|58929821|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
30896425|NCT02064231|58929822|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
30896426|NCT02064231|58929819|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
30896427|NCT02064231|58929820|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
30896428|NCT02064231|58929821|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
30896429|NCT02064231|58929822|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
30896430|NCT02063217|58929837|FG000|Overall Study|Withdrawal by Subject|1|||
30896431|NCT02063217|58929838|FG001|Overall Study|Withdrawal by Subject|0|||
30896432|NCT02063217|58929839|FG002|Overall Study|Withdrawal by Subject|0|||
30896433|NCT02497001|58929851|FG000|Overall Study|Lost to Follow-up|10|||
30896434|NCT02497001|58929852|FG001|Overall Study|Lost to Follow-up|2|||
30896435|NCT02497001|58929853|FG002|Overall Study|Lost to Follow-up|0|||
30896436|NCT02497001|58929854|FG003|Overall Study|Lost to Follow-up|2|||
30896437|NCT02497001|58929851|FG000|Overall Study|Adverse Event|28|||
30896438|NCT02497001|58929852|FG001|Overall Study|Adverse Event|30|||
30896439|NCT02497001|58929853|FG002|Overall Study|Adverse Event|11|||
30896440|NCT02497001|58929854|FG003|Overall Study|Adverse Event|11|||
30896441|NCT02497001|58929851|FG000|Overall Study|Withdrawal by Subject|14|||
30896442|NCT02497001|58929852|FG001|Overall Study|Withdrawal by Subject|37|||
30896443|NCT02497001|58929853|FG002|Overall Study|Withdrawal by Subject|19|||
30896444|NCT02497001|58929854|FG003|Overall Study|Withdrawal by Subject|15|||
30896445|NCT02497001|58929851|FG000|Overall Study|Physician Decision|5|||
30896446|NCT02497001|58929852|FG001|Overall Study|Physician Decision|11|||
30896447|NCT02497001|58929853|FG002|Overall Study|Physician Decision|5|||
30896448|NCT02497001|58929854|FG003|Overall Study|Physician Decision|1|||
30896449|NCT02497001|58929851|FG000|Overall Study|subjects that were not treated|1|||
30896450|NCT02497001|58929852|FG001|Overall Study|subjects that were not treated|2|||
30896451|NCT02497001|58929853|FG002|Overall Study|subjects that were not treated|2|||
30896452|NCT02497001|58929854|FG003|Overall Study|subjects that were not treated|1|||
30896453|NCT02497001|58929851|FG000|Overall Study|Major Protocol Deviation|3|||
30896454|NCT02497001|58929852|FG001|Overall Study|Major Protocol Deviation|4|||
30896455|NCT02497001|58929853|FG002|Overall Study|Major Protocol Deviation|4|||
30896456|NCT02497001|58929854|FG003|Overall Study|Major Protocol Deviation|4|||
30896457|NCT02497001|58929851|FG000|Overall Study|Lack of Efficacy|10|||
30896458|NCT02497001|58929852|FG001|Overall Study|Lack of Efficacy|16|||
30896459|NCT02497001|58929853|FG002|Overall Study|Lack of Efficacy|6|||
30896460|NCT02497001|58929854|FG003|Overall Study|Lack of Efficacy|6|||
30896461|NCT02497001|58929851|FG000|Overall Study|Protocol Violation|3|||
30896462|NCT02497001|58929852|FG001|Overall Study|Protocol Violation|1|||
30896463|NCT02497001|58929853|FG002|Overall Study|Protocol Violation|3|||
30896464|NCT02497001|58929854|FG003|Overall Study|Protocol Violation|1|||
30896465|NCT02366143|58929870|FG000|Overall Study|Death|307|||
30896466|NCT02366143|58929871|FG001|Overall Study|Death|278|||
30896467|NCT02366143|58929872|FG002|Overall Study|Death|280|||
30896468|NCT02366143|58929870|FG000|Overall Study|Lost to Follow-up|2|||
30896469|NCT02366143|58929871|FG001|Overall Study|Lost to Follow-up|4|||
30896470|NCT02366143|58929872|FG002|Overall Study|Lost to Follow-up|2|||
30896471|NCT02366143|58929870|FG000|Overall Study|Physician Decision|1|||
30896472|NCT02366143|58929871|FG001|Overall Study|Physician Decision|2|||
30896473|NCT02366143|58929872|FG002|Overall Study|Physician Decision|1|||
30896474|NCT02366143|58929870|FG000|Overall Study|Protocol Violation|0|||
30896475|NCT02366143|58929871|FG001|Overall Study|Protocol Violation|0|||
30896476|NCT02366143|58929872|FG002|Overall Study|Protocol Violation|2|||
30896477|NCT02366143|58929870|FG000|Overall Study|Withdrawal by Subject|16|||
30896478|NCT02366143|58929871|FG001|Overall Study|Withdrawal by Subject|17|||
30896479|NCT02366143|58929872|FG002|Overall Study|Withdrawal by Subject|22|||
30896480|NCT02366143|58929870|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
30896481|NCT02366143|58929871|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
30896482|NCT02366143|58929872|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
30896483|NCT02366143|58929870|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
30896484|NCT02366143|58929871|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
30896485|NCT02366143|58929872|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
30896486|NCT02366143|58929870|FG000|Overall Study|Randomization Error|1|||
30896487|NCT02366143|58929871|FG001|Overall Study|Randomization Error|0|||
30896488|NCT02366143|58929872|FG002|Overall Study|Randomization Error|0|||
30896489|NCT02366143|58929870|FG000|Overall Study|PI Move and Site Closure|1|||
30896490|NCT02366143|58929871|FG001|Overall Study|PI Move and Site Closure|0|||
30896491|NCT02366143|58929872|FG002|Overall Study|PI Move and Site Closure|1|||
30896492|NCT02366143|58929870|FG000|Overall Study|Study Terminated By Sponsor|0|||
30896493|NCT02366143|58929871|FG001|Overall Study|Study Terminated By Sponsor|0|||
30896494|NCT02366143|58929872|FG002|Overall Study|Study Terminated By Sponsor|2|||
30896495|NCT02366143|58929870|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
30896496|NCT02366143|58929871|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
30896497|NCT02366143|58929872|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
30896498|NCT02366143|58929870|FG000|Overall Study|Patient moved to roll-over study|1|||
30896499|NCT02366143|58929871|FG001|Overall Study|Patient moved to roll-over study|19|||
30896500|NCT02366143|58929872|FG002|Overall Study|Patient moved to roll-over study|28|||
30896501|NCT02366143|58929870|FG000|Overall Study|Patient moved to commercial stock|0|||
30896502|NCT02366143|58929871|FG001|Overall Study|Patient moved to commercial stock|0|||
30896503|NCT02366143|58929872|FG002|Overall Study|Patient moved to commercial stock|1|||
30896504|NCT02366143|58929870|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
30896505|NCT02366143|58929871|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
30896506|NCT02366143|58929872|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
30896507|NCT02366143|58929870|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
30896508|NCT02366143|58929871|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
30896509|NCT02366143|58929872|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
30896510|NCT02366143|58929870|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
30896511|NCT02366143|58929871|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
30896512|NCT02366143|58929872|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
30896513|NCT02366143|58929870|FG000|Overall Study|Requester's instructions|1|||
30896514|NCT02366143|58929871|FG001|Overall Study|Requester's instructions|1|||
30896515|NCT02366143|58929872|FG002|Overall Study|Requester's instructions|1|||
30896516|NCT02366143|58929870|FG000|Overall Study|Uneligible|0|||
30896517|NCT02366143|58929871|FG001|Overall Study|Uneligible|1|||
30896518|NCT02366143|58929872|FG002|Overall Study|Uneligible|0|||
30896519|NCT02366143|58929870|FG000|Overall Study|Post Trial Migration|0|||
30896520|NCT02366143|58929871|FG001|Overall Study|Post Trial Migration|1|||
30896521|NCT02366143|58929872|FG002|Overall Study|Post Trial Migration|0|||
30896522|NCT02366143|58929870|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
30896523|NCT02366143|58929871|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
30896524|NCT02366143|58929872|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
30896525|NCT02366143|58929870|FG000|Overall Study|Patient switched to PTAP|0|||
30896526|NCT02366143|58929871|FG001|Overall Study|Patient switched to PTAP|1|||
30896527|NCT02366143|58929872|FG002|Overall Study|Patient switched to PTAP|0|||
30896528|NCT02366143|58929870|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
30896529|NCT02366143|58929871|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
30896530|NCT02366143|58929872|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
30896531|NCT02098395|58929888|FG000|Overall Study|Protocol Violation|2|||
30896532|NCT02098395|58929889|FG001|Overall Study|Protocol Violation|2|||
30896533|NCT02098395|58929890|FG002|Overall Study|Protocol Violation|0|||
30896534|NCT02098395|58929891|FG003|Overall Study|Protocol Violation|7|||
30896535|NCT02098395|58929888|FG000|Overall Study|Withdrawal by Subject|10|||
30896536|NCT02098395|58929889|FG001|Overall Study|Withdrawal by Subject|10|||
30896537|NCT02098395|58929890|FG002|Overall Study|Withdrawal by Subject|5|||
30896538|NCT02098395|58929891|FG003|Overall Study|Withdrawal by Subject|13|||
30896539|NCT02098395|58929888|FG000|Overall Study|Adverse Event|12|||
30896540|NCT02098395|58929889|FG001|Overall Study|Adverse Event|19|||
30896541|NCT02098395|58929890|FG002|Overall Study|Adverse Event|34|||
30896542|NCT02098395|58929891|FG003|Overall Study|Adverse Event|2|||
30896543|NCT02098395|58929888|FG000|Overall Study|Lost to Follow-up|2|||
30896544|NCT02098395|58929889|FG001|Overall Study|Lost to Follow-up|1|||
30896545|NCT02098395|58929890|FG002|Overall Study|Lost to Follow-up|0|||
30896546|NCT02098395|58929891|FG003|Overall Study|Lost to Follow-up|3|||
30896547|NCT02098395|58929888|FG000|Overall Study|Unclassified|0|||
30896548|NCT02098395|58929889|FG001|Overall Study|Unclassified|0|||
30896549|NCT02098395|58929890|FG002|Overall Study|Unclassified|3|||
30896550|NCT02098395|58929891|FG003|Overall Study|Unclassified|2|||
30896551|NCT02041923|58929903|FG000|Overall Study|Lost to Follow-up|26|||
30896552|NCT02041923|58929904|FG001|Overall Study|Lost to Follow-up|30|||
30896553|NCT02062437|58929912|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
30896554|NCT02062437|58929912|FG000|Overall Study|Patient not available for the 2y visit|18|||
30896555|NCT02062437|58929912|FG000|Overall Study|Death|2|||
30896556|NCT02062437|58929912|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
30896557|NCT02365519|58929918|FG000|Randomized and Treated|Adverse Event|0|||
30896558|NCT02365519|58929919|FG001|Randomized and Treated|Adverse Event|1|||
30896559|NCT02365519|58929920|FG002|Randomized and Treated|Adverse Event|0|||
30896560|NCT02365519|58929918|FG000|Randomized and Treated|Withdrawal by Subject|0|||
30896561|NCT02365519|58929919|FG001|Randomized and Treated|Withdrawal by Subject|1|||
30896562|NCT02365519|58929920|FG002|Randomized and Treated|Withdrawal by Subject|1|||
30896563|NCT02061813|58929929|FG000|Overall Study|Withdrawal by Subject|1|||
30896564|NCT02061813|58929929|FG000|Overall Study|Protocol Violation|2|||
30896565|NCT02096835|58929939|FG000|Overall Study|Withdrawal by Subject|1|||
30896566|NCT02096835|58929940|FG001|Overall Study|Withdrawal by Subject|0|||
30896567|NCT02096835|58929941|FG002|Overall Study|Withdrawal by Subject|0|||
30896568|NCT02096835|58929939|FG000|Overall Study|converted to open procedures|1|||
30896569|NCT02096835|58929940|FG001|Overall Study|converted to open procedures|0|||
30896570|NCT02096835|58929941|FG002|Overall Study|converted to open procedures|0|||
30896571|NCT02096835|58929939|FG000|Overall Study|Lost to Follow-up|1|||
30896572|NCT02096835|58929940|FG001|Overall Study|Lost to Follow-up|0|||
30896573|NCT02096835|58929941|FG002|Overall Study|Lost to Follow-up|1|||
30896574|NCT02324569|58929951|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
30896575|NCT02324569|58929952|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
30896576|NCT02324569|58929951|FG000|Overall Study|Voluntary Withdrawal|3|||
30896577|NCT02324569|58929952|FG001|Overall Study|Voluntary Withdrawal|6|||
30896578|NCT02324569|58929951|FG000|Overall Study|Lack of Efficacy|2|||
30896579|NCT02324569|58929952|FG001|Overall Study|Lack of Efficacy|3|||
30896580|NCT02324569|58929951|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
30896581|NCT02324569|58929952|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
30896582|NCT02324569|58929951|FG000|Overall Study|Inconvenient Schedule|2|||
30896583|NCT02324569|58929952|FG001|Overall Study|Inconvenient Schedule|0|||
30896584|NCT02294773|58929960|FG000|Overall Study|Withdrawal by Subject|0|||
30896585|NCT02294773|58929961|FG001|Overall Study|Withdrawal by Subject|2|||
30896586|NCT02365285|58929971|FG000|Overall Study|Physician Decision|0|||
30896587|NCT02365285|58929972|FG001|Overall Study|Physician Decision|1|||
30896588|NCT02365285|58929973|FG002|Overall Study|Physician Decision|1|||
30896589|NCT02365285|58929974|FG003|Overall Study|Physician Decision|0|||
30896590|NCT02365285|58929971|FG000|Overall Study|Adverse Event|0|||
30896591|NCT02365285|58929972|FG001|Overall Study|Adverse Event|0|||
30896592|NCT02365285|58929973|FG002|Overall Study|Adverse Event|0|||
30896593|NCT02365285|58929974|FG003|Overall Study|Adverse Event|2|||
30896594|NCT02041299|58929988|FG000|Overall Study|Adverse Event|9|||
30896595|NCT02041299|58929989|FG001|Overall Study|Adverse Event|3|||
30896596|NCT02041299|58929988|FG000|Overall Study|Lost to Follow-up|4|||
30896597|NCT02041299|58929989|FG001|Overall Study|Lost to Follow-up|1|||
30896598|NCT02041299|58929988|FG000|Overall Study|Physician Decision|1|||
30896599|NCT02041299|58929989|FG001|Overall Study|Physician Decision|1|||
30896600|NCT02041299|58929988|FG000|Overall Study|Withdrawal by Subject|13|||
30896601|NCT02041299|58929989|FG001|Overall Study|Withdrawal by Subject|7|||
30896602|NCT02041299|58929988|FG000|Overall Study|Protocol Violation|11|||
30896603|NCT02041299|58929989|FG001|Overall Study|Protocol Violation|4|||
30896604|NCT02041299|58929988|FG000|Overall Study|Termination of the study|7|||
30896605|NCT02041299|58929989|FG001|Overall Study|Termination of the study|3|||
30896606|NCT02041299|58929988|FG000|Overall Study|Required bone marrow transplant|0|||
30896607|NCT02041299|58929989|FG001|Overall Study|Required bone marrow transplant|1|||
30896608|NCT02041299|58929988|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
30896609|NCT02041299|58929989|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
30896610|NCT01645735|58930001|FG000|Overall Study|Physician Decision|2|||
30896611|NCT01645735|58930002|FG001|Overall Study|Physician Decision|0|||
30896612|NCT01645735|58930001|FG000|Overall Study|Withdrawal by Subject|1|||
30896613|NCT01645735|58930002|FG001|Overall Study|Withdrawal by Subject|0|||
30896614|NCT01645735|58930001|FG000|Overall Study|Protocol Violation|1|||
30896615|NCT01645735|58930002|FG001|Overall Study|Protocol Violation|0|||
30896616|NCT01645735|58930001|FG000|Overall Study|Adverse Event|0|||
30896617|NCT01645735|58930002|FG001|Overall Study|Adverse Event|1|||
30896618|NCT02365207|58930009|FG000|Overall Study|Withdrawal by Subject|1|||
30896619|NCT02365207|58930009|FG000|Overall Study|Physician Decision|1|||
30896620|NCT01645111|58930013|FG000|Overall Study|Did not require Clevidipine|15|||
30896621|NCT02364037|58930019|FG000|Overall Study|Withdrawal by Subject|7|||
30896622|NCT02364037|58930020|FG001|Overall Study|Withdrawal by Subject|4|||
30896623|NCT02364037|58930019|FG000|Overall Study|Lost to Follow-up|37|||
30896624|NCT02364037|58930020|FG001|Overall Study|Lost to Follow-up|49|||
30896625|NCT01919164|58930031|FG000|Overall Study|Adverse Event|6|||
30896626|NCT01919164|58930032|FG001|Overall Study|Adverse Event|4|||
30896627|NCT01919164|58930033|FG002|Overall Study|Adverse Event|9|||
30896628|NCT01919164|58930034|FG003|Overall Study|Adverse Event|3|||
30896629|NCT01919164|58930035|FG004|Overall Study|Adverse Event|2|||
30896630|NCT01919164|58930031|FG000|Overall Study|Lost to Follow-up|2|||
30896631|NCT01919164|58930032|FG001|Overall Study|Lost to Follow-up|2|||
30896632|NCT01919164|58930033|FG002|Overall Study|Lost to Follow-up|2|||
30896633|NCT01919164|58930034|FG003|Overall Study|Lost to Follow-up|0|||
30896634|NCT01919164|58930035|FG004|Overall Study|Lost to Follow-up|4|||
30896635|NCT01919164|58930031|FG000|Overall Study|Death|1|||
30896636|NCT01919164|58930032|FG001|Overall Study|Death|0|||
30896637|NCT01919164|58930033|FG002|Overall Study|Death|0|||
30896638|NCT01919164|58930034|FG003|Overall Study|Death|0|||
30896639|NCT01919164|58930035|FG004|Overall Study|Death|0|||
30896640|NCT01919164|58930031|FG000|Overall Study|Protocol Violation|6|||
30896641|NCT01919164|58930032|FG001|Overall Study|Protocol Violation|0|||
30896642|NCT01919164|58930033|FG002|Overall Study|Protocol Violation|3|||
30896643|NCT01919164|58930034|FG003|Overall Study|Protocol Violation|2|||
30896644|NCT01919164|58930035|FG004|Overall Study|Protocol Violation|2|||
30896645|NCT01919164|58930031|FG000|Overall Study|Disease progression|2|||
30896646|NCT01919164|58930032|FG001|Overall Study|Disease progression|2|||
30896647|NCT01919164|58930033|FG002|Overall Study|Disease progression|1|||
30896648|NCT01919164|58930034|FG003|Overall Study|Disease progression|2|||
30896649|NCT01919164|58930035|FG004|Overall Study|Disease progression|1|||
30896650|NCT01919164|58930031|FG000|Overall Study|Withdrew consent|13|||
30896651|NCT01919164|58930032|FG001|Overall Study|Withdrew consent|13|||
30896652|NCT01919164|58930033|FG002|Overall Study|Withdrew consent|14|||
30896653|NCT01919164|58930034|FG003|Overall Study|Withdrew consent|14|||
30896654|NCT01919164|58930035|FG004|Overall Study|Withdrew consent|9|||
30896655|NCT01919164|58930031|FG000|Overall Study|Other Un-specified|13|||
30896656|NCT01919164|58930032|FG001|Overall Study|Other Un-specified|9|||
30896657|NCT01919164|58930033|FG002|Overall Study|Other Un-specified|8|||
30896658|NCT01919164|58930034|FG003|Overall Study|Other Un-specified|7|||
30896659|NCT01919164|58930035|FG004|Overall Study|Other Un-specified|15|||
30896660|NCT01901224|58930047|FG000|Overall Study|study was not funded and terminated|2|||
30896661|NCT01901146|58930053|FG000|Neoadjuvant Phase|Death|1|||
30896662|NCT01901146|58930054|FG001|Neoadjuvant Phase|Death|2|||
30896663|NCT01901146|58930055|FG002|Neoadjuvant Phase|Death|0|||
30896664|NCT01901146|58930056|FG003|Neoadjuvant Phase|Death|0|||
30896665|NCT01901146|58930057|FG004|Neoadjuvant Phase|Death|0|||
30896666|NCT01901146|58930053|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
30896667|NCT01901146|58930054|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
30896668|NCT01901146|58930055|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
30896669|NCT01901146|58930056|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
30896670|NCT01901146|58930057|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
30896671|NCT01901146|58930053|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
30896672|NCT01901146|58930054|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
30896673|NCT01901146|58930055|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
30896674|NCT01901146|58930056|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
30896675|NCT01901146|58930057|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
30896676|NCT01901146|58930053|FG000|Neoadjuvant Phase|Physician Decision|1|||
30896677|NCT01901146|58930054|FG001|Neoadjuvant Phase|Physician Decision|2|||
30896678|NCT01901146|58930055|FG002|Neoadjuvant Phase|Physician Decision|0|||
30896679|NCT01901146|58930056|FG003|Neoadjuvant Phase|Physician Decision|0|||
30896680|NCT01901146|58930057|FG004|Neoadjuvant Phase|Physician Decision|0|||
30896681|NCT01901146|58930053|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
30896682|NCT01901146|58930054|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
30896683|NCT01901146|58930055|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
30896684|NCT01901146|58930056|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
30896685|NCT01901146|58930057|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
30896686|NCT01901146|58930053|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
30896687|NCT01901146|58930054|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
30896688|NCT01901146|58930055|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
30896689|NCT01901146|58930056|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
30896690|NCT01901146|58930057|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
30896691|NCT01901146|58930053|FG000|Adjuvant Phase|Other|0|||
30896692|NCT01901146|58930054|FG001|Adjuvant Phase|Other|0|||
30896693|NCT01901146|58930055|FG002|Adjuvant Phase|Other|1|||
30896694|NCT01901146|58930056|FG003|Adjuvant Phase|Other|0|||
30896695|NCT01901146|58930057|FG004|Adjuvant Phase|Other|0|||
30896696|NCT01901146|58930053|FG000|Adjuvant Phase|Death|0|||
30896697|NCT01901146|58930054|FG001|Adjuvant Phase|Death|0|||
30896698|NCT01901146|58930055|FG002|Adjuvant Phase|Death|0|||
30896699|NCT01901146|58930056|FG003|Adjuvant Phase|Death|0|||
30896700|NCT01901146|58930057|FG004|Adjuvant Phase|Death|3|||
30896701|NCT01901146|58930053|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
30896702|NCT01901146|58930054|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
30896703|NCT01901146|58930055|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
30896704|NCT01901146|58930056|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
30896705|NCT01901146|58930057|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
30896706|NCT01901146|58930053|FG000|Adjuvant Phase|Physician Decision|0|||
30896707|NCT01901146|58930054|FG001|Adjuvant Phase|Physician Decision|0|||
30896708|NCT01901146|58930055|FG002|Adjuvant Phase|Physician Decision|9|||
30896709|NCT01901146|58930056|FG003|Adjuvant Phase|Physician Decision|2|||
30896710|NCT01901146|58930057|FG004|Adjuvant Phase|Physician Decision|4|||
30896711|NCT01901146|58930053|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
30896712|NCT01901146|58930054|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
30896713|NCT01901146|58930055|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
30896714|NCT01901146|58930056|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
30896715|NCT01901146|58930057|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
30896716|NCT01644643|58930070|FG000|Overall Study|Death|1|||
30896717|NCT01644643|58930071|FG001|Overall Study|Death|0|||
30896718|NCT01644643|58930072|FG002|Overall Study|Death|3|||
30896719|NCT01644643|58930073|FG003|Overall Study|Death|3|||
30896720|NCT01644643|58930070|FG000|Overall Study|Lost to Follow-up|0|||
30896721|NCT01644643|58930071|FG001|Overall Study|Lost to Follow-up|0|||
30896722|NCT01644643|58930072|FG002|Overall Study|Lost to Follow-up|0|||
30896723|NCT01644643|58930073|FG003|Overall Study|Lost to Follow-up|4|||
30896724|NCT01644643|58930070|FG000|Overall Study|Withdrawal by Subject|1|||
30896725|NCT01644643|58930071|FG001|Overall Study|Withdrawal by Subject|0|||
30896726|NCT01644643|58930072|FG002|Overall Study|Withdrawal by Subject|2|||
30896727|NCT01644643|58930073|FG003|Overall Study|Withdrawal by Subject|1|||
30709972|NCT00454636|58723511|FG003|Overall Study|Protocol Violation|3|||
30709973|NCT00454636|58723508|FG000|Overall Study|Death|6|||
30709974|NCT00454636|58723509|FG001|Overall Study|Death|1|||
30709975|NCT00454636|58723510|FG002|Overall Study|Death|1|||
30896728|NCT01644643|58930070|FG000|Overall Study|Other Eligibility criteria|0|||
30896729|NCT01644643|58930071|FG001|Overall Study|Other Eligibility criteria|0|||
30896730|NCT01644643|58930072|FG002|Overall Study|Other Eligibility criteria|0|||
30896731|NCT01644643|58930073|FG003|Overall Study|Other Eligibility criteria|2|||
30896732|NCT01864564|58930091|FG000|Overall Study|Lost to Follow-up|17|||
30896733|NCT01864564|58930092|FG001|Overall Study|Lost to Follow-up|23|||
30896734|NCT01864564|58930091|FG000|Overall Study|Withdrawal by Subject|20|||
30896735|NCT01864564|58930092|FG001|Overall Study|Withdrawal by Subject|11|||
30896736|NCT01864564|58930091|FG000|Overall Study|Protocol Violation|0|||
30896737|NCT01864564|58930092|FG001|Overall Study|Protocol Violation|27|||
30896738|NCT01864564|58930091|FG000|Overall Study|not reported|0|||
30896739|NCT01864564|58930092|FG001|Overall Study|not reported|34|||
30896740|NCT01864174|58930100|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
30896741|NCT01864174|58930101|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
30896742|NCT01864174|58930100|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
30896743|NCT01864174|58930101|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
30896744|NCT01864174|58930100|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
30896745|NCT01864174|58930101|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
30709976|NCT00454636|58723511|FG003|Overall Study|Death|1|||
30896746|NCT01864174|58930100|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
30896747|NCT01864174|58930101|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
30896748|NCT01864174|58930100|FG000|Double Blind - Compliant Randomized|Death|1|||
30896749|NCT01864174|58930101|FG001|Double Blind - Compliant Randomized|Death|0|||
30896750|NCT01864174|58930100|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
30709977|NCT00454636|58723508|FG000|Overall Study|Patient refusal|1|||
30896751|NCT01864174|58930101|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
30896752|NCT01864174|58930100|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
30896753|NCT01864174|58930101|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
30896754|NCT01864174|58930100|FG000|Double Blind - Compliant Randomized|Other|6|||
30896755|NCT01864174|58930101|FG001|Double Blind - Compliant Randomized|Other|10|||
30896756|NCT01864174|58930100|FG000|Off Treatment Follow-Up|Other|2|||
30896757|NCT01864174|58930101|FG001|Off Treatment Follow-Up|Other|0|||
30896758|NCT01864174|58930100|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
30896759|NCT01864174|58930101|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
30896760|NCT01900444|58930107|FG000|Overall Study|Protocol Violation|2|||
30896761|NCT01900444|58930107|FG000|Overall Study|Lost to Follow-up|1|||
30896762|NCT02294227|58930114|FG000|Overall Study|Death|0|||
30896763|NCT02294227|58930115|FG001|Overall Study|Death|0|||
30896764|NCT02294227|58930116|FG002|Overall Study|Death|1|||
30896765|NCT02294227|58930114|FG000|Overall Study|Subject/Guardian Decision|6|||
30896766|NCT02294227|58930115|FG001|Overall Study|Subject/Guardian Decision|3|||
30896767|NCT02294227|58930116|FG002|Overall Study|Subject/Guardian Decision|7|||
30896768|NCT02294227|58930114|FG000|Overall Study|Physician Decision|1|||
30896769|NCT02294227|58930115|FG001|Overall Study|Physician Decision|2|||
30896770|NCT02294227|58930116|FG002|Overall Study|Physician Decision|1|||
30896771|NCT02294227|58930114|FG000|Overall Study|Lost to Follow-up|1|||
30896772|NCT02294227|58930115|FG001|Overall Study|Lost to Follow-up|0|||
30896773|NCT02294227|58930116|FG002|Overall Study|Lost to Follow-up|0|||
30896774|NCT02294227|58930114|FG000|Overall Study|Lack of Efficacy|11|||
30896775|NCT02294227|58930115|FG001|Overall Study|Lack of Efficacy|12|||
30896776|NCT02294227|58930116|FG002|Overall Study|Lack of Efficacy|8|||
30896777|NCT02294227|58930114|FG000|Overall Study|Adverse Event|6|||
30896778|NCT02294227|58930115|FG001|Overall Study|Adverse Event|8|||
30896779|NCT02294227|58930116|FG002|Overall Study|Adverse Event|2|||
30896780|NCT02496767|58930130|FG000|Open-label Lead-in Phase|Adverse Event|176|||
30896781|NCT02496767|58930131|FG001|Open-label Lead-in Phase|Adverse Event|0|||
30896782|NCT02496767|58930132|FG002|Open-label Lead-in Phase|Adverse Event|0|||
30896783|NCT02496767|58930133|FG003|Open-label Lead-in Phase|Adverse Event|0|||
30896784|NCT02496767|58930134|FG004|Open-label Lead-in Phase|Adverse Event|0|||
30896785|NCT02496767|58930135|FG005|Open-label Lead-in Phase|Adverse Event|0|||
30896786|NCT02496767|58930136|FG006|Open-label Lead-in Phase|Adverse Event|0|||
30896787|NCT02496767|58930137|FG007|Open-label Lead-in Phase|Adverse Event|0|||
30896788|NCT02496767|58930130|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
30896789|NCT02496767|58930131|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
30896790|NCT02496767|58930132|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
30896791|NCT02496767|58930133|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
30896792|NCT02496767|58930134|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
30896793|NCT02496767|58930135|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
30896794|NCT02496767|58930136|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
30896795|NCT02496767|58930137|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
30896796|NCT02496767|58930130|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
30896797|NCT02496767|58930131|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
30896798|NCT02496767|58930132|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
30896799|NCT02496767|58930133|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
30896800|NCT02496767|58930134|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
30896801|NCT02496767|58930135|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
30896802|NCT02496767|58930136|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
30896803|NCT02496767|58930137|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
30896804|NCT02496767|58930130|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
30896805|NCT02496767|58930131|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
30896806|NCT02496767|58930132|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
30896807|NCT02496767|58930133|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
30896808|NCT02496767|58930134|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
30896809|NCT02496767|58930135|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
30896810|NCT02496767|58930136|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
30896811|NCT02496767|58930137|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
30896812|NCT02496767|58930130|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
30709978|NCT00454636|58723509|FG001|Overall Study|Patient refusal|1|||
30896813|NCT02496767|58930131|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
30896814|NCT02496767|58930132|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
30896815|NCT02496767|58930133|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
30896816|NCT02496767|58930134|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
30896817|NCT02496767|58930135|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
30896818|NCT02496767|58930136|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
30896819|NCT02496767|58930137|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
30896820|NCT02496767|58930130|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
30709979|NCT00454636|58723510|FG002|Overall Study|Patient refusal|3|||
30896821|NCT02496767|58930131|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
30896822|NCT02496767|58930132|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
30896823|NCT02496767|58930133|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
30709980|NCT00454636|58723511|FG003|Overall Study|Patient refusal|2|||
30709981|NCT00454636|58723508|FG000|Overall Study|Lost to Follow-up|0|||
30709982|NCT00454636|58723509|FG001|Overall Study|Lost to Follow-up|1|||
30709983|NCT00454636|58723510|FG002|Overall Study|Lost to Follow-up|0|||
30709984|NCT00454636|58723511|FG003|Overall Study|Lost to Follow-up|0|||
30709985|NCT00427960|58723523|FG000|Overall Study|Adverse Event|2|||
30709986|NCT00427960|58723524|FG001|Overall Study|Adverse Event|0|||
30709987|NCT00427960|58723523|FG000|Overall Study|Withdrawal by Subject|0|||
30709988|NCT00427960|58723524|FG001|Overall Study|Withdrawal by Subject|3|||
30709989|NCT00427960|58723523|FG000|Overall Study|Other|0|||
30709990|NCT00427960|58723524|FG001|Overall Study|Other|1|||
30709991|NCT00548340|58723533|FG000|Overall Study|Protocol Violation|2|||
30709992|NCT00548340|58723534|FG001|Overall Study|Protocol Violation|3|||
30709993|NCT00548340|58723535|FG002|Overall Study|Protocol Violation|3|||
30709994|NCT00548340|58723533|FG000|Overall Study|Adverse Event|2|||
30709995|NCT00548340|58723534|FG001|Overall Study|Adverse Event|2|||
30709996|NCT00548340|58723535|FG002|Overall Study|Adverse Event|2|||
30709997|NCT00548340|58723533|FG000|Overall Study|Lost to Follow-up|1|||
30709998|NCT00548340|58723534|FG001|Overall Study|Lost to Follow-up|1|||
30709999|NCT00548340|58723535|FG002|Overall Study|Lost to Follow-up|0|||
30710000|NCT00548340|58723533|FG000|Overall Study|Withdrawal by Subject|2|||
30710001|NCT00548340|58723534|FG001|Overall Study|Withdrawal by Subject|4|||
30710002|NCT00548340|58723535|FG002|Overall Study|Withdrawal by Subject|3|||
30710003|NCT00548340|58723533|FG000|Overall Study|Other|1|||
30710004|NCT00548340|58723534|FG001|Overall Study|Other|1|||
30710005|NCT00548340|58723535|FG002|Overall Study|Other|1|||
30710006|NCT00454246|58723546|FG000|Overall Study|Adverse Event|2|||
30710007|NCT00454246|58723547|FG001|Overall Study|Adverse Event|2|||
30710008|NCT00454246|58723548|FG002|Overall Study|Adverse Event|0|||
30710009|NCT00454246|58723546|FG000|Overall Study|Violation of selection criteria at entry|6|||
30710010|NCT00454246|58723547|FG001|Overall Study|Violation of selection criteria at entry|0|||
30710011|NCT00454246|58723548|FG002|Overall Study|Violation of selection criteria at entry|0|||
30710012|NCT00454246|58723546|FG000|Overall Study|Protocol Violation|1|||
30710013|NCT00454246|58723547|FG001|Overall Study|Protocol Violation|0|||
30710014|NCT00454246|58723548|FG002|Overall Study|Protocol Violation|0|||
30710015|NCT00454246|58723546|FG000|Overall Study|Refused Treatment|1|||
30710016|NCT00454246|58723547|FG001|Overall Study|Refused Treatment|1|||
30710017|NCT00454246|58723548|FG002|Overall Study|Refused Treatment|0|||
30710018|NCT00454246|58723546|FG000|Overall Study|Failure to return|1|||
30710019|NCT00454246|58723547|FG001|Overall Study|Failure to return|0|||
30710020|NCT00454246|58723548|FG002|Overall Study|Failure to return|0|||
30710021|NCT00454246|58723546|FG000|Overall Study|Early termination of study|62|||
30710022|NCT00454246|58723547|FG001|Overall Study|Early termination of study|26|||
30710023|NCT00454246|58723548|FG002|Overall Study|Early termination of study|9|||
30710024|NCT00434590|58723558|FG000|Overall Study|Administrative problems|5|||
30710025|NCT00434590|58723559|FG001|Overall Study|Administrative problems|5|||
30710026|NCT02891837|58723567|FG000|Overall Study|Lost to Follow-up|2|||
30710027|NCT02891837|58723568|FG001|Overall Study|Lost to Follow-up|0|||
30710028|NCT02891837|58723567|FG000|Overall Study|Withdrawal by Subject|1|||
30710029|NCT02891837|58723568|FG001|Overall Study|Withdrawal by Subject|0|||
30710030|NCT00695903|58723592|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
30710031|NCT00695903|58723593|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
30710032|NCT00695903|58723592|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
30710033|NCT00695903|58723593|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
30710034|NCT00695903|58723592|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
30710035|NCT00695903|58723593|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
30710036|NCT00695903|58723592|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
30710037|NCT00695903|58723593|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
30710038|NCT00695903|58723592|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
30710039|NCT00695903|58723593|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
30710040|NCT00695903|58723592|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
30710041|NCT00695903|58723593|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
30710042|NCT00695903|58723592|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
30710043|NCT00695903|58723593|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
30710044|NCT00695903|58723592|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
30710045|NCT00695903|58723593|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
30710046|NCT00695903|58723592|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
30710047|NCT00695903|58723593|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
30710048|NCT02759861|58723599|FG000|Overall Study|Death|1|||
30896824|NCT02496767|58930134|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
30896825|NCT02496767|58930135|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
30896826|NCT02496767|58930136|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
30896827|NCT02496767|58930137|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
30896828|NCT02496767|58930130|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
30896829|NCT02496767|58930131|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
30896830|NCT02496767|58930132|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
30896831|NCT02496767|58930133|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
30896832|NCT02496767|58930134|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
30896833|NCT02496767|58930135|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
30896834|NCT02496767|58930136|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
30896835|NCT02496767|58930137|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
30896836|NCT02496767|58930130|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
30896837|NCT02496767|58930131|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
30896838|NCT02496767|58930132|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
30896839|NCT02496767|58930133|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
30896840|NCT02496767|58930134|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
30896841|NCT02496767|58930135|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
30896842|NCT02496767|58930136|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
30896843|NCT02496767|58930137|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
30896844|NCT02496767|58930130|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
30896845|NCT02496767|58930131|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
30896846|NCT02496767|58930132|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
30896847|NCT02496767|58930133|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
30896848|NCT02496767|58930134|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
30896849|NCT02496767|58930135|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
30896850|NCT02496767|58930136|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
30896851|NCT02496767|58930137|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
30896852|NCT02496767|58930130|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
30896853|NCT02496767|58930131|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
30896854|NCT02496767|58930132|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
30896855|NCT02496767|58930133|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
30896856|NCT02496767|58930134|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
30896857|NCT02496767|58930135|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
30896858|NCT02496767|58930136|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
30896859|NCT02496767|58930137|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
30896860|NCT02496767|58930130|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
30896861|NCT02496767|58930131|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
30896862|NCT02496767|58930132|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
30896863|NCT02496767|58930133|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
30896864|NCT02496767|58930134|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
30896865|NCT02496767|58930135|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
30896866|NCT02496767|58930136|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
30710049|NCT00548262|58723604|FG000|Overall Study|Death|21|||
30710050|NCT00548262|58723604|FG000|Overall Study|Adverse Event|2|||
30896867|NCT02496767|58930137|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
30896868|NCT02496767|58930130|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
30896869|NCT02496767|58930131|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
30896870|NCT02496767|58930132|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
30896871|NCT02496767|58930133|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
30896872|NCT02496767|58930134|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
30896873|NCT02496767|58930135|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
30896874|NCT02496767|58930136|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
30896875|NCT02496767|58930137|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
30896876|NCT02496767|58930130|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
30896877|NCT02496767|58930131|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
30896878|NCT02496767|58930132|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
30896879|NCT02496767|58930133|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
30896880|NCT02496767|58930134|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
30896881|NCT02496767|58930135|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
30896882|NCT02496767|58930136|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
30896883|NCT02496767|58930137|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
30896884|NCT02496767|58930130|FG000|Double-blind, Withdrawal Phase|Death|0|||
30896885|NCT02496767|58930131|FG001|Double-blind, Withdrawal Phase|Death|0|||
30896886|NCT02496767|58930132|FG002|Double-blind, Withdrawal Phase|Death|0|||
30896887|NCT02496767|58930133|FG003|Double-blind, Withdrawal Phase|Death|0|||
30896888|NCT02496767|58930134|FG004|Double-blind, Withdrawal Phase|Death|0|||
30896889|NCT02496767|58930135|FG005|Double-blind, Withdrawal Phase|Death|0|||
30896890|NCT02496767|58930136|FG006|Double-blind, Withdrawal Phase|Death|1|||
30896891|NCT02496767|58930137|FG007|Double-blind, Withdrawal Phase|Death|2|||
30896892|NCT02496767|58930130|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
30896893|NCT02496767|58930131|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
30896894|NCT02496767|58930132|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
30896895|NCT02496767|58930133|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
30896896|NCT02496767|58930134|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
30896897|NCT02496767|58930135|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
30896898|NCT02496767|58930136|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
30896899|NCT02496767|58930137|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
30896900|NCT02496533|58930153|FG000|Overall Study|Lack of data on outcome|3|||
30896901|NCT02496533|58930154|FG001|Overall Study|Lack of data on outcome|0|||
30896902|NCT02496533|58930153|FG000|Overall Study|Patient did not complete all measures|0|||
30896903|NCT02496533|58930154|FG001|Overall Study|Patient did not complete all measures|4|||
30896904|NCT02496533|58930153|FG000|Overall Study|Late for radiologic testing|0|||
30896905|NCT02496533|58930154|FG001|Overall Study|Late for radiologic testing|2|||
30896906|NCT02496221|58930160|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
30896907|NCT02496221|58930161|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
30896908|NCT02496221|58930160|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
30896909|NCT02496221|58930161|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
30896910|NCT02496221|58930160|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
30896911|NCT02496221|58930161|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
30896912|NCT02475629|58930169|FG000|Overall Study|Adverse Event|1|||
30896913|NCT02475629|58930169|FG000|Overall Study|Death|4|||
30896914|NCT02475629|58930169|FG000|Overall Study|Physician Decision|1|||
30896915|NCT02475629|58930169|FG000|Overall Study|Withdrawal by Subject|1|||
30896916|NCT02475629|58930169|FG000|Overall Study|Lost to Follow-up|1|||
30896917|NCT02475629|58930169|FG000|Overall Study|Subject non-compliance|1|||
30896918|NCT02475395|58930175|FG000|Overall Study|Protocol Violation|30|||
30896919|NCT02475395|58930176|FG001|Overall Study|Protocol Violation|3|||
30896920|NCT01653743|58930184|FG000|Overall Study|Withdrawal by Subject|1|||
30896921|NCT01653743|58930185|FG001|Overall Study|Withdrawal by Subject|0|||
30896922|NCT01653743|58930184|FG000|Overall Study|Investigator discretion|3|||
30896923|NCT01653743|58930185|FG001|Overall Study|Investigator discretion|0|||
30896924|NCT02293993|58930195|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
30896925|NCT02293993|58930196|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
30896926|NCT02293993|58930197|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
30896927|NCT02293993|58930198|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
30896928|NCT02293993|58930195|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
30896929|NCT02293993|58930196|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
30896930|NCT02293993|58930197|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
30896931|NCT02293993|58930198|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
30896932|NCT02293993|58930195|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
30896933|NCT02293993|58930196|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
30896934|NCT02293993|58930197|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
30896935|NCT02293993|58930198|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
30896936|NCT02293993|58930195|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
30896937|NCT02293993|58930196|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
30896938|NCT02293993|58930197|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
30896939|NCT02293993|58930198|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
30896940|NCT02293993|58930195|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
30896941|NCT02293993|58930196|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
30896942|NCT02293993|58930197|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
30896943|NCT02293993|58930198|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
30896944|NCT02322775|58930218|FG000|Overall Study|Adverse Event|1|||
30896945|NCT02322775|58930219|FG001|Overall Study|Adverse Event|0|||
30896946|NCT02322775|58930218|FG000|Overall Study|Lost to Follow-up|0|||
30896947|NCT02322775|58930219|FG001|Overall Study|Lost to Follow-up|1|||
30896948|NCT02322775|58930218|FG000|Overall Study|Protocol Violation|1|||
30896949|NCT02322775|58930219|FG001|Overall Study|Protocol Violation|0|||
30896950|NCT02322775|58930218|FG000|Overall Study|Withdrawal by Subject|3|||
30896951|NCT02322775|58930219|FG001|Overall Study|Withdrawal by Subject|4|||
30896952|NCT02322775|58930218|FG000|Overall Study|Not willing to perform all FU visits|0|||
30896953|NCT02322775|58930219|FG001|Overall Study|Not willing to perform all FU visits|1|||
30896954|NCT02322229|58930225|FG000|Overall Study|Physician Decision|2|||
30896955|NCT02363959|58930232|FG000|Overall Study|Medical instability|1|||
30896956|NCT02363959|58930233|FG001|Overall Study|Medical instability|0|||
30896957|NCT02362789|58930241|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
30896958|NCT02362789|58930242|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
30896959|NCT02362789|58930243|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
30896960|NCT02362789|58930241|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
30896961|NCT02362789|58930242|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
30896962|NCT02362789|58930243|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
30896963|NCT02362789|58930241|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
30896964|NCT02362789|58930242|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
30896965|NCT02362789|58930243|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
30896966|NCT02362789|58930241|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
30896967|NCT02362789|58930242|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
30896968|NCT02362789|58930243|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
30896969|NCT02362789|58930241|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
30896970|NCT02362789|58930242|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
30896971|NCT02362789|58930243|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
30896972|NCT01646827|58930252|FG000|Overall Study|Lost to Follow-up|0|||
30896973|NCT01646827|58930253|FG001|Overall Study|Lost to Follow-up|3|||
30896974|NCT01646827|58930252|FG000|Overall Study|Physician Decision|1|||
30896975|NCT01646827|58930253|FG001|Overall Study|Physician Decision|2|||
30896976|NCT01646827|58930252|FG000|Overall Study|Withdrawal by Subject|1|||
30896977|NCT01646827|58930253|FG001|Overall Study|Withdrawal by Subject|0|||
30896978|NCT02293837|58930263|FG000|Overall Study|Lost to Follow-up|0|||
30896979|NCT02293837|58930264|FG001|Overall Study|Lost to Follow-up|2|||
30896980|NCT02293837|58930265|FG002|Overall Study|Lost to Follow-up|1|||
30896981|NCT02293837|58930266|FG003|Overall Study|Lost to Follow-up|0|||
30896982|NCT02293837|58930263|FG000|Overall Study|Withdrawal by Subject|2|||
30896983|NCT02293837|58930264|FG001|Overall Study|Withdrawal by Subject|1|||
30896984|NCT02293837|58930265|FG002|Overall Study|Withdrawal by Subject|2|||
30896985|NCT02293837|58930266|FG003|Overall Study|Withdrawal by Subject|1|||
30896986|NCT02293837|58930263|FG000|Overall Study|COVID-19 Related|1|||
30896987|NCT02293837|58930264|FG001|Overall Study|COVID-19 Related|1|||
30896988|NCT02293837|58930265|FG002|Overall Study|COVID-19 Related|0|||
30896989|NCT02293837|58930266|FG003|Overall Study|COVID-19 Related|0|||
30896990|NCT02293837|58930263|FG000|Overall Study|Participant ill and could not be infused|0|||
30896991|NCT02293837|58930264|FG001|Overall Study|Participant ill and could not be infused|0|||
30896992|NCT02293837|58930265|FG002|Overall Study|Participant ill and could not be infused|1|||
30896993|NCT02293837|58930266|FG003|Overall Study|Participant ill and could not be infused|0|||
30896994|NCT02361307|58930282|FG000|Overall Study|Unstable medical condition.|0|||
30896995|NCT02361307|58930283|FG001|Overall Study|Unstable medical condition.|1|||
30896996|NCT02320903|58930292|FG000|Overall Study|Withdrawal by Subject|0|||
30896997|NCT02320903|58930293|FG001|Overall Study|Withdrawal by Subject|9|||
30896998|NCT02320903|58930294|FG002|Overall Study|Withdrawal by Subject|9|||
30896999|NCT02320903|58930292|FG000|Overall Study|Exited therapy; no longer eligible|8|||
30897000|NCT02320903|58930293|FG001|Overall Study|Exited therapy; no longer eligible|2|||
30897001|NCT02320903|58930294|FG002|Overall Study|Exited therapy; no longer eligible|2|||
30897002|NCT02320903|58930292|FG000|Overall Study|Lost to Follow-up|0|||
30897003|NCT02320903|58930293|FG001|Overall Study|Lost to Follow-up|5|||
30897004|NCT02320903|58930294|FG002|Overall Study|Lost to Follow-up|5|||
30897005|NCT02320123|58930305|FG000|Overall Study|Lost to Follow-up|4|||
30897006|NCT02320123|58930306|FG001|Overall Study|Lost to Follow-up|6|||
30897007|NCT02320123|58930305|FG000|Overall Study|Death|6|||
30897008|NCT02320123|58930306|FG001|Overall Study|Death|5|||
30897009|NCT02360995|58930319|FG000|Overall Study|Lost to Follow-up|2|||
30897010|NCT02360995|58930320|FG001|Overall Study|Lost to Follow-up|0|||
30897011|NCT02360995|58930321|FG002|Overall Study|Lost to Follow-up|2|||
30897012|NCT02360995|58930319|FG000|Overall Study|Withdrawal by Subject|0|||
30897013|NCT02360995|58930320|FG001|Overall Study|Withdrawal by Subject|1|||
30897014|NCT02360995|58930321|FG002|Overall Study|Withdrawal by Subject|0|||
30897015|NCT02360605|58930331|FG000|Overall Study|Withdrawal by Subject|4|||
30897016|NCT02360605|58930332|FG001|Overall Study|Withdrawal by Subject|9|||
30897017|NCT02360605|58930331|FG000|Overall Study|Lost to Follow-up|7|||
30897018|NCT02360605|58930332|FG001|Overall Study|Lost to Follow-up|8|||
30897019|NCT02360605|58930331|FG000|Overall Study|Death|0|||
30897020|NCT02360605|58930332|FG001|Overall Study|Death|1|||
30897021|NCT02360293|58930342|FG000|Overall Study|Lost to Follow-up|73|||
30897022|NCT02360293|58930343|FG001|Overall Study|Lost to Follow-up|95|||
30897023|NCT02360293|58930342|FG000|Overall Study|Withdrawal by Subject|2|||
30897024|NCT02360293|58930343|FG001|Overall Study|Withdrawal by Subject|1|||
30897025|NCT02360293|58930342|FG000|Overall Study|Excluded|1|||
30897026|NCT02360293|58930343|FG001|Overall Study|Excluded|0|||
30897027|NCT02359903|58930351|FG000|Overall Study|Adverse Event|0|||
30897028|NCT02359903|58930352|FG001|Overall Study|Adverse Event|2|||
30897029|NCT02291419|58930360|FG000|Overall Study|Early study termination|1|||
30897030|NCT02291419|58930361|FG001|Overall Study|Early study termination|5|||
30897031|NCT02319031|58930369|FG000|Treatment Period|Death|1|||
30897032|NCT02319031|58930370|FG001|Treatment Period|Death|0|||
30897033|NCT02318797|58930378|FG000|Overall Study|Death|3|||
30897034|NCT02318797|58930379|FG001|Overall Study|Death|6|||
30897035|NCT02318797|58930378|FG000|Overall Study|Lost to Follow-up|85|||
30897036|NCT02318797|58930379|FG001|Overall Study|Lost to Follow-up|96|||
30897037|NCT02359435|58930387|FG000|Overall Study|Lost to Follow-up|4|||
30897038|NCT02359435|58930388|FG001|Overall Study|Lost to Follow-up|4|||
30897039|NCT02318719|58930398|FG000|Double-blind Phase|Adverse Event|7|||
30897040|NCT02318719|58930399|FG001|Double-blind Phase|Adverse Event|6|||
30897041|NCT02318719|58930400|FG002|Double-blind Phase|Adverse Event|12|||
30897042|NCT02318719|58930401|FG003|Double-blind Phase|Adverse Event|4|||
30897043|NCT02318719|58930402|FG004|Double-blind Phase|Adverse Event|0|||
30897044|NCT02318719|58930398|FG000|Double-blind Phase|Lack of Efficacy|5|||
30897045|NCT02318719|58930399|FG001|Double-blind Phase|Lack of Efficacy|0|||
30897046|NCT02318719|58930400|FG002|Double-blind Phase|Lack of Efficacy|1|||
30897047|NCT02318719|58930401|FG003|Double-blind Phase|Lack of Efficacy|1|||
30897048|NCT02318719|58930402|FG004|Double-blind Phase|Lack of Efficacy|0|||
30897049|NCT02318719|58930398|FG000|Double-blind Phase|Protocol Violation|0|||
30897050|NCT02318719|58930399|FG001|Double-blind Phase|Protocol Violation|1|||
30897051|NCT02318719|58930400|FG002|Double-blind Phase|Protocol Violation|3|||
30897052|NCT02318719|58930401|FG003|Double-blind Phase|Protocol Violation|0|||
30897053|NCT02318719|58930402|FG004|Double-blind Phase|Protocol Violation|0|||
30897054|NCT02318719|58930398|FG000|Double-blind Phase|Withdrawal by Subject|25|||
30897055|NCT02318719|58930399|FG001|Double-blind Phase|Withdrawal by Subject|7|||
30897056|NCT02318719|58930400|FG002|Double-blind Phase|Withdrawal by Subject|9|||
30897057|NCT02318719|58930401|FG003|Double-blind Phase|Withdrawal by Subject|10|||
30897058|NCT02318719|58930402|FG004|Double-blind Phase|Withdrawal by Subject|0|||
30897059|NCT02318719|58930398|FG000|Double-blind Phase|Other|1|||
30897060|NCT02318719|58930399|FG001|Double-blind Phase|Other|2|||
30710051|NCT00548262|58723604|FG000|Overall Study|Lack of Efficacy|4|||
30710052|NCT00548262|58723604|FG000|Overall Study|Lost to Follow-up|1|||
30710053|NCT00548262|58723604|FG000|Overall Study|Other|3|||
30897061|NCT02318719|58930400|FG002|Double-blind Phase|Other|0|||
30897062|NCT02318719|58930401|FG003|Double-blind Phase|Other|0|||
30897063|NCT02318719|58930402|FG004|Double-blind Phase|Other|0|||
30897064|NCT02318719|58930398|FG000|Open-label Extension Phase|Adverse Event|0|||
30897065|NCT02318719|58930399|FG001|Open-label Extension Phase|Adverse Event|0|||
30897066|NCT02318719|58930400|FG002|Open-label Extension Phase|Adverse Event|0|||
30897067|NCT02318719|58930401|FG003|Open-label Extension Phase|Adverse Event|0|||
30897068|NCT02318719|58930402|FG004|Open-label Extension Phase|Adverse Event|15|||
30897069|NCT02318719|58930398|FG000|Open-label Extension Phase|Death|0|||
30897070|NCT02318719|58930399|FG001|Open-label Extension Phase|Death|0|||
30897071|NCT02318719|58930400|FG002|Open-label Extension Phase|Death|0|||
30897072|NCT02318719|58930401|FG003|Open-label Extension Phase|Death|0|||
30897073|NCT02318719|58930402|FG004|Open-label Extension Phase|Death|1|||
30897074|NCT02318719|58930398|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
30897075|NCT02318719|58930399|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
30897076|NCT02318719|58930400|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
30897077|NCT02318719|58930401|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
30897078|NCT02318719|58930402|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
30710054|NCT00548262|58723604|FG000|Overall Study|Withdrawal by Subject|1|||
30710055|NCT00095173|58723608|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
30710056|NCT00095173|58723609|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
30710057|NCT00095173|58723610|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
30710058|NCT00095173|58723611|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
30710059|NCT00095173|58723612|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
30710060|NCT00095173|58723613|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
30710061|NCT00095173|58723608|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
30710062|NCT00095173|58723609|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
30710063|NCT00095173|58723610|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
30710064|NCT00095173|58723611|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
30710065|NCT00095173|58723612|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
30710066|NCT00095173|58723613|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
30710067|NCT00095173|58723608|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
30710068|NCT00095173|58723609|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
30710069|NCT00095173|58723610|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
30710070|NCT00095173|58723611|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
30710071|NCT00095173|58723612|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
30710072|NCT00095173|58723613|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
30710073|NCT00095173|58723608|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
30710074|NCT00095173|58723609|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
30710075|NCT00095173|58723610|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
30710076|NCT00095173|58723611|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
30710077|NCT00095173|58723612|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
30710078|NCT00095173|58723613|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
30710079|NCT00095173|58723608|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
30710080|NCT00095173|58723609|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
30710081|NCT00095173|58723610|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
30710082|NCT00095173|58723611|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
30710083|NCT00095173|58723612|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
30710084|NCT00095173|58723613|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
30710085|NCT00095173|58723608|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
30710086|NCT00095173|58723609|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
30710087|NCT00095173|58723610|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
30897079|NCT02318719|58930398|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
30897080|NCT02318719|58930399|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
30897081|NCT02318719|58930400|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
30897082|NCT02318719|58930401|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
30897083|NCT02318719|58930402|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
30897084|NCT02318719|58930398|FG000|Open-label Extension Phase|Other|0|||
30710088|NCT00095173|58723611|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
30897085|NCT02318719|58930399|FG001|Open-label Extension Phase|Other|0|||
30897086|NCT02318719|58930400|FG002|Open-label Extension Phase|Other|0|||
30710089|NCT00095173|58723612|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
30897087|NCT02318719|58930401|FG003|Open-label Extension Phase|Other|0|||
30897088|NCT02318719|58930402|FG004|Open-label Extension Phase|Other|7|||
30897089|NCT01870726|58930421|FG000|Overall Study|Withdrawal of informed consent|0|||
30897090|NCT01870726|58930422|FG001|Overall Study|Withdrawal of informed consent|0|||
30897091|NCT01870726|58930423|FG002|Overall Study|Withdrawal of informed consent|0|||
30897092|NCT01870726|58930424|FG003|Overall Study|Withdrawal of informed consent|1|||
30897093|NCT01870726|58930425|FG004|Overall Study|Withdrawal of informed consent|0|||
30897094|NCT01870726|58930426|FG005|Overall Study|Withdrawal of informed consent|0|||
30897095|NCT01870726|58930427|FG006|Overall Study|Withdrawal of informed consent|0|||
30897096|NCT01870726|58930421|FG000|Overall Study|Withdrawal by Subject|0|||
30897097|NCT01870726|58930422|FG001|Overall Study|Withdrawal by Subject|1|||
30897098|NCT01870726|58930423|FG002|Overall Study|Withdrawal by Subject|0|||
30897099|NCT01870726|58930424|FG003|Overall Study|Withdrawal by Subject|0|||
30897100|NCT01870726|58930425|FG004|Overall Study|Withdrawal by Subject|0|||
30897101|NCT01870726|58930426|FG005|Overall Study|Withdrawal by Subject|0|||
30897102|NCT01870726|58930427|FG006|Overall Study|Withdrawal by Subject|0|||
30897103|NCT01870726|58930421|FG000|Overall Study|Adverse Event|0|||
30897104|NCT01870726|58930422|FG001|Overall Study|Adverse Event|0|||
30897105|NCT01870726|58930423|FG002|Overall Study|Adverse Event|0|||
30897106|NCT01870726|58930424|FG003|Overall Study|Adverse Event|0|||
30897107|NCT01870726|58930425|FG004|Overall Study|Adverse Event|1|||
30897108|NCT01870726|58930426|FG005|Overall Study|Adverse Event|1|||
30897109|NCT01870726|58930427|FG006|Overall Study|Adverse Event|0|||
30897110|NCT01870726|58930421|FG000|Overall Study|Progressive disease|5|||
30897111|NCT01870726|58930422|FG001|Overall Study|Progressive disease|5|||
30897112|NCT01870726|58930423|FG002|Overall Study|Progressive disease|4|||
30897113|NCT01870726|58930424|FG003|Overall Study|Progressive disease|5|||
30897114|NCT01870726|58930425|FG004|Overall Study|Progressive disease|6|||
30897115|NCT01870726|58930426|FG005|Overall Study|Progressive disease|4|||
30897116|NCT01870726|58930427|FG006|Overall Study|Progressive disease|10|||
30897117|NCT01900054|58930452|FG000|Overall Study|Physician Decision|1|||
30897118|NCT01900054|58930452|FG000|Overall Study|Withdrawal by Subject|1|||
30897119|NCT01612156|58930458|FG000|Overall Study|Protocol Violation|2|||
30897120|NCT01612156|58930459|FG001|Overall Study|Protocol Violation|0|||
30897121|NCT01899742|58930467|FG000|Overall Study|Adverse Event|5|||
30897122|NCT01899742|58930468|FG001|Overall Study|Adverse Event|4|||
30897123|NCT01899742|58930467|FG000|Overall Study|Lack of Efficacy|1|||
30897124|NCT01899742|58930468|FG001|Overall Study|Lack of Efficacy|5|||
30897125|NCT01899742|58930467|FG000|Overall Study|Protocol Violation|2|||
30897126|NCT01899742|58930468|FG001|Overall Study|Protocol Violation|2|||
30897127|NCT01899742|58930467|FG000|Overall Study|Withdrawal by Subject|9|||
30897128|NCT01899742|58930468|FG001|Overall Study|Withdrawal by Subject|5|||
30897129|NCT01615822|58930477|FG000|Period 1|Withdrawal by Subject|0|||
30897130|NCT01615822|58930478|FG001|Period 1|Withdrawal by Subject|1|||
30897131|NCT01615822|58930479|FG002|Period 1|Withdrawal by Subject|0|||
30897132|NCT01615822|58930477|FG000|Period 1|Adverse Event|1|||
30897133|NCT01615822|58930478|FG001|Period 1|Adverse Event|1|||
30710090|NCT00095173|58723613|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
30710091|NCT00095173|58723608|FG000|Open-Label Extension Phase (Period C)|Death|0|||
30710092|NCT00095173|58723609|FG001|Open-Label Extension Phase (Period C)|Death|0|||
30897134|NCT01615822|58930479|FG002|Period 1|Adverse Event|0|||
30897135|NCT01615822|58930477|FG000|Period 2|Lost to Follow-up|0|||
30897136|NCT01615822|58930478|FG001|Period 2|Lost to Follow-up|1|||
30897137|NCT01615822|58930479|FG002|Period 2|Lost to Follow-up|2|||
30897138|NCT01898884|58930495|FG000|Multiple Dose Period|Adverse Event|0|||
30710093|NCT00095173|58723610|FG002|Open-Label Extension Phase (Period C)|Death|0|||
30710094|NCT00095173|58723611|FG003|Open-Label Extension Phase (Period C)|Death|0|||
30710095|NCT00095173|58723612|FG004|Open-Label Extension Phase (Period C)|Death|0|||
30710096|NCT00095173|58723613|FG005|Open-Label Extension Phase (Period C)|Death|1|||
30710097|NCT00095173|58723608|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
30710098|NCT00095173|58723609|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
30710099|NCT00095173|58723610|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
30710100|NCT00095173|58723611|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
30710101|NCT00095173|58723612|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
30710102|NCT00095173|58723613|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
30710103|NCT00095173|58723608|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
30710104|NCT00095173|58723609|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
30710105|NCT00095173|58723610|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
30710106|NCT00095173|58723611|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
30710107|NCT00095173|58723612|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
30710108|NCT00095173|58723613|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
30710109|NCT00095173|58723608|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
30710110|NCT00095173|58723609|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
30710111|NCT00095173|58723610|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
30710112|NCT00095173|58723611|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
30710113|NCT00095173|58723612|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
30710114|NCT00095173|58723613|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
30710115|NCT00095173|58723608|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
30710116|NCT00095173|58723609|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
30710117|NCT00095173|58723610|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
30710118|NCT00095173|58723611|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
30710119|NCT00095173|58723612|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
30710120|NCT00095173|58723613|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
30710121|NCT00095173|58723608|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
30710122|NCT00095173|58723609|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
30710123|NCT00095173|58723610|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
30710124|NCT00095173|58723611|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
30710125|NCT00095173|58723612|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
30621020|NCT01197755|58632597|FG001|Overall Study|Study-specific discontinuation criteria|1|||
30621021|NCT01197755|58632598|FG002|Overall Study|Study-specific discontinuation criteria|0|||
30621022|NCT01197755|58632596|FG000|Overall Study|Entered the long-term extension study|18|||
30621023|NCT01197755|58632597|FG001|Overall Study|Entered the long-term extension study|21|||
30621024|NCT01197755|58632598|FG002|Overall Study|Entered the long-term extension study|35|||
30621025|NCT01197755|58632596|FG000|Overall Study|Lack of therapeutic response|0|||
30621026|NCT01197755|58632597|FG001|Overall Study|Lack of therapeutic response|7|||
30621027|NCT01197755|58632598|FG002|Overall Study|Lack of therapeutic response|4|||
30897139|NCT01898884|58930496|FG001|Multiple Dose Period|Adverse Event|0|||
30897140|NCT01898884|58930497|FG002|Multiple Dose Period|Adverse Event|0|||
30897141|NCT01898884|58930498|FG003|Multiple Dose Period|Adverse Event|0|||
30710126|NCT00095173|58723613|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
30710127|NCT00095173|58723608|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
30790892|NCT00836056|58803981|FG001|First Intervention|Adverse Event|0|||
30897142|NCT01898884|58930499|FG004|Multiple Dose Period|Adverse Event|0|||
30897143|NCT01898884|58930500|FG005|Multiple Dose Period|Adverse Event|0|||
30897144|NCT01898884|58930501|FG006|Multiple Dose Period|Adverse Event|1|||
30897145|NCT01898884|58930502|FG007|Multiple Dose Period|Adverse Event|0|||
30897146|NCT01898884|58930503|FG008|Multiple Dose Period|Adverse Event|0|||
30897147|NCT01898884|58930495|FG000|Multiple Dose Period|Randomized Not Treated|0|||
30897148|NCT01898884|58930496|FG001|Multiple Dose Period|Randomized Not Treated|0|||
30897149|NCT01898884|58930497|FG002|Multiple Dose Period|Randomized Not Treated|0|||
30897150|NCT01898884|58930498|FG003|Multiple Dose Period|Randomized Not Treated|0|||
30897151|NCT01898884|58930499|FG004|Multiple Dose Period|Randomized Not Treated|0|||
30897152|NCT01898884|58930500|FG005|Multiple Dose Period|Randomized Not Treated|0|||
30897153|NCT01898884|58930501|FG006|Multiple Dose Period|Randomized Not Treated|0|||
30897154|NCT01898884|58930502|FG007|Multiple Dose Period|Randomized Not Treated|0|||
30897155|NCT01898884|58930503|FG008|Multiple Dose Period|Randomized Not Treated|1|||
30897156|NCT01613326|58930541|FG000|Overall Study|Adverse Event|7|||
30897157|NCT01613326|58930542|FG001|Overall Study|Adverse Event|5|||
30897158|NCT01613326|58930541|FG000|Overall Study|Withdrawal by Subject|3|||
30897159|NCT01613326|58930542|FG001|Overall Study|Withdrawal by Subject|4|||
30897160|NCT01613326|58930541|FG000|Overall Study|Abnormal test procedure result(s)|2|||
30897161|NCT01613326|58930542|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30897162|NCT01613326|58930541|FG000|Overall Study|inability to use device|1|||
30897163|NCT01613326|58930542|FG001|Overall Study|inability to use device|0|||
30897164|NCT01613326|58930541|FG000|Overall Study|Lack of Efficacy|0|||
30897165|NCT01613326|58930542|FG001|Overall Study|Lack of Efficacy|1|||
30897166|NCT01613326|58930541|FG000|Overall Study|Lost to Follow-up|0|||
30897167|NCT01613326|58930542|FG001|Overall Study|Lost to Follow-up|1|||
30897168|NCT01613326|58930541|FG000|Overall Study|Administrative|0|||
30897169|NCT01613326|58930542|FG001|Overall Study|Administrative|2|||
30897170|NCT01613326|58930541|FG000|Overall Study|Protocol Violation|0|||
30897171|NCT01613326|58930542|FG001|Overall Study|Protocol Violation|1|||
30897172|NCT01613248|58930554|FG000|Overall Study|Adverse Event|0|||
30897173|NCT01613248|58930555|FG001|Overall Study|Adverse Event|0|||
30897174|NCT01613248|58930556|FG002|Overall Study|Adverse Event|0|||
30897175|NCT01613248|58930557|FG003|Overall Study|Adverse Event|1|||
30897176|NCT01613248|58930558|FG004|Overall Study|Adverse Event|0|||
30897177|NCT01613248|58930559|FG005|Overall Study|Adverse Event|0|||
30897178|NCT01613248|58930554|FG000|Overall Study|Withdrawal by Subject|3|||
30897179|NCT01613248|58930555|FG001|Overall Study|Withdrawal by Subject|2|||
30897180|NCT01613248|58930556|FG002|Overall Study|Withdrawal by Subject|2|||
30897181|NCT01613248|58930557|FG003|Overall Study|Withdrawal by Subject|5|||
30897182|NCT01613248|58930558|FG004|Overall Study|Withdrawal by Subject|0|||
30897183|NCT01613248|58930559|FG005|Overall Study|Withdrawal by Subject|1|||
30897184|NCT01613248|58930554|FG000|Overall Study|Lost to Follow-up|5|||
30897185|NCT01613248|58930555|FG001|Overall Study|Lost to Follow-up|7|||
30897186|NCT01613248|58930556|FG002|Overall Study|Lost to Follow-up|4|||
30897187|NCT01613248|58930557|FG003|Overall Study|Lost to Follow-up|8|||
30897188|NCT01613248|58930558|FG004|Overall Study|Lost to Follow-up|4|||
30897189|NCT01613248|58930559|FG005|Overall Study|Lost to Follow-up|2|||
30897190|NCT01613248|58930554|FG000|Overall Study|Study Terminated by Sponsor|4|||
30897191|NCT01613248|58930555|FG001|Overall Study|Study Terminated by Sponsor|6|||
30897192|NCT01613248|58930556|FG002|Overall Study|Study Terminated by Sponsor|8|||
30897193|NCT01613248|58930557|FG003|Overall Study|Study Terminated by Sponsor|8|||
30897194|NCT01613248|58930558|FG004|Overall Study|Study Terminated by Sponsor|9|||
30897195|NCT01613248|58930559|FG005|Overall Study|Study Terminated by Sponsor|11|||
30897196|NCT01613248|58930554|FG000|Overall Study|Physician Decision|8|||
30897197|NCT01613248|58930555|FG001|Overall Study|Physician Decision|8|||
30897198|NCT01613248|58930556|FG002|Overall Study|Physician Decision|9|||
30897199|NCT01613248|58930557|FG003|Overall Study|Physician Decision|4|||
30897200|NCT01613248|58930558|FG004|Overall Study|Physician Decision|7|||
30897201|NCT01613248|58930559|FG005|Overall Study|Physician Decision|6|||
30897202|NCT01613248|58930554|FG000|Overall Study|Lack of Qualifying Event|9|||
30897203|NCT01613248|58930555|FG001|Overall Study|Lack of Qualifying Event|11|||
30897204|NCT01613248|58930556|FG002|Overall Study|Lack of Qualifying Event|10|||
30897205|NCT01613248|58930557|FG003|Overall Study|Lack of Qualifying Event|11|||
30897206|NCT01613248|58930558|FG004|Overall Study|Lack of Qualifying Event|15|||
30897207|NCT01613248|58930559|FG005|Overall Study|Lack of Qualifying Event|18|||
30897208|NCT01613248|58930554|FG000|Overall Study|Pregnancy|0|||
30897209|NCT01613248|58930555|FG001|Overall Study|Pregnancy|0|||
30897210|NCT01613248|58930556|FG002|Overall Study|Pregnancy|0|||
30897211|NCT01613248|58930557|FG003|Overall Study|Pregnancy|1|||
30897212|NCT01613248|58930558|FG004|Overall Study|Pregnancy|0|||
30897213|NCT01613248|58930559|FG005|Overall Study|Pregnancy|0|||
30897214|NCT01898806|58930573|FG000|Overall Study|Withdrawal by Subject|2|||
30897215|NCT01898806|58930573|FG000|Overall Study|Physician Decision|1|||
30897216|NCT02291029|58930583|FG000|Overall Study|Withdrawal by Subject|0|||
30897217|NCT02291029|58930584|FG001|Overall Study|Withdrawal by Subject|0|||
30897218|NCT02291029|58930585|FG002|Overall Study|Withdrawal by Subject|1|||
30897219|NCT02291029|58930586|FG003|Overall Study|Withdrawal by Subject|0|||
30897220|NCT02291029|58930587|FG004|Overall Study|Withdrawal by Subject|0|||
30897221|NCT02291029|58930588|FG005|Overall Study|Withdrawal by Subject|0|||
30897222|NCT02291029|58930583|FG000|Overall Study|Adverse Event|0|||
30897223|NCT02291029|58930584|FG001|Overall Study|Adverse Event|1|||
30897224|NCT02291029|58930585|FG002|Overall Study|Adverse Event|0|||
30897225|NCT02291029|58930586|FG003|Overall Study|Adverse Event|0|||
30897226|NCT02291029|58930587|FG004|Overall Study|Adverse Event|0|||
30897227|NCT02291029|58930588|FG005|Overall Study|Adverse Event|0|||
30897228|NCT02290873|58930605|FG000|Overall Study|Withdrawal by Subject|0|||
30897229|NCT02290873|58930606|FG001|Overall Study|Withdrawal by Subject|1|||
30897230|NCT02290873|58930607|FG002|Overall Study|Withdrawal by Subject|1|||
30897231|NCT02290873|58930605|FG000|Overall Study|Nellcor device error|1|||
30897232|NCT02290873|58930606|FG001|Overall Study|Nellcor device error|0|||
30897233|NCT02290873|58930607|FG002|Overall Study|Nellcor device error|0|||
30897234|NCT02290873|58930605|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
30897235|NCT02290873|58930606|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
30897236|NCT02290873|58930607|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
30897237|NCT02290873|58930605|FG000|Overall Study|Protocol Violation|0|||
30897238|NCT02290873|58930606|FG001|Overall Study|Protocol Violation|0|||
30897239|NCT02290873|58930607|FG002|Overall Study|Protocol Violation|1|||
30897240|NCT02290405|58930618|FG000|Overall Study|Withdrawal by Subject|1|||
30897241|NCT02290405|58930619|FG001|Overall Study|Withdrawal by Subject|0|||
30897242|NCT02359045|58930627|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
30897243|NCT02359045|58930628|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
30897244|NCT02359045|58930627|FG000|Overall Study|Lost to Follow-up|1|||
30897245|NCT02359045|58930628|FG001|Overall Study|Lost to Follow-up|1|||
30897246|NCT02359045|58930627|FG000|Overall Study|Adverse Event|0|||
30897247|NCT02359045|58930628|FG001|Overall Study|Adverse Event|1|||
30897248|NCT02358343|58930649|FG000|Screening Intervention|Death|0|||
30897249|NCT02358343|58930650|FG001|Screening Intervention|Death|2|||
30897250|NCT02358343|58930651|FG002|Screening Intervention|Death|0|||
30897251|NCT02358343|58930652|FG003|Screening Intervention|Death|0|||
30897252|NCT02358343|58930653|FG004|Screening Intervention|Death|0|||
30897253|NCT02358343|58930649|FG000|Screening Intervention|Withdrawal by Subject|1|||
30897254|NCT02358343|58930650|FG001|Screening Intervention|Withdrawal by Subject|0|||
30710128|NCT00095173|58723609|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
30710129|NCT00095173|58723610|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
30710130|NCT00095173|58723611|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
30710131|NCT00095173|58723612|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
30710132|NCT00095173|58723613|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
30710133|NCT00095173|58723608|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
30710134|NCT00095173|58723609|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
30710135|NCT00095173|58723610|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
30710136|NCT00095173|58723611|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
30710137|NCT00095173|58723612|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
30710138|NCT00095173|58723613|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
30710139|NCT00095173|58723608|FG000|Open-Label Extension Phase (Period C)|Other|0|||
30710140|NCT00095173|58723609|FG001|Open-Label Extension Phase (Period C)|Other|0|||
30897255|NCT02358343|58930651|FG002|Screening Intervention|Withdrawal by Subject|0|||
30897256|NCT02358343|58930652|FG003|Screening Intervention|Withdrawal by Subject|0|||
30897257|NCT02358343|58930653|FG004|Screening Intervention|Withdrawal by Subject|0|||
30897258|NCT02358343|58930649|FG000|Screening Intervention|Determined Ineligible|5|||
30897259|NCT02358343|58930650|FG001|Screening Intervention|Determined Ineligible|6|||
30897260|NCT02358343|58930651|FG002|Screening Intervention|Determined Ineligible|0|||
30897261|NCT02358343|58930652|FG003|Screening Intervention|Determined Ineligible|0|||
30710141|NCT00095173|58723610|FG002|Open-Label Extension Phase (Period C)|Other|0|||
30897262|NCT02358343|58930653|FG004|Screening Intervention|Determined Ineligible|0|||
30897263|NCT02358343|58930649|FG000|Comparative Efficacy Trial / Observation|Death|0|||
30897264|NCT02358343|58930650|FG001|Comparative Efficacy Trial / Observation|Death|0|||
30897265|NCT02358343|58930651|FG002|Comparative Efficacy Trial / Observation|Death|2|||
30897266|NCT02358343|58930652|FG003|Comparative Efficacy Trial / Observation|Death|0|||
30897267|NCT02358343|58930653|FG004|Comparative Efficacy Trial / Observation|Death|0|||
30897268|NCT02358343|58930649|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
30897269|NCT02358343|58930650|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
30897270|NCT02358343|58930651|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
30897271|NCT02358343|58930652|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
30897272|NCT02358343|58930653|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
30897273|NCT02358343|58930649|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
30710142|NCT00095173|58723611|FG003|Open-Label Extension Phase (Period C)|Other|4|||
30897274|NCT02358343|58930650|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
30897275|NCT02358343|58930651|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
30897276|NCT02358343|58930652|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
30897277|NCT02358343|58930653|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
30897278|NCT02356783|58930666|FG000|Overall Study|Lost to Follow-up|1|||
30897279|NCT02356783|58930667|FG001|Overall Study|Lost to Follow-up|3|||
30897280|NCT02289469|58930675|FG000|Overall Study|Unable to match a control|6|||
30897281|NCT02289469|58930676|FG001|Overall Study|Unable to match a control|0|||
30897282|NCT02318095|58930682|FG000|Overall Study|Adverse Event|1|||
30897283|NCT02317705|58930687|FG000|Overall Study|Withdrawal by Subject|3|||
30897284|NCT02317705|58930687|FG000|Overall Study|Physician Decision|1|||
30897285|NCT02317705|58930687|FG000|Overall Study|Drug not usable|1|||
30897286|NCT02474069|58930691|FG000|Selection Phase (SP)|Adverse Event|8|||
30710143|NCT00095173|58723612|FG004|Open-Label Extension Phase (Period C)|Other|6|||
30710144|NCT00095173|58723613|FG005|Open-Label Extension Phase (Period C)|Other|8|||
30710145|NCT00690443|58723629|FG000|Overall Study|Adverse Event|1|||
30710146|NCT00690443|58723630|FG001|Overall Study|Adverse Event|2|||
30897287|NCT02474069|58930692|FG001|Selection Phase (SP)|Adverse Event|0|||
30897288|NCT02474069|58930693|FG002|Selection Phase (SP)|Adverse Event|0|||
30897289|NCT02474069|58930691|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
30897290|NCT02474069|58930692|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
30897291|NCT02474069|58930693|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
30897292|NCT02474069|58930691|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
30897293|NCT02474069|58930692|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
30897294|NCT02474069|58930693|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
30897295|NCT02474069|58930691|FG000|Selection Phase (SP)|Physician Decision|1|||
30897296|NCT02474069|58930692|FG001|Selection Phase (SP)|Physician Decision|0|||
30897297|NCT02474069|58930693|FG002|Selection Phase (SP)|Physician Decision|0|||
30897298|NCT02474069|58930691|FG000|Selection Phase (SP)|Protocol Violation|1|||
30897299|NCT02474069|58930692|FG001|Selection Phase (SP)|Protocol Violation|0|||
30897300|NCT02474069|58930693|FG002|Selection Phase (SP)|Protocol Violation|0|||
30897301|NCT02474069|58930691|FG000|Selection Phase (SP)|No longer requires treatment|1|||
30897302|NCT02474069|58930692|FG001|Selection Phase (SP)|No longer requires treatment|0|||
30897303|NCT02474069|58930693|FG002|Selection Phase (SP)|No longer requires treatment|0|||
30897304|NCT02474069|58930691|FG000|Selection Phase (SP)|Technical Problem|1|||
30897305|NCT02474069|58930692|FG001|Selection Phase (SP)|Technical Problem|0|||
30897306|NCT02474069|58930693|FG002|Selection Phase (SP)|Technical Problem|0|||
30897307|NCT02474069|58930691|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
30897308|NCT02474069|58930692|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
30897309|NCT02474069|58930693|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
30897310|NCT02474069|58930691|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
30897311|NCT02474069|58930692|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
30897312|NCT02474069|58930693|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
30897313|NCT02474069|58930691|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
30710147|NCT03954834|58723640|FG000|Overall Study|Adverse Event|1|||
30710148|NCT03954834|58723641|FG001|Overall Study|Adverse Event|3|||
30710149|NCT03954834|58723642|FG002|Overall Study|Adverse Event|1|||
30897314|NCT02474069|58930692|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
30897315|NCT02474069|58930693|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
30897316|NCT02474069|58930691|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
30897317|NCT02474069|58930692|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
30897318|NCT02474069|58930693|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
30897319|NCT02474069|58930691|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
30897320|NCT02474069|58930692|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
30897321|NCT02474069|58930693|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
30897322|NCT02474069|58930691|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
30897323|NCT02474069|58930692|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
30897324|NCT02474069|58930693|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
30710150|NCT03954834|58723643|FG003|Overall Study|Adverse Event|1|||
30710151|NCT03954834|58723640|FG000|Overall Study|Death|0|||
30710152|NCT03954834|58723641|FG001|Overall Study|Death|0|||
30710153|NCT03954834|58723642|FG002|Overall Study|Death|0|||
30710154|NCT03954834|58723643|FG003|Overall Study|Death|1|||
30710155|NCT03954834|58723640|FG000|Overall Study|Physician Decision|0|||
30710156|NCT03954834|58723641|FG001|Overall Study|Physician Decision|1|||
30710157|NCT03954834|58723642|FG002|Overall Study|Physician Decision|0|||
30710158|NCT03954834|58723643|FG003|Overall Study|Physician Decision|2|||
30710159|NCT03954834|58723640|FG000|Overall Study|Protocol Violation|1|||
30710160|NCT03954834|58723641|FG001|Overall Study|Protocol Violation|0|||
30710161|NCT03954834|58723642|FG002|Overall Study|Protocol Violation|0|||
30710162|NCT03954834|58723643|FG003|Overall Study|Protocol Violation|1|||
30710163|NCT03954834|58723640|FG000|Overall Study|Withdrawal by Subject|2|||
30710164|NCT03954834|58723641|FG001|Overall Study|Withdrawal by Subject|3|||
30710165|NCT03954834|58723642|FG002|Overall Study|Withdrawal by Subject|13|||
30710166|NCT03954834|58723643|FG003|Overall Study|Withdrawal by Subject|6|||
30710167|NCT03954834|58723640|FG000|Overall Study|Participant left the country|0|||
30710168|NCT03954834|58723641|FG001|Overall Study|Participant left the country|0|||
30710169|NCT03954834|58723642|FG002|Overall Study|Participant left the country|1|||
30710170|NCT03954834|58723643|FG003|Overall Study|Participant left the country|0|||
30710171|NCT03954834|58723640|FG000|Overall Study|Lost to Follow-up|3|||
30710172|NCT03954834|58723641|FG001|Overall Study|Lost to Follow-up|2|||
30710173|NCT03954834|58723642|FG002|Overall Study|Lost to Follow-up|3|||
30710174|NCT03954834|58723643|FG003|Overall Study|Lost to Follow-up|5|||
30710175|NCT00693017|58723655|FG000|Overall Study|Sponsor Decision|2|||
30710176|NCT00693017|58723656|FG001|Overall Study|Sponsor Decision|1|||
30710177|NCT00693017|58723655|FG000|Overall Study|Death|0|||
30710178|NCT00693017|58723656|FG001|Overall Study|Death|1|||
30710179|NCT00692237|58723664|FG000|Overall Study|Withdrawal by Subject|1|||
30710180|NCT00692237|58723665|FG001|Overall Study|Withdrawal by Subject|3|||
30710181|NCT00692237|58723664|FG000|Overall Study|Adverse Event|0|||
30710182|NCT00692237|58723665|FG001|Overall Study|Adverse Event|1|||
30710183|NCT00110149|58723671|FG000|Overall Study|Physician Decision|3|||
30710184|NCT03954444|58723679|FG000|Overall Study|Withdrawal by Subject|5|||
30710185|NCT03954444|58723680|FG001|Overall Study|Withdrawal by Subject|5|||
30710186|NCT03954444|58723681|FG002|Overall Study|Withdrawal by Subject|5|||
30710187|NCT03954444|58723679|FG000|Overall Study|Adverse Event|1|||
30710188|NCT03954444|58723680|FG001|Overall Study|Adverse Event|3|||
30710189|NCT03954444|58723681|FG002|Overall Study|Adverse Event|2|||
30710190|NCT03954444|58723679|FG000|Overall Study|Protocol Violation|0|||
30710191|NCT03954444|58723680|FG001|Overall Study|Protocol Violation|3|||
30897325|NCT02317627|58930706|FG000|Overall Study|Withdrawal by Subject|0|||
30897326|NCT02317627|58930707|FG001|Overall Study|Withdrawal by Subject|1|||
30710192|NCT03954444|58723681|FG002|Overall Study|Protocol Violation|5|||
30710193|NCT03954444|58723679|FG000|Overall Study|Use of prohibited therapy|1|||
30710194|NCT03954444|58723680|FG001|Overall Study|Use of prohibited therapy|1|||
30710195|NCT03954444|58723681|FG002|Overall Study|Use of prohibited therapy|2|||
30710196|NCT03954444|58723679|FG000|Overall Study|Lost to Follow-up|1|||
30710197|NCT03954444|58723680|FG001|Overall Study|Lost to Follow-up|0|||
30710198|NCT03954444|58723681|FG002|Overall Study|Lost to Follow-up|1|||
30710199|NCT03954444|58723679|FG000|Overall Study|Non-compliant with study drug application|2|||
30897327|NCT02317627|58930708|FG002|Overall Study|Withdrawal by Subject|1|||
30897328|NCT02317627|58930706|FG000|Overall Study|Lost to Follow-up|2|||
30897329|NCT02317627|58930707|FG001|Overall Study|Lost to Follow-up|0|||
30897330|NCT02317627|58930708|FG002|Overall Study|Lost to Follow-up|0|||
30897331|NCT02317627|58930706|FG000|Overall Study|Stopped by Investigator|0|||
30897332|NCT02317627|58930707|FG001|Overall Study|Stopped by Investigator|1|||
30897333|NCT02317627|58930708|FG002|Overall Study|Stopped by Investigator|0|||
30897334|NCT02317627|58930706|FG000|Overall Study|Adverse Event|0|||
30897335|NCT02317627|58930707|FG001|Overall Study|Adverse Event|2|||
30897336|NCT02317627|58930708|FG002|Overall Study|Adverse Event|3|||
30897337|NCT02317627|58930706|FG000|Overall Study|Non-compliance with study drug|0|||
30897338|NCT02317627|58930707|FG001|Overall Study|Non-compliance with study drug|1|||
30897339|NCT02317627|58930708|FG002|Overall Study|Non-compliance with study drug|0|||
30897340|NCT02517905|58930724|FG000|Overall Study|Lost to Follow-up|4|||
30897341|NCT02517905|58930725|FG001|Overall Study|Lost to Follow-up|0|||
30897342|NCT02517905|58930724|FG000|Overall Study|Withdrawal by Subject|4|||
30897343|NCT02517905|58930725|FG001|Overall Study|Withdrawal by Subject|0|||
30897344|NCT02517905|58930724|FG000|Overall Study|Screen failure|2|||
30897345|NCT02517905|58930725|FG001|Overall Study|Screen failure|2|||
30897346|NCT02473913|58930733|FG000|Overall Study|Lost to Follow-up|3|||
30897347|NCT02473913|58930734|FG001|Overall Study|Lost to Follow-up|3|||
30897348|NCT02316847|58930742|FG000|Overall Study|Adverse Event|0|||
30897349|NCT02316847|58930743|FG001|Overall Study|Adverse Event|3|||
30897350|NCT02316847|58930742|FG000|Overall Study|Lost to Follow-up|0|||
30897351|NCT02316847|58930743|FG001|Overall Study|Lost to Follow-up|2|||
30897352|NCT02316847|58930742|FG000|Overall Study|Physician Decision|0|||
30897353|NCT02316847|58930743|FG001|Overall Study|Physician Decision|1|||
30897354|NCT02316847|58930742|FG000|Overall Study|Pregnancy|0|||
30897355|NCT02316847|58930743|FG001|Overall Study|Pregnancy|1|||
30897356|NCT02316847|58930742|FG000|Overall Study|Withdrawal by Subject|2|||
30897357|NCT02316847|58930743|FG001|Overall Study|Withdrawal by Subject|9|||
30897358|NCT02316847|58930742|FG000|Overall Study|Noncompliance with study drug|0|||
30897359|NCT02316847|58930743|FG001|Overall Study|Noncompliance with study drug|3|||
30897360|NCT02316847|58930742|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
30897361|NCT02316847|58930743|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
30897362|NCT02473523|58930751|FG000|Overall Study|Death|1|||
30897363|NCT02473523|58930751|FG000|Overall Study|Lost to Follow-up|1|||
30897364|NCT02316769|58930757|FG000|Overall Study|Physician Decision|1|||
30897365|NCT02316769|58930758|FG001|Overall Study|Physician Decision|0|||
30897366|NCT02316769|58930757|FG000|Overall Study|Withdrawal by Subject|1|||
30897367|NCT02316769|58930758|FG001|Overall Study|Withdrawal by Subject|0|||
30790893|NCT03200912|58803988|FG000|Overall Study|Adverse Event|3|||
30897368|NCT02473445|58930764|FG000|Overall Study|Withdrawal by Subject|2|||
30897369|NCT02473445|58930764|FG000|Overall Study|Sponsor Decision|20|||
30897370|NCT02473367|58930768|FG000|Wait 1|Withdrawal by Subject|1|||
30897371|NCT02473367|58930768|FG000|Period 4|Lost to Follow-up|1|||
30897372|NCT02316613|58930778|FG000|Overall Study|Death|63|||
30897373|NCT02316613|58930778|FG000|Overall Study|Lost to Follow-up|9|||
30897374|NCT02316613|58930778|FG000|Overall Study|Lymphoma transformation|2|||
30897375|NCT02316613|58930778|FG000|Overall Study|Participant moved/changed medical team|11|||
30897376|NCT02316613|58930778|FG000|Overall Study|No data and duplicate cases|5|||
30897377|NCT02316613|58930778|FG000|Overall Study|Did not met selection criteria|14|||
30897378|NCT02492165|58930797|FG000|Overall Study|Withdrawal by Subject|0|||
30897379|NCT02492165|58930798|FG001|Overall Study|Withdrawal by Subject|1|||
30897380|NCT02492165|58930799|FG002|Overall Study|Withdrawal by Subject|0|||
30897381|NCT02492165|58930800|FG003|Overall Study|Withdrawal by Subject|0|||
30897382|NCT02355691|58930812|FG000|Overall Study|Loss of Research Personnel|7|||
30897383|NCT02355691|58930813|FG001|Overall Study|Loss of Research Personnel|9|||
30897384|NCT02473289|58930821|FG000|Overall Study|Adverse Event|2|||
30897385|NCT02473289|58930822|FG001|Overall Study|Adverse Event|3|||
30897386|NCT02473289|58930821|FG000|Overall Study|Lost to Follow-up|1|||
30897387|NCT02473289|58930822|FG001|Overall Study|Lost to Follow-up|1|||
30897388|NCT02473289|58930821|FG000|Overall Study|Protocol Violation|0|||
30897389|NCT02473289|58930822|FG001|Overall Study|Protocol Violation|1|||
30897390|NCT02473289|58930821|FG000|Overall Study|Withdrawal of consent|6|||
30897391|NCT02473289|58930822|FG001|Overall Study|Withdrawal of consent|7|||
30897392|NCT02473289|58930821|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
30710200|NCT03954444|58723680|FG001|Overall Study|Non-compliant with study drug application|2|||
30710201|NCT03954444|58723681|FG002|Overall Study|Non-compliant with study drug application|0|||
30710202|NCT03954444|58723679|FG000|Overall Study|Administrative reasons|0|||
30710203|NCT03954444|58723680|FG001|Overall Study|Administrative reasons|0|||
30710204|NCT03954444|58723681|FG002|Overall Study|Administrative reasons|1|||
30710205|NCT03954444|58723679|FG000|Overall Study|Miscellaneous|3|||
30710206|NCT03954444|58723680|FG001|Overall Study|Miscellaneous|2|||
30710207|NCT03954444|58723681|FG002|Overall Study|Miscellaneous|1|||
30710208|NCT03953820|58723689|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
30710209|NCT03953820|58723690|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
30710210|NCT03953820|58723691|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
30710211|NCT03953820|58723689|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
30710212|NCT03953820|58723690|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
30710213|NCT03953820|58723691|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
30710214|NCT00117949|58723708|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
30710215|NCT00117949|58723709|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
30710216|NCT00117949|58723710|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
30710217|NCT00117949|58723711|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
30710218|NCT00117949|58723708|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
30710219|NCT00117949|58723709|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
30710220|NCT00117949|58723710|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
30710221|NCT00117949|58723711|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
30710222|NCT00117949|58723708|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
30710223|NCT00117949|58723709|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
30710224|NCT00117949|58723710|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
30710225|NCT00117949|58723711|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
30710226|NCT00117949|58723708|FG000|Overall Study|PSA increase >=10ng/mL|0|||
30710227|NCT00117949|58723709|FG001|Overall Study|PSA increase >=10ng/mL|1|||
30710228|NCT00117949|58723710|FG002|Overall Study|PSA increase >=10ng/mL|1|||
30710229|NCT00117949|58723711|FG003|Overall Study|PSA increase >=10ng/mL|0|||
30710230|NCT00117949|58723708|FG000|Overall Study|PSA reduction <=50%|0|||
30710231|NCT00117949|58723709|FG001|Overall Study|PSA reduction <=50%|2|||
30710232|NCT00117949|58723710|FG002|Overall Study|PSA reduction <=50%|2|||
30710233|NCT00117949|58723711|FG003|Overall Study|PSA reduction <=50%|4|||
30710234|NCT00117949|58723708|FG000|Overall Study|Hepatic abnormalities|0|||
30710235|NCT00117949|58723709|FG001|Overall Study|Hepatic abnormalities|1|||
30710236|NCT00117949|58723710|FG002|Overall Study|Hepatic abnormalities|0|||
30710237|NCT00117949|58723711|FG003|Overall Study|Hepatic abnormalities|1|||
30710238|NCT02611037|58723721|FG000|Overall Study|Withdrawal prior to treatment|2|||
30710239|NCT02611037|58723722|FG001|Overall Study|Withdrawal prior to treatment|0|||
30710240|NCT00117793|58723727|FG000|Overall Study|Withdrawal by Subject|12|||
30710241|NCT00695669|58723736|FG000|Overall Study|Adverse Event|0|||
30710242|NCT00695669|58723737|FG001|Overall Study|Adverse Event|0|||
30710243|NCT00695669|58723738|FG002|Overall Study|Adverse Event|2|||
30710244|NCT00695669|58723739|FG003|Overall Study|Adverse Event|0|||
30710245|NCT00695669|58723736|FG000|Overall Study|Lost to Follow-up|4|||
30710246|NCT00695669|58723737|FG001|Overall Study|Lost to Follow-up|4|||
30710247|NCT00695669|58723738|FG002|Overall Study|Lost to Follow-up|1|||
30710248|NCT00695669|58723739|FG003|Overall Study|Lost to Follow-up|4|||
30710249|NCT03671369|58723752|FG000|Overall Study|Other|1|||
30710250|NCT03671369|58723752|FG000|Overall Study|Withdrawal by Subject|289|||
30710251|NCT03671369|58723752|FG000|Overall Study|Not willing to be vaccinated|1|||
30897393|NCT02473289|58930822|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
30897394|NCT02473289|58930821|FG000|Overall Study|Other|2|||
30897395|NCT02473289|58930822|FG001|Overall Study|Other|0|||
30897396|NCT02354599|58930834|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
30897397|NCT02354599|58930835|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
30897398|NCT02354599|58930836|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
30897399|NCT02354599|58930837|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
30897400|NCT02354599|58930838|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
30897401|NCT02354599|58930839|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
30897402|NCT02354599|58930834|FG000|Overall Study|Withdrawal by Subject|1|||
30897403|NCT02354599|58930835|FG001|Overall Study|Withdrawal by Subject|1|||
30897404|NCT02354599|58930836|FG002|Overall Study|Withdrawal by Subject|0|||
30897405|NCT02354599|58930837|FG003|Overall Study|Withdrawal by Subject|0|||
30897406|NCT02354599|58930838|FG004|Overall Study|Withdrawal by Subject|0|||
30897407|NCT02354599|58930839|FG005|Overall Study|Withdrawal by Subject|0|||
30897408|NCT02316223|58930862|FG000|Overall Study|Lack of Efficacy|0|||
30897409|NCT02316223|58930863|FG001|Overall Study|Lack of Efficacy|1|||
30897410|NCT02316223|58930864|FG002|Overall Study|Lack of Efficacy|1|||
30897411|NCT02316223|58930862|FG000|Overall Study|Lost to Follow-up|27|||
30897412|NCT02316223|58930863|FG001|Overall Study|Lost to Follow-up|34|||
30897413|NCT02316223|58930864|FG002|Overall Study|Lost to Follow-up|36|||
30897414|NCT02316223|58930862|FG000|Overall Study|COPD Diagnosis|3|||
30897415|NCT02316223|58930863|FG001|Overall Study|COPD Diagnosis|2|||
30897416|NCT02316223|58930864|FG002|Overall Study|COPD Diagnosis|3|||
30897417|NCT02316223|58930862|FG000|Overall Study|Reside outside study area|1|||
30897418|NCT02316223|58930863|FG001|Overall Study|Reside outside study area|1|||
30897419|NCT02316223|58930864|FG002|Overall Study|Reside outside study area|1|||
30897420|NCT02316223|58930862|FG000|Overall Study|No asthma|2|||
30897421|NCT02316223|58930863|FG001|Overall Study|No asthma|0|||
30897422|NCT02316223|58930864|FG002|Overall Study|No asthma|0|||
30897423|NCT02316223|58930862|FG000|Overall Study|Discontinued by PI|11|||
30897424|NCT02316223|58930863|FG001|Overall Study|Discontinued by PI|19|||
30897425|NCT02316223|58930864|FG002|Overall Study|Discontinued by PI|3|||
30897426|NCT02286895|58930874|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
30897427|NCT02286895|58930875|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
30897428|NCT02286895|58930874|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
30897429|NCT02286895|58930875|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
30897430|NCT02286895|58930874|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
30897431|NCT02286895|58930875|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
30897432|NCT02472977|58930884|FG000|Overall Study|Disease progression|4|||
30897433|NCT02472977|58930885|FG001|Overall Study|Disease progression|25|||
30897434|NCT02472977|58930886|FG002|Overall Study|Disease progression|6|||
30897435|NCT02472977|58930884|FG000|Overall Study|Withdrawal by Subject|0|||
30897436|NCT02472977|58930885|FG001|Overall Study|Withdrawal by Subject|1|||
30897437|NCT02472977|58930886|FG002|Overall Study|Withdrawal by Subject|0|||
30897438|NCT02472977|58930884|FG000|Overall Study|Study drug toxicity|2|||
30897439|NCT02472977|58930885|FG001|Overall Study|Study drug toxicity|0|||
30897440|NCT02472977|58930886|FG002|Overall Study|Study drug toxicity|2|||
30897441|NCT02472977|58930884|FG000|Overall Study|Subject request to discontinue treatment|0|||
30897442|NCT02472977|58930885|FG001|Overall Study|Subject request to discontinue treatment|1|||
30897443|NCT02472977|58930886|FG002|Overall Study|Subject request to discontinue treatment|0|||
30897444|NCT02060487|58930897|FG000|Overall Study|Other|1|||
30897445|NCT02060487|58930898|FG001|Overall Study|Other|2|||
30897446|NCT02060487|58930899|FG002|Overall Study|Other|1|||
30897447|NCT02060487|58930897|FG000|Overall Study|Lack of Efficacy|0|||
30897448|NCT02060487|58930898|FG001|Overall Study|Lack of Efficacy|1|||
30897449|NCT02060487|58930899|FG002|Overall Study|Lack of Efficacy|0|||
30897450|NCT02060487|58930897|FG000|Overall Study|Withdrawal by Subject|3|||
30897451|NCT02060487|58930898|FG001|Overall Study|Withdrawal by Subject|10|||
30897452|NCT02060487|58930899|FG002|Overall Study|Withdrawal by Subject|4|||
30897453|NCT02060487|58930897|FG000|Overall Study|Study Terminated By Sponsor|87|||
30897454|NCT02060487|58930898|FG001|Overall Study|Study Terminated By Sponsor|89|||
30897455|NCT02060487|58930899|FG002|Overall Study|Study Terminated By Sponsor|100|||
30897456|NCT02060487|58930897|FG000|Overall Study|Randomized in error|1|||
30897457|NCT02060487|58930898|FG001|Overall Study|Randomized in error|0|||
30897458|NCT02060487|58930899|FG002|Overall Study|Randomized in error|0|||
30897459|NCT02060487|58930897|FG000|Overall Study|Protocol Violation|0|||
30897460|NCT02060487|58930898|FG001|Overall Study|Protocol Violation|1|||
30897461|NCT02060487|58930899|FG002|Overall Study|Protocol Violation|1|||
30897462|NCT02060487|58930897|FG000|Overall Study|Lost to Follow-up|3|||
30897463|NCT02060487|58930898|FG001|Overall Study|Lost to Follow-up|0|||
30897464|NCT02060487|58930899|FG002|Overall Study|Lost to Follow-up|2|||
30897465|NCT02060487|58930897|FG000|Overall Study|Death|34|||
30897466|NCT02060487|58930898|FG001|Overall Study|Death|25|||
30897467|NCT02060487|58930899|FG002|Overall Study|Death|19|||
30897468|NCT02060487|58930897|FG000|Overall Study|Adverse Event|0|||
30897469|NCT02060487|58930898|FG001|Overall Study|Adverse Event|0|||
30897470|NCT02060487|58930899|FG002|Overall Study|Adverse Event|1|||
30897471|NCT02059395|58930909|FG000|Overall Study|Lost to Follow-up|2|||
30897472|NCT02059395|58930910|FG001|Overall Study|Lost to Follow-up|4|||
30897473|NCT02059239|58930918|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
30897474|NCT02059239|58930919|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
30897475|NCT02059239|58930918|FG000|Overall Study|Physician Decision|1|||
30897476|NCT02059239|58930919|FG001|Overall Study|Physician Decision|0|||
30897477|NCT02059161|58930928|FG000|Overall Study|Pregnancy|0|||
30897478|NCT02059161|58930929|FG001|Overall Study|Pregnancy|2|||
30897479|NCT02059161|58930928|FG000|Overall Study|Adverse Event|2|||
30897480|NCT02059161|58930929|FG001|Overall Study|Adverse Event|6|||
30897481|NCT02059161|58930928|FG000|Overall Study|Lost to Follow-up|20|||
30897482|NCT02059161|58930929|FG001|Overall Study|Lost to Follow-up|12|||
30897483|NCT02059161|58930928|FG000|Overall Study|Physician Decision|4|||
30897484|NCT02059161|58930929|FG001|Overall Study|Physician Decision|4|||
30897485|NCT02059161|58930928|FG000|Overall Study|Protocol Violation|1|||
30897486|NCT02059161|58930929|FG001|Overall Study|Protocol Violation|1|||
30897487|NCT02059161|58930928|FG000|Overall Study|Withdrawal by Subject|16|||
30897488|NCT02059161|58930929|FG001|Overall Study|Withdrawal by Subject|13|||
30897489|NCT02059161|58930928|FG000|Overall Study|Randomized in error, no study drug|0|||
30897490|NCT02059161|58930929|FG001|Overall Study|Randomized in error, no study drug|1|||
30897491|NCT02059161|58930928|FG000|Overall Study|Non-compliance with study drug|6|||
30897492|NCT02059161|58930929|FG001|Overall Study|Non-compliance with study drug|2|||
30897493|NCT01897714|58930941|FG000|Phase I (Dose Escalation)|Disease progression|3|||
30897494|NCT01897714|58930942|FG001|Phase I (Dose Escalation)|Disease progression|5|||
30897495|NCT01897714|58930943|FG002|Phase I (Dose Escalation)|Disease progression|1|||
30897496|NCT01897714|58930944|FG003|Phase I (Dose Escalation)|Disease progression|3|||
30897497|NCT01897714|58930945|FG004|Phase I (Dose Escalation)|Disease progression|0|||
30897498|NCT01897714|58930946|FG005|Phase I (Dose Escalation)|Disease progression|0|||
30897499|NCT01897714|58930941|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
30897500|NCT01897714|58930942|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
30897501|NCT01897714|58930943|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
30897502|NCT01897714|58930944|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
30897503|NCT01897714|58930945|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
30897504|NCT01897714|58930946|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
30897505|NCT01897714|58930941|FG000|Phase I (Dose Escalation)|Other|0|||
30897506|NCT01897714|58930942|FG001|Phase I (Dose Escalation)|Other|1|||
30897507|NCT01897714|58930943|FG002|Phase I (Dose Escalation)|Other|0|||
30897508|NCT01897714|58930944|FG003|Phase I (Dose Escalation)|Other|0|||
30897509|NCT01897714|58930945|FG004|Phase I (Dose Escalation)|Other|0|||
30897510|NCT01897714|58930946|FG005|Phase I (Dose Escalation)|Other|0|||
30897511|NCT01897714|58930941|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
30897512|NCT01897714|58930942|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
30897513|NCT01897714|58930943|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
30897514|NCT01897714|58930944|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
30897515|NCT01897714|58930945|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
30897516|NCT01897714|58930946|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
30897517|NCT01897714|58930941|FG000|Phase II (MTD)|Lost to Follow-up|0|||
30897518|NCT01897714|58930942|FG001|Phase II (MTD)|Lost to Follow-up|0|||
30897519|NCT01897714|58930943|FG002|Phase II (MTD)|Lost to Follow-up|0|||
30897520|NCT01897714|58930944|FG003|Phase II (MTD)|Lost to Follow-up|0|||
30897521|NCT01897714|58930945|FG004|Phase II (MTD)|Lost to Follow-up|1|||
30897522|NCT01897714|58930946|FG005|Phase II (MTD)|Lost to Follow-up|0|||
30897523|NCT01897714|58930941|FG000|Phase II (MTD)|Death|0|||
30897524|NCT01897714|58930942|FG001|Phase II (MTD)|Death|0|||
30897525|NCT01897714|58930943|FG002|Phase II (MTD)|Death|0|||
30897526|NCT01897714|58930944|FG003|Phase II (MTD)|Death|0|||
30897527|NCT01897714|58930945|FG004|Phase II (MTD)|Death|25|||
30897528|NCT01897714|58930946|FG005|Phase II (MTD)|Death|10|||
30897529|NCT01897714|58930941|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
30897530|NCT01897714|58930942|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
30897531|NCT01897714|58930943|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
30897532|NCT01897714|58930944|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
30897533|NCT01897714|58930945|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
30897534|NCT01897714|58930946|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
30897535|NCT01897714|58930941|FG000|Phase II (MTD)|Other|0|||
30897536|NCT01897714|58930942|FG001|Phase II (MTD)|Other|0|||
30897537|NCT01897714|58930943|FG002|Phase II (MTD)|Other|0|||
30897538|NCT01897714|58930944|FG003|Phase II (MTD)|Other|0|||
30897539|NCT01897714|58930945|FG004|Phase II (MTD)|Other|3|||
30897540|NCT01897714|58930946|FG005|Phase II (MTD)|Other|0|||
30897541|NCT01861522|58930964|FG000|Overall Study|Adverse Event|1|||
30897542|NCT01861522|58930965|FG001|Overall Study|Adverse Event|0|||
30897543|NCT01861522|58930964|FG000|Overall Study|Withdrawal by Subject|2|||
30897544|NCT01861522|58930965|FG001|Overall Study|Withdrawal by Subject|0|||
30897545|NCT01860976|58930973|FG000|Blinded Treatment|Adverse Event|1|||
30897546|NCT01860976|58930974|FG001|Blinded Treatment|Adverse Event|3|||
30897547|NCT01860976|58930973|FG000|Blinded Treatment|Lack of Efficacy|5|||
30897548|NCT01860976|58930974|FG001|Blinded Treatment|Lack of Efficacy|12|||
30897549|NCT01860976|58930973|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
30897550|NCT01860976|58930974|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
30897551|NCT01860976|58930973|FG000|Blinded Treatment|Withdrawal by Subject|3|||
30897552|NCT01860976|58930974|FG001|Blinded Treatment|Withdrawal by Subject|5|||
30897553|NCT01860976|58930973|FG000|Blinded Treatment|Subject no longer met criteria|1|||
30897554|NCT01860976|58930974|FG001|Blinded Treatment|Subject no longer met criteria|0|||
30897555|NCT01860976|58930973|FG000|Blinded Treatment|Entered Open-Label in error|0|||
30897556|NCT01860976|58930974|FG001|Blinded Treatment|Entered Open-Label in error|1|||
30897557|NCT01860976|58930973|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
30897558|NCT01860976|58930974|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
30897559|NCT01860976|58930973|FG000|Open-Label|Adverse Event|2|||
30897560|NCT01860976|58930974|FG001|Open-Label|Adverse Event|4|||
30897561|NCT01860976|58930973|FG000|Open-Label|Lack of Efficacy|16|||
30897562|NCT01860976|58930974|FG001|Open-Label|Lack of Efficacy|8|||
30897563|NCT01860976|58930973|FG000|Open-Label|Lost to Follow-up|1|||
30897564|NCT01860976|58930974|FG001|Open-Label|Lost to Follow-up|2|||
30897565|NCT01860976|58930973|FG000|Open-Label|Subject request discontinue treatment|4|||
30897566|NCT01860976|58930974|FG001|Open-Label|Subject request discontinue treatment|3|||
30897567|NCT01860976|58930973|FG000|Open-Label|Withdrawal by Subject|4|||
30897568|NCT01860976|58930974|FG001|Open-Label|Withdrawal by Subject|1|||
30897569|NCT01860976|58930973|FG000|Open-Label|Other Reasons|1|||
30897570|NCT01860976|58930974|FG001|Open-Label|Other Reasons|1|||
30897571|NCT01860976|58930973|FG000|Long Term Extension|Adverse Event|4|||
30897572|NCT01860976|58930974|FG001|Long Term Extension|Adverse Event|0|||
30897573|NCT01860976|58930973|FG000|Long Term Extension|Lack of Efficacy|2|||
30897574|NCT01860976|58930974|FG001|Long Term Extension|Lack of Efficacy|0|||
30897575|NCT01860976|58930973|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
30897576|NCT01860976|58930974|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
30897577|NCT01860976|58930973|FG000|Long Term Extension|Lost to Follow-up|2|||
30897578|NCT01860976|58930974|FG001|Long Term Extension|Lost to Follow-up|0|||
30897579|NCT01860976|58930973|FG000|Long Term Extension|subject withdrew consent|7|||
30897580|NCT01860976|58930974|FG001|Long Term Extension|subject withdrew consent|0|||
30897581|NCT01860040|58930985|FG000|Overall Study|Withdrawal by Subject|1|||
30897582|NCT01860040|58930986|FG001|Overall Study|Withdrawal by Subject|0|||
30897583|NCT01896934|58930991|FG000|Overall Study|Adverse Event|1|||
30897584|NCT01896934|58930991|FG000|Overall Study|Withdrawal by Subject|1|||
30897585|NCT02039505|58930998|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
30897586|NCT02039505|58930999|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
30897587|NCT02039505|58931000|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
30897588|NCT02039505|58931001|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
30897589|NCT02039505|58931002|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
30897590|NCT02039505|58931003|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
30897591|NCT02039505|58931004|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
30897592|NCT02039505|58930998|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
30897593|NCT02039505|58930999|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
30897594|NCT02039505|58931000|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
30897595|NCT02039505|58931001|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
30897596|NCT02039505|58931002|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
30897597|NCT02039505|58931003|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
30897598|NCT02039505|58931004|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
30897599|NCT02039505|58930998|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
30897600|NCT02039505|58930999|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
30897601|NCT02039505|58931000|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
30897602|NCT02039505|58931001|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
30897603|NCT02039505|58931002|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
30897604|NCT02039505|58931003|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
30710252|NCT00692003|58723758|FG000|Overall Study|Sponsor Decision|5|||
30710253|NCT00692003|58723759|FG001|Overall Study|Sponsor Decision|1|||
30710254|NCT00434512|58723771|FG000|Overall Study|Migrated/moved from study area|0|||
30710255|NCT00434512|58723772|FG001|Overall Study|Migrated/moved from study area|0|||
30710256|NCT00434512|58723773|FG002|Overall Study|Migrated/moved from study area|0|||
30710257|NCT00434512|58723774|FG003|Overall Study|Migrated/moved from study area|1|||
30710258|NCT00434512|58723775|FG004|Overall Study|Migrated/moved from study area|1|||
30710259|NCT00434512|58723776|FG005|Overall Study|Migrated/moved from study area|1|||
30710260|NCT00434512|58723771|FG000|Overall Study|Other|0|||
30710261|NCT00434512|58723772|FG001|Overall Study|Other|1|||
30710262|NCT00434512|58723773|FG002|Overall Study|Other|0|||
30710263|NCT00434512|58723774|FG003|Overall Study|Other|0|||
30710264|NCT00434512|58723775|FG004|Overall Study|Other|0|||
30710265|NCT00434512|58723776|FG005|Overall Study|Other|0|||
30710266|NCT00427648|58723796|FG000|Overall Study|Protocol Violation|1|||
30710267|NCT00427648|58723797|FG001|Overall Study|Protocol Violation|2|||
30710268|NCT00427648|58723796|FG000|Overall Study|Adverse Event|0|||
30710269|NCT00427648|58723797|FG001|Overall Study|Adverse Event|1|||
30710270|NCT00416884|58723805|FG000|Overall Study|Study terminated due to low accrual|1|||
30710271|NCT00434122|58723811|FG000|Overall Study|Non-compliance with protocol|0|||
30710272|NCT00434122|58723812|FG001|Overall Study|Non-compliance with protocol|1|||
30710273|NCT00434122|58723811|FG000|Overall Study|loss of subject contact|1|||
30710274|NCT00434122|58723812|FG001|Overall Study|loss of subject contact|1|||
30710275|NCT00434122|58723811|FG000|Overall Study|Personal reasons|1|||
30710276|NCT00434122|58723812|FG001|Overall Study|Personal reasons|1|||
30710277|NCT00434122|58723811|FG000|Overall Study|Large follicle size|2|||
30710278|NCT00434122|58723812|FG001|Overall Study|Large follicle size|2|||
30710279|NCT00434122|58723811|FG000|Overall Study|Low follicular response.|1|||
30710280|NCT00434122|58723812|FG001|Overall Study|Low follicular response.|2|||
30710281|NCT00434122|58723811|FG000|Overall Study|Travelling of subject.|1|||
30710282|NCT00434122|58723812|FG001|Overall Study|Travelling of subject.|0|||
30710283|NCT00555620|58723826|FG000|Overall Study|Death|0|||
30710284|NCT00555620|58723827|FG001|Overall Study|Death|1|||
30710285|NCT00555620|58723828|FG002|Overall Study|Death|0|||
30710286|NCT00555620|58723829|FG003|Overall Study|Death|0|||
30710287|NCT00555620|58723830|FG004|Overall Study|Death|0|||
30897605|NCT02039505|58931004|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
30710288|NCT00555620|58723831|FG005|Overall Study|Death|1|||
30710289|NCT00555620|58723826|FG000|Overall Study|Study terminated by sponsor|0|||
30710290|NCT00555620|58723827|FG001|Overall Study|Study terminated by sponsor|0|||
30710291|NCT00555620|58723828|FG002|Overall Study|Study terminated by sponsor|1|||
30710292|NCT00555620|58723829|FG003|Overall Study|Study terminated by sponsor|0|||
30710293|NCT00555620|58723830|FG004|Overall Study|Study terminated by sponsor|0|||
30710294|NCT00555620|58723831|FG005|Overall Study|Study terminated by sponsor|0|||
30710295|NCT00555620|58723826|FG000|Overall Study|Adverse Event|0|||
30897606|NCT02039505|58930998|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
30897607|NCT02039505|58930999|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
30897608|NCT02039505|58931000|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
30897609|NCT02039505|58931001|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
30897610|NCT02039505|58931002|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
30897611|NCT02039505|58931003|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
30897612|NCT02039505|58931004|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
30897613|NCT02039505|58930998|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
30897614|NCT02039505|58930999|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
30897615|NCT02039505|58931000|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
30897616|NCT02039505|58931001|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
30897617|NCT02039505|58931002|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
30897618|NCT02039505|58931003|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
30897619|NCT02039505|58931004|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
30897620|NCT02039505|58930998|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
30897621|NCT02039505|58930999|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
30897622|NCT02039505|58931000|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
30897623|NCT02039505|58931001|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
30897624|NCT02039505|58931002|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
30897625|NCT02039505|58931003|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
30897626|NCT02039505|58931004|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
30897627|NCT02039505|58930998|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
30897628|NCT02039505|58930999|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
30897629|NCT02039505|58931000|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
30897630|NCT02039505|58931001|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
30897631|NCT02039505|58931002|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
30897632|NCT02039505|58931003|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
30897633|NCT02039505|58931004|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
30897634|NCT02039505|58930998|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
30897635|NCT02039505|58930999|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
30897636|NCT02039505|58931000|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
30897637|NCT02039505|58931001|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
30897638|NCT02039505|58931002|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
30897639|NCT02039505|58931003|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
30897640|NCT02039505|58931004|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
30897641|NCT02039505|58930998|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
30897642|NCT02039505|58930999|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
30897643|NCT02039505|58931000|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
30897644|NCT02039505|58931001|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
30897645|NCT02039505|58931002|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
30897646|NCT02039505|58931003|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
30897647|NCT02039505|58931004|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
30897648|NCT02039505|58930998|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
30897649|NCT02039505|58930999|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
30897650|NCT02039505|58931000|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
30897651|NCT02039505|58931001|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
30897652|NCT02039505|58931002|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
30897653|NCT02039505|58931003|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
30897654|NCT02039505|58931004|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
30897655|NCT02039505|58930998|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
30897656|NCT02039505|58930999|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
30897657|NCT02039505|58931000|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
30897658|NCT02039505|58931001|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
30897659|NCT02039505|58931002|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
30897660|NCT02039505|58931003|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
30897661|NCT02039505|58931004|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
30897662|NCT02095197|58931026|FG000|Overall Study|Lost to Follow-up|0|||
30897663|NCT02095197|58931027|FG001|Overall Study|Lost to Follow-up|3|||
30897664|NCT02039427|58931037|FG000|Overall Study|Duration of surgery > 3h|1|||
30897665|NCT02039427|58931038|FG001|Overall Study|Duration of surgery > 3h|1|||
30897666|NCT02039427|58931039|FG002|Overall Study|Duration of surgery > 3h|0|||
30897667|NCT02039427|58931040|FG003|Overall Study|Duration of surgery > 3h|0|||
30897668|NCT02039427|58931037|FG000|Overall Study|Withdrawal on concent|0|||
30897669|NCT02039427|58931038|FG001|Overall Study|Withdrawal on concent|0|||
30897670|NCT02039427|58931039|FG002|Overall Study|Withdrawal on concent|0|||
30897671|NCT02039427|58931040|FG003|Overall Study|Withdrawal on concent|1|||
30897672|NCT02039427|58931037|FG000|Overall Study|Cancellation of surgery|0|||
30897673|NCT02039427|58931038|FG001|Overall Study|Cancellation of surgery|0|||
30897674|NCT02039427|58931039|FG002|Overall Study|Cancellation of surgery|1|||
30897675|NCT02039427|58931040|FG003|Overall Study|Cancellation of surgery|0|||
30897676|NCT02039427|58931037|FG000|Overall Study|Loss of follow - up|1|||
30897677|NCT02039427|58931038|FG001|Overall Study|Loss of follow - up|0|||
30897678|NCT02039427|58931039|FG002|Overall Study|Loss of follow - up|2|||
30897679|NCT02039427|58931040|FG003|Overall Study|Loss of follow - up|4|||
30897680|NCT02039427|58931037|FG000|Overall Study|Steroid Use|1|||
30897681|NCT02039427|58931038|FG001|Overall Study|Steroid Use|0|||
30897682|NCT02039427|58931039|FG002|Overall Study|Steroid Use|0|||
30897683|NCT02039427|58931040|FG003|Overall Study|Steroid Use|0|||
30897684|NCT02094885|58931056|FG000|Overall Study|Death|1|||
30897685|NCT02094885|58931057|FG001|Overall Study|Death|5|||
30897686|NCT02094885|58931056|FG000|Overall Study|Withdrawn due to age|1|||
30897687|NCT02094885|58931057|FG001|Overall Study|Withdrawn due to age|0|||
30897688|NCT01896856|58931069|FG000|Overall Study|Transportation issues / Non-compliance|0|||
30897689|NCT01896856|58931070|FG001|Overall Study|Transportation issues / Non-compliance|0|||
30897690|NCT01896856|58931071|FG002|Overall Study|Transportation issues / Non-compliance|1|||
30897691|NCT01896856|58931072|FG003|Overall Study|Transportation issues / Non-compliance|0|||
30897692|NCT01896856|58931073|FG004|Overall Study|Transportation issues / Non-compliance|0|||
30897693|NCT01896856|58931074|FG005|Overall Study|Transportation issues / Non-compliance|0|||
30897694|NCT02038959|58931091|FG000|Overall Study|Withdrawal by Subject|6|||
30897695|NCT02038959|58931092|FG001|Overall Study|Withdrawal by Subject|8|||
30897696|NCT01896700|58931100|FG000|Overall Study|Adverse Event|4|||
30897697|NCT01896700|58931101|FG001|Overall Study|Adverse Event|5|||
30897698|NCT01896700|58931100|FG000|Overall Study|Withdrawal by Subject|0|||
30897699|NCT01896700|58931101|FG001|Overall Study|Withdrawal by Subject|1|||
30897700|NCT02352493|58931125|FG000|Overall Study|Pregnancy|0|||
30897701|NCT02352493|58931126|FG001|Overall Study|Pregnancy|0|||
30897702|NCT02352493|58931127|FG002|Overall Study|Pregnancy|0|||
30897703|NCT02352493|58931128|FG003|Overall Study|Pregnancy|0|||
30897704|NCT02352493|58931129|FG004|Overall Study|Pregnancy|0|||
30897705|NCT02352493|58931130|FG005|Overall Study|Pregnancy|0|||
30897706|NCT02352493|58931131|FG006|Overall Study|Pregnancy|1|||
30897707|NCT02352493|58931132|FG007|Overall Study|Pregnancy|0|||
30897708|NCT02352493|58931133|FG008|Overall Study|Pregnancy|1|||
30897709|NCT02352493|58931134|FG009|Overall Study|Pregnancy|0|||
30897710|NCT02352493|58931135|FG010|Overall Study|Pregnancy|0|||
30897711|NCT02352493|58931136|FG011|Overall Study|Pregnancy|0|||
30897712|NCT02352493|58931137|FG012|Overall Study|Pregnancy|0|||
30897713|NCT02352493|58931138|FG013|Overall Study|Pregnancy|0|||
30897714|NCT02352493|58931139|FG014|Overall Study|Pregnancy|0|||
30897715|NCT02352493|58931140|FG015|Overall Study|Pregnancy|0|||
30897716|NCT02352493|58931141|FG016|Overall Study|Pregnancy|0|||
30897717|NCT02352493|58931142|FG017|Overall Study|Pregnancy|0|||
30897718|NCT02352493|58931125|FG000|Overall Study|Withdrawal by Subject|0|||
30897719|NCT02352493|58931126|FG001|Overall Study|Withdrawal by Subject|0|||
30897720|NCT02352493|58931127|FG002|Overall Study|Withdrawal by Subject|0|||
30897721|NCT02352493|58931128|FG003|Overall Study|Withdrawal by Subject|0|||
30897722|NCT02352493|58931129|FG004|Overall Study|Withdrawal by Subject|0|||
30897723|NCT02352493|58931130|FG005|Overall Study|Withdrawal by Subject|0|||
30897724|NCT02352493|58931131|FG006|Overall Study|Withdrawal by Subject|0|||
30897725|NCT02352493|58931132|FG007|Overall Study|Withdrawal by Subject|0|||
30897726|NCT02352493|58931133|FG008|Overall Study|Withdrawal by Subject|1|||
30897727|NCT02352493|58931134|FG009|Overall Study|Withdrawal by Subject|0|||
30897728|NCT02352493|58931135|FG010|Overall Study|Withdrawal by Subject|0|||
30897729|NCT02352493|58931136|FG011|Overall Study|Withdrawal by Subject|0|||
30897730|NCT02352493|58931137|FG012|Overall Study|Withdrawal by Subject|0|||
30897731|NCT02352493|58931138|FG013|Overall Study|Withdrawal by Subject|0|||
30897732|NCT02352493|58931139|FG014|Overall Study|Withdrawal by Subject|1|||
30897733|NCT02352493|58931140|FG015|Overall Study|Withdrawal by Subject|0|||
30897734|NCT02352493|58931141|FG016|Overall Study|Withdrawal by Subject|0|||
30897735|NCT02352493|58931142|FG017|Overall Study|Withdrawal by Subject|0|||
30897736|NCT02352493|58931125|FG000|Overall Study|Lost to Follow-up|0|||
30897737|NCT02352493|58931126|FG001|Overall Study|Lost to Follow-up|0|||
30897738|NCT02352493|58931127|FG002|Overall Study|Lost to Follow-up|0|||
30897739|NCT02352493|58931128|FG003|Overall Study|Lost to Follow-up|0|||
30897740|NCT02352493|58931129|FG004|Overall Study|Lost to Follow-up|0|||
30897741|NCT02352493|58931130|FG005|Overall Study|Lost to Follow-up|0|||
30897742|NCT02352493|58931131|FG006|Overall Study|Lost to Follow-up|0|||
30897743|NCT02352493|58931132|FG007|Overall Study|Lost to Follow-up|0|||
30897744|NCT02352493|58931133|FG008|Overall Study|Lost to Follow-up|0|||
30897745|NCT02352493|58931134|FG009|Overall Study|Lost to Follow-up|1|||
30897746|NCT02352493|58931135|FG010|Overall Study|Lost to Follow-up|0|||
30897747|NCT02352493|58931136|FG011|Overall Study|Lost to Follow-up|0|||
30897748|NCT02352493|58931137|FG012|Overall Study|Lost to Follow-up|1|||
30897749|NCT02352493|58931138|FG013|Overall Study|Lost to Follow-up|2|||
30897750|NCT02352493|58931139|FG014|Overall Study|Lost to Follow-up|0|||
30897751|NCT02352493|58931140|FG015|Overall Study|Lost to Follow-up|0|||
30897752|NCT02352493|58931141|FG016|Overall Study|Lost to Follow-up|0|||
30897753|NCT02352493|58931142|FG017|Overall Study|Lost to Follow-up|0|||
30897754|NCT02286193|58931197|FG000|Overall Study|Referred: CRS unable to make contact|62|||
30897755|NCT02286193|58931197|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
30897756|NCT02286193|58931197|FG000|Overall Study|Referred: Declined service|38|||
30897757|NCT01896232|58931204|FG000|Overall Study|Death|6|||
30897758|NCT01896232|58931205|FG001|Overall Study|Death|10|||
30897759|NCT01896232|58931204|FG000|Overall Study|Withdrawal by Subject|32|||
30897760|NCT01896232|58931205|FG001|Overall Study|Withdrawal by Subject|31|||
30897761|NCT01896232|58931204|FG000|Overall Study|Sponsor Decision|2|||
30897762|NCT01896232|58931205|FG001|Overall Study|Sponsor Decision|0|||
30897763|NCT01896232|58931204|FG000|Overall Study|Lost to Follow-up|9|||
30897764|NCT01896232|58931205|FG001|Overall Study|Lost to Follow-up|12|||
30897765|NCT02460224|58931240|FG000|Overall Study|Adverse Event|0|||
30897766|NCT02460224|58931241|FG001|Overall Study|Adverse Event|0|||
30897767|NCT02460224|58931242|FG002|Overall Study|Adverse Event|0|||
30897768|NCT02460224|58931243|FG003|Overall Study|Adverse Event|0|||
30897769|NCT02460224|58931244|FG004|Overall Study|Adverse Event|0|||
30897770|NCT02460224|58931245|FG005|Overall Study|Adverse Event|0|||
30897771|NCT02460224|58931246|FG006|Overall Study|Adverse Event|1|||
30710296|NCT00555620|58723827|FG001|Overall Study|Adverse Event|0|||
30710297|NCT00555620|58723828|FG002|Overall Study|Adverse Event|1|||
30710298|NCT00555620|58723829|FG003|Overall Study|Adverse Event|5|||
30710299|NCT00555620|58723830|FG004|Overall Study|Adverse Event|0|||
30897772|NCT02460224|58931247|FG007|Overall Study|Adverse Event|0|||
30897773|NCT02460224|58931248|FG008|Overall Study|Adverse Event|0|||
30897774|NCT02460224|58931249|FG009|Overall Study|Adverse Event|0|||
30897775|NCT02460224|58931250|FG010|Overall Study|Adverse Event|0|||
30710300|NCT00555620|58723831|FG005|Overall Study|Adverse Event|1|||
30897776|NCT02460224|58931251|FG011|Overall Study|Adverse Event|0|||
30897777|NCT02460224|58931252|FG012|Overall Study|Adverse Event|1|||
30897778|NCT02460224|58931253|FG013|Overall Study|Adverse Event|0|||
30897779|NCT02460224|58931254|FG014|Overall Study|Adverse Event|0|||
30897780|NCT02460224|58931255|FG015|Overall Study|Adverse Event|0|||
30897781|NCT02460224|58931256|FG016|Overall Study|Adverse Event|1|||
30897782|NCT02460224|58931257|FG017|Overall Study|Adverse Event|0|||
30897783|NCT02460224|58931258|FG018|Overall Study|Adverse Event|1|||
30897784|NCT02460224|58931259|FG019|Overall Study|Adverse Event|0|||
30897785|NCT02460224|58931260|FG020|Overall Study|Adverse Event|1|||
30897786|NCT02460224|58931261|FG021|Overall Study|Adverse Event|1|||
30710301|NCT00555620|58723826|FG000|Overall Study|Objective progression or relapse|6|||
30710302|NCT00555620|58723827|FG001|Overall Study|Objective progression or relapse|5|||
30710303|NCT00555620|58723828|FG002|Overall Study|Objective progression or relapse|12|||
30710304|NCT00555620|58723829|FG003|Overall Study|Objective progression or relapse|17|||
30710305|NCT00555620|58723830|FG004|Overall Study|Objective progression or relapse|3|||
30710306|NCT00555620|58723831|FG005|Overall Study|Objective progression or relapse|16|||
30710307|NCT00555620|58723826|FG000|Overall Study|Participant refused treatment|0|||
30710308|NCT00555620|58723827|FG001|Overall Study|Participant refused treatment|1|||
30710309|NCT00555620|58723828|FG002|Overall Study|Participant refused treatment|1|||
30710310|NCT00555620|58723829|FG003|Overall Study|Participant refused treatment|0|||
30710311|NCT00555620|58723830|FG004|Overall Study|Participant refused treatment|0|||
30710312|NCT00555620|58723831|FG005|Overall Study|Participant refused treatment|1|||
30710313|NCT00555620|58723826|FG000|Overall Study|Other|0|||
30710314|NCT00555620|58723827|FG001|Overall Study|Other|0|||
30710315|NCT00555620|58723828|FG002|Overall Study|Other|0|||
30710316|NCT00555620|58723829|FG003|Overall Study|Other|1|||
30710317|NCT00555620|58723830|FG004|Overall Study|Other|0|||
30710318|NCT00555620|58723831|FG005|Overall Study|Other|3|||
30710319|NCT00433966|58723851|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
30710320|NCT00433966|58723852|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
30710321|NCT00433966|58723853|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
30710322|NCT00433966|58723854|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
30710323|NCT00433966|58723851|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
30710324|NCT00433966|58723852|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
30710325|NCT00433966|58723853|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
30710326|NCT00433966|58723854|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
30710327|NCT00433966|58723851|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
30710328|NCT00433966|58723852|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
30710329|NCT00433966|58723853|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
30710330|NCT00433966|58723854|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
30710331|NCT00433966|58723851|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
30710332|NCT00433966|58723852|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
30710333|NCT00433966|58723853|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
30710334|NCT00433966|58723854|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
30710335|NCT00433966|58723851|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
30710336|NCT00433966|58723852|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
30710337|NCT00433966|58723853|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
30710338|NCT00433966|58723854|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
30710339|NCT03952650|58723871|FG000|Overall Study|TRAVEL|0|||
30710340|NCT03952650|58723872|FG001|Overall Study|TRAVEL|4|||
30710341|NCT03952650|58723873|FG002|Overall Study|TRAVEL|0|||
30897787|NCT02460224|58931262|FG022|Overall Study|Adverse Event|1|||
30897788|NCT02460224|58931263|FG023|Overall Study|Adverse Event|0|||
30897789|NCT02460224|58931264|FG024|Overall Study|Adverse Event|0|||
30897790|NCT02460224|58931265|FG025|Overall Study|Adverse Event|0|||
30897791|NCT02460224|58931266|FG026|Overall Study|Adverse Event|11|||
30897792|NCT02460224|58931267|FG027|Overall Study|Adverse Event|1|||
30621028|NCT01197755|58632596|FG000|Overall Study|Severe non-compliance to the protocol|2|||
30621029|NCT01197755|58632597|FG001|Overall Study|Severe non-compliance to the protocol|1|||
30621030|NCT01197755|58632598|FG002|Overall Study|Severe non-compliance to the protocol|2|||
30621031|NCT01197755|58632596|FG000|Overall Study|Withdrawal by Subject|1|||
30621032|NCT01197755|58632597|FG001|Overall Study|Withdrawal by Subject|0|||
30621033|NCT01197755|58632598|FG002|Overall Study|Withdrawal by Subject|0|||
30621034|NCT01197755|58632596|FG000|Overall Study|Lost to Follow-up|0|||
30621035|NCT01197755|58632597|FG001|Overall Study|Lost to Follow-up|0|||
30621036|NCT01197755|58632598|FG002|Overall Study|Lost to Follow-up|1|||
30621037|NCT01197755|58632596|FG000|Overall Study|eg, change in circumstances|7|||
30710342|NCT03952650|58723874|FG003|Overall Study|TRAVEL|4|||
30710343|NCT03952650|58723875|FG004|Overall Study|TRAVEL|0|||
30710344|NCT03952650|58723876|FG005|Overall Study|TRAVEL|3|||
30710345|NCT03952650|58723877|FG006|Overall Study|TRAVEL|2|||
30621038|NCT01197755|58632597|FG001|Overall Study|eg, change in circumstances|3|||
30710346|NCT03952650|58723871|FG000|Overall Study|Withdrawal by Subject|0|||
30897793|NCT02460224|58931268|FG028|Overall Study|Adverse Event|6|||
30897794|NCT02460224|58931240|FG000|Overall Study|Death|0|||
30621039|NCT01197755|58632598|FG002|Overall Study|eg, change in circumstances|2|||
30621040|NCT01179048|58632610|FG000|Overall Study|Withdrawn - does not allow contact|4|||
30897795|NCT02460224|58931241|FG001|Overall Study|Death|0|||
30897796|NCT02460224|58931242|FG002|Overall Study|Death|0|||
30897797|NCT02460224|58931243|FG003|Overall Study|Death|0|||
30897798|NCT02460224|58931244|FG004|Overall Study|Death|0|||
30897799|NCT02460224|58931245|FG005|Overall Study|Death|2|||
30897800|NCT02460224|58931246|FG006|Overall Study|Death|1|||
30897801|NCT02460224|58931247|FG007|Overall Study|Death|0|||
30897802|NCT02460224|58931248|FG008|Overall Study|Death|0|||
30897803|NCT02460224|58931249|FG009|Overall Study|Death|1|||
30897804|NCT02460224|58931250|FG010|Overall Study|Death|0|||
30897805|NCT02460224|58931251|FG011|Overall Study|Death|0|||
30897806|NCT02460224|58931252|FG012|Overall Study|Death|0|||
30897807|NCT02460224|58931253|FG013|Overall Study|Death|1|||
30897808|NCT02460224|58931254|FG014|Overall Study|Death|0|||
30897809|NCT02460224|58931255|FG015|Overall Study|Death|0|||
30897810|NCT02460224|58931256|FG016|Overall Study|Death|2|||
30897811|NCT02460224|58931257|FG017|Overall Study|Death|1|||
30897812|NCT02460224|58931258|FG018|Overall Study|Death|0|||
30897813|NCT02460224|58931259|FG019|Overall Study|Death|2|||
30897814|NCT02460224|58931260|FG020|Overall Study|Death|0|||
30897815|NCT02460224|58931261|FG021|Overall Study|Death|0|||
30897816|NCT02460224|58931262|FG022|Overall Study|Death|0|||
30897817|NCT02460224|58931263|FG023|Overall Study|Death|0|||
30897818|NCT02460224|58931264|FG024|Overall Study|Death|1|||
30897819|NCT02460224|58931265|FG025|Overall Study|Death|1|||
30897820|NCT02460224|58931266|FG026|Overall Study|Death|5|||
30897821|NCT02460224|58931267|FG027|Overall Study|Death|0|||
30897822|NCT02460224|58931268|FG028|Overall Study|Death|1|||
30897823|NCT02460224|58931240|FG000|Overall Study|Lost to Follow-up|0|||
30897824|NCT02460224|58931241|FG001|Overall Study|Lost to Follow-up|0|||
30897825|NCT02460224|58931242|FG002|Overall Study|Lost to Follow-up|0|||
30897826|NCT02460224|58931243|FG003|Overall Study|Lost to Follow-up|0|||
30897827|NCT02460224|58931244|FG004|Overall Study|Lost to Follow-up|0|||
30897828|NCT02460224|58931245|FG005|Overall Study|Lost to Follow-up|0|||
30897829|NCT02460224|58931246|FG006|Overall Study|Lost to Follow-up|0|||
30897830|NCT02460224|58931247|FG007|Overall Study|Lost to Follow-up|0|||
30897831|NCT02460224|58931248|FG008|Overall Study|Lost to Follow-up|0|||
30897832|NCT02460224|58931249|FG009|Overall Study|Lost to Follow-up|0|||
30897833|NCT02460224|58931250|FG010|Overall Study|Lost to Follow-up|0|||
30897834|NCT02460224|58931251|FG011|Overall Study|Lost to Follow-up|0|||
30897835|NCT02460224|58931252|FG012|Overall Study|Lost to Follow-up|0|||
30897836|NCT02460224|58931253|FG013|Overall Study|Lost to Follow-up|0|||
30897837|NCT02460224|58931254|FG014|Overall Study|Lost to Follow-up|0|||
30897838|NCT02460224|58931255|FG015|Overall Study|Lost to Follow-up|0|||
30897839|NCT02460224|58931256|FG016|Overall Study|Lost to Follow-up|0|||
30897840|NCT02460224|58931257|FG017|Overall Study|Lost to Follow-up|0|||
30897841|NCT02460224|58931258|FG018|Overall Study|Lost to Follow-up|0|||
30897842|NCT02460224|58931259|FG019|Overall Study|Lost to Follow-up|0|||
30897843|NCT02460224|58931260|FG020|Overall Study|Lost to Follow-up|0|||
30897844|NCT02460224|58931261|FG021|Overall Study|Lost to Follow-up|0|||
30897845|NCT02460224|58931262|FG022|Overall Study|Lost to Follow-up|1|||
30897846|NCT02460224|58931263|FG023|Overall Study|Lost to Follow-up|0|||
30897847|NCT02460224|58931264|FG024|Overall Study|Lost to Follow-up|0|||
30897848|NCT02460224|58931265|FG025|Overall Study|Lost to Follow-up|0|||
30897849|NCT02460224|58931266|FG026|Overall Study|Lost to Follow-up|0|||
30897850|NCT02460224|58931267|FG027|Overall Study|Lost to Follow-up|0|||
30897851|NCT02460224|58931268|FG028|Overall Study|Lost to Follow-up|0|||
30897852|NCT02460224|58931240|FG000|Overall Study|Physician Decision|0|||
30897853|NCT02460224|58931241|FG001|Overall Study|Physician Decision|1|||
30897854|NCT02460224|58931242|FG002|Overall Study|Physician Decision|0|||
30897855|NCT02460224|58931243|FG003|Overall Study|Physician Decision|0|||
30897856|NCT02460224|58931244|FG004|Overall Study|Physician Decision|1|||
30897857|NCT02460224|58931245|FG005|Overall Study|Physician Decision|0|||
30897858|NCT02460224|58931246|FG006|Overall Study|Physician Decision|0|||
30897859|NCT02460224|58931247|FG007|Overall Study|Physician Decision|1|||
30897860|NCT02460224|58931248|FG008|Overall Study|Physician Decision|0|||
30897861|NCT02460224|58931249|FG009|Overall Study|Physician Decision|0|||
30897862|NCT02460224|58931250|FG010|Overall Study|Physician Decision|0|||
30897863|NCT02460224|58931251|FG011|Overall Study|Physician Decision|1|||
30897864|NCT02460224|58931252|FG012|Overall Study|Physician Decision|0|||
30897865|NCT02460224|58931253|FG013|Overall Study|Physician Decision|1|||
30897866|NCT02460224|58931254|FG014|Overall Study|Physician Decision|0|||
30897867|NCT02460224|58931255|FG015|Overall Study|Physician Decision|0|||
30897868|NCT02460224|58931256|FG016|Overall Study|Physician Decision|2|||
30897869|NCT02460224|58931257|FG017|Overall Study|Physician Decision|1|||
30897870|NCT02460224|58931258|FG018|Overall Study|Physician Decision|1|||
30897871|NCT02460224|58931259|FG019|Overall Study|Physician Decision|2|||
30897872|NCT02460224|58931260|FG020|Overall Study|Physician Decision|1|||
30897873|NCT02460224|58931261|FG021|Overall Study|Physician Decision|1|||
30897874|NCT02460224|58931262|FG022|Overall Study|Physician Decision|0|||
30897875|NCT02460224|58931263|FG023|Overall Study|Physician Decision|0|||
30897876|NCT02460224|58931264|FG024|Overall Study|Physician Decision|1|||
30897877|NCT02460224|58931265|FG025|Overall Study|Physician Decision|0|||
30897878|NCT02460224|58931266|FG026|Overall Study|Physician Decision|14|||
30897879|NCT02460224|58931267|FG027|Overall Study|Physician Decision|1|||
30897880|NCT02460224|58931268|FG028|Overall Study|Physician Decision|6|||
30897881|NCT02460224|58931240|FG000|Overall Study|Progressive disease|15|||
30897882|NCT02460224|58931241|FG001|Overall Study|Progressive disease|11|||
30897883|NCT02460224|58931242|FG002|Overall Study|Progressive disease|5|||
30897884|NCT02460224|58931243|FG003|Overall Study|Progressive disease|6|||
30897885|NCT02460224|58931244|FG004|Overall Study|Progressive disease|3|||
30897886|NCT02460224|58931245|FG005|Overall Study|Progressive disease|26|||
30897887|NCT02460224|58931246|FG006|Overall Study|Progressive disease|28|||
30897888|NCT02460224|58931247|FG007|Overall Study|Progressive disease|4|||
30897889|NCT02460224|58931248|FG008|Overall Study|Progressive disease|5|||
30897890|NCT02460224|58931249|FG009|Overall Study|Progressive disease|9|||
30897891|NCT02460224|58931250|FG010|Overall Study|Progressive disease|5|||
30897892|NCT02460224|58931251|FG011|Overall Study|Progressive disease|4|||
30897893|NCT02460224|58931252|FG012|Overall Study|Progressive disease|5|||
30897894|NCT02460224|58931253|FG013|Overall Study|Progressive disease|4|||
30897895|NCT02460224|58931254|FG014|Overall Study|Progressive disease|5|||
30897896|NCT02460224|58931255|FG015|Overall Study|Progressive disease|5|||
30897897|NCT02460224|58931256|FG016|Overall Study|Progressive disease|15|||
30897898|NCT02460224|58931257|FG017|Overall Study|Progressive disease|3|||
30897899|NCT02460224|58931258|FG018|Overall Study|Progressive disease|8|||
30897900|NCT02460224|58931259|FG019|Overall Study|Progressive disease|3|||
30897901|NCT02460224|58931260|FG020|Overall Study|Progressive disease|4|||
30897902|NCT02460224|58931261|FG021|Overall Study|Progressive disease|9|||
30897903|NCT02460224|58931262|FG022|Overall Study|Progressive disease|4|||
30897904|NCT02460224|58931263|FG023|Overall Study|Progressive disease|11|||
30897905|NCT02460224|58931264|FG024|Overall Study|Progressive disease|4|||
30897906|NCT02460224|58931265|FG025|Overall Study|Progressive disease|5|||
30897907|NCT02460224|58931266|FG026|Overall Study|Progressive disease|85|||
30897908|NCT02460224|58931267|FG027|Overall Study|Progressive disease|17|||
30897909|NCT02460224|58931268|FG028|Overall Study|Progressive disease|77|||
30897910|NCT02460224|58931240|FG000|Overall Study|Subject/guardian decision|2|||
30897911|NCT02460224|58931241|FG001|Overall Study|Subject/guardian decision|0|||
30897912|NCT02460224|58931242|FG002|Overall Study|Subject/guardian decision|1|||
30897913|NCT02460224|58931243|FG003|Overall Study|Subject/guardian decision|0|||
30897914|NCT02460224|58931244|FG004|Overall Study|Subject/guardian decision|2|||
30897915|NCT02460224|58931245|FG005|Overall Study|Subject/guardian decision|2|||
30897916|NCT02460224|58931246|FG006|Overall Study|Subject/guardian decision|0|||
30897917|NCT02460224|58931247|FG007|Overall Study|Subject/guardian decision|0|||
30897918|NCT02460224|58931248|FG008|Overall Study|Subject/guardian decision|1|||
30897919|NCT02460224|58931249|FG009|Overall Study|Subject/guardian decision|1|||
30897920|NCT02460224|58931250|FG010|Overall Study|Subject/guardian decision|0|||
30897921|NCT02460224|58931251|FG011|Overall Study|Subject/guardian decision|1|||
30897922|NCT02460224|58931252|FG012|Overall Study|Subject/guardian decision|0|||
30897923|NCT02460224|58931253|FG013|Overall Study|Subject/guardian decision|0|||
30897924|NCT02460224|58931254|FG014|Overall Study|Subject/guardian decision|0|||
30897925|NCT02460224|58931255|FG015|Overall Study|Subject/guardian decision|1|||
30897926|NCT02460224|58931256|FG016|Overall Study|Subject/guardian decision|0|||
30897927|NCT02460224|58931257|FG017|Overall Study|Subject/guardian decision|1|||
30897928|NCT02460224|58931258|FG018|Overall Study|Subject/guardian decision|2|||
30897929|NCT02460224|58931259|FG019|Overall Study|Subject/guardian decision|0|||
30897930|NCT02460224|58931260|FG020|Overall Study|Subject/guardian decision|0|||
30897931|NCT02460224|58931261|FG021|Overall Study|Subject/guardian decision|1|||
30897932|NCT02460224|58931262|FG022|Overall Study|Subject/guardian decision|0|||
30897933|NCT02460224|58931263|FG023|Overall Study|Subject/guardian decision|0|||
30897934|NCT02460224|58931264|FG024|Overall Study|Subject/guardian decision|0|||
30897935|NCT02460224|58931265|FG025|Overall Study|Subject/guardian decision|0|||
30897936|NCT02460224|58931266|FG026|Overall Study|Subject/guardian decision|6|||
30897937|NCT02460224|58931267|FG027|Overall Study|Subject/guardian decision|2|||
30897938|NCT02460224|58931268|FG028|Overall Study|Subject/guardian decision|3|||
30897939|NCT02094573|58931342|FG000|Overall Study|Adverse Event|4|||
30897940|NCT02094573|58931343|FG001|Overall Study|Adverse Event|14|||
30897941|NCT02094573|58931342|FG000|Overall Study|Clinical Progressive Disease|9|||
30897942|NCT02094573|58931343|FG001|Overall Study|Clinical Progressive Disease|13|||
30897943|NCT02094573|58931342|FG000|Overall Study|Death|11|||
30897944|NCT02094573|58931343|FG001|Overall Study|Death|3|||
30897945|NCT02094573|58931342|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
30897946|NCT02094573|58931343|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
30897947|NCT02094573|58931342|FG000|Overall Study|Non-compliance with Study Drug|1|||
30897948|NCT02094573|58931343|FG001|Overall Study|Non-compliance with Study Drug|1|||
30897949|NCT02094573|58931342|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
30897950|NCT02094573|58931343|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
30897951|NCT02094573|58931342|FG000|Overall Study|Physician Decision|4|||
30897952|NCT02094573|58931343|FG001|Overall Study|Physician Decision|4|||
30897953|NCT02094573|58931342|FG000|Overall Study|Site Terminated by Sponsor|10|||
30897954|NCT02094573|58931343|FG001|Overall Study|Site Terminated by Sponsor|17|||
30897955|NCT02094573|58931342|FG000|Overall Study|Withdrawal by Subject|6|||
30897956|NCT02094573|58931343|FG001|Overall Study|Withdrawal by Subject|8|||
30897957|NCT02094573|58931342|FG000|Overall Study|Randomized but not Treated|3|||
30897958|NCT02094573|58931343|FG001|Overall Study|Randomized but not Treated|0|||
30897959|NCT01859494|58931349|FG000|Overall Study|Adverse Event|1|||
30897960|NCT01858636|58931353|FG000|Overall Study|No Device Deployment Attempted|24|||
30897961|NCT01858636|58931353|FG000|Overall Study|Physician Decision|1|||
30897962|NCT01858636|58931353|FG000|Overall Study|Death|1|||
30897963|NCT01858636|58931353|FG000|Overall Study|Lost to Follow-up|1|||
30897964|NCT01858636|58931353|FG000|Overall Study|Withdrawal by Subject|1|||
30897965|NCT02058849|58931360|FG000|Overall Study|Hospitalization|1|||
30897966|NCT02058849|58931361|FG001|Overall Study|Hospitalization|1|||
30897967|NCT02058849|58931360|FG000|Overall Study|Death|1|||
30897968|NCT02058849|58931361|FG001|Overall Study|Death|0|||
30897969|NCT02058849|58931360|FG000|Overall Study|Lost to Follow-up|1|||
30897970|NCT02058849|58931361|FG001|Overall Study|Lost to Follow-up|0|||
30897971|NCT02058849|58931360|FG000|Overall Study|Withdrawal by Subject|4|||
30897972|NCT02058849|58931361|FG001|Overall Study|Withdrawal by Subject|0|||
30897973|NCT01858558|58931369|FG000|Overall Study|Death|1|||
30897974|NCT01858558|58931370|FG001|Overall Study|Death|1|||
30897975|NCT01858558|58931369|FG000|Overall Study|Lost to Follow-up|1|||
30897976|NCT01858558|58931370|FG001|Overall Study|Lost to Follow-up|0|||
30897977|NCT01858558|58931369|FG000|Overall Study|Disease progression|3|||
30897978|NCT01858558|58931370|FG001|Overall Study|Disease progression|1|||
30897979|NCT01858558|58931369|FG000|Overall Study|Product contamination|2|||
30897980|NCT01858558|58931370|FG001|Overall Study|Product contamination|0|||
30897981|NCT01858558|58931369|FG000|Overall Study|Failed expansion of cell product|2|||
30897982|NCT01858558|58931370|FG001|Overall Study|Failed expansion of cell product|0|||
30897983|NCT02058537|58931376|FG000|Overall Study|Withdrawal by Subject|1|||
30897984|NCT01612000|58931384|FG000|Overall Study|Lost to Follow-up|6|||
30897985|NCT01612000|58931385|FG001|Overall Study|Lost to Follow-up|4|||
30897986|NCT01612000|58931386|FG002|Overall Study|Lost to Follow-up|4|||
30897987|NCT01612000|58931387|FG003|Overall Study|Lost to Follow-up|8|||
30897988|NCT01612000|58931384|FG000|Overall Study|Physician Decision|0|||
30897989|NCT01612000|58931385|FG001|Overall Study|Physician Decision|0|||
30897990|NCT01612000|58931386|FG002|Overall Study|Physician Decision|1|||
30897991|NCT01612000|58931387|FG003|Overall Study|Physician Decision|0|||
30897992|NCT01612000|58931384|FG000|Overall Study|Withdrawal by Subject|3|||
30897993|NCT01612000|58931385|FG001|Overall Study|Withdrawal by Subject|1|||
30897994|NCT01612000|58931386|FG002|Overall Study|Withdrawal by Subject|2|||
30897995|NCT01612000|58931387|FG003|Overall Study|Withdrawal by Subject|2|||
30897996|NCT01895608|58931401|FG000|Overall Study|change in health status|0|||
30897997|NCT01895608|58931402|FG001|Overall Study|change in health status|1|||
30897998|NCT01895608|58931403|FG002|Overall Study|change in health status|1|||
30897999|NCT01895608|58931404|FG003|Overall Study|change in health status|0|||
30898000|NCT01895608|58931401|FG000|Overall Study|Withdrawal by Subject|0|||
30898001|NCT01895608|58931402|FG001|Overall Study|Withdrawal by Subject|0|||
30898002|NCT01895608|58931403|FG002|Overall Study|Withdrawal by Subject|2|||
30898003|NCT01895608|58931404|FG003|Overall Study|Withdrawal by Subject|0|||
30898004|NCT02409680|58931416|FG000|Overall Study|Lost to Follow-up|15|||
30898005|NCT02409680|58931417|FG001|Overall Study|Lost to Follow-up|30|||
30898006|NCT01895452|58931425|FG000|Overall Study|Adverse Event|1|||
30898007|NCT01895452|58931426|FG001|Overall Study|Adverse Event|4|||
30898008|NCT01895452|58931425|FG000|Overall Study|Lost to Follow-up|1|||
30898009|NCT01895452|58931426|FG001|Overall Study|Lost to Follow-up|5|||
30898010|NCT01895452|58931425|FG000|Overall Study|Pregnancy|0|||
30898011|NCT01895452|58931426|FG001|Overall Study|Pregnancy|1|||
30898012|NCT01895452|58931425|FG000|Overall Study|Withdrawal by Subject|2|||
30898013|NCT01895452|58931426|FG001|Overall Study|Withdrawal by Subject|14|||
30898014|NCT01895452|58931425|FG000|Overall Study|Underlying disease|0|||
30898015|NCT01895452|58931426|FG001|Overall Study|Underlying disease|3|||
30898016|NCT01895452|58931425|FG000|Overall Study|Noncompliance with study drug|0|||
30898017|NCT01895452|58931426|FG001|Overall Study|Noncompliance with study drug|1|||
30898018|NCT02094417|58931436|FG000|Overall Study|Adverse Event|0|||
30898019|NCT02094417|58931437|FG001|Overall Study|Adverse Event|0|||
30898020|NCT02094417|58931438|FG002|Overall Study|Adverse Event|0|||
30898021|NCT02094417|58931439|FG003|Overall Study|Adverse Event|1|||
30898022|NCT02094417|58931436|FG000|Overall Study|Eligibility criteria|0|||
30898023|NCT02094417|58931437|FG001|Overall Study|Eligibility criteria|1|||
30898024|NCT02094417|58931438|FG002|Overall Study|Eligibility criteria|0|||
30898025|NCT02094417|58931439|FG003|Overall Study|Eligibility criteria|0|||
30898026|NCT02094417|58931436|FG000|Overall Study|No responder|4|||
30898027|NCT02094417|58931437|FG001|Overall Study|No responder|4|||
30898028|NCT02094417|58931438|FG002|Overall Study|No responder|4|||
30898029|NCT02094417|58931439|FG003|Overall Study|No responder|3|||
30898030|NCT02094417|58931436|FG000|Overall Study|Unable to conduct observations or assess|0|||
30898031|NCT02094417|58931437|FG001|Overall Study|Unable to conduct observations or assess|1|||
30898032|NCT02094417|58931438|FG002|Overall Study|Unable to conduct observations or assess|0|||
30898033|NCT02094417|58931439|FG003|Overall Study|Unable to conduct observations or assess|0|||
30898034|NCT02094417|58931436|FG000|Overall Study|Withdrawal by Subject|1|||
30898035|NCT02094417|58931437|FG001|Overall Study|Withdrawal by Subject|2|||
30898036|NCT02094417|58931438|FG002|Overall Study|Withdrawal by Subject|1|||
30898037|NCT02094417|58931439|FG003|Overall Study|Withdrawal by Subject|3|||
30898038|NCT01894984|58931451|FG000|Overall Study|Other|314|||
30898039|NCT01894984|58931452|FG001|Overall Study|Other|175|||
30898040|NCT02375672|58931458|FG000|Overall Study|remain on follow up|20|||
30898041|NCT01894516|58931466|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
30898042|NCT01894516|58931467|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
30898043|NCT01894516|58931468|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
30898044|NCT01894516|58931469|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
30898045|NCT01894516|58931466|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
30898046|NCT01894516|58931467|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
30898047|NCT01894516|58931468|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
30898048|NCT01894516|58931469|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
30898049|NCT01894516|58931466|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
30898050|NCT01894516|58931467|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
30898051|NCT01894516|58931468|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
30898052|NCT01894516|58931469|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
30898053|NCT01894516|58931466|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
30898054|NCT01894516|58931467|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
30898055|NCT01894516|58931468|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
30898056|NCT01894516|58931469|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
30898057|NCT01894516|58931466|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
30898058|NCT01894516|58931467|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
30898059|NCT01894516|58931468|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
30898060|NCT01894516|58931469|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
30710347|NCT03952650|58723872|FG001|Overall Study|Withdrawal by Subject|2|||
30710348|NCT03952650|58723873|FG002|Overall Study|Withdrawal by Subject|0|||
30710349|NCT03952650|58723874|FG003|Overall Study|Withdrawal by Subject|3|||
30710350|NCT03952650|58723875|FG004|Overall Study|Withdrawal by Subject|0|||
30710351|NCT03952650|58723876|FG005|Overall Study|Withdrawal by Subject|1|||
30710352|NCT03952650|58723877|FG006|Overall Study|Withdrawal by Subject|1|||
30710353|NCT03952650|58723871|FG000|Overall Study|Lost to Follow-up|0|||
30710354|NCT03952650|58723872|FG001|Overall Study|Lost to Follow-up|1|||
30710355|NCT03952650|58723873|FG002|Overall Study|Lost to Follow-up|0|||
30710356|NCT03952650|58723874|FG003|Overall Study|Lost to Follow-up|0|||
30710357|NCT03952650|58723875|FG004|Overall Study|Lost to Follow-up|0|||
30710358|NCT03952650|58723876|FG005|Overall Study|Lost to Follow-up|1|||
30710359|NCT03952650|58723877|FG006|Overall Study|Lost to Follow-up|1|||
30710360|NCT03952650|58723871|FG000|Overall Study|Received wrong vaccine and travelled|0|||
30710361|NCT03952650|58723872|FG001|Overall Study|Received wrong vaccine and travelled|0|||
30710362|NCT03952650|58723873|FG002|Overall Study|Received wrong vaccine and travelled|0|||
30710363|NCT03952650|58723874|FG003|Overall Study|Received wrong vaccine and travelled|0|||
30710364|NCT03952650|58723875|FG004|Overall Study|Received wrong vaccine and travelled|0|||
30710365|NCT03952650|58723876|FG005|Overall Study|Received wrong vaccine and travelled|1|||
30710366|NCT03952650|58723877|FG006|Overall Study|Received wrong vaccine and travelled|0|||
30710367|NCT03952650|58723871|FG000|Overall Study|Unable to make study visit|0|||
30898061|NCT01894516|58931466|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
30710368|NCT03952650|58723872|FG001|Overall Study|Unable to make study visit|0|||
30710369|NCT03952650|58723873|FG002|Overall Study|Unable to make study visit|0|||
30710370|NCT03952650|58723874|FG003|Overall Study|Unable to make study visit|0|||
30710371|NCT03952650|58723875|FG004|Overall Study|Unable to make study visit|0|||
30710372|NCT03952650|58723876|FG005|Overall Study|Unable to make study visit|1|||
30710373|NCT03952650|58723877|FG006|Overall Study|Unable to make study visit|0|||
30898062|NCT01894516|58931467|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
30898063|NCT01894516|58931468|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
30898064|NCT01894516|58931469|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
30898065|NCT01894516|58931466|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
30898066|NCT01894516|58931467|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
30898067|NCT01894516|58931468|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
30898068|NCT01894516|58931469|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
30898069|NCT01894516|58931466|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
30898070|NCT01894516|58931467|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
30898071|NCT01894516|58931468|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
30898072|NCT01894516|58931469|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
30898073|NCT02491463|58931487|FG000|Overall Study|Withdrawal by Subject|1|||
30898074|NCT02491463|58931488|FG001|Overall Study|Withdrawal by Subject|2|||
30898075|NCT02491463|58931489|FG002|Overall Study|Withdrawal by Subject|0|||
30898076|NCT02491463|58931490|FG003|Overall Study|Withdrawal by Subject|0|||
30898077|NCT02491463|58931487|FG000|Overall Study|Migrated/moved from study area|1|||
30898078|NCT02491463|58931488|FG001|Overall Study|Migrated/moved from study area|5|||
30898079|NCT02491463|58931489|FG002|Overall Study|Migrated/moved from study area|1|||
30898080|NCT02491463|58931490|FG003|Overall Study|Migrated/moved from study area|1|||
30898081|NCT02491463|58931487|FG000|Overall Study|Lost to Follow-up|0|||
30898082|NCT02491463|58931488|FG001|Overall Study|Lost to Follow-up|3|||
30898083|NCT02491463|58931489|FG002|Overall Study|Lost to Follow-up|3|||
30898084|NCT02491463|58931490|FG003|Overall Study|Lost to Follow-up|0|||
30898085|NCT02038881|58931503|FG000|Overall Study|Withdrawal by Subject|0|||
30898086|NCT02038881|58931504|FG001|Overall Study|Withdrawal by Subject|0|||
30898087|NCT02038881|58931505|FG002|Overall Study|Withdrawal by Subject|1|||
30898088|NCT02038881|58931503|FG000|Overall Study|Lost to Follow-up|2|||
30898089|NCT02038881|58931504|FG001|Overall Study|Lost to Follow-up|0|||
30898090|NCT02038881|58931505|FG002|Overall Study|Lost to Follow-up|0|||
30898091|NCT02038881|58931503|FG000|Overall Study|incarcerated|1|||
30898092|NCT02038881|58931504|FG001|Overall Study|incarcerated|0|||
30898093|NCT02038881|58931505|FG002|Overall Study|incarcerated|0|||
30898094|NCT01857622|58931518|FG000|Overall Study|Adverse Event|5|||
30898095|NCT01857622|58931519|FG001|Overall Study|Adverse Event|0|||
30898096|NCT01857622|58931520|FG002|Overall Study|Adverse Event|2|||
30898097|NCT01857622|58931518|FG000|Overall Study|Physician Decision|1|||
30898098|NCT01857622|58931519|FG001|Overall Study|Physician Decision|0|||
30898099|NCT01857622|58931520|FG002|Overall Study|Physician Decision|0|||
30898100|NCT01857622|58931518|FG000|Overall Study|Protocol Violation|4|||
30898101|NCT01857622|58931519|FG001|Overall Study|Protocol Violation|1|||
30898102|NCT01857622|58931520|FG002|Overall Study|Protocol Violation|0|||
30898103|NCT01857622|58931518|FG000|Overall Study|Withdrawal by Subject|1|||
30898104|NCT01857622|58931519|FG001|Overall Study|Withdrawal by Subject|0|||
30898105|NCT01857622|58931520|FG002|Overall Study|Withdrawal by Subject|0|||
30898106|NCT01857310|58931530|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
30898107|NCT01857310|58931531|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
30898108|NCT02472353|58931539|FG000|Overall Study|Lost to Follow-up|1|||
30898109|NCT02472353|58931540|FG001|Overall Study|Lost to Follow-up|1|||
30898110|NCT02472353|58931539|FG000|Overall Study|Withdrawal by Subject|2|||
30898111|NCT02472353|58931540|FG001|Overall Study|Withdrawal by Subject|1|||
30898112|NCT02472353|58931539|FG000|Overall Study|Study Termination|1|||
30898113|NCT02472353|58931540|FG001|Overall Study|Study Termination|4|||
30898114|NCT02491073|58931548|FG000|Overall Study|screen failure|1|||
30898115|NCT02491073|58931549|FG001|Overall Study|screen failure|0|||
30898116|NCT02314117|58931573|FG000|Overall Study|Lost to Follow-up|9|||
30898117|NCT02314117|58931574|FG001|Overall Study|Lost to Follow-up|14|||
30898118|NCT02314117|58931573|FG000|Overall Study|Withdrawal by Subject|3|||
30898119|NCT02314117|58931574|FG001|Overall Study|Withdrawal by Subject|2|||
30898120|NCT01893346|58931585|FG000|Overall Study|Lost to Follow-up|0|||
30898121|NCT01893346|58931586|FG001|Overall Study|Lost to Follow-up|1|||
30898122|NCT01893346|58931587|FG002|Overall Study|Lost to Follow-up|0|||
30898123|NCT01893346|58931588|FG003|Overall Study|Lost to Follow-up|0|||
30898124|NCT01893346|58931585|FG000|Overall Study|Protocol Violation|1|||
30898125|NCT01893346|58931586|FG001|Overall Study|Protocol Violation|0|||
30621041|NCT01179048|58632611|FG001|Overall Study|Withdrawn - does not allow contact|8|||
30898126|NCT01893346|58931587|FG002|Overall Study|Protocol Violation|0|||
30898127|NCT01893346|58931588|FG003|Overall Study|Protocol Violation|0|||
30898128|NCT01893346|58931585|FG000|Overall Study|Withdrawal by Subject|2|||
30898129|NCT01893346|58931586|FG001|Overall Study|Withdrawal by Subject|0|||
30898130|NCT01893346|58931587|FG002|Overall Study|Withdrawal by Subject|0|||
30898131|NCT01893346|58931588|FG003|Overall Study|Withdrawal by Subject|0|||
30898132|NCT02490371|58931600|FG000|Overall Study|Lost to Follow-up|1|||
30898133|NCT02490371|58931601|FG001|Overall Study|Lost to Follow-up|1|||
30898134|NCT02058147|58931610|FG000|Overall Study|Randomized but not treated|0|||
30898135|NCT02058147|58931611|FG001|Overall Study|Randomized but not treated|0|||
30898136|NCT02058147|58931612|FG002|Overall Study|Randomized but not treated|1|||
30898137|NCT02058147|58931610|FG000|Overall Study|Adverse Event|12|||
30898138|NCT02058147|58931611|FG001|Overall Study|Adverse Event|9|||
30898139|NCT02058147|58931612|FG002|Overall Study|Adverse Event|21|||
30898140|NCT02058147|58931610|FG000|Overall Study|Lack of Efficacy|1|||
30898141|NCT02058147|58931611|FG001|Overall Study|Lack of Efficacy|0|||
30898142|NCT02058147|58931612|FG002|Overall Study|Lack of Efficacy|3|||
30898143|NCT02058147|58931610|FG000|Overall Study|Poor compliance to protocol|8|||
30898144|NCT02058147|58931611|FG001|Overall Study|Poor compliance to protocol|9|||
30898145|NCT02058147|58931612|FG002|Overall Study|Poor compliance to protocol|4|||
30898146|NCT02058147|58931610|FG000|Overall Study|Other than specified|8|||
30898147|NCT02058147|58931611|FG001|Overall Study|Other than specified|9|||
30898148|NCT02058147|58931612|FG002|Overall Study|Other than specified|0|||
30898149|NCT02489981|58931620|FG000|Overall Study|Adverse Event|21|||
30898150|NCT02489981|58931620|FG000|Overall Study|Insufficient effectiveness|16|||
30898151|NCT02489981|58931620|FG000|Overall Study|Improved|31|||
30898152|NCT02489981|58931620|FG000|Overall Study|Lost to Follow-up|31|||
30898153|NCT02489981|58931620|FG000|Overall Study|Other than listed|28|||
30898154|NCT02471183|58931624|FG000|Main Treatment Period|Adverse Event|1|||
30898155|NCT02471183|58931624|FG000|Main Treatment Period|Withdrawal by Subject|1|||
30898156|NCT02471183|58931624|FG000|Extended Treatment Period|Lack of Efficacy|1|||
30898157|NCT01855828|58931628|FG000|Overall Study|Adverse Event|1|||
30898158|NCT01855828|58931628|FG000|Overall Study|Withdrawal by Subject|1|||
30898159|NCT02489279|58931639|FG000|Overall Study|Lost to Follow-up|12|||
30898160|NCT02489279|58931640|FG001|Overall Study|Lost to Follow-up|10|||
30898161|NCT02489045|58931646|FG000|Overall Study|unable to collect usable data|53|||
30898162|NCT02489045|58931646|FG000|Follow-up|Lost to Follow-up|10|||
30898163|NCT02488109|58931652|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
30898164|NCT02488109|58931653|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
30898165|NCT02488109|58931652|FG000|12-month Follow-Up|Lost to Follow-up|4|||
30898166|NCT02488109|58931653|FG001|12-month Follow-Up|Lost to Follow-up|7|||
30898167|NCT02351167|58931664|FG000|Overall Study|Withdrawal by Subject|19|||
30898168|NCT02351167|58931665|FG001|Overall Study|Withdrawal by Subject|18|||
30898169|NCT02351167|58931666|FG002|Overall Study|Withdrawal by Subject|21|||
30898170|NCT02350309|58931681|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
30898171|NCT02350309|58931682|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
30898172|NCT02350309|58931683|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
30898173|NCT02350309|58931684|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
30898174|NCT02350309|58931685|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
30898175|NCT02350309|58931686|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
30898176|NCT02350309|58931681|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
30898177|NCT02350309|58931682|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
30898178|NCT02350309|58931683|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
30898179|NCT02350309|58931684|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
30898180|NCT02350309|58931685|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
30898181|NCT02350309|58931686|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
30898182|NCT02038647|58931703|FG000|Overall Study|Progressive Disease|50|||
30898183|NCT02038647|58931704|FG001|Overall Study|Progressive Disease|59|||
30898184|NCT02038647|58931703|FG000|Overall Study|Adverse Event|18|||
30898185|NCT02038647|58931704|FG001|Overall Study|Adverse Event|10|||
30898186|NCT02038647|58931703|FG000|Overall Study|Symptomatic Deterioration|7|||
30898187|NCT02038647|58931704|FG001|Overall Study|Symptomatic Deterioration|7|||
30898188|NCT02038647|58931703|FG000|Overall Study|Withdrawal by Subject|5|||
30898189|NCT02038647|58931704|FG001|Overall Study|Withdrawal by Subject|2|||
30898190|NCT02038647|58931703|FG000|Overall Study|Not Reported|0|||
30898191|NCT02038647|58931704|FG001|Overall Study|Not Reported|1|||
30898192|NCT02038647|58931703|FG000|Overall Study|Ongoing at Datacut|9|||
30898193|NCT02038647|58931704|FG001|Overall Study|Ongoing at Datacut|10|||
30898194|NCT02058069|58931710|FG000|Overall Study|Exclusion due to implant size|5|||
30898195|NCT02058069|58931710|FG000|Overall Study|Withdrawal by Subject|6|||
30898196|NCT02057835|58931724|FG000|Overall Study|Withdrawal by Subject|0|||
30898197|NCT02057835|58931725|FG001|Overall Study|Withdrawal by Subject|2|||
30898198|NCT02057835|58931726|FG002|Overall Study|Withdrawal by Subject|0|||
30898199|NCT02057835|58931727|FG003|Overall Study|Withdrawal by Subject|0|||
30898200|NCT02057835|58931728|FG004|Overall Study|Withdrawal by Subject|0|||
30898201|NCT02057835|58931729|FG005|Overall Study|Withdrawal by Subject|0|||
30898202|NCT02057835|58931730|FG006|Overall Study|Withdrawal by Subject|0|||
30898203|NCT02057835|58931731|FG007|Overall Study|Withdrawal by Subject|0|||
30898204|NCT02057835|58931732|FG008|Overall Study|Withdrawal by Subject|0|||
30898205|NCT02057835|58931733|FG009|Overall Study|Withdrawal by Subject|0|||
30898206|NCT02057757|58931764|FG000|Overall Study|Withdrawal by Subject|3|||
30898207|NCT02057757|58931765|FG001|Overall Study|Withdrawal by Subject|5|||
30898208|NCT02057757|58931764|FG000|Overall Study|Death|2|||
30898209|NCT02057757|58931765|FG001|Overall Study|Death|0|||
30898210|NCT02057757|58931764|FG000|Overall Study|Lost to Follow-up|8|||
30898211|NCT02057757|58931765|FG001|Overall Study|Lost to Follow-up|3|||
30898212|NCT02057757|58931764|FG000|Overall Study|Non-compliance|1|||
30898213|NCT02057757|58931765|FG001|Overall Study|Non-compliance|0|||
30898214|NCT02037477|58931779|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
30898215|NCT02037477|58931780|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
30898216|NCT02037477|58931781|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
30898217|NCT02037477|58931782|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
30898218|NCT02057523|58931792|FG000|Overall Study|Withdrawal by Subject|1|||
30898219|NCT02057523|58931792|FG000|Overall Study|Lack of Efficacy|1|||
30898220|NCT02037165|58931801|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
30898221|NCT02037165|58931802|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
30898222|NCT02037165|58931803|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
30898223|NCT02037165|58931804|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
30898224|NCT02037165|58931805|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
30898225|NCT02470403|58931826|FG000|Overall Study|Adverse Event|1|||
30898226|NCT02470403|58931827|FG001|Overall Study|Adverse Event|0|||
30898227|NCT02470403|58931828|FG002|Overall Study|Adverse Event|0|||
30898228|NCT02470403|58931829|FG003|Overall Study|Adverse Event|0|||
30898229|NCT02470403|58931830|FG004|Overall Study|Adverse Event|0|||
30898230|NCT02470403|58931826|FG000|Overall Study|Lost to Follow-up|0|||
30898231|NCT02470403|58931827|FG001|Overall Study|Lost to Follow-up|1|||
30898232|NCT02470403|58931828|FG002|Overall Study|Lost to Follow-up|0|||
30898233|NCT02470403|58931829|FG003|Overall Study|Lost to Follow-up|0|||
30898234|NCT02470403|58931830|FG004|Overall Study|Lost to Follow-up|0|||
30898235|NCT02470403|58931826|FG000|Overall Study|Subject/guardian decision|1|||
30898236|NCT02470403|58931827|FG001|Overall Study|Subject/guardian decision|0|||
30898237|NCT02470403|58931828|FG002|Overall Study|Subject/guardian decision|0|||
30898238|NCT02470403|58931829|FG003|Overall Study|Subject/guardian decision|4|||
30898239|NCT02470403|58931830|FG004|Overall Study|Subject/guardian decision|0|||
30898240|NCT01855750|58931847|FG000|Overall Study|Death|78|||
30898241|NCT01855750|58931848|FG001|Overall Study|Death|78|||
30898242|NCT01855750|58931847|FG000|Overall Study|Lost to Follow-up|9|||
30898243|NCT01855750|58931848|FG001|Overall Study|Lost to Follow-up|23|||
30898244|NCT01855750|58931847|FG000|Overall Study|Withdrawal by Subject|35|||
30898245|NCT01855750|58931848|FG001|Overall Study|Withdrawal by Subject|28|||
30898246|NCT01855750|58931847|FG000|Overall Study|Sponsor ends the study|297|||
30898247|NCT01855750|58931848|FG001|Overall Study|Sponsor ends the study|290|||
30898248|NCT01855126|58931856|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
30898249|NCT01855126|58931857|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
30898250|NCT01855126|58931856|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
30898251|NCT01855126|58931857|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
30898252|NCT01622673|58931873|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30898253|NCT01622673|58931874|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30898254|NCT01622673|58931875|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30898255|NCT01622673|58931876|FG003|Treatment Period 1|Withdrawal by Subject|1|||
30898256|NCT01622673|58931877|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30898257|NCT01622673|58931878|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30898258|NCT01622673|58931873|FG000|Treatment Period 1|Protocol Violation|0|||
30898259|NCT01622673|58931874|FG001|Treatment Period 1|Protocol Violation|1|||
30898260|NCT01622673|58931875|FG002|Treatment Period 1|Protocol Violation|0|||
30898261|NCT01622673|58931876|FG003|Treatment Period 1|Protocol Violation|0|||
30898262|NCT01622673|58931877|FG004|Treatment Period 1|Protocol Violation|0|||
30898263|NCT01622673|58931878|FG005|Treatment Period 1|Protocol Violation|0|||
30898264|NCT01622673|58931873|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30898265|NCT01622673|58931874|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30898266|NCT01622673|58931875|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30898267|NCT01622673|58931876|FG003|Treatment Period 2|Withdrawal by Subject|1|||
30898268|NCT01622673|58931877|FG004|Treatment Period 2|Withdrawal by Subject|0|||
30898269|NCT01622673|58931878|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30898270|NCT01622673|58931873|FG000|Treatment Period 3|Protocol Violation|0|||
30898271|NCT01622673|58931874|FG001|Treatment Period 3|Protocol Violation|1|||
30898272|NCT01622673|58931875|FG002|Treatment Period 3|Protocol Violation|0|||
30898273|NCT01622673|58931876|FG003|Treatment Period 3|Protocol Violation|0|||
30898274|NCT01622673|58931877|FG004|Treatment Period 3|Protocol Violation|0|||
30898275|NCT01622673|58931878|FG005|Treatment Period 3|Protocol Violation|0|||
30898276|NCT01855048|58931903|FG000|Overall Study|Withdrawal by Subject|0|||
30898277|NCT01855048|58931904|FG001|Overall Study|Withdrawal by Subject|1|||
30898278|NCT01855048|58931905|FG002|Overall Study|Withdrawal by Subject|0|||
30898279|NCT01855048|58931906|FG003|Overall Study|Withdrawal by Subject|0|||
30898280|NCT01855048|58931907|FG004|Overall Study|Withdrawal by Subject|1|||
30898281|NCT01855048|58931908|FG005|Overall Study|Withdrawal by Subject|0|||
30898282|NCT02469857|58931934|FG000|Overall Study|Death|24|||
30898283|NCT02469857|58931935|FG001|Overall Study|Death|29|||
30898284|NCT02469857|58931934|FG000|Overall Study|Discontinuation|1|||
30898285|NCT02469857|58931935|FG001|Overall Study|Discontinuation|3|||
30898286|NCT02036853|58931945|FG000|Overall Study|Adverse Event|0|||
30898287|NCT02036853|58931946|FG001|Overall Study|Adverse Event|2|||
30898288|NCT02036853|58931945|FG000|Overall Study|Lack of Efficacy|0|||
30898289|NCT02036853|58931946|FG001|Overall Study|Lack of Efficacy|2|||
30898290|NCT02036853|58931945|FG000|Overall Study|Physician Decision|0|||
30898291|NCT02036853|58931946|FG001|Overall Study|Physician Decision|1|||
30898292|NCT02036853|58931945|FG000|Overall Study|Withdrawal by Subject|0|||
30898293|NCT02036853|58931946|FG001|Overall Study|Withdrawal by Subject|1|||
30898294|NCT02469623|58931952|FG000|Overall Study|Not consented for long-term follow-up|4|||
30898295|NCT02469623|58931952|FG000|Overall Study|Lost to Follow-up|4|||
30898296|NCT02469623|58931952|FG000|Overall Study|Withdrawal by Subject|2|||
30898297|NCT02469623|58931952|FG000|Overall Study|Death|3|||
30898298|NCT02469077|58931959|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
30898299|NCT02469077|58931960|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
30898300|NCT02469077|58931959|FG000|Post Randomization/Intervention Period|Relocated|1|||
30898301|NCT02469077|58931960|FG001|Post Randomization/Intervention Period|Relocated|1|||
30898302|NCT02469077|58931959|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
30898303|NCT02469077|58931960|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
30898304|NCT02469077|58931959|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
30898305|NCT02469077|58931960|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
30898306|NCT02486627|58931972|FG000|Overall Study|Death|1|||
30898307|NCT02486627|58931973|FG001|Overall Study|Death|0|||
30898308|NCT02486627|58931972|FG000|Overall Study|Other Unspecified|0|||
30898309|NCT02486627|58931973|FG001|Overall Study|Other Unspecified|2|||
30898310|NCT02486627|58931972|FG000|Overall Study|Consent Withdrawn by Participant|4|||
30898311|NCT02486627|58931973|FG001|Overall Study|Consent Withdrawn by Participant|3|||
30898312|NCT02486627|58931972|FG000|Overall Study|Significant Participant Noncompliance|1|||
30898313|NCT02486627|58931973|FG001|Overall Study|Significant Participant Noncompliance|1|||
30898314|NCT02486627|58931972|FG000|Overall Study|Lost to Follow-up|1|||
30898315|NCT02486627|58931973|FG001|Overall Study|Lost to Follow-up|3|||
30898316|NCT01644565|58931979|FG000|Overall Study|Undisclosed Medical History|1|||
30710374|NCT00691301|58723893|FG000|Overall Study|Adverse Event|10|||
30898317|NCT01644565|58931980|FG001|Overall Study|Undisclosed Medical History|0|||
30898318|NCT01644565|58931981|FG002|Overall Study|Undisclosed Medical History|0|||
30898319|NCT01644565|58931982|FG003|Overall Study|Undisclosed Medical History|0|||
30898320|NCT01644565|58931983|FG004|Overall Study|Undisclosed Medical History|0|||
30898321|NCT01644565|58931984|FG005|Overall Study|Undisclosed Medical History|0|||
30898322|NCT01644565|58931985|FG006|Overall Study|Undisclosed Medical History|0|||
30898323|NCT01644565|58931986|FG007|Overall Study|Undisclosed Medical History|0|||
30710375|NCT00691301|58723893|FG000|Overall Study|Death|2|||
30898324|NCT01644565|58931987|FG008|Overall Study|Undisclosed Medical History|0|||
30898325|NCT01644565|58931979|FG000|Overall Study|Lost to Follow-up|0|||
30898326|NCT01644565|58931980|FG001|Overall Study|Lost to Follow-up|0|||
30898327|NCT01644565|58931981|FG002|Overall Study|Lost to Follow-up|0|||
30898328|NCT01644565|58931982|FG003|Overall Study|Lost to Follow-up|1|||
30898329|NCT01644565|58931983|FG004|Overall Study|Lost to Follow-up|0|||
30898330|NCT01644565|58931984|FG005|Overall Study|Lost to Follow-up|0|||
30898331|NCT01644565|58931985|FG006|Overall Study|Lost to Follow-up|0|||
30898332|NCT01644565|58931986|FG007|Overall Study|Lost to Follow-up|2|||
30898333|NCT01644565|58931987|FG008|Overall Study|Lost to Follow-up|0|||
30898334|NCT01644565|58931979|FG000|Overall Study|Family emergency|0|||
30898335|NCT01644565|58931980|FG001|Overall Study|Family emergency|0|||
30898336|NCT01644565|58931981|FG002|Overall Study|Family emergency|0|||
30898337|NCT01644565|58931982|FG003|Overall Study|Family emergency|0|||
30898338|NCT01644565|58931983|FG004|Overall Study|Family emergency|1|||
30898339|NCT01644565|58931984|FG005|Overall Study|Family emergency|0|||
30898340|NCT01644565|58931985|FG006|Overall Study|Family emergency|0|||
30898341|NCT01644565|58931986|FG007|Overall Study|Family emergency|0|||
30898342|NCT01644565|58931987|FG008|Overall Study|Family emergency|0|||
30898343|NCT01644565|58931979|FG000|Overall Study|Relocation|0|||
30898344|NCT01644565|58931980|FG001|Overall Study|Relocation|0|||
30898345|NCT01644565|58931981|FG002|Overall Study|Relocation|0|||
30898346|NCT01644565|58931982|FG003|Overall Study|Relocation|0|||
30898347|NCT01644565|58931983|FG004|Overall Study|Relocation|0|||
30898348|NCT01644565|58931984|FG005|Overall Study|Relocation|0|||
30898349|NCT01644565|58931985|FG006|Overall Study|Relocation|0|||
30898350|NCT01644565|58931986|FG007|Overall Study|Relocation|0|||
30898351|NCT01644565|58931987|FG008|Overall Study|Relocation|1|||
30898352|NCT02485925|58932007|FG000|Overall Study|Withdrawal by Subject|3|||
30898353|NCT02485925|58932007|FG000|Overall Study|Death|1|||
30898354|NCT02485925|58932007|FG000|Overall Study|Lost to Follow-up|11|||
30898355|NCT02282293|58932013|FG000|Overall Study|Lost to Follow-up|2|||
30898356|NCT02282293|58932014|FG001|Overall Study|Lost to Follow-up|2|||
30898357|NCT02282293|58932013|FG000|Overall Study|Unable to comply with study procedures|1|||
30898358|NCT02282293|58932014|FG001|Overall Study|Unable to comply with study procedures|0|||
30898359|NCT02282293|58932013|FG000|Overall Study|Moved out of study area|0|||
30898360|NCT02282293|58932014|FG001|Overall Study|Moved out of study area|1|||
30898361|NCT01854658|58932024|FG000|Overall Study|Protocol Violation|6|||
30898362|NCT01854658|58932025|FG001|Overall Study|Protocol Violation|2|||
30898363|NCT01854658|58932026|FG002|Overall Study|Protocol Violation|2|||
30898364|NCT01854658|58932027|FG003|Overall Study|Protocol Violation|1|||
30898365|NCT01854658|58932024|FG000|Overall Study|Physician Decision|7|||
30898366|NCT01854658|58932025|FG001|Overall Study|Physician Decision|5|||
30898367|NCT01854658|58932026|FG002|Overall Study|Physician Decision|2|||
30898368|NCT01854658|58932027|FG003|Overall Study|Physician Decision|4|||
30621042|NCT01179048|58632610|FG000|Overall Study|Lost to Follow-up|8|||
30710376|NCT00691301|58723893|FG000|Overall Study|Lack of Efficacy|32|||
30710377|NCT00691301|58723893|FG000|Overall Study|Withdrawal by Subject|4|||
30898369|NCT01854658|58932024|FG000|Overall Study|Lost to Follow-up|8|||
30898370|NCT01854658|58932025|FG001|Overall Study|Lost to Follow-up|9|||
30898371|NCT01854658|58932026|FG002|Overall Study|Lost to Follow-up|8|||
30898372|NCT01854658|58932027|FG003|Overall Study|Lost to Follow-up|4|||
30898373|NCT01854658|58932024|FG000|Overall Study|Withdrawal by Subject|28|||
30621043|NCT01179048|58632611|FG001|Overall Study|Lost to Follow-up|9|||
30621044|NCT01179048|58632610|FG000|Overall Study|Alive|127|||
30621045|NCT01179048|58632611|FG001|Overall Study|Alive|142|||
30621046|NCT00603265|58632620|FG000|Overall Study|Adverse Event|2|||
30621047|NCT00603265|58632621|FG001|Overall Study|Adverse Event|11|||
30621048|NCT00603265|58632622|FG002|Overall Study|Adverse Event|1|||
30621049|NCT00603265|58632620|FG000|Overall Study|Withdrawal by Subject|1|||
30898374|NCT01854658|58932025|FG001|Overall Study|Withdrawal by Subject|21|||
30898375|NCT01854658|58932026|FG002|Overall Study|Withdrawal by Subject|29|||
30898376|NCT01854658|58932027|FG003|Overall Study|Withdrawal by Subject|15|||
30898377|NCT01854658|58932024|FG000|Overall Study|Protocol-specified criteria|15|||
30621050|NCT00603265|58632621|FG001|Overall Study|Withdrawal by Subject|2|||
30621051|NCT00603265|58632622|FG002|Overall Study|Withdrawal by Subject|1|||
30898378|NCT01854658|58932025|FG001|Overall Study|Protocol-specified criteria|15|||
30898379|NCT01854658|58932026|FG002|Overall Study|Protocol-specified criteria|10|||
30621052|NCT00603265|58632620|FG000|Overall Study|Lack of Efficacy|3|||
30621053|NCT00603265|58632621|FG001|Overall Study|Lack of Efficacy|0|||
30621054|NCT00603265|58632622|FG002|Overall Study|Lack of Efficacy|3|||
30621055|NCT00603265|58632620|FG000|Overall Study|Lost to Follow-up|0|||
30898380|NCT01854658|58932027|FG003|Overall Study|Protocol-specified criteria|7|||
30898381|NCT01854658|58932024|FG000|Overall Study|Lack of Efficacy|3|||
30898382|NCT01854658|58932025|FG001|Overall Study|Lack of Efficacy|8|||
30898383|NCT01854658|58932026|FG002|Overall Study|Lack of Efficacy|4|||
30898384|NCT01854658|58932027|FG003|Overall Study|Lack of Efficacy|7|||
30898385|NCT01854658|58932024|FG000|Overall Study|Adverse Event|21|||
30898386|NCT01854658|58932025|FG001|Overall Study|Adverse Event|14|||
30898387|NCT01854658|58932026|FG002|Overall Study|Adverse Event|23|||
30898388|NCT01854658|58932027|FG003|Overall Study|Adverse Event|19|||
30898389|NCT01854658|58932024|FG000|Overall Study|Administrative reasons|5|||
30898390|NCT01854658|58932025|FG001|Overall Study|Administrative reasons|1|||
30898391|NCT01854658|58932026|FG002|Overall Study|Administrative reasons|2|||
30898392|NCT01854658|58932027|FG003|Overall Study|Administrative reasons|2|||
30898393|NCT01892020|58932037|FG000|Period 1|Adverse Event|1|||
30898394|NCT01892020|58932038|FG001|Period 1|Adverse Event|1|||
30898395|NCT01892020|58932037|FG000|Period 1|Protocol Violation|2|||
30898396|NCT01892020|58932038|FG001|Period 1|Protocol Violation|4|||
30898397|NCT01892020|58932037|FG000|Period 1|Unclassified|0|||
30898398|NCT01892020|58932038|FG001|Period 1|Unclassified|1|||
30898399|NCT01892020|58932037|FG000|Period 2|Protocol Violation|1|||
30898400|NCT01892020|58932038|FG001|Period 2|Protocol Violation|0|||
30898401|NCT02485691|58932046|FG000|Overall Study|Adverse Event|25|||
30898402|NCT02485691|58932047|FG001|Overall Study|Adverse Event|11|||
30898403|NCT02485691|58932046|FG000|Overall Study|Poor compliance to protocol|0|||
30898404|NCT02485691|58932047|FG001|Overall Study|Poor compliance to protocol|1|||
30898405|NCT02485691|58932046|FG000|Overall Study|Disease progression|57|||
30898406|NCT02485691|58932047|FG001|Overall Study|Disease progression|92|||
30898407|NCT02485691|58932046|FG000|Overall Study|Investigator's decision|23|||
30898408|NCT02485691|58932047|FG001|Overall Study|Investigator's decision|5|||
30898409|NCT02485691|58932046|FG000|Overall Study|Participant's request|13|||
30898410|NCT02485691|58932047|FG001|Overall Study|Participant's request|6|||
30898411|NCT02485691|58932046|FG000|Overall Study|Other reason|8|||
30898412|NCT02485691|58932047|FG001|Overall Study|Other reason|9|||
30898413|NCT02485691|58932046|FG000|Overall Study|Randomized and not treated|3|||
30898414|NCT02485691|58932047|FG001|Overall Study|Randomized and not treated|2|||
30898415|NCT02517515|58932056|FG000|Overall Study|Adverse Event|0|||
30898416|NCT02517515|58932057|FG001|Overall Study|Adverse Event|1|||
30898417|NCT02517515|58932056|FG000|Overall Study|Withdrew Consent|0|||
30898418|NCT02517515|58932057|FG001|Overall Study|Withdrew Consent|1|||
30898419|NCT02517515|58932056|FG000|Overall Study|Lost to Follow-up|1|||
30898420|NCT02517515|58932057|FG001|Overall Study|Lost to Follow-up|0|||
30898421|NCT02517515|58932056|FG000|Overall Study|Other|1|||
30898422|NCT02517515|58932057|FG001|Overall Study|Other|0|||
30898423|NCT02466659|58932066|FG000|Overall Study|Lost to Follow-up|5|||
30898424|NCT02466659|58932067|FG001|Overall Study|Lost to Follow-up|2|||
30898425|NCT01891864|58932075|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
30898426|NCT01891864|58932076|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
30898427|NCT01891864|58932077|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
30898428|NCT01891864|58932078|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
30898429|NCT01891864|58932079|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
30898430|NCT01891864|58932080|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
30898431|NCT01891864|58932075|FG000|Treatment Period 1|Physician Decision|0|||
30898432|NCT01891864|58932076|FG001|Treatment Period 1|Physician Decision|1|||
30898433|NCT01891864|58932077|FG002|Treatment Period 1|Physician Decision|0|||
30898434|NCT01891864|58932078|FG003|Treatment Period 1|Physician Decision|0|||
30898435|NCT01891864|58932079|FG004|Treatment Period 1|Physician Decision|0|||
30898436|NCT01891864|58932080|FG005|Treatment Period 1|Physician Decision|0|||
30898437|NCT01891864|58932075|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
30898438|NCT01891864|58932076|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
30898439|NCT01891864|58932077|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
30898440|NCT01891864|58932078|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
30898441|NCT01891864|58932079|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
30898442|NCT01891864|58932080|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
30898443|NCT01891864|58932075|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
30898444|NCT01891864|58932076|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
30898445|NCT01891864|58932077|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
30898446|NCT01891864|58932078|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
30898447|NCT01891864|58932079|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
30898448|NCT01891864|58932080|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
30898449|NCT01891864|58932075|FG000|Treatment Period 1|Withdrawal by Subject|2|||
30898450|NCT01891864|58932076|FG001|Treatment Period 1|Withdrawal by Subject|5|||
30898451|NCT01891864|58932077|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30898452|NCT01891864|58932078|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30898453|NCT01891864|58932079|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30898454|NCT01891864|58932080|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30898455|NCT01891864|58932075|FG000|Treatment Period 1|Lost to Follow-up|1|||
30898456|NCT01891864|58932076|FG001|Treatment Period 1|Lost to Follow-up|0|||
30898457|NCT01891864|58932077|FG002|Treatment Period 1|Lost to Follow-up|0|||
30898458|NCT01891864|58932078|FG003|Treatment Period 1|Lost to Follow-up|0|||
30898459|NCT01891864|58932079|FG004|Treatment Period 1|Lost to Follow-up|0|||
30898460|NCT01891864|58932080|FG005|Treatment Period 1|Lost to Follow-up|0|||
30710378|NCT00691301|58723893|FG000|Overall Study|Concurrent illness|2|||
30710379|NCT00691301|58723893|FG000|Overall Study|other reason|3|||
30710380|NCT00691301|58723893|FG000|Overall Study|Did not initiate study treatment|1|||
30710381|NCT00927563|58723903|FG000|Overall Study|Lost to Follow-up|1|||
30710382|NCT00927563|58723903|FG000|Overall Study|Withdrawal by Subject|1|||
30710383|NCT00653159|58723918|FG000|Overall Study|Adverse Event|4|||
30710384|NCT00653159|58723919|FG001|Overall Study|Adverse Event|1|||
30710385|NCT00653159|58723918|FG000|Overall Study|Lost to Follow-up|1|||
30710386|NCT00653159|58723919|FG001|Overall Study|Lost to Follow-up|2|||
30710387|NCT00117637|58723927|FG000|First Intervention (Period 1)|Adverse Event|11|||
30710388|NCT00117637|58723928|FG001|First Intervention (Period 1)|Adverse Event|16|||
30710389|NCT00117637|58723927|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
30710390|NCT00117637|58723928|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
30710391|NCT00117637|58723927|FG000|First Intervention (Period 1)|Protocol Violation|1|||
30710392|NCT00117637|58723928|FG001|First Intervention (Period 1)|Protocol Violation|0|||
30710393|NCT00117637|58723927|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
30710394|NCT00117637|58723928|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
30710395|NCT00117637|58723927|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
30710396|NCT00117637|58723928|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
30710397|NCT00117637|58723927|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
30710398|NCT00117637|58723928|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
30710399|NCT00117637|58723927|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
30710400|NCT00117637|58723928|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
30710401|NCT00117637|58723927|FG000|First Intervention (Period 1)|reason not reported|0|||
30710402|NCT00117637|58723928|FG001|First Intervention (Period 1)|reason not reported|1|||
30710403|NCT00117637|58723927|FG000|Second Intervention (Period 2)|Adverse Event|0|||
30710404|NCT00117637|58723928|FG001|Second Intervention (Period 2)|Adverse Event|9|||
30710405|NCT00117637|58723927|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
30710406|NCT00117637|58723928|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
30710407|NCT00117637|58723927|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
30710408|NCT00117637|58723928|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
30710409|NCT00117637|58723927|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
30710410|NCT00117637|58723928|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
30898461|NCT01891864|58932075|FG000|Treatment Period 2|Protocol Violation|0|||
30898462|NCT01891864|58932076|FG001|Treatment Period 2|Protocol Violation|0|||
30898463|NCT01891864|58932077|FG002|Treatment Period 2|Protocol Violation|0|||
30898464|NCT01891864|58932078|FG003|Treatment Period 2|Protocol Violation|1|||
30898465|NCT01891864|58932079|FG004|Treatment Period 2|Protocol Violation|0|||
30898466|NCT01891864|58932080|FG005|Treatment Period 2|Protocol Violation|0|||
30898467|NCT01891864|58932075|FG000|Treatment Period 2|Physician Decision|0|||
30898468|NCT01891864|58932076|FG001|Treatment Period 2|Physician Decision|0|||
30898469|NCT01891864|58932077|FG002|Treatment Period 2|Physician Decision|1|||
30898470|NCT01891864|58932078|FG003|Treatment Period 2|Physician Decision|0|||
30710411|NCT00117637|58723927|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
30898471|NCT01891864|58932079|FG004|Treatment Period 2|Physician Decision|0|||
30898472|NCT01891864|58932080|FG005|Treatment Period 2|Physician Decision|0|||
30898473|NCT01891864|58932075|FG000|Treatment Period 2|Site Termination|0|||
30898474|NCT01891864|58932076|FG001|Treatment Period 2|Site Termination|0|||
30710412|NCT00117637|58723928|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
30898475|NCT01891864|58932077|FG002|Treatment Period 2|Site Termination|1|||
30898476|NCT01891864|58932078|FG003|Treatment Period 2|Site Termination|2|||
30898477|NCT01891864|58932079|FG004|Treatment Period 2|Site Termination|0|||
30898478|NCT01891864|58932080|FG005|Treatment Period 2|Site Termination|0|||
30898479|NCT01891864|58932075|FG000|Treatment Period 2|Lack of Efficacy|0|||
30898480|NCT01891864|58932076|FG001|Treatment Period 2|Lack of Efficacy|0|||
30898481|NCT01891864|58932077|FG002|Treatment Period 2|Lack of Efficacy|1|||
30898482|NCT01891864|58932078|FG003|Treatment Period 2|Lack of Efficacy|0|||
30898483|NCT01891864|58932079|FG004|Treatment Period 2|Lack of Efficacy|1|||
30898484|NCT01891864|58932080|FG005|Treatment Period 2|Lack of Efficacy|0|||
30898485|NCT01891864|58932075|FG000|Treatment Period 2|Adverse Event|0|||
30898486|NCT01891864|58932076|FG001|Treatment Period 2|Adverse Event|0|||
30898487|NCT01891864|58932077|FG002|Treatment Period 2|Adverse Event|1|||
30898488|NCT01891864|58932078|FG003|Treatment Period 2|Adverse Event|2|||
30898489|NCT01891864|58932079|FG004|Treatment Period 2|Adverse Event|0|||
30898490|NCT01891864|58932080|FG005|Treatment Period 2|Adverse Event|4|||
30898491|NCT01891864|58932075|FG000|Treatment Period 2|Termination of Site|0|||
30898492|NCT01891864|58932076|FG001|Treatment Period 2|Termination of Site|0|||
30898493|NCT01891864|58932077|FG002|Treatment Period 2|Termination of Site|0|||
30898494|NCT01891864|58932078|FG003|Treatment Period 2|Termination of Site|0|||
30898495|NCT01891864|58932079|FG004|Treatment Period 2|Termination of Site|2|||
30898496|NCT01891864|58932080|FG005|Treatment Period 2|Termination of Site|0|||
30898497|NCT01891864|58932075|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30898498|NCT01891864|58932076|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30898499|NCT01891864|58932077|FG002|Treatment Period 2|Withdrawal by Subject|3|||
30898500|NCT01891864|58932078|FG003|Treatment Period 2|Withdrawal by Subject|4|||
30898501|NCT01891864|58932079|FG004|Treatment Period 2|Withdrawal by Subject|1|||
30898502|NCT01891864|58932080|FG005|Treatment Period 2|Withdrawal by Subject|1|||
30898503|NCT01891864|58932075|FG000|Extension Period|Lack of Efficacy|0|||
30898504|NCT01891864|58932076|FG001|Extension Period|Lack of Efficacy|0|||
30898505|NCT01891864|58932077|FG002|Extension Period|Lack of Efficacy|0|||
30898506|NCT01891864|58932078|FG003|Extension Period|Lack of Efficacy|1|||
30898507|NCT01891864|58932079|FG004|Extension Period|Lack of Efficacy|1|||
30898508|NCT01891864|58932080|FG005|Extension Period|Lack of Efficacy|0|||
30898509|NCT01891864|58932075|FG000|Extension Period|Pregnancy|0|||
30898510|NCT01891864|58932076|FG001|Extension Period|Pregnancy|0|||
30898511|NCT01891864|58932077|FG002|Extension Period|Pregnancy|1|||
30898512|NCT01891864|58932078|FG003|Extension Period|Pregnancy|0|||
30898513|NCT01891864|58932079|FG004|Extension Period|Pregnancy|0|||
30898514|NCT01891864|58932080|FG005|Extension Period|Pregnancy|0|||
30898515|NCT01891864|58932075|FG000|Extension Period|Adverse Event|0|||
30898516|NCT01891864|58932076|FG001|Extension Period|Adverse Event|0|||
30898517|NCT01891864|58932077|FG002|Extension Period|Adverse Event|4|||
30898518|NCT01891864|58932078|FG003|Extension Period|Adverse Event|2|||
30898519|NCT01891864|58932079|FG004|Extension Period|Adverse Event|2|||
30898520|NCT01891864|58932080|FG005|Extension Period|Adverse Event|0|||
30898521|NCT01891864|58932075|FG000|Extension Period|Withdrawal by Subject|0|||
30898522|NCT01891864|58932076|FG001|Extension Period|Withdrawal by Subject|0|||
30898523|NCT01891864|58932077|FG002|Extension Period|Withdrawal by Subject|1|||
30898524|NCT01891864|58932078|FG003|Extension Period|Withdrawal by Subject|2|||
30898525|NCT01891864|58932079|FG004|Extension Period|Withdrawal by Subject|4|||
30898526|NCT01891864|58932080|FG005|Extension Period|Withdrawal by Subject|0|||
30898527|NCT01891864|58932075|FG000|Extension Period|Lost to Follow-up|0|||
30898528|NCT01891864|58932076|FG001|Extension Period|Lost to Follow-up|0|||
30898529|NCT01891864|58932077|FG002|Extension Period|Lost to Follow-up|2|||
30898530|NCT01891864|58932078|FG003|Extension Period|Lost to Follow-up|0|||
30898531|NCT01891864|58932079|FG004|Extension Period|Lost to Follow-up|0|||
30898532|NCT01891864|58932080|FG005|Extension Period|Lost to Follow-up|0|||
30898533|NCT02485301|58932094|FG000|Overall Study|Serious Adverse Events|2|||
30898534|NCT02485301|58932095|FG001|Overall Study|Serious Adverse Events|1|||
30898535|NCT02485301|58932094|FG000|Overall Study|Protocol Violation|0|||
30898536|NCT02485301|58932095|FG001|Overall Study|Protocol Violation|1|||
30898537|NCT02485301|58932094|FG000|Overall Study|Withdrawal by Subject|6|||
30898538|NCT02485301|58932095|FG001|Overall Study|Withdrawal by Subject|7|||
30898539|NCT02485301|58932094|FG000|Overall Study|Migrated/moved from study area|10|||
30898540|NCT02485301|58932095|FG001|Overall Study|Migrated/moved from study area|19|||
30898541|NCT02485301|58932094|FG000|Overall Study|Lost to Follow-up|17|||
30898542|NCT02485301|58932095|FG001|Overall Study|Lost to Follow-up|17|||
30898543|NCT02485301|58932094|FG000|Overall Study|Other|3|||
30898544|NCT02485301|58932095|FG001|Overall Study|Other|4|||
30898545|NCT02484911|58932103|FG000|Overall Study|Withdrawal by Subject|2|||
30898546|NCT02484911|58932104|FG001|Overall Study|Withdrawal by Subject|1|||
30898547|NCT02484911|58932103|FG000|Overall Study|Protocol Violation|2|||
30898548|NCT02484911|58932104|FG001|Overall Study|Protocol Violation|1|||
30898549|NCT02466425|58932113|FG000|Overall Study|Adverse Event|3|||
30898550|NCT02466425|58932114|FG001|Overall Study|Adverse Event|11|||
30898551|NCT02466425|58932113|FG000|Overall Study|Lack of Efficacy|4|||
30898552|NCT02466425|58932114|FG001|Overall Study|Lack of Efficacy|1|||
30898553|NCT02466425|58932113|FG000|Overall Study|Lost to Follow-up|3|||
30898554|NCT02466425|58932114|FG001|Overall Study|Lost to Follow-up|0|||
30898555|NCT02466425|58932113|FG000|Overall Study|Protocol Violation|1|||
30898556|NCT02466425|58932114|FG001|Overall Study|Protocol Violation|0|||
30898557|NCT02466425|58932113|FG000|Overall Study|Withdrawal by Subject|0|||
30898558|NCT02466425|58932114|FG001|Overall Study|Withdrawal by Subject|1|||
30898559|NCT02466425|58932113|FG000|Overall Study|Other|1|||
30898560|NCT02466425|58932114|FG001|Overall Study|Other|3|||
30898561|NCT02466425|58932113|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
30898562|NCT02466425|58932114|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
30898563|NCT02451917|58932122|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
30898564|NCT02451917|58932123|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
30898565|NCT02451917|58932122|FG000|First Intervention (24 Weeks)|Death|0|||
30898566|NCT02451917|58932123|FG001|First Intervention (24 Weeks)|Death|1|||
30898567|NCT02451917|58932122|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
30898568|NCT02451917|58932123|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
30898569|NCT02349451|58932136|FG000|Overall Study|Withdrawal by Subject|0|||
30898570|NCT02349451|58932137|FG001|Overall Study|Withdrawal by Subject|1|||
30898571|NCT02349451|58932138|FG002|Overall Study|Withdrawal by Subject|2|||
30898572|NCT02349451|58932139|FG003|Overall Study|Withdrawal by Subject|1|||
30898573|NCT02409368|58932156|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
30898574|NCT02409368|58932157|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
30898575|NCT02409368|58932158|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
30898576|NCT02409368|58932159|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
30898577|NCT02409368|58932156|FG000|ECOG Reclassification|Death|1|||
30898578|NCT02409368|58932157|FG001|ECOG Reclassification|Death|5|||
30898579|NCT02409368|58932158|FG002|ECOG Reclassification|Death|0|||
30898580|NCT02409368|58932159|FG003|ECOG Reclassification|Death|0|||
30898581|NCT02409368|58932156|FG000|ECOG Reclassification|Disease Progression|113|||
30898582|NCT02409368|58932157|FG001|ECOG Reclassification|Disease Progression|382|||
30898583|NCT02409368|58932158|FG002|ECOG Reclassification|Disease Progression|70|||
30898584|NCT02409368|58932159|FG003|ECOG Reclassification|Disease Progression|1|||
30898585|NCT02409368|58932156|FG000|ECOG Reclassification|Lost to Follow-up|1|||
30898586|NCT02409368|58932157|FG001|ECOG Reclassification|Lost to Follow-up|5|||
30898587|NCT02409368|58932158|FG002|ECOG Reclassification|Lost to Follow-up|0|||
30898588|NCT02409368|58932159|FG003|ECOG Reclassification|Lost to Follow-up|0|||
30898589|NCT02409368|58932156|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
30898590|NCT02409368|58932157|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
30898591|NCT02409368|58932158|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
30898592|NCT02409368|58932159|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
30898593|NCT02409368|58932156|FG000|ECOG Reclassification|Poor/non-compliance|0|||
30898594|NCT02409368|58932157|FG001|ECOG Reclassification|Poor/non-compliance|3|||
30898595|NCT02409368|58932158|FG002|ECOG Reclassification|Poor/non-compliance|2|||
30898596|NCT02409368|58932159|FG003|ECOG Reclassification|Poor/non-compliance|0|||
30898597|NCT02409368|58932156|FG000|ECOG Reclassification|Study drug toxicity|17|||
30898598|NCT02409368|58932157|FG001|ECOG Reclassification|Study drug toxicity|42|||
30898599|NCT02409368|58932158|FG002|ECOG Reclassification|Study drug toxicity|7|||
30898600|NCT02409368|58932159|FG003|ECOG Reclassification|Study drug toxicity|0|||
30898601|NCT02409368|58932156|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
30898602|NCT02409368|58932157|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
30898603|NCT02409368|58932158|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
30898604|NCT02409368|58932159|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
30898605|NCT02409368|58932156|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
30898606|NCT02409368|58932157|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
30898607|NCT02409368|58932158|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
30898608|NCT02409368|58932159|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
30898609|NCT02409368|58932156|FG000|ECOG Reclassification|Participant withdrew consent|2|||
30621056|NCT00603265|58632621|FG001|Overall Study|Lost to Follow-up|1|||
30898610|NCT02409368|58932157|FG001|ECOG Reclassification|Participant withdrew consent|3|||
30898611|NCT02409368|58932158|FG002|ECOG Reclassification|Participant withdrew consent|4|||
30898612|NCT02409368|58932159|FG003|ECOG Reclassification|Participant withdrew consent|0|||
30898613|NCT02409368|58932156|FG000|ECOG Reclassification|Other Reasons|5|||
30898614|NCT02409368|58932157|FG001|ECOG Reclassification|Other Reasons|26|||
30898615|NCT02409368|58932158|FG002|ECOG Reclassification|Other Reasons|2|||
30898616|NCT02409368|58932159|FG003|ECOG Reclassification|Other Reasons|0|||
30710413|NCT00117637|58723927|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
30710414|NCT00117637|58723928|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
30710415|NCT00117637|58723927|FG000|Second Intervention (Period 2)|reason not reported|1|||
30710416|NCT00117637|58723928|FG001|Second Intervention (Period 2)|reason not reported|0|||
30710417|NCT00690755|58723948|FG000|Overall Study|Physician Decision|2|||
30710418|NCT00690755|58723949|FG001|Overall Study|Physician Decision|0|||
30710419|NCT00690755|58723950|FG002|Overall Study|Physician Decision|46|||
30710420|NCT00690755|58723951|FG003|Overall Study|Physician Decision|5|||
30710421|NCT00690755|58723952|FG004|Overall Study|Physician Decision|0|||
30710422|NCT00690755|58723953|FG005|Overall Study|Physician Decision|4|||
30710423|NCT00690755|58723954|FG006|Overall Study|Physician Decision|0|||
30710424|NCT00549302|58723972|FG000|Double-Blind|Death|2|||
30710425|NCT00549302|58723973|FG001|Double-Blind|Death|9|||
30710426|NCT00549302|58723974|FG002|Double-Blind|Death|0|||
30710427|NCT00549302|58723972|FG000|Double-Blind|Adverse Event|3|||
30710428|NCT00549302|58723973|FG001|Double-Blind|Adverse Event|16|||
30710429|NCT00549302|58723974|FG002|Double-Blind|Adverse Event|0|||
30710430|NCT00549302|58723972|FG000|Double-Blind|Withdrawal by Subject|3|||
30710431|NCT00549302|58723973|FG001|Double-Blind|Withdrawal by Subject|8|||
30710432|NCT00549302|58723974|FG002|Double-Blind|Withdrawal by Subject|0|||
30710433|NCT00549302|58723972|FG000|Double-Blind|Investigator Decision|1|||
30710434|NCT00549302|58723973|FG001|Double-Blind|Investigator Decision|5|||
30710435|NCT00549302|58723974|FG002|Double-Blind|Investigator Decision|0|||
30710436|NCT00549302|58723972|FG000|Double-Blind|Sponsor Decision|0|||
30710437|NCT00549302|58723973|FG001|Double-Blind|Sponsor Decision|1|||
30710438|NCT00549302|58723974|FG002|Double-Blind|Sponsor Decision|0|||
30710439|NCT00549302|58723972|FG000|Double-Blind|Lost to Follow-up|1|||
30710440|NCT00549302|58723973|FG001|Double-Blind|Lost to Follow-up|2|||
30710441|NCT00549302|58723974|FG002|Double-Blind|Lost to Follow-up|0|||
30710442|NCT00549302|58723972|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
30710443|NCT00549302|58723973|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
30710444|NCT00549302|58723974|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
30710445|NCT00549302|58723972|FG000|Double-Blind|New condition or starts new therapy|0|||
30710446|NCT00549302|58723973|FG001|Double-Blind|New condition or starts new therapy|2|||
30710447|NCT00549302|58723974|FG002|Double-Blind|New condition or starts new therapy|0|||
30710448|NCT00549302|58723972|FG000|Open-Label|Adverse Event|0|||
30710449|NCT00549302|58723973|FG001|Open-Label|Adverse Event|0|||
30710450|NCT00549302|58723974|FG002|Open-Label|Adverse Event|11|||
30710451|NCT00549302|58723972|FG000|Open-Label|Death|0|||
30710452|NCT00549302|58723973|FG001|Open-Label|Death|0|||
30710453|NCT00549302|58723974|FG002|Open-Label|Death|40|||
30710454|NCT00549302|58723972|FG000|Open-Label|Investigator Decision|0|||
30710455|NCT00549302|58723973|FG001|Open-Label|Investigator Decision|0|||
30710456|NCT00549302|58723974|FG002|Open-Label|Investigator Decision|5|||
30710457|NCT00549302|58723972|FG000|Open-Label|Lost to Follow-up|0|||
30710458|NCT00549302|58723973|FG001|Open-Label|Lost to Follow-up|0|||
30710459|NCT00549302|58723974|FG002|Open-Label|Lost to Follow-up|2|||
30710460|NCT00549302|58723972|FG000|Open-Label|Other|0|||
30710461|NCT00549302|58723973|FG001|Open-Label|Other|0|||
30710462|NCT00549302|58723974|FG002|Open-Label|Other|3|||
30710463|NCT00549302|58723972|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
30710464|NCT00549302|58723973|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
30710465|NCT00549302|58723974|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
30710466|NCT00549302|58723972|FG000|Open-Label|Withdrawal by Subject|0|||
30710467|NCT00549302|58723973|FG001|Open-Label|Withdrawal by Subject|0|||
30710468|NCT00549302|58723974|FG002|Open-Label|Withdrawal by Subject|6|||
30710469|NCT00117325|58723984|FG000|Overall Study|Adverse Event|3|||
30710470|NCT00117325|58723985|FG001|Overall Study|Adverse Event|3|||
30710471|NCT00117325|58723984|FG000|Overall Study|Lost to Follow-up|1|||
30710472|NCT00117325|58723985|FG001|Overall Study|Lost to Follow-up|1|||
30898617|NCT02409368|58932156|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
30898618|NCT02409368|58932157|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
30898619|NCT02409368|58932158|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
30710473|NCT00117325|58723984|FG000|Overall Study|Protocol Violation|2|||
30710474|NCT00117325|58723985|FG001|Overall Study|Protocol Violation|3|||
30710475|NCT00117325|58723984|FG000|Overall Study|Withdrawal by Subject|3|||
30710476|NCT00117325|58723985|FG001|Overall Study|Withdrawal by Subject|2|||
30710477|NCT00117325|58723984|FG000|Overall Study|Lack of Efficacy|1|||
30710478|NCT00117325|58723985|FG001|Overall Study|Lack of Efficacy|0|||
30710479|NCT00117325|58723984|FG000|Overall Study|Use of prohibited medicine|1|||
30710480|NCT00117325|58723985|FG001|Overall Study|Use of prohibited medicine|2|||
30710481|NCT00117325|58723984|FG000|Overall Study|Early termination|1|||
30710482|NCT00117325|58723985|FG001|Overall Study|Early termination|1|||
30710483|NCT00117325|58723984|FG000|Overall Study|Admisnitrative|1|||
30898620|NCT02409368|58932159|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
30898621|NCT01853878|58932172|FG000|Overall Study|Recurrence|2|||
30898622|NCT01853878|58932173|FG001|Overall Study|Recurrence|0|||
30898623|NCT01853878|58932172|FG000|Overall Study|Adverse Event|2|||
30898624|NCT01853878|58932173|FG001|Overall Study|Adverse Event|0|||
30898625|NCT01853878|58932172|FG000|Overall Study|Withdrawal by Subject|3|||
30898626|NCT01853878|58932173|FG001|Overall Study|Withdrawal by Subject|1|||
30898627|NCT01853878|58932172|FG000|Overall Study|Migrated/moved from the study area|1|||
30898628|NCT01853878|58932173|FG001|Overall Study|Migrated/moved from the study area|0|||
30898629|NCT01853878|58932172|FG000|Overall Study|Other|55|||
30898630|NCT01853878|58932173|FG001|Overall Study|Other|43|||
30898631|NCT02342678|58932181|FG000|Overall Study|Lost to Follow-up|0|||
30898632|NCT02342678|58932182|FG001|Overall Study|Lost to Follow-up|1|||
30898633|NCT02342678|58932181|FG000|Overall Study|Too busy to complete study|0|||
30898634|NCT02342678|58932182|FG001|Overall Study|Too busy to complete study|2|||
30898635|NCT02342678|58932181|FG000|Overall Study|Family illness/emergency|0|||
30898636|NCT02342678|58932182|FG001|Overall Study|Family illness/emergency|1|||
30898637|NCT02342678|58932181|FG000|Overall Study|Illness/medical reason|1|||
30898638|NCT02342678|58932182|FG001|Overall Study|Illness/medical reason|1|||
30898639|NCT02408120|58932190|FG000|Overall Study|Withdrawal by Subject|0|||
30898640|NCT02408120|58932191|FG001|Overall Study|Withdrawal by Subject|1|||
30898641|NCT02408120|58932190|FG000|Overall Study|Treatment Refusal|1|||
30898642|NCT02408120|58932191|FG001|Overall Study|Treatment Refusal|0|||
30898643|NCT02408120|58932190|FG000|Overall Study|Received Steroids|1|||
30898644|NCT02408120|58932191|FG001|Overall Study|Received Steroids|1|||
30898645|NCT02408120|58932190|FG000|Overall Study|Discharged same day|1|||
30898646|NCT02408120|58932191|FG001|Overall Study|Discharged same day|1|||
30898647|NCT02408120|58932190|FG000|Overall Study|Did not receive insulin|1|||
30898648|NCT02408120|58932191|FG001|Overall Study|Did not receive insulin|2|||
30898649|NCT02342288|58932199|FG000|Overall Study|no protocol anesthesiologist available|3|||
30898650|NCT02342288|58932200|FG001|Overall Study|no protocol anesthesiologist available|2|||
30898651|NCT02342288|58932199|FG000|Overall Study|anesthesia leak in system|1|||
30898652|NCT02342288|58932200|FG001|Overall Study|anesthesia leak in system|0|||
30898653|NCT02342288|58932199|FG000|Overall Study|Withdrawal by Subject|1|||
30898654|NCT02342288|58932200|FG001|Overall Study|Withdrawal by Subject|0|||
30898655|NCT02342288|58932199|FG000|Overall Study|coordinator contaminated with blood|0|||
30898656|NCT02342288|58932200|FG001|Overall Study|coordinator contaminated with blood|1|||
30898657|NCT02342288|58932199|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
30898658|NCT02342288|58932200|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
30898659|NCT02342288|58932199|FG000|Overall Study|coordinator not available|0|||
30898660|NCT02342288|58932200|FG001|Overall Study|coordinator not available|2|||
30898661|NCT01853644|58932206|FG000|Registration and Treatment Start|Did not start treatment|1|||
30898662|NCT01853644|58932206|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
30898663|NCT01853644|58932206|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
30898664|NCT01853644|58932206|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
30898665|NCT01853644|58932206|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
30898666|NCT01853644|58932206|FG000|Continued Treatment After First Response|Adverse Event|2|||
30898667|NCT01853644|58932206|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
30898668|NCT02374346|58932210|FG000|Overall Study|operated or discharged during weekend|48|||
30898669|NCT01853254|58932216|FG000|Overall Study|Abnormal Laboratory Test|1|||
30898670|NCT01853254|58932216|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
30898671|NCT01853254|58932216|FG000|Overall Study|Death|1|||
30898672|NCT01853254|58932216|FG000|Overall Study|Failure to Return|43|||
30898673|NCT01853254|58932216|FG000|Overall Study|Insufficient Therapeutic Response|22|||
30898674|NCT01853254|58932216|FG000|Overall Study|Refusal of Treatment|1|||
30898675|NCT01853254|58932216|FG000|Overall Study|Other Protocol Violation|1|||
30898676|NCT01853254|58932216|FG000|Overall Study|Withdrawal of Consent|16|||
30898677|NCT01853254|58932216|FG000|Overall Study|Administrative/Other|16|||
30898678|NCT02373098|58932222|FG000|Overall Study|Lost to Follow-up|1|||
30898679|NCT02373098|58932223|FG001|Overall Study|Lost to Follow-up|0|||
30898680|NCT02373098|58932222|FG000|Overall Study|Protocol Violation|3|||
30898681|NCT02373098|58932223|FG001|Overall Study|Protocol Violation|0|||
30898682|NCT02373098|58932222|FG000|Overall Study|Withdrawal by Subject|5|||
30898683|NCT02373098|58932223|FG001|Overall Study|Withdrawal by Subject|0|||
30898684|NCT02373098|58932222|FG000|Overall Study|Adverse Event|3|||
30898685|NCT02373098|58932223|FG001|Overall Study|Adverse Event|0|||
30898686|NCT01853176|58932237|FG000|Overall Study|Study terminated|4|||
30898687|NCT01853176|58932238|FG001|Overall Study|Study terminated|0|||
30898688|NCT02372396|58932246|FG000|Overall Study|Lost to Follow-up|7|||
30898689|NCT02372396|58932247|FG001|Overall Study|Lost to Follow-up|9|||
30898690|NCT01835548|58932255|FG000|Dose Optimization Period|Adverse Event|0|||
30898691|NCT01835548|58932256|FG001|Dose Optimization Period|Adverse Event|0|||
30898692|NCT01835548|58932257|FG002|Dose Optimization Period|Adverse Event|1|||
30898693|NCT01835548|58932255|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
30898694|NCT01835548|58932256|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
30898695|NCT01835548|58932257|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
30898696|NCT01835548|58932255|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30898697|NCT01835548|58932256|FG001|Double-Blind Treatment Period|Adverse Event|1|||
30898698|NCT01835548|58932257|FG002|Double-Blind Treatment Period|Adverse Event|0|||
30898699|NCT01835548|58932255|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30898700|NCT01835548|58932256|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
30898701|NCT01835548|58932257|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30898702|NCT01852942|58932271|FG000|Overall Study|Physician Decision|1|||
30898703|NCT01852942|58932272|FG001|Overall Study|Physician Decision|0|||
30898704|NCT01852942|58932271|FG000|Overall Study|Death|1|||
30898705|NCT01852942|58932272|FG001|Overall Study|Death|1|||
30898706|NCT01852942|58932271|FG000|Overall Study|Withdrawal by Subject|2|||
30898707|NCT01852942|58932272|FG001|Overall Study|Withdrawal by Subject|3|||
30898708|NCT01852942|58932271|FG000|Overall Study|Lost to Follow-up|1|||
30898709|NCT01852942|58932272|FG001|Overall Study|Lost to Follow-up|2|||
30898710|NCT01852162|58932281|FG000|Overall Study|Adverse Event|1|||
30898711|NCT01852162|58932282|FG001|Overall Study|Adverse Event|0|||
30898712|NCT01852162|58932281|FG000|Overall Study|Withdrawal by Subject|3|||
30898713|NCT01852162|58932282|FG001|Overall Study|Withdrawal by Subject|1|||
30898714|NCT01835470|58932288|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
30898715|NCT01835470|58932288|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
30898716|NCT02451137|58932295|FG000|Overall Study|Randomized but not treated|19|||
30898717|NCT02451137|58932296|FG001|Overall Study|Randomized but not treated|27|||
30898718|NCT02451137|58932295|FG000|Overall Study|Adverse Event|43|||
30898719|NCT02451137|58932296|FG001|Overall Study|Adverse Event|42|||
30898720|NCT02451137|58932295|FG000|Overall Study|Lack of Efficacy|4|||
30898721|NCT02451137|58932296|FG001|Overall Study|Lack of Efficacy|9|||
30898722|NCT02451137|58932295|FG000|Overall Study|Participant decision:discontinue insulin|41|||
30898723|NCT02451137|58932296|FG001|Overall Study|Participant decision:discontinue insulin|43|||
30898724|NCT02451137|58932295|FG000|Overall Study|Hypoglycemia|2|||
30898725|NCT02451137|58932296|FG001|Overall Study|Hypoglycemia|1|||
30898726|NCT02451137|58932295|FG000|Overall Study|Investigator's decision|23|||
30898727|NCT02451137|58932296|FG001|Overall Study|Investigator's decision|19|||
30898728|NCT02451137|58932295|FG000|Overall Study|Lost to Follow-up|53|||
30898729|NCT02451137|58932296|FG001|Overall Study|Lost to Follow-up|61|||
30898730|NCT02451137|58932295|FG000|Overall Study|Physician Decision|6|||
30710484|NCT00117325|58723985|FG001|Overall Study|Admisnitrative|0|||
30710485|NCT00108433|58723994|FG000|Overall Study|Lack of Efficacy|1|||
30710486|NCT00108433|58723995|FG001|Overall Study|Lack of Efficacy|2|||
30710487|NCT00108433|58723994|FG000|Overall Study|Death|3|||
30710488|NCT00108433|58723995|FG001|Overall Study|Death|0|||
30710489|NCT00108433|58723994|FG000|Overall Study|Adverse Event|3|||
30710490|NCT00108433|58723995|FG001|Overall Study|Adverse Event|1|||
30710491|NCT00108433|58723994|FG000|Overall Study|Other|14|||
30710492|NCT00108433|58723995|FG001|Overall Study|Other|14|||
30710493|NCT00116779|58724003|FG000|Overall Study|Adverse Event|4|||
30710494|NCT00116779|58724004|FG001|Overall Study|Adverse Event|2|||
30710495|NCT00116779|58724003|FG000|Overall Study|Protocol Violation|1|||
30710496|NCT00116779|58724004|FG001|Overall Study|Protocol Violation|4|||
30710497|NCT00116779|58724003|FG000|Overall Study|Withdrawal by Subject|4|||
30710498|NCT00116779|58724004|FG001|Overall Study|Withdrawal by Subject|1|||
30710499|NCT00116779|58724003|FG000|Overall Study|Inadequate testosterone suppression|7|||
30710500|NCT00116779|58724004|FG001|Overall Study|Inadequate testosterone suppression|9|||
30710501|NCT00116779|58724003|FG000|Overall Study|Physician Decision|3|||
30710502|NCT00116779|58724004|FG001|Overall Study|Physician Decision|1|||
30710503|NCT00116779|58724003|FG000|Overall Study|Elevated PSA levels|2|||
30710504|NCT00116779|58724004|FG001|Overall Study|Elevated PSA levels|2|||
30710505|NCT03943290|58724019|FG000|Overall Study|Sponsor Terminated Study|6|||
30710506|NCT03943290|58724020|FG001|Overall Study|Sponsor Terminated Study|1|||
30710507|NCT03943290|58724021|FG002|Overall Study|Sponsor Terminated Study|11|||
30710508|NCT03943290|58724022|FG003|Overall Study|Sponsor Terminated Study|6|||
30710509|NCT03943290|58724023|FG004|Overall Study|Sponsor Terminated Study|7|||
30898731|NCT02451137|58932296|FG001|Overall Study|Physician Decision|5|||
30710510|NCT03943290|58724024|FG005|Overall Study|Sponsor Terminated Study|6|||
30898732|NCT02451137|58932295|FG000|Overall Study|Sponsor decision|13|||
30898733|NCT02451137|58932296|FG001|Overall Study|Sponsor decision|25|||
30898734|NCT02451137|58932295|FG000|Overall Study|Withdrawal by Subject|40|||
30898735|NCT02451137|58932296|FG001|Overall Study|Withdrawal by Subject|63|||
30710511|NCT03943290|58724025|FG006|Overall Study|Sponsor Terminated Study|6|||
30710512|NCT03943290|58724026|FG007|Overall Study|Sponsor Terminated Study|7|||
30710513|NCT03943290|58724027|FG008|Overall Study|Sponsor Terminated Study|8|||
30710514|NCT03943290|58724019|FG000|Overall Study|Lost to Follow-up|1|||
30710515|NCT03943290|58724020|FG001|Overall Study|Lost to Follow-up|0|||
30710516|NCT03943290|58724021|FG002|Overall Study|Lost to Follow-up|1|||
30898736|NCT02451137|58932295|FG000|Overall Study|Other than specified above|2|||
30898737|NCT02451137|58932296|FG001|Overall Study|Other than specified above|3|||
30898738|NCT02372006|58932305|FG000|Overall Study|Progressive disease|8|||
30898739|NCT02372006|58932306|FG001|Overall Study|Progressive disease|7|||
30898740|NCT02372006|58932307|FG002|Overall Study|Progressive disease|34|||
30898741|NCT02372006|58932305|FG000|Overall Study|Dose limiting toxicity|0|||
30898742|NCT02372006|58932306|FG001|Overall Study|Dose limiting toxicity|1|||
30898743|NCT02372006|58932307|FG002|Overall Study|Dose limiting toxicity|0|||
30898744|NCT02372006|58932305|FG000|Overall Study|Adverse Event|0|||
30898745|NCT02372006|58932306|FG001|Overall Study|Adverse Event|0|||
30898746|NCT02372006|58932307|FG002|Overall Study|Adverse Event|3|||
30898747|NCT02372006|58932305|FG000|Overall Study|Withdrawal by Subject|0|||
30898748|NCT02372006|58932306|FG001|Overall Study|Withdrawal by Subject|1|||
30898749|NCT02372006|58932307|FG002|Overall Study|Withdrawal by Subject|1|||
30898750|NCT02372006|58932305|FG000|Overall Study|Other reason for not completing|0|||
30898751|NCT02372006|58932306|FG001|Overall Study|Other reason for not completing|0|||
30898752|NCT02372006|58932307|FG002|Overall Study|Other reason for not completing|1|||
30898753|NCT02406248|58932316|FG000|Overall Study|Death|7|||
30898754|NCT02406248|58932316|FG000|Overall Study|Withdrawal by Subject|2|||
30898755|NCT02450903|58932320|FG000|Overall Study|Adverse Event|3|||
30898756|NCT02450903|58932320|FG000|Overall Study|Progressive disease|15|||
30898757|NCT02450903|58932320|FG000|Overall Study|Switched to commercial drug|1|||
30898758|NCT02450903|58932320|FG000|Overall Study|Subject/guardian decision|1|||
30898759|NCT02371616|58932326|FG000|Overall Study|Protocol Violation|2|||
30898760|NCT02371616|58932327|FG001|Overall Study|Protocol Violation|1|||
30898761|NCT02371616|58932326|FG000|Overall Study|Adverse Event|0|||
30898762|NCT02371616|58932327|FG001|Overall Study|Adverse Event|1|||
30898763|NCT02371616|58932326|FG000|Overall Study|Withdrawal of Consent|1|||
30898764|NCT02371616|58932327|FG001|Overall Study|Withdrawal of Consent|0|||
30898765|NCT02371616|58932326|FG000|Overall Study|Other (Not specified)|1|||
30898766|NCT02371616|58932327|FG001|Overall Study|Other (Not specified)|5|||
30898767|NCT02370914|58932333|FG000|Overall Study|Protocol Violation|2|||
30898768|NCT02370602|58932343|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
30898769|NCT02370602|58932344|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
30898770|NCT02370602|58932345|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
30898771|NCT02370602|58932346|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
30898772|NCT02370602|58932347|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
30898773|NCT02370602|58932348|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
30898774|NCT02370368|58932367|FG000|Overall Study|Adverse Event|1|||
30898775|NCT02370368|58932368|FG001|Overall Study|Adverse Event|2|||
30898776|NCT02370368|58932367|FG000|Overall Study|Withdrawal by Subject|5|||
30898777|NCT02370368|58932368|FG001|Overall Study|Withdrawal by Subject|4|||
30898778|NCT02340806|58932376|FG000|Overall Study|Protocol Violation|2|||
30898779|NCT02340806|58932377|FG001|Overall Study|Protocol Violation|0|||
30898780|NCT02340806|58932376|FG000|Overall Study|epidural catheter replaced|2|||
30898781|NCT02340806|58932377|FG001|Overall Study|epidural catheter replaced|1|||
30898782|NCT02340806|58932376|FG000|Overall Study|history of chronic pain medication|1|||
30898783|NCT02340806|58932377|FG001|Overall Study|history of chronic pain medication|0|||
30898784|NCT02340806|58932376|FG000|Overall Study|re-dose < 90 min of CSE|1|||
30898785|NCT02340806|58932377|FG001|Overall Study|re-dose < 90 min of CSE|3|||
30898786|NCT02338154|58932383|FG000|Overall Study|Death|46|||
30898787|NCT02338154|58932383|FG000|Overall Study|Valve Implant Failure|17|||
30898788|NCT02338154|58932383|FG000|Overall Study|Valve Explant|11|||
30898789|NCT02338154|58932383|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
30898790|NCT02338154|58932383|FG000|Overall Study|Lost to Follow-up|8|||
30898791|NCT02338154|58932383|FG000|Overall Study|Other Reason|3|||
30898792|NCT02338154|58932383|FG000|Overall Study|Patients Without Exit Form|47|||
30898793|NCT02338154|58932383|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
30898794|NCT01835158|58932397|FG000|Overall Study|Withdrawal by Subject|1|||
30898795|NCT01835158|58932398|FG001|Overall Study|Withdrawal by Subject|6|||
30898796|NCT02337764|58932404|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
30898797|NCT02337764|58932404|FG000|Overall Study|Voluntary Withdrawal|12|||
30898798|NCT02337764|58932404|FG000|Overall Study|Lack of Efficacy|2|||
30898799|NCT01834222|58932408|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
30898800|NCT01833832|58932412|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
30898801|NCT01833520|58932418|FG000|Overall Study|Lack of Efficacy|3|||
30898802|NCT01833520|58932419|FG001|Overall Study|Lack of Efficacy|3|||
30898803|NCT01833520|58932420|FG002|Overall Study|Lack of Efficacy|8|||
30898804|NCT01833520|58932421|FG003|Overall Study|Lack of Efficacy|3|||
30898805|NCT01850602|58932435|FG000|Overall Study|Adverse Event|7|||
30898806|NCT01850602|58932436|FG001|Overall Study|Adverse Event|10|||
30898807|NCT01850602|58932435|FG000|Overall Study|Physician Decision|2|||
30898808|NCT01850602|58932436|FG001|Overall Study|Physician Decision|1|||
30898809|NCT01850602|58932435|FG000|Overall Study|Withdrawal by Subject|2|||
30898810|NCT01850602|58932436|FG001|Overall Study|Withdrawal by Subject|4|||
30898811|NCT01850602|58932435|FG000|Overall Study|Decrease in serum calcium|2|||
30898812|NCT01850602|58932436|FG001|Overall Study|Decrease in serum calcium|3|||
30898813|NCT01850602|58932435|FG000|Overall Study|Increase in serum ferritin|1|||
30898814|NCT01850602|58932436|FG001|Overall Study|Increase in serum ferritin|0|||
30898815|NCT01832818|58932442|FG000|Overall Study|Lost to Follow-up|6|||
30898816|NCT02405780|58932450|FG000|Period I|Adverse Event|8|||
30898817|NCT02405780|58932451|FG001|Period I|Adverse Event|0|||
30898818|NCT02405780|58932452|FG002|Period I|Adverse Event|3|||
30898819|NCT02405780|58932453|FG003|Period I|Adverse Event|7|||
30898820|NCT02405780|58932450|FG000|Period I|Medical reasons|1|||
30898821|NCT02405780|58932451|FG001|Period I|Medical reasons|1|||
30898822|NCT02405780|58932452|FG002|Period I|Medical reasons|0|||
30898823|NCT02405780|58932453|FG003|Period I|Medical reasons|1|||
30898824|NCT02405780|58932450|FG000|Period I|Screening Failure|1|||
30898825|NCT02405780|58932451|FG001|Period I|Screening Failure|0|||
30898826|NCT02405780|58932452|FG002|Period I|Screening Failure|1|||
30898827|NCT02405780|58932453|FG003|Period I|Screening Failure|0|||
30898828|NCT02405780|58932450|FG000|Period I|Withdrawal by Subject|9|||
30898829|NCT02405780|58932451|FG001|Period I|Withdrawal by Subject|1|||
30898830|NCT02405780|58932452|FG002|Period I|Withdrawal by Subject|3|||
30898831|NCT02405780|58932453|FG003|Period I|Withdrawal by Subject|4|||
30898832|NCT02405780|58932450|FG000|Period I|Non-compliance with study procedures|8|||
30898833|NCT02405780|58932451|FG001|Period I|Non-compliance with study procedures|6|||
30898834|NCT02405780|58932452|FG002|Period I|Non-compliance with study procedures|8|||
30898835|NCT02405780|58932453|FG003|Period I|Non-compliance with study procedures|11|||
30898836|NCT02405780|58932450|FG000|Period II|Adverse Event|3|||
30898837|NCT02405780|58932451|FG001|Period II|Adverse Event|5|||
30898838|NCT02405780|58932452|FG002|Period II|Adverse Event|4|||
30898839|NCT02405780|58932453|FG003|Period II|Adverse Event|11|||
30898840|NCT02405780|58932450|FG000|Period II|Medical reason|0|||
30898841|NCT02405780|58932451|FG001|Period II|Medical reason|1|||
30898842|NCT02405780|58932452|FG002|Period II|Medical reason|0|||
30898843|NCT02405780|58932453|FG003|Period II|Medical reason|0|||
30898844|NCT02405780|58932450|FG000|Period II|Pregnancy|0|||
30898845|NCT02405780|58932451|FG001|Period II|Pregnancy|0|||
30898846|NCT02405780|58932452|FG002|Period II|Pregnancy|1|||
30898847|NCT02405780|58932453|FG003|Period II|Pregnancy|0|||
30898848|NCT02405780|58932450|FG000|Period II|Withdrawal by Subject|7|||
30898849|NCT02405780|58932451|FG001|Period II|Withdrawal by Subject|4|||
30898850|NCT02405780|58932452|FG002|Period II|Withdrawal by Subject|0|||
30898851|NCT02405780|58932453|FG003|Period II|Withdrawal by Subject|3|||
30898852|NCT02405780|58932450|FG000|Period II|Non-compliance with study procedures|5|||
30898853|NCT02405780|58932451|FG001|Period II|Non-compliance with study procedures|2|||
30898854|NCT02405780|58932452|FG002|Period II|Non-compliance with study procedures|7|||
30898855|NCT02405780|58932453|FG003|Period II|Non-compliance with study procedures|4|||
30898856|NCT02369510|58932481|FG000|Overall Study|Spilled Medication|1|||
30898857|NCT02369510|58932482|FG001|Overall Study|Spilled Medication|2|||
30898858|NCT02369510|58932483|FG002|Overall Study|Spilled Medication|1|||
30898859|NCT02369510|58932481|FG000|Overall Study|Epidural Activation|1|||
30898860|NCT02369510|58932482|FG001|Overall Study|Epidural Activation|1|||
30898861|NCT02369510|58932483|FG002|Overall Study|Epidural Activation|5|||
30898862|NCT01650194|58932491|FG000|Overall Study|Progressive Disease (PD)|35|||
30898863|NCT01650194|58932491|FG000|Overall Study|Withdrawal by Subject|2|||
30898864|NCT01650194|58932491|FG000|Overall Study|Miscellaneous|10|||
30898865|NCT02367716|58932496|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
30898866|NCT02366936|58932501|FG000|Overall Study|Withdrawal by Subject|2|||
30898867|NCT02366936|58932501|FG000|Overall Study|Lost to Follow-up|4|||
30898868|NCT02366936|58932501|FG000|Overall Study|Physician Decision|2|||
30898869|NCT01648166|58932507|FG000|Overall Study|inadequate toenail samples|53|||
30898870|NCT01648166|58932508|FG001|Overall Study|inadequate toenail samples|100|||
30898871|NCT02336282|58932514|FG000|Overall Study|Unrelated illness|1|||
30898872|NCT02336282|58932514|FG000|Overall Study|Uncomfortable with technology|1|||
30898873|NCT02336282|58932514|FG000|Overall Study|Lost to Follow-up|1|||
30898874|NCT02336282|58932514|FG000|Overall Study|Not enough time to complete sessions|2|||
30898875|NCT02404220|58932530|FG000|Overall Study|Adverse Event|0|||
30898876|NCT02404220|58932531|FG001|Overall Study|Adverse Event|0|||
30898877|NCT02404220|58932532|FG002|Overall Study|Adverse Event|1|||
30898878|NCT02404220|58932533|FG003|Overall Study|Adverse Event|0|||
30898879|NCT02404220|58932530|FG000|Overall Study|Death|5|||
30898880|NCT02404220|58932531|FG001|Overall Study|Death|5|||
30621057|NCT00603265|58632622|FG002|Overall Study|Lost to Follow-up|0|||
30898881|NCT02404220|58932532|FG002|Overall Study|Death|3|||
30898882|NCT02404220|58932533|FG003|Overall Study|Death|8|||
30898883|NCT02404220|58932530|FG000|Overall Study|Progressive Disease|0|||
30898884|NCT02404220|58932531|FG001|Overall Study|Progressive Disease|0|||
30898885|NCT02404220|58932532|FG002|Overall Study|Progressive Disease|1|||
30898886|NCT02404220|58932533|FG003|Overall Study|Progressive Disease|1|||
30898887|NCT02404220|58932530|FG000|Overall Study|Study Terminated by Sponsor|0|||
30621058|NCT00603265|58632620|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
30898888|NCT02404220|58932531|FG001|Overall Study|Study Terminated by Sponsor|0|||
30898889|NCT02404220|58932532|FG002|Overall Study|Study Terminated by Sponsor|2|||
30898890|NCT02404220|58932533|FG003|Overall Study|Study Terminated by Sponsor|1|||
30898891|NCT02404220|58932530|FG000|Overall Study|Withdrawal by Subject|0|||
30898892|NCT02404220|58932531|FG001|Overall Study|Withdrawal by Subject|1|||
30898893|NCT02404220|58932532|FG002|Overall Study|Withdrawal by Subject|0|||
30898894|NCT02404220|58932533|FG003|Overall Study|Withdrawal by Subject|0|||
30898895|NCT02404220|58932530|FG000|Overall Study|Enrolled but Never Treated|0|||
30898896|NCT02404220|58932531|FG001|Overall Study|Enrolled but Never Treated|2|||
30898897|NCT02404220|58932532|FG002|Overall Study|Enrolled but Never Treated|0|||
30898898|NCT02404220|58932533|FG003|Overall Study|Enrolled but Never Treated|0|||
30898899|NCT02335658|58932545|FG000|Overall Study|Adverse Event|18|||
30898900|NCT02335658|58932546|FG001|Overall Study|Adverse Event|12|||
30898901|NCT02335658|58932545|FG000|Overall Study|Lack of Efficacy|4|||
30898902|NCT02335658|58932546|FG001|Overall Study|Lack of Efficacy|5|||
30898903|NCT02335658|58932545|FG000|Overall Study|Pregnancy|1|||
30898904|NCT02335658|58932546|FG001|Overall Study|Pregnancy|0|||
30898905|NCT02335658|58932545|FG000|Overall Study|Withdrawal by Subject|13|||
30898906|NCT02335658|58932546|FG001|Overall Study|Withdrawal by Subject|21|||
30898907|NCT02335658|58932545|FG000|Overall Study|non-compliance|2|||
30898908|NCT02335658|58932546|FG001|Overall Study|non-compliance|3|||
30898909|NCT02335658|58932545|FG000|Overall Study|other reason|2|||
30898910|NCT02335658|58932546|FG001|Overall Study|other reason|3|||
30898911|NCT02366468|58932556|FG000|Overall Study|Adverse Event|2|||
30898912|NCT02366468|58932557|FG001|Overall Study|Adverse Event|0|||
30898913|NCT02366468|58932556|FG000|Overall Study|Withdrawal by Subject|1|||
30898914|NCT02366468|58932557|FG001|Overall Study|Withdrawal by Subject|5|||
30898915|NCT02366468|58932556|FG000|Overall Study|Lost to Follow-up|2|||
30898916|NCT02366468|58932557|FG001|Overall Study|Lost to Follow-up|0|||
30898917|NCT02366468|58932556|FG000|Overall Study|Death|1|||
30898918|NCT02366468|58932557|FG001|Overall Study|Death|2|||
30898919|NCT02366468|58932556|FG000|Overall Study|Other|0|||
30898920|NCT02366468|58932557|FG001|Overall Study|Other|2|||
30898921|NCT02366312|58932565|FG000|Overall Study|Lost to Follow-up|0|||
30898922|NCT02366312|58932566|FG001|Overall Study|Lost to Follow-up|1|||
30898923|NCT02335346|58932572|FG000|Overall Study|Adverse Event|11|||
30898924|NCT02335346|58932572|FG000|Overall Study|Withdrawal by Subject|1|||
30898925|NCT02403674|58932578|FG000|Overall Study|Adverse Event|10|||
30898926|NCT02403674|58932579|FG001|Overall Study|Adverse Event|23|||
30898927|NCT02403674|58932578|FG000|Overall Study|Death|1|||
30898928|NCT02403674|58932579|FG001|Overall Study|Death|3|||
30898929|NCT02403674|58932578|FG000|Overall Study|Lack of Efficacy|18|||
30898930|NCT02403674|58932579|FG001|Overall Study|Lack of Efficacy|10|||
30898931|NCT02403674|58932578|FG000|Overall Study|Lost to Follow-up|6|||
30898932|NCT02403674|58932579|FG001|Overall Study|Lost to Follow-up|7|||
30898933|NCT02403674|58932578|FG000|Overall Study|Noncompliance with study drug|1|||
30898934|NCT02403674|58932579|FG001|Overall Study|Noncompliance with study drug|2|||
30898935|NCT02403674|58932578|FG000|Overall Study|Withdrawal by Subject|8|||
30898936|NCT02403674|58932579|FG001|Overall Study|Withdrawal by Subject|11|||
30898937|NCT02403674|58932578|FG000|Overall Study|Physician Decision|2|||
30898938|NCT02403674|58932579|FG001|Overall Study|Physician Decision|2|||
30898939|NCT02403674|58932578|FG000|Overall Study|Not treated with study drug|4|||
30898940|NCT02403674|58932579|FG001|Overall Study|Not treated with study drug|2|||
30898941|NCT02403674|58932578|FG000|Overall Study|Pregnancy|1|||
30898942|NCT02403674|58932579|FG001|Overall Study|Pregnancy|1|||
30898943|NCT02403674|58932578|FG000|Overall Study|Protocol Violation|4|||
30898944|NCT02403674|58932579|FG001|Overall Study|Protocol Violation|2|||
30898945|NCT02403206|58932587|FG000|Overall Study|Lost to Follow-up|4|||
30898946|NCT02403206|58932588|FG001|Overall Study|Lost to Follow-up|3|||
30898947|NCT02403206|58932587|FG000|Overall Study|Physician Decision|2|||
30898948|NCT02403206|58932588|FG001|Overall Study|Physician Decision|0|||
30898949|NCT02403206|58932587|FG000|Overall Study|Withdrawal by Subject|3|||
30898950|NCT02403206|58932588|FG001|Overall Study|Withdrawal by Subject|3|||
30898951|NCT02403206|58932587|FG000|Overall Study|Reason not given|2|||
30898952|NCT02403206|58932588|FG001|Overall Study|Reason not given|4|||
30898953|NCT02333630|58932597|FG000|Overall Study|Lost to Follow-up|5|||
30898954|NCT02333630|58932598|FG001|Overall Study|Lost to Follow-up|2|||
30898955|NCT02401412|58932610|FG000|Overall Study|Lost to Follow-up|1|||
30898956|NCT02401412|58932611|FG001|Overall Study|Lost to Follow-up|0|||
30898957|NCT02401412|58932610|FG000|Overall Study|Discontinued Intervention|15|||
30898958|NCT02401412|58932611|FG001|Overall Study|Discontinued Intervention|21|||
30898959|NCT02401412|58932610|FG000|Overall Study|Withdrawal by Subject|4|||
30898960|NCT02401412|58932611|FG001|Overall Study|Withdrawal by Subject|4|||
30898961|NCT02401412|58932610|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
30898962|NCT02401412|58932611|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
30898963|NCT02401412|58932610|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
30898964|NCT02401412|58932611|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
30898965|NCT02365298|58932617|FG000|Period 2|incorrect Rx dispensed|1|||
30898966|NCT02365298|58932618|FG001|Period 2|incorrect Rx dispensed|0|||
30898967|NCT02365298|58932617|FG000|Period 2|Discontinued at request of Sponsor|1|||
30898968|NCT02365298|58932618|FG001|Period 2|Discontinued at request of Sponsor|0|||
30898969|NCT02365298|58932617|FG000|Period 2|Test Article longer available|0|||
30898970|NCT02365298|58932618|FG001|Period 2|Test Article longer available|1|||
30898971|NCT02365298|58932617|FG000|Period 2|Protocol Violation|0|||
30898972|NCT02365298|58932618|FG001|Period 2|Protocol Violation|1|||
30898973|NCT02365064|58932626|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
30898974|NCT02365064|58932627|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
30898975|NCT02365064|58932626|FG000|Overall Study|Withdrawal by Subject|6|||
30898976|NCT02365064|58932627|FG001|Overall Study|Withdrawal by Subject|9|||
30898977|NCT02365064|58932626|FG000|Overall Study|Treatment intolerance|2|||
30898978|NCT02365064|58932627|FG001|Overall Study|Treatment intolerance|4|||
30898979|NCT02401256|58932633|FG000|Overall Study|Adverse Event|5|||
30898980|NCT02401256|58932633|FG000|Overall Study|Withdrawal by Subject|12|||
30898981|NCT02349295|58932642|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
30898982|NCT02349295|58932643|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
30898983|NCT02349295|58932644|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
30898984|NCT02349295|58932645|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
30898985|NCT02349295|58932646|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
30898986|NCT02349295|58932647|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
30898987|NCT02349295|58932648|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
30898988|NCT02349295|58932649|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
30898989|NCT02349295|58932650|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
30898990|NCT02349295|58932651|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
30898991|NCT02349295|58932652|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
30898992|NCT02349295|58932653|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
30898993|NCT02349295|58932654|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
30898994|NCT02349295|58932655|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
30898995|NCT02349295|58932642|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
30898996|NCT02349295|58932643|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
30898997|NCT02349295|58932644|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
30898998|NCT02349295|58932645|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
30898999|NCT02349295|58932646|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
30899000|NCT02349295|58932647|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
30899001|NCT02349295|58932648|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
30899002|NCT02349295|58932649|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
30899003|NCT02349295|58932650|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
30899004|NCT02349295|58932651|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
30899005|NCT02349295|58932652|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
30899006|NCT02349295|58932653|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
30899007|NCT02349295|58932654|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
30899008|NCT02349295|58932655|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
30899009|NCT02349295|58932642|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
30899010|NCT02349295|58932643|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
30899011|NCT02349295|58932644|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
30899012|NCT02349295|58932645|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
30899013|NCT02349295|58932646|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
30899014|NCT02349295|58932647|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
30899015|NCT02349295|58932648|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
30899016|NCT02349295|58932649|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
30899017|NCT02349295|58932650|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
30899018|NCT02349295|58932651|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
30899019|NCT02349295|58932652|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
30710517|NCT03943290|58724022|FG003|Overall Study|Lost to Follow-up|0|||
30710518|NCT03943290|58724023|FG004|Overall Study|Lost to Follow-up|0|||
30710519|NCT03943290|58724024|FG005|Overall Study|Lost to Follow-up|0|||
30710520|NCT03943290|58724025|FG006|Overall Study|Lost to Follow-up|0|||
30710521|NCT03943290|58724026|FG007|Overall Study|Lost to Follow-up|1|||
30710522|NCT03943290|58724027|FG008|Overall Study|Lost to Follow-up|0|||
30710523|NCT03943290|58724019|FG000|Overall Study|Withdrawal by Subject|0|||
30710524|NCT03943290|58724020|FG001|Overall Study|Withdrawal by Subject|0|||
30710525|NCT03943290|58724021|FG002|Overall Study|Withdrawal by Subject|1|||
30710526|NCT03943290|58724022|FG003|Overall Study|Withdrawal by Subject|0|||
30710527|NCT03943290|58724023|FG004|Overall Study|Withdrawal by Subject|0|||
30710528|NCT03943290|58724024|FG005|Overall Study|Withdrawal by Subject|0|||
30710529|NCT03943290|58724025|FG006|Overall Study|Withdrawal by Subject|0|||
30710530|NCT03943290|58724026|FG007|Overall Study|Withdrawal by Subject|0|||
30710531|NCT03943290|58724027|FG008|Overall Study|Withdrawal by Subject|0|||
30710532|NCT00108355|58724062|FG000|Overall Study|Peritonitis at index paracentesis|1|||
30710533|NCT00108355|58724063|FG001|Overall Study|Peritonitis at index paracentesis|1|||
30710534|NCT00108355|58724062|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
30710535|NCT00108355|58724063|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
30710536|NCT00094861|58724084|FG000|Overall Study|Adverse Event|5|||
30710537|NCT00094861|58724085|FG001|Overall Study|Adverse Event|2|||
30710538|NCT00094861|58724084|FG000|Overall Study|Withdrawal by Subject|5|||
30710539|NCT00094861|58724085|FG001|Overall Study|Withdrawal by Subject|3|||
30710540|NCT00094861|58724084|FG000|Overall Study|Physician Decision|1|||
30710541|NCT00094861|58724085|FG001|Overall Study|Physician Decision|1|||
30710542|NCT00094861|58724084|FG000|Overall Study|Lost to Follow-up|0|||
30710543|NCT00094861|58724085|FG001|Overall Study|Lost to Follow-up|1|||
30710544|NCT00094861|58724084|FG000|Overall Study|Death|4|||
30710545|NCT00094861|58724085|FG001|Overall Study|Death|2|||
30710546|NCT00094861|58724084|FG000|Overall Study|Other|3|||
30710547|NCT00094861|58724085|FG001|Overall Study|Other|0|||
30710548|NCT00426556|58724095|FG000|Phase I - Core Phase|Disease Progression|0|||
30710549|NCT00426556|58724096|FG001|Phase I - Core Phase|Disease Progression|6|||
30710550|NCT00426556|58724097|FG002|Phase I - Core Phase|Disease Progression|2|||
30710551|NCT00426556|58724098|FG003|Phase I - Core Phase|Disease Progression|0|||
30710552|NCT00426556|58724095|FG000|Phase I - Core Phase|Adverse Event|1|||
30710553|NCT00426556|58724096|FG001|Phase I - Core Phase|Adverse Event|3|||
30710554|NCT00426556|58724097|FG002|Phase I - Core Phase|Adverse Event|1|||
30710555|NCT00426556|58724098|FG003|Phase I - Core Phase|Adverse Event|0|||
30710556|NCT00426556|58724095|FG000|Phase I - Core Phase|Death|0|||
30710557|NCT00426556|58724096|FG001|Phase I - Core Phase|Death|1|||
30710558|NCT00426556|58724097|FG002|Phase I - Core Phase|Death|0|||
30710559|NCT00426556|58724098|FG003|Phase I - Core Phase|Death|0|||
30710560|NCT00426556|58724095|FG000|Phase I - Extension Phase|Adverse Event|0|||
30710561|NCT00426556|58724096|FG001|Phase I - Extension Phase|Adverse Event|1|||
30710562|NCT00426556|58724097|FG002|Phase I - Extension Phase|Adverse Event|1|||
30710563|NCT00426556|58724098|FG003|Phase I - Extension Phase|Adverse Event|0|||
30710564|NCT00426556|58724095|FG000|Phase I - Extension Phase|Disease Progression|5|||
30710565|NCT00426556|58724096|FG001|Phase I - Extension Phase|Disease Progression|5|||
30710566|NCT00426556|58724097|FG002|Phase I - Extension Phase|Disease Progression|6|||
30710567|NCT00426556|58724098|FG003|Phase I - Extension Phase|Disease Progression|0|||
30899020|NCT02349295|58932653|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
30899021|NCT02349295|58932654|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
30899022|NCT02349295|58932655|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
30899023|NCT02349295|58932642|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
30899024|NCT02349295|58932643|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
30899025|NCT02349295|58932644|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
30899026|NCT02349295|58932645|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
30899027|NCT02349295|58932646|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
30899028|NCT02349295|58932647|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
30899029|NCT02349295|58932648|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
30899030|NCT02349295|58932649|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
30899031|NCT02349295|58932650|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
30899032|NCT02349295|58932651|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
30899033|NCT02349295|58932652|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
30899034|NCT02349295|58932653|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
30899035|NCT02349295|58932654|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
30899036|NCT02349295|58932655|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
30899037|NCT02349295|58932642|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30899038|NCT02349295|58932643|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
30710568|NCT00426556|58724095|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
30710569|NCT00426556|58724096|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
30899039|NCT02349295|58932644|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
30710570|NCT00426556|58724097|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
30710571|NCT00426556|58724098|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
30710572|NCT00426556|58724095|FG000|Phase II - Core Phase|Disease Progression|0|||
30710573|NCT00426556|58724096|FG001|Phase II - Core Phase|Disease Progression|0|||
30710574|NCT00426556|58724097|FG002|Phase II - Core Phase|Disease Progression|0|||
30710575|NCT00426556|58724098|FG003|Phase II - Core Phase|Disease Progression|16|||
30710576|NCT00426556|58724095|FG000|Phase II - Core Phase|Adverse Event|0|||
30710577|NCT00426556|58724096|FG001|Phase II - Core Phase|Adverse Event|0|||
30710578|NCT00426556|58724097|FG002|Phase II - Core Phase|Adverse Event|0|||
30710579|NCT00426556|58724098|FG003|Phase II - Core Phase|Adverse Event|8|||
30710580|NCT00426556|58724095|FG000|Phase II - Extension Phase|Disease Progression|0|||
30710581|NCT00426556|58724096|FG001|Phase II - Extension Phase|Disease Progression|0|||
30710582|NCT00426556|58724097|FG002|Phase II - Extension Phase|Disease Progression|0|||
30710583|NCT00426556|58724098|FG003|Phase II - Extension Phase|Disease Progression|21|||
30710584|NCT00426556|58724095|FG000|Phase II - Extension Phase|Adverse Event|0|||
30710585|NCT00426556|58724096|FG001|Phase II - Extension Phase|Adverse Event|0|||
30710586|NCT00426556|58724097|FG002|Phase II - Extension Phase|Adverse Event|0|||
30710587|NCT00426556|58724098|FG003|Phase II - Extension Phase|Adverse Event|2|||
30710588|NCT00107653|58724110|FG000|Overall Study|Adverse Event|24|||
30710589|NCT00107653|58724111|FG001|Overall Study|Adverse Event|43|||
30790894|NCT03200912|58803989|FG001|Overall Study|Adverse Event|0|||
30899040|NCT02349295|58932645|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30899041|NCT02349295|58932646|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30899042|NCT02349295|58932647|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30710590|NCT00107653|58724110|FG000|Overall Study|Insufficient Therapeutic Response|25|||
30710591|NCT00107653|58724111|FG001|Overall Study|Insufficient Therapeutic Response|11|||
30710592|NCT00107653|58724110|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
30710593|NCT00107653|58724111|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
30899043|NCT02349295|58932648|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30899044|NCT02349295|58932649|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30899045|NCT02349295|58932650|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30899046|NCT02349295|58932651|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30899047|NCT02349295|58932652|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30899048|NCT02349295|58932653|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30899049|NCT02349295|58932654|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30899050|NCT02349295|58932655|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
30899051|NCT02349295|58932642|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
30899052|NCT02349295|58932643|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
30899053|NCT02349295|58932644|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
30899054|NCT02349295|58932645|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
30899055|NCT02349295|58932646|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
30899056|NCT02349295|58932647|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
30899057|NCT02349295|58932648|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
30899058|NCT02349295|58932649|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
30899059|NCT02349295|58932650|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
30899060|NCT02349295|58932651|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
30899061|NCT02349295|58932652|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
30899062|NCT02349295|58932653|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
30899063|NCT02349295|58932654|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
30899064|NCT02349295|58932655|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
30899065|NCT02349295|58932642|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
30899066|NCT02349295|58932643|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
30899067|NCT02349295|58932644|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
30899068|NCT02349295|58932645|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
30899069|NCT02349295|58932646|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
30899070|NCT02349295|58932647|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
30899071|NCT02349295|58932648|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
30899072|NCT02349295|58932649|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
30899073|NCT02349295|58932650|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
30899074|NCT02349295|58932651|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
30899075|NCT02349295|58932652|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
30899076|NCT02349295|58932653|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
30899077|NCT02349295|58932654|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
30621059|NCT00603265|58632621|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
30899078|NCT02349295|58932655|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
30899079|NCT02349295|58932642|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
30899080|NCT02349295|58932643|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
30899081|NCT02349295|58932644|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
30899082|NCT02349295|58932645|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
30899083|NCT02349295|58932646|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
30899084|NCT02349295|58932647|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
30899085|NCT02349295|58932648|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
30621060|NCT00603265|58632622|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
30899086|NCT02349295|58932649|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
30899087|NCT02349295|58932650|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
30899088|NCT02349295|58932651|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
30899089|NCT02349295|58932652|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
30899090|NCT02349295|58932653|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
30899091|NCT02349295|58932654|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
30899092|NCT02349295|58932655|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
30899093|NCT02349295|58932642|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899094|NCT02349295|58932643|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899095|NCT02349295|58932644|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899096|NCT02349295|58932645|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899097|NCT02349295|58932646|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899098|NCT02349295|58932647|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899099|NCT02349295|58932648|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899100|NCT02349295|58932649|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
30899101|NCT02349295|58932650|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899102|NCT02349295|58932651|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
30899103|NCT02349295|58932652|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899104|NCT02349295|58932653|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899105|NCT02349295|58932654|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899106|NCT02349295|58932655|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
30899107|NCT02349295|58932642|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
30899108|NCT02349295|58932643|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
30899109|NCT02349295|58932644|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
30899110|NCT02349295|58932645|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
30899111|NCT02349295|58932646|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
30899112|NCT02349295|58932647|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
30899113|NCT02349295|58932648|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
30899114|NCT02349295|58932649|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
30899115|NCT02349295|58932650|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
30899116|NCT02349295|58932651|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
30899117|NCT02349295|58932652|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
30899118|NCT02349295|58932653|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
30899119|NCT02349295|58932654|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
30899120|NCT02349295|58932655|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
30899121|NCT02349295|58932642|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
30899122|NCT02349295|58932643|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
30899123|NCT02349295|58932644|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
30899124|NCT02349295|58932645|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
30899125|NCT02349295|58932646|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
30899126|NCT02349295|58932647|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
30899127|NCT02349295|58932648|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
30899128|NCT02349295|58932649|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
30899129|NCT02349295|58932650|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
30899130|NCT02349295|58932651|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
30899131|NCT02349295|58932652|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
30899132|NCT02349295|58932653|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
30899133|NCT02349295|58932654|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
30899134|NCT02349295|58932655|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
30899135|NCT02349295|58932642|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899136|NCT02349295|58932643|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899137|NCT02349295|58932644|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899138|NCT02349295|58932645|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899139|NCT02349295|58932646|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899140|NCT02349295|58932647|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899141|NCT02349295|58932648|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899142|NCT02349295|58932649|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
30899143|NCT02349295|58932650|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
30899144|NCT02349295|58932651|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899145|NCT02349295|58932652|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899146|NCT02349295|58932653|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899147|NCT02349295|58932654|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899148|NCT02349295|58932655|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
30899149|NCT02349295|58932642|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899150|NCT02349295|58932643|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899151|NCT02349295|58932644|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899152|NCT02349295|58932645|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899153|NCT02349295|58932646|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899154|NCT02349295|58932647|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899155|NCT02349295|58932648|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899156|NCT02349295|58932649|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
30899157|NCT02349295|58932650|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
30899158|NCT02349295|58932651|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899159|NCT02349295|58932652|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899160|NCT02349295|58932653|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899161|NCT02349295|58932654|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899162|NCT02349295|58932655|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
30899163|NCT02349295|58932642|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
30899164|NCT02349295|58932643|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
30899165|NCT02349295|58932644|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
30899166|NCT02349295|58932645|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
30899167|NCT02349295|58932646|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
30899168|NCT02349295|58932647|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
30899169|NCT02349295|58932648|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
30899170|NCT02349295|58932649|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
30899171|NCT02349295|58932650|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
30899172|NCT02349295|58932651|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
30899173|NCT02349295|58932652|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
30899174|NCT02349295|58932653|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
30899175|NCT02349295|58932654|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
30899176|NCT02349295|58932655|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
30899177|NCT02349295|58932642|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899178|NCT02349295|58932643|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899179|NCT02349295|58932644|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899180|NCT02349295|58932645|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899181|NCT02349295|58932646|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899182|NCT02349295|58932647|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899183|NCT02349295|58932648|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899184|NCT02349295|58932649|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899185|NCT02349295|58932650|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899186|NCT02349295|58932651|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899187|NCT02349295|58932652|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899188|NCT02349295|58932653|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
30899189|NCT02349295|58932654|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
30899190|NCT02349295|58932655|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
30899191|NCT02349295|58932642|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899192|NCT02349295|58932643|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899193|NCT02349295|58932644|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899194|NCT02349295|58932645|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899195|NCT02349295|58932646|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899196|NCT02349295|58932647|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899197|NCT02349295|58932648|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899198|NCT02349295|58932649|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899199|NCT02349295|58932650|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899200|NCT02349295|58932651|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899201|NCT02349295|58932652|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899202|NCT02349295|58932653|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
30899203|NCT02349295|58932654|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
30899204|NCT02349295|58932655|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
30899205|NCT02349295|58932642|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899206|NCT02349295|58932643|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899207|NCT02349295|58932644|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899208|NCT02349295|58932645|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899209|NCT02349295|58932646|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899210|NCT02349295|58932647|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899211|NCT02349295|58932648|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899212|NCT02349295|58932649|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899213|NCT02349295|58932650|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899214|NCT02349295|58932651|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899215|NCT02349295|58932652|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899216|NCT02349295|58932653|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
30899217|NCT02349295|58932654|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899218|NCT02349295|58932655|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
30899219|NCT02349295|58932642|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899220|NCT02349295|58932643|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899221|NCT02349295|58932644|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899222|NCT02349295|58932645|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899223|NCT02349295|58932646|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899224|NCT02349295|58932647|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899225|NCT02349295|58932648|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899226|NCT02349295|58932649|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899227|NCT02349295|58932650|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899228|NCT02349295|58932651|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899229|NCT02349295|58932652|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899230|NCT02349295|58932653|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
30899231|NCT02349295|58932654|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899232|NCT02349295|58932655|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
30899233|NCT02281357|58932682|FG000|Overall Study|Adverse Event|2|||
30899234|NCT02281357|58932683|FG001|Overall Study|Adverse Event|1|||
30899235|NCT02281357|58932682|FG000|Overall Study|Lost to Follow-up|1|||
30899236|NCT02281357|58932683|FG001|Overall Study|Lost to Follow-up|0|||
30899237|NCT02281357|58932682|FG000|Overall Study|Withdrawal by Subject|4|||
30899238|NCT02281357|58932683|FG001|Overall Study|Withdrawal by Subject|3|||
30899239|NCT02284243|58932691|FG000|Overall Study|Lack of Efficacy|3|||
30899240|NCT02284243|58932692|FG001|Overall Study|Lack of Efficacy|3|||
30899241|NCT02284243|58932691|FG000|Overall Study|Adverse Event|1|||
30899242|NCT02284243|58932692|FG001|Overall Study|Adverse Event|0|||
30899243|NCT02284009|58932700|FG000|Overall Study|Adverse Event|3|||
30899244|NCT02284009|58932701|FG001|Overall Study|Adverse Event|0|||
30899245|NCT02284009|58932700|FG000|Overall Study|Lost to Follow-up|1|||
30899246|NCT02284009|58932701|FG001|Overall Study|Lost to Follow-up|3|||
30899247|NCT02284009|58932700|FG000|Overall Study|Physician Decision|0|||
30899248|NCT02284009|58932701|FG001|Overall Study|Physician Decision|2|||
30899249|NCT02284009|58932700|FG000|Overall Study|Withdrawal by Subject|2|||
30899250|NCT02284009|58932701|FG001|Overall Study|Withdrawal by Subject|5|||
30899251|NCT02280499|58932709|FG000|Overall Study|Death|14|||
30899252|NCT02280499|58932709|FG000|Overall Study|Lost to Follow-up|42|||
30899253|NCT02280499|58932709|FG000|Overall Study|Adverse Event|5|||
30899254|NCT02400476|58932719|FG000|Overall Study|Adverse Event|57|||
30790895|NCT03200912|58803990|FG002|Overall Study|Adverse Event|0|||
30899255|NCT02400476|58932720|FG001|Overall Study|Adverse Event|10|||
30790896|NCT03200912|58803988|FG000|Overall Study|Withdrawal by Subject|1|||
30899256|NCT02400476|58932721|FG002|Overall Study|Adverse Event|22|||
30899257|NCT02400476|58932722|FG003|Overall Study|Adverse Event|19|||
30899258|NCT02400476|58932723|FG004|Overall Study|Adverse Event|5|||
30899259|NCT02400476|58932724|FG005|Overall Study|Adverse Event|8|||
30899260|NCT02400476|58932719|FG000|Overall Study|Withdrawal by Subject|4|||
30899261|NCT02400476|58932720|FG001|Overall Study|Withdrawal by Subject|1|||
30899262|NCT02400476|58932721|FG002|Overall Study|Withdrawal by Subject|12|||
30899263|NCT02400476|58932722|FG003|Overall Study|Withdrawal by Subject|7|||
30899264|NCT02400476|58932723|FG004|Overall Study|Withdrawal by Subject|5|||
30899265|NCT02400476|58932724|FG005|Overall Study|Withdrawal by Subject|5|||
30899266|NCT02400476|58932719|FG000|Overall Study|Lost to Follow-up|0|||
30899267|NCT02400476|58932720|FG001|Overall Study|Lost to Follow-up|0|||
30899268|NCT02400476|58932721|FG002|Overall Study|Lost to Follow-up|0|||
30899269|NCT02400476|58932722|FG003|Overall Study|Lost to Follow-up|1|||
30899270|NCT02400476|58932723|FG004|Overall Study|Lost to Follow-up|3|||
30899271|NCT02400476|58932724|FG005|Overall Study|Lost to Follow-up|1|||
30899272|NCT02400476|58932719|FG000|Overall Study|Physician Decision|0|||
30899273|NCT02400476|58932720|FG001|Overall Study|Physician Decision|0|||
30899274|NCT02400476|58932721|FG002|Overall Study|Physician Decision|1|||
30899275|NCT02400476|58932722|FG003|Overall Study|Physician Decision|1|||
30899276|NCT02400476|58932723|FG004|Overall Study|Physician Decision|0|||
30899277|NCT02400476|58932724|FG005|Overall Study|Physician Decision|1|||
30899278|NCT02400476|58932719|FG000|Overall Study|Other, Disease Progression|0|||
30899279|NCT02400476|58932720|FG001|Overall Study|Other, Disease Progression|1|||
30899280|NCT02400476|58932721|FG002|Overall Study|Other, Disease Progression|2|||
30899281|NCT02400476|58932722|FG003|Overall Study|Other, Disease Progression|1|||
30899282|NCT02400476|58932723|FG004|Overall Study|Other, Disease Progression|2|||
30899283|NCT02400476|58932724|FG005|Overall Study|Other, Disease Progression|1|||
30899284|NCT02400476|58932719|FG000|Overall Study|Other, Decreased Quality of Life|0|||
30899285|NCT02400476|58932720|FG001|Overall Study|Other, Decreased Quality of Life|0|||
30899286|NCT02400476|58932721|FG002|Overall Study|Other, Decreased Quality of Life|2|||
30899287|NCT02400476|58932722|FG003|Overall Study|Other, Decreased Quality of Life|0|||
30899288|NCT02400476|58932723|FG004|Overall Study|Other, Decreased Quality of Life|0|||
30899289|NCT02400476|58932724|FG005|Overall Study|Other, Decreased Quality of Life|0|||
30899290|NCT02400476|58932719|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
30899291|NCT02400476|58932720|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
30899292|NCT02400476|58932721|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
30899293|NCT02400476|58932722|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
30899294|NCT02400476|58932723|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
30899295|NCT02400476|58932724|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
30899296|NCT02363738|58932740|FG000|Overall Study|Adverse Event|5|||
30899297|NCT02363738|58932741|FG001|Overall Study|Adverse Event|2|||
30899298|NCT02363738|58932740|FG000|Overall Study|Lack of Efficacy|1|||
30899299|NCT02363738|58932741|FG001|Overall Study|Lack of Efficacy|2|||
30899300|NCT02363738|58932740|FG000|Overall Study|Lost to Follow-up|2|||
30899301|NCT02363738|58932741|FG001|Overall Study|Lost to Follow-up|1|||
30899302|NCT02331680|58932750|FG000|Overall Study|Adverse Event|3|||
30899303|NCT02331680|58932751|FG001|Overall Study|Adverse Event|0|||
30899304|NCT02331680|58932752|FG002|Overall Study|Adverse Event|2|||
30899305|NCT02331680|58932750|FG000|Overall Study|Physician Decision|1|||
30899306|NCT02331680|58932751|FG001|Overall Study|Physician Decision|1|||
30899307|NCT02331680|58932752|FG002|Overall Study|Physician Decision|2|||
30899308|NCT02331680|58932750|FG000|Overall Study|Withdrawal by Subject|0|||
30899309|NCT02331680|58932751|FG001|Overall Study|Withdrawal by Subject|1|||
30899310|NCT02331680|58932752|FG002|Overall Study|Withdrawal by Subject|2|||
30899311|NCT02331680|58932750|FG000|Overall Study|Met withdrawal criteria|2|||
30899312|NCT02331680|58932751|FG001|Overall Study|Met withdrawal criteria|2|||
30899313|NCT02331680|58932752|FG002|Overall Study|Met withdrawal criteria|5|||
30899314|NCT02331680|58932750|FG000|Overall Study|Non-compliance with study drug|0|||
30899315|NCT02331680|58932751|FG001|Overall Study|Non-compliance with study drug|0|||
30899316|NCT02331680|58932752|FG002|Overall Study|Non-compliance with study drug|1|||
30899317|NCT02331680|58932750|FG000|Overall Study|Protocol Violation|0|||
30899318|NCT02331680|58932751|FG001|Overall Study|Protocol Violation|0|||
30899319|NCT02331680|58932752|FG002|Overall Study|Protocol Violation|3|||
30899320|NCT02331446|58932764|FG000|Overall Study|Lost to Follow-up|2|||
30899321|NCT02331446|58932765|FG001|Overall Study|Lost to Follow-up|1|||
30621061|NCT00603265|58632620|FG000|Overall Study|Participant Left Country, No Responses|0|||
30899322|NCT02331446|58932766|FG002|Overall Study|Lost to Follow-up|0|||
30899323|NCT02331446|58932767|FG003|Overall Study|Lost to Follow-up|1|||
30899324|NCT02331446|58932764|FG000|Overall Study|Personal Problem|2|||
30899325|NCT02331446|58932765|FG001|Overall Study|Personal Problem|0|||
30899326|NCT02331446|58932766|FG002|Overall Study|Personal Problem|0|||
30899327|NCT02331446|58932767|FG003|Overall Study|Personal Problem|0|||
30899328|NCT02331446|58932764|FG000|Overall Study|Disease|0|||
30899329|NCT02331446|58932765|FG001|Overall Study|Disease|2|||
30899330|NCT02331446|58932766|FG002|Overall Study|Disease|2|||
30899331|NCT02331446|58932767|FG003|Overall Study|Disease|1|||
30899332|NCT02331446|58932764|FG000|Overall Study|Physician Decision|0|||
30899333|NCT02331446|58932765|FG001|Overall Study|Physician Decision|1|||
30899334|NCT02331446|58932766|FG002|Overall Study|Physician Decision|0|||
30899335|NCT02331446|58932767|FG003|Overall Study|Physician Decision|1|||
30899336|NCT02331446|58932764|FG000|Overall Study|Lost before baseline analysis|0|||
30899337|NCT02331446|58932765|FG001|Overall Study|Lost before baseline analysis|1|||
30899338|NCT02331446|58932766|FG002|Overall Study|Lost before baseline analysis|1|||
30899339|NCT02331446|58932767|FG003|Overall Study|Lost before baseline analysis|0|||
30899340|NCT02349061|58932779|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
30899341|NCT02349061|58932780|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
30621062|NCT00603265|58632621|FG001|Overall Study|Participant Left Country, No Responses|1|||
30621063|NCT00603265|58632622|FG002|Overall Study|Participant Left Country, No Responses|0|||
30899342|NCT02349061|58932781|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
30899343|NCT02349061|58932779|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
30899344|NCT02349061|58932780|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
30899345|NCT02349061|58932781|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
30899346|NCT02349061|58932779|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
30899347|NCT02349061|58932780|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
30899348|NCT02349061|58932781|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
30899349|NCT02349061|58932779|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
30899350|NCT02349061|58932780|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
30899351|NCT02349061|58932781|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
30899352|NCT02349061|58932779|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
30899353|NCT02349061|58932780|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
30899354|NCT02349061|58932781|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
30899355|NCT02349061|58932779|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
30899356|NCT02349061|58932780|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
30899357|NCT02349061|58932781|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
30899358|NCT02349061|58932779|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
30899359|NCT02349061|58932780|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
30899360|NCT02349061|58932781|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
30899361|NCT02349061|58932779|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
30899362|NCT02349061|58932780|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
30899363|NCT02349061|58932781|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
30899364|NCT02349061|58932779|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
30899365|NCT02349061|58932780|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
30899366|NCT02349061|58932781|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
30899367|NCT02349061|58932779|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
30710594|NCT00107653|58724110|FG000|Overall Study|Protocol Violation|1|||
30899368|NCT02349061|58932780|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
30899369|NCT02349061|58932781|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
30899370|NCT02349061|58932779|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
30899371|NCT02349061|58932780|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
30899372|NCT02349061|58932781|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
30899373|NCT02349061|58932779|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
30899374|NCT02349061|58932780|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
30899375|NCT02349061|58932781|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
30899376|NCT02349061|58932779|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
30899377|NCT02349061|58932780|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
30899378|NCT02349061|58932781|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
30899379|NCT02331368|58932791|FG000|Overall Study|Withdrawal by Subject|3|||
30899380|NCT02362724|58932797|FG000|Overall Study|Withdrawal by Subject|3|||
30899381|NCT02362724|58932798|FG001|Overall Study|Withdrawal by Subject|1|||
30899382|NCT02362724|58932797|FG000|Overall Study|Adverse Event|3|||
30899383|NCT02362724|58932798|FG001|Overall Study|Adverse Event|0|||
30899384|NCT02362646|58932806|FG000|Overall Study|Death|15|||
30899385|NCT02362646|58932807|FG001|Overall Study|Death|8|||
30899386|NCT02362646|58932806|FG000|Overall Study|Withdrawal by Subject|2|||
30899387|NCT02362646|58932807|FG001|Overall Study|Withdrawal by Subject|2|||
30899388|NCT02362646|58932806|FG000|Overall Study|received transplant|21|||
30899389|NCT02362646|58932807|FG001|Overall Study|received transplant|14|||
30899390|NCT02280421|58932817|FG000|Washout (2 Weeks)|Adverse Event|0|||
30899391|NCT02280421|58932818|FG001|Washout (2 Weeks)|Adverse Event|1|||
30899392|NCT02280421|58932817|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
30899393|NCT02280421|58932818|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
30899394|NCT02362412|58932836|FG000|Treatment Period III|Lost to Follow-up|0|||
30899395|NCT02362412|58932837|FG001|Treatment Period III|Lost to Follow-up|1|||
30899396|NCT02280187|58932849|FG000|Overall Study|Lost to Follow-up|218|||
30899397|NCT02347813|58932855|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
30899398|NCT02347813|58932856|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
30899399|NCT02347813|58932855|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
30899400|NCT02347813|58932856|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
30899401|NCT02329730|58932866|FG000|Overall Study|Protocol Violation|0|||
30899402|NCT02329730|58932867|FG001|Overall Study|Protocol Violation|0|||
30899403|NCT02329730|58932868|FG002|Overall Study|Protocol Violation|0|||
30899404|NCT02329730|58932869|FG003|Overall Study|Protocol Violation|0|||
30899405|NCT02329730|58932870|FG004|Overall Study|Protocol Violation|2|||
30899406|NCT02329730|58932871|FG005|Overall Study|Protocol Violation|2|||
30899407|NCT02329730|58932872|FG006|Overall Study|Protocol Violation|0|||
30899408|NCT02329730|58932873|FG007|Overall Study|Protocol Violation|0|||
30899409|NCT02329730|58932874|FG008|Overall Study|Protocol Violation|0|||
30899410|NCT02329730|58932875|FG009|Overall Study|Protocol Violation|0|||
30899411|NCT02329730|58932876|FG010|Overall Study|Protocol Violation|0|||
30899412|NCT02329730|58932877|FG011|Overall Study|Protocol Violation|0|||
30899413|NCT02329730|58932866|FG000|Overall Study|Withdrawal by Subject|0|||
30899414|NCT02329730|58932867|FG001|Overall Study|Withdrawal by Subject|0|||
30899415|NCT02329730|58932868|FG002|Overall Study|Withdrawal by Subject|0|||
30899416|NCT02329730|58932869|FG003|Overall Study|Withdrawal by Subject|0|||
30899417|NCT02329730|58932870|FG004|Overall Study|Withdrawal by Subject|1|||
30899418|NCT02329730|58932871|FG005|Overall Study|Withdrawal by Subject|0|||
30899419|NCT02329730|58932872|FG006|Overall Study|Withdrawal by Subject|1|||
30899420|NCT02329730|58932873|FG007|Overall Study|Withdrawal by Subject|1|||
30899421|NCT02329730|58932874|FG008|Overall Study|Withdrawal by Subject|1|||
30899422|NCT02329730|58932875|FG009|Overall Study|Withdrawal by Subject|1|||
30899423|NCT02329730|58932876|FG010|Overall Study|Withdrawal by Subject|0|||
30899424|NCT02329730|58932877|FG011|Overall Study|Withdrawal by Subject|0|||
30899425|NCT02328326|58932897|FG000|Overall Study|Withdrawal by Subject|10|||
30899426|NCT02328326|58932898|FG001|Overall Study|Withdrawal by Subject|3|||
30899427|NCT02328326|58932897|FG000|Overall Study|Death|2|||
30899428|NCT02328326|58932898|FG001|Overall Study|Death|1|||
30899429|NCT02328326|58932897|FG000|Overall Study|Lost to Follow-up|10|||
30899430|NCT02328326|58932898|FG001|Overall Study|Lost to Follow-up|4|||
30899431|NCT01649804|58932906|FG000|Overall Study|Administrative/Other|8|||
30899432|NCT02397278|58932912|FG000|Overall Study|Withdrawal by Subject|0|||
30899433|NCT02397278|58932913|FG001|Overall Study|Withdrawal by Subject|2|||
30899434|NCT02397278|58932912|FG000|Overall Study|Deemed ineligible following surgery|1|||
30899435|NCT02397278|58932913|FG001|Overall Study|Deemed ineligible following surgery|1|||
30899436|NCT02360228|58932922|FG000|Overall Study|Withdrawal by Subject|1|||
30899437|NCT02360228|58932923|FG001|Overall Study|Withdrawal by Subject|0|||
30899438|NCT02360228|58932924|FG002|Overall Study|Withdrawal by Subject|0|||
30899439|NCT02360228|58932922|FG000|Overall Study|Self-discontinued medication|0|||
30899440|NCT02360228|58932923|FG001|Overall Study|Self-discontinued medication|1|||
30899441|NCT02360228|58932924|FG002|Overall Study|Self-discontinued medication|0|||
30899442|NCT02360228|58932922|FG000|Overall Study|Unstable symptoms during screening|0|||
30899443|NCT02360228|58932923|FG001|Overall Study|Unstable symptoms during screening|0|||
30899444|NCT02360228|58932924|FG002|Overall Study|Unstable symptoms during screening|1|||
30899445|NCT02359994|58932934|FG000|Overall Population Study|Adverse Event|1|||
30899446|NCT02359994|58932935|FG001|Overall Population Study|Adverse Event|1|||
30899447|NCT02359994|58932934|FG000|Overall Population Study|Death|1|||
30899448|NCT02359994|58932935|FG001|Overall Population Study|Death|5|||
30899449|NCT02359994|58932934|FG000|Overall Population Study|Lost to Follow-up|1|||
30899450|NCT02359994|58932935|FG001|Overall Population Study|Lost to Follow-up|1|||
30899451|NCT02359994|58932934|FG000|Overall Population Study|Withdrawal by Subject|1|||
30899452|NCT02359994|58932935|FG001|Overall Population Study|Withdrawal by Subject|0|||
30899453|NCT02359994|58932934|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
30899454|NCT02359994|58932935|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
30899455|NCT02359994|58932934|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
30899456|NCT02359994|58932935|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
30899457|NCT02359994|58932934|FG000|Extended Oncology 24-Month Survival|Death|19|||
30899458|NCT02359994|58932935|FG001|Extended Oncology 24-Month Survival|Death|21|||
30899459|NCT02359994|58932934|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
30899460|NCT02359994|58932935|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
30899461|NCT02326298|58932944|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899462|NCT02326298|58932945|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899463|NCT02326298|58932946|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
30899464|NCT02326298|58932947|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899465|NCT02326298|58932948|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899466|NCT02326298|58932949|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899467|NCT02326298|58932950|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899468|NCT02326298|58932951|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899469|NCT02326298|58932952|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899470|NCT02326298|58932953|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899471|NCT02326298|58932954|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899472|NCT02326298|58932955|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899473|NCT02326298|58932956|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899474|NCT02326298|58932957|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30899475|NCT02326298|58932944|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
30899476|NCT02326298|58932945|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899477|NCT02326298|58932946|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899478|NCT02326298|58932947|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899479|NCT02326298|58932948|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899480|NCT02326298|58932949|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899481|NCT02326298|58932950|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899482|NCT02326298|58932951|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899483|NCT02326298|58932952|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899484|NCT02326298|58932953|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899485|NCT02326298|58932954|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899486|NCT02326298|58932955|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899487|NCT02326298|58932956|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899488|NCT02326298|58932957|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
30899489|NCT02326298|58932944|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
30899490|NCT02326298|58932945|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
30899491|NCT02326298|58932946|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899492|NCT02326298|58932947|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899493|NCT02326298|58932948|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899494|NCT02326298|58932949|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899495|NCT02326298|58932950|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899496|NCT02326298|58932951|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899497|NCT02326298|58932952|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899498|NCT02326298|58932953|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899499|NCT02326298|58932954|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899500|NCT02326298|58932955|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899501|NCT02326298|58932956|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899502|NCT02326298|58932957|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
30899503|NCT02326298|58932944|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
30899504|NCT02326298|58932945|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
30899505|NCT02326298|58932946|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899506|NCT02326298|58932947|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899507|NCT02326298|58932948|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899508|NCT02326298|58932949|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899509|NCT02326298|58932950|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899510|NCT02326298|58932951|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899511|NCT02326298|58932952|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899512|NCT02326298|58932953|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899513|NCT02326298|58932954|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899514|NCT02326298|58932955|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899515|NCT02326298|58932956|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899516|NCT02326298|58932957|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30899517|NCT02326298|58932944|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899518|NCT02326298|58932945|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899519|NCT02326298|58932946|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
30899520|NCT02326298|58932947|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899521|NCT02326298|58932948|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899522|NCT02326298|58932949|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899523|NCT02326298|58932950|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899524|NCT02326298|58932951|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30790897|NCT03200912|58803989|FG001|Overall Study|Withdrawal by Subject|2|||
30899525|NCT02326298|58932952|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899526|NCT02326298|58932953|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899527|NCT02326298|58932954|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899528|NCT02326298|58932955|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899529|NCT02326298|58932956|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899530|NCT02326298|58932957|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
30899531|NCT02326298|58932944|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30899532|NCT02326298|58932945|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30899533|NCT02326298|58932946|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30899534|NCT02326298|58932947|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30899535|NCT02326298|58932948|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30899536|NCT02326298|58932949|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30899537|NCT02326298|58932950|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
30899538|NCT02326298|58932951|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30899539|NCT02326298|58932952|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30899540|NCT02326298|58932953|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
30899541|NCT02326298|58932954|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30899542|NCT02326298|58932955|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30899543|NCT02326298|58932956|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30899544|NCT02326298|58932957|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
30899545|NCT02326298|58932944|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
30899546|NCT02326298|58932945|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
30899547|NCT02326298|58932946|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
30899548|NCT02326298|58932947|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
30899549|NCT02326298|58932948|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
30899550|NCT02326298|58932949|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
30899551|NCT02326298|58932950|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
30899552|NCT02326298|58932951|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
30899553|NCT02326298|58932952|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
30899554|NCT02326298|58932953|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
30899555|NCT02326298|58932954|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
30899556|NCT02326298|58932955|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
30899557|NCT02326298|58932956|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
30899558|NCT02326298|58932957|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
30899559|NCT02326298|58932944|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899560|NCT02326298|58932945|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899561|NCT02326298|58932946|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899562|NCT02326298|58932947|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899563|NCT02326298|58932948|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899564|NCT02326298|58932949|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
30899565|NCT02326298|58932950|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899566|NCT02326298|58932951|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899567|NCT02326298|58932952|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899568|NCT02326298|58932953|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899569|NCT02326298|58932954|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899570|NCT02326298|58932955|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899571|NCT02326298|58932956|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899572|NCT02326298|58932957|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
30899573|NCT02326298|58932944|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899574|NCT02326298|58932945|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30621064|NCT00603265|58632620|FG000|Overall Study|Protocol Violation|1|||
30710595|NCT00107653|58724111|FG001|Overall Study|Protocol Violation|0|||
30621065|NCT00603265|58632621|FG001|Overall Study|Protocol Violation|0|||
30790898|NCT03200912|58803990|FG002|Overall Study|Withdrawal by Subject|4|||
30899575|NCT02326298|58932946|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899576|NCT02326298|58932947|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899577|NCT02326298|58932948|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899578|NCT02326298|58932949|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899579|NCT02326298|58932950|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
30899580|NCT02326298|58932951|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899581|NCT02326298|58932952|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899582|NCT02326298|58932953|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899583|NCT02326298|58932954|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899584|NCT02326298|58932955|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899585|NCT02326298|58932956|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899586|NCT02326298|58932957|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
30899587|NCT02326298|58932944|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899588|NCT02326298|58932945|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899589|NCT02326298|58932946|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899590|NCT02326298|58932947|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899591|NCT02326298|58932948|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899592|NCT02326298|58932949|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899593|NCT02326298|58932950|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899594|NCT02326298|58932951|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
30899595|NCT02326298|58932952|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899596|NCT02326298|58932953|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899597|NCT02326298|58932954|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899598|NCT02326298|58932955|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899599|NCT02326298|58932956|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899600|NCT02326298|58932957|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
30899601|NCT02326298|58932944|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899602|NCT02326298|58932945|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899603|NCT02326298|58932946|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899604|NCT02326298|58932947|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899605|NCT02326298|58932948|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899606|NCT02326298|58932949|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899607|NCT02326298|58932950|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
30899608|NCT02326298|58932951|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
30899609|NCT02326298|58932952|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899610|NCT02326298|58932953|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899611|NCT02326298|58932954|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899612|NCT02326298|58932955|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899613|NCT02326298|58932956|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899614|NCT02326298|58932957|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
30899615|NCT02326298|58932944|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899616|NCT02326298|58932945|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899617|NCT02326298|58932946|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899618|NCT02326298|58932947|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899619|NCT02326298|58932948|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899620|NCT02326298|58932949|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899621|NCT02326298|58932950|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899622|NCT02326298|58932951|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
30899623|NCT02326298|58932952|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899624|NCT02326298|58932953|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899625|NCT02326298|58932954|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899626|NCT02326298|58932955|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899627|NCT02326298|58932956|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899628|NCT02326298|58932957|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
30899629|NCT02326298|58932944|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899630|NCT02326298|58932945|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899631|NCT02326298|58932946|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899632|NCT02326298|58932947|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899633|NCT02326298|58932948|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899634|NCT02326298|58932949|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
30899635|NCT02326298|58932950|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899636|NCT02326298|58932951|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899637|NCT02326298|58932952|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899638|NCT02326298|58932953|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899639|NCT02326298|58932954|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899640|NCT02326298|58932955|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899641|NCT02326298|58932956|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899642|NCT02326298|58932957|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
30899643|NCT02326298|58932944|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
30899644|NCT02326298|58932945|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
30899645|NCT02326298|58932946|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
30899646|NCT02326298|58932947|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
30899647|NCT02326298|58932948|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
30899648|NCT02326298|58932949|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
30899649|NCT02326298|58932950|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
30899650|NCT02326298|58932951|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
30899651|NCT02326298|58932952|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
30899652|NCT02326298|58932953|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
30899653|NCT02326298|58932954|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
30899654|NCT02326298|58932955|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
30899655|NCT02326298|58932956|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
30899656|NCT02326298|58932957|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
30899657|NCT02326298|58932944|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899658|NCT02326298|58932945|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899659|NCT02326298|58932946|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899660|NCT02326298|58932947|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899661|NCT02326298|58932948|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899662|NCT02326298|58932949|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899663|NCT02326298|58932950|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899664|NCT02326298|58932951|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899665|NCT02326298|58932952|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899666|NCT02326298|58932953|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899667|NCT02326298|58932954|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899668|NCT02326298|58932955|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
30899669|NCT02326298|58932956|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
30710596|NCT00107653|58724110|FG000|Overall Study|Withdrawal by Subject|12|||
30899670|NCT02326298|58932957|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
30899671|NCT02326298|58932944|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899672|NCT02326298|58932945|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899673|NCT02326298|58932946|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899674|NCT02326298|58932947|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899675|NCT02326298|58932948|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899676|NCT02326298|58932949|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899677|NCT02326298|58932950|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899678|NCT02326298|58932951|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899679|NCT02326298|58932952|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899680|NCT02326298|58932953|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899681|NCT02326298|58932954|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899682|NCT02326298|58932955|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
30899683|NCT02326298|58932956|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
30899684|NCT02326298|58932957|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
30899685|NCT02326298|58932944|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899686|NCT02326298|58932945|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899687|NCT02326298|58932946|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899688|NCT02326298|58932947|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899689|NCT02326298|58932948|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899690|NCT02326298|58932949|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899691|NCT02326298|58932950|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899692|NCT02326298|58932951|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899693|NCT02326298|58932952|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899694|NCT02326298|58932953|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899695|NCT02326298|58932954|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899696|NCT02326298|58932955|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899697|NCT02326298|58932956|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
30899698|NCT02326298|58932957|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
30899699|NCT02326298|58932944|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30899700|NCT02326298|58932945|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30899701|NCT02326298|58932946|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30899702|NCT02326298|58932947|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30899703|NCT02326298|58932948|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30899704|NCT02326298|58932949|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30899705|NCT02326298|58932950|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30899706|NCT02326298|58932951|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30899707|NCT02326298|58932952|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30899708|NCT02326298|58932953|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30899709|NCT02326298|58932954|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
30899710|NCT02326298|58932955|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
30899711|NCT02326298|58932956|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
30899712|NCT02326298|58932957|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
30899713|NCT02326298|58932944|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30899714|NCT02326298|58932945|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30899715|NCT02326298|58932946|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30899716|NCT02326298|58932947|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30899717|NCT02326298|58932948|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30899718|NCT02326298|58932949|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30899719|NCT02326298|58932950|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30899720|NCT02326298|58932951|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30899721|NCT02326298|58932952|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30899722|NCT02326298|58932953|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30899723|NCT02326298|58932954|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
30899724|NCT02326298|58932955|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
30899725|NCT02326298|58932956|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
30899726|NCT02326298|58932957|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
30899727|NCT02326298|58932944|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30899728|NCT02326298|58932945|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30899729|NCT02326298|58932946|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30899730|NCT02326298|58932947|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30899731|NCT02326298|58932948|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30899732|NCT02326298|58932949|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30899733|NCT02326298|58932950|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30899734|NCT02326298|58932951|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30899735|NCT02326298|58932952|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30899736|NCT02326298|58932953|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30899737|NCT02326298|58932954|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
30899738|NCT02326298|58932955|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
30899739|NCT02326298|58932956|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
30899740|NCT02326298|58932957|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
30899741|NCT02396420|58932966|FG000|Overall Study|Death|1|||
30899742|NCT02279719|58932978|FG000|Overall Study|Patients randomized but never treated|0|||
30899743|NCT02279719|58932979|FG001|Overall Study|Patients randomized but never treated|0|||
30899744|NCT02279719|58932980|FG002|Overall Study|Patients randomized but never treated|0|||
30899745|NCT02279719|58932981|FG003|Overall Study|Patients randomized but never treated|0|||
30899746|NCT02279719|58932982|FG004|Overall Study|Patients randomized but never treated|3|||
30899747|NCT02279719|58932983|FG005|Overall Study|Patients randomized but never treated|0|||
30899748|NCT02279719|58932984|FG006|Overall Study|Patients randomized but never treated|3|||
30899749|NCT02279407|58933021|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
30899750|NCT02279407|58933022|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
30899751|NCT02279407|58933023|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
30899752|NCT02279407|58933024|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
30899753|NCT02279407|58933021|FG000|Overall Study|Withdrawal by Subject|1|||
30899754|NCT02279407|58933022|FG001|Overall Study|Withdrawal by Subject|0|||
30899755|NCT02279407|58933023|FG002|Overall Study|Withdrawal by Subject|1|||
30899756|NCT02279407|58933024|FG003|Overall Study|Withdrawal by Subject|1|||
30899757|NCT02279407|58933021|FG000|Overall Study|Adverse Event|1|||
30899758|NCT02279407|58933022|FG001|Overall Study|Adverse Event|1|||
30899759|NCT02279407|58933023|FG002|Overall Study|Adverse Event|2|||
30899760|NCT02279407|58933024|FG003|Overall Study|Adverse Event|0|||
30899761|NCT02326220|58933036|FG000|Double-blind Treatment Period|Adverse Event|1|||
30899762|NCT02326220|58933037|FG001|Double-blind Treatment Period|Adverse Event|2|||
30899763|NCT02326220|58933038|FG002|Double-blind Treatment Period|Adverse Event|0|||
30899764|NCT02326220|58933036|FG000|Double-blind Treatment Period|Protocol Violation|0|||
30899765|NCT02326220|58933037|FG001|Double-blind Treatment Period|Protocol Violation|1|||
30899766|NCT02326220|58933038|FG002|Double-blind Treatment Period|Protocol Violation|0|||
30899767|NCT02326220|58933036|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
30899768|NCT02326220|58933037|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
30899769|NCT02326220|58933038|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
30899770|NCT02326220|58933036|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
30899771|NCT02326220|58933037|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
30899772|NCT02326220|58933038|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
30899773|NCT02326220|58933036|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
30899774|NCT02326220|58933037|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
30899775|NCT02326220|58933038|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
30899776|NCT02279173|58933048|FG000|Overall Study|Protocol-specified Criteria|67|||
30899777|NCT02279173|58933048|FG000|Overall Study|Withdrawal by Subject|20|||
30899778|NCT02279173|58933048|FG000|Overall Study|Decision by Sponsor|4|||
30899779|NCT02279173|58933048|FG000|Overall Study|Lost to Follow-up|3|||
30899780|NCT02282917|58933054|FG000|Overall Study|Withdrawal by Subject|1|||
30899781|NCT02282917|58933054|FG000|Overall Study|Screen Failure/Not Eligible|1|||
30899782|NCT02358668|58933061|FG000|Overall Study|Adverse Event|2|||
30899783|NCT02358668|58933062|FG001|Overall Study|Adverse Event|0|||
30899784|NCT02358668|58933063|FG002|Overall Study|Adverse Event|0|||
30899785|NCT02358668|58933061|FG000|Overall Study|Withdrawal by Subject|0|||
30899786|NCT02358668|58933062|FG001|Overall Study|Withdrawal by Subject|1|||
30899787|NCT02358668|58933063|FG002|Overall Study|Withdrawal by Subject|0|||
30899788|NCT02282605|58933074|FG000|Overall Study|negative SA result on Day -1|3|||
30899789|NCT02282605|58933075|FG001|Overall Study|negative SA result on Day -1|0|||
30899790|NCT02282605|58933076|FG002|Overall Study|negative SA result on Day -1|0|||
30899791|NCT02282527|58933086|FG000|Overall Study|Lost to Follow-up|0|||
30899792|NCT02282527|58933087|FG001|Overall Study|Lost to Follow-up|1|||
30899793|NCT02282527|58933086|FG000|Overall Study|Lack of home health aid|1|||
30899794|NCT02282527|58933087|FG001|Overall Study|Lack of home health aid|0|||
30899795|NCT02278939|58933098|FG000|Overall Study|lack of time|1|||
30899796|NCT02278939|58933099|FG001|Overall Study|lack of time|0|||
30899797|NCT02278939|58933098|FG000|Overall Study|Lost to Follow-up|1|||
30899798|NCT02278939|58933099|FG001|Overall Study|Lost to Follow-up|1|||
30899799|NCT02278939|58933098|FG000|Overall Study|death in family|1|||
30899800|NCT02278939|58933099|FG001|Overall Study|death in family|0|||
30899801|NCT02278939|58933098|FG000|Overall Study|family emergency unable to commit|2|||
30899802|NCT02278939|58933099|FG001|Overall Study|family emergency unable to commit|0|||
30899803|NCT02278471|58933107|FG000|Overall Study|Lost to Follow-up|6|||
30899804|NCT02278471|58933108|FG001|Overall Study|Lost to Follow-up|15|||
30899805|NCT02278471|58933107|FG000|Overall Study|Death|2|||
30899806|NCT02278471|58933108|FG001|Overall Study|Death|2|||
30899807|NCT02278471|58933107|FG000|Overall Study|Withdrawal by Subject|0|||
30899808|NCT02278471|58933108|FG001|Overall Study|Withdrawal by Subject|3|||
30899809|NCT02278003|58933117|FG000|Overall Study|Withdrawal by Subject|11|||
30899810|NCT02278003|58933118|FG001|Overall Study|Withdrawal by Subject|0|||
30899811|NCT02278003|58933117|FG000|Overall Study|Not Treated|1|||
30899812|NCT02278003|58933118|FG001|Overall Study|Not Treated|0|||
30899813|NCT02278003|58933117|FG000|Overall Study|Recognition task improperly completed|7|||
30899814|NCT02278003|58933118|FG001|Overall Study|Recognition task improperly completed|0|||
30899815|NCT02277769|58933127|FG000|Overall Study|Protocol Violation|3|||
30899816|NCT02277769|58933128|FG001|Overall Study|Protocol Violation|3|||
30899817|NCT02277769|58933129|FG002|Overall Study|Protocol Violation|5|||
30899818|NCT02277769|58933127|FG000|Overall Study|Lack of Efficacy|17|||
30899819|NCT02277769|58933128|FG001|Overall Study|Lack of Efficacy|0|||
30899820|NCT02277769|58933129|FG002|Overall Study|Lack of Efficacy|4|||
30899821|NCT02277769|58933127|FG000|Overall Study|Adverse Event|14|||
30899822|NCT02277769|58933128|FG001|Overall Study|Adverse Event|2|||
30710597|NCT00107653|58724111|FG001|Overall Study|Withdrawal by Subject|13|||
30710598|NCT00107653|58724110|FG000|Overall Study|Lost to Follow-up|13|||
30710599|NCT00107653|58724111|FG001|Overall Study|Lost to Follow-up|5|||
30710600|NCT00107653|58724110|FG000|Overall Study|Administrative Reasons|3|||
30899823|NCT02277769|58933129|FG002|Overall Study|Adverse Event|4|||
30899824|NCT02277769|58933127|FG000|Overall Study|Other than specified above|12|||
30621066|NCT00603265|58632622|FG002|Overall Study|Protocol Violation|0|||
30621067|NCT04010227|58632632|FG000|Overall Study|Death|1|||
30621068|NCT04010227|58632633|FG001|Overall Study|Death|2|||
30621069|NCT04010227|58632632|FG000|Overall Study|Medical Reasons|4|||
30621070|NCT04010227|58632633|FG001|Overall Study|Medical Reasons|3|||
30621071|NCT04010227|58632632|FG000|Overall Study|Withdrawal by Subject|2|||
30621072|NCT04010227|58632633|FG001|Overall Study|Withdrawal by Subject|0|||
30621073|NCT04010227|58632632|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
30621074|NCT04010227|58632633|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
30621075|NCT01158534|58632640|FG000|Overall Study|Withdrawal by Subject|1|||
30621076|NCT01158534|58632640|FG000|Overall Study|Death|1|||
30621077|NCT01158534|58632640|FG000|Overall Study|Other|1|||
30621078|NCT01158378|58632646|FG000|Overall Study|Death|4|||
30621079|NCT01158378|58632647|FG001|Overall Study|Death|5|||
30621080|NCT01158378|58632646|FG000|Overall Study|Lost to Follow-up|2|||
30621081|NCT01158378|58632647|FG001|Overall Study|Lost to Follow-up|4|||
30621082|NCT01158378|58632646|FG000|Overall Study|Withdrawal by Subject|4|||
30621083|NCT01158378|58632647|FG001|Overall Study|Withdrawal by Subject|0|||
30621084|NCT00602797|58632654|FG000|Overall Study|Adverse Event|1|||
30621085|NCT01158222|58632659|FG000|Overall Study|Not eligible for intermediate phase|17|||
30621086|NCT01197521|58632666|FG000|Overall Study|Not reported|24|||
30621087|NCT01197521|58632667|FG001|Overall Study|Not reported|25|||
30621088|NCT01197521|58632668|FG002|Overall Study|Not reported|21|||
30621089|NCT01197521|58632666|FG000|Overall Study|Enrolment in long term extension|42|||
30621090|NCT01197521|58632667|FG001|Overall Study|Enrolment in long term extension|36|||
30621091|NCT01197521|58632668|FG002|Overall Study|Enrolment in long term extension|87|||
30621092|NCT01197521|58632666|FG000|Overall Study|Severe non-compliance to protocol|1|||
30621093|NCT01197521|58632667|FG001|Overall Study|Severe non-compliance to protocol|3|||
30621094|NCT01197521|58632668|FG002|Overall Study|Severe non-compliance to protocol|3|||
30621095|NCT01197521|58632666|FG000|Overall Study|Lack of therapeutic response|2|||
30621096|NCT01197521|58632667|FG001|Overall Study|Lack of therapeutic response|3|||
30621097|NCT01197521|58632668|FG002|Overall Study|Lack of therapeutic response|4|||
30621098|NCT01197521|58632666|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
30621099|NCT01197521|58632667|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
30710601|NCT00107653|58724111|FG001|Overall Study|Administrative Reasons|3|||
30710602|NCT03950856|58724121|FG000|Overall Study|Death|1|||
30621100|NCT01197521|58632668|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
30621101|NCT01197521|58632666|FG000|Overall Study|Lost to Follow-up|3|||
30621102|NCT01197521|58632667|FG001|Overall Study|Lost to Follow-up|2|||
30621103|NCT01197521|58632668|FG002|Overall Study|Lost to Follow-up|2|||
30621104|NCT01197521|58632666|FG000|Overall Study|Adverse Event|25|||
30621105|NCT01197521|58632667|FG001|Overall Study|Adverse Event|28|||
30621106|NCT01197521|58632668|FG002|Overall Study|Adverse Event|24|||
30621107|NCT01157676|58632681|FG000|Randomization|Death|1|||
30710603|NCT03950856|58724122|FG001|Overall Study|Death|2|||
30899825|NCT02277769|58933128|FG001|Overall Study|Other than specified above|8|||
30899826|NCT02277769|58933129|FG002|Overall Study|Other than specified above|5|||
30621108|NCT01157676|58632682|FG001|Randomization|Death|1|||
30621109|NCT01157676|58632681|FG000|Randomization|unresectable|2|||
30621110|NCT01157676|58632682|FG001|Randomization|unresectable|3|||
30621111|NCT01157676|58632681|FG000|Randomization|Withdrawal by Subject|17|||
30621112|NCT01157676|58632682|FG001|Randomization|Withdrawal by Subject|13|||
30621113|NCT01157676|58632681|FG000|Randomization|Physician Decision|1|||
30621114|NCT01157676|58632682|FG001|Randomization|Physician Decision|0|||
30621115|NCT01157676|58632681|FG000|Surgery|underwent open cystectomy|0|||
30621116|NCT01157676|58632682|FG001|Surgery|underwent open cystectomy|4|||
30621117|NCT01157676|58632681|FG000|Surgery|converted to open procedure|0|||
30621118|NCT01157676|58632682|FG001|Surgery|converted to open procedure|5|||
30621119|NCT01157676|58632681|FG000|Surgery|underwent robotic cystectomy|1|||
30710604|NCT03950856|58724123|FG002|Overall Study|Death|0|||
30710605|NCT03950856|58724124|FG003|Overall Study|Death|0|||
30710606|NCT03950856|58724121|FG000|Overall Study|Lost to Follow-up|5|||
30710607|NCT03950856|58724122|FG001|Overall Study|Lost to Follow-up|6|||
30710608|NCT03950856|58724123|FG002|Overall Study|Lost to Follow-up|8|||
30710609|NCT03950856|58724124|FG003|Overall Study|Lost to Follow-up|2|||
30710610|NCT03950856|58724121|FG000|Overall Study|Protocol Violation|2|||
30710611|NCT03950856|58724122|FG001|Overall Study|Protocol Violation|0|||
30710612|NCT03950856|58724123|FG002|Overall Study|Protocol Violation|0|||
30710613|NCT03950856|58724124|FG003|Overall Study|Protocol Violation|1|||
30710614|NCT03950856|58724121|FG000|Overall Study|Withdrawal by Subject|4|||
30710615|NCT03950856|58724122|FG001|Overall Study|Withdrawal by Subject|1|||
30710616|NCT03950856|58724123|FG002|Overall Study|Withdrawal by Subject|3|||
30710617|NCT03950856|58724124|FG003|Overall Study|Withdrawal by Subject|1|||
30710618|NCT03950856|58724121|FG000|Overall Study|Unable to phone|7|||
30710619|NCT03950856|58724122|FG001|Overall Study|Unable to phone|6|||
30710620|NCT03950856|58724123|FG002|Overall Study|Unable to phone|7|||
30710621|NCT03950856|58724124|FG003|Overall Study|Unable to phone|2|||
30710622|NCT00433654|58724138|FG000|Overall Study|Death|4|||
30710623|NCT00433654|58724139|FG001|Overall Study|Death|0|||
30710624|NCT00433654|58724138|FG000|Overall Study|Missed visit|6|||
30710625|NCT00433654|58724139|FG001|Overall Study|Missed visit|3|||
30710626|NCT00433654|58724138|FG000|Overall Study|Subject not yet due for visit|4|||
30710627|NCT00433654|58724139|FG001|Overall Study|Subject not yet due for visit|0|||
30710628|NCT00433654|58724138|FG000|Overall Study|Withdrawal by Subject|1|||
30710629|NCT00433654|58724139|FG001|Overall Study|Withdrawal by Subject|2|||
30710630|NCT00689351|58724153|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
30710631|NCT00689351|58724154|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
30710632|NCT00689351|58724153|FG000|Infant Series of Dosing|Adverse Event|1|||
30710633|NCT00689351|58724154|FG001|Infant Series of Dosing|Adverse Event|0|||
30710634|NCT00689351|58724153|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
30710635|NCT00689351|58724154|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
30710636|NCT00689351|58724153|FG000|After Infant Series|Parent/legal guardian request|1|||
30710637|NCT00689351|58724154|FG001|After Infant Series|Parent/legal guardian request|0|||
30710638|NCT03950622|58724166|FG000|Overall Study|Withdrawal by Subject|1|||
30710639|NCT03950622|58724167|FG001|Overall Study|Withdrawal by Subject|0|||
30710640|NCT03950622|58724166|FG000|Overall Study|Protocol Deviation|0|||
30710641|NCT03950622|58724167|FG001|Overall Study|Protocol Deviation|1|||
30710642|NCT03950622|58724166|FG000|Overall Study|Physician Decision|1|||
30621120|NCT01157676|58632682|FG001|Surgery|underwent robotic cystectomy|0|||
30621121|NCT00991341|58632696|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
30621122|NCT00991341|58632697|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
30621123|NCT00991341|58632696|FG000|Overall Study|Death|3|||
30621124|NCT00991341|58632697|FG001|Overall Study|Death|0|||
30621125|NCT00991341|58632696|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
30621126|NCT00991341|58632697|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
30710643|NCT03950622|58724167|FG001|Overall Study|Physician Decision|0|||
30710644|NCT03950622|58724166|FG000|Overall Study|Lost to Follow-up|5|||
30710645|NCT03950622|58724167|FG001|Overall Study|Lost to Follow-up|5|||
30710646|NCT03950622|58724166|FG000|Overall Study|Death|1|||
30710647|NCT03950622|58724167|FG001|Overall Study|Death|1|||
30710648|NCT03937908|58724173|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
30710649|NCT03937908|58724174|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
30710650|NCT00689273|58724182|FG000|Overall Study|Adverse Event|3|||
30621127|NCT00991341|58632696|FG000|Overall Study|Physician Decision|1|||
30710651|NCT00689273|58724183|FG001|Overall Study|Adverse Event|1|||
30710652|NCT00689273|58724182|FG000|Overall Study|Lack of Efficacy|3|||
30710653|NCT00689273|58724183|FG001|Overall Study|Lack of Efficacy|0|||
30710654|NCT00689273|58724182|FG000|Overall Study|Lost to Follow-up|0|||
30710655|NCT00689273|58724183|FG001|Overall Study|Lost to Follow-up|2|||
30710656|NCT00689273|58724182|FG000|Overall Study|Other|6|||
30710657|NCT00689273|58724183|FG001|Overall Study|Other|2|||
30710658|NCT00689273|58724182|FG000|Overall Study|Randomized but not Treated|1|||
30710659|NCT00689273|58724183|FG001|Overall Study|Randomized but not Treated|0|||
30710660|NCT00553358|58724192|FG000|Overall Study|Randomized but did not receive treatment|3|||
30710661|NCT00553358|58724193|FG001|Overall Study|Randomized but did not receive treatment|3|||
30710662|NCT00553358|58724194|FG002|Overall Study|Randomized but did not receive treatment|1|||
30710663|NCT00553358|58724192|FG000|Overall Study|Lost to Follow-up|22|||
30710664|NCT00553358|58724193|FG001|Overall Study|Lost to Follow-up|26|||
30710665|NCT00553358|58724194|FG002|Overall Study|Lost to Follow-up|18|||
30710666|NCT00553358|58724192|FG000|Overall Study|Withdrew completely|23|||
30710667|NCT00553358|58724193|FG001|Overall Study|Withdrew completely|33|||
30899827|NCT01641991|58933141|FG000|Overall Study|Physician Decision|0|||
30899828|NCT01641991|58933142|FG001|Overall Study|Physician Decision|1|||
30710668|NCT00553358|58724194|FG002|Overall Study|Withdrew completely|34|||
30710669|NCT00553358|58724192|FG000|Overall Study|Died during clinical follow-up|25|||
30710670|NCT00553358|58724193|FG001|Overall Study|Died during clinical follow-up|29|||
30710671|NCT00553358|58724194|FG002|Overall Study|Died during clinical follow-up|32|||
30710672|NCT00553358|58724192|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
30710673|NCT00553358|58724193|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
30710674|NCT00553358|58724194|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
30710675|NCT00553358|58724192|FG000|Overall Study|Died after clinical follow-up ended|1|||
30710676|NCT00553358|58724193|FG001|Overall Study|Died after clinical follow-up ended|2|||
30710677|NCT00553358|58724194|FG002|Overall Study|Died after clinical follow-up ended|0|||
30710678|NCT00553358|58724192|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
30710679|NCT00553358|58724193|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
30899829|NCT01641991|58933143|FG002|Overall Study|Physician Decision|7|||
30621128|NCT00991341|58632697|FG001|Overall Study|Physician Decision|2|||
30710680|NCT00553358|58724194|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
30710681|NCT00688259|58724210|FG000|Overall Study|Lost to Follow-up|2|||
30710682|NCT00688259|58724211|FG001|Overall Study|Lost to Follow-up|4|||
30710683|NCT00688259|58724210|FG000|Overall Study|Physician Decision|1|||
30710684|NCT00688259|58724211|FG001|Overall Study|Physician Decision|0|||
30710685|NCT00688259|58724210|FG000|Overall Study|Withdrawal by Subject|2|||
30710686|NCT00688259|58724211|FG001|Overall Study|Withdrawal by Subject|0|||
30710687|NCT00688259|58724210|FG000|Overall Study|Declined Interview|2|||
30710688|NCT00688259|58724211|FG001|Overall Study|Declined Interview|3|||
30710689|NCT00688259|58724210|FG000|Overall Study|Hospitalized at Follow-up|0|||
30710690|NCT00688259|58724211|FG001|Overall Study|Hospitalized at Follow-up|1|||
30710691|NCT00688181|58724217|FG000|Overall Study|Lost to Follow-up|17|||
30710692|NCT00688181|58724217|FG000|Overall Study|Unknown Reason|4|||
30710693|NCT00688181|58724217|FG000|Overall Study|Non-clinical Reason|2|||
30621129|NCT00991341|58632696|FG000|Overall Study|Withdrawal by Subject|3|||
30621130|NCT00991341|58632697|FG001|Overall Study|Withdrawal by Subject|4|||
30621131|NCT00990249|58632703|FG000|Overall Study|Disease Progression|8|||
30621132|NCT00990249|58632703|FG000|Overall Study|Non-Compliance|1|||
30621133|NCT00990249|58632703|FG000|Overall Study|Death|2|||
30621134|NCT00990249|58632703|FG000|Overall Study|Not treated|2|||
30621135|NCT02846545|58632709|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
30621136|NCT02846545|58632710|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
30621137|NCT02846545|58632709|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
30621138|NCT02846545|58632710|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
30710694|NCT00689117|58724236|FG000|Overall Study|Adverse Event|6|||
30710695|NCT00689117|58724237|FG001|Overall Study|Adverse Event|0|||
30710696|NCT00689117|58724238|FG002|Overall Study|Adverse Event|5|||
30710697|NCT00689117|58724239|FG003|Overall Study|Adverse Event|0|||
30710698|NCT00689117|58724236|FG000|Overall Study|Lost to Follow-up|26|||
30710699|NCT00689117|58724237|FG001|Overall Study|Lost to Follow-up|19|||
30710700|NCT00689117|58724238|FG002|Overall Study|Lost to Follow-up|17|||
30710701|NCT00689117|58724239|FG003|Overall Study|Lost to Follow-up|11|||
30710702|NCT00689117|58724236|FG000|Overall Study|Lack of Efficacy|1|||
30710703|NCT00689117|58724237|FG001|Overall Study|Lack of Efficacy|2|||
30710704|NCT00689117|58724238|FG002|Overall Study|Lack of Efficacy|2|||
30710705|NCT00689117|58724239|FG003|Overall Study|Lack of Efficacy|2|||
30710706|NCT00689117|58724236|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
30710707|NCT00689117|58724237|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
30710708|NCT00689117|58724238|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
30710709|NCT00689117|58724239|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
30710710|NCT00689117|58724236|FG000|Overall Study|Withdrawal by Subject|19|||
30710711|NCT00689117|58724237|FG001|Overall Study|Withdrawal by Subject|18|||
30710712|NCT00689117|58724238|FG002|Overall Study|Withdrawal by Subject|26|||
30710713|NCT00689117|58724239|FG003|Overall Study|Withdrawal by Subject|13|||
30710714|NCT00689117|58724236|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
30710715|NCT00689117|58724237|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
30710716|NCT00689117|58724238|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
30710717|NCT00689117|58724239|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
30710718|NCT00689117|58724236|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
30710719|NCT00689117|58724237|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
30899830|NCT01641991|58933144|FG003|Overall Study|Physician Decision|5|||
30710720|NCT00689117|58724238|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30710721|NCT00689117|58724239|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30710722|NCT00689117|58724236|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
30710723|NCT00689117|58724237|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
30710724|NCT00689117|58724238|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
30710725|NCT00689117|58724239|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
30710726|NCT00689117|58724236|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
30710727|NCT00689117|58724237|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
30710728|NCT00689117|58724238|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
30710729|NCT00689117|58724239|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
30710730|NCT00689117|58724236|FG000|Overall Study|Use of Prohibitive Medication|2|||
30710731|NCT00689117|58724237|FG001|Overall Study|Use of Prohibitive Medication|1|||
30710732|NCT00689117|58724238|FG002|Overall Study|Use of Prohibitive Medication|3|||
30710733|NCT00689117|58724239|FG003|Overall Study|Use of Prohibitive Medication|0|||
30710734|NCT00689117|58724236|FG000|Overall Study|Pregnancy|0|||
30710735|NCT00689117|58724237|FG001|Overall Study|Pregnancy|2|||
30710736|NCT00689117|58724238|FG002|Overall Study|Pregnancy|0|||
30710737|NCT00689117|58724239|FG003|Overall Study|Pregnancy|2|||
30710738|NCT00689117|58724236|FG000|Overall Study|Incarceration|2|||
30710739|NCT00689117|58724237|FG001|Overall Study|Incarceration|0|||
30710740|NCT00689117|58724238|FG002|Overall Study|Incarceration|0|||
30710741|NCT00689117|58724239|FG003|Overall Study|Incarceration|0|||
30710742|NCT00689117|58724236|FG000|Overall Study|Fear of Birth Defects|0|||
30710743|NCT00689117|58724237|FG001|Overall Study|Fear of Birth Defects|0|||
30710744|NCT00689117|58724238|FG002|Overall Study|Fear of Birth Defects|1|||
30710745|NCT00689117|58724239|FG003|Overall Study|Fear of Birth Defects|0|||
30710746|NCT00689117|58724236|FG000|Overall Study|Transportation|1|||
30710747|NCT00689117|58724237|FG001|Overall Study|Transportation|0|||
30710748|NCT00689117|58724238|FG002|Overall Study|Transportation|0|||
30710749|NCT00689117|58724239|FG003|Overall Study|Transportation|0|||
30710750|NCT00689117|58724236|FG000|Overall Study|Patient Withdrew from Study|0|||
30710751|NCT00689117|58724237|FG001|Overall Study|Patient Withdrew from Study|0|||
30710752|NCT00689117|58724238|FG002|Overall Study|Patient Withdrew from Study|0|||
30710753|NCT00689117|58724239|FG003|Overall Study|Patient Withdrew from Study|1|||
30710754|NCT00689117|58724236|FG000|Overall Study|Personal Reason|0|||
30710755|NCT00689117|58724237|FG001|Overall Study|Personal Reason|1|||
30710756|NCT00689117|58724238|FG002|Overall Study|Personal Reason|0|||
30710757|NCT00689117|58724239|FG003|Overall Study|Personal Reason|0|||
30710758|NCT00689117|58724236|FG000|Overall Study|Dispensing Error|0|||
30710759|NCT00689117|58724237|FG001|Overall Study|Dispensing Error|1|||
30710760|NCT00689117|58724238|FG002|Overall Study|Dispensing Error|0|||
30710761|NCT00689117|58724239|FG003|Overall Study|Dispensing Error|0|||
30710762|NCT00547248|58724253|FG000|Overall Study|Protocol Violation|0|||
30710763|NCT00547248|58724254|FG001|Overall Study|Protocol Violation|0|||
30710764|NCT00547248|58724255|FG002|Overall Study|Protocol Violation|1|||
30710765|NCT00547248|58724256|FG003|Overall Study|Protocol Violation|1|||
30710766|NCT00547248|58724253|FG000|Overall Study|Migrated/moved from study area|0|||
30710767|NCT00547248|58724254|FG001|Overall Study|Migrated/moved from study area|0|||
30710768|NCT00547248|58724255|FG002|Overall Study|Migrated/moved from study area|2|||
30710769|NCT00547248|58724256|FG003|Overall Study|Migrated/moved from study area|0|||
30710770|NCT00547248|58724253|FG000|Overall Study|Withdrawal by Subject|0|||
30710771|NCT00547248|58724254|FG001|Overall Study|Withdrawal by Subject|0|||
30899831|NCT01641991|58933141|FG000|Overall Study|Withdrawal by Subject|4|||
30899832|NCT01641991|58933142|FG001|Overall Study|Withdrawal by Subject|2|||
30710772|NCT00547248|58724255|FG002|Overall Study|Withdrawal by Subject|7|||
30710773|NCT00547248|58724256|FG003|Overall Study|Withdrawal by Subject|1|||
30710774|NCT00688103|58724271|FG000|Overall Study|Adverse Event|4|||
30710775|NCT00688103|58724272|FG001|Overall Study|Adverse Event|1|||
30710776|NCT00688103|58724271|FG000|Overall Study|Lack of Efficacy|11|||
30710777|NCT00688103|58724272|FG001|Overall Study|Lack of Efficacy|1|||
30710778|NCT00688103|58724271|FG000|Overall Study|Withdrawal by Subject|4|||
30710779|NCT00688103|58724272|FG001|Overall Study|Withdrawal by Subject|2|||
30710780|NCT00688103|58724271|FG000|Overall Study|complex reasons|11|||
30710781|NCT00688103|58724272|FG001|Overall Study|complex reasons|9|||
30710782|NCT00686855|58724282|FG000|Overall Study|Lost to Follow-up|1|||
30710783|NCT00686855|58724283|FG001|Overall Study|Lost to Follow-up|0|||
30710784|NCT00686855|58724282|FG000|Overall Study|Progressive GVHD|0|||
30710785|NCT00686855|58724283|FG001|Overall Study|Progressive GVHD|1|||
30710786|NCT00686777|58724289|FG000|Overall Study|Adverse Event|2|||
30710787|NCT00686777|58724289|FG000|Overall Study|Pregnancy|1|||
30710788|NCT00686777|58724289|FG000|Overall Study|Withdrawal by Subject|2|||
30710789|NCT00686777|58724289|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
30710790|NCT00686777|58724289|FG000|Overall Study|No Visit|1|||
30710791|NCT00686699|58724295|FG000|Treatment Period 1|Adverse Event|0|||
30710792|NCT00686699|58724296|FG001|Treatment Period 1|Adverse Event|2|||
30710793|NCT00106639|58724305|FG000|Overall Study|Adverse Event|3|||
30710794|NCT00106639|58724306|FG001|Overall Study|Adverse Event|4|||
30710795|NCT00106639|58724307|FG002|Overall Study|Adverse Event|1|||
30710796|NCT00106639|58724305|FG000|Overall Study|Protocol Violation|0|||
30710797|NCT00106639|58724306|FG001|Overall Study|Protocol Violation|1|||
30710798|NCT00106639|58724307|FG002|Overall Study|Protocol Violation|0|||
30710799|NCT00106639|58724305|FG000|Overall Study|Withdrawal by Subject|0|||
30710800|NCT00106639|58724306|FG001|Overall Study|Withdrawal by Subject|1|||
30710801|NCT00106639|58724307|FG002|Overall Study|Withdrawal by Subject|0|||
30710802|NCT00106639|58724305|FG000|Overall Study|Participant defaulted|0|||
30710803|NCT00106639|58724306|FG001|Overall Study|Participant defaulted|1|||
30710804|NCT00106639|58724307|FG002|Overall Study|Participant defaulted|1|||
30710805|NCT00106249|58724318|FG000|Overall Study|Lost to Follow-up|3|||
30710806|NCT00106249|58724319|FG001|Overall Study|Lost to Follow-up|2|||
30710807|NCT00105469|58724327|FG000|Overall Study|Adverse Event|9|||
30710808|NCT00105469|58724328|FG001|Overall Study|Adverse Event|8|||
30710809|NCT00105469|58724327|FG000|Overall Study|Protocol Violation|4|||
30710810|NCT00105469|58724328|FG001|Overall Study|Protocol Violation|0|||
30710811|NCT00105469|58724327|FG000|Overall Study|Withdrawal by Subject|2|||
30710812|NCT00105469|58724328|FG001|Overall Study|Withdrawal by Subject|3|||
30710813|NCT00105469|58724327|FG000|Overall Study|Lost to Follow-up|1|||
30710814|NCT00105469|58724328|FG001|Overall Study|Lost to Follow-up|0|||
30710815|NCT00105469|58724327|FG000|Overall Study|Lack of Efficacy|2|||
30710816|NCT00105469|58724328|FG001|Overall Study|Lack of Efficacy|0|||
30710817|NCT00105469|58724327|FG000|Overall Study|Other Reason|4|||
30710818|NCT00105469|58724328|FG001|Overall Study|Other Reason|0|||
30710819|NCT00105235|58724334|FG000|Overall Study|Death|4|||
30710820|NCT00105235|58724334|FG000|Overall Study|Physician Decision|1|||
30710821|NCT00105235|58724334|FG000|Overall Study|Withdrawal by Subject|2|||
30710822|NCT00547118|58724344|FG000|Overall Study|Did not qualify prior to starting drug|1|||
30710823|NCT00547118|58724345|FG001|Overall Study|Did not qualify prior to starting drug|1|||
30710824|NCT00547118|58724344|FG000|Overall Study|Study suspended|7|||
30710825|NCT00547118|58724345|FG001|Overall Study|Study suspended|8|||
30710826|NCT00502593|58724365|FG000|Overall Study|Withdrawn unspecified reason|1|||
30710827|NCT00502593|58724366|FG001|Overall Study|Withdrawn unspecified reason|1|||
30710828|NCT00502593|58724367|FG002|Overall Study|Withdrawn unspecified reason|3|||
30710829|NCT00502593|58724368|FG003|Overall Study|Withdrawn unspecified reason|1|||
30710830|NCT00502593|58724369|FG004|Overall Study|Withdrawn unspecified reason|2|||
30710831|NCT00502593|58724370|FG005|Overall Study|Withdrawn unspecified reason|0|||
30710832|NCT00502593|58724371|FG006|Overall Study|Withdrawn unspecified reason|2|||
30710833|NCT00502593|58724372|FG007|Overall Study|Withdrawn unspecified reason|0|||
30710834|NCT00502593|58724373|FG008|Overall Study|Withdrawn unspecified reason|0|||
30710835|NCT00502593|58724374|FG009|Overall Study|Withdrawn unspecified reason|0|||
30710836|NCT00502593|58724375|FG010|Overall Study|Withdrawn unspecified reason|0|||
30710837|NCT00502593|58724376|FG011|Overall Study|Withdrawn unspecified reason|0|||
30710838|NCT00502593|58724365|FG000|Overall Study|Withdrawal by Subject|0|||
30710839|NCT00502593|58724366|FG001|Overall Study|Withdrawal by Subject|0|||
30710840|NCT00502593|58724367|FG002|Overall Study|Withdrawal by Subject|6|||
30710841|NCT00502593|58724368|FG003|Overall Study|Withdrawal by Subject|2|||
30710842|NCT00502593|58724369|FG004|Overall Study|Withdrawal by Subject|2|||
30710843|NCT00502593|58724370|FG005|Overall Study|Withdrawal by Subject|0|||
30710844|NCT00502593|58724371|FG006|Overall Study|Withdrawal by Subject|3|||
30710845|NCT00502593|58724372|FG007|Overall Study|Withdrawal by Subject|0|||
30899833|NCT01641991|58933143|FG002|Overall Study|Withdrawal by Subject|1|||
30899834|NCT01641991|58933144|FG003|Overall Study|Withdrawal by Subject|5|||
30710846|NCT00502593|58724373|FG008|Overall Study|Withdrawal by Subject|3|||
30710847|NCT00502593|58724374|FG009|Overall Study|Withdrawal by Subject|0|||
30710848|NCT00502593|58724375|FG010|Overall Study|Withdrawal by Subject|1|||
30710849|NCT00502593|58724376|FG011|Overall Study|Withdrawal by Subject|0|||
30710850|NCT00502593|58724365|FG000|Overall Study|Lost to Follow-up|2|||
30710851|NCT00502593|58724366|FG001|Overall Study|Lost to Follow-up|1|||
30710852|NCT00502593|58724367|FG002|Overall Study|Lost to Follow-up|1|||
30710853|NCT00502593|58724368|FG003|Overall Study|Lost to Follow-up|1|||
30710854|NCT00502593|58724369|FG004|Overall Study|Lost to Follow-up|0|||
30710855|NCT00502593|58724370|FG005|Overall Study|Lost to Follow-up|0|||
30710856|NCT00502593|58724371|FG006|Overall Study|Lost to Follow-up|0|||
30710857|NCT00502593|58724372|FG007|Overall Study|Lost to Follow-up|0|||
30710858|NCT00502593|58724373|FG008|Overall Study|Lost to Follow-up|3|||
30710859|NCT00502593|58724374|FG009|Overall Study|Lost to Follow-up|0|||
30710860|NCT00502593|58724375|FG010|Overall Study|Lost to Follow-up|1|||
30710861|NCT00502593|58724376|FG011|Overall Study|Lost to Follow-up|0|||
30710862|NCT00686543|58724429|FG000|Overall Study|Adverse Event|9|||
30710863|NCT00686543|58724430|FG001|Overall Study|Adverse Event|1|||
30710864|NCT00686543|58724431|FG002|Overall Study|Adverse Event|3|||
30710865|NCT00686543|58724432|FG003|Overall Study|Adverse Event|2|||
30710866|NCT00686543|58724429|FG000|Overall Study|Withdrawal by Subject|2|||
30710867|NCT00686543|58724430|FG001|Overall Study|Withdrawal by Subject|0|||
30710868|NCT00686543|58724431|FG002|Overall Study|Withdrawal by Subject|0|||
30710869|NCT00686543|58724432|FG003|Overall Study|Withdrawal by Subject|0|||
30710870|NCT00686543|58724429|FG000|Overall Study|Protocol Violation|3|||
30710871|NCT00686543|58724430|FG001|Overall Study|Protocol Violation|0|||
30710872|NCT00686543|58724431|FG002|Overall Study|Protocol Violation|2|||
30710873|NCT00686543|58724432|FG003|Overall Study|Protocol Violation|1|||
30710874|NCT00545688|58724446|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
30710875|NCT00545688|58724447|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
30710876|NCT00545688|58724448|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
30710877|NCT00545688|58724449|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
30710878|NCT00545688|58724446|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
30710879|NCT00545688|58724447|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
30899835|NCT01641991|58933141|FG000|Overall Study|Adverse Event|2|||
30710880|NCT00545688|58724448|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
30710881|NCT00545688|58724449|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
30710882|NCT00545688|58724446|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
30710883|NCT00545688|58724447|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
30710884|NCT00545688|58724448|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
30710885|NCT00545688|58724449|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
30710886|NCT00545688|58724446|FG000|Neo-Adjuvant Treatment Period|Death|0|||
30710887|NCT00545688|58724447|FG001|Neo-Adjuvant Treatment Period|Death|1|||
30710888|NCT00545688|58724448|FG002|Neo-Adjuvant Treatment Period|Death|0|||
30710889|NCT00545688|58724449|FG003|Neo-Adjuvant Treatment Period|Death|0|||
30710890|NCT00545688|58724446|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
30710891|NCT00545688|58724447|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
30710892|NCT00545688|58724448|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
30710893|NCT00545688|58724449|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
30710894|NCT00545688|58724446|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
30710895|NCT00545688|58724447|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
30710896|NCT00545688|58724448|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
30710897|NCT00545688|58724449|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
30710898|NCT00545688|58724446|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
30710899|NCT00545688|58724447|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
30710900|NCT00545688|58724448|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
30710901|NCT00545688|58724449|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
30710902|NCT00545688|58724446|FG000|Adjuvant Treatment Period|Disease Progression|3|||
30710903|NCT00545688|58724447|FG001|Adjuvant Treatment Period|Disease Progression|3|||
30710904|NCT00545688|58724448|FG002|Adjuvant Treatment Period|Disease Progression|0|||
30710905|NCT00545688|58724449|FG003|Adjuvant Treatment Period|Disease Progression|7|||
30710906|NCT00545688|58724446|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
30710907|NCT00545688|58724447|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
30710908|NCT00545688|58724448|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
30710909|NCT00545688|58724449|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
30710910|NCT00545688|58724446|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
30710911|NCT00545688|58724447|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
30710912|NCT00545688|58724448|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
30710913|NCT00545688|58724449|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
30710914|NCT00545688|58724446|FG000|Adjuvant Treatment Period|Adverse Event|0|||
30710915|NCT00545688|58724447|FG001|Adjuvant Treatment Period|Adverse Event|3|||
30710916|NCT00545688|58724448|FG002|Adjuvant Treatment Period|Adverse Event|2|||
30710917|NCT00545688|58724449|FG003|Adjuvant Treatment Period|Adverse Event|2|||
30710918|NCT00545688|58724446|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
30710919|NCT00545688|58724447|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
30710920|NCT00545688|58724448|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
30710921|NCT00545688|58724449|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
30710922|NCT00545688|58724446|FG000|Follow-Up Period|Death|4|||
30710923|NCT00545688|58724447|FG001|Follow-Up Period|Death|2|||
30710924|NCT00545688|58724448|FG002|Follow-Up Period|Death|2|||
30710925|NCT00545688|58724449|FG003|Follow-Up Period|Death|6|||
30710926|NCT00545688|58724446|FG000|Follow-Up Period|Disease Progression|6|||
30710927|NCT00545688|58724447|FG001|Follow-Up Period|Disease Progression|5|||
30710928|NCT00545688|58724448|FG002|Follow-Up Period|Disease Progression|9|||
30710929|NCT00545688|58724449|FG003|Follow-Up Period|Disease Progression|9|||
30710930|NCT00545688|58724446|FG000|Follow-Up Period|Refused Treatment|6|||
30710931|NCT00545688|58724447|FG001|Follow-Up Period|Refused Treatment|2|||
30710932|NCT00545688|58724448|FG002|Follow-Up Period|Refused Treatment|0|||
30710933|NCT00545688|58724449|FG003|Follow-Up Period|Refused Treatment|2|||
30710934|NCT00545688|58724446|FG000|Follow-Up Period|Lost to Follow-up|3|||
30710935|NCT00545688|58724447|FG001|Follow-Up Period|Lost to Follow-up|3|||
30710936|NCT00545688|58724448|FG002|Follow-Up Period|Lost to Follow-up|3|||
30710937|NCT00545688|58724449|FG003|Follow-Up Period|Lost to Follow-up|1|||
30710938|NCT00545688|58724446|FG000|Follow-Up Period|Unspecified Reason|2|||
30710939|NCT00545688|58724447|FG001|Follow-Up Period|Unspecified Reason|5|||
30710940|NCT00545688|58724448|FG002|Follow-Up Period|Unspecified Reason|6|||
30899836|NCT01641991|58933142|FG001|Overall Study|Adverse Event|1|||
30899837|NCT01641991|58933143|FG002|Overall Study|Adverse Event|2|||
30899838|NCT01641991|58933144|FG003|Overall Study|Adverse Event|1|||
30899839|NCT01641991|58933141|FG000|Overall Study|Lost to Follow-up|0|||
30899840|NCT01641991|58933142|FG001|Overall Study|Lost to Follow-up|2|||
30899841|NCT01641991|58933143|FG002|Overall Study|Lost to Follow-up|3|||
30899842|NCT01641991|58933144|FG003|Overall Study|Lost to Follow-up|1|||
30899843|NCT01641991|58933141|FG000|Overall Study|Protocol Violation|1|||
30710941|NCT00545688|58724449|FG003|Follow-Up Period|Unspecified Reason|8|||
30710942|NCT00545688|58724446|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
30710943|NCT00545688|58724447|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
30710944|NCT00545688|58724448|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
30710945|NCT00545688|58724449|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
30710946|NCT00502203|58724462|FG000|Overall Study|Inevaluable|1|||
30710947|NCT00546078|58724468|FG000|Overall Study|Lost to Follow-up|1|||
30710948|NCT00546078|58724469|FG001|Overall Study|Lost to Follow-up|3|||
30710949|NCT00546078|58724468|FG000|Overall Study|Withdrawal by Subject|2|||
30710950|NCT00546078|58724469|FG001|Overall Study|Withdrawal by Subject|3|||
30710951|NCT00546078|58724468|FG000|Overall Study|Other reason|1|||
30710952|NCT00546078|58724469|FG001|Overall Study|Other reason|1|||
30710953|NCT00546000|58724475|FG000|Overall Study|Adverse Event|1|||
30710954|NCT00546000|58724475|FG000|Overall Study|Lost to Follow-up|1|||
30710955|NCT00546000|58724475|FG000|Overall Study|Baseline HPA Axis Supression|2|||
30710956|NCT00501969|58724479|FG000|Overall Study|Major Protocol Violation|4|||
30710957|NCT00501969|58724479|FG000|Overall Study|Lack of Efficacy|29|||
30710958|NCT00501969|58724479|FG000|Overall Study|Adverse Event|76|||
30710959|NCT00501969|58724479|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
30710960|NCT00501969|58724479|FG000|Overall Study|Subject withdrew consent|51|||
30710961|NCT00501969|58724479|FG000|Overall Study|Lost to Follow-up|4|||
30710962|NCT00501969|58724479|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
30710963|NCT00501969|58724479|FG000|Overall Study|Other: Sponsors Request|10|||
30710964|NCT00501969|58724479|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
30710965|NCT00501969|58724479|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
30710966|NCT00501969|58724479|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
30710967|NCT00501969|58724479|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
30710968|NCT00501969|58724479|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
30710969|NCT00501969|58724479|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
30710970|NCT00501969|58724479|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
30710971|NCT00501969|58724479|FG000|Overall Study|Other: As Required by Local EC|2|||
30710972|NCT00501969|58724479|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
30710973|NCT00501969|58724479|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
30710974|NCT03942042|58724485|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
30710975|NCT03942042|58724486|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
30710976|NCT03942042|58724485|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
30710977|NCT03942042|58724486|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
30710978|NCT00104299|58724498|FG000|Overall Study|Adverse Event|3|||
30710979|NCT00104299|58724499|FG001|Overall Study|Adverse Event|1|||
30710980|NCT00104299|58724498|FG000|Overall Study|Death|2|||
30710981|NCT00104299|58724499|FG001|Overall Study|Death|2|||
30710982|NCT00104299|58724498|FG000|Overall Study|Withdrawal by Subject|2|||
30710983|NCT00104299|58724499|FG001|Overall Study|Withdrawal by Subject|6|||
30710984|NCT00104299|58724498|FG000|Overall Study|Physician Decision|1|||
30710985|NCT00104299|58724499|FG001|Overall Study|Physician Decision|1|||
30710986|NCT00104299|58724498|FG000|Overall Study|To have renal transplant|1|||
30710987|NCT00104299|58724499|FG001|Overall Study|To have renal transplant|0|||
30710988|NCT03939312|58724505|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
30710989|NCT03939312|58724505|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
30710990|NCT03939312|58724505|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
30710991|NCT03939312|58724505|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
30710992|NCT03939312|58724505|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
30710993|NCT03939312|58724505|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
30710994|NCT03939312|58724505|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
30710995|NCT03939312|58724505|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
30710996|NCT03939312|58724505|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
30710997|NCT03939312|58724505|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
30710998|NCT03939312|58724505|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
30710999|NCT03939312|58724505|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
30711000|NCT00082381|58724513|FG000|Overall Study|Adverse Event|27|||
30711001|NCT00082381|58724514|FG001|Overall Study|Adverse Event|2|||
30711002|NCT00082381|58724513|FG000|Overall Study|Lost to Follow-up|5|||
30711003|NCT00082381|58724514|FG001|Overall Study|Lost to Follow-up|7|||
30711004|NCT00082381|58724513|FG000|Overall Study|Patient Decision|8|||
30711005|NCT00082381|58724514|FG001|Overall Study|Patient Decision|4|||
30711006|NCT00082381|58724513|FG000|Overall Study|Physician Decision|1|||
30711007|NCT00082381|58724514|FG001|Overall Study|Physician Decision|2|||
30711008|NCT00082381|58724513|FG000|Overall Study|Protocol Violation|10|||
30711009|NCT00082381|58724514|FG001|Overall Study|Protocol Violation|11|||
30711010|NCT00082381|58724513|FG000|Overall Study|Loss of Glucose Control|4|||
30711011|NCT00082381|58724514|FG001|Overall Study|Loss of Glucose Control|0|||
30711012|NCT00545844|58724520|FG000|Overall Study|Lost to Follow-up|9|||
30899844|NCT01641991|58933142|FG001|Overall Study|Protocol Violation|1|||
30899845|NCT01641991|58933143|FG002|Overall Study|Protocol Violation|3|||
30711013|NCT00545844|58724520|FG000|Overall Study|Protocol Violation|1|||
30899846|NCT01641991|58933144|FG003|Overall Study|Protocol Violation|0|||
30899847|NCT01641991|58933141|FG000|Overall Study|Pregnancy|0|||
30899848|NCT01641991|58933142|FG001|Overall Study|Pregnancy|0|||
30899849|NCT01641991|58933143|FG002|Overall Study|Pregnancy|1|||
30711014|NCT00545844|58724520|FG000|Overall Study|Withdrawal by Subject|2|||
30711015|NCT00492063|58724530|FG000|Overall Study|Death|0|||
30711016|NCT00492063|58724531|FG001|Overall Study|Death|0|||
30711017|NCT00492063|58724532|FG002|Overall Study|Death|1|||
30711018|NCT00492063|58724533|FG003|Overall Study|Death|2|||
30711019|NCT00492063|58724530|FG000|Overall Study|Withdrawal by Subject|4|||
30711020|NCT00492063|58724531|FG001|Overall Study|Withdrawal by Subject|3|||
30711021|NCT00492063|58724532|FG002|Overall Study|Withdrawal by Subject|5|||
30711022|NCT00492063|58724533|FG003|Overall Study|Withdrawal by Subject|4|||
30711023|NCT00492063|58724530|FG000|Overall Study|Lost to Follow-up|6|||
30711024|NCT00492063|58724531|FG001|Overall Study|Lost to Follow-up|11|||
30711025|NCT00492063|58724532|FG002|Overall Study|Lost to Follow-up|5|||
30711026|NCT00492063|58724533|FG003|Overall Study|Lost to Follow-up|3|||
30711027|NCT00492063|58724530|FG000|Overall Study|Protocol Violation|0|||
30711028|NCT00492063|58724531|FG001|Overall Study|Protocol Violation|0|||
30711029|NCT00492063|58724532|FG002|Overall Study|Protocol Violation|0|||
30711030|NCT00492063|58724533|FG003|Overall Study|Protocol Violation|1|||
30711031|NCT00093145|58724543|FG000|Overall Study|Unacceptable Toxicity Only|2|||
30711032|NCT00093145|58724543|FG000|Overall Study|Physician Decision|5|||
30711033|NCT00093145|58724543|FG000|Overall Study|Withdrawal by Subject|9|||
30711034|NCT00093145|58724543|FG000|Overall Study|Other|1|||
30711035|NCT00513357|58724549|FG000|Overall Study|did not receive allocated placebo|2|||
30711036|NCT00513357|58724550|FG001|Overall Study|did not receive allocated placebo|3|||
30711037|NCT00513357|58724549|FG000|Overall Study|Adverse Event|4|||
30711038|NCT00513357|58724550|FG001|Overall Study|Adverse Event|2|||
30711039|NCT00513357|58724549|FG000|Overall Study|Death|2|||
30711040|NCT00513357|58724550|FG001|Overall Study|Death|0|||
30711041|NCT00513357|58724549|FG000|Overall Study|Withdrawal by Subject|5|||
30711042|NCT00513357|58724550|FG001|Overall Study|Withdrawal by Subject|4|||
30711043|NCT00513357|58724549|FG000|Overall Study|Disease Progression|2|||
30711044|NCT00513357|58724550|FG001|Overall Study|Disease Progression|1|||
30711045|NCT03933462|58724556|FG000|Overall Study|Adverse Event|2|||
30711046|NCT03933462|58724557|FG001|Overall Study|Adverse Event|0|||
30711047|NCT03929562|58724565|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
30711048|NCT03929562|58724566|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
30711049|NCT03929562|58724565|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
30711050|NCT03929562|58724566|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
30711051|NCT03929562|58724565|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
30711052|NCT03929562|58724566|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
30711053|NCT00415636|58724580|FG000|Overall Study|Symptomatic deterioration|1|||
30711054|NCT00415636|58724581|FG001|Overall Study|Symptomatic deterioration|0|||
30711055|NCT00415636|58724582|FG002|Overall Study|Symptomatic deterioration|1|||
30711056|NCT00415636|58724583|FG003|Overall Study|Symptomatic deterioration|2|||
30711057|NCT00415636|58724584|FG004|Overall Study|Symptomatic deterioration|0|||
30711058|NCT00415636|58724585|FG005|Overall Study|Symptomatic deterioration|1|||
30711059|NCT00415636|58724580|FG000|Overall Study|Adverse Event|0|||
30711060|NCT00415636|58724581|FG001|Overall Study|Adverse Event|0|||
30711061|NCT00415636|58724582|FG002|Overall Study|Adverse Event|0|||
30711062|NCT00415636|58724583|FG003|Overall Study|Adverse Event|1|||
30711063|NCT00415636|58724584|FG004|Overall Study|Adverse Event|1|||
30711064|NCT00415636|58724585|FG005|Overall Study|Adverse Event|0|||
30711065|NCT00415636|58724580|FG000|Overall Study|Withdrawal by Subject|0|||
30711066|NCT00415636|58724581|FG001|Overall Study|Withdrawal by Subject|0|||
30711067|NCT00415636|58724582|FG002|Overall Study|Withdrawal by Subject|0|||
30711068|NCT00415636|58724583|FG003|Overall Study|Withdrawal by Subject|0|||
30711069|NCT00415636|58724584|FG004|Overall Study|Withdrawal by Subject|1|||
30711070|NCT00415636|58724585|FG005|Overall Study|Withdrawal by Subject|0|||
30711071|NCT00415636|58724580|FG000|Overall Study|Disease progression|0|||
30711072|NCT00415636|58724581|FG001|Overall Study|Disease progression|0|||
30711073|NCT00415636|58724582|FG002|Overall Study|Disease progression|0|||
30711074|NCT00415636|58724583|FG003|Overall Study|Disease progression|3|||
30711075|NCT00415636|58724584|FG004|Overall Study|Disease progression|0|||
30711076|NCT00415636|58724585|FG005|Overall Study|Disease progression|1|||
30711077|NCT00425854|58724609|FG000|Overall Study|Progressive Disease|19|||
30711078|NCT00425854|58724610|FG001|Overall Study|Progressive Disease|12|||
30711079|NCT00425854|58724609|FG000|Overall Study|Dose reduction toxicity AE|8|||
30711080|NCT00425854|58724610|FG001|Overall Study|Dose reduction toxicity AE|7|||
30711081|NCT00425854|58724609|FG000|Overall Study|Other Adverse Event|2|||
30711082|NCT00425854|58724610|FG001|Overall Study|Other Adverse Event|2|||
30899850|NCT01641991|58933144|FG003|Overall Study|Pregnancy|0|||
30899851|NCT01641991|58933141|FG000|Overall Study|no longer eligible|2|||
30711083|NCT00425698|58724619|FG000|Overall Study|Adverse Event|3|||
30711084|NCT00425698|58724620|FG001|Overall Study|Adverse Event|1|||
30711085|NCT00425698|58724619|FG000|Overall Study|Withdrawal by Subject|0|||
30711086|NCT00425698|58724620|FG001|Overall Study|Withdrawal by Subject|1|||
30711087|NCT00425308|58724628|FG000|Overall Study|Adverse Event|2|||
30711088|NCT00425308|58724629|FG001|Overall Study|Adverse Event|1|||
30899852|NCT01641991|58933142|FG001|Overall Study|no longer eligible|1|||
30621139|NCT02846545|58632709|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
30899853|NCT01641991|58933143|FG002|Overall Study|no longer eligible|0|||
30899854|NCT01641991|58933144|FG003|Overall Study|no longer eligible|4|||
30899855|NCT02277691|58933157|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
30899856|NCT02277691|58933157|FG000|Overall Study|Voluntary Withdrawal|7|||
30899857|NCT02277691|58933157|FG000|Overall Study|Lack of Efficacy|5|||
30899858|NCT02277691|58933157|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
30899859|NCT02395172|58933163|FG000|Overall Study|Participants randomized but not treated|3|||
30899860|NCT02395172|58933164|FG001|Overall Study|Participants randomized but not treated|31|||
30899861|NCT02276053|58933170|FG000|Overall Study|Death|2|||
30899862|NCT02276053|58933170|FG000|Overall Study|Adverse Event|5|||
30899863|NCT02276053|58933170|FG000|Overall Study|Lack of Efficacy|2|||
30790899|NCT03200912|58803988|FG000|Overall Study|Non-compliance with study drug|0|||
30621140|NCT02846545|58632710|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
30711089|NCT00425308|58724628|FG000|Overall Study|Withdrawal by Subject|1|||
30711090|NCT00425308|58724629|FG001|Overall Study|Withdrawal by Subject|0|||
30899864|NCT02276053|58933170|FG000|Overall Study|Withdrawal by Subject|1|||
30899865|NCT02276053|58933170|FG000|Overall Study|Patient does not meet selection criteria|3|||
30899866|NCT02276053|58933170|FG000|Overall Study|Patient needs to increase baseline AED|1|||
30899867|NCT02275819|58933177|FG000|Overall Study|Adverse Event|0|||
30899868|NCT02275819|58933178|FG001|Overall Study|Adverse Event|1|||
30899869|NCT02358044|58933186|FG000|Overall Study|Adverse Event|0|||
30899870|NCT02358044|58933187|FG001|Overall Study|Adverse Event|1|||
30899871|NCT02358044|58933186|FG000|Overall Study|Lost to Follow-up|2|||
30899872|NCT02358044|58933187|FG001|Overall Study|Lost to Follow-up|1|||
30899873|NCT02358044|58933186|FG000|Overall Study|Physician Decision|0|||
30899874|NCT02358044|58933187|FG001|Overall Study|Physician Decision|1|||
30899875|NCT02358044|58933186|FG000|Overall Study|Withdrawal by Subject|0|||
30899876|NCT02358044|58933187|FG001|Overall Study|Withdrawal by Subject|4|||
30899877|NCT02275117|58933198|FG000|Overall Study|Adverse Event|0|||
30899878|NCT02275117|58933199|FG001|Overall Study|Adverse Event|0|||
30899879|NCT02275117|58933200|FG002|Overall Study|Adverse Event|0|||
30899880|NCT02275117|58933201|FG003|Overall Study|Adverse Event|0|||
30899881|NCT02275117|58933202|FG004|Overall Study|Adverse Event|1|||
30899882|NCT02275117|58933198|FG000|Overall Study|Lack of Efficacy|6|||
30899883|NCT02275117|58933199|FG001|Overall Study|Lack of Efficacy|7|||
30899884|NCT02275117|58933200|FG002|Overall Study|Lack of Efficacy|5|||
30899885|NCT02275117|58933201|FG003|Overall Study|Lack of Efficacy|2|||
30899886|NCT02275117|58933202|FG004|Overall Study|Lack of Efficacy|10|||
30899887|NCT02275117|58933198|FG000|Overall Study|Lost to Follow-up|11|||
30899888|NCT02275117|58933199|FG001|Overall Study|Lost to Follow-up|16|||
30899889|NCT02275117|58933200|FG002|Overall Study|Lost to Follow-up|15|||
30899890|NCT02275117|58933201|FG003|Overall Study|Lost to Follow-up|16|||
30899891|NCT02275117|58933202|FG004|Overall Study|Lost to Follow-up|8|||
30899892|NCT02275117|58933198|FG000|Overall Study|Physician Decision|0|||
30899893|NCT02275117|58933199|FG001|Overall Study|Physician Decision|1|||
30899894|NCT02275117|58933200|FG002|Overall Study|Physician Decision|1|||
30621141|NCT02846545|58632709|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
30899895|NCT02275117|58933201|FG003|Overall Study|Physician Decision|0|||
30899896|NCT02275117|58933202|FG004|Overall Study|Physician Decision|1|||
30899897|NCT02275117|58933198|FG000|Overall Study|Protocol Violation|1|||
30899898|NCT02275117|58933199|FG001|Overall Study|Protocol Violation|0|||
30899899|NCT02275117|58933200|FG002|Overall Study|Protocol Violation|1|||
30899900|NCT02275117|58933201|FG003|Overall Study|Protocol Violation|1|||
30899901|NCT02275117|58933202|FG004|Overall Study|Protocol Violation|0|||
30621142|NCT02846545|58632710|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
30621143|NCT02846545|58632709|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
30899902|NCT02275117|58933198|FG000|Overall Study|Withdrawal by Subject|6|||
30899903|NCT02275117|58933199|FG001|Overall Study|Withdrawal by Subject|4|||
30899904|NCT02275117|58933200|FG002|Overall Study|Withdrawal by Subject|7|||
30899905|NCT02275117|58933201|FG003|Overall Study|Withdrawal by Subject|3|||
30899906|NCT02275117|58933202|FG004|Overall Study|Withdrawal by Subject|3|||
30899907|NCT02275117|58933198|FG000|Overall Study|Terminated by Sponsor|4|||
30899908|NCT02275117|58933199|FG001|Overall Study|Terminated by Sponsor|4|||
30899909|NCT02275117|58933200|FG002|Overall Study|Terminated by Sponsor|4|||
30621144|NCT02846545|58632710|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
30899910|NCT02275117|58933201|FG003|Overall Study|Terminated by Sponsor|6|||
30899911|NCT02275117|58933202|FG004|Overall Study|Terminated by Sponsor|4|||
30711091|NCT00425308|58724628|FG000|Overall Study|Death|1|||
30711092|NCT00425308|58724629|FG001|Overall Study|Death|0|||
30711093|NCT00545064|58724635|FG000|Overall Study|Lost to Follow-up|3|||
30711094|NCT00545064|58724635|FG000|Overall Study|Withdrawal by Subject|2|||
30711095|NCT00545064|58724635|FG000|Overall Study|did not complete course of treatment|1|||
30711096|NCT00545064|58724635|FG000|Overall Study|cancel all appointments, no rebooking|1|||
30711097|NCT00545064|58724635|FG000|Overall Study|inclement weather|1|||
30711098|NCT00432562|58724643|FG000|Overall Study|Death|3|||
30711099|NCT00432562|58724644|FG001|Overall Study|Death|0|||
30711100|NCT00432172|58724654|FG000|Overall Study|Physician Decision|0|||
30711101|NCT00432172|58724655|FG001|Overall Study|Physician Decision|0|||
30711102|NCT00432172|58724656|FG002|Overall Study|Physician Decision|2|||
30711103|NCT00432172|58724657|FG003|Overall Study|Physician Decision|0|||
30711104|NCT00432172|58724654|FG000|Overall Study|Adverse Event|4|||
30711105|NCT00432172|58724655|FG001|Overall Study|Adverse Event|2|||
30711106|NCT00432172|58724656|FG002|Overall Study|Adverse Event|4|||
30711107|NCT00432172|58724657|FG003|Overall Study|Adverse Event|3|||
30711108|NCT00432172|58724654|FG000|Overall Study|Disease progression|0|||
30711109|NCT00432172|58724655|FG001|Overall Study|Disease progression|2|||
30711110|NCT00432172|58724656|FG002|Overall Study|Disease progression|5|||
30711111|NCT00432172|58724657|FG003|Overall Study|Disease progression|1|||
30711112|NCT00432172|58724654|FG000|Overall Study|Withdrawal by Subject|0|||
30711113|NCT00432172|58724655|FG001|Overall Study|Withdrawal by Subject|1|||
30711114|NCT00432172|58724656|FG002|Overall Study|Withdrawal by Subject|0|||
30711115|NCT00432172|58724657|FG003|Overall Study|Withdrawal by Subject|2|||
30711116|NCT00432172|58724654|FG000|Overall Study|No treatment received|2|||
30711117|NCT00432172|58724655|FG001|Overall Study|No treatment received|2|||
30711118|NCT00432172|58724656|FG002|Overall Study|No treatment received|0|||
30711119|NCT00432172|58724657|FG003|Overall Study|No treatment received|1|||
30711120|NCT00415168|58724669|FG000|Overall Study|Death|26|||
30711121|NCT00415168|58724669|FG000|Overall Study|Lost to Follow-up|3|||
30711122|NCT00415168|58724669|FG000|Overall Study|Physician Decision|13|||
30711123|NCT00415168|58724669|FG000|Overall Study|Sponsor Decision|4|||
30711124|NCT00415168|58724669|FG000|Overall Study|Withdrawal by Subject|6|||
30711125|NCT00424762|58724675|FG000|Overall Study|Withdrawal by Subject|18|||
30711126|NCT00424762|58724676|FG001|Overall Study|Withdrawal by Subject|19|||
30711127|NCT00424762|58724675|FG000|Overall Study|Lost to Follow-up|2|||
30711128|NCT00424762|58724676|FG001|Overall Study|Lost to Follow-up|3|||
30711129|NCT00414544|58724682|FG000|Overall Study|Lost to Follow-up|14|||
30711130|NCT00414466|58724692|FG000|Overall Study|Adverse Event|0|||
30711131|NCT00414466|58724693|FG001|Overall Study|Adverse Event|0|||
30711132|NCT00414466|58724694|FG002|Overall Study|Adverse Event|1|||
30711133|NCT00414466|58724695|FG003|Overall Study|Adverse Event|1|||
30711134|NCT00414466|58724692|FG000|Overall Study|Lack of Efficacy|1|||
30711135|NCT00414466|58724693|FG001|Overall Study|Lack of Efficacy|0|||
30711136|NCT00414466|58724694|FG002|Overall Study|Lack of Efficacy|0|||
30711137|NCT00414466|58724695|FG003|Overall Study|Lack of Efficacy|0|||
30711138|NCT00414466|58724692|FG000|Overall Study|Withdrawn by Sponsor|1|||
30711139|NCT00414466|58724693|FG001|Overall Study|Withdrawn by Sponsor|0|||
30711140|NCT00414466|58724694|FG002|Overall Study|Withdrawn by Sponsor|0|||
30711141|NCT00414466|58724695|FG003|Overall Study|Withdrawn by Sponsor|0|||
30711142|NCT00424528|58724711|FG000|Overall Study|Adverse Event|2|||
30711143|NCT00424528|58724712|FG001|Overall Study|Adverse Event|1|||
30711144|NCT00424528|58724713|FG002|Overall Study|Adverse Event|2|||
30711145|NCT00424528|58724711|FG000|Overall Study|Protocol Violation|1|||
30711146|NCT00424528|58724712|FG001|Overall Study|Protocol Violation|1|||
30711147|NCT00424528|58724713|FG002|Overall Study|Protocol Violation|0|||
30711148|NCT00424528|58724711|FG000|Overall Study|Lost to Follow-up|0|||
30711149|NCT00424528|58724712|FG001|Overall Study|Lost to Follow-up|1|||
30711150|NCT00424528|58724713|FG002|Overall Study|Lost to Follow-up|0|||
30711151|NCT00424528|58724711|FG000|Overall Study|noncompliance with study requirements|2|||
30711152|NCT00424528|58724712|FG001|Overall Study|noncompliance with study requirements|1|||
30711153|NCT00424528|58724713|FG002|Overall Study|noncompliance with study requirements|2|||
30711154|NCT00545532|58724723|FG000|Overall Study|Withdrawal by Subject|1|||
30711155|NCT00545532|58724724|FG001|Overall Study|Withdrawal by Subject|3|||
30711156|NCT00545532|58724723|FG000|Overall Study|Lost to Follow-up|5|||
30711157|NCT00545532|58724724|FG001|Overall Study|Lost to Follow-up|6|||
30711158|NCT00545532|58724723|FG000|Overall Study|Death|0|||
30711159|NCT00545532|58724724|FG001|Overall Study|Death|1|||
30711160|NCT00544440|58724732|FG000|Overall Study|Other|1|||
30711161|NCT00544440|58724732|FG000|Overall Study|Adverse Event|1|||
30711162|NCT00544440|58724732|FG000|Overall Study|Withdrawal by Subject|2|||
30711163|NCT00544440|58724732|FG000|Overall Study|Subject Non-compliance|1|||
30711164|NCT00544440|58724732|FG000|Overall Study|Progressive Disease|47|||
30711165|NCT00544440|58724732|FG000|Overall Study|Other|5|||
30711166|NCT03920670|58724738|FG000|Overall Study|Protocol Violation|2|||
30711167|NCT03920670|58724739|FG001|Overall Study|Protocol Violation|2|||
30711168|NCT03920670|58724738|FG000|Overall Study|Adverse Event|1|||
30711169|NCT03920670|58724739|FG001|Overall Study|Adverse Event|0|||
30711170|NCT00430300|58724749|FG000|Overall Study|Adverse Event|0|||
30711171|NCT00430300|58724750|FG001|Overall Study|Adverse Event|2|||
30711172|NCT00430300|58724751|FG002|Overall Study|Adverse Event|1|||
30711173|NCT00430300|58724752|FG003|Overall Study|Adverse Event|1|||
30711174|NCT00430300|58724749|FG000|Overall Study|Withdrawal by Subject|1|||
30711175|NCT00430300|58724750|FG001|Overall Study|Withdrawal by Subject|0|||
30711176|NCT00430300|58724751|FG002|Overall Study|Withdrawal by Subject|5|||
30711177|NCT00430300|58724752|FG003|Overall Study|Withdrawal by Subject|0|||
30711178|NCT00430300|58724749|FG000|Overall Study|Laboratory abnormality|1|||
30711179|NCT00430300|58724750|FG001|Overall Study|Laboratory abnormality|0|||
30711180|NCT00430300|58724751|FG002|Overall Study|Laboratory abnormality|0|||
30711181|NCT00430300|58724752|FG003|Overall Study|Laboratory abnormality|0|||
30711182|NCT00430300|58724749|FG000|Overall Study|Other|0|||
30711183|NCT00430300|58724750|FG001|Overall Study|Other|0|||
30790900|NCT03200912|58803989|FG001|Overall Study|Non-compliance with study drug|1|||
30621145|NCT00990093|58632720|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
30711184|NCT00430300|58724751|FG002|Overall Study|Other|0|||
30711185|NCT00430300|58724752|FG003|Overall Study|Other|1|||
30711186|NCT03927846|58724764|FG000|Overall Study|Lost to Follow-up|10|||
30711187|NCT03927846|58724765|FG001|Overall Study|Lost to Follow-up|11|||
30711188|NCT03927144|58724773|FG000|Overall Study|Adverse Event|9|||
30711189|NCT03927144|58724774|FG001|Overall Study|Adverse Event|5|||
30711190|NCT03927144|58724773|FG000|Overall Study|Lost to Follow-up|3|||
30711191|NCT03927144|58724774|FG001|Overall Study|Lost to Follow-up|2|||
30711192|NCT03927144|58724773|FG000|Overall Study|New Therapy for Study Indication|0|||
30711193|NCT03927144|58724774|FG001|Overall Study|New Therapy for Study Indication|1|||
30711194|NCT03927144|58724773|FG000|Overall Study|No Longer Clinically Benefiting|4|||
30711195|NCT03927144|58724774|FG001|Overall Study|No Longer Clinically Benefiting|4|||
30621146|NCT00990093|58632721|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
30621147|NCT00990093|58632720|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
30621148|NCT00990093|58632721|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
30621149|NCT00990093|58632720|FG000|Test Period 1 (1-14 Days)|Other|1|||
30621150|NCT00990093|58632721|FG001|Test Period 1 (1-14 Days)|Other|0|||
30621151|NCT00990093|58632720|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
30621152|NCT00990093|58632721|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
30621153|NCT00990093|58632720|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
30621154|NCT00990093|58632721|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
30711196|NCT03927144|58724773|FG000|Overall Study|Physician Decision|2|||
30711197|NCT03927144|58724774|FG001|Overall Study|Physician Decision|8|||
30711198|NCT03927144|58724773|FG000|Overall Study|Protocol Violation|2|||
30711199|NCT03927144|58724774|FG001|Overall Study|Protocol Violation|2|||
30711200|NCT03927144|58724773|FG000|Overall Study|Withdrawal by Subject|16|||
30711201|NCT03927144|58724774|FG001|Overall Study|Withdrawal by Subject|40|||
30711202|NCT00545298|58724783|FG000|Overall Study|Issues with Standard of Care|2|||
30711203|NCT00545298|58724784|FG001|Overall Study|Issues with Standard of Care|0|||
30711204|NCT00545298|58724785|FG002|Overall Study|Issues with Standard of Care|1|||
30711205|NCT00429364|58724798|FG000|Overall Study|Withdrawal by Subject|11|||
30711206|NCT00429364|58724799|FG001|Overall Study|Withdrawal by Subject|5|||
30711207|NCT00429364|58724798|FG000|Overall Study|Physician Decision|4|||
30711208|NCT00429364|58724799|FG001|Overall Study|Physician Decision|2|||
30711209|NCT00429364|58724798|FG000|Overall Study|Lost to Follow-up|7|||
30711210|NCT00429364|58724799|FG001|Overall Study|Lost to Follow-up|6|||
30711211|NCT00429364|58724798|FG000|Overall Study|Death|0|||
30711212|NCT00429364|58724799|FG001|Overall Study|Death|1|||
30711213|NCT00429364|58724798|FG000|Overall Study|Underwent aortic root surgery|10|||
30711214|NCT00429364|58724799|FG001|Overall Study|Underwent aortic root surgery|18|||
30711215|NCT00429364|58724798|FG000|Overall Study|Pregnancy|0|||
30711216|NCT00429364|58724799|FG001|Overall Study|Pregnancy|1|||
30711217|NCT00414388|58724805|FG000|Overall Study|Adverse Event|1|||
30711218|NCT03920280|58724812|FG000|Overall Study|Adverse Event|2|||
30711219|NCT03920280|58724813|FG001|Overall Study|Adverse Event|3|||
30711220|NCT03920280|58724812|FG000|Overall Study|Lost to Follow-up|0|||
30711221|NCT03920280|58724813|FG001|Overall Study|Lost to Follow-up|1|||
30621155|NCT00990093|58632720|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
30621156|NCT00990093|58632721|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
30621157|NCT00990093|58632720|FG000|Test Period 2 (15-28 Days)|Other|0|||
30621158|NCT00990093|58632721|FG001|Test Period 2 (15-28 Days)|Other|1|||
30621159|NCT00984165|58632731|FG000|Overall Study|Death on study|2|||
30621160|NCT00984165|58632732|FG001|Overall Study|Death on study|0|||
30621161|NCT00984165|58632733|FG002|Overall Study|Death on study|0|||
30621162|NCT00984165|58632734|FG003|Overall Study|Death on study|0|||
30621163|NCT00984165|58632731|FG000|Overall Study|Disease progression on study|5|||
30711222|NCT03920280|58724812|FG000|Overall Study|Withdrawal by Subject|1|||
30711223|NCT03920280|58724813|FG001|Overall Study|Withdrawal by Subject|1|||
30711224|NCT03920280|58724812|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
30711225|NCT03920280|58724813|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
30711226|NCT00424372|58724822|FG000|Overall Study|Death|1|||
30711227|NCT00424372|58724822|FG000|Overall Study|Adverse Event|18|||
30711228|NCT00424372|58724822|FG000|Overall Study|Lack of Efficacy|6|||
30711229|NCT00424372|58724822|FG000|Overall Study|Withdrawal by Subject|4|||
30711230|NCT00424372|58724822|FG000|Overall Study|Protocol Violation|1|||
30711231|NCT00424372|58724822|FG000|Overall Study|Health deterioration|1|||
30711232|NCT00414310|58724828|FG000|Overall Study|Not treated|1|||
30711233|NCT00414310|58724829|FG001|Overall Study|Not treated|0|||
30711234|NCT00542880|58724839|FG000|Period 1|Eligibility criteria not fulfilled|2|||
30711235|NCT00542880|58724840|FG001|Period 1|Eligibility criteria not fulfilled|6|||
30711236|NCT00542880|58724839|FG000|Period 1|Adverse Event|2|||
30711237|NCT00542880|58724840|FG001|Period 1|Adverse Event|2|||
30711238|NCT00542880|58724839|FG000|Period 1|Development of study-specific criteria|1|||
30711239|NCT00542880|58724840|FG001|Period 1|Development of study-specific criteria|2|||
30711240|NCT00542880|58724839|FG000|Period 1|Withdrawal by Subject|1|||
30711241|NCT00542880|58724840|FG001|Period 1|Withdrawal by Subject|1|||
30711242|NCT00542880|58724839|FG000|Period 1|Protocol Violation|0|||
30711243|NCT00542880|58724840|FG001|Period 1|Protocol Violation|1|||
30711244|NCT00542880|58724839|FG000|Period 2|Adverse Event|5|||
30899912|NCT02275117|58933198|FG000|Overall Study|Worsening of Study Indication|0|||
30899913|NCT02275117|58933199|FG001|Overall Study|Worsening of Study Indication|1|||
30621164|NCT00984165|58632732|FG001|Overall Study|Disease progression on study|1|||
30621165|NCT00984165|58632733|FG002|Overall Study|Disease progression on study|0|||
30621166|NCT00984165|58632734|FG003|Overall Study|Disease progression on study|0|||
30621167|NCT00984165|58632731|FG000|Overall Study|Death of recipient|0|||
30621168|NCT00984165|58632732|FG001|Overall Study|Death of recipient|0|||
30621169|NCT00984165|58632733|FG002|Overall Study|Death of recipient|0|||
30621170|NCT00984165|58632734|FG003|Overall Study|Death of recipient|1|||
30621171|NCT00984165|58632731|FG000|Overall Study|New protocol|0|||
30621172|NCT00984165|58632732|FG001|Overall Study|New protocol|0|||
30621173|NCT00984165|58632733|FG002|Overall Study|New protocol|0|||
30621174|NCT00984165|58632734|FG003|Overall Study|New protocol|1|||
30621175|NCT00984165|58632731|FG000|Overall Study|P+/donor pair removed from protocol|0|||
30621176|NCT00984165|58632732|FG001|Overall Study|P+/donor pair removed from protocol|0|||
30621177|NCT00984165|58632733|FG002|Overall Study|P+/donor pair removed from protocol|0|||
30621178|NCT00984165|58632734|FG003|Overall Study|P+/donor pair removed from protocol|1|||
30621179|NCT00984165|58632731|FG000|Overall Study|removed with a pair recipient|0|||
30621180|NCT00984165|58632732|FG001|Overall Study|removed with a pair recipient|0|||
30621181|NCT00984165|58632733|FG002|Overall Study|removed with a pair recipient|0|||
30621182|NCT00984165|58632734|FG003|Overall Study|removed with a pair recipient|1|||
30621183|NCT00993291|58632745|FG000|Overall Study|Withdrawal by Subject|1|||
30621184|NCT01196975|58632754|FG000|Overall Study|Adverse Event|2|||
30621185|NCT01196975|58632755|FG001|Overall Study|Adverse Event|2|||
30621186|NCT01196975|58632756|FG002|Overall Study|Adverse Event|0|||
30621187|NCT01196975|58632757|FG003|Overall Study|Adverse Event|0|||
30621188|NCT01196975|58632758|FG004|Overall Study|Adverse Event|2|||
30621189|NCT01196975|58632754|FG000|Overall Study|Withdrawal by Subject|2|||
30621190|NCT01196975|58632755|FG001|Overall Study|Withdrawal by Subject|1|||
30621191|NCT01196975|58632756|FG002|Overall Study|Withdrawal by Subject|0|||
30621192|NCT01196975|58632757|FG003|Overall Study|Withdrawal by Subject|1|||
30621193|NCT01196975|58632758|FG004|Overall Study|Withdrawal by Subject|0|||
30711245|NCT00542880|58724840|FG001|Period 2|Adverse Event|7|||
30711246|NCT00542880|58724839|FG000|Period 2|Eligibility not fulfilled|0|||
30711247|NCT00542880|58724840|FG001|Period 2|Eligibility not fulfilled|1|||
30621194|NCT01196975|58632754|FG000|Overall Study|Lost to Follow-up|11|||
30621195|NCT01196975|58632755|FG001|Overall Study|Lost to Follow-up|6|||
30621196|NCT01196975|58632756|FG002|Overall Study|Lost to Follow-up|5|||
30621197|NCT01196975|58632757|FG003|Overall Study|Lost to Follow-up|5|||
30621198|NCT01196975|58632758|FG004|Overall Study|Lost to Follow-up|11|||
30621199|NCT00992589|58632793|FG000|Open-Label Phase|Adverse Event|4|||
30621200|NCT00992589|58632794|FG001|Open-Label Phase|Adverse Event|0|||
30621201|NCT00992589|58632795|FG002|Open-Label Phase|Adverse Event|0|||
30711248|NCT00542880|58724839|FG000|Period 2|Discontinuation criteria|2|||
30711249|NCT00542880|58724840|FG001|Period 2|Discontinuation criteria|0|||
30711250|NCT00542880|58724839|FG000|Period 2|Severe non-compliance|0|||
30711251|NCT00542880|58724840|FG001|Period 2|Severe non-compliance|1|||
30711252|NCT00542880|58724839|FG000|Period 2|Other|0|||
30711253|NCT00542880|58724840|FG001|Period 2|Other|1|||
30711254|NCT00542880|58724839|FG000|Period 3|Adverse Event|0|||
30711255|NCT00542880|58724840|FG001|Period 3|Adverse Event|2|||
30711256|NCT00414076|58724849|FG000|Overall Study|Progression|1|||
30711257|NCT00414076|58724850|FG001|Overall Study|Progression|2|||
30711258|NCT00414076|58724849|FG000|Overall Study|Withdrawal by Subject|1|||
30711259|NCT00414076|58724850|FG001|Overall Study|Withdrawal by Subject|3|||
30711260|NCT00414076|58724849|FG000|Overall Study|Adverse Event|1|||
30711261|NCT00414076|58724850|FG001|Overall Study|Adverse Event|0|||
30711262|NCT00092677|58724858|FG000|Overall Study|Lost to Follow-up|0|||
30711263|NCT00092677|58724859|FG001|Overall Study|Lost to Follow-up|2|||
30711264|NCT00092677|58724858|FG000|Overall Study|Adminstrative|5|||
30711265|NCT00092677|58724859|FG001|Overall Study|Adminstrative|9|||
30711266|NCT00542178|58724871|FG000|Overall Study|did not complete year 4 follow-up|75|||
30711267|NCT00542178|58724872|FG001|Overall Study|did not complete year 4 follow-up|80|||
30711268|NCT00542178|58724873|FG002|Overall Study|did not complete year 4 follow-up|74|||
30711269|NCT00542178|58724874|FG003|Overall Study|did not complete year 4 follow-up|62|||
30711270|NCT00542178|58724875|FG004|Overall Study|did not complete year 4 follow-up|64|||
30711271|NCT00542178|58724876|FG005|Overall Study|did not complete year 4 follow-up|89|||
30711272|NCT00542178|58724877|FG006|Overall Study|did not complete year 4 follow-up|87|||
30711273|NCT00542178|58724878|FG007|Overall Study|did not complete year 4 follow-up|85|||
30711274|NCT00424294|58724894|FG000|Overall Study|Adverse Event|4|||
30711275|NCT00424294|58724895|FG001|Overall Study|Adverse Event|10|||
30711276|NCT00424294|58724894|FG000|Overall Study|Lack of Efficacy|2|||
30711277|NCT00424294|58724895|FG001|Overall Study|Lack of Efficacy|1|||
30711278|NCT00424294|58724894|FG000|Overall Study|Withdrawal by Subject|1|||
30711279|NCT00424294|58724895|FG001|Overall Study|Withdrawal by Subject|2|||
30711280|NCT00424294|58724894|FG000|Overall Study|Other|0|||
30711281|NCT00424294|58724895|FG001|Overall Study|Other|2|||
30711282|NCT00424294|58724894|FG000|Overall Study|Randomized but not Treated|1|||
30711283|NCT00424294|58724895|FG001|Overall Study|Randomized but not Treated|0|||
30711284|NCT00092521|58724904|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
30711285|NCT00092521|58724905|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
30711286|NCT00092521|58724906|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
30711287|NCT00092521|58724907|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
30711288|NCT00092521|58724904|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
30711289|NCT00092521|58724905|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
30711290|NCT00092521|58724906|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
30711291|NCT00092521|58724907|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
30711292|NCT00092521|58724904|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
30711293|NCT00092521|58724905|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
30711294|NCT00092521|58724906|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
30711295|NCT00092521|58724907|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
30711296|NCT00092521|58724904|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
30711297|NCT00092521|58724905|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
30711298|NCT00092521|58724906|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
30711299|NCT00092521|58724907|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
30711300|NCT00092521|58724904|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
30711301|NCT00092521|58724905|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
30711302|NCT00092521|58724906|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
30711303|NCT00092521|58724907|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
30711304|NCT00092521|58724904|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
30711305|NCT00092521|58724905|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
30711306|NCT00092521|58724906|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
30711307|NCT00092521|58724907|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
30711308|NCT00092521|58724904|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
30711309|NCT00092521|58724905|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
30711310|NCT00092521|58724906|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
30711311|NCT00092521|58724907|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
30711312|NCT00092521|58724904|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
30711313|NCT00092521|58724905|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
30711314|NCT00092521|58724906|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
30711315|NCT00092521|58724907|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
30711316|NCT00092521|58724904|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
30711317|NCT00092521|58724905|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
30711318|NCT00092521|58724906|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
30711319|NCT00092521|58724907|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
30711320|NCT00092521|58724904|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
30711321|NCT00092521|58724905|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
30711322|NCT00092521|58724906|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
30711323|NCT00092521|58724907|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
30711324|NCT00092521|58724904|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
30711325|NCT00092521|58724905|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
30711326|NCT00092521|58724906|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
30711327|NCT00092521|58724907|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
30711328|NCT00092521|58724904|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
30711329|NCT00092521|58724905|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
30711330|NCT00092521|58724906|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
30711331|NCT00092521|58724907|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
30711332|NCT00092521|58724904|FG000|Follow-Up (After Month 7)|Death|2|||
30711333|NCT00092521|58724905|FG001|Follow-Up (After Month 7)|Death|0|||
30711334|NCT00092521|58724906|FG002|Follow-Up (After Month 7)|Death|1|||
30711335|NCT00092521|58724907|FG003|Follow-Up (After Month 7)|Death|0|||
30711336|NCT00092521|58724904|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
30711337|NCT00092521|58724905|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
30711338|NCT00092521|58724906|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
30711339|NCT00092521|58724907|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
30711340|NCT00092521|58724904|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
30711341|NCT00092521|58724905|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
30711342|NCT00092521|58724906|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
30711343|NCT00092521|58724907|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
30711344|NCT00092521|58724904|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
30711345|NCT00092521|58724905|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
30711346|NCT00092521|58724906|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
30711347|NCT00092521|58724907|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
30711348|NCT00092521|58724904|FG000|Follow-Up (After Month 7)|Moved|32|||
30711349|NCT00092521|58724905|FG001|Follow-Up (After Month 7)|Moved|2|||
30711350|NCT00092521|58724906|FG002|Follow-Up (After Month 7)|Moved|28|||
30711351|NCT00092521|58724907|FG003|Follow-Up (After Month 7)|Moved|0|||
30621202|NCT00992589|58632796|FG003|Open-Label Phase|Adverse Event|0|||
30621203|NCT00992589|58632793|FG000|Open-Label Phase|Withdrawal by Subject|20|||
30621204|NCT00992589|58632794|FG001|Open-Label Phase|Withdrawal by Subject|0|||
30621205|NCT00992589|58632795|FG002|Open-Label Phase|Withdrawal by Subject|0|||
30621206|NCT00992589|58632796|FG003|Open-Label Phase|Withdrawal by Subject|0|||
30621207|NCT00992589|58632793|FG000|Open-Label Phase|Lost to Follow-up|1|||
30621208|NCT00992589|58632794|FG001|Open-Label Phase|Lost to Follow-up|0|||
30621209|NCT00992589|58632795|FG002|Open-Label Phase|Lost to Follow-up|0|||
30621210|NCT00992589|58632796|FG003|Open-Label Phase|Lost to Follow-up|0|||
30621211|NCT00992589|58632793|FG000|Open-Label Phase|Protocol Violation|3|||
30621212|NCT00992589|58632794|FG001|Open-Label Phase|Protocol Violation|0|||
30621213|NCT00992589|58632795|FG002|Open-Label Phase|Protocol Violation|0|||
30621214|NCT00992589|58632796|FG003|Open-Label Phase|Protocol Violation|0|||
30621215|NCT00992589|58632793|FG000|Open-Label Phase|Physician Decision|4|||
30621216|NCT00992589|58632794|FG001|Open-Label Phase|Physician Decision|0|||
30621217|NCT00992589|58632795|FG002|Open-Label Phase|Physician Decision|0|||
30621218|NCT00992589|58632796|FG003|Open-Label Phase|Physician Decision|0|||
30621219|NCT00992589|58632793|FG000|Open-Label Phase|Other|45|||
30711352|NCT00092521|58724904|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
30711353|NCT00092521|58724905|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
30711354|NCT00092521|58724906|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
30711355|NCT00092521|58724907|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
30711356|NCT00092521|58724904|FG000|Follow-Up (After Month 7)|Travel|2|||
30711357|NCT00092521|58724905|FG001|Follow-Up (After Month 7)|Travel|0|||
30711358|NCT00092521|58724906|FG002|Follow-Up (After Month 7)|Travel|0|||
30621220|NCT00992589|58632794|FG001|Open-Label Phase|Other|0|||
30621221|NCT00992589|58632795|FG002|Open-Label Phase|Other|0|||
30621222|NCT00992589|58632796|FG003|Open-Label Phase|Other|0|||
30711359|NCT00092521|58724907|FG003|Follow-Up (After Month 7)|Travel|0|||
30711360|NCT00092521|58724904|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
30711361|NCT00092521|58724905|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
30711362|NCT00092521|58724906|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
30711363|NCT00092521|58724907|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
30711364|NCT00092521|58724904|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
30711365|NCT00092521|58724905|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
30711366|NCT00092521|58724906|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
30711367|NCT00092521|58724907|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
30711368|NCT00092521|58724904|FG000|Extension Study (Group 4)|Adverse Event|0|||
30711369|NCT00092521|58724905|FG001|Extension Study (Group 4)|Adverse Event|0|||
30711370|NCT00092521|58724906|FG002|Extension Study (Group 4)|Adverse Event|0|||
30711371|NCT00092521|58724907|FG003|Extension Study (Group 4)|Adverse Event|2|||
30711372|NCT00092521|58724904|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
30711373|NCT00092521|58724905|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
30711374|NCT00092521|58724906|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
30711375|NCT00092521|58724907|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
30711376|NCT00092521|58724904|FG000|Extension Study (Group 4)|Pregnancy|0|||
30711377|NCT00092521|58724905|FG001|Extension Study (Group 4)|Pregnancy|0|||
30711378|NCT00092521|58724906|FG002|Extension Study (Group 4)|Pregnancy|0|||
30711379|NCT00092521|58724907|FG003|Extension Study (Group 4)|Pregnancy|4|||
30711380|NCT00092521|58724904|FG000|Extension Study (Group 4)|Protocol Violation|0|||
30621223|NCT00992589|58632793|FG000|Double-Blind Phase|Adverse Event|0|||
30621224|NCT00992589|58632794|FG001|Double-Blind Phase|Adverse Event|6|||
30621225|NCT00992589|58632795|FG002|Double-Blind Phase|Adverse Event|2|||
30621226|NCT00992589|58632796|FG003|Double-Blind Phase|Adverse Event|3|||
30621227|NCT00992589|58632793|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
30621228|NCT00992589|58632794|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
30621229|NCT00992589|58632795|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
30621230|NCT00992589|58632796|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
30621231|NCT00992589|58632793|FG000|Double-Blind Phase|Lost to Follow-up|0|||
30621232|NCT00992589|58632794|FG001|Double-Blind Phase|Lost to Follow-up|0|||
30621233|NCT00992589|58632795|FG002|Double-Blind Phase|Lost to Follow-up|0|||
30621234|NCT00992589|58632796|FG003|Double-Blind Phase|Lost to Follow-up|2|||
30621235|NCT00992589|58632793|FG000|Double-Blind Phase|Other|0|||
30621236|NCT00992589|58632794|FG001|Double-Blind Phase|Other|1|||
30621237|NCT00992589|58632795|FG002|Double-Blind Phase|Other|6|||
30621238|NCT00992589|58632796|FG003|Double-Blind Phase|Other|3|||
30621239|NCT01196741|58632816|FG000|Overall Study|Disease progression|34|||
30621240|NCT01196741|58632817|FG001|Overall Study|Disease progression|14|||
30621241|NCT01196741|58632816|FG000|Overall Study|Adverse Event|10|||
30621242|NCT01196741|58632817|FG001|Overall Study|Adverse Event|6|||
30621243|NCT01196741|58632816|FG000|Overall Study|Serious Adverse Event|3|||
30711381|NCT00092521|58724905|FG001|Extension Study (Group 4)|Protocol Violation|0|||
30711382|NCT00092521|58724906|FG002|Extension Study (Group 4)|Protocol Violation|0|||
30711383|NCT00092521|58724907|FG003|Extension Study (Group 4)|Protocol Violation|2|||
30711384|NCT00092521|58724904|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
30711385|NCT00092521|58724905|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
30711386|NCT00092521|58724906|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
30711387|NCT00092521|58724907|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
30711388|NCT00092521|58724904|FG000|Extension Study (Group 4)|Moved|0|||
30711389|NCT00092521|58724905|FG001|Extension Study (Group 4)|Moved|0|||
30711390|NCT00092521|58724906|FG002|Extension Study (Group 4)|Moved|0|||
30711391|NCT00092521|58724907|FG003|Extension Study (Group 4)|Moved|16|||
30711392|NCT00092521|58724904|FG000|Extension Study (Group 4)|Site Terminated|0|||
30711393|NCT00092521|58724905|FG001|Extension Study (Group 4)|Site Terminated|0|||
30711394|NCT00092521|58724906|FG002|Extension Study (Group 4)|Site Terminated|0|||
30711395|NCT00092521|58724907|FG003|Extension Study (Group 4)|Site Terminated|4|||
30711396|NCT00092521|58724904|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
30711397|NCT00092521|58724905|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
30711398|NCT00092521|58724906|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
30711399|NCT00092521|58724907|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
30711400|NCT03908970|58724917|FG000|Overall Study|Adverse Event|7|||
30711401|NCT03908970|58724918|FG001|Overall Study|Adverse Event|21|||
30711402|NCT03908970|58724917|FG000|Overall Study|Physician Decision|1|||
30711403|NCT03908970|58724918|FG001|Overall Study|Physician Decision|4|||
30711404|NCT03908970|58724917|FG000|Overall Study|Withdrawal by Subject|9|||
30711405|NCT03908970|58724918|FG001|Overall Study|Withdrawal by Subject|22|||
30711406|NCT00092443|58724926|FG000|Overall Study|Adverse Event|9|||
30711407|NCT00092443|58724927|FG001|Overall Study|Adverse Event|13|||
30711408|NCT00092443|58724926|FG000|Overall Study|Lost to Follow-up|7|||
30711409|NCT00092443|58724927|FG001|Overall Study|Lost to Follow-up|3|||
30711410|NCT00092443|58724926|FG000|Overall Study|Protocol Violation|11|||
30711411|NCT00092443|58724927|FG001|Overall Study|Protocol Violation|9|||
30711412|NCT00092443|58724926|FG000|Overall Study|Withdrawal by Subject|9|||
30711413|NCT00092443|58724927|FG001|Overall Study|Withdrawal by Subject|11|||
30711414|NCT00092443|58724926|FG000|Overall Study|Moved|5|||
30711415|NCT00092443|58724927|FG001|Overall Study|Moved|5|||
30711416|NCT00092443|58724926|FG000|Overall Study|Other|17|||
30711417|NCT00092443|58724927|FG001|Overall Study|Other|13|||
30711418|NCT00413920|58724945|FG000|Overall Study|Adverse Event|9|||
30711419|NCT00413920|58724946|FG001|Overall Study|Adverse Event|11|||
30711420|NCT00413920|58724945|FG000|Overall Study|Lack of Efficacy|11|||
30711421|NCT00413920|58724946|FG001|Overall Study|Lack of Efficacy|9|||
30711422|NCT00413920|58724945|FG000|Overall Study|Death|3|||
30711423|NCT00413920|58724946|FG001|Overall Study|Death|5|||
30711424|NCT00413920|58724945|FG000|Overall Study|Graft Loss|5|||
30711425|NCT00413920|58724946|FG001|Overall Study|Graft Loss|3|||
30621244|NCT01196741|58632817|FG001|Overall Study|Serious Adverse Event|1|||
30621245|NCT01196741|58632816|FG000|Overall Study|Dose limiting Adverse Event|2|||
30621246|NCT01196741|58632817|FG001|Overall Study|Dose limiting Adverse Event|1|||
30621247|NCT01196741|58632816|FG000|Overall Study|Withdrawal by Subject|3|||
30621248|NCT01196741|58632817|FG001|Overall Study|Withdrawal by Subject|0|||
30711426|NCT00091819|58724954|FG000|Overall Study|Adverse Event|1|||
30711427|NCT00091819|58724955|FG001|Overall Study|Adverse Event|1|||
30711428|NCT00091819|58724954|FG000|Overall Study|Death|4|||
30711429|NCT00091819|58724955|FG001|Overall Study|Death|5|||
30711430|NCT00091819|58724954|FG000|Overall Study|Lost to Follow-up|26|||
30711431|NCT00091819|58724955|FG001|Overall Study|Lost to Follow-up|23|||
30711432|NCT00091819|58724954|FG000|Overall Study|Withdrawal by Subject|5|||
30711433|NCT00091819|58724955|FG001|Overall Study|Withdrawal by Subject|8|||
30711434|NCT00091819|58724954|FG000|Overall Study|Protocol Violation|1|||
30711435|NCT00091819|58724955|FG001|Overall Study|Protocol Violation|2|||
30711436|NCT00091819|58724954|FG000|Overall Study|Other|2|||
30711437|NCT00091819|58724955|FG001|Overall Study|Other|3|||
30711438|NCT00091819|58724954|FG000|Overall Study|Never received study treatment|3|||
30711439|NCT00091819|58724955|FG001|Overall Study|Never received study treatment|4|||
30711440|NCT00540228|58724966|FG000|Overall Study|Adverse Event|2|||
30711441|NCT00540228|58724967|FG001|Overall Study|Adverse Event|0|||
30711442|NCT00540228|58724968|FG002|Overall Study|Adverse Event|0|||
30711443|NCT00540228|58724969|FG003|Overall Study|Adverse Event|0|||
30711444|NCT00540228|58724970|FG004|Overall Study|Adverse Event|0|||
30711445|NCT00540228|58724966|FG000|Overall Study|Lost to Follow-up|1|||
30711446|NCT00540228|58724967|FG001|Overall Study|Lost to Follow-up|1|||
30711447|NCT00540228|58724968|FG002|Overall Study|Lost to Follow-up|0|||
30711448|NCT00540228|58724969|FG003|Overall Study|Lost to Follow-up|0|||
30711449|NCT00540228|58724970|FG004|Overall Study|Lost to Follow-up|0|||
30711450|NCT05013385|58724995|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
30711451|NCT04250636|58725018|FG000|Overall Study|Lost to Follow-up|2|||
30711452|NCT03989115|58725030|FG000|Overall Study|Withdrawal by Subject|2|||
30711453|NCT03989115|58725031|FG001|Overall Study|Withdrawal by Subject|1|||
30711454|NCT03989115|58725032|FG002|Overall Study|Withdrawal by Subject|3|||
30711455|NCT03989115|58725033|FG003|Overall Study|Withdrawal by Subject|0|||
30711456|NCT03989115|58725034|FG004|Overall Study|Withdrawal by Subject|17|||
30711457|NCT03989115|58725035|FG005|Overall Study|Withdrawal by Subject|1|||
30711458|NCT03989115|58725036|FG006|Overall Study|Withdrawal by Subject|0|||
30711459|NCT03989115|58725037|FG007|Overall Study|Withdrawal by Subject|0|||
30711460|NCT03989115|58725030|FG000|Overall Study|Sponsor decision to terminate the study|1|||
30711461|NCT03989115|58725031|FG001|Overall Study|Sponsor decision to terminate the study|1|||
30711462|NCT03989115|58725032|FG002|Overall Study|Sponsor decision to terminate the study|0|||
30711463|NCT03989115|58725033|FG003|Overall Study|Sponsor decision to terminate the study|1|||
30711464|NCT03989115|58725034|FG004|Overall Study|Sponsor decision to terminate the study|11|||
30711465|NCT03989115|58725035|FG005|Overall Study|Sponsor decision to terminate the study|0|||
30711466|NCT03989115|58725036|FG006|Overall Study|Sponsor decision to terminate the study|2|||
30711467|NCT03989115|58725037|FG007|Overall Study|Sponsor decision to terminate the study|1|||
30711468|NCT03989115|58725030|FG000|Overall Study|Lost to Follow-up|2|||
30711469|NCT03989115|58725031|FG001|Overall Study|Lost to Follow-up|0|||
30711470|NCT03989115|58725032|FG002|Overall Study|Lost to Follow-up|0|||
30711471|NCT03989115|58725033|FG003|Overall Study|Lost to Follow-up|0|||
30621249|NCT01196741|58632816|FG000|Overall Study|Other reason|3|||
30621250|NCT01196741|58632817|FG001|Overall Study|Other reason|3|||
30621251|NCT01196741|58632816|FG000|Overall Study|Other|3|||
30621252|NCT01196741|58632817|FG001|Overall Study|Other|2|||
30621253|NCT01196741|58632816|FG000|Overall Study|Protocol Violation|2|||
30621254|NCT01196741|58632817|FG001|Overall Study|Protocol Violation|1|||
30621255|NCT00983385|58632823|FG000|Observation Period|Not eligible to be dosed|20|||
30621256|NCT00983385|58632823|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
30621257|NCT00992511|58632846|FG000|Overall Study|Migrated/moved from study area|1|||
30621258|NCT00992511|58632847|FG001|Overall Study|Migrated/moved from study area|0|||
30621259|NCT00992511|58632848|FG002|Overall Study|Migrated/moved from study area|1|||
30621260|NCT00992511|58632849|FG003|Overall Study|Migrated/moved from study area|2|||
30621261|NCT00992511|58632846|FG000|Overall Study|Lost to Follow-up|1|||
30621262|NCT00992511|58632847|FG001|Overall Study|Lost to Follow-up|0|||
30621263|NCT00992511|58632848|FG002|Overall Study|Lost to Follow-up|0|||
30621264|NCT00992511|58632849|FG003|Overall Study|Lost to Follow-up|2|||
30621265|NCT00992511|58632846|FG000|Overall Study|Withdrawal by Subject|0|||
30621266|NCT00992511|58632847|FG001|Overall Study|Withdrawal by Subject|0|||
30621267|NCT00992511|58632848|FG002|Overall Study|Withdrawal by Subject|1|||
30621268|NCT00992511|58632849|FG003|Overall Study|Withdrawal by Subject|1|||
30621269|NCT01196429|58632861|FG000|Overall Study|Ineligible - inadequate pathology|1|||
30621270|NCT01196429|58632862|FG001|Overall Study|Ineligible - inadequate pathology|0|||
30899914|NCT02275117|58933200|FG002|Overall Study|Worsening of Study Indication|2|||
30899915|NCT02275117|58933201|FG003|Overall Study|Worsening of Study Indication|0|||
30899916|NCT02275117|58933202|FG004|Overall Study|Worsening of Study Indication|0|||
30899917|NCT02275117|58933198|FG000|Overall Study|Study Burden|5|||
30899918|NCT02275117|58933199|FG001|Overall Study|Study Burden|4|||
30899919|NCT02275117|58933200|FG002|Overall Study|Study Burden|7|||
30899920|NCT02275117|58933201|FG003|Overall Study|Study Burden|5|||
30899921|NCT02275117|58933202|FG004|Overall Study|Study Burden|7|||
30899922|NCT02275117|58933198|FG000|Overall Study|Other|1|||
30899923|NCT02275117|58933199|FG001|Overall Study|Other|0|||
30899924|NCT02275117|58933200|FG002|Overall Study|Other|0|||
30621271|NCT01196429|58632861|FG000|Overall Study|Ineligible - wrong cell type|1|||
30621272|NCT01196429|58632862|FG001|Overall Study|Ineligible - wrong cell type|0|||
30621273|NCT01196429|58632861|FG000|Overall Study|Refused - Never Treated|1|||
30621274|NCT01196429|58632862|FG001|Overall Study|Refused - Never Treated|0|||
30621275|NCT01157364|58632876|FG000|Overall Study|Other Reasons|1|||
30621276|NCT01157364|58632877|FG001|Overall Study|Other Reasons|1|||
30621277|NCT01157364|58632878|FG002|Overall Study|Other Reasons|2|||
30621278|NCT01157364|58632879|FG003|Overall Study|Other Reasons|1|||
30621279|NCT01157364|58632880|FG004|Overall Study|Other Reasons|0|||
30899925|NCT02275117|58933201|FG003|Overall Study|Other|0|||
30899926|NCT02275117|58933202|FG004|Overall Study|Other|2|||
30899927|NCT02274493|58933214|FG000|Overall Study|Withdrawal by Subject|1|||
30899928|NCT02273167|58933221|FG000|Overall Study|Adverse Event|1|||
30711472|NCT03989115|58725034|FG004|Overall Study|Lost to Follow-up|1|||
30711473|NCT03989115|58725035|FG005|Overall Study|Lost to Follow-up|0|||
30711474|NCT03989115|58725036|FG006|Overall Study|Lost to Follow-up|0|||
30711475|NCT03989115|58725037|FG007|Overall Study|Lost to Follow-up|0|||
30711476|NCT03989115|58725030|FG000|Overall Study|Death|2|||
30711477|NCT03989115|58725031|FG001|Overall Study|Death|2|||
30711478|NCT03989115|58725032|FG002|Overall Study|Death|9|||
30711479|NCT03989115|58725033|FG003|Overall Study|Death|6|||
30711480|NCT03989115|58725034|FG004|Overall Study|Death|31|||
30711481|NCT03989115|58725035|FG005|Overall Study|Death|6|||
30711482|NCT03989115|58725036|FG006|Overall Study|Death|2|||
30711483|NCT03989115|58725037|FG007|Overall Study|Death|3|||
30711484|NCT03989115|58725030|FG000|Overall Study|Other|1|||
30711485|NCT03989115|58725031|FG001|Overall Study|Other|2|||
30711486|NCT03989115|58725032|FG002|Overall Study|Other|0|||
30711487|NCT03989115|58725033|FG003|Overall Study|Other|0|||
30711488|NCT03989115|58725034|FG004|Overall Study|Other|5|||
30711489|NCT03989115|58725035|FG005|Overall Study|Other|0|||
30711490|NCT03989115|58725036|FG006|Overall Study|Other|0|||
30711491|NCT03989115|58725037|FG007|Overall Study|Other|0|||
30711492|NCT03797898|58725066|FG000|Overall Study|Lost to Follow-up|60|||
30711493|NCT03797898|58725067|FG001|Overall Study|Lost to Follow-up|69|||
30711494|NCT03797898|58725066|FG000|Overall Study|Withdrawal by Subject|9|||
30711495|NCT03797898|58725067|FG001|Overall Study|Withdrawal by Subject|7|||
30711496|NCT03797898|58725066|FG000|Overall Study|Became ineligible|5|||
30711497|NCT03797898|58725067|FG001|Overall Study|Became ineligible|2|||
30711498|NCT03559192|58725089|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
30711499|NCT03559192|58725090|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
30711500|NCT03559192|58725091|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
30711501|NCT03559192|58725089|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
30711502|NCT03559192|58725090|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
30711503|NCT03559192|58725091|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
30711504|NCT03559192|58725089|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
30711505|NCT03559192|58725090|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
30711506|NCT03559192|58725091|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
30711507|NCT03559192|58725089|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
30711508|NCT03559192|58725090|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
30711509|NCT03559192|58725091|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
30711510|NCT03559192|58725089|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
30711511|NCT03559192|58725090|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
30711512|NCT03559192|58725091|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
30711513|NCT03559192|58725089|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
30711514|NCT03559192|58725090|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
30711515|NCT03559192|58725091|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
30711516|NCT03559192|58725089|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
30711517|NCT03559192|58725090|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
30711518|NCT03559192|58725091|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
30711519|NCT03559192|58725089|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
30711520|NCT03559192|58725090|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
30711521|NCT03559192|58725091|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
30711522|NCT03559192|58725089|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
30711523|NCT03559192|58725090|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
30711524|NCT03559192|58725091|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
30711525|NCT03523585|58725102|FG000|Overall Study|Progressive Disease|174|||
30711526|NCT03523585|58725103|FG001|Overall Study|Progressive Disease|64|||
30711527|NCT03523585|58725104|FG002|Overall Study|Progressive Disease|77|||
30711528|NCT03523585|58725102|FG000|Overall Study|Adverse Event|74|||
30711529|NCT03523585|58725103|FG001|Overall Study|Adverse Event|5|||
30711530|NCT03523585|58725104|FG002|Overall Study|Adverse Event|9|||
30711531|NCT03523585|58725102|FG000|Overall Study|Withdrawal by Subject|30|||
30711532|NCT03523585|58725103|FG001|Overall Study|Withdrawal by Subject|11|||
30711533|NCT03523585|58725104|FG002|Overall Study|Withdrawal by Subject|6|||
30711534|NCT03523585|58725102|FG000|Overall Study|Clinical Progression|23|||
30899929|NCT02273167|58933222|FG001|Overall Study|Adverse Event|0|||
30621280|NCT01157364|58632881|FG005|Overall Study|Other Reasons|0|||
30621281|NCT01157364|58632876|FG000|Overall Study|Personal Reasons|0|||
30621282|NCT01157364|58632877|FG001|Overall Study|Personal Reasons|2|||
30621283|NCT01157364|58632878|FG002|Overall Study|Personal Reasons|0|||
30621284|NCT01157364|58632879|FG003|Overall Study|Personal Reasons|0|||
30621285|NCT01157364|58632880|FG004|Overall Study|Personal Reasons|1|||
30621286|NCT01157364|58632881|FG005|Overall Study|Personal Reasons|1|||
30621287|NCT01157364|58632876|FG000|Overall Study|Lost to Follow-up|1|||
30621288|NCT01157364|58632877|FG001|Overall Study|Lost to Follow-up|0|||
30621289|NCT01157364|58632878|FG002|Overall Study|Lost to Follow-up|1|||
30621290|NCT01157364|58632879|FG003|Overall Study|Lost to Follow-up|0|||
30621291|NCT01157364|58632880|FG004|Overall Study|Lost to Follow-up|0|||
30621292|NCT01157364|58632881|FG005|Overall Study|Lost to Follow-up|0|||
30621293|NCT01157364|58632876|FG000|Overall Study|Lack of Efficacy|0|||
30621294|NCT01157364|58632877|FG001|Overall Study|Lack of Efficacy|0|||
30621295|NCT01157364|58632878|FG002|Overall Study|Lack of Efficacy|0|||
30621296|NCT01157364|58632879|FG003|Overall Study|Lack of Efficacy|1|||
30621297|NCT01157364|58632880|FG004|Overall Study|Lack of Efficacy|0|||
30621298|NCT01157364|58632881|FG005|Overall Study|Lack of Efficacy|0|||
30621299|NCT01157364|58632876|FG000|Overall Study|Adverse Event|0|||
30621300|NCT01157364|58632877|FG001|Overall Study|Adverse Event|1|||
30621301|NCT01157364|58632878|FG002|Overall Study|Adverse Event|1|||
30621302|NCT01157364|58632879|FG003|Overall Study|Adverse Event|0|||
30621303|NCT01157364|58632880|FG004|Overall Study|Adverse Event|1|||
30621304|NCT01157364|58632881|FG005|Overall Study|Adverse Event|0|||
30621305|NCT01195415|58632895|FG000|Overall Study|No repeat biopsy due to progression|2|||
30899930|NCT02273167|58933223|FG002|Overall Study|Adverse Event|0|||
30899931|NCT02273167|58933221|FG000|Overall Study|Protocol Violation|3|||
30899932|NCT02273167|58933222|FG001|Overall Study|Protocol Violation|1|||
30899933|NCT02273167|58933223|FG002|Overall Study|Protocol Violation|1|||
30899934|NCT02273167|58933221|FG000|Overall Study|Lost to Follow-up|0|||
30899935|NCT02273167|58933222|FG001|Overall Study|Lost to Follow-up|1|||
30711535|NCT03523585|58725103|FG001|Overall Study|Clinical Progression|5|||
30899936|NCT02273167|58933223|FG002|Overall Study|Lost to Follow-up|1|||
30711536|NCT03523585|58725104|FG002|Overall Study|Clinical Progression|10|||
30711537|NCT03523585|58725102|FG000|Overall Study|Death|4|||
30711538|NCT03523585|58725103|FG001|Overall Study|Death|0|||
30711539|NCT03523585|58725104|FG002|Overall Study|Death|1|||
30711540|NCT03523585|58725102|FG000|Overall Study|Physician Decision|2|||
30711541|NCT03523585|58725103|FG001|Overall Study|Physician Decision|1|||
30711542|NCT03523585|58725104|FG002|Overall Study|Physician Decision|0|||
30711543|NCT03523585|58725102|FG000|Overall Study|Lost to Follow-up|1|||
30711544|NCT03523585|58725103|FG001|Overall Study|Lost to Follow-up|0|||
30711545|NCT03523585|58725104|FG002|Overall Study|Lost to Follow-up|0|||
30711546|NCT03523585|58725102|FG000|Overall Study|Miscellaneous|1|||
30711547|NCT03523585|58725103|FG001|Overall Study|Miscellaneous|0|||
30711548|NCT03523585|58725104|FG002|Overall Study|Miscellaneous|0|||
30711549|NCT03523585|58725102|FG000|Overall Study|Protocol Deviation|1|||
30711550|NCT03523585|58725103|FG001|Overall Study|Protocol Deviation|0|||
30711551|NCT03523585|58725104|FG002|Overall Study|Protocol Deviation|1|||
30711552|NCT03523585|58725102|FG000|Overall Study|Randomized But Not Treated|2|||
30711553|NCT03523585|58725103|FG001|Overall Study|Randomized But Not Treated|4|||
30711554|NCT03523585|58725104|FG002|Overall Study|Randomized But Not Treated|3|||
30711555|NCT03485911|58725114|FG000|Part 1|Perceived lack of efficacy|1|||
30711556|NCT03485911|58725115|FG001|Part 1|Perceived lack of efficacy|1|||
30711557|NCT03485911|58725116|FG002|Part 1|Perceived lack of efficacy|2|||
30711558|NCT03485911|58725117|FG003|Part 1|Perceived lack of efficacy|0|||
30899937|NCT02273167|58933221|FG000|Overall Study|Withdrawal by Subject|10|||
30711559|NCT03485911|58725114|FG000|Part 1|Subject withdrew consent|0|||
30711560|NCT03485911|58725115|FG001|Part 1|Subject withdrew consent|1|||
30711561|NCT03485911|58725116|FG002|Part 1|Subject withdrew consent|0|||
30711562|NCT03485911|58725117|FG003|Part 1|Subject withdrew consent|1|||
30711563|NCT03485911|58725114|FG000|Part 1|Lab abnormalities/AEs|3|||
30711564|NCT03485911|58725115|FG001|Part 1|Lab abnormalities/AEs|1|||
30711565|NCT03485911|58725116|FG002|Part 1|Lab abnormalities/AEs|1|||
30711566|NCT03485911|58725117|FG003|Part 1|Lab abnormalities/AEs|0|||
30711567|NCT03485911|58725114|FG000|Part 1|Withdrew Consent prior to dosing|0|||
30711568|NCT03485911|58725115|FG001|Part 1|Withdrew Consent prior to dosing|0|||
30899938|NCT02273167|58933222|FG001|Overall Study|Withdrawal by Subject|12|||
30899939|NCT02273167|58933223|FG002|Overall Study|Withdrawal by Subject|11|||
30711569|NCT03485911|58725116|FG002|Part 1|Withdrew Consent prior to dosing|0|||
30711570|NCT03485911|58725117|FG003|Part 1|Withdrew Consent prior to dosing|1|||
30899940|NCT02273167|58933221|FG000|Overall Study|Various|10|||
30899941|NCT02273167|58933222|FG001|Overall Study|Various|9|||
30899942|NCT02273167|58933223|FG002|Overall Study|Various|8|||
30621306|NCT01195103|58632902|FG000|Overall Study|Withdrawal by Subject|1|||
30621307|NCT01195103|58632903|FG001|Overall Study|Withdrawal by Subject|0|||
30621308|NCT01195103|58632904|FG002|Overall Study|Withdrawal by Subject|0|||
30621309|NCT01194869|58632912|FG000|Overall Study|Disease Progression|2|||
30899943|NCT02272777|58933234|FG000|Overall Study|Adverse Event|0|||
30711571|NCT03485911|58725114|FG000|Part 1|Other NOS|0|||
30621310|NCT01194869|58632912|FG000|Overall Study|Toxicity|2|||
30711572|NCT03485911|58725115|FG001|Part 1|Other NOS|0|||
30899944|NCT02272777|58933235|FG001|Overall Study|Adverse Event|1|||
30899945|NCT02272777|58933234|FG000|Overall Study|Withdrawal by Subject|0|||
30711573|NCT03485911|58725116|FG002|Part 1|Other NOS|0|||
30711574|NCT03485911|58725117|FG003|Part 1|Other NOS|1|||
30711575|NCT03485911|58725114|FG000|Part 2|Perceived lack of efficacy|5|||
30711576|NCT03485911|58725115|FG001|Part 2|Perceived lack of efficacy|3|||
30711577|NCT03485911|58725116|FG002|Part 2|Perceived lack of efficacy|0|||
30711578|NCT03485911|58725117|FG003|Part 2|Perceived lack of efficacy|2|||
30711579|NCT03485911|58725114|FG000|Part 2|Subject withdrew consent|1|||
30711580|NCT03485911|58725115|FG001|Part 2|Subject withdrew consent|0|||
30711581|NCT03485911|58725116|FG002|Part 2|Subject withdrew consent|2|||
30711582|NCT03485911|58725117|FG003|Part 2|Subject withdrew consent|1|||
30711583|NCT03485911|58725114|FG000|Part 2|Lab abnormalities/AEs|1|||
30711584|NCT03485911|58725115|FG001|Part 2|Lab abnormalities/AEs|2|||
30711585|NCT03485911|58725116|FG002|Part 2|Lab abnormalities/AEs|0|||
30711586|NCT03485911|58725117|FG003|Part 2|Lab abnormalities/AEs|0|||
30711587|NCT03485911|58725114|FG000|Part 2|Other NOS|0|||
30711588|NCT03485911|58725115|FG001|Part 2|Other NOS|1|||
30711589|NCT03485911|58725116|FG002|Part 2|Other NOS|0|||
30711590|NCT03485911|58725117|FG003|Part 2|Other NOS|0|||
30711591|NCT03485911|58725114|FG000|Part 2|Intercurrent illness/new medical condition|1|||
30711592|NCT03485911|58725115|FG001|Part 2|Intercurrent illness/new medical condition|0|||
30711593|NCT03485911|58725116|FG002|Part 2|Intercurrent illness/new medical condition|0|||
30711594|NCT03485911|58725117|FG003|Part 2|Intercurrent illness/new medical condition|0|||
30711595|NCT03485911|58725114|FG000|Part 2|Investigator judgement|1|||
30711596|NCT03485911|58725115|FG001|Part 2|Investigator judgement|0|||
30711597|NCT03485911|58725116|FG002|Part 2|Investigator judgement|0|||
30711598|NCT03485911|58725117|FG003|Part 2|Investigator judgement|0|||
30711599|NCT03485911|58725114|FG000|Part 3|Perceived lack of efficacy|2|||
30711600|NCT03485911|58725115|FG001|Part 3|Perceived lack of efficacy|2|||
30711601|NCT03485911|58725116|FG002|Part 3|Perceived lack of efficacy|2|||
30711602|NCT03485911|58725117|FG003|Part 3|Perceived lack of efficacy|0|||
30711603|NCT03485911|58725114|FG000|Part 3|Subject withdrew consent|1|||
30711604|NCT03485911|58725115|FG001|Part 3|Subject withdrew consent|4|||
30711605|NCT03485911|58725116|FG002|Part 3|Subject withdrew consent|0|||
30711606|NCT03485911|58725117|FG003|Part 3|Subject withdrew consent|1|||
30711607|NCT03485911|58725114|FG000|Part 3|Lab abnormalities/AEs|1|||
30711608|NCT03485911|58725115|FG001|Part 3|Lab abnormalities/AEs|1|||
30711609|NCT03485911|58725116|FG002|Part 3|Lab abnormalities/AEs|0|||
30711610|NCT03485911|58725117|FG003|Part 3|Lab abnormalities/AEs|2|||
30711611|NCT03485911|58725114|FG000|Part 3|Other NOS|1|||
30711612|NCT03485911|58725115|FG001|Part 3|Other NOS|1|||
30711613|NCT03485911|58725116|FG002|Part 3|Other NOS|0|||
30711614|NCT03485911|58725117|FG003|Part 3|Other NOS|0|||
30711615|NCT03485911|58725114|FG000|Part 3|Intercurrent illness/new medical condition|0|||
30711616|NCT03485911|58725115|FG001|Part 3|Intercurrent illness/new medical condition|1|||
30711617|NCT03485911|58725116|FG002|Part 3|Intercurrent illness/new medical condition|1|||
30711618|NCT03485911|58725117|FG003|Part 3|Intercurrent illness/new medical condition|0|||
30711619|NCT03485911|58725114|FG000|Part 3|Sponsor discontinuation|1|||
30711620|NCT03485911|58725115|FG001|Part 3|Sponsor discontinuation|0|||
30711621|NCT03485911|58725116|FG002|Part 3|Sponsor discontinuation|0|||
30711622|NCT03485911|58725117|FG003|Part 3|Sponsor discontinuation|0|||
30711623|NCT03485911|58725114|FG000|Part 3|Berotralstat provided by alternative means|13|||
30711624|NCT03485911|58725115|FG001|Part 3|Berotralstat provided by alternative means|13|||
30711625|NCT03485911|58725116|FG002|Part 3|Berotralstat provided by alternative means|7|||
30711626|NCT03485911|58725117|FG003|Part 3|Berotralstat provided by alternative means|7|||
30711627|NCT02933489|58725176|FG000|Overall Study|Ineligible|3|||
30711628|NCT02933489|58725177|FG001|Overall Study|Ineligible|3|||
30711629|NCT02933489|58725176|FG000|Overall Study|Withdrawal by Subject|27|||
30711630|NCT02933489|58725177|FG001|Overall Study|Withdrawal by Subject|18|||
30621311|NCT01177800|58632918|FG000|Overall Study|Adverse Event|9|||
30621312|NCT01177800|58632919|FG001|Overall Study|Adverse Event|3|||
30621313|NCT01177800|58632918|FG000|Overall Study|Protocol Violation|0|||
30621314|NCT01177800|58632919|FG001|Overall Study|Protocol Violation|1|||
30621315|NCT01177800|58632918|FG000|Overall Study|Physician Decision|1|||
30621316|NCT01177800|58632919|FG001|Overall Study|Physician Decision|0|||
30621317|NCT01177800|58632918|FG000|Overall Study|Withdrawal of informed consent|0|||
30621318|NCT01177800|58632919|FG001|Overall Study|Withdrawal of informed consent|1|||
30621319|NCT01177722|58632929|FG000|Overall Study|Serious Adverse Event|0|||
30621320|NCT01177722|58632930|FG001|Overall Study|Serious Adverse Event|0|||
30621321|NCT01177722|58632931|FG002|Overall Study|Serious Adverse Event|1|||
30621322|NCT01177722|58632932|FG003|Overall Study|Serious Adverse Event|0|||
30621323|NCT01177722|58632929|FG000|Overall Study|Protocol Violation|0|||
30621324|NCT01177722|58632930|FG001|Overall Study|Protocol Violation|0|||
30621325|NCT01177722|58632931|FG002|Overall Study|Protocol Violation|1|||
30621326|NCT01177722|58632932|FG003|Overall Study|Protocol Violation|0|||
30621327|NCT01177722|58632929|FG000|Overall Study|Lost to Follow-up|3|||
30621328|NCT01177722|58632930|FG001|Overall Study|Lost to Follow-up|4|||
30621329|NCT01177722|58632931|FG002|Overall Study|Lost to Follow-up|3|||
30621330|NCT01177722|58632932|FG003|Overall Study|Lost to Follow-up|1|||
30621331|NCT01177722|58632929|FG000|Overall Study|Withdrawal by Subject|10|||
30621332|NCT01177722|58632930|FG001|Overall Study|Withdrawal by Subject|6|||
30790901|NCT03200912|58803990|FG002|Overall Study|Non-compliance with study drug|0|||
30621333|NCT01177722|58632931|FG002|Overall Study|Withdrawal by Subject|4|||
30621334|NCT01177722|58632932|FG003|Overall Study|Withdrawal by Subject|6|||
30621335|NCT01177410|58632946|FG000|Overall Study|Adverse Event|0|||
30621336|NCT01177410|58632947|FG001|Overall Study|Adverse Event|2|||
30621337|NCT01177410|58632948|FG002|Overall Study|Adverse Event|2|||
30790902|NCT00835666|58804000|FG000|Washout|Protocol Violation|1|||
30790903|NCT00835666|58804001|FG001|Washout|Protocol Violation|0|||
30621338|NCT01177410|58632946|FG000|Overall Study|Withdrawal by Subject|1|||
30621339|NCT01177410|58632947|FG001|Overall Study|Withdrawal by Subject|4|||
30621340|NCT01177410|58632948|FG002|Overall Study|Withdrawal by Subject|3|||
30621341|NCT01177410|58632946|FG000|Overall Study|Lost to Follow-up|0|||
30621342|NCT01177410|58632947|FG001|Overall Study|Lost to Follow-up|1|||
30621343|NCT01177410|58632948|FG002|Overall Study|Lost to Follow-up|0|||
30621344|NCT01156116|58632958|FG000|Overall Study|Withdrawal by Subject|3|||
30621345|NCT01156116|58632959|FG001|Overall Study|Withdrawal by Subject|1|||
30621346|NCT01156116|58632958|FG000|Overall Study|CPAP intolerance|2|||
30621347|NCT01156116|58632959|FG001|Overall Study|CPAP intolerance|0|||
30621348|NCT01155726|58632965|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
30711631|NCT02933489|58725176|FG000|Overall Study|Unable to complete exams (other)|14|||
30711632|NCT02933489|58725177|FG001|Overall Study|Unable to complete exams (other)|7|||
30711633|NCT02886936|58725213|FG000|Overall Study|Lost to Follow-up|4|||
30711634|NCT02886936|58725214|FG001|Overall Study|Lost to Follow-up|3|||
30711635|NCT02886936|58725215|FG002|Overall Study|Lost to Follow-up|0|||
30711636|NCT02589522|58725228|FG000|Overall Study|Physician Decision|1|||
30711637|NCT02589522|58725229|FG001|Overall Study|Physician Decision|2|||
30711638|NCT02589522|58725230|FG002|Overall Study|Physician Decision|0|||
30711639|NCT02589522|58725228|FG000|Overall Study|Did not start treatment|1|||
30711640|NCT02589522|58725229|FG001|Overall Study|Did not start treatment|0|||
30711641|NCT02589522|58725230|FG002|Overall Study|Did not start treatment|0|||
30711642|NCT02542293|58725240|FG000|Overall Study|Death|367|||
30621349|NCT01155726|58632966|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
30711643|NCT02542293|58725241|FG001|Overall Study|Death|377|||
30711644|NCT02542293|58725240|FG000|Overall Study|Withdrawal by Subject|8|||
30711645|NCT02542293|58725241|FG001|Overall Study|Withdrawal by Subject|19|||
30711646|NCT02242942|58725270|FG000|Overall Study|Death|17|||
30711647|NCT02242942|58725271|FG001|Overall Study|Death|20|||
30711648|NCT02242942|58725272|FG002|Overall Study|Death|2|||
30711649|NCT02242942|58725270|FG000|Overall Study|Physician Decision|1|||
30711650|NCT02242942|58725271|FG001|Overall Study|Physician Decision|0|||
30711651|NCT02242942|58725272|FG002|Overall Study|Physician Decision|0|||
30711652|NCT02242942|58725270|FG000|Overall Study|Withdrawal by Subject|8|||
30711653|NCT02242942|58725271|FG001|Overall Study|Withdrawal by Subject|10|||
30711654|NCT02242942|58725272|FG002|Overall Study|Withdrawal by Subject|0|||
30711655|NCT02242942|58725270|FG000|Overall Study|On-going in Study|190|||
30711656|NCT02242942|58725271|FG001|Overall Study|On-going in Study|186|||
30711657|NCT02242942|58725272|FG002|Overall Study|On-going in Study|11|||
30711658|NCT02162511|58725294|FG000|Overall Study|Lack of Efficacy|0|||
30711659|NCT02162511|58725295|FG001|Overall Study|Lack of Efficacy|0|||
30711660|NCT02162511|58725296|FG002|Overall Study|Lack of Efficacy|2|||
30711661|NCT02065869|58725300|FG000|Overall Study|Death|7|||
30711662|NCT02065869|58725300|FG000|Overall Study|Disease relapse|16|||
30711663|NCT02065869|58725300|FG000|Overall Study|Lost to Follow-up|4|||
30711664|NCT02065869|58725300|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
30711665|NCT02065869|58725300|FG000|Overall Study|Withdrawal by Subject|1|||
30711666|NCT00539994|58725365|FG000|Overall Study|Lost to Follow-up|2|||
30711667|NCT00539994|58725366|FG001|Overall Study|Lost to Follow-up|1|||
30711668|NCT00539994|58725367|FG002|Overall Study|Lost to Follow-up|0|||
30711669|NCT00539994|58725365|FG000|Overall Study|Withdrawal by Subject|1|||
30711670|NCT00539994|58725366|FG001|Overall Study|Withdrawal by Subject|0|||
30711671|NCT00539994|58725367|FG002|Overall Study|Withdrawal by Subject|1|||
30711672|NCT00539994|58725365|FG000|Overall Study|Physician Decision|0|||
30711673|NCT00539994|58725366|FG001|Overall Study|Physician Decision|0|||
30711674|NCT00539994|58725367|FG002|Overall Study|Physician Decision|1|||
30711675|NCT00098839|58725384|FG000|Overall Study|Adverse Event|5|||
30711676|NCT00098839|58725385|FG001|Overall Study|Adverse Event|2|||
30711677|NCT00098839|58725384|FG000|Overall Study|Death|1|||
30711678|NCT00098839|58725385|FG001|Overall Study|Death|2|||
30711679|NCT00098839|58725384|FG000|Overall Study|Physician Decision|4|||
30711680|NCT00098839|58725385|FG001|Overall Study|Physician Decision|14|||
30711681|NCT00098839|58725384|FG000|Overall Study|Withdrawal by Subject|1|||
30711682|NCT00098839|58725385|FG001|Overall Study|Withdrawal by Subject|0|||
30711683|NCT00098839|58725384|FG000|Overall Study|Refusal of further protocol therapy|3|||
30711684|NCT00098839|58725385|FG001|Overall Study|Refusal of further protocol therapy|1|||
30711685|NCT00098839|58725384|FG000|Overall Study|Relapse|6|||
30711686|NCT00098839|58725385|FG001|Overall Study|Relapse|3|||
30711687|NCT00098839|58725384|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
30711688|NCT00098839|58725385|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
30711689|NCT00098839|58725384|FG000|Overall Study|Ineligible|2|||
30711690|NCT00098839|58725385|FG001|Overall Study|Ineligible|0|||
30711691|NCT03811093|58725394|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
30711692|NCT03811093|58725395|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
30711693|NCT03811093|58725394|FG000|Overall Study|Unable to measure body fat percentage|2|||
30711694|NCT03811093|58725395|FG001|Overall Study|Unable to measure body fat percentage|0|||
30711695|NCT00485589|58725407|FG000|Overall Study|Death|2|||
30711696|NCT00485589|58725408|FG001|Overall Study|Death|2|||
30711697|NCT00485589|58725409|FG002|Overall Study|Death|0|||
30711698|NCT00485589|58725407|FG000|Overall Study|Failure to return|6|||
30711699|NCT00485589|58725408|FG001|Overall Study|Failure to return|5|||
30711700|NCT00485589|58725409|FG002|Overall Study|Failure to return|1|||
30711701|NCT00485589|58725407|FG000|Overall Study|Protocol Violation|1|||
30711702|NCT00485589|58725408|FG001|Overall Study|Protocol Violation|0|||
30711703|NCT00485589|58725409|FG002|Overall Study|Protocol Violation|0|||
30711704|NCT00485589|58725407|FG000|Overall Study|Violation of selection criteria at entry|0|||
30711705|NCT00485589|58725408|FG001|Overall Study|Violation of selection criteria at entry|3|||
30711706|NCT00485589|58725409|FG002|Overall Study|Violation of selection criteria at entry|1|||
30711707|NCT00485589|58725407|FG000|Overall Study|Administrative/Other|1|||
30790904|NCT00835666|58804000|FG000|Washout|Withdrawal by Subject|1|||
30790905|NCT00835666|58804001|FG001|Washout|Withdrawal by Subject|0|||
30711708|NCT00485589|58725408|FG001|Overall Study|Administrative/Other|2|||
30711709|NCT00485589|58725409|FG002|Overall Study|Administrative/Other|1|||
30711710|NCT00485589|58725407|FG000|Overall Study|Insufficient therapeutic response|10|||
30711711|NCT00485589|58725408|FG001|Overall Study|Insufficient therapeutic response|3|||
30711712|NCT00485589|58725409|FG002|Overall Study|Insufficient therapeutic response|1|||
30711713|NCT00485589|58725407|FG000|Overall Study|Refused treatment/did not cooperate|1|||
30711714|NCT00485589|58725408|FG001|Overall Study|Refused treatment/did not cooperate|0|||
30711715|NCT00485589|58725409|FG002|Overall Study|Refused treatment/did not cooperate|2|||
30711716|NCT00485589|58725407|FG000|Overall Study|Withdrawal by Subject|3|||
30711717|NCT00485589|58725408|FG001|Overall Study|Withdrawal by Subject|2|||
30711718|NCT00485589|58725409|FG002|Overall Study|Withdrawal by Subject|2|||
30711719|NCT00485589|58725407|FG000|Overall Study|Adverse Event|3|||
30711720|NCT00485589|58725408|FG001|Overall Study|Adverse Event|3|||
30711721|NCT00485589|58725409|FG002|Overall Study|Adverse Event|10|||
30711722|NCT00490971|58725428|FG000|Acute/Continuation|Adverse Event|62|||
30711723|NCT00490971|58725429|FG001|Acute/Continuation|Adverse Event|13|||
30711724|NCT00490971|58725430|FG002|Acute/Continuation|Adverse Event|0|||
30711725|NCT00490971|58725431|FG003|Acute/Continuation|Adverse Event|0|||
30711726|NCT00490971|58725432|FG004|Acute/Continuation|Adverse Event|0|||
30711727|NCT00490971|58725428|FG000|Acute/Continuation|Death|2|||
30711728|NCT00490971|58725429|FG001|Acute/Continuation|Death|0|||
30711729|NCT00490971|58725430|FG002|Acute/Continuation|Death|0|||
30711730|NCT00490971|58725431|FG003|Acute/Continuation|Death|0|||
30711731|NCT00490971|58725432|FG004|Acute/Continuation|Death|0|||
30711732|NCT00490971|58725428|FG000|Acute/Continuation|Lack of Efficacy|106|||
30711733|NCT00490971|58725429|FG001|Acute/Continuation|Lack of Efficacy|12|||
30711734|NCT00490971|58725430|FG002|Acute/Continuation|Lack of Efficacy|0|||
30711735|NCT00490971|58725431|FG003|Acute/Continuation|Lack of Efficacy|0|||
30711736|NCT00490971|58725432|FG004|Acute/Continuation|Lack of Efficacy|0|||
30711737|NCT00490971|58725428|FG000|Acute/Continuation|Lost to Follow-up|23|||
30711738|NCT00490971|58725429|FG001|Acute/Continuation|Lost to Follow-up|7|||
30711739|NCT00490971|58725430|FG002|Acute/Continuation|Lost to Follow-up|0|||
30711740|NCT00490971|58725431|FG003|Acute/Continuation|Lost to Follow-up|0|||
30711741|NCT00490971|58725432|FG004|Acute/Continuation|Lost to Follow-up|0|||
30711742|NCT00490971|58725428|FG000|Acute/Continuation|Protocol Violation|10|||
30711743|NCT00490971|58725429|FG001|Acute/Continuation|Protocol Violation|2|||
30711744|NCT00490971|58725430|FG002|Acute/Continuation|Protocol Violation|0|||
30711745|NCT00490971|58725431|FG003|Acute/Continuation|Protocol Violation|0|||
30711746|NCT00490971|58725432|FG004|Acute/Continuation|Protocol Violation|0|||
30621350|NCT01155726|58632967|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
30621351|NCT01155726|58632968|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
30621352|NCT01155570|58632990|FG000|Overall Study|Adverse Event|39|||
30621353|NCT01155570|58632990|FG000|Overall Study|Lack of Efficacy|46|||
30621354|NCT01155570|58632990|FG000|Overall Study|Participant's Economic Reasons|17|||
30621355|NCT01155570|58632990|FG000|Overall Study|No Hospital Visits|7|||
30621356|NCT01155570|58632990|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
30621357|NCT01155570|58632990|FG000|Overall Study|Adverse Event + Other Reasons|7|||
30621358|NCT01155570|58632990|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
30621359|NCT01155570|58632990|FG000|Overall Study|Other Reasons|23|||
30711747|NCT00490971|58725428|FG000|Acute/Continuation|Withdrawal by Subject|92|||
30711748|NCT00490971|58725429|FG001|Acute/Continuation|Withdrawal by Subject|24|||
30711749|NCT00490971|58725430|FG002|Acute/Continuation|Withdrawal by Subject|0|||
30621360|NCT01155024|58632996|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
30711750|NCT00490971|58725431|FG003|Acute/Continuation|Withdrawal by Subject|0|||
30711751|NCT00490971|58725432|FG004|Acute/Continuation|Withdrawal by Subject|0|||
30711752|NCT00490971|58725428|FG000|Acute/Continuation|Other|11|||
30711753|NCT00490971|58725429|FG001|Acute/Continuation|Other|4|||
30625591|NCT00889720|58637788|FG000|Overall Study|Withdrawal by Subject|4|||
30711754|NCT00490971|58725430|FG002|Acute/Continuation|Other|0|||
30711755|NCT00490971|58725431|FG003|Acute/Continuation|Other|0|||
30711756|NCT00490971|58725432|FG004|Acute/Continuation|Other|0|||
30711757|NCT00490971|58725428|FG000|Maintenance|Adverse Event|0|||
30621361|NCT01155024|58632997|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
30621362|NCT01155024|58632996|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
30711758|NCT00490971|58725429|FG001|Maintenance|Adverse Event|0|||
30711759|NCT00490971|58725430|FG002|Maintenance|Adverse Event|4|||
30711760|NCT00490971|58725431|FG003|Maintenance|Adverse Event|5|||
30711761|NCT00490971|58725432|FG004|Maintenance|Adverse Event|7|||
30711762|NCT00490971|58725428|FG000|Maintenance|Death|0|||
30711763|NCT00490971|58725429|FG001|Maintenance|Death|0|||
30711764|NCT00490971|58725430|FG002|Maintenance|Death|0|||
30711765|NCT00490971|58725431|FG003|Maintenance|Death|2|||
30711766|NCT00490971|58725432|FG004|Maintenance|Death|0|||
30711767|NCT00490971|58725428|FG000|Maintenance|Lost to Follow-up|0|||
30711768|NCT00490971|58725429|FG001|Maintenance|Lost to Follow-up|0|||
30711769|NCT00490971|58725430|FG002|Maintenance|Lost to Follow-up|5|||
30711770|NCT00490971|58725431|FG003|Maintenance|Lost to Follow-up|8|||
30711771|NCT00490971|58725432|FG004|Maintenance|Lost to Follow-up|10|||
30711772|NCT00490971|58725428|FG000|Maintenance|Pregnancy|0|||
30711773|NCT00490971|58725429|FG001|Maintenance|Pregnancy|0|||
30711774|NCT00490971|58725430|FG002|Maintenance|Pregnancy|1|||
30711775|NCT00490971|58725431|FG003|Maintenance|Pregnancy|0|||
30711776|NCT00490971|58725432|FG004|Maintenance|Pregnancy|0|||
30711777|NCT00490971|58725428|FG000|Maintenance|Protocol Violation|0|||
30711778|NCT00490971|58725429|FG001|Maintenance|Protocol Violation|0|||
30711779|NCT00490971|58725430|FG002|Maintenance|Protocol Violation|4|||
30711780|NCT00490971|58725431|FG003|Maintenance|Protocol Violation|1|||
30711781|NCT00490971|58725432|FG004|Maintenance|Protocol Violation|1|||
30711782|NCT00490971|58725428|FG000|Maintenance|Withdrawal by Subject|0|||
30711783|NCT00490971|58725429|FG001|Maintenance|Withdrawal by Subject|0|||
30711784|NCT00490971|58725430|FG002|Maintenance|Withdrawal by Subject|26|||
30711785|NCT00490971|58725431|FG003|Maintenance|Withdrawal by Subject|28|||
30621363|NCT01155024|58632997|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
30621364|NCT01155024|58632996|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
30621365|NCT01155024|58632997|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
30621366|NCT01176240|58633008|FG000|Study 306A|Lack of Efficacy|2|||
30621367|NCT01176240|58633009|FG001|Study 306A|Lack of Efficacy|1|||
30711786|NCT00490971|58725432|FG004|Maintenance|Withdrawal by Subject|18|||
30711787|NCT00490971|58725428|FG000|Maintenance|Other|0|||
30711788|NCT00490971|58725429|FG001|Maintenance|Other|0|||
30711789|NCT00490971|58725430|FG002|Maintenance|Other|11|||
30711790|NCT00490971|58725431|FG003|Maintenance|Other|9|||
30711791|NCT00490971|58725432|FG004|Maintenance|Other|3|||
30711792|NCT00686075|58725454|FG000|Overall Study|Withdrawal by Subject|4|||
30711793|NCT00686075|58725455|FG001|Overall Study|Withdrawal by Subject|3|||
30621368|NCT01176240|58633008|FG000|Study 306A|Protocol Violation|0|||
30621369|NCT01176240|58633009|FG001|Study 306A|Protocol Violation|1|||
30711794|NCT00686075|58725456|FG002|Overall Study|Withdrawal by Subject|3|||
30711795|NCT00686075|58725457|FG003|Overall Study|Withdrawal by Subject|7|||
30711796|NCT00686075|58725458|FG004|Overall Study|Withdrawal by Subject|1|||
30711797|NCT00686075|58725459|FG005|Overall Study|Withdrawal by Subject|0|||
30711798|NCT00686075|58725460|FG006|Overall Study|Withdrawal by Subject|0|||
30711799|NCT00686075|58725461|FG007|Overall Study|Withdrawal by Subject|2|||
30711800|NCT00686075|58725462|FG008|Overall Study|Withdrawal by Subject|4|||
30621370|NCT01176240|58633008|FG000|Study 306A|Withdrawal by Subject|0|||
30621371|NCT01176240|58633009|FG001|Study 306A|Withdrawal by Subject|1|||
30621372|NCT01176240|58633008|FG000|Study 306A|Stop due to diverse problems|1|||
30621373|NCT01176240|58633009|FG001|Study 306A|Stop due to diverse problems|0|||
30621374|NCT01176240|58633008|FG000|Study 306B|Lack of Efficacy|5|||
30621375|NCT01176240|58633009|FG001|Study 306B|Lack of Efficacy|3|||
30621376|NCT01176240|58633008|FG000|Study 306B|Adverse Event|10|||
30621377|NCT01176240|58633009|FG001|Study 306B|Adverse Event|5|||
30621378|NCT01176240|58633008|FG000|Study 306B|Protocol Violation|2|||
30621379|NCT01176240|58633009|FG001|Study 306B|Protocol Violation|3|||
30711801|NCT00686075|58725463|FG009|Overall Study|Withdrawal by Subject|6|||
30711802|NCT00686075|58725454|FG000|Overall Study|Lost to Follow-up|3|||
30711803|NCT00686075|58725455|FG001|Overall Study|Lost to Follow-up|6|||
30711804|NCT00686075|58725456|FG002|Overall Study|Lost to Follow-up|3|||
30711805|NCT00686075|58725457|FG003|Overall Study|Lost to Follow-up|2|||
30711806|NCT00686075|58725458|FG004|Overall Study|Lost to Follow-up|3|||
30711807|NCT00686075|58725459|FG005|Overall Study|Lost to Follow-up|3|||
30711808|NCT00686075|58725460|FG006|Overall Study|Lost to Follow-up|0|||
30711809|NCT00686075|58725461|FG007|Overall Study|Lost to Follow-up|0|||
30711810|NCT00686075|58725462|FG008|Overall Study|Lost to Follow-up|2|||
30711811|NCT00686075|58725463|FG009|Overall Study|Lost to Follow-up|3|||
30711812|NCT00686075|58725454|FG000|Overall Study|Other|1|||
30711813|NCT00686075|58725455|FG001|Overall Study|Other|1|||
30711814|NCT00686075|58725456|FG002|Overall Study|Other|0|||
30711815|NCT00686075|58725457|FG003|Overall Study|Other|0|||
30711816|NCT00686075|58725458|FG004|Overall Study|Other|0|||
30711817|NCT00686075|58725459|FG005|Overall Study|Other|0|||
30711818|NCT00686075|58725460|FG006|Overall Study|Other|0|||
30621380|NCT01176240|58633008|FG000|Study 306B|Withdrawal by Subject|4|||
30621381|NCT01176240|58633009|FG001|Study 306B|Withdrawal by Subject|1|||
30621382|NCT01176240|58633008|FG000|Study 306B|Physician Decision|2|||
30621383|NCT01176240|58633009|FG001|Study 306B|Physician Decision|1|||
30621384|NCT01176240|58633008|FG000|Study 306B|Supine Hypertension|1|||
30621385|NCT01176240|58633009|FG001|Study 306B|Supine Hypertension|2|||
30621386|NCT01176240|58633008|FG000|Study 306B|Lost to Follow-up|0|||
30711819|NCT00686075|58725461|FG007|Overall Study|Other|0|||
30711820|NCT00686075|58725462|FG008|Overall Study|Other|0|||
30711821|NCT00686075|58725463|FG009|Overall Study|Other|1|||
30711822|NCT00685763|58725485|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
30621387|NCT01176240|58633009|FG001|Study 306B|Lost to Follow-up|1|||
30621388|NCT01176240|58633008|FG000|Study 306B|withdrew prior to dosing|2|||
30621389|NCT01176240|58633009|FG001|Study 306B|withdrew prior to dosing|1|||
30711823|NCT00685763|58725485|FG000|Overall Study|Protocol Violation|1|||
30711824|NCT00098293|58725492|FG000|Double-blind (DB) Phase|Adverse Event|14|||
30621390|NCT00988221|58633018|FG000|Part I|Adverse Event|0|||
30621391|NCT00988221|58633019|FG001|Part I|Adverse Event|1|||
30711825|NCT00098293|58725493|FG001|Double-blind (DB) Phase|Adverse Event|27|||
30711826|NCT00098293|58725494|FG002|Double-blind (DB) Phase|Adverse Event|60|||
30711827|NCT00098293|58725495|FG003|Double-blind (DB) Phase|Adverse Event|0|||
30711828|NCT00098293|58725496|FG004|Double-blind (DB) Phase|Adverse Event|0|||
30711829|NCT00098293|58725492|FG000|Double-blind (DB) Phase|Pregnancy|0|||
30711830|NCT00098293|58725493|FG001|Double-blind (DB) Phase|Pregnancy|7|||
30711831|NCT00098293|58725494|FG002|Double-blind (DB) Phase|Pregnancy|9|||
30711832|NCT00098293|58725495|FG003|Double-blind (DB) Phase|Pregnancy|0|||
30711833|NCT00098293|58725496|FG004|Double-blind (DB) Phase|Pregnancy|0|||
30711834|NCT00098293|58725492|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
30711835|NCT00098293|58725493|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
30711836|NCT00098293|58725494|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
30711837|NCT00098293|58725495|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
30711838|NCT00098293|58725496|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
30711839|NCT00098293|58725492|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
30711840|NCT00098293|58725493|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
30711841|NCT00098293|58725494|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
30711842|NCT00098293|58725495|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
30711843|NCT00098293|58725496|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
30711844|NCT00098293|58725492|FG000|Double-blind (DB) Phase|Death|1|||
30711845|NCT00098293|58725493|FG001|Double-blind (DB) Phase|Death|2|||
30711846|NCT00098293|58725494|FG002|Double-blind (DB) Phase|Death|2|||
30711847|NCT00098293|58725495|FG003|Double-blind (DB) Phase|Death|0|||
30711848|NCT00098293|58725496|FG004|Double-blind (DB) Phase|Death|0|||
30711849|NCT00098293|58725492|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
30711850|NCT00098293|58725493|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
30711851|NCT00098293|58725494|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
30711852|NCT00098293|58725495|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
30711853|NCT00098293|58725496|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
30711854|NCT00098293|58725492|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
30711855|NCT00098293|58725493|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
30711856|NCT00098293|58725494|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
30711857|NCT00098293|58725495|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
30711858|NCT00098293|58725496|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
30711859|NCT00098293|58725492|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
30711860|NCT00098293|58725493|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
30711861|NCT00098293|58725494|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
30711862|NCT00098293|58725495|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
30711863|NCT00098293|58725496|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
30711864|NCT00098293|58725492|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
30711865|NCT00098293|58725493|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
30711866|NCT00098293|58725494|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
30711867|NCT00098293|58725495|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
30711868|NCT00098293|58725496|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
30711869|NCT00098293|58725492|FG000|Open-label (OL) Phase|Adverse Event|0|||
30711870|NCT00098293|58725493|FG001|Open-label (OL) Phase|Adverse Event|3|||
30711871|NCT00098293|58725494|FG002|Open-label (OL) Phase|Adverse Event|7|||
30711872|NCT00098293|58725495|FG003|Open-label (OL) Phase|Adverse Event|6|||
30711873|NCT00098293|58725496|FG004|Open-label (OL) Phase|Adverse Event|0|||
30711874|NCT00098293|58725492|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
30711875|NCT00098293|58725493|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
30711876|NCT00098293|58725494|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
30711877|NCT00098293|58725495|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
30711878|NCT00098293|58725496|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
30711879|NCT00098293|58725492|FG000|Open-label (OL) Phase|Pregnancy|0|||
30711880|NCT00098293|58725493|FG001|Open-label (OL) Phase|Pregnancy|1|||
30711881|NCT00098293|58725494|FG002|Open-label (OL) Phase|Pregnancy|0|||
30711882|NCT00098293|58725495|FG003|Open-label (OL) Phase|Pregnancy|3|||
30899946|NCT02272777|58933235|FG001|Overall Study|Withdrawal by Subject|3|||
30899947|NCT02272777|58933234|FG000|Overall Study|Lost to Follow-up|2|||
30899948|NCT02272777|58933235|FG001|Overall Study|Lost to Follow-up|0|||
30899949|NCT02272777|58933234|FG000|Overall Study|Other|2|||
30621392|NCT00988221|58633020|FG002|Part I|Adverse Event|2|||
30621393|NCT00988221|58633021|FG003|Part I|Adverse Event|0|||
30621394|NCT00988221|58633018|FG000|Part I|Insufficient Therapeutic Response|4|||
30621395|NCT00988221|58633019|FG001|Part I|Insufficient Therapeutic Response|6|||
30621396|NCT00988221|58633020|FG002|Part I|Insufficient Therapeutic Response|5|||
30621397|NCT00988221|58633021|FG003|Part I|Insufficient Therapeutic Response|0|||
30621398|NCT00988221|58633018|FG000|Part I|Refused Treatment|0|||
30621399|NCT00988221|58633019|FG001|Part I|Refused Treatment|2|||
30621400|NCT00988221|58633020|FG002|Part I|Refused Treatment|1|||
30621401|NCT00988221|58633021|FG003|Part I|Refused Treatment|0|||
30621402|NCT00988221|58633018|FG000|Part I|Lost to Follow-up|0|||
30621403|NCT00988221|58633019|FG001|Part I|Lost to Follow-up|1|||
30621404|NCT00988221|58633020|FG002|Part I|Lost to Follow-up|0|||
30621405|NCT00988221|58633021|FG003|Part I|Lost to Follow-up|0|||
30621406|NCT00988221|58633018|FG000|Part II|Adverse Event|1|||
30621407|NCT00988221|58633019|FG001|Part II|Adverse Event|0|||
30621408|NCT00988221|58633020|FG002|Part II|Adverse Event|0|||
30621409|NCT00988221|58633021|FG003|Part II|Adverse Event|1|||
30711883|NCT00098293|58725496|FG004|Open-label (OL) Phase|Pregnancy|0|||
30711884|NCT00098293|58725492|FG000|Open-label (OL) Phase|Protocol Violation|0|||
30711885|NCT00098293|58725493|FG001|Open-label (OL) Phase|Protocol Violation|6|||
30711886|NCT00098293|58725494|FG002|Open-label (OL) Phase|Protocol Violation|13|||
30621410|NCT00988221|58633018|FG000|Part II|Withdrawal by Subject|0|||
30621411|NCT00988221|58633019|FG001|Part II|Withdrawal by Subject|0|||
30621412|NCT00988221|58633020|FG002|Part II|Withdrawal by Subject|2|||
30621413|NCT00988221|58633021|FG003|Part II|Withdrawal by Subject|2|||
30621414|NCT00988221|58633018|FG000|Part II|Reason not Specified|0|||
30621415|NCT00988221|58633019|FG001|Part II|Reason not Specified|0|||
30621416|NCT00988221|58633020|FG002|Part II|Reason not Specified|1|||
30621417|NCT00988221|58633021|FG003|Part II|Reason not Specified|0|||
30621418|NCT00988221|58633018|FG000|Part III|Adverse Event|1|||
30711887|NCT00098293|58725495|FG003|Open-label (OL) Phase|Protocol Violation|16|||
30711888|NCT00098293|58725496|FG004|Open-label (OL) Phase|Protocol Violation|0|||
30711889|NCT00098293|58725492|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
30621419|NCT00988221|58633019|FG001|Part III|Adverse Event|0|||
30621420|NCT00988221|58633020|FG002|Part III|Adverse Event|1|||
30621421|NCT00988221|58633021|FG003|Part III|Adverse Event|0|||
30621422|NCT00988221|58633018|FG000|Part III|Insufficient Therapeutic Response|0|||
30621423|NCT00988221|58633019|FG001|Part III|Insufficient Therapeutic Response|1|||
30621424|NCT00988221|58633020|FG002|Part III|Insufficient Therapeutic Response|1|||
30621425|NCT00988221|58633021|FG003|Part III|Insufficient Therapeutic Response|0|||
30621426|NCT00988221|58633018|FG000|Part III|Refused Treatment|0|||
30711890|NCT00098293|58725493|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
30711891|NCT00098293|58725494|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
30621427|NCT00988221|58633019|FG001|Part III|Refused Treatment|0|||
30621428|NCT00988221|58633020|FG002|Part III|Refused Treatment|1|||
30621429|NCT00988221|58633021|FG003|Part III|Refused Treatment|0|||
30621430|NCT01149096|58633042|FG000|Overall Study|Lost to Follow-up|0|||
30621431|NCT01149096|58633043|FG001|Overall Study|Lost to Follow-up|1|||
30621432|NCT01175382|58633053|FG000|Overall Study|Lost to Follow-up|4|||
30711892|NCT00098293|58725495|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
30711893|NCT00098293|58725496|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
30711894|NCT00098293|58725492|FG000|Open-label (OL) Phase|Death|0|||
30711895|NCT00098293|58725493|FG001|Open-label (OL) Phase|Death|2|||
30711896|NCT00098293|58725494|FG002|Open-label (OL) Phase|Death|3|||
30711897|NCT00098293|58725495|FG003|Open-label (OL) Phase|Death|0|||
30711898|NCT00098293|58725496|FG004|Open-label (OL) Phase|Death|0|||
30711899|NCT00098293|58725492|FG000|Supplemental Phase (SP)|Death|0|||
30711900|NCT00098293|58725493|FG001|Supplemental Phase (SP)|Death|0|||
30711901|NCT00098293|58725494|FG002|Supplemental Phase (SP)|Death|0|||
30711902|NCT00098293|58725495|FG003|Supplemental Phase (SP)|Death|0|||
30711903|NCT00098293|58725496|FG004|Supplemental Phase (SP)|Death|1|||
30711904|NCT00098293|58725492|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
30711905|NCT00098293|58725493|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
30711906|NCT00098293|58725494|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
30711907|NCT00098293|58725495|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
30711908|NCT00098293|58725496|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
30711909|NCT00098293|58725492|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
30711910|NCT00098293|58725493|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
30711911|NCT00098293|58725494|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
30711912|NCT00098293|58725495|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
30711913|NCT00098293|58725496|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
30711914|NCT00098293|58725492|FG000|Supplemental Phase (SP)|Other|0|||
30711915|NCT00098293|58725493|FG001|Supplemental Phase (SP)|Other|0|||
30711916|NCT00098293|58725494|FG002|Supplemental Phase (SP)|Other|0|||
30711917|NCT00098293|58725495|FG003|Supplemental Phase (SP)|Other|0|||
30711918|NCT00098293|58725496|FG004|Supplemental Phase (SP)|Other|22|||
30711919|NCT00685685|58725507|FG000|Washout Period of 7 Days|Adverse Event|2|||
30711920|NCT00685685|58725508|FG001|Washout Period of 7 Days|Adverse Event|0|||
30711921|NCT00685685|58725507|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
30711922|NCT00685685|58725508|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
30711923|NCT00684671|58725517|FG000|Overall Study|Adverse Event|1|||
30711924|NCT00684671|58725518|FG001|Overall Study|Adverse Event|0|||
30711925|NCT00684671|58725519|FG002|Overall Study|Adverse Event|0|||
30711926|NCT00684671|58725517|FG000|Overall Study|Lost to Follow-up|1|||
30711927|NCT00684671|58725518|FG001|Overall Study|Lost to Follow-up|0|||
30711928|NCT00684671|58725519|FG002|Overall Study|Lost to Follow-up|0|||
30711929|NCT00684671|58725517|FG000|Overall Study|Alcoholic dependance|1|||
30711930|NCT00684671|58725518|FG001|Overall Study|Alcoholic dependance|0|||
30711931|NCT00684671|58725519|FG002|Overall Study|Alcoholic dependance|0|||
30711932|NCT03859323|58725540|FG000|Overall Study|Lost to Follow-up|0|||
30711933|NCT03859323|58725541|FG001|Overall Study|Lost to Follow-up|0|||
30711934|NCT03859323|58725542|FG002|Overall Study|Lost to Follow-up|0|||
30711935|NCT03859323|58725543|FG003|Overall Study|Lost to Follow-up|0|||
30711936|NCT03859323|58725544|FG004|Overall Study|Lost to Follow-up|0|||
30711937|NCT03859323|58725545|FG005|Overall Study|Lost to Follow-up|0|||
30711938|NCT03859323|58725546|FG006|Overall Study|Lost to Follow-up|1|||
30711939|NCT03859323|58725547|FG007|Overall Study|Lost to Follow-up|0|||
30711940|NCT03859323|58725548|FG008|Overall Study|Lost to Follow-up|0|||
30711941|NCT03859323|58725549|FG009|Overall Study|Lost to Follow-up|0|||
30711942|NCT03859323|58725550|FG010|Overall Study|Lost to Follow-up|0|||
30711943|NCT03859323|58725551|FG011|Overall Study|Lost to Follow-up|0|||
30711944|NCT03859323|58725552|FG012|Overall Study|Lost to Follow-up|0|||
30711945|NCT03859323|58725540|FG000|Overall Study|Withdrawal by Subject|0|||
30621433|NCT01175382|58633054|FG001|Overall Study|Lost to Follow-up|3|||
30621434|NCT01175382|58633055|FG002|Overall Study|Lost to Follow-up|1|||
30621435|NCT01175382|58633053|FG000|Overall Study|Physician Decision|0|||
30711946|NCT03859323|58725541|FG001|Overall Study|Withdrawal by Subject|0|||
30621436|NCT01175382|58633054|FG001|Overall Study|Physician Decision|1|||
30621437|NCT01175382|58633055|FG002|Overall Study|Physician Decision|0|||
30621438|NCT01175382|58633053|FG000|Overall Study|Withdrawal by Subject|0|||
30621439|NCT01175382|58633054|FG001|Overall Study|Withdrawal by Subject|0|||
30621440|NCT01175382|58633055|FG002|Overall Study|Withdrawal by Subject|1|||
30621441|NCT01175382|58633053|FG000|Overall Study|No longer having problem|1|||
30621442|NCT01175382|58633054|FG001|Overall Study|No longer having problem|0|||
30621443|NCT01175382|58633055|FG002|Overall Study|No longer having problem|1|||
30621444|NCT01175382|58633053|FG000|Overall Study|Unable/unwilling to attend visits|3|||
30621445|NCT01175382|58633054|FG001|Overall Study|Unable/unwilling to attend visits|1|||
30621446|NCT01175382|58633055|FG002|Overall Study|Unable/unwilling to attend visits|2|||
30711947|NCT03859323|58725542|FG002|Overall Study|Withdrawal by Subject|1|||
30711948|NCT03859323|58725543|FG003|Overall Study|Withdrawal by Subject|0|||
30711949|NCT03859323|58725544|FG004|Overall Study|Withdrawal by Subject|0|||
30711950|NCT03859323|58725545|FG005|Overall Study|Withdrawal by Subject|1|||
30711951|NCT03859323|58725546|FG006|Overall Study|Withdrawal by Subject|0|||
30711952|NCT03859323|58725547|FG007|Overall Study|Withdrawal by Subject|0|||
30711953|NCT03859323|58725548|FG008|Overall Study|Withdrawal by Subject|0|||
30711954|NCT03859323|58725549|FG009|Overall Study|Withdrawal by Subject|1|||
30711955|NCT03859323|58725550|FG010|Overall Study|Withdrawal by Subject|1|||
30711956|NCT03859323|58725551|FG011|Overall Study|Withdrawal by Subject|2|||
30711957|NCT03859323|58725552|FG012|Overall Study|Withdrawal by Subject|1|||
30711958|NCT03859323|58725540|FG000|Overall Study|Pregnancy|0|||
30711959|NCT03859323|58725541|FG001|Overall Study|Pregnancy|0|||
30711960|NCT03859323|58725542|FG002|Overall Study|Pregnancy|0|||
30899950|NCT02272777|58933235|FG001|Overall Study|Other|0|||
30711961|NCT03859323|58725543|FG003|Overall Study|Pregnancy|0|||
30711962|NCT03859323|58725544|FG004|Overall Study|Pregnancy|0|||
30711963|NCT03859323|58725545|FG005|Overall Study|Pregnancy|0|||
30711964|NCT03859323|58725546|FG006|Overall Study|Pregnancy|0|||
30711965|NCT03859323|58725547|FG007|Overall Study|Pregnancy|0|||
30711966|NCT03859323|58725548|FG008|Overall Study|Pregnancy|0|||
30711967|NCT03859323|58725549|FG009|Overall Study|Pregnancy|1|||
30711968|NCT03859323|58725550|FG010|Overall Study|Pregnancy|0|||
30711969|NCT03859323|58725551|FG011|Overall Study|Pregnancy|0|||
30711970|NCT03859323|58725552|FG012|Overall Study|Pregnancy|0|||
30711971|NCT03857841|58725595|FG000|Overall Study|Death|1|||
30711972|NCT03857841|58725596|FG001|Overall Study|Death|0|||
30711973|NCT03857841|58725597|FG002|Overall Study|Death|0|||
30711974|NCT03857841|58725598|FG003|Overall Study|Death|0|||
30711975|NCT03857841|58725595|FG000|Overall Study|Study Terminated by Sponsor|1|||
30711976|NCT03857841|58725596|FG001|Overall Study|Study Terminated by Sponsor|0|||
30711977|NCT03857841|58725597|FG002|Overall Study|Study Terminated by Sponsor|0|||
30711978|NCT03857841|58725598|FG003|Overall Study|Study Terminated by Sponsor|0|||
30711979|NCT00500331|58725615|FG000|Overall Study|Adverse Event|0|||
30711980|NCT00500331|58725616|FG001|Overall Study|Adverse Event|2|||
30711981|NCT00500331|58725617|FG002|Overall Study|Adverse Event|0|||
30711982|NCT00500331|58725618|FG003|Overall Study|Adverse Event|1|||
30711983|NCT00500331|58725619|FG004|Overall Study|Adverse Event|2|||
30711984|NCT00500331|58725620|FG005|Overall Study|Adverse Event|2|||
30711985|NCT00500331|58725621|FG006|Overall Study|Adverse Event|0|||
30711986|NCT00500331|58725615|FG000|Overall Study|Lost to Follow-up|1|||
30711987|NCT00500331|58725616|FG001|Overall Study|Lost to Follow-up|1|||
30711988|NCT00500331|58725617|FG002|Overall Study|Lost to Follow-up|1|||
30711989|NCT00500331|58725618|FG003|Overall Study|Lost to Follow-up|2|||
30711990|NCT00500331|58725619|FG004|Overall Study|Lost to Follow-up|1|||
30711991|NCT00500331|58725620|FG005|Overall Study|Lost to Follow-up|0|||
30711992|NCT00500331|58725621|FG006|Overall Study|Lost to Follow-up|0|||
30711993|NCT00500331|58725615|FG000|Overall Study|Protocol Violation|3|||
30711994|NCT00500331|58725616|FG001|Overall Study|Protocol Violation|1|||
30711995|NCT00500331|58725617|FG002|Overall Study|Protocol Violation|1|||
30711996|NCT00500331|58725618|FG003|Overall Study|Protocol Violation|0|||
30711997|NCT00500331|58725619|FG004|Overall Study|Protocol Violation|1|||
30711998|NCT00500331|58725620|FG005|Overall Study|Protocol Violation|1|||
30711999|NCT00500331|58725621|FG006|Overall Study|Protocol Violation|1|||
30712000|NCT00500331|58725615|FG000|Overall Study|Withdrawal by Subject|4|||
30712001|NCT00500331|58725616|FG001|Overall Study|Withdrawal by Subject|0|||
30712002|NCT00500331|58725617|FG002|Overall Study|Withdrawal by Subject|1|||
30712003|NCT00500331|58725618|FG003|Overall Study|Withdrawal by Subject|5|||
30712004|NCT00500331|58725619|FG004|Overall Study|Withdrawal by Subject|0|||
30712005|NCT00500331|58725620|FG005|Overall Study|Withdrawal by Subject|1|||
30712006|NCT00500331|58725621|FG006|Overall Study|Withdrawal by Subject|1|||
30712007|NCT00500331|58725615|FG000|Overall Study|Lack of Efficacy|3|||
30712008|NCT00500331|58725616|FG001|Overall Study|Lack of Efficacy|1|||
30712009|NCT00500331|58725617|FG002|Overall Study|Lack of Efficacy|0|||
30712010|NCT00500331|58725618|FG003|Overall Study|Lack of Efficacy|0|||
30712011|NCT00500331|58725619|FG004|Overall Study|Lack of Efficacy|0|||
30712012|NCT00500331|58725620|FG005|Overall Study|Lack of Efficacy|0|||
30712013|NCT00500331|58725621|FG006|Overall Study|Lack of Efficacy|0|||
30712014|NCT00500331|58725615|FG000|Overall Study|Liver function test abnormality|0|||
30712015|NCT00500331|58725616|FG001|Overall Study|Liver function test abnormality|0|||
30712016|NCT00500331|58725617|FG002|Overall Study|Liver function test abnormality|1|||
30712017|NCT00500331|58725618|FG003|Overall Study|Liver function test abnormality|0|||
30712018|NCT00500331|58725619|FG004|Overall Study|Liver function test abnormality|0|||
30712019|NCT00500331|58725620|FG005|Overall Study|Liver function test abnormality|0|||
30712020|NCT00500331|58725621|FG006|Overall Study|Liver function test abnormality|0|||
30712021|NCT00500331|58725615|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
30712022|NCT00500331|58725616|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
30712023|NCT00500331|58725617|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
30712024|NCT00500331|58725618|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
30712025|NCT00500331|58725619|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
30712026|NCT00500331|58725620|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
30712027|NCT00500331|58725621|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
30712028|NCT00500331|58725615|FG000|Overall Study|Didn't return for continuation of study|1|||
30712029|NCT00500331|58725616|FG001|Overall Study|Didn't return for continuation of study|0|||
30712030|NCT00500331|58725617|FG002|Overall Study|Didn't return for continuation of study|0|||
30712031|NCT00500331|58725618|FG003|Overall Study|Didn't return for continuation of study|0|||
30712032|NCT00500331|58725619|FG004|Overall Study|Didn't return for continuation of study|0|||
30712033|NCT00500331|58725620|FG005|Overall Study|Didn't return for continuation of study|0|||
30712034|NCT00500331|58725621|FG006|Overall Study|Didn't return for continuation of study|0|||
30712035|NCT00500331|58725615|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
30712036|NCT00500331|58725616|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
30712037|NCT00500331|58725617|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
30712038|NCT00500331|58725618|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
30712039|NCT00500331|58725619|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
30712040|NCT00500331|58725620|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
30712041|NCT00500331|58725621|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
30712042|NCT00500331|58725615|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
30712043|NCT00500331|58725616|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
30712044|NCT00500331|58725617|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
30712045|NCT00500331|58725618|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
30712046|NCT00500331|58725619|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
30712047|NCT00500331|58725620|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
30712048|NCT00500331|58725621|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
30712049|NCT00500331|58725615|FG000|Overall Study|Participant was randomized by mistake|1|||
30712050|NCT00500331|58725616|FG001|Overall Study|Participant was randomized by mistake|0|||
30712051|NCT00500331|58725617|FG002|Overall Study|Participant was randomized by mistake|0|||
30712052|NCT00500331|58725618|FG003|Overall Study|Participant was randomized by mistake|0|||
30712053|NCT00500331|58725619|FG004|Overall Study|Participant was randomized by mistake|0|||
30712054|NCT00500331|58725620|FG005|Overall Study|Participant was randomized by mistake|0|||
30712055|NCT00500331|58725621|FG006|Overall Study|Participant was randomized by mistake|0|||
30712056|NCT00500331|58725615|FG000|Overall Study|Diabetologist nurse in the study|0|||
30712057|NCT00500331|58725616|FG001|Overall Study|Diabetologist nurse in the study|0|||
30712058|NCT00500331|58725617|FG002|Overall Study|Diabetologist nurse in the study|1|||
30712059|NCT00500331|58725618|FG003|Overall Study|Diabetologist nurse in the study|0|||
30712060|NCT00500331|58725619|FG004|Overall Study|Diabetologist nurse in the study|0|||
30712061|NCT00500331|58725620|FG005|Overall Study|Diabetologist nurse in the study|0|||
30712062|NCT00500331|58725621|FG006|Overall Study|Diabetologist nurse in the study|0|||
30712063|NCT00500331|58725615|FG000|Overall Study|State ban of biological samples export|0|||
30712064|NCT00500331|58725616|FG001|Overall Study|State ban of biological samples export|0|||
30712065|NCT00500331|58725617|FG002|Overall Study|State ban of biological samples export|0|||
30712066|NCT00500331|58725618|FG003|Overall Study|State ban of biological samples export|1|||
30712067|NCT00500331|58725619|FG004|Overall Study|State ban of biological samples export|0|||
30712068|NCT00500331|58725620|FG005|Overall Study|State ban of biological samples export|0|||
30712069|NCT00500331|58725621|FG006|Overall Study|State ban of biological samples export|0|||
30712070|NCT00500331|58725615|FG000|Overall Study|Protocol violated|0|||
30712071|NCT00500331|58725616|FG001|Overall Study|Protocol violated|0|||
30712072|NCT00500331|58725617|FG002|Overall Study|Protocol violated|0|||
30712073|NCT00500331|58725618|FG003|Overall Study|Protocol violated|1|||
30712074|NCT00500331|58725619|FG004|Overall Study|Protocol violated|0|||
30712075|NCT00500331|58725620|FG005|Overall Study|Protocol violated|0|||
30712076|NCT00500331|58725621|FG006|Overall Study|Protocol violated|0|||
30712077|NCT00499863|58725640|FG000|Overall Study|Lack of Efficacy|21|||
30712078|NCT00499863|58725641|FG001|Overall Study|Lack of Efficacy|27|||
30712079|NCT00499863|58725640|FG000|Overall Study|Protocol Violation|12|||
30712080|NCT00499863|58725641|FG001|Overall Study|Protocol Violation|7|||
30712081|NCT00499863|58725640|FG000|Overall Study|Withdrawal by Subject|6|||
30712082|NCT00499863|58725641|FG001|Overall Study|Withdrawal by Subject|4|||
30712083|NCT00499863|58725640|FG000|Overall Study|Adverse Event|8|||
30712084|NCT00499863|58725641|FG001|Overall Study|Adverse Event|2|||
30712085|NCT00499863|58725640|FG000|Overall Study|Sponsor decision|2|||
30712086|NCT00499863|58725641|FG001|Overall Study|Sponsor decision|2|||
30712087|NCT00499863|58725640|FG000|Overall Study|Lost to Follow-up|1|||
30712088|NCT00499863|58725641|FG001|Overall Study|Lost to Follow-up|1|||
30712089|NCT00484185|58725647|FG000|Overall Study|Lost to Follow-up|44|||
30712090|NCT00484185|58725647|FG000|Overall Study|Other|20|||
30712091|NCT00484185|58725647|FG000|Overall Study|Randomized but not treated|5|||
30712092|NCT00484185|58725647|FG000|Overall Study|Death|2|||
30712093|NCT00097981|58725653|FG000|Overall Study|Adverse Event|31|||
30712094|NCT00097981|58725654|FG001|Overall Study|Adverse Event|44|||
30712095|NCT00097981|58725653|FG000|Overall Study|Withdrawal by Subject|10|||
30790906|NCT03200366|58804015|FG000|Patient Navigation Intervention Given|Death|0|||
30790907|NCT03200366|58804016|FG001|Patient Navigation Intervention Given|Death|2|||
30899951|NCT02357810|58933241|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
30621447|NCT01175382|58633053|FG000|Overall Study|Unwilling to follow protocol|0|||
30621448|NCT01175382|58633054|FG001|Overall Study|Unwilling to follow protocol|1|||
30621449|NCT01175382|58633055|FG002|Overall Study|Unwilling to follow protocol|0|||
30621450|NCT01175382|58633053|FG000|Overall Study|Unable to tolerate study meds|0|||
30621451|NCT01175382|58633054|FG001|Overall Study|Unable to tolerate study meds|1|||
30621452|NCT01175382|58633055|FG002|Overall Study|Unable to tolerate study meds|1|||
30621453|NCT01194245|58633068|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
30621454|NCT01194245|58633069|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
30621455|NCT01194245|58633070|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
30621456|NCT01194245|58633071|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
30621457|NCT01194245|58633072|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
30621458|NCT01194245|58633068|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
30621459|NCT01194245|58633069|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
30621460|NCT01194245|58633070|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
30621461|NCT01194245|58633071|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
30621462|NCT01194245|58633072|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
30621463|NCT01194245|58633068|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
30621464|NCT01194245|58633069|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
30621465|NCT01194245|58633070|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
30621466|NCT01194245|58633071|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
30621467|NCT01194245|58633072|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
30621468|NCT01194245|58633068|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
30621469|NCT01194245|58633069|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
30621470|NCT01194245|58633070|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
30621471|NCT01194245|58633071|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
30621472|NCT01194245|58633072|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
30621473|NCT01194245|58633068|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30621474|NCT01194245|58633069|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30621475|NCT01194245|58633070|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30712096|NCT00097981|58725654|FG001|Overall Study|Withdrawal by Subject|8|||
30712097|NCT00097981|58725653|FG000|Overall Study|Protocol Violation|1|||
30712098|NCT00097981|58725654|FG001|Overall Study|Protocol Violation|1|||
30712099|NCT00097981|58725653|FG000|Overall Study|Death|2|||
30712100|NCT00097981|58725654|FG001|Overall Study|Death|4|||
30712101|NCT00097981|58725653|FG000|Overall Study|Physician Decision|7|||
30712102|NCT00097981|58725654|FG001|Overall Study|Physician Decision|1|||
30712103|NCT00097981|58725653|FG000|Overall Study|Disease Progression|8|||
30712104|NCT00097981|58725654|FG001|Overall Study|Disease Progression|2|||
30712105|NCT00097981|58725653|FG000|Overall Study|Transplant planned|28|||
30712106|NCT00097981|58725654|FG001|Overall Study|Transplant planned|27|||
30712107|NCT00097981|58725653|FG000|Overall Study|Other|19|||
30712108|NCT00097981|58725654|FG001|Overall Study|Other|13|||
30712109|NCT00499083|58725660|FG000|Overall Study|Not evaluable|3|||
30712110|NCT00572195|58725664|FG000|Overall Study|Withdrawal by Subject|50|||
30712111|NCT00572195|58725664|FG000|Overall Study|Death|9|||
30712112|NCT00572195|58725664|FG000|Overall Study|Adverse Event|4|||
30712113|NCT00572195|58725664|FG000|Overall Study|Lost to Follow-up|5|||
30712114|NCT00572039|58725670|FG000|Overall Study|Withdrawal by Subject|9|||
30712115|NCT00572039|58725671|FG001|Overall Study|Withdrawal by Subject|6|||
30712116|NCT00572039|58725670|FG000|Overall Study|Death|2|||
30712117|NCT00572039|58725671|FG001|Overall Study|Death|3|||
30712118|NCT00572039|58725670|FG000|Overall Study|Ill|5|||
30712119|NCT00572039|58725671|FG001|Overall Study|Ill|1|||
30712120|NCT00684593|58725681|FG000|Overall Study|Adverse Event|0|||
30712121|NCT00684593|58725682|FG001|Overall Study|Adverse Event|2|||
30712122|NCT00685373|58725688|FG000|Overall Study|Adverse Event|3|||
30712123|NCT00685373|58725688|FG000|Overall Study|Withdrawal by Subject|5|||
30712124|NCT00685373|58725688|FG000|Overall Study|Lack of Efficacy|3|||
30712125|NCT00685373|58725688|FG000|Overall Study|Condition no longer requires study drug|1|||
30712126|NCT00685373|58725688|FG000|Overall Study|Lost to Follow-up|2|||
30712127|NCT00685373|58725688|FG000|Overall Study|Protocol Violation|1|||
30712128|NCT00684515|58725695|FG000|Overall Study|Adverse Event|3|||
30712129|NCT00684515|58725696|FG001|Overall Study|Adverse Event|3|||
30712130|NCT00684515|58725697|FG002|Overall Study|Adverse Event|1|||
30712131|NCT00684515|58725695|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
30712132|NCT00684515|58725696|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
30712133|NCT00684515|58725697|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
30712134|NCT00490815|58725707|FG000|Overall Study|Adverse Event|2|||
30712135|NCT00490815|58725708|FG001|Overall Study|Adverse Event|3|||
30712136|NCT00490815|58725707|FG000|Overall Study|Withdrawal by Subject|4|||
30712137|NCT00490815|58725708|FG001|Overall Study|Withdrawal by Subject|0|||
30712138|NCT00490815|58725707|FG000|Overall Study|Lost to Follow-up|1|||
30712139|NCT00490815|58725708|FG001|Overall Study|Lost to Follow-up|3|||
30712140|NCT00490815|58725707|FG000|Overall Study|Death|1|||
30712141|NCT00490815|58725708|FG001|Overall Study|Death|3|||
30712142|NCT03855189|58725717|FG000|Overall Study|Adverse Event|5|||
30712143|NCT03855189|58725718|FG001|Overall Study|Adverse Event|2|||
30712144|NCT03855189|58725719|FG002|Overall Study|Adverse Event|4|||
30712145|NCT03855189|58725717|FG000|Overall Study|Treatment Failure|1|||
30712146|NCT03855189|58725718|FG001|Overall Study|Treatment Failure|1|||
30712147|NCT03855189|58725719|FG002|Overall Study|Treatment Failure|2|||
30712148|NCT03855189|58725717|FG000|Overall Study|Noncompliance with Protocol|0|||
30712149|NCT03855189|58725718|FG001|Overall Study|Noncompliance with Protocol|1|||
30712150|NCT03855189|58725719|FG002|Overall Study|Noncompliance with Protocol|0|||
30712151|NCT03855189|58725717|FG000|Overall Study|Did Not Return|4|||
30712152|NCT03855189|58725718|FG001|Overall Study|Did Not Return|3|||
30712153|NCT03855189|58725719|FG002|Overall Study|Did Not Return|0|||
30712154|NCT03853551|58725727|FG000|Overall Study|Death|2|||
30712155|NCT03853551|58725727|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
30712156|NCT00423670|58725738|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
30712157|NCT00423670|58725739|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
30712158|NCT00423670|58725740|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
30712159|NCT00423670|58725741|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
30712160|NCT00423670|58725742|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
30712161|NCT00423670|58725743|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
30712162|NCT00423670|58725744|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
30712163|NCT00423670|58725745|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
30712164|NCT00423670|58725738|FG000|Treatment Period|Adverse Event|8|||
30712165|NCT00423670|58725739|FG001|Treatment Period|Adverse Event|12|||
30712166|NCT00423670|58725740|FG002|Treatment Period|Adverse Event|15|||
30712167|NCT00423670|58725741|FG003|Treatment Period|Adverse Event|20|||
30712168|NCT00423670|58725742|FG004|Treatment Period|Adverse Event|9|||
30712169|NCT00423670|58725743|FG005|Treatment Period|Adverse Event|4|||
30712170|NCT00423670|58725744|FG006|Treatment Period|Adverse Event|7|||
30712171|NCT00423670|58725745|FG007|Treatment Period|Adverse Event|2|||
30712172|NCT00423670|58725738|FG000|Treatment Period|Protocol-defined clinical event|0|||
30712173|NCT00423670|58725739|FG001|Treatment Period|Protocol-defined clinical event|7|||
30712174|NCT00423670|58725740|FG002|Treatment Period|Protocol-defined clinical event|4|||
30712175|NCT00423670|58725741|FG003|Treatment Period|Protocol-defined clinical event|12|||
30712176|NCT00423670|58725742|FG004|Treatment Period|Protocol-defined clinical event|5|||
30712177|NCT00423670|58725743|FG005|Treatment Period|Protocol-defined clinical event|4|||
30712178|NCT00423670|58725744|FG006|Treatment Period|Protocol-defined clinical event|16|||
30712179|NCT00423670|58725745|FG007|Treatment Period|Protocol-defined clinical event|15|||
30712180|NCT00423670|58725738|FG000|Treatment Period|Lost to Follow-up|2|||
30712181|NCT00423670|58725739|FG001|Treatment Period|Lost to Follow-up|1|||
30712182|NCT00423670|58725740|FG002|Treatment Period|Lost to Follow-up|3|||
30712183|NCT00423670|58725741|FG003|Treatment Period|Lost to Follow-up|1|||
30712184|NCT00423670|58725742|FG004|Treatment Period|Lost to Follow-up|6|||
30712185|NCT00423670|58725743|FG005|Treatment Period|Lost to Follow-up|0|||
30712186|NCT00423670|58725744|FG006|Treatment Period|Lost to Follow-up|3|||
30712187|NCT00423670|58725745|FG007|Treatment Period|Lost to Follow-up|1|||
30712188|NCT00423670|58725738|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
30712189|NCT00423670|58725739|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
30712190|NCT00423670|58725740|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
30712191|NCT00423670|58725741|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
30712192|NCT00423670|58725742|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
30712193|NCT00423670|58725743|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
30712194|NCT00423670|58725744|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
30712195|NCT00423670|58725745|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
30712196|NCT00423670|58725738|FG000|Treatment Period|Investigator decision|0|||
30712197|NCT00423670|58725739|FG001|Treatment Period|Investigator decision|0|||
30712198|NCT00423670|58725740|FG002|Treatment Period|Investigator decision|0|||
30712199|NCT00423670|58725741|FG003|Treatment Period|Investigator decision|0|||
30712200|NCT00423670|58725742|FG004|Treatment Period|Investigator decision|0|||
30712201|NCT00423670|58725743|FG005|Treatment Period|Investigator decision|0|||
30712202|NCT00423670|58725744|FG006|Treatment Period|Investigator decision|0|||
30712203|NCT00423670|58725745|FG007|Treatment Period|Investigator decision|1|||
30712204|NCT00423670|58725738|FG000|Treatment Period|Non-compliance with protocol|3|||
30712205|NCT00423670|58725739|FG001|Treatment Period|Non-compliance with protocol|1|||
30712206|NCT00423670|58725740|FG002|Treatment Period|Non-compliance with protocol|1|||
30712207|NCT00423670|58725741|FG003|Treatment Period|Non-compliance with protocol|3|||
30712208|NCT00423670|58725742|FG004|Treatment Period|Non-compliance with protocol|2|||
30712209|NCT00423670|58725743|FG005|Treatment Period|Non-compliance with protocol|0|||
30712210|NCT00423670|58725744|FG006|Treatment Period|Non-compliance with protocol|2|||
30712211|NCT00423670|58725745|FG007|Treatment Period|Non-compliance with protocol|2|||
30712212|NCT00423670|58725738|FG000|Follow-up Period|Lost to Follow-up|0|||
30712213|NCT00423670|58725739|FG001|Follow-up Period|Lost to Follow-up|12|||
30712214|NCT00423670|58725740|FG002|Follow-up Period|Lost to Follow-up|8|||
30712215|NCT00423670|58725741|FG003|Follow-up Period|Lost to Follow-up|3|||
30712216|NCT00423670|58725742|FG004|Follow-up Period|Lost to Follow-up|1|||
30712217|NCT00423670|58725743|FG005|Follow-up Period|Lost to Follow-up|0|||
30712218|NCT00423670|58725744|FG006|Follow-up Period|Lost to Follow-up|5|||
30712219|NCT00423670|58725745|FG007|Follow-up Period|Lost to Follow-up|0|||
30712220|NCT00423670|58725738|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
30712221|NCT00423670|58725739|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
30712222|NCT00423670|58725740|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
30712223|NCT00423670|58725741|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
30712224|NCT00423670|58725742|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
30712225|NCT00423670|58725743|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
30712226|NCT00423670|58725744|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
30712227|NCT00423670|58725745|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
30712228|NCT00423670|58725738|FG000|Follow-up Period|Non-compliance with protocol|2|||
30712229|NCT00423670|58725739|FG001|Follow-up Period|Non-compliance with protocol|0|||
30712230|NCT00423670|58725740|FG002|Follow-up Period|Non-compliance with protocol|1|||
30712231|NCT00423670|58725741|FG003|Follow-up Period|Non-compliance with protocol|1|||
30712232|NCT00423670|58725742|FG004|Follow-up Period|Non-compliance with protocol|0|||
30712233|NCT00423670|58725743|FG005|Follow-up Period|Non-compliance with protocol|0|||
30712234|NCT00423670|58725744|FG006|Follow-up Period|Non-compliance with protocol|3|||
30712235|NCT00423670|58725745|FG007|Follow-up Period|Non-compliance with protocol|2|||
30712236|NCT00483717|58725768|FG000|Overall Study|Protocol Violation|5|||
30712237|NCT00483717|58725769|FG001|Overall Study|Protocol Violation|7|||
30712238|NCT00483717|58725768|FG000|Overall Study|Time of dosing missing|1|||
30712239|NCT00483717|58725769|FG001|Overall Study|Time of dosing missing|1|||
30712240|NCT00483717|58725768|FG000|Overall Study|No treatment for migraine|16|||
30712241|NCT00483717|58725769|FG001|Overall Study|No treatment for migraine|13|||
30712242|NCT00483717|58725768|FG000|Overall Study|Lost to Follow-up|1|||
30712243|NCT00483717|58725769|FG001|Overall Study|Lost to Follow-up|0|||
30712244|NCT00483717|58725768|FG000|Overall Study|Withdrawal by Subject|1|||
30712245|NCT00483717|58725769|FG001|Overall Study|Withdrawal by Subject|0|||
30712246|NCT00406354|58725778|FG000|All Randomized Patients|Protocol Violation|0|||
30712247|NCT00406354|58725779|FG001|All Randomized Patients|Protocol Violation|0|||
30712248|NCT00406354|58725780|FG002|All Randomized Patients|Protocol Violation|1|||
30712249|NCT00406354|58725778|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
30712250|NCT00406354|58725779|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
30712251|NCT00406354|58725780|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
30712252|NCT00406354|58725778|FG000|All Randomized and Treated Patients|Adverse Event|6|||
30712253|NCT00406354|58725779|FG001|All Randomized and Treated Patients|Adverse Event|2|||
30712254|NCT00406354|58725780|FG002|All Randomized and Treated Patients|Adverse Event|1|||
30712255|NCT00406354|58725778|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
30712256|NCT00406354|58725779|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
30712257|NCT00406354|58725780|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
30712258|NCT00406354|58725778|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
30712259|NCT00406354|58725779|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
30712260|NCT00406354|58725780|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
30712261|NCT00406354|58725778|FG000|All Randomized and Treated Patients|Physician Decision|0|||
30712262|NCT00406354|58725779|FG001|All Randomized and Treated Patients|Physician Decision|0|||
30712263|NCT00406354|58725780|FG002|All Randomized and Treated Patients|Physician Decision|1|||
30712264|NCT00483405|58725788|FG000|Overall Study|Adverse Event|8|||
30712265|NCT00483405|58725788|FG000|Overall Study|Lack of Efficacy|14|||
30712266|NCT00483405|58725788|FG000|Overall Study|Death|3|||
30712267|NCT00483405|58725788|FG000|Overall Study|Withdrawal by Subject|2|||
30712268|NCT00483405|58725788|FG000|Overall Study|Other complicating disease|1|||
30712269|NCT00483327|58725796|FG000|Overall Study|Adverse Event|1|||
30712270|NCT00483327|58725796|FG000|Overall Study|Withdrawal by Subject|3|||
30712271|NCT00483327|58725796|FG000|Overall Study|Lost to Follow-up|4|||
30712272|NCT00483327|58725796|FG000|Overall Study|Patient Non Compliance|2|||
30712273|NCT00684203|58725808|FG000|Overall Study|Adverse Event|6|||
30712274|NCT00684203|58725809|FG001|Overall Study|Adverse Event|4|||
30712275|NCT00684203|58725810|FG002|Overall Study|Adverse Event|8|||
30712276|NCT00684203|58725811|FG003|Overall Study|Adverse Event|0|||
30712277|NCT00684203|58725812|FG004|Overall Study|Adverse Event|0|||
30712278|NCT00684203|58725813|FG005|Overall Study|Adverse Event|0|||
30712279|NCT00684203|58725808|FG000|Overall Study|Protocol-defined clinical event|3|||
30712280|NCT00684203|58725809|FG001|Overall Study|Protocol-defined clinical event|1|||
30712281|NCT00684203|58725810|FG002|Overall Study|Protocol-defined clinical event|0|||
30712282|NCT00684203|58725811|FG003|Overall Study|Protocol-defined clinical event|0|||
30712283|NCT00684203|58725812|FG004|Overall Study|Protocol-defined clinical event|0|||
30712284|NCT00684203|58725813|FG005|Overall Study|Protocol-defined clinical event|0|||
30712285|NCT00684203|58725808|FG000|Overall Study|Withdrawal by Subject|0|||
30712286|NCT00684203|58725809|FG001|Overall Study|Withdrawal by Subject|2|||
30712287|NCT00684203|58725810|FG002|Overall Study|Withdrawal by Subject|1|||
30712288|NCT00684203|58725811|FG003|Overall Study|Withdrawal by Subject|0|||
30712289|NCT00684203|58725812|FG004|Overall Study|Withdrawal by Subject|0|||
30712290|NCT00684203|58725813|FG005|Overall Study|Withdrawal by Subject|0|||
30712291|NCT00684203|58725808|FG000|Overall Study|Did not meet protocol eligibility|0|||
30712292|NCT00684203|58725809|FG001|Overall Study|Did not meet protocol eligibility|1|||
30712293|NCT00684203|58725810|FG002|Overall Study|Did not meet protocol eligibility|0|||
30712294|NCT00684203|58725811|FG003|Overall Study|Did not meet protocol eligibility|0|||
30712295|NCT00684203|58725812|FG004|Overall Study|Did not meet protocol eligibility|0|||
30712296|NCT00684203|58725813|FG005|Overall Study|Did not meet protocol eligibility|0|||
30712297|NCT00423592|58725834|FG000|Overall Study|Adverse Event (through Week 12)|2|||
30712298|NCT00423592|58725834|FG000|Overall Study|Adverse Event (post Week 12)|5|||
30712299|NCT00683657|58725840|FG000|Overall Study|Adverse Event|0|||
30712300|NCT00683657|58725841|FG001|Overall Study|Adverse Event|1|||
30712301|NCT00683657|58725840|FG000|Overall Study|Subject Withdrew Consent|1|||
30712302|NCT00683657|58725841|FG001|Overall Study|Subject Withdrew Consent|0|||
30712303|NCT00680771|58725849|FG000|Overall Study|Withdrawal by Subject|1|||
30712304|NCT00680771|58725850|FG001|Overall Study|Withdrawal by Subject|0|||
30712305|NCT00680771|58725849|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
30712306|NCT00680771|58725850|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
30712307|NCT00680771|58725849|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
30712308|NCT00680771|58725850|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
30712309|NCT00482703|58725858|FG000|Overall Study|Poor compliance|1|||
30712310|NCT00482703|58725859|FG001|Overall Study|Poor compliance|0|||
30712311|NCT00482391|58725872|FG000|Overall Study|Withdrawal by Subject|1|||
30712312|NCT00482391|58725872|FG000|Overall Study|Adverse Event|1|||
30712313|NCT00482391|58725872|FG000|Overall Study|Death|1|||
30712314|NCT00423046|58725879|FG000|Overall Study|Other|340|||
30712315|NCT00423046|58725880|FG001|Overall Study|Other|345|||
30712316|NCT00496587|58725888|FG000|Overall Study|Adverse Event|2|||
30712317|NCT00496587|58725888|FG000|Overall Study|Progressive Disease|24|||
30790908|NCT03200366|58804017|FG002|Patient Navigation Intervention Given|Death|0|||
30712318|NCT00496587|58725888|FG000|Overall Study|Withdrawal by Subject|2|||
30712319|NCT00496587|58725888|FG000|Overall Study|Death|1|||
30712320|NCT00496587|58725888|FG000|Overall Study|Complications unrelated|2|||
30712321|NCT00405652|58725892|FG000|Overall Study|Adverse Event|4|||
30712322|NCT00422734|58725898|FG000|Overall Study|Physician Decision|1|||
30712323|NCT00422734|58725899|FG001|Overall Study|Physician Decision|1|||
30712324|NCT00422734|58725898|FG000|Overall Study|Protocol Violation|1|||
30712325|NCT00422734|58725899|FG001|Overall Study|Protocol Violation|6|||
30712326|NCT00422734|58725898|FG000|Overall Study|Withdrawal by Subject|12|||
30712327|NCT00422734|58725899|FG001|Overall Study|Withdrawal by Subject|8|||
30712328|NCT00422734|58725898|FG000|Overall Study|Adverse Event|0|||
30712329|NCT00422734|58725899|FG001|Overall Study|Adverse Event|3|||
30712330|NCT00422734|58725898|FG000|Overall Study|Partner Decision|0|||
30712331|NCT00422734|58725899|FG001|Overall Study|Partner Decision|3|||
30712332|NCT00422422|58725905|FG000|Overall Study|Lack of Efficacy|1|||
30712333|NCT00422422|58725905|FG000|Overall Study|Protocol Violation|1|||
30712334|NCT00422422|58725905|FG000|Overall Study|Withdrawal by Subject|2|||
30712335|NCT00422422|58725905|FG000|Overall Study|SAE, non-fatal|1|||
30712336|NCT00422422|58725905|FG000|Overall Study|AE, non-serious non-fatal|5|||
30712337|NCT00413374|58725913|FG000|Overall Study|Ineligible due to screening criteria.|3|||
30712338|NCT00413374|58725914|FG001|Overall Study|Ineligible due to screening criteria.|0|||
30712339|NCT00413374|58725913|FG000|Overall Study|Adverse Event|1|||
30712340|NCT00413374|58725914|FG001|Overall Study|Adverse Event|0|||
30712341|NCT00413374|58725913|FG000|Overall Study|Lost to Follow-up|1|||
30712342|NCT00413374|58725914|FG001|Overall Study|Lost to Follow-up|0|||
30712343|NCT00413374|58725913|FG000|Overall Study|Surgery|1|||
30712344|NCT00413374|58725914|FG001|Overall Study|Surgery|0|||
30712345|NCT00682643|58725925|FG000|Overall Study|Adverse Event|12|||
30712346|NCT00682643|58725926|FG001|Overall Study|Adverse Event|23|||
30712347|NCT00682643|58725925|FG000|Overall Study|Lack of Efficacy|2|||
30712348|NCT00682643|58725926|FG001|Overall Study|Lack of Efficacy|0|||
30712349|NCT00682643|58725925|FG000|Overall Study|Protocol Violation|38|||
30712350|NCT00682643|58725926|FG001|Overall Study|Protocol Violation|76|||
30712351|NCT00682643|58725925|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
30712352|NCT00682643|58725926|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
30712353|NCT00682643|58725925|FG000|Overall Study|Lost to Follow-up|1|||
30712354|NCT00682643|58725926|FG001|Overall Study|Lost to Follow-up|6|||
30712355|NCT00682643|58725925|FG000|Overall Study|Physician Decision|2|||
30712356|NCT00682643|58725926|FG001|Overall Study|Physician Decision|6|||
30712357|NCT00682643|58725925|FG000|Overall Study|Withdrawal by Subject|19|||
30712358|NCT00682643|58725926|FG001|Overall Study|Withdrawal by Subject|53|||
30712359|NCT00682643|58725925|FG000|Overall Study|Did Not Receive Study Drug|1|||
30712360|NCT00682643|58725926|FG001|Overall Study|Did Not Receive Study Drug|1|||
30712361|NCT00421408|58725935|FG000|Overall Study|Lost to Follow-up|30|||
30712362|NCT00421408|58725936|FG001|Overall Study|Lost to Follow-up|20|||
30712363|NCT00421408|58725935|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
30712364|NCT00421408|58725936|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
30712365|NCT00679913|58725944|FG000|Overall Study|Protocol Violation|18|||
30712366|NCT00679913|58725945|FG001|Overall Study|Protocol Violation|13|||
30712367|NCT00482001|58725954|FG000|Overall Study|Protocol Violation|1|||
30712368|NCT00482001|58725955|FG001|Overall Study|Protocol Violation|1|||
30712369|NCT00490035|58725967|FG000|Overall Study|AE, non-serious non-fatal|3|||
30712370|NCT00490035|58725968|FG001|Overall Study|AE, non-serious non-fatal|4|||
30712371|NCT00490035|58725969|FG002|Overall Study|AE, non-serious non-fatal|4|||
30712372|NCT00490035|58725970|FG003|Overall Study|AE, non-serious non-fatal|5|||
30712373|NCT00490035|58725967|FG000|Overall Study|Lost to Follow-up|2|||
30712374|NCT00490035|58725968|FG001|Overall Study|Lost to Follow-up|0|||
30712375|NCT00490035|58725969|FG002|Overall Study|Lost to Follow-up|1|||
30712376|NCT00490035|58725970|FG003|Overall Study|Lost to Follow-up|0|||
30712377|NCT00490035|58725967|FG000|Overall Study|Withdrawal by Subject|2|||
30712378|NCT00490035|58725968|FG001|Overall Study|Withdrawal by Subject|1|||
30712379|NCT00490035|58725969|FG002|Overall Study|Withdrawal by Subject|1|||
30712380|NCT00490035|58725970|FG003|Overall Study|Withdrawal by Subject|0|||
30712381|NCT00490035|58725967|FG000|Overall Study|Other reason|0|||
30712382|NCT00490035|58725968|FG001|Overall Study|Other reason|1|||
30712383|NCT00490035|58725969|FG002|Overall Study|Other reason|3|||
30712384|NCT00490035|58725970|FG003|Overall Study|Other reason|1|||
30712385|NCT00490035|58725967|FG000|Overall Study|AE, serious fatal|1|||
30712386|NCT00490035|58725968|FG001|Overall Study|AE, serious fatal|0|||
30712387|NCT00490035|58725969|FG002|Overall Study|AE, serious fatal|0|||
30712388|NCT00490035|58725970|FG003|Overall Study|AE, serious fatal|0|||
30712389|NCT00490035|58725967|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
30712390|NCT00490035|58725968|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
30712391|NCT00490035|58725969|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
30712392|NCT00490035|58725970|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
30712393|NCT00490035|58725967|FG000|Overall Study|AE of unknown type|0|||
30712394|NCT00490035|58725968|FG001|Overall Study|AE of unknown type|0|||
30712395|NCT00490035|58725969|FG002|Overall Study|AE of unknown type|2|||
30712396|NCT00490035|58725970|FG003|Overall Study|AE of unknown type|0|||
30712397|NCT00404248|58725983|FG000|Overall Study|pts declining status|0|||
30712398|NCT00404248|58725984|FG001|Overall Study|pts declining status|1|||
30712399|NCT00404248|58725985|FG002|Overall Study|pts declining status|0|||
30712400|NCT00404248|58725986|FG003|Overall Study|pts declining status|0|||
30712401|NCT00404248|58725987|FG004|Overall Study|pts declining status|0|||
30712402|NCT00404248|58725988|FG005|Overall Study|pts declining status|0|||
30712403|NCT00404248|58725989|FG006|Overall Study|pts declining status|0|||
30712404|NCT00404248|58725990|FG007|Overall Study|pts declining status|0|||
30712405|NCT00404248|58725991|FG008|Overall Study|pts declining status|0|||
30712406|NCT00421174|58726019|FG000|Overall Study|Withdrawal by Subject|0|||
30712407|NCT00421174|58726020|FG001|Overall Study|Withdrawal by Subject|1|||
30712408|NCT00421174|58726019|FG000|Overall Study|Ineligible due to infection|2|||
30712409|NCT00421174|58726020|FG001|Overall Study|Ineligible due to infection|0|||
30712410|NCT00496197|58726026|FG000|Overall Study|Discontinued study due to death|43|||
30712411|NCT00496197|58726026|FG000|Overall Study|Adverse Event|13|||
30712412|NCT00496197|58726026|FG000|Overall Study|Does not meet entrance criteria|5|||
30712413|NCT00496197|58726026|FG000|Overall Study|Insufficient clinical response|3|||
30712414|NCT00496197|58726026|FG000|Overall Study|Insufficient bacteriological response|10|||
30712415|NCT00496197|58726026|FG000|Overall Study|Lost to Follow-up|11|||
30712416|NCT00496197|58726026|FG000|Overall Study|Withdrawal by Subject|11|||
30712417|NCT00496197|58726026|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
30712418|NCT00496197|58726026|FG000|Overall Study|Other|14|||
30712419|NCT00496197|58726026|FG000|Overall Study|Protocol Violation|8|||
30712420|NCT00495495|58726030|FG000|Overall Study|Protocol Violation|99|||
30712421|NCT00404092|58726039|FG000|Overall Study|Death|1|||
30712422|NCT00404092|58726040|FG001|Overall Study|Death|0|||
30712423|NCT00404092|58726041|FG002|Overall Study|Death|0|||
30712424|NCT00404092|58726042|FG003|Overall Study|Death|0|||
30712425|NCT00404092|58726039|FG000|Overall Study|Adverse Event|0|||
30712426|NCT00404092|58726040|FG001|Overall Study|Adverse Event|0|||
30712427|NCT00404092|58726041|FG002|Overall Study|Adverse Event|1|||
30712428|NCT00404092|58726042|FG003|Overall Study|Adverse Event|0|||
30712429|NCT00481767|58726054|FG000|Overall Study|Withdrawal by Subject|16|||
30712430|NCT00481767|58726055|FG001|Overall Study|Withdrawal by Subject|11|||
30712431|NCT00481767|58726054|FG000|Overall Study|Lost to Follow-up|16|||
30712432|NCT00481767|58726055|FG001|Overall Study|Lost to Follow-up|10|||
30712433|NCT00489489|58726064|FG000|Overall Study|Not treated due to protocol violation|0|||
30712434|NCT00489489|58726065|FG001|Overall Study|Not treated due to protocol violation|1|||
30712435|NCT00489489|58726066|FG002|Overall Study|Not treated due to protocol violation|1|||
30712436|NCT00489489|58726064|FG000|Overall Study|Adverse Event|1|||
30712437|NCT00489489|58726065|FG001|Overall Study|Adverse Event|1|||
30712438|NCT00489489|58726066|FG002|Overall Study|Adverse Event|1|||
30712439|NCT00489489|58726064|FG000|Overall Study|Protocol Violation|1|||
30712440|NCT00489489|58726065|FG001|Overall Study|Protocol Violation|0|||
30712441|NCT00489489|58726066|FG002|Overall Study|Protocol Violation|1|||
30712442|NCT00489489|58726064|FG000|Overall Study|Progressive disease|0|||
30712443|NCT00489489|58726065|FG001|Overall Study|Progressive disease|1|||
30712444|NCT00489489|58726066|FG002|Overall Study|Progressive disease|0|||
30712445|NCT00489489|58726064|FG000|Overall Study|Participant did not wish to continue|1|||
30712446|NCT00489489|58726065|FG001|Overall Study|Participant did not wish to continue|1|||
30712447|NCT00489489|58726066|FG002|Overall Study|Participant did not wish to continue|0|||
30712448|NCT00489489|58726064|FG000|Overall Study|Other than above|0|||
30712449|NCT00489489|58726065|FG001|Overall Study|Other than above|1|||
30712450|NCT00489489|58726066|FG002|Overall Study|Other than above|0|||
30712451|NCT00489411|58726078|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
30712452|NCT00489411|58726079|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
30712453|NCT00489411|58726078|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
30712454|NCT00489411|58726079|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
30712455|NCT00489411|58726078|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
30712456|NCT00489411|58726079|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
30712457|NCT00489411|58726078|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
30712458|NCT00489411|58726079|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
30712459|NCT00489411|58726078|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
30712460|NCT00489411|58726079|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
30712461|NCT00420784|58726089|FG000|Overall Study|Adverse Event|11|||
30712462|NCT00420784|58726090|FG001|Overall Study|Adverse Event|29|||
30712463|NCT00420784|58726091|FG002|Overall Study|Adverse Event|10|||
30712464|NCT00420784|58726092|FG003|Overall Study|Adverse Event|5|||
30712465|NCT00420784|58726089|FG000|Overall Study|Withdrawal by Subject|0|||
30712466|NCT00420784|58726090|FG001|Overall Study|Withdrawal by Subject|1|||
30712467|NCT00420784|58726091|FG002|Overall Study|Withdrawal by Subject|0|||
30712468|NCT00420784|58726092|FG003|Overall Study|Withdrawal by Subject|0|||
30712469|NCT00420784|58726089|FG000|Overall Study|Lost to Follow-up|0|||
30712470|NCT00420784|58726090|FG001|Overall Study|Lost to Follow-up|0|||
30712471|NCT00420784|58726091|FG002|Overall Study|Lost to Follow-up|2|||
30712472|NCT00420784|58726092|FG003|Overall Study|Lost to Follow-up|1|||
30712473|NCT00420784|58726089|FG000|Overall Study|Virologic Stopping Rule|17|||
30712474|NCT00420784|58726090|FG001|Overall Study|Virologic Stopping Rule|26|||
30712475|NCT00420784|58726091|FG002|Overall Study|Virologic Stopping Rule|41|||
30712476|NCT00420784|58726092|FG003|Overall Study|Virologic Stopping Rule|67|||
30712477|NCT00420784|58726089|FG000|Overall Study|Other|1|||
30712478|NCT00420784|58726090|FG001|Overall Study|Other|2|||
30712479|NCT00420784|58726091|FG002|Overall Study|Other|0|||
30712480|NCT00420784|58726092|FG003|Overall Study|Other|5|||
30712481|NCT00420628|58726105|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
30712482|NCT00420628|58726106|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
30712483|NCT00420628|58726105|FG000|Overall Study|Lost to Follow-up|3|||
30712484|NCT00420628|58726106|FG001|Overall Study|Lost to Follow-up|2|||
30712485|NCT00420628|58726105|FG000|Overall Study|Adverse Event|1|||
30712486|NCT00420628|58726106|FG001|Overall Study|Adverse Event|0|||
30712487|NCT00489255|58726114|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
30712488|NCT00489255|58726115|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
30712489|NCT00489255|58726114|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
30712490|NCT00489255|58726115|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
30712491|NCT00489255|58726114|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
30712492|NCT00489255|58726115|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
30712493|NCT00489255|58726114|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
30712494|NCT00489255|58726115|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
30712495|NCT00489255|58726114|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
30712496|NCT00489255|58726115|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
30712497|NCT00489255|58726114|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
30712498|NCT00489255|58726115|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
30712499|NCT00489255|58726114|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
30712500|NCT00489255|58726115|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
30712501|NCT00489255|58726114|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
30712502|NCT00489255|58726115|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
30712503|NCT00489255|58726114|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
30712504|NCT00489255|58726115|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
30712505|NCT00489255|58726114|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
30712506|NCT00489255|58726115|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
30712507|NCT00413218|58726123|FG000|Overall Study|Randomized but didn't receive study drug|2|||
30712508|NCT00413218|58726124|FG001|Overall Study|Randomized but didn't receive study drug|8|||
30712509|NCT00413218|58726123|FG000|Overall Study|Death|57|||
30712510|NCT00413218|58726124|FG001|Overall Study|Death|56|||
30712511|NCT00413218|58726123|FG000|Overall Study|Lost to Follow-up|14|||
30712512|NCT00413218|58726124|FG001|Overall Study|Lost to Follow-up|17|||
30712513|NCT00413218|58726123|FG000|Overall Study|Admin|20|||
30712514|NCT00413218|58726124|FG001|Overall Study|Admin|14|||
30712515|NCT00413218|58726123|FG000|Overall Study|Missing|1|||
30712516|NCT00413218|58726124|FG001|Overall Study|Missing|0|||
30712517|NCT00413218|58726123|FG000|Overall Study|Withdrawal by Subject|9|||
30712518|NCT00413218|58726124|FG001|Overall Study|Withdrawal by Subject|1|||
30712519|NCT00420316|58726133|FG000|Overall Study|Withdrawal by Subject|0|||
30712520|NCT00420316|58726134|FG001|Overall Study|Withdrawal by Subject|1|||
30712521|NCT00420316|58726133|FG000|Overall Study|Lost to Follow-up|12|||
30712522|NCT00420316|58726134|FG001|Overall Study|Lost to Follow-up|8|||
30712523|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
30712524|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
30712525|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
30712526|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
30712527|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Death|8|||
30712528|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Death|3|||
30712529|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
30712530|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
30712531|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
30712532|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
30712533|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
30712534|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
30712535|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
30712536|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
30712537|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
30712538|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
30712539|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
30712540|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
30712541|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
30712542|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
30712543|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
30712544|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
30712545|NCT00494871|58726142|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
30712546|NCT00494871|58726143|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
30712547|NCT00494871|58726142|FG000|Follow-up (FU) Period|Adverse Event|1|||
30712548|NCT00494871|58726143|FG001|Follow-up (FU) Period|Adverse Event|1|||
30712549|NCT00494871|58726142|FG000|Follow-up (FU) Period|Death|13|||
30712550|NCT00494871|58726143|FG001|Follow-up (FU) Period|Death|12|||
30712551|NCT00494871|58726142|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
30712552|NCT00494871|58726143|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
30712553|NCT00494871|58726142|FG000|Follow-up (FU) Period|Physician Decision|0|||
30712554|NCT00494871|58726143|FG001|Follow-up (FU) Period|Physician Decision|1|||
30712555|NCT00494871|58726142|FG000|Follow-up (FU) Period|Protocol Violation|1|||
30712556|NCT00494871|58726143|FG001|Follow-up (FU) Period|Protocol Violation|0|||
30712557|NCT00494871|58726142|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
30712558|NCT00494871|58726143|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
30712559|NCT00494871|58726142|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
30712560|NCT00494871|58726143|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
30712561|NCT00420238|58726153|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
30712562|NCT00420238|58726154|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
30712563|NCT00420238|58726153|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
30712564|NCT00420238|58726154|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
30712565|NCT00420238|58726153|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
30712566|NCT00420238|58726154|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
30712567|NCT00420238|58726153|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
30712568|NCT00420238|58726154|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
30712569|NCT00420238|58726153|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
30712570|NCT00420238|58726154|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
30712571|NCT00420238|58726153|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
30712572|NCT00420238|58726154|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
30712573|NCT00420004|58726169|FG000|Overall Study|Adverse Event|4|||
30712574|NCT00420004|58726170|FG001|Overall Study|Adverse Event|1|||
30712575|NCT00420004|58726171|FG002|Overall Study|Adverse Event|1|||
30712576|NCT00420004|58726169|FG000|Overall Study|Lack of Efficacy|5|||
30712577|NCT00420004|58726170|FG001|Overall Study|Lack of Efficacy|4|||
30712578|NCT00420004|58726171|FG002|Overall Study|Lack of Efficacy|1|||
30712579|NCT00420004|58726169|FG000|Overall Study|Lost to Follow-up|31|||
30712580|NCT00420004|58726170|FG001|Overall Study|Lost to Follow-up|12|||
30712581|NCT00420004|58726171|FG002|Overall Study|Lost to Follow-up|10|||
30712582|NCT00420004|58726169|FG000|Overall Study|Entry Criteria Not Met|0|||
30712583|NCT00420004|58726170|FG001|Overall Study|Entry Criteria Not Met|1|||
30712584|NCT00420004|58726171|FG002|Overall Study|Entry Criteria Not Met|0|||
30712585|NCT00420004|58726169|FG000|Overall Study|Physician Decision|14|||
30712586|NCT00420004|58726170|FG001|Overall Study|Physician Decision|4|||
30712587|NCT00420004|58726171|FG002|Overall Study|Physician Decision|2|||
30712588|NCT00420004|58726169|FG000|Overall Study|Protocol Violation|5|||
30712589|NCT00420004|58726170|FG001|Overall Study|Protocol Violation|4|||
30712590|NCT00420004|58726171|FG002|Overall Study|Protocol Violation|3|||
30712591|NCT00420004|58726169|FG000|Overall Study|Withdrawal by Subject|67|||
30712592|NCT00420004|58726170|FG001|Overall Study|Withdrawal by Subject|42|||
30712593|NCT00420004|58726171|FG002|Overall Study|Withdrawal by Subject|14|||
30712594|NCT00420004|58726169|FG000|Overall Study|Sponsor Decision|3|||
30712595|NCT00420004|58726170|FG001|Overall Study|Sponsor Decision|3|||
30712596|NCT00420004|58726171|FG002|Overall Study|Sponsor Decision|1|||
30712597|NCT00494481|58726185|FG000|Overall Study|Condition under investigation worsened|11|||
30712598|NCT00494481|58726186|FG001|Overall Study|Condition under investigation worsened|13|||
30712599|NCT00494481|58726185|FG000|Overall Study|Adverse Event|15|||
30712600|NCT00494481|58726186|FG001|Overall Study|Adverse Event|11|||
30712601|NCT00494481|58726185|FG000|Overall Study|Other|1|||
30712602|NCT00494481|58726186|FG001|Overall Study|Other|0|||
30712603|NCT00494481|58726185|FG000|Overall Study|Never received IP|2|||
30712604|NCT00494481|58726186|FG001|Overall Study|Never received IP|0|||
30712605|NCT00097591|58726194|FG000|Overall Study|Withdrawal of consent|342|||
30712606|NCT00097591|58726195|FG001|Overall Study|Withdrawal of consent|323|||
30712607|NCT00097591|58726194|FG000|Overall Study|Less than 6 months on study drug|9|||
30621476|NCT01194245|58633071|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30621477|NCT01194245|58633072|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
30712608|NCT00097591|58726195|FG001|Overall Study|Less than 6 months on study drug|7|||
30712609|NCT00097591|58726194|FG000|Overall Study|Unable to attend termination visit|53|||
30712610|NCT00097591|58726195|FG001|Overall Study|Unable to attend termination visit|51|||
30712611|NCT00097591|58726194|FG000|Overall Study|Lost to follow up|6|||
30712612|NCT00097591|58726195|FG001|Overall Study|Lost to follow up|10|||
30712613|NCT00097591|58726194|FG000|Overall Study|Other|0|||
30712614|NCT00097591|58726195|FG001|Overall Study|Other|3|||
30712615|NCT00419926|58726203|FG000|Overall Study|Withdrawal by Subject|7|||
30712616|NCT00419926|58726204|FG001|Overall Study|Withdrawal by Subject|3|||
30712617|NCT00419926|58726203|FG000|Overall Study|Administrative Problem|4|||
30712618|NCT00419926|58726204|FG001|Overall Study|Administrative Problem|4|||
30712619|NCT00419926|58726203|FG000|Overall Study|Lost to Follow-up|1|||
30712620|NCT00419926|58726204|FG001|Overall Study|Lost to Follow-up|2|||
30712621|NCT00419926|58726203|FG000|Overall Study|Death|2|||
30712622|NCT00419926|58726204|FG001|Overall Study|Death|1|||
30712623|NCT00419770|58726212|FG000|Overall Study|Withdrawal by Subject|5|||
30712624|NCT00419770|58726213|FG001|Overall Study|Withdrawal by Subject|1|||
30712625|NCT00080119|58726223|FG000|Overall Study|Discontinued because of study closure|0|||
30712626|NCT00080119|58726224|FG001|Overall Study|Discontinued because of study closure|0|||
30712627|NCT00080119|58726225|FG002|Overall Study|Discontinued because of study closure|130|||
30712628|NCT00080119|58726226|FG003|Overall Study|Discontinued because of study closure|141|||
30712629|NCT00080119|58726223|FG000|Overall Study|Unable to get to clinic|24|||
30712630|NCT00080119|58726224|FG001|Overall Study|Unable to get to clinic|24|||
30712631|NCT00080119|58726225|FG002|Overall Study|Unable to get to clinic|7|||
30712632|NCT00080119|58726226|FG003|Overall Study|Unable to get to clinic|1|||
30712633|NCT00080119|58726223|FG000|Overall Study|Consent withdrawn|13|||
30712634|NCT00080119|58726224|FG001|Overall Study|Consent withdrawn|17|||
30712635|NCT00080119|58726225|FG002|Overall Study|Consent withdrawn|4|||
30712636|NCT00080119|58726226|FG003|Overall Study|Consent withdrawn|6|||
30712637|NCT00080119|58726223|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
30712638|NCT00080119|58726224|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
30712639|NCT00080119|58726225|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
30712640|NCT00080119|58726226|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
30712641|NCT00080119|58726223|FG000|Overall Study|Lost to Follow-up|16|||
30712642|NCT00080119|58726224|FG001|Overall Study|Lost to Follow-up|19|||
30712643|NCT00080119|58726225|FG002|Overall Study|Lost to Follow-up|19|||
30712644|NCT00080119|58726226|FG003|Overall Study|Lost to Follow-up|14|||
30712645|NCT00419380|58726240|FG000|Overall Study|Lack of Efficacy|1|||
30712646|NCT00419380|58726241|FG001|Overall Study|Lack of Efficacy|7|||
30712647|NCT00419380|58726240|FG000|Overall Study|Physician Decision|0|||
30712648|NCT00419380|58726241|FG001|Overall Study|Physician Decision|1|||
30712649|NCT00419380|58726240|FG000|Overall Study|Lost to Follow-up|0|||
30712650|NCT00419380|58726241|FG001|Overall Study|Lost to Follow-up|1|||
30712651|NCT00419380|58726240|FG000|Overall Study|Withdrawal by Subject|0|||
30712652|NCT00419380|58726241|FG001|Overall Study|Withdrawal by Subject|1|||
30712653|NCT00413062|58726249|FG000|Overall Study|Adverse event/serious adverse event|289|||
30712654|NCT00413062|58726250|FG001|Overall Study|Adverse event/serious adverse event|56|||
30712655|NCT00413062|58726249|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
30712656|NCT00413062|58726250|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
30712657|NCT00413062|58726249|FG000|Overall Study|Withdrawal of informed consent|111|||
30712658|NCT00413062|58726250|FG001|Overall Study|Withdrawal of informed consent|36|||
30712659|NCT00413062|58726249|FG000|Overall Study|Pregnancy|15|||
30712660|NCT00413062|58726250|FG001|Overall Study|Pregnancy|5|||
30712661|NCT00413062|58726249|FG000|Overall Study|Pregnancy wish|17|||
30712662|NCT00413062|58726250|FG001|Overall Study|Pregnancy wish|6|||
30712663|NCT00413062|58726249|FG000|Overall Study|Lost to Follow-up|175|||
30712664|NCT00413062|58726250|FG001|Overall Study|Lost to Follow-up|73|||
30712665|NCT00413062|58726249|FG000|Overall Study|Other reason|70|||
30712666|NCT00413062|58726250|FG001|Overall Study|Other reason|34|||
30712667|NCT00494091|58726260|FG000|Overall Study|Death|5|||
30712668|NCT00494091|58726261|FG001|Overall Study|Death|54|||
30712669|NCT00494091|58726260|FG000|Overall Study|Lost to Follow-up|0|||
30712670|NCT00494091|58726261|FG001|Overall Study|Lost to Follow-up|4|||
30712671|NCT00494091|58726260|FG000|Overall Study|Other|1|||
30712672|NCT00494091|58726261|FG001|Overall Study|Other|11|||
30712673|NCT00494091|58726260|FG000|Overall Study|Withdrawal by Subject|0|||
30712674|NCT00494091|58726261|FG001|Overall Study|Withdrawal by Subject|7|||
30712675|NCT00494013|58726270|FG000|Overall Study|Adverse Event|0|||
30712676|NCT00494013|58726271|FG001|Overall Study|Adverse Event|1|||
30712677|NCT00494013|58726270|FG000|Overall Study|Entry Criteria Not Met|1|||
30712678|NCT00494013|58726271|FG001|Overall Study|Entry Criteria Not Met|4|||
30712679|NCT00494013|58726270|FG000|Overall Study|Lost to Follow-up|5|||
30712680|NCT00494013|58726271|FG001|Overall Study|Lost to Follow-up|6|||
30712681|NCT00494013|58726270|FG000|Overall Study|Physician Decision|3|||
30712682|NCT00494013|58726271|FG001|Overall Study|Physician Decision|5|||
30712683|NCT00494013|58726270|FG000|Overall Study|Protocol Violation|8|||
30712684|NCT00494013|58726271|FG001|Overall Study|Protocol Violation|5|||
30712685|NCT00494013|58726270|FG000|Overall Study|Withdrawal by Subject|13|||
30712686|NCT00494013|58726271|FG001|Overall Study|Withdrawal by Subject|14|||
30712687|NCT00494013|58726270|FG000|Overall Study|Sponsor Decision|0|||
30712688|NCT00494013|58726271|FG001|Overall Study|Sponsor Decision|1|||
30712689|NCT00079339|58726280|FG000|Overall Study|Adverse Event|1|||
30712690|NCT00079339|58726281|FG001|Overall Study|Adverse Event|7|||
30712691|NCT00079339|58726282|FG002|Overall Study|Adverse Event|2|||
30712692|NCT00079339|58726280|FG000|Overall Study|Death|1|||
30712693|NCT00079339|58726281|FG001|Overall Study|Death|0|||
30712694|NCT00079339|58726282|FG002|Overall Study|Death|0|||
30712695|NCT00079339|58726280|FG000|Overall Study|Non-compliance|0|||
30712696|NCT00079339|58726281|FG001|Overall Study|Non-compliance|0|||
30712697|NCT00079339|58726282|FG002|Overall Study|Non-compliance|1|||
30712698|NCT00079339|58726280|FG000|Overall Study|Withdrawal by Subject|0|||
30712699|NCT00079339|58726281|FG001|Overall Study|Withdrawal by Subject|4|||
30712700|NCT00079339|58726282|FG002|Overall Study|Withdrawal by Subject|1|||
30712701|NCT00079339|58726280|FG000|Overall Study|Disease progression|3|||
30712702|NCT00079339|58726281|FG001|Overall Study|Disease progression|28|||
30712703|NCT00079339|58726282|FG002|Overall Study|Disease progression|2|||
30712704|NCT00493779|58726295|FG000|Overall Study|Logistical issue at site|1|||
30712705|NCT00541866|58726305|FG000|Overall Study|Adverse Event|3|||
30712706|NCT00541866|58726306|FG001|Overall Study|Adverse Event|0|||
30712707|NCT00541866|58726307|FG002|Overall Study|Adverse Event|0|||
30712708|NCT00541866|58726308|FG003|Overall Study|Adverse Event|0|||
30712709|NCT00541866|58726309|FG004|Overall Study|Adverse Event|0|||
30712710|NCT00541866|58726305|FG000|Overall Study|Death|1|||
30712711|NCT00541866|58726306|FG001|Overall Study|Death|0|||
30712712|NCT00541866|58726307|FG002|Overall Study|Death|0|||
30712713|NCT00541866|58726308|FG003|Overall Study|Death|0|||
30712714|NCT00541866|58726309|FG004|Overall Study|Death|0|||
30712715|NCT00541866|58726305|FG000|Overall Study|Lack of Efficacy|19|||
30712716|NCT00541866|58726306|FG001|Overall Study|Lack of Efficacy|15|||
30712717|NCT00541866|58726307|FG002|Overall Study|Lack of Efficacy|10|||
30712718|NCT00541866|58726308|FG003|Overall Study|Lack of Efficacy|12|||
30712719|NCT00541866|58726309|FG004|Overall Study|Lack of Efficacy|14|||
30712720|NCT00541866|58726305|FG000|Overall Study|Not Reported or Other|11|||
30712721|NCT00541866|58726306|FG001|Overall Study|Not Reported or Other|3|||
30712722|NCT00541866|58726307|FG002|Overall Study|Not Reported or Other|3|||
30712723|NCT00541866|58726308|FG003|Overall Study|Not Reported or Other|3|||
30712724|NCT00541866|58726309|FG004|Overall Study|Not Reported or Other|1|||
30712725|NCT00541866|58726305|FG000|Overall Study|Physician Decision|0|||
30712726|NCT00541866|58726306|FG001|Overall Study|Physician Decision|0|||
30712727|NCT00541866|58726307|FG002|Overall Study|Physician Decision|2|||
30712728|NCT00541866|58726308|FG003|Overall Study|Physician Decision|1|||
30712729|NCT00541866|58726309|FG004|Overall Study|Physician Decision|0|||
30712730|NCT00493467|58726337|FG000|Overall Study|Death|1|||
30712731|NCT00090493|58726341|FG000|Overall Study|Physician Decision|2|||
30712732|NCT04329702|58726348|FG000|Overall Study|illness|3|||
30712733|NCT04329702|58726349|FG001|Overall Study|illness|4|||
30712734|NCT04329702|58726350|FG002|Overall Study|illness|0|||
30712735|NCT04329702|58726348|FG000|Overall Study|Lost to Follow-up|0|||
30712736|NCT04329702|58726349|FG001|Overall Study|Lost to Follow-up|0|||
30712737|NCT04329702|58726350|FG002|Overall Study|Lost to Follow-up|2|||
30712738|NCT04329702|58726348|FG000|Overall Study|Death|0|||
30712739|NCT04329702|58726349|FG001|Overall Study|Death|2|||
30712740|NCT04329702|58726350|FG002|Overall Study|Death|0|||
30712741|NCT00481065|58726371|FG000|Overall Study|Adverse event or death|1|||
30712742|NCT00481065|58726372|FG001|Overall Study|Adverse event or death|1|||
30712743|NCT00481065|58726373|FG002|Overall Study|Adverse event or death|3|||
30712744|NCT00481065|58726374|FG003|Overall Study|Adverse event or death|0|||
30712745|NCT00481065|58726375|FG004|Overall Study|Adverse event or death|2|||
30899952|NCT02357810|58933241|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
30712746|NCT00481065|58726376|FG005|Overall Study|Adverse event or death|0|||
30712747|NCT00481065|58726377|FG006|Overall Study|Adverse event or death|1|||
30712748|NCT00481065|58726378|FG007|Overall Study|Adverse event or death|1|||
30712749|NCT00481065|58726371|FG000|Overall Study|Withdrawal by Subject|11|||
30712750|NCT00481065|58726372|FG001|Overall Study|Withdrawal by Subject|12|||
30712751|NCT00481065|58726373|FG002|Overall Study|Withdrawal by Subject|7|||
30712752|NCT00481065|58726374|FG003|Overall Study|Withdrawal by Subject|11|||
30712753|NCT00481065|58726375|FG004|Overall Study|Withdrawal by Subject|13|||
30712754|NCT00481065|58726376|FG005|Overall Study|Withdrawal by Subject|12|||
30712755|NCT00481065|58726377|FG006|Overall Study|Withdrawal by Subject|9|||
30712756|NCT00481065|58726378|FG007|Overall Study|Withdrawal by Subject|10|||
30712757|NCT00481065|58726371|FG000|Overall Study|Lost to Follow-up|4|||
30712758|NCT00481065|58726372|FG001|Overall Study|Lost to Follow-up|2|||
30712759|NCT00481065|58726373|FG002|Overall Study|Lost to Follow-up|4|||
30712760|NCT00481065|58726374|FG003|Overall Study|Lost to Follow-up|3|||
30712761|NCT00481065|58726375|FG004|Overall Study|Lost to Follow-up|3|||
30712762|NCT00481065|58726376|FG005|Overall Study|Lost to Follow-up|3|||
30712763|NCT00481065|58726377|FG006|Overall Study|Lost to Follow-up|2|||
30712764|NCT00481065|58726378|FG007|Overall Study|Lost to Follow-up|5|||
30712765|NCT00481065|58726371|FG000|Overall Study|Inappropriate enrollment|4|||
30712766|NCT00481065|58726372|FG001|Overall Study|Inappropriate enrollment|0|||
30712767|NCT00481065|58726373|FG002|Overall Study|Inappropriate enrollment|2|||
30712768|NCT00481065|58726374|FG003|Overall Study|Inappropriate enrollment|0|||
30712769|NCT00481065|58726375|FG004|Overall Study|Inappropriate enrollment|2|||
30712770|NCT00481065|58726376|FG005|Overall Study|Inappropriate enrollment|1|||
30712771|NCT00481065|58726377|FG006|Overall Study|Inappropriate enrollment|0|||
30712772|NCT00481065|58726378|FG007|Overall Study|Inappropriate enrollment|1|||
30712773|NCT00481065|58726371|FG000|Overall Study|Administrative reason|0|||
30712774|NCT00481065|58726372|FG001|Overall Study|Administrative reason|0|||
30712775|NCT00481065|58726373|FG002|Overall Study|Administrative reason|0|||
30712776|NCT00481065|58726374|FG003|Overall Study|Administrative reason|0|||
30712777|NCT00481065|58726375|FG004|Overall Study|Administrative reason|0|||
30712778|NCT00481065|58726376|FG005|Overall Study|Administrative reason|2|||
30712779|NCT00481065|58726377|FG006|Overall Study|Administrative reason|1|||
30712780|NCT00481065|58726378|FG007|Overall Study|Administrative reason|0|||
30712781|NCT00481065|58726371|FG000|Overall Study|Protocol Violation|2|||
30712782|NCT00481065|58726372|FG001|Overall Study|Protocol Violation|1|||
30712783|NCT00481065|58726373|FG002|Overall Study|Protocol Violation|1|||
30712784|NCT00481065|58726374|FG003|Overall Study|Protocol Violation|1|||
30712785|NCT00481065|58726375|FG004|Overall Study|Protocol Violation|2|||
30712786|NCT00481065|58726376|FG005|Overall Study|Protocol Violation|6|||
30712787|NCT00481065|58726377|FG006|Overall Study|Protocol Violation|3|||
30712788|NCT00481065|58726378|FG007|Overall Study|Protocol Violation|2|||
30712789|NCT00481065|58726371|FG000|Overall Study|Unable to classify|0|||
30712790|NCT00481065|58726372|FG001|Overall Study|Unable to classify|1|||
30712791|NCT00481065|58726373|FG002|Overall Study|Unable to classify|2|||
30712792|NCT00481065|58726374|FG003|Overall Study|Unable to classify|0|||
30712793|NCT00481065|58726375|FG004|Overall Study|Unable to classify|1|||
30712794|NCT00481065|58726376|FG005|Overall Study|Unable to classify|0|||
30712795|NCT00481065|58726377|FG006|Overall Study|Unable to classify|0|||
30712796|NCT00481065|58726378|FG007|Overall Study|Unable to classify|0|||
30712797|NCT00493311|58726400|FG000|Overall Study|Need for rescue medication|2|||
30712798|NCT00493311|58726401|FG001|Overall Study|Need for rescue medication|2|||
30712799|NCT00571649|58726409|FG000|Treatment Period|Adverse Event|438|||
30712800|NCT00571649|58726410|FG001|Treatment Period|Adverse Event|385|||
30712801|NCT00571649|58726409|FG000|Treatment Period|Clinical endpoint reached|50|||
30712802|NCT00571649|58726410|FG001|Treatment Period|Clinical endpoint reached|56|||
30712803|NCT00571649|58726409|FG000|Treatment Period|Withdrawal by Subject|285|||
30712804|NCT00571649|58726410|FG001|Treatment Period|Withdrawal by Subject|255|||
30712805|NCT00571649|58726409|FG000|Treatment Period|Death|76|||
30712806|NCT00571649|58726410|FG001|Treatment Period|Death|59|||
30712807|NCT00571649|58726409|FG000|Treatment Period|Physician Decision|8|||
30712808|NCT00571649|58726410|FG001|Treatment Period|Physician Decision|9|||
30712809|NCT00571649|58726409|FG000|Treatment Period|Lost to Follow-up|43|||
30712810|NCT00571649|58726410|FG001|Treatment Period|Lost to Follow-up|41|||
30712811|NCT00571649|58726409|FG000|Treatment Period|Non-compliant with study medication|88|||
30712812|NCT00571649|58726410|FG001|Treatment Period|Non-compliant with study medication|89|||
30712813|NCT00571649|58726409|FG000|Treatment Period|Patient convenience|11|||
30712814|NCT00571649|58726410|FG001|Treatment Period|Patient convenience|13|||
30712815|NCT00571649|58726409|FG000|Treatment Period|Protocol Violation|90|||
30712816|NCT00571649|58726410|FG001|Treatment Period|Protocol Violation|92|||
30712817|NCT00571649|58726409|FG000|Treatment Period|Technical problems|3|||
30712818|NCT00571649|58726410|FG001|Treatment Period|Technical problems|5|||
30712819|NCT00571649|58726409|FG000|Follow-up Period|Adverse Event|46|||
30712820|NCT00571649|58726410|FG001|Follow-up Period|Adverse Event|40|||
30899953|NCT02357810|58933241|FG000|Reached 12 Weeks Response|Adverse Event|5|||
30712821|NCT00571649|58726409|FG000|Follow-up Period|Clinical endpoint reached|5|||
30712822|NCT00571649|58726410|FG001|Follow-up Period|Clinical endpoint reached|2|||
30712823|NCT00571649|58726409|FG000|Follow-up Period|Withdrawal by Subject|119|||
30712824|NCT00571649|58726410|FG001|Follow-up Period|Withdrawal by Subject|115|||
30899954|NCT02357810|58933241|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
30712825|NCT00571649|58726409|FG000|Follow-up Period|Death|132|||
30712826|NCT00571649|58726410|FG001|Follow-up Period|Death|133|||
30712827|NCT00571649|58726409|FG000|Follow-up Period|Physician Decision|7|||
30712828|NCT00571649|58726410|FG001|Follow-up Period|Physician Decision|13|||
30712829|NCT00571649|58726409|FG000|Follow-up Period|Lost to Follow-up|95|||
30712830|NCT00571649|58726410|FG001|Follow-up Period|Lost to Follow-up|92|||
30712831|NCT00571649|58726409|FG000|Follow-up Period|Patient convenience|136|||
30712832|NCT00571649|58726410|FG001|Follow-up Period|Patient convenience|121|||
30712833|NCT00571649|58726409|FG000|Follow-up Period|Protocol Violation|5|||
30712834|NCT00571649|58726410|FG001|Follow-up Period|Protocol Violation|12|||
30712835|NCT00546572|58726418|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
30712836|NCT00546572|58726419|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
30712837|NCT00546572|58726418|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
30712838|NCT00546572|58726419|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
30712839|NCT00546572|58726418|FG000|Vax 1 / Year 0|Protocol Violation|3|||
30712840|NCT00546572|58726419|FG001|Vax 1 / Year 0|Protocol Violation|4|||
30712841|NCT00546572|58726418|FG000|Vax 1 / Year 0|Death|2|||
30712842|NCT00546572|58726419|FG001|Vax 1 / Year 0|Death|2|||
30712843|NCT00546572|58726418|FG000|Vax 1 / Year 0|Adverse Event|0|||
30712844|NCT00546572|58726419|FG001|Vax 1 / Year 0|Adverse Event|1|||
30712845|NCT00546572|58726418|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
30712846|NCT00546572|58726419|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
30712847|NCT00546572|58726418|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
30712848|NCT00546572|58726419|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
30712849|NCT00546572|58726418|FG000|Vax 2 / Year 1|Other|1|||
30712850|NCT00546572|58726419|FG001|Vax 2 / Year 1|Other|1|||
30712851|NCT00546572|58726418|FG000|Vax 2 / Year 1|Adverse Event|1|||
30712852|NCT00546572|58726419|FG001|Vax 2 / Year 1|Adverse Event|0|||
30712853|NCT00546572|58726418|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
30712854|NCT00546572|58726419|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
30712855|NCT03917472|58726438|FG000|Overall Study|Physician Decision|4|||
30712856|NCT03917472|58726439|FG001|Overall Study|Physician Decision|0|||
30712857|NCT03917472|58726438|FG000|Overall Study|Adverse Event|3|||
30712858|NCT03917472|58726439|FG001|Overall Study|Adverse Event|1|||
30712859|NCT03917472|58726438|FG000|Overall Study|Death|7|||
30712860|NCT03917472|58726439|FG001|Overall Study|Death|5|||
30712861|NCT03917472|58726438|FG000|Overall Study|Withdrawal by Subject|11|||
30712862|NCT03917472|58726439|FG001|Overall Study|Withdrawal by Subject|4|||
30712863|NCT03917472|58726438|FG000|Overall Study|Lost to Follow-up|10|||
30712864|NCT03917472|58726439|FG001|Overall Study|Lost to Follow-up|5|||
30712865|NCT00681863|58726446|FG000|Overall Study|Adverse Event|1|||
30712866|NCT00681863|58726446|FG000|Overall Study|Lost to Follow-up|2|||
30712867|NCT00681863|58726446|FG000|Overall Study|Lack of Efficacy|2|||
30712868|NCT00681863|58726446|FG000|Overall Study|Other|18|||
30712869|NCT00681629|58726452|FG000|Overall Study|Study termination|4|||
30712870|NCT00681629|58726453|FG001|Overall Study|Study termination|2|||
30712871|NCT00681629|58726452|FG000|Overall Study|Adverse Event|1|||
30712872|NCT00681629|58726453|FG001|Overall Study|Adverse Event|0|||
30712873|NCT00679367|58726459|FG000|Overall Study|Adverse Event|7|||
30712874|NCT00679367|58726459|FG000|Overall Study|inability to swallow oral drugs|1|||
30712875|NCT00679367|58726459|FG000|Overall Study|Lack of Efficacy|3|||
30712876|NCT00679367|58726459|FG000|Overall Study|Withdrawal by Subject|1|||
30712877|NCT03937778|58726464|FG000|Overall Study|Withdrawal by Subject|1|||
30712878|NCT03937778|58726464|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
30712879|NCT03935126|58726468|FG000|Overall Study|Study termination by sponsor|3|||
30712880|NCT00545714|58726472|FG000|Induction Phase (6 Months)|Physician Decision|3|||
30712881|NCT00545714|58726472|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
30712882|NCT00545714|58726472|FG000|Induction Phase (6 Months)|Disease Progression|1|||
30712883|NCT00545714|58726472|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
30712884|NCT00545714|58726472|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
30712885|NCT00545714|58726472|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
30712886|NCT00545714|58726472|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
30712887|NCT00545714|58726472|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
30712888|NCT00545714|58726472|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
30712889|NCT00545714|58726472|FG000|Maintenance Phase (36 Months)|Death|2|||
30712890|NCT00539838|58726479|FG000|Overall Study|Fail to return|2|||
30712891|NCT00539838|58726480|FG001|Overall Study|Fail to return|0|||
30712892|NCT00539838|58726481|FG002|Overall Study|Fail to return|0|||
30712893|NCT00539838|58726479|FG000|Overall Study|Withdrawal by Subject|0|||
30712894|NCT00539838|58726480|FG001|Overall Study|Withdrawal by Subject|4|||
30712895|NCT00539838|58726481|FG002|Overall Study|Withdrawal by Subject|0|||
30712896|NCT00539838|58726479|FG000|Overall Study|Death|0|||
30712897|NCT00539838|58726480|FG001|Overall Study|Death|2|||
30712898|NCT00539838|58726481|FG002|Overall Study|Death|0|||
30712899|NCT00539838|58726479|FG000|Overall Study|Did not cooperate|1|||
30712900|NCT00539838|58726480|FG001|Overall Study|Did not cooperate|0|||
30712901|NCT00539838|58726481|FG002|Overall Study|Did not cooperate|1|||
30712902|NCT00539838|58726479|FG000|Overall Study|Administrative|4|||
30712903|NCT00539838|58726480|FG001|Overall Study|Administrative|0|||
30712904|NCT00539838|58726481|FG002|Overall Study|Administrative|8|||
30712905|NCT00679289|58726494|FG000|Overall Study|Progressive disease|4|||
30712906|NCT00679289|58726495|FG001|Overall Study|Progressive disease|5|||
30712907|NCT00679289|58726496|FG002|Overall Study|Progressive disease|18|||
30712908|NCT00679289|58726494|FG000|Overall Study|Withdrawal by Subject|0|||
30712909|NCT00679289|58726495|FG001|Overall Study|Withdrawal by Subject|1|||
30712910|NCT00679289|58726496|FG002|Overall Study|Withdrawal by Subject|1|||
30712911|NCT00679289|58726494|FG000|Overall Study|Adverse Event|0|||
30712912|NCT00679289|58726495|FG001|Overall Study|Adverse Event|0|||
30712913|NCT00679289|58726496|FG002|Overall Study|Adverse Event|3|||
30712914|NCT00679289|58726494|FG000|Overall Study|Physician Decision|1|||
30712915|NCT00679289|58726495|FG001|Overall Study|Physician Decision|0|||
30712916|NCT00679289|58726496|FG002|Overall Study|Physician Decision|1|||
30712917|NCT00679211|58726506|FG000|Overall Study|Progressive disease|82|||
30712918|NCT00679211|58726506|FG000|Overall Study|Adverse Event|7|||
30712919|NCT00679211|58726506|FG000|Overall Study|Withdrawal by Subject|2|||
30712920|NCT00679211|58726506|FG000|Overall Study|Physician Decision|5|||
30712921|NCT00679211|58726506|FG000|Overall Study|Refused to undergo protocol procedures|1|||
30712922|NCT00679211|58726506|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
30712923|NCT00679211|58726506|FG000|Overall Study|Other|1|||
30712924|NCT00545948|58726515|FG000|Overall Study|Not Treated|1|||
30712925|NCT00545948|58726516|FG001|Overall Study|Not Treated|1|||
30712926|NCT00545948|58726517|FG002|Overall Study|Not Treated|7|||
30712927|NCT00679055|58726528|FG000|Overall Study|Adverse Event|0|||
30712928|NCT00679055|58726529|FG001|Overall Study|Adverse Event|1|||
30712929|NCT00679055|58726528|FG000|Overall Study|Other|0|||
30712930|NCT00679055|58726529|FG001|Overall Study|Other|3|||
30712931|NCT00679055|58726528|FG000|Overall Study|Study Terminated|2|||
30712932|NCT00679055|58726529|FG001|Overall Study|Study Terminated|1|||
30712933|NCT03927950|58726535|FG000|Overall Study|Adverse Event|9|||
30712934|NCT00678899|58726540|FG000|Overall Study|Adverse Event|1|||
30712935|NCT00678587|58726547|FG000|Overall Study|Adverse Event|3|||
30712936|NCT00678587|58726548|FG001|Overall Study|Adverse Event|3|||
30712937|NCT00678587|58726547|FG000|Overall Study|Lack of Efficacy|1|||
30712938|NCT00678587|58726548|FG001|Overall Study|Lack of Efficacy|0|||
30712939|NCT00678587|58726547|FG000|Overall Study|Protocol Violation|2|||
30712940|NCT00678587|58726548|FG001|Overall Study|Protocol Violation|1|||
30712941|NCT00678587|58726547|FG000|Overall Study|Study Closed/Terminated|1|||
30712942|NCT00678587|58726548|FG001|Overall Study|Study Closed/Terminated|0|||
30712943|NCT00678587|58726547|FG000|Overall Study|Lost to Follow-up|3|||
30712944|NCT00678587|58726548|FG001|Overall Study|Lost to Follow-up|5|||
30712945|NCT00678587|58726547|FG000|Overall Study|Investigator Discretion|2|||
30712946|NCT00678587|58726548|FG001|Overall Study|Investigator Discretion|6|||
30712947|NCT00678587|58726547|FG000|Overall Study|Withdrew Consent|8|||
30712948|NCT00678587|58726548|FG001|Overall Study|Withdrew Consent|3|||
30712949|NCT03523728|58726560|FG000|Stage 1 (24 Months)|Adverse Event|2|||
30712950|NCT03523728|58726561|FG001|Stage 1 (24 Months)|Adverse Event|2|||
30712951|NCT03523728|58726562|FG002|Stage 1 (24 Months)|Adverse Event|4|||
30712952|NCT03523728|58726563|FG003|Stage 1 (24 Months)|Adverse Event|0|||
30712953|NCT03523728|58726564|FG004|Stage 1 (24 Months)|Adverse Event|0|||
30712954|NCT03523728|58726560|FG000|Stage 1 (24 Months)|Progressive disease|0|||
30712955|NCT03523728|58726561|FG001|Stage 1 (24 Months)|Progressive disease|0|||
30712956|NCT03523728|58726562|FG002|Stage 1 (24 Months)|Progressive disease|1|||
30712957|NCT03523728|58726563|FG003|Stage 1 (24 Months)|Progressive disease|0|||
30712958|NCT03523728|58726564|FG004|Stage 1 (24 Months)|Progressive disease|0|||
30712959|NCT03523728|58726560|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
30899955|NCT02357810|58933241|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
30712960|NCT03523728|58726561|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
30712961|NCT03523728|58726562|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
30712962|NCT03523728|58726563|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
30712963|NCT03523728|58726564|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
30712964|NCT03523728|58726560|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
30712965|NCT03523728|58726561|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
30712966|NCT03523728|58726562|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
30712967|NCT03523728|58726563|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
30712968|NCT03523728|58726564|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
30712969|NCT03523728|58726560|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
30712970|NCT03523728|58726561|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
30712971|NCT03523728|58726562|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
30712972|NCT03523728|58726563|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
30712973|NCT03523728|58726564|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
30712974|NCT03523728|58726560|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
30712975|NCT03523728|58726561|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
30712976|NCT03523728|58726562|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
30712977|NCT03523728|58726563|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
30712978|NCT03523728|58726564|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
30712979|NCT03523728|58726560|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
30712980|NCT03523728|58726561|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
30712981|NCT03523728|58726562|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
30712982|NCT03523728|58726563|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
30712983|NCT03523728|58726564|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
30712984|NCT03523728|58726560|FG000|Stage 2 (24 Months)|Adverse Event|0|||
30712985|NCT03523728|58726561|FG001|Stage 2 (24 Months)|Adverse Event|0|||
30712986|NCT03523728|58726562|FG002|Stage 2 (24 Months)|Adverse Event|0|||
30712987|NCT03523728|58726563|FG003|Stage 2 (24 Months)|Adverse Event|1|||
30712988|NCT03523728|58726564|FG004|Stage 2 (24 Months)|Adverse Event|2|||
30712989|NCT03523728|58726560|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
30712990|NCT03523728|58726561|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
30712991|NCT03523728|58726562|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
30712992|NCT03523728|58726563|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
30712993|NCT03523728|58726564|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
30712994|NCT03523728|58726560|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
30712995|NCT03523728|58726561|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
30712996|NCT03523728|58726562|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
30712997|NCT03523728|58726563|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
30712998|NCT03523728|58726564|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
30712999|NCT03523728|58726560|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
30713000|NCT03523728|58726561|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
30713001|NCT03523728|58726562|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
30713002|NCT03523728|58726563|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
30713003|NCT03523728|58726564|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
30713004|NCT03523728|58726560|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
30713005|NCT03523728|58726561|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
30713006|NCT03523728|58726562|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
30713007|NCT03523728|58726563|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
30713008|NCT03523728|58726564|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
30713009|NCT00538590|58726583|FG000|Overall Study|Death|1|||
30713010|NCT00538590|58726584|FG001|Overall Study|Death|0|||
30713011|NCT00466947|58726592|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
30713012|NCT00466947|58726593|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
30713013|NCT00466947|58726592|FG000|Study End Analysis Period|Adverse Event|35|||
30713014|NCT00466947|58726593|FG001|Study End Analysis Period|Adverse Event|43|||
30713015|NCT00466947|58726592|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
30621478|NCT01194245|58633068|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30621479|NCT01194245|58633069|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30713016|NCT00466947|58726593|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
30713017|NCT00466947|58726592|FG000|Study End Analysis Period|Physician Decision|29|||
30713018|NCT00466947|58726593|FG001|Study End Analysis Period|Physician Decision|29|||
30713019|NCT00466947|58726592|FG000|Study End Analysis Period|Protocol Violation|9|||
30713020|NCT00466947|58726593|FG001|Study End Analysis Period|Protocol Violation|17|||
30713021|NCT00466947|58726592|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
30713022|NCT00466947|58726593|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
30713023|NCT00466947|58726592|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
30713024|NCT00466947|58726593|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
30713025|NCT00466947|58726592|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
30713026|NCT00466947|58726593|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
30713027|NCT00466947|58726592|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
30713028|NCT00466947|58726593|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
30713029|NCT00537810|58726604|FG000|Overall Study|Withdrawal by Subject|4|||
30713030|NCT00537810|58726605|FG001|Overall Study|Withdrawal by Subject|11|||
30713031|NCT00537810|58726606|FG002|Overall Study|Withdrawal by Subject|4|||
30713032|NCT00537810|58726607|FG003|Overall Study|Withdrawal by Subject|3|||
30713033|NCT00537810|58726604|FG000|Overall Study|Medically withdrawn|2|||
30713034|NCT00537810|58726605|FG001|Overall Study|Medically withdrawn|2|||
30713035|NCT00537810|58726606|FG002|Overall Study|Medically withdrawn|0|||
30713036|NCT00537810|58726607|FG003|Overall Study|Medically withdrawn|1|||
30713037|NCT01287936|58726620|FG000|Overall Study|Lost to Follow-up|0|||
30713038|NCT01287936|58726621|FG001|Overall Study|Lost to Follow-up|1|||
30713039|NCT01287936|58726622|FG002|Overall Study|Lost to Follow-up|1|||
30713040|NCT00090259|58726632|FG000|Overall Study|Lost to Follow-up|30|||
30713041|NCT00090259|58726633|FG001|Overall Study|Lost to Follow-up|26|||
30713042|NCT00090259|58726632|FG000|Overall Study|Withdrawal by Subject|21|||
30713043|NCT00090259|58726633|FG001|Overall Study|Withdrawal by Subject|15|||
30713044|NCT00090259|58726632|FG000|Overall Study|Investigator site closed|11|||
30713045|NCT00090259|58726633|FG001|Overall Study|Investigator site closed|7|||
30713046|NCT00079183|58726639|FG000|Overall Study|Withdrawal by Subject|4|||
30713047|NCT00079183|58726639|FG000|Overall Study|Study medication non-compliance|2|||
30713048|NCT00079183|58726639|FG000|Overall Study|Specimen collection non-compliance|1|||
30713049|NCT00676403|58726650|FG000|Overall Study|Adverse Event|1|||
30713050|NCT00676403|58726651|FG001|Overall Study|Adverse Event|2|||
30713051|NCT00676403|58726652|FG002|Overall Study|Adverse Event|0|||
30713052|NCT00676403|58726653|FG003|Overall Study|Adverse Event|5|||
30713053|NCT00676403|58726654|FG004|Overall Study|Adverse Event|1|||
30713054|NCT00676403|58726655|FG005|Overall Study|Adverse Event|2|||
30713055|NCT00676403|58726650|FG000|Overall Study|Lost to Follow-up|0|||
30713056|NCT00676403|58726651|FG001|Overall Study|Lost to Follow-up|0|||
30621480|NCT01194245|58633070|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
30621481|NCT01194245|58633071|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
30621482|NCT01194245|58633072|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
30621483|NCT00979407|58633083|FG000|Overall Study|Withdrawal by Subject|3|||
30713057|NCT00676403|58726652|FG002|Overall Study|Lost to Follow-up|0|||
30713058|NCT00676403|58726653|FG003|Overall Study|Lost to Follow-up|0|||
30621484|NCT00979407|58633084|FG001|Overall Study|Withdrawal by Subject|4|||
30621485|NCT00979407|58633083|FG000|Overall Study|Lost to Follow-up|3|||
30621486|NCT00979407|58633084|FG001|Overall Study|Lost to Follow-up|3|||
30621487|NCT01148862|58633092|FG000|Second Intervention|Withdrawal by Subject|0|||
30621488|NCT01148862|58633093|FG001|Second Intervention|Withdrawal by Subject|2|||
30713059|NCT00676403|58726654|FG004|Overall Study|Lost to Follow-up|0|||
30713060|NCT00676403|58726655|FG005|Overall Study|Lost to Follow-up|1|||
30713061|NCT00676403|58726650|FG000|Overall Study|Reason Unspecified|1|||
30713062|NCT00676403|58726651|FG001|Overall Study|Reason Unspecified|0|||
30713063|NCT00676403|58726652|FG002|Overall Study|Reason Unspecified|1|||
30713064|NCT00676403|58726653|FG003|Overall Study|Reason Unspecified|0|||
30713065|NCT00676403|58726654|FG004|Overall Study|Reason Unspecified|0|||
30713066|NCT00676403|58726655|FG005|Overall Study|Reason Unspecified|1|||
30713067|NCT00676403|58726650|FG000|Overall Study|Withdrawal by Subject|0|||
30713068|NCT00676403|58726651|FG001|Overall Study|Withdrawal by Subject|0|||
30713069|NCT00676403|58726652|FG002|Overall Study|Withdrawal by Subject|0|||
30713070|NCT00676403|58726653|FG003|Overall Study|Withdrawal by Subject|0|||
30713071|NCT00676403|58726654|FG004|Overall Study|Withdrawal by Subject|0|||
30713072|NCT00676403|58726655|FG005|Overall Study|Withdrawal by Subject|1|||
30713073|NCT00078325|58726678|FG000|Overall Study|Adverse Event|15|||
30713074|NCT00078325|58726679|FG001|Overall Study|Adverse Event|10|||
30713075|NCT00078325|58726680|FG002|Overall Study|Adverse Event|5|||
30713076|NCT00078325|58726678|FG000|Overall Study|Protocol Violation|2|||
30713077|NCT00078325|58726679|FG001|Overall Study|Protocol Violation|2|||
30713078|NCT00078325|58726680|FG002|Overall Study|Protocol Violation|0|||
30621489|NCT00975975|58633099|FG000|Overall Study|Death|6|||
30621490|NCT01193153|58633103|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
30713079|NCT00078325|58726678|FG000|Overall Study|Withdrawal by Subject|1|||
30713080|NCT00078325|58726679|FG001|Overall Study|Withdrawal by Subject|5|||
30713081|NCT00078325|58726680|FG002|Overall Study|Withdrawal by Subject|3|||
30713082|NCT00078325|58726678|FG000|Overall Study|Lost to Follow-up|0|||
30713083|NCT00078325|58726679|FG001|Overall Study|Lost to Follow-up|1|||
30713084|NCT00078325|58726680|FG002|Overall Study|Lost to Follow-up|1|||
30713085|NCT00078325|58726678|FG000|Overall Study|Physician Decision|2|||
30713086|NCT00078325|58726679|FG001|Overall Study|Physician Decision|0|||
30713087|NCT00078325|58726680|FG002|Overall Study|Physician Decision|1|||
30713088|NCT00078325|58726678|FG000|Overall Study|Miscellaneous|1|||
30713089|NCT00078325|58726679|FG001|Overall Study|Miscellaneous|1|||
30713090|NCT00078325|58726680|FG002|Overall Study|Miscellaneous|1|||
30713091|NCT00077857|58726690|FG000|Overall Study|Adverse Event|30|||
30713092|NCT00077857|58726691|FG001|Overall Study|Adverse Event|32|||
30713093|NCT00077857|58726690|FG000|Overall Study|Death|7|||
30713094|NCT00077857|58726691|FG001|Overall Study|Death|3|||
30713095|NCT00077857|58726690|FG000|Overall Study|Insufficient therapeutic response|112|||
30713096|NCT00077857|58726691|FG001|Overall Study|Insufficient therapeutic response|128|||
30713097|NCT00077857|58726690|FG000|Overall Study|Violation of selection criteria at entry|3|||
30713098|NCT00077857|58726691|FG001|Overall Study|Violation of selection criteria at entry|1|||
30713099|NCT00077857|58726690|FG000|Overall Study|Other protocol violation|0|||
30713100|NCT00077857|58726691|FG001|Overall Study|Other protocol violation|1|||
30713101|NCT00077857|58726690|FG000|Overall Study|Refused treatment|29|||
30713102|NCT00077857|58726691|FG001|Overall Study|Refused treatment|21|||
30713103|NCT00077857|58726690|FG000|Overall Study|Failure to return|5|||
30713104|NCT00077857|58726691|FG001|Overall Study|Failure to return|5|||
30713105|NCT00077857|58726690|FG000|Overall Study|Other|15|||
30713106|NCT00077857|58726691|FG001|Overall Study|Other|13|||
30713107|NCT00545402|58726699|FG000|Overall Study|Discontinuation of treatment|17|||
30713108|NCT00545402|58726700|FG001|Overall Study|Discontinuation of treatment|9|||
30713109|NCT00545402|58726699|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
30713110|NCT00545402|58726700|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
30713111|NCT00545402|58726699|FG000|Overall Study|Death|5|||
30713112|NCT00545402|58726700|FG001|Overall Study|Death|7|||
30713113|NCT00545402|58726699|FG000|Overall Study|Graft loss|2|||
30713114|NCT00545402|58726700|FG001|Overall Study|Graft loss|4|||
30713115|NCT00545402|58726699|FG000|Overall Study|Withdrawal by Subject|0|||
30713116|NCT00545402|58726700|FG001|Overall Study|Withdrawal by Subject|1|||
30713117|NCT00545402|58726699|FG000|Overall Study|Protocol Violation|1|||
30713118|NCT00545402|58726700|FG001|Overall Study|Protocol Violation|0|||
30713119|NCT00545402|58726699|FG000|Overall Study|Reason not specified|1|||
30713120|NCT00545402|58726700|FG001|Overall Study|Reason not specified|1|||
30713121|NCT00545792|58726706|FG000|Overall Study|Withdrawal by Subject|1|||
30621491|NCT01193153|58633104|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
30621492|NCT01193153|58633103|FG000|Open-label Lead in Period|Pregnancy|1|||
30621493|NCT01193153|58633104|FG001|Open-label Lead in Period|Pregnancy|0|||
30713122|NCT00545168|58726713|FG000|Overall Study|Lost to Follow-up|5|||
30713123|NCT00545168|58726714|FG001|Overall Study|Lost to Follow-up|5|||
30713124|NCT00545168|58726715|FG002|Overall Study|Lost to Follow-up|5|||
30713125|NCT00545168|58726713|FG000|Overall Study|Withdrawal by Subject|9|||
30713126|NCT00545168|58726714|FG001|Overall Study|Withdrawal by Subject|0|||
30713127|NCT00545168|58726715|FG002|Overall Study|Withdrawal by Subject|13|||
30713128|NCT00545168|58726713|FG000|Overall Study|Protocol Violation|1|||
30713129|NCT00545168|58726714|FG001|Overall Study|Protocol Violation|0|||
30713130|NCT00545168|58726715|FG002|Overall Study|Protocol Violation|1|||
30713131|NCT00545168|58726713|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
30713132|NCT00545168|58726714|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
30713133|NCT00545168|58726715|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
30713134|NCT00544544|58726724|FG000|Overall Study|Withdrawal by Subject|1|||
30713135|NCT00544544|58726724|FG000|Overall Study|Adverse Event|1|||
30713136|NCT00544544|58726724|FG000|Overall Study|Lost to Follow-up|1|||
30713137|NCT00541346|58726728|FG000|Follow-up|Adverse Event|1|||
30713138|NCT00077623|58726735|FG000|Overall Study|Adverse Event|1|||
30713139|NCT00077623|58726736|FG001|Overall Study|Adverse Event|0|||
30713140|NCT00077623|58726737|FG002|Overall Study|Adverse Event|1|||
30713141|NCT00077623|58726735|FG000|Overall Study|Withdrawal by Subject|2|||
30713142|NCT00077623|58726736|FG001|Overall Study|Withdrawal by Subject|10|||
30713143|NCT00077623|58726737|FG002|Overall Study|Withdrawal by Subject|1|||
30713144|NCT00077623|58726735|FG000|Overall Study|Other-Non safety reason|18|||
30713145|NCT00077623|58726736|FG001|Overall Study|Other-Non safety reason|15|||
30713146|NCT00077623|58726737|FG002|Overall Study|Other-Non safety reason|19|||
30713147|NCT00077623|58726735|FG000|Overall Study|Insufficient therapeutic response|2|||
30713148|NCT00077623|58726736|FG001|Overall Study|Insufficient therapeutic response|0|||
30713149|NCT00077623|58726737|FG002|Overall Study|Insufficient therapeutic response|0|||
30713150|NCT00077623|58726735|FG000|Overall Study|Death|12|||
30713151|NCT00077623|58726736|FG001|Overall Study|Death|18|||
30713152|NCT00077623|58726737|FG002|Overall Study|Death|11|||
30713153|NCT00077623|58726735|FG000|Overall Study|Failure to return|1|||
30713154|NCT00077623|58726736|FG001|Overall Study|Failure to return|0|||
30713155|NCT00077623|58726737|FG002|Overall Study|Failure to return|0|||
30713156|NCT00541034|58726745|FG000|Overall Study|Non-Compliance|3|||
30713157|NCT00540644|58726751|FG000|Overall Study|Adverse Event|3|||
30713158|NCT00540644|58726752|FG001|Overall Study|Adverse Event|1|||
30713159|NCT00540644|58726751|FG000|Overall Study|Disease Progression|3|||
30713160|NCT00540644|58726752|FG001|Overall Study|Disease Progression|1|||
30713161|NCT00540644|58726751|FG000|Overall Study|Physician Decision|0|||
30713162|NCT00540644|58726752|FG001|Overall Study|Physician Decision|5|||
30713163|NCT00540644|58726751|FG000|Overall Study|Withdrawal by Subject|2|||
30713164|NCT00540644|58726752|FG001|Overall Study|Withdrawal by Subject|2|||
30713165|NCT00540644|58726751|FG000|Overall Study|Noncomplilance|1|||
30713166|NCT00540644|58726752|FG001|Overall Study|Noncomplilance|0|||
30713167|NCT00543296|58726758|FG000|Overall Study|Physician Decision|7|||
30713168|NCT00543140|58726762|FG000|Overall Study|Lost to Follow-up|33|||
30713169|NCT00543140|58726762|FG000|Overall Study|Withdrawal by Subject|13|||
30713170|NCT00543140|58726762|FG000|Overall Study|Protocol Violation|10|||
30713171|NCT00543140|58726762|FG000|Overall Study|Insufficient weight loss|10|||
30713172|NCT00543140|58726762|FG000|Overall Study|SAE leading to explant of SAGB|3|||
30713173|NCT00543140|58726762|FG000|Overall Study|Death|1|||
30713174|NCT00543140|58726762|FG000|Overall Study|Subject moved|1|||
30713175|NCT00543140|58726762|FG000|Overall Study|Conversion to different procedure|1|||
30713176|NCT00543062|58726766|FG000|Overall Study|Withdrawal by Subject|1|||
30713177|NCT00543062|58726767|FG001|Overall Study|Withdrawal by Subject|0|||
30713178|NCT00543062|58726768|FG002|Overall Study|Withdrawal by Subject|2|||
30713179|NCT00543062|58726769|FG003|Overall Study|Withdrawal by Subject|0|||
30713180|NCT00543062|58726766|FG000|Overall Study|Adverse Event|0|||
30713181|NCT00543062|58726767|FG001|Overall Study|Adverse Event|1|||
30713182|NCT00543062|58726768|FG002|Overall Study|Adverse Event|1|||
30713183|NCT00543062|58726769|FG003|Overall Study|Adverse Event|1|||
30713184|NCT00543062|58726766|FG000|Overall Study|Protocol Violation|1|||
30713185|NCT00543062|58726767|FG001|Overall Study|Protocol Violation|0|||
30713186|NCT00543062|58726768|FG002|Overall Study|Protocol Violation|0|||
30713187|NCT00543062|58726769|FG003|Overall Study|Protocol Violation|0|||
30713188|NCT03911960|58726789|FG000|Overall Study|Lost to Follow-up|5|||
30713189|NCT03911960|58726790|FG001|Overall Study|Lost to Follow-up|3|||
30713190|NCT00676091|58726799|FG000|Infant Series|Parent or legal guardian request|10|||
30713191|NCT00676091|58726800|FG001|Infant Series|Parent or legal guardian request|8|||
30713192|NCT00676091|58726799|FG000|Infant Series|Protocol Violation|6|||
30713193|NCT00676091|58726800|FG001|Infant Series|Protocol Violation|3|||
30713194|NCT00676091|58726799|FG000|Infant Series|Adverse Event|2|||
30713195|NCT00676091|58726800|FG001|Infant Series|Adverse Event|3|||
30713196|NCT00676091|58726799|FG000|Infant Series|Failed to return|1|||
30713197|NCT00676091|58726800|FG001|Infant Series|Failed to return|3|||
30713198|NCT00676091|58726799|FG000|Infant Series|Lost to Follow-up|1|||
30713199|NCT00676091|58726800|FG001|Infant Series|Lost to Follow-up|0|||
30713200|NCT00676091|58726799|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
30713201|NCT00676091|58726800|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
30713202|NCT00676091|58726799|FG000|After Infant Series|Adverse Event|0|||
30713203|NCT00676091|58726800|FG001|After Infant Series|Adverse Event|1|||
30713204|NCT00676091|58726799|FG000|After Infant Series|Protocol Violation|0|||
30713205|NCT00676091|58726800|FG001|After Infant Series|Protocol Violation|1|||
30713206|NCT00676091|58726799|FG000|After Infant Series|Failed to return|1|||
30713207|NCT00676091|58726800|FG001|After Infant Series|Failed to return|1|||
30713208|NCT00676091|58726799|FG000|Toddler Dose|Failed to return|2|||
30713209|NCT00676091|58726800|FG001|Toddler Dose|Failed to return|0|||
30713210|NCT00676091|58726799|FG000|Toddler Dose|Parent or legal guardian request|1|||
30713211|NCT00676091|58726800|FG001|Toddler Dose|Parent or legal guardian request|0|||
30713212|NCT00678041|58726812|FG000|Overall Study|Physician Decision|5|||
30713213|NCT00678041|58726813|FG001|Overall Study|Physician Decision|5|||
30713214|NCT03903822|58726828|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
30713215|NCT03903822|58726829|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
30713216|NCT03903822|58726830|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
30713217|NCT03903822|58726831|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
30899956|NCT02357810|58933241|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
30713218|NCT03903822|58726832|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
30713219|NCT03903822|58726833|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
30713220|NCT03903822|58726834|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
30713221|NCT03903822|58726835|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
30713222|NCT03903822|58726828|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
30713223|NCT03903822|58726829|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
30713224|NCT03903822|58726830|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
30713225|NCT03903822|58726831|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
30713226|NCT03903822|58726832|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
30713227|NCT03903822|58726833|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
30713228|NCT03903822|58726834|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
30713229|NCT03903822|58726835|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
30713230|NCT03903822|58726828|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
30713231|NCT03903822|58726829|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
30713232|NCT03903822|58726830|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
30713233|NCT03903822|58726831|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
30713234|NCT03903822|58726832|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
30713235|NCT03903822|58726833|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
30713236|NCT03903822|58726834|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
30713237|NCT03903822|58726835|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
30713238|NCT03903822|58726828|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
30713239|NCT03903822|58726829|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
30713240|NCT03903822|58726830|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
30713241|NCT03903822|58726831|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
30713242|NCT03903822|58726832|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
30713243|NCT03903822|58726833|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
30713244|NCT03903822|58726834|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
30713245|NCT03903822|58726835|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
30713246|NCT03903822|58726828|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
30713247|NCT03903822|58726829|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
30713248|NCT03903822|58726830|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
30713249|NCT03903822|58726831|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
30713250|NCT03903822|58726832|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
30713251|NCT03903822|58726833|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
30713252|NCT03903822|58726834|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
30713253|NCT03903822|58726835|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
30713254|NCT03903822|58726828|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
30713255|NCT03903822|58726829|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
30713256|NCT03903822|58726830|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
30713257|NCT03903822|58726831|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
30713258|NCT03903822|58726832|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
30713259|NCT03903822|58726833|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
30713260|NCT03903822|58726834|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
30713261|NCT03903822|58726835|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
30713262|NCT03903822|58726828|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
30713263|NCT03903822|58726829|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
30713264|NCT03903822|58726830|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
30713265|NCT03903822|58726831|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
30713266|NCT03903822|58726832|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
30713267|NCT03903822|58726833|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
30713268|NCT03903822|58726834|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
30713269|NCT03903822|58726835|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
30713270|NCT03903822|58726828|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
30713271|NCT03903822|58726829|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
30713272|NCT03903822|58726830|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
30713273|NCT03903822|58726831|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
30713274|NCT03903822|58726832|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
30713275|NCT03903822|58726833|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
30713276|NCT03903822|58726834|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
30713277|NCT03903822|58726835|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
30713278|NCT03903822|58726828|FG000|Treatment Phase (6 Weeks)|Other|2|||
30713279|NCT03903822|58726829|FG001|Treatment Phase (6 Weeks)|Other|1|||
30713280|NCT03903822|58726830|FG002|Treatment Phase (6 Weeks)|Other|0|||
30713281|NCT03903822|58726831|FG003|Treatment Phase (6 Weeks)|Other|0|||
30713282|NCT03903822|58726832|FG004|Treatment Phase (6 Weeks)|Other|1|||
30713283|NCT03903822|58726833|FG005|Treatment Phase (6 Weeks)|Other|1|||
30713284|NCT03903822|58726834|FG006|Treatment Phase (6 Weeks)|Other|0|||
30713285|NCT03903822|58726835|FG007|Treatment Phase (6 Weeks)|Other|0|||
30713286|NCT03903822|58726828|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
30713287|NCT03903822|58726829|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
30713288|NCT03903822|58726830|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
30713289|NCT03903822|58726831|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
30713290|NCT03903822|58726832|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
30713291|NCT03903822|58726833|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
30713292|NCT03903822|58726834|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
30713293|NCT03903822|58726835|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
30713294|NCT03903822|58726828|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
30713295|NCT03903822|58726829|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
30713296|NCT03903822|58726830|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
30713297|NCT03903822|58726831|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
30713298|NCT03903822|58726832|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
30713299|NCT03903822|58726833|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
30713300|NCT03903822|58726834|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
30713301|NCT03903822|58726835|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
30713302|NCT03903822|58726828|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
30713303|NCT03903822|58726829|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
30713304|NCT03903822|58726830|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
30713305|NCT03903822|58726831|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
30713306|NCT03903822|58726832|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
30713307|NCT03903822|58726833|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
30713308|NCT03903822|58726834|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
30713309|NCT03903822|58726835|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
30713310|NCT03903822|58726828|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
30713311|NCT03903822|58726829|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
30713312|NCT03903822|58726830|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
30713313|NCT03903822|58726831|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
30713314|NCT03903822|58726832|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
30713315|NCT03903822|58726833|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
30713316|NCT03903822|58726834|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
30713317|NCT03903822|58726835|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
30713318|NCT03903822|58726828|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
30713319|NCT03903822|58726829|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
30713320|NCT03903822|58726830|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
30713321|NCT03903822|58726831|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
30713322|NCT03903822|58726832|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
30713323|NCT03903822|58726833|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
30713324|NCT03903822|58726834|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
30713325|NCT03903822|58726835|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
30713326|NCT03903822|58726828|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
30713327|NCT03903822|58726829|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
30899957|NCT02357810|58933241|FG000|Reached 12 Weeks Response|Death|1|||
30899958|NCT02357810|58933241|FG000|Reached 12 Weeks Response|Physician Decision|1|||
30899959|NCT02357810|58933241|FG000|Reached 12 Weeks Response|Other|1|||
30899960|NCT02357810|58933241|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
30899961|NCT02357810|58933241|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
30899962|NCT02357810|58933241|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
30899963|NCT02357810|58933241|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
30713328|NCT03903822|58726830|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
30713329|NCT03903822|58726831|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
30713330|NCT03903822|58726832|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
30713331|NCT03903822|58726833|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
30713332|NCT03903822|58726834|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
30713333|NCT03903822|58726835|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
30713334|NCT03903822|58726828|FG000|Follow up Phase (4 Weeks)|Other|1|||
30713335|NCT03903822|58726829|FG001|Follow up Phase (4 Weeks)|Other|1|||
30713336|NCT03903822|58726830|FG002|Follow up Phase (4 Weeks)|Other|0|||
30713337|NCT03903822|58726831|FG003|Follow up Phase (4 Weeks)|Other|0|||
30713338|NCT03903822|58726832|FG004|Follow up Phase (4 Weeks)|Other|0|||
30713339|NCT03903822|58726833|FG005|Follow up Phase (4 Weeks)|Other|0|||
30713340|NCT03903822|58726834|FG006|Follow up Phase (4 Weeks)|Other|0|||
30713341|NCT03903822|58726835|FG007|Follow up Phase (4 Weeks)|Other|0|||
30713342|NCT00677807|58726856|FG000|Overall Study|Adverse Event|4|||
30713343|NCT00677807|58726857|FG001|Overall Study|Adverse Event|1|||
30713344|NCT00677807|58726858|FG002|Overall Study|Adverse Event|6|||
30713345|NCT00677807|58726856|FG000|Overall Study|Lack of Efficacy|0|||
30713346|NCT00677807|58726857|FG001|Overall Study|Lack of Efficacy|0|||
30713347|NCT00677807|58726858|FG002|Overall Study|Lack of Efficacy|2|||
30713348|NCT00677807|58726856|FG000|Overall Study|Participant no longer needs study drug|0|||
30713349|NCT00677807|58726857|FG001|Overall Study|Participant no longer needs study drug|0|||
30713350|NCT00677807|58726858|FG002|Overall Study|Participant no longer needs study drug|1|||
30713351|NCT00677807|58726856|FG000|Overall Study|Withdrawal by Subject|10|||
30713352|NCT00677807|58726857|FG001|Overall Study|Withdrawal by Subject|3|||
30713353|NCT00677807|58726858|FG002|Overall Study|Withdrawal by Subject|6|||
30713354|NCT00677807|58726856|FG000|Overall Study|Lost to Follow-up|2|||
30713355|NCT00677807|58726857|FG001|Overall Study|Lost to Follow-up|2|||
30713356|NCT00677807|58726858|FG002|Overall Study|Lost to Follow-up|2|||
30713357|NCT00677807|58726856|FG000|Overall Study|Administrative problems|1|||
30713358|NCT00677807|58726857|FG001|Overall Study|Administrative problems|1|||
30713359|NCT00677807|58726858|FG002|Overall Study|Administrative problems|2|||
30713360|NCT00677807|58726856|FG000|Overall Study|Death|0|||
30713361|NCT00677807|58726857|FG001|Overall Study|Death|1|||
30713362|NCT00677807|58726858|FG002|Overall Study|Death|1|||
30713363|NCT00677807|58726856|FG000|Overall Study|Protocol Deviation|1|||
30713364|NCT00677807|58726857|FG001|Overall Study|Protocol Deviation|3|||
30713365|NCT00677807|58726858|FG002|Overall Study|Protocol Deviation|0|||
30713366|NCT00687401|58726866|FG000|Overall Study|Protocol Violation|7|||
30713367|NCT00687401|58726866|FG000|Overall Study|Adverse Event|6|||
30713368|NCT00687401|58726866|FG000|Overall Study|Lack of Efficacy|6|||
30713369|NCT00687401|58726866|FG000|Overall Study|Withdrawal by Subject|4|||
30713370|NCT00687401|58726866|FG000|Overall Study|Did not return for visit|3|||
30713371|NCT00687401|58726866|FG000|Overall Study|For reasons different from those above|4|||
30713372|NCT00538902|58726886|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
30713373|NCT00538902|58726887|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
30713374|NCT00538902|58726888|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
30713375|NCT00538902|58726886|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
30713376|NCT00538902|58726887|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
30713377|NCT00538902|58726888|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
30713378|NCT00538902|58726886|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
30790909|NCT03200366|58804015|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
30790910|NCT03200366|58804016|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
30899964|NCT02357810|58933241|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
30899965|NCT02357810|58933241|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
30899966|NCT02357576|58933247|FG000|Treatment Period|Withdrawal by Subject|0|||
30899967|NCT02357576|58933248|FG001|Treatment Period|Withdrawal by Subject|1|||
30899968|NCT02357576|58933247|FG000|Treatment Period|Physician Decision|0|||
30713379|NCT00538902|58726887|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
30713380|NCT00538902|58726888|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
30899969|NCT02357576|58933248|FG001|Treatment Period|Physician Decision|1|||
30899970|NCT02357576|58933247|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
30713381|NCT00538902|58726886|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
30713382|NCT00538902|58726887|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
30713383|NCT00538902|58726888|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
30713384|NCT00538902|58726886|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
30713385|NCT00538902|58726887|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
30713386|NCT00538902|58726888|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
30713387|NCT00538902|58726886|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
30713388|NCT00538902|58726887|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
30713389|NCT00538902|58726888|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
30713390|NCT00538902|58726886|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
30713391|NCT00538902|58726887|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
30713392|NCT00538902|58726888|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
30713393|NCT00538902|58726886|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
30713394|NCT00538902|58726887|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
30713395|NCT00538902|58726888|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
30713396|NCT00541970|58726902|FG000|Month 7|Protocol Violation|9|||
30713397|NCT00541970|58726903|FG001|Month 7|Protocol Violation|13|||
30713398|NCT00541970|58726904|FG002|Month 7|Protocol Violation|11|||
30713399|NCT00541970|58726905|FG003|Month 7|Protocol Violation|5|||
30713400|NCT00541970|58726902|FG000|Month 12|Adverse Event|0|||
30713401|NCT00541970|58726903|FG001|Month 12|Adverse Event|1|||
30713402|NCT00541970|58726904|FG002|Month 12|Adverse Event|1|||
30713403|NCT00541970|58726905|FG003|Month 12|Adverse Event|1|||
30713404|NCT00541970|58726902|FG000|Month 12|Protocol Violation|12|||
30713405|NCT00541970|58726903|FG001|Month 12|Protocol Violation|21|||
30713406|NCT00541970|58726904|FG002|Month 12|Protocol Violation|20|||
30713407|NCT00541970|58726905|FG003|Month 12|Protocol Violation|15|||
30713408|NCT00541970|58726902|FG000|Month 18|Adverse Event|0|||
30713409|NCT00541970|58726903|FG001|Month 18|Adverse Event|1|||
30713410|NCT00541970|58726904|FG002|Month 18|Adverse Event|1|||
30713411|NCT00541970|58726905|FG003|Month 18|Adverse Event|1|||
30713412|NCT00541970|58726902|FG000|Month 18|Protocol Violation|14|||
30713413|NCT00541970|58726903|FG001|Month 18|Protocol Violation|23|||
30713414|NCT00541970|58726904|FG002|Month 18|Protocol Violation|24|||
30713415|NCT00541970|58726905|FG003|Month 18|Protocol Violation|16|||
30713416|NCT00541970|58726902|FG000|Month 24|Adverse Event|0|||
30713417|NCT00541970|58726903|FG001|Month 24|Adverse Event|1|||
30713418|NCT00541970|58726904|FG002|Month 24|Adverse Event|1|||
30713419|NCT00541970|58726905|FG003|Month 24|Adverse Event|1|||
30713420|NCT00541970|58726902|FG000|Month 24|Protocol Violation|29|||
30713421|NCT00541970|58726903|FG001|Month 24|Protocol Violation|31|||
30713422|NCT00541970|58726904|FG002|Month 24|Protocol Violation|31|||
30713423|NCT00541970|58726905|FG003|Month 24|Protocol Violation|21|||
30713424|NCT00541970|58726902|FG000|Month 36|Protocol Violation|61|||
30713425|NCT00541970|58726903|FG001|Month 36|Protocol Violation|66|||
30713426|NCT00541970|58726904|FG002|Month 36|Protocol Violation|66|||
30713427|NCT00541970|58726905|FG003|Month 36|Protocol Violation|60|||
30713428|NCT00541970|58726902|FG000|Month 48|Withdrawal by Subject|2|||
30713429|NCT00541970|58726903|FG001|Month 48|Withdrawal by Subject|4|||
30713430|NCT00541970|58726904|FG002|Month 48|Withdrawal by Subject|4|||
30713431|NCT00541970|58726905|FG003|Month 48|Withdrawal by Subject|2|||
30713432|NCT00541970|58726902|FG000|Month 48|Other|3|||
30713433|NCT00541970|58726903|FG001|Month 48|Other|1|||
30713434|NCT00541970|58726904|FG002|Month 48|Other|1|||
30713435|NCT00541970|58726905|FG003|Month 48|Other|0|||
30713436|NCT00541970|58726902|FG000|Month 48|Lost to Follow-up|66|||
30713437|NCT00541970|58726903|FG001|Month 48|Lost to Follow-up|68|||
30713438|NCT00541970|58726904|FG002|Month 48|Lost to Follow-up|68|||
30713439|NCT00541970|58726905|FG003|Month 48|Lost to Follow-up|73|||
30713440|NCT00541970|58726902|FG000|Month 60|Protocol Violation|78|||
30713441|NCT00541970|58726903|FG001|Month 60|Protocol Violation|77|||
30713442|NCT00541970|58726904|FG002|Month 60|Protocol Violation|82|||
30713443|NCT00541970|58726905|FG003|Month 60|Protocol Violation|72|||
30713444|NCT00687323|58726915|FG000|Overall Study|Death|25|||
30899971|NCT02357576|58933248|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
30713445|NCT00687323|58726915|FG000|Overall Study|Withdrawal by Subject|1|||
30713446|NCT00687323|58726915|FG000|Overall Study|Excluded from efficacy evaluations|6|||
30713447|NCT00687323|58726915|FG000|Overall Study|Screen failure|148|||
30713448|NCT03899064|58726932|FG000|Overall Study|Lost to Follow-up|1|||
30713449|NCT03899064|58726932|FG000|Overall Study|Protocol Violation|2|||
30713450|NCT03899064|58726932|FG000|Overall Study|Withdrawal by Subject|2|||
30713451|NCT03899064|58726932|FG000|Overall Study|Other|2|||
30713452|NCT03902574|58726939|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
30713453|NCT03902574|58726940|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
30713454|NCT03902574|58726941|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
30713455|NCT00542828|58726953|FG000|Overall Study|Physician Decision|1|||
30713456|NCT00542828|58726953|FG000|Overall Study|Need for Prohibited Treatment|3|||
30713457|NCT00542828|58726953|FG000|Overall Study|Study Prematurely Discontinued|7|||
30713458|NCT00542828|58726953|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
30713459|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
30713460|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
30713461|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
30713462|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
30713463|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
30713464|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
30713465|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
30713466|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
30713467|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
30713468|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
30713469|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
30713470|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
30713471|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
30713472|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
30713473|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
30713474|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
30713475|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
30713476|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
30713477|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
30713478|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
30713479|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
30713480|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
30713481|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
30713482|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
30713483|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
30713484|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
30713485|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
30713486|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
30713487|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
30713488|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
30713489|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
30713490|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
30713491|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
30713492|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
30713493|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
30713494|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
30713495|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
30713496|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
30713497|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
30713498|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
30713499|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
30713500|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
30713501|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
30621494|NCT01193153|58633103|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
30621495|NCT01193153|58633104|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
30621496|NCT01193153|58633103|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
30713502|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
30713503|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
30713504|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
30713505|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
30713506|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
30713507|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
30713508|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
30713509|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
30713510|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
30713511|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
30713512|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
30713513|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
30713514|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
30713515|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
30713516|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
30713517|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
30713518|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
30713519|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
30713520|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
30713521|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
30713522|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
30713523|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
30713524|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
30713525|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
30713526|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
30713527|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
30713528|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
30713529|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
30713530|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
30713531|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
30713532|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
30899972|NCT02357576|58933247|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
30899973|NCT02357576|58933248|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
30899974|NCT02357576|58933247|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
30899975|NCT02357576|58933248|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
30713533|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
30713534|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
30713535|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
30713536|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
30713537|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
30713538|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
30713539|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
30713540|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
30713541|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
30713542|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
30713543|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
30713544|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
30713545|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
30713546|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
30713547|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
30713548|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
30713549|NCT00090103|58726960|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
30713550|NCT00090103|58726961|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
30713551|NCT00090103|58726962|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
30713552|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
30713553|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
30713554|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
30713555|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
30713556|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
30713557|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
30713558|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
30713559|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
30713560|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
30713561|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
30713562|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
30713563|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
30713564|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
30713565|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
30713566|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
30713567|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
30713568|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
30713569|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
30713570|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
30713571|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
30713572|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
30713573|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
30713574|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
30713575|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
30713576|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
30713577|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
30713578|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
30713579|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
30713580|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
30713581|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
30713582|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
30713583|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
30713584|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
30713585|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
30713586|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
30713587|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
30713588|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
30713589|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
30713590|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
30713591|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
30713592|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
30713593|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
30713594|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
30713595|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
30713596|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
30713597|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
30713598|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
30713599|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
30713600|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Death|1|||
30713601|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Death|0|||
30713602|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Death|1|||
30713603|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
30713604|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
30713605|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
30713606|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
30713607|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
30713608|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
30713609|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
30713610|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
30713611|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
30713612|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
30713613|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
30713614|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
30713615|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
30713616|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
30713617|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
30713618|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
30713619|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
30713620|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
30713621|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
30713622|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
30713623|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
30713624|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Depression|0|||
30713625|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Depression|1|||
30713626|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Depression|0|||
30713627|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
30713628|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
30713629|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
30713630|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Jailed|0|||
30713631|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Jailed|1|||
30713632|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Jailed|0|||
30713633|NCT00090103|58726960|FG000|16-Week Safety Follow-up Period|Other|0|||
30713634|NCT00090103|58726961|FG001|16-Week Safety Follow-up Period|Other|1|||
30713635|NCT00090103|58726962|FG002|16-Week Safety Follow-up Period|Other|0|||
30713636|NCT00087607|58726972|FG000|Overall Study|Adverse Event|14|||
30713637|NCT00087607|58726973|FG001|Overall Study|Adverse Event|24|||
30713638|NCT00087607|58726972|FG000|Overall Study|Death|0|||
30713639|NCT00087607|58726973|FG001|Overall Study|Death|1|||
30713640|NCT00087607|58726972|FG000|Overall Study|Insufficient Therapeutic Response|53|||
30713641|NCT00087607|58726973|FG001|Overall Study|Insufficient Therapeutic Response|42|||
30713642|NCT00087607|58726972|FG000|Overall Study|Failure to return|21|||
30713643|NCT00087607|58726973|FG001|Overall Study|Failure to return|17|||
30713644|NCT00087607|58726972|FG000|Overall Study|Withdrew Consent|12|||
30713645|NCT00087607|58726973|FG001|Overall Study|Withdrew Consent|16|||
30713646|NCT00087607|58726972|FG000|Overall Study|Administrative|12|||
30713647|NCT00087607|58726973|FG001|Overall Study|Administrative|12|||
30713648|NCT00087607|58726972|FG000|Overall Study|Refused Treatment|5|||
30713649|NCT00087607|58726973|FG001|Overall Study|Refused Treatment|7|||
30713650|NCT00087607|58726972|FG000|Overall Study|Other Protocol Violation|5|||
30713651|NCT00087607|58726973|FG001|Overall Study|Other Protocol Violation|2|||
30713652|NCT00087607|58726972|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
30713653|NCT00087607|58726973|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
30713654|NCT00069823|58726985|FG000|Overall Study|Did not have follow-up diary cards|6|||
30713655|NCT00069823|58726986|FG001|Overall Study|Did not have follow-up diary cards|3|||
30713656|NCT00086515|58726998|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
30713657|NCT00086515|58726999|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
30713658|NCT00086515|58726998|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
30713659|NCT00086515|58726999|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
30713660|NCT00086515|58726998|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
30713661|NCT00086515|58726999|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
30713662|NCT00086515|58726998|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
30713663|NCT00086515|58726999|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
30713664|NCT00086515|58726998|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
30713665|NCT00086515|58726999|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
30713666|NCT00086515|58726998|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
30713667|NCT00086515|58726999|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
30713668|NCT00086515|58726998|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
30713669|NCT00086515|58726999|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
30713670|NCT00086515|58726998|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
30621497|NCT01193153|58633104|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
30713671|NCT00086515|58726999|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
30713672|NCT00086515|58726998|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
30713673|NCT00086515|58726999|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
30713674|NCT00086515|58726998|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
30713675|NCT00086515|58726999|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
30713676|NCT00086515|58726998|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
30713677|NCT00086515|58726999|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
30790911|NCT03200366|58804017|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
30713678|NCT00086515|58726998|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
30713679|NCT00086515|58726999|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
30713680|NCT00086515|58726998|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
30713681|NCT00086515|58726999|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
30713682|NCT00086515|58726998|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
30713683|NCT00086515|58726999|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
30713684|NCT00086515|58726998|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
30713685|NCT00086515|58726999|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
30713686|NCT00086515|58726998|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
30713687|NCT00086515|58726999|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
30713688|NCT00086515|58726998|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
30713689|NCT00086515|58726999|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
30713690|NCT00086515|58726998|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
30713691|NCT00086515|58726999|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
30713692|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
30713693|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
30713694|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
30713695|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
30713696|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
30713697|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
30713698|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
30713699|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
30713700|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
30713701|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
30713702|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
30713703|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
30713704|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
30713705|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
30713706|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
30713707|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
30713708|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
30713709|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
30713710|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
30713711|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
30713712|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
30713713|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
30713714|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
30713715|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
30713716|NCT00086515|58726998|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
30713717|NCT00086515|58726999|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
30713718|NCT00541658|58727008|FG000|Overall Study|Adverse Event|28|||
30713719|NCT00541658|58727009|FG001|Overall Study|Adverse Event|37|||
30713720|NCT00541658|58727010|FG002|Overall Study|Adverse Event|25|||
30713721|NCT00541658|58727008|FG000|Overall Study|Physician Decision|0|||
30713722|NCT00541658|58727009|FG001|Overall Study|Physician Decision|0|||
30713723|NCT00541658|58727010|FG002|Overall Study|Physician Decision|4|||
30713724|NCT00541658|58727008|FG000|Overall Study|Lost to Follow-up|3|||
30713725|NCT00541658|58727009|FG001|Overall Study|Lost to Follow-up|3|||
30713726|NCT00541658|58727010|FG002|Overall Study|Lost to Follow-up|6|||
30713727|NCT00541658|58727008|FG000|Overall Study|Protocol Violation|0|||
30713728|NCT00541658|58727009|FG001|Overall Study|Protocol Violation|1|||
30713729|NCT00541658|58727010|FG002|Overall Study|Protocol Violation|1|||
30899976|NCT02357576|58933247|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
30899977|NCT02357576|58933248|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
30621498|NCT01193153|58633103|FG000|Open-label Lead in Period|Other|14|||
30899978|NCT01850446|58933256|FG000|Overall Study|Lack of Efficacy|1|||
30713730|NCT00541658|58727008|FG000|Overall Study|Withdrawal by Subject|28|||
30713731|NCT00541658|58727009|FG001|Overall Study|Withdrawal by Subject|32|||
30713732|NCT00541658|58727010|FG002|Overall Study|Withdrawal by Subject|32|||
30713733|NCT00541658|58727008|FG000|Overall Study|Took No Study Drug|1|||
30713734|NCT00541658|58727009|FG001|Overall Study|Took No Study Drug|0|||
30713735|NCT00541658|58727010|FG002|Overall Study|Took No Study Drug|0|||
30713736|NCT03907280|58727034|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
30713737|NCT03907280|58727035|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
30713738|NCT03907280|58727036|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
30713739|NCT04120376|58727048|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
30713740|NCT04120376|58727049|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
30713741|NCT03905642|58727056|FG000|Overall Study|Withdrawal by Subject|3|||
30713742|NCT03905642|58727056|FG000|Overall Study|Pregnancy|1|||
30713743|NCT03905642|58727056|FG000|Overall Study|Adverse Event|1|||
30713744|NCT03905642|58727056|FG000|Overall Study|Lack of Efficacy|1|||
30713745|NCT03905642|58727056|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
30713746|NCT00412984|58727096|FG000|Overall Study|Death|331|||
30713747|NCT00412984|58727097|FG001|Overall Study|Death|349|||
30713748|NCT00412984|58727096|FG000|Overall Study|Adverse Event|679|||
30713749|NCT00412984|58727097|FG001|Overall Study|Adverse Event|738|||
30713750|NCT00412984|58727096|FG000|Overall Study|Withdrawal by Subject|921|||
30713751|NCT00412984|58727097|FG001|Overall Study|Withdrawal by Subject|989|||
30713752|NCT00412984|58727096|FG000|Overall Study|Lost to Follow-up|51|||
30713753|NCT00412984|58727097|FG001|Overall Study|Lost to Follow-up|39|||
30713754|NCT00412984|58727096|FG000|Overall Study|Poor/Noncompliance|57|||
30713755|NCT00412984|58727097|FG001|Overall Study|Poor/Noncompliance|77|||
30713756|NCT00412984|58727096|FG000|Overall Study|Pregnancy|1|||
30713757|NCT00412984|58727097|FG001|Overall Study|Pregnancy|0|||
30713758|NCT00412984|58727096|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
30713759|NCT00412984|58727097|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
30713760|NCT00412984|58727096|FG000|Overall Study|Administrative Reason by Sponsor|11|||
30713761|NCT00412984|58727097|FG001|Overall Study|Administrative Reason by Sponsor|8|||
30713762|NCT00412984|58727096|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
30713763|NCT00412984|58727097|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
30713764|NCT00412984|58727096|FG000|Overall Study|Other Reason|80|||
30713765|NCT00412984|58727097|FG001|Overall Study|Other Reason|92|||
30713766|NCT00412984|58727096|FG000|Overall Study|Not Reported|11|||
30713767|NCT00412984|58727097|FG001|Overall Study|Not Reported|12|||
30713768|NCT00539864|58727105|FG000|Overall Study|Lost to Follow-up|0|||
30713769|NCT00539864|58727106|FG001|Overall Study|Lost to Follow-up|1|||
30713770|NCT00539864|58727105|FG000|Overall Study|Withdrawal by Subject|1|||
30713771|NCT00539864|58727106|FG001|Overall Study|Withdrawal by Subject|1|||
30713772|NCT00673049|58727114|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
30713773|NCT00673049|58727115|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
30713774|NCT00673049|58727116|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
30713775|NCT00673049|58727117|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
30713776|NCT00673049|58727114|FG000|Before Progression on Erlotinib|Death|235|||
30713777|NCT00673049|58727115|FG001|Before Progression on Erlotinib|Death|167|||
30713778|NCT00673049|58727116|FG002|Before Progression on Erlotinib|Death|1|||
30713779|NCT00673049|58727117|FG003|Before Progression on Erlotinib|Death|0|||
30713780|NCT00673049|58727114|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
30713781|NCT00673049|58727115|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
30713782|NCT00673049|58727116|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
30713783|NCT00673049|58727117|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
30713784|NCT00673049|58727114|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
30713785|NCT00673049|58727115|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
30713786|NCT00673049|58727116|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
30713787|NCT00673049|58727117|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
30713788|NCT00673049|58727114|FG000|Before Progression on Erlotinib|Other|1|||
30713789|NCT00673049|58727115|FG001|Before Progression on Erlotinib|Other|2|||
30713790|NCT00673049|58727116|FG002|Before Progression on Erlotinib|Other|0|||
30713791|NCT00673049|58727117|FG003|Before Progression on Erlotinib|Other|0|||
30713792|NCT00673049|58727114|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
30713793|NCT00673049|58727115|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
30713794|NCT00673049|58727116|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
30713795|NCT00673049|58727117|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
30713796|NCT00673049|58727114|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
30713797|NCT00673049|58727115|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
30713798|NCT00673049|58727116|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
30713799|NCT00673049|58727117|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
30713800|NCT00673049|58727114|FG000|After Progression on Erlotinib|Death|0|||
30713801|NCT00673049|58727115|FG001|After Progression on Erlotinib|Death|0|||
30713802|NCT00673049|58727116|FG002|After Progression on Erlotinib|Death|0|||
30713803|NCT00673049|58727117|FG003|After Progression on Erlotinib|Death|71|||
30713804|NCT00673049|58727114|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
30713805|NCT00673049|58727115|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
30713806|NCT00673049|58727116|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
30713807|NCT00673049|58727117|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
30713808|NCT00673049|58727114|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
30713809|NCT00673049|58727115|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
30713810|NCT00673049|58727116|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
30713811|NCT00673049|58727117|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
30713812|NCT00673049|58727114|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
30713813|NCT00673049|58727115|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
30713814|NCT00673049|58727116|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
30713815|NCT00673049|58727117|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
30713816|NCT00412750|58727128|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30713817|NCT00412750|58727129|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30713818|NCT00412750|58727130|FG002|Overall Study|Abnormal laboratory value(s)|0|||
30713819|NCT00412750|58727128|FG000|Overall Study|Administrative problems|21|||
30713820|NCT00412750|58727129|FG001|Overall Study|Administrative problems|17|||
30713821|NCT00412750|58727130|FG002|Overall Study|Administrative problems|14|||
30713822|NCT00412750|58727128|FG000|Overall Study|Adverse Event|8|||
30713823|NCT00412750|58727129|FG001|Overall Study|Adverse Event|3|||
30713824|NCT00412750|58727130|FG002|Overall Study|Adverse Event|3|||
30713825|NCT00412750|58727128|FG000|Overall Study|Lost to Follow-up|1|||
30713826|NCT00412750|58727129|FG001|Overall Study|Lost to Follow-up|0|||
30713827|NCT00412750|58727130|FG002|Overall Study|Lost to Follow-up|1|||
30713828|NCT00412750|58727128|FG000|Overall Study|Withdrawal by Subject|0|||
30713829|NCT00412750|58727129|FG001|Overall Study|Withdrawal by Subject|1|||
30713830|NCT00412750|58727130|FG002|Overall Study|Withdrawal by Subject|2|||
30713831|NCT00412750|58727128|FG000|Overall Study|Lack of Efficacy|0|||
30713832|NCT00412750|58727129|FG001|Overall Study|Lack of Efficacy|0|||
30713833|NCT00412750|58727130|FG002|Overall Study|Lack of Efficacy|3|||
30713834|NCT00076999|58727144|FG000|Overall Study|Adverse Event|2|||
30713835|NCT00076999|58727145|FG001|Overall Study|Adverse Event|8|||
30713836|NCT00076999|58727146|FG002|Overall Study|Adverse Event|6|||
30713837|NCT00076999|58727147|FG003|Overall Study|Adverse Event|0|||
30713838|NCT00076999|58727148|FG004|Overall Study|Adverse Event|2|||
30713839|NCT00076999|58727144|FG000|Overall Study|Protocol Violation|0|||
30713840|NCT00076999|58727145|FG001|Overall Study|Protocol Violation|3|||
30713841|NCT00076999|58727146|FG002|Overall Study|Protocol Violation|4|||
30713842|NCT00076999|58727147|FG003|Overall Study|Protocol Violation|0|||
30713843|NCT00076999|58727148|FG004|Overall Study|Protocol Violation|9|||
30713844|NCT00076999|58727144|FG000|Overall Study|Lost to Follow-up|2|||
30713845|NCT00076999|58727145|FG001|Overall Study|Lost to Follow-up|1|||
30713846|NCT00076999|58727146|FG002|Overall Study|Lost to Follow-up|0|||
30899979|NCT01850446|58933257|FG001|Overall Study|Lack of Efficacy|0|||
30713847|NCT00076999|58727147|FG003|Overall Study|Lost to Follow-up|0|||
30713848|NCT00076999|58727148|FG004|Overall Study|Lost to Follow-up|0|||
30713849|NCT00076999|58727144|FG000|Overall Study|Withdrawal by Subject|0|||
30713850|NCT00076999|58727145|FG001|Overall Study|Withdrawal by Subject|4|||
30713851|NCT00076999|58727146|FG002|Overall Study|Withdrawal by Subject|3|||
30713852|NCT00076999|58727147|FG003|Overall Study|Withdrawal by Subject|0|||
30713853|NCT00076999|58727148|FG004|Overall Study|Withdrawal by Subject|1|||
30713854|NCT00076999|58727144|FG000|Overall Study|Other reason (not specified)|8|||
30713855|NCT00076999|58727145|FG001|Overall Study|Other reason (not specified)|8|||
30713856|NCT00076999|58727146|FG002|Overall Study|Other reason (not specified)|4|||
30713857|NCT00076999|58727147|FG003|Overall Study|Other reason (not specified)|1|||
30713858|NCT00076999|58727148|FG004|Overall Study|Other reason (not specified)|13|||
30713859|NCT03905096|58727163|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
30713860|NCT03905096|58727164|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
30713861|NCT00412360|58727179|FG000|Overall Study|Lost to Follow-up|0|||
30713862|NCT00412360|58727180|FG001|Overall Study|Lost to Follow-up|1|||
30713863|NCT00412360|58727179|FG000|Overall Study|Not Transplanted|1|||
30713864|NCT00412360|58727180|FG001|Overall Study|Not Transplanted|2|||
30713865|NCT00571103|58727186|FG000|Overall Study|Withdrawal by Subject|1|||
30713866|NCT00571103|58727186|FG000|Overall Study|Lost to Follow-up|1|||
30713867|NCT00084799|58727192|FG000|Overall Study|Disease Progression|1|||
30713868|NCT00084799|58727193|FG001|Overall Study|Disease Progression|0|||
30713869|NCT00069277|58727199|FG000|Overall Study|Adverse Event|3|||
30713870|NCT00069277|58727199|FG000|Overall Study|Withdrawal by Subject|1|||
30713871|NCT00069277|58727199|FG000|Overall Study|Progressive Disease|15|||
30713872|NCT00069277|58727199|FG000|Overall Study|Physician Decision|2|||
30899980|NCT01850446|58933256|FG000|Overall Study|Withdrawal by Subject|4|||
30899981|NCT01850446|58933257|FG001|Overall Study|Withdrawal by Subject|0|||
30621499|NCT01193153|58633104|FG001|Open-label Lead in Period|Other|0|||
30621500|NCT01193153|58633103|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
30621501|NCT01193153|58633104|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
30621502|NCT01193153|58633103|FG000|Open-label Lead in Period|Adverse Event|41|||
30621503|NCT01193153|58633104|FG001|Open-label Lead in Period|Adverse Event|0|||
30621504|NCT01193153|58633103|FG000|Open-label Lead in Period|Death|1|||
30621505|NCT01193153|58633104|FG001|Open-label Lead in Period|Death|0|||
30621506|NCT01193153|58633103|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
30621507|NCT01193153|58633104|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
30621508|NCT01193153|58633103|FG000|Open-label Stabilization Period|Adverse Event|9|||
30621509|NCT01193153|58633104|FG001|Open-label Stabilization Period|Adverse Event|0|||
30621510|NCT01193153|58633103|FG000|Open-label Stabilization Period|Death|2|||
30621511|NCT01193153|58633104|FG001|Open-label Stabilization Period|Death|0|||
30621512|NCT01193153|58633103|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
30621513|NCT01193153|58633104|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
30621514|NCT01193153|58633103|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
30621515|NCT01193153|58633104|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
30621516|NCT01193153|58633103|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
30621517|NCT01193153|58633104|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
30621518|NCT01193153|58633103|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
30621519|NCT01193153|58633104|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
30713873|NCT00418522|58727205|FG000|Overall Study|Adverse Event|7|||
30713874|NCT00418522|58727206|FG001|Overall Study|Adverse Event|1|||
30621520|NCT01193153|58633103|FG000|Open-label Stabilization Period|Other|8|||
30621521|NCT01193153|58633104|FG001|Open-label Stabilization Period|Other|0|||
30621522|NCT01193153|58633103|FG000|Double Blind Relapse Prevention Period|Other|2|||
30713875|NCT00418522|58727205|FG000|Overall Study|Lack of Efficacy|1|||
30713876|NCT00418522|58727206|FG001|Overall Study|Lack of Efficacy|3|||
30713877|NCT00418522|58727205|FG000|Overall Study|Lost to Follow-up|10|||
30713878|NCT00418522|58727206|FG001|Overall Study|Lost to Follow-up|4|||
30713879|NCT00418522|58727205|FG000|Overall Study|Withdrawal by Subject|31|||
30713880|NCT00418522|58727206|FG001|Overall Study|Withdrawal by Subject|7|||
30713881|NCT00418522|58727205|FG000|Overall Study|Other|27|||
30713882|NCT00418522|58727206|FG001|Overall Study|Other|23|||
30713883|NCT00418522|58727205|FG000|Overall Study|Randomized but did not receive treatment|7|||
30713884|NCT00418522|58727206|FG001|Overall Study|Randomized but did not receive treatment|4|||
30713885|NCT00403546|58727214|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
30713886|NCT00403546|58727215|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
30713887|NCT00403546|58727216|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
30713888|NCT00403546|58727214|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
30713889|NCT00403546|58727215|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
30713890|NCT00403546|58727216|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
30713891|NCT00403546|58727214|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
30713892|NCT00403546|58727215|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
30713893|NCT00403546|58727216|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
30713894|NCT00403546|58727214|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
30713895|NCT00403546|58727215|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
30713896|NCT00403546|58727216|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
30713897|NCT00403546|58727214|FG000|Screening Phase|Screening Failure|22|||
30713898|NCT00403546|58727215|FG001|Screening Phase|Screening Failure|0|||
30713899|NCT00403546|58727216|FG002|Screening Phase|Screening Failure|0|||
30713900|NCT00403546|58727214|FG000|Screening Phase|Adverse Event|1|||
30713901|NCT00403546|58727215|FG001|Screening Phase|Adverse Event|0|||
30713902|NCT00403546|58727216|FG002|Screening Phase|Adverse Event|0|||
30713903|NCT00403546|58727214|FG000|Screening Phase|Terminated Prior to Randomization|5|||
30713904|NCT00403546|58727215|FG001|Screening Phase|Terminated Prior to Randomization|0|||
30713905|NCT00403546|58727216|FG002|Screening Phase|Terminated Prior to Randomization|0|||
30713906|NCT00403546|58727214|FG000|Randomized Trial|Early Terminations|0|||
30713907|NCT00403546|58727215|FG001|Randomized Trial|Early Terminations|17|||
30713908|NCT00403546|58727216|FG002|Randomized Trial|Early Terminations|16|||
30713909|NCT00403390|58727227|FG000|Overall Study|Withdrawal by Subject|1|||
30713910|NCT00403390|58727228|FG001|Overall Study|Withdrawal by Subject|0|||
30713911|NCT00403390|58727227|FG000|Overall Study|samples lost|1|||
30713912|NCT00403390|58727228|FG001|Overall Study|samples lost|0|||
30713913|NCT00403390|58727227|FG000|Overall Study|non-compliant|1|||
30713914|NCT00403390|58727228|FG001|Overall Study|non-compliant|0|||
30713915|NCT00403234|58727238|FG000|Overall Study|Withdrawal by Subject|0|||
30713916|NCT00403234|58727239|FG001|Overall Study|Withdrawal by Subject|1|||
30713917|NCT00403234|58727240|FG002|Overall Study|Withdrawal by Subject|0|||
30713918|NCT00403234|58727241|FG003|Overall Study|Withdrawal by Subject|0|||
30713919|NCT00403234|58727238|FG000|Overall Study|Adverse Event|1|||
30713920|NCT00403234|58727239|FG001|Overall Study|Adverse Event|0|||
30713921|NCT00403234|58727240|FG002|Overall Study|Adverse Event|1|||
30713922|NCT00403234|58727241|FG003|Overall Study|Adverse Event|0|||
30713923|NCT00402688|58727254|FG000|Overall Study|Adverse Event|12|||
30713924|NCT00402688|58727255|FG001|Overall Study|Adverse Event|9|||
30713925|NCT00402688|58727256|FG002|Overall Study|Adverse Event|3|||
30713926|NCT00402688|58727254|FG000|Overall Study|Withdrawal by Subject|3|||
30713927|NCT00402688|58727255|FG001|Overall Study|Withdrawal by Subject|1|||
30713928|NCT00402688|58727256|FG002|Overall Study|Withdrawal by Subject|1|||
30713929|NCT00402688|58727254|FG000|Overall Study|Physician Decision|0|||
30713930|NCT00402688|58727255|FG001|Overall Study|Physician Decision|0|||
30713931|NCT00402688|58727256|FG002|Overall Study|Physician Decision|1|||
30713932|NCT00402688|58727254|FG000|Overall Study|Lack of Efficacy|4|||
30713933|NCT00402688|58727255|FG001|Overall Study|Lack of Efficacy|4|||
30713934|NCT00402688|58727256|FG002|Overall Study|Lack of Efficacy|5|||
30713935|NCT00402688|58727254|FG000|Overall Study|Protocol Violation|1|||
30713936|NCT00402688|58727255|FG001|Overall Study|Protocol Violation|1|||
30713937|NCT00402688|58727256|FG002|Overall Study|Protocol Violation|1|||
30713938|NCT00402688|58727254|FG000|Overall Study|Lost to Follow-up|1|||
30713939|NCT00402688|58727255|FG001|Overall Study|Lost to Follow-up|0|||
30713940|NCT00402688|58727256|FG002|Overall Study|Lost to Follow-up|2|||
30713941|NCT00402688|58727254|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
30713942|NCT00402688|58727255|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
30713943|NCT00402688|58727256|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
30713944|NCT00402688|58727254|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
30713945|NCT00402688|58727255|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
30713946|NCT00402688|58727256|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
30713947|NCT00402688|58727254|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
30713948|NCT00402688|58727255|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
30713949|NCT00402688|58727256|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
30713950|NCT00671879|58727267|FG000|Overall Study|Withdrawal by Subject|0|||
30713951|NCT00671879|58727268|FG001|Overall Study|Withdrawal by Subject|4|||
30713952|NCT00671879|58727269|FG002|Overall Study|Withdrawal by Subject|6|||
30713953|NCT00402298|58727280|FG000|Overall Study|Withdrawal by Subject|1|||
30713954|NCT00402298|58727281|FG001|Overall Study|Withdrawal by Subject|0|||
30713955|NCT00401830|58727289|FG000|Overall Study|Adverse Event|10|||
30713956|NCT00401830|58727290|FG001|Overall Study|Adverse Event|18|||
30713957|NCT00401830|58727289|FG000|Overall Study|Lack of Efficacy|11|||
30713958|NCT00401830|58727290|FG001|Overall Study|Lack of Efficacy|5|||
30713959|NCT00401830|58727289|FG000|Overall Study|Withdrawal by Subject|4|||
30713960|NCT00401830|58727290|FG001|Overall Study|Withdrawal by Subject|3|||
30713961|NCT00401830|58727289|FG000|Overall Study|Protocol Violation|3|||
30713962|NCT00401830|58727290|FG001|Overall Study|Protocol Violation|3|||
30713963|NCT00401830|58727289|FG000|Overall Study|Non-compliance with drug study|1|||
30713964|NCT00401830|58727290|FG001|Overall Study|Non-compliance with drug study|0|||
30713965|NCT00401830|58727289|FG000|Overall Study|Lost to Follow-up|1|||
30713966|NCT00401830|58727290|FG001|Overall Study|Lost to Follow-up|3|||
30713967|NCT00401830|58727289|FG000|Overall Study|Other: Personal / Family problems|1|||
30713968|NCT00401830|58727290|FG001|Overall Study|Other: Personal / Family problems|0|||
30713969|NCT00401752|58727298|FG000|Overall Study|Adverse Event|2|||
30713970|NCT00401752|58727299|FG001|Overall Study|Adverse Event|5|||
30713971|NCT00401752|58727298|FG000|Overall Study|Withdrawal by Subject|2|||
30713972|NCT00401752|58727299|FG001|Overall Study|Withdrawal by Subject|6|||
30713973|NCT00401752|58727298|FG000|Overall Study|Lost to Follow-up|1|||
30713974|NCT00401752|58727299|FG001|Overall Study|Lost to Follow-up|4|||
30713975|NCT00401752|58727298|FG000|Overall Study|Development of any exclusion criteria|4|||
30713976|NCT00401752|58727299|FG001|Overall Study|Development of any exclusion criteria|2|||
30713977|NCT00401752|58727298|FG000|Overall Study|Physician Decision|1|||
30713978|NCT00401752|58727299|FG001|Overall Study|Physician Decision|1|||
30713979|NCT00539240|58727308|FG000|Overall Study|Withdrawal by Subject|0|||
30713980|NCT00539240|58727309|FG001|Overall Study|Withdrawal by Subject|2|||
30713981|NCT00539240|58727310|FG002|Overall Study|Withdrawal by Subject|0|||
30713982|NCT00539240|58727308|FG000|Overall Study|Protocol Violation|1|||
30713983|NCT00539240|58727309|FG001|Overall Study|Protocol Violation|1|||
30713984|NCT00539240|58727310|FG002|Overall Study|Protocol Violation|4|||
30713985|NCT00539240|58727308|FG000|Overall Study|Lost to Follow-up|2|||
30713986|NCT00539240|58727309|FG001|Overall Study|Lost to Follow-up|3|||
30713987|NCT00539240|58727310|FG002|Overall Study|Lost to Follow-up|1|||
30713988|NCT00539240|58727308|FG000|Overall Study|Adverse Event|3|||
30713989|NCT00539240|58727309|FG001|Overall Study|Adverse Event|1|||
30713990|NCT00539240|58727310|FG002|Overall Study|Adverse Event|10|||
30621523|NCT01193153|58633104|FG001|Double Blind Relapse Prevention Period|Other|3|||
30621524|NCT01193153|58633103|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
30621525|NCT01193153|58633104|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
30621526|NCT01193153|58633103|FG000|Double Blind Relapse Prevention Period|Death|2|||
30713991|NCT00417976|58727318|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
30713992|NCT00417976|58727318|FG000|Overall Study|Treatment -related toxicity|2|||
30713993|NCT00673673|58727323|FG000|Overall Study|Progressive disease|27|||
30713994|NCT00673673|58727323|FG000|Overall Study|Adverse Event|4|||
30713995|NCT00673673|58727323|FG000|Overall Study|Withdrawal by Subject|3|||
30713996|NCT00673673|58727323|FG000|Overall Study|Investigators' discretion|2|||
30713997|NCT00069121|58727329|FG000|Overall Study|Death|286|||
30713998|NCT00069121|58727330|FG001|Overall Study|Death|242|||
30713999|NCT00069121|58727329|FG000|Overall Study|Withdrawal by Subject|18|||
30714000|NCT00069121|58727330|FG001|Overall Study|Withdrawal by Subject|20|||
30714001|NCT00069121|58727329|FG000|Overall Study|Lost to Follow-up|63|||
30714002|NCT00069121|58727330|FG001|Overall Study|Lost to Follow-up|63|||
30714003|NCT00399802|58727342|FG000|Overall Study|Adverse Event|0|||
30714004|NCT00399802|58727343|FG001|Overall Study|Adverse Event|2|||
30714005|NCT00399802|58727342|FG000|Overall Study|Participant discontinued by mistake|0|||
30714006|NCT00399802|58727343|FG001|Overall Study|Participant discontinued by mistake|1|||
30714007|NCT00399568|58727351|FG000|Overall Study|Adverse Event|1|||
30714008|NCT00399568|58727352|FG001|Overall Study|Adverse Event|2|||
30714009|NCT00399568|58727351|FG000|Overall Study|Withdrawal by Subject|7|||
30714010|NCT00399568|58727352|FG001|Overall Study|Withdrawal by Subject|3|||
30714011|NCT00399568|58727351|FG000|Overall Study|Protocol non-compliance|2|||
30714012|NCT00399568|58727352|FG001|Overall Study|Protocol non-compliance|2|||
30714013|NCT00399568|58727351|FG000|Overall Study|Lost to Follow-up|2|||
30714014|NCT00399568|58727352|FG001|Overall Study|Lost to Follow-up|2|||
30714015|NCT03900728|58727363|FG000|Overall Study|No text responses|0|||
30714016|NCT03900728|58727364|FG001|Overall Study|No text responses|0|||
30714017|NCT03900728|58727365|FG002|Overall Study|No text responses|4|||
30714018|NCT00068419|58727373|FG000|Overall Study|Adverse Event|3|||
30714019|NCT00068419|58727373|FG000|Overall Study|Lack of Efficacy|24|||
30714020|NCT00068419|58727373|FG000|Overall Study|Lost to Follow-up|1|||
30714021|NCT00068419|58727373|FG000|Overall Study|Physician Decision|7|||
30714022|NCT00068419|58727373|FG000|Overall Study|Withdrawal by Subject|14|||
30714023|NCT00068419|58727373|FG000|Overall Study|Ineligible|11|||
30714024|NCT00068107|58727377|FG000|Overall Study|end-stage renal disease|6|||
30714025|NCT00068107|58727377|FG000|Overall Study|Death|2|||
30714026|NCT00068107|58727377|FG000|Overall Study|Withdrawal by Subject|1|||
30714027|NCT00394654|58727386|FG000|Overall Study|Lost to Follow-up|1|||
30714028|NCT00394654|58727387|FG001|Overall Study|Lost to Follow-up|0|||
30714029|NCT00394654|58727386|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
30714030|NCT00394654|58727387|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
30714031|NCT03900416|58727395|FG000|Six Week Follow-up|Lost to Follow-up|1|||
30714032|NCT03900416|58727396|FG001|Six Week Follow-up|Lost to Follow-up|0|||
30714033|NCT03900416|58727395|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
30714034|NCT03900416|58727396|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
30714035|NCT03900416|58727395|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
30714036|NCT03900416|58727396|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
30714037|NCT03900416|58727395|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
30714038|NCT03900416|58727396|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
30714039|NCT03900416|58727395|FG000|Twelve Week Follow-up|Adverse Event|1|||
30714040|NCT03900416|58727396|FG001|Twelve Week Follow-up|Adverse Event|1|||
30714041|NCT03900416|58727395|FG000|Six Month Follow-up|Lost to Follow-up|4|||
30714042|NCT03900416|58727396|FG001|Six Month Follow-up|Lost to Follow-up|3|||
30714043|NCT03900416|58727395|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
30714044|NCT03900416|58727396|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
30714045|NCT00399490|58727402|FG000|Overall Study|Adverse Event|19|||
30714046|NCT00399490|58727402|FG000|Overall Study|Lack of Efficacy|31|||
30714047|NCT00399490|58727402|FG000|Overall Study|Lost to Follow-up|5|||
30714048|NCT00399490|58727402|FG000|Overall Study|Withdrawal by Subject|18|||
30714049|NCT00399490|58727402|FG000|Overall Study|Other|25|||
30714050|NCT00398866|58727411|FG000|Overall Study|Adverse Event|1|||
30714051|NCT00398866|58727412|FG001|Overall Study|Adverse Event|0|||
30714052|NCT00398866|58727413|FG002|Overall Study|Adverse Event|0|||
30714053|NCT00398866|58727411|FG000|Overall Study|Lack of Efficacy|0|||
30714054|NCT00398866|58727412|FG001|Overall Study|Lack of Efficacy|0|||
30714055|NCT00398866|58727413|FG002|Overall Study|Lack of Efficacy|1|||
30621527|NCT01193153|58633104|FG001|Double Blind Relapse Prevention Period|Death|0|||
30621528|NCT01193153|58633103|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
30714056|NCT00398866|58727411|FG000|Overall Study|Lost to Follow-up|7|||
30714057|NCT00398866|58727412|FG001|Overall Study|Lost to Follow-up|6|||
30714058|NCT00398866|58727413|FG002|Overall Study|Lost to Follow-up|4|||
30714059|NCT00398866|58727411|FG000|Overall Study|Withdrawal by Subject|5|||
30714060|NCT00398866|58727412|FG001|Overall Study|Withdrawal by Subject|1|||
30714061|NCT00398866|58727413|FG002|Overall Study|Withdrawal by Subject|2|||
30714062|NCT00398866|58727411|FG000|Overall Study|Unable to complete requirements of study|1|||
30714063|NCT00398866|58727412|FG001|Overall Study|Unable to complete requirements of study|1|||
30714064|NCT00398866|58727413|FG002|Overall Study|Unable to complete requirements of study|1|||
30714065|NCT00398632|58727422|FG000|Overall Study|Withdrawal by Subject|1|||
30714066|NCT00398632|58727422|FG000|Overall Study|Lack of Efficacy|1|||
30714067|NCT00673361|58727427|FG000|Overall Study|Screen Failure|2|||
30714068|NCT00393718|58727433|FG000|Overall Study|Adverse Event|20|||
30714069|NCT00393718|58727434|FG001|Overall Study|Adverse Event|8|||
30714070|NCT00393718|58727433|FG000|Overall Study|Protocol Violation|1|||
30714071|NCT00393718|58727434|FG001|Overall Study|Protocol Violation|2|||
30714072|NCT00393718|58727433|FG000|Overall Study|Lack of Efficacy|10|||
30714073|NCT00393718|58727434|FG001|Overall Study|Lack of Efficacy|9|||
30714074|NCT00393718|58727433|FG000|Overall Study|Hypoglycaemia|3|||
30714075|NCT00393718|58727434|FG001|Overall Study|Hypoglycaemia|2|||
30714076|NCT00393718|58727433|FG000|Overall Study|Subject decision|5|||
30714077|NCT00393718|58727434|FG001|Overall Study|Subject decision|0|||
30714078|NCT00393718|58727433|FG000|Overall Study|Withdrawal of consent|2|||
30714079|NCT00393718|58727434|FG001|Overall Study|Withdrawal of consent|1|||
30714080|NCT00393718|58727433|FG000|Overall Study|Missed measurement|1|||
30714081|NCT00393718|58727434|FG001|Overall Study|Missed measurement|0|||
30714082|NCT00393718|58727433|FG000|Overall Study|Move|1|||
30714083|NCT00393718|58727434|FG001|Overall Study|Move|0|||
30714084|NCT00669071|58727440|FG000|Overall Study|Lost to Follow-up|3|||
30714085|NCT00669071|58727440|FG000|Overall Study|Final visit 40 days out of window|1|||
30714086|NCT00398320|58727446|FG000|Overall Study|Death|1|||
30714087|NCT00398320|58727446|FG000|Overall Study|Adverse Event|4|||
30714088|NCT00398320|58727446|FG000|Overall Study|Physician Decision|1|||
30714089|NCT00670007|58727450|FG000|Overall Study|Drug abuse|1|||
30714090|NCT00670007|58727450|FG000|Overall Study|Lung transplant|1|||
30714091|NCT00670007|58727450|FG000|Overall Study|Travel/Vacation|1|||
30714092|NCT00670007|58727450|FG000|Overall Study|Adverse event, serious fatal|1|||
30714093|NCT00670007|58727450|FG000|Overall Study|Adverse Event|1|||
30714094|NCT00670007|58727450|FG000|Overall Study|Withdrawal by Subject|4|||
30714095|NCT00535496|58727457|FG000|Overall Study|Lost to Follow-up|0|||
30714096|NCT00535496|58727458|FG001|Overall Study|Lost to Follow-up|1|||
30714097|NCT00535496|58727459|FG002|Overall Study|Lost to Follow-up|0|||
30714098|NCT00535496|58727460|FG003|Overall Study|Lost to Follow-up|0|||
30714099|NCT00535496|58727457|FG000|Overall Study|Not treated with sugammadex|0|||
30714100|NCT00535496|58727458|FG001|Overall Study|Not treated with sugammadex|1|||
30714101|NCT00535496|58727459|FG002|Overall Study|Not treated with sugammadex|0|||
30714102|NCT00535496|58727460|FG003|Overall Study|Not treated with sugammadex|0|||
30714103|NCT00539006|58727471|FG000|Pre-treatment|Other|0|||
30714104|NCT00539006|58727472|FG001|Pre-treatment|Other|1|||
30714105|NCT00539006|58727473|FG002|Pre-treatment|Other|0|||
30714106|NCT00539006|58727474|FG003|Pre-treatment|Other|0|||
30714107|NCT00539006|58727471|FG000|Treatment Period 1|Lost to Follow-up|0|||
30714108|NCT00539006|58727472|FG001|Treatment Period 1|Lost to Follow-up|0|||
30714109|NCT00539006|58727473|FG002|Treatment Period 1|Lost to Follow-up|1|||
30714110|NCT00539006|58727474|FG003|Treatment Period 1|Lost to Follow-up|0|||
30714111|NCT00539006|58727471|FG000|Treatment Period 1|Protocol Violation|0|||
30714112|NCT00539006|58727472|FG001|Treatment Period 1|Protocol Violation|0|||
30714113|NCT00539006|58727473|FG002|Treatment Period 1|Protocol Violation|1|||
30714114|NCT00539006|58727474|FG003|Treatment Period 1|Protocol Violation|0|||
30714115|NCT00539006|58727471|FG000|Treatment Period 1|Lack of Efficacy|0|||
30714116|NCT00539006|58727472|FG001|Treatment Period 1|Lack of Efficacy|0|||
30714117|NCT00539006|58727473|FG002|Treatment Period 1|Lack of Efficacy|0|||
30714118|NCT00539006|58727474|FG003|Treatment Period 1|Lack of Efficacy|1|||
30714119|NCT00539006|58727471|FG000|Washout|Adverse Event|2|||
30714120|NCT00539006|58727472|FG001|Washout|Adverse Event|1|||
30714121|NCT00539006|58727473|FG002|Washout|Adverse Event|0|||
30714122|NCT00539006|58727474|FG003|Washout|Adverse Event|0|||
30714123|NCT00539006|58727471|FG000|Washout|Protocol Violation|1|||
30714124|NCT00539006|58727472|FG001|Washout|Protocol Violation|1|||
30714125|NCT00539006|58727473|FG002|Washout|Protocol Violation|0|||
30714126|NCT00539006|58727474|FG003|Washout|Protocol Violation|0|||
30714127|NCT00539006|58727471|FG000|Washout|Withdrawal by Subject|0|||
30714128|NCT00539006|58727472|FG001|Washout|Withdrawal by Subject|2|||
30714129|NCT00539006|58727473|FG002|Washout|Withdrawal by Subject|0|||
30714130|NCT00539006|58727474|FG003|Washout|Withdrawal by Subject|0|||
30714131|NCT00539006|58727471|FG000|Washout|Failed to meet continuation criteria|16|||
30714132|NCT00539006|58727472|FG001|Washout|Failed to meet continuation criteria|5|||
30714133|NCT00539006|58727473|FG002|Washout|Failed to meet continuation criteria|14|||
30714134|NCT00539006|58727474|FG003|Washout|Failed to meet continuation criteria|6|||
30714135|NCT00539006|58727471|FG000|Washout|Other|1|||
30714136|NCT00539006|58727472|FG001|Washout|Other|1|||
30714137|NCT00539006|58727473|FG002|Washout|Other|2|||
30714138|NCT00539006|58727474|FG003|Washout|Other|3|||
30714139|NCT00539006|58727471|FG000|Treatment Period 2|Protocol Violation|1|||
30714140|NCT00539006|58727472|FG001|Treatment Period 2|Protocol Violation|0|||
30899982|NCT01850446|58933256|FG000|Overall Study|Protocol Violation|0|||
30714141|NCT00539006|58727473|FG002|Treatment Period 2|Protocol Violation|0|||
30899983|NCT01850446|58933257|FG001|Overall Study|Protocol Violation|2|||
30899984|NCT02465567|58933267|FG000|Overall Study|Adverse Event|118|||
30714142|NCT00539006|58727474|FG003|Treatment Period 2|Protocol Violation|0|||
30714143|NCT00539006|58727471|FG000|Treatment Period 2|Other|0|||
30714144|NCT00539006|58727472|FG001|Treatment Period 2|Other|1|||
30714145|NCT00539006|58727473|FG002|Treatment Period 2|Other|0|||
30714146|NCT00539006|58727474|FG003|Treatment Period 2|Other|0|||
30714147|NCT00537056|58727490|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
30714148|NCT00535262|58727496|FG000|Overall Study|No funding|3|||
30714149|NCT00074581|58727502|FG000|Overall Study|Death|15|||
30714150|NCT00074581|58727503|FG001|Overall Study|Death|16|||
30714151|NCT00074581|58727502|FG000|Overall Study|Withdrawal by Subject|50|||
30714152|NCT00074581|58727503|FG001|Overall Study|Withdrawal by Subject|49|||
30714153|NCT00074581|58727502|FG000|Overall Study|Unable to adhere to visit schedule|13|||
30714154|NCT00074581|58727503|FG001|Overall Study|Unable to adhere to visit schedule|14|||
30714155|NCT00074581|58727502|FG000|Overall Study|Relocated|14|||
30714156|NCT00074581|58727503|FG001|Overall Study|Relocated|9|||
30899985|NCT02465567|58933268|FG001|Overall Study|Adverse Event|113|||
30714157|NCT00074581|58727502|FG000|Overall Study|Were withdrawn by investigator|5|||
30714158|NCT00074581|58727503|FG001|Overall Study|Were withdrawn by investigator|2|||
30714159|NCT00074581|58727502|FG000|Overall Study|Lost to Follow-up|16|||
30714160|NCT00074581|58727503|FG001|Overall Study|Lost to Follow-up|11|||
30714161|NCT00074581|58727502|FG000|Overall Study|Ended relationship w. index participant|117|||
30714162|NCT00074581|58727503|FG001|Overall Study|Ended relationship w. index participant|106|||
30714163|NCT00074581|58727502|FG000|Overall Study|Other|14|||
30714164|NCT00074581|58727503|FG001|Overall Study|Other|19|||
30714165|NCT03895034|58727509|FG000|Overall Study|Lost to Follow-up|2|||
30714166|NCT00536978|58727513|FG000|Overall Study|Not eligible for Adback Infusion|22|||
30714167|NCT03809611|58727519|FG000|Overall Study|Withdrawal by Subject|1|||
30714168|NCT03809611|58727520|FG001|Overall Study|Withdrawal by Subject|1|||
30714169|NCT03807739|58727531|FG000|Overall Study|Adverse Event|1|||
30714170|NCT03807739|58727532|FG001|Overall Study|Adverse Event|0|||
30714171|NCT03807739|58727533|FG002|Overall Study|Adverse Event|0|||
30714172|NCT03807739|58727534|FG003|Overall Study|Adverse Event|0|||
30714173|NCT03807739|58727531|FG000|Overall Study|Withdrawal by Subject|1|||
30714174|NCT03807739|58727532|FG001|Overall Study|Withdrawal by Subject|0|||
30714175|NCT03807739|58727533|FG002|Overall Study|Withdrawal by Subject|0|||
30714176|NCT03807739|58727534|FG003|Overall Study|Withdrawal by Subject|0|||
30714177|NCT00536744|58727546|FG000|Overall Study|Adverse Event|13|||
30714178|NCT00536744|58727547|FG001|Overall Study|Adverse Event|10|||
30714179|NCT00536744|58727546|FG000|Overall Study|Death|2|||
30714180|NCT00536744|58727547|FG001|Overall Study|Death|1|||
30714181|NCT00536744|58727546|FG000|Overall Study|Physician Decision|3|||
30714182|NCT00536744|58727547|FG001|Overall Study|Physician Decision|1|||
30714183|NCT00536744|58727546|FG000|Overall Study|Lost to Follow-up|3|||
30714184|NCT00536744|58727547|FG001|Overall Study|Lost to Follow-up|5|||
30714185|NCT00536744|58727546|FG000|Overall Study|Withdrawal by Subject|7|||
30714186|NCT00536744|58727547|FG001|Overall Study|Withdrawal by Subject|8|||
30714187|NCT00536744|58727546|FG000|Overall Study|PI tried alternative treatment|1|||
30714188|NCT00536744|58727547|FG001|Overall Study|PI tried alternative treatment|3|||
30714189|NCT00536510|58727564|FG000|Overall Study|Adverse Event|27|||
30714190|NCT00536510|58727565|FG001|Overall Study|Adverse Event|4|||
30714191|NCT00536510|58727564|FG000|Overall Study|Lost to Follow-up|11|||
30714192|NCT00536510|58727565|FG001|Overall Study|Lost to Follow-up|8|||
30714193|NCT00536510|58727564|FG000|Overall Study|Protocol Violation|4|||
30714194|NCT00536510|58727565|FG001|Overall Study|Protocol Violation|5|||
30714195|NCT00536510|58727564|FG000|Overall Study|Withdrawal by Subject|16|||
30714196|NCT00536510|58727565|FG001|Overall Study|Withdrawal by Subject|9|||
30714197|NCT00536510|58727564|FG000|Overall Study|Flushing with Product|20|||
30714198|NCT00536510|58727565|FG001|Overall Study|Flushing with Product|0|||
30714199|NCT00536510|58727564|FG000|Overall Study|Laboratory Adverse Event|2|||
30714200|NCT00536510|58727565|FG001|Overall Study|Laboratory Adverse Event|1|||
30714201|NCT00536510|58727564|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
30714202|NCT00536510|58727565|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
30714203|NCT00398086|58727574|FG000|Overall Study|Unacceptable Toxicity|2|||
30714204|NCT00398086|58727575|FG001|Overall Study|Unacceptable Toxicity|8|||
30714205|NCT00398086|58727576|FG002|Overall Study|Unacceptable Toxicity|2|||
30714206|NCT00398086|58727574|FG000|Overall Study|Adverse Event|1|||
30714207|NCT00398086|58727575|FG001|Overall Study|Adverse Event|4|||
30714208|NCT00398086|58727576|FG002|Overall Study|Adverse Event|0|||
30714209|NCT00398086|58727574|FG000|Overall Study|Physician Decision|1|||
30714210|NCT00398086|58727575|FG001|Overall Study|Physician Decision|4|||
30714211|NCT00398086|58727576|FG002|Overall Study|Physician Decision|0|||
30714212|NCT00398086|58727574|FG000|Overall Study|Withdrawal by Subject|5|||
30714213|NCT00398086|58727575|FG001|Overall Study|Withdrawal by Subject|7|||
30714214|NCT00398086|58727576|FG002|Overall Study|Withdrawal by Subject|0|||
30714215|NCT00536198|58727586|FG000|Overall Study|Lost to Follow-up|15|||
30714216|NCT00536198|58727587|FG001|Overall Study|Lost to Follow-up|14|||
30714217|NCT00536198|58727586|FG000|Overall Study|Withdrawal by Subject|16|||
30714218|NCT00536198|58727587|FG001|Overall Study|Withdrawal by Subject|12|||
30714219|NCT00536198|58727586|FG000|Overall Study|Adverse Event|2|||
30714220|NCT00536198|58727587|FG001|Overall Study|Adverse Event|2|||
30714221|NCT00536198|58727586|FG000|Overall Study|Rescue|3|||
30714222|NCT00536198|58727587|FG001|Overall Study|Rescue|9|||
30714223|NCT00536198|58727586|FG000|Overall Study|Pregnancy|1|||
30714224|NCT00536198|58727587|FG001|Overall Study|Pregnancy|1|||
30714225|NCT00536198|58727586|FG000|Overall Study|Protocol Violation|0|||
30714226|NCT00536198|58727587|FG001|Overall Study|Protocol Violation|1|||
30714227|NCT00393484|58727597|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
30899986|NCT02465567|58933269|FG002|Overall Study|Adverse Event|147|||
30714228|NCT00393484|58727598|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
30714229|NCT00393484|58727597|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
30714230|NCT00393484|58727598|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
30714231|NCT00393484|58727597|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
30714232|NCT00393484|58727598|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
30714233|NCT00393484|58727597|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
30714234|NCT00393484|58727598|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
30714235|NCT00393484|58727597|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
30714236|NCT00393484|58727598|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
30714237|NCT00393484|58727597|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
30714238|NCT00393484|58727598|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
30714239|NCT00393484|58727597|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
30714240|NCT00393484|58727598|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
30714241|NCT00393484|58727597|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
30714242|NCT00393484|58727598|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
30714243|NCT00393484|58727597|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
30714244|NCT00393484|58727598|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
30714245|NCT00393484|58727597|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
30714246|NCT00393484|58727598|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
30714247|NCT00667823|58727606|FG000|Overall Study|Lost to Follow-up|5|||
30714248|NCT00667823|58727606|FG000|Overall Study|Adverse Event|7|||
30714249|NCT00667823|58727606|FG000|Overall Study|Death|182|||
30714250|NCT00667823|58727606|FG000|Overall Study|Withdrawal by Subject|12|||
30714251|NCT00667823|58727606|FG000|Overall Study|Other|8|||
30714252|NCT00667823|58727606|FG000|Overall Study|Missing (completion page missing)|2|||
30714253|NCT00397930|58727612|FG000|Overall Study|Personal reasons|14|||
30714254|NCT00397930|58727613|FG001|Overall Study|Personal reasons|8|||
30714255|NCT00397930|58727612|FG000|Overall Study|Other medical|9|||
30714256|NCT00397930|58727613|FG001|Overall Study|Other medical|4|||
30714257|NCT00397930|58727612|FG000|Overall Study|Unknown reasons|9|||
30714258|NCT00397930|58727613|FG001|Overall Study|Unknown reasons|14|||
30714259|NCT00397930|58727612|FG000|Overall Study|Noncompliant|3|||
30714260|NCT00397930|58727613|FG001|Overall Study|Noncompliant|2|||
30714261|NCT00397930|58727612|FG000|Overall Study|Too time-consuming|2|||
30714262|NCT00397930|58727613|FG001|Overall Study|Too time-consuming|9|||
30714263|NCT00397930|58727612|FG000|Overall Study|Started own yoga program|1|||
30714264|NCT00397930|58727613|FG001|Overall Study|Started own yoga program|1|||
30714265|NCT00397930|58727612|FG000|Overall Study|Did not want to be in control group|0|||
30714266|NCT00397930|58727613|FG001|Overall Study|Did not want to be in control group|1|||
30714267|NCT00397930|58727612|FG000|Overall Study|Withdrawal by Subject|0|||
30714268|NCT00397930|58727613|FG001|Overall Study|Withdrawal by Subject|8|||
30714269|NCT00397930|58727612|FG000|Overall Study|Missing data|0|||
30714270|NCT00397930|58727613|FG001|Overall Study|Missing data|4|||
30714271|NCT00397540|58727621|FG000|Overall Study|short follow-up duration < 12 months|1|||
30714272|NCT00397540|58727622|FG001|Overall Study|short follow-up duration < 12 months|0|||
30714273|NCT00536120|58727631|FG000|Overall Study|Lost to Follow-up|1|||
30714274|NCT00536120|58727632|FG001|Overall Study|Lost to Follow-up|0|||
30714275|NCT00536120|58727631|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
30714276|NCT00536120|58727632|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
30714277|NCT00536120|58727631|FG000|Overall Study|Non-compliance|1|||
30714278|NCT00536120|58727632|FG001|Overall Study|Non-compliance|0|||
30714279|NCT00536120|58727631|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
30714280|NCT00536120|58727632|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
30714281|NCT00536120|58727631|FG000|Overall Study|Steroid Use|0|||
30714282|NCT00536120|58727632|FG001|Overall Study|Steroid Use|2|||
30714283|NCT00536120|58727631|FG000|Overall Study|Missed Study Visit|0|||
30714284|NCT00536120|58727632|FG001|Overall Study|Missed Study Visit|1|||
30714285|NCT00057811|58727640|FG000|Overall Study|Lack of Efficacy|1|||
30714286|NCT00057811|58727641|FG001|Overall Study|Lack of Efficacy|4|||
30714287|NCT00057811|58727640|FG000|Overall Study|Physician Decision|1|||
30714288|NCT00057811|58727641|FG001|Overall Study|Physician Decision|0|||
30714289|NCT00057811|58727640|FG000|Overall Study|Withdrawal by Subject|3|||
30714290|NCT00057811|58727641|FG001|Overall Study|Withdrawal by Subject|4|||
30899987|NCT02465567|58933270|FG003|Overall Study|Adverse Event|138|||
30714291|NCT00057811|58727640|FG000|Overall Study|Ineligible|4|||
30714292|NCT00057811|58727641|FG001|Overall Study|Ineligible|2|||
30714293|NCT00057811|58727640|FG000|Overall Study|Inevaluable|1|||
30714294|NCT00057811|58727641|FG001|Overall Study|Inevaluable|2|||
30714295|NCT02866682|58727654|FG000|Overall Study|Death|0|||
30714296|NCT02866682|58727655|FG001|Overall Study|Death|1|||
30714297|NCT02866682|58727654|FG000|Overall Study|Lost to Follow-up|0|||
30714298|NCT02866682|58727655|FG001|Overall Study|Lost to Follow-up|4|||
30899988|NCT02465567|58933267|FG000|Overall Study|Lack of Efficacy|103|||
30714299|NCT02866682|58727654|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
30714300|NCT02866682|58727655|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
30714301|NCT02866682|58727654|FG000|Overall Study|Other|0|||
30714302|NCT02866682|58727655|FG001|Overall Study|Other|1|||
30714303|NCT00570713|58727672|FG000|Overall Study|Adverse Event|16|||
30714304|NCT00570713|58727673|FG001|Overall Study|Adverse Event|9|||
30714305|NCT00570713|58727672|FG000|Overall Study|Death|7|||
30714306|NCT00570713|58727673|FG001|Overall Study|Death|7|||
30714307|NCT00570713|58727672|FG000|Overall Study|Lack of Efficacy|40|||
30714308|NCT00570713|58727673|FG001|Overall Study|Lack of Efficacy|49|||
30714309|NCT00570713|58727672|FG000|Overall Study|Physician Decision|2|||
30714310|NCT00570713|58727673|FG001|Overall Study|Physician Decision|2|||
30714311|NCT00570713|58727672|FG000|Overall Study|Withdrawal by Subject|3|||
30714312|NCT00570713|58727673|FG001|Overall Study|Withdrawal by Subject|3|||
30714313|NCT00570713|58727672|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
30714314|NCT00570713|58727673|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
30714315|NCT00669617|58727683|FG000|Period 1|Withdrawal by Subject|0|||
30714316|NCT00669617|58727684|FG001|Period 1|Withdrawal by Subject|0|||
30714317|NCT00669617|58727685|FG002|Period 1|Withdrawal by Subject|1|||
30714318|NCT00669617|58727686|FG003|Period 1|Withdrawal by Subject|0|||
30714319|NCT00669617|58727687|FG004|Period 1|Withdrawal by Subject|0|||
30714320|NCT00669617|58727683|FG000|Period 1|Protocol Deviation|0|||
30714321|NCT00669617|58727684|FG001|Period 1|Protocol Deviation|0|||
30714322|NCT00669617|58727685|FG002|Period 1|Protocol Deviation|0|||
30714323|NCT00669617|58727686|FG003|Period 1|Protocol Deviation|0|||
30714324|NCT00669617|58727687|FG004|Period 1|Protocol Deviation|1|||
30714325|NCT00669617|58727683|FG000|Period 3|Lost to Follow-up|1|||
30714326|NCT00669617|58727684|FG001|Period 3|Lost to Follow-up|0|||
30714327|NCT00669617|58727685|FG002|Period 3|Lost to Follow-up|0|||
30714328|NCT00669617|58727686|FG003|Period 3|Lost to Follow-up|0|||
30714329|NCT00669617|58727687|FG004|Period 3|Lost to Follow-up|0|||
30714330|NCT00535730|58727701|FG000|Overall Study|Adverse Event|1|||
30714331|NCT00535730|58727702|FG001|Overall Study|Adverse Event|1|||
30714332|NCT00535730|58727701|FG000|Overall Study|Lost to Follow-up|0|||
30714333|NCT00535730|58727702|FG001|Overall Study|Lost to Follow-up|1|||
30714334|NCT00535730|58727701|FG000|Overall Study|Physician Decision|0|||
30714335|NCT00535730|58727702|FG001|Overall Study|Physician Decision|1|||
30714336|NCT00535730|58727701|FG000|Overall Study|Protocol Violation|1|||
30714337|NCT00535730|58727702|FG001|Overall Study|Protocol Violation|0|||
30714338|NCT00535730|58727701|FG000|Overall Study|Withdrawal by Subject|0|||
30714339|NCT00535730|58727702|FG001|Overall Study|Withdrawal by Subject|4|||
30714340|NCT00666965|58727713|FG000|Overall Study|Adverse Event|0|||
30714341|NCT00666965|58727714|FG001|Overall Study|Adverse Event|2|||
30714342|NCT00666965|58727715|FG002|Overall Study|Adverse Event|1|||
30714343|NCT00666965|58727716|FG003|Overall Study|Adverse Event|9|||
30714344|NCT00666965|58727713|FG000|Overall Study|Lack of Efficacy|1|||
30714345|NCT00666965|58727714|FG001|Overall Study|Lack of Efficacy|1|||
30714346|NCT00666965|58727715|FG002|Overall Study|Lack of Efficacy|0|||
30714347|NCT00666965|58727716|FG003|Overall Study|Lack of Efficacy|0|||
30714348|NCT00666965|58727713|FG000|Overall Study|Protocol Violation|0|||
30714349|NCT00666965|58727714|FG001|Overall Study|Protocol Violation|0|||
30714350|NCT00666965|58727715|FG002|Overall Study|Protocol Violation|0|||
30714351|NCT00666965|58727716|FG003|Overall Study|Protocol Violation|2|||
30714352|NCT00666965|58727713|FG000|Overall Study|Discontinuation criteria|2|||
30714353|NCT00666965|58727714|FG001|Overall Study|Discontinuation criteria|1|||
30714354|NCT00666965|58727715|FG002|Overall Study|Discontinuation criteria|1|||
30714355|NCT00666965|58727716|FG003|Overall Study|Discontinuation criteria|2|||
30714356|NCT00666965|58727713|FG000|Overall Study|Withdrawal by Subject|0|||
30714357|NCT00666965|58727714|FG001|Overall Study|Withdrawal by Subject|0|||
30714358|NCT00666965|58727715|FG002|Overall Study|Withdrawal by Subject|0|||
30714359|NCT00666965|58727716|FG003|Overall Study|Withdrawal by Subject|2|||
30714360|NCT03889886|58727730|FG000|Overall Study|Other|0|||
30714361|NCT03889886|58727731|FG001|Overall Study|Other|1|||
30714362|NCT03889886|58727732|FG002|Overall Study|Other|0|||
30714363|NCT03889886|58727733|FG003|Overall Study|Other|1|||
30714364|NCT03889886|58727730|FG000|Overall Study|Withdrawal by Subject|0|||
30714365|NCT03889886|58727731|FG001|Overall Study|Withdrawal by Subject|0|||
30714366|NCT03889886|58727732|FG002|Overall Study|Withdrawal by Subject|1|||
30714367|NCT03889886|58727733|FG003|Overall Study|Withdrawal by Subject|0|||
30714368|NCT03889886|58727730|FG000|Overall Study|Adverse Event|0|||
30714369|NCT03889886|58727731|FG001|Overall Study|Adverse Event|0|||
30714370|NCT03889886|58727732|FG002|Overall Study|Adverse Event|0|||
30714371|NCT03889886|58727733|FG003|Overall Study|Adverse Event|6|||
30714372|NCT03888482|58727745|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
30714373|NCT03888482|58727746|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
30714374|NCT03888482|58727745|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
30714375|NCT03888482|58727746|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
30714376|NCT00667355|58727754|FG000|Overall Study|Adverse Event|5|||
30714377|NCT00667355|58727754|FG000|Overall Study|Lost to Follow-up|1|||
30714378|NCT00667355|58727754|FG000|Overall Study|Other reason was not specified|5|||
30714379|NCT00532844|58727760|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
30714380|NCT00532844|58727761|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
30714381|NCT00532844|58727760|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
30714382|NCT00532844|58727761|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
30714383|NCT00532844|58727760|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
30714384|NCT00532844|58727761|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
30714385|NCT00532844|58727760|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
30714386|NCT00532844|58727761|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
30714387|NCT00532844|58727760|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
30714388|NCT00532844|58727761|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
30714389|NCT00666263|58727789|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
30714390|NCT00666263|58727790|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
30714391|NCT00666263|58727789|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
30714392|NCT00666263|58727790|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
30714393|NCT00666263|58727789|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
30714394|NCT00666263|58727790|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
30714395|NCT00667277|58727835|FG000|Overall Study|Withdrawal by Subject|2|||
30714396|NCT00534638|58727841|FG000|Overall Study|Withdrawal by Subject|3|||
30714397|NCT00534638|58727842|FG001|Overall Study|Withdrawal by Subject|4|||
30714398|NCT00534638|58727841|FG000|Overall Study|Migrated/moved from study area|13|||
30714399|NCT00534638|58727842|FG001|Overall Study|Migrated/moved from study area|11|||
30714400|NCT00534638|58727841|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
30714401|NCT00534638|58727842|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
30714402|NCT00534638|58727841|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
30714403|NCT00534638|58727842|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
30714404|NCT00534638|58727841|FG000|Overall Study|Other|1685|||
30714405|NCT00534638|58727842|FG001|Overall Study|Other|902|||
30714406|NCT00662129|58727853|FG000|Overall Study|Protocol Violation|1|||
30714407|NCT00662129|58727853|FG000|Overall Study|Cancel prior to beginning treatment|1|||
30714408|NCT00662129|58727853|FG000|Overall Study|Ineligible|1|||
30714409|NCT00664859|58727860|FG000|Overall Study|Adverse Event|2|||
30714410|NCT00664859|58727861|FG001|Overall Study|Adverse Event|1|||
30714411|NCT00664859|58727862|FG002|Overall Study|Adverse Event|3|||
30714412|NCT00664859|58727860|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
30714413|NCT00664859|58727861|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
30714414|NCT00664859|58727862|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
30714415|NCT00664859|58727860|FG000|Overall Study|Noncompliance with protocol|1|||
30714416|NCT00664859|58727861|FG001|Overall Study|Noncompliance with protocol|0|||
30714417|NCT00664859|58727862|FG002|Overall Study|Noncompliance with protocol|4|||
30714418|NCT00664859|58727860|FG000|Overall Study|Laboratory abnormality|2|||
30714419|NCT00664859|58727861|FG001|Overall Study|Laboratory abnormality|1|||
30714420|NCT00664859|58727862|FG002|Overall Study|Laboratory abnormality|4|||
30714421|NCT00664859|58727860|FG000|Overall Study|Withdrawal by Subject|4|||
30714422|NCT00664859|58727861|FG001|Overall Study|Withdrawal by Subject|1|||
30714423|NCT00664859|58727862|FG002|Overall Study|Withdrawal by Subject|3|||
30714424|NCT00664859|58727860|FG000|Overall Study|Lost to Follow-up|2|||
30714425|NCT00664859|58727861|FG001|Overall Study|Lost to Follow-up|2|||
30714426|NCT00664859|58727862|FG002|Overall Study|Lost to Follow-up|1|||
30714427|NCT00664859|58727860|FG000|Overall Study|Other|0|||
30714428|NCT00664859|58727861|FG001|Overall Study|Other|1|||
30714429|NCT00664859|58727862|FG002|Overall Study|Other|2|||
30714430|NCT00570401|58727870|FG000|Overall Study|Adverse Event|2|||
30714431|NCT00532298|58727880|FG000|Overall Study|Adverse Event|1|||
30714432|NCT00532298|58727881|FG001|Overall Study|Adverse Event|0|||
30714433|NCT00532298|58727882|FG002|Overall Study|Adverse Event|0|||
30714434|NCT00532298|58727883|FG003|Overall Study|Adverse Event|0|||
30714435|NCT00532298|58727884|FG004|Overall Study|Adverse Event|1|||
30714436|NCT00532298|58727885|FG005|Overall Study|Adverse Event|1|||
30714437|NCT00532298|58727880|FG000|Overall Study|Lost to Follow-up|1|||
30714438|NCT00532298|58727881|FG001|Overall Study|Lost to Follow-up|1|||
30714439|NCT00532298|58727882|FG002|Overall Study|Lost to Follow-up|1|||
30714440|NCT00532298|58727883|FG003|Overall Study|Lost to Follow-up|0|||
30714441|NCT00532298|58727884|FG004|Overall Study|Lost to Follow-up|0|||
30714442|NCT00532298|58727885|FG005|Overall Study|Lost to Follow-up|1|||
30714443|NCT00410410|58727905|FG000|Induction Period (IP)|Death|1|||
30714444|NCT00410410|58727906|FG001|Induction Period (IP)|Death|0|||
30714445|NCT00410410|58727907|FG002|Induction Period (IP)|Death|0|||
30714446|NCT00410410|58727908|FG003|Induction Period (IP)|Death|0|||
30714447|NCT00410410|58727909|FG004|Induction Period (IP)|Death|0|||
30714448|NCT00410410|58727910|FG005|Induction Period (IP)|Death|0|||
30714449|NCT00410410|58727911|FG006|Induction Period (IP)|Death|0|||
30714450|NCT00410410|58727912|FG007|Induction Period (IP)|Death|0|||
30714451|NCT00410410|58727913|FG008|Induction Period (IP)|Death|0|||
30625592|NCT00889720|58637788|FG000|Overall Study|Other|4|||
30714452|NCT00410410|58727905|FG000|Induction Period (IP)|Adverse Event|3|||
30714453|NCT00410410|58727906|FG001|Induction Period (IP)|Adverse Event|4|||
30714454|NCT00410410|58727907|FG002|Induction Period (IP)|Adverse Event|2|||
30625593|NCT01116648|58637807|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
30625594|NCT01116648|58637808|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
30625595|NCT01116648|58637809|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
30625596|NCT01116648|58637810|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
30625597|NCT01116648|58637811|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
30625598|NCT01116648|58637812|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
30625599|NCT01116648|58637813|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
30714455|NCT00410410|58727908|FG003|Induction Period (IP)|Adverse Event|4|||
30714456|NCT00410410|58727909|FG004|Induction Period (IP)|Adverse Event|1|||
30714457|NCT00410410|58727910|FG005|Induction Period (IP)|Adverse Event|0|||
30714458|NCT00410410|58727911|FG006|Induction Period (IP)|Adverse Event|0|||
30714459|NCT00410410|58727912|FG007|Induction Period (IP)|Adverse Event|0|||
30714460|NCT00410410|58727913|FG008|Induction Period (IP)|Adverse Event|0|||
30714461|NCT00410410|58727905|FG000|Induction Period (IP)|Lack of Efficacy|26|||
30714462|NCT00410410|58727906|FG001|Induction Period (IP)|Lack of Efficacy|24|||
30714463|NCT00410410|58727907|FG002|Induction Period (IP)|Lack of Efficacy|8|||
30714464|NCT00410410|58727908|FG003|Induction Period (IP)|Lack of Efficacy|8|||
30714465|NCT00410410|58727909|FG004|Induction Period (IP)|Lack of Efficacy|7|||
30714466|NCT00410410|58727910|FG005|Induction Period (IP)|Lack of Efficacy|7|||
30714467|NCT00410410|58727911|FG006|Induction Period (IP)|Lack of Efficacy|0|||
30714468|NCT00410410|58727912|FG007|Induction Period (IP)|Lack of Efficacy|0|||
30714469|NCT00410410|58727913|FG008|Induction Period (IP)|Lack of Efficacy|0|||
30714470|NCT00410410|58727905|FG000|Induction Period (IP)|Lost to Follow-up|2|||
30714471|NCT00410410|58727906|FG001|Induction Period (IP)|Lost to Follow-up|2|||
30714472|NCT00410410|58727907|FG002|Induction Period (IP)|Lost to Follow-up|2|||
30714473|NCT00410410|58727908|FG003|Induction Period (IP)|Lost to Follow-up|3|||
30714474|NCT00410410|58727909|FG004|Induction Period (IP)|Lost to Follow-up|0|||
30714475|NCT00410410|58727910|FG005|Induction Period (IP)|Lost to Follow-up|1|||
30714476|NCT00410410|58727911|FG006|Induction Period (IP)|Lost to Follow-up|0|||
30714477|NCT00410410|58727912|FG007|Induction Period (IP)|Lost to Follow-up|0|||
30714478|NCT00410410|58727913|FG008|Induction Period (IP)|Lost to Follow-up|0|||
30714479|NCT00410410|58727905|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
30714480|NCT00410410|58727906|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
30714481|NCT00410410|58727907|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
30714482|NCT00410410|58727908|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
30714483|NCT00410410|58727909|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
30714484|NCT00410410|58727910|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
30714485|NCT00410410|58727911|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
30714486|NCT00410410|58727912|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
30714487|NCT00410410|58727913|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
30714488|NCT00410410|58727905|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
30714489|NCT00410410|58727906|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
30714490|NCT00410410|58727907|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
30714491|NCT00410410|58727908|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
30714492|NCT00410410|58727909|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
30714493|NCT00410410|58727910|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
30714494|NCT00410410|58727911|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
30714495|NCT00410410|58727912|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
30714496|NCT00410410|58727913|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
30714497|NCT00410410|58727905|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
30714498|NCT00410410|58727906|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
30714499|NCT00410410|58727907|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
30621529|NCT01193153|58633104|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
30714500|NCT00410410|58727908|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
30714501|NCT00410410|58727909|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
30714502|NCT00410410|58727910|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
30714503|NCT00410410|58727911|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
30714504|NCT00410410|58727912|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
30714505|NCT00410410|58727913|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
30714506|NCT00410410|58727905|FG000|Induction Period (IP)|Other|0|||
30714507|NCT00410410|58727906|FG001|Induction Period (IP)|Other|0|||
30714508|NCT00410410|58727907|FG002|Induction Period (IP)|Other|1|||
30714509|NCT00410410|58727908|FG003|Induction Period (IP)|Other|0|||
30714510|NCT00410410|58727909|FG004|Induction Period (IP)|Other|0|||
30714511|NCT00410410|58727910|FG005|Induction Period (IP)|Other|0|||
30714512|NCT00410410|58727911|FG006|Induction Period (IP)|Other|0|||
30714513|NCT00410410|58727912|FG007|Induction Period (IP)|Other|0|||
30714514|NCT00410410|58727913|FG008|Induction Period (IP)|Other|0|||
30714515|NCT00410410|58727905|FG000|Maintenance Period (MP)|Death|0|||
30714516|NCT00410410|58727906|FG001|Maintenance Period (MP)|Death|0|||
30714517|NCT00410410|58727907|FG002|Maintenance Period (MP)|Death|0|||
30714518|NCT00410410|58727908|FG003|Maintenance Period (MP)|Death|0|||
30714519|NCT00410410|58727909|FG004|Maintenance Period (MP)|Death|0|||
30714520|NCT00410410|58727910|FG005|Maintenance Period (MP)|Death|0|||
30714521|NCT00410410|58727911|FG006|Maintenance Period (MP)|Death|1|||
30714522|NCT00410410|58727912|FG007|Maintenance Period (MP)|Death|0|||
30714523|NCT00410410|58727913|FG008|Maintenance Period (MP)|Death|0|||
30714524|NCT00410410|58727905|FG000|Maintenance Period (MP)|Adverse Event|0|||
30714525|NCT00410410|58727906|FG001|Maintenance Period (MP)|Adverse Event|0|||
30714526|NCT00410410|58727907|FG002|Maintenance Period (MP)|Adverse Event|0|||
30714527|NCT00410410|58727908|FG003|Maintenance Period (MP)|Adverse Event|0|||
30714528|NCT00410410|58727909|FG004|Maintenance Period (MP)|Adverse Event|0|||
30714529|NCT00410410|58727910|FG005|Maintenance Period (MP)|Adverse Event|0|||
30714530|NCT00410410|58727911|FG006|Maintenance Period (MP)|Adverse Event|1|||
30714531|NCT00410410|58727912|FG007|Maintenance Period (MP)|Adverse Event|3|||
30714532|NCT00410410|58727913|FG008|Maintenance Period (MP)|Adverse Event|0|||
30714533|NCT00410410|58727905|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
30714534|NCT00410410|58727906|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
30714535|NCT00410410|58727907|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
30714536|NCT00410410|58727908|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
30714537|NCT00410410|58727909|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
30714538|NCT00410410|58727910|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
30714539|NCT00410410|58727911|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
30714540|NCT00410410|58727912|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
30714541|NCT00410410|58727913|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
30714542|NCT00410410|58727905|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
30714543|NCT00410410|58727906|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
30714544|NCT00410410|58727907|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
30714545|NCT00410410|58727908|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
30714546|NCT00410410|58727909|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
30714547|NCT00410410|58727910|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
30714548|NCT00410410|58727911|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
30714549|NCT00410410|58727912|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
30714550|NCT00410410|58727913|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
30714551|NCT00410410|58727905|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
30714552|NCT00410410|58727906|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
30714553|NCT00410410|58727907|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
30714554|NCT00410410|58727908|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
30714555|NCT00410410|58727909|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
30714556|NCT00410410|58727910|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
30714557|NCT00410410|58727911|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
30714558|NCT00410410|58727912|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
30714559|NCT00410410|58727913|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
30714560|NCT00410410|58727905|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
30714561|NCT00410410|58727906|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
30714562|NCT00410410|58727907|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
30714563|NCT00410410|58727908|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
30714564|NCT00410410|58727909|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
30714565|NCT00410410|58727910|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
30714566|NCT00410410|58727911|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
30899989|NCT02465567|58933268|FG001|Overall Study|Lack of Efficacy|102|||
30714567|NCT00410410|58727912|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
30714568|NCT00410410|58727913|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
30714569|NCT00410410|58727905|FG000|Open-Label Period (OL)|Death|0|||
30621530|NCT01193153|58633103|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
30714570|NCT00410410|58727906|FG001|Open-Label Period (OL)|Death|0|||
30714571|NCT00410410|58727907|FG002|Open-Label Period (OL)|Death|0|||
30714572|NCT00410410|58727908|FG003|Open-Label Period (OL)|Death|0|||
30714573|NCT00410410|58727909|FG004|Open-Label Period (OL)|Death|0|||
30714574|NCT00410410|58727910|FG005|Open-Label Period (OL)|Death|0|||
30714575|NCT00410410|58727911|FG006|Open-Label Period (OL)|Death|0|||
30714576|NCT00410410|58727912|FG007|Open-Label Period (OL)|Death|0|||
30714577|NCT00410410|58727913|FG008|Open-Label Period (OL)|Death|1|||
30714578|NCT00410410|58727905|FG000|Open-Label Period (OL)|Adverse Event|0|||
30714579|NCT00410410|58727906|FG001|Open-Label Period (OL)|Adverse Event|0|||
30714580|NCT00410410|58727907|FG002|Open-Label Period (OL)|Adverse Event|0|||
30714581|NCT00410410|58727908|FG003|Open-Label Period (OL)|Adverse Event|0|||
30714582|NCT00410410|58727909|FG004|Open-Label Period (OL)|Adverse Event|0|||
30714583|NCT00410410|58727910|FG005|Open-Label Period (OL)|Adverse Event|0|||
30714584|NCT00410410|58727911|FG006|Open-Label Period (OL)|Adverse Event|0|||
30714585|NCT00410410|58727912|FG007|Open-Label Period (OL)|Adverse Event|0|||
30714586|NCT00410410|58727913|FG008|Open-Label Period (OL)|Adverse Event|10|||
30714587|NCT00410410|58727905|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
30714588|NCT00410410|58727906|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
30714589|NCT00410410|58727907|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
30714590|NCT00410410|58727908|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
30714591|NCT00410410|58727909|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
30714592|NCT00410410|58727910|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
30714593|NCT00410410|58727911|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
30714594|NCT00410410|58727912|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
30714595|NCT00410410|58727913|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
30714596|NCT00410410|58727905|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
30714597|NCT00410410|58727906|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
30714598|NCT00410410|58727907|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
30714599|NCT00410410|58727908|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
30714600|NCT00410410|58727909|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
30714601|NCT00410410|58727910|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
30714602|NCT00410410|58727911|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
30714603|NCT00410410|58727912|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
30714604|NCT00410410|58727913|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
30714605|NCT00410410|58727905|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
30714606|NCT00410410|58727906|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
30714607|NCT00410410|58727907|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
30714608|NCT00410410|58727908|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
30714609|NCT00410410|58727909|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
30714610|NCT00410410|58727910|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
30714611|NCT00410410|58727911|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
30714612|NCT00410410|58727912|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
30714613|NCT00410410|58727913|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
30714614|NCT00410410|58727905|FG000|Open-Label Period (OL)|Pregnancy|0|||
30714615|NCT00410410|58727906|FG001|Open-Label Period (OL)|Pregnancy|0|||
30714616|NCT00410410|58727907|FG002|Open-Label Period (OL)|Pregnancy|0|||
30714617|NCT00410410|58727908|FG003|Open-Label Period (OL)|Pregnancy|0|||
30714618|NCT00410410|58727909|FG004|Open-Label Period (OL)|Pregnancy|0|||
30714619|NCT00410410|58727910|FG005|Open-Label Period (OL)|Pregnancy|0|||
30714620|NCT00410410|58727911|FG006|Open-Label Period (OL)|Pregnancy|0|||
30714621|NCT00410410|58727912|FG007|Open-Label Period (OL)|Pregnancy|0|||
30714622|NCT00410410|58727913|FG008|Open-Label Period (OL)|Pregnancy|1|||
30714623|NCT00410410|58727905|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
30714624|NCT00410410|58727906|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
30621531|NCT01193153|58633104|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
30714625|NCT00410410|58727907|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
30714626|NCT00410410|58727908|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
30714627|NCT00410410|58727909|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
30714628|NCT00410410|58727910|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
30714629|NCT00410410|58727911|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
30714630|NCT00410410|58727912|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
30714631|NCT00410410|58727913|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
30714632|NCT00410410|58727905|FG000|Open-Label Period (OL)|Other|0|||
30714633|NCT00410410|58727906|FG001|Open-Label Period (OL)|Other|0|||
30714634|NCT00410410|58727907|FG002|Open-Label Period (OL)|Other|0|||
30714635|NCT00410410|58727908|FG003|Open-Label Period (OL)|Other|0|||
30714636|NCT00410410|58727909|FG004|Open-Label Period (OL)|Other|0|||
30714637|NCT00410410|58727910|FG005|Open-Label Period (OL)|Other|0|||
30714638|NCT00410410|58727911|FG006|Open-Label Period (OL)|Other|0|||
30714639|NCT00410410|58727912|FG007|Open-Label Period (OL)|Other|0|||
30714640|NCT00410410|58727913|FG008|Open-Label Period (OL)|Other|7|||
30714641|NCT00534404|58727951|FG000|Overall Study|Death|0|||
30714642|NCT00534404|58727952|FG001|Overall Study|Death|0|||
30714643|NCT00534404|58727953|FG002|Overall Study|Death|2|||
30714644|NCT00534404|58727951|FG000|Overall Study|Withdrawal by Subject|8|||
30714645|NCT00534404|58727952|FG001|Overall Study|Withdrawal by Subject|2|||
30714646|NCT00534404|58727953|FG002|Overall Study|Withdrawal by Subject|38|||
30714647|NCT00534404|58727951|FG000|Overall Study|Removed by study staff|2|||
30714648|NCT00534404|58727952|FG001|Overall Study|Removed by study staff|3|||
30714649|NCT00534404|58727953|FG002|Overall Study|Removed by study staff|1|||
30714650|NCT00534404|58727951|FG000|Overall Study|Lost to Follow-up|170|||
30714651|NCT00534404|58727952|FG001|Overall Study|Lost to Follow-up|138|||
30714652|NCT00534404|58727953|FG002|Overall Study|Lost to Follow-up|201|||
30714653|NCT00393094|58727961|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
30714654|NCT00393094|58727961|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
30714655|NCT00409786|58727967|FG000|Overall Study|Withdrawal by Subject|3|||
30714656|NCT00409708|58727973|FG000|Treatment|Abnormal test procedure result(s)|1|||
30714657|NCT00409708|58727974|FG001|Treatment|Abnormal test procedure result(s)|0|||
30714658|NCT00409708|58727973|FG000|Treatment|Lack of Efficacy|0|||
30714659|NCT00409708|58727974|FG001|Treatment|Lack of Efficacy|1|||
30714660|NCT00409708|58727973|FG000|Treatment|Protocol Violation|6|||
30714661|NCT00409708|58727974|FG001|Treatment|Protocol Violation|2|||
30714662|NCT00409708|58727973|FG000|Treatment|Withdrawal by Subject|3|||
30714663|NCT00409708|58727974|FG001|Treatment|Withdrawal by Subject|8|||
30714664|NCT00409708|58727973|FG000|Treatment|Lost to Follow-up|0|||
30714665|NCT00409708|58727974|FG001|Treatment|Lost to Follow-up|6|||
30714666|NCT00409708|58727973|FG000|Treatment|Administrative problems|5|||
30714667|NCT00409708|58727974|FG001|Treatment|Administrative problems|0|||
30714668|NCT00409708|58727973|FG000|Washout|Lack of Efficacy|9|||
30714669|NCT00409708|58727974|FG001|Washout|Lack of Efficacy|1|||
30714670|NCT00409708|58727973|FG000|Washout|Protocol Violation|0|||
30714671|NCT00409708|58727974|FG001|Washout|Protocol Violation|1|||
30714672|NCT00409708|58727973|FG000|Washout|Withdrawal by Subject|11|||
30714673|NCT00409708|58727974|FG001|Washout|Withdrawal by Subject|5|||
30714674|NCT00409708|58727973|FG000|Washout|Lost to Follow-up|1|||
30714675|NCT00409708|58727974|FG001|Washout|Lost to Follow-up|3|||
30714676|NCT00391846|58727991|FG000|Overall Study|Adverse Event|4|||
30714677|NCT00391846|58727992|FG001|Overall Study|Adverse Event|1|||
30714678|NCT00391846|58727991|FG000|Overall Study|Did not meet the required elig. crit|2|||
30714679|NCT00391846|58727992|FG001|Overall Study|Did not meet the required elig. crit|2|||
30714680|NCT00391846|58727991|FG000|Overall Study|Withdrawal by Subject|2|||
30714681|NCT00391846|58727992|FG001|Overall Study|Withdrawal by Subject|3|||
30714682|NCT00391846|58727991|FG000|Overall Study|Developed study specific DC criteria|0|||
30714683|NCT00391846|58727992|FG001|Overall Study|Developed study specific DC criteria|1|||
30714684|NCT00534248|58728017|FG000|Overall Study|Adverse Event|19|||
30714685|NCT00534248|58728018|FG001|Overall Study|Adverse Event|29|||
30714686|NCT00534248|58728017|FG000|Overall Study|Lost to Follow-up|353|||
30714687|NCT00534248|58728018|FG001|Overall Study|Lost to Follow-up|375|||
30714688|NCT00534248|58728017|FG000|Overall Study|Other protocol specified criteria|13|||
30714689|NCT00534248|58728018|FG001|Overall Study|Other protocol specified criteria|3|||
30714690|NCT00534248|58728017|FG000|Overall Study|Physician Decision|10|||
30714691|NCT00534248|58728018|FG001|Overall Study|Physician Decision|7|||
30714692|NCT00534248|58728017|FG000|Overall Study|Protocol Violation|3|||
30714693|NCT00534248|58728018|FG001|Overall Study|Protocol Violation|4|||
30714694|NCT00534248|58728017|FG000|Overall Study|Withdrawal by Subject|263|||
30714695|NCT00534248|58728018|FG001|Overall Study|Withdrawal by Subject|255|||
30714696|NCT00391768|58728031|FG000|Overall Study|Withdrawal by Subject|0|||
30714697|NCT00391768|58728032|FG001|Overall Study|Withdrawal by Subject|0|||
30714698|NCT00391768|58728033|FG002|Overall Study|Withdrawal by Subject|1|||
30714699|NCT00391768|58728034|FG003|Overall Study|Withdrawal by Subject|0|||
30714700|NCT00391768|58728035|FG004|Overall Study|Withdrawal by Subject|0|||
30714701|NCT00391768|58728036|FG005|Overall Study|Withdrawal by Subject|1|||
30714702|NCT00391768|58728037|FG006|Overall Study|Withdrawal by Subject|1|||
30714703|NCT00391768|58728031|FG000|Overall Study|Lost to Follow-up|0|||
30714704|NCT00391768|58728032|FG001|Overall Study|Lost to Follow-up|0|||
30714705|NCT00391768|58728033|FG002|Overall Study|Lost to Follow-up|0|||
30714706|NCT00391768|58728034|FG003|Overall Study|Lost to Follow-up|1|||
30714707|NCT00391768|58728035|FG004|Overall Study|Lost to Follow-up|2|||
30714708|NCT00391768|58728036|FG005|Overall Study|Lost to Follow-up|2|||
30714709|NCT00391768|58728037|FG006|Overall Study|Lost to Follow-up|3|||
30714710|NCT00391222|58728074|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
30621532|NCT01193153|58633103|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
30714711|NCT00391222|58728075|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
30714712|NCT00391222|58728076|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
30899990|NCT02465567|58933269|FG002|Overall Study|Lack of Efficacy|171|||
30714713|NCT00391222|58728077|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
30714714|NCT00391222|58728074|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
30621533|NCT01193153|58633104|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
30621534|NCT01193153|58633103|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
30714715|NCT00391222|58728075|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
30714716|NCT00391222|58728076|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
30714717|NCT00391222|58728077|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
30714718|NCT00391222|58728074|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
30714719|NCT00391222|58728075|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
30714720|NCT00391222|58728076|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
30714721|NCT00391222|58728077|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
30714722|NCT00391222|58728074|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
30714723|NCT00391222|58728075|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
30714724|NCT00391222|58728076|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
30714725|NCT00391222|58728077|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
30714726|NCT00391222|58728074|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
30714727|NCT00391222|58728075|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
30714728|NCT00391222|58728076|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
30714729|NCT00391222|58728077|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
30714730|NCT00391222|58728074|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
30714731|NCT00391222|58728075|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
30714732|NCT00391222|58728076|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
30714733|NCT00391222|58728077|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
30714734|NCT00391222|58728074|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
30714735|NCT00391222|58728075|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
30714736|NCT00391222|58728076|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
30714737|NCT00391222|58728077|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
30714738|NCT00391222|58728074|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
30714739|NCT00391222|58728075|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
30714740|NCT00391222|58728076|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
30714741|NCT00391222|58728077|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
30714742|NCT00391222|58728074|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
30714743|NCT00391222|58728075|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
30714744|NCT00391222|58728076|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
30714745|NCT00391222|58728077|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
30714746|NCT00391222|58728074|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
30714747|NCT00391222|58728075|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
30714748|NCT00391222|58728076|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
30714749|NCT00391222|58728077|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
30714750|NCT00391222|58728074|FG000|Period III (Double-Blind Treatment)|Other|6|||
30714751|NCT00391222|58728075|FG001|Period III (Double-Blind Treatment)|Other|1|||
30714752|NCT00391222|58728076|FG002|Period III (Double-Blind Treatment)|Other|6|||
30714753|NCT00391222|58728077|FG003|Period III (Double-Blind Treatment)|Other|0|||
30714754|NCT00409006|58728089|FG000|Overall Study|Death|15|||
30714755|NCT00409006|58728090|FG001|Overall Study|Death|6|||
30714756|NCT00409006|58728089|FG000|Overall Study|Lost to Follow-up|1|||
30714757|NCT00409006|58728090|FG001|Overall Study|Lost to Follow-up|2|||
30714758|NCT00409006|58728089|FG000|Overall Study|Withdrawal by Subject|3|||
30714759|NCT00409006|58728090|FG001|Overall Study|Withdrawal by Subject|2|||
30714760|NCT00409006|58728089|FG000|Overall Study|Physician Decision|1|||
30621535|NCT01193153|58633104|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
30621536|NCT01193153|58633103|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
30625600|NCT01116648|58637814|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
30625601|NCT01116648|58637815|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
30625602|NCT01116648|58637816|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
30625603|NCT01116648|58637817|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
30625604|NCT01116648|58637818|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
30625605|NCT01116648|58637819|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
30625606|NCT01116648|58637820|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
30625607|NCT01116648|58637821|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
30625608|NCT00880087|58637848|FG000|Overall Study|Lost to Follow-up|0|||
30714761|NCT00409006|58728090|FG001|Overall Study|Physician Decision|2|||
30714762|NCT00534092|58728098|FG000|Overall Study|Lost to Follow-up|1|||
30714763|NCT00534092|58728099|FG001|Overall Study|Lost to Follow-up|0|||
30714764|NCT00534092|58728098|FG000|Overall Study|personal reasons/family concerns|1|||
30714765|NCT00534092|58728099|FG001|Overall Study|personal reasons/family concerns|0|||
30714766|NCT00408928|58728107|FG000|Overall Study|Withdrawal by Subject|1|||
30714767|NCT00408928|58728107|FG000|Overall Study|Death|1|||
30714768|NCT00408928|58728107|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
30714769|NCT00390910|58728114|FG000|Overall Study|Adverse Event|1|||
30714770|NCT00390910|58728115|FG001|Overall Study|Adverse Event|0|||
30714771|NCT00390910|58728116|FG002|Overall Study|Adverse Event|0|||
30714772|NCT00390910|58728114|FG000|Overall Study|Lost to Follow-up|0|||
30714773|NCT00390910|58728115|FG001|Overall Study|Lost to Follow-up|1|||
30714774|NCT00390910|58728116|FG002|Overall Study|Lost to Follow-up|5|||
30714775|NCT00390910|58728114|FG000|Overall Study|Withdrawal by Subject|1|||
30714776|NCT00390910|58728115|FG001|Overall Study|Withdrawal by Subject|3|||
30714777|NCT00390910|58728116|FG002|Overall Study|Withdrawal by Subject|2|||
30714778|NCT00390910|58728114|FG000|Overall Study|Migrated/moved from study area|0|||
30714779|NCT00390910|58728115|FG001|Overall Study|Migrated/moved from study area|0|||
30714780|NCT00390910|58728116|FG002|Overall Study|Migrated/moved from study area|3|||
30714781|NCT00533702|58728128|FG000|Overall Study|Withdrawal by Subject|3|||
30714782|NCT00533702|58728129|FG001|Overall Study|Withdrawal by Subject|1|||
30714783|NCT00533702|58728128|FG000|Overall Study|Found ineligible after randomization|2|||
30714784|NCT00533702|58728129|FG001|Overall Study|Found ineligible after randomization|1|||
30714785|NCT00408694|58728135|FG000|Overall Study|Ineligible|1|||
30714786|NCT00408694|58728135|FG000|Overall Study|No protocol treatment|1|||
30714787|NCT00396136|58728139|FG000|Overall Study|Death|43|||
30714788|NCT00396136|58728139|FG000|Overall Study|Withdrawal by Subject|59|||
30714789|NCT00396136|58728139|FG000|Overall Study|Lost to Follow-up|15|||
30714790|NCT00396136|58728139|FG000|Overall Study|Study device explanted|8|||
30714791|NCT00530894|58728147|FG000|Overall Study|Death|84|||
30714792|NCT00530894|58728148|FG001|Overall Study|Death|89|||
30714793|NCT00530894|58728149|FG002|Overall Study|Death|55|||
30714794|NCT00530894|58728150|FG003|Overall Study|Death|89|||
30714795|NCT00530894|58728147|FG000|Overall Study|Lost to Follow-up|1|||
30714796|NCT00530894|58728148|FG001|Overall Study|Lost to Follow-up|3|||
30714797|NCT00530894|58728149|FG002|Overall Study|Lost to Follow-up|0|||
30714798|NCT00530894|58728150|FG003|Overall Study|Lost to Follow-up|0|||
30714799|NCT00530894|58728147|FG000|Overall Study|Withdrawal by Subject|1|||
30714800|NCT00530894|58728148|FG001|Overall Study|Withdrawal by Subject|23|||
30714801|NCT00530894|58728149|FG002|Overall Study|Withdrawal by Subject|0|||
30714802|NCT00530894|58728150|FG003|Overall Study|Withdrawal by Subject|5|||
30714803|NCT00530894|58728147|FG000|Overall Study|Alive and censored prior to 1 year|2|||
30714804|NCT00530894|58728148|FG001|Overall Study|Alive and censored prior to 1 year|0|||
30714805|NCT00530894|58728149|FG002|Overall Study|Alive and censored prior to 1 year|0|||
30714806|NCT00530894|58728150|FG003|Overall Study|Alive and censored prior to 1 year|0|||
30714807|NCT00056407|58728164|FG000|Overall Study|Adverse Event|282|||
30714808|NCT00056407|58728165|FG001|Overall Study|Adverse Event|364|||
30714809|NCT00056407|58728164|FG000|Overall Study|Withdrawal by Subject|377|||
30714810|NCT00056407|58728165|FG001|Overall Study|Withdrawal by Subject|361|||
30714811|NCT00056407|58728164|FG000|Overall Study|Lost to Follow-up|123|||
30714812|NCT00056407|58728165|FG001|Overall Study|Lost to Follow-up|113|||
30714813|NCT00056407|58728164|FG000|Overall Study|Protocol Violation|104|||
30714814|NCT00056407|58728165|FG001|Overall Study|Protocol Violation|95|||
30714815|NCT00056407|58728164|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
30714816|NCT00056407|58728165|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
30714817|NCT00056407|58728164|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
30714818|NCT00056407|58728165|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
30714819|NCT00056407|58728164|FG000|Overall Study|Missing|25|||
30714820|NCT00056407|58728165|FG001|Overall Study|Missing|34|||
30714821|NCT00388726|58728173|FG000|Overall Study|Adverse Event|50|||
30714822|NCT00388726|58728174|FG001|Overall Study|Adverse Event|24|||
30714823|NCT00388726|58728173|FG000|Overall Study|Progressive Disease|336|||
30714824|NCT00388726|58728174|FG001|Overall Study|Progressive Disease|153|||
30714825|NCT00388726|58728173|FG000|Overall Study|Clinical Progression|61|||
30714826|NCT00388726|58728174|FG001|Overall Study|Clinical Progression|36|||
30714827|NCT00388726|58728173|FG000|Overall Study|Withdrawal by Subject|10|||
30714828|NCT00388726|58728174|FG001|Overall Study|Withdrawal by Subject|7|||
30714829|NCT00388726|58728173|FG000|Overall Study|Administrative|6|||
30714830|NCT00388726|58728174|FG001|Overall Study|Administrative|9|||
30714831|NCT00388726|58728173|FG000|Overall Study|Physician Decision|18|||
30714832|NCT00388726|58728174|FG001|Overall Study|Physician Decision|13|||
30714833|NCT00388726|58728173|FG000|Overall Study|Death|3|||
30714834|NCT00388726|58728174|FG001|Overall Study|Death|2|||
30714835|NCT00387790|58728180|FG000|Overall Study|Adverse Event|5|||
30714836|NCT00387790|58728180|FG000|Overall Study|Lack of Efficacy|2|||
30714837|NCT00387790|58728180|FG000|Overall Study|Physician Decision|2|||
30714838|NCT00387790|58728180|FG000|Overall Study|Withdrawal by Subject|3|||
30714839|NCT00387790|58728180|FG000|Overall Study|Ineligible for study|2|||
30714840|NCT00073021|58728186|FG000|Overall Study|Protocol Violation|2|||
30714841|NCT00073021|58728187|FG001|Overall Study|Protocol Violation|1|||
30714842|NCT00073021|58728186|FG000|Overall Study|Adverse Event|4|||
30714843|NCT00073021|58728187|FG001|Overall Study|Adverse Event|4|||
30714844|NCT00073021|58728186|FG000|Overall Study|Withdrawal by Subject|6|||
30714845|NCT00073021|58728187|FG001|Overall Study|Withdrawal by Subject|5|||
30714846|NCT00073021|58728186|FG000|Overall Study|Physician Decision|3|||
30714847|NCT00073021|58728187|FG001|Overall Study|Physician Decision|1|||
30714848|NCT00073021|58728186|FG000|Overall Study|Lack of Efficacy|11|||
30714849|NCT00073021|58728187|FG001|Overall Study|Lack of Efficacy|5|||
30714850|NCT00407758|58728193|FG000|Overall Study|ineligible -improper prior treatment|1|||
30714851|NCT00531752|58728201|FG000|First Double-blind Intervention Period|Adverse Event|2|||
30714852|NCT00531752|58728202|FG001|First Double-blind Intervention Period|Adverse Event|0|||
30714853|NCT00531752|58728203|FG002|First Double-blind Intervention Period|Adverse Event|1|||
30714854|NCT00531752|58728204|FG003|First Double-blind Intervention Period|Adverse Event|1|||
30714855|NCT00531752|58728201|FG000|First Double-blind Intervention Period|Other|1|||
30714856|NCT00531752|58728202|FG001|First Double-blind Intervention Period|Other|4|||
30714857|NCT00531752|58728203|FG002|First Double-blind Intervention Period|Other|4|||
30714858|NCT00531752|58728204|FG003|First Double-blind Intervention Period|Other|0|||
30714859|NCT00531752|58728201|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
30714860|NCT00531752|58728202|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
30625609|NCT00880087|58637849|FG001|Overall Study|Lost to Follow-up|2|||
30625610|NCT00889252|58637857|FG000|Overall Study|Adverse Event|2|||
30625611|NCT00889252|58637858|FG001|Overall Study|Adverse Event|4|||
30625612|NCT00889252|58637857|FG000|Overall Study|Withdrawal by Subject|3|||
30625613|NCT00889252|58637858|FG001|Overall Study|Withdrawal by Subject|0|||
30625614|NCT00889252|58637857|FG000|Overall Study|Protocol Violation|2|||
30625615|NCT00889252|58637858|FG001|Overall Study|Protocol Violation|0|||
30625616|NCT01110330|58637867|FG000|Overall Study|Adverse Event|0|||
30714861|NCT00531752|58728203|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
30714862|NCT00531752|58728204|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
30714863|NCT00531752|58728201|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
30714864|NCT00531752|58728202|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
30714865|NCT00531752|58728203|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
30714866|NCT00531752|58728204|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
30714867|NCT00531752|58728201|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
30714868|NCT00531752|58728202|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
30714869|NCT00531752|58728203|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
30714870|NCT00531752|58728204|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
30714871|NCT00531752|58728201|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
30714872|NCT00531752|58728202|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
30714873|NCT00531752|58728203|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
30714874|NCT00531752|58728204|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
30714875|NCT00531752|58728201|FG000|Second Double-blind Intervention Period|Other|1|||
30714876|NCT00531752|58728202|FG001|Second Double-blind Intervention Period|Other|1|||
30714877|NCT00531752|58728203|FG002|Second Double-blind Intervention Period|Other|0|||
30714878|NCT00531752|58728204|FG003|Second Double-blind Intervention Period|Other|0|||
30714879|NCT00531752|58728201|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
30714880|NCT00531752|58728202|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
30714881|NCT00531752|58728203|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
30714882|NCT00531752|58728204|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
30714883|NCT00531752|58728201|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
30714884|NCT00531752|58728202|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
30714885|NCT00531752|58728203|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
30714886|NCT00531752|58728204|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
30714887|NCT00395746|58728215|FG000|Overall Study|Adverse Event|5|||
30714888|NCT00395746|58728216|FG001|Overall Study|Adverse Event|2|||
30714889|NCT00395746|58728217|FG002|Overall Study|Adverse Event|2|||
30714890|NCT00395746|58728215|FG000|Overall Study|Protocol Violation|0|||
30714891|NCT00395746|58728216|FG001|Overall Study|Protocol Violation|1|||
30714892|NCT00395746|58728217|FG002|Overall Study|Protocol Violation|0|||
30714893|NCT00395746|58728215|FG000|Overall Study|Lack of Efficacy|2|||
30714894|NCT00395746|58728216|FG001|Overall Study|Lack of Efficacy|0|||
30714895|NCT00395746|58728217|FG002|Overall Study|Lack of Efficacy|17|||
30714896|NCT00395746|58728215|FG000|Overall Study|Hypoglycaemia|2|||
30714897|NCT00395746|58728216|FG001|Overall Study|Hypoglycaemia|1|||
30714898|NCT00395746|58728217|FG002|Overall Study|Hypoglycaemia|0|||
30714899|NCT00395746|58728215|FG000|Overall Study|Subject decision|0|||
30714900|NCT00395746|58728216|FG001|Overall Study|Subject decision|0|||
30714901|NCT00395746|58728217|FG002|Overall Study|Subject decision|1|||
30714902|NCT00395746|58728215|FG000|Overall Study|Withdrawal of consent|0|||
30714903|NCT00395746|58728216|FG001|Overall Study|Withdrawal of consent|0|||
30714904|NCT00395746|58728217|FG002|Overall Study|Withdrawal of consent|1|||
30714905|NCT00395746|58728215|FG000|Overall Study|Difficultulty in use of device|0|||
30714906|NCT00395746|58728216|FG001|Overall Study|Difficultulty in use of device|0|||
30714907|NCT00395746|58728217|FG002|Overall Study|Difficultulty in use of device|1|||
30714908|NCT00395746|58728215|FG000|Overall Study|Unable to visit site on schedule|1|||
30714909|NCT00395746|58728216|FG001|Overall Study|Unable to visit site on schedule|0|||
30714910|NCT00395746|58728217|FG002|Overall Study|Unable to visit site on schedule|0|||
30714911|NCT00055471|58728228|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
30714912|NCT00055471|58728229|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
30714913|NCT00055471|58728230|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
30714914|NCT00055471|58728228|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
30714915|NCT00055471|58728229|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
30714916|NCT00055471|58728230|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
30714917|NCT00055471|58728228|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
30714918|NCT00055471|58728229|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
30714919|NCT00055471|58728230|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
30714920|NCT00395512|58728242|FG000|Overall Study|Adverse Event|3|||
30714921|NCT00395512|58728243|FG001|Overall Study|Adverse Event|8|||
30714922|NCT00395512|58728244|FG002|Overall Study|Adverse Event|6|||
30714923|NCT00395512|58728245|FG003|Overall Study|Adverse Event|6|||
30714924|NCT00395512|58728242|FG000|Overall Study|Protocol Violation|2|||
30714925|NCT00395512|58728243|FG001|Overall Study|Protocol Violation|3|||
30714926|NCT00395512|58728244|FG002|Overall Study|Protocol Violation|6|||
30714927|NCT00395512|58728245|FG003|Overall Study|Protocol Violation|7|||
30714928|NCT00395512|58728242|FG000|Overall Study|Lost to Follow-up|2|||
30714929|NCT00395512|58728243|FG001|Overall Study|Lost to Follow-up|6|||
30714930|NCT00395512|58728244|FG002|Overall Study|Lost to Follow-up|5|||
30714931|NCT00395512|58728245|FG003|Overall Study|Lost to Follow-up|5|||
30714932|NCT00395512|58728242|FG000|Overall Study|Withdrawal by Subject|6|||
30714933|NCT00395512|58728243|FG001|Overall Study|Withdrawal by Subject|5|||
30714934|NCT00395512|58728244|FG002|Overall Study|Withdrawal by Subject|5|||
30714935|NCT00395512|58728245|FG003|Overall Study|Withdrawal by Subject|12|||
30714936|NCT00395512|58728242|FG000|Overall Study|Physician Decision|6|||
30714937|NCT00395512|58728243|FG001|Overall Study|Physician Decision|4|||
30714938|NCT00395512|58728244|FG002|Overall Study|Physician Decision|2|||
30714939|NCT00395512|58728245|FG003|Overall Study|Physician Decision|2|||
30625617|NCT01110330|58637868|FG001|Overall Study|Adverse Event|4|||
30625618|NCT01110330|58637869|FG002|Overall Study|Adverse Event|3|||
30625619|NCT01110330|58637867|FG000|Overall Study|Lack of Efficacy|3|||
30625620|NCT01110330|58637868|FG001|Overall Study|Lack of Efficacy|1|||
30625621|NCT01110330|58637869|FG002|Overall Study|Lack of Efficacy|1|||
30625622|NCT01110330|58637867|FG000|Overall Study|Lost to Follow-up|9|||
30625623|NCT01110330|58637868|FG001|Overall Study|Lost to Follow-up|10|||
30625624|NCT01110330|58637869|FG002|Overall Study|Lost to Follow-up|15|||
30625625|NCT01110330|58637867|FG000|Overall Study|Physician Decision|0|||
30625626|NCT01110330|58637868|FG001|Overall Study|Physician Decision|1|||
30625627|NCT01110330|58637869|FG002|Overall Study|Physician Decision|0|||
30625628|NCT01110330|58637867|FG000|Overall Study|Protocol Violation|2|||
30625629|NCT01110330|58637868|FG001|Overall Study|Protocol Violation|0|||
30625630|NCT01110330|58637869|FG002|Overall Study|Protocol Violation|4|||
30625631|NCT01110330|58637867|FG000|Overall Study|Withdrawal by Subject|0|||
30625632|NCT01110330|58637868|FG001|Overall Study|Withdrawal by Subject|6|||
30625633|NCT01110330|58637869|FG002|Overall Study|Withdrawal by Subject|2|||
30625634|NCT01110330|58637867|FG000|Overall Study|Other|1|||
30625635|NCT01110330|58637868|FG001|Overall Study|Other|1|||
30625636|NCT01110330|58637869|FG002|Overall Study|Other|1|||
30625637|NCT00596947|58637879|FG000|Overall Study|study halted due to low enrollment|5|||
30625638|NCT00596947|58637880|FG001|Overall Study|study halted due to low enrollment|3|||
30625639|NCT00596947|58637879|FG000|Overall Study|Lost to Follow-up|1|||
30625640|NCT00596947|58637880|FG001|Overall Study|Lost to Follow-up|0|||
30625641|NCT00888940|58637888|FG000|Overall Study|Adverse Event|12|||
30625642|NCT00888940|58637889|FG001|Overall Study|Adverse Event|3|||
30625643|NCT00888940|58637888|FG000|Overall Study|Lost to Follow-up|5|||
30625644|NCT00888940|58637889|FG001|Overall Study|Lost to Follow-up|5|||
30625645|NCT00888940|58637888|FG000|Overall Study|Randomized Not Treated|11|||
30625646|NCT00888940|58637889|FG001|Overall Study|Randomized Not Treated|13|||
30625647|NCT00595621|58637897|FG000|Open Label Run in|Adverse Event|1|||
30625648|NCT00595621|58637898|FG001|Open Label Run in|Adverse Event|0|||
30625649|NCT00595621|58637897|FG000|Open Label Run in|Physician Decision|1|||
30625650|NCT00595621|58637898|FG001|Open Label Run in|Physician Decision|0|||
30625651|NCT00595621|58637897|FG000|Open Label Run in|Withdrawal by Subject|1|||
30625652|NCT00595621|58637898|FG001|Open Label Run in|Withdrawal by Subject|0|||
30625653|NCT00595621|58637897|FG000|Randomization and Study|Adverse Event|2|||
30625654|NCT00595621|58637898|FG001|Randomization and Study|Adverse Event|0|||
30714940|NCT00395512|58728242|FG000|Overall Study|Other|1|||
30714941|NCT00395512|58728243|FG001|Overall Study|Other|1|||
30714942|NCT00395512|58728244|FG002|Overall Study|Other|0|||
30714943|NCT00395512|58728245|FG003|Overall Study|Other|0|||
30714944|NCT00395512|58728242|FG000|Overall Study|Hyperglycemic Rescue|18|||
30714945|NCT00395512|58728243|FG001|Overall Study|Hyperglycemic Rescue|10|||
30714946|NCT00395512|58728244|FG002|Overall Study|Hyperglycemic Rescue|4|||
30714947|NCT00395512|58728245|FG003|Overall Study|Hyperglycemic Rescue|6|||
30714948|NCT00054691|58728255|FG000|Overall Study|Unmeasurable Disease|2|||
30714949|NCT00054691|58728255|FG000|Overall Study|Noncompliant|1|||
30714950|NCT00387712|58728261|FG000|Overall Study|Physician Decision|6|||
30714951|NCT00387712|58728262|FG001|Overall Study|Physician Decision|4|||
30714952|NCT00387712|58728261|FG000|Overall Study|Lost to Follow-up|17|||
30714953|NCT00387712|58728262|FG001|Overall Study|Lost to Follow-up|20|||
30714954|NCT00387712|58728261|FG000|Overall Study|Withdrawal by Subject|6|||
30714955|NCT00387712|58728262|FG001|Overall Study|Withdrawal by Subject|12|||
30714956|NCT00066703|58728270|FG000|Overall Study|Adverse Event|80|||
30714957|NCT00066703|58728271|FG001|Overall Study|Adverse Event|111|||
30714958|NCT00066703|58728270|FG000|Overall Study|Death|3|||
30714959|NCT00066703|58728271|FG001|Overall Study|Death|0|||
30714960|NCT00066703|58728270|FG000|Overall Study|Lack of Efficacy|114|||
30714961|NCT00066703|58728271|FG001|Overall Study|Lack of Efficacy|69|||
30714962|NCT00066703|58728270|FG000|Overall Study|Lost to Follow-up|31|||
30714963|NCT00066703|58728271|FG001|Overall Study|Lost to Follow-up|28|||
30714964|NCT00066703|58728270|FG000|Overall Study|Withdrawal by Subject|38|||
30714965|NCT00066703|58728271|FG001|Overall Study|Withdrawal by Subject|63|||
30714966|NCT00066703|58728270|FG000|Overall Study|Treatment ongoing|346|||
30714967|NCT00066703|58728271|FG001|Overall Study|Treatment ongoing|311|||
30714968|NCT00072475|58728277|FG000|Overall Study|Adverse Event|44|||
30714969|NCT00072475|58728277|FG000|Overall Study|Death|3|||
30714970|NCT00072475|58728277|FG000|Overall Study|Withdrawal by Subject|46|||
30714971|NCT00072475|58728277|FG000|Overall Study|Patient/Investigator Decision|4|||
30714972|NCT00066469|58728281|FG000|Overall Study|Death|3|||
30714973|NCT00066469|58728281|FG000|Overall Study|Lack of Efficacy|9|||
30714974|NCT00066469|58728281|FG000|Overall Study|Lost to Follow-up|1|||
30714975|NCT00066469|58728281|FG000|Overall Study|Physician Decision|1|||
30714976|NCT00066469|58728281|FG000|Overall Study|Withdrawal by Subject|1|||
30714977|NCT00066469|58728281|FG000|Overall Study|ineligible|1|||
30714978|NCT00387088|58728287|FG000|Overall Study|Adverse Event|143|||
30714979|NCT00387088|58728288|FG001|Overall Study|Adverse Event|156|||
30714980|NCT00387088|58728287|FG000|Overall Study|Protocol Violation|47|||
30714981|NCT00387088|58728288|FG001|Overall Study|Protocol Violation|35|||
30714982|NCT00387088|58728287|FG000|Overall Study|Withdrawal by Subject|20|||
30714983|NCT00387088|58728288|FG001|Overall Study|Withdrawal by Subject|35|||
30714984|NCT00387088|58728287|FG000|Overall Study|Lack of Efficacy|28|||
30714985|NCT00387088|58728288|FG001|Overall Study|Lack of Efficacy|67|||
30714986|NCT00387088|58728287|FG000|Overall Study|Lost to Follow-up|22|||
30714987|NCT00387088|58728288|FG001|Overall Study|Lost to Follow-up|28|||
30714988|NCT00387088|58728287|FG000|Overall Study|Other|58|||
30714989|NCT00387088|58728288|FG001|Overall Study|Other|52|||
30714990|NCT00053365|58728294|FG000|Overall Study|Incorrect cell type|1|||
30714991|NCT00053365|58728294|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
30714992|NCT00053365|58728294|FG000|Overall Study|Never treated|4|||
30714993|NCT00387010|58728300|FG000|Dose Titration Period|Adverse Event|12|||
30714994|NCT00387010|58728300|FG000|Dose Titration Period|Lack of Efficacy|5|||
30714995|NCT00387010|58728300|FG000|Dose Titration Period|Withdrawal by Subject|3|||
30714996|NCT00387010|58728300|FG000|Dose Titration Period|Protocol Violation|1|||
30714997|NCT00387010|58728300|FG000|Dose Titration Period|Lost to Follow-up|2|||
30714998|NCT00387010|58728300|FG000|Dose Titration Period|Noncompliance with study medication|8|||
30714999|NCT00387010|58728300|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
30715000|NCT00387010|58728300|FG000|Treatment Period|Adverse Event|4|||
30715001|NCT00387010|58728300|FG000|Treatment Period|Withdrawal by Subject|1|||
30715002|NCT00387010|58728300|FG000|Treatment Period|Noncompliance with study medication|2|||
30715003|NCT00387010|58728300|FG000|Treatment Period|Noncompliance with study procedures|3|||
30715004|NCT00387010|58728300|FG000|Treatment Period|Participant reported study drug stolen|1|||
30715005|NCT00386776|58728304|FG000|Overall Study|Withdrawal by Subject|8|||
30715006|NCT00065065|58728312|FG000|Overall Study|Adverse Event|3|||
30715007|NCT00065065|58728313|FG001|Overall Study|Adverse Event|2|||
30715008|NCT00065065|58728312|FG000|Overall Study|Withdrawal by Subject|1|||
30715009|NCT00065065|58728313|FG001|Overall Study|Withdrawal by Subject|5|||
30715010|NCT00065065|58728312|FG000|Overall Study|Lack of Efficacy|4|||
30715011|NCT00065065|58728313|FG001|Overall Study|Lack of Efficacy|11|||
30715012|NCT00065065|58728312|FG000|Overall Study|Other|2|||
30715013|NCT00065065|58728313|FG001|Overall Study|Other|2|||
30715014|NCT00386308|58728323|FG000|Overall Study|Adverse Event|3|||
30715015|NCT00386308|58728324|FG001|Overall Study|Adverse Event|3|||
30715016|NCT00386308|58728323|FG000|Overall Study|Protocol Violation|2|||
30715017|NCT00386308|58728324|FG001|Overall Study|Protocol Violation|5|||
30715018|NCT00386308|58728323|FG000|Overall Study|Lack of Efficacy|0|||
30715019|NCT00386308|58728324|FG001|Overall Study|Lack of Efficacy|2|||
30715020|NCT00386308|58728323|FG000|Overall Study|Lost to Follow-up|10|||
30715021|NCT00386308|58728324|FG001|Overall Study|Lost to Follow-up|6|||
30715022|NCT00386308|58728323|FG000|Overall Study|Withdrawal by Subject|6|||
30715023|NCT00386308|58728324|FG001|Overall Study|Withdrawal by Subject|2|||
30715024|NCT00386308|58728323|FG000|Overall Study|Other Event|8|||
30715025|NCT00386308|58728324|FG001|Overall Study|Other Event|1|||
30715026|NCT00064987|58728332|FG000|Overall Study|Physician Decision|3|||
30715027|NCT00064987|58728333|FG001|Overall Study|Physician Decision|0|||
30715028|NCT00374452|58728341|FG000|Overall Study|Left clinic before intervention started|4|||
30715029|NCT00374452|58728342|FG001|Overall Study|Left clinic before intervention started|1|||
30715030|NCT00374452|58728341|FG000|Overall Study|Change in job role before intervention|0|||
30715031|NCT00374452|58728342|FG001|Overall Study|Change in job role before intervention|1|||
30715032|NCT00374452|58728341|FG000|Overall Study|Left clinic after intervention started|1|||
30715033|NCT00374452|58728342|FG001|Overall Study|Left clinic after intervention started|1|||
30715034|NCT00374452|58728341|FG000|Overall Study|Withdrawal by Subject|0|||
30715035|NCT00374452|58728342|FG001|Overall Study|Withdrawal by Subject|2|||
30715036|NCT00064753|58728350|FG000|Overall Study|Death|251|||
30715037|NCT00064753|58728351|FG001|Overall Study|Death|242|||
30715038|NCT00064753|58728350|FG000|Overall Study|Withdrawal by Subject|198|||
30715039|NCT00064753|58728351|FG001|Overall Study|Withdrawal by Subject|171|||
30715040|NCT00064753|58728350|FG000|Overall Study|Lost to Follow-up|225|||
30715041|NCT00064753|58728351|FG001|Overall Study|Lost to Follow-up|235|||
30715042|NCT00374140|58728357|FG000|Overall Study|Lost to Follow-up|1|||
30715043|NCT00374140|58728357|FG000|Overall Study|Protocol Violation|1|||
30715044|NCT00665561|58728363|FG000|Overall Study|Death recorded on subject summary pages|75|||
30715045|NCT00665561|58728364|FG001|Overall Study|Death recorded on subject summary pages|75|||
30715046|NCT00665561|58728363|FG000|Overall Study|Does not meet entrance criteria|19|||
30715047|NCT00665561|58728364|FG001|Overall Study|Does not meet entrance criteria|21|||
30715048|NCT00665561|58728363|FG000|Overall Study|Lost to Follow-up|203|||
30715049|NCT00665561|58728364|FG001|Overall Study|Lost to Follow-up|264|||
30715050|NCT00665561|58728363|FG000|Overall Study|Withdrawal by Subject|74|||
30715051|NCT00665561|58728364|FG001|Overall Study|Withdrawal by Subject|65|||
30715052|NCT00665561|58728363|FG000|Overall Study|Other|123|||
30715053|NCT00665561|58728364|FG001|Overall Study|Other|108|||
30715054|NCT00665561|58728363|FG000|Overall Study|Site closed|8|||
30715055|NCT00665561|58728364|FG001|Overall Study|Site closed|0|||
30715056|NCT00665561|58728363|FG000|Overall Study|Withdrawn due to pregnancy|0|||
30715057|NCT00665561|58728364|FG001|Overall Study|Withdrawn due to pregnancy|1|||
30715058|NCT00663923|58728370|FG000|Overall Study|Lost to Follow-up|2|||
30715059|NCT00386152|58728379|FG000|Overall Study|Adverse Event|6|||
30715060|NCT00386152|58728380|FG001|Overall Study|Adverse Event|5|||
30715061|NCT00386152|58728381|FG002|Overall Study|Adverse Event|4|||
30715062|NCT00386152|58728379|FG000|Overall Study|Chang from original chemo stratification|4|||
30715063|NCT00386152|58728380|FG001|Overall Study|Chang from original chemo stratification|5|||
30715064|NCT00386152|58728381|FG002|Overall Study|Chang from original chemo stratification|6|||
30715065|NCT00386152|58728379|FG000|Overall Study|Death|3|||
30715066|NCT00386152|58728380|FG001|Overall Study|Death|0|||
30715067|NCT00386152|58728381|FG002|Overall Study|Death|1|||
30715068|NCT00386152|58728379|FG000|Overall Study|Disease progression|7|||
30715069|NCT00386152|58728380|FG001|Overall Study|Disease progression|4|||
30715070|NCT00386152|58728381|FG002|Overall Study|Disease progression|5|||
30715071|NCT00386152|58728379|FG000|Overall Study|Physician Decision|13|||
30715072|NCT00386152|58728380|FG001|Overall Study|Physician Decision|10|||
30715073|NCT00386152|58728381|FG002|Overall Study|Physician Decision|4|||
30715074|NCT00386152|58728379|FG000|Overall Study|Lost to Follow-up|1|||
30715075|NCT00386152|58728380|FG001|Overall Study|Lost to Follow-up|0|||
30715076|NCT00386152|58728381|FG002|Overall Study|Lost to Follow-up|0|||
30715077|NCT00386152|58728379|FG000|Overall Study|Completed chemotherapy|4|||
30715078|NCT00386152|58728380|FG001|Overall Study|Completed chemotherapy|5|||
30715079|NCT00386152|58728381|FG002|Overall Study|Completed chemotherapy|1|||
30715080|NCT00386152|58728379|FG000|Overall Study|Protocol Violation|3|||
30715081|NCT00386152|58728380|FG001|Overall Study|Protocol Violation|5|||
30715082|NCT00386152|58728381|FG002|Overall Study|Protocol Violation|2|||
30715083|NCT00386152|58728379|FG000|Overall Study|Withdrawal by Subject|3|||
30715084|NCT00386152|58728380|FG001|Overall Study|Withdrawal by Subject|6|||
30715085|NCT00386152|58728381|FG002|Overall Study|Withdrawal by Subject|10|||
30715086|NCT00385918|58728391|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
30715087|NCT00385918|58728392|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
30715088|NCT00385918|58728393|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
30715089|NCT00385918|58728391|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
30715090|NCT00385918|58728392|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
30715091|NCT00385918|58728393|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
30715092|NCT00385918|58728391|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
30715093|NCT00385918|58728392|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
30715094|NCT00385918|58728393|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
30715095|NCT00385918|58728391|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
30715096|NCT00385918|58728392|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
30715097|NCT00385918|58728393|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
30715098|NCT00385918|58728391|FG000|Intervention Phase After Randomization|Physician Decision|1|||
30715099|NCT00385918|58728392|FG001|Intervention Phase After Randomization|Physician Decision|0|||
30715100|NCT00385918|58728393|FG002|Intervention Phase After Randomization|Physician Decision|0|||
30715101|NCT00385918|58728391|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
30715102|NCT00385918|58728392|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
30715103|NCT00385918|58728393|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
30715104|NCT00385840|58728402|FG000|Overall Study|Adverse Event|1|||
30715105|NCT00385840|58728403|FG001|Overall Study|Adverse Event|1|||
30715106|NCT00385840|58728402|FG000|Overall Study|Lost to Follow-up|3|||
30715107|NCT00385840|58728403|FG001|Overall Study|Lost to Follow-up|13|||
30715108|NCT00385762|58728409|FG000|Overall Study|Adverse Event|1|||
30715109|NCT00385762|58728409|FG000|Overall Study|Lost to Follow-up|1|||
30715110|NCT00385684|58728413|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
30715111|NCT00385684|58728414|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
30715112|NCT00385684|58728413|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
30715113|NCT00385684|58728414|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
30715114|NCT00385684|58728413|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
30715115|NCT00385684|58728414|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
30715116|NCT00661661|58728422|FG000|Overall Study|Adverse Event|99|||
30715117|NCT00661661|58728423|FG001|Overall Study|Adverse Event|24|||
30715118|NCT00661661|58728422|FG000|Overall Study|Lack of Efficacy|3|||
30715119|NCT00661661|58728423|FG001|Overall Study|Lack of Efficacy|2|||
30715120|NCT00661661|58728422|FG000|Overall Study|Lost to Follow-up|0|||
30715121|NCT00661661|58728423|FG001|Overall Study|Lost to Follow-up|1|||
30715122|NCT00661661|58728422|FG000|Overall Study|Withdrawal by Subject|15|||
30715123|NCT00661661|58728423|FG001|Overall Study|Withdrawal by Subject|5|||
30715124|NCT00661661|58728422|FG000|Overall Study|Other|22|||
30715125|NCT00661661|58728423|FG001|Overall Study|Other|7|||
30715126|NCT00661661|58728422|FG000|Overall Study|Not assigned treatment|1|||
30715127|NCT00661661|58728423|FG001|Overall Study|Not assigned treatment|0|||
30715128|NCT00038467|58728433|FG000|Overall Study|Adverse Event|170|||
30715129|NCT00038467|58728434|FG001|Overall Study|Adverse Event|145|||
30715130|NCT00038467|58728433|FG000|Overall Study|Withdrawal by Subject|150|||
30715131|NCT00038467|58728434|FG001|Overall Study|Withdrawal by Subject|107|||
30715132|NCT00038467|58728433|FG000|Overall Study|Protocol Violation|19|||
30715133|NCT00038467|58728434|FG001|Overall Study|Protocol Violation|22|||
30715134|NCT00038467|58728433|FG000|Overall Study|Death|22|||
30715135|NCT00038467|58728434|FG001|Overall Study|Death|16|||
30715136|NCT00038467|58728433|FG000|Overall Study|Lost to Follow-up|15|||
30715137|NCT00038467|58728434|FG001|Overall Study|Lost to Follow-up|10|||
30715138|NCT00038467|58728433|FG000|Overall Study|Recurrence|109|||
30715139|NCT00038467|58728434|FG001|Overall Study|Recurrence|179|||
30715140|NCT00038467|58728433|FG000|Overall Study|Randomized, but not treated|31|||
30715141|NCT00038467|58728434|FG001|Overall Study|Randomized, but not treated|35|||
30715142|NCT00038467|58728433|FG000|Overall Study|Other|26|||
30715143|NCT00038467|58728434|FG001|Overall Study|Other|28|||
30715144|NCT00051025|58728442|FG000|Overall Study|Progressive Disease|1|||
30715145|NCT00051025|58728443|FG001|Overall Study|Progressive Disease|1|||
30715146|NCT00051025|58728442|FG000|Overall Study|Adverse Event|1|||
30715147|NCT00051025|58728443|FG001|Overall Study|Adverse Event|1|||
30715148|NCT00051025|58728442|FG000|Overall Study|Withdrawal by Subject|0|||
30715149|NCT00051025|58728443|FG001|Overall Study|Withdrawal by Subject|1|||
30715150|NCT00051025|58728442|FG000|Overall Study|Death|0|||
30715151|NCT00051025|58728443|FG001|Overall Study|Death|1|||
30715152|NCT00660179|58728452|FG000|Overall Study|Death|44|||
30715153|NCT00660179|58728453|FG001|Overall Study|Death|47|||
30715154|NCT00660179|58728454|FG002|Overall Study|Death|34|||
30715155|NCT00660179|58728452|FG000|Overall Study|Withdrawal of consent|4|||
30715156|NCT00660179|58728453|FG001|Overall Study|Withdrawal of consent|6|||
30715157|NCT00660179|58728454|FG002|Overall Study|Withdrawal of consent|4|||
30715158|NCT00660179|58728452|FG000|Overall Study|Lost to Follow-up|7|||
30715159|NCT00660179|58728453|FG001|Overall Study|Lost to Follow-up|5|||
30715160|NCT00660179|58728454|FG002|Overall Study|Lost to Follow-up|2|||
30715161|NCT00660179|58728452|FG000|Overall Study|Administrative reason|0|||
30715162|NCT00660179|58728453|FG001|Overall Study|Administrative reason|0|||
30715163|NCT00660179|58728454|FG002|Overall Study|Administrative reason|1|||
30715164|NCT00660179|58728452|FG000|Overall Study|Incorrect randomization|1|||
30715165|NCT00660179|58728453|FG001|Overall Study|Incorrect randomization|0|||
30715166|NCT00660179|58728454|FG002|Overall Study|Incorrect randomization|0|||
30715167|NCT00050167|58728464|FG000|Overall Study|not eligible not invasive|1|||
30715168|NCT00050167|58728465|FG001|Overall Study|not eligible not invasive|1|||
30715169|NCT00660023|58728471|FG000|Overall Study|Adverse Event|2|||
30715170|NCT00660023|58728471|FG000|Overall Study|Death|8|||
30715171|NCT00660023|58728471|FG000|Overall Study|Blood Transfusion|5|||
30715172|NCT00660023|58728471|FG000|Overall Study|Renal Transplantation|3|||
30715173|NCT00660023|58728471|FG000|Overall Study|Withdrawal by Subject|1|||
30715174|NCT00660023|58728471|FG000|Overall Study|Missed Pregnancy Test|1|||
30715175|NCT00660023|58728471|FG000|Overall Study|Other Screening Failure|9|||
30715176|NCT00062647|58728477|FG000|Overall Study|Death|2|||
30715177|NCT00062647|58728478|FG001|Overall Study|Death|2|||
30715178|NCT00062647|58728477|FG000|Overall Study|Adverse Event|1|||
30715179|NCT00062647|58728478|FG001|Overall Study|Adverse Event|1|||
30715180|NCT00062647|58728477|FG000|Overall Study|Withdrawal by Subject|2|||
30715181|NCT00062647|58728478|FG001|Overall Study|Withdrawal by Subject|1|||
30715182|NCT00062647|58728477|FG000|Overall Study|Protocol Violation|1|||
30715183|NCT00062647|58728478|FG001|Overall Study|Protocol Violation|0|||
30715184|NCT00062647|58728477|FG000|Overall Study|Lost to Follow-up|1|||
30715185|NCT00062647|58728478|FG001|Overall Study|Lost to Follow-up|2|||
30715186|NCT00062647|58728477|FG000|Overall Study|Failed continuation criteria|4|||
30715187|NCT00062647|58728478|FG001|Overall Study|Failed continuation criteria|2|||
30715188|NCT00062647|58728477|FG000|Overall Study|Other|4|||
30715189|NCT00062647|58728478|FG001|Overall Study|Other|4|||
30715190|NCT00062647|58728477|FG000|Overall Study|Never received study treatment|1|||
30715191|NCT00062647|58728478|FG001|Overall Study|Never received study treatment|1|||
30715192|NCT00570323|58728486|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
30715193|NCT00570323|58728487|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
30715194|NCT00570323|58728486|FG000|Started Treatment After Randomization|Protocol Violation|1|||
30715195|NCT00570323|58728487|FG001|Started Treatment After Randomization|Protocol Violation|0|||
30715196|NCT00570323|58728486|FG000|Started Treatment After Randomization|Physician Decision|1|||
30715197|NCT00570323|58728487|FG001|Started Treatment After Randomization|Physician Decision|0|||
30715198|NCT00570323|58728486|FG000|Complete Study After Start|Lost to Follow-up|0|||
30715199|NCT00570323|58728487|FG001|Complete Study After Start|Lost to Follow-up|1|||
30715200|NCT00570323|58728486|FG000|Complete Study After Start|Withdrawal by Subject|2|||
30715201|NCT00570323|58728487|FG001|Complete Study After Start|Withdrawal by Subject|0|||
30715202|NCT00570323|58728486|FG000|Complete Study After Start|Physician Decision|1|||
30899991|NCT02465567|58933270|FG003|Overall Study|Lack of Efficacy|135|||
30899992|NCT02465567|58933267|FG000|Overall Study|Withdrawal by Subject|104|||
30899993|NCT02465567|58933268|FG001|Overall Study|Withdrawal by Subject|94|||
30899994|NCT02465567|58933269|FG002|Overall Study|Withdrawal by Subject|123|||
30715203|NCT00570323|58728487|FG001|Complete Study After Start|Physician Decision|0|||
30715204|NCT00661505|58728495|FG000|Overall Study|Adverse Event|3|||
30715205|NCT00661505|58728495|FG000|Overall Study|Protocol Violation|14|||
30899995|NCT02465567|58933270|FG003|Overall Study|Withdrawal by Subject|130|||
30899996|NCT02465567|58933267|FG000|Overall Study|Physician Decision|23|||
30715206|NCT00661505|58728495|FG000|Overall Study|Withdrawal by Subject|8|||
30715207|NCT00661505|58728495|FG000|Overall Study|Lost to Follow-up|3|||
30715208|NCT00661505|58728495|FG000|Overall Study|Other|2|||
30715209|NCT00662909|58728503|FG000|Overall Study|Adverse Event|17|||
30715210|NCT00662909|58728504|FG001|Overall Study|Adverse Event|18|||
30715211|NCT00662909|58728505|FG002|Overall Study|Adverse Event|19|||
30715212|NCT00662909|58728503|FG000|Overall Study|Lack of Efficacy|9|||
30715213|NCT00662909|58728504|FG001|Overall Study|Lack of Efficacy|1|||
30715214|NCT00662909|58728505|FG002|Overall Study|Lack of Efficacy|5|||
30715215|NCT00662909|58728503|FG000|Overall Study|Withdrawal by Subject|29|||
30715216|NCT00662909|58728504|FG001|Overall Study|Withdrawal by Subject|22|||
30715217|NCT00662909|58728505|FG002|Overall Study|Withdrawal by Subject|16|||
30715218|NCT00662909|58728503|FG000|Overall Study|Lost to Follow-up|2|||
30715219|NCT00662909|58728504|FG001|Overall Study|Lost to Follow-up|9|||
30715220|NCT00662909|58728505|FG002|Overall Study|Lost to Follow-up|3|||
30715221|NCT00662909|58728503|FG000|Overall Study|Protocol Violation|7|||
30715222|NCT00662909|58728504|FG001|Overall Study|Protocol Violation|4|||
30715223|NCT00662909|58728505|FG002|Overall Study|Protocol Violation|5|||
30715224|NCT00662909|58728503|FG000|Overall Study|Randomized- never received study drug|1|||
30715225|NCT00662909|58728504|FG001|Overall Study|Randomized- never received study drug|0|||
30715226|NCT00662909|58728505|FG002|Overall Study|Randomized- never received study drug|0|||
30715227|NCT00662909|58728503|FG000|Overall Study|Non-compliance with study procedures|3|||
30715228|NCT00662909|58728504|FG001|Overall Study|Non-compliance with study procedures|3|||
30715229|NCT00662909|58728505|FG002|Overall Study|Non-compliance with study procedures|2|||
30715230|NCT00662909|58728503|FG000|Overall Study|Physician Decision|1|||
30715231|NCT00662909|58728504|FG001|Overall Study|Physician Decision|1|||
30715232|NCT00662909|58728505|FG002|Overall Study|Physician Decision|2|||
30715233|NCT00662909|58728503|FG000|Overall Study|Eligibility criterion not met|0|||
30899997|NCT02465567|58933268|FG001|Overall Study|Physician Decision|33|||
30899998|NCT02465567|58933269|FG002|Overall Study|Physician Decision|38|||
30715234|NCT00662909|58728504|FG001|Overall Study|Eligibility criterion not met|1|||
30715235|NCT00662909|58728505|FG002|Overall Study|Eligibility criterion not met|1|||
30715236|NCT00050011|58728515|FG000|Overall Study|Adverse Event|41|||
30715237|NCT00050011|58728516|FG001|Overall Study|Adverse Event|46|||
30715238|NCT00050011|58728515|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30715239|NCT00050011|58728516|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30715240|NCT00050011|58728515|FG000|Overall Study|Abnormal test procedure results|0|||
30715241|NCT00050011|58728516|FG001|Overall Study|Abnormal test procedure results|1|||
30715242|NCT00050011|58728515|FG000|Overall Study|Lack of Efficacy|16|||
30715243|NCT00050011|58728516|FG001|Overall Study|Lack of Efficacy|21|||
30715244|NCT00050011|58728515|FG000|Overall Study|Participant condition no longer required|1|||
30715245|NCT00050011|58728516|FG001|Overall Study|Participant condition no longer required|0|||
30715246|NCT00050011|58728515|FG000|Overall Study|Protocol Violation|4|||
30715247|NCT00050011|58728516|FG001|Overall Study|Protocol Violation|10|||
30715248|NCT00050011|58728515|FG000|Overall Study|Withdrawal by Subject|34|||
30715249|NCT00050011|58728516|FG001|Overall Study|Withdrawal by Subject|26|||
30715250|NCT00050011|58728515|FG000|Overall Study|Lost to Follow-up|7|||
30715251|NCT00050011|58728516|FG001|Overall Study|Lost to Follow-up|9|||
30899999|NCT02465567|58933270|FG003|Overall Study|Physician Decision|28|||
30900000|NCT02465567|58933267|FG000|Overall Study|Major Protocol Deviation|24|||
30715252|NCT00050011|58728515|FG000|Overall Study|Administrative problems|10|||
30715253|NCT00050011|58728516|FG001|Overall Study|Administrative problems|6|||
30900001|NCT02465567|58933268|FG001|Overall Study|Major Protocol Deviation|26|||
30715254|NCT00050011|58728515|FG000|Overall Study|Death|7|||
30715255|NCT00050011|58728516|FG001|Overall Study|Death|4|||
30715256|NCT00050011|58728515|FG000|Overall Study|Unknown - Reason is missing|0|||
30715257|NCT00050011|58728516|FG001|Overall Study|Unknown - Reason is missing|2|||
30715258|NCT00661427|58728525|FG000|Overall Study|Adverse Event|5|||
30715259|NCT00661427|58728526|FG001|Overall Study|Adverse Event|5|||
30715260|NCT00661427|58728525|FG000|Overall Study|Patient not treated|0|||
30715261|NCT00661427|58728526|FG001|Overall Study|Patient not treated|2|||
30715262|NCT00049543|58728534|FG000|Overall Study|still on treatment|2|||
30715263|NCT00049543|58728535|FG001|Overall Study|still on treatment|9|||
30715264|NCT00048997|58728543|FG000|Overall Study|Protocol Violation|7|||
30715265|NCT00048997|58728544|FG001|Overall Study|Protocol Violation|2|||
30715266|NCT00048997|58728543|FG000|Overall Study|Withdrawal by Subject|6|||
30715267|NCT00048997|58728544|FG001|Overall Study|Withdrawal by Subject|1|||
30715268|NCT00035815|58728551|FG000|Overall Study|Withdrawal by Subject|17|||
30715269|NCT00035815|58728552|FG001|Overall Study|Withdrawal by Subject|11|||
30715270|NCT00662831|58728560|FG000|Overall Study|Death|4|||
30715271|NCT00662831|58728561|FG001|Overall Study|Death|1|||
30715272|NCT00662831|58728560|FG000|Overall Study|Lack of Efficacy|6|||
30715273|NCT00662831|58728561|FG001|Overall Study|Lack of Efficacy|6|||
30715274|NCT00662831|58728560|FG000|Overall Study|Lost to Follow-up|1|||
30715275|NCT00662831|58728561|FG001|Overall Study|Lost to Follow-up|0|||
30715276|NCT00662831|58728560|FG000|Overall Study|Withdrawal by Subject|2|||
30715277|NCT00662831|58728561|FG001|Overall Study|Withdrawal by Subject|1|||
30715278|NCT00662831|58728560|FG000|Overall Study|Other|62|||
30715279|NCT00662831|58728561|FG001|Overall Study|Other|31|||
30715280|NCT00662831|58728560|FG000|Overall Study|Protocol Violation|8|||
30715281|NCT00662831|58728561|FG001|Overall Study|Protocol Violation|4|||
30715282|NCT00662831|58728560|FG000|Overall Study|Adverse Event|23|||
30715283|NCT00662831|58728561|FG001|Overall Study|Adverse Event|16|||
30715284|NCT00662363|58728569|FG000|Overall Study|Withdrawal by Subject|6|||
30715285|NCT00662363|58728570|FG001|Overall Study|Withdrawal by Subject|5|||
30715286|NCT00662363|58728569|FG000|Overall Study|Adverse Event|0|||
30715287|NCT00662363|58728570|FG001|Overall Study|Adverse Event|3|||
30715288|NCT00662363|58728569|FG000|Overall Study|Discharged early from rehab|4|||
30715289|NCT00662363|58728570|FG001|Overall Study|Discharged early from rehab|1|||
30715290|NCT00662363|58728569|FG000|Overall Study|Protocol Violation|1|||
30715291|NCT00662363|58728570|FG001|Overall Study|Protocol Violation|1|||
30715292|NCT00661271|58728580|FG000|Overall Study|Lost to Follow-up|28|||
30715293|NCT00661271|58728581|FG001|Overall Study|Lost to Follow-up|25|||
30715294|NCT00661193|58728589|FG000|Overall Study|Adverse Event|2|||
30715295|NCT00661193|58728590|FG001|Overall Study|Adverse Event|1|||
30715296|NCT00661193|58728589|FG000|Overall Study|Withdrawal by Subject|3|||
30715297|NCT00661193|58728590|FG001|Overall Study|Withdrawal by Subject|1|||
30715298|NCT00661193|58728589|FG000|Overall Study|Progression|27|||
30715299|NCT00661193|58728590|FG001|Overall Study|Progression|24|||
30715300|NCT00661193|58728589|FG000|Overall Study|Not protocol specified|1|||
30715301|NCT00661193|58728590|FG001|Overall Study|Not protocol specified|0|||
30715302|NCT00658541|58728596|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
30715303|NCT00658541|58728597|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
30715304|NCT00658541|58728596|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
30715305|NCT00658541|58728597|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
30715306|NCT00048061|58728607|FG000|Overall Study|Adverse Event|41|||
30715307|NCT00048061|58728608|FG001|Overall Study|Adverse Event|32|||
30715308|NCT00048061|58728609|FG002|Overall Study|Adverse Event|44|||
30715309|NCT00048061|58728610|FG003|Overall Study|Adverse Event|37|||
30900002|NCT02465567|58933269|FG002|Overall Study|Major Protocol Deviation|22|||
30900003|NCT02465567|58933270|FG003|Overall Study|Major Protocol Deviation|25|||
30900004|NCT02465567|58933267|FG000|Overall Study|Lost to Follow-up|25|||
30900005|NCT02465567|58933268|FG001|Overall Study|Lost to Follow-up|21|||
30900006|NCT02465567|58933269|FG002|Overall Study|Lost to Follow-up|19|||
30900007|NCT02465567|58933270|FG003|Overall Study|Lost to Follow-up|15|||
30900008|NCT02465567|58933267|FG000|Overall Study|Protocol Specified Criteria|20|||
30900009|NCT02465567|58933268|FG001|Overall Study|Protocol Specified Criteria|10|||
30715310|NCT00048061|58728607|FG000|Overall Study|Lost to Follow-up|3|||
30715311|NCT00048061|58728608|FG001|Overall Study|Lost to Follow-up|2|||
30715312|NCT00048061|58728609|FG002|Overall Study|Lost to Follow-up|4|||
30715313|NCT00048061|58728610|FG003|Overall Study|Lost to Follow-up|5|||
30715314|NCT00048061|58728607|FG000|Overall Study|Withdrawal by Subject|20|||
30715315|NCT00048061|58728608|FG001|Overall Study|Withdrawal by Subject|29|||
30715316|NCT00048061|58728609|FG002|Overall Study|Withdrawal by Subject|29|||
30715317|NCT00048061|58728610|FG003|Overall Study|Withdrawal by Subject|32|||
30715318|NCT00048061|58728607|FG000|Overall Study|Did not follow-up|5|||
30715319|NCT00048061|58728608|FG001|Overall Study|Did not follow-up|5|||
30715320|NCT00048061|58728609|FG002|Overall Study|Did not follow-up|4|||
30715321|NCT00048061|58728610|FG003|Overall Study|Did not follow-up|5|||
30900010|NCT02465567|58933269|FG002|Overall Study|Protocol Specified Criteria|9|||
30900011|NCT02465567|58933270|FG003|Overall Study|Protocol Specified Criteria|12|||
30715322|NCT00048061|58728607|FG000|Overall Study|Early improvement|6|||
30715323|NCT00048061|58728608|FG001|Overall Study|Early improvement|5|||
30715324|NCT00048061|58728609|FG002|Overall Study|Early improvement|3|||
30715325|NCT00048061|58728610|FG003|Overall Study|Early improvement|0|||
30715326|NCT00656513|58728623|FG000|Overall Study|Protocol Violation|1|||
30715327|NCT00656513|58728624|FG001|Overall Study|Protocol Violation|0|||
30715328|NCT00656513|58728625|FG002|Overall Study|Protocol Violation|2|||
30715329|NCT00656513|58728623|FG000|Overall Study|Withdrawal by Subject|0|||
30715330|NCT00656513|58728624|FG001|Overall Study|Withdrawal by Subject|11|||
30715331|NCT00656513|58728625|FG002|Overall Study|Withdrawal by Subject|4|||
30715332|NCT00656513|58728623|FG000|Overall Study|Death|0|||
30715333|NCT00656513|58728624|FG001|Overall Study|Death|0|||
30715334|NCT00656513|58728625|FG002|Overall Study|Death|1|||
30715335|NCT00656513|58728623|FG000|Overall Study|Missing data|0|||
30715336|NCT00656513|58728624|FG001|Overall Study|Missing data|11|||
30715337|NCT00656513|58728625|FG002|Overall Study|Missing data|9|||
30715338|NCT00656513|58728623|FG000|Overall Study|Incomplete treatment|3|||
30715339|NCT00656513|58728624|FG001|Overall Study|Incomplete treatment|0|||
30715340|NCT00656513|58728625|FG002|Overall Study|Incomplete treatment|0|||
30715341|NCT00656513|58728623|FG000|Overall Study|Treatment completed outside of timeframe|0|||
30715342|NCT00656513|58728624|FG001|Overall Study|Treatment completed outside of timeframe|3|||
30715343|NCT00656513|58728625|FG002|Overall Study|Treatment completed outside of timeframe|1|||
30715344|NCT00656513|58728623|FG000|Overall Study|Missing baseline form|0|||
30715345|NCT00656513|58728624|FG001|Overall Study|Missing baseline form|5|||
30715346|NCT00656513|58728625|FG002|Overall Study|Missing baseline form|5|||
30715347|NCT00655889|58728633|FG000|Overall Study|Inadequate cell growth|1|||
30715348|NCT00655889|58728633|FG000|Overall Study|Protocol Violation|1|||
30715349|NCT00655733|58728639|FG000|Overall Study|Lost to Follow-up|2|||
30715350|NCT00655733|58728640|FG001|Overall Study|Lost to Follow-up|2|||
30715351|NCT00655733|58728639|FG000|Overall Study|Adverse Event|2|||
30715352|NCT00655733|58728640|FG001|Overall Study|Adverse Event|2|||
30715353|NCT00655733|58728639|FG000|Overall Study|Withdrawal by Subject|3|||
30715354|NCT00655733|58728640|FG001|Overall Study|Withdrawal by Subject|3|||
30715355|NCT00655733|58728639|FG000|Overall Study|Physician Decision|0|||
30715356|NCT00655733|58728640|FG001|Overall Study|Physician Decision|1|||
30715357|NCT00657371|58728648|FG000|Overall Study|Poor bowel preparation|15|||
30715358|NCT00657371|58728648|FG000|Overall Study|Unable to intubate the cecum|5|||
30715359|NCT00657371|58728648|FG000|Overall Study|Protocol Violation|2|||
30715360|NCT00657371|58728648|FG000|Overall Study|Device- related reasons|13|||
30715361|NCT00657371|58728648|FG000|Overall Study|Pre-existing medical condition|4|||
30715362|NCT00658775|58728654|FG000|Overall Study|Adverse Event|4|||
30715363|NCT00658775|58728655|FG001|Overall Study|Adverse Event|6|||
30715364|NCT00658775|58728654|FG000|Overall Study|Lost to Follow-up|17|||
30715365|NCT00658775|58728655|FG001|Overall Study|Lost to Follow-up|18|||
30715366|NCT00658775|58728654|FG000|Overall Study|Withdrawal by Subject|6|||
30715367|NCT00658775|58728655|FG001|Overall Study|Withdrawal by Subject|4|||
30715368|NCT00658775|58728654|FG000|Overall Study|Withdrawal of consent|8|||
30715369|NCT00658775|58728655|FG001|Overall Study|Withdrawal of consent|7|||
30715370|NCT00658775|58728654|FG000|Overall Study|Other|7|||
30715371|NCT00658775|58728655|FG001|Overall Study|Other|8|||
30715372|NCT00488631|58728667|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
30715373|NCT00488631|58728668|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
30715374|NCT00488631|58728669|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
30715375|NCT00488631|58728670|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
30715376|NCT00488631|58728671|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
30715377|NCT00488631|58728672|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
30715378|NCT00488631|58728673|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
30715379|NCT00488631|58728674|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
30715380|NCT00488631|58728675|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
30715381|NCT00488631|58728676|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
30715382|NCT00488631|58728667|FG000|Double Blind Period (Week 0-54)|Death|0|||
30715383|NCT00488631|58728668|FG001|Double Blind Period (Week 0-54)|Death|0|||
30715384|NCT00488631|58728669|FG002|Double Blind Period (Week 0-54)|Death|0|||
30715385|NCT00488631|58728670|FG003|Double Blind Period (Week 0-54)|Death|0|||
30715386|NCT00488631|58728671|FG004|Double Blind Period (Week 0-54)|Death|0|||
30715387|NCT00488631|58728672|FG005|Double Blind Period (Week 0-54)|Death|1|||
30715388|NCT00488631|58728673|FG006|Double Blind Period (Week 0-54)|Death|0|||
30715389|NCT00488631|58728674|FG007|Double Blind Period (Week 0-54)|Death|0|||
30715390|NCT00488631|58728675|FG008|Double Blind Period (Week 0-54)|Death|0|||
30715391|NCT00488631|58728676|FG009|Double Blind Period (Week 0-54)|Death|0|||
30715392|NCT00488631|58728667|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
30715393|NCT00488631|58728668|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
30715394|NCT00488631|58728669|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
30715395|NCT00488631|58728670|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
30715396|NCT00488631|58728671|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
30715397|NCT00488631|58728672|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
30715398|NCT00488631|58728673|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
30715399|NCT00488631|58728674|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
30715400|NCT00488631|58728675|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
30715401|NCT00488631|58728676|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
30715402|NCT00488631|58728667|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
30715403|NCT00488631|58728668|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
30715404|NCT00488631|58728669|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
30715405|NCT00488631|58728670|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
30715406|NCT00488631|58728671|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
30715407|NCT00488631|58728672|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
30715408|NCT00488631|58728673|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
30715409|NCT00488631|58728674|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
30715410|NCT00488631|58728675|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
30900012|NCT02465567|58933267|FG000|Overall Study|Administrative Reasons|12|||
30900013|NCT02465567|58933268|FG001|Overall Study|Administrative Reasons|9|||
30900014|NCT02465567|58933269|FG002|Overall Study|Administrative Reasons|11|||
30900015|NCT02465567|58933270|FG003|Overall Study|Administrative Reasons|5|||
30900016|NCT02465567|58933267|FG000|Overall Study|Randomized but not treated|1|||
30715411|NCT00488631|58728676|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
30900017|NCT02465567|58933268|FG001|Overall Study|Randomized but not treated|5|||
30900018|NCT02465567|58933269|FG002|Overall Study|Randomized but not treated|4|||
30715412|NCT00488631|58728667|FG000|Double Blind Period (Week 0-54)|Other|6|||
30715413|NCT00488631|58728668|FG001|Double Blind Period (Week 0-54)|Other|12|||
30715414|NCT00488631|58728669|FG002|Double Blind Period (Week 0-54)|Other|10|||
30715415|NCT00488631|58728670|FG003|Double Blind Period (Week 0-54)|Other|11|||
30715416|NCT00488631|58728671|FG004|Double Blind Period (Week 0-54)|Other|14|||
30715417|NCT00488631|58728672|FG005|Double Blind Period (Week 0-54)|Other|34|||
30715418|NCT00488631|58728673|FG006|Double Blind Period (Week 0-54)|Other|0|||
30715419|NCT00488631|58728674|FG007|Double Blind Period (Week 0-54)|Other|0|||
30715420|NCT00488631|58728675|FG008|Double Blind Period (Week 0-54)|Other|0|||
30715421|NCT00488631|58728676|FG009|Double Blind Period (Week 0-54)|Other|0|||
30715422|NCT00488631|58728667|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
30715423|NCT00488631|58728668|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
30715424|NCT00488631|58728669|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
30715425|NCT00488631|58728670|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
30715426|NCT00488631|58728671|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
30715427|NCT00488631|58728672|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
30715428|NCT00488631|58728673|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
30715429|NCT00488631|58728674|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
30715430|NCT00488631|58728675|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
30715431|NCT00488631|58728676|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
30715432|NCT00488631|58728667|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
30715433|NCT00488631|58728668|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
30715434|NCT00488631|58728669|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
30715435|NCT00488631|58728670|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
30715436|NCT00488631|58728671|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
30715437|NCT00488631|58728672|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
30715438|NCT00488631|58728673|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
30715439|NCT00488631|58728674|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
30715440|NCT00488631|58728675|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
30715441|NCT00488631|58728676|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
30715442|NCT00488631|58728667|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
30715443|NCT00488631|58728668|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
30715444|NCT00488631|58728669|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
30715445|NCT00488631|58728670|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
30715446|NCT00488631|58728671|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
30715447|NCT00488631|58728672|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
30715448|NCT00488631|58728673|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
30715449|NCT00488631|58728674|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
30715450|NCT00488631|58728675|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
30715451|NCT00488631|58728676|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
30715452|NCT00488631|58728667|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
30715453|NCT00488631|58728668|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
30715454|NCT00488631|58728669|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
30715455|NCT00488631|58728670|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
30715456|NCT00488631|58728671|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
30715457|NCT00488631|58728672|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
30715458|NCT00488631|58728673|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
30900019|NCT02465567|58933270|FG003|Overall Study|Randomized but not treated|5|||
30900020|NCT02465567|58933267|FG000|Overall Study|enrolled in >1 studies|18|||
30900021|NCT02465567|58933268|FG001|Overall Study|enrolled in >1 studies|11|||
30900022|NCT02465567|58933269|FG002|Overall Study|enrolled in >1 studies|19|||
30900023|NCT02465567|58933270|FG003|Overall Study|enrolled in >1 studies|15|||
30900024|NCT02465567|58933267|FG000|Overall Study|missing PI Signature|1|||
30900025|NCT02465567|58933268|FG001|Overall Study|missing PI Signature|0|||
30900026|NCT02465567|58933269|FG002|Overall Study|missing PI Signature|0|||
30900027|NCT02465567|58933270|FG003|Overall Study|missing PI Signature|0|||
30900028|NCT01644175|58933282|FG000|Overall Study|Randomized But Not Treated|0|||
30900029|NCT01644175|58933283|FG001|Overall Study|Randomized But Not Treated|2|||
30900030|NCT01644175|58933282|FG000|Overall Study|Adverse Event|8|||
30900031|NCT01644175|58933283|FG001|Overall Study|Adverse Event|13|||
30900032|NCT01644175|58933282|FG000|Overall Study|Death|1|||
30900033|NCT01644175|58933283|FG001|Overall Study|Death|2|||
30900034|NCT01644175|58933282|FG000|Overall Study|Poor compliance to protocol|9|||
30900035|NCT01644175|58933283|FG001|Overall Study|Poor compliance to protocol|10|||
30900036|NCT01644175|58933282|FG000|Overall Study|Physician Decision|1|||
30900037|NCT01644175|58933283|FG001|Overall Study|Physician Decision|2|||
30900038|NCT01644175|58933282|FG000|Overall Study|Participant Moved|1|||
30900039|NCT01644175|58933283|FG001|Overall Study|Participant Moved|2|||
30900040|NCT01644175|58933282|FG000|Overall Study|Consent withdrawn by participant|3|||
30900041|NCT01644175|58933283|FG001|Overall Study|Consent withdrawn by participant|4|||
30900042|NCT01644175|58933282|FG000|Overall Study|Related to Autoinjector Administration|2|||
30900043|NCT01644175|58933283|FG001|Overall Study|Related to Autoinjector Administration|1|||
30900044|NCT01644175|58933282|FG000|Overall Study|Last visit outside protocol visit window|4|||
30715459|NCT00488631|58728674|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
30715460|NCT00488631|58728675|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
30715461|NCT00488631|58728676|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
30715462|NCT00488631|58728667|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
30715463|NCT00488631|58728668|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
30715464|NCT00488631|58728669|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
30715465|NCT00488631|58728670|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
30715466|NCT00488631|58728671|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
30715467|NCT00488631|58728672|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
30715468|NCT00488631|58728673|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
30715469|NCT00488631|58728674|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
30715470|NCT00488631|58728675|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
30715471|NCT00488631|58728676|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
30715472|NCT00655499|58728699|FG000|Overall Study|not eligible|4|||
30715473|NCT00654875|58728706|FG000|Overall Study|Adverse Event|5|||
30715474|NCT00654875|58728707|FG001|Overall Study|Adverse Event|5|||
30715475|NCT00654875|58728706|FG000|Overall Study|Withdrawal by Subject|4|||
30715476|NCT00654875|58728707|FG001|Overall Study|Withdrawal by Subject|4|||
30715477|NCT00654875|58728706|FG000|Overall Study|Protocol Violation|3|||
30715478|NCT00654875|58728707|FG001|Overall Study|Protocol Violation|3|||
30900045|NCT01644175|58933283|FG001|Overall Study|Last visit outside protocol visit window|11|||
30900046|NCT01644175|58933282|FG000|Overall Study|Selection criteria finally not met|0|||
30900047|NCT01644175|58933283|FG001|Overall Study|Selection criteria finally not met|1|||
30900048|NCT01644175|58933282|FG000|Overall Study|Site closure|2|||
30900049|NCT01644175|58933283|FG001|Overall Study|Site closure|2|||
30900050|NCT01644175|58933282|FG000|Overall Study|Lost to Follow-up|1|||
30900051|NCT01644175|58933283|FG001|Overall Study|Lost to Follow-up|0|||
30900052|NCT01644175|58933282|FG000|Overall Study|Other than specified above|0|||
30900053|NCT01644175|58933283|FG001|Overall Study|Other than specified above|3|||
30900054|NCT02357420|58933293|FG000|Overall Study|Adverse Event|3|||
30900055|NCT02357420|58933294|FG001|Overall Study|Adverse Event|3|||
30900056|NCT02357420|58933295|FG002|Overall Study|Adverse Event|8|||
30900057|NCT02357420|58933296|FG003|Overall Study|Adverse Event|9|||
30900058|NCT02357420|58933293|FG000|Overall Study|Investigator Decision|1|||
30900059|NCT02357420|58933294|FG001|Overall Study|Investigator Decision|0|||
30621537|NCT01193153|58633104|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
30715479|NCT00654875|58728706|FG000|Overall Study|Lack of Efficacy|2|||
30715480|NCT00654875|58728707|FG001|Overall Study|Lack of Efficacy|2|||
30900060|NCT02357420|58933295|FG002|Overall Study|Investigator Decision|0|||
30715481|NCT00654875|58728706|FG000|Overall Study|Lost to Follow-up|1|||
30715482|NCT00654875|58728707|FG001|Overall Study|Lost to Follow-up|3|||
30715483|NCT00654875|58728706|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
30715484|NCT00654875|58728707|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
30715485|NCT00654875|58728706|FG000|Overall Study|Administrative Problems|1|||
30715486|NCT00654875|58728707|FG001|Overall Study|Administrative Problems|0|||
30715487|NCT00651755|58728713|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
30715488|NCT00651755|58728714|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
30715489|NCT00651755|58728713|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
30715490|NCT00651755|58728714|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
30715491|NCT00654641|58728723|FG000|Overall Study|Lost to Follow-up|2|||
30715492|NCT00654641|58728724|FG001|Overall Study|Lost to Follow-up|3|||
30715493|NCT00569777|58728732|FG000|Overall Study|Withdrawal by Subject|4|||
30715494|NCT00569777|58728733|FG001|Overall Study|Withdrawal by Subject|0|||
30715495|NCT00569777|58728732|FG000|Overall Study|Adverse Event|3|||
30715496|NCT00569777|58728733|FG001|Overall Study|Adverse Event|0|||
30715497|NCT00569777|58728732|FG000|Overall Study|Lost to Follow-up|1|||
30715498|NCT00569777|58728733|FG001|Overall Study|Lost to Follow-up|0|||
30715499|NCT00569777|58728732|FG000|Overall Study|scheduled eye surgery|0|||
30715500|NCT00569777|58728733|FG001|Overall Study|scheduled eye surgery|1|||
30715501|NCT00569777|58728732|FG000|Overall Study|did not meet exclusion criteria|1|||
30715502|NCT00569777|58728733|FG001|Overall Study|did not meet exclusion criteria|2|||
30715503|NCT00569777|58728732|FG000|Overall Study|pregnant|1|||
30715504|NCT00569777|58728733|FG001|Overall Study|pregnant|0|||
30715505|NCT00569231|58728739|FG000|Overall Study|Study unrelated surgery|1|||
30715506|NCT00569231|58728739|FG000|Overall Study|Airfare expense|2|||
30715507|NCT00569231|58728739|FG000|Overall Study|Withdrawal by Subject|1|||
30715508|NCT00569231|58728739|FG000|Overall Study|Car accident injury|1|||
30715509|NCT00569231|58728739|FG000|Overall Study|Non-compliance|2|||
30715510|NCT00654095|58728743|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
30715511|NCT00654095|58728743|FG000|Overall Study|Elevated triglyceride level (2)|1|||
30715512|NCT00654095|58728743|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
30715513|NCT00654095|58728743|FG000|Overall Study|Adverse Event|11|||
30715514|NCT00654095|58728743|FG000|Overall Study|Withdrawal by Subject|5|||
30715515|NCT00654095|58728743|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
30715516|NCT00654095|58728743|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
30715517|NCT00654095|58728743|FG000|Overall Study|Did not meet inclusion criteria|1|||
30715518|NCT00650585|58728749|FG000|Overall Study|Lost to Follow-up|505|||
30715519|NCT00650585|58728750|FG001|Overall Study|Lost to Follow-up|482|||
30715520|NCT00650585|58728749|FG000|Overall Study|No parental consent|935|||
30715521|NCT00650585|58728750|FG001|Overall Study|No parental consent|866|||
30715522|NCT00650585|58728749|FG000|Overall Study|Excluded/ruled ineligible|357|||
30715523|NCT00650585|58728750|FG001|Overall Study|Excluded/ruled ineligible|129|||
30715524|NCT00653939|58728758|FG000|Overall Study|Adverse Event|1|||
30715525|NCT00653939|58728759|FG001|Overall Study|Adverse Event|3|||
30715526|NCT00653939|58728758|FG000|Overall Study|Withdrawal by Subject|3|||
30715527|NCT00653939|58728759|FG001|Overall Study|Withdrawal by Subject|3|||
30715528|NCT00653939|58728758|FG000|Overall Study|Physician Decision|4|||
30715529|NCT00653939|58728759|FG001|Overall Study|Physician Decision|0|||
30715530|NCT00653939|58728758|FG000|Overall Study|Disease Progression|2|||
30715531|NCT00653939|58728759|FG001|Overall Study|Disease Progression|3|||
30715532|NCT00653939|58728758|FG000|Overall Study|Other|2|||
30715533|NCT00653939|58728759|FG001|Overall Study|Other|6|||
30715534|NCT00646451|58728767|FG000|Overall Study|Adverse Event|3|||
30715535|NCT00646451|58728768|FG001|Overall Study|Adverse Event|0|||
30715536|NCT00646451|58728767|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
30715537|NCT00646451|58728768|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
30715538|NCT00642707|58728780|FG000|Overall Study|Adverse Event|0|||
30715539|NCT00642707|58728781|FG001|Overall Study|Adverse Event|0|||
30715540|NCT00642707|58728782|FG002|Overall Study|Adverse Event|0|||
30715541|NCT00642707|58728783|FG003|Overall Study|Adverse Event|2|||
30715542|NCT00642707|58728780|FG000|Overall Study|Withdrawal by Subject|1|||
30715543|NCT00642707|58728781|FG001|Overall Study|Withdrawal by Subject|0|||
30715544|NCT00642707|58728782|FG002|Overall Study|Withdrawal by Subject|0|||
30715545|NCT00642707|58728783|FG003|Overall Study|Withdrawal by Subject|0|||
30715546|NCT00568685|58728796|FG000|Overall Study|Adverse Event|2|||
30715547|NCT00568685|58728797|FG001|Overall Study|Adverse Event|3|||
30715548|NCT00568685|58728798|FG002|Overall Study|Adverse Event|3|||
30715549|NCT00568685|58728796|FG000|Overall Study|Withdrawal by Subject|7|||
30715550|NCT00568685|58728797|FG001|Overall Study|Withdrawal by Subject|2|||
30715551|NCT00568685|58728798|FG002|Overall Study|Withdrawal by Subject|2|||
30715552|NCT00568685|58728796|FG000|Overall Study|Protocol Violation|1|||
30715553|NCT00568685|58728797|FG001|Overall Study|Protocol Violation|0|||
30715554|NCT00568685|58728798|FG002|Overall Study|Protocol Violation|0|||
30715555|NCT00061945|58728812|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
30715556|NCT00061945|58728813|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
30715557|NCT00061945|58728812|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
30715558|NCT00061945|58728813|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
30715559|NCT00061945|58728812|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
30715560|NCT00061945|58728813|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
30715561|NCT00061945|58728812|FG000|Course IV: Alemtuzumab|Early exits|6|||
30715562|NCT00061945|58728813|FG001|Course IV: Alemtuzumab|Early exits|15|||
30900061|NCT02357420|58933296|FG003|Overall Study|Investigator Decision|0|||
30900062|NCT02357420|58933293|FG000|Overall Study|Prohibited Medication|1|||
30715563|NCT00642473|58728824|FG000|Overall Study|Withdrawal by Subject|0|||
30900063|NCT02357420|58933294|FG001|Overall Study|Prohibited Medication|1|||
30900064|NCT02357420|58933295|FG002|Overall Study|Prohibited Medication|0|||
30900065|NCT02357420|58933296|FG003|Overall Study|Prohibited Medication|0|||
30715564|NCT00642473|58728825|FG001|Overall Study|Withdrawal by Subject|5|||
30715565|NCT00642473|58728824|FG000|Overall Study|Progression or death|2|||
30715566|NCT00642473|58728825|FG001|Overall Study|Progression or death|4|||
30715567|NCT00642473|58728824|FG000|Overall Study|Other|2|||
30715568|NCT00642473|58728825|FG001|Overall Study|Other|2|||
30715569|NCT00645671|58728836|FG000|Overall Study|Protocol Violation|1|||
30715570|NCT00645671|58728837|FG001|Overall Study|Protocol Violation|0|||
30715571|NCT00645671|58728836|FG000|Overall Study|Withdrawal by Subject|0|||
30715572|NCT00645671|58728837|FG001|Overall Study|Withdrawal by Subject|4|||
30715573|NCT00645671|58728836|FG000|Overall Study|Adverse Event|0|||
30715574|NCT00645671|58728837|FG001|Overall Study|Adverse Event|1|||
30715575|NCT00645671|58728836|FG000|Overall Study|Physician Decision|0|||
30715576|NCT00645671|58728837|FG001|Overall Study|Physician Decision|1|||
30715577|NCT00366340|58728845|FG000|Infant Series|Protocol Violation|3|||
30715578|NCT00366340|58728846|FG001|Infant Series|Protocol Violation|4|||
30715579|NCT00366340|58728845|FG000|Infant Series|Withdrawal by Subject|3|||
30715580|NCT00366340|58728846|FG001|Infant Series|Withdrawal by Subject|3|||
30715581|NCT00366340|58728845|FG000|Infant Series|Adverse Event|0|||
30715582|NCT00366340|58728846|FG001|Infant Series|Adverse Event|2|||
30715583|NCT00366340|58728845|FG000|Infant Series|Lost to Follow-up|1|||
30715584|NCT00366340|58728846|FG001|Infant Series|Lost to Follow-up|1|||
30715585|NCT00366340|58728845|FG000|Infant Series|Failure to return|1|||
30715586|NCT00366340|58728846|FG001|Infant Series|Failure to return|0|||
30621538|NCT01192295|58633115|FG000|Overall Study|Adverse Event|3|||
30621539|NCT01192295|58633116|FG001|Overall Study|Adverse Event|7|||
30715587|NCT00366340|58728845|FG000|After the Infant Series|Parent/legal guardian request|1|||
30715588|NCT00366340|58728846|FG001|After the Infant Series|Parent/legal guardian request|1|||
30715589|NCT00366340|58728845|FG000|After the Infant Series|Failed to return|0|||
30715590|NCT00366340|58728846|FG001|After the Infant Series|Failed to return|1|||
30715591|NCT00366340|58728845|FG000|After the Infant Series|Protocol Violation|2|||
30715592|NCT00366340|58728846|FG001|After the Infant Series|Protocol Violation|2|||
30715593|NCT00366340|58728845|FG000|After the Infant Series|Adverse Event|0|||
30715594|NCT00366340|58728846|FG001|After the Infant Series|Adverse Event|1|||
30715595|NCT00366340|58728845|FG000|After the Infant Series|Lost to Follow-up|0|||
30900066|NCT02357420|58933293|FG000|Overall Study|Protocol Non-compliance|0|||
30900067|NCT02357420|58933294|FG001|Overall Study|Protocol Non-compliance|0|||
30900068|NCT02357420|58933295|FG002|Overall Study|Protocol Non-compliance|0|||
30900069|NCT02357420|58933296|FG003|Overall Study|Protocol Non-compliance|1|||
30900070|NCT02357420|58933293|FG000|Overall Study|Withdrawn Consent|4|||
30900071|NCT02357420|58933294|FG001|Overall Study|Withdrawn Consent|8|||
30900072|NCT02357420|58933295|FG002|Overall Study|Withdrawn Consent|6|||
30900073|NCT02357420|58933296|FG003|Overall Study|Withdrawn Consent|6|||
30900074|NCT02357420|58933293|FG000|Overall Study|Lost to Follow-up|3|||
30900075|NCT02357420|58933294|FG001|Overall Study|Lost to Follow-up|0|||
30715596|NCT00366340|58728846|FG001|After the Infant Series|Lost to Follow-up|1|||
30715597|NCT00366340|58728845|FG000|Toddler Dose|Failed to return|1|||
30715598|NCT00366340|58728846|FG001|Toddler Dose|Failed to return|0|||
30715599|NCT00366340|58728845|FG000|Toddler Dose|Parent/legal guardian request|0|||
30715600|NCT00366340|58728846|FG001|Toddler Dose|Parent/legal guardian request|1|||
30715601|NCT00061633|58728878|FG000|Overall Study|Adverse Event|1|||
30715602|NCT00061633|58728879|FG001|Overall Study|Adverse Event|2|||
30715603|NCT00061633|58728878|FG000|Overall Study|Withdrawal by Subject|2|||
30715604|NCT00061633|58728879|FG001|Overall Study|Withdrawal by Subject|2|||
30715605|NCT00061633|58728878|FG000|Overall Study|Lost to Follow-up|1|||
30715606|NCT00061633|58728879|FG001|Overall Study|Lost to Follow-up|4|||
30715607|NCT00061633|58728878|FG000|Overall Study|Other|1|||
30715608|NCT00061633|58728879|FG001|Overall Study|Other|1|||
30715609|NCT00061633|58728878|FG000|Overall Study|Never received study treatment|0|||
30715610|NCT00061633|58728879|FG001|Overall Study|Never received study treatment|2|||
30715611|NCT00645593|58728887|FG000|Overall Study|Later found to be ineligible|1|||
30715612|NCT00645593|58728888|FG001|Overall Study|Later found to be ineligible|0|||
30715613|NCT03832738|58728897|FG000|Overall Study|Withdrawal by Subject|6|||
30715614|NCT03832738|58728898|FG001|Overall Study|Withdrawal by Subject|7|||
30715615|NCT03832738|58728899|FG002|Overall Study|Withdrawal by Subject|16|||
30715616|NCT03832738|58728897|FG000|Overall Study|Physician Decision|0|||
30715617|NCT03832738|58728898|FG001|Overall Study|Physician Decision|1|||
30715618|NCT03832738|58728899|FG002|Overall Study|Physician Decision|2|||
30715619|NCT03832738|58728897|FG000|Overall Study|Adverse Event|2|||
30715620|NCT03832738|58728898|FG001|Overall Study|Adverse Event|3|||
30715621|NCT03832738|58728899|FG002|Overall Study|Adverse Event|1|||
30715622|NCT03832738|58728897|FG000|Overall Study|Pregnancy|0|||
30715623|NCT03832738|58728898|FG001|Overall Study|Pregnancy|1|||
30715624|NCT03832738|58728899|FG002|Overall Study|Pregnancy|0|||
30715625|NCT00046891|58728909|FG000|Overall Study|Cancels|5|||
30715626|NCT00046891|58728910|FG001|Overall Study|Cancels|9|||
30715627|NCT00046891|58728909|FG000|Overall Study|Ineligible|1|||
30715628|NCT00046891|58728910|FG001|Overall Study|Ineligible|1|||
30715629|NCT00046891|58728909|FG000|Overall Study|Withdrawal by Subject|18|||
30715630|NCT00046891|58728910|FG001|Overall Study|Withdrawal by Subject|15|||
30715631|NCT00046891|58728909|FG000|Overall Study|Adverse Event|5|||
30715632|NCT00046891|58728910|FG001|Overall Study|Adverse Event|5|||
30715633|NCT00365794|58728924|FG000|Overall Study|Withdrawal by Subject|2|||
30715634|NCT00383500|58728932|FG000|Overall Study|Withdrawal by Subject|8|||
30715635|NCT00383500|58728933|FG001|Overall Study|Withdrawal by Subject|3|||
30715636|NCT00383500|58728934|FG002|Overall Study|Withdrawal by Subject|0|||
30715637|NCT00383500|58728932|FG000|Overall Study|Lost to Follow-up|0|||
30715638|NCT00383500|58728933|FG001|Overall Study|Lost to Follow-up|0|||
30715639|NCT00383500|58728934|FG002|Overall Study|Lost to Follow-up|2|||
30715640|NCT00365716|58728948|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
30715641|NCT00365716|58728949|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
30715642|NCT00365716|58728950|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
30715643|NCT00365716|58728951|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
30715644|NCT00365716|58728952|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
30715645|NCT00365716|58728953|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
30715646|NCT00365716|58728954|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
30715647|NCT00365716|58728948|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
30715648|NCT00365716|58728949|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
30715649|NCT00365716|58728950|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
30900076|NCT02357420|58933295|FG002|Overall Study|Lost to Follow-up|2|||
30900077|NCT02357420|58933296|FG003|Overall Study|Lost to Follow-up|3|||
30900078|NCT01832038|58933306|FG000|Overall Study|Death|5|||
30900079|NCT01832038|58933306|FG000|Overall Study|Adverse Event|50|||
30621540|NCT01192295|58633115|FG000|Overall Study|Withdrawal by Subject|3|||
30621541|NCT01192295|58633116|FG001|Overall Study|Withdrawal by Subject|4|||
30715650|NCT00365716|58728951|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
30715651|NCT00365716|58728952|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
30715652|NCT00365716|58728953|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
30715653|NCT00365716|58728954|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
30715654|NCT00365716|58728948|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
30715655|NCT00365716|58728949|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
30715656|NCT00365716|58728950|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
30715657|NCT00365716|58728951|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
30715658|NCT00365716|58728952|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
30900080|NCT01832038|58933306|FG000|Overall Study|Lack of Efficacy|81|||
30715659|NCT00365716|58728953|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
30715660|NCT00365716|58728954|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
30715661|NCT00365716|58728948|FG000|Base Study (Day 1 to Month 7)|Other|0|||
30900081|NCT01832038|58933306|FG000|Overall Study|Protocol Violation|7|||
30900082|NCT01832038|58933306|FG000|Overall Study|Lost to Follow-up|10|||
30900083|NCT01832038|58933306|FG000|Overall Study|Withdrawal by Subject|49|||
30621542|NCT01192295|58633115|FG000|Overall Study|Lost to Follow-up|0|||
30715662|NCT00365716|58728949|FG001|Base Study (Day 1 to Month 7)|Other|1|||
30715663|NCT00365716|58728950|FG002|Base Study (Day 1 to Month 7)|Other|0|||
30715664|NCT00365716|58728951|FG003|Base Study (Day 1 to Month 7)|Other|0|||
30715665|NCT00365716|58728952|FG004|Base Study (Day 1 to Month 7)|Other|0|||
30715666|NCT00365716|58728953|FG005|Base Study (Day 1 to Month 7)|Other|0|||
30715667|NCT00365716|58728954|FG006|Base Study (Day 1 to Month 7)|Other|0|||
30715668|NCT00365716|58728948|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
30715669|NCT00365716|58728949|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
30715670|NCT00365716|58728950|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
30715671|NCT00365716|58728951|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
30715672|NCT00365716|58728952|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
30715673|NCT00365716|58728953|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
30715674|NCT00365716|58728954|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
30715675|NCT00365716|58728948|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
30715676|NCT00365716|58728949|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
30715677|NCT00365716|58728950|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
30715678|NCT00365716|58728951|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
30715679|NCT00365716|58728952|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
30715680|NCT00365716|58728953|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
30715681|NCT00365716|58728954|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
30715682|NCT00365716|58728948|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
30715683|NCT00365716|58728949|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
30715684|NCT00365716|58728950|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
30715685|NCT00365716|58728951|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
30715686|NCT00365716|58728952|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
30715687|NCT00365716|58728953|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
30715688|NCT00365716|58728954|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
30715689|NCT00365716|58728948|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
30715690|NCT00365716|58728949|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
30715691|NCT00365716|58728950|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
30715692|NCT00365716|58728951|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
30715693|NCT00365716|58728952|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
30715694|NCT00365716|58728953|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
30715695|NCT00365716|58728954|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
30715696|NCT00365716|58728948|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
30715697|NCT00365716|58728949|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
30715698|NCT00365716|58728950|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
30715699|NCT00365716|58728951|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
30715700|NCT00365716|58728952|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
30715701|NCT00365716|58728953|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
30715702|NCT00365716|58728954|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
30715703|NCT00365716|58728948|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
30715704|NCT00365716|58728949|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
30715705|NCT00365716|58728950|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
30715706|NCT00365716|58728951|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
30715707|NCT00365716|58728952|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
30715708|NCT00365716|58728953|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
30715709|NCT00365716|58728954|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
30715710|NCT00365716|58728948|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
30715711|NCT00365716|58728949|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
30715712|NCT00365716|58728950|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
30715713|NCT00365716|58728951|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
30715714|NCT00365716|58728952|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
30715715|NCT00365716|58728953|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
30715716|NCT00365716|58728954|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
30715717|NCT00365716|58728948|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
30715718|NCT00365716|58728949|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
30715719|NCT00365716|58728950|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
30715720|NCT00365716|58728951|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
30715721|NCT00365716|58728952|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
30715722|NCT00365716|58728953|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
30715723|NCT00365716|58728954|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
30715724|NCT00365716|58728948|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
30715725|NCT00365716|58728949|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
30715726|NCT00365716|58728950|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
30715727|NCT00365716|58728951|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
30715728|NCT00365716|58728952|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
30715729|NCT00365716|58728953|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
30715730|NCT00365716|58728954|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
30715731|NCT00365716|58728948|FG000|Extension 1|Lost to Follow-up|0|||
30715732|NCT00365716|58728949|FG001|Extension 1|Lost to Follow-up|0|||
30715733|NCT00365716|58728950|FG002|Extension 1|Lost to Follow-up|0|||
30715734|NCT00365716|58728951|FG003|Extension 1|Lost to Follow-up|0|||
30715735|NCT00365716|58728952|FG004|Extension 1|Lost to Follow-up|0|||
30715736|NCT00365716|58728953|FG005|Extension 1|Lost to Follow-up|1|||
30715737|NCT00365716|58728954|FG006|Extension 1|Lost to Follow-up|0|||
30715738|NCT00365716|58728948|FG000|Extension 1|Other|0|||
30715739|NCT00365716|58728949|FG001|Extension 1|Other|0|||
30715740|NCT00365716|58728950|FG002|Extension 1|Other|0|||
30715741|NCT00365716|58728951|FG003|Extension 1|Other|0|||
30715742|NCT00365716|58728952|FG004|Extension 1|Other|0|||
30715743|NCT00365716|58728953|FG005|Extension 1|Other|9|||
30715744|NCT00365716|58728954|FG006|Extension 1|Other|0|||
30715745|NCT00365716|58728948|FG000|Extension 1|Moved|0|||
30715746|NCT00365716|58728949|FG001|Extension 1|Moved|0|||
30715747|NCT00365716|58728950|FG002|Extension 1|Moved|0|||
30715748|NCT00365716|58728951|FG003|Extension 1|Moved|0|||
30715749|NCT00365716|58728952|FG004|Extension 1|Moved|0|||
30715750|NCT00365716|58728953|FG005|Extension 1|Moved|4|||
30715751|NCT00365716|58728954|FG006|Extension 1|Moved|0|||
30715752|NCT00365716|58728948|FG000|Extension 1|Withdrawal by Subject|0|||
30715753|NCT00365716|58728949|FG001|Extension 1|Withdrawal by Subject|0|||
30715754|NCT00365716|58728950|FG002|Extension 1|Withdrawal by Subject|0|||
30715755|NCT00365716|58728951|FG003|Extension 1|Withdrawal by Subject|0|||
30715756|NCT00365716|58728952|FG004|Extension 1|Withdrawal by Subject|0|||
30715757|NCT00365716|58728953|FG005|Extension 1|Withdrawal by Subject|3|||
30715758|NCT00365716|58728954|FG006|Extension 1|Withdrawal by Subject|0|||
30715759|NCT00365716|58728948|FG000|Extension 1|Pregnancy|0|||
30715760|NCT00365716|58728949|FG001|Extension 1|Pregnancy|0|||
30715761|NCT00365716|58728950|FG002|Extension 1|Pregnancy|0|||
30715762|NCT00365716|58728951|FG003|Extension 1|Pregnancy|0|||
30715763|NCT00365716|58728952|FG004|Extension 1|Pregnancy|0|||
30715764|NCT00365716|58728953|FG005|Extension 1|Pregnancy|4|||
30715765|NCT00365716|58728954|FG006|Extension 1|Pregnancy|0|||
30715766|NCT00365716|58728948|FG000|Extension 1|Protocol Violation|0|||
30715767|NCT00365716|58728949|FG001|Extension 1|Protocol Violation|0|||
30715768|NCT00365716|58728950|FG002|Extension 1|Protocol Violation|0|||
30715769|NCT00365716|58728951|FG003|Extension 1|Protocol Violation|0|||
30715770|NCT00365716|58728952|FG004|Extension 1|Protocol Violation|0|||
30715771|NCT00365716|58728953|FG005|Extension 1|Protocol Violation|1|||
30715772|NCT00365716|58728954|FG006|Extension 1|Protocol Violation|0|||
30715773|NCT00365716|58728948|FG000|Extension 2|Lost to Follow-up|0|||
30715774|NCT00365716|58728949|FG001|Extension 2|Lost to Follow-up|0|||
30715775|NCT00365716|58728950|FG002|Extension 2|Lost to Follow-up|0|||
30715776|NCT00365716|58728951|FG003|Extension 2|Lost to Follow-up|0|||
30715777|NCT00365716|58728952|FG004|Extension 2|Lost to Follow-up|0|||
30715778|NCT00365716|58728953|FG005|Extension 2|Lost to Follow-up|0|||
30715779|NCT00365716|58728954|FG006|Extension 2|Lost to Follow-up|2|||
30715780|NCT00365716|58728948|FG000|Extension 2|Other|0|||
30715781|NCT00365716|58728949|FG001|Extension 2|Other|0|||
30900084|NCT01832038|58933306|FG000|Overall Study|Visit non-compliance|2|||
30900085|NCT01832038|58933306|FG000|Overall Study|Subject refused to return visit|2|||
30900086|NCT01832038|58933306|FG000|Overall Study|Not convenient to come back to site|2|||
30900087|NCT01832038|58933306|FG000|Overall Study|Participant was asked to quit|5|||
30715782|NCT00365716|58728950|FG002|Extension 2|Other|0|||
30715783|NCT00365716|58728951|FG003|Extension 2|Other|0|||
30715784|NCT00365716|58728952|FG004|Extension 2|Other|0|||
30715785|NCT00365716|58728953|FG005|Extension 2|Other|0|||
30715786|NCT00365716|58728954|FG006|Extension 2|Other|3|||
30715787|NCT00365716|58728948|FG000|Extension 2|Withdrawal by Subject|0|||
30715788|NCT00365716|58728949|FG001|Extension 2|Withdrawal by Subject|0|||
30715789|NCT00365716|58728950|FG002|Extension 2|Withdrawal by Subject|0|||
30715790|NCT00365716|58728951|FG003|Extension 2|Withdrawal by Subject|0|||
30715791|NCT00365716|58728952|FG004|Extension 2|Withdrawal by Subject|0|||
30900088|NCT01832038|58933306|FG000|Overall Study|Back home|1|||
30900089|NCT01832038|58933306|FG000|Overall Study|Pregnancy|1|||
30900090|NCT01832038|58933306|FG000|Overall Study|Low compliance|3|||
30900091|NCT01832038|58933306|FG000|Overall Study|Prohibit procedure|2|||
30900092|NCT01832038|58933306|FG000|Overall Study|Not possible to visit the hospital|1|||
30900093|NCT01832038|58933306|FG000|Overall Study|Changes of implementation system|3|||
30900094|NCT01832038|58933306|FG000|Overall Study|Plan to pregnancy|7|||
30900095|NCT01832038|58933306|FG000|Overall Study|Bad mood and has suicidal thought|1|||
30900096|NCT01832038|58933306|FG000|Overall Study|Prohibited concomitant medication|1|||
30715792|NCT00365716|58728953|FG005|Extension 2|Withdrawal by Subject|0|||
30715793|NCT00365716|58728954|FG006|Extension 2|Withdrawal by Subject|5|||
30715794|NCT00059839|58728970|FG000|Overall Study|Death|1|||
30715795|NCT00059839|58728971|FG001|Overall Study|Death|1|||
30900097|NCT01832038|58933306|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
30900098|NCT01832038|58933306|FG000|Overall Study|Subject considered the efficacy was poor|1|||
30900099|NCT01849588|58933311|FG000|Overall Study|Lack of Efficacy|3|||
30900100|NCT02357342|58933317|FG000|First 6 Months|Death|2|||
30900101|NCT02357342|58933318|FG001|First 6 Months|Death|0|||
30900102|NCT02271529|58933324|FG000|Overall Study|Withdrawal by Subject|1|||
30900103|NCT02325518|58933330|FG000|Overall Study|Adverse Event|4|||
30900104|NCT02325518|58933331|FG001|Overall Study|Adverse Event|1|||
30900105|NCT02325518|58933330|FG000|Overall Study|Physician Decision|0|||
30900106|NCT02325518|58933331|FG001|Overall Study|Physician Decision|1|||
30900107|NCT02325518|58933330|FG000|Overall Study|Withdrawal by Subject|0|||
30900108|NCT02325518|58933331|FG001|Overall Study|Withdrawal by Subject|1|||
30715796|NCT00059839|58728970|FG000|Overall Study|Lack of Efficacy|6|||
30715797|NCT00059839|58728971|FG001|Overall Study|Lack of Efficacy|5|||
30715798|NCT00059839|58728970|FG000|Overall Study|Lost to Follow-up|2|||
30715799|NCT00059839|58728971|FG001|Overall Study|Lost to Follow-up|0|||
30715800|NCT00059839|58728970|FG000|Overall Study|Physician Decision|1|||
30715801|NCT00059839|58728971|FG001|Overall Study|Physician Decision|2|||
30715802|NCT00059839|58728970|FG000|Overall Study|Withdrawal by Subject|1|||
30715803|NCT00059839|58728971|FG001|Overall Study|Withdrawal by Subject|6|||
30715804|NCT00059839|58728970|FG000|Overall Study|Ineligible|1|||
30715805|NCT00059839|58728971|FG001|Overall Study|Ineligible|3|||
30715806|NCT00059215|58728981|FG000|Overall Study|Adverse Event|5|||
30715807|NCT00059215|58728982|FG001|Overall Study|Adverse Event|5|||
30715808|NCT00059215|58728983|FG002|Overall Study|Adverse Event|9|||
30715809|NCT00059215|58728984|FG003|Overall Study|Adverse Event|9|||
30715810|NCT00059215|58728981|FG000|Overall Study|Death|0|||
30715811|NCT00059215|58728982|FG001|Overall Study|Death|0|||
30715812|NCT00059215|58728983|FG002|Overall Study|Death|3|||
30715813|NCT00059215|58728984|FG003|Overall Study|Death|0|||
30715814|NCT00059215|58728981|FG000|Overall Study|Lost to Follow-up|1|||
30715815|NCT00059215|58728982|FG001|Overall Study|Lost to Follow-up|2|||
30715816|NCT00059215|58728983|FG002|Overall Study|Lost to Follow-up|0|||
30715817|NCT00059215|58728984|FG003|Overall Study|Lost to Follow-up|0|||
30715818|NCT00059215|58728981|FG000|Overall Study|Withdrawal by Subject|4|||
30715819|NCT00059215|58728982|FG001|Overall Study|Withdrawal by Subject|4|||
30715820|NCT00059215|58728983|FG002|Overall Study|Withdrawal by Subject|1|||
30715821|NCT00059215|58728984|FG003|Overall Study|Withdrawal by Subject|3|||
30715822|NCT00059215|58728981|FG000|Overall Study|Protocol Violation|1|||
30715823|NCT00059215|58728982|FG001|Overall Study|Protocol Violation|0|||
30715824|NCT00059215|58728983|FG002|Overall Study|Protocol Violation|1|||
30715825|NCT00059215|58728984|FG003|Overall Study|Protocol Violation|0|||
30715826|NCT00059215|58728981|FG000|Overall Study|Protocol entry criteria not met|1|||
30715827|NCT00059215|58728982|FG001|Overall Study|Protocol entry criteria not met|1|||
30715828|NCT00059215|58728983|FG002|Overall Study|Protocol entry criteria not met|0|||
30715829|NCT00059215|58728984|FG003|Overall Study|Protocol entry criteria not met|2|||
30715830|NCT00059215|58728981|FG000|Overall Study|Physician Decision|1|||
30715831|NCT00059215|58728982|FG001|Overall Study|Physician Decision|2|||
30715832|NCT00059215|58728983|FG002|Overall Study|Physician Decision|1|||
30900109|NCT02270983|58933341|FG000|Overall Study|Adverse Event|3|||
30900110|NCT02270983|58933342|FG001|Overall Study|Adverse Event|2|||
30900111|NCT02270983|58933343|FG002|Overall Study|Adverse Event|6|||
30900112|NCT02270983|58933341|FG000|Overall Study|Lack of Efficacy|2|||
30715833|NCT00059215|58728984|FG003|Overall Study|Physician Decision|1|||
30900113|NCT02270983|58933342|FG001|Overall Study|Lack of Efficacy|1|||
30715834|NCT00058825|58728995|FG000|Overall Study|Relapse|9|||
30715835|NCT00058825|58728995|FG000|Overall Study|Progressive Disease|5|||
30715836|NCT00058825|58728995|FG000|Overall Study|Graft Failure|5|||
30715837|NCT00058825|58728995|FG000|Overall Study|Death|3|||
30715838|NCT00364858|58729003|FG000|Overall Study|Adverse Event|1|||
30715839|NCT00364858|58729004|FG001|Overall Study|Adverse Event|5|||
30715840|NCT00364858|58729003|FG000|Overall Study|Withdrawal by Subject|1|||
30715841|NCT00364858|58729004|FG001|Overall Study|Withdrawal by Subject|1|||
30715842|NCT00364858|58729003|FG000|Overall Study|Pregnancy|1|||
30715843|NCT00364858|58729004|FG001|Overall Study|Pregnancy|1|||
30715844|NCT00364858|58729003|FG000|Overall Study|Clinical failure|2|||
30715845|NCT00364858|58729004|FG001|Overall Study|Clinical failure|13|||
30715846|NCT00364858|58729003|FG000|Overall Study|Discontinuation at baseline|1|||
30715847|NCT00364858|58729004|FG001|Overall Study|Discontinuation at baseline|0|||
30715848|NCT00364858|58729003|FG000|Overall Study|Non-compliant|1|||
30715849|NCT00364858|58729004|FG001|Overall Study|Non-compliant|0|||
30715850|NCT00364858|58729003|FG000|Overall Study|Return to Q2 regimen|0|||
30715851|NCT00364858|58729004|FG001|Overall Study|Return to Q2 regimen|1|||
30715852|NCT00364858|58729003|FG000|Overall Study|Clinical baseline issue|0|||
30715853|NCT00364858|58729004|FG001|Overall Study|Clinical baseline issue|1|||
30715854|NCT03803059|58729011|FG000|Overall Study|Protocol Violation|2|||
30715855|NCT03803059|58729011|FG000|Overall Study|Lost to Follow-up|1|||
30715856|NCT00372424|58729016|FG000|Overall Study|Adverse Event|2|||
30715857|NCT00372424|58729016|FG000|Overall Study|Withdrawal by Subject|1|||
30715858|NCT00372424|58729016|FG000|Overall Study|Death|1|||
30715859|NCT00372424|58729016|FG000|Overall Study|Objective Progression or Relapse|14|||
30715860|NCT00372424|58729016|FG000|Overall Study|Other|7|||
30715861|NCT00372424|58729016|FG000|Overall Study|Enrolled, Not Treated|1|||
30715862|NCT00372190|58729022|FG000|Overall Study|Lost to Follow-up|3|||
30715863|NCT00372190|58729023|FG001|Overall Study|Lost to Follow-up|1|||
30715864|NCT00044083|58729033|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
30715865|NCT00044083|58729034|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
30715866|NCT00044083|58729033|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
30715867|NCT00044083|58729034|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
30715868|NCT00044083|58729033|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
30715869|NCT00044083|58729034|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
30715870|NCT00044083|58729033|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
30715871|NCT00044083|58729034|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
30715872|NCT00044083|58729033|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
30715873|NCT00044083|58729034|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
30715874|NCT00044083|58729033|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
30715875|NCT00044083|58729034|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
30715876|NCT00044083|58729033|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
30715877|NCT00044083|58729034|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
30715878|NCT00044083|58729033|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
30715879|NCT00044083|58729034|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
30715880|NCT00044083|58729033|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
30715881|NCT00044083|58729034|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
30715882|NCT00044083|58729033|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
30715883|NCT00044083|58729034|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
30715884|NCT00058123|58729067|FG000|Overall Study|Wrong histology|9|||
30715885|NCT00058123|58729067|FG000|Overall Study|Received >3 prior treatments|1|||
30715886|NCT00022633|58729074|FG000|Overall Study|Adverse Event|11|||
30715887|NCT00022633|58729075|FG001|Overall Study|Adverse Event|1|||
30621543|NCT01192295|58633116|FG001|Overall Study|Lost to Follow-up|1|||
30715888|NCT00022633|58729074|FG000|Overall Study|Refusal unrelated to adverse event|1|||
30715889|NCT00022633|58729075|FG001|Overall Study|Refusal unrelated to adverse event|0|||
30715890|NCT00022633|58729074|FG000|Overall Study|Progression/relapse|9|||
30715891|NCT00022633|58729075|FG001|Overall Study|Progression/relapse|2|||
30715892|NCT00022633|58729074|FG000|Overall Study|Death|4|||
30715893|NCT00022633|58729075|FG001|Overall Study|Death|0|||
30715894|NCT00022633|58729074|FG000|Overall Study|Other - not protocol specified|3|||
30715895|NCT00022633|58729075|FG001|Overall Study|Other - not protocol specified|2|||
30715896|NCT00022633|58729074|FG000|Overall Study|Ineligible|4|||
30715897|NCT00022633|58729075|FG001|Overall Study|Ineligible|0|||
30715898|NCT00021541|58729082|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
30715899|NCT00021541|58729083|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
30715900|NCT00021541|58729082|FG000|Period 1-First Treatment|Adverse Event|2|||
30715901|NCT00021541|58729083|FG001|Period 1-First Treatment|Adverse Event|1|||
30715902|NCT00021541|58729082|FG000|Period 1-First Treatment|non-adherence|3|||
30715903|NCT00021541|58729083|FG001|Period 1-First Treatment|non-adherence|0|||
30715904|NCT00021541|58729082|FG000|Period 1-First Treatment|Death|1|||
30715905|NCT00021541|58729083|FG001|Period 1-First Treatment|Death|0|||
30715906|NCT00021541|58729082|FG000|Period 1-First Treatment|Pts that did not progress|2|||
30715907|NCT00021541|58729083|FG001|Period 1-First Treatment|Pts that did not progress|2|||
30715908|NCT00021541|58729082|FG000|Period 1-First Treatment|Ineligible|0|||
30715909|NCT00021541|58729083|FG001|Period 1-First Treatment|Ineligible|2|||
30715910|NCT00021541|58729082|FG000|Period 2-crossover|refused phase B|2|||
30715911|NCT00021541|58729083|FG001|Period 2-crossover|refused phase B|2|||
30715912|NCT00021541|58729082|FG000|Period 2-crossover|Withdrawal by Subject|3|||
30715913|NCT00021541|58729083|FG001|Period 2-crossover|Withdrawal by Subject|4|||
30715914|NCT00021541|58729082|FG000|Period 2-crossover|Adverse Event|2|||
30715915|NCT00021541|58729083|FG001|Period 2-crossover|Adverse Event|2|||
30715916|NCT00021541|58729082|FG000|Period 2-crossover|non-adherence|1|||
30715917|NCT00021541|58729083|FG001|Period 2-crossover|non-adherence|0|||
30715918|NCT00021541|58729082|FG000|Period 2-crossover|Pts that did not progress|2|||
30715919|NCT00021541|58729083|FG001|Period 2-crossover|Pts that did not progress|3|||
30900114|NCT02270983|58933343|FG002|Overall Study|Lack of Efficacy|1|||
30900115|NCT02270983|58933341|FG000|Overall Study|Withdrawal by Subject|1|||
30621544|NCT01192295|58633115|FG000|Overall Study|Lack of Efficacy|0|||
30715920|NCT00021229|58729094|FG000|Overall Study|Adverse Event|10|||
30715921|NCT00021229|58729095|FG001|Overall Study|Adverse Event|5|||
30715922|NCT00021229|58729096|FG002|Overall Study|Adverse Event|2|||
30715923|NCT00021229|58729094|FG000|Overall Study|Death|0|||
30715924|NCT00021229|58729095|FG001|Overall Study|Death|1|||
30715925|NCT00021229|58729096|FG002|Overall Study|Death|0|||
30715926|NCT00021229|58729094|FG000|Overall Study|Withdrawal by Subject|7|||
30715927|NCT00021229|58729095|FG001|Overall Study|Withdrawal by Subject|7|||
30715928|NCT00021229|58729096|FG002|Overall Study|Withdrawal by Subject|1|||
30715929|NCT00021229|58729094|FG000|Overall Study|Progressive Disease|15|||
30715930|NCT00021229|58729095|FG001|Overall Study|Progressive Disease|19|||
30715931|NCT00021229|58729096|FG002|Overall Study|Progressive Disease|12|||
30715932|NCT00021229|58729094|FG000|Overall Study|Protocol Violation|1|||
30715933|NCT00021229|58729095|FG001|Overall Study|Protocol Violation|1|||
30715934|NCT00021229|58729096|FG002|Overall Study|Protocol Violation|0|||
30715935|NCT00021229|58729094|FG000|Overall Study|Physician Decision|0|||
30715936|NCT00021229|58729095|FG001|Overall Study|Physician Decision|0|||
30715937|NCT00021229|58729096|FG002|Overall Study|Physician Decision|1|||
30715938|NCT00021229|58729094|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
30715939|NCT00021229|58729095|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
30715940|NCT00021229|58729096|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
30715941|NCT00372112|58729110|FG000|Overall Study|Adverse Event|0|||
30715942|NCT00372112|58729111|FG001|Overall Study|Adverse Event|1|||
30715943|NCT00372112|58729112|FG002|Overall Study|Adverse Event|1|||
30715944|NCT00372112|58729113|FG003|Overall Study|Adverse Event|1|||
30715945|NCT00372112|58729110|FG000|Overall Study|Withdrawal by Subject|0|||
30715946|NCT00372112|58729111|FG001|Overall Study|Withdrawal by Subject|0|||
30715947|NCT00372112|58729112|FG002|Overall Study|Withdrawal by Subject|2|||
30715948|NCT00372112|58729113|FG003|Overall Study|Withdrawal by Subject|1|||
30715949|NCT00372112|58729110|FG000|Overall Study|Exacerbation|0|||
30715950|NCT00372112|58729111|FG001|Overall Study|Exacerbation|0|||
30715951|NCT00372112|58729112|FG002|Overall Study|Exacerbation|0|||
30715952|NCT00372112|58729113|FG003|Overall Study|Exacerbation|1|||
30715953|NCT00372112|58729110|FG000|Overall Study|PR >240 at Visit 3|0|||
30715954|NCT00372112|58729111|FG001|Overall Study|PR >240 at Visit 3|0|||
30715955|NCT00372112|58729112|FG002|Overall Study|PR >240 at Visit 3|0|||
30715956|NCT00372112|58729113|FG003|Overall Study|PR >240 at Visit 3|1|||
30715957|NCT00372112|58729110|FG000|Overall Study|Hepatitis B|1|||
30715958|NCT00372112|58729111|FG001|Overall Study|Hepatitis B|0|||
30715959|NCT00372112|58729112|FG002|Overall Study|Hepatitis B|0|||
30715960|NCT00372112|58729113|FG003|Overall Study|Hepatitis B|0|||
30715961|NCT00372112|58729110|FG000|Overall Study|Other-protocol violation|0|||
30715962|NCT00372112|58729111|FG001|Overall Study|Other-protocol violation|0|||
30715963|NCT00372112|58729112|FG002|Overall Study|Other-protocol violation|1|||
30715964|NCT00372112|58729113|FG003|Overall Study|Other-protocol violation|0|||
30715965|NCT00488475|58729126|FG000|Overall Study|Other|1754|||
30715966|NCT00042991|58729137|FG000|Overall Study|Adverse Event|1|||
30715967|NCT00042991|58729138|FG001|Overall Study|Adverse Event|4|||
30715968|NCT00042991|58729139|FG002|Overall Study|Adverse Event|2|||
30715969|NCT00042991|58729140|FG003|Overall Study|Adverse Event|0|||
30715970|NCT00042991|58729141|FG004|Overall Study|Adverse Event|0|||
30715971|NCT00042991|58729142|FG005|Overall Study|Adverse Event|1|||
30715972|NCT00042991|58729143|FG006|Overall Study|Adverse Event|0|||
30715973|NCT00042991|58729137|FG000|Overall Study|Withdrawal by Subject|0|||
30715974|NCT00042991|58729138|FG001|Overall Study|Withdrawal by Subject|7|||
30715975|NCT00042991|58729139|FG002|Overall Study|Withdrawal by Subject|2|||
30715976|NCT00042991|58729140|FG003|Overall Study|Withdrawal by Subject|0|||
30715977|NCT00042991|58729141|FG004|Overall Study|Withdrawal by Subject|1|||
30715978|NCT00042991|58729142|FG005|Overall Study|Withdrawal by Subject|0|||
30715979|NCT00042991|58729143|FG006|Overall Study|Withdrawal by Subject|0|||
30715980|NCT00042991|58729137|FG000|Overall Study|Disease Progression|5|||
30715981|NCT00042991|58729138|FG001|Overall Study|Disease Progression|29|||
30715982|NCT00042991|58729139|FG002|Overall Study|Disease Progression|2|||
30715983|NCT00042991|58729140|FG003|Overall Study|Disease Progression|2|||
30715984|NCT00042991|58729141|FG004|Overall Study|Disease Progression|1|||
30715985|NCT00042991|58729142|FG005|Overall Study|Disease Progression|4|||
30715986|NCT00042991|58729143|FG006|Overall Study|Disease Progression|2|||
30715987|NCT00042991|58729137|FG000|Overall Study|Alternative Therapy|0|||
30715988|NCT00042991|58729138|FG001|Overall Study|Alternative Therapy|0|||
30715989|NCT00042991|58729139|FG002|Overall Study|Alternative Therapy|0|||
30715990|NCT00042991|58729140|FG003|Overall Study|Alternative Therapy|0|||
30715991|NCT00042991|58729141|FG004|Overall Study|Alternative Therapy|1|||
30715992|NCT00042991|58729142|FG005|Overall Study|Alternative Therapy|0|||
30900116|NCT02270983|58933342|FG001|Overall Study|Withdrawal by Subject|0|||
30900117|NCT02270983|58933343|FG002|Overall Study|Withdrawal by Subject|2|||
30900118|NCT02270983|58933341|FG000|Overall Study|Lost to Follow-up|1|||
30900119|NCT02270983|58933342|FG001|Overall Study|Lost to Follow-up|1|||
30900120|NCT02270983|58933343|FG002|Overall Study|Lost to Follow-up|2|||
30900121|NCT02270983|58933341|FG000|Overall Study|Protocol Violation|1|||
30900122|NCT02270983|58933342|FG001|Overall Study|Protocol Violation|1|||
30900123|NCT02270983|58933343|FG002|Overall Study|Protocol Violation|1|||
30900124|NCT02270983|58933341|FG000|Overall Study|family emergency|0|||
30900125|NCT02270983|58933342|FG001|Overall Study|family emergency|1|||
30900126|NCT02270983|58933343|FG002|Overall Study|family emergency|0|||
30900127|NCT02270983|58933341|FG000|Overall Study|study procedure non-compliance|1|||
30715993|NCT00042991|58729143|FG006|Overall Study|Alternative Therapy|0|||
30715994|NCT00466167|58729164|FG000|Overall Study|Adverse Event|8|||
30715995|NCT00466167|58729165|FG001|Overall Study|Adverse Event|8|||
30715996|NCT00466167|58729166|FG002|Overall Study|Adverse Event|7|||
30715997|NCT00466167|58729164|FG000|Overall Study|Lack of Efficacy|2|||
30715998|NCT00466167|58729165|FG001|Overall Study|Lack of Efficacy|0|||
30715999|NCT00466167|58729166|FG002|Overall Study|Lack of Efficacy|3|||
30716000|NCT00466167|58729164|FG000|Overall Study|Protocol Violation|1|||
30716001|NCT00466167|58729165|FG001|Overall Study|Protocol Violation|1|||
30716002|NCT00466167|58729166|FG002|Overall Study|Protocol Violation|2|||
30716003|NCT00466167|58729164|FG000|Overall Study|Lost to Follow-up|3|||
30716004|NCT00466167|58729165|FG001|Overall Study|Lost to Follow-up|2|||
30716005|NCT00466167|58729166|FG002|Overall Study|Lost to Follow-up|2|||
30716006|NCT00466167|58729164|FG000|Overall Study|Withdrawal by Subject|4|||
30716007|NCT00466167|58729165|FG001|Overall Study|Withdrawal by Subject|1|||
30716008|NCT00466167|58729166|FG002|Overall Study|Withdrawal by Subject|6|||
30716009|NCT00466167|58729164|FG000|Overall Study|patient did not meet inclusion criteria|1|||
30716010|NCT00466167|58729165|FG001|Overall Study|patient did not meet inclusion criteria|0|||
30716011|NCT00466167|58729166|FG002|Overall Study|patient did not meet inclusion criteria|1|||
30716012|NCT00466167|58729164|FG000|Overall Study|Not treated|1|||
30716013|NCT00466167|58729165|FG001|Overall Study|Not treated|0|||
30716014|NCT00466167|58729166|FG002|Overall Study|Not treated|0|||
30716015|NCT00480441|58729176|FG000|Screening|Not Eligible|37|||
30716016|NCT00480441|58729177|FG001|Screening|Not Eligible|0|||
30716017|NCT00480441|58729178|FG002|Screening|Not Eligible|0|||
30716018|NCT00480441|58729176|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
30716019|NCT00480441|58729177|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
30716020|NCT00480441|58729178|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
30716021|NCT00480441|58729176|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
30716022|NCT00480441|58729177|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
30716023|NCT00480441|58729178|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
30716024|NCT00480441|58729176|FG000|Baseline Functional MRI|physical contraindication|4|||
30716025|NCT00480441|58729177|FG001|Baseline Functional MRI|physical contraindication|0|||
30716026|NCT00480441|58729178|FG002|Baseline Functional MRI|physical contraindication|0|||
30716027|NCT00480441|58729176|FG000|Randomization|Lost to Follow-up|0|||
30716028|NCT00480441|58729177|FG001|Randomization|Lost to Follow-up|7|||
30716029|NCT00480441|58729178|FG002|Randomization|Lost to Follow-up|2|||
30716030|NCT00488319|58729188|FG000|Overall Study|Adverse Event|1|||
30716031|NCT00488319|58729189|FG001|Overall Study|Adverse Event|2|||
30716032|NCT00488319|58729190|FG002|Overall Study|Adverse Event|23|||
30716033|NCT00488319|58729188|FG000|Overall Study|Lack of Efficacy|6|||
30716034|NCT00488319|58729189|FG001|Overall Study|Lack of Efficacy|12|||
30716035|NCT00488319|58729190|FG002|Overall Study|Lack of Efficacy|27|||
30716036|NCT00488319|58729188|FG000|Overall Study|Lost to Follow-up|3|||
30716037|NCT00488319|58729189|FG001|Overall Study|Lost to Follow-up|5|||
30900128|NCT02270983|58933342|FG001|Overall Study|study procedure non-compliance|0|||
30900129|NCT02270983|58933343|FG002|Overall Study|study procedure non-compliance|0|||
30900130|NCT02270983|58933341|FG000|Overall Study|moved away from study site|0|||
30900131|NCT02270983|58933342|FG001|Overall Study|moved away from study site|1|||
30900132|NCT02270983|58933343|FG002|Overall Study|moved away from study site|0|||
30716038|NCT00488319|58729190|FG002|Overall Study|Lost to Follow-up|16|||
30716039|NCT00488319|58729188|FG000|Overall Study|Withdrawal by Subject|5|||
30716040|NCT00488319|58729189|FG001|Overall Study|Withdrawal by Subject|20|||
30716041|NCT00488319|58729190|FG002|Overall Study|Withdrawal by Subject|44|||
30716042|NCT00488319|58729188|FG000|Overall Study|Other reasons for withdrawal|0|||
30900133|NCT02449889|58933354|FG000|Overall Study|Adverse Event|1|||
30900134|NCT02449889|58933355|FG001|Overall Study|Adverse Event|2|||
30900135|NCT02449889|58933356|FG002|Overall Study|Adverse Event|0|||
30900136|NCT02449889|58933354|FG000|Overall Study|Protocol Violation|0|||
30716043|NCT00488319|58729189|FG001|Overall Study|Other reasons for withdrawal|4|||
30716044|NCT00488319|58729190|FG002|Overall Study|Other reasons for withdrawal|12|||
30716045|NCT00463047|58729199|FG000|Titration Period 1|Adverse Event|10|||
30716046|NCT00463047|58729200|FG001|Titration Period 1|Adverse Event|8|||
30716047|NCT00463047|58729199|FG000|Titration Period 1|Lack of Efficacy|10|||
30716048|NCT00463047|58729200|FG001|Titration Period 1|Lack of Efficacy|4|||
30716049|NCT00463047|58729199|FG000|Titration Period 1|Lost to Follow-up|2|||
30716050|NCT00463047|58729200|FG001|Titration Period 1|Lost to Follow-up|0|||
30716051|NCT00463047|58729199|FG000|Titration Period 1|Non-compliance with study medication|3|||
30716052|NCT00463047|58729200|FG001|Titration Period 1|Non-compliance with study medication|5|||
30716053|NCT00463047|58729199|FG000|Titration Period 1|Protocol Violation|5|||
30716054|NCT00463047|58729200|FG001|Titration Period 1|Protocol Violation|5|||
30716055|NCT00463047|58729199|FG000|Titration Period 1|Withdrawal by Subject|3|||
30716056|NCT00463047|58729200|FG001|Titration Period 1|Withdrawal by Subject|5|||
30716057|NCT00463047|58729199|FG000|Titration Period 1|Non-compliance procedures|4|||
30716058|NCT00463047|58729200|FG001|Titration Period 1|Non-compliance procedures|10|||
30716059|NCT00463047|58729199|FG000|Titration Period 1|Other|0|||
30716060|NCT00463047|58729200|FG001|Titration Period 1|Other|2|||
30716061|NCT00463047|58729199|FG000|Titration Period 2|Adverse Event|9|||
30716062|NCT00463047|58729200|FG001|Titration Period 2|Adverse Event|9|||
30716063|NCT00463047|58729199|FG000|Titration Period 2|Lack of Efficacy|6|||
30716064|NCT00463047|58729200|FG001|Titration Period 2|Lack of Efficacy|4|||
30716065|NCT00463047|58729199|FG000|Titration Period 2|Withdrawal by Subject|1|||
30716066|NCT00463047|58729200|FG001|Titration Period 2|Withdrawal by Subject|0|||
30716067|NCT00463047|58729199|FG000|Titration Period 2|Protocol Violation|2|||
30716068|NCT00463047|58729200|FG001|Titration Period 2|Protocol Violation|3|||
30716069|NCT00463047|58729199|FG000|Titration Period 2|Lost to Follow-up|1|||
30716070|NCT00463047|58729200|FG001|Titration Period 2|Lost to Follow-up|2|||
30716071|NCT00463047|58729199|FG000|Titration Period 2|Non-compliance study medication|4|||
30716072|NCT00463047|58729200|FG001|Titration Period 2|Non-compliance study medication|2|||
30716073|NCT00463047|58729199|FG000|Titration Period 2|Non-compliance procedures|4|||
30716074|NCT00463047|58729200|FG001|Titration Period 2|Non-compliance procedures|1|||
30716075|NCT00463047|58729199|FG000|Titration Period 2|Other|3|||
30716076|NCT00463047|58729200|FG001|Titration Period 2|Other|2|||
30716077|NCT00463047|58729199|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
30716078|NCT00463047|58729200|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
30716079|NCT00463047|58729199|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
30716080|NCT00463047|58729200|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
30716081|NCT00463047|58729199|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
30716082|NCT00463047|58729200|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
30716083|NCT00463047|58729199|FG000|Double-Blind Treatment Period 1|Other|1|||
30716084|NCT00463047|58729200|FG001|Double-Blind Treatment Period 1|Other|0|||
30716085|NCT00463047|58729199|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
30716086|NCT00463047|58729200|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
30716087|NCT00463047|58729199|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
30716088|NCT00463047|58729200|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
30716089|NCT00463047|58729199|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
30716090|NCT00463047|58729200|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
30716091|NCT00487695|58729207|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
30716092|NCT00487695|58729208|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
30716093|NCT00487695|58729207|FG000|First Procedure|active wheezing (did not have procedure)|1|||
30716094|NCT00487695|58729208|FG001|First Procedure|active wheezing (did not have procedure)|0|||
30716095|NCT00487695|58729207|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
30716096|NCT00487695|58729208|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
30716097|NCT00487695|58729207|FG000|Second Procedure|active wheezing|0|||
30716098|NCT00487695|58729208|FG001|Second Procedure|active wheezing|1|||
30716099|NCT00487695|58729207|FG000|Second Procedure|Withdrawal by Subject|1|||
30716100|NCT00487695|58729208|FG001|Second Procedure|Withdrawal by Subject|2|||
30716101|NCT00487539|58729218|FG000|Overall Study|Adverse Event|3|||
30716102|NCT00487539|58729219|FG001|Overall Study|Adverse Event|2|||
30716103|NCT00487539|58729220|FG002|Overall Study|Adverse Event|1|||
30716104|NCT00487539|58729221|FG003|Overall Study|Adverse Event|1|||
30716105|NCT00487539|58729218|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30716106|NCT00487539|58729219|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30716107|NCT00487539|58729220|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
30716108|NCT00487539|58729221|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
30716109|NCT00487539|58729218|FG000|Overall Study|Other|3|||
30716110|NCT00487539|58729219|FG001|Overall Study|Other|1|||
30716111|NCT00487539|58729220|FG002|Overall Study|Other|2|||
30716112|NCT00487539|58729221|FG003|Overall Study|Other|2|||
30716113|NCT00486837|58729232|FG000|Overall Study|Withdrawal by Subject|1|||
30716114|NCT00486837|58729233|FG001|Overall Study|Withdrawal by Subject|0|||
30716115|NCT00486837|58729232|FG000|Overall Study|Adverse Event|1|||
30716116|NCT00486837|58729233|FG001|Overall Study|Adverse Event|1|||
30716117|NCT00486837|58729232|FG000|Overall Study|Protocol Violation|4|||
30716118|NCT00486837|58729233|FG001|Overall Study|Protocol Violation|2|||
30716119|NCT00486837|58729232|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
30716120|NCT00486837|58729233|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
30716121|NCT00486759|58729243|FG000|Treatment|Adverse event/intercurrent illness|86|||
30716122|NCT00486759|58729244|FG001|Treatment|Adverse event/intercurrent illness|39|||
30716123|NCT00486759|58729243|FG000|Treatment|Insufficient therapeutic response|37|||
30716124|NCT00486759|58729244|FG001|Treatment|Insufficient therapeutic response|39|||
30716125|NCT00486759|58729243|FG000|Treatment|Death|17|||
30716126|NCT00486759|58729244|FG001|Treatment|Death|10|||
30716127|NCT00486759|58729243|FG000|Treatment|Withdrew consent|15|||
30716128|NCT00486759|58729244|FG001|Treatment|Withdrew consent|12|||
30716129|NCT00486759|58729243|FG000|Treatment|Administrative/reason not specified|17|||
30716130|NCT00486759|58729244|FG001|Treatment|Administrative/reason not specified|21|||
30716131|NCT00486759|58729243|FG000|Treatment|Refused treatment|10|||
30716132|NCT00486759|58729244|FG001|Treatment|Refused treatment|7|||
30716133|NCT00486759|58729243|FG000|Treatment|Violation of selection criteria at entry|3|||
30716134|NCT00486759|58729244|FG001|Treatment|Violation of selection criteria at entry|3|||
30716135|NCT00486759|58729243|FG000|Treatment|Other protocol violation|1|||
30716136|NCT00486759|58729244|FG001|Treatment|Other protocol violation|5|||
30716137|NCT00486759|58729243|FG000|Treatment|Failure to return|1|||
30716138|NCT00486759|58729244|FG001|Treatment|Failure to return|1|||
30716139|NCT00486759|58729243|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
30716140|NCT00486759|58729244|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
30716141|NCT00486759|58729243|FG000|Safety Follow-up|Death|40|||
30716142|NCT00486759|58729244|FG001|Safety Follow-up|Death|29|||
30716143|NCT00486759|58729243|FG000|Safety Follow-up|Withdrew consent|32|||
30716144|NCT00486759|58729244|FG001|Safety Follow-up|Withdrew consent|23|||
30716145|NCT00486759|58729243|FG000|Safety Follow-up|Failure to return|9|||
30716146|NCT00486759|58729244|FG001|Safety Follow-up|Failure to return|6|||
30716147|NCT00486759|58729243|FG000|Safety Follow-up|Administrative/not specified|8|||
30716148|NCT00486759|58729244|FG001|Safety Follow-up|Administrative/not specified|6|||
30716149|NCT00486759|58729243|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
30716150|NCT00486759|58729244|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
30716151|NCT00486759|58729243|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
30716152|NCT00486759|58729244|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
30716153|NCT00486603|58729252|FG000|Overall Study|Withdrawal by Subject|1|||
30716154|NCT00486603|58729253|FG001|Overall Study|Withdrawal by Subject|0|||
30716155|NCT00486603|58729254|FG002|Overall Study|Withdrawal by Subject|0|||
30716156|NCT00486603|58729255|FG003|Overall Study|Withdrawal by Subject|0|||
30716157|NCT00486603|58729256|FG004|Overall Study|Withdrawal by Subject|0|||
30716158|NCT00486603|58729252|FG000|Overall Study|Physician Decision|0|||
30716159|NCT00486603|58729253|FG001|Overall Study|Physician Decision|1|||
30716160|NCT00486603|58729254|FG002|Overall Study|Physician Decision|0|||
30716161|NCT00486603|58729255|FG003|Overall Study|Physician Decision|0|||
30716162|NCT00486603|58729256|FG004|Overall Study|Physician Decision|0|||
30716163|NCT00486291|58729273|FG000|Overall Study|Adverse Event|3|||
30716164|NCT00486291|58729274|FG001|Overall Study|Adverse Event|4|||
30716165|NCT00486291|58729273|FG000|Overall Study|Lost to Follow-up|3|||
30716166|NCT00486291|58729274|FG001|Overall Study|Lost to Follow-up|7|||
30716167|NCT00486291|58729273|FG000|Overall Study|protocol non-compliance|10|||
30716168|NCT00486291|58729274|FG001|Overall Study|protocol non-compliance|15|||
30716169|NCT00486291|58729273|FG000|Overall Study|requirement for restricted medication|0|||
30716170|NCT00486291|58729274|FG001|Overall Study|requirement for restricted medication|3|||
30716171|NCT00474045|58729282|FG000|Overall Study|Adverse Event|18|||
30716172|NCT00474045|58729283|FG001|Overall Study|Adverse Event|8|||
30716173|NCT00474045|58729282|FG000|Overall Study|Unclassified|1|||
30716174|NCT00474045|58729283|FG001|Overall Study|Unclassified|3|||
30716175|NCT00474045|58729282|FG000|Overall Study|Lack of Efficacy|0|||
30716176|NCT00474045|58729283|FG001|Overall Study|Lack of Efficacy|9|||
30716177|NCT00474045|58729282|FG000|Overall Study|Lost to Follow-up|1|||
30716178|NCT00474045|58729283|FG001|Overall Study|Lost to Follow-up|1|||
30621545|NCT01192295|58633116|FG001|Overall Study|Lack of Efficacy|5|||
30716179|NCT00474045|58729282|FG000|Overall Study|Protocol Violation|10|||
30716180|NCT00474045|58729283|FG001|Overall Study|Protocol Violation|12|||
30716181|NCT00474045|58729282|FG000|Overall Study|Withdrawal by Subject|16|||
30716182|NCT00474045|58729283|FG001|Overall Study|Withdrawal by Subject|18|||
30716183|NCT00474045|58729282|FG000|Overall Study|Withdrawal criteria|60|||
30716184|NCT00474045|58729283|FG001|Overall Study|Withdrawal criteria|50|||
30716185|NCT00462501|58729289|FG000|Overall Study|Not treated|3|||
30716186|NCT00462501|58729289|FG000|Overall Study|Adverse Event|2|||
30716187|NCT00383188|58729298|FG000|Overall Study|Adverse Event|4|||
30716188|NCT00383188|58729299|FG001|Overall Study|Adverse Event|7|||
30716189|NCT00383188|58729300|FG002|Overall Study|Adverse Event|9|||
30716190|NCT00383188|58729301|FG003|Overall Study|Adverse Event|8|||
30716191|NCT00383188|58729302|FG004|Overall Study|Adverse Event|8|||
30716192|NCT00383188|58729298|FG000|Overall Study|Lack of Efficacy|9|||
30716193|NCT00383188|58729299|FG001|Overall Study|Lack of Efficacy|3|||
30716194|NCT00383188|58729300|FG002|Overall Study|Lack of Efficacy|3|||
30716195|NCT00383188|58729301|FG003|Overall Study|Lack of Efficacy|2|||
30716196|NCT00383188|58729302|FG004|Overall Study|Lack of Efficacy|6|||
30716197|NCT00383188|58729298|FG000|Overall Study|Other|3|||
30716198|NCT00383188|58729299|FG001|Overall Study|Other|1|||
30716199|NCT00383188|58729300|FG002|Overall Study|Other|0|||
30716200|NCT00383188|58729301|FG003|Overall Study|Other|2|||
30716201|NCT00383188|58729302|FG004|Overall Study|Other|6|||
30716202|NCT00383188|58729298|FG000|Overall Study|No longer willing to participate|1|||
30716203|NCT00383188|58729299|FG001|Overall Study|No longer willing to participate|0|||
30716204|NCT00383188|58729300|FG002|Overall Study|No longer willing to participate|1|||
30716205|NCT00383188|58729301|FG003|Overall Study|No longer willing to participate|0|||
30716206|NCT00383188|58729302|FG004|Overall Study|No longer willing to participate|2|||
30716207|NCT00383188|58729298|FG000|Overall Study|Lost to Follow-up|0|||
30716208|NCT00383188|58729299|FG001|Overall Study|Lost to Follow-up|0|||
30716209|NCT00383188|58729300|FG002|Overall Study|Lost to Follow-up|0|||
30716210|NCT00383188|58729301|FG003|Overall Study|Lost to Follow-up|0|||
30716211|NCT00383188|58729302|FG004|Overall Study|Lost to Follow-up|1|||
30716212|NCT00462345|58729316|FG000|Overall Study|Withdrawal by Subject|2|||
30716213|NCT00462345|58729316|FG000|Overall Study|Did not complete second course|1|||
30716214|NCT00453999|58729323|FG000|Overall Study|Adverse Event|1|||
30716215|NCT00453999|58729324|FG001|Overall Study|Adverse Event|2|||
30716216|NCT00453999|58729325|FG002|Overall Study|Adverse Event|1|||
30716217|NCT00453999|58729323|FG000|Overall Study|Lost to Follow-up|0|||
30716218|NCT00453999|58729324|FG001|Overall Study|Lost to Follow-up|1|||
30716219|NCT00453999|58729325|FG002|Overall Study|Lost to Follow-up|1|||
30716220|NCT00453999|58729323|FG000|Overall Study|Withdrawal by Subject|2|||
30716221|NCT00453999|58729324|FG001|Overall Study|Withdrawal by Subject|1|||
30716222|NCT00453999|58729325|FG002|Overall Study|Withdrawal by Subject|1|||
30716223|NCT00453999|58729323|FG000|Overall Study|Subject Request|2|||
30716224|NCT00453999|58729324|FG001|Overall Study|Subject Request|1|||
30716225|NCT00453999|58729325|FG002|Overall Study|Subject Request|0|||
30716226|NCT00453921|58729338|FG000|Overall Study|Withdrawal by Subject|1|||
30716227|NCT00453921|58729339|FG001|Overall Study|Withdrawal by Subject|1|||
30716228|NCT00453921|58729340|FG002|Overall Study|Withdrawal by Subject|1|||
30716229|NCT00453921|58729341|FG003|Overall Study|Withdrawal by Subject|1|||
30716230|NCT00453921|58729338|FG000|Overall Study|Lost to Follow-up|0|||
30716231|NCT00453921|58729339|FG001|Overall Study|Lost to Follow-up|0|||
30716232|NCT00453921|58729340|FG002|Overall Study|Lost to Follow-up|1|||
30716233|NCT00453921|58729341|FG003|Overall Study|Lost to Follow-up|0|||
30716234|NCT00382720|58729358|FG000|Overall Study|Adverse Event|21|||
30716235|NCT00382720|58729359|FG001|Overall Study|Adverse Event|23|||
30716236|NCT00382720|58729360|FG002|Overall Study|Adverse Event|15|||
30716237|NCT00382720|58729358|FG000|Overall Study|Protocol Violation|2|||
30716238|NCT00382720|58729359|FG001|Overall Study|Protocol Violation|5|||
30716239|NCT00382720|58729360|FG002|Overall Study|Protocol Violation|1|||
30716240|NCT00382720|58729358|FG000|Overall Study|Death|0|||
30716241|NCT00382720|58729359|FG001|Overall Study|Death|1|||
30716242|NCT00382720|58729360|FG002|Overall Study|Death|2|||
30716243|NCT00382720|58729358|FG000|Overall Study|Progressive disease|37|||
30790912|NCT03200366|58804015|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
30790913|NCT03200366|58804016|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
30790914|NCT03200366|58804017|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
30790915|NCT03200366|58804015|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
30790916|NCT03200366|58804016|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
30790917|NCT03200366|58804017|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
30716244|NCT00382720|58729359|FG001|Overall Study|Progressive disease|28|||
30716245|NCT00382720|58729360|FG002|Overall Study|Progressive disease|38|||
30716246|NCT00382720|58729358|FG000|Overall Study|Withdrew consent|1|||
30716247|NCT00382720|58729359|FG001|Overall Study|Withdrew consent|1|||
30716248|NCT00382720|58729360|FG002|Overall Study|Withdrew consent|2|||
30716249|NCT00382720|58729358|FG000|Overall Study|Withdrawal by Subject|11|||
30716250|NCT00382720|58729359|FG001|Overall Study|Withdrawal by Subject|20|||
30716251|NCT00382720|58729360|FG002|Overall Study|Withdrawal by Subject|12|||
30716252|NCT00382720|58729358|FG000|Overall Study|Surgery|1|||
30716253|NCT00382720|58729359|FG001|Overall Study|Surgery|1|||
30716254|NCT00382720|58729360|FG002|Overall Study|Surgery|4|||
30716255|NCT00382720|58729358|FG000|Overall Study|Patient did not receive study medication|1|||
30716256|NCT00382720|58729359|FG001|Overall Study|Patient did not receive study medication|1|||
30716257|NCT00382720|58729360|FG002|Overall Study|Patient did not receive study medication|4|||
30716258|NCT00382720|58729358|FG000|Overall Study|Clinically progressive disease|0|||
30716259|NCT00382720|58729359|FG001|Overall Study|Clinically progressive disease|1|||
30716260|NCT00382720|58729360|FG002|Overall Study|Clinically progressive disease|0|||
30716261|NCT00382720|58729358|FG000|Overall Study|Good prognosis|0|||
30716262|NCT00382720|58729359|FG001|Overall Study|Good prognosis|1|||
30716263|NCT00382720|58729360|FG002|Overall Study|Good prognosis|0|||
30716264|NCT00382720|58729358|FG000|Overall Study|Investigator/Clinical decision|5|||
30716265|NCT00382720|58729359|FG001|Overall Study|Investigator/Clinical decision|6|||
30716266|NCT00382720|58729360|FG002|Overall Study|Investigator/Clinical decision|6|||
30716267|NCT00382720|58729358|FG000|Overall Study|Discontinued at end of study|0|||
30716268|NCT00382720|58729359|FG001|Overall Study|Discontinued at end of study|1|||
30716269|NCT00382720|58729360|FG002|Overall Study|Discontinued at end of study|2|||
30716270|NCT00453063|58729370|FG000|Overall Study|Adverse Event|1|||
30716271|NCT00453063|58729371|FG001|Overall Study|Adverse Event|2|||
30716272|NCT00453063|58729370|FG000|Overall Study|Withdrawal by Subject|1|||
30716273|NCT00453063|58729371|FG001|Overall Study|Withdrawal by Subject|1|||
30716274|NCT00453063|58729370|FG000|Overall Study|Protocol Violation|1|||
30716275|NCT00453063|58729371|FG001|Overall Study|Protocol Violation|0|||
30716276|NCT00371566|58729379|FG000|Treatment Phase|Withdrawal by Subject|0|||
30716277|NCT00371566|58729380|FG001|Treatment Phase|Withdrawal by Subject|1|||
30716278|NCT00371566|58729379|FG000|Treatment Phase|Adverse Event|0|||
30716279|NCT00371566|58729380|FG001|Treatment Phase|Adverse Event|1|||
30716280|NCT00371566|58729379|FG000|Treatment Phase|Protocol Violation|0|||
30716281|NCT00371566|58729380|FG001|Treatment Phase|Protocol Violation|1|||
30716282|NCT00371566|58729379|FG000|Chemoradiation Phase|Physician Decision|2|||
30716283|NCT00371566|58729380|FG001|Chemoradiation Phase|Physician Decision|0|||
30716284|NCT00371566|58729379|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
30716285|NCT00371566|58729380|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
30716286|NCT00371566|58729379|FG000|Chemoradiation Phase|Non compliant|0|||
30716287|NCT00371566|58729380|FG001|Chemoradiation Phase|Non compliant|1|||
30716288|NCT00371566|58729379|FG000|Chemoradiation Phase|Progressive Disease|1|||
30716289|NCT00371566|58729380|FG001|Chemoradiation Phase|Progressive Disease|1|||
30716290|NCT00371566|58729379|FG000|Chemoradiation Phase|Death|2|||
30716291|NCT00371566|58729380|FG001|Chemoradiation Phase|Death|0|||
30716292|NCT00371566|58729379|FG000|Follow Up Phase|Death|0|||
30716293|NCT00371566|58729380|FG001|Follow Up Phase|Death|5|||
30716294|NCT00371566|58729379|FG000|Follow Up Phase|Disease progression|1|||
30716295|NCT00371566|58729380|FG001|Follow Up Phase|Disease progression|0|||
30716296|NCT00371566|58729379|FG000|Follow Up Phase|Withdrawal by Subject|0|||
30716297|NCT00371566|58729380|FG001|Follow Up Phase|Withdrawal by Subject|1|||
30716298|NCT00371566|58729379|FG000|Follow Up Phase|Physician Decision|1|||
30716299|NCT00371566|58729380|FG001|Follow Up Phase|Physician Decision|1|||
30716300|NCT00371566|58729379|FG000|Follow Up Phase|Lost to Follow-up|1|||
30716301|NCT00371566|58729380|FG001|Follow Up Phase|Lost to Follow-up|0|||
30716302|NCT00382408|58729388|FG000|Overall Study|Did not meet protocol requirement|3|||
30716303|NCT00382408|58729389|FG001|Overall Study|Did not meet protocol requirement|3|||
30716304|NCT00382408|58729388|FG000|Overall Study|Protocol Violation|2|||
30716305|NCT00382408|58729389|FG001|Overall Study|Protocol Violation|2|||
30716306|NCT00382408|58729388|FG000|Overall Study|Physician Decision|1|||
30716307|NCT00382408|58729389|FG001|Overall Study|Physician Decision|0|||
30716308|NCT00382408|58729388|FG000|Overall Study|Withdrawal by Subject|17|||
30716309|NCT00382408|58729389|FG001|Overall Study|Withdrawal by Subject|6|||
30716310|NCT00382408|58729388|FG000|Overall Study|Pregnancy|2|||
30716311|NCT00382408|58729389|FG001|Overall Study|Pregnancy|0|||
30716312|NCT00382408|58729388|FG000|Overall Study|Lost to Follow-up|19|||
30716313|NCT00382408|58729389|FG001|Overall Study|Lost to Follow-up|8|||
30716314|NCT00382408|58729388|FG000|Overall Study|Other|100|||
30716315|NCT00382408|58729389|FG001|Overall Study|Other|35|||
30716316|NCT00371254|58729397|FG000|Overall Study|Disease progression|13|||
30716317|NCT00371254|58729398|FG001|Overall Study|Disease progression|13|||
30716318|NCT00371254|58729397|FG000|Overall Study|Study drug toxicity|3|||
30716319|NCT00371254|58729398|FG001|Overall Study|Study drug toxicity|5|||
30716320|NCT00371254|58729397|FG000|Overall Study|Subject request|5|||
30716321|NCT00371254|58729398|FG001|Overall Study|Subject request|0|||
30716322|NCT00371254|58729397|FG000|Overall Study|Investigator Decision|2|||
30716323|NCT00371254|58729398|FG001|Overall Study|Investigator Decision|0|||
30716324|NCT00371254|58729397|FG000|Overall Study|Adverse event unrelated to study drug|0|||
30716325|NCT00371254|58729398|FG001|Overall Study|Adverse event unrelated to study drug|1|||
30716326|NCT00371254|58729397|FG000|Overall Study|Lost to Follow-up|0|||
30716327|NCT00371254|58729398|FG001|Overall Study|Lost to Follow-up|1|||
30716328|NCT00371254|58729397|FG000|Overall Study|Withdrawal by Subject|0|||
30716329|NCT00371254|58729398|FG001|Overall Study|Withdrawal by Subject|1|||
30716330|NCT00452673|58729408|FG000|Dose Escalation Period|Disease Progression|6|||
30716331|NCT00452673|58729409|FG001|Dose Escalation Period|Disease Progression|6|||
30716332|NCT00452673|58729410|FG002|Dose Escalation Period|Disease Progression|2|||
30716333|NCT00452673|58729411|FG003|Dose Escalation Period|Disease Progression|6|||
30716334|NCT00452673|58729412|FG004|Dose Escalation Period|Disease Progression|0|||
30716335|NCT00452673|58729408|FG000|Dose Escalation Period|study drug toxicity|1|||
30716336|NCT00452673|58729409|FG001|Dose Escalation Period|study drug toxicity|3|||
30716337|NCT00452673|58729410|FG002|Dose Escalation Period|study drug toxicity|3|||
30716338|NCT00452673|58729411|FG003|Dose Escalation Period|study drug toxicity|1|||
30716339|NCT00452673|58729412|FG004|Dose Escalation Period|study drug toxicity|0|||
30716340|NCT00452673|58729408|FG000|Dose Escalation Period|Other|0|||
30716341|NCT00452673|58729409|FG001|Dose Escalation Period|Other|0|||
30716342|NCT00452673|58729410|FG002|Dose Escalation Period|Other|1|||
30716343|NCT00452673|58729411|FG003|Dose Escalation Period|Other|0|||
30716344|NCT00452673|58729412|FG004|Dose Escalation Period|Other|0|||
30716345|NCT00452673|58729408|FG000|Dose Escalation Period|Adverse Event|0|||
30716346|NCT00452673|58729409|FG001|Dose Escalation Period|Adverse Event|0|||
30716347|NCT00452673|58729410|FG002|Dose Escalation Period|Adverse Event|0|||
30716348|NCT00452673|58729411|FG003|Dose Escalation Period|Adverse Event|1|||
30716349|NCT00452673|58729412|FG004|Dose Escalation Period|Adverse Event|0|||
30716350|NCT00452673|58729408|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
30716351|NCT00452673|58729409|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
30716352|NCT00452673|58729410|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
30716353|NCT00452673|58729411|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
30716354|NCT00452673|58729412|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
30716355|NCT00452673|58729408|FG000|Dose Expansion Period|Disease Progression|0|||
30716356|NCT00452673|58729409|FG001|Dose Expansion Period|Disease Progression|0|||
30716357|NCT00452673|58729410|FG002|Dose Expansion Period|Disease Progression|0|||
30716358|NCT00452673|58729411|FG003|Dose Expansion Period|Disease Progression|0|||
30716359|NCT00452673|58729412|FG004|Dose Expansion Period|Disease Progression|19|||
30716360|NCT00452673|58729408|FG000|Dose Expansion Period|Other|0|||
30716361|NCT00452673|58729409|FG001|Dose Expansion Period|Other|0|||
30716362|NCT00452673|58729410|FG002|Dose Expansion Period|Other|0|||
30716363|NCT00452673|58729411|FG003|Dose Expansion Period|Other|0|||
30716364|NCT00452673|58729412|FG004|Dose Expansion Period|Other|2|||
30716365|NCT00461253|58729425|FG000|Overall Study|Death|985|||
30716366|NCT00461253|58729426|FG001|Overall Study|Death|0|||
30716367|NCT00461253|58729425|FG000|Overall Study|Protocol Violation|613|||
30716368|NCT00461253|58729426|FG001|Overall Study|Protocol Violation|236|||
30716369|NCT00461253|58729425|FG000|Overall Study|no response|2609|||
30716370|NCT00461253|58729426|FG001|Overall Study|no response|11789|||
30716371|NCT00461253|58729425|FG000|Overall Study|administrative|773|||
30716372|NCT00461253|58729426|FG001|Overall Study|administrative|7773|||
30716373|NCT00469833|58729432|FG000|Overall Study|No IV access|2|||
30716374|NCT00382174|58729444|FG000|Overall Study|Lost to Follow-up|1|||
30716375|NCT00382174|58729445|FG001|Overall Study|Lost to Follow-up|4|||
30716376|NCT00382174|58729446|FG002|Overall Study|Lost to Follow-up|5|||
30716377|NCT00382174|58729444|FG000|Overall Study|Adverse Event|1|||
30716378|NCT00382174|58729445|FG001|Overall Study|Adverse Event|4|||
30716379|NCT00382174|58729446|FG002|Overall Study|Adverse Event|5|||
30716380|NCT00382174|58729444|FG000|Overall Study|Withdrawal by Subject|1|||
30716381|NCT00382174|58729445|FG001|Overall Study|Withdrawal by Subject|4|||
30716382|NCT00382174|58729446|FG002|Overall Study|Withdrawal by Subject|5|||
30716383|NCT00382174|58729444|FG000|Overall Study|Non compliance|1|||
30716384|NCT00382174|58729445|FG001|Overall Study|Non compliance|0|||
30716385|NCT00382174|58729446|FG002|Overall Study|Non compliance|1|||
30716386|NCT00382174|58729444|FG000|Overall Study|Physician Decision|0|||
30716387|NCT00382174|58729445|FG001|Overall Study|Physician Decision|2|||
30716388|NCT00382174|58729446|FG002|Overall Study|Physician Decision|2|||
30716389|NCT00382174|58729444|FG000|Overall Study|Failed to meet criteria|0|||
30716390|NCT00382174|58729445|FG001|Overall Study|Failed to meet criteria|1|||
30716391|NCT00382174|58729446|FG002|Overall Study|Failed to meet criteria|1|||
30716392|NCT00382174|58729444|FG000|Overall Study|Wounds merged|0|||
30716393|NCT00382174|58729445|FG001|Overall Study|Wounds merged|2|||
30716394|NCT00382174|58729446|FG002|Overall Study|Wounds merged|2|||
30716395|NCT00641537|58729459|FG000|96-week Period|Adverse Event|0|||
30716396|NCT00641537|58729460|FG001|96-week Period|Adverse Event|1|||
30716397|NCT00641537|58729461|FG002|96-week Period|Adverse Event|3|||
30716398|NCT00641537|58729462|FG003|96-week Period|Adverse Event|0|||
30716399|NCT00641537|58729463|FG004|96-week Period|Adverse Event|2|||
30716400|NCT00641537|58729464|FG005|96-week Period|Adverse Event|0|||
30716401|NCT00641537|58729465|FG006|96-week Period|Adverse Event|0|||
30716402|NCT00641537|58729466|FG007|96-week Period|Adverse Event|0|||
30716403|NCT00641537|58729459|FG000|96-week Period|Lost to Follow-up|3|||
30716404|NCT00641537|58729460|FG001|96-week Period|Lost to Follow-up|1|||
30716405|NCT00641537|58729461|FG002|96-week Period|Lost to Follow-up|2|||
30716406|NCT00641537|58729462|FG003|96-week Period|Lost to Follow-up|2|||
30716407|NCT00641537|58729463|FG004|96-week Period|Lost to Follow-up|4|||
30716408|NCT00641537|58729464|FG005|96-week Period|Lost to Follow-up|0|||
30716409|NCT00641537|58729465|FG006|96-week Period|Lost to Follow-up|1|||
30716410|NCT00641537|58729466|FG007|96-week Period|Lost to Follow-up|0|||
30716411|NCT00641537|58729459|FG000|96-week Period|Protocol Violation|0|||
30716412|NCT00641537|58729460|FG001|96-week Period|Protocol Violation|1|||
30716413|NCT00641537|58729461|FG002|96-week Period|Protocol Violation|0|||
30716414|NCT00641537|58729462|FG003|96-week Period|Protocol Violation|1|||
30716415|NCT00641537|58729463|FG004|96-week Period|Protocol Violation|0|||
30716416|NCT00641537|58729464|FG005|96-week Period|Protocol Violation|1|||
30716417|NCT00641537|58729465|FG006|96-week Period|Protocol Violation|0|||
30716418|NCT00641537|58729466|FG007|96-week Period|Protocol Violation|0|||
30716419|NCT00641537|58729459|FG000|96-week Period|Death|2|||
30716420|NCT00641537|58729460|FG001|96-week Period|Death|0|||
30716421|NCT00641537|58729461|FG002|96-week Period|Death|1|||
30716422|NCT00641537|58729462|FG003|96-week Period|Death|0|||
30716423|NCT00641537|58729463|FG004|96-week Period|Death|0|||
30716424|NCT00641537|58729464|FG005|96-week Period|Death|0|||
30716425|NCT00641537|58729465|FG006|96-week Period|Death|0|||
30716426|NCT00641537|58729466|FG007|96-week Period|Death|0|||
30716427|NCT00641537|58729459|FG000|96-week Period|Other|4|||
30716428|NCT00641537|58729460|FG001|96-week Period|Other|7|||
30716429|NCT00641537|58729461|FG002|96-week Period|Other|14|||
30716430|NCT00641537|58729462|FG003|96-week Period|Other|9|||
30716431|NCT00641537|58729463|FG004|96-week Period|Other|11|||
30716432|NCT00641537|58729464|FG005|96-week Period|Other|6|||
30716433|NCT00641537|58729465|FG006|96-week Period|Other|4|||
30716434|NCT00641537|58729466|FG007|96-week Period|Other|6|||
30716435|NCT00641537|58729459|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
30716436|NCT00641537|58729460|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
30716437|NCT00641537|58729461|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
30621546|NCT01192295|58633115|FG000|Overall Study|Administrative|4|||
30621547|NCT01192295|58633116|FG001|Overall Study|Administrative|6|||
30621548|NCT01154166|58633126|FG000|Overall Study|Adverse Event|14|||
30716438|NCT00641537|58729462|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
30716439|NCT00641537|58729463|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
30716440|NCT00641537|58729464|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
30716441|NCT00641537|58729465|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
30716442|NCT00641537|58729466|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
30716443|NCT00641537|58729459|FG000|24-Week Supplemental Follow-up Period|Other|0|||
30716444|NCT00641537|58729460|FG001|24-Week Supplemental Follow-up Period|Other|2|||
30716445|NCT00641537|58729461|FG002|24-Week Supplemental Follow-up Period|Other|2|||
30716446|NCT00641537|58729462|FG003|24-Week Supplemental Follow-up Period|Other|1|||
30716447|NCT00641537|58729463|FG004|24-Week Supplemental Follow-up Period|Other|3|||
30716448|NCT00641537|58729464|FG005|24-Week Supplemental Follow-up Period|Other|0|||
30716449|NCT00641537|58729465|FG006|24-Week Supplemental Follow-up Period|Other|1|||
30716450|NCT00641537|58729466|FG007|24-Week Supplemental Follow-up Period|Other|1|||
30716451|NCT03840135|58729486|FG000|Overall Study|Protocol Violation|6|||
30716452|NCT03840135|58729487|FG001|Overall Study|Protocol Violation|1|||
30716453|NCT03840135|58729486|FG000|Overall Study|Withdrawal by Subject|1|||
30716454|NCT03840135|58729487|FG001|Overall Study|Withdrawal by Subject|0|||
30716455|NCT00461175|58729499|FG000|Overall Study|Protocol Violation|522|||
30716456|NCT00461175|58729500|FG001|Overall Study|Protocol Violation|365|||
30716457|NCT00641147|58729508|FG000|Completed 4 Months.|Physician Decision|1|||
30716458|NCT00641147|58729509|FG001|Completed 4 Months.|Physician Decision|0|||
30716459|NCT00641147|58729508|FG000|Completed 4 Months.|Adverse Event|1|||
30716460|NCT00641147|58729509|FG001|Completed 4 Months.|Adverse Event|0|||
30716461|NCT00641147|58729508|FG000|Completed 8 Months.|Physician Decision|2|||
30716462|NCT00641147|58729509|FG001|Completed 8 Months.|Physician Decision|1|||
30716463|NCT00641147|58729508|FG000|Completed 8 Months.|non compliance|1|||
30716464|NCT00641147|58729509|FG001|Completed 8 Months.|non compliance|0|||
30716465|NCT00641147|58729508|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
30716466|NCT00641147|58729509|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
30716467|NCT00641147|58729508|FG000|Completed 12 Months.|Physician Decision|1|||
30716468|NCT00641147|58729509|FG001|Completed 12 Months.|Physician Decision|1|||
30716469|NCT00641147|58729508|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
30716470|NCT00641147|58729509|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
30716471|NCT00641147|58729508|FG000|Completed 16 Months.|Physician Decision|1|||
30716472|NCT00641147|58729509|FG001|Completed 16 Months.|Physician Decision|0|||
30716473|NCT00641147|58729508|FG000|Completed 16 Months.|Lost to Follow-up|1|||
30900137|NCT02449889|58933355|FG001|Overall Study|Protocol Violation|4|||
30621549|NCT01154166|58633127|FG001|Overall Study|Adverse Event|9|||
30716474|NCT00641147|58729509|FG001|Completed 16 Months.|Lost to Follow-up|0|||
30716475|NCT00460239|58729519|FG000|Overall Study|Physician Decision|0|||
30716476|NCT00460239|58729520|FG001|Overall Study|Physician Decision|1|||
30716477|NCT00460239|58729521|FG002|Overall Study|Physician Decision|0|||
30716478|NCT00460239|58729522|FG003|Overall Study|Physician Decision|0|||
30716479|NCT00460239|58729523|FG004|Overall Study|Physician Decision|0|||
30716480|NCT00460239|58729524|FG005|Overall Study|Physician Decision|2|||
30716481|NCT00460239|58729525|FG006|Overall Study|Physician Decision|0|||
30716482|NCT00460239|58729526|FG007|Overall Study|Physician Decision|0|||
30716483|NCT00460239|58729527|FG008|Overall Study|Physician Decision|0|||
30900138|NCT02449889|58933356|FG002|Overall Study|Protocol Violation|1|||
30900139|NCT01831804|58933373|FG000|Overall Study|Adverse Event|0|||
30900140|NCT01831804|58933374|FG001|Overall Study|Adverse Event|0|||
30900141|NCT01831804|58933375|FG002|Overall Study|Adverse Event|0|||
30900142|NCT01831804|58933376|FG003|Overall Study|Adverse Event|0|||
30900143|NCT01831804|58933377|FG004|Overall Study|Adverse Event|0|||
30900144|NCT01831804|58933378|FG005|Overall Study|Adverse Event|0|||
30621550|NCT01154166|58633126|FG000|Overall Study|Lost to Follow-up|1|||
30716484|NCT00460239|58729519|FG000|Overall Study|Withdrawal by Subject|0|||
30621551|NCT01154166|58633127|FG001|Overall Study|Lost to Follow-up|1|||
30716485|NCT00460239|58729520|FG001|Overall Study|Withdrawal by Subject|0|||
30716486|NCT00460239|58729521|FG002|Overall Study|Withdrawal by Subject|0|||
30716487|NCT00460239|58729522|FG003|Overall Study|Withdrawal by Subject|0|||
30716488|NCT00460239|58729523|FG004|Overall Study|Withdrawal by Subject|0|||
30716489|NCT00460239|58729524|FG005|Overall Study|Withdrawal by Subject|1|||
30716490|NCT00460239|58729525|FG006|Overall Study|Withdrawal by Subject|0|||
30716491|NCT00460239|58729526|FG007|Overall Study|Withdrawal by Subject|0|||
30716492|NCT00460239|58729527|FG008|Overall Study|Withdrawal by Subject|0|||
30716493|NCT00640835|58729542|FG000|Overall Study|Adverse Event|5|||
30716494|NCT00640835|58729543|FG001|Overall Study|Adverse Event|3|||
30716495|NCT00640835|58729542|FG000|Overall Study|Withdrawal by Subject|12|||
30716496|NCT00640835|58729543|FG001|Overall Study|Withdrawal by Subject|14|||
30716497|NCT00640835|58729542|FG000|Overall Study|Physician Decision|10|||
30716498|NCT00640835|58729543|FG001|Overall Study|Physician Decision|14|||
30716499|NCT00640835|58729542|FG000|Overall Study|Sponsor's Decision|11|||
30716500|NCT00640835|58729543|FG001|Overall Study|Sponsor's Decision|7|||
30716501|NCT00640835|58729542|FG000|Overall Study|Protocol Violation|2|||
30716502|NCT00640835|58729543|FG001|Overall Study|Protocol Violation|2|||
30716503|NCT00640835|58729542|FG000|Overall Study|Lost to Follow-up|17|||
30716504|NCT00640835|58729543|FG001|Overall Study|Lost to Follow-up|13|||
30716505|NCT00640835|58729542|FG000|Overall Study|Other Reason|19|||
30716506|NCT00640835|58729543|FG001|Overall Study|Other Reason|4|||
30716507|NCT03839355|58729551|FG000|Overall Study|Withdrawal by Subject|1|||
30716508|NCT03839355|58729552|FG001|Overall Study|Withdrawal by Subject|0|||
30716509|NCT00382018|58729562|FG000|Overall Study|Progression|0|||
30716510|NCT00382018|58729563|FG001|Overall Study|Progression|136|||
30716511|NCT00382018|58729564|FG002|Overall Study|Progression|51|||
30716512|NCT00382018|58729565|FG003|Overall Study|Progression|43|||
30716513|NCT00382018|58729562|FG000|Overall Study|Death|0|||
30716514|NCT00382018|58729563|FG001|Overall Study|Death|9|||
30716515|NCT00382018|58729564|FG002|Overall Study|Death|7|||
30716516|NCT00382018|58729565|FG003|Overall Study|Death|11|||
30716517|NCT00382018|58729562|FG000|Overall Study|Withdrawal by Subject|0|||
30716518|NCT00382018|58729563|FG001|Overall Study|Withdrawal by Subject|4|||
30716519|NCT00382018|58729564|FG002|Overall Study|Withdrawal by Subject|3|||
30716520|NCT00382018|58729565|FG003|Overall Study|Withdrawal by Subject|4|||
30716521|NCT00382018|58729562|FG000|Overall Study|Other, not protocol specified|0|||
30716522|NCT00382018|58729563|FG001|Overall Study|Other, not protocol specified|16|||
30716523|NCT00382018|58729564|FG002|Overall Study|Other, not protocol specified|3|||
30716524|NCT00382018|58729565|FG003|Overall Study|Other, not protocol specified|1|||
30716525|NCT00640601|58729578|FG000|Overall Study|Adverse Event|43|||
30716526|NCT00640601|58729578|FG000|Overall Study|Withdrawal by Subject|20|||
30716527|NCT00640601|58729578|FG000|Overall Study|Protocol Violation|6|||
30716528|NCT00640601|58729578|FG000|Overall Study|Lack of Efficacy|16|||
30716529|NCT00640601|58729578|FG000|Overall Study|Lost to Follow-up|9|||
30716530|NCT00640601|58729578|FG000|Overall Study|Physician Decision|8|||
30716531|NCT00640601|58729578|FG000|Overall Study|treatment naive, combination therapy|10|||
30716532|NCT03838731|58729584|FG000|Overall Study|Pregnancy|0|||
30716533|NCT03838731|58729585|FG001|Overall Study|Pregnancy|1|||
30716534|NCT03838731|58729584|FG000|Overall Study|Withdrawal of consent|1|||
30716535|NCT03838731|58729585|FG001|Overall Study|Withdrawal of consent|0|||
30716536|NCT00452439|58729593|FG000|Overall Study|Lost to Follow-up|1|||
30716537|NCT00452439|58729594|FG001|Overall Study|Lost to Follow-up|1|||
30716538|NCT00452439|58729593|FG000|Overall Study|Refused Treatment|4|||
30716539|NCT00452439|58729594|FG001|Overall Study|Refused Treatment|3|||
30716540|NCT00452439|58729593|FG000|Overall Study|Death|3|||
30716541|NCT00452439|58729594|FG001|Overall Study|Death|1|||
30716542|NCT00452439|58729593|FG000|Overall Study|Bone Marrow Transplant|0|||
30716543|NCT00452439|58729594|FG001|Overall Study|Bone Marrow Transplant|1|||
30716544|NCT00452439|58729593|FG000|Overall Study|Too Ill to Continue|0|||
30716545|NCT00452439|58729594|FG001|Overall Study|Too Ill to Continue|1|||
30716546|NCT00452439|58729593|FG000|Overall Study|Failed to achieve complete response|2|||
30716547|NCT00452439|58729594|FG001|Overall Study|Failed to achieve complete response|0|||
30716548|NCT00452439|58729593|FG000|Overall Study|Relapse|3|||
30716549|NCT00452439|58729594|FG001|Overall Study|Relapse|0|||
30716550|NCT00452439|58729593|FG000|Overall Study|Fracture|1|||
30716551|NCT00452439|58729594|FG001|Overall Study|Fracture|0|||
30716552|NCT00381940|58729600|FG000|Overall Study|Lack of Efficacy|3|||
30716553|NCT00381940|58729600|FG000|Overall Study|Protocol Violation|1|||
30716554|NCT00381940|58729600|FG000|Overall Study|Ineligible|1|||
30716555|NCT00364156|58729606|FG000|Overall Study|Withdrawal by Subject|73|||
30716556|NCT00364156|58729607|FG001|Overall Study|Withdrawal by Subject|80|||
30716557|NCT00364156|58729606|FG000|Overall Study|Protocol Violation|6|||
30716558|NCT00364156|58729607|FG001|Overall Study|Protocol Violation|1|||
30716559|NCT00452361|58729615|FG000|Overall Study|Adverse Event|8|||
30716560|NCT00452361|58729616|FG001|Overall Study|Adverse Event|0|||
30716561|NCT00452361|58729615|FG000|Overall Study|Withdrawal by Subject|0|||
30716562|NCT00452361|58729616|FG001|Overall Study|Withdrawal by Subject|1|||
30716563|NCT00452361|58729615|FG000|Overall Study|Premature termination|13|||
30716564|NCT00452361|58729616|FG001|Overall Study|Premature termination|9|||
30716565|NCT00640289|58729622|FG000|Overall Study|Death|3|||
30716566|NCT00640289|58729622|FG000|Overall Study|Withdrawal by Subject|1|||
30716567|NCT00640289|58729622|FG000|Overall Study|Lost to Follow-up|1|||
30716568|NCT00640289|58729622|FG000|Overall Study|Data collected under different amendment|2|||
30716569|NCT00640289|58729622|FG000|Overall Study|Transferred to another center|1|||
30716570|NCT00640289|58729622|FG000|Overall Study|Missing status|5|||
30716571|NCT00568451|58729630|FG000|Overall Study|Disease Progression|0|||
30716572|NCT00568451|58729631|FG001|Overall Study|Disease Progression|0|||
30716573|NCT00568451|58729632|FG002|Overall Study|Disease Progression|2|||
30716574|NCT00568451|58729633|FG003|Overall Study|Disease Progression|7|||
30716575|NCT00459537|58729646|FG000|Overall Study|Adverse Event|1|||
30716576|NCT00459537|58729647|FG001|Overall Study|Adverse Event|6|||
30716577|NCT00459537|58729646|FG000|Overall Study|Lack of Efficacy|10|||
30716578|NCT00459537|58729647|FG001|Overall Study|Lack of Efficacy|11|||
30716579|NCT00459537|58729646|FG000|Overall Study|Withdrawal by Subject|20|||
30716580|NCT00459537|58729647|FG001|Overall Study|Withdrawal by Subject|26|||
30716581|NCT00459537|58729646|FG000|Overall Study|Lost to Follow-up|27|||
30716582|NCT00459537|58729647|FG001|Overall Study|Lost to Follow-up|30|||
30716583|NCT00459537|58729646|FG000|Overall Study|Administrative problems|3|||
30716584|NCT00459537|58729647|FG001|Overall Study|Administrative problems|0|||
30716585|NCT00459537|58729646|FG000|Overall Study|Protocol Violation|4|||
30716586|NCT00459537|58729647|FG001|Overall Study|Protocol Violation|3|||
30716587|NCT00459537|58729646|FG000|Overall Study|Missing|1|||
30716588|NCT00459537|58729647|FG001|Overall Study|Missing|0|||
30716589|NCT03850509|58729655|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
30716590|NCT03850509|58729656|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
30716591|NCT00635999|58729665|FG000|Overall Study|Withdrawal by Subject|4|||
30716592|NCT00635999|58729666|FG001|Overall Study|Withdrawal by Subject|2|||
30716593|NCT00635999|58729667|FG002|Overall Study|Withdrawal by Subject|1|||
30716594|NCT00469209|58729678|FG000|Overall Study|Adverse Event|1|||
30716595|NCT00469209|58729679|FG001|Overall Study|Adverse Event|0|||
30716596|NCT00469209|58729680|FG002|Overall Study|Adverse Event|1|||
30716597|NCT00635219|58729693|FG000|Overall Study|Adverse Event|12|||
30716598|NCT00635219|58729694|FG001|Overall Study|Adverse Event|10|||
30716599|NCT00635219|58729695|FG002|Overall Study|Adverse Event|18|||
30716600|NCT00635219|58729696|FG003|Overall Study|Adverse Event|15|||
30716601|NCT00635219|58729697|FG004|Overall Study|Adverse Event|19|||
30716602|NCT00635219|58729693|FG000|Overall Study|Lack of Efficacy|5|||
30716603|NCT00635219|58729694|FG001|Overall Study|Lack of Efficacy|6|||
30716604|NCT00635219|58729695|FG002|Overall Study|Lack of Efficacy|3|||
30716605|NCT00635219|58729696|FG003|Overall Study|Lack of Efficacy|4|||
30716606|NCT00635219|58729697|FG004|Overall Study|Lack of Efficacy|6|||
30716607|NCT00635219|58729693|FG000|Overall Study|Non-compliance With Study Product|0|||
30716608|NCT00635219|58729694|FG001|Overall Study|Non-compliance With Study Product|0|||
30716609|NCT00635219|58729695|FG002|Overall Study|Non-compliance With Study Product|0|||
30716610|NCT00635219|58729696|FG003|Overall Study|Non-compliance With Study Product|2|||
30716611|NCT00635219|58729697|FG004|Overall Study|Non-compliance With Study Product|1|||
30716612|NCT00635219|58729693|FG000|Overall Study|Protocol Violation|0|||
30716613|NCT00635219|58729694|FG001|Overall Study|Protocol Violation|2|||
30716614|NCT00635219|58729695|FG002|Overall Study|Protocol Violation|3|||
30716615|NCT00635219|58729696|FG003|Overall Study|Protocol Violation|2|||
30716616|NCT00635219|58729697|FG004|Overall Study|Protocol Violation|4|||
30716617|NCT00635219|58729693|FG000|Overall Study|Withdrawal of Consent|8|||
30716618|NCT00635219|58729694|FG001|Overall Study|Withdrawal of Consent|6|||
30716619|NCT00635219|58729695|FG002|Overall Study|Withdrawal of Consent|8|||
30716620|NCT00635219|58729696|FG003|Overall Study|Withdrawal of Consent|11|||
30900145|NCT01831804|58933379|FG006|Overall Study|Adverse Event|1|||
30716621|NCT00635219|58729697|FG004|Overall Study|Withdrawal of Consent|8|||
30716622|NCT00635219|58729693|FG000|Overall Study|Lost to Follow-up|0|||
30716623|NCT00635219|58729694|FG001|Overall Study|Lost to Follow-up|0|||
30716624|NCT00635219|58729695|FG002|Overall Study|Lost to Follow-up|2|||
30716625|NCT00635219|58729696|FG003|Overall Study|Lost to Follow-up|0|||
30716626|NCT00635219|58729697|FG004|Overall Study|Lost to Follow-up|3|||
30716627|NCT00635219|58729693|FG000|Overall Study|Administrative or Other Reasons|0|||
30716628|NCT00635219|58729694|FG001|Overall Study|Administrative or Other Reasons|1|||
30716629|NCT00635219|58729695|FG002|Overall Study|Administrative or Other Reasons|1|||
30716630|NCT00635219|58729696|FG003|Overall Study|Administrative or Other Reasons|0|||
30716631|NCT00635219|58729697|FG004|Overall Study|Administrative or Other Reasons|1|||
30716632|NCT00363766|58729711|FG000|Overall Study|Progressive Disease|15|||
30716633|NCT00363766|58729712|FG001|Overall Study|Progressive Disease|9|||
30716634|NCT00363766|58729711|FG000|Overall Study|Adverse Event|10|||
30716635|NCT00363766|58729712|FG001|Overall Study|Adverse Event|2|||
30716636|NCT00363766|58729711|FG000|Overall Study|Disease Related Death|1|||
30716637|NCT00363766|58729712|FG001|Overall Study|Disease Related Death|3|||
30716638|NCT00363766|58729711|FG000|Overall Study|Not Disease Related Death|3|||
30716639|NCT00363766|58729712|FG001|Overall Study|Not Disease Related Death|4|||
30716640|NCT00363766|58729711|FG000|Overall Study|Withdrawal by Subject|2|||
30716641|NCT00363766|58729712|FG001|Overall Study|Withdrawal by Subject|0|||
30716642|NCT00363766|58729711|FG000|Overall Study|Physician Decision|1|||
30716643|NCT00363766|58729712|FG001|Overall Study|Physician Decision|2|||
30716644|NCT00468819|58729722|FG000|Overall Study|Withdrawal by Subject|4|||
30716645|NCT00468819|58729723|FG001|Overall Study|Withdrawal by Subject|0|||
30716646|NCT00468819|58729724|FG002|Overall Study|Withdrawal by Subject|1|||
30716647|NCT00468819|58729722|FG000|Overall Study|Lost to Follow-up|0|||
30716648|NCT00468819|58729723|FG001|Overall Study|Lost to Follow-up|0|||
30621552|NCT01154166|58633126|FG000|Overall Study|Protocol Violation|4|||
30716649|NCT00468819|58729724|FG002|Overall Study|Lost to Follow-up|1|||
30621553|NCT01154166|58633127|FG001|Overall Study|Protocol Violation|1|||
30621554|NCT01154166|58633126|FG000|Overall Study|Withdrawal by Subject|10|||
30621555|NCT01154166|58633127|FG001|Overall Study|Withdrawal by Subject|1|||
30716650|NCT00468819|58729722|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
30716651|NCT00468819|58729723|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
30716652|NCT00468819|58729724|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
30716653|NCT00451191|58729736|FG000|Overall Study|withdrawal or received alternate tx|15|||
30716654|NCT00451191|58729737|FG001|Overall Study|withdrawal or received alternate tx|11|||
30716655|NCT00451035|58729743|FG000|Overall Study|Disease progression|11|||
30716656|NCT00451035|58729743|FG000|Overall Study|Death|3|||
30716657|NCT00451035|58729743|FG000|Overall Study|New anti-neoplastic therapy|3|||
30900146|NCT01831804|58933380|FG007|Overall Study|Adverse Event|0|||
30900147|NCT01831804|58933381|FG008|Overall Study|Adverse Event|1|||
30900148|NCT01831804|58933373|FG000|Overall Study|Protocol Violation|0|||
30621556|NCT01154166|58633126|FG000|Overall Study|Lack of Efficacy|3|||
30716658|NCT00468585|58729752|FG000|Overall Study|Patient not treated|1|||
30716659|NCT00468585|58729753|FG001|Overall Study|Patient not treated|0|||
30716660|NCT00468585|58729754|FG002|Overall Study|Patient not treated|1|||
30716661|NCT00468585|58729755|FG003|Overall Study|Patient not treated|0|||
30716662|NCT00468585|58729752|FG000|Overall Study|Patient found to be ineligible|0|||
30716663|NCT00468585|58729753|FG001|Overall Study|Patient found to be ineligible|0|||
30716664|NCT00468585|58729754|FG002|Overall Study|Patient found to be ineligible|1|||
30716665|NCT00468585|58729755|FG003|Overall Study|Patient found to be ineligible|0|||
30716666|NCT00468585|58729752|FG000|Overall Study|Adverse Event|0|||
30716667|NCT00468585|58729753|FG001|Overall Study|Adverse Event|0|||
30716668|NCT00468585|58729754|FG002|Overall Study|Adverse Event|1|||
30900149|NCT01831804|58933374|FG001|Overall Study|Protocol Violation|0|||
30716669|NCT00468585|58729755|FG003|Overall Study|Adverse Event|0|||
30716670|NCT00468585|58729752|FG000|Overall Study|Withdrawal by Subject|0|||
30716671|NCT00468585|58729753|FG001|Overall Study|Withdrawal by Subject|0|||
30716672|NCT00468585|58729754|FG002|Overall Study|Withdrawal by Subject|2|||
30716673|NCT00468585|58729755|FG003|Overall Study|Withdrawal by Subject|1|||
30716674|NCT00450801|58729765|FG000|Overall Study|Death|1|||
30716675|NCT00458211|58729774|FG000|Overall Study|Lack of Efficacy|12|||
30716676|NCT00458211|58729774|FG000|Overall Study|Withdrawal by Subject|2|||
30900150|NCT01831804|58933375|FG002|Overall Study|Protocol Violation|2|||
30716677|NCT00458211|58729774|FG000|Overall Study|Protocol Violation|2|||
30716678|NCT00450723|58729782|FG000|Overall Study|Physician Decision|5|||
30716679|NCT00467961|58729787|FG000|Overall Study|Technical Failures|5|||
30716680|NCT00467961|58729787|FG000|Overall Study|Disease Progression|2|||
30716681|NCT00457821|58729799|FG000|Part 2|Withdrawal by Subject|0|||
30716682|NCT00457821|58729800|FG001|Part 2|Withdrawal by Subject|0|||
30716683|NCT00457821|58729801|FG002|Part 2|Withdrawal by Subject|0|||
30716684|NCT00457821|58729802|FG003|Part 2|Withdrawal by Subject|0|||
30716685|NCT00457821|58729803|FG004|Part 2|Withdrawal by Subject|0|||
30716686|NCT00457821|58729804|FG005|Part 2|Withdrawal by Subject|0|||
30716687|NCT00457821|58729805|FG006|Part 2|Withdrawal by Subject|0|||
30716688|NCT00457821|58729806|FG007|Part 2|Withdrawal by Subject|1|||
30716689|NCT00633893|58729826|FG000|Overall Study|Death|1|||
30716690|NCT00633893|58729827|FG001|Overall Study|Death|3|||
30716691|NCT00633893|58729828|FG002|Overall Study|Death|9|||
30716692|NCT00633893|58729826|FG000|Overall Study|Adverse Event|65|||
30716693|NCT00633893|58729827|FG001|Overall Study|Adverse Event|58|||
30716694|NCT00633893|58729828|FG002|Overall Study|Adverse Event|126|||
30716695|NCT00633893|58729826|FG000|Overall Study|Withdrawal by Subject|7|||
30716696|NCT00633893|58729827|FG001|Overall Study|Withdrawal by Subject|12|||
30716697|NCT00633893|58729828|FG002|Overall Study|Withdrawal by Subject|6|||
30716698|NCT00633893|58729826|FG000|Overall Study|Lost to Follow-up|2|||
30716699|NCT00633893|58729827|FG001|Overall Study|Lost to Follow-up|4|||
30716700|NCT00633893|58729828|FG002|Overall Study|Lost to Follow-up|8|||
30716701|NCT00633893|58729826|FG000|Overall Study|Poor/non-compliance|5|||
30716702|NCT00633893|58729827|FG001|Overall Study|Poor/non-compliance|12|||
30621557|NCT01154166|58633127|FG001|Overall Study|Lack of Efficacy|0|||
30716703|NCT00633893|58729828|FG002|Overall Study|Poor/non-compliance|3|||
30716704|NCT00633893|58729826|FG000|Overall Study|Pregnancy|2|||
30716705|NCT00633893|58729827|FG001|Overall Study|Pregnancy|1|||
30716706|NCT00633893|58729828|FG002|Overall Study|Pregnancy|1|||
30716707|NCT00633893|58729826|FG000|Overall Study|Not meet/no longer meets criteria|4|||
30716708|NCT00633893|58729827|FG001|Overall Study|Not meet/no longer meets criteria|6|||
30716709|NCT00633893|58729828|FG002|Overall Study|Not meet/no longer meets criteria|4|||
30716710|NCT00633893|58729826|FG000|Overall Study|Other|28|||
30716711|NCT00633893|58729827|FG001|Overall Study|Other|33|||
30716712|NCT00633893|58729828|FG002|Overall Study|Other|31|||
30716713|NCT00457743|58729839|FG000|Overall Study|Adverse Event|0|||
30716714|NCT00457743|58729840|FG001|Overall Study|Adverse Event|4|||
30716715|NCT00457743|58729841|FG002|Overall Study|Adverse Event|0|||
30716716|NCT00457743|58729839|FG000|Overall Study|Lack of Efficacy|3|||
30716717|NCT00457743|58729840|FG001|Overall Study|Lack of Efficacy|23|||
30716718|NCT00457743|58729841|FG002|Overall Study|Lack of Efficacy|3|||
30716719|NCT00450411|58729850|FG000|Overall Study|Protocol Violation|6|||
30716720|NCT00450411|58729850|FG000|Overall Study|No protocol treatment|2|||
30716721|NCT00644969|58729856|FG000|Treatment Phase|Randomized, not treated|1|||
30716722|NCT00644969|58729857|FG001|Treatment Phase|Randomized, not treated|0|||
30716723|NCT00644969|58729856|FG000|Treatment Phase|Adverse Event|3|||
30716724|NCT00644969|58729857|FG001|Treatment Phase|Adverse Event|0|||
30716725|NCT00644969|58729856|FG000|Treatment Phase|Withdrawal by Subject|4|||
30716726|NCT00644969|58729857|FG001|Treatment Phase|Withdrawal by Subject|0|||
30716727|NCT00644969|58729856|FG000|Treatment Phase|Lost to Follow-up|2|||
30716728|NCT00644969|58729857|FG001|Treatment Phase|Lost to Follow-up|2|||
30716729|NCT00644969|58729856|FG000|Treatment Phase|Other|4|||
30716730|NCT00644969|58729857|FG001|Treatment Phase|Other|1|||
30716731|NCT00644969|58729856|FG000|Post Treatment Phase|Death|1|||
30716732|NCT00644969|58729857|FG001|Post Treatment Phase|Death|0|||
30716733|NCT00644969|58729856|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
30716734|NCT00644969|58729857|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
30716735|NCT00644969|58729856|FG000|Post Treatment Phase|Lost to Follow-up|4|||
30716736|NCT00644969|58729857|FG001|Post Treatment Phase|Lost to Follow-up|1|||
30716737|NCT00644969|58729856|FG000|Post Treatment Phase|Other|1|||
30716738|NCT00644969|58729857|FG001|Post Treatment Phase|Other|0|||
30716739|NCT00644423|58729865|FG000|Overall Study|Lost to Follow-up|1|||
30716740|NCT00644423|58729866|FG001|Overall Study|Lost to Follow-up|1|||
30716741|NCT00628355|58729874|FG000|Overall Study|Withdrawal by Subject|1|||
30716742|NCT00628355|58729875|FG001|Overall Study|Withdrawal by Subject|1|||
30716743|NCT00627497|58729886|FG000|Overall Study|Lost to Follow-up|1|||
30716744|NCT00627497|58729887|FG001|Overall Study|Lost to Follow-up|1|||
30716745|NCT00627497|58729888|FG002|Overall Study|Lost to Follow-up|0|||
30716746|NCT00627497|58729889|FG003|Overall Study|Lost to Follow-up|0|||
30716747|NCT00648167|58729899|FG000|Overall Study|Adverse Event|6|||
30716748|NCT00648167|58729899|FG000|Overall Study|unable to swallow tablets|1|||
30716749|NCT00647699|58729933|FG000|Overall Study|Lost to Follow-up|5|||
30716750|NCT00647699|58729934|FG001|Overall Study|Lost to Follow-up|4|||
30716751|NCT00647699|58729933|FG000|Overall Study|Withdrawal by Subject|3|||
30716752|NCT00647699|58729934|FG001|Overall Study|Withdrawal by Subject|8|||
30716753|NCT00467649|58729942|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
30716754|NCT00467649|58729943|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
30716755|NCT00467649|58729944|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
30716756|NCT00467649|58729945|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
30716757|NCT00467649|58729946|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
30716758|NCT00467649|58729947|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
30716759|NCT00467649|58729942|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
30716760|NCT00467649|58729943|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
30716761|NCT00467649|58729944|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
30716762|NCT00467649|58729945|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
30716763|NCT00467649|58729946|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
30716764|NCT00467649|58729947|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
30716765|NCT00467649|58729942|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
30716766|NCT00467649|58729943|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
30900151|NCT01831804|58933376|FG003|Overall Study|Protocol Violation|0|||
30900152|NCT01831804|58933377|FG004|Overall Study|Protocol Violation|0|||
30716767|NCT00467649|58729944|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
30716768|NCT00467649|58729945|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
30621558|NCT01154166|58633126|FG000|Overall Study|Disease Progression|1|||
30716769|NCT00467649|58729946|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
30716770|NCT00467649|58729947|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
30716771|NCT00467649|58729942|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
30621559|NCT01154166|58633127|FG001|Overall Study|Disease Progression|0|||
30716772|NCT00467649|58729943|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
30716773|NCT00467649|58729944|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
30900153|NCT01831804|58933378|FG005|Overall Study|Protocol Violation|0|||
30900154|NCT01831804|58933379|FG006|Overall Study|Protocol Violation|0|||
30900155|NCT01831804|58933380|FG007|Overall Study|Protocol Violation|0|||
30900156|NCT01831804|58933381|FG008|Overall Study|Protocol Violation|0|||
30716774|NCT00467649|58729945|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
30716775|NCT00467649|58729946|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
30621560|NCT01154166|58633126|FG000|Overall Study|Poor Compliance|1|||
30900157|NCT01831804|58933373|FG000|Overall Study|Protocol defined stopping criteria|1|||
30621561|NCT01154166|58633127|FG001|Overall Study|Poor Compliance|0|||
30716776|NCT00467649|58729947|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
30716777|NCT00467649|58729942|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
30716778|NCT00467649|58729943|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
30716779|NCT00467649|58729944|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
30621562|NCT00975585|58633135|FG000|Overall Study|Adverse Event|0|||
30621563|NCT00975585|58633136|FG001|Overall Study|Adverse Event|4|||
30621564|NCT00975585|58633135|FG000|Overall Study|Lost to Follow-up|3|||
30716780|NCT00467649|58729945|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
30716781|NCT00467649|58729946|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
30900158|NCT01831804|58933374|FG001|Overall Study|Protocol defined stopping criteria|1|||
30716782|NCT00467649|58729947|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
30716783|NCT00467649|58729942|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
30716784|NCT00467649|58729943|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
30716785|NCT00467649|58729944|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
30716786|NCT00467649|58729945|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
30716787|NCT00467649|58729946|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
30716788|NCT00467649|58729947|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
30716789|NCT00467649|58729942|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
30716790|NCT00467649|58729943|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
30716791|NCT00467649|58729944|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
30716792|NCT00467649|58729945|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
30716793|NCT00467649|58729946|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
30716794|NCT00467649|58729947|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
30716795|NCT00450333|58729969|FG000|Overall Study|Study terminated|47|||
30716796|NCT00450333|58729970|FG001|Overall Study|Study terminated|54|||
30716797|NCT00450333|58729971|FG002|Overall Study|Study terminated|16|||
30716798|NCT00450333|58729972|FG003|Overall Study|Study terminated|21|||
30716799|NCT00450333|58729969|FG000|Overall Study|Adverse Event|1|||
30716800|NCT00450333|58729970|FG001|Overall Study|Adverse Event|7|||
30716801|NCT00450333|58729971|FG002|Overall Study|Adverse Event|2|||
30716802|NCT00450333|58729972|FG003|Overall Study|Adverse Event|2|||
30716803|NCT00450333|58729969|FG000|Overall Study|Protocol Violation|1|||
30716804|NCT00450333|58729970|FG001|Overall Study|Protocol Violation|0|||
30716805|NCT00450333|58729971|FG002|Overall Study|Protocol Violation|1|||
30716806|NCT00450333|58729972|FG003|Overall Study|Protocol Violation|0|||
30716807|NCT00450333|58729969|FG000|Overall Study|Withdrawal by Subject|1|||
30716808|NCT00450333|58729970|FG001|Overall Study|Withdrawal by Subject|0|||
30716809|NCT00450333|58729971|FG002|Overall Study|Withdrawal by Subject|3|||
30716810|NCT00450333|58729972|FG003|Overall Study|Withdrawal by Subject|0|||
30716811|NCT00450333|58729969|FG000|Overall Study|Kidney transplant|1|||
30716812|NCT00450333|58729970|FG001|Overall Study|Kidney transplant|0|||
30716813|NCT00450333|58729971|FG002|Overall Study|Kidney transplant|1|||
30716814|NCT00450333|58729972|FG003|Overall Study|Kidney transplant|3|||
30716815|NCT00450333|58729969|FG000|Overall Study|Death|3|||
30716816|NCT00450333|58729970|FG001|Overall Study|Death|2|||
30716817|NCT00450333|58729971|FG002|Overall Study|Death|2|||
30716818|NCT00450333|58729972|FG003|Overall Study|Death|2|||
30716819|NCT00643565|58729984|FG000|Overall Study|Death|12|||
30716820|NCT00643565|58729985|FG001|Overall Study|Death|11|||
30716821|NCT00643565|58729984|FG000|Overall Study|Withdrawal by Subject|4|||
30716822|NCT00643565|58729985|FG001|Overall Study|Withdrawal by Subject|1|||
30716823|NCT00643565|58729984|FG000|Overall Study|Lost to Follow-up|0|||
30716824|NCT00643565|58729985|FG001|Overall Study|Lost to Follow-up|6|||
30716825|NCT00643565|58729984|FG000|Overall Study|Other|7|||
30716826|NCT00643565|58729985|FG001|Overall Study|Other|8|||
30716827|NCT00643565|58729984|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
30716828|NCT00643565|58729985|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
30716829|NCT00643565|58729984|FG000|Overall Study|Recurrence of Disease|2|||
30716830|NCT00643565|58729985|FG001|Overall Study|Recurrence of Disease|1|||
30716831|NCT00643565|58729984|FG000|Overall Study|Progression of Disease|18|||
30716832|NCT00643565|58729985|FG001|Overall Study|Progression of Disease|14|||
30716833|NCT00643565|58729984|FG000|Overall Study|Protocol Violation|3|||
30621565|NCT00975585|58633136|FG001|Overall Study|Lost to Follow-up|5|||
30716834|NCT00643565|58729985|FG001|Overall Study|Protocol Violation|0|||
30716835|NCT00643565|58729984|FG000|Overall Study|Did Not Cooperate|0|||
30716836|NCT00643565|58729985|FG001|Overall Study|Did Not Cooperate|1|||
30716837|NCT00643565|58729984|FG000|Overall Study|Administrative|22|||
30716838|NCT00643565|58729985|FG001|Overall Study|Administrative|16|||
30716839|NCT00643565|58729984|FG000|Overall Study|Adverse Event|5|||
30900159|NCT01831804|58933375|FG002|Overall Study|Protocol defined stopping criteria|3|||
30900160|NCT01831804|58933376|FG003|Overall Study|Protocol defined stopping criteria|0|||
30900161|NCT01831804|58933377|FG004|Overall Study|Protocol defined stopping criteria|1|||
30900162|NCT01831804|58933378|FG005|Overall Study|Protocol defined stopping criteria|0|||
30900163|NCT01831804|58933379|FG006|Overall Study|Protocol defined stopping criteria|0|||
30900164|NCT01831804|58933380|FG007|Overall Study|Protocol defined stopping criteria|0|||
30900165|NCT01831804|58933381|FG008|Overall Study|Protocol defined stopping criteria|0|||
30900166|NCT01831804|58933373|FG000|Overall Study|Lost to Follow-up|0|||
30900167|NCT01831804|58933374|FG001|Overall Study|Lost to Follow-up|0|||
30900168|NCT01831804|58933375|FG002|Overall Study|Lost to Follow-up|1|||
30900169|NCT01831804|58933376|FG003|Overall Study|Lost to Follow-up|0|||
30900170|NCT01831804|58933377|FG004|Overall Study|Lost to Follow-up|0|||
30900171|NCT01831804|58933378|FG005|Overall Study|Lost to Follow-up|0|||
30900172|NCT01831804|58933379|FG006|Overall Study|Lost to Follow-up|0|||
30900173|NCT01831804|58933380|FG007|Overall Study|Lost to Follow-up|0|||
30900174|NCT01831804|58933381|FG008|Overall Study|Lost to Follow-up|1|||
30900175|NCT01831804|58933373|FG000|Overall Study|Investigator discretion|0|||
30900176|NCT01831804|58933374|FG001|Overall Study|Investigator discretion|0|||
30900177|NCT01831804|58933375|FG002|Overall Study|Investigator discretion|0|||
30900178|NCT01831804|58933376|FG003|Overall Study|Investigator discretion|0|||
30900179|NCT01831804|58933377|FG004|Overall Study|Investigator discretion|1|||
30900180|NCT01831804|58933378|FG005|Overall Study|Investigator discretion|0|||
30900181|NCT01831804|58933379|FG006|Overall Study|Investigator discretion|0|||
30900182|NCT01831804|58933380|FG007|Overall Study|Investigator discretion|1|||
30900183|NCT01831804|58933381|FG008|Overall Study|Investigator discretion|0|||
30900184|NCT01831804|58933373|FG000|Overall Study|Withdrew Consent|0|||
30900185|NCT01831804|58933374|FG001|Overall Study|Withdrew Consent|1|||
30716840|NCT00643565|58729985|FG001|Overall Study|Adverse Event|8|||
30900186|NCT01831804|58933375|FG002|Overall Study|Withdrew Consent|0|||
30900187|NCT01831804|58933376|FG003|Overall Study|Withdrew Consent|0|||
30621566|NCT00975585|58633135|FG000|Overall Study|Withdrawal by Subject|2|||
30621567|NCT00975585|58633136|FG001|Overall Study|Withdrawal by Subject|1|||
30621568|NCT00975585|58633135|FG000|Overall Study|Lens issue|2|||
30621569|NCT00975585|58633136|FG001|Overall Study|Lens issue|2|||
30716841|NCT00643487|58729992|FG000|Overall Study|Technical difficulty|3|||
30900188|NCT01831804|58933377|FG004|Overall Study|Withdrew Consent|0|||
30900189|NCT01831804|58933378|FG005|Overall Study|Withdrew Consent|0|||
30900190|NCT01831804|58933379|FG006|Overall Study|Withdrew Consent|0|||
30900191|NCT01831804|58933380|FG007|Overall Study|Withdrew Consent|2|||
30900192|NCT01831804|58933381|FG008|Overall Study|Withdrew Consent|0|||
30900193|NCT02270671|58933412|FG000|Overall Study|Withdrawal by Subject|1|||
30900194|NCT02270671|58933413|FG001|Overall Study|Withdrawal by Subject|1|||
30900195|NCT02270671|58933412|FG000|Overall Study|Protocol Violation|0|||
30900196|NCT02270671|58933413|FG001|Overall Study|Protocol Violation|1|||
30900197|NCT02270671|58933412|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
30900198|NCT02270671|58933413|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
30900199|NCT02270671|58933412|FG000|Overall Study|Lost to Follow-up|2|||
30900200|NCT02270671|58933413|FG001|Overall Study|Lost to Follow-up|1|||
30900201|NCT02324270|58933422|FG000|Overall Study|Withdrawal by Subject|0|||
30900202|NCT02324270|58933423|FG001|Overall Study|Withdrawal by Subject|1|||
30900203|NCT02324270|58933424|FG002|Overall Study|Withdrawal by Subject|0|||
30900204|NCT02324270|58933422|FG000|Overall Study|Lost to Follow-up|4|||
30900205|NCT02324270|58933423|FG001|Overall Study|Lost to Follow-up|3|||
30900206|NCT02324270|58933424|FG002|Overall Study|Lost to Follow-up|4|||
30900207|NCT02324270|58933422|FG000|Overall Study|Protocol Violation|0|||
30900208|NCT02324270|58933423|FG001|Overall Study|Protocol Violation|1|||
30900209|NCT02324270|58933424|FG002|Overall Study|Protocol Violation|1|||
30900210|NCT02324270|58933422|FG000|Overall Study|Non Compliance with Study Drug|1|||
30900211|NCT02324270|58933423|FG001|Overall Study|Non Compliance with Study Drug|2|||
30900212|NCT02324270|58933424|FG002|Overall Study|Non Compliance with Study Drug|0|||
30900213|NCT02270515|58933432|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
30900214|NCT02270515|58933432|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
30900215|NCT02270515|58933432|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
30716842|NCT00450255|58729996|FG000|Overall Study|Prior RFA ablation of liver|1|||
30716843|NCT00450177|58730003|FG000|Overall Study|Adverse Event|7|||
30716844|NCT00450177|58730004|FG001|Overall Study|Adverse Event|4|||
30790918|NCT03200366|58804015|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
30621570|NCT01181921|58633144|FG000|Overall Study|Lost to Follow-up|1|||
30716845|NCT00450177|58730003|FG000|Overall Study|Withdrawal by Subject|1|||
30716846|NCT00450177|58730004|FG001|Overall Study|Withdrawal by Subject|6|||
30900216|NCT02270515|58933432|FG000|Intervention Period 1: 0-6 Months|Death|7|||
30900217|NCT02270515|58933432|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
30716847|NCT00450177|58730003|FG000|Overall Study|Withdrawal by Primary Team|1|||
30716848|NCT00450177|58730004|FG001|Overall Study|Withdrawal by Primary Team|1|||
30716849|NCT03848949|58730012|FG000|Overall Study|Lost to Follow-up|5|||
30716850|NCT03848949|58730013|FG001|Overall Study|Lost to Follow-up|7|||
30716851|NCT00467259|58730021|FG000|Overall Study|Adverse Event|24|||
30716852|NCT00467259|58730022|FG001|Overall Study|Adverse Event|90|||
30716853|NCT00467259|58730021|FG000|Overall Study|Protocol Violation|1|||
30716854|NCT00467259|58730022|FG001|Overall Study|Protocol Violation|7|||
30716855|NCT00467259|58730021|FG000|Overall Study|Withdrawal by Subject|34|||
30716856|NCT00467259|58730022|FG001|Overall Study|Withdrawal by Subject|108|||
30716857|NCT00467259|58730021|FG000|Overall Study|Physician Decision|0|||
30716858|NCT00467259|58730022|FG001|Overall Study|Physician Decision|2|||
30716859|NCT00467259|58730021|FG000|Overall Study|Lost to Follow-up|14|||
30716860|NCT00467259|58730022|FG001|Overall Study|Lost to Follow-up|34|||
30716861|NCT00467259|58730021|FG000|Overall Study|Site Closed|2|||
30716862|NCT00467259|58730022|FG001|Overall Study|Site Closed|1|||
30716863|NCT00449865|58730030|FG000|Overall Study|Withdrawal by Subject|110|||
30716864|NCT00449865|58730031|FG001|Overall Study|Withdrawal by Subject|110|||
30716865|NCT00449865|58730030|FG000|Overall Study|Lost to Follow-up|36|||
30716866|NCT00449865|58730031|FG001|Overall Study|Lost to Follow-up|37|||
30716867|NCT00449865|58730030|FG000|Overall Study|Physician Decision|13|||
30716868|NCT00449865|58730031|FG001|Overall Study|Physician Decision|12|||
30716869|NCT00449865|58730030|FG000|Overall Study|Death|31|||
30716870|NCT00449865|58730031|FG001|Overall Study|Death|40|||
30716871|NCT00449865|58730030|FG000|Overall Study|Protocol Violation|8|||
30716872|NCT00449865|58730031|FG001|Overall Study|Protocol Violation|7|||
30716873|NCT00449865|58730030|FG000|Overall Study|Study was stopped|324|||
30716874|NCT00449865|58730031|FG001|Overall Study|Study was stopped|328|||
30716875|NCT00449787|58730039|FG000|Overall Study|Lost to Follow-up|10|||
30716876|NCT00449787|58730040|FG001|Overall Study|Lost to Follow-up|8|||
30716877|NCT00449787|58730039|FG000|Overall Study|Did not require medication|95|||
30716878|NCT00449787|58730040|FG001|Overall Study|Did not require medication|92|||
30716879|NCT00449163|58730048|FG000|Overall Study|Physician Decision|3|||
30716880|NCT00448539|58730054|FG000|Overall Study|Medication non-compliance|4|||
30716881|NCT00448539|58730055|FG001|Overall Study|Medication non-compliance|1|||
30716882|NCT00448539|58730054|FG000|Overall Study|Protocol Violation|1|||
30716883|NCT00448539|58730055|FG001|Overall Study|Protocol Violation|0|||
30716884|NCT00448539|58730054|FG000|Overall Study|Request of the investigator or sponsor|67|||
30716885|NCT00448539|58730055|FG001|Overall Study|Request of the investigator or sponsor|54|||
30716886|NCT00448539|58730054|FG000|Overall Study|Withdrawal by Subject|20|||
30716887|NCT00448539|58730055|FG001|Overall Study|Withdrawal by Subject|24|||
30716888|NCT00448539|58730054|FG000|Overall Study|Diary non-compliance|1|||
30716889|NCT00448539|58730055|FG001|Overall Study|Diary non-compliance|0|||
30716890|NCT00448539|58730054|FG000|Overall Study|Adverse Event|9|||
30716891|NCT00448539|58730055|FG001|Overall Study|Adverse Event|26|||
30716892|NCT00448539|58730054|FG000|Overall Study|Lack of Efficacy|27|||
30716893|NCT00448539|58730055|FG001|Overall Study|Lack of Efficacy|40|||
30716894|NCT00448539|58730054|FG000|Overall Study|Miscellaneous|2|||
30716895|NCT00448539|58730055|FG001|Overall Study|Miscellaneous|1|||
30716896|NCT00448539|58730054|FG000|Overall Study|Change of meds|2|||
30716897|NCT00448539|58730055|FG001|Overall Study|Change of meds|3|||
30716898|NCT00448539|58730054|FG000|Overall Study|Lost to Follow-up|1|||
30716899|NCT00448539|58730055|FG001|Overall Study|Lost to Follow-up|3|||
30716900|NCT00457665|58730063|FG000|12 Months|Drug allergy|1|||
30716901|NCT00457665|58730064|FG001|12 Months|Drug allergy|1|||
30716902|NCT00457665|58730063|FG000|12 Months|High HIV viral load|5|||
30716903|NCT00457665|58730064|FG001|12 Months|High HIV viral load|1|||
30716904|NCT00457665|58730063|FG000|12 Months|Lipodystrophy|2|||
30716905|NCT00457665|58730064|FG001|12 Months|Lipodystrophy|0|||
30716906|NCT00457665|58730063|FG000|12 Months|Withdrawal by Subject|0|||
30716907|NCT00457665|58730064|FG001|12 Months|Withdrawal by Subject|2|||
30716908|NCT00457665|58730063|FG000|12 Months|Abnormal Liver function tests|0|||
30716909|NCT00457665|58730064|FG001|12 Months|Abnormal Liver function tests|5|||
30716910|NCT00457665|58730063|FG000|24 Months|Withdrawal by Subject|3|||
30716911|NCT00457665|58730064|FG001|24 Months|Withdrawal by Subject|2|||
30716912|NCT00457665|58730063|FG000|24 Months|Lipodystrophy|1|||
30716913|NCT00457665|58730064|FG001|24 Months|Lipodystrophy|1|||
30716914|NCT00457665|58730063|FG000|24 Months|Abnormal liver function tests|1|||
30716915|NCT00457665|58730064|FG001|24 Months|Abnormal liver function tests|5|||
30716916|NCT00447603|58730070|FG000|Screening|Withdrawal by Subject|1|||
30716917|NCT00447603|58730071|FG001|Screening|Withdrawal by Subject|0|||
30716918|NCT00447603|58730072|FG002|Screening|Withdrawal by Subject|0|||
30716919|NCT00447603|58730070|FG000|Screening|Protocol Violation|1|||
30716920|NCT00447603|58730071|FG001|Screening|Protocol Violation|0|||
30716921|NCT00447603|58730072|FG002|Screening|Protocol Violation|0|||
30716922|NCT00447603|58730070|FG000|Screening|Screen Failure|4|||
30716923|NCT00447603|58730071|FG001|Screening|Screen Failure|0|||
30716924|NCT00447603|58730072|FG002|Screening|Screen Failure|0|||
30716925|NCT00447603|58730070|FG000|Screening|Study Terminated by Sponsor|15|||
30716926|NCT00447603|58730071|FG001|Screening|Study Terminated by Sponsor|0|||
30716927|NCT00447603|58730072|FG002|Screening|Study Terminated by Sponsor|0|||
30716928|NCT00447603|58730070|FG000|Filter Period|Adverse Event|0|||
30716929|NCT00447603|58730071|FG001|Filter Period|Adverse Event|0|||
30716930|NCT00447603|58730072|FG002|Filter Period|Adverse Event|1|||
30716931|NCT00447603|58730070|FG000|Filter Period|Screen Failure|0|||
30716932|NCT00447603|58730071|FG001|Filter Period|Screen Failure|3|||
30716933|NCT00447603|58730072|FG002|Filter Period|Screen Failure|4|||
30716934|NCT00447603|58730070|FG000|Filter Period|Study terminated by Sponsor|0|||
30716935|NCT00447603|58730071|FG001|Filter Period|Study terminated by Sponsor|1|||
30716936|NCT00447603|58730072|FG002|Filter Period|Study terminated by Sponsor|10|||
30716937|NCT00447057|58730084|FG000|Overall Study|Adverse Event|4|||
30716938|NCT00447057|58730085|FG001|Overall Study|Adverse Event|10|||
30716939|NCT00447057|58730086|FG002|Overall Study|Adverse Event|0|||
30716940|NCT00447057|58730087|FG003|Overall Study|Adverse Event|3|||
30716941|NCT00447057|58730084|FG000|Overall Study|Death due to study disease|6|||
30716942|NCT00447057|58730085|FG001|Overall Study|Death due to study disease|4|||
30716943|NCT00447057|58730086|FG002|Overall Study|Death due to study disease|1|||
30716944|NCT00447057|58730087|FG003|Overall Study|Death due to study disease|1|||
30716945|NCT00447057|58730084|FG000|Overall Study|Lost to Follow-up|0|||
30716946|NCT00447057|58730085|FG001|Overall Study|Lost to Follow-up|1|||
30716947|NCT00447057|58730086|FG002|Overall Study|Lost to Follow-up|0|||
30716948|NCT00447057|58730087|FG003|Overall Study|Lost to Follow-up|0|||
30716949|NCT00447057|58730084|FG000|Overall Study|Entry criteria not met|1|||
30716950|NCT00447057|58730085|FG001|Overall Study|Entry criteria not met|1|||
30900218|NCT02270515|58933432|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
30716951|NCT00447057|58730086|FG002|Overall Study|Entry criteria not met|0|||
30716952|NCT00447057|58730087|FG003|Overall Study|Entry criteria not met|0|||
30716953|NCT00447057|58730084|FG000|Overall Study|Protocol Violation|0|||
30716954|NCT00447057|58730085|FG001|Overall Study|Protocol Violation|1|||
30716955|NCT00447057|58730086|FG002|Overall Study|Protocol Violation|0|||
30716956|NCT00447057|58730087|FG003|Overall Study|Protocol Violation|0|||
30716957|NCT00447057|58730084|FG000|Overall Study|Withdrawal by Subject|4|||
30716958|NCT00447057|58730085|FG001|Overall Study|Withdrawal by Subject|5|||
30716959|NCT00447057|58730086|FG002|Overall Study|Withdrawal by Subject|1|||
30716960|NCT00447057|58730087|FG003|Overall Study|Withdrawal by Subject|1|||
30716961|NCT00447057|58730084|FG000|Overall Study|Physician Decision|9|||
30716962|NCT00447057|58730085|FG001|Overall Study|Physician Decision|6|||
30716963|NCT00447057|58730086|FG002|Overall Study|Physician Decision|3|||
30716964|NCT00447057|58730087|FG003|Overall Study|Physician Decision|1|||
30716965|NCT00447057|58730084|FG000|Overall Study|Sponsor decision|1|||
30716966|NCT00447057|58730085|FG001|Overall Study|Sponsor decision|1|||
30716967|NCT00447057|58730086|FG002|Overall Study|Sponsor decision|0|||
30716968|NCT00447057|58730087|FG003|Overall Study|Sponsor decision|0|||
30716969|NCT00447057|58730084|FG000|Overall Study|Progressive disease|58|||
30716970|NCT00447057|58730085|FG001|Overall Study|Progressive disease|43|||
30716971|NCT00447057|58730086|FG002|Overall Study|Progressive disease|13|||
30716972|NCT00447057|58730087|FG003|Overall Study|Progressive disease|18|||
30716973|NCT00447057|58730084|FG000|Overall Study|Death due to adverse event|0|||
30716974|NCT00447057|58730085|FG001|Overall Study|Death due to adverse event|0|||
30716975|NCT00447057|58730086|FG002|Overall Study|Death due to adverse event|1|||
30716976|NCT00447057|58730087|FG003|Overall Study|Death due to adverse event|2|||
30716977|NCT00447057|58730084|FG000|Overall Study|Death, study drug related|0|||
30716978|NCT00447057|58730085|FG001|Overall Study|Death, study drug related|1|||
30716979|NCT00447057|58730086|FG002|Overall Study|Death, study drug related|0|||
30716980|NCT00447057|58730087|FG003|Overall Study|Death, study drug related|0|||
30716981|NCT00446511|58730099|FG000|Overall Study|Adverse Event|7|||
30716982|NCT00446511|58730100|FG001|Overall Study|Adverse Event|2|||
30716983|NCT00446511|58730101|FG002|Overall Study|Adverse Event|3|||
30716984|NCT00446511|58730102|FG003|Overall Study|Adverse Event|1|||
30716985|NCT00446511|58730099|FG000|Overall Study|Protocol Violation|0|||
30716986|NCT00446511|58730100|FG001|Overall Study|Protocol Violation|0|||
30716987|NCT00446511|58730101|FG002|Overall Study|Protocol Violation|0|||
30716988|NCT00446511|58730102|FG003|Overall Study|Protocol Violation|1|||
30716989|NCT00446511|58730099|FG000|Overall Study|Withdrawal by Subject|0|||
30716990|NCT00446511|58730100|FG001|Overall Study|Withdrawal by Subject|0|||
30716991|NCT00446511|58730101|FG002|Overall Study|Withdrawal by Subject|0|||
30716992|NCT00446511|58730102|FG003|Overall Study|Withdrawal by Subject|3|||
30716993|NCT00446511|58730099|FG000|Overall Study|Administrative Problems|3|||
30716994|NCT00446511|58730100|FG001|Overall Study|Administrative Problems|0|||
30716995|NCT00446511|58730101|FG002|Overall Study|Administrative Problems|4|||
30716996|NCT00446511|58730102|FG003|Overall Study|Administrative Problems|1|||
30716997|NCT00446199|58730118|FG000|Overall Study|Adverse Event|7|||
30716998|NCT00446199|58730119|FG001|Overall Study|Adverse Event|4|||
30716999|NCT00446199|58730120|FG002|Overall Study|Adverse Event|6|||
30717000|NCT00446199|58730121|FG003|Overall Study|Adverse Event|4|||
30717001|NCT00446199|58730118|FG000|Overall Study|Lost to Follow-up|4|||
30717002|NCT00446199|58730119|FG001|Overall Study|Lost to Follow-up|5|||
30717003|NCT00446199|58730120|FG002|Overall Study|Lost to Follow-up|2|||
30717004|NCT00446199|58730121|FG003|Overall Study|Lost to Follow-up|6|||
30717005|NCT00446199|58730118|FG000|Overall Study|Protocol Violation|1|||
30717006|NCT00446199|58730119|FG001|Overall Study|Protocol Violation|2|||
30717007|NCT00446199|58730120|FG002|Overall Study|Protocol Violation|1|||
30717008|NCT00446199|58730121|FG003|Overall Study|Protocol Violation|3|||
30717009|NCT00446199|58730118|FG000|Overall Study|Withdrawal by Subject|2|||
30717010|NCT00446199|58730119|FG001|Overall Study|Withdrawal by Subject|5|||
30717011|NCT00446199|58730120|FG002|Overall Study|Withdrawal by Subject|9|||
30717012|NCT00446199|58730121|FG003|Overall Study|Withdrawal by Subject|10|||
30717013|NCT00446199|58730118|FG000|Overall Study|Site termination|2|||
30717014|NCT00446199|58730119|FG001|Overall Study|Site termination|0|||
30717015|NCT00446199|58730120|FG002|Overall Study|Site termination|0|||
30717016|NCT00446199|58730121|FG003|Overall Study|Site termination|1|||
30717017|NCT00446199|58730118|FG000|Overall Study|Randomization in Error|2|||
30717018|NCT00446199|58730119|FG001|Overall Study|Randomization in Error|0|||
30717019|NCT00446199|58730120|FG002|Overall Study|Randomization in Error|1|||
30717020|NCT00446199|58730121|FG003|Overall Study|Randomization in Error|1|||
30717021|NCT00446199|58730118|FG000|Overall Study|Lack of Efficacy|1|||
30717022|NCT00446199|58730119|FG001|Overall Study|Lack of Efficacy|0|||
30717023|NCT00446199|58730120|FG002|Overall Study|Lack of Efficacy|0|||
30717024|NCT00446199|58730121|FG003|Overall Study|Lack of Efficacy|1|||
30717025|NCT00446199|58730118|FG000|Overall Study|Non-compliant with study drug|1|||
30717026|NCT00446199|58730119|FG001|Overall Study|Non-compliant with study drug|0|||
30900219|NCT02270515|58933432|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
30900220|NCT02270515|58933432|FG000|Intervention Period 2: 6-12 Months|Death|5|||
30717027|NCT00446199|58730120|FG002|Overall Study|Non-compliant with study drug|5|||
30717028|NCT00446199|58730121|FG003|Overall Study|Non-compliant with study drug|0|||
30717029|NCT00446199|58730118|FG000|Overall Study|Non-compliant with visit schedule|1|||
30717030|NCT00446199|58730119|FG001|Overall Study|Non-compliant with visit schedule|1|||
30717031|NCT00446199|58730120|FG002|Overall Study|Non-compliant with visit schedule|1|||
30717032|NCT00446199|58730121|FG003|Overall Study|Non-compliant with visit schedule|2|||
30717033|NCT00446199|58730118|FG000|Overall Study|Hormone fear|0|||
30717034|NCT00446199|58730119|FG001|Overall Study|Hormone fear|0|||
30717035|NCT00446199|58730120|FG002|Overall Study|Hormone fear|0|||
30717036|NCT00446199|58730121|FG003|Overall Study|Hormone fear|1|||
30717037|NCT00446199|58730118|FG000|Overall Study|Lost interest in study participation|0|||
30717038|NCT00446199|58730119|FG001|Overall Study|Lost interest in study participation|1|||
30717039|NCT00446199|58730120|FG002|Overall Study|Lost interest in study participation|0|||
30717040|NCT00446199|58730121|FG003|Overall Study|Lost interest in study participation|0|||
30717041|NCT00446199|58730118|FG000|Overall Study|In-/Exclusion criterion violated|2|||
30717042|NCT00446199|58730119|FG001|Overall Study|In-/Exclusion criterion violated|1|||
30717043|NCT00446199|58730120|FG002|Overall Study|In-/Exclusion criterion violated|2|||
30717044|NCT00446199|58730121|FG003|Overall Study|In-/Exclusion criterion violated|1|||
30717045|NCT00446199|58730118|FG000|Overall Study|Move|0|||
30717046|NCT00446199|58730119|FG001|Overall Study|Move|1|||
30717047|NCT00446199|58730120|FG002|Overall Study|Move|0|||
30717048|NCT00446199|58730121|FG003|Overall Study|Move|0|||
30717049|NCT00456495|58730131|FG000|Overall Study|Physician Decision|2|||
30717050|NCT00445341|58730136|FG000|Overall Study|refused further treatment|1|||
30717051|NCT00445341|58730136|FG000|Overall Study|taken off treatment too early|1|||
30717052|NCT03846453|58730142|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
30717053|NCT03846453|58730143|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
30717054|NCT03846453|58730144|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
30717055|NCT03846453|58730142|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
30717056|NCT03846453|58730143|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
30717057|NCT03846453|58730144|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
30717058|NCT03846453|58730142|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
30717059|NCT03846453|58730143|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
30717060|NCT03846453|58730144|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
30717061|NCT03846453|58730142|FG000|Placebo Run-in (14 Days)|Other|2|||
30717062|NCT03846453|58730143|FG001|Placebo Run-in (14 Days)|Other|0|||
30717063|NCT03846453|58730144|FG002|Placebo Run-in (14 Days)|Other|0|||
30717064|NCT03846453|58730142|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
30717065|NCT03846453|58730143|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
30717066|NCT03846453|58730144|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
30717067|NCT03846453|58730142|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
30717068|NCT03846453|58730143|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
30717069|NCT03846453|58730144|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
30717070|NCT03846453|58730142|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
30717071|NCT03846453|58730143|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
30717072|NCT03846453|58730144|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
30717073|NCT03846453|58730142|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
30717074|NCT03846453|58730143|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
30717075|NCT03846453|58730144|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
30717076|NCT03846453|58730142|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
30900221|NCT02270515|58933432|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
30900222|NCT02270515|58933432|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
30900223|NCT02270515|58933432|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
30900224|NCT02270515|58933432|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
30900225|NCT02270515|58933432|FG000|Intervention Period 3: 12-18 Months|Death|3|||
30900226|NCT02270515|58933432|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
30900227|NCT02448875|58933446|FG000|Overall Study|Adverse Event|2|||
30900228|NCT02448875|58933447|FG001|Overall Study|Adverse Event|1|||
30900229|NCT02448875|58933448|FG002|Overall Study|Adverse Event|0|||
30717077|NCT03846453|58730143|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
30717078|NCT03846453|58730144|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
30717079|NCT00444951|58730155|FG000|Overall Study|Lost to Follow-up|1|||
30717080|NCT00444951|58730156|FG001|Overall Study|Lost to Follow-up|1|||
30717081|NCT00444951|58730157|FG002|Overall Study|Lost to Follow-up|0|||
30717082|NCT00444951|58730155|FG000|Overall Study|Withdrawal by Subject|4|||
30717083|NCT00444951|58730156|FG001|Overall Study|Withdrawal by Subject|5|||
30717084|NCT00444951|58730157|FG002|Overall Study|Withdrawal by Subject|3|||
30717085|NCT00444795|58730165|FG000|Overall Study|Not Treated|1|||
30717086|NCT00444795|58730165|FG000|Overall Study|Treated Prior to the Contract Date|2|||
30717087|NCT03846219|58730172|FG000|Overall Study|Withdrawal by Subject|3|||
30717088|NCT03846219|58730173|FG001|Overall Study|Withdrawal by Subject|2|||
30717089|NCT03846219|58730174|FG002|Overall Study|Withdrawal by Subject|2|||
30717090|NCT03846219|58730172|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
30717091|NCT03846219|58730173|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
30717092|NCT03846219|58730174|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
30717093|NCT03846219|58730172|FG000|Overall Study|Physician Decision|0|||
30717094|NCT03846219|58730173|FG001|Overall Study|Physician Decision|0|||
30717095|NCT03846219|58730174|FG002|Overall Study|Physician Decision|2|||
30717096|NCT00455325|58730190|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
30717097|NCT00455325|58730191|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
30717098|NCT00455325|58730192|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
30717099|NCT00455325|58730193|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
30717100|NCT00455325|58730190|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
30717101|NCT00455325|58730191|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
30717102|NCT00455325|58730192|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
30717103|NCT00455325|58730193|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
30717104|NCT00455325|58730190|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
30717105|NCT00455325|58730191|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
30717106|NCT00455325|58730192|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
30717107|NCT00455325|58730193|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
30717108|NCT00455325|58730190|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
30717109|NCT00455325|58730191|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
30717110|NCT00455325|58730192|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
30717111|NCT00455325|58730193|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
30717112|NCT00455325|58730190|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
30717113|NCT00455325|58730191|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
30717114|NCT00455325|58730192|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
30717115|NCT00455325|58730193|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
30717116|NCT00455325|58730190|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
30717117|NCT00455325|58730191|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
30717118|NCT00455325|58730192|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
30717119|NCT00455325|58730193|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
30717120|NCT00455325|58730190|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
30717121|NCT00455325|58730191|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
30717122|NCT00455325|58730192|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
30717123|NCT00455325|58730193|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
30717124|NCT00443781|58730204|FG000|Overall Study|Lost to Follow-up|10|||
30717125|NCT00443781|58730204|FG000|Overall Study|Physician Decision|2|||
30717126|NCT00443781|58730204|FG000|Overall Study|Protocol Violation|1|||
30717127|NCT00443781|58730204|FG000|Overall Study|Withdrawal by Subject|6|||
30717128|NCT00443781|58730204|FG000|Overall Study|Unable to comply with study follow up|2|||
30717129|NCT00443781|58730204|FG000|Overall Study|Investigator terminated participation|1|||
30717130|NCT00443781|58730204|FG000|Overall Study|Insurance not covered|2|||
30717131|NCT00443781|58730204|FG000|Overall Study|PD/FAD not done|1|||
30717132|NCT00443703|58730210|FG000|Overall Study|Never Treated|3|||
30717133|NCT00443703|58730211|FG001|Overall Study|Never Treated|1|||
30717134|NCT00443703|58730210|FG000|Overall Study|Adverse Event|7|||
30900230|NCT02448875|58933446|FG000|Overall Study|Lost to Follow-up|1|||
30717135|NCT00443703|58730211|FG001|Overall Study|Adverse Event|3|||
30717136|NCT00443703|58730210|FG000|Overall Study|Lack of Efficacy|3|||
30717137|NCT00443703|58730211|FG001|Overall Study|Lack of Efficacy|1|||
30717138|NCT00443703|58730210|FG000|Overall Study|Lost to Follow-up|0|||
30717139|NCT00443703|58730211|FG001|Overall Study|Lost to Follow-up|4|||
30717140|NCT00443703|58730210|FG000|Overall Study|Physician Decision|4|||
30717141|NCT00443703|58730211|FG001|Overall Study|Physician Decision|2|||
30717142|NCT00443703|58730210|FG000|Overall Study|Protocol Violation|1|||
30717143|NCT00443703|58730211|FG001|Overall Study|Protocol Violation|1|||
30717144|NCT00443703|58730210|FG000|Overall Study|Withdrawal by Subject|9|||
30717145|NCT00443703|58730211|FG001|Overall Study|Withdrawal by Subject|6|||
30717146|NCT00443703|58730210|FG000|Overall Study|Progressive Disease|1|||
30717147|NCT00443703|58730211|FG001|Overall Study|Progressive Disease|0|||
30717148|NCT00381706|58730223|FG000|Overall Study|Never treated|7|||
30717149|NCT00381706|58730224|FG001|Overall Study|Never treated|2|||
30717150|NCT00381706|58730225|FG002|Overall Study|Never treated|1|||
30717151|NCT00535236|58730249|FG000|Overall Study|Adverse Event|1|||
30717152|NCT00535236|58730250|FG001|Overall Study|Adverse Event|0|||
30717153|NCT00535236|58730251|FG002|Overall Study|Adverse Event|9|||
30717154|NCT00535236|58730252|FG003|Overall Study|Adverse Event|3|||
30717155|NCT00535236|58730253|FG004|Overall Study|Adverse Event|3|||
30717156|NCT00535236|58730254|FG005|Overall Study|Adverse Event|0|||
30717157|NCT00535236|58730255|FG006|Overall Study|Adverse Event|5|||
30717158|NCT00535236|58730256|FG007|Overall Study|Adverse Event|1|||
30717159|NCT00535236|58730257|FG008|Overall Study|Adverse Event|2|||
30717160|NCT00535236|58730258|FG009|Overall Study|Adverse Event|1|||
30717161|NCT00535236|58730249|FG000|Overall Study|Lost to Follow-up|1|||
30717162|NCT00535236|58730250|FG001|Overall Study|Lost to Follow-up|2|||
30717163|NCT00535236|58730251|FG002|Overall Study|Lost to Follow-up|0|||
30717164|NCT00535236|58730252|FG003|Overall Study|Lost to Follow-up|0|||
30717165|NCT00535236|58730253|FG004|Overall Study|Lost to Follow-up|2|||
30717166|NCT00535236|58730254|FG005|Overall Study|Lost to Follow-up|0|||
30717167|NCT00535236|58730255|FG006|Overall Study|Lost to Follow-up|0|||
30717168|NCT00535236|58730256|FG007|Overall Study|Lost to Follow-up|0|||
30717169|NCT00535236|58730257|FG008|Overall Study|Lost to Follow-up|6|||
30717170|NCT00535236|58730258|FG009|Overall Study|Lost to Follow-up|1|||
30717171|NCT00535236|58730249|FG000|Overall Study|Physician Decision|0|||
30900231|NCT02448875|58933447|FG001|Overall Study|Lost to Follow-up|0|||
30717172|NCT00535236|58730250|FG001|Overall Study|Physician Decision|0|||
30717173|NCT00535236|58730251|FG002|Overall Study|Physician Decision|0|||
30717174|NCT00535236|58730252|FG003|Overall Study|Physician Decision|0|||
30717175|NCT00535236|58730253|FG004|Overall Study|Physician Decision|1|||
30717176|NCT00535236|58730254|FG005|Overall Study|Physician Decision|0|||
30900232|NCT02448875|58933448|FG002|Overall Study|Lost to Follow-up|0|||
30717177|NCT00535236|58730255|FG006|Overall Study|Physician Decision|1|||
30717178|NCT00535236|58730256|FG007|Overall Study|Physician Decision|0|||
30717179|NCT00535236|58730257|FG008|Overall Study|Physician Decision|0|||
30717180|NCT00535236|58730258|FG009|Overall Study|Physician Decision|0|||
30717181|NCT00535236|58730249|FG000|Overall Study|Protocol Violation|2|||
30717182|NCT00535236|58730250|FG001|Overall Study|Protocol Violation|0|||
30717183|NCT00535236|58730251|FG002|Overall Study|Protocol Violation|1|||
30717184|NCT00535236|58730252|FG003|Overall Study|Protocol Violation|0|||
30717185|NCT00535236|58730253|FG004|Overall Study|Protocol Violation|0|||
30717186|NCT00535236|58730254|FG005|Overall Study|Protocol Violation|0|||
30717187|NCT00535236|58730255|FG006|Overall Study|Protocol Violation|0|||
30717188|NCT00535236|58730256|FG007|Overall Study|Protocol Violation|0|||
30717189|NCT00535236|58730257|FG008|Overall Study|Protocol Violation|1|||
30717190|NCT00535236|58730258|FG009|Overall Study|Protocol Violation|0|||
30717191|NCT00535236|58730249|FG000|Overall Study|Withdrawal by Subject|3|||
30717192|NCT00535236|58730250|FG001|Overall Study|Withdrawal by Subject|0|||
30717193|NCT00535236|58730251|FG002|Overall Study|Withdrawal by Subject|2|||
30717194|NCT00535236|58730252|FG003|Overall Study|Withdrawal by Subject|1|||
30717195|NCT00535236|58730253|FG004|Overall Study|Withdrawal by Subject|6|||
30717196|NCT00535236|58730254|FG005|Overall Study|Withdrawal by Subject|1|||
30717197|NCT00535236|58730255|FG006|Overall Study|Withdrawal by Subject|5|||
30717198|NCT00535236|58730256|FG007|Overall Study|Withdrawal by Subject|0|||
30717199|NCT00535236|58730257|FG008|Overall Study|Withdrawal by Subject|4|||
30717200|NCT00535236|58730258|FG009|Overall Study|Withdrawal by Subject|2|||
30717201|NCT00370552|58730286|FG000|Overall Study|Adverse Event|2|||
30717202|NCT00370552|58730287|FG001|Overall Study|Adverse Event|2|||
30717203|NCT00370552|58730288|FG002|Overall Study|Adverse Event|2|||
30717204|NCT00370552|58730286|FG000|Overall Study|Disease progression|23|||
30717205|NCT00370552|58730287|FG001|Overall Study|Disease progression|23|||
30717206|NCT00370552|58730288|FG002|Overall Study|Disease progression|15|||
30717207|NCT00370552|58730286|FG000|Overall Study|Maximum clinical benefit|3|||
30717208|NCT00370552|58730287|FG001|Overall Study|Maximum clinical benefit|5|||
30717209|NCT00370552|58730288|FG002|Overall Study|Maximum clinical benefit|5|||
30717210|NCT00370552|58730286|FG000|Overall Study|Poor or noncompliance|0|||
30717211|NCT00370552|58730287|FG001|Overall Study|Poor or noncompliance|0|||
30717212|NCT00370552|58730288|FG002|Overall Study|Poor or noncompliance|1|||
30717213|NCT00370552|58730286|FG000|Overall Study|Study drug toxicity|11|||
30717214|NCT00370552|58730287|FG001|Overall Study|Study drug toxicity|8|||
30717215|NCT00370552|58730288|FG002|Overall Study|Study drug toxicity|6|||
30717216|NCT00370552|58730286|FG000|Overall Study|Withdrawal by Subject|2|||
30717217|NCT00370552|58730287|FG001|Overall Study|Withdrawal by Subject|0|||
30717218|NCT00370552|58730288|FG002|Overall Study|Withdrawal by Subject|1|||
30717219|NCT00370552|58730286|FG000|Overall Study|Still on treatment|1|||
30717220|NCT00370552|58730287|FG001|Overall Study|Still on treatment|3|||
30717221|NCT00370552|58730288|FG002|Overall Study|Still on treatment|2|||
30717222|NCT00370552|58730286|FG000|Overall Study|Never treated|1|||
30717223|NCT00370552|58730287|FG001|Overall Study|Never treated|0|||
30717224|NCT00370552|58730288|FG002|Overall Study|Never treated|0|||
30717225|NCT00370552|58730286|FG000|Overall Study|Physician Decision|1|||
30717226|NCT00370552|58730287|FG001|Overall Study|Physician Decision|1|||
30717227|NCT00370552|58730288|FG002|Overall Study|Physician Decision|0|||
30717228|NCT00370552|58730286|FG000|Overall Study|Investigator decision|2|||
30717229|NCT00370552|58730287|FG001|Overall Study|Investigator decision|1|||
30717230|NCT00370552|58730288|FG002|Overall Study|Investigator decision|0|||
30717231|NCT00370552|58730286|FG000|Overall Study|High risk of allergic reaction|0|||
30717232|NCT00370552|58730287|FG001|Overall Study|High risk of allergic reaction|1|||
30717233|NCT00370552|58730288|FG002|Overall Study|High risk of allergic reaction|0|||
30717234|NCT00370552|58730286|FG000|Overall Study|Planned radiation for palliation|0|||
30717235|NCT00370552|58730287|FG001|Overall Study|Planned radiation for palliation|1|||
30717236|NCT00370552|58730288|FG002|Overall Study|Planned radiation for palliation|0|||
30717237|NCT00537030|58730296|FG000|Overall Study|Physician Decision|2|||
30717238|NCT00537030|58730296|FG000|Overall Study|Withdrawal by Subject|2|||
30717239|NCT00537030|58730296|FG000|Overall Study|≥ Grade 2 allergy|7|||
30717240|NCT00537030|58730296|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
30717241|NCT00537030|58730296|FG000|Overall Study|Ineligible|2|||
30717242|NCT00537030|58730296|FG000|Overall Study|Inevaluable|2|||
30717243|NCT00381238|58730300|FG000|Overall Study|Adverse Event|3|||
30717244|NCT00381238|58730300|FG000|Overall Study|Protocol Violation|1|||
30717245|NCT00381238|58730300|FG000|Overall Study|Withdrawal by Subject|4|||
30717246|NCT00381238|58730300|FG000|Overall Study|Lack of Efficacy|2|||
30717247|NCT00381238|58730300|FG000|Overall Study|Withdrew by physician|1|||
30717248|NCT00381238|58730300|FG000|Overall Study|Disease progression|1|||
30717249|NCT03896022|58730307|FG000|Overall Study|Withdrawal by Subject|1|||
30717250|NCT03896022|58730308|FG001|Overall Study|Withdrawal by Subject|0|||
30717251|NCT03896022|58730309|FG002|Overall Study|Withdrawal by Subject|0|||
30717252|NCT03896022|58730307|FG000|Overall Study|Did not have procedure|3|||
30717253|NCT03896022|58730308|FG001|Overall Study|Did not have procedure|0|||
30717254|NCT03896022|58730309|FG002|Overall Study|Did not have procedure|0|||
30717255|NCT03831880|58730321|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
30717256|NCT03831880|58730322|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
30717257|NCT03831880|58730321|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
30717258|NCT03831880|58730322|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
30717259|NCT00380692|58730345|FG000|Study Period II - Double Blind|Adverse Event|1|||
30717260|NCT00380692|58730346|FG001|Study Period II - Double Blind|Adverse Event|0|||
30717261|NCT00380692|58730345|FG000|Study Period II - Double Blind|Protocol Violation|2|||
30717262|NCT00380692|58730346|FG001|Study Period II - Double Blind|Protocol Violation|2|||
30717263|NCT00380692|58730345|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
30717264|NCT00380692|58730346|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
30717265|NCT00380692|58730345|FG000|Study Period II - Double Blind|Physician Decision|0|||
30717266|NCT00380692|58730346|FG001|Study Period II - Double Blind|Physician Decision|1|||
30717267|NCT00380692|58730345|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
30717268|NCT00380692|58730346|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
30717269|NCT00380692|58730345|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
30717270|NCT00380692|58730346|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
30717271|NCT00380692|58730345|FG000|Study Period III - Open Label|Adverse Event|5|||
30717272|NCT00380692|58730346|FG001|Study Period III - Open Label|Adverse Event|3|||
30717273|NCT00380692|58730345|FG000|Study Period III - Open Label|Protocol Violation|0|||
30717274|NCT00380692|58730346|FG001|Study Period III - Open Label|Protocol Violation|0|||
30717275|NCT00380692|58730345|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
30717276|NCT00380692|58730346|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
30717277|NCT00380692|58730345|FG000|Study Period III - Open Label|Physician Decision|0|||
30717278|NCT00380692|58730346|FG001|Study Period III - Open Label|Physician Decision|3|||
30717279|NCT00380692|58730345|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
30717280|NCT00380692|58730346|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
30717281|NCT00380692|58730345|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
30717282|NCT00380692|58730346|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
30717283|NCT00536874|58730352|FG000|Overall Study|Adverse Event|1|||
30717284|NCT00536874|58730352|FG000|Overall Study|Death|2|||
30717285|NCT00536874|58730352|FG000|Overall Study|Withdrawal by Subject|1|||
30717286|NCT00380068|58730356|FG000|Overall Study|Adverse Event|40|||
30717287|NCT00380068|58730356|FG000|Overall Study|Withdrawal by Subject|10|||
30717288|NCT00380068|58730356|FG000|Overall Study|Not compliant|6|||
30717289|NCT00380068|58730356|FG000|Overall Study|Lost to Follow-up|1|||
30717290|NCT00380068|58730356|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
30717291|NCT00380068|58730356|FG000|Overall Study|Lung transplant|3|||
30717292|NCT00380068|58730356|FG000|Overall Study|Physician Decision|2|||
30717293|NCT00380068|58730356|FG000|Overall Study|Partipant moved away|1|||
30717294|NCT00380068|58730356|FG000|Overall Study|Lack of Efficacy|5|||
30717295|NCT00536484|58730362|FG000|Overall Study|Adverse Event|21|||
30717296|NCT00536484|58730363|FG001|Overall Study|Adverse Event|34|||
30717297|NCT00536484|58730362|FG000|Overall Study|Withdrawal by Subject|11|||
30717298|NCT00536484|58730363|FG001|Overall Study|Withdrawal by Subject|11|||
30717299|NCT00536484|58730362|FG000|Overall Study|Lost to Follow-up|8|||
30621571|NCT01174446|58633148|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
30621572|NCT01174446|58633149|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
30621573|NCT01174446|58633150|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
30621574|NCT01174446|58633151|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
30621575|NCT01174446|58633148|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
30621576|NCT01174446|58633149|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
30717300|NCT00536484|58730363|FG001|Overall Study|Lost to Follow-up|6|||
30717301|NCT00536484|58730362|FG000|Overall Study|Lack of Efficacy|16|||
30717302|NCT00536484|58730363|FG001|Overall Study|Lack of Efficacy|5|||
30717303|NCT00536484|58730362|FG000|Overall Study|Other|4|||
30717304|NCT00536484|58730363|FG001|Overall Study|Other|0|||
30717305|NCT00370396|58730372|FG000|Overall Study|Withdrawal by Subject|0|||
30717306|NCT00370396|58730373|FG001|Overall Study|Withdrawal by Subject|0|||
30717307|NCT00370396|58730374|FG002|Overall Study|Withdrawal by Subject|1|||
30717308|NCT00370396|58730372|FG000|Overall Study|Lost to Follow-up|11|||
30717309|NCT00370396|58730373|FG001|Overall Study|Lost to Follow-up|1|||
30717310|NCT00370396|58730374|FG002|Overall Study|Lost to Follow-up|0|||
30717311|NCT00455013|58730385|FG000|Short Term Period|Adverse Event|2|||
30717312|NCT00455013|58730386|FG001|Short Term Period|Adverse Event|5|||
30717313|NCT00455013|58730387|FG002|Short Term Period|Adverse Event|0|||
30717314|NCT00455013|58730385|FG000|Short Term Period|Withdrawal by Subject|0|||
30717315|NCT00455013|58730386|FG001|Short Term Period|Withdrawal by Subject|0|||
30717316|NCT00455013|58730387|FG002|Short Term Period|Withdrawal by Subject|1|||
30717317|NCT00455013|58730385|FG000|Short Term Period|Lack of Efficacy|4|||
30717318|NCT00455013|58730386|FG001|Short Term Period|Lack of Efficacy|0|||
30717319|NCT00455013|58730387|FG002|Short Term Period|Lack of Efficacy|0|||
30717320|NCT00455013|58730385|FG000|Short Term Period|Other|0|||
30717321|NCT00455013|58730386|FG001|Short Term Period|Other|0|||
30717322|NCT00455013|58730387|FG002|Short Term Period|Other|1|||
30717323|NCT00455013|58730385|FG000|Long Term Extension (LTE)|Adverse Event|0|||
30717324|NCT00455013|58730386|FG001|Long Term Extension (LTE)|Adverse Event|1|||
30717325|NCT00455013|58730387|FG002|Long Term Extension (LTE)|Adverse Event|1|||
30717326|NCT00455013|58730385|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
30717327|NCT00455013|58730386|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
30717328|NCT00455013|58730387|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
30717329|NCT00455013|58730385|FG000|Long Term Extension (LTE)|Death|1|||
30717330|NCT00455013|58730386|FG001|Long Term Extension (LTE)|Death|1|||
30717331|NCT00455013|58730387|FG002|Long Term Extension (LTE)|Death|0|||
30717332|NCT00455013|58730385|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
30717333|NCT00455013|58730386|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
30717334|NCT00455013|58730387|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
30717335|NCT00455013|58730385|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
30717336|NCT00455013|58730386|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
30717337|NCT00455013|58730387|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
30717338|NCT00455013|58730385|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
30717339|NCT00455013|58730386|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
30717340|NCT00455013|58730387|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
30717341|NCT00455013|58730385|FG000|Long Term Extension (LTE)|non-specified|0|||
30717342|NCT00455013|58730386|FG001|Long Term Extension (LTE)|non-specified|0|||
30717343|NCT00455013|58730387|FG002|Long Term Extension (LTE)|non-specified|1|||
30717344|NCT00363298|58730397|FG000|First Study Week|Lack of Efficacy|6|||
30717345|NCT00363298|58730398|FG001|First Study Week|Lack of Efficacy|5|||
30717346|NCT00363298|58730397|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
30717347|NCT00363298|58730398|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
30717348|NCT00363142|58730407|FG000|Overall Study|Adverse Event|2|||
30717349|NCT00363142|58730408|FG001|Overall Study|Adverse Event|0|||
30717350|NCT00363142|58730407|FG000|Overall Study|Lack of Efficacy|0|||
30717351|NCT00363142|58730408|FG001|Overall Study|Lack of Efficacy|1|||
30717352|NCT00363142|58730407|FG000|Overall Study|Lost to Follow-up|1|||
30717353|NCT00363142|58730408|FG001|Overall Study|Lost to Follow-up|0|||
30717354|NCT00363142|58730407|FG000|Overall Study|Non-compliance|1|||
30717355|NCT00363142|58730408|FG001|Overall Study|Non-compliance|1|||
30717356|NCT00363142|58730407|FG000|Overall Study|Withdrawal by Subject|3|||
30717357|NCT00363142|58730408|FG001|Overall Study|Withdrawal by Subject|1|||
30717358|NCT00454857|58730417|FG000|Overall Study|Withdrawal by Subject|15|||
30717359|NCT00454857|58730417|FG000|Overall Study|Lost to Follow-up|16|||
30717360|NCT00454857|58730417|FG000|Overall Study|Noncompliance|6|||
30717361|NCT00454857|58730417|FG000|Overall Study|Death|5|||
30717362|NCT00454857|58730417|FG000|Overall Study|Other|11|||
30717363|NCT00454857|58730417|FG000|Overall Study|Reason unknown|1|||
30717364|NCT00379912|58730423|FG000|Overall Study|Lack of Efficacy|1|||
30717365|NCT00379912|58730424|FG001|Overall Study|Lack of Efficacy|0|||
30717366|NCT00379834|58730436|FG000|Overall Study|Time constraints|2|||
30717367|NCT00379210|58730442|FG000|Overall Study|Withdrawal by Subject|10|||
30717368|NCT00379210|58730443|FG001|Overall Study|Withdrawal by Subject|7|||
30717369|NCT00378898|58730451|FG000|Overall Study|Withdrawal by Subject|10|||
30717370|NCT00378898|58730452|FG001|Overall Study|Withdrawal by Subject|5|||
30717371|NCT00378898|58730451|FG000|Overall Study|Protocol Violation|1|||
30717372|NCT00378898|58730452|FG001|Overall Study|Protocol Violation|1|||
30717373|NCT00378508|58730462|FG000|Overall Study|Withdrawal by Subject|1|||
30717374|NCT00378508|58730463|FG001|Overall Study|Withdrawal by Subject|3|||
30717375|NCT00378508|58730462|FG000|Overall Study|Lost to Follow-up|1|||
30717376|NCT00378508|58730463|FG001|Overall Study|Lost to Follow-up|0|||
30717377|NCT00454779|58730472|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
30717378|NCT00454779|58730473|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
30717379|NCT00454779|58730472|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
30717380|NCT00454779|58730473|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
30717381|NCT00454779|58730472|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
30717382|NCT00454779|58730473|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
30717383|NCT00454779|58730472|FG000|First-line Treatment Phase|Protocol Violation|0|||
30717384|NCT00454779|58730473|FG001|First-line Treatment Phase|Protocol Violation|1|||
30717385|NCT00454779|58730472|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
30717386|NCT00454779|58730473|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
30717387|NCT00454779|58730472|FG000|First-line Treatment Phase|Ongoing|1|||
30717388|NCT00454779|58730473|FG001|First-line Treatment Phase|Ongoing|0|||
30717389|NCT00454779|58730472|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
30717390|NCT00454779|58730473|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
30717391|NCT00454779|58730472|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
30717392|NCT00454779|58730473|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
30717393|NCT00454779|58730472|FG000|Second-line Treatment Phase|Ongoing|0|||
30717394|NCT00454779|58730473|FG001|Second-line Treatment Phase|Ongoing|1|||
30717395|NCT00439569|58730483|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
30717396|NCT00439569|58730483|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
30717397|NCT00439569|58730483|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
30717398|NCT00443079|58730489|FG000|Overall Study|Lost to Follow-up|0|||
30717399|NCT00443079|58730490|FG001|Overall Study|Lost to Follow-up|1|||
30717400|NCT00427635|58730526|FG000|Treatment Phase|Withdrawal by Subject|1|||
30717401|NCT00427635|58730527|FG001|Treatment Phase|Withdrawal by Subject|0|||
30717402|NCT00427635|58730526|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
30717403|NCT00427635|58730527|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
30717404|NCT00427011|58730533|FG000|Overall Study|Adverse Event|10|||
30717405|NCT00427011|58730533|FG000|Overall Study|Withdrawal by Subject|1|||
30717406|NCT00427011|58730533|FG000|Overall Study|Lack of Efficacy|2|||
30717407|NCT00427011|58730533|FG000|Overall Study|Other|12|||
30717408|NCT03891264|58730538|FG000|Overall Study|Adverse Event|1|||
30717409|NCT03891264|58730538|FG000|Overall Study|Withdrawal by Subject|2|||
30717410|NCT03891264|58730538|FG000|Overall Study|Physician Decision|2|||
30717411|NCT00439179|58730546|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
30717412|NCT00439179|58730547|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
30717413|NCT00439179|58730548|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
30717414|NCT00439179|58730549|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
30717415|NCT00438633|58730564|FG000|Overall Study|Withdrawal by Subject|1|||
30717416|NCT00438633|58730565|FG001|Overall Study|Withdrawal by Subject|0|||
30717417|NCT00438633|58730564|FG000|Overall Study|Lost to Follow-up|15|||
30717418|NCT00438633|58730565|FG001|Overall Study|Lost to Follow-up|17|||
30717419|NCT00438399|58730574|FG000|Overall Study|Lost to Follow-up|2|||
30717420|NCT00438399|58730575|FG001|Overall Study|Lost to Follow-up|2|||
30717421|NCT00438399|58730576|FG002|Overall Study|Lost to Follow-up|1|||
30900233|NCT02448875|58933446|FG000|Overall Study|Investigator Decision|3|||
30717422|NCT00438399|58730577|FG003|Overall Study|Lost to Follow-up|1|||
30717423|NCT00438399|58730578|FG004|Overall Study|Lost to Follow-up|1|||
30717424|NCT00438399|58730579|FG005|Overall Study|Lost to Follow-up|1|||
30717425|NCT00438399|58730574|FG000|Overall Study|Adverse Event|0|||
30900234|NCT02448875|58933447|FG001|Overall Study|Investigator Decision|0|||
30900235|NCT02448875|58933448|FG002|Overall Study|Investigator Decision|1|||
30900236|NCT02448875|58933446|FG000|Overall Study|Withdrawal by Subject|1|||
30900237|NCT02448875|58933447|FG001|Overall Study|Withdrawal by Subject|0|||
30717426|NCT00438399|58730575|FG001|Overall Study|Adverse Event|0|||
30717427|NCT00438399|58730576|FG002|Overall Study|Adverse Event|1|||
30717428|NCT00438399|58730577|FG003|Overall Study|Adverse Event|1|||
30717429|NCT00438399|58730578|FG004|Overall Study|Adverse Event|0|||
30717430|NCT00438399|58730579|FG005|Overall Study|Adverse Event|1|||
30717431|NCT00438399|58730574|FG000|Overall Study|Withdrawal by Subject|5|||
30717432|NCT00438399|58730575|FG001|Overall Study|Withdrawal by Subject|6|||
30717433|NCT00438399|58730576|FG002|Overall Study|Withdrawal by Subject|3|||
30717434|NCT00438399|58730577|FG003|Overall Study|Withdrawal by Subject|2|||
30717435|NCT00438399|58730578|FG004|Overall Study|Withdrawal by Subject|2|||
30717436|NCT00438399|58730579|FG005|Overall Study|Withdrawal by Subject|2|||
30717437|NCT00438399|58730574|FG000|Overall Study|Protocol Violation|0|||
30717438|NCT00438399|58730575|FG001|Overall Study|Protocol Violation|0|||
30717439|NCT00438399|58730576|FG002|Overall Study|Protocol Violation|1|||
30717440|NCT00438399|58730577|FG003|Overall Study|Protocol Violation|0|||
30717441|NCT00438399|58730578|FG004|Overall Study|Protocol Violation|0|||
30717442|NCT00438399|58730579|FG005|Overall Study|Protocol Violation|1|||
30717443|NCT00438399|58730574|FG000|Overall Study|Subje stopped study|0|||
30717444|NCT00438399|58730575|FG001|Overall Study|Subje stopped study|0|||
30717445|NCT00438399|58730576|FG002|Overall Study|Subje stopped study|1|||
30717446|NCT00438399|58730577|FG003|Overall Study|Subje stopped study|0|||
30717447|NCT00438399|58730578|FG004|Overall Study|Subje stopped study|0|||
30717448|NCT00438399|58730579|FG005|Overall Study|Subje stopped study|0|||
30717449|NCT00438399|58730574|FG000|Overall Study|Pregnancy|0|||
30717450|NCT00438399|58730575|FG001|Overall Study|Pregnancy|0|||
30717451|NCT00438399|58730576|FG002|Overall Study|Pregnancy|0|||
30717452|NCT00438399|58730577|FG003|Overall Study|Pregnancy|0|||
30717453|NCT00438399|58730578|FG004|Overall Study|Pregnancy|0|||
30717454|NCT00438399|58730579|FG005|Overall Study|Pregnancy|1|||
30717455|NCT00438399|58730574|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
30717456|NCT00438399|58730575|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
30717457|NCT00438399|58730576|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
30717458|NCT00438399|58730577|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
30717459|NCT00438399|58730578|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
30717460|NCT00438399|58730579|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
30717461|NCT00426231|58730590|FG000|Overall Study|Withdrawal by Subject|9|||
30717462|NCT00426231|58730591|FG001|Overall Study|Withdrawal by Subject|12|||
30717463|NCT00425607|58730597|FG000|Overall Study|Death|1|||
30717464|NCT00425607|58730597|FG000|Overall Study|Withdrawal by Subject|1|||
30717465|NCT00437073|58730603|FG000|Overall Study|Sponsor Terminated Study|1|||
30717466|NCT00437073|58730604|FG001|Overall Study|Sponsor Terminated Study|0|||
30717467|NCT00437073|58730603|FG000|Overall Study|Physician Decision|0|||
30717468|NCT00437073|58730604|FG001|Overall Study|Physician Decision|1|||
30717469|NCT00425373|58730619|FG000|Overall Study|Adverse Event|2|||
30717470|NCT00425373|58730620|FG001|Overall Study|Adverse Event|2|||
30717471|NCT00425373|58730621|FG002|Overall Study|Adverse Event|0|||
30717472|NCT00425373|58730622|FG003|Overall Study|Adverse Event|1|||
30717473|NCT00425373|58730623|FG004|Overall Study|Adverse Event|4|||
30717474|NCT00425373|58730624|FG005|Overall Study|Adverse Event|6|||
30717475|NCT00425373|58730625|FG006|Overall Study|Adverse Event|2|||
30717476|NCT00425373|58730626|FG007|Overall Study|Adverse Event|3|||
30717477|NCT00425373|58730627|FG008|Overall Study|Adverse Event|8|||
30717478|NCT00425373|58730619|FG000|Overall Study|Lost to Follow-up|0|||
30717479|NCT00425373|58730620|FG001|Overall Study|Lost to Follow-up|1|||
30717480|NCT00425373|58730621|FG002|Overall Study|Lost to Follow-up|0|||
30717481|NCT00425373|58730622|FG003|Overall Study|Lost to Follow-up|0|||
30717482|NCT00425373|58730623|FG004|Overall Study|Lost to Follow-up|1|||
30717483|NCT00425373|58730624|FG005|Overall Study|Lost to Follow-up|0|||
30717484|NCT00425373|58730625|FG006|Overall Study|Lost to Follow-up|0|||
30717485|NCT00425373|58730626|FG007|Overall Study|Lost to Follow-up|0|||
30717486|NCT00425373|58730627|FG008|Overall Study|Lost to Follow-up|0|||
30717487|NCT00425373|58730619|FG000|Overall Study|Protocol Violation|1|||
30717488|NCT00425373|58730620|FG001|Overall Study|Protocol Violation|0|||
30717489|NCT00425373|58730621|FG002|Overall Study|Protocol Violation|1|||
30717490|NCT00425373|58730622|FG003|Overall Study|Protocol Violation|0|||
30717491|NCT00425373|58730623|FG004|Overall Study|Protocol Violation|0|||
30717492|NCT00425373|58730624|FG005|Overall Study|Protocol Violation|0|||
30717493|NCT00425373|58730625|FG006|Overall Study|Protocol Violation|0|||
30717494|NCT00425373|58730626|FG007|Overall Study|Protocol Violation|5|||
30717495|NCT00425373|58730627|FG008|Overall Study|Protocol Violation|3|||
30717496|NCT00425373|58730619|FG000|Overall Study|Withdrawal by Subject|2|||
30717497|NCT00425373|58730620|FG001|Overall Study|Withdrawal by Subject|0|||
30717498|NCT00425373|58730621|FG002|Overall Study|Withdrawal by Subject|2|||
30717499|NCT00425373|58730622|FG003|Overall Study|Withdrawal by Subject|1|||
30717500|NCT00425373|58730623|FG004|Overall Study|Withdrawal by Subject|4|||
30717501|NCT00425373|58730624|FG005|Overall Study|Withdrawal by Subject|0|||
30717502|NCT00425373|58730625|FG006|Overall Study|Withdrawal by Subject|2|||
30717503|NCT00425373|58730626|FG007|Overall Study|Withdrawal by Subject|2|||
30717504|NCT00425373|58730627|FG008|Overall Study|Withdrawal by Subject|2|||
30717505|NCT00425373|58730619|FG000|Overall Study|Lack of Efficacy|0|||
30717506|NCT00425373|58730620|FG001|Overall Study|Lack of Efficacy|0|||
30717507|NCT00425373|58730621|FG002|Overall Study|Lack of Efficacy|0|||
30717508|NCT00425373|58730622|FG003|Overall Study|Lack of Efficacy|0|||
30717509|NCT00425373|58730623|FG004|Overall Study|Lack of Efficacy|1|||
30717510|NCT00425373|58730624|FG005|Overall Study|Lack of Efficacy|3|||
30717511|NCT00425373|58730625|FG006|Overall Study|Lack of Efficacy|3|||
30717512|NCT00425373|58730626|FG007|Overall Study|Lack of Efficacy|0|||
30717513|NCT00425373|58730627|FG008|Overall Study|Lack of Efficacy|5|||
30717514|NCT03894540|58730653|FG000|Overall Study|Adverse Event|0|||
30717515|NCT03894540|58730654|FG001|Overall Study|Adverse Event|0|||
30717516|NCT03894540|58730655|FG002|Overall Study|Adverse Event|0|||
30717517|NCT03894540|58730656|FG003|Overall Study|Adverse Event|0|||
30717518|NCT03894540|58730657|FG004|Overall Study|Adverse Event|1|||
30717519|NCT03894540|58730658|FG005|Overall Study|Adverse Event|0|||
30717520|NCT03894540|58730653|FG000|Overall Study|Withdrawal by Subject|0|||
30717521|NCT03894540|58730654|FG001|Overall Study|Withdrawal by Subject|0|||
30717522|NCT03894540|58730655|FG002|Overall Study|Withdrawal by Subject|0|||
30717523|NCT03894540|58730656|FG003|Overall Study|Withdrawal by Subject|0|||
30717524|NCT03894540|58730657|FG004|Overall Study|Withdrawal by Subject|1|||
30717525|NCT03894540|58730658|FG005|Overall Study|Withdrawal by Subject|0|||
30717526|NCT03894540|58730653|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
30717527|NCT03894540|58730654|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
30717528|NCT03894540|58730655|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
30717529|NCT03894540|58730656|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
30717530|NCT03894540|58730657|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
30717531|NCT03894540|58730658|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
30717532|NCT03894540|58730653|FG000|Overall Study|Progressive Disease Clinical|1|||
30717533|NCT03894540|58730654|FG001|Overall Study|Progressive Disease Clinical|1|||
30900238|NCT02448875|58933448|FG002|Overall Study|Withdrawal by Subject|0|||
30717534|NCT03894540|58730655|FG002|Overall Study|Progressive Disease Clinical|0|||
30717535|NCT03894540|58730656|FG003|Overall Study|Progressive Disease Clinical|1|||
30717536|NCT03894540|58730657|FG004|Overall Study|Progressive Disease Clinical|5|||
30717537|NCT03894540|58730658|FG005|Overall Study|Progressive Disease Clinical|1|||
30717538|NCT03894540|58730653|FG000|Overall Study|Study termination by sponsor|0|||
30900239|NCT01831726|58933459|FG000|Overall Study|Adverse Event|16|||
30717539|NCT03894540|58730654|FG001|Overall Study|Study termination by sponsor|0|||
30717540|NCT03894540|58730655|FG002|Overall Study|Study termination by sponsor|0|||
30717541|NCT03894540|58730656|FG003|Overall Study|Study termination by sponsor|0|||
30717542|NCT03894540|58730657|FG004|Overall Study|Study termination by sponsor|2|||
30717543|NCT03894540|58730658|FG005|Overall Study|Study termination by sponsor|0|||
30717544|NCT00535626|58730676|FG000|Overall Study|Death|15|||
30717545|NCT00535626|58730676|FG000|Overall Study|Lost to Follow-up|29|||
30717546|NCT00535626|58730676|FG000|Overall Study|Withdrawal by Subject|20|||
30717547|NCT00535626|58730676|FG000|Overall Study|Removal/revision of study component|8|||
30717548|NCT00535626|58730676|FG000|Overall Study|Subject terminated|31|||
30717549|NCT00535626|58730676|FG000|Overall Study|Unable to return|2|||
30717550|NCT03889704|58730699|FG000|Overall Study|Study terminated due to pandemic|1|||
30717551|NCT03887442|58730705|FG000|Overall Study|Adverse Event|1|||
30717552|NCT03887442|58730706|FG001|Overall Study|Adverse Event|0|||
30717553|NCT00425061|58730721|FG000|Overall Study|Adverse Event|1|||
30717554|NCT00425061|58730722|FG001|Overall Study|Adverse Event|0|||
30717555|NCT00425061|58730723|FG002|Overall Study|Adverse Event|0|||
30717556|NCT00425061|58730724|FG003|Overall Study|Adverse Event|2|||
30717557|NCT00425061|58730725|FG004|Overall Study|Adverse Event|2|||
30717558|NCT00425061|58730726|FG005|Overall Study|Adverse Event|0|||
30717559|NCT00425061|58730727|FG006|Overall Study|Adverse Event|0|||
30717560|NCT00425061|58730721|FG000|Overall Study|Lost to Follow-up|0|||
30717561|NCT00425061|58730722|FG001|Overall Study|Lost to Follow-up|1|||
30717562|NCT00425061|58730723|FG002|Overall Study|Lost to Follow-up|0|||
30717563|NCT00425061|58730724|FG003|Overall Study|Lost to Follow-up|0|||
30717564|NCT00425061|58730725|FG004|Overall Study|Lost to Follow-up|0|||
30717565|NCT00425061|58730726|FG005|Overall Study|Lost to Follow-up|0|||
30717566|NCT00425061|58730727|FG006|Overall Study|Lost to Follow-up|0|||
30717567|NCT00425061|58730721|FG000|Overall Study|Protocol Violation|1|||
30717568|NCT00425061|58730722|FG001|Overall Study|Protocol Violation|0|||
30717569|NCT00425061|58730723|FG002|Overall Study|Protocol Violation|0|||
30717570|NCT00425061|58730724|FG003|Overall Study|Protocol Violation|0|||
30717571|NCT00425061|58730725|FG004|Overall Study|Protocol Violation|0|||
30717572|NCT00425061|58730726|FG005|Overall Study|Protocol Violation|0|||
30717573|NCT00425061|58730727|FG006|Overall Study|Protocol Violation|0|||
30717574|NCT00425061|58730721|FG000|Overall Study|Withdrawal by Subject|0|||
30717575|NCT00425061|58730722|FG001|Overall Study|Withdrawal by Subject|1|||
30717576|NCT00425061|58730723|FG002|Overall Study|Withdrawal by Subject|0|||
30717577|NCT00425061|58730724|FG003|Overall Study|Withdrawal by Subject|0|||
30717578|NCT00425061|58730725|FG004|Overall Study|Withdrawal by Subject|1|||
30717579|NCT00425061|58730726|FG005|Overall Study|Withdrawal by Subject|0|||
30717580|NCT00425061|58730727|FG006|Overall Study|Withdrawal by Subject|3|||
30717581|NCT00425061|58730721|FG000|Overall Study|Sponsor's request|0|||
30717582|NCT00425061|58730722|FG001|Overall Study|Sponsor's request|0|||
30717583|NCT00425061|58730723|FG002|Overall Study|Sponsor's request|0|||
30717584|NCT00425061|58730724|FG003|Overall Study|Sponsor's request|0|||
30717585|NCT00425061|58730725|FG004|Overall Study|Sponsor's request|19|||
30717586|NCT00425061|58730726|FG005|Overall Study|Sponsor's request|4|||
30717587|NCT00425061|58730727|FG006|Overall Study|Sponsor's request|15|||
30717588|NCT00425061|58730721|FG000|Overall Study|Physician Decision|0|||
30717589|NCT00425061|58730722|FG001|Overall Study|Physician Decision|0|||
30717590|NCT00425061|58730723|FG002|Overall Study|Physician Decision|0|||
30717591|NCT00425061|58730724|FG003|Overall Study|Physician Decision|0|||
30900240|NCT01831726|58933459|FG000|Overall Study|Death|7|||
30900241|NCT01831726|58933459|FG000|Overall Study|Disease Progression|49|||
30900242|NCT01831726|58933459|FG000|Overall Study|Physician Decision|1|||
30900243|NCT01831726|58933459|FG000|Overall Study|Subject/guardian decision|7|||
30900244|NCT01831258|58933463|FG000|Overall Study|Withdrawal by Subject|2|||
30900245|NCT01831258|58933464|FG001|Overall Study|Withdrawal by Subject|1|||
30900246|NCT01831258|58933463|FG000|Overall Study|Lost to Follow-up|3|||
30900247|NCT01831258|58933464|FG001|Overall Study|Lost to Follow-up|2|||
30900248|NCT01849276|58933472|FG000|Followed for Survival for 5 Years|Death|1|||
30900249|NCT01849276|58933472|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
30900250|NCT02465489|58933476|FG000|Overall Study|Adverse Event|5|||
30900251|NCT01829464|58933491|FG000|Overall Study|Adverse Event|1|||
30900252|NCT01829464|58933492|FG001|Overall Study|Adverse Event|0|||
30900253|NCT01829464|58933493|FG002|Overall Study|Adverse Event|0|||
30717592|NCT00425061|58730725|FG004|Overall Study|Physician Decision|1|||
30717593|NCT00425061|58730726|FG005|Overall Study|Physician Decision|0|||
30717594|NCT00425061|58730727|FG006|Overall Study|Physician Decision|0|||
30717595|NCT00425061|58730721|FG000|Overall Study|Other|0|||
30717596|NCT00425061|58730722|FG001|Overall Study|Other|0|||
30900254|NCT01829464|58933491|FG000|Overall Study|Lost to Follow-up|0|||
30900255|NCT01829464|58933492|FG001|Overall Study|Lost to Follow-up|0|||
30717597|NCT00425061|58730723|FG002|Overall Study|Other|0|||
30717598|NCT00425061|58730724|FG003|Overall Study|Other|0|||
30717599|NCT00425061|58730725|FG004|Overall Study|Other|3|||
30717600|NCT00425061|58730726|FG005|Overall Study|Other|0|||
30717601|NCT00425061|58730727|FG006|Overall Study|Other|1|||
30717602|NCT00424827|58730745|FG000|Overall Study|Adverse Event|1|||
30717603|NCT03885726|58730750|FG000|Overall Study|Staffing issues/lost interest|1|||
30717604|NCT03885726|58730750|FG000|Overall Study|Early discharge from hospital|3|||
30717605|NCT00377962|58730760|FG000|Core Study: 0-12 Months|Adverse Event|18|||
30900256|NCT01829464|58933493|FG002|Overall Study|Lost to Follow-up|1|||
30717606|NCT00377962|58730761|FG001|Core Study: 0-12 Months|Adverse Event|2|||
30717607|NCT00377962|58730760|FG000|Core Study: 0-12 Months|Death|3|||
30717608|NCT00377962|58730761|FG001|Core Study: 0-12 Months|Death|0|||
30717609|NCT00377962|58730760|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
30717610|NCT00377962|58730761|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
30717611|NCT00377962|58730760|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
30717612|NCT00377962|58730761|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
30717613|NCT00377962|58730760|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
30717614|NCT00377962|58730761|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
30717615|NCT00377962|58730760|FG000|Extension Study: 12-24 Months|Death|1|||
30717616|NCT00377962|58730761|FG001|Extension Study: 12-24 Months|Death|1|||
30717617|NCT00377962|58730760|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
30717618|NCT00377962|58730761|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
30717619|NCT00377962|58730760|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
30717620|NCT00377962|58730761|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
30717621|NCT00377962|58730760|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
30717622|NCT00377962|58730761|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
30717623|NCT00424749|58730773|FG000|Overall Study|Withdrawal by Subject|1|||
30717624|NCT00424593|58730779|FG000|Acute Double-Blind Period|Adverse Event|16|||
30717625|NCT00424593|58730780|FG001|Acute Double-Blind Period|Adverse Event|7|||
30717626|NCT00424593|58730779|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
30717627|NCT00424593|58730780|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
30717628|NCT00424593|58730779|FG000|Acute Double-Blind Period|Protocol Violation|2|||
30717629|NCT00424593|58730780|FG001|Acute Double-Blind Period|Protocol Violation|2|||
30717630|NCT00424593|58730779|FG000|Acute Double-Blind Period|Physician Decision|1|||
30717631|NCT00424593|58730780|FG001|Acute Double-Blind Period|Physician Decision|2|||
30717632|NCT00424593|58730779|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
30717633|NCT00424593|58730780|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
30717634|NCT00424593|58730779|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
30717635|NCT00424593|58730780|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
30717636|NCT00424593|58730779|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
30717637|NCT00424593|58730780|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
30717638|NCT00424593|58730779|FG000|Dose-Blind Extension Period|Adverse Event|18|||
30717639|NCT00424593|58730780|FG001|Dose-Blind Extension Period|Adverse Event|0|||
30717640|NCT00424593|58730779|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
30717641|NCT00424593|58730780|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
30717642|NCT00424593|58730779|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
30717643|NCT00424593|58730780|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
30717644|NCT00424593|58730779|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
30717645|NCT00424593|58730780|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
30717646|NCT00424593|58730779|FG000|Dose-Blind Extension Period|Physician Decision|3|||
30717647|NCT00424593|58730780|FG001|Dose-Blind Extension Period|Physician Decision|0|||
30717648|NCT00369382|58730788|FG000|Overall Study|Death|0|||
30717649|NCT00369382|58730789|FG001|Overall Study|Death|2|||
30717650|NCT00369382|58730788|FG000|Overall Study|Physician Decision|2|||
30717651|NCT00369382|58730789|FG001|Overall Study|Physician Decision|1|||
30717652|NCT00369382|58730788|FG000|Overall Study|Withdrawal by Subject|5|||
30717653|NCT00369382|58730789|FG001|Overall Study|Withdrawal by Subject|0|||
30717654|NCT00369382|58730788|FG000|Overall Study|Randomized, not treated|2|||
30717655|NCT00369382|58730789|FG001|Overall Study|Randomized, not treated|0|||
30717656|NCT00369382|58730788|FG000|Overall Study|Other|1|||
30717657|NCT00369382|58730789|FG001|Overall Study|Other|0|||
30717658|NCT00424515|58730798|FG000|Overall Study|Progressive Disease|10|||
30717659|NCT00424515|58730799|FG001|Overall Study|Progressive Disease|11|||
30717660|NCT00424515|58730798|FG000|Overall Study|Adverse Event|0|||
30717661|NCT00424515|58730799|FG001|Overall Study|Adverse Event|1|||
30717662|NCT00424515|58730798|FG000|Overall Study|Intercurrent Illness|0|||
30717663|NCT00424515|58730799|FG001|Overall Study|Intercurrent Illness|1|||
30717664|NCT00424515|58730798|FG000|Overall Study|Withdrawal by Subject|1|||
30717665|NCT00424515|58730799|FG001|Overall Study|Withdrawal by Subject|0|||
30717666|NCT00377260|58730807|FG000|Overall Study|Lost to Follow-up|0|||
30717667|NCT00377260|58730808|FG001|Overall Study|Lost to Follow-up|1|||
30900257|NCT01829464|58933491|FG000|Overall Study|Withdrawal by Subject|2|||
30900258|NCT01829464|58933492|FG001|Overall Study|Withdrawal by Subject|0|||
30900259|NCT01829464|58933493|FG002|Overall Study|Withdrawal by Subject|0|||
30900260|NCT01829464|58933491|FG000|Overall Study|Study terminated by sponsor|25|||
30900261|NCT01829464|58933492|FG001|Overall Study|Study terminated by sponsor|28|||
30900262|NCT01829464|58933493|FG002|Overall Study|Study terminated by sponsor|25|||
30900263|NCT01829464|58933491|FG000|Overall Study|Lack of Efficacy|0|||
30900264|NCT01829464|58933492|FG001|Overall Study|Lack of Efficacy|1|||
30900265|NCT01829464|58933493|FG002|Overall Study|Lack of Efficacy|0|||
30900266|NCT01847092|58933503|FG000|Overall Study|Adverse Event|12|||
30900267|NCT01847092|58933504|FG001|Overall Study|Adverse Event|3|||
30900268|NCT01847092|58933503|FG000|Overall Study|Withdrawal by Subject|5|||
30900269|NCT01847092|58933504|FG001|Overall Study|Withdrawal by Subject|5|||
30717668|NCT00377260|58730807|FG000|Overall Study|Withdrawal by Subject|2|||
30717669|NCT00377260|58730808|FG001|Overall Study|Withdrawal by Subject|4|||
30717670|NCT00441441|58730816|FG000|Overall Study|Adverse Event|2|||
30717671|NCT00441441|58730817|FG001|Overall Study|Adverse Event|1|||
30717672|NCT00441441|58730816|FG000|Overall Study|Protocol Violation|4|||
30900270|NCT01847092|58933503|FG000|Overall Study|Protocol Specified|8|||
30900271|NCT01847092|58933504|FG001|Overall Study|Protocol Specified|0|||
30717673|NCT00441441|58730817|FG001|Overall Study|Protocol Violation|6|||
30717674|NCT00441441|58730816|FG000|Overall Study|Exacerbation of asthma|1|||
30717675|NCT00441441|58730817|FG001|Overall Study|Exacerbation of asthma|2|||
30717676|NCT00441441|58730816|FG000|Overall Study|Withdrawal by Subject|1|||
30717677|NCT00441441|58730817|FG001|Overall Study|Withdrawal by Subject|2|||
30717678|NCT00441441|58730816|FG000|Overall Study|Other|3|||
30717679|NCT00441441|58730817|FG001|Overall Study|Other|3|||
30717680|NCT00436917|58730837|FG000|Overall Study|Withdrawal by Subject|13|||
30717681|NCT00436917|58730837|FG000|Overall Study|Adverse Event|2|||
30717682|NCT00436917|58730837|FG000|Overall Study|Physician Decision|1|||
30717683|NCT00436917|58730837|FG000|Overall Study|Death|1|||
30717684|NCT00436917|58730837|FG000|Overall Study|Lost to Follow-up|1|||
30717685|NCT00436917|58730837|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
30717686|NCT00436917|58730837|FG000|Overall Study|Increased creatinine|1|||
30717687|NCT00436917|58730837|FG000|Overall Study|Personal conflicts of patient|1|||
30717688|NCT00436605|58730841|FG000|Overall Study|Protocol Violation|3|||
30717689|NCT00368992|58730845|FG000|Overall Study|Ineligible|5|||
30717690|NCT00368992|58730845|FG000|Overall Study|Refused treatment|3|||
30717691|NCT00368992|58730845|FG000|Overall Study|Lack of Efficacy|63|||
30717692|NCT00368992|58730845|FG000|Overall Study|Adverse Event|26|||
30717693|NCT00368992|58730845|FG000|Overall Study|Death|4|||
30717694|NCT00368992|58730845|FG000|Overall Study|Other|9|||
30717695|NCT00376246|58730850|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
30717696|NCT00376246|58730851|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
30717697|NCT00376246|58730850|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
30717698|NCT00376246|58730851|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
30717699|NCT00376246|58730850|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
30717700|NCT00376246|58730851|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
30717701|NCT00368836|58730861|FG000|Phase II|Screen Failure|1|||
30717702|NCT00368836|58730861|FG000|Phase II|Withdrawal by Subject|1|||
30717703|NCT00368836|58730861|FG000|Phase II|unable to collect blood and/or breath|17|||
30717704|NCT00368836|58730861|FG000|Phase II|Protocol Violation|2|||
30717705|NCT00376168|58730870|FG000|Overall Study|Adverse Event|1|||
30717706|NCT00376168|58730871|FG001|Overall Study|Adverse Event|1|||
30717707|NCT00376168|58730870|FG000|Overall Study|Pregnancy|1|||
30717708|NCT00376168|58730871|FG001|Overall Study|Pregnancy|0|||
30717709|NCT00375934|58730879|FG000|Overall Study|Adverse Event|1|||
30717710|NCT00375934|58730880|FG001|Overall Study|Adverse Event|1|||
30717711|NCT00375934|58730879|FG000|Overall Study|Withdrawal by Subject|2|||
30717712|NCT00375934|58730880|FG001|Overall Study|Withdrawal by Subject|2|||
30717713|NCT00375934|58730879|FG000|Overall Study|Lack of Efficacy|0|||
30717714|NCT00375934|58730880|FG001|Overall Study|Lack of Efficacy|2|||
30717715|NCT00375934|58730879|FG000|Overall Study|Physician Decision|0|||
30717716|NCT00375934|58730880|FG001|Overall Study|Physician Decision|1|||
30717717|NCT00642941|58730898|FG000|Overall Study|Physician Decision|3|||
30717718|NCT00642941|58730899|FG001|Overall Study|Physician Decision|1|||
30717719|NCT00642941|58730900|FG002|Overall Study|Physician Decision|0|||
30717720|NCT00642941|58730901|FG003|Overall Study|Physician Decision|0|||
30717721|NCT00642941|58730902|FG004|Overall Study|Physician Decision|0|||
30717722|NCT00642941|58730903|FG005|Overall Study|Physician Decision|0|||
30717723|NCT00642941|58730904|FG006|Overall Study|Physician Decision|1|||
30717724|NCT00642941|58730905|FG007|Overall Study|Physician Decision|0|||
30717725|NCT00642941|58730906|FG008|Overall Study|Physician Decision|0|||
30717726|NCT00642941|58730907|FG009|Overall Study|Physician Decision|1|||
30717727|NCT00642941|58730908|FG010|Overall Study|Physician Decision|0|||
30717728|NCT00642941|58730909|FG011|Overall Study|Physician Decision|1|||
30717729|NCT00642941|58730898|FG000|Overall Study|Death|4|||
30717730|NCT00642941|58730899|FG001|Overall Study|Death|0|||
30717731|NCT00642941|58730900|FG002|Overall Study|Death|1|||
30717732|NCT00642941|58730901|FG003|Overall Study|Death|1|||
30717733|NCT00642941|58730902|FG004|Overall Study|Death|2|||
30717734|NCT00642941|58730903|FG005|Overall Study|Death|1|||
30717735|NCT00642941|58730904|FG006|Overall Study|Death|0|||
30717736|NCT00642941|58730905|FG007|Overall Study|Death|0|||
30717737|NCT00642941|58730906|FG008|Overall Study|Death|0|||
30717738|NCT00642941|58730907|FG009|Overall Study|Death|0|||
30717739|NCT00642941|58730908|FG010|Overall Study|Death|0|||
30717740|NCT00642941|58730909|FG011|Overall Study|Death|1|||
30717741|NCT00642941|58730898|FG000|Overall Study|Study closed by Sponsor|0|||
30717742|NCT00642941|58730899|FG001|Overall Study|Study closed by Sponsor|1|||
30717743|NCT00642941|58730900|FG002|Overall Study|Study closed by Sponsor|0|||
30717744|NCT00642941|58730901|FG003|Overall Study|Study closed by Sponsor|0|||
30717745|NCT00642941|58730902|FG004|Overall Study|Study closed by Sponsor|0|||
30717746|NCT00642941|58730903|FG005|Overall Study|Study closed by Sponsor|0|||
30717747|NCT00642941|58730904|FG006|Overall Study|Study closed by Sponsor|0|||
30717748|NCT00642941|58730905|FG007|Overall Study|Study closed by Sponsor|0|||
30717749|NCT00642941|58730906|FG008|Overall Study|Study closed by Sponsor|0|||
30717750|NCT00642941|58730907|FG009|Overall Study|Study closed by Sponsor|0|||
30717751|NCT00642941|58730908|FG010|Overall Study|Study closed by Sponsor|0|||
30717752|NCT00642941|58730909|FG011|Overall Study|Study closed by Sponsor|0|||
30717753|NCT00642941|58730898|FG000|Overall Study|Withdrawal by Subject|1|||
30717754|NCT00642941|58730899|FG001|Overall Study|Withdrawal by Subject|0|||
30717755|NCT00642941|58730900|FG002|Overall Study|Withdrawal by Subject|0|||
30717756|NCT00642941|58730901|FG003|Overall Study|Withdrawal by Subject|2|||
30717757|NCT00642941|58730902|FG004|Overall Study|Withdrawal by Subject|0|||
30717758|NCT00642941|58730903|FG005|Overall Study|Withdrawal by Subject|0|||
30717759|NCT00642941|58730904|FG006|Overall Study|Withdrawal by Subject|2|||
30717760|NCT00642941|58730905|FG007|Overall Study|Withdrawal by Subject|0|||
30717761|NCT00642941|58730906|FG008|Overall Study|Withdrawal by Subject|1|||
30717762|NCT00642941|58730907|FG009|Overall Study|Withdrawal by Subject|0|||
30717763|NCT00642941|58730908|FG010|Overall Study|Withdrawal by Subject|0|||
30717764|NCT00642941|58730909|FG011|Overall Study|Withdrawal by Subject|1|||
30717765|NCT00642941|58730898|FG000|Overall Study|Protocol Violation|0|||
30717766|NCT00642941|58730899|FG001|Overall Study|Protocol Violation|0|||
30717767|NCT00642941|58730900|FG002|Overall Study|Protocol Violation|0|||
30717768|NCT00642941|58730901|FG003|Overall Study|Protocol Violation|0|||
30717769|NCT00642941|58730902|FG004|Overall Study|Protocol Violation|0|||
30717770|NCT00642941|58730903|FG005|Overall Study|Protocol Violation|0|||
30717771|NCT00642941|58730904|FG006|Overall Study|Protocol Violation|1|||
30717772|NCT00642941|58730905|FG007|Overall Study|Protocol Violation|0|||
30717773|NCT00642941|58730906|FG008|Overall Study|Protocol Violation|0|||
30717774|NCT00642941|58730907|FG009|Overall Study|Protocol Violation|0|||
30717775|NCT00642941|58730908|FG010|Overall Study|Protocol Violation|0|||
30717776|NCT00642941|58730909|FG011|Overall Study|Protocol Violation|0|||
30717777|NCT00642941|58730898|FG000|Overall Study|Adverse Event|1|||
30717778|NCT00642941|58730899|FG001|Overall Study|Adverse Event|1|||
30717779|NCT00642941|58730900|FG002|Overall Study|Adverse Event|0|||
30717780|NCT00642941|58730901|FG003|Overall Study|Adverse Event|0|||
30717781|NCT00642941|58730902|FG004|Overall Study|Adverse Event|0|||
30717782|NCT00642941|58730903|FG005|Overall Study|Adverse Event|0|||
30717783|NCT00642941|58730904|FG006|Overall Study|Adverse Event|1|||
30717784|NCT00642941|58730905|FG007|Overall Study|Adverse Event|1|||
30717785|NCT00642941|58730906|FG008|Overall Study|Adverse Event|0|||
30717786|NCT00642941|58730907|FG009|Overall Study|Adverse Event|1|||
30717787|NCT00642941|58730908|FG010|Overall Study|Adverse Event|0|||
30717788|NCT00642941|58730909|FG011|Overall Study|Adverse Event|0|||
30717789|NCT00642941|58730898|FG000|Overall Study|Other|1|||
30717790|NCT00642941|58730899|FG001|Overall Study|Other|1|||
30717791|NCT00642941|58730900|FG002|Overall Study|Other|1|||
30717792|NCT00642941|58730901|FG003|Overall Study|Other|1|||
30717793|NCT00642941|58730902|FG004|Overall Study|Other|0|||
30717794|NCT00642941|58730903|FG005|Overall Study|Other|1|||
30717795|NCT00642941|58730904|FG006|Overall Study|Other|0|||
30717796|NCT00642941|58730905|FG007|Overall Study|Other|1|||
30717797|NCT00642941|58730906|FG008|Overall Study|Other|0|||
30717798|NCT00642941|58730907|FG009|Overall Study|Other|0|||
30717799|NCT00642941|58730908|FG010|Overall Study|Other|0|||
30717800|NCT00642941|58730909|FG011|Overall Study|Other|1|||
30717801|NCT00642941|58730898|FG000|Overall Study|Disease progression|60|||
30717802|NCT00642941|58730899|FG001|Overall Study|Disease progression|50|||
30717803|NCT00642941|58730900|FG002|Overall Study|Disease progression|5|||
30717804|NCT00642941|58730901|FG003|Overall Study|Disease progression|36|||
30717805|NCT00642941|58730902|FG004|Overall Study|Disease progression|23|||
30717806|NCT00642941|58730903|FG005|Overall Study|Disease progression|39|||
30717807|NCT00642941|58730904|FG006|Overall Study|Disease progression|18|||
30717808|NCT00642941|58730905|FG007|Overall Study|Disease progression|12|||
30717809|NCT00642941|58730906|FG008|Overall Study|Disease progression|10|||
30717810|NCT00642941|58730907|FG009|Overall Study|Disease progression|7|||
30717811|NCT00642941|58730908|FG010|Overall Study|Disease progression|12|||
30717812|NCT00642941|58730909|FG011|Overall Study|Disease progression|7|||
30717813|NCT00531960|58730958|FG000|Overall Study|Adverse Event|5|||
30717814|NCT00531960|58730959|FG001|Overall Study|Adverse Event|4|||
30717815|NCT00531960|58730958|FG000|Overall Study|Death|3|||
30717816|NCT00531960|58730959|FG001|Overall Study|Death|2|||
30717817|NCT00531960|58730958|FG000|Overall Study|Lack of Efficacy|42|||
30717818|NCT00531960|58730959|FG001|Overall Study|Lack of Efficacy|41|||
30717819|NCT00531960|58730958|FG000|Overall Study|Violation of Selection Criteria|2|||
30717820|NCT00531960|58730959|FG001|Overall Study|Violation of Selection Criteria|0|||
30717821|NCT00531960|58730958|FG000|Overall Study|Refused Treatment|5|||
30717822|NCT00531960|58730959|FG001|Overall Study|Refused Treatment|6|||
30717823|NCT00531960|58730958|FG000|Overall Study|Other|4|||
30717824|NCT00531960|58730959|FG001|Overall Study|Other|10|||
30717825|NCT00361504|58730967|FG000|Overall Study|Withdrawal by Subject|94|||
30717826|NCT00361504|58730968|FG001|Overall Study|Withdrawal by Subject|31|||
30717827|NCT00361504|58730967|FG000|Overall Study|Lost to Follow-up|40|||
30717828|NCT00361504|58730968|FG001|Overall Study|Lost to Follow-up|7|||
30717829|NCT00361504|58730967|FG000|Overall Study|Adverse Event|203|||
30717830|NCT00361504|58730968|FG001|Overall Study|Adverse Event|82|||
30717831|NCT00361504|58730967|FG000|Overall Study|Lack of Efficacy|72|||
30717832|NCT00361504|58730968|FG001|Overall Study|Lack of Efficacy|7|||
30717833|NCT00361504|58730967|FG000|Overall Study|Resolution of Pain|2|||
30717834|NCT00361504|58730968|FG001|Overall Study|Resolution of Pain|0|||
30717835|NCT00361504|58730967|FG000|Overall Study|Study medication non compliant|42|||
30717836|NCT00361504|58730968|FG001|Overall Study|Study medication non compliant|15|||
30717837|NCT00361504|58730967|FG000|Overall Study|All other|28|||
30717838|NCT00361504|58730968|FG001|Overall Study|All other|3|||
30717839|NCT00361270|58730978|FG000|Overall Study|Death|0|||
30717840|NCT00361270|58730979|FG001|Overall Study|Death|0|||
30717841|NCT00361270|58730980|FG002|Overall Study|Death|0|||
30717842|NCT00361270|58730981|FG003|Overall Study|Death|2|||
30717843|NCT00361270|58730978|FG000|Overall Study|Lost to Follow-up|4|||
30717844|NCT00361270|58730979|FG001|Overall Study|Lost to Follow-up|1|||
30717845|NCT00361270|58730980|FG002|Overall Study|Lost to Follow-up|0|||
30717846|NCT00361270|58730981|FG003|Overall Study|Lost to Follow-up|0|||
30717847|NCT00361270|58730978|FG000|Overall Study|Physician Decision|0|||
30717848|NCT00361270|58730979|FG001|Overall Study|Physician Decision|0|||
30717849|NCT00361270|58730980|FG002|Overall Study|Physician Decision|1|||
30717850|NCT00361270|58730981|FG003|Overall Study|Physician Decision|0|||
30717851|NCT00361270|58730978|FG000|Overall Study|Protocol Violation|9|||
30717852|NCT00361270|58730979|FG001|Overall Study|Protocol Violation|4|||
30717853|NCT00361270|58730980|FG002|Overall Study|Protocol Violation|5|||
30717854|NCT00361270|58730981|FG003|Overall Study|Protocol Violation|4|||
30717855|NCT00361270|58730978|FG000|Overall Study|Withdrawal by Subject|6|||
30717856|NCT00361270|58730979|FG001|Overall Study|Withdrawal by Subject|6|||
30717857|NCT00361270|58730980|FG002|Overall Study|Withdrawal by Subject|3|||
30717858|NCT00361270|58730981|FG003|Overall Study|Withdrawal by Subject|7|||
30717859|NCT00361270|58730978|FG000|Overall Study|Afraid of Hypnosis|1|||
30717860|NCT00361270|58730979|FG001|Overall Study|Afraid of Hypnosis|2|||
30717861|NCT00361270|58730980|FG002|Overall Study|Afraid of Hypnosis|0|||
30717862|NCT00361270|58730981|FG003|Overall Study|Afraid of Hypnosis|0|||
30717863|NCT00361270|58730978|FG000|Overall Study|Problems with Transportation|4|||
30717864|NCT00361270|58730979|FG001|Overall Study|Problems with Transportation|0|||
30717865|NCT00361270|58730980|FG002|Overall Study|Problems with Transportation|0|||
30717866|NCT00361270|58730981|FG003|Overall Study|Problems with Transportation|0|||
30717867|NCT00361270|58730978|FG000|Overall Study|Adverse Event|0|||
30717868|NCT00361270|58730979|FG001|Overall Study|Adverse Event|1|||
30717869|NCT00361270|58730980|FG002|Overall Study|Adverse Event|1|||
30717870|NCT00361270|58730981|FG003|Overall Study|Adverse Event|0|||
30717871|NCT00367744|58731000|FG000|Overall Study|Lost to Follow-up|4|||
30717872|NCT00367744|58731001|FG001|Overall Study|Lost to Follow-up|5|||
30717873|NCT03883386|58731010|FG000|First Assignment|Lost to Follow-up|1|||
30717874|NCT03883386|58731011|FG001|First Assignment|Lost to Follow-up|0|||
30717875|NCT03883386|58731010|FG000|First Assignment|Withdrawal by Subject|1|||
30717876|NCT03883386|58731011|FG001|First Assignment|Withdrawal by Subject|1|||
30717877|NCT00530946|58731021|FG000|Overall Study|Adverse Event|1|||
30717878|NCT00530946|58731022|FG001|Overall Study|Adverse Event|2|||
30717879|NCT00530946|58731023|FG002|Overall Study|Adverse Event|1|||
30717880|NCT00530946|58731024|FG003|Overall Study|Adverse Event|1|||
30717881|NCT00530946|58731021|FG000|Overall Study|Protocol Violation|0|||
30717882|NCT00530946|58731022|FG001|Overall Study|Protocol Violation|0|||
30717883|NCT00530946|58731023|FG002|Overall Study|Protocol Violation|0|||
30843718|NCT01915498|58869663|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30717884|NCT00530946|58731024|FG003|Overall Study|Protocol Violation|1|||
30717885|NCT00530946|58731021|FG000|Overall Study|Noncompliance|1|||
30717886|NCT00530946|58731022|FG001|Overall Study|Noncompliance|0|||
30717887|NCT00530946|58731023|FG002|Overall Study|Noncompliance|0|||
30717888|NCT00530946|58731024|FG003|Overall Study|Noncompliance|0|||
30717889|NCT00424047|58731036|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
30717890|NCT00424047|58731037|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
30717891|NCT00424047|58731036|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
30717892|NCT00424047|58731037|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
30717893|NCT00424047|58731036|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
30717894|NCT00424047|58731037|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
30717895|NCT00424047|58731036|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
30717896|NCT00424047|58731037|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
30717897|NCT00424047|58731036|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
30717898|NCT00424047|58731037|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
30717899|NCT00424047|58731036|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
30717900|NCT00424047|58731037|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
30717901|NCT00424047|58731036|FG000|On Study at Time of Unblinding|Adverse Event|22|||
30717902|NCT00424047|58731037|FG001|On Study at Time of Unblinding|Adverse Event|12|||
30717903|NCT00424047|58731036|FG000|On Study at Time of Unblinding|Progression of disease|92|||
30717904|NCT00424047|58731037|FG001|On Study at Time of Unblinding|Progression of disease|128|||
30717905|NCT00424047|58731036|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
30717906|NCT00424047|58731037|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
30717907|NCT00424047|58731036|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
30717908|NCT00424047|58731037|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
30717909|NCT00424047|58731036|FG000|On Study at Time of Unblinding|Death|11|||
30717910|NCT00424047|58731037|FG001|On Study at Time of Unblinding|Death|11|||
30717911|NCT00424047|58731036|FG000|On Study at Time of Unblinding|Other|5|||
30717912|NCT00424047|58731037|FG001|On Study at Time of Unblinding|Other|4|||
30717913|NCT00424047|58731036|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
30717914|NCT00424047|58731037|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
30717915|NCT00424047|58731036|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
30717916|NCT00424047|58731037|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
30717917|NCT00424047|58731036|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
30717918|NCT00424047|58731037|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
30717919|NCT00424047|58731036|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
30717920|NCT00424047|58731037|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
30717921|NCT00424047|58731036|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
30717922|NCT00424047|58731037|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
30717923|NCT00530790|58731048|FG000|Overall Study|Adverse Event|2|||
30717924|NCT00530790|58731048|FG000|Overall Study|Withdrawal by Subject|2|||
30717925|NCT00530790|58731048|FG000|Overall Study|Physician Decision|1|||
30717926|NCT00530088|58731052|FG000|Overall Study|Disease Progression|4|||
30717927|NCT00530088|58731052|FG000|Overall Study|Physician Decision|4|||
30717928|NCT00530088|58731052|FG000|Overall Study|Other Not Specified|2|||
30717929|NCT00360568|58731058|FG000|Overall Study|Adverse Event|1|||
30717930|NCT00360568|58731059|FG001|Overall Study|Adverse Event|2|||
30717931|NCT00360568|58731058|FG000|Overall Study|Lack of Efficacy|1|||
30717932|NCT00360568|58731059|FG001|Overall Study|Lack of Efficacy|0|||
30717933|NCT00360568|58731058|FG000|Overall Study|Withdrawal by Subject|0|||
30717934|NCT00360568|58731059|FG001|Overall Study|Withdrawal by Subject|3|||
30717935|NCT00436215|58731067|FG000|Overall Study|Refused further treatment|3|||
30717936|NCT00436215|58731067|FG000|Overall Study|Small bowel obstruction|1|||
30717937|NCT00441363|58731073|FG000|Overall Study|Adverse Event|4|||
30621577|NCT01174446|58633150|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
30717938|NCT00441363|58731074|FG001|Overall Study|Adverse Event|2|||
30717939|NCT00441363|58731073|FG000|Overall Study|Withdrawal by Subject|3|||
30717940|NCT00441363|58731074|FG001|Overall Study|Withdrawal by Subject|4|||
30717941|NCT00441363|58731073|FG000|Overall Study|Physician Decision|6|||
30717942|NCT00441363|58731074|FG001|Overall Study|Physician Decision|7|||
30717943|NCT00441363|58731073|FG000|Overall Study|Lost to Follow-up|2|||
30717944|NCT00441363|58731074|FG001|Overall Study|Lost to Follow-up|2|||
30717945|NCT00441363|58731073|FG000|Overall Study|Other|2|||
30717946|NCT00441363|58731074|FG001|Overall Study|Other|0|||
30717947|NCT00530712|58731080|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
30717948|NCT00530712|58731080|FG000|30 Day Follow-up Visit|Missed Visit|5|||
30717949|NCT00530712|58731080|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
30717950|NCT00530712|58731080|FG000|6 Month Follow-up Visit|Missed Visit|3|||
30717951|NCT00530712|58731080|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
30717952|NCT00530712|58731080|FG000|6 Month Follow-up Visit|Death|2|||
30717953|NCT00530712|58731080|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
30717954|NCT00530712|58731080|FG000|12 Month Follow-up Visit|Missed Visit|3|||
30717955|NCT00530712|58731080|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
30717956|NCT00530712|58731080|FG000|12 Month Follow-up Visit|Death|9|||
30717957|NCT00626795|58731088|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
30717958|NCT00626795|58731089|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
30717959|NCT00626795|58731090|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
30717960|NCT00626795|58731088|FG000|Blinded Treatment|Lack of Efficacy|2|||
30717961|NCT00626795|58731089|FG001|Blinded Treatment|Lack of Efficacy|0|||
30717962|NCT00626795|58731090|FG002|Blinded Treatment|Lack of Efficacy|0|||
30717963|NCT00626795|58731088|FG000|Blinded Treatment|Unacceptable adverse event|0|||
30717964|NCT00626795|58731089|FG001|Blinded Treatment|Unacceptable adverse event|0|||
30717965|NCT00626795|58731090|FG002|Blinded Treatment|Unacceptable adverse event|1|||
30717966|NCT00626795|58731088|FG000|Blinded Treatment|Protocol Violation|0|||
30717967|NCT00626795|58731089|FG001|Blinded Treatment|Protocol Violation|1|||
30717968|NCT00626795|58731090|FG002|Blinded Treatment|Protocol Violation|1|||
30717969|NCT00626795|58731088|FG000|Blinded Treatment|Withdrawal by Subject|1|||
30717970|NCT00626795|58731089|FG001|Blinded Treatment|Withdrawal by Subject|1|||
30717971|NCT00626795|58731090|FG002|Blinded Treatment|Withdrawal by Subject|0|||
30717972|NCT00626795|58731088|FG000|Blinded Treatment|Other reasons|2|||
30717973|NCT00626795|58731089|FG001|Blinded Treatment|Other reasons|0|||
30717974|NCT00626795|58731090|FG002|Blinded Treatment|Other reasons|2|||
30717975|NCT00626795|58731088|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
30717976|NCT00626795|58731089|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
30717977|NCT00626795|58731090|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
30717978|NCT00626639|58731104|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
30717979|NCT00626639|58731105|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
30717980|NCT00626561|58731113|FG000|Overall Study|Withdrawal by Subject|2|||
30717981|NCT00626561|58731113|FG000|Overall Study|Disease Progression|2|||
30717982|NCT03880266|58731125|FG000|Overall Study|Withdrawal by Subject|0|||
30717983|NCT03880266|58731126|FG001|Overall Study|Withdrawal by Subject|1|||
30717984|NCT03880266|58731127|FG002|Overall Study|Withdrawal by Subject|1|||
30717985|NCT03880266|58731128|FG003|Overall Study|Withdrawal by Subject|0|||
30717986|NCT03880266|58731129|FG004|Overall Study|Withdrawal by Subject|0|||
30717987|NCT03880266|58731130|FG005|Overall Study|Withdrawal by Subject|0|||
30717988|NCT03880266|58731131|FG006|Overall Study|Withdrawal by Subject|0|||
30717989|NCT03880266|58731132|FG007|Overall Study|Withdrawal by Subject|0|||
30717990|NCT00423891|58731153|FG000|Enrolled|Withdrawal by Subject|0|||
30717991|NCT00423891|58731154|FG001|Enrolled|Withdrawal by Subject|0|||
30717992|NCT00423891|58731155|FG002|Enrolled|Withdrawal by Subject|1|||
30717993|NCT00423891|58731153|FG000|Enrolled|Lost to Follow-up|0|||
30717994|NCT00423891|58731154|FG001|Enrolled|Lost to Follow-up|0|||
30717995|NCT00423891|58731155|FG002|Enrolled|Lost to Follow-up|1|||
30717996|NCT00423891|58731153|FG000|Enrolled|No longer met criteria|11|||
30717997|NCT00423891|58731154|FG001|Enrolled|No longer met criteria|2|||
30717998|NCT00423891|58731155|FG002|Enrolled|No longer met criteria|1|||
30717999|NCT00423891|58731153|FG000|Treatment|Withdrawal by Subject|1|||
30718000|NCT00423891|58731154|FG001|Treatment|Withdrawal by Subject|0|||
30718001|NCT00423891|58731155|FG002|Treatment|Withdrawal by Subject|0|||
30718002|NCT00423891|58731153|FG000|Treatment|Lost to Follow-up|1|||
30718003|NCT00423891|58731154|FG001|Treatment|Lost to Follow-up|0|||
30718004|NCT00423891|58731155|FG002|Treatment|Lost to Follow-up|0|||
30718005|NCT00423891|58731153|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
30718006|NCT00423891|58731154|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
30718007|NCT00423891|58731155|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
30718008|NCT00423891|58731153|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
30718009|NCT00423891|58731154|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
30718010|NCT00423891|58731155|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
30718011|NCT00423813|58731168|FG000|Overall Study|Adverse Event|11|||
30718012|NCT00423813|58731169|FG001|Overall Study|Adverse Event|30|||
30718013|NCT00423813|58731170|FG002|Overall Study|Adverse Event|40|||
30718014|NCT00423813|58731168|FG000|Overall Study|Withdrawal by Subject|6|||
30718015|NCT00423813|58731169|FG001|Overall Study|Withdrawal by Subject|8|||
30718016|NCT00423813|58731170|FG002|Overall Study|Withdrawal by Subject|5|||
30718017|NCT00423813|58731168|FG000|Overall Study|Lost to Follow-up|5|||
30718018|NCT00423813|58731169|FG001|Overall Study|Lost to Follow-up|4|||
30718019|NCT00423813|58731170|FG002|Overall Study|Lost to Follow-up|4|||
30718020|NCT00423813|58731168|FG000|Overall Study|Lack of Efficacy|23|||
30718021|NCT00423813|58731169|FG001|Overall Study|Lack of Efficacy|18|||
30718022|NCT00423813|58731170|FG002|Overall Study|Lack of Efficacy|19|||
30718023|NCT00423813|58731168|FG000|Overall Study|Physician Decision|2|||
30718024|NCT00423813|58731169|FG001|Overall Study|Physician Decision|0|||
30718025|NCT00423813|58731170|FG002|Overall Study|Physician Decision|0|||
30718026|NCT00423813|58731168|FG000|Overall Study|Sponsor Decision|0|||
30718027|NCT00423813|58731169|FG001|Overall Study|Sponsor Decision|1|||
30718028|NCT00423813|58731170|FG002|Overall Study|Sponsor Decision|0|||
30718029|NCT00423813|58731168|FG000|Overall Study|Protocol Violation|9|||
30718030|NCT00423813|58731169|FG001|Overall Study|Protocol Violation|4|||
30718031|NCT00423813|58731170|FG002|Overall Study|Protocol Violation|4|||
30718032|NCT00423813|58731168|FG000|Overall Study|Pregnancy|0|||
30718033|NCT00423813|58731169|FG001|Overall Study|Pregnancy|0|||
30718034|NCT00423813|58731170|FG002|Overall Study|Pregnancy|1|||
30718035|NCT00423813|58731168|FG000|Overall Study|Subject started night shift work|1|||
30718036|NCT00423813|58731169|FG001|Overall Study|Subject started night shift work|0|||
30718037|NCT00423813|58731170|FG002|Overall Study|Subject started night shift work|0|||
30718038|NCT00423813|58731168|FG000|Overall Study|Will start exclusionary medications|0|||
30718039|NCT00423813|58731169|FG001|Overall Study|Will start exclusionary medications|1|||
30718040|NCT00423813|58731170|FG002|Overall Study|Will start exclusionary medications|0|||
30718041|NCT00423813|58731168|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
30718042|NCT00423813|58731169|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
30718043|NCT00423813|58731170|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
30718044|NCT03687372|58731180|FG000|Overall Study|Lost to Follow-up|12|||
30718045|NCT03687372|58731181|FG001|Overall Study|Lost to Follow-up|21|||
30718046|NCT03687372|58731180|FG000|Overall Study|Withdrawal by Subject|4|||
30718047|NCT03687372|58731181|FG001|Overall Study|Withdrawal by Subject|17|||
30718048|NCT03687372|58731180|FG000|Overall Study|Investigator Decision|1|||
30718049|NCT03687372|58731181|FG001|Overall Study|Investigator Decision|1|||
30718050|NCT00626405|58731191|FG000|Overall Study|Deemed Ineligible|1|||
30718051|NCT00626405|58731192|FG001|Overall Study|Deemed Ineligible|0|||
30718052|NCT00626405|58731191|FG000|Overall Study|Withdrawal by Subject|0|||
30718053|NCT00626405|58731192|FG001|Overall Study|Withdrawal by Subject|1|||
30718054|NCT00358150|58731198|FG000|Overall Study|Adverse Event|3|||
30718055|NCT00358150|58731198|FG000|Overall Study|Withdrawal by Subject|1|||
30718056|NCT00358150|58731198|FG000|Overall Study|Undefined|3|||
30718057|NCT05061966|58731225|FG000|Overall Study|Lost to Follow-up|13|||
30718058|NCT05061966|58731226|FG001|Overall Study|Lost to Follow-up|13|||
30718059|NCT05027815|58731234|FG000|Overall Study|Death|2|||
30718060|NCT05027815|58731235|FG001|Overall Study|Death|1|||
30718061|NCT04827134|58731245|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
30718062|NCT04827134|58731246|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
30718063|NCT04827134|58731247|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
30718064|NCT04827134|58731248|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
30718065|NCT04818593|58731262|FG000|Overall Study|Low Oocyte Yield|8|||
30718066|NCT04818593|58731263|FG001|Overall Study|Low Oocyte Yield|8|||
30718067|NCT04818593|58731262|FG000|Overall Study|Not ICSI Insemination|7|||
30718068|NCT04818593|58731263|FG001|Overall Study|Not ICSI Insemination|7|||
30718069|NCT04818593|58731262|FG000|Overall Study|Poor Sperm Quality|2|||
30718070|NCT04818593|58731263|FG001|Overall Study|Poor Sperm Quality|2|||
30718071|NCT04818593|58731262|FG000|Overall Study|Withdrawal by Subject|2|||
30718072|NCT04818593|58731263|FG001|Overall Study|Withdrawal by Subject|2|||
30718073|NCT04818593|58731262|FG000|Overall Study|Conversion to IUI due to low response|1|||
30718074|NCT04818593|58731263|FG001|Overall Study|Conversion to IUI due to low response|1|||
30718075|NCT04680975|58731269|FG000|Overall Study|Adverse Event|3|||
30718076|NCT04680975|58731269|FG000|Overall Study|Death|1|||
30718077|NCT04680975|58731269|FG000|Overall Study|Progressive Disease|1|||
30718078|NCT04680975|58731269|FG000|Overall Study|Withdrawal by Subject|1|||
30718079|NCT04673786|58731275|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
30718080|NCT04673786|58731276|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
30718081|NCT04673786|58731277|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
30718082|NCT04673786|58731275|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
30718083|NCT04673786|58731276|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
30718084|NCT04673786|58731277|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
30718085|NCT04673786|58731275|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
30718086|NCT04673786|58731276|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
30718087|NCT04673786|58731277|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
30718088|NCT04673786|58731275|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
30718089|NCT04673786|58731276|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
30718090|NCT04673786|58731277|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
30718091|NCT04673786|58731275|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
30718092|NCT04673786|58731276|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
30718093|NCT04673786|58731277|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
30718094|NCT04673786|58731275|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
30718095|NCT04673786|58731276|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
30718096|NCT04673786|58731277|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
30718097|NCT04583969|58731301|FG000|Overall Study|Death|31|||
30718098|NCT04583969|58731302|FG001|Overall Study|Death|38|||
30718099|NCT04583969|58731301|FG000|Overall Study|Lost to Follow-up|16|||
30718100|NCT04583969|58731302|FG001|Overall Study|Lost to Follow-up|13|||
30718101|NCT04583969|58731301|FG000|Overall Study|Protocol Violation|1|||
30718102|NCT04583969|58731302|FG001|Overall Study|Protocol Violation|0|||
30718103|NCT04583969|58731301|FG000|Overall Study|Withdrawal by Subject|3|||
30718104|NCT04583969|58731302|FG001|Overall Study|Withdrawal by Subject|3|||
30718105|NCT04583969|58731301|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
30718106|NCT04583969|58731302|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
30718107|NCT04583969|58731301|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
30718108|NCT04583969|58731302|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
30718109|NCT04583969|58731301|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
30718110|NCT04583969|58731302|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
30718111|NCT04583969|58731301|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
30718112|NCT04583969|58731302|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
30718113|NCT04583969|58731301|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
30718114|NCT04583969|58731302|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
30718115|NCT04561115|58731308|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
30718116|NCT04561115|58731309|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
30718117|NCT04561115|58731308|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
30718118|NCT04561115|58731309|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
30760609|NCT03264404|58769100|FG000|Overall Study|Off study prior to treatment|2|||
30900272|NCT01847092|58933503|FG000|Overall Study|Physician Decision|1|||
30718119|NCT04561115|58731308|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
30718120|NCT04561115|58731309|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
30718121|NCT04546425|58731317|FG000|Overall Study|Protocol Violation|2|||
30718122|NCT04546425|58731318|FG001|Overall Study|Protocol Violation|1|||
30718123|NCT04546425|58731317|FG000|Overall Study|Adverse Event|3|||
30718124|NCT04546425|58731318|FG001|Overall Study|Adverse Event|0|||
30718125|NCT04546425|58731317|FG000|Overall Study|No Longer met eligibility criteria|3|||
30718126|NCT04546425|58731318|FG001|Overall Study|No Longer met eligibility criteria|3|||
30718127|NCT04546425|58731317|FG000|Overall Study|Withdrawal by parent/guardian|7|||
30718128|NCT04546425|58731318|FG001|Overall Study|Withdrawal by parent/guardian|5|||
30718129|NCT04546425|58731317|FG000|Overall Study|Lost to Follow-up|5|||
30718130|NCT04546425|58731318|FG001|Overall Study|Lost to Follow-up|4|||
30718131|NCT04546425|58731317|FG000|Overall Study|Other|0|||
30718132|NCT04546425|58731318|FG001|Overall Study|Other|1|||
30718133|NCT04366258|58731324|FG000|Baseline Assessments|Screen Failure|21|||
30718134|NCT04366258|58731324|FG000|Baseline Assessments|Early Termination|3|||
30718135|NCT04101331|58731372|FG000|Overall Study|Adverse Event|7|||
30718136|NCT04101331|58731372|FG000|Overall Study|Disease progression|79|||
30718137|NCT04101331|58731372|FG000|Overall Study|Withdrawal by Subject|1|||
30718138|NCT04101331|58731372|FG000|Overall Study|Investigator decision|6|||
30718139|NCT04101331|58731372|FG000|Overall Study|Death|6|||
30718140|NCT04101331|58731372|FG000|Overall Study|Allogenic transplant|1|||
30718141|NCT04082884|58731376|FG000|Overall Study|Withdrawal by Subject|1|||
30718142|NCT03891667|58731393|FG000|Overall Study|Physician Decision|1|||
30718143|NCT03891667|58731394|FG001|Overall Study|Physician Decision|0|||
30718144|NCT03891667|58731393|FG000|Overall Study|COVID related pause|1|||
30718145|NCT03891667|58731394|FG001|Overall Study|COVID related pause|1|||
30718146|NCT03891667|58731393|FG000|Overall Study|Withdrawal by Subject|0|||
30718147|NCT03891667|58731394|FG001|Overall Study|Withdrawal by Subject|1|||
30718148|NCT03891667|58731393|FG000|Overall Study|Adverse Event|0|||
30718149|NCT03891667|58731394|FG001|Overall Study|Adverse Event|1|||
30718150|NCT03715153|58731418|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
30718151|NCT03715153|58731419|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
30718152|NCT03715153|58731418|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
30718153|NCT03715153|58731419|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
30718154|NCT03715153|58731418|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
30718155|NCT03715153|58731419|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
30718156|NCT03715153|58731418|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
30718157|NCT03715153|58731419|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
30718158|NCT03715153|58731418|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
30718159|NCT03715153|58731419|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
30718160|NCT03715153|58731418|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
30718161|NCT03715153|58731419|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
30718162|NCT03569293|58731448|FG000|Overall Study|Adverse Event|4|||
30718163|NCT03569293|58731449|FG001|Overall Study|Adverse Event|1|||
30718164|NCT03569293|58731450|FG002|Overall Study|Adverse Event|5|||
30718165|NCT03569293|58731451|FG003|Overall Study|Adverse Event|1|||
30718166|NCT03569293|58731452|FG004|Overall Study|Adverse Event|0|||
30718167|NCT03569293|58731453|FG005|Overall Study|Adverse Event|0|||
30718168|NCT03569293|58731448|FG000|Overall Study|Withdrawal by Subject|16|||
30718169|NCT03569293|58731449|FG001|Overall Study|Withdrawal by Subject|2|||
30718170|NCT03569293|58731450|FG002|Overall Study|Withdrawal by Subject|4|||
30718171|NCT03569293|58731451|FG003|Overall Study|Withdrawal by Subject|1|||
30718172|NCT03569293|58731452|FG004|Overall Study|Withdrawal by Subject|0|||
30718173|NCT03569293|58731453|FG005|Overall Study|Withdrawal by Subject|0|||
30718174|NCT03569293|58731448|FG000|Overall Study|Lost to Follow-up|1|||
30718175|NCT03569293|58731449|FG001|Overall Study|Lost to Follow-up|3|||
30718176|NCT03569293|58731450|FG002|Overall Study|Lost to Follow-up|1|||
30718177|NCT03569293|58731451|FG003|Overall Study|Lost to Follow-up|1|||
30718178|NCT03569293|58731452|FG004|Overall Study|Lost to Follow-up|0|||
30718179|NCT03569293|58731453|FG005|Overall Study|Lost to Follow-up|0|||
30718180|NCT03569293|58731448|FG000|Overall Study|Other|8|||
30718181|NCT03569293|58731449|FG001|Overall Study|Other|2|||
30718182|NCT03569293|58731450|FG002|Overall Study|Other|1|||
30718183|NCT03569293|58731451|FG003|Overall Study|Other|1|||
30718184|NCT03569293|58731452|FG004|Overall Study|Other|0|||
30718185|NCT03569293|58731453|FG005|Overall Study|Other|0|||
30718186|NCT03569293|58731448|FG000|Overall Study|Ongoing at Time of Analysis|8|||
30718187|NCT03569293|58731449|FG001|Overall Study|Ongoing at Time of Analysis|1|||
30718188|NCT03569293|58731450|FG002|Overall Study|Ongoing at Time of Analysis|3|||
30718189|NCT03569293|58731451|FG003|Overall Study|Ongoing at Time of Analysis|0|||
30718190|NCT03569293|58731452|FG004|Overall Study|Ongoing at Time of Analysis|0|||
30718191|NCT03569293|58731453|FG005|Overall Study|Ongoing at Time of Analysis|0|||
30718192|NCT03464136|58731469|FG000|Overall Study|Lost to Follow-up|5|||
30718193|NCT03464136|58731470|FG001|Overall Study|Lost to Follow-up|8|||
30718194|NCT03464136|58731469|FG000|Overall Study|Withdrawal by Subject|16|||
30718195|NCT03464136|58731470|FG001|Overall Study|Withdrawal by Subject|13|||
30718196|NCT03464136|58731469|FG000|Overall Study|Death|1|||
30718197|NCT03464136|58731470|FG001|Overall Study|Death|0|||
30718198|NCT03464136|58731469|FG000|Overall Study|Other|8|||
30718199|NCT03464136|58731470|FG001|Overall Study|Other|4|||
30718200|NCT03020823|58731494|FG000|Overall Study|Physician Decision|4|||
30718201|NCT03020823|58731494|FG000|Overall Study|Lack of Efficacy|4|||
30718202|NCT03020823|58731494|FG000|Overall Study|Adverse Event|2|||
30718203|NCT02969369|58731502|FG000|Study|Adverse Event|1|||
30718204|NCT02969369|58731503|FG001|Study|Adverse Event|6|||
30718205|NCT02969369|58731502|FG000|Study|Lack of Efficacy|0|||
30718206|NCT02969369|58731503|FG001|Study|Lack of Efficacy|1|||
30718207|NCT02969369|58731502|FG000|Study|Lost to Follow-up|0|||
30718208|NCT02969369|58731503|FG001|Study|Lost to Follow-up|1|||
30718209|NCT02969369|58731502|FG000|Study|Withdrawal by Subject|3|||
30718210|NCT02969369|58731503|FG001|Study|Withdrawal by Subject|5|||
30718211|NCT02969369|58731502|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
30718212|NCT02969369|58731503|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
30718213|NCT02969369|58731502|FG000|Double-blind Period|Adverse Event|1|||
30718214|NCT02969369|58731503|FG001|Double-blind Period|Adverse Event|5|||
30718215|NCT02969369|58731502|FG000|Double-blind Period|Lost to Follow-up|0|||
30718216|NCT02969369|58731503|FG001|Double-blind Period|Lost to Follow-up|1|||
30718217|NCT02969369|58731502|FG000|Double-blind Period|Withdrawal by Subject|2|||
30718218|NCT02969369|58731503|FG001|Double-blind Period|Withdrawal by Subject|3|||
30621578|NCT01174446|58633151|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
30718219|NCT02969369|58731502|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
30718220|NCT02969369|58731503|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
30718221|NCT02969369|58731502|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
30718222|NCT02969369|58731503|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
30718223|NCT02969369|58731502|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
30718224|NCT02969369|58731503|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
30718225|NCT02969369|58731502|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
30718226|NCT02969369|58731503|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
30718227|NCT02583269|58731532|FG000|Overall Study|Patient hospitalized prior to start|1|||
30718228|NCT02583269|58731533|FG001|Overall Study|Patient hospitalized prior to start|0|||
30718229|NCT02583269|58731534|FG002|Overall Study|Patient hospitalized prior to start|0|||
30718230|NCT02583269|58731535|FG003|Overall Study|Patient hospitalized prior to start|0|||
30718231|NCT02583269|58731536|FG004|Overall Study|Patient hospitalized prior to start|0|||
30718232|NCT02546921|58731556|FG000|Overall Study|Adverse Event|0|||
30718233|NCT02546921|58731557|FG001|Overall Study|Adverse Event|5|||
30718234|NCT02546921|58731558|FG002|Overall Study|Adverse Event|2|||
30718235|NCT02546921|58731559|FG003|Overall Study|Adverse Event|0|||
30718236|NCT02546921|58731560|FG004|Overall Study|Adverse Event|0|||
30718237|NCT02546921|58731561|FG005|Overall Study|Adverse Event|0|||
30718238|NCT02546921|58731562|FG006|Overall Study|Adverse Event|0|||
30718239|NCT02546921|58731556|FG000|Overall Study|Evidence of Disease Progression|1|||
30718240|NCT02546921|58731557|FG001|Overall Study|Evidence of Disease Progression|0|||
30718241|NCT02546921|58731558|FG002|Overall Study|Evidence of Disease Progression|0|||
30718242|NCT02546921|58731559|FG003|Overall Study|Evidence of Disease Progression|0|||
30718243|NCT02546921|58731560|FG004|Overall Study|Evidence of Disease Progression|1|||
30718244|NCT02546921|58731561|FG005|Overall Study|Evidence of Disease Progression|0|||
30718245|NCT02546921|58731562|FG006|Overall Study|Evidence of Disease Progression|0|||
30718246|NCT02546921|58731556|FG000|Overall Study|Patient Choice|0|||
30718247|NCT02546921|58731557|FG001|Overall Study|Patient Choice|1|||
30718248|NCT02546921|58731558|FG002|Overall Study|Patient Choice|0|||
30718249|NCT02546921|58731559|FG003|Overall Study|Patient Choice|0|||
30718250|NCT02546921|58731560|FG004|Overall Study|Patient Choice|0|||
30718251|NCT02546921|58731561|FG005|Overall Study|Patient Choice|1|||
30718252|NCT02546921|58731562|FG006|Overall Study|Patient Choice|0|||
30718253|NCT02513329|58731596|FG000|Overall Study|Lost to Follow-up|5|||
30718254|NCT02513329|58731597|FG001|Overall Study|Lost to Follow-up|2|||
30718255|NCT02425826|58731607|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
30718256|NCT02425826|58731608|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
30718257|NCT02425826|58731609|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
30718258|NCT02425826|58731607|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
30718259|NCT02425826|58731608|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
30718260|NCT02425826|58731609|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
30718261|NCT02425826|58731607|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
30718262|NCT02425826|58731608|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
30718263|NCT02425826|58731609|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
30718264|NCT02425826|58731607|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
30718265|NCT02425826|58731608|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
30718266|NCT02425826|58731609|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
30718267|NCT02425826|58731607|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
30718268|NCT02425826|58731608|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
30718269|NCT02425826|58731609|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
30718270|NCT02425826|58731607|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
30718271|NCT02425826|58731608|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
30718272|NCT02425826|58731609|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
30718273|NCT02425826|58731607|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
30718274|NCT02425826|58731608|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
30718275|NCT02425826|58731609|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
30718276|NCT02425826|58731607|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
30718277|NCT02425826|58731608|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
30718278|NCT02425826|58731609|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
30718279|NCT02425826|58731607|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
30718280|NCT02425826|58731608|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
30718281|NCT02425826|58731609|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
30718282|NCT02425826|58731607|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
30718283|NCT02425826|58731608|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
30718284|NCT02425826|58731609|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
30718285|NCT02406027|58731622|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
30718286|NCT02406027|58731623|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
30621579|NCT01174446|58633148|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
30718287|NCT02406027|58731624|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
30718288|NCT02406027|58731625|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
30718289|NCT02406027|58731626|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
30718290|NCT02406027|58731627|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
30718291|NCT02406027|58731628|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
30718292|NCT02406027|58731622|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
30718293|NCT02406027|58731623|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
30718294|NCT02406027|58731624|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
30718295|NCT02406027|58731625|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
30718296|NCT02406027|58731626|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
30718297|NCT02406027|58731627|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
30718298|NCT02406027|58731628|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
30718299|NCT02406027|58731622|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
30718300|NCT02406027|58731623|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
30718301|NCT02406027|58731624|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
30718302|NCT02406027|58731625|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
30718303|NCT02406027|58731626|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
30718304|NCT02406027|58731627|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
30718305|NCT02406027|58731628|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
30718306|NCT02406027|58731622|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
30718307|NCT02406027|58731623|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
30718308|NCT02406027|58731624|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
30718309|NCT02406027|58731625|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
30718310|NCT02406027|58731626|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
30718311|NCT02406027|58731627|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
30718312|NCT02406027|58731628|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
30718313|NCT02406027|58731622|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
30718314|NCT02406027|58731623|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
30718315|NCT02406027|58731624|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
30718316|NCT02406027|58731625|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
30718317|NCT02406027|58731626|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
30718318|NCT02406027|58731627|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
30718319|NCT02406027|58731628|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
30718320|NCT02406027|58731622|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
30718321|NCT02406027|58731623|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
30718322|NCT02406027|58731624|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
30718323|NCT02406027|58731625|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
30718324|NCT02406027|58731626|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
30718325|NCT02406027|58731627|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
30718326|NCT02406027|58731628|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
30718327|NCT02406027|58731622|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
30718328|NCT02406027|58731623|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
30718329|NCT02406027|58731624|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
30718330|NCT02406027|58731625|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
30718331|NCT02406027|58731626|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
30718332|NCT02406027|58731627|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
30718333|NCT02406027|58731628|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
30718334|NCT02406027|58731622|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
30718335|NCT02406027|58731623|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
30718336|NCT02406027|58731624|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
30718337|NCT02406027|58731625|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
30718338|NCT02406027|58731626|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
30718339|NCT02406027|58731627|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
30718340|NCT02406027|58731628|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
30718341|NCT02406027|58731622|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
30718342|NCT02406027|58731623|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
30718343|NCT02406027|58731624|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
30718344|NCT02406027|58731625|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
30718345|NCT02406027|58731626|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
30718346|NCT02406027|58731627|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
30718347|NCT02406027|58731628|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
30718348|NCT02406027|58731622|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
30900273|NCT01847092|58933504|FG001|Overall Study|Physician Decision|1|||
30718349|NCT02406027|58731623|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
30718350|NCT02406027|58731624|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
30718351|NCT02406027|58731625|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
30718352|NCT02406027|58731626|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
30718353|NCT02406027|58731627|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
30718354|NCT02406027|58731628|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
30718355|NCT02278120|58731646|FG000|Overall Study|Progressive disease|122|||
30718356|NCT02278120|58731647|FG001|Overall Study|Progressive disease|174|||
30718357|NCT02278120|58731646|FG000|Overall Study|Patient/guardian decision|14|||
30718358|NCT02278120|58731647|FG001|Overall Study|Patient/guardian decision|8|||
30718359|NCT02278120|58731646|FG000|Overall Study|Adverse Event|12|||
30718360|NCT02278120|58731647|FG001|Overall Study|Adverse Event|10|||
30718361|NCT02278120|58731646|FG000|Overall Study|Physician Decision|8|||
30718362|NCT02278120|58731647|FG001|Overall Study|Physician Decision|19|||
30718363|NCT02278120|58731646|FG000|Overall Study|Death|3|||
30718364|NCT02278120|58731647|FG001|Overall Study|Death|3|||
30718365|NCT02278120|58731646|FG000|Overall Study|Lost to Follow-up|2|||
30718366|NCT02278120|58731647|FG001|Overall Study|Lost to Follow-up|0|||
30718367|NCT02278120|58731646|FG000|Overall Study|Protocol Violation|0|||
30718368|NCT02278120|58731647|FG001|Overall Study|Protocol Violation|2|||
30718369|NCT02255357|58731655|FG000|Overall Study|Physician Decision|10|||
30718370|NCT02255357|58731656|FG001|Overall Study|Physician Decision|24|||
30718371|NCT02211131|58731664|FG000|Overall Study|Death|26|||
30718372|NCT02211131|58731665|FG001|Overall Study|Death|16|||
30718373|NCT02211131|58731664|FG000|Overall Study|Lost to Follow-up|4|||
30718374|NCT02211131|58731665|FG001|Overall Study|Lost to Follow-up|3|||
30718375|NCT02211131|58731664|FG000|Overall Study|Decision by Sponsor|1|||
30718376|NCT02211131|58731665|FG001|Overall Study|Decision by Sponsor|1|||
30718377|NCT02211131|58731664|FG000|Overall Study|Withdrawal by Subject|3|||
30718378|NCT02211131|58731665|FG001|Overall Study|Withdrawal by Subject|8|||
30718379|NCT02155647|58731680|FG000|Overall Study|Still on Treatment|26|||
30718380|NCT02155647|58731681|FG001|Overall Study|Still on Treatment|26|||
30718381|NCT02155647|58731680|FG000|Overall Study|Off-Treatment, but follow up ongoing|15|||
30718382|NCT02155647|58731681|FG001|Overall Study|Off-Treatment, but follow up ongoing|26|||
30718383|NCT02134587|58731691|FG000|Overall Study|Did not completed all meetings|30|||
30718384|NCT01752920|58731708|FG000|Overall Study|Adverse Event|1|||
30718385|NCT01752920|58731709|FG001|Overall Study|Adverse Event|0|||
30718386|NCT01752920|58731710|FG002|Overall Study|Adverse Event|5|||
30718387|NCT01752920|58731711|FG003|Overall Study|Adverse Event|10|||
30718388|NCT01752920|58731708|FG000|Overall Study|Clinical Disease Progression|6|||
30718389|NCT01752920|58731709|FG001|Overall Study|Clinical Disease Progression|4|||
30718390|NCT01752920|58731710|FG002|Overall Study|Clinical Disease Progression|1|||
30718391|NCT01752920|58731711|FG003|Overall Study|Clinical Disease Progression|13|||
30718392|NCT01752920|58731708|FG000|Overall Study|Physician Decision|1|||
30718393|NCT01752920|58731709|FG001|Overall Study|Physician Decision|0|||
30718394|NCT01752920|58731710|FG002|Overall Study|Physician Decision|0|||
30718395|NCT01752920|58731711|FG003|Overall Study|Physician Decision|3|||
30718396|NCT01752920|58731708|FG000|Overall Study|Radiographic Disease Progression|20|||
30718397|NCT01752920|58731709|FG001|Overall Study|Radiographic Disease Progression|7|||
30718398|NCT01752920|58731710|FG002|Overall Study|Radiographic Disease Progression|12|||
30718399|NCT01752920|58731711|FG003|Overall Study|Radiographic Disease Progression|29|||
30718400|NCT01752920|58731708|FG000|Overall Study|Study Terminated by Sponsor|0|||
30718401|NCT01752920|58731709|FG001|Overall Study|Study Terminated by Sponsor|0|||
30718402|NCT01752920|58731710|FG002|Overall Study|Study Terminated by Sponsor|0|||
30718403|NCT01752920|58731711|FG003|Overall Study|Study Terminated by Sponsor|1|||
30718404|NCT01752920|58731708|FG000|Overall Study|Withdrawal by Subject|0|||
30718405|NCT01752920|58731709|FG001|Overall Study|Withdrawal by Subject|1|||
30718406|NCT01752920|58731710|FG002|Overall Study|Withdrawal by Subject|0|||
30718407|NCT01752920|58731711|FG003|Overall Study|Withdrawal by Subject|1|||
30718408|NCT01752920|58731708|FG000|Overall Study|Lack of clinical benefit|1|||
30718409|NCT01752920|58731709|FG001|Overall Study|Lack of clinical benefit|1|||
30718410|NCT01752920|58731710|FG002|Overall Study|Lack of clinical benefit|1|||
30718411|NCT01752920|58731711|FG003|Overall Study|Lack of clinical benefit|1|||
30760610|NCT03118570|58769118|FG000|Overall Study|Adverse Event|2|||
30900274|NCT01847092|58933503|FG000|Overall Study|Protocol Violation|0|||
30718412|NCT00976963|58731725|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
30718413|NCT00976963|58731726|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
30718414|NCT00976963|58731725|FG000|Overall Study|administrative error|1|||
30718415|NCT00976963|58731726|FG001|Overall Study|administrative error|0|||
30718416|NCT00976963|58731725|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
30718417|NCT00976963|58731726|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
30718418|NCT00423735|58731743|FG000|Overall Study|Ineligible / No protocol treatment|8|||
30718419|NCT00423735|58731744|FG001|Overall Study|Ineligible / No protocol treatment|6|||
30718420|NCT00423735|58731745|FG002|Overall Study|Ineligible / No protocol treatment|0|||
30718421|NCT00626327|58731758|FG000|Overall Study|Withdrawal by Subject|21|||
30718422|NCT00626327|58731759|FG001|Overall Study|Withdrawal by Subject|29|||
30718423|NCT00626327|58731760|FG002|Overall Study|Withdrawal by Subject|30|||
30718424|NCT00626327|58731758|FG000|Overall Study|Adverse Event|1|||
30718425|NCT00626327|58731759|FG001|Overall Study|Adverse Event|0|||
30718426|NCT00626327|58731760|FG002|Overall Study|Adverse Event|0|||
30718427|NCT00626327|58731758|FG000|Overall Study|Lost to Follow-up|24|||
30718428|NCT00626327|58731759|FG001|Overall Study|Lost to Follow-up|21|||
30718429|NCT00626327|58731760|FG002|Overall Study|Lost to Follow-up|23|||
30718430|NCT00626327|58731758|FG000|Overall Study|Inappropriate enrollment|4|||
30718431|NCT00626327|58731759|FG001|Overall Study|Inappropriate enrollment|5|||
30718432|NCT00626327|58731760|FG002|Overall Study|Inappropriate enrollment|3|||
30718433|NCT00626327|58731758|FG000|Overall Study|Administrative Reason|2|||
30718434|NCT00626327|58731759|FG001|Overall Study|Administrative Reason|0|||
30718435|NCT00626327|58731760|FG002|Overall Study|Administrative Reason|6|||
30718436|NCT00626327|58731758|FG000|Overall Study|Protocol Violation|26|||
30718437|NCT00626327|58731759|FG001|Overall Study|Protocol Violation|4|||
30718438|NCT00626327|58731760|FG002|Overall Study|Protocol Violation|26|||
30718439|NCT00357994|58731778|FG000|Overall Study|Adverse Event|1|||
30718440|NCT00357994|58731779|FG001|Overall Study|Adverse Event|2|||
30718441|NCT00357994|58731778|FG000|Overall Study|Lack of Efficacy|0|||
30718442|NCT00357994|58731779|FG001|Overall Study|Lack of Efficacy|1|||
30718443|NCT00357994|58731778|FG000|Overall Study|Protocol Violation|1|||
30718444|NCT00357994|58731779|FG001|Overall Study|Protocol Violation|0|||
30718445|NCT00423657|58731787|FG000|Overall Study|Withdrew consent|10|||
30718446|NCT00423657|58731788|FG001|Overall Study|Withdrew consent|8|||
30718447|NCT00423657|58731787|FG000|Overall Study|Non-compliance|0|||
30718448|NCT00423657|58731788|FG001|Overall Study|Non-compliance|1|||
30718449|NCT00423657|58731787|FG000|Overall Study|Other|15|||
30718450|NCT00423657|58731788|FG001|Overall Study|Other|16|||
30718451|NCT00423657|58731787|FG000|Overall Study|Request of sponsor/investigator|1|||
30718452|NCT00423657|58731788|FG001|Overall Study|Request of sponsor/investigator|0|||
30718453|NCT00367432|58731794|FG000|First Period (16 Weeks)|Adverse Event|6|||
30718454|NCT00367432|58731795|FG001|First Period (16 Weeks)|Adverse Event|0|||
30718455|NCT00367432|58731794|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
30718456|NCT00367432|58731795|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
30718457|NCT00367432|58731794|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
30718458|NCT00367432|58731795|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
30790919|NCT03200366|58804016|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
30718459|NCT00367432|58731794|FG000|First Period (16 Weeks)|Other Reason|2|||
30718460|NCT00367432|58731795|FG001|First Period (16 Weeks)|Other Reason|0|||
30718461|NCT00367432|58731794|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
30718462|NCT00367432|58731795|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
30718463|NCT00367432|58731794|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
30718464|NCT00367432|58731795|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
30790920|NCT03200366|58804017|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
30900275|NCT01847092|58933504|FG001|Overall Study|Protocol Violation|2|||
30718465|NCT00367432|58731794|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
30718466|NCT00367432|58731795|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
30718467|NCT00367432|58731794|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
30718468|NCT00367432|58731795|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
30718469|NCT00367432|58731794|FG000|Second Period (up to 54 Months)|Other Reason|6|||
30718470|NCT00367432|58731795|FG001|Second Period (up to 54 Months)|Other Reason|2|||
30718471|NCT00623363|58731801|FG000|Overall Study|Adverse Event|2|||
30718472|NCT00623363|58731802|FG001|Overall Study|Adverse Event|2|||
30718473|NCT00423267|58731811|FG000|Period A|Withdrawal by Subject|0|||
30718474|NCT00423267|58731812|FG001|Period A|Withdrawal by Subject|1|||
30718475|NCT00423267|58731811|FG000|Period A|Non-compliance with protocol|1|||
30718476|NCT00423267|58731812|FG001|Period A|Non-compliance with protocol|0|||
30718477|NCT00423267|58731811|FG000|Period A|Administrative|1|||
30718478|NCT00423267|58731812|FG001|Period A|Administrative|0|||
30718479|NCT00626093|58731820|FG000|Overall Study|Lost to Follow-up|5|||
30718480|NCT00626093|58731820|FG000|Overall Study|Death|1|||
30718481|NCT00626093|58731820|FG000|Overall Study|Physician Decision|4|||
30718482|NCT00626093|58731820|FG000|Overall Study|Withdrawal by Subject|6|||
30718483|NCT00626093|58731820|FG000|Overall Study|Protocol Violation|1|||
30718484|NCT00626093|58731820|FG000|Overall Study|One of the required devices not implante|6|||
30718485|NCT00357760|58731826|FG000|Overall Study|Disease progression|44|||
30718486|NCT00357760|58731827|FG001|Overall Study|Disease progression|17|||
30718487|NCT00357760|58731826|FG000|Overall Study|Adverse Event|10|||
30718488|NCT00357760|58731827|FG001|Overall Study|Adverse Event|7|||
30718489|NCT00357760|58731826|FG000|Overall Study|Death|0|||
30718490|NCT00357760|58731827|FG001|Overall Study|Death|3|||
30718491|NCT00357760|58731826|FG000|Overall Study|Alternative therapy|1|||
30718492|NCT00357760|58731827|FG001|Overall Study|Alternative therapy|0|||
30718493|NCT00357760|58731826|FG000|Overall Study|Withdrawal by Subject|0|||
30718494|NCT00357760|58731827|FG001|Overall Study|Withdrawal by Subject|2|||
30718495|NCT00357760|58731826|FG000|Overall Study|Never started treatment|2|||
30718496|NCT00357760|58731827|FG001|Overall Study|Never started treatment|1|||
30718497|NCT00357760|58731826|FG000|Overall Study|Ineligible|0|||
30718498|NCT00357760|58731827|FG001|Overall Study|Ineligible|2|||
30718499|NCT00357760|58731826|FG000|Overall Study|Physician Decision|2|||
30718500|NCT00357760|58731827|FG001|Overall Study|Physician Decision|1|||
30718501|NCT00357760|58731826|FG000|Overall Study|Protocol Violation|0|||
30718502|NCT00357760|58731827|FG001|Overall Study|Protocol Violation|1|||
30718503|NCT00357760|58731826|FG000|Overall Study|To receive hospice care|0|||
30718504|NCT00357760|58731827|FG001|Overall Study|To receive hospice care|1|||
30718505|NCT00622739|58731835|FG000|Overall Study|Physician Decision|1|||
30718506|NCT00622739|58731836|FG001|Overall Study|Physician Decision|0|||
30718507|NCT00622739|58731835|FG000|Overall Study|Adverse Event|1|||
30718508|NCT00622739|58731836|FG001|Overall Study|Adverse Event|2|||
30718509|NCT00622739|58731835|FG000|Overall Study|Lack of Efficacy|0|||
30718510|NCT00622739|58731836|FG001|Overall Study|Lack of Efficacy|2|||
30718511|NCT00622739|58731835|FG000|Overall Study|Withdrawal by Subject|0|||
30718512|NCT00622739|58731836|FG001|Overall Study|Withdrawal by Subject|1|||
30718513|NCT00622739|58731835|FG000|Overall Study|Lost to Follow-up|0|||
30718514|NCT00622739|58731836|FG001|Overall Study|Lost to Follow-up|1|||
30718515|NCT00435825|58731848|FG000|Overall Study|Abnormality of Laboratory Test|0|||
30718516|NCT00435825|58731849|FG001|Overall Study|Abnormality of Laboratory Test|1|||
30718517|NCT00435825|58731850|FG002|Overall Study|Abnormality of Laboratory Test|0|||
30718518|NCT00435825|58731851|FG003|Overall Study|Abnormality of Laboratory Test|0|||
30718519|NCT00435825|58731848|FG000|Overall Study|Insufficient Therapeutic Response|3|||
30718520|NCT00435825|58731849|FG001|Overall Study|Insufficient Therapeutic Response|1|||
30718521|NCT00435825|58731850|FG002|Overall Study|Insufficient Therapeutic Response|0|||
30718522|NCT00435825|58731851|FG003|Overall Study|Insufficient Therapeutic Response|3|||
30718523|NCT00435825|58731848|FG000|Overall Study|Other Protocol Violation|1|||
30718524|NCT00435825|58731849|FG001|Overall Study|Other Protocol Violation|0|||
30718525|NCT00435825|58731850|FG002|Overall Study|Other Protocol Violation|0|||
30718526|NCT00435825|58731851|FG003|Overall Study|Other Protocol Violation|0|||
30718527|NCT00435825|58731848|FG000|Overall Study|Refused treatment|2|||
30718528|NCT00435825|58731849|FG001|Overall Study|Refused treatment|0|||
30718529|NCT00435825|58731850|FG002|Overall Study|Refused treatment|0|||
30718530|NCT00435825|58731851|FG003|Overall Study|Refused treatment|5|||
30718531|NCT00435825|58731848|FG000|Overall Study|Failure to return|5|||
30718532|NCT00435825|58731849|FG001|Overall Study|Failure to return|0|||
30718533|NCT00435825|58731850|FG002|Overall Study|Failure to return|4|||
30718534|NCT00435825|58731851|FG003|Overall Study|Failure to return|0|||
30718535|NCT00435825|58731848|FG000|Overall Study|Did not receive study drug|1|||
30718536|NCT00435825|58731849|FG001|Overall Study|Did not receive study drug|0|||
30718537|NCT00435825|58731850|FG002|Overall Study|Did not receive study drug|2|||
30718538|NCT00435825|58731851|FG003|Overall Study|Did not receive study drug|0|||
30718539|NCT00435825|58731848|FG000|Overall Study|Did not enter follow-up|0|||
30718540|NCT00435825|58731849|FG001|Overall Study|Did not enter follow-up|4|||
30718541|NCT00435825|58731850|FG002|Overall Study|Did not enter follow-up|1|||
30718542|NCT00435825|58731851|FG003|Overall Study|Did not enter follow-up|3|||
30718543|NCT00435825|58731848|FG000|Overall Study|Did not complete full follow-up period|6|||
30718544|NCT00435825|58731849|FG001|Overall Study|Did not complete full follow-up period|6|||
30718545|NCT00435825|58731850|FG002|Overall Study|Did not complete full follow-up period|4|||
30718546|NCT00435825|58731851|FG003|Overall Study|Did not complete full follow-up period|5|||
30718547|NCT00574145|58731863|FG000|Overall Study|Withdrawal by Subject|2|||
30718548|NCT00574145|58731864|FG001|Overall Study|Withdrawal by Subject|1|||
30718549|NCT00423189|58731873|FG000|Overall Study|Death|0|||
30718550|NCT00423189|58731874|FG001|Overall Study|Death|1|||
30718551|NCT00423189|58731875|FG002|Overall Study|Death|0|||
30718552|NCT00422799|58731888|FG000|Overall Study|Withdrawal by Subject|6|||
30718553|NCT00422799|58731888|FG000|Overall Study|Adverse Event|7|||
30718554|NCT00435045|58731894|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
30718555|NCT00435045|58731895|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
30718556|NCT00435045|58731894|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
30718557|NCT00435045|58731895|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
30718558|NCT00435045|58731894|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
30718559|NCT00435045|58731895|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
30718560|NCT00435045|58731894|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
30718561|NCT00435045|58731895|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
30718562|NCT00435045|58731894|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
30718563|NCT00435045|58731895|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
30718564|NCT00435045|58731894|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
30718565|NCT00435045|58731895|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
30718566|NCT00435045|58731894|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
30718567|NCT00435045|58731895|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
30718568|NCT00435045|58731894|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
30718569|NCT00435045|58731895|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
30718570|NCT00435045|58731894|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
30718571|NCT00435045|58731895|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
30718572|NCT00435045|58731894|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
30718573|NCT00435045|58731895|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
30718574|NCT00435045|58731894|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
30718575|NCT00435045|58731895|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
30718576|NCT00441129|58731903|FG000|Overall Study|Withdrawal by Subject|6|||
30718577|NCT00441129|58731904|FG001|Overall Study|Withdrawal by Subject|14|||
30718578|NCT00622505|58731912|FG000|Overall Study|Adverse Event|9|||
30718579|NCT00622505|58731913|FG001|Overall Study|Adverse Event|7|||
30718580|NCT00622505|58731912|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
30718581|NCT00622505|58731913|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
30718582|NCT00622505|58731912|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
30718583|NCT00622505|58731913|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
30718584|NCT00622505|58731912|FG000|Overall Study|Withdrawal by Subject|12|||
30718585|NCT00622505|58731913|FG001|Overall Study|Withdrawal by Subject|5|||
30718586|NCT00622505|58731912|FG000|Overall Study|Administrative Problems|2|||
30718587|NCT00622505|58731913|FG001|Overall Study|Administrative Problems|4|||
30718588|NCT00622505|58731912|FG000|Overall Study|Death|2|||
30718589|NCT00622505|58731913|FG001|Overall Study|Death|2|||
30718612|NCT00357370|58731933|FG000|Cohort 2|Lack of Efficacy|0|||
30718613|NCT00357370|58731934|FG001|Cohort 2|Lack of Efficacy|2|||
30718614|NCT00357370|58731935|FG002|Cohort 2|Lack of Efficacy|1|||
30718615|NCT00357370|58731933|FG000|Cohort 2|Adverse Event|1|||
30718616|NCT00357370|58731934|FG001|Cohort 2|Adverse Event|1|||
30718617|NCT00357370|58731935|FG002|Cohort 2|Adverse Event|1|||
30718618|NCT00357370|58731933|FG000|Cohort 2|Lost to Follow-up|0|||
30718619|NCT00357370|58731934|FG001|Cohort 2|Lost to Follow-up|1|||
30718620|NCT00357370|58731935|FG002|Cohort 2|Lost to Follow-up|0|||
30718621|NCT00357370|58731933|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
30718622|NCT00357370|58731934|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
30718623|NCT00357370|58731935|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
30718624|NCT00357370|58731933|FG000|Cohort 2|Withdrawal by Subject|0|||
30718625|NCT00357370|58731934|FG001|Cohort 2|Withdrawal by Subject|2|||
30718626|NCT00357370|58731935|FG002|Cohort 2|Withdrawal by Subject|0|||
30718627|NCT00574847|58731945|FG000|Overall Study|Adverse Event|2|||
30718628|NCT00574847|58731946|FG001|Overall Study|Adverse Event|0|||
30718629|NCT00574847|58731945|FG000|Overall Study|Death|1|||
30718630|NCT00574847|58731946|FG001|Overall Study|Death|0|||
30718631|NCT00574847|58731945|FG000|Overall Study|Withdrawal by Subject|2|||
30718632|NCT00574847|58731946|FG001|Overall Study|Withdrawal by Subject|2|||
30718633|NCT00574847|58731945|FG000|Overall Study|Physician Decision|1|||
30718634|NCT00574847|58731946|FG001|Overall Study|Physician Decision|0|||
30718635|NCT00574847|58731945|FG000|Overall Study|Did not receive medication (declined)|2|||
30718636|NCT00574847|58731946|FG001|Overall Study|Did not receive medication (declined)|5|||
30718637|NCT00348790|58731952|FG000|Completed Treatment|Withdrawal by Subject|4|||
30718638|NCT00348790|58731952|FG000|Completed Treatment|Disease progression|14|||
30718639|NCT00348790|58731952|FG000|Completed Treatment|Adverse Event|4|||
30718640|NCT00348790|58731952|FG000|Completed Treatment|Required surgery|2|||
30718641|NCT00348790|58731952|FG000|Completed Treatment|Unable to travel to study site|1|||
30718642|NCT00360490|58731959|FG000|Overall Study|Adverse Event|4|||
30718643|NCT00360490|58731960|FG001|Overall Study|Adverse Event|2|||
30718644|NCT00360490|58731959|FG000|Overall Study|Lost to Follow-up|2|||
30718645|NCT00360490|58731960|FG001|Overall Study|Lost to Follow-up|1|||
30718646|NCT00360490|58731959|FG000|Overall Study|Physician Decision|2|||
30718647|NCT00360490|58731960|FG001|Overall Study|Physician Decision|1|||
30718648|NCT00360490|58731959|FG000|Overall Study|Protocol Violation|0|||
30718649|NCT00360490|58731960|FG001|Overall Study|Protocol Violation|4|||
30718650|NCT00360490|58731959|FG000|Overall Study|Withdrawal by Subject|1|||
30718651|NCT00360490|58731960|FG001|Overall Study|Withdrawal by Subject|3|||
30718652|NCT00624377|58731966|FG000|Overall Study|Lost to Follow-up|355|||
30718653|NCT00624377|58731966|FG000|Overall Study|Withdrawal by Subject|100|||
30718654|NCT00624377|58731966|FG000|Overall Study|Adverse Event|14|||
30718655|NCT00624377|58731966|FG000|Overall Study|Other|91|||
30718656|NCT00624377|58731966|FG000|Overall Study|Non-evaluable population|84|||
30718657|NCT00624065|58731972|FG000|Overall Study|Adverse Event|5|||
30718658|NCT00624065|58731973|FG001|Overall Study|Adverse Event|6|||
30718659|NCT00624065|58731972|FG000|Overall Study|Lost to Follow-up|4|||
30718660|NCT00624065|58731973|FG001|Overall Study|Lost to Follow-up|1|||
30718661|NCT00624065|58731972|FG000|Overall Study|Consent withdrawn|6|||
30718662|NCT00624065|58731973|FG001|Overall Study|Consent withdrawn|5|||
30718663|NCT00624065|58731972|FG000|Overall Study|Lack of Efficacy|0|||
30718664|NCT00624065|58731973|FG001|Overall Study|Lack of Efficacy|3|||
30718665|NCT00624065|58731972|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
30718666|NCT00624065|58731973|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
30718667|NCT00360412|58731981|FG000|Overall Study|Adverse Event|37|||
30718668|NCT00360412|58731982|FG001|Overall Study|Adverse Event|65|||
30718669|NCT00360412|58731981|FG000|Overall Study|Protocol Violation|2|||
30718670|NCT00360412|58731982|FG001|Overall Study|Protocol Violation|5|||
30718671|NCT00360412|58731981|FG000|Overall Study|Patient withdrew consent|27|||
30718672|NCT00360412|58731982|FG001|Overall Study|Patient withdrew consent|52|||
30718673|NCT00360412|58731981|FG000|Overall Study|Lack of therapeutic efficacy|46|||
30718674|NCT00360412|58731982|FG001|Overall Study|Lack of therapeutic efficacy|61|||
30718675|NCT00360412|58731981|FG000|Overall Study|Physician Decision|2|||
30718676|NCT00360412|58731982|FG001|Overall Study|Physician Decision|4|||
30718677|NCT00360412|58731981|FG000|Overall Study|Other|5|||
30718678|NCT00360412|58731982|FG001|Overall Study|Other|6|||
30718679|NCT00360412|58731981|FG000|Overall Study|Study termination by Sponsor|214|||
30718680|NCT00360412|58731982|FG001|Overall Study|Study termination by Sponsor|469|||
30718681|NCT00623831|58731990|FG000|Overall Study|Withdrawal by Subject|1|||
30718682|NCT00623831|58731991|FG001|Overall Study|Withdrawal by Subject|0|||
30718683|NCT00623831|58731990|FG000|Overall Study|Progressive Disease|0|||
30718684|NCT00623831|58731991|FG001|Overall Study|Progressive Disease|1|||
30718685|NCT00360334|58732002|FG000|Overall Study|Adverse Event|7|||
30718686|NCT00360334|58732003|FG001|Overall Study|Adverse Event|4|||
30718687|NCT00360334|58732002|FG000|Overall Study|Protocol Violation|1|||
30718688|NCT00360334|58732003|FG001|Overall Study|Protocol Violation|1|||
30718689|NCT00360334|58732002|FG000|Overall Study|Physician Decision|2|||
30718690|NCT00360334|58732003|FG001|Overall Study|Physician Decision|3|||
30718691|NCT00360334|58732002|FG000|Overall Study|Lack of Efficacy|0|||
30718692|NCT00360334|58732003|FG001|Overall Study|Lack of Efficacy|1|||
30718693|NCT00360334|58732002|FG000|Overall Study|Entry criterion not met|1|||
30718694|NCT00360334|58732003|FG001|Overall Study|Entry criterion not met|2|||
30718695|NCT00360334|58732002|FG000|Overall Study|Subject decision|8|||
30718696|NCT00360334|58732003|FG001|Overall Study|Subject decision|2|||
30718697|NCT00422097|58732015|FG000|Dose Level 2|Still on treatment|0|||
30718698|NCT00422097|58732016|FG001|Dose Level 2|Still on treatment|1|||
30718699|NCT00422097|58732017|FG002|Dose Level 2|Still on treatment|0|||
30718700|NCT00422097|58732018|FG003|Dose Level 2|Still on treatment|0|||
30718701|NCT00422097|58732019|FG004|Dose Level 2|Still on treatment|0|||
30718702|NCT00422097|58732020|FG005|Dose Level 2|Still on treatment|0|||
30718703|NCT00422097|58732021|FG006|Dose Level 2|Still on treatment|0|||
30718704|NCT00422097|58732022|FG007|Dose Level 2|Still on treatment|0|||
30718705|NCT00348556|58732046|FG000|Overall Study|Adverse Event|1|||
30718706|NCT00434967|58732054|FG000|Overall Study|Adverse Event|2|||
30718707|NCT00434967|58732055|FG001|Overall Study|Adverse Event|4|||
30718708|NCT00434967|58732056|FG002|Overall Study|Adverse Event|3|||
30718709|NCT00434967|58732057|FG003|Overall Study|Adverse Event|3|||
30718710|NCT00434967|58732054|FG000|Overall Study|Lost to Follow-up|0|||
30718711|NCT00434967|58732055|FG001|Overall Study|Lost to Follow-up|0|||
30718712|NCT00434967|58732056|FG002|Overall Study|Lost to Follow-up|1|||
30718713|NCT00434967|58732057|FG003|Overall Study|Lost to Follow-up|0|||
30718714|NCT00434967|58732054|FG000|Overall Study|Withdrawal by Subject|2|||
30718715|NCT00434967|58732055|FG001|Overall Study|Withdrawal by Subject|2|||
30718716|NCT00434967|58732056|FG002|Overall Study|Withdrawal by Subject|4|||
30718717|NCT00434967|58732057|FG003|Overall Study|Withdrawal by Subject|6|||
30718718|NCT00434967|58732054|FG000|Overall Study|Randomized in error|0|||
30718719|NCT00434967|58732055|FG001|Overall Study|Randomized in error|0|||
30718720|NCT00434967|58732056|FG002|Overall Study|Randomized in error|0|||
30718721|NCT00434967|58732057|FG003|Overall Study|Randomized in error|1|||
30718722|NCT00434967|58732054|FG000|Overall Study|Protocol Violation|0|||
30718723|NCT00434967|58732055|FG001|Overall Study|Protocol Violation|1|||
30718724|NCT00434967|58732056|FG002|Overall Study|Protocol Violation|0|||
30718725|NCT00434967|58732057|FG003|Overall Study|Protocol Violation|1|||
30718726|NCT00434967|58732054|FG000|Overall Study|Physician Decision|1|||
30718727|NCT00434967|58732055|FG001|Overall Study|Physician Decision|1|||
30718728|NCT00434967|58732056|FG002|Overall Study|Physician Decision|1|||
30718729|NCT00434967|58732057|FG003|Overall Study|Physician Decision|0|||
30718730|NCT00434967|58732054|FG000|Overall Study|Patient Disposition Challenges|2|||
30718731|NCT00434967|58732055|FG001|Overall Study|Patient Disposition Challenges|0|||
30718732|NCT00434967|58732056|FG002|Overall Study|Patient Disposition Challenges|0|||
30718733|NCT00434967|58732057|FG003|Overall Study|Patient Disposition Challenges|3|||
30718734|NCT00356590|58732067|FG000|Overall Study|Adverse Event|54|||
30718735|NCT00356590|58732067|FG000|Overall Study|Death|10|||
30718736|NCT00356590|58732067|FG000|Overall Study|Lost to Follow-up|35|||
30718737|NCT00356590|58732067|FG000|Overall Study|Physician Decision|46|||
30718738|NCT00356590|58732067|FG000|Overall Study|Withdrawal by Subject|41|||
30718739|NCT00356590|58732067|FG000|Overall Study|Completed month 12 only|2|||
30718740|NCT00356590|58732067|FG000|Overall Study|Protocol issues|6|||
30718741|NCT00356590|58732067|FG000|Overall Study|Response status|28|||
30718742|NCT00356590|58732067|FG000|Overall Study|Other|52|||
30718743|NCT00356278|58732074|FG000|Overall Study|Withdrawal by Subject|25|||
30718744|NCT00356278|58732075|FG001|Overall Study|Withdrawal by Subject|15|||
30718745|NCT00356278|58732076|FG002|Overall Study|Withdrawal by Subject|19|||
30718746|NCT00356200|58732086|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
30718747|NCT00356200|58732087|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
30718748|NCT00356200|58732086|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
30718749|NCT00356200|58732087|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
30718750|NCT00356122|58732099|FG000|TREATMENT|Lack of Efficacy|26|||
30718751|NCT00356122|58732099|FG000|TREATMENT|Adverse Event|10|||
30718752|NCT00356122|58732099|FG000|TREATMENT|Subject's request|4|||
30718753|NCT00356122|58732099|FG000|TREATMENT|Other|4|||
30718754|NCT00356122|58732099|FG000|TREATMENT|Did not receive study medication|1|||
30718755|NCT00356122|58732099|FG000|FOLLOW-UP|Death|37|||
30718756|NCT00356122|58732099|FG000|FOLLOW-UP|Lost to Follow-up|2|||
30718757|NCT00356122|58732099|FG000|FOLLOW-UP|Other|2|||
30718758|NCT00347932|58732105|FG000|Overall Study|Adverse Event|4|||
30718759|NCT00347932|58732106|FG001|Overall Study|Adverse Event|5|||
30718760|NCT00347932|58732105|FG000|Overall Study|Lack of Efficacy|3|||
30718761|NCT00347932|58732106|FG001|Overall Study|Lack of Efficacy|14|||
30718762|NCT00347932|58732105|FG000|Overall Study|Lost to Follow-up|10|||
30718763|NCT00347932|58732106|FG001|Overall Study|Lost to Follow-up|9|||
30718764|NCT00347932|58732105|FG000|Overall Study|Withdrawal by Subject|10|||
30718765|NCT00347932|58732106|FG001|Overall Study|Withdrawal by Subject|16|||
30718766|NCT00347932|58732105|FG000|Overall Study|Did not meet inclusion criteria|4|||
30718767|NCT00347932|58732106|FG001|Overall Study|Did not meet inclusion criteria|8|||
30718768|NCT00528996|58732117|FG000|Overall Study|Other reasons than listing|6|||
30718769|NCT00528996|58732118|FG001|Overall Study|Other reasons than listing|7|||
30718770|NCT00528996|58732119|FG002|Overall Study|Other reasons than listing|14|||
30718771|NCT00528996|58732120|FG003|Overall Study|Other reasons than listing|11|||
30718772|NCT00528996|58732121|FG004|Overall Study|Other reasons than listing|5|||
30718773|NCT00528996|58732117|FG000|Overall Study|Refused continue medication|16|||
30718774|NCT00528996|58732118|FG001|Overall Study|Refused continue medication|0|||
30718775|NCT00528996|58732119|FG002|Overall Study|Refused continue medication|3|||
30718776|NCT00528996|58732120|FG003|Overall Study|Refused continue medication|3|||
30718777|NCT00528996|58732121|FG004|Overall Study|Refused continue medication|6|||
30718778|NCT00528996|58732117|FG000|Overall Study|Lost to Follow-up|2|||
30718779|NCT00528996|58732118|FG001|Overall Study|Lost to Follow-up|0|||
30718780|NCT00528996|58732119|FG002|Overall Study|Lost to Follow-up|4|||
30718781|NCT00528996|58732120|FG003|Overall Study|Lost to Follow-up|1|||
30718782|NCT00528996|58732121|FG004|Overall Study|Lost to Follow-up|3|||
30718783|NCT00528996|58732117|FG000|Overall Study|Protocol Violation|1|||
30718784|NCT00528996|58732118|FG001|Overall Study|Protocol Violation|2|||
30718785|NCT00528996|58732119|FG002|Overall Study|Protocol Violation|3|||
30718786|NCT00528996|58732120|FG003|Overall Study|Protocol Violation|3|||
30718787|NCT00528996|58732121|FG004|Overall Study|Protocol Violation|2|||
30718788|NCT00528996|58732117|FG000|Overall Study|Lack of Efficacy|7|||
30718789|NCT00528996|58732118|FG001|Overall Study|Lack of Efficacy|2|||
30718790|NCT00528996|58732119|FG002|Overall Study|Lack of Efficacy|1|||
30718791|NCT00528996|58732120|FG003|Overall Study|Lack of Efficacy|3|||
30718792|NCT00528996|58732121|FG004|Overall Study|Lack of Efficacy|3|||
30718793|NCT00528996|58732117|FG000|Overall Study|Adverse Event|32|||
30718794|NCT00528996|58732118|FG001|Overall Study|Adverse Event|13|||
30718795|NCT00528996|58732119|FG002|Overall Study|Adverse Event|18|||
30621580|NCT01174446|58633149|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
30621581|NCT01174446|58633150|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
30621582|NCT01174446|58633151|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
30718796|NCT00528996|58732120|FG003|Overall Study|Adverse Event|29|||
30718797|NCT00528996|58732121|FG004|Overall Study|Adverse Event|18|||
30718798|NCT00359788|58732138|FG000|Overall Study|Adverse Event|11|||
30718799|NCT00359788|58732139|FG001|Overall Study|Adverse Event|10|||
30718800|NCT00359788|58732138|FG000|Overall Study|Lack of Efficacy|1|||
30718801|NCT00359788|58732139|FG001|Overall Study|Lack of Efficacy|2|||
30718802|NCT00359788|58732138|FG000|Overall Study|Lost to Follow-up|3|||
30718803|NCT00359788|58732139|FG001|Overall Study|Lost to Follow-up|2|||
30790921|NCT03200366|58804015|FG000|6 Month Post-Baseline Interview|Death|1|||
30718804|NCT00359788|58732138|FG000|Overall Study|Withdrawal by Subject|4|||
30790922|NCT03200366|58804016|FG001|6 Month Post-Baseline Interview|Death|1|||
30900276|NCT01601821|58933512|FG000|Overall Study|Death|2|||
30718805|NCT00359788|58732139|FG001|Overall Study|Withdrawal by Subject|1|||
30718806|NCT00359788|58732138|FG000|Overall Study|Protocol Violation|4|||
30718807|NCT00359788|58732139|FG001|Overall Study|Protocol Violation|2|||
30718808|NCT03878160|58732148|FG000|Overall Study|Lost to Follow-up|1|||
30718809|NCT03878160|58732149|FG001|Overall Study|Lost to Follow-up|1|||
30718810|NCT03878160|58732150|FG002|Overall Study|Lost to Follow-up|1|||
30718811|NCT03878160|58732148|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
30718812|NCT03878160|58732149|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
30718813|NCT03878160|58732150|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
30718814|NCT00623597|58732160|FG000|Overall Study|Failed to return|1|||
30718815|NCT00623597|58732161|FG001|Overall Study|Failed to return|0|||
30718816|NCT00347776|58732172|FG000|1.5 Month Follow-up|Death|2|||
30718817|NCT00347776|58732173|FG001|1.5 Month Follow-up|Death|0|||
30718818|NCT00347776|58732174|FG002|1.5 Month Follow-up|Death|0|||
30718819|NCT00347776|58732172|FG000|1.5 Month Follow-up|reached the endpoint|12|||
30718820|NCT00347776|58732173|FG001|1.5 Month Follow-up|reached the endpoint|8|||
30718821|NCT00347776|58732174|FG002|1.5 Month Follow-up|reached the endpoint|12|||
30718822|NCT00347776|58732172|FG000|6 Month Follow-up|Death|2|||
30718823|NCT00347776|58732173|FG001|6 Month Follow-up|Death|1|||
30718824|NCT00347776|58732174|FG002|6 Month Follow-up|Death|3|||
30718825|NCT00347776|58732172|FG000|6 Month Follow-up|reached endpont|20|||
30718826|NCT00347776|58732173|FG001|6 Month Follow-up|reached endpont|12|||
30718827|NCT00347776|58732174|FG002|6 Month Follow-up|reached endpont|15|||
30718828|NCT00347776|58732172|FG000|12 Month Follow-up|Lost to Follow-up|7|||
30718829|NCT00347776|58732173|FG001|12 Month Follow-up|Lost to Follow-up|6|||
30718830|NCT00347776|58732174|FG002|12 Month Follow-up|Lost to Follow-up|6|||
30718831|NCT00347776|58732172|FG000|12 Month Follow-up|Death|3|||
30718832|NCT00347776|58732173|FG001|12 Month Follow-up|Death|4|||
30718833|NCT00347776|58732174|FG002|12 Month Follow-up|Death|4|||
30718834|NCT00347776|58732172|FG000|12 Month Follow-up|Reached endpoint|13|||
30718835|NCT00347776|58732173|FG001|12 Month Follow-up|Reached endpoint|6|||
30718836|NCT00347776|58732174|FG002|12 Month Follow-up|Reached endpoint|9|||
30718837|NCT03829228|58732182|FG000|Overall Study|Protocol Violation|1|||
30718838|NCT00529542|58732188|FG000|Overall Study|Withdrawal by Subject|1|||
30718839|NCT00529542|58732189|FG001|Overall Study|Withdrawal by Subject|0|||
30718840|NCT00529542|58732188|FG000|Overall Study|Lost to Follow-up|0|||
30718841|NCT00529542|58732189|FG001|Overall Study|Lost to Follow-up|1|||
30718842|NCT00621959|58732197|FG000|Overall Study|Adverse Event|4|||
30718843|NCT00621959|58732198|FG001|Overall Study|Adverse Event|2|||
30718844|NCT00621959|58732197|FG000|Overall Study|Lack of Efficacy|1|||
30718845|NCT00621959|58732198|FG001|Overall Study|Lack of Efficacy|1|||
30718846|NCT00621959|58732197|FG000|Overall Study|Lost to Follow-up|0|||
30718847|NCT00621959|58732198|FG001|Overall Study|Lost to Follow-up|2|||
30718848|NCT00621959|58732197|FG000|Overall Study|Withdrawal by Subject|1|||
30718849|NCT00621959|58732198|FG001|Overall Study|Withdrawal by Subject|1|||
30718850|NCT00621959|58732197|FG000|Overall Study|Other|1|||
30718851|NCT00621959|58732198|FG001|Overall Study|Other|3|||
30718852|NCT03877224|58732206|FG000|Overall Study|Death|3|||
30718853|NCT03877224|58732207|FG001|Overall Study|Death|2|||
30718854|NCT03877224|58732206|FG000|Overall Study|Withdrawal by Subject|1|||
30718855|NCT03877224|58732207|FG001|Overall Study|Withdrawal by Subject|6|||
30718856|NCT03877224|58732206|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
30718857|NCT03877224|58732207|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
30718858|NCT00528606|58732215|FG000|Overall Study|Withdrew consent|4|||
30718859|NCT00528606|58732216|FG001|Overall Study|Withdrew consent|3|||
30718860|NCT00528606|58732215|FG000|Overall Study|Lost to Follow-up|4|||
30718861|NCT00528606|58732216|FG001|Overall Study|Lost to Follow-up|1|||
30718862|NCT00528606|58732215|FG000|Overall Study|Adverse Event|3|||
30718863|NCT00528606|58732216|FG001|Overall Study|Adverse Event|0|||
30718864|NCT00528606|58732215|FG000|Overall Study|Other|2|||
30718865|NCT00528606|58732216|FG001|Overall Study|Other|0|||
30718866|NCT00621257|58732227|FG000|Overall Study|Lost to Follow-up|4|||
30718867|NCT00621257|58732228|FG001|Overall Study|Lost to Follow-up|0|||
30718868|NCT00621257|58732229|FG002|Overall Study|Lost to Follow-up|2|||
30718869|NCT00621257|58732230|FG003|Overall Study|Lost to Follow-up|4|||
30718870|NCT00621257|58732231|FG004|Overall Study|Lost to Follow-up|7|||
30718871|NCT00621257|58732227|FG000|Overall Study|Adverse Event|0|||
30718872|NCT00621257|58732228|FG001|Overall Study|Adverse Event|1|||
30718873|NCT00621257|58732229|FG002|Overall Study|Adverse Event|1|||
30718874|NCT00621257|58732230|FG003|Overall Study|Adverse Event|0|||
30718875|NCT00621257|58732231|FG004|Overall Study|Adverse Event|0|||
30718876|NCT00621257|58732227|FG000|Overall Study|Physician Decision|0|||
30718877|NCT00621257|58732228|FG001|Overall Study|Physician Decision|2|||
30718878|NCT00621257|58732229|FG002|Overall Study|Physician Decision|0|||
30718879|NCT00621257|58732230|FG003|Overall Study|Physician Decision|1|||
30718880|NCT00621257|58732231|FG004|Overall Study|Physician Decision|1|||
30718881|NCT00621257|58732227|FG000|Overall Study|Withdrawal by Subject|0|||
30718882|NCT00621257|58732228|FG001|Overall Study|Withdrawal by Subject|0|||
30718883|NCT00621257|58732229|FG002|Overall Study|Withdrawal by Subject|0|||
30718884|NCT00621257|58732230|FG003|Overall Study|Withdrawal by Subject|1|||
30718885|NCT00621257|58732231|FG004|Overall Study|Withdrawal by Subject|1|||
30718886|NCT00528840|58732243|FG000|Overall Study|Lost to Follow-up|10|||
30718887|NCT00528840|58732243|FG000|Overall Study|Adverse Event|1|||
30718888|NCT00528840|58732243|FG000|Overall Study|Withdrawal by Subject|17|||
30718889|NCT00528840|58732243|FG000|Overall Study|Death|2|||
30718890|NCT00528840|58732243|FG000|Overall Study|Administrative Reasons|1|||
30718891|NCT00528840|58732243|FG000|Overall Study|Other|2|||
30718892|NCT00528528|58732251|FG000|Overall Study|Lost to Follow-up|0|||
30718893|NCT00528528|58732252|FG001|Overall Study|Lost to Follow-up|0|||
30718894|NCT00528528|58732253|FG002|Overall Study|Lost to Follow-up|1|||
30718895|NCT00528528|58732254|FG003|Overall Study|Lost to Follow-up|1|||
30718896|NCT00528528|58732251|FG000|Overall Study|Ineligible to continue the trial|0|||
30718897|NCT00528528|58732252|FG001|Overall Study|Ineligible to continue the trial|0|||
30718898|NCT00528528|58732253|FG002|Overall Study|Ineligible to continue the trial|0|||
30760611|NCT03118570|58769119|FG001|Overall Study|Adverse Event|0|||
30718899|NCT00528528|58732254|FG003|Overall Study|Ineligible to continue the trial|1|||
30718900|NCT00528528|58732251|FG000|Overall Study|Other|0|||
30718901|NCT00528528|58732252|FG001|Overall Study|Other|1|||
30718902|NCT00528528|58732253|FG002|Overall Study|Other|0|||
30718903|NCT00528528|58732254|FG003|Overall Study|Other|0|||
30718904|NCT00528528|58732251|FG000|Overall Study|Withdrawal by Subject|3|||
30718905|NCT00528528|58732252|FG001|Overall Study|Withdrawal by Subject|2|||
30718906|NCT00528528|58732253|FG002|Overall Study|Withdrawal by Subject|1|||
30718907|NCT00528528|58732254|FG003|Overall Study|Withdrawal by Subject|1|||
30718908|NCT00528528|58732251|FG000|Overall Study|Ongoing participant|0|||
30718909|NCT00528528|58732252|FG001|Overall Study|Ongoing participant|0|||
30718910|NCT00528528|58732253|FG002|Overall Study|Ongoing participant|1|||
30718911|NCT00528528|58732254|FG003|Overall Study|Ongoing participant|0|||
30718912|NCT00620555|58732266|FG000|Overall Study|Adverse Event|4|||
30718913|NCT00620555|58732266|FG000|Overall Study|Protocol Violation|2|||
30718914|NCT00620555|58732266|FG000|Overall Study|Lack of Efficacy|12|||
30718915|NCT00620555|58732266|FG000|Overall Study|Withdrawal by Subject|1|||
30718916|NCT00620555|58732266|FG000|Overall Study|Choice of other treatment|1|||
30718917|NCT00620555|58732266|FG000|Overall Study|Visit failure against planned|1|||
30718918|NCT00529386|58732270|FG000|Overall Study|Lost to Follow-up|1|||
30718919|NCT03875118|58732276|FG000|Overall Study|Withdrawal by Subject|4|||
30718920|NCT03875118|58732277|FG001|Overall Study|Withdrawal by Subject|4|||
30718921|NCT00529308|58732285|FG000|Overall Study|Withdrawal by Subject|1|||
30718922|NCT00529308|58732286|FG001|Overall Study|Withdrawal by Subject|1|||
30718923|NCT03875508|58732292|FG000|Overall Study|Adverse Event|1|||
30718924|NCT03875508|58732292|FG000|Overall Study|Lost to Follow-up|8|||
30718925|NCT03875508|58732292|FG000|Overall Study|Lack of Efficacy|1|||
30718926|NCT03875508|58732292|FG000|Overall Study|Other, not specified|2|||
30718927|NCT00620321|58732298|FG000|Overall Study|Adverse Event|1|||
30718928|NCT00620321|58732299|FG001|Overall Study|Adverse Event|1|||
30718929|NCT00620321|58732298|FG000|Overall Study|Death|1|||
30718930|NCT00620321|58732299|FG001|Overall Study|Death|1|||
30718931|NCT00620321|58732298|FG000|Overall Study|Physician Decision|0|||
30718932|NCT00620321|58732299|FG001|Overall Study|Physician Decision|7|||
30718933|NCT00620321|58732298|FG000|Overall Study|Progressive Disease|5|||
30718934|NCT00620321|58732299|FG001|Overall Study|Progressive Disease|5|||
30718935|NCT00620321|58732298|FG000|Overall Study|Sponsor Decision|0|||
30718936|NCT00620321|58732299|FG001|Overall Study|Sponsor Decision|1|||
30718937|NCT00620321|58732298|FG000|Overall Study|Withdrawal by Subject|1|||
30718938|NCT00620321|58732299|FG001|Overall Study|Withdrawal by Subject|1|||
30718939|NCT00621023|58732305|FG000|Overall Study|Death|5|||
30718940|NCT00621023|58732305|FG000|Overall Study|Follow up discontinued|1|||
30718941|NCT00528372|58732318|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
30718942|NCT00528372|58732319|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
30718943|NCT00528372|58732320|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
30718944|NCT00528372|58732321|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
30718945|NCT00528372|58732322|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
30718946|NCT00528372|58732323|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
30718947|NCT00528372|58732324|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
30718948|NCT00528372|58732325|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
30718949|NCT00528372|58732326|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
30718950|NCT00528372|58732318|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
30718951|NCT00528372|58732319|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
30718952|NCT00528372|58732320|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
30718953|NCT00528372|58732321|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
30718954|NCT00528372|58732322|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
30718955|NCT00528372|58732323|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
30718956|NCT00528372|58732324|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
30718957|NCT00528372|58732325|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
30718958|NCT00528372|58732326|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
30718959|NCT00528372|58732318|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
30718960|NCT00528372|58732319|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
30718961|NCT00528372|58732320|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
30621583|NCT01174446|58633148|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
30718962|NCT00528372|58732321|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
30621584|NCT01174446|58633149|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
30718963|NCT00528372|58732322|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
30718964|NCT00528372|58732323|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
30718965|NCT00528372|58732324|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
30718966|NCT00528372|58732325|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
30718967|NCT00528372|58732326|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
30718968|NCT00528372|58732318|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
30718969|NCT00528372|58732319|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
30718970|NCT00528372|58732320|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
30718971|NCT00528372|58732321|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
30718972|NCT00528372|58732322|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
30718973|NCT00528372|58732323|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
30718974|NCT00528372|58732324|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
30718975|NCT00528372|58732325|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
30718976|NCT00528372|58732326|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
30718977|NCT00528372|58732318|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
30718978|NCT00528372|58732319|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
30718979|NCT00528372|58732320|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
30718980|NCT00528372|58732321|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
30718981|NCT00528372|58732322|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
30718982|NCT00528372|58732323|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
30718983|NCT00528372|58732324|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
30718984|NCT00528372|58732325|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
30718985|NCT00528372|58732326|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
30718986|NCT00528372|58732318|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
30718987|NCT00528372|58732319|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
30718988|NCT00528372|58732320|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
30718989|NCT00528372|58732321|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
30718990|NCT00528372|58732322|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
30718991|NCT00528372|58732323|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
30718992|NCT00528372|58732324|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
30718993|NCT00528372|58732325|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
30718994|NCT00528372|58732326|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
30718995|NCT00528372|58732318|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
30718996|NCT00528372|58732319|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
30718997|NCT00528372|58732320|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
30718998|NCT00528372|58732321|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
30718999|NCT00528372|58732322|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
30719000|NCT00528372|58732323|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
30719001|NCT00528372|58732324|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
30719002|NCT00528372|58732325|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
30719003|NCT00528372|58732326|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
30719004|NCT00528372|58732318|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
30719005|NCT00528372|58732319|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
30719006|NCT00528372|58732320|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
30719007|NCT00528372|58732321|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
30719008|NCT00528372|58732322|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
30719009|NCT00528372|58732323|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
30719010|NCT00528372|58732324|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
30719011|NCT00528372|58732325|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
30719012|NCT00528372|58732326|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
30719013|NCT00528372|58732318|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
30719014|NCT00528372|58732319|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
30719015|NCT00528372|58732320|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
30719016|NCT00528372|58732321|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
30719017|NCT00528372|58732322|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
30719018|NCT00528372|58732323|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
30719019|NCT00528372|58732324|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
30719020|NCT00528372|58732325|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
30719021|NCT00528372|58732326|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
30719022|NCT00528372|58732318|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
30719023|NCT00528372|58732319|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
30719024|NCT00528372|58732320|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
30719025|NCT00528372|58732321|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
30719026|NCT00528372|58732322|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
30719027|NCT00528372|58732323|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
30719028|NCT00528372|58732324|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
30719029|NCT00528372|58732325|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
30719030|NCT00528372|58732326|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
30719031|NCT00528372|58732318|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
30719032|NCT00528372|58732319|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
30719033|NCT00528372|58732320|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
30719034|NCT00528372|58732321|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
30719035|NCT00528372|58732322|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
30719036|NCT00528372|58732323|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
30719037|NCT00528372|58732324|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
30719038|NCT00528372|58732325|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
30719039|NCT00528372|58732326|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
30719040|NCT00528372|58732318|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
30719041|NCT00528372|58732319|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
30719042|NCT00528372|58732320|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
30719043|NCT00528372|58732321|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
30719044|NCT00528372|58732322|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
30719045|NCT00528372|58732323|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
30719046|NCT00528372|58732324|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
30719047|NCT00528372|58732325|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
30719048|NCT00528372|58732326|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
30719049|NCT00528372|58732318|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
30719050|NCT00528372|58732319|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
30719051|NCT00528372|58732320|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
30719052|NCT00528372|58732321|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
30719053|NCT00528372|58732322|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
30719054|NCT00528372|58732323|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
30719055|NCT00528372|58732324|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
30719056|NCT00528372|58732325|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
30719057|NCT00528372|58732326|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
30719058|NCT00528372|58732318|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
30719059|NCT00528372|58732319|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
30719060|NCT00528372|58732320|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
30719061|NCT00528372|58732321|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
30719062|NCT00528372|58732322|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
30719063|NCT00528372|58732323|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
30719064|NCT00528372|58732324|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
30719065|NCT00528372|58732325|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
30719066|NCT00528372|58732326|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
30719067|NCT00528372|58732318|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
30719068|NCT00528372|58732319|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
30719069|NCT00528372|58732320|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
30719070|NCT00528372|58732321|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
30719071|NCT00528372|58732322|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
30719072|NCT00528372|58732323|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
30719073|NCT00528372|58732324|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
30719074|NCT00528372|58732325|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
30719075|NCT00528372|58732326|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
30719076|NCT00527982|58732374|FG000|Overall Study|Physician Decision|1|||
30719077|NCT00527982|58732375|FG001|Overall Study|Physician Decision|0|||
30719078|NCT00527904|58732381|FG000|Overall Study|Adverse Event|45|||
30719079|NCT00527904|58732381|FG000|Overall Study|Withdrawal by Subject|21|||
30719080|NCT00527904|58732381|FG000|Overall Study|Lost to Follow-up|8|||
30719081|NCT00527904|58732381|FG000|Overall Study|misc|22|||
30719082|NCT00619619|58732393|FG000|Overall Study|Physician Decision|0|||
30719083|NCT00619619|58732394|FG001|Overall Study|Physician Decision|0|||
30719084|NCT00619619|58732395|FG002|Overall Study|Physician Decision|1|||
30621585|NCT01174446|58633150|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
30621586|NCT01174446|58633151|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
30621587|NCT00932698|58633209|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
30621588|NCT00932698|58633210|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
30621589|NCT00932698|58633211|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
30621590|NCT00932698|58633212|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
30621591|NCT00932698|58633213|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
30621592|NCT00932698|58633214|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
30621593|NCT00932698|58633215|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
30621594|NCT00932698|58633216|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
30621595|NCT00932698|58633217|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
30719085|NCT00619619|58732396|FG003|Overall Study|Physician Decision|0|||
30719086|NCT00619619|58732397|FG004|Overall Study|Physician Decision|0|||
30719087|NCT00619619|58732398|FG005|Overall Study|Physician Decision|0|||
30719088|NCT00619619|58732399|FG006|Overall Study|Physician Decision|0|||
30719089|NCT00619619|58732400|FG007|Overall Study|Physician Decision|0|||
30719090|NCT00619619|58732393|FG000|Overall Study|Protocol Violation|0|||
30719091|NCT00619619|58732394|FG001|Overall Study|Protocol Violation|0|||
30719092|NCT00619619|58732395|FG002|Overall Study|Protocol Violation|0|||
30719093|NCT00619619|58732396|FG003|Overall Study|Protocol Violation|1|||
30719094|NCT00619619|58732397|FG004|Overall Study|Protocol Violation|0|||
30719095|NCT00619619|58732398|FG005|Overall Study|Protocol Violation|0|||
30719096|NCT00619619|58732399|FG006|Overall Study|Protocol Violation|1|||
30719097|NCT00619619|58732400|FG007|Overall Study|Protocol Violation|1|||
30719098|NCT00619619|58732393|FG000|Overall Study|Adverse Event|0|||
30621596|NCT00932698|58633218|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
30719099|NCT00619619|58732394|FG001|Overall Study|Adverse Event|0|||
30719100|NCT00619619|58732395|FG002|Overall Study|Adverse Event|0|||
30719101|NCT00619619|58732396|FG003|Overall Study|Adverse Event|0|||
30719102|NCT00619619|58732397|FG004|Overall Study|Adverse Event|2|||
30719103|NCT00619619|58732398|FG005|Overall Study|Adverse Event|0|||
30719104|NCT00619619|58732399|FG006|Overall Study|Adverse Event|0|||
30719105|NCT00619619|58732400|FG007|Overall Study|Adverse Event|2|||
30719106|NCT00527826|58732423|FG000|Overall Study|Adverse Event|10|||
30719107|NCT00527826|58732424|FG001|Overall Study|Adverse Event|10|||
30719108|NCT00527826|58732423|FG000|Overall Study|Lost to Follow-up|3|||
30719109|NCT00527826|58732424|FG001|Overall Study|Lost to Follow-up|2|||
30719110|NCT00527826|58732423|FG000|Overall Study|Withdrawal by Subject|5|||
30719111|NCT00527826|58732424|FG001|Overall Study|Withdrawal by Subject|8|||
30719112|NCT00527826|58732423|FG000|Overall Study|Inclusion Criteria Not Met|3|||
30719113|NCT00527826|58732424|FG001|Overall Study|Inclusion Criteria Not Met|3|||
30719114|NCT00527826|58732423|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
30719115|NCT00527826|58732424|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
30719116|NCT00527826|58732423|FG000|Overall Study|Additional Intake of Viani forte|0|||
30719117|NCT00527826|58732424|FG001|Overall Study|Additional Intake of Viani forte|1|||
30719118|NCT00527826|58732423|FG000|Overall Study|Participant moved away|0|||
30719119|NCT00527826|58732424|FG001|Overall Study|Participant moved away|1|||
30719120|NCT00527748|58732442|FG000|Overall Study|Other|3|||
30719121|NCT00619385|58732449|FG000|Overall Study|Adverse Event|0|||
30719122|NCT00619385|58732450|FG001|Overall Study|Adverse Event|0|||
30719123|NCT00619385|58732451|FG002|Overall Study|Adverse Event|3|||
30719124|NCT00619385|58732449|FG000|Overall Study|Other|1|||
30719125|NCT00619385|58732450|FG001|Overall Study|Other|2|||
30719126|NCT00619385|58732451|FG002|Overall Study|Other|1|||
30719127|NCT00619307|58732464|FG000|Overall Study|Adverse Event|0|||
30719128|NCT00619307|58732465|FG001|Overall Study|Adverse Event|1|||
30719129|NCT00619307|58732464|FG000|Overall Study|Lost to Follow-up|0|||
30719130|NCT00619307|58732465|FG001|Overall Study|Lost to Follow-up|1|||
30719131|NCT00619307|58732464|FG000|Overall Study|Protocol Violation|3|||
30719132|NCT00619307|58732465|FG001|Overall Study|Protocol Violation|0|||
30719133|NCT00619307|58732464|FG000|Overall Study|Withdrew consent|1|||
30719134|NCT00619307|58732465|FG001|Overall Study|Withdrew consent|0|||
30719135|NCT00619307|58732464|FG000|Overall Study|Severe migraine|0|||
30719136|NCT00619307|58732465|FG001|Overall Study|Severe migraine|1|||
30719137|NCT00619307|58732464|FG000|Overall Study|MS attack plus steroids|0|||
30719138|NCT00619307|58732465|FG001|Overall Study|MS attack plus steroids|1|||
30719139|NCT00619229|58732473|FG000|Overall Study|Withdrawal by Subject|1|||
30719140|NCT00619229|58732474|FG001|Overall Study|Withdrawal by Subject|1|||
30719141|NCT00619229|58732473|FG000|Overall Study|Lost to Follow-up|1|||
30719142|NCT00619229|58732474|FG001|Overall Study|Lost to Follow-up|0|||
30719143|NCT00619229|58732473|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
30719144|NCT00619229|58732474|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
30719145|NCT00619229|58732473|FG000|Overall Study|Investigator planned Cataract Operation|1|||
30719146|NCT00619229|58732474|FG001|Overall Study|Investigator planned Cataract Operation|0|||
30719147|NCT00619151|58732482|FG000|Overall Study|Study terminated prior to followup|1|||
30719148|NCT00619151|58732483|FG001|Overall Study|Study terminated prior to followup|0|||
30719149|NCT00618995|58732489|FG000|Period 1|Adverse Event|0|||
30719150|NCT00618995|58732490|FG001|Period 1|Adverse Event|0|||
30719151|NCT00618995|58732491|FG002|Period 1|Adverse Event|1|||
30719152|NCT00618995|58732492|FG003|Period 1|Adverse Event|0|||
30719153|NCT00618995|58732489|FG000|Period 1|Protocol Violation|0|||
30719154|NCT00618995|58732490|FG001|Period 1|Protocol Violation|1|||
30719155|NCT00618995|58732491|FG002|Period 1|Protocol Violation|1|||
30719156|NCT00618995|58732492|FG003|Period 1|Protocol Violation|0|||
30719157|NCT00618995|58732489|FG000|Period 2|Protocol Violation|0|||
30719158|NCT00618995|58732490|FG001|Period 2|Protocol Violation|0|||
30719159|NCT00618995|58732491|FG002|Period 2|Protocol Violation|1|||
30719160|NCT00618995|58732492|FG003|Period 2|Protocol Violation|0|||
30719161|NCT00618995|58732489|FG000|Period 4|Adverse Event|1|||
30719162|NCT00618995|58732490|FG001|Period 4|Adverse Event|0|||
30719163|NCT00618995|58732491|FG002|Period 4|Adverse Event|0|||
30719164|NCT00618995|58732492|FG003|Period 4|Adverse Event|0|||
30719165|NCT03685344|58732506|FG000|Overall Study|Withdrawal by Subject|1|||
30719166|NCT03685344|58732507|FG001|Overall Study|Withdrawal by Subject|1|||
30719167|NCT03685344|58732508|FG002|Overall Study|Withdrawal by Subject|2|||
30719168|NCT03685344|58732509|FG003|Overall Study|Withdrawal by Subject|0|||
30719169|NCT03685344|58732506|FG000|Overall Study|Physician Decision|1|||
30719170|NCT03685344|58732507|FG001|Overall Study|Physician Decision|1|||
30719171|NCT03685344|58732508|FG002|Overall Study|Physician Decision|5|||
30719172|NCT03685344|58732509|FG003|Overall Study|Physician Decision|0|||
30719173|NCT03685344|58732506|FG000|Overall Study|Death|1|||
30719174|NCT03685344|58732507|FG001|Overall Study|Death|1|||
30719175|NCT03685344|58732508|FG002|Overall Study|Death|0|||
30719176|NCT03685344|58732509|FG003|Overall Study|Death|0|||
30719177|NCT00520572|58732525|FG000|Overall Study|Adverse Event|9|||
30719178|NCT00520572|58732526|FG001|Overall Study|Adverse Event|3|||
30719179|NCT00520572|58732527|FG002|Overall Study|Adverse Event|6|||
30719180|NCT00520572|58732528|FG003|Overall Study|Adverse Event|9|||
30719181|NCT00520572|58732529|FG004|Overall Study|Adverse Event|7|||
30719182|NCT00520572|58732530|FG005|Overall Study|Adverse Event|2|||
30719183|NCT00520572|58732525|FG000|Overall Study|Withdrawal by Subject|0|||
30719184|NCT00520572|58732526|FG001|Overall Study|Withdrawal by Subject|9|||
30719185|NCT00520572|58732527|FG002|Overall Study|Withdrawal by Subject|5|||
30719186|NCT00520572|58732528|FG003|Overall Study|Withdrawal by Subject|2|||
30719187|NCT00520572|58732529|FG004|Overall Study|Withdrawal by Subject|2|||
30719188|NCT00520572|58732530|FG005|Overall Study|Withdrawal by Subject|0|||
30719189|NCT00520572|58732525|FG000|Overall Study|Protocol Violation|0|||
30719190|NCT00520572|58732526|FG001|Overall Study|Protocol Violation|0|||
30719191|NCT00520572|58732527|FG002|Overall Study|Protocol Violation|1|||
30719192|NCT00520572|58732528|FG003|Overall Study|Protocol Violation|0|||
30719193|NCT00520572|58732529|FG004|Overall Study|Protocol Violation|0|||
30719194|NCT00520572|58732530|FG005|Overall Study|Protocol Violation|0|||
30719195|NCT00520572|58732525|FG000|Overall Study|Lack of Efficacy|1|||
30719196|NCT00520572|58732526|FG001|Overall Study|Lack of Efficacy|1|||
30719197|NCT00520572|58732527|FG002|Overall Study|Lack of Efficacy|1|||
30719198|NCT00520572|58732528|FG003|Overall Study|Lack of Efficacy|2|||
30719199|NCT00520572|58732529|FG004|Overall Study|Lack of Efficacy|1|||
30719200|NCT00520572|58732530|FG005|Overall Study|Lack of Efficacy|0|||
30719201|NCT00520572|58732525|FG000|Overall Study|Lost to Follow-up|0|||
30719202|NCT00520572|58732526|FG001|Overall Study|Lost to Follow-up|0|||
30719203|NCT00520572|58732527|FG002|Overall Study|Lost to Follow-up|0|||
30719204|NCT00520572|58732528|FG003|Overall Study|Lost to Follow-up|0|||
30719205|NCT00520572|58732529|FG004|Overall Study|Lost to Follow-up|1|||
30719206|NCT00520572|58732530|FG005|Overall Study|Lost to Follow-up|0|||
30719207|NCT00520572|58732525|FG000|Overall Study|Incorrect enrollment|1|||
30719208|NCT00520572|58732526|FG001|Overall Study|Incorrect enrollment|0|||
30719209|NCT00520572|58732527|FG002|Overall Study|Incorrect enrollment|1|||
30719210|NCT00520572|58732528|FG003|Overall Study|Incorrect enrollment|0|||
30719211|NCT00520572|58732529|FG004|Overall Study|Incorrect enrollment|1|||
30719212|NCT00520572|58732530|FG005|Overall Study|Incorrect enrollment|0|||
30719213|NCT00520572|58732525|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
30719214|NCT00520572|58732526|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
30719215|NCT00520572|58732527|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
30719216|NCT00520572|58732528|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
30719217|NCT00520572|58732529|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
30719218|NCT00520572|58732530|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
30719219|NCT00520572|58732525|FG000|Overall Study|Long break in taking Medication|0|||
30719220|NCT00520572|58732526|FG001|Overall Study|Long break in taking Medication|0|||
30719221|NCT00520572|58732527|FG002|Overall Study|Long break in taking Medication|0|||
30719222|NCT00520572|58732528|FG003|Overall Study|Long break in taking Medication|1|||
30719223|NCT00520572|58732529|FG004|Overall Study|Long break in taking Medication|0|||
30719224|NCT00520572|58732530|FG005|Overall Study|Long break in taking Medication|0|||
30719225|NCT00520572|58732525|FG000|Overall Study|Did not receive Treatment|1|||
30719226|NCT00520572|58732526|FG001|Overall Study|Did not receive Treatment|0|||
30719227|NCT00520572|58732527|FG002|Overall Study|Did not receive Treatment|1|||
30719228|NCT00520572|58732528|FG003|Overall Study|Did not receive Treatment|0|||
30719229|NCT00520572|58732529|FG004|Overall Study|Did not receive Treatment|0|||
30719230|NCT00520572|58732530|FG005|Overall Study|Did not receive Treatment|0|||
30719231|NCT00573833|58732544|FG000|Overall Study|Not Treated|2|||
30719232|NCT00520494|58732548|FG000|Overall Study|Withdrawal by Subject|1|||
30719233|NCT00527514|58732552|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
30719234|NCT00527514|58732552|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
30719235|NCT00527514|58732552|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
30719236|NCT00527514|58732552|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
30719237|NCT00527514|58732552|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
30719238|NCT00527514|58732552|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
30719239|NCT00527514|58732552|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
30719240|NCT00618449|58732565|FG000|Overall Study|Lost to Follow-up|98|||
30719241|NCT00618449|58732566|FG001|Overall Study|Lost to Follow-up|110|||
30719242|NCT03684642|58732575|FG000|Overall Study|Adverse Event|6|||
30719243|NCT03684642|58732576|FG001|Overall Study|Adverse Event|15|||
30719244|NCT03684642|58732577|FG002|Overall Study|Adverse Event|11|||
30719245|NCT03684642|58732575|FG000|Overall Study|Withdrawal by Subject|35|||
30719246|NCT03684642|58732576|FG001|Overall Study|Withdrawal by Subject|53|||
30719247|NCT03684642|58732577|FG002|Overall Study|Withdrawal by Subject|23|||
30719248|NCT03684642|58732575|FG000|Overall Study|Lack of Efficacy|0|||
30719249|NCT03684642|58732576|FG001|Overall Study|Lack of Efficacy|0|||
30719250|NCT03684642|58732577|FG002|Overall Study|Lack of Efficacy|1|||
30719251|NCT03684642|58732575|FG000|Overall Study|Poor compliance to protocol|0|||
30719252|NCT03684642|58732576|FG001|Overall Study|Poor compliance to protocol|4|||
30719253|NCT03684642|58732577|FG002|Overall Study|Poor compliance to protocol|1|||
30621597|NCT00932698|58633219|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
30719254|NCT03684642|58732575|FG000|Overall Study|Other than specified|62|||
30719255|NCT03684642|58732576|FG001|Overall Study|Other than specified|60|||
30719256|NCT03684642|58732577|FG002|Overall Study|Other than specified|67|||
30719257|NCT03684642|58732575|FG000|Overall Study|Randomized and not treated|0|||
30719258|NCT03684642|58732576|FG001|Overall Study|Randomized and not treated|0|||
30719259|NCT03684642|58732577|FG002|Overall Study|Randomized and not treated|1|||
30719260|NCT03684642|58732575|FG000|Overall Study|Missing completion status but alive at last contact|0|||
30719261|NCT03684642|58732576|FG001|Overall Study|Missing completion status but alive at last contact|1|||
30719262|NCT03684642|58732577|FG002|Overall Study|Missing completion status but alive at last contact|2|||
30719263|NCT00519636|58732589|FG000|Treatment Period 1|Adverse Event|1|||
30719264|NCT00519636|58732590|FG001|Treatment Period 1|Adverse Event|0|||
30719265|NCT00519636|58732591|FG002|Treatment Period 1|Adverse Event|1|||
30719266|NCT00519636|58732592|FG003|Treatment Period 1|Adverse Event|0|||
30719267|NCT00519636|58732589|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
30719268|NCT00519636|58732590|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
30719269|NCT00519636|58732591|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
30719270|NCT00519636|58732592|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
30719271|NCT00519636|58732589|FG000|Washout Period|Adverse Event|2|||
30719272|NCT00519636|58732590|FG001|Washout Period|Adverse Event|1|||
30719273|NCT00519636|58732591|FG002|Washout Period|Adverse Event|1|||
30719274|NCT00519636|58732592|FG003|Washout Period|Adverse Event|0|||
30719275|NCT00519636|58732589|FG000|Washout Period|Lost to Follow-up|1|||
30719276|NCT00519636|58732590|FG001|Washout Period|Lost to Follow-up|0|||
30719277|NCT00519636|58732591|FG002|Washout Period|Lost to Follow-up|0|||
30719278|NCT00519636|58732592|FG003|Washout Period|Lost to Follow-up|0|||
30719279|NCT00519636|58732589|FG000|Washout Period|Protocol Violation|0|||
30719280|NCT00519636|58732590|FG001|Washout Period|Protocol Violation|0|||
30719281|NCT00519636|58732591|FG002|Washout Period|Protocol Violation|1|||
30719282|NCT00519636|58732592|FG003|Washout Period|Protocol Violation|2|||
30719283|NCT00519636|58732589|FG000|Washout Period|Withdrawal by Subject|1|||
30719284|NCT00519636|58732590|FG001|Washout Period|Withdrawal by Subject|0|||
30719285|NCT00519636|58732591|FG002|Washout Period|Withdrawal by Subject|1|||
30719286|NCT00519636|58732592|FG003|Washout Period|Withdrawal by Subject|0|||
30719287|NCT00519636|58732589|FG000|Washout Period|Failed to meet continuation criteria|14|||
30719288|NCT00519636|58732590|FG001|Washout Period|Failed to meet continuation criteria|11|||
30719289|NCT00519636|58732591|FG002|Washout Period|Failed to meet continuation criteria|9|||
30719290|NCT00519636|58732592|FG003|Washout Period|Failed to meet continuation criteria|3|||
30719291|NCT00519636|58732589|FG000|Washout Period|Out of pollen area > 48 hours|1|||
30719292|NCT00519636|58732590|FG001|Washout Period|Out of pollen area > 48 hours|0|||
30719293|NCT00519636|58732591|FG002|Washout Period|Out of pollen area > 48 hours|0|||
30719294|NCT00519636|58732592|FG003|Washout Period|Out of pollen area > 48 hours|0|||
30719295|NCT00519636|58732589|FG000|Washout Period|Participating in study at another site|1|||
30719296|NCT00519636|58732590|FG001|Washout Period|Participating in study at another site|0|||
30719297|NCT00519636|58732591|FG002|Washout Period|Participating in study at another site|0|||
30719298|NCT00519636|58732592|FG003|Washout Period|Participating in study at another site|0|||
30719299|NCT00519636|58732589|FG000|Washout Period|Non-compliant|0|||
30719300|NCT00519636|58732590|FG001|Washout Period|Non-compliant|1|||
30719301|NCT00519636|58732591|FG002|Washout Period|Non-compliant|0|||
30719302|NCT00519636|58732592|FG003|Washout Period|Non-compliant|0|||
30719303|NCT00519636|58732589|FG000|Washout Period|Per doctors request|0|||
30719304|NCT00519636|58732590|FG001|Washout Period|Per doctors request|1|||
30719305|NCT00519636|58732591|FG002|Washout Period|Per doctors request|0|||
30719306|NCT00519636|58732592|FG003|Washout Period|Per doctors request|0|||
30719307|NCT00519636|58732589|FG000|Washout Period|Subject randomized in error|0|||
30719308|NCT00519636|58732590|FG001|Washout Period|Subject randomized in error|0|||
30719309|NCT00519636|58732591|FG002|Washout Period|Subject randomized in error|1|||
30719310|NCT00519636|58732592|FG003|Washout Period|Subject randomized in error|0|||
30719311|NCT00519636|58732589|FG000|Washout Period|Prohibited medications|0|||
30719312|NCT00519636|58732590|FG001|Washout Period|Prohibited medications|0|||
30719313|NCT00519636|58732591|FG002|Washout Period|Prohibited medications|1|||
30900277|NCT01601821|58933513|FG001|Overall Study|Death|5|||
30900278|NCT01601821|58933512|FG000|Overall Study|Protocol Violation|2|||
30900279|NCT01601821|58933513|FG001|Overall Study|Protocol Violation|2|||
30900280|NCT01601821|58933512|FG000|Overall Study|Lost to Follow-up|6|||
30900281|NCT01601821|58933513|FG001|Overall Study|Lost to Follow-up|14|||
30900282|NCT01601821|58933512|FG000|Overall Study|Withdrawal by Subject|1|||
30900283|NCT01601821|58933513|FG001|Overall Study|Withdrawal by Subject|0|||
30900284|NCT01601821|58933512|FG000|Overall Study|Graft Loss|6|||
30900285|NCT01601821|58933513|FG001|Overall Study|Graft Loss|6|||
30900286|NCT01601821|58933512|FG000|Overall Study|Study Events|7|||
30900287|NCT01601821|58933513|FG001|Overall Study|Study Events|1|||
30900288|NCT01601821|58933512|FG000|Overall Study|Other|5|||
30900289|NCT01601821|58933513|FG001|Overall Study|Other|1|||
30900290|NCT02323646|58933522|FG000|Treatment Course 1|Adverse Event|1|||
30900291|NCT02323646|58933523|FG001|Treatment Course 1|Adverse Event|0|||
30900292|NCT02323646|58933524|FG002|Treatment Course 1|Adverse Event|1|||
30900293|NCT02323646|58933522|FG000|Treatment Course 1|Heavy Bleeding|1|||
30900294|NCT02323646|58933523|FG001|Treatment Course 1|Heavy Bleeding|1|||
30900295|NCT02323646|58933524|FG002|Treatment Course 1|Heavy Bleeding|0|||
30900296|NCT02323646|58933522|FG000|Treatment Course 1|Lost to Follow-up|1|||
30900297|NCT02323646|58933523|FG001|Treatment Course 1|Lost to Follow-up|0|||
30900298|NCT02323646|58933524|FG002|Treatment Course 1|Lost to Follow-up|2|||
30719314|NCT00519636|58732592|FG003|Washout Period|Prohibited medications|0|||
30719315|NCT00519636|58732589|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
30719316|NCT00519636|58732590|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
30719317|NCT00519636|58732591|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
30719318|NCT00519636|58732592|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
30719319|NCT00519636|58732589|FG000|Treatment Period 2|Subject randomized in error|0|||
30719320|NCT00519636|58732590|FG001|Treatment Period 2|Subject randomized in error|1|||
30719321|NCT00519636|58732591|FG002|Treatment Period 2|Subject randomized in error|0|||
30719322|NCT00519636|58732592|FG003|Treatment Period 2|Subject randomized in error|0|||
30900299|NCT02323646|58933522|FG000|Treatment Course 1|Withdrawal by Subject|0|||
30900300|NCT02323646|58933523|FG001|Treatment Course 1|Withdrawal by Subject|2|||
30900301|NCT02323646|58933524|FG002|Treatment Course 1|Withdrawal by Subject|0|||
30719323|NCT00519636|58732589|FG000|Treatment Period 2|Per doctors request|0|||
30719324|NCT00519636|58732590|FG001|Treatment Period 2|Per doctors request|0|||
30719325|NCT00519636|58732591|FG002|Treatment Period 2|Per doctors request|1|||
30719326|NCT00519636|58732592|FG003|Treatment Period 2|Per doctors request|0|||
30719327|NCT00519636|58732589|FG000|Treatment Period 2|Subject misrandomized|0|||
30719328|NCT00519636|58732590|FG001|Treatment Period 2|Subject misrandomized|0|||
30719329|NCT00519636|58732591|FG002|Treatment Period 2|Subject misrandomized|0|||
30719330|NCT00519636|58732592|FG003|Treatment Period 2|Subject misrandomized|1|||
30719331|NCT00519636|58732589|FG000|Post Study Period|Subject randomized in error|0|||
30719332|NCT00519636|58732590|FG001|Post Study Period|Subject randomized in error|0|||
30719333|NCT00519636|58732591|FG002|Post Study Period|Subject randomized in error|0|||
30719334|NCT00519636|58732592|FG003|Post Study Period|Subject randomized in error|1|||
30719335|NCT00618371|58732606|FG000|Overall Study|Withdrawal by Subject|2|||
30719336|NCT00526890|58732611|FG000|Overall Study|Adverse Event|2|||
30719337|NCT03864900|58732617|FG000|Overall Study|Withdrawal by Subject|1|||
30719338|NCT03864900|58732618|FG001|Overall Study|Withdrawal by Subject|1|||
30719339|NCT03864900|58732617|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
30719340|NCT03864900|58732618|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
30719341|NCT00526656|58732624|FG000|Overall Study|Death|1|||
30719342|NCT00526656|58732624|FG000|Overall Study|Refused surgery|1|||
30719343|NCT00617903|58732631|FG000|Overall Study|Withdrawal by Subject|2|||
30719344|NCT00617903|58732632|FG001|Overall Study|Withdrawal by Subject|3|||
30719345|NCT00617903|58732631|FG000|Overall Study|Lost to Follow-up|1|||
30719346|NCT00617903|58732632|FG001|Overall Study|Lost to Follow-up|1|||
30719347|NCT00617903|58732631|FG000|Overall Study|Lack of Efficacy|0|||
30719348|NCT00617903|58732632|FG001|Overall Study|Lack of Efficacy|1|||
30719349|NCT00617903|58732631|FG000|Overall Study|Adverse Event|0|||
30719350|NCT00617903|58732632|FG001|Overall Study|Adverse Event|1|||
30719351|NCT00617903|58732631|FG000|Overall Study|noncompliance|0|||
30719352|NCT00617903|58732632|FG001|Overall Study|noncompliance|1|||
30719353|NCT00526110|58732640|FG000|Overall Study|Adverse Event|2|||
30719354|NCT00526110|58732641|FG001|Overall Study|Adverse Event|9|||
30719355|NCT00526110|58732640|FG000|Overall Study|Disease Progression|0|||
30719356|NCT00526110|58732641|FG001|Overall Study|Disease Progression|19|||
30719357|NCT00526110|58732640|FG000|Overall Study|Maximal Response|0|||
30719358|NCT00526110|58732641|FG001|Overall Study|Maximal Response|6|||
30719359|NCT00526110|58732640|FG000|Overall Study|Withdrawal by Subject|0|||
30719360|NCT00526110|58732641|FG001|Overall Study|Withdrawal by Subject|2|||
30719361|NCT00526110|58732640|FG000|Overall Study|Poor Tolerance|0|||
30719362|NCT00526110|58732641|FG001|Overall Study|Poor Tolerance|5|||
30719363|NCT00512148|58732647|FG000|Primay Study Period|Withdrawal by Subject|1|||
30719364|NCT00511836|58732655|FG000|Double-blind Period|Lost to Follow-up|1|||
30719365|NCT00511836|58732656|FG001|Double-blind Period|Lost to Follow-up|0|||
30719366|NCT00573755|58732665|FG000|Overall Study|Still receiving treatment|1|||
30719367|NCT00573755|58732666|FG001|Overall Study|Still receiving treatment|0|||
30719368|NCT00524316|58732672|FG000|Overall Study|Withdrawal by Subject|2|||
30719369|NCT00524316|58732672|FG000|Overall Study|Adverse Event|7|||
30719370|NCT00524316|58732672|FG000|Overall Study|Disease Progression|7|||
30719371|NCT03861936|58732689|FG000|Overall Study|Withdrawal by Subject|4|||
30719372|NCT03861936|58732690|FG001|Overall Study|Withdrawal by Subject|1|||
30719373|NCT03861936|58732691|FG002|Overall Study|Withdrawal by Subject|3|||
30719374|NCT03861936|58732689|FG000|Overall Study|Lost to Follow-up|5|||
30719375|NCT03861936|58732690|FG001|Overall Study|Lost to Follow-up|3|||
30719376|NCT03861936|58732691|FG002|Overall Study|Lost to Follow-up|3|||
30719377|NCT03861936|58732689|FG000|Overall Study|Physician Decision|0|||
30719378|NCT03861936|58732690|FG001|Overall Study|Physician Decision|1|||
30719379|NCT03861936|58732691|FG002|Overall Study|Physician Decision|0|||
30719380|NCT03861936|58732689|FG000|Overall Study|Protocol Deviation|0|||
30719381|NCT03861936|58732690|FG001|Overall Study|Protocol Deviation|0|||
30719382|NCT03861936|58732691|FG002|Overall Study|Protocol Deviation|1|||
30719383|NCT03861936|58732689|FG000|Overall Study|Reason not Specified|5|||
30719384|NCT03861936|58732690|FG001|Overall Study|Reason not Specified|5|||
30719385|NCT03861936|58732691|FG002|Overall Study|Reason not Specified|3|||
30719386|NCT00434577|58732704|FG000|Months 0-3|Serious Adverse Event|0|||
30719387|NCT00434577|58732705|FG001|Months 0-3|Serious Adverse Event|0|||
30719388|NCT00434577|58732706|FG002|Months 0-3|Serious Adverse Event|1|||
30719389|NCT00434577|58732707|FG003|Months 0-3|Serious Adverse Event|0|||
30900302|NCT02323646|58933522|FG000|Treatment Course 2|Adverse Event|1|||
30719390|NCT00434577|58732708|FG004|Months 0-3|Serious Adverse Event|0|||
30719391|NCT00434577|58732704|FG000|Months 0-3|Adverse Event|0|||
30719392|NCT00434577|58732705|FG001|Months 0-3|Adverse Event|1|||
30719393|NCT00434577|58732706|FG002|Months 0-3|Adverse Event|1|||
30719394|NCT00434577|58732707|FG003|Months 0-3|Adverse Event|0|||
30719395|NCT00434577|58732708|FG004|Months 0-3|Adverse Event|0|||
30719396|NCT00434577|58732704|FG000|Months 0-3|Lost to Follow-up|0|||
30719397|NCT00434577|58732705|FG001|Months 0-3|Lost to Follow-up|0|||
30719398|NCT00434577|58732706|FG002|Months 0-3|Lost to Follow-up|0|||
30719399|NCT00434577|58732707|FG003|Months 0-3|Lost to Follow-up|0|||
30719400|NCT00434577|58732708|FG004|Months 0-3|Lost to Follow-up|2|||
30719401|NCT00434577|58732704|FG000|Months 0-3|Protocol Violation|1|||
30719402|NCT00434577|58732705|FG001|Months 0-3|Protocol Violation|0|||
30719403|NCT00434577|58732706|FG002|Months 0-3|Protocol Violation|1|||
30719404|NCT00434577|58732707|FG003|Months 0-3|Protocol Violation|0|||
30719405|NCT00434577|58732708|FG004|Months 0-3|Protocol Violation|0|||
30719406|NCT00434577|58732704|FG000|Months 0-3|Withdrawal by Subject|2|||
30719407|NCT00434577|58732705|FG001|Months 0-3|Withdrawal by Subject|1|||
30719408|NCT00434577|58732706|FG002|Months 0-3|Withdrawal by Subject|1|||
30719409|NCT00434577|58732707|FG003|Months 0-3|Withdrawal by Subject|1|||
30719410|NCT00434577|58732708|FG004|Months 0-3|Withdrawal by Subject|1|||
30719411|NCT00434421|58732720|FG000|Overall Study|Withdrawal by Subject|1|||
30719412|NCT00434421|58732720|FG000|Overall Study|Non-compliance with study treatment|1|||
30719413|NCT00421707|58732726|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
30719414|NCT00421707|58732727|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
30719415|NCT00421707|58732726|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
30719416|NCT00421707|58732727|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
30719417|NCT00421707|58732726|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
30719418|NCT00421707|58732727|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
30719419|NCT00421707|58732726|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
30719420|NCT00421707|58732727|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
30719421|NCT00421707|58732726|FG000|Period 2: Washout|Adverse Event|1|||
30719422|NCT00421707|58732727|FG001|Period 2: Washout|Adverse Event|1|||
30719423|NCT00421707|58732726|FG000|Period 2: Washout|Withdrawal by Subject|0|||
30719424|NCT00421707|58732727|FG001|Period 2: Washout|Withdrawal by Subject|1|||
30719425|NCT00421707|58732726|FG000|Period 2: Washout|Lost to Follow-up|0|||
30719426|NCT00421707|58732727|FG001|Period 2: Washout|Lost to Follow-up|1|||
30719427|NCT00421707|58732726|FG000|Period 2: Washout|Other: Pregnancy|0|||
30719428|NCT00421707|58732727|FG001|Period 2: Washout|Other: Pregnancy|1|||
30719429|NCT00421707|58732726|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
30719430|NCT00421707|58732727|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
30719431|NCT00421707|58732726|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
30719432|NCT00421707|58732727|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
30719433|NCT00421707|58732726|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
30719434|NCT00421707|58732727|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
30719435|NCT00518622|58732753|FG000|Overall Study|Lost to Follow-up|0|||
30719436|NCT00518622|58732754|FG001|Overall Study|Lost to Follow-up|0|||
30719437|NCT00518622|58732755|FG002|Overall Study|Lost to Follow-up|1|||
30719438|NCT00518622|58732756|FG003|Overall Study|Lost to Follow-up|0|||
30719439|NCT00518622|58732757|FG004|Overall Study|Lost to Follow-up|0|||
30719440|NCT00518622|58732758|FG005|Overall Study|Lost to Follow-up|0|||
30719441|NCT00518622|58732759|FG006|Overall Study|Lost to Follow-up|0|||
30719442|NCT00518622|58732760|FG007|Overall Study|Lost to Follow-up|0|||
30719443|NCT00518622|58732753|FG000|Overall Study|Study medication taken incorrectly|0|||
30719444|NCT00518622|58732754|FG001|Overall Study|Study medication taken incorrectly|1|||
30719445|NCT00518622|58732755|FG002|Overall Study|Study medication taken incorrectly|0|||
30719446|NCT00518622|58732756|FG003|Overall Study|Study medication taken incorrectly|0|||
30719447|NCT00518622|58732757|FG004|Overall Study|Study medication taken incorrectly|0|||
30719448|NCT00518622|58732758|FG005|Overall Study|Study medication taken incorrectly|0|||
30719449|NCT00518622|58732759|FG006|Overall Study|Study medication taken incorrectly|0|||
30719450|NCT00518622|58732760|FG007|Overall Study|Study medication taken incorrectly|0|||
30719451|NCT03783078|58732778|FG000|Overall Study|Participants Ongoing|29|||
30719452|NCT03783078|58732778|FG000|Overall Study|Death|26|||
30719453|NCT00517296|58732784|FG000|Overall Study|Withdrawal by Subject|1|||
30719454|NCT00517296|58732785|FG001|Overall Study|Withdrawal by Subject|0|||
30719455|NCT00516906|58732793|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
30719456|NCT00516906|58732794|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
30719457|NCT00523848|58732800|FG000|Overall Study|Adverse Event|11|||
30719458|NCT00523848|58732800|FG000|Overall Study|Withdrawal by Subject|2|||
30719459|NCT00523848|58732800|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
30719460|NCT00523848|58732800|FG000|Overall Study|Disease Progression|5|||
30719461|NCT00523848|58732800|FG000|Overall Study|Other, unspecified|4|||
30719462|NCT00617669|58732806|FG000|Overall Study|Withdrawal by Subject|71|||
30719463|NCT00617669|58732807|FG001|Overall Study|Withdrawal by Subject|77|||
30719464|NCT00617669|58732806|FG000|Overall Study|Lost to Follow-up|3|||
30719465|NCT00617669|58732807|FG001|Overall Study|Lost to Follow-up|2|||
30719466|NCT00617669|58732806|FG000|Overall Study|Adverse Event|87|||
30719467|NCT00617669|58732807|FG001|Overall Study|Adverse Event|76|||
30719468|NCT00617669|58732806|FG000|Overall Study|Protocol Violation|2|||
30719469|NCT00617669|58732807|FG001|Overall Study|Protocol Violation|3|||
30719470|NCT00617669|58732806|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
30719471|NCT00617669|58732807|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
30719472|NCT00617669|58732806|FG000|Overall Study|Patients randomized but not treated|2|||
30719473|NCT00617669|58732807|FG001|Overall Study|Patients randomized but not treated|3|||
30719474|NCT03682848|58732813|FG000|Overall Study|Withdrawal by Subject|2|||
30719475|NCT03682848|58732813|FG000|Overall Study|Site closed|5|||
30719476|NCT03682848|58732813|FG000|Overall Study|Protocol Deviation|1|||
30719477|NCT03682848|58732813|FG000|Overall Study|Adverse Event|1|||
30719478|NCT00510510|58732820|FG000|Overall Study|Adverse Event|4|||
30719479|NCT00510510|58732821|FG001|Overall Study|Adverse Event|3|||
30719480|NCT00510510|58732822|FG002|Overall Study|Adverse Event|6|||
30719481|NCT00510510|58732820|FG000|Overall Study|Lack of Efficacy|0|||
30719482|NCT00510510|58732821|FG001|Overall Study|Lack of Efficacy|1|||
30719483|NCT00510510|58732822|FG002|Overall Study|Lack of Efficacy|1|||
30719484|NCT00510510|58732820|FG000|Overall Study|Subjects no longer requires study drug|0|||
30719485|NCT00510510|58732821|FG001|Overall Study|Subjects no longer requires study drug|0|||
30719486|NCT00510510|58732822|FG002|Overall Study|Subjects no longer requires study drug|2|||
30719487|NCT00510510|58732820|FG000|Overall Study|Withdrawal by Subject|1|||
30719488|NCT00510510|58732821|FG001|Overall Study|Withdrawal by Subject|2|||
30719489|NCT00510510|58732822|FG002|Overall Study|Withdrawal by Subject|3|||
30719490|NCT00510510|58732820|FG000|Overall Study|Lost to Follow-up|0|||
30719491|NCT00510510|58732821|FG001|Overall Study|Lost to Follow-up|0|||
30719492|NCT00510510|58732822|FG002|Overall Study|Lost to Follow-up|1|||
30719493|NCT00510510|58732820|FG000|Overall Study|Protocol Violation|0|||
30719494|NCT00510510|58732821|FG001|Overall Study|Protocol Violation|3|||
30719495|NCT00510510|58732822|FG002|Overall Study|Protocol Violation|4|||
30719496|NCT00617591|58732830|FG000|Overall Study|Withdrew consent during Induction|4|||
30719497|NCT00617591|58732830|FG000|Overall Study|Withdrew consent during Maintenance|6|||
30719498|NCT00510276|58732837|FG000|Acute Double-Blind Phase|Adverse Event|21|||
30760612|NCT03118570|58769120|FG002|Overall Study|Adverse Event|0|||
30719499|NCT00510276|58732838|FG001|Acute Double-Blind Phase|Adverse Event|6|||
30719500|NCT00510276|58732837|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
30719501|NCT00510276|58732838|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
30719502|NCT00510276|58732837|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
30719503|NCT00510276|58732838|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
30719504|NCT00510276|58732837|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
30719505|NCT00510276|58732838|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
30719506|NCT00510276|58732837|FG000|Acute Double-Blind Phase|Physician Decision|0|||
30719507|NCT00510276|58732838|FG001|Acute Double-Blind Phase|Physician Decision|3|||
30719508|NCT00510276|58732837|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
30719509|NCT00510276|58732838|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
30719510|NCT00510276|58732837|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
30719511|NCT00510276|58732838|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
30719512|NCT00510276|58732837|FG000|Acute Double-Blind Phase|Subject Decision|26|||
30719513|NCT00510276|58732838|FG001|Acute Double-Blind Phase|Subject Decision|28|||
30719514|NCT00510276|58732837|FG000|Extension Open-Label Phase|Adverse Event|9|||
30719515|NCT00510276|58732838|FG001|Extension Open-Label Phase|Adverse Event|18|||
30719516|NCT00510276|58732837|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
30719517|NCT00510276|58732838|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
30719518|NCT00510276|58732837|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
30719519|NCT00510276|58732838|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
30719520|NCT00510276|58732837|FG000|Extension Open-Label Phase|Physician Decision|2|||
30719521|NCT00510276|58732838|FG001|Extension Open-Label Phase|Physician Decision|3|||
30719522|NCT00510276|58732837|FG000|Extension Open-Label Phase|Protocol Violation|0|||
30719523|NCT00510276|58732838|FG001|Extension Open-Label Phase|Protocol Violation|1|||
30719524|NCT00510276|58732837|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
30719525|NCT00510276|58732838|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
30719526|NCT00510276|58732837|FG000|Extension Open-Label Phase|Subject Decision|7|||
30719527|NCT00510276|58732838|FG001|Extension Open-Label Phase|Subject Decision|9|||
30719528|NCT00616655|58732854|FG000|Overall Study|Adverse Event|10|||
30719529|NCT00616655|58732855|FG001|Overall Study|Adverse Event|7|||
30719530|NCT00616655|58732856|FG002|Overall Study|Adverse Event|12|||
30719531|NCT00616655|58732854|FG000|Overall Study|Lack of Efficacy|5|||
30719532|NCT00616655|58732855|FG001|Overall Study|Lack of Efficacy|5|||
30719533|NCT00616655|58732856|FG002|Overall Study|Lack of Efficacy|5|||
30719534|NCT00616655|58732854|FG000|Overall Study|Lost to Follow-up|3|||
30719535|NCT00616655|58732855|FG001|Overall Study|Lost to Follow-up|12|||
30719536|NCT00616655|58732856|FG002|Overall Study|Lost to Follow-up|10|||
30719537|NCT00616655|58732854|FG000|Overall Study|Protocol Violation|2|||
30719538|NCT00616655|58732855|FG001|Overall Study|Protocol Violation|4|||
30719539|NCT00616655|58732856|FG002|Overall Study|Protocol Violation|3|||
30719540|NCT00616655|58732854|FG000|Overall Study|Withdrawal by Subject|9|||
30719541|NCT00616655|58732855|FG001|Overall Study|Withdrawal by Subject|7|||
30719542|NCT00616655|58732856|FG002|Overall Study|Withdrawal by Subject|11|||
30719543|NCT00616655|58732854|FG000|Overall Study|Does not meet in/ex criteria|0|||
30719544|NCT00616655|58732855|FG001|Overall Study|Does not meet in/ex criteria|0|||
30719545|NCT00616655|58732856|FG002|Overall Study|Does not meet in/ex criteria|2|||
30719546|NCT00616655|58732854|FG000|Overall Study|Other|6|||
30719547|NCT00616655|58732855|FG001|Overall Study|Other|6|||
30719548|NCT00616655|58732856|FG002|Overall Study|Other|5|||
30719549|NCT00510198|58732866|FG000|Overall Study|Withdrawal by Subject|5|||
30719550|NCT00510198|58732867|FG001|Overall Study|Withdrawal by Subject|4|||
30719551|NCT00516048|58732877|FG000|Overall Study|Death|0|||
30719552|NCT00516048|58732878|FG001|Overall Study|Death|0|||
30719553|NCT00516048|58732879|FG002|Overall Study|Death|1|||
30719554|NCT00516048|58732877|FG000|Overall Study|Subject Decision|0|||
30719555|NCT00516048|58732878|FG001|Overall Study|Subject Decision|2|||
30719556|NCT00516048|58732879|FG002|Overall Study|Subject Decision|0|||
30719557|NCT00617357|58732887|FG000|Overall Study|Lost to Follow-up|7|||
30719558|NCT00617357|58732887|FG000|Overall Study|Death|5|||
30719559|NCT00617357|58732887|FG000|Overall Study|insurance concerns|2|||
30719560|NCT00617357|58732887|FG000|Overall Study|Withdrawal by Subject|1|||
30719561|NCT00617357|58732887|FG000|Overall Study|Physician Decision|1|||
30719562|NCT00420927|58732899|FG000|Period 1|Adverse Event|19|||
30719563|NCT00420927|58732900|FG001|Period 1|Adverse Event|15|||
30719564|NCT00420927|58732901|FG002|Period 1|Adverse Event|0|||
30719565|NCT00420927|58732902|FG003|Period 1|Adverse Event|0|||
30719566|NCT00420927|58732903|FG004|Period 1|Adverse Event|0|||
30719567|NCT00420927|58732904|FG005|Period 1|Adverse Event|0|||
30719568|NCT00420927|58732905|FG006|Period 1|Adverse Event|0|||
30719569|NCT00420927|58732899|FG000|Period 1|Withdrawal by Subject|7|||
30719570|NCT00420927|58732900|FG001|Period 1|Withdrawal by Subject|12|||
30719571|NCT00420927|58732901|FG002|Period 1|Withdrawal by Subject|0|||
30719572|NCT00420927|58732902|FG003|Period 1|Withdrawal by Subject|0|||
30719573|NCT00420927|58732903|FG004|Period 1|Withdrawal by Subject|0|||
30719574|NCT00420927|58732904|FG005|Period 1|Withdrawal by Subject|0|||
30719575|NCT00420927|58732905|FG006|Period 1|Withdrawal by Subject|0|||
30719576|NCT00420927|58732899|FG000|Period 1|Lost to Follow-up|8|||
30719577|NCT00420927|58732900|FG001|Period 1|Lost to Follow-up|6|||
30719578|NCT00420927|58732901|FG002|Period 1|Lost to Follow-up|0|||
30719579|NCT00420927|58732902|FG003|Period 1|Lost to Follow-up|0|||
30719580|NCT00420927|58732903|FG004|Period 1|Lost to Follow-up|0|||
30719581|NCT00420927|58732904|FG005|Period 1|Lost to Follow-up|0|||
30719582|NCT00420927|58732905|FG006|Period 1|Lost to Follow-up|0|||
30719583|NCT00420927|58732899|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
30719584|NCT00420927|58732900|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
30719585|NCT00420927|58732901|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
30719586|NCT00420927|58732902|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
30719587|NCT00420927|58732903|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
30719588|NCT00420927|58732904|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
30719589|NCT00420927|58732905|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
30719590|NCT00420927|58732899|FG000|Period 1|Death|2|||
30719591|NCT00420927|58732900|FG001|Period 1|Death|0|||
30719592|NCT00420927|58732901|FG002|Period 1|Death|0|||
30719593|NCT00420927|58732902|FG003|Period 1|Death|0|||
30719594|NCT00420927|58732903|FG004|Period 1|Death|0|||
30719595|NCT00420927|58732904|FG005|Period 1|Death|0|||
30719596|NCT00420927|58732905|FG006|Period 1|Death|0|||
30719597|NCT00420927|58732899|FG000|Period 1|Subject moved/relocated|0|||
30719598|NCT00420927|58732900|FG001|Period 1|Subject moved/relocated|2|||
30719599|NCT00420927|58732901|FG002|Period 1|Subject moved/relocated|0|||
30719600|NCT00420927|58732902|FG003|Period 1|Subject moved/relocated|0|||
30719601|NCT00420927|58732903|FG004|Period 1|Subject moved/relocated|0|||
30719602|NCT00420927|58732904|FG005|Period 1|Subject moved/relocated|0|||
30719603|NCT00420927|58732905|FG006|Period 1|Subject moved/relocated|0|||
30719604|NCT00420927|58732899|FG000|Period 1|Noncompliant with study drug|1|||
30719605|NCT00420927|58732900|FG001|Period 1|Noncompliant with study drug|1|||
30719606|NCT00420927|58732901|FG002|Period 1|Noncompliant with study drug|0|||
30719607|NCT00420927|58732902|FG003|Period 1|Noncompliant with study drug|0|||
30719608|NCT00420927|58732903|FG004|Period 1|Noncompliant with study drug|0|||
30719609|NCT00420927|58732904|FG005|Period 1|Noncompliant with study drug|0|||
30719610|NCT00420927|58732905|FG006|Period 1|Noncompliant with study drug|0|||
30719611|NCT00420927|58732899|FG000|Period 1|Randomization error|1|||
30719612|NCT00420927|58732900|FG001|Period 1|Randomization error|0|||
30719613|NCT00420927|58732901|FG002|Period 1|Randomization error|0|||
30719614|NCT00420927|58732902|FG003|Period 1|Randomization error|0|||
30719615|NCT00420927|58732903|FG004|Period 1|Randomization error|0|||
30719616|NCT00420927|58732904|FG005|Period 1|Randomization error|0|||
30719617|NCT00420927|58732905|FG006|Period 1|Randomization error|0|||
30719618|NCT00420927|58732899|FG000|Period 1|Suspected tuberculosis/positive test|1|||
30719619|NCT00420927|58732900|FG001|Period 1|Suspected tuberculosis/positive test|1|||
30719620|NCT00420927|58732901|FG002|Period 1|Suspected tuberculosis/positive test|0|||
30719621|NCT00420927|58732902|FG003|Period 1|Suspected tuberculosis/positive test|0|||
30719622|NCT00420927|58732903|FG004|Period 1|Suspected tuberculosis/positive test|0|||
30719623|NCT00420927|58732904|FG005|Period 1|Suspected tuberculosis/positive test|0|||
30719624|NCT00420927|58732905|FG006|Period 1|Suspected tuberculosis/positive test|0|||
30719625|NCT00420927|58732899|FG000|Period 1|Study site closure|0|||
30719626|NCT00420927|58732900|FG001|Period 1|Study site closure|1|||
30719627|NCT00420927|58732901|FG002|Period 1|Study site closure|0|||
30719628|NCT00420927|58732902|FG003|Period 1|Study site closure|0|||
30719629|NCT00420927|58732903|FG004|Period 1|Study site closure|0|||
30719630|NCT00420927|58732904|FG005|Period 1|Study site closure|0|||
30719631|NCT00420927|58732905|FG006|Period 1|Study site closure|0|||
30719632|NCT00420927|58732899|FG000|Period 1|Subject received new diagnosis|0|||
30719633|NCT00420927|58732900|FG001|Period 1|Subject received new diagnosis|2|||
30719634|NCT00420927|58732901|FG002|Period 1|Subject received new diagnosis|0|||
30719635|NCT00420927|58732902|FG003|Period 1|Subject received new diagnosis|0|||
30719636|NCT00420927|58732903|FG004|Period 1|Subject received new diagnosis|0|||
30719637|NCT00420927|58732904|FG005|Period 1|Subject received new diagnosis|0|||
30719638|NCT00420927|58732905|FG006|Period 1|Subject received new diagnosis|0|||
30719639|NCT00420927|58732899|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
30719640|NCT00420927|58732900|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
30719641|NCT00420927|58732901|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
30719642|NCT00420927|58732902|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
30719643|NCT00420927|58732903|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
30719644|NCT00420927|58732904|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
30719645|NCT00420927|58732905|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
30719646|NCT00420927|58732899|FG000|Period 1|Failed to meet entry criteria|8|||
30719647|NCT00420927|58732900|FG001|Period 1|Failed to meet entry criteria|7|||
30719648|NCT00420927|58732901|FG002|Period 1|Failed to meet entry criteria|0|||
30719649|NCT00420927|58732902|FG003|Period 1|Failed to meet entry criteria|0|||
30719650|NCT00420927|58732903|FG004|Period 1|Failed to meet entry criteria|0|||
30719651|NCT00420927|58732904|FG005|Period 1|Failed to meet entry criteria|0|||
30719652|NCT00420927|58732905|FG006|Period 1|Failed to meet entry criteria|0|||
30719653|NCT00420927|58732899|FG000|Period 1|Took prohibited medication|1|||
30719654|NCT00420927|58732900|FG001|Period 1|Took prohibited medication|3|||
30719655|NCT00420927|58732901|FG002|Period 1|Took prohibited medication|0|||
30719656|NCT00420927|58732902|FG003|Period 1|Took prohibited medication|0|||
30719657|NCT00420927|58732903|FG004|Period 1|Took prohibited medication|0|||
30719658|NCT00420927|58732904|FG005|Period 1|Took prohibited medication|0|||
30719659|NCT00420927|58732905|FG006|Period 1|Took prohibited medication|0|||
30719660|NCT00420927|58732899|FG000|Period 2|Adverse Event|0|||
30719661|NCT00420927|58732900|FG001|Period 2|Adverse Event|0|||
30719662|NCT00420927|58732901|FG002|Period 2|Adverse Event|7|||
30719663|NCT00420927|58732902|FG003|Period 2|Adverse Event|3|||
30719664|NCT00420927|58732903|FG004|Period 2|Adverse Event|17|||
30719665|NCT00420927|58732904|FG005|Period 2|Adverse Event|6|||
30719666|NCT00420927|58732905|FG006|Period 2|Adverse Event|20|||
30719667|NCT00420927|58732899|FG000|Period 2|Withdrawal by Subject|0|||
30719668|NCT00420927|58732900|FG001|Period 2|Withdrawal by Subject|0|||
30719669|NCT00420927|58732901|FG002|Period 2|Withdrawal by Subject|1|||
30719670|NCT00420927|58732902|FG003|Period 2|Withdrawal by Subject|3|||
30719671|NCT00420927|58732903|FG004|Period 2|Withdrawal by Subject|11|||
30719672|NCT00420927|58732904|FG005|Period 2|Withdrawal by Subject|2|||
30719673|NCT00420927|58732905|FG006|Period 2|Withdrawal by Subject|12|||
30719674|NCT00420927|58732899|FG000|Period 2|Lost to Follow-up|0|||
30719675|NCT00420927|58732900|FG001|Period 2|Lost to Follow-up|0|||
30719676|NCT00420927|58732901|FG002|Period 2|Lost to Follow-up|2|||
30719677|NCT00420927|58732902|FG003|Period 2|Lost to Follow-up|2|||
30719678|NCT00420927|58732903|FG004|Period 2|Lost to Follow-up|6|||
30719679|NCT00420927|58732904|FG005|Period 2|Lost to Follow-up|3|||
30719680|NCT00420927|58732905|FG006|Period 2|Lost to Follow-up|9|||
30719681|NCT00420927|58732899|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
30719682|NCT00420927|58732900|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
30621598|NCT00932698|58633209|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
30719683|NCT00420927|58732901|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
30719684|NCT00420927|58732902|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
30719685|NCT00420927|58732903|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
30719686|NCT00420927|58732904|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
30719687|NCT00420927|58732905|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
30719688|NCT00420927|58732899|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
30719689|NCT00420927|58732900|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
30719690|NCT00420927|58732901|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
30719691|NCT00420927|58732902|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
30719692|NCT00420927|58732903|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
30719693|NCT00420927|58732904|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
30719694|NCT00420927|58732905|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
30719695|NCT00420927|58732899|FG000|Period 2|Subject unable to find transportation|0|||
30719696|NCT00420927|58732900|FG001|Period 2|Subject unable to find transportation|0|||
30719697|NCT00420927|58732901|FG002|Period 2|Subject unable to find transportation|0|||
30719698|NCT00420927|58732902|FG003|Period 2|Subject unable to find transportation|0|||
30719699|NCT00420927|58732903|FG004|Period 2|Subject unable to find transportation|0|||
30719700|NCT00420927|58732904|FG005|Period 2|Subject unable to find transportation|0|||
30719701|NCT00420927|58732905|FG006|Period 2|Subject unable to find transportation|1|||
30719702|NCT00420927|58732899|FG000|Period 2|Physician Decision|0|||
30719703|NCT00420927|58732900|FG001|Period 2|Physician Decision|0|||
30719704|NCT00420927|58732901|FG002|Period 2|Physician Decision|0|||
30719705|NCT00420927|58732902|FG003|Period 2|Physician Decision|0|||
30719706|NCT00420927|58732903|FG004|Period 2|Physician Decision|1|||
30719707|NCT00420927|58732904|FG005|Period 2|Physician Decision|1|||
30719708|NCT00420927|58732905|FG006|Period 2|Physician Decision|0|||
30719709|NCT00420927|58732899|FG000|Period 2|Sponsor decision|0|||
30719710|NCT00420927|58732900|FG001|Period 2|Sponsor decision|0|||
30719711|NCT00420927|58732901|FG002|Period 2|Sponsor decision|1|||
30719712|NCT00420927|58732902|FG003|Period 2|Sponsor decision|0|||
30719713|NCT00420927|58732903|FG004|Period 2|Sponsor decision|0|||
30790923|NCT03200366|58804017|FG002|6 Month Post-Baseline Interview|Death|1|||
30719714|NCT00420927|58732904|FG005|Period 2|Sponsor decision|0|||
30719715|NCT00420927|58732905|FG006|Period 2|Sponsor decision|1|||
30719716|NCT00420927|58732899|FG000|Period 2|Randomization error|0|||
30719717|NCT00420927|58732900|FG001|Period 2|Randomization error|0|||
30719718|NCT00420927|58732901|FG002|Period 2|Randomization error|0|||
30719719|NCT00420927|58732902|FG003|Period 2|Randomization error|0|||
30719720|NCT00420927|58732903|FG004|Period 2|Randomization error|1|||
30719721|NCT00420927|58732904|FG005|Period 2|Randomization error|1|||
30719722|NCT00420927|58732905|FG006|Period 2|Randomization error|0|||
30719723|NCT00420927|58732899|FG000|Period 2|Noncompliant with study drug|0|||
30719724|NCT00420927|58732900|FG001|Period 2|Noncompliant with study drug|0|||
30719725|NCT00420927|58732901|FG002|Period 2|Noncompliant with study drug|0|||
30719726|NCT00420927|58732902|FG003|Period 2|Noncompliant with study drug|1|||
30719727|NCT00420927|58732903|FG004|Period 2|Noncompliant with study drug|0|||
30719728|NCT00420927|58732904|FG005|Period 2|Noncompliant with study drug|0|||
30719729|NCT00420927|58732905|FG006|Period 2|Noncompliant with study drug|2|||
30719730|NCT00420927|58732899|FG000|Period 2|Methotrexate intolerance|0|||
30719731|NCT00420927|58732900|FG001|Period 2|Methotrexate intolerance|0|||
30719732|NCT00420927|58732901|FG002|Period 2|Methotrexate intolerance|0|||
30719733|NCT00420927|58732902|FG003|Period 2|Methotrexate intolerance|0|||
30719734|NCT00420927|58732903|FG004|Period 2|Methotrexate intolerance|0|||
30719735|NCT00420927|58732904|FG005|Period 2|Methotrexate intolerance|0|||
30719736|NCT00420927|58732905|FG006|Period 2|Methotrexate intolerance|1|||
30719737|NCT00420927|58732899|FG000|Period 2|Took prohibited medication|0|||
30719738|NCT00420927|58732900|FG001|Period 2|Took prohibited medication|0|||
30719739|NCT00420927|58732901|FG002|Period 2|Took prohibited medication|0|||
30719740|NCT00420927|58732902|FG003|Period 2|Took prohibited medication|0|||
30719741|NCT00420927|58732903|FG004|Period 2|Took prohibited medication|1|||
30719742|NCT00420927|58732904|FG005|Period 2|Took prohibited medication|0|||
30719743|NCT00420927|58732905|FG006|Period 2|Took prohibited medication|0|||
30719744|NCT00573443|58732922|FG000|Double-Blind Phase|Lost to Follow-up|1|||
30719745|NCT00573443|58732923|FG001|Double-Blind Phase|Lost to Follow-up|3|||
30719746|NCT00573443|58732924|FG002|Double-Blind Phase|Lost to Follow-up|2|||
30719747|NCT00573443|58732922|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
30719748|NCT00573443|58732923|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
30719749|NCT00573443|58732924|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
30719750|NCT00573443|58732922|FG000|Double-Blind Phase|Adverse Event|1|||
30719751|NCT00573443|58732923|FG001|Double-Blind Phase|Adverse Event|5|||
30719752|NCT00573443|58732924|FG002|Double-Blind Phase|Adverse Event|0|||
30719753|NCT00573443|58732922|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
30719754|NCT00573443|58732923|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
30719755|NCT00573443|58732924|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
30719756|NCT00573443|58732922|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
30719757|NCT00573443|58732923|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
30719758|NCT00573443|58732924|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
30719759|NCT00573443|58732922|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
30719760|NCT00573443|58732923|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
30719761|NCT00573443|58732924|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
30719762|NCT00573443|58732922|FG000|Double-Blind Phase|Protocol Violation|0|||
30719763|NCT00573443|58732923|FG001|Double-Blind Phase|Protocol Violation|2|||
30719764|NCT00573443|58732924|FG002|Double-Blind Phase|Protocol Violation|1|||
30719765|NCT00573443|58732922|FG000|Double-Blind Phase|Other|0|||
30719766|NCT00573443|58732923|FG001|Double-Blind Phase|Other|2|||
30719767|NCT00573443|58732924|FG002|Double-Blind Phase|Other|3|||
30719768|NCT00573443|58732922|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
30719769|NCT00573443|58732923|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
30719770|NCT00573443|58732924|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
30719771|NCT00573443|58732922|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
30719772|NCT00573443|58732923|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
30719773|NCT00573443|58732924|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
30719774|NCT00573443|58732922|FG000|Open-Label Extension Phase|Adverse Event|3|||
30719775|NCT00573443|58732923|FG001|Open-Label Extension Phase|Adverse Event|0|||
30719776|NCT00573443|58732924|FG002|Open-Label Extension Phase|Adverse Event|0|||
30719777|NCT00573443|58732922|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
30719778|NCT00573443|58732923|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
30719779|NCT00573443|58732924|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
30719780|NCT00573443|58732922|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
30719781|NCT00573443|58732923|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
30719782|NCT00573443|58732924|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
30719783|NCT00573443|58732922|FG000|Open-Label Extension Phase|Protocol Violation|2|||
30719784|NCT00573443|58732923|FG001|Open-Label Extension Phase|Protocol Violation|0|||
30719785|NCT00573443|58732924|FG002|Open-Label Extension Phase|Protocol Violation|0|||
30719786|NCT00573443|58732922|FG000|Open-Label Extension Phase|Other|2|||
30719787|NCT00573443|58732923|FG001|Open-Label Extension Phase|Other|0|||
30621599|NCT00932698|58633210|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
30719788|NCT00573443|58732924|FG002|Open-Label Extension Phase|Other|0|||
30719789|NCT00420849|58732946|FG000|Overall Study|Lack of Efficacy|154|||
30719790|NCT00420849|58732946|FG000|Overall Study|Adverse Event|107|||
30719791|NCT00420849|58732946|FG000|Overall Study|Withdrawal by Subject|28|||
30719792|NCT00420849|58732946|FG000|Overall Study|Death|18|||
30719793|NCT00420849|58732946|FG000|Overall Study|Other|14|||
30719794|NCT00420849|58732946|FG000|Overall Study|Transplant|8|||
30719795|NCT00420849|58732946|FG000|Overall Study|Protocol Violation|1|||
30719796|NCT00420849|58732946|FG000|Overall Study|Lost to Follow-up|1|||
30719797|NCT00617279|58732955|FG000|Overall Study|Study terminated by Sponsor|10|||
30719798|NCT00617279|58732956|FG001|Overall Study|Study terminated by Sponsor|15|||
30719799|NCT00617279|58732955|FG000|Overall Study|Graft abandonment|2|||
30719800|NCT00617279|58732956|FG001|Overall Study|Graft abandonment|0|||
30719801|NCT00617279|58732955|FG000|Overall Study|Lost to Follow-up|1|||
30719802|NCT00617279|58732956|FG001|Overall Study|Lost to Follow-up|0|||
30719803|NCT00617279|58732955|FG000|Overall Study|Death|1|||
30719804|NCT00617279|58732956|FG001|Overall Study|Death|2|||
30719805|NCT00420381|58732962|FG000|Overall Study|Protocol Violation|1|||
30719806|NCT00617201|58732968|FG000|Overall Study|Lost to Follow-up|9|||
30719807|NCT00617201|58732969|FG001|Overall Study|Lost to Follow-up|13|||
30719808|NCT00420303|58732979|FG000|Overall Study|Serious Adverse Event|1|||
30719809|NCT00420303|58732980|FG001|Overall Study|Serious Adverse Event|0|||
30719810|NCT00420303|58732979|FG000|Overall Study|Lack of Efficacy|0|||
30719811|NCT00420303|58732980|FG001|Overall Study|Lack of Efficacy|3|||
30719812|NCT00420303|58732979|FG000|Overall Study|Physician Decision|0|||
30719813|NCT00420303|58732980|FG001|Overall Study|Physician Decision|1|||
30719814|NCT00617123|58732988|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
30719815|NCT00617123|58732989|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
30719816|NCT00617123|58732988|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
30719817|NCT00617123|58732989|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
30719818|NCT00617123|58732988|FG000|Referral Screening Period|Adverse Event|0|||
30719819|NCT00617123|58732989|FG001|Referral Screening Period|Adverse Event|1|||
30719820|NCT00617123|58732988|FG000|Study Treatment Period|Withdrawal by Subject|8|||
30719821|NCT00617123|58732989|FG001|Study Treatment Period|Withdrawal by Subject|12|||
30719822|NCT00617123|58732988|FG000|Study Treatment Period|Adverse Event|7|||
30719823|NCT00617123|58732989|FG001|Study Treatment Period|Adverse Event|3|||
30719824|NCT00617123|58732988|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
30719825|NCT00617123|58732989|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
30719826|NCT00617123|58732988|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
30719827|NCT00617123|58732989|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
30719828|NCT00419757|58732997|FG000|Overall Study|Adverse Event|1|||
30719829|NCT00419757|58732998|FG001|Overall Study|Adverse Event|4|||
30719830|NCT00419757|58732997|FG000|Overall Study|Lost to Follow-up|1|||
30719831|NCT00419757|58732998|FG001|Overall Study|Lost to Follow-up|4|||
30719832|NCT00419757|58732997|FG000|Overall Study|Withdrawal by Subject|7|||
30719833|NCT00419757|58732998|FG001|Overall Study|Withdrawal by Subject|1|||
30719834|NCT00419757|58732997|FG000|Overall Study|Protocol Violation|2|||
30719835|NCT00419757|58732998|FG001|Overall Study|Protocol Violation|3|||
30719836|NCT00419757|58732997|FG000|Overall Study|Study specific discontinuation criteria|4|||
30719837|NCT00419757|58732998|FG001|Overall Study|Study specific discontinuation criteria|8|||
30719838|NCT00419757|58732997|FG000|Overall Study|Multiple reasons|3|||
30719839|NCT00419757|58732998|FG001|Overall Study|Multiple reasons|1|||
30719840|NCT00434109|58733006|FG000|Overall Study|Physician Decision|9|||
30719841|NCT00434109|58733006|FG000|Overall Study|Adverse Event|5|||
30719842|NCT00434109|58733006|FG000|Overall Study|Protocol Violation|1|||
30719843|NCT00434109|58733006|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
30719844|NCT00433329|58733010|FG000|Overall Study|Adverse Event|9|||
30719845|NCT00433329|58733010|FG000|Overall Study|Death|4|||
30719846|NCT00433329|58733010|FG000|Overall Study|Withdrew consent|3|||
30719847|NCT00433329|58733010|FG000|Overall Study|Discontinued sildenafil|2|||
30719848|NCT00433329|58733010|FG000|Overall Study|Moved out of state|1|||
30719849|NCT00433329|58733010|FG000|Overall Study|Lost to Follow-up|1|||
30719850|NCT00433329|58733010|FG000|Overall Study|Physician Decision|1|||
30719851|NCT00616421|58733017|FG000|Overall Study|Withdrawal by Subject|9|||
30719852|NCT00616421|58733018|FG001|Overall Study|Withdrawal by Subject|11|||
30719853|NCT00616421|58733019|FG002|Overall Study|Withdrawal by Subject|8|||
30719854|NCT00616421|58733017|FG000|Overall Study|Lost to Follow-up|12|||
30719855|NCT00616421|58733018|FG001|Overall Study|Lost to Follow-up|26|||
30719856|NCT00616421|58733019|FG002|Overall Study|Lost to Follow-up|30|||
30719857|NCT00616421|58733017|FG000|Overall Study|Inappropriate enrollment|3|||
30719858|NCT00616421|58733018|FG001|Overall Study|Inappropriate enrollment|0|||
30719859|NCT00616421|58733019|FG002|Overall Study|Inappropriate enrollment|1|||
30719860|NCT00616421|58733017|FG000|Overall Study|Administrative reason|1|||
30719861|NCT00616421|58733018|FG001|Overall Study|Administrative reason|0|||
30719862|NCT00616421|58733019|FG002|Overall Study|Administrative reason|0|||
30719863|NCT00616421|58733017|FG000|Overall Study|Protocol Violation|0|||
30719864|NCT00616421|58733018|FG001|Overall Study|Protocol Violation|1|||
30719865|NCT00616421|58733019|FG002|Overall Study|Protocol Violation|2|||
30719866|NCT00616421|58733017|FG000|Overall Study|Unable to classify|1|||
30719867|NCT00616421|58733018|FG001|Overall Study|Unable to classify|0|||
30719868|NCT00616421|58733019|FG002|Overall Study|Unable to classify|0|||
30719869|NCT00433017|58733043|FG000|Overall Study|Adverse Event|5|||
30719870|NCT00433017|58733044|FG001|Overall Study|Adverse Event|3|||
30719871|NCT00433017|58733043|FG000|Overall Study|Withdrawal by Subject|4|||
30719872|NCT00433017|58733044|FG001|Overall Study|Withdrawal by Subject|5|||
30719873|NCT00433017|58733043|FG000|Overall Study|Lost to Follow-up|3|||
30719874|NCT00433017|58733044|FG001|Overall Study|Lost to Follow-up|4|||
30719875|NCT00433017|58733043|FG000|Overall Study|Administrative problems|80|||
30719876|NCT00433017|58733044|FG001|Overall Study|Administrative problems|86|||
30719877|NCT00433017|58733043|FG000|Overall Study|Protocol Violation|1|||
30719878|NCT00433017|58733044|FG001|Overall Study|Protocol Violation|0|||
30719879|NCT00433017|58733043|FG000|Overall Study|Death|2|||
30719880|NCT00433017|58733044|FG001|Overall Study|Death|2|||
30719881|NCT00433017|58733043|FG000|Overall Study|Subject no longer requires study drug|1|||
30719882|NCT00433017|58733044|FG001|Overall Study|Subject no longer requires study drug|1|||
30719883|NCT00615719|58733076|FG000|Overall Study|Physician Decision|5|||
30719884|NCT00418665|58733083|FG000|Treatment Period|Ineligibility determined|1|||
30719885|NCT00418665|58733084|FG001|Treatment Period|Ineligibility determined|1|||
30719886|NCT00418665|58733085|FG002|Treatment Period|Ineligibility determined|0|||
30719887|NCT00418665|58733083|FG000|Treatment Period|Adverse Event|2|||
30719888|NCT00418665|58733084|FG001|Treatment Period|Adverse Event|2|||
30719889|NCT00418665|58733085|FG002|Treatment Period|Adverse Event|0|||
30719890|NCT00418665|58733083|FG000|Treatment Period|Withdrawal by Subject|0|||
30719891|NCT00418665|58733084|FG001|Treatment Period|Withdrawal by Subject|3|||
30719892|NCT00418665|58733085|FG002|Treatment Period|Withdrawal by Subject|1|||
30719893|NCT00418665|58733083|FG000|Treatment Period|Requirement for alternative therapy|1|||
30719894|NCT00418665|58733084|FG001|Treatment Period|Requirement for alternative therapy|0|||
30719895|NCT00418665|58733085|FG002|Treatment Period|Requirement for alternative therapy|0|||
30719896|NCT00418665|58733083|FG000|Treatment Period|Physician Decision|1|||
30719897|NCT00418665|58733084|FG001|Treatment Period|Physician Decision|0|||
30719898|NCT00418665|58733085|FG002|Treatment Period|Physician Decision|3|||
30719899|NCT00418665|58733083|FG000|Treatment Extension|Adverse Event|1|||
30719900|NCT00418665|58733084|FG001|Treatment Extension|Adverse Event|0|||
30719901|NCT00418665|58733085|FG002|Treatment Extension|Adverse Event|0|||
30719902|NCT00418665|58733083|FG000|Treatment Extension|Withdrawal by Subject|1|||
30719903|NCT00418665|58733084|FG001|Treatment Extension|Withdrawal by Subject|0|||
30719904|NCT00418665|58733085|FG002|Treatment Extension|Withdrawal by Subject|0|||
30719905|NCT00418665|58733083|FG000|Treatment Extension|Requirement for alternative therapy|2|||
30719906|NCT00418665|58733084|FG001|Treatment Extension|Requirement for alternative therapy|2|||
30719907|NCT00418665|58733085|FG002|Treatment Extension|Requirement for alternative therapy|0|||
30719908|NCT00418665|58733083|FG000|Treatment Extension|Physician Decision|2|||
30719909|NCT00418665|58733084|FG001|Treatment Extension|Physician Decision|2|||
30719910|NCT00418665|58733085|FG002|Treatment Extension|Physician Decision|1|||
30719911|NCT00418665|58733083|FG000|Treatment Extension|Death|0|||
30719912|NCT00418665|58733084|FG001|Treatment Extension|Death|0|||
30719913|NCT00418665|58733085|FG002|Treatment Extension|Death|1|||
30719914|NCT00432237|58733097|FG000|Overall Study|Adverse Event|0|||
30719915|NCT00432237|58733098|FG001|Overall Study|Adverse Event|0|||
30719916|NCT00432237|58733099|FG002|Overall Study|Adverse Event|0|||
30719917|NCT00432237|58733100|FG003|Overall Study|Adverse Event|1|||
30719918|NCT00432237|58733097|FG000|Overall Study|Lack of Efficacy|0|||
30719919|NCT00432237|58733098|FG001|Overall Study|Lack of Efficacy|0|||
30719920|NCT00432237|58733099|FG002|Overall Study|Lack of Efficacy|0|||
30719921|NCT00432237|58733100|FG003|Overall Study|Lack of Efficacy|1|||
30719922|NCT00432237|58733097|FG000|Overall Study|Lost to Follow-up|10|||
30719923|NCT00432237|58733098|FG001|Overall Study|Lost to Follow-up|10|||
30719924|NCT00432237|58733099|FG002|Overall Study|Lost to Follow-up|18|||
30719925|NCT00432237|58733100|FG003|Overall Study|Lost to Follow-up|18|||
30719926|NCT00432237|58733097|FG000|Overall Study|Physician Decision|1|||
30719927|NCT00432237|58733098|FG001|Overall Study|Physician Decision|3|||
30719928|NCT00432237|58733099|FG002|Overall Study|Physician Decision|2|||
30719929|NCT00432237|58733100|FG003|Overall Study|Physician Decision|1|||
30719930|NCT00432237|58733097|FG000|Overall Study|Pregnancy|0|||
30719931|NCT00432237|58733098|FG001|Overall Study|Pregnancy|1|||
30719932|NCT00432237|58733099|FG002|Overall Study|Pregnancy|0|||
30719933|NCT00432237|58733100|FG003|Overall Study|Pregnancy|0|||
30719934|NCT00432237|58733097|FG000|Overall Study|Protocol Violation|13|||
30719935|NCT00432237|58733098|FG001|Overall Study|Protocol Violation|10|||
30719936|NCT00432237|58733099|FG002|Overall Study|Protocol Violation|11|||
30719937|NCT00432237|58733100|FG003|Overall Study|Protocol Violation|8|||
30719938|NCT00432237|58733097|FG000|Overall Study|Withdrawal by Subject|5|||
30719939|NCT00432237|58733098|FG001|Overall Study|Withdrawal by Subject|6|||
30719940|NCT00432237|58733099|FG002|Overall Study|Withdrawal by Subject|9|||
30719941|NCT00432237|58733100|FG003|Overall Study|Withdrawal by Subject|11|||
30719942|NCT00432237|58733097|FG000|Overall Study|Lack of Qualifying Event|38|||
30719943|NCT00432237|58733098|FG001|Overall Study|Lack of Qualifying Event|71|||
30719944|NCT00432237|58733099|FG002|Overall Study|Lack of Qualifying Event|69|||
30719945|NCT00432237|58733100|FG003|Overall Study|Lack of Qualifying Event|84|||
30719946|NCT00531284|58733127|FG000|Overall Study|Progressive Disease|1|||
30719947|NCT00531284|58733128|FG001|Overall Study|Progressive Disease|3|||
30719948|NCT00531284|58733129|FG002|Overall Study|Progressive Disease|5|||
30719949|NCT00531284|58733130|FG003|Overall Study|Progressive Disease|42|||
30719950|NCT00531284|58733131|FG004|Overall Study|Progressive Disease|4|||
30719951|NCT00531284|58733132|FG005|Overall Study|Progressive Disease|4|||
30719952|NCT00531284|58733133|FG006|Overall Study|Progressive Disease|3|||
30719953|NCT00531284|58733134|FG007|Overall Study|Progressive Disease|8|||
30719954|NCT00531284|58733135|FG008|Overall Study|Progressive Disease|6|||
30719955|NCT00531284|58733136|FG009|Overall Study|Progressive Disease|3|||
30719956|NCT00531284|58733137|FG010|Overall Study|Progressive Disease|3|||
30719957|NCT00531284|58733138|FG011|Overall Study|Progressive Disease|14|||
30719958|NCT00531284|58733139|FG012|Overall Study|Progressive Disease|2|||
30719959|NCT00531284|58733140|FG013|Overall Study|Progressive Disease|1|||
30719960|NCT00531284|58733141|FG014|Overall Study|Progressive Disease|2|||
30719961|NCT00531284|58733142|FG015|Overall Study|Progressive Disease|11|||
30719962|NCT00531284|58733143|FG016|Overall Study|Progressive Disease|5|||
30719963|NCT00531284|58733127|FG000|Overall Study|Adverse Event|0|||
30719964|NCT00531284|58733128|FG001|Overall Study|Adverse Event|1|||
30719965|NCT00531284|58733129|FG002|Overall Study|Adverse Event|1|||
30719966|NCT00531284|58733130|FG003|Overall Study|Adverse Event|7|||
30719967|NCT00531284|58733131|FG004|Overall Study|Adverse Event|0|||
30719968|NCT00531284|58733132|FG005|Overall Study|Adverse Event|2|||
30719969|NCT00531284|58733133|FG006|Overall Study|Adverse Event|3|||
30719970|NCT00531284|58733134|FG007|Overall Study|Adverse Event|2|||
30719971|NCT00531284|58733135|FG008|Overall Study|Adverse Event|3|||
30719972|NCT00531284|58733136|FG009|Overall Study|Adverse Event|0|||
30719973|NCT00531284|58733137|FG010|Overall Study|Adverse Event|0|||
30719974|NCT00531284|58733138|FG011|Overall Study|Adverse Event|5|||
30719975|NCT00531284|58733139|FG012|Overall Study|Adverse Event|0|||
30719976|NCT00531284|58733140|FG013|Overall Study|Adverse Event|1|||
30719977|NCT00531284|58733141|FG014|Overall Study|Adverse Event|1|||
30719978|NCT00531284|58733142|FG015|Overall Study|Adverse Event|0|||
30719979|NCT00531284|58733143|FG016|Overall Study|Adverse Event|2|||
30719980|NCT00531284|58733127|FG000|Overall Study|Withdrawal by Subject|1|||
30719981|NCT00531284|58733128|FG001|Overall Study|Withdrawal by Subject|0|||
30719982|NCT00531284|58733129|FG002|Overall Study|Withdrawal by Subject|0|||
30719983|NCT00531284|58733130|FG003|Overall Study|Withdrawal by Subject|4|||
30719984|NCT00531284|58733131|FG004|Overall Study|Withdrawal by Subject|0|||
30719985|NCT00531284|58733132|FG005|Overall Study|Withdrawal by Subject|0|||
30719986|NCT00531284|58733133|FG006|Overall Study|Withdrawal by Subject|0|||
30719987|NCT00531284|58733134|FG007|Overall Study|Withdrawal by Subject|0|||
30719988|NCT00531284|58733135|FG008|Overall Study|Withdrawal by Subject|0|||
30719989|NCT00531284|58733136|FG009|Overall Study|Withdrawal by Subject|0|||
30719990|NCT00531284|58733137|FG010|Overall Study|Withdrawal by Subject|0|||
30719991|NCT00531284|58733138|FG011|Overall Study|Withdrawal by Subject|3|||
30719992|NCT00531284|58733139|FG012|Overall Study|Withdrawal by Subject|0|||
30719993|NCT00531284|58733140|FG013|Overall Study|Withdrawal by Subject|1|||
30719994|NCT00531284|58733141|FG014|Overall Study|Withdrawal by Subject|0|||
30719995|NCT00531284|58733142|FG015|Overall Study|Withdrawal by Subject|1|||
30719996|NCT00531284|58733143|FG016|Overall Study|Withdrawal by Subject|1|||
30719997|NCT00531284|58733127|FG000|Overall Study|Other|1|||
30719998|NCT00531284|58733128|FG001|Overall Study|Other|0|||
30719999|NCT00531284|58733129|FG002|Overall Study|Other|0|||
30720000|NCT00531284|58733130|FG003|Overall Study|Other|10|||
30720001|NCT00531284|58733131|FG004|Overall Study|Other|2|||
30720002|NCT00531284|58733132|FG005|Overall Study|Other|1|||
30720003|NCT00531284|58733133|FG006|Overall Study|Other|0|||
30720004|NCT00531284|58733134|FG007|Overall Study|Other|0|||
30720005|NCT00531284|58733135|FG008|Overall Study|Other|2|||
30720006|NCT00531284|58733136|FG009|Overall Study|Other|1|||
30720007|NCT00531284|58733137|FG010|Overall Study|Other|0|||
30720008|NCT00531284|58733138|FG011|Overall Study|Other|2|||
30720009|NCT00531284|58733139|FG012|Overall Study|Other|0|||
30720010|NCT00531284|58733140|FG013|Overall Study|Other|0|||
30790924|NCT03200366|58804015|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
30790925|NCT03200366|58804016|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
30720011|NCT00531284|58733141|FG014|Overall Study|Other|1|||
30720012|NCT00531284|58733142|FG015|Overall Study|Other|0|||
30720013|NCT00531284|58733143|FG016|Overall Study|Other|0|||
30720014|NCT00531206|58733199|FG000|Overall Study|Adverse Event related|5|||
30720015|NCT00531206|58733199|FG000|Overall Study|Lack of Efficacy|2|||
30720016|NCT00531206|58733199|FG000|Overall Study|Lost to Follow-up|5|||
30720017|NCT00531206|58733199|FG000|Overall Study|including non-related adverse events|8|||
30720018|NCT00530816|58733206|FG000|Overall Study|Progressive Disease|16|||
30720019|NCT00530816|58733207|FG001|Overall Study|Progressive Disease|24|||
30720020|NCT00530816|58733208|FG002|Overall Study|Progressive Disease|24|||
30720021|NCT00530816|58733206|FG000|Overall Study|Adverse Event|6|||
30720022|NCT00530816|58733207|FG001|Overall Study|Adverse Event|13|||
30720023|NCT00530816|58733208|FG002|Overall Study|Adverse Event|7|||
30720024|NCT00530816|58733206|FG000|Overall Study|Other|3|||
30720025|NCT00530816|58733207|FG001|Overall Study|Other|3|||
30720026|NCT00530816|58733208|FG002|Overall Study|Other|4|||
30720027|NCT00530816|58733206|FG000|Overall Study|Withdrawal by Subject|1|||
30720028|NCT00530816|58733207|FG001|Overall Study|Withdrawal by Subject|2|||
30720029|NCT00530816|58733208|FG002|Overall Study|Withdrawal by Subject|6|||
30720030|NCT00615017|58733222|FG000|Overall Study|Adverse Event|0|||
30720031|NCT00615017|58733223|FG001|Overall Study|Adverse Event|1|||
30900303|NCT02323646|58933523|FG001|Treatment Course 2|Adverse Event|0|||
30720032|NCT00615017|58733224|FG002|Overall Study|Adverse Event|2|||
30720033|NCT00615017|58733225|FG003|Overall Study|Adverse Event|0|||
30720034|NCT00615017|58733226|FG004|Overall Study|Adverse Event|0|||
30720035|NCT00615017|58733227|FG005|Overall Study|Adverse Event|1|||
30720036|NCT00615017|58733222|FG000|Overall Study|Death|0|||
30720037|NCT00615017|58733223|FG001|Overall Study|Death|0|||
30720038|NCT00615017|58733224|FG002|Overall Study|Death|2|||
30720039|NCT00615017|58733225|FG003|Overall Study|Death|0|||
30720040|NCT00615017|58733226|FG004|Overall Study|Death|1|||
30720041|NCT00615017|58733227|FG005|Overall Study|Death|1|||
30720042|NCT00615017|58733222|FG000|Overall Study|Sepsis resolved|0|||
30720043|NCT00615017|58733223|FG001|Overall Study|Sepsis resolved|0|||
30720044|NCT00615017|58733224|FG002|Overall Study|Sepsis resolved|1|||
30720045|NCT00615017|58733225|FG003|Overall Study|Sepsis resolved|0|||
30720046|NCT00615017|58733226|FG004|Overall Study|Sepsis resolved|0|||
30720047|NCT00615017|58733227|FG005|Overall Study|Sepsis resolved|0|||
30720048|NCT00615017|58733222|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
30720049|NCT00615017|58733223|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
30720050|NCT00615017|58733224|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
30720051|NCT00615017|58733225|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
30720052|NCT00615017|58733226|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
30720053|NCT00615017|58733227|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
30720054|NCT00615017|58733222|FG000|Overall Study|Physician discontinued drug|0|||
30720055|NCT00615017|58733223|FG001|Overall Study|Physician discontinued drug|0|||
30720056|NCT00615017|58733224|FG002|Overall Study|Physician discontinued drug|0|||
30720057|NCT00615017|58733225|FG003|Overall Study|Physician discontinued drug|0|||
30720058|NCT00615017|58733226|FG004|Overall Study|Physician discontinued drug|0|||
30720059|NCT00615017|58733227|FG005|Overall Study|Physician discontinued drug|1|||
30720060|NCT00614939|58733243|FG000|Overall Study|Withdrawal by Subject|10|||
30720061|NCT00614939|58733244|FG001|Overall Study|Withdrawal by Subject|17|||
30720062|NCT00614939|58733243|FG000|Overall Study|Study specific discontinuation criteris|13|||
30720063|NCT00614939|58733244|FG001|Overall Study|Study specific discontinuation criteris|16|||
30720064|NCT00614939|58733243|FG000|Overall Study|Adverse Event|2|||
30720065|NCT00614939|58733244|FG001|Overall Study|Adverse Event|5|||
30720066|NCT00614939|58733243|FG000|Overall Study|Incorrect enrollment|1|||
30720067|NCT00614939|58733244|FG001|Overall Study|Incorrect enrollment|2|||
30720068|NCT00614939|58733243|FG000|Overall Study|Death|4|||
30720069|NCT00614939|58733244|FG001|Overall Study|Death|3|||
30720070|NCT00614939|58733243|FG000|Overall Study|Poor/non-compliance|4|||
30720071|NCT00614939|58733244|FG001|Overall Study|Poor/non-compliance|0|||
30720072|NCT00614939|58733243|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
30720073|NCT00614939|58733244|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
30720074|NCT00530504|58733250|FG000|Overall Study|Death|54|||
30720075|NCT00530504|58733250|FG000|Overall Study|Lost to Follow-up|26|||
30720076|NCT00530504|58733250|FG000|Overall Study|Withdrawal by Subject|39|||
30720077|NCT00530504|58733250|FG000|Overall Study|Exited study due to other reasons|33|||
30720078|NCT04720664|58733280|FG000|Overall Study|Adverse Event|2|||
30720079|NCT04720664|58733280|FG000|Overall Study|Lack of Efficacy|9|||
30720080|NCT04626297|58733286|FG000|Overall Study|Adverse Event|5|||
30720081|NCT04626297|58733287|FG001|Overall Study|Adverse Event|3|||
30720082|NCT04626297|58733286|FG000|Overall Study|Lost to Follow-up|7|||
30720083|NCT04626297|58733287|FG001|Overall Study|Lost to Follow-up|3|||
30720084|NCT04626297|58733286|FG000|Overall Study|Protocol Violation|5|||
30720085|NCT04626297|58733287|FG001|Overall Study|Protocol Violation|1|||
30720086|NCT04626297|58733286|FG000|Overall Study|Withdrawal by Subject|20|||
30720087|NCT04626297|58733287|FG001|Overall Study|Withdrawal by Subject|6|||
30720088|NCT04626297|58733286|FG000|Overall Study|Sponsor decision|2|||
30720089|NCT04626297|58733287|FG001|Overall Study|Sponsor decision|1|||
30720090|NCT04371198|58733302|FG000|Overall Study|inadequate sample|4|||
30720091|NCT04288154|58733308|FG000|Overall Study|Withdrawal by Subject|9|||
30720092|NCT04288154|58733309|FG001|Overall Study|Withdrawal by Subject|9|||
30720093|NCT04258579|58733315|FG000|Overall Study|Withdrawal by Subject|7|||
30720094|NCT04258579|58733315|FG000|Overall Study|Lost to Follow-up|3|||
30720095|NCT04258579|58733315|FG000|Overall Study|Protocol Violation|2|||
30720096|NCT04258579|58733315|FG000|Overall Study|Adverse Event|1|||
30720097|NCT03945214|58733323|FG000|Overall Study|Lost to Follow-up|3|||
30720098|NCT03945214|58733324|FG001|Overall Study|Lost to Follow-up|4|||
30720099|NCT03945214|58733325|FG002|Overall Study|Lost to Follow-up|7|||
30720100|NCT03945214|58733326|FG003|Overall Study|Lost to Follow-up|4|||
30720101|NCT03829683|58733338|FG000|Overall Study|Lost to Follow-up|1|||
30720102|NCT03829683|58733339|FG001|Overall Study|Lost to Follow-up|0|||
30720103|NCT03829683|58733338|FG000|Overall Study|Physician Decision|3|||
30720104|NCT03829683|58733339|FG001|Overall Study|Physician Decision|1|||
30720105|NCT03829683|58733338|FG000|Overall Study|Withdrawal by Subject|0|||
30720106|NCT03829683|58733339|FG001|Overall Study|Withdrawal by Subject|1|||
30720107|NCT03829683|58733338|FG000|Overall Study|Discharge from hospital|1|||
30720108|NCT03829683|58733339|FG001|Overall Study|Discharge from hospital|0|||
30720109|NCT03810456|58733348|FG000|Treatment|Urgent Family Matters|3|||
30720110|NCT03810456|58733349|FG001|Treatment|Urgent Family Matters|0|||
30720111|NCT03810456|58733350|FG002|Treatment|Urgent Family Matters|0|||
30720112|NCT03810456|58733348|FG000|Treatment|Scheduling Conflicts|0|||
30720113|NCT03810456|58733349|FG001|Treatment|Scheduling Conflicts|11|||
30720114|NCT03810456|58733350|FG002|Treatment|Scheduling Conflicts|0|||
30720115|NCT03810456|58733348|FG000|Treatment|No Longer Interested|0|||
30720116|NCT03810456|58733349|FG001|Treatment|No Longer Interested|12|||
30720117|NCT03810456|58733350|FG002|Treatment|No Longer Interested|0|||
30720118|NCT03810456|58733348|FG000|Treatment|Transportation Issues|0|||
30720119|NCT03810456|58733349|FG001|Treatment|Transportation Issues|1|||
30720120|NCT03810456|58733350|FG002|Treatment|Transportation Issues|0|||
30720121|NCT03810456|58733348|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
30720122|NCT03810456|58733349|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
30720123|NCT03810456|58733350|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
30720124|NCT03810456|58733348|FG000|1 Month Follow-Up|Relocated to Different State|1|||
30720125|NCT03810456|58733349|FG001|1 Month Follow-Up|Relocated to Different State|0|||
30720126|NCT03810456|58733350|FG002|1 Month Follow-Up|Relocated to Different State|1|||
30720127|NCT03810456|58733348|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
30720128|NCT03810456|58733349|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
30720129|NCT03810456|58733350|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
30720130|NCT03810456|58733348|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
30720131|NCT03810456|58733349|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
30720132|NCT03810456|58733350|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
30720133|NCT03810456|58733348|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
30720134|NCT03810456|58733349|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
30720135|NCT03810456|58733350|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
30720136|NCT03810456|58733348|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
30720137|NCT03810456|58733349|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
30720138|NCT03810456|58733350|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
30720139|NCT03810456|58733348|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
30720140|NCT03810456|58733349|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
30720141|NCT03810456|58733350|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
30720142|NCT03450057|58733362|FG000|Overall Study|Death|17|||
30720143|NCT03450057|58733362|FG000|Overall Study|ICF withdrawal|4|||
30720144|NCT03450057|58733362|FG000|Overall Study|Lost to Follow-up|2|||
30720145|NCT03353415|58733375|FG000|Masked CGM Wear|Lost to Follow-up|2|||
30720146|NCT03353415|58733375|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
30720147|NCT02873195|58733434|FG000|Overall Study|Ineligible|5|||
30720148|NCT02873195|58733435|FG001|Overall Study|Ineligible|0|||
30720149|NCT02658890|58733468|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720150|NCT02658890|58733469|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720151|NCT02658890|58733470|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720152|NCT02658890|58733471|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720153|NCT02658890|58733472|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720154|NCT02658890|58733473|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720155|NCT02658890|58733474|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720156|NCT02658890|58733475|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720157|NCT02658890|58733476|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
30720158|NCT02658890|58733477|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720159|NCT02658890|58733478|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720160|NCT02658890|58733479|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720161|NCT02658890|58733480|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720162|NCT02658890|58733481|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720163|NCT02658890|58733482|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720164|NCT02658890|58733483|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720165|NCT02658890|58733484|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720166|NCT02658890|58733485|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720167|NCT02658890|58733486|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720168|NCT02658890|58733487|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720169|NCT02658890|58733488|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720170|NCT02658890|58733489|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720171|NCT02658890|58733490|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720172|NCT02658890|58733491|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720173|NCT02658890|58733492|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720174|NCT02658890|58733493|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720175|NCT02658890|58733494|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720176|NCT02658890|58733468|FG000|Treatment Phase|Adverse Event|0|||
30720177|NCT02658890|58733469|FG001|Treatment Phase|Adverse Event|1|||
30720178|NCT02658890|58733470|FG002|Treatment Phase|Adverse Event|2|||
30720179|NCT02658890|58733471|FG003|Treatment Phase|Adverse Event|2|||
30720180|NCT02658890|58733472|FG004|Treatment Phase|Adverse Event|1|||
30720181|NCT02658890|58733473|FG005|Treatment Phase|Adverse Event|0|||
30720182|NCT02658890|58733474|FG006|Treatment Phase|Adverse Event|0|||
30720183|NCT02658890|58733475|FG007|Treatment Phase|Adverse Event|2|||
30720184|NCT02658890|58733476|FG008|Treatment Phase|Adverse Event|1|||
30720185|NCT02658890|58733477|FG009|Treatment Phase|Adverse Event|2|||
30720186|NCT02658890|58733478|FG010|Treatment Phase|Adverse Event|3|||
30720187|NCT02658890|58733479|FG011|Treatment Phase|Adverse Event|0|||
30720188|NCT02658890|58733480|FG012|Treatment Phase|Adverse Event|1|||
30720189|NCT02658890|58733481|FG013|Treatment Phase|Adverse Event|4|||
30720190|NCT02658890|58733482|FG014|Treatment Phase|Adverse Event|0|||
30720191|NCT02658890|58733483|FG015|Treatment Phase|Adverse Event|0|||
30720192|NCT02658890|58733484|FG016|Treatment Phase|Adverse Event|0|||
30720193|NCT02658890|58733485|FG017|Treatment Phase|Adverse Event|0|||
30720194|NCT02658890|58733486|FG018|Treatment Phase|Adverse Event|5|||
30720195|NCT02658890|58733487|FG019|Treatment Phase|Adverse Event|1|||
30720196|NCT02658890|58733488|FG020|Treatment Phase|Adverse Event|3|||
30720197|NCT02658890|58733489|FG021|Treatment Phase|Adverse Event|0|||
30720198|NCT02658890|58733490|FG022|Treatment Phase|Adverse Event|5|||
30720199|NCT02658890|58733491|FG023|Treatment Phase|Adverse Event|0|||
30720200|NCT02658890|58733492|FG024|Treatment Phase|Adverse Event|0|||
30720201|NCT02658890|58733493|FG025|Treatment Phase|Adverse Event|2|||
30720202|NCT02658890|58733494|FG026|Treatment Phase|Adverse Event|1|||
30720203|NCT02658890|58733468|FG000|Treatment Phase|Death|0|||
30720204|NCT02658890|58733469|FG001|Treatment Phase|Death|0|||
30720205|NCT02658890|58733470|FG002|Treatment Phase|Death|0|||
30720206|NCT02658890|58733471|FG003|Treatment Phase|Death|0|||
30720207|NCT02658890|58733472|FG004|Treatment Phase|Death|0|||
30720208|NCT02658890|58733473|FG005|Treatment Phase|Death|0|||
30720209|NCT02658890|58733474|FG006|Treatment Phase|Death|0|||
30720210|NCT02658890|58733475|FG007|Treatment Phase|Death|0|||
30720211|NCT02658890|58733476|FG008|Treatment Phase|Death|0|||
30720212|NCT02658890|58733477|FG009|Treatment Phase|Death|0|||
30720213|NCT02658890|58733478|FG010|Treatment Phase|Death|0|||
30720214|NCT02658890|58733479|FG011|Treatment Phase|Death|0|||
30720215|NCT02658890|58733480|FG012|Treatment Phase|Death|0|||
30720216|NCT02658890|58733481|FG013|Treatment Phase|Death|0|||
30720217|NCT02658890|58733482|FG014|Treatment Phase|Death|0|||
30720218|NCT02658890|58733483|FG015|Treatment Phase|Death|0|||
30720219|NCT02658890|58733484|FG016|Treatment Phase|Death|0|||
30720220|NCT02658890|58733485|FG017|Treatment Phase|Death|0|||
30720221|NCT02658890|58733486|FG018|Treatment Phase|Death|1|||
30720222|NCT02658890|58733487|FG019|Treatment Phase|Death|0|||
30720223|NCT02658890|58733488|FG020|Treatment Phase|Death|0|||
30720224|NCT02658890|58733489|FG021|Treatment Phase|Death|0|||
30720225|NCT02658890|58733490|FG022|Treatment Phase|Death|0|||
30720226|NCT02658890|58733491|FG023|Treatment Phase|Death|0|||
30720227|NCT02658890|58733492|FG024|Treatment Phase|Death|0|||
30720228|NCT02658890|58733493|FG025|Treatment Phase|Death|0|||
30720229|NCT02658890|58733494|FG026|Treatment Phase|Death|0|||
30720230|NCT02658890|58733468|FG000|Treatment Phase|Lost to Follow-up|0|||
30720231|NCT02658890|58733469|FG001|Treatment Phase|Lost to Follow-up|0|||
30720232|NCT02658890|58733470|FG002|Treatment Phase|Lost to Follow-up|0|||
30720233|NCT02658890|58733471|FG003|Treatment Phase|Lost to Follow-up|0|||
30720234|NCT02658890|58733472|FG004|Treatment Phase|Lost to Follow-up|0|||
30720235|NCT02658890|58733473|FG005|Treatment Phase|Lost to Follow-up|0|||
30720236|NCT02658890|58733474|FG006|Treatment Phase|Lost to Follow-up|1|||
30720237|NCT02658890|58733475|FG007|Treatment Phase|Lost to Follow-up|0|||
30720238|NCT02658890|58733476|FG008|Treatment Phase|Lost to Follow-up|0|||
30720239|NCT02658890|58733477|FG009|Treatment Phase|Lost to Follow-up|0|||
30720240|NCT02658890|58733478|FG010|Treatment Phase|Lost to Follow-up|0|||
30720241|NCT02658890|58733479|FG011|Treatment Phase|Lost to Follow-up|0|||
30720242|NCT02658890|58733480|FG012|Treatment Phase|Lost to Follow-up|0|||
30720243|NCT02658890|58733481|FG013|Treatment Phase|Lost to Follow-up|0|||
30720244|NCT02658890|58733482|FG014|Treatment Phase|Lost to Follow-up|0|||
30720245|NCT02658890|58733483|FG015|Treatment Phase|Lost to Follow-up|0|||
30720246|NCT02658890|58733484|FG016|Treatment Phase|Lost to Follow-up|0|||
30720247|NCT02658890|58733485|FG017|Treatment Phase|Lost to Follow-up|0|||
30720248|NCT02658890|58733486|FG018|Treatment Phase|Lost to Follow-up|0|||
30720249|NCT02658890|58733487|FG019|Treatment Phase|Lost to Follow-up|0|||
30720250|NCT02658890|58733488|FG020|Treatment Phase|Lost to Follow-up|0|||
30720251|NCT02658890|58733489|FG021|Treatment Phase|Lost to Follow-up|0|||
30720252|NCT02658890|58733490|FG022|Treatment Phase|Lost to Follow-up|0|||
30720253|NCT02658890|58733491|FG023|Treatment Phase|Lost to Follow-up|0|||
30720254|NCT02658890|58733492|FG024|Treatment Phase|Lost to Follow-up|0|||
30720255|NCT02658890|58733493|FG025|Treatment Phase|Lost to Follow-up|0|||
30720256|NCT02658890|58733494|FG026|Treatment Phase|Lost to Follow-up|0|||
30720257|NCT02658890|58733468|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
30720258|NCT02658890|58733469|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
30720259|NCT02658890|58733470|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
30720260|NCT02658890|58733471|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
30720261|NCT02658890|58733472|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
30720262|NCT02658890|58733473|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
30720263|NCT02658890|58733474|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
30720264|NCT02658890|58733475|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
30720265|NCT02658890|58733476|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
30720266|NCT02658890|58733477|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
30720267|NCT02658890|58733478|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
30720268|NCT02658890|58733479|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
30720269|NCT02658890|58733480|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
30720270|NCT02658890|58733481|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
30720271|NCT02658890|58733482|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
30720272|NCT02658890|58733483|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
30720273|NCT02658890|58733484|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
30720274|NCT02658890|58733485|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
30720275|NCT02658890|58733486|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
30720276|NCT02658890|58733487|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
30720277|NCT02658890|58733488|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
30720278|NCT02658890|58733489|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
30720279|NCT02658890|58733490|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
30720280|NCT02658890|58733491|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
30720281|NCT02658890|58733492|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
30720282|NCT02658890|58733493|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
30720283|NCT02658890|58733494|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
30720284|NCT02658890|58733468|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
30720285|NCT02658890|58733469|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
30720286|NCT02658890|58733470|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
30720287|NCT02658890|58733471|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
30720288|NCT02658890|58733472|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
30720289|NCT02658890|58733473|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
30720290|NCT02658890|58733474|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
30720291|NCT02658890|58733475|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
30720292|NCT02658890|58733476|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
30720293|NCT02658890|58733477|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
30720294|NCT02658890|58733478|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
30720295|NCT02658890|58733479|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
30720296|NCT02658890|58733480|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
30720297|NCT02658890|58733481|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
30720298|NCT02658890|58733482|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
30720299|NCT02658890|58733483|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
30720300|NCT02658890|58733484|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
30621600|NCT00932698|58633211|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
30621601|NCT00932698|58633212|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
30621602|NCT00932698|58633213|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
30720301|NCT02658890|58733485|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
30720302|NCT02658890|58733486|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
30720303|NCT02658890|58733487|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
30720304|NCT02658890|58733488|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
30720305|NCT02658890|58733489|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
30720306|NCT02658890|58733490|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
30720307|NCT02658890|58733491|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
30720308|NCT02658890|58733492|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
30720309|NCT02658890|58733493|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
30720310|NCT02658890|58733494|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
30720311|NCT02658890|58733468|FG000|Treatment Phase|Other Reasons|0|||
30720312|NCT02658890|58733469|FG001|Treatment Phase|Other Reasons|0|||
30720313|NCT02658890|58733470|FG002|Treatment Phase|Other Reasons|0|||
30720314|NCT02658890|58733471|FG003|Treatment Phase|Other Reasons|0|||
30720315|NCT02658890|58733472|FG004|Treatment Phase|Other Reasons|0|||
30720316|NCT02658890|58733473|FG005|Treatment Phase|Other Reasons|0|||
30720317|NCT02658890|58733474|FG006|Treatment Phase|Other Reasons|1|||
30720318|NCT02658890|58733475|FG007|Treatment Phase|Other Reasons|0|||
30720319|NCT02658890|58733476|FG008|Treatment Phase|Other Reasons|1|||
30720320|NCT02658890|58733477|FG009|Treatment Phase|Other Reasons|0|||
30720321|NCT02658890|58733478|FG010|Treatment Phase|Other Reasons|0|||
30720322|NCT02658890|58733479|FG011|Treatment Phase|Other Reasons|0|||
30720323|NCT02658890|58733480|FG012|Treatment Phase|Other Reasons|0|||
30720324|NCT02658890|58733481|FG013|Treatment Phase|Other Reasons|2|||
30720325|NCT02658890|58733482|FG014|Treatment Phase|Other Reasons|0|||
30720326|NCT02658890|58733483|FG015|Treatment Phase|Other Reasons|0|||
30720327|NCT02658890|58733484|FG016|Treatment Phase|Other Reasons|0|||
30720328|NCT02658890|58733485|FG017|Treatment Phase|Other Reasons|0|||
30720329|NCT02658890|58733486|FG018|Treatment Phase|Other Reasons|1|||
30720330|NCT02658890|58733487|FG019|Treatment Phase|Other Reasons|0|||
30720331|NCT02658890|58733488|FG020|Treatment Phase|Other Reasons|0|||
30720332|NCT02658890|58733489|FG021|Treatment Phase|Other Reasons|0|||
30720333|NCT02658890|58733490|FG022|Treatment Phase|Other Reasons|0|||
30720334|NCT02658890|58733491|FG023|Treatment Phase|Other Reasons|0|||
30720335|NCT02658890|58733492|FG024|Treatment Phase|Other Reasons|1|||
30720336|NCT02658890|58733493|FG025|Treatment Phase|Other Reasons|0|||
30720337|NCT02658890|58733494|FG026|Treatment Phase|Other Reasons|1|||
30720338|NCT02658890|58733468|FG000|Treatment Phase|Progressive Disease|6|||
30720339|NCT02658890|58733469|FG001|Treatment Phase|Progressive Disease|7|||
30720340|NCT02658890|58733470|FG002|Treatment Phase|Progressive Disease|6|||
30720341|NCT02658890|58733471|FG003|Treatment Phase|Progressive Disease|12|||
30720342|NCT02658890|58733472|FG004|Treatment Phase|Progressive Disease|6|||
30720343|NCT02658890|58733473|FG005|Treatment Phase|Progressive Disease|18|||
30720344|NCT02658890|58733474|FG006|Treatment Phase|Progressive Disease|12|||
30720345|NCT02658890|58733475|FG007|Treatment Phase|Progressive Disease|19|||
30720346|NCT02658890|58733476|FG008|Treatment Phase|Progressive Disease|26|||
30720347|NCT02658890|58733477|FG009|Treatment Phase|Progressive Disease|8|||
30720348|NCT02658890|58733478|FG010|Treatment Phase|Progressive Disease|7|||
30720349|NCT02658890|58733479|FG011|Treatment Phase|Progressive Disease|9|||
30720350|NCT02658890|58733480|FG012|Treatment Phase|Progressive Disease|8|||
30720351|NCT02658890|58733481|FG013|Treatment Phase|Progressive Disease|29|||
30720352|NCT02658890|58733482|FG014|Treatment Phase|Progressive Disease|6|||
30720353|NCT02658890|58733483|FG015|Treatment Phase|Progressive Disease|2|||
30720354|NCT02658890|58733484|FG016|Treatment Phase|Progressive Disease|32|||
30621603|NCT00932698|58633214|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
30720355|NCT02658890|58733485|FG017|Treatment Phase|Progressive Disease|14|||
30720356|NCT02658890|58733486|FG018|Treatment Phase|Progressive Disease|40|||
30720357|NCT02658890|58733487|FG019|Treatment Phase|Progressive Disease|32|||
30720358|NCT02658890|58733488|FG020|Treatment Phase|Progressive Disease|19|||
30720359|NCT02658890|58733489|FG021|Treatment Phase|Progressive Disease|30|||
30720360|NCT02658890|58733490|FG022|Treatment Phase|Progressive Disease|15|||
30760613|NCT03118570|58769121|FG003|Overall Study|Adverse Event|0|||
30720361|NCT02658890|58733491|FG023|Treatment Phase|Progressive Disease|0|||
30720362|NCT02658890|58733492|FG024|Treatment Phase|Progressive Disease|0|||
30720363|NCT02658890|58733493|FG025|Treatment Phase|Progressive Disease|14|||
30720364|NCT02658890|58733494|FG026|Treatment Phase|Progressive Disease|11|||
30720365|NCT02658890|58733468|FG000|Treatment Phase|Study Drug Toxicity|0|||
30720366|NCT02658890|58733469|FG001|Treatment Phase|Study Drug Toxicity|0|||
30720367|NCT02658890|58733470|FG002|Treatment Phase|Study Drug Toxicity|2|||
30720368|NCT02658890|58733471|FG003|Treatment Phase|Study Drug Toxicity|0|||
30720369|NCT02658890|58733472|FG004|Treatment Phase|Study Drug Toxicity|0|||
30720370|NCT02658890|58733473|FG005|Treatment Phase|Study Drug Toxicity|0|||
30720371|NCT02658890|58733474|FG006|Treatment Phase|Study Drug Toxicity|0|||
30720372|NCT02658890|58733475|FG007|Treatment Phase|Study Drug Toxicity|0|||
30720373|NCT02658890|58733476|FG008|Treatment Phase|Study Drug Toxicity|3|||
30900304|NCT02323646|58933524|FG002|Treatment Course 2|Adverse Event|1|||
30900305|NCT02323646|58933522|FG000|Treatment Course 2|Lost to Follow-up|0|||
30900306|NCT02323646|58933523|FG001|Treatment Course 2|Lost to Follow-up|0|||
30900307|NCT02323646|58933524|FG002|Treatment Course 2|Lost to Follow-up|1|||
30900308|NCT02323646|58933522|FG000|Treatment Course 2|Non-compliance|0|||
30900309|NCT02323646|58933523|FG001|Treatment Course 2|Non-compliance|1|||
30900310|NCT02323646|58933524|FG002|Treatment Course 2|Non-compliance|1|||
30900311|NCT01846624|58933532|FG000|Overall Study|Died during induction, no midostaurin|1|||
30900312|NCT01829230|58933538|FG000|Overall Study|Protocol Violation|0|||
30900313|NCT01829230|58933539|FG001|Overall Study|Protocol Violation|2|||
30900314|NCT01829230|58933538|FG000|Overall Study|Withdrawal by Subject|0|||
30900315|NCT01829230|58933539|FG001|Overall Study|Withdrawal by Subject|1|||
30900316|NCT01829230|58933538|FG000|Overall Study|Lost to Follow-up|1|||
30900317|NCT01829230|58933539|FG001|Overall Study|Lost to Follow-up|1|||
30900318|NCT02269657|58933545|FG000|Overall Study|Protocol Violation|3|||
30900319|NCT02269423|58933555|FG000|Overall Study|Discontinued due to change in residence|0|||
30900320|NCT02269423|58933556|FG001|Overall Study|Discontinued due to change in residence|1|||
30900321|NCT02269423|58933557|FG002|Overall Study|Discontinued due to change in residence|0|||
30900322|NCT02269423|58933558|FG003|Overall Study|Discontinued due to change in residence|1|||
30900323|NCT01827670|58933570|FG000|Overall Study|Withdrawal of Consent|3|||
30900324|NCT01827670|58933571|FG001|Overall Study|Withdrawal of Consent|2|||
30900325|NCT01827670|58933570|FG000|Overall Study|Lost to Follow-up|0|||
30900326|NCT01827670|58933571|FG001|Overall Study|Lost to Follow-up|1|||
30900327|NCT02267317|58933585|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
30900328|NCT02267317|58933586|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
30900329|NCT02267317|58933587|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
30720374|NCT02658890|58733477|FG009|Treatment Phase|Study Drug Toxicity|0|||
30720375|NCT02658890|58733478|FG010|Treatment Phase|Study Drug Toxicity|1|||
30720376|NCT02658890|58733479|FG011|Treatment Phase|Study Drug Toxicity|1|||
30900330|NCT02267317|58933588|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
30900331|NCT02267317|58933589|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
30720377|NCT02658890|58733480|FG012|Treatment Phase|Study Drug Toxicity|2|||
30900332|NCT02267317|58933590|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
30900333|NCT02267317|58933585|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
30900334|NCT02267317|58933586|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
30720378|NCT02658890|58733481|FG013|Treatment Phase|Study Drug Toxicity|9|||
30720379|NCT02658890|58733482|FG014|Treatment Phase|Study Drug Toxicity|0|||
30720380|NCT02658890|58733483|FG015|Treatment Phase|Study Drug Toxicity|1|||
30720381|NCT02658890|58733484|FG016|Treatment Phase|Study Drug Toxicity|1|||
30720382|NCT02658890|58733485|FG017|Treatment Phase|Study Drug Toxicity|0|||
30720383|NCT02658890|58733486|FG018|Treatment Phase|Study Drug Toxicity|8|||
30720384|NCT02658890|58733487|FG019|Treatment Phase|Study Drug Toxicity|3|||
30720385|NCT02658890|58733488|FG020|Treatment Phase|Study Drug Toxicity|2|||
30720386|NCT02658890|58733489|FG021|Treatment Phase|Study Drug Toxicity|0|||
30720387|NCT02658890|58733490|FG022|Treatment Phase|Study Drug Toxicity|8|||
30720388|NCT02658890|58733491|FG023|Treatment Phase|Study Drug Toxicity|0|||
30720389|NCT02658890|58733492|FG024|Treatment Phase|Study Drug Toxicity|0|||
30720390|NCT02658890|58733493|FG025|Treatment Phase|Study Drug Toxicity|2|||
30720391|NCT02658890|58733494|FG026|Treatment Phase|Study Drug Toxicity|0|||
30720392|NCT02658890|58733468|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720393|NCT02658890|58733469|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720394|NCT02658890|58733470|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720395|NCT02658890|58733471|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
30720396|NCT02658890|58733472|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720397|NCT02658890|58733473|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720398|NCT02658890|58733474|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720399|NCT02658890|58733475|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720400|NCT02658890|58733476|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720401|NCT02658890|58733477|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
30720402|NCT02658890|58733478|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720403|NCT02658890|58733479|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720404|NCT02658890|58733480|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30621604|NCT00932698|58633215|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
30720405|NCT02658890|58733481|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30621605|NCT00932698|58633216|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
30720406|NCT02658890|58733482|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720407|NCT02658890|58733483|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720408|NCT02658890|58733484|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720409|NCT02658890|58733485|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720410|NCT02658890|58733486|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
30720411|NCT02658890|58733487|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720412|NCT02658890|58733488|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720413|NCT02658890|58733489|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720414|NCT02658890|58733490|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
30720415|NCT02658890|58733491|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720416|NCT02658890|58733492|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720417|NCT02658890|58733493|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720418|NCT02658890|58733494|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
30720419|NCT02658890|58733468|FG000|Treatment Phase|Withdrawal by Subject|0|||
30720420|NCT02658890|58733469|FG001|Treatment Phase|Withdrawal by Subject|1|||
30720421|NCT02658890|58733470|FG002|Treatment Phase|Withdrawal by Subject|0|||
30720422|NCT02658890|58733471|FG003|Treatment Phase|Withdrawal by Subject|0|||
30720423|NCT02658890|58733472|FG004|Treatment Phase|Withdrawal by Subject|0|||
30720424|NCT02658890|58733473|FG005|Treatment Phase|Withdrawal by Subject|0|||
30720425|NCT02658890|58733474|FG006|Treatment Phase|Withdrawal by Subject|1|||
30720426|NCT02658890|58733475|FG007|Treatment Phase|Withdrawal by Subject|0|||
30720427|NCT02658890|58733476|FG008|Treatment Phase|Withdrawal by Subject|0|||
30720428|NCT02658890|58733477|FG009|Treatment Phase|Withdrawal by Subject|1|||
30720429|NCT02658890|58733478|FG010|Treatment Phase|Withdrawal by Subject|0|||
30720430|NCT02658890|58733479|FG011|Treatment Phase|Withdrawal by Subject|0|||
30720431|NCT02658890|58733480|FG012|Treatment Phase|Withdrawal by Subject|1|||
30720432|NCT02658890|58733481|FG013|Treatment Phase|Withdrawal by Subject|3|||
30720433|NCT02658890|58733482|FG014|Treatment Phase|Withdrawal by Subject|0|||
30720434|NCT02658890|58733483|FG015|Treatment Phase|Withdrawal by Subject|0|||
30720435|NCT02658890|58733484|FG016|Treatment Phase|Withdrawal by Subject|1|||
30720436|NCT02658890|58733485|FG017|Treatment Phase|Withdrawal by Subject|0|||
30720437|NCT02658890|58733486|FG018|Treatment Phase|Withdrawal by Subject|4|||
30720438|NCT02658890|58733487|FG019|Treatment Phase|Withdrawal by Subject|3|||
30720439|NCT02658890|58733488|FG020|Treatment Phase|Withdrawal by Subject|0|||
30720440|NCT02658890|58733489|FG021|Treatment Phase|Withdrawal by Subject|4|||
30720441|NCT02658890|58733490|FG022|Treatment Phase|Withdrawal by Subject|1|||
30720442|NCT02658890|58733491|FG023|Treatment Phase|Withdrawal by Subject|1|||
30720443|NCT02658890|58733492|FG024|Treatment Phase|Withdrawal by Subject|0|||
30720444|NCT02658890|58733493|FG025|Treatment Phase|Withdrawal by Subject|0|||
30720445|NCT02658890|58733494|FG026|Treatment Phase|Withdrawal by Subject|0|||
30720446|NCT02597062|58733586|FG000|Overall Study|Ineligible|1|||
30760614|NCT03118570|58769122|FG004|Overall Study|Adverse Event|3|||
30760615|NCT03118570|58769118|FG000|Overall Study|Withdrawal by Subject|0|||
30760616|NCT03118570|58769119|FG001|Overall Study|Withdrawal by Subject|1|||
30760617|NCT03118570|58769120|FG002|Overall Study|Withdrawal by Subject|4|||
30760618|NCT03118570|58769121|FG003|Overall Study|Withdrawal by Subject|0|||
30760619|NCT03118570|58769122|FG004|Overall Study|Withdrawal by Subject|1|||
30760620|NCT03118570|58769118|FG000|Overall Study|Lost to Follow-up|2|||
30760621|NCT03118570|58769119|FG001|Overall Study|Lost to Follow-up|3|||
30760622|NCT03118570|58769120|FG002|Overall Study|Lost to Follow-up|1|||
30760623|NCT03118570|58769121|FG003|Overall Study|Lost to Follow-up|0|||
30760624|NCT03118570|58769122|FG004|Overall Study|Lost to Follow-up|1|||
30760625|NCT03118570|58769118|FG000|Overall Study|Other, Not Specified|1|||
30760626|NCT03118570|58769119|FG001|Overall Study|Other, Not Specified|3|||
30760627|NCT03118570|58769120|FG002|Overall Study|Other, Not Specified|0|||
30760628|NCT03118570|58769121|FG003|Overall Study|Other, Not Specified|0|||
30760629|NCT03118570|58769122|FG004|Overall Study|Other, Not Specified|0|||
30760630|NCT02971683|58769137|FG000|Overall Study|Other reasons|0|||
30760631|NCT02971683|58769138|FG001|Overall Study|Other reasons|1|||
30760632|NCT02971683|58769137|FG000|Overall Study|Poor/Non-Compliance|0|||
30760633|NCT02971683|58769138|FG001|Overall Study|Poor/Non-Compliance|1|||
30760634|NCT02971683|58769137|FG000|Overall Study|Lost to Follow-up|1|||
30760635|NCT02971683|58769138|FG001|Overall Study|Lost to Follow-up|0|||
30760636|NCT02971683|58769137|FG000|Overall Study|Participant withdrew consent|1|||
30720447|NCT05159362|58733627|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
30720448|NCT05159362|58733628|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
30720449|NCT05159362|58733629|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
30720450|NCT04975191|58733644|FG000|Overall Study|Protocol Violation|1|||
30720451|NCT04975191|58733645|FG001|Overall Study|Protocol Violation|2|||
30720452|NCT04975191|58733646|FG002|Overall Study|Protocol Violation|2|||
30720453|NCT04975191|58733647|FG003|Overall Study|Protocol Violation|2|||
30720454|NCT04975191|58733644|FG000|Overall Study|Lost to Follow-up|13|||
30720455|NCT04975191|58733645|FG001|Overall Study|Lost to Follow-up|3|||
30720456|NCT04975191|58733646|FG002|Overall Study|Lost to Follow-up|8|||
30720457|NCT04975191|58733647|FG003|Overall Study|Lost to Follow-up|8|||
30720458|NCT04492020|58733673|FG000|Overall Study|Adverse Event|1|||
30720459|NCT04492020|58733674|FG001|Overall Study|Adverse Event|3|||
30720460|NCT04492020|58733673|FG000|Overall Study|Withdrawal by Subject|4|||
30720461|NCT04492020|58733674|FG001|Overall Study|Withdrawal by Subject|3|||
30720462|NCT04492020|58733673|FG000|Overall Study|Lost to Follow-up|4|||
30720463|NCT04492020|58733674|FG001|Overall Study|Lost to Follow-up|3|||
30720464|NCT04492020|58733673|FG000|Overall Study|Protocol Violation|5|||
30720465|NCT04492020|58733674|FG001|Overall Study|Protocol Violation|2|||
30720466|NCT04492020|58733673|FG000|Overall Study|Lack of Qualifying Event|25|||
30720467|NCT04492020|58733674|FG001|Overall Study|Lack of Qualifying Event|27|||
30720468|NCT04492020|58733673|FG000|Overall Study|Non-compliance with Study Drug|2|||
30720469|NCT04492020|58733674|FG001|Overall Study|Non-compliance with Study Drug|1|||
30720470|NCT04382911|58733680|FG000|Overall Study|unable to be imaged prior to surgery|2|||
30720471|NCT04072575|58733688|FG000|Overall Study|Physician Decision|1|||
30720472|NCT04072575|58733688|FG000|Overall Study|Adverse Event|7|||
30720473|NCT04072575|58733688|FG000|Overall Study|Withdrawal by Subject|14|||
30720474|NCT04072575|58733688|FG000|Overall Study|Other|2|||
30720475|NCT03911869|58733694|FG000|Safety Lead-in Phase|Death|7|||
30720476|NCT03911869|58733695|FG001|Safety Lead-in Phase|Death|0|||
30720477|NCT03911869|58733696|FG002|Safety Lead-in Phase|Death|0|||
30720478|NCT03911869|58733694|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
30720479|NCT03911869|58733695|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
30720480|NCT03911869|58733696|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
30720481|NCT03911869|58733694|FG000|Safety Lead-in Phase|Other|1|||
30720482|NCT03911869|58733695|FG001|Safety Lead-in Phase|Other|0|||
30720483|NCT03911869|58733696|FG002|Safety Lead-in Phase|Other|0|||
30720484|NCT03911869|58733694|FG000|Phase 2|Death|0|||
30720485|NCT03911869|58733695|FG001|Phase 2|Death|3|||
30720486|NCT03911869|58733696|FG002|Phase 2|Death|0|||
30720487|NCT03897088|58733705|FG000|Overall Study|Withdrawal by Subject|12|||
30720488|NCT03897088|58733706|FG001|Overall Study|Withdrawal by Subject|12|||
30720489|NCT03897088|58733705|FG000|Overall Study|Lost to Follow-up|7|||
30720490|NCT03897088|58733706|FG001|Overall Study|Lost to Follow-up|15|||
30720491|NCT03897088|58733705|FG000|Overall Study|Sponsor Decision|1|||
30720492|NCT03897088|58733706|FG001|Overall Study|Sponsor Decision|2|||
30720493|NCT03897088|58733705|FG000|Overall Study|COVID-19|2|||
30720494|NCT03897088|58733706|FG001|Overall Study|COVID-19|0|||
30720495|NCT03897088|58733705|FG000|Overall Study|Other|3|||
30720496|NCT03897088|58733706|FG001|Overall Study|Other|0|||
30720497|NCT03897088|58733705|FG000|Overall Study|Non-compliance with Study Drug|1|||
30720498|NCT03897088|58733706|FG001|Overall Study|Non-compliance with Study Drug|1|||
30720499|NCT03897088|58733705|FG000|Overall Study|Pregnancy|0|||
30720500|NCT03897088|58733706|FG001|Overall Study|Pregnancy|1|||
30720501|NCT03700684|58733734|FG000|Overall Study|COVID-19|0|||
30720502|NCT03700684|58733735|FG001|Overall Study|COVID-19|0|||
30720503|NCT03700684|58733736|FG002|Overall Study|COVID-19|2|||
30720504|NCT03659136|58733746|FG000|Overall Study|Not treated|2|||
30720505|NCT03659136|58733747|FG001|Overall Study|Not treated|0|||
30720506|NCT03659136|58733746|FG000|Overall Study|Covid-19 related|1|||
30720507|NCT03659136|58733747|FG001|Overall Study|Covid-19 related|1|||
30720508|NCT03659136|58733746|FG000|Overall Study|Withdrawal by Subject|1|||
30720509|NCT03659136|58733747|FG001|Overall Study|Withdrawal by Subject|6|||
30720510|NCT03659136|58733746|FG000|Overall Study|Adverse Event|4|||
30720511|NCT03659136|58733747|FG001|Overall Study|Adverse Event|6|||
30720512|NCT03659136|58733746|FG000|Overall Study|Progressive disease|37|||
30720513|NCT03659136|58733747|FG001|Overall Study|Progressive disease|31|||
30720514|NCT03659136|58733746|FG000|Overall Study|Study closure|2|||
30720515|NCT03659136|58733747|FG001|Overall Study|Study closure|2|||
30720516|NCT03659136|58733746|FG000|Overall Study|Sponsor decision/recommendation|3|||
30720517|NCT03659136|58733747|FG001|Overall Study|Sponsor decision/recommendation|2|||
30720518|NCT03659136|58733746|FG000|Overall Study|Switched to other drug/therapy|2|||
30720519|NCT03659136|58733747|FG001|Overall Study|Switched to other drug/therapy|2|||
30720520|NCT03659136|58733746|FG000|Overall Study|Lack of clinical benefit|0|||
30720521|NCT03659136|58733747|FG001|Overall Study|Lack of clinical benefit|1|||
30720522|NCT03390036|58733782|FG000|Overall Study|Lost to Follow-up|1|||
30720523|NCT03390036|58733783|FG001|Overall Study|Lost to Follow-up|0|||
30720524|NCT03390036|58733784|FG002|Overall Study|Lost to Follow-up|0|||
30720525|NCT03390036|58733782|FG000|Overall Study|Lack of Efficacy|1|||
30720526|NCT03390036|58733783|FG001|Overall Study|Lack of Efficacy|0|||
30720527|NCT03390036|58733784|FG002|Overall Study|Lack of Efficacy|0|||
30720528|NCT03366844|58733809|FG000|Overall Study|Physician Decision|1|||
30720529|NCT03366844|58733809|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
30720530|NCT03341936|58733815|FG000|Overall Study|Ineligible|1|||
30720531|NCT03341936|58733815|FG000|Overall Study|Disease Progression|2|||
30720532|NCT03341936|58733815|FG000|Overall Study|Withdrew Consent|4|||
30720533|NCT03341936|58733815|FG000|Overall Study|Non-Compliance|1|||
30720534|NCT03341936|58733815|FG000|Overall Study|Physician Decision|1|||
30720535|NCT03341936|58733815|FG000|Overall Study|Withdrawal by Subject|1|||
30720536|NCT03341936|58733815|FG000|Overall Study|Other|1|||
30720537|NCT03284203|58733819|FG000|Overall Study|Lost to Follow-up|3|||
30760637|NCT02971683|58769138|FG001|Overall Study|Participant withdrew consent|1|||
30720538|NCT03233724|58733838|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
30720539|NCT03233724|58733839|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
30720540|NCT03233724|58733840|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
30720541|NCT03233724|58733841|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
30720542|NCT03233724|58733842|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
30720543|NCT03233724|58733838|FG000|Phase I Dose Escalation|Best interest of participant|1|||
30720544|NCT03233724|58733839|FG001|Phase I Dose Escalation|Best interest of participant|1|||
30720545|NCT03233724|58733840|FG002|Phase I Dose Escalation|Best interest of participant|1|||
30720546|NCT03233724|58733841|FG003|Phase I Dose Escalation|Best interest of participant|0|||
30720547|NCT03233724|58733842|FG004|Phase I Dose Escalation|Best interest of participant|0|||
30720548|NCT03233724|58733838|FG000|Phase I Dose Escalation|Physician Decision|0|||
30720549|NCT03233724|58733839|FG001|Phase I Dose Escalation|Physician Decision|0|||
30720550|NCT03233724|58733840|FG002|Phase I Dose Escalation|Physician Decision|1|||
30720551|NCT03233724|58733841|FG003|Phase I Dose Escalation|Physician Decision|0|||
30720552|NCT03233724|58733842|FG004|Phase I Dose Escalation|Physician Decision|0|||
30720553|NCT03233724|58733838|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
30720554|NCT03233724|58733839|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
30720555|NCT03233724|58733840|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
30720556|NCT03233724|58733841|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
30720557|NCT03233724|58733842|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
30720558|NCT03026283|58733856|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
30720559|NCT03026283|58733857|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
30720560|NCT03026283|58733858|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
30720561|NCT03026283|58733859|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
30720562|NCT03026283|58733860|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
30720563|NCT03026283|58733861|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
30720564|NCT03026283|58733862|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
30720565|NCT03026283|58733863|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
30720566|NCT03026283|58733856|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
30720567|NCT03026283|58733857|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
30720568|NCT03026283|58733858|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
30720569|NCT03026283|58733859|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
30720570|NCT03026283|58733860|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
30720571|NCT03026283|58733861|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
30720572|NCT03026283|58733862|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
30720573|NCT03026283|58733863|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
30720574|NCT03026283|58733856|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
30720575|NCT03026283|58733857|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
30720576|NCT03026283|58733858|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
30720577|NCT03026283|58733859|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
30720578|NCT03026283|58733860|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
30720579|NCT03026283|58733861|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
30720580|NCT03026283|58733862|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
30720581|NCT03026283|58733863|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
30720582|NCT03026283|58733856|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
30720583|NCT03026283|58733857|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
30720584|NCT03026283|58733858|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
30720585|NCT03026283|58733859|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
30720586|NCT03026283|58733860|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
30720587|NCT03026283|58733861|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
30720588|NCT03026283|58733862|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
30720589|NCT03026283|58733863|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
30720590|NCT03026283|58733856|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
30720591|NCT03026283|58733857|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
30720592|NCT03026283|58733858|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
30720593|NCT03026283|58733859|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
30720594|NCT03026283|58733860|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
30720595|NCT03026283|58733861|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
30720596|NCT03026283|58733862|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
30720597|NCT03026283|58733863|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
30720598|NCT03026283|58733856|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
30720599|NCT03026283|58733857|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
30720600|NCT03026283|58733858|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
30720601|NCT03026283|58733859|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
30720602|NCT03026283|58733860|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
30720603|NCT03026283|58733861|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
30720604|NCT03026283|58733862|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
30720605|NCT03026283|58733863|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
30720606|NCT03026283|58733856|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
30720607|NCT03026283|58733857|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
30720608|NCT03026283|58733858|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
30720609|NCT03026283|58733859|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
30720610|NCT03026283|58733860|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
30720611|NCT03026283|58733861|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
30720612|NCT03026283|58733862|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
30720613|NCT03026283|58733863|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
30720614|NCT03026283|58733856|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
30720615|NCT03026283|58733857|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
30720616|NCT03026283|58733858|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
30720617|NCT03026283|58733859|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
30720618|NCT03026283|58733860|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
30720619|NCT03026283|58733861|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
30720620|NCT03026283|58733862|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
30720621|NCT03026283|58733863|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
30720622|NCT03026283|58733856|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
30720623|NCT03026283|58733857|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
30720624|NCT03026283|58733858|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
30720625|NCT03026283|58733859|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
30720626|NCT03026283|58733860|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
30720627|NCT03026283|58733861|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
30720628|NCT03026283|58733862|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
30720629|NCT03026283|58733863|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
30720630|NCT02701283|58733897|FG000|Overall Study|Death|25|||
30720631|NCT02701283|58733898|FG001|Overall Study|Death|29|||
30720632|NCT02701283|58733899|FG002|Overall Study|Death|19|||
30720633|NCT02701283|58733897|FG000|Overall Study|Lost to Follow-up|3|||
30720634|NCT02701283|58733898|FG001|Overall Study|Lost to Follow-up|8|||
30720635|NCT02701283|58733899|FG002|Overall Study|Lost to Follow-up|1|||
30720636|NCT02701283|58733897|FG000|Overall Study|Withdrawal by Subject|12|||
30720637|NCT02701283|58733898|FG001|Overall Study|Withdrawal by Subject|41|||
30720638|NCT02701283|58733899|FG002|Overall Study|Withdrawal by Subject|1|||
30720639|NCT02701283|58733897|FG000|Overall Study|Missed 2-year visit|22|||
30720640|NCT02701283|58733898|FG001|Overall Study|Missed 2-year visit|27|||
30720641|NCT02701283|58733899|FG002|Overall Study|Missed 2-year visit|0|||
30720642|NCT02701283|58733897|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
30720643|NCT02701283|58733898|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
30720644|NCT02701283|58733899|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
30720645|NCT02166463|58733946|FG000|Overall Study|Lost to Follow-up|0|||
30720646|NCT02166463|58733947|FG001|Overall Study|Lost to Follow-up|1|||
30720647|NCT02166463|58733946|FG000|Overall Study|Physician Decision|10|||
30720648|NCT02166463|58733947|FG001|Overall Study|Physician Decision|10|||
30720649|NCT02166463|58733946|FG000|Overall Study|Ineligible|11|||
30720650|NCT02166463|58733947|FG001|Overall Study|Ineligible|2|||
30720651|NCT02166463|58733946|FG000|Overall Study|Progressive Disease|9|||
30720652|NCT02166463|58733947|FG001|Overall Study|Progressive Disease|6|||
30720653|NCT02166463|58733946|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
30720654|NCT02166463|58733947|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
30720655|NCT02166463|58733946|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
30720656|NCT02166463|58733947|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
30720657|NCT02166463|58733946|FG000|Overall Study|Refusal of further protocol therapy|5|||
30720658|NCT02166463|58733947|FG001|Overall Study|Refusal of further protocol therapy|6|||
30720659|NCT01994954|58733964|FG000|Overall Study|Death|1|||
30720660|NCT01994954|58733965|FG001|Overall Study|Death|0|||
30720661|NCT01994954|58733964|FG000|Overall Study|Withdrawal by Subject|9|||
30720662|NCT01994954|58733965|FG001|Overall Study|Withdrawal by Subject|14|||
30720663|NCT01994954|58733964|FG000|Overall Study|Physician Decision|2|||
30720664|NCT01994954|58733965|FG001|Overall Study|Physician Decision|2|||
30720665|NCT01994954|58733964|FG000|Overall Study|Lost to Follow-up|8|||
30720666|NCT01994954|58733965|FG001|Overall Study|Lost to Follow-up|10|||
30720667|NCT01994954|58733964|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
30720668|NCT01994954|58733965|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
30720669|NCT01902173|58733983|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
30720670|NCT01902173|58733984|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
30720671|NCT01902173|58733985|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
30720672|NCT01902173|58733986|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
30720673|NCT01902173|58733987|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
30720674|NCT01902173|58733988|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
30720675|NCT01902173|58733983|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
30720676|NCT01902173|58733984|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
30720677|NCT01902173|58733985|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
30720678|NCT01902173|58733986|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
30720679|NCT01902173|58733987|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
30720680|NCT01902173|58733988|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
30720681|NCT01902173|58733983|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
30720682|NCT01902173|58733984|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
30720683|NCT01902173|58733985|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
30720684|NCT01902173|58733986|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
30720685|NCT01902173|58733987|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
30720686|NCT01902173|58733988|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
30720687|NCT01902173|58733983|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
30720688|NCT01902173|58733984|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
30720689|NCT01902173|58733985|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
30720690|NCT01902173|58733986|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
30720691|NCT01902173|58733987|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
30720692|NCT01902173|58733988|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
30720693|NCT01902173|58733983|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
30720694|NCT01902173|58733984|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
30720695|NCT01902173|58733985|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
30720696|NCT01902173|58733986|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
30720697|NCT01902173|58733987|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
30720698|NCT01902173|58733988|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
30720699|NCT01902173|58733983|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
30720700|NCT01902173|58733984|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
30720701|NCT01902173|58733985|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
30720702|NCT01902173|58733986|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
30720703|NCT01902173|58733987|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
30720704|NCT01902173|58733988|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
30720705|NCT01902173|58733983|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
30720706|NCT01902173|58733984|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
30720707|NCT01902173|58733985|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
30720708|NCT01902173|58733986|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
30720709|NCT01902173|58733987|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
30720710|NCT01902173|58733988|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
30720711|NCT01902173|58733983|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
30720712|NCT01902173|58733984|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
30720713|NCT01902173|58733985|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
30720714|NCT01902173|58733986|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
30720715|NCT01902173|58733987|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
30720716|NCT01902173|58733988|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
30720717|NCT01902173|58733983|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
30720718|NCT01902173|58733984|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
30720719|NCT01902173|58733985|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
30720720|NCT01902173|58733986|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
30720721|NCT01902173|58733987|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
30720722|NCT01902173|58733988|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
30720723|NCT01902173|58733983|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
30720724|NCT01902173|58733984|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
30720725|NCT01902173|58733985|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
30720726|NCT01902173|58733986|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
30720727|NCT01902173|58733987|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
30720728|NCT01902173|58733988|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
30720729|NCT01902173|58733983|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
30720730|NCT01902173|58733984|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
30720731|NCT01902173|58733985|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
30720732|NCT01902173|58733986|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
30720733|NCT01902173|58733987|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
30720734|NCT01902173|58733988|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
30720735|NCT01902173|58733983|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
30720736|NCT01902173|58733984|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
30720737|NCT01902173|58733985|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
30720738|NCT01902173|58733986|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
30720739|NCT01902173|58733987|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
30720740|NCT01902173|58733988|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
30720741|NCT01902173|58733983|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
30720742|NCT01902173|58733984|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
30720743|NCT01902173|58733985|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
30720744|NCT01902173|58733986|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
30720745|NCT01902173|58733987|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
30720746|NCT01902173|58733988|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
30720747|NCT01902173|58733983|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
30720748|NCT01902173|58733984|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
30720749|NCT01902173|58733985|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
30720750|NCT01902173|58733986|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
30720751|NCT01902173|58733987|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
30720752|NCT01902173|58733988|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
30720753|NCT00861705|58734067|FG000|Overall Study|Never Began Treatment|7|||
30720754|NCT00861705|58734068|FG001|Overall Study|Never Began Treatment|3|||
30621606|NCT00932698|58633217|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
30720755|NCT00861705|58734069|FG002|Overall Study|Never Began Treatment|0|||
30720756|NCT00861705|58734070|FG003|Overall Study|Never Began Treatment|1|||
30720757|NCT00380367|58734095|FG000|Overall Study|Lost to Follow-up|1|||
30720758|NCT00380367|58734095|FG000|Overall Study|Withdrawal by Subject|1|||
30720759|NCT00531050|58734105|FG000|Part 1: Period 1|Adverse Event|0|||
30720760|NCT00531050|58734106|FG001|Part 1: Period 1|Adverse Event|1|||
30720761|NCT00531050|58734107|FG002|Part 1: Period 1|Adverse Event|0|||
30720762|NCT00531050|58734108|FG003|Part 1: Period 1|Adverse Event|0|||
30720763|NCT00531050|58734109|FG004|Part 1: Period 1|Adverse Event|0|||
30720764|NCT00531050|58734110|FG005|Part 1: Period 1|Adverse Event|0|||
30720765|NCT00531050|58734105|FG000|Part 1: Period 1|Protocol Deviation|0|||
30720766|NCT00531050|58734106|FG001|Part 1: Period 1|Protocol Deviation|0|||
30720767|NCT00531050|58734107|FG002|Part 1: Period 1|Protocol Deviation|0|||
30720768|NCT00531050|58734108|FG003|Part 1: Period 1|Protocol Deviation|1|||
30720769|NCT00531050|58734109|FG004|Part 1: Period 1|Protocol Deviation|0|||
30720770|NCT00531050|58734110|FG005|Part 1: Period 1|Protocol Deviation|0|||
30720771|NCT00531050|58734105|FG000|Part 1: Period 3|Adverse Event|1|||
30720772|NCT00531050|58734106|FG001|Part 1: Period 3|Adverse Event|0|||
30720773|NCT00531050|58734107|FG002|Part 1: Period 3|Adverse Event|0|||
30720774|NCT00531050|58734108|FG003|Part 1: Period 3|Adverse Event|0|||
30720775|NCT00531050|58734109|FG004|Part 1: Period 3|Adverse Event|0|||
30720776|NCT00531050|58734110|FG005|Part 1: Period 3|Adverse Event|0|||
30720777|NCT00531050|58734105|FG000|Part 2: Period 1|Adverse Event|0|||
30720778|NCT00531050|58734106|FG001|Part 2: Period 1|Adverse Event|0|||
30720779|NCT00531050|58734107|FG002|Part 2: Period 1|Adverse Event|0|||
30621607|NCT00932698|58633218|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
30720780|NCT00531050|58734108|FG003|Part 2: Period 1|Adverse Event|0|||
30720781|NCT00531050|58734109|FG004|Part 2: Period 1|Adverse Event|0|||
30720782|NCT00531050|58734110|FG005|Part 2: Period 1|Adverse Event|1|||
30720783|NCT00531050|58734105|FG000|Part 2: Period 3|Abnormal test procedure|1|||
30720784|NCT00531050|58734106|FG001|Part 2: Period 3|Abnormal test procedure|0|||
30720785|NCT00531050|58734107|FG002|Part 2: Period 3|Abnormal test procedure|0|||
30720786|NCT00531050|58734108|FG003|Part 2: Period 3|Abnormal test procedure|0|||
30720787|NCT00531050|58734109|FG004|Part 2: Period 3|Abnormal test procedure|0|||
30720788|NCT00531050|58734110|FG005|Part 2: Period 3|Abnormal test procedure|1|||
30720789|NCT00530348|58734129|FG000|Overall Study|Adverse Event|5|||
30720790|NCT00530348|58734130|FG001|Overall Study|Adverse Event|1|||
30720791|NCT00530348|58734129|FG000|Overall Study|Death|0|||
30720792|NCT00530348|58734130|FG001|Overall Study|Death|1|||
30720793|NCT00530348|58734129|FG000|Overall Study|Lack of Efficacy|2|||
30720794|NCT00530348|58734130|FG001|Overall Study|Lack of Efficacy|0|||
30720795|NCT00530348|58734129|FG000|Overall Study|Lost to Follow-up|0|||
30720796|NCT00530348|58734130|FG001|Overall Study|Lost to Follow-up|2|||
30720797|NCT00530348|58734129|FG000|Overall Study|Physician Decision|1|||
30720798|NCT00530348|58734130|FG001|Overall Study|Physician Decision|2|||
30720799|NCT00530348|58734129|FG000|Overall Study|Pregnancy|1|||
30720800|NCT00530348|58734130|FG001|Overall Study|Pregnancy|0|||
30720801|NCT00530348|58734129|FG000|Overall Study|Withdrawal by Subject|12|||
30720802|NCT00530348|58734130|FG001|Overall Study|Withdrawal by Subject|12|||
30720803|NCT00530348|58734129|FG000|Overall Study|Randomised in error|1|||
30720804|NCT00530348|58734130|FG001|Overall Study|Randomised in error|0|||
30720805|NCT00530348|58734129|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
30720806|NCT00530348|58734130|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
30720807|NCT03886220|58734138|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
30720808|NCT03886220|58734139|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
30720809|NCT03886220|58734138|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
30720810|NCT03886220|58734139|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30720811|NCT03886220|58734138|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
30720812|NCT03886220|58734139|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
30720813|NCT00530270|58734147|FG000|Overall Study|Protocol Violation|1|||
30720814|NCT00530270|58734148|FG001|Overall Study|Protocol Violation|0|||
30720815|NCT03885596|58734158|FG000|Overall Study|Withdrawal by Subject|2|||
30720816|NCT03885596|58734159|FG001|Overall Study|Withdrawal by Subject|1|||
30720817|NCT03885596|58734160|FG002|Overall Study|Withdrawal by Subject|0|||
30720818|NCT03885596|58734161|FG003|Overall Study|Withdrawal by Subject|0|||
30720819|NCT00529100|58734177|FG000|Overall Study|Adverse Event|0|||
30720820|NCT00529100|58734178|FG001|Overall Study|Adverse Event|5|||
30720821|NCT00529100|58734177|FG000|Overall Study|Protocol Violation|0|||
30720822|NCT00529100|58734178|FG001|Overall Study|Protocol Violation|1|||
30720823|NCT00529100|58734177|FG000|Overall Study|Progressive Disease|0|||
30720824|NCT00529100|58734178|FG001|Overall Study|Progressive Disease|1|||
30720825|NCT00529100|58734177|FG000|Overall Study|Withdrawal by Subject|0|||
30720826|NCT00529100|58734178|FG001|Overall Study|Withdrawal by Subject|1|||
30720827|NCT00529100|58734177|FG000|Overall Study|Participant Ineligibility|0|||
30720828|NCT00529100|58734178|FG001|Overall Study|Participant Ineligibility|1|||
30720829|NCT03878108|58734190|FG000|Overall Study|Adverse Event|1|||
30720830|NCT03878108|58734191|FG001|Overall Study|Adverse Event|0|||
30720831|NCT00529958|58734200|FG000|2-Year Follow-up|Lost to Follow-up|1|||
30720832|NCT00529958|58734201|FG001|2-Year Follow-up|Lost to Follow-up|2|||
30720833|NCT00529958|58734202|FG002|2-Year Follow-up|Lost to Follow-up|2|||
30720834|NCT00529958|58734200|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
30720835|NCT00529958|58734201|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
30720836|NCT00529958|58734202|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
30720837|NCT00529958|58734200|FG000|5-Year Follow-up|Lost to Follow-up|2|||
30720838|NCT00529958|58734201|FG001|5-Year Follow-up|Lost to Follow-up|3|||
30720839|NCT00529958|58734202|FG002|5-Year Follow-up|Lost to Follow-up|1|||
30720840|NCT00529958|58734200|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
30720841|NCT00529958|58734201|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
30720842|NCT00529958|58734202|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
30720843|NCT00529802|58734210|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
30720844|NCT00529802|58734210|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
30720845|NCT00529802|58734210|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
30720846|NCT00529802|58734210|FG000|Evaluable for Primary Endpoint|Death|1|||
30720847|NCT00529802|58734210|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
30720848|NCT00529802|58734210|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
30720849|NCT00529802|58734210|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
30720850|NCT00528866|58734216|FG000|Overall Study|Protocol Violation|6|||
30720851|NCT00614393|58734226|FG000|Overall Study|Adverse Event|20|||
30720852|NCT00614393|58734227|FG001|Overall Study|Adverse Event|2|||
30720853|NCT00614393|58734228|FG002|Overall Study|Adverse Event|3|||
30720854|NCT00614393|58734229|FG003|Overall Study|Adverse Event|13|||
30720855|NCT00614393|58734230|FG004|Overall Study|Adverse Event|21|||
30720856|NCT00614393|58734226|FG000|Overall Study|Lost to Follow-up|0|||
30720857|NCT00614393|58734227|FG001|Overall Study|Lost to Follow-up|0|||
30720858|NCT00614393|58734228|FG002|Overall Study|Lost to Follow-up|0|||
30720859|NCT00614393|58734229|FG003|Overall Study|Lost to Follow-up|1|||
30720860|NCT00614393|58734230|FG004|Overall Study|Lost to Follow-up|2|||
30720861|NCT00614393|58734226|FG000|Overall Study|Physician Decision|17|||
30720862|NCT00614393|58734227|FG001|Overall Study|Physician Decision|0|||
30720863|NCT00614393|58734228|FG002|Overall Study|Physician Decision|1|||
30720864|NCT00614393|58734229|FG003|Overall Study|Physician Decision|8|||
30720865|NCT00614393|58734230|FG004|Overall Study|Physician Decision|9|||
30720866|NCT00614393|58734226|FG000|Overall Study|Progressive Disease|118|||
30720867|NCT00614393|58734227|FG001|Overall Study|Progressive Disease|5|||
30720868|NCT00614393|58734228|FG002|Overall Study|Progressive Disease|5|||
30720869|NCT00614393|58734229|FG003|Overall Study|Progressive Disease|138|||
30720870|NCT00614393|58734230|FG004|Overall Study|Progressive Disease|130|||
30720871|NCT00614393|58734226|FG000|Overall Study|Protocol Violation|1|||
30720872|NCT00614393|58734227|FG001|Overall Study|Protocol Violation|0|||
30720873|NCT00614393|58734228|FG002|Overall Study|Protocol Violation|0|||
30720874|NCT00614393|58734229|FG003|Overall Study|Protocol Violation|0|||
30720875|NCT00614393|58734230|FG004|Overall Study|Protocol Violation|0|||
30720876|NCT00614393|58734226|FG000|Overall Study|Terminated by Sponsor|0|||
30720877|NCT00614393|58734227|FG001|Overall Study|Terminated by Sponsor|0|||
30720878|NCT00614393|58734228|FG002|Overall Study|Terminated by Sponsor|0|||
30720879|NCT00614393|58734229|FG003|Overall Study|Terminated by Sponsor|0|||
30720880|NCT00614393|58734230|FG004|Overall Study|Terminated by Sponsor|1|||
30720881|NCT00614393|58734226|FG000|Overall Study|Withdrawal by Subject|20|||
30720882|NCT00614393|58734227|FG001|Overall Study|Withdrawal by Subject|1|||
30720883|NCT00614393|58734228|FG002|Overall Study|Withdrawal by Subject|1|||
30720884|NCT00614393|58734229|FG003|Overall Study|Withdrawal by Subject|16|||
30720885|NCT00614393|58734230|FG004|Overall Study|Withdrawal by Subject|13|||
30720886|NCT00614393|58734226|FG000|Overall Study|Other|4|||
30720887|NCT00614393|58734227|FG001|Overall Study|Other|0|||
30720888|NCT00614393|58734228|FG002|Overall Study|Other|0|||
30720889|NCT00614393|58734229|FG003|Overall Study|Other|4|||
30720890|NCT00614393|58734230|FG004|Overall Study|Other|2|||
30720891|NCT00614393|58734226|FG000|Overall Study|Not Treated|0|||
30720892|NCT00614393|58734227|FG001|Overall Study|Not Treated|0|||
30720893|NCT00614393|58734228|FG002|Overall Study|Not Treated|0|||
30720894|NCT00614393|58734229|FG003|Overall Study|Not Treated|0|||
30720895|NCT00614393|58734230|FG004|Overall Study|Not Treated|2|||
30720896|NCT00612677|58734242|FG000|Overall Study|study closed before treatment started|1|||
30720897|NCT00613925|58734248|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
30720898|NCT00613925|58734249|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
30720899|NCT00613301|58734255|FG000|Overall Study|Adverse Event|49|||
30720900|NCT00613301|58734255|FG000|Overall Study|Lost to Follow-up|88|||
30720901|NCT00613301|58734255|FG000|Overall Study|Withdrawal by Subject|5|||
30720902|NCT00613301|58734255|FG000|Overall Study|Death|6|||
30720903|NCT00613301|58734255|FG000|Overall Study|Lack of Efficacy|13|||
30720904|NCT00613301|58734255|FG000|Overall Study|Physician Decision|2|||
30720905|NCT00613301|58734255|FG000|Overall Study|No data was collected|53|||
30720906|NCT00613301|58734255|FG000|Overall Study|Irregularly enrolled patients|12|||
30720907|NCT00609947|58734260|FG000|Overall Study|Death|1|||
30720908|NCT00609869|58734265|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
30720909|NCT00609869|58734265|FG000|Overall Study|Severe hematologic toxicity|1|||
30720910|NCT00609869|58734265|FG000|Overall Study|Withdrawal by Subject|1|||
30720911|NCT00609869|58734265|FG000|Overall Study|Seizures|1|||
30720912|NCT00609869|58734265|FG000|Overall Study|Severe tumor flare reaction|1|||
30720913|NCT00609869|58734265|FG000|Overall Study|Hepatitis B infection|1|||
30720914|NCT00609869|58734265|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
30720915|NCT00609869|58734265|FG000|Overall Study|Mantle cell: not evaluable|4|||
30720916|NCT00529568|58734271|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
30720917|NCT00529568|58734272|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
30720918|NCT00529568|58734273|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
30720919|NCT00529568|58734271|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
30720920|NCT00529568|58734272|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
30720921|NCT00529568|58734273|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
30720922|NCT00529568|58734271|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
30720923|NCT00529568|58734272|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
30720924|NCT00529568|58734273|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
30720925|NCT00529568|58734271|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
30720926|NCT00529568|58734272|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
30720927|NCT00529568|58734273|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
30720928|NCT00529568|58734271|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
30720929|NCT00529568|58734272|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
30720930|NCT00529568|58734273|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
30720931|NCT00529568|58734271|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
30720932|NCT00529568|58734272|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
30720933|NCT00529568|58734273|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
30720934|NCT00529568|58734271|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
30720935|NCT00529568|58734272|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
30720936|NCT00529568|58734273|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
30720937|NCT00529568|58734271|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
30720938|NCT00529568|58734272|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
30720939|NCT00529568|58734273|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
30720940|NCT00529568|58734271|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
30720941|NCT00529568|58734272|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
30720942|NCT00529568|58734273|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
30720943|NCT00529568|58734271|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
30720944|NCT00529568|58734272|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
30720945|NCT00529568|58734273|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
30720946|NCT00529568|58734271|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
30720947|NCT00529568|58734272|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
30720948|NCT00529568|58734273|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
30720949|NCT00611975|58734284|FG000|Overall Study|Withdrawal by Subject|3|||
30720950|NCT00611975|58734285|FG001|Overall Study|Withdrawal by Subject|7|||
30720951|NCT00611975|58734284|FG000|Overall Study|Pregnancy|2|||
30720952|NCT00611975|58734285|FG001|Overall Study|Pregnancy|1|||
30720953|NCT00573131|58734293|FG000|Overall Study|Withdrawal by Subject|10|||
30621608|NCT00932698|58633219|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
30621609|NCT00932698|58633209|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
30720954|NCT00573131|58734294|FG001|Overall Study|Withdrawal by Subject|8|||
30720955|NCT00521144|58734305|FG000|Overall Study|Not Treated|0|||
30720956|NCT00521144|58734306|FG001|Overall Study|Not Treated|0|||
30720957|NCT00521144|58734307|FG002|Overall Study|Not Treated|0|||
30720958|NCT00521144|58734308|FG003|Overall Study|Not Treated|1|||
30720959|NCT00521144|58734309|FG004|Overall Study|Not Treated|0|||
30720960|NCT00521144|58734305|FG000|Overall Study|Adverse Event|0|||
30720961|NCT00521144|58734306|FG001|Overall Study|Adverse Event|1|||
30720962|NCT00521144|58734307|FG002|Overall Study|Adverse Event|0|||
30720963|NCT00521144|58734308|FG003|Overall Study|Adverse Event|0|||
30720964|NCT00521144|58734309|FG004|Overall Study|Adverse Event|1|||
30720965|NCT00521144|58734305|FG000|Overall Study|Progressive Disease|4|||
30720966|NCT00521144|58734306|FG001|Overall Study|Progressive Disease|2|||
30720967|NCT00521144|58734307|FG002|Overall Study|Progressive Disease|2|||
30720968|NCT00521144|58734308|FG003|Overall Study|Progressive Disease|0|||
30720969|NCT00521144|58734309|FG004|Overall Study|Progressive Disease|6|||
30720970|NCT00520676|58734323|FG000|Overall Study|Death|84|||
30720971|NCT00520676|58734324|FG001|Overall Study|Death|81|||
30720972|NCT00520676|58734323|FG000|Overall Study|Lost to Follow-up|6|||
30720973|NCT00520676|58734324|FG001|Overall Study|Lost to Follow-up|10|||
30720974|NCT00520676|58734323|FG000|Overall Study|Physician Decision|4|||
30720975|NCT00520676|58734324|FG001|Overall Study|Physician Decision|1|||
30720976|NCT00520676|58734323|FG000|Overall Study|Withdrawal by Subject|7|||
30720977|NCT00520676|58734324|FG001|Overall Study|Withdrawal by Subject|11|||
30720978|NCT00610649|58734341|FG000|Overall Study|Adverse Event|1|||
30720979|NCT00610649|58734342|FG001|Overall Study|Adverse Event|0|||
30720980|NCT00610649|58734343|FG002|Overall Study|Adverse Event|0|||
30720981|NCT00610649|58734344|FG003|Overall Study|Adverse Event|0|||
30720982|NCT00610649|58734345|FG004|Overall Study|Adverse Event|0|||
30720983|NCT00610649|58734346|FG005|Overall Study|Adverse Event|0|||
30720984|NCT00610649|58734347|FG006|Overall Study|Adverse Event|0|||
30720985|NCT00610649|58734348|FG007|Overall Study|Adverse Event|0|||
30720986|NCT00610649|58734349|FG008|Overall Study|Adverse Event|0|||
30720987|NCT00610649|58734350|FG009|Overall Study|Adverse Event|0|||
30720988|NCT00610649|58734351|FG010|Overall Study|Adverse Event|1|||
30720989|NCT00610649|58734341|FG000|Overall Study|Family Emergency|0|||
30720990|NCT00610649|58734342|FG001|Overall Study|Family Emergency|1|||
30720991|NCT00610649|58734343|FG002|Overall Study|Family Emergency|0|||
30720992|NCT00610649|58734344|FG003|Overall Study|Family Emergency|0|||
30720993|NCT00610649|58734345|FG004|Overall Study|Family Emergency|0|||
30720994|NCT00610649|58734346|FG005|Overall Study|Family Emergency|0|||
30720995|NCT00610649|58734347|FG006|Overall Study|Family Emergency|0|||
30720996|NCT00610649|58734348|FG007|Overall Study|Family Emergency|0|||
30720997|NCT00610649|58734349|FG008|Overall Study|Family Emergency|0|||
30720998|NCT00610649|58734350|FG009|Overall Study|Family Emergency|0|||
30720999|NCT00610649|58734351|FG010|Overall Study|Family Emergency|0|||
30721000|NCT00610649|58734341|FG000|Overall Study|Withdrawal by Subject|0|||
30721001|NCT00610649|58734342|FG001|Overall Study|Withdrawal by Subject|0|||
30721002|NCT00610649|58734343|FG002|Overall Study|Withdrawal by Subject|0|||
30721003|NCT00610649|58734344|FG003|Overall Study|Withdrawal by Subject|0|||
30621610|NCT00932698|58633210|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
30721004|NCT00610649|58734345|FG004|Overall Study|Withdrawal by Subject|0|||
30721005|NCT00610649|58734346|FG005|Overall Study|Withdrawal by Subject|0|||
30721006|NCT00610649|58734347|FG006|Overall Study|Withdrawal by Subject|0|||
30721007|NCT00610649|58734348|FG007|Overall Study|Withdrawal by Subject|0|||
30721008|NCT00610649|58734349|FG008|Overall Study|Withdrawal by Subject|0|||
30721009|NCT00610649|58734350|FG009|Overall Study|Withdrawal by Subject|1|||
30721010|NCT00610649|58734351|FG010|Overall Study|Withdrawal by Subject|0|||
30721011|NCT00608543|58734375|FG000|Overall Study|Adverse Event|4|||
30721012|NCT00520130|58734382|FG000|Overall Study|Disease progression on study|4|||
30721013|NCT00520130|58734383|FG001|Overall Study|Disease progression on study|0|||
30721014|NCT00520130|58734382|FG000|Overall Study|Physician Decision|1|||
30721015|NCT00520130|58734383|FG001|Overall Study|Physician Decision|1|||
30721016|NCT00519896|58734393|FG000|Overall Study|Protocol Violation|1|||
30721017|NCT00519896|58734393|FG000|Overall Study|Adverse Event|1|||
30721018|NCT00527618|58734406|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
30721019|NCT00527618|58734407|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
30721020|NCT00527618|58734406|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
30721021|NCT00527618|58734407|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
30721022|NCT00527618|58734406|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
30721023|NCT00527618|58734407|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
30721024|NCT00527618|58734406|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
30721025|NCT00527618|58734407|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
30721026|NCT00527618|58734406|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
30721027|NCT00527618|58734407|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
30721028|NCT00527618|58734406|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
30721029|NCT00527618|58734407|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
30721030|NCT00527072|58734414|FG000|Overall Study|Adverse Event|13|||
30721031|NCT00527072|58734414|FG000|Overall Study|Lack of Efficacy|11|||
30721032|NCT00527072|58734414|FG000|Overall Study|Lost to Follow-up|3|||
30721033|NCT00527072|58734414|FG000|Overall Study|Protocol Violation|2|||
30721034|NCT00527072|58734414|FG000|Overall Study|Withdrawal by Subject|7|||
30721035|NCT00526994|58734422|FG000|Overall Study|Lost to Follow-up|98|||
30721036|NCT00526994|58734423|FG001|Overall Study|Lost to Follow-up|108|||
30721037|NCT00526994|58734424|FG002|Overall Study|Lost to Follow-up|96|||
30721038|NCT00526994|58734422|FG000|Overall Study|Death|4|||
30721039|NCT00526994|58734423|FG001|Overall Study|Death|3|||
30721040|NCT00526994|58734424|FG002|Overall Study|Death|3|||
30721041|NCT00526994|58734422|FG000|Overall Study|Withdrawal by Subject|2|||
30721042|NCT00526994|58734423|FG001|Overall Study|Withdrawal by Subject|7|||
30721043|NCT00526994|58734424|FG002|Overall Study|Withdrawal by Subject|5|||
30721044|NCT00526994|58734422|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
30721045|NCT00526994|58734423|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
30721046|NCT00526994|58734424|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
30721047|NCT00519428|58734435|FG000|Overall Study|Adverse Event|5|||
30721048|NCT00519428|58734436|FG001|Overall Study|Adverse Event|2|||
30721049|NCT00519428|58734437|FG002|Overall Study|Adverse Event|10|||
30721050|NCT00519428|58734435|FG000|Overall Study|Lost to Follow-up|7|||
30721051|NCT00519428|58734436|FG001|Overall Study|Lost to Follow-up|7|||
30721052|NCT00519428|58734437|FG002|Overall Study|Lost to Follow-up|6|||
30721053|NCT00519428|58734435|FG000|Overall Study|Withdrawal by Subject|8|||
30721054|NCT00519428|58734436|FG001|Overall Study|Withdrawal by Subject|3|||
30721055|NCT00519428|58734437|FG002|Overall Study|Withdrawal by Subject|7|||
30721056|NCT00519428|58734435|FG000|Overall Study|unstated|1|||
30721057|NCT00519428|58734436|FG001|Overall Study|unstated|3|||
30721058|NCT00519428|58734437|FG002|Overall Study|unstated|2|||
30721059|NCT00432159|58734453|FG000|Overall Study|Death|0|||
30721060|NCT00432159|58734454|FG001|Overall Study|Death|1|||
30721061|NCT00432159|58734455|FG002|Overall Study|Death|0|||
30721062|NCT00432159|58734456|FG003|Overall Study|Death|0|||
30721063|NCT00432159|58734457|FG004|Overall Study|Death|0|||
30721064|NCT00432159|58734453|FG000|Overall Study|Failure|9|||
30721065|NCT00432159|58734454|FG001|Overall Study|Failure|5|||
30721066|NCT00432159|58734455|FG002|Overall Study|Failure|3|||
30721067|NCT00432159|58734456|FG003|Overall Study|Failure|2|||
30721068|NCT00432159|58734457|FG004|Overall Study|Failure|3|||
30721069|NCT00432159|58734453|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
30721070|NCT00432159|58734454|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
30721071|NCT00432159|58734455|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
30721072|NCT00432159|58734456|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
30721073|NCT00432159|58734457|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
30721074|NCT00519194|58734469|FG000|Overall Study|Withdrawal by Subject|9|||
30721075|NCT00519194|58734469|FG000|Overall Study|Death|9|||
30721076|NCT00519194|58734469|FG000|Overall Study|Lost to Follow-up|3|||
30721077|NCT00431847|58734477|FG000|Overall Study|completion of less than two study visits|6|||
30721078|NCT00431847|58734478|FG001|Overall Study|completion of less than two study visits|3|||
30721079|NCT00431847|58734479|FG002|Overall Study|completion of less than two study visits|4|||
30721080|NCT00431847|58734480|FG003|Overall Study|completion of less than two study visits|14|||
30721081|NCT00431847|58734481|FG004|Overall Study|completion of less than two study visits|0|||
30721082|NCT00431847|58734477|FG000|Overall Study|Protocol Violation|0|||
30721083|NCT00431847|58734478|FG001|Overall Study|Protocol Violation|0|||
30721084|NCT00431847|58734479|FG002|Overall Study|Protocol Violation|0|||
30721085|NCT00431847|58734480|FG003|Overall Study|Protocol Violation|0|||
30721086|NCT00431847|58734481|FG004|Overall Study|Protocol Violation|1|||
30721087|NCT00431067|58734491|FG000|Overall Study|Other Adverse Event|9|||
30721088|NCT00431067|58734491|FG000|Overall Study|Progressive disease|30|||
30721089|NCT00431067|58734491|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
30721090|NCT00430989|58734497|FG000|Overall Study|Lost to Follow-up|2|||
30721091|NCT00430989|58734498|FG001|Overall Study|Lost to Follow-up|3|||
30721092|NCT00430989|58734497|FG000|Overall Study|Withdrawal by Subject|15|||
30721093|NCT00430989|58734498|FG001|Overall Study|Withdrawal by Subject|14|||
30721094|NCT00430989|58734497|FG000|Overall Study|Protocol Violation|30|||
30721095|NCT00430989|58734498|FG001|Overall Study|Protocol Violation|37|||
30721096|NCT00430989|58734497|FG000|Overall Study|Not eligible|13|||
30721097|NCT00430989|58734498|FG001|Overall Study|Not eligible|6|||
30721098|NCT00430755|58734506|FG000|Overall Study|Withdrawal by Subject|53|||
30721099|NCT00518882|58734512|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
30721100|NCT00518882|58734513|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
30721101|NCT00518882|58734512|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
30721102|NCT00518882|58734513|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
30721103|NCT00518882|58734512|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
30721104|NCT00518882|58734513|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
30721105|NCT00518882|58734512|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
30721106|NCT00518882|58734513|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
30721107|NCT00518882|58734512|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
30721108|NCT00518882|58734513|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
30721109|NCT00518882|58734512|FG000|Double-Blind, Week 0-26|Subject decision|1|||
30721110|NCT00518882|58734513|FG001|Double-Blind, Week 0-26|Subject decision|1|||
30721111|NCT00518882|58734512|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
30721112|NCT00518882|58734513|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
30721113|NCT00518882|58734512|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
30721114|NCT00518882|58734513|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
30721115|NCT00518882|58734512|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
30721116|NCT00518882|58734513|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
30721117|NCT00518882|58734512|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
30721118|NCT00518882|58734513|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
30721119|NCT00518882|58734512|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
30721120|NCT00518882|58734513|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
30721121|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
30721122|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
30721123|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
30721124|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
30721125|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
30721126|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
30721127|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
30721128|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
30721129|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
30721130|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
30721131|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
30721132|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
30721133|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
30721134|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
30721135|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
30721136|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
30721137|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
30721138|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
30721139|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
30721140|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
30721141|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
30721142|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
30721143|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
30721144|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
30721145|NCT00518882|58734512|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
30721146|NCT00518882|58734513|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
30721147|NCT00518336|58734521|FG000|Year 7|Lost to Follow-up|2|||
30721148|NCT00518336|58734522|FG001|Year 7|Lost to Follow-up|0|||
30721149|NCT00518336|58734521|FG000|Year 7|Could not attend in time|0|||
30721150|NCT00518336|58734522|FG001|Year 7|Could not attend in time|3|||
30721151|NCT00518336|58734521|FG000|Year 8|Lost to Follow-up|1|||
30721152|NCT00518336|58734522|FG001|Year 8|Lost to Follow-up|1|||
30721153|NCT00518336|58734521|FG000|Year 8|Could not attend in time|0|||
30721154|NCT00518336|58734522|FG001|Year 8|Could not attend in time|1|||
30721155|NCT00518336|58734521|FG000|Year 9|Migrated/moved from study area|1|||
30721156|NCT00518336|58734522|FG001|Year 9|Migrated/moved from study area|1|||
30721157|NCT00518336|58734521|FG000|Year 9|Lost to Follow-up|3|||
30721158|NCT00518336|58734522|FG001|Year 9|Lost to Follow-up|0|||
30721159|NCT00518336|58734521|FG000|Year 9|Personal reasons|1|||
30621611|NCT00932698|58633211|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
30721160|NCT00518336|58734522|FG001|Year 9|Personal reasons|0|||
30721161|NCT00518180|58734531|FG000|Overall Study|Withdrawal by Subject|29|||
30721162|NCT00518180|58734532|FG001|Overall Study|Withdrawal by Subject|30|||
30721163|NCT00518180|58734533|FG002|Overall Study|Withdrawal by Subject|42|||
30721164|NCT00518180|58734531|FG000|Overall Study|Lost to Follow-up|30|||
30721165|NCT00518180|58734532|FG001|Overall Study|Lost to Follow-up|28|||
30721166|NCT00518180|58734533|FG002|Overall Study|Lost to Follow-up|34|||
30721167|NCT00518180|58734531|FG000|Overall Study|Administrative reason|0|||
30721168|NCT00518180|58734532|FG001|Overall Study|Administrative reason|2|||
30721169|NCT00518180|58734533|FG002|Overall Study|Administrative reason|2|||
30721170|NCT00518180|58734531|FG000|Overall Study|Protocol Violation|5|||
30721171|NCT00518180|58734532|FG001|Overall Study|Protocol Violation|7|||
30721172|NCT00518180|58734533|FG002|Overall Study|Protocol Violation|4|||
30721173|NCT00518180|58734531|FG000|Overall Study|Unable to classify|0|||
30721174|NCT00518180|58734532|FG001|Overall Study|Unable to classify|2|||
30721175|NCT00518180|58734533|FG002|Overall Study|Unable to classify|0|||
30721176|NCT00518180|58734531|FG000|Overall Study|Adverse Event|1|||
30721177|NCT00518180|58734532|FG001|Overall Study|Adverse Event|0|||
30721178|NCT00518180|58734533|FG002|Overall Study|Adverse Event|0|||
30721179|NCT00525902|58734550|FG000|Overall Study|Lack of Efficacy|1|||
30721180|NCT00525824|58734558|FG000|Overall Study|Adverse Event|7|||
30721181|NCT00525824|58734559|FG001|Overall Study|Adverse Event|11|||
30721182|NCT00525824|58734560|FG002|Overall Study|Adverse Event|6|||
30721183|NCT00525824|58734561|FG003|Overall Study|Adverse Event|7|||
30721184|NCT00525824|58734558|FG000|Overall Study|Withdrawal by Subject|5|||
30721185|NCT00525824|58734559|FG001|Overall Study|Withdrawal by Subject|9|||
30721186|NCT00525824|58734560|FG002|Overall Study|Withdrawal by Subject|3|||
30721187|NCT00525824|58734561|FG003|Overall Study|Withdrawal by Subject|4|||
30721188|NCT00525824|58734558|FG000|Overall Study|Lost to Follow-up|4|||
30721189|NCT00525824|58734559|FG001|Overall Study|Lost to Follow-up|2|||
30721190|NCT00525824|58734560|FG002|Overall Study|Lost to Follow-up|4|||
30721191|NCT00525824|58734561|FG003|Overall Study|Lost to Follow-up|0|||
30721192|NCT00525824|58734558|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
30721193|NCT00525824|58734559|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
30721194|NCT00525824|58734560|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
30721195|NCT00525824|58734561|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
30721196|NCT00525824|58734558|FG000|Overall Study|Severe non-compliance|0|||
30721197|NCT00525824|58734559|FG001|Overall Study|Severe non-compliance|1|||
30721198|NCT00525824|58734560|FG002|Overall Study|Severe non-compliance|1|||
30721199|NCT00525824|58734561|FG003|Overall Study|Severe non-compliance|1|||
30721200|NCT00525824|58734558|FG000|Overall Study|Safety reasons|1|||
30721201|NCT00525824|58734559|FG001|Overall Study|Safety reasons|0|||
30721202|NCT00525824|58734560|FG002|Overall Study|Safety reasons|1|||
30721203|NCT00525824|58734561|FG003|Overall Study|Safety reasons|0|||
30721204|NCT00525824|58734558|FG000|Overall Study|Other|1|||
30721205|NCT00525824|58734559|FG001|Overall Study|Other|3|||
30721206|NCT00525824|58734560|FG002|Overall Study|Other|3|||
30721207|NCT00525824|58734561|FG003|Overall Study|Other|1|||
30721208|NCT00525590|58734575|FG000|Overall Study|Adverse Event|3|||
30721209|NCT00525590|58734575|FG000|Overall Study|Physician Decision|3|||
30721210|NCT00525590|58734575|FG000|Overall Study|Withdrawal by Subject|16|||
30721211|NCT00525590|58734575|FG000|Overall Study|Lost to Follow-up|1|||
30721212|NCT00525590|58734575|FG000|Overall Study|Death|9|||
30721213|NCT00525590|58734575|FG000|Overall Study|Other|13|||
30721214|NCT00430677|58734582|FG000|Short-term Period|Death|1|||
30721215|NCT00430677|58734583|FG001|Short-term Period|Death|1|||
30721216|NCT00430677|58734584|FG002|Short-term Period|Death|5|||
30721217|NCT00430677|58734582|FG000|Short-term Period|Adverse Event|15|||
30721218|NCT00430677|58734583|FG001|Short-term Period|Adverse Event|13|||
30721219|NCT00430677|58734584|FG002|Short-term Period|Adverse Event|9|||
30721220|NCT00430677|58734582|FG000|Short-term Period|Lack of Efficacy|5|||
30721221|NCT00430677|58734583|FG001|Short-term Period|Lack of Efficacy|6|||
30721222|NCT00430677|58734584|FG002|Short-term Period|Lack of Efficacy|4|||
30721223|NCT00430677|58734582|FG000|Short-term Period|Withdrawal by Subject|1|||
30721224|NCT00430677|58734583|FG001|Short-term Period|Withdrawal by Subject|1|||
30721225|NCT00430677|58734584|FG002|Short-term Period|Withdrawal by Subject|2|||
30721226|NCT00430677|58734582|FG000|Short-term Period|Participant no longer met study criteria|1|||
30721227|NCT00430677|58734583|FG001|Short-term Period|Participant no longer met study criteria|1|||
30721228|NCT00430677|58734584|FG002|Short-term Period|Participant no longer met study criteria|2|||
30721229|NCT00430677|58734582|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
30721230|NCT00430677|58734583|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
30721231|NCT00430677|58734584|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
30721232|NCT00430677|58734582|FG000|Short-term Period|Pregnancy|0|||
30721233|NCT00430677|58734583|FG001|Short-term Period|Pregnancy|2|||
30721234|NCT00430677|58734584|FG002|Short-term Period|Pregnancy|0|||
30721235|NCT00430677|58734582|FG000|Long-term Extension Period|Death|1|||
30721236|NCT00430677|58734583|FG001|Long-term Extension Period|Death|0|||
30721237|NCT00430677|58734584|FG002|Long-term Extension Period|Death|0|||
30721238|NCT00430677|58734582|FG000|Long-term Extension Period|Adverse Event|3|||
30721239|NCT00430677|58734583|FG001|Long-term Extension Period|Adverse Event|2|||
30721240|NCT00430677|58734584|FG002|Long-term Extension Period|Adverse Event|5|||
30721241|NCT00430677|58734582|FG000|Long-term Extension Period|Lack of Efficacy|5|||
30721242|NCT00430677|58734583|FG001|Long-term Extension Period|Lack of Efficacy|3|||
30721243|NCT00430677|58734584|FG002|Long-term Extension Period|Lack of Efficacy|8|||
30721244|NCT00430677|58734582|FG000|Long-term Extension Period|Lost to Follow-up|1|||
30721245|NCT00430677|58734583|FG001|Long-term Extension Period|Lost to Follow-up|1|||
30721246|NCT00430677|58734584|FG002|Long-term Extension Period|Lost to Follow-up|1|||
30721247|NCT00430677|58734582|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
30721248|NCT00430677|58734583|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
30721249|NCT00430677|58734584|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
30721250|NCT00430677|58734582|FG000|Long-term Extension Period|Pregnancy|1|||
30721251|NCT00430677|58734583|FG001|Long-term Extension Period|Pregnancy|1|||
30721252|NCT00430677|58734584|FG002|Long-term Extension Period|Pregnancy|0|||
30721253|NCT00430677|58734582|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
30721254|NCT00430677|58734583|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
30721255|NCT00430677|58734584|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
30721256|NCT00430677|58734582|FG000|Long-term Extension Period|Other|2|||
30721257|NCT00430677|58734583|FG001|Long-term Extension Period|Other|1|||
30721258|NCT00430677|58734584|FG002|Long-term Extension Period|Other|1|||
30721259|NCT00430677|58734582|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
30721260|NCT00430677|58734583|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
30721261|NCT00430677|58734584|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
30721262|NCT00525512|58734612|FG000|Double-Blind Phase|Adverse Event|48|||
30721263|NCT00525512|58734613|FG001|Double-Blind Phase|Adverse Event|28|||
30721264|NCT00525512|58734614|FG002|Double-Blind Phase|Adverse Event|0|||
30721265|NCT00525512|58734615|FG003|Double-Blind Phase|Adverse Event|0|||
30721266|NCT00525512|58734612|FG000|Double-Blind Phase|Protocol Violation|3|||
30721267|NCT00525512|58734613|FG001|Double-Blind Phase|Protocol Violation|1|||
30721268|NCT00525512|58734614|FG002|Double-Blind Phase|Protocol Violation|0|||
30721269|NCT00525512|58734615|FG003|Double-Blind Phase|Protocol Violation|0|||
30721270|NCT00525512|58734612|FG000|Double-Blind Phase|Lost to Follow-up|3|||
30721271|NCT00525512|58734613|FG001|Double-Blind Phase|Lost to Follow-up|7|||
30721272|NCT00525512|58734614|FG002|Double-Blind Phase|Lost to Follow-up|0|||
30721273|NCT00525512|58734615|FG003|Double-Blind Phase|Lost to Follow-up|0|||
30721274|NCT00525512|58734612|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
30721275|NCT00525512|58734613|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
30721276|NCT00525512|58734614|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
30721277|NCT00525512|58734615|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
30721278|NCT00525512|58734612|FG000|Double-Blind Phase|Lack of Efficacy|13|||
30721279|NCT00525512|58734613|FG001|Double-Blind Phase|Lack of Efficacy|5|||
30721280|NCT00525512|58734614|FG002|Double-Blind Phase|Lack of Efficacy|0|||
30721281|NCT00525512|58734615|FG003|Double-Blind Phase|Lack of Efficacy|0|||
30721282|NCT00525512|58734612|FG000|Double-Blind Phase|Other reason (not specified)|12|||
30721283|NCT00525512|58734613|FG001|Double-Blind Phase|Other reason (not specified)|13|||
30721284|NCT00525512|58734614|FG002|Double-Blind Phase|Other reason (not specified)|0|||
30721285|NCT00525512|58734615|FG003|Double-Blind Phase|Other reason (not specified)|0|||
30721286|NCT00525512|58734612|FG000|Open-Label Phase|Adverse Event|0|||
30721287|NCT00525512|58734613|FG001|Open-Label Phase|Adverse Event|0|||
30721288|NCT00525512|58734614|FG002|Open-Label Phase|Adverse Event|1|||
30721289|NCT00525512|58734615|FG003|Open-Label Phase|Adverse Event|0|||
30721290|NCT00525512|58734612|FG000|Open-Label Phase|Lost to Follow-up|0|||
30721291|NCT00525512|58734613|FG001|Open-Label Phase|Lost to Follow-up|0|||
30721292|NCT00525512|58734614|FG002|Open-Label Phase|Lost to Follow-up|1|||
30721293|NCT00525512|58734615|FG003|Open-Label Phase|Lost to Follow-up|0|||
30721294|NCT00525512|58734612|FG000|Open-Label Phase|Other reason (not specified)|0|||
30721295|NCT00525512|58734613|FG001|Open-Label Phase|Other reason (not specified)|0|||
30721296|NCT00525512|58734614|FG002|Open-Label Phase|Other reason (not specified)|4|||
30721297|NCT00525512|58734615|FG003|Open-Label Phase|Other reason (not specified)|5|||
30721298|NCT00517634|58734627|FG000|Second Treatment Period|Withdrawal by Subject|0|||
30721299|NCT00517634|58734628|FG001|Second Treatment Period|Withdrawal by Subject|0|||
30721300|NCT00517634|58734629|FG002|Second Treatment Period|Withdrawal by Subject|0|||
30721301|NCT00517634|58734630|FG003|Second Treatment Period|Withdrawal by Subject|0|||
30721302|NCT00517634|58734631|FG004|Second Treatment Period|Withdrawal by Subject|1|||
30721303|NCT00517634|58734632|FG005|Second Treatment Period|Withdrawal by Subject|0|||
30721304|NCT03683576|58734644|FG000|Overall Study|Withdrawal by Subject|2|||
30721305|NCT03683576|58734645|FG001|Overall Study|Withdrawal by Subject|0|||
30721306|NCT03683576|58734646|FG002|Overall Study|Withdrawal by Subject|8|||
30721307|NCT03683576|58734647|FG003|Overall Study|Withdrawal by Subject|3|||
30721308|NCT03683576|58734644|FG000|Overall Study|Adverse Event|3|||
30721309|NCT03683576|58734645|FG001|Overall Study|Adverse Event|0|||
30721310|NCT03683576|58734646|FG002|Overall Study|Adverse Event|0|||
30721311|NCT03683576|58734647|FG003|Overall Study|Adverse Event|4|||
30721312|NCT03683576|58734644|FG000|Overall Study|Lack of Efficacy|1|||
30721313|NCT03683576|58734645|FG001|Overall Study|Lack of Efficacy|0|||
30721314|NCT03683576|58734646|FG002|Overall Study|Lack of Efficacy|1|||
30721315|NCT03683576|58734647|FG003|Overall Study|Lack of Efficacy|1|||
30721316|NCT03683576|58734644|FG000|Overall Study|Lost to Follow-up|0|||
30721317|NCT03683576|58734645|FG001|Overall Study|Lost to Follow-up|1|||
30721318|NCT03683576|58734646|FG002|Overall Study|Lost to Follow-up|2|||
30721319|NCT03683576|58734647|FG003|Overall Study|Lost to Follow-up|0|||
30721320|NCT03683576|58734644|FG000|Overall Study|Other, Not Specified|0|||
30721321|NCT03683576|58734645|FG001|Overall Study|Other, Not Specified|2|||
30721322|NCT03683576|58734646|FG002|Overall Study|Other, Not Specified|0|||
30721323|NCT03683576|58734647|FG003|Overall Study|Other, Not Specified|0|||
30721324|NCT03683576|58734644|FG000|Overall Study|Protocol Violation|0|||
30721325|NCT03683576|58734645|FG001|Overall Study|Protocol Violation|1|||
30721326|NCT03683576|58734646|FG002|Overall Study|Protocol Violation|1|||
30721327|NCT03683576|58734647|FG003|Overall Study|Protocol Violation|0|||
30721328|NCT03863834|58734657|FG000|Overall Study|Lost to Follow-up|3|||
30721329|NCT00430521|58734669|FG000|Overall Study|Adverse Event|0|||
30721330|NCT00430521|58734670|FG001|Overall Study|Adverse Event|0|||
30721331|NCT00430521|58734671|FG002|Overall Study|Adverse Event|0|||
30721332|NCT00430521|58734672|FG003|Overall Study|Adverse Event|0|||
30721333|NCT00430521|58734673|FG004|Overall Study|Adverse Event|0|||
30721334|NCT00430521|58734674|FG005|Overall Study|Adverse Event|2|||
30721335|NCT00430521|58734675|FG006|Overall Study|Adverse Event|1|||
30721336|NCT00430521|58734676|FG007|Overall Study|Adverse Event|0|||
30721337|NCT00430521|58734669|FG000|Overall Study|Lost to Follow-up|7|||
30721338|NCT00430521|58734670|FG001|Overall Study|Lost to Follow-up|8|||
30721339|NCT00430521|58734671|FG002|Overall Study|Lost to Follow-up|3|||
30721340|NCT00430521|58734672|FG003|Overall Study|Lost to Follow-up|5|||
30721341|NCT00430521|58734673|FG004|Overall Study|Lost to Follow-up|5|||
30721342|NCT00430521|58734674|FG005|Overall Study|Lost to Follow-up|2|||
30721343|NCT00430521|58734675|FG006|Overall Study|Lost to Follow-up|8|||
30721344|NCT00430521|58734676|FG007|Overall Study|Lost to Follow-up|10|||
30721345|NCT00430521|58734669|FG000|Overall Study|Pregnancy|0|||
30721346|NCT00430521|58734670|FG001|Overall Study|Pregnancy|0|||
30721347|NCT00430521|58734671|FG002|Overall Study|Pregnancy|0|||
30721348|NCT00430521|58734672|FG003|Overall Study|Pregnancy|0|||
30721349|NCT00430521|58734673|FG004|Overall Study|Pregnancy|0|||
30721350|NCT00430521|58734674|FG005|Overall Study|Pregnancy|0|||
30721351|NCT00430521|58734675|FG006|Overall Study|Pregnancy|1|||
30721352|NCT00430521|58734676|FG007|Overall Study|Pregnancy|0|||
30721353|NCT00430521|58734669|FG000|Overall Study|Vaccine Expired|0|||
30721354|NCT00430521|58734670|FG001|Overall Study|Vaccine Expired|0|||
30721355|NCT00430521|58734671|FG002|Overall Study|Vaccine Expired|0|||
30721356|NCT00430521|58734672|FG003|Overall Study|Vaccine Expired|0|||
30721357|NCT00430521|58734673|FG004|Overall Study|Vaccine Expired|0|||
30721358|NCT00430521|58734674|FG005|Overall Study|Vaccine Expired|1|||
30721359|NCT00430521|58734675|FG006|Overall Study|Vaccine Expired|0|||
30721360|NCT00430521|58734676|FG007|Overall Study|Vaccine Expired|0|||
30721361|NCT00430521|58734669|FG000|Overall Study|Protocol Violation|1|||
30721362|NCT00430521|58734670|FG001|Overall Study|Protocol Violation|0|||
30721363|NCT00430521|58734671|FG002|Overall Study|Protocol Violation|0|||
30721364|NCT00430521|58734672|FG003|Overall Study|Protocol Violation|0|||
30721365|NCT00430521|58734673|FG004|Overall Study|Protocol Violation|0|||
30721366|NCT00430521|58734674|FG005|Overall Study|Protocol Violation|0|||
30721367|NCT00430521|58734675|FG006|Overall Study|Protocol Violation|0|||
30721368|NCT00430521|58734676|FG007|Overall Study|Protocol Violation|0|||
30721369|NCT00430521|58734669|FG000|Overall Study|Withdrawal by Subject|3|||
30721370|NCT00430521|58734670|FG001|Overall Study|Withdrawal by Subject|1|||
30721371|NCT00430521|58734671|FG002|Overall Study|Withdrawal by Subject|0|||
30721372|NCT00430521|58734672|FG003|Overall Study|Withdrawal by Subject|3|||
30721373|NCT00430521|58734673|FG004|Overall Study|Withdrawal by Subject|0|||
30721374|NCT00430521|58734674|FG005|Overall Study|Withdrawal by Subject|0|||
30621612|NCT00932698|58633212|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
30621613|NCT00932698|58633213|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
30721375|NCT00430521|58734675|FG006|Overall Study|Withdrawal by Subject|0|||
30721376|NCT00430521|58734676|FG007|Overall Study|Withdrawal by Subject|2|||
30721377|NCT00429663|58734709|FG000|Overall Study|Lost to Follow-up|24|||
30721378|NCT00429663|58734710|FG001|Overall Study|Lost to Follow-up|31|||
30721379|NCT00429663|58734709|FG000|Overall Study|Physician Decision|6|||
30721380|NCT00429663|58734710|FG001|Overall Study|Physician Decision|3|||
30721381|NCT00429663|58734709|FG000|Overall Study|Withdrawal by Subject|2|||
30721382|NCT00429663|58734710|FG001|Overall Study|Withdrawal by Subject|5|||
30721383|NCT00429663|58734709|FG000|Overall Study|Death|4|||
30721384|NCT00429663|58734710|FG001|Overall Study|Death|0|||
30721385|NCT00429585|58734718|FG000|Overall Study|Death|1|||
30721386|NCT00429585|58734719|FG001|Overall Study|Death|0|||
30721387|NCT00429585|58734718|FG000|Overall Study|Lost to Follow-up|27|||
30721388|NCT00429585|58734719|FG001|Overall Study|Lost to Follow-up|20|||
30721389|NCT00429585|58734718|FG000|Overall Study|Physician Decision|2|||
30721390|NCT00429585|58734719|FG001|Overall Study|Physician Decision|0|||
30721391|NCT00440271|58734727|FG000|Overall Study|Protocol Violation|1|||
30721392|NCT00440271|58734728|FG001|Overall Study|Protocol Violation|1|||
30721393|NCT00440271|58734727|FG000|Overall Study|Adverse Event|0|||
30721394|NCT00440271|58734728|FG001|Overall Study|Adverse Event|1|||
30721395|NCT00440271|58734727|FG000|Overall Study|Lost to Follow-up|1|||
30721396|NCT00440271|58734728|FG001|Overall Study|Lost to Follow-up|0|||
30721397|NCT00440271|58734727|FG000|Overall Study|Withdrawal by Subject|0|||
30721398|NCT00440271|58734728|FG001|Overall Study|Withdrawal by Subject|2|||
30721399|NCT00440271|58734727|FG000|Overall Study|Lack of Efficacy|0|||
30721400|NCT00440271|58734728|FG001|Overall Study|Lack of Efficacy|1|||
30721401|NCT00440271|58734727|FG000|Overall Study|Due to closure of trial|8|||
30721402|NCT00440271|58734728|FG001|Overall Study|Due to closure of trial|10|||
30721403|NCT00440271|58734727|FG000|Overall Study|Other|2|||
30721404|NCT00440271|58734728|FG001|Overall Study|Other|0|||
30721405|NCT00346216|58734737|FG000|Overall Study|Other|181|||
30721406|NCT00346216|58734738|FG001|Overall Study|Other|231|||
30721407|NCT00346216|58734739|FG002|Overall Study|Other|205|||
30721408|NCT00346216|58734737|FG000|Overall Study|No longer willing to participate|600|||
30721409|NCT00346216|58734738|FG001|Overall Study|No longer willing to participate|606|||
30721410|NCT00346216|58734739|FG002|Overall Study|No longer willing to participate|585|||
30721411|NCT00346216|58734737|FG000|Overall Study|Withdrawal by Subject|661|||
30721412|NCT00346216|58734738|FG001|Overall Study|Withdrawal by Subject|692|||
30721413|NCT00346216|58734739|FG002|Overall Study|Withdrawal by Subject|651|||
30721414|NCT00346216|58734737|FG000|Overall Study|Lost to Follow-up|611|||
30721415|NCT00346216|58734738|FG001|Overall Study|Lost to Follow-up|588|||
30721416|NCT00346216|58734739|FG002|Overall Study|Lost to Follow-up|542|||
30721417|NCT00346216|58734737|FG000|Overall Study|Physician Decision|80|||
30721418|NCT00346216|58734738|FG001|Overall Study|Physician Decision|76|||
30721419|NCT00346216|58734739|FG002|Overall Study|Physician Decision|59|||
30721420|NCT00346216|58734737|FG000|Overall Study|Does not meet entrance criteria|13|||
30721421|NCT00346216|58734738|FG001|Overall Study|Does not meet entrance criteria|10|||
30721422|NCT00346216|58734739|FG002|Overall Study|Does not meet entrance criteria|8|||
30721423|NCT00346216|58734737|FG000|Overall Study|Death|189|||
30721424|NCT00346216|58734738|FG001|Overall Study|Death|192|||
30721425|NCT00346216|58734739|FG002|Overall Study|Death|228|||
30721426|NCT00346216|58734737|FG000|Overall Study|Study terminated by sponsor|11|||
30721427|NCT00346216|58734738|FG001|Overall Study|Study terminated by sponsor|4|||
30721428|NCT00346216|58734739|FG002|Overall Study|Study terminated by sponsor|8|||
30721429|NCT00346216|58734737|FG000|Overall Study|Missing Subject Summary Status|62|||
30721430|NCT00346216|58734738|FG001|Overall Study|Missing Subject Summary Status|61|||
30721431|NCT00346216|58734739|FG002|Overall Study|Missing Subject Summary Status|62|||
30721432|NCT00417963|58734747|FG000|Overall Study|Lost to Follow-up|3|||
30721433|NCT00417963|58734747|FG000|Overall Study|Withdrawal by Subject|18|||
30721434|NCT00417963|58734747|FG000|Overall Study|Death|17|||
30721435|NCT00417963|58734747|FG000|Overall Study|Study device could not be deployed|3|||
30721436|NCT00429273|58734759|FG000|Overall Study|Lost to Follow-up|1|||
30721437|NCT00429273|58734760|FG001|Overall Study|Lost to Follow-up|2|||
30721438|NCT00429273|58734761|FG002|Overall Study|Lost to Follow-up|2|||
30721439|NCT00429273|58734759|FG000|Overall Study|Physician Decision|6|||
30721440|NCT00429273|58734760|FG001|Overall Study|Physician Decision|5|||
30721441|NCT00429273|58734761|FG002|Overall Study|Physician Decision|5|||
30721442|NCT00429273|58734759|FG000|Overall Study|Adverse Event|1|||
30721443|NCT00429273|58734760|FG001|Overall Study|Adverse Event|1|||
30721444|NCT00429273|58734761|FG002|Overall Study|Adverse Event|2|||
30721445|NCT00359632|58734771|FG000|Overall Study|Death|2|||
30721446|NCT00359632|58734772|FG001|Overall Study|Death|0|||
30721447|NCT00359632|58734771|FG000|Overall Study|Adverse Event|1|||
30721448|NCT00359632|58734772|FG001|Overall Study|Adverse Event|0|||
30721449|NCT00359632|58734771|FG000|Overall Study|Non-compliance with visit schedule|1|||
30721450|NCT00359632|58734772|FG001|Overall Study|Non-compliance with visit schedule|0|||
30721451|NCT00417885|58734778|FG000|Overall Study|Adverse Event|1|||
30721452|NCT00417885|58734778|FG000|Overall Study|Objective Progression or Relapse|3|||
30721453|NCT00417885|58734778|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
30721454|NCT04488770|58734795|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721455|NCT04488770|58734796|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721456|NCT04488770|58734797|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721457|NCT04488770|58734798|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
30721458|NCT04488770|58734799|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721459|NCT04488770|58734800|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721460|NCT04488770|58734801|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721461|NCT04488770|58734802|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721462|NCT04488770|58734803|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721463|NCT04488770|58734804|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721464|NCT04488770|58734805|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721465|NCT04488770|58734806|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721466|NCT04488770|58734807|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
30721467|NCT04488770|58734795|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
30721468|NCT04488770|58734796|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30721469|NCT04488770|58734797|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30721470|NCT04488770|58734798|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30721471|NCT04488770|58734799|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30721472|NCT04488770|58734800|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30721473|NCT04488770|58734801|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30721474|NCT04488770|58734802|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30721475|NCT04488770|58734803|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30621614|NCT00932698|58633214|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
30721476|NCT04488770|58734804|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30721477|NCT04488770|58734805|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30721478|NCT04488770|58734806|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30721479|NCT04488770|58734807|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
30721480|NCT04488770|58734795|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30721481|NCT04488770|58734796|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30721482|NCT04488770|58734797|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30721483|NCT04488770|58734798|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30721484|NCT04488770|58734799|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30721485|NCT04488770|58734800|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
30721486|NCT04488770|58734801|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
30721487|NCT04488770|58734802|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30900335|NCT02267317|58933587|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
30900336|NCT02267317|58933588|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
30721488|NCT04488770|58734803|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30721489|NCT04488770|58734804|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30721490|NCT04488770|58734805|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30721491|NCT04488770|58734806|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30721492|NCT04488770|58734807|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30721493|NCT04488770|58734795|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721494|NCT04488770|58734796|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721495|NCT04488770|58734797|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721496|NCT04488770|58734798|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721497|NCT04488770|58734799|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
30721498|NCT04488770|58734800|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721499|NCT04488770|58734801|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721500|NCT04488770|58734802|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721501|NCT04488770|58734803|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721502|NCT04488770|58734804|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721503|NCT04488770|58734805|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721504|NCT04488770|58734806|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721505|NCT04488770|58734807|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
30721506|NCT00525044|58734853|FG000|Overall Study|Lost to Follow-up|0|||
30721507|NCT00525044|58734854|FG001|Overall Study|Lost to Follow-up|1|||
30721508|NCT00355342|58734862|FG000|Overall Study|Adverse Event|13|||
30721509|NCT00355342|58734863|FG001|Overall Study|Adverse Event|15|||
30721510|NCT00355342|58734862|FG000|Overall Study|Lost to Follow-up|4|||
30721511|NCT00355342|58734863|FG001|Overall Study|Lost to Follow-up|2|||
30721512|NCT00355342|58734862|FG000|Overall Study|Withdrawal by Subject|14|||
30721513|NCT00355342|58734863|FG001|Overall Study|Withdrawal by Subject|11|||
30721514|NCT00355342|58734862|FG000|Overall Study|Sponsor terminated study|2|||
30721515|NCT00355342|58734863|FG001|Overall Study|Sponsor terminated study|2|||
30721516|NCT00355342|58734862|FG000|Overall Study|Overcompliant-PI discretion|1|||
30721517|NCT00355342|58734863|FG001|Overall Study|Overcompliant-PI discretion|0|||
30721518|NCT00355342|58734862|FG000|Overall Study|Use of prohibited medication|1|||
30721519|NCT00355342|58734863|FG001|Overall Study|Use of prohibited medication|0|||
30721520|NCT00355342|58734862|FG000|Overall Study|COPD exacerbation|1|||
30721521|NCT00355342|58734863|FG001|Overall Study|COPD exacerbation|1|||
30721522|NCT00355342|58734862|FG000|Overall Study|Dispensed wrong study drug kit|1|||
30721523|NCT00355342|58734863|FG001|Overall Study|Dispensed wrong study drug kit|0|||
30721524|NCT00355342|58734862|FG000|Overall Study|Non-compliance with Dexa scans|1|||
30721525|NCT00355342|58734863|FG001|Overall Study|Non-compliance with Dexa scans|0|||
30721526|NCT00355342|58734862|FG000|Overall Study|Withdrawal by participant and physician|1|||
30721527|NCT00355342|58734863|FG001|Overall Study|Withdrawal by participant and physician|0|||
30721528|NCT00355342|58734862|FG000|Overall Study|Participant relocated|0|||
30721529|NCT00355342|58734863|FG001|Overall Study|Participant relocated|1|||
30721530|NCT00355342|58734862|FG000|Overall Study|Participant discontinued study drug|0|||
30721531|NCT00355342|58734863|FG001|Overall Study|Participant discontinued study drug|1|||
30721532|NCT00355342|58734862|FG000|Overall Study|Study management|0|||
30721533|NCT00355342|58734863|FG001|Overall Study|Study management|1|||
30721534|NCT00355342|58734862|FG000|Overall Study|Protocol Violation|0|||
30721535|NCT00355342|58734863|FG001|Overall Study|Protocol Violation|1|||
30721536|NCT00355342|58734862|FG000|Overall Study|Use of protocol excluded medication|0|||
30721537|NCT00355342|58734863|FG001|Overall Study|Use of protocol excluded medication|1|||
30721538|NCT01573754|58734871|FG000|Overall Study|Noncompliance or remission not achieved|3|||
30721539|NCT01573754|58734872|FG001|Overall Study|Noncompliance or remission not achieved|15|||
30721540|NCT00355264|58734878|FG000|Extension (Variable Duration)|Adverse Event|1|||
30721541|NCT00355264|58734878|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
30721542|NCT00355030|58734889|FG000|Study Period 1 Treatment|Adverse Event|1|||
30721543|NCT00355030|58734890|FG001|Study Period 1 Treatment|Adverse Event|1|||
30721544|NCT00355030|58734889|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
30721545|NCT00355030|58734890|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
30721546|NCT00355030|58734889|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
30721547|NCT00355030|58734890|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
30621615|NCT00932698|58633215|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
30621616|NCT00932698|58633216|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
30721548|NCT00355030|58734889|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
30721549|NCT00355030|58734890|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
30721550|NCT00355030|58734889|FG000|Study Period 1 Treatment|Physician Decision|0|||
30721551|NCT00355030|58734890|FG001|Study Period 1 Treatment|Physician Decision|1|||
30721552|NCT00355030|58734889|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
30721553|NCT00355030|58734890|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
30721554|NCT00355030|58734889|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
30721555|NCT00355030|58734890|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
30721556|NCT00355030|58734889|FG000|Study Period 1 Treatment|Other|2|||
30721557|NCT00355030|58734890|FG001|Study Period 1 Treatment|Other|6|||
30721558|NCT00355030|58734889|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
30721559|NCT00355030|58734890|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
30721560|NCT00355030|58734889|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
30721561|NCT00355030|58734890|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
30721562|NCT00354172|58734896|FG000|Overall Study|Did not receive transplant|1|||
30721563|NCT00345592|58734902|FG000|Overall Study|Death|14|||
30721564|NCT00345592|58734903|FG001|Overall Study|Death|16|||
30721565|NCT00345592|58734902|FG000|Overall Study|Withdrawal by Subject|11|||
30721566|NCT00345592|58734903|FG001|Overall Study|Withdrawal by Subject|8|||
30721567|NCT00353704|58734911|FG000|Overall Study|Protocol Violation|3|||
30721568|NCT00353704|58734912|FG001|Overall Study|Protocol Violation|1|||
30721569|NCT00512252|58734921|FG000|Overall Study|Lost to Follow-up|0|||
30721570|NCT00512252|58734922|FG001|Overall Study|Lost to Follow-up|0|||
30721571|NCT00512252|58734923|FG002|Overall Study|Lost to Follow-up|1|||
30721572|NCT00512252|58734921|FG000|Overall Study|Protocol Violation|0|||
30721573|NCT00512252|58734922|FG001|Overall Study|Protocol Violation|0|||
30721574|NCT00512252|58734923|FG002|Overall Study|Protocol Violation|1|||
30721575|NCT00512252|58734921|FG000|Overall Study|Death|0|||
30721576|NCT00512252|58734922|FG001|Overall Study|Death|0|||
30721577|NCT00512252|58734923|FG002|Overall Study|Death|1|||
30721578|NCT00516386|58734938|FG000|Overall Study|not interested in the study|4|||
30721579|NCT00516386|58734938|FG000|Overall Study|Lost to Follow-up|2|||
30721580|NCT00524420|58734944|FG000|Overall Study|Lack of Efficacy|1|||
30721581|NCT00524420|58734945|FG001|Overall Study|Lack of Efficacy|0|||
30721582|NCT00512096|58734953|FG000|Overall Study|Adverse Event|2|||
30721583|NCT00512096|58734953|FG000|Overall Study|Withdrawal by Subject|2|||
30721584|NCT00512096|58734953|FG000|Overall Study|Lack of Efficacy|3|||
30721585|NCT00524030|58734959|FG000|Overall Study|Lack of Efficacy|10|||
30721586|NCT00524030|58734960|FG001|Overall Study|Lack of Efficacy|24|||
30721587|NCT00524030|58734959|FG000|Overall Study|Lost to Follow-up|0|||
30721588|NCT00524030|58734960|FG001|Overall Study|Lost to Follow-up|2|||
30721589|NCT00524030|58734959|FG000|Overall Study|Withdrawal by Subject|3|||
30721590|NCT00524030|58734960|FG001|Overall Study|Withdrawal by Subject|8|||
30721591|NCT00524030|58734959|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
30721592|NCT00524030|58734960|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
30721593|NCT00524030|58734959|FG000|Overall Study|Protocol Violation|0|||
30721594|NCT00524030|58734960|FG001|Overall Study|Protocol Violation|1|||
30721595|NCT00524030|58734959|FG000|Overall Study|Pregnancy|1|||
30721596|NCT00524030|58734960|FG001|Overall Study|Pregnancy|0|||
30721597|NCT00524030|58734959|FG000|Overall Study|Adverse Event|3|||
30721598|NCT00524030|58734960|FG001|Overall Study|Adverse Event|21|||
30721599|NCT00524030|58734959|FG000|Overall Study|Death|0|||
30721600|NCT00524030|58734960|FG001|Overall Study|Death|1|||
30721601|NCT00523718|58734969|FG000|Overall Study|Withdrawal by Subject|1|||
30721602|NCT00523718|58734970|FG001|Overall Study|Withdrawal by Subject|0|||
30721603|NCT00523718|58734969|FG000|Overall Study|Protocol Violation|2|||
30721604|NCT00523718|58734970|FG001|Overall Study|Protocol Violation|0|||
30721605|NCT00523640|58734976|FG000|Overall Study|Death|1|||
30721606|NCT00345358|58734984|FG000|Primary Vaccination Phase|Other|0|||
30721607|NCT00345358|58734985|FG001|Primary Vaccination Phase|Other|1|||
30721608|NCT00345358|58734986|FG002|Primary Vaccination Phase|Other|1|||
30721609|NCT00345358|58734987|FG003|Primary Vaccination Phase|Other|0|||
30721610|NCT00345358|58734984|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
30721611|NCT00345358|58734985|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
30621617|NCT00932698|58633217|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
30721612|NCT00345358|58734986|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
30721613|NCT00345358|58734987|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
30721614|NCT00345358|58734984|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
30721615|NCT00345358|58734985|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
30721616|NCT00345358|58734986|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
30721617|NCT00345358|58734987|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
30721618|NCT00345358|58734984|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
30721619|NCT00345358|58734985|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
30721620|NCT00345358|58734986|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
30721621|NCT00345358|58734987|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
30721622|NCT00345358|58734984|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
30721623|NCT00345358|58734985|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
30721624|NCT00345358|58734986|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
30721625|NCT00345358|58734987|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
30721626|NCT00345358|58734984|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
30721627|NCT00345358|58734985|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
30721628|NCT00345358|58734986|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
30721629|NCT00345358|58734987|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
30721630|NCT03869684|58735000|FG000|Overall Study|Adverse Event|0|||
30721631|NCT03869684|58735001|FG001|Overall Study|Adverse Event|3|||
30721632|NCT03869684|58735002|FG002|Overall Study|Adverse Event|1|||
30721633|NCT03869684|58735000|FG000|Overall Study|Withdrawal by Subject|1|||
30721634|NCT03869684|58735001|FG001|Overall Study|Withdrawal by Subject|0|||
30721635|NCT03869684|58735002|FG002|Overall Study|Withdrawal by Subject|0|||
30721636|NCT03869684|58735000|FG000|Overall Study|Lost to Follow-up|1|||
30721637|NCT03869684|58735001|FG001|Overall Study|Lost to Follow-up|0|||
30721638|NCT03869684|58735002|FG002|Overall Study|Lost to Follow-up|0|||
30721639|NCT03869684|58735000|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
30721640|NCT03869684|58735001|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
30721641|NCT03869684|58735002|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
30721642|NCT00516074|58735012|FG000|Overall Study|Adverse Event|0|||
30721643|NCT00516074|58735013|FG001|Overall Study|Adverse Event|1|||
30721644|NCT00516074|58735012|FG000|Overall Study|Subject Decision|4|||
30721645|NCT00516074|58735013|FG001|Overall Study|Subject Decision|2|||
30721646|NCT00516074|58735012|FG000|Overall Study|Loss of Glucose Control|2|||
30721647|NCT00516074|58735013|FG001|Overall Study|Loss of Glucose Control|0|||
30721648|NCT00515294|58735023|FG000|Overall Study|Lost to Follow-up|3|||
30721649|NCT00515294|58735024|FG001|Overall Study|Lost to Follow-up|2|||
30721650|NCT00515294|58735025|FG002|Overall Study|Lost to Follow-up|3|||
30721651|NCT00515294|58735026|FG003|Overall Study|Lost to Follow-up|1|||
30721652|NCT00515294|58735023|FG000|Overall Study|Driver simulator problems|1|||
30721653|NCT00515294|58735024|FG001|Overall Study|Driver simulator problems|1|||
30721654|NCT00515294|58735025|FG002|Overall Study|Driver simulator problems|1|||
30721655|NCT00515294|58735026|FG003|Overall Study|Driver simulator problems|3|||
30721656|NCT00515294|58735023|FG000|Overall Study|Caffeine amount inaccurate|5|||
30721657|NCT00515294|58735024|FG001|Overall Study|Caffeine amount inaccurate|0|||
30721658|NCT00515294|58735025|FG002|Overall Study|Caffeine amount inaccurate|7|||
30721659|NCT00515294|58735026|FG003|Overall Study|Caffeine amount inaccurate|0|||
30721660|NCT00345046|58735039|FG000|Overall Study|Protocol Violation|1|||
30721661|NCT00345046|58735040|FG001|Overall Study|Protocol Violation|1|||
30721662|NCT00345046|58735041|FG002|Overall Study|Protocol Violation|2|||
30721663|NCT00515216|58735049|FG000|Overall Study|Withdrawal by Subject|1|||
30721664|NCT01004978|58735056|FG000|Overall Study|Disease progression|31|||
30721665|NCT01004978|58735057|FG001|Overall Study|Disease progression|48|||
30621618|NCT00932698|58633218|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
30621619|NCT00932698|58633219|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
30721666|NCT01004978|58735056|FG000|Overall Study|Adverse Event|42|||
30721667|NCT01004978|58735057|FG001|Overall Study|Adverse Event|22|||
30721668|NCT01004978|58735056|FG000|Overall Study|Death|3|||
30721669|NCT01004978|58735057|FG001|Overall Study|Death|2|||
30721670|NCT01004978|58735056|FG000|Overall Study|Withdrawal by Subject|16|||
30721671|NCT01004978|58735057|FG001|Overall Study|Withdrawal by Subject|16|||
30721672|NCT01004978|58735056|FG000|Overall Study|Alternative therapy|4|||
30721673|NCT01004978|58735057|FG001|Overall Study|Alternative therapy|8|||
30721674|NCT01004978|58735056|FG000|Overall Study|Physician Decision|6|||
30621620|NCT00932698|58633209|FG000|Part 1 (Dose Escalation)|Other|0|||
30721675|NCT01004978|58735057|FG001|Overall Study|Physician Decision|3|||
30721676|NCT01004978|58735056|FG000|Overall Study|Other complicating disease|2|||
30721677|NCT01004978|58735057|FG001|Overall Study|Other complicating disease|2|||
30721678|NCT01004978|58735056|FG000|Overall Study|Protocol Violation|2|||
30721679|NCT01004978|58735057|FG001|Overall Study|Protocol Violation|3|||
30721680|NCT01004978|58735056|FG000|Overall Study|Non-compliance|3|||
30721681|NCT01004978|58735057|FG001|Overall Study|Non-compliance|2|||
30721682|NCT01004978|58735056|FG000|Overall Study|Ineligible|1|||
30721683|NCT01004978|58735057|FG001|Overall Study|Ineligible|0|||
30721684|NCT01004978|58735056|FG000|Overall Study|Unblinded|0|||
30721685|NCT01004978|58735057|FG001|Overall Study|Unblinded|1|||
30721686|NCT01004978|58735056|FG000|Overall Study|Performance status worsening|0|||
30721687|NCT01004978|58735057|FG001|Overall Study|Performance status worsening|1|||
30721688|NCT01004978|58735056|FG000|Overall Study|Never started treatment|8|||
30721689|NCT01004978|58735057|FG001|Overall Study|Never started treatment|9|||
30721690|NCT00522626|58735063|FG000|Overall Study|Lost to Follow-up|7|||
30721691|NCT00440193|58735069|FG000|Treatment Period|Adverse Event|74|||
30721692|NCT00440193|58735070|FG001|Treatment Period|Adverse Event|67|||
30721693|NCT00440193|58735069|FG000|Treatment Period|Death|19|||
30721694|NCT00440193|58735070|FG001|Treatment Period|Death|22|||
30721695|NCT00440193|58735069|FG000|Treatment Period|Lack of Efficacy|0|||
30721696|NCT00440193|58735070|FG001|Treatment Period|Lack of Efficacy|1|||
30721697|NCT00440193|58735069|FG000|Treatment Period|Lost to Follow-up|12|||
30721698|NCT00440193|58735070|FG001|Treatment Period|Lost to Follow-up|18|||
30721699|NCT00440193|58735069|FG000|Treatment Period|Physician Decision|3|||
30721700|NCT00440193|58735070|FG001|Treatment Period|Physician Decision|6|||
30721701|NCT00440193|58735069|FG000|Treatment Period|Protocol Violation|16|||
30721702|NCT00440193|58735070|FG001|Treatment Period|Protocol Violation|19|||
30721703|NCT00440193|58735069|FG000|Treatment Period|Withdrawal by Subject|36|||
30721704|NCT00440193|58735070|FG001|Treatment Period|Withdrawal by Subject|77|||
30721705|NCT00440193|58735069|FG000|Treatment Period|Clinical endpoint reached|28|||
30721706|NCT00440193|58735070|FG001|Treatment Period|Clinical endpoint reached|25|||
30721707|NCT00440193|58735069|FG000|Treatment Period|Study terminated by sponsor|102|||
30721708|NCT00440193|58735070|FG001|Treatment Period|Study terminated by sponsor|94|||
30721709|NCT00440193|58735069|FG000|Treatment Period|Protocol driven decision point|2|||
30721710|NCT00440193|58735070|FG001|Treatment Period|Protocol driven decision point|2|||
30721711|NCT00440193|58735069|FG000|Treatment Period|Switch to commercial drug|0|||
30721712|NCT00440193|58735070|FG001|Treatment Period|Switch to commercial drug|2|||
30721713|NCT00440193|58735069|FG000|Treatment Period|Technical problems|1|||
30721714|NCT00440193|58735070|FG001|Treatment Period|Technical problems|1|||
30721715|NCT00440193|58735069|FG000|Treatment Period|Participant convenience|5|||
30721716|NCT00440193|58735070|FG001|Treatment Period|Participant convenience|2|||
30721717|NCT00440193|58735069|FG000|Treatment Period|Participant did not receive treatment|7|||
30721718|NCT00440193|58735070|FG001|Treatment Period|Participant did not receive treatment|13|||
30721719|NCT00440193|58735069|FG000|Treatment Period|Site closed by investigator|0|||
30721720|NCT00440193|58735070|FG001|Treatment Period|Site closed by investigator|2|||
30721721|NCT00440193|58735069|FG000|Observational Period|Adverse Event|2|||
30721722|NCT00440193|58735070|FG001|Observational Period|Adverse Event|2|||
30721723|NCT00440193|58735069|FG000|Observational Period|Death|15|||
30721724|NCT00440193|58735070|FG001|Observational Period|Death|20|||
30621621|NCT00932698|58633210|FG001|Part 1 (Dose Escalation)|Other|0|||
30621622|NCT00932698|58633211|FG002|Part 1 (Dose Escalation)|Other|1|||
30621623|NCT00932698|58633212|FG003|Part 1 (Dose Escalation)|Other|0|||
30621624|NCT00932698|58633213|FG004|Part 1 (Dose Escalation)|Other|0|||
30621625|NCT00932698|58633214|FG005|Part 1 (Dose Escalation)|Other|0|||
30621626|NCT00932698|58633215|FG006|Part 1 (Dose Escalation)|Other|1|||
30721725|NCT00440193|58735069|FG000|Observational Period|Lost to Follow-up|12|||
30721726|NCT00440193|58735070|FG001|Observational Period|Lost to Follow-up|8|||
30721727|NCT00440193|58735069|FG000|Observational Period|Protocol Violation|1|||
30721728|NCT00440193|58735070|FG001|Observational Period|Protocol Violation|0|||
30721729|NCT00440193|58735069|FG000|Observational Period|Withdrawal by Subject|11|||
30721730|NCT00440193|58735070|FG001|Observational Period|Withdrawal by Subject|8|||
30721731|NCT00440193|58735069|FG000|Observational Period|Physician Decision|1|||
30721732|NCT00440193|58735070|FG001|Observational Period|Physician Decision|0|||
30721733|NCT00440193|58735069|FG000|Observational Period|Clinical endpoint reached|1|||
30721734|NCT00440193|58735070|FG001|Observational Period|Clinical endpoint reached|0|||
30721735|NCT00440193|58735069|FG000|Observational Period|Participant convenience|2|||
30721736|NCT00440193|58735070|FG001|Observational Period|Participant convenience|0|||
30721737|NCT00511472|58735078|FG000|Overall Study|Clinical Adverse Event|1|||
30721738|NCT00511472|58735079|FG001|Overall Study|Clinical Adverse Event|2|||
30721739|NCT00511472|58735078|FG000|Overall Study|Laboratory Adverse Event|0|||
30721740|NCT00511472|58735079|FG001|Overall Study|Laboratory Adverse Event|2|||
30721741|NCT00511472|58735078|FG000|Overall Study|Not reported|2|||
30721742|NCT00511472|58735079|FG001|Overall Study|Not reported|2|||
30721743|NCT00514904|58735096|FG000|Overall Study|Withdrawal by Subject|3|||
30721744|NCT00514904|58735097|FG001|Overall Study|Withdrawal by Subject|2|||
30721745|NCT00514904|58735096|FG000|Overall Study|Lost to Follow-up|21|||
30721746|NCT00514904|58735097|FG001|Overall Study|Lost to Follow-up|3|||
30721747|NCT00440115|58735106|FG000|Overall Study|Death|7|||
30721748|NCT00440115|58735107|FG001|Overall Study|Death|9|||
30721749|NCT00440115|58735108|FG002|Overall Study|Death|5|||
30721750|NCT00440115|58735106|FG000|Overall Study|Incarceration|0|||
30721751|NCT00440115|58735107|FG001|Overall Study|Incarceration|2|||
30721752|NCT00440115|58735108|FG002|Overall Study|Incarceration|1|||
30721753|NCT00440037|58735116|FG000|Overall Study|Withdrawal by Subject|6|||
30721754|NCT00440037|58735116|FG000|Overall Study|Administrative decision|3|||
30721755|NCT00417027|58735123|FG000|Overall Study|Protocol Violation|0|||
30721756|NCT00417027|58735124|FG001|Overall Study|Protocol Violation|5|||
30721757|NCT00417027|58735125|FG002|Overall Study|Protocol Violation|5|||
30721758|NCT00416949|58735133|FG000|Overall Study|Patients refused to participate|5|||
30721759|NCT00416715|58735137|FG000|Overall Study|Not evaluable for joint aches|7|||
30721760|NCT00416715|58735137|FG000|Overall Study|Vitamin D levels not evaluable|8|||
30721761|NCT00406029|58735149|FG000|Overall Study|Adverse Event|12|||
30721762|NCT00406029|58735150|FG001|Overall Study|Adverse Event|2|||
30721763|NCT00406029|58735151|FG002|Overall Study|Adverse Event|5|||
30721764|NCT00406029|58735152|FG003|Overall Study|Adverse Event|10|||
30721765|NCT00406029|58735153|FG004|Overall Study|Adverse Event|7|||
30721766|NCT00406029|58735149|FG000|Overall Study|Withdrawal by Subject|3|||
30721767|NCT00406029|58735150|FG001|Overall Study|Withdrawal by Subject|4|||
30721768|NCT00406029|58735151|FG002|Overall Study|Withdrawal by Subject|2|||
30721769|NCT00406029|58735152|FG003|Overall Study|Withdrawal by Subject|2|||
30721770|NCT00406029|58735153|FG004|Overall Study|Withdrawal by Subject|0|||
30721771|NCT00406029|58735149|FG000|Overall Study|Protocol Violation|1|||
30721772|NCT00406029|58735150|FG001|Overall Study|Protocol Violation|2|||
30721773|NCT00406029|58735151|FG002|Overall Study|Protocol Violation|0|||
30721774|NCT00406029|58735152|FG003|Overall Study|Protocol Violation|2|||
30721775|NCT00406029|58735153|FG004|Overall Study|Protocol Violation|0|||
30721776|NCT00406029|58735149|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
30721777|NCT00406029|58735150|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
30721778|NCT00406029|58735151|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
30721779|NCT00406029|58735152|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
30721780|NCT00406029|58735153|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
30721781|NCT00406029|58735149|FG000|Overall Study|Randomized in Error|0|||
30721782|NCT00406029|58735150|FG001|Overall Study|Randomized in Error|0|||
30721783|NCT00406029|58735151|FG002|Overall Study|Randomized in Error|2|||
30721784|NCT00406029|58735152|FG003|Overall Study|Randomized in Error|3|||
30721785|NCT00406029|58735153|FG004|Overall Study|Randomized in Error|1|||
30721786|NCT00514514|58735168|FG000|Pre-phase|Death|10|||
30721787|NCT00514514|58735169|FG001|Pre-phase|Death|0|||
30721788|NCT00514514|58735170|FG002|Pre-phase|Death|0|||
30721789|NCT00514514|58735168|FG000|Pre-phase|administrative problems|2|||
30721790|NCT00514514|58735169|FG001|Pre-phase|administrative problems|0|||
30721791|NCT00514514|58735170|FG002|Pre-phase|administrative problems|0|||
30721792|NCT00514514|58735168|FG000|Pre-phase|Protocol Violation|6|||
30721793|NCT00514514|58735169|FG001|Pre-phase|Protocol Violation|0|||
30721794|NCT00514514|58735170|FG002|Pre-phase|Protocol Violation|0|||
30721795|NCT00514514|58735168|FG000|Pre-phase|condition no longer requires study drug|7|||
30721796|NCT00514514|58735169|FG001|Pre-phase|condition no longer requires study drug|0|||
30721797|NCT00514514|58735170|FG002|Pre-phase|condition no longer requires study drug|0|||
30721798|NCT00514514|58735168|FG000|Pre-phase|abnormal test procedure results|15|||
30721799|NCT00514514|58735169|FG001|Pre-phase|abnormal test procedure results|0|||
30721800|NCT00514514|58735170|FG002|Pre-phase|abnormal test procedure results|0|||
30721801|NCT00514514|58735168|FG000|Pre-phase|Lost to Follow-up|2|||
30721802|NCT00514514|58735169|FG001|Pre-phase|Lost to Follow-up|0|||
30721803|NCT00514514|58735170|FG002|Pre-phase|Lost to Follow-up|0|||
30721804|NCT00514514|58735168|FG000|Pre-phase|abnormal lab values|23|||
30721805|NCT00514514|58735169|FG001|Pre-phase|abnormal lab values|0|||
30721806|NCT00514514|58735170|FG002|Pre-phase|abnormal lab values|0|||
30721807|NCT00514514|58735168|FG000|Pre-phase|Lack of Efficacy|35|||
30721808|NCT00514514|58735169|FG001|Pre-phase|Lack of Efficacy|0|||
30721809|NCT00514514|58735170|FG002|Pre-phase|Lack of Efficacy|0|||
30721810|NCT00514514|58735168|FG000|Pre-phase|Adverse Event|137|||
30721811|NCT00514514|58735169|FG001|Pre-phase|Adverse Event|0|||
30721812|NCT00514514|58735170|FG002|Pre-phase|Adverse Event|0|||
30721813|NCT00514514|58735168|FG000|Pre-phase|Withdrawal by Subject|66|||
30721814|NCT00514514|58735169|FG001|Pre-phase|Withdrawal by Subject|0|||
30721815|NCT00514514|58735170|FG002|Pre-phase|Withdrawal by Subject|0|||
30721816|NCT00514514|58735168|FG000|Randomized - 9 Month|Death|3|||
30721817|NCT00514514|58735169|FG001|Randomized - 9 Month|Death|2|||
30721818|NCT00514514|58735170|FG002|Randomized - 9 Month|Death|2|||
30721819|NCT00514514|58735168|FG000|Randomized - 9 Month|Administrative problems|1|||
30721820|NCT00514514|58735169|FG001|Randomized - 9 Month|Administrative problems|1|||
30721821|NCT00514514|58735170|FG002|Randomized - 9 Month|Administrative problems|2|||
30721822|NCT00514514|58735168|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
30721823|NCT00514514|58735169|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
30721824|NCT00514514|58735170|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
30721825|NCT00514514|58735168|FG000|Randomized - 9 Month|Protocol Violation|1|||
30721826|NCT00514514|58735169|FG001|Randomized - 9 Month|Protocol Violation|1|||
30721827|NCT00514514|58735170|FG002|Randomized - 9 Month|Protocol Violation|0|||
30721828|NCT00514514|58735168|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
30721829|NCT00514514|58735169|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
30721830|NCT00514514|58735170|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
30721831|NCT00514514|58735168|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
30721832|NCT00514514|58735169|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
30721833|NCT00514514|58735170|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
30721834|NCT00514514|58735168|FG000|Randomized - 9 Month|Adverse Event|25|||
30721835|NCT00514514|58735169|FG001|Randomized - 9 Month|Adverse Event|44|||
30721836|NCT00514514|58735170|FG002|Randomized - 9 Month|Adverse Event|27|||
30721837|NCT00514514|58735168|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
30721838|NCT00514514|58735169|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
30721839|NCT00514514|58735170|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
30721840|NCT00514514|58735168|FG000|Extension - 4 Years|Lost to Follow-up|12|||
30721841|NCT00514514|58735169|FG001|Extension - 4 Years|Lost to Follow-up|10|||
30721842|NCT00514514|58735170|FG002|Extension - 4 Years|Lost to Follow-up|9|||
30721843|NCT00514514|58735168|FG000|Extension - 4 Years|Administrative problems|3|||
30721844|NCT00514514|58735169|FG001|Extension - 4 Years|Administrative problems|1|||
30721845|NCT00514514|58735170|FG002|Extension - 4 Years|Administrative problems|1|||
30721846|NCT00514514|58735168|FG000|Extension - 4 Years|Death|8|||
30721847|NCT00514514|58735169|FG001|Extension - 4 Years|Death|3|||
30721848|NCT00514514|58735170|FG002|Extension - 4 Years|Death|6|||
30721849|NCT00514514|58735168|FG000|Extension - 4 Years|Adverse Event|9|||
30721850|NCT00514514|58735169|FG001|Extension - 4 Years|Adverse Event|6|||
30721851|NCT00514514|58735170|FG002|Extension - 4 Years|Adverse Event|3|||
30721852|NCT00405639|58735180|FG000|Overall Study|Withdrawal by Subject|1|||
30721853|NCT00405639|58735181|FG001|Overall Study|Withdrawal by Subject|0|||
30721854|NCT00405639|58735180|FG000|Overall Study|Adverse Event|1|||
30721855|NCT00405639|58735181|FG001|Overall Study|Adverse Event|0|||
30721856|NCT00405639|58735180|FG000|Overall Study|Seizure prior to receiving BNP|1|||
30721857|NCT00405639|58735181|FG001|Overall Study|Seizure prior to receiving BNP|0|||
30721858|NCT00439725|58735189|FG000|Treatment Period|Withdrawal by Subject|22|||
30721859|NCT00439725|58735190|FG001|Treatment Period|Withdrawal by Subject|19|||
30721860|NCT00439725|58735189|FG000|Treatment Period|Study terminated by sponsor|156|||
30721861|NCT00439725|58735190|FG001|Treatment Period|Study terminated by sponsor|148|||
30721862|NCT00439725|58735189|FG000|Treatment Period|Site closed by investigator|1|||
30721863|NCT00439725|58735190|FG001|Treatment Period|Site closed by investigator|2|||
30721864|NCT00439725|58735189|FG000|Treatment Period|Adverse Event|39|||
30721865|NCT00439725|58735190|FG001|Treatment Period|Adverse Event|18|||
30721866|NCT00439725|58735189|FG000|Treatment Period|Physician Decision|1|||
30721867|NCT00439725|58735190|FG001|Treatment Period|Physician Decision|1|||
30721868|NCT00439725|58735189|FG000|Treatment Period|Protocol Violation|2|||
30721869|NCT00439725|58735190|FG001|Treatment Period|Protocol Violation|1|||
30721870|NCT00439725|58735189|FG000|Treatment Period|Clinical endpoint reached|6|||
30721871|NCT00439725|58735190|FG001|Treatment Period|Clinical endpoint reached|50|||
30721872|NCT00439725|58735189|FG000|Treatment Period|Technical problems|1|||
30721873|NCT00439725|58735190|FG001|Treatment Period|Technical problems|0|||
30721874|NCT00439725|58735189|FG000|Treatment Period|Lost to Follow-up|1|||
30721875|NCT00439725|58735190|FG001|Treatment Period|Lost to Follow-up|1|||
30721876|NCT00439725|58735189|FG000|Treatment Period|Participant convenience|1|||
30721877|NCT00439725|58735190|FG001|Treatment Period|Participant convenience|0|||
30721878|NCT00439725|58735189|FG000|Treatment Period|Protocol driven decision point|1|||
30721879|NCT00439725|58735190|FG001|Treatment Period|Protocol driven decision point|1|||
30721880|NCT00439725|58735189|FG000|Treatment Period|Death|1|||
30721881|NCT00439725|58735190|FG001|Treatment Period|Death|1|||
30721882|NCT00439725|58735189|FG000|Treatment Period|Participant did not receive treatment|4|||
30721883|NCT00439725|58735190|FG001|Treatment Period|Participant did not receive treatment|4|||
30721884|NCT00439725|58735189|FG000|Observational Period|Withdrawal by Subject|2|||
30721885|NCT00439725|58735190|FG001|Observational Period|Withdrawal by Subject|2|||
30721886|NCT00439725|58735189|FG000|Observational Period|Lost to Follow-up|0|||
30721887|NCT00439725|58735190|FG001|Observational Period|Lost to Follow-up|1|||
30721888|NCT00439725|58735189|FG000|Observational Period|Death|0|||
30721889|NCT00439725|58735190|FG001|Observational Period|Death|2|||
30721890|NCT00439725|58735189|FG000|Observational Period|Study termination by sponsor|1|||
30721891|NCT00439725|58735190|FG001|Observational Period|Study termination by sponsor|1|||
30721892|NCT00439725|58735189|FG000|Observational Period|Clinical endpoint reached|3|||
30721893|NCT00439725|58735190|FG001|Observational Period|Clinical endpoint reached|1|||
30721894|NCT00439725|58735189|FG000|Observational Period|Technical problems|1|||
30721895|NCT00439725|58735190|FG001|Observational Period|Technical problems|0|||
30721896|NCT00439725|58735189|FG000|Observational Period|Participant convenience|1|||
30721897|NCT00439725|58735190|FG001|Observational Period|Participant convenience|0|||
30721898|NCT00521586|58735198|FG000|Initial Vaccination (Year 0)|Subject request|8|||
30721899|NCT00521586|58735199|FG001|Initial Vaccination (Year 0)|Subject request|11|||
30721900|NCT00521586|58735198|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
30721901|NCT00521586|58735199|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
30721902|NCT00521586|58735198|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
30721903|NCT00521586|58735199|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
30721904|NCT00521586|58735198|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
30721905|NCT00521586|58735199|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
30721906|NCT00521586|58735198|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
30721907|NCT00521586|58735199|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
30721908|NCT00521586|58735198|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
30721909|NCT00521586|58735199|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
30721910|NCT00521586|58735198|FG000|Initial Vaccination (Year 0)|Death|1|||
30721911|NCT00521586|58735199|FG001|Initial Vaccination (Year 0)|Death|0|||
30721912|NCT00521586|58735198|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
30721913|NCT00521586|58735199|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
30721914|NCT00521586|58735198|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
30721915|NCT00521586|58735199|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
30721916|NCT00521586|58735198|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
30721917|NCT00521586|58735199|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
30721918|NCT00521586|58735198|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
30721919|NCT00521586|58735199|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
30721920|NCT00521586|58735198|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
30721921|NCT00521586|58735199|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
30721922|NCT00521586|58735198|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
30721923|NCT00521586|58735199|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
30721924|NCT00521586|58735198|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
30721925|NCT00521586|58735199|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
30721926|NCT00521586|58735198|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
30721927|NCT00521586|58735199|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
30721928|NCT00521586|58735198|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
30721929|NCT00521586|58735199|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
30621627|NCT00932698|58633216|FG007|Part 1 (Dose Escalation)|Other|0|||
30721930|NCT00521586|58735198|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
30621628|NCT00932698|58633217|FG008|Part 1 (Dose Escalation)|Other|0|||
30721931|NCT00521586|58735199|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
30721932|NCT00521586|58735198|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
30721933|NCT00521586|58735199|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
30721934|NCT00521586|58735198|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
30721935|NCT00521586|58735199|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
30721936|NCT00515502|58735217|FG000|Treatment Period 1|Adverse Event|0|||
30721937|NCT00515502|58735218|FG001|Treatment Period 1|Adverse Event|0|||
30721938|NCT00515502|58735219|FG002|Treatment Period 1|Adverse Event|0|||
30721939|NCT00515502|58735220|FG003|Treatment Period 1|Adverse Event|0|||
30721940|NCT00515502|58735221|FG004|Treatment Period 1|Adverse Event|0|||
30721941|NCT00515502|58735222|FG005|Treatment Period 1|Adverse Event|0|||
30721942|NCT00515502|58735223|FG006|Treatment Period 1|Adverse Event|1|||
30721943|NCT00515502|58735224|FG007|Treatment Period 1|Adverse Event|0|||
30721944|NCT00515502|58735225|FG008|Treatment Period 1|Adverse Event|1|||
30721945|NCT00515502|58735226|FG009|Treatment Period 1|Adverse Event|0|||
30721946|NCT00515502|58735227|FG010|Treatment Period 1|Adverse Event|0|||
30721947|NCT00515502|58735228|FG011|Treatment Period 1|Adverse Event|1|||
30721948|NCT00515502|58735217|FG000|Treatment Period 2|Adverse Event|0|||
30721949|NCT00515502|58735218|FG001|Treatment Period 2|Adverse Event|1|||
30721950|NCT00515502|58735219|FG002|Treatment Period 2|Adverse Event|0|||
30721951|NCT00515502|58735220|FG003|Treatment Period 2|Adverse Event|0|||
30721952|NCT00515502|58735221|FG004|Treatment Period 2|Adverse Event|0|||
30721953|NCT00515502|58735222|FG005|Treatment Period 2|Adverse Event|0|||
30721954|NCT00515502|58735223|FG006|Treatment Period 2|Adverse Event|0|||
30721955|NCT00515502|58735224|FG007|Treatment Period 2|Adverse Event|0|||
30721956|NCT00515502|58735225|FG008|Treatment Period 2|Adverse Event|0|||
30721957|NCT00515502|58735226|FG009|Treatment Period 2|Adverse Event|0|||
30721958|NCT00515502|58735227|FG010|Treatment Period 2|Adverse Event|0|||
30721959|NCT00515502|58735228|FG011|Treatment Period 2|Adverse Event|0|||
30721960|NCT00439647|58735247|FG000|Overall Study|Withdrawal by Subject|25|||
30721961|NCT00439647|58735248|FG001|Overall Study|Withdrawal by Subject|22|||
30721962|NCT00439647|58735247|FG000|Overall Study|Death|15|||
30721963|NCT00439647|58735248|FG001|Overall Study|Death|18|||
30721964|NCT00439647|58735247|FG000|Overall Study|Adverse Event|11|||
30721965|NCT00439647|58735248|FG001|Overall Study|Adverse Event|11|||
30721966|NCT00439647|58735247|FG000|Overall Study|Lost to Follow-up|4|||
30721967|NCT00439647|58735248|FG001|Overall Study|Lost to Follow-up|12|||
30721968|NCT00439647|58735247|FG000|Overall Study|Protocol Violation|3|||
30721969|NCT00439647|58735248|FG001|Overall Study|Protocol Violation|4|||
30721970|NCT00439647|58735247|FG000|Overall Study|Lack of Efficacy|0|||
30721971|NCT00439647|58735248|FG001|Overall Study|Lack of Efficacy|4|||
30721972|NCT00515112|58735256|FG000|Overall Study|Death|0|||
30721973|NCT00515112|58735257|FG001|Overall Study|Death|1|||
30721974|NCT00515112|58735256|FG000|Overall Study|The study was terminated|3|||
30721975|NCT00515112|58735257|FG001|Overall Study|The study was terminated|2|||
30721976|NCT00404547|58735265|FG000|Overall Study|Adverse Event|39|||
30721977|NCT00404547|58735266|FG001|Overall Study|Adverse Event|6|||
30721978|NCT00404547|58735265|FG000|Overall Study|Withdrawal by Subject|19|||
30721979|NCT00404547|58735266|FG001|Overall Study|Withdrawal by Subject|2|||
30721980|NCT00404547|58735265|FG000|Overall Study|Protocol Violation|0|||
30621629|NCT00932698|58633218|FG009|Part 1 (Dose Escalation)|Other|0|||
30721981|NCT00404547|58735266|FG001|Overall Study|Protocol Violation|1|||
30721982|NCT00404547|58735265|FG000|Overall Study|Lost to Follow-up|20|||
30721983|NCT00404547|58735266|FG001|Overall Study|Lost to Follow-up|9|||
30721984|NCT00404547|58735265|FG000|Overall Study|Lack of compliance|5|||
30721985|NCT00404547|58735266|FG001|Overall Study|Lack of compliance|1|||
30721986|NCT00404547|58735265|FG000|Overall Study|Other|4|||
30721987|NCT00404547|58735266|FG001|Overall Study|Other|0|||
30721988|NCT00404547|58735265|FG000|Overall Study|Reason not stated|3|||
30721989|NCT00404547|58735266|FG001|Overall Study|Reason not stated|6|||
30721990|NCT00515034|58735276|FG000|Overall Study|Adverse Event|2|||
30721991|NCT00515034|58735277|FG001|Overall Study|Adverse Event|0|||
30721992|NCT00515034|58735278|FG002|Overall Study|Adverse Event|1|||
30721993|NCT00515034|58735279|FG003|Overall Study|Adverse Event|0|||
30721994|NCT00515034|58735276|FG000|Overall Study|Death|4|||
30721995|NCT00515034|58735277|FG001|Overall Study|Death|2|||
30721996|NCT00515034|58735278|FG002|Overall Study|Death|1|||
30721997|NCT00515034|58735279|FG003|Overall Study|Death|3|||
30721998|NCT00515034|58735276|FG000|Overall Study|Withdrawal by Subject|1|||
30721999|NCT00515034|58735277|FG001|Overall Study|Withdrawal by Subject|0|||
30722000|NCT00515034|58735278|FG002|Overall Study|Withdrawal by Subject|3|||
30722001|NCT00515034|58735279|FG003|Overall Study|Withdrawal by Subject|0|||
30722002|NCT00515034|58735276|FG000|Overall Study|Physician Decision|0|||
30722003|NCT00515034|58735277|FG001|Overall Study|Physician Decision|0|||
30722004|NCT00515034|58735278|FG002|Overall Study|Physician Decision|1|||
30722005|NCT00515034|58735279|FG003|Overall Study|Physician Decision|1|||
30722006|NCT00515034|58735276|FG000|Overall Study|Other|1|||
30722007|NCT00515034|58735277|FG001|Overall Study|Other|0|||
30722008|NCT00515034|58735278|FG002|Overall Study|Other|2|||
30722009|NCT00515034|58735279|FG003|Overall Study|Other|1|||
30722010|NCT00404235|58735291|FG000|Overall Study|Withdrawal by Subject|1|||
30722011|NCT00404235|58735292|FG001|Overall Study|Withdrawal by Subject|2|||
30722012|NCT00404079|58735300|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
30722013|NCT00404079|58735301|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
30722014|NCT00403845|58735307|FG000|Treatment Period 1|Subject withdrew consent|1|||
30722015|NCT00403845|58735308|FG001|Treatment Period 1|Subject withdrew consent|0|||
30722016|NCT00403845|58735309|FG002|Treatment Period 1|Subject withdrew consent|0|||
30722017|NCT00403845|58735310|FG003|Treatment Period 1|Subject withdrew consent|0|||
30722018|NCT00403845|58735307|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
30722019|NCT00403845|58735308|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
30722020|NCT00403845|58735309|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
30722021|NCT00403845|58735310|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
30722022|NCT00403845|58735307|FG000|Treatment Period 2|Subject withdrew consent|1|||
30722023|NCT00403845|58735308|FG001|Treatment Period 2|Subject withdrew consent|0|||
30722024|NCT00403845|58735309|FG002|Treatment Period 2|Subject withdrew consent|0|||
30722025|NCT00403845|58735310|FG003|Treatment Period 2|Subject withdrew consent|0|||
30722026|NCT00403845|58735307|FG000|Treatment Period 3|Subject withdrew consent|0|||
30722027|NCT00403845|58735308|FG001|Treatment Period 3|Subject withdrew consent|0|||
30722028|NCT00403845|58735309|FG002|Treatment Period 3|Subject withdrew consent|0|||
30722029|NCT00403845|58735310|FG003|Treatment Period 3|Subject withdrew consent|1|||
30722030|NCT00403845|58735307|FG000|Treatment Period 3|Adverse Event|0|||
30722031|NCT00403845|58735308|FG001|Treatment Period 3|Adverse Event|0|||
30722032|NCT00403845|58735309|FG002|Treatment Period 3|Adverse Event|0|||
30722033|NCT00403845|58735310|FG003|Treatment Period 3|Adverse Event|1|||
30722034|NCT00509262|58735322|FG000|Overall Study|Adverse Event|16|||
30722035|NCT00509262|58735323|FG001|Overall Study|Adverse Event|18|||
30722036|NCT00509262|58735322|FG000|Overall Study|Other|2|||
30722037|NCT00509262|58735323|FG001|Overall Study|Other|2|||
30722038|NCT00509262|58735322|FG000|Overall Study|Lack of Efficacy|1|||
30722039|NCT00509262|58735323|FG001|Overall Study|Lack of Efficacy|0|||
30722040|NCT00509262|58735322|FG000|Overall Study|Lost to Follow-up|1|||
30722041|NCT00509262|58735323|FG001|Overall Study|Lost to Follow-up|6|||
30722042|NCT00509262|58735322|FG000|Overall Study|Physician Decision|1|||
30722043|NCT00509262|58735323|FG001|Overall Study|Physician Decision|3|||
30722044|NCT00509262|58735322|FG000|Overall Study|Protocol Violation|2|||
30722045|NCT00509262|58735323|FG001|Overall Study|Protocol Violation|2|||
30722046|NCT00509262|58735322|FG000|Overall Study|Withdrawal by Subject|24|||
30722047|NCT00509262|58735323|FG001|Overall Study|Withdrawal by Subject|11|||
30722048|NCT00607997|58735333|FG000|Overall Study|Lack of Efficacy|6|||
30722049|NCT00607997|58735334|FG001|Overall Study|Lack of Efficacy|20|||
30722050|NCT00607997|58735335|FG002|Overall Study|Lack of Efficacy|14|||
30722051|NCT00607997|58735336|FG003|Overall Study|Lack of Efficacy|10|||
30722052|NCT00607997|58735333|FG000|Overall Study|Death|8|||
30722053|NCT00607997|58735334|FG001|Overall Study|Death|5|||
30722054|NCT00607997|58735335|FG002|Overall Study|Death|2|||
30722055|NCT00607997|58735336|FG003|Overall Study|Death|5|||
30722056|NCT00607997|58735333|FG000|Overall Study|Adverse Event|3|||
30722057|NCT00607997|58735334|FG001|Overall Study|Adverse Event|1|||
30722058|NCT00607997|58735335|FG002|Overall Study|Adverse Event|2|||
30722059|NCT00607997|58735336|FG003|Overall Study|Adverse Event|0|||
30722060|NCT00607997|58735333|FG000|Overall Study|Physician Decision|4|||
30722061|NCT00607997|58735334|FG001|Overall Study|Physician Decision|1|||
30722062|NCT00607997|58735335|FG002|Overall Study|Physician Decision|0|||
30722063|NCT00607997|58735336|FG003|Overall Study|Physician Decision|0|||
30722064|NCT00607997|58735333|FG000|Overall Study|Relapse, recurrent illness|4|||
30722065|NCT00607997|58735334|FG001|Overall Study|Relapse, recurrent illness|0|||
30722066|NCT00607997|58735335|FG002|Overall Study|Relapse, recurrent illness|2|||
30722067|NCT00607997|58735336|FG003|Overall Study|Relapse, recurrent illness|0|||
30722068|NCT00607997|58735333|FG000|Overall Study|Other without explanation|2|||
30722069|NCT00607997|58735334|FG001|Overall Study|Other without explanation|0|||
30722070|NCT00607997|58735335|FG002|Overall Study|Other without explanation|4|||
30722071|NCT00607997|58735336|FG003|Overall Study|Other without explanation|1|||
30722072|NCT00509106|58735353|FG000|Overall Study|Adverse Event|3|||
30722073|NCT00509106|58735354|FG001|Overall Study|Adverse Event|2|||
30722074|NCT00509106|58735353|FG000|Overall Study|Noncompliance|0|||
30722075|NCT00509106|58735354|FG001|Overall Study|Noncompliance|1|||
30722076|NCT00509106|58735353|FG000|Overall Study|At the request of sponsor/investigator|1|||
30722077|NCT00509106|58735354|FG001|Overall Study|At the request of sponsor/investigator|2|||
30722078|NCT00509106|58735353|FG000|Overall Study|Withdrew consent|4|||
30722079|NCT00509106|58735354|FG001|Overall Study|Withdrew consent|8|||
30722080|NCT00509106|58735353|FG000|Overall Study|Lost to Follow-up|16|||
30722081|NCT00509106|58735354|FG001|Overall Study|Lost to Follow-up|10|||
30722082|NCT00509106|58735353|FG000|Overall Study|Other|1|||
30722083|NCT00509106|58735354|FG001|Overall Study|Other|0|||
30722084|NCT00509106|58735353|FG000|Overall Study|Death|6|||
30722085|NCT00509106|58735354|FG001|Overall Study|Death|6|||
30722086|NCT00607919|58735362|FG000|Acute Phase|Adverse Event|9|||
30722087|NCT00607919|58735363|FG001|Acute Phase|Adverse Event|2|||
30722088|NCT00607919|58735362|FG000|Acute Phase|Entry Criteria Not Met|1|||
30722089|NCT00607919|58735363|FG001|Acute Phase|Entry Criteria Not Met|1|||
30722090|NCT00607919|58735362|FG000|Acute Phase|Lack of Efficacy|1|||
30722091|NCT00607919|58735363|FG001|Acute Phase|Lack of Efficacy|2|||
30722092|NCT00607919|58735362|FG000|Acute Phase|Lost to Follow-up|9|||
30722093|NCT00607919|58735363|FG001|Acute Phase|Lost to Follow-up|3|||
30722094|NCT00607919|58735362|FG000|Acute Phase|Parent/Caregiver Decision|6|||
30722095|NCT00607919|58735363|FG001|Acute Phase|Parent/Caregiver Decision|4|||
30722096|NCT00607919|58735362|FG000|Acute Phase|Protocol Violation|5|||
30722097|NCT00607919|58735363|FG001|Acute Phase|Protocol Violation|1|||
30722098|NCT00607919|58735362|FG000|Acute Phase|Withdrawal by Subject|3|||
30722099|NCT00607919|58735363|FG001|Acute Phase|Withdrawal by Subject|3|||
30722100|NCT00607919|58735362|FG000|Open-Label Phase|Adverse Event|1|||
30722101|NCT00607919|58735363|FG001|Open-Label Phase|Adverse Event|5|||
30722102|NCT00607919|58735362|FG000|Open-Label Phase|Lost to Follow-up|4|||
30722103|NCT00607919|58735363|FG001|Open-Label Phase|Lost to Follow-up|1|||
30722104|NCT00607919|58735362|FG000|Open-Label Phase|Protocol Violation|2|||
30722105|NCT00607919|58735363|FG001|Open-Label Phase|Protocol Violation|2|||
30722106|NCT00607919|58735362|FG000|Open-Label Phase|Withdrawal by Subject|2|||
30722107|NCT00607919|58735363|FG001|Open-Label Phase|Withdrawal by Subject|2|||
30722108|NCT00607919|58735362|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
30722109|NCT00607919|58735363|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
30722110|NCT00344968|58735374|FG000|Overall Study|Adverse Event|5|||
30900337|NCT02267317|58933589|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
30900338|NCT02267317|58933590|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
30722111|NCT00344968|58735375|FG001|Overall Study|Adverse Event|4|||
30722112|NCT00344968|58735376|FG002|Overall Study|Adverse Event|15|||
30900339|NCT01844830|58933606|FG000|Overall Study|Withdrawal by Subject|1|||
30621630|NCT00932698|58633219|FG010|Part 1 (Dose Escalation)|Other|0|||
30722113|NCT00344968|58735374|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
30722114|NCT00344968|58735375|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
30722115|NCT00344968|58735376|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
30722116|NCT00344968|58735374|FG000|Overall Study|Protocol Violation|2|||
30722117|NCT00344968|58735375|FG001|Overall Study|Protocol Violation|2|||
30722118|NCT00344968|58735376|FG002|Overall Study|Protocol Violation|5|||
30722119|NCT00344968|58735374|FG000|Overall Study|Withdrawal by Subject|14|||
30722120|NCT00344968|58735375|FG001|Overall Study|Withdrawal by Subject|31|||
30722121|NCT00344968|58735376|FG002|Overall Study|Withdrawal by Subject|27|||
30722122|NCT00344968|58735374|FG000|Overall Study|Lost to Follow-up|24|||
30722123|NCT00344968|58735375|FG001|Overall Study|Lost to Follow-up|37|||
30722124|NCT00344968|58735376|FG002|Overall Study|Lost to Follow-up|37|||
30722125|NCT00344968|58735374|FG000|Overall Study|Death|11|||
30722126|NCT00344968|58735375|FG001|Overall Study|Death|27|||
30722127|NCT00344968|58735376|FG002|Overall Study|Death|31|||
30722128|NCT00344968|58735374|FG000|Overall Study|Other|0|||
30722129|NCT00344968|58735375|FG001|Overall Study|Other|1|||
30722130|NCT00344968|58735376|FG002|Overall Study|Other|0|||
30722131|NCT00509028|58735387|FG000|Overall Study|Adverse Event|2|||
30722132|NCT00509028|58735388|FG001|Overall Study|Adverse Event|0|||
30722133|NCT00509028|58735387|FG000|Overall Study|Withdrawal by Subject|4|||
30722134|NCT00509028|58735388|FG001|Overall Study|Withdrawal by Subject|3|||
30722135|NCT00509028|58735387|FG000|Overall Study|Lost to Follow-up|0|||
30722136|NCT00509028|58735388|FG001|Overall Study|Lost to Follow-up|1|||
30722137|NCT00509028|58735387|FG000|Overall Study|Protocol Violation|4|||
30722138|NCT00509028|58735388|FG001|Overall Study|Protocol Violation|2|||
30722139|NCT00509028|58735387|FG000|Overall Study|Non-compliance|2|||
30722140|NCT00509028|58735388|FG001|Overall Study|Non-compliance|1|||
30722141|NCT00352846|58735396|FG000|Overall Study|Disease progression|0|||
30722142|NCT00352846|58735397|FG001|Overall Study|Disease progression|2|||
30722143|NCT00352846|58735396|FG000|Overall Study|Withdrawal by Subject|3|||
30722144|NCT00352846|58735397|FG001|Overall Study|Withdrawal by Subject|8|||
30722145|NCT00352846|58735396|FG000|Overall Study|Ineligible|3|||
30722146|NCT00352846|58735397|FG001|Overall Study|Ineligible|2|||
30722147|NCT00352846|58735396|FG000|Overall Study|Non-compliance|2|||
30722148|NCT00352846|58735397|FG001|Overall Study|Non-compliance|0|||
30722149|NCT00352846|58735396|FG000|Overall Study|Death|0|||
30722150|NCT00352846|58735397|FG001|Overall Study|Death|1|||
30722151|NCT00508872|58735403|FG000|Overall Study|Lost to Follow-up|1|||
30722152|NCT00508872|58735403|FG000|Overall Study|Physician Decision|1|||
30722153|NCT00508482|58735410|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
30722154|NCT00508482|58735411|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
30722155|NCT00508482|58735412|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
30722156|NCT00508482|58735410|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
30722157|NCT00508482|58735411|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
30722158|NCT00508482|58735412|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
30722159|NCT00508482|58735410|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
30722160|NCT00508482|58735411|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
30722161|NCT00508482|58735412|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
30722162|NCT00344500|58735423|FG000|Overall Study|Adverse Event|6|||
30722163|NCT00344500|58735424|FG001|Overall Study|Adverse Event|2|||
30722164|NCT00344500|58735425|FG002|Overall Study|Adverse Event|0|||
30722165|NCT00344500|58735423|FG000|Overall Study|Lost to Follow-up|5|||
30722166|NCT00344500|58735424|FG001|Overall Study|Lost to Follow-up|13|||
30722167|NCT00344500|58735425|FG002|Overall Study|Lost to Follow-up|1|||
30722168|NCT00344500|58735423|FG000|Overall Study|Withdrawal by Subject|7|||
30722169|NCT00344500|58735424|FG001|Overall Study|Withdrawal by Subject|10|||
30722170|NCT00344500|58735425|FG002|Overall Study|Withdrawal by Subject|0|||
30722171|NCT00344500|58735423|FG000|Overall Study|Protocol Violation|4|||
30722172|NCT00344500|58735424|FG001|Overall Study|Protocol Violation|7|||
30722173|NCT00344500|58735425|FG002|Overall Study|Protocol Violation|1|||
30722174|NCT00344500|58735423|FG000|Overall Study|Not Noted|1|||
30722175|NCT00344500|58735424|FG001|Overall Study|Not Noted|3|||
30722176|NCT00344500|58735425|FG002|Overall Study|Not Noted|0|||
30722177|NCT00344032|58735434|FG000|Overall Study|Adverse Event|0|||
30722178|NCT00344032|58735435|FG001|Overall Study|Adverse Event|1|||
30722179|NCT00344032|58735434|FG000|Overall Study|Withdrawal by Subject|6|||
30722180|NCT00344032|58735435|FG001|Overall Study|Withdrawal by Subject|2|||
30722181|NCT00344032|58735434|FG000|Overall Study|Lost to Follow-up|4|||
30722182|NCT00344032|58735435|FG001|Overall Study|Lost to Follow-up|6|||
30722183|NCT00344032|58735434|FG000|Overall Study|Physician Decision|4|||
30722184|NCT00344032|58735435|FG001|Overall Study|Physician Decision|1|||
30722185|NCT00607373|58735443|FG000|Treatment Period|Adverse Event|0|||
30722186|NCT00607373|58735444|FG001|Treatment Period|Adverse Event|4|||
30722187|NCT00607373|58735443|FG000|Treatment Period|Physician Decision|0|||
30722188|NCT00607373|58735444|FG001|Treatment Period|Physician Decision|1|||
30722189|NCT00607373|58735443|FG000|Treatment Period|Withdrawal by Subject|0|||
30722190|NCT00607373|58735444|FG001|Treatment Period|Withdrawal by Subject|1|||
30722191|NCT00607373|58735443|FG000|Follow-up Period|Other|0|||
30722192|NCT00607373|58735444|FG001|Follow-up Period|Other|1|||
30722193|NCT00607373|58735443|FG000|Follow-up Period|Protocol Violation|0|||
30722194|NCT00607373|58735444|FG001|Follow-up Period|Protocol Violation|1|||
30722195|NCT00607373|58735443|FG000|Follow-up Period|Withdrawal by Subject|1|||
30722196|NCT00607373|58735444|FG001|Follow-up Period|Withdrawal by Subject|3|||
30722197|NCT00508404|58735450|FG000|Overall Study|Ongoing at Data Cut-off|12|||
30722198|NCT00508404|58735450|FG000|Overall Study|Adverse Event|2|||
30722199|NCT00508404|58735450|FG000|Overall Study|Death|16|||
30722200|NCT00508404|58735450|FG000|Overall Study|Physician Decision|2|||
30722201|NCT00508404|58735450|FG000|Overall Study|Withdrawal by Subject|3|||
30722202|NCT00508404|58735450|FG000|Overall Study|Protocol-specified Criteria|2|||
30722203|NCT00508404|58735450|FG000|Overall Study|Lost to Follow-up|2|||
30722204|NCT00508404|58735450|FG000|Overall Study|Other - Not Specified|3|||
30722205|NCT00352690|58735457|FG000|Overall Study|Determined to be ineligible|2|||
30722206|NCT00352690|58735458|FG001|Overall Study|Determined to be ineligible|0|||
30722207|NCT00609245|58735464|FG000|Overall Study|Adverse Event|1|||
30722208|NCT00343642|58735473|FG000|Overall Study|Lost to Follow-up|0|||
30722209|NCT00343642|58735474|FG001|Overall Study|Lost to Follow-up|1|||
30722210|NCT00343642|58735475|FG002|Overall Study|Lost to Follow-up|0|||
30722211|NCT00343642|58735473|FG000|Overall Study|Pregnancy|1|||
30722212|NCT00343642|58735474|FG001|Overall Study|Pregnancy|0|||
30722213|NCT00343642|58735475|FG002|Overall Study|Pregnancy|2|||
30722214|NCT00343642|58735473|FG000|Overall Study|Withdrawal by Subject|2|||
30722215|NCT00343642|58735474|FG001|Overall Study|Withdrawal by Subject|3|||
30722216|NCT00343642|58735475|FG002|Overall Study|Withdrawal by Subject|4|||
30722217|NCT00343642|58735473|FG000|Overall Study|Adverse Event|0|||
30722218|NCT00343642|58735474|FG001|Overall Study|Adverse Event|0|||
30722219|NCT00343642|58735475|FG002|Overall Study|Adverse Event|1|||
30722220|NCT00343642|58735473|FG000|Overall Study|Flare up|6|||
30722221|NCT00343642|58735474|FG001|Overall Study|Flare up|4|||
30722222|NCT00343642|58735475|FG002|Overall Study|Flare up|0|||
30722223|NCT00609167|58735488|FG000|Overall Study|Withdrawal by Subject|1|||
30722224|NCT00609167|58735489|FG001|Overall Study|Withdrawal by Subject|0|||
30722225|NCT00609167|58735488|FG000|Overall Study|Lack of Efficacy|1|||
30722226|NCT00609167|58735489|FG001|Overall Study|Lack of Efficacy|0|||
30722227|NCT00609167|58735488|FG000|Overall Study|Adverse Event|5|||
30722228|NCT00609167|58735489|FG001|Overall Study|Adverse Event|1|||
30722229|NCT00609167|58735488|FG000|Overall Study|Disease Progression|1|||
30722230|NCT00609167|58735489|FG001|Overall Study|Disease Progression|0|||
30722231|NCT00609167|58735488|FG000|Overall Study|Stem Cell Transplant|0|||
30722232|NCT00609167|58735489|FG001|Overall Study|Stem Cell Transplant|6|||
30722233|NCT00606281|58735497|FG000|Overall Study|Adverse Event|11|||
30722234|NCT00606281|58735498|FG001|Overall Study|Adverse Event|12|||
30722235|NCT00606281|58735497|FG000|Overall Study|Death|1|||
30722236|NCT00606281|58735498|FG001|Overall Study|Death|0|||
30722237|NCT00606281|58735497|FG000|Overall Study|Lack of Efficacy|28|||
30722238|NCT00606281|58735498|FG001|Overall Study|Lack of Efficacy|35|||
30722239|NCT00606281|58735497|FG000|Overall Study|Physician Decision|0|||
30722240|NCT00606281|58735498|FG001|Overall Study|Physician Decision|1|||
30722241|NCT00606281|58735497|FG000|Overall Study|Protocol Violation|3|||
30722242|NCT00606281|58735498|FG001|Overall Study|Protocol Violation|3|||
30722243|NCT00606281|58735497|FG000|Overall Study|Withdrawal by Subject|11|||
30722244|NCT00606281|58735498|FG001|Overall Study|Withdrawal by Subject|13|||
30722245|NCT00606281|58735497|FG000|Overall Study|Progression to depressive phase|1|||
30722246|NCT00606281|58735498|FG001|Overall Study|Progression to depressive phase|1|||
30722247|NCT00606281|58735497|FG000|Overall Study|Change of residence or other commitments|1|||
30722248|NCT00606281|58735498|FG001|Overall Study|Change of residence or other commitments|1|||
30722249|NCT00506142|58735506|FG000|Overall Study|Adverse Event|8|||
30722250|NCT00506142|58735507|FG001|Overall Study|Adverse Event|7|||
30722251|NCT00506142|58735506|FG000|Overall Study|Lack of Efficacy|21|||
30722252|NCT00506142|58735507|FG001|Overall Study|Lack of Efficacy|7|||
30722253|NCT00506142|58735506|FG000|Overall Study|Withdrawal by Subject|4|||
30722254|NCT00506142|58735507|FG001|Overall Study|Withdrawal by Subject|5|||
30722255|NCT00506142|58735506|FG000|Overall Study|Physician Decision|1|||
30722256|NCT00506142|58735507|FG001|Overall Study|Physician Decision|0|||
30722257|NCT00506142|58735506|FG000|Overall Study|New health condition|1|||
30722258|NCT00506142|58735507|FG001|Overall Study|New health condition|0|||
30722259|NCT00514020|58735513|FG000|Overall Study|Adverse Event|6|||
30722260|NCT00514020|58735513|FG000|Overall Study|Withdrawal by Subject|3|||
30722261|NCT00514020|58735513|FG000|Overall Study|Physician Decision|1|||
30722262|NCT00514020|58735513|FG000|Overall Study|disease progression|9|||
30722263|NCT00514020|58735513|FG000|Overall Study|other complicating disease|2|||
30722264|NCT00514020|58735513|FG000|Overall Study|patient went to radiation treatment|1|||
30722265|NCT00514020|58735513|FG000|Overall Study|"patients moved to the no tx group"|6|||
30722266|NCT00513708|58735520|FG000|Overall Study|Lost to Follow-up|4|||
30722267|NCT00513708|58735521|FG001|Overall Study|Lost to Follow-up|4|||
30722268|NCT00513708|58735522|FG002|Overall Study|Lost to Follow-up|4|||
30722269|NCT00513474|58735532|FG000|Overall Study|Death|6|||
30722270|NCT00513474|58735533|FG001|Overall Study|Death|9|||
30722271|NCT00513474|58735532|FG000|Overall Study|Participant Withdrew Consent|1|||
30722272|NCT00513474|58735533|FG001|Overall Study|Participant Withdrew Consent|0|||
30722273|NCT00505752|58735543|FG000|Overall Study|Adverse Event|1|||
30722274|NCT00505752|58735544|FG001|Overall Study|Adverse Event|0|||
30722275|NCT00505752|58735545|FG002|Overall Study|Adverse Event|1|||
30722276|NCT00505752|58735546|FG003|Overall Study|Adverse Event|0|||
30722277|NCT00505752|58735543|FG000|Overall Study|Lost to Follow-up|1|||
30722278|NCT00505752|58735544|FG001|Overall Study|Lost to Follow-up|0|||
30722279|NCT00505752|58735545|FG002|Overall Study|Lost to Follow-up|0|||
30722280|NCT00505752|58735546|FG003|Overall Study|Lost to Follow-up|0|||
30722281|NCT00505752|58735543|FG000|Overall Study|Lack of ovarian response|1|||
30722282|NCT00505752|58735544|FG001|Overall Study|Lack of ovarian response|3|||
30722283|NCT00505752|58735545|FG002|Overall Study|Lack of ovarian response|0|||
30722284|NCT00505752|58735546|FG003|Overall Study|Lack of ovarian response|0|||
30722285|NCT00505752|58735543|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
30722286|NCT00505752|58735544|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
30722287|NCT00505752|58735545|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
30722288|NCT00505752|58735546|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
30722289|NCT00505752|58735543|FG000|Overall Study|No oocytes retrieved|0|||
30722290|NCT00505752|58735544|FG001|Overall Study|No oocytes retrieved|2|||
30722291|NCT00505752|58735545|FG002|Overall Study|No oocytes retrieved|0|||
30722292|NCT00505752|58735546|FG003|Overall Study|No oocytes retrieved|1|||
30722293|NCT00505752|58735543|FG000|Overall Study|No Fertilization|1|||
30722294|NCT00505752|58735544|FG001|Overall Study|No Fertilization|1|||
30722295|NCT00505752|58735545|FG002|Overall Study|No Fertilization|2|||
30722296|NCT00505752|58735546|FG003|Overall Study|No Fertilization|1|||
30722297|NCT00505752|58735543|FG000|Overall Study|All embryos/blastocysts discarded|0|||
30722298|NCT00505752|58735544|FG001|Overall Study|All embryos/blastocysts discarded|0|||
30722299|NCT00505752|58735545|FG002|Overall Study|All embryos/blastocysts discarded|1|||
30722300|NCT00505752|58735546|FG003|Overall Study|All embryos/blastocysts discarded|1|||
30722301|NCT00505752|58735543|FG000|Overall Study|Other|1|||
30722302|NCT00505752|58735544|FG001|Overall Study|Other|2|||
30722303|NCT00505752|58735545|FG002|Overall Study|Other|1|||
30722304|NCT00505752|58735546|FG003|Overall Study|Other|2|||
30722305|NCT03601637|58735558|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
30722306|NCT03601637|58735559|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
30722307|NCT03601637|58735558|FG000|Overall Study|Adverse Event|1|||
30722308|NCT03601637|58735559|FG001|Overall Study|Adverse Event|1|||
30722309|NCT03601637|58735558|FG000|Overall Study|Other|0|||
30722310|NCT03601637|58735559|FG001|Overall Study|Other|1|||
30722311|NCT00343252|58735574|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
30722312|NCT00343252|58735575|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
30722313|NCT00343252|58735574|FG000|6 Months (All Treated Participants)|Death|0|||
30722314|NCT00343252|58735575|FG001|6 Months (All Treated Participants)|Death|2|||
30722315|NCT00343252|58735574|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
30722316|NCT00343252|58735575|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
30621631|NCT00932698|58633209|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
30722317|NCT00343252|58735574|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
30722318|NCT00343252|58735575|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
30621632|NCT00932698|58633210|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
30722319|NCT00343252|58735574|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
30722320|NCT00343252|58735575|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
30722321|NCT00343252|58735574|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
30722322|NCT00343252|58735575|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
30722323|NCT00343252|58735574|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
30722324|NCT00343252|58735575|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
30722325|NCT00343252|58735574|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
30722326|NCT00343252|58735575|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
30722327|NCT00343252|58735574|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
30722328|NCT00343252|58735575|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
30722329|NCT00343252|58735574|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
30722330|NCT00343252|58735575|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
30722331|NCT00343252|58735574|FG000|12 Months (All Treated Participants)|Death|3|||
30722332|NCT00343252|58735575|FG001|12 Months (All Treated Participants)|Death|3|||
30722333|NCT00343252|58735574|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
30722334|NCT00343252|58735575|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
30722335|NCT00343252|58735574|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
30722336|NCT00343252|58735575|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
30722337|NCT00343252|58735574|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
30722338|NCT00343252|58735575|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
30722339|NCT00343252|58735574|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
30722340|NCT00343252|58735575|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
30722341|NCT00343252|58735574|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
30722342|NCT00343252|58735575|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
30722343|NCT00343252|58735574|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
30722344|NCT00343252|58735575|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
30722345|NCT00343252|58735574|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
30722346|NCT00343252|58735575|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
30722347|NCT00343252|58735574|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
30722348|NCT00343252|58735575|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
30722349|NCT00343252|58735574|FG000|18 Months (All Treated Participants)|Death|4|||
30722350|NCT00343252|58735575|FG001|18 Months (All Treated Participants)|Death|5|||
30722351|NCT00343252|58735574|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
30722352|NCT00343252|58735575|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
30722353|NCT00343252|58735574|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
30722354|NCT00343252|58735575|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
30722355|NCT00343252|58735574|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
30722356|NCT00343252|58735575|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
30722357|NCT00343252|58735574|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
30722358|NCT00343252|58735575|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
30722359|NCT00343252|58735574|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
30722360|NCT00343252|58735575|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
30722361|NCT00343252|58735574|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
30722362|NCT00343252|58735575|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
30722363|NCT00343252|58735574|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
30722364|NCT00343252|58735575|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
30722365|NCT00342628|58735584|FG000|Overall Study|Withdrawal by Subject|19|||
30722366|NCT00342628|58735585|FG001|Overall Study|Withdrawal by Subject|19|||
30722367|NCT00342628|58735586|FG002|Overall Study|Withdrawal by Subject|18|||
30722368|NCT00342628|58735584|FG000|Overall Study|Death|1|||
30722369|NCT00342628|58735585|FG001|Overall Study|Death|1|||
30722370|NCT00342628|58735586|FG002|Overall Study|Death|0|||
30722371|NCT00342628|58735584|FG000|Overall Study|moved residence|0|||
30722372|NCT00342628|58735585|FG001|Overall Study|moved residence|1|||
30722373|NCT00342628|58735586|FG002|Overall Study|moved residence|1|||
30722374|NCT00505284|58735599|FG000|Overall Study|Adverse Event|3|||
30722375|NCT00505284|58735600|FG001|Overall Study|Adverse Event|7|||
30722376|NCT00505284|58735601|FG002|Overall Study|Adverse Event|9|||
30722377|NCT00505284|58735602|FG003|Overall Study|Adverse Event|14|||
30722378|NCT00505284|58735603|FG004|Overall Study|Adverse Event|22|||
30722379|NCT00505284|58735599|FG000|Overall Study|Protocol Violation|0|||
30722380|NCT00505284|58735600|FG001|Overall Study|Protocol Violation|1|||
30722381|NCT00505284|58735601|FG002|Overall Study|Protocol Violation|1|||
30722382|NCT00505284|58735602|FG003|Overall Study|Protocol Violation|0|||
30722383|NCT00505284|58735603|FG004|Overall Study|Protocol Violation|0|||
30722384|NCT00505284|58735599|FG000|Overall Study|Withdrawal by Subject|2|||
30722385|NCT00505284|58735600|FG001|Overall Study|Withdrawal by Subject|6|||
30722386|NCT00505284|58735601|FG002|Overall Study|Withdrawal by Subject|1|||
30722387|NCT00505284|58735602|FG003|Overall Study|Withdrawal by Subject|0|||
30722388|NCT00505284|58735603|FG004|Overall Study|Withdrawal by Subject|6|||
30722389|NCT00505284|58735599|FG000|Overall Study|Lack of Efficacy|0|||
30722390|NCT00505284|58735600|FG001|Overall Study|Lack of Efficacy|1|||
30722391|NCT00505284|58735601|FG002|Overall Study|Lack of Efficacy|1|||
30722392|NCT00505284|58735602|FG003|Overall Study|Lack of Efficacy|1|||
30722393|NCT00505284|58735603|FG004|Overall Study|Lack of Efficacy|1|||
30722394|NCT00505284|58735599|FG000|Overall Study|Physician Decision|0|||
30722395|NCT00505284|58735600|FG001|Overall Study|Physician Decision|1|||
30722396|NCT00505284|58735601|FG002|Overall Study|Physician Decision|0|||
30722397|NCT00505284|58735602|FG003|Overall Study|Physician Decision|0|||
30722398|NCT00505284|58735603|FG004|Overall Study|Physician Decision|0|||
30722399|NCT00505284|58735599|FG000|Overall Study|Other|5|||
30722400|NCT00505284|58735600|FG001|Overall Study|Other|0|||
30722401|NCT00505284|58735601|FG002|Overall Study|Other|0|||
30722402|NCT00505284|58735602|FG003|Overall Study|Other|4|||
30722403|NCT00505284|58735603|FG004|Overall Study|Other|4|||
30722404|NCT00337168|58735615|FG000|Overall Study|Death|5|||
30722405|NCT00337168|58735615|FG000|Overall Study|Not protocol specified|2|||
30722406|NCT00337168|58735615|FG000|Overall Study|Did not start therapy|1|||
30722407|NCT00606905|58735622|FG000|Overall Study|No Pregnancy|9|||
30722408|NCT00606905|58735623|FG001|Overall Study|No Pregnancy|6|||
30722409|NCT00606905|58735622|FG000|Overall Study|Non-Index Pregnancy|1|||
30722410|NCT00606905|58735623|FG001|Overall Study|Non-Index Pregnancy|4|||
30722411|NCT00606905|58735622|FG000|Overall Study|Withdrew|5|||
30722412|NCT00606905|58735623|FG001|Overall Study|Withdrew|5|||
30722413|NCT00606593|58735629|FG000|Overall Study|Adverse Event|0|||
30722414|NCT00606593|58735630|FG001|Overall Study|Adverse Event|0|||
30722415|NCT00606593|58735631|FG002|Overall Study|Adverse Event|0|||
30722416|NCT00606593|58735632|FG003|Overall Study|Adverse Event|1|||
30722417|NCT00606593|58735633|FG004|Overall Study|Adverse Event|1|||
30722418|NCT00606593|58735634|FG005|Overall Study|Adverse Event|0|||
30722419|NCT00606593|58735635|FG006|Overall Study|Adverse Event|1|||
30722420|NCT00606593|58735636|FG007|Overall Study|Adverse Event|2|||
30722421|NCT00606593|58735637|FG008|Overall Study|Adverse Event|1|||
30722422|NCT00606593|58735638|FG009|Overall Study|Adverse Event|0|||
30722423|NCT00606593|58735629|FG000|Overall Study|Withdrawal of consent|1|||
30722424|NCT00606593|58735630|FG001|Overall Study|Withdrawal of consent|0|||
30722425|NCT00606593|58735631|FG002|Overall Study|Withdrawal of consent|1|||
30722426|NCT00606593|58735632|FG003|Overall Study|Withdrawal of consent|0|||
30722427|NCT00606593|58735633|FG004|Overall Study|Withdrawal of consent|0|||
30722428|NCT00606593|58735634|FG005|Overall Study|Withdrawal of consent|0|||
30722429|NCT00606593|58735635|FG006|Overall Study|Withdrawal of consent|0|||
30722430|NCT00606593|58735636|FG007|Overall Study|Withdrawal of consent|0|||
30722431|NCT00606593|58735637|FG008|Overall Study|Withdrawal of consent|0|||
30722432|NCT00606593|58735638|FG009|Overall Study|Withdrawal of consent|0|||
30722433|NCT00606593|58735629|FG000|Overall Study|Administrative/Other|0|||
30722434|NCT00606593|58735630|FG001|Overall Study|Administrative/Other|0|||
30722435|NCT00606593|58735631|FG002|Overall Study|Administrative/Other|1|||
30722436|NCT00606593|58735632|FG003|Overall Study|Administrative/Other|0|||
30722437|NCT00606593|58735633|FG004|Overall Study|Administrative/Other|0|||
30722438|NCT00606593|58735634|FG005|Overall Study|Administrative/Other|0|||
30722439|NCT00606593|58735635|FG006|Overall Study|Administrative/Other|0|||
30722440|NCT00606593|58735636|FG007|Overall Study|Administrative/Other|0|||
30722441|NCT00606593|58735637|FG008|Overall Study|Administrative/Other|0|||
30722442|NCT00606593|58735638|FG009|Overall Study|Administrative/Other|0|||
30722443|NCT00605267|58735653|FG000|Overall Study|Adverse Event|0|||
30722444|NCT00605267|58735654|FG001|Overall Study|Adverse Event|1|||
30722445|NCT00605267|58735653|FG000|Overall Study|Lack of Efficacy|1|||
30722446|NCT00605267|58735654|FG001|Overall Study|Lack of Efficacy|5|||
30722447|NCT00605267|58735653|FG000|Overall Study|Withdrawal by Subject|2|||
30722448|NCT00605267|58735654|FG001|Overall Study|Withdrawal by Subject|3|||
30722449|NCT00605813|58735660|FG000|Overall Study|Protocol Violation|25|||
30722450|NCT00604721|58735673|FG000|Overall Study|Physician Decision|1|||
30722451|NCT00604721|58735673|FG000|Overall Study|Withdrawal by Subject|1|||
30722452|NCT00605657|58735678|FG000|Overall Study|Adverse Event|1|||
30722453|NCT00605657|58735678|FG000|Overall Study|Protocol Violation|1|||
30722454|NCT00604565|58735684|FG000|Overall Study|Study terminated|0|||
30722455|NCT00604565|58735685|FG001|Overall Study|Study terminated|3|||
30722456|NCT00605345|58735693|FG000|Overall Study|Withdrawal by Subject|1|||
30722457|NCT00605345|58735694|FG001|Overall Study|Withdrawal by Subject|0|||
30722458|NCT00605345|58735693|FG000|Overall Study|Adverse Event|0|||
30722459|NCT00605345|58735694|FG001|Overall Study|Adverse Event|1|||
30722460|NCT00605345|58735693|FG000|Overall Study|Protocol Violation|0|||
30722461|NCT00605345|58735694|FG001|Overall Study|Protocol Violation|2|||
30722462|NCT00604175|58735703|FG000|Entry Through Week 28|Death|2|||
30722463|NCT00604175|58735704|FG001|Entry Through Week 28|Death|0|||
30722464|NCT00604175|58735705|FG002|Entry Through Week 28|Death|0|||
30722465|NCT00604175|58735703|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
30722466|NCT00604175|58735704|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
30722467|NCT00604175|58735705|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
30722468|NCT00604175|58735703|FG000|Entry Through Week 28|Lost to Follow-up|4|||
30722469|NCT00604175|58735704|FG001|Entry Through Week 28|Lost to Follow-up|3|||
30722470|NCT00604175|58735705|FG002|Entry Through Week 28|Lost to Follow-up|0|||
30722471|NCT00604175|58735703|FG000|Entry Through Week 28|Ineligible|1|||
30722472|NCT00604175|58735704|FG001|Entry Through Week 28|Ineligible|0|||
30722473|NCT00604175|58735705|FG002|Entry Through Week 28|Ineligible|0|||
30900340|NCT01844830|58933607|FG001|Overall Study|Withdrawal by Subject|0|||
30900341|NCT01827592|58933616|FG000|Overall Study|Adverse Event|11|||
30900342|NCT01827592|58933617|FG001|Overall Study|Adverse Event|9|||
30900343|NCT01827592|58933618|FG002|Overall Study|Adverse Event|2|||
30900344|NCT01827592|58933616|FG000|Overall Study|Physician Decision|0|||
30900345|NCT01827592|58933617|FG001|Overall Study|Physician Decision|2|||
30900346|NCT01827592|58933618|FG002|Overall Study|Physician Decision|1|||
30900347|NCT01827592|58933616|FG000|Overall Study|Protocol Violation|2|||
30900348|NCT01827592|58933617|FG001|Overall Study|Protocol Violation|1|||
30900349|NCT01827592|58933618|FG002|Overall Study|Protocol Violation|0|||
30900350|NCT01827592|58933616|FG000|Overall Study|Lost to Follow-up|1|||
30900351|NCT01827592|58933617|FG001|Overall Study|Lost to Follow-up|2|||
30900352|NCT01827592|58933618|FG002|Overall Study|Lost to Follow-up|2|||
30900353|NCT01827592|58933616|FG000|Overall Study|Withdrawal by Subject|12|||
30722474|NCT00604175|58735703|FG000|Entry Through Week 28|Did not start intervention|2|||
30722475|NCT00604175|58735704|FG001|Entry Through Week 28|Did not start intervention|0|||
30722476|NCT00604175|58735705|FG002|Entry Through Week 28|Did not start intervention|1|||
30722477|NCT00604175|58735703|FG000|Week 29 Through Week 72|Death|0|||
30722478|NCT00604175|58735704|FG001|Week 29 Through Week 72|Death|0|||
30722479|NCT00604175|58735705|FG002|Week 29 Through Week 72|Death|1|||
30722480|NCT00604175|58735703|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
30722481|NCT00604175|58735704|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
30722482|NCT00604175|58735705|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
30722483|NCT00604175|58735703|FG000|Week 29 Through Week 72|Site closure|0|||
30722484|NCT00604175|58735704|FG001|Week 29 Through Week 72|Site closure|1|||
30722485|NCT00604175|58735705|FG002|Week 29 Through Week 72|Site closure|0|||
30722486|NCT00604175|58735703|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
30722487|NCT00604175|58735704|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
30722488|NCT00604175|58735705|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
30722489|NCT00605189|58735740|FG000|Overall Study|Adverse Event|1|||
30722490|NCT00605189|58735741|FG001|Overall Study|Adverse Event|0|||
30722491|NCT00605189|58735742|FG002|Overall Study|Adverse Event|0|||
30722492|NCT00605189|58735740|FG000|Overall Study|Other|2|||
30722493|NCT00605189|58735741|FG001|Overall Study|Other|2|||
30722494|NCT00605189|58735742|FG002|Overall Study|Other|0|||
30722495|NCT00340834|58735755|FG000|Core Phase of Study|Adverse Event|26|||
30722496|NCT00340834|58735756|FG001|Core Phase of Study|Adverse Event|9|||
30722497|NCT00340834|58735757|FG002|Core Phase of Study|Adverse Event|9|||
30722498|NCT00340834|58735758|FG003|Core Phase of Study|Adverse Event|0|||
30722499|NCT00340834|58735759|FG004|Core Phase of Study|Adverse Event|0|||
30722500|NCT00340834|58735755|FG000|Core Phase of Study|Withdrawal by Subject|11|||
30722501|NCT00340834|58735756|FG001|Core Phase of Study|Withdrawal by Subject|9|||
30722502|NCT00340834|58735757|FG002|Core Phase of Study|Withdrawal by Subject|16|||
30722503|NCT00340834|58735758|FG003|Core Phase of Study|Withdrawal by Subject|0|||
30722504|NCT00340834|58735759|FG004|Core Phase of Study|Withdrawal by Subject|0|||
30722505|NCT00340834|58735755|FG000|Core Phase of Study|Administrative Problems|6|||
30722506|NCT00340834|58735756|FG001|Core Phase of Study|Administrative Problems|2|||
30722507|NCT00340834|58735757|FG002|Core Phase of Study|Administrative Problems|7|||
30722508|NCT00340834|58735758|FG003|Core Phase of Study|Administrative Problems|0|||
30722509|NCT00340834|58735759|FG004|Core Phase of Study|Administrative Problems|0|||
30722510|NCT00340834|58735755|FG000|Core Phase of Study|Lack of Efficacy|3|||
30722511|NCT00340834|58735756|FG001|Core Phase of Study|Lack of Efficacy|3|||
30722512|NCT00340834|58735757|FG002|Core Phase of Study|Lack of Efficacy|7|||
30722513|NCT00340834|58735758|FG003|Core Phase of Study|Lack of Efficacy|0|||
30722514|NCT00340834|58735759|FG004|Core Phase of Study|Lack of Efficacy|0|||
30722515|NCT00340834|58735755|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
30722516|NCT00340834|58735756|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
30722517|NCT00340834|58735757|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
30722518|NCT00340834|58735758|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
30900354|NCT01827592|58933617|FG001|Overall Study|Withdrawal by Subject|11|||
30722519|NCT00340834|58735759|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
30722520|NCT00340834|58735755|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
30722521|NCT00340834|58735756|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
30722522|NCT00340834|58735757|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
30722523|NCT00340834|58735758|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
30722524|NCT00340834|58735759|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
30900355|NCT01827592|58933618|FG002|Overall Study|Withdrawal by Subject|11|||
30900356|NCT01827592|58933616|FG000|Overall Study|Patient's substantial non-compliance|1|||
30900357|NCT01827592|58933617|FG001|Overall Study|Patient's substantial non-compliance|1|||
30900358|NCT01827592|58933618|FG002|Overall Study|Patient's substantial non-compliance|6|||
30900359|NCT01827592|58933616|FG000|Overall Study|Trial terminated by Sponsor|47|||
30722525|NCT00340834|58735755|FG000|Core Phase of Study|Lost to Follow-up|1|||
30722526|NCT00340834|58735756|FG001|Core Phase of Study|Lost to Follow-up|1|||
30722527|NCT00340834|58735757|FG002|Core Phase of Study|Lost to Follow-up|4|||
30722528|NCT00340834|58735758|FG003|Core Phase of Study|Lost to Follow-up|0|||
30722529|NCT00340834|58735759|FG004|Core Phase of Study|Lost to Follow-up|0|||
30722530|NCT00340834|58735755|FG000|Core Phase of Study|Death|2|||
30722531|NCT00340834|58735756|FG001|Core Phase of Study|Death|0|||
30722532|NCT00340834|58735757|FG002|Core Phase of Study|Death|0|||
30722533|NCT00340834|58735758|FG003|Core Phase of Study|Death|0|||
30722534|NCT00340834|58735759|FG004|Core Phase of Study|Death|0|||
30722535|NCT00340834|58735755|FG000|Core Phase of Study|Protocol Violation|0|||
30722536|NCT00340834|58735756|FG001|Core Phase of Study|Protocol Violation|0|||
30722537|NCT00340834|58735757|FG002|Core Phase of Study|Protocol Violation|2|||
30722538|NCT00340834|58735758|FG003|Core Phase of Study|Protocol Violation|0|||
30722539|NCT00340834|58735759|FG004|Core Phase of Study|Protocol Violation|0|||
30722540|NCT00340834|58735755|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
30722541|NCT00340834|58735756|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
30722542|NCT00340834|58735757|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
30722543|NCT00340834|58735758|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
30722544|NCT00340834|58735759|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
30722545|NCT00340834|58735755|FG000|Extension Phase of Study|Subject withdrew consent|26|||
30722546|NCT00340834|58735756|FG001|Extension Phase of Study|Subject withdrew consent|31|||
30722547|NCT00340834|58735757|FG002|Extension Phase of Study|Subject withdrew consent|0|||
30722548|NCT00340834|58735758|FG003|Extension Phase of Study|Subject withdrew consent|12|||
30722549|NCT00340834|58735759|FG004|Extension Phase of Study|Subject withdrew consent|15|||
30722550|NCT00340834|58735755|FG000|Extension Phase of Study|Adverse Event|21|||
30722551|NCT00340834|58735756|FG001|Extension Phase of Study|Adverse Event|22|||
30722552|NCT00340834|58735757|FG002|Extension Phase of Study|Adverse Event|0|||
30722553|NCT00340834|58735758|FG003|Extension Phase of Study|Adverse Event|19|||
30722554|NCT00340834|58735759|FG004|Extension Phase of Study|Adverse Event|7|||
30722555|NCT00340834|58735755|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
30722556|NCT00340834|58735756|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
30722557|NCT00340834|58735757|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
30722558|NCT00340834|58735758|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
30722559|NCT00340834|58735759|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
30722560|NCT00340834|58735755|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
30722561|NCT00340834|58735756|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
30722562|NCT00340834|58735757|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
30722563|NCT00340834|58735758|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
30722564|NCT00340834|58735759|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
30722565|NCT00340834|58735755|FG000|Extension Phase of Study|Lost to Follow-up|1|||
30722566|NCT00340834|58735756|FG001|Extension Phase of Study|Lost to Follow-up|1|||
30722567|NCT00340834|58735757|FG002|Extension Phase of Study|Lost to Follow-up|0|||
30722568|NCT00340834|58735758|FG003|Extension Phase of Study|Lost to Follow-up|2|||
30722569|NCT00340834|58735759|FG004|Extension Phase of Study|Lost to Follow-up|3|||
30722570|NCT00340834|58735755|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
30722571|NCT00340834|58735756|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
30722572|NCT00340834|58735757|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
30722573|NCT00340834|58735758|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
30722574|NCT00340834|58735759|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
30722575|NCT00340834|58735755|FG000|Extension Phase of Study|Administrative problems|3|||
30722576|NCT00340834|58735756|FG001|Extension Phase of Study|Administrative problems|0|||
30722577|NCT00340834|58735757|FG002|Extension Phase of Study|Administrative problems|0|||
30722578|NCT00340834|58735758|FG003|Extension Phase of Study|Administrative problems|1|||
30722579|NCT00340834|58735759|FG004|Extension Phase of Study|Administrative problems|1|||
30722580|NCT00340834|58735755|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
30722581|NCT00340834|58735756|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
30722582|NCT00340834|58735757|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
30900360|NCT01827592|58933617|FG001|Overall Study|Trial terminated by Sponsor|53|||
30900361|NCT01827592|58933618|FG002|Overall Study|Trial terminated by Sponsor|51|||
30900362|NCT01827592|58933616|FG000|Overall Study|Others|0|||
30900363|NCT01827592|58933617|FG001|Overall Study|Others|1|||
30722583|NCT00340834|58735758|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
30722584|NCT00340834|58735759|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
30900364|NCT01827592|58933618|FG002|Overall Study|Others|3|||
30900365|NCT02323334|58933636|FG000|Period 3|Lost to Follow-up|0|||
30722585|NCT00340834|58735755|FG000|Extension Phase of Study|Protocol Violation|3|||
30722586|NCT00340834|58735756|FG001|Extension Phase of Study|Protocol Violation|0|||
30722587|NCT00340834|58735757|FG002|Extension Phase of Study|Protocol Violation|0|||
30722588|NCT00340834|58735758|FG003|Extension Phase of Study|Protocol Violation|0|||
30722589|NCT00340834|58735759|FG004|Extension Phase of Study|Protocol Violation|0|||
30722590|NCT00340834|58735755|FG000|Extension Phase of Study|Death|0|||
30722591|NCT00340834|58735756|FG001|Extension Phase of Study|Death|0|||
30722592|NCT00340834|58735757|FG002|Extension Phase of Study|Death|0|||
30722593|NCT00340834|58735758|FG003|Extension Phase of Study|Death|0|||
30722594|NCT00340834|58735759|FG004|Extension Phase of Study|Death|1|||
30722595|NCT00603941|58735772|FG000|Overall Study|Disease progression|6|||
30722596|NCT00603941|58735773|FG001|Overall Study|Disease progression|7|||
30722597|NCT00603941|58735774|FG002|Overall Study|Disease progression|1|||
30722598|NCT00603941|58735772|FG000|Overall Study|Adverse Event|1|||
30621633|NCT00932698|58633211|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
30722599|NCT00603941|58735773|FG001|Overall Study|Adverse Event|0|||
30722600|NCT00603941|58735774|FG002|Overall Study|Adverse Event|1|||
30722601|NCT00603941|58735772|FG000|Overall Study|Physician Decision|0|||
30722602|NCT00603941|58735773|FG001|Overall Study|Physician Decision|1|||
30722603|NCT00603941|58735774|FG002|Overall Study|Physician Decision|0|||
30722604|NCT00603941|58735772|FG000|Overall Study|Withdrawal by Subject|0|||
30722605|NCT00603941|58735773|FG001|Overall Study|Withdrawal by Subject|2|||
30722606|NCT00603941|58735774|FG002|Overall Study|Withdrawal by Subject|0|||
30722607|NCT00340678|58735787|FG000|Overall Study|Lost to Follow-up|1|||
30722608|NCT00340678|58735788|FG001|Overall Study|Lost to Follow-up|0|||
30722609|NCT00340678|58735789|FG002|Overall Study|Lost to Follow-up|0|||
30722610|NCT00340678|58735790|FG003|Overall Study|Lost to Follow-up|0|||
30722611|NCT00336544|58735800|FG000|Overall Study|Lack of Efficacy|8|||
30722612|NCT00336544|58735801|FG001|Overall Study|Lack of Efficacy|5|||
30722613|NCT00336544|58735800|FG000|Overall Study|Adverse Event|4|||
30722614|NCT00336544|58735801|FG001|Overall Study|Adverse Event|9|||
30722615|NCT00336544|58735800|FG000|Overall Study|Withdrawal by Subject|4|||
30722616|NCT00336544|58735801|FG001|Overall Study|Withdrawal by Subject|3|||
30722617|NCT00336544|58735800|FG000|Overall Study|Other|3|||
30722618|NCT00336544|58735801|FG001|Overall Study|Other|5|||
30722619|NCT00605033|58735809|FG000|Overall Study|Adverse Event|2|||
30722620|NCT00605033|58735810|FG001|Overall Study|Adverse Event|2|||
30722621|NCT00605033|58735809|FG000|Overall Study|Lost to Follow-up|1|||
30722622|NCT00605033|58735810|FG001|Overall Study|Lost to Follow-up|1|||
30722623|NCT00605033|58735809|FG000|Overall Study|Withdrawal by Subject|3|||
30722624|NCT00605033|58735810|FG001|Overall Study|Withdrawal by Subject|4|||
30722625|NCT00605033|58735809|FG000|Overall Study|Protocol Violation|1|||
30722626|NCT00605033|58735810|FG001|Overall Study|Protocol Violation|1|||
30722627|NCT00339040|58735818|FG000|Stage I|Not able to attend clinic|1|||
30722628|NCT00339040|58735819|FG001|Stage I|Not able to attend clinic|0|||
30722629|NCT00339040|58735818|FG000|Stage I|Protocol Violation|1|||
30722630|NCT00339040|58735819|FG001|Stage I|Protocol Violation|1|||
30722631|NCT00339040|58735818|FG000|Stage II|Lost to Follow-up|3|||
30722632|NCT00339040|58735819|FG001|Stage II|Lost to Follow-up|0|||
30722633|NCT00339040|58735818|FG000|Stage II|Withdrawal by Subject|1|||
30722634|NCT00339040|58735819|FG001|Stage II|Withdrawal by Subject|2|||
30722635|NCT00339040|58735818|FG000|Stage II|Protocol Violation|3|||
30722636|NCT00339040|58735819|FG001|Stage II|Protocol Violation|0|||
30722637|NCT00339040|58735818|FG000|Stage II|Not able to attend clinic|1|||
30722638|NCT00339040|58735819|FG001|Stage II|Not able to attend clinic|0|||
30722639|NCT00339040|58735818|FG000|Stage II|Site closing|2|||
30621634|NCT00932698|58633212|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
30621635|NCT00932698|58633213|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
30722640|NCT00339040|58735819|FG001|Stage II|Site closing|0|||
30722641|NCT00338962|58735829|FG000|Overall Study|Lost to Follow-up|3|||
30722642|NCT00338962|58735830|FG001|Overall Study|Lost to Follow-up|3|||
30722643|NCT00338962|58735831|FG002|Overall Study|Lost to Follow-up|2|||
30722644|NCT00338962|58735832|FG003|Overall Study|Lost to Follow-up|3|||
30722645|NCT00338962|58735829|FG000|Overall Study|Withdrawal by Subject|1|||
30722646|NCT00338962|58735830|FG001|Overall Study|Withdrawal by Subject|0|||
30722647|NCT00338962|58735831|FG002|Overall Study|Withdrawal by Subject|0|||
30722648|NCT00338962|58735832|FG003|Overall Study|Withdrawal by Subject|0|||
30722649|NCT00338962|58735829|FG000|Overall Study|No Transportation|2|||
30722650|NCT00338962|58735830|FG001|Overall Study|No Transportation|0|||
30722651|NCT00338962|58735831|FG002|Overall Study|No Transportation|0|||
30722652|NCT00338962|58735832|FG003|Overall Study|No Transportation|0|||
30722653|NCT00338962|58735829|FG000|Overall Study|Time Constraint|2|||
30722654|NCT00338962|58735830|FG001|Overall Study|Time Constraint|0|||
30722655|NCT00338962|58735831|FG002|Overall Study|Time Constraint|0|||
30722656|NCT00338962|58735832|FG003|Overall Study|Time Constraint|0|||
30722657|NCT00338962|58735829|FG000|Overall Study|Moved|0|||
30722658|NCT00338962|58735830|FG001|Overall Study|Moved|1|||
30722659|NCT00338962|58735831|FG002|Overall Study|Moved|0|||
30722660|NCT00338962|58735832|FG003|Overall Study|Moved|0|||
30722661|NCT00338962|58735829|FG000|Overall Study|Adverse Event|0|||
30722662|NCT00338962|58735830|FG001|Overall Study|Adverse Event|0|||
30722663|NCT00338962|58735831|FG002|Overall Study|Adverse Event|2|||
30722664|NCT00338962|58735832|FG003|Overall Study|Adverse Event|0|||
30722665|NCT00338962|58735829|FG000|Overall Study|Poor Compliance|0|||
30722666|NCT00338962|58735830|FG001|Overall Study|Poor Compliance|0|||
30722667|NCT00338962|58735831|FG002|Overall Study|Poor Compliance|2|||
30722668|NCT00338962|58735832|FG003|Overall Study|Poor Compliance|0|||
30722669|NCT00568061|58735844|FG000|Overall Study|Inclusion / exclusion criteria|5|||
30722670|NCT00568061|58735845|FG001|Overall Study|Inclusion / exclusion criteria|1|||
30722671|NCT00568061|58735844|FG000|Overall Study|Adverse Event|0|||
30722672|NCT00568061|58735845|FG001|Overall Study|Adverse Event|1|||
30722673|NCT00338884|58735852|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
30722674|NCT00338884|58735852|FG000|Overall Study|Adverse Event|14|||
30722675|NCT00338884|58735852|FG000|Overall Study|Death|8|||
30722676|NCT00338884|58735852|FG000|Overall Study|Other|4|||
30722677|NCT00338884|58735852|FG000|Overall Study|Global Deterioration of Health Status|3|||
30722678|NCT00338884|58735852|FG000|Overall Study|Withdrawal by Subject|3|||
30722679|NCT00338884|58735852|FG000|Overall Study|Lost to Follow-up|1|||
30722680|NCT00338884|58735852|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
30722681|NCT00338806|58735858|FG000|Acute Phase|Withdrawal by Subject|0|||
30722682|NCT00338806|58735859|FG001|Acute Phase|Withdrawal by Subject|1|||
30722683|NCT00338806|58735858|FG000|Follow-up|Lost to Follow-up|1|||
30722684|NCT00338806|58735859|FG001|Follow-up|Lost to Follow-up|3|||
30722685|NCT03038100|58735869|FG000|Overall Study|Death|289|||
30722686|NCT03038100|58735870|FG001|Overall Study|Death|272|||
30722687|NCT03038100|58735869|FG000|Overall Study|Lost to Follow-up|9|||
30722688|NCT03038100|58735870|FG001|Overall Study|Lost to Follow-up|10|||
30722689|NCT03038100|58735869|FG000|Overall Study|Protocol Deviation|1|||
30722690|NCT03038100|58735870|FG001|Overall Study|Protocol Deviation|4|||
30722691|NCT03038100|58735869|FG000|Overall Study|Withdrawal by Subject|45|||
30722692|NCT03038100|58735870|FG001|Overall Study|Withdrawal by Subject|51|||
30722693|NCT03038100|58735869|FG000|Overall Study|Study Terminated By Sponsor|305|||
30722694|NCT03038100|58735870|FG001|Overall Study|Study Terminated By Sponsor|311|||
30722695|NCT03038100|58735869|FG000|Overall Study|Physician Decision|1|||
30722696|NCT03038100|58735870|FG001|Overall Study|Physician Decision|3|||
30722697|NCT00338728|58735877|FG000|Overall Study|Screen Failure|14|||
30722698|NCT00336856|58735881|FG000|Overall Study|Withdrawal by Subject|3|||
30722699|NCT00336856|58735881|FG000|Overall Study|Found ineligible at time of analysis|1|||
30722700|NCT00566501|58735887|FG000|Overall Study|Adverse Event|68|||
30722701|NCT00566501|58735888|FG001|Overall Study|Adverse Event|59|||
30722702|NCT00566501|58735887|FG000|Overall Study|Medication Non-compliance|5|||
30722703|NCT00566501|58735888|FG001|Overall Study|Medication Non-compliance|0|||
30621636|NCT00932698|58633214|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
30722704|NCT00566501|58735887|FG000|Overall Study|Protocol Violation|2|||
30722705|NCT00566501|58735888|FG001|Overall Study|Protocol Violation|2|||
30722706|NCT00566501|58735887|FG000|Overall Study|Request of Investigator or Sponsor|6|||
30722707|NCT00566501|58735888|FG001|Overall Study|Request of Investigator or Sponsor|7|||
30722708|NCT00566501|58735887|FG000|Overall Study|Withdrawal by Subject|33|||
30722709|NCT00566501|58735888|FG001|Overall Study|Withdrawal by Subject|30|||
30722710|NCT00566501|58735887|FG000|Overall Study|Lack of Efficacy|8|||
30722711|NCT00566501|58735888|FG001|Overall Study|Lack of Efficacy|3|||
30722712|NCT00566501|58735887|FG000|Overall Study|Other|25|||
30621637|NCT00932698|58633215|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
30621638|NCT00932698|58633216|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
30722713|NCT00566501|58735888|FG001|Overall Study|Other|21|||
30722714|NCT00504894|58735897|FG000|Overall Study|fMRI technical problems|1|||
30722715|NCT00504894|58735898|FG001|Overall Study|fMRI technical problems|1|||
30722716|NCT00504894|58735899|FG002|Overall Study|fMRI technical problems|0|||
30722717|NCT00504894|58735897|FG000|Overall Study|Withdrawal by Subject|0|||
30722718|NCT00504894|58735898|FG001|Overall Study|Withdrawal by Subject|1|||
30722719|NCT00504894|58735899|FG002|Overall Study|Withdrawal by Subject|0|||
30722720|NCT00504894|58735897|FG000|Overall Study|Infusion technical problems|0|||
30722721|NCT00504894|58735898|FG001|Overall Study|Infusion technical problems|1|||
30722722|NCT00504894|58735899|FG002|Overall Study|Infusion technical problems|0|||
30722723|NCT00504894|58735897|FG000|Overall Study|poor subject data|2|||
30722724|NCT00504894|58735898|FG001|Overall Study|poor subject data|0|||
30722725|NCT00504894|58735899|FG002|Overall Study|poor subject data|0|||
30722726|NCT00513240|58735909|FG000|Overall Study|Did not have intended surgery|3|||
30722727|NCT00513240|58735910|FG001|Overall Study|Did not have intended surgery|0|||
30722728|NCT00513240|58735909|FG000|Overall Study|Death|3|||
30722729|NCT00513240|58735910|FG001|Overall Study|Death|3|||
30722730|NCT00513240|58735909|FG000|Overall Study|Withdrawal by Subject|7|||
30722731|NCT00513240|58735910|FG001|Overall Study|Withdrawal by Subject|4|||
30722732|NCT00504426|58735923|FG000|Overall Study|Adverse Event|0|||
30722733|NCT00504426|58735924|FG001|Overall Study|Adverse Event|0|||
30722734|NCT00504426|58735925|FG002|Overall Study|Adverse Event|2|||
30722735|NCT00504426|58735926|FG003|Overall Study|Adverse Event|0|||
30722736|NCT00504426|58735923|FG000|Overall Study|Protocol Violation|1|||
30722737|NCT00504426|58735924|FG001|Overall Study|Protocol Violation|1|||
30722738|NCT00504426|58735925|FG002|Overall Study|Protocol Violation|2|||
30722739|NCT00504426|58735926|FG003|Overall Study|Protocol Violation|0|||
30722740|NCT00504426|58735923|FG000|Overall Study|Withdrawal by Subject|2|||
30722741|NCT00504426|58735924|FG001|Overall Study|Withdrawal by Subject|0|||
30722742|NCT00504426|58735925|FG002|Overall Study|Withdrawal by Subject|0|||
30722743|NCT00504426|58735926|FG003|Overall Study|Withdrawal by Subject|0|||
30722744|NCT00504348|58735939|FG000|Overall Study|Adverse Event|3|||
30722745|NCT00504348|58735939|FG000|Overall Study|Lack of Efficacy|4|||
30722746|NCT00504348|58735939|FG000|Overall Study|Physician Decision|1|||
30722747|NCT00507546|58735945|FG000|Overall Study|Withdrawal by Subject|1|||
30722748|NCT00507546|58735946|FG001|Overall Study|Withdrawal by Subject|0|||
30900366|NCT02323334|58933637|FG001|Period 3|Lost to Follow-up|0|||
30722749|NCT00507546|58735945|FG000|Overall Study|Protocol Violation|1|||
30722750|NCT00507546|58735946|FG001|Overall Study|Protocol Violation|0|||
30722751|NCT00507546|58735945|FG000|Overall Study|Physician Decision|0|||
30722752|NCT00507546|58735946|FG001|Overall Study|Physician Decision|1|||
30722753|NCT00567593|58735954|FG000|Overall Study|Adverse Event|1|||
30722754|NCT00567593|58735954|FG000|Overall Study|Physician Decision|1|||
30722755|NCT00335764|58735963|FG000|Overall Study|wrong histology|1|||
30722756|NCT00335764|58735964|FG001|Overall Study|wrong histology|0|||
30722757|NCT00335764|58735965|FG002|Overall Study|wrong histology|0|||
30722758|NCT00335764|58735966|FG003|Overall Study|wrong histology|0|||
30722759|NCT00335764|58735967|FG004|Overall Study|wrong histology|1|||
30722760|NCT00567359|58736003|FG000|Overall Study|Withdrawal by Subject|1|||
30722761|NCT00492726|58736009|FG000|Overall Study|Adverse Event|10|||
30722762|NCT00492726|58736010|FG001|Overall Study|Adverse Event|6|||
30722763|NCT00492726|58736009|FG000|Overall Study|Death|7|||
30722764|NCT00492726|58736010|FG001|Overall Study|Death|2|||
30722765|NCT00492726|58736009|FG000|Overall Study|Lack of Efficacy|0|||
30722766|NCT00492726|58736010|FG001|Overall Study|Lack of Efficacy|2|||
30722767|NCT00492726|58736009|FG000|Overall Study|Lost to Follow-up|27|||
30722768|NCT00492726|58736010|FG001|Overall Study|Lost to Follow-up|19|||
30722769|NCT00492726|58736009|FG000|Overall Study|Physician Decision|0|||
30722770|NCT00492726|58736010|FG001|Overall Study|Physician Decision|1|||
30722771|NCT00492726|58736009|FG000|Overall Study|Withdrawal by Subject|6|||
30722772|NCT00492726|58736010|FG001|Overall Study|Withdrawal by Subject|3|||
30722773|NCT00492726|58736009|FG000|Overall Study|Non compliant with study medication|0|||
30722774|NCT00492726|58736010|FG001|Overall Study|Non compliant with study medication|3|||
30722775|NCT00309946|58736016|FG000|Overall Study|Withdrawal by Subject|1|||
30722776|NCT00492648|58736022|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
30722777|NCT00492648|58736023|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
30722778|NCT00506922|58736034|FG000|Overall Study|Physician Decision|0|||
30722779|NCT00506922|58736035|FG001|Overall Study|Physician Decision|0|||
30722780|NCT00506922|58736036|FG002|Overall Study|Physician Decision|0|||
30722781|NCT00506922|58736037|FG003|Overall Study|Physician Decision|2|||
30722782|NCT00506922|58736038|FG004|Overall Study|Physician Decision|0|||
30722783|NCT00506922|58736034|FG000|Overall Study|Withdrawal by Subject|0|||
30722784|NCT00506922|58736035|FG001|Overall Study|Withdrawal by Subject|0|||
30722785|NCT00506922|58736036|FG002|Overall Study|Withdrawal by Subject|0|||
30722786|NCT00506922|58736037|FG003|Overall Study|Withdrawal by Subject|0|||
30722787|NCT00506922|58736038|FG004|Overall Study|Withdrawal by Subject|1|||
30722788|NCT00492024|58736048|FG000|Treatment|Adverse Event|3|||
30722789|NCT00492024|58736049|FG001|Treatment|Adverse Event|1|||
30722790|NCT00492024|58736048|FG000|Treatment|Lack of Efficacy|21|||
30722791|NCT00492024|58736049|FG001|Treatment|Lack of Efficacy|20|||
30722792|NCT00492024|58736048|FG000|Treatment|Lost to Follow-up|3|||
30722793|NCT00492024|58736049|FG001|Treatment|Lost to Follow-up|1|||
30722794|NCT00492024|58736048|FG000|Treatment|Withdrawal by Subject|2|||
30722795|NCT00492024|58736049|FG001|Treatment|Withdrawal by Subject|0|||
30722796|NCT00492024|58736048|FG000|Follow up|Lack of Efficacy|0|||
30722797|NCT00492024|58736049|FG001|Follow up|Lack of Efficacy|1|||
30722798|NCT00492024|58736048|FG000|Follow up|Lost to Follow-up|1|||
30722799|NCT00492024|58736049|FG001|Follow up|Lost to Follow-up|1|||
30722800|NCT00491556|58736057|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
30722801|NCT00491556|58736058|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
30722802|NCT00491556|58736057|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
30722803|NCT00491556|58736058|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
30722804|NCT00491556|58736057|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
30722805|NCT00491556|58736058|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
30722806|NCT00491556|58736057|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
30722807|NCT00491556|58736058|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
30722808|NCT00491556|58736057|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
30722809|NCT00491556|58736058|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
30722810|NCT00491556|58736057|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
30722811|NCT00491556|58736058|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
30722812|NCT00491556|58736057|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
30722813|NCT00491556|58736058|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
30722814|NCT00491556|58736057|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
30722815|NCT00491556|58736058|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
30722816|NCT00491556|58736057|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
30722817|NCT00491556|58736058|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
30900367|NCT02323334|58933638|FG002|Period 3|Lost to Follow-up|1|||
30722818|NCT00491556|58736057|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
30722819|NCT00491556|58736058|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
30722820|NCT00491556|58736057|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
30722821|NCT00491556|58736058|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
30722822|NCT00491556|58736057|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
30722823|NCT00491556|58736058|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
30722824|NCT00491556|58736057|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
30722825|NCT00491556|58736058|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
30722826|NCT00491556|58736057|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
30722827|NCT00491556|58736058|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
30722828|NCT00491556|58736057|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
30722829|NCT00491556|58736058|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
30722830|NCT00491556|58736057|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
30722831|NCT00491556|58736058|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
30722832|NCT00491556|58736057|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
30722833|NCT00491556|58736058|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
30722834|NCT00491556|58736057|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
30722835|NCT00491556|58736058|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
30722836|NCT00491556|58736057|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
30722837|NCT00491556|58736058|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
30722838|NCT00491556|58736057|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
30722839|NCT00491556|58736058|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
30722840|NCT00506454|58736074|FG000|Overall Study|Withdrawal by Subject|1|||
30722841|NCT00506454|58736075|FG001|Overall Study|Withdrawal by Subject|1|||
30722842|NCT00485472|58736083|FG000|Overall Study|Adverse Event|8|||
30722843|NCT00485472|58736084|FG001|Overall Study|Adverse Event|5|||
30722844|NCT00485472|58736083|FG000|Overall Study|Lack of Efficacy|5|||
30722845|NCT00485472|58736084|FG001|Overall Study|Lack of Efficacy|4|||
30722846|NCT00485472|58736083|FG000|Overall Study|Withdrawal by Subject|1|||
30722847|NCT00485472|58736084|FG001|Overall Study|Withdrawal by Subject|0|||
30722848|NCT00485472|58736083|FG000|Overall Study|Protocol Violation|0|||
30722849|NCT00485472|58736084|FG001|Overall Study|Protocol Violation|1|||
30722850|NCT00485472|58736083|FG000|Overall Study|Other|2|||
30722851|NCT00485472|58736084|FG001|Overall Study|Other|1|||
30722852|NCT00485472|58736083|FG000|Overall Study|Lost to Follow-up|0|||
30722853|NCT00485472|58736084|FG001|Overall Study|Lost to Follow-up|1|||
30722854|NCT00491400|58736092|FG000|Overall Study|Withdrawal by Subject|5|||
30722855|NCT00491400|58736093|FG001|Overall Study|Withdrawal by Subject|4|||
30722856|NCT00491322|58736103|FG000|Overall Study|Protocol Violation|1|||
30722857|NCT00491322|58736104|FG001|Overall Study|Protocol Violation|0|||
30722858|NCT00491322|58736103|FG000|Overall Study|Pregnancy|0|||
30722859|NCT00491322|58736104|FG001|Overall Study|Pregnancy|1|||
30722860|NCT00502320|58736112|FG000|Overall Study|Lost to Follow-up|1|||
30722861|NCT00502320|58736113|FG001|Overall Study|Lost to Follow-up|1|||
30722862|NCT00502320|58736112|FG000|Overall Study|Withdrew Consent|1|||
30722863|NCT00502320|58736113|FG001|Overall Study|Withdrew Consent|0|||
30722864|NCT00502320|58736112|FG000|Overall Study|No longer met criteria|1|||
30722865|NCT00502320|58736113|FG001|Overall Study|No longer met criteria|0|||
30722866|NCT00502320|58736112|FG000|Overall Study|Screen Failure|0|||
30722867|NCT00502320|58736113|FG001|Overall Study|Screen Failure|1|||
30722868|NCT00502320|58736112|FG000|Overall Study|Adverse Event|3|||
30722869|NCT00502320|58736113|FG001|Overall Study|Adverse Event|5|||
30722870|NCT02567825|58736121|FG000|Overall Study|No follow-up post-randomization|5|||
30722871|NCT02567825|58736122|FG001|Overall Study|No follow-up post-randomization|1|||
30722872|NCT02567825|58736121|FG000|Overall Study|Follow-up less than 23 months|16|||
30722873|NCT02567825|58736122|FG001|Overall Study|Follow-up less than 23 months|20|||
30722874|NCT00490776|58736128|FG000|Overall Study|Withdrawal by Subject|1|||
30722875|NCT00490776|58736128|FG000|Overall Study|Administrative Problems|1|||
30722876|NCT00490776|58736128|FG000|Overall Study|Death|1|||
30722877|NCT00490776|58736128|FG000|Overall Study|New Cancer Therapy|1|||
30722878|NCT00490776|58736128|FG000|Overall Study|Disease Progression|5|||
30722879|NCT00566735|58736134|FG000|Overall Study|Withdrawal by Subject|0|||
30900368|NCT02323334|58933639|FG003|Period 3|Lost to Follow-up|0|||
30722880|NCT00566735|58736135|FG001|Overall Study|Withdrawal by Subject|1|||
30722881|NCT00566735|58736134|FG000|Overall Study|Refused neuropsychological testing|2|||
30722882|NCT00566735|58736135|FG001|Overall Study|Refused neuropsychological testing|5|||
30722883|NCT00566735|58736134|FG000|Overall Study|Switched into a manic episode|0|||
30722884|NCT00566735|58736135|FG001|Overall Study|Switched into a manic episode|1|||
30722885|NCT00566111|58736143|FG000|Overall Study|Adverse Event|0|||
30722886|NCT00566111|58736144|FG001|Overall Study|Adverse Event|2|||
30722887|NCT00514046|58736159|FG000|Overall Study|transferred to another protocol|2|||
30722888|NCT00514046|58736160|FG001|Overall Study|transferred to another protocol|1|||
30722889|NCT00514046|58736161|FG002|Overall Study|transferred to another protocol|3|||
30722890|NCT00514046|58736162|FG003|Overall Study|transferred to another protocol|0|||
30722891|NCT00514046|58736163|FG004|Overall Study|transferred to another protocol|1|||
30722892|NCT00514046|58736164|FG005|Overall Study|transferred to another protocol|0|||
30722893|NCT00514046|58736165|FG006|Overall Study|transferred to another protocol|0|||
30722894|NCT00514046|58736166|FG007|Overall Study|transferred to another protocol|0|||
30722895|NCT00514046|58736167|FG008|Overall Study|transferred to another protocol|0|||
30722896|NCT00514046|58736159|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
30722897|NCT00514046|58736160|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
30722898|NCT00514046|58736161|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
30722899|NCT00514046|58736162|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
30722900|NCT00514046|58736163|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
30722901|NCT00514046|58736164|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
30722902|NCT00514046|58736165|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
30722903|NCT00514046|58736166|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
30722904|NCT00514046|58736167|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
30722905|NCT00514046|58736159|FG000|Overall Study|Disease progression on study|0|||
30722906|NCT00514046|58736160|FG001|Overall Study|Disease progression on study|0|||
30722907|NCT00514046|58736161|FG002|Overall Study|Disease progression on study|2|||
30722908|NCT00514046|58736162|FG003|Overall Study|Disease progression on study|0|||
30722909|NCT00514046|58736163|FG004|Overall Study|Disease progression on study|0|||
30722910|NCT00514046|58736164|FG005|Overall Study|Disease progression on study|1|||
30722911|NCT00514046|58736165|FG006|Overall Study|Disease progression on study|0|||
30722912|NCT00514046|58736166|FG007|Overall Study|Disease progression on study|0|||
30722913|NCT00514046|58736167|FG008|Overall Study|Disease progression on study|0|||
30722914|NCT00564629|58736191|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
30722915|NCT00564629|58736192|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
30722916|NCT00564395|58736198|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
30722917|NCT00564395|58736199|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
30722918|NCT00564395|58736198|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
30722919|NCT00564395|58736199|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
30722920|NCT00502242|58736207|FG000|Overall Study|Lack of Efficacy|1|||
30722921|NCT00502242|58736208|FG001|Overall Study|Lack of Efficacy|11|||
30722922|NCT00502242|58736207|FG000|Overall Study|Adverse Event|31|||
30722923|NCT00502242|58736208|FG001|Overall Study|Adverse Event|20|||
30722924|NCT00502242|58736207|FG000|Overall Study|Physician Decision|2|||
30722925|NCT00502242|58736208|FG001|Overall Study|Physician Decision|3|||
30722926|NCT00502242|58736207|FG000|Overall Study|Other - Unspecified|8|||
30722927|NCT00502242|58736208|FG001|Overall Study|Other - Unspecified|14|||
30722928|NCT00502242|58736207|FG000|Overall Study|Protocol Violation|3|||
30722929|NCT00502242|58736208|FG001|Overall Study|Protocol Violation|1|||
30722930|NCT00502242|58736207|FG000|Overall Study|Withdrawal by Subject|6|||
30722931|NCT00502242|58736208|FG001|Overall Study|Withdrawal by Subject|7|||
30722932|NCT03972137|58736218|FG000|Overall Study|Lost to Follow-up|2|||
30722933|NCT03972137|58736218|FG000|Overall Study|Withdrawal by Subject|4|||
30722934|NCT00490698|58736234|FG000|Overall Study|Withdrawal by Subject|1|||
30722935|NCT00490698|58736234|FG000|Overall Study|Disease Progression|7|||
30722936|NCT00490698|58736234|FG000|Overall Study|Physician Decision|2|||
30722937|NCT03855228|58736242|FG000|Overall Study|Adverse Event|2|||
30722938|NCT03855228|58736243|FG001|Overall Study|Adverse Event|4|||
30722939|NCT03855228|58736244|FG002|Overall Study|Adverse Event|4|||
30722940|NCT03855228|58736245|FG003|Overall Study|Adverse Event|8|||
30722941|NCT03855228|58736242|FG000|Overall Study|Treatment Failure|1|||
30722942|NCT03855228|58736243|FG001|Overall Study|Treatment Failure|2|||
30722943|NCT03855228|58736244|FG002|Overall Study|Treatment Failure|1|||
30722944|NCT03855228|58736245|FG003|Overall Study|Treatment Failure|8|||
30722945|NCT03855228|58736242|FG000|Overall Study|Lost to Follow-up|0|||
30722946|NCT03855228|58736243|FG001|Overall Study|Lost to Follow-up|0|||
30722947|NCT03855228|58736244|FG002|Overall Study|Lost to Follow-up|0|||
30722948|NCT03855228|58736245|FG003|Overall Study|Lost to Follow-up|1|||
30722949|NCT03855228|58736242|FG000|Overall Study|Protocol Violation|0|||
30722950|NCT03855228|58736243|FG001|Overall Study|Protocol Violation|1|||
30722951|NCT03855228|58736244|FG002|Overall Study|Protocol Violation|2|||
30722952|NCT03855228|58736245|FG003|Overall Study|Protocol Violation|1|||
30722953|NCT03855228|58736242|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
30722954|NCT03855228|58736243|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
30722955|NCT03855228|58736244|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
30722956|NCT03855228|58736245|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
30722957|NCT00511238|58736257|FG000|Overall Study|Adverse Event|13|||
30722958|NCT00511238|58736258|FG001|Overall Study|Adverse Event|33|||
30722959|NCT00511238|58736257|FG000|Overall Study|Withdrawal by Subject|2|||
30722960|NCT00511238|58736258|FG001|Overall Study|Withdrawal by Subject|22|||
30722961|NCT00511238|58736257|FG000|Overall Study|Progressive Disease|23|||
30722962|NCT00511238|58736258|FG001|Overall Study|Progressive Disease|157|||
30722963|NCT00511238|58736257|FG000|Overall Study|various reasons|4|||
30722964|NCT00511238|58736258|FG001|Overall Study|various reasons|14|||
30722965|NCT00513500|58736276|FG000|Overall Study|Lost to Follow-up|35|||
30722966|NCT00513500|58736277|FG001|Overall Study|Lost to Follow-up|39|||
30722967|NCT00513500|58736276|FG000|Overall Study|Death|2|||
30722968|NCT00513500|58736277|FG001|Overall Study|Death|1|||
30722969|NCT00513500|58736276|FG000|Overall Study|Hospitalized|4|||
30722970|NCT00513500|58736277|FG001|Overall Study|Hospitalized|14|||
30722971|NCT03969719|58736286|FG000|Overall Study|Other reasons not specified|1|||
30722972|NCT03969719|58736287|FG001|Overall Study|Other reasons not specified|1|||
30722973|NCT03969719|58736288|FG002|Overall Study|Other reasons not specified|3|||
30722974|NCT03969719|58736286|FG000|Overall Study|Withdrawal by Subject|2|||
30722975|NCT03969719|58736287|FG001|Overall Study|Withdrawal by Subject|3|||
30722976|NCT03969719|58736288|FG002|Overall Study|Withdrawal by Subject|2|||
30722977|NCT03969719|58736286|FG000|Overall Study|Protocol Violation|1|||
30722978|NCT03969719|58736287|FG001|Overall Study|Protocol Violation|2|||
30722979|NCT03969719|58736288|FG002|Overall Study|Protocol Violation|0|||
30722980|NCT03969719|58736286|FG000|Overall Study|Adverse Event|0|||
30722981|NCT03969719|58736287|FG001|Overall Study|Adverse Event|2|||
30722982|NCT03969719|58736288|FG002|Overall Study|Adverse Event|0|||
30722983|NCT03969719|58736286|FG000|Overall Study|Lost to Follow-up|0|||
30722984|NCT03969719|58736287|FG001|Overall Study|Lost to Follow-up|1|||
30722985|NCT03969719|58736288|FG002|Overall Study|Lost to Follow-up|0|||
30722986|NCT00511004|58736299|FG000|Overall Study|Lost to Follow-up|0|||
30722987|NCT00511004|58736300|FG001|Overall Study|Lost to Follow-up|0|||
30722988|NCT00511004|58736301|FG002|Overall Study|Lost to Follow-up|4|||
30722989|NCT02877134|58736328|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
30722990|NCT02877134|58736329|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
30722991|NCT02877134|58736330|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
30722992|NCT02877134|58736331|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
30722993|NCT02877134|58736332|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
30722994|NCT02877134|58736333|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
30722995|NCT02877134|58736334|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
30722996|NCT02877134|58736335|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
30722997|NCT02877134|58736336|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
30722998|NCT02877134|58736337|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
30722999|NCT02877134|58736338|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
30723000|NCT02877134|58736339|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
30723001|NCT02877134|58736328|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
30723002|NCT02877134|58736329|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
30723003|NCT02877134|58736330|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
30723004|NCT02877134|58736331|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
30723005|NCT02877134|58736332|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
30723006|NCT02877134|58736333|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
30723007|NCT02877134|58736334|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
30723008|NCT02877134|58736335|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
30723009|NCT02877134|58736336|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
30723010|NCT02877134|58736337|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
30723011|NCT02877134|58736338|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
30723012|NCT02877134|58736339|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
30723013|NCT02877134|58736328|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
30723014|NCT02877134|58736329|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
30723015|NCT02877134|58736330|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
30723016|NCT02877134|58736331|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
30723017|NCT02877134|58736332|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
30723018|NCT02877134|58736333|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
30723019|NCT02877134|58736334|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
30723020|NCT02877134|58736335|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
30723021|NCT02877134|58736336|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
30723022|NCT02877134|58736337|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
30723023|NCT02877134|58736338|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
30723024|NCT02877134|58736339|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
30723025|NCT02877134|58736328|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
30723026|NCT02877134|58736329|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
30723027|NCT02877134|58736330|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
30723028|NCT02877134|58736331|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
30723029|NCT02877134|58736332|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
30723030|NCT02877134|58736333|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
30723031|NCT02877134|58736334|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
30723032|NCT02877134|58736335|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
30723033|NCT02877134|58736336|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
30723034|NCT02877134|58736337|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
30723035|NCT02877134|58736338|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
30723036|NCT02877134|58736339|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
30723037|NCT02877134|58736328|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
30723038|NCT02877134|58736329|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
30723039|NCT02877134|58736330|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
30723040|NCT02877134|58736331|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
30723041|NCT02877134|58736332|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
30723042|NCT02877134|58736333|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
30723043|NCT02877134|58736334|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
30723044|NCT02877134|58736335|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
30723045|NCT02877134|58736336|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
30723046|NCT02877134|58736337|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
30900369|NCT02323334|58933640|FG004|Period 3|Lost to Follow-up|0|||
30900370|NCT02323334|58933641|FG005|Period 3|Lost to Follow-up|0|||
30900371|NCT02323334|58933642|FG006|Period 3|Lost to Follow-up|0|||
30723047|NCT02877134|58736338|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
30723048|NCT02877134|58736339|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
30723049|NCT02877134|58736328|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
30723050|NCT02877134|58736329|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
30723051|NCT02877134|58736330|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
30723052|NCT02877134|58736331|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
30723053|NCT02877134|58736332|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
30723054|NCT02877134|58736333|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
30723055|NCT02877134|58736334|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
30723056|NCT02877134|58736335|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
30723057|NCT02877134|58736336|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
30723058|NCT02877134|58736337|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
30723059|NCT02877134|58736338|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
30723060|NCT02877134|58736339|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
30723061|NCT02877134|58736328|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
30723062|NCT02877134|58736329|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
30723063|NCT02877134|58736330|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
30723064|NCT02877134|58736331|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
30723065|NCT02877134|58736332|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
30723066|NCT02877134|58736333|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
30723067|NCT02877134|58736334|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
30723068|NCT02877134|58736335|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
30723069|NCT02877134|58736336|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
30723070|NCT02877134|58736337|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
30723071|NCT02877134|58736338|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
30723072|NCT02877134|58736339|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
30723073|NCT02877134|58736328|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
30723074|NCT02877134|58736329|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
30723075|NCT02877134|58736330|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
30723076|NCT02877134|58736331|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
30723077|NCT02877134|58736332|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
30723078|NCT02877134|58736333|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
30723079|NCT02877134|58736334|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
30723080|NCT02877134|58736335|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
30723081|NCT02877134|58736336|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
30723082|NCT02877134|58736337|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
30723083|NCT02877134|58736338|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
30723084|NCT02877134|58736339|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
30723085|NCT00563381|58736365|FG000|Overall Study|Adverse Event|264|||
30723086|NCT00563381|58736366|FG001|Overall Study|Adverse Event|292|||
30723087|NCT00563381|58736365|FG000|Overall Study|Protocol Violation|66|||
30723088|NCT00563381|58736366|FG001|Overall Study|Protocol Violation|74|||
30723089|NCT00563381|58736365|FG000|Overall Study|Lost to Follow-up|7|||
30723090|NCT00563381|58736366|FG001|Overall Study|Lost to Follow-up|15|||
30723091|NCT00563381|58736365|FG000|Overall Study|Withdrawal by Subject|192|||
30723092|NCT00563381|58736366|FG001|Overall Study|Withdrawal by Subject|209|||
30723093|NCT00563381|58736365|FG000|Overall Study|Lack of Efficacy|32|||
30723094|NCT00563381|58736366|FG001|Overall Study|Lack of Efficacy|24|||
30723095|NCT00563381|58736365|FG000|Overall Study|Individual different reasons|24|||
30723096|NCT00563381|58736366|FG001|Overall Study|Individual different reasons|34|||
30723097|NCT00512798|58736374|FG000|Overall Study|Death|0|||
30723098|NCT00512798|58736375|FG001|Overall Study|Death|3|||
30723099|NCT00512798|58736374|FG000|Overall Study|Adverse Event|2|||
30723100|NCT00512798|58736375|FG001|Overall Study|Adverse Event|4|||
30723101|NCT00512798|58736374|FG000|Overall Study|Progression of disease|14|||
30723102|NCT00512798|58736375|FG001|Overall Study|Progression of disease|20|||
30723103|NCT00512798|58736374|FG000|Overall Study|Withdrawal by Subject|3|||
30723104|NCT00512798|58736375|FG001|Overall Study|Withdrawal by Subject|0|||
30723105|NCT00565721|58736382|FG000|Overall Study|Screen Failure|2|||
30723106|NCT00565721|58736382|FG000|Overall Study|Lost to Follow-up|6|||
30723107|NCT00565721|58736382|FG000|Overall Study|Technical Problems|1|||
30723108|NCT00565721|58736382|FG000|Overall Study|Physician Decision|2|||
30723109|NCT00565721|58736382|FG000|Overall Study|Other reasons|6|||
30723110|NCT00561977|58736412|FG000|Overall Study|Withdrawal by Subject|0|||
30723111|NCT00561977|58736413|FG001|Overall Study|Withdrawal by Subject|2|||
30723112|NCT00561977|58736414|FG002|Overall Study|Withdrawal by Subject|1|||
30723113|NCT00561977|58736412|FG000|Overall Study|Pregnancy|0|||
30723114|NCT00561977|58736413|FG001|Overall Study|Pregnancy|1|||
30723115|NCT00561977|58736414|FG002|Overall Study|Pregnancy|1|||
30723116|NCT00561821|58736426|FG000|Overall Study|Not treated|0|||
30723117|NCT00561821|58736427|FG001|Overall Study|Not treated|0|||
30723118|NCT00561821|58736428|FG002|Overall Study|Not treated|1|||
30723119|NCT00561821|58736429|FG003|Overall Study|Not treated|0|||
30723120|NCT00561821|58736426|FG000|Overall Study|Withdrawal by Subject|0|||
30723121|NCT00561821|58736427|FG001|Overall Study|Withdrawal by Subject|1|||
30723122|NCT00561821|58736428|FG002|Overall Study|Withdrawal by Subject|0|||
30723123|NCT00561821|58736429|FG003|Overall Study|Withdrawal by Subject|2|||
30723124|NCT00561821|58736426|FG000|Overall Study|Reasons not related to trial|2|||
30723125|NCT00561821|58736427|FG001|Overall Study|Reasons not related to trial|1|||
30723126|NCT00561821|58736428|FG002|Overall Study|Reasons not related to trial|0|||
30723127|NCT00561821|58736429|FG003|Overall Study|Reasons not related to trial|0|||
30723128|NCT00561821|58736426|FG000|Overall Study|Other (reason not specified)|1|||
30723129|NCT00561821|58736427|FG001|Overall Study|Other (reason not specified)|1|||
30723130|NCT00561821|58736428|FG002|Overall Study|Other (reason not specified)|0|||
30723131|NCT00561821|58736429|FG003|Overall Study|Other (reason not specified)|0|||
30723132|NCT00561821|58736426|FG000|Overall Study|Adverse Event|2|||
30723133|NCT00561821|58736427|FG001|Overall Study|Adverse Event|3|||
30723134|NCT00561821|58736428|FG002|Overall Study|Adverse Event|1|||
30723135|NCT00561821|58736429|FG003|Overall Study|Adverse Event|1|||
30723136|NCT00558701|58736441|FG000|Overall Study|Protocol Deviations|1|||
30723137|NCT00558701|58736442|FG001|Overall Study|Protocol Deviations|4|||
30723138|NCT03684044|58736450|FG000|Overall Study|Adverse Event|3|||
30723139|NCT03684044|58736451|FG001|Overall Study|Adverse Event|0|||
30723140|NCT03684044|58736450|FG000|Overall Study|Death|4|||
30723141|NCT03684044|58736451|FG001|Overall Study|Death|7|||
30723142|NCT03684044|58736450|FG000|Overall Study|Lost to Follow-up|3|||
30723143|NCT03684044|58736451|FG001|Overall Study|Lost to Follow-up|2|||
30723144|NCT03684044|58736450|FG000|Overall Study|Patient Not Available|0|||
30723145|NCT03684044|58736451|FG001|Overall Study|Patient Not Available|2|||
30723146|NCT03684044|58736450|FG000|Overall Study|Physician Decision|1|||
30723147|NCT03684044|58736451|FG001|Overall Study|Physician Decision|0|||
30723148|NCT03684044|58736450|FG000|Overall Study|Withdrawal by Subject|11|||
30723149|NCT03684044|58736451|FG001|Overall Study|Withdrawal by Subject|9|||
30723150|NCT00510692|58736459|FG000|Overall Study|Adverse Event|1|||
30723151|NCT00510692|58736460|FG001|Overall Study|Adverse Event|3|||
30723152|NCT00510692|58736459|FG000|Overall Study|Withdrawal by Subject|1|||
30723153|NCT00510692|58736460|FG001|Overall Study|Withdrawal by Subject|0|||
30723154|NCT00335452|58736472|FG000|Overall Study|Death|156|||
30723155|NCT00335452|58736473|FG001|Overall Study|Death|144|||
30723156|NCT00335452|58736474|FG002|Overall Study|Death|158|||
30723157|NCT00335452|58736475|FG003|Overall Study|Death|129|||
30723158|NCT00335452|58736472|FG000|Overall Study|Lost to Follow-up|2|||
30723159|NCT00335452|58736473|FG001|Overall Study|Lost to Follow-up|3|||
30723160|NCT00335452|58736474|FG002|Overall Study|Lost to Follow-up|1|||
30723161|NCT00335452|58736475|FG003|Overall Study|Lost to Follow-up|2|||
30723162|NCT00522548|58736492|FG000|Overall Study|Adverse Event|2|||
30723163|NCT00522548|58736493|FG001|Overall Study|Adverse Event|2|||
30723164|NCT00522548|58736492|FG000|Overall Study|Withdrawal by Subject|0|||
30723165|NCT00522548|58736493|FG001|Overall Study|Withdrawal by Subject|2|||
30723166|NCT00522392|58736501|FG000|Overall Study|Disease progression|0|||
30723167|NCT00522392|58736502|FG001|Overall Study|Disease progression|3|||
30723168|NCT00522392|58736501|FG000|Overall Study|Adverse Event|7|||
30723169|NCT00522392|58736502|FG001|Overall Study|Adverse Event|7|||
30723170|NCT00522392|58736501|FG000|Overall Study|Withdrawal by Subject|1|||
30723171|NCT00522392|58736502|FG001|Overall Study|Withdrawal by Subject|1|||
30723172|NCT00522392|58736501|FG000|Overall Study|Physician Decision|0|||
30723173|NCT00522392|58736502|FG001|Overall Study|Physician Decision|1|||
30723174|NCT00522392|58736501|FG000|Overall Study|Non-compliance|0|||
30723175|NCT00522392|58736502|FG001|Overall Study|Non-compliance|1|||
30723176|NCT00309244|58736510|FG000|Overall Study|Adverse Event|29|||
30723177|NCT00309244|58736511|FG001|Overall Study|Adverse Event|12|||
30723178|NCT00309244|58736510|FG000|Overall Study|Lost to Follow-up|6|||
30723179|NCT00309244|58736511|FG001|Overall Study|Lost to Follow-up|22|||
30723180|NCT00309244|58736510|FG000|Overall Study|Physician Decision|5|||
30723181|NCT00309244|58736511|FG001|Overall Study|Physician Decision|8|||
30723182|NCT00309244|58736510|FG000|Overall Study|Protocol Violation|6|||
30723183|NCT00309244|58736511|FG001|Overall Study|Protocol Violation|3|||
30723184|NCT00309244|58736510|FG000|Overall Study|Withdrawal by Subject|50|||
30723185|NCT00309244|58736511|FG001|Overall Study|Withdrawal by Subject|32|||
30723186|NCT00309244|58736510|FG000|Overall Study|Various|7|||
30723187|NCT00309244|58736511|FG001|Overall Study|Various|7|||
30723188|NCT00309244|58736510|FG000|Overall Study|Randomized but not dosed|11|||
30723189|NCT00309244|58736511|FG001|Overall Study|Randomized but not dosed|12|||
30723190|NCT00309244|58736510|FG000|Overall Study|Death|4|||
30723191|NCT00309244|58736511|FG001|Overall Study|Death|1|||
30723192|NCT00483756|58736520|FG000|Overall Study|Death|2|||
30723193|NCT00483756|58736521|FG001|Overall Study|Death|0|||
30723194|NCT00483756|58736522|FG002|Overall Study|Death|1|||
30723195|NCT00483756|58736520|FG000|Overall Study|Adverse Event|19|||
30723196|NCT00483756|58736521|FG001|Overall Study|Adverse Event|38|||
30723197|NCT00483756|58736522|FG002|Overall Study|Adverse Event|40|||
30723198|NCT00483756|58736520|FG000|Overall Study|Lack of Efficacy|1|||
30723199|NCT00483756|58736521|FG001|Overall Study|Lack of Efficacy|0|||
30723200|NCT00483756|58736522|FG002|Overall Study|Lack of Efficacy|0|||
30723201|NCT00483756|58736520|FG000|Overall Study|Lost to Follow-up|3|||
30723202|NCT00483756|58736521|FG001|Overall Study|Lost to Follow-up|1|||
30723203|NCT00483756|58736522|FG002|Overall Study|Lost to Follow-up|0|||
30723204|NCT00483756|58736520|FG000|Overall Study|Withdrawal by Subject|5|||
30723205|NCT00483756|58736521|FG001|Overall Study|Withdrawal by Subject|3|||
30723206|NCT00483756|58736522|FG002|Overall Study|Withdrawal by Subject|4|||
30723207|NCT00483756|58736520|FG000|Overall Study|Other|2|||
30723208|NCT00483756|58736521|FG001|Overall Study|Other|4|||
30723209|NCT00483756|58736522|FG002|Overall Study|Other|3|||
30723210|NCT00483756|58736520|FG000|Overall Study|Randomized, Not Treated|1|||
30723211|NCT00483756|58736521|FG001|Overall Study|Randomized, Not Treated|4|||
30723212|NCT00483756|58736522|FG002|Overall Study|Randomized, Not Treated|4|||
30723213|NCT00309166|58736532|FG000|Overall Study|Adverse event, non-fatal|1|||
30723214|NCT00309166|58736533|FG001|Overall Study|Adverse event, non-fatal|0|||
30723215|NCT00309166|58736532|FG000|Overall Study|Withdrawal by Subject|4|||
30723216|NCT00309166|58736533|FG001|Overall Study|Withdrawal by Subject|3|||
30723217|NCT00501852|58736539|FG000|Overall Study|Adverse Event|3|||
30723218|NCT00501852|58736539|FG000|Overall Study|Withdrawal by Subject|2|||
30723219|NCT00482274|58736553|FG000|Overall Study|Adverse Event|1|||
30723220|NCT00490542|58736559|FG000|Overall Study|Lost to Follow-up|3|||
30723221|NCT00490542|58736560|FG001|Overall Study|Lost to Follow-up|0|||
30723222|NCT00490542|58736559|FG000|Overall Study|Adverse Event|3|||
30723223|NCT00490542|58736560|FG001|Overall Study|Adverse Event|3|||
30723224|NCT00490542|58736559|FG000|Overall Study|Lack of Efficacy|1|||
30723225|NCT00490542|58736560|FG001|Overall Study|Lack of Efficacy|1|||
30723226|NCT00501540|58736566|FG000|Overall Study|Death|5|||
30723227|NCT00322348|58736572|FG000|Overall Study|Adverse Event|0|||
30723228|NCT00322348|58736573|FG001|Overall Study|Adverse Event|1|||
30723229|NCT00322348|58736572|FG000|Overall Study|Withdrawal by Subject|1|||
30723230|NCT00322348|58736573|FG001|Overall Study|Withdrawal by Subject|4|||
30723231|NCT00322348|58736572|FG000|Overall Study|Lost to Follow-up|1|||
30723232|NCT00322348|58736573|FG001|Overall Study|Lost to Follow-up|0|||
30723233|NCT00322348|58736572|FG000|Overall Study|Death|0|||
30723234|NCT00322348|58736573|FG001|Overall Study|Death|2|||
30723235|NCT00322348|58736572|FG000|Overall Study|Disease Progression|30|||
30723236|NCT00322348|58736573|FG001|Overall Study|Disease Progression|25|||
30723237|NCT00322348|58736572|FG000|Overall Study|Reasons not specified|5|||
30723238|NCT00322348|58736573|FG001|Overall Study|Reasons not specified|1|||
30723239|NCT00501228|58736579|FG000|Overall Study|Withdrawal by Subject|1|||
30723240|NCT00308620|58736586|FG000|Overall Study|Death|1|||
30723241|NCT00308620|58736587|FG001|Overall Study|Death|1|||
30723242|NCT00308620|58736588|FG002|Overall Study|Death|0|||
30723243|NCT00308620|58736586|FG000|Overall Study|Lost to Follow-up|0|||
30723244|NCT00308620|58736587|FG001|Overall Study|Lost to Follow-up|0|||
30723245|NCT00308620|58736588|FG002|Overall Study|Lost to Follow-up|1|||
30723246|NCT00492752|58736598|FG000|Double Blind Treatment|Death|13|||
30723247|NCT00492752|58736599|FG001|Double Blind Treatment|Death|0|||
30723248|NCT00492752|58736600|FG002|Double Blind Treatment|Death|2|||
30723249|NCT00492752|58736601|FG003|Double Blind Treatment|Death|0|||
30723250|NCT00492752|58736598|FG000|Double Blind Treatment|Adverse Event|1|||
30723251|NCT00492752|58736599|FG001|Double Blind Treatment|Adverse Event|0|||
30723252|NCT00492752|58736600|FG002|Double Blind Treatment|Adverse Event|0|||
30723253|NCT00492752|58736601|FG003|Double Blind Treatment|Adverse Event|0|||
30723254|NCT00492752|58736598|FG000|Double Blind Treatment|Protocol Violation|0|||
30723255|NCT00492752|58736599|FG001|Double Blind Treatment|Protocol Violation|0|||
30723256|NCT00492752|58736600|FG002|Double Blind Treatment|Protocol Violation|1|||
30621639|NCT00932698|58633217|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
30723257|NCT00492752|58736601|FG003|Double Blind Treatment|Protocol Violation|0|||
30723258|NCT00492752|58736598|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
30723259|NCT00492752|58736599|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
30723260|NCT00492752|58736600|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
30723261|NCT00492752|58736601|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
30723262|NCT00492752|58736598|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
30723263|NCT00492752|58736599|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
30723264|NCT00492752|58736600|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
30723265|NCT00492752|58736601|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
30723266|NCT00492752|58736598|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
30723267|NCT00492752|58736599|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
30723268|NCT00492752|58736600|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
30723269|NCT00492752|58736601|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
30723270|NCT00492752|58736598|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
30723271|NCT00492752|58736599|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
30723272|NCT00492752|58736600|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
30723273|NCT00492752|58736601|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
30723274|NCT00492752|58736598|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
30723275|NCT00492752|58736599|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
30723276|NCT00492752|58736600|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
30723277|NCT00492752|58736601|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
30723278|NCT00492752|58736598|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
30723279|NCT00492752|58736599|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
30723280|NCT00492752|58736600|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
30723281|NCT00492752|58736601|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
30723282|NCT00492752|58736598|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
30723283|NCT00492752|58736599|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
30723284|NCT00492752|58736600|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
30723285|NCT00492752|58736601|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
30723286|NCT00492752|58736598|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
30723287|NCT00492752|58736599|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
30723288|NCT00492752|58736600|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
30723289|NCT00492752|58736601|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
30723290|NCT00308308|58736610|FG000|Overall Study|Adverse Event|17|||
30723291|NCT00308308|58736611|FG001|Overall Study|Adverse Event|2|||
30723292|NCT00308308|58736610|FG000|Overall Study|Lost to Follow-up|5|||
30723293|NCT00308308|58736611|FG001|Overall Study|Lost to Follow-up|5|||
30723294|NCT00308308|58736610|FG000|Overall Study|Physician Decision|15|||
30723295|NCT00308308|58736611|FG001|Overall Study|Physician Decision|7|||
30723296|NCT00308308|58736610|FG000|Overall Study|Protocol Violation|3|||
30723297|NCT00308308|58736611|FG001|Overall Study|Protocol Violation|14|||
30723298|NCT00308308|58736610|FG000|Overall Study|Withdrawal by Subject|47|||
30723299|NCT00308308|58736611|FG001|Overall Study|Withdrawal by Subject|19|||
30723300|NCT00308308|58736610|FG000|Overall Study|Various|7|||
30723301|NCT00308308|58736611|FG001|Overall Study|Various|5|||
30723302|NCT00308308|58736610|FG000|Overall Study|Randomized but not dosed|8|||
30723303|NCT00308308|58736611|FG001|Overall Study|Randomized but not dosed|16|||
30723304|NCT00308308|58736610|FG000|Overall Study|Other|1|||
30723305|NCT00308308|58736611|FG001|Overall Study|Other|0|||
30723306|NCT00505934|58736617|FG000|Overall Study|Adverse Event|1|||
30723307|NCT00505934|58736617|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
30723308|NCT00505934|58736617|FG000|Overall Study|Other: IV dose needed to be changed|1|||
30723309|NCT00505778|58736623|FG000|Overall Study|Adverse Event|2|||
30723310|NCT00505778|58736624|FG001|Overall Study|Adverse Event|7|||
30723311|NCT00505778|58736623|FG000|Overall Study|Physician Decision|8|||
30723312|NCT00505778|58736624|FG001|Overall Study|Physician Decision|14|||
30723313|NCT00505778|58736623|FG000|Overall Study|Lost to Follow-up|17|||
30723314|NCT00505778|58736624|FG001|Overall Study|Lost to Follow-up|23|||
30723315|NCT00505778|58736623|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
30723316|NCT00505778|58736624|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
30723317|NCT00505778|58736623|FG000|Overall Study|Protocol Violation|7|||
30723318|NCT00505778|58736624|FG001|Overall Study|Protocol Violation|9|||
30723319|NCT00505778|58736623|FG000|Overall Study|Withdrawal by Subject|29|||
30723320|NCT00505778|58736624|FG001|Overall Study|Withdrawal by Subject|14|||
30723321|NCT00505778|58736623|FG000|Overall Study|Relapse|65|||
30723322|NCT00505778|58736624|FG001|Overall Study|Relapse|65|||
30723323|NCT00505778|58736623|FG000|Overall Study|Took No Study Drug|2|||
30723324|NCT00505778|58736624|FG001|Overall Study|Took No Study Drug|2|||
30723325|NCT00308074|58736630|FG000|Overall Study|Withdrawal by Subject|1|||
30723326|NCT00500760|58736636|FG000|Overall Study|Death|32|||
30900372|NCT02323334|58933643|FG007|Period 3|Lost to Follow-up|0|||
30723327|NCT00500760|58736637|FG001|Overall Study|Death|15|||
30723328|NCT00500760|58736636|FG000|Overall Study|Withdrawal by Subject|5|||
30723329|NCT00500760|58736637|FG001|Overall Study|Withdrawal by Subject|7|||
30723330|NCT00500760|58736636|FG000|Overall Study|Administrative decision|2|||
30723331|NCT00500760|58736637|FG001|Overall Study|Administrative decision|0|||
30723332|NCT00500760|58736636|FG000|Overall Study|Lost to Follow-up|3|||
30723333|NCT00500760|58736637|FG001|Overall Study|Lost to Follow-up|0|||
30723334|NCT00500760|58736636|FG000|Overall Study|Other|1|||
30723335|NCT00500760|58736637|FG001|Overall Study|Other|2|||
30723336|NCT00505622|58736646|FG000|Overall Study|Adverse Event|5|||
30723337|NCT00505622|58736647|FG001|Overall Study|Adverse Event|6|||
30723338|NCT00505622|58736648|FG002|Overall Study|Adverse Event|4|||
30723339|NCT00505622|58736646|FG000|Overall Study|Protocol Violation|1|||
30723340|NCT00505622|58736647|FG001|Overall Study|Protocol Violation|1|||
30723341|NCT00505622|58736648|FG002|Overall Study|Protocol Violation|0|||
30723342|NCT00505622|58736646|FG000|Overall Study|Withdrawal by Subject|0|||
30723343|NCT00505622|58736647|FG001|Overall Study|Withdrawal by Subject|3|||
30723344|NCT00505622|58736648|FG002|Overall Study|Withdrawal by Subject|2|||
30723345|NCT00505622|58736646|FG000|Overall Study|Study termination by sponsor|115|||
30723346|NCT00505622|58736647|FG001|Overall Study|Study termination by sponsor|98|||
30723347|NCT00505622|58736648|FG002|Overall Study|Study termination by sponsor|90|||
30723348|NCT03851094|58736658|FG000|Overall Study|Withdrawal by Subject|0|||
30723349|NCT03851094|58736659|FG001|Overall Study|Withdrawal by Subject|1|||
30723350|NCT03851094|58736658|FG000|Overall Study|Participant lost device|0|||
30723351|NCT03851094|58736659|FG001|Overall Study|Participant lost device|1|||
30723352|NCT03851094|58736658|FG000|Overall Study|Participant returned device|0|||
30723353|NCT03851094|58736659|FG001|Overall Study|Participant returned device|2|||
30723354|NCT00505076|58736670|FG000|Overall Study|Adverse Event|1|||
30723355|NCT00505076|58736671|FG001|Overall Study|Adverse Event|0|||
30723356|NCT00505076|58736672|FG002|Overall Study|Adverse Event|1|||
30723357|NCT00505076|58736670|FG000|Overall Study|Protocol Violation|2|||
30723358|NCT00505076|58736671|FG001|Overall Study|Protocol Violation|1|||
30723359|NCT00505076|58736672|FG002|Overall Study|Protocol Violation|2|||
30723360|NCT00505076|58736670|FG000|Overall Study|Withdrawal by Subject|0|||
30723361|NCT00505076|58736671|FG001|Overall Study|Withdrawal by Subject|1|||
30723362|NCT00505076|58736672|FG002|Overall Study|Withdrawal by Subject|2|||
30723363|NCT00307684|58736680|FG000|Open Label Phase|Lack of Efficacy|0|||
30723364|NCT00307684|58736681|FG001|Open Label Phase|Lack of Efficacy|0|||
30723365|NCT00307684|58736682|FG002|Open Label Phase|Lack of Efficacy|3|||
30723366|NCT00307684|58736680|FG000|Open Label Phase|Adverse Event|0|||
30723367|NCT00307684|58736681|FG001|Open Label Phase|Adverse Event|0|||
30723368|NCT00307684|58736682|FG002|Open Label Phase|Adverse Event|16|||
30723369|NCT00307684|58736680|FG000|Open Label Phase|Withdrawal by Subject|0|||
30723370|NCT00307684|58736681|FG001|Open Label Phase|Withdrawal by Subject|0|||
30723371|NCT00307684|58736682|FG002|Open Label Phase|Withdrawal by Subject|15|||
30723372|NCT00307684|58736680|FG000|Open Label Phase|Lost to Follow-up|0|||
30723373|NCT00307684|58736681|FG001|Open Label Phase|Lost to Follow-up|0|||
30723374|NCT00307684|58736682|FG002|Open Label Phase|Lost to Follow-up|11|||
30723375|NCT00307684|58736680|FG000|Open Label Phase|non compliance|0|||
30723376|NCT00307684|58736681|FG001|Open Label Phase|non compliance|0|||
30723377|NCT00307684|58736682|FG002|Open Label Phase|non compliance|5|||
30723378|NCT00307684|58736680|FG000|Open Label Phase|other|0|||
30723379|NCT00307684|58736681|FG001|Open Label Phase|other|0|||
30723380|NCT00307684|58736682|FG002|Open Label Phase|other|6|||
30723381|NCT00307684|58736680|FG000|Double Blind Phase|Lack of Efficacy|2|||
30723382|NCT00307684|58736681|FG001|Double Blind Phase|Lack of Efficacy|5|||
30723383|NCT00307684|58736682|FG002|Double Blind Phase|Lack of Efficacy|0|||
30723384|NCT00489918|58736695|FG000|Overall Study|Withdrawal by Subject|2|||
30723385|NCT00489918|58736696|FG001|Overall Study|Withdrawal by Subject|1|||
30723386|NCT00489918|58736697|FG002|Overall Study|Withdrawal by Subject|1|||
30723387|NCT00489918|58736698|FG003|Overall Study|Withdrawal by Subject|0|||
30723388|NCT00489918|58736699|FG004|Overall Study|Withdrawal by Subject|1|||
30723389|NCT00489918|58736695|FG000|Overall Study|Adverse Event|0|||
30723390|NCT00489918|58736696|FG001|Overall Study|Adverse Event|1|||
30723391|NCT00489918|58736697|FG002|Overall Study|Adverse Event|1|||
30723392|NCT00489918|58736698|FG003|Overall Study|Adverse Event|0|||
30723393|NCT00489918|58736699|FG004|Overall Study|Adverse Event|0|||
30723394|NCT00489918|58736695|FG000|Overall Study|Lost to Follow-up|0|||
30723395|NCT00489918|58736696|FG001|Overall Study|Lost to Follow-up|0|||
30723396|NCT00489918|58736697|FG002|Overall Study|Lost to Follow-up|1|||
30723397|NCT00489918|58736698|FG003|Overall Study|Lost to Follow-up|1|||
30723398|NCT00489918|58736699|FG004|Overall Study|Lost to Follow-up|0|||
30723399|NCT00489918|58736695|FG000|Overall Study|Physician Decision|0|||
30723400|NCT00489918|58736696|FG001|Overall Study|Physician Decision|0|||
30723401|NCT00489918|58736697|FG002|Overall Study|Physician Decision|1|||
30723402|NCT00489918|58736698|FG003|Overall Study|Physician Decision|0|||
30723403|NCT00489918|58736699|FG004|Overall Study|Physician Decision|0|||
30723404|NCT00307294|58736711|FG000|Overall Study|Withdrawal by Subject|1|||
30723405|NCT03963401|58736722|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
30723406|NCT03963401|58736723|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
30723407|NCT03963401|58736724|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
30723408|NCT03963401|58736725|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
30723409|NCT03963401|58736726|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
30723410|NCT03963401|58736727|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
30723411|NCT03963401|58736722|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
30723412|NCT03963401|58736723|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
30723413|NCT03963401|58736724|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
30723414|NCT03963401|58736725|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
30723415|NCT03963401|58736726|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
30723416|NCT03963401|58736727|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
30723417|NCT03963401|58736722|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
30723418|NCT03963401|58736723|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
30723419|NCT03963401|58736724|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
30723420|NCT03963401|58736725|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
30723421|NCT03963401|58736726|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
30723422|NCT03963401|58736727|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
30723423|NCT03963401|58736722|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
30723424|NCT03963401|58736723|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
30723425|NCT03963401|58736724|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
30723426|NCT03963401|58736725|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
30723427|NCT03963401|58736726|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
30723428|NCT03963401|58736727|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
30723429|NCT03963401|58736722|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
30723430|NCT03963401|58736723|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
30723431|NCT03963401|58736724|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
30723432|NCT03963401|58736725|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
30723433|NCT03963401|58736726|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
30723434|NCT03963401|58736727|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
30723435|NCT03963401|58736722|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
30723436|NCT03963401|58736723|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
30723437|NCT03963401|58736724|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
30723438|NCT03963401|58736725|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
30723439|NCT03963401|58736726|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
30723440|NCT03963401|58736727|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
30723441|NCT03963401|58736722|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
30723442|NCT03963401|58736723|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
30723443|NCT03963401|58736724|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
30723444|NCT03963401|58736725|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
30723445|NCT03963401|58736726|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
30723446|NCT03963401|58736727|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
30723447|NCT03963401|58736722|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
30723448|NCT03963401|58736723|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
30723449|NCT03963401|58736724|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
30723450|NCT03963401|58736725|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
30723451|NCT03963401|58736726|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
30723452|NCT03963401|58736727|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
30723453|NCT03963401|58736722|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
30723454|NCT03963401|58736723|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
30723455|NCT03963401|58736724|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
30723456|NCT03963401|58736725|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
30723457|NCT03963401|58736726|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
30723458|NCT03963401|58736727|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
30723459|NCT03963401|58736722|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
30723460|NCT03963401|58736723|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
30723461|NCT03963401|58736724|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
30723462|NCT03963401|58736725|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
30723463|NCT03963401|58736726|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
30723464|NCT03963401|58736727|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
30723465|NCT03963401|58736722|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
30723466|NCT03963401|58736723|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
30723467|NCT03963401|58736724|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
30723468|NCT03963401|58736725|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
30723469|NCT03963401|58736726|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
30723470|NCT03963401|58736727|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
30723471|NCT00334282|58736747|FG000|Overall Study|Lost to Follow-up|11|||
30723472|NCT00334282|58736748|FG001|Overall Study|Lost to Follow-up|5|||
30723473|NCT00334282|58736747|FG000|Overall Study|Withdrawal by Subject|17|||
30723474|NCT00334282|58736748|FG001|Overall Study|Withdrawal by Subject|3|||
30723475|NCT00334282|58736747|FG000|Overall Study|Death|194|||
30723476|NCT00334282|58736748|FG001|Overall Study|Death|100|||
30723477|NCT00306670|58736760|FG000|Overall Study|patients recruited; Genentech, the st|0|||
30723478|NCT00306670|58736761|FG001|Overall Study|patients recruited; Genentech, the st|2|||
30723479|NCT00306592|58736767|FG000|Overall Study|Adverse Event|8|||
30723480|NCT00306592|58736768|FG001|Overall Study|Adverse Event|15|||
30723481|NCT00306592|58736767|FG000|Overall Study|Lost to Follow-up|1|||
30723482|NCT00306592|58736768|FG001|Overall Study|Lost to Follow-up|0|||
30723483|NCT00306592|58736767|FG000|Overall Study|Noncompliance|0|||
30723484|NCT00306592|58736768|FG001|Overall Study|Noncompliance|2|||
30723485|NCT00306592|58736767|FG000|Overall Study|Persistent Antibodies|6|||
30723486|NCT00306592|58736768|FG001|Overall Study|Persistent Antibodies|3|||
30723487|NCT00306592|58736767|FG000|Overall Study|Voluntary|10|||
30723488|NCT00306592|58736768|FG001|Overall Study|Voluntary|6|||
30723489|NCT00306592|58736767|FG000|Overall Study|Other|5|||
30723490|NCT00306592|58736768|FG001|Overall Study|Other|10|||
30723491|NCT00306592|58736767|FG000|Overall Study|Other|1|||
30723492|NCT00306592|58736768|FG001|Overall Study|Other|2|||
30723493|NCT00306592|58736767|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
30723494|NCT00306592|58736768|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
30723495|NCT00321646|58736772|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
30723496|NCT00321646|58736772|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
30723497|NCT00321646|58736772|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
30723498|NCT00403767|58736778|FG000|Overall Study|Adverse Event|993|||
30723499|NCT00403767|58736779|FG001|Overall Study|Adverse Event|919|||
30723500|NCT00403767|58736778|FG000|Overall Study|Non-compliant with study medication|134|||
30723501|NCT00403767|58736779|FG001|Overall Study|Non-compliant with study medication|164|||
30723502|NCT00403767|58736778|FG000|Overall Study|Consent withdrawn|671|||
30723503|NCT00403767|58736779|FG001|Overall Study|Consent withdrawn|673|||
30723504|NCT00403767|58736778|FG000|Overall Study|Investigator dec./not protocol-related|191|||
30723505|NCT00403767|58736779|FG001|Overall Study|Investigator dec./not protocol-related|178|||
30723506|NCT00403767|58736778|FG000|Overall Study|Lost to Follow-up|6|||
30723507|NCT00403767|58736779|FG001|Overall Study|Lost to Follow-up|8|||
30723508|NCT00403767|58736778|FG000|Overall Study|Protocol Violation|142|||
30723509|NCT00403767|58736779|FG001|Overall Study|Protocol Violation|124|||
30723510|NCT00403767|58736778|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
30723511|NCT00403767|58736779|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
30723512|NCT00403767|58736778|FG000|Overall Study|Study terminated by sponsor|82|||
30723513|NCT00403767|58736779|FG001|Overall Study|Study terminated by sponsor|69|||
30723514|NCT00403767|58736778|FG000|Overall Study|Missing/incomplete data|1|||
30723515|NCT00403767|58736779|FG001|Overall Study|Missing/incomplete data|1|||
30723516|NCT00492284|58736789|FG000|Overall Study|Adverse Event|0|||
30723517|NCT00492284|58736790|FG001|Overall Study|Adverse Event|1|||
30723518|NCT00492284|58736791|FG002|Overall Study|Adverse Event|1|||
30723519|NCT00492284|58736792|FG003|Overall Study|Adverse Event|2|||
30723520|NCT00492284|58736789|FG000|Overall Study|Lost to Follow-up|0|||
30723521|NCT00492284|58736790|FG001|Overall Study|Lost to Follow-up|0|||
30723522|NCT00492284|58736791|FG002|Overall Study|Lost to Follow-up|3|||
30723523|NCT00492284|58736792|FG003|Overall Study|Lost to Follow-up|1|||
30723524|NCT00492284|58736789|FG000|Overall Study|Death|0|||
30723525|NCT00492284|58736790|FG001|Overall Study|Death|3|||
30723526|NCT00492284|58736791|FG002|Overall Study|Death|2|||
30723527|NCT00492284|58736792|FG003|Overall Study|Death|5|||
30723528|NCT00492284|58736789|FG000|Overall Study|Withdrawal by Subject|1|||
30723529|NCT00492284|58736790|FG001|Overall Study|Withdrawal by Subject|0|||
30723530|NCT00492284|58736791|FG002|Overall Study|Withdrawal by Subject|0|||
30723531|NCT00492284|58736792|FG003|Overall Study|Withdrawal by Subject|2|||
30723532|NCT00510458|58736802|FG000|Overall Study|5 year not evaluable/missed|21|||
30723533|NCT00510458|58736802|FG000|Overall Study|Death|1|||
30723534|NCT00510458|58736802|FG000|Overall Study|Terminated|14|||
30723535|NCT00510458|58736802|FG000|Overall Study|Lost to Follow-up|6|||
30723536|NCT00510458|58736802|FG000|Overall Study|Withdrawal by Subject|3|||
30723537|NCT00510458|58736802|FG000|Overall Study|Revision|2|||
30723538|NCT00414765|58736809|FG000|Overall Study|Adverse Event|5|||
30723539|NCT00414765|58736810|FG001|Overall Study|Adverse Event|9|||
30723540|NCT00414765|58736809|FG000|Overall Study|Withdrawal by Subject|1|||
30723541|NCT00414765|58736810|FG001|Overall Study|Withdrawal by Subject|1|||
30723542|NCT00414765|58736809|FG000|Overall Study|Disease Progression|0|||
30723543|NCT00414765|58736810|FG001|Overall Study|Disease Progression|1|||
30723544|NCT00500682|58736818|FG000|Overall Study|Adverse Event|37|||
30723545|NCT00500682|58736819|FG001|Overall Study|Adverse Event|29|||
30723546|NCT00500682|58736818|FG000|Overall Study|Death|25|||
30723547|NCT00500682|58736819|FG001|Overall Study|Death|16|||
30723548|NCT00500682|58736818|FG000|Overall Study|Lost to Follow-up|11|||
30723549|NCT00500682|58736819|FG001|Overall Study|Lost to Follow-up|11|||
30723550|NCT00500682|58736818|FG000|Overall Study|Physician Decision|6|||
30723551|NCT00500682|58736819|FG001|Overall Study|Physician Decision|10|||
30723552|NCT00500682|58736818|FG000|Overall Study|Pregnancy|2|||
30723553|NCT00500682|58736819|FG001|Overall Study|Pregnancy|0|||
30723554|NCT00500682|58736818|FG000|Overall Study|Protocol Violation|1|||
30723555|NCT00500682|58736819|FG001|Overall Study|Protocol Violation|3|||
30723556|NCT00500682|58736818|FG000|Overall Study|Withdrawal by Subject|80|||
30723557|NCT00500682|58736819|FG001|Overall Study|Withdrawal by Subject|74|||
30723558|NCT00500682|58736818|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
30723559|NCT00500682|58736819|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
30723560|NCT00500370|58736827|FG000|Overall Study|Adverse Event|9|||
30723561|NCT00500370|58736828|FG001|Overall Study|Adverse Event|3|||
30723562|NCT00500370|58736827|FG000|Overall Study|Lost to Follow-up|10|||
30723563|NCT00500370|58736828|FG001|Overall Study|Lost to Follow-up|10|||
30723564|NCT00500370|58736827|FG000|Overall Study|Protocol Violation|2|||
30723565|NCT00500370|58736828|FG001|Overall Study|Protocol Violation|4|||
30723566|NCT00500370|58736827|FG000|Overall Study|Sponsor Decision|2|||
30723567|NCT00500370|58736828|FG001|Overall Study|Sponsor Decision|0|||
30723568|NCT00500370|58736827|FG000|Overall Study|Subject Decision|10|||
30723569|NCT00500370|58736828|FG001|Overall Study|Subject Decision|17|||
30723570|NCT00320788|58736839|FG000|Overall Study|Adverse Event|0|||
30723571|NCT00320788|58736840|FG001|Overall Study|Adverse Event|0|||
30723572|NCT00320788|58736841|FG002|Overall Study|Adverse Event|0|||
30723573|NCT00320788|58736842|FG003|Overall Study|Adverse Event|1|||
30723574|NCT00320788|58736843|FG004|Overall Study|Adverse Event|0|||
30723575|NCT00320788|58736839|FG000|Overall Study|Death|0|||
30723576|NCT00320788|58736840|FG001|Overall Study|Death|0|||
30723577|NCT00320788|58736841|FG002|Overall Study|Death|1|||
30900373|NCT02323334|58933644|FG008|Period 3|Lost to Follow-up|0|||
30900374|NCT02323334|58933645|FG009|Period 3|Lost to Follow-up|0|||
30723578|NCT00320788|58736842|FG003|Overall Study|Death|0|||
30723579|NCT00320788|58736843|FG004|Overall Study|Death|1|||
30723580|NCT00320788|58736839|FG000|Overall Study|Lost to Follow-up|0|||
30723581|NCT00320788|58736840|FG001|Overall Study|Lost to Follow-up|2|||
30723582|NCT00320788|58736841|FG002|Overall Study|Lost to Follow-up|1|||
30723583|NCT00320788|58736842|FG003|Overall Study|Lost to Follow-up|0|||
30723584|NCT00320788|58736843|FG004|Overall Study|Lost to Follow-up|0|||
30723585|NCT00320788|58736839|FG000|Overall Study|Decision by the Sponsor|1|||
30723586|NCT00320788|58736840|FG001|Overall Study|Decision by the Sponsor|1|||
30723587|NCT00320788|58736841|FG002|Overall Study|Decision by the Sponsor|0|||
30723588|NCT00320788|58736842|FG003|Overall Study|Decision by the Sponsor|0|||
30723589|NCT00320788|58736843|FG004|Overall Study|Decision by the Sponsor|1|||
30723590|NCT00320788|58736839|FG000|Overall Study|Other|1|||
30723591|NCT00320788|58736840|FG001|Overall Study|Other|2|||
30723592|NCT00320788|58736841|FG002|Overall Study|Other|1|||
30723593|NCT00320788|58736842|FG003|Overall Study|Other|1|||
30723594|NCT00320788|58736843|FG004|Overall Study|Other|1|||
30723595|NCT00320788|58736839|FG000|Overall Study|Physician Decision|1|||
30723596|NCT00320788|58736840|FG001|Overall Study|Physician Decision|1|||
30723597|NCT00320788|58736841|FG002|Overall Study|Physician Decision|0|||
30723598|NCT00320788|58736842|FG003|Overall Study|Physician Decision|0|||
30723599|NCT00320788|58736843|FG004|Overall Study|Physician Decision|0|||
30723600|NCT00320788|58736839|FG000|Overall Study|Protocol Violation|0|||
30723601|NCT00320788|58736840|FG001|Overall Study|Protocol Violation|0|||
30723602|NCT00320788|58736841|FG002|Overall Study|Protocol Violation|0|||
30723603|NCT00320788|58736842|FG003|Overall Study|Protocol Violation|0|||
30723604|NCT00320788|58736843|FG004|Overall Study|Protocol Violation|1|||
30723605|NCT00320788|58736839|FG000|Overall Study|Withdrawal by Subject|3|||
30723606|NCT00320788|58736840|FG001|Overall Study|Withdrawal by Subject|0|||
30723607|NCT00320788|58736841|FG002|Overall Study|Withdrawal by Subject|0|||
30723608|NCT00320788|58736842|FG003|Overall Study|Withdrawal by Subject|3|||
30723609|NCT00320788|58736843|FG004|Overall Study|Withdrawal by Subject|1|||
30723610|NCT00503984|58736863|FG000|Overall Study|Protocol Violation|0|||
30723611|NCT00503984|58736864|FG001|Overall Study|Protocol Violation|1|||
30723612|NCT00503984|58736865|FG002|Overall Study|Protocol Violation|0|||
30723613|NCT00503984|58736866|FG003|Overall Study|Protocol Violation|0|||
30723614|NCT00503984|58736867|FG004|Overall Study|Protocol Violation|0|||
30723615|NCT00503984|58736868|FG005|Overall Study|Protocol Violation|0|||
30723616|NCT00503984|58736863|FG000|Overall Study|Adverse Event|0|||
30723617|NCT00503984|58736864|FG001|Overall Study|Adverse Event|1|||
30723618|NCT00503984|58736865|FG002|Overall Study|Adverse Event|0|||
30723619|NCT00503984|58736866|FG003|Overall Study|Adverse Event|0|||
30723620|NCT00503984|58736867|FG004|Overall Study|Adverse Event|0|||
30723621|NCT00503984|58736868|FG005|Overall Study|Adverse Event|0|||
30723622|NCT00503984|58736863|FG000|Overall Study|Death|0|||
30723623|NCT00503984|58736864|FG001|Overall Study|Death|0|||
30723624|NCT00503984|58736865|FG002|Overall Study|Death|0|||
30723625|NCT00503984|58736866|FG003|Overall Study|Death|0|||
30790926|NCT03200366|58804017|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
30790927|NCT03200366|58804015|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
30790928|NCT03200366|58804016|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
30790929|NCT03200366|58804017|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
30790930|NCT03200366|58804015|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
30790931|NCT03200366|58804016|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
30790932|NCT03200366|58804017|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
30790933|NCT03200366|58804015|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
30790934|NCT03200366|58804016|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
30790935|NCT03200366|58804017|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
30900375|NCT02323334|58933646|FG010|Period 3|Lost to Follow-up|0|||
30723626|NCT00503984|58736867|FG004|Overall Study|Death|1|||
30723627|NCT00503984|58736868|FG005|Overall Study|Death|0|||
30723628|NCT00565409|58736892|FG000|Period 1 Open Label|Adverse Event|17|||
30723629|NCT00565409|58736893|FG001|Period 1 Open Label|Adverse Event|0|||
30723630|NCT00565409|58736894|FG002|Period 1 Open Label|Adverse Event|0|||
30723631|NCT00565409|58736895|FG003|Period 1 Open Label|Adverse Event|0|||
30723632|NCT00565409|58736892|FG000|Period 1 Open Label|Death|2|||
30723633|NCT00565409|58736893|FG001|Period 1 Open Label|Death|0|||
30723634|NCT00565409|58736894|FG002|Period 1 Open Label|Death|0|||
30723635|NCT00565409|58736895|FG003|Period 1 Open Label|Death|0|||
30723636|NCT00565409|58736892|FG000|Period 1 Open Label|Lost to Follow-up|1|||
30723637|NCT00565409|58736893|FG001|Period 1 Open Label|Lost to Follow-up|0|||
30900376|NCT02323334|58933647|FG011|Period 3|Lost to Follow-up|0|||
30723638|NCT00565409|58736894|FG002|Period 1 Open Label|Lost to Follow-up|0|||
30723639|NCT00565409|58736895|FG003|Period 1 Open Label|Lost to Follow-up|0|||
30723640|NCT00565409|58736892|FG000|Period 1 Open Label|Other|21|||
30723641|NCT00565409|58736893|FG001|Period 1 Open Label|Other|0|||
30723642|NCT00565409|58736894|FG002|Period 1 Open Label|Other|0|||
30723643|NCT00565409|58736895|FG003|Period 1 Open Label|Other|0|||
30723644|NCT00565409|58736892|FG000|Period 1 Open Label|Protocol Violation|14|||
30723645|NCT00565409|58736893|FG001|Period 1 Open Label|Protocol Violation|0|||
30900377|NCT02323334|58933648|FG012|Period 3|Lost to Follow-up|0|||
30723646|NCT00565409|58736894|FG002|Period 1 Open Label|Protocol Violation|0|||
30723647|NCT00565409|58736895|FG003|Period 1 Open Label|Protocol Violation|0|||
30723648|NCT00565409|58736892|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
30723649|NCT00565409|58736893|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
30723650|NCT00565409|58736894|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
30723651|NCT00565409|58736895|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
30723652|NCT00565409|58736892|FG000|Period 1 Open Label|no conclusion of participation record|1|||
30723653|NCT00565409|58736893|FG001|Period 1 Open Label|no conclusion of participation record|0|||
30723654|NCT00565409|58736894|FG002|Period 1 Open Label|no conclusion of participation record|0|||
30723655|NCT00565409|58736895|FG003|Period 1 Open Label|no conclusion of participation record|0|||
30723656|NCT00565409|58736892|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
30723657|NCT00565409|58736893|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
30723658|NCT00565409|58736894|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
30723659|NCT00565409|58736895|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
30723660|NCT00565409|58736892|FG000|Period 2 Double-Blind|Adverse Event|0|||
30723661|NCT00565409|58736893|FG001|Period 2 Double-Blind|Adverse Event|7|||
30723662|NCT00565409|58736894|FG002|Period 2 Double-Blind|Adverse Event|4|||
30723663|NCT00565409|58736895|FG003|Period 2 Double-Blind|Adverse Event|5|||
30723664|NCT00565409|58736892|FG000|Period 2 Double-Blind|Death|0|||
30723665|NCT00565409|58736893|FG001|Period 2 Double-Blind|Death|2|||
30723666|NCT00565409|58736894|FG002|Period 2 Double-Blind|Death|0|||
30723667|NCT00565409|58736895|FG003|Period 2 Double-Blind|Death|0|||
30723668|NCT00565409|58736892|FG000|Period 2 Double-Blind|Protocol Violation|0|||
30723669|NCT00565409|58736893|FG001|Period 2 Double-Blind|Protocol Violation|4|||
30723670|NCT00565409|58736894|FG002|Period 2 Double-Blind|Protocol Violation|6|||
30723671|NCT00565409|58736895|FG003|Period 2 Double-Blind|Protocol Violation|2|||
30723672|NCT00565409|58736892|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
30723673|NCT00565409|58736893|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
30723674|NCT00565409|58736894|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
30723675|NCT00565409|58736895|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
30723676|NCT00565409|58736892|FG000|Period 2 Double-Blind|Other|0|||
30723677|NCT00565409|58736893|FG001|Period 2 Double-Blind|Other|4|||
30723678|NCT00565409|58736894|FG002|Period 2 Double-Blind|Other|5|||
30723679|NCT00565409|58736895|FG003|Period 2 Double-Blind|Other|9|||
30723680|NCT00565409|58736892|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
30723681|NCT00565409|58736893|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
30723682|NCT00565409|58736894|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
30723683|NCT00565409|58736895|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
30723684|NCT00394251|58736907|FG000|Overall Study|Adverse Event|7|||
30723685|NCT00394251|58736908|FG001|Overall Study|Adverse Event|5|||
30900378|NCT02323334|58933649|FG013|Period 3|Lost to Follow-up|0|||
30900379|NCT02323334|58933650|FG014|Period 3|Lost to Follow-up|0|||
30900380|NCT02323334|58933651|FG015|Period 3|Lost to Follow-up|0|||
30790936|NCT03200366|58804015|FG000|9 Month Post-Baseline Interview|Death|1|||
30790937|NCT03200366|58804016|FG001|9 Month Post-Baseline Interview|Death|1|||
30900381|NCT02323334|58933652|FG016|Period 3|Lost to Follow-up|0|||
30723686|NCT00394251|58736907|FG000|Overall Study|Unacceptable Toxicity|20|||
30723687|NCT00394251|58736908|FG001|Overall Study|Unacceptable Toxicity|18|||
30723688|NCT00394251|58736907|FG000|Overall Study|Physician Decision|1|||
30723689|NCT00394251|58736908|FG001|Overall Study|Physician Decision|1|||
30723690|NCT00394251|58736907|FG000|Overall Study|Protocol Violation|0|||
30723691|NCT00394251|58736908|FG001|Overall Study|Protocol Violation|1|||
30723692|NCT00394251|58736907|FG000|Overall Study|Withdrawal by Subject|7|||
30900382|NCT02323334|58933636|FG000|Period 3|Withdrawal by Subject|1|||
30723693|NCT00394251|58736908|FG001|Overall Study|Withdrawal by Subject|11|||
30723694|NCT00394251|58736907|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
30723695|NCT00394251|58736908|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
30723696|NCT00394095|58736920|FG000|Overall Study|Adverse Event|1|||
30723697|NCT00394095|58736921|FG001|Overall Study|Adverse Event|0|||
30723698|NCT00503906|58736928|FG000|Overall Study|Withdrawal by Subject|1|||
30723699|NCT00305110|58736933|FG000|Overall Study|Missing data|29|||
30723700|NCT00491894|58736937|FG000|Overall Study|Adverse Event|14|||
30723701|NCT00491894|58736937|FG000|Overall Study|Withdrawal by Subject|5|||
30723702|NCT00491894|58736937|FG000|Overall Study|Death|3|||
30900383|NCT02323334|58933637|FG001|Period 3|Withdrawal by Subject|0|||
30723703|NCT00491894|58736937|FG000|Overall Study|Lost to Follow-up|3|||
30723704|NCT00491894|58736937|FG000|Overall Study|Lack of Efficacy|2|||
30723705|NCT00491894|58736937|FG000|Overall Study|Other-Failed to meet any criteria|2|||
30723706|NCT00491894|58736937|FG000|Overall Study|Physician Decision|2|||
30723707|NCT00491894|58736937|FG000|Overall Study|Protocol Violation|2|||
30723708|NCT00491894|58736937|FG000|Overall Study|Other-Intake of prohibited medication|1|||
30723709|NCT00491504|58736945|FG000|Overall Study|Adverse Event|0|||
30723710|NCT00491504|58736946|FG001|Overall Study|Adverse Event|1|||
30723711|NCT00491504|58736947|FG002|Overall Study|Adverse Event|0|||
30723712|NCT00491504|58736948|FG003|Overall Study|Adverse Event|0|||
30723713|NCT00491504|58736945|FG000|Overall Study|Withdrawal by Subject|0|||
30723714|NCT00491504|58736946|FG001|Overall Study|Withdrawal by Subject|0|||
30723715|NCT00491504|58736947|FG002|Overall Study|Withdrawal by Subject|1|||
30723716|NCT00491504|58736948|FG003|Overall Study|Withdrawal by Subject|2|||
30723717|NCT00491504|58736945|FG000|Overall Study|Protocol Violation|0|||
30723718|NCT00491504|58736946|FG001|Overall Study|Protocol Violation|0|||
30723719|NCT00491504|58736947|FG002|Overall Study|Protocol Violation|3|||
30723720|NCT00491504|58736948|FG003|Overall Study|Protocol Violation|2|||
30723721|NCT00500292|58736959|FG000|Overall Study|Adverse Event|3|||
30723722|NCT00500292|58736960|FG001|Overall Study|Adverse Event|6|||
30723723|NCT00500292|58736961|FG002|Overall Study|Adverse Event|4|||
30723724|NCT00500292|58736959|FG000|Overall Study|Condition under investigation worsened|21|||
30723725|NCT00500292|58736960|FG001|Overall Study|Condition under investigation worsened|23|||
30723726|NCT00500292|58736961|FG002|Overall Study|Condition under investigation worsened|19|||
30723727|NCT00500292|58736959|FG000|Overall Study|Withdrawal by Subject|0|||
30723728|NCT00500292|58736960|FG001|Overall Study|Withdrawal by Subject|1|||
30723729|NCT00500292|58736961|FG002|Overall Study|Withdrawal by Subject|0|||
30723730|NCT00500292|58736959|FG000|Overall Study|Other|1|||
30723731|NCT00500292|58736960|FG001|Overall Study|Other|1|||
30723732|NCT00500292|58736961|FG002|Overall Study|Other|4|||
30723733|NCT00499746|58736969|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
30723734|NCT00499746|58736969|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
30723735|NCT00499746|58736969|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
30723736|NCT00499746|58736969|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
30723737|NCT00489216|58736983|FG000|Overall Study|Adverse Event|1|||
30723738|NCT00499590|58736990|FG000|Overall Study|Study Terminated|112|||
30723739|NCT00499590|58736991|FG001|Overall Study|Study Terminated|112|||
30723740|NCT00499590|58736992|FG002|Overall Study|Study Terminated|112|||
30723741|NCT00499590|58736990|FG000|Overall Study|Not treated|1|||
30723742|NCT00499590|58736991|FG001|Overall Study|Not treated|0|||
30723743|NCT00499590|58736992|FG002|Overall Study|Not treated|1|||
30723744|NCT00510146|58737003|FG000|Double-Blind Treatment|Adverse Event|30|||
30723745|NCT00510146|58737004|FG001|Double-Blind Treatment|Adverse Event|13|||
30723746|NCT00510146|58737003|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
30723747|NCT00510146|58737004|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
30723748|NCT00510146|58737003|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
30723749|NCT00510146|58737004|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
30723750|NCT00510146|58737003|FG000|Double-Blind Treatment|Physician Decision|6|||
30723751|NCT00510146|58737004|FG001|Double-Blind Treatment|Physician Decision|0|||
30723752|NCT00510146|58737003|FG000|Double-Blind Treatment|Protocol Violation|1|||
30723753|NCT00510146|58737004|FG001|Double-Blind Treatment|Protocol Violation|2|||
30723754|NCT00510146|58737003|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
30723755|NCT00510146|58737004|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
30723756|NCT00510146|58737003|FG000|Double-Blind Treatment|Clinical Relapse|0|||
30723757|NCT00510146|58737004|FG001|Double-Blind Treatment|Clinical Relapse|1|||
30723758|NCT00510146|58737003|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
30723759|NCT00510146|58737004|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
30723760|NCT00510146|58737003|FG000|Open-Label Treatment|Adverse Event|22|||
30723761|NCT00510146|58737004|FG001|Open-Label Treatment|Adverse Event|8|||
30723762|NCT00510146|58737003|FG000|Open-Label Treatment|Death|1|||
30723763|NCT00510146|58737004|FG001|Open-Label Treatment|Death|1|||
30723764|NCT00510146|58737003|FG000|Open-Label Treatment|Lack of Efficacy|4|||
30723765|NCT00510146|58737004|FG001|Open-Label Treatment|Lack of Efficacy|0|||
30723766|NCT00510146|58737003|FG000|Open-Label Treatment|Lost to Follow-up|10|||
30723767|NCT00510146|58737004|FG001|Open-Label Treatment|Lost to Follow-up|1|||
30723768|NCT00510146|58737003|FG000|Open-Label Treatment|Physician Decision|3|||
30723769|NCT00510146|58737004|FG001|Open-Label Treatment|Physician Decision|1|||
30723770|NCT00510146|58737003|FG000|Open-Label Treatment|Protocol Violation|4|||
30723771|NCT00510146|58737004|FG001|Open-Label Treatment|Protocol Violation|2|||
30723772|NCT00510146|58737003|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
30723773|NCT00510146|58737004|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
30723774|NCT00510146|58737003|FG000|Open-Label Treatment|Clinical Relapse|1|||
30723775|NCT00510146|58737004|FG001|Open-Label Treatment|Clinical Relapse|1|||
30723776|NCT00510146|58737003|FG000|Open-Label Treatment|Sponsor Decision|2|||
30723777|NCT00510146|58737004|FG001|Open-Label Treatment|Sponsor Decision|0|||
30723778|NCT00480636|58737012|FG000|Overall Study|Death|12|||
30723779|NCT00480636|58737012|FG000|Overall Study|Lost to Follow-up|4|||
30723780|NCT00480636|58737012|FG000|Overall Study|Other|2|||
30723781|NCT00480636|58737012|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
30723782|NCT00499122|58737016|FG000|Overall Study|Withdrawal by Subject|2|||
30723783|NCT00393939|58737023|FG000|Overall Study|Protocol Violation|1|||
30723784|NCT00393939|58737024|FG001|Overall Study|Protocol Violation|1|||
30723785|NCT00393939|58737023|FG000|Overall Study|Lost to Follow-up|2|||
30723786|NCT00393939|58737024|FG001|Overall Study|Lost to Follow-up|4|||
30723787|NCT00393939|58737023|FG000|Overall Study|Death|10|||
30723788|NCT00393939|58737024|FG001|Overall Study|Death|4|||
30723789|NCT00393939|58737023|FG000|Overall Study|Sponsor|5|||
30723790|NCT00393939|58737024|FG001|Overall Study|Sponsor|13|||
30723791|NCT00393939|58737023|FG000|Overall Study|Objective progression or relapse|239|||
30723792|NCT00393939|58737024|FG001|Overall Study|Objective progression or relapse|223|||
30723793|NCT00393939|58737023|FG000|Overall Study|Withdrawal by Subject|2|||
30723794|NCT00393939|58737024|FG001|Overall Study|Withdrawal by Subject|7|||
30723795|NCT00393939|58737023|FG000|Overall Study|Other|37|||
30723796|NCT00393939|58737024|FG001|Overall Study|Other|45|||
30723797|NCT00488982|58737030|FG000|Course 1|Physician Decision|0|||
30723798|NCT00488982|58737031|FG001|Course 1|Physician Decision|2|||
30723799|NCT00488982|58737032|FG002|Course 1|Physician Decision|4|||
30723800|NCT00488982|58737030|FG000|Course 1|Withdrawal by Subject|0|||
30723801|NCT00488982|58737031|FG001|Course 1|Withdrawal by Subject|8|||
30723802|NCT00488982|58737032|FG002|Course 1|Withdrawal by Subject|2|||
30723803|NCT00488982|58737030|FG000|Course 1|nonprotocol therapy|0|||
30723804|NCT00488982|58737031|FG001|Course 1|nonprotocol therapy|2|||
30723805|NCT00488982|58737032|FG002|Course 1|nonprotocol therapy|2|||
30723806|NCT00488982|58737030|FG000|Course 1|Adverse Event|0|||
30723807|NCT00488982|58737031|FG001|Course 1|Adverse Event|0|||
30723808|NCT00488982|58737032|FG002|Course 1|Adverse Event|6|||
30723809|NCT00488826|58737049|FG000|Overall Study|Withdrawal by Subject|40|||
30723810|NCT00488826|58737050|FG001|Overall Study|Withdrawal by Subject|35|||
30723811|NCT00488826|58737051|FG002|Overall Study|Withdrawal by Subject|19|||
30723812|NCT00488826|58737049|FG000|Overall Study|Protocol Violation|0|||
30723813|NCT00488826|58737050|FG001|Overall Study|Protocol Violation|0|||
30723814|NCT00488826|58737051|FG002|Overall Study|Protocol Violation|2|||
30723815|NCT00488826|58737049|FG000|Overall Study|Adverse Event|9|||
30723816|NCT00488826|58737050|FG001|Overall Study|Adverse Event|15|||
30723817|NCT00488826|58737051|FG002|Overall Study|Adverse Event|4|||
30723818|NCT00488826|58737049|FG000|Overall Study|Lost to Follow-up|5|||
30723819|NCT00488826|58737050|FG001|Overall Study|Lost to Follow-up|1|||
30723820|NCT00488826|58737051|FG002|Overall Study|Lost to Follow-up|0|||
30723821|NCT00488826|58737049|FG000|Overall Study|Protocol Deviations|2|||
30723822|NCT00488826|58737050|FG001|Overall Study|Protocol Deviations|1|||
30723823|NCT00488826|58737051|FG002|Overall Study|Protocol Deviations|1|||
30723824|NCT00393861|58737059|FG000|Overall Study|Adverse Event|2|||
30723825|NCT00393861|58737059|FG000|Overall Study|Disease Progression|24|||
30723826|NCT00480324|58737065|FG000|Overall Study|Adverse Event|1|||
30723827|NCT00480324|58737066|FG001|Overall Study|Adverse Event|1|||
30723828|NCT00480324|58737065|FG000|Overall Study|Protocol Violation|0|||
30723829|NCT00480324|58737066|FG001|Overall Study|Protocol Violation|1|||
30723830|NCT00480324|58737065|FG000|Overall Study|Withdrawal by Subject|14|||
30723831|NCT00480324|58737066|FG001|Overall Study|Withdrawal by Subject|5|||
30723832|NCT00480324|58737065|FG000|Overall Study|Lost to Follow-up|17|||
30723833|NCT00480324|58737066|FG001|Overall Study|Lost to Follow-up|8|||
30723834|NCT00480324|58737065|FG000|Overall Study|Subject's mother pregnant|0|||
30723835|NCT00480324|58737066|FG001|Overall Study|Subject's mother pregnant|1|||
30723836|NCT00488592|58737072|FG000|Overall Study|Withdrawal by Subject|1|||
30723837|NCT00488592|58737072|FG000|Overall Study|Disease progression|1|||
30723838|NCT00488592|58737072|FG000|Overall Study|Enrolled but not treated|1|||
30723839|NCT00488514|58737076|FG000|Overall Study|Adverse Event|41|||
30723840|NCT00488514|58737076|FG000|Overall Study|Lost to Follow-up|44|||
30723841|NCT00488514|58737076|FG000|Overall Study|Protocol Violation|32|||
30723842|NCT00488514|58737076|FG000|Overall Study|Withdrawal by Subject|106|||
30723843|NCT00488514|58737076|FG000|Overall Study|Lack of Efficacy|28|||
30723844|NCT00488514|58737076|FG000|Overall Study|Did not meet criteria for treatment|30|||
30723845|NCT00488514|58737076|FG000|Overall Study|Postive drug screen|1|||
30723846|NCT00488514|58737076|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
30723847|NCT00488514|58737076|FG000|Overall Study|Investigator decision|1|||
30723848|NCT00488514|58737076|FG000|Overall Study|Participant had too few migraines|5|||
30723849|NCT00488514|58737076|FG000|Overall Study|Increase in number of migraines|2|||
30723850|NCT00488514|58737076|FG000|Overall Study|Increased use of concomitant medication|1|||
30790938|NCT03200366|58804017|FG002|9 Month Post-Baseline Interview|Death|1|||
30723851|NCT00320710|58737100|FG000|Overall Study|Disease progression|24|||
30723852|NCT00320710|58737101|FG001|Overall Study|Disease progression|19|||
30723853|NCT00320710|58737102|FG002|Overall Study|Disease progression|2|||
30723854|NCT00320710|58737100|FG000|Overall Study|Death|10|||
30723855|NCT00320710|58737101|FG001|Overall Study|Death|7|||
30723856|NCT00320710|58737102|FG002|Overall Study|Death|1|||
30900384|NCT02323334|58933638|FG002|Period 3|Withdrawal by Subject|0|||
30723857|NCT00320710|58737100|FG000|Overall Study|Administrative problems|1|||
30723858|NCT00320710|58737101|FG001|Overall Study|Administrative problems|2|||
30723859|NCT00320710|58737102|FG002|Overall Study|Administrative problems|0|||
30723860|NCT00320710|58737100|FG000|Overall Study|Withdrawal by Subject|20|||
30723861|NCT00320710|58737101|FG001|Overall Study|Withdrawal by Subject|26|||
30723862|NCT00320710|58737102|FG002|Overall Study|Withdrawal by Subject|1|||
30723863|NCT00320710|58737100|FG000|Overall Study|Protocol Violation|6|||
30723864|NCT00320710|58737101|FG001|Overall Study|Protocol Violation|5|||
30723865|NCT00320710|58737102|FG002|Overall Study|Protocol Violation|0|||
30723866|NCT00320710|58737100|FG000|Overall Study|Abnormal test procedure result(s)|2|||
30723867|NCT00320710|58737101|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30723868|NCT00320710|58737102|FG002|Overall Study|Abnormal test procedure result(s)|0|||
30723869|NCT00320710|58737100|FG000|Overall Study|Abnormal laboratory value(s)|12|||
30723870|NCT00320710|58737101|FG001|Overall Study|Abnormal laboratory value(s)|3|||
30723871|NCT00320710|58737102|FG002|Overall Study|Abnormal laboratory value(s)|0|||
30723872|NCT00320710|58737100|FG000|Overall Study|Adverse Event|18|||
30723873|NCT00320710|58737101|FG001|Overall Study|Adverse Event|14|||
30723874|NCT00320710|58737102|FG002|Overall Study|Adverse Event|1|||
30723875|NCT00320710|58737100|FG000|Overall Study|Lost to Follow-up|1|||
30723876|NCT00320710|58737101|FG001|Overall Study|Lost to Follow-up|0|||
30723877|NCT00320710|58737102|FG002|Overall Study|Lost to Follow-up|0|||
30723878|NCT00320398|58737111|FG000|Overall Study|Adverse Event|1|||
30723879|NCT00320398|58737112|FG001|Overall Study|Adverse Event|4|||
30723880|NCT00320398|58737111|FG000|Overall Study|Other|1|||
30723881|NCT00320398|58737112|FG001|Overall Study|Other|0|||
30723882|NCT00498186|58737119|FG000|Overall Study|Protocol Violation|10|||
30723883|NCT00498186|58737119|FG000|Overall Study|Lack of Efficacy|31|||
30723884|NCT00498186|58737119|FG000|Overall Study|Adverse Event|89|||
30723885|NCT00498186|58737119|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
30723886|NCT00498186|58737119|FG000|Overall Study|Withdrawal by Subject|18|||
30723887|NCT00498186|58737119|FG000|Overall Study|Lost to Follow-up|3|||
30723888|NCT00498186|58737119|FG000|Overall Study|Other|10|||
30723889|NCT00333970|58737125|FG000|Overall Study|Withdrawal by Subject|13|||
30723890|NCT00333970|58737126|FG001|Overall Study|Withdrawal by Subject|7|||
30723891|NCT00477594|58737134|FG000|Year 1 and Year 2|Adverse Event|4|||
30723892|NCT00477594|58737135|FG001|Year 1 and Year 2|Adverse Event|2|||
30723893|NCT00477594|58737134|FG000|Year 1 and Year 2|Physician Decision|2|||
30723894|NCT00477594|58737135|FG001|Year 1 and Year 2|Physician Decision|1|||
30723895|NCT00477594|58737134|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
30723896|NCT00477594|58737135|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
30723897|NCT00477594|58737134|FG000|Year 1 and Year 2|Other|1|||
30723898|NCT00477594|58737135|FG001|Year 1 and Year 2|Other|0|||
30723899|NCT00477594|58737134|FG000|Year 3|Adverse Event|1|||
30723900|NCT00477594|58737135|FG001|Year 3|Adverse Event|0|||
30723901|NCT00477594|58737134|FG000|Year 3|Withdrawal by Subject|1|||
30723902|NCT00477594|58737135|FG001|Year 3|Withdrawal by Subject|0|||
30723903|NCT00477594|58737134|FG000|Follow-up Period|Withdrawal by Subject|2|||
30723904|NCT00477594|58737135|FG001|Follow-up Period|Withdrawal by Subject|1|||
30723905|NCT00477594|58737134|FG000|Follow-up Period|Other|1|||
30723906|NCT00477594|58737135|FG001|Follow-up Period|Other|0|||
30723907|NCT00475722|58737143|FG000|Overall Study|Withdrawal by Subject|12|||
30723908|NCT00475722|58737144|FG001|Overall Study|Withdrawal by Subject|12|||
30723909|NCT00475722|58737143|FG000|Overall Study|Protocol Violation|3|||
30723910|NCT00475722|58737144|FG001|Overall Study|Protocol Violation|0|||
30723911|NCT00304954|58737154|FG000|Overall Study|Withdrawal by Subject|0|||
30723912|NCT00304954|58737155|FG001|Overall Study|Withdrawal by Subject|0|||
30723913|NCT00304954|58737156|FG002|Overall Study|Withdrawal by Subject|1|||
30723914|NCT00304954|58737157|FG003|Overall Study|Withdrawal by Subject|0|||
30723915|NCT00304954|58737154|FG000|Overall Study|Adverse Event|1|||
30723916|NCT00304954|58737155|FG001|Overall Study|Adverse Event|0|||
30723917|NCT00304954|58737156|FG002|Overall Study|Adverse Event|0|||
30723918|NCT00304954|58737157|FG003|Overall Study|Adverse Event|0|||
30723919|NCT00475176|58737175|FG000|Overall Study|Adverse Event|2|||
30723920|NCT00475176|58737175|FG000|Overall Study|Withdrawal by Subject|1|||
30723921|NCT00475176|58737175|FG000|Overall Study|Protocol Violation|1|||
30723922|NCT00414609|58737181|FG000|Core Study|Adverse Event|9|||
30723923|NCT00414609|58737182|FG001|Core Study|Adverse Event|11|||
30723924|NCT00414609|58737183|FG002|Core Study|Adverse Event|0|||
30723925|NCT00414609|58737181|FG000|Core Study|Abnormal laboratory values|0|||
30723926|NCT00414609|58737182|FG001|Core Study|Abnormal laboratory values|1|||
30723927|NCT00414609|58737183|FG002|Core Study|Abnormal laboratory values|0|||
30723928|NCT00414609|58737181|FG000|Core Study|Abnormal test procedure results|1|||
30723929|NCT00414609|58737182|FG001|Core Study|Abnormal test procedure results|1|||
30723930|NCT00414609|58737183|FG002|Core Study|Abnormal test procedure results|0|||
30723931|NCT00414609|58737181|FG000|Core Study|Protocol deviation|0|||
30723932|NCT00414609|58737182|FG001|Core Study|Protocol deviation|1|||
30723933|NCT00414609|58737183|FG002|Core Study|Protocol deviation|0|||
30723934|NCT00414609|58737181|FG000|Core Study|Patient withdrew consent|10|||
30723935|NCT00414609|58737182|FG001|Core Study|Patient withdrew consent|11|||
30723936|NCT00414609|58737183|FG002|Core Study|Patient withdrew consent|0|||
30723937|NCT00414609|58737181|FG000|Core Study|Lost to Follow-up|7|||
30723938|NCT00414609|58737182|FG001|Core Study|Lost to Follow-up|4|||
30723939|NCT00414609|58737183|FG002|Core Study|Lost to Follow-up|0|||
30723940|NCT00414609|58737181|FG000|Core Study|Administrative problems|0|||
30723941|NCT00414609|58737182|FG001|Core Study|Administrative problems|2|||
30723942|NCT00414609|58737183|FG002|Core Study|Administrative problems|0|||
30723943|NCT00414609|58737181|FG000|Core Study|Death|7|||
30723944|NCT00414609|58737182|FG001|Core Study|Death|14|||
30723945|NCT00414609|58737183|FG002|Core Study|Death|0|||
30723946|NCT00414609|58737181|FG000|Extension Study|Adverse Event|0|||
30723947|NCT00414609|58737182|FG001|Extension Study|Adverse Event|0|||
30723948|NCT00414609|58737183|FG002|Extension Study|Adverse Event|14|||
30723949|NCT00414609|58737181|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
30723950|NCT00414609|58737182|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
30723951|NCT00414609|58737183|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
30723952|NCT00414609|58737181|FG000|Extension Study|Withdrawal by Subject|0|||
30723953|NCT00414609|58737182|FG001|Extension Study|Withdrawal by Subject|0|||
30723954|NCT00414609|58737183|FG002|Extension Study|Withdrawal by Subject|13|||
30723955|NCT00414609|58737181|FG000|Extension Study|Lost to Follow-up|0|||
30723956|NCT00414609|58737182|FG001|Extension Study|Lost to Follow-up|0|||
30723957|NCT00414609|58737183|FG002|Extension Study|Lost to Follow-up|10|||
30723958|NCT00414609|58737181|FG000|Extension Study|Administrative problems|0|||
30723959|NCT00414609|58737182|FG001|Extension Study|Administrative problems|0|||
30723960|NCT00414609|58737183|FG002|Extension Study|Administrative problems|1|||
30723961|NCT00414609|58737181|FG000|Extension Study|Death|0|||
30723962|NCT00414609|58737182|FG001|Extension Study|Death|0|||
30723963|NCT00414609|58737183|FG002|Extension Study|Death|17|||
30723964|NCT00393705|58737194|FG000|Overall Study|Adverse Event|0|||
30723965|NCT00393705|58737195|FG001|Overall Study|Adverse Event|2|||
30723966|NCT00393705|58737194|FG000|Overall Study|Death|0|||
30723967|NCT00393705|58737195|FG001|Overall Study|Death|1|||
30723968|NCT00393705|58737194|FG000|Overall Study|Lost to Follow-up|2|||
30723969|NCT00393705|58737195|FG001|Overall Study|Lost to Follow-up|2|||
30723970|NCT00393705|58737194|FG000|Overall Study|Entry Criteria Not Met|10|||
30723971|NCT00393705|58737195|FG001|Overall Study|Entry Criteria Not Met|10|||
30723972|NCT00393705|58737194|FG000|Overall Study|Protocol Violation|4|||
30723973|NCT00393705|58737195|FG001|Overall Study|Protocol Violation|3|||
30723974|NCT00393705|58737194|FG000|Overall Study|Withdrawal by Subject|5|||
30723975|NCT00393705|58737195|FG001|Overall Study|Withdrawal by Subject|3|||
30723976|NCT00393705|58737194|FG000|Overall Study|Physician Decision|2|||
30723977|NCT00393705|58737195|FG001|Overall Study|Physician Decision|2|||
30723978|NCT00303628|58737203|FG000|Overall Study|Disease progression|0|||
30723979|NCT00303628|58737204|FG001|Overall Study|Disease progression|1|||
30723980|NCT00303628|58737203|FG000|Overall Study|Adverse Event|26|||
30723981|NCT00303628|58737204|FG001|Overall Study|Adverse Event|36|||
30790939|NCT03200366|58804015|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
30790940|NCT03200366|58804016|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
30900385|NCT02323334|58933639|FG003|Period 3|Withdrawal by Subject|0|||
30900386|NCT02323334|58933640|FG004|Period 3|Withdrawal by Subject|0|||
30900387|NCT02323334|58933641|FG005|Period 3|Withdrawal by Subject|0|||
30723982|NCT00303628|58737203|FG000|Overall Study|Death|0|||
30723983|NCT00303628|58737204|FG001|Overall Study|Death|1|||
30723984|NCT00303628|58737203|FG000|Overall Study|Withdrawal by Subject|11|||
30723985|NCT00303628|58737204|FG001|Overall Study|Withdrawal by Subject|20|||
30723986|NCT00303628|58737203|FG000|Overall Study|Alternative therapy|2|||
30723987|NCT00303628|58737204|FG001|Overall Study|Alternative therapy|0|||
30723988|NCT00303628|58737203|FG000|Overall Study|Other complicating disease|0|||
30723989|NCT00303628|58737204|FG001|Overall Study|Other complicating disease|1|||
30723990|NCT00303628|58737203|FG000|Overall Study|Not start protocol therapy|3|||
30723991|NCT00303628|58737204|FG001|Overall Study|Not start protocol therapy|5|||
30723992|NCT00303628|58737203|FG000|Overall Study|Other|8|||
30723993|NCT00303628|58737204|FG001|Overall Study|Other|9|||
30723994|NCT00414453|58737210|FG000|Overall Study|Abnormal lab work|16|||
30723995|NCT00332488|58737223|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
30723996|NCT00332488|58737224|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
30723997|NCT00332488|58737225|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
30723998|NCT00332488|58737223|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
30723999|NCT00332488|58737224|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
30724000|NCT00332488|58737225|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
30724001|NCT00332488|58737223|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
30724002|NCT00332488|58737224|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
30724003|NCT00332488|58737225|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
30724004|NCT00332488|58737223|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
30724005|NCT00332488|58737224|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
30724006|NCT00332488|58737225|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
30724007|NCT00332488|58737223|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
30724008|NCT00332488|58737224|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
30724009|NCT00332488|58737225|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
30724010|NCT00332488|58737223|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
30724011|NCT00332488|58737224|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
30724012|NCT00332488|58737225|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
30724013|NCT00332488|58737223|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
30724014|NCT00332488|58737224|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
30724015|NCT00332488|58737225|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
30724016|NCT00332488|58737223|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
30724017|NCT00332488|58737224|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
30724018|NCT00332488|58737225|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
30724019|NCT00332488|58737223|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
30724020|NCT00332488|58737224|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
30724021|NCT00332488|58737225|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
30724022|NCT00332488|58737223|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
30724023|NCT00332488|58737224|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
30724024|NCT00332488|58737225|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
30724025|NCT00332488|58737223|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
30724026|NCT00332488|58737224|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
30724027|NCT00332488|58737225|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
30724028|NCT00332488|58737223|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
30724029|NCT00332488|58737224|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
30724030|NCT00332488|58737225|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
30724031|NCT00332332|58737235|FG000|Overall Study|Adverse Event|13|||
30724032|NCT00332332|58737235|FG000|Overall Study|Death|1|||
30724033|NCT00332332|58737235|FG000|Overall Study|Withdrawal by Subject|8|||
30724034|NCT00332332|58737235|FG000|Overall Study|Physician Decision|1|||
30724035|NCT00332332|58737235|FG000|Overall Study|Lost to Follow-up|3|||
30724036|NCT00332332|58737235|FG000|Overall Study|Protocol deviation|4|||
30724037|NCT00332332|58737235|FG000|Overall Study|Noncompliance|2|||
30724038|NCT00332332|58737235|FG000|Overall Study|Disease progression|2|||
30724039|NCT00332332|58737235|FG000|Overall Study|Other|18|||
30724040|NCT00332332|58737235|FG000|Overall Study|Did not receive study treatment|16|||
30724041|NCT00392925|58737243|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
30724042|NCT00392925|58737244|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
30724043|NCT00392925|58737245|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
30724044|NCT00392925|58737246|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
30724045|NCT00392925|58737243|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
30724046|NCT00392925|58737244|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
30724047|NCT00392925|58737245|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
30724048|NCT00392925|58737246|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
30724049|NCT00392925|58737243|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
30724050|NCT00392925|58737244|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
30724051|NCT00392925|58737245|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
30724052|NCT00392925|58737246|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
30724053|NCT00392925|58737243|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
30724054|NCT00392925|58737244|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
30724055|NCT00392925|58737245|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
30724056|NCT00392925|58737246|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
30724057|NCT00392925|58737243|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
30724058|NCT00392925|58737244|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
30724059|NCT00392925|58737245|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
30724060|NCT00392925|58737246|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
30724061|NCT00392925|58737243|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
30724062|NCT00392925|58737244|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
30724063|NCT00392925|58737245|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
30724064|NCT00392925|58737246|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
30724065|NCT00392925|58737243|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
30724066|NCT00392925|58737244|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
30724067|NCT00392925|58737245|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
30724068|NCT00392925|58737246|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
30724069|NCT00392925|58737243|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
30724070|NCT00392925|58737244|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
30724071|NCT00392925|58737245|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
30724072|NCT00392925|58737246|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
30724073|NCT00392925|58737243|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
30724074|NCT00392925|58737244|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
30724075|NCT00392925|58737245|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
30724076|NCT00392925|58737246|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
30724077|NCT00474786|58737264|FG000|Overall Study|Not Meeting Study Criteria|0|||
30724078|NCT00474786|58737265|FG001|Overall Study|Not Meeting Study Criteria|1|||
30724079|NCT00474786|58737264|FG000|Overall Study|Investigator Request|2|||
30724080|NCT00474786|58737265|FG001|Overall Study|Investigator Request|1|||
30724081|NCT00474786|58737264|FG000|Overall Study|Death|189|||
30724082|NCT00474786|58737265|FG001|Overall Study|Death|170|||
30724083|NCT00474786|58737264|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
30724084|NCT00474786|58737265|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
30724085|NCT00474786|58737264|FG000|Overall Study|Lost to Follow-up|4|||
30724086|NCT00474786|58737265|FG001|Overall Study|Lost to Follow-up|7|||
30724087|NCT00474786|58737264|FG000|Overall Study|Protocol Violation|2|||
30724088|NCT00474786|58737265|FG001|Overall Study|Protocol Violation|0|||
30724089|NCT00474786|58737264|FG000|Overall Study|Withdrawal by Subject|15|||
30724090|NCT00474786|58737265|FG001|Overall Study|Withdrawal by Subject|15|||
30724091|NCT00474786|58737264|FG000|Overall Study|Other|5|||
30724092|NCT00474786|58737265|FG001|Overall Study|Other|0|||
30724093|NCT00392769|58737271|FG000|Overall Study|Clinical Deterioration|9|||
30724094|NCT00392769|58737271|FG000|Overall Study|Adverse Event|1|||
30724095|NCT00319696|58737275|FG000|Overall Study|Adverse Event|36|||
30724096|NCT00319696|58737275|FG000|Overall Study|withdrawal of consent|14|||
30724097|NCT00319696|58737275|FG000|Overall Study|administrative|7|||
30724098|NCT00319696|58737275|FG000|Overall Study|Lost to Follow-up|3|||
30724099|NCT00474630|58737287|FG000|Overall Study|Adverse Event|98|||
30724100|NCT00474630|58737288|FG001|Overall Study|Adverse Event|26|||
30724101|NCT00474630|58737287|FG000|Overall Study|Lost to Follow-up|22|||
30724102|NCT00474630|58737288|FG001|Overall Study|Lost to Follow-up|15|||
30724103|NCT00474630|58737287|FG000|Overall Study|Withdrawal by Subject|21|||
30724104|NCT00474630|58737288|FG001|Overall Study|Withdrawal by Subject|15|||
30724105|NCT00474630|58737287|FG000|Overall Study|Protocol Violation|3|||
30724106|NCT00474630|58737288|FG001|Overall Study|Protocol Violation|4|||
30724107|NCT00474630|58737287|FG000|Overall Study|Lack of Efficacy|5|||
30724108|NCT00474630|58737288|FG001|Overall Study|Lack of Efficacy|6|||
30724109|NCT00474630|58737287|FG000|Overall Study|Drug noncompliance, other|11|||
30724110|NCT00474630|58737288|FG001|Overall Study|Drug noncompliance, other|4|||
30724111|NCT00392379|58737297|FG000|Overall Study|Withdrawal by Subject|17|||
30724112|NCT00392379|58737298|FG001|Overall Study|Withdrawal by Subject|28|||
30724113|NCT00392379|58737297|FG000|Overall Study|Lost to Follow-up|4|||
30724114|NCT00392379|58737298|FG001|Overall Study|Lost to Follow-up|9|||
30724115|NCT00392379|58737297|FG000|Overall Study|Adverse Event|1|||
30724116|NCT00392379|58737298|FG001|Overall Study|Adverse Event|1|||
30724117|NCT00497874|58737306|FG000|Overall Study|Withdrawal by Subject|48|||
30724118|NCT00497874|58737307|FG001|Overall Study|Withdrawal by Subject|17|||
30724119|NCT00497874|58737306|FG000|Overall Study|Illness|8|||
30724120|NCT00497874|58737307|FG001|Overall Study|Illness|4|||
30724121|NCT00497874|58737306|FG000|Overall Study|Death|2|||
30724122|NCT00497874|58737307|FG001|Overall Study|Death|4|||
30724123|NCT00497874|58737306|FG000|Overall Study|Unable to contact|52|||
30724124|NCT00497874|58737307|FG001|Overall Study|Unable to contact|67|||
30724125|NCT00497874|58737306|FG000|Overall Study|Unable to schedule|37|||
30724126|NCT00497874|58737307|FG001|Overall Study|Unable to schedule|24|||
30724127|NCT00403455|58737315|FG000|Overall Study|Withdrawal by Subject|1|||
30724128|NCT00318370|58737319|FG000|Period 1|Lack of Efficacy|5|||
30724129|NCT00318370|58737320|FG001|Period 1|Lack of Efficacy|0|||
30724130|NCT00318370|58737321|FG002|Period 1|Lack of Efficacy|0|||
30724131|NCT00318370|58737319|FG000|Period 1|Physician Decision|1|||
30724132|NCT00318370|58737320|FG001|Period 1|Physician Decision|0|||
30724133|NCT00318370|58737321|FG002|Period 1|Physician Decision|0|||
30724134|NCT00318370|58737319|FG000|Period 1|Withdrawal by Subject|1|||
30724135|NCT00318370|58737320|FG001|Period 1|Withdrawal by Subject|0|||
30724136|NCT00318370|58737321|FG002|Period 1|Withdrawal by Subject|0|||
30724137|NCT00318370|58737319|FG000|Period 2|Adverse Event|0|||
30724138|NCT00318370|58737320|FG001|Period 2|Adverse Event|3|||
30724139|NCT00318370|58737321|FG002|Period 2|Adverse Event|0|||
30724140|NCT00318370|58737319|FG000|Period 2|Lack of Efficacy|0|||
30724141|NCT00318370|58737320|FG001|Period 2|Lack of Efficacy|5|||
30724142|NCT00318370|58737321|FG002|Period 2|Lack of Efficacy|0|||
30724143|NCT00318370|58737319|FG000|Period 2|Physician Decision|0|||
30724144|NCT00318370|58737320|FG001|Period 2|Physician Decision|1|||
30724145|NCT00318370|58737321|FG002|Period 2|Physician Decision|0|||
30724146|NCT00318370|58737319|FG000|Period 2|Withdrawal by Subject|0|||
30724147|NCT00318370|58737320|FG001|Period 2|Withdrawal by Subject|1|||
30724148|NCT00318370|58737321|FG002|Period 2|Withdrawal by Subject|0|||
30724149|NCT00318370|58737319|FG000|Period 2|Other|0|||
30724150|NCT00318370|58737320|FG001|Period 2|Other|1|||
30724151|NCT00318370|58737321|FG002|Period 2|Other|0|||
30724152|NCT00318370|58737319|FG000|Period 3|Adverse Event|0|||
30724153|NCT00318370|58737320|FG001|Period 3|Adverse Event|0|||
30724154|NCT00318370|58737321|FG002|Period 3|Adverse Event|1|||
30724155|NCT00318370|58737319|FG000|Period 3|Lack of Efficacy|0|||
30724156|NCT00318370|58737320|FG001|Period 3|Lack of Efficacy|0|||
30724157|NCT00318370|58737321|FG002|Period 3|Lack of Efficacy|24|||
30724158|NCT00318370|58737319|FG000|Period 3|Death|0|||
30724159|NCT00318370|58737320|FG001|Period 3|Death|0|||
30724160|NCT00318370|58737321|FG002|Period 3|Death|1|||
30724161|NCT00318370|58737319|FG000|Period 3|Physician Decision|0|||
30724162|NCT00318370|58737320|FG001|Period 3|Physician Decision|0|||
30724163|NCT00318370|58737321|FG002|Period 3|Physician Decision|1|||
30724164|NCT00318370|58737319|FG000|Period 3|Withdrawal by Subject|0|||
30724165|NCT00318370|58737320|FG001|Period 3|Withdrawal by Subject|0|||
30724166|NCT00318370|58737321|FG002|Period 3|Withdrawal by Subject|3|||
30724167|NCT00318370|58737319|FG000|Period 3|Other|0|||
30724168|NCT00318370|58737320|FG001|Period 3|Other|0|||
30724169|NCT00318370|58737321|FG002|Period 3|Other|3|||
30724170|NCT00510068|58737329|FG000|Double-blind Period|Disease progression|98|||
30724171|NCT00510068|58737330|FG001|Double-blind Period|Disease progression|169|||
30724172|NCT00510068|58737329|FG000|Double-blind Period|Final primary analysis|52|||
30724173|NCT00510068|58737330|FG001|Double-blind Period|Final primary analysis|18|||
30724174|NCT00510068|58737329|FG000|Double-blind Period|Adverse Event|37|||
30724175|NCT00510068|58737330|FG001|Double-blind Period|Adverse Event|7|||
30724176|NCT00510068|58737329|FG000|Double-blind Period|Withdrawal by Subject|8|||
30724177|NCT00510068|58737330|FG001|Double-blind Period|Withdrawal by Subject|6|||
30724178|NCT00510068|58737329|FG000|Double-blind Period|Death|4|||
30724179|NCT00510068|58737330|FG001|Double-blind Period|Death|3|||
30724180|NCT00510068|58737329|FG000|Double-blind Period|Abnormal test result (s)|1|||
30724181|NCT00510068|58737330|FG001|Double-blind Period|Abnormal test result (s)|0|||
30724182|NCT00510068|58737329|FG000|Double-blind Period|Lost to Follow-up|1|||
30724183|NCT00510068|58737330|FG001|Double-blind Period|Lost to Follow-up|0|||
30724184|NCT00510068|58737329|FG000|Double-blind Period|Protocol Violation|6|||
30724185|NCT00510068|58737330|FG001|Double-blind Period|Protocol Violation|0|||
30724186|NCT00510068|58737329|FG000|Open-label Period|Disease Progression|124|||
30724187|NCT00510068|58737330|FG001|Open-label Period|Disease Progression|0|||
30724188|NCT00510068|58737329|FG000|Open-label Period|Adverse Event|46|||
30724189|NCT00510068|58737330|FG001|Open-label Period|Adverse Event|0|||
30724190|NCT00510068|58737329|FG000|Open-label Period|Withdrawal by Subject|21|||
30724191|NCT00510068|58737330|FG001|Open-label Period|Withdrawal by Subject|0|||
30724192|NCT00510068|58737329|FG000|Open-label Period|Administrative problems|17|||
30724193|NCT00510068|58737330|FG001|Open-label Period|Administrative problems|0|||
30724194|NCT00510068|58737329|FG000|Open-label Period|Death|7|||
30724195|NCT00510068|58737330|FG001|Open-label Period|Death|0|||
30724196|NCT00510068|58737329|FG000|Open-label Period|New cancer therapy|7|||
30724197|NCT00510068|58737330|FG001|Open-label Period|New cancer therapy|0|||
30724198|NCT00510068|58737329|FG000|Open-label Period|Protocol Violation|2|||
30724199|NCT00510068|58737330|FG001|Open-label Period|Protocol Violation|0|||
30724200|NCT00510068|58737329|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
30724201|NCT00510068|58737330|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
30724202|NCT00509600|58737338|FG000|Overall Study|Adverse Event|1|||
30724203|NCT00402987|58737346|FG000|Overall Study|Lack of Efficacy|0|||
30724204|NCT00402987|58737347|FG001|Overall Study|Lack of Efficacy|0|||
30724205|NCT00402987|58737348|FG002|Overall Study|Lack of Efficacy|1|||
30724206|NCT00402987|58737349|FG003|Overall Study|Lack of Efficacy|0|||
30724207|NCT00501644|58737373|FG000|Overall Study|Adverse Event|4|||
30724208|NCT00501644|58737373|FG000|Overall Study|Withdrawal by Subject|1|||
30724209|NCT00497796|58737379|FG000|Overall Study|Adverse event (not related)|9|||
30724210|NCT00497796|58737380|FG001|Overall Study|Adverse event (not related)|9|||
30724211|NCT00497796|58737379|FG000|Overall Study|Adverse event (related)|5|||
30724212|NCT00497796|58737380|FG001|Overall Study|Adverse event (related)|4|||
30724213|NCT00497796|58737379|FG000|Overall Study|CMV infection or disease treatment|30|||
30724214|NCT00497796|58737380|FG001|Overall Study|CMV infection or disease treatment|4|||
30724215|NCT00497796|58737379|FG000|Overall Study|Consent withdrawn|10|||
30724216|NCT00497796|58737380|FG001|Overall Study|Consent withdrawn|3|||
30724217|NCT00497796|58737379|FG000|Overall Study|Investigator/sponsor discretion|31|||
30724218|NCT00497796|58737380|FG001|Overall Study|Investigator/sponsor discretion|34|||
30724219|NCT00497796|58737379|FG000|Overall Study|Lost to Follow-up|0|||
30724220|NCT00497796|58737380|FG001|Overall Study|Lost to Follow-up|1|||
30724221|NCT00497796|58737379|FG000|Overall Study|Not applicable (randomized not treated)|0|||
30724222|NCT00497796|58737380|FG001|Overall Study|Not applicable (randomized not treated)|4|||
30724223|NCT00496782|58737388|FG000|Overall Study|Protocol Violation|1|||
30724224|NCT00496782|58737389|FG001|Overall Study|Protocol Violation|2|||
30724225|NCT00402831|58737397|FG000|Overall Study|Lost to Follow-up|1|||
30724226|NCT00402831|58737398|FG001|Overall Study|Lost to Follow-up|2|||
30724227|NCT00402831|58737397|FG000|Overall Study|Non-compliance with protocol|0|||
30724228|NCT00402831|58737398|FG001|Overall Study|Non-compliance with protocol|1|||
30724229|NCT00496626|58737408|FG000|Overall Study|Lost to Follow-up|0|||
30724230|NCT00496626|58737409|FG001|Overall Study|Lost to Follow-up|1|||
30724231|NCT00496626|58737408|FG000|Overall Study|Protocol Violation|1|||
30724232|NCT00496626|58737409|FG001|Overall Study|Protocol Violation|0|||
30724233|NCT00496626|58737408|FG000|Overall Study|Withdrawal by Subject|5|||
30724234|NCT00496626|58737409|FG001|Overall Study|Withdrawal by Subject|4|||
30724235|NCT00496626|58737408|FG000|Overall Study|Relocated|0|||
30724236|NCT00496626|58737409|FG001|Overall Study|Relocated|1|||
30724237|NCT00471822|58737419|FG000|Overall Study|Protocol Violation|2|||
30724238|NCT00471276|58737423|FG000|Overall Study|Death|2|||
30724239|NCT00471276|58737423|FG000|Overall Study|Adverse Event|16|||
30724240|NCT00471276|58737423|FG000|Overall Study|Protocol Violation|1|||
30724241|NCT00471276|58737423|FG000|Overall Study|Objective progression or relapse|54|||
30724242|NCT00471276|58737423|FG000|Overall Study|Global deterioration of health status|1|||
30724243|NCT00471276|58737423|FG000|Overall Study|Other|3|||
30724244|NCT00471276|58737423|FG000|Overall Study|Refused treatment|6|||
30724245|NCT00470262|58737429|FG000|Overall Study|Withdrawal by Subject|2|||
30724246|NCT00470262|58737430|FG001|Overall Study|Withdrawal by Subject|0|||
30724247|NCT00496470|58737439|FG000|Overall Study|Adverse Event|8|||
30724248|NCT00496470|58737440|FG001|Overall Study|Adverse Event|10|||
30724249|NCT00496470|58737439|FG000|Overall Study|Withdrawal by Subject|5|||
30724250|NCT00496470|58737440|FG001|Overall Study|Withdrawal by Subject|12|||
30724251|NCT00496470|58737439|FG000|Overall Study|Incorrectly enrolled|13|||
30724252|NCT00496470|58737440|FG001|Overall Study|Incorrectly enrolled|5|||
30724253|NCT00496470|58737439|FG000|Overall Study|Other reason|0|||
30724254|NCT00496470|58737440|FG001|Overall Study|Other reason|2|||
30724255|NCT00496080|58737446|FG000|Overall Study|Lost to Follow-up|9|||
30724256|NCT00496080|58737446|FG000|Overall Study|Surgical re-intervention|7|||
30724257|NCT00496080|58737446|FG000|Overall Study|Withdrawal by Subject|5|||
30724258|NCT00496080|58737446|FG000|Overall Study|Physician Decision|6|||
30724259|NCT00487578|58737453|FG000|Overall Study|Adverse Event|1|||
30724260|NCT00487578|58737454|FG001|Overall Study|Adverse Event|2|||
30724261|NCT00487578|58737453|FG000|Overall Study|Lack of Efficacy|0|||
30724262|NCT00487578|58737454|FG001|Overall Study|Lack of Efficacy|1|||
30724263|NCT00487578|58737453|FG000|Overall Study|Lost to Follow-up|0|||
30724264|NCT00487578|58737454|FG001|Overall Study|Lost to Follow-up|1|||
30724265|NCT00495612|58737462|FG000|Overall Study|Lost to Follow-up|1|||
30724266|NCT00495612|58737463|FG001|Overall Study|Lost to Follow-up|0|||
30724267|NCT00495612|58737462|FG000|Overall Study|Subject's Decision to Withdraw|3|||
30724268|NCT00495612|58737463|FG001|Overall Study|Subject's Decision to Withdraw|0|||
30724269|NCT00487188|58737471|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
30724270|NCT00487188|58737472|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
30724271|NCT00487188|58737473|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
30724272|NCT00487188|58737471|FG000|Induction Phase|Adverse Event|5|||
30724273|NCT00487188|58737472|FG001|Induction Phase|Adverse Event|0|||
30724274|NCT00487188|58737473|FG002|Induction Phase|Adverse Event|0|||
30724275|NCT00487188|58737471|FG000|Induction Phase|Lack of Efficacy|0|||
30724276|NCT00487188|58737472|FG001|Induction Phase|Lack of Efficacy|1|||
30724277|NCT00487188|58737473|FG002|Induction Phase|Lack of Efficacy|0|||
30724278|NCT00487188|58737471|FG000|Induction Phase|Protocol Violation|1|||
30724279|NCT00487188|58737472|FG001|Induction Phase|Protocol Violation|0|||
30724280|NCT00487188|58737473|FG002|Induction Phase|Protocol Violation|0|||
30724281|NCT00487188|58737471|FG000|Induction Phase|Refused Treatment|1|||
30724282|NCT00487188|58737472|FG001|Induction Phase|Refused Treatment|2|||
30724283|NCT00487188|58737473|FG002|Induction Phase|Refused Treatment|0|||
30724284|NCT00487188|58737471|FG000|Induction Phase|Lost to Follow-up|2|||
30724285|NCT00487188|58737472|FG001|Induction Phase|Lost to Follow-up|2|||
30724286|NCT00487188|58737473|FG002|Induction Phase|Lost to Follow-up|0|||
30724287|NCT00487188|58737471|FG000|Induction Phase|Administrative|0|||
30724288|NCT00487188|58737472|FG001|Induction Phase|Administrative|1|||
30724289|NCT00487188|58737473|FG002|Induction Phase|Administrative|0|||
30724290|NCT00487188|58737471|FG000|Maintenance Phase|Adverse Event|1|||
30724291|NCT00487188|58737472|FG001|Maintenance Phase|Adverse Event|0|||
30724292|NCT00487188|58737473|FG002|Maintenance Phase|Adverse Event|0|||
30724293|NCT00487188|58737471|FG000|Maintenance Phase|Death|1|||
30724294|NCT00487188|58737472|FG001|Maintenance Phase|Death|0|||
30724295|NCT00487188|58737473|FG002|Maintenance Phase|Death|0|||
30724296|NCT00487188|58737471|FG000|Maintenance Phase|Lost to Follow-up|1|||
30724297|NCT00487188|58737472|FG001|Maintenance Phase|Lost to Follow-up|0|||
30724298|NCT00487188|58737473|FG002|Maintenance Phase|Lost to Follow-up|0|||
30724299|NCT00487188|58737471|FG000|Maintenance Phase|Administrative|0|||
30724300|NCT00487188|58737472|FG001|Maintenance Phase|Administrative|0|||
30724301|NCT00487188|58737473|FG002|Maintenance Phase|Administrative|1|||
30724302|NCT00509366|58737494|FG000|Overall Study|Not Treated (Screen Failure)|1|||
30724303|NCT00509366|58737495|FG001|Overall Study|Not Treated (Screen Failure)|1|||
30724304|NCT00509366|58737496|FG002|Overall Study|Not Treated (Screen Failure)|1|||
30724305|NCT00509366|58737497|FG003|Overall Study|Not Treated (Screen Failure)|0|||
30724306|NCT00509366|58737498|FG004|Overall Study|Not Treated (Screen Failure)|0|||
30724307|NCT00500318|58737510|FG000|Overall Study|Adverse Event|3|||
30724308|NCT00500318|58737511|FG001|Overall Study|Adverse Event|8|||
30724309|NCT00500318|58737510|FG000|Overall Study|Protocol Violation|1|||
30724310|NCT00500318|58737511|FG001|Overall Study|Protocol Violation|3|||
30724311|NCT00500318|58737510|FG000|Overall Study|Withdrawal by Subject|1|||
30724312|NCT00500318|58737511|FG001|Overall Study|Withdrawal by Subject|2|||
30724313|NCT00500318|58737510|FG000|Overall Study|Lack of Efficacy|0|||
30724314|NCT00500318|58737511|FG001|Overall Study|Lack of Efficacy|3|||
30724315|NCT00500318|58737510|FG000|Overall Study|Other Reason|0|||
30724316|NCT00500318|58737511|FG001|Overall Study|Other Reason|1|||
30724317|NCT00508820|58737519|FG000|Overall Study|Adverse Event|6|||
30724318|NCT00508820|58737520|FG001|Overall Study|Adverse Event|10|||
30724319|NCT00508820|58737519|FG000|Overall Study|Death|6|||
30724320|NCT00508820|58737520|FG001|Overall Study|Death|8|||
30724321|NCT00508820|58737519|FG000|Overall Study|Lost to Follow-up|1|||
30724322|NCT00508820|58737520|FG001|Overall Study|Lost to Follow-up|1|||
30724323|NCT00508820|58737519|FG000|Overall Study|Physician Decision|8|||
30724324|NCT00508820|58737520|FG001|Overall Study|Physician Decision|2|||
30724325|NCT00508820|58737519|FG000|Overall Study|Pregnancy|0|||
30724326|NCT00508820|58737520|FG001|Overall Study|Pregnancy|2|||
30724327|NCT00508820|58737519|FG000|Overall Study|Protocol Violation|2|||
30724328|NCT00508820|58737520|FG001|Overall Study|Protocol Violation|0|||
30724329|NCT00508820|58737519|FG000|Overall Study|Withdrawal by Subject|10|||
30724330|NCT00508820|58737520|FG001|Overall Study|Withdrawal by Subject|12|||
30724331|NCT00508820|58737519|FG000|Overall Study|Other|11|||
30724332|NCT00508820|58737520|FG001|Overall Study|Other|2|||
30724333|NCT00508820|58737519|FG000|Overall Study|Noncompliance|1|||
30724334|NCT00508820|58737520|FG001|Overall Study|Noncompliance|0|||
30724335|NCT00508820|58737519|FG000|Overall Study|Requirement for alternative therapy|7|||
30724336|NCT00508820|58737520|FG001|Overall Study|Requirement for alternative therapy|15|||
30724337|NCT00508820|58737519|FG000|Overall Study|Protocol-specified Criteria|3|||
30724338|NCT00508820|58737520|FG001|Overall Study|Protocol-specified Criteria|12|||
30724339|NCT00499694|58737526|FG000|Overall Study|Patient never received treatment.|1|||
30724340|NCT00486954|58737535|FG000|Pilot Part|Adverse Event|4|||
30724341|NCT00486954|58737536|FG001|Pilot Part|Adverse Event|0|||
30724342|NCT00486954|58737537|FG002|Pilot Part|Adverse Event|5|||
30724343|NCT00486954|58737538|FG003|Pilot Part|Adverse Event|0|||
30724344|NCT00486954|58737539|FG004|Pilot Part|Adverse Event|0|||
30724345|NCT00486954|58737535|FG000|Pilot Part|Disease Progression|2|||
30724346|NCT00486954|58737536|FG001|Pilot Part|Disease Progression|0|||
30724347|NCT00486954|58737537|FG002|Pilot Part|Disease Progression|1|||
30724348|NCT00486954|58737538|FG003|Pilot Part|Disease Progression|0|||
30724349|NCT00486954|58737539|FG004|Pilot Part|Disease Progression|0|||
30724350|NCT00486954|58737535|FG000|Randomized Part|Lost to Follow-up|0|||
30724351|NCT00486954|58737536|FG001|Randomized Part|Lost to Follow-up|0|||
30724352|NCT00486954|58737537|FG002|Randomized Part|Lost to Follow-up|0|||
30724353|NCT00486954|58737538|FG003|Randomized Part|Lost to Follow-up|0|||
30724354|NCT00486954|58737539|FG004|Randomized Part|Lost to Follow-up|1|||
30724355|NCT00486954|58737535|FG000|Randomized Part|Withdrawal by Subject|0|||
30724356|NCT00486954|58737536|FG001|Randomized Part|Withdrawal by Subject|0|||
30724357|NCT00486954|58737537|FG002|Randomized Part|Withdrawal by Subject|0|||
30724358|NCT00486954|58737538|FG003|Randomized Part|Withdrawal by Subject|1|||
30724359|NCT00486954|58737539|FG004|Randomized Part|Withdrawal by Subject|0|||
30724360|NCT00486954|58737535|FG000|Randomized Part|Sponsor Terminated Study|0|||
30724361|NCT00486954|58737536|FG001|Randomized Part|Sponsor Terminated Study|0|||
30724362|NCT00486954|58737537|FG002|Randomized Part|Sponsor Terminated Study|0|||
30724363|NCT00486954|58737538|FG003|Randomized Part|Sponsor Terminated Study|19|||
30790941|NCT03200366|58804017|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
30724364|NCT00486954|58737539|FG004|Randomized Part|Sponsor Terminated Study|13|||
30724365|NCT00494676|58737549|FG000|Allocation|Withdrawal by Subject|2|||
30724366|NCT00494676|58737550|FG001|Allocation|Withdrawal by Subject|4|||
30724367|NCT00494676|58737549|FG000|First Intervention|Withdrawal by Subject|1|||
30724368|NCT00494676|58737550|FG001|First Intervention|Withdrawal by Subject|3|||
30724369|NCT00494676|58737549|FG000|Second Intervention|Withdrawal by Subject|1|||
30724370|NCT00494676|58737550|FG001|Second Intervention|Withdrawal by Subject|1|||
30724371|NCT00486720|58737558|FG000|Overall Study|Adverse Event|1|||
30724372|NCT00486720|58737559|FG001|Overall Study|Adverse Event|2|||
30724373|NCT00486720|58737558|FG000|Overall Study|Lack of Efficacy|4|||
30724374|NCT00486720|58737559|FG001|Overall Study|Lack of Efficacy|6|||
30724375|NCT00486720|58737558|FG000|Overall Study|Physician Decision|1|||
30724376|NCT00486720|58737559|FG001|Overall Study|Physician Decision|2|||
30724377|NCT00486720|58737558|FG000|Overall Study|Protocol Violation|1|||
30724378|NCT00486720|58737559|FG001|Overall Study|Protocol Violation|0|||
30724379|NCT00486720|58737558|FG000|Overall Study|Withdrawal by Subject|3|||
30724380|NCT00486720|58737559|FG001|Overall Study|Withdrawal by Subject|1|||
30724381|NCT00486720|58737558|FG000|Overall Study|Progressive Disease|0|||
30724382|NCT00486720|58737559|FG001|Overall Study|Progressive Disease|1|||
30724383|NCT00486330|58737565|FG000|Overall Study|Adverse Event|2|||
30724384|NCT00486252|58737569|FG000|Overall Study|Adverse Event|7|||
30724385|NCT00486252|58737569|FG000|Overall Study|Lack of Efficacy|9|||
30724386|NCT00486252|58737569|FG000|Overall Study|Lost to Follow-up|24|||
30724387|NCT00486252|58737569|FG000|Overall Study|Other|18|||
30724388|NCT00494442|58737577|FG000|Overall Study|Death|1|||
30724389|NCT00494442|58737578|FG001|Overall Study|Death|1|||
30724390|NCT00494442|58737577|FG000|Overall Study|Lack of Efficacy|16|||
30724391|NCT00494442|58737578|FG001|Overall Study|Lack of Efficacy|10|||
30724392|NCT00494442|58737577|FG000|Overall Study|Adverse Event|0|||
30724393|NCT00494442|58737578|FG001|Overall Study|Adverse Event|2|||
30724394|NCT00494442|58737577|FG000|Overall Study|Physician Decision|0|||
30724395|NCT00494442|58737578|FG001|Overall Study|Physician Decision|1|||
30724396|NCT00494442|58737577|FG000|Overall Study|Non-compliance|0|||
30724397|NCT00494442|58737578|FG001|Overall Study|Non-compliance|1|||
30724398|NCT00494442|58737577|FG000|Overall Study|Intercurrent illness|0|||
30724399|NCT00494442|58737578|FG001|Overall Study|Intercurrent illness|1|||
30724400|NCT03851016|58737586|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
30724401|NCT03851016|58737587|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
30724402|NCT00493974|58737595|FG000|Overall Study|Death|1|||
30724403|NCT00493974|58737596|FG001|Overall Study|Death|2|||
30724404|NCT00493974|58737595|FG000|Overall Study|Withdrawal by Subject|8|||
30724405|NCT00493974|58737596|FG001|Overall Study|Withdrawal by Subject|6|||
30724406|NCT00493974|58737595|FG000|Overall Study|Lost to Follow-up|4|||
30724407|NCT00493974|58737596|FG001|Overall Study|Lost to Follow-up|6|||
30724408|NCT00469092|58737604|FG000|Overall Study|Adverse Event|5|||
30724409|NCT00469092|58737605|FG001|Overall Study|Adverse Event|4|||
30724410|NCT00469092|58737604|FG000|Overall Study|Lack of Efficacy|1|||
30724411|NCT00469092|58737605|FG001|Overall Study|Lack of Efficacy|0|||
30724412|NCT00469092|58737604|FG000|Overall Study|Lost to Follow-up|1|||
30724413|NCT00469092|58737605|FG001|Overall Study|Lost to Follow-up|2|||
30724414|NCT00469092|58737604|FG000|Overall Study|Protocol Violation|3|||
30724415|NCT00469092|58737605|FG001|Overall Study|Protocol Violation|3|||
30724416|NCT00469092|58737604|FG000|Overall Study|Withdrawal by Subject|4|||
30724417|NCT00469092|58737605|FG001|Overall Study|Withdrawal by Subject|4|||
30724418|NCT00469092|58737604|FG000|Overall Study|Withdrawal Criteria|3|||
30724419|NCT00469092|58737605|FG001|Overall Study|Withdrawal Criteria|4|||
30724420|NCT00469092|58737604|FG000|Overall Study|Incorrectly Randomised|4|||
30724421|NCT00469092|58737605|FG001|Overall Study|Incorrectly Randomised|3|||
30724422|NCT00469092|58737604|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
30724423|NCT00469092|58737605|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
30724424|NCT00469092|58737604|FG000|Overall Study|Use of lipid lowering drug|1|||
30724425|NCT00469092|58737605|FG001|Overall Study|Use of lipid lowering drug|0|||
30724426|NCT00469092|58737604|FG000|Overall Study|Hypoglycaemic Episodes|1|||
30724427|NCT00469092|58737605|FG001|Overall Study|Hypoglycaemic Episodes|1|||
30724428|NCT00469092|58737604|FG000|Overall Study|Abnormal lab value|1|||
30724429|NCT00469092|58737605|FG001|Overall Study|Abnormal lab value|0|||
30724430|NCT00469092|58737604|FG000|Overall Study|Use of Corticosteroid|1|||
30724431|NCT00469092|58737605|FG001|Overall Study|Use of Corticosteroid|0|||
30724432|NCT00499616|58737615|FG000|Overall Study|Death|1|||
30724433|NCT00499616|58737616|FG001|Overall Study|Death|5|||
30724434|NCT00499616|58737617|FG002|Overall Study|Death|3|||
30724435|NCT00499616|58737618|FG003|Overall Study|Death|1|||
30724436|NCT00499616|58737615|FG000|Overall Study|Lack of Efficacy|5|||
30724437|NCT00499616|58737616|FG001|Overall Study|Lack of Efficacy|0|||
30724438|NCT00499616|58737617|FG002|Overall Study|Lack of Efficacy|19|||
30724439|NCT00499616|58737618|FG003|Overall Study|Lack of Efficacy|0|||
30724440|NCT00499616|58737615|FG000|Overall Study|Lost to Follow-up|0|||
30724441|NCT00499616|58737616|FG001|Overall Study|Lost to Follow-up|0|||
30724442|NCT00499616|58737617|FG002|Overall Study|Lost to Follow-up|1|||
30724443|NCT00499616|58737618|FG003|Overall Study|Lost to Follow-up|0|||
30724444|NCT00499616|58737615|FG000|Overall Study|Physician Decision|6|||
30724445|NCT00499616|58737616|FG001|Overall Study|Physician Decision|16|||
30724446|NCT00499616|58737617|FG002|Overall Study|Physician Decision|9|||
30724447|NCT00499616|58737618|FG003|Overall Study|Physician Decision|0|||
30724448|NCT00499616|58737615|FG000|Overall Study|Withdrawal by Subject|1|||
30724449|NCT00499616|58737616|FG001|Overall Study|Withdrawal by Subject|0|||
30724450|NCT00499616|58737617|FG002|Overall Study|Withdrawal by Subject|1|||
30724451|NCT00499616|58737618|FG003|Overall Study|Withdrawal by Subject|0|||
30724452|NCT00499616|58737615|FG000|Overall Study|Ineligible|1|||
30724453|NCT00499616|58737616|FG001|Overall Study|Ineligible|2|||
30724454|NCT00499616|58737617|FG002|Overall Study|Ineligible|0|||
30724455|NCT00499616|58737618|FG003|Overall Study|Ineligible|15|||
30724456|NCT00499616|58737615|FG000|Overall Study|Not evaluable|0|||
30724457|NCT00499616|58737616|FG001|Overall Study|Not evaluable|0|||
30724458|NCT00499616|58737617|FG002|Overall Study|Not evaluable|0|||
30724459|NCT00499616|58737618|FG003|Overall Study|Not evaluable|41|||
30724460|NCT00499616|58737615|FG000|Overall Study|Patient/Parent Refusal|1|||
30724461|NCT00499616|58737616|FG001|Overall Study|Patient/Parent Refusal|5|||
30724462|NCT00499616|58737617|FG002|Overall Study|Patient/Parent Refusal|3|||
30724463|NCT00499616|58737618|FG003|Overall Study|Patient/Parent Refusal|0|||
30724464|NCT00402597|58737636|FG000|Overall Study|Death|15|||
30724465|NCT00402597|58737637|FG001|Overall Study|Death|7|||
30724466|NCT00402597|58737638|FG002|Overall Study|Death|6|||
30724467|NCT00402597|58737639|FG003|Overall Study|Death|4|||
30724468|NCT00402597|58737640|FG004|Overall Study|Death|6|||
30724469|NCT00402597|58737636|FG000|Overall Study|Adverse Event|81|||
30724470|NCT00402597|58737637|FG001|Overall Study|Adverse Event|18|||
30724471|NCT00402597|58737638|FG002|Overall Study|Adverse Event|106|||
30724472|NCT00402597|58737639|FG003|Overall Study|Adverse Event|39|||
30724473|NCT00402597|58737640|FG004|Overall Study|Adverse Event|71|||
30724474|NCT00402597|58737636|FG000|Overall Study|Lost to Follow-up|8|||
30724475|NCT00402597|58737637|FG001|Overall Study|Lost to Follow-up|1|||
30724476|NCT00402597|58737638|FG002|Overall Study|Lost to Follow-up|8|||
30724477|NCT00402597|58737639|FG003|Overall Study|Lost to Follow-up|2|||
30724478|NCT00402597|58737640|FG004|Overall Study|Lost to Follow-up|3|||
30724479|NCT00402597|58737636|FG000|Overall Study|Withdrawal by Subject|57|||
30724480|NCT00402597|58737637|FG001|Overall Study|Withdrawal by Subject|16|||
30724481|NCT00402597|58737638|FG002|Overall Study|Withdrawal by Subject|65|||
30724482|NCT00402597|58737639|FG003|Overall Study|Withdrawal by Subject|15|||
30724483|NCT00402597|58737640|FG004|Overall Study|Withdrawal by Subject|24|||
30724484|NCT00402597|58737636|FG000|Overall Study|reason not specified|30|||
30724485|NCT00402597|58737637|FG001|Overall Study|reason not specified|4|||
30724486|NCT00402597|58737638|FG002|Overall Study|reason not specified|27|||
30724487|NCT00402597|58737639|FG003|Overall Study|reason not specified|14|||
30724488|NCT00402597|58737640|FG004|Overall Study|reason not specified|20|||
30724489|NCT00402363|58737656|FG000|Overall Study|Adverse Event|9|||
30724490|NCT00402363|58737657|FG001|Overall Study|Adverse Event|14|||
30724491|NCT00402363|58737658|FG002|Overall Study|Adverse Event|2|||
30724492|NCT00402363|58737659|FG003|Overall Study|Adverse Event|2|||
30724493|NCT00402363|58737656|FG000|Overall Study|Withdrew Consent|10|||
30724494|NCT00402363|58737657|FG001|Overall Study|Withdrew Consent|5|||
30724495|NCT00402363|58737658|FG002|Overall Study|Withdrew Consent|2|||
30724496|NCT00402363|58737659|FG003|Overall Study|Withdrew Consent|1|||
30724497|NCT00402363|58737656|FG000|Overall Study|Protocol Violation|3|||
30900388|NCT02323334|58933642|FG006|Period 3|Withdrawal by Subject|0|||
30900389|NCT02323334|58933643|FG007|Period 3|Withdrawal by Subject|0|||
30900390|NCT02323334|58933644|FG008|Period 3|Withdrawal by Subject|0|||
30900391|NCT02323334|58933645|FG009|Period 3|Withdrawal by Subject|0|||
30900392|NCT02323334|58933646|FG010|Period 3|Withdrawal by Subject|0|||
30900393|NCT02323334|58933647|FG011|Period 3|Withdrawal by Subject|0|||
30724498|NCT00402363|58737657|FG001|Overall Study|Protocol Violation|5|||
30724499|NCT00402363|58737658|FG002|Overall Study|Protocol Violation|0|||
30724500|NCT00402363|58737659|FG003|Overall Study|Protocol Violation|3|||
30724501|NCT00402363|58737656|FG000|Overall Study|Lost to Follow-up|5|||
30724502|NCT00402363|58737657|FG001|Overall Study|Lost to Follow-up|4|||
30621640|NCT00932698|58633218|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
30724503|NCT00402363|58737658|FG002|Overall Study|Lost to Follow-up|0|||
30724504|NCT00402363|58737659|FG003|Overall Study|Lost to Follow-up|2|||
30724505|NCT00402363|58737656|FG000|Overall Study|"Captured as Other"|6|||
30724506|NCT00402363|58737657|FG001|Overall Study|"Captured as Other"|2|||
30724507|NCT00402363|58737658|FG002|Overall Study|"Captured as Other"|2|||
30724508|NCT00402363|58737659|FG003|Overall Study|"Captured as Other"|2|||
30724509|NCT00469014|58737679|FG000|Initial Phase Randomization|Disease Progression|0|||
30724510|NCT00469014|58737680|FG001|Initial Phase Randomization|Disease Progression|1|||
30724511|NCT00469014|58737681|FG002|Initial Phase Randomization|Disease Progression|1|||
30724512|NCT00469014|58737682|FG003|Initial Phase Randomization|Disease Progression|0|||
30724513|NCT00469014|58737679|FG000|Initial Phase Randomization|No Response|1|||
30724514|NCT00469014|58737680|FG001|Initial Phase Randomization|No Response|0|||
30724515|NCT00469014|58737681|FG002|Initial Phase Randomization|No Response|0|||
30724516|NCT00469014|58737682|FG003|Initial Phase Randomization|No Response|1|||
30724517|NCT00469014|58737679|FG000|Adaptive Randomization|Not Evaluable|1|||
30724518|NCT00469014|58737680|FG001|Adaptive Randomization|Not Evaluable|0|||
30724519|NCT00469014|58737681|FG002|Adaptive Randomization|Not Evaluable|0|||
30724520|NCT00469014|58737682|FG003|Adaptive Randomization|Not Evaluable|1|||
30724521|NCT00469014|58737679|FG000|Adaptive Randomization|No Response|0|||
30724522|NCT00469014|58737680|FG001|Adaptive Randomization|No Response|1|||
30724523|NCT00469014|58737681|FG002|Adaptive Randomization|No Response|0|||
30724524|NCT00469014|58737682|FG003|Adaptive Randomization|No Response|0|||
30724525|NCT00469014|58737679|FG000|Adaptive Randomization|Death|0|||
30724526|NCT00469014|58737680|FG001|Adaptive Randomization|Death|0|||
30724527|NCT00469014|58737681|FG002|Adaptive Randomization|Death|1|||
30724528|NCT00469014|58737682|FG003|Adaptive Randomization|Death|0|||
30724529|NCT00493038|58737694|FG000|Treatment|Adverse Event|8|||
30724530|NCT00493038|58737695|FG001|Treatment|Adverse Event|4|||
30724531|NCT00493038|58737694|FG000|Treatment|Lost to Follow-up|5|||
30724532|NCT00493038|58737695|FG001|Treatment|Lost to Follow-up|3|||
30724533|NCT00493038|58737694|FG000|Treatment|Withdrawal by Subject|11|||
30724534|NCT00493038|58737695|FG001|Treatment|Withdrawal by Subject|12|||
30724535|NCT00493038|58737694|FG000|Treatment|Other|0|||
30724536|NCT00493038|58737695|FG001|Treatment|Other|1|||
30724537|NCT00493038|58737694|FG000|Follow-up|Lost to Follow-up|1|||
30724538|NCT00493038|58737695|FG001|Follow-up|Lost to Follow-up|0|||
30724539|NCT00392223|58737703|FG000|Overall Study|Adverse Event|5|||
30724540|NCT00392223|58737704|FG001|Overall Study|Adverse Event|4|||
30724541|NCT00392223|58737703|FG000|Overall Study|Lost to Follow-up|1|||
30724542|NCT00392223|58737704|FG001|Overall Study|Lost to Follow-up|4|||
30724543|NCT00392223|58737703|FG000|Overall Study|Protocol Violation|0|||
30724544|NCT00392223|58737704|FG001|Overall Study|Protocol Violation|3|||
30724545|NCT00392223|58737703|FG000|Overall Study|Withdrawal by Subject|3|||
30724546|NCT00392223|58737704|FG001|Overall Study|Withdrawal by Subject|2|||
30724547|NCT00402285|58737713|FG000|Overall Study|insufficient RNA quality|7|||
30724548|NCT00402285|58737714|FG001|Overall Study|insufficient RNA quality|6|||
30724549|NCT00402285|58737715|FG002|Overall Study|insufficient RNA quality|2|||
30724550|NCT00413283|58737725|FG000|Overall Study|Withdrawal by Subject|1|||
30724551|NCT00413283|58737726|FG001|Overall Study|Withdrawal by Subject|0|||
30724552|NCT00413283|58737727|FG002|Overall Study|Withdrawal by Subject|0|||
30724553|NCT00413283|58737728|FG003|Overall Study|Withdrawal by Subject|1|||
30724554|NCT00413283|58737725|FG000|Overall Study|Death|0|||
30724555|NCT00413283|58737726|FG001|Overall Study|Death|0|||
30724556|NCT00413283|58737727|FG002|Overall Study|Death|1|||
30724557|NCT00413283|58737728|FG003|Overall Study|Death|1|||
30724558|NCT00413283|58737725|FG000|Overall Study|Adverse Event|0|||
30724559|NCT00413283|58737726|FG001|Overall Study|Adverse Event|0|||
30724560|NCT00413283|58737727|FG002|Overall Study|Adverse Event|0|||
30724561|NCT00413283|58737728|FG003|Overall Study|Adverse Event|1|||
30724562|NCT00413283|58737725|FG000|Overall Study|Ineligibility determined|0|||
30724563|NCT00413283|58737726|FG001|Overall Study|Ineligibility determined|0|||
30724564|NCT00413283|58737727|FG002|Overall Study|Ineligibility determined|0|||
30724565|NCT00413283|58737728|FG003|Overall Study|Ineligibility determined|1|||
30724566|NCT00413283|58737725|FG000|Overall Study|Protocol deviation|0|||
30724567|NCT00413283|58737726|FG001|Overall Study|Protocol deviation|1|||
30724568|NCT00413283|58737727|FG002|Overall Study|Protocol deviation|0|||
30724569|NCT00413283|58737728|FG003|Overall Study|Protocol deviation|0|||
30724570|NCT00413283|58737725|FG000|Overall Study|Requirement for alternative therapy|0|||
30724571|NCT00413283|58737726|FG001|Overall Study|Requirement for alternative therapy|2|||
30724572|NCT00413283|58737727|FG002|Overall Study|Requirement for alternative therapy|0|||
30724573|NCT00413283|58737728|FG003|Overall Study|Requirement for alternative therapy|0|||
30724574|NCT00413283|58737725|FG000|Overall Study|Other|0|||
30724575|NCT00413283|58737726|FG001|Overall Study|Other|0|||
30724576|NCT00413283|58737727|FG002|Overall Study|Other|1|||
30724577|NCT00413283|58737728|FG003|Overall Study|Other|0|||
30724578|NCT00402051|58737740|FG000|Overall Study|Progressive Disease|13|||
30724579|NCT00402051|58737741|FG001|Overall Study|Progressive Disease|20|||
30724580|NCT00402051|58737740|FG000|Overall Study|Adverse Event|11|||
30724581|NCT00402051|58737741|FG001|Overall Study|Adverse Event|4|||
30724582|NCT00402051|58737740|FG000|Overall Study|Physician Decision|7|||
30724583|NCT00402051|58737741|FG001|Overall Study|Physician Decision|3|||
30724584|NCT00402051|58737740|FG000|Overall Study|Withdrawal by Subject|3|||
30724585|NCT00402051|58737741|FG001|Overall Study|Withdrawal by Subject|3|||
30724586|NCT00402051|58737740|FG000|Overall Study|Death - Related to Study Drug|1|||
30724587|NCT00402051|58737741|FG001|Overall Study|Death - Related to Study Drug|2|||
30900394|NCT02323334|58933648|FG012|Period 3|Withdrawal by Subject|0|||
30724588|NCT00402051|58737740|FG000|Overall Study|Death Due to Study Disease|2|||
30724589|NCT00402051|58737741|FG001|Overall Study|Death Due to Study Disease|1|||
30724590|NCT00402051|58737740|FG000|Overall Study|Death Due to Adverse Event|0|||
30724591|NCT00402051|58737741|FG001|Overall Study|Death Due to Adverse Event|2|||
30724592|NCT00402051|58737740|FG000|Overall Study|Lost to Follow-up|1|||
30724593|NCT00402051|58737741|FG001|Overall Study|Lost to Follow-up|0|||
30724594|NCT00468858|58737750|FG000|Overall Study|Adverse Event|0|||
30724595|NCT00468858|58737751|FG001|Overall Study|Adverse Event|1|||
30724596|NCT00468858|58737752|FG002|Overall Study|Adverse Event|0|||
30724597|NCT00468858|58737750|FG000|Overall Study|Withdrawal by Subject|7|||
30724598|NCT00468858|58737751|FG001|Overall Study|Withdrawal by Subject|4|||
30724599|NCT00468858|58737752|FG002|Overall Study|Withdrawal by Subject|5|||
30724600|NCT00468858|58737750|FG000|Overall Study|Relocation|1|||
30724601|NCT00468858|58737751|FG001|Overall Study|Relocation|3|||
30724602|NCT00468858|58737752|FG002|Overall Study|Relocation|3|||
30724603|NCT00468858|58737750|FG000|Overall Study|Lost to Follow-up|1|||
30724604|NCT00468858|58737751|FG001|Overall Study|Lost to Follow-up|2|||
30724605|NCT00468858|58737752|FG002|Overall Study|Lost to Follow-up|5|||
30724606|NCT00468858|58737750|FG000|Overall Study|Other|0|||
30724607|NCT00468858|58737751|FG001|Overall Study|Other|0|||
30724608|NCT00468858|58737752|FG002|Overall Study|Other|1|||
30724609|NCT00401973|58737817|FG000|Overall Study|Adverse Event|2|||
30724610|NCT00401973|58737818|FG001|Overall Study|Adverse Event|8|||
30724611|NCT00401973|58737819|FG002|Overall Study|Adverse Event|4|||
30724612|NCT00401973|58737817|FG000|Overall Study|Clinical Relapse|0|||
30724613|NCT00401973|58737818|FG001|Overall Study|Clinical Relapse|1|||
30724614|NCT00401973|58737819|FG002|Overall Study|Clinical Relapse|1|||
30724615|NCT00401973|58737817|FG000|Overall Study|Lack of Efficacy|0|||
30724616|NCT00401973|58737818|FG001|Overall Study|Lack of Efficacy|0|||
30724617|NCT00401973|58737819|FG002|Overall Study|Lack of Efficacy|3|||
30724618|NCT00401973|58737817|FG000|Overall Study|Lost to Follow-up|2|||
30724619|NCT00401973|58737818|FG001|Overall Study|Lost to Follow-up|2|||
30724620|NCT00401973|58737819|FG002|Overall Study|Lost to Follow-up|2|||
30724621|NCT00401973|58737817|FG000|Overall Study|Physician Decision|2|||
30724622|NCT00401973|58737818|FG001|Overall Study|Physician Decision|0|||
30724623|NCT00401973|58737819|FG002|Overall Study|Physician Decision|1|||
30724624|NCT00401973|58737817|FG000|Overall Study|Protocol Violation|1|||
30724625|NCT00401973|58737818|FG001|Overall Study|Protocol Violation|2|||
30724626|NCT00401973|58737819|FG002|Overall Study|Protocol Violation|3|||
30724627|NCT00401973|58737817|FG000|Overall Study|Sponsor Decision|0|||
30724628|NCT00401973|58737818|FG001|Overall Study|Sponsor Decision|1|||
30724629|NCT00401973|58737819|FG002|Overall Study|Sponsor Decision|0|||
30724630|NCT00401973|58737817|FG000|Overall Study|Withdrawal by Subject|4|||
30724631|NCT00401973|58737818|FG001|Overall Study|Withdrawal by Subject|12|||
30724632|NCT00401973|58737819|FG002|Overall Study|Withdrawal by Subject|9|||
30724633|NCT00401193|58737832|FG000|Overall Study|Adverse Event|1|||
30724634|NCT00401193|58737833|FG001|Overall Study|Adverse Event|3|||
30900395|NCT02323334|58933649|FG013|Period 3|Withdrawal by Subject|0|||
30724635|NCT00401193|58737834|FG002|Overall Study|Adverse Event|1|||
30724636|NCT00401193|58737832|FG000|Overall Study|Protocol Violation|3|||
30724637|NCT00401193|58737833|FG001|Overall Study|Protocol Violation|1|||
30724638|NCT00401193|58737834|FG002|Overall Study|Protocol Violation|1|||
30724639|NCT00401193|58737832|FG000|Overall Study|Lost to Follow-up|6|||
30724640|NCT00401193|58737833|FG001|Overall Study|Lost to Follow-up|5|||
30724641|NCT00401193|58737834|FG002|Overall Study|Lost to Follow-up|1|||
30724642|NCT00401193|58737832|FG000|Overall Study|Withdrawal by Subject|2|||
30724643|NCT00401193|58737833|FG001|Overall Study|Withdrawal by Subject|0|||
30724644|NCT00401193|58737834|FG002|Overall Study|Withdrawal by Subject|1|||
30724645|NCT00401193|58737832|FG000|Overall Study|Other Event|3|||
30724646|NCT00401193|58737833|FG001|Overall Study|Other Event|2|||
30724647|NCT00401193|58737834|FG002|Overall Study|Other Event|2|||
30724648|NCT00400569|58737843|FG000|Overall Study|Death|1|||
30724649|NCT00413049|58737852|FG000|Overall Study|Adverse Event|10|||
30724650|NCT00413049|58737853|FG001|Overall Study|Adverse Event|8|||
30724651|NCT00413049|58737852|FG000|Overall Study|Withdrawal by Subject|7|||
30724652|NCT00413049|58737853|FG001|Overall Study|Withdrawal by Subject|5|||
30724653|NCT00413049|58737852|FG000|Overall Study|Lost to Follow-up|2|||
30724654|NCT00413049|58737853|FG001|Overall Study|Lost to Follow-up|3|||
30724655|NCT00413049|58737852|FG000|Overall Study|Protocol Violation|3|||
30724656|NCT00413049|58737853|FG001|Overall Study|Protocol Violation|1|||
30724657|NCT00413049|58737852|FG000|Overall Study|Subject no longer requires study drug|0|||
30724658|NCT00413049|58737853|FG001|Overall Study|Subject no longer requires study drug|1|||
30724659|NCT00413049|58737852|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30724660|NCT00413049|58737853|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30724661|NCT00413049|58737852|FG000|Overall Study|Lack of Efficacy|1|||
30724662|NCT00413049|58737853|FG001|Overall Study|Lack of Efficacy|0|||
30724663|NCT00454194|58737861|FG000|Overall Study|Adverse Event|7|||
30724664|NCT00454194|58737862|FG001|Overall Study|Adverse Event|2|||
30724665|NCT00454194|58737861|FG000|Overall Study|Withdrawal by Subject|12|||
30724666|NCT00454194|58737862|FG001|Overall Study|Withdrawal by Subject|8|||
30724667|NCT00454194|58737861|FG000|Overall Study|Other Medical Problems|1|||
30724668|NCT00454194|58737862|FG001|Overall Study|Other Medical Problems|2|||
30724669|NCT00454194|58737861|FG000|Overall Study|Other Unspecified Reason|2|||
30724670|NCT00454194|58737862|FG001|Overall Study|Other Unspecified Reason|2|||
30724671|NCT00412971|58737870|FG000|Overall Study|Lost to Follow-up|17|||
30724672|NCT00412971|58737871|FG001|Overall Study|Lost to Follow-up|9|||
30724673|NCT00412971|58737870|FG000|Overall Study|Protocol Violation|13|||
30724674|NCT00412971|58737871|FG001|Overall Study|Protocol Violation|1|||
30724675|NCT00303472|58737884|FG000|Treatment Period|Adverse Event|0|||
30621641|NCT00932698|58633219|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
30724676|NCT00303472|58737885|FG001|Treatment Period|Adverse Event|0|||
30724677|NCT00303472|58737886|FG002|Treatment Period|Adverse Event|0|||
30724678|NCT00303472|58737887|FG003|Treatment Period|Adverse Event|0|||
30724679|NCT00303472|58737888|FG004|Treatment Period|Adverse Event|1|||
30724680|NCT00303472|58737889|FG005|Treatment Period|Adverse Event|0|||
30724681|NCT00303472|58737890|FG006|Treatment Period|Adverse Event|0|||
30724682|NCT00303472|58737884|FG000|Treatment Period|Death|0|||
30724683|NCT00303472|58737885|FG001|Treatment Period|Death|0|||
30724684|NCT00303472|58737886|FG002|Treatment Period|Death|0|||
30724685|NCT00303472|58737887|FG003|Treatment Period|Death|1|||
30724686|NCT00303472|58737888|FG004|Treatment Period|Death|0|||
30724687|NCT00303472|58737889|FG005|Treatment Period|Death|0|||
30724688|NCT00303472|58737890|FG006|Treatment Period|Death|1|||
30724689|NCT00303472|58737884|FG000|Treatment Period|Withdrawal by Subject|0|||
30724690|NCT00303472|58737885|FG001|Treatment Period|Withdrawal by Subject|0|||
30724691|NCT00303472|58737886|FG002|Treatment Period|Withdrawal by Subject|0|||
30724692|NCT00303472|58737887|FG003|Treatment Period|Withdrawal by Subject|1|||
30724693|NCT00303472|58737888|FG004|Treatment Period|Withdrawal by Subject|0|||
30724694|NCT00303472|58737889|FG005|Treatment Period|Withdrawal by Subject|1|||
30724695|NCT00303472|58737890|FG006|Treatment Period|Withdrawal by Subject|0|||
30724696|NCT00303472|58737884|FG000|Treatment Period|Other|0|||
30724697|NCT00303472|58737885|FG001|Treatment Period|Other|0|||
30724698|NCT00303472|58737886|FG002|Treatment Period|Other|0|||
30724699|NCT00303472|58737887|FG003|Treatment Period|Other|0|||
30724700|NCT00303472|58737888|FG004|Treatment Period|Other|1|||
30724701|NCT00303472|58737889|FG005|Treatment Period|Other|0|||
30724702|NCT00303472|58737890|FG006|Treatment Period|Other|1|||
30724703|NCT00303472|58737884|FG000|Treatment Period|Disease Progression (to AML)|0|||
30724704|NCT00303472|58737885|FG001|Treatment Period|Disease Progression (to AML)|0|||
30724705|NCT00303472|58737886|FG002|Treatment Period|Disease Progression (to AML)|0|||
30724706|NCT00303472|58737887|FG003|Treatment Period|Disease Progression (to AML)|0|||
30724707|NCT00303472|58737888|FG004|Treatment Period|Disease Progression (to AML)|1|||
30724708|NCT00303472|58737889|FG005|Treatment Period|Disease Progression (to AML)|0|||
30724709|NCT00303472|58737890|FG006|Treatment Period|Disease Progression (to AML)|0|||
30724710|NCT00303472|58737884|FG000|Treatment Extension (Optional)|Adverse Event|1|||
30724711|NCT00303472|58737885|FG001|Treatment Extension (Optional)|Adverse Event|0|||
30724712|NCT00303472|58737886|FG002|Treatment Extension (Optional)|Adverse Event|1|||
30724713|NCT00303472|58737887|FG003|Treatment Extension (Optional)|Adverse Event|0|||
30724714|NCT00303472|58737888|FG004|Treatment Extension (Optional)|Adverse Event|0|||
30724715|NCT00303472|58737889|FG005|Treatment Extension (Optional)|Adverse Event|0|||
30724716|NCT00303472|58737890|FG006|Treatment Extension (Optional)|Adverse Event|0|||
30724717|NCT00303472|58737884|FG000|Treatment Extension (Optional)|Death|2|||
30724718|NCT00303472|58737885|FG001|Treatment Extension (Optional)|Death|0|||
30724719|NCT00303472|58737886|FG002|Treatment Extension (Optional)|Death|1|||
30724720|NCT00303472|58737887|FG003|Treatment Extension (Optional)|Death|0|||
30724721|NCT00303472|58737888|FG004|Treatment Extension (Optional)|Death|0|||
30724722|NCT00303472|58737889|FG005|Treatment Extension (Optional)|Death|0|||
30724723|NCT00303472|58737890|FG006|Treatment Extension (Optional)|Death|0|||
30724724|NCT00303472|58737884|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
30724725|NCT00303472|58737885|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
30724726|NCT00303472|58737886|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
30724727|NCT00303472|58737887|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
30724728|NCT00303472|58737888|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
30724729|NCT00303472|58737889|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
30724730|NCT00303472|58737890|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
30724731|NCT00303472|58737884|FG000|Treatment Extension (Optional)|Physician Decision|0|||
30724732|NCT00303472|58737885|FG001|Treatment Extension (Optional)|Physician Decision|4|||
30724733|NCT00303472|58737886|FG002|Treatment Extension (Optional)|Physician Decision|2|||
30724734|NCT00303472|58737887|FG003|Treatment Extension (Optional)|Physician Decision|3|||
30724735|NCT00303472|58737888|FG004|Treatment Extension (Optional)|Physician Decision|2|||
30724736|NCT00303472|58737889|FG005|Treatment Extension (Optional)|Physician Decision|0|||
30724737|NCT00303472|58737890|FG006|Treatment Extension (Optional)|Physician Decision|0|||
30724738|NCT00303472|58737884|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
30724739|NCT00303472|58737885|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
30724740|NCT00303472|58737886|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
30724741|NCT00303472|58737887|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
30724742|NCT00303472|58737888|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
30621642|NCT00932698|58633209|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
30621643|NCT00932698|58633210|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
30724743|NCT00303472|58737889|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
30724744|NCT00303472|58737890|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
30724745|NCT00303472|58737884|FG000|Treatment Extension (Optional)|Other|0|||
30724746|NCT00303472|58737885|FG001|Treatment Extension (Optional)|Other|2|||
30724747|NCT00303472|58737886|FG002|Treatment Extension (Optional)|Other|4|||
30724748|NCT00303472|58737887|FG003|Treatment Extension (Optional)|Other|2|||
30724749|NCT00303472|58737888|FG004|Treatment Extension (Optional)|Other|1|||
30724750|NCT00303472|58737889|FG005|Treatment Extension (Optional)|Other|0|||
30724751|NCT00303472|58737890|FG006|Treatment Extension (Optional)|Other|0|||
30724752|NCT00303472|58737884|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
30724753|NCT00303472|58737885|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
30724754|NCT00303472|58737886|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
30724755|NCT00303472|58737887|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
30724756|NCT00303472|58737888|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
30724757|NCT00303472|58737889|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
30724758|NCT00303472|58737890|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
30724759|NCT00468546|58737908|FG000|Week 24 Analysis|Lack of Efficacy|83|||
30724760|NCT00468546|58737909|FG001|Week 24 Analysis|Lack of Efficacy|37|||
30724761|NCT00468546|58737908|FG000|Week 24 Analysis|Refused treatment|5|||
30724762|NCT00468546|58737909|FG001|Week 24 Analysis|Refused treatment|5|||
30724763|NCT00468546|58737908|FG000|Week 24 Analysis|Adverse Event|1|||
30724764|NCT00468546|58737909|FG001|Week 24 Analysis|Adverse Event|8|||
30724765|NCT00468546|58737908|FG000|Week 24 Analysis|Failure to return|3|||
30724766|NCT00468546|58737909|FG001|Week 24 Analysis|Failure to return|4|||
30724767|NCT00468546|58737908|FG000|Week 24 Analysis|Rescue therapy|2|||
30724768|NCT00468546|58737909|FG001|Week 24 Analysis|Rescue therapy|0|||
30724769|NCT00468546|58737908|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
30724770|NCT00468546|58737909|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
30724771|NCT00468546|58737908|FG000|Week 24 Analysis|Due to clinical hold|1|||
30724772|NCT00468546|58737909|FG001|Week 24 Analysis|Due to clinical hold|0|||
30724773|NCT00468546|58737908|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
30724774|NCT00468546|58737909|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
30724775|NCT00468546|58737908|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
30724776|NCT00468546|58737909|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
30724777|NCT00468546|58737908|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
30724778|NCT00468546|58737909|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
30724779|NCT00468546|58737908|FG000|Week 24 to Week 104 Analysis|Death|1|||
30724780|NCT00468546|58737909|FG001|Week 24 to Week 104 Analysis|Death|0|||
30724781|NCT00468546|58737908|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
30724782|NCT00468546|58737909|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
30724783|NCT00468546|58737908|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
30724784|NCT00468546|58737909|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
30724785|NCT00468546|58737908|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
30724786|NCT00468546|58737909|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
30724787|NCT00468546|58737908|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
30724788|NCT00468546|58737909|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
30900396|NCT02323334|58933650|FG014|Period 3|Withdrawal by Subject|0|||
30900397|NCT02323334|58933651|FG015|Period 3|Withdrawal by Subject|0|||
30900398|NCT02323334|58933652|FG016|Period 3|Withdrawal by Subject|0|||
30900399|NCT02448719|58933725|FG000|Overall Study|Withdrawal by Subject|0|||
30900400|NCT02448719|58933726|FG001|Overall Study|Withdrawal by Subject|0|||
30900401|NCT02448719|58933727|FG002|Overall Study|Withdrawal by Subject|0|||
30724789|NCT00468546|58737908|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
30724790|NCT00468546|58737909|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
30724791|NCT00468546|58737908|FG000|Week 24 to Week 104 Analysis|Other|17|||
30724792|NCT00468546|58737909|FG001|Week 24 to Week 104 Analysis|Other|14|||
30724793|NCT00303316|58737917|FG000|Overall Study|Protocol Violation|1|||
30724794|NCT00303316|58737918|FG001|Overall Study|Protocol Violation|0|||
30724795|NCT00303316|58737917|FG000|Overall Study|Lost to Follow-up|0|||
30724796|NCT00303316|58737918|FG001|Overall Study|Lost to Follow-up|1|||
30724797|NCT00303316|58737917|FG000|Overall Study|Withdrawal by Subject|1|||
30724798|NCT00303316|58737918|FG001|Overall Study|Withdrawal by Subject|2|||
30724799|NCT00468312|58737926|FG000|Overall Study|Adverse Event|2|||
30724800|NCT00468312|58737927|FG001|Overall Study|Adverse Event|1|||
30724801|NCT00468312|58737926|FG000|Overall Study|Lack of Efficacy|0|||
30724802|NCT00468312|58737927|FG001|Overall Study|Lack of Efficacy|1|||
30724803|NCT00468312|58737926|FG000|Overall Study|Withdrawal by Subject|0|||
30724804|NCT00468312|58737927|FG001|Overall Study|Withdrawal by Subject|1|||
30724805|NCT00468312|58737926|FG000|Overall Study|Protocol Violation|2|||
30724806|NCT00468312|58737927|FG001|Overall Study|Protocol Violation|1|||
30900402|NCT02448719|58933728|FG003|Overall Study|Withdrawal by Subject|0|||
30724807|NCT00468312|58737926|FG000|Overall Study|Did not meet protocol eligibility|0|||
30724808|NCT00468312|58737927|FG001|Overall Study|Did not meet protocol eligibility|1|||
30724809|NCT00331864|58737935|FG000|Overall Study|Adverse Event|30|||
30724810|NCT00331864|58737936|FG001|Overall Study|Adverse Event|1|||
30724811|NCT00331864|58737935|FG000|Overall Study|Lack of Efficacy|4|||
30724812|NCT00331864|58737936|FG001|Overall Study|Lack of Efficacy|0|||
30724813|NCT00331864|58737935|FG000|Overall Study|Protocol Violation|3|||
30724814|NCT00331864|58737936|FG001|Overall Study|Protocol Violation|0|||
30724815|NCT00331864|58737935|FG000|Overall Study|Withdrawal by Subject|10|||
30724816|NCT00331864|58737936|FG001|Overall Study|Withdrawal by Subject|0|||
30724817|NCT00331864|58737935|FG000|Overall Study|Lost to Follow-up|4|||
30724818|NCT00331864|58737936|FG001|Overall Study|Lost to Follow-up|3|||
30724819|NCT00331864|58737935|FG000|Overall Study|Administrative Problems|1|||
30724820|NCT00331864|58737936|FG001|Overall Study|Administrative Problems|0|||
30724821|NCT00331864|58737935|FG000|Overall Study|Death|6|||
30724822|NCT00331864|58737936|FG001|Overall Study|Death|0|||
30724823|NCT00331630|58737942|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
30724824|NCT00331630|58737942|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
30724825|NCT00331630|58737942|FG000|Follow up for 5 Years|Death|5|||
30724826|NCT00331630|58737942|FG000|Follow up for 5 Years|Data collection was stopped|24|||
30724827|NCT00331552|58737948|FG000|Period 3: Phase II|Neurological Symptoms|1|||
30724828|NCT00331552|58737949|FG001|Period 3: Phase II|Neurological Symptoms|0|||
30724829|NCT00331552|58737948|FG000|Period 3: Phase II|Severe Nausea|1|||
30724830|NCT00331552|58737949|FG001|Period 3: Phase II|Severe Nausea|0|||
30724831|NCT00317356|58737964|FG000|Overall Study|Adverse Event|0|||
30724832|NCT00317356|58737965|FG001|Overall Study|Adverse Event|0|||
30724833|NCT00317356|58737966|FG002|Overall Study|Adverse Event|1|||
30724834|NCT00317356|58737967|FG003|Overall Study|Adverse Event|0|||
30724835|NCT00317356|58737964|FG000|Overall Study|Lack of Efficacy|1|||
30724836|NCT00317356|58737965|FG001|Overall Study|Lack of Efficacy|1|||
30724837|NCT00317356|58737966|FG002|Overall Study|Lack of Efficacy|0|||
30724838|NCT00317356|58737967|FG003|Overall Study|Lack of Efficacy|3|||
30724839|NCT00317356|58737964|FG000|Overall Study|Physician Decision|0|||
30724840|NCT00317356|58737965|FG001|Overall Study|Physician Decision|1|||
30724841|NCT00317356|58737966|FG002|Overall Study|Physician Decision|0|||
30724842|NCT00317356|58737967|FG003|Overall Study|Physician Decision|0|||
30724843|NCT00331006|58737977|FG000|Screening Phase|Withdrawal by Subject|1|||
30724844|NCT00331006|58737977|FG000|Screening Phase|enrollment halted|1|||
30724845|NCT00331006|58737977|FG000|Screening Phase|Lost to Follow-up|1|||
30724846|NCT00331006|58737977|FG000|Screening Phase|Ineligible for treatment phase|4|||
30724847|NCT00331006|58737977|FG000|Treatment Phase|Withdrawal by Subject|1|||
30724848|NCT00331006|58737977|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
30724849|NCT00331006|58737977|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
30724850|NCT00302458|58737981|FG000|Overall Study|Lost to Follow-up|1|||
30724851|NCT00302458|58737981|FG000|Overall Study|Ineligible after screening|1|||
30724852|NCT00302458|58737981|FG000|Overall Study|Withdrawal by Subject|1|||
30724853|NCT00391053|58737993|FG000|Overall Study|Serious Adverse Events|1|||
30724854|NCT00391053|58737994|FG001|Overall Study|Serious Adverse Events|0|||
30724855|NCT00391053|58737995|FG002|Overall Study|Serious Adverse Events|1|||
30724856|NCT00391053|58737996|FG003|Overall Study|Serious Adverse Events|4|||
30724857|NCT00391053|58737993|FG000|Overall Study|Protocol Violation|2|||
30724858|NCT00391053|58737994|FG001|Overall Study|Protocol Violation|0|||
30724859|NCT00391053|58737995|FG002|Overall Study|Protocol Violation|0|||
30724860|NCT00391053|58737996|FG003|Overall Study|Protocol Violation|0|||
30724861|NCT00391053|58737993|FG000|Overall Study|Lost to Follow-up|1|||
30724862|NCT00391053|58737994|FG001|Overall Study|Lost to Follow-up|0|||
30724863|NCT00391053|58737995|FG002|Overall Study|Lost to Follow-up|0|||
30724864|NCT00391053|58737996|FG003|Overall Study|Lost to Follow-up|5|||
30724865|NCT00391053|58737993|FG000|Overall Study|Withdrawal by Subject|5|||
30724866|NCT00391053|58737994|FG001|Overall Study|Withdrawal by Subject|1|||
30724867|NCT00391053|58737995|FG002|Overall Study|Withdrawal by Subject|1|||
30724868|NCT00391053|58737996|FG003|Overall Study|Withdrawal by Subject|1|||
30724869|NCT00317044|58738009|FG000|Overall Study|Protocol Violation|28|||
30724870|NCT00317044|58738010|FG001|Overall Study|Protocol Violation|22|||
30724871|NCT00317044|58738011|FG002|Overall Study|Protocol Violation|20|||
30724872|NCT00317044|58738009|FG000|Overall Study|Adverse Event|4|||
30724873|NCT00317044|58738010|FG001|Overall Study|Adverse Event|7|||
30724874|NCT00317044|58738011|FG002|Overall Study|Adverse Event|4|||
30724875|NCT00317044|58738009|FG000|Overall Study|Withdrawal by Subject|10|||
30724876|NCT00317044|58738010|FG001|Overall Study|Withdrawal by Subject|7|||
30724877|NCT00317044|58738011|FG002|Overall Study|Withdrawal by Subject|12|||
30724878|NCT00317044|58738009|FG000|Overall Study|Lost to Follow-up|0|||
30724879|NCT00317044|58738010|FG001|Overall Study|Lost to Follow-up|2|||
30724880|NCT00317044|58738011|FG002|Overall Study|Lost to Follow-up|3|||
30724881|NCT00317044|58738009|FG000|Overall Study|Multiple Reasons|6|||
30724882|NCT00317044|58738010|FG001|Overall Study|Multiple Reasons|2|||
30724883|NCT00317044|58738011|FG002|Overall Study|Multiple Reasons|6|||
30724884|NCT00301834|58738019|FG000|Overall Study|Death|1|||
30724885|NCT00301366|58738026|FG000|Overall Study|Adverse Event|1|||
30724886|NCT00330928|58738030|FG000|Overall Study|Lost to Follow-up|6|||
30724887|NCT00330928|58738030|FG000|Overall Study|Physician Decision|9|||
30724888|NCT00330928|58738030|FG000|Overall Study|Death|1|||
30724889|NCT00330928|58738030|FG000|Overall Study|IVUS could not be performed.|1|||
30724890|NCT00330616|58738034|FG000|Overall Study|Adverse Event|13|||
30724891|NCT00330616|58738034|FG000|Overall Study|Lack of Efficacy|1|||
30724892|NCT00330616|58738034|FG000|Overall Study|Lost to Follow-up|2|||
30724893|NCT00330616|58738034|FG000|Overall Study|Withdrawal by Subject|4|||
30724894|NCT00330616|58738034|FG000|Overall Study|Other|1|||
30724895|NCT00466440|58738041|FG000|Overall Study|Adverse Event|0|||
30724896|NCT00466440|58738042|FG001|Overall Study|Adverse Event|3|||
30724897|NCT00466440|58738043|FG002|Overall Study|Adverse Event|1|||
30724898|NCT00466440|58738041|FG000|Overall Study|Death|1|||
30724899|NCT00466440|58738042|FG001|Overall Study|Death|1|||
30724900|NCT00466440|58738043|FG002|Overall Study|Death|0|||
30724901|NCT00466440|58738041|FG000|Overall Study|Progressive disease|13|||
30724902|NCT00466440|58738042|FG001|Overall Study|Progressive disease|5|||
30724903|NCT00466440|58738043|FG002|Overall Study|Progressive disease|4|||
30724904|NCT00466440|58738041|FG000|Overall Study|Lost to Follow-up|0|||
30724905|NCT00466440|58738042|FG001|Overall Study|Lost to Follow-up|1|||
30724906|NCT00466440|58738043|FG002|Overall Study|Lost to Follow-up|0|||
30724907|NCT00466440|58738041|FG000|Overall Study|Physician Decision|0|||
30724908|NCT00466440|58738042|FG001|Overall Study|Physician Decision|1|||
30724909|NCT00466440|58738043|FG002|Overall Study|Physician Decision|2|||
30724910|NCT00466440|58738041|FG000|Overall Study|Protocol entry criteria not met|0|||
30724911|NCT00466440|58738042|FG001|Overall Study|Protocol entry criteria not met|0|||
30724912|NCT00466440|58738043|FG002|Overall Study|Protocol entry criteria not met|4|||
30724913|NCT00466440|58738041|FG000|Overall Study|Withdrawal by Subject|0|||
30724914|NCT00466440|58738042|FG001|Overall Study|Withdrawal by Subject|1|||
30724915|NCT00466440|58738043|FG002|Overall Study|Withdrawal by Subject|0|||
30724916|NCT00466440|58738041|FG000|Overall Study|Sponsor decision|0|||
30724917|NCT00466440|58738042|FG001|Overall Study|Sponsor decision|0|||
30724918|NCT00466440|58738043|FG002|Overall Study|Sponsor decision|1|||
30724919|NCT00465972|58738062|FG000|Overall Study|Withdrawal by Subject|2|||
30724920|NCT00465972|58738063|FG001|Overall Study|Withdrawal by Subject|1|||
30724921|NCT00465894|58738073|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
30724922|NCT00465894|58738074|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
30724923|NCT00465894|58738073|FG000|Treatment For 12 Weeks|Family Issues|1|||
30724924|NCT00465894|58738074|FG001|Treatment For 12 Weeks|Family Issues|1|||
30724925|NCT00465894|58738073|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
30724926|NCT00465894|58738074|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
30724927|NCT00330460|58738098|FG000|Overall Study|Physician Decision|1|||
30724928|NCT00330460|58738099|FG001|Overall Study|Physician Decision|0|||
30724929|NCT00330460|58738098|FG000|Overall Study|Adverse Event|10|||
30724930|NCT00330460|58738099|FG001|Overall Study|Adverse Event|8|||
30724931|NCT00330460|58738098|FG000|Overall Study|Withdrawal by Subject|18|||
30724932|NCT00330460|58738099|FG001|Overall Study|Withdrawal by Subject|17|||
30724933|NCT00330460|58738098|FG000|Overall Study|Death|1|||
30724934|NCT00330460|58738099|FG001|Overall Study|Death|1|||
30724935|NCT00330460|58738098|FG000|Overall Study|Ineligibility determined|1|||
30724936|NCT00330460|58738099|FG001|Overall Study|Ineligibility determined|3|||
30724937|NCT00330460|58738098|FG000|Overall Study|Lost to Follow-up|8|||
30724938|NCT00330460|58738099|FG001|Overall Study|Lost to Follow-up|3|||
30724939|NCT00330460|58738098|FG000|Overall Study|Noncompliance|2|||
30724940|NCT00330460|58738099|FG001|Overall Study|Noncompliance|1|||
30724941|NCT00330460|58738098|FG000|Overall Study|Other|1|||
30724942|NCT00330460|58738099|FG001|Overall Study|Other|0|||
30724943|NCT00454116|58738108|FG000|Overall Study|Adverse Event|5|||
30724944|NCT00454116|58738109|FG001|Overall Study|Adverse Event|11|||
30724945|NCT00454116|58738110|FG002|Overall Study|Adverse Event|9|||
30724946|NCT00454116|58738108|FG000|Overall Study|Condition under investigation worsened|17|||
30724947|NCT00454116|58738109|FG001|Overall Study|Condition under investigation worsened|13|||
30724948|NCT00454116|58738110|FG002|Overall Study|Condition under investigation worsened|18|||
30724949|NCT00454116|58738108|FG000|Overall Study|Withdrawal by Subject|3|||
30724950|NCT00454116|58738109|FG001|Overall Study|Withdrawal by Subject|3|||
30724951|NCT00454116|58738110|FG002|Overall Study|Withdrawal by Subject|1|||
30724952|NCT00454116|58738108|FG000|Overall Study|Other|2|||
30724953|NCT00454116|58738109|FG001|Overall Study|Other|2|||
30724954|NCT00454116|58738110|FG002|Overall Study|Other|0|||
30790942|NCT03200366|58804015|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
30724955|NCT00465816|58738121|FG000|Overall Study|Lost to Follow-up|0|||
30724956|NCT00465816|58738122|FG001|Overall Study|Lost to Follow-up|0|||
30724957|NCT00465816|58738123|FG002|Overall Study|Lost to Follow-up|2|||
30724958|NCT00465738|58738134|FG000|Overall Study|Lost to Follow-up|2|||
30724959|NCT00465738|58738135|FG001|Overall Study|Lost to Follow-up|0|||
30724960|NCT00465738|58738134|FG000|Overall Study|Adverse Event|0|||
30724961|NCT00465738|58738135|FG001|Overall Study|Adverse Event|1|||
30724962|NCT00465738|58738134|FG000|Overall Study|Withdrawal by Subject|2|||
30724963|NCT00465738|58738135|FG001|Overall Study|Withdrawal by Subject|0|||
30724964|NCT00465738|58738134|FG000|Overall Study|Other|2|||
30724965|NCT00465738|58738135|FG001|Overall Study|Other|5|||
30724966|NCT00400179|58738143|FG000|Overall Study|Adverse Event|2|||
30724967|NCT00400179|58738144|FG001|Overall Study|Adverse Event|2|||
30724968|NCT00400179|58738143|FG000|Overall Study|Death|1|||
30724969|NCT00400179|58738144|FG001|Overall Study|Death|2|||
30724970|NCT00400179|58738143|FG000|Overall Study|Withdrew Consent|1|||
30724971|NCT00400179|58738144|FG001|Overall Study|Withdrew Consent|5|||
30724972|NCT00400179|58738143|FG000|Overall Study|Disease progression|1|||
30724973|NCT00400179|58738144|FG001|Overall Study|Disease progression|1|||
30724974|NCT00400179|58738143|FG000|Overall Study|Intercurrent illness|0|||
30724975|NCT00400179|58738144|FG001|Overall Study|Intercurrent illness|1|||
30724976|NCT00400179|58738143|FG000|Overall Study|Investigator judgment|0|||
30724977|NCT00400179|58738144|FG001|Overall Study|Investigator judgment|1|||
30724978|NCT00400179|58738143|FG000|Overall Study|Randomization error/patient ineligible|1|||
30724979|NCT00400179|58738144|FG001|Overall Study|Randomization error/patient ineligible|6|||
30724980|NCT00465270|58738152|FG000|Overall Study|Death|7|||
30724981|NCT00465270|58738153|FG001|Overall Study|Death|11|||
30724982|NCT00465270|58738152|FG000|Overall Study|Withdrawal by Subject|34|||
30724983|NCT00465270|58738153|FG001|Overall Study|Withdrawal by Subject|78|||
30724984|NCT00465270|58738152|FG000|Overall Study|Lost to Follow-up|60|||
30724985|NCT00465270|58738153|FG001|Overall Study|Lost to Follow-up|67|||
30724986|NCT00465270|58738152|FG000|Overall Study|Investigator request|3|||
30724987|NCT00465270|58738153|FG001|Overall Study|Investigator request|4|||
30724988|NCT00464568|58738159|FG000|Overall Study|Adverse Event|2|||
30724989|NCT00464490|58738178|FG000|Overall Study|Physician Decision|11|||
30724990|NCT00464490|58738179|FG001|Overall Study|Physician Decision|11|||
30724991|NCT03849300|58738189|FG000|Overall Study|move out to different area|1|||
30724992|NCT03849300|58738190|FG001|Overall Study|move out to different area|3|||
30724993|NCT03849300|58738191|FG002|Overall Study|move out to different area|1|||
30724994|NCT03849300|58738192|FG003|Overall Study|move out to different area|4|||
30724995|NCT03849300|58738189|FG000|Overall Study|scheduling/transportation conflict|4|||
30724996|NCT03849300|58738190|FG001|Overall Study|scheduling/transportation conflict|4|||
30724997|NCT03849300|58738191|FG002|Overall Study|scheduling/transportation conflict|3|||
30724998|NCT03849300|58738192|FG003|Overall Study|scheduling/transportation conflict|2|||
30724999|NCT00412893|58738206|FG000|Overall Study|Adverse Event|31|||
30725000|NCT00412893|58738207|FG001|Overall Study|Adverse Event|53|||
30725001|NCT00412893|58738206|FG000|Overall Study|Death|17|||
30725002|NCT00412893|58738207|FG001|Overall Study|Death|21|||
30725003|NCT00412893|58738206|FG000|Overall Study|Insufficient Therapeutic Response|39|||
30621644|NCT00932698|58633211|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
30621645|NCT00932698|58633212|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
30621646|NCT00932698|58633213|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
30621647|NCT00932698|58633214|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
30621648|NCT00932698|58633215|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
30621649|NCT00932698|58633216|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
30621650|NCT00932698|58633217|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
30621651|NCT00932698|58633218|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
30621652|NCT00932698|58633219|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
30621653|NCT00932698|58633209|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
30621654|NCT00932698|58633210|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
30621655|NCT00932698|58633211|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
30621656|NCT00932698|58633212|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
30621657|NCT00932698|58633213|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
30621658|NCT00932698|58633214|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
30621659|NCT00932698|58633215|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
30621660|NCT00932698|58633216|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
30621661|NCT00932698|58633217|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
30621662|NCT00932698|58633218|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
30621663|NCT00932698|58633219|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
30621664|NCT00978627|58633247|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
30621665|NCT00978627|58633248|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
30621666|NCT00978627|58633247|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
30621667|NCT00978627|58633248|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
30621668|NCT00978627|58633247|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
30725004|NCT00412893|58738207|FG001|Overall Study|Insufficient Therapeutic Response|23|||
30725005|NCT00412893|58738206|FG000|Overall Study|Lost to Follow-up|2|||
30725006|NCT00412893|58738207|FG001|Overall Study|Lost to Follow-up|1|||
30725007|NCT00412893|58738206|FG000|Overall Study|Violation of Selection at Entry|17|||
30725008|NCT00412893|58738207|FG001|Overall Study|Violation of Selection at Entry|10|||
30725009|NCT00412893|58738206|FG000|Overall Study|Other Protocol Violation|10|||
30725010|NCT00412893|58738207|FG001|Overall Study|Other Protocol Violation|6|||
30725011|NCT00412893|58738206|FG000|Overall Study|Did Not Cooperate|12|||
30725012|NCT00412893|58738207|FG001|Overall Study|Did Not Cooperate|9|||
30725013|NCT00412893|58738206|FG000|Overall Study|Administrative Reason|12|||
30725014|NCT00412893|58738207|FG001|Overall Study|Administrative Reason|15|||
30725015|NCT00412893|58738206|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
30725016|NCT00412893|58738207|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
30725017|NCT00412737|58738215|FG000|Overall Study|Death|1|||
30725018|NCT00412737|58738216|FG001|Overall Study|Death|0|||
30725019|NCT00412737|58738215|FG000|Overall Study|Adverse Event|3|||
30725020|NCT00412737|58738216|FG001|Overall Study|Adverse Event|2|||
30725021|NCT00412737|58738215|FG000|Overall Study|Refused Treatment|6|||
30725022|NCT00412737|58738216|FG001|Overall Study|Refused Treatment|2|||
30725023|NCT00412737|58738215|FG000|Overall Study|Failure to Return|6|||
30725024|NCT00412737|58738216|FG001|Overall Study|Failure to Return|2|||
30725025|NCT00508742|58738224|FG000|Period 1: Infant Series|Adverse Event|5|||
30725026|NCT00508742|58738225|FG001|Period 1: Infant Series|Adverse Event|4|||
30725027|NCT00508742|58738224|FG000|Period 1: Infant Series|Protocol Violation|1|||
30725028|NCT00508742|58738225|FG001|Period 1: Infant Series|Protocol Violation|0|||
30725029|NCT00508742|58738224|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
30725030|NCT00508742|58738225|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
30725031|NCT00508742|58738224|FG000|Period 1: Infant Series|Physician Decision|1|||
30725032|NCT00508742|58738225|FG001|Period 1: Infant Series|Physician Decision|0|||
30725033|NCT00508742|58738224|FG000|Period 1: Infant Series|Other|4|||
30725034|NCT00508742|58738225|FG001|Period 1: Infant Series|Other|1|||
30725035|NCT00508742|58738224|FG000|Period 2: After Infant Series|Adverse Event|2|||
30725036|NCT00508742|58738225|FG001|Period 2: After Infant Series|Adverse Event|6|||
30725037|NCT00508742|58738224|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
30725038|NCT00508742|58738225|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
30725039|NCT00508742|58738224|FG000|Period 2: After Infant Series|Protocol Violation|1|||
30725040|NCT00508742|58738225|FG001|Period 2: After Infant Series|Protocol Violation|0|||
30725041|NCT00508742|58738224|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
30725042|NCT00508742|58738225|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
30725043|NCT00508742|58738224|FG000|Period 2: After Infant Series|Failed to Return|1|||
30725044|NCT00508742|58738225|FG001|Period 2: After Infant Series|Failed to Return|0|||
30725045|NCT00508742|58738224|FG000|Period 2: After Infant Series|Other|2|||
30725046|NCT00508742|58738225|FG001|Period 2: After Infant Series|Other|1|||
30725047|NCT00508742|58738224|FG000|Period 3: Toddler Dose|Adverse Event|1|||
30725048|NCT00508742|58738225|FG001|Period 3: Toddler Dose|Adverse Event|0|||
30725049|NCT00508742|58738224|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
30725050|NCT00508742|58738225|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
30725051|NCT00508742|58738224|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
30725052|NCT00508742|58738225|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
30725053|NCT00508742|58738224|FG000|Period 3: Toddler Dose|Other|5|||
30725054|NCT00508742|58738225|FG001|Period 3: Toddler Dose|Other|4|||
30725055|NCT00508274|58738246|FG000|Overall Study|Adverse Event|5|||
30725056|NCT00508274|58738246|FG000|Overall Study|Death|7|||
30725057|NCT00508274|58738246|FG000|Overall Study|Disease progression|32|||
30725058|NCT00508274|58738246|FG000|Overall Study|Withdrawal by Subject|1|||
30725059|NCT00508274|58738246|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
30725060|NCT00508274|58738246|FG000|Overall Study|Missing|3|||
30725061|NCT00499460|58738252|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
30725062|NCT00499460|58738253|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
30725063|NCT00499460|58738252|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
30725064|NCT00499460|58738253|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
30725065|NCT00499460|58738252|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
30725066|NCT00499460|58738253|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
30900403|NCT02448719|58933729|FG004|Overall Study|Withdrawal by Subject|1|||
30900404|NCT02448719|58933730|FG005|Overall Study|Withdrawal by Subject|0|||
30900405|NCT02448719|58933731|FG006|Overall Study|Withdrawal by Subject|0|||
30900406|NCT02448719|58933732|FG007|Overall Study|Withdrawal by Subject|0|||
30900407|NCT02448719|58933733|FG008|Overall Study|Withdrawal by Subject|0|||
30725067|NCT00412113|58738271|FG000|Overall Study|Adverse Event|11|||
30725068|NCT00412113|58738272|FG001|Overall Study|Adverse Event|15|||
30725069|NCT00412113|58738271|FG000|Overall Study|did not receive treatment|1|||
30725070|NCT00412113|58738272|FG001|Overall Study|did not receive treatment|0|||
30725071|NCT00411645|58738280|FG000|Overall Study|Consent Withdrawn|13|||
30725072|NCT00411645|58738281|FG001|Overall Study|Consent Withdrawn|22|||
30725073|NCT00411645|58738280|FG000|Overall Study|Death|56|||
30725074|NCT00411645|58738281|FG001|Overall Study|Death|135|||
30725075|NCT00411645|58738280|FG000|Overall Study|Investigator/Sponsor Decision|10|||
30900408|NCT02448719|58933734|FG009|Overall Study|Withdrawal by Subject|0|||
30725076|NCT00411645|58738281|FG001|Overall Study|Investigator/Sponsor Decision|7|||
30725077|NCT00411645|58738280|FG000|Overall Study|Lost to Follow-up|2|||
30725078|NCT00411645|58738281|FG001|Overall Study|Lost to Follow-up|0|||
30725079|NCT00490724|58738291|FG000|Period I|Physician Decision|0|||
30725080|NCT00490724|58738292|FG001|Period I|Physician Decision|0|||
30725081|NCT00490724|58738293|FG002|Period I|Physician Decision|1|||
30725082|NCT00490724|58738291|FG000|Period II|Treatment Discontinuation|3|||
30725083|NCT00490724|58738292|FG001|Period II|Treatment Discontinuation|1|||
30725084|NCT00490724|58738293|FG002|Period II|Treatment Discontinuation|3|||
30725085|NCT03835221|58738301|FG000|Methafilcon A|Withdrawal by Subject|1|||
30725086|NCT00398073|58738309|FG000|Overall Study|Withdrawal by Subject|1|||
30725087|NCT00398073|58738310|FG001|Overall Study|Withdrawal by Subject|0|||
30725088|NCT00490646|58738318|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
30725089|NCT00490646|58738319|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
30725090|NCT00490646|58738318|FG000|Overall Study|Never Treated (had an adverse event)|1|||
30725091|NCT00490646|58738319|FG001|Overall Study|Never Treated (had an adverse event)|0|||
30725092|NCT00490646|58738318|FG000|Overall Study|Never Treated (withdrew consent)|0|||
30725093|NCT00490646|58738319|FG001|Overall Study|Never Treated (withdrew consent)|1|||
30725094|NCT00388947|58738325|FG000|Overall Study|Protocol Violation|47|||
30725095|NCT00490568|58738329|FG000|Overall Study|Adverse Event|116|||
30725096|NCT00490568|58738329|FG000|Overall Study|Lost to Follow-up|13|||
30725097|NCT00490568|58738329|FG000|Overall Study|Protocol Violation|45|||
30725098|NCT00490568|58738329|FG000|Overall Study|Withdrawal by Subject|135|||
30725099|NCT00490568|58738329|FG000|Overall Study|Still in the study at termination|974|||
30725100|NCT00490568|58738329|FG000|Overall Study|Other|1|||
30725101|NCT00490568|58738329|FG000|Overall Study|Exclusion criteria met|1|||
30725102|NCT00490568|58738329|FG000|Overall Study|Caregiver related|20|||
30725103|NCT00490568|58738329|FG000|Overall Study|Abnormal ECG|25|||
30725104|NCT00490568|58738329|FG000|Overall Study|Participant refused follow-up|9|||
30725105|NCT00490568|58738329|FG000|Overall Study|Legal representative withdrew consent|1|||
30725106|NCT00490568|58738329|FG000|Overall Study|Disease progression|4|||
30725107|NCT00490568|58738329|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
30725108|NCT00490568|58738329|FG000|Overall Study|Investigator decision|3|||
30725109|NCT00490568|58738329|FG000|Overall Study|Non-Compliance|7|||
30725110|NCT00490568|58738329|FG000|Overall Study|Efficacy related|3|||
30725111|NCT00490568|58738329|FG000|Overall Study|Participant died|1|||
30725112|NCT00490568|58738329|FG000|Overall Study|Participant withdrawal due to surgery|1|||
30725113|NCT00561353|58738344|FG000|Overall Study|Subject reached a virologic endpoint|2|||
30725114|NCT00561353|58738345|FG001|Overall Study|Subject reached a virologic endpoint|1|||
30725115|NCT00561353|58738346|FG002|Overall Study|Subject reached a virologic endpoint|1|||
30725116|NCT00561353|58738347|FG003|Overall Study|Subject reached a virologic endpoint|4|||
30725117|NCT00561353|58738348|FG004|Overall Study|Subject reached a virologic endpoint|1|||
30725118|NCT00561353|58738349|FG005|Overall Study|Subject reached a virologic endpoint|3|||
30725119|NCT00561353|58738350|FG006|Overall Study|Subject reached a virologic endpoint|4|||
30725120|NCT00561353|58738351|FG007|Overall Study|Subject reached a virologic endpoint|4|||
30725121|NCT00561353|58738352|FG008|Overall Study|Subject reached a virologic endpoint|5|||
30725122|NCT00561353|58738353|FG009|Overall Study|Subject reached a virologic endpoint|0|||
30725123|NCT00561353|58738344|FG000|Overall Study|Subject ineligible to continue the trial|0|||
30725124|NCT00561353|58738345|FG001|Overall Study|Subject ineligible to continue the trial|0|||
30725125|NCT00561353|58738346|FG002|Overall Study|Subject ineligible to continue the trial|0|||
30725126|NCT00561353|58738347|FG003|Overall Study|Subject ineligible to continue the trial|0|||
30725127|NCT00561353|58738348|FG004|Overall Study|Subject ineligible to continue the trial|0|||
30725128|NCT00561353|58738349|FG005|Overall Study|Subject ineligible to continue the trial|1|||
30725129|NCT00561353|58738350|FG006|Overall Study|Subject ineligible to continue the trial|1|||
30725130|NCT00561353|58738351|FG007|Overall Study|Subject ineligible to continue the trial|0|||
30725131|NCT00561353|58738352|FG008|Overall Study|Subject ineligible to continue the trial|2|||
30725132|NCT00561353|58738353|FG009|Overall Study|Subject ineligible to continue the trial|1|||
30725133|NCT00561353|58738344|FG000|Overall Study|Other|1|||
30725134|NCT00561353|58738345|FG001|Overall Study|Other|0|||
30725135|NCT00561353|58738346|FG002|Overall Study|Other|1|||
30725136|NCT00561353|58738347|FG003|Overall Study|Other|0|||
30725137|NCT00561353|58738348|FG004|Overall Study|Other|0|||
30725138|NCT00561353|58738349|FG005|Overall Study|Other|2|||
30725139|NCT00561353|58738350|FG006|Overall Study|Other|0|||
30725140|NCT00561353|58738351|FG007|Overall Study|Other|0|||
30725141|NCT00561353|58738352|FG008|Overall Study|Other|0|||
30725142|NCT00561353|58738353|FG009|Overall Study|Other|0|||
30725143|NCT00561353|58738344|FG000|Overall Study|Adverse Event|0|||
30725144|NCT00561353|58738345|FG001|Overall Study|Adverse Event|0|||
30725145|NCT00561353|58738346|FG002|Overall Study|Adverse Event|0|||
30725146|NCT00561353|58738347|FG003|Overall Study|Adverse Event|2|||
30725147|NCT00561353|58738348|FG004|Overall Study|Adverse Event|0|||
30725148|NCT00561353|58738349|FG005|Overall Study|Adverse Event|0|||
30725149|NCT00561353|58738350|FG006|Overall Study|Adverse Event|1|||
30725150|NCT00561353|58738351|FG007|Overall Study|Adverse Event|0|||
30725151|NCT00561353|58738352|FG008|Overall Study|Adverse Event|0|||
30725152|NCT00561353|58738353|FG009|Overall Study|Adverse Event|1|||
30725153|NCT00561353|58738344|FG000|Overall Study|Lost to Follow-up|2|||
30725154|NCT00561353|58738345|FG001|Overall Study|Lost to Follow-up|0|||
30725155|NCT00561353|58738346|FG002|Overall Study|Lost to Follow-up|1|||
30725156|NCT00561353|58738347|FG003|Overall Study|Lost to Follow-up|0|||
30725157|NCT00561353|58738348|FG004|Overall Study|Lost to Follow-up|0|||
30725158|NCT00561353|58738349|FG005|Overall Study|Lost to Follow-up|0|||
30725159|NCT00561353|58738350|FG006|Overall Study|Lost to Follow-up|0|||
30725160|NCT00561353|58738351|FG007|Overall Study|Lost to Follow-up|0|||
30725161|NCT00561353|58738352|FG008|Overall Study|Lost to Follow-up|0|||
30725162|NCT00561353|58738353|FG009|Overall Study|Lost to Follow-up|0|||
30725163|NCT00561353|58738344|FG000|Overall Study|Withdrawal by Subject|0|||
30725164|NCT00561353|58738345|FG001|Overall Study|Withdrawal by Subject|2|||
30725165|NCT00561353|58738346|FG002|Overall Study|Withdrawal by Subject|0|||
30725166|NCT00561353|58738347|FG003|Overall Study|Withdrawal by Subject|0|||
30725167|NCT00561353|58738348|FG004|Overall Study|Withdrawal by Subject|0|||
30725168|NCT00561353|58738349|FG005|Overall Study|Withdrawal by Subject|0|||
30725169|NCT00561353|58738350|FG006|Overall Study|Withdrawal by Subject|0|||
30725170|NCT00561353|58738351|FG007|Overall Study|Withdrawal by Subject|0|||
30725171|NCT00561353|58738352|FG008|Overall Study|Withdrawal by Subject|0|||
30725172|NCT00561353|58738353|FG009|Overall Study|Withdrawal by Subject|0|||
30725173|NCT00560885|58738420|FG000|Overall Study|Death|7|||
30725174|NCT00560885|58738420|FG000|Overall Study|Withdrawal by Subject|1|||
30725175|NCT00397215|58738428|FG000|Month 0 (Day 0)|Adverse Event|0|||
30725176|NCT00397215|58738429|FG001|Month 0 (Day 0)|Adverse Event|1|||
30725177|NCT00397215|58738430|FG002|Month 0 (Day 0)|Adverse Event|0|||
30725178|NCT00397215|58738431|FG003|Month 0 (Day 0)|Adverse Event|0|||
30725179|NCT00397215|58738428|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
30725180|NCT00397215|58738429|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
30725181|NCT00397215|58738430|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
30725182|NCT00397215|58738431|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
30725183|NCT00397215|58738428|FG000|Month 0 (Day 0)|Other|4|||
30725184|NCT00397215|58738429|FG001|Month 0 (Day 0)|Other|1|||
30725185|NCT00397215|58738430|FG002|Month 0 (Day 0)|Other|3|||
30725186|NCT00397215|58738431|FG003|Month 0 (Day 0)|Other|3|||
30725187|NCT00397215|58738428|FG000|Month 6 (Day 180)|Adverse Event|0|||
30725188|NCT00397215|58738429|FG001|Month 6 (Day 180)|Adverse Event|3|||
30725189|NCT00397215|58738430|FG002|Month 6 (Day 180)|Adverse Event|2|||
30725190|NCT00397215|58738431|FG003|Month 6 (Day 180)|Adverse Event|0|||
30725191|NCT00397215|58738428|FG000|Month 6 (Day 180)|Other|2|||
30725192|NCT00397215|58738429|FG001|Month 6 (Day 180)|Other|0|||
30725193|NCT00397215|58738430|FG002|Month 6 (Day 180)|Other|3|||
30725194|NCT00397215|58738431|FG003|Month 6 (Day 180)|Other|0|||
30725195|NCT00556439|58738448|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
30725196|NCT00556439|58738449|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
30725197|NCT00556439|58738450|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
30725198|NCT00556439|58738451|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
30725199|NCT00556439|58738448|FG000|Study Entry to Week 12|Physician Decision|1|||
30725200|NCT00556439|58738449|FG001|Study Entry to Week 12|Physician Decision|0|||
30725201|NCT00556439|58738450|FG002|Study Entry to Week 12|Physician Decision|0|||
30725202|NCT00556439|58738451|FG003|Study Entry to Week 12|Physician Decision|0|||
30725203|NCT00556439|58738448|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
30725204|NCT00556439|58738449|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
30725205|NCT00556439|58738450|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
30725206|NCT00556439|58738451|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
30725207|NCT00556439|58738448|FG000|Study Entry to Week 12|Recurrent infection|1|||
30725208|NCT00556439|58738449|FG001|Study Entry to Week 12|Recurrent infection|0|||
30725209|NCT00556439|58738450|FG002|Study Entry to Week 12|Recurrent infection|0|||
30725210|NCT00556439|58738451|FG003|Study Entry to Week 12|Recurrent infection|0|||
30725211|NCT00556439|58738448|FG000|Study Entry to Week 12|Malignancy|0|||
30725212|NCT00556439|58738449|FG001|Study Entry to Week 12|Malignancy|0|||
30725213|NCT00556439|58738450|FG002|Study Entry to Week 12|Malignancy|1|||
30725214|NCT00556439|58738451|FG003|Study Entry to Week 12|Malignancy|0|||
30725215|NCT00556439|58738448|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
30725216|NCT00556439|58738449|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
30725217|NCT00556439|58738450|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
30725218|NCT00556439|58738451|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
30725219|NCT00556439|58738448|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
30725220|NCT00556439|58738449|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
30725221|NCT00556439|58738450|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
30725222|NCT00556439|58738451|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
30725223|NCT00556439|58738448|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
30725224|NCT00556439|58738449|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
30725225|NCT00556439|58738450|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
30725226|NCT00556439|58738451|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
30725227|NCT00556439|58738448|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
30725228|NCT00556439|58738449|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
30725229|NCT00556439|58738450|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
30725230|NCT00556439|58738451|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
30725231|NCT00387465|58738464|FG000|Overall Study|Withdrawal by Subject|0|||
30725232|NCT00387465|58738465|FG001|Overall Study|Withdrawal by Subject|1|||
30725233|NCT00387465|58738466|FG002|Overall Study|Withdrawal by Subject|0|||
30725234|NCT00387153|58738483|FG000|Overall Study|Adverse Event|1|||
30725235|NCT00387153|58738483|FG000|Overall Study|Disease Progression|3|||
30725236|NCT00387153|58738483|FG000|Overall Study|Lack of Response|4|||
30725237|NCT00386607|58738487|FG000|Core|Adverse Event|40|||
30725238|NCT00386607|58738488|FG001|Core|Adverse Event|0|||
30725239|NCT00386607|58738487|FG000|Core|Abnormal laboratory value(s)|3|||
30725240|NCT00386607|58738488|FG001|Core|Abnormal laboratory value(s)|0|||
30725241|NCT00386607|58738487|FG000|Core|Unsatisfactory therapeutic effect|23|||
30725242|NCT00386607|58738488|FG001|Core|Unsatisfactory therapeutic effect|0|||
30725243|NCT00386607|58738487|FG000|Core|Condition no longer requires study drug|4|||
30725244|NCT00386607|58738488|FG001|Core|Condition no longer requires study drug|0|||
30725245|NCT00386607|58738487|FG000|Core|Patient withdrew consent|15|||
30725246|NCT00386607|58738488|FG001|Core|Patient withdrew consent|0|||
30725247|NCT00386607|58738487|FG000|Core|Lost to Follow-up|23|||
30725248|NCT00386607|58738488|FG001|Core|Lost to Follow-up|0|||
30725249|NCT00386607|58738487|FG000|Core|Administrative problems|1|||
30725250|NCT00386607|58738488|FG001|Core|Administrative problems|0|||
30725251|NCT00386607|58738487|FG000|Core|Protocol Deviation|6|||
30725252|NCT00386607|58738488|FG001|Core|Protocol Deviation|0|||
30725253|NCT00386607|58738487|FG000|Extension|Adverse Event|0|||
30725254|NCT00386607|58738488|FG001|Extension|Adverse Event|6|||
30725255|NCT00386607|58738487|FG000|Extension|Abnormal laboratory value(s)|0|||
30725256|NCT00386607|58738488|FG001|Extension|Abnormal laboratory value(s)|1|||
30725257|NCT00386607|58738487|FG000|Extension|Administrative problems|0|||
30725258|NCT00386607|58738488|FG001|Extension|Administrative problems|1|||
30725259|NCT00386607|58738487|FG000|Extension|Lost to Follow-up|0|||
30725260|NCT00386607|58738488|FG001|Extension|Lost to Follow-up|3|||
30725261|NCT00386607|58738487|FG000|Extension|Patient withdrew consent|0|||
30725262|NCT00386607|58738488|FG001|Extension|Patient withdrew consent|5|||
30725263|NCT00386607|58738487|FG000|Extension|Unsatisfactory therapeutic effect|0|||
30725264|NCT00386607|58738488|FG001|Extension|Unsatisfactory therapeutic effect|1|||
30725265|NCT00410163|58738502|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
30900409|NCT02448719|58933735|FG010|Overall Study|Withdrawal by Subject|0|||
30900410|NCT02322866|58933798|FG000|Overall Study|Adverse Event|6|||
30725266|NCT00410163|58738503|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
30725267|NCT00410163|58738502|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
30725268|NCT00410163|58738503|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
30725269|NCT00410163|58738502|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
30725270|NCT00410163|58738503|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
30725271|NCT00410163|58738502|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
30725272|NCT00410163|58738503|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
30725273|NCT00410163|58738502|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
30725274|NCT00410163|58738503|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
30900411|NCT02322866|58933799|FG001|Overall Study|Adverse Event|11|||
30725275|NCT00410163|58738502|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
30725276|NCT00410163|58738503|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
30725277|NCT00410163|58738502|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
30725278|NCT00410163|58738503|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
30725279|NCT00410163|58738502|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
30725280|NCT00410163|58738503|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
30725281|NCT00410163|58738502|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
30725282|NCT00410163|58738503|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
30725283|NCT00410163|58738502|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
30725284|NCT00410163|58738503|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
30725285|NCT00410163|58738502|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
30725286|NCT00410163|58738503|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
30725287|NCT00410163|58738502|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
30725288|NCT00410163|58738503|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
30725289|NCT00410163|58738502|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
30725290|NCT00410163|58738503|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
30725291|NCT00410163|58738502|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
30725292|NCT00410163|58738503|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
30725293|NCT00409617|58738539|FG000|Overall Study|Adverse Event|57|||
30725294|NCT00409617|58738539|FG000|Overall Study|Lack of Efficacy|54|||
30725295|NCT00409617|58738539|FG000|Overall Study|Lost to Follow-up|2|||
30725296|NCT00409617|58738539|FG000|Overall Study|Protocol Violation|24|||
30725297|NCT00409617|58738539|FG000|Overall Study|Withdrawal by Subject|8|||
30725298|NCT00409617|58738539|FG000|Overall Study|Administrative reasons|1|||
30725299|NCT00409617|58738539|FG000|Overall Study|Not described|14|||
30725300|NCT00300274|58738546|FG000|Overall Study|Withdrawal by Subject|12|||
30725301|NCT00300274|58738547|FG001|Overall Study|Withdrawal by Subject|3|||
30725302|NCT00300274|58738548|FG002|Overall Study|Withdrawal by Subject|14|||
30725303|NCT00300274|58738546|FG000|Overall Study|Lost to Follow-up|3|||
30725304|NCT00300274|58738547|FG001|Overall Study|Lost to Follow-up|4|||
30725305|NCT00300274|58738548|FG002|Overall Study|Lost to Follow-up|5|||
30725306|NCT00300274|58738546|FG000|Overall Study|Death|31|||
30725307|NCT00300274|58738547|FG001|Overall Study|Death|20|||
30725308|NCT00300274|58738548|FG002|Overall Study|Death|25|||
30725309|NCT00300274|58738546|FG000|Overall Study|Re-transplant|0|||
30725310|NCT00300274|58738547|FG001|Overall Study|Re-transplant|0|||
30725311|NCT00300274|58738548|FG002|Overall Study|Re-transplant|1|||
30725312|NCT00299728|58738558|FG000|Overall Study|Lost to Follow-up|0|||
30725313|NCT00299728|58738559|FG001|Overall Study|Lost to Follow-up|1|||
30725314|NCT00299728|58738558|FG000|Overall Study|Withdrawal by Subject|0|||
30725315|NCT00299728|58738559|FG001|Overall Study|Withdrawal by Subject|1|||
30725316|NCT00299728|58738558|FG000|Overall Study|Progressive disease|0|||
30725317|NCT00299728|58738559|FG001|Overall Study|Progressive disease|1|||
30725318|NCT00396591|58738565|FG000|Overall Study|Disease Progression|13|||
30725319|NCT00396591|58738565|FG000|Overall Study|Adverse Event|2|||
30725320|NCT00396591|58738565|FG000|Overall Study|Participant request|1|||
30725321|NCT00316264|58738572|FG000|Overall Study|Lost to Follow-up|0|||
30725322|NCT00316264|58738573|FG001|Overall Study|Lost to Follow-up|1|||
30725323|NCT00316264|58738574|FG002|Overall Study|Lost to Follow-up|0|||
30725324|NCT00316264|58738572|FG000|Overall Study|Withdrawal of Consent|3|||
30725325|NCT00316264|58738573|FG001|Overall Study|Withdrawal of Consent|5|||
30725326|NCT00316264|58738574|FG002|Overall Study|Withdrawal of Consent|6|||
30725327|NCT00316264|58738572|FG000|Overall Study|Death|2|||
30725328|NCT00316264|58738573|FG001|Overall Study|Death|0|||
30725329|NCT00316264|58738574|FG002|Overall Study|Death|0|||
30725330|NCT00316264|58738572|FG000|Overall Study|Other|1|||
30725331|NCT00316264|58738573|FG001|Overall Study|Other|1|||
30725332|NCT00316264|58738574|FG002|Overall Study|Other|0|||
30725333|NCT00385827|58738585|FG000|Part 1|Adverse Event|1|||
30725334|NCT00385827|58738586|FG001|Part 1|Adverse Event|0|||
30725335|NCT00385827|58738587|FG002|Part 1|Adverse Event|0|||
30725336|NCT00385827|58738585|FG000|Part 1|Death|2|||
30725337|NCT00385827|58738586|FG001|Part 1|Death|0|||
30725338|NCT00385827|58738587|FG002|Part 1|Death|0|||
30725339|NCT00385827|58738585|FG000|Part 1|Lack of Efficacy|5|||
30725340|NCT00385827|58738586|FG001|Part 1|Lack of Efficacy|0|||
30725341|NCT00385827|58738587|FG002|Part 1|Lack of Efficacy|0|||
30725342|NCT00385827|58738585|FG000|Part 1|Other|1|||
30725343|NCT00385827|58738586|FG001|Part 1|Other|0|||
30725344|NCT00385827|58738587|FG002|Part 1|Other|0|||
30725345|NCT00385827|58738585|FG000|Part 2|Adverse Event|0|||
30725346|NCT00385827|58738586|FG001|Part 2|Adverse Event|6|||
30725347|NCT00385827|58738587|FG002|Part 2|Adverse Event|10|||
30725348|NCT00385827|58738585|FG000|Part 2|Death|0|||
30725349|NCT00385827|58738586|FG001|Part 2|Death|0|||
30725350|NCT00385827|58738587|FG002|Part 2|Death|2|||
30725351|NCT00385827|58738585|FG000|Part 2|Lack of Efficacy|0|||
30725352|NCT00385827|58738586|FG001|Part 2|Lack of Efficacy|14|||
30725353|NCT00385827|58738587|FG002|Part 2|Lack of Efficacy|13|||
30725354|NCT00385827|58738585|FG000|Part 2|Randomized but not treated|0|||
30725355|NCT00385827|58738586|FG001|Part 2|Randomized but not treated|2|||
30725356|NCT00385827|58738587|FG002|Part 2|Randomized but not treated|2|||
30725357|NCT00385827|58738585|FG000|Part 2|Other|0|||
30725358|NCT00385827|58738586|FG001|Part 2|Other|11|||
30725359|NCT00385827|58738587|FG002|Part 2|Other|21|||
30725360|NCT00498602|58738604|FG000|Overall Study|Death|0|||
30725361|NCT00498602|58738605|FG001|Overall Study|Death|0|||
30725362|NCT00498602|58738606|FG002|Overall Study|Death|0|||
30725363|NCT00498602|58738607|FG003|Overall Study|Death|0|||
30725364|NCT00498602|58738608|FG004|Overall Study|Death|0|||
30725365|NCT00498602|58738609|FG005|Overall Study|Death|1|||
30725366|NCT00498602|58738610|FG006|Overall Study|Death|0|||
30725367|NCT00498602|58738604|FG000|Overall Study|Lack of Efficacy|1|||
30725368|NCT00498602|58738605|FG001|Overall Study|Lack of Efficacy|0|||
30725369|NCT00498602|58738606|FG002|Overall Study|Lack of Efficacy|0|||
30725370|NCT00498602|58738607|FG003|Overall Study|Lack of Efficacy|0|||
30725371|NCT00498602|58738608|FG004|Overall Study|Lack of Efficacy|0|||
30725372|NCT00498602|58738609|FG005|Overall Study|Lack of Efficacy|0|||
30725373|NCT00498602|58738610|FG006|Overall Study|Lack of Efficacy|0|||
30725374|NCT00498602|58738604|FG000|Overall Study|Lost to Follow-up|0|||
30725375|NCT00498602|58738605|FG001|Overall Study|Lost to Follow-up|2|||
30725376|NCT00498602|58738606|FG002|Overall Study|Lost to Follow-up|0|||
30725377|NCT00498602|58738607|FG003|Overall Study|Lost to Follow-up|2|||
30725378|NCT00498602|58738608|FG004|Overall Study|Lost to Follow-up|0|||
30725379|NCT00498602|58738609|FG005|Overall Study|Lost to Follow-up|0|||
30725380|NCT00498602|58738610|FG006|Overall Study|Lost to Follow-up|0|||
30725381|NCT00498602|58738604|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
30725382|NCT00498602|58738605|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
30725383|NCT00498602|58738606|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
30725384|NCT00498602|58738607|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
30725385|NCT00498602|58738608|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
30725386|NCT00498602|58738609|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
30725387|NCT00498602|58738610|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
30725388|NCT00498602|58738604|FG000|Overall Study|AE not related to Study Drug|1|||
30725389|NCT00498602|58738605|FG001|Overall Study|AE not related to Study Drug|3|||
30725390|NCT00498602|58738606|FG002|Overall Study|AE not related to Study Drug|0|||
30725391|NCT00498602|58738607|FG003|Overall Study|AE not related to Study Drug|0|||
30725392|NCT00498602|58738608|FG004|Overall Study|AE not related to Study Drug|2|||
30725393|NCT00498602|58738609|FG005|Overall Study|AE not related to Study Drug|2|||
30725394|NCT00498602|58738610|FG006|Overall Study|AE not related to Study Drug|1|||
30725395|NCT00498602|58738604|FG000|Overall Study|Caregiver Request|2|||
30725396|NCT00498602|58738605|FG001|Overall Study|Caregiver Request|2|||
30725397|NCT00498602|58738606|FG002|Overall Study|Caregiver Request|2|||
30725398|NCT00498602|58738607|FG003|Overall Study|Caregiver Request|0|||
30725399|NCT00498602|58738608|FG004|Overall Study|Caregiver Request|1|||
30725400|NCT00498602|58738609|FG005|Overall Study|Caregiver Request|2|||
30725401|NCT00498602|58738610|FG006|Overall Study|Caregiver Request|0|||
30725402|NCT00498602|58738604|FG000|Overall Study|Investigator Request|0|||
30725403|NCT00498602|58738605|FG001|Overall Study|Investigator Request|0|||
30725404|NCT00498602|58738606|FG002|Overall Study|Investigator Request|1|||
30725405|NCT00498602|58738607|FG003|Overall Study|Investigator Request|0|||
30725406|NCT00498602|58738608|FG004|Overall Study|Investigator Request|0|||
30725407|NCT00498602|58738609|FG005|Overall Study|Investigator Request|0|||
30725408|NCT00498602|58738610|FG006|Overall Study|Investigator Request|0|||
30725409|NCT00498602|58738604|FG000|Overall Study|Subject Request|3|||
30725410|NCT00498602|58738605|FG001|Overall Study|Subject Request|0|||
30725411|NCT00498602|58738606|FG002|Overall Study|Subject Request|1|||
30725412|NCT00498602|58738607|FG003|Overall Study|Subject Request|1|||
30900412|NCT02322866|58933798|FG000|Overall Study|Withdrawal of Consent|16|||
30725413|NCT00498602|58738608|FG004|Overall Study|Subject Request|1|||
30725414|NCT00498602|58738609|FG005|Overall Study|Subject Request|4|||
30725415|NCT00498602|58738610|FG006|Overall Study|Subject Request|1|||
30725416|NCT00498602|58738604|FG000|Overall Study|Other|2|||
30725417|NCT00498602|58738605|FG001|Overall Study|Other|3|||
30725418|NCT00498602|58738606|FG002|Overall Study|Other|1|||
30725419|NCT00498602|58738607|FG003|Overall Study|Other|0|||
30725420|NCT00498602|58738608|FG004|Overall Study|Other|0|||
30725421|NCT00498602|58738609|FG005|Overall Study|Other|3|||
30725422|NCT00498602|58738610|FG006|Overall Study|Other|0|||
30900413|NCT02322866|58933799|FG001|Overall Study|Withdrawal of Consent|25|||
30725423|NCT00507728|58738629|FG000|Randomization to Month 3|Lost to Follow-up|15|||
30725424|NCT00507728|58738630|FG001|Randomization to Month 3|Lost to Follow-up|14|||
30725425|NCT00507728|58738631|FG002|Randomization to Month 3|Lost to Follow-up|20|||
30725426|NCT00507728|58738629|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
30725427|NCT00507728|58738630|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
30725428|NCT00507728|58738631|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
30725429|NCT00498368|58738647|FG000|Overall Study|Withdrawal by Subject|3|||
30725430|NCT00498368|58738648|FG001|Overall Study|Withdrawal by Subject|2|||
30725431|NCT00385671|58738657|FG000|Overall Study|Adverse Event|14|||
30725432|NCT00385671|58738658|FG001|Overall Study|Adverse Event|27|||
30725433|NCT00385671|58738659|FG002|Overall Study|Adverse Event|18|||
30725434|NCT00385671|58738657|FG000|Overall Study|Lack of Efficacy|5|||
30725435|NCT00385671|58738658|FG001|Overall Study|Lack of Efficacy|9|||
30725436|NCT00385671|58738659|FG002|Overall Study|Lack of Efficacy|5|||
30725437|NCT00385671|58738657|FG000|Overall Study|Lost to Follow-up|6|||
30725438|NCT00385671|58738658|FG001|Overall Study|Lost to Follow-up|6|||
30725439|NCT00385671|58738659|FG002|Overall Study|Lost to Follow-up|5|||
30725440|NCT00385671|58738657|FG000|Overall Study|Physician Decision|2|||
30725441|NCT00385671|58738658|FG001|Overall Study|Physician Decision|1|||
30725442|NCT00385671|58738659|FG002|Overall Study|Physician Decision|2|||
30725443|NCT00385671|58738657|FG000|Overall Study|Protocol Violation|5|||
30725444|NCT00385671|58738658|FG001|Overall Study|Protocol Violation|2|||
30725445|NCT00385671|58738659|FG002|Overall Study|Protocol Violation|1|||
30725446|NCT00385671|58738657|FG000|Overall Study|Sponsor Decision|2|||
30725447|NCT00385671|58738658|FG001|Overall Study|Sponsor Decision|2|||
30725448|NCT00385671|58738659|FG002|Overall Study|Sponsor Decision|1|||
30725449|NCT00385671|58738657|FG000|Overall Study|Withdrawal by Subject|4|||
30725450|NCT00385671|58738658|FG001|Overall Study|Withdrawal by Subject|4|||
30725451|NCT00385671|58738659|FG002|Overall Study|Withdrawal by Subject|4|||
30725452|NCT00497198|58738671|FG000|Overall Study|Adverse Event|4|||
30725453|NCT00497198|58738672|FG001|Overall Study|Adverse Event|2|||
30725454|NCT00497198|58738671|FG000|Overall Study|Physician Decision|1|||
30725455|NCT00497198|58738672|FG001|Overall Study|Physician Decision|2|||
30725456|NCT00497198|58738671|FG000|Overall Study|Withdrawal by Subject|0|||
30725457|NCT00497198|58738672|FG001|Overall Study|Withdrawal by Subject|1|||
30725458|NCT00496964|58738680|FG000|Overall Study|Withdrawal by Subject|0|||
30725459|NCT00496964|58738681|FG001|Overall Study|Withdrawal by Subject|1|||
30725460|NCT00490490|58738689|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
30725461|NCT00490490|58738689|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
30725462|NCT00385593|58738695|FG000|Overall Study|Adverse Event|3|||
30725463|NCT00385593|58738696|FG001|Overall Study|Adverse Event|2|||
30725464|NCT00385593|58738695|FG000|Overall Study|Withdrawal by Subject|17|||
30725465|NCT00385593|58738696|FG001|Overall Study|Withdrawal by Subject|7|||
30725466|NCT00385593|58738695|FG000|Overall Study|Lost to Follow-up|12|||
30725467|NCT00385593|58738696|FG001|Overall Study|Lost to Follow-up|8|||
30725468|NCT00385593|58738695|FG000|Overall Study|Protocol Violation|7|||
30725469|NCT00385593|58738696|FG001|Overall Study|Protocol Violation|4|||
30725470|NCT00385593|58738695|FG000|Overall Study|Several reasons|17|||
30725471|NCT00385593|58738696|FG001|Overall Study|Several reasons|15|||
30725472|NCT00385593|58738695|FG000|Overall Study|Incorrect inclusion|2|||
30725473|NCT00385593|58738696|FG001|Overall Study|Incorrect inclusion|0|||
30725474|NCT00385593|58738695|FG000|Overall Study|Incorrect randomization|0|||
30725475|NCT00385593|58738696|FG001|Overall Study|Incorrect randomization|1|||
30725476|NCT00495794|58738704|FG000|Overall Study|Pharmacist did not activate patient|522|||
30725477|NCT00495794|58738705|FG001|Overall Study|Pharmacist did not activate patient|0|||
30725478|NCT00495170|58738711|FG000|Overall Study|Lost to Follow-up|9|||
30725479|NCT00495170|58738711|FG000|Overall Study|Withdrawal by Subject|3|||
30725480|NCT00495170|58738711|FG000|Overall Study|Inappropriate staging|8|||
30725481|NCT03853148|58738719|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
30725482|NCT03853148|58738720|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
30725483|NCT03853148|58738721|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
30725484|NCT03853148|58738722|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
30725485|NCT00385203|58738734|FG000|Overall Study|Adverse Event|5|||
30725486|NCT00385203|58738735|FG001|Overall Study|Adverse Event|4|||
30725487|NCT00385203|58738734|FG000|Overall Study|Death|1|||
30725488|NCT00385203|58738735|FG001|Overall Study|Death|0|||
30725489|NCT00385203|58738734|FG000|Overall Study|Condition under investigation worsened|18|||
30725490|NCT00385203|58738735|FG001|Overall Study|Condition under investigation worsened|3|||
30725491|NCT00385203|58738734|FG000|Overall Study|Incorrect enrollment|2|||
30725492|NCT00385203|58738735|FG001|Overall Study|Incorrect enrollment|0|||
30725493|NCT00408993|58738744|FG000|Overall Study|Adverse Event|15|||
30725494|NCT00408993|58738745|FG001|Overall Study|Adverse Event|4|||
30725495|NCT00408993|58738744|FG000|Overall Study|Protocol Violation|1|||
30725496|NCT00408993|58738745|FG001|Overall Study|Protocol Violation|6|||
30725497|NCT00408993|58738744|FG000|Overall Study|Lack of Efficacy|1|||
30725498|NCT00408993|58738745|FG001|Overall Study|Lack of Efficacy|4|||
30725499|NCT00408993|58738744|FG000|Overall Study|Withdrawal by Subject|2|||
30725500|NCT00408993|58738745|FG001|Overall Study|Withdrawal by Subject|3|||
30725501|NCT00395967|58738755|FG000|Treatment Period|Failed Mobilization|1|||
30725502|NCT00395967|58738755|FG000|Follow-up Period|Death|1|||
30725503|NCT00395967|58738755|FG000|Follow-up Period|Lost to Follow-up|1|||
30725504|NCT00395733|58738761|FG000|Period 2|Withdrawal by Subject|1|||
30725505|NCT00395733|58738762|FG001|Period 2|Withdrawal by Subject|2|||
30725506|NCT00395733|58738761|FG000|Period 2|Protocol Violation|0|||
30725507|NCT00395733|58738762|FG001|Period 2|Protocol Violation|1|||
30725508|NCT00395733|58738761|FG000|Period 2|Adverse Event|0|||
30725509|NCT00395733|58738762|FG001|Period 2|Adverse Event|2|||
30725510|NCT00395733|58738761|FG000|Period 2|Technical problems|1|||
30725511|NCT00395733|58738762|FG001|Period 2|Technical problems|0|||
30725512|NCT00395343|58738770|FG000|Overall Study|Adverse Event|13|||
30725513|NCT00395343|58738771|FG001|Overall Study|Adverse Event|5|||
30725514|NCT00395343|58738770|FG000|Overall Study|Lack of Efficacy|0|||
30725515|NCT00395343|58738771|FG001|Overall Study|Lack of Efficacy|1|||
30725516|NCT00395343|58738770|FG000|Overall Study|Lost to Follow-up|4|||
30725517|NCT00395343|58738771|FG001|Overall Study|Lost to Follow-up|4|||
30725518|NCT00395343|58738770|FG000|Overall Study|Physician Decision|2|||
30725519|NCT00395343|58738771|FG001|Overall Study|Physician Decision|4|||
30725520|NCT00395343|58738770|FG000|Overall Study|Protocol Violation|6|||
30725521|NCT00395343|58738771|FG001|Overall Study|Protocol Violation|8|||
30725522|NCT00395343|58738770|FG000|Overall Study|Withdrawal by Subject|11|||
30725523|NCT00395343|58738771|FG001|Overall Study|Withdrawal by Subject|12|||
30725524|NCT00395343|58738770|FG000|Overall Study|Other|5|||
30725525|NCT00395343|58738771|FG001|Overall Study|Other|2|||
30725526|NCT00560573|58738777|FG000|Overall Study|Death|4|||
30725527|NCT00560573|58738778|FG001|Overall Study|Death|1|||
30725528|NCT00560573|58738779|FG002|Overall Study|Death|4|||
30725529|NCT00560573|58738780|FG003|Overall Study|Death|5|||
30725530|NCT00560573|58738781|FG004|Overall Study|Death|1|||
30725531|NCT00560573|58738782|FG005|Overall Study|Death|10|||
30725532|NCT00560573|58738777|FG000|Overall Study|Lost to Follow-up|0|||
30725533|NCT00560573|58738778|FG001|Overall Study|Lost to Follow-up|0|||
30725534|NCT00560573|58738779|FG002|Overall Study|Lost to Follow-up|0|||
30725535|NCT00560573|58738780|FG003|Overall Study|Lost to Follow-up|1|||
30725536|NCT00560573|58738781|FG004|Overall Study|Lost to Follow-up|1|||
30725537|NCT00560573|58738782|FG005|Overall Study|Lost to Follow-up|0|||
30725538|NCT00560573|58738777|FG000|Overall Study|Withdrawal by Subject|0|||
30725539|NCT00560573|58738778|FG001|Overall Study|Withdrawal by Subject|0|||
30725540|NCT00560573|58738779|FG002|Overall Study|Withdrawal by Subject|0|||
30725541|NCT00560573|58738780|FG003|Overall Study|Withdrawal by Subject|1|||
30725542|NCT00560573|58738781|FG004|Overall Study|Withdrawal by Subject|1|||
30725543|NCT00560573|58738782|FG005|Overall Study|Withdrawal by Subject|0|||
30725544|NCT00560573|58738777|FG000|Overall Study|Other|2|||
30725545|NCT00560573|58738778|FG001|Overall Study|Other|2|||
30725546|NCT00560573|58738779|FG002|Overall Study|Other|2|||
30725547|NCT00560573|58738780|FG003|Overall Study|Other|3|||
30725548|NCT00560573|58738781|FG004|Overall Study|Other|3|||
30725549|NCT00560573|58738782|FG005|Overall Study|Other|3|||
30725550|NCT00560573|58738777|FG000|Overall Study|Enrolled, not treated|0|||
30725551|NCT00560573|58738778|FG001|Overall Study|Enrolled, not treated|0|||
30725552|NCT00560573|58738779|FG002|Overall Study|Enrolled, not treated|0|||
30725553|NCT00560573|58738780|FG003|Overall Study|Enrolled, not treated|0|||
30725554|NCT00560573|58738781|FG004|Overall Study|Enrolled, not treated|1|||
30725555|NCT00560573|58738782|FG005|Overall Study|Enrolled, not treated|0|||
30725556|NCT03961529|58738815|FG000|Overall Study|Adverse Event|13|||
30725557|NCT03961529|58738816|FG001|Overall Study|Adverse Event|5|||
30725558|NCT03961529|58738817|FG002|Overall Study|Adverse Event|2|||
30725559|NCT03961529|58738815|FG000|Overall Study|Withdrawal by Subject|17|||
30725560|NCT03961529|58738816|FG001|Overall Study|Withdrawal by Subject|2|||
30725561|NCT03961529|58738817|FG002|Overall Study|Withdrawal by Subject|1|||
30725562|NCT03961529|58738815|FG000|Overall Study|Withdrawal by parent/guardian|0|||
30725563|NCT03961529|58738816|FG001|Overall Study|Withdrawal by parent/guardian|7|||
30725564|NCT03961529|58738817|FG002|Overall Study|Withdrawal by parent/guardian|0|||
30725565|NCT03961529|58738815|FG000|Overall Study|Physician Decision|2|||
30725566|NCT03961529|58738816|FG001|Overall Study|Physician Decision|1|||
30725567|NCT03961529|58738817|FG002|Overall Study|Physician Decision|1|||
30725568|NCT03961529|58738815|FG000|Overall Study|Lost to Follow-up|2|||
30725569|NCT03961529|58738816|FG001|Overall Study|Lost to Follow-up|1|||
30725570|NCT03961529|58738817|FG002|Overall Study|Lost to Follow-up|0|||
30725571|NCT03961529|58738815|FG000|Overall Study|Lack of Efficacy|2|||
30725572|NCT03961529|58738816|FG001|Overall Study|Lack of Efficacy|0|||
30725573|NCT03961529|58738817|FG002|Overall Study|Lack of Efficacy|1|||
30725574|NCT03961529|58738815|FG000|Overall Study|Other|6|||
30725575|NCT03961529|58738816|FG001|Overall Study|Other|1|||
30725576|NCT03961529|58738817|FG002|Overall Study|Other|0|||
30725577|NCT00494780|58738827|FG000|Overall Study|Adverse Event|1|||
30725578|NCT00494780|58738828|FG001|Overall Study|Adverse Event|0|||
30725579|NCT00494780|58738827|FG000|Overall Study|Withdrew before Dosed|0|||
30725580|NCT00494780|58738828|FG001|Overall Study|Withdrew before Dosed|1|||
30725581|NCT00494780|58738827|FG000|Overall Study|Progression of Study Disease|7|||
30725582|NCT00494780|58738828|FG001|Overall Study|Progression of Study Disease|8|||
30725583|NCT00494780|58738827|FG000|Overall Study|New Treatment|2|||
30725584|NCT00494780|58738828|FG001|Overall Study|New Treatment|2|||
30725585|NCT00494780|58738827|FG000|Overall Study|Non-compliance|1|||
30725586|NCT00494780|58738828|FG001|Overall Study|Non-compliance|0|||
30725587|NCT00494780|58738827|FG000|Overall Study|Residual Tumour Mass|0|||
30725588|NCT00494780|58738828|FG001|Overall Study|Residual Tumour Mass|1|||
30725589|NCT00494780|58738827|FG000|Overall Study|Insurance Issues|0|||
30725590|NCT00494780|58738828|FG001|Overall Study|Insurance Issues|1|||
30725591|NCT00490022|58738838|FG000|Overall Study|Adverse Event|0|||
30725592|NCT00490022|58738839|FG001|Overall Study|Adverse Event|2|||
30725593|NCT00490022|58738838|FG000|Overall Study|Withdrawal by Subject|1|||
30725594|NCT00490022|58738839|FG001|Overall Study|Withdrawal by Subject|0|||
30725595|NCT00490022|58738838|FG000|Overall Study|Subject failed to disclose concommitant|0|||
30725596|NCT00490022|58738839|FG001|Overall Study|Subject failed to disclose concommitant|1|||
30725597|NCT00493454|58738845|FG000|Overall Study|Withdrawal by Subject|1|||
30725598|NCT00493220|58738855|FG000|Third Intervention|Withdrawal by Subject|1|||
30725599|NCT00493220|58738856|FG001|Third Intervention|Withdrawal by Subject|0|||
30725600|NCT00493220|58738857|FG002|Third Intervention|Withdrawal by Subject|0|||
30725601|NCT00493220|58738858|FG003|Third Intervention|Withdrawal by Subject|0|||
30725602|NCT00493220|58738859|FG004|Third Intervention|Withdrawal by Subject|0|||
30725603|NCT00493220|58738860|FG005|Third Intervention|Withdrawal by Subject|0|||
30725604|NCT00394953|58738872|FG000|First Treatment Period|Adverse Event|1|||
30725605|NCT00394953|58738873|FG001|First Treatment Period|Adverse Event|2|||
30725606|NCT00394953|58738872|FG000|First Treatment Period|Death|6|||
30725607|NCT00394953|58738873|FG001|First Treatment Period|Death|7|||
30725608|NCT00394953|58738872|FG000|First Treatment Period|Lack of Efficacy|1|||
30725609|NCT00394953|58738873|FG001|First Treatment Period|Lack of Efficacy|1|||
30725610|NCT00394953|58738872|FG000|First Treatment Period|Withdrawal by Subject|6|||
30725611|NCT00394953|58738873|FG001|First Treatment Period|Withdrawal by Subject|3|||
30725612|NCT00394953|58738872|FG000|First Treatment Period|Lost to Follow-up|0|||
30725613|NCT00394953|58738873|FG001|First Treatment Period|Lost to Follow-up|1|||
30725614|NCT00394953|58738872|FG000|First Treatment Period|Renal transplant|11|||
30725615|NCT00394953|58738873|FG001|First Treatment Period|Renal transplant|7|||
30725616|NCT00394953|58738872|FG000|First Treatment Period|Not defined|4|||
30725617|NCT00394953|58738873|FG001|First Treatment Period|Not defined|1|||
30725618|NCT00394953|58738872|FG000|Second Treatment Period|Adverse Event|2|||
30725619|NCT00394953|58738873|FG001|Second Treatment Period|Adverse Event|5|||
30725620|NCT00394953|58738872|FG000|Second Treatment Period|Death|8|||
30725621|NCT00394953|58738873|FG001|Second Treatment Period|Death|4|||
30725622|NCT00394953|58738872|FG000|Second Treatment Period|Lack of Efficacy|9|||
30725623|NCT00394953|58738873|FG001|Second Treatment Period|Lack of Efficacy|47|||
30725624|NCT00394953|58738872|FG000|Second Treatment Period|Withdrawal by Subject|3|||
30725625|NCT00394953|58738873|FG001|Second Treatment Period|Withdrawal by Subject|3|||
30725626|NCT00394953|58738872|FG000|Second Treatment Period|Lost to Follow-up|0|||
30725627|NCT00394953|58738873|FG001|Second Treatment Period|Lost to Follow-up|1|||
30725628|NCT00394953|58738872|FG000|Second Treatment Period|Renal transplant|4|||
30725629|NCT00394953|58738873|FG001|Second Treatment Period|Renal transplant|6|||
30725630|NCT00394953|58738872|FG000|Second Treatment Period|Not defined|3|||
30725631|NCT00394953|58738873|FG001|Second Treatment Period|Not defined|8|||
30725632|NCT00485732|58738881|FG000|Overall Study|Protocol Violation|1|||
30725633|NCT00485732|58738882|FG001|Overall Study|Protocol Violation|3|||
30725634|NCT00485732|58738881|FG000|Overall Study|Withdrawal by Subject|5|||
30725635|NCT00485732|58738882|FG001|Overall Study|Withdrawal by Subject|4|||
30725636|NCT00485732|58738881|FG000|Overall Study|Lost to Follow-up|2|||
30725637|NCT00485732|58738882|FG001|Overall Study|Lost to Follow-up|2|||
30725638|NCT00489554|58738888|FG000|Overall Study|Adverse Event|2|||
30725639|NCT00489554|58738888|FG000|Overall Study|Withdrawal by Subject|1|||
30725640|NCT00489554|58738888|FG000|Overall Study|Lost to Follow-up|1|||
30725641|NCT00408681|58738892|FG000|Overall Study|Lack of Efficacy|2|||
30725642|NCT00408681|58738892|FG000|Overall Study|Adverse Event|7|||
30725643|NCT00560417|58738899|FG000|Overall Study|Adverse Event|3|||
30725644|NCT00560417|58738900|FG001|Overall Study|Adverse Event|2|||
30725645|NCT00560417|58738899|FG000|Overall Study|Entry Criteria Not Met|1|||
30725646|NCT00560417|58738900|FG001|Overall Study|Entry Criteria Not Met|0|||
30725647|NCT00560417|58738899|FG000|Overall Study|Lost to Follow-up|0|||
30725648|NCT00560417|58738900|FG001|Overall Study|Lost to Follow-up|1|||
30725649|NCT00560417|58738899|FG000|Overall Study|Physician Decision|2|||
30725650|NCT00560417|58738900|FG001|Overall Study|Physician Decision|6|||
30725651|NCT00560417|58738899|FG000|Overall Study|Protocol Violation|6|||
30725652|NCT00560417|58738900|FG001|Overall Study|Protocol Violation|5|||
30725653|NCT00560417|58738899|FG000|Overall Study|Sponsor Decision|2|||
30725654|NCT00560417|58738900|FG001|Overall Study|Sponsor Decision|0|||
30725655|NCT00560417|58738899|FG000|Overall Study|Withdrawal by Subject|3|||
30725656|NCT00560417|58738900|FG001|Overall Study|Withdrawal by Subject|3|||
30725657|NCT03968159|58738913|FG000|Overall Study|Adverse Event|4|||
30725658|NCT03968159|58738914|FG001|Overall Study|Adverse Event|4|||
30725659|NCT03968159|58738913|FG000|Overall Study|Lost to Follow-up|1|||
30725660|NCT03968159|58738914|FG001|Overall Study|Lost to Follow-up|1|||
30725661|NCT03968159|58738913|FG000|Overall Study|Use of prohibited medication|0|||
30725662|NCT03968159|58738914|FG001|Overall Study|Use of prohibited medication|1|||
30725663|NCT03968159|58738913|FG000|Overall Study|Protocol Violation|2|||
30725664|NCT03968159|58738914|FG001|Overall Study|Protocol Violation|2|||
30725665|NCT03968159|58738913|FG000|Overall Study|Withdrawal by Subject|4|||
30725666|NCT03968159|58738914|FG001|Overall Study|Withdrawal by Subject|6|||
30725667|NCT03968159|58738913|FG000|Overall Study|Lack of Efficacy|0|||
30900414|NCT02322866|58933798|FG000|Overall Study|Lost to Follow-up|36|||
30725668|NCT03968159|58738914|FG001|Overall Study|Lack of Efficacy|1|||
30725669|NCT03968159|58738913|FG000|Overall Study|Not further specified|2|||
30725670|NCT03968159|58738914|FG001|Overall Study|Not further specified|0|||
30725671|NCT03966911|58738922|FG000|Overall Study|Adverse Event|1|||
30725672|NCT03966911|58738923|FG001|Overall Study|Adverse Event|1|||
30725673|NCT03966911|58738922|FG000|Overall Study|Withdrawal by Subject|8|||
30725674|NCT03966911|58738923|FG001|Overall Study|Withdrawal by Subject|2|||
30725675|NCT03966911|58738922|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
30725676|NCT03966911|58738923|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
30725677|NCT03966365|58738933|FG000|Overall Study|Protocol Violation|1|||
30725678|NCT03966365|58738934|FG001|Overall Study|Protocol Violation|0|||
30725679|NCT00375219|58738943|FG000|Overall Study|Failure to achieve a response|16|||
30725680|NCT00375219|58738944|FG001|Overall Study|Failure to achieve a response|2|||
30725681|NCT00375219|58738945|FG002|Overall Study|Failure to achieve a response|0|||
30725682|NCT00375219|58738943|FG000|Overall Study|Adverse Event|8|||
30725683|NCT00375219|58738944|FG001|Overall Study|Adverse Event|2|||
30725684|NCT00375219|58738945|FG002|Overall Study|Adverse Event|1|||
30725685|NCT00375219|58738943|FG000|Overall Study|Protocol Violation|1|||
30725686|NCT00375219|58738944|FG001|Overall Study|Protocol Violation|0|||
30725687|NCT00375219|58738945|FG002|Overall Study|Protocol Violation|1|||
30725688|NCT00375219|58738943|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
30725689|NCT00375219|58738944|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
30725690|NCT00375219|58738945|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
30725691|NCT00375219|58738943|FG000|Overall Study|Lost to Follow-up|1|||
30725692|NCT00375219|58738944|FG001|Overall Study|Lost to Follow-up|1|||
30725693|NCT00375219|58738945|FG002|Overall Study|Lost to Follow-up|0|||
30725694|NCT00375219|58738943|FG000|Overall Study|Disease progression|18|||
30725695|NCT00375219|58738944|FG001|Overall Study|Disease progression|9|||
30725696|NCT00375219|58738945|FG002|Overall Study|Disease progression|12|||
30725697|NCT00375219|58738943|FG000|Overall Study|Death|4|||
30725698|NCT00375219|58738944|FG001|Overall Study|Death|3|||
30725699|NCT00375219|58738945|FG002|Overall Study|Death|7|||
30725700|NCT00375219|58738943|FG000|Overall Study|Hematologic resistance|1|||
30725701|NCT00375219|58738944|FG001|Overall Study|Hematologic resistance|0|||
30725702|NCT00375219|58738945|FG002|Overall Study|Hematologic resistance|0|||
30725703|NCT00375219|58738943|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
30725704|NCT00375219|58738944|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
30725705|NCT00375219|58738945|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
30725706|NCT00375219|58738943|FG000|Overall Study|Allograft|2|||
30725707|NCT00375219|58738944|FG001|Overall Study|Allograft|0|||
30725708|NCT00375219|58738945|FG002|Overall Study|Allograft|0|||
30725709|NCT00375219|58738943|FG000|Overall Study|Cord blood transplantation|1|||
30725710|NCT00375219|58738944|FG001|Overall Study|Cord blood transplantation|0|||
30725711|NCT00375219|58738945|FG002|Overall Study|Cord blood transplantation|0|||
30725712|NCT00375219|58738943|FG000|Overall Study|Withdrawal by Subject|1|||
30725713|NCT00375219|58738944|FG001|Overall Study|Withdrawal by Subject|0|||
30725714|NCT00375219|58738945|FG002|Overall Study|Withdrawal by Subject|0|||
30725715|NCT03965351|58738954|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
30725716|NCT03965351|58738955|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
30725717|NCT03965351|58738954|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
30725718|NCT03965351|58738955|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
30725719|NCT00554801|58738963|FG000|Overall Study|left area before completion|5|||
30725720|NCT00554801|58738964|FG001|Overall Study|left area before completion|0|||
30725721|NCT00554801|58738963|FG000|Overall Study|Withdrawal by Subject|14|||
30725722|NCT00554801|58738964|FG001|Overall Study|Withdrawal by Subject|0|||
30725723|NCT00374907|58738974|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
30725724|NCT00374907|58738975|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
30725725|NCT00374907|58738974|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
30725726|NCT00374907|58738975|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
30725727|NCT00374907|58738974|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
30725728|NCT00374907|58738975|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
30725729|NCT00374907|58738974|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
30725730|NCT00374907|58738975|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
30725731|NCT00374907|58738974|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
30725732|NCT00374907|58738975|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
30725733|NCT00374127|58738983|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
30725734|NCT00374127|58738983|FG000|Overall Study|Blood could not be drawn.|2|||
30725735|NCT00374127|58738983|FG000|Overall Study|Protocol Violation|5|||
30725736|NCT00374127|58738983|FG000|Overall Study|Pregnancy|1|||
30725737|NCT00553787|58738996|FG000|Overall Study|Adverse Event|34|||
30725738|NCT00553787|58738997|FG001|Overall Study|Adverse Event|21|||
30725739|NCT00553787|58738998|FG002|Overall Study|Adverse Event|67|||
30725740|NCT00553787|58738996|FG000|Overall Study|Lost to Follow-up|132|||
30725741|NCT00553787|58738997|FG001|Overall Study|Lost to Follow-up|44|||
30725742|NCT00553787|58738998|FG002|Overall Study|Lost to Follow-up|78|||
30725743|NCT00553787|58738996|FG000|Overall Study|Withdrawal by Subject|151|||
30725744|NCT00553787|58738997|FG001|Overall Study|Withdrawal by Subject|40|||
30725745|NCT00553787|58738998|FG002|Overall Study|Withdrawal by Subject|83|||
30725746|NCT00553787|58738996|FG000|Overall Study|Lack of Efficacy|31|||
30725747|NCT00553787|58738997|FG001|Overall Study|Lack of Efficacy|1|||
30725748|NCT00553787|58738998|FG002|Overall Study|Lack of Efficacy|3|||
30725749|NCT00553787|58738996|FG000|Overall Study|Pregnancy|0|||
30725750|NCT00553787|58738997|FG001|Overall Study|Pregnancy|1|||
30725751|NCT00553787|58738998|FG002|Overall Study|Pregnancy|2|||
30725752|NCT00553787|58738996|FG000|Overall Study|non compliance|4|||
30725753|NCT00553787|58738997|FG001|Overall Study|non compliance|0|||
30725754|NCT00553787|58738998|FG002|Overall Study|non compliance|11|||
30725755|NCT00553787|58738996|FG000|Overall Study|Requirement for restricted medication|8|||
30725756|NCT00553787|58738997|FG001|Overall Study|Requirement for restricted medication|7|||
30725757|NCT00553787|58738998|FG002|Overall Study|Requirement for restricted medication|5|||
30725758|NCT00553787|58738996|FG000|Overall Study|Other|18|||
30725759|NCT00553787|58738997|FG001|Overall Study|Other|10|||
30725760|NCT00553787|58738998|FG002|Overall Study|Other|13|||
30725761|NCT00407745|58739008|FG000|Overall Study|Lack of Efficacy|1|||
30725762|NCT00407745|58739009|FG001|Overall Study|Lack of Efficacy|2|||
30725763|NCT00407745|58739008|FG000|Overall Study|Withdrawal by Subject|3|||
30725764|NCT00407745|58739009|FG001|Overall Study|Withdrawal by Subject|3|||
30725765|NCT00407745|58739008|FG000|Overall Study|Protocol Violation|5|||
30725766|NCT00407745|58739009|FG001|Overall Study|Protocol Violation|3|||
30725767|NCT00407745|58739008|FG000|Overall Study|Adverse Event|8|||
30725768|NCT00407745|58739009|FG001|Overall Study|Adverse Event|8|||
30725769|NCT00407745|58739008|FG000|Overall Study|Other|2|||
30725770|NCT00407745|58739009|FG001|Overall Study|Other|0|||
30725771|NCT00407745|58739008|FG000|Overall Study|Randomized, unknown if treated|0|||
30725772|NCT00407745|58739009|FG001|Overall Study|Randomized, unknown if treated|1|||
30725773|NCT03958955|58739015|FG000|Overall Study|Adverse Event|1|||
30725774|NCT00464334|58739032|FG000|Overall Study|Adverse Event|0|||
30725775|NCT00464334|58739033|FG001|Overall Study|Adverse Event|0|||
30725776|NCT00464334|58739034|FG002|Overall Study|Adverse Event|0|||
30725777|NCT00464334|58739035|FG003|Overall Study|Adverse Event|1|||
30725778|NCT00464334|58739036|FG004|Overall Study|Adverse Event|1|||
30725779|NCT00464334|58739037|FG005|Overall Study|Adverse Event|1|||
30725780|NCT00464334|58739038|FG006|Overall Study|Adverse Event|0|||
30725781|NCT00464334|58739039|FG007|Overall Study|Adverse Event|0|||
30725782|NCT00464334|58739040|FG008|Overall Study|Adverse Event|2|||
30725783|NCT00464334|58739041|FG009|Overall Study|Adverse Event|1|||
30725784|NCT00464334|58739042|FG010|Overall Study|Adverse Event|2|||
30725785|NCT00464334|58739032|FG000|Overall Study|Lack of Efficacy|0|||
30725786|NCT00464334|58739033|FG001|Overall Study|Lack of Efficacy|1|||
30725787|NCT00464334|58739034|FG002|Overall Study|Lack of Efficacy|0|||
30725788|NCT00464334|58739035|FG003|Overall Study|Lack of Efficacy|0|||
30725789|NCT00464334|58739036|FG004|Overall Study|Lack of Efficacy|0|||
30725790|NCT00464334|58739037|FG005|Overall Study|Lack of Efficacy|0|||
30725791|NCT00464334|58739038|FG006|Overall Study|Lack of Efficacy|0|||
30725792|NCT00464334|58739039|FG007|Overall Study|Lack of Efficacy|0|||
30725793|NCT00464334|58739040|FG008|Overall Study|Lack of Efficacy|0|||
30725794|NCT00464334|58739041|FG009|Overall Study|Lack of Efficacy|0|||
30725795|NCT00464334|58739042|FG010|Overall Study|Lack of Efficacy|0|||
30725796|NCT00464334|58739032|FG000|Overall Study|Lost to Follow-up|0|||
30725797|NCT00464334|58739033|FG001|Overall Study|Lost to Follow-up|0|||
30725798|NCT00464334|58739034|FG002|Overall Study|Lost to Follow-up|1|||
30725799|NCT00464334|58739035|FG003|Overall Study|Lost to Follow-up|0|||
30725800|NCT00464334|58739036|FG004|Overall Study|Lost to Follow-up|1|||
30725801|NCT00464334|58739037|FG005|Overall Study|Lost to Follow-up|0|||
30725802|NCT00464334|58739038|FG006|Overall Study|Lost to Follow-up|1|||
30725803|NCT00464334|58739039|FG007|Overall Study|Lost to Follow-up|0|||
30725804|NCT00464334|58739040|FG008|Overall Study|Lost to Follow-up|0|||
30725805|NCT00464334|58739041|FG009|Overall Study|Lost to Follow-up|0|||
30725806|NCT00464334|58739042|FG010|Overall Study|Lost to Follow-up|2|||
30725807|NCT00464334|58739032|FG000|Overall Study|Progressive Disease|0|||
30725808|NCT00464334|58739033|FG001|Overall Study|Progressive Disease|0|||
30725809|NCT00464334|58739034|FG002|Overall Study|Progressive Disease|0|||
30725810|NCT00464334|58739035|FG003|Overall Study|Progressive Disease|0|||
30725811|NCT00464334|58739036|FG004|Overall Study|Progressive Disease|0|||
30725812|NCT00464334|58739037|FG005|Overall Study|Progressive Disease|1|||
30725813|NCT00464334|58739038|FG006|Overall Study|Progressive Disease|0|||
30725814|NCT00464334|58739039|FG007|Overall Study|Progressive Disease|0|||
30725815|NCT00464334|58739040|FG008|Overall Study|Progressive Disease|1|||
30725816|NCT00464334|58739041|FG009|Overall Study|Progressive Disease|0|||
30725817|NCT00464334|58739042|FG010|Overall Study|Progressive Disease|0|||
30725818|NCT00464334|58739032|FG000|Overall Study|Study Terminated by Sponsor|0|||
30725819|NCT00464334|58739033|FG001|Overall Study|Study Terminated by Sponsor|0|||
30725820|NCT00464334|58739034|FG002|Overall Study|Study Terminated by Sponsor|0|||
30725821|NCT00464334|58739035|FG003|Overall Study|Study Terminated by Sponsor|1|||
30725822|NCT00464334|58739036|FG004|Overall Study|Study Terminated by Sponsor|0|||
30725823|NCT00464334|58739037|FG005|Overall Study|Study Terminated by Sponsor|0|||
30725824|NCT00464334|58739038|FG006|Overall Study|Study Terminated by Sponsor|0|||
30725825|NCT00464334|58739039|FG007|Overall Study|Study Terminated by Sponsor|0|||
30725826|NCT00464334|58739040|FG008|Overall Study|Study Terminated by Sponsor|0|||
30725827|NCT00464334|58739041|FG009|Overall Study|Study Terminated by Sponsor|0|||
30725828|NCT00464334|58739042|FG010|Overall Study|Study Terminated by Sponsor|0|||
30725829|NCT00464334|58739032|FG000|Overall Study|Withdrawal by Subject|1|||
30725830|NCT00464334|58739033|FG001|Overall Study|Withdrawal by Subject|7|||
30725831|NCT00464334|58739034|FG002|Overall Study|Withdrawal by Subject|4|||
30725832|NCT00464334|58739035|FG003|Overall Study|Withdrawal by Subject|2|||
30725833|NCT00464334|58739036|FG004|Overall Study|Withdrawal by Subject|2|||
30725834|NCT00464334|58739037|FG005|Overall Study|Withdrawal by Subject|2|||
30725835|NCT00464334|58739038|FG006|Overall Study|Withdrawal by Subject|2|||
30725836|NCT00464334|58739039|FG007|Overall Study|Withdrawal by Subject|1|||
30725837|NCT00464334|58739040|FG008|Overall Study|Withdrawal by Subject|3|||
30725838|NCT00464334|58739041|FG009|Overall Study|Withdrawal by Subject|0|||
30725839|NCT00464334|58739042|FG010|Overall Study|Withdrawal by Subject|0|||
30725840|NCT00299494|58739083|FG000|Overall Study|Withdrawal by Subject|0|||
30725841|NCT00299494|58739084|FG001|Overall Study|Withdrawal by Subject|0|||
30725842|NCT00299494|58739085|FG002|Overall Study|Withdrawal by Subject|0|||
30725843|NCT00299494|58739086|FG003|Overall Study|Withdrawal by Subject|3|||
30725844|NCT00299494|58739087|FG004|Overall Study|Withdrawal by Subject|1|||
30725845|NCT00299494|58739088|FG005|Overall Study|Withdrawal by Subject|4|||
30725846|NCT00299494|58739083|FG000|Overall Study|Physician Decision|0|||
30725847|NCT00299494|58739084|FG001|Overall Study|Physician Decision|0|||
30725848|NCT00299494|58739085|FG002|Overall Study|Physician Decision|0|||
30725849|NCT00299494|58739086|FG003|Overall Study|Physician Decision|0|||
30725850|NCT00299494|58739087|FG004|Overall Study|Physician Decision|1|||
30725851|NCT00299494|58739088|FG005|Overall Study|Physician Decision|0|||
30725852|NCT00299494|58739083|FG000|Overall Study|Death|3|||
30725853|NCT00299494|58739084|FG001|Overall Study|Death|1|||
30725854|NCT00299494|58739085|FG002|Overall Study|Death|4|||
30725855|NCT00299494|58739086|FG003|Overall Study|Death|6|||
30725856|NCT00299494|58739087|FG004|Overall Study|Death|18|||
30725857|NCT00299494|58739088|FG005|Overall Study|Death|19|||
30725858|NCT00299494|58739083|FG000|Overall Study|Lost to Follow-up|0|||
30725859|NCT00299494|58739084|FG001|Overall Study|Lost to Follow-up|0|||
30725860|NCT00299494|58739085|FG002|Overall Study|Lost to Follow-up|0|||
30725861|NCT00299494|58739086|FG003|Overall Study|Lost to Follow-up|0|||
30725862|NCT00299494|58739087|FG004|Overall Study|Lost to Follow-up|3|||
30725863|NCT00299494|58739088|FG005|Overall Study|Lost to Follow-up|1|||
30725864|NCT00299494|58739083|FG000|Overall Study|Other - Unspecified|0|||
30725865|NCT00299494|58739084|FG001|Overall Study|Other - Unspecified|0|||
30725866|NCT00299494|58739085|FG002|Overall Study|Other - Unspecified|0|||
30725867|NCT00299494|58739086|FG003|Overall Study|Other - Unspecified|0|||
30725868|NCT00299494|58739087|FG004|Overall Study|Other - Unspecified|3|||
30725869|NCT00299494|58739088|FG005|Overall Study|Other - Unspecified|1|||
30725870|NCT00299494|58739083|FG000|Overall Study|Other - site closure|0|||
30725871|NCT00299494|58739084|FG001|Overall Study|Other - site closure|0|||
30725872|NCT00299494|58739085|FG002|Overall Study|Other - site closure|0|||
30725873|NCT00299494|58739086|FG003|Overall Study|Other - site closure|1|||
30725874|NCT00299494|58739087|FG004|Overall Study|Other - site closure|1|||
30725875|NCT00299494|58739088|FG005|Overall Study|Other - site closure|1|||
30725876|NCT00453180|58739115|FG000|Overall Study|Lost to Follow-up|2|||
30725877|NCT00453180|58739116|FG001|Overall Study|Lost to Follow-up|1|||
30725878|NCT00453180|58739115|FG000|Overall Study|Adverse Event|1|||
30725879|NCT00453180|58739116|FG001|Overall Study|Adverse Event|2|||
30725880|NCT00464178|58739122|FG000|Overall Study|Protocol Violation|1|||
30725881|NCT00464178|58739122|FG000|Overall Study|Withdrawal by Subject|1|||
30725882|NCT00560105|58739129|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
30725883|NCT00560105|58739130|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
30725884|NCT00467610|58739136|FG000|Overall Study|Withdrawal by Subject|1|||
30725885|NCT00316186|58739140|FG000|Overall Study|Adverse Event|6|||
30725886|NCT00316186|58739140|FG000|Overall Study|Disease Progression|4|||
30725887|NCT00316186|58739140|FG000|Overall Study|Lost to Follow-up|1|||
30725888|NCT00316186|58739140|FG000|Overall Study|Other|1|||
30725889|NCT00453102|58739144|FG000|Overall Study|Withdrawal by Subject|2|||
30725890|NCT00299182|58739155|FG000|Overall Study|Withdrawal by Subject|0|||
30725891|NCT00299182|58739156|FG001|Overall Study|Withdrawal by Subject|0|||
30725892|NCT00299182|58739157|FG002|Overall Study|Withdrawal by Subject|1|||
30725893|NCT00299182|58739158|FG003|Overall Study|Withdrawal by Subject|0|||
30725894|NCT00299182|58739159|FG004|Overall Study|Withdrawal by Subject|1|||
30725895|NCT00299182|58739160|FG005|Overall Study|Withdrawal by Subject|2|||
30725896|NCT00299182|58739161|FG006|Overall Study|Withdrawal by Subject|0|||
30725897|NCT00299182|58739155|FG000|Overall Study|Chemotherapy Changed|0|||
30725898|NCT00299182|58739156|FG001|Overall Study|Chemotherapy Changed|0|||
30725899|NCT00299182|58739157|FG002|Overall Study|Chemotherapy Changed|1|||
30725900|NCT00299182|58739158|FG003|Overall Study|Chemotherapy Changed|0|||
30725901|NCT00299182|58739159|FG004|Overall Study|Chemotherapy Changed|1|||
30725902|NCT00299182|58739160|FG005|Overall Study|Chemotherapy Changed|0|||
30725903|NCT00299182|58739161|FG006|Overall Study|Chemotherapy Changed|1|||
30725904|NCT00299182|58739155|FG000|Overall Study|Adverse Event|0|||
30725905|NCT00299182|58739156|FG001|Overall Study|Adverse Event|0|||
30725906|NCT00299182|58739157|FG002|Overall Study|Adverse Event|0|||
30725907|NCT00299182|58739158|FG003|Overall Study|Adverse Event|0|||
30725908|NCT00299182|58739159|FG004|Overall Study|Adverse Event|0|||
30725909|NCT00299182|58739160|FG005|Overall Study|Adverse Event|1|||
30725910|NCT00299182|58739161|FG006|Overall Study|Adverse Event|0|||
30725911|NCT00299182|58739155|FG000|Overall Study|Not Eligible|0|||
30725912|NCT00299182|58739156|FG001|Overall Study|Not Eligible|0|||
30725913|NCT00299182|58739157|FG002|Overall Study|Not Eligible|0|||
30725914|NCT00299182|58739158|FG003|Overall Study|Not Eligible|0|||
30725915|NCT00299182|58739159|FG004|Overall Study|Not Eligible|1|||
30725916|NCT00299182|58739160|FG005|Overall Study|Not Eligible|0|||
30725917|NCT00299182|58739161|FG006|Overall Study|Not Eligible|0|||
30725918|NCT00467142|58739179|FG000|Overall Study|Withdrawal by Subject|1|||
30725919|NCT00467142|58739179|FG000|Overall Study|Adverse Event|1|||
30725920|NCT00467142|58739179|FG000|Overall Study|Protocol Violation|1|||
30725921|NCT00553475|58739186|FG000|Overall Study|Adverse Event|7|||
30725922|NCT00553475|58739187|FG001|Overall Study|Adverse Event|17|||
30725923|NCT00553475|58739188|FG002|Overall Study|Adverse Event|13|||
30725924|NCT00553475|58739186|FG000|Overall Study|Lack of Efficacy|7|||
30725925|NCT00553475|58739187|FG001|Overall Study|Lack of Efficacy|1|||
30725926|NCT00553475|58739188|FG002|Overall Study|Lack of Efficacy|0|||
30725927|NCT00553475|58739186|FG000|Overall Study|Withdrawal by Subject|1|||
30725928|NCT00553475|58739187|FG001|Overall Study|Withdrawal by Subject|1|||
30725929|NCT00553475|58739188|FG002|Overall Study|Withdrawal by Subject|0|||
30725930|NCT00553475|58739186|FG000|Overall Study|Physician Decision|1|||
30725931|NCT00553475|58739187|FG001|Overall Study|Physician Decision|0|||
30725932|NCT00553475|58739188|FG002|Overall Study|Physician Decision|0|||
30725933|NCT00553475|58739186|FG000|Overall Study|Due to moving|0|||
30725934|NCT00553475|58739187|FG001|Overall Study|Due to moving|1|||
30725935|NCT00553475|58739188|FG002|Overall Study|Due to moving|0|||
30725936|NCT00329602|58739200|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
30725937|NCT00329602|58739201|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
30725938|NCT00329602|58739202|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
30725939|NCT00329602|58739200|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
30725940|NCT00329602|58739201|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
30725941|NCT00329602|58739202|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
30725942|NCT00329602|58739200|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
30725943|NCT00329602|58739201|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
30725944|NCT00329602|58739202|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
30725945|NCT00329602|58739200|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
30725946|NCT00329602|58739201|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
30725947|NCT00329602|58739202|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
30725948|NCT00329602|58739200|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
30725949|NCT00329602|58739201|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
30725950|NCT00329602|58739202|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
30725951|NCT00329602|58739200|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
30725952|NCT00329602|58739201|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
30725953|NCT00329602|58739202|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
30725954|NCT00463866|58739220|FG000|Overall Study|Adverse Event|70|||
30725955|NCT00463866|58739221|FG001|Overall Study|Adverse Event|93|||
30725956|NCT00463866|58739220|FG000|Overall Study|Withdrawal by Subject|81|||
30725957|NCT00463866|58739221|FG001|Overall Study|Withdrawal by Subject|79|||
30725958|NCT00463866|58739220|FG000|Overall Study|Lost to Follow-up|46|||
30725959|NCT00463866|58739221|FG001|Overall Study|Lost to Follow-up|55|||
30725960|NCT00463866|58739220|FG000|Overall Study|Incorrect Enrolment|64|||
30725961|NCT00463866|58739221|FG001|Overall Study|Incorrect Enrolment|66|||
30725962|NCT00463866|58739220|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
30725963|NCT00463866|58739221|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
30725964|NCT00463866|58739220|FG000|Overall Study|Safety Reason|1|||
30725965|NCT00463866|58739221|FG001|Overall Study|Safety Reason|3|||
30725966|NCT00463866|58739220|FG000|Overall Study|Mis-Randomization of subject|0|||
30725967|NCT00463866|58739221|FG001|Overall Study|Mis-Randomization of subject|1|||
30725968|NCT00463866|58739220|FG000|Overall Study|Other|22|||
30725969|NCT00463866|58739221|FG001|Overall Study|Other|22|||
30725970|NCT00313846|58739229|FG000|Overall Study|Withdrawal by Subject|2|||
30725971|NCT00313846|58739230|FG001|Overall Study|Withdrawal by Subject|0|||
30725972|NCT00313846|58739229|FG000|Overall Study|Adverse Event|1|||
30725973|NCT00313846|58739230|FG001|Overall Study|Adverse Event|8|||
30725974|NCT00313846|58739229|FG000|Overall Study|Administrative|2|||
30725975|NCT00313846|58739230|FG001|Overall Study|Administrative|3|||
30725976|NCT00551135|58739241|FG000|Overall Study|Adverse Event|1|||
30725977|NCT00551135|58739242|FG001|Overall Study|Adverse Event|0|||
30725978|NCT00551135|58739243|FG002|Overall Study|Adverse Event|1|||
30725979|NCT00551135|58739244|FG003|Overall Study|Adverse Event|1|||
30725980|NCT00551135|58739241|FG000|Overall Study|Lost to Follow-up|0|||
30725981|NCT00551135|58739242|FG001|Overall Study|Lost to Follow-up|0|||
30725982|NCT00551135|58739243|FG002|Overall Study|Lost to Follow-up|0|||
30725983|NCT00551135|58739244|FG003|Overall Study|Lost to Follow-up|1|||
30725984|NCT00551135|58739241|FG000|Overall Study|Other|3|||
30725985|NCT00551135|58739242|FG001|Overall Study|Other|2|||
30725986|NCT00551135|58739243|FG002|Overall Study|Other|1|||
30725987|NCT00551135|58739244|FG003|Overall Study|Other|2|||
30725988|NCT00551135|58739241|FG000|Overall Study|Withdrawal by Subject|1|||
30725989|NCT00551135|58739242|FG001|Overall Study|Withdrawal by Subject|0|||
30725990|NCT00551135|58739243|FG002|Overall Study|Withdrawal by Subject|3|||
30725991|NCT00551135|58739244|FG003|Overall Study|Withdrawal by Subject|1|||
30725992|NCT00299104|58739257|FG000|Treatment Period|Adverse Event|14|||
30725993|NCT00299104|58739258|FG001|Treatment Period|Adverse Event|9|||
30725994|NCT00299104|58739259|FG002|Treatment Period|Adverse Event|7|||
30725995|NCT00299104|58739257|FG000|Treatment Period|Death|1|||
30725996|NCT00299104|58739258|FG001|Treatment Period|Death|1|||
30725997|NCT00299104|58739259|FG002|Treatment Period|Death|1|||
30725998|NCT00299104|58739257|FG000|Treatment Period|Insufficient therapeutic response|34|||
30725999|NCT00299104|58739258|FG001|Treatment Period|Insufficient therapeutic response|13|||
30726000|NCT00299104|58739259|FG002|Treatment Period|Insufficient therapeutic response|8|||
30726001|NCT00299104|58739257|FG000|Treatment Period|Failure to return|9|||
30726002|NCT00299104|58739258|FG001|Treatment Period|Failure to return|8|||
30726003|NCT00299104|58739259|FG002|Treatment Period|Failure to return|8|||
30726004|NCT00299104|58739257|FG000|Treatment Period|Violation of selection criteria|1|||
30726005|NCT00299104|58739258|FG001|Treatment Period|Violation of selection criteria|2|||
30726006|NCT00299104|58739259|FG002|Treatment Period|Violation of selection criteria|0|||
30726007|NCT00299104|58739257|FG000|Treatment Period|Protocol Violation|1|||
30726008|NCT00299104|58739258|FG001|Treatment Period|Protocol Violation|1|||
30726009|NCT00299104|58739259|FG002|Treatment Period|Protocol Violation|0|||
30726010|NCT00299104|58739257|FG000|Treatment Period|Refused treatment|9|||
30726011|NCT00299104|58739258|FG001|Treatment Period|Refused treatment|2|||
30726012|NCT00299104|58739259|FG002|Treatment Period|Refused treatment|2|||
30726013|NCT00299104|58739257|FG000|Treatment Period|Withdrew consent|14|||
30726014|NCT00299104|58739258|FG001|Treatment Period|Withdrew consent|19|||
30726015|NCT00299104|58739259|FG002|Treatment Period|Withdrew consent|9|||
30726016|NCT00299104|58739257|FG000|Treatment Period|Administrative reasons|106|||
30726017|NCT00299104|58739258|FG001|Treatment Period|Administrative reasons|120|||
30726018|NCT00299104|58739259|FG002|Treatment Period|Administrative reasons|137|||
30726019|NCT00299104|58739257|FG000|Safety Follow-Up (SFU) Period|Death|3|||
30726020|NCT00299104|58739258|FG001|Safety Follow-Up (SFU) Period|Death|2|||
30726021|NCT00299104|58739259|FG002|Safety Follow-Up (SFU) Period|Death|1|||
30726022|NCT00299104|58739257|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
30726023|NCT00299104|58739258|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
30726024|NCT00299104|58739259|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
30726025|NCT00299104|58739257|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
30726026|NCT00299104|58739258|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
30726027|NCT00299104|58739259|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
30726028|NCT00299104|58739257|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
30726029|NCT00299104|58739258|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
30726030|NCT00299104|58739259|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
30726031|NCT00299104|58739257|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
30726032|NCT00299104|58739258|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
30726033|NCT00299104|58739259|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
30726034|NCT00299104|58739257|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
30726035|NCT00299104|58739258|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
30726036|NCT00299104|58739259|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
30726037|NCT00299104|58739257|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
30726038|NCT00299104|58739258|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
30726039|NCT00299104|58739259|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
30726040|NCT00299104|58739257|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
30726041|NCT00299104|58739258|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
30726042|NCT00299104|58739259|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
30726043|NCT00313612|58739269|FG000|Overall Study|Patient never received treatment|0|||
30726044|NCT00313612|58739270|FG001|Overall Study|Patient never received treatment|1|||
30726045|NCT00507416|58739279|FG000|Overall Study|Adverse Event|58|||
30726046|NCT00507416|58739280|FG001|Overall Study|Adverse Event|67|||
30726047|NCT00507416|58739281|FG002|Overall Study|Adverse Event|65|||
30726048|NCT00507416|58739279|FG000|Overall Study|Protocol Violation|1|||
30726049|NCT00507416|58739280|FG001|Overall Study|Protocol Violation|2|||
30726050|NCT00507416|58739281|FG002|Overall Study|Protocol Violation|0|||
30726051|NCT00507416|58739279|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
30726052|NCT00507416|58739280|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
30726053|NCT00507416|58739281|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
30726054|NCT00507416|58739279|FG000|Overall Study|Progressive Disease|20|||
30726055|NCT00507416|58739280|FG001|Overall Study|Progressive Disease|10|||
30726056|NCT00507416|58739281|FG002|Overall Study|Progressive Disease|13|||
30726057|NCT00507416|58739279|FG000|Overall Study|Patient declined further treatment|18|||
30726058|NCT00507416|58739280|FG001|Overall Study|Patient declined further treatment|14|||
30726059|NCT00507416|58739281|FG002|Overall Study|Patient declined further treatment|11|||
30726060|NCT00507416|58739279|FG000|Overall Study|Other|11|||
30726061|NCT00507416|58739280|FG001|Overall Study|Other|16|||
30726062|NCT00507416|58739281|FG002|Overall Study|Other|13|||
30726063|NCT00507416|58739279|FG000|Overall Study|Did not Receive Study Treatment|3|||
30726064|NCT00507416|58739280|FG001|Overall Study|Did not Receive Study Treatment|9|||
30726065|NCT00507416|58739281|FG002|Overall Study|Did not Receive Study Treatment|4|||
30726066|NCT00489476|58739293|FG000|Overall Study|Lost to Follow-up|0|||
30726067|NCT00489476|58739294|FG001|Overall Study|Lost to Follow-up|1|||
30726068|NCT00489476|58739295|FG002|Overall Study|Lost to Follow-up|0|||
30726069|NCT00489476|58739296|FG003|Overall Study|Lost to Follow-up|0|||
30726070|NCT00550745|58739308|FG000|Overall Study|Death|20|||
30726071|NCT00550745|58739309|FG001|Overall Study|Death|16|||
30726072|NCT00550745|58739308|FG000|Overall Study|Lost to Follow-up|45|||
30726073|NCT00550745|58739309|FG001|Overall Study|Lost to Follow-up|30|||
30726074|NCT00550745|58739308|FG000|Overall Study|Physician Decision|0|||
30726075|NCT00550745|58739309|FG001|Overall Study|Physician Decision|2|||
30726076|NCT00550745|58739308|FG000|Overall Study|Protocol Violation|4|||
30726077|NCT00550745|58739309|FG001|Overall Study|Protocol Violation|2|||
30726078|NCT00550745|58739308|FG000|Overall Study|Withdrawal by Subject|17|||
30726079|NCT00550745|58739309|FG001|Overall Study|Withdrawal by Subject|10|||
30726080|NCT00550745|58739308|FG000|Overall Study|Screen failure|1|||
30726081|NCT00550745|58739309|FG001|Overall Study|Screen failure|0|||
30726082|NCT00452790|58739317|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
30726083|NCT00452790|58739318|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
30726084|NCT00452790|58739317|FG000|Infant Series|Parent/legal guardian request|8|||
30726085|NCT00452790|58739318|FG001|Infant Series|Parent/legal guardian request|6|||
30726086|NCT00452790|58739317|FG000|Infant Series|Failed to return|4|||
30726087|NCT00452790|58739318|FG001|Infant Series|Failed to return|1|||
30726088|NCT00452790|58739317|FG000|Infant Series|Protocol Violation|1|||
30726089|NCT00452790|58739318|FG001|Infant Series|Protocol Violation|3|||
30726090|NCT00452790|58739317|FG000|Infant Series|Lost to Follow-up|2|||
30726091|NCT00452790|58739318|FG001|Infant Series|Lost to Follow-up|2|||
30726092|NCT00452790|58739317|FG000|Infant Series|Adverse Event|1|||
30726093|NCT00452790|58739318|FG001|Infant Series|Adverse Event|2|||
30726094|NCT00452790|58739317|FG000|Infant Series|Other reasons|1|||
30726095|NCT00452790|58739318|FG001|Infant Series|Other reasons|2|||
30726096|NCT00452790|58739317|FG000|Infant Series|Investigator request|0|||
30726097|NCT00452790|58739318|FG001|Infant Series|Investigator request|1|||
30726098|NCT00452790|58739317|FG000|Infant Series|Death|0|||
30726099|NCT00452790|58739318|FG001|Infant Series|Death|1|||
30726100|NCT00452790|58739317|FG000|After Infant Series|Investigator request|10|||
30726101|NCT00452790|58739318|FG001|After Infant Series|Investigator request|10|||
30726102|NCT00452790|58739317|FG000|After Infant Series|Adverse Event|4|||
30726103|NCT00452790|58739318|FG001|After Infant Series|Adverse Event|1|||
30726104|NCT00452790|58739317|FG000|After Infant Series|Parent/legal guardian request|1|||
30726105|NCT00452790|58739318|FG001|After Infant Series|Parent/legal guardian request|3|||
30726106|NCT00452790|58739317|FG000|After Infant Series|Lost to Follow-up|4|||
30726107|NCT00452790|58739318|FG001|After Infant Series|Lost to Follow-up|0|||
30726108|NCT00452790|58739317|FG000|After Infant Series|Failed to return|1|||
30726109|NCT00452790|58739318|FG001|After Infant Series|Failed to return|0|||
30726110|NCT00452790|58739317|FG000|After Infant Series|Other reasons|1|||
30726111|NCT00452790|58739318|FG001|After Infant Series|Other reasons|0|||
30726112|NCT00452790|58739317|FG000|Toddler Dose|Failed to return|0|||
30726113|NCT00452790|58739318|FG001|Toddler Dose|Failed to return|1|||
30726114|NCT00452790|58739317|FG000|Toddler Dose|Parent/legal guardian request|0|||
30726115|NCT00452790|58739318|FG001|Toddler Dose|Parent/legal guardian request|1|||
30726116|NCT00463788|58739330|FG000|Overall Study|Progressive Disease|86|||
30726117|NCT00463788|58739331|FG001|Overall Study|Progressive Disease|42|||
30726118|NCT00463788|58739330|FG000|Overall Study|Adverse Event|6|||
30900415|NCT02322866|58933799|FG001|Overall Study|Lost to Follow-up|39|||
30726119|NCT00463788|58739331|FG001|Overall Study|Adverse Event|2|||
30726120|NCT00463788|58739330|FG000|Overall Study|Withdrawal by Subject|6|||
30726121|NCT00463788|58739331|FG001|Overall Study|Withdrawal by Subject|2|||
30726122|NCT00463788|58739330|FG000|Overall Study|Death|4|||
30726123|NCT00463788|58739331|FG001|Overall Study|Death|3|||
30726124|NCT00463788|58739330|FG000|Overall Study|Symptomatic Deterioration|2|||
30726125|NCT00463788|58739331|FG001|Overall Study|Symptomatic Deterioration|3|||
30900416|NCT02322866|58933798|FG000|Overall Study|Protocol Violation|1|||
30900417|NCT02322866|58933799|FG001|Overall Study|Protocol Violation|0|||
30726126|NCT00463788|58739330|FG000|Overall Study|Lost to Follow-up|1|||
30726127|NCT00463788|58739331|FG001|Overall Study|Lost to Follow-up|0|||
30726128|NCT00463788|58739330|FG000|Overall Study|Protocol Violation|0|||
30726129|NCT00463788|58739331|FG001|Overall Study|Protocol Violation|1|||
30726130|NCT00463788|58739330|FG000|Overall Study|Other|3|||
30726131|NCT00463788|58739331|FG001|Overall Study|Other|0|||
30726132|NCT00463788|58739330|FG000|Overall Study|Randomized but not treated|1|||
30726133|NCT00463788|58739331|FG001|Overall Study|Randomized but not treated|1|||
30726134|NCT00548249|58739343|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
30726135|NCT00548249|58739344|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
30726136|NCT00548249|58739345|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
30726137|NCT00548249|58739346|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
30726138|NCT00548249|58739347|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
30726139|NCT00548249|58739343|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
30726140|NCT00548249|58739344|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
30726141|NCT00548249|58739345|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
30726142|NCT00548249|58739346|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
30726143|NCT00548249|58739347|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
30726144|NCT00548249|58739343|FG000|Overall Study|Protocol Violation|1|||
30726145|NCT00548249|58739344|FG001|Overall Study|Protocol Violation|1|||
30726146|NCT00548249|58739345|FG002|Overall Study|Protocol Violation|4|||
30726147|NCT00548249|58739346|FG003|Overall Study|Protocol Violation|0|||
30726148|NCT00548249|58739347|FG004|Overall Study|Protocol Violation|3|||
30726149|NCT00548249|58739343|FG000|Overall Study|Miscellaneous|2|||
30726150|NCT00548249|58739344|FG001|Overall Study|Miscellaneous|3|||
30726151|NCT00548249|58739345|FG002|Overall Study|Miscellaneous|2|||
30726152|NCT00548249|58739346|FG003|Overall Study|Miscellaneous|0|||
30726153|NCT00548249|58739347|FG004|Overall Study|Miscellaneous|2|||
30726154|NCT00548249|58739343|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
30726155|NCT00548249|58739344|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
30726156|NCT00548249|58739345|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
30726157|NCT00548249|58739346|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
30726158|NCT00548249|58739347|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
30726159|NCT00548249|58739343|FG000|Overall Study|Adverse Event|2|||
30621669|NCT00978627|58633248|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
30726160|NCT00548249|58739344|FG001|Overall Study|Adverse Event|2|||
30726161|NCT00548249|58739345|FG002|Overall Study|Adverse Event|0|||
30726162|NCT00548249|58739346|FG003|Overall Study|Adverse Event|1|||
30726163|NCT00548249|58739347|FG004|Overall Study|Adverse Event|1|||
30726164|NCT00548249|58739343|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
30726165|NCT00548249|58739344|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
30726166|NCT00548249|58739345|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
30726167|NCT00548249|58739346|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
30726168|NCT00548249|58739347|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
30726169|NCT00548249|58739343|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
30726170|NCT00548249|58739344|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
30726171|NCT00548249|58739345|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
30726172|NCT00548249|58739346|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
30726173|NCT00548249|58739347|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
30726174|NCT00548249|58739343|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
30726175|NCT00548249|58739344|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
30726176|NCT00548249|58739345|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
30726177|NCT00548249|58739346|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
30726178|NCT00548249|58739347|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
30726179|NCT00548249|58739343|FG000|Overall Study|Prolonged hospitalization|0|||
30726180|NCT00548249|58739344|FG001|Overall Study|Prolonged hospitalization|0|||
30726181|NCT00548249|58739345|FG002|Overall Study|Prolonged hospitalization|2|||
30726182|NCT00548249|58739346|FG003|Overall Study|Prolonged hospitalization|1|||
30726183|NCT00548249|58739347|FG004|Overall Study|Prolonged hospitalization|0|||
30726184|NCT00548249|58739343|FG000|Overall Study|Withdrawal by Subject|2|||
30726185|NCT00548249|58739344|FG001|Overall Study|Withdrawal by Subject|0|||
30726186|NCT00548249|58739345|FG002|Overall Study|Withdrawal by Subject|0|||
30726187|NCT00548249|58739346|FG003|Overall Study|Withdrawal by Subject|0|||
30726188|NCT00548249|58739347|FG004|Overall Study|Withdrawal by Subject|0|||
30726189|NCT00548249|58739343|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
30726190|NCT00548249|58739344|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
30726191|NCT00548249|58739345|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
30726192|NCT00548249|58739346|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
30726193|NCT00548249|58739347|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
30726194|NCT00548249|58739343|FG000|Overall Study|Sponsor's request|0|||
30726195|NCT00548249|58739344|FG001|Overall Study|Sponsor's request|0|||
30726196|NCT00548249|58739345|FG002|Overall Study|Sponsor's request|0|||
30726197|NCT00548249|58739346|FG003|Overall Study|Sponsor's request|1|||
30726198|NCT00548249|58739347|FG004|Overall Study|Sponsor's request|0|||
30726199|NCT00463476|58739361|FG000|Overall Study|Withdrawal by Subject|1|||
30726200|NCT00463476|58739362|FG001|Overall Study|Withdrawal by Subject|2|||
30726201|NCT00463476|58739361|FG000|Overall Study|Lost to Follow-up|1|||
30726202|NCT00463476|58739362|FG001|Overall Study|Lost to Follow-up|1|||
30726203|NCT03839940|58739370|FG000|Overall Study|Withdrawal by Subject|3|||
30726204|NCT03839940|58739371|FG001|Overall Study|Withdrawal by Subject|0|||
30726205|NCT03839940|58739370|FG000|Overall Study|Protocol Violation|0|||
30726206|NCT03839940|58739371|FG001|Overall Study|Protocol Violation|1|||
30726207|NCT03839940|58739370|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
30726208|NCT03839940|58739371|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
30726209|NCT03839628|58739379|FG000|Overall Study|Withdrawal by Subject|1|||
30726210|NCT00462462|58739385|FG000|Overall Study|Physician Decision|0|||
30726211|NCT00462462|58739386|FG001|Overall Study|Physician Decision|1|||
30726212|NCT00462384|58739394|FG000|Overall Study|Adverse Event|2|||
30726213|NCT00462384|58739394|FG000|Overall Study|Death|2|||
30726214|NCT00462384|58739394|FG000|Overall Study|Withdrawal by Subject|1|||
30726215|NCT00462384|58739394|FG000|Overall Study|Other|4|||
30726216|NCT00452400|58739403|FG000|Overall Study|Adverse Event|1|||
30726217|NCT00452400|58739404|FG001|Overall Study|Adverse Event|1|||
30726218|NCT00452400|58739405|FG002|Overall Study|Adverse Event|5|||
30726219|NCT00452400|58739406|FG003|Overall Study|Adverse Event|0|||
30726220|NCT00452400|58739407|FG004|Overall Study|Adverse Event|2|||
30726221|NCT00452400|58739403|FG000|Overall Study|Protocol Violation|0|||
30726222|NCT00452400|58739404|FG001|Overall Study|Protocol Violation|0|||
30726223|NCT00452400|58739405|FG002|Overall Study|Protocol Violation|1|||
30726224|NCT00452400|58739406|FG003|Overall Study|Protocol Violation|0|||
30726225|NCT00452400|58739407|FG004|Overall Study|Protocol Violation|0|||
30726226|NCT00452400|58739403|FG000|Overall Study|Lost to Follow-up|1|||
30726227|NCT00452400|58739404|FG001|Overall Study|Lost to Follow-up|0|||
30726228|NCT00452400|58739405|FG002|Overall Study|Lost to Follow-up|0|||
30726229|NCT00452400|58739406|FG003|Overall Study|Lost to Follow-up|0|||
30726230|NCT00452400|58739407|FG004|Overall Study|Lost to Follow-up|0|||
30726231|NCT00452400|58739403|FG000|Overall Study|Withdrawal by Subject|1|||
30726232|NCT00452400|58739404|FG001|Overall Study|Withdrawal by Subject|0|||
30726233|NCT00452400|58739405|FG002|Overall Study|Withdrawal by Subject|1|||
30726234|NCT00452400|58739406|FG003|Overall Study|Withdrawal by Subject|0|||
30726235|NCT00452400|58739407|FG004|Overall Study|Withdrawal by Subject|0|||
30726236|NCT00452400|58739403|FG000|Overall Study|Lack of Efficacy|2|||
30726237|NCT00452400|58739404|FG001|Overall Study|Lack of Efficacy|0|||
30726238|NCT00452400|58739405|FG002|Overall Study|Lack of Efficacy|0|||
30726239|NCT00452400|58739406|FG003|Overall Study|Lack of Efficacy|0|||
30726240|NCT00452400|58739407|FG004|Overall Study|Lack of Efficacy|0|||
30726241|NCT00452400|58739403|FG000|Overall Study|Other reasons not listed above|0|||
30726242|NCT00452400|58739404|FG001|Overall Study|Other reasons not listed above|0|||
30726243|NCT00452400|58739405|FG002|Overall Study|Other reasons not listed above|0|||
30726244|NCT00452400|58739406|FG003|Overall Study|Other reasons not listed above|1|||
30726245|NCT00452400|58739407|FG004|Overall Study|Other reasons not listed above|1|||
30726246|NCT00462306|58739421|FG000|Overall Study|insufficient data|0|||
30726247|NCT00462306|58739422|FG001|Overall Study|insufficient data|13|||
30726248|NCT00461682|58739430|FG000|Overall Study|Protocol Violation|1|||
30726249|NCT00443430|58739438|FG000|Overall Study|Lack of Efficacy|3|||
30726250|NCT00443430|58739439|FG001|Overall Study|Lack of Efficacy|3|||
30726251|NCT00443430|58739438|FG000|Overall Study|Adverse Event|1|||
30726252|NCT00443430|58739439|FG001|Overall Study|Adverse Event|1|||
30726253|NCT00460746|58739445|FG000|Overall Study|Adverse Event|1|||
30726254|NCT00460746|58739445|FG000|Overall Study|Lost to Follow-up|1|||
30726255|NCT00443118|58739452|FG000|Overall Study|unknown primary outcome|3|||
30726256|NCT00443118|58739453|FG001|Overall Study|unknown primary outcome|1|||
30726257|NCT00443118|58739454|FG002|Overall Study|unknown primary outcome|0|||
30726258|NCT00443118|58739452|FG000|Overall Study|Withdrawal by Subject|1|||
30726259|NCT00443118|58739453|FG001|Overall Study|Withdrawal by Subject|0|||
30726260|NCT00443118|58739454|FG002|Overall Study|Withdrawal by Subject|0|||
30726261|NCT00460434|58739482|FG000|Overall Study|Lost to Follow-up|3|||
30726262|NCT00460434|58739483|FG001|Overall Study|Lost to Follow-up|7|||
30726263|NCT00373425|58739494|FG000|Overall Study|Relapse of NSCLC|116|||
30726264|NCT00373425|58739495|FG001|Overall Study|Relapse of NSCLC|104|||
30726265|NCT00373425|58739496|FG002|Overall Study|Relapse of NSCLC|19|||
30726266|NCT00373425|58739497|FG003|Overall Study|Relapse of NSCLC|2|||
30726267|NCT00373425|58739498|FG004|Overall Study|Relapse of NSCLC|26|||
30726268|NCT00373425|58739494|FG000|Overall Study|Adverse Event|191|||
30726269|NCT00373425|58739495|FG001|Overall Study|Adverse Event|22|||
30726270|NCT00373425|58739496|FG002|Overall Study|Adverse Event|59|||
30726271|NCT00373425|58739497|FG003|Overall Study|Adverse Event|0|||
30726272|NCT00373425|58739498|FG004|Overall Study|Adverse Event|34|||
30726273|NCT00373425|58739494|FG000|Overall Study|Patient request|35|||
30726274|NCT00373425|58739495|FG001|Overall Study|Patient request|18|||
30726275|NCT00373425|58739496|FG002|Overall Study|Patient request|43|||
30726276|NCT00373425|58739497|FG003|Overall Study|Patient request|6|||
30726277|NCT00373425|58739498|FG004|Overall Study|Patient request|7|||
30726278|NCT00373425|58739494|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
30726279|NCT00373425|58739495|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
30726280|NCT00373425|58739496|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
30726281|NCT00373425|58739497|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
30726282|NCT00373425|58739498|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
30726283|NCT00373425|58739494|FG000|Overall Study|Death|7|||
30726284|NCT00373425|58739495|FG001|Overall Study|Death|0|||
30726285|NCT00373425|58739496|FG002|Overall Study|Death|3|||
30726286|NCT00373425|58739497|FG003|Overall Study|Death|1|||
30726287|NCT00373425|58739498|FG004|Overall Study|Death|0|||
30726288|NCT00459342|58739507|FG000|Overall Study|Not eligible|1|||
30726289|NCT00443040|58739514|FG000|Overall Study|Withdrawal by Subject|1|||
30726290|NCT00443040|58739515|FG001|Overall Study|Withdrawal by Subject|0|||
30726291|NCT00443040|58739516|FG002|Overall Study|Withdrawal by Subject|0|||
30726292|NCT00443040|58739514|FG000|Overall Study|Converted to an open laparotomy|3|||
30726293|NCT00443040|58739515|FG001|Overall Study|Converted to an open laparotomy|0|||
30726294|NCT00443040|58739516|FG002|Overall Study|Converted to an open laparotomy|1|||
30726295|NCT00442962|58739524|FG000|Overall Study|Pregnancy|1|||
30726296|NCT00442962|58739524|FG000|Overall Study|Lost to Follow-up|7|||
30726297|NCT00313300|58739533|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
30726298|NCT00313300|58739534|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
30726299|NCT00313300|58739535|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
30900418|NCT02322866|58933798|FG000|Overall Study|Noncompliance with Treatment|3|||
30726300|NCT00313300|58739536|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
30726301|NCT00313300|58739537|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
30726302|NCT00313300|58739533|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
30726303|NCT00313300|58739534|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
30726304|NCT00313300|58739535|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
30726305|NCT00313300|58739536|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
30726306|NCT00313300|58739537|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
30726307|NCT00313300|58739533|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
30726308|NCT00313300|58739534|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
30726309|NCT00313300|58739535|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
30726310|NCT00313300|58739536|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
30726311|NCT00313300|58739537|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
30726312|NCT00313300|58739533|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
30726313|NCT00313300|58739534|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
30900419|NCT02322866|58933799|FG001|Overall Study|Noncompliance with Treatment|4|||
30726314|NCT00313300|58739535|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
30726315|NCT00313300|58739536|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
30726316|NCT00313300|58739537|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
30726317|NCT00313300|58739533|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
30726318|NCT00313300|58739534|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
30726319|NCT00313300|58739535|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
30726320|NCT00313300|58739536|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
30726321|NCT00313300|58739537|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
30726322|NCT00313300|58739533|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
30726323|NCT00313300|58739534|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
30726324|NCT00313300|58739535|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
30726325|NCT00313300|58739536|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
30726326|NCT00313300|58739537|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
30726327|NCT00313300|58739533|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
30726328|NCT00313300|58739534|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
30726329|NCT00313300|58739535|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
30726330|NCT00313300|58739536|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
30726331|NCT00313300|58739537|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
30726332|NCT00313300|58739533|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
30726333|NCT00313300|58739534|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
30726334|NCT00313300|58739535|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
30726335|NCT00313300|58739536|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
30726336|NCT00313300|58739537|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
30726337|NCT00313300|58739533|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
30726338|NCT00313300|58739534|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
30726339|NCT00313300|58739535|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
30726340|NCT00313300|58739536|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
30726341|NCT00313300|58739537|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
30726342|NCT00313300|58739533|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
30726343|NCT00313300|58739534|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
30726344|NCT00313300|58739535|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
30726345|NCT00313300|58739536|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
30726346|NCT00313300|58739537|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
30726347|NCT00313300|58739533|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
30726348|NCT00313300|58739534|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
30726349|NCT00313300|58739535|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
30726350|NCT00313300|58739536|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
30726351|NCT00313300|58739537|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
30726352|NCT00313300|58739533|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
30726353|NCT00313300|58739534|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
30621670|NCT00978627|58633247|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
30621671|NCT00978627|58633248|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
30621672|NCT00978627|58633247|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
30621673|NCT00978627|58633248|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
30621674|NCT00978627|58633247|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
30621675|NCT00978627|58633248|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
30621676|NCT00978627|58633247|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
30621677|NCT00978627|58633248|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
30621678|NCT00978627|58633247|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
30621679|NCT00978627|58633248|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
30621680|NCT00978627|58633247|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
30621681|NCT00978627|58633248|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
30621682|NCT01181609|58633254|FG000|Overall Study|Adverse Event|1|||
30621683|NCT01181609|58633254|FG000|Overall Study|Withdrawal by Subject|1|||
30621684|NCT01181609|58633254|FG000|Overall Study|Lost to Follow-up|1|||
30621685|NCT01181609|58633254|FG000|Overall Study|Death|50|||
30621686|NCT01154010|58633260|FG000|Overall Study|Lost to Follow-up|0|||
30621687|NCT01154010|58633261|FG001|Overall Study|Lost to Follow-up|1|||
30621688|NCT01153698|58633267|FG000|Overall Study|Adverse Event|12|||
30621689|NCT01153698|58633267|FG000|Overall Study|Lost to Follow-up|4|||
30621690|NCT01153698|58633267|FG000|Overall Study|Withdrawal by Subject|2|||
30621691|NCT01153698|58633267|FG000|Overall Study|Switch to other anticoagulants|4|||
30621692|NCT01153698|58633267|FG000|Overall Study|Other|2|||
30621693|NCT01153698|58633267|FG000|Overall Study|Not treated with Pradaxa|5|||
30621694|NCT01174368|58633272|FG000|Overall Study|Withdrawal by Subject|1|||
30621695|NCT01147926|58633278|FG000|Overall Study|Subject Withdrew Consent|9|||
30621696|NCT01147926|58633279|FG001|Overall Study|Subject Withdrew Consent|10|||
30621697|NCT01147926|58633278|FG000|Overall Study|Adverse Event|7|||
30726354|NCT00313300|58739535|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
30726355|NCT00313300|58739536|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
30726356|NCT00313300|58739537|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
30726357|NCT00313300|58739533|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
30726358|NCT00313300|58739534|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
30726359|NCT00313300|58739535|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
30726360|NCT00313300|58739536|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
30726361|NCT00313300|58739537|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
30726362|NCT00313300|58739533|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
30726363|NCT00313300|58739534|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
30726364|NCT00313300|58739535|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
30726365|NCT00313300|58739536|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
30726366|NCT00313300|58739537|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
30726367|NCT00313300|58739533|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
30726368|NCT00313300|58739534|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
30726369|NCT00313300|58739535|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
30726370|NCT00313300|58739536|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
30726371|NCT00313300|58739537|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
30726372|NCT00313300|58739533|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
30726373|NCT00313300|58739534|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
30726374|NCT00313300|58739535|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
30726375|NCT00313300|58739536|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
30726376|NCT00313300|58739537|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
30726377|NCT00313300|58739533|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
30726378|NCT00313300|58739534|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
30726379|NCT00313300|58739535|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
30726380|NCT00313300|58739536|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
30726381|NCT00313300|58739537|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
30726382|NCT00313300|58739533|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
30726383|NCT00313300|58739534|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
30726384|NCT00313300|58739535|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
30726385|NCT00313300|58739536|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
30726386|NCT00313300|58739537|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
30726387|NCT00313300|58739533|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
30726388|NCT00313300|58739534|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
30726389|NCT00313300|58739535|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
30726390|NCT00313300|58739536|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
30726391|NCT00313300|58739537|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
30726392|NCT00313300|58739533|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
30726393|NCT00313300|58739534|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
30726394|NCT00313300|58739535|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
30726395|NCT00313300|58739536|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
30726396|NCT00313300|58739537|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
30726397|NCT00313300|58739533|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
30726398|NCT00313300|58739534|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
30726399|NCT00313300|58739535|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
30726400|NCT00313300|58739536|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
30726401|NCT00313300|58739537|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
30726402|NCT00459186|58739555|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
30726403|NCT00459186|58739555|FG000|PET Imaging and Assessment|Adverse Event|3|||
30726404|NCT00328510|58739561|FG000|Overall Study|Gag disorder, could not use frame|4|||
30726405|NCT00328510|58739562|FG001|Overall Study|Gag disorder, could not use frame|0|||
30726406|NCT00328510|58739561|FG000|Overall Study|Dentition problems, could not use frame|1|||
30726407|NCT00328510|58739562|FG001|Overall Study|Dentition problems, could not use frame|0|||
30726408|NCT00328510|58739561|FG000|Overall Study|Withdrawal by Subject|4|||
30726409|NCT00328510|58739562|FG001|Overall Study|Withdrawal by Subject|2|||
30726410|NCT00328510|58739561|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
30726411|NCT00328510|58739562|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
30726412|NCT00328510|58739561|FG000|Overall Study|Treatment changed to a single fraction|1|||
30726413|NCT00328510|58739562|FG001|Overall Study|Treatment changed to a single fraction|1|||
30726414|NCT00313144|58739568|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
30726415|NCT00313144|58739568|FG000|Overall Study|Death|7|||
30726416|NCT00313144|58739568|FG000|Overall Study|Lost to Follow-up|5|||
30726417|NCT00313144|58739568|FG000|Overall Study|Withdrawal by Subject|4|||
30726418|NCT00313144|58739568|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
30726419|NCT00313144|58739568|FG000|Overall Study|Physician Decision|4|||
30726420|NCT00313144|58739568|FG000|Overall Study|Adverse event - transient|5|||
30726421|NCT00313144|58739568|FG000|Overall Study|Liver transplant|1|||
30726422|NCT00313144|58739568|FG000|Overall Study|Insurance (homecare provider) change|1|||
30726423|NCT00313144|58739568|FG000|Overall Study|Change to different product|1|||
30726424|NCT00313144|58739568|FG000|Overall Study|Due to termination of the study|66|||
30726425|NCT00459108|58739581|FG000|Overall Study|Withdrawal by Subject|5|||
30726426|NCT00459108|58739581|FG000|Overall Study|Adverse Event|3|||
30726427|NCT00459108|58739581|FG000|Overall Study|Death|2|||
30726428|NCT00459108|58739581|FG000|Overall Study|Progression|1|||
30726429|NCT00458484|58739593|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
30726430|NCT00458484|58739594|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
30726431|NCT00458484|58739595|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
30726432|NCT00458484|58739596|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
30726433|NCT00458484|58739597|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
30726434|NCT00458484|58739598|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
30726435|NCT00458484|58739599|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
30726436|NCT00328198|58739624|FG000|Treatment|Adverse Event|21|||
30726437|NCT00328198|58739624|FG000|Treatment|Death|1|||
30726438|NCT00328198|58739624|FG000|Treatment|Physician Decision|5|||
30726439|NCT00328198|58739624|FG000|Treatment|Withdrawal by Subject|5|||
30726440|NCT00328198|58739624|FG000|Treatment|Evidence of disease progression|2|||
30726441|NCT00328198|58739624|FG000|Treatment|Non-compliance|1|||
30726442|NCT00328198|58739624|FG000|Treatment|Confirmed complete response, MRD -|3|||
30726443|NCT00328198|58739624|FG000|Follow-up|Lost to Follow-up|4|||
30726444|NCT00328198|58739624|FG000|Follow-up|Death|31|||
30726445|NCT00450450|58739630|FG000|Overall Study|Death|1|||
30726446|NCT00450450|58739631|FG001|Overall Study|Death|3|||
30726447|NCT00450450|58739630|FG000|Overall Study|Relapse|2|||
30726448|NCT00450450|58739631|FG001|Overall Study|Relapse|0|||
30726449|NCT00450450|58739630|FG000|Overall Study|Missing Data|2|||
30726450|NCT00450450|58739631|FG001|Overall Study|Missing Data|0|||
30726451|NCT00442572|58739639|FG000|Overall Study|Relapse|8|||
30726452|NCT00442572|58739640|FG001|Overall Study|Relapse|1|||
30726453|NCT00442572|58739639|FG000|Overall Study|Lost to Follow-up|0|||
30726454|NCT00442572|58739640|FG001|Overall Study|Lost to Follow-up|1|||
30726455|NCT00442572|58739639|FG000|Overall Study|Withdrawal by Subject|0|||
30726456|NCT00442572|58739640|FG001|Overall Study|Withdrawal by Subject|1|||
30726457|NCT00442416|58739649|FG000|Overall Study|Adverse Event|4|||
30726458|NCT00442416|58739650|FG001|Overall Study|Adverse Event|1|||
30726459|NCT00442416|58739649|FG000|Overall Study|Death|1|||
30726460|NCT00442416|58739650|FG001|Overall Study|Death|0|||
30726461|NCT00442416|58739649|FG000|Overall Study|Lack of Efficacy|2|||
30726462|NCT00442416|58739650|FG001|Overall Study|Lack of Efficacy|0|||
30726463|NCT00442416|58739649|FG000|Overall Study|Protocol Violation|2|||
30726464|NCT00442416|58739650|FG001|Overall Study|Protocol Violation|3|||
30726465|NCT00442416|58739649|FG000|Overall Study|Withdrew consent|1|||
30726466|NCT00442416|58739650|FG001|Overall Study|Withdrew consent|2|||
30726467|NCT00442416|58739649|FG000|Overall Study|Administrative/Other|27|||
30726468|NCT00442416|58739650|FG001|Overall Study|Administrative/Other|33|||
30726469|NCT00441792|58739658|FG000|Overall Study|Lost to Follow-up|0|||
30726470|NCT00441792|58739659|FG001|Overall Study|Lost to Follow-up|2|||
30726471|NCT00312208|58739667|FG000|Overall Study|Adverse Event|97|||
30726472|NCT00312208|58739668|FG001|Overall Study|Adverse Event|61|||
30726473|NCT00312208|58739667|FG000|Overall Study|Protocol Violation|5|||
30726474|NCT00312208|58739668|FG001|Overall Study|Protocol Violation|3|||
30726475|NCT00312208|58739667|FG000|Overall Study|Death|2|||
30726476|NCT00312208|58739668|FG001|Overall Study|Death|1|||
30726477|NCT00312208|58739667|FG000|Overall Study|Lack of Efficacy|7|||
30621698|NCT01147926|58633279|FG001|Overall Study|Adverse Event|6|||
30621699|NCT01147926|58633278|FG000|Overall Study|Subject Non-Compliant|5|||
30621700|NCT01147926|58633279|FG001|Overall Study|Subject Non-Compliant|4|||
30621701|NCT01147926|58633278|FG000|Overall Study|Principal investigator left hospital|1|||
30621702|NCT01147926|58633279|FG001|Overall Study|Principal investigator left hospital|3|||
30621703|NCT01147926|58633278|FG000|Overall Study|Selection criteria not met|3|||
30621704|NCT01147926|58633279|FG001|Overall Study|Selection criteria not met|1|||
30621705|NCT01147926|58633278|FG000|Overall Study|Lost to Follow-up|0|||
30621706|NCT01147926|58633279|FG001|Overall Study|Lost to Follow-up|2|||
30621707|NCT01147926|58633278|FG000|Overall Study|Sponsor's Decision|0|||
30621708|NCT01147926|58633279|FG001|Overall Study|Sponsor's Decision|1|||
30621709|NCT01147926|58633278|FG000|Overall Study|Lack of Efficacy|1|||
30621710|NCT01147926|58633279|FG001|Overall Study|Lack of Efficacy|0|||
30621711|NCT01147926|58633278|FG000|Overall Study|Too busy, no time for study|1|||
30621712|NCT01147926|58633279|FG001|Overall Study|Too busy, no time for study|0|||
30621713|NCT01147926|58633278|FG000|Overall Study|Went on holiday|0|||
30621714|NCT01147926|58633279|FG001|Overall Study|Went on holiday|1|||
30726478|NCT00312208|58739668|FG001|Overall Study|Lack of Efficacy|4|||
30726479|NCT00312208|58739667|FG000|Overall Study|Lost to Follow-up|3|||
30726480|NCT00312208|58739668|FG001|Overall Study|Lost to Follow-up|5|||
30726481|NCT00312208|58739667|FG000|Overall Study|Withdrawal by Subject|53|||
30726482|NCT00312208|58739668|FG001|Overall Study|Withdrawal by Subject|42|||
30726483|NCT00312208|58739667|FG000|Overall Study|Other|5|||
30726484|NCT00312208|58739668|FG001|Overall Study|Other|7|||
30726485|NCT00297778|58739676|FG000|Overall Study|Adverse Event|16|||
30726486|NCT00297778|58739677|FG001|Overall Study|Adverse Event|10|||
30726487|NCT00297778|58739676|FG000|Overall Study|Withdrawal by Subject|1|||
30726488|NCT00297778|58739677|FG001|Overall Study|Withdrawal by Subject|5|||
30726489|NCT00297778|58739676|FG000|Overall Study|Lack of Efficacy|2|||
30726490|NCT00297778|58739677|FG001|Overall Study|Lack of Efficacy|1|||
30726491|NCT00297778|58739676|FG000|Overall Study|Non-compliant with trial protocol|0|||
30726492|NCT00297778|58739677|FG001|Overall Study|Non-compliant with trial protocol|3|||
30726493|NCT00297778|58739676|FG000|Overall Study|Other|0|||
30726494|NCT00297778|58739677|FG001|Overall Study|Other|1|||
30726495|NCT03848832|58739686|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
30726496|NCT03848832|58739687|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
30726497|NCT03848832|58739688|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
30726498|NCT03848832|58739686|FG000|Overall Study|Withdrawal by Subject|0|||
30726499|NCT03848832|58739687|FG001|Overall Study|Withdrawal by Subject|0|||
30726500|NCT03848832|58739688|FG002|Overall Study|Withdrawal by Subject|1|||
30726501|NCT03848832|58739686|FG000|Overall Study|Withdrawal (Covid-19)|0|||
30726502|NCT03848832|58739687|FG001|Overall Study|Withdrawal (Covid-19)|2|||
30726503|NCT03848832|58739688|FG002|Overall Study|Withdrawal (Covid-19)|0|||
30726504|NCT03848832|58739686|FG000|Overall Study|Physician Decision|2|||
30726505|NCT03848832|58739687|FG001|Overall Study|Physician Decision|1|||
30726506|NCT03848832|58739688|FG002|Overall Study|Physician Decision|3|||
30726507|NCT03848832|58739686|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
30726508|NCT03848832|58739687|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
30726509|NCT03848832|58739688|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
30726510|NCT03848832|58739686|FG000|Overall Study|Adverse Event|1|||
30726511|NCT03848832|58739687|FG001|Overall Study|Adverse Event|0|||
30726512|NCT03848832|58739688|FG002|Overall Study|Adverse Event|0|||
30726513|NCT00450372|58739698|FG000|Overall Study|Physician Decision|1|||
30726514|NCT00327340|58739707|FG000|Overall Study|Withdrawal by Subject|1|||
30726515|NCT00327340|58739708|FG001|Overall Study|Withdrawal by Subject|5|||
30726516|NCT00327340|58739707|FG000|Overall Study|Physician Decision|1|||
30726517|NCT00327340|58739708|FG001|Overall Study|Physician Decision|1|||
30726518|NCT00327340|58739707|FG000|Overall Study|Disease Progression|10|||
30726519|NCT00327340|58739708|FG001|Overall Study|Disease Progression|19|||
30726520|NCT00327340|58739707|FG000|Overall Study|Symptomatic Disease|0|||
30726521|NCT00327340|58739708|FG001|Overall Study|Symptomatic Disease|2|||
30726522|NCT00327340|58739707|FG000|Overall Study|Adverse Event|3|||
30726523|NCT00327340|58739708|FG001|Overall Study|Adverse Event|3|||
30726524|NCT00548093|58739718|FG000|Overall Study|Death|33|||
30726525|NCT00548093|58739719|FG001|Overall Study|Death|13|||
30726526|NCT00548093|58739718|FG000|Overall Study|Lost to Follow-up|3|||
30726527|NCT00548093|58739719|FG001|Overall Study|Lost to Follow-up|1|||
30726528|NCT00548093|58739718|FG000|Overall Study|Objective progression or relapse|1|||
30726529|NCT00548093|58739719|FG001|Overall Study|Objective progression or relapse|1|||
30726530|NCT00548093|58739718|FG000|Overall Study|Other|11|||
30726531|NCT00548093|58739719|FG001|Overall Study|Other|1|||
30726532|NCT00548093|58739718|FG000|Overall Study|Withdrawal by Subject|1|||
30726533|NCT00548093|58739719|FG001|Overall Study|Withdrawal by Subject|0|||
30726534|NCT00548093|58739718|FG000|Overall Study|Completed post-treatment follow-up|1|||
30726535|NCT00548093|58739719|FG001|Overall Study|Completed post-treatment follow-up|0|||
30726536|NCT00450216|58739730|FG000|Overall Study|Adverse Event|38|||
30726537|NCT00450216|58739731|FG001|Overall Study|Adverse Event|23|||
30726538|NCT00450216|58739730|FG000|Overall Study|Withdrawal by Subject|48|||
30726539|NCT00450216|58739731|FG001|Overall Study|Withdrawal by Subject|26|||
30726540|NCT00450216|58739730|FG000|Overall Study|Lost to Follow-up|16|||
30726541|NCT00450216|58739731|FG001|Overall Study|Lost to Follow-up|9|||
30726542|NCT00450216|58739730|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
30726543|NCT00450216|58739731|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
30726544|NCT00450216|58739730|FG000|Overall Study|misc|21|||
30726545|NCT00450216|58739731|FG001|Overall Study|misc|20|||
30726546|NCT00441480|58739739|FG000|Overall Study|Protocol Violation|1|||
30726547|NCT00441480|58739740|FG001|Overall Study|Protocol Violation|1|||
30726548|NCT00441480|58739739|FG000|Overall Study|Withdrawal by Subject|2|||
30726549|NCT00441480|58739740|FG001|Overall Study|Withdrawal by Subject|3|||
30726550|NCT00547703|58739748|FG000|Overall Study|Lost to Follow-up|1|||
30726551|NCT00547703|58739749|FG001|Overall Study|Lost to Follow-up|0|||
30726552|NCT00297232|58739755|FG000|Overall Study|Lack of Efficacy|7|||
30726553|NCT00297232|58739755|FG000|Overall Study|Lost to Follow-up|10|||
30726554|NCT00297232|58739755|FG000|Overall Study|Adverse Event|63|||
30726555|NCT00297232|58739755|FG000|Overall Study|Voluntary Withdrawal|120|||
30726556|NCT00297232|58739755|FG000|Overall Study|Subject was Noncompliant|9|||
30726557|NCT00297232|58739755|FG000|Overall Study|Death|9|||
30726558|NCT00297232|58739755|FG000|Overall Study|Anti-natalizumab Positive|8|||
30726559|NCT00297232|58739755|FG000|Overall Study|Switched to Commercial Tysabri|22|||
30726560|NCT00297232|58739755|FG000|Overall Study|Disease Progression|8|||
30726561|NCT00297232|58739755|FG000|Overall Study|Fear of PML|10|||
30726562|NCT00297232|58739755|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
30726563|NCT00297232|58739755|FG000|Overall Study|Miscellaneous|5|||
30726564|NCT00297232|58739755|FG000|Overall Study|Sponsor Decision|34|||
30726565|NCT00297232|58739755|FG000|Overall Study|Subject Relocated|7|||
30726566|NCT00297232|58739755|FG000|Overall Study|Subject Withdrew Consent|37|||
30726567|NCT00297232|58739755|FG000|Overall Study|Persistently Positive Antibodies|11|||
30726568|NCT00297232|58739755|FG000|Overall Study|Investigator Withdrew From Program|19|||
30726569|NCT00297232|58739755|FG000|Overall Study|Did Not Enroll to Week 264|34|||
30726570|NCT00297232|58739755|FG000|Overall Study|Did Not Enroll to Week 480|17|||
30726571|NCT00297232|58739755|FG000|Overall Study|No data available after Week 264|161|||
30726572|NCT00297232|58739755|FG000|Overall Study|Other|1|||
30726573|NCT00449670|58739771|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
30726574|NCT00449670|58739772|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
30726575|NCT00449670|58739771|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
30726576|NCT00449670|58739772|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
30726577|NCT00449670|58739771|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
30726578|NCT00449670|58739772|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
30726579|NCT00449670|58739771|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
30726580|NCT00449670|58739772|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
30726581|NCT00449670|58739771|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
30726582|NCT00449670|58739772|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
30726583|NCT00449670|58739771|FG000|Booster Phase (Study no.109873)|Other|0|||
30726584|NCT00449670|58739772|FG001|Booster Phase (Study no.109873)|Other|2|||
30726585|NCT00296374|58739788|FG000|Overall Study|Adverse Event|14|||
30726586|NCT00296374|58739789|FG001|Overall Study|Adverse Event|10|||
30726587|NCT00296374|58739790|FG002|Overall Study|Adverse Event|7|||
30726588|NCT00296374|58739788|FG000|Overall Study|Withdrawal by Subject|3|||
30726589|NCT00296374|58739789|FG001|Overall Study|Withdrawal by Subject|5|||
30726590|NCT00296374|58739790|FG002|Overall Study|Withdrawal by Subject|11|||
30726591|NCT00296374|58739788|FG000|Overall Study|Incorrect enrollment|3|||
30726592|NCT00296374|58739789|FG001|Overall Study|Incorrect enrollment|3|||
30726593|NCT00296374|58739790|FG002|Overall Study|Incorrect enrollment|4|||
30726594|NCT00296374|58739788|FG000|Overall Study|Protocol Violation|1|||
30726595|NCT00296374|58739789|FG001|Overall Study|Protocol Violation|2|||
30726596|NCT00296374|58739790|FG002|Overall Study|Protocol Violation|3|||
30726597|NCT00296374|58739788|FG000|Overall Study|Lost to Follow-up|3|||
30726598|NCT00296374|58739789|FG001|Overall Study|Lost to Follow-up|1|||
30726599|NCT00296374|58739790|FG002|Overall Study|Lost to Follow-up|1|||
30726600|NCT00296374|58739788|FG000|Overall Study|Relocated to another state|1|||
30726601|NCT00296374|58739789|FG001|Overall Study|Relocated to another state|0|||
30726602|NCT00296374|58739790|FG002|Overall Study|Relocated to another state|0|||
30726603|NCT00296374|58739788|FG000|Overall Study|Stopped drug before end of study visit|0|||
30726604|NCT00296374|58739789|FG001|Overall Study|Stopped drug before end of study visit|1|||
30726605|NCT00296374|58739790|FG002|Overall Study|Stopped drug before end of study visit|0|||
30726606|NCT00296374|58739788|FG000|Overall Study|Nephrologist introduced ACE|0|||
30726607|NCT00296374|58739789|FG001|Overall Study|Nephrologist introduced ACE|1|||
30726608|NCT00296374|58739790|FG002|Overall Study|Nephrologist introduced ACE|0|||
30726609|NCT00296374|58739788|FG000|Overall Study|Pregnancy|0|||
30726610|NCT00296374|58739789|FG001|Overall Study|Pregnancy|0|||
30726611|NCT00296374|58739790|FG002|Overall Study|Pregnancy|2|||
30726612|NCT00296374|58739788|FG000|Overall Study|Other|0|||
30726613|NCT00296374|58739789|FG001|Overall Study|Other|0|||
30726614|NCT00296374|58739790|FG002|Overall Study|Other|1|||
30726615|NCT00326950|58739813|FG000|Overall Study|Progressive Disease|1|||
30726616|NCT00548717|58739819|FG000|Overall Study|Death|5|||
30726617|NCT00548717|58739820|FG001|Overall Study|Death|2|||
30726618|NCT00548717|58739819|FG000|Overall Study|Relapse|3|||
30726619|NCT00548717|58739820|FG001|Overall Study|Relapse|0|||
30726620|NCT00548717|58739819|FG000|Overall Study|Alternative treatment for GVHD|1|||
30726621|NCT00548717|58739820|FG001|Overall Study|Alternative treatment for GVHD|0|||
30726622|NCT00441168|58739831|FG000|Treatment Period|Death|3|||
30726623|NCT00441168|58739832|FG001|Treatment Period|Death|0|||
30726624|NCT00441168|58739831|FG000|Treatment Period|Adverse Event|1|||
30726625|NCT00441168|58739832|FG001|Treatment Period|Adverse Event|2|||
30726626|NCT00441168|58739831|FG000|Treatment Period|Progressive Disease|0|||
30726627|NCT00441168|58739832|FG001|Treatment Period|Progressive Disease|2|||
30726628|NCT00441168|58739831|FG000|Treatment Period|Protocol Violation|0|||
30726629|NCT00441168|58739832|FG001|Treatment Period|Protocol Violation|1|||
30726630|NCT00441168|58739831|FG000|Treatment Period|Lost to Follow-up|0|||
30726631|NCT00441168|58739832|FG001|Treatment Period|Lost to Follow-up|1|||
30726632|NCT00441168|58739831|FG000|Treatment Period|Withdrawal by Subject|3|||
30726633|NCT00441168|58739832|FG001|Treatment Period|Withdrawal by Subject|0|||
30726634|NCT00441168|58739831|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
30726635|NCT00441168|58739832|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
30726636|NCT00441168|58739831|FG000|Treatment Period|refractory disease|1|||
30726637|NCT00441168|58739832|FG001|Treatment Period|refractory disease|0|||
30726638|NCT00441168|58739831|FG000|Follow-up Period|Death|3|||
30726639|NCT00441168|58739832|FG001|Follow-up Period|Death|0|||
30726640|NCT00441168|58739831|FG000|Follow-up Period|Lost to Follow-up|5|||
30726641|NCT00441168|58739832|FG001|Follow-up Period|Lost to Follow-up|6|||
30726642|NCT00441168|58739831|FG000|Follow-up Period|Withdrawal by Subject|3|||
30726643|NCT00441168|58739832|FG001|Follow-up Period|Withdrawal by Subject|0|||
30726644|NCT00441168|58739831|FG000|Follow-up Period|Other|1|||
30726645|NCT00441168|58739832|FG001|Follow-up Period|Other|3|||
30726646|NCT00296140|58739840|FG000|Overall Study|Lost to Follow-up|1|||
30726647|NCT00296140|58739841|FG001|Overall Study|Lost to Follow-up|0|||
30726648|NCT00296140|58739840|FG000|Overall Study|Withdrawal by Subject|1|||
30726649|NCT00296140|58739841|FG001|Overall Study|Withdrawal by Subject|0|||
30726650|NCT00296140|58739840|FG000|Overall Study|Discharge to Nursing Home|1|||
30726651|NCT00296140|58739841|FG001|Overall Study|Discharge to Nursing Home|0|||
30726652|NCT03958331|58739850|FG000|Overall Study|Withdrawal by Subject|3|||
30726653|NCT03958331|58739851|FG001|Overall Study|Withdrawal by Subject|1|||
30726654|NCT03958331|58739852|FG002|Overall Study|Withdrawal by Subject|5|||
30726655|NCT03958331|58739850|FG000|Overall Study|Weaned from medicine|2|||
30726656|NCT03958331|58739851|FG001|Overall Study|Weaned from medicine|0|||
30726657|NCT03958331|58739852|FG002|Overall Study|Weaned from medicine|0|||
30726658|NCT03958331|58739850|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
30726659|NCT03958331|58739851|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
30726660|NCT03958331|58739852|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
30726661|NCT03956615|58739858|FG000|Overall Study|No multiple myeloma confirmed|2|||
30726662|NCT03956615|58739858|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
30726663|NCT03956615|58739858|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
30726664|NCT03956615|58739858|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
30726665|NCT03956225|58739864|FG000|Overall Study|Lack of Efficacy|1|||
30726666|NCT03956225|58739865|FG001|Overall Study|Lack of Efficacy|1|||
30726667|NCT03956225|58739864|FG000|Overall Study|Lost to Follow-up|0|||
30726668|NCT03956225|58739865|FG001|Overall Study|Lost to Follow-up|1|||
30726669|NCT03956225|58739864|FG000|Overall Study|Withdrawal by Subject|2|||
30726670|NCT03956225|58739865|FG001|Overall Study|Withdrawal by Subject|1|||
30726671|NCT03956225|58739864|FG000|Overall Study|Other Reasons|2|||
30726672|NCT03956225|58739865|FG001|Overall Study|Other Reasons|1|||
30726673|NCT00457626|58739874|FG000|Overall Study|Adverse Event|3|||
30726674|NCT00457626|58739874|FG000|Overall Study|Administrative Problems|2|||
30726675|NCT00457626|58739874|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
30726676|NCT00373113|58739880|FG000|Overall Study|Death|1|||
30726677|NCT00373113|58739881|FG001|Overall Study|Death|7|||
30726678|NCT00373113|58739880|FG000|Overall Study|Adverse Event|38|||
30726679|NCT00373113|58739881|FG001|Overall Study|Adverse Event|24|||
30726680|NCT00373113|58739880|FG000|Overall Study|Study terminated by sponsor|9|||
30726681|NCT00373113|58739881|FG001|Overall Study|Study terminated by sponsor|1|||
30726682|NCT00373113|58739880|FG000|Overall Study|Global deterioration of health status|10|||
30726683|NCT00373113|58739881|FG001|Overall Study|Global deterioration of health status|7|||
30726684|NCT00373113|58739880|FG000|Overall Study|Lost to Follow-up|1|||
30726685|NCT00373113|58739881|FG001|Overall Study|Lost to Follow-up|3|||
30726686|NCT00373113|58739880|FG000|Overall Study|Objective progression or relapse|150|||
30726687|NCT00373113|58739881|FG001|Overall Study|Objective progression or relapse|169|||
30726688|NCT00373113|58739880|FG000|Overall Study|Other|14|||
30726689|NCT00373113|58739881|FG001|Overall Study|Other|17|||
30726690|NCT00373113|58739880|FG000|Overall Study|Protocol Violation|5|||
30726691|NCT00373113|58739881|FG001|Overall Study|Protocol Violation|1|||
30726692|NCT00373113|58739880|FG000|Overall Study|Withdrawal by Subject|10|||
30726693|NCT00373113|58739881|FG001|Overall Study|Withdrawal by Subject|15|||
30726694|NCT00407511|58739887|FG000|Overall Study|Adverse Event|9|||
30726695|NCT00407511|58739887|FG000|Overall Study|Lost to Follow-up|4|||
30726696|NCT00407511|58739887|FG000|Overall Study|Other|5|||
30726697|NCT00407511|58739887|FG000|Overall Study|Withdrawal by Subject|4|||
30726698|NCT00384189|58739895|FG000|Overall Study|Reason Not Specified|50|||
30726699|NCT00384189|58739896|FG001|Overall Study|Reason Not Specified|57|||
30726700|NCT00384189|58739897|FG002|Overall Study|Reason Not Specified|58|||
30726701|NCT00384189|58739898|FG003|Overall Study|Reason Not Specified|40|||
30726702|NCT00326716|58739910|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
30726703|NCT00326716|58739911|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
30726704|NCT00326716|58739912|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
30726705|NCT00326716|58739913|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
30726706|NCT00548405|58739946|FG000|Overall Study|Adverse Event|6|||
30726707|NCT00548405|58739947|FG001|Overall Study|Adverse Event|2|||
30726708|NCT00548405|58739948|FG002|Overall Study|Adverse Event|0|||
30726709|NCT00548405|58739946|FG000|Overall Study|Lack of Efficacy|6|||
30726710|NCT00548405|58739947|FG001|Overall Study|Lack of Efficacy|0|||
30726711|NCT00548405|58739948|FG002|Overall Study|Lack of Efficacy|0|||
30726712|NCT00548405|58739946|FG000|Overall Study|Physician Decision|3|||
30726713|NCT00548405|58739947|FG001|Overall Study|Physician Decision|4|||
30726714|NCT00548405|58739948|FG002|Overall Study|Physician Decision|1|||
30726715|NCT00548405|58739946|FG000|Overall Study|Pregnancy|1|||
30726716|NCT00548405|58739947|FG001|Overall Study|Pregnancy|0|||
30726717|NCT00548405|58739948|FG002|Overall Study|Pregnancy|0|||
30726718|NCT00548405|58739946|FG000|Overall Study|Protocol Violation|1|||
30726719|NCT00548405|58739947|FG001|Overall Study|Protocol Violation|0|||
30726720|NCT00548405|58739948|FG002|Overall Study|Protocol Violation|0|||
30726721|NCT00548405|58739946|FG000|Overall Study|Withdrawal by Subject|36|||
30726722|NCT00548405|58739947|FG001|Overall Study|Withdrawal by Subject|12|||
30726723|NCT00548405|58739948|FG002|Overall Study|Withdrawal by Subject|5|||
30726724|NCT00548405|58739946|FG000|Overall Study|Lost to Follow-up|1|||
30726725|NCT00548405|58739947|FG001|Overall Study|Lost to Follow-up|1|||
30726726|NCT00548405|58739948|FG002|Overall Study|Lost to Follow-up|2|||
30726727|NCT00548405|58739946|FG000|Overall Study|Death|0|||
30726728|NCT00548405|58739947|FG001|Overall Study|Death|1|||
30726729|NCT00548405|58739948|FG002|Overall Study|Death|1|||
30726730|NCT00548405|58739946|FG000|Overall Study|Sponsor decision|1|||
30726731|NCT00548405|58739947|FG001|Overall Study|Sponsor decision|0|||
30726732|NCT00548405|58739948|FG002|Overall Study|Sponsor decision|0|||
30726733|NCT00548405|58739946|FG000|Overall Study|Randomized but not treated|1|||
30726734|NCT00548405|58739947|FG001|Overall Study|Randomized but not treated|0|||
30726735|NCT00548405|58739948|FG002|Overall Study|Randomized but not treated|0|||
30726736|NCT00295750|58739960|FG000|Overall Study|Adverse Event|19|||
30726737|NCT00295750|58739961|FG001|Overall Study|Adverse Event|15|||
30726738|NCT00295750|58739962|FG002|Overall Study|Adverse Event|12|||
30726739|NCT00295750|58739960|FG000|Overall Study|Lack of Efficacy|1|||
30726740|NCT00295750|58739961|FG001|Overall Study|Lack of Efficacy|1|||
30726741|NCT00295750|58739962|FG002|Overall Study|Lack of Efficacy|0|||
30726742|NCT00295750|58739960|FG000|Overall Study|Lost to Follow-up|1|||
30726743|NCT00295750|58739961|FG001|Overall Study|Lost to Follow-up|4|||
30726744|NCT00295750|58739962|FG002|Overall Study|Lost to Follow-up|1|||
30726745|NCT00295750|58739960|FG000|Overall Study|Taking prohibited therapy|2|||
30726746|NCT00295750|58739961|FG001|Overall Study|Taking prohibited therapy|3|||
30726747|NCT00295750|58739962|FG002|Overall Study|Taking prohibited therapy|2|||
30726748|NCT00295750|58739960|FG000|Overall Study|Administrative errors|2|||
30726749|NCT00295750|58739961|FG001|Overall Study|Administrative errors|4|||
30726750|NCT00295750|58739962|FG002|Overall Study|Administrative errors|5|||
30726751|NCT00295750|58739960|FG000|Overall Study|Trial drug errors|1|||
30726752|NCT00295750|58739961|FG001|Overall Study|Trial drug errors|1|||
30726753|NCT00295750|58739962|FG002|Overall Study|Trial drug errors|0|||
30726754|NCT00295750|58739960|FG000|Overall Study|Disease progression|2|||
30726755|NCT00295750|58739961|FG001|Overall Study|Disease progression|1|||
30726756|NCT00295750|58739962|FG002|Overall Study|Disease progression|0|||
30726757|NCT00295750|58739960|FG000|Overall Study|Personal reasons|0|||
30726758|NCT00295750|58739961|FG001|Overall Study|Personal reasons|1|||
30726759|NCT00295750|58739962|FG002|Overall Study|Personal reasons|0|||
30726760|NCT00295750|58739960|FG000|Overall Study|Randomized but never received trial drug|4|||
30726761|NCT00295750|58739961|FG001|Overall Study|Randomized but never received trial drug|3|||
30726762|NCT00295750|58739962|FG002|Overall Study|Randomized but never received trial drug|3|||
30726763|NCT00295750|58739960|FG000|Overall Study|Withdrawal by Subject|9|||
30726764|NCT00295750|58739961|FG001|Overall Study|Withdrawal by Subject|4|||
30726765|NCT00295750|58739962|FG002|Overall Study|Withdrawal by Subject|7|||
30726766|NCT00295750|58739960|FG000|Overall Study|Protocol Violation|2|||
30726767|NCT00295750|58739961|FG001|Overall Study|Protocol Violation|4|||
30726768|NCT00295750|58739962|FG002|Overall Study|Protocol Violation|2|||
30621715|NCT01147926|58633278|FG000|Overall Study|Colonoscopy result|0|||
30726769|NCT03948581|58739972|FG000|Overall Study|Lost to Follow-up|0|||
30726770|NCT03948581|58739973|FG001|Overall Study|Lost to Follow-up|1|||
30726771|NCT00548327|58739981|FG000|Overall Study|Adverse Event|0|||
30726772|NCT00548327|58739982|FG001|Overall Study|Adverse Event|1|||
30726773|NCT03953183|58740004|FG000|Overall Study|Physician Decision|0|||
30726774|NCT03953183|58740005|FG001|Overall Study|Physician Decision|1|||
30726775|NCT03953183|58740004|FG000|Overall Study|Withdrawal by Subject|0|||
30726776|NCT03953183|58740005|FG001|Overall Study|Withdrawal by Subject|1|||
30726777|NCT00406653|58740015|FG000|Induction Period|Adverse Event|1|||
30726778|NCT00406653|58740016|FG001|Induction Period|Adverse Event|10|||
30726779|NCT00406653|58740017|FG002|Induction Period|Adverse Event|4|||
30726780|NCT00406653|58740018|FG003|Induction Period|Adverse Event|11|||
30726781|NCT00406653|58740019|FG004|Induction Period|Adverse Event|0|||
30726782|NCT00406653|58740020|FG005|Induction Period|Adverse Event|0|||
30726783|NCT00406653|58740021|FG006|Induction Period|Adverse Event|0|||
30726784|NCT00406653|58740015|FG000|Induction Period|Lack of Efficacy|11|||
30726785|NCT00406653|58740016|FG001|Induction Period|Lack of Efficacy|14|||
30726786|NCT00406653|58740017|FG002|Induction Period|Lack of Efficacy|8|||
30726787|NCT00406653|58740018|FG003|Induction Period|Lack of Efficacy|10|||
30726788|NCT00406653|58740019|FG004|Induction Period|Lack of Efficacy|0|||
30726789|NCT00406653|58740020|FG005|Induction Period|Lack of Efficacy|0|||
30726790|NCT00406653|58740021|FG006|Induction Period|Lack of Efficacy|0|||
30726791|NCT00406653|58740015|FG000|Induction Period|Lost to Follow-up|0|||
30726792|NCT00406653|58740016|FG001|Induction Period|Lost to Follow-up|2|||
30726793|NCT00406653|58740017|FG002|Induction Period|Lost to Follow-up|0|||
30726794|NCT00406653|58740018|FG003|Induction Period|Lost to Follow-up|0|||
30726795|NCT00406653|58740019|FG004|Induction Period|Lost to Follow-up|0|||
30726796|NCT00406653|58740020|FG005|Induction Period|Lost to Follow-up|0|||
30726797|NCT00406653|58740021|FG006|Induction Period|Lost to Follow-up|0|||
30726798|NCT00406653|58740015|FG000|Induction Period|Withdrawal of Consent|2|||
30726799|NCT00406653|58740016|FG001|Induction Period|Withdrawal of Consent|5|||
30726800|NCT00406653|58740017|FG002|Induction Period|Withdrawal of Consent|1|||
30726801|NCT00406653|58740018|FG003|Induction Period|Withdrawal of Consent|2|||
30726802|NCT00406653|58740019|FG004|Induction Period|Withdrawal of Consent|0|||
30726803|NCT00406653|58740020|FG005|Induction Period|Withdrawal of Consent|0|||
30726804|NCT00406653|58740021|FG006|Induction Period|Withdrawal of Consent|0|||
30726805|NCT00406653|58740015|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
30726806|NCT00406653|58740016|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
30726807|NCT00406653|58740017|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
30726808|NCT00406653|58740018|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
30726809|NCT00406653|58740019|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
30726810|NCT00406653|58740020|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
30726811|NCT00406653|58740021|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
30726812|NCT00406653|58740015|FG000|Induction Period|Pregnancy|1|||
30726813|NCT00406653|58740016|FG001|Induction Period|Pregnancy|0|||
30726814|NCT00406653|58740017|FG002|Induction Period|Pregnancy|0|||
30726815|NCT00406653|58740018|FG003|Induction Period|Pregnancy|0|||
30726816|NCT00406653|58740019|FG004|Induction Period|Pregnancy|0|||
30726817|NCT00406653|58740020|FG005|Induction Period|Pregnancy|0|||
30726818|NCT00406653|58740021|FG006|Induction Period|Pregnancy|0|||
30726819|NCT00406653|58740015|FG000|Induction Period|Declined participation but followup done|0|||
30726820|NCT00406653|58740016|FG001|Induction Period|Declined participation but followup done|2|||
30726821|NCT00406653|58740017|FG002|Induction Period|Declined participation but followup done|1|||
30726822|NCT00406653|58740018|FG003|Induction Period|Declined participation but followup done|1|||
30726823|NCT00406653|58740019|FG004|Induction Period|Declined participation but followup done|0|||
30726824|NCT00406653|58740020|FG005|Induction Period|Declined participation but followup done|0|||
30726825|NCT00406653|58740021|FG006|Induction Period|Declined participation but followup done|0|||
30726826|NCT00406653|58740015|FG000|Induction Period|Given prohibited drug|0|||
30726827|NCT00406653|58740016|FG001|Induction Period|Given prohibited drug|1|||
30726828|NCT00406653|58740017|FG002|Induction Period|Given prohibited drug|2|||
30726829|NCT00406653|58740018|FG003|Induction Period|Given prohibited drug|0|||
30726830|NCT00406653|58740019|FG004|Induction Period|Given prohibited drug|0|||
30726831|NCT00406653|58740020|FG005|Induction Period|Given prohibited drug|0|||
30726832|NCT00406653|58740021|FG006|Induction Period|Given prohibited drug|0|||
30726833|NCT00406653|58740015|FG000|Induction Period|Incarcerated|0|||
30726834|NCT00406653|58740016|FG001|Induction Period|Incarcerated|0|||
30726835|NCT00406653|58740017|FG002|Induction Period|Incarcerated|1|||
30726836|NCT00406653|58740018|FG003|Induction Period|Incarcerated|0|||
30726837|NCT00406653|58740019|FG004|Induction Period|Incarcerated|0|||
30726838|NCT00406653|58740020|FG005|Induction Period|Incarcerated|0|||
30726839|NCT00406653|58740021|FG006|Induction Period|Incarcerated|0|||
30726840|NCT00406653|58740015|FG000|Induction Period|Patient relocated|0|||
30726841|NCT00406653|58740016|FG001|Induction Period|Patient relocated|0|||
30726842|NCT00406653|58740017|FG002|Induction Period|Patient relocated|1|||
30726843|NCT00406653|58740018|FG003|Induction Period|Patient relocated|0|||
30726844|NCT00406653|58740019|FG004|Induction Period|Patient relocated|0|||
30726845|NCT00406653|58740020|FG005|Induction Period|Patient relocated|0|||
30726846|NCT00406653|58740021|FG006|Induction Period|Patient relocated|0|||
30726847|NCT00406653|58740015|FG000|Maintenance Period|Adverse Event|0|||
30726848|NCT00406653|58740016|FG001|Maintenance Period|Adverse Event|0|||
30726849|NCT00406653|58740017|FG002|Maintenance Period|Adverse Event|0|||
30726850|NCT00406653|58740018|FG003|Maintenance Period|Adverse Event|0|||
30726851|NCT00406653|58740019|FG004|Maintenance Period|Adverse Event|1|||
30726852|NCT00406653|58740020|FG005|Maintenance Period|Adverse Event|1|||
30726853|NCT00406653|58740021|FG006|Maintenance Period|Adverse Event|0|||
30726854|NCT00406653|58740015|FG000|Maintenance Period|Lack of Efficacy|0|||
30726855|NCT00406653|58740016|FG001|Maintenance Period|Lack of Efficacy|0|||
30726856|NCT00406653|58740017|FG002|Maintenance Period|Lack of Efficacy|0|||
30726857|NCT00406653|58740018|FG003|Maintenance Period|Lack of Efficacy|0|||
30726858|NCT00406653|58740019|FG004|Maintenance Period|Lack of Efficacy|20|||
30726859|NCT00406653|58740020|FG005|Maintenance Period|Lack of Efficacy|26|||
30726860|NCT00406653|58740021|FG006|Maintenance Period|Lack of Efficacy|0|||
30726861|NCT00406653|58740015|FG000|Maintenance Period|Lost to Follow-up|0|||
30726862|NCT00406653|58740016|FG001|Maintenance Period|Lost to Follow-up|0|||
30726863|NCT00406653|58740017|FG002|Maintenance Period|Lost to Follow-up|0|||
30726864|NCT00406653|58740018|FG003|Maintenance Period|Lost to Follow-up|0|||
30726865|NCT00406653|58740019|FG004|Maintenance Period|Lost to Follow-up|2|||
30726866|NCT00406653|58740020|FG005|Maintenance Period|Lost to Follow-up|1|||
30726867|NCT00406653|58740021|FG006|Maintenance Period|Lost to Follow-up|0|||
30726868|NCT00406653|58740015|FG000|Maintenance Period|Withdrawal of Consent|0|||
30726869|NCT00406653|58740016|FG001|Maintenance Period|Withdrawal of Consent|0|||
30726870|NCT00406653|58740017|FG002|Maintenance Period|Withdrawal of Consent|0|||
30726871|NCT00406653|58740018|FG003|Maintenance Period|Withdrawal of Consent|0|||
30726872|NCT00406653|58740019|FG004|Maintenance Period|Withdrawal of Consent|2|||
30726873|NCT00406653|58740020|FG005|Maintenance Period|Withdrawal of Consent|0|||
30726874|NCT00406653|58740021|FG006|Maintenance Period|Withdrawal of Consent|0|||
30726875|NCT00406653|58740015|FG000|Maintenance Period|Pregnancy|0|||
30726876|NCT00406653|58740016|FG001|Maintenance Period|Pregnancy|0|||
30726877|NCT00406653|58740017|FG002|Maintenance Period|Pregnancy|0|||
30726878|NCT00406653|58740018|FG003|Maintenance Period|Pregnancy|0|||
30726879|NCT00406653|58740019|FG004|Maintenance Period|Pregnancy|0|||
30726880|NCT00406653|58740020|FG005|Maintenance Period|Pregnancy|1|||
30726881|NCT00406653|58740021|FG006|Maintenance Period|Pregnancy|0|||
30726882|NCT00406653|58740015|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
30726883|NCT00406653|58740016|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
30726884|NCT00406653|58740017|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
30726885|NCT00406653|58740018|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
30726886|NCT00406653|58740019|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
30900420|NCT02322866|58933798|FG000|Overall Study|Lack of Efficacy|3|||
30726887|NCT00406653|58740020|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
30726888|NCT00406653|58740021|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
30726889|NCT00406653|58740015|FG000|Maintenance Period|Error in disease score evaluation|0|||
30726890|NCT00406653|58740016|FG001|Maintenance Period|Error in disease score evaluation|0|||
30726891|NCT00406653|58740017|FG002|Maintenance Period|Error in disease score evaluation|0|||
30726892|NCT00406653|58740018|FG003|Maintenance Period|Error in disease score evaluation|0|||
30726893|NCT00406653|58740019|FG004|Maintenance Period|Error in disease score evaluation|1|||
30726894|NCT00406653|58740020|FG005|Maintenance Period|Error in disease score evaluation|0|||
30726895|NCT00406653|58740021|FG006|Maintenance Period|Error in disease score evaluation|0|||
30726896|NCT00406653|58740015|FG000|Open-Label Period|Death|0|||
30726897|NCT00406653|58740016|FG001|Open-Label Period|Death|0|||
30726898|NCT00406653|58740017|FG002|Open-Label Period|Death|0|||
30726899|NCT00406653|58740018|FG003|Open-Label Period|Death|0|||
30726900|NCT00406653|58740019|FG004|Open-Label Period|Death|0|||
30726901|NCT00406653|58740020|FG005|Open-Label Period|Death|0|||
30726902|NCT00406653|58740021|FG006|Open-Label Period|Death|1|||
30726903|NCT00406653|58740015|FG000|Open-Label Period|Adverse Event|0|||
30726904|NCT00406653|58740016|FG001|Open-Label Period|Adverse Event|0|||
30726905|NCT00406653|58740017|FG002|Open-Label Period|Adverse Event|0|||
30726906|NCT00406653|58740018|FG003|Open-Label Period|Adverse Event|0|||
30726907|NCT00406653|58740019|FG004|Open-Label Period|Adverse Event|0|||
30726908|NCT00406653|58740020|FG005|Open-Label Period|Adverse Event|0|||
30726909|NCT00406653|58740021|FG006|Open-Label Period|Adverse Event|18|||
30726910|NCT00406653|58740015|FG000|Open-Label Period|Lack of Efficacy|0|||
30726911|NCT00406653|58740016|FG001|Open-Label Period|Lack of Efficacy|0|||
30726912|NCT00406653|58740017|FG002|Open-Label Period|Lack of Efficacy|0|||
30726913|NCT00406653|58740018|FG003|Open-Label Period|Lack of Efficacy|0|||
30726914|NCT00406653|58740019|FG004|Open-Label Period|Lack of Efficacy|0|||
30726915|NCT00406653|58740020|FG005|Open-Label Period|Lack of Efficacy|0|||
30726916|NCT00406653|58740021|FG006|Open-Label Period|Lack of Efficacy|160|||
30726917|NCT00406653|58740015|FG000|Open-Label Period|Lost to Follow-up|0|||
30726918|NCT00406653|58740016|FG001|Open-Label Period|Lost to Follow-up|0|||
30726919|NCT00406653|58740017|FG002|Open-Label Period|Lost to Follow-up|0|||
30726920|NCT00406653|58740018|FG003|Open-Label Period|Lost to Follow-up|0|||
30726921|NCT00406653|58740019|FG004|Open-Label Period|Lost to Follow-up|0|||
30726922|NCT00406653|58740020|FG005|Open-Label Period|Lost to Follow-up|0|||
30726923|NCT00406653|58740021|FG006|Open-Label Period|Lost to Follow-up|6|||
30726924|NCT00406653|58740015|FG000|Open-Label Period|Withdrawal of Consent|0|||
30726925|NCT00406653|58740016|FG001|Open-Label Period|Withdrawal of Consent|0|||
30726926|NCT00406653|58740017|FG002|Open-Label Period|Withdrawal of Consent|0|||
30726927|NCT00406653|58740018|FG003|Open-Label Period|Withdrawal of Consent|0|||
30726928|NCT00406653|58740019|FG004|Open-Label Period|Withdrawal of Consent|0|||
30726929|NCT00406653|58740020|FG005|Open-Label Period|Withdrawal of Consent|0|||
30726930|NCT00406653|58740021|FG006|Open-Label Period|Withdrawal of Consent|11|||
30726931|NCT00406653|58740015|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
30726932|NCT00406653|58740016|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
30726933|NCT00406653|58740017|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
30726934|NCT00406653|58740018|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
30726935|NCT00406653|58740019|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
30726936|NCT00406653|58740020|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
30726937|NCT00406653|58740021|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
30726938|NCT00406653|58740015|FG000|Open-Label Period|Pregnancy|0|||
30726939|NCT00406653|58740016|FG001|Open-Label Period|Pregnancy|0|||
30726940|NCT00406653|58740017|FG002|Open-Label Period|Pregnancy|0|||
30726941|NCT00406653|58740018|FG003|Open-Label Period|Pregnancy|0|||
30726942|NCT00406653|58740019|FG004|Open-Label Period|Pregnancy|0|||
30726943|NCT00406653|58740020|FG005|Open-Label Period|Pregnancy|0|||
30726944|NCT00406653|58740021|FG006|Open-Label Period|Pregnancy|2|||
30726945|NCT00406653|58740015|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
30726946|NCT00406653|58740016|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
30726947|NCT00406653|58740017|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
30726948|NCT00406653|58740018|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
30726949|NCT00406653|58740019|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
30726950|NCT00406653|58740020|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
30726951|NCT00406653|58740021|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
30726952|NCT00406653|58740015|FG000|Open-Label Period|Declined participation but followup done|0|||
30726953|NCT00406653|58740016|FG001|Open-Label Period|Declined participation but followup done|0|||
30726954|NCT00406653|58740017|FG002|Open-Label Period|Declined participation but followup done|0|||
30726955|NCT00406653|58740018|FG003|Open-Label Period|Declined participation but followup done|0|||
30726956|NCT00406653|58740019|FG004|Open-Label Period|Declined participation but followup done|0|||
30726957|NCT00406653|58740020|FG005|Open-Label Period|Declined participation but followup done|0|||
30726958|NCT00406653|58740021|FG006|Open-Label Period|Declined participation but followup done|8|||
30726959|NCT00406653|58740015|FG000|Open-Label Period|Discontinued by Sponsor|0|||
30726960|NCT00406653|58740016|FG001|Open-Label Period|Discontinued by Sponsor|0|||
30726961|NCT00406653|58740017|FG002|Open-Label Period|Discontinued by Sponsor|0|||
30726962|NCT00406653|58740018|FG003|Open-Label Period|Discontinued by Sponsor|0|||
30726963|NCT00406653|58740019|FG004|Open-Label Period|Discontinued by Sponsor|0|||
30621716|NCT01147926|58633279|FG001|Overall Study|Colonoscopy result|1|||
30726964|NCT00406653|58740020|FG005|Open-Label Period|Discontinued by Sponsor|0|||
30726965|NCT00406653|58740021|FG006|Open-Label Period|Discontinued by Sponsor|1|||
30726966|NCT00406653|58740015|FG000|Open-Label Period|Refused followup|0|||
30726967|NCT00406653|58740016|FG001|Open-Label Period|Refused followup|0|||
30726968|NCT00406653|58740017|FG002|Open-Label Period|Refused followup|0|||
30726969|NCT00406653|58740018|FG003|Open-Label Period|Refused followup|0|||
30726970|NCT00406653|58740019|FG004|Open-Label Period|Refused followup|0|||
30726971|NCT00406653|58740020|FG005|Open-Label Period|Refused followup|0|||
30726972|NCT00406653|58740021|FG006|Open-Label Period|Refused followup|1|||
30726973|NCT00547157|58740043|FG000|Overall Study|Other|1|||
30726974|NCT00547157|58740044|FG001|Overall Study|Other|0|||
30726975|NCT00547157|58740043|FG000|Overall Study|Death|38|||
30726976|NCT00547157|58740044|FG001|Overall Study|Death|18|||
30726977|NCT00547157|58740043|FG000|Overall Study|Withdrawal by Subject|3|||
30726978|NCT00547157|58740044|FG001|Overall Study|Withdrawal by Subject|1|||
30726979|NCT00547157|58740043|FG000|Overall Study|Administrative decision|3|||
30726980|NCT00547157|58740044|FG001|Overall Study|Administrative decision|2|||
30726981|NCT00547157|58740043|FG000|Overall Study|Lost to Follow-up|4|||
30726982|NCT00547157|58740044|FG001|Overall Study|Lost to Follow-up|2|||
30726983|NCT00384033|58740054|FG000|Overall Study|Adverse Event|10|||
30726984|NCT00384033|58740055|FG001|Overall Study|Adverse Event|8|||
30726985|NCT00384033|58740056|FG002|Overall Study|Adverse Event|11|||
30726986|NCT00384033|58740057|FG003|Overall Study|Adverse Event|20|||
30726987|NCT00384033|58740054|FG000|Overall Study|Failed to return|1|||
30726988|NCT00384033|58740055|FG001|Overall Study|Failed to return|3|||
30726989|NCT00384033|58740056|FG002|Overall Study|Failed to return|2|||
30726990|NCT00384033|58740057|FG003|Overall Study|Failed to return|2|||
30726991|NCT00384033|58740054|FG000|Overall Study|Physician Decision|1|||
30726992|NCT00384033|58740055|FG001|Overall Study|Physician Decision|0|||
30726993|NCT00384033|58740056|FG002|Overall Study|Physician Decision|0|||
30726994|NCT00384033|58740057|FG003|Overall Study|Physician Decision|0|||
30726995|NCT00384033|58740054|FG000|Overall Study|Lost to Follow-up|6|||
30726996|NCT00384033|58740055|FG001|Overall Study|Lost to Follow-up|12|||
30726997|NCT00384033|58740056|FG002|Overall Study|Lost to Follow-up|7|||
30726998|NCT00384033|58740057|FG003|Overall Study|Lost to Follow-up|7|||
30726999|NCT00384033|58740054|FG000|Overall Study|Other|2|||
30727000|NCT00384033|58740055|FG001|Overall Study|Other|0|||
30727001|NCT00384033|58740056|FG002|Overall Study|Other|0|||
30727002|NCT00384033|58740057|FG003|Overall Study|Other|0|||
30727003|NCT00384033|58740054|FG000|Overall Study|Protocol Violation|5|||
30727004|NCT00384033|58740055|FG001|Overall Study|Protocol Violation|0|||
30727005|NCT00384033|58740056|FG002|Overall Study|Protocol Violation|5|||
30727006|NCT00384033|58740057|FG003|Overall Study|Protocol Violation|6|||
30727007|NCT00384033|58740054|FG000|Overall Study|Withdrawal by Subject|6|||
30727008|NCT00384033|58740055|FG001|Overall Study|Withdrawal by Subject|2|||
30727009|NCT00384033|58740056|FG002|Overall Study|Withdrawal by Subject|5|||
30727010|NCT00384033|58740057|FG003|Overall Study|Withdrawal by Subject|2|||
30727011|NCT00384033|58740054|FG000|Overall Study|Lack of Efficacy|7|||
30727012|NCT00384033|58740055|FG001|Overall Study|Lack of Efficacy|3|||
30727013|NCT00384033|58740056|FG002|Overall Study|Lack of Efficacy|3|||
30727014|NCT00384033|58740057|FG003|Overall Study|Lack of Efficacy|1|||
30727015|NCT00384033|58740054|FG000|Overall Study|Randomized but not treated|3|||
30727016|NCT00384033|58740055|FG001|Overall Study|Randomized but not treated|7|||
30727017|NCT00384033|58740056|FG002|Overall Study|Randomized but not treated|10|||
30727018|NCT00384033|58740057|FG003|Overall Study|Randomized but not treated|2|||
30727019|NCT00546377|58740067|FG000|Overall Study|Deemed ineligible|1|||
30727020|NCT00546377|58740067|FG000|Overall Study|Adverse Event|6|||
30727021|NCT00545753|58740074|FG000|Overall Study|Withdrawal by Subject|0|||
30621717|NCT00975507|58633287|FG000|Overall Study|Adverse Event|1|||
30727022|NCT00545753|58740075|FG001|Overall Study|Withdrawal by Subject|1|||
30727023|NCT00545753|58740076|FG002|Overall Study|Withdrawal by Subject|10|||
30727024|NCT00545753|58740074|FG000|Overall Study|Lost to Follow-up|13|||
30727025|NCT00545753|58740075|FG001|Overall Study|Lost to Follow-up|3|||
30727026|NCT00545753|58740076|FG002|Overall Study|Lost to Follow-up|12|||
30727027|NCT00545753|58740074|FG000|Overall Study|Protocol Violation|3|||
30727028|NCT00545753|58740075|FG001|Overall Study|Protocol Violation|1|||
30727029|NCT00545753|58740076|FG002|Overall Study|Protocol Violation|4|||
30727030|NCT00406419|58740088|FG000|Overall Study|Death|3|||
30727031|NCT00406419|58740089|FG001|Overall Study|Death|1|||
30727032|NCT00406419|58740090|FG002|Overall Study|Death|4|||
30727033|NCT00406419|58740088|FG000|Overall Study|Protocol Violation|6|||
30727034|NCT00406419|58740089|FG001|Overall Study|Protocol Violation|2|||
30727035|NCT00406419|58740090|FG002|Overall Study|Protocol Violation|5|||
30727036|NCT00406419|58740088|FG000|Overall Study|Study Terminated by Sponsor|260|||
30727037|NCT00406419|58740089|FG001|Overall Study|Study Terminated by Sponsor|288|||
30727038|NCT00406419|58740090|FG002|Overall Study|Study Terminated by Sponsor|282|||
30727039|NCT00406419|58740088|FG000|Overall Study|Withdrawal by Subject|17|||
30727040|NCT00406419|58740089|FG001|Overall Study|Withdrawal by Subject|24|||
30727041|NCT00406419|58740090|FG002|Overall Study|Withdrawal by Subject|26|||
30727042|NCT00406419|58740088|FG000|Overall Study|Lack of Efficacy|12|||
30727043|NCT00406419|58740089|FG001|Overall Study|Lack of Efficacy|1|||
30727044|NCT00406419|58740090|FG002|Overall Study|Lack of Efficacy|6|||
30727045|NCT00406419|58740088|FG000|Overall Study|Non-Compliance with Study Drug|5|||
30727046|NCT00406419|58740089|FG001|Overall Study|Non-Compliance with Study Drug|6|||
30727047|NCT00406419|58740090|FG002|Overall Study|Non-Compliance with Study Drug|3|||
30727048|NCT00406419|58740088|FG000|Overall Study|Adverse Event|10|||
30727049|NCT00406419|58740089|FG001|Overall Study|Adverse Event|12|||
30727050|NCT00406419|58740090|FG002|Overall Study|Adverse Event|16|||
30727051|NCT00406419|58740088|FG000|Overall Study|Lost to Follow-up|11|||
30727052|NCT00406419|58740089|FG001|Overall Study|Lost to Follow-up|10|||
30727053|NCT00406419|58740090|FG002|Overall Study|Lost to Follow-up|5|||
30727054|NCT00325468|58740103|FG000|Overall Study|Adverse Event|1|||
30727055|NCT00325468|58740104|FG001|Overall Study|Adverse Event|1|||
30727056|NCT00325468|58740105|FG002|Overall Study|Adverse Event|0|||
30727057|NCT00325468|58740106|FG003|Overall Study|Adverse Event|5|||
30727058|NCT00325468|58740107|FG004|Overall Study|Adverse Event|1|||
30727059|NCT00325468|58740103|FG000|Overall Study|Death|2|||
30727060|NCT00325468|58740104|FG001|Overall Study|Death|0|||
30727061|NCT00325468|58740105|FG002|Overall Study|Death|2|||
30727062|NCT00325468|58740106|FG003|Overall Study|Death|4|||
30727063|NCT00325468|58740107|FG004|Overall Study|Death|0|||
30727064|NCT00325468|58740103|FG000|Overall Study|Lost to Follow-up|0|||
30727065|NCT00325468|58740104|FG001|Overall Study|Lost to Follow-up|0|||
30727066|NCT00325468|58740105|FG002|Overall Study|Lost to Follow-up|1|||
30727067|NCT00325468|58740106|FG003|Overall Study|Lost to Follow-up|2|||
30727068|NCT00325468|58740107|FG004|Overall Study|Lost to Follow-up|2|||
30727069|NCT00325468|58740103|FG000|Overall Study|Physician Decision|1|||
30727070|NCT00325468|58740104|FG001|Overall Study|Physician Decision|1|||
30727071|NCT00325468|58740105|FG002|Overall Study|Physician Decision|0|||
30727072|NCT00325468|58740106|FG003|Overall Study|Physician Decision|1|||
30727073|NCT00325468|58740107|FG004|Overall Study|Physician Decision|0|||
30727074|NCT00325468|58740103|FG000|Overall Study|Withdrawal by Subject|3|||
30727075|NCT00325468|58740104|FG001|Overall Study|Withdrawal by Subject|1|||
30727076|NCT00325468|58740105|FG002|Overall Study|Withdrawal by Subject|0|||
30727077|NCT00325468|58740106|FG003|Overall Study|Withdrawal by Subject|14|||
30727078|NCT00325468|58740107|FG004|Overall Study|Withdrawal by Subject|4|||
30727079|NCT00325468|58740103|FG000|Overall Study|site closure etc|4|||
30727080|NCT00325468|58740104|FG001|Overall Study|site closure etc|2|||
30727081|NCT00325468|58740105|FG002|Overall Study|site closure etc|1|||
30727082|NCT00325468|58740106|FG003|Overall Study|site closure etc|8|||
30727083|NCT00325468|58740107|FG004|Overall Study|site closure etc|1|||
30727084|NCT03833661|58740120|FG000|Overall Study|Treatment ongoing|9|||
30727085|NCT00311584|58740126|FG000|Overall Study|Death|1|||
30727086|NCT00311584|58740127|FG001|Overall Study|Death|0|||
30727087|NCT00311584|58740126|FG000|Overall Study|Lack of Efficacy|12|||
30727088|NCT00311584|58740127|FG001|Overall Study|Lack of Efficacy|15|||
30727089|NCT00311584|58740126|FG000|Overall Study|Physician Decision|4|||
30727090|NCT00311584|58740127|FG001|Overall Study|Physician Decision|5|||
30727091|NCT00311584|58740126|FG000|Overall Study|Withdrawal by Subject|1|||
30727092|NCT00311584|58740127|FG001|Overall Study|Withdrawal by Subject|1|||
30727093|NCT00311584|58740126|FG000|Overall Study|ineligible|2|||
30727094|NCT00311584|58740127|FG001|Overall Study|ineligible|2|||
30727095|NCT00383331|58740135|FG000|Overall Study|Protocol Violation|0|||
30727096|NCT00383331|58740136|FG001|Overall Study|Protocol Violation|1|||
30727097|NCT03934541|58740146|FG000|Overall Study|Study Terminated by Sponsor|0|||
30727098|NCT03934541|58740147|FG001|Overall Study|Study Terminated by Sponsor|1|||
30727099|NCT03934541|58740148|FG002|Overall Study|Study Terminated by Sponsor|0|||
30727100|NCT03934541|58740149|FG003|Overall Study|Study Terminated by Sponsor|0|||
30727101|NCT00325234|58740161|FG000|Overall Study|Adverse Event|10|||
30727102|NCT00325234|58740162|FG001|Overall Study|Adverse Event|7|||
30727103|NCT00325234|58740161|FG000|Overall Study|Death due to Study Disease|1|||
30727104|NCT00325234|58740162|FG001|Overall Study|Death due to Study Disease|0|||
30621718|NCT00975507|58633288|FG001|Overall Study|Adverse Event|0|||
30727105|NCT00325234|58740161|FG000|Overall Study|Entry Criteria Not Met|1|||
30727106|NCT00325234|58740162|FG001|Overall Study|Entry Criteria Not Met|2|||
30727107|NCT00325234|58740161|FG000|Overall Study|Subject Decision|6|||
30727108|NCT00325234|58740162|FG001|Overall Study|Subject Decision|8|||
30727109|NCT00325234|58740161|FG000|Overall Study|Physician Decision|17|||
30727110|NCT00325234|58740162|FG001|Overall Study|Physician Decision|12|||
30727111|NCT00325234|58740161|FG000|Overall Study|Progressive Disease|34|||
30727112|NCT00325234|58740162|FG001|Overall Study|Progressive Disease|37|||
30727113|NCT00366249|58740172|FG000|Overall Study|Adverse Event|53|||
30727114|NCT00366249|58740173|FG001|Overall Study|Adverse Event|28|||
30727115|NCT00366249|58740172|FG000|Overall Study|Death|0|||
30727116|NCT00366249|58740173|FG001|Overall Study|Death|1|||
30727117|NCT00366249|58740172|FG000|Overall Study|Physician Decision|5|||
30727118|NCT00366249|58740173|FG001|Overall Study|Physician Decision|2|||
30727119|NCT00366249|58740172|FG000|Overall Study|Lost to Follow-up|2|||
30727120|NCT00366249|58740173|FG001|Overall Study|Lost to Follow-up|0|||
30727121|NCT00366249|58740172|FG000|Overall Study|Protocol Violation|1|||
30727122|NCT00366249|58740173|FG001|Overall Study|Protocol Violation|2|||
30727123|NCT00366249|58740172|FG000|Overall Study|Withdrawal by Subject|18|||
30727124|NCT00366249|58740173|FG001|Overall Study|Withdrawal by Subject|4|||
30727125|NCT00366249|58740172|FG000|Overall Study|Lack of Efficacy|21|||
30727126|NCT00366249|58740173|FG001|Overall Study|Lack of Efficacy|21|||
30727127|NCT00366249|58740172|FG000|Overall Study|Most due to osteomylitis status|31|||
30727128|NCT00366249|58740173|FG001|Overall Study|Most due to osteomylitis status|20|||
30727129|NCT00325156|58740179|FG000|Overall Study|Protocol Violation|8|||
30727130|NCT00325156|58740179|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
30727131|NCT00325156|58740179|FG000|Overall Study|Migrated/moved from study area|12|||
30727132|NCT00325156|58740179|FG000|Overall Study|Adverse event, non-fatal|3|||
30727133|NCT00325156|58740179|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
30727134|NCT00325156|58740179|FG000|Overall Study|Other|1|||
30727135|NCT00325156|58740179|FG000|Overall Study|Withdrawal by Subject|31|||
30727136|NCT03927911|58740189|FG000|Overall Study|problems with eDiary|0|||
30727137|NCT03927911|58740190|FG001|Overall Study|problems with eDiary|1|||
30727138|NCT03927911|58740191|FG002|Overall Study|problems with eDiary|0|||
30727139|NCT03927911|58740192|FG003|Overall Study|problems with eDiary|1|||
30727140|NCT03927911|58740193|FG004|Overall Study|problems with eDiary|0|||
30727141|NCT03927911|58740194|FG005|Overall Study|problems with eDiary|4|||
30727142|NCT03927911|58740189|FG000|Overall Study|Adverse Event|0|||
30727143|NCT03927911|58740190|FG001|Overall Study|Adverse Event|0|||
30727144|NCT03927911|58740191|FG002|Overall Study|Adverse Event|0|||
30727145|NCT03927911|58740192|FG003|Overall Study|Adverse Event|0|||
30727146|NCT03927911|58740193|FG004|Overall Study|Adverse Event|0|||
30727147|NCT03927911|58740194|FG005|Overall Study|Adverse Event|1|||
30727148|NCT03927911|58740189|FG000|Overall Study|not treated -study terminated by sponsor|0|||
30727149|NCT03927911|58740190|FG001|Overall Study|not treated -study terminated by sponsor|1|||
30727150|NCT03927911|58740191|FG002|Overall Study|not treated -study terminated by sponsor|0|||
30727151|NCT03927911|58740192|FG003|Overall Study|not treated -study terminated by sponsor|0|||
30727152|NCT03927911|58740193|FG004|Overall Study|not treated -study terminated by sponsor|0|||
30727153|NCT03927911|58740194|FG005|Overall Study|not treated -study terminated by sponsor|0|||
30727154|NCT03927911|58740189|FG000|Overall Study|Surgery cancelled|0|||
30727155|NCT03927911|58740190|FG001|Overall Study|Surgery cancelled|0|||
30727156|NCT03927911|58740191|FG002|Overall Study|Surgery cancelled|0|||
30727157|NCT03927911|58740192|FG003|Overall Study|Surgery cancelled|1|||
30727158|NCT03927911|58740193|FG004|Overall Study|Surgery cancelled|0|||
30727159|NCT03927911|58740194|FG005|Overall Study|Surgery cancelled|1|||
30727160|NCT03927911|58740189|FG000|Overall Study|Protocol Violation|0|||
30727161|NCT03927911|58740190|FG001|Overall Study|Protocol Violation|0|||
30727162|NCT03927911|58740191|FG002|Overall Study|Protocol Violation|0|||
30727163|NCT03927911|58740192|FG003|Overall Study|Protocol Violation|0|||
30727164|NCT03927911|58740193|FG004|Overall Study|Protocol Violation|0|||
30727165|NCT03927911|58740194|FG005|Overall Study|Protocol Violation|1|||
30727166|NCT00383019|58740210|FG000|Overall Study|Adverse Event|5|||
30727167|NCT00383019|58740211|FG001|Overall Study|Adverse Event|1|||
30727168|NCT00383019|58740210|FG000|Overall Study|Withdrawal by Subject|0|||
30727169|NCT00383019|58740211|FG001|Overall Study|Withdrawal by Subject|1|||
30727170|NCT00310804|58740219|FG000|Overall Study|Lost to Follow-up|2|||
30727171|NCT00310804|58740220|FG001|Overall Study|Lost to Follow-up|0|||
30727172|NCT00310804|58740219|FG000|Overall Study|Withdrawal by Subject|3|||
30727173|NCT00310804|58740220|FG001|Overall Study|Withdrawal by Subject|0|||
30727174|NCT03826186|58740242|FG000|Overall Study|Protocol Violation|2|||
30727175|NCT03826186|58740243|FG001|Overall Study|Protocol Violation|0|||
30727176|NCT03826186|58740242|FG000|Overall Study|Withdrawal by Subject|1|||
30727177|NCT03826186|58740243|FG001|Overall Study|Withdrawal by Subject|0|||
30727178|NCT00382863|58740251|FG000|Overall Study|Death|9|||
30727179|NCT00382863|58740252|FG001|Overall Study|Death|9|||
30900421|NCT02322866|58933799|FG001|Overall Study|Lack of Efficacy|1|||
30900422|NCT02322866|58933798|FG000|Overall Study|Other Miscellaneous Reasons|6|||
30900423|NCT02322866|58933799|FG001|Overall Study|Other Miscellaneous Reasons|6|||
30621719|NCT00975507|58633287|FG000|Overall Study|Lost to Follow-up|7|||
30727180|NCT00382863|58740251|FG000|Overall Study|Lost to Follow-up|1|||
30727181|NCT00382863|58740252|FG001|Overall Study|Lost to Follow-up|2|||
30727182|NCT00382863|58740251|FG000|Overall Study|Withdrawal by Subject|5|||
30727183|NCT00382863|58740252|FG001|Overall Study|Withdrawal by Subject|25|||
30727184|NCT03933449|58740260|FG000|Overall Study|Adverse Event|6|||
30727185|NCT03933449|58740261|FG001|Overall Study|Adverse Event|4|||
30727186|NCT03933449|58740260|FG000|Overall Study|Death|55|||
30727187|NCT03933449|58740261|FG001|Overall Study|Death|57|||
30727188|NCT03933449|58740260|FG000|Overall Study|Sponsor Decision|1|||
30727189|NCT03933449|58740261|FG001|Overall Study|Sponsor Decision|0|||
30727190|NCT00290758|58740284|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
30727191|NCT00290758|58740285|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
30727192|NCT00290758|58740284|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
30900424|NCT01640353|58933805|FG000|Overall Study|Withdrew prior to treatment|10|||
30727193|NCT00290758|58740285|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
30727194|NCT00290758|58740284|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
30727195|NCT00290758|58740285|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
30727196|NCT00290758|58740284|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
30727197|NCT00290758|58740285|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
30727198|NCT00290758|58740284|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
30727199|NCT00290758|58740285|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
30727200|NCT00290758|58740284|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
30727201|NCT00290758|58740285|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
30727202|NCT00290758|58740284|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
30727203|NCT00290758|58740285|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
30727204|NCT00290758|58740284|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
30727205|NCT00290758|58740285|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
30727206|NCT00372567|58740298|FG000|Phase 3 Study|Adverse Event|5|||
30727207|NCT00372567|58740299|FG001|Phase 3 Study|Adverse Event|1|||
30727208|NCT00372567|58740300|FG002|Phase 3 Study|Adverse Event|1|||
30727209|NCT00372567|58740298|FG000|Phase 3 Study|Death|1|||
30727210|NCT00372567|58740299|FG001|Phase 3 Study|Death|1|||
30727211|NCT00372567|58740300|FG002|Phase 3 Study|Death|0|||
30727212|NCT00372567|58740298|FG000|Phase 3 Study|Protocol Violation|0|||
30727213|NCT00372567|58740299|FG001|Phase 3 Study|Protocol Violation|0|||
30727214|NCT00372567|58740300|FG002|Phase 3 Study|Protocol Violation|1|||
30727215|NCT00372567|58740298|FG000|Phase 3 Study|Objective progression or relapse|10|||
30727216|NCT00372567|58740299|FG001|Phase 3 Study|Objective progression or relapse|13|||
30727217|NCT00372567|58740300|FG002|Phase 3 Study|Objective progression or relapse|4|||
30727218|NCT00372567|58740298|FG000|Phase 3 Study|Global deterioration of health status|0|||
30727219|NCT00372567|58740299|FG001|Phase 3 Study|Global deterioration of health status|1|||
30727220|NCT00372567|58740300|FG002|Phase 3 Study|Global deterioration of health status|0|||
30727221|NCT00372567|58740298|FG000|Phase 3 Study|Other|2|||
30727222|NCT00372567|58740299|FG001|Phase 3 Study|Other|2|||
30727223|NCT00372567|58740300|FG002|Phase 3 Study|Other|1|||
30727224|NCT00372567|58740298|FG000|Phase 3 Study|study terminated by sponsor|13|||
30727225|NCT00372567|58740299|FG001|Phase 3 Study|study terminated by sponsor|8|||
30727226|NCT00372567|58740300|FG002|Phase 3 Study|study terminated by sponsor|5|||
30727227|NCT00365547|58740308|FG000|Overall Study|Insurance did not cover Avastin|1|||
30727228|NCT00365547|58740308|FG000|Overall Study|Screen failure|1|||
30727229|NCT00365547|58740308|FG000|Overall Study|Withdrawal by Subject|1|||
30727230|NCT00545441|58740317|FG000|Overall Study|Fistula draining at 6 months|2|||
30727231|NCT00545441|58740318|FG001|Overall Study|Fistula draining at 6 months|4|||
30727232|NCT00545441|58740317|FG000|Overall Study|Lost to Follow-up|9|||
30727233|NCT00545441|58740318|FG001|Overall Study|Lost to Follow-up|5|||
30727234|NCT00545441|58740317|FG000|Overall Study|Technical failure|0|||
30727235|NCT00545441|58740318|FG001|Overall Study|Technical failure|1|||
30727236|NCT00545441|58740317|FG000|Overall Study|Withdrawal by Subject|1|||
30727237|NCT00545441|58740318|FG001|Overall Study|Withdrawal by Subject|1|||
30727238|NCT00545441|58740317|FG000|Overall Study|Persistence or recurrence of fistula|5|||
30727239|NCT00545441|58740318|FG001|Overall Study|Persistence or recurrence of fistula|2|||
30727240|NCT00545441|58740317|FG000|Overall Study|Patients were not treated|1|||
30727241|NCT00545441|58740318|FG001|Overall Study|Patients were not treated|3|||
30727242|NCT00294658|58740326|FG000|Overall Study|Death|0|||
30727243|NCT00294658|58740327|FG001|Overall Study|Death|1|||
30727244|NCT00294658|58740326|FG000|Overall Study|Lost to Follow-up|4|||
30727245|NCT00294658|58740327|FG001|Overall Study|Lost to Follow-up|0|||
30727246|NCT00294658|58740326|FG000|Overall Study|Physician Decision|1|||
30727247|NCT00294658|58740327|FG001|Overall Study|Physician Decision|2|||
30727248|NCT00294658|58740326|FG000|Overall Study|Pregnancy|0|||
30727249|NCT00294658|58740327|FG001|Overall Study|Pregnancy|1|||
30727250|NCT00294658|58740326|FG000|Overall Study|Withdrawal by Subject|0|||
30727251|NCT00294658|58740327|FG001|Overall Study|Withdrawal by Subject|4|||
30727252|NCT00294658|58740326|FG000|Overall Study|Found to have invasive thymoma|1|||
30727253|NCT00294658|58740327|FG001|Overall Study|Found to have invasive thymoma|0|||
30727254|NCT00294658|58740326|FG000|Overall Study|Patient and family were not satisfied|0|||
30727255|NCT00294658|58740327|FG001|Overall Study|Patient and family were not satisfied|1|||
30727256|NCT03923933|58740335|FG000|Overall Study|Lost to Follow-up|1|||
30727257|NCT03923933|58740336|FG001|Overall Study|Lost to Follow-up|0|||
30727258|NCT03923933|58740335|FG000|Overall Study|Withdrawal by Subject|0|||
30727259|NCT03923933|58740336|FG001|Overall Study|Withdrawal by Subject|1|||
30727260|NCT00372489|58740342|FG000|Overall Study|Adverse Event|18|||
30727261|NCT00372489|58740342|FG000|Overall Study|Lack of Efficacy|1|||
30727262|NCT00372489|58740342|FG000|Overall Study|Lost to Follow-up|3|||
30727263|NCT00372489|58740342|FG000|Overall Study|Physician Decision|3|||
30727264|NCT00372489|58740342|FG000|Overall Study|Withdrawal by Subject|5|||
30727265|NCT00372489|58740342|FG000|Overall Study|Patient Relocation|2|||
30727266|NCT00372489|58740342|FG000|Overall Study|Renal transplant|6|||
30727267|NCT00372489|58740342|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
30727268|NCT00372411|58740349|FG000|Overall Study|Withdrawal by Subject|3|||
30727269|NCT00372411|58740350|FG001|Overall Study|Withdrawal by Subject|4|||
30727270|NCT00372411|58740351|FG002|Overall Study|Withdrawal by Subject|1|||
30727271|NCT00372411|58740349|FG000|Overall Study|Death|0|||
30727272|NCT00372411|58740350|FG001|Overall Study|Death|2|||
30727273|NCT00372411|58740351|FG002|Overall Study|Death|1|||
30727274|NCT00372411|58740349|FG000|Overall Study|Lost to Follow-up|1|||
30727275|NCT00372411|58740350|FG001|Overall Study|Lost to Follow-up|1|||
30727276|NCT00372411|58740351|FG002|Overall Study|Lost to Follow-up|1|||
30727277|NCT00372411|58740349|FG000|Overall Study|Adverse Event|1|||
30727278|NCT00372411|58740350|FG001|Overall Study|Adverse Event|1|||
30727279|NCT00372411|58740351|FG002|Overall Study|Adverse Event|0|||
30727280|NCT00372255|58740361|FG000|Overall Study|Withdrawn for other reasons|2|||
30727281|NCT00372255|58740362|FG001|Overall Study|Withdrawn for other reasons|1|||
30727282|NCT00274456|58740373|FG000|Overall Study|Still on treatment|2|||
30727283|NCT00274456|58740374|FG001|Overall Study|Still on treatment|3|||
30727284|NCT00274456|58740375|FG002|Overall Study|Still on treatment|5|||
30727285|NCT00274456|58740376|FG003|Overall Study|Still on treatment|1|||
30727286|NCT00274456|58740373|FG000|Overall Study|Unacceptable toxicity|10|||
30727287|NCT00274456|58740374|FG001|Overall Study|Unacceptable toxicity|5|||
30727288|NCT00274456|58740375|FG002|Overall Study|Unacceptable toxicity|12|||
30727289|NCT00274456|58740376|FG003|Overall Study|Unacceptable toxicity|16|||
30727290|NCT00274456|58740373|FG000|Overall Study|Adverse Event|0|||
30727291|NCT00274456|58740374|FG001|Overall Study|Adverse Event|1|||
30727292|NCT00274456|58740375|FG002|Overall Study|Adverse Event|2|||
30727293|NCT00274456|58740376|FG003|Overall Study|Adverse Event|2|||
30727294|NCT00274456|58740373|FG000|Overall Study|Physician Decision|7|||
30727295|NCT00274456|58740374|FG001|Overall Study|Physician Decision|5|||
30727296|NCT00274456|58740375|FG002|Overall Study|Physician Decision|6|||
30727297|NCT00274456|58740376|FG003|Overall Study|Physician Decision|13|||
30727298|NCT00274456|58740373|FG000|Overall Study|Lost to Follow-up|0|||
30727299|NCT00274456|58740374|FG001|Overall Study|Lost to Follow-up|0|||
30727300|NCT00274456|58740375|FG002|Overall Study|Lost to Follow-up|1|||
30727301|NCT00274456|58740376|FG003|Overall Study|Lost to Follow-up|0|||
30727302|NCT00274456|58740373|FG000|Overall Study|Withdrawal by Subject|18|||
30727303|NCT00274456|58740374|FG001|Overall Study|Withdrawal by Subject|13|||
30727304|NCT00274456|58740375|FG002|Overall Study|Withdrawal by Subject|9|||
30727305|NCT00274456|58740376|FG003|Overall Study|Withdrawal by Subject|13|||
30727306|NCT00364923|58740386|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
30727307|NCT00364923|58740386|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
30727308|NCT00381849|58740392|FG000|Wash Out|Withdrawal by Subject|0|||
30727309|NCT00381849|58740393|FG001|Wash Out|Withdrawal by Subject|1|||
30727310|NCT00273052|58740401|FG000|Overall Study|Withdrawal by Subject|16|||
30727311|NCT00273052|58740402|FG001|Overall Study|Withdrawal by Subject|19|||
30727312|NCT00273052|58740401|FG000|Overall Study|Adverse Event|21|||
30727313|NCT00273052|58740402|FG001|Overall Study|Adverse Event|19|||
30727314|NCT00273052|58740401|FG000|Overall Study|Protocol Violation|14|||
30727315|NCT00273052|58740402|FG001|Overall Study|Protocol Violation|18|||
30727316|NCT00273052|58740401|FG000|Overall Study|Lost to Follow-up|7|||
30727317|NCT00273052|58740402|FG001|Overall Study|Lost to Follow-up|25|||
30727318|NCT00273052|58740401|FG000|Overall Study|Lack of Efficacy|6|||
30727319|NCT00273052|58740402|FG001|Overall Study|Lack of Efficacy|4|||
30727320|NCT00273052|58740401|FG000|Overall Study|Non-Compliance|3|||
30727321|NCT00273052|58740402|FG001|Overall Study|Non-Compliance|1|||
30727322|NCT00273052|58740401|FG000|Overall Study|Other|2|||
30727323|NCT00273052|58740402|FG001|Overall Study|Other|0|||
30727324|NCT00273052|58740401|FG000|Overall Study|Worsening serum lipid levels|0|||
30727325|NCT00273052|58740402|FG001|Overall Study|Worsening serum lipid levels|2|||
30727326|NCT00290290|58740410|FG000|Overall Study|Death|3|||
30727327|NCT00290290|58740411|FG001|Overall Study|Death|4|||
30727328|NCT00290290|58740410|FG000|Overall Study|Withdrawal by Subject|2|||
30727329|NCT00290290|58740411|FG001|Overall Study|Withdrawal by Subject|2|||
30727330|NCT00290290|58740410|FG000|Overall Study|Underwent clean surgical procedure|13|||
30727331|NCT00290290|58740411|FG001|Overall Study|Underwent clean surgical procedure|12|||
30727332|NCT00272038|58740417|FG000|Overall Study|withdrew before they received 2 cycles|7|||
30727333|NCT00271024|58740426|FG000|Overall Study|Lost Interest|3|||
30727334|NCT00271024|58740427|FG001|Overall Study|Lost Interest|4|||
30727335|NCT00271024|58740428|FG002|Overall Study|Lost Interest|2|||
30727336|NCT00271024|58740429|FG003|Overall Study|Lost Interest|3|||
30727337|NCT00271024|58740426|FG000|Overall Study|Unknown/Unspecified|11|||
30727338|NCT00271024|58740427|FG001|Overall Study|Unknown/Unspecified|11|||
30727339|NCT00271024|58740428|FG002|Overall Study|Unknown/Unspecified|8|||
30727340|NCT00271024|58740429|FG003|Overall Study|Unknown/Unspecified|4|||
30727341|NCT00271024|58740426|FG000|Overall Study|Protocol Violation|1|||
30727342|NCT00271024|58740427|FG001|Overall Study|Protocol Violation|6|||
30727343|NCT00271024|58740428|FG002|Overall Study|Protocol Violation|5|||
30727344|NCT00271024|58740429|FG003|Overall Study|Protocol Violation|11|||
30727345|NCT00271024|58740426|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
30727346|NCT00271024|58740427|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
30727347|NCT00271024|58740428|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
30727348|NCT00271024|58740429|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
30727349|NCT00271024|58740426|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
30727350|NCT00271024|58740427|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
30727351|NCT00271024|58740428|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
30727352|NCT00271024|58740429|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
30727353|NCT00381693|58740439|FG000|Overall Study|Death|1|||
30727354|NCT00381693|58740439|FG000|Overall Study|Adverse Event|4|||
30727355|NCT00381693|58740439|FG000|Overall Study|Patient Choice|1|||
30727356|NCT00381693|58740439|FG000|Overall Study|Progression|2|||
30727357|NCT00545363|58740445|FG000|Overall Study|Adverse Event|6|||
30727358|NCT00545363|58740446|FG001|Overall Study|Adverse Event|7|||
30727359|NCT00545363|58740445|FG000|Overall Study|Withdrawal by Subject|6|||
30727360|NCT00545363|58740446|FG001|Overall Study|Withdrawal by Subject|5|||
30727361|NCT00545363|58740445|FG000|Overall Study|Non-compliance|3|||
30727362|NCT00545363|58740446|FG001|Overall Study|Non-compliance|1|||
30727363|NCT00545363|58740445|FG000|Overall Study|Did not meet entry criteria|1|||
30727364|NCT00545363|58740446|FG001|Overall Study|Did not meet entry criteria|1|||
30727365|NCT00545363|58740445|FG000|Overall Study|Lost to Follow-up|2|||
30727366|NCT00545363|58740446|FG001|Overall Study|Lost to Follow-up|0|||
30727367|NCT00545363|58740445|FG000|Overall Study|Other|1|||
30727368|NCT00545363|58740446|FG001|Overall Study|Other|1|||
30727369|NCT00457392|58740454|FG000|Overall Study|Objective Progression or Relapse|229|||
30727370|NCT00457392|58740455|FG001|Overall Study|Objective Progression or Relapse|296|||
30727371|NCT00457392|58740454|FG000|Overall Study|Death|106|||
30727372|NCT00457392|58740455|FG001|Overall Study|Death|106|||
30727373|NCT00457392|58740454|FG000|Overall Study|Adverse Event|84|||
30727374|NCT00457392|58740455|FG001|Overall Study|Adverse Event|41|||
30727375|NCT00457392|58740454|FG000|Overall Study|Global Deterioration of Health Status|22|||
30727376|NCT00457392|58740455|FG001|Overall Study|Global Deterioration of Health Status|8|||
30727377|NCT00457392|58740454|FG000|Overall Study|Withdrawal by Subject|14|||
30727378|NCT00457392|58740455|FG001|Overall Study|Withdrawal by Subject|8|||
30727379|NCT00457392|58740454|FG000|Overall Study|Lost to Follow-up|6|||
30727380|NCT00457392|58740455|FG001|Overall Study|Lost to Follow-up|7|||
30727381|NCT00457392|58740454|FG000|Overall Study|Protocol Violation|4|||
30727382|NCT00457392|58740455|FG001|Overall Study|Protocol Violation|3|||
30727383|NCT00457392|58740454|FG000|Overall Study|Other|7|||
30727384|NCT00457392|58740455|FG001|Overall Study|Other|4|||
30727385|NCT00457392|58740454|FG000|Overall Study|Study Terminated by Sponsor|1|||
30727386|NCT00457392|58740455|FG001|Overall Study|Study Terminated by Sponsor|4|||
30727387|NCT00457392|58740454|FG000|Overall Study|Randomized, Not Treated|7|||
30727388|NCT00457392|58740455|FG001|Overall Study|Randomized, Not Treated|3|||
30727389|NCT00545051|58740463|FG000|Overall Study|Adverse Event|7|||
30727390|NCT00545051|58740464|FG001|Overall Study|Adverse Event|3|||
30727391|NCT00545051|58740463|FG000|Overall Study|Death|1|||
30727392|NCT00545051|58740464|FG001|Overall Study|Death|0|||
30727393|NCT00545051|58740463|FG000|Overall Study|Violation of inclusion/exclusion|0|||
30727394|NCT00545051|58740464|FG001|Overall Study|Violation of inclusion/exclusion|2|||
30727395|NCT00545051|58740463|FG000|Overall Study|Protocol Violation|1|||
30727396|NCT00545051|58740464|FG001|Overall Study|Protocol Violation|0|||
30727397|NCT00545051|58740463|FG000|Overall Study|Withdrawal by Subject|0|||
30900425|NCT01640353|58933805|FG000|Overall Study|Withdrawn from analysis at term site|12|||
30727398|NCT00545051|58740464|FG001|Overall Study|Withdrawal by Subject|1|||
30727399|NCT00545051|58740463|FG000|Overall Study|Administrative reasons|0|||
30727400|NCT00545051|58740464|FG001|Overall Study|Administrative reasons|1|||
30727401|NCT00381615|58740474|FG000|Overall Study|Withdrawal by Subject|1|||
30727402|NCT00381615|58740475|FG001|Overall Study|Withdrawal by Subject|3|||
30727403|NCT00381615|58740476|FG002|Overall Study|Withdrawal by Subject|0|||
30727404|NCT00381615|58740477|FG003|Overall Study|Withdrawal by Subject|1|||
30727405|NCT00381615|58740474|FG000|Overall Study|Lost to Follow-up|3|||
30727406|NCT00381615|58740475|FG001|Overall Study|Lost to Follow-up|2|||
30727407|NCT00381615|58740476|FG002|Overall Study|Lost to Follow-up|0|||
30900426|NCT01640353|58933805|FG000|Overall Study|Withdrawal by Subject|5|||
30727408|NCT00381615|58740477|FG003|Overall Study|Lost to Follow-up|1|||
30727409|NCT00381615|58740474|FG000|Overall Study|Protocol Violation|0|||
30727410|NCT00381615|58740475|FG001|Overall Study|Protocol Violation|0|||
30727411|NCT00381615|58740476|FG002|Overall Study|Protocol Violation|1|||
30727412|NCT00381615|58740477|FG003|Overall Study|Protocol Violation|0|||
30727413|NCT00371865|58740491|FG000|Overall Study|Lack of Efficacy|0|||
30727414|NCT00371865|58740492|FG001|Overall Study|Lack of Efficacy|2|||
30727415|NCT00371865|58740491|FG000|Overall Study|Protocol Violation|3|||
30727416|NCT00371865|58740492|FG001|Overall Study|Protocol Violation|2|||
30727417|NCT00371865|58740491|FG000|Overall Study|Withdrawal by Subject|12|||
30727418|NCT00371865|58740492|FG001|Overall Study|Withdrawal by Subject|10|||
30727419|NCT00364845|58740500|FG000|Overall Study|Adverse Event|1|||
30727420|NCT00364845|58740501|FG001|Overall Study|Adverse Event|0|||
30727421|NCT00364845|58740500|FG000|Overall Study|Withdrawal by Subject|2|||
30727422|NCT00364845|58740501|FG001|Overall Study|Withdrawal by Subject|1|||
30727423|NCT00364845|58740500|FG000|Overall Study|Physician Decision|8|||
30727424|NCT00364845|58740501|FG001|Overall Study|Physician Decision|8|||
30727425|NCT00364845|58740500|FG000|Overall Study|Lost to Follow-up|0|||
30727426|NCT00364845|58740501|FG001|Overall Study|Lost to Follow-up|1|||
30727427|NCT00364845|58740500|FG000|Overall Study|Death|0|||
30727428|NCT00364845|58740501|FG001|Overall Study|Death|1|||
30727429|NCT00293722|58740507|FG000|Overall Study|Other|427|||
30727430|NCT00381303|58740513|FG000|Overall Study|Lost to Follow-up|25|||
30727431|NCT00381303|58740514|FG001|Overall Study|Lost to Follow-up|9|||
30727432|NCT00381303|58740513|FG000|Overall Study|AE/HIV-related event|22|||
30727433|NCT00381303|58740514|FG001|Overall Study|AE/HIV-related event|6|||
30727434|NCT00381303|58740513|FG000|Overall Study|Non-Adherence|13|||
30727435|NCT00381303|58740514|FG001|Overall Study|Non-Adherence|6|||
30727436|NCT00381303|58740513|FG000|Overall Study|Withdrawal by Subject|13|||
30727437|NCT00381303|58740514|FG001|Overall Study|Withdrawal by Subject|6|||
30727438|NCT00381303|58740513|FG000|Overall Study|Virologic failure|6|||
30727439|NCT00381303|58740514|FG001|Overall Study|Virologic failure|4|||
30727440|NCT00381303|58740513|FG000|Overall Study|Ineligible to continue the trial|2|||
30727441|NCT00381303|58740514|FG001|Overall Study|Ineligible to continue the trial|1|||
30727442|NCT00381303|58740513|FG000|Overall Study|Pregnancy|2|||
30727443|NCT00381303|58740514|FG001|Overall Study|Pregnancy|0|||
30727444|NCT00381303|58740513|FG000|Overall Study|Physician Decision|1|||
30727445|NCT00381303|58740514|FG001|Overall Study|Physician Decision|0|||
30727446|NCT00381303|58740513|FG000|Overall Study|Physician's decision to close the site|3|||
30727447|NCT00381303|58740514|FG001|Overall Study|Physician's decision to close the site|1|||
30727448|NCT00381303|58740513|FG000|Overall Study|Subject moved out of state|2|||
30727449|NCT00381303|58740514|FG001|Overall Study|Subject moved out of state|0|||
30727450|NCT00381303|58740513|FG000|Overall Study|Subject taking too many different meds|1|||
30727451|NCT00381303|58740514|FG001|Overall Study|Subject taking too many different meds|0|||
30727452|NCT00381303|58740513|FG000|Overall Study|No virologic response by week 12|1|||
30727453|NCT00381303|58740514|FG001|Overall Study|No virologic response by week 12|0|||
30727454|NCT00381303|58740513|FG000|Overall Study|Subject was too busy for appointments|1|||
30727455|NCT00381303|58740514|FG001|Overall Study|Subject was too busy for appointments|0|||
30727456|NCT00381303|58740513|FG000|Overall Study|Subject did not continue visits|1|||
30727457|NCT00381303|58740514|FG001|Overall Study|Subject did not continue visits|0|||
30727458|NCT00381303|58740513|FG000|Overall Study|Subject primary physician's decision|1|||
30727459|NCT00381303|58740514|FG001|Overall Study|Subject primary physician's decision|0|||
30727460|NCT00448812|58740534|FG000|Year 2|Missed visit but remained in study|4|||
30727461|NCT00448812|58740535|FG001|Year 2|Missed visit but remained in study|1|||
30727462|NCT00448812|58740534|FG000|Year 3|Withdrawal by Subject|1|||
30727463|NCT00448812|58740535|FG001|Year 3|Withdrawal by Subject|3|||
30727464|NCT00448812|58740534|FG000|Year 3|Lost to Follow-up|1|||
30727465|NCT00448812|58740535|FG001|Year 3|Lost to Follow-up|0|||
30727466|NCT00448812|58740534|FG000|Year 3|Missed visit but remained in study|2|||
30727467|NCT00448812|58740535|FG001|Year 3|Missed visit but remained in study|0|||
30727468|NCT00448812|58740534|FG000|Year 5|Missed visit but remained in study|1|||
30727469|NCT00448812|58740535|FG001|Year 5|Missed visit but remained in study|0|||
30727470|NCT00364689|58740556|FG000|Overall Study|Lost to Follow-up|1|||
30621720|NCT00975507|58633288|FG001|Overall Study|Lost to Follow-up|1|||
30727471|NCT00545129|58740564|FG000|Overall Study|Lack of Efficacy|2|||
30727472|NCT00545129|58740565|FG001|Overall Study|Lack of Efficacy|5|||
30727473|NCT00545129|58740564|FG000|Overall Study|Death|2|||
30727474|NCT00545129|58740565|FG001|Overall Study|Death|1|||
30727475|NCT00545129|58740564|FG000|Overall Study|Adverse Event|1|||
30727476|NCT00545129|58740565|FG001|Overall Study|Adverse Event|1|||
30727477|NCT00545129|58740564|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
30727478|NCT00545129|58740565|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
30621721|NCT00975507|58633287|FG000|Overall Study|Protocol Violation|2|||
30727479|NCT00545129|58740564|FG000|Overall Study|Other|3|||
30727480|NCT00545129|58740565|FG001|Overall Study|Other|3|||
30727481|NCT00364611|58740573|FG000|Overall Study|Did not receive study medication|0|||
30727482|NCT00364611|58740574|FG001|Overall Study|Did not receive study medication|1|||
30727483|NCT00364611|58740573|FG000|Overall Study|Adverse Event|7|||
30727484|NCT00364611|58740574|FG001|Overall Study|Adverse Event|4|||
30727485|NCT00364611|58740573|FG000|Overall Study|Participant's Request|3|||
30727486|NCT00364611|58740574|FG001|Overall Study|Participant's Request|4|||
30727487|NCT00364611|58740573|FG000|Overall Study|Disease Progression|38|||
30727488|NCT00364611|58740574|FG001|Overall Study|Disease Progression|8|||
30727489|NCT00364611|58740573|FG000|Overall Study|Investigator decision|2|||
30727490|NCT00364611|58740574|FG001|Overall Study|Investigator decision|2|||
30727491|NCT00364611|58740573|FG000|Overall Study|Found Ineligible|1|||
30727492|NCT00364611|58740574|FG001|Overall Study|Found Ineligible|0|||
30727493|NCT00364611|58740573|FG000|Overall Study|Presumed CR on Study|0|||
30727494|NCT00364611|58740574|FG001|Overall Study|Presumed CR on Study|1|||
30727495|NCT00364611|58740573|FG000|Overall Study|Receiving Liver Ablation|0|||
30727496|NCT00364611|58740574|FG001|Overall Study|Receiving Liver Ablation|1|||
30727497|NCT00364533|58740585|FG000|Overall Study|Adverse Event|8|||
30727498|NCT00364533|58740586|FG001|Overall Study|Adverse Event|7|||
30727499|NCT00364533|58740587|FG002|Overall Study|Adverse Event|15|||
30727500|NCT00364533|58740588|FG003|Overall Study|Adverse Event|5|||
30727501|NCT00364533|58740589|FG004|Overall Study|Adverse Event|2|||
30727502|NCT00364533|58740585|FG000|Overall Study|Withdrawal by Subject|4|||
30727503|NCT00364533|58740586|FG001|Overall Study|Withdrawal by Subject|8|||
30727504|NCT00364533|58740587|FG002|Overall Study|Withdrawal by Subject|6|||
30727505|NCT00364533|58740588|FG003|Overall Study|Withdrawal by Subject|6|||
30727506|NCT00364533|58740589|FG004|Overall Study|Withdrawal by Subject|6|||
30727507|NCT00364533|58740585|FG000|Overall Study|Lack of Efficacy|22|||
30727508|NCT00364533|58740586|FG001|Overall Study|Lack of Efficacy|22|||
30727509|NCT00364533|58740587|FG002|Overall Study|Lack of Efficacy|21|||
30727510|NCT00364533|58740588|FG003|Overall Study|Lack of Efficacy|17|||
30727511|NCT00364533|58740589|FG004|Overall Study|Lack of Efficacy|42|||
30727512|NCT00364533|58740585|FG000|Overall Study|Subject discharged from hospital|4|||
30727513|NCT00364533|58740586|FG001|Overall Study|Subject discharged from hospital|1|||
30727514|NCT00364533|58740587|FG002|Overall Study|Subject discharged from hospital|2|||
30727515|NCT00364533|58740588|FG003|Overall Study|Subject discharged from hospital|3|||
30727516|NCT00364533|58740589|FG004|Overall Study|Subject discharged from hospital|1|||
30727517|NCT00364533|58740585|FG000|Overall Study|Variations in drug compliance|2|||
30727518|NCT00364533|58740586|FG001|Overall Study|Variations in drug compliance|1|||
30727519|NCT00364533|58740587|FG002|Overall Study|Variations in drug compliance|1|||
30727520|NCT00364533|58740588|FG003|Overall Study|Variations in drug compliance|0|||
30727521|NCT00364533|58740589|FG004|Overall Study|Variations in drug compliance|0|||
30727522|NCT00364533|58740585|FG000|Overall Study|Non-compliance|1|||
30727523|NCT00364533|58740586|FG001|Overall Study|Non-compliance|0|||
30727524|NCT00364533|58740587|FG002|Overall Study|Non-compliance|0|||
30727525|NCT00364533|58740588|FG003|Overall Study|Non-compliance|0|||
30727526|NCT00364533|58740589|FG004|Overall Study|Non-compliance|0|||
30727527|NCT00364533|58740585|FG000|Overall Study|Protocol Violation|1|||
30727528|NCT00364533|58740586|FG001|Overall Study|Protocol Violation|1|||
30727529|NCT00364533|58740587|FG002|Overall Study|Protocol Violation|0|||
30727530|NCT00364533|58740588|FG003|Overall Study|Protocol Violation|0|||
30727531|NCT00364533|58740589|FG004|Overall Study|Protocol Violation|0|||
30727532|NCT04006847|58740601|FG000|Overall Study|Product issue|1|||
30727533|NCT00544817|58740605|FG000|Combined Modality|Lack of Efficacy|2|||
30727534|NCT00544817|58740605|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
30727535|NCT00544817|58740605|FG000|Combined Modality|Adverse Event|2|||
30727536|NCT00544817|58740605|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
30727537|NCT00544817|58740605|FG000|No Treatment Interval|Lack of Efficacy|8|||
30727538|NCT00544817|58740605|FG000|No Treatment Interval|Physician Decision|3|||
30727539|NCT00544817|58740605|FG000|No Treatment Interval|Adverse Event|1|||
30727540|NCT00544817|58740605|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
30727541|NCT00544817|58740605|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
30727542|NCT00544817|58740605|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
30727543|NCT00289978|58740612|FG000|Overall Study|Withdrawal by Subject|31|||
30727544|NCT00289978|58740613|FG001|Overall Study|Withdrawal by Subject|17|||
30727545|NCT00289978|58740614|FG002|Overall Study|Withdrawal by Subject|28|||
30727546|NCT00289978|58740612|FG000|Overall Study|Adverse Event|22|||
30727547|NCT00289978|58740613|FG001|Overall Study|Adverse Event|13|||
30727548|NCT00289978|58740614|FG002|Overall Study|Adverse Event|18|||
30727549|NCT00289978|58740612|FG000|Overall Study|Lack of Efficacy|13|||
30727550|NCT00289978|58740613|FG001|Overall Study|Lack of Efficacy|6|||
30727551|NCT00289978|58740614|FG002|Overall Study|Lack of Efficacy|25|||
30727552|NCT00289978|58740612|FG000|Overall Study|Abnormal laboratory value(s)|20|||
30727553|NCT00289978|58740613|FG001|Overall Study|Abnormal laboratory value(s)|9|||
30727554|NCT00289978|58740614|FG002|Overall Study|Abnormal laboratory value(s)|1|||
30727555|NCT00289978|58740612|FG000|Overall Study|Lost to Follow-up|3|||
30727556|NCT00289978|58740613|FG001|Overall Study|Lost to Follow-up|5|||
30727557|NCT00289978|58740614|FG002|Overall Study|Lost to Follow-up|7|||
30727558|NCT00289978|58740612|FG000|Overall Study|Protocol Violation|5|||
30727559|NCT00289978|58740613|FG001|Overall Study|Protocol Violation|5|||
30727560|NCT00289978|58740614|FG002|Overall Study|Protocol Violation|4|||
30727561|NCT00289978|58740612|FG000|Overall Study|Abnormal test procedure result(s)|2|||
30727562|NCT00289978|58740613|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30727563|NCT00289978|58740614|FG002|Overall Study|Abnormal test procedure result(s)|1|||
30727564|NCT00289978|58740612|FG000|Overall Study|Death|1|||
30727565|NCT00289978|58740613|FG001|Overall Study|Death|0|||
30727566|NCT00289978|58740614|FG002|Overall Study|Death|2|||
30727567|NCT00543803|58740622|FG000|Overall Study|Adverse Event|14|||
30727568|NCT00543803|58740622|FG000|Overall Study|Lack of Efficacy|22|||
30727569|NCT00543803|58740622|FG000|Overall Study|Lost to Follow-up|20|||
30727570|NCT00543803|58740622|FG000|Overall Study|Other|86|||
30727571|NCT00542321|58740630|FG000|Overall Study|Death|0|||
30727572|NCT00542321|58740631|FG001|Overall Study|Death|1|||
30727573|NCT00289900|58740643|FG000|Overall Study|Adverse Event|28|||
30727574|NCT00289900|58740644|FG001|Overall Study|Adverse Event|40|||
30727575|NCT00289900|58740645|FG002|Overall Study|Adverse Event|13|||
30727576|NCT00289900|58740646|FG003|Overall Study|Adverse Event|19|||
30727577|NCT00289900|58740647|FG004|Overall Study|Adverse Event|20|||
30727578|NCT00289900|58740648|FG005|Overall Study|Adverse Event|33|||
30727579|NCT00289900|58740643|FG000|Overall Study|Lost to Follow-up|7|||
30727580|NCT00289900|58740644|FG001|Overall Study|Lost to Follow-up|7|||
30727581|NCT00289900|58740645|FG002|Overall Study|Lost to Follow-up|8|||
30727582|NCT00289900|58740646|FG003|Overall Study|Lost to Follow-up|8|||
30727583|NCT00289900|58740647|FG004|Overall Study|Lost to Follow-up|4|||
30727584|NCT00289900|58740648|FG005|Overall Study|Lost to Follow-up|8|||
30727585|NCT00289900|58740643|FG000|Overall Study|Participant had flushing|18|||
30727586|NCT00289900|58740644|FG001|Overall Study|Participant had flushing|42|||
30727587|NCT00289900|58740645|FG002|Overall Study|Participant had flushing|1|||
30727588|NCT00289900|58740646|FG003|Overall Study|Participant had flushing|2|||
30727589|NCT00289900|58740647|FG004|Overall Study|Participant had flushing|0|||
30727590|NCT00289900|58740648|FG005|Overall Study|Participant had flushing|4|||
30727591|NCT00289900|58740643|FG000|Overall Study|Other|0|||
30727592|NCT00289900|58740644|FG001|Overall Study|Other|0|||
30727593|NCT00289900|58740645|FG002|Overall Study|Other|0|||
30727594|NCT00289900|58740646|FG003|Overall Study|Other|5|||
30727595|NCT00289900|58740647|FG004|Overall Study|Other|1|||
30727596|NCT00289900|58740648|FG005|Overall Study|Other|0|||
30727597|NCT00289900|58740643|FG000|Overall Study|Participant moved|1|||
30727598|NCT00289900|58740644|FG001|Overall Study|Participant moved|0|||
30727599|NCT00289900|58740645|FG002|Overall Study|Participant moved|0|||
30727600|NCT00289900|58740646|FG003|Overall Study|Participant moved|1|||
30727601|NCT00289900|58740647|FG004|Overall Study|Participant moved|1|||
30727602|NCT00289900|58740648|FG005|Overall Study|Participant moved|1|||
30727603|NCT00289900|58740643|FG000|Overall Study|Withdrawal by Subject|10|||
30727604|NCT00289900|58740644|FG001|Overall Study|Withdrawal by Subject|21|||
30727605|NCT00289900|58740645|FG002|Overall Study|Withdrawal by Subject|8|||
30727606|NCT00289900|58740646|FG003|Overall Study|Withdrawal by Subject|18|||
30727607|NCT00289900|58740647|FG004|Overall Study|Withdrawal by Subject|12|||
30727608|NCT00289900|58740648|FG005|Overall Study|Withdrawal by Subject|11|||
30727609|NCT00289900|58740643|FG000|Overall Study|Protocol Violation|3|||
30727610|NCT00289900|58740644|FG001|Overall Study|Protocol Violation|9|||
30727611|NCT00289900|58740645|FG002|Overall Study|Protocol Violation|2|||
30727612|NCT00289900|58740646|FG003|Overall Study|Protocol Violation|6|||
30727613|NCT00289900|58740647|FG004|Overall Study|Protocol Violation|7|||
30727614|NCT00289900|58740648|FG005|Overall Study|Protocol Violation|4|||
30727615|NCT00289900|58740643|FG000|Overall Study|site terminated|1|||
30727616|NCT00289900|58740644|FG001|Overall Study|site terminated|0|||
30727617|NCT00289900|58740645|FG002|Overall Study|site terminated|1|||
30727618|NCT00289900|58740646|FG003|Overall Study|site terminated|0|||
30727619|NCT00289900|58740647|FG004|Overall Study|site terminated|0|||
30727620|NCT00289900|58740648|FG005|Overall Study|site terminated|0|||
30727621|NCT00289900|58740643|FG000|Overall Study|Not treated|0|||
30727622|NCT00289900|58740644|FG001|Overall Study|Not treated|1|||
30727623|NCT00289900|58740645|FG002|Overall Study|Not treated|0|||
30727624|NCT00289900|58740646|FG003|Overall Study|Not treated|0|||
30727625|NCT00289900|58740647|FG004|Overall Study|Not treated|0|||
30727626|NCT00289900|58740648|FG005|Overall Study|Not treated|0|||
30727627|NCT00543725|58740667|FG000|Overall Study|Adverse Event|18|||
30727628|NCT00543725|58740668|FG001|Overall Study|Adverse Event|27|||
30727629|NCT00543725|58740667|FG000|Overall Study|Sponsor's Decision|0|||
30727630|NCT00543725|58740668|FG001|Overall Study|Sponsor's Decision|1|||
30727631|NCT00543725|58740667|FG000|Overall Study|Subject Non-Compliant|4|||
30727632|NCT00543725|58740668|FG001|Overall Study|Subject Non-Compliant|4|||
30727633|NCT00543725|58740667|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
30727634|NCT00543725|58740668|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
30727635|NCT00543725|58740667|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
30727636|NCT00543725|58740668|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
30727637|NCT00543725|58740667|FG000|Overall Study|Protocol Violation|0|||
30727638|NCT00543725|58740668|FG001|Overall Study|Protocol Violation|1|||
30727639|NCT00543725|58740667|FG000|Overall Study|Withdrawal by Subject|4|||
30727640|NCT00543725|58740668|FG001|Overall Study|Withdrawal by Subject|13|||
30727641|NCT00543725|58740667|FG000|Overall Study|Lost to Follow-up|15|||
30727642|NCT00543725|58740668|FG001|Overall Study|Lost to Follow-up|11|||
30727643|NCT00543725|58740667|FG000|Overall Study|Other|3|||
30727644|NCT00543725|58740668|FG001|Overall Study|Other|3|||
30727645|NCT00269152|58740676|FG000|Overall Study|Adverse Event|9|||
30727646|NCT00269152|58740677|FG001|Overall Study|Adverse Event|3|||
30727647|NCT00269152|58740676|FG000|Overall Study|Withdrawal by Subject|7|||
30727648|NCT00269152|58740677|FG001|Overall Study|Withdrawal by Subject|3|||
30727649|NCT00269152|58740676|FG000|Overall Study|Physician Decision|2|||
30727650|NCT00269152|58740677|FG001|Overall Study|Physician Decision|3|||
30727651|NCT00269152|58740676|FG000|Overall Study|Protocol Violation|0|||
30727652|NCT00269152|58740677|FG001|Overall Study|Protocol Violation|1|||
30727653|NCT00379899|58740685|FG000|Overall Study|Adverse Event|7|||
30727654|NCT00379899|58740686|FG001|Overall Study|Adverse Event|3|||
30727655|NCT00379899|58740685|FG000|Overall Study|Death|10|||
30727656|NCT00379899|58740686|FG001|Overall Study|Death|10|||
30727657|NCT00379899|58740685|FG000|Overall Study|Lost to Follow-up|2|||
30727658|NCT00379899|58740686|FG001|Overall Study|Lost to Follow-up|4|||
30727659|NCT00379899|58740685|FG000|Overall Study|Physician Decision|3|||
30727660|NCT00379899|58740686|FG001|Overall Study|Physician Decision|4|||
30727661|NCT00379899|58740685|FG000|Overall Study|Withdrawal by Subject|5|||
30727662|NCT00379899|58740686|FG001|Overall Study|Withdrawal by Subject|5|||
30727663|NCT00379899|58740685|FG000|Overall Study|Ineligibility determined|0|||
30727664|NCT00379899|58740686|FG001|Overall Study|Ineligibility determined|1|||
30727665|NCT00379899|58740685|FG000|Overall Study|Noncompliance|1|||
30727666|NCT00379899|58740686|FG001|Overall Study|Noncompliance|1|||
30727667|NCT00379899|58740685|FG000|Overall Study|Parathyroidectomy|0|||
30727668|NCT00379899|58740686|FG001|Overall Study|Parathyroidectomy|2|||
30727669|NCT00379899|58740685|FG000|Overall Study|Renal transplantation|5|||
30727670|NCT00379899|58740686|FG001|Overall Study|Renal transplantation|4|||
30727671|NCT00379899|58740685|FG000|Overall Study|Coronary artery bypass graft|1|||
30727672|NCT00379899|58740686|FG001|Overall Study|Coronary artery bypass graft|1|||
30727673|NCT00379899|58740685|FG000|Overall Study|Other protocol-specified criteria|3|||
30727674|NCT00379899|58740686|FG001|Overall Study|Other protocol-specified criteria|4|||
30727675|NCT00379899|58740685|FG000|Overall Study|Other|3|||
30727676|NCT00379899|58740686|FG001|Overall Study|Other|1|||
30727677|NCT00371787|58740694|FG000|Overall Study|Withdrawal by Subject|3|||
30727678|NCT00371787|58740695|FG001|Overall Study|Withdrawal by Subject|1|||
30727679|NCT00363129|58740703|FG000|Overall Study|Withdrawal by Subject|11|||
30727680|NCT00363129|58740704|FG001|Overall Study|Withdrawal by Subject|18|||
30727681|NCT00363129|58740703|FG000|Overall Study|Adverse Event|8|||
30727682|NCT00363129|58740704|FG001|Overall Study|Adverse Event|3|||
30727683|NCT00363129|58740703|FG000|Overall Study|Alternate Treatment|2|||
30727684|NCT00363129|58740704|FG001|Overall Study|Alternate Treatment|4|||
30727685|NCT00363129|58740703|FG000|Overall Study|Other Medical Problems|2|||
30727686|NCT00363129|58740704|FG001|Overall Study|Other Medical Problems|4|||
30727687|NCT00363129|58740703|FG000|Overall Study|Death|0|||
30727688|NCT00363129|58740704|FG001|Overall Study|Death|1|||
30727689|NCT00363129|58740703|FG000|Overall Study|Other Reasons|6|||
30727690|NCT00363129|58740704|FG001|Overall Study|Other Reasons|3|||
30727691|NCT00268996|58740712|FG000|Overall Study|Adverse Event|11|||
30727692|NCT00268996|58740713|FG001|Overall Study|Adverse Event|7|||
30727693|NCT00268996|58740712|FG000|Overall Study|Lost to Follow-up|3|||
30727694|NCT00268996|58740713|FG001|Overall Study|Lost to Follow-up|1|||
30727695|NCT00268996|58740712|FG000|Overall Study|Withdrawal by Subject|5|||
30727696|NCT00268996|58740713|FG001|Overall Study|Withdrawal by Subject|11|||
30727697|NCT00268996|58740712|FG000|Overall Study|Non-compliance|1|||
30727698|NCT00268996|58740713|FG001|Overall Study|Non-compliance|0|||
30727699|NCT00268996|58740712|FG000|Overall Study|Other|1|||
30727700|NCT00268996|58740713|FG001|Overall Study|Other|1|||
30727701|NCT00371397|58740721|FG000|Session 1|Withdrawal by Subject|1|||
30727702|NCT00371397|58740722|FG001|Session 1|Withdrawal by Subject|0|||
30727703|NCT00371397|58740723|FG002|Session 1|Withdrawal by Subject|0|||
30727704|NCT00371397|58740724|FG003|Session 1|Withdrawal by Subject|0|||
30727705|NCT00371397|58740725|FG004|Session 1|Withdrawal by Subject|0|||
30727706|NCT00371397|58740726|FG005|Session 1|Withdrawal by Subject|0|||
30727707|NCT00371397|58740727|FG006|Session 1|Withdrawal by Subject|0|||
30727708|NCT00371397|58740728|FG007|Session 1|Withdrawal by Subject|1|||
30727709|NCT00371397|58740729|FG008|Session 1|Withdrawal by Subject|0|||
30727710|NCT00371397|58740730|FG009|Session 1|Withdrawal by Subject|0|||
30727711|NCT00371397|58740731|FG010|Session 1|Withdrawal by Subject|0|||
30727712|NCT00371397|58740732|FG011|Session 1|Withdrawal by Subject|0|||
30727713|NCT00379587|58740738|FG000|Overall Study|Lost to Follow-up|2|||
30727714|NCT00289276|58740744|FG000|Second Part of FAST Study (Expansion)|Death|0|||
30727715|NCT00289276|58740745|FG001|Second Part of FAST Study (Expansion)|Death|2|||
30900427|NCT01640353|58933805|FG000|Overall Study|Death|2|||
30727716|NCT00289276|58740744|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
30727717|NCT00289276|58740745|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
30727718|NCT00289198|58740753|FG000|Overall Study|Adverse Event|0|||
30727719|NCT00289198|58740754|FG001|Overall Study|Adverse Event|2|||
30727720|NCT00289198|58740753|FG000|Overall Study|Protocol Violation|2|||
30727721|NCT00289198|58740754|FG001|Overall Study|Protocol Violation|1|||
30727722|NCT00289198|58740753|FG000|Overall Study|Withdrawal by Subject|4|||
30727723|NCT00289198|58740754|FG001|Overall Study|Withdrawal by Subject|1|||
30727724|NCT00289198|58740753|FG000|Overall Study|Lack of Efficacy|2|||
30727725|NCT00289198|58740754|FG001|Overall Study|Lack of Efficacy|0|||
30727726|NCT00289198|58740753|FG000|Overall Study|Other: Low compliance|0|||
30727727|NCT00289198|58740754|FG001|Overall Study|Other: Low compliance|1|||
30727728|NCT00289198|58740753|FG000|Overall Study|Other: Physician's decision|0|||
30727729|NCT00289198|58740754|FG001|Overall Study|Other: Physician's decision|1|||
30727730|NCT00289198|58740753|FG000|Overall Study|Other: Unable to attend on schedule|2|||
30727731|NCT00289198|58740754|FG001|Overall Study|Other: Unable to attend on schedule|1|||
30727732|NCT00289198|58740753|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
30727733|NCT00289198|58740754|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
30727734|NCT00289198|58740753|FG000|Overall Study|Other: Impossible to come on visit|0|||
30727735|NCT00289198|58740754|FG001|Overall Study|Other: Impossible to come on visit|1|||
30727736|NCT00363051|58740763|FG000|Overall Study|Adminstrative problems|1|||
30727737|NCT00363051|58740764|FG001|Overall Study|Adminstrative problems|1|||
30727738|NCT00363051|58740763|FG000|Overall Study|Adverse Event|21|||
30727739|NCT00363051|58740764|FG001|Overall Study|Adverse Event|12|||
30727740|NCT00363051|58740763|FG000|Overall Study|New Cancer Therapy|2|||
30727741|NCT00363051|58740764|FG001|Overall Study|New Cancer Therapy|1|||
30727742|NCT00363051|58740763|FG000|Overall Study|Withdrawal by Subject|11|||
30727743|NCT00363051|58740764|FG001|Overall Study|Withdrawal by Subject|3|||
30727744|NCT00363051|58740763|FG000|Overall Study|Lost to Follow-up|0|||
30727745|NCT00363051|58740764|FG001|Overall Study|Lost to Follow-up|1|||
30727746|NCT00363051|58740763|FG000|Overall Study|Protocol Violation|0|||
30727747|NCT00363051|58740764|FG001|Overall Study|Protocol Violation|2|||
30727748|NCT00363051|58740763|FG000|Overall Study|Death|3|||
30727749|NCT00363051|58740764|FG001|Overall Study|Death|2|||
30727750|NCT00379353|58740774|FG000|Overall Study|Hospitalization|3|||
30727751|NCT00379353|58740775|FG001|Overall Study|Hospitalization|3|||
30727752|NCT00379353|58740774|FG000|Overall Study|Withdrawal by Subject|5|||
30727753|NCT00379353|58740775|FG001|Overall Study|Withdrawal by Subject|2|||
30727754|NCT00379353|58740774|FG000|Overall Study|Death|1|||
30727755|NCT00379353|58740775|FG001|Overall Study|Death|0|||
30727756|NCT00379353|58740774|FG000|Overall Study|Cardiac Tamponade|1|||
30727757|NCT00379353|58740775|FG001|Overall Study|Cardiac Tamponade|0|||
30727758|NCT00379353|58740774|FG000|Overall Study|Non-compliance|1|||
30727759|NCT00379353|58740775|FG001|Overall Study|Non-compliance|0|||
30727760|NCT00379353|58740774|FG000|Overall Study|Conflicting drug treatment|0|||
30727761|NCT00379353|58740775|FG001|Overall Study|Conflicting drug treatment|1|||
30727762|NCT00378573|58740791|FG000|Treatment Period|Adverse Event|9|||
30727763|NCT00378573|58740791|FG000|Treatment Period|Physician Decision|1|||
30727764|NCT00378573|58740791|FG000|Treatment Period|Withdrawal by Subject|2|||
30727765|NCT00378573|58740791|FG000|Treatment Period|Disease Progression|4|||
30727766|NCT00378573|58740791|FG000|Treatment Period|Sponsor decision to close study|1|||
30727767|NCT00378573|58740791|FG000|Follow-up|Death|12|||
30727768|NCT00378573|58740791|FG000|Follow-up|Lost to Follow-up|1|||
30727769|NCT00378573|58740791|FG000|Follow-up|Withdrawal by Subject|1|||
30727770|NCT03831945|58740797|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
30727771|NCT03831945|58740798|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
30727772|NCT03831945|58740797|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
30727773|NCT03831945|58740798|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
30727774|NCT03831945|58740797|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
30760638|NCT02971683|58769137|FG000|Overall Study|Participant request to discontinue study treatment|1|||
30727775|NCT03831945|58740798|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
30727776|NCT00457002|58740806|FG000|Overall Study|Death|40|||
30727777|NCT00457002|58740807|FG001|Overall Study|Death|47|||
30727778|NCT00457002|58740806|FG000|Overall Study|Adverse Event|284|||
30727779|NCT00457002|58740807|FG001|Overall Study|Adverse Event|260|||
30727780|NCT00457002|58740806|FG000|Overall Study|Withdrawal by Subject|299|||
30727781|NCT00457002|58740807|FG001|Overall Study|Withdrawal by Subject|271|||
30727782|NCT00457002|58740806|FG000|Overall Study|Lost to Follow-up|72|||
30727783|NCT00457002|58740807|FG001|Overall Study|Lost to Follow-up|71|||
30727784|NCT00457002|58740806|FG000|Overall Study|Poor/Non-compliance|46|||
30727785|NCT00457002|58740807|FG001|Overall Study|Poor/Non-compliance|33|||
30727786|NCT00457002|58740806|FG000|Overall Study|No longer met criteria|41|||
30727787|NCT00457002|58740807|FG001|Overall Study|No longer met criteria|37|||
30727788|NCT00457002|58740806|FG000|Overall Study|Administrative reason by Sponsor|1|||
30727789|NCT00457002|58740807|FG001|Overall Study|Administrative reason by Sponsor|0|||
30727790|NCT00457002|58740806|FG000|Overall Study|non-specified|29|||
30727791|NCT00457002|58740807|FG001|Overall Study|non-specified|38|||
30727792|NCT00457002|58740806|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
30727793|NCT00457002|58740807|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
30727794|NCT00362115|58740820|FG000|Overall Study|Adverse Event|0|||
30727795|NCT00362115|58740821|FG001|Overall Study|Adverse Event|1|||
30727796|NCT00362115|58740822|FG002|Overall Study|Adverse Event|1|||
30727797|NCT00362115|58740823|FG003|Overall Study|Adverse Event|1|||
30727798|NCT00362115|58740824|FG004|Overall Study|Adverse Event|2|||
30727799|NCT00362115|58740825|FG005|Overall Study|Adverse Event|2|||
30727800|NCT00362115|58740826|FG006|Overall Study|Adverse Event|1|||
30727801|NCT00362115|58740820|FG000|Overall Study|Protocol Violation|0|||
30727802|NCT00362115|58740821|FG001|Overall Study|Protocol Violation|0|||
30727803|NCT00362115|58740822|FG002|Overall Study|Protocol Violation|0|||
30727804|NCT00362115|58740823|FG003|Overall Study|Protocol Violation|0|||
30727805|NCT00362115|58740824|FG004|Overall Study|Protocol Violation|0|||
30727806|NCT00362115|58740825|FG005|Overall Study|Protocol Violation|1|||
30727807|NCT00362115|58740826|FG006|Overall Study|Protocol Violation|0|||
30727808|NCT00362115|58740820|FG000|Overall Study|Lost to Follow-up|0|||
30727809|NCT00362115|58740821|FG001|Overall Study|Lost to Follow-up|1|||
30727810|NCT00362115|58740822|FG002|Overall Study|Lost to Follow-up|0|||
30727811|NCT00362115|58740823|FG003|Overall Study|Lost to Follow-up|0|||
30727812|NCT00362115|58740824|FG004|Overall Study|Lost to Follow-up|2|||
30727813|NCT00362115|58740825|FG005|Overall Study|Lost to Follow-up|0|||
30727814|NCT00362115|58740826|FG006|Overall Study|Lost to Follow-up|1|||
30727815|NCT00362115|58740820|FG000|Overall Study|Withdrawal by Subject|1|||
30727816|NCT00362115|58740821|FG001|Overall Study|Withdrawal by Subject|3|||
30727817|NCT00362115|58740822|FG002|Overall Study|Withdrawal by Subject|1|||
30727818|NCT00362115|58740823|FG003|Overall Study|Withdrawal by Subject|0|||
30727819|NCT00362115|58740824|FG004|Overall Study|Withdrawal by Subject|1|||
30727820|NCT00362115|58740825|FG005|Overall Study|Withdrawal by Subject|3|||
30727821|NCT00362115|58740826|FG006|Overall Study|Withdrawal by Subject|4|||
30727822|NCT00362115|58740820|FG000|Overall Study|Lack of Efficacy|1|||
30727823|NCT00362115|58740821|FG001|Overall Study|Lack of Efficacy|0|||
30727824|NCT00362115|58740822|FG002|Overall Study|Lack of Efficacy|5|||
30727825|NCT00362115|58740823|FG003|Overall Study|Lack of Efficacy|2|||
30727826|NCT00362115|58740824|FG004|Overall Study|Lack of Efficacy|2|||
30727827|NCT00362115|58740825|FG005|Overall Study|Lack of Efficacy|0|||
30727828|NCT00362115|58740826|FG006|Overall Study|Lack of Efficacy|3|||
30727829|NCT00362115|58740820|FG000|Overall Study|Physician Decision|0|||
30727830|NCT00362115|58740821|FG001|Overall Study|Physician Decision|0|||
30727831|NCT00362115|58740822|FG002|Overall Study|Physician Decision|0|||
30727832|NCT00362115|58740823|FG003|Overall Study|Physician Decision|0|||
30727833|NCT00362115|58740824|FG004|Overall Study|Physician Decision|0|||
30727834|NCT00362115|58740825|FG005|Overall Study|Physician Decision|0|||
30727835|NCT00362115|58740826|FG006|Overall Study|Physician Decision|3|||
30727836|NCT00362115|58740820|FG000|Overall Study|Other|0|||
30727837|NCT00362115|58740821|FG001|Overall Study|Other|1|||
30727838|NCT00362115|58740822|FG002|Overall Study|Other|0|||
30727839|NCT00362115|58740823|FG003|Overall Study|Other|1|||
30727840|NCT00362115|58740824|FG004|Overall Study|Other|0|||
30727841|NCT00362115|58740825|FG005|Overall Study|Other|1|||
30727842|NCT00362115|58740826|FG006|Overall Study|Other|0|||
30727843|NCT00485264|58740848|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
30727844|NCT00485264|58740849|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
30727845|NCT00485264|58740850|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
30727846|NCT00485264|58740851|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
30727847|NCT00485264|58740852|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
30727848|NCT00485264|58740853|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
30727849|NCT00485264|58740848|FG000|Overall Study|Death|1|||
30727850|NCT00485264|58740849|FG001|Overall Study|Death|0|||
30727851|NCT00485264|58740850|FG002|Overall Study|Death|0|||
30727852|NCT00485264|58740851|FG003|Overall Study|Death|0|||
30727853|NCT00485264|58740852|FG004|Overall Study|Death|1|||
30727854|NCT00485264|58740853|FG005|Overall Study|Death|0|||
30727855|NCT00485264|58740848|FG000|Overall Study|Adverse Event|1|||
30727856|NCT00485264|58740849|FG001|Overall Study|Adverse Event|0|||
30727857|NCT00485264|58740850|FG002|Overall Study|Adverse Event|2|||
30727858|NCT00485264|58740851|FG003|Overall Study|Adverse Event|3|||
30727859|NCT00485264|58740852|FG004|Overall Study|Adverse Event|1|||
30727860|NCT00485264|58740853|FG005|Overall Study|Adverse Event|3|||
30727861|NCT00485264|58740848|FG000|Overall Study|Pregnancy|4|||
30727862|NCT00485264|58740849|FG001|Overall Study|Pregnancy|0|||
30727863|NCT00485264|58740850|FG002|Overall Study|Pregnancy|0|||
30727864|NCT00485264|58740851|FG003|Overall Study|Pregnancy|0|||
30727865|NCT00485264|58740852|FG004|Overall Study|Pregnancy|0|||
30727866|NCT00485264|58740853|FG005|Overall Study|Pregnancy|0|||
30727867|NCT00485264|58740848|FG000|Overall Study|Disallowed Medication|0|||
30727868|NCT00485264|58740849|FG001|Overall Study|Disallowed Medication|0|||
30727869|NCT00485264|58740850|FG002|Overall Study|Disallowed Medication|0|||
30727870|NCT00485264|58740851|FG003|Overall Study|Disallowed Medication|0|||
30727871|NCT00485264|58740852|FG004|Overall Study|Disallowed Medication|0|||
30727872|NCT00485264|58740853|FG005|Overall Study|Disallowed Medication|1|||
30727873|NCT00485264|58740848|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
30727874|NCT00485264|58740849|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
30727875|NCT00485264|58740850|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
30727876|NCT00485264|58740851|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
30727877|NCT00485264|58740852|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
30727878|NCT00485264|58740853|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
30727879|NCT00485264|58740848|FG000|Overall Study|Lack of Efficacy|0|||
30727880|NCT00485264|58740849|FG001|Overall Study|Lack of Efficacy|1|||
30727881|NCT00485264|58740850|FG002|Overall Study|Lack of Efficacy|0|||
30727882|NCT00485264|58740851|FG003|Overall Study|Lack of Efficacy|0|||
30727883|NCT00485264|58740852|FG004|Overall Study|Lack of Efficacy|0|||
30727884|NCT00485264|58740853|FG005|Overall Study|Lack of Efficacy|0|||
30727885|NCT00485264|58740848|FG000|Overall Study|Guardian Consent Withdrawn|1|||
30727886|NCT00485264|58740849|FG001|Overall Study|Guardian Consent Withdrawn|0|||
30727887|NCT00485264|58740850|FG002|Overall Study|Guardian Consent Withdrawn|0|||
30727888|NCT00485264|58740851|FG003|Overall Study|Guardian Consent Withdrawn|0|||
30900428|NCT01640353|58933805|FG000|Overall Study|Early site termination|3|||
30727889|NCT00485264|58740852|FG004|Overall Study|Guardian Consent Withdrawn|1|||
30727890|NCT00485264|58740853|FG005|Overall Study|Guardian Consent Withdrawn|0|||
30727891|NCT00485264|58740848|FG000|Overall Study|Physician Decision|0|||
30727892|NCT00485264|58740849|FG001|Overall Study|Physician Decision|2|||
30727893|NCT00485264|58740850|FG002|Overall Study|Physician Decision|0|||
30900429|NCT01640353|58933805|FG000|Overall Study|Lost to Follow-up|12|||
30900430|NCT01640353|58933805|FG000|Overall Study|Physician Decision|1|||
30900431|NCT02463071|58933812|FG000|Overall Study|Adverse Event|3|||
30727894|NCT00485264|58740851|FG003|Overall Study|Physician Decision|0|||
30727895|NCT00485264|58740852|FG004|Overall Study|Physician Decision|0|||
30727896|NCT00485264|58740853|FG005|Overall Study|Physician Decision|0|||
30727897|NCT00485264|58740848|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
30727898|NCT00485264|58740849|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
30727899|NCT00485264|58740850|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
30727900|NCT00485264|58740851|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
30727901|NCT00485264|58740852|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
30727902|NCT00485264|58740853|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
30900432|NCT02463071|58933813|FG001|Overall Study|Adverse Event|5|||
30900433|NCT02463071|58933814|FG002|Overall Study|Adverse Event|1|||
30727903|NCT00485264|58740848|FG000|Overall Study|Not Able to Attend Clinic|5|||
30727904|NCT00485264|58740849|FG001|Overall Study|Not Able to Attend Clinic|0|||
30727905|NCT00485264|58740850|FG002|Overall Study|Not Able to Attend Clinic|0|||
30727906|NCT00485264|58740851|FG003|Overall Study|Not Able to Attend Clinic|1|||
30727907|NCT00485264|58740852|FG004|Overall Study|Not Able to Attend Clinic|1|||
30727908|NCT00485264|58740853|FG005|Overall Study|Not Able to Attend Clinic|2|||
30727909|NCT00485264|58740848|FG000|Overall Study|Non-Compliant|17|||
30727910|NCT00485264|58740849|FG001|Overall Study|Non-Compliant|2|||
30727911|NCT00485264|58740850|FG002|Overall Study|Non-Compliant|1|||
30727912|NCT00485264|58740851|FG003|Overall Study|Non-Compliant|0|||
30727913|NCT00485264|58740852|FG004|Overall Study|Non-Compliant|1|||
30727914|NCT00485264|58740853|FG005|Overall Study|Non-Compliant|0|||
30727915|NCT00485264|58740848|FG000|Overall Study|Lost to Follow-up|2|||
30727916|NCT00485264|58740849|FG001|Overall Study|Lost to Follow-up|1|||
30727917|NCT00485264|58740850|FG002|Overall Study|Lost to Follow-up|1|||
30727918|NCT00485264|58740851|FG003|Overall Study|Lost to Follow-up|0|||
30727919|NCT00485264|58740852|FG004|Overall Study|Lost to Follow-up|0|||
30727920|NCT00485264|58740853|FG005|Overall Study|Lost to Follow-up|1|||
30727921|NCT00485264|58740848|FG000|Overall Study|Other Reason|3|||
30727922|NCT00485264|58740849|FG001|Overall Study|Other Reason|0|||
30727923|NCT00485264|58740850|FG002|Overall Study|Other Reason|0|||
30727924|NCT00485264|58740851|FG003|Overall Study|Other Reason|0|||
30727925|NCT00485264|58740852|FG004|Overall Study|Other Reason|0|||
30727926|NCT00485264|58740853|FG005|Overall Study|Other Reason|0|||
30727927|NCT00293254|58740874|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
30727928|NCT00293254|58740875|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
30727929|NCT00293254|58740874|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
30727930|NCT00293254|58740875|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
30727931|NCT00293254|58740874|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
30727932|NCT00293254|58740875|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
30727933|NCT00293254|58740874|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
30727934|NCT00293254|58740875|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
30727935|NCT00293254|58740874|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
30727936|NCT00293254|58740875|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
30727937|NCT00293254|58740874|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
30727938|NCT00293254|58740875|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
30727939|NCT00293254|58740874|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
30727940|NCT00293254|58740875|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
30727941|NCT00293254|58740874|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
30727942|NCT00293254|58740875|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
30727943|NCT00293254|58740874|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
30727944|NCT00293254|58740875|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
30727945|NCT00293254|58740874|FG000|Extension - Double-Blind Week 49-156|Death|4|||
30727946|NCT00293254|58740875|FG001|Extension - Double-Blind Week 49-156|Death|1|||
30727947|NCT00293254|58740874|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
30727948|NCT00293254|58740875|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
30727949|NCT00293254|58740874|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
30727950|NCT00293254|58740875|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
30727951|NCT00293254|58740874|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
30727952|NCT00293254|58740875|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
30727953|NCT00293254|58740874|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
30727954|NCT00293254|58740875|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
30727955|NCT00293254|58740874|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
30727956|NCT00293254|58740875|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
30727957|NCT00293254|58740874|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
30727958|NCT00293254|58740875|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
30727959|NCT00293254|58740874|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
30727960|NCT00293254|58740875|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
30727961|NCT00293254|58740874|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
30727962|NCT00293254|58740875|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
30727963|NCT00293254|58740874|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
30727964|NCT00293254|58740875|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
30727965|NCT00293254|58740874|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
30727966|NCT00293254|58740875|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
30900434|NCT02463071|58933812|FG000|Overall Study|Death|1|||
30900435|NCT02463071|58933813|FG001|Overall Study|Death|0|||
30900436|NCT02463071|58933814|FG002|Overall Study|Death|0|||
30900437|NCT02463071|58933812|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
30727967|NCT00293254|58740874|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
30727968|NCT00293254|58740875|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
30727969|NCT00293254|58740874|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
30900438|NCT02463071|58933813|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30900439|NCT02463071|58933814|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
30727970|NCT00293254|58740875|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
30727971|NCT00293254|58740874|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
30727972|NCT00293254|58740875|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
30727973|NCT00293254|58740874|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
30727974|NCT00293254|58740875|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
30727975|NCT00293254|58740874|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
30727976|NCT00293254|58740875|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
30727977|NCT00293254|58740874|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
30727978|NCT00293254|58740875|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
30727979|NCT00293254|58740874|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
30727980|NCT00293254|58740875|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
30727981|NCT00456846|58740889|FG000|Overall Study|Adverse Event|2|||
30727982|NCT00456846|58740890|FG001|Overall Study|Adverse Event|15|||
30727983|NCT00456846|58740889|FG000|Overall Study|Physician Decision|11|||
30727984|NCT00456846|58740890|FG001|Overall Study|Physician Decision|6|||
30727985|NCT00456846|58740889|FG000|Overall Study|Protocol Deviation|2|||
30727986|NCT00456846|58740890|FG001|Overall Study|Protocol Deviation|0|||
30727987|NCT00456846|58740889|FG000|Overall Study|Participant Discretion|1|||
30727988|NCT00456846|58740890|FG001|Overall Study|Participant Discretion|5|||
30727989|NCT00456846|58740889|FG000|Overall Study|Other|0|||
30727990|NCT00456846|58740890|FG001|Overall Study|Other|2|||
30727991|NCT00448344|58740898|FG000|Overall Study|Lost to Follow-up|20|||
30727992|NCT00448344|58740899|FG001|Overall Study|Lost to Follow-up|22|||
30727993|NCT00448344|58740898|FG000|Overall Study|Withdrawal by Subject|6|||
30727994|NCT00448344|58740899|FG001|Overall Study|Withdrawal by Subject|8|||
30727995|NCT00448344|58740898|FG000|Overall Study|Death|3|||
30727996|NCT00448344|58740899|FG001|Overall Study|Death|4|||
30727997|NCT00448344|58740898|FG000|Overall Study|Physician Decision|1|||
30727998|NCT00448344|58740899|FG001|Overall Study|Physician Decision|2|||
30727999|NCT00484094|58740905|FG000|Overall Study|Discontinued|39|||
30728000|NCT00484094|58740905|FG000|Overall Study|Other|3|||
30728001|NCT00447876|58740911|FG000|Overall Study|Withdrawal by Subject|1|||
30728002|NCT00447876|58740912|FG001|Overall Study|Withdrawal by Subject|4|||
30728003|NCT00447876|58740911|FG000|Overall Study|Lost to Follow-up|1|||
30728004|NCT00447876|58740912|FG001|Overall Study|Lost to Follow-up|0|||
30728005|NCT00447876|58740911|FG000|Overall Study|Deterioration of symptomology|1|||
30728006|NCT00447876|58740912|FG001|Overall Study|Deterioration of symptomology|0|||
30728007|NCT00456612|58740918|FG000|Overall Study|Withdrawal by Subject|3|||
30728008|NCT00456300|58740923|FG000|Overall Study|Adverse Event|1|||
30728009|NCT00456300|58740924|FG001|Overall Study|Adverse Event|0|||
30728010|NCT00267748|58740935|FG000|Non-randomized Period|Progressive disease|10|||
30728011|NCT00267748|58740936|FG001|Non-randomized Period|Progressive disease|0|||
30728012|NCT00267748|58740937|FG002|Non-randomized Period|Progressive disease|0|||
30728013|NCT00267748|58740935|FG000|Non-randomized Period|Adverse Event|8|||
30728014|NCT00267748|58740936|FG001|Non-randomized Period|Adverse Event|0|||
30728015|NCT00267748|58740937|FG002|Non-randomized Period|Adverse Event|0|||
30728016|NCT00267748|58740935|FG000|Non-randomized Period|Death|1|||
30728017|NCT00267748|58740936|FG001|Non-randomized Period|Death|0|||
30728018|NCT00267748|58740937|FG002|Non-randomized Period|Death|0|||
30728019|NCT00267748|58740935|FG000|Non-randomized Period|Participant not willing to participate|1|||
30728020|NCT00267748|58740936|FG001|Non-randomized Period|Participant not willing to participate|0|||
30728021|NCT00267748|58740937|FG002|Non-randomized Period|Participant not willing to participate|0|||
30728022|NCT00267748|58740935|FG000|Non-randomized Period|Other|3|||
30728023|NCT00267748|58740936|FG001|Non-randomized Period|Other|0|||
30728024|NCT00267748|58740937|FG002|Non-randomized Period|Other|0|||
30728025|NCT00267748|58740935|FG000|Randomized Period|Death|0|||
30728026|NCT00267748|58740936|FG001|Randomized Period|Death|2|||
30728027|NCT00267748|58740937|FG002|Randomized Period|Death|3|||
30728028|NCT00267748|58740935|FG000|Randomized Period|Adverse Event|0|||
30728029|NCT00267748|58740936|FG001|Randomized Period|Adverse Event|23|||
30728030|NCT00267748|58740937|FG002|Randomized Period|Adverse Event|25|||
30728031|NCT00267748|58740935|FG000|Randomized Period|Global deterioration of health status|0|||
30728032|NCT00267748|58740936|FG001|Randomized Period|Global deterioration of health status|6|||
30621722|NCT00975507|58633288|FG001|Overall Study|Protocol Violation|0|||
30728033|NCT00267748|58740937|FG002|Randomized Period|Global deterioration of health status|7|||
30728034|NCT00267748|58740935|FG000|Randomized Period|Lost to Follow-up|0|||
30728035|NCT00267748|58740936|FG001|Randomized Period|Lost to Follow-up|1|||
30728036|NCT00267748|58740937|FG002|Randomized Period|Lost to Follow-up|0|||
30728037|NCT00267748|58740935|FG000|Randomized Period|Objective progression or relapse|0|||
30728038|NCT00267748|58740936|FG001|Randomized Period|Objective progression or relapse|77|||
30728039|NCT00267748|58740937|FG002|Randomized Period|Objective progression or relapse|86|||
30728040|NCT00267748|58740935|FG000|Randomized Period|Withdrawal by Subject|0|||
30728041|NCT00267748|58740936|FG001|Randomized Period|Withdrawal by Subject|9|||
30728042|NCT00267748|58740937|FG002|Randomized Period|Withdrawal by Subject|2|||
30728043|NCT00267748|58740935|FG000|Randomized Period|Other|0|||
30728044|NCT00267748|58740936|FG001|Randomized Period|Other|9|||
30728045|NCT00267748|58740937|FG002|Randomized Period|Other|6|||
30728046|NCT00267748|58740935|FG000|Randomized Period|randomized but not treated|0|||
30728047|NCT00267748|58740936|FG001|Randomized Period|randomized but not treated|0|||
30728048|NCT00267748|58740937|FG002|Randomized Period|randomized but not treated|3|||
30728049|NCT00267202|58740946|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
30728050|NCT00267202|58740947|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
30728051|NCT00267202|58740946|FG000|Overall Study|Withdrawal by Subject|12|||
30728052|NCT00267202|58740947|FG001|Overall Study|Withdrawal by Subject|15|||
30728053|NCT00267202|58740946|FG000|Overall Study|Adverse Event|13|||
30728054|NCT00267202|58740947|FG001|Overall Study|Adverse Event|7|||
30728055|NCT00267202|58740946|FG000|Overall Study|Protocol Violation|2|||
30728056|NCT00267202|58740947|FG001|Overall Study|Protocol Violation|3|||
30728057|NCT00267202|58740946|FG000|Overall Study|Administrative problems|2|||
30728058|NCT00267202|58740947|FG001|Overall Study|Administrative problems|1|||
30728059|NCT00267202|58740946|FG000|Overall Study|Lost to Follow-up|3|||
30728060|NCT00267202|58740947|FG001|Overall Study|Lost to Follow-up|0|||
30728061|NCT00267046|58740956|FG000|Overall Study|Disease progression|4|||
30728062|NCT00267046|58740957|FG001|Overall Study|Disease progression|2|||
30728063|NCT00267046|58740956|FG000|Overall Study|Chemotoxicity|2|||
30728064|NCT00267046|58740957|FG001|Overall Study|Chemotoxicity|0|||
30728065|NCT00267046|58740956|FG000|Overall Study|Open-label palifermin|2|||
30728066|NCT00267046|58740957|FG001|Overall Study|Open-label palifermin|7|||
30728067|NCT00267046|58740956|FG000|Overall Study|Surgery|3|||
30728068|NCT00267046|58740957|FG001|Overall Study|Surgery|1|||
30728069|NCT00267046|58740956|FG000|Overall Study|Withdrawal by Subject|1|||
30728070|NCT00267046|58740957|FG001|Overall Study|Withdrawal by Subject|0|||
30728071|NCT00267046|58740956|FG000|Overall Study|Radiation|0|||
30728072|NCT00267046|58740957|FG001|Overall Study|Radiation|1|||
30728073|NCT00441090|58740968|FG000|Overall Study|Adverse Event|0|||
30728074|NCT00441090|58740969|FG001|Overall Study|Adverse Event|1|||
30728075|NCT00441090|58740970|FG002|Overall Study|Adverse Event|1|||
30728076|NCT00441090|58740971|FG003|Overall Study|Adverse Event|0|||
30728077|NCT00441090|58740972|FG004|Overall Study|Adverse Event|0|||
30728078|NCT00441090|58740968|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
30728079|NCT00441090|58740969|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
30728080|NCT00441090|58740970|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
30728081|NCT00441090|58740971|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
30728082|NCT00441090|58740972|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
30728083|NCT00441090|58740968|FG000|Overall Study|Withdrawal by Subject|1|||
30728084|NCT00441090|58740969|FG001|Overall Study|Withdrawal by Subject|0|||
30728085|NCT00441090|58740970|FG002|Overall Study|Withdrawal by Subject|1|||
30728086|NCT00441090|58740971|FG003|Overall Study|Withdrawal by Subject|0|||
30728087|NCT00441090|58740972|FG004|Overall Study|Withdrawal by Subject|0|||
30728088|NCT00441090|58740968|FG000|Overall Study|Lack of Efficacy|1|||
30728089|NCT00441090|58740969|FG001|Overall Study|Lack of Efficacy|0|||
30728090|NCT00441090|58740970|FG002|Overall Study|Lack of Efficacy|0|||
30728091|NCT00441090|58740971|FG003|Overall Study|Lack of Efficacy|0|||
30728092|NCT00441090|58740972|FG004|Overall Study|Lack of Efficacy|0|||
30728093|NCT00441012|58740986|FG000|Overall Study|Adverse Event|0|||
30728094|NCT00441012|58740987|FG001|Overall Study|Adverse Event|1|||
30728095|NCT00441012|58740986|FG000|Overall Study|Lost to Follow-up|3|||
30728096|NCT00441012|58740987|FG001|Overall Study|Lost to Follow-up|3|||
30728097|NCT00441012|58740986|FG000|Overall Study|Protocol Violation|10|||
30728098|NCT00441012|58740987|FG001|Overall Study|Protocol Violation|9|||
30728099|NCT00441012|58740986|FG000|Overall Study|Withdrawal by Subject|4|||
30728100|NCT00441012|58740987|FG001|Overall Study|Withdrawal by Subject|0|||
30728101|NCT00441012|58740986|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
30728102|NCT00441012|58740987|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
30728103|NCT00286468|58740996|FG000|Overall Study|Hyperglycemic Rescue|28|||
30728104|NCT00286468|58740997|FG001|Overall Study|Hyperglycemic Rescue|30|||
30728105|NCT00286468|58740998|FG002|Overall Study|Hyperglycemic Rescue|31|||
30728106|NCT00286468|58740996|FG000|Overall Study|Adverse Event|2|||
30728107|NCT00286468|58740997|FG001|Overall Study|Adverse Event|6|||
30728108|NCT00286468|58740998|FG002|Overall Study|Adverse Event|4|||
30728109|NCT00286468|58740996|FG000|Overall Study|Protocol Violation|0|||
30728110|NCT00286468|58740997|FG001|Overall Study|Protocol Violation|3|||
30728111|NCT00286468|58740998|FG002|Overall Study|Protocol Violation|1|||
30728112|NCT00286468|58740996|FG000|Overall Study|Lost to Follow-up|1|||
30900440|NCT02463071|58933812|FG000|Overall Study|Reason not specified|7|||
30900441|NCT02463071|58933813|FG001|Overall Study|Reason not specified|9|||
30900442|NCT02463071|58933814|FG002|Overall Study|Reason not specified|4|||
30900443|NCT02463071|58933812|FG000|Overall Study|Protocol Violation|0|||
30900444|NCT02463071|58933813|FG001|Overall Study|Protocol Violation|2|||
30900445|NCT02463071|58933814|FG002|Overall Study|Protocol Violation|0|||
30900446|NCT02463071|58933812|FG000|Overall Study|Lost to Follow-up|0|||
30900447|NCT02463071|58933813|FG001|Overall Study|Lost to Follow-up|0|||
30900448|NCT02463071|58933814|FG002|Overall Study|Lost to Follow-up|1|||
30900449|NCT02266381|58933825|FG000|Overall Study|Physician Decision|3|||
30728113|NCT00286468|58740997|FG001|Overall Study|Lost to Follow-up|1|||
30900450|NCT02266381|58933826|FG001|Overall Study|Physician Decision|5|||
30900451|NCT02266381|58933827|FG002|Overall Study|Physician Decision|4|||
30900452|NCT01827046|58933839|FG000|Overall Study|Lost to Follow-up|1|||
30900453|NCT01827046|58933840|FG001|Overall Study|Lost to Follow-up|5|||
30728114|NCT00286468|58740998|FG002|Overall Study|Lost to Follow-up|2|||
30728115|NCT00286468|58740996|FG000|Overall Study|Withdrawal by Subject|3|||
30728116|NCT00286468|58740997|FG001|Overall Study|Withdrawal by Subject|8|||
30728117|NCT00286468|58740998|FG002|Overall Study|Withdrawal by Subject|11|||
30728118|NCT00286468|58740996|FG000|Overall Study|Physician Decision|3|||
30728119|NCT00286468|58740997|FG001|Overall Study|Physician Decision|2|||
30728120|NCT00286468|58740998|FG002|Overall Study|Physician Decision|1|||
30728121|NCT00507026|58741009|FG000|Overall Study|Lack of Efficacy|6|||
30728122|NCT00507026|58741010|FG001|Overall Study|Lack of Efficacy|4|||
30728123|NCT00507026|58741011|FG002|Overall Study|Lack of Efficacy|21|||
30728124|NCT00507026|58741009|FG000|Overall Study|Withdrawal by Subject|2|||
30728125|NCT00507026|58741010|FG001|Overall Study|Withdrawal by Subject|0|||
30728126|NCT00507026|58741011|FG002|Overall Study|Withdrawal by Subject|0|||
30728127|NCT00507026|58741009|FG000|Overall Study|Investigator Decision|1|||
30728128|NCT00507026|58741010|FG001|Overall Study|Investigator Decision|0|||
30728129|NCT00507026|58741011|FG002|Overall Study|Investigator Decision|0|||
30728130|NCT00507026|58741009|FG000|Overall Study|Adverse Event|2|||
30728131|NCT00507026|58741010|FG001|Overall Study|Adverse Event|0|||
30728132|NCT00507026|58741011|FG002|Overall Study|Adverse Event|0|||
30728133|NCT00507026|58741009|FG000|Overall Study|Protocol Violation|1|||
30728134|NCT00507026|58741010|FG001|Overall Study|Protocol Violation|0|||
30728135|NCT00507026|58741011|FG002|Overall Study|Protocol Violation|0|||
30728136|NCT00507026|58741009|FG000|Overall Study|Other|1|||
30728137|NCT00507026|58741010|FG001|Overall Study|Other|0|||
30728138|NCT00507026|58741011|FG002|Overall Study|Other|0|||
30728139|NCT00446550|58741021|FG000|Overall Study|Adverse Event|1|||
30728140|NCT00446550|58741022|FG001|Overall Study|Adverse Event|0|||
30728141|NCT03847974|58741029|FG000|Overall Study|relocated out of region|3|||
30728142|NCT03847974|58741029|FG000|Overall Study|Withdrawal by Subject|2|||
30728143|NCT03847974|58741029|FG000|Overall Study|Adverse Event|1|||
30728144|NCT00506948|58741033|FG000|Overall Study|Death|4|||
30728145|NCT00506948|58741033|FG000|Overall Study|Adverse Event|5|||
30728146|NCT00506948|58741033|FG000|Overall Study|Physician Decision|1|||
30728147|NCT00286234|58741041|FG000|Overall Study|Protocol Violation|1|||
30728148|NCT00286234|58741042|FG001|Overall Study|Protocol Violation|2|||
30728149|NCT00286234|58741043|FG002|Overall Study|Protocol Violation|0|||
30728150|NCT00286234|58741044|FG003|Overall Study|Protocol Violation|1|||
30728151|NCT00286234|58741041|FG000|Overall Study|Physician Decision|1|||
30728152|NCT00286234|58741042|FG001|Overall Study|Physician Decision|0|||
30728153|NCT00286234|58741043|FG002|Overall Study|Physician Decision|0|||
30728154|NCT00286234|58741044|FG003|Overall Study|Physician Decision|1|||
30728155|NCT00286234|58741041|FG000|Overall Study|Adverse Event|0|||
30728156|NCT00286234|58741042|FG001|Overall Study|Adverse Event|0|||
30728157|NCT00286234|58741043|FG002|Overall Study|Adverse Event|0|||
30728158|NCT00286234|58741044|FG003|Overall Study|Adverse Event|1|||
30728159|NCT00286234|58741041|FG000|Overall Study|Adverse Event|0|||
30728160|NCT00286234|58741042|FG001|Overall Study|Adverse Event|0|||
30728161|NCT00286234|58741043|FG002|Overall Study|Adverse Event|0|||
30728162|NCT00286234|58741044|FG003|Overall Study|Adverse Event|1|||
30728163|NCT00445848|58741054|FG000|Overall Study|Adverse Event|14|||
30728164|NCT00445848|58741054|FG000|Overall Study|Withdrawal by Subject|4|||
30728165|NCT00445848|58741054|FG000|Overall Study|Progression|62|||
30728166|NCT00445848|58741054|FG000|Overall Study|Other-Not protocol specified|5|||
30728167|NCT00286156|58741061|FG000|Overall Study|Missed 12 month visit|0|||
30728168|NCT00286156|58741062|FG001|Overall Study|Missed 12 month visit|0|||
30728169|NCT00286156|58741063|FG002|Overall Study|Missed 12 month visit|1|||
30728170|NCT00286156|58741061|FG000|Overall Study|AE: pulmonary embolus|0|||
30728171|NCT00286156|58741062|FG001|Overall Study|AE: pulmonary embolus|1|||
30728172|NCT00286156|58741063|FG002|Overall Study|AE: pulmonary embolus|0|||
30728173|NCT00286156|58741061|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
30728174|NCT00286156|58741062|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
30728175|NCT00286156|58741063|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
30728176|NCT00286156|58741061|FG000|Overall Study|AE: pneumonia|1|||
30728177|NCT00286156|58741062|FG001|Overall Study|AE: pneumonia|0|||
30900454|NCT01827046|58933839|FG000|Overall Study|Withdrawal by Subject|0|||
30728178|NCT00286156|58741063|FG002|Overall Study|AE: pneumonia|0|||
30728179|NCT00455520|58741073|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
30728180|NCT00455520|58741074|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
30728181|NCT00455520|58741073|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
30728182|NCT00455520|58741074|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
30728183|NCT00455520|58741073|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
30728184|NCT00455520|58741074|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
30728185|NCT00455520|58741073|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
30728186|NCT00455520|58741074|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
30728187|NCT00455520|58741073|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
30728188|NCT00455520|58741074|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
30728189|NCT00455520|58741073|FG000|Open Label Tapentadol Extended Release|All other|33|||
30728190|NCT00455520|58741074|FG001|Open Label Tapentadol Extended Release|All other|0|||
30728191|NCT00455520|58741073|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
30728192|NCT00455520|58741074|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
30728193|NCT00455520|58741073|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
30728194|NCT00455520|58741074|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
30728195|NCT00455520|58741073|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
30728196|NCT00455520|58741074|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
30728197|NCT00455520|58741073|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
30728198|NCT00455520|58741074|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
30728199|NCT00455520|58741073|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
30728200|NCT00455520|58741074|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
30728201|NCT00455520|58741073|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
30728202|NCT00455520|58741074|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
30728203|NCT00440700|58741083|FG000|Overall Study|Withdrawal by Subject|8|||
30728204|NCT00440700|58741084|FG001|Overall Study|Withdrawal by Subject|8|||
30728205|NCT00440700|58741085|FG002|Overall Study|Withdrawal by Subject|4|||
30728206|NCT00284050|58741096|FG000|Overall Study|Adverse Event|1|||
30728207|NCT00284050|58741097|FG001|Overall Study|Adverse Event|1|||
30728208|NCT00284050|58741098|FG002|Overall Study|Adverse Event|1|||
30728209|NCT00284050|58741096|FG000|Overall Study|Lack of Efficacy|0|||
30728210|NCT00284050|58741097|FG001|Overall Study|Lack of Efficacy|1|||
30728211|NCT00284050|58741098|FG002|Overall Study|Lack of Efficacy|3|||
30728212|NCT00284050|58741096|FG000|Overall Study|Protocol Violation|0|||
30728213|NCT00284050|58741097|FG001|Overall Study|Protocol Violation|1|||
30728214|NCT00284050|58741098|FG002|Overall Study|Protocol Violation|2|||
30728215|NCT00284050|58741096|FG000|Overall Study|Withdrawal by Subject|2|||
30728216|NCT00284050|58741097|FG001|Overall Study|Withdrawal by Subject|2|||
30728217|NCT00284050|58741098|FG002|Overall Study|Withdrawal by Subject|2|||
30728218|NCT00284050|58741096|FG000|Overall Study|Lost to Follow-up|1|||
30728219|NCT00284050|58741097|FG001|Overall Study|Lost to Follow-up|0|||
30728220|NCT00284050|58741098|FG002|Overall Study|Lost to Follow-up|1|||
30728221|NCT00284050|58741096|FG000|Overall Study|Death|1|||
30728222|NCT00284050|58741097|FG001|Overall Study|Death|0|||
30728223|NCT00284050|58741098|FG002|Overall Study|Death|0|||
30728224|NCT00293020|58741106|FG000|Overall Study|Withdrawal by Subject|34|||
30728225|NCT00293020|58741106|FG000|Overall Study|Adverse Event|30|||
30728226|NCT00293020|58741106|FG000|Overall Study|Death|32|||
30728227|NCT00293020|58741106|FG000|Overall Study|Lack of Efficacy|12|||
30728228|NCT00293020|58741106|FG000|Overall Study|Lost to Follow-up|4|||
30728229|NCT00293020|58741106|FG000|Overall Study|Protocol Violation|6|||
30728230|NCT00293020|58741106|FG000|Overall Study|Physician Decision|21|||
30728231|NCT00293020|58741106|FG000|Overall Study|Other Reason|22|||
30728232|NCT00293020|58741106|FG000|Overall Study|No dose taken|1|||
30728233|NCT00377637|58741114|FG000|Induction Phase|Adverse Event|12|||
30728234|NCT00377637|58741115|FG001|Induction Phase|Adverse Event|21|||
30728235|NCT00377637|58741116|FG002|Induction Phase|Adverse Event|0|||
30728236|NCT00377637|58741117|FG003|Induction Phase|Adverse Event|0|||
30728237|NCT00377637|58741114|FG000|Induction Phase|Deterioration/serum creatinine|2|||
30728238|NCT00377637|58741115|FG001|Induction Phase|Deterioration/serum creatinine|0|||
30728239|NCT00377637|58741116|FG002|Induction Phase|Deterioration/serum creatinine|0|||
30728240|NCT00377637|58741117|FG003|Induction Phase|Deterioration/serum creatinine|0|||
30728241|NCT00377637|58741114|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
30728242|NCT00377637|58741115|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
30621723|NCT00975507|58633287|FG000|Overall Study|Withdrawal by Subject|10|||
30728243|NCT00377637|58741116|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
30728244|NCT00377637|58741117|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
30900455|NCT01827046|58933840|FG001|Overall Study|Withdrawal by Subject|4|||
30728245|NCT00377637|58741114|FG000|Induction Phase|Lost to Follow-up|2|||
30728246|NCT00377637|58741115|FG001|Induction Phase|Lost to Follow-up|1|||
30728247|NCT00377637|58741116|FG002|Induction Phase|Lost to Follow-up|0|||
30728248|NCT00377637|58741117|FG003|Induction Phase|Lost to Follow-up|0|||
30728249|NCT00377637|58741114|FG000|Induction Phase|Death|1|||
30728250|NCT00377637|58741115|FG001|Induction Phase|Death|3|||
30728251|NCT00377637|58741116|FG002|Induction Phase|Death|0|||
30728252|NCT00377637|58741117|FG003|Induction Phase|Death|0|||
30728253|NCT00377637|58741114|FG000|Induction Phase|Withdrawal by Subject|5|||
30728254|NCT00377637|58741115|FG001|Induction Phase|Withdrawal by Subject|6|||
30728255|NCT00377637|58741116|FG002|Induction Phase|Withdrawal by Subject|0|||
30728256|NCT00377637|58741117|FG003|Induction Phase|Withdrawal by Subject|0|||
30728257|NCT00377637|58741114|FG000|Induction Phase|Physician Decision|3|||
30728258|NCT00377637|58741115|FG001|Induction Phase|Physician Decision|1|||
30728259|NCT00377637|58741116|FG002|Induction Phase|Physician Decision|0|||
30728260|NCT00377637|58741117|FG003|Induction Phase|Physician Decision|0|||
30728261|NCT00377637|58741114|FG000|Induction Phase|Sponsor decision|1|||
30728262|NCT00377637|58741115|FG001|Induction Phase|Sponsor decision|2|||
30728263|NCT00377637|58741116|FG002|Induction Phase|Sponsor decision|0|||
30728264|NCT00377637|58741117|FG003|Induction Phase|Sponsor decision|0|||
30728265|NCT00377637|58741114|FG000|Induction Phase|Non-Compliance|1|||
30728266|NCT00377637|58741115|FG001|Induction Phase|Non-Compliance|0|||
30728267|NCT00377637|58741116|FG002|Induction Phase|Non-Compliance|0|||
30728268|NCT00377637|58741117|FG003|Induction Phase|Non-Compliance|0|||
30728269|NCT00377637|58741114|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
30728270|NCT00377637|58741115|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
30728271|NCT00377637|58741116|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
30728272|NCT00377637|58741117|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
30728273|NCT00377637|58741114|FG000|Maintenance Phase|Adverse Event|0|||
30728274|NCT00377637|58741115|FG001|Maintenance Phase|Adverse Event|0|||
30728275|NCT00377637|58741116|FG002|Maintenance Phase|Adverse Event|29|||
30728276|NCT00377637|58741117|FG003|Maintenance Phase|Adverse Event|43|||
30728277|NCT00377637|58741114|FG000|Maintenance Phase|Physician Decision|0|||
30728278|NCT00377637|58741115|FG001|Maintenance Phase|Physician Decision|0|||
30728279|NCT00377637|58741116|FG002|Maintenance Phase|Physician Decision|5|||
30728280|NCT00377637|58741117|FG003|Maintenance Phase|Physician Decision|4|||
30728281|NCT00377637|58741114|FG000|Maintenance Phase|Lost to Follow-up|0|||
30728282|NCT00377637|58741115|FG001|Maintenance Phase|Lost to Follow-up|0|||
30728283|NCT00377637|58741116|FG002|Maintenance Phase|Lost to Follow-up|3|||
30728284|NCT00377637|58741117|FG003|Maintenance Phase|Lost to Follow-up|1|||
30728285|NCT00377637|58741114|FG000|Maintenance Phase|Withdrawal by Subject|0|||
30728286|NCT00377637|58741115|FG001|Maintenance Phase|Withdrawal by Subject|0|||
30728287|NCT00377637|58741116|FG002|Maintenance Phase|Withdrawal by Subject|3|||
30728288|NCT00377637|58741117|FG003|Maintenance Phase|Withdrawal by Subject|3|||
30728289|NCT00377637|58741114|FG000|Maintenance Phase|Sponsor decision|0|||
30728290|NCT00377637|58741115|FG001|Maintenance Phase|Sponsor decision|0|||
30728291|NCT00377637|58741116|FG002|Maintenance Phase|Sponsor decision|2|||
30728292|NCT00377637|58741117|FG003|Maintenance Phase|Sponsor decision|3|||
30728293|NCT00377637|58741114|FG000|Maintenance Phase|Non-compliance|0|||
30728294|NCT00377637|58741115|FG001|Maintenance Phase|Non-compliance|0|||
30728295|NCT00377637|58741116|FG002|Maintenance Phase|Non-compliance|1|||
30728296|NCT00377637|58741117|FG003|Maintenance Phase|Non-compliance|1|||
30728297|NCT00377637|58741114|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
30728298|NCT00377637|58741115|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
30728299|NCT00377637|58741116|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
30728300|NCT00377637|58741117|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
30728301|NCT00377637|58741114|FG000|Maintenance Phase|Death|0|||
30728302|NCT00377637|58741115|FG001|Maintenance Phase|Death|0|||
30728303|NCT00377637|58741116|FG002|Maintenance Phase|Death|0|||
30728304|NCT00377637|58741117|FG003|Maintenance Phase|Death|1|||
30728305|NCT00377403|58741133|FG000|Overall Study|Unable to contact for telephone intervie|4|||
30728306|NCT00377403|58741134|FG001|Overall Study|Unable to contact for telephone intervie|7|||
30728307|NCT00370149|58741142|FG000|Overall Study|Physician Decision|16|||
30728308|NCT00370149|58741143|FG001|Overall Study|Physician Decision|16|||
30728309|NCT00370149|58741142|FG000|Overall Study|Protocol Violation|1|||
30728310|NCT00370149|58741143|FG001|Overall Study|Protocol Violation|0|||
30728311|NCT00370149|58741142|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
30728312|NCT00370149|58741143|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
30728313|NCT00370149|58741142|FG000|Overall Study|Pre-existing infection|0|||
30728314|NCT00370149|58741143|FG001|Overall Study|Pre-existing infection|1|||
30728315|NCT00370149|58741142|FG000|Overall Study|Antibiotic coated dressing placed|0|||
30728316|NCT00370149|58741143|FG001|Overall Study|Antibiotic coated dressing placed|1|||
30728317|NCT00292942|58741156|FG000|Overall Study|Withdrawal by Subject|0|||
30728318|NCT00292942|58741157|FG001|Overall Study|Withdrawal by Subject|0|||
30728319|NCT00292942|58741158|FG002|Overall Study|Withdrawal by Subject|1|||
30728320|NCT00292942|58741159|FG003|Overall Study|Withdrawal by Subject|0|||
30728321|NCT00292942|58741156|FG000|Overall Study|Adverse Event|0|||
30728322|NCT00292942|58741157|FG001|Overall Study|Adverse Event|0|||
30728323|NCT00292942|58741158|FG002|Overall Study|Adverse Event|0|||
30728324|NCT00292942|58741159|FG003|Overall Study|Adverse Event|1|||
30728325|NCT00483938|58741179|FG000|Overall Study|Protocol Violation|0|||
30728326|NCT00483938|58741180|FG001|Overall Study|Protocol Violation|0|||
30728327|NCT00483938|58741181|FG002|Overall Study|Protocol Violation|0|||
30728328|NCT00483938|58741182|FG003|Overall Study|Protocol Violation|0|||
30728329|NCT00483938|58741183|FG004|Overall Study|Protocol Violation|0|||
30728330|NCT00483938|58741184|FG005|Overall Study|Protocol Violation|0|||
30728331|NCT00483938|58741185|FG006|Overall Study|Protocol Violation|3|||
30728332|NCT00483938|58741179|FG000|Overall Study|Withdrawal by Subject|1|||
30728333|NCT00483938|58741180|FG001|Overall Study|Withdrawal by Subject|6|||
30728334|NCT00483938|58741181|FG002|Overall Study|Withdrawal by Subject|0|||
30728335|NCT00483938|58741182|FG003|Overall Study|Withdrawal by Subject|0|||
30728336|NCT00483938|58741183|FG004|Overall Study|Withdrawal by Subject|1|||
30728337|NCT00483938|58741184|FG005|Overall Study|Withdrawal by Subject|3|||
30728338|NCT00483938|58741185|FG006|Overall Study|Withdrawal by Subject|2|||
30728339|NCT00483938|58741179|FG000|Overall Study|Lost to Follow-up|1|||
30728340|NCT00483938|58741180|FG001|Overall Study|Lost to Follow-up|2|||
30728341|NCT00483938|58741181|FG002|Overall Study|Lost to Follow-up|0|||
30728342|NCT00483938|58741182|FG003|Overall Study|Lost to Follow-up|2|||
30728343|NCT00483938|58741183|FG004|Overall Study|Lost to Follow-up|1|||
30728344|NCT00483938|58741184|FG005|Overall Study|Lost to Follow-up|1|||
30728345|NCT00483938|58741185|FG006|Overall Study|Lost to Follow-up|3|||
30728346|NCT00483938|58741179|FG000|Overall Study|Death|0|||
30728347|NCT00483938|58741180|FG001|Overall Study|Death|2|||
30728348|NCT00483938|58741181|FG002|Overall Study|Death|0|||
30728349|NCT00483938|58741182|FG003|Overall Study|Death|0|||
30728350|NCT00483938|58741183|FG004|Overall Study|Death|0|||
30728351|NCT00483938|58741184|FG005|Overall Study|Death|0|||
30728352|NCT00483938|58741185|FG006|Overall Study|Death|0|||
30728353|NCT00483938|58741179|FG000|Overall Study|Other|3|||
30728354|NCT00483938|58741180|FG001|Overall Study|Other|9|||
30728355|NCT00483938|58741181|FG002|Overall Study|Other|0|||
30728356|NCT00483938|58741182|FG003|Overall Study|Other|4|||
30728357|NCT00483938|58741183|FG004|Overall Study|Other|0|||
30728358|NCT00483938|58741184|FG005|Overall Study|Other|4|||
30728359|NCT00483938|58741185|FG006|Overall Study|Other|32|||
30728360|NCT00370071|58741204|FG000|Overall Study|Withdrawal by Subject|2|||
30728361|NCT00369915|58741210|FG000|Overall Study|expected side effects|2|||
30728362|NCT00369915|58741211|FG001|Overall Study|expected side effects|1|||
30728363|NCT00369915|58741210|FG000|Overall Study|Withdrawal by Subject|4|||
30728364|NCT00369915|58741211|FG001|Overall Study|Withdrawal by Subject|1|||
30728365|NCT00369915|58741210|FG000|Overall Study|W/drawl by investigators|0|||
30728366|NCT00369915|58741211|FG001|Overall Study|W/drawl by investigators|1|||
30728367|NCT00369681|58741217|FG000|Overall Study|Death|1|||
30728368|NCT00266812|58741223|FG000|Overall Study|Disease Progression|9|||
30728369|NCT00266812|58741224|FG001|Overall Study|Disease Progression|3|||
30728370|NCT00266812|58741223|FG000|Overall Study|Death|5|||
30728371|NCT00266812|58741224|FG001|Overall Study|Death|4|||
30728372|NCT00266812|58741223|FG000|Overall Study|Adverse Event|3|||
30728373|NCT00266812|58741224|FG001|Overall Study|Adverse Event|1|||
30728374|NCT00266812|58741223|FG000|Overall Study|Protocol Violation|0|||
30728375|NCT00266812|58741224|FG001|Overall Study|Protocol Violation|1|||
30728376|NCT00266812|58741223|FG000|Overall Study|Withdrawal by Subject|0|||
30728377|NCT00266812|58741224|FG001|Overall Study|Withdrawal by Subject|2|||
30728378|NCT00266812|58741223|FG000|Overall Study|Discontinued before starting study drug|4|||
30728379|NCT00266812|58741224|FG001|Overall Study|Discontinued before starting study drug|0|||
30728380|NCT00488774|58741234|FG000|Overall Study|Withdrawal of consent|2|||
30728381|NCT00488774|58741235|FG001|Overall Study|Withdrawal of consent|2|||
30728382|NCT00488774|58741236|FG002|Overall Study|Withdrawal of consent|2|||
30728383|NCT00488774|58741237|FG003|Overall Study|Withdrawal of consent|0|||
30728384|NCT00488774|58741234|FG000|Overall Study|Other|6|||
30728385|NCT00488774|58741235|FG001|Overall Study|Other|3|||
30728386|NCT00488774|58741236|FG002|Overall Study|Other|2|||
30728387|NCT00488774|58741237|FG003|Overall Study|Other|2|||
30728388|NCT00488774|58741234|FG000|Overall Study|Lost to Follow-up|0|||
30728389|NCT00488774|58741235|FG001|Overall Study|Lost to Follow-up|0|||
30728390|NCT00488774|58741236|FG002|Overall Study|Lost to Follow-up|1|||
30728391|NCT00488774|58741237|FG003|Overall Study|Lost to Follow-up|1|||
30728392|NCT00361569|58741252|FG000|Overall Study|Protocol Violation|3|||
30728393|NCT00361569|58741253|FG001|Overall Study|Protocol Violation|2|||
30728394|NCT00361569|58741254|FG002|Overall Study|Protocol Violation|4|||
30728395|NCT00361569|58741255|FG003|Overall Study|Protocol Violation|2|||
30728396|NCT00361569|58741252|FG000|Overall Study|Withdrawal by Subject|2|||
30728397|NCT00361569|58741253|FG001|Overall Study|Withdrawal by Subject|1|||
30728398|NCT00361569|58741254|FG002|Overall Study|Withdrawal by Subject|9|||
30728399|NCT00361569|58741255|FG003|Overall Study|Withdrawal by Subject|14|||
30728400|NCT00361569|58741252|FG000|Overall Study|Adverse Event|3|||
30728401|NCT00361569|58741253|FG001|Overall Study|Adverse Event|5|||
30728402|NCT00361569|58741254|FG002|Overall Study|Adverse Event|2|||
30728403|NCT00361569|58741255|FG003|Overall Study|Adverse Event|2|||
30728404|NCT00361569|58741252|FG000|Overall Study|Lost to Follow-up|2|||
30728405|NCT00361569|58741253|FG001|Overall Study|Lost to Follow-up|3|||
30728406|NCT00361569|58741254|FG002|Overall Study|Lost to Follow-up|3|||
30728407|NCT00361569|58741255|FG003|Overall Study|Lost to Follow-up|2|||
30728408|NCT00361569|58741252|FG000|Overall Study|Not specified by investigator|2|||
30728409|NCT00361569|58741253|FG001|Overall Study|Not specified by investigator|0|||
30728410|NCT00361569|58741254|FG002|Overall Study|Not specified by investigator|0|||
30728411|NCT00361569|58741255|FG003|Overall Study|Not specified by investigator|1|||
30728412|NCT00488618|58741267|FG000|Overall Study|Adverse Event|13|||
30728413|NCT00488618|58741268|FG001|Overall Study|Adverse Event|17|||
30728414|NCT00488618|58741267|FG000|Overall Study|Insufficient Therapeutic Response|18|||
30728415|NCT00488618|58741268|FG001|Overall Study|Insufficient Therapeutic Response|11|||
30728416|NCT00488618|58741267|FG000|Overall Study|Protocol Violation|0|||
30728417|NCT00488618|58741268|FG001|Overall Study|Protocol Violation|2|||
30728418|NCT00488618|58741267|FG000|Overall Study|Withdrawal of Consent|15|||
30728419|NCT00488618|58741268|FG001|Overall Study|Withdrawal of Consent|13|||
30728420|NCT00488618|58741267|FG000|Overall Study|Lost to Follow-up|1|||
30728421|NCT00488618|58741268|FG001|Overall Study|Lost to Follow-up|0|||
30728422|NCT00266656|58741276|FG000|Overall Study|Death|1|||
30728423|NCT00266656|58741277|FG001|Overall Study|Death|0|||
30728424|NCT00266656|58741276|FG000|Overall Study|Lost to Follow-up|4|||
30728425|NCT00266656|58741277|FG001|Overall Study|Lost to Follow-up|1|||
30728426|NCT00266656|58741276|FG000|Overall Study|Withdrawal by Subject|4|||
30728427|NCT00266656|58741277|FG001|Overall Study|Withdrawal by Subject|2|||
30728428|NCT00266656|58741276|FG000|Overall Study|Did Not Reach Final Height|4|||
30728429|NCT00266656|58741277|FG001|Overall Study|Did Not Reach Final Height|8|||
30728430|NCT00266656|58741276|FG000|Overall Study|Parent/Caregiver Decision|1|||
30728431|NCT00266656|58741277|FG001|Overall Study|Parent/Caregiver Decision|2|||
30728432|NCT00483704|58741286|FG000|Randomization|Withdrawal by Subject|19|||
30728433|NCT00483704|58741287|FG001|Randomization|Withdrawal by Subject|28|||
30728434|NCT00483704|58741288|FG002|Randomization|Withdrawal by Subject|18|||
30728435|NCT00483704|58741286|FG000|Randomization|Protocol Violation|14|||
30728436|NCT00483704|58741287|FG001|Randomization|Protocol Violation|25|||
30728437|NCT00483704|58741288|FG002|Randomization|Protocol Violation|22|||
30728438|NCT00483704|58741286|FG000|Randomization|Lost to Follow-up|14|||
30728439|NCT00483704|58741287|FG001|Randomization|Lost to Follow-up|14|||
30728440|NCT00483704|58741288|FG002|Randomization|Lost to Follow-up|19|||
30728441|NCT00483704|58741286|FG000|Randomization|Pregnancy|1|||
30728442|NCT00483704|58741287|FG001|Randomization|Pregnancy|0|||
30728443|NCT00483704|58741288|FG002|Randomization|Pregnancy|0|||
30900456|NCT02356562|58933848|FG000|Overall Study|Withdrawal by Subject|0|||
30728444|NCT00483704|58741286|FG000|Randomization|Physician Decision|2|||
30728445|NCT00483704|58741287|FG001|Randomization|Physician Decision|4|||
30728446|NCT00483704|58741288|FG002|Randomization|Physician Decision|0|||
30728447|NCT00483704|58741286|FG000|Randomization|Progressive disease|0|||
30728448|NCT00483704|58741287|FG001|Randomization|Progressive disease|0|||
30728449|NCT00483704|58741288|FG002|Randomization|Progressive disease|1|||
30728450|NCT00483704|58741286|FG000|Randomization|Lack of qualifying migraines|21|||
30728451|NCT00483704|58741287|FG001|Randomization|Lack of qualifying migraines|25|||
30728452|NCT00483704|58741288|FG002|Randomization|Lack of qualifying migraines|31|||
30728453|NCT00483704|58741286|FG000|Treatment|Lack of qualifying migraines|101|||
30728454|NCT00483704|58741287|FG001|Treatment|Lack of qualifying migraines|99|||
30728455|NCT00483704|58741288|FG002|Treatment|Lack of qualifying migraines|116|||
30728456|NCT00483704|58741286|FG000|Treatment|Adverse Event|3|||
30728457|NCT00483704|58741287|FG001|Treatment|Adverse Event|5|||
30728458|NCT00483704|58741288|FG002|Treatment|Adverse Event|4|||
30728459|NCT00483704|58741286|FG000|Treatment|Withdrawal by Subject|16|||
30728460|NCT00483704|58741287|FG001|Treatment|Withdrawal by Subject|12|||
30728461|NCT00483704|58741288|FG002|Treatment|Withdrawal by Subject|21|||
30728462|NCT00483704|58741286|FG000|Treatment|Protocol Violation|6|||
30728463|NCT00483704|58741287|FG001|Treatment|Protocol Violation|3|||
30728464|NCT00483704|58741288|FG002|Treatment|Protocol Violation|5|||
30728465|NCT00483704|58741286|FG000|Treatment|Lost to Follow-up|2|||
30728466|NCT00483704|58741287|FG001|Treatment|Lost to Follow-up|7|||
30728467|NCT00483704|58741288|FG002|Treatment|Lost to Follow-up|5|||
30728468|NCT00483704|58741286|FG000|Treatment|Lack of Efficacy|1|||
30728469|NCT00483704|58741287|FG001|Treatment|Lack of Efficacy|1|||
30728470|NCT00483704|58741288|FG002|Treatment|Lack of Efficacy|1|||
30728471|NCT00483704|58741286|FG000|Treatment|Pregnancy|0|||
30728472|NCT00483704|58741287|FG001|Treatment|Pregnancy|1|||
30728473|NCT00483704|58741288|FG002|Treatment|Pregnancy|0|||
30728474|NCT00483704|58741286|FG000|Treatment|Physician Decision|0|||
30728475|NCT00483704|58741287|FG001|Treatment|Physician Decision|1|||
30728476|NCT00483704|58741288|FG002|Treatment|Physician Decision|4|||
30728477|NCT00483548|58741301|FG000|Overall Study|Randomized; not treated with study drug|1|||
30728478|NCT00483548|58741302|FG001|Overall Study|Randomized; not treated with study drug|3|||
30728479|NCT00483548|58741301|FG000|Overall Study|Adverse Event|25|||
30728480|NCT00483548|58741302|FG001|Overall Study|Adverse Event|14|||
30728481|NCT00483548|58741301|FG000|Overall Study|Laboratory abnormality|1|||
30728482|NCT00483548|58741302|FG001|Overall Study|Laboratory abnormality|2|||
30728483|NCT00483548|58741301|FG000|Overall Study|Lack of Efficacy|4|||
30728484|NCT00483548|58741302|FG001|Overall Study|Lack of Efficacy|8|||
30728485|NCT00483548|58741301|FG000|Overall Study|Protocol Violation|11|||
30728486|NCT00483548|58741302|FG001|Overall Study|Protocol Violation|7|||
30728487|NCT00483548|58741301|FG000|Overall Study|Pregnancy|1|||
30728488|NCT00483548|58741302|FG001|Overall Study|Pregnancy|0|||
30728489|NCT00483548|58741301|FG000|Overall Study|Protocol required discontinuation|6|||
30728490|NCT00483548|58741302|FG001|Overall Study|Protocol required discontinuation|6|||
30728491|NCT00483548|58741301|FG000|Overall Study|Unable to comply with protocol schedule|1|||
30728492|NCT00483548|58741302|FG001|Overall Study|Unable to comply with protocol schedule|0|||
30728493|NCT00483548|58741301|FG000|Overall Study|Non-compliance with medication|2|||
30728494|NCT00483548|58741302|FG001|Overall Study|Non-compliance with medication|0|||
30728495|NCT00483548|58741301|FG000|Overall Study|Lost to Follow-up|3|||
30728496|NCT00483548|58741302|FG001|Overall Study|Lost to Follow-up|4|||
30728497|NCT00483548|58741301|FG000|Overall Study|Withdrawal by Subject|5|||
30728498|NCT00483548|58741302|FG001|Overall Study|Withdrawal by Subject|2|||
30728499|NCT00445770|58741311|FG000|Overall Study|Adverse Event|9|||
30728500|NCT00445770|58741312|FG001|Overall Study|Adverse Event|15|||
30728501|NCT00445770|58741313|FG002|Overall Study|Adverse Event|19|||
30728502|NCT00445770|58741311|FG000|Overall Study|Lack of Efficacy|38|||
30728503|NCT00445770|58741312|FG001|Overall Study|Lack of Efficacy|13|||
30728504|NCT00445770|58741313|FG002|Overall Study|Lack of Efficacy|6|||
30728505|NCT00445770|58741311|FG000|Overall Study|Lost to Follow-up|0|||
30728506|NCT00445770|58741312|FG001|Overall Study|Lost to Follow-up|2|||
30728507|NCT00445770|58741313|FG002|Overall Study|Lost to Follow-up|0|||
30728508|NCT00445770|58741311|FG000|Overall Study|Other|6|||
30728509|NCT00445770|58741312|FG001|Overall Study|Other|5|||
30728510|NCT00445770|58741313|FG002|Overall Study|Other|6|||
30728511|NCT00266032|58741326|FG000|Treatment|Adverse Event|42|||
30728512|NCT00266032|58741327|FG001|Treatment|Adverse Event|26|||
30728513|NCT00266032|58741328|FG002|Treatment|Adverse Event|10|||
30728514|NCT00266032|58741326|FG000|Treatment|Lost to Follow-up|19|||
30728515|NCT00266032|58741327|FG001|Treatment|Lost to Follow-up|4|||
30728516|NCT00266032|58741328|FG002|Treatment|Lost to Follow-up|2|||
30728517|NCT00266032|58741326|FG000|Treatment|Pregnancy|3|||
30728518|NCT00266032|58741327|FG001|Treatment|Pregnancy|2|||
30728519|NCT00266032|58741328|FG002|Treatment|Pregnancy|2|||
30728520|NCT00266032|58741326|FG000|Treatment|Protocol Violation|6|||
30728521|NCT00266032|58741327|FG001|Treatment|Protocol Violation|14|||
30728522|NCT00266032|58741328|FG002|Treatment|Protocol Violation|13|||
30728523|NCT00266032|58741326|FG000|Treatment|Withdrawal by Subject|28|||
30728524|NCT00266032|58741327|FG001|Treatment|Withdrawal by Subject|13|||
30728525|NCT00266032|58741328|FG002|Treatment|Withdrawal by Subject|12|||
30728526|NCT00266032|58741326|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
30728527|NCT00266032|58741327|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
30728528|NCT00266032|58741328|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
30728529|NCT00266032|58741326|FG000|Open-label Safety Extension|Adverse Event|5|||
30728530|NCT00266032|58741327|FG001|Open-label Safety Extension|Adverse Event|0|||
30728531|NCT00266032|58741328|FG002|Open-label Safety Extension|Adverse Event|4|||
30728532|NCT00266032|58741326|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
30728533|NCT00266032|58741327|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
30728534|NCT00266032|58741328|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
30728535|NCT00266032|58741326|FG000|Open-label Safety Extension|Pregnancy|4|||
30728536|NCT00266032|58741327|FG001|Open-label Safety Extension|Pregnancy|1|||
30728537|NCT00266032|58741328|FG002|Open-label Safety Extension|Pregnancy|2|||
30728538|NCT00266032|58741326|FG000|Open-label Safety Extension|Protocol Violation|1|||
30728539|NCT00266032|58741327|FG001|Open-label Safety Extension|Protocol Violation|3|||
30728540|NCT00266032|58741328|FG002|Open-label Safety Extension|Protocol Violation|2|||
30728541|NCT00266032|58741326|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
30728542|NCT00266032|58741327|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
30728543|NCT00266032|58741328|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
30728544|NCT00266032|58741326|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
30728545|NCT00266032|58741327|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
30728546|NCT00266032|58741328|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
30728547|NCT00483002|58741336|FG000|Overall Study|Adverse Event|68|||
30728548|NCT00483002|58741336|FG000|Overall Study|Lack of Efficacy|555|||
30728549|NCT00483002|58741336|FG000|Overall Study|Lost to Follow-up|962|||
30728550|NCT00483002|58741336|FG000|Overall Study|Other|2|||
30728551|NCT00483002|58741336|FG000|Overall Study|Other|967|||
30728552|NCT00482612|58741344|FG000|In-treatment Period|No study medication administered|0|||
30728553|NCT00482612|58741345|FG001|In-treatment Period|No study medication administered|0|||
30728554|NCT00482612|58741346|FG002|In-treatment Period|No study medication administered|1|||
30728555|NCT00482612|58741347|FG003|In-treatment Period|No study medication administered|0|||
30728556|NCT00482612|58741344|FG000|Follow-up Period|Other|4|||
30900457|NCT02356562|58933849|FG001|Overall Study|Withdrawal by Subject|1|||
30728557|NCT00482612|58741345|FG001|Follow-up Period|Other|2|||
30728558|NCT00482612|58741346|FG002|Follow-up Period|Other|1|||
30728559|NCT00482612|58741347|FG003|Follow-up Period|Other|2|||
30728560|NCT00482612|58741344|FG000|Follow-up Period|Lack of compliance|0|||
30728561|NCT00482612|58741345|FG001|Follow-up Period|Lack of compliance|0|||
30728562|NCT00482612|58741346|FG002|Follow-up Period|Lack of compliance|1|||
30728563|NCT00482612|58741347|FG003|Follow-up Period|Lack of compliance|0|||
30728564|NCT00482612|58741344|FG000|Follow-up Period|Lost to Follow-up|0|||
30900458|NCT02356562|58933848|FG000|Overall Study|Re-entered treatment in a previous study|1|||
30728565|NCT00482612|58741345|FG001|Follow-up Period|Lost to Follow-up|4|||
30728566|NCT00482612|58741346|FG002|Follow-up Period|Lost to Follow-up|2|||
30728567|NCT00482612|58741347|FG003|Follow-up Period|Lost to Follow-up|1|||
30728568|NCT00482612|58741344|FG000|Follow-up Period|Adverse Event|4|||
30728569|NCT00482612|58741345|FG001|Follow-up Period|Adverse Event|7|||
30728570|NCT00482612|58741346|FG002|Follow-up Period|Adverse Event|9|||
30728571|NCT00482612|58741347|FG003|Follow-up Period|Adverse Event|0|||
30728572|NCT00482612|58741344|FG000|Follow-up Period|Lack of Efficacy|2|||
30728573|NCT00482612|58741345|FG001|Follow-up Period|Lack of Efficacy|0|||
30728574|NCT00482612|58741346|FG002|Follow-up Period|Lack of Efficacy|1|||
30728575|NCT00482612|58741347|FG003|Follow-up Period|Lack of Efficacy|0|||
30728576|NCT00482612|58741344|FG000|Follow-up Period|Withdrawal by Subject|3|||
30728577|NCT00482612|58741345|FG001|Follow-up Period|Withdrawal by Subject|5|||
30728578|NCT00482612|58741346|FG002|Follow-up Period|Withdrawal by Subject|7|||
30728579|NCT00482612|58741347|FG003|Follow-up Period|Withdrawal by Subject|2|||
30728580|NCT00482612|58741344|FG000|Follow-up Period|Reasons not related to trial|1|||
30728581|NCT00482612|58741345|FG001|Follow-up Period|Reasons not related to trial|0|||
30728582|NCT00482612|58741346|FG002|Follow-up Period|Reasons not related to trial|1|||
30728583|NCT00482612|58741347|FG003|Follow-up Period|Reasons not related to trial|3|||
30728584|NCT00282568|58741361|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
30728585|NCT00282568|58741361|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
30728586|NCT00282568|58741361|FG000|Extended Treatment Period|Adverse Event|17|||
30728587|NCT00282568|58741361|FG000|Extended Treatment Period|Non-compliance|4|||
30728588|NCT00282568|58741361|FG000|Extended Treatment Period|Physician Decision|1|||
30728589|NCT00282568|58741361|FG000|Extended Treatment Period|Lost to Follow-up|2|||
30728590|NCT00265564|58741367|FG000|Overall Study|Lost to Follow-up|5|||
30728591|NCT00265564|58741368|FG001|Overall Study|Lost to Follow-up|7|||
30728592|NCT00265564|58741367|FG000|Overall Study|met exclusion criteria|5|||
30728593|NCT00265564|58741368|FG001|Overall Study|met exclusion criteria|2|||
30728594|NCT00376623|58741377|FG000|Overall Study|Progressive disease|35|||
30728595|NCT00376623|58741378|FG001|Overall Study|Progressive disease|22|||
30728596|NCT00376623|58741379|FG002|Overall Study|Progressive disease|17|||
30728597|NCT00376623|58741377|FG000|Overall Study|Lost to Follow-up|0|||
30728598|NCT00376623|58741378|FG001|Overall Study|Lost to Follow-up|1|||
30728599|NCT00376623|58741379|FG002|Overall Study|Lost to Follow-up|0|||
30728600|NCT00376623|58741377|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
30900459|NCT02356562|58933849|FG001|Overall Study|Re-entered treatment in a previous study|0|||
30900460|NCT02356562|58933848|FG000|Overall Study|site closure|1|||
30900461|NCT02356562|58933849|FG001|Overall Study|site closure|0|||
30900462|NCT02448563|58933860|FG000|Overall Study|Lost to Follow-up|16|||
30900463|NCT02448563|58933861|FG001|Overall Study|Lost to Follow-up|10|||
30900464|NCT02448563|58933860|FG000|Overall Study|Withdrawal by Subject|0|||
30900465|NCT02448563|58933861|FG001|Overall Study|Withdrawal by Subject|1|||
30728601|NCT00376623|58741378|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
30728602|NCT00376623|58741379|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
30728603|NCT00376623|58741377|FG000|Overall Study|Not treated with BI 2536|1|||
30728604|NCT00376623|58741378|FG001|Overall Study|Not treated with BI 2536|0|||
30728605|NCT00376623|58741379|FG002|Overall Study|Not treated with BI 2536|0|||
30728606|NCT00376623|58741377|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
30728607|NCT00376623|58741378|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
30900466|NCT02266225|58933871|FG000|Overall Study|Lost to Follow-up|2|||
30900467|NCT02266225|58933871|FG000|Overall Study|Death|1|||
30900468|NCT02266225|58933871|FG000|Overall Study|Withdrawal by Subject|13|||
30728608|NCT00376623|58741379|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
30728609|NCT00376623|58741377|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
30728610|NCT00376623|58741378|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
30728611|NCT00376623|58741379|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
30728612|NCT00376623|58741377|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
30728613|NCT00376623|58741378|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
30728614|NCT00376623|58741379|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
30728615|NCT00376623|58741377|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
30728616|NCT00376623|58741378|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
30728617|NCT00376623|58741379|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
30728618|NCT00376623|58741377|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
30728619|NCT00376623|58741378|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
30728620|NCT00376623|58741379|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
30728621|NCT00376623|58741377|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
30728622|NCT00376623|58741378|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
30728623|NCT00376623|58741379|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
30728624|NCT00376623|58741377|FG000|Overall Study|Increase of tumour markers|0|||
30728625|NCT00376623|58741378|FG001|Overall Study|Increase of tumour markers|1|||
30728626|NCT00376623|58741379|FG002|Overall Study|Increase of tumour markers|0|||
30728627|NCT00376623|58741377|FG000|Overall Study|Bone metastasis|1|||
30728628|NCT00376623|58741378|FG001|Overall Study|Bone metastasis|0|||
30728629|NCT00376623|58741379|FG002|Overall Study|Bone metastasis|0|||
30728630|NCT00445692|58741393|FG000|Overall Study|Adverse Event|11|||
30728631|NCT00445692|58741393|FG000|Overall Study|Lack of Efficacy|5|||
30728632|NCT03824236|58741402|FG000|Overall Study|Lost to Follow-up|0|||
30728633|NCT03824236|58741403|FG001|Overall Study|Lost to Follow-up|0|||
30728634|NCT03824236|58741404|FG002|Overall Study|Lost to Follow-up|1|||
30728635|NCT00282412|58741412|FG000|Overall Study|Death|2|||
30728636|NCT00282334|58741418|FG000|Overall Study|Withdrawal by Subject|8|||
30728637|NCT00282334|58741419|FG001|Overall Study|Withdrawal by Subject|5|||
30728638|NCT00282256|58741425|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
30728639|NCT00282256|58741425|FG000|Extension Treatment Period|Adverse Event|2|||
30728640|NCT00265330|58741429|FG000|Overall Study|Adverse Event|41|||
30728641|NCT00265330|58741429|FG000|Overall Study|Lost to Follow-up|8|||
30728642|NCT00265330|58741429|FG000|Overall Study|Withdrawal by Subject|34|||
30728643|NCT00265330|58741429|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
30728644|NCT00265330|58741429|FG000|Overall Study|Lack of Efficacy|4|||
30728645|NCT00265330|58741429|FG000|Overall Study|Family Scheduling Conflicts|1|||
30728646|NCT00265330|58741429|FG000|Overall Study|Began Taking Formulary Geodon|1|||
30728647|NCT00265330|58741429|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
30728648|NCT00265330|58741429|FG000|Overall Study|Site Closed by Sponsor|1|||
30728649|NCT00265330|58741429|FG000|Overall Study|Principal Investigators Request|1|||
30728650|NCT00265330|58741429|FG000|Overall Study|Withdrew Consent|1|||
30728651|NCT00265330|58741429|FG000|Overall Study|Protocol Violation|1|||
30728652|NCT00292318|58741435|FG000|Overall Study|Study terminated by officials|2|||
30728653|NCT00292318|58741436|FG001|Overall Study|Study terminated by officials|1|||
30728654|NCT00281632|58741442|FG000|Overall Study|Adverse Event|7|||
30728655|NCT00281632|58741442|FG000|Overall Study|Withdrawal by Subject|2|||
30728656|NCT00281632|58741442|FG000|Overall Study|Disease Progression|22|||
30728657|NCT00281632|58741442|FG000|Overall Study|Death|1|||
30900469|NCT02354690|58933876|FG000|Overall Study|Physician Decision|1|||
30728658|NCT00281632|58741442|FG000|Overall Study|Physician Decision|1|||
30728659|NCT00281632|58741442|FG000|Overall Study|Ongoing|3|||
30728660|NCT00543569|58741458|FG000|Overall Study|Death|2|||
30728661|NCT00543569|58741459|FG001|Overall Study|Death|2|||
30728662|NCT00543569|58741460|FG002|Overall Study|Death|3|||
30728663|NCT00543569|58741461|FG003|Overall Study|Death|1|||
30728664|NCT00543569|58741458|FG000|Overall Study|Lost to Follow-up|0|||
30728665|NCT00543569|58741459|FG001|Overall Study|Lost to Follow-up|0|||
30728666|NCT00543569|58741460|FG002|Overall Study|Lost to Follow-up|1|||
30728667|NCT00543569|58741461|FG003|Overall Study|Lost to Follow-up|1|||
30900470|NCT02354222|58933882|FG000|Overall Study|Adverse Event|0|||
30728668|NCT00543569|58741458|FG000|Overall Study|Miscellaneous Reasons|7|||
30728669|NCT00543569|58741459|FG001|Overall Study|Miscellaneous Reasons|3|||
30728670|NCT00543569|58741460|FG002|Overall Study|Miscellaneous Reasons|11|||
30728671|NCT00543569|58741461|FG003|Overall Study|Miscellaneous Reasons|4|||
30728672|NCT00543569|58741458|FG000|Overall Study|Randomized but never received study drug|3|||
30728673|NCT00543569|58741459|FG001|Overall Study|Randomized but never received study drug|3|||
30728674|NCT00543569|58741460|FG002|Overall Study|Randomized but never received study drug|5|||
30728675|NCT00543569|58741461|FG003|Overall Study|Randomized but never received study drug|3|||
30728676|NCT00445458|58741475|FG000|Overall Study|Disease Progression|3|||
30728677|NCT00445458|58741476|FG001|Overall Study|Disease Progression|4|||
30728678|NCT00445458|58741477|FG002|Overall Study|Disease Progression|54|||
30728679|NCT00445458|58741478|FG003|Overall Study|Disease Progression|27|||
30728680|NCT00445458|58741475|FG000|Overall Study|Withdrawal by Subject|0|||
30728681|NCT00445458|58741476|FG001|Overall Study|Withdrawal by Subject|0|||
30728682|NCT00445458|58741477|FG002|Overall Study|Withdrawal by Subject|7|||
30728683|NCT00445458|58741478|FG003|Overall Study|Withdrawal by Subject|0|||
30728684|NCT00445458|58741475|FG000|Overall Study|Adverse Event|0|||
30728685|NCT00445458|58741476|FG001|Overall Study|Adverse Event|0|||
30728686|NCT00445458|58741477|FG002|Overall Study|Adverse Event|3|||
30728687|NCT00445458|58741478|FG003|Overall Study|Adverse Event|0|||
30728688|NCT00445458|58741475|FG000|Overall Study|Death|0|||
30728689|NCT00445458|58741476|FG001|Overall Study|Death|1|||
30728690|NCT00445458|58741477|FG002|Overall Study|Death|2|||
30728691|NCT00445458|58741478|FG003|Overall Study|Death|0|||
30728692|NCT00445458|58741475|FG000|Overall Study|Physician Decision|0|||
30728693|NCT00445458|58741476|FG001|Overall Study|Physician Decision|0|||
30728694|NCT00445458|58741477|FG002|Overall Study|Physician Decision|1|||
30728695|NCT00445458|58741478|FG003|Overall Study|Physician Decision|1|||
30728696|NCT00445458|58741475|FG000|Overall Study|Surgery|0|||
30728697|NCT00445458|58741476|FG001|Overall Study|Surgery|0|||
30728698|NCT00445458|58741477|FG002|Overall Study|Surgery|1|||
30728699|NCT00445458|58741478|FG003|Overall Study|Surgery|0|||
30728700|NCT03914417|58741491|FG000|Overall Study|Withdrawal by Subject|2|||
30728701|NCT00541385|58741497|FG000|Overall Study|Adverse Event|6|||
30728702|NCT00541385|58741498|FG001|Overall Study|Adverse Event|3|||
30728703|NCT00541385|58741497|FG000|Overall Study|Withdrawal by Subject|2|||
30728704|NCT00541385|58741498|FG001|Overall Study|Withdrawal by Subject|2|||
30728705|NCT00541385|58741497|FG000|Overall Study|Lost to Follow-up|6|||
30728706|NCT00541385|58741498|FG001|Overall Study|Lost to Follow-up|1|||
30728707|NCT00541385|58741497|FG000|Overall Study|Parasite reappearance/malaria|67|||
30728708|NCT00541385|58741498|FG001|Overall Study|Parasite reappearance/malaria|32|||
30728709|NCT00265096|58741507|FG000|Overall Study|Adverse Event|14|||
30728710|NCT00265096|58741508|FG001|Overall Study|Adverse Event|18|||
30728711|NCT00265096|58741509|FG002|Overall Study|Adverse Event|18|||
30728712|NCT00265096|58741507|FG000|Overall Study|Lost to Follow-up|2|||
30728713|NCT00265096|58741508|FG001|Overall Study|Lost to Follow-up|5|||
30728714|NCT00265096|58741509|FG002|Overall Study|Lost to Follow-up|3|||
30728715|NCT00265096|58741507|FG000|Overall Study|Death|0|||
30728716|NCT00265096|58741508|FG001|Overall Study|Death|1|||
30728717|NCT00265096|58741509|FG002|Overall Study|Death|2|||
30728718|NCT00265096|58741507|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
30728719|NCT00265096|58741508|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
30728720|NCT00265096|58741509|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
30728721|NCT00265096|58741507|FG000|Overall Study|Other|11|||
30728722|NCT00265096|58741508|FG001|Overall Study|Other|19|||
30728723|NCT00265096|58741509|FG002|Overall Study|Other|10|||
30728724|NCT02201108|58741521|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
30728725|NCT02201108|58741522|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
30728726|NCT02201108|58741521|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
30728727|NCT02201108|58741522|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
30728728|NCT02201108|58741521|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
30728729|NCT02201108|58741522|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
30728730|NCT02201108|58741521|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
30728731|NCT02201108|58741522|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
30728732|NCT02201108|58741521|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
30728733|NCT02201108|58741522|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
30728734|NCT02201108|58741521|FG000|Open Label Period (up to Week 192)|Other reason|4|||
30728735|NCT02201108|58741522|FG001|Open Label Period (up to Week 192)|Other reason|7|||
30728736|NCT02201108|58741521|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
30728737|NCT02201108|58741522|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
30728738|NCT00281320|58741543|FG000|Overall Study|Adverse Event|12|||
30728739|NCT00281320|58741544|FG001|Overall Study|Adverse Event|9|||
30728740|NCT00281320|58741543|FG000|Overall Study|Lack of Efficacy|4|||
30728741|NCT00281320|58741544|FG001|Overall Study|Lack of Efficacy|3|||
30728742|NCT00281320|58741543|FG000|Overall Study|Withdrawal by Subject|5|||
30728743|NCT00281320|58741544|FG001|Overall Study|Withdrawal by Subject|6|||
30728744|NCT00281320|58741543|FG000|Overall Study|Lost to Follow-up|1|||
30728745|NCT00281320|58741544|FG001|Overall Study|Lost to Follow-up|2|||
30728746|NCT00281320|58741543|FG000|Overall Study|Other|3|||
30728747|NCT00281320|58741544|FG001|Overall Study|Other|1|||
30728748|NCT00541307|58741556|FG000|Overall Study|Death|5|||
30728749|NCT00541307|58741556|FG000|Overall Study|Physician Decision|3|||
30728750|NCT00541307|58741556|FG000|Overall Study|Withdrawal by Subject|6|||
30728751|NCT00541307|58741556|FG000|Overall Study|Lost to Follow-up|4|||
30728752|NCT00541307|58741556|FG000|Overall Study|Subject returned early (outside window)|1|||
30728753|NCT00541307|58741556|FG000|Overall Study|Surgical Bypass|5|||
30728754|NCT00541229|58741566|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
30728755|NCT00541229|58741567|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
30900471|NCT02354222|58933883|FG001|Overall Study|Adverse Event|3|||
30728756|NCT00541229|58741568|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
30728757|NCT00541229|58741569|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
30728758|NCT00541229|58741570|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
30728759|NCT00541229|58741571|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
30900472|NCT02354222|58933882|FG000|Overall Study|Physician Decision|1|||
30728760|NCT00541229|58741566|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
30728761|NCT00541229|58741567|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
30728762|NCT00541229|58741568|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
30728763|NCT00541229|58741569|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
30728764|NCT00541229|58741570|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
30728765|NCT00541229|58741571|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
30728766|NCT00541229|58741566|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
30728767|NCT00541229|58741567|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
30728768|NCT00541229|58741568|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
30728769|NCT00541229|58741569|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
30728770|NCT00541229|58741570|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
30728771|NCT00541229|58741571|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
30728772|NCT00541229|58741566|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
30728773|NCT00541229|58741567|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
30728774|NCT00541229|58741568|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
30728775|NCT00541229|58741569|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
30728776|NCT00541229|58741570|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
30728777|NCT00541229|58741571|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
30728778|NCT00541229|58741566|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
30728779|NCT00541229|58741567|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
30728780|NCT00541229|58741568|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
30728781|NCT00541229|58741569|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
30728782|NCT00541229|58741570|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
30728783|NCT00541229|58741571|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
30728784|NCT00541229|58741566|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
30728785|NCT00541229|58741567|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
30728786|NCT00541229|58741568|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
30728787|NCT00541229|58741569|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
30728788|NCT00541229|58741570|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
30728789|NCT00541229|58741571|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
30728790|NCT00541229|58741566|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
30728791|NCT00541229|58741567|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
30728792|NCT00541229|58741568|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
30728793|NCT00541229|58741569|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
30728794|NCT00541229|58741570|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
30728795|NCT00541229|58741571|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
30728796|NCT00541229|58741566|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
30728797|NCT00541229|58741567|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
30728798|NCT00541229|58741568|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
30728799|NCT00541229|58741569|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
30728800|NCT00541229|58741570|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
30728801|NCT00541229|58741571|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
30728802|NCT00541229|58741566|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
30728803|NCT00541229|58741567|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
30728804|NCT00541229|58741568|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
30728805|NCT00541229|58741569|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
30728806|NCT00541229|58741570|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
30728807|NCT00541229|58741571|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
30728808|NCT00541229|58741566|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
30728809|NCT00541229|58741567|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
30728810|NCT00541229|58741568|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
30728811|NCT00541229|58741569|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
30728812|NCT00541229|58741570|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
30728813|NCT00541229|58741571|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
30728814|NCT00541229|58741566|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
30728815|NCT00541229|58741567|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
30728816|NCT00541229|58741568|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
30728817|NCT00541229|58741569|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
30728818|NCT00541229|58741570|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
30728819|NCT00541229|58741571|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
30728820|NCT00541229|58741566|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
30728821|NCT00541229|58741567|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
30728822|NCT00541229|58741568|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
30900473|NCT02354222|58933883|FG001|Overall Study|Physician Decision|1|||
30728823|NCT00541229|58741569|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
30728824|NCT00541229|58741570|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
30728825|NCT00541229|58741571|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
30728826|NCT00541229|58741566|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
30728827|NCT00541229|58741567|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
30728828|NCT00541229|58741568|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
30728829|NCT00541229|58741569|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
30728830|NCT00541229|58741570|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
30728831|NCT00541229|58741571|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
30728832|NCT00541229|58741566|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
30728833|NCT00541229|58741567|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
30728834|NCT00541229|58741568|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
30728835|NCT00541229|58741569|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
30728836|NCT00541229|58741570|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
30728837|NCT00541229|58741571|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
30728838|NCT00541229|58741566|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
30728839|NCT00541229|58741567|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
30728840|NCT00541229|58741568|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
30728841|NCT00541229|58741569|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
30728842|NCT00541229|58741570|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
30728843|NCT00541229|58741571|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
30728844|NCT00541229|58741566|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
30728845|NCT00541229|58741567|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
30728846|NCT00541229|58741568|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
30728847|NCT00541229|58741569|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
30728848|NCT00541229|58741570|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
30728849|NCT00541229|58741571|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
30728850|NCT00481988|58741581|FG000|Overall Study|Withdrawal by Subject|1|||
30728851|NCT00481988|58741582|FG001|Overall Study|Withdrawal by Subject|1|||
30728852|NCT00481832|58741599|FG000|Enrollment|Physician Decision|8|||
30728853|NCT00481832|58741599|FG000|Enrollment|Unable to collect enough stem cells|2|||
30728854|NCT00481832|58741599|FG000|Inter-transplant Period|Adverse Event|4|||
30728855|NCT00481832|58741599|FG000|Inter-transplant Period|Death|3|||
30728856|NCT00481832|58741599|FG000|Inter-transplant Period|Physician Decision|4|||
30728857|NCT00481832|58741599|FG000|Inter-transplant Period|Disease relapse|11|||
30728858|NCT00481832|58741599|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
30728859|NCT00481676|58741605|FG000|Overall Study|Adverse Event|0|||
30728860|NCT00481676|58741606|FG001|Overall Study|Adverse Event|1|||
30728861|NCT00481676|58741605|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30728862|NCT00481676|58741606|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
30728863|NCT00481676|58741605|FG000|Overall Study|Administrative problem|1|||
30728864|NCT00481676|58741606|FG001|Overall Study|Administrative problem|0|||
30728865|NCT00542789|58741614|FG000|Overall Study|Adverse Event|18|||
30728866|NCT00542789|58741615|FG001|Overall Study|Adverse Event|17|||
30728867|NCT00542789|58741614|FG000|Overall Study|Withdrawal by Subject|7|||
30728868|NCT00542789|58741615|FG001|Overall Study|Withdrawal by Subject|3|||
30728869|NCT00542789|58741614|FG000|Overall Study|Protocol Violation|8|||
30728870|NCT00542789|58741615|FG001|Overall Study|Protocol Violation|1|||
30728871|NCT00542789|58741614|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
30728872|NCT00542789|58741615|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
30728873|NCT00464672|58741623|FG000|Overall Study|withdrawal of consent|0|||
30728874|NCT00464672|58741624|FG001|Overall Study|withdrawal of consent|0|||
30728875|NCT00464672|58741625|FG002|Overall Study|withdrawal of consent|0|||
30728876|NCT00464672|58741626|FG003|Overall Study|withdrawal of consent|1|||
30728877|NCT00464672|58741627|FG004|Overall Study|withdrawal of consent|9|||
30728878|NCT00464672|58741628|FG005|Overall Study|withdrawal of consent|4|||
30728879|NCT00464672|58741623|FG000|Overall Study|Lost to Follow-up|25|||
30728880|NCT00464672|58741624|FG001|Overall Study|Lost to Follow-up|10|||
30728881|NCT00464672|58741625|FG002|Overall Study|Lost to Follow-up|0|||
30728882|NCT00464672|58741626|FG003|Overall Study|Lost to Follow-up|0|||
30728883|NCT00464672|58741627|FG004|Overall Study|Lost to Follow-up|1|||
30728884|NCT00464672|58741628|FG005|Overall Study|Lost to Follow-up|0|||
30728885|NCT00473876|58741658|FG000|Overall Study|Lost to Follow-up|3|||
30728886|NCT00473876|58741659|FG001|Overall Study|Lost to Follow-up|1|||
30728887|NCT00463580|58741669|FG000|Overall Study|Lost to Follow-up|1|||
30728888|NCT00463580|58741670|FG001|Overall Study|Lost to Follow-up|0|||
30728889|NCT00463580|58741669|FG000|Overall Study|Schedule conflict|2|||
30728890|NCT00463580|58741670|FG001|Overall Study|Schedule conflict|0|||
30728891|NCT00463580|58741669|FG000|Overall Study|Medical/psychiatric complications|0|||
30900474|NCT02354222|58933882|FG000|Overall Study|Pregnancy|1|||
30900475|NCT02354222|58933883|FG001|Overall Study|Pregnancy|0|||
30728892|NCT00463580|58741670|FG001|Overall Study|Medical/psychiatric complications|2|||
30728893|NCT00540449|58741684|FG000|Overall Study|Adverse Event|12|||
30728894|NCT00540449|58741685|FG001|Overall Study|Adverse Event|32|||
30728895|NCT00540449|58741684|FG000|Overall Study|Sponsor's Decision|1|||
30728896|NCT00540449|58741685|FG001|Overall Study|Sponsor's Decision|1|||
30728897|NCT00540449|58741684|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
30728898|NCT00540449|58741685|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
30728899|NCT00540449|58741684|FG000|Overall Study|Lost to Follow-up|19|||
30728900|NCT00540449|58741685|FG001|Overall Study|Lost to Follow-up|17|||
30728901|NCT00540449|58741684|FG000|Overall Study|Subject Non-Compliant|7|||
30728902|NCT00540449|58741685|FG001|Overall Study|Subject Non-Compliant|5|||
30728903|NCT00540449|58741684|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
30728904|NCT00540449|58741685|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
30728905|NCT00540449|58741684|FG000|Overall Study|Withdrawal by Subject|10|||
30728906|NCT00540449|58741685|FG001|Overall Study|Withdrawal by Subject|10|||
30728907|NCT00540449|58741684|FG000|Overall Study|Other|1|||
30728908|NCT00540449|58741685|FG001|Overall Study|Other|4|||
30728909|NCT03911843|58741693|FG000|Overall Study|Adverse Event|2|||
30728910|NCT03911843|58741694|FG001|Overall Study|Adverse Event|0|||
30728911|NCT03911843|58741693|FG000|Overall Study|Protocol Violation|2|||
30728912|NCT03911843|58741694|FG001|Overall Study|Protocol Violation|0|||
30728913|NCT03911843|58741693|FG000|Overall Study|Lost to Follow-up|0|||
30728914|NCT03911843|58741694|FG001|Overall Study|Lost to Follow-up|1|||
30728915|NCT00361335|58741705|FG000|IV Period: Baseline to E0|Adverse Event|9|||
30728916|NCT00361335|58741706|FG001|IV Period: Baseline to E0|Adverse Event|4|||
30728917|NCT00361335|58741707|FG002|IV Period: Baseline to E0|Adverse Event|5|||
30728918|NCT00361335|58741708|FG003|IV Period: Baseline to E0|Adverse Event|9|||
30728919|NCT00361335|58741709|FG004|IV Period: Baseline to E0|Adverse Event|8|||
30728920|NCT00361335|58741710|FG005|IV Period: Baseline to E0|Adverse Event|0|||
30728921|NCT00361335|58741711|FG006|IV Period: Baseline to E0|Adverse Event|0|||
30728922|NCT00361335|58741705|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
30728923|NCT00361335|58741706|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
30728924|NCT00361335|58741707|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
30728925|NCT00361335|58741708|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
30728926|NCT00361335|58741709|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
30728927|NCT00361335|58741710|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
30728928|NCT00361335|58741711|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
30728929|NCT00361335|58741705|FG000|IV Period: Baseline to E0|Death|1|||
30728930|NCT00361335|58741706|FG001|IV Period: Baseline to E0|Death|1|||
30728931|NCT00361335|58741707|FG002|IV Period: Baseline to E0|Death|1|||
30728932|NCT00361335|58741708|FG003|IV Period: Baseline to E0|Death|1|||
30728933|NCT00361335|58741709|FG004|IV Period: Baseline to E0|Death|0|||
30728934|NCT00361335|58741710|FG005|IV Period: Baseline to E0|Death|0|||
30728935|NCT00361335|58741711|FG006|IV Period: Baseline to E0|Death|0|||
30728936|NCT00361335|58741705|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
30728937|NCT00361335|58741706|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
30728938|NCT00361335|58741707|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
30728939|NCT00361335|58741708|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
30728940|NCT00361335|58741709|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
30728941|NCT00361335|58741710|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
30728942|NCT00361335|58741711|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
30728943|NCT00361335|58741705|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
30728944|NCT00361335|58741706|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
30728945|NCT00361335|58741707|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
30728946|NCT00361335|58741708|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
30728947|NCT00361335|58741709|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
30728948|NCT00361335|58741710|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
30728949|NCT00361335|58741711|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
30728950|NCT00361335|58741705|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
30728951|NCT00361335|58741706|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
30728952|NCT00361335|58741707|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
30728953|NCT00361335|58741708|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
30728954|NCT00361335|58741709|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
30728955|NCT00361335|58741710|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
30728956|NCT00361335|58741711|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
30728957|NCT00361335|58741705|FG000|IV Period: Baseline to E0|Other|2|||
30728958|NCT00361335|58741706|FG001|IV Period: Baseline to E0|Other|9|||
30728959|NCT00361335|58741707|FG002|IV Period: Baseline to E0|Other|9|||
30728960|NCT00361335|58741708|FG003|IV Period: Baseline to E0|Other|3|||
30728961|NCT00361335|58741709|FG004|IV Period: Baseline to E0|Other|2|||
30728962|NCT00361335|58741710|FG005|IV Period: Baseline to E0|Other|0|||
30728963|NCT00361335|58741711|FG006|IV Period: Baseline to E0|Other|0|||
30728964|NCT00361335|58741705|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
30728965|NCT00361335|58741706|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
30728966|NCT00361335|58741707|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
30728967|NCT00361335|58741708|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
30728968|NCT00361335|58741709|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
30728969|NCT00361335|58741710|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
30728970|NCT00361335|58741711|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
30728971|NCT00361335|58741705|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
30728972|NCT00361335|58741706|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
30728973|NCT00361335|58741707|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
30728974|NCT00361335|58741708|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
30728975|NCT00361335|58741709|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
30728976|NCT00361335|58741710|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
30728977|NCT00361335|58741711|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
30728978|NCT00361335|58741705|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
30728979|NCT00361335|58741706|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
30728980|NCT00361335|58741707|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
30728981|NCT00361335|58741708|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
30728982|NCT00361335|58741709|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
30728983|NCT00361335|58741710|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
30728984|NCT00361335|58741711|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
30728985|NCT00361335|58741705|FG000|SC Period: Week E0 to Week E24|Death|0|||
30728986|NCT00361335|58741706|FG001|SC Period: Week E0 to Week E24|Death|0|||
30728987|NCT00361335|58741707|FG002|SC Period: Week E0 to Week E24|Death|0|||
30728988|NCT00361335|58741708|FG003|SC Period: Week E0 to Week E24|Death|0|||
30728989|NCT00361335|58741709|FG004|SC Period: Week E0 to Week E24|Death|0|||
30728990|NCT00361335|58741710|FG005|SC Period: Week E0 to Week E24|Death|0|||
30728991|NCT00361335|58741711|FG006|SC Period: Week E0 to Week E24|Death|1|||
30728992|NCT00361335|58741705|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
30728993|NCT00361335|58741706|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
30728994|NCT00361335|58741707|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
30728995|NCT00361335|58741708|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
30728996|NCT00361335|58741709|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
30728997|NCT00361335|58741710|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
30728998|NCT00361335|58741711|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
30728999|NCT00361335|58741705|FG000|SC Period: Week E0 to Week E24|Other|1|||
30729000|NCT00361335|58741706|FG001|SC Period: Week E0 to Week E24|Other|0|||
30729001|NCT00361335|58741707|FG002|SC Period: Week E0 to Week E24|Other|0|||
30729002|NCT00361335|58741708|FG003|SC Period: Week E0 to Week E24|Other|1|||
30729003|NCT00361335|58741709|FG004|SC Period: Week E0 to Week E24|Other|0|||
30729004|NCT00361335|58741710|FG005|SC Period: Week E0 to Week E24|Other|1|||
30729005|NCT00361335|58741711|FG006|SC Period: Week E0 to Week E24|Other|2|||
30729006|NCT00361335|58741705|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
30729007|NCT00361335|58741706|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
30729008|NCT00361335|58741707|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
30729009|NCT00361335|58741708|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
30729010|NCT00361335|58741709|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
30729011|NCT00361335|58741710|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
30729012|NCT00361335|58741711|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
30729013|NCT00264550|58741731|FG000|Overall Study|Death|0|||
30729014|NCT00264550|58741732|FG001|Overall Study|Death|3|||
30729015|NCT00264550|58741733|FG002|Overall Study|Death|0|||
30729016|NCT00264550|58741734|FG003|Overall Study|Death|0|||
30729017|NCT00264550|58741731|FG000|Overall Study|Lost to Follow-up|3|||
30729018|NCT00264550|58741732|FG001|Overall Study|Lost to Follow-up|1|||
30729019|NCT00264550|58741733|FG002|Overall Study|Lost to Follow-up|1|||
30729020|NCT00264550|58741734|FG003|Overall Study|Lost to Follow-up|1|||
30729021|NCT00264550|58741731|FG000|Overall Study|Adverse Event|23|||
30729022|NCT00264550|58741732|FG001|Overall Study|Adverse Event|18|||
30729023|NCT00264550|58741733|FG002|Overall Study|Adverse Event|9|||
30729024|NCT00264550|58741734|FG003|Overall Study|Adverse Event|14|||
30729025|NCT00264550|58741731|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
30729026|NCT00264550|58741732|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
30729027|NCT00264550|58741733|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
30729028|NCT00264550|58741734|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
30729029|NCT00264550|58741731|FG000|Overall Study|Discontinued oral study agent|0|||
30729030|NCT00264550|58741732|FG001|Overall Study|Discontinued oral study agent|1|||
30729031|NCT00264550|58741733|FG002|Overall Study|Discontinued oral study agent|0|||
30729032|NCT00264550|58741734|FG003|Overall Study|Discontinued oral study agent|0|||
30729033|NCT00264550|58741731|FG000|Overall Study|Other|13|||
30729034|NCT00264550|58741732|FG001|Overall Study|Other|7|||
30729035|NCT00264550|58741733|FG002|Overall Study|Other|3|||
30729036|NCT00264550|58741734|FG003|Overall Study|Other|9|||
30729037|NCT00541931|58741746|FG000|Overall Study|Adverse Event|1|||
30729038|NCT00541931|58741747|FG001|Overall Study|Adverse Event|0|||
30729039|NCT00541931|58741746|FG000|Overall Study|Lost to Follow-up|3|||
30729040|NCT00541931|58741747|FG001|Overall Study|Lost to Follow-up|3|||
30729041|NCT00541931|58741746|FG000|Overall Study|Withdrawal by Subject|1|||
30729042|NCT00541931|58741747|FG001|Overall Study|Withdrawal by Subject|0|||
30729043|NCT00541931|58741746|FG000|Overall Study|Transportation Issue|0|||
30729044|NCT00541931|58741747|FG001|Overall Study|Transportation Issue|1|||
30729045|NCT00368979|58741757|FG000|Overall Study|Adverse Event|9|||
30729046|NCT00368979|58741758|FG001|Overall Study|Adverse Event|16|||
30729047|NCT00368979|58741757|FG000|Overall Study|Lack of Efficacy|5|||
30729048|NCT00368979|58741758|FG001|Overall Study|Lack of Efficacy|3|||
30729049|NCT00368979|58741757|FG000|Overall Study|Other|3|||
30729050|NCT00368979|58741758|FG001|Overall Study|Other|1|||
30729051|NCT00368979|58741757|FG000|Overall Study|Lost to Follow-up|1|||
30729052|NCT00368979|58741758|FG001|Overall Study|Lost to Follow-up|0|||
30729053|NCT00368979|58741757|FG000|Overall Study|Protocol Violation|2|||
30729054|NCT00368979|58741758|FG001|Overall Study|Protocol Violation|1|||
30729055|NCT00368979|58741757|FG000|Overall Study|Withdrawal by Subject|5|||
30729056|NCT00368979|58741758|FG001|Overall Study|Withdrawal by Subject|9|||
30729057|NCT00264238|58741764|FG000|Overall Study|Protocol Violation|1|||
30729058|NCT00540293|58741770|FG000|Overall Study|Adverse event related to study drug|10|||
30729059|NCT00540293|58741770|FG000|Overall Study|Adverse event not related to study drug|7|||
30729060|NCT00540293|58741770|FG000|Overall Study|Withdrawal by Subject|6|||
30729061|NCT00540293|58741770|FG000|Overall Study|Protocol violation, & subject schedule|12|||
30729062|NCT00359073|58741811|FG000|Overall Study|Withdrawal by Subject|1|||
30729063|NCT00359073|58741812|FG001|Overall Study|Withdrawal by Subject|1|||
30729064|NCT00359073|58741811|FG000|Overall Study|Eligibility criteria no longer met|3|||
30729065|NCT00359073|58741812|FG001|Overall Study|Eligibility criteria no longer met|0|||
30729066|NCT00359073|58741811|FG000|Overall Study|developed RV16 antibody|0|||
30729067|NCT00359073|58741812|FG001|Overall Study|developed RV16 antibody|1|||
30729068|NCT03918239|58741822|FG000|Overall Study|Lost to Follow-up|3|||
30729069|NCT03918239|58741823|FG001|Overall Study|Lost to Follow-up|1|||
30729070|NCT03918239|58741822|FG000|Overall Study|Pregnancy|0|||
30729071|NCT03918239|58741823|FG001|Overall Study|Pregnancy|2|||
30729072|NCT03918239|58741822|FG000|Overall Study|Withdrawal by Subject|3|||
30729073|NCT03918239|58741823|FG001|Overall Study|Withdrawal by Subject|3|||
30729074|NCT03918239|58741822|FG000|Overall Study|positive urine drug screening results|4|||
30729075|NCT03918239|58741823|FG001|Overall Study|positive urine drug screening results|1|||
30729076|NCT00368745|58741831|FG000|Double-blind Treatment Period|Adverse Event|6|||
30729077|NCT00368745|58741832|FG001|Double-blind Treatment Period|Adverse Event|6|||
30729078|NCT00368745|58741831|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
30729079|NCT00368745|58741832|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
30729080|NCT00368745|58741831|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
30729081|NCT00368745|58741832|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
30729082|NCT00368745|58741831|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
30729083|NCT00368745|58741832|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
30729084|NCT00368745|58741831|FG000|Double-blind Treatment Period|Other|7|||
30729085|NCT00368745|58741832|FG001|Double-blind Treatment Period|Other|6|||
30729086|NCT00454818|58741846|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
30729087|NCT00454818|58741847|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
30900476|NCT02354222|58933882|FG000|Overall Study|Withdrawal by Subject|2|||
30729088|NCT00454818|58741848|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
30729089|NCT00454818|58741849|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
30729090|NCT00454818|58741850|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
30729091|NCT00454818|58741846|FG000|Phase I: Open-label Dose-escalation|Death|0|||
30729092|NCT00454818|58741847|FG001|Phase I: Open-label Dose-escalation|Death|1|||
30729093|NCT00454818|58741848|FG002|Phase I: Open-label Dose-escalation|Death|0|||
30729094|NCT00454818|58741849|FG003|Phase I: Open-label Dose-escalation|Death|0|||
30729095|NCT00454818|58741850|FG004|Phase I: Open-label Dose-escalation|Death|0|||
30729096|NCT00454818|58741846|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
30729097|NCT00454818|58741847|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
30729098|NCT00454818|58741848|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
30729099|NCT00454818|58741849|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
30729100|NCT00454818|58741850|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
30729101|NCT00454818|58741846|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
30729102|NCT00454818|58741847|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
30729103|NCT00454818|58741848|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
30729104|NCT00454818|58741849|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
30729105|NCT00454818|58741850|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
30729106|NCT00454818|58741846|FG000|Phase 2: Randomized Double-blind|Death|0|||
30729107|NCT00454818|58741847|FG001|Phase 2: Randomized Double-blind|Death|1|||
30729108|NCT00454818|58741848|FG002|Phase 2: Randomized Double-blind|Death|0|||
30729109|NCT00454818|58741849|FG003|Phase 2: Randomized Double-blind|Death|0|||
30729110|NCT00454818|58741850|FG004|Phase 2: Randomized Double-blind|Death|1|||
30729111|NCT00454818|58741846|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
30729112|NCT00454818|58741847|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
30729113|NCT00454818|58741848|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
30729114|NCT00454818|58741849|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
30729115|NCT00454818|58741850|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
30729116|NCT00454818|58741846|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
30729117|NCT00454818|58741847|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
30729118|NCT00454818|58741848|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
30729119|NCT00454818|58741849|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
30729120|NCT00454818|58741850|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
30729121|NCT00445224|58741869|FG000|Specific Exercises|Withdrawal by Subject|3|||
30729122|NCT00445224|58741870|FG001|Specific Exercises|Withdrawal by Subject|3|||
30729123|NCT00445224|58741869|FG000|Specific Exercises|Withdrawal by Subject|1|||
30729124|NCT00445224|58741870|FG001|Specific Exercises|Withdrawal by Subject|0|||
30729125|NCT00358917|58741887|FG000|Overall Study|Adverse Event|14|||
30729126|NCT00358917|58741888|FG001|Overall Study|Adverse Event|21|||
30729127|NCT00358917|58741887|FG000|Overall Study|Withdrawal by Subject|5|||
30729128|NCT00358917|58741888|FG001|Overall Study|Withdrawal by Subject|7|||
30729129|NCT00358917|58741887|FG000|Overall Study|Lost to Follow-up|20|||
30729130|NCT00358917|58741888|FG001|Overall Study|Lost to Follow-up|17|||
30729131|NCT00358917|58741887|FG000|Overall Study|Noncompliance|12|||
30729132|NCT00358917|58741888|FG001|Overall Study|Noncompliance|11|||
30729133|NCT00358917|58741887|FG000|Overall Study|Death|2|||
30729134|NCT00358917|58741888|FG001|Overall Study|Death|3|||
30729135|NCT00358917|58741887|FG000|Overall Study|Virologic failure|11|||
30729136|NCT00358917|58741888|FG001|Overall Study|Virologic failure|8|||
30729137|NCT00358917|58741887|FG000|Overall Study|Unable to Continue Participation|2|||
30729138|NCT00358917|58741888|FG001|Overall Study|Unable to Continue Participation|2|||
30729139|NCT00264004|58741900|FG000|Overall Study|Adverse Event|2|||
30729140|NCT00264004|58741901|FG001|Overall Study|Adverse Event|3|||
30729141|NCT00264004|58741902|FG002|Overall Study|Adverse Event|6|||
30729142|NCT00264004|58741903|FG003|Overall Study|Adverse Event|4|||
30729143|NCT00264004|58741900|FG000|Overall Study|Withdrawal by Subject|0|||
30729144|NCT00264004|58741901|FG001|Overall Study|Withdrawal by Subject|1|||
30729145|NCT00264004|58741902|FG002|Overall Study|Withdrawal by Subject|2|||
30729146|NCT00264004|58741903|FG003|Overall Study|Withdrawal by Subject|2|||
30729147|NCT00264004|58741900|FG000|Overall Study|Other|2|||
30729148|NCT00264004|58741901|FG001|Overall Study|Other|2|||
30729149|NCT00264004|58741902|FG002|Overall Study|Other|0|||
30729150|NCT00264004|58741903|FG003|Overall Study|Other|3|||
30729151|NCT00264004|58741900|FG000|Overall Study|Development study specific disc. crit.|1|||
30729152|NCT00264004|58741901|FG001|Overall Study|Development study specific disc. crit.|0|||
30729153|NCT00264004|58741902|FG002|Overall Study|Development study specific disc. crit.|1|||
30729154|NCT00264004|58741903|FG003|Overall Study|Development study specific disc. crit.|0|||
30729155|NCT00264004|58741900|FG000|Overall Study|Cond. under inv. worsened|9|||
30729156|NCT00264004|58741901|FG001|Overall Study|Cond. under inv. worsened|5|||
30621724|NCT00975507|58633288|FG001|Overall Study|Withdrawal by Subject|3|||
30729157|NCT00264004|58741902|FG002|Overall Study|Cond. under inv. worsened|3|||
30729158|NCT00264004|58741903|FG003|Overall Study|Cond. under inv. worsened|4|||
30729159|NCT00264004|58741900|FG000|Overall Study|Not treated|3|||
30729160|NCT00264004|58741901|FG001|Overall Study|Not treated|0|||
30729161|NCT00264004|58741902|FG002|Overall Study|Not treated|2|||
30729162|NCT00264004|58741903|FG003|Overall Study|Not treated|2|||
30729163|NCT00368355|58741915|FG000|Overall Study|Adverse Event|1|||
30729164|NCT00368355|58741916|FG001|Overall Study|Adverse Event|0|||
30729165|NCT00368355|58741915|FG000|Overall Study|Death|2|||
30729166|NCT00368355|58741916|FG001|Overall Study|Death|4|||
30729167|NCT00368355|58741915|FG000|Overall Study|Relapse|6|||
30729168|NCT00368355|58741916|FG001|Overall Study|Relapse|10|||
30729169|NCT00368355|58741915|FG000|Overall Study|Subsequent transplant|0|||
30729170|NCT00368355|58741916|FG001|Overall Study|Subsequent transplant|3|||
30729171|NCT00368355|58741915|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
30729172|NCT00368355|58741916|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
30729173|NCT00445146|58741922|FG000|Overall Study|Withdrew Consent|29|||
30729174|NCT00445146|58741922|FG000|Overall Study|Lack of Efficacy|28|||
30729175|NCT00445146|58741922|FG000|Overall Study|Investigator's Discretion|22|||
30729176|NCT00445146|58741922|FG000|Overall Study|Adverse Event|13|||
30729177|NCT00445146|58741922|FG000|Overall Study|Lost to Follow-up|13|||
30729178|NCT00445146|58741922|FG000|Overall Study|Death|9|||
30729179|NCT00445146|58741922|FG000|Overall Study|Protocol Violation|4|||
30729180|NCT00445146|58741922|FG000|Overall Study|Pregnancy|1|||
30729181|NCT00368277|58741928|FG000|Overall Study|Adverse Event|33|||
30729182|NCT00368277|58741929|FG001|Overall Study|Adverse Event|49|||
30729183|NCT00368277|58741928|FG000|Overall Study|Death|2|||
30729184|NCT00368277|58741929|FG001|Overall Study|Death|1|||
30729185|NCT00368277|58741928|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
30729186|NCT00368277|58741929|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
30729187|NCT00368277|58741928|FG000|Overall Study|Protocol deviation|7|||
30729188|NCT00368277|58741929|FG001|Overall Study|Protocol deviation|0|||
30729189|NCT00368277|58741928|FG000|Overall Study|Patient withdrew consent|32|||
30729190|NCT00368277|58741929|FG001|Overall Study|Patient withdrew consent|28|||
30729191|NCT00368277|58741928|FG000|Overall Study|Lost to Follow-up|8|||
30621725|NCT01147848|58633298|FG000|Run-in Period|Screen Failure|623|||
30621726|NCT01147848|58633299|FG001|Run-in Period|Screen Failure|0|||
30621727|NCT01147848|58633300|FG002|Run-in Period|Screen Failure|0|||
30621728|NCT01147848|58633298|FG000|Run-in Period|Run-in Failure|135|||
30729192|NCT00368277|58741929|FG001|Overall Study|Lost to Follow-up|6|||
30729193|NCT00280150|58741939|FG000|Overall Study|Adverse Event|0|||
30729194|NCT00280150|58741940|FG001|Overall Study|Adverse Event|1|||
30729195|NCT00280150|58741941|FG002|Overall Study|Adverse Event|2|||
30729196|NCT00280150|58741942|FG003|Overall Study|Adverse Event|3|||
30729197|NCT00280150|58741939|FG000|Overall Study|Lack of Efficacy|0|||
30729198|NCT00280150|58741940|FG001|Overall Study|Lack of Efficacy|0|||
30729199|NCT00280150|58741941|FG002|Overall Study|Lack of Efficacy|0|||
30729200|NCT00280150|58741942|FG003|Overall Study|Lack of Efficacy|3|||
30729201|NCT00280150|58741939|FG000|Overall Study|Physician Decision|0|||
30729202|NCT00280150|58741940|FG001|Overall Study|Physician Decision|0|||
30729203|NCT00280150|58741941|FG002|Overall Study|Physician Decision|0|||
30729204|NCT00280150|58741942|FG003|Overall Study|Physician Decision|1|||
30729205|NCT00280150|58741939|FG000|Overall Study|Protocol Violation|0|||
30729206|NCT00280150|58741940|FG001|Overall Study|Protocol Violation|0|||
30729207|NCT00280150|58741941|FG002|Overall Study|Protocol Violation|0|||
30729208|NCT00280150|58741942|FG003|Overall Study|Protocol Violation|1|||
30729209|NCT00280150|58741939|FG000|Overall Study|Withdrawal by Subject|0|||
30729210|NCT00280150|58741940|FG001|Overall Study|Withdrawal by Subject|0|||
30729211|NCT00280150|58741941|FG002|Overall Study|Withdrawal by Subject|0|||
30729212|NCT00280150|58741942|FG003|Overall Study|Withdrawal by Subject|1|||
30729213|NCT00280150|58741939|FG000|Overall Study|Did not get consolidation therapy|3|||
30729214|NCT00280150|58741940|FG001|Overall Study|Did not get consolidation therapy|0|||
30729215|NCT00280150|58741941|FG002|Overall Study|Did not get consolidation therapy|3|||
30729216|NCT00280150|58741942|FG003|Overall Study|Did not get consolidation therapy|0|||
30729217|NCT00280150|58741939|FG000|Overall Study|Declining Performance Status|0|||
30729218|NCT00280150|58741940|FG001|Overall Study|Declining Performance Status|0|||
30729219|NCT00280150|58741941|FG002|Overall Study|Declining Performance Status|0|||
30729220|NCT00280150|58741942|FG003|Overall Study|Declining Performance Status|1|||
30729221|NCT00279916|58741955|FG000|Overall Study|Withdrawal by Subject|4|||
30729222|NCT00279916|58741956|FG001|Overall Study|Withdrawal by Subject|3|||
30729223|NCT00279916|58741955|FG000|Overall Study|Lost to Follow-up|3|||
30729224|NCT00279916|58741956|FG001|Overall Study|Lost to Follow-up|2|||
30729225|NCT00358527|58741964|FG000|Overall Study|Adverse Event|4|||
30729226|NCT00358527|58741965|FG001|Overall Study|Adverse Event|0|||
30729227|NCT00358527|58741964|FG000|Overall Study|Withdrawal by Subject|1|||
30729228|NCT00358527|58741965|FG001|Overall Study|Withdrawal by Subject|1|||
30729229|NCT00358527|58741964|FG000|Overall Study|Non-compliance with protocol|6|||
30729230|NCT00358527|58741965|FG001|Overall Study|Non-compliance with protocol|1|||
30729231|NCT00358527|58741964|FG000|Overall Study|Administrative|2|||
30729232|NCT00358527|58741965|FG001|Overall Study|Administrative|1|||
30621729|NCT01147848|58633299|FG001|Run-in Period|Run-in Failure|0|||
30621730|NCT01147848|58633300|FG002|Run-in Period|Run-in Failure|0|||
30621731|NCT01147848|58633298|FG000|Randomized Phase|Adverse Event|0|||
30729233|NCT00251758|58741974|FG000|Overall Study|Adverse Event|7|||
30729234|NCT00251758|58741975|FG001|Overall Study|Adverse Event|9|||
30729235|NCT00251758|58741976|FG002|Overall Study|Adverse Event|11|||
30729236|NCT00251758|58741974|FG000|Overall Study|Lost to Follow-up|4|||
30729237|NCT00251758|58741975|FG001|Overall Study|Lost to Follow-up|2|||
30729238|NCT00251758|58741976|FG002|Overall Study|Lost to Follow-up|5|||
30729239|NCT00251758|58741974|FG000|Overall Study|Withdrawal by Subject|13|||
30729240|NCT00251758|58741975|FG001|Overall Study|Withdrawal by Subject|7|||
30729241|NCT00251758|58741976|FG002|Overall Study|Withdrawal by Subject|3|||
30729242|NCT00251758|58741974|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
30729243|NCT00251758|58741975|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
30729244|NCT00251758|58741976|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
30729245|NCT00251758|58741974|FG000|Overall Study|Lack of Efficacy|3|||
30729246|NCT00251758|58741975|FG001|Overall Study|Lack of Efficacy|0|||
30729247|NCT00251758|58741976|FG002|Overall Study|Lack of Efficacy|0|||
30729248|NCT00251758|58741974|FG000|Overall Study|Noncompliant|0|||
30729249|NCT00251758|58741975|FG001|Overall Study|Noncompliant|2|||
30729250|NCT00251758|58741976|FG002|Overall Study|Noncompliant|2|||
30729251|NCT00251758|58741974|FG000|Overall Study|Pregnancy|0|||
30729252|NCT00251758|58741975|FG001|Overall Study|Pregnancy|1|||
30729253|NCT00251758|58741976|FG002|Overall Study|Pregnancy|0|||
30729254|NCT00251758|58741974|FG000|Overall Study|Per Subject Request|0|||
30729255|NCT00251758|58741975|FG001|Overall Study|Per Subject Request|0|||
30729256|NCT00251758|58741976|FG002|Overall Study|Per Subject Request|1|||
30729257|NCT00251758|58741974|FG000|Overall Study|Per Investigator Request|1|||
30729258|NCT00251758|58741975|FG001|Overall Study|Per Investigator Request|0|||
30729259|NCT00251758|58741976|FG002|Overall Study|Per Investigator Request|0|||
30729260|NCT00279214|58741986|FG000|Overall Study|Physician Decision|3|||
30729261|NCT00279214|58741987|FG001|Overall Study|Physician Decision|2|||
30729262|NCT00262834|58741995|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
30729263|NCT00262834|58741996|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
30729264|NCT00541775|58742009|FG000|Overall Study|Adverse Event|3|||
30729265|NCT00541775|58742010|FG001|Overall Study|Adverse Event|2|||
30729266|NCT00541775|58742011|FG002|Overall Study|Adverse Event|1|||
30729267|NCT00541775|58742009|FG000|Overall Study|Lack of Efficacy|0|||
30729268|NCT00541775|58742010|FG001|Overall Study|Lack of Efficacy|0|||
30729269|NCT00541775|58742011|FG002|Overall Study|Lack of Efficacy|3|||
30729270|NCT00541775|58742009|FG000|Overall Study|Lost to Follow-up|0|||
30729271|NCT00541775|58742010|FG001|Overall Study|Lost to Follow-up|0|||
30729272|NCT00541775|58742011|FG002|Overall Study|Lost to Follow-up|2|||
30729273|NCT00541775|58742009|FG000|Overall Study|Protocol Violation|1|||
30729274|NCT00541775|58742010|FG001|Overall Study|Protocol Violation|0|||
30729275|NCT00541775|58742011|FG002|Overall Study|Protocol Violation|0|||
30729276|NCT00541775|58742009|FG000|Overall Study|Withdrawal by Subject and Other|5|||
30729277|NCT00541775|58742010|FG001|Overall Study|Withdrawal by Subject and Other|0|||
30729278|NCT00541775|58742011|FG002|Overall Study|Withdrawal by Subject and Other|2|||
30729279|NCT00539513|58742021|FG000|Overall Study|Withdrawal by Subject|2|||
30729280|NCT00539513|58742022|FG001|Overall Study|Withdrawal by Subject|1|||
30729281|NCT00539513|58742021|FG000|Overall Study|Lost to Follow-up|0|||
30729282|NCT00539513|58742022|FG001|Overall Study|Lost to Follow-up|1|||
30729283|NCT00454584|58742031|FG000|Controlled Period|Adverse Event|5|||
30729284|NCT00454584|58742032|FG001|Controlled Period|Adverse Event|2|||
30729285|NCT00454584|58742033|FG002|Controlled Period|Adverse Event|1|||
30729286|NCT00454584|58742034|FG003|Controlled Period|Adverse Event|0|||
30729287|NCT00454584|58742035|FG004|Controlled Period|Adverse Event|0|||
30729288|NCT00454584|58742036|FG005|Controlled Period|Adverse Event|0|||
30729289|NCT00454584|58742031|FG000|Controlled Period|Lost to Follow-up|1|||
30729290|NCT00454584|58742032|FG001|Controlled Period|Lost to Follow-up|2|||
30729291|NCT00454584|58742033|FG002|Controlled Period|Lost to Follow-up|2|||
30729292|NCT00454584|58742034|FG003|Controlled Period|Lost to Follow-up|0|||
30729293|NCT00454584|58742035|FG004|Controlled Period|Lost to Follow-up|0|||
30729294|NCT00454584|58742036|FG005|Controlled Period|Lost to Follow-up|0|||
30729295|NCT00454584|58742031|FG000|Controlled Period|Other|5|||
30729296|NCT00454584|58742032|FG001|Controlled Period|Other|4|||
30729297|NCT00454584|58742033|FG002|Controlled Period|Other|2|||
30729298|NCT00454584|58742034|FG003|Controlled Period|Other|0|||
30729299|NCT00454584|58742035|FG004|Controlled Period|Other|0|||
30729300|NCT00454584|58742036|FG005|Controlled Period|Other|0|||
30729301|NCT00454584|58742031|FG000|After Controlled Period|Adverse Event|0|||
30729302|NCT00454584|58742032|FG001|After Controlled Period|Adverse Event|0|||
30729303|NCT00454584|58742033|FG002|After Controlled Period|Adverse Event|0|||
30729304|NCT00454584|58742034|FG003|After Controlled Period|Adverse Event|9|||
30729305|NCT00454584|58742035|FG004|After Controlled Period|Adverse Event|3|||
30729306|NCT00454584|58742036|FG005|After Controlled Period|Adverse Event|9|||
30729307|NCT00454584|58742031|FG000|After Controlled Period|Lack of Efficacy|0|||
30729308|NCT00454584|58742032|FG001|After Controlled Period|Lack of Efficacy|0|||
30729309|NCT00454584|58742033|FG002|After Controlled Period|Lack of Efficacy|0|||
30729310|NCT00454584|58742034|FG003|After Controlled Period|Lack of Efficacy|1|||
30729311|NCT00454584|58742035|FG004|After Controlled Period|Lack of Efficacy|0|||
30729312|NCT00454584|58742036|FG005|After Controlled Period|Lack of Efficacy|0|||
30729313|NCT00454584|58742031|FG000|After Controlled Period|Lost to Follow-up|0|||
30729314|NCT00454584|58742032|FG001|After Controlled Period|Lost to Follow-up|0|||
30729315|NCT00454584|58742033|FG002|After Controlled Period|Lost to Follow-up|0|||
30729316|NCT00454584|58742034|FG003|After Controlled Period|Lost to Follow-up|2|||
30729317|NCT00454584|58742035|FG004|After Controlled Period|Lost to Follow-up|4|||
30729318|NCT00454584|58742036|FG005|After Controlled Period|Lost to Follow-up|6|||
30729319|NCT00454584|58742031|FG000|After Controlled Period|Other|0|||
30729320|NCT00454584|58742032|FG001|After Controlled Period|Other|0|||
30729321|NCT00454584|58742033|FG002|After Controlled Period|Other|0|||
30729322|NCT00454584|58742034|FG003|After Controlled Period|Other|1|||
30729323|NCT00454584|58742035|FG004|After Controlled Period|Other|0|||
30729324|NCT00454584|58742036|FG005|After Controlled Period|Other|0|||
30729325|NCT00454584|58742031|FG000|After Controlled Period|Other|0|||
30729326|NCT00454584|58742032|FG001|After Controlled Period|Other|0|||
30729327|NCT00454584|58742033|FG002|After Controlled Period|Other|0|||
30729328|NCT00454584|58742034|FG003|After Controlled Period|Other|13|||
30729329|NCT00454584|58742035|FG004|After Controlled Period|Other|5|||
30729330|NCT00454584|58742036|FG005|After Controlled Period|Other|17|||
30729331|NCT00445068|58742050|FG000|Overall Study|Disease progression|26|||
30729332|NCT00445068|58742050|FG000|Overall Study|Adverse Event|5|||
30729333|NCT00445068|58742050|FG000|Overall Study|Abnormal laboratory value|2|||
30729334|NCT00445068|58742050|FG000|Overall Study|Withdrawal by Subject|2|||
30729335|NCT00445068|58742050|FG000|Overall Study|Death|1|||
30729336|NCT00539279|58742056|FG000|Treatment|Withdrawal by Subject|10|||
30729337|NCT00539279|58742057|FG001|Treatment|Withdrawal by Subject|8|||
30729338|NCT00539279|58742056|FG000|Treatment|Death|1|||
30729339|NCT00539279|58742057|FG001|Treatment|Death|0|||
30729340|NCT00539279|58742056|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
30729341|NCT00539279|58742057|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
30729342|NCT00539279|58742056|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
30729343|NCT00539279|58742057|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
30729344|NCT00444912|58742065|FG000|Overall Study|Death|1|||
30729345|NCT00444912|58742066|FG001|Overall Study|Death|2|||
30729346|NCT00444912|58742065|FG000|Overall Study|Lost to Follow-up|1|||
30729347|NCT00444912|58742066|FG001|Overall Study|Lost to Follow-up|0|||
30729348|NCT00444912|58742065|FG000|Overall Study|Participant Failed Mobilization|1|||
30729349|NCT00444912|58742066|FG001|Overall Study|Participant Failed Mobilization|0|||
30729350|NCT00538733|58742072|FG000|Overall Study|Adverse Event|8|||
30729351|NCT00538733|58742072|FG000|Overall Study|Death|1|||
30729352|NCT00538733|58742072|FG000|Overall Study|declined to participate|2|||
30729353|NCT00538733|58742072|FG000|Overall Study|still on therapy|1|||
30729354|NCT00444678|58742079|FG000|Overall Study|Toxicity|11|||
30729355|NCT00444678|58742079|FG000|Overall Study|Disease Progression|12|||
30621732|NCT01147848|58633299|FG001|Randomized Phase|Adverse Event|6|||
30621733|NCT01147848|58633300|FG002|Randomized Phase|Adverse Event|8|||
30621734|NCT01147848|58633298|FG000|Randomized Phase|Lack of Efficacy|0|||
30621735|NCT01147848|58633299|FG001|Randomized Phase|Lack of Efficacy|20|||
30621736|NCT01147848|58633300|FG002|Randomized Phase|Lack of Efficacy|11|||
30729356|NCT00444678|58742079|FG000|Overall Study|Death|3|||
30729357|NCT00444678|58742079|FG000|Overall Study|Physician Decision|3|||
30729358|NCT00444678|58742079|FG000|Overall Study|Withdrawal by Subject|2|||
30729359|NCT00358449|58742086|FG000|Overall Study|Adverse Event|1|||
30729360|NCT00358449|58742087|FG001|Overall Study|Adverse Event|0|||
30729361|NCT00358449|58742088|FG002|Overall Study|Adverse Event|1|||
30729362|NCT00358449|58742086|FG000|Overall Study|Lost to Follow-up|1|||
30729363|NCT00358449|58742087|FG001|Overall Study|Lost to Follow-up|0|||
30729364|NCT00358449|58742088|FG002|Overall Study|Lost to Follow-up|0|||
30729365|NCT00358449|58742086|FG000|Overall Study|Withdrawal by Subject|2|||
30729366|NCT00358449|58742087|FG001|Overall Study|Withdrawal by Subject|0|||
30729367|NCT00358449|58742088|FG002|Overall Study|Withdrawal by Subject|0|||
30729368|NCT00358449|58742086|FG000|Overall Study|Lack of Efficacy|0|||
30729369|NCT00358449|58742087|FG001|Overall Study|Lack of Efficacy|1|||
30729370|NCT00358449|58742088|FG002|Overall Study|Lack of Efficacy|0|||
30729371|NCT00358449|58742086|FG000|Overall Study|Steriod Inhaler was Increased|0|||
30729372|NCT00358449|58742087|FG001|Overall Study|Steriod Inhaler was Increased|0|||
30729373|NCT00358449|58742088|FG002|Overall Study|Steriod Inhaler was Increased|1|||
30729374|NCT00539981|58742100|FG000|Overall Study|Adverse events (AE)|3|||
30729375|NCT00539981|58742101|FG001|Overall Study|Adverse events (AE)|3|||
30729376|NCT00539981|58742100|FG000|Overall Study|Lost to Follow-up|260|||
30729377|NCT00539981|58742101|FG001|Overall Study|Lost to Follow-up|251|||
30729378|NCT00539981|58742100|FG000|Overall Study|Withdrew consent|22|||
30729379|NCT00539981|58742101|FG001|Overall Study|Withdrew consent|14|||
30729380|NCT00539981|58742100|FG000|Overall Study|Death|1|||
30729381|NCT00539981|58742101|FG001|Overall Study|Death|1|||
30729382|NCT00539981|58742100|FG000|Overall Study|Other reason-unspecified|9|||
30729383|NCT00539981|58742101|FG001|Overall Study|Other reason-unspecified|13|||
30729384|NCT00367341|58742112|FG000|Overall Study|Physician Decision|1|||
30729385|NCT00367341|58742113|FG001|Overall Study|Physician Decision|0|||
30729386|NCT00367341|58742112|FG000|Overall Study|Protocol Violation|1|||
30729387|NCT00367341|58742113|FG001|Overall Study|Protocol Violation|0|||
30729388|NCT00440466|58742122|FG000|Overall Study|Death|3|||
30729389|NCT00440466|58742123|FG001|Overall Study|Death|2|||
30729390|NCT00440466|58742124|FG002|Overall Study|Death|9|||
30729391|NCT00440466|58742122|FG000|Overall Study|Adverse Event|3|||
30729392|NCT00440466|58742123|FG001|Overall Study|Adverse Event|4|||
30729393|NCT00440466|58742124|FG002|Overall Study|Adverse Event|11|||
30729394|NCT00440466|58742122|FG000|Overall Study|Lost to Follow-up|1|||
30729395|NCT00440466|58742123|FG001|Overall Study|Lost to Follow-up|0|||
30729396|NCT00440466|58742124|FG002|Overall Study|Lost to Follow-up|2|||
30729397|NCT00440466|58742122|FG000|Overall Study|Physician Decision|2|||
30729398|NCT00440466|58742123|FG001|Overall Study|Physician Decision|0|||
30729399|NCT00440466|58742124|FG002|Overall Study|Physician Decision|1|||
30729400|NCT00440466|58742122|FG000|Overall Study|Protocol Violation|2|||
30729401|NCT00440466|58742123|FG001|Overall Study|Protocol Violation|0|||
30729402|NCT00440466|58742124|FG002|Overall Study|Protocol Violation|4|||
30729403|NCT00440466|58742122|FG000|Overall Study|Withdrawal by Subject|2|||
30729404|NCT00440466|58742123|FG001|Overall Study|Withdrawal by Subject|5|||
30729405|NCT00440466|58742124|FG002|Overall Study|Withdrawal by Subject|9|||
30729406|NCT00440466|58742122|FG000|Overall Study|Began Dialysis|0|||
30621737|NCT01147848|58633298|FG000|Randomized Phase|Protocol Violation|0|||
30621738|NCT01147848|58633299|FG001|Randomized Phase|Protocol Violation|7|||
30729407|NCT00440466|58742123|FG001|Overall Study|Began Dialysis|0|||
30729408|NCT00440466|58742124|FG002|Overall Study|Began Dialysis|1|||
30729409|NCT00440466|58742122|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
30729410|NCT00440466|58742123|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
30729411|NCT00440466|58742124|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
30729412|NCT00537485|58742156|FG000|Overall Study|Adverse Event|10|||
30729413|NCT00537485|58742157|FG001|Overall Study|Adverse Event|5|||
30729414|NCT00537485|58742156|FG000|Overall Study|Withdrawal by Subject|3|||
30729415|NCT00537485|58742157|FG001|Overall Study|Withdrawal by Subject|2|||
30729416|NCT00537485|58742156|FG000|Overall Study|Withdrawal by Subject|1|||
30729417|NCT00537485|58742157|FG001|Overall Study|Withdrawal by Subject|3|||
30729418|NCT00537485|58742156|FG000|Overall Study|Physician Decision|1|||
30729419|NCT00537485|58742157|FG001|Overall Study|Physician Decision|0|||
30729420|NCT00616967|58742165|FG000|Overall Study|Withdrawal by Subject|0|||
30729421|NCT00616967|58742166|FG001|Overall Study|Withdrawal by Subject|0|||
30729422|NCT00616967|58742167|FG002|Overall Study|Withdrawal by Subject|1|||
30729423|NCT00537329|58742185|FG000|Overall Study|Death|10|||
30729424|NCT00537329|58742185|FG000|Overall Study|Adverse Event|3|||
30729425|NCT00537329|58742185|FG000|Overall Study|Lack of Efficacy|2|||
30729426|NCT00537329|58742185|FG000|Overall Study|Lost to Follow-up|6|||
30729427|NCT00537329|58742185|FG000|Overall Study|Withdrawal by Subject|4|||
30729428|NCT00537329|58742185|FG000|Overall Study|Other|1|||
30729429|NCT03897179|58742189|FG000|Overall Study|Withdrawal by Subject|1|||
30729430|NCT03905135|58742195|FG000|Dose Escalation|Adverse Event|1|||
30729431|NCT03905135|58742196|FG001|Dose Escalation|Adverse Event|1|||
30729432|NCT03905135|58742195|FG000|Dose Escalation|Progressive disease|3|||
30729433|NCT03905135|58742196|FG001|Dose Escalation|Progressive disease|1|||
30729434|NCT03905135|58742195|FG000|Dose Escalation|Intercurrent illness|1|||
30729435|NCT03905135|58742196|FG001|Dose Escalation|Intercurrent illness|0|||
30729436|NCT00357903|58742206|FG000|Overall Study|Adverse Event|87|||
30729437|NCT00357903|58742207|FG001|Overall Study|Adverse Event|4|||
30729438|NCT00357903|58742206|FG000|Overall Study|Death|33|||
30729439|NCT00357903|58742207|FG001|Overall Study|Death|0|||
30729440|NCT00357903|58742206|FG000|Overall Study|Lost to Follow-up|23|||
30729441|NCT00357903|58742207|FG001|Overall Study|Lost to Follow-up|4|||
30729442|NCT00357903|58742206|FG000|Overall Study|Physician Decision|39|||
30729443|NCT00357903|58742207|FG001|Overall Study|Physician Decision|5|||
30729444|NCT00357903|58742206|FG000|Overall Study|Withdrawal by Subject|57|||
30729445|NCT00357903|58742207|FG001|Overall Study|Withdrawal by Subject|7|||
30729446|NCT00357903|58742206|FG000|Overall Study|Completed month 12 only|0|||
30729447|NCT00357903|58742207|FG001|Overall Study|Completed month 12 only|1|||
30729448|NCT00357903|58742206|FG000|Overall Study|Protocol issues|14|||
30729449|NCT00357903|58742207|FG001|Overall Study|Protocol issues|3|||
30729450|NCT00357903|58742206|FG000|Overall Study|Response status|61|||
30729451|NCT00357903|58742207|FG001|Overall Study|Response status|9|||
30729452|NCT00357903|58742206|FG000|Overall Study|Other|49|||
30729453|NCT00357903|58742207|FG001|Overall Study|Other|10|||
30729454|NCT00348933|58742214|FG000|Overall Study|Withdrawal by Subject|10|||
30729455|NCT00348933|58742214|FG000|Overall Study|Lost to Follow-up|6|||
30729456|NCT00348933|58742214|FG000|Overall Study|Protocol Violation|2|||
30729457|NCT00348933|58742214|FG000|Overall Study|Adverse Event|7|||
30729458|NCT03896477|58742222|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
30729459|NCT03896477|58742223|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
30729460|NCT03896477|58742224|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
30729461|NCT03896477|58742222|FG000|Overall Study|Parent Requested Withdrawal|8|||
30729462|NCT03896477|58742223|FG001|Overall Study|Parent Requested Withdrawal|12|||
30729463|NCT03896477|58742224|FG002|Overall Study|Parent Requested Withdrawal|9|||
30729464|NCT03896477|58742222|FG000|Overall Study|Adverse Event|0|||
30729465|NCT03896477|58742223|FG001|Overall Study|Adverse Event|0|||
30729466|NCT03896477|58742224|FG002|Overall Study|Adverse Event|1|||
30729467|NCT03896477|58742222|FG000|Overall Study|Death|1|||
30729468|NCT03896477|58742223|FG001|Overall Study|Death|0|||
30729469|NCT03896477|58742224|FG002|Overall Study|Death|0|||
30729470|NCT03896477|58742222|FG000|Overall Study|Other|5|||
30729471|NCT03896477|58742223|FG001|Overall Study|Other|6|||
30729472|NCT03896477|58742224|FG002|Overall Study|Other|7|||
30729473|NCT03896477|58742222|FG000|Overall Study|Lost to Follow-up|2|||
30729474|NCT03896477|58742223|FG001|Overall Study|Lost to Follow-up|1|||
30729475|NCT03896477|58742224|FG002|Overall Study|Lost to Follow-up|1|||
30729476|NCT00444600|58742239|FG000|Overall Study|Death|7|||
30729477|NCT00444600|58742240|FG001|Overall Study|Death|5|||
30729478|NCT00444600|58742241|FG002|Overall Study|Death|3|||
30729479|NCT00444600|58742242|FG003|Overall Study|Death|2|||
30729480|NCT00444600|58742239|FG000|Overall Study|Dropped|11|||
30729481|NCT00444600|58742240|FG001|Overall Study|Dropped|11|||
30729482|NCT00444600|58742241|FG002|Overall Study|Dropped|7|||
30729483|NCT00444600|58742242|FG003|Overall Study|Dropped|7|||
30729484|NCT00444600|58742239|FG000|Overall Study|Missed visit|1|||
30729485|NCT00444600|58742240|FG001|Overall Study|Missed visit|0|||
30729486|NCT00444600|58742241|FG002|Overall Study|Missed visit|0|||
30729487|NCT00444600|58742242|FG003|Overall Study|Missed visit|1|||
30729488|NCT00537095|58742260|FG000|Overall Study|surgery|1|||
30729489|NCT00537095|58742261|FG001|Overall Study|surgery|0|||
30729490|NCT00537095|58742260|FG000|Overall Study|Adverse Event|24|||
30729491|NCT00537095|58742261|FG001|Overall Study|Adverse Event|4|||
30729492|NCT00537095|58742260|FG000|Overall Study|disease progression|21|||
30729493|NCT00537095|58742261|FG001|Overall Study|disease progression|48|||
30729494|NCT00537095|58742260|FG000|Overall Study|Death|3|||
30729495|NCT00537095|58742261|FG001|Overall Study|Death|1|||
30729496|NCT00537095|58742260|FG000|Overall Study|Withdrawal by Subject|2|||
30729497|NCT00537095|58742261|FG001|Overall Study|Withdrawal by Subject|2|||
30729498|NCT00537095|58742260|FG000|Overall Study|subjective disease progression|0|||
30729499|NCT00537095|58742261|FG001|Overall Study|subjective disease progression|1|||
30729500|NCT00537095|58742260|FG000|Overall Study|Incorrect enrolment|0|||
30729501|NCT00537095|58742261|FG001|Overall Study|Incorrect enrolment|1|||
30729502|NCT00443898|58742271|FG000|Overall Study|Adverse Event|0|||
30729503|NCT00443898|58742272|FG001|Overall Study|Adverse Event|0|||
30729504|NCT00443898|58742273|FG002|Overall Study|Adverse Event|1|||
30729505|NCT00443898|58742274|FG003|Overall Study|Adverse Event|1|||
30729506|NCT00443898|58742271|FG000|Overall Study|Lack of Efficacy|2|||
30729507|NCT00443898|58742272|FG001|Overall Study|Lack of Efficacy|3|||
30729508|NCT00443898|58742273|FG002|Overall Study|Lack of Efficacy|3|||
30729509|NCT00443898|58742274|FG003|Overall Study|Lack of Efficacy|1|||
30729510|NCT00443898|58742271|FG000|Overall Study|Protocol Violation|1|||
30729511|NCT00443898|58742272|FG001|Overall Study|Protocol Violation|1|||
30729512|NCT00443898|58742273|FG002|Overall Study|Protocol Violation|1|||
30729513|NCT00443898|58742274|FG003|Overall Study|Protocol Violation|0|||
30729514|NCT00443898|58742271|FG000|Overall Study|Withdrawal by Subject|11|||
30729515|NCT00443898|58742272|FG001|Overall Study|Withdrawal by Subject|10|||
30729516|NCT00443898|58742273|FG002|Overall Study|Withdrawal by Subject|10|||
30729517|NCT00443898|58742274|FG003|Overall Study|Withdrawal by Subject|6|||
30729518|NCT00443898|58742271|FG000|Overall Study|Lost to Follow-up|10|||
30729519|NCT00443898|58742272|FG001|Overall Study|Lost to Follow-up|10|||
30729520|NCT00443898|58742273|FG002|Overall Study|Lost to Follow-up|14|||
30729521|NCT00443898|58742274|FG003|Overall Study|Lost to Follow-up|10|||
30729522|NCT00443898|58742271|FG000|Overall Study|Death|0|||
30729523|NCT00443898|58742272|FG001|Overall Study|Death|1|||
30729524|NCT00443898|58742273|FG002|Overall Study|Death|0|||
30729525|NCT00443898|58742274|FG003|Overall Study|Death|0|||
30729526|NCT00537017|58742284|FG000|Treatment Phase|Adverse Event|19|||
30729527|NCT00537017|58742284|FG000|Treatment Phase|Withdrawal by Subject|13|||
30729528|NCT00537017|58742284|FG000|Treatment Phase|Protocol Violation|2|||
30729529|NCT00537017|58742284|FG000|Follow-up Phase|Withdrawal by Subject|9|||
30760639|NCT02971683|58769138|FG001|Overall Study|Participant request to discontinue study treatment|1|||
30760640|NCT02971683|58769137|FG000|Overall Study|Adverse Event|1|||
30760641|NCT02971683|58769138|FG001|Overall Study|Adverse Event|2|||
30760642|NCT02971683|58769137|FG000|Overall Study|Lack of Efficacy|2|||
30760643|NCT02971683|58769138|FG001|Overall Study|Lack of Efficacy|2|||
30760644|NCT02949219|58769144|FG000|Overall Study|Withdrawal by Subject|1|||
30760645|NCT02899299|58769150|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
30760646|NCT02899299|58769151|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
30760647|NCT02899299|58769150|FG000|Pre-treatment|Participant withdrew consent|1|||
30760648|NCT02899299|58769151|FG001|Pre-treatment|Participant withdrew consent|11|||
30760649|NCT02899299|58769150|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
30760650|NCT02899299|58769151|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
30760651|NCT02899299|58769150|FG000|Pre-treatment|Not reported|0|||
30760652|NCT02899299|58769151|FG001|Pre-treatment|Not reported|1|||
30760653|NCT02899299|58769150|FG000|Treatment|Disease Progression|182|||
30760654|NCT02899299|58769151|FG001|Treatment|Disease Progression|44|||
30760655|NCT02899299|58769150|FG000|Treatment|Study Drug Toxicity|59|||
30760656|NCT02899299|58769151|FG001|Treatment|Study Drug Toxicity|24|||
30760657|NCT02899299|58769150|FG000|Treatment|Adverse Event unrelated to Study Drug|12|||
30760658|NCT02899299|58769151|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
30760659|NCT02899299|58769150|FG000|Treatment|Participant request to discontinue Study treatment|4|||
30760660|NCT02899299|58769151|FG001|Treatment|Participant request to discontinue Study treatment|10|||
30760661|NCT02899299|58769150|FG000|Treatment|Participant withdrew consent|6|||
30760662|NCT02899299|58769151|FG001|Treatment|Participant withdrew consent|3|||
30621739|NCT01147848|58633300|FG002|Randomized Phase|Protocol Violation|10|||
30760663|NCT02899299|58769150|FG000|Treatment|Lost to Follow-up|0|||
30760664|NCT02899299|58769151|FG001|Treatment|Lost to Follow-up|1|||
30760665|NCT02899299|58769150|FG000|Treatment|Maximum Clinical Benefit|10|||
30760666|NCT02899299|58769151|FG001|Treatment|Maximum Clinical Benefit|2|||
30760667|NCT02899299|58769150|FG000|Treatment|Poor/Non-compliance|1|||
30760668|NCT02899299|58769151|FG001|Treatment|Poor/Non-compliance|0|||
30760669|NCT02899299|58769150|FG000|Treatment|Participant no longer meets Study criteria|4|||
30760670|NCT02899299|58769151|FG001|Treatment|Participant no longer meets Study criteria|0|||
30760671|NCT02899299|58769150|FG000|Treatment|Administrative reason by Sponsor|2|||
30760672|NCT02899299|58769151|FG001|Treatment|Administrative reason by Sponsor|0|||
30760673|NCT02899299|58769150|FG000|Treatment|Other reasons|11|||
30760674|NCT02899299|58769151|FG001|Treatment|Other reasons|2|||
30760675|NCT02899299|58769150|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4|||
30729530|NCT00348309|58742291|FG000|Overall Study|Adverse Event|56|||
30729531|NCT00348309|58742292|FG001|Overall Study|Adverse Event|28|||
30729532|NCT00348309|58742293|FG002|Overall Study|Adverse Event|63|||
30729533|NCT00348309|58742291|FG000|Overall Study|Lost to Follow-up|6|||
30729534|NCT00348309|58742292|FG001|Overall Study|Lost to Follow-up|7|||
30729535|NCT00348309|58742293|FG002|Overall Study|Lost to Follow-up|4|||
30729536|NCT00348309|58742291|FG000|Overall Study|Protocol Violation|7|||
30729537|NCT00348309|58742292|FG001|Overall Study|Protocol Violation|12|||
30729538|NCT00348309|58742293|FG002|Overall Study|Protocol Violation|7|||
30729539|NCT00348309|58742291|FG000|Overall Study|Withdrawal by Subject|33|||
30729540|NCT00348309|58742292|FG001|Overall Study|Withdrawal by Subject|37|||
30729541|NCT00348309|58742293|FG002|Overall Study|Withdrawal by Subject|40|||
30729542|NCT00348309|58742291|FG000|Overall Study|Non-compliance|8|||
30729543|NCT00348309|58742292|FG001|Overall Study|Non-compliance|6|||
30729544|NCT00348309|58742293|FG002|Overall Study|Non-compliance|8|||
30729545|NCT00348309|58742291|FG000|Overall Study|Death of caregiver|1|||
30729546|NCT00348309|58742292|FG001|Overall Study|Death of caregiver|0|||
30729547|NCT00348309|58742293|FG002|Overall Study|Death of caregiver|1|||
30729548|NCT00348309|58742291|FG000|Overall Study|Lack of insight, dementia|1|||
30729549|NCT00348309|58742292|FG001|Overall Study|Lack of insight, dementia|0|||
30729550|NCT00348309|58742293|FG002|Overall Study|Lack of insight, dementia|0|||
30729551|NCT00348309|58742291|FG000|Overall Study|Wrong bottle allocated|1|||
30729552|NCT00348309|58742292|FG001|Overall Study|Wrong bottle allocated|0|||
30729553|NCT00348309|58742293|FG002|Overall Study|Wrong bottle allocated|0|||
30729554|NCT00348309|58742291|FG000|Overall Study|Caregiver sick|1|||
30729555|NCT00348309|58742292|FG001|Overall Study|Caregiver sick|0|||
30729556|NCT00348309|58742293|FG002|Overall Study|Caregiver sick|0|||
30729557|NCT00348309|58742291|FG000|Overall Study|Use of prohibited medication|5|||
30729558|NCT00348309|58742292|FG001|Overall Study|Use of prohibited medication|2|||
30729559|NCT00348309|58742293|FG002|Overall Study|Use of prohibited medication|2|||
30729560|NCT00348309|58742291|FG000|Overall Study|Caregiver withdrawal|3|||
30729561|NCT00348309|58742292|FG001|Overall Study|Caregiver withdrawal|0|||
30729562|NCT00348309|58742293|FG002|Overall Study|Caregiver withdrawal|7|||
30729563|NCT00348309|58742291|FG000|Overall Study|Unable to complete ET visit|1|||
30729564|NCT00348309|58742292|FG001|Overall Study|Unable to complete ET visit|0|||
30729565|NCT00348309|58742293|FG002|Overall Study|Unable to complete ET visit|0|||
30729566|NCT00348309|58742291|FG000|Overall Study|PI closing medical practice|1|||
30729567|NCT00348309|58742292|FG001|Overall Study|PI closing medical practice|0|||
30729568|NCT00348309|58742293|FG002|Overall Study|PI closing medical practice|0|||
30729569|NCT00348309|58742291|FG000|Overall Study|Principal investigator's decision|1|||
30729570|NCT00348309|58742292|FG001|Overall Study|Principal investigator's decision|0|||
30729571|NCT00348309|58742293|FG002|Overall Study|Principal investigator's decision|0|||
30729572|NCT00348309|58742291|FG000|Overall Study|No disponibility of medication|1|||
30729573|NCT00348309|58742292|FG001|Overall Study|No disponibility of medication|0|||
30729574|NCT00348309|58742293|FG002|Overall Study|No disponibility of medication|0|||
30729575|NCT00348309|58742291|FG000|Overall Study|Worsened neurodegenerative disease|1|||
30729576|NCT00348309|58742292|FG001|Overall Study|Worsened neurodegenerative disease|0|||
30729577|NCT00348309|58742293|FG002|Overall Study|Worsened neurodegenerative disease|0|||
30729578|NCT00348309|58742291|FG000|Overall Study|Cognitive and behaviour worsening|2|||
30729579|NCT00348309|58742292|FG001|Overall Study|Cognitive and behaviour worsening|0|||
30729580|NCT00348309|58742293|FG002|Overall Study|Cognitive and behaviour worsening|0|||
30729581|NCT00348309|58742291|FG000|Overall Study|Worsening of alzheimer|1|||
30729582|NCT00348309|58742292|FG001|Overall Study|Worsening of alzheimer|0|||
30729583|NCT00348309|58742293|FG002|Overall Study|Worsening of alzheimer|1|||
30729584|NCT00348309|58742291|FG000|Overall Study|Did not appear in time for Visit 3|1|||
30729585|NCT00348309|58742292|FG001|Overall Study|Did not appear in time for Visit 3|0|||
30729586|NCT00348309|58742293|FG002|Overall Study|Did not appear in time for Visit 3|0|||
30729587|NCT00348309|58742291|FG000|Overall Study|Participant died|2|||
30729588|NCT00348309|58742292|FG001|Overall Study|Participant died|1|||
30729589|NCT00348309|58742293|FG002|Overall Study|Participant died|1|||
30729590|NCT00348309|58742291|FG000|Overall Study|Decision of sponsor|1|||
30729591|NCT00348309|58742292|FG001|Overall Study|Decision of sponsor|0|||
30729592|NCT00348309|58742293|FG002|Overall Study|Decision of sponsor|0|||
30729593|NCT00348309|58742291|FG000|Overall Study|Ineffectiveness of treatment|0|||
30729594|NCT00348309|58742292|FG001|Overall Study|Ineffectiveness of treatment|1|||
30729595|NCT00348309|58742293|FG002|Overall Study|Ineffectiveness of treatment|0|||
30729596|NCT00348309|58742291|FG000|Overall Study|A foul of exclusion criteria|0|||
30729597|NCT00348309|58742292|FG001|Overall Study|A foul of exclusion criteria|1|||
30729598|NCT00348309|58742293|FG002|Overall Study|A foul of exclusion criteria|0|||
30729599|NCT00348309|58742291|FG000|Overall Study|Participant was hospitalized|0|||
30729600|NCT00348309|58742292|FG001|Overall Study|Participant was hospitalized|1|||
30729601|NCT00348309|58742293|FG002|Overall Study|Participant was hospitalized|0|||
30729602|NCT00348309|58742291|FG000|Overall Study|Sponsor refuseal|0|||
30729603|NCT00348309|58742292|FG001|Overall Study|Sponsor refuseal|1|||
30729604|NCT00348309|58742293|FG002|Overall Study|Sponsor refuseal|1|||
30729605|NCT00348309|58742291|FG000|Overall Study|Forgot often medication|0|||
30729606|NCT00348309|58742292|FG001|Overall Study|Forgot often medication|1|||
30729607|NCT00348309|58742293|FG002|Overall Study|Forgot often medication|0|||
30729608|NCT00348309|58742291|FG000|Overall Study|Medical Monitor decision|0|||
30729609|NCT00348309|58742292|FG001|Overall Study|Medical Monitor decision|0|||
30729610|NCT00348309|58742293|FG002|Overall Study|Medical Monitor decision|1|||
30729611|NCT00348309|58742291|FG000|Overall Study|Increased dose of Aricept|0|||
30729612|NCT00348309|58742292|FG001|Overall Study|Increased dose of Aricept|0|||
30729613|NCT00348309|58742293|FG002|Overall Study|Increased dose of Aricept|1|||
30729614|NCT00348309|58742291|FG000|Overall Study|Site closure|0|||
30729615|NCT00348309|58742292|FG001|Overall Study|Site closure|0|||
30729616|NCT00348309|58742293|FG002|Overall Study|Site closure|1|||
30729617|NCT00348309|58742291|FG000|Overall Study|Adverse event not attended|0|||
30729618|NCT00348309|58742292|FG001|Overall Study|Adverse event not attended|0|||
30729619|NCT00348309|58742293|FG002|Overall Study|Adverse event not attended|1|||
30729620|NCT00348309|58742291|FG000|Overall Study|ECG abnormal|0|||
30729621|NCT00348309|58742292|FG001|Overall Study|ECG abnormal|0|||
30729622|NCT00348309|58742293|FG002|Overall Study|ECG abnormal|2|||
30729623|NCT00348309|58742291|FG000|Overall Study|Cardiologist recommendations|0|||
30729624|NCT00348309|58742292|FG001|Overall Study|Cardiologist recommendations|0|||
30729625|NCT00348309|58742293|FG002|Overall Study|Cardiologist recommendations|1|||
30729626|NCT00348309|58742291|FG000|Overall Study|HCV career|0|||
30729627|NCT00348309|58742292|FG001|Overall Study|HCV career|0|||
30729628|NCT00348309|58742293|FG002|Overall Study|HCV career|1|||
30729629|NCT00440310|58742304|FG000|Overall Study|Lost to Follow-up|4|||
30729630|NCT00440310|58742305|FG001|Overall Study|Lost to Follow-up|5|||
30729631|NCT00440310|58742304|FG000|Overall Study|Protocol Violation|0|||
30729632|NCT00440310|58742305|FG001|Overall Study|Protocol Violation|1|||
30729633|NCT00440310|58742304|FG000|Overall Study|Withdrawal by Subject|15|||
30729634|NCT00440310|58742305|FG001|Overall Study|Withdrawal by Subject|14|||
30729635|NCT00440310|58742304|FG000|Overall Study|No Reply at EOS|7|||
30729636|NCT00440310|58742305|FG001|Overall Study|No Reply at EOS|7|||
30729637|NCT00440310|58742304|FG000|Overall Study|Other|1|||
30729638|NCT00440310|58742305|FG001|Overall Study|Other|0|||
30729639|NCT00440310|58742304|FG000|Overall Study|Status Unknown|1|||
30729640|NCT00440310|58742305|FG001|Overall Study|Status Unknown|3|||
30729641|NCT00440232|58742313|FG000|Overall Study|Lost to Follow-up|1|||
30729642|NCT00440232|58742314|FG001|Overall Study|Lost to Follow-up|1|||
30729643|NCT00440232|58742313|FG000|Overall Study|Unable to treat within allowed time|0|||
30729644|NCT00440232|58742314|FG001|Overall Study|Unable to treat within allowed time|1|||
30729645|NCT00440232|58742313|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
30729646|NCT00440232|58742314|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
30729647|NCT00356889|58742320|FG000|Overall Study|Protocol Violation|2|||
30729648|NCT00356889|58742320|FG000|Overall Study|Adverse Event|1|||
30729649|NCT00356811|58742325|FG000|Overall Study|Death|35|||
30729650|NCT00356811|58742325|FG000|Overall Study|Lost to Follow-up|2|||
30729651|NCT00356811|58742325|FG000|Overall Study|Withdrawal by Subject|6|||
30729652|NCT00356811|58742325|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
30729653|NCT00356811|58742325|FG000|Overall Study|Study Is Terminating|3|||
30729654|NCT00356811|58742325|FG000|Overall Study|Site Closed during Follow-up|2|||
30729655|NCT00439218|58742330|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
30729656|NCT00535223|58742349|FG000|Overall Study|Withdrawal by Subject|4|||
30729657|NCT00535223|58742350|FG001|Overall Study|Withdrawal by Subject|1|||
30729658|NCT00536939|58742356|FG000|Overall Study|Withdrawal by Subject|1|||
30729659|NCT00536939|58742357|FG001|Overall Study|Withdrawal by Subject|0|||
30729660|NCT00536939|58742356|FG000|Overall Study|Other Complicating Disease|1|||
30729661|NCT00536939|58742357|FG001|Overall Study|Other Complicating Disease|0|||
30729662|NCT00347919|58742365|FG000|Overall Study|Lost to Follow-up|11|||
30729663|NCT00347919|58742366|FG001|Overall Study|Lost to Follow-up|13|||
30729664|NCT00347919|58742367|FG002|Overall Study|Lost to Follow-up|0|||
30729665|NCT00347919|58742365|FG000|Overall Study|Withdrawal by Subject|6|||
30729666|NCT00347919|58742366|FG001|Overall Study|Withdrawal by Subject|8|||
30729667|NCT00347919|58742367|FG002|Overall Study|Withdrawal by Subject|0|||
30729668|NCT00347919|58742365|FG000|Overall Study|Physician Decision|1|||
30729669|NCT00347919|58742366|FG001|Overall Study|Physician Decision|1|||
30729670|NCT00347919|58742367|FG002|Overall Study|Physician Decision|0|||
30729671|NCT00347919|58742365|FG000|Overall Study|Sponsor terminated study|15|||
30729672|NCT00347919|58742366|FG001|Overall Study|Sponsor terminated study|10|||
30729673|NCT00347919|58742367|FG002|Overall Study|Sponsor terminated study|16|||
30729674|NCT00347919|58742365|FG000|Overall Study|Death|35|||
30729675|NCT00347919|58742366|FG001|Overall Study|Death|42|||
30729676|NCT00347919|58742367|FG002|Overall Study|Death|19|||
30729677|NCT00347919|58742365|FG000|Overall Study|Par. Started Other Treatment|1|||
30729678|NCT00347919|58742366|FG001|Overall Study|Par. Started Other Treatment|1|||
30729679|NCT00347919|58742367|FG002|Overall Study|Par. Started Other Treatment|1|||
30729680|NCT00347919|58742365|FG000|Overall Study|Missing|2|||
30729681|NCT00347919|58742366|FG001|Overall Study|Missing|1|||
30729682|NCT00347919|58742367|FG002|Overall Study|Missing|2|||
30729683|NCT00439140|58742380|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
30729684|NCT00439140|58742381|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
30729685|NCT00439140|58742382|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
30729686|NCT00439140|58742380|FG000|Treatment Cycle 1|Personal reasons|0|||
30729687|NCT00439140|58742381|FG001|Treatment Cycle 1|Personal reasons|2|||
30729688|NCT00439140|58742382|FG002|Treatment Cycle 1|Personal reasons|0|||
30729689|NCT00439140|58742380|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
30729690|NCT00439140|58742381|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
30729691|NCT00439140|58742382|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
30729692|NCT00439140|58742380|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
30729693|NCT00439140|58742381|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
30729694|NCT00439140|58742382|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
30729695|NCT00439140|58742380|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
30729696|NCT00439140|58742381|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
30729697|NCT00439140|58742382|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
30729698|NCT00356421|58742392|FG000|Overall Study|Lack of Efficacy|3|||
30729699|NCT00356421|58742393|FG001|Overall Study|Lack of Efficacy|0|||
30729700|NCT00356421|58742392|FG000|Overall Study|Withdrawal by Subject|9|||
30729701|NCT00356421|58742393|FG001|Overall Study|Withdrawal by Subject|2|||
30729702|NCT00356421|58742392|FG000|Overall Study|Related to study drug|15|||
30729703|NCT00356421|58742393|FG001|Overall Study|Related to study drug|12|||
30729704|NCT00356421|58742392|FG000|Overall Study|Not related to study drug|5|||
30729705|NCT00356421|58742393|FG001|Overall Study|Not related to study drug|3|||
30729706|NCT00443820|58742403|FG000|Overall Study|Adverse Event|1|||
30729707|NCT00443820|58742404|FG001|Overall Study|Adverse Event|1|||
30729708|NCT00443820|58742405|FG002|Overall Study|Adverse Event|0|||
30729709|NCT00443820|58742406|FG003|Overall Study|Adverse Event|0|||
30729710|NCT00443820|58742403|FG000|Overall Study|Lack of Efficacy|3|||
30729711|NCT00443820|58742404|FG001|Overall Study|Lack of Efficacy|2|||
30729712|NCT00443820|58742405|FG002|Overall Study|Lack of Efficacy|1|||
30729713|NCT00443820|58742406|FG003|Overall Study|Lack of Efficacy|1|||
30729714|NCT00443820|58742403|FG000|Overall Study|Protocol Violation|2|||
30729715|NCT00443820|58742404|FG001|Overall Study|Protocol Violation|1|||
30729716|NCT00443820|58742405|FG002|Overall Study|Protocol Violation|2|||
30729717|NCT00443820|58742406|FG003|Overall Study|Protocol Violation|1|||
30729718|NCT00443820|58742403|FG000|Overall Study|Withdrawal by Subject|6|||
30729719|NCT00443820|58742404|FG001|Overall Study|Withdrawal by Subject|7|||
30729720|NCT00443820|58742405|FG002|Overall Study|Withdrawal by Subject|8|||
30729721|NCT00443820|58742406|FG003|Overall Study|Withdrawal by Subject|9|||
30729722|NCT00443820|58742403|FG000|Overall Study|Lost to Follow-up|9|||
30729723|NCT00443820|58742404|FG001|Overall Study|Lost to Follow-up|8|||
30729724|NCT00443820|58742405|FG002|Overall Study|Lost to Follow-up|6|||
30729725|NCT00443820|58742406|FG003|Overall Study|Lost to Follow-up|5|||
30729726|NCT00443820|58742403|FG000|Overall Study|Administrative problems|0|||
30729727|NCT00443820|58742404|FG001|Overall Study|Administrative problems|0|||
30729728|NCT00443820|58742405|FG002|Overall Study|Administrative problems|0|||
30729729|NCT00443820|58742406|FG003|Overall Study|Administrative problems|1|||
30621740|NCT01147848|58633298|FG000|Randomized Phase|Lost to Follow-up|0|||
30729730|NCT00443820|58742403|FG000|Overall Study|Death|0|||
30729731|NCT00443820|58742404|FG001|Overall Study|Death|0|||
30729732|NCT00443820|58742405|FG002|Overall Study|Death|1|||
30729733|NCT00443820|58742406|FG003|Overall Study|Death|0|||
30729734|NCT00438672|58742418|FG000|Overall Study|Lost to Follow-up|7|||
30729735|NCT00438672|58742419|FG001|Overall Study|Lost to Follow-up|9|||
30729736|NCT00438360|58742427|FG000|Overall Study|Adverse Event|6|||
30729737|NCT00438360|58742428|FG001|Overall Study|Adverse Event|1|||
30729738|NCT00438360|58742427|FG000|Overall Study|Lack of Efficacy|42|||
30729739|NCT00438360|58742428|FG001|Overall Study|Lack of Efficacy|27|||
30729740|NCT00438360|58742427|FG000|Overall Study|Other|24|||
30729741|NCT00438360|58742428|FG001|Overall Study|Other|15|||
30729742|NCT00536471|58742438|FG000|Overall Study|Lost to Follow-up|48|||
30729743|NCT00536471|58742439|FG001|Overall Study|Lost to Follow-up|23|||
30729744|NCT00536471|58742440|FG002|Overall Study|Lost to Follow-up|48|||
30729745|NCT00536471|58742441|FG003|Overall Study|Lost to Follow-up|22|||
30729746|NCT00536471|58742438|FG000|Overall Study|Adverse Event|32|||
30729747|NCT00536471|58742439|FG001|Overall Study|Adverse Event|16|||
30729748|NCT00536471|58742440|FG002|Overall Study|Adverse Event|28|||
30729749|NCT00536471|58742441|FG003|Overall Study|Adverse Event|13|||
30729750|NCT00536471|58742438|FG000|Overall Study|Withdrawal by Subject|40|||
30729751|NCT00536471|58742439|FG001|Overall Study|Withdrawal by Subject|24|||
30729752|NCT00536471|58742440|FG002|Overall Study|Withdrawal by Subject|43|||
30729753|NCT00536471|58742441|FG003|Overall Study|Withdrawal by Subject|21|||
30729754|NCT00536471|58742438|FG000|Overall Study|Lack of Efficacy|17|||
30729755|NCT00536471|58742439|FG001|Overall Study|Lack of Efficacy|18|||
30729756|NCT00536471|58742440|FG002|Overall Study|Lack of Efficacy|11|||
30729757|NCT00536471|58742441|FG003|Overall Study|Lack of Efficacy|9|||
30729758|NCT00536471|58742438|FG000|Overall Study|Protocol Violation|8|||
30729759|NCT00536471|58742439|FG001|Overall Study|Protocol Violation|1|||
30729760|NCT00536471|58742440|FG002|Overall Study|Protocol Violation|2|||
30729761|NCT00536471|58742441|FG003|Overall Study|Protocol Violation|3|||
30729762|NCT00536471|58742438|FG000|Overall Study|Physician Decision|11|||
30729763|NCT00536471|58742439|FG001|Overall Study|Physician Decision|1|||
30729764|NCT00536471|58742440|FG002|Overall Study|Physician Decision|3|||
30729765|NCT00536471|58742441|FG003|Overall Study|Physician Decision|2|||
30729766|NCT00536471|58742438|FG000|Overall Study|Death|0|||
30729767|NCT00536471|58742439|FG001|Overall Study|Death|0|||
30729768|NCT00536471|58742440|FG002|Overall Study|Death|1|||
30729769|NCT00536471|58742441|FG003|Overall Study|Death|2|||
30729770|NCT00536471|58742438|FG000|Overall Study|Sponsor Decision|0|||
30729771|NCT00536471|58742439|FG001|Overall Study|Sponsor Decision|1|||
30729772|NCT00536471|58742440|FG002|Overall Study|Sponsor Decision|3|||
30729773|NCT00536471|58742441|FG003|Overall Study|Sponsor Decision|2|||
30729774|NCT00359619|58742465|FG000|Overall Study|Adverse Event|0|||
30729775|NCT00359619|58742466|FG001|Overall Study|Adverse Event|0|||
30729776|NCT00359619|58742467|FG002|Overall Study|Adverse Event|1|||
30729777|NCT00359619|58742468|FG003|Overall Study|Adverse Event|0|||
30729778|NCT00359619|58742469|FG004|Overall Study|Adverse Event|0|||
30729779|NCT00359619|58742470|FG005|Overall Study|Adverse Event|0|||
30729780|NCT00359619|58742471|FG006|Overall Study|Adverse Event|1|||
30729781|NCT00359619|58742465|FG000|Overall Study|Withdrawal by Subject|3|||
30729782|NCT00359619|58742466|FG001|Overall Study|Withdrawal by Subject|1|||
30729783|NCT00359619|58742467|FG002|Overall Study|Withdrawal by Subject|4|||
30729784|NCT00359619|58742468|FG003|Overall Study|Withdrawal by Subject|2|||
30729785|NCT00359619|58742469|FG004|Overall Study|Withdrawal by Subject|2|||
30729786|NCT00359619|58742470|FG005|Overall Study|Withdrawal by Subject|0|||
30729787|NCT00359619|58742471|FG006|Overall Study|Withdrawal by Subject|3|||
30729788|NCT00359619|58742465|FG000|Overall Study|Other|1|||
30729789|NCT00359619|58742466|FG001|Overall Study|Other|0|||
30729790|NCT00359619|58742467|FG002|Overall Study|Other|0|||
30729791|NCT00359619|58742468|FG003|Overall Study|Other|0|||
30729792|NCT00359619|58742469|FG004|Overall Study|Other|0|||
30729793|NCT00359619|58742470|FG005|Overall Study|Other|0|||
30729794|NCT00359619|58742471|FG006|Overall Study|Other|0|||
30729795|NCT00359619|58742465|FG000|Overall Study|Lost to Follow-up|4|||
30729796|NCT00359619|58742466|FG001|Overall Study|Lost to Follow-up|4|||
30729797|NCT00359619|58742467|FG002|Overall Study|Lost to Follow-up|2|||
30729798|NCT00359619|58742468|FG003|Overall Study|Lost to Follow-up|1|||
30729799|NCT00359619|58742469|FG004|Overall Study|Lost to Follow-up|1|||
30729800|NCT00359619|58742470|FG005|Overall Study|Lost to Follow-up|5|||
30729801|NCT00359619|58742471|FG006|Overall Study|Lost to Follow-up|0|||
30729802|NCT00437658|58742490|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
30729803|NCT00437658|58742491|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
30729804|NCT00437658|58742492|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
30729805|NCT00437658|58742490|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
30729806|NCT00437658|58742491|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
30729807|NCT00437658|58742492|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
30729808|NCT00437658|58742490|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
30729809|NCT00437658|58742491|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
30621741|NCT01147848|58633299|FG001|Randomized Phase|Lost to Follow-up|5|||
30729810|NCT00437658|58742492|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
30729811|NCT00437658|58742490|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
30729812|NCT00437658|58742491|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
30729813|NCT00437658|58742492|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
30729814|NCT00437658|58742490|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
30729815|NCT00437658|58742491|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
30729816|NCT00437658|58742492|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
30729817|NCT00437658|58742490|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
30729818|NCT00437658|58742491|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
30729819|NCT00437658|58742492|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
30729820|NCT00437658|58742490|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
30729821|NCT00437658|58742491|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
30729822|NCT00437658|58742492|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
30729823|NCT00437658|58742490|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
30729824|NCT00437658|58742491|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
30729825|NCT00437658|58742492|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
30729826|NCT00437658|58742490|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
30729827|NCT00437658|58742491|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
30729828|NCT00437658|58742492|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
30729829|NCT00437658|58742490|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
30729830|NCT00437658|58742491|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
30729831|NCT00437658|58742492|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
30729832|NCT00437658|58742490|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
30729833|NCT00437658|58742491|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
30729834|NCT00437658|58742492|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
30729835|NCT00437658|58742490|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
30729836|NCT00437658|58742491|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
30729837|NCT00437658|58742492|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
30729838|NCT03828747|58742502|FG000|Double-Blind Treatment Period|Adverse Event|6|||
30729839|NCT03828747|58742503|FG001|Double-Blind Treatment Period|Adverse Event|6|||
30729840|NCT03828747|58742502|FG000|Double-Blind Treatment Period|Death|1|||
30729841|NCT03828747|58742503|FG001|Double-Blind Treatment Period|Death|2|||
30729842|NCT03828747|58742502|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
30729843|NCT03828747|58742503|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
30729844|NCT03828747|58742502|FG000|Double-Blind Treatment Period|Withdrawal by Subject|19|||
30729845|NCT03828747|58742503|FG001|Double-Blind Treatment Period|Withdrawal by Subject|21|||
30729846|NCT03828747|58742502|FG000|Double-Blind Treatment Period|Physician Decision|0|||
30729847|NCT03828747|58742503|FG001|Double-Blind Treatment Period|Physician Decision|3|||
30729848|NCT03828747|58742502|FG000|Double-Blind Treatment Period|Various reasons|5|||
30729849|NCT03828747|58742503|FG001|Double-Blind Treatment Period|Various reasons|3|||
30729850|NCT03828747|58742502|FG000|Open-Label Extension|Continuing on Study|77|||
30729851|NCT03828747|58742503|FG001|Open-Label Extension|Continuing on Study|72|||
30729852|NCT03828747|58742502|FG000|Open-Label Extension|Adverse Event|3|||
30729853|NCT03828747|58742503|FG001|Open-Label Extension|Adverse Event|4|||
30729854|NCT03828747|58742502|FG000|Open-Label Extension|Death|0|||
30729855|NCT03828747|58742503|FG001|Open-Label Extension|Death|2|||
30729856|NCT03828747|58742502|FG000|Open-Label Extension|Lost to Follow-up|4|||
30729857|NCT03828747|58742503|FG001|Open-Label Extension|Lost to Follow-up|0|||
30729858|NCT03828747|58742502|FG000|Open-Label Extension|Withdrawal by Subject|19|||
30729859|NCT03828747|58742503|FG001|Open-Label Extension|Withdrawal by Subject|16|||
30729860|NCT03828747|58742502|FG000|Open-Label Extension|Various reasons|1|||
30729861|NCT03828747|58742503|FG001|Open-Label Extension|Various reasons|1|||
30729862|NCT00356265|58742513|FG000|Overall Study|Withdrawal by Subject|0|||
30729863|NCT00356265|58742514|FG001|Overall Study|Withdrawal by Subject|0|||
30729864|NCT00356265|58742515|FG002|Overall Study|Withdrawal by Subject|1|||
30729865|NCT00535145|58742524|FG000|Phase I|Adverse Event|3|||
30729866|NCT00535145|58742524|FG000|Phase I|Lost to Follow-up|7|||
30729867|NCT00535145|58742524|FG000|Phase I|Withdrawal by Subject|6|||
30729868|NCT00535145|58742524|FG000|Phase I|(eligibility)|8|||
30729869|NCT00535145|58742524|FG000|Phase I|(protocol violation)|1|||
30729870|NCT00535145|58742524|FG000|Phase I|(PI decision)|1|||
30729871|NCT00535145|58742524|FG000|Phase I|(diagnosis)|3|||
30729872|NCT00535145|58742524|FG000|Phase II|Adverse Event|2|||
30729873|NCT00535145|58742524|FG000|Phase II|Lack of Efficacy|1|||
30729874|NCT00535145|58742524|FG000|Phase II|Lost to Follow-up|5|||
30729875|NCT00535145|58742524|FG000|Phase II|Withdrawal by Subject|5|||
30729876|NCT00535145|58742524|FG000|Phase II|Subject non-compliance|2|||
30729877|NCT00437268|58742534|FG000|Overall Study|Adverse Event|1|||
30729878|NCT00437268|58742535|FG001|Overall Study|Adverse Event|1|||
30729879|NCT00437268|58742534|FG000|Overall Study|Withdrawal by Subject|2|||
30729880|NCT00437268|58742535|FG001|Overall Study|Withdrawal by Subject|2|||
30729881|NCT00437268|58742534|FG000|Overall Study|Progressive disease|9|||
30729882|NCT00437268|58742535|FG001|Overall Study|Progressive disease|9|||
30729883|NCT00437268|58742534|FG000|Overall Study|Physician Decision|1|||
30729884|NCT00437268|58742535|FG001|Overall Study|Physician Decision|0|||
30729885|NCT00437268|58742534|FG000|Overall Study|Death|0|||
30729886|NCT00437268|58742535|FG001|Overall Study|Death|1|||
30729887|NCT00437034|58742543|FG000|Overall Study|Adverse Event|1|||
30729888|NCT00437034|58742543|FG000|Overall Study|Disease progression during treatment|5|||
30729889|NCT00337467|58742547|FG000|Overall Study|Adverse Event|3|||
30729890|NCT00337467|58742547|FG000|Overall Study|Subject Withdrew Consent|2|||
30729891|NCT00337467|58742547|FG000|Overall Study|Pregnancy|1|||
30729892|NCT00337467|58742547|FG000|Overall Study|Lost to Follow-up|2|||
30729893|NCT00337467|58742547|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
30729894|NCT00337077|58742557|FG000|Overall Study|Progressive disease|25|||
30729895|NCT00337077|58742558|FG001|Overall Study|Progressive disease|37|||
30729896|NCT00337077|58742559|FG002|Overall Study|Progressive disease|19|||
30729897|NCT00337077|58742557|FG000|Overall Study|Adverse Event|7|||
30729898|NCT00337077|58742558|FG001|Overall Study|Adverse Event|7|||
30729899|NCT00337077|58742559|FG002|Overall Study|Adverse Event|1|||
30729900|NCT00337077|58742557|FG000|Overall Study|Death|0|||
30729901|NCT00337077|58742558|FG001|Overall Study|Death|1|||
30729902|NCT00337077|58742559|FG002|Overall Study|Death|0|||
30729903|NCT00337077|58742557|FG000|Overall Study|Withdrawal by Subject|7|||
30729904|NCT00337077|58742558|FG001|Overall Study|Withdrawal by Subject|2|||
30729905|NCT00337077|58742559|FG002|Overall Study|Withdrawal by Subject|2|||
30729906|NCT00337077|58742557|FG000|Overall Study|Alternative therapy|1|||
30729907|NCT00337077|58742558|FG001|Overall Study|Alternative therapy|0|||
30729908|NCT00337077|58742559|FG002|Overall Study|Alternative therapy|0|||
30729909|NCT00337077|58742557|FG000|Overall Study|Physician Decision|1|||
30729910|NCT00337077|58742558|FG001|Overall Study|Physician Decision|4|||
30729911|NCT00337077|58742559|FG002|Overall Study|Physician Decision|2|||
30729912|NCT00337077|58742557|FG000|Overall Study|Never started treatment|1|||
30729913|NCT00337077|58742558|FG001|Overall Study|Never started treatment|1|||
30729914|NCT00337077|58742559|FG002|Overall Study|Never started treatment|0|||
30729915|NCT00337077|58742557|FG000|Overall Study|Ineligible|1|||
30729916|NCT00337077|58742558|FG001|Overall Study|Ineligible|1|||
30729917|NCT00337077|58742559|FG002|Overall Study|Ineligible|1|||
30729918|NCT00428220|58742565|FG000|Overall Study|Participant died|8|||
30729919|NCT00428220|58742565|FG000|Overall Study|Global deterioration of health status|7|||
30729920|NCT00428220|58742565|FG000|Overall Study|Lost to Follow-up|4|||
30729921|NCT00428220|58742565|FG000|Overall Study|Objective progression or relapse|123|||
30729922|NCT00428220|58742565|FG000|Overall Study|Participant refused continued treatment|7|||
30729923|NCT00428220|58742565|FG000|Overall Study|Adverse Event|51|||
30729924|NCT00428220|58742565|FG000|Overall Study|Other|23|||
30729925|NCT00345579|58742595|FG000|Overall Study|Adverse Event|9|||
30729926|NCT00345579|58742596|FG001|Overall Study|Adverse Event|6|||
30729927|NCT00345579|58742595|FG000|Overall Study|Protocol Violation|14|||
30729928|NCT00345579|58742596|FG001|Overall Study|Protocol Violation|5|||
30729929|NCT00345579|58742595|FG000|Overall Study|Withdrawal by Subject|50|||
30729930|NCT00345579|58742596|FG001|Overall Study|Withdrawal by Subject|17|||
30729931|NCT00345579|58742595|FG000|Overall Study|Lost to Follow-up|82|||
30729932|NCT00345579|58742596|FG001|Overall Study|Lost to Follow-up|36|||
30729933|NCT00345579|58742595|FG000|Overall Study|Other|9|||
30729934|NCT00345579|58742596|FG001|Overall Study|Other|1|||
30729935|NCT00335829|58742603|FG000|Overall Study|Withdrawal by Subject|1|||
30729936|NCT00335829|58742603|FG000|Overall Study|Lost to Follow-up|1|||
30729937|NCT00335829|58742603|FG000|Overall Study|Adverse Event|1|||
30729938|NCT00344019|58742610|FG000|Overall Study|did not meet final inclusion criteria|0|||
30729939|NCT00344019|58742611|FG001|Overall Study|did not meet final inclusion criteria|0|||
30729940|NCT00344019|58742612|FG002|Overall Study|did not meet final inclusion criteria|74|||
30729941|NCT00535847|58742626|FG000|Overall Study|Adverse Event|5|||
30729942|NCT00535847|58742627|FG001|Overall Study|Adverse Event|3|||
30729943|NCT00535847|58742628|FG002|Overall Study|Adverse Event|2|||
30729944|NCT00535847|58742626|FG000|Overall Study|Non compliance|1|||
30729945|NCT00535847|58742627|FG001|Overall Study|Non compliance|1|||
30729946|NCT00535847|58742628|FG002|Overall Study|Non compliance|0|||
30729947|NCT00535847|58742626|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
30729948|NCT00535847|58742627|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
30729949|NCT00535847|58742628|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
30729950|NCT00334893|58742642|FG000|Overall Study|Not Treated|1|||
30729951|NCT00334893|58742643|FG001|Overall Study|Not Treated|0|||
30729952|NCT00334737|58742654|FG000|Hospital Phase|Death|1|||
30729953|NCT00334737|58742655|FG001|Hospital Phase|Death|2|||
30729954|NCT00334737|58742656|FG002|Hospital Phase|Death|3|||
30729955|NCT00334737|58742654|FG000|Hospital Phase|Withdrawal by Subject|0|||
30729956|NCT00334737|58742655|FG001|Hospital Phase|Withdrawal by Subject|0|||
30729957|NCT00334737|58742656|FG002|Hospital Phase|Withdrawal by Subject|1|||
30729958|NCT00334737|58742654|FG000|Hospital Phase|Did not receive study drug|1|||
30729959|NCT00334737|58742655|FG001|Hospital Phase|Did not receive study drug|0|||
30729960|NCT00334737|58742656|FG002|Hospital Phase|Did not receive study drug|0|||
30729961|NCT00334737|58742654|FG000|Follow up Phase|Lost to Follow-up|5|||
30729962|NCT00334737|58742655|FG001|Follow up Phase|Lost to Follow-up|3|||
30729963|NCT00334737|58742656|FG002|Follow up Phase|Lost to Follow-up|6|||
30729964|NCT00427908|58742668|FG000|Primary Phase|Lost to Follow-up|4|||
30729965|NCT00427908|58742669|FG001|Primary Phase|Lost to Follow-up|0|||
30729966|NCT00427908|58742670|FG002|Primary Phase|Lost to Follow-up|2|||
30729967|NCT00427908|58742671|FG003|Primary Phase|Lost to Follow-up|0|||
30729968|NCT00427908|58742668|FG000|Primary Phase|Withdrawal by Subject|1|||
30729969|NCT00427908|58742669|FG001|Primary Phase|Withdrawal by Subject|2|||
30729970|NCT00427908|58742670|FG002|Primary Phase|Withdrawal by Subject|1|||
30729971|NCT00427908|58742671|FG003|Primary Phase|Withdrawal by Subject|0|||
30729972|NCT00427908|58742668|FG000|Primary Phase|Adverse Event|0|||
30729973|NCT00427908|58742669|FG001|Primary Phase|Adverse Event|1|||
30729974|NCT00427908|58742670|FG002|Primary Phase|Adverse Event|0|||
30729975|NCT00427908|58742671|FG003|Primary Phase|Adverse Event|0|||
30729976|NCT00334113|58742708|FG000|Overall Study|Lost to Follow-up|2|||
30729977|NCT00334113|58742709|FG001|Overall Study|Lost to Follow-up|2|||
30729978|NCT00334113|58742708|FG000|Overall Study|Withdrawal by Subject|0|||
30729979|NCT00334113|58742709|FG001|Overall Study|Withdrawal by Subject|1|||
30729980|NCT00416598|58742715|FG000|Induction & Intensification|Adverse Event|38|||
30729981|NCT00416598|58742715|FG000|Induction & Intensification|Death|32|||
30729982|NCT00416598|58742715|FG000|Induction & Intensification|Withdrawal by Subject|46|||
30729983|NCT00416598|58742715|FG000|Induction & Intensification|Alternative Treatment|135|||
30729984|NCT00416598|58742715|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
30729985|NCT00416598|58742715|FG000|Induction & Intensification|Relapse/progression|29|||
30729986|NCT00416598|58742715|FG000|Induction & Intensification|Failed induction|87|||
30729987|NCT00416598|58742715|FG000|Decitabine Maintenance|Adverse Event|5|||
30729988|NCT00416598|58742715|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
30729989|NCT00416598|58742715|FG000|Decitabine Maintenance|Progression/relapse|38|||
30729990|NCT00416598|58742715|FG000|Decitabine Maintenance|Alternative treatment|2|||
30729991|NCT00416598|58742715|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
30729992|NCT00534599|58742721|FG000|Overall Study|Adverse Event|25|||
30729993|NCT00534599|58742722|FG001|Overall Study|Adverse Event|4|||
30729994|NCT00534599|58742721|FG000|Overall Study|Incorrect enrollment|2|||
30729995|NCT00534599|58742722|FG001|Overall Study|Incorrect enrollment|1|||
30729996|NCT00534599|58742721|FG000|Overall Study|Mis-randomization|2|||
30729997|NCT00534599|58742722|FG001|Overall Study|Mis-randomization|2|||
30729998|NCT00534599|58742721|FG000|Overall Study|Developed study-specific d/c criteria|5|||
30729999|NCT00534599|58742722|FG001|Overall Study|Developed study-specific d/c criteria|0|||
30730000|NCT00534599|58742721|FG000|Overall Study|Lack of Efficacy|0|||
30730001|NCT00534599|58742722|FG001|Overall Study|Lack of Efficacy|1|||
30730002|NCT00534599|58742721|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
30730003|NCT00534599|58742722|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
30730004|NCT00534599|58742721|FG000|Overall Study|Protocol Violation|1|||
30730005|NCT00534599|58742722|FG001|Overall Study|Protocol Violation|3|||
30730006|NCT00534599|58742721|FG000|Overall Study|Lost to Follow-up|11|||
30730007|NCT00534599|58742722|FG001|Overall Study|Lost to Follow-up|14|||
30730008|NCT00534599|58742721|FG000|Overall Study|Withdrawal by Subject|4|||
30730009|NCT00534599|58742722|FG001|Overall Study|Withdrawal by Subject|6|||
30730010|NCT00534599|58742721|FG000|Overall Study|Other|7|||
30730011|NCT00534599|58742722|FG001|Overall Study|Other|0|||
30730012|NCT03892889|58742745|FG000|Overall Study|Adverse Event|17|||
30730013|NCT03892889|58742745|FG000|Overall Study|Lack of Efficacy|1|||
30730014|NCT03892889|58742745|FG000|Overall Study|Lost to Follow-up|46|||
30730015|NCT03892889|58742745|FG000|Overall Study|Non-compliance with study drug|22|||
30730016|NCT03892889|58742745|FG000|Overall Study|Pregnancy|1|||
30730017|NCT03892889|58742745|FG000|Overall Study|Protocol Deviation|3|||
30730018|NCT03892889|58742745|FG000|Overall Study|Withdrawal by Subject|50|||
30730019|NCT03892889|58742745|FG000|Overall Study|Withdrawal by Caregiver|1|||
30730020|NCT03892889|58742745|FG000|Overall Study|Study Terminated by Sponsor|50|||
30730021|NCT03892889|58742745|FG000|Overall Study|Physician Decision|8|||
30730022|NCT03892889|58742745|FG000|Overall Study|Reason not Specified|5|||
30730023|NCT00473330|58742752|FG000|Core Study|Adverse Event|4|||
30730024|NCT00473330|58742753|FG001|Core Study|Adverse Event|4|||
30730025|NCT00473330|58742754|FG002|Core Study|Adverse Event|1|||
30730026|NCT00473330|58742752|FG000|Core Study|Death|6|||
30730027|NCT00473330|58742753|FG001|Core Study|Death|4|||
30730028|NCT00473330|58742754|FG002|Core Study|Death|4|||
30730029|NCT00473330|58742752|FG000|Core Study|Lost to Follow-up|5|||
30730030|NCT00473330|58742753|FG001|Core Study|Lost to Follow-up|5|||
30730031|NCT00473330|58742754|FG002|Core Study|Lost to Follow-up|10|||
30730032|NCT00473330|58742752|FG000|Core Study|Physician Decision|2|||
30730033|NCT00473330|58742753|FG001|Core Study|Physician Decision|1|||
30730034|NCT00473330|58742754|FG002|Core Study|Physician Decision|3|||
30730035|NCT00473330|58742752|FG000|Core Study|Subject Non-compliance|1|||
30730036|NCT00473330|58742753|FG001|Core Study|Subject Non-compliance|2|||
30730037|NCT00473330|58742754|FG002|Core Study|Subject Non-compliance|1|||
30730038|NCT00473330|58742752|FG000|Core Study|Subject Required Other Therapy|0|||
30730039|NCT00473330|58742753|FG001|Core Study|Subject Required Other Therapy|1|||
30730040|NCT00473330|58742754|FG002|Core Study|Subject Required Other Therapy|3|||
30730041|NCT00473330|58742752|FG000|Core Study|Subject's Decision|9|||
30730042|NCT00473330|58742753|FG001|Core Study|Subject's Decision|8|||
30730043|NCT00473330|58742754|FG002|Core Study|Subject's Decision|19|||
30730044|NCT00473330|58742752|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
30730045|NCT00473330|58742753|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
30730046|NCT00473330|58742754|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
30730047|NCT00473330|58742752|FG000|Open-label Extension Through Month 48|Death|2|||
30730048|NCT00473330|58742753|FG001|Open-label Extension Through Month 48|Death|0|||
30730049|NCT00473330|58742754|FG002|Open-label Extension Through Month 48|Death|0|||
30730050|NCT00473330|58742752|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
30730051|NCT00473330|58742753|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
30730052|NCT00473330|58742754|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
30730053|NCT00473330|58742752|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
30730054|NCT00473330|58742753|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
30730055|NCT00473330|58742754|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
30730056|NCT00473330|58742752|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
30730057|NCT00473330|58742753|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
30730058|NCT00473330|58742754|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
30730059|NCT00473330|58742752|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
30730060|NCT00473330|58742753|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
30730061|NCT00473330|58742754|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
30730062|NCT00473330|58742752|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
30730063|NCT00473330|58742753|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
30730064|NCT00473330|58742754|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
30730065|NCT00473330|58742752|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
30730066|NCT00473330|58742753|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
30730067|NCT00473330|58742754|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
30730068|NCT00473330|58742752|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
30730069|NCT00473330|58742753|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
30730070|NCT00473330|58742754|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
30621742|NCT01147848|58633300|FG002|Randomized Phase|Lost to Follow-up|7|||
30621743|NCT01147848|58633298|FG000|Randomized Phase|Physician Decision|0|||
30621744|NCT01147848|58633299|FG001|Randomized Phase|Physician Decision|0|||
30621745|NCT01147848|58633300|FG002|Randomized Phase|Physician Decision|1|||
30621746|NCT01147848|58633298|FG000|Randomized Phase|Withdrawal by Subject|0|||
30621747|NCT01147848|58633299|FG001|Randomized Phase|Withdrawal by Subject|7|||
30900477|NCT02354222|58933883|FG001|Overall Study|Withdrawal by Subject|3|||
30900478|NCT02354222|58933882|FG000|Overall Study|Conflict with the stopping criteria|0|||
30900479|NCT02354222|58933883|FG001|Overall Study|Conflict with the stopping criteria|4|||
30900480|NCT02353442|58933891|FG000|Overall Study|Withdrawal by Subject|3|||
30900481|NCT02353442|58933892|FG001|Overall Study|Withdrawal by Subject|4|||
30900482|NCT02351960|58933900|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
30900483|NCT02351960|58933901|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
30900484|NCT02351960|58933900|FG000|Overall Study|Voluntary Withdrawal|5|||
30900485|NCT02351960|58933901|FG001|Overall Study|Voluntary Withdrawal|4|||
30621748|NCT01147848|58633300|FG002|Randomized Phase|Withdrawal by Subject|9|||
30621749|NCT00929656|58633309|FG000|Overall Study|Lost to Follow-up|0|||
30621750|NCT00929656|58633310|FG001|Overall Study|Lost to Follow-up|1|||
30621751|NCT00977613|58633316|FG000|Overall Study|Lost to Follow-up|16|||
30621752|NCT01152996|58633320|FG000|Overall Study|Withdrawal by Subject|142|||
30621753|NCT01152996|58633320|FG000|Overall Study|Adverse Event|115|||
30621754|NCT01152996|58633320|FG000|Overall Study|Lost to Follow-up|112|||
30621755|NCT01152996|58633320|FG000|Overall Study|Lack of Efficacy|68|||
30621756|NCT01152996|58633320|FG000|Overall Study|Noncompliance|41|||
30621757|NCT01152996|58633320|FG000|Overall Study|Other|36|||
30621758|NCT01152996|58633320|FG000|Overall Study|Protocol Violation|22|||
30621759|NCT01152996|58633320|FG000|Overall Study|Elevated liver enzymes|1|||
30621760|NCT00979953|58633328|FG000|Overall Study|Adverse Event|5|||
30621761|NCT00979953|58633329|FG001|Overall Study|Adverse Event|2|||
30621762|NCT00979953|58633330|FG002|Overall Study|Adverse Event|17|||
30621763|NCT00979953|58633331|FG003|Overall Study|Adverse Event|4|||
30621764|NCT00979953|58633328|FG000|Overall Study|Lack of Efficacy|1|||
30621765|NCT00979953|58633329|FG001|Overall Study|Lack of Efficacy|2|||
30621766|NCT00979953|58633330|FG002|Overall Study|Lack of Efficacy|0|||
30621767|NCT00979953|58633331|FG003|Overall Study|Lack of Efficacy|0|||
30621768|NCT00979953|58633328|FG000|Overall Study|Lost to Follow-up|1|||
30621769|NCT00979953|58633329|FG001|Overall Study|Lost to Follow-up|1|||
30621770|NCT00979953|58633330|FG002|Overall Study|Lost to Follow-up|1|||
30621771|NCT00979953|58633331|FG003|Overall Study|Lost to Follow-up|0|||
30621772|NCT00979953|58633328|FG000|Overall Study|Withdrawal by Subject|0|||
30621773|NCT00979953|58633329|FG001|Overall Study|Withdrawal by Subject|0|||
30621774|NCT00979953|58633330|FG002|Overall Study|Withdrawal by Subject|2|||
30621775|NCT00979953|58633331|FG003|Overall Study|Withdrawal by Subject|1|||
30621776|NCT00979953|58633328|FG000|Overall Study|Protocol Violation|1|||
30621777|NCT00979953|58633329|FG001|Overall Study|Protocol Violation|0|||
30621778|NCT00979953|58633330|FG002|Overall Study|Protocol Violation|2|||
30621779|NCT00979953|58633331|FG003|Overall Study|Protocol Violation|2|||
30621780|NCT01181531|58633343|FG000|Overall Study|Other|17|||
30621781|NCT01181531|58633344|FG001|Overall Study|Other|12|||
30621782|NCT01181531|58633343|FG000|Overall Study|Partial consent by subject withdrawn|0|||
30621783|NCT01181531|58633344|FG001|Overall Study|Partial consent by subject withdrawn|1|||
30730071|NCT00473330|58742752|FG000|Open-label Extension Through Month 60|Death|2|||
30730072|NCT00473330|58742753|FG001|Open-label Extension Through Month 60|Death|2|||
30730073|NCT00473330|58742754|FG002|Open-label Extension Through Month 60|Death|1|||
30730074|NCT00473330|58742752|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
30730075|NCT00473330|58742753|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
30730076|NCT00473330|58742754|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
30730077|NCT00473330|58742752|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
30730078|NCT00473330|58742753|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
30730079|NCT00473330|58742754|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
30730080|NCT00473330|58742752|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
30730081|NCT00473330|58742753|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
30730082|NCT00473330|58742754|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
30730083|NCT00473330|58742752|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
30730084|NCT00473330|58742753|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
30730085|NCT00473330|58742754|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
30730086|NCT00473330|58742752|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
30730087|NCT00473330|58742753|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
30730088|NCT00473330|58742754|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
30730089|NCT00473330|58742752|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
30730090|NCT00473330|58742753|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
30730091|NCT00473330|58742754|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
30730092|NCT00416520|58742784|FG000|Open-label Period|Adverse Event|28|||
30730093|NCT00416520|58742785|FG001|Open-label Period|Adverse Event|10|||
30730094|NCT00416520|58742786|FG002|Open-label Period|Adverse Event|0|||
30730095|NCT00416520|58742787|FG003|Open-label Period|Adverse Event|0|||
30730096|NCT00416520|58742784|FG000|Open-label Period|Death|2|||
30730097|NCT00416520|58742785|FG001|Open-label Period|Death|1|||
30621784|NCT01181531|58633343|FG000|Overall Study|Physician Decision|3|||
30621785|NCT01181531|58633344|FG001|Overall Study|Physician Decision|1|||
30621786|NCT01181531|58633343|FG000|Overall Study|Noncompliance|2|||
30621787|NCT01181531|58633344|FG001|Overall Study|Noncompliance|2|||
30621788|NCT01181531|58633343|FG000|Overall Study|Ineligibility determined|1|||
30621789|NCT01181531|58633344|FG001|Overall Study|Ineligibility determined|2|||
30621790|NCT01181531|58633343|FG000|Overall Study|Protocol Specified Criteria|15|||
30621791|NCT01181531|58633344|FG001|Overall Study|Protocol Specified Criteria|8|||
30621792|NCT01181531|58633343|FG000|Overall Study|Pregnancy|0|||
30621793|NCT01181531|58633344|FG001|Overall Study|Pregnancy|1|||
30621794|NCT01181531|58633343|FG000|Overall Study|Withdrawal by Subject|8|||
30621795|NCT01181531|58633344|FG001|Overall Study|Withdrawal by Subject|7|||
30621796|NCT01181531|58633343|FG000|Overall Study|Protocol Violation|6|||
30730098|NCT00416520|58742786|FG002|Open-label Period|Death|0|||
30730099|NCT00416520|58742787|FG003|Open-label Period|Death|0|||
30730100|NCT00416520|58742784|FG000|Open-label Period|Lack of Efficacy|8|||
30730101|NCT00416520|58742785|FG001|Open-label Period|Lack of Efficacy|1|||
30730102|NCT00416520|58742786|FG002|Open-label Period|Lack of Efficacy|0|||
30730103|NCT00416520|58742787|FG003|Open-label Period|Lack of Efficacy|0|||
30730104|NCT00416520|58742784|FG000|Open-label Period|Protocol Violation|3|||
30730105|NCT00416520|58742785|FG001|Open-label Period|Protocol Violation|3|||
30730106|NCT00416520|58742786|FG002|Open-label Period|Protocol Violation|0|||
30730107|NCT00416520|58742787|FG003|Open-label Period|Protocol Violation|0|||
30730108|NCT00416520|58742784|FG000|Open-label Period|Withdrawal by Subject|16|||
30730109|NCT00416520|58742785|FG001|Open-label Period|Withdrawal by Subject|5|||
30730110|NCT00416520|58742786|FG002|Open-label Period|Withdrawal by Subject|0|||
30730111|NCT00416520|58742787|FG003|Open-label Period|Withdrawal by Subject|0|||
30730112|NCT00416520|58742784|FG000|Open-label Period|Other Reasons|3|||
30730113|NCT00416520|58742785|FG001|Open-label Period|Other Reasons|12|||
30730114|NCT00416520|58742786|FG002|Open-label Period|Other Reasons|0|||
30730115|NCT00416520|58742787|FG003|Open-label Period|Other Reasons|0|||
30730116|NCT00416520|58742784|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
30730117|NCT00416520|58742785|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
30730118|NCT00416520|58742786|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
30730119|NCT00416520|58742787|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
30730120|NCT00416520|58742784|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
30730121|NCT00416520|58742785|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
30730122|NCT00416520|58742786|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
30730123|NCT00416520|58742787|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
30730124|NCT00416520|58742784|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
30730125|NCT00416520|58742785|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
30730126|NCT00416520|58742786|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
30730127|NCT00416520|58742787|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
30730128|NCT00533429|58742799|FG000|Overall Study|Adverse Event|3|||
30730129|NCT00533429|58742800|FG001|Overall Study|Adverse Event|1|||
30730130|NCT00533429|58742799|FG000|Overall Study|Death|1|||
30730131|NCT00533429|58742800|FG001|Overall Study|Death|0|||
30730132|NCT00533429|58742799|FG000|Overall Study|Withdrawal by Subject|2|||
30730133|NCT00533429|58742800|FG001|Overall Study|Withdrawal by Subject|0|||
30730134|NCT00533429|58742799|FG000|Overall Study|Progressive Disease|12|||
30730135|NCT00533429|58742800|FG001|Overall Study|Progressive Disease|13|||
30730136|NCT00533429|58742799|FG000|Overall Study|Symptomatic deterioration|1|||
30730137|NCT00533429|58742800|FG001|Overall Study|Symptomatic deterioration|2|||
30730138|NCT00533273|58742810|FG000|Double-blind|Withdrew consent|0|||
30730139|NCT00533273|58742811|FG001|Double-blind|Withdrew consent|2|||
30730140|NCT00533273|58742810|FG000|Open-label|Withdrawal by Subject|6|||
30730141|NCT00533273|58742811|FG001|Open-label|Withdrawal by Subject|0|||
30730142|NCT03891641|58742819|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
30730143|NCT03891641|58742820|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
30730144|NCT00339183|58742828|FG000|Overall Study|Adverse Event|5|||
30730145|NCT00339183|58742829|FG001|Overall Study|Adverse Event|3|||
30730146|NCT00339183|58742828|FG000|Overall Study|Withdrawal by Subject|16|||
30730147|NCT00339183|58742829|FG001|Overall Study|Withdrawal by Subject|19|||
30730148|NCT00339183|58742828|FG000|Overall Study|Physician Decision|2|||
30730149|NCT00339183|58742829|FG001|Overall Study|Physician Decision|4|||
30730150|NCT00339183|58742828|FG000|Overall Study|Lost to Follow-up|17|||
30730151|NCT00339183|58742829|FG001|Overall Study|Lost to Follow-up|17|||
30730152|NCT00339183|58742828|FG000|Overall Study|Protocol-specified criteria|12|||
30730153|NCT00339183|58742829|FG001|Overall Study|Protocol-specified criteria|8|||
30730154|NCT00339183|58742828|FG000|Overall Study|Missing reason|3|||
30730155|NCT00339183|58742829|FG001|Overall Study|Missing reason|1|||
30730156|NCT00339183|58742828|FG000|Overall Study|Other|46|||
30730157|NCT00339183|58742829|FG001|Overall Study|Other|40|||
30730158|NCT00339183|58742828|FG000|Overall Study|Ongoing|20|||
30730159|NCT00339183|58742829|FG001|Overall Study|Ongoing|13|||
30730160|NCT00333801|58742841|FG000|Overall Study|Moved to another state|5|||
30730161|NCT00333801|58742842|FG001|Overall Study|Moved to another state|3|||
30730162|NCT00333801|58742841|FG000|Overall Study|Lost to Follow-up|2|||
30730163|NCT00333801|58742842|FG001|Overall Study|Lost to Follow-up|0|||
30900486|NCT02351960|58933900|FG000|Overall Study|Significant Protocol Deviation|0|||
30730164|NCT00333801|58742841|FG000|Overall Study|Incarcerated|1|||
30730165|NCT00333801|58742842|FG001|Overall Study|Incarcerated|2|||
30730166|NCT00333801|58742841|FG000|Overall Study|Withdrawal by Subject|0|||
30730167|NCT00333801|58742842|FG001|Overall Study|Withdrawal by Subject|1|||
30730168|NCT00532883|58742852|FG000|Overall Study|Adverse Event|1|||
30730169|NCT00532883|58742853|FG001|Overall Study|Adverse Event|0|||
30730170|NCT00532883|58742854|FG002|Overall Study|Adverse Event|0|||
30730171|NCT00532883|58742855|FG003|Overall Study|Adverse Event|1|||
30730172|NCT00532883|58742852|FG000|Overall Study|Lost to Follow-up|1|||
30730173|NCT00532883|58742853|FG001|Overall Study|Lost to Follow-up|1|||
30730174|NCT00532883|58742854|FG002|Overall Study|Lost to Follow-up|1|||
30730175|NCT00532883|58742855|FG003|Overall Study|Lost to Follow-up|0|||
30730176|NCT00532883|58742852|FG000|Overall Study|Withdrawal by Subject|0|||
30730177|NCT00532883|58742853|FG001|Overall Study|Withdrawal by Subject|1|||
30730178|NCT00532883|58742854|FG002|Overall Study|Withdrawal by Subject|1|||
30730179|NCT00532883|58742855|FG003|Overall Study|Withdrawal by Subject|0|||
30730180|NCT00532883|58742852|FG000|Overall Study|Subject was Nonadherent|0|||
30730181|NCT00532883|58742853|FG001|Overall Study|Subject was Nonadherent|1|||
30730182|NCT00532883|58742854|FG002|Overall Study|Subject was Nonadherent|1|||
30730183|NCT00532883|58742855|FG003|Overall Study|Subject was Nonadherent|0|||
30730184|NCT00532883|58742852|FG000|Overall Study|Early Study Termination|4|||
30730185|NCT00532883|58742853|FG001|Overall Study|Early Study Termination|4|||
30730186|NCT00532883|58742854|FG002|Overall Study|Early Study Termination|1|||
30730187|NCT00532883|58742855|FG003|Overall Study|Early Study Termination|4|||
30730188|NCT00354159|58742867|FG000|Randomized Study Period|Withdrawal by Subject|5|||
30621797|NCT01181531|58633344|FG001|Overall Study|Protocol Violation|6|||
30730189|NCT00354159|58742868|FG001|Randomized Study Period|Withdrawal by Subject|3|||
30730190|NCT00354159|58742867|FG000|Randomized Study Period|Physician Decision|6|||
30730191|NCT00354159|58742868|FG001|Randomized Study Period|Physician Decision|10|||
30730192|NCT00354159|58742867|FG000|Randomized Study Period|Lost to Follow-up|4|||
30900487|NCT02351960|58933901|FG001|Overall Study|Significant Protocol Deviation|5|||
30730193|NCT00354159|58742868|FG001|Randomized Study Period|Lost to Follow-up|0|||
30730194|NCT00354159|58742867|FG000|Randomized Study Period|Death|7|||
30730195|NCT00354159|58742868|FG001|Randomized Study Period|Death|9|||
30730196|NCT00354159|58742867|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
30730197|NCT00354159|58742868|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
30730198|NCT00354159|58742867|FG000|Long-term Follow-up|Physician Decision|127|||
30730199|NCT00354159|58742868|FG001|Long-term Follow-up|Physician Decision|122|||
30730200|NCT00354159|58742867|FG000|Long-term Follow-up|Lost to Follow-up|1|||
30730201|NCT00354159|58742868|FG001|Long-term Follow-up|Lost to Follow-up|0|||
30730202|NCT00354159|58742867|FG000|Long-term Follow-up|Death|14|||
30730203|NCT00354159|58742868|FG001|Long-term Follow-up|Death|11|||
30730204|NCT00354159|58742867|FG000|Long-term Follow-up|Study Closed|29|||
30730205|NCT00354159|58742868|FG001|Long-term Follow-up|Study Closed|34|||
30730206|NCT00338949|58742883|FG000|Subject Screening|Screen failures|11|||
30730207|NCT00338949|58742884|FG001|Subject Screening|Screen failures|11|||
30730208|NCT00338949|58742883|FG000|Randomization|Withdrawal by Subject|1|||
30730209|NCT00338949|58742884|FG001|Randomization|Withdrawal by Subject|0|||
30730210|NCT00338949|58742883|FG000|Randomization|Adverse Event|0|||
30730211|NCT00338949|58742884|FG001|Randomization|Adverse Event|5|||
30730212|NCT00332709|58742892|FG000|Overall Study|Adverse Event|11|||
30730213|NCT00332709|58742893|FG001|Overall Study|Adverse Event|14|||
30730214|NCT00332709|58742892|FG000|Overall Study|Withdrawal by Subject|2|||
30730215|NCT00332709|58742893|FG001|Overall Study|Withdrawal by Subject|3|||
30730216|NCT00332709|58742892|FG000|Overall Study|Lost to Follow-up|2|||
30730217|NCT00332709|58742893|FG001|Overall Study|Lost to Follow-up|0|||
30730218|NCT00332709|58742892|FG000|Overall Study|Administrative Problems|0|||
30730219|NCT00332709|58742893|FG001|Overall Study|Administrative Problems|3|||
30730220|NCT00332709|58742892|FG000|Overall Study|Abnormal test procedure result|1|||
30730221|NCT00332709|58742893|FG001|Overall Study|Abnormal test procedure result|0|||
30730222|NCT00332241|58742901|FG000|Overall Study|Lack of Efficacy|6|||
30730223|NCT00332241|58742902|FG001|Overall Study|Lack of Efficacy|1|||
30730224|NCT00332241|58742901|FG000|Overall Study|Adverse Event|3|||
30730225|NCT00332241|58742902|FG001|Overall Study|Adverse Event|5|||
30730226|NCT00332241|58742901|FG000|Overall Study|Withdrawal by Subject|2|||
30730227|NCT00332241|58742902|FG001|Overall Study|Withdrawal by Subject|1|||
30730228|NCT00332241|58742901|FG000|Overall Study|Lost to Follow-up|4|||
30730229|NCT00332241|58742902|FG001|Overall Study|Lost to Follow-up|1|||
30730230|NCT00337935|58742910|FG000|Overall Study|Adverse Event|2|||
30730231|NCT00337935|58742911|FG001|Overall Study|Adverse Event|5|||
30730232|NCT00337935|58742910|FG000|Overall Study|Death|2|||
30730233|NCT00337935|58742911|FG001|Overall Study|Death|8|||
30730234|NCT00337935|58742910|FG000|Overall Study|Physician Decision|1|||
30730235|NCT00337935|58742911|FG001|Overall Study|Physician Decision|1|||
30730236|NCT00337935|58742910|FG000|Overall Study|Lost to Follow-up|0|||
30730237|NCT00337935|58742911|FG001|Overall Study|Lost to Follow-up|1|||
30730238|NCT00337935|58742910|FG000|Overall Study|Protocol Violation|4|||
30730239|NCT00337935|58742911|FG001|Overall Study|Protocol Violation|3|||
30730240|NCT00337935|58742910|FG000|Overall Study|Withdrawal by Subject|1|||
30730241|NCT00337935|58742911|FG001|Overall Study|Withdrawal by Subject|7|||
30730242|NCT00337935|58742910|FG000|Overall Study|Other|0|||
30730243|NCT00337935|58742911|FG001|Overall Study|Other|1|||
30730244|NCT00337935|58742910|FG000|Overall Study|Lack of Efficacy|0|||
30730245|NCT00337935|58742911|FG001|Overall Study|Lack of Efficacy|1|||
30730246|NCT00337779|58742920|FG000|Overall Study|Withdrawal by Subject|10|||
30730247|NCT00337779|58742921|FG001|Overall Study|Withdrawal by Subject|12|||
30730248|NCT00337779|58742920|FG000|Overall Study|Sponsor decision|1|||
30730249|NCT00337779|58742921|FG001|Overall Study|Sponsor decision|1|||
30730250|NCT00337779|58742920|FG000|Overall Study|Physician Decision|3|||
30730251|NCT00337779|58742921|FG001|Overall Study|Physician Decision|6|||
30730252|NCT00337779|58742920|FG000|Overall Study|Protocol Violation|1|||
30730253|NCT00337779|58742921|FG001|Overall Study|Protocol Violation|1|||
30730254|NCT00337779|58742920|FG000|Overall Study|Lost to Follow-up|6|||
30730255|NCT00337779|58742921|FG001|Overall Study|Lost to Follow-up|5|||
30730256|NCT00337779|58742920|FG000|Overall Study|Adverse Event|28|||
30730257|NCT00337779|58742921|FG001|Overall Study|Adverse Event|51|||
30730258|NCT00337779|58742920|FG000|Overall Study|Pregnancy|3|||
30730259|NCT00337779|58742921|FG001|Overall Study|Pregnancy|2|||
30730260|NCT00337779|58742920|FG000|Overall Study|Death|0|||
30730261|NCT00337779|58742921|FG001|Overall Study|Death|1|||
30730262|NCT00352755|58742927|FG000|Overall Study|Physician Decision|1|||
30730263|NCT00352755|58742927|FG000|Overall Study|Adverse Event|1|||
30730264|NCT00533897|58742934|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
30730265|NCT00533897|58742935|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
30730266|NCT00533897|58742936|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
30730267|NCT00533897|58742937|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
30730268|NCT00533897|58742938|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
30730269|NCT00533897|58742939|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
30730270|NCT00533897|58742940|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
30730271|NCT00533897|58742941|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
30730272|NCT00533897|58742934|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
30730273|NCT00533897|58742935|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
30730274|NCT00533897|58742936|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
30730275|NCT00533897|58742937|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
30730276|NCT00533897|58742938|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
30730277|NCT00533897|58742939|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
30730278|NCT00533897|58742940|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
30730279|NCT00533897|58742941|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
30730280|NCT00533897|58742934|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
30730281|NCT00533897|58742935|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
30730282|NCT00533897|58742936|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
30730283|NCT00533897|58742937|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
30730284|NCT00533897|58742938|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
30730285|NCT00533897|58742939|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
30730286|NCT00533897|58742940|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
30730287|NCT00533897|58742941|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
30730288|NCT00533897|58742934|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
30730289|NCT00533897|58742935|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
30730290|NCT00533897|58742936|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
30730291|NCT00533897|58742937|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
30730292|NCT00533897|58742938|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
30730293|NCT00533897|58742939|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
30730294|NCT00533897|58742940|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
30730295|NCT00533897|58742941|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
30730296|NCT00533897|58742934|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
30730297|NCT00533897|58742935|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
30730298|NCT00533897|58742936|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
30730299|NCT00533897|58742937|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
30730300|NCT00533897|58742938|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
30730301|NCT00533897|58742939|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
30730302|NCT00533897|58742940|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
30730303|NCT00533897|58742941|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
30730304|NCT00533897|58742934|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
30730305|NCT00533897|58742935|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
30730306|NCT00533897|58742936|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
30730307|NCT00533897|58742937|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
30730308|NCT00533897|58742938|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
30730309|NCT00533897|58742939|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
30730310|NCT00533897|58742940|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
30730311|NCT00533897|58742941|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
30730312|NCT00533897|58742934|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
30730313|NCT00533897|58742935|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
30730314|NCT00533897|58742936|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
30730315|NCT00533897|58742937|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
30730316|NCT00533897|58742938|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
30730317|NCT00533897|58742939|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
30900488|NCT02351180|58933910|FG000|Overall Study|Withdrawal by Subject|1|||
30900489|NCT02351180|58933911|FG001|Overall Study|Withdrawal by Subject|0|||
30730318|NCT00533897|58742940|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
30730319|NCT00533897|58742941|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
30730320|NCT00533897|58742934|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
30730321|NCT00533897|58742935|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
30730322|NCT00533897|58742936|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
30730323|NCT00533897|58742937|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
30900490|NCT02350478|58933919|FG000|Overall Study|Lost to Follow-up|5|||
30900491|NCT02350478|58933920|FG001|Overall Study|Lost to Follow-up|1|||
30900492|NCT02349542|58933926|FG000|Overall Study|Withdrawal by Subject|5|||
30730324|NCT00533897|58742938|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
30730325|NCT00533897|58742939|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
30730326|NCT00533897|58742940|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
30730327|NCT00533897|58742941|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
30730328|NCT00533897|58742934|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
30730329|NCT00533897|58742935|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
30730330|NCT00533897|58742936|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
30730331|NCT00533897|58742937|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
30730332|NCT00533897|58742938|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
30730333|NCT00533897|58742939|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
30730334|NCT00533897|58742940|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
30730335|NCT00533897|58742941|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
30730336|NCT00533897|58742934|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
30730337|NCT00533897|58742935|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
30730338|NCT00533897|58742936|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
30730339|NCT00533897|58742937|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
30730340|NCT00533897|58742938|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
30730341|NCT00533897|58742939|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
30730342|NCT00533897|58742940|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
30730343|NCT00533897|58742941|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
30730344|NCT00533897|58742934|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
30730345|NCT00533897|58742935|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
30730346|NCT00533897|58742936|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
30730347|NCT00533897|58742937|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
30730348|NCT00533897|58742938|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
30730349|NCT00533897|58742939|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
30730350|NCT00533897|58742940|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
30730351|NCT00533897|58742941|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
30730352|NCT00533897|58742934|FG000|Long Term Extension (LTE)|Death|0|||
30730353|NCT00533897|58742935|FG001|Long Term Extension (LTE)|Death|0|||
30730354|NCT00533897|58742936|FG002|Long Term Extension (LTE)|Death|0|||
30730355|NCT00533897|58742937|FG003|Long Term Extension (LTE)|Death|0|||
30730356|NCT00533897|58742938|FG004|Long Term Extension (LTE)|Death|0|||
30730357|NCT00533897|58742939|FG005|Long Term Extension (LTE)|Death|0|||
30730358|NCT00533897|58742940|FG006|Long Term Extension (LTE)|Death|1|||
30730359|NCT00533897|58742941|FG007|Long Term Extension (LTE)|Death|3|||
30730360|NCT00533897|58742934|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
30730361|NCT00533897|58742935|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
30730362|NCT00533897|58742936|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
30730363|NCT00533897|58742937|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
30730364|NCT00533897|58742938|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
30730365|NCT00533897|58742939|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
30730366|NCT00533897|58742940|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
30730367|NCT00533897|58742941|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
30730368|NCT00533897|58742934|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
30730369|NCT00533897|58742935|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
30730370|NCT00533897|58742936|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
30730371|NCT00533897|58742937|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
30730372|NCT00533897|58742938|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
30730373|NCT00533897|58742939|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
30730374|NCT00533897|58742940|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
30730375|NCT00533897|58742941|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
30730376|NCT00533897|58742934|FG000|Long Term Extension (LTE)|Adverse Event|0|||
30900493|NCT02321930|58933930|FG000|Overall Study|Lost to Follow-up|1|||
30730377|NCT00533897|58742935|FG001|Long Term Extension (LTE)|Adverse Event|0|||
30730378|NCT00533897|58742936|FG002|Long Term Extension (LTE)|Adverse Event|0|||
30730379|NCT00533897|58742937|FG003|Long Term Extension (LTE)|Adverse Event|0|||
30730380|NCT00533897|58742938|FG004|Long Term Extension (LTE)|Adverse Event|0|||
30730381|NCT00533897|58742939|FG005|Long Term Extension (LTE)|Adverse Event|0|||
30730382|NCT00533897|58742940|FG006|Long Term Extension (LTE)|Adverse Event|2|||
30730383|NCT00533897|58742941|FG007|Long Term Extension (LTE)|Adverse Event|5|||
30730384|NCT00533897|58742934|FG000|Long Term Extension (LTE)|Pregnancy|0|||
30730385|NCT00533897|58742935|FG001|Long Term Extension (LTE)|Pregnancy|0|||
30730386|NCT00533897|58742936|FG002|Long Term Extension (LTE)|Pregnancy|0|||
30730387|NCT00533897|58742937|FG003|Long Term Extension (LTE)|Pregnancy|0|||
30730388|NCT00533897|58742938|FG004|Long Term Extension (LTE)|Pregnancy|0|||
30730389|NCT00533897|58742939|FG005|Long Term Extension (LTE)|Pregnancy|0|||
30730390|NCT00533897|58742940|FG006|Long Term Extension (LTE)|Pregnancy|0|||
30730391|NCT00533897|58742941|FG007|Long Term Extension (LTE)|Pregnancy|2|||
30730392|NCT00533897|58742934|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
30730393|NCT00533897|58742935|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
30730394|NCT00533897|58742936|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
30730395|NCT00533897|58742937|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
30730396|NCT00533897|58742938|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
30730397|NCT00533897|58742939|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
30730398|NCT00533897|58742940|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
30730399|NCT00533897|58742941|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
30730400|NCT00533897|58742934|FG000|Long Term Extension (LTE)|Other|0|||
30730401|NCT00533897|58742935|FG001|Long Term Extension (LTE)|Other|0|||
30730402|NCT00533897|58742936|FG002|Long Term Extension (LTE)|Other|0|||
30730403|NCT00533897|58742937|FG003|Long Term Extension (LTE)|Other|0|||
30730404|NCT00533897|58742938|FG004|Long Term Extension (LTE)|Other|0|||
30730405|NCT00533897|58742939|FG005|Long Term Extension (LTE)|Other|0|||
30730406|NCT00533897|58742940|FG006|Long Term Extension (LTE)|Other|1|||
30730407|NCT00533897|58742941|FG007|Long Term Extension (LTE)|Other|6|||
30730408|NCT00426660|58742972|FG000|Overall Study|Death|14|||
30730409|NCT00426660|58742972|FG000|Overall Study|Adverse Event|23|||
30730410|NCT00426660|58742972|FG000|Overall Study|Insufficient Clinical Response|22|||
30730411|NCT00426660|58742972|FG000|Overall Study|Lost to Follow-up|15|||
30730412|NCT00426660|58742972|FG000|Overall Study|Other|23|||
30730413|NCT00426660|58742972|FG000|Overall Study|Withdrawal by Subject|18|||
30730414|NCT00426660|58742972|FG000|Overall Study|Protocol Violation|1|||
30730415|NCT00426660|58742972|FG000|Overall Study|Enrolled Not Treated|15|||
30730416|NCT00426270|58742976|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
30730417|NCT00426270|58742976|FG000|Overall Study|Adverse Event|5|||
30730418|NCT00330681|58742982|FG000|Overall Study|Adverse Event|3|||
30730419|NCT00330681|58742983|FG001|Overall Study|Adverse Event|6|||
30730420|NCT00330681|58742982|FG000|Overall Study|Protocol Violation|0|||
30730421|NCT00330681|58742983|FG001|Overall Study|Protocol Violation|1|||
30730422|NCT00330681|58742982|FG000|Overall Study|Withdrawal by Subject|5|||
30730423|NCT00330681|58742983|FG001|Overall Study|Withdrawal by Subject|5|||
30730424|NCT00330681|58742982|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
30730425|NCT00330681|58742983|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
30730426|NCT00329901|58742992|FG000|Overall Study|Withdrawal by Subject|4|||
30730427|NCT00329901|58742993|FG001|Overall Study|Withdrawal by Subject|3|||
30730428|NCT00329901|58742994|FG002|Overall Study|Withdrawal by Subject|2|||
30730429|NCT00329901|58742992|FG000|Overall Study|Lost to Follow-up|2|||
30730430|NCT00329901|58742993|FG001|Overall Study|Lost to Follow-up|0|||
30730431|NCT00329901|58742994|FG002|Overall Study|Lost to Follow-up|1|||
30730432|NCT00329901|58742992|FG000|Overall Study|Protocol Violation|1|||
30730433|NCT00329901|58742993|FG001|Overall Study|Protocol Violation|0|||
30730434|NCT00329901|58742994|FG002|Overall Study|Protocol Violation|1|||
30730435|NCT00329901|58742992|FG000|Overall Study|Unable to classify|2|||
30730436|NCT00329901|58742993|FG001|Overall Study|Unable to classify|2|||
30621798|NCT01181531|58633343|FG000|Overall Study|Death|9|||
30730437|NCT00329901|58742994|FG002|Overall Study|Unable to classify|0|||
30621799|NCT01181531|58633344|FG001|Overall Study|Death|12|||
30730438|NCT00436956|58743006|FG000|Overall Study|Not evaluable|1|||
30730439|NCT00436956|58743007|FG001|Overall Study|Not evaluable|0|||
30730440|NCT00329745|58743016|FG000|Overall Study|Protocol Violation|1|||
30621800|NCT01181531|58633343|FG000|Overall Study|Adverse Event|0|||
30730441|NCT00329745|58743017|FG001|Overall Study|Protocol Violation|0|||
30730442|NCT00329745|58743016|FG000|Overall Study|Withdrawal by Subject|0|||
30730443|NCT00329745|58743017|FG001|Overall Study|Withdrawal by Subject|1|||
30730444|NCT00329745|58743016|FG000|Overall Study|Lost to Follow-up|86|||
30730445|NCT00329745|58743017|FG001|Overall Study|Lost to Follow-up|101|||
30730446|NCT00436644|58743023|FG000|Overall Study|Adverse Event|2|||
30730447|NCT00436644|58743023|FG000|Overall Study|Death|1|||
30730448|NCT00324987|58743029|FG000|Overall Study|Adverse Event|2|||
30730449|NCT00324987|58743030|FG001|Overall Study|Adverse Event|1|||
30730450|NCT00324987|58743029|FG000|Overall Study|Withdrawal by Subject|1|||
30730451|NCT00324987|58743030|FG001|Overall Study|Withdrawal by Subject|1|||
30730452|NCT00324987|58743029|FG000|Overall Study|Progression|1|||
30730453|NCT00324987|58743030|FG001|Overall Study|Progression|1|||
30730454|NCT00324987|58743029|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
30730455|NCT00324987|58743030|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
30730456|NCT00324675|58743038|FG000|Overall Study|Adverse Event|1|||
30730457|NCT00324675|58743039|FG001|Overall Study|Adverse Event|0|||
30730458|NCT00436566|58743045|FG000|Overall Study|Withdrawal by Subject|2|||
30730459|NCT00436566|58743045|FG000|Overall Study|Protocol Violation|1|||
30730460|NCT00352365|58743049|FG000|Induction Therapy|Adverse Event|7|||
30730461|NCT00352365|58743049|FG000|Induction Therapy|Progression/Relapse|8|||
30730462|NCT00352365|58743049|FG000|Induction Therapy|Death|7|||
30730463|NCT00352365|58743049|FG000|Induction Therapy|Not protocol specified|1|||
30730464|NCT00352365|58743049|FG000|Induction Therapy|Not eligible|3|||
30730465|NCT00352365|58743049|FG000|Induction Therapy|Death before starting protocol therapy|1|||
30730466|NCT00352365|58743049|FG000|Maintenance Therapy|Progression/Relapse|3|||
30730467|NCT00352365|58743049|FG000|Maintenance Therapy|Death|2|||
30730468|NCT00352365|58743049|FG000|Maintenance Therapy|Not protocol specified|3|||
30730469|NCT00352365|58743049|FG000|Maintenance Therapy|Not eligible|4|||
30730470|NCT00532493|58743059|FG000|Overall Study|Death|1|||
30730471|NCT00532493|58743060|FG001|Overall Study|Death|1|||
30730472|NCT00532493|58743059|FG000|Overall Study|Lost to Follow-up|10|||
30730473|NCT00532493|58743060|FG001|Overall Study|Lost to Follow-up|7|||
30730474|NCT00532493|58743059|FG000|Overall Study|Withdrawal by Subject|7|||
30730475|NCT00532493|58743060|FG001|Overall Study|Withdrawal by Subject|9|||
30730476|NCT00532493|58743059|FG000|Overall Study|Physician Decision|1|||
30730477|NCT00532493|58743060|FG001|Overall Study|Physician Decision|6|||
30730478|NCT00532493|58743059|FG000|Overall Study|Adverse Event|6|||
30730479|NCT00532493|58743060|FG001|Overall Study|Adverse Event|5|||
30730480|NCT00532493|58743059|FG000|Overall Study|Protocol Deviation|1|||
30730481|NCT00532493|58743060|FG001|Overall Study|Protocol Deviation|0|||
30730482|NCT00532493|58743059|FG000|Overall Study|Subject Moved Away|3|||
30730483|NCT00532493|58743060|FG001|Overall Study|Subject Moved Away|1|||
30730484|NCT00532493|58743059|FG000|Overall Study|Contraindicative Medication|1|||
30730485|NCT00532493|58743060|FG001|Overall Study|Contraindicative Medication|0|||
30730486|NCT00533507|58743068|FG000|Overall Study|Withdrawal by Subject|1|||
30730487|NCT03886493|58743072|FG000|Overall Study|Adverse Event|1|||
30730488|NCT00352053|58743078|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
30730489|NCT00352053|58743079|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
30730490|NCT00352053|58743078|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
30730491|NCT00352053|58743079|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
30730492|NCT00352053|58743078|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
30730493|NCT00352053|58743079|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
30730494|NCT00352053|58743078|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
30730495|NCT00352053|58743079|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
30730496|NCT00352053|58743078|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
30730497|NCT00352053|58743079|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
30730498|NCT00352053|58743078|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
30730499|NCT00352053|58743079|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
30730500|NCT00352053|58743078|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
30730501|NCT00352053|58743079|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
30730502|NCT00352053|58743078|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
30730503|NCT00352053|58743079|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
30730504|NCT00352053|58743078|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
30730505|NCT00352053|58743079|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
30730506|NCT00352053|58743078|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
30730507|NCT00352053|58743079|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
30730508|NCT00352053|58743078|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
30730509|NCT00352053|58743079|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
30730510|NCT00352053|58743078|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
30730511|NCT00352053|58743079|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
30730512|NCT00352053|58743078|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
30730513|NCT00352053|58743079|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
30730514|NCT00351819|58743095|FG000|Overall Study|Lost to Follow-up|4|||
30730515|NCT00351819|58743096|FG001|Overall Study|Lost to Follow-up|4|||
30900494|NCT01647542|58933937|FG000|Overall Study|Major Protocol Deviation|1|||
30900495|NCT01647542|58933938|FG001|Overall Study|Major Protocol Deviation|0|||
30900496|NCT01647542|58933939|FG002|Overall Study|Major Protocol Deviation|0|||
30730516|NCT00351819|58743095|FG000|Overall Study|Withdrawal by Subject|0|||
30730517|NCT00351819|58743096|FG001|Overall Study|Withdrawal by Subject|4|||
30730518|NCT00351819|58743095|FG000|Overall Study|Elevated PSA|1|||
30730519|NCT00351819|58743096|FG001|Overall Study|Elevated PSA|1|||
30730520|NCT00351819|58743095|FG000|Overall Study|Traumatic ankle fracture|1|||
30900497|NCT01647542|58933937|FG000|Overall Study|Adverse Event|4|||
30730521|NCT00351819|58743096|FG001|Overall Study|Traumatic ankle fracture|0|||
30730522|NCT00351819|58743095|FG000|Overall Study|Unprofessional behavior|1|||
30730523|NCT00351819|58743096|FG001|Overall Study|Unprofessional behavior|0|||
30730524|NCT00351819|58743095|FG000|Overall Study|Non-compliance|0|||
30730525|NCT00351819|58743096|FG001|Overall Study|Non-compliance|1|||
30730526|NCT00351819|58743095|FG000|Overall Study|Incarcerated|0|||
30730527|NCT00351819|58743096|FG001|Overall Study|Incarcerated|1|||
30730528|NCT00351819|58743095|FG000|Overall Study|Enrolled in another trial|0|||
30730529|NCT00351819|58743096|FG001|Overall Study|Enrolled in another trial|1|||
30730530|NCT00351351|58743104|FG000|Overall Study|surgical access pbs; device issues|9|||
30730531|NCT00351351|58743105|FG001|Overall Study|surgical access pbs; device issues|4|||
30730532|NCT00323115|58743111|FG000|Vaccine Administration|Adverse Event|1|||
30730533|NCT00323115|58743111|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
30730534|NCT00322881|58743120|FG000|Overall Study|Death|2|||
30730535|NCT00322881|58743120|FG000|Overall Study|Adverse Event|1|||
30730536|NCT00322881|58743120|FG000|Overall Study|Disease Progression|2|||
30730537|NCT00415194|58743126|FG000|Overall Study|Adverse Event|37|||
30730538|NCT00415194|58743127|FG001|Overall Study|Adverse Event|32|||
30730539|NCT00415194|58743126|FG000|Overall Study|Entry Criteria Not Met|4|||
30730540|NCT00415194|58743127|FG001|Overall Study|Entry Criteria Not Met|8|||
30730541|NCT00415194|58743126|FG000|Overall Study|Lost to Follow-up|1|||
30730542|NCT00415194|58743127|FG001|Overall Study|Lost to Follow-up|0|||
30730543|NCT00415194|58743126|FG000|Overall Study|Physician Decision|10|||
30730544|NCT00415194|58743127|FG001|Overall Study|Physician Decision|16|||
30730545|NCT00415194|58743126|FG000|Overall Study|Progressive Disease|180|||
30730546|NCT00415194|58743127|FG001|Overall Study|Progressive Disease|217|||
30730547|NCT00415194|58743126|FG000|Overall Study|Protocol Violation|4|||
30730548|NCT00415194|58743127|FG001|Overall Study|Protocol Violation|2|||
30730549|NCT00415194|58743126|FG000|Overall Study|Withdrawal by Subject|28|||
30730550|NCT00415194|58743127|FG001|Overall Study|Withdrawal by Subject|21|||
30730551|NCT00415194|58743126|FG000|Overall Study|Death Due to Study Disease|26|||
30730552|NCT00415194|58743127|FG001|Overall Study|Death Due to Study Disease|29|||
30730553|NCT00415194|58743126|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
30730554|NCT00415194|58743127|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
30730555|NCT00415194|58743126|FG000|Overall Study|Death Due to Procedural Related AE|0|||
30730556|NCT00415194|58743127|FG001|Overall Study|Death Due to Procedural Related AE|1|||
30730557|NCT00415194|58743126|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
30730558|NCT00415194|58743127|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
30730559|NCT00436332|58743133|FG000|Overall Study|Adverse Event|9|||
30730560|NCT00436332|58743133|FG000|Overall Study|Withdrawal by Subject|2|||
30730561|NCT00436332|58743133|FG000|Overall Study|Progression|59|||
30730562|NCT00436332|58743133|FG000|Overall Study|Death|2|||
30730563|NCT00436332|58743133|FG000|Overall Study|Not Protocol Specified|6|||
30730564|NCT00436332|58743133|FG000|Overall Study|Ineligible|2|||
30730565|NCT00436332|58743133|FG000|Overall Study|Never Received Treatment|3|||
30730566|NCT00532259|58743137|FG000|Overall Study|Withdrawal by Subject|2|||
30730567|NCT00532259|58743137|FG000|Overall Study|Adverse Event|1|||
30730568|NCT00532259|58743137|FG000|Overall Study|Death|1|||
30730569|NCT00532259|58743137|FG000|Overall Study|Lack of Efficacy|21|||
30730570|NCT00532259|58743137|FG000|Overall Study|Lost to Follow-up|3|||
30730571|NCT00532259|58743137|FG000|Overall Study|Physician Decision|3|||
30730572|NCT00532259|58743137|FG000|Overall Study|Protocol Violation|1|||
30730573|NCT00322491|58743144|FG000|Overall Study|Adverse Event|1|||
30730574|NCT00322491|58743145|FG001|Overall Study|Adverse Event|0|||
30730575|NCT00322491|58743144|FG000|Overall Study|Death|1|||
30730576|NCT00322491|58743145|FG001|Overall Study|Death|2|||
30730577|NCT00322023|58743155|FG000|Overall Study|various|0|||
30730578|NCT00322023|58743156|FG001|Overall Study|various|2|||
30730579|NCT00322023|58743157|FG002|Overall Study|various|6|||
30730580|NCT00414960|58743167|FG000|Overall Study|Adverse Event|4|||
30730581|NCT00414960|58743168|FG001|Overall Study|Adverse Event|0|||
30730582|NCT00414960|58743167|FG000|Overall Study|Withdrawal by Subject|3|||
30730583|NCT00414960|58743168|FG001|Overall Study|Withdrawal by Subject|0|||
30730584|NCT00414960|58743167|FG000|Overall Study|Physician Decision|0|||
30730585|NCT00414960|58743168|FG001|Overall Study|Physician Decision|1|||
30730586|NCT00321789|58743176|FG000|Overall Study|Lost to Follow-up|4|||
30730587|NCT00321789|58743177|FG001|Overall Study|Lost to Follow-up|7|||
30730588|NCT00321789|58743176|FG000|Overall Study|Withdrawal by Subject|6|||
30730589|NCT00321789|58743177|FG001|Overall Study|Withdrawal by Subject|6|||
30730590|NCT00321789|58743176|FG000|Overall Study|Protocol Violation|5|||
30730591|NCT00321789|58743177|FG001|Overall Study|Protocol Violation|3|||
30730592|NCT00414726|58743185|FG000|Overall Study|Withdrawal by Subject|0|||
30730593|NCT00414726|58743186|FG001|Overall Study|Withdrawal by Subject|1|||
30730594|NCT00531947|58743194|FG000|Overall Study|Adverse Event|5|||
30730595|NCT00531947|58743195|FG001|Overall Study|Adverse Event|10|||
30730596|NCT00531947|58743194|FG000|Overall Study|Lost to Follow-up|12|||
30730597|NCT00531947|58743195|FG001|Overall Study|Lost to Follow-up|9|||
30730598|NCT00531947|58743194|FG000|Overall Study|Withdrawal by Subject|14|||
30730599|NCT00531947|58743195|FG001|Overall Study|Withdrawal by Subject|19|||
30730600|NCT00531947|58743194|FG000|Overall Study|Protocol Violation|2|||
30730601|NCT00531947|58743195|FG001|Overall Study|Protocol Violation|1|||
30730602|NCT00531947|58743194|FG000|Overall Study|Non-Compliance|4|||
30730603|NCT00531947|58743195|FG001|Overall Study|Non-Compliance|7|||
30730604|NCT00531947|58743194|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
30730605|NCT00531947|58743195|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
30730606|NCT00530855|58743201|FG000|Overall Study|Lack of Efficacy|20|||
30730607|NCT00530855|58743201|FG000|Overall Study|Withdrawal by Subject|30|||
30730608|NCT00530855|58743201|FG000|Overall Study|Fatal Serious AE|3|||
30730609|NCT00530855|58743201|FG000|Overall Study|Non Fatal Serious AE|7|||
30730610|NCT00530855|58743201|FG000|Overall Study|Non Fatal Non Serious AE|12|||
30730611|NCT00530855|58743201|FG000|Overall Study|Protocol Violation|3|||
30730612|NCT00530855|58743201|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
30730613|NCT00530855|58743201|FG000|Overall Study|Lost to Follow-up|9|||
30730614|NCT00530855|58743201|FG000|Overall Study|Other reason for premature termination|17|||
30730615|NCT00530777|58743207|FG000|Overall Study|Lost to Follow-up|0|||
30730616|NCT00530777|58743208|FG001|Overall Study|Lost to Follow-up|1|||
30730617|NCT00530777|58743207|FG000|Overall Study|Death|1|||
30730618|NCT00530777|58743208|FG001|Overall Study|Death|2|||
30730619|NCT00530777|58743207|FG000|Overall Study|Physician Decision|1|||
30730620|NCT00530777|58743208|FG001|Overall Study|Physician Decision|0|||
30730621|NCT00530777|58743207|FG000|Overall Study|Withdrawal by Subject|0|||
30730622|NCT00530777|58743208|FG001|Overall Study|Withdrawal by Subject|1|||
30730623|NCT00530777|58743207|FG000|Overall Study|Unable to adhere to visit schedule|5|||
30730624|NCT00530777|58743208|FG001|Overall Study|Unable to adhere to visit schedule|1|||
30730625|NCT03882047|58743217|FG000|Overall Study|Adverse Event|0|||
30730626|NCT03882047|58743218|FG001|Overall Study|Adverse Event|2|||
30730627|NCT03882047|58743219|FG002|Overall Study|Adverse Event|2|||
30730628|NCT03882047|58743217|FG000|Overall Study|Treatment Failure|3|||
30730629|NCT03882047|58743218|FG001|Overall Study|Treatment Failure|3|||
30730630|NCT03882047|58743219|FG002|Overall Study|Treatment Failure|12|||
30730631|NCT03882047|58743217|FG000|Overall Study|Lost to Follow-up|0|||
30730632|NCT03882047|58743218|FG001|Overall Study|Lost to Follow-up|1|||
30730633|NCT03882047|58743219|FG002|Overall Study|Lost to Follow-up|0|||
30730634|NCT03882047|58743217|FG000|Overall Study|Did Not Wish to Continue|1|||
30730635|NCT03882047|58743218|FG001|Overall Study|Did Not Wish to Continue|4|||
30730636|NCT03882047|58743219|FG002|Overall Study|Did Not Wish to Continue|1|||
30730637|NCT03882047|58743217|FG000|Overall Study|Noncompliance With Protocol|2|||
30730638|NCT03882047|58743218|FG001|Overall Study|Noncompliance With Protocol|0|||
30730639|NCT03882047|58743219|FG002|Overall Study|Noncompliance With Protocol|0|||
30730640|NCT03882047|58743217|FG000|Overall Study|Did Not Meet Eligibility|0|||
30730641|NCT03882047|58743218|FG001|Overall Study|Did Not Meet Eligibility|0|||
30730642|NCT03882047|58743219|FG002|Overall Study|Did Not Meet Eligibility|1|||
30730643|NCT00530621|58743229|FG000|Overall Study|Adverse Event|11|||
30730644|NCT00530621|58743230|FG001|Overall Study|Adverse Event|8|||
30730645|NCT00530621|58743229|FG000|Overall Study|Physician Decision|2|||
30730646|NCT00530621|58743230|FG001|Overall Study|Physician Decision|4|||
30730647|NCT00530621|58743229|FG000|Overall Study|Progressive Disease (PD)|47|||
30730648|NCT00530621|58743230|FG001|Overall Study|Progressive Disease (PD)|40|||
30730649|NCT00530621|58743229|FG000|Overall Study|Sponsor Decision|12|||
30730650|NCT00530621|58743230|FG001|Overall Study|Sponsor Decision|15|||
30730651|NCT00530621|58743229|FG000|Overall Study|Subject Decision|4|||
30730652|NCT00530621|58743230|FG001|Overall Study|Subject Decision|7|||
30730653|NCT00530621|58743229|FG000|Overall Study|Death|3|||
30730654|NCT00530621|58743230|FG001|Overall Study|Death|6|||
30730655|NCT00530621|58743229|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
30730656|NCT00530621|58743230|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
30730657|NCT00531479|58743242|FG000|Overall Study|Death|68|||
30730658|NCT00531479|58743243|FG001|Overall Study|Death|71|||
30730659|NCT00531479|58743242|FG000|Overall Study|Lost to Follow-up|0|||
30730660|NCT00531479|58743243|FG001|Overall Study|Lost to Follow-up|2|||
30730661|NCT00531479|58743242|FG000|Overall Study|Other|0|||
30730662|NCT00531479|58743243|FG001|Overall Study|Other|1|||
30730663|NCT00531479|58743242|FG000|Overall Study|Withdrawal by Subject|6|||
30730664|NCT00531479|58743243|FG001|Overall Study|Withdrawal by Subject|6|||
30730665|NCT00531479|58743242|FG000|Overall Study|Did not receive treatment|2|||
30730666|NCT00531479|58743243|FG001|Overall Study|Did not receive treatment|3|||
30730667|NCT00530075|58743249|FG000|Overall Study|Adverse Event|1|||
30730668|NCT00530075|58743249|FG000|Overall Study|Death|1|||
30730669|NCT00530075|58743249|FG000|Overall Study|Lack of Efficacy|3|||
30730670|NCT00530075|58743249|FG000|Overall Study|Protocol Violation|1|||
30730671|NCT00530075|58743249|FG000|Overall Study|Withdrawal by Subject|1|||
30730672|NCT00531011|58743255|FG000|Overall Study|Withdrawal by Subject|2|||
30730673|NCT00531011|58743256|FG001|Overall Study|Withdrawal by Subject|4|||
30730674|NCT00531011|58743255|FG000|Overall Study|Death|1|||
30730675|NCT00531011|58743256|FG001|Overall Study|Death|0|||
30730676|NCT00531011|58743255|FG000|Overall Study|Lost to Follow-up|1|||
30730677|NCT00531011|58743256|FG001|Overall Study|Lost to Follow-up|0|||
30730678|NCT00531011|58743255|FG000|Overall Study|Physician Decision|0|||
30730679|NCT00531011|58743256|FG001|Overall Study|Physician Decision|3|||
30730680|NCT00529217|58743262|FG000|Overall Study|Lack of Efficacy|2|||
30730681|NCT00529217|58743262|FG000|Overall Study|Unable to adhere to study schedule|2|||
30730682|NCT00471146|58743269|FG000|Overall Study|Adverse Event|32|||
30730683|NCT00471146|58743270|FG001|Overall Study|Adverse Event|33|||
30730684|NCT00471146|58743269|FG000|Overall Study|Withdrawal by Subject|14|||
30730685|NCT00471146|58743270|FG001|Overall Study|Withdrawal by Subject|11|||
30730686|NCT00471146|58743269|FG000|Overall Study|Death|11|||
30730687|NCT00471146|58743270|FG001|Overall Study|Death|12|||
30730688|NCT00471146|58743269|FG000|Overall Study|Lost to Follow-up|4|||
30730689|NCT00471146|58743270|FG001|Overall Study|Lost to Follow-up|2|||
30730690|NCT00471146|58743269|FG000|Overall Study|Protocol Violation|2|||
30730691|NCT00471146|58743270|FG001|Overall Study|Protocol Violation|2|||
30730692|NCT00471146|58743269|FG000|Overall Study|Objective progression or relapse|84|||
30730693|NCT00471146|58743270|FG001|Overall Study|Objective progression or relapse|87|||
30730694|NCT00471146|58743269|FG000|Overall Study|Global deterioration of health status|12|||
30730695|NCT00471146|58743270|FG001|Overall Study|Global deterioration of health status|14|||
30730696|NCT00471146|58743269|FG000|Overall Study|Randomized but not treated|9|||
30730697|NCT00471146|58743270|FG001|Overall Study|Randomized but not treated|8|||
30730698|NCT00471146|58743269|FG000|Overall Study|Other|4|||
30730699|NCT00471146|58743270|FG001|Overall Study|Other|5|||
30730700|NCT00469898|58743276|FG000|Overall Study|Adverse Event|7|||
30730701|NCT00469898|58743276|FG000|Overall Study|Withdrawal by Subject|4|||
30730702|NCT00469898|58743276|FG000|Overall Study|Death|4|||
30730703|NCT00469898|58743276|FG000|Overall Study|Disease progression|9|||
30730704|NCT00469898|58743276|FG000|Overall Study|Decreased performance status|1|||
30730705|NCT00529763|58743283|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
30730706|NCT00529763|58743284|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
30730707|NCT00529763|58743285|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
30730708|NCT00529763|58743283|FG000|Overall Study|Death|1|||
30730709|NCT00529763|58743284|FG001|Overall Study|Death|1|||
30730710|NCT00529763|58743285|FG002|Overall Study|Death|1|||
30730711|NCT00529763|58743283|FG000|Overall Study|Disease Progression|10|||
30730712|NCT00529763|58743284|FG001|Overall Study|Disease Progression|16|||
30730713|NCT00529763|58743285|FG002|Overall Study|Disease Progression|11|||
30730714|NCT00529763|58743283|FG000|Overall Study|Lost to Follow-up|1|||
30730715|NCT00529763|58743284|FG001|Overall Study|Lost to Follow-up|2|||
30730716|NCT00529763|58743285|FG002|Overall Study|Lost to Follow-up|3|||
30730717|NCT00529763|58743283|FG000|Overall Study|Stem Cell Transplant|0|||
30730718|NCT00529763|58743284|FG001|Overall Study|Stem Cell Transplant|3|||
30730719|NCT00529763|58743285|FG002|Overall Study|Stem Cell Transplant|1|||
30730720|NCT00529763|58743283|FG000|Overall Study|Study Drug Toxicity|3|||
30730721|NCT00529763|58743284|FG001|Overall Study|Study Drug Toxicity|6|||
30730722|NCT00529763|58743285|FG002|Overall Study|Study Drug Toxicity|4|||
30730723|NCT00529763|58743283|FG000|Overall Study|Participant Withdrew Consent|2|||
30730724|NCT00529763|58743284|FG001|Overall Study|Participant Withdrew Consent|3|||
30730725|NCT00529763|58743285|FG002|Overall Study|Participant Withdrew Consent|4|||
30730726|NCT00529763|58743283|FG000|Overall Study|Other reasons|2|||
30730727|NCT00529763|58743284|FG001|Overall Study|Other reasons|0|||
30730728|NCT00529763|58743285|FG002|Overall Study|Other reasons|2|||
30730729|NCT00529763|58743283|FG000|Overall Study|Participant request to discontinue treatment|1|||
30730730|NCT00529763|58743284|FG001|Overall Study|Participant request to discontinue treatment|1|||
30730731|NCT00529763|58743285|FG002|Overall Study|Participant request to discontinue treatment|3|||
30730732|NCT00486902|58743300|FG000|Overall Study|Withdrawal by Subject|1|||
30730733|NCT00486902|58743301|FG001|Overall Study|Withdrawal by Subject|2|||
30730734|NCT00486902|58743300|FG000|Overall Study|decision for postpartum tubal ligation|3|||
30730735|NCT00486902|58743301|FG001|Overall Study|decision for postpartum tubal ligation|1|||
30730736|NCT00486902|58743300|FG000|Overall Study|spinal anesthetic protocal violation|1|||
30730737|NCT00486902|58743301|FG001|Overall Study|spinal anesthetic protocal violation|1|||
30730738|NCT00486902|58743300|FG000|Overall Study|Did not meet inclusion criteria|1|||
30621801|NCT01181531|58633344|FG001|Overall Study|Adverse Event|1|||
30730739|NCT00486902|58743301|FG001|Overall Study|Did not meet inclusion criteria|0|||
30730740|NCT00486902|58743300|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
30730741|NCT00486902|58743301|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
30730742|NCT03687827|58743307|FG000|Treatment Period 1|Death|0|||
30730743|NCT03687827|58743308|FG001|Treatment Period 1|Death|1|||
30730744|NCT03687827|58743307|FG000|Treatment Period 1|Lost to Follow-up|2|||
30730745|NCT03687827|58743308|FG001|Treatment Period 1|Lost to Follow-up|2|||
30730746|NCT03687827|58743307|FG000|Treatment Period 1|Physician Decision|5|||
30730747|NCT03687827|58743308|FG001|Treatment Period 1|Physician Decision|2|||
30730748|NCT03687827|58743307|FG000|Treatment Period 1|Withdrawal by Subject|7|||
30730749|NCT03687827|58743308|FG001|Treatment Period 1|Withdrawal by Subject|3|||
30730750|NCT03687827|58743307|FG000|Treatment Period 2|Physician Decision|4|||
30730751|NCT03687827|58743308|FG001|Treatment Period 2|Physician Decision|1|||
30730752|NCT03687827|58743307|FG000|Treatment Period 2|Withdrawal by Subject|1|||
30730753|NCT03687827|58743308|FG001|Treatment Period 2|Withdrawal by Subject|2|||
30730754|NCT00529529|58743317|FG000|Overall Study|Adverse Event|12|||
30730755|NCT00529529|58743318|FG001|Overall Study|Adverse Event|17|||
30730756|NCT00529529|58743319|FG002|Overall Study|Adverse Event|8|||
30730757|NCT00529529|58743317|FG000|Overall Study|Subject withdrew consent|12|||
30730758|NCT00529529|58743318|FG001|Overall Study|Subject withdrew consent|9|||
30730759|NCT00529529|58743319|FG002|Overall Study|Subject withdrew consent|12|||
30730760|NCT00529529|58743317|FG000|Overall Study|Protocol deviation|8|||
30730761|NCT00529529|58743318|FG001|Overall Study|Protocol deviation|12|||
30730762|NCT00529529|58743319|FG002|Overall Study|Protocol deviation|5|||
30730763|NCT00529529|58743317|FG000|Overall Study|Lost to Follow-up|5|||
30730764|NCT00529529|58743318|FG001|Overall Study|Lost to Follow-up|3|||
30730765|NCT00529529|58743319|FG002|Overall Study|Lost to Follow-up|1|||
30730766|NCT00529529|58743317|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30730767|NCT00529529|58743318|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30730768|NCT00529529|58743319|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
30730769|NCT00529529|58743317|FG000|Overall Study|Death|2|||
30730770|NCT00529529|58743318|FG001|Overall Study|Death|0|||
30730771|NCT00529529|58743319|FG002|Overall Study|Death|0|||
30730772|NCT00529529|58743317|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30730773|NCT00529529|58743318|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30730774|NCT00529529|58743319|FG002|Overall Study|Abnormal test procedure result(s)|0|||
30730775|NCT00529529|58743317|FG000|Overall Study|Administrative problems|1|||
30730776|NCT00529529|58743318|FG001|Overall Study|Administrative problems|0|||
30730777|NCT00529529|58743319|FG002|Overall Study|Administrative problems|3|||
30730778|NCT05655377|58743327|FG000|Overall Study|Withdrawal by Subject|2|||
30730779|NCT00486434|58743333|FG000|Overall Study|Withdrawal by Subject|34|||
30730780|NCT00486434|58743334|FG001|Overall Study|Withdrawal by Subject|39|||
30730781|NCT00486434|58743333|FG000|Overall Study|Adverse Event|118|||
30730782|NCT00486434|58743334|FG001|Overall Study|Adverse Event|44|||
30730783|NCT00486434|58743333|FG000|Overall Study|Protocol Violation|22|||
30730784|NCT00486434|58743334|FG001|Overall Study|Protocol Violation|21|||
30730785|NCT00486434|58743333|FG000|Overall Study|Lack of Efficacy|12|||
30730786|NCT00486434|58743334|FG001|Overall Study|Lack of Efficacy|19|||
30730787|NCT00486434|58743333|FG000|Overall Study|Lost to Follow-up|2|||
30730788|NCT00486434|58743334|FG001|Overall Study|Lost to Follow-up|3|||
30730789|NCT00486434|58743333|FG000|Overall Study|Death|1|||
30730790|NCT00486434|58743334|FG001|Overall Study|Death|2|||
30730791|NCT00486434|58743333|FG000|Overall Study|Personal reasons|5|||
30730792|NCT00486434|58743334|FG001|Overall Study|Personal reasons|6|||
30730793|NCT00424632|58743343|FG000|Overall Study|Death|0|||
30730794|NCT00424632|58743344|FG001|Overall Study|Death|0|||
30730795|NCT00424632|58743345|FG002|Overall Study|Death|0|||
30730796|NCT00424632|58743346|FG003|Overall Study|Death|0|||
30730797|NCT00424632|58743347|FG004|Overall Study|Death|0|||
30730798|NCT00424632|58743348|FG005|Overall Study|Death|2|||
30730799|NCT00424632|58743349|FG006|Overall Study|Death|0|||
30730800|NCT00424632|58743350|FG007|Overall Study|Death|0|||
30730801|NCT00424632|58743351|FG008|Overall Study|Death|0|||
30730802|NCT00424632|58743352|FG009|Overall Study|Death|0|||
30730803|NCT00424632|58743343|FG000|Overall Study|Adverse Event|0|||
30730804|NCT00424632|58743344|FG001|Overall Study|Adverse Event|0|||
30621802|NCT01152450|58633350|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
30730805|NCT00424632|58743345|FG002|Overall Study|Adverse Event|0|||
30730806|NCT00424632|58743346|FG003|Overall Study|Adverse Event|0|||
30730807|NCT00424632|58743347|FG004|Overall Study|Adverse Event|0|||
30730808|NCT00424632|58743348|FG005|Overall Study|Adverse Event|0|||
30730809|NCT00424632|58743349|FG006|Overall Study|Adverse Event|0|||
30730810|NCT00424632|58743350|FG007|Overall Study|Adverse Event|0|||
30730811|NCT00424632|58743351|FG008|Overall Study|Adverse Event|3|||
30730812|NCT00424632|58743352|FG009|Overall Study|Adverse Event|2|||
30730813|NCT00424632|58743343|FG000|Overall Study|Global deterioration of health status|0|||
30730814|NCT00424632|58743344|FG001|Overall Study|Global deterioration of health status|0|||
30730815|NCT00424632|58743345|FG002|Overall Study|Global deterioration of health status|0|||
30900498|NCT01647542|58933938|FG001|Overall Study|Adverse Event|5|||
30730816|NCT00424632|58743346|FG003|Overall Study|Global deterioration of health status|1|||
30730817|NCT00424632|58743347|FG004|Overall Study|Global deterioration of health status|1|||
30730818|NCT00424632|58743348|FG005|Overall Study|Global deterioration of health status|0|||
30730819|NCT00424632|58743349|FG006|Overall Study|Global deterioration of health status|0|||
30730820|NCT00424632|58743350|FG007|Overall Study|Global deterioration of health status|0|||
30730821|NCT00424632|58743351|FG008|Overall Study|Global deterioration of health status|0|||
30730822|NCT00424632|58743352|FG009|Overall Study|Global deterioration of health status|0|||
30730823|NCT00424632|58743343|FG000|Overall Study|Objective progression or relapse|1|||
30730824|NCT00424632|58743344|FG001|Overall Study|Objective progression or relapse|1|||
30730825|NCT00424632|58743345|FG002|Overall Study|Objective progression or relapse|1|||
30730826|NCT00424632|58743346|FG003|Overall Study|Objective progression or relapse|2|||
30730827|NCT00424632|58743347|FG004|Overall Study|Objective progression or relapse|2|||
30730828|NCT00424632|58743348|FG005|Overall Study|Objective progression or relapse|13|||
30730829|NCT00424632|58743349|FG006|Overall Study|Objective progression or relapse|7|||
30730830|NCT00424632|58743350|FG007|Overall Study|Objective progression or relapse|3|||
30730831|NCT00424632|58743351|FG008|Overall Study|Objective progression or relapse|12|||
30730832|NCT00424632|58743352|FG009|Overall Study|Objective progression or relapse|4|||
30730833|NCT00424632|58743343|FG000|Overall Study|Other|0|||
30730834|NCT00424632|58743344|FG001|Overall Study|Other|0|||
30730835|NCT00424632|58743345|FG002|Overall Study|Other|0|||
30730836|NCT00424632|58743346|FG003|Overall Study|Other|1|||
30730837|NCT00424632|58743347|FG004|Overall Study|Other|0|||
30730838|NCT00424632|58743348|FG005|Overall Study|Other|0|||
30730839|NCT00424632|58743349|FG006|Overall Study|Other|0|||
30730840|NCT00424632|58743350|FG007|Overall Study|Other|0|||
30730841|NCT00424632|58743351|FG008|Overall Study|Other|1|||
30730842|NCT00424632|58743352|FG009|Overall Study|Other|0|||
30730843|NCT00529451|58743387|FG000|Overall Study|Subject withdrew consent|16|||
30730844|NCT00529451|58743388|FG001|Overall Study|Subject withdrew consent|21|||
30730845|NCT00529451|58743389|FG002|Overall Study|Subject withdrew consent|13|||
30730846|NCT00529451|58743390|FG003|Overall Study|Subject withdrew consent|12|||
30730847|NCT00529451|58743387|FG000|Overall Study|Adverse Event|9|||
30730848|NCT00529451|58743388|FG001|Overall Study|Adverse Event|16|||
30730849|NCT00529451|58743389|FG002|Overall Study|Adverse Event|14|||
30730850|NCT00529451|58743390|FG003|Overall Study|Adverse Event|8|||
30730851|NCT00529451|58743387|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
30730852|NCT00529451|58743388|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
30730853|NCT00529451|58743389|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
30730854|NCT00529451|58743390|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
30730855|NCT00529451|58743387|FG000|Overall Study|Lost to Follow-up|4|||
30730856|NCT00529451|58743388|FG001|Overall Study|Lost to Follow-up|7|||
30730857|NCT00529451|58743389|FG002|Overall Study|Lost to Follow-up|4|||
30730858|NCT00529451|58743390|FG003|Overall Study|Lost to Follow-up|4|||
30730859|NCT00529451|58743387|FG000|Overall Study|Protocol deviation|1|||
30730860|NCT00529451|58743388|FG001|Overall Study|Protocol deviation|1|||
30730861|NCT00529451|58743389|FG002|Overall Study|Protocol deviation|4|||
30730862|NCT00529451|58743390|FG003|Overall Study|Protocol deviation|1|||
30730863|NCT00529451|58743387|FG000|Overall Study|Administrative problems|1|||
30730864|NCT00529451|58743388|FG001|Overall Study|Administrative problems|1|||
30730865|NCT00529451|58743389|FG002|Overall Study|Administrative problems|0|||
30730866|NCT00529451|58743390|FG003|Overall Study|Administrative problems|2|||
30730867|NCT03876743|58743407|FG000|Overall Study|Lost to Follow-up|6|||
30730868|NCT03876743|58743408|FG001|Overall Study|Lost to Follow-up|4|||
30730869|NCT03876743|58743409|FG002|Overall Study|Lost to Follow-up|4|||
30730870|NCT03876743|58743410|FG003|Overall Study|Lost to Follow-up|7|||
30730871|NCT00486278|58743424|FG000|Overall Study|Adverse Event|5|||
30730872|NCT00486278|58743424|FG000|Overall Study|Withdrawal by Subject|2|||
30730873|NCT00486278|58743424|FG000|Overall Study|Physician Decision|2|||
30730874|NCT00321711|58743443|FG000|Part A|Adverse Event|3|||
30730875|NCT00321711|58743444|FG001|Part A|Adverse Event|3|||
30730876|NCT00321711|58743445|FG002|Part A|Adverse Event|2|||
30730877|NCT00321711|58743446|FG003|Part A|Adverse Event|0|||
30730878|NCT00321711|58743447|FG004|Part A|Adverse Event|0|||
30730879|NCT00321711|58743443|FG000|Part A|Withdrawal by Subject|1|||
30730880|NCT00321711|58743444|FG001|Part A|Withdrawal by Subject|1|||
30730881|NCT00321711|58743445|FG002|Part A|Withdrawal by Subject|1|||
30730882|NCT00321711|58743446|FG003|Part A|Withdrawal by Subject|0|||
30730883|NCT00321711|58743447|FG004|Part A|Withdrawal by Subject|0|||
30730884|NCT00321711|58743443|FG000|Part A|Disease progression|0|||
30730885|NCT00321711|58743444|FG001|Part A|Disease progression|1|||
30730886|NCT00321711|58743445|FG002|Part A|Disease progression|0|||
30730887|NCT00321711|58743446|FG003|Part A|Disease progression|0|||
30621803|NCT01152450|58633351|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
30621804|NCT01152450|58633352|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
30730888|NCT00321711|58743447|FG004|Part A|Disease progression|0|||
30730889|NCT00321711|58743443|FG000|Part A|Requirement for alternative therapy|0|||
30730890|NCT00321711|58743444|FG001|Part A|Requirement for alternative therapy|2|||
30730891|NCT00321711|58743445|FG002|Part A|Requirement for alternative therapy|1|||
30730892|NCT00321711|58743446|FG003|Part A|Requirement for alternative therapy|0|||
30730893|NCT00321711|58743447|FG004|Part A|Requirement for alternative therapy|0|||
30730894|NCT00321711|58743443|FG000|Part A|Physician Decision|0|||
30730895|NCT00321711|58743444|FG001|Part A|Physician Decision|1|||
30730896|NCT00321711|58743445|FG002|Part A|Physician Decision|3|||
30730897|NCT00321711|58743446|FG003|Part A|Physician Decision|0|||
30730898|NCT00321711|58743447|FG004|Part A|Physician Decision|0|||
30730899|NCT00321711|58743443|FG000|Part A|Other|1|||
30730900|NCT00321711|58743444|FG001|Part A|Other|2|||
30730901|NCT00321711|58743445|FG002|Part A|Other|3|||
30730902|NCT00321711|58743446|FG003|Part A|Other|0|||
30730903|NCT00321711|58743447|FG004|Part A|Other|0|||
30730904|NCT00321711|58743443|FG000|Part A|Protocol deviation|0|||
30730905|NCT00321711|58743444|FG001|Part A|Protocol deviation|0|||
30730906|NCT00321711|58743445|FG002|Part A|Protocol deviation|1|||
30730907|NCT00321711|58743446|FG003|Part A|Protocol deviation|0|||
30730908|NCT00321711|58743447|FG004|Part A|Protocol deviation|0|||
30730909|NCT00321711|58743443|FG000|Part B|Noncompliance|0|||
30730910|NCT00321711|58743444|FG001|Part B|Noncompliance|0|||
30730911|NCT00321711|58743445|FG002|Part B|Noncompliance|0|||
30730912|NCT00321711|58743446|FG003|Part B|Noncompliance|0|||
30730913|NCT00321711|58743447|FG004|Part B|Noncompliance|1|||
30730914|NCT00321711|58743443|FG000|Part B|Adverse Event|0|||
30730915|NCT00321711|58743444|FG001|Part B|Adverse Event|0|||
30730916|NCT00321711|58743445|FG002|Part B|Adverse Event|0|||
30730917|NCT00321711|58743446|FG003|Part B|Adverse Event|2|||
30730918|NCT00321711|58743447|FG004|Part B|Adverse Event|1|||
30730919|NCT00321711|58743443|FG000|Part B|Disease progression|0|||
30730920|NCT00321711|58743444|FG001|Part B|Disease progression|0|||
30730921|NCT00321711|58743445|FG002|Part B|Disease progression|0|||
30730922|NCT00321711|58743446|FG003|Part B|Disease progression|1|||
30730923|NCT00321711|58743447|FG004|Part B|Disease progression|0|||
30730924|NCT00321711|58743443|FG000|Part B|Physician Decision|0|||
30730925|NCT00321711|58743444|FG001|Part B|Physician Decision|0|||
30730926|NCT00321711|58743445|FG002|Part B|Physician Decision|0|||
30730927|NCT00321711|58743446|FG003|Part B|Physician Decision|1|||
30730928|NCT00321711|58743447|FG004|Part B|Physician Decision|2|||
30730929|NCT00321711|58743443|FG000|Part B|Death|0|||
30730930|NCT00321711|58743444|FG001|Part B|Death|0|||
30730931|NCT00321711|58743445|FG002|Part B|Death|0|||
30730932|NCT00321711|58743446|FG003|Part B|Death|2|||
30730933|NCT00321711|58743447|FG004|Part B|Death|1|||
30730934|NCT00486044|58743461|FG000|Overall Study|Withdrawal by Subject|2|||
30730935|NCT00486044|58743462|FG001|Overall Study|Withdrawal by Subject|1|||
30730936|NCT00486044|58743461|FG000|Overall Study|Adverse Event|0|||
30730937|NCT00486044|58743462|FG001|Overall Study|Adverse Event|1|||
30730938|NCT00486044|58743461|FG000|Overall Study|Lost to Follow-up|0|||
30730939|NCT00486044|58743462|FG001|Overall Study|Lost to Follow-up|1|||
30730940|NCT00351273|58743471|FG000|Overall Study|Lost to Follow-up|1|||
30730941|NCT00351273|58743472|FG001|Overall Study|Lost to Follow-up|2|||
30730942|NCT00351273|58743473|FG002|Overall Study|Lost to Follow-up|5|||
30730943|NCT00327717|58743488|FG000|Overall Study|Adverse Event|6|||
30730944|NCT00327717|58743489|FG001|Overall Study|Adverse Event|6|||
30730945|NCT00327717|58743488|FG000|Overall Study|Lack of Efficacy|0|||
30730946|NCT00327717|58743489|FG001|Overall Study|Lack of Efficacy|1|||
30730947|NCT00327717|58743488|FG000|Overall Study|Withdrawal by Subject|3|||
30730948|NCT00327717|58743489|FG001|Overall Study|Withdrawal by Subject|7|||
30730949|NCT00463346|58743497|FG000|Overall Study|Withdrawal by Subject|3|||
30730950|NCT00463346|58743498|FG001|Overall Study|Withdrawal by Subject|3|||
30730951|NCT00462488|58743508|FG000|Overall Study|Protocol Violation|1|||
30730952|NCT00462488|58743509|FG001|Overall Study|Protocol Violation|0|||
30730953|NCT00462488|58743508|FG000|Overall Study|Lack of Efficacy|19|||
30730954|NCT00462488|58743509|FG001|Overall Study|Lack of Efficacy|17|||
30730955|NCT00454142|58743515|FG000|Overall Study|Withdrawal by Subject|1|||
30730956|NCT00424476|58743524|FG000|Overall Study|Withdrawal by Subject|7|||
30730957|NCT00424476|58743525|FG001|Overall Study|Withdrawal by Subject|6|||
30730958|NCT00424476|58743526|FG002|Overall Study|Withdrawal by Subject|3|||
30730959|NCT00424476|58743524|FG000|Overall Study|Adverse Event|19|||
30730960|NCT00424476|58743525|FG001|Overall Study|Adverse Event|16|||
30730961|NCT00424476|58743526|FG002|Overall Study|Adverse Event|15|||
30730962|NCT00424476|58743524|FG000|Overall Study|Lack of Efficacy|16|||
30730963|NCT00424476|58743525|FG001|Overall Study|Lack of Efficacy|12|||
30730964|NCT00424476|58743526|FG002|Overall Study|Lack of Efficacy|12|||
30730965|NCT00424476|58743524|FG000|Overall Study|Lack of Compliance|1|||
30730966|NCT00424476|58743525|FG001|Overall Study|Lack of Compliance|1|||
30730967|NCT00424476|58743526|FG002|Overall Study|Lack of Compliance|1|||
30730968|NCT00424476|58743524|FG000|Overall Study|Lost to Follow-up|4|||
30730969|NCT00424476|58743525|FG001|Overall Study|Lost to Follow-up|6|||
30730970|NCT00424476|58743526|FG002|Overall Study|Lost to Follow-up|3|||
30730971|NCT00424476|58743524|FG000|Overall Study|Protocol Violation|7|||
30730972|NCT00424476|58743525|FG001|Overall Study|Protocol Violation|2|||
30730973|NCT00424476|58743526|FG002|Overall Study|Protocol Violation|3|||
30730974|NCT00424476|58743524|FG000|Overall Study|Physician Decision|3|||
30730975|NCT00424476|58743525|FG001|Overall Study|Physician Decision|2|||
30730976|NCT00424476|58743526|FG002|Overall Study|Physician Decision|3|||
30730977|NCT00424476|58743524|FG000|Overall Study|Other|4|||
30730978|NCT00424476|58743525|FG001|Overall Study|Other|3|||
30730979|NCT00424476|58743526|FG002|Overall Study|Other|9|||
30730980|NCT00453986|58743539|FG000|Overall Study|Lost to Follow-up|6|||
30730981|NCT00453986|58743540|FG001|Overall Study|Lost to Follow-up|5|||
30730982|NCT00453986|58743541|FG002|Overall Study|Lost to Follow-up|6|||
30730983|NCT00453986|58743542|FG003|Overall Study|Lost to Follow-up|2|||
30730984|NCT00453986|58743543|FG004|Overall Study|Lost to Follow-up|0|||
30730985|NCT00435942|58743561|FG000|Overall Study|Death|17|||
30730986|NCT00435942|58743562|FG001|Overall Study|Death|10|||
30730987|NCT00435942|58743561|FG000|Overall Study|Withdrawal by Subject|2|||
30730988|NCT00435942|58743562|FG001|Overall Study|Withdrawal by Subject|0|||
30730989|NCT00435942|58743561|FG000|Overall Study|Lost to Follow-up|0|||
30730990|NCT00435942|58743562|FG001|Overall Study|Lost to Follow-up|16|||
30730991|NCT00435942|58743561|FG000|Overall Study|Conversion to Open Repair|1|||
30730992|NCT00435942|58743562|FG001|Overall Study|Conversion to Open Repair|0|||
30730993|NCT00435942|58743561|FG000|Overall Study|Technical Failure|3|||
30730994|NCT00435942|58743562|FG001|Overall Study|Technical Failure|0|||
30730995|NCT00435942|58743561|FG000|Overall Study|Other|0|||
30730996|NCT00435942|58743562|FG001|Overall Study|Other|1|||
30730997|NCT00453362|58743568|FG000|Overall Study|Adverse Event|5|||
30730998|NCT00453362|58743568|FG000|Overall Study|Death|7|||
30730999|NCT00453362|58743568|FG000|Overall Study|Physician Decision|2|||
30731000|NCT00453362|58743568|FG000|Overall Study|Withdrawal by Subject|3|||
30731001|NCT00453362|58743568|FG000|Overall Study|Progression of disease|56|||
30731002|NCT00453362|58743568|FG000|Overall Study|Screening Failure|14|||
30731003|NCT00424398|58743587|FG000|Overall Study|Withdrawal by Subject|2|||
30731004|NCT00424398|58743588|FG001|Overall Study|Withdrawal by Subject|1|||
30731005|NCT00424398|58743589|FG002|Overall Study|Withdrawal by Subject|0|||
30731006|NCT00424398|58743587|FG000|Overall Study|Subject met exclusion criteria|1|||
30731007|NCT00424398|58743588|FG001|Overall Study|Subject met exclusion criteria|0|||
30731008|NCT00424398|58743589|FG002|Overall Study|Subject met exclusion criteria|0|||
30731009|NCT00461786|58743597|FG000|Overall Study|Entry Criteria Not Met|2|||
30731010|NCT00461786|58743597|FG000|Overall Study|Inevaluable (Never Treated)|1|||
30731011|NCT00435162|58743604|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
30731012|NCT00435162|58743605|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
30731013|NCT00435162|58743606|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
30731014|NCT00435162|58743607|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
30731015|NCT00435162|58743608|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
30731016|NCT00435162|58743609|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
30731017|NCT03836664|58743624|FG000|Overall Study|Didn't complete forms and lost drug|3|||
30731018|NCT03836664|58743625|FG001|Overall Study|Didn't complete forms and lost drug|3|||
30731019|NCT00350727|58743638|FG000|Phase I: Dose Escalation|Adverse Event|4|||
30731020|NCT00350727|58743639|FG001|Phase I: Dose Escalation|Adverse Event|0|||
30731021|NCT00350727|58743640|FG002|Phase I: Dose Escalation|Adverse Event|0|||
30731022|NCT00350727|58743638|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
30731023|NCT00350727|58743639|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
30731024|NCT00350727|58743640|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
30731025|NCT00350727|58743638|FG000|Phase I: Dose Escalation|Death|1|||
30731026|NCT00350727|58743639|FG001|Phase I: Dose Escalation|Death|0|||
30731027|NCT00350727|58743640|FG002|Phase I: Dose Escalation|Death|0|||
30731028|NCT00350727|58743638|FG000|Phase I: Dose Escalation|Physician Decision|1|||
30731029|NCT00350727|58743639|FG001|Phase I: Dose Escalation|Physician Decision|0|||
30731030|NCT00350727|58743640|FG002|Phase I: Dose Escalation|Physician Decision|0|||
30621805|NCT01152450|58633353|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
30731031|NCT00350727|58743638|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
30731032|NCT00350727|58743639|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
30731033|NCT00350727|58743640|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
30731034|NCT00350727|58743638|FG000|Phase II|Disease Progression|0|||
30731035|NCT00350727|58743639|FG001|Phase II|Disease Progression|15|||
30731036|NCT00350727|58743640|FG002|Phase II|Disease Progression|16|||
30731037|NCT00350727|58743638|FG000|Phase II|Clinical Deterioration|0|||
30731038|NCT00350727|58743639|FG001|Phase II|Clinical Deterioration|1|||
30731039|NCT00350727|58743640|FG002|Phase II|Clinical Deterioration|0|||
30731040|NCT00350727|58743638|FG000|Phase II|Withdrawal by Subject|0|||
30731041|NCT00350727|58743639|FG001|Phase II|Withdrawal by Subject|2|||
30731042|NCT00350727|58743640|FG002|Phase II|Withdrawal by Subject|1|||
30731043|NCT00350727|58743638|FG000|Phase II|Adverse Event|0|||
30731044|NCT00350727|58743639|FG001|Phase II|Adverse Event|1|||
30731045|NCT00350727|58743640|FG002|Phase II|Adverse Event|1|||
30731046|NCT00350727|58743638|FG000|Phase II|Death|0|||
30731047|NCT00350727|58743639|FG001|Phase II|Death|0|||
30731048|NCT00350727|58743640|FG002|Phase II|Death|2|||
30731049|NCT00350727|58743638|FG000|Phase II|Sponsor Terminated Study|0|||
30731050|NCT00350727|58743639|FG001|Phase II|Sponsor Terminated Study|0|||
30731051|NCT00350727|58743640|FG002|Phase II|Sponsor Terminated Study|1|||
30731052|NCT00350727|58743638|FG000|Phase II|Enrolled in Rollover Study|0|||
30731053|NCT00350727|58743639|FG001|Phase II|Enrolled in Rollover Study|0|||
30731054|NCT00350727|58743640|FG002|Phase II|Enrolled in Rollover Study|1|||
30731055|NCT00434304|58743659|FG000|Overall Study|Adverse Event|14|||
30731056|NCT00434304|58743659|FG000|Overall Study|Lack of Efficacy|2|||
30731057|NCT00434304|58743659|FG000|Overall Study|Withdrawal by Subject|4|||
30731058|NCT00424008|58743666|FG000|Overall Study|Adverse Event|8|||
30731059|NCT00424008|58743667|FG001|Overall Study|Adverse Event|6|||
30731060|NCT00424008|58743666|FG000|Overall Study|Lack of Efficacy|40|||
30731061|NCT00424008|58743667|FG001|Overall Study|Lack of Efficacy|34|||
30731062|NCT00424008|58743666|FG000|Overall Study|Lost to Follow-up|1|||
30731063|NCT00424008|58743667|FG001|Overall Study|Lost to Follow-up|2|||
30731064|NCT00424008|58743666|FG000|Overall Study|Withdrawal by Subject|5|||
30731065|NCT00424008|58743667|FG001|Overall Study|Withdrawal by Subject|8|||
30731066|NCT00424008|58743666|FG000|Overall Study|Noncompliance with protocol|13|||
30731067|NCT00424008|58743667|FG001|Overall Study|Noncompliance with protocol|7|||
30731068|NCT00424008|58743666|FG000|Overall Study|Did not meet protocol eligibility|16|||
30731069|NCT00424008|58743667|FG001|Overall Study|Did not meet protocol eligibility|21|||
30731070|NCT00424008|58743666|FG000|Overall Study|Administrative|266|||
30731071|NCT00424008|58743667|FG001|Overall Study|Administrative|257|||
30731072|NCT00423930|58743674|FG000|Overall Study|Withdrawal by Subject|2|||
30731073|NCT00423852|58743678|FG000|Overall Study|Removed pior to the high-dose portion|3|||
30731074|NCT00461708|58743684|FG000|Overall Study|Adverse Event|17|||
30731075|NCT00461708|58743685|FG001|Overall Study|Adverse Event|7|||
30731076|NCT00461708|58743684|FG000|Overall Study|Lack of Efficacy|68|||
30731077|NCT00461708|58743685|FG001|Overall Study|Lack of Efficacy|20|||
30731078|NCT00461708|58743684|FG000|Overall Study|Physician Decision|10|||
30731079|NCT00461708|58743685|FG001|Overall Study|Physician Decision|4|||
30731080|NCT00461708|58743684|FG000|Overall Study|Withdrawal by Subject|8|||
30731081|NCT00461708|58743685|FG001|Overall Study|Withdrawal by Subject|2|||
30731082|NCT00461708|58743684|FG000|Overall Study|Other|4|||
30731083|NCT00461708|58743685|FG001|Overall Study|Other|4|||
30731084|NCT00461708|58743684|FG000|Overall Study|Death|8|||
30731085|NCT00461708|58743685|FG001|Overall Study|Death|1|||
30731086|NCT00327171|58743696|FG000|Overall Study|Did not receive study medication|3|||
30731087|NCT00327171|58743697|FG001|Overall Study|Did not receive study medication|0|||
30731088|NCT00327171|58743696|FG000|Overall Study|Adverse Event|23|||
30731089|NCT00327171|58743697|FG001|Overall Study|Adverse Event|23|||
30731090|NCT00327171|58743696|FG000|Overall Study|Disease progression/lack of efficacy|68|||
30731091|NCT00327171|58743697|FG001|Overall Study|Disease progression/lack of efficacy|69|||
30731092|NCT00327171|58743696|FG000|Overall Study|Investigator/participant request|1|||
30731093|NCT00327171|58743697|FG001|Overall Study|Investigator/participant request|8|||
30731094|NCT00327171|58743696|FG000|Overall Study|Clinical progression|12|||
30731095|NCT00327171|58743697|FG001|Overall Study|Clinical progression|8|||
30731096|NCT00327171|58743696|FG000|Overall Study|Undisclosed history of ischemia|0|||
30731097|NCT00327171|58743697|FG001|Overall Study|Undisclosed history of ischemia|1|||
30731098|NCT00327171|58743696|FG000|Overall Study|Other|1|||
30731099|NCT00327171|58743697|FG001|Overall Study|Other|0|||
30731100|NCT00461630|58743705|FG000|Overall Study|Death|798|||
30731101|NCT00461630|58743706|FG001|Overall Study|Death|732|||
30731102|NCT00461630|58743705|FG000|Overall Study|Lost to Follow-up|108|||
30731103|NCT00461630|58743706|FG001|Overall Study|Lost to Follow-up|95|||
30731104|NCT00461552|58743714|FG000|Overall Study|Drug Dispensing error|0|||
30731105|NCT00461552|58743715|FG001|Overall Study|Drug Dispensing error|2|||
30731106|NCT00453206|58743721|FG000|Overall Study|Death|1|||
30731107|NCT03850496|58743728|FG000|Overall Study|Withdrawal by Subject|1|||
30731108|NCT03850496|58743729|FG001|Overall Study|Withdrawal by Subject|0|||
30731109|NCT03850496|58743730|FG002|Overall Study|Withdrawal by Subject|0|||
30731110|NCT03850496|58743728|FG000|Overall Study|Lost to Follow-up|0|||
30731111|NCT03850496|58743729|FG001|Overall Study|Lost to Follow-up|1|||
30731112|NCT03850496|58743730|FG002|Overall Study|Lost to Follow-up|4|||
30731113|NCT00327015|58743742|FG000|Overall Study|Lack of Efficacy|18|||
30731114|NCT00327015|58743743|FG001|Overall Study|Lack of Efficacy|18|||
30731115|NCT00327015|58743744|FG002|Overall Study|Lack of Efficacy|35|||
30731116|NCT00327015|58743745|FG003|Overall Study|Lack of Efficacy|29|||
30731117|NCT00327015|58743742|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
30731118|NCT00327015|58743743|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
30731119|NCT00327015|58743744|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
30731120|NCT00327015|58743745|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
30731121|NCT00327015|58743742|FG000|Overall Study|Lost to Follow-up|22|||
30731122|NCT00327015|58743743|FG001|Overall Study|Lost to Follow-up|23|||
30731123|NCT00327015|58743744|FG002|Overall Study|Lost to Follow-up|29|||
30731124|NCT00327015|58743745|FG003|Overall Study|Lost to Follow-up|22|||
30731125|NCT00327015|58743742|FG000|Overall Study|Adverse Event|14|||
30731126|NCT00327015|58743743|FG001|Overall Study|Adverse Event|10|||
30731127|NCT00327015|58743744|FG002|Overall Study|Adverse Event|14|||
30731128|NCT00327015|58743745|FG003|Overall Study|Adverse Event|14|||
30731129|NCT00327015|58743742|FG000|Overall Study|Subject no longer meets study criteria|4|||
30731130|NCT00327015|58743743|FG001|Overall Study|Subject no longer meets study criteria|2|||
30731131|NCT00327015|58743744|FG002|Overall Study|Subject no longer meets study criteria|8|||
30731132|NCT00327015|58743745|FG003|Overall Study|Subject no longer meets study criteria|7|||
30731133|NCT00327015|58743742|FG000|Overall Study|Poor/Noncompliance|11|||
30731134|NCT00327015|58743743|FG001|Overall Study|Poor/Noncompliance|8|||
30731135|NCT00327015|58743744|FG002|Overall Study|Poor/Noncompliance|4|||
30731136|NCT00327015|58743745|FG003|Overall Study|Poor/Noncompliance|5|||
30731137|NCT00327015|58743742|FG000|Overall Study|Physician Decision|0|||
30731138|NCT00327015|58743743|FG001|Overall Study|Physician Decision|1|||
30731139|NCT00327015|58743744|FG002|Overall Study|Physician Decision|3|||
30731140|NCT00327015|58743745|FG003|Overall Study|Physician Decision|2|||
30731141|NCT00327015|58743742|FG000|Overall Study|Death|1|||
30731142|NCT00327015|58743743|FG001|Overall Study|Death|2|||
30731143|NCT00327015|58743744|FG002|Overall Study|Death|2|||
30731144|NCT00327015|58743745|FG003|Overall Study|Death|3|||
30731145|NCT00327015|58743742|FG000|Overall Study|Pregnancy|0|||
30731146|NCT00327015|58743743|FG001|Overall Study|Pregnancy|2|||
30731147|NCT00327015|58743744|FG002|Overall Study|Pregnancy|1|||
30731148|NCT00327015|58743745|FG003|Overall Study|Pregnancy|1|||
30731149|NCT00327015|58743742|FG000|Overall Study|Administrative Reason by Sponsor|1|||
30731150|NCT00327015|58743743|FG001|Overall Study|Administrative Reason by Sponsor|2|||
30731151|NCT00327015|58743744|FG002|Overall Study|Administrative Reason by Sponsor|2|||
30731152|NCT00327015|58743745|FG003|Overall Study|Administrative Reason by Sponsor|1|||
30731153|NCT00434148|58743757|FG000|Overall Study|Adverse Event|18|||
30731154|NCT00434148|58743758|FG001|Overall Study|Adverse Event|18|||
30731155|NCT00434148|58743757|FG000|Overall Study|Lack of Efficacy|25|||
30731156|NCT00434148|58743758|FG001|Overall Study|Lack of Efficacy|28|||
30731157|NCT00434148|58743757|FG000|Overall Study|Withdrawal by Subject|15|||
30731158|NCT00434148|58743758|FG001|Overall Study|Withdrawal by Subject|15|||
30731159|NCT00434148|58743757|FG000|Overall Study|Protocol Violation|4|||
30731160|NCT00434148|58743758|FG001|Overall Study|Protocol Violation|0|||
30731161|NCT00434148|58743757|FG000|Overall Study|Administrative problems|6|||
30731162|NCT00434148|58743758|FG001|Overall Study|Administrative problems|10|||
30731163|NCT00434148|58743757|FG000|Overall Study|Lost to Follow-up|0|||
30731164|NCT00434148|58743758|FG001|Overall Study|Lost to Follow-up|1|||
30731165|NCT00434148|58743757|FG000|Overall Study|Condition no longer requires study drug|1|||
30731166|NCT00434148|58743758|FG001|Overall Study|Condition no longer requires study drug|0|||
30731167|NCT00434148|58743757|FG000|Overall Study|Abnormal test procedure result|0|||
30731168|NCT00434148|58743758|FG001|Overall Study|Abnormal test procedure result|1|||
30731169|NCT00468728|58743766|FG000|Treatment|criteria for mITT population|4|||
30731170|NCT00468728|58743767|FG001|Treatment|criteria for mITT population|11|||
30731171|NCT00468728|58743766|FG000|Follow-up|mITT failure|34|||
30731172|NCT00468728|58743767|FG001|Follow-up|mITT failure|31|||
30731173|NCT00433914|58743777|FG000|Overall Study|Withdrawal by Subject|0|||
30731174|NCT00433914|58743778|FG001|Overall Study|Withdrawal by Subject|2|||
30731175|NCT00433914|58743777|FG000|Overall Study|Lost to Follow-up|0|||
30731176|NCT00433914|58743778|FG001|Overall Study|Lost to Follow-up|1|||
30731177|NCT00468650|58743784|FG000|Overall Study|Lost to Follow-up|4|||
30731178|NCT00468650|58743784|FG000|Overall Study|Withdrawal by Subject|2|||
30731179|NCT00468650|58743784|FG000|Overall Study|Protocol Violation|1|||
30731180|NCT00423150|58743789|FG000|Overall Study|Adverse Event|11|||
30731181|NCT00423150|58743789|FG000|Overall Study|Progression of disease being studied|69|||
30731182|NCT00423150|58743789|FG000|Overall Study|Withdrawal by Subject|1|||
30731183|NCT00423150|58743789|FG000|Overall Study|Non-compliance with protocol|1|||
30731184|NCT00423150|58743789|FG000|Overall Study|Administrative|4|||
30731185|NCT00433836|58743795|FG000|Overall Study|Adverse Event|7|||
30731186|NCT00433836|58743796|FG001|Overall Study|Adverse Event|0|||
30731187|NCT00433836|58743795|FG000|Overall Study|Lost to Follow-up|3|||
30731188|NCT00433836|58743796|FG001|Overall Study|Lost to Follow-up|0|||
30731189|NCT00433836|58743795|FG000|Overall Study|Withdrawal by Subject|2|||
30731190|NCT00433836|58743796|FG001|Overall Study|Withdrawal by Subject|1|||
30731191|NCT00433836|58743795|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30731192|NCT00433836|58743796|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30731193|NCT00433836|58743795|FG000|Overall Study|Protocol Violation|0|||
30731194|NCT00433836|58743796|FG001|Overall Study|Protocol Violation|2|||
30731195|NCT00433836|58743795|FG000|Overall Study|Condition no longer requires study drug|0|||
30731196|NCT00433836|58743796|FG001|Overall Study|Condition no longer requires study drug|1|||
30731197|NCT00433836|58743795|FG000|Overall Study|Abnormal laboratory values|0|||
30731198|NCT00433836|58743796|FG001|Overall Study|Abnormal laboratory values|1|||
30731199|NCT00433446|58743802|FG000|Overall Study|Adverse Event|4|||
30731200|NCT00433446|58743802|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
30731201|NCT00433446|58743802|FG000|Overall Study|Progression|44|||
30731202|NCT00433446|58743802|FG000|Overall Study|Other - Not Protocol specified|3|||
30621806|NCT01152450|58633354|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
30621807|NCT01152450|58633355|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
30621808|NCT01152450|58633350|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
30731203|NCT00433446|58743802|FG000|Overall Study|Ineligible|9|||
30731204|NCT00468104|58743806|FG000|First Intervention|Protocol Violation|2|||
30731205|NCT00468104|58743807|FG001|First Intervention|Protocol Violation|1|||
30731206|NCT00468104|58743806|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
30731207|NCT00468104|58743807|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
30731208|NCT00468104|58743806|FG000|First Intervention|died within 3 weeks|1|||
30731209|NCT00468104|58743807|FG001|First Intervention|died within 3 weeks|0|||
30731210|NCT00468104|58743806|FG000|First Intervention|malposition/blocked chest tube tube|2|||
30731211|NCT00468104|58743807|FG001|First Intervention|malposition/blocked chest tube tube|0|||
30731212|NCT00468104|58743806|FG000|First Intervention|large lung mass with minimal effusion|1|||
30731213|NCT00468104|58743807|FG001|First Intervention|large lung mass with minimal effusion|0|||
30731214|NCT00468104|58743806|FG000|First Intervention|associated prolonged pneumothorax|1|||
30731215|NCT00468104|58743807|FG001|First Intervention|associated prolonged pneumothorax|0|||
30731216|NCT00468104|58743806|FG000|First Intervention|trapped lung|1|||
30731217|NCT00468104|58743807|FG001|First Intervention|trapped lung|0|||
30731218|NCT00468104|58743806|FG000|Second Intervention|Withdrawal by Subject|5|||
30731219|NCT00468104|58743807|FG001|Second Intervention|Withdrawal by Subject|2|||
30731220|NCT00468104|58743806|FG000|Second Intervention|discarded for malposition of chest tube|0|||
30731221|NCT00468104|58743807|FG001|Second Intervention|discarded for malposition of chest tube|2|||
30731222|NCT00326625|58743818|FG000|Overall Study|Adverse Event|20|||
30731223|NCT00326625|58743819|FG001|Overall Study|Adverse Event|9|||
30731224|NCT00326625|58743818|FG000|Overall Study|Withdrawal by Subject|15|||
30731225|NCT00326625|58743819|FG001|Overall Study|Withdrawal by Subject|12|||
30731226|NCT00326625|58743818|FG000|Overall Study|Death|18|||
30731227|NCT00326625|58743819|FG001|Overall Study|Death|16|||
30731228|NCT00326625|58743818|FG000|Overall Study|Lost to Follow-up|1|||
30731229|NCT00326625|58743819|FG001|Overall Study|Lost to Follow-up|0|||
30731230|NCT00326625|58743818|FG000|Overall Study|prescheduled medical intervention|0|||
30731231|NCT00326625|58743819|FG001|Overall Study|prescheduled medical intervention|1|||
30731232|NCT00433290|58743827|FG000|Overall Study|Adverse Event|24|||
30731233|NCT00433290|58743828|FG001|Overall Study|Adverse Event|7|||
30731234|NCT00433290|58743827|FG000|Overall Study|Lack of Efficacy|1|||
30621809|NCT01152450|58633351|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
30731235|NCT00433290|58743828|FG001|Overall Study|Lack of Efficacy|5|||
30731236|NCT00433290|58743827|FG000|Overall Study|Withdrawal by Subject|4|||
30731237|NCT00433290|58743828|FG001|Overall Study|Withdrawal by Subject|2|||
30731238|NCT00433290|58743827|FG000|Overall Study|Protocol Violation|3|||
30621810|NCT01152450|58633352|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
30621811|NCT01152450|58633353|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
30621812|NCT01152450|58633354|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
30621813|NCT01152450|58633355|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
30621814|NCT01152450|58633350|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
30621815|NCT01152450|58633351|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
30621816|NCT01152450|58633352|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
30621817|NCT01152450|58633353|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
30621818|NCT01152450|58633354|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
30621819|NCT01152450|58633355|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
30731239|NCT00433290|58743828|FG001|Overall Study|Protocol Violation|2|||
30731240|NCT00433290|58743827|FG000|Overall Study|Physician Decision|2|||
30731241|NCT00433290|58743828|FG001|Overall Study|Physician Decision|0|||
30731242|NCT00433290|58743827|FG000|Overall Study|Entry Criteria Not Met|0|||
30731243|NCT00433290|58743828|FG001|Overall Study|Entry Criteria Not Met|1|||
30731244|NCT00433290|58743827|FG000|Overall Study|Lost to Follow-up|1|||
30731245|NCT00433290|58743828|FG001|Overall Study|Lost to Follow-up|0|||
30731246|NCT00467870|58743840|FG000|Overall Study|Adverse Event|13|||
30731247|NCT00467870|58743841|FG001|Overall Study|Adverse Event|9|||
30731248|NCT00467870|58743842|FG002|Overall Study|Adverse Event|1|||
30731249|NCT00467870|58743843|FG003|Overall Study|Adverse Event|15|||
30731250|NCT00467870|58743844|FG004|Overall Study|Adverse Event|15|||
30731251|NCT00467870|58743845|FG005|Overall Study|Adverse Event|1|||
30731252|NCT00467870|58743840|FG000|Overall Study|Protocol Violation|2|||
30731253|NCT00467870|58743841|FG001|Overall Study|Protocol Violation|1|||
30731254|NCT00467870|58743842|FG002|Overall Study|Protocol Violation|1|||
30731255|NCT00467870|58743843|FG003|Overall Study|Protocol Violation|2|||
30731256|NCT00467870|58743844|FG004|Overall Study|Protocol Violation|0|||
30731257|NCT00467870|58743845|FG005|Overall Study|Protocol Violation|0|||
30731258|NCT00467870|58743840|FG000|Overall Study|Withdrawal by Subject|14|||
30731259|NCT00467870|58743841|FG001|Overall Study|Withdrawal by Subject|21|||
30731260|NCT00467870|58743842|FG002|Overall Study|Withdrawal by Subject|0|||
30731261|NCT00467870|58743843|FG003|Overall Study|Withdrawal by Subject|9|||
30731262|NCT00467870|58743844|FG004|Overall Study|Withdrawal by Subject|10|||
30731263|NCT00467870|58743845|FG005|Overall Study|Withdrawal by Subject|1|||
30731264|NCT00467870|58743840|FG000|Overall Study|Lost to Follow-up|5|||
30731265|NCT00467870|58743841|FG001|Overall Study|Lost to Follow-up|3|||
30731266|NCT00467870|58743842|FG002|Overall Study|Lost to Follow-up|1|||
30731267|NCT00467870|58743843|FG003|Overall Study|Lost to Follow-up|1|||
30731268|NCT00467870|58743844|FG004|Overall Study|Lost to Follow-up|3|||
30731269|NCT00467870|58743845|FG005|Overall Study|Lost to Follow-up|0|||
30731270|NCT00467870|58743840|FG000|Overall Study|Subject Non-compliance|3|||
30731271|NCT00467870|58743841|FG001|Overall Study|Subject Non-compliance|4|||
30731272|NCT00467870|58743842|FG002|Overall Study|Subject Non-compliance|0|||
30731273|NCT00467870|58743843|FG003|Overall Study|Subject Non-compliance|1|||
30731274|NCT00467870|58743844|FG004|Overall Study|Subject Non-compliance|5|||
30731275|NCT00467870|58743845|FG005|Overall Study|Subject Non-compliance|0|||
30731276|NCT00467870|58743840|FG000|Overall Study|Other/Unknown|8|||
30731277|NCT00467870|58743841|FG001|Overall Study|Other/Unknown|5|||
30731278|NCT00467870|58743842|FG002|Overall Study|Other/Unknown|1|||
30731279|NCT00467870|58743843|FG003|Overall Study|Other/Unknown|5|||
30731280|NCT00467870|58743844|FG004|Overall Study|Other/Unknown|4|||
30731281|NCT00467870|58743845|FG005|Overall Study|Other/Unknown|0|||
30731282|NCT00467558|58743857|FG000|Overall Study|Lost to Follow-up|2|||
30731283|NCT00467558|58743858|FG001|Overall Study|Lost to Follow-up|0|||
30731284|NCT00422292|58743868|FG000|Overall Study|Serious adverse events|1|||
30731285|NCT00422292|58743869|FG001|Overall Study|Serious adverse events|4|||
30731286|NCT00422292|58743870|FG002|Overall Study|Serious adverse events|0|||
30731287|NCT00422292|58743871|FG003|Overall Study|Serious adverse events|0|||
30731288|NCT00422292|58743868|FG000|Overall Study|Adverse Event|1|||
30731289|NCT00422292|58743869|FG001|Overall Study|Adverse Event|0|||
30731290|NCT00422292|58743870|FG002|Overall Study|Adverse Event|1|||
30731291|NCT00422292|58743871|FG003|Overall Study|Adverse Event|0|||
30731292|NCT00422292|58743868|FG000|Overall Study|Protocol Violation|4|||
30621820|NCT01181141|58633365|FG000|Overall Study|Adverse Event|2|||
30731293|NCT00422292|58743869|FG001|Overall Study|Protocol Violation|25|||
30621821|NCT01181141|58633366|FG001|Overall Study|Adverse Event|1|||
30621822|NCT01181141|58633365|FG000|Overall Study|Lack of Efficacy|1|||
30731294|NCT00422292|58743870|FG002|Overall Study|Protocol Violation|8|||
30731295|NCT00422292|58743871|FG003|Overall Study|Protocol Violation|5|||
30731296|NCT00422292|58743868|FG000|Overall Study|Lost to Follow-up|6|||
30731297|NCT00422292|58743869|FG001|Overall Study|Lost to Follow-up|12|||
30731298|NCT00422292|58743870|FG002|Overall Study|Lost to Follow-up|6|||
30731299|NCT00422292|58743871|FG003|Overall Study|Lost to Follow-up|6|||
30731300|NCT00422292|58743868|FG000|Overall Study|Withdrawal by Subject|6|||
30731301|NCT00422292|58743869|FG001|Overall Study|Withdrawal by Subject|25|||
30731302|NCT00422292|58743870|FG002|Overall Study|Withdrawal by Subject|7|||
30731303|NCT00422292|58743871|FG003|Overall Study|Withdrawal by Subject|13|||
30731304|NCT00452348|58743883|FG000|Overall Study|Adverse Event|6|||
30731305|NCT00452348|58743884|FG001|Overall Study|Adverse Event|9|||
30731306|NCT00452348|58743883|FG000|Overall Study|Lack of Efficacy|10|||
30731307|NCT00452348|58743884|FG001|Overall Study|Lack of Efficacy|9|||
30731308|NCT00452348|58743883|FG000|Overall Study|Lost to Follow-up|14|||
30731309|NCT00452348|58743884|FG001|Overall Study|Lost to Follow-up|8|||
30731310|NCT00452348|58743883|FG000|Overall Study|Protocol Violation|22|||
30731311|NCT00452348|58743884|FG001|Overall Study|Protocol Violation|28|||
30731312|NCT00452348|58743883|FG000|Overall Study|Withdrawal by Subject|18|||
30731313|NCT00452348|58743884|FG001|Overall Study|Withdrawal by Subject|21|||
30731314|NCT00452348|58743883|FG000|Overall Study|Other|9|||
30731315|NCT00452348|58743884|FG001|Overall Study|Other|9|||
30731316|NCT00452114|58743892|FG000|Overall Study|Physician Decision|3|||
30731317|NCT00452114|58743893|FG001|Overall Study|Physician Decision|3|||
30731318|NCT00320541|58743901|FG000|Overall Study|Adverse Event|21|||
30731319|NCT00320541|58743902|FG001|Overall Study|Adverse Event|19|||
30731320|NCT00320541|58743901|FG000|Overall Study|Protocol Violation|0|||
30731321|NCT00320541|58743902|FG001|Overall Study|Protocol Violation|1|||
30731322|NCT00320541|58743901|FG000|Overall Study|Withdrawal by Subject|12|||
30731323|NCT00320541|58743902|FG001|Overall Study|Withdrawal by Subject|16|||
30731324|NCT00320541|58743901|FG000|Overall Study|Physician Decision|9|||
30731325|NCT00320541|58743902|FG001|Overall Study|Physician Decision|13|||
30731326|NCT00320541|58743901|FG000|Overall Study|Other|3|||
30731327|NCT00320541|58743902|FG001|Overall Study|Other|4|||
30731328|NCT00320541|58743901|FG000|Overall Study|Sponsor Decision|2|||
30731329|NCT00320541|58743902|FG001|Overall Study|Sponsor Decision|1|||
30731330|NCT00320541|58743901|FG000|Overall Study|Death due to Study Disease|1|||
30731331|NCT00320541|58743902|FG001|Overall Study|Death due to Study Disease|3|||
30731332|NCT00320541|58743901|FG000|Overall Study|Death due to Adverse Event(s)|1|||
30731333|NCT00320541|58743902|FG001|Overall Study|Death due to Adverse Event(s)|0|||
30731334|NCT00320541|58743901|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
30731335|NCT00320541|58743902|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
30731336|NCT00320385|58743910|FG000|Overall Study|Lost to Follow-up|7|||
30731337|NCT00320385|58743911|FG001|Overall Study|Lost to Follow-up|10|||
30731338|NCT00320385|58743910|FG000|Overall Study|Withdrawal by Subject|6|||
30731339|NCT00320385|58743911|FG001|Overall Study|Withdrawal by Subject|7|||
30731340|NCT00320385|58743910|FG000|Overall Study|Sponsor Terminated Study|2|||
30731341|NCT00320385|58743911|FG001|Overall Study|Sponsor Terminated Study|1|||
30731342|NCT00320385|58743910|FG000|Overall Study|Investigator Decision|0|||
30731343|NCT00320385|58743911|FG001|Overall Study|Investigator Decision|1|||
30731344|NCT00320385|58743910|FG000|Overall Study|Death|1|||
30731345|NCT00320385|58743911|FG001|Overall Study|Death|2|||
30731346|NCT00320385|58743910|FG000|Overall Study|Serious Adverse Event|1|||
30731347|NCT00320385|58743911|FG001|Overall Study|Serious Adverse Event|0|||
30731348|NCT00320385|58743910|FG000|Overall Study|Withdrew Consent|1|||
30731349|NCT00320385|58743911|FG001|Overall Study|Withdrew Consent|0|||
30731350|NCT00320385|58743910|FG000|Overall Study|Adverse Event|0|||
30731351|NCT00320385|58743911|FG001|Overall Study|Adverse Event|1|||
30731352|NCT00326001|58743919|FG000|Overall Study|Adverse Event|4|||
30731353|NCT00326001|58743920|FG001|Overall Study|Adverse Event|5|||
30731354|NCT00326001|58743919|FG000|Overall Study|Physician Decision|3|||
30731355|NCT00326001|58743920|FG001|Overall Study|Physician Decision|3|||
30731356|NCT00309777|58743930|FG000|Overall Study|Adverse Event|13|||
30731357|NCT00309777|58743931|FG001|Overall Study|Adverse Event|2|||
30731358|NCT00309777|58743932|FG002|Overall Study|Adverse Event|8|||
30731359|NCT00309777|58743933|FG003|Overall Study|Adverse Event|1|||
30731360|NCT00309777|58743930|FG000|Overall Study|Protocol Violation|4|||
30731361|NCT00309777|58743931|FG001|Overall Study|Protocol Violation|1|||
30731362|NCT00309777|58743932|FG002|Overall Study|Protocol Violation|3|||
30731363|NCT00309777|58743933|FG003|Overall Study|Protocol Violation|1|||
30731364|NCT00309777|58743930|FG000|Overall Study|Withdrawal by Subject|6|||
30731365|NCT00309777|58743931|FG001|Overall Study|Withdrawal by Subject|5|||
30731366|NCT00309777|58743932|FG002|Overall Study|Withdrawal by Subject|7|||
30731367|NCT00309777|58743933|FG003|Overall Study|Withdrawal by Subject|2|||
30731368|NCT00309777|58743930|FG000|Overall Study|Lost to Follow-up|0|||
30731369|NCT00309777|58743931|FG001|Overall Study|Lost to Follow-up|0|||
30731370|NCT00309777|58743932|FG002|Overall Study|Lost to Follow-up|1|||
30731371|NCT00309777|58743933|FG003|Overall Study|Lost to Follow-up|0|||
30731372|NCT00309777|58743930|FG000|Overall Study|Death|0|||
30731373|NCT00309777|58743931|FG001|Overall Study|Death|1|||
30900499|NCT01647542|58933939|FG002|Overall Study|Adverse Event|4|||
30731374|NCT00309777|58743932|FG002|Overall Study|Death|0|||
30731375|NCT00309777|58743933|FG003|Overall Study|Death|0|||
30731376|NCT00309387|58743945|FG000|Overall Study|Death|72|||
30731377|NCT00309387|58743946|FG001|Overall Study|Death|73|||
30731378|NCT00309387|58743945|FG000|Overall Study|Lost to Follow-up|70|||
30900500|NCT01647542|58933937|FG000|Overall Study|Lost to Follow-up|0|||
30731379|NCT00309387|58743946|FG001|Overall Study|Lost to Follow-up|86|||
30731380|NCT00325143|58743953|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
30731381|NCT00325143|58743953|FG000|Overall Study|Migrated/moved from study area|1|||
30731382|NCT00325143|58743953|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
30731383|NCT00325143|58743953|FG000|Overall Study|Withdrawal by Subject|8|||
30731384|NCT00319839|58743957|FG000|Overall Study|Adverse Event|5|||
30731385|NCT00319839|58743957|FG000|Overall Study|Withdrawal by Subject|1|||
30731386|NCT00319449|58743963|FG000|Overall Study|Subject did not wish to continue|1|||
30731387|NCT00319449|58743964|FG001|Overall Study|Subject did not wish to continue|0|||
30731388|NCT00319449|58743963|FG000|Overall Study|Noncompliance with the protocol|1|||
30731389|NCT00319449|58743964|FG001|Overall Study|Noncompliance with the protocol|0|||
30731390|NCT00308997|58743972|FG000|Overall Study|Subject feigned clinical data|0|||
30731391|NCT00308997|58743973|FG001|Overall Study|Subject feigned clinical data|1|||
30731392|NCT00308997|58743972|FG000|Overall Study|Unable to tolerate intervention|1|||
30731393|NCT00308997|58743973|FG001|Overall Study|Unable to tolerate intervention|0|||
30731394|NCT00308685|58743981|FG000|Overall Study|Lost to Follow-up|1|||
30731395|NCT00308685|58743982|FG001|Overall Study|Lost to Follow-up|0|||
30731396|NCT00308685|58743981|FG000|Overall Study|Need to administer prohibited medication|1|||
30731397|NCT00308685|58743982|FG001|Overall Study|Need to administer prohibited medication|2|||
30731398|NCT00308685|58743981|FG000|Overall Study|Other than specified|1|||
30731399|NCT00308685|58743982|FG001|Overall Study|Other than specified|3|||
30731400|NCT00317109|58743990|FG000|Overall Study|Withdrawal by Subject|2|||
30731401|NCT00317109|58743991|FG001|Overall Study|Withdrawal by Subject|0|||
30731402|NCT00317109|58743990|FG000|Overall Study|Migated/moved from study area|1|||
30731403|NCT00317109|58743991|FG001|Overall Study|Migated/moved from study area|0|||
30731404|NCT00316719|58743999|FG000|Overall Study|Adverse Event|0|||
30731405|NCT00316719|58744000|FG001|Overall Study|Adverse Event|6|||
30731406|NCT00316719|58743999|FG000|Overall Study|Consent withdrawn|2|||
30731407|NCT00316719|58744000|FG001|Overall Study|Consent withdrawn|0|||
30731408|NCT00422058|58744012|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
30731409|NCT00422058|58744013|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
30731410|NCT00422058|58744014|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
30731411|NCT00422058|58744015|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
30731412|NCT00422058|58744016|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
30731413|NCT00422058|58744017|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
30731414|NCT00422058|58744012|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
30731415|NCT00422058|58744013|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
30731416|NCT00422058|58744014|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
30731417|NCT00422058|58744015|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
30731418|NCT00422058|58744016|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
30731419|NCT00422058|58744017|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
30731420|NCT00422058|58744012|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
30731421|NCT00422058|58744013|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
30731422|NCT00422058|58744014|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
30731423|NCT00422058|58744015|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
30731424|NCT00422058|58744016|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
30731425|NCT00422058|58744017|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
30731426|NCT00422058|58744012|FG000|Double-Blind, Week 0-20|Other|11|||
30731427|NCT00422058|58744013|FG001|Double-Blind, Week 0-20|Other|3|||
30731428|NCT00422058|58744014|FG002|Double-Blind, Week 0-20|Other|8|||
30900501|NCT01647542|58933938|FG001|Overall Study|Lost to Follow-up|2|||
30900502|NCT01647542|58933939|FG002|Overall Study|Lost to Follow-up|2|||
30900503|NCT01647542|58933937|FG000|Overall Study|Withdrawal by Subject|6|||
30731429|NCT00422058|58744015|FG003|Double-Blind, Week 0-20|Other|8|||
30731430|NCT00422058|58744016|FG004|Double-Blind, Week 0-20|Other|4|||
30731431|NCT00422058|58744017|FG005|Double-Blind, Week 0-20|Other|10|||
30731432|NCT00422058|58744012|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
30731433|NCT00422058|58744013|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
30731434|NCT00422058|58744014|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
30731435|NCT00422058|58744015|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
30731436|NCT00422058|58744016|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
30731437|NCT00422058|58744017|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
30731438|NCT00422058|58744012|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
30731439|NCT00422058|58744013|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
30731440|NCT00422058|58744014|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
30731441|NCT00422058|58744015|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
30900504|NCT01647542|58933938|FG001|Overall Study|Withdrawal by Subject|4|||
30900505|NCT01647542|58933939|FG002|Overall Study|Withdrawal by Subject|0|||
30731442|NCT00422058|58744016|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
30731443|NCT00422058|58744017|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
30731444|NCT00422058|58744012|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
30731445|NCT00422058|58744013|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
30731446|NCT00422058|58744014|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
30731447|NCT00422058|58744015|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
30731448|NCT00422058|58744016|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
30731449|NCT00422058|58744017|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
30731450|NCT00422058|58744012|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
30731451|NCT00422058|58744013|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
30731452|NCT00422058|58744014|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
30731453|NCT00422058|58744015|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
30731454|NCT00422058|58744016|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
30731455|NCT00422058|58744017|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
30731456|NCT00422058|58744012|FG000|Open-Label Extension, Week 20-104|Other|13|||
30731457|NCT00422058|58744013|FG001|Open-Label Extension, Week 20-104|Other|14|||
30731458|NCT00422058|58744014|FG002|Open-Label Extension, Week 20-104|Other|6|||
30731459|NCT00422058|58744015|FG003|Open-Label Extension, Week 20-104|Other|13|||
30731460|NCT00422058|58744016|FG004|Open-Label Extension, Week 20-104|Other|16|||
30731461|NCT00422058|58744017|FG005|Open-Label Extension, Week 20-104|Other|18|||
30731462|NCT00413244|58744041|FG000|Overall Study|Withdrawal by Subject|10|||
30731463|NCT00413244|58744042|FG001|Overall Study|Withdrawal by Subject|1|||
30731464|NCT00420420|58744070|FG000|Overall Study|Adverse Event|5|||
30731465|NCT00420420|58744071|FG001|Overall Study|Adverse Event|3|||
30731466|NCT00420420|58744070|FG000|Overall Study|Protocol Violation|1|||
30731467|NCT00420420|58744071|FG001|Overall Study|Protocol Violation|1|||
30731468|NCT00420420|58744070|FG000|Overall Study|Withdrawal by Subject|1|||
30731469|NCT00420420|58744071|FG001|Overall Study|Withdrawal by Subject|0|||
30731470|NCT00420420|58744070|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
30731471|NCT00420420|58744071|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
30731472|NCT00420342|58744080|FG000|Overall Study|Lost to Follow-up|1|||
30731473|NCT00420342|58744081|FG001|Overall Study|Lost to Follow-up|0|||
30731474|NCT00420342|58744082|FG002|Overall Study|Lost to Follow-up|1|||
30731475|NCT00420342|58744080|FG000|Overall Study|Withdrawal by Subject|0|||
30731476|NCT00420342|58744081|FG001|Overall Study|Withdrawal by Subject|2|||
30731477|NCT00420342|58744082|FG002|Overall Study|Withdrawal by Subject|0|||
30731478|NCT00432744|58744092|FG000|Months 0-6|Withdrawal by Subject|4|||
30731479|NCT00432744|58744093|FG001|Months 0-6|Withdrawal by Subject|4|||
30731480|NCT00432744|58744092|FG000|Months 0-6|Too disabled to score|1|||
30731481|NCT00432744|58744093|FG001|Months 0-6|Too disabled to score|0|||
30731482|NCT00432744|58744092|FG000|Months 7 - 12|Withdrawal by Subject|1|||
30731483|NCT00432744|58744093|FG001|Months 7 - 12|Withdrawal by Subject|0|||
30731484|NCT00432744|58744092|FG000|Months 7 - 12|Too disabled to score|0|||
30731485|NCT00432744|58744093|FG001|Months 7 - 12|Too disabled to score|1|||
30731486|NCT00432666|58744101|FG000|Main Period|Adverse Event|1|||
30731487|NCT00432666|58744102|FG001|Main Period|Adverse Event|1|||
30731488|NCT00432666|58744101|FG000|Main Period|Consent Withdrawn|1|||
30731489|NCT00432666|58744102|FG001|Main Period|Consent Withdrawn|0|||
30731490|NCT00432666|58744101|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
30731491|NCT00432666|58744102|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
30731492|NCT00432666|58744101|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
30731493|NCT00432666|58744102|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
30731494|NCT00432666|58744101|FG000|Open-Label Extension Period|Adverse Event|5|||
30731495|NCT00432666|58744102|FG001|Open-Label Extension Period|Adverse Event|0|||
30731496|NCT00432666|58744101|FG000|Open-Label Extension Period|Consent withdrawn|10|||
30731497|NCT00432666|58744102|FG001|Open-Label Extension Period|Consent withdrawn|0|||
30731498|NCT00432666|58744101|FG000|Open-Label Extension Period|Physician Decision|3|||
30731499|NCT00432666|58744102|FG001|Open-Label Extension Period|Physician Decision|0|||
30731500|NCT00451958|58744112|FG000|CS21A (NCT00451958)|Adverse Event|21|||
30731501|NCT00451958|58744113|FG001|CS21A (NCT00451958)|Adverse Event|34|||
30731502|NCT00451958|58744114|FG002|CS21A (NCT00451958)|Adverse Event|14|||
30731503|NCT00451958|58744115|FG003|CS21A (NCT00451958)|Adverse Event|17|||
30731504|NCT00451958|58744116|FG004|CS21A (NCT00451958)|Adverse Event|0|||
30731505|NCT00451958|58744112|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
30731506|NCT00451958|58744113|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
30731507|NCT00451958|58744114|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
30731508|NCT00451958|58744115|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
30731509|NCT00451958|58744116|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
30731510|NCT00451958|58744112|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
30731511|NCT00451958|58744113|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
30731512|NCT00451958|58744114|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
30731513|NCT00451958|58744115|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
30731514|NCT00451958|58744116|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
30731515|NCT00451958|58744112|FG000|CS21A (NCT00451958)|Physician Decision|2|||
30731516|NCT00451958|58744113|FG001|CS21A (NCT00451958)|Physician Decision|4|||
30731517|NCT00451958|58744114|FG002|CS21A (NCT00451958)|Physician Decision|4|||
30731518|NCT00451958|58744115|FG003|CS21A (NCT00451958)|Physician Decision|4|||
30731519|NCT00451958|58744116|FG004|CS21A (NCT00451958)|Physician Decision|0|||
30731520|NCT00451958|58744112|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
30731521|NCT00451958|58744113|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
30731522|NCT00451958|58744114|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
30731523|NCT00451958|58744115|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
30731524|NCT00451958|58744116|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
30731525|NCT00451958|58744112|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
30731526|NCT00451958|58744113|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
30731527|NCT00451958|58744114|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
30731528|NCT00451958|58744115|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
30731529|NCT00451958|58744116|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
30731530|NCT00432276|58744132|FG000|Overall Study|Hyperglycemic Rescue|44|||
30731531|NCT00432276|58744133|FG001|Overall Study|Hyperglycemic Rescue|87|||
30731532|NCT00432276|58744132|FG000|Overall Study|Adverse Event|13|||
30731533|NCT00432276|58744133|FG001|Overall Study|Adverse Event|16|||
30731534|NCT00432276|58744132|FG000|Overall Study|Protocol Violation|25|||
30731535|NCT00432276|58744133|FG001|Overall Study|Protocol Violation|20|||
30731536|NCT00432276|58744132|FG000|Overall Study|Lost to Follow-up|6|||
30731537|NCT00432276|58744133|FG001|Overall Study|Lost to Follow-up|2|||
30731538|NCT00432276|58744132|FG000|Overall Study|Withdrawal by Subject|25|||
30731539|NCT00432276|58744133|FG001|Overall Study|Withdrawal by Subject|20|||
30731540|NCT00432276|58744132|FG000|Overall Study|Physician Decision|6|||
30731541|NCT00432276|58744133|FG001|Overall Study|Physician Decision|8|||
30731542|NCT00432276|58744132|FG000|Overall Study|Other|2|||
30731543|NCT00432276|58744133|FG001|Overall Study|Other|3|||
30731544|NCT00413010|58744141|FG000|Overall Study|Adverse Event|8|||
30731545|NCT00413010|58744142|FG001|Overall Study|Adverse Event|4|||
30731546|NCT00413010|58744141|FG000|Overall Study|Laboratory abnormality|0|||
30731547|NCT00413010|58744142|FG001|Overall Study|Laboratory abnormality|2|||
30731548|NCT00413010|58744141|FG000|Overall Study|Lack of Efficacy|0|||
30731549|NCT00413010|58744142|FG001|Overall Study|Lack of Efficacy|3|||
30731550|NCT00413010|58744141|FG000|Overall Study|Lost to Follow-up|3|||
30731551|NCT00413010|58744142|FG001|Overall Study|Lost to Follow-up|0|||
30731552|NCT00413010|58744141|FG000|Overall Study|Withdrawal by Subject|7|||
30731553|NCT00413010|58744142|FG001|Overall Study|Withdrawal by Subject|2|||
30731554|NCT00413010|58744141|FG000|Overall Study|Due to termination of the study|54|||
30731555|NCT00413010|58744142|FG001|Overall Study|Due to termination of the study|52|||
30731556|NCT00459290|58744148|FG000|Overall Study|Adverse Event|3|||
30731557|NCT00459290|58744148|FG000|Overall Study|Ineligible|2|||
30731558|NCT00443534|58744159|FG000|Overall Study|Lack of Efficacy|67|||
30731559|NCT00443534|58744159|FG000|Overall Study|Adverse Event|16|||
30731560|NCT00443534|58744159|FG000|Overall Study|Death|9|||
30731561|NCT00443534|58744159|FG000|Overall Study|Withdrawal by Subject|8|||
30731562|NCT00443534|58744159|FG000|Overall Study|Study Terminated by Sponsor|12|||
30731563|NCT00443534|58744159|FG000|Overall Study|Other|10|||
30731564|NCT00443534|58744159|FG000|Overall Study|Enrolled, Not Treated|1|||
30731565|NCT00419952|58744165|FG000|Overall Study|Adverse Event|8|||
30731566|NCT00419952|58744166|FG001|Overall Study|Adverse Event|10|||
30731567|NCT00419952|58744165|FG000|Overall Study|Withdrawal by Subject|44|||
30731568|NCT00419952|58744166|FG001|Overall Study|Withdrawal by Subject|43|||
30731569|NCT00419952|58744165|FG000|Overall Study|Lost to Follow-up|43|||
30731570|NCT00419952|58744166|FG001|Overall Study|Lost to Follow-up|34|||
30731571|NCT00419952|58744165|FG000|Overall Study|Protocol Violation|32|||
30731572|NCT00419952|58744166|FG001|Overall Study|Protocol Violation|24|||
30731573|NCT00419952|58744165|FG000|Overall Study|Pregnancy|4|||
30731574|NCT00419952|58744166|FG001|Overall Study|Pregnancy|2|||
30731575|NCT00419952|58744165|FG000|Overall Study|Physician Decision|1|||
30731576|NCT00419952|58744166|FG001|Overall Study|Physician Decision|3|||
30731577|NCT00419952|58744165|FG000|Overall Study|Incorrectly enrolled|10|||
30731578|NCT00419952|58744166|FG001|Overall Study|Incorrectly enrolled|3|||
30731579|NCT00419952|58744165|FG000|Overall Study|Intake of prohibited medication|2|||
30731580|NCT00419952|58744166|FG001|Overall Study|Intake of prohibited medication|2|||
30731581|NCT00419952|58744165|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
30731582|NCT00419952|58744166|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
30731583|NCT00419952|58744165|FG000|Overall Study|Diary or medication non-compliance|2|||
30731584|NCT00419952|58744166|FG001|Overall Study|Diary or medication non-compliance|4|||
30731585|NCT00419952|58744165|FG000|Overall Study|Abnormal ECG|1|||
30731586|NCT00419952|58744166|FG001|Overall Study|Abnormal ECG|0|||
30731587|NCT00443456|58744172|FG000|Overall Study|Adverse Event|16|||
30731588|NCT00443456|58744172|FG000|Overall Study|Move|1|||
30731589|NCT00443456|58744172|FG000|Overall Study|Withdrawal by Subject|1|||
30731590|NCT00419562|58744182|FG000|Overall Study|Lost to Follow-up|12|||
30731591|NCT00419562|58744183|FG001|Overall Study|Lost to Follow-up|13|||
30731592|NCT00419562|58744182|FG000|Overall Study|Withdrawal by Subject|20|||
30731593|NCT00419562|58744183|FG001|Overall Study|Withdrawal by Subject|18|||
30731594|NCT00419562|58744182|FG000|Overall Study|Participant Institutionalized|1|||
30731595|NCT00419562|58744183|FG001|Overall Study|Participant Institutionalized|0|||
30731596|NCT00432042|58744192|FG000|Overall Study|Protocol Violation|2|||
30731597|NCT00432042|58744193|FG001|Overall Study|Protocol Violation|0|||
30731598|NCT00432042|58744194|FG002|Overall Study|Protocol Violation|0|||
30731599|NCT00432042|58744192|FG000|Overall Study|Withdrawal by Subject|0|||
30731600|NCT00432042|58744193|FG001|Overall Study|Withdrawal by Subject|0|||
30731601|NCT00432042|58744194|FG002|Overall Study|Withdrawal by Subject|2|||
30731602|NCT00432042|58744192|FG000|Overall Study|Lost to Follow-up|5|||
30731603|NCT00432042|58744193|FG001|Overall Study|Lost to Follow-up|1|||
30731604|NCT00432042|58744194|FG002|Overall Study|Lost to Follow-up|0|||
30731605|NCT00308139|58744204|FG000|Overall Study|Adverse Event|20|||
30731606|NCT00308139|58744205|FG001|Overall Study|Adverse Event|14|||
30731607|NCT00308139|58744204|FG000|Overall Study|Lost to Follow-up|13|||
30731608|NCT00308139|58744205|FG001|Overall Study|Lost to Follow-up|8|||
30731609|NCT00308139|58744204|FG000|Overall Study|Protocol Violation|3|||
30731610|NCT00308139|58744205|FG001|Overall Study|Protocol Violation|2|||
30731611|NCT00308139|58744204|FG000|Overall Study|Withdrawal of Consent|40|||
30731612|NCT00308139|58744205|FG001|Overall Study|Withdrawal of Consent|42|||
30731613|NCT00308139|58744204|FG000|Overall Study|Investigator Decision|11|||
30731614|NCT00308139|58744205|FG001|Overall Study|Investigator Decision|10|||
30731615|NCT00308139|58744204|FG000|Overall Study|Loss of Glucose Control|5|||
30731616|NCT00308139|58744205|FG001|Overall Study|Loss of Glucose Control|7|||
30731617|NCT00308139|58744204|FG000|Overall Study|Administrative|1|||
30731618|NCT00308139|58744205|FG001|Overall Study|Administrative|4|||
30731619|NCT00308139|58744204|FG000|Overall Study|Other|1|||
30731620|NCT00308139|58744205|FG001|Overall Study|Other|0|||
30731621|NCT00459134|58744233|FG000|Overall Study|Physician Decision|1|||
30731622|NCT00459134|58744234|FG001|Overall Study|Physician Decision|1|||
30731623|NCT00459134|58744233|FG000|Overall Study|Withdrawal by Subject|8|||
30731624|NCT00459134|58744234|FG001|Overall Study|Withdrawal by Subject|7|||
30731625|NCT00459134|58744233|FG000|Overall Study|Lost to Follow-up|6|||
30731626|NCT00459134|58744234|FG001|Overall Study|Lost to Follow-up|7|||
30731627|NCT00459134|58744233|FG000|Overall Study|Surgery|1|||
30731628|NCT00459134|58744234|FG001|Overall Study|Surgery|2|||
30731629|NCT00459134|58744233|FG000|Overall Study|Toxicity|4|||
30731630|NCT00459134|58744234|FG001|Overall Study|Toxicity|5|||
30731631|NCT00459134|58744233|FG000|Overall Study|Progression|1|||
30731632|NCT00459134|58744234|FG001|Overall Study|Progression|0|||
30731633|NCT00459134|58744233|FG000|Overall Study|Multiple Reasons|2|||
30731634|NCT00459134|58744234|FG001|Overall Study|Multiple Reasons|3|||
30731635|NCT00459056|58744242|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
30731636|NCT00459056|58744243|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
30731637|NCT00431964|58744251|FG000|Overall Study|Adverse Event|1|||
30731638|NCT00431964|58744252|FG001|Overall Study|Adverse Event|0|||
30731639|NCT00431964|58744251|FG000|Overall Study|Lost to Follow-up|1|||
30731640|NCT00431964|58744252|FG001|Overall Study|Lost to Follow-up|2|||
30731641|NCT00431964|58744251|FG000|Overall Study|Physician Decision|2|||
30731642|NCT00431964|58744252|FG001|Overall Study|Physician Decision|2|||
30731643|NCT00431964|58744251|FG000|Overall Study|Withdrawal by Subject|2|||
30731644|NCT00431964|58744252|FG001|Overall Study|Withdrawal by Subject|1|||
30731645|NCT00431964|58744251|FG000|Overall Study|Parental Consent Withdrawn|0|||
30731646|NCT00431964|58744252|FG001|Overall Study|Parental Consent Withdrawn|2|||
30731647|NCT00431964|58744251|FG000|Overall Study|Due to Unstable Health|0|||
30731648|NCT00431964|58744252|FG001|Overall Study|Due to Unstable Health|1|||
30731649|NCT00412854|58744260|FG000|Overall Study|Withdrawn due to adverse events|1|||
30731650|NCT00412854|58744261|FG001|Overall Study|Withdrawn due to adverse events|5|||
30731651|NCT00412854|58744260|FG000|Overall Study|Withdrawn for other reasons|13|||
30731652|NCT00412854|58744261|FG001|Overall Study|Withdrawn for other reasons|11|||
30731653|NCT00431496|58744267|FG000|Overall Study|Adverse Event|3|||
30731654|NCT00431496|58744267|FG000|Overall Study|Lost to Follow-up|1|||
30731655|NCT00431496|58744267|FG000|Overall Study|Withdrawal by Subject|2|||
30731656|NCT00431496|58744267|FG000|Overall Study|Protocol-specified criteria|5|||
30731657|NCT00316173|58744273|FG000|Run-in Phase|Adverse Event|1|||
30731658|NCT00316173|58744274|FG001|Run-in Phase|Adverse Event|0|||
30731659|NCT00316173|58744273|FG000|Run-in Phase|Protocol Violation|1|||
30731660|NCT00316173|58744274|FG001|Run-in Phase|Protocol Violation|0|||
30731661|NCT00316173|58744273|FG000|Run-in Phase|Study Follow-up Stopped|5|||
30731662|NCT00316173|58744274|FG001|Run-in Phase|Study Follow-up Stopped|0|||
30731663|NCT00316173|58744273|FG000|Treatment Phase|Adverse Event|0|||
30731664|NCT00316173|58744274|FG001|Treatment Phase|Adverse Event|1|||
30731665|NCT00316173|58744273|FG000|Treatment Phase|Lack of Efficacy|0|||
30731666|NCT00316173|58744274|FG001|Treatment Phase|Lack of Efficacy|3|||
30731667|NCT00316173|58744273|FG000|Treatment Phase|Lost to Follow-up|0|||
30731668|NCT00316173|58744274|FG001|Treatment Phase|Lost to Follow-up|3|||
30731669|NCT00316173|58744273|FG000|Treatment Phase|Withdrawal by Subject|0|||
30731670|NCT00316173|58744274|FG001|Treatment Phase|Withdrawal by Subject|1|||
30731671|NCT00316173|58744273|FG000|Treatment Phase|Study Follow-up Stopped|0|||
30731672|NCT00316173|58744274|FG001|Treatment Phase|Study Follow-up Stopped|34|||
30731673|NCT00412542|58744281|FG000|Overall Study|Withdrawal by Subject|0|||
30731674|NCT00412542|58744282|FG001|Overall Study|Withdrawal by Subject|2|||
30731675|NCT00412542|58744281|FG000|Overall Study|Not Eligible|0|||
30731676|NCT00412542|58744282|FG001|Overall Study|Not Eligible|1|||
30731677|NCT00316017|58744289|FG000|Overall Study|Protocol Violation|11|||
30731678|NCT00316017|58744290|FG001|Overall Study|Protocol Violation|13|||
30731679|NCT00316017|58744291|FG002|Overall Study|Protocol Violation|19|||
30731680|NCT00451178|58744301|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
30731681|NCT00451178|58744302|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
30731682|NCT00451178|58744301|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
30731683|NCT00451178|58744302|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
30731684|NCT00451178|58744301|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
30731685|NCT00451178|58744302|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
30900506|NCT01647542|58933937|FG000|Overall Study|Study Termination|64|||
30731686|NCT00451178|58744301|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
30900507|NCT01647542|58933938|FG001|Overall Study|Study Termination|61|||
30900508|NCT01647542|58933939|FG002|Overall Study|Study Termination|65|||
30731687|NCT00451178|58744302|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
30731688|NCT00451178|58744301|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
30731689|NCT00451178|58744302|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
30900509|NCT01647542|58933937|FG000|Overall Study|Lack of Efficacy|1|||
30731690|NCT00451178|58744301|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
30731691|NCT00451178|58744302|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
30731692|NCT00451178|58744301|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
30900510|NCT01647542|58933938|FG001|Overall Study|Lack of Efficacy|1|||
30731693|NCT00451178|58744302|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
30731694|NCT00451178|58744301|FG000|Prior to Maintenance Therapy|PD|2|||
30731695|NCT00451178|58744302|FG001|Prior to Maintenance Therapy|PD|0|||
30731696|NCT00451178|58744301|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
30731697|NCT00451178|58744302|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
30731698|NCT00451178|58744301|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
30731699|NCT00451178|58744302|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
30731700|NCT00451178|58744301|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
30731701|NCT00451178|58744302|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
30731702|NCT00451178|58744301|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
30731703|NCT00451178|58744302|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
30731704|NCT00451178|58744301|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
30731705|NCT00451178|58744302|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
30731706|NCT00451178|58744301|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
30731707|NCT00451178|58744302|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
30731708|NCT00451178|58744301|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
30731709|NCT00451178|58744302|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
30731710|NCT00450866|58744312|FG000|Overall Study|Adverse Event|0|||
30731711|NCT00450866|58744313|FG001|Overall Study|Adverse Event|1|||
30731712|NCT00450866|58744312|FG000|Overall Study|Withdrawal by Subject|5|||
30731713|NCT00450866|58744313|FG001|Overall Study|Withdrawal by Subject|2|||
30731714|NCT00450866|58744312|FG000|Overall Study|Death|1|||
30731715|NCT00450866|58744313|FG001|Overall Study|Death|0|||
30731716|NCT00450866|58744312|FG000|Overall Study|Physician Decision|1|||
30731717|NCT00450866|58744313|FG001|Overall Study|Physician Decision|0|||
30731718|NCT00442598|58744322|FG000|Overall Study|Adverse Event|1|||
30731719|NCT00442598|58744323|FG001|Overall Study|Adverse Event|0|||
30731720|NCT00442598|58744324|FG002|Overall Study|Adverse Event|0|||
30731721|NCT00442598|58744322|FG000|Overall Study|Tumor progression|3|||
30731722|NCT00442598|58744323|FG001|Overall Study|Tumor progression|4|||
30731723|NCT00442598|58744324|FG002|Overall Study|Tumor progression|0|||
30731724|NCT00442598|58744322|FG000|Overall Study|Clinical deterioration|1|||
30731725|NCT00442598|58744323|FG001|Overall Study|Clinical deterioration|2|||
30731726|NCT00442598|58744324|FG002|Overall Study|Clinical deterioration|0|||
30731727|NCT00442598|58744322|FG000|Overall Study|CA125 progression|0|||
30731728|NCT00442598|58744323|FG001|Overall Study|CA125 progression|1|||
30731729|NCT00442598|58744324|FG002|Overall Study|CA125 progression|0|||
30731730|NCT00442598|58744322|FG000|Overall Study|Reduced creatinine clearance|1|||
30731731|NCT00442598|58744323|FG001|Overall Study|Reduced creatinine clearance|0|||
30731732|NCT00442598|58744324|FG002|Overall Study|Reduced creatinine clearance|0|||
30731733|NCT00442598|58744322|FG000|Overall Study|Death|0|||
30731734|NCT00442598|58744323|FG001|Overall Study|Death|1|||
30731735|NCT00442598|58744324|FG002|Overall Study|Death|0|||
30731736|NCT00442286|58744334|FG000|Overall Study|Death|2|||
30731737|NCT00442286|58744335|FG001|Overall Study|Death|2|||
30731738|NCT00442286|58744334|FG000|Overall Study|Lost to Follow-up|1|||
30731739|NCT00442286|58744335|FG001|Overall Study|Lost to Follow-up|0|||
30731740|NCT00442286|58744334|FG000|Overall Study|Withdrawal by Subject|2|||
30731741|NCT00442286|58744335|FG001|Overall Study|Withdrawal by Subject|0|||
30731742|NCT00442286|58744334|FG000|Overall Study|System explanted|1|||
30731743|NCT00442286|58744335|FG001|Overall Study|System explanted|0|||
30731744|NCT00442286|58744334|FG000|Overall Study|Patient Injury|1|||
30731745|NCT00442286|58744335|FG001|Overall Study|Patient Injury|0|||
30731746|NCT00441974|58744343|FG000|Overall Study|Adverse Event|6|||
30731747|NCT00441974|58744343|FG000|Overall Study|Consent Withdrawn|35|||
30731748|NCT00441974|58744343|FG000|Overall Study|Lost to Follow-up|80|||
30731749|NCT00441974|58744343|FG000|Overall Study|Protocol Violation|7|||
30731750|NCT00441584|58744350|FG000|Overall Study|Lack of Efficacy|79|||
30731751|NCT00441584|58744350|FG000|Overall Study|Withdrawal by Subject|8|||
30731752|NCT00441584|58744350|FG000|Overall Study|Adverse Event|6|||
30731753|NCT00441584|58744350|FG000|Overall Study|Protocol Violation|5|||
30731754|NCT00441584|58744350|FG000|Overall Study|Lost to Follow-up|4|||
30731755|NCT00441584|58744350|FG000|Overall Study|Failure to meet eligibility criteria|3|||
30731756|NCT00430716|58744357|FG000|Double Blind Phase|Death|1|||
30731757|NCT00430716|58744358|FG001|Double Blind Phase|Death|0|||
30731758|NCT00430716|58744359|FG002|Double Blind Phase|Death|0|||
30731759|NCT00430716|58744357|FG000|Double Blind Phase|No longer willing to participate|2|||
30731760|NCT00430716|58744358|FG001|Double Blind Phase|No longer willing to participate|1|||
30731761|NCT00430716|58744359|FG002|Double Blind Phase|No longer willing to participate|1|||
30731762|NCT00430716|58744357|FG000|Double Blind Phase|Other|0|||
30731763|NCT00430716|58744358|FG001|Double Blind Phase|Other|2|||
30731764|NCT00430716|58744359|FG002|Double Blind Phase|Other|0|||
30731765|NCT00430716|58744357|FG000|Double Blind Phase|Study terminated by sponsor|1|||
30731766|NCT00430716|58744358|FG001|Double Blind Phase|Study terminated by sponsor|1|||
30731767|NCT00430716|58744359|FG002|Double Blind Phase|Study terminated by sponsor|2|||
30731768|NCT00430716|58744357|FG000|Double Blind Phase|Adverse Event|1|||
30731769|NCT00430716|58744358|FG001|Double Blind Phase|Adverse Event|1|||
30731770|NCT00430716|58744359|FG002|Double Blind Phase|Adverse Event|3|||
30731771|NCT00430716|58744357|FG000|Double Blind Phase|Not treated|1|||
30731772|NCT00430716|58744358|FG001|Double Blind Phase|Not treated|0|||
30731773|NCT00430716|58744359|FG002|Double Blind Phase|Not treated|0|||
30731774|NCT00430716|58744357|FG000|Open Label Phase|Lost to Follow-up|1|||
30731775|NCT00430716|58744358|FG001|Open Label Phase|Lost to Follow-up|0|||
30731776|NCT00430716|58744359|FG002|Open Label Phase|Lost to Follow-up|1|||
30731777|NCT00430716|58744357|FG000|Open Label Phase|No longer willing to participate|0|||
30731778|NCT00430716|58744358|FG001|Open Label Phase|No longer willing to participate|1|||
30731779|NCT00430716|58744359|FG002|Open Label Phase|No longer willing to participate|1|||
30731780|NCT00430716|58744357|FG000|Open Label Phase|Other|3|||
30731781|NCT00430716|58744358|FG001|Open Label Phase|Other|1|||
30731782|NCT00430716|58744359|FG002|Open Label Phase|Other|1|||
30731783|NCT00430716|58744357|FG000|Open Label Phase|Protocol Violation|1|||
30731784|NCT00430716|58744358|FG001|Open Label Phase|Protocol Violation|0|||
30731785|NCT00430716|58744359|FG002|Open Label Phase|Protocol Violation|0|||
30731786|NCT00430716|58744357|FG000|Open Label Phase|Study terminated by sponsor|4|||
30731787|NCT00430716|58744358|FG001|Open Label Phase|Study terminated by sponsor|5|||
30731788|NCT00430716|58744359|FG002|Open Label Phase|Study terminated by sponsor|4|||
30731789|NCT00441272|58744369|FG000|Overall Study|Study terminated prior to enrollment|25|||
30731790|NCT00441272|58744370|FG001|Overall Study|Study terminated prior to enrollment|25|||
30731791|NCT00430638|58744378|FG000|Overall Study|Adverse Event|15|||
30731792|NCT00430638|58744379|FG001|Overall Study|Adverse Event|15|||
30731793|NCT00430638|58744378|FG000|Overall Study|Uncontrolled blood pressure|48|||
30731794|NCT00430638|58744379|FG001|Overall Study|Uncontrolled blood pressure|13|||
30731795|NCT00430638|58744378|FG000|Overall Study|Lost to Follow-up|1|||
30731796|NCT00430638|58744379|FG001|Overall Study|Lost to Follow-up|7|||
30731797|NCT00430638|58744378|FG000|Overall Study|Protocol Violation|6|||
30731798|NCT00430638|58744379|FG001|Overall Study|Protocol Violation|4|||
30731799|NCT00430638|58744378|FG000|Overall Study|Withdrawal by Subject|4|||
30731800|NCT00430638|58744379|FG001|Overall Study|Withdrawal by Subject|6|||
30731801|NCT00430638|58744378|FG000|Overall Study|Non-compliant|2|||
30731802|NCT00430638|58744379|FG001|Overall Study|Non-compliant|1|||
30731803|NCT00430638|58744378|FG000|Overall Study|Other|2|||
30731804|NCT00430638|58744379|FG001|Overall Study|Other|2|||
30731805|NCT00430482|58744391|FG000|Completed Treatment|Insufficient Treatment|7|||
30731806|NCT00430482|58744392|FG001|Completed Treatment|Insufficient Treatment|11|||
30731807|NCT00449930|58744400|FG000|Overall Study|Adverse Event|9|||
30731808|NCT00449930|58744401|FG001|Overall Study|Adverse Event|19|||
30731809|NCT00449930|58744400|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
30731810|NCT00449930|58744401|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
30731811|NCT00449930|58744400|FG000|Overall Study|Lack of Efficacy|10|||
30731812|NCT00449930|58744401|FG001|Overall Study|Lack of Efficacy|1|||
30731813|NCT00449930|58744400|FG000|Overall Study|Lost to Follow-up|9|||
30731814|NCT00449930|58744401|FG001|Overall Study|Lost to Follow-up|14|||
30731815|NCT00449930|58744400|FG000|Overall Study|Physician Decision|1|||
30731816|NCT00449930|58744401|FG001|Overall Study|Physician Decision|2|||
30731817|NCT00449930|58744400|FG000|Overall Study|Protocol Violation|14|||
30731818|NCT00449930|58744401|FG001|Overall Study|Protocol Violation|15|||
30731819|NCT00449930|58744400|FG000|Overall Study|Withdrawal by Subject|16|||
30731820|NCT00449930|58744401|FG001|Overall Study|Withdrawal by Subject|23|||
30731821|NCT00449930|58744400|FG000|Overall Study|Glycemic discontinuation criteria|1|||
30731822|NCT00449930|58744401|FG001|Overall Study|Glycemic discontinuation criteria|1|||
30731823|NCT00449696|58744409|FG000|Overall Study|Other Treatment Required|6|||
30731824|NCT00449696|58744410|FG001|Overall Study|Other Treatment Required|1|||
30731825|NCT00449696|58744409|FG000|Overall Study|Withdrawal by Subject|5|||
30731826|NCT00449696|58744410|FG001|Overall Study|Withdrawal by Subject|5|||
30731827|NCT00449696|58744409|FG000|Overall Study|Lost to Follow-up|2|||
30731828|NCT00449696|58744410|FG001|Overall Study|Lost to Follow-up|3|||
30731829|NCT00449696|58744409|FG000|Overall Study|Others|7|||
30731830|NCT00449696|58744410|FG001|Overall Study|Others|0|||
30731831|NCT00441116|58744418|FG000|Overall Study|Adverse Event|1|||
30731832|NCT00441116|58744419|FG001|Overall Study|Adverse Event|1|||
30731833|NCT00441116|58744418|FG000|Overall Study|Withdrawal by Subject|1|||
30731834|NCT00441116|58744419|FG001|Overall Study|Withdrawal by Subject|0|||
30731835|NCT00441116|58744418|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
30621823|NCT01181141|58633366|FG001|Overall Study|Lack of Efficacy|0|||
30731836|NCT00441116|58744419|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
30731837|NCT00430248|58744428|FG000|Overall Study|Adverse Event|49|||
30731838|NCT00430248|58744429|FG001|Overall Study|Adverse Event|61|||
30731839|NCT00430248|58744430|FG002|Overall Study|Adverse Event|64|||
30731840|NCT00430248|58744428|FG000|Overall Study|Protocol Violation|10|||
30731841|NCT00430248|58744429|FG001|Overall Study|Protocol Violation|2|||
30621824|NCT01181141|58633365|FG000|Overall Study|Lost to Follow-up|1|||
30731842|NCT00430248|58744430|FG002|Overall Study|Protocol Violation|4|||
30731843|NCT00430248|58744428|FG000|Overall Study|Personal Reasons|12|||
30731844|NCT00430248|58744429|FG001|Overall Study|Personal Reasons|24|||
30731845|NCT00430248|58744430|FG002|Overall Study|Personal Reasons|9|||
30900511|NCT01647542|58933939|FG002|Overall Study|Lack of Efficacy|0|||
30900512|NCT01647542|58933937|FG000|Overall Study|Death|0|||
30900513|NCT01647542|58933938|FG001|Overall Study|Death|0|||
30900514|NCT01647542|58933939|FG002|Overall Study|Death|1|||
30731846|NCT00430248|58744428|FG000|Overall Study|Lost to Follow-up|28|||
30731847|NCT00430248|58744429|FG001|Overall Study|Lost to Follow-up|33|||
30731848|NCT00430248|58744430|FG002|Overall Study|Lost to Follow-up|28|||
30731849|NCT00430248|58744428|FG000|Overall Study|Therapeutic Failure|1|||
30731850|NCT00430248|58744429|FG001|Overall Study|Therapeutic Failure|1|||
30731851|NCT00430248|58744430|FG002|Overall Study|Therapeutic Failure|1|||
30731852|NCT00430248|58744428|FG000|Overall Study|Withdrawal by Subject|14|||
30731853|NCT00430248|58744429|FG001|Overall Study|Withdrawal by Subject|20|||
30731854|NCT00430248|58744430|FG002|Overall Study|Withdrawal by Subject|16|||
30731855|NCT00430248|58744428|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30731856|NCT00430248|58744429|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
30731857|NCT00430248|58744430|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30731858|NCT00430248|58744428|FG000|Overall Study|Gout Flare|3|||
30731859|NCT00430248|58744429|FG001|Overall Study|Gout Flare|7|||
30731860|NCT00430248|58744430|FG002|Overall Study|Gout Flare|2|||
30731861|NCT00430248|58744428|FG000|Overall Study|Reason Not Specified|8|||
30731862|NCT00430248|58744429|FG001|Overall Study|Reason Not Specified|8|||
30731863|NCT00430248|58744430|FG002|Overall Study|Reason Not Specified|11|||
30731864|NCT00449540|58744440|FG000|Pretreatment Phase|No migraine experienced|66|||
30731865|NCT00449540|58744441|FG001|Pretreatment Phase|No migraine experienced|0|||
30731866|NCT00449540|58744442|FG002|Pretreatment Phase|No migraine experienced|0|||
30731867|NCT00449540|58744440|FG000|Treatment Phase|did not experience or treat migraine|0|||
30731868|NCT00449540|58744441|FG001|Treatment Phase|did not experience or treat migraine|20|||
30731869|NCT00449540|58744442|FG002|Treatment Phase|did not experience or treat migraine|17|||
30731870|NCT00411762|58744450|FG000|Overall Study|Withdrawal by Subject|5|||
30731871|NCT00429858|58744454|FG000|Overall Study|Withdrawal by Subject|1|||
30731872|NCT00429858|58744454|FG000|Overall Study|Study Termination|1|||
30731873|NCT00449150|58744462|FG000|Overall Study|Adverse Event|11|||
30731874|NCT00449150|58744463|FG001|Overall Study|Adverse Event|18|||
30731875|NCT00449150|58744464|FG002|Overall Study|Adverse Event|9|||
30731876|NCT00449150|58744462|FG000|Overall Study|Lack of Efficacy|1|||
30731877|NCT00449150|58744463|FG001|Overall Study|Lack of Efficacy|2|||
30731878|NCT00449150|58744464|FG002|Overall Study|Lack of Efficacy|2|||
30731879|NCT00449150|58744462|FG000|Overall Study|Other|16|||
30731880|NCT00449150|58744463|FG001|Overall Study|Other|13|||
30731881|NCT00449150|58744464|FG002|Overall Study|Other|14|||
30731882|NCT00449150|58744462|FG000|Overall Study|Withdrawal by Subject|17|||
30731883|NCT00449150|58744463|FG001|Overall Study|Withdrawal by Subject|18|||
30731884|NCT00449150|58744464|FG002|Overall Study|Withdrawal by Subject|21|||
30731885|NCT00449150|58744462|FG000|Overall Study|Protocol Violation|1|||
30731886|NCT00449150|58744463|FG001|Overall Study|Protocol Violation|2|||
30731887|NCT00449150|58744464|FG002|Overall Study|Protocol Violation|1|||
30731888|NCT00428844|58744478|FG000|Completed Study Drug Treatment|Adverse Event|2|||
30731889|NCT00428844|58744479|FG001|Completed Study Drug Treatment|Adverse Event|4|||
30731890|NCT00428844|58744480|FG002|Completed Study Drug Treatment|Adverse Event|4|||
30731891|NCT00428844|58744478|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
30731892|NCT00428844|58744479|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
30731893|NCT00428844|58744480|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
30731894|NCT00428844|58744478|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
30731895|NCT00428844|58744479|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
30731896|NCT00428844|58744480|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
30731897|NCT00428844|58744478|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
30731898|NCT00428844|58744479|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
30731899|NCT00428844|58744480|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
30731900|NCT00428844|58744478|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
30900515|NCT02321462|58933949|FG000|Overall Study|Withdrawal by Subject|5|||
30900516|NCT02321462|58933950|FG001|Overall Study|Withdrawal by Subject|2|||
30731901|NCT00428844|58744479|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
30731902|NCT00428844|58744480|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
30731903|NCT00428844|58744478|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
30731904|NCT00428844|58744479|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
30731905|NCT00428844|58744480|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
30731906|NCT00428844|58744478|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
30731907|NCT00428844|58744479|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
30731908|NCT00428844|58744480|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
30900517|NCT02321462|58933949|FG000|Overall Study|Subject withdrawn before any treatment|1|||
30621825|NCT01181141|58633366|FG001|Overall Study|Lost to Follow-up|1|||
30621826|NCT01181141|58633365|FG000|Overall Study|Physician Decision|2|||
30731909|NCT00428844|58744478|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
30731910|NCT00428844|58744479|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
30731911|NCT00428844|58744480|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
30731912|NCT00428844|58744478|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
30731913|NCT00428844|58744479|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
30731914|NCT00428844|58744480|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
30731915|NCT00457418|58744488|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
30731916|NCT00457418|58744488|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
30731917|NCT00457418|58744488|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
30731918|NCT00457418|58744488|FG000|Post PK Maintenance|Adverse Event|10|||
30731919|NCT00457418|58744488|FG000|Post PK Maintenance|Progression of Disease|6|||
30731920|NCT00457418|58744488|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
30731921|NCT00457418|58744488|FG000|Post PK Maintenance|Lost to Follow-up|1|||
30731922|NCT00449072|58744494|FG000|Overall Study|Adverse Event|3|||
30731923|NCT00449072|58744495|FG001|Overall Study|Adverse Event|1|||
30731924|NCT00449072|58744494|FG000|Overall Study|Protocol Violation|14|||
30731925|NCT00449072|58744495|FG001|Overall Study|Protocol Violation|12|||
30731926|NCT00449072|58744494|FG000|Overall Study|Lost to Follow-up|5|||
30731927|NCT00449072|58744495|FG001|Overall Study|Lost to Follow-up|7|||
30731928|NCT00449072|58744494|FG000|Overall Study|Withdrawal by Subject|11|||
30731929|NCT00449072|58744495|FG001|Overall Study|Withdrawal by Subject|8|||
30731930|NCT00449072|58744494|FG000|Overall Study|Lack of Efficacy|1|||
30731931|NCT00449072|58744495|FG001|Overall Study|Lack of Efficacy|1|||
30731932|NCT00449072|58744494|FG000|Overall Study|Physician Decision|1|||
30731933|NCT00449072|58744495|FG001|Overall Study|Physician Decision|0|||
30731934|NCT00449072|58744494|FG000|Overall Study|Not treated|0|||
30731935|NCT00449072|58744495|FG001|Overall Study|Not treated|1|||
30731936|NCT00449072|58744494|FG000|Overall Study|Excluded medication|0|||
30731937|NCT00449072|58744495|FG001|Overall Study|Excluded medication|2|||
30731938|NCT00449072|58744494|FG000|Overall Study|Non-compliance|2|||
30731939|NCT00449072|58744495|FG001|Overall Study|Non-compliance|5|||
30731940|NCT00449072|58744494|FG000|Overall Study|Sponsor decision|1|||
30731941|NCT00449072|58744495|FG001|Overall Study|Sponsor decision|3|||
30731942|NCT00449072|58744494|FG000|Overall Study|Relocation|3|||
30731943|NCT00449072|58744495|FG001|Overall Study|Relocation|2|||
30731944|NCT00428610|58744504|FG000|Overall Study|Death Due to Adverse Event|3|||
30731945|NCT00428610|58744505|FG001|Overall Study|Death Due to Adverse Event|0|||
30731946|NCT00428610|58744506|FG002|Overall Study|Death Due to Adverse Event|5|||
30731947|NCT00428610|58744504|FG000|Overall Study|Death Due to Progressive Disease|0|||
30731948|NCT00428610|58744505|FG001|Overall Study|Death Due to Progressive Disease|0|||
30731949|NCT00428610|58744506|FG002|Overall Study|Death Due to Progressive Disease|2|||
30731950|NCT00428610|58744504|FG000|Overall Study|Adverse Event|2|||
30731951|NCT00428610|58744505|FG001|Overall Study|Adverse Event|3|||
30731952|NCT00428610|58744506|FG002|Overall Study|Adverse Event|2|||
30731953|NCT00428610|58744504|FG000|Overall Study|Investigator Decision|2|||
30731954|NCT00428610|58744505|FG001|Overall Study|Investigator Decision|1|||
30731955|NCT00428610|58744506|FG002|Overall Study|Investigator Decision|1|||
30731956|NCT00428610|58744504|FG000|Overall Study|Progressive Disease|42|||
30731957|NCT00428610|58744505|FG001|Overall Study|Progressive Disease|14|||
30731958|NCT00428610|58744506|FG002|Overall Study|Progressive Disease|22|||
30731959|NCT00428610|58744504|FG000|Overall Study|Withdrawal by Subject|4|||
30731960|NCT00428610|58744505|FG001|Overall Study|Withdrawal by Subject|0|||
30731961|NCT00428610|58744506|FG002|Overall Study|Withdrawal by Subject|0|||
30731962|NCT00419094|58744516|FG000|Overall Study|Adverse Event|3|||
30731963|NCT00419094|58744517|FG001|Overall Study|Adverse Event|7|||
30731964|NCT00419094|58744516|FG000|Overall Study|Lack of Efficacy|1|||
30731965|NCT00419094|58744517|FG001|Overall Study|Lack of Efficacy|0|||
30731966|NCT00419094|58744516|FG000|Overall Study|Lost to Follow-up|0|||
30731967|NCT00419094|58744517|FG001|Overall Study|Lost to Follow-up|2|||
30731968|NCT00419094|58744516|FG000|Overall Study|Protocol Violation|1|||
30731969|NCT00419094|58744517|FG001|Overall Study|Protocol Violation|14|||
30731970|NCT00419094|58744516|FG000|Overall Study|Withdrawal of consent|1|||
30731971|NCT00419094|58744517|FG001|Overall Study|Withdrawal of consent|5|||
30731972|NCT00419094|58744516|FG000|Overall Study|Other: Error determining exit criteria|1|||
30731973|NCT00419094|58744517|FG001|Overall Study|Other: Error determining exit criteria|0|||
30900518|NCT02321462|58933950|FG001|Overall Study|Subject withdrawn before any treatment|1|||
30731974|NCT00419094|58744516|FG000|Overall Study|Other: Patient non-compliant|0|||
30731975|NCT00419094|58744517|FG001|Overall Study|Other: Patient non-compliant|1|||
30731976|NCT00419094|58744516|FG000|Overall Study|Other: No contact for extended period|0|||
30731977|NCT00419094|58744517|FG001|Overall Study|Other: No contact for extended period|1|||
30731978|NCT00448916|58744527|FG000|Overall Study|Adverse Event|2|||
30731979|NCT00448916|58744528|FG001|Overall Study|Adverse Event|2|||
30731980|NCT00448916|58744529|FG002|Overall Study|Adverse Event|3|||
30731981|NCT00448916|58744530|FG003|Overall Study|Adverse Event|2|||
30731982|NCT00448916|58744527|FG000|Overall Study|Lack of Efficacy|1|||
30731983|NCT00448916|58744528|FG001|Overall Study|Lack of Efficacy|0|||
30731984|NCT00448916|58744529|FG002|Overall Study|Lack of Efficacy|2|||
30731985|NCT00448916|58744530|FG003|Overall Study|Lack of Efficacy|1|||
30731986|NCT00448916|58744527|FG000|Overall Study|Withdrawal by Subject|3|||
30731987|NCT00448916|58744528|FG001|Overall Study|Withdrawal by Subject|3|||
30731988|NCT00448916|58744529|FG002|Overall Study|Withdrawal by Subject|1|||
30731989|NCT00448916|58744530|FG003|Overall Study|Withdrawal by Subject|1|||
30731990|NCT00448916|58744527|FG000|Overall Study|Other|1|||
30731991|NCT00448916|58744528|FG001|Overall Study|Other|0|||
30731992|NCT00448916|58744529|FG002|Overall Study|Other|0|||
30731993|NCT00448916|58744530|FG003|Overall Study|Other|0|||
30731994|NCT00448916|58744527|FG000|Overall Study|Lost to Follow-up|0|||
30731995|NCT00448916|58744528|FG001|Overall Study|Lost to Follow-up|1|||
30731996|NCT00448916|58744529|FG002|Overall Study|Lost to Follow-up|0|||
30731997|NCT00448916|58744530|FG003|Overall Study|Lost to Follow-up|1|||
30731998|NCT00448916|58744527|FG000|Overall Study|Protocol Violation|0|||
30731999|NCT00448916|58744528|FG001|Overall Study|Protocol Violation|0|||
30732000|NCT00448916|58744529|FG002|Overall Study|Protocol Violation|0|||
30732001|NCT00448916|58744530|FG003|Overall Study|Protocol Violation|1|||
30732002|NCT00418938|58744544|FG000|Overall Study|Reimbursement|1|||
30732003|NCT00418938|58744545|FG001|Overall Study|Reimbursement|0|||
30732004|NCT00418938|58744544|FG000|Overall Study|Administrative decision|3|||
30732005|NCT00418938|58744545|FG001|Overall Study|Administrative decision|3|||
30732006|NCT00418938|58744544|FG000|Overall Study|Withdrawal by Subject|16|||
30732007|NCT00418938|58744545|FG001|Overall Study|Withdrawal by Subject|15|||
30732008|NCT00418938|58744544|FG000|Overall Study|Lost to Follow-up|1|||
30732009|NCT00418938|58744545|FG001|Overall Study|Lost to Follow-up|3|||
30732010|NCT00418938|58744544|FG000|Overall Study|Adverse Event|1|||
30732011|NCT00418938|58744545|FG001|Overall Study|Adverse Event|1|||
30732012|NCT00418938|58744544|FG000|Overall Study|On-going|1|||
30732013|NCT00418938|58744545|FG001|Overall Study|On-going|1|||
30621827|NCT01181141|58633366|FG001|Overall Study|Physician Decision|0|||
30621828|NCT01181141|58633365|FG000|Overall Study|Protocol Violation|3|||
30732014|NCT00418938|58744544|FG000|Overall Study|Ineligibility Determined|1|||
30621829|NCT01181141|58633366|FG001|Overall Study|Protocol Violation|1|||
30732015|NCT00418938|58744545|FG001|Overall Study|Ineligibility Determined|0|||
30732016|NCT00448760|58744551|FG000|Overall Study|Death|3|||
30732017|NCT00418314|58744557|FG000|Overall Study|Withdrawal by Subject|1|||
30732018|NCT00418314|58744558|FG001|Overall Study|Withdrawal by Subject|2|||
30732019|NCT00448448|58744566|FG000|Overall Study|Withdrawal by Subject|13|||
30732020|NCT00448448|58744567|FG001|Overall Study|Withdrawal by Subject|2|||
30732021|NCT00448448|58744566|FG000|Overall Study|On protocol when study ended|83|||
30732022|NCT00448448|58744567|FG001|Overall Study|On protocol when study ended|36|||
30732023|NCT00448448|58744566|FG000|Overall Study|Lost to Follow-up|2|||
30732024|NCT00448448|58744567|FG001|Overall Study|Lost to Follow-up|1|||
30732025|NCT00448448|58744566|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
30732026|NCT00448448|58744567|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
30732027|NCT00448448|58744566|FG000|Overall Study|Signed consent lost|0|||
30732028|NCT00448448|58744567|FG001|Overall Study|Signed consent lost|1|||
30732029|NCT00405912|58744576|FG000|Overall Study|Withdrawal by Subject|12|||
30732030|NCT00405912|58744577|FG001|Overall Study|Withdrawal by Subject|11|||
30732031|NCT00405912|58744578|FG002|Overall Study|Withdrawal by Subject|12|||
30732032|NCT00405912|58744576|FG000|Overall Study|Lost to Follow-up|4|||
30732033|NCT00405912|58744577|FG001|Overall Study|Lost to Follow-up|8|||
30732034|NCT00405912|58744578|FG002|Overall Study|Lost to Follow-up|4|||
30732035|NCT00448136|58744588|FG000|Overall Study|Death|3|||
30732036|NCT00448136|58744589|FG001|Overall Study|Death|8|||
30732037|NCT00448136|58744588|FG000|Overall Study|Investigator's decision (progression)|1|||
30732038|NCT00448136|58744589|FG001|Overall Study|Investigator's decision (progression)|0|||
30732039|NCT00447902|58744597|FG000|Overall Study|Adverse Event|0|||
30732040|NCT00447902|58744598|FG001|Overall Study|Adverse Event|3|||
30732041|NCT00447902|58744597|FG000|Overall Study|Protocol Violation|1|||
30732042|NCT00447902|58744598|FG001|Overall Study|Protocol Violation|0|||
30732043|NCT00447902|58744597|FG000|Overall Study|Withdrawal by Subject|0|||
30732044|NCT00447902|58744598|FG001|Overall Study|Withdrawal by Subject|1|||
30732045|NCT00447902|58744597|FG000|Overall Study|included patients who discontinued|1|||
30732046|NCT00447902|58744598|FG001|Overall Study|included patients who discontinued|1|||
30732047|NCT00447902|58744597|FG000|Overall Study|Lack of Efficacy|2|||
30732048|NCT00447902|58744598|FG001|Overall Study|Lack of Efficacy|1|||
30732049|NCT00307437|58744607|FG000|Controlled Period|Adverse Event|7|||
30732050|NCT00307437|58744608|FG001|Controlled Period|Adverse Event|2|||
30732051|NCT00307437|58744609|FG002|Controlled Period|Adverse Event|5|||
30732052|NCT00307437|58744610|FG003|Controlled Period|Adverse Event|0|||
30732053|NCT00307437|58744611|FG004|Controlled Period|Adverse Event|0|||
30732054|NCT00307437|58744612|FG005|Controlled Period|Adverse Event|0|||
30732055|NCT00307437|58744613|FG006|Controlled Period|Adverse Event|0|||
30732056|NCT00307437|58744607|FG000|Controlled Period|Death|0|||
30732057|NCT00307437|58744608|FG001|Controlled Period|Death|0|||
30732058|NCT00307437|58744609|FG002|Controlled Period|Death|1|||
30732059|NCT00307437|58744610|FG003|Controlled Period|Death|0|||
30732060|NCT00307437|58744611|FG004|Controlled Period|Death|0|||
30732061|NCT00307437|58744612|FG005|Controlled Period|Death|0|||
30732062|NCT00307437|58744613|FG006|Controlled Period|Death|0|||
30732063|NCT00307437|58744607|FG000|Controlled Period|Lack of Efficacy|2|||
30732064|NCT00307437|58744608|FG001|Controlled Period|Lack of Efficacy|0|||
30732065|NCT00307437|58744609|FG002|Controlled Period|Lack of Efficacy|0|||
30732066|NCT00307437|58744610|FG003|Controlled Period|Lack of Efficacy|0|||
30732067|NCT00307437|58744611|FG004|Controlled Period|Lack of Efficacy|0|||
30732068|NCT00307437|58744612|FG005|Controlled Period|Lack of Efficacy|0|||
30732069|NCT00307437|58744613|FG006|Controlled Period|Lack of Efficacy|0|||
30732070|NCT00307437|58744607|FG000|Controlled Period|Lost to Follow-up|2|||
30732071|NCT00307437|58744608|FG001|Controlled Period|Lost to Follow-up|3|||
30732072|NCT00307437|58744609|FG002|Controlled Period|Lost to Follow-up|0|||
30732073|NCT00307437|58744610|FG003|Controlled Period|Lost to Follow-up|0|||
30732074|NCT00307437|58744611|FG004|Controlled Period|Lost to Follow-up|0|||
30732075|NCT00307437|58744612|FG005|Controlled Period|Lost to Follow-up|0|||
30732076|NCT00307437|58744613|FG006|Controlled Period|Lost to Follow-up|0|||
30732077|NCT00307437|58744607|FG000|Controlled Period|Other|5|||
30732078|NCT00307437|58744608|FG001|Controlled Period|Other|1|||
30732079|NCT00307437|58744609|FG002|Controlled Period|Other|3|||
30732080|NCT00307437|58744610|FG003|Controlled Period|Other|0|||
30900519|NCT02391584|58933959|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
30900520|NCT02391584|58933960|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
30732081|NCT00307437|58744611|FG004|Controlled Period|Other|0|||
30732082|NCT00307437|58744612|FG005|Controlled Period|Other|0|||
30732083|NCT00307437|58744613|FG006|Controlled Period|Other|0|||
30732084|NCT00307437|58744607|FG000|After Controlled Period|Adverse Event|0|||
30732085|NCT00307437|58744608|FG001|After Controlled Period|Adverse Event|0|||
30732086|NCT00307437|58744609|FG002|After Controlled Period|Adverse Event|0|||
30732087|NCT00307437|58744610|FG003|After Controlled Period|Adverse Event|18|||
30732088|NCT00307437|58744611|FG004|After Controlled Period|Adverse Event|16|||
30732089|NCT00307437|58744612|FG005|After Controlled Period|Adverse Event|31|||
30732090|NCT00307437|58744613|FG006|After Controlled Period|Adverse Event|40|||
30732091|NCT00307437|58744607|FG000|After Controlled Period|Death|0|||
30732092|NCT00307437|58744608|FG001|After Controlled Period|Death|0|||
30732093|NCT00307437|58744609|FG002|After Controlled Period|Death|0|||
30900521|NCT02391584|58933959|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
30732094|NCT00307437|58744610|FG003|After Controlled Period|Death|3|||
30732095|NCT00307437|58744611|FG004|After Controlled Period|Death|1|||
30732096|NCT00307437|58744612|FG005|After Controlled Period|Death|1|||
30732097|NCT00307437|58744613|FG006|After Controlled Period|Death|3|||
30732098|NCT00307437|58744607|FG000|After Controlled Period|Lack of Efficacy|0|||
30732099|NCT00307437|58744608|FG001|After Controlled Period|Lack of Efficacy|0|||
30732100|NCT00307437|58744609|FG002|After Controlled Period|Lack of Efficacy|0|||
30732101|NCT00307437|58744610|FG003|After Controlled Period|Lack of Efficacy|15|||
30732102|NCT00307437|58744611|FG004|After Controlled Period|Lack of Efficacy|17|||
30732103|NCT00307437|58744612|FG005|After Controlled Period|Lack of Efficacy|37|||
30732104|NCT00307437|58744613|FG006|After Controlled Period|Lack of Efficacy|24|||
30732105|NCT00307437|58744607|FG000|After Controlled Period|Lost to Follow-up|0|||
30732106|NCT00307437|58744608|FG001|After Controlled Period|Lost to Follow-up|0|||
30732107|NCT00307437|58744609|FG002|After Controlled Period|Lost to Follow-up|0|||
30732108|NCT00307437|58744610|FG003|After Controlled Period|Lost to Follow-up|7|||
30732109|NCT00307437|58744611|FG004|After Controlled Period|Lost to Follow-up|12|||
30732110|NCT00307437|58744612|FG005|After Controlled Period|Lost to Follow-up|13|||
30732111|NCT00307437|58744613|FG006|After Controlled Period|Lost to Follow-up|18|||
30732112|NCT00307437|58744607|FG000|After Controlled Period|Other|0|||
30732113|NCT00307437|58744608|FG001|After Controlled Period|Other|0|||
30732114|NCT00307437|58744609|FG002|After Controlled Period|Other|0|||
30732115|NCT00307437|58744610|FG003|After Controlled Period|Other|15|||
30732116|NCT00307437|58744611|FG004|After Controlled Period|Other|9|||
30732117|NCT00307437|58744612|FG005|After Controlled Period|Other|40|||
30732118|NCT00307437|58744613|FG006|After Controlled Period|Other|28|||
30732119|NCT00440726|58744638|FG000|Phase 1|Dose-Limiting Toxicity|0|||
30732120|NCT00440726|58744639|FG001|Phase 1|Dose-Limiting Toxicity|1|||
30732121|NCT00440726|58744640|FG002|Phase 1|Dose-Limiting Toxicity|0|||
30732122|NCT00440726|58744638|FG000|Phase 1|Physician Decision|1|||
30732123|NCT00440726|58744639|FG001|Phase 1|Physician Decision|0|||
30732124|NCT00440726|58744640|FG002|Phase 1|Physician Decision|0|||
30732125|NCT00440726|58744638|FG000|Phase 2|Death|0|||
30732126|NCT00440726|58744639|FG001|Phase 2|Death|0|||
30732127|NCT00440726|58744640|FG002|Phase 2|Death|1|||
30732128|NCT00440726|58744638|FG000|Phase 2|Adverse Event|0|||
30732129|NCT00440726|58744639|FG001|Phase 2|Adverse Event|0|||
30732130|NCT00440726|58744640|FG002|Phase 2|Adverse Event|1|||
30732131|NCT00447590|58744651|FG000|Overall Study|Withdrawal by Subject|26|||
30732132|NCT00447590|58744651|FG000|Overall Study|Lost to Follow-up|24|||
30732133|NCT00447590|58744651|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
30732134|NCT00447278|58744657|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
30732135|NCT00447278|58744658|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
30732136|NCT00447278|58744657|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
30732137|NCT00447278|58744658|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
30732138|NCT00447278|58744657|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
30732139|NCT00447278|58744658|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
30732140|NCT00447278|58744657|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
30732141|NCT00447278|58744658|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
30732142|NCT00447278|58744657|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
30732143|NCT00447278|58744658|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
30732144|NCT00447278|58744657|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
30732145|NCT00447278|58744658|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
30732146|NCT00447278|58744657|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
30732147|NCT00447278|58744658|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
30732148|NCT00447278|58744657|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
30732149|NCT00447278|58744658|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
30732150|NCT00447278|58744657|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
30732151|NCT00447278|58744658|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
30732152|NCT00447278|58744657|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
30732153|NCT00447278|58744658|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
30732154|NCT00447278|58744657|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
30732155|NCT00447278|58744658|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
30732156|NCT00447278|58744657|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
30732157|NCT00447278|58744658|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
30732158|NCT00447278|58744657|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
30732159|NCT00447278|58744658|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
30732160|NCT00447278|58744657|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
30732161|NCT00447278|58744658|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
30732162|NCT00446966|58744667|FG000|Overall Study|Lost to Follow-up|10|||
30732163|NCT00446966|58744668|FG001|Overall Study|Lost to Follow-up|7|||
30732164|NCT00446654|58744676|FG000|Overall Study|Withdrawal by Subject|1|||
30732165|NCT00446654|58744677|FG001|Overall Study|Withdrawal by Subject|0|||
30732166|NCT00446654|58744676|FG000|Overall Study|Adverse Event|1|||
30732167|NCT00446654|58744677|FG001|Overall Study|Adverse Event|0|||
30732168|NCT00405756|58744686|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
30732169|NCT00405756|58744687|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
30732170|NCT00405756|58744688|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
30732171|NCT00405756|58744686|FG000|Double-blind Treatment|Adverse Event|31|||
30732172|NCT00405756|58744687|FG001|Double-blind Treatment|Adverse Event|27|||
30732173|NCT00405756|58744688|FG002|Double-blind Treatment|Adverse Event|12|||
30732174|NCT00405756|58744686|FG000|Double-blind Treatment|Disease Progression|47|||
30732175|NCT00405756|58744687|FG001|Double-blind Treatment|Disease Progression|81|||
30732176|NCT00405756|58744688|FG002|Double-blind Treatment|Disease Progression|102|||
30732177|NCT00405756|58744686|FG000|Double-blind Treatment|Lack of Efficacy|1|||
30732178|NCT00405756|58744687|FG001|Double-blind Treatment|Lack of Efficacy|4|||
30732179|NCT00405756|58744688|FG002|Double-blind Treatment|Lack of Efficacy|2|||
30732180|NCT00405756|58744686|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
30732181|NCT00405756|58744687|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
30732182|NCT00405756|58744688|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
30732183|NCT00405756|58744686|FG000|Double-blind Treatment|Lost to Follow-up|1|||
30732184|NCT00405756|58744687|FG001|Double-blind Treatment|Lost to Follow-up|0|||
30732185|NCT00405756|58744688|FG002|Double-blind Treatment|Lost to Follow-up|0|||
30732186|NCT00405756|58744686|FG000|Double-blind Treatment|Death|4|||
30732187|NCT00405756|58744687|FG001|Double-blind Treatment|Death|4|||
30732188|NCT00405756|58744688|FG002|Double-blind Treatment|Death|4|||
30732189|NCT00405756|58744686|FG000|Double-blind Treatment|Protocol Violation|1|||
30732190|NCT00405756|58744687|FG001|Double-blind Treatment|Protocol Violation|0|||
30732191|NCT00405756|58744688|FG002|Double-blind Treatment|Protocol Violation|2|||
30732192|NCT00405756|58744686|FG000|Double-blind Treatment|Other|7|||
30732193|NCT00405756|58744687|FG001|Double-blind Treatment|Other|4|||
30732194|NCT00405756|58744688|FG002|Double-blind Treatment|Other|4|||
30732195|NCT00405756|58744686|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
30732196|NCT00405756|58744687|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
30732197|NCT00405756|58744688|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
30732198|NCT00405756|58744686|FG000|Open-label Extension|Adverse Event|1|||
30732199|NCT00405756|58744687|FG001|Open-label Extension|Adverse Event|3|||
30732200|NCT00405756|58744688|FG002|Open-label Extension|Adverse Event|7|||
30732201|NCT00405756|58744686|FG000|Open-label Extension|Disease Progression|8|||
30732202|NCT00405756|58744687|FG001|Open-label Extension|Disease Progression|23|||
30732203|NCT00405756|58744688|FG002|Open-label Extension|Disease Progression|26|||
30732204|NCT00405756|58744686|FG000|Open-label Extension|Withdrawal by Subject|2|||
30732205|NCT00405756|58744687|FG001|Open-label Extension|Withdrawal by Subject|3|||
30732206|NCT00405756|58744688|FG002|Open-label Extension|Withdrawal by Subject|3|||
30732207|NCT00405756|58744686|FG000|Open-label Extension|Death|1|||
30732208|NCT00405756|58744687|FG001|Open-label Extension|Death|2|||
30732209|NCT00405756|58744688|FG002|Open-label Extension|Death|4|||
30732210|NCT00405756|58744686|FG000|Open-label Extension|Other|0|||
30732211|NCT00405756|58744687|FG001|Open-label Extension|Other|1|||
30732212|NCT00405756|58744688|FG002|Open-label Extension|Other|7|||
30732213|NCT00405756|58744686|FG000|Follow-up|Ongoing in Follow-up Period|52|||
30732214|NCT00405756|58744687|FG001|Follow-up|Ongoing in Follow-up Period|51|||
30732215|NCT00405756|58744688|FG002|Follow-up|Ongoing in Follow-up Period|60|||
30732216|NCT00405756|58744686|FG000|Follow-up|Death|21|||
30732217|NCT00405756|58744687|FG001|Follow-up|Death|31|||
30732218|NCT00405756|58744688|FG002|Follow-up|Death|24|||
30732219|NCT00405756|58744686|FG000|Follow-up|Lost to Follow-up|2|||
30732220|NCT00405756|58744687|FG001|Follow-up|Lost to Follow-up|8|||
30732221|NCT00405756|58744688|FG002|Follow-up|Lost to Follow-up|4|||
30732222|NCT00456092|58744699|FG000|Extension Phase|Grade 2 or Greater AE|2|||
30732223|NCT00456092|58744700|FG001|Extension Phase|Grade 2 or Greater AE|2|||
30732224|NCT00456092|58744701|FG002|Extension Phase|Grade 2 or Greater AE|0|||
30732225|NCT00456092|58744702|FG003|Extension Phase|Grade 2 or Greater AE|0|||
30732226|NCT00456092|58744703|FG004|Extension Phase|Grade 2 or Greater AE|2|||
30732227|NCT00456092|58744699|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
30732228|NCT00456092|58744700|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
30732229|NCT00456092|58744701|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
30732230|NCT00456092|58744702|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
30732231|NCT00456092|58744703|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
30732232|NCT00456092|58744699|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
30732233|NCT00456092|58744700|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
30732234|NCT00456092|58744701|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
30732235|NCT00456092|58744702|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
30732236|NCT00456092|58744703|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
30732237|NCT00456092|58744699|FG000|Extension Phase|Withdrew Consent|2|||
30732238|NCT00456092|58744700|FG001|Extension Phase|Withdrew Consent|0|||
30732239|NCT00456092|58744701|FG002|Extension Phase|Withdrew Consent|0|||
30732240|NCT00456092|58744702|FG003|Extension Phase|Withdrew Consent|0|||
30732241|NCT00456092|58744703|FG004|Extension Phase|Withdrew Consent|0|||
30732242|NCT00456092|58744699|FG000|Extension Phase|Lost to Follow-up|1|||
30732243|NCT00456092|58744700|FG001|Extension Phase|Lost to Follow-up|1|||
30732244|NCT00456092|58744701|FG002|Extension Phase|Lost to Follow-up|0|||
30732245|NCT00456092|58744702|FG003|Extension Phase|Lost to Follow-up|0|||
30732246|NCT00456092|58744703|FG004|Extension Phase|Lost to Follow-up|1|||
30732247|NCT00456092|58744699|FG000|Extension Phase|Other|2|||
30732248|NCT00456092|58744700|FG001|Extension Phase|Other|0|||
30732249|NCT00456092|58744701|FG002|Extension Phase|Other|0|||
30732250|NCT00456092|58744702|FG003|Extension Phase|Other|1|||
30732251|NCT00456092|58744703|FG004|Extension Phase|Other|1|||
30732252|NCT00456092|58744699|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
30732253|NCT00456092|58744700|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
30732254|NCT00456092|58744701|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
30732255|NCT00456092|58744702|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
30732256|NCT00456092|58744703|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
30732257|NCT00456092|58744699|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
30732258|NCT00456092|58744700|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
30732259|NCT00456092|58744701|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
30732260|NCT00456092|58744702|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
30732261|NCT00456092|58744703|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
30732262|NCT00456092|58744699|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
30732263|NCT00456092|58744700|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
30732264|NCT00456092|58744701|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
30732265|NCT00456092|58744702|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
30732266|NCT00456092|58744703|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
30732267|NCT00456092|58744699|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
30732268|NCT00456092|58744700|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
30732269|NCT00456092|58744701|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
30732270|NCT00456092|58744702|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
30732271|NCT00456092|58744703|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
30732272|NCT00456092|58744699|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
30732273|NCT00456092|58744700|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
30732274|NCT00456092|58744701|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
30732275|NCT00456092|58744702|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
30732276|NCT00456092|58744703|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
30732277|NCT00456092|58744699|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
30732278|NCT00456092|58744700|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
30732279|NCT00456092|58744701|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
30732280|NCT00456092|58744702|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
30732281|NCT00456092|58744703|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
30732282|NCT00456092|58744699|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
30732283|NCT00456092|58744700|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
30732284|NCT00456092|58744701|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
30732285|NCT00456092|58744702|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
30732286|NCT00456092|58744703|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
30732287|NCT00456092|58744699|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
30732288|NCT00456092|58744700|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
30732289|NCT00456092|58744701|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
30732290|NCT00456092|58744702|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
30732291|NCT00456092|58744703|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
30732292|NCT00456092|58744699|FG000|Treatment Phase (12 Weeks)|Other|1|||
30732293|NCT00456092|58744700|FG001|Treatment Phase (12 Weeks)|Other|0|||
30732294|NCT00456092|58744701|FG002|Treatment Phase (12 Weeks)|Other|1|||
30732295|NCT00456092|58744702|FG003|Treatment Phase (12 Weeks)|Other|0|||
30732296|NCT00456092|58744703|FG004|Treatment Phase (12 Weeks)|Other|0|||
30732297|NCT00411450|58744717|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
30732298|NCT00404820|58744725|FG000|Overall Study|Adverse Event|4|||
30732299|NCT00404820|58744726|FG001|Overall Study|Adverse Event|16|||
30732300|NCT00404820|58744725|FG000|Overall Study|Withdrawal by Subject|5|||
30732301|NCT00404820|58744726|FG001|Overall Study|Withdrawal by Subject|3|||
30732302|NCT00404820|58744725|FG000|Overall Study|Lost to Follow-up|7|||
30732303|NCT00404820|58744726|FG001|Overall Study|Lost to Follow-up|3|||
30732304|NCT00404820|58744725|FG000|Overall Study|Administrative problems|2|||
30732305|NCT00404820|58744726|FG001|Overall Study|Administrative problems|0|||
30732306|NCT00404820|58744725|FG000|Overall Study|Death|1|||
30732307|NCT00404820|58744726|FG001|Overall Study|Death|0|||
30732308|NCT00404820|58744725|FG000|Overall Study|Other|0|||
30732309|NCT00404820|58744726|FG001|Overall Study|Other|2|||
30732310|NCT00417612|58744734|FG000|Overall Study|Errant diagnosis|0|||
30732311|NCT00417612|58744735|FG001|Overall Study|Errant diagnosis|1|||
30732312|NCT00417612|58744734|FG000|Overall Study|Adverse Event|2|||
30732313|NCT00417612|58744735|FG001|Overall Study|Adverse Event|0|||
30732314|NCT00417612|58744734|FG000|Overall Study|Protocol Violation|0|||
30732315|NCT00417612|58744735|FG001|Overall Study|Protocol Violation|2|||
30732316|NCT00417612|58744734|FG000|Overall Study|Lost to Follow-up|1|||
30732317|NCT00417612|58744735|FG001|Overall Study|Lost to Follow-up|0|||
30732318|NCT00446030|58744745|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
30732319|NCT00446030|58744746|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
30732320|NCT00446030|58744745|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
30732321|NCT00446030|58744746|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
30732322|NCT00446030|58744745|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
30732323|NCT00446030|58744746|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
30732324|NCT00446030|58744745|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
30732325|NCT00446030|58744746|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
30732326|NCT00446030|58744745|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
30732327|NCT00446030|58744746|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
30732328|NCT00446030|58744745|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
30732329|NCT00446030|58744746|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
30732330|NCT00446030|58744745|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
30732331|NCT00446030|58744746|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
30732332|NCT00446030|58744745|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
30732333|NCT00446030|58744746|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
30732334|NCT00446030|58744745|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
30732335|NCT00446030|58744746|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
30732336|NCT00446030|58744745|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
30732337|NCT00446030|58744746|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
30732338|NCT00446030|58744745|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
30732339|NCT00446030|58744746|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
30732340|NCT00446030|58744745|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
30732341|NCT00446030|58744746|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
30732342|NCT00446030|58744745|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
30732343|NCT00446030|58744746|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
30732344|NCT00446030|58744745|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
30732345|NCT00446030|58744746|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
30732346|NCT00446030|58744745|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
30732347|NCT00446030|58744746|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
30732348|NCT00446030|58744745|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
30732349|NCT00446030|58744746|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
30732350|NCT00446030|58744745|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
30732351|NCT00446030|58744746|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
30900522|NCT02391584|58933960|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
30900523|NCT02391584|58933959|FG000|3 Month|Lost to Follow-up|1|||
30732352|NCT00446030|58744745|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
30732353|NCT00446030|58744746|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
30732354|NCT00446030|58744745|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
30732355|NCT00446030|58744746|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
30732356|NCT00411216|58744754|FG000|Overall Study|Ten participants were entered into the c|0|||
30732357|NCT00411216|58744755|FG001|Overall Study|Ten participants were entered into the c|2|||
30732358|NCT00410514|58744764|FG000|Overall Study|Adverse Event|2|||
30732359|NCT00410514|58744765|FG001|Overall Study|Adverse Event|2|||
30732360|NCT00410514|58744766|FG002|Overall Study|Adverse Event|2|||
30732361|NCT00410514|58744764|FG000|Overall Study|Protocol Violation|0|||
30732362|NCT00410514|58744765|FG001|Overall Study|Protocol Violation|1|||
30732363|NCT00410514|58744766|FG002|Overall Study|Protocol Violation|1|||
30732364|NCT00410514|58744764|FG000|Overall Study|Lost to Follow-up|0|||
30732365|NCT00410514|58744765|FG001|Overall Study|Lost to Follow-up|0|||
30732366|NCT00410514|58744766|FG002|Overall Study|Lost to Follow-up|2|||
30732367|NCT00410514|58744764|FG000|Overall Study|Non-compliant with study procedures|0|||
30732368|NCT00410514|58744765|FG001|Overall Study|Non-compliant with study procedures|0|||
30732369|NCT00410514|58744766|FG002|Overall Study|Non-compliant with study procedures|2|||
30732370|NCT03847610|58744774|FG000|Overall Study|Withdrawal by Subject|1|||
30732371|NCT03843632|58744782|FG000|Overall Study|Withdrawal by Subject|1|||
30732372|NCT03843632|58744783|FG001|Overall Study|Withdrawal by Subject|0|||
30732373|NCT03843632|58744784|FG002|Overall Study|Withdrawal by Subject|0|||
30732374|NCT03843632|58744785|FG003|Overall Study|Withdrawal by Subject|0|||
30732375|NCT00455858|58744795|FG000|Overall Study|Lost to Follow-up|2|||
30732376|NCT00455858|58744795|FG000|Overall Study|Protocol Violation|1|||
30732377|NCT00455858|58744795|FG000|Overall Study|Lack of Efficacy|1|||
30732378|NCT00455858|58744795|FG000|Overall Study|Well controlled FPG without insulin|1|||
30732379|NCT00455858|58744795|FG000|Overall Study|Withdrawal|1|||
30732380|NCT00439556|58744802|FG000|Overall Study|Patient was taken off study for non-comp|0|||
30732381|NCT00439556|58744803|FG001|Overall Study|Patient was taken off study for non-comp|1|||
30732382|NCT00439556|58744804|FG002|Overall Study|Patient was taken off study for non-comp|0|||
30732383|NCT00410202|58744816|FG000|On-Treatment|Continuing treatment|69|||
30732384|NCT00410202|58744817|FG001|On-Treatment|Continuing treatment|71|||
30732385|NCT00410202|58744818|FG002|On-Treatment|Continuing treatment|66|||
30732386|NCT00410202|58744816|FG000|On-Treatment|Adverse Event|1|||
30732387|NCT00410202|58744817|FG001|On-Treatment|Adverse Event|3|||
30732388|NCT00410202|58744818|FG002|On-Treatment|Adverse Event|2|||
30732389|NCT00410202|58744816|FG000|On-Treatment|Death|1|||
30732390|NCT00410202|58744817|FG001|On-Treatment|Death|0|||
30732391|NCT00410202|58744818|FG002|On-Treatment|Death|0|||
30732392|NCT00410202|58744816|FG000|On-Treatment|Lost to Follow-up|1|||
30732393|NCT00410202|58744817|FG001|On-Treatment|Lost to Follow-up|0|||
30732394|NCT00410202|58744818|FG002|On-Treatment|Lost to Follow-up|1|||
30732395|NCT00410202|58744816|FG000|On-Treatment|Lack of Efficacy|1|||
30732396|NCT00410202|58744817|FG001|On-Treatment|Lack of Efficacy|4|||
30732397|NCT00410202|58744818|FG002|On-Treatment|Lack of Efficacy|0|||
30732398|NCT00410202|58744816|FG000|On-Treatment|Withdrawal by Subject|2|||
30732399|NCT00410202|58744817|FG001|On-Treatment|Withdrawal by Subject|1|||
30732400|NCT00410202|58744818|FG002|On-Treatment|Withdrawal by Subject|1|||
30732401|NCT00410202|58744816|FG000|On-Treatment|Other Reason|0|||
30732402|NCT00410202|58744817|FG001|On-Treatment|Other Reason|0|||
30732403|NCT00410202|58744818|FG002|On-Treatment|Other Reason|1|||
30732404|NCT00410202|58744816|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
30732405|NCT00410202|58744817|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
30732406|NCT00410202|58744818|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
30732407|NCT00410202|58744816|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
30732408|NCT00410202|58744817|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
30732409|NCT00410202|58744818|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
30732410|NCT00410202|58744816|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
30732411|NCT00410202|58744817|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
30732412|NCT00410202|58744818|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
30732413|NCT00445328|58744829|FG000|Overall Study|Death|0|||
30732414|NCT00445328|58744830|FG001|Overall Study|Death|1|||
30732415|NCT00445328|58744829|FG000|Overall Study|Adverse Event|0|||
30732416|NCT00445328|58744830|FG001|Overall Study|Adverse Event|3|||
30732417|NCT00445328|58744829|FG000|Overall Study|Other|0|||
30732418|NCT00445328|58744830|FG001|Overall Study|Other|2|||
30732419|NCT00445328|58744829|FG000|Overall Study|Withdrawal by Subject|2|||
30732420|NCT00445328|58744830|FG001|Overall Study|Withdrawal by Subject|0|||
30732421|NCT00445328|58744829|FG000|Overall Study|Protocol Violation|1|||
30732422|NCT00445328|58744830|FG001|Overall Study|Protocol Violation|0|||
30732423|NCT00455312|58744838|FG000|Overall Study|Death|0|||
30732424|NCT00455312|58744839|FG001|Overall Study|Death|1|||
30732425|NCT00444626|58744845|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
30732426|NCT00444626|58744845|FG000|Initial Treatment Period|Adverse Event|1|||
30732427|NCT00444626|58744845|FG000|Initial Treatment Period|Lost to Follow-up|9|||
30732428|NCT00404352|58744872|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
30732429|NCT00404352|58744873|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
30732430|NCT00404352|58744874|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
30732431|NCT00404352|58744875|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
30732432|NCT00404352|58744876|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
30732433|NCT00404352|58744877|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
30732434|NCT00404352|58744878|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
30732435|NCT00404352|58744879|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
30732436|NCT00404352|58744880|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
30732437|NCT00404352|58744872|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
30732438|NCT00404352|58744873|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
30732439|NCT00404352|58744874|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
30732440|NCT00404352|58744875|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
30732441|NCT00404352|58744876|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
30732442|NCT00404352|58744877|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
30732443|NCT00404352|58744878|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
30732444|NCT00404352|58744879|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
30732445|NCT00404352|58744880|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
30732446|NCT00404352|58744872|FG000|Double Blind (up to 24 Month)|Death|0|||
30732447|NCT00404352|58744873|FG001|Double Blind (up to 24 Month)|Death|0|||
30732448|NCT00404352|58744874|FG002|Double Blind (up to 24 Month)|Death|1|||
30732449|NCT00404352|58744875|FG003|Double Blind (up to 24 Month)|Death|0|||
30732450|NCT00404352|58744876|FG004|Double Blind (up to 24 Month)|Death|0|||
30732451|NCT00404352|58744877|FG005|Double Blind (up to 24 Month)|Death|0|||
30732452|NCT00404352|58744878|FG006|Double Blind (up to 24 Month)|Death|0|||
30732453|NCT00404352|58744879|FG007|Double Blind (up to 24 Month)|Death|0|||
30732454|NCT00404352|58744880|FG008|Double Blind (up to 24 Month)|Death|0|||
30732455|NCT00404352|58744872|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
30732456|NCT00404352|58744873|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
30732457|NCT00404352|58744874|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
30732458|NCT00404352|58744875|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
30732459|NCT00404352|58744876|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
30732460|NCT00404352|58744877|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
30732461|NCT00404352|58744878|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
30732462|NCT00404352|58744879|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
30732463|NCT00404352|58744880|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
30732464|NCT00404352|58744872|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
30732465|NCT00404352|58744873|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
30732466|NCT00404352|58744874|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
30732467|NCT00404352|58744875|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
30732468|NCT00404352|58744876|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
30732469|NCT00404352|58744877|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
30732470|NCT00404352|58744878|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
30732471|NCT00404352|58744879|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
30732472|NCT00404352|58744880|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
30732473|NCT00404352|58744872|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
30732474|NCT00404352|58744873|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
30732475|NCT00404352|58744874|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
30732476|NCT00404352|58744875|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
30732477|NCT00404352|58744876|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
30732478|NCT00404352|58744877|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
30732479|NCT00404352|58744878|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
30732480|NCT00404352|58744879|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
30732481|NCT00404352|58744880|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
30732482|NCT00404352|58744872|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
30732483|NCT00404352|58744873|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
30732484|NCT00404352|58744874|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
30732485|NCT00404352|58744875|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
30732486|NCT00404352|58744876|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
30732487|NCT00404352|58744877|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
30732488|NCT00404352|58744878|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
30732489|NCT00404352|58744879|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
30732490|NCT00404352|58744880|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
30732491|NCT00404352|58744872|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
30732492|NCT00404352|58744873|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
30732493|NCT00404352|58744874|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
30732494|NCT00404352|58744875|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
30732495|NCT00404352|58744876|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
30732496|NCT00404352|58744877|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
30732497|NCT00404352|58744878|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
30732498|NCT00404352|58744879|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
30732499|NCT00404352|58744880|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
30732500|NCT00404352|58744872|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
30732501|NCT00404352|58744873|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
30732502|NCT00404352|58744874|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
30732503|NCT00404352|58744875|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
30732504|NCT00404352|58744876|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
30732505|NCT00404352|58744877|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
30732506|NCT00404352|58744878|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
30732507|NCT00404352|58744879|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
30732508|NCT00404352|58744880|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
30732509|NCT00404352|58744872|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
30732510|NCT00404352|58744873|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
30732511|NCT00404352|58744874|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
30732512|NCT00404352|58744875|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
30732513|NCT00404352|58744876|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
30732514|NCT00404352|58744877|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
30732515|NCT00404352|58744878|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
30732516|NCT00404352|58744879|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
30732517|NCT00404352|58744880|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
30732518|NCT00404352|58744872|FG000|Double Blind (up to 24 Month)|Other|0|||
30732519|NCT00404352|58744873|FG001|Double Blind (up to 24 Month)|Other|1|||
30732520|NCT00404352|58744874|FG002|Double Blind (up to 24 Month)|Other|0|||
30732521|NCT00404352|58744875|FG003|Double Blind (up to 24 Month)|Other|0|||
30732522|NCT00404352|58744876|FG004|Double Blind (up to 24 Month)|Other|0|||
30732523|NCT00404352|58744877|FG005|Double Blind (up to 24 Month)|Other|0|||
30732524|NCT00404352|58744878|FG006|Double Blind (up to 24 Month)|Other|0|||
30732525|NCT00404352|58744879|FG007|Double Blind (up to 24 Month)|Other|0|||
30732526|NCT00404352|58744880|FG008|Double Blind (up to 24 Month)|Other|0|||
30732527|NCT00404352|58744872|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
30732528|NCT00404352|58744873|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
30732529|NCT00404352|58744874|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
30732530|NCT00404352|58744875|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
30732531|NCT00404352|58744876|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
30732532|NCT00404352|58744877|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
30732533|NCT00404352|58744878|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
30732534|NCT00404352|58744879|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
30732535|NCT00404352|58744880|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
30732536|NCT00404352|58744872|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
30732537|NCT00404352|58744873|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
30732538|NCT00404352|58744874|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
30732539|NCT00404352|58744875|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
30732540|NCT00404352|58744876|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
30732541|NCT00404352|58744877|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
30732542|NCT00404352|58744878|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
30732543|NCT00404352|58744879|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
30732544|NCT00404352|58744880|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
30732545|NCT00404352|58744872|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
30732546|NCT00404352|58744873|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
30732547|NCT00404352|58744874|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
30732548|NCT00404352|58744875|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
30732549|NCT00404352|58744876|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
30732550|NCT00404352|58744877|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
30732551|NCT00404352|58744878|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
30732552|NCT00404352|58744879|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
30732553|NCT00404352|58744880|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
30732554|NCT00404352|58744872|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
30732555|NCT00404352|58744873|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
30732556|NCT00404352|58744874|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
30732557|NCT00404352|58744875|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
30732558|NCT00404352|58744876|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
30732559|NCT00404352|58744877|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
30732560|NCT00404352|58744878|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
30732561|NCT00404352|58744879|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
30732562|NCT00404352|58744880|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
30732563|NCT00404352|58744872|FG000|Open Label (up to 24 Month)|Disease progression|0|||
30732564|NCT00404352|58744873|FG001|Open Label (up to 24 Month)|Disease progression|0|||
30732565|NCT00404352|58744874|FG002|Open Label (up to 24 Month)|Disease progression|0|||
30732566|NCT00404352|58744875|FG003|Open Label (up to 24 Month)|Disease progression|1|||
30732567|NCT00404352|58744876|FG004|Open Label (up to 24 Month)|Disease progression|0|||
30732568|NCT00404352|58744877|FG005|Open Label (up to 24 Month)|Disease progression|0|||
30732569|NCT00404352|58744878|FG006|Open Label (up to 24 Month)|Disease progression|0|||
30732570|NCT00404352|58744879|FG007|Open Label (up to 24 Month)|Disease progression|0|||
30732571|NCT00404352|58744880|FG008|Open Label (up to 24 Month)|Disease progression|0|||
30732572|NCT00404352|58744872|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
30732573|NCT00404352|58744873|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
30732574|NCT00404352|58744874|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
30732575|NCT00404352|58744875|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
30732576|NCT00404352|58744876|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
30732577|NCT00404352|58744877|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
30732578|NCT00404352|58744878|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
30732579|NCT00404352|58744879|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
30732580|NCT00404352|58744880|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
30732581|NCT00404352|58744872|FG000|Open Label Extension (up to 36 Months)|Other|0|||
30732582|NCT00404352|58744873|FG001|Open Label Extension (up to 36 Months)|Other|0|||
30732583|NCT00404352|58744874|FG002|Open Label Extension (up to 36 Months)|Other|0|||
30732584|NCT00404352|58744875|FG003|Open Label Extension (up to 36 Months)|Other|0|||
30732585|NCT00404352|58744876|FG004|Open Label Extension (up to 36 Months)|Other|0|||
30732586|NCT00404352|58744877|FG005|Open Label Extension (up to 36 Months)|Other|0|||
30732587|NCT00404352|58744878|FG006|Open Label Extension (up to 36 Months)|Other|0|||
30732588|NCT00404352|58744879|FG007|Open Label Extension (up to 36 Months)|Other|0|||
30732589|NCT00404352|58744880|FG008|Open Label Extension (up to 36 Months)|Other|2|||
30732590|NCT00439244|58744900|FG000|Overall Study|Adverse Event|5|||
30732591|NCT00439244|58744901|FG001|Overall Study|Adverse Event|2|||
30732592|NCT00439244|58744902|FG002|Overall Study|Adverse Event|3|||
30732593|NCT00439244|58744900|FG000|Overall Study|Withdrawal by Subject|3|||
30732594|NCT00439244|58744901|FG001|Overall Study|Withdrawal by Subject|1|||
30732595|NCT00439244|58744902|FG002|Overall Study|Withdrawal by Subject|2|||
30732596|NCT00439244|58744900|FG000|Overall Study|Lost to Follow-up|2|||
30732597|NCT00439244|58744901|FG001|Overall Study|Lost to Follow-up|1|||
30732598|NCT00439244|58744902|FG002|Overall Study|Lost to Follow-up|2|||
30732599|NCT00439244|58744900|FG000|Overall Study|Death|0|||
30732600|NCT00439244|58744901|FG001|Overall Study|Death|1|||
30732601|NCT00439244|58744902|FG002|Overall Study|Death|0|||
30732602|NCT00439244|58744900|FG000|Overall Study|Protocol Violation|0|||
30732603|NCT00439244|58744901|FG001|Overall Study|Protocol Violation|1|||
30732604|NCT00439244|58744902|FG002|Overall Study|Protocol Violation|0|||
30732605|NCT00439244|58744900|FG000|Overall Study|Administrative problems|1|||
30732606|NCT00439244|58744901|FG001|Overall Study|Administrative problems|0|||
30732607|NCT00439244|58744902|FG002|Overall Study|Administrative problems|0|||
30732608|NCT00438464|58744921|FG000|Overall Study|Terminated Early|14|||
30732609|NCT00438464|58744922|FG001|Overall Study|Terminated Early|5|||
30732610|NCT00438464|58744921|FG000|Overall Study|Incomplete data submission|0|||
30732611|NCT00438464|58744922|FG001|Overall Study|Incomplete data submission|2|||
30732612|NCT00437294|58744942|FG000|Overall Study|Adverse Event|5|||
30732613|NCT00437294|58744943|FG001|Overall Study|Adverse Event|4|||
30732614|NCT00437294|58744942|FG000|Overall Study|Death|5|||
30732615|NCT00437294|58744943|FG001|Overall Study|Death|2|||
30732616|NCT00437294|58744942|FG000|Overall Study|Physician Decision|0|||
30732617|NCT00437294|58744943|FG001|Overall Study|Physician Decision|3|||
30732618|NCT00437294|58744942|FG000|Overall Study|Withdrawal by Subject|5|||
30732619|NCT00437294|58744943|FG001|Overall Study|Withdrawal by Subject|0|||
30732620|NCT00437294|58744942|FG000|Overall Study|Progressive Disease|19|||
30732621|NCT00437294|58744943|FG001|Overall Study|Progressive Disease|23|||
30732622|NCT00437294|58744942|FG000|Overall Study|Sponsor Decision|8|||
30732623|NCT00437294|58744943|FG001|Overall Study|Sponsor Decision|9|||
30732624|NCT00437294|58744942|FG000|Overall Study|Protocol Violation|0|||
30732625|NCT00437294|58744943|FG001|Overall Study|Protocol Violation|1|||
30732626|NCT00437294|58744942|FG000|Overall Study|Entry criteria not met|1|||
30732627|NCT00437294|58744943|FG001|Overall Study|Entry criteria not met|1|||
30732628|NCT00436982|58744957|FG000|Overall Study|Withdrawal by Subject|3|||
30732629|NCT00436982|58744958|FG001|Overall Study|Withdrawal by Subject|1|||
30732630|NCT00436982|58744957|FG000|Overall Study|Did not receive allocated intervention|0|||
30732631|NCT00436982|58744958|FG001|Overall Study|Did not receive allocated intervention|1|||
30732632|NCT00436982|58744957|FG000|Overall Study|no RSA data|1|||
30732633|NCT00436982|58744958|FG001|Overall Study|no RSA data|2|||
30732634|NCT00443846|58744970|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
30732635|NCT00443846|58744971|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
30732636|NCT00443846|58744970|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
30732637|NCT00443846|58744971|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
30732638|NCT00443846|58744970|FG000|Overall Study|Adverse Event|0|||
30732639|NCT00443846|58744971|FG001|Overall Study|Adverse Event|1|||
30732640|NCT00443846|58744970|FG000|Overall Study|Personal reason|8|||
30732641|NCT00443846|58744971|FG001|Overall Study|Personal reason|3|||
30732642|NCT00443846|58744970|FG000|Overall Study|Lost to Follow-up|1|||
30732643|NCT00443846|58744971|FG001|Overall Study|Lost to Follow-up|2|||
30732644|NCT00436826|58744979|FG000|Double Blind Period (DBP)|Adverse Event|2|||
30732645|NCT00436826|58744980|FG001|Double Blind Period (DBP)|Adverse Event|0|||
30732646|NCT00436826|58744981|FG002|Double Blind Period (DBP)|Adverse Event|0|||
30732647|NCT00436826|58744982|FG003|Double Blind Period (DBP)|Adverse Event|0|||
30732648|NCT00436826|58744983|FG004|Double Blind Period (DBP)|Adverse Event|0|||
30732649|NCT00436826|58744984|FG005|Double Blind Period (DBP)|Adverse Event|0|||
30732650|NCT00436826|58744979|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
30732651|NCT00436826|58744980|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
30732652|NCT00436826|58744981|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
30732653|NCT00436826|58744982|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
30732654|NCT00436826|58744983|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
30732655|NCT00436826|58744984|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
30732656|NCT00436826|58744979|FG000|Double Blind Period (DBP)|Other|10|||
30732657|NCT00436826|58744980|FG001|Double Blind Period (DBP)|Other|11|||
30732658|NCT00436826|58744981|FG002|Double Blind Period (DBP)|Other|0|||
30732659|NCT00436826|58744982|FG003|Double Blind Period (DBP)|Other|0|||
30732660|NCT00436826|58744983|FG004|Double Blind Period (DBP)|Other|0|||
30732661|NCT00436826|58744984|FG005|Double Blind Period (DBP)|Other|0|||
30732662|NCT00436826|58744979|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
30732663|NCT00436826|58744980|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
30732664|NCT00436826|58744981|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
30732665|NCT00436826|58744982|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
30732666|NCT00436826|58744983|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
30732667|NCT00436826|58744984|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
30732668|NCT00436826|58744979|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
30732669|NCT00436826|58744980|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
30732670|NCT00436826|58744981|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
30732671|NCT00436826|58744982|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
30732672|NCT00436826|58744983|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
30732673|NCT00436826|58744984|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
30732674|NCT00436826|58744979|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
30732675|NCT00436826|58744980|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
30732676|NCT00436826|58744981|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
30732677|NCT00436826|58744982|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
30732678|NCT00436826|58744983|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
30732679|NCT00436826|58744984|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
30732680|NCT00410124|58745002|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
30732681|NCT00410124|58745003|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
30732682|NCT00410124|58745002|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
30732683|NCT00410124|58745003|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
30732684|NCT00410124|58745002|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
30732685|NCT00410124|58745003|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
30732686|NCT00410124|58745002|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
30732687|NCT00410124|58745003|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
30732688|NCT00410124|58745002|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
30732689|NCT00410124|58745003|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
30732690|NCT00410124|58745002|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
30732691|NCT00410124|58745003|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
30732692|NCT00410124|58745002|FG000|Core Phase Double Blind (15 Months)|Death|7|||
30732693|NCT00410124|58745003|FG001|Core Phase Double Blind (15 Months)|Death|4|||
30732694|NCT00410124|58745002|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
30900524|NCT02391584|58933960|FG001|3 Month|Lost to Follow-up|0|||
30900525|NCT02391584|58933959|FG000|6 Month|Withdrawal by Subject|1|||
30900526|NCT02391584|58933960|FG001|6 Month|Withdrawal by Subject|0|||
30900527|NCT02391584|58933959|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
30900528|NCT02391584|58933960|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
30732695|NCT00410124|58745003|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
30732696|NCT00410124|58745002|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
30732697|NCT00410124|58745003|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
30732698|NCT00410124|58745002|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
30732699|NCT00410124|58745003|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
30732700|NCT00410124|58745002|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
30732701|NCT00410124|58745003|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
30732702|NCT00410124|58745002|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
30732703|NCT00410124|58745003|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
30732704|NCT00410124|58745002|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
30732705|NCT00410124|58745003|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
30732706|NCT00410124|58745002|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
30732707|NCT00410124|58745003|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
30732708|NCT00410124|58745002|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
30732709|NCT00410124|58745003|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
30732710|NCT00410124|58745002|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
30732711|NCT00410124|58745003|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
30732712|NCT00410046|58745013|FG000|Overall Study|Adverse Event|3|||
30732713|NCT00410046|58745013|FG000|Overall Study|Withdrawal by Subject|1|||
30732714|NCT00410046|58745013|FG000|Overall Study|Lost to Follow-up|1|||
30732715|NCT00416624|58745022|FG000|Overall Study|Withdrawal by Subject|1|||
30732716|NCT00416624|58745023|FG001|Overall Study|Withdrawal by Subject|6|||
30732717|NCT00416624|58745024|FG002|Overall Study|Withdrawal by Subject|4|||
30732718|NCT00416624|58745025|FG003|Overall Study|Withdrawal by Subject|9|||
30732719|NCT00416624|58745022|FG000|Overall Study|Death|4|||
30732720|NCT00416624|58745023|FG001|Overall Study|Death|7|||
30732721|NCT00416624|58745024|FG002|Overall Study|Death|7|||
30732722|NCT00416624|58745025|FG003|Overall Study|Death|1|||
30732723|NCT00416624|58745022|FG000|Overall Study|Adverse Event|8|||
30732724|NCT00416624|58745023|FG001|Overall Study|Adverse Event|3|||
30732725|NCT00416624|58745024|FG002|Overall Study|Adverse Event|2|||
30732726|NCT00416624|58745025|FG003|Overall Study|Adverse Event|2|||
30732727|NCT00416624|58745022|FG000|Overall Study|Other|8|||
30732728|NCT00416624|58745023|FG001|Overall Study|Other|11|||
30732729|NCT00416624|58745024|FG002|Overall Study|Other|5|||
30732730|NCT00416624|58745025|FG003|Overall Study|Other|5|||
30732731|NCT00416624|58745022|FG000|Overall Study|Cancel|1|||
30732732|NCT00416624|58745023|FG001|Overall Study|Cancel|0|||
30732733|NCT00416624|58745024|FG002|Overall Study|Cancel|0|||
30732734|NCT00416624|58745025|FG003|Overall Study|Cancel|0|||
30732735|NCT00262600|58745038|FG000|Overall Study|Lost to Follow-up|17|||
30732736|NCT00262600|58745039|FG001|Overall Study|Lost to Follow-up|31|||
30732737|NCT00262600|58745040|FG002|Overall Study|Lost to Follow-up|41|||
30732738|NCT00262600|58745038|FG000|Overall Study|Withdrawal by Subject|128|||
30732739|NCT00262600|58745039|FG001|Overall Study|Withdrawal by Subject|145|||
30732740|NCT00262600|58745040|FG002|Overall Study|Withdrawal by Subject|139|||
30732741|NCT00262600|58745038|FG000|Overall Study|Not Treated|32|||
30732742|NCT00262600|58745039|FG001|Overall Study|Not Treated|17|||
30732743|NCT00262600|58745040|FG002|Overall Study|Not Treated|24|||
30732744|NCT00262600|58745038|FG000|Overall Study|Other|58|||
30732745|NCT00262600|58745039|FG001|Overall Study|Other|59|||
30732746|NCT00262600|58745040|FG002|Overall Study|Other|62|||
30732747|NCT00409578|58745052|FG000|Overall Study|Adverse Event|27|||
30732748|NCT00409578|58745053|FG001|Overall Study|Adverse Event|37|||
30732749|NCT00409578|58745054|FG002|Overall Study|Adverse Event|25|||
30732750|NCT00409578|58745055|FG003|Overall Study|Adverse Event|33|||
30732751|NCT00409578|58745052|FG000|Overall Study|Abnormal laboratory value(s)|2|||
30621830|NCT01181141|58633365|FG000|Overall Study|Withdrawal by Subject|3|||
30732752|NCT00409578|58745053|FG001|Overall Study|Abnormal laboratory value(s)|2|||
30732753|NCT00409578|58745054|FG002|Overall Study|Abnormal laboratory value(s)|2|||
30732754|NCT00409578|58745055|FG003|Overall Study|Abnormal laboratory value(s)|4|||
30732755|NCT00409578|58745052|FG000|Overall Study|Lack of Efficacy|0|||
30732756|NCT00409578|58745053|FG001|Overall Study|Lack of Efficacy|0|||
30732757|NCT00409578|58745054|FG002|Overall Study|Lack of Efficacy|0|||
30621831|NCT01181141|58633366|FG001|Overall Study|Withdrawal by Subject|1|||
30732758|NCT00409578|58745055|FG003|Overall Study|Lack of Efficacy|2|||
30732759|NCT00409578|58745052|FG000|Overall Study|Subject no longer requires study drug|0|||
30732760|NCT00409578|58745053|FG001|Overall Study|Subject no longer requires study drug|0|||
30732761|NCT00409578|58745054|FG002|Overall Study|Subject no longer requires study drug|0|||
30732762|NCT00409578|58745055|FG003|Overall Study|Subject no longer requires study drug|1|||
30732763|NCT00409578|58745052|FG000|Overall Study|Withdrawal by Subject|8|||
30732764|NCT00409578|58745053|FG001|Overall Study|Withdrawal by Subject|15|||
30621832|NCT01173120|58633372|FG000|Overall Study|Lack of Efficacy|2|||
30732765|NCT00409578|58745054|FG002|Overall Study|Withdrawal by Subject|16|||
30732766|NCT00409578|58745055|FG003|Overall Study|Withdrawal by Subject|17|||
30732767|NCT00409578|58745052|FG000|Overall Study|Lost to Follow-up|2|||
30732768|NCT00409578|58745053|FG001|Overall Study|Lost to Follow-up|0|||
30732769|NCT00409578|58745054|FG002|Overall Study|Lost to Follow-up|2|||
30732770|NCT00409578|58745055|FG003|Overall Study|Lost to Follow-up|2|||
30732771|NCT00409578|58745052|FG000|Overall Study|Administrative problems|8|||
30732772|NCT00409578|58745053|FG001|Overall Study|Administrative problems|9|||
30732773|NCT00409578|58745054|FG002|Overall Study|Administrative problems|2|||
30732774|NCT00409578|58745055|FG003|Overall Study|Administrative problems|4|||
30732775|NCT00409578|58745052|FG000|Overall Study|Death|2|||
30732776|NCT00409578|58745053|FG001|Overall Study|Death|4|||
30732777|NCT00409578|58745054|FG002|Overall Study|Death|4|||
30732778|NCT00409578|58745055|FG003|Overall Study|Death|2|||
30732779|NCT00409578|58745052|FG000|Overall Study|Protocol Violation|3|||
30732780|NCT00409578|58745053|FG001|Overall Study|Protocol Violation|2|||
30732781|NCT00409578|58745054|FG002|Overall Study|Protocol Violation|3|||
30732782|NCT00409578|58745055|FG003|Overall Study|Protocol Violation|1|||
30732783|NCT00409578|58745052|FG000|Overall Study|Missing|0|||
30732784|NCT00409578|58745053|FG001|Overall Study|Missing|1|||
30732785|NCT00409578|58745054|FG002|Overall Study|Missing|0|||
30732786|NCT00409578|58745055|FG003|Overall Study|Missing|1|||
30732787|NCT00428090|58745069|FG000|Overall Study|Adverse Event|10|||
30732788|NCT00428090|58745070|FG001|Overall Study|Adverse Event|8|||
30732789|NCT00428090|58745071|FG002|Overall Study|Adverse Event|10|||
30732790|NCT00428090|58745072|FG003|Overall Study|Adverse Event|11|||
30732791|NCT00428090|58745069|FG000|Overall Study|Lost to Follow-up|3|||
30732792|NCT00428090|58745070|FG001|Overall Study|Lost to Follow-up|6|||
30732793|NCT00428090|58745071|FG002|Overall Study|Lost to Follow-up|1|||
30732794|NCT00428090|58745072|FG003|Overall Study|Lost to Follow-up|4|||
30732795|NCT00428090|58745069|FG000|Overall Study|Protocol Violation|3|||
30732796|NCT00428090|58745070|FG001|Overall Study|Protocol Violation|1|||
30732797|NCT00428090|58745071|FG002|Overall Study|Protocol Violation|3|||
30732798|NCT00428090|58745072|FG003|Overall Study|Protocol Violation|3|||
30732799|NCT00428090|58745069|FG000|Overall Study|Withdrawal by Subject|10|||
30732800|NCT00428090|58745070|FG001|Overall Study|Withdrawal by Subject|12|||
30732801|NCT00428090|58745071|FG002|Overall Study|Withdrawal by Subject|15|||
30732802|NCT00428090|58745072|FG003|Overall Study|Withdrawal by Subject|5|||
30732803|NCT00428090|58745069|FG000|Overall Study|Sponsor terminated study|0|||
30732804|NCT00428090|58745070|FG001|Overall Study|Sponsor terminated study|1|||
30732805|NCT00428090|58745071|FG002|Overall Study|Sponsor terminated study|0|||
30732806|NCT00428090|58745072|FG003|Overall Study|Sponsor terminated study|0|||
30732807|NCT00428090|58745069|FG000|Overall Study|Non-compliance|4|||
30732808|NCT00428090|58745070|FG001|Overall Study|Non-compliance|0|||
30732809|NCT00428090|58745071|FG002|Overall Study|Non-compliance|1|||
30732810|NCT00428090|58745072|FG003|Overall Study|Non-compliance|3|||
30732811|NCT00428090|58745069|FG000|Overall Study|Par. did not returned to visit|1|||
30732812|NCT00428090|58745070|FG001|Overall Study|Par. did not returned to visit|0|||
30732813|NCT00428090|58745071|FG002|Overall Study|Par. did not returned to visit|0|||
30732814|NCT00428090|58745072|FG003|Overall Study|Par. did not returned to visit|1|||
30732815|NCT00428090|58745069|FG000|Overall Study|Follow-Up visit not possible|1|||
30732816|NCT00428090|58745070|FG001|Overall Study|Follow-Up visit not possible|0|||
30732817|NCT00428090|58745071|FG002|Overall Study|Follow-Up visit not possible|0|||
30732818|NCT00428090|58745072|FG003|Overall Study|Follow-Up visit not possible|0|||
30732819|NCT00428090|58745069|FG000|Overall Study|Prohibited medication used for SAE|1|||
30732820|NCT00428090|58745070|FG001|Overall Study|Prohibited medication used for SAE|0|||
30732821|NCT00428090|58745071|FG002|Overall Study|Prohibited medication used for SAE|0|||
30732822|NCT00428090|58745072|FG003|Overall Study|Prohibited medication used for SAE|0|||
30732823|NCT00428090|58745069|FG000|Overall Study|Death of par.|1|||
30732824|NCT00428090|58745070|FG001|Overall Study|Death of par.|0|||
30732825|NCT00428090|58745071|FG002|Overall Study|Death of par.|1|||
30732826|NCT00428090|58745072|FG003|Overall Study|Death of par.|0|||
30732827|NCT00428090|58745069|FG000|Overall Study|Visit 7 exceed the visit window|0|||
30732828|NCT00428090|58745070|FG001|Overall Study|Visit 7 exceed the visit window|1|||
30732829|NCT00428090|58745071|FG002|Overall Study|Visit 7 exceed the visit window|0|||
30732830|NCT00428090|58745072|FG003|Overall Study|Visit 7 exceed the visit window|0|||
30732831|NCT00428090|58745069|FG000|Overall Study|Medical monitor terminated par.|0|||
30732832|NCT00428090|58745070|FG001|Overall Study|Medical monitor terminated par.|1|||
30732833|NCT00428090|58745071|FG002|Overall Study|Medical monitor terminated par.|0|||
30732834|NCT00428090|58745072|FG003|Overall Study|Medical monitor terminated par.|0|||
30732835|NCT00428090|58745069|FG000|Overall Study|Mental status of par. was|0|||
30732836|NCT00428090|58745070|FG001|Overall Study|Mental status of par. was|1|||
30732837|NCT00428090|58745071|FG002|Overall Study|Mental status of par. was|0|||
30732838|NCT00428090|58745072|FG003|Overall Study|Mental status of par. was|0|||
30732839|NCT00428090|58745069|FG000|Overall Study|Worsening of AD|0|||
30732840|NCT00428090|58745070|FG001|Overall Study|Worsening of AD|0|||
30732841|NCT00428090|58745071|FG002|Overall Study|Worsening of AD|1|||
30732842|NCT00428090|58745072|FG003|Overall Study|Worsening of AD|0|||
30732843|NCT00428090|58745069|FG000|Overall Study|Excluded for concerning QTc value|0|||
30732844|NCT00428090|58745070|FG001|Overall Study|Excluded for concerning QTc value|0|||
30732845|NCT00428090|58745071|FG002|Overall Study|Excluded for concerning QTc value|1|||
30732846|NCT00428090|58745072|FG003|Overall Study|Excluded for concerning QTc value|0|||
30732847|NCT00428090|58745069|FG000|Overall Study|Insufficient AD documentation|0|||
30732848|NCT00428090|58745070|FG001|Overall Study|Insufficient AD documentation|0|||
30732849|NCT00428090|58745071|FG002|Overall Study|Insufficient AD documentation|1|||
30732850|NCT00428090|58745072|FG003|Overall Study|Insufficient AD documentation|0|||
30732851|NCT00428090|58745069|FG000|Overall Study|High MMSE scores|0|||
30732852|NCT00428090|58745070|FG001|Overall Study|High MMSE scores|0|||
30732853|NCT00428090|58745071|FG002|Overall Study|High MMSE scores|1|||
30732854|NCT00428090|58745072|FG003|Overall Study|High MMSE scores|0|||
30732855|NCT00428090|58745069|FG000|Overall Study|Deterioration of cognitive status|0|||
30732856|NCT00428090|58745070|FG001|Overall Study|Deterioration of cognitive status|0|||
30732857|NCT00428090|58745071|FG002|Overall Study|Deterioration of cognitive status|1|||
30732858|NCT00428090|58745072|FG003|Overall Study|Deterioration of cognitive status|0|||
30732859|NCT00428090|58745069|FG000|Overall Study|Serious adverse event|0|||
30732860|NCT00428090|58745070|FG001|Overall Study|Serious adverse event|0|||
30732861|NCT00428090|58745071|FG002|Overall Study|Serious adverse event|1|||
30732862|NCT00428090|58745072|FG003|Overall Study|Serious adverse event|0|||
30732863|NCT00428090|58745069|FG000|Overall Study|Excluded for heart insufficiency|0|||
30732864|NCT00428090|58745070|FG001|Overall Study|Excluded for heart insufficiency|0|||
30732865|NCT00428090|58745071|FG002|Overall Study|Excluded for heart insufficiency|1|||
30732866|NCT00428090|58745072|FG003|Overall Study|Excluded for heart insufficiency|0|||
30732867|NCT00428090|58745069|FG000|Overall Study|Raised Creatinine Value|0|||
30732868|NCT00428090|58745070|FG001|Overall Study|Raised Creatinine Value|0|||
30732869|NCT00428090|58745071|FG002|Overall Study|Raised Creatinine Value|0|||
30732870|NCT00428090|58745072|FG003|Overall Study|Raised Creatinine Value|1|||
30732871|NCT00416312|58745090|FG000|Overall Study|tumors not visible on imaging|2|||
30732872|NCT00436436|58745094|FG000|Overall Study|Progression|4|||
30732873|NCT00436436|58745094|FG000|Overall Study|Adverse Event|2|||
30732874|NCT00436436|58745094|FG000|Overall Study|Death|6|||
30732875|NCT00262522|58745102|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
30732876|NCT00262522|58745103|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
30732877|NCT00262522|58745104|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
30732878|NCT00262522|58745105|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
30732879|NCT00262522|58745102|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
30732880|NCT00262522|58745103|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
30732881|NCT00262522|58745104|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
30732882|NCT00262522|58745105|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
30732883|NCT00262522|58745102|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
30732884|NCT00262522|58745103|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
30732885|NCT00262522|58745104|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
30732886|NCT00262522|58745105|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
30732887|NCT00262522|58745102|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
30732888|NCT00262522|58745103|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
30732889|NCT00262522|58745104|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
30732890|NCT00262522|58745105|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
30732891|NCT00262522|58745102|FG000|Study Start Through 8 Weeks|Death|1|||
30732892|NCT00262522|58745103|FG001|Study Start Through 8 Weeks|Death|0|||
30732893|NCT00262522|58745104|FG002|Study Start Through 8 Weeks|Death|0|||
30732894|NCT00262522|58745105|FG003|Study Start Through 8 Weeks|Death|0|||
30732895|NCT00262522|58745102|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
30732896|NCT00262522|58745103|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
30732897|NCT00262522|58745104|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
30732898|NCT00262522|58745105|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
30732899|NCT00262522|58745102|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
30732900|NCT00262522|58745103|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
30732901|NCT00262522|58745104|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
30732902|NCT00262522|58745105|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
30732903|NCT00262522|58745102|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
30732904|NCT00262522|58745103|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
30900529|NCT02266147|58933973|FG000|PART 1: Dose Escalation|Physician Decision|0|||
30900530|NCT02266147|58933974|FG001|PART 1: Dose Escalation|Physician Decision|0|||
30732905|NCT00262522|58745104|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
30732906|NCT00262522|58745105|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
30732907|NCT00262522|58745102|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
30732908|NCT00262522|58745103|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
30732909|NCT00262522|58745104|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
30732910|NCT00262522|58745105|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
30732911|NCT00262522|58745102|FG000|Study Start Through 48 Weeks|Death|2|||
30732912|NCT00262522|58745103|FG001|Study Start Through 48 Weeks|Death|0|||
30732913|NCT00262522|58745104|FG002|Study Start Through 48 Weeks|Death|1|||
30732914|NCT00262522|58745105|FG003|Study Start Through 48 Weeks|Death|0|||
30732915|NCT00262522|58745102|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
30732916|NCT00262522|58745103|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
30732917|NCT00262522|58745104|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
30732918|NCT00262522|58745105|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
30732919|NCT00262522|58745102|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
30732920|NCT00262522|58745103|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
30732921|NCT00262522|58745104|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
30732922|NCT00262522|58745105|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
30732923|NCT00262522|58745102|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
30732924|NCT00262522|58745103|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
30732925|NCT00262522|58745104|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
30732926|NCT00262522|58745105|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
30732927|NCT00262522|58745102|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
30732928|NCT00262522|58745103|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
30732929|NCT00262522|58745104|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
30732930|NCT00262522|58745105|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
30732931|NCT00262522|58745102|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
30732932|NCT00262522|58745103|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
30732933|NCT00262522|58745104|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
30732934|NCT00262522|58745105|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
30732935|NCT00262522|58745102|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
30732936|NCT00262522|58745103|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
30732937|NCT00262522|58745104|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
30732938|NCT00262522|58745105|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
30732939|NCT00262522|58745102|FG000|Study Start Through 96 Weeks|Death|2|||
30732940|NCT00262522|58745103|FG001|Study Start Through 96 Weeks|Death|0|||
30732941|NCT00262522|58745104|FG002|Study Start Through 96 Weeks|Death|2|||
30732942|NCT00262522|58745105|FG003|Study Start Through 96 Weeks|Death|0|||
30732943|NCT00262522|58745102|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
30732944|NCT00262522|58745103|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
30732945|NCT00262522|58745104|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
30732946|NCT00262522|58745105|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
30732947|NCT00262522|58745102|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
30732948|NCT00262522|58745103|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
30732949|NCT00262522|58745104|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
30732950|NCT00262522|58745105|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
30732951|NCT00436280|58745113|FG000|Period 1: Induction|Adverse Event|8|||
30732952|NCT00436280|58745113|FG000|Period 1: Induction|Progressive Disease|12|||
30732953|NCT00436280|58745113|FG000|Period 1: Induction|Stable Disease|6|||
30732954|NCT00436280|58745113|FG000|Period 1: Induction|Withdrawal by Subject|1|||
30732955|NCT00436280|58745113|FG000|Period 1: Induction|Death|1|||
30732956|NCT00436280|58745113|FG000|Period 2: Consolidation|Adverse Event|1|||
30732957|NCT00436280|58745113|FG000|Period 2: Consolidation|Progressive Disease|10|||
30732958|NCT00436280|58745113|FG000|Period 2: Consolidation|Stable Disease|1|||
30732959|NCT00436280|58745113|FG000|Period 2: Consolidation|Physician Decision|2|||
30732960|NCT00436280|58745113|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
30732961|NCT00436280|58745113|FG000|Period 2: Consolidation|Death|1|||
30732962|NCT00436280|58745113|FG000|Period 3: Maintenance|Adverse Event|6|||
30732963|NCT00436280|58745113|FG000|Period 3: Maintenance|Progressive Disease|12|||
30732964|NCT00394836|58745119|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
30732965|NCT00394836|58745120|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
30732966|NCT00394836|58745119|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
30732967|NCT00394836|58745120|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
30732968|NCT00394836|58745119|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
30732969|NCT00394836|58745120|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
30732970|NCT00394836|58745119|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
30732971|NCT00394836|58745120|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
30732972|NCT00394836|58745119|FG000|Teatment or Follow-up Phase|Death|0|||
30732973|NCT00394836|58745120|FG001|Teatment or Follow-up Phase|Death|1|||
30900531|NCT02266147|58933975|FG002|PART 1: Dose Escalation|Physician Decision|1|||
30732974|NCT00394836|58745119|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
30732975|NCT00394836|58745120|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
30732976|NCT00394836|58745119|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
30732977|NCT00394836|58745120|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
30732978|NCT00394836|58745119|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
30732979|NCT00394836|58745120|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
30732980|NCT00394836|58745119|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
30732981|NCT00394836|58745120|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
30732982|NCT00394836|58745119|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
30732983|NCT00394836|58745120|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
30732984|NCT00394836|58745119|FG000|Teatment or Follow-up Phase|Non compliance|0|||
30732985|NCT00394836|58745120|FG001|Teatment or Follow-up Phase|Non compliance|1|||
30732986|NCT00394836|58745119|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
30732987|NCT00394836|58745120|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
30732988|NCT00394836|58745119|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
30732989|NCT00394836|58745120|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
30732990|NCT00394836|58745119|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
30732991|NCT00394836|58745120|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
30732992|NCT00394836|58745119|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
30732993|NCT00394836|58745120|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
30732994|NCT00250588|58745131|FG000|Overall Study|Withdrawal by Subject|3|||
30732995|NCT00250588|58745132|FG001|Overall Study|Withdrawal by Subject|6|||
30732996|NCT00250588|58745133|FG002|Overall Study|Withdrawal by Subject|0|||
30732997|NCT00250588|58745131|FG000|Overall Study|Lost to Follow-up|6|||
30732998|NCT00250588|58745132|FG001|Overall Study|Lost to Follow-up|13|||
30732999|NCT00250588|58745133|FG002|Overall Study|Lost to Follow-up|13|||
30733000|NCT00416078|58745143|FG000|Overall Study|Death|3|||
30733001|NCT00416078|58745144|FG001|Overall Study|Death|4|||
30733002|NCT00416078|58745143|FG000|Overall Study|Withdrawal by Subject|3|||
30733003|NCT00416078|58745144|FG001|Overall Study|Withdrawal by Subject|2|||
30733004|NCT00416078|58745143|FG000|Overall Study|Physician Decision|1|||
30733005|NCT00416078|58745144|FG001|Overall Study|Physician Decision|0|||
30733006|NCT00416078|58745143|FG000|Overall Study|Lost to Follow-up|4|||
30733007|NCT00416078|58745144|FG001|Overall Study|Lost to Follow-up|2|||
30733008|NCT00394524|58745152|FG000|Overall Study|Protocol Violation|2|||
30733009|NCT00394524|58745153|FG001|Overall Study|Protocol Violation|3|||
30733010|NCT00394524|58745152|FG000|Overall Study|Death|1|||
30733011|NCT00394524|58745153|FG001|Overall Study|Death|0|||
30733012|NCT00394524|58745152|FG000|Overall Study|Withdrawal by Subject|0|||
30733013|NCT00394524|58745153|FG001|Overall Study|Withdrawal by Subject|1|||
30733014|NCT00409344|58745163|FG000|Overall Study|no enrollment|0|||
30733015|NCT00409344|58745164|FG001|Overall Study|no enrollment|0|||
30733016|NCT00415610|58745173|FG000|Overall Study|Death|3|||
30733017|NCT00415610|58745174|FG001|Overall Study|Death|2|||
30733018|NCT00415610|58745175|FG002|Overall Study|Death|5|||
30733019|NCT00394212|58745185|FG000|Overall Study|Lost to Follow-up|3|||
30733020|NCT00394212|58745186|FG001|Overall Study|Lost to Follow-up|0|||
30733021|NCT00394212|58745185|FG000|Overall Study|Withdrawal by Subject|4|||
30733022|NCT00394212|58745186|FG001|Overall Study|Withdrawal by Subject|1|||
30733023|NCT00250432|58745194|FG000|Overall Study|Adverse Event|25|||
30733024|NCT00250432|58745195|FG001|Overall Study|Adverse Event|29|||
30733025|NCT00250432|58745194|FG000|Overall Study|Lack of Efficacy|2|||
30733026|NCT00250432|58745195|FG001|Overall Study|Lack of Efficacy|1|||
30733027|NCT00250432|58745194|FG000|Overall Study|Lost to Follow-up|6|||
30733028|NCT00250432|58745195|FG001|Overall Study|Lost to Follow-up|5|||
30733029|NCT00250432|58745194|FG000|Overall Study|Patient Moved|0|||
30733030|NCT00250432|58745195|FG001|Overall Study|Patient Moved|1|||
30733031|NCT00250432|58745194|FG000|Overall Study|Protocol Violation|0|||
30733032|NCT00250432|58745195|FG001|Overall Study|Protocol Violation|3|||
30733033|NCT00250432|58745194|FG000|Overall Study|Withdrawal by Subject|6|||
30733034|NCT00250432|58745195|FG001|Overall Study|Withdrawal by Subject|2|||
30733035|NCT00250432|58745194|FG000|Overall Study|Pt died out of posttherapy report period|6|||
30733036|NCT00250432|58745195|FG001|Overall Study|Pt died out of posttherapy report period|5|||
30733037|NCT00250432|58745194|FG000|Overall Study|Pt was considered untreatable|0|||
30733038|NCT00250432|58745195|FG001|Overall Study|Pt was considered untreatable|1|||
30733039|NCT00250276|58745205|FG000|Overall Study|Serious Adverse Event|0|||
30733040|NCT00250276|58745206|FG001|Overall Study|Serious Adverse Event|0|||
30733041|NCT00250276|58745207|FG002|Overall Study|Serious Adverse Event|1|||
30733042|NCT00250276|58745208|FG003|Overall Study|Serious Adverse Event|0|||
30733043|NCT00250276|58745205|FG000|Overall Study|Non-serious Adverse Event|2|||
30733044|NCT00250276|58745206|FG001|Overall Study|Non-serious Adverse Event|0|||
30733045|NCT00250276|58745207|FG002|Overall Study|Non-serious Adverse Event|0|||
30733046|NCT00250276|58745208|FG003|Overall Study|Non-serious Adverse Event|2|||
30733047|NCT00250276|58745205|FG000|Overall Study|Protocol Violation|0|||
30733048|NCT00250276|58745206|FG001|Overall Study|Protocol Violation|1|||
30733049|NCT00250276|58745207|FG002|Overall Study|Protocol Violation|0|||
30733050|NCT00250276|58745208|FG003|Overall Study|Protocol Violation|0|||
30733051|NCT00250276|58745205|FG000|Overall Study|Withdrawal by Subject|1|||
30733052|NCT00250276|58745206|FG001|Overall Study|Withdrawal by Subject|2|||
30733053|NCT00250276|58745207|FG002|Overall Study|Withdrawal by Subject|3|||
30733054|NCT00250276|58745208|FG003|Overall Study|Withdrawal by Subject|2|||
30733055|NCT00250276|58745205|FG000|Overall Study|Migrated/moved from study area|3|||
30733056|NCT00250276|58745206|FG001|Overall Study|Migrated/moved from study area|0|||
30733057|NCT00250276|58745207|FG002|Overall Study|Migrated/moved from study area|2|||
30733058|NCT00250276|58745208|FG003|Overall Study|Migrated/moved from study area|7|||
30733059|NCT00250276|58745205|FG000|Overall Study|Lost to Follow-up|11|||
30733060|NCT00250276|58745206|FG001|Overall Study|Lost to Follow-up|18|||
30733061|NCT00250276|58745207|FG002|Overall Study|Lost to Follow-up|13|||
30733062|NCT00250276|58745208|FG003|Overall Study|Lost to Follow-up|8|||
30733063|NCT00249808|58745223|FG000|Overall Study|Other|27|||
30733064|NCT00249808|58745223|FG000|Overall Study|Protocol Violation|3|||
30733065|NCT00249808|58745223|FG000|Overall Study|Lost to Follow-up|8|||
30733066|NCT00249808|58745223|FG000|Overall Study|Adverse Event|81|||
30733067|NCT00249808|58745223|FG000|Overall Study|Lack of Efficacy|52|||
30733068|NCT00249808|58745223|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
30733069|NCT00278512|58745229|FG000|Overall Study|Death|1|||
30733070|NCT00278512|58745230|FG001|Overall Study|Death|0|||
30733071|NCT00427934|58745240|FG000|Overall Study|Adverse Event|1|||
30733072|NCT00427934|58745241|FG001|Overall Study|Adverse Event|0|||
30733073|NCT00427934|58745242|FG002|Overall Study|Adverse Event|5|||
30733074|NCT00427934|58745243|FG003|Overall Study|Adverse Event|4|||
30733075|NCT00427934|58745240|FG000|Overall Study|Lack of Efficacy|0|||
30733076|NCT00427934|58745241|FG001|Overall Study|Lack of Efficacy|0|||
30733077|NCT00427934|58745242|FG002|Overall Study|Lack of Efficacy|5|||
30733078|NCT00427934|58745243|FG003|Overall Study|Lack of Efficacy|2|||
30733079|NCT00427934|58745240|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
30733080|NCT00427934|58745241|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
30733081|NCT00427934|58745242|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
30733082|NCT00427934|58745243|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
30733083|NCT00427934|58745240|FG000|Overall Study|Other|0|||
30733084|NCT00427934|58745241|FG001|Overall Study|Other|0|||
30733085|NCT00427934|58745242|FG002|Overall Study|Other|11|||
30733086|NCT00427934|58745243|FG003|Overall Study|Other|5|||
30733087|NCT00427934|58745240|FG000|Overall Study|Withdrawal by Subject|0|||
30733088|NCT00427934|58745241|FG001|Overall Study|Withdrawal by Subject|0|||
30733089|NCT00427934|58745242|FG002|Overall Study|Withdrawal by Subject|1|||
30733090|NCT00427934|58745243|FG003|Overall Study|Withdrawal by Subject|3|||
30621833|NCT01173120|58633372|FG000|Overall Study|Lost to Follow-up|1|||
30733091|NCT00435188|58745257|FG000|Overall Study|Death|1|||
30733092|NCT00435188|58745258|FG001|Overall Study|Death|6|||
30733093|NCT00435188|58745257|FG000|Overall Study|Withdrawal by Subject|16|||
30733094|NCT00435188|58745258|FG001|Overall Study|Withdrawal by Subject|11|||
30733095|NCT00435188|58745257|FG000|Overall Study|Lost to Follow-up|5|||
30733096|NCT00435188|58745258|FG001|Overall Study|Lost to Follow-up|6|||
30733097|NCT00427778|58745266|FG000|First Intervention (4 Weeks)|no longer interested|1|||
30733098|NCT00427778|58745267|FG001|First Intervention (4 Weeks)|no longer interested|0|||
30733099|NCT00427778|58745266|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
30733100|NCT00427778|58745267|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
30733101|NCT00427778|58745266|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
30733102|NCT00427778|58745267|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
30733103|NCT00427778|58745266|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
30733104|NCT00427778|58745267|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
30733105|NCT00427700|58745288|FG000|Overall Study|Lost to Follow-up|2|||
30733106|NCT00427700|58745289|FG001|Overall Study|Lost to Follow-up|5|||
30733107|NCT00427700|58745288|FG000|Overall Study|no induction of menses|1|||
30733108|NCT00427700|58745289|FG001|Overall Study|no induction of menses|4|||
30733109|NCT00427700|58745288|FG000|Overall Study|Pregnancy|0|||
30733110|NCT00427700|58745289|FG001|Overall Study|Pregnancy|2|||
30733111|NCT00409188|58745298|FG000|Overall Study|Ongoing at data cut-off|383|||
30733112|NCT00409188|58745299|FG001|Overall Study|Ongoing at data cut-off|175|||
30733113|NCT00434954|58745307|FG000|Overall Study|Adverse Event|17|||
30733114|NCT00434954|58745308|FG001|Overall Study|Adverse Event|2|||
30733115|NCT00434954|58745307|FG000|Overall Study|Entry criteria not met|14|||
30733116|NCT00434954|58745308|FG001|Overall Study|Entry criteria not met|16|||
30733117|NCT00434954|58745307|FG000|Overall Study|Lost to Follow-up|0|||
30733118|NCT00434954|58745308|FG001|Overall Study|Lost to Follow-up|1|||
30733119|NCT00434954|58745307|FG000|Overall Study|Physician Decision|6|||
30733120|NCT00434954|58745308|FG001|Overall Study|Physician Decision|3|||
30733121|NCT00434954|58745307|FG000|Overall Study|Protocol Violation|36|||
30733122|NCT00434954|58745308|FG001|Overall Study|Protocol Violation|27|||
30733123|NCT00434954|58745307|FG000|Overall Study|Sponsor decision|1|||
30733124|NCT00434954|58745308|FG001|Overall Study|Sponsor decision|0|||
30733125|NCT00434954|58745307|FG000|Overall Study|Subject decision|8|||
30733126|NCT00434954|58745308|FG001|Overall Study|Subject decision|22|||
30733127|NCT00276484|58745316|FG000|Overall Study|Adverse Event|4|||
30733128|NCT00276484|58745317|FG001|Overall Study|Adverse Event|7|||
30733129|NCT00276484|58745316|FG000|Overall Study|Lost to Follow-up|1|||
30733130|NCT00276484|58745317|FG001|Overall Study|Lost to Follow-up|1|||
30733131|NCT00276484|58745316|FG000|Overall Study|Protocol Violation|0|||
30733132|NCT00276484|58745317|FG001|Overall Study|Protocol Violation|1|||
30733133|NCT00276484|58745316|FG000|Overall Study|Withdrawal by Subject|4|||
30733134|NCT00276484|58745317|FG001|Overall Study|Withdrawal by Subject|3|||
30733135|NCT00276484|58745316|FG000|Overall Study|Could not take time off work|0|||
30733136|NCT00276484|58745317|FG001|Overall Study|Could not take time off work|1|||
30733137|NCT00426842|58745323|FG000|Overall Study|Lost to Follow-up|1|||
30733138|NCT00434876|58745331|FG000|Overall Study|Lost to Follow-up|1|||
30733139|NCT00434876|58745332|FG001|Overall Study|Lost to Follow-up|1|||
30733140|NCT00276094|58745341|FG000|Overall Study|Adverse Event|15|||
30733141|NCT00276094|58745342|FG001|Overall Study|Adverse Event|13|||
30733142|NCT00276094|58745343|FG002|Overall Study|Adverse Event|11|||
30733143|NCT00276094|58745341|FG000|Overall Study|Withdrawal by Subject|14|||
30733144|NCT00276094|58745342|FG001|Overall Study|Withdrawal by Subject|14|||
30733145|NCT00276094|58745343|FG002|Overall Study|Withdrawal by Subject|12|||
30733146|NCT00276094|58745341|FG000|Overall Study|Protocol Violation|16|||
30733147|NCT00276094|58745342|FG001|Overall Study|Protocol Violation|7|||
30733148|NCT00276094|58745343|FG002|Overall Study|Protocol Violation|10|||
30733149|NCT00276094|58745341|FG000|Overall Study|Lost to Follow-up|8|||
30733150|NCT00276094|58745342|FG001|Overall Study|Lost to Follow-up|6|||
30733151|NCT00276094|58745343|FG002|Overall Study|Lost to Follow-up|4|||
30733152|NCT00276094|58745341|FG000|Overall Study|Other-Subject moved out of country|1|||
30733153|NCT00276094|58745342|FG001|Overall Study|Other-Subject moved out of country|0|||
30733154|NCT00276094|58745343|FG002|Overall Study|Other-Subject moved out of country|0|||
30733155|NCT00276094|58745341|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
30733156|NCT00276094|58745342|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
30733157|NCT00276094|58745343|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
30733158|NCT00276094|58745341|FG000|Overall Study|Other-Lack of efficacy|1|||
30733159|NCT00276094|58745342|FG001|Overall Study|Other-Lack of efficacy|0|||
30733160|NCT00276094|58745343|FG002|Overall Study|Other-Lack of efficacy|0|||
30733161|NCT00276094|58745341|FG000|Overall Study|Other-Refused follow-up visit|1|||
30733162|NCT00276094|58745342|FG001|Overall Study|Other-Refused follow-up visit|0|||
30733163|NCT00276094|58745343|FG002|Overall Study|Other-Refused follow-up visit|0|||
30733164|NCT00276094|58745341|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
30733165|NCT00276094|58745342|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
30733166|NCT00276094|58745343|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
30733167|NCT00276094|58745341|FG000|Overall Study|Other-Relocation|0|||
30733168|NCT00276094|58745342|FG001|Overall Study|Other-Relocation|1|||
30733169|NCT00276094|58745343|FG002|Overall Study|Other-Relocation|0|||
30733170|NCT00276094|58745341|FG000|Overall Study|Other-Study medication lost|0|||
30733171|NCT00276094|58745342|FG001|Overall Study|Other-Study medication lost|0|||
30733172|NCT00276094|58745343|FG002|Overall Study|Other-Study medication lost|1|||
30733173|NCT00276016|58745357|FG000|Intervention 1|Withdrawal by Subject|0|||
30733174|NCT00276016|58745358|FG001|Intervention 1|Withdrawal by Subject|1|||
30733175|NCT00276016|58745359|FG002|Intervention 1|Withdrawal by Subject|0|||
30733176|NCT00276016|58745360|FG003|Intervention 1|Withdrawal by Subject|0|||
30733177|NCT00276016|58745361|FG004|Intervention 1|Withdrawal by Subject|0|||
30733178|NCT00276016|58745362|FG005|Intervention 1|Withdrawal by Subject|0|||
30733179|NCT00434642|58745373|FG000|Blinded Treatment Phase|Adverse Event|12|||
30733180|NCT00434642|58745374|FG001|Blinded Treatment Phase|Adverse Event|58|||
30733181|NCT00434642|58745373|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
30733182|NCT00434642|58745374|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
30733183|NCT00434642|58745373|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
30733184|NCT00434642|58745374|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
30733185|NCT00434642|58745373|FG000|Blinded Treatment Phase|Physician Decision|19|||
30733186|NCT00434642|58745374|FG001|Blinded Treatment Phase|Physician Decision|27|||
30733187|NCT00434642|58745373|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
30733188|NCT00434642|58745374|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
30733189|NCT00434642|58745373|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
30733190|NCT00434642|58745374|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
30733191|NCT00434642|58745373|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
30733192|NCT00434642|58745374|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
30733193|NCT00434642|58745373|FG000|Open-label Treatment Phase|Adverse Event|0|||
30733194|NCT00434642|58745374|FG001|Open-label Treatment Phase|Adverse Event|5|||
30733195|NCT00434642|58745373|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
30733196|NCT00434642|58745374|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
30733197|NCT00434330|58745386|FG000|Overall Study|Adverse Event|0|||
30733198|NCT00434330|58745387|FG001|Overall Study|Adverse Event|0|||
30733199|NCT00434330|58745388|FG002|Overall Study|Adverse Event|1|||
30733200|NCT00434330|58745389|FG003|Overall Study|Adverse Event|0|||
30733201|NCT00434330|58745390|FG004|Overall Study|Adverse Event|0|||
30733202|NCT00434330|58745391|FG005|Overall Study|Adverse Event|0|||
30733203|NCT00434330|58745386|FG000|Overall Study|Death|1|||
30733204|NCT00434330|58745387|FG001|Overall Study|Death|0|||
30733205|NCT00434330|58745388|FG002|Overall Study|Death|0|||
30733206|NCT00434330|58745389|FG003|Overall Study|Death|0|||
30733207|NCT00434330|58745390|FG004|Overall Study|Death|1|||
30733208|NCT00434330|58745391|FG005|Overall Study|Death|1|||
30733209|NCT00434330|58745386|FG000|Overall Study|Withdrawal by Subject|0|||
30733210|NCT00434330|58745387|FG001|Overall Study|Withdrawal by Subject|0|||
30733211|NCT00434330|58745388|FG002|Overall Study|Withdrawal by Subject|1|||
30733212|NCT00434330|58745389|FG003|Overall Study|Withdrawal by Subject|1|||
30733213|NCT00434330|58745390|FG004|Overall Study|Withdrawal by Subject|0|||
30733214|NCT00434330|58745391|FG005|Overall Study|Withdrawal by Subject|0|||
30733215|NCT00434330|58745386|FG000|Overall Study|Renal transplant|0|||
30733216|NCT00434330|58745387|FG001|Overall Study|Renal transplant|0|||
30733217|NCT00434330|58745388|FG002|Overall Study|Renal transplant|0|||
30733218|NCT00434330|58745389|FG003|Overall Study|Renal transplant|1|||
30733219|NCT00434330|58745390|FG004|Overall Study|Renal transplant|0|||
30733220|NCT00434330|58745391|FG005|Overall Study|Renal transplant|0|||
30733221|NCT00434330|58745386|FG000|Overall Study|Subject Not Compliant With Study|0|||
30733222|NCT00434330|58745387|FG001|Overall Study|Subject Not Compliant With Study|0|||
30733223|NCT00434330|58745388|FG002|Overall Study|Subject Not Compliant With Study|1|||
30733224|NCT00434330|58745389|FG003|Overall Study|Subject Not Compliant With Study|0|||
30733225|NCT00434330|58745390|FG004|Overall Study|Subject Not Compliant With Study|0|||
30733226|NCT00434330|58745391|FG005|Overall Study|Subject Not Compliant With Study|0|||
30733227|NCT00426764|58745405|FG000|Overall Study|Protocol Violation|1|||
30733228|NCT00426764|58745405|FG000|Overall Study|Withdrawal by Subject|4|||
30733229|NCT00426764|58745405|FG000|Overall Study|Physician Decision|6|||
30733230|NCT00426764|58745405|FG000|Overall Study|Compassionate Use|1|||
30733231|NCT00426764|58745405|FG000|Overall Study|Progressive Disease|83|||
30733232|NCT00426764|58745405|FG000|Overall Study|Adverse Event|24|||
30733233|NCT00426764|58745405|FG000|Overall Study|Other|1|||
30733234|NCT00426764|58745405|FG000|Overall Study|Death|1|||
30733235|NCT00426764|58745405|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
30733236|NCT00434252|58745417|FG000|Overall Study|Lack of Efficacy|50|||
30733237|NCT00434252|58745418|FG001|Overall Study|Lack of Efficacy|100|||
30733238|NCT00434252|58745417|FG000|Overall Study|Adverse Event|6|||
30733239|NCT00434252|58745418|FG001|Overall Study|Adverse Event|13|||
30733240|NCT00434252|58745417|FG000|Overall Study|Death|1|||
30733241|NCT00434252|58745418|FG001|Overall Study|Death|2|||
30733242|NCT00434252|58745417|FG000|Overall Study|Lost to Follow-up|0|||
30733243|NCT00434252|58745418|FG001|Overall Study|Lost to Follow-up|1|||
30733244|NCT00434252|58745417|FG000|Overall Study|Physician Decision|4|||
30733245|NCT00434252|58745418|FG001|Overall Study|Physician Decision|8|||
30733246|NCT00434252|58745417|FG000|Overall Study|Withdrawal by Subject|3|||
30733247|NCT00434252|58745418|FG001|Overall Study|Withdrawal by Subject|7|||
30733248|NCT00425750|58745424|FG000|Overall Study|Death|1|||
30733249|NCT00425750|58745424|FG000|Overall Study|Withdrawal by Subject|3|||
30621834|NCT01173120|58633372|FG000|Overall Study|Participant Decision|2|||
30733250|NCT00425750|58745424|FG000|Overall Study|Adverse Event|3|||
30733251|NCT00425750|58745424|FG000|Overall Study|Progression of disease|18|||
30621835|NCT01173120|58633372|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
30733252|NCT00414908|58745430|FG000|Overall Study|Protocol Violation|1|||
30733253|NCT00414908|58745431|FG001|Overall Study|Protocol Violation|1|||
30733254|NCT00242710|58745443|FG000|Core Study (up to Year 1)|Adverse Event|30|||
30733255|NCT00242710|58745444|FG001|Core Study (up to Year 1)|Adverse Event|25|||
30733256|NCT00242710|58745445|FG002|Core Study (up to Year 1)|Adverse Event|23|||
30733257|NCT00242710|58745446|FG003|Core Study (up to Year 1)|Adverse Event|14|||
30733258|NCT00242710|58745443|FG000|Core Study (up to Year 1)|Death|0|||
30733259|NCT00242710|58745444|FG001|Core Study (up to Year 1)|Death|0|||
30900532|NCT02266147|58933976|FG003|PART 1: Dose Escalation|Physician Decision|0|||
30733260|NCT00242710|58745445|FG002|Core Study (up to Year 1)|Death|1|||
30733261|NCT00242710|58745446|FG003|Core Study (up to Year 1)|Death|0|||
30733262|NCT00242710|58745443|FG000|Core Study (up to Year 1)|Physician Decision|0|||
30733263|NCT00242710|58745444|FG001|Core Study (up to Year 1)|Physician Decision|1|||
30733264|NCT00242710|58745445|FG002|Core Study (up to Year 1)|Physician Decision|0|||
30733265|NCT00242710|58745446|FG003|Core Study (up to Year 1)|Physician Decision|1|||
30733266|NCT00242710|58745443|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
30733267|NCT00242710|58745444|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
30733268|NCT00242710|58745445|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
30733269|NCT00242710|58745446|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
30733270|NCT00242710|58745443|FG000|Core Study (up to Year 1)|Other|6|||
30733271|NCT00242710|58745444|FG001|Core Study (up to Year 1)|Other|1|||
30733272|NCT00242710|58745445|FG002|Core Study (up to Year 1)|Other|0|||
30733273|NCT00242710|58745446|FG003|Core Study (up to Year 1)|Other|2|||
30733274|NCT00242710|58745443|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
30733275|NCT00242710|58745444|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
30733276|NCT00242710|58745445|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
30733277|NCT00242710|58745446|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
30733278|NCT00242710|58745443|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
30733279|NCT00242710|58745444|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
30733280|NCT00242710|58745445|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
30733281|NCT00242710|58745446|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
30733282|NCT00242710|58745443|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
30733283|NCT00242710|58745444|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
30733284|NCT00242710|58745445|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
30733285|NCT00242710|58745446|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
30733286|NCT00242710|58745443|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
30733287|NCT00242710|58745444|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
30733288|NCT00242710|58745445|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
30733289|NCT00242710|58745446|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
30733290|NCT00242710|58745443|FG000|Period Between Core Study and Extension|Adverse Event|2|||
30733291|NCT00242710|58745444|FG001|Period Between Core Study and Extension|Adverse Event|3|||
30733292|NCT00242710|58745445|FG002|Period Between Core Study and Extension|Adverse Event|5|||
30733293|NCT00242710|58745446|FG003|Period Between Core Study and Extension|Adverse Event|2|||
30733294|NCT00242710|58745443|FG000|Period Between Core Study and Extension|Physician Decision|1|||
30733295|NCT00242710|58745444|FG001|Period Between Core Study and Extension|Physician Decision|1|||
30733296|NCT00242710|58745445|FG002|Period Between Core Study and Extension|Physician Decision|0|||
30733297|NCT00242710|58745446|FG003|Period Between Core Study and Extension|Physician Decision|0|||
30733298|NCT00242710|58745443|FG000|Period Between Core Study and Extension|Other|24|||
30733299|NCT00242710|58745444|FG001|Period Between Core Study and Extension|Other|24|||
30733300|NCT00242710|58745445|FG002|Period Between Core Study and Extension|Other|9|||
30733301|NCT00242710|58745446|FG003|Period Between Core Study and Extension|Other|11|||
30733302|NCT00242710|58745443|FG000|Period Between Core Study and Extension|Extension not Available|17|||
30733303|NCT00242710|58745444|FG001|Period Between Core Study and Extension|Extension not Available|21|||
30733304|NCT00242710|58745445|FG002|Period Between Core Study and Extension|Extension not Available|8|||
30733305|NCT00242710|58745446|FG003|Period Between Core Study and Extension|Extension not Available|7|||
30733306|NCT00242710|58745443|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
30733307|NCT00242710|58745444|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
30733308|NCT00242710|58745445|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
30733309|NCT00242710|58745446|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
30733310|NCT00242710|58745443|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
30733311|NCT00242710|58745444|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
30733312|NCT00242710|58745445|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
30733313|NCT00242710|58745446|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
30733314|NCT00242710|58745443|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
30733315|NCT00242710|58745444|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
30733316|NCT00242710|58745445|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
30733317|NCT00242710|58745446|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
30733318|NCT00242710|58745443|FG000|Study Extension (up to Year 2)|Death|0|||
30733319|NCT00242710|58745444|FG001|Study Extension (up to Year 2)|Death|0|||
30733320|NCT00242710|58745445|FG002|Study Extension (up to Year 2)|Death|0|||
30733321|NCT00242710|58745446|FG003|Study Extension (up to Year 2)|Death|1|||
30733322|NCT00242710|58745443|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
30733323|NCT00242710|58745444|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
30733324|NCT00242710|58745445|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
30733325|NCT00242710|58745446|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
30733326|NCT00242710|58745443|FG000|Study Extension (up to Year 2)|Other|3|||
30733327|NCT00242710|58745444|FG001|Study Extension (up to Year 2)|Other|5|||
30733328|NCT00242710|58745445|FG002|Study Extension (up to Year 2)|Other|4|||
30733329|NCT00242710|58745446|FG003|Study Extension (up to Year 2)|Other|3|||
30733330|NCT00242710|58745443|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
30733331|NCT00242710|58745444|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
30733332|NCT00242710|58745445|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
30733333|NCT00242710|58745446|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
30733334|NCT00242710|58745443|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
30733335|NCT00242710|58745444|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
30733336|NCT00242710|58745445|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
30733337|NCT00242710|58745446|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
30733338|NCT00408876|58745460|FG000|Overall Study|Adverse Event|9|||
30733339|NCT00408876|58745461|FG001|Overall Study|Adverse Event|17|||
30733340|NCT00408876|58745462|FG002|Overall Study|Adverse Event|27|||
30733341|NCT00408876|58745463|FG003|Overall Study|Adverse Event|10|||
30733342|NCT00408876|58745460|FG000|Overall Study|Withdrawal by Subject|3|||
30733343|NCT00408876|58745461|FG001|Overall Study|Withdrawal by Subject|6|||
30733344|NCT00408876|58745462|FG002|Overall Study|Withdrawal by Subject|6|||
30733345|NCT00408876|58745463|FG003|Overall Study|Withdrawal by Subject|14|||
30733346|NCT00408876|58745460|FG000|Overall Study|Lack of Efficacy|2|||
30733347|NCT00408876|58745461|FG001|Overall Study|Lack of Efficacy|4|||
30733348|NCT00408876|58745462|FG002|Overall Study|Lack of Efficacy|5|||
30733349|NCT00408876|58745463|FG003|Overall Study|Lack of Efficacy|6|||
30733350|NCT00408876|58745460|FG000|Overall Study|Lost to Follow-up|1|||
30733351|NCT00408876|58745461|FG001|Overall Study|Lost to Follow-up|6|||
30733352|NCT00408876|58745462|FG002|Overall Study|Lost to Follow-up|5|||
30733353|NCT00408876|58745463|FG003|Overall Study|Lost to Follow-up|2|||
30733354|NCT00408876|58745460|FG000|Overall Study|Protocol Violation|0|||
30733355|NCT00408876|58745461|FG001|Overall Study|Protocol Violation|3|||
30733356|NCT00408876|58745462|FG002|Overall Study|Protocol Violation|4|||
30733357|NCT00408876|58745463|FG003|Overall Study|Protocol Violation|3|||
30733358|NCT00408876|58745460|FG000|Overall Study|Physician Decision|1|||
30733359|NCT00408876|58745461|FG001|Overall Study|Physician Decision|0|||
30733360|NCT00408876|58745462|FG002|Overall Study|Physician Decision|3|||
30733361|NCT00408876|58745463|FG003|Overall Study|Physician Decision|0|||
30733362|NCT00240994|58745473|FG000|Overall Study|Lost to Follow-up|1|||
30733363|NCT00240994|58745473|FG000|Overall Study|Protocol Violation|1|||
30733364|NCT00240994|58745473|FG000|Overall Study|Graft failure|1|||
30733365|NCT00239590|58745477|FG000|Randomized|Lost to Follow-up|0|||
30733366|NCT00239590|58745478|FG001|Randomized|Lost to Follow-up|1|||
30733367|NCT00239590|58745477|FG000|Randomized|Withdrawal by Subject|0|||
30733368|NCT00239590|58745478|FG001|Randomized|Withdrawal by Subject|1|||
30733369|NCT00239590|58745477|FG000|Completed Study Protocol|Adverse Event|1|||
30733370|NCT00239590|58745478|FG001|Completed Study Protocol|Adverse Event|1|||
30733371|NCT00239590|58745477|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
30733372|NCT00239590|58745478|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
30733373|NCT00433160|58745488|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
30733374|NCT00433160|58745489|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
30733375|NCT00433160|58745488|FG000|52-Week Double-Blind (DB) Period|Death|0|||
30733376|NCT00433160|58745489|FG001|52-Week Double-Blind (DB) Period|Death|0|||
30733377|NCT00433160|58745488|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
30733378|NCT00433160|58745489|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
30733379|NCT00433160|58745488|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
30733380|NCT00433160|58745489|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
30733381|NCT00433160|58745488|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
30733382|NCT00433160|58745489|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
30900533|NCT02266147|58933973|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
30900534|NCT02266147|58933974|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
30733383|NCT00433160|58745488|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
30733384|NCT00433160|58745489|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
30733385|NCT00433160|58745488|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
30733386|NCT00433160|58745489|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
30733387|NCT00433160|58745488|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
30733388|NCT00433160|58745489|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
30733389|NCT00433160|58745488|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
30733390|NCT00433160|58745489|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
30733391|NCT00433160|58745488|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
30733392|NCT00433160|58745489|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
30733393|NCT00433160|58745488|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
30733394|NCT00433160|58745489|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
30733395|NCT00433160|58745488|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
30733396|NCT00433160|58745489|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
30733397|NCT00433160|58745488|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
30733398|NCT00433160|58745489|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
30733399|NCT00433160|58745488|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
30733400|NCT00433160|58745489|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
30733401|NCT00433160|58745488|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
30733402|NCT00433160|58745489|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
30733403|NCT00433160|58745488|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
30733404|NCT00433160|58745489|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
30733405|NCT00239356|58745501|FG000|Overall Study|Lack of Efficacy|1|||
30733406|NCT00239356|58745502|FG001|Overall Study|Lack of Efficacy|0|||
30733407|NCT00239356|58745501|FG000|Overall Study|Adverse Event|6|||
30733408|NCT00239356|58745502|FG001|Overall Study|Adverse Event|0|||
30733409|NCT00239356|58745501|FG000|Overall Study|Withdrawal by Subject|15|||
30733410|NCT00239356|58745502|FG001|Overall Study|Withdrawal by Subject|6|||
30733411|NCT00239356|58745501|FG000|Overall Study|Lost to Follow-up|3|||
30733412|NCT00239356|58745502|FG001|Overall Study|Lost to Follow-up|0|||
30733413|NCT00239356|58745501|FG000|Overall Study|poor/non-compliance|2|||
30733414|NCT00239356|58745502|FG001|Overall Study|poor/non-compliance|0|||
30733415|NCT00239356|58745501|FG000|Overall Study|Pregnancy|1|||
30733416|NCT00239356|58745502|FG001|Overall Study|Pregnancy|0|||
30733417|NCT00239356|58745501|FG000|Overall Study|Administrative reason|0|||
30733418|NCT00239356|58745502|FG001|Overall Study|Administrative reason|1|||
30733419|NCT00239356|58745501|FG000|Overall Study|Drug available on market|11|||
30733420|NCT00239356|58745502|FG001|Overall Study|Drug available on market|2|||
30733421|NCT00393510|58745510|FG000|Overall Study|Physician Decision|3|||
30733422|NCT00393510|58745511|FG001|Overall Study|Physician Decision|9|||
30733423|NCT00425438|58745519|FG000|Overall Study|Termination by Sponsor|25|||
30733424|NCT00425438|58745520|FG001|Overall Study|Termination by Sponsor|27|||
30733425|NCT00275002|58745528|FG000|Overall Study|Death|1|||
30733426|NCT00275002|58745529|FG001|Overall Study|Death|0|||
30733427|NCT00275002|58745528|FG000|Overall Study|Disease progression|21|||
30733428|NCT00275002|58745529|FG001|Overall Study|Disease progression|15|||
30733429|NCT00275002|58745528|FG000|Overall Study|Adverse Event|0|||
30733430|NCT00275002|58745529|FG001|Overall Study|Adverse Event|1|||
30733431|NCT00433004|58745537|FG000|Overall Study|Lost to Follow-up|5|||
30733432|NCT00433004|58745538|FG001|Overall Study|Lost to Follow-up|7|||
30733433|NCT00238264|58745544|FG000|Overall Study|Death|7|||
30733434|NCT00238264|58745544|FG000|Overall Study|Lost to Follow-up|18|||
30733435|NCT00238264|58745544|FG000|Overall Study|Withdrawal by Subject|4|||
30733436|NCT00238264|58745544|FG000|Overall Study|Ineligible|7|||
30733437|NCT00414596|58745548|FG000|Overall Study|Protocol Violation|2|||
30733438|NCT00393042|58745552|FG000|First Intervention|Withdrawal by Subject|1|||
30733439|NCT00393042|58745553|FG001|First Intervention|Withdrawal by Subject|2|||
30733440|NCT00393042|58745552|FG000|First Intervention|Lost to Follow-up|3|||
30733441|NCT00393042|58745553|FG001|First Intervention|Lost to Follow-up|3|||
30733442|NCT00393042|58745552|FG000|First Intervention|Protocol Violation|1|||
30733443|NCT00393042|58745553|FG001|First Intervention|Protocol Violation|0|||
30733444|NCT00393042|58745552|FG000|First Intervention|Adverse Event|0|||
30733445|NCT00393042|58745553|FG001|First Intervention|Adverse Event|1|||
30733446|NCT00393042|58745552|FG000|Second Intervetion|Adverse Event|0|||
30733447|NCT00393042|58745553|FG001|Second Intervetion|Adverse Event|3|||
30733448|NCT00393042|58745552|FG000|Second Intervetion|Withdrawal by Subject|0|||
30733449|NCT00393042|58745553|FG001|Second Intervetion|Withdrawal by Subject|2|||
30733450|NCT00393042|58745552|FG000|Second Intervetion|Lack of Efficacy|1|||
30733451|NCT00393042|58745553|FG001|Second Intervetion|Lack of Efficacy|0|||
30733452|NCT00393042|58745552|FG000|Second Intervetion|Lost to Follow-up|0|||
30733453|NCT00393042|58745553|FG001|Second Intervetion|Lost to Follow-up|2|||
30733454|NCT00393042|58745552|FG000|Second Intervetion|Protocol Violation|1|||
30733455|NCT00393042|58745553|FG001|Second Intervetion|Protocol Violation|1|||
30733456|NCT00392808|58745611|FG000|Overall Study|Lost to Follow-up|3|||
30733457|NCT00392808|58745612|FG001|Overall Study|Lost to Follow-up|2|||
30733458|NCT00392808|58745613|FG002|Overall Study|Lost to Follow-up|1|||
30733459|NCT00392808|58745614|FG003|Overall Study|Lost to Follow-up|2|||
30733460|NCT00392808|58745611|FG000|Overall Study|Unable to withdraw blood|3|||
30733461|NCT00392808|58745612|FG001|Overall Study|Unable to withdraw blood|1|||
30733462|NCT00392808|58745613|FG002|Overall Study|Unable to withdraw blood|1|||
30733463|NCT00392808|58745614|FG003|Overall Study|Unable to withdraw blood|2|||
30733464|NCT00274846|58745633|FG000|Overall Study|Did not receive adequate NK cells|1|||
30733465|NCT00237796|58745640|FG000|Overall Study|Baseline and one other ILSS required|10|||
30733466|NCT00237796|58745641|FG001|Overall Study|Baseline and one other ILSS required|5|||
30733467|NCT00414440|58745650|FG000|Core Period|Withdrawal by Subject|70|||
30733468|NCT00414440|58745651|FG001|Core Period|Withdrawal by Subject|32|||
30733469|NCT00414440|58745650|FG000|Extension Period|Lost to Follow-up|44|||
30733470|NCT00414440|58745651|FG001|Extension Period|Lost to Follow-up|52|||
30733471|NCT00414440|58745650|FG000|Extension Period|Did not consent to continue follow up|61|||
30733472|NCT00414440|58745651|FG001|Extension Period|Did not consent to continue follow up|54|||
30733473|NCT00414440|58745650|FG000|Extension Period|Other|1|||
30733474|NCT00414440|58745651|FG001|Extension Period|Other|1|||
30733475|NCT00414440|58745650|FG000|Extension Period|Administrative|16|||
30733476|NCT00414440|58745651|FG001|Extension Period|Administrative|16|||
30733477|NCT00414440|58745650|FG000|Extension Period|Death|1|||
30733478|NCT00414440|58745651|FG001|Extension Period|Death|2|||
30733479|NCT00414440|58745650|FG000|Extension Period|Withdrawal by Subject|9|||
30733480|NCT00414440|58745651|FG001|Extension Period|Withdrawal by Subject|7|||
30733481|NCT00414440|58745650|FG000|Extension Period|Not included in follow up period|18|||
30733482|NCT00414440|58745651|FG001|Extension Period|Not included in follow up period|8|||
30733483|NCT00209560|58745659|FG000|Overall Study|Lack of Efficacy|1|||
30733484|NCT00209560|58745660|FG001|Overall Study|Lack of Efficacy|0|||
30733485|NCT00236080|58745671|FG000|Overall Study|Adverse Event|0|||
30733486|NCT00236080|58745672|FG001|Overall Study|Adverse Event|0|||
30733487|NCT00236080|58745673|FG002|Overall Study|Adverse Event|3|||
30733488|NCT00236080|58745674|FG003|Overall Study|Adverse Event|1|||
30733489|NCT00236080|58745675|FG004|Overall Study|Adverse Event|0|||
30733490|NCT00236080|58745671|FG000|Overall Study|Lost to Follow-up|0|||
30733491|NCT00236080|58745672|FG001|Overall Study|Lost to Follow-up|1|||
30733492|NCT00236080|58745673|FG002|Overall Study|Lost to Follow-up|0|||
30733493|NCT00236080|58745674|FG003|Overall Study|Lost to Follow-up|0|||
30733494|NCT00236080|58745675|FG004|Overall Study|Lost to Follow-up|0|||
30733495|NCT00236080|58745671|FG000|Overall Study|Physician Decision|1|||
30733496|NCT00236080|58745672|FG001|Overall Study|Physician Decision|0|||
30733497|NCT00236080|58745673|FG002|Overall Study|Physician Decision|1|||
30733498|NCT00236080|58745674|FG003|Overall Study|Physician Decision|1|||
30733499|NCT00236080|58745675|FG004|Overall Study|Physician Decision|1|||
30733500|NCT00236080|58745671|FG000|Overall Study|Withdrawal by Subject|1|||
30733501|NCT00236080|58745672|FG001|Overall Study|Withdrawal by Subject|0|||
30733502|NCT00236080|58745673|FG002|Overall Study|Withdrawal by Subject|0|||
30733503|NCT00236080|58745674|FG003|Overall Study|Withdrawal by Subject|0|||
30733504|NCT00236080|58745675|FG004|Overall Study|Withdrawal by Subject|0|||
30733505|NCT00236080|58745671|FG000|Overall Study|Miscellaneous|0|||
30733506|NCT00236080|58745672|FG001|Overall Study|Miscellaneous|0|||
30733507|NCT00236080|58745673|FG002|Overall Study|Miscellaneous|1|||
30733508|NCT00236080|58745674|FG003|Overall Study|Miscellaneous|0|||
30733509|NCT00236080|58745675|FG004|Overall Study|Miscellaneous|0|||
30733510|NCT00432380|58745690|FG000|Overall Study|Migrated/moved from study area|3|||
30733511|NCT00432380|58745691|FG001|Overall Study|Migrated/moved from study area|4|||
30733512|NCT00432380|58745692|FG002|Overall Study|Migrated/moved from study area|1|||
30733513|NCT00432380|58745690|FG000|Overall Study|Adverse Event|1|||
30733514|NCT00432380|58745691|FG001|Overall Study|Adverse Event|0|||
30733515|NCT00432380|58745692|FG002|Overall Study|Adverse Event|0|||
30733516|NCT00234052|58745701|FG000|Treatment|Withdrawal by Subject|3|||
30733517|NCT00234052|58745701|FG000|Treatment|Adverse Event|5|||
30733518|NCT00234052|58745701|FG000|Treatment|Death|2|||
30733519|NCT00234052|58745701|FG000|Treatment|Progressive Disease|11|||
30733520|NCT00234052|58745701|FG000|Follow-up for 5 Years|Death|41|||
30733521|NCT00234052|58745701|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
30733522|NCT00234052|58745701|FG000|Follow-up for 5 Years|Other|7|||
30733523|NCT00408408|58745711|FG000|Overall Study|No follow up data|2|||
30733524|NCT00408408|58745712|FG001|Overall Study|No follow up data|3|||
30733525|NCT00408408|58745713|FG002|Overall Study|No follow up data|0|||
30733526|NCT00408408|58745714|FG003|Overall Study|No follow up data|7|||
30733527|NCT00408408|58745715|FG004|Overall Study|No follow up data|5|||
30733528|NCT00408408|58745716|FG005|Overall Study|No follow up data|3|||
30733529|NCT00414050|58745734|FG000|Overall Study|Adverse Event|1|||
30733530|NCT00414050|58745735|FG001|Overall Study|Adverse Event|1|||
30733531|NCT00414050|58745736|FG002|Overall Study|Adverse Event|1|||
30733532|NCT00414050|58745737|FG003|Overall Study|Adverse Event|1|||
30733533|NCT00414050|58745734|FG000|Overall Study|Lost to Follow-up|2|||
30733534|NCT00414050|58745735|FG001|Overall Study|Lost to Follow-up|2|||
30733535|NCT00414050|58745736|FG002|Overall Study|Lost to Follow-up|1|||
30733536|NCT00414050|58745737|FG003|Overall Study|Lost to Follow-up|1|||
30733537|NCT00414050|58745734|FG000|Overall Study|Withdrawal by Subject|5|||
30733538|NCT00414050|58745735|FG001|Overall Study|Withdrawal by Subject|3|||
30733539|NCT00414050|58745736|FG002|Overall Study|Withdrawal by Subject|2|||
30733540|NCT00414050|58745737|FG003|Overall Study|Withdrawal by Subject|4|||
30733541|NCT00414050|58745734|FG000|Overall Study|Subject discontinued for other reason|1|||
30733542|NCT00414050|58745735|FG001|Overall Study|Subject discontinued for other reason|2|||
30733543|NCT00414050|58745736|FG002|Overall Study|Subject discontinued for other reason|2|||
30733544|NCT00414050|58745737|FG003|Overall Study|Subject discontinued for other reason|1|||
30733545|NCT00414050|58745734|FG000|Overall Study|Subject Moved|0|||
30733546|NCT00414050|58745735|FG001|Overall Study|Subject Moved|0|||
30733547|NCT00414050|58745736|FG002|Overall Study|Subject Moved|0|||
30733548|NCT00414050|58745737|FG003|Overall Study|Subject Moved|1|||
30733549|NCT00413972|58745751|FG000|Overall Study|Adverse Event|2|||
30733550|NCT00413972|58745752|FG001|Overall Study|Adverse Event|1|||
30733551|NCT00413972|58745753|FG002|Overall Study|Adverse Event|0|||
30733552|NCT00413972|58745754|FG003|Overall Study|Adverse Event|0|||
30733553|NCT00413972|58745751|FG000|Overall Study|Lost to Follow-up|1|||
30733554|NCT00413972|58745752|FG001|Overall Study|Lost to Follow-up|2|||
30733555|NCT00413972|58745753|FG002|Overall Study|Lost to Follow-up|1|||
30733556|NCT00413972|58745754|FG003|Overall Study|Lost to Follow-up|0|||
30733557|NCT00413972|58745751|FG000|Overall Study|Withdrawal by Subject|4|||
30733558|NCT00413972|58745752|FG001|Overall Study|Withdrawal by Subject|5|||
30733559|NCT00413972|58745753|FG002|Overall Study|Withdrawal by Subject|7|||
30733560|NCT00413972|58745754|FG003|Overall Study|Withdrawal by Subject|2|||
30733561|NCT00413972|58745751|FG000|Overall Study|Protocol Violation|0|||
30733562|NCT00413972|58745752|FG001|Overall Study|Protocol Violation|0|||
30733563|NCT00413972|58745753|FG002|Overall Study|Protocol Violation|2|||
30733564|NCT00413972|58745754|FG003|Overall Study|Protocol Violation|0|||
30733565|NCT00413972|58745751|FG000|Overall Study|Other|0|||
30733566|NCT00413972|58745752|FG001|Overall Study|Other|0|||
30733567|NCT00413972|58745753|FG002|Overall Study|Other|0|||
30733568|NCT00413972|58745754|FG003|Overall Study|Other|1|||
30733569|NCT00259012|58745766|FG000|Overall Study|Adverse Event|0|||
30733570|NCT00259012|58745767|FG001|Overall Study|Adverse Event|1|||
30733571|NCT00259012|58745766|FG000|Overall Study|Withdrawal by Subject|1|||
30733572|NCT00259012|58745767|FG001|Overall Study|Withdrawal by Subject|0|||
30733573|NCT00259012|58745766|FG000|Overall Study|Physician Decision|0|||
30733574|NCT00259012|58745767|FG001|Overall Study|Physician Decision|1|||
30733575|NCT00259012|58745766|FG000|Overall Study|Lost to Follow-up|0|||
30733576|NCT00259012|58745767|FG001|Overall Study|Lost to Follow-up|1|||
30733577|NCT00259012|58745766|FG000|Overall Study|Protocol Violation|1|||
30733578|NCT00259012|58745767|FG001|Overall Study|Protocol Violation|1|||
30733579|NCT00209170|58745775|FG000|Overall Study|Adverse Event|0|||
30733580|NCT00209170|58745776|FG001|Overall Study|Adverse Event|1|||
30733581|NCT00209170|58745775|FG000|Overall Study|Withdrawal by Subject|2|||
30733582|NCT00209170|58745776|FG001|Overall Study|Withdrawal by Subject|1|||
30733583|NCT00209170|58745775|FG000|Overall Study|Lack of Efficacy|0|||
30733584|NCT00209170|58745776|FG001|Overall Study|Lack of Efficacy|1|||
30733585|NCT00413894|58745782|FG000|Overall Study|Withdrawal by Subject|10|||
30733586|NCT00413894|58745782|FG000|Overall Study|Administrative Reasons|1|||
30733587|NCT00413894|58745782|FG000|Overall Study|Hb <10 grams/deciliter|12|||
30733588|NCT00413894|58745782|FG000|Overall Study|Adverse Event|28|||
30733589|NCT00413894|58745782|FG000|Overall Study|Protocol Violation|11|||
30733590|NCT00413894|58745782|FG000|Overall Study|Other|18|||
30733591|NCT00407550|58745791|FG000|Overall Study|Adverse Event|0|||
30733592|NCT00407550|58745792|FG001|Overall Study|Adverse Event|1|||
30733593|NCT00407550|58745791|FG000|Overall Study|Withdrawal by Subject|0|||
30733594|NCT00407550|58745792|FG001|Overall Study|Withdrawal by Subject|2|||
30733595|NCT00407550|58745791|FG000|Overall Study|Death|1|||
30733596|NCT00407550|58745792|FG001|Overall Study|Death|0|||
30733597|NCT00407550|58745791|FG000|Overall Study|Insurance or Other medical condition|2|||
30733598|NCT00407550|58745792|FG001|Overall Study|Insurance or Other medical condition|1|||
30733599|NCT00209092|58745800|FG000|Overall Study|Progression of disease|7|||
30733600|NCT00209092|58745801|FG001|Overall Study|Progression of disease|1|||
30733601|NCT00209092|58745800|FG000|Overall Study|Adverse Event|0|||
30733602|NCT00209092|58745801|FG001|Overall Study|Adverse Event|1|||
30733603|NCT00209092|58745800|FG000|Overall Study|Withdrawal by Subject|1|||
30733604|NCT00209092|58745801|FG001|Overall Study|Withdrawal by Subject|0|||
30733605|NCT00403494|58745809|FG000|Overall Study|Adverse Event|10|||
30733606|NCT00403494|58745810|FG001|Overall Study|Adverse Event|8|||
30733607|NCT00403494|58745809|FG000|Overall Study|Withdrew Consent|3|||
30733608|NCT00403494|58745810|FG001|Overall Study|Withdrew Consent|2|||
30733609|NCT00403494|58745809|FG000|Overall Study|Inappropriately enrolled|0|||
30733610|NCT00403494|58745810|FG001|Overall Study|Inappropriately enrolled|1|||
30733611|NCT00403494|58745809|FG000|Overall Study|Lost to Follow-up|0|||
30733612|NCT00403494|58745810|FG001|Overall Study|Lost to Follow-up|2|||
30733613|NCT00403494|58745809|FG000|Overall Study|Protocol noncompliance|0|||
30733614|NCT00403494|58745810|FG001|Overall Study|Protocol noncompliance|1|||
30733615|NCT00403494|58745809|FG000|Overall Study|Death|1|||
30733616|NCT00403494|58745810|FG001|Overall Study|Death|0|||
30733617|NCT00403494|58745809|FG000|Overall Study|Sponsor Request|1|||
30733618|NCT00403494|58745810|FG001|Overall Study|Sponsor Request|0|||
30733619|NCT00403260|58745820|FG000|Overall Study|Adverse Event|5|||
30733620|NCT00403260|58745821|FG001|Overall Study|Adverse Event|4|||
30733621|NCT00403260|58745820|FG000|Overall Study|Withdrawal by Subject|5|||
30733622|NCT00403260|58745821|FG001|Overall Study|Withdrawal by Subject|6|||
30733623|NCT00403260|58745820|FG000|Overall Study|Lost to Follow-up|49|||
30733624|NCT00403260|58745821|FG001|Overall Study|Lost to Follow-up|25|||
30733625|NCT00403260|58745820|FG000|Overall Study|Re-appearance of P. falciparum|34|||
30733626|NCT00403260|58745821|FG001|Overall Study|Re-appearance of P. falciparum|25|||
30733627|NCT00403260|58745820|FG000|Overall Study|P. vivax infection|26|||
30733628|NCT00403260|58745821|FG001|Overall Study|P. vivax infection|4|||
30733629|NCT00403260|58745820|FG000|Overall Study|Mixed infection with P. vivax|2|||
30733630|NCT00403260|58745821|FG001|Overall Study|Mixed infection with P. vivax|0|||
30733631|NCT00403260|58745820|FG000|Overall Study|Mixed infection with P. falciparum|1|||
30733632|NCT00403260|58745821|FG001|Overall Study|Mixed infection with P. falciparum|0|||
30733633|NCT00403260|58745820|FG000|Overall Study|P. vivax infection at screening|1|||
30733634|NCT00403260|58745821|FG001|Overall Study|P. vivax infection at screening|0|||
30733635|NCT00403260|58745820|FG000|Overall Study|P. ovale infection|1|||
30733636|NCT00403260|58745821|FG001|Overall Study|P. ovale infection|0|||
30733637|NCT00403260|58745820|FG000|Overall Study|Gametocyte re-appearance|1|||
30733638|NCT00403260|58745821|FG001|Overall Study|Gametocyte re-appearance|1|||
30733639|NCT00403260|58745820|FG000|Overall Study|Withdrawn from study accidentally|0|||
30733640|NCT00403260|58745821|FG001|Overall Study|Withdrawn from study accidentally|1|||
30733641|NCT00406848|58745829|FG000|Overall Study|Withdrawal by Subject|27|||
30733642|NCT00406848|58745830|FG001|Overall Study|Withdrawal by Subject|22|||
30733643|NCT00406848|58745829|FG000|Overall Study|Adverse Event|38|||
30733644|NCT00406848|58745830|FG001|Overall Study|Adverse Event|7|||
30733645|NCT00406848|58745829|FG000|Overall Study|Lack of Efficacy|9|||
30733646|NCT00406848|58745830|FG001|Overall Study|Lack of Efficacy|14|||
30733647|NCT00406848|58745829|FG000|Overall Study|Protocol Violation|10|||
30733648|NCT00406848|58745830|FG001|Overall Study|Protocol Violation|6|||
30733649|NCT00406848|58745829|FG000|Overall Study|Lost to Follow-up|6|||
30733650|NCT00406848|58745830|FG001|Overall Study|Lost to Follow-up|2|||
30733651|NCT00406848|58745829|FG000|Overall Study|Physician Decision|2|||
30733652|NCT00406848|58745830|FG001|Overall Study|Physician Decision|2|||
30733653|NCT00406848|58745829|FG000|Overall Study|Sponsor Decision|1|||
30733654|NCT00406848|58745830|FG001|Overall Study|Sponsor Decision|1|||
30733655|NCT00406692|58745839|FG000|Overall Study|Withdrawal by Subject|4|||
30733656|NCT00406692|58745839|FG000|Overall Study|Physician Decision|1|||
30733657|NCT00406692|58745839|FG000|Overall Study|Adverse Event|1|||
30733658|NCT00406692|58745839|FG000|Overall Study|Lack of Efficacy|1|||
30733659|NCT00315705|58745845|FG000|Phase 1|Refused further treatment|1|||
30733660|NCT00315705|58745845|FG000|Phase 1|Failure to achieve response|8|||
30733661|NCT00315705|58745845|FG000|Phase 1|Disease relapse|4|||
30733662|NCT00315705|58745845|FG000|Phase 1|Scheduled for transplant|9|||
30733663|NCT00315705|58745845|FG000|Phase 1|Death|3|||
30733664|NCT00315705|58745845|FG000|Phase 2|Physician Decision|4|||
30733665|NCT00315705|58745845|FG000|Phase 2|Adverse Event|1|||
30733666|NCT00315705|58745845|FG000|Phase 2|Failure to achieve response|3|||
30733667|NCT00315705|58745845|FG000|Phase 2|Disease relapse|1|||
30733668|NCT00315705|58745845|FG000|Phase 2|Scheduled for transplant|8|||
30733669|NCT00315705|58745845|FG000|Phase 2|Other|1|||
30733670|NCT00315705|58745845|FG000|Phase 2|Death|7|||
30733671|NCT00307125|58745864|FG000|Screening Phase|Adverse Event|1|||
30733672|NCT00307125|58745865|FG001|Screening Phase|Adverse Event|0|||
30733673|NCT00307125|58745866|FG002|Screening Phase|Adverse Event|0|||
30733674|NCT00307125|58745864|FG000|Screening Phase|Protocol Violation|27|||
30733675|NCT00307125|58745865|FG001|Screening Phase|Protocol Violation|0|||
30733676|NCT00307125|58745866|FG002|Screening Phase|Protocol Violation|0|||
30733677|NCT00307125|58745864|FG000|Screening Phase|Lost to Follow-up|87|||
30733678|NCT00307125|58745865|FG001|Screening Phase|Lost to Follow-up|0|||
30733679|NCT00307125|58745866|FG002|Screening Phase|Lost to Follow-up|0|||
30733680|NCT00307125|58745864|FG000|Screening Phase|Death|10|||
30733681|NCT00307125|58745865|FG001|Screening Phase|Death|0|||
30733682|NCT00307125|58745866|FG002|Screening Phase|Death|0|||
30733683|NCT00307125|58745864|FG000|Screening Phase|Withdrawal by Subject|77|||
30733684|NCT00307125|58745865|FG001|Screening Phase|Withdrawal by Subject|0|||
30733685|NCT00307125|58745866|FG002|Screening Phase|Withdrawal by Subject|0|||
30733686|NCT00307125|58745864|FG000|Screening Phase|Physician Decision|26|||
30733687|NCT00307125|58745865|FG001|Screening Phase|Physician Decision|0|||
30733688|NCT00307125|58745866|FG002|Screening Phase|Physician Decision|0|||
30733689|NCT00307125|58745864|FG000|Screening Phase|Sponsor Decision|4|||
30733690|NCT00307125|58745865|FG001|Screening Phase|Sponsor Decision|0|||
30733691|NCT00307125|58745866|FG002|Screening Phase|Sponsor Decision|0|||
30733692|NCT00307125|58745864|FG000|Screening Phase|Study Terminated|17|||
30621836|NCT01173120|58633372|FG000|Overall Study|Switch-Participant Decision|12|||
30733693|NCT00307125|58745865|FG001|Screening Phase|Study Terminated|0|||
30733694|NCT00307125|58745866|FG002|Screening Phase|Study Terminated|0|||
30733695|NCT00307125|58745864|FG000|Screening Phase|Graft Loss|3|||
30733696|NCT00307125|58745865|FG001|Screening Phase|Graft Loss|0|||
30733697|NCT00307125|58745866|FG002|Screening Phase|Graft Loss|0|||
30733698|NCT00307125|58745864|FG000|Screening Phase|Graft Failure|8|||
30733699|NCT00307125|58745865|FG001|Screening Phase|Graft Failure|0|||
30733700|NCT00307125|58745866|FG002|Screening Phase|Graft Failure|0|||
30733701|NCT00307125|58745864|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
30733702|NCT00307125|58745865|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
30733703|NCT00307125|58745866|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
30733704|NCT00307125|58745864|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
30733705|NCT00307125|58745865|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
30733706|NCT00307125|58745866|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
30733707|NCT00307125|58745864|FG000|Screening Phase|Moved or transferred facilities|34|||
30733708|NCT00307125|58745865|FG001|Screening Phase|Moved or transferred facilities|0|||
30733709|NCT00307125|58745866|FG002|Screening Phase|Moved or transferred facilities|0|||
30733710|NCT00307125|58745864|FG000|Screening Phase|Received Pancreas Transplant|8|||
30733711|NCT00307125|58745865|FG001|Screening Phase|Received Pancreas Transplant|0|||
30733712|NCT00307125|58745866|FG002|Screening Phase|Received Pancreas Transplant|0|||
30733713|NCT00307125|58745864|FG000|Screening Phase|Ineligible for pilot|4|||
30733714|NCT00307125|58745865|FG001|Screening Phase|Ineligible for pilot|0|||
30733715|NCT00307125|58745866|FG002|Screening Phase|Ineligible for pilot|0|||
30733716|NCT00307125|58745864|FG000|Screening Phase|Try to get pregnant|1|||
30733717|NCT00307125|58745865|FG001|Screening Phase|Try to get pregnant|0|||
30733718|NCT00307125|58745866|FG002|Screening Phase|Try to get pregnant|0|||
30733719|NCT00307125|58745864|FG000|Screening Phase|Developed acute leukemia|1|||
30733720|NCT00307125|58745865|FG001|Screening Phase|Developed acute leukemia|0|||
30733721|NCT00307125|58745866|FG002|Screening Phase|Developed acute leukemia|0|||
30733722|NCT00307125|58745864|FG000|Screening Phase|Metastatic colon cancer|1|||
30733723|NCT00307125|58745865|FG001|Screening Phase|Metastatic colon cancer|0|||
30733724|NCT00307125|58745866|FG002|Screening Phase|Metastatic colon cancer|0|||
30733725|NCT00307125|58745864|FG000|Screening Phase|Malignancy|1|||
30733726|NCT00307125|58745865|FG001|Screening Phase|Malignancy|0|||
30733727|NCT00307125|58745866|FG002|Screening Phase|Malignancy|0|||
30733728|NCT00307125|58745864|FG000|Screening Phase|PAK|1|||
30733729|NCT00307125|58745865|FG001|Screening Phase|PAK|0|||
30733730|NCT00307125|58745866|FG002|Screening Phase|PAK|0|||
30733731|NCT00307125|58745864|FG000|Screening Phase|Ineligible|1|||
30733732|NCT00307125|58745865|FG001|Screening Phase|Ineligible|0|||
30733733|NCT00307125|58745866|FG002|Screening Phase|Ineligible|0|||
30733734|NCT00307125|58745864|FG000|Screening Phase|Screen Error|1|||
30733735|NCT00307125|58745865|FG001|Screening Phase|Screen Error|0|||
30733736|NCT00307125|58745866|FG002|Screening Phase|Screen Error|0|||
30733737|NCT00307125|58745864|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
30733738|NCT00307125|58745865|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
30733739|NCT00307125|58745866|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
30733740|NCT00307125|58745864|FG000|Screening Phase|AMR and treated with rituximab|1|||
30733741|NCT00307125|58745865|FG001|Screening Phase|AMR and treated with rituximab|0|||
30733742|NCT00307125|58745866|FG002|Screening Phase|AMR and treated with rituximab|0|||
30733743|NCT00307125|58745864|FG000|Screening Phase|Coronary artery bypass|1|||
30733744|NCT00307125|58745865|FG001|Screening Phase|Coronary artery bypass|0|||
30733745|NCT00307125|58745866|FG002|Screening Phase|Coronary artery bypass|0|||
30733746|NCT00307125|58745864|FG000|Pilot Phase|Lost to Follow-up|0|||
30733747|NCT00307125|58745865|FG001|Pilot Phase|Lost to Follow-up|1|||
30621837|NCT01173120|58633372|FG000|Overall Study|Switch-Difficulty With Device|12|||
30733748|NCT00307125|58745866|FG002|Pilot Phase|Lost to Follow-up|0|||
30733749|NCT00307125|58745864|FG000|Pilot Phase|Withdrawal by Subject|0|||
30733750|NCT00307125|58745865|FG001|Pilot Phase|Withdrawal by Subject|1|||
30733751|NCT00307125|58745866|FG002|Pilot Phase|Withdrawal by Subject|1|||
30790943|NCT03200366|58804016|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
30733752|NCT00307047|58745878|FG000|Overall Study|Lost to Follow-up|35|||
30733753|NCT00307047|58745879|FG001|Overall Study|Lost to Follow-up|24|||
30733754|NCT00307047|58745878|FG000|Overall Study|Withdrawal by Subject|6|||
30733755|NCT00307047|58745879|FG001|Overall Study|Withdrawal by Subject|6|||
30733756|NCT00307047|58745878|FG000|Overall Study|Physician Decision|1|||
30733757|NCT00307047|58745879|FG001|Overall Study|Physician Decision|2|||
30733758|NCT00307047|58745878|FG000|Overall Study|Lost to follow-up for other reasons|0|||
30733759|NCT00307047|58745879|FG001|Overall Study|Lost to follow-up for other reasons|1|||
30733760|NCT00307047|58745878|FG000|Overall Study|All death, all MI, all Revascularization|27|||
30733761|NCT00307047|58745879|FG001|Overall Study|All death, all MI, all Revascularization|16|||
30733762|NCT00306891|58745889|FG000|Part A|Withdrawal by Subject|1|||
30733763|NCT00306891|58745890|FG001|Part A|Withdrawal by Subject|1|||
30733764|NCT00306891|58745891|FG002|Part A|Withdrawal by Subject|0|||
30733765|NCT00306891|58745892|FG003|Part A|Withdrawal by Subject|0|||
30733766|NCT00306891|58745889|FG000|Part A|Condition under investigation worsened|2|||
30733767|NCT00306891|58745890|FG001|Part A|Condition under investigation worsened|2|||
30733768|NCT00306891|58745891|FG002|Part A|Condition under investigation worsened|0|||
30733769|NCT00306891|58745892|FG003|Part A|Condition under investigation worsened|0|||
30733770|NCT00306891|58745889|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
30733771|NCT00306891|58745890|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
30733772|NCT00306891|58745891|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
30733773|NCT00306891|58745892|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
30733774|NCT00306891|58745889|FG000|Part A|Partial bowel obstruction|1|||
30733775|NCT00306891|58745890|FG001|Part A|Partial bowel obstruction|0|||
30733776|NCT00306891|58745891|FG002|Part A|Partial bowel obstruction|0|||
30733777|NCT00306891|58745892|FG003|Part A|Partial bowel obstruction|0|||
30733778|NCT00306891|58745889|FG000|Part A|Reaccumul. of ascites following drainage|0|||
30733779|NCT00306891|58745890|FG001|Part A|Reaccumul. of ascites following drainage|1|||
30733780|NCT00306891|58745891|FG002|Part A|Reaccumul. of ascites following drainage|0|||
30733781|NCT00306891|58745892|FG003|Part A|Reaccumul. of ascites following drainage|0|||
30733782|NCT00306891|58745889|FG000|Part A|Suspicion of second malignancy|0|||
30733783|NCT00306891|58745890|FG001|Part A|Suspicion of second malignancy|1|||
30733784|NCT00306891|58745891|FG002|Part A|Suspicion of second malignancy|0|||
30733785|NCT00306891|58745892|FG003|Part A|Suspicion of second malignancy|0|||
30733786|NCT00306891|58745889|FG000|Part A|QTC interval outwith elig. criteria|1|||
30733787|NCT00306891|58745890|FG001|Part A|QTC interval outwith elig. criteria|0|||
30733788|NCT00306891|58745891|FG002|Part A|QTC interval outwith elig. criteria|0|||
30733789|NCT00306891|58745892|FG003|Part A|QTC interval outwith elig. criteria|0|||
30733790|NCT00306891|58745889|FG000|Part B|Death|0|||
30733791|NCT00306891|58745890|FG001|Part B|Death|0|||
30733792|NCT00306891|58745891|FG002|Part B|Death|1|||
30733793|NCT00306891|58745892|FG003|Part B|Death|2|||
30733794|NCT00306891|58745889|FG000|Part B|Adverse Event|0|||
30733795|NCT00306891|58745890|FG001|Part B|Adverse Event|0|||
30733796|NCT00306891|58745891|FG002|Part B|Adverse Event|5|||
30733797|NCT00306891|58745892|FG003|Part B|Adverse Event|5|||
30733798|NCT00306891|58745889|FG000|Part B|Withdrawal by Subject|0|||
30733799|NCT00306891|58745890|FG001|Part B|Withdrawal by Subject|0|||
30733800|NCT00306891|58745891|FG002|Part B|Withdrawal by Subject|3|||
30733801|NCT00306891|58745892|FG003|Part B|Withdrawal by Subject|1|||
30733802|NCT00306891|58745889|FG000|Part B|Condition under investigation worsened|0|||
30733803|NCT00306891|58745890|FG001|Part B|Condition under investigation worsened|0|||
30733804|NCT00306891|58745891|FG002|Part B|Condition under investigation worsened|2|||
30733805|NCT00306891|58745892|FG003|Part B|Condition under investigation worsened|8|||
30733806|NCT00306891|58745889|FG000|Part B|Development of study specific disc crit.|0|||
30733807|NCT00306891|58745890|FG001|Part B|Development of study specific disc crit.|0|||
30733808|NCT00306891|58745891|FG002|Part B|Development of study specific disc crit.|0|||
30733809|NCT00306891|58745892|FG003|Part B|Development of study specific disc crit.|1|||
30733810|NCT00314145|58745905|FG000|Overall Study|Withdrawal by Subject|8|||
30733811|NCT00314145|58745906|FG001|Overall Study|Withdrawal by Subject|10|||
30790944|NCT03200366|58804017|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
30733812|NCT00314145|58745905|FG000|Overall Study|Lost to Follow-up|5|||
30733813|NCT00314145|58745906|FG001|Overall Study|Lost to Follow-up|12|||
30733814|NCT00314145|58745905|FG000|Overall Study|Physician Decision|3|||
30733815|NCT00314145|58745906|FG001|Overall Study|Physician Decision|4|||
30733816|NCT00314145|58745905|FG000|Overall Study|Adverse Event|0|||
30733817|NCT00314145|58745906|FG001|Overall Study|Adverse Event|3|||
30733818|NCT00314145|58745905|FG000|Overall Study|Protocol Violation|3|||
30733819|NCT00314145|58745906|FG001|Overall Study|Protocol Violation|0|||
30733820|NCT00314145|58745905|FG000|Overall Study|Sponsor Decision|2|||
30733821|NCT00314145|58745906|FG001|Overall Study|Sponsor Decision|0|||
30733822|NCT00313911|58745915|FG000|Overall Study|Serious adverse event|6|||
30733823|NCT00313911|58745916|FG001|Overall Study|Serious adverse event|1|||
30733824|NCT00313911|58745915|FG000|Overall Study|Adverse Event|2|||
30733825|NCT00313911|58745916|FG001|Overall Study|Adverse Event|3|||
30733826|NCT00313911|58745915|FG000|Overall Study|Protocol Violation|19|||
30733827|NCT00313911|58745916|FG001|Overall Study|Protocol Violation|10|||
30733828|NCT00313911|58745915|FG000|Overall Study|Lost to Follow-up|27|||
30733829|NCT00313911|58745916|FG001|Overall Study|Lost to Follow-up|14|||
30733830|NCT00313911|58745915|FG000|Overall Study|Withdrawal by Subject|39|||
30733831|NCT00313911|58745916|FG001|Overall Study|Withdrawal by Subject|12|||
30733832|NCT00313911|58745915|FG000|Overall Study|Did not meet age criteria|1|||
30733833|NCT00313911|58745916|FG001|Overall Study|Did not meet age criteria|1|||
30733834|NCT00391872|58745924|FG000|Overall Study|Protocol Violation|7|||
30733835|NCT00391872|58745925|FG001|Overall Study|Protocol Violation|2|||
30733836|NCT00391872|58745924|FG000|Overall Study|Withdrawal by Subject|296|||
30733837|NCT00391872|58745925|FG001|Overall Study|Withdrawal by Subject|249|||
30733838|NCT00391872|58745924|FG000|Overall Study|Reason unknown|2|||
30733839|NCT00391872|58745925|FG001|Overall Study|Reason unknown|4|||
30733840|NCT00391872|58745924|FG000|Overall Study|Lost to Follow-up|2|||
30733841|NCT00391872|58745925|FG001|Overall Study|Lost to Follow-up|0|||
30733842|NCT00391170|58745933|FG000|Overall Study|Withdrawal by Subject|1|||
30733843|NCT00391170|58745934|FG001|Overall Study|Withdrawal by Subject|0|||
30733844|NCT00391170|58745933|FG000|Overall Study|Adverse Event|3|||
30733845|NCT00391170|58745934|FG001|Overall Study|Adverse Event|2|||
30733846|NCT00391170|58745933|FG000|Overall Study|Physician Decision|2|||
30733847|NCT00391170|58745934|FG001|Overall Study|Physician Decision|2|||
30733848|NCT00402324|58745942|FG000|Overall Study|Lost to Follow-up|11|||
30733849|NCT00402324|58745943|FG001|Overall Study|Lost to Follow-up|11|||
30733850|NCT00402324|58745942|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
30733851|NCT00402324|58745943|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
30733852|NCT00402324|58745942|FG000|Overall Study|Protocol Violation|8|||
30733853|NCT00402324|58745943|FG001|Overall Study|Protocol Violation|7|||
30733854|NCT00402324|58745942|FG000|Overall Study|Withdrawal by Subject|5|||
30733855|NCT00402324|58745943|FG001|Overall Study|Withdrawal by Subject|2|||
30733856|NCT00402324|58745942|FG000|Overall Study|Physician Decision|2|||
30733857|NCT00402324|58745943|FG001|Overall Study|Physician Decision|4|||
30733858|NCT00402324|58745942|FG000|Overall Study|Sponsor Decision|4|||
30733859|NCT00402324|58745943|FG001|Overall Study|Sponsor Decision|5|||
30733860|NCT00402324|58745942|FG000|Overall Study|Lack of Efficacy|1|||
30733861|NCT00402324|58745943|FG001|Overall Study|Lack of Efficacy|4|||
30733862|NCT00402324|58745942|FG000|Overall Study|Adverse Event|6|||
30733863|NCT00402324|58745943|FG001|Overall Study|Adverse Event|4|||
30733864|NCT00402324|58745942|FG000|Overall Study|Death|1|||
30733865|NCT00402324|58745943|FG001|Overall Study|Death|0|||
30733866|NCT00294723|58745952|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
30733867|NCT00294723|58745953|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
30733868|NCT00294723|58745954|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
30733869|NCT00294723|58745952|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
30733870|NCT00294723|58745953|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
30733871|NCT00294723|58745954|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
30733872|NCT00294723|58745952|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
30733873|NCT00294723|58745953|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
30733874|NCT00294723|58745954|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
30733875|NCT00294723|58745952|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
30733876|NCT00294723|58745953|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
30733877|NCT00294723|58745954|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
30733878|NCT00294723|58745952|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
30733879|NCT00294723|58745953|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
30733880|NCT00294723|58745954|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
30733881|NCT00294723|58745952|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
30733882|NCT00294723|58745953|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
30733883|NCT00294723|58745954|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
30733884|NCT00294723|58745952|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
30733885|NCT00294723|58745953|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
30733886|NCT00294723|58745954|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
30733887|NCT00294723|58745952|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
30733888|NCT00294723|58745953|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
30733889|NCT00294723|58745954|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
30733890|NCT00294723|58745952|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
30733891|NCT00294723|58745953|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
30733892|NCT00294723|58745954|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
30733893|NCT00294723|58745952|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
30733894|NCT00294723|58745953|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
30733895|NCT00294723|58745954|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
30733896|NCT00294723|58745952|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
30733897|NCT00294723|58745953|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
30733898|NCT00294723|58745954|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
30733899|NCT00294723|58745952|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
30733900|NCT00294723|58745953|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
30733901|NCT00294723|58745954|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
30733902|NCT00402246|58745967|FG000|Overall Study|Death|62|||
30733903|NCT00402246|58745968|FG001|Overall Study|Death|58|||
30733904|NCT00402246|58745967|FG000|Overall Study|Lost to Follow-up|20|||
30733905|NCT00402246|58745968|FG001|Overall Study|Lost to Follow-up|28|||
30733906|NCT00402246|58745967|FG000|Overall Study|Withdrawal by Subject|72|||
30733907|NCT00402246|58745968|FG001|Overall Study|Withdrawal by Subject|87|||
30733908|NCT00402246|58745967|FG000|Overall Study|Physician Decision|24|||
30733909|NCT00402246|58745968|FG001|Overall Study|Physician Decision|26|||
30733910|NCT00402246|58745967|FG000|Overall Study|Protocol Violation|25|||
30733911|NCT00402246|58745968|FG001|Overall Study|Protocol Violation|24|||
30733912|NCT00402246|58745967|FG000|Overall Study|Missed Final Visit|1|||
30733913|NCT00402246|58745968|FG001|Overall Study|Missed Final Visit|2|||
30733914|NCT00402246|58745967|FG000|Overall Study|Insurance Issues|2|||
30733915|NCT00402246|58745968|FG001|Overall Study|Insurance Issues|1|||
30733916|NCT00402246|58745967|FG000|Overall Study|Heart Transplant|0|||
30733917|NCT00402246|58745968|FG001|Overall Study|Heart Transplant|1|||
30733918|NCT00402246|58745967|FG000|Overall Study|Patient's device explanted|6|||
30733919|NCT00402246|58745968|FG001|Overall Study|Patient's device explanted|2|||
30733920|NCT00402246|58745967|FG000|Overall Study|Center Closure|5|||
30733921|NCT00402246|58745968|FG001|Overall Study|Center Closure|3|||
30733922|NCT00402246|58745967|FG000|Overall Study|Deterioriating Condition|3|||
30733923|NCT00402246|58745968|FG001|Overall Study|Deterioriating Condition|2|||
30733924|NCT00375492|58745978|FG000|Overall Study|Adverse Event|4|||
30733925|NCT00375492|58745979|FG001|Overall Study|Adverse Event|5|||
30733926|NCT00375492|58745978|FG000|Overall Study|Entry Criteria Not Met|0|||
30733927|NCT00375492|58745979|FG001|Overall Study|Entry Criteria Not Met|1|||
30733928|NCT00375492|58745978|FG000|Overall Study|Loss of Glucose Control|0|||
30733929|NCT00375492|58745979|FG001|Overall Study|Loss of Glucose Control|1|||
30733930|NCT00375492|58745978|FG000|Overall Study|Lost to Follow-up|10|||
30733931|NCT00375492|58745979|FG001|Overall Study|Lost to Follow-up|5|||
30733932|NCT00375492|58745978|FG000|Overall Study|Physician Decision|0|||
30733933|NCT00375492|58745979|FG001|Overall Study|Physician Decision|4|||
30733934|NCT00375492|58745978|FG000|Overall Study|Protocol Violation|6|||
30733935|NCT00375492|58745979|FG001|Overall Study|Protocol Violation|3|||
30733936|NCT00375492|58745978|FG000|Overall Study|Sponsor Decision|0|||
30733937|NCT00375492|58745979|FG001|Overall Study|Sponsor Decision|1|||
30621838|NCT00977379|58633380|FG000|Overall Study|Withdrawal by Subject|1|||
30621839|NCT00977379|58633381|FG001|Overall Study|Withdrawal by Subject|1|||
30733938|NCT00375492|58745978|FG000|Overall Study|Withdrawal by Subject|6|||
30733939|NCT00375492|58745979|FG001|Overall Study|Withdrawal by Subject|6|||
30733940|NCT00306189|58745989|FG000|Overall Study|Physician Decision|0|||
30733941|NCT00306189|58745990|FG001|Overall Study|Physician Decision|0|||
30733942|NCT00306189|58745991|FG002|Overall Study|Physician Decision|0|||
30733943|NCT00306189|58745992|FG003|Overall Study|Physician Decision|1|||
30733944|NCT00306189|58745989|FG000|Overall Study|Adverse Event|3|||
30733945|NCT00306189|58745990|FG001|Overall Study|Adverse Event|3|||
30733946|NCT00306189|58745991|FG002|Overall Study|Adverse Event|2|||
30733947|NCT00306189|58745992|FG003|Overall Study|Adverse Event|2|||
30733948|NCT00306189|58745989|FG000|Overall Study|Withdrawal by Subject|4|||
30733949|NCT00306189|58745990|FG001|Overall Study|Withdrawal by Subject|2|||
30733950|NCT00306189|58745991|FG002|Overall Study|Withdrawal by Subject|8|||
30733951|NCT00306189|58745992|FG003|Overall Study|Withdrawal by Subject|1|||
30733952|NCT00306189|58745989|FG000|Overall Study|Ineligibility determined|1|||
30733953|NCT00306189|58745990|FG001|Overall Study|Ineligibility determined|1|||
30733954|NCT00306189|58745991|FG002|Overall Study|Ineligibility determined|1|||
30733955|NCT00306189|58745992|FG003|Overall Study|Ineligibility determined|1|||
30733956|NCT00306189|58745989|FG000|Overall Study|Other|1|||
30733957|NCT00306189|58745990|FG001|Overall Study|Other|0|||
30733958|NCT00306189|58745991|FG002|Overall Study|Other|0|||
30733959|NCT00306189|58745992|FG003|Overall Study|Other|0|||
30733960|NCT00312897|58746004|FG000|Overall Study|Adverse Event|1|||
30733961|NCT00312897|58746005|FG001|Overall Study|Adverse Event|0|||
30733962|NCT00312897|58746004|FG000|Overall Study|Lost to Follow-up|2|||
30733963|NCT00312897|58746005|FG001|Overall Study|Lost to Follow-up|0|||
30733964|NCT00312897|58746004|FG000|Overall Study|Physician Decision|1|||
30733965|NCT00312897|58746005|FG001|Overall Study|Physician Decision|0|||
30733966|NCT00312897|58746004|FG000|Overall Study|Withdrawal by Subject|1|||
30733967|NCT00312897|58746005|FG001|Overall Study|Withdrawal by Subject|3|||
30733968|NCT00312897|58746004|FG000|Overall Study|Pregnancy|1|||
30733969|NCT00312897|58746005|FG001|Overall Study|Pregnancy|0|||
30733970|NCT00312897|58746004|FG000|Overall Study|discontinued prior to getting treatment|0|||
30733971|NCT00312897|58746005|FG001|Overall Study|discontinued prior to getting treatment|3|||
30733972|NCT00312663|58746014|FG000|Immunization Phase|Adverse Event|0|||
30733973|NCT00312663|58746015|FG001|Immunization Phase|Adverse Event|1|||
30733974|NCT00312663|58746016|FG002|Immunization Phase|Adverse Event|0|||
30733975|NCT00294645|58746027|FG000|Overall Study|Death|10|||
30733976|NCT00294645|58746028|FG001|Overall Study|Death|18|||
30733977|NCT00294645|58746027|FG000|Overall Study|Lost to Follow-up|1|||
30733978|NCT00294645|58746028|FG001|Overall Study|Lost to Follow-up|10|||
30733979|NCT00294645|58746027|FG000|Overall Study|Withdrawal by Subject|18|||
30733980|NCT00294645|58746028|FG001|Overall Study|Withdrawal by Subject|34|||
30733981|NCT00294645|58746027|FG000|Overall Study|Physician Decision|15|||
30733982|NCT00294645|58746028|FG001|Overall Study|Physician Decision|20|||
30733983|NCT00294645|58746027|FG000|Overall Study|Other|4|||
30733984|NCT00294645|58746028|FG001|Overall Study|Other|10|||
30733985|NCT00305877|58746036|FG000|Overall Study|Lack of Efficacy|6|||
30733986|NCT00305877|58746037|FG001|Overall Study|Lack of Efficacy|9|||
30733987|NCT00305877|58746036|FG000|Overall Study|Adverse Event|9|||
30733988|NCT00305877|58746037|FG001|Overall Study|Adverse Event|14|||
30733989|NCT00305877|58746036|FG000|Overall Study|Death|0|||
30733990|NCT00305877|58746037|FG001|Overall Study|Death|1|||
30733991|NCT00305877|58746036|FG000|Overall Study|Withdrawal by Subject|4|||
30733992|NCT00305877|58746037|FG001|Overall Study|Withdrawal by Subject|2|||
30733993|NCT00305877|58746036|FG000|Overall Study|Physician Decision|1|||
30733994|NCT00305877|58746037|FG001|Overall Study|Physician Decision|1|||
30733995|NCT00305877|58746036|FG000|Overall Study|Never start treatment|2|||
30733996|NCT00305877|58746037|FG001|Overall Study|Never start treatment|5|||
30733997|NCT00305877|58746036|FG000|Overall Study|Ineligible|2|||
30733998|NCT00305877|58746037|FG001|Overall Study|Ineligible|1|||
30733999|NCT00305877|58746036|FG000|Overall Study|Transportation issue with daily RT|0|||
30734000|NCT00305877|58746037|FG001|Overall Study|Transportation issue with daily RT|1|||
30734001|NCT00312195|58746045|FG000|Overall Study|Adverse Event|4|||
30734002|NCT00312195|58746046|FG001|Overall Study|Adverse Event|6|||
30734003|NCT00312195|58746045|FG000|Overall Study|Lost to Follow-up|1|||
30734004|NCT00312195|58746046|FG001|Overall Study|Lost to Follow-up|0|||
30734005|NCT00312195|58746045|FG000|Overall Study|Protocol Violation|1|||
30734006|NCT00312195|58746046|FG001|Overall Study|Protocol Violation|0|||
30734007|NCT00305253|58746056|FG000|Overall Study|Withdrawal by Subject|0|||
30734008|NCT00305253|58746057|FG001|Overall Study|Withdrawal by Subject|1|||
30790945|NCT03200366|58804015|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
30790946|NCT03200366|58804016|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
30790947|NCT03200366|58804017|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
30790948|NCT00835354|58804029|FG000|First Intervention|Adverse Event|0|||
30790949|NCT00835354|58804030|FG001|First Intervention|Adverse Event|1|||
30734009|NCT00293709|58746063|FG000|Overall Study|Other|47|||
30734010|NCT00311181|58746067|FG000|Overall Study|Final DFTs were not obtained|96|||
30734011|NCT00293397|58746071|FG000|Overall Study|Death|2|||
30734012|NCT00290745|58746076|FG000|Overall Study|Withdrawal by Subject|4|||
30734013|NCT00290745|58746076|FG000|Overall Study|Physician Decision|2|||
30734014|NCT00290745|58746076|FG000|Overall Study|Surgery after 3 months for progression|3|||
30734015|NCT00290745|58746076|FG000|Overall Study|Baseline MRI not available|3|||
30734016|NCT00402168|58746082|FG000|Randomized|Lost to Follow-up|1|||
30734017|NCT00402168|58746083|FG001|Randomized|Lost to Follow-up|0|||
30734018|NCT00402168|58746082|FG000|Randomized|Withdrawal by Subject|0|||
30734019|NCT00402168|58746083|FG001|Randomized|Withdrawal by Subject|1|||
30734020|NCT00402168|58746082|FG000|Treatment (up to 12 Months)|Death|0|||
30734021|NCT00402168|58746083|FG001|Treatment (up to 12 Months)|Death|1|||
30734022|NCT00402168|58746082|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
30734023|NCT00402168|58746083|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
30734024|NCT00402168|58746082|FG000|Treatment (up to 12 Months)|non-specified|0|||
30734025|NCT00402168|58746083|FG001|Treatment (up to 12 Months)|non-specified|1|||
30734026|NCT00402168|58746082|FG000|Long Term (LT)|Adverse Event|1|||
30734027|NCT00402168|58746083|FG001|Long Term (LT)|Adverse Event|5|||
30734028|NCT00402168|58746082|FG000|Long Term (LT)|Withdrawal by Subject|4|||
30734029|NCT00402168|58746083|FG001|Long Term (LT)|Withdrawal by Subject|7|||
30734030|NCT00402168|58746082|FG000|Long Term (LT)|Pregnancy|0|||
30734031|NCT00402168|58746083|FG001|Long Term (LT)|Pregnancy|1|||
30734032|NCT00402168|58746082|FG000|Long Term (LT)|Lost to Follow-up|1|||
30734033|NCT00402168|58746083|FG001|Long Term (LT)|Lost to Follow-up|0|||
30734034|NCT00402168|58746082|FG000|Long Term (LT)|Death|4|||
30734035|NCT00402168|58746083|FG001|Long Term (LT)|Death|0|||
30734036|NCT00402168|58746082|FG000|Long Term (LT)|Lack of Efficacy|0|||
30734037|NCT00402168|58746083|FG001|Long Term (LT)|Lack of Efficacy|2|||
30734038|NCT00402168|58746082|FG000|Long Term (LT)|non-specified|1|||
30734039|NCT00402168|58746083|FG001|Long Term (LT)|non-specified|2|||
30734040|NCT00402168|58746082|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
30734041|NCT00402168|58746083|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
30734042|NCT00402168|58746082|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
30734043|NCT00402168|58746083|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
30734044|NCT00290589|58746099|FG000|Overall Study|Lost to Follow-up|2|||
30734045|NCT00290589|58746100|FG001|Overall Study|Lost to Follow-up|2|||
30734046|NCT00290511|58746106|FG000|Overall Study|Adverse Event|1|||
30734047|NCT00290511|58746106|FG000|Overall Study|Death|1|||
30734048|NCT00290511|58746106|FG000|Overall Study|Physician Decision|1|||
30734049|NCT00290511|58746106|FG000|Overall Study|Withdrawal by Subject|1|||
30734050|NCT00290433|58746110|FG000|Overall Study|Disease Progression|13|||
30734051|NCT00290433|58746110|FG000|Overall Study|Adverse Event|14|||
30734052|NCT00290433|58746110|FG000|Overall Study|Withdrawal by Subject|1|||
30734053|NCT00290433|58746110|FG000|Overall Study|Non-Compliance|1|||
30734054|NCT00290433|58746110|FG000|Overall Study|Congestive Heart Failure|1|||
30734055|NCT00290433|58746110|FG000|Overall Study|Transplant in CR|5|||
30734056|NCT00290433|58746110|FG000|Overall Study|Unrelated Infection/Death|1|||
30734057|NCT00304083|58746116|FG000|Overall Study|Withdrawal by Subject|4|||
30734058|NCT00304083|58746117|FG001|Overall Study|Withdrawal by Subject|2|||
30734059|NCT00304083|58746116|FG000|Overall Study|Physician Decision|8|||
30734060|NCT00304083|58746117|FG001|Overall Study|Physician Decision|3|||
30734061|NCT00304083|58746116|FG000|Overall Study|Disease Progression|5|||
30734062|NCT00304083|58746117|FG001|Overall Study|Disease Progression|1|||
30734063|NCT00304083|58746116|FG000|Overall Study|Other|5|||
30734064|NCT00304083|58746117|FG001|Overall Study|Other|2|||
30734065|NCT00293241|58746125|FG000|Overall Study|Lost to Follow-up|9|||
30734066|NCT00293241|58746126|FG001|Overall Study|Lost to Follow-up|16|||
30734067|NCT00293241|58746125|FG000|Overall Study|Physician Decision|23|||
30734068|NCT00293241|58746126|FG001|Overall Study|Physician Decision|17|||
30734069|NCT00293241|58746125|FG000|Overall Study|Withdrawal by Subject|4|||
30734070|NCT00293241|58746126|FG001|Overall Study|Withdrawal by Subject|8|||
30734071|NCT00391092|58746137|FG000|Overall Study|Death|78|||
30734072|NCT00391092|58746138|FG001|Overall Study|Death|81|||
30734073|NCT00391092|58746137|FG000|Overall Study|Lost to Follow-up|13|||
30734074|NCT00391092|58746138|FG001|Overall Study|Lost to Follow-up|18|||
30734075|NCT00391092|58746137|FG000|Overall Study|Alive on treatment|29|||
30734076|NCT00391092|58746138|FG001|Overall Study|Alive on treatment|33|||
30734077|NCT00391092|58746137|FG000|Overall Study|Alive in follow-up|88|||
30734078|NCT00391092|58746138|FG001|Overall Study|Alive in follow-up|84|||
30734079|NCT00374868|58746144|FG000|Overall Study|Adverse Event|12|||
30734080|NCT00374868|58746144|FG000|Overall Study|Progressive Disease|7|||
30734081|NCT00374868|58746144|FG000|Overall Study|Physician Decision|13|||
30734082|NCT00374868|58746144|FG000|Overall Study|Lost to Follow-up|1|||
30734083|NCT00374868|58746144|FG000|Overall Study|Death|2|||
30734084|NCT00374868|58746144|FG000|Overall Study|Other - Not Specified|1|||
30734085|NCT00374556|58746150|FG000|Overall Study|Lost to Follow-up|1|||
30734086|NCT00374556|58746151|FG001|Overall Study|Lost to Follow-up|0|||
30734087|NCT00374556|58746150|FG000|Overall Study|Removed at baseline due to medical cond|0|||
30734088|NCT00374556|58746151|FG001|Overall Study|Removed at baseline due to medical cond|1|||
30734089|NCT00290355|58746159|FG000|Overall Study|Serious adverse event|7|||
30734090|NCT00290355|58746160|FG001|Overall Study|Serious adverse event|4|||
30734091|NCT00290355|58746159|FG000|Overall Study|Study product reactogenicity|1|||
30734092|NCT00290355|58746160|FG001|Overall Study|Study product reactogenicity|0|||
30734093|NCT00290355|58746159|FG000|Overall Study|Protocol Violation|1|||
30734094|NCT00290355|58746160|FG001|Overall Study|Protocol Violation|0|||
30734095|NCT00290355|58746159|FG000|Overall Study|Withdrawal by Subject|2|||
30734096|NCT00290355|58746160|FG001|Overall Study|Withdrawal by Subject|0|||
30734097|NCT00290355|58746159|FG000|Overall Study|Migrated / moved from the study area|1|||
30734098|NCT00290355|58746160|FG001|Overall Study|Migrated / moved from the study area|0|||
30734099|NCT00290355|58746159|FG000|Overall Study|Lost to Follow-up|3|||
30734100|NCT00290355|58746160|FG001|Overall Study|Lost to Follow-up|1|||
30734101|NCT00290355|58746159|FG000|Overall Study|Other|2|||
30734102|NCT00290355|58746160|FG001|Overall Study|Other|0|||
30734103|NCT00374322|58746168|FG000|Overall Study|Lost to Follow-up|92|||
30734104|NCT00374322|58746169|FG001|Overall Study|Lost to Follow-up|90|||
30734105|NCT00374322|58746168|FG000|Overall Study|Protocol Violation|8|||
30734106|NCT00374322|58746169|FG001|Overall Study|Protocol Violation|3|||
30734107|NCT00374322|58746168|FG000|Overall Study|Withdrawal by Subject|235|||
30734108|NCT00374322|58746169|FG001|Overall Study|Withdrawal by Subject|167|||
30734109|NCT00374322|58746168|FG000|Overall Study|Sponsor Terminated Study|866|||
30734110|NCT00374322|58746169|FG001|Overall Study|Sponsor Terminated Study|990|||
30734111|NCT00374322|58746168|FG000|Overall Study|Physician Decision|36|||
30734112|NCT00374322|58746169|FG001|Overall Study|Physician Decision|32|||
30734113|NCT00374322|58746168|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
30734114|NCT00374322|58746169|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
30734115|NCT00374322|58746168|FG000|Overall Study|Sponsor Decision|2|||
30734116|NCT00374322|58746169|FG001|Overall Study|Sponsor Decision|3|||
30734117|NCT00374322|58746168|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
30734118|NCT00374322|58746169|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
30734119|NCT00374322|58746168|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
30734120|NCT00374322|58746169|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
30734121|NCT00374322|58746168|FG000|Overall Study|Severe Toxicity|1|||
30734122|NCT00374322|58746169|FG001|Overall Study|Severe Toxicity|0|||
30734123|NCT00374322|58746168|FG000|Overall Study|Site Closed|2|||
30734124|NCT00374322|58746169|FG001|Overall Study|Site Closed|2|||
30734125|NCT00374322|58746168|FG000|Overall Study|Participant Changed Physician|1|||
30734126|NCT00374322|58746169|FG001|Overall Study|Participant Changed Physician|0|||
30734127|NCT00374322|58746168|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
30734128|NCT00374322|58746169|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
30734129|NCT00374322|58746168|FG000|Overall Study|Noncompliance with Study Requirements|0|||
30734130|NCT00374322|58746169|FG001|Overall Study|Noncompliance with Study Requirements|1|||
30734131|NCT00374322|58746168|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
30734132|NCT00374322|58746169|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
30734133|NCT00374322|58746168|FG000|Overall Study|Did Not Receive Study Medication|8|||
30734134|NCT00374322|58746169|FG001|Overall Study|Did Not Receive Study Medication|6|||
30734135|NCT00303459|58746178|FG000|Overall Study|Death|33|||
30734136|NCT00303459|58746179|FG001|Overall Study|Death|44|||
30734137|NCT00303459|58746178|FG000|Overall Study|Withdrawal of consent|32|||
30734138|NCT00303459|58746179|FG001|Overall Study|Withdrawal of consent|26|||
30734139|NCT00303459|58746178|FG000|Overall Study|Lost to Follow-up|5|||
30734140|NCT00303459|58746179|FG001|Overall Study|Lost to Follow-up|4|||
30734141|NCT00303459|58746178|FG000|Overall Study|Administrative reason|7|||
30734142|NCT00303459|58746179|FG001|Overall Study|Administrative reason|7|||
30734143|NCT00303459|58746178|FG000|Overall Study|Decision by the investigator|5|||
30734144|NCT00303459|58746179|FG001|Overall Study|Decision by the investigator|7|||
30734145|NCT00303459|58746178|FG000|Overall Study|Lung transplantation|1|||
30734146|NCT00303459|58746179|FG001|Overall Study|Lung transplantation|1|||
30734147|NCT00289887|58746188|FG000|Overall Study|Adverse Event|3|||
30734148|NCT00289887|58746189|FG001|Overall Study|Adverse Event|3|||
30734149|NCT00289887|58746188|FG000|Overall Study|Lack of Efficacy|3|||
30734150|NCT00289887|58746189|FG001|Overall Study|Lack of Efficacy|11|||
30734151|NCT00289887|58746188|FG000|Overall Study|Lost to Follow-up|3|||
30734152|NCT00289887|58746189|FG001|Overall Study|Lost to Follow-up|3|||
30734153|NCT00289887|58746188|FG000|Overall Study|Protocol Violation|3|||
30734154|NCT00289887|58746189|FG001|Overall Study|Protocol Violation|1|||
30734155|NCT00289887|58746188|FG000|Overall Study|Withdrawal by Subject|3|||
30734156|NCT00289887|58746189|FG001|Overall Study|Withdrawal by Subject|8|||
30734157|NCT00289887|58746188|FG000|Overall Study|Other|7|||
30734158|NCT00289887|58746189|FG001|Overall Study|Other|3|||
30734159|NCT00303069|58746199|FG000|Overall Study|Lost to Follow-up|1|||
30734160|NCT00303069|58746200|FG001|Overall Study|Lost to Follow-up|0|||
30734161|NCT00303069|58746201|FG002|Overall Study|Lost to Follow-up|0|||
30734162|NCT00303069|58746202|FG003|Overall Study|Lost to Follow-up|2|||
30734163|NCT00303069|58746199|FG000|Overall Study|subject moved|1|||
30734164|NCT00303069|58746200|FG001|Overall Study|subject moved|0|||
30734165|NCT00303069|58746201|FG002|Overall Study|subject moved|0|||
30734166|NCT00303069|58746202|FG003|Overall Study|subject moved|0|||
30734167|NCT00303069|58746199|FG000|Overall Study|Recruitment into Army Reserves|0|||
30734168|NCT00303069|58746200|FG001|Overall Study|Recruitment into Army Reserves|0|||
30734169|NCT00303069|58746201|FG002|Overall Study|Recruitment into Army Reserves|1|||
30734170|NCT00303069|58746202|FG003|Overall Study|Recruitment into Army Reserves|0|||
30734171|NCT00401544|58746216|FG000|Overall Study|Adverse Event|5|||
30734172|NCT00401544|58746217|FG001|Overall Study|Adverse Event|1|||
30734173|NCT00401544|58746218|FG002|Overall Study|Adverse Event|1|||
30734174|NCT00401544|58746219|FG003|Overall Study|Adverse Event|1|||
30734175|NCT00401544|58746216|FG000|Overall Study|Death|3|||
30734176|NCT00401544|58746217|FG001|Overall Study|Death|6|||
30734177|NCT00401544|58746218|FG002|Overall Study|Death|2|||
30734178|NCT00401544|58746219|FG003|Overall Study|Death|5|||
30734179|NCT00401544|58746216|FG000|Overall Study|Lost to Follow-up|2|||
30734180|NCT00401544|58746217|FG001|Overall Study|Lost to Follow-up|0|||
30734181|NCT00401544|58746218|FG002|Overall Study|Lost to Follow-up|1|||
30734182|NCT00401544|58746219|FG003|Overall Study|Lost to Follow-up|1|||
30734183|NCT00401544|58746216|FG000|Overall Study|Withdrawal by Subject|7|||
30734184|NCT00401544|58746217|FG001|Overall Study|Withdrawal by Subject|6|||
30734185|NCT00401544|58746218|FG002|Overall Study|Withdrawal by Subject|6|||
30734186|NCT00401544|58746219|FG003|Overall Study|Withdrawal by Subject|5|||
30734187|NCT00401544|58746216|FG000|Overall Study|Physician Decision|1|||
30734188|NCT00401544|58746217|FG001|Overall Study|Physician Decision|3|||
30734189|NCT00401544|58746218|FG002|Overall Study|Physician Decision|0|||
30734190|NCT00401544|58746219|FG003|Overall Study|Physician Decision|0|||
30734191|NCT00401544|58746216|FG000|Overall Study|Ineligibility determined|0|||
30734192|NCT00401544|58746217|FG001|Overall Study|Ineligibility determined|1|||
30734193|NCT00401544|58746218|FG002|Overall Study|Ineligibility determined|0|||
30734194|NCT00401544|58746219|FG003|Overall Study|Ineligibility determined|2|||
30734195|NCT00401544|58746216|FG000|Overall Study|Disease progression|0|||
30734196|NCT00401544|58746217|FG001|Overall Study|Disease progression|1|||
30734197|NCT00401544|58746218|FG002|Overall Study|Disease progression|0|||
30734198|NCT00401544|58746219|FG003|Overall Study|Disease progression|0|||
30734199|NCT00401544|58746216|FG000|Overall Study|Other|0|||
30734200|NCT00401544|58746217|FG001|Overall Study|Other|0|||
30734201|NCT00401544|58746218|FG002|Overall Study|Other|2|||
30734202|NCT00401544|58746219|FG003|Overall Study|Other|2|||
30734203|NCT00289731|58746237|FG000|Overall Study|Adverse Event|1|||
30734204|NCT00289731|58746238|FG001|Overall Study|Adverse Event|2|||
30734205|NCT00289731|58746239|FG002|Overall Study|Adverse Event|2|||
30734206|NCT00289731|58746237|FG000|Overall Study|Other|1|||
30734207|NCT00289731|58746238|FG001|Overall Study|Other|0|||
30734208|NCT00289731|58746239|FG002|Overall Study|Other|0|||
30734209|NCT00289185|58746251|FG000|Overall Study|Withdrawal by Subject|4|||
30734210|NCT00289185|58746252|FG001|Overall Study|Withdrawal by Subject|8|||
30734211|NCT00289185|58746251|FG000|Overall Study|Lost to Follow-up|23|||
30734212|NCT00289185|58746252|FG001|Overall Study|Lost to Follow-up|17|||
30734213|NCT00289185|58746251|FG000|Overall Study|Death|1|||
30734214|NCT00289185|58746252|FG001|Overall Study|Death|1|||
30734215|NCT00292461|58746261|FG000|Overall Study|Adverse Event|4|||
30734216|NCT00292461|58746262|FG001|Overall Study|Adverse Event|2|||
30734217|NCT00292461|58746261|FG000|Overall Study|Lack of Efficacy|1|||
30734218|NCT00292461|58746262|FG001|Overall Study|Lack of Efficacy|0|||
30734219|NCT00292461|58746261|FG000|Overall Study|Withdrawal by Subject|0|||
30734220|NCT00292461|58746262|FG001|Overall Study|Withdrawal by Subject|1|||
30734221|NCT00292461|58746261|FG000|Overall Study|Protocol Violation|4|||
30734222|NCT00292461|58746262|FG001|Overall Study|Protocol Violation|3|||
30734223|NCT00292461|58746261|FG000|Overall Study|Lost to Follow-up|1|||
30734224|NCT00292461|58746262|FG001|Overall Study|Lost to Follow-up|0|||
30734225|NCT00288639|58746268|FG000|Overall Study|Adverse Event|5|||
30734226|NCT00288639|58746268|FG000|Overall Study|Lack of Efficacy|4|||
30734227|NCT00288639|58746268|FG000|Overall Study|Withdrawal by Subject|2|||
30734228|NCT00288639|58746268|FG000|Overall Study|Other|1|||
30734229|NCT00390858|58746274|FG000|Overall Study|Adverse Event|6|||
30734230|NCT00390858|58746275|FG001|Overall Study|Adverse Event|2|||
30734231|NCT00390858|58746274|FG000|Overall Study|Lack of Efficacy|0|||
30734232|NCT00390858|58746275|FG001|Overall Study|Lack of Efficacy|1|||
30734233|NCT00390858|58746274|FG000|Overall Study|Withdrawal by Subject|3|||
30734234|NCT00390858|58746275|FG001|Overall Study|Withdrawal by Subject|4|||
30734235|NCT00390780|58746283|FG000|Overall Study|Not completed|10|||
30734236|NCT00390780|58746284|FG001|Overall Study|Not completed|4|||
30734237|NCT00390780|58746283|FG000|Overall Study|Protocol Violation|6|||
30734238|NCT00390780|58746284|FG001|Overall Study|Protocol Violation|4|||
30734239|NCT00390780|58746283|FG000|Overall Study|Lost to Follow-up|3|||
30734240|NCT00390780|58746284|FG001|Overall Study|Lost to Follow-up|6|||
30734241|NCT00390780|58746283|FG000|Overall Study|Adverse Event|2|||
30734242|NCT00390780|58746284|FG001|Overall Study|Adverse Event|3|||
30734243|NCT00390780|58746283|FG000|Overall Study|Death|1|||
30734244|NCT00390780|58746284|FG001|Overall Study|Death|3|||
30734245|NCT00390780|58746283|FG000|Overall Study|Withdrawal by Subject|1|||
30734246|NCT00390780|58746284|FG001|Overall Study|Withdrawal by Subject|2|||
30734247|NCT00390780|58746283|FG000|Overall Study|Inclusion criteria not satisfied|0|||
30734248|NCT00390780|58746284|FG001|Overall Study|Inclusion criteria not satisfied|2|||
30734249|NCT00390780|58746283|FG000|Overall Study|Lost to follow up and other reasons|0|||
30734250|NCT00390780|58746284|FG001|Overall Study|Lost to follow up and other reasons|1|||
30734251|NCT00390780|58746283|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
30734252|NCT00390780|58746284|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
30734253|NCT00390780|58746283|FG000|Overall Study|SAE, death|0|||
30734254|NCT00390780|58746284|FG001|Overall Study|SAE, death|1|||
30734255|NCT00390546|58746292|FG000|Overall Study|Renal impairment|1|||
30734256|NCT00390546|58746293|FG001|Overall Study|Renal impairment|0|||
30734257|NCT00390546|58746292|FG000|Overall Study|Physician Decision|5|||
30734258|NCT00390546|58746293|FG001|Overall Study|Physician Decision|5|||
30734259|NCT00390468|58746300|FG000|Overall Study|Protocol Violation|2|||
30734260|NCT00390468|58746300|FG000|Overall Study|Lack of Efficacy|1|||
30734261|NCT00400764|58746309|FG000|Phase Ib|Adverse Event|1|||
30734262|NCT00400764|58746310|FG001|Phase Ib|Adverse Event|0|||
30734263|NCT00400764|58746311|FG002|Phase Ib|Adverse Event|0|||
30734264|NCT00400764|58746312|FG003|Phase Ib|Adverse Event|0|||
30734265|NCT00400764|58746313|FG004|Phase Ib|Adverse Event|0|||
30734266|NCT00400764|58746309|FG000|Phase Ib|Death|1|||
30734267|NCT00400764|58746310|FG001|Phase Ib|Death|0|||
30734268|NCT00400764|58746311|FG002|Phase Ib|Death|0|||
30734269|NCT00400764|58746312|FG003|Phase Ib|Death|0|||
30734270|NCT00400764|58746313|FG004|Phase Ib|Death|0|||
30734271|NCT00400764|58746309|FG000|Phase Ib|Disease Progression|4|||
30734272|NCT00400764|58746310|FG001|Phase Ib|Disease Progression|4|||
30734273|NCT00400764|58746311|FG002|Phase Ib|Disease Progression|0|||
30734274|NCT00400764|58746312|FG003|Phase Ib|Disease Progression|0|||
30734275|NCT00400764|58746313|FG004|Phase Ib|Disease Progression|0|||
30734276|NCT00400764|58746309|FG000|Phase II|Death|0|||
30734277|NCT00400764|58746310|FG001|Phase II|Death|0|||
30734278|NCT00400764|58746311|FG002|Phase II|Death|1|||
30734279|NCT00400764|58746312|FG003|Phase II|Death|2|||
30734280|NCT00400764|58746313|FG004|Phase II|Death|0|||
30734281|NCT00400764|58746309|FG000|Phase II|Lost to Follow-up|0|||
30734282|NCT00400764|58746310|FG001|Phase II|Lost to Follow-up|0|||
30734283|NCT00400764|58746311|FG002|Phase II|Lost to Follow-up|1|||
30734284|NCT00400764|58746312|FG003|Phase II|Lost to Follow-up|0|||
30734285|NCT00400764|58746313|FG004|Phase II|Lost to Follow-up|0|||
30734286|NCT00400764|58746309|FG000|Phase II|Physician Decision|0|||
30734287|NCT00400764|58746310|FG001|Phase II|Physician Decision|0|||
30734288|NCT00400764|58746311|FG002|Phase II|Physician Decision|1|||
30734289|NCT00400764|58746312|FG003|Phase II|Physician Decision|1|||
30734290|NCT00400764|58746313|FG004|Phase II|Physician Decision|0|||
30734291|NCT00400764|58746309|FG000|Phase II|Sponsor's decision to terminate|0|||
30734292|NCT00400764|58746310|FG001|Phase II|Sponsor's decision to terminate|0|||
30734293|NCT00400764|58746311|FG002|Phase II|Sponsor's decision to terminate|18|||
30734294|NCT00400764|58746312|FG003|Phase II|Sponsor's decision to terminate|22|||
30734295|NCT00400764|58746313|FG004|Phase II|Sponsor's decision to terminate|11|||
30734296|NCT00400764|58746309|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
30734297|NCT00400764|58746310|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
30734298|NCT00400764|58746311|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
30734299|NCT00400764|58746312|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
30734300|NCT00400764|58746313|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
30734301|NCT00400764|58746309|FG000|Phase II|Withdrawal by Subject|0|||
30734302|NCT00400764|58746310|FG001|Phase II|Withdrawal by Subject|0|||
30734303|NCT00400764|58746311|FG002|Phase II|Withdrawal by Subject|1|||
30734304|NCT00400764|58746312|FG003|Phase II|Withdrawal by Subject|1|||
30734305|NCT00400764|58746313|FG004|Phase II|Withdrawal by Subject|0|||
30621840|NCT00977379|58633380|FG000|Overall Study|Death|7|||
30734306|NCT00302211|58746333|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
30734307|NCT00302211|58746334|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
30734308|NCT00302211|58746335|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
30734309|NCT00302211|58746336|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
30734310|NCT00302211|58746337|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
30734311|NCT00302211|58746333|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
30734312|NCT00302211|58746334|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
30734313|NCT00302211|58746335|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
30734314|NCT00302211|58746336|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
30734315|NCT00302211|58746337|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
30734316|NCT00302211|58746333|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
30734317|NCT00302211|58746334|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
30734318|NCT00302211|58746335|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
30734319|NCT00302211|58746336|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
30734320|NCT00302211|58746337|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
30734321|NCT00302211|58746333|FG000|Double Blind Period (New Patients)|Disease progression|0|||
30734322|NCT00302211|58746334|FG001|Double Blind Period (New Patients)|Disease progression|1|||
30734323|NCT00302211|58746335|FG002|Double Blind Period (New Patients)|Disease progression|1|||
30734324|NCT00302211|58746336|FG003|Double Blind Period (New Patients)|Disease progression|0|||
30734325|NCT00302211|58746337|FG004|Double Blind Period (New Patients)|Disease progression|0|||
30734326|NCT00302211|58746333|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
30734327|NCT00302211|58746334|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
30734328|NCT00302211|58746335|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
30734329|NCT00302211|58746336|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
30734330|NCT00302211|58746337|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
30734331|NCT00302211|58746333|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
30734332|NCT00302211|58746334|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
30734333|NCT00302211|58746335|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
30734334|NCT00302211|58746336|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
30734335|NCT00302211|58746337|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
30734336|NCT00302211|58746333|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
30734337|NCT00302211|58746334|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
30734338|NCT00302211|58746335|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
30734339|NCT00302211|58746336|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
30734340|NCT00302211|58746337|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
30734341|NCT00302211|58746333|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
30621841|NCT00977379|58633381|FG001|Overall Study|Death|9|||
30621842|NCT00977379|58633380|FG000|Overall Study|Premature Study Termination|4|||
30734342|NCT00302211|58746334|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
30734343|NCT00302211|58746335|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
30734344|NCT00302211|58746336|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
30734345|NCT00302211|58746337|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
30734346|NCT00302211|58746333|FG000|Open Label-Patients From Double-Blind|Death|0|||
30734347|NCT00302211|58746334|FG001|Open Label-Patients From Double-Blind|Death|0|||
30734348|NCT00302211|58746335|FG002|Open Label-Patients From Double-Blind|Death|0|||
30734349|NCT00302211|58746336|FG003|Open Label-Patients From Double-Blind|Death|1|||
30734350|NCT00302211|58746337|FG004|Open Label-Patients From Double-Blind|Death|1|||
30734351|NCT00302211|58746333|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
30734352|NCT00302211|58746334|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
30734353|NCT00302211|58746335|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
30734354|NCT00302211|58746336|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
30734355|NCT00302211|58746337|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
30734356|NCT00302211|58746333|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
30734357|NCT00302211|58746334|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
30734358|NCT00302211|58746335|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
30734359|NCT00302211|58746336|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
30734360|NCT00302211|58746337|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
30734361|NCT00302211|58746333|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
30734362|NCT00302211|58746334|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
30734363|NCT00302211|58746335|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
30734364|NCT00302211|58746336|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
30734365|NCT00302211|58746337|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
30734366|NCT00288015|58746349|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
30734367|NCT00288015|58746349|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
30734368|NCT00288015|58746349|FG000|First Response Assessment|Withdrawal by Subject|1|||
30734369|NCT00288015|58746349|FG000|First Response Assessment|Death|1|||
30734370|NCT00288015|58746349|FG000|First Response Assessment|Physician Decision|2|||
30734371|NCT00288015|58746349|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
30734372|NCT00288015|58746349|FG000|Follow up for Survival x 2 Years|Death|13|||
30734373|NCT00288015|58746349|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
30734374|NCT00288015|58746349|FG000|Follow up for Survival x 2 Years|Other|9|||
30734375|NCT00389064|58746355|FG000|Overall Study|Adverse Event|11|||
30734376|NCT00389064|58746356|FG001|Overall Study|Adverse Event|3|||
30734377|NCT00389064|58746355|FG000|Overall Study|Lack of Efficacy|3|||
30734378|NCT00389064|58746356|FG001|Overall Study|Lack of Efficacy|14|||
30734379|NCT00389064|58746355|FG000|Overall Study|Withdrawal by Subject|17|||
30734380|NCT00389064|58746356|FG001|Overall Study|Withdrawal by Subject|27|||
30734381|NCT00389064|58746355|FG000|Overall Study|Physician Decision|2|||
30734382|NCT00389064|58746356|FG001|Overall Study|Physician Decision|2|||
30734383|NCT00389064|58746355|FG000|Overall Study|Lost to Follow-up|1|||
30734384|NCT00389064|58746356|FG001|Overall Study|Lost to Follow-up|2|||
30734385|NCT00389064|58746355|FG000|Overall Study|Protocol Violation|2|||
30734386|NCT00389064|58746356|FG001|Overall Study|Protocol Violation|0|||
30734387|NCT00389064|58746355|FG000|Overall Study|Multiple Reasons|9|||
30734388|NCT00389064|58746356|FG001|Overall Study|Multiple Reasons|11|||
30734389|NCT00388674|58746364|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
30734390|NCT00388674|58746365|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
30734391|NCT00388674|58746364|FG000|Initial Treatment|Adverse Event|22|||
30734392|NCT00388674|58746365|FG001|Initial Treatment|Adverse Event|87|||
30734393|NCT00388674|58746364|FG000|Initial Treatment|Death|215|||
30734394|NCT00388674|58746365|FG001|Initial Treatment|Death|216|||
30734395|NCT00388674|58746364|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
30734396|NCT00388674|58746365|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
30734397|NCT00388674|58746364|FG000|Initial Treatment|HCC|12|||
30734398|NCT00388674|58746365|FG001|Initial Treatment|HCC|20|||
30734399|NCT00388674|58746364|FG000|Initial Treatment|Lost to Follow-up|526|||
30734400|NCT00388674|58746365|FG001|Initial Treatment|Lost to Follow-up|624|||
30734401|NCT00388674|58746364|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
30734402|NCT00388674|58746365|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
30790950|NCT00835042|58804061|FG000|First Intervention|Withdrawal by Subject|3|||
30734403|NCT00388674|58746364|FG000|Initial Treatment|Never Treated with Study Medication|1|||
30734404|NCT00388674|58746365|FG001|Initial Treatment|Never Treated with Study Medication|7|||
30734405|NCT00388674|58746364|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
30734406|NCT00388674|58746365|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
30734407|NCT00388674|58746364|FG000|Initial Treatment|Not Defined|125|||
30734408|NCT00388674|58746365|FG001|Initial Treatment|Not Defined|172|||
30734409|NCT00388674|58746364|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
30734410|NCT00388674|58746365|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
30734411|NCT00388674|58746364|FG000|Initial Treatment|Pregnancy|26|||
30734412|NCT00388674|58746365|FG001|Initial Treatment|Pregnancy|16|||
30734413|NCT00388674|58746364|FG000|Initial Treatment|Study Drug Toxicity|5|||
30734414|NCT00388674|58746365|FG001|Initial Treatment|Study Drug Toxicity|92|||
30734415|NCT00388674|58746364|FG000|Initial Treatment|Participant Request|501|||
30734416|NCT00388674|58746365|FG001|Initial Treatment|Participant Request|673|||
30734417|NCT00388674|58746364|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
30734418|NCT00388674|58746365|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
30734419|NCT00388674|58746364|FG000|Initial Treatment|Not Reported|10|||
30734420|NCT00388674|58746365|FG001|Initial Treatment|Not Reported|12|||
30734421|NCT00388674|58746364|FG000|End of Study|Administrative Reason By Sponsor|299|||
30734422|NCT00388674|58746365|FG001|End of Study|Administrative Reason By Sponsor|253|||
30734423|NCT00388674|58746364|FG000|End of Study|Death|239|||
30734424|NCT00388674|58746365|FG001|End of Study|Death|262|||
30734425|NCT00388674|58746364|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
30734426|NCT00388674|58746365|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
30734427|NCT00388674|58746364|FG000|End of Study|HCC|8|||
30734428|NCT00388674|58746365|FG001|End of Study|HCC|7|||
30734429|NCT00388674|58746364|FG000|End of Study|Lost to Follow-up|587|||
30734430|NCT00388674|58746365|FG001|End of Study|Lost to Follow-up|715|||
30734431|NCT00388674|58746364|FG000|End of Study|Malignancy (Non-HCC)|1|||
30734432|NCT00388674|58746365|FG001|End of Study|Malignancy (Non-HCC)|1|||
30734433|NCT00388674|58746364|FG000|End of Study|Non-Study Related Comorbidities|3|||
30734434|NCT00388674|58746365|FG001|End of Study|Non-Study Related Comorbidities|4|||
30734435|NCT00388674|58746364|FG000|End of Study|Not Defined|135|||
30734436|NCT00388674|58746365|FG001|End of Study|Not Defined|214|||
30734437|NCT00388674|58746364|FG000|End of Study|Participant Withdrew Consent|437|||
30734438|NCT00388674|58746365|FG001|End of Study|Participant Withdrew Consent|673|||
30734439|NCT00388674|58746364|FG000|End of Study|No Off-Treatment Status Data|22|||
30734440|NCT00388674|58746365|FG001|End of Study|No Off-Treatment Status Data|30|||
30734441|NCT00388674|58746364|FG000|End of Study|Not Reported|0|||
30734442|NCT00388674|58746365|FG001|End of Study|Not Reported|1|||
30734443|NCT00388362|58746371|FG000|Enrolled|Ineligible|1|||
30734444|NCT00388362|58746371|FG000|Enrolled|Adverse Event|9|||
30734445|NCT00388362|58746371|FG000|Enrolled|Death|1|||
30734446|NCT00388362|58746371|FG000|Enrolled|Loss insurance|1|||
30734447|NCT00388362|58746371|FG000|Enrolled|Withdrawal by Subject|1|||
30734448|NCT00388362|58746371|FG000|Remained on Study Median of 514 Days|Death|2|||
30734449|NCT00387894|58746375|FG000|Overall Study|Withdrawal by Subject|1|||
30734450|NCT00387426|58746379|FG000|Overall Study|Lack of Response|7|||
30734451|NCT00387426|58746379|FG000|Overall Study|Toxicities|4|||
30734452|NCT00387426|58746379|FG000|Overall Study|Disease Progression|3|||
30734453|NCT00387348|58746386|FG000|Overall Study|Death|1|||
30734454|NCT00387348|58746387|FG001|Overall Study|Death|1|||
30734455|NCT00387348|58746388|FG002|Overall Study|Death|0|||
30734456|NCT00387348|58746386|FG000|Overall Study|Physician Decision|1|||
30734457|NCT00387348|58746387|FG001|Overall Study|Physician Decision|0|||
30734458|NCT00387348|58746388|FG002|Overall Study|Physician Decision|1|||
30734459|NCT00387348|58746386|FG000|Overall Study|Withdrawal by Subject|0|||
30734460|NCT00387348|58746387|FG001|Overall Study|Withdrawal by Subject|2|||
30734461|NCT00387348|58746388|FG002|Overall Study|Withdrawal by Subject|2|||
30734462|NCT00387348|58746386|FG000|Overall Study|Adverse Event|1|||
30734463|NCT00387348|58746387|FG001|Overall Study|Adverse Event|0|||
30734464|NCT00387348|58746388|FG002|Overall Study|Adverse Event|1|||
30734465|NCT00413660|58746408|FG000|Up To Week 12|Adverse Event|1|||
30734466|NCT00413660|58746409|FG001|Up To Week 12|Adverse Event|3|||
30734467|NCT00413660|58746410|FG002|Up To Week 12|Adverse Event|1|||
30734468|NCT00413660|58746411|FG003|Up To Week 12|Adverse Event|4|||
30734469|NCT00413660|58746412|FG004|Up To Week 12|Adverse Event|6|||
30734470|NCT00413660|58746413|FG005|Up To Week 12|Adverse Event|4|||
30734471|NCT00413660|58746414|FG006|Up To Week 12|Adverse Event|1|||
30734472|NCT00413660|58746415|FG007|Up To Week 12|Adverse Event|0|||
30734473|NCT00413660|58746416|FG008|Up To Week 12|Adverse Event|0|||
30734474|NCT00413660|58746417|FG009|Up To Week 12|Adverse Event|0|||
30734475|NCT00413660|58746418|FG010|Up To Week 12|Adverse Event|0|||
30734476|NCT00413660|58746408|FG000|Up To Week 12|Lack of Efficacy|2|||
30734477|NCT00413660|58746409|FG001|Up To Week 12|Lack of Efficacy|0|||
30734478|NCT00413660|58746410|FG002|Up To Week 12|Lack of Efficacy|0|||
30734479|NCT00413660|58746411|FG003|Up To Week 12|Lack of Efficacy|0|||
30734480|NCT00413660|58746412|FG004|Up To Week 12|Lack of Efficacy|0|||
30734481|NCT00413660|58746413|FG005|Up To Week 12|Lack of Efficacy|0|||
30734482|NCT00413660|58746414|FG006|Up To Week 12|Lack of Efficacy|5|||
30734483|NCT00413660|58746415|FG007|Up To Week 12|Lack of Efficacy|0|||
30734484|NCT00413660|58746416|FG008|Up To Week 12|Lack of Efficacy|0|||
30734485|NCT00413660|58746417|FG009|Up To Week 12|Lack of Efficacy|0|||
30734486|NCT00413660|58746418|FG010|Up To Week 12|Lack of Efficacy|0|||
30734487|NCT00413660|58746408|FG000|Up To Week 12|Lost to Follow-up|0|||
30734488|NCT00413660|58746409|FG001|Up To Week 12|Lost to Follow-up|1|||
30734489|NCT00413660|58746410|FG002|Up To Week 12|Lost to Follow-up|0|||
30734490|NCT00413660|58746411|FG003|Up To Week 12|Lost to Follow-up|0|||
30734491|NCT00413660|58746412|FG004|Up To Week 12|Lost to Follow-up|1|||
30734492|NCT00413660|58746413|FG005|Up To Week 12|Lost to Follow-up|0|||
30734493|NCT00413660|58746414|FG006|Up To Week 12|Lost to Follow-up|0|||
30734494|NCT00413660|58746415|FG007|Up To Week 12|Lost to Follow-up|0|||
30734495|NCT00413660|58746416|FG008|Up To Week 12|Lost to Follow-up|0|||
30734496|NCT00413660|58746417|FG009|Up To Week 12|Lost to Follow-up|0|||
30734497|NCT00413660|58746418|FG010|Up To Week 12|Lost to Follow-up|0|||
30790951|NCT00835042|58804062|FG001|First Intervention|Withdrawal by Subject|0|||
30734498|NCT00413660|58746408|FG000|Up To Week 12|Withdrawal by Subject|0|||
30734499|NCT00413660|58746409|FG001|Up To Week 12|Withdrawal by Subject|2|||
30734500|NCT00413660|58746410|FG002|Up To Week 12|Withdrawal by Subject|0|||
30734501|NCT00413660|58746411|FG003|Up To Week 12|Withdrawal by Subject|2|||
30734502|NCT00413660|58746412|FG004|Up To Week 12|Withdrawal by Subject|0|||
30734503|NCT00413660|58746413|FG005|Up To Week 12|Withdrawal by Subject|2|||
30734504|NCT00413660|58746414|FG006|Up To Week 12|Withdrawal by Subject|2|||
30734505|NCT00413660|58746415|FG007|Up To Week 12|Withdrawal by Subject|0|||
30734506|NCT00413660|58746416|FG008|Up To Week 12|Withdrawal by Subject|0|||
30734507|NCT00413660|58746417|FG009|Up To Week 12|Withdrawal by Subject|0|||
30734508|NCT00413660|58746418|FG010|Up To Week 12|Withdrawal by Subject|0|||
30734509|NCT00413660|58746408|FG000|Up To Week 12|Randomized, Not Treated|1|||
30734510|NCT00413660|58746409|FG001|Up To Week 12|Randomized, Not Treated|0|||
30734511|NCT00413660|58746410|FG002|Up To Week 12|Randomized, Not Treated|0|||
30734512|NCT00413660|58746411|FG003|Up To Week 12|Randomized, Not Treated|1|||
30734513|NCT00413660|58746412|FG004|Up To Week 12|Randomized, Not Treated|0|||
30734514|NCT00413660|58746413|FG005|Up To Week 12|Randomized, Not Treated|0|||
30734515|NCT00413660|58746414|FG006|Up To Week 12|Randomized, Not Treated|0|||
30734516|NCT00413660|58746415|FG007|Up To Week 12|Randomized, Not Treated|0|||
30734517|NCT00413660|58746416|FG008|Up To Week 12|Randomized, Not Treated|0|||
30734518|NCT00413660|58746417|FG009|Up To Week 12|Randomized, Not Treated|0|||
30734519|NCT00413660|58746418|FG010|Up To Week 12|Randomized, Not Treated|0|||
30734520|NCT00413660|58746408|FG000|Up To Week 12|Other|3|||
30734521|NCT00413660|58746409|FG001|Up To Week 12|Other|1|||
30734522|NCT00413660|58746410|FG002|Up To Week 12|Other|6|||
30734523|NCT00413660|58746411|FG003|Up To Week 12|Other|1|||
30734524|NCT00413660|58746412|FG004|Up To Week 12|Other|2|||
30734525|NCT00413660|58746413|FG005|Up To Week 12|Other|4|||
30734526|NCT00413660|58746414|FG006|Up To Week 12|Other|3|||
30734527|NCT00413660|58746415|FG007|Up To Week 12|Other|0|||
30734528|NCT00413660|58746416|FG008|Up To Week 12|Other|0|||
30734529|NCT00413660|58746417|FG009|Up To Week 12|Other|0|||
30734530|NCT00413660|58746418|FG010|Up To Week 12|Other|0|||
30734531|NCT00413660|58746408|FG000|Post Week 12|Adverse Event|2|||
30734532|NCT00413660|58746409|FG001|Post Week 12|Adverse Event|0|||
30734533|NCT00413660|58746410|FG002|Post Week 12|Adverse Event|2|||
30734534|NCT00413660|58746411|FG003|Post Week 12|Adverse Event|1|||
30734535|NCT00413660|58746412|FG004|Post Week 12|Adverse Event|4|||
30734536|NCT00413660|58746413|FG005|Post Week 12|Adverse Event|2|||
30734537|NCT00413660|58746414|FG006|Post Week 12|Adverse Event|2|||
30734538|NCT00413660|58746415|FG007|Post Week 12|Adverse Event|0|||
30734539|NCT00413660|58746416|FG008|Post Week 12|Adverse Event|0|||
30734540|NCT00413660|58746417|FG009|Post Week 12|Adverse Event|0|||
30734541|NCT00413660|58746418|FG010|Post Week 12|Adverse Event|0|||
30734542|NCT00413660|58746408|FG000|Post Week 12|Lack of Efficacy|0|||
30734543|NCT00413660|58746409|FG001|Post Week 12|Lack of Efficacy|0|||
30734544|NCT00413660|58746410|FG002|Post Week 12|Lack of Efficacy|1|||
30734545|NCT00413660|58746411|FG003|Post Week 12|Lack of Efficacy|0|||
30734546|NCT00413660|58746412|FG004|Post Week 12|Lack of Efficacy|0|||
30734547|NCT00413660|58746413|FG005|Post Week 12|Lack of Efficacy|0|||
30734548|NCT00413660|58746414|FG006|Post Week 12|Lack of Efficacy|0|||
30734549|NCT00413660|58746415|FG007|Post Week 12|Lack of Efficacy|0|||
30734550|NCT00413660|58746416|FG008|Post Week 12|Lack of Efficacy|0|||
30734551|NCT00413660|58746417|FG009|Post Week 12|Lack of Efficacy|1|||
30734552|NCT00413660|58746418|FG010|Post Week 12|Lack of Efficacy|0|||
30734553|NCT00413660|58746408|FG000|Post Week 12|Lost to Follow-up|0|||
30734554|NCT00413660|58746409|FG001|Post Week 12|Lost to Follow-up|1|||
30734555|NCT00413660|58746410|FG002|Post Week 12|Lost to Follow-up|1|||
30734556|NCT00413660|58746411|FG003|Post Week 12|Lost to Follow-up|0|||
30734557|NCT00413660|58746412|FG004|Post Week 12|Lost to Follow-up|0|||
30734558|NCT00413660|58746413|FG005|Post Week 12|Lost to Follow-up|0|||
30734559|NCT00413660|58746414|FG006|Post Week 12|Lost to Follow-up|0|||
30734560|NCT00413660|58746415|FG007|Post Week 12|Lost to Follow-up|0|||
30734561|NCT00413660|58746416|FG008|Post Week 12|Lost to Follow-up|0|||
30734562|NCT00413660|58746417|FG009|Post Week 12|Lost to Follow-up|0|||
30734563|NCT00413660|58746418|FG010|Post Week 12|Lost to Follow-up|0|||
30734564|NCT00413660|58746408|FG000|Post Week 12|Withdrawal by Subject|0|||
30734565|NCT00413660|58746409|FG001|Post Week 12|Withdrawal by Subject|1|||
30734566|NCT00413660|58746410|FG002|Post Week 12|Withdrawal by Subject|1|||
30734567|NCT00413660|58746411|FG003|Post Week 12|Withdrawal by Subject|0|||
30734568|NCT00413660|58746412|FG004|Post Week 12|Withdrawal by Subject|1|||
30734569|NCT00413660|58746413|FG005|Post Week 12|Withdrawal by Subject|0|||
30734570|NCT00413660|58746414|FG006|Post Week 12|Withdrawal by Subject|0|||
30734571|NCT00413660|58746415|FG007|Post Week 12|Withdrawal by Subject|0|||
30734572|NCT00413660|58746416|FG008|Post Week 12|Withdrawal by Subject|0|||
30734573|NCT00413660|58746417|FG009|Post Week 12|Withdrawal by Subject|0|||
30734574|NCT00413660|58746418|FG010|Post Week 12|Withdrawal by Subject|1|||
30734575|NCT00413660|58746408|FG000|Post Week 12|Other|1|||
30734576|NCT00413660|58746409|FG001|Post Week 12|Other|2|||
30734577|NCT00413660|58746410|FG002|Post Week 12|Other|3|||
30734578|NCT00413660|58746411|FG003|Post Week 12|Other|0|||
30734579|NCT00413660|58746412|FG004|Post Week 12|Other|1|||
30734580|NCT00413660|58746413|FG005|Post Week 12|Other|1|||
30734581|NCT00413660|58746414|FG006|Post Week 12|Other|1|||
30734582|NCT00413660|58746415|FG007|Post Week 12|Other|0|||
30734583|NCT00413660|58746416|FG008|Post Week 12|Other|0|||
30734584|NCT00413660|58746417|FG009|Post Week 12|Other|0|||
30734585|NCT00413660|58746418|FG010|Post Week 12|Other|0|||
30734586|NCT00431834|58746452|FG000|Overall Study|Withdrawal by Subject|7|||
30734587|NCT00431834|58746452|FG000|Overall Study|Death|3|||
30734588|NCT00431834|58746452|FG000|Overall Study|Missed Endpoint Visit|2|||
30734589|NCT00431834|58746452|FG000|Overall Study|Lost to Follow-up|1|||
30734590|NCT00431444|58746461|FG000|Overall Study|Protocol Violation|1|||
30734591|NCT00431444|58746462|FG001|Overall Study|Protocol Violation|4|||
30734592|NCT00431444|58746461|FG000|Overall Study|Adverse Event|2|||
30734593|NCT00431444|58746462|FG001|Overall Study|Adverse Event|1|||
30734594|NCT00431444|58746461|FG000|Overall Study|Withdrawal by Subject|1|||
30734595|NCT00431444|58746462|FG001|Overall Study|Withdrawal by Subject|1|||
30734596|NCT00431444|58746461|FG000|Overall Study|Lost to Follow-up|1|||
30734597|NCT00431444|58746462|FG001|Overall Study|Lost to Follow-up|0|||
30734598|NCT00431444|58746461|FG000|Overall Study|Administrative Problems|0|||
30734599|NCT00431444|58746462|FG001|Overall Study|Administrative Problems|1|||
30734600|NCT00430352|58746468|FG000|Overall Study|Disease progression|58|||
30734601|NCT00430352|58746468|FG000|Overall Study|Withdrawal by Subject|11|||
30734602|NCT00430352|58746468|FG000|Overall Study|Adverse Event|16|||
30734603|NCT00430352|58746468|FG000|Overall Study|Death|5|||
30734604|NCT00430352|58746468|FG000|Overall Study|Other|48|||
30734605|NCT00287469|58746474|FG000|Overall Study|serious adverse event|1|||
30734606|NCT00287469|58746475|FG001|Overall Study|serious adverse event|6|||
30734607|NCT00287469|58746474|FG000|Overall Study|Adverse Event|1|||
30734608|NCT00287469|58746475|FG001|Overall Study|Adverse Event|1|||
30734609|NCT00287469|58746474|FG000|Overall Study|moved from area|144|||
30734610|NCT00287469|58746475|FG001|Overall Study|moved from area|138|||
30734611|NCT00287469|58746474|FG000|Overall Study|Lost to Follow-up|74|||
30734612|NCT00287469|58746475|FG001|Overall Study|Lost to Follow-up|69|||
30734613|NCT00429572|58746483|FG000|Overall Study|Disease progression|1|||
30734614|NCT00287079|58746489|FG000|Overall Study|Qualifying relapse|12|||
30734615|NCT00287079|58746490|FG001|Overall Study|Qualifying relapse|1|||
30734616|NCT00287079|58746489|FG000|Overall Study|Non-qualifying relapse|1|||
30734617|NCT00287079|58746490|FG001|Overall Study|Non-qualifying relapse|0|||
30734618|NCT00287079|58746489|FG000|Overall Study|Adverse Event|5|||
30734619|NCT00287079|58746490|FG001|Overall Study|Adverse Event|0|||
30734620|NCT00287079|58746489|FG000|Overall Study|Protocol Violation|1|||
30734621|NCT00287079|58746490|FG001|Overall Study|Protocol Violation|0|||
30734622|NCT00287079|58746489|FG000|Overall Study|Other|3|||
30734623|NCT00287079|58746490|FG001|Overall Study|Other|0|||
30734624|NCT00429494|58746496|FG000|Overall Study|Withdrawal by Subject|9|||
30734625|NCT00429494|58746496|FG000|Overall Study|Death|6|||
30734626|NCT00429416|58746500|FG000|Overall Study|Death|1|||
30734627|NCT00429182|58746504|FG000|Overall Study|Not evaluable, Disease Progression|2|||
30734628|NCT00429182|58746504|FG000|Overall Study|Not eligible|5|||
30734629|NCT00429104|58746508|FG000|Overall Study|Protocol Violation|1|||
30734630|NCT00429026|58746512|FG000|Overall Study|Inevaluable for response.|40|||
30734631|NCT00301821|58746516|FG000|Overall Study|Ineligible|25|||
30734632|NCT00301821|58746516|FG000|Overall Study|Cancel|1|||
30734633|NCT00372996|58746522|FG000|Overall Study|Death|11|||
30734634|NCT00372996|58746523|FG001|Overall Study|Death|4|||
30734635|NCT00372996|58746524|FG002|Overall Study|Death|8|||
30734636|NCT00372996|58746525|FG003|Overall Study|Death|7|||
30734637|NCT00372996|58746522|FG000|Overall Study|Lost to Follow-up|0|||
30734638|NCT00372996|58746523|FG001|Overall Study|Lost to Follow-up|2|||
30734639|NCT00372996|58746524|FG002|Overall Study|Lost to Follow-up|0|||
30734640|NCT00372996|58746525|FG003|Overall Study|Lost to Follow-up|1|||
30734641|NCT00372996|58746522|FG000|Overall Study|Withdrawal by Subject|12|||
30734642|NCT00372996|58746523|FG001|Overall Study|Withdrawal by Subject|6|||
30734643|NCT00372996|58746524|FG002|Overall Study|Withdrawal by Subject|9|||
30734644|NCT00372996|58746525|FG003|Overall Study|Withdrawal by Subject|5|||
30734645|NCT00372996|58746522|FG000|Overall Study|Study Terminated by Sponsor|4|||
30734646|NCT00372996|58746523|FG001|Overall Study|Study Terminated by Sponsor|0|||
30734647|NCT00372996|58746524|FG002|Overall Study|Study Terminated by Sponsor|4|||
30734648|NCT00372996|58746525|FG003|Overall Study|Study Terminated by Sponsor|0|||
30734649|NCT00372996|58746522|FG000|Overall Study|Other|10|||
30734650|NCT00372996|58746523|FG001|Overall Study|Other|2|||
30734651|NCT00372996|58746524|FG002|Overall Study|Other|7|||
30734652|NCT00372996|58746525|FG003|Overall Study|Other|7|||
30734653|NCT00399516|58746535|FG000|Overall Study|Lost to Follow-up|2|||
30734654|NCT00399360|58746543|FG000|Overall Study|Lost to Follow-up|2|||
30734655|NCT00399360|58746544|FG001|Overall Study|Lost to Follow-up|1|||
30734656|NCT00399360|58746545|FG002|Overall Study|Lost to Follow-up|2|||
30734657|NCT00399360|58746546|FG003|Overall Study|Lost to Follow-up|4|||
30734658|NCT00399360|58746543|FG000|Overall Study|Adverse Event|0|||
30734659|NCT00399360|58746544|FG001|Overall Study|Adverse Event|0|||
30734660|NCT00399360|58746545|FG002|Overall Study|Adverse Event|1|||
30734661|NCT00399360|58746546|FG003|Overall Study|Adverse Event|0|||
30734662|NCT00399360|58746543|FG000|Overall Study|Withdrawal by Subject|0|||
30734663|NCT00399360|58746544|FG001|Overall Study|Withdrawal by Subject|2|||
30734664|NCT00399360|58746545|FG002|Overall Study|Withdrawal by Subject|0|||
30734665|NCT00399360|58746546|FG003|Overall Study|Withdrawal by Subject|2|||
30734666|NCT00428948|58746563|FG000|Overall Study|Lost to Follow-up|15|||
30734667|NCT00428948|58746564|FG001|Overall Study|Lost to Follow-up|8|||
30734668|NCT00428948|58746563|FG000|Overall Study|Adverse Event|148|||
30734669|NCT00428948|58746564|FG001|Overall Study|Adverse Event|24|||
30734670|NCT00428948|58746563|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
30734671|NCT00428948|58746564|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
30734672|NCT00428948|58746563|FG000|Overall Study|Investigator Withdrew Subject|3|||
30734673|NCT00428948|58746564|FG001|Overall Study|Investigator Withdrew Subject|4|||
30734674|NCT00428948|58746563|FG000|Overall Study|Subject Withdrew Consent|50|||
30734675|NCT00428948|58746564|FG001|Overall Study|Subject Withdrew Consent|30|||
30734676|NCT00428948|58746563|FG000|Overall Study|Protocol Deviation|1|||
30734677|NCT00428948|58746564|FG001|Overall Study|Protocol Deviation|1|||
30734678|NCT00428792|58746572|FG000|Overall Study|Lack of Efficacy|1|||
30734679|NCT00428792|58746573|FG001|Overall Study|Lack of Efficacy|3|||
30734680|NCT00428792|58746572|FG000|Overall Study|Lost to Follow-up|0|||
30734681|NCT00428792|58746573|FG001|Overall Study|Lost to Follow-up|1|||
30734682|NCT00300885|58746581|FG000|Treatment|Adverse Event|134|||
30734683|NCT00300885|58746582|FG001|Treatment|Adverse Event|82|||
30734684|NCT00300885|58746581|FG000|Treatment|Death|20|||
30734685|NCT00300885|58746582|FG001|Treatment|Death|7|||
30734686|NCT00300885|58746581|FG000|Treatment|Lack of Efficacy|1|||
30734687|NCT00300885|58746582|FG001|Treatment|Lack of Efficacy|1|||
30734688|NCT00300885|58746581|FG000|Treatment|Lost to Follow-up|3|||
30734689|NCT00300885|58746582|FG001|Treatment|Lost to Follow-up|2|||
30734690|NCT00300885|58746581|FG000|Treatment|Physician Decision|4|||
30734691|NCT00300885|58746582|FG001|Treatment|Physician Decision|5|||
30734692|NCT00300885|58746581|FG000|Treatment|Protocol Violation|11|||
30734693|NCT00300885|58746582|FG001|Treatment|Protocol Violation|11|||
30734694|NCT00300885|58746581|FG000|Treatment|Withdrawal by Subject|26|||
30734695|NCT00300885|58746582|FG001|Treatment|Withdrawal by Subject|23|||
30734696|NCT00300885|58746581|FG000|Treatment|Disease progression|171|||
30734697|NCT00300885|58746582|FG001|Treatment|Disease progression|238|||
30734698|NCT00300885|58746581|FG000|Treatment|Random code broken (subject died)|0|||
30734699|NCT00300885|58746582|FG001|Treatment|Random code broken (subject died)|1|||
30734700|NCT00300885|58746581|FG000|Treatment|Non-compliant with study medication|3|||
30734701|NCT00300885|58746582|FG001|Treatment|Non-compliant with study medication|4|||
30734702|NCT00300885|58746581|FG000|Follow-up|Death|141|||
30734703|NCT00300885|58746582|FG001|Follow-up|Death|163|||
30734704|NCT00300885|58746581|FG000|Follow-up|Lost to Follow-up|11|||
30734705|NCT00300885|58746582|FG001|Follow-up|Lost to Follow-up|7|||
30734706|NCT00300885|58746581|FG000|Follow-up|Withdrawal by Subject|26|||
30734707|NCT00300885|58746582|FG001|Follow-up|Withdrawal by Subject|25|||
30734708|NCT00386334|58746590|FG000|Double Blind Period|Adverse Event|9|||
30734709|NCT00386334|58746591|FG001|Double Blind Period|Adverse Event|14|||
30734710|NCT00386334|58746590|FG000|Double Blind Period|Protocol Violation|1|||
30734711|NCT00386334|58746591|FG001|Double Blind Period|Protocol Violation|1|||
30734712|NCT00386334|58746590|FG000|Double Blind Period|Withdrawal by Subject|9|||
30734713|NCT00386334|58746591|FG001|Double Blind Period|Withdrawal by Subject|13|||
30734714|NCT00386334|58746590|FG000|Double Blind Period|Lack of Efficacy|20|||
30734715|NCT00386334|58746591|FG001|Double Blind Period|Lack of Efficacy|11|||
30734716|NCT00386334|58746590|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
30734717|NCT00386334|58746591|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
30734718|NCT00386334|58746590|FG000|Double Blind Period|Other|3|||
30734719|NCT00386334|58746591|FG001|Double Blind Period|Other|3|||
30790952|NCT00835042|58804061|FG000|First Intervention|Adverse Event|1|||
30734720|NCT00386334|58746590|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
30734721|NCT00386334|58746591|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
30734722|NCT00428714|58746608|FG000|Overall Study|Progressive Disease|28|||
30734723|NCT00428714|58746609|FG001|Overall Study|Progressive Disease|36|||
30734724|NCT00428714|58746608|FG000|Overall Study|Withdrawal by Subject|0|||
30734725|NCT00428714|58746609|FG001|Overall Study|Withdrawal by Subject|3|||
30734726|NCT00428714|58746608|FG000|Overall Study|Adverse Event|0|||
30734727|NCT00428714|58746609|FG001|Overall Study|Adverse Event|2|||
30734728|NCT00428714|58746608|FG000|Overall Study|Physician Decision|1|||
30734729|NCT00428714|58746609|FG001|Overall Study|Physician Decision|1|||
30734730|NCT00428714|58746608|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
30734731|NCT00428714|58746609|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
30734732|NCT00428714|58746608|FG000|Overall Study|Death due to other then PD|1|||
30734733|NCT00428714|58746609|FG001|Overall Study|Death due to other then PD|0|||
30734734|NCT00292227|58746618|FG000|Patch Period|Adverse Event|1|||
30734735|NCT00292227|58746619|FG001|Patch Period|Adverse Event|0|||
30734736|NCT00292227|58746620|FG002|Patch Period|Adverse Event|2|||
30734737|NCT00292227|58746618|FG000|Patch Period|Withdrawal by Subject|0|||
30734738|NCT00292227|58746619|FG001|Patch Period|Withdrawal by Subject|0|||
30734739|NCT00292227|58746620|FG002|Patch Period|Withdrawal by Subject|1|||
30734740|NCT00386100|58746630|FG000|Overall Study|Did not receive study medication|6|||
30734741|NCT00386100|58746631|FG001|Overall Study|Did not receive study medication|4|||
30734742|NCT00386100|58746630|FG000|Overall Study|Adverse Event|15|||
30734743|NCT00386100|58746631|FG001|Overall Study|Adverse Event|25|||
30734744|NCT00386100|58746630|FG000|Overall Study|Death|0|||
30734745|NCT00386100|58746631|FG001|Overall Study|Death|1|||
30734746|NCT00386100|58746630|FG000|Overall Study|Insufficient therapeutic effect|30|||
30734747|NCT00386100|58746631|FG001|Overall Study|Insufficient therapeutic effect|6|||
30734748|NCT00386100|58746630|FG000|Overall Study|Lost to Follow-up|29|||
30734749|NCT00386100|58746631|FG001|Overall Study|Lost to Follow-up|29|||
30734750|NCT00386100|58746630|FG000|Overall Study|Non-compliance|18|||
30734751|NCT00386100|58746631|FG001|Overall Study|Non-compliance|19|||
30734752|NCT00386100|58746630|FG000|Overall Study|Protocol Violation|5|||
30734753|NCT00386100|58746631|FG001|Overall Study|Protocol Violation|3|||
30734754|NCT00386100|58746630|FG000|Overall Study|Withdrawal by Subject|32|||
30734755|NCT00386100|58746631|FG001|Overall Study|Withdrawal by Subject|31|||
30734756|NCT00386100|58746630|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
30734757|NCT00386100|58746631|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
30734758|NCT00386100|58746630|FG000|Overall Study|BMD <2.5|1|||
30734759|NCT00386100|58746631|FG001|Overall Study|BMD <2.5|0|||
30734760|NCT00386100|58746630|FG000|Overall Study|Consecutive elevated Hba1C|1|||
30734761|NCT00386100|58746631|FG001|Overall Study|Consecutive elevated Hba1C|0|||
30734762|NCT00386100|58746630|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
30734763|NCT00386100|58746631|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
30734764|NCT00386100|58746630|FG000|Overall Study|Laboratory findings|1|||
30734765|NCT00386100|58746631|FG001|Overall Study|Laboratory findings|0|||
30734766|NCT00386100|58746630|FG000|Overall Study|Participant's concern due to CPK levels|1|||
30734767|NCT00386100|58746631|FG001|Overall Study|Participant's concern due to CPK levels|0|||
30734768|NCT00386100|58746630|FG000|Overall Study|Participant moving out of state|2|||
30734769|NCT00386100|58746631|FG001|Overall Study|Participant moving out of state|0|||
30734770|NCT00386100|58746630|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
30734771|NCT00386100|58746631|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
30734772|NCT00386100|58746630|FG000|Overall Study|Didn't meet entry criteria|1|||
30734773|NCT00386100|58746631|FG001|Overall Study|Didn't meet entry criteria|1|||
30734774|NCT00386100|58746630|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
30734775|NCT00386100|58746631|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
30734776|NCT00386100|58746630|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
30734777|NCT00386100|58746631|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
30734778|NCT00386100|58746630|FG000|Overall Study|Bad metabolic control & patient security|1|||
30734779|NCT00386100|58746631|FG001|Overall Study|Bad metabolic control & patient security|0|||
30734780|NCT00386100|58746630|FG000|Overall Study|Bone loss by DXA bone scan|1|||
30734781|NCT00386100|58746631|FG001|Overall Study|Bone loss by DXA bone scan|0|||
30734782|NCT00386100|58746630|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
30734783|NCT00386100|58746631|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
30734784|NCT00386100|58746630|FG000|Overall Study|7.6% bone loss|1|||
30734785|NCT00386100|58746631|FG001|Overall Study|7.6% bone loss|0|||
30734786|NCT00386100|58746630|FG000|Overall Study|Osteoporosis|0|||
30734787|NCT00386100|58746631|FG001|Overall Study|Osteoporosis|1|||
30734788|NCT00386100|58746630|FG000|Overall Study|Positive pregnancy test|1|||
30734789|NCT00386100|58746631|FG001|Overall Study|Positive pregnancy test|3|||
30734790|NCT00386100|58746630|FG000|Overall Study|Out of country for 5 months|1|||
30734791|NCT00386100|58746631|FG001|Overall Study|Out of country for 5 months|0|||
30734792|NCT00386100|58746630|FG000|Overall Study|Hb1Ac >8%|0|||
30734793|NCT00386100|58746631|FG001|Overall Study|Hb1Ac >8%|1|||
30734794|NCT00386100|58746630|FG000|Overall Study|Participant randomized in error|1|||
30734795|NCT00386100|58746631|FG001|Overall Study|Participant randomized in error|0|||
30734796|NCT00300495|58746639|FG000|Overall Study|Protocol Violation|4|||
30734797|NCT00300495|58746640|FG001|Overall Study|Protocol Violation|1|||
30734798|NCT00386022|58746648|FG000|Plus Estrogen|Lost to Follow-up|2|||
30734799|NCT00386022|58746649|FG001|Plus Estrogen|Lost to Follow-up|0|||
30734800|NCT00386022|58746648|FG000|Plus Estrogen|Adverse Event|0|||
30734801|NCT00386022|58746649|FG001|Plus Estrogen|Adverse Event|1|||
30734802|NCT00286455|58746660|FG000|Overall Study|Hyperglycemia rescue|19|||
30734803|NCT00286455|58746661|FG001|Overall Study|Hyperglycemia rescue|13|||
30734804|NCT00286455|58746662|FG002|Overall Study|Hyperglycemia rescue|10|||
30734805|NCT00286455|58746660|FG000|Overall Study|Adverse Event|1|||
30734806|NCT00286455|58746661|FG001|Overall Study|Adverse Event|3|||
30734807|NCT00286455|58746662|FG002|Overall Study|Adverse Event|2|||
30734808|NCT00286455|58746660|FG000|Overall Study|Lost to Follow-up|0|||
30734809|NCT00286455|58746661|FG001|Overall Study|Lost to Follow-up|3|||
30734810|NCT00286455|58746662|FG002|Overall Study|Lost to Follow-up|3|||
30734811|NCT00286455|58746660|FG000|Overall Study|Physician Decision|3|||
30734812|NCT00286455|58746661|FG001|Overall Study|Physician Decision|0|||
30734813|NCT00286455|58746662|FG002|Overall Study|Physician Decision|2|||
30734814|NCT00286455|58746660|FG000|Overall Study|Protocol Violation|1|||
30734815|NCT00286455|58746661|FG001|Overall Study|Protocol Violation|1|||
30734816|NCT00286455|58746662|FG002|Overall Study|Protocol Violation|0|||
30734817|NCT00286455|58746660|FG000|Overall Study|Participant Non-compliance|1|||
30734818|NCT00286455|58746661|FG001|Overall Study|Participant Non-compliance|0|||
30734819|NCT00286455|58746662|FG002|Overall Study|Participant Non-compliance|0|||
30734820|NCT00286455|58746660|FG000|Overall Study|Withdrawal by Subject|0|||
30734821|NCT00286455|58746661|FG001|Overall Study|Withdrawal by Subject|8|||
30734822|NCT00286455|58746662|FG002|Overall Study|Withdrawal by Subject|7|||
30734823|NCT00385944|58746672|FG000|1st Maintenance Dose Period|Physician Decision|1|||
30734824|NCT00385944|58746673|FG001|1st Maintenance Dose Period|Physician Decision|0|||
30734825|NCT00385944|58746674|FG002|1st Maintenance Dose Period|Physician Decision|0|||
30734826|NCT00385944|58746672|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
30734827|NCT00385944|58746673|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
30734828|NCT00385944|58746674|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
30734829|NCT00385944|58746672|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
30734830|NCT00385944|58746673|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
30734831|NCT00385944|58746674|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
30734832|NCT00385944|58746672|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
30790953|NCT00835042|58804062|FG001|First Intervention|Adverse Event|2|||
30734833|NCT00385944|58746673|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
30734834|NCT00385944|58746674|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
30734835|NCT00286221|58746693|FG000|Overall Study|Protocol Violation|2|||
30734836|NCT00286221|58746694|FG001|Overall Study|Protocol Violation|1|||
30734837|NCT00286221|58746695|FG002|Overall Study|Protocol Violation|6|||
30734838|NCT00286221|58746696|FG003|Overall Study|Protocol Violation|4|||
30734839|NCT00286221|58746693|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
30734840|NCT00286221|58746694|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
30734841|NCT00286221|58746695|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
30734842|NCT00286221|58746696|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
30734843|NCT00286221|58746693|FG000|Overall Study|Inability to trigger PCA|2|||
30734844|NCT00286221|58746694|FG001|Overall Study|Inability to trigger PCA|0|||
30734845|NCT00286221|58746695|FG002|Overall Study|Inability to trigger PCA|0|||
30734846|NCT00286221|58746696|FG003|Overall Study|Inability to trigger PCA|0|||
30734847|NCT00286221|58746693|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
30734848|NCT00286221|58746694|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
30734849|NCT00286221|58746695|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
30734850|NCT00286221|58746696|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
30734851|NCT00285207|58746708|FG000|Overall Study|Lost to Follow-up|3|||
30734852|NCT00285207|58746709|FG001|Overall Study|Lost to Follow-up|2|||
30734853|NCT00285207|58746708|FG000|Overall Study|Withdrawal by Subject|5|||
30734854|NCT00285207|58746709|FG001|Overall Study|Withdrawal by Subject|2|||
30734855|NCT00285207|58746708|FG000|Overall Study|Pregnancy|1|||
30734856|NCT00285207|58746709|FG001|Overall Study|Pregnancy|1|||
30734857|NCT00285207|58746708|FG000|Overall Study|non-compliance|0|||
30734858|NCT00285207|58746709|FG001|Overall Study|non-compliance|1|||
30734859|NCT00398112|58746715|FG000|Overall Study|Adverse Event|4|||
30734860|NCT00398112|58746715|FG000|Overall Study|Disease progression|9|||
30734861|NCT00398112|58746715|FG000|Overall Study|Alternative treatment|1|||
30734862|NCT00398112|58746715|FG000|Overall Study|Withdrawal by Subject|3|||
30734863|NCT00398112|58746715|FG000|Overall Study|Death|1|||
30734864|NCT00424346|58746723|FG000|Core Study|Adverse Event|5|||
30621843|NCT00977379|58633381|FG001|Overall Study|Premature Study Termination|0|||
30734865|NCT00424346|58746724|FG001|Core Study|Adverse Event|3|||
30734866|NCT00424346|58746725|FG002|Core Study|Adverse Event|1|||
30734867|NCT00424346|58746726|FG003|Core Study|Adverse Event|1|||
30734868|NCT00424346|58746723|FG000|Core Study|Abnormal Laboratory Values|0|||
30621844|NCT00977379|58633380|FG000|Overall Study|Participant Moving House|0|||
30621845|NCT00977379|58633381|FG001|Overall Study|Participant Moving House|1|||
30734869|NCT00424346|58746724|FG001|Core Study|Abnormal Laboratory Values|1|||
30734870|NCT00424346|58746725|FG002|Core Study|Abnormal Laboratory Values|0|||
30734871|NCT00424346|58746726|FG003|Core Study|Abnormal Laboratory Values|0|||
30734872|NCT00424346|58746723|FG000|Core Study|Lack of Efficacy|1|||
30734873|NCT00424346|58746724|FG001|Core Study|Lack of Efficacy|3|||
30734874|NCT00424346|58746725|FG002|Core Study|Lack of Efficacy|0|||
30734875|NCT00424346|58746726|FG003|Core Study|Lack of Efficacy|4|||
30734876|NCT00424346|58746723|FG000|Core Study|Withdrawal by Subject|1|||
30734877|NCT00424346|58746724|FG001|Core Study|Withdrawal by Subject|0|||
30734878|NCT00424346|58746725|FG002|Core Study|Withdrawal by Subject|0|||
30734879|NCT00424346|58746726|FG003|Core Study|Withdrawal by Subject|2|||
30734880|NCT00424346|58746723|FG000|Core Study|Lost to Follow-up|1|||
30734881|NCT00424346|58746724|FG001|Core Study|Lost to Follow-up|1|||
30734882|NCT00424346|58746725|FG002|Core Study|Lost to Follow-up|0|||
30734883|NCT00424346|58746726|FG003|Core Study|Lost to Follow-up|0|||
30734884|NCT00424346|58746723|FG000|Core Study|Administrative Problems|1|||
30734885|NCT00424346|58746724|FG001|Core Study|Administrative Problems|0|||
30734886|NCT00424346|58746725|FG002|Core Study|Administrative Problems|1|||
30734887|NCT00424346|58746726|FG003|Core Study|Administrative Problems|0|||
30734888|NCT00424346|58746723|FG000|Core Study|Protocol Violation|0|||
30734889|NCT00424346|58746724|FG001|Core Study|Protocol Violation|0|||
30734890|NCT00424346|58746725|FG002|Core Study|Protocol Violation|2|||
30734891|NCT00424346|58746726|FG003|Core Study|Protocol Violation|0|||
30734892|NCT00424346|58746723|FG000|Extension Phase|Adverse Event|0|||
30734893|NCT00424346|58746724|FG001|Extension Phase|Adverse Event|9|||
30734894|NCT00424346|58746725|FG002|Extension Phase|Adverse Event|5|||
30734895|NCT00424346|58746726|FG003|Extension Phase|Adverse Event|4|||
30734896|NCT00424346|58746723|FG000|Extension Phase|Lack of Efficacy|0|||
30734897|NCT00424346|58746724|FG001|Extension Phase|Lack of Efficacy|16|||
30734898|NCT00424346|58746725|FG002|Extension Phase|Lack of Efficacy|14|||
30734899|NCT00424346|58746726|FG003|Extension Phase|Lack of Efficacy|11|||
30734900|NCT00424346|58746723|FG000|Extension Phase|Withdrawal by Subject|0|||
30734901|NCT00424346|58746724|FG001|Extension Phase|Withdrawal by Subject|5|||
30734902|NCT00424346|58746725|FG002|Extension Phase|Withdrawal by Subject|3|||
30621846|NCT00977379|58633380|FG000|Overall Study|Randomization Error|0|||
30621847|NCT00977379|58633381|FG001|Overall Study|Randomization Error|1|||
30734903|NCT00424346|58746726|FG003|Extension Phase|Withdrawal by Subject|4|||
30734904|NCT00424346|58746723|FG000|Extension Phase|Lost to Follow-up|0|||
30734905|NCT00424346|58746724|FG001|Extension Phase|Lost to Follow-up|2|||
30734906|NCT00424346|58746725|FG002|Extension Phase|Lost to Follow-up|0|||
30734907|NCT00424346|58746726|FG003|Extension Phase|Lost to Follow-up|0|||
30734908|NCT00424346|58746723|FG000|Extension Phase|Administrative Problems|0|||
30734909|NCT00424346|58746724|FG001|Extension Phase|Administrative Problems|69|||
30734910|NCT00424346|58746725|FG002|Extension Phase|Administrative Problems|32|||
30621848|NCT01180985|58633387|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
30734911|NCT00424346|58746726|FG003|Extension Phase|Administrative Problems|35|||
30734912|NCT00424346|58746723|FG000|Extension Phase|Death|0|||
30734913|NCT00424346|58746724|FG001|Extension Phase|Death|0|||
30734914|NCT00424346|58746725|FG002|Extension Phase|Death|0|||
30734915|NCT00424346|58746726|FG003|Extension Phase|Death|1|||
30734916|NCT00424346|58746723|FG000|Extension Phase|Protocol Violation|0|||
30734917|NCT00424346|58746724|FG001|Extension Phase|Protocol Violation|1|||
30734918|NCT00424346|58746725|FG002|Extension Phase|Protocol Violation|1|||
30734919|NCT00424346|58746726|FG003|Extension Phase|Protocol Violation|0|||
30734920|NCT00283959|58746739|FG000|Extension Period|Low Compliance|1|||
30734921|NCT00372528|58746743|FG000|Overall Study|Lack of Efficacy|1|||
30734922|NCT00372528|58746743|FG000|Overall Study|Adverse Event|1|||
30734923|NCT00372528|58746743|FG000|Overall Study|Study Terminated by Sponsor|18|||
30734924|NCT00372528|58746743|FG000|Overall Study|Other|1|||
30734925|NCT00283803|58746747|FG000|Overall Study|Physician Decision|9|||
30734926|NCT00283803|58746747|FG000|Overall Study|Withdrawal by Subject|4|||
30734927|NCT00397488|58746751|FG000|Overall Study|Withdrawal by Subject|3|||
30734928|NCT00397488|58746751|FG000|Overall Study|Adverse Event|3|||
30734929|NCT00397488|58746751|FG000|Overall Study|Death|1|||
30734930|NCT00424190|58746757|FG000|Overall Study|Withdrew consent|3|||
30734931|NCT00424190|58746758|FG001|Overall Study|Withdrew consent|4|||
30734932|NCT00424190|58746757|FG000|Overall Study|Death|3|||
30734933|NCT00424190|58746758|FG001|Overall Study|Death|0|||
30734934|NCT00424190|58746757|FG000|Overall Study|Noncompliance|1|||
30734935|NCT00424190|58746758|FG001|Overall Study|Noncompliance|2|||
30734936|NCT00424190|58746757|FG000|Overall Study|Request of sponsor or investigator|0|||
30734937|NCT00424190|58746758|FG001|Overall Study|Request of sponsor or investigator|2|||
30734938|NCT00424190|58746757|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
30734939|NCT00424190|58746758|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
30734940|NCT00424190|58746757|FG000|Overall Study|Other|15|||
30734941|NCT00424190|58746758|FG001|Overall Study|Other|21|||
30734942|NCT00428246|58746767|FG000|Overall Study|Withdrawal by Subject|0|||
30734943|NCT00428246|58746768|FG001|Overall Study|Withdrawal by Subject|0|||
30734944|NCT00428246|58746769|FG002|Overall Study|Withdrawal by Subject|1|||
30734945|NCT00428246|58746767|FG000|Overall Study|Adverse Event|1|||
30734946|NCT00428246|58746768|FG001|Overall Study|Adverse Event|0|||
30734947|NCT00428246|58746769|FG002|Overall Study|Adverse Event|0|||
30734948|NCT00274287|58746777|FG000|Overall Study|Withdrawal by Subject|1|||
30734949|NCT00274287|58746777|FG000|Overall Study|subject non-compliance|1|||
30734950|NCT00423800|58746784|FG000|Overall Study|Protocol Violation|0|||
30734951|NCT00423800|58746785|FG001|Overall Study|Protocol Violation|1|||
30734952|NCT00405548|58746794|FG000|Overall Study|Cognitive Memory problems on study day|1|||
30734953|NCT00405548|58746795|FG001|Overall Study|Cognitive Memory problems on study day|0|||
30734954|NCT00405548|58746794|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
30734955|NCT00405548|58746795|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
30734956|NCT00405548|58746794|FG000|Overall Study|Unable to self-administer shots|1|||
30734957|NCT00405548|58746795|FG001|Overall Study|Unable to self-administer shots|0|||
30734958|NCT00405548|58746794|FG000|Overall Study|Venous access failed during study day|1|||
30734959|NCT00405548|58746795|FG001|Overall Study|Venous access failed during study day|0|||
30734960|NCT00405548|58746794|FG000|Overall Study|Withdrawal by Subject|1|||
30734961|NCT00405548|58746795|FG001|Overall Study|Withdrawal by Subject|0|||
30734962|NCT00405392|58746803|FG000|Overall Study|Adverse Event|15|||
30734963|NCT00405392|58746804|FG001|Overall Study|Adverse Event|14|||
30734964|NCT00405392|58746803|FG000|Overall Study|Did not meet Eligibility criteria|7|||
30734965|NCT00405392|58746804|FG001|Overall Study|Did not meet Eligibility criteria|2|||
30734966|NCT00405392|58746803|FG000|Overall Study|Withdrawal by Subject|4|||
30734967|NCT00405392|58746804|FG001|Overall Study|Withdrawal by Subject|3|||
30734968|NCT00405392|58746803|FG000|Overall Study|Lost to Follow-up|1|||
30734969|NCT00405392|58746804|FG001|Overall Study|Lost to Follow-up|2|||
30734970|NCT00405392|58746803|FG000|Overall Study|Data missing|2|||
30734971|NCT00405392|58746804|FG001|Overall Study|Data missing|0|||
30734972|NCT00405392|58746803|FG000|Overall Study|Non-compliance|0|||
30734973|NCT00405392|58746804|FG001|Overall Study|Non-compliance|1|||
30734974|NCT00405392|58746803|FG000|Overall Study|Other|1|||
30734975|NCT00405392|58746804|FG001|Overall Study|Other|5|||
30734976|NCT00282243|58746810|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
30734977|NCT00282243|58746810|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
30734978|NCT00282243|58746810|FG000|Extension Treatment Period|Adverse Event|15|||
30734979|NCT00282243|58746810|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
30734980|NCT00282243|58746810|FG000|Extension Treatment Period|Non-compliance|2|||
30734981|NCT00282243|58746810|FG000|Extension Treatment Period|Physician Decision|1|||
30734982|NCT00272961|58746819|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
30734983|NCT00272961|58746820|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
30734984|NCT00272961|58746821|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
30734985|NCT00272961|58746822|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
30734986|NCT00272961|58746823|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
30734987|NCT00272961|58746819|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
30734988|NCT00272961|58746820|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
30734989|NCT00272961|58746821|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
30734990|NCT00272961|58746822|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
30734991|NCT00272961|58746823|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
30734992|NCT00272961|58746819|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
30734993|NCT00272961|58746820|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
30734994|NCT00272961|58746821|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
30734995|NCT00272961|58746822|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
30734996|NCT00272961|58746823|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
30734997|NCT00272961|58746819|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
30734998|NCT00272961|58746820|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
30734999|NCT00272961|58746821|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
30735000|NCT00272961|58746822|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
30735001|NCT00272961|58746823|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
30735002|NCT00272961|58746819|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
30735003|NCT00272961|58746820|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
30735004|NCT00272961|58746821|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
30735005|NCT00272961|58746822|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
30735006|NCT00272961|58746823|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
30735007|NCT00272961|58746819|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
30735008|NCT00272961|58746820|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
30735009|NCT00272961|58746821|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
30621849|NCT01180985|58633388|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
30735010|NCT00272961|58746822|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
30735011|NCT00272961|58746823|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
30735012|NCT00272961|58746819|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
30735013|NCT00272961|58746820|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
30735014|NCT00272961|58746821|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
30735015|NCT00272961|58746822|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
30735016|NCT00272961|58746823|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
30735017|NCT00272961|58746819|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
30735018|NCT00272961|58746820|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
30735019|NCT00272961|58746821|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
30735020|NCT00272961|58746822|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
30735021|NCT00272961|58746823|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
30735022|NCT00282087|58746835|FG000|Overall Study|Death|1|||
30735023|NCT00404924|58746842|FG000|Overall Study|Adverse Event|75|||
30735024|NCT00404924|58746843|FG001|Overall Study|Adverse Event|16|||
30735025|NCT00404924|58746842|FG000|Overall Study|Condition under investigation worsened|475|||
30735026|NCT00404924|58746843|FG001|Overall Study|Condition under investigation worsened|264|||
30735027|NCT00404924|58746842|FG000|Overall Study|Lost to Follow-up|1|||
30735028|NCT00404924|58746843|FG001|Overall Study|Lost to Follow-up|1|||
30735029|NCT00404924|58746842|FG000|Overall Study|Withdrawal by Subject|26|||
30735030|NCT00404924|58746843|FG001|Overall Study|Withdrawal by Subject|13|||
30735031|NCT00404924|58746842|FG000|Overall Study|Other|25|||
30735032|NCT00404924|58746843|FG001|Overall Study|Other|11|||
30735033|NCT00404924|58746842|FG000|Overall Study|Randomised but not received treatment|1|||
30735034|NCT00404924|58746843|FG001|Overall Study|Randomised but not received treatment|1|||
30621850|NCT01147536|58633395|FG000|Overall Study|Administrative study close|2|||
30735035|NCT00281697|58746851|FG000|Overall Study|> 60 days since last dose of study drug|4|||
30735036|NCT00281697|58746852|FG001|Overall Study|> 60 days since last dose of study drug|4|||
30735037|NCT00281697|58746851|FG000|Overall Study|Adverse Event|54|||
30735038|NCT00281697|58746852|FG001|Overall Study|Adverse Event|15|||
30735039|NCT00281697|58746851|FG000|Overall Study|Death|8|||
30735040|NCT00281697|58746852|FG001|Overall Study|Death|3|||
30735041|NCT00281697|58746851|FG000|Overall Study|Disease progression|279|||
30735042|NCT00281697|58746852|FG001|Overall Study|Disease progression|149|||
30735043|NCT00281697|58746851|FG000|Overall Study|Other|5|||
30735044|NCT00281697|58746852|FG001|Overall Study|Other|6|||
30735045|NCT00281697|58746851|FG000|Overall Study|Physician's decision to withdraw|15|||
30735046|NCT00281697|58746852|FG001|Overall Study|Physician's decision to withdraw|12|||
30735047|NCT00281697|58746851|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
30735048|NCT00281697|58746852|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
30735049|NCT00281697|58746851|FG000|Overall Study|Did not receive study drug|3|||
30735050|NCT00281697|58746852|FG001|Overall Study|Did not receive study drug|2|||
30735051|NCT00271947|58746858|FG000|Overall Study|Lost to Follow-up|1|||
30735052|NCT00232180|58746864|FG000|Double-blind (DB) Phase|Death|186|||
30735053|NCT00232180|58746865|FG001|Double-blind (DB) Phase|Death|222|||
30735054|NCT00232180|58746866|FG002|Double-blind (DB) Phase|Death|0|||
30735055|NCT00232180|58746864|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
30735056|NCT00232180|58746865|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
30735057|NCT00232180|58746866|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
30735058|NCT00232180|58746864|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
30735059|NCT00232180|58746865|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
30735060|NCT00232180|58746866|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
30735061|NCT00232180|58746864|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
30735062|NCT00232180|58746865|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
30735063|NCT00232180|58746866|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
30735064|NCT00232180|58746864|FG000|Double-blind (DB) Phase|Adverse Event|83|||
30735065|NCT00232180|58746865|FG001|Double-blind (DB) Phase|Adverse Event|100|||
30735066|NCT00232180|58746866|FG002|Double-blind (DB) Phase|Adverse Event|0|||
30735067|NCT00232180|58746864|FG000|Double-blind (DB) Phase|Other|70|||
30735068|NCT00232180|58746865|FG001|Double-blind (DB) Phase|Other|75|||
30735069|NCT00232180|58746866|FG002|Double-blind (DB) Phase|Other|0|||
30735070|NCT00232180|58746864|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
30735071|NCT00232180|58746865|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
30735072|NCT00232180|58746866|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
30735073|NCT00232180|58746864|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
30735074|NCT00232180|58746865|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
30735075|NCT00232180|58746866|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
30735076|NCT00232180|58746864|FG000|Open Label Phase|Death|0|||
30735077|NCT00232180|58746865|FG001|Open Label Phase|Death|0|||
30735078|NCT00232180|58746866|FG002|Open Label Phase|Death|48|||
30735079|NCT00232180|58746864|FG000|Open Label Phase|Lost to Follow-up|0|||
30735080|NCT00232180|58746865|FG001|Open Label Phase|Lost to Follow-up|0|||
30735081|NCT00232180|58746866|FG002|Open Label Phase|Lost to Follow-up|5|||
30735082|NCT00232180|58746864|FG000|Open Label Phase|Protocol Violation|0|||
30735083|NCT00232180|58746865|FG001|Open Label Phase|Protocol Violation|0|||
30735084|NCT00232180|58746866|FG002|Open Label Phase|Protocol Violation|3|||
30735085|NCT00232180|58746864|FG000|Open Label Phase|Study terminated by sponsor|0|||
30735086|NCT00232180|58746865|FG001|Open Label Phase|Study terminated by sponsor|0|||
30735087|NCT00232180|58746866|FG002|Open Label Phase|Study terminated by sponsor|3|||
30735088|NCT00232180|58746864|FG000|Open Label Phase|Withdrawal by Subject|0|||
30735089|NCT00232180|58746865|FG001|Open Label Phase|Withdrawal by Subject|0|||
30735090|NCT00232180|58746866|FG002|Open Label Phase|Withdrawal by Subject|37|||
30735091|NCT00232180|58746864|FG000|Open Label Phase|Other|0|||
30735092|NCT00232180|58746865|FG001|Open Label Phase|Other|0|||
30735093|NCT00232180|58746866|FG002|Open Label Phase|Other|16|||
30735094|NCT00232180|58746864|FG000|Open Label Phase|Adverse Event|0|||
30735095|NCT00232180|58746865|FG001|Open Label Phase|Adverse Event|0|||
30735096|NCT00232180|58746866|FG002|Open Label Phase|Adverse Event|25|||
30735097|NCT00232180|58746864|FG000|Open Label Phase|Laboratory abnormality|0|||
30735098|NCT00232180|58746865|FG001|Open Label Phase|Laboratory abnormality|0|||
30735099|NCT00232180|58746866|FG002|Open Label Phase|Laboratory abnormality|10|||
30735100|NCT00232180|58746864|FG000|Open Label Phase|Randomized but not treated|0|||
30735101|NCT00232180|58746865|FG001|Open Label Phase|Randomized but not treated|0|||
30735102|NCT00232180|58746866|FG002|Open Label Phase|Randomized but not treated|1|||
30735103|NCT00280917|58746879|FG000|Overall Study|Adverse Event|1|||
30735104|NCT00280917|58746880|FG001|Overall Study|Adverse Event|1|||
30735105|NCT00280917|58746881|FG002|Overall Study|Adverse Event|4|||
30735106|NCT00280917|58746882|FG003|Overall Study|Adverse Event|1|||
30735107|NCT00280917|58746879|FG000|Overall Study|Change Therapy|1|||
30735108|NCT00280917|58746880|FG001|Overall Study|Change Therapy|2|||
30735109|NCT00280917|58746881|FG002|Overall Study|Change Therapy|0|||
30735110|NCT00280917|58746882|FG003|Overall Study|Change Therapy|0|||
30735111|NCT00280917|58746879|FG000|Overall Study|Withdrawal by Subject|0|||
30735112|NCT00280917|58746880|FG001|Overall Study|Withdrawal by Subject|2|||
30735113|NCT00280917|58746881|FG002|Overall Study|Withdrawal by Subject|0|||
30735114|NCT00280917|58746882|FG003|Overall Study|Withdrawal by Subject|1|||
30735115|NCT00280917|58746879|FG000|Overall Study|Noncompliance|0|||
30735116|NCT00280917|58746880|FG001|Overall Study|Noncompliance|1|||
30735117|NCT00280917|58746881|FG002|Overall Study|Noncompliance|2|||
30735118|NCT00280917|58746882|FG003|Overall Study|Noncompliance|0|||
30735119|NCT00280683|58746894|FG000|Overall Study|Withdrawal by Subject|1|||
30735120|NCT00280683|58746895|FG001|Overall Study|Withdrawal by Subject|2|||
30735121|NCT00280683|58746894|FG000|Overall Study|Adverse Event|1|||
30735122|NCT00280683|58746895|FG001|Overall Study|Adverse Event|1|||
30735123|NCT00270855|58746905|FG000|Overall Study|Withdrawal by Subject|8|||
30735124|NCT00270855|58746906|FG001|Overall Study|Withdrawal by Subject|8|||
30735125|NCT00404768|58746918|FG000|Part A and B|Withdrawn due to labor progression|1|||
30735126|NCT00404768|58746919|FG001|Part A and B|Withdrawn due to labor progression|0|||
30735127|NCT00404768|58746920|FG002|Part A and B|Withdrawn due to labor progression|0|||
30735128|NCT00404768|58746921|FG003|Part A and B|Withdrawn due to labor progression|0|||
30735129|NCT00404768|58746918|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
30735130|NCT00404768|58746919|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
30735131|NCT00404768|58746920|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
30735132|NCT00404768|58746921|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
30735133|NCT00404768|58746918|FG000|Part C|Adverse Event|0|||
30735134|NCT00404768|58746919|FG001|Part C|Adverse Event|0|||
30735135|NCT00404768|58746920|FG002|Part C|Adverse Event|0|||
30735136|NCT00404768|58746921|FG003|Part C|Adverse Event|3|||
30735137|NCT00404768|58746918|FG000|Part C|Lost to Follow-up|0|||
30735138|NCT00404768|58746919|FG001|Part C|Lost to Follow-up|0|||
30735139|NCT00404768|58746920|FG002|Part C|Lost to Follow-up|3|||
30735140|NCT00404768|58746921|FG003|Part C|Lost to Follow-up|1|||
30735141|NCT00404768|58746918|FG000|Part C|Withdrawal by Subject|0|||
30735142|NCT00404768|58746919|FG001|Part C|Withdrawal by Subject|0|||
30735143|NCT00404768|58746920|FG002|Part C|Withdrawal by Subject|2|||
30735144|NCT00404768|58746921|FG003|Part C|Withdrawal by Subject|1|||
30735145|NCT00404768|58746918|FG000|Part C|Early withdrawal from study medication|0|||
30735146|NCT00404768|58746919|FG001|Part C|Early withdrawal from study medication|0|||
30735147|NCT00404768|58746920|FG002|Part C|Early withdrawal from study medication|1|||
30735148|NCT00404768|58746921|FG003|Part C|Early withdrawal from study medication|0|||
30735149|NCT00404768|58746918|FG000|Part C|Participant did not respond to therapy|0|||
30735150|NCT00404768|58746919|FG001|Part C|Participant did not respond to therapy|0|||
30735151|NCT00404768|58746920|FG002|Part C|Participant did not respond to therapy|1|||
30735152|NCT00404768|58746921|FG003|Part C|Participant did not respond to therapy|1|||
30735153|NCT00404768|58746918|FG000|Part C|Physician withdrew the study medication|0|||
30735154|NCT00404768|58746919|FG001|Part C|Physician withdrew the study medication|0|||
30735155|NCT00404768|58746920|FG002|Part C|Physician withdrew the study medication|1|||
30735156|NCT00404768|58746921|FG003|Part C|Physician withdrew the study medication|0|||
30735157|NCT00404768|58746918|FG000|Part C|Participant delivered baby|0|||
30735158|NCT00404768|58746919|FG001|Part C|Participant delivered baby|0|||
30735159|NCT00404768|58746920|FG002|Part C|Participant delivered baby|0|||
30735160|NCT00404768|58746921|FG003|Part C|Participant delivered baby|1|||
30735161|NCT00404768|58746918|FG000|Part C|Unsatisfactory uterine response to IP|0|||
30735162|NCT00404768|58746919|FG001|Part C|Unsatisfactory uterine response to IP|0|||
30735163|NCT00404768|58746920|FG002|Part C|Unsatisfactory uterine response to IP|0|||
30735164|NCT00404768|58746921|FG003|Part C|Unsatisfactory uterine response to IP|1|||
30735165|NCT00404768|58746918|FG000|Part C|Active labor|0|||
30735166|NCT00404768|58746919|FG001|Part C|Active labor|0|||
30735167|NCT00404768|58746920|FG002|Part C|Active labor|0|||
30735168|NCT00404768|58746921|FG003|Part C|Active labor|1|||
30735169|NCT00404768|58746918|FG000|Part C|Lack of Efficacy|0|||
30735170|NCT00404768|58746919|FG001|Part C|Lack of Efficacy|0|||
30735171|NCT00404768|58746920|FG002|Part C|Lack of Efficacy|0|||
30735172|NCT00404768|58746921|FG003|Part C|Lack of Efficacy|2|||
30735173|NCT00404768|58746918|FG000|Part C|Treatment failure|0|||
30735174|NCT00404768|58746919|FG001|Part C|Treatment failure|0|||
30735175|NCT00404768|58746920|FG002|Part C|Treatment failure|0|||
30735176|NCT00404768|58746921|FG003|Part C|Treatment failure|1|||
30735177|NCT00404768|58746918|FG000|Part C|Investigator discretion|0|||
30735178|NCT00404768|58746919|FG001|Part C|Investigator discretion|0|||
30735179|NCT00404768|58746920|FG002|Part C|Investigator discretion|0|||
30735180|NCT00404768|58746921|FG003|Part C|Investigator discretion|1|||
30735181|NCT00404768|58746918|FG000|Part C|Researcher suspended study medication|0|||
30735182|NCT00404768|58746919|FG001|Part C|Researcher suspended study medication|0|||
30735183|NCT00404768|58746920|FG002|Part C|Researcher suspended study medication|0|||
30735184|NCT00404768|58746921|FG003|Part C|Researcher suspended study medication|1|||
30735185|NCT00270231|58746936|FG000|First Intervention|Lost to Follow-up|1|||
30735186|NCT00270231|58746937|FG001|First Intervention|Lost to Follow-up|1|||
30735187|NCT00270231|58746936|FG000|Washout Period|Lost to Follow-up|1|||
30735188|NCT00270231|58746937|FG001|Washout Period|Lost to Follow-up|0|||
30735189|NCT00270231|58746936|FG000|Second Intervention|Lost to Follow-up|0|||
30735190|NCT00270231|58746937|FG001|Second Intervention|Lost to Follow-up|1|||
30735191|NCT00258856|58746947|FG000|Overall Study|Lost to Follow-up|1|||
30735192|NCT00258856|58746948|FG001|Overall Study|Lost to Follow-up|0|||
30735193|NCT00258856|58746949|FG002|Overall Study|Lost to Follow-up|2|||
30735194|NCT00258856|58746950|FG003|Overall Study|Lost to Follow-up|0|||
30735195|NCT00258856|58746947|FG000|Overall Study|Non-compliance|2|||
30735196|NCT00258856|58746948|FG001|Overall Study|Non-compliance|0|||
30735197|NCT00258856|58746949|FG002|Overall Study|Non-compliance|0|||
30735198|NCT00258856|58746950|FG003|Overall Study|Non-compliance|1|||
30735199|NCT00269919|58746960|FG000|Overall Study|Other|26|||
30735200|NCT00269919|58746960|FG000|Overall Study|Started but not treated|1|||
30735201|NCT00258154|58746967|FG000|Overall Study|Adverse Event|1|||
30735202|NCT00258154|58746968|FG001|Overall Study|Adverse Event|0|||
30735203|NCT00258154|58746967|FG000|Overall Study|Lost to Follow-up|0|||
30735204|NCT00258154|58746968|FG001|Overall Study|Lost to Follow-up|1|||
30735205|NCT00258154|58746967|FG000|Overall Study|Protocol Violation|2|||
30735206|NCT00258154|58746968|FG001|Overall Study|Protocol Violation|1|||
30735207|NCT00258154|58746967|FG000|Overall Study|Withdrawal by Subject|3|||
30735208|NCT00258154|58746968|FG001|Overall Study|Withdrawal by Subject|4|||
30735209|NCT00258154|58746967|FG000|Overall Study|Patient Moved|3|||
30735210|NCT00258154|58746968|FG001|Overall Study|Patient Moved|1|||
30735211|NCT00257920|58746976|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
30735212|NCT00257920|58746977|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
30735213|NCT00257920|58746976|FG000|Period: Second Intervention|Other|2|||
30735214|NCT00257920|58746977|FG001|Period: Second Intervention|Other|1|||
30735215|NCT00268983|58746986|FG000|Overall Study|Death|3|||
30735216|NCT00268983|58746987|FG001|Overall Study|Death|0|||
30735217|NCT00257608|58746995|FG000|Chemotherapy Phase|Adverse Event|138|||
30735218|NCT00257608|58746996|FG001|Chemotherapy Phase|Adverse Event|0|||
30735219|NCT00257608|58746997|FG002|Chemotherapy Phase|Adverse Event|0|||
30735220|NCT00257608|58746995|FG000|Chemotherapy Phase|Disease progression|139|||
30735221|NCT00257608|58746996|FG001|Chemotherapy Phase|Disease progression|0|||
30735222|NCT00257608|58746997|FG002|Chemotherapy Phase|Disease progression|0|||
30735223|NCT00257608|58746995|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
30735224|NCT00257608|58746996|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
30735225|NCT00257608|58746997|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
30735226|NCT00257608|58746995|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
30790954|NCT00835042|58804061|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
30735227|NCT00257608|58746996|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
30735228|NCT00257608|58746997|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
30735229|NCT00257608|58746995|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
30735230|NCT00257608|58746996|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
30735231|NCT00257608|58746997|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
30735232|NCT00257608|58746995|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
30735233|NCT00257608|58746996|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
30735234|NCT00257608|58746997|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
30735235|NCT00257608|58746995|FG000|Chemotherapy Phase|Physician Decision|28|||
30735236|NCT00257608|58746996|FG001|Chemotherapy Phase|Physician Decision|0|||
30735237|NCT00257608|58746997|FG002|Chemotherapy Phase|Physician Decision|0|||
30735238|NCT00257608|58746995|FG000|Post Chemotherapy Phase|Adverse Event|0|||
30735239|NCT00257608|58746996|FG001|Post Chemotherapy Phase|Adverse Event|34|||
30735240|NCT00257608|58746997|FG002|Post Chemotherapy Phase|Adverse Event|38|||
30735241|NCT00257608|58746995|FG000|Post Chemotherapy Phase|Disease progression|0|||
30735242|NCT00257608|58746996|FG001|Post Chemotherapy Phase|Disease progression|204|||
30735243|NCT00257608|58746997|FG002|Post Chemotherapy Phase|Disease progression|168|||
30735244|NCT00257608|58746995|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
30735245|NCT00257608|58746996|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
30735246|NCT00257608|58746997|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
30735247|NCT00257608|58746995|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
30735248|NCT00257608|58746996|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
30735249|NCT00257608|58746997|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
30735250|NCT00257608|58746995|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
30735251|NCT00257608|58746996|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
30735252|NCT00257608|58746997|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
30735253|NCT00257608|58746995|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
30735254|NCT00257608|58746996|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
30735255|NCT00257608|58746997|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
30735256|NCT00257608|58746995|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
30735257|NCT00257608|58746996|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
30735258|NCT00257608|58746997|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
30735259|NCT00257608|58746995|FG000|Post Chemotherapy Phase|Physician Decision|0|||
30735260|NCT00257608|58746996|FG001|Post Chemotherapy Phase|Physician Decision|8|||
30735261|NCT00257608|58746997|FG002|Post Chemotherapy Phase|Physician Decision|11|||
30735262|NCT00257608|58746995|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
30735263|NCT00257608|58746996|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
30735264|NCT00257608|58746997|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
30735265|NCT00257608|58746995|FG000|Post Chemotherapy Phase|Not treated|0|||
30735266|NCT00257608|58746996|FG001|Post Chemotherapy Phase|Not treated|4|||
30735267|NCT00257608|58746997|FG002|Post Chemotherapy Phase|Not treated|7|||
30735268|NCT00231478|58747012|FG000|Overall Study|Protocol Violation|3|||
30735269|NCT00231478|58747013|FG001|Overall Study|Protocol Violation|2|||
30735270|NCT00231478|58747012|FG000|Overall Study|Refused Treatment|1|||
30735271|NCT00231478|58747013|FG001|Overall Study|Refused Treatment|1|||
30735272|NCT00231478|58747012|FG000|Overall Study|Withdrawal by Subject|1|||
30735273|NCT00231478|58747013|FG001|Overall Study|Withdrawal by Subject|0|||
30735274|NCT00231478|58747012|FG000|Overall Study|Adverse Event|0|||
30735275|NCT00231478|58747013|FG001|Overall Study|Adverse Event|1|||
30735276|NCT00231478|58747012|FG000|Overall Study|Administrative|3|||
30735277|NCT00231478|58747013|FG001|Overall Study|Administrative|2|||
30735278|NCT00413192|58747023|FG000|Overall Study|Disease progression|26|||
30735279|NCT00413192|58747024|FG001|Overall Study|Disease progression|31|||
30735280|NCT00413192|58747025|FG002|Overall Study|Disease progression|16|||
30735281|NCT00413192|58747026|FG003|Overall Study|Disease progression|25|||
30735282|NCT00413192|58747023|FG000|Overall Study|Toxicity|3|||
30735283|NCT00413192|58747024|FG001|Overall Study|Toxicity|2|||
30735284|NCT00413192|58747025|FG002|Overall Study|Toxicity|2|||
30735285|NCT00413192|58747026|FG003|Overall Study|Toxicity|2|||
30735286|NCT00413192|58747023|FG000|Overall Study|Withdrawal by Subject|3|||
30735287|NCT00413192|58747024|FG001|Overall Study|Withdrawal by Subject|5|||
30735288|NCT00413192|58747025|FG002|Overall Study|Withdrawal by Subject|0|||
30735289|NCT00413192|58747026|FG003|Overall Study|Withdrawal by Subject|1|||
30735290|NCT00413192|58747023|FG000|Overall Study|Intercurrent illness|0|||
30621851|NCT01147536|58633395|FG000|Overall Study|Death|1|||
30735291|NCT00413192|58747024|FG001|Overall Study|Intercurrent illness|0|||
30735292|NCT00413192|58747025|FG002|Overall Study|Intercurrent illness|0|||
30735293|NCT00413192|58747026|FG003|Overall Study|Intercurrent illness|1|||
30735294|NCT00413192|58747023|FG000|Overall Study|Intercurrent death|0|||
30735295|NCT00413192|58747024|FG001|Overall Study|Intercurrent death|1|||
30735296|NCT00413192|58747025|FG002|Overall Study|Intercurrent death|0|||
30735297|NCT00413192|58747026|FG003|Overall Study|Intercurrent death|0|||
30735298|NCT00413192|58747023|FG000|Overall Study|Other|5|||
30735299|NCT00413192|58747024|FG001|Overall Study|Other|1|||
30621852|NCT01154088|58633402|FG000|Overall Study|Lost to Follow-up|4|||
30735300|NCT00413192|58747025|FG002|Overall Study|Other|1|||
30735301|NCT00413192|58747026|FG003|Overall Study|Other|2|||
30735302|NCT00413192|58747023|FG000|Overall Study|Not treated|0|||
30735303|NCT00413192|58747024|FG001|Overall Study|Not treated|0|||
30735304|NCT00413192|58747025|FG002|Overall Study|Not treated|0|||
30735305|NCT00413192|58747026|FG003|Overall Study|Not treated|1|||
30735306|NCT00207142|58747039|FG000|Induction Phase|Adverse Event|9|||
30735307|NCT00207142|58747040|FG001|Induction Phase|Adverse Event|0|||
30735308|NCT00207142|58747041|FG002|Induction Phase|Adverse Event|0|||
30735309|NCT00207142|58747042|FG003|Induction Phase|Adverse Event|0|||
30735310|NCT00207142|58747039|FG000|Induction Phase|Death|1|||
30735311|NCT00207142|58747040|FG001|Induction Phase|Death|0|||
30735312|NCT00207142|58747041|FG002|Induction Phase|Death|0|||
30735313|NCT00207142|58747042|FG003|Induction Phase|Death|0|||
30735314|NCT00207142|58747039|FG000|Induction Phase|Lack of Efficacy|1|||
30735315|NCT00207142|58747040|FG001|Induction Phase|Lack of Efficacy|0|||
30735316|NCT00207142|58747041|FG002|Induction Phase|Lack of Efficacy|0|||
30735317|NCT00207142|58747042|FG003|Induction Phase|Lack of Efficacy|0|||
30735318|NCT00207142|58747039|FG000|Induction Phase|Lost to Follow-up|5|||
30735319|NCT00207142|58747040|FG001|Induction Phase|Lost to Follow-up|0|||
30735320|NCT00207142|58747041|FG002|Induction Phase|Lost to Follow-up|0|||
30735321|NCT00207142|58747042|FG003|Induction Phase|Lost to Follow-up|0|||
30735322|NCT00207142|58747039|FG000|Induction Phase|Physician Decision|2|||
30735323|NCT00207142|58747040|FG001|Induction Phase|Physician Decision|0|||
30735324|NCT00207142|58747041|FG002|Induction Phase|Physician Decision|0|||
30735325|NCT00207142|58747042|FG003|Induction Phase|Physician Decision|0|||
30735326|NCT00207142|58747039|FG000|Induction Phase|Poor/noncompliance|2|||
30735327|NCT00207142|58747040|FG001|Induction Phase|Poor/noncompliance|0|||
30735328|NCT00207142|58747041|FG002|Induction Phase|Poor/noncompliance|0|||
30735329|NCT00207142|58747042|FG003|Induction Phase|Poor/noncompliance|0|||
30735330|NCT00207142|58747039|FG000|Induction Phase|Pregnancy|1|||
30735331|NCT00207142|58747040|FG001|Induction Phase|Pregnancy|0|||
30735332|NCT00207142|58747041|FG002|Induction Phase|Pregnancy|0|||
30735333|NCT00207142|58747042|FG003|Induction Phase|Pregnancy|0|||
30735334|NCT00207142|58747039|FG000|Induction Phase|Subject no longer meets study criteria|3|||
30735335|NCT00207142|58747040|FG001|Induction Phase|Subject no longer meets study criteria|0|||
30735336|NCT00207142|58747041|FG002|Induction Phase|Subject no longer meets study criteria|0|||
30735337|NCT00207142|58747042|FG003|Induction Phase|Subject no longer meets study criteria|0|||
30735338|NCT00207142|58747039|FG000|Induction Phase|Withdrawal by Subject|4|||
30735339|NCT00207142|58747040|FG001|Induction Phase|Withdrawal by Subject|0|||
30735340|NCT00207142|58747041|FG002|Induction Phase|Withdrawal by Subject|0|||
30735341|NCT00207142|58747042|FG003|Induction Phase|Withdrawal by Subject|0|||
30735342|NCT00207142|58747039|FG000|Induction Phase|Incarceration|1|||
30735343|NCT00207142|58747040|FG001|Induction Phase|Incarceration|0|||
30735344|NCT00207142|58747041|FG002|Induction Phase|Incarceration|0|||
30735345|NCT00207142|58747042|FG003|Induction Phase|Incarceration|0|||
30735346|NCT00207142|58747039|FG000|Induction Phase|Missing lab data|1|||
30735347|NCT00207142|58747040|FG001|Induction Phase|Missing lab data|0|||
30735348|NCT00207142|58747041|FG002|Induction Phase|Missing lab data|0|||
30735349|NCT00207142|58747042|FG003|Induction Phase|Missing lab data|0|||
30735350|NCT00207142|58747039|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
30735351|NCT00207142|58747040|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
30735352|NCT00207142|58747041|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
30735353|NCT00207142|58747042|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
30900535|NCT02266147|58933975|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
30900536|NCT02266147|58933976|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
30735354|NCT00207142|58747039|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
30735355|NCT00207142|58747040|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
30735356|NCT00207142|58747041|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
30735357|NCT00207142|58747042|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
30735358|NCT00207142|58747039|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
30735359|NCT00207142|58747040|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
30735360|NCT00207142|58747041|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
30735361|NCT00207142|58747042|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
30735362|NCT00207142|58747039|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
30735363|NCT00207142|58747040|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
30735364|NCT00207142|58747041|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
30735365|NCT00207142|58747042|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
30735366|NCT00207142|58747039|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
30735367|NCT00207142|58747040|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
30735368|NCT00207142|58747041|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
30735369|NCT00207142|58747042|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
30735370|NCT00207142|58747039|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
30735371|NCT00207142|58747040|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
30735372|NCT00207142|58747041|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
30735373|NCT00207142|58747042|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
30735374|NCT00207142|58747039|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
30735375|NCT00207142|58747040|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
30735376|NCT00207142|58747041|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
30735377|NCT00207142|58747042|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
30735378|NCT00207142|58747039|FG000|Maintenance Phase/Rescue Phase|Death|0|||
30735379|NCT00207142|58747040|FG001|Maintenance Phase/Rescue Phase|Death|0|||
30735380|NCT00207142|58747041|FG002|Maintenance Phase/Rescue Phase|Death|0|||
30735381|NCT00207142|58747042|FG003|Maintenance Phase/Rescue Phase|Death|1|||
30735382|NCT00207142|58747039|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
30735383|NCT00207142|58747040|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
30735384|NCT00207142|58747041|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
30735385|NCT00207142|58747042|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
30735386|NCT00268905|58747060|FG000|Overall Study|Adverse Event|3|||
30735387|NCT00268905|58747061|FG001|Overall Study|Adverse Event|0|||
30735388|NCT00268905|58747062|FG002|Overall Study|Adverse Event|4|||
30735389|NCT00268905|58747060|FG000|Overall Study|Lost to Follow-up|0|||
30735390|NCT00268905|58747061|FG001|Overall Study|Lost to Follow-up|1|||
30735391|NCT00268905|58747062|FG002|Overall Study|Lost to Follow-up|0|||
30735392|NCT00268905|58747060|FG000|Overall Study|Withdrawal by Subject|0|||
30735393|NCT00268905|58747061|FG001|Overall Study|Withdrawal by Subject|0|||
30735394|NCT00268905|58747062|FG002|Overall Study|Withdrawal by Subject|3|||
30735395|NCT00268905|58747060|FG000|Overall Study|Progressive Disease|28|||
30735396|NCT00268905|58747061|FG001|Overall Study|Progressive Disease|4|||
30735397|NCT00268905|58747062|FG002|Overall Study|Progressive Disease|3|||
30735398|NCT00268905|58747060|FG000|Overall Study|Physician Decision|3|||
30735399|NCT00268905|58747061|FG001|Overall Study|Physician Decision|0|||
30735400|NCT00268905|58747062|FG002|Overall Study|Physician Decision|1|||
30735401|NCT00268905|58747060|FG000|Overall Study|Clinical Progression|9|||
30735402|NCT00268905|58747061|FG001|Overall Study|Clinical Progression|4|||
30735403|NCT00268905|58747062|FG002|Overall Study|Clinical Progression|1|||
30735404|NCT00206518|58747072|FG000|Overall Study|Lack of Efficacy|6|||
30735405|NCT00206518|58747073|FG001|Overall Study|Lack of Efficacy|4|||
30735406|NCT00206518|58747072|FG000|Overall Study|Adverse Event|2|||
30735407|NCT00206518|58747073|FG001|Overall Study|Adverse Event|1|||
30735408|NCT00206518|58747072|FG000|Overall Study|Physician Decision|1|||
30735409|NCT00206518|58747073|FG001|Overall Study|Physician Decision|0|||
30735410|NCT00206518|58747072|FG000|Overall Study|Protocol Violation|1|||
30735411|NCT00206518|58747073|FG001|Overall Study|Protocol Violation|1|||
30735412|NCT00423722|58747081|FG000|Overall Study|Death|4|||
30735413|NCT00423722|58747082|FG001|Overall Study|Death|4|||
30735414|NCT00423722|58747081|FG000|Overall Study|Declined to participate|2|||
30735415|NCT00423722|58747082|FG001|Overall Study|Declined to participate|3|||
30735416|NCT00423722|58747081|FG000|Overall Study|Unable to complete questionnaires|4|||
30735417|NCT00423722|58747082|FG001|Overall Study|Unable to complete questionnaires|4|||
30735418|NCT00423722|58747081|FG000|Overall Study|Withdrawal by Subject|4|||
30735419|NCT00423722|58747082|FG001|Overall Study|Withdrawal by Subject|2|||
30735420|NCT00206440|58747096|FG000|Overall Study|Protocol Violation|1|||
30735421|NCT00206440|58747097|FG001|Overall Study|Protocol Violation|2|||
30735422|NCT00206440|58747096|FG000|Overall Study|Adverse Event|4|||
30735423|NCT00206440|58747097|FG001|Overall Study|Adverse Event|2|||
30735424|NCT00268437|58747103|FG000|Overall Study|Ineligible|1|||
30735425|NCT00423488|58747110|FG000|Overall Study|No evidence of study drug intake|2|||
30735426|NCT00423488|58747111|FG001|Overall Study|No evidence of study drug intake|1|||
30735427|NCT00423488|58747110|FG000|Overall Study|No post baseline data|3|||
30735428|NCT00423488|58747111|FG001|Overall Study|No post baseline data|0|||
30735429|NCT00404066|58747117|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
30735430|NCT00404066|58747117|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
30735431|NCT00423332|58747123|FG000|Overall Study|Adverse Event|6|||
30735432|NCT00423332|58747124|FG001|Overall Study|Adverse Event|2|||
30735433|NCT00423332|58747123|FG000|Overall Study|Withdrawal by Subject|1|||
30735434|NCT00423332|58747124|FG001|Overall Study|Withdrawal by Subject|0|||
30735435|NCT00423332|58747123|FG000|Overall Study|Condition under investigation worsened|1|||
30735436|NCT00423332|58747124|FG001|Overall Study|Condition under investigation worsened|1|||
30735437|NCT00423332|58747123|FG000|Overall Study|Progressive at Week 6|0|||
30735438|NCT00423332|58747124|FG001|Overall Study|Progressive at Week 6|1|||
30735439|NCT00423332|58747123|FG000|Overall Study|Unblinded before 12 weeks|1|||
30735440|NCT00423332|58747124|FG001|Overall Study|Unblinded before 12 weeks|3|||
30735441|NCT00413036|58747131|FG000|Overall Study|Adverse Event|44|||
30735442|NCT00413036|58747131|FG000|Overall Study|Lack of Efficacy|129|||
30735443|NCT00413036|58747131|FG000|Overall Study|Withdrawal by Subject|7|||
30735444|NCT00413036|58747131|FG000|Overall Study|Death|9|||
30735445|NCT00413036|58747131|FG000|Overall Study|Other|26|||
30735446|NCT00413036|58747131|FG000|Overall Study|Missing|2|||
30735447|NCT00412958|58747139|FG000|Overall Study|Withdrawal by Subject|3|||
30735448|NCT00412958|58747140|FG001|Overall Study|Withdrawal by Subject|0|||
30735449|NCT00412958|58747141|FG002|Overall Study|Withdrawal by Subject|0|||
30735450|NCT00412958|58747142|FG003|Overall Study|Withdrawal by Subject|1|||
30735451|NCT00412958|58747139|FG000|Overall Study|Adverse Event|0|||
30735452|NCT00412958|58747140|FG001|Overall Study|Adverse Event|1|||
30735453|NCT00412958|58747141|FG002|Overall Study|Adverse Event|0|||
30735454|NCT00412958|58747142|FG003|Overall Study|Adverse Event|0|||
30735455|NCT00412958|58747139|FG000|Overall Study|Lost to Follow-up|0|||
30735456|NCT00412958|58747140|FG001|Overall Study|Lost to Follow-up|1|||
30735457|NCT00412958|58747141|FG002|Overall Study|Lost to Follow-up|0|||
30735458|NCT00412958|58747142|FG003|Overall Study|Lost to Follow-up|0|||
30735459|NCT00412958|58747139|FG000|Overall Study|Death|0|||
30735460|NCT00412958|58747140|FG001|Overall Study|Death|1|||
30735461|NCT00412958|58747141|FG002|Overall Study|Death|0|||
30735462|NCT00412958|58747142|FG003|Overall Study|Death|0|||
30735463|NCT00412958|58747139|FG000|Overall Study|Transport issue|0|||
30735464|NCT00412958|58747140|FG001|Overall Study|Transport issue|1|||
30735465|NCT00412958|58747141|FG002|Overall Study|Transport issue|0|||
30735466|NCT00412958|58747142|FG003|Overall Study|Transport issue|0|||
30735467|NCT00423176|58747154|FG000|Overall Study|Adverse Event|4|||
30735468|NCT00423176|58747155|FG001|Overall Study|Adverse Event|6|||
30735469|NCT00423176|58747154|FG000|Overall Study|Treatment Failure|1|||
30735470|NCT00423176|58747155|FG001|Overall Study|Treatment Failure|6|||
30735471|NCT00423176|58747154|FG000|Overall Study|Lost to Follow-up|4|||
30735472|NCT00423176|58747155|FG001|Overall Study|Lost to Follow-up|7|||
30735473|NCT00423176|58747154|FG000|Overall Study|Withdrawal by Subject|4|||
30735474|NCT00423176|58747155|FG001|Overall Study|Withdrawal by Subject|3|||
30735475|NCT00423176|58747154|FG000|Overall Study|Protocol Violation|1|||
30735476|NCT00423176|58747155|FG001|Overall Study|Protocol Violation|3|||
30735477|NCT00423176|58747154|FG000|Overall Study|Did not meet protocol eligibility|2|||
30735478|NCT00423176|58747155|FG001|Overall Study|Did not meet protocol eligibility|4|||
30735479|NCT00412880|58747161|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
30735480|NCT00412880|58747161|FG000|Overall Study|Consent withdrawn|1|||
30735481|NCT00412880|58747161|FG000|Overall Study|Adverse Event|1|||
30735482|NCT00412880|58747161|FG000|Overall Study|Progressive disease|20|||
30735483|NCT00268203|58747165|FG000|Overall Study|Lost to Follow-up|92|||
30735484|NCT00268203|58747165|FG000|Overall Study|Withdrawal by Subject|9|||
30735485|NCT00268203|58747165|FG000|Overall Study|Received Other NHL Therapy|7|||
30735486|NCT00268203|58747165|FG000|Overall Study|Progressive Disease|359|||
30735487|NCT00268203|58747165|FG000|Overall Study|Death|84|||
30735488|NCT00268203|58747165|FG000|Overall Study|Reason Not Specified|34|||
30735489|NCT00268203|58747165|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
30735490|NCT00384930|58747174|FG000|Overall Study|Adverse Event|5|||
30735491|NCT00384930|58747175|FG001|Overall Study|Adverse Event|4|||
30735492|NCT00384930|58747176|FG002|Overall Study|Adverse Event|12|||
30735493|NCT00384930|58747177|FG003|Overall Study|Adverse Event|11|||
30735494|NCT00384930|58747178|FG004|Overall Study|Adverse Event|14|||
30735495|NCT00384930|58747174|FG000|Overall Study|Entry Criteria Not Met|2|||
30735496|NCT00384930|58747175|FG001|Overall Study|Entry Criteria Not Met|6|||
30735497|NCT00384930|58747176|FG002|Overall Study|Entry Criteria Not Met|7|||
30735498|NCT00384930|58747177|FG003|Overall Study|Entry Criteria Not Met|8|||
30735499|NCT00384930|58747178|FG004|Overall Study|Entry Criteria Not Met|4|||
30735500|NCT00384930|58747174|FG000|Overall Study|Lack of Efficacy|1|||
30735501|NCT00384930|58747175|FG001|Overall Study|Lack of Efficacy|1|||
30735502|NCT00384930|58747176|FG002|Overall Study|Lack of Efficacy|2|||
30735503|NCT00384930|58747177|FG003|Overall Study|Lack of Efficacy|1|||
30735504|NCT00384930|58747178|FG004|Overall Study|Lack of Efficacy|2|||
30735505|NCT00384930|58747174|FG000|Overall Study|Lost to Follow-up|5|||
30735506|NCT00384930|58747175|FG001|Overall Study|Lost to Follow-up|3|||
30735507|NCT00384930|58747176|FG002|Overall Study|Lost to Follow-up|0|||
30735508|NCT00384930|58747177|FG003|Overall Study|Lost to Follow-up|4|||
30735509|NCT00384930|58747178|FG004|Overall Study|Lost to Follow-up|6|||
30735510|NCT00384930|58747174|FG000|Overall Study|Physician Decision|0|||
30735511|NCT00384930|58747175|FG001|Overall Study|Physician Decision|1|||
30735512|NCT00384930|58747176|FG002|Overall Study|Physician Decision|1|||
30735513|NCT00384930|58747177|FG003|Overall Study|Physician Decision|0|||
30735514|NCT00384930|58747178|FG004|Overall Study|Physician Decision|1|||
30735515|NCT00384930|58747174|FG000|Overall Study|Protocol Violation|1|||
30735516|NCT00384930|58747175|FG001|Overall Study|Protocol Violation|0|||
30735517|NCT00384930|58747176|FG002|Overall Study|Protocol Violation|1|||
30735518|NCT00384930|58747177|FG003|Overall Study|Protocol Violation|6|||
30735519|NCT00384930|58747178|FG004|Overall Study|Protocol Violation|4|||
30735520|NCT00384930|58747174|FG000|Overall Study|Sponsor Decision|3|||
30735521|NCT00384930|58747175|FG001|Overall Study|Sponsor Decision|4|||
30735522|NCT00384930|58747176|FG002|Overall Study|Sponsor Decision|0|||
30735523|NCT00384930|58747177|FG003|Overall Study|Sponsor Decision|5|||
30735524|NCT00384930|58747178|FG004|Overall Study|Sponsor Decision|0|||
30735525|NCT00384930|58747174|FG000|Overall Study|Withdrawal by Subject|9|||
30735526|NCT00384930|58747175|FG001|Overall Study|Withdrawal by Subject|7|||
30735527|NCT00384930|58747176|FG002|Overall Study|Withdrawal by Subject|7|||
30735528|NCT00384930|58747177|FG003|Overall Study|Withdrawal by Subject|6|||
30735529|NCT00384930|58747178|FG004|Overall Study|Withdrawal by Subject|16|||
30735530|NCT00384930|58747174|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
30735531|NCT00384930|58747175|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
30735532|NCT00384930|58747176|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
30735533|NCT00384930|58747177|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
30735534|NCT00384930|58747178|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
30735535|NCT00423098|58747195|FG000|Overall Study|Adverse Event|1|||
30735536|NCT00423098|58747196|FG001|Overall Study|Adverse Event|2|||
30735537|NCT00423098|58747195|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30900537|NCT02266147|58933973|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
30735538|NCT00423098|58747196|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30735539|NCT00423098|58747195|FG000|Overall Study|Administrative problems|0|||
30735540|NCT00423098|58747196|FG001|Overall Study|Administrative problems|1|||
30735541|NCT00423098|58747195|FG000|Overall Study|Death|2|||
30735542|NCT00423098|58747196|FG001|Overall Study|Death|0|||
30735543|NCT00750698|58747213|FG000|Overall Study|Withdrawal by Subject|1|||
30735544|NCT00750698|58747214|FG001|Overall Study|Withdrawal by Subject|0|||
30735545|NCT00750698|58747213|FG000|Overall Study|Progressive disease|5|||
30735546|NCT00750698|58747214|FG001|Overall Study|Progressive disease|2|||
30735547|NCT00411788|58747220|FG000|Overall Study|Protocol Violation|1|||
30735548|NCT00411788|58747220|FG000|Overall Study|Adverse Event|1|||
30735549|NCT00422942|58747224|FG000|Overall Study|Study terminated by Sponsor|3|||
30735550|NCT00422162|58747230|FG000|Overall Study|Adverse Event|11|||
30735551|NCT00422162|58747231|FG001|Overall Study|Adverse Event|9|||
30735552|NCT00422162|58747230|FG000|Overall Study|Lack of Efficacy|4|||
30735553|NCT00422162|58747231|FG001|Overall Study|Lack of Efficacy|10|||
30735554|NCT00422162|58747230|FG000|Overall Study|Withdrawal by Subject|7|||
30735555|NCT00422162|58747231|FG001|Overall Study|Withdrawal by Subject|6|||
30735556|NCT00422162|58747230|FG000|Overall Study|Lost to Follow-up|1|||
30735557|NCT00422162|58747231|FG001|Overall Study|Lost to Follow-up|2|||
30735558|NCT00422162|58747230|FG000|Overall Study|Non-Compliant with Protocol|1|||
30735559|NCT00422162|58747231|FG001|Overall Study|Non-Compliant with Protocol|1|||
30735560|NCT00422162|58747230|FG000|Overall Study|Other|0|||
30735561|NCT00422162|58747231|FG001|Overall Study|Other|1|||
30735562|NCT00422162|58747230|FG000|Overall Study|Didn't Receive Treatment|0|||
30735563|NCT00422162|58747231|FG001|Overall Study|Didn't Receive Treatment|1|||
30735564|NCT00411632|58747247|FG000|Overall Study|Death|1|||
30735565|NCT00422084|58747253|FG000|Overall Study|Adverse Event|21|||
30735566|NCT00422084|58747254|FG001|Overall Study|Adverse Event|7|||
30735567|NCT00422084|58747253|FG000|Overall Study|Withdrawal by Subject|12|||
30735568|NCT00422084|58747254|FG001|Overall Study|Withdrawal by Subject|9|||
30735569|NCT00422084|58747253|FG000|Overall Study|Lost to Follow-up|14|||
30735570|NCT00422084|58747254|FG001|Overall Study|Lost to Follow-up|9|||
30735571|NCT00422084|58747253|FG000|Overall Study|Protocol Violation|4|||
30735572|NCT00422084|58747254|FG001|Overall Study|Protocol Violation|1|||
30735573|NCT00422084|58747253|FG000|Overall Study|Lack of Efficacy|40|||
30735574|NCT00422084|58747254|FG001|Overall Study|Lack of Efficacy|42|||
30735575|NCT00422084|58747253|FG000|Overall Study|P. vivax infection|3|||
30735576|NCT00422084|58747254|FG001|Overall Study|P. vivax infection|6|||
30735577|NCT00422084|58747253|FG000|Overall Study|Cyesis|1|||
30735578|NCT00422084|58747254|FG001|Overall Study|Cyesis|0|||
30735579|NCT00422084|58747253|FG000|Overall Study|Withdrawn from study accidentally|1|||
30735580|NCT00422084|58747254|FG001|Overall Study|Withdrawn from study accidentally|0|||
30735581|NCT00422084|58747253|FG000|Overall Study|Non-compliance|1|||
30735582|NCT00422084|58747254|FG001|Overall Study|Non-compliance|0|||
30735583|NCT00422084|58747253|FG000|Overall Study|Re-location|0|||
30735584|NCT00422084|58747254|FG001|Overall Study|Re-location|1|||
30735585|NCT00422084|58747253|FG000|Overall Study|Not defined|1|||
30735586|NCT00422084|58747254|FG001|Overall Study|Not defined|1|||
30735587|NCT00421928|58747263|FG000|Overall Study|Adverse Event|61|||
30735588|NCT00421928|58747264|FG001|Overall Study|Adverse Event|140|||
30735589|NCT00421928|58747265|FG002|Overall Study|Adverse Event|22|||
30735590|NCT00421928|58747263|FG000|Overall Study|Lost to Follow-up|5|||
30735591|NCT00421928|58747264|FG001|Overall Study|Lost to Follow-up|0|||
30735592|NCT00421928|58747265|FG002|Overall Study|Lost to Follow-up|3|||
30735593|NCT00421928|58747263|FG000|Overall Study|Withdrawal by Subject|50|||
30735594|NCT00421928|58747264|FG001|Overall Study|Withdrawal by Subject|48|||
30735595|NCT00421928|58747265|FG002|Overall Study|Withdrawal by Subject|43|||
30735596|NCT00421928|58747263|FG000|Overall Study|Lack of Efficacy|15|||
30735597|NCT00421928|58747264|FG001|Overall Study|Lack of Efficacy|7|||
30735598|NCT00421928|58747265|FG002|Overall Study|Lack of Efficacy|35|||
30735599|NCT00421928|58747263|FG000|Overall Study|Study drug non-compliant|6|||
30735600|NCT00421928|58747264|FG001|Overall Study|Study drug non-compliant|7|||
30735601|NCT00421928|58747265|FG002|Overall Study|Study drug non-compliant|4|||
30735602|NCT00421928|58747263|FG000|Overall Study|All other|26|||
30735603|NCT00421928|58747264|FG001|Overall Study|All other|21|||
30735604|NCT00421928|58747265|FG002|Overall Study|All other|27|||
30735605|NCT00421928|58747263|FG000|Overall Study|Death|0|||
30735606|NCT00421928|58747264|FG001|Overall Study|Death|1|||
30735607|NCT00421928|58747265|FG002|Overall Study|Death|0|||
30735608|NCT00383292|58747276|FG000|Overall Study|Adverse Event|4|||
30735609|NCT00383292|58747277|FG001|Overall Study|Adverse Event|1|||
30735610|NCT00383292|58747278|FG002|Overall Study|Adverse Event|2|||
30735611|NCT00383292|58747276|FG000|Overall Study|Death|3|||
30735612|NCT00383292|58747277|FG001|Overall Study|Death|3|||
30735613|NCT00383292|58747278|FG002|Overall Study|Death|3|||
30735614|NCT00383292|58747276|FG000|Overall Study|Physician Decision|4|||
30735615|NCT00383292|58747277|FG001|Overall Study|Physician Decision|0|||
30735616|NCT00383292|58747278|FG002|Overall Study|Physician Decision|1|||
30735617|NCT00383292|58747276|FG000|Overall Study|Withdrawal by Subject|3|||
30735618|NCT00383292|58747277|FG001|Overall Study|Withdrawal by Subject|2|||
30735619|NCT00383292|58747278|FG002|Overall Study|Withdrawal by Subject|2|||
30735620|NCT00383292|58747276|FG000|Overall Study|Other|1|||
30735621|NCT00383292|58747277|FG001|Overall Study|Other|0|||
30735622|NCT00383292|58747278|FG002|Overall Study|Other|0|||
30735623|NCT00372060|58747289|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
30735624|NCT00372060|58747290|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
30735625|NCT00372060|58747289|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
30735626|NCT00372060|58747290|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
30735627|NCT00372060|58747289|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
30735628|NCT00372060|58747290|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
30735629|NCT00372060|58747289|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
30735630|NCT00372060|58747290|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
30735631|NCT00372060|58747289|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
30735632|NCT00372060|58747290|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
30735633|NCT00372060|58747289|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
30735634|NCT00372060|58747290|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
30735635|NCT00421304|58747302|FG000|Overall Study|Lost to Follow-up|5|||
30735636|NCT00421304|58747303|FG001|Overall Study|Lost to Follow-up|2|||
30735637|NCT00421304|58747304|FG002|Overall Study|Lost to Follow-up|5|||
30735638|NCT00421304|58747302|FG000|Overall Study|Withdrawal by Subject|2|||
30735639|NCT00421304|58747303|FG001|Overall Study|Withdrawal by Subject|2|||
30735640|NCT00421304|58747304|FG002|Overall Study|Withdrawal by Subject|2|||
30735641|NCT00421304|58747302|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
30735642|NCT00421304|58747303|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
30735643|NCT00421304|58747304|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
30735644|NCT00421304|58747302|FG000|Overall Study|Did not attend Day 360 visit|0|||
30735645|NCT00421304|58747303|FG001|Overall Study|Did not attend Day 360 visit|0|||
30735646|NCT00421304|58747304|FG002|Overall Study|Did not attend Day 360 visit|1|||
30735647|NCT00396630|58747316|FG000|Overall Study|Lost to Follow-up|1|||
30735648|NCT00396630|58747317|FG001|Overall Study|Lost to Follow-up|1|||
30735649|NCT00396630|58747316|FG000|Overall Study|Withdrawal by Subject|1|||
30735650|NCT00396630|58747317|FG001|Overall Study|Withdrawal by Subject|1|||
30735651|NCT00396630|58747316|FG000|Overall Study|Not vaccinated at Visit 3|3|||
30735652|NCT00396630|58747317|FG001|Overall Study|Not vaccinated at Visit 3|3|||
30735653|NCT00396318|58747324|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
30735654|NCT00396162|58747330|FG000|Overall Study|Withdrawal by Subject|2|||
30735655|NCT00396162|58747331|FG001|Overall Study|Withdrawal by Subject|3|||
30735656|NCT00381888|58747341|FG000|Overall Study|Death|1|||
30735657|NCT00381888|58747341|FG000|Overall Study|Withdrawal by Subject|1|||
30735658|NCT00381888|58747341|FG000|Overall Study|Physician Decision|1|||
30735659|NCT00381888|58747341|FG000|Overall Study|Protocol Violation|9|||
30735660|NCT00381888|58747341|FG000|Overall Study|Had laparoscopic surgery|2|||
30735661|NCT00381888|58747341|FG000|Overall Study|Surgery was cancelled|2|||
30735662|NCT00381888|58747341|FG000|Overall Study|Adverse Event|1|||
30735663|NCT00267969|58747348|FG000|Controlled Period|Adverse Event|6|||
30735664|NCT00267969|58747349|FG001|Controlled Period|Adverse Event|0|||
30735665|NCT00267969|58747350|FG002|Controlled Period|Adverse Event|2|||
30735666|NCT00267969|58747351|FG003|Controlled Period|Adverse Event|0|||
30735667|NCT00267969|58747352|FG004|Controlled Period|Adverse Event|0|||
30735668|NCT00267969|58747353|FG005|Controlled Period|Adverse Event|0|||
30735669|NCT00267969|58747354|FG006|Controlled Period|Adverse Event|0|||
30735670|NCT00267969|58747348|FG000|Controlled Period|Lack of Efficacy|3|||
30735671|NCT00267969|58747349|FG001|Controlled Period|Lack of Efficacy|0|||
30735672|NCT00267969|58747350|FG002|Controlled Period|Lack of Efficacy|1|||
30735673|NCT00267969|58747351|FG003|Controlled Period|Lack of Efficacy|0|||
30735674|NCT00267969|58747352|FG004|Controlled Period|Lack of Efficacy|0|||
30735675|NCT00267969|58747353|FG005|Controlled Period|Lack of Efficacy|0|||
30735676|NCT00267969|58747354|FG006|Controlled Period|Lack of Efficacy|0|||
30735677|NCT00267969|58747348|FG000|Controlled Period|Lost to Follow-up|1|||
30735678|NCT00267969|58747349|FG001|Controlled Period|Lost to Follow-up|0|||
30735679|NCT00267969|58747350|FG002|Controlled Period|Lost to Follow-up|1|||
30735680|NCT00267969|58747351|FG003|Controlled Period|Lost to Follow-up|0|||
30735681|NCT00267969|58747352|FG004|Controlled Period|Lost to Follow-up|0|||
30790955|NCT00835042|58804062|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
30790956|NCT00834418|58804099|FG000|Overall Study|Adverse Event|0|||
30790957|NCT00834418|58804100|FG001|Overall Study|Adverse Event|2|||
30790958|NCT00834340|58804106|FG000|Washout|Adverse Event|1|||
30735682|NCT00267969|58747353|FG005|Controlled Period|Lost to Follow-up|0|||
30735683|NCT00267969|58747354|FG006|Controlled Period|Lost to Follow-up|0|||
30735684|NCT00267969|58747348|FG000|Controlled Period|Randomized but not treated|0|||
30735685|NCT00267969|58747349|FG001|Controlled Period|Randomized but not treated|0|||
30735686|NCT00267969|58747350|FG002|Controlled Period|Randomized but not treated|1|||
30735687|NCT00267969|58747351|FG003|Controlled Period|Randomized but not treated|0|||
30735688|NCT00267969|58747352|FG004|Controlled Period|Randomized but not treated|0|||
30735689|NCT00267969|58747353|FG005|Controlled Period|Randomized but not treated|0|||
30735690|NCT00267969|58747354|FG006|Controlled Period|Randomized but not treated|0|||
30735691|NCT00267969|58747348|FG000|Controlled Period|Other|2|||
30735692|NCT00267969|58747349|FG001|Controlled Period|Other|1|||
30735693|NCT00267969|58747350|FG002|Controlled Period|Other|6|||
30735694|NCT00267969|58747351|FG003|Controlled Period|Other|0|||
30735695|NCT00267969|58747352|FG004|Controlled Period|Other|0|||
30735696|NCT00267969|58747353|FG005|Controlled Period|Other|0|||
30735697|NCT00267969|58747354|FG006|Controlled Period|Other|0|||
30735698|NCT00267969|58747348|FG000|After Controlled Period|Adverse Event|0|||
30735699|NCT00267969|58747349|FG001|After Controlled Period|Adverse Event|0|||
30735700|NCT00267969|58747350|FG002|After Controlled Period|Adverse Event|0|||
30735701|NCT00267969|58747351|FG003|After Controlled Period|Adverse Event|7|||
30735702|NCT00267969|58747352|FG004|After Controlled Period|Adverse Event|8|||
30735703|NCT00267969|58747353|FG005|After Controlled Period|Adverse Event|23|||
30735704|NCT00267969|58747354|FG006|After Controlled Period|Adverse Event|21|||
30735705|NCT00267969|58747348|FG000|After Controlled Period|Death|0|||
30735706|NCT00267969|58747349|FG001|After Controlled Period|Death|0|||
30735707|NCT00267969|58747350|FG002|After Controlled Period|Death|0|||
30735708|NCT00267969|58747351|FG003|After Controlled Period|Death|1|||
30735709|NCT00267969|58747352|FG004|After Controlled Period|Death|2|||
30735710|NCT00267969|58747353|FG005|After Controlled Period|Death|0|||
30735711|NCT00267969|58747354|FG006|After Controlled Period|Death|1|||
30735712|NCT00267969|58747348|FG000|After Controlled Period|Lack of Efficacy|0|||
30735713|NCT00267969|58747349|FG001|After Controlled Period|Lack of Efficacy|0|||
30735714|NCT00267969|58747350|FG002|After Controlled Period|Lack of Efficacy|0|||
30735715|NCT00267969|58747351|FG003|After Controlled Period|Lack of Efficacy|10|||
30735716|NCT00267969|58747352|FG004|After Controlled Period|Lack of Efficacy|6|||
30735717|NCT00267969|58747353|FG005|After Controlled Period|Lack of Efficacy|28|||
30735718|NCT00267969|58747354|FG006|After Controlled Period|Lack of Efficacy|15|||
30735719|NCT00267969|58747348|FG000|After Controlled Period|Lost to Follow-up|0|||
30735720|NCT00267969|58747349|FG001|After Controlled Period|Lost to Follow-up|0|||
30735721|NCT00267969|58747350|FG002|After Controlled Period|Lost to Follow-up|0|||
30735722|NCT00267969|58747351|FG003|After Controlled Period|Lost to Follow-up|5|||
30735723|NCT00267969|58747352|FG004|After Controlled Period|Lost to Follow-up|8|||
30735724|NCT00267969|58747353|FG005|After Controlled Period|Lost to Follow-up|9|||
30735725|NCT00267969|58747354|FG006|After Controlled Period|Lost to Follow-up|10|||
30735726|NCT00267969|58747348|FG000|After Controlled Period|Other|0|||
30735727|NCT00267969|58747349|FG001|After Controlled Period|Other|0|||
30735728|NCT00267969|58747350|FG002|After Controlled Period|Other|0|||
30735729|NCT00267969|58747351|FG003|After Controlled Period|Other|13|||
30735730|NCT00267969|58747352|FG004|After Controlled Period|Other|11|||
30735731|NCT00267969|58747353|FG005|After Controlled Period|Other|22|||
30735732|NCT00267969|58747354|FG006|After Controlled Period|Other|25|||
30735733|NCT00280293|58747374|FG000|Overall Study|Protocol Violation|3|||
30735734|NCT00280293|58747375|FG001|Overall Study|Protocol Violation|0|||
30735735|NCT00280293|58747374|FG000|Overall Study|Physician Decision|5|||
30735736|NCT00280293|58747375|FG001|Overall Study|Physician Decision|4|||
30735737|NCT00280293|58747374|FG000|Overall Study|Lost to Follow-up|14|||
30735738|NCT00280293|58747375|FG001|Overall Study|Lost to Follow-up|12|||
30735739|NCT00280293|58747374|FG000|Overall Study|Withdrawal by Subject|3|||
30735740|NCT00280293|58747375|FG001|Overall Study|Withdrawal by Subject|5|||
30735741|NCT00280293|58747374|FG000|Overall Study|Incarceration/Legal Reasons|1|||
30735742|NCT00280293|58747375|FG001|Overall Study|Incarceration/Legal Reasons|1|||
30735743|NCT00280293|58747374|FG000|Overall Study|Adverse Event|0|||
30735744|NCT00280293|58747375|FG001|Overall Study|Adverse Event|1|||
30735745|NCT00421148|58747401|FG000|Overall Study|Lost to Follow-up|0|||
30735746|NCT00421148|58747402|FG001|Overall Study|Lost to Follow-up|0|||
30735747|NCT00421148|58747403|FG002|Overall Study|Lost to Follow-up|0|||
30735748|NCT00421148|58747404|FG003|Overall Study|Lost to Follow-up|0|||
30735749|NCT00421148|58747405|FG004|Overall Study|Lost to Follow-up|0|||
30735750|NCT00421148|58747406|FG005|Overall Study|Lost to Follow-up|0|||
30735751|NCT00421148|58747407|FG006|Overall Study|Lost to Follow-up|0|||
30735752|NCT00421148|58747408|FG007|Overall Study|Lost to Follow-up|0|||
30735753|NCT00421148|58747409|FG008|Overall Study|Lost to Follow-up|0|||
30735754|NCT00421148|58747410|FG009|Overall Study|Lost to Follow-up|0|||
30735755|NCT00421148|58747411|FG010|Overall Study|Lost to Follow-up|0|||
30735756|NCT00421148|58747412|FG011|Overall Study|Lost to Follow-up|0|||
30735757|NCT00421148|58747413|FG012|Overall Study|Lost to Follow-up|0|||
30735758|NCT00421148|58747414|FG013|Overall Study|Lost to Follow-up|0|||
30735759|NCT00421148|58747415|FG014|Overall Study|Lost to Follow-up|0|||
30735760|NCT00421148|58747416|FG015|Overall Study|Lost to Follow-up|0|||
30735761|NCT00421148|58747417|FG016|Overall Study|Lost to Follow-up|0|||
30735762|NCT00421148|58747418|FG017|Overall Study|Lost to Follow-up|1|||
30735763|NCT00421148|58747419|FG018|Overall Study|Lost to Follow-up|0|||
30735764|NCT00421148|58747420|FG019|Overall Study|Lost to Follow-up|0|||
30735765|NCT00421148|58747401|FG000|Overall Study|Withdrawal by Subject|0|||
30735766|NCT00421148|58747402|FG001|Overall Study|Withdrawal by Subject|0|||
30735767|NCT00421148|58747403|FG002|Overall Study|Withdrawal by Subject|0|||
30735768|NCT00421148|58747404|FG003|Overall Study|Withdrawal by Subject|0|||
30735769|NCT00421148|58747405|FG004|Overall Study|Withdrawal by Subject|0|||
30735770|NCT00421148|58747406|FG005|Overall Study|Withdrawal by Subject|0|||
30735771|NCT00421148|58747407|FG006|Overall Study|Withdrawal by Subject|0|||
30735772|NCT00421148|58747408|FG007|Overall Study|Withdrawal by Subject|0|||
30735773|NCT00421148|58747409|FG008|Overall Study|Withdrawal by Subject|0|||
30735774|NCT00421148|58747410|FG009|Overall Study|Withdrawal by Subject|0|||
30735775|NCT00421148|58747411|FG010|Overall Study|Withdrawal by Subject|0|||
30735776|NCT00421148|58747412|FG011|Overall Study|Withdrawal by Subject|0|||
30735777|NCT00421148|58747413|FG012|Overall Study|Withdrawal by Subject|0|||
30735778|NCT00421148|58747414|FG013|Overall Study|Withdrawal by Subject|0|||
30735779|NCT00421148|58747415|FG014|Overall Study|Withdrawal by Subject|0|||
30735780|NCT00421148|58747416|FG015|Overall Study|Withdrawal by Subject|0|||
30735781|NCT00421148|58747417|FG016|Overall Study|Withdrawal by Subject|0|||
30735782|NCT00421148|58747418|FG017|Overall Study|Withdrawal by Subject|1|||
30735783|NCT00421148|58747419|FG018|Overall Study|Withdrawal by Subject|0|||
30735784|NCT00421148|58747420|FG019|Overall Study|Withdrawal by Subject|0|||
30735785|NCT00421148|58747401|FG000|Overall Study|Protocol Violation|0|||
30735786|NCT00421148|58747402|FG001|Overall Study|Protocol Violation|0|||
30735787|NCT00421148|58747403|FG002|Overall Study|Protocol Violation|0|||
30735788|NCT00421148|58747404|FG003|Overall Study|Protocol Violation|0|||
30735789|NCT00421148|58747405|FG004|Overall Study|Protocol Violation|0|||
30735790|NCT00421148|58747406|FG005|Overall Study|Protocol Violation|1|||
30735791|NCT00421148|58747407|FG006|Overall Study|Protocol Violation|0|||
30735792|NCT00421148|58747408|FG007|Overall Study|Protocol Violation|0|||
30735793|NCT00421148|58747409|FG008|Overall Study|Protocol Violation|0|||
30735794|NCT00421148|58747410|FG009|Overall Study|Protocol Violation|0|||
30735795|NCT00421148|58747411|FG010|Overall Study|Protocol Violation|0|||
30735796|NCT00421148|58747412|FG011|Overall Study|Protocol Violation|0|||
30735797|NCT00421148|58747413|FG012|Overall Study|Protocol Violation|0|||
30735798|NCT00421148|58747414|FG013|Overall Study|Protocol Violation|0|||
30735799|NCT00421148|58747415|FG014|Overall Study|Protocol Violation|0|||
30735800|NCT00421148|58747416|FG015|Overall Study|Protocol Violation|0|||
30735801|NCT00421148|58747417|FG016|Overall Study|Protocol Violation|0|||
30735802|NCT00421148|58747418|FG017|Overall Study|Protocol Violation|0|||
30735803|NCT00421148|58747419|FG018|Overall Study|Protocol Violation|1|||
30735804|NCT00421148|58747420|FG019|Overall Study|Protocol Violation|0|||
30735805|NCT00403754|58747462|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
30735806|NCT00403754|58747463|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
30735807|NCT00403754|58747464|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
30735808|NCT00403754|58747465|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
30735809|NCT00403754|58747462|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
30735810|NCT00403754|58747463|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
30735811|NCT00403754|58747464|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
30735812|NCT00403754|58747465|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
30735813|NCT00280059|58747479|FG000|Efficacy Assessment Phase|Death|2|||
30735814|NCT00280059|58747480|FG001|Efficacy Assessment Phase|Death|0|||
30735815|NCT00280059|58747479|FG000|Efficacy Assessment Phase|Adverse Event|33|||
30735816|NCT00280059|58747480|FG001|Efficacy Assessment Phase|Adverse Event|31|||
30735817|NCT00280059|58747479|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
30735818|NCT00280059|58747480|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
30735819|NCT00280059|58747479|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
30735820|NCT00280059|58747480|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
30735821|NCT00280059|58747479|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
30735822|NCT00280059|58747480|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
30735823|NCT00280059|58747479|FG000|Efficacy Assessment Phase|Other|7|||
30735824|NCT00280059|58747480|FG001|Efficacy Assessment Phase|Other|8|||
30735825|NCT00280059|58747479|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
30735826|NCT00280059|58747480|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
30735827|NCT00403130|58747494|FG000|2 Years From Start of Treatment|Not Eligible|3|||
30735828|NCT00403130|58747494|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
30735829|NCT00403130|58747494|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
30790959|NCT00834340|58804107|FG001|Washout|Adverse Event|0|||
30735830|NCT00403130|58747494|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
30735831|NCT00402740|58747498|FG000|Overall Study|Withdrawal by Subject|18|||
30735832|NCT00402740|58747498|FG000|Overall Study|Death|50|||
30735833|NCT00402740|58747498|FG000|Overall Study|Lost to Follow-up|6|||
30735834|NCT00402740|58747498|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
30735835|NCT00402740|58747498|FG000|Overall Study|Subject disposition unknown.|1|||
30735836|NCT00420290|58747508|FG000|Overall Study|Adverse Event|3|||
30735837|NCT00420290|58747509|FG001|Overall Study|Adverse Event|1|||
30735838|NCT00420290|58747508|FG000|Overall Study|Withdrawal by Subject|0|||
30735839|NCT00420290|58747509|FG001|Overall Study|Withdrawal by Subject|2|||
30735840|NCT00420290|58747508|FG000|Overall Study|did not meet inclusion/exclusion|1|||
30735841|NCT00420290|58747509|FG001|Overall Study|did not meet inclusion/exclusion|1|||
30735842|NCT00267189|58747517|FG000|Overall Study|Patient withdrew consent|1|||
30735843|NCT00267189|58747518|FG001|Overall Study|Patient withdrew consent|1|||
30735844|NCT00267189|58747517|FG000|Overall Study|Death|1|||
30735845|NCT00267189|58747518|FG001|Overall Study|Death|0|||
30735846|NCT00267189|58747517|FG000|Overall Study|Missing|3|||
30735847|NCT00267189|58747518|FG001|Overall Study|Missing|0|||
30735848|NCT03834350|58747524|FG000|Overall Study|Withdrawal by Subject|1|||
30735849|NCT00402116|58747532|FG000|Overall Study|Jaw infection after surgery-other|1|||
30735850|NCT00402116|58747533|FG001|Overall Study|Jaw infection after surgery-other|0|||
30735851|NCT00402116|58747534|FG002|Overall Study|Jaw infection after surgery-other|0|||
30735852|NCT00402116|58747532|FG000|Overall Study|Withdrawal by Subject|1|||
30735853|NCT00402116|58747533|FG001|Overall Study|Withdrawal by Subject|0|||
30735854|NCT00402116|58747534|FG002|Overall Study|Withdrawal by Subject|5|||
30735855|NCT00402116|58747532|FG000|Overall Study|Treatment completed per protocol|1|||
30735856|NCT00402116|58747533|FG001|Overall Study|Treatment completed per protocol|1|||
30735857|NCT00402116|58747534|FG002|Overall Study|Treatment completed per protocol|2|||
30735858|NCT00402116|58747532|FG000|Overall Study|other complicating disease|0|||
30735859|NCT00402116|58747533|FG001|Overall Study|other complicating disease|0|||
30735860|NCT00402116|58747534|FG002|Overall Study|other complicating disease|2|||
30735861|NCT00402116|58747532|FG000|Overall Study|Disease Progression|0|||
30735862|NCT00402116|58747533|FG001|Overall Study|Disease Progression|4|||
30735863|NCT00402116|58747534|FG002|Overall Study|Disease Progression|38|||
30735864|NCT00402116|58747532|FG000|Overall Study|mistaken thrombocytopenia|0|||
30735865|NCT00402116|58747533|FG001|Overall Study|mistaken thrombocytopenia|0|||
30735866|NCT00402116|58747534|FG002|Overall Study|mistaken thrombocytopenia|1|||
30735867|NCT00402116|58747532|FG000|Overall Study|decline related hyponatremia/tumor|0|||
30735868|NCT00402116|58747533|FG001|Overall Study|decline related hyponatremia/tumor|0|||
30735869|NCT00402116|58747534|FG002|Overall Study|decline related hyponatremia/tumor|1|||
30735870|NCT00402116|58747532|FG000|Overall Study|Adverse Event|0|||
30735871|NCT00402116|58747533|FG001|Overall Study|Adverse Event|1|||
30735872|NCT00402116|58747534|FG002|Overall Study|Adverse Event|6|||
30735873|NCT00401960|58747564|FG000|Overall Study|Lost to Follow-up|3|||
30735874|NCT00401960|58747565|FG001|Overall Study|Lost to Follow-up|0|||
30735875|NCT00401960|58747564|FG000|Overall Study|Death|2|||
30735876|NCT00401960|58747565|FG001|Overall Study|Death|0|||
30735877|NCT00401726|58747575|FG000|Overall Study|Adverse Event|34|||
30735878|NCT00401726|58747576|FG001|Overall Study|Adverse Event|45|||
30735879|NCT00401726|58747575|FG000|Overall Study|Death|0|||
30735880|NCT00401726|58747576|FG001|Overall Study|Death|3|||
30735881|NCT00401726|58747575|FG000|Overall Study|Sponsor Request|0|||
30735882|NCT00401726|58747576|FG001|Overall Study|Sponsor Request|1|||
30735883|NCT00401726|58747575|FG000|Overall Study|Physician Decision|3|||
30735884|NCT00401726|58747576|FG001|Overall Study|Physician Decision|6|||
30735885|NCT00401726|58747575|FG000|Overall Study|Lost to Follow-up|23|||
30735886|NCT00401726|58747576|FG001|Overall Study|Lost to Follow-up|20|||
30735887|NCT00401726|58747575|FG000|Overall Study|Protocol Violation|6|||
30735888|NCT00401726|58747576|FG001|Overall Study|Protocol Violation|3|||
30735889|NCT00401726|58747575|FG000|Overall Study|Withdrawal by Subject|18|||
30735890|NCT00401726|58747576|FG001|Overall Study|Withdrawal by Subject|24|||
30735891|NCT00401726|58747575|FG000|Overall Study|Lack of Efficacy|4|||
30735892|NCT00401726|58747576|FG001|Overall Study|Lack of Efficacy|6|||
30735893|NCT00401726|58747575|FG000|Overall Study|Protocol Deviation|9|||
30735894|NCT00401726|58747576|FG001|Overall Study|Protocol Deviation|4|||
30790960|NCT00834340|58804106|FG000|Washout|Withdrawal by Subject|1|||
30790961|NCT00834340|58804107|FG001|Washout|Withdrawal by Subject|0|||
30900538|NCT02266147|58933974|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
30900539|NCT02266147|58933975|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
30735895|NCT00371826|58747585|FG000|Core Phase (12 Months)|Adverse Event|15|||
30735896|NCT00371826|58747586|FG001|Core Phase (12 Months)|Adverse Event|4|||
30735897|NCT00371826|58747587|FG002|Core Phase (12 Months)|Adverse Event|9|||
30900540|NCT02266147|58933976|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
30900541|NCT02266147|58933973|FG000|PART 1: Dose Escalation|Other|1|||
30900542|NCT02266147|58933974|FG001|PART 1: Dose Escalation|Other|1|||
30735898|NCT00371826|58747585|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
30735899|NCT00371826|58747586|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
30900543|NCT02266147|58933975|FG002|PART 1: Dose Escalation|Other|0|||
30735900|NCT00371826|58747587|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
30735901|NCT00371826|58747585|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
30900544|NCT02266147|58933976|FG003|PART 1: Dose Escalation|Other|0|||
30735902|NCT00371826|58747586|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
30735903|NCT00371826|58747587|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
30735904|NCT00371826|58747585|FG000|Core Phase (12 Months)|Protocol Violation|1|||
30900545|NCT02266147|58933973|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
30900546|NCT02266147|58933974|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
30735905|NCT00371826|58747586|FG001|Core Phase (12 Months)|Protocol Violation|0|||
30735906|NCT00371826|58747587|FG002|Core Phase (12 Months)|Protocol Violation|1|||
30735907|NCT00371826|58747585|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
30735908|NCT00371826|58747586|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
30735909|NCT00371826|58747587|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
30735910|NCT00371826|58747585|FG000|Core Phase (12 Months)|Administrative problems|1|||
30735911|NCT00371826|58747586|FG001|Core Phase (12 Months)|Administrative problems|0|||
30735912|NCT00371826|58747587|FG002|Core Phase (12 Months)|Administrative problems|8|||
30735913|NCT00371826|58747585|FG000|Core Phase (12 Months)|Graft Loss|0|||
30735914|NCT00371826|58747586|FG001|Core Phase (12 Months)|Graft Loss|1|||
30735915|NCT00371826|58747587|FG002|Core Phase (12 Months)|Graft Loss|0|||
30735916|NCT00371826|58747585|FG000|Extension Phase (24 Months)|Adverse Event|4|||
30735917|NCT00371826|58747586|FG001|Extension Phase (24 Months)|Adverse Event|5|||
30735918|NCT00371826|58747587|FG002|Extension Phase (24 Months)|Adverse Event|0|||
30735919|NCT00371826|58747585|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
30735920|NCT00371826|58747586|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
30735921|NCT00371826|58747587|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
30735922|NCT00371826|58747585|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
30735923|NCT00371826|58747586|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
30735924|NCT00371826|58747587|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
30735925|NCT00371826|58747585|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
30735926|NCT00371826|58747586|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
30735927|NCT00371826|58747587|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
30735928|NCT00371826|58747585|FG000|Extension Phase (24 Months)|Administrative problems|0|||
30735929|NCT00371826|58747586|FG001|Extension Phase (24 Months)|Administrative problems|0|||
30735930|NCT00371826|58747587|FG002|Extension Phase (24 Months)|Administrative problems|2|||
30735931|NCT00396084|58747601|FG000|Overall Study|Adverse Event|0|||
30735932|NCT00396084|58747602|FG001|Overall Study|Adverse Event|0|||
30735933|NCT00396084|58747603|FG002|Overall Study|Adverse Event|0|||
30735934|NCT00396084|58747604|FG003|Overall Study|Adverse Event|0|||
30735935|NCT00396084|58747605|FG004|Overall Study|Adverse Event|1|||
30735936|NCT00396084|58747606|FG005|Overall Study|Adverse Event|2|||
30735937|NCT00396084|58747601|FG000|Overall Study|Withdrawal by Subject|0|||
30735938|NCT00396084|58747602|FG001|Overall Study|Withdrawal by Subject|0|||
30735939|NCT00396084|58747603|FG002|Overall Study|Withdrawal by Subject|0|||
30735940|NCT00396084|58747604|FG003|Overall Study|Withdrawal by Subject|1|||
30735941|NCT00396084|58747605|FG004|Overall Study|Withdrawal by Subject|0|||
30735942|NCT00396084|58747606|FG005|Overall Study|Withdrawal by Subject|0|||
30735943|NCT00395850|58747628|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
30735944|NCT00395850|58747629|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
30735945|NCT00395850|58747630|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
30735946|NCT00395850|58747631|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
30735947|NCT00395850|58747628|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
30735948|NCT00395850|58747629|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
30735949|NCT00395850|58747630|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
30735950|NCT00395850|58747631|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
30735951|NCT00395850|58747628|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
30735952|NCT00395850|58747629|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
30735953|NCT00395850|58747630|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
30735954|NCT00395850|58747631|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
30735955|NCT00395850|58747628|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
30735956|NCT00395850|58747629|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
30735957|NCT00395850|58747630|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
30735958|NCT00395850|58747631|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
30735959|NCT00395850|58747628|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
30735960|NCT00395850|58747629|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
30735961|NCT00395850|58747630|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
30735962|NCT00395850|58747631|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
30735963|NCT00395850|58747628|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
30735964|NCT00395850|58747629|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
30735965|NCT00395850|58747630|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
30735966|NCT00395850|58747631|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
30735967|NCT00395850|58747628|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
30735968|NCT00395850|58747629|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
30790962|NCT00151996|58804113|FG000|Overall Study|Adverse Event|3|||
30735969|NCT00395850|58747630|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
30735970|NCT00395850|58747631|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
30735971|NCT00420212|58747644|FG000|Overall Study|Adverse Event|22|||
30735972|NCT00420212|58747645|FG001|Overall Study|Adverse Event|40|||
30900547|NCT02266147|58933975|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
30900548|NCT02266147|58933976|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
30900549|NCT02266147|58933973|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
30900550|NCT02266147|58933974|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
30900551|NCT02266147|58933975|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
30900552|NCT02266147|58933976|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
30900553|NCT02264977|58933988|FG000|Overall Study|Death|3|||
30900554|NCT02264977|58933988|FG000|Overall Study|Physician Decision|1|||
30900555|NCT02264977|58933988|FG000|Overall Study|Refuse to return|1|||
30900556|NCT02264821|58933995|FG000|Overall Study|Protocol Violation|1|||
30900557|NCT02264821|58933996|FG001|Overall Study|Protocol Violation|3|||
30900558|NCT02264821|58933997|FG002|Overall Study|Protocol Violation|6|||
30900559|NCT02261467|58934007|FG000|Overall Study|Enrolled in Error|1|||
30900560|NCT02261467|58934008|FG001|Overall Study|Enrolled in Error|0|||
30900561|NCT02261467|58934007|FG000|Overall Study|Protocol Violation|0|||
30900562|NCT02261467|58934008|FG001|Overall Study|Protocol Violation|1|||
30900563|NCT02261467|58934007|FG000|Overall Study|Personal Reasons|17|||
30900564|NCT02261467|58934008|FG001|Overall Study|Personal Reasons|22|||
30900565|NCT02261467|58934007|FG000|Overall Study|Lost to Follow-up|2|||
30900566|NCT02261467|58934008|FG001|Overall Study|Lost to Follow-up|13|||
30735973|NCT00420212|58747646|FG002|Overall Study|Adverse Event|36|||
30900567|NCT02261467|58934007|FG000|Overall Study|Adverse Event|1|||
30900568|NCT02261467|58934008|FG001|Overall Study|Adverse Event|1|||
30900569|NCT01643473|58934016|FG000|Overall Study|Lost to Follow-up|1|||
30900570|NCT01643473|58934017|FG001|Overall Study|Lost to Follow-up|0|||
30735974|NCT00420212|58747644|FG000|Overall Study|Lost to Follow-up|9|||
30735975|NCT00420212|58747645|FG001|Overall Study|Lost to Follow-up|11|||
30735976|NCT00420212|58747646|FG002|Overall Study|Lost to Follow-up|11|||
30735977|NCT00420212|58747644|FG000|Overall Study|Withdrawal by Subject|31|||
30735978|NCT00420212|58747645|FG001|Overall Study|Withdrawal by Subject|22|||
30735979|NCT00420212|58747646|FG002|Overall Study|Withdrawal by Subject|19|||
30735980|NCT00420212|58747644|FG000|Overall Study|Physician Decision|4|||
30735981|NCT00420212|58747645|FG001|Overall Study|Physician Decision|4|||
30735982|NCT00420212|58747646|FG002|Overall Study|Physician Decision|3|||
30735983|NCT00420212|58747644|FG000|Overall Study|Protocol Violation|4|||
30735984|NCT00420212|58747645|FG001|Overall Study|Protocol Violation|4|||
30735985|NCT00420212|58747646|FG002|Overall Study|Protocol Violation|8|||
30735986|NCT00420212|58747644|FG000|Overall Study|Death|0|||
30735987|NCT00420212|58747645|FG001|Overall Study|Death|0|||
30735988|NCT00420212|58747646|FG002|Overall Study|Death|1|||
30735989|NCT00420212|58747644|FG000|Overall Study|Other-Unspecified|21|||
30735990|NCT00420212|58747645|FG001|Overall Study|Other-Unspecified|14|||
30735991|NCT00420212|58747646|FG002|Overall Study|Other-Unspecified|18|||
30735992|NCT00401258|58747657|FG000|Overall Study|Adverse Event|7|||
30735993|NCT00380874|58747663|FG000|Overall Study|Adverse Event|7|||
30735994|NCT00380874|58747664|FG001|Overall Study|Adverse Event|7|||
30735995|NCT00380874|58747663|FG000|Overall Study|Death|1|||
30735996|NCT00380874|58747664|FG001|Overall Study|Death|0|||
30735997|NCT00380874|58747663|FG000|Overall Study|Withdrawal by Subject|2|||
30735998|NCT00380874|58747664|FG001|Overall Study|Withdrawal by Subject|1|||
30735999|NCT00380874|58747663|FG000|Overall Study|Not related to study drug|3|||
30736000|NCT00380874|58747664|FG001|Overall Study|Not related to study drug|2|||
30736001|NCT00420056|58747670|FG000|Overall Study|Objective progression or relapse|17|||
30736002|NCT00411554|58747676|FG000|Overall Study|Adverse Event|2|||
30736003|NCT00411554|58747677|FG001|Overall Study|Adverse Event|4|||
30736004|NCT00411554|58747676|FG000|Overall Study|Lack of Efficacy|2|||
30736005|NCT00411554|58747677|FG001|Overall Study|Lack of Efficacy|5|||
30736006|NCT00411554|58747676|FG000|Overall Study|Withdrawal by Subject|3|||
30736007|NCT00411554|58747677|FG001|Overall Study|Withdrawal by Subject|0|||
30736008|NCT00411554|58747676|FG000|Overall Study|Patient Moved|1|||
30736009|NCT00411554|58747677|FG001|Overall Study|Patient Moved|0|||
30736010|NCT00400712|58747685|FG000|Overall Study|Death|1|||
30736011|NCT00400712|58747686|FG001|Overall Study|Death|0|||
30736012|NCT00400712|58747685|FG000|Overall Study|Withdrawal by Subject|11|||
30900571|NCT02258659|58934023|FG000|Overall Study|Withdrawal by Subject|1|||
30900572|NCT02320058|58934029|FG000|Overall Study|Death|25|||
30736013|NCT00400712|58747686|FG001|Overall Study|Withdrawal by Subject|12|||
30736014|NCT00400712|58747685|FG000|Overall Study|Physician Decision|5|||
30736015|NCT00400712|58747686|FG001|Overall Study|Physician Decision|4|||
30736016|NCT00380718|58747694|FG000|Overall Study|Adverse Event|1|||
30790963|NCT00151996|58804114|FG001|Overall Study|Adverse Event|2|||
30900573|NCT02320058|58934030|FG001|Overall Study|Death|10|||
30900574|NCT02320058|58934029|FG000|Overall Study|Lost to Follow-up|4|||
30900575|NCT02320058|58934030|FG001|Overall Study|Lost to Follow-up|0|||
30900576|NCT02320058|58934029|FG000|Overall Study|Other reasons|4|||
30736017|NCT00380718|58747694|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
30736018|NCT00380250|58747700|FG000|Overall Study|Withdrawal by Subject|39|||
30736019|NCT00380250|58747701|FG001|Overall Study|Withdrawal by Subject|28|||
30736020|NCT00380250|58747700|FG000|Overall Study|Adverse Event|20|||
30736021|NCT00380250|58747701|FG001|Overall Study|Adverse Event|9|||
30736022|NCT00380250|58747700|FG000|Overall Study|Lack of Efficacy|10|||
30736023|NCT00380250|58747701|FG001|Overall Study|Lack of Efficacy|8|||
30736024|NCT00380250|58747700|FG000|Overall Study|Protocol Violation|15|||
30736025|NCT00380250|58747701|FG001|Overall Study|Protocol Violation|5|||
30736026|NCT00380250|58747700|FG000|Overall Study|Lost to Follow-up|14|||
30736027|NCT00380250|58747701|FG001|Overall Study|Lost to Follow-up|5|||
30736028|NCT00380250|58747700|FG000|Overall Study|Physician Decision|1|||
30736029|NCT00380250|58747701|FG001|Overall Study|Physician Decision|0|||
30736030|NCT00400400|58747709|FG000|Overall Study|Adverse Event|9|||
30736031|NCT00400400|58747710|FG001|Overall Study|Adverse Event|8|||
30736032|NCT00400400|58747709|FG000|Overall Study|Protocol Violation|2|||
30736033|NCT00400400|58747710|FG001|Overall Study|Protocol Violation|0|||
30736034|NCT00400400|58747709|FG000|Overall Study|Withdrawal by Subject|1|||
30736035|NCT00400400|58747710|FG001|Overall Study|Withdrawal by Subject|3|||
30736036|NCT00400400|58747709|FG000|Overall Study|Administrative Problem|1|||
30736037|NCT00400400|58747710|FG001|Overall Study|Administrative Problem|0|||
30736038|NCT00400400|58747709|FG000|Overall Study|Lost to Follow-up|0|||
30736039|NCT00400400|58747710|FG001|Overall Study|Lost to Follow-up|1|||
30736040|NCT00400400|58747709|FG000|Overall Study|Did not receive study drug|1|||
30736041|NCT00400400|58747710|FG001|Overall Study|Did not receive study drug|3|||
30736042|NCT00395694|58747718|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
30736043|NCT00395694|58747719|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
30736044|NCT00395694|58747718|FG000|Continuation Phase|Adverse Event|1|||
30736045|NCT00395694|58747719|FG001|Continuation Phase|Adverse Event|0|||
30736046|NCT00395694|58747718|FG000|Continuation Phase|Lack of Efficacy|12|||
30736047|NCT00395694|58747719|FG001|Continuation Phase|Lack of Efficacy|11|||
30736048|NCT00395694|58747718|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
30736049|NCT00395694|58747719|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
30736050|NCT00395694|58747718|FG000|Continuation Phase|Poor Compliance|1|||
30736051|NCT00395694|58747719|FG001|Continuation Phase|Poor Compliance|0|||
30900577|NCT02320058|58934030|FG001|Overall Study|Other reasons|1|||
30900578|NCT02320058|58934029|FG000|Overall Study|Withdrawal by Subject|8|||
30900579|NCT02320058|58934030|FG001|Overall Study|Withdrawal by Subject|2|||
30736052|NCT00395694|58747718|FG000|Continuation Phase|Withdrawal by Subject|0|||
30736053|NCT00395694|58747719|FG001|Continuation Phase|Withdrawal by Subject|2|||
30736054|NCT00419744|58747731|FG000|Overall Study|Adverse Event|39|||
30736055|NCT00419744|58747732|FG001|Overall Study|Adverse Event|40|||
30736056|NCT00419744|58747733|FG002|Overall Study|Adverse Event|50|||
30736057|NCT00419744|58747731|FG000|Overall Study|Withdrawal by Subject|45|||
30736058|NCT00419744|58747732|FG001|Overall Study|Withdrawal by Subject|49|||
30736059|NCT00419744|58747733|FG002|Overall Study|Withdrawal by Subject|52|||
30736060|NCT00419744|58747731|FG000|Overall Study|Lost to Follow-up|8|||
30736061|NCT00419744|58747732|FG001|Overall Study|Lost to Follow-up|10|||
30736062|NCT00419744|58747733|FG002|Overall Study|Lost to Follow-up|6|||
30736063|NCT00419744|58747731|FG000|Overall Study|Protocol Violation|4|||
30736064|NCT00419744|58747732|FG001|Overall Study|Protocol Violation|7|||
30736065|NCT00419744|58747733|FG002|Overall Study|Protocol Violation|8|||
30736066|NCT00419744|58747731|FG000|Overall Study|Randomized in error|9|||
30736067|NCT00419744|58747732|FG001|Overall Study|Randomized in error|6|||
30736068|NCT00419744|58747733|FG002|Overall Study|Randomized in error|7|||
30736069|NCT00419744|58747731|FG000|Overall Study|Moving out of state|2|||
30736070|NCT00419744|58747732|FG001|Overall Study|Moving out of state|0|||
30736071|NCT00419744|58747733|FG002|Overall Study|Moving out of state|1|||
30736072|NCT00419744|58747731|FG000|Overall Study|Physician Decision|10|||
30736073|NCT00419744|58747732|FG001|Overall Study|Physician Decision|5|||
30736074|NCT00419744|58747733|FG002|Overall Study|Physician Decision|6|||
30736075|NCT00419744|58747731|FG000|Overall Study|Spirometry mouthpiece issues|0|||
30736076|NCT00419744|58747732|FG001|Overall Study|Spirometry mouthpiece issues|1|||
30900580|NCT02320058|58934029|FG000|Overall Study|Not reported|1|||
30900581|NCT02320058|58934030|FG001|Overall Study|Not reported|0|||
30900582|NCT02319668|58934038|FG000|Overall Study|Other (Not specified)|0|||
30736077|NCT00419744|58747733|FG002|Overall Study|Spirometry mouthpiece issues|2|||
30736078|NCT00419744|58747731|FG000|Overall Study|Incorrect medication kit dispensed|0|||
30736079|NCT00419744|58747732|FG001|Overall Study|Incorrect medication kit dispensed|0|||
30900583|NCT02319668|58934039|FG001|Overall Study|Other (Not specified)|2|||
30900584|NCT02092467|58934051|FG000|Overall Study|Death|49|||
30900585|NCT02092467|58934052|FG001|Overall Study|Death|66|||
30900586|NCT02092467|58934053|FG002|Overall Study|Death|38|||
30900587|NCT02092467|58934051|FG000|Overall Study|Lost to Follow-up|38|||
30900588|NCT02092467|58934052|FG001|Overall Study|Lost to Follow-up|35|||
30900589|NCT02092467|58934053|FG002|Overall Study|Lost to Follow-up|40|||
30736080|NCT00419744|58747733|FG002|Overall Study|Incorrect medication kit dispensed|1|||
30736081|NCT00395538|58747744|FG000|Overall Study|Did not re-consent to revised protocol|1|||
30736082|NCT00395538|58747745|FG001|Overall Study|Did not re-consent to revised protocol|10|||
30736083|NCT00395538|58747746|FG002|Overall Study|Did not re-consent to revised protocol|0|||
30900590|NCT02092467|58934051|FG000|Overall Study|Global Deterioration of Health Status|1|||
30736084|NCT00395538|58747744|FG000|Overall Study|FDA partial hold on PTH|0|||
30736085|NCT00395538|58747745|FG001|Overall Study|FDA partial hold on PTH|0|||
30900591|NCT02092467|58934052|FG001|Overall Study|Global Deterioration of Health Status|0|||
30900592|NCT02092467|58934053|FG002|Overall Study|Global Deterioration of Health Status|0|||
30900593|NCT02092467|58934051|FG000|Overall Study|Other|32|||
30900594|NCT02092467|58934052|FG001|Overall Study|Other|30|||
30736086|NCT00395538|58747746|FG002|Overall Study|FDA partial hold on PTH|11|||
30736087|NCT00395538|58747744|FG000|Overall Study|Failed screening|0|||
30736088|NCT00395538|58747745|FG001|Overall Study|Failed screening|0|||
30736089|NCT00395538|58747746|FG002|Overall Study|Failed screening|4|||
30900595|NCT02092467|58934053|FG002|Overall Study|Other|24|||
30900596|NCT02092467|58934051|FG000|Overall Study|Withdrawal by Subject|282|||
30900597|NCT02092467|58934052|FG001|Overall Study|Withdrawal by Subject|327|||
30900598|NCT02092467|58934053|FG002|Overall Study|Withdrawal by Subject|289|||
30900599|NCT02092467|58934051|FG000|Overall Study|Randomized but not treated|2|||
30900600|NCT02092467|58934052|FG001|Overall Study|Randomized but not treated|1|||
30736090|NCT00395538|58747744|FG000|Overall Study|Switch to Natpara|0|||
30736091|NCT00395538|58747745|FG001|Overall Study|Switch to Natpara|0|||
30736092|NCT00395538|58747746|FG002|Overall Study|Switch to Natpara|3|||
30736093|NCT00395538|58747744|FG000|Overall Study|Adverse Event|1|||
30736094|NCT00395538|58747745|FG001|Overall Study|Adverse Event|0|||
30736095|NCT00395538|58747746|FG002|Overall Study|Adverse Event|2|||
30736096|NCT00395538|58747744|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
30736097|NCT00395538|58747745|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
30736098|NCT00395538|58747746|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
30736099|NCT00395538|58747744|FG000|Overall Study|Non-compliance with study protocol|0|||
30736100|NCT00395538|58747745|FG001|Overall Study|Non-compliance with study protocol|1|||
30736101|NCT00395538|58747746|FG002|Overall Study|Non-compliance with study protocol|0|||
30736102|NCT00395538|58747744|FG000|Overall Study|PTH resistance|0|||
30736103|NCT00395538|58747745|FG001|Overall Study|PTH resistance|0|||
30736104|NCT00395538|58747746|FG002|Overall Study|PTH resistance|1|||
30736105|NCT00395538|58747744|FG000|Overall Study|Pregnancy|1|||
30736106|NCT00395538|58747745|FG001|Overall Study|Pregnancy|0|||
30736107|NCT00395538|58747746|FG002|Overall Study|Pregnancy|0|||
30736108|NCT00395538|58747744|FG000|Overall Study|Partial recovery of parathyroid function|0|||
30736109|NCT00395538|58747745|FG001|Overall Study|Partial recovery of parathyroid function|0|||
30736110|NCT00395538|58747746|FG002|Overall Study|Partial recovery of parathyroid function|1|||
30736111|NCT00395538|58747744|FG000|Overall Study|Participant elected to discontinue|0|||
30736112|NCT00395538|58747745|FG001|Overall Study|Participant elected to discontinue|0|||
30736113|NCT00395538|58747746|FG002|Overall Study|Participant elected to discontinue|1|||
30736114|NCT00395460|58747756|FG000|Overall Study|Withdrawal by Subject|1|||
30736115|NCT00395460|58747757|FG001|Overall Study|Withdrawal by Subject|0|||
30736116|NCT00395304|58747763|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30736117|NCT00395304|58747764|FG001|Treatment Period 1|Withdrawal by Subject|3|||
30736118|NCT00395304|58747765|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30736119|NCT00395304|58747766|FG003|Treatment Period 1|Withdrawal by Subject|2|||
30736120|NCT00395304|58747767|FG004|Treatment Period 1|Withdrawal by Subject|1|||
30736121|NCT00395304|58747768|FG005|Treatment Period 1|Withdrawal by Subject|1|||
30736122|NCT00395304|58747763|FG000|Treatment Period 1|Lost to Follow-up|1|||
30736123|NCT00395304|58747764|FG001|Treatment Period 1|Lost to Follow-up|0|||
30736124|NCT00395304|58747765|FG002|Treatment Period 1|Lost to Follow-up|0|||
30736125|NCT00395304|58747766|FG003|Treatment Period 1|Lost to Follow-up|1|||
30736126|NCT00395304|58747767|FG004|Treatment Period 1|Lost to Follow-up|0|||
30736127|NCT00395304|58747768|FG005|Treatment Period 1|Lost to Follow-up|1|||
30736128|NCT00395304|58747763|FG000|Treatment Period 1|Physician Decision|0|||
30900601|NCT02092467|58934053|FG002|Overall Study|Randomized but not treated|7|||
30736129|NCT00395304|58747764|FG001|Treatment Period 1|Physician Decision|1|||
30736130|NCT00395304|58747765|FG002|Treatment Period 1|Physician Decision|0|||
30736131|NCT00395304|58747766|FG003|Treatment Period 1|Physician Decision|0|||
30736132|NCT00395304|58747767|FG004|Treatment Period 1|Physician Decision|0|||
30736133|NCT00395304|58747768|FG005|Treatment Period 1|Physician Decision|0|||
30736134|NCT00395304|58747763|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30736135|NCT00395304|58747764|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30900602|NCT02462759|58934065|FG000|Part 1: Double Blind|Death|1|||
30900603|NCT02462759|58934066|FG001|Part 1: Double Blind|Death|0|||
30900604|NCT02462759|58934067|FG002|Part 1: Double Blind|Death|0|||
30900605|NCT02349386|58934082|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
30900606|NCT02349386|58934083|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
30900607|NCT02349386|58934084|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
30900608|NCT02349386|58934085|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
30900609|NCT02349386|58934082|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
30900610|NCT02349386|58934083|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
30900611|NCT02349386|58934084|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
30900612|NCT02349386|58934085|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
30900613|NCT02349386|58934082|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
30900614|NCT02349386|58934083|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
30900615|NCT02349386|58934084|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
30900616|NCT02349386|58934085|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
30900617|NCT02349386|58934082|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
30900618|NCT02349386|58934083|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
30900619|NCT02349386|58934084|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
30900620|NCT02349386|58934085|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
30900621|NCT02349386|58934082|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
30900622|NCT02349386|58934083|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
30900623|NCT02349386|58934084|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
30900624|NCT02349386|58934085|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
30900625|NCT02349386|58934082|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
30900626|NCT02349386|58934083|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
30900627|NCT02349386|58934084|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
30900628|NCT02349386|58934085|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
30900629|NCT02036775|58934095|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
30900630|NCT02036775|58934096|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
30900631|NCT02036775|58934097|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
30900632|NCT02036775|58934098|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
30900633|NCT02036775|58934099|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
30900634|NCT02036775|58934100|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
30900635|NCT02092389|58934108|FG000|Overall Study|Adverse Event|1|||
30900636|NCT02092389|58934108|FG000|Overall Study|Other|5|||
30900637|NCT02034591|58934112|FG000|Overall Study|Withdrawal by Subject|0|||
30900638|NCT02034591|58934113|FG001|Overall Study|Withdrawal by Subject|0|||
30900639|NCT02034591|58934114|FG002|Overall Study|Withdrawal by Subject|0|||
30900640|NCT02034591|58934115|FG003|Overall Study|Withdrawal by Subject|0|||
30900641|NCT02034591|58934116|FG004|Overall Study|Withdrawal by Subject|1|||
30900642|NCT02034591|58934117|FG005|Overall Study|Withdrawal by Subject|0|||
30900643|NCT02391116|58934126|FG000|Treatment|Withdrawal by Subject|1|||
30900644|NCT02391116|58934126|FG000|Treatment|Protocol Violation|1|||
30900645|NCT02391116|58934126|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
30900646|NCT02391116|58934126|FG000|Treatment|AE with Clinical PD|3|||
30736136|NCT00395304|58747765|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30736137|NCT00395304|58747766|FG003|Treatment Period 2|Withdrawal by Subject|1|||
30736138|NCT00395304|58747767|FG004|Treatment Period 2|Withdrawal by Subject|0|||
30736139|NCT00395304|58747768|FG005|Treatment Period 2|Withdrawal by Subject|2|||
30736140|NCT00395304|58747763|FG000|Treatment Period 2|Lost to Follow-up|0|||
30736141|NCT00395304|58747764|FG001|Treatment Period 2|Lost to Follow-up|3|||
30736142|NCT00395304|58747765|FG002|Treatment Period 2|Lost to Follow-up|0|||
30736143|NCT00395304|58747766|FG003|Treatment Period 2|Lost to Follow-up|0|||
30736144|NCT00395304|58747767|FG004|Treatment Period 2|Lost to Follow-up|0|||
30736145|NCT00395304|58747768|FG005|Treatment Period 2|Lost to Follow-up|0|||
30736146|NCT00395304|58747763|FG000|Treatment Period 2|Physician Decision|0|||
30736147|NCT00395304|58747764|FG001|Treatment Period 2|Physician Decision|0|||
30736148|NCT00395304|58747765|FG002|Treatment Period 2|Physician Decision|1|||
30736149|NCT00395304|58747766|FG003|Treatment Period 2|Physician Decision|0|||
30736150|NCT00395304|58747767|FG004|Treatment Period 2|Physician Decision|0|||
30736151|NCT00395304|58747768|FG005|Treatment Period 2|Physician Decision|0|||
30736152|NCT00395304|58747763|FG000|Treatment Period 2|Other|0|||
30736153|NCT00395304|58747764|FG001|Treatment Period 2|Other|1|||
30736154|NCT00395304|58747765|FG002|Treatment Period 2|Other|0|||
30736155|NCT00395304|58747766|FG003|Treatment Period 2|Other|0|||
30736156|NCT00395304|58747767|FG004|Treatment Period 2|Other|0|||
30736157|NCT00395304|58747768|FG005|Treatment Period 2|Other|0|||
30736158|NCT00395304|58747763|FG000|Treatment Period 3|Withdrawal by Subject|0|||
30736159|NCT00395304|58747764|FG001|Treatment Period 3|Withdrawal by Subject|0|||
30736160|NCT00395304|58747765|FG002|Treatment Period 3|Withdrawal by Subject|0|||
30736161|NCT00395304|58747766|FG003|Treatment Period 3|Withdrawal by Subject|1|||
30736162|NCT00395304|58747767|FG004|Treatment Period 3|Withdrawal by Subject|0|||
30736163|NCT00395304|58747768|FG005|Treatment Period 3|Withdrawal by Subject|1|||
30900647|NCT02391116|58934126|FG000|Safety Follow-up|Adverse Event|1|||
30900648|NCT02391116|58934126|FG000|Safety Follow-up|Withdrawal by Subject|4|||
30736164|NCT00395304|58747763|FG000|Treatment Period 3|Lost to Follow-up|1|||
30736165|NCT00395304|58747764|FG001|Treatment Period 3|Lost to Follow-up|1|||
30736166|NCT00395304|58747765|FG002|Treatment Period 3|Lost to Follow-up|0|||
30736167|NCT00395304|58747766|FG003|Treatment Period 3|Lost to Follow-up|0|||
30736168|NCT00395304|58747767|FG004|Treatment Period 3|Lost to Follow-up|0|||
30736169|NCT00395304|58747768|FG005|Treatment Period 3|Lost to Follow-up|0|||
30736170|NCT00395304|58747763|FG000|Treatment Period 3|Physician Decision|0|||
30736171|NCT00395304|58747764|FG001|Treatment Period 3|Physician Decision|1|||
30736172|NCT00395304|58747765|FG002|Treatment Period 3|Physician Decision|0|||
30736173|NCT00395304|58747766|FG003|Treatment Period 3|Physician Decision|0|||
30736174|NCT00395304|58747767|FG004|Treatment Period 3|Physician Decision|0|||
30736175|NCT00395304|58747768|FG005|Treatment Period 3|Physician Decision|0|||
30736176|NCT00395304|58747763|FG000|Treatment Period 3|Other|0|||
30736177|NCT00395304|58747764|FG001|Treatment Period 3|Other|0|||
30736178|NCT00395304|58747765|FG002|Treatment Period 3|Other|0|||
30736179|NCT00395304|58747766|FG003|Treatment Period 3|Other|1|||
30736180|NCT00395304|58747767|FG004|Treatment Period 3|Other|0|||
30736181|NCT00395304|58747768|FG005|Treatment Period 3|Other|0|||
30736182|NCT00395226|58747777|FG000|Overall Study|Adverse Event|4|||
30736183|NCT00395226|58747778|FG001|Overall Study|Adverse Event|3|||
30736184|NCT00395226|58747777|FG000|Overall Study|Withdrawal by Subject|0|||
30736185|NCT00395226|58747778|FG001|Overall Study|Withdrawal by Subject|1|||
30736186|NCT00395226|58747777|FG000|Overall Study|Lost to Follow-up|0|||
30736187|NCT00395226|58747778|FG001|Overall Study|Lost to Follow-up|1|||
30736188|NCT00394914|58747786|FG000|Treatment Period|Adverse Event|0|||
30736189|NCT00394914|58747787|FG001|Treatment Period|Adverse Event|3|||
30736190|NCT00394914|58747788|FG002|Treatment Period|Adverse Event|1|||
30736191|NCT00394914|58747786|FG000|Treatment Period|Lost to Follow-up|0|||
30736192|NCT00394914|58747787|FG001|Treatment Period|Lost to Follow-up|1|||
30736193|NCT00394914|58747788|FG002|Treatment Period|Lost to Follow-up|0|||
30736194|NCT00394914|58747786|FG000|Treatment Period|Withdrawal by Subject|0|||
30736195|NCT00394914|58747787|FG001|Treatment Period|Withdrawal by Subject|2|||
30736196|NCT00394914|58747788|FG002|Treatment Period|Withdrawal by Subject|2|||
30736197|NCT00394914|58747786|FG000|Treatment Period|Noncompliance with protocol|0|||
30736198|NCT00394914|58747787|FG001|Treatment Period|Noncompliance with protocol|3|||
30736199|NCT00394914|58747788|FG002|Treatment Period|Noncompliance with protocol|2|||
30736200|NCT00394914|58747786|FG000|Treatment Period|Did not meet protocol eligibility|0|||
30736201|NCT00394914|58747787|FG001|Treatment Period|Did not meet protocol eligibility|1|||
30736202|NCT00394914|58747788|FG002|Treatment Period|Did not meet protocol eligibility|1|||
30736203|NCT00366444|58747796|FG000|Overall Study|Withdrawal by Subject|1|||
30736204|NCT00366444|58747797|FG001|Overall Study|Withdrawal by Subject|1|||
30736205|NCT00366444|58747796|FG000|Overall Study|Lack of Efficacy|0|||
30736206|NCT00366444|58747797|FG001|Overall Study|Lack of Efficacy|1|||
30736207|NCT00365976|58747805|FG000|Overall Study|Withdrawal by Subject|1|||
30736208|NCT00365976|58747806|FG001|Overall Study|Withdrawal by Subject|5|||
30736209|NCT00379236|58747814|FG000|Double-blind|Adverse Event|11|||
30900649|NCT02391116|58934126|FG000|Safety Follow-up|Switching to Other Therapy|4|||
30736210|NCT00379236|58747815|FG001|Double-blind|Adverse Event|6|||
30736211|NCT00379236|58747816|FG002|Double-blind|Adverse Event|0|||
30736212|NCT00379236|58747814|FG000|Double-blind|Protocol Violation|3|||
30736213|NCT00379236|58747815|FG001|Double-blind|Protocol Violation|3|||
30736214|NCT00379236|58747816|FG002|Double-blind|Protocol Violation|0|||
30736215|NCT00379236|58747814|FG000|Double-blind|Withdrawal by Subject|12|||
30736216|NCT00379236|58747815|FG001|Double-blind|Withdrawal by Subject|13|||
30900650|NCT02391116|58934126|FG000|Safety Follow-up|No Follow Up|1|||
30736217|NCT00379236|58747816|FG002|Double-blind|Withdrawal by Subject|0|||
30736218|NCT00379236|58747814|FG000|Double-blind|Lost to Follow-up|4|||
30736219|NCT00379236|58747815|FG001|Double-blind|Lost to Follow-up|3|||
30736220|NCT00379236|58747816|FG002|Double-blind|Lost to Follow-up|0|||
30736221|NCT00379236|58747814|FG000|Double-blind|Use of exclusionary medication|1|||
30736222|NCT00379236|58747815|FG001|Double-blind|Use of exclusionary medication|2|||
30736223|NCT00379236|58747816|FG002|Double-blind|Use of exclusionary medication|0|||
30736224|NCT00379236|58747814|FG000|Double-blind|Other|3|||
30736225|NCT00379236|58747815|FG001|Double-blind|Other|7|||
30736226|NCT00379236|58747816|FG002|Double-blind|Other|0|||
30736227|NCT00379236|58747814|FG000|Double-blind|Data could not be retrieved|2|||
30900651|NCT02391116|58934126|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
30900652|NCT02391116|58934126|FG000|Active Follow-up|Withdrawal by Subject|1|||
30900653|NCT02391116|58934126|FG000|Active Follow-up|Switching to Other Therapy|2|||
30900654|NCT02391116|58934126|FG000|Survival Follow-up|Withdrawal by Subject|3|||
30900655|NCT02391116|58934126|FG000|Survival Follow-up|Switching to Other Therapy|1|||
30900656|NCT02091921|58934137|FG000|Overall Study|Adverse Event|3|||
30900657|NCT02447081|58934144|FG000|Overall Study|Death|161|||
30900658|NCT02447081|58934144|FG000|Overall Study|Lost to Follow-up|36|||
30900659|NCT02447081|58934144|FG000|Overall Study|Visit not completed|17|||
30900660|NCT02447081|58934144|FG000|Overall Study|unsuccessful implant procedure|10|||
30900661|NCT02391038|58934148|FG000|Overall Study|Progressive disease|3|||
30900662|NCT02391038|58934149|FG001|Overall Study|Progressive disease|3|||
30900663|NCT02391038|58934150|FG002|Overall Study|Progressive disease|6|||
30900664|NCT02260921|58934161|FG000|Overall Study|Adverse Event|1|||
30900665|NCT02260921|58934162|FG001|Overall Study|Adverse Event|0|||
30900666|NCT02260921|58934161|FG000|Overall Study|Lost to Follow-up|4|||
30736228|NCT00379236|58747815|FG001|Double-blind|Data could not be retrieved|2|||
30736229|NCT00379236|58747816|FG002|Double-blind|Data could not be retrieved|0|||
30736230|NCT00379236|58747814|FG000|Open-label Extension|Adverse Event|0|||
30900667|NCT02260921|58934162|FG001|Overall Study|Lost to Follow-up|3|||
30900668|NCT02260921|58934161|FG000|Overall Study|Withdraw Consent|4|||
30900669|NCT02260921|58934162|FG001|Overall Study|Withdraw Consent|1|||
30900670|NCT02260921|58934161|FG000|Overall Study|Death|1|||
30900671|NCT02260921|58934162|FG001|Overall Study|Death|0|||
30900672|NCT02260921|58934161|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
30900673|NCT02260921|58934162|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
30900674|NCT02462603|58934168|FG000|Overall Study|Investigator Decision|1|||
30900675|NCT02462603|58934168|FG000|Overall Study|Non-Compliance|1|||
30900676|NCT02462603|58934168|FG000|Overall Study|Withdrawal by Subject|2|||
30900677|NCT02034513|58934174|FG000|Overall Study|Adverse Event|11|||
30900678|NCT02034513|58934175|FG001|Overall Study|Adverse Event|10|||
30900679|NCT02034513|58934174|FG000|Overall Study|Lack of Efficacy|0|||
30900680|NCT02034513|58934175|FG001|Overall Study|Lack of Efficacy|1|||
30900681|NCT02034513|58934174|FG000|Overall Study|Lost to Follow-up|6|||
30900682|NCT02034513|58934175|FG001|Overall Study|Lost to Follow-up|7|||
30900683|NCT02034513|58934174|FG000|Overall Study|Pregnancy|0|||
30900684|NCT02034513|58934175|FG001|Overall Study|Pregnancy|3|||
30736231|NCT00379236|58747815|FG001|Open-label Extension|Adverse Event|0|||
30736232|NCT00379236|58747816|FG002|Open-label Extension|Adverse Event|13|||
30736233|NCT00379236|58747814|FG000|Open-label Extension|Protocol Violation|0|||
30736234|NCT00379236|58747815|FG001|Open-label Extension|Protocol Violation|0|||
30736235|NCT00379236|58747816|FG002|Open-label Extension|Protocol Violation|7|||
30736236|NCT00379236|58747814|FG000|Open-label Extension|Withdrawal by Subject|0|||
30790964|NCT00151996|58804113|FG000|Overall Study|Withdrawal by Subject|1|||
30736237|NCT00379236|58747815|FG001|Open-label Extension|Withdrawal by Subject|0|||
30736238|NCT00379236|58747816|FG002|Open-label Extension|Withdrawal by Subject|13|||
30736239|NCT00379236|58747814|FG000|Open-label Extension|Lost to Follow-up|0|||
30736240|NCT00379236|58747815|FG001|Open-label Extension|Lost to Follow-up|0|||
30736241|NCT00379236|58747816|FG002|Open-label Extension|Lost to Follow-up|12|||
30900685|NCT02034513|58934174|FG000|Overall Study|Protocol Violation|7|||
30900686|NCT02034513|58934175|FG001|Overall Study|Protocol Violation|10|||
30736242|NCT00379236|58747814|FG000|Open-label Extension|Use of exclusionary medication|0|||
30736243|NCT00379236|58747815|FG001|Open-label Extension|Use of exclusionary medication|0|||
30736244|NCT00379236|58747816|FG002|Open-label Extension|Use of exclusionary medication|3|||
30736245|NCT00379236|58747814|FG000|Open-label Extension|Other|0|||
30736246|NCT00379236|58747815|FG001|Open-label Extension|Other|0|||
30736247|NCT00379236|58747816|FG002|Open-label Extension|Other|7|||
30736248|NCT00379080|58747831|FG000|Overall Study|Withdrawal by Subject|0|||
30736249|NCT00379080|58747832|FG001|Overall Study|Withdrawal by Subject|4|||
30736250|NCT00379080|58747833|FG002|Overall Study|Withdrawal by Subject|0|||
30736251|NCT00378534|58747858|FG000|Overall Study|Participants did not receive transplant|3|||
30736252|NCT00378534|58747859|FG001|Overall Study|Participants did not receive transplant|0|||
30736253|NCT00377676|58747866|FG000|Overall Study|Adverse Event|498|||
30736254|NCT00377676|58747867|FG001|Overall Study|Adverse Event|107|||
30736255|NCT00377676|58747866|FG000|Overall Study|Protocol Violation|33|||
30736256|NCT00377676|58747867|FG001|Overall Study|Protocol Violation|27|||
30736257|NCT00377676|58747866|FG000|Overall Study|Death|5|||
30736258|NCT00377676|58747867|FG001|Overall Study|Death|2|||
30736259|NCT00377676|58747866|FG000|Overall Study|Withdrawal by Subject|187|||
30736260|NCT00377676|58747867|FG001|Overall Study|Withdrawal by Subject|72|||
30736261|NCT00377676|58747866|FG000|Overall Study|Lost to Follow-up|120|||
30736262|NCT00377676|58747867|FG001|Overall Study|Lost to Follow-up|56|||
30736263|NCT00377676|58747866|FG000|Overall Study|Other|118|||
30900687|NCT02034513|58934174|FG000|Overall Study|Withdrawal by Subject|25|||
30900688|NCT02034513|58934175|FG001|Overall Study|Withdrawal by Subject|25|||
30900689|NCT02034513|58934174|FG000|Overall Study|Unclassified|0|||
30900690|NCT02034513|58934175|FG001|Overall Study|Unclassified|1|||
30900691|NCT02348840|58934187|FG000|Overall Study|Withdrawal by Subject|2|||
30900692|NCT02348840|58934188|FG001|Overall Study|Withdrawal by Subject|1|||
30900693|NCT02348840|58934189|FG002|Overall Study|Withdrawal by Subject|0|||
30900694|NCT02348840|58934190|FG003|Overall Study|Withdrawal by Subject|0|||
30900695|NCT02462057|58934205|FG000|Overall Study|Left Vitality|32|||
30900696|NCT02462057|58934206|FG001|Overall Study|Left Vitality|27|||
30900697|NCT02462057|58934207|FG002|Overall Study|Left Vitality|23|||
30900698|NCT02462057|58934208|FG003|Overall Study|Left Vitality|35|||
30900699|NCT02462057|58934209|FG004|Overall Study|Left Vitality|33|||
30900700|NCT02462057|58934205|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
30900701|NCT02462057|58934206|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
30900702|NCT02462057|58934207|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
30900703|NCT02462057|58934208|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
30900704|NCT02462057|58934209|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
30900705|NCT02461745|58934223|FG000|Overall Study|Lack of Efficacy|9|||
30900706|NCT02461745|58934224|FG001|Overall Study|Lack of Efficacy|1|||
30900707|NCT02461745|58934223|FG000|Overall Study|Lost to Follow-up|2|||
30900708|NCT02461745|58934224|FG001|Overall Study|Lost to Follow-up|2|||
30900709|NCT02461745|58934223|FG000|Overall Study|Withdrawal by Subject|3|||
30736264|NCT00377676|58747867|FG001|Overall Study|Other|58|||
30736265|NCT00377520|58747873|FG000|Overall Study|Ineligible (Prior radiation)|1|||
30736266|NCT00377364|58747879|FG000|Overall Study|Lost to Follow-up|1|||
30900710|NCT02461745|58934224|FG001|Overall Study|Withdrawal by Subject|1|||
30736267|NCT00377364|58747880|FG001|Overall Study|Lost to Follow-up|0|||
30736268|NCT00377364|58747879|FG000|Overall Study|Withdrawal by Subject|1|||
30736269|NCT00377364|58747880|FG001|Overall Study|Withdrawal by Subject|0|||
30736270|NCT03831282|58747888|FG000|Overall Study|Could not place sensor|1|||
30736271|NCT00365508|58747894|FG000|Overall Study|Lost to Follow-up|139|||
30736272|NCT00365508|58747895|FG001|Overall Study|Lost to Follow-up|154|||
30736273|NCT00365352|58747904|FG000|Overall Study|Adverse Event|6|||
30736274|NCT00365352|58747905|FG001|Overall Study|Adverse Event|7|||
30736275|NCT00365352|58747906|FG002|Overall Study|Adverse Event|8|||
30736276|NCT00365352|58747904|FG000|Overall Study|Participant Withdrew Consent|8|||
30736277|NCT00365352|58747905|FG001|Overall Study|Participant Withdrew Consent|3|||
30736278|NCT00365352|58747906|FG002|Overall Study|Participant Withdrew Consent|4|||
30736279|NCT00365352|58747904|FG000|Overall Study|Lack of Efficacy|3|||
30736280|NCT00365352|58747905|FG001|Overall Study|Lack of Efficacy|0|||
30736281|NCT00365352|58747906|FG002|Overall Study|Lack of Efficacy|0|||
30736282|NCT00365352|58747904|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
30736283|NCT00365352|58747905|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
30736284|NCT00365352|58747906|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
30736285|NCT00365352|58747904|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
30736286|NCT00365352|58747905|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
30736287|NCT00365352|58747906|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
30736288|NCT00365352|58747904|FG000|Overall Study|Lost to Follow-up|1|||
30736289|NCT00365352|58747905|FG001|Overall Study|Lost to Follow-up|1|||
30736290|NCT00365352|58747906|FG002|Overall Study|Lost to Follow-up|0|||
30736291|NCT00365352|58747904|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
30736292|NCT00365352|58747905|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
30736293|NCT00365352|58747906|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
30736294|NCT00376506|58747919|FG000|Overall Study|Death|0|||
30736295|NCT00376506|58747920|FG001|Overall Study|Death|2|||
30736296|NCT00410384|58747932|FG000|Overall Study|Withdrawal by Subject|28|||
30736297|NCT00410384|58747933|FG001|Overall Study|Withdrawal by Subject|17|||
30736298|NCT00410384|58747934|FG002|Overall Study|Withdrawal by Subject|20|||
30736299|NCT00410384|58747932|FG000|Overall Study|Adverse Event|23|||
30736300|NCT00410384|58747933|FG001|Overall Study|Adverse Event|18|||
30736301|NCT00410384|58747934|FG002|Overall Study|Adverse Event|23|||
30736302|NCT00410384|58747932|FG000|Overall Study|Lack of Efficacy|20|||
30736303|NCT00410384|58747933|FG001|Overall Study|Lack of Efficacy|12|||
30736304|NCT00410384|58747934|FG002|Overall Study|Lack of Efficacy|17|||
30736305|NCT00410384|58747932|FG000|Overall Study|Lack of Compliance|2|||
30736306|NCT00410384|58747933|FG001|Overall Study|Lack of Compliance|2|||
30736307|NCT00410384|58747934|FG002|Overall Study|Lack of Compliance|2|||
30736308|NCT00410384|58747932|FG000|Overall Study|Lost to Follow-up|4|||
30736309|NCT00410384|58747933|FG001|Overall Study|Lost to Follow-up|6|||
30736310|NCT00410384|58747934|FG002|Overall Study|Lost to Follow-up|6|||
30736311|NCT00410384|58747932|FG000|Overall Study|Protocol Violation|6|||
30736312|NCT00410384|58747933|FG001|Overall Study|Protocol Violation|6|||
30736313|NCT00410384|58747934|FG002|Overall Study|Protocol Violation|6|||
30736314|NCT00410384|58747932|FG000|Overall Study|Physician Decision|3|||
30736315|NCT00410384|58747933|FG001|Overall Study|Physician Decision|3|||
30736316|NCT00410384|58747934|FG002|Overall Study|Physician Decision|4|||
30736317|NCT00410384|58747932|FG000|Overall Study|Other|3|||
30736318|NCT00410384|58747933|FG001|Overall Study|Other|8|||
30736319|NCT00410384|58747934|FG002|Overall Study|Other|4|||
30736320|NCT00370032|58747944|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
30736321|NCT00370032|58747945|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
30736322|NCT00370032|58747944|FG000|Washout Period|Withdrawal by Subject|0|||
30736323|NCT00370032|58747945|FG001|Washout Period|Withdrawal by Subject|1|||
30736324|NCT00370032|58747944|FG000|Washout Period|Lost to Follow-up|0|||
30736325|NCT00370032|58747945|FG001|Washout Period|Lost to Follow-up|1|||
30736326|NCT00370032|58747944|FG000|Washout Period|Adverse Event|1|||
30736327|NCT00370032|58747945|FG001|Washout Period|Adverse Event|0|||
30736328|NCT00370032|58747944|FG000|Follow-up Period|Withdrawal by Subject|1|||
30736329|NCT00370032|58747945|FG001|Follow-up Period|Withdrawal by Subject|0|||
30736330|NCT00410072|58747962|FG000|Day 1 to Week 48|Adverse Event|1|||
30736331|NCT00410072|58747963|FG001|Day 1 to Week 48|Adverse Event|2|||
30736332|NCT00410072|58747962|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
30736333|NCT00410072|58747963|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
30736334|NCT00410072|58747962|FG000|Day 1 to Week 48|Other|0|||
30736335|NCT00410072|58747963|FG001|Day 1 to Week 48|Other|1|||
30736336|NCT00410072|58747962|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
30736337|NCT00410072|58747963|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
30736338|NCT00410072|58747962|FG000|Day 1 to Week 48|Pregnancy|0|||
30736339|NCT00410072|58747963|FG001|Day 1 to Week 48|Pregnancy|2|||
30736340|NCT00410072|58747962|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
30736341|NCT00410072|58747963|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
30736342|NCT00410072|58747962|FG000|After Week 48 to Week 96|Adverse Event|1|||
30736343|NCT00410072|58747963|FG001|After Week 48 to Week 96|Adverse Event|2|||
30736344|NCT00410072|58747962|FG000|After Week 48 to Week 96|Death|0|||
30736345|NCT00410072|58747963|FG001|After Week 48 to Week 96|Death|1|||
30736346|NCT00410072|58747962|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
30736347|NCT00410072|58747963|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
30736348|NCT00410072|58747962|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
30736349|NCT00410072|58747963|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
30736350|NCT00410072|58747962|FG000|After Week 48 to Week 96|Other|2|||
30736351|NCT00410072|58747963|FG001|After Week 48 to Week 96|Other|0|||
30736352|NCT00410072|58747962|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
30736353|NCT00410072|58747963|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
30736354|NCT00410072|58747962|FG000|After Week 48 to Week 96|Pregnancy|0|||
30736355|NCT00410072|58747963|FG001|After Week 48 to Week 96|Pregnancy|2|||
30736356|NCT00410072|58747962|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
30736357|NCT00410072|58747963|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
30736358|NCT00409838|58747971|FG000|Short-term Period|Adverse Event|0|||
30736359|NCT00409838|58747972|FG001|Short-term Period|Adverse Event|1|||
30736360|NCT00409838|58747971|FG000|Short-term Period|Lost to Follow-up|0|||
30736361|NCT00409838|58747972|FG001|Short-term Period|Lost to Follow-up|1|||
30736362|NCT00409838|58747971|FG000|Short-term Period|Withdrawal by Subject|2|||
30736363|NCT00409838|58747972|FG001|Short-term Period|Withdrawal by Subject|3|||
30736364|NCT00409838|58747971|FG000|Short-term Period|Never Treated|1|||
30736365|NCT00409838|58747972|FG001|Short-term Period|Never Treated|0|||
30736366|NCT00409838|58747971|FG000|Long-term Extension Period|Adverse Event|10|||
30736367|NCT00409838|58747972|FG001|Long-term Extension Period|Adverse Event|0|||
30736368|NCT00409838|58747971|FG000|Long-term Extension Period|Death|1|||
30736369|NCT00409838|58747972|FG001|Long-term Extension Period|Death|0|||
30736370|NCT00409838|58747971|FG000|Long-term Extension Period|Lack of Efficacy|2|||
30736371|NCT00409838|58747972|FG001|Long-term Extension Period|Lack of Efficacy|0|||
30736372|NCT00409838|58747971|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
30736373|NCT00409838|58747972|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
30736374|NCT00409838|58747971|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
30736375|NCT00409838|58747972|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
30736376|NCT00409838|58747971|FG000|Long-term Extension Period|Pregnancy|1|||
30736377|NCT00409838|58747972|FG001|Long-term Extension Period|Pregnancy|0|||
30736378|NCT00399542|58747997|FG000|Overall Study|Adverse Event|18|||
30736379|NCT00399542|58747998|FG001|Overall Study|Adverse Event|15|||
30736380|NCT00399542|58747997|FG000|Overall Study|Protocol Violation|13|||
30736381|NCT00399542|58747998|FG001|Overall Study|Protocol Violation|3|||
30736382|NCT00399542|58747997|FG000|Overall Study|Withdrawal by Subject|28|||
30736383|NCT00399542|58747998|FG001|Overall Study|Withdrawal by Subject|10|||
30736384|NCT00399542|58747997|FG000|Overall Study|Lack of Efficacy|18|||
30736385|NCT00399542|58747998|FG001|Overall Study|Lack of Efficacy|8|||
30736386|NCT00399542|58747997|FG000|Overall Study|Lost to Follow-up|6|||
30736387|NCT00399542|58747998|FG001|Overall Study|Lost to Follow-up|6|||
30736388|NCT00399542|58747997|FG000|Overall Study|Other|1|||
30736389|NCT00399542|58747998|FG001|Overall Study|Other|0|||
30736390|NCT00399542|58747997|FG000|Overall Study|Physician Decision|0|||
30736391|NCT00399542|58747998|FG001|Overall Study|Physician Decision|1|||
30736392|NCT00409682|58748007|FG000|Open-label Induction Period|Adverse Event|1|||
30736393|NCT00409682|58748008|FG001|Open-label Induction Period|Adverse Event|0|||
30736394|NCT00409682|58748009|FG002|Open-label Induction Period|Adverse Event|0|||
30736395|NCT00409682|58748007|FG000|Open-label Induction Period|Lack of Efficacy|1|||
30736396|NCT00409682|58748008|FG001|Open-label Induction Period|Lack of Efficacy|0|||
30736397|NCT00409682|58748009|FG002|Open-label Induction Period|Lack of Efficacy|0|||
30736398|NCT00409682|58748007|FG000|Open-label Induction Period|Protocol Violation|1|||
30736399|NCT00409682|58748008|FG001|Open-label Induction Period|Protocol Violation|0|||
30736400|NCT00409682|58748009|FG002|Open-label Induction Period|Protocol Violation|0|||
30736401|NCT00409682|58748007|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
30736402|NCT00409682|58748008|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
30736403|NCT00409682|58748009|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
30736404|NCT00409682|58748007|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
30736405|NCT00409682|58748008|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
30736406|NCT00409682|58748009|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
30736407|NCT00409682|58748007|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
30736408|NCT00409682|58748008|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
30736409|NCT00409682|58748009|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
30736410|NCT00409682|58748007|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
30736411|NCT00409682|58748008|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
30736412|NCT00409682|58748009|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
30736413|NCT00409682|58748007|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
30736414|NCT00409682|58748008|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
30736415|NCT00409682|58748009|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
30736416|NCT00409682|58748007|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
30736417|NCT00409682|58748008|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
30736418|NCT00409682|58748009|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
30736419|NCT00409682|58748007|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
30736420|NCT00409682|58748008|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
30736421|NCT00409682|58748009|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
30736422|NCT00398216|58748021|FG000|Overall Study|Adverse Event|4|||
30736423|NCT00398216|58748022|FG001|Overall Study|Adverse Event|2|||
30736424|NCT00398216|58748023|FG002|Overall Study|Adverse Event|5|||
30736425|NCT00398216|58748024|FG003|Overall Study|Adverse Event|7|||
30736426|NCT00398216|58748025|FG004|Overall Study|Adverse Event|2|||
30736427|NCT00398216|58748021|FG000|Overall Study|Protocol Violation|2|||
30736428|NCT00398216|58748022|FG001|Overall Study|Protocol Violation|4|||
30736429|NCT00398216|58748023|FG002|Overall Study|Protocol Violation|5|||
30736430|NCT00398216|58748024|FG003|Overall Study|Protocol Violation|7|||
30736431|NCT00398216|58748025|FG004|Overall Study|Protocol Violation|5|||
30736432|NCT00398216|58748021|FG000|Overall Study|Lost to Follow-up|1|||
30736433|NCT00398216|58748022|FG001|Overall Study|Lost to Follow-up|6|||
30736434|NCT00398216|58748023|FG002|Overall Study|Lost to Follow-up|4|||
30736435|NCT00398216|58748024|FG003|Overall Study|Lost to Follow-up|4|||
30736436|NCT00398216|58748025|FG004|Overall Study|Lost to Follow-up|1|||
30736437|NCT00398216|58748021|FG000|Overall Study|Death|0|||
30736438|NCT00398216|58748022|FG001|Overall Study|Death|3|||
30736439|NCT00398216|58748023|FG002|Overall Study|Death|0|||
30736440|NCT00398216|58748024|FG003|Overall Study|Death|0|||
30736441|NCT00398216|58748025|FG004|Overall Study|Death|0|||
30736442|NCT00398216|58748021|FG000|Overall Study|Withdrawal by Subject|1|||
30736443|NCT00398216|58748022|FG001|Overall Study|Withdrawal by Subject|0|||
30736444|NCT00398216|58748023|FG002|Overall Study|Withdrawal by Subject|3|||
30736445|NCT00398216|58748024|FG003|Overall Study|Withdrawal by Subject|1|||
30736446|NCT00398216|58748025|FG004|Overall Study|Withdrawal by Subject|2|||
30736447|NCT00398216|58748021|FG000|Overall Study|administrative reasons|3|||
30736448|NCT00398216|58748022|FG001|Overall Study|administrative reasons|4|||
30736449|NCT00398216|58748023|FG002|Overall Study|administrative reasons|4|||
30736450|NCT00398216|58748024|FG003|Overall Study|administrative reasons|3|||
30736451|NCT00398216|58748025|FG004|Overall Study|administrative reasons|3|||
30736452|NCT00398216|58748021|FG000|Overall Study|entrance criteria|0|||
30736453|NCT00398216|58748022|FG001|Overall Study|entrance criteria|0|||
30736454|NCT00398216|58748023|FG002|Overall Study|entrance criteria|0|||
30736455|NCT00398216|58748024|FG003|Overall Study|entrance criteria|0|||
30736456|NCT00398216|58748025|FG004|Overall Study|entrance criteria|2|||
30736457|NCT00398138|58748037|FG000|Overall Study|Adverse Event|2|||
30736458|NCT00397982|58748041|FG000|Overall Study|Withdrawal by Subject|1|||
30736459|NCT00397982|58748041|FG000|Overall Study|Adverse Event|1|||
30736460|NCT00397982|58748041|FG000|Overall Study|noncompliance|1|||
30736461|NCT00397982|58748041|FG000|Overall Study|Unrelated health issues|1|||
30736462|NCT00408902|58748046|FG000|Overall Study|Lack of Efficacy|7|||
30736463|NCT00408902|58748046|FG000|Overall Study|Adverse Event|3|||
30736464|NCT00397514|58748051|FG000|Overall Study|Withdrawal by Subject|1|||
30736465|NCT00397514|58748051|FG000|Overall Study|Pacing wire malfunction|1|||
30736466|NCT00397514|58748051|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
30736467|NCT00397514|58748051|FG000|Overall Study|early extubation|2|||
30736468|NCT00397514|58748051|FG000|Overall Study|poor echocardiographic windows|1|||
30736469|NCT00397046|58748065|FG000|Overall Study|Disease Progression|3|||
30736470|NCT00397046|58748066|FG001|Overall Study|Disease Progression|3|||
30736471|NCT00397046|58748067|FG002|Overall Study|Disease Progression|10|||
30736472|NCT00397046|58748068|FG003|Overall Study|Disease Progression|5|||
30736473|NCT00396812|58748079|FG000|Overall Study|Physician Decision|1|||
30736474|NCT00396656|58748083|FG000|First Treatment Period|Withdrawal by Subject|0|||
30736475|NCT00396656|58748084|FG001|First Treatment Period|Withdrawal by Subject|2|||
30736476|NCT00396656|58748083|FG000|Second Treatment Period|Adverse Event|0|||
30736477|NCT00396656|58748084|FG001|Second Treatment Period|Adverse Event|1|||
30736478|NCT00408434|58748097|FG000|Overall Study|Adverse Event|0|||
30736479|NCT00408434|58748098|FG001|Overall Study|Adverse Event|0|||
30736480|NCT00408434|58748099|FG002|Overall Study|Adverse Event|1|||
30736481|NCT00408434|58748100|FG003|Overall Study|Adverse Event|0|||
30736482|NCT00408434|58748101|FG004|Overall Study|Adverse Event|0|||
30736483|NCT00408434|58748102|FG005|Overall Study|Adverse Event|0|||
30736484|NCT00408434|58748103|FG006|Overall Study|Adverse Event|0|||
30736485|NCT00408434|58748097|FG000|Overall Study|Progressive disease|6|||
30736486|NCT00408434|58748098|FG001|Overall Study|Progressive disease|3|||
30736487|NCT00408434|58748099|FG002|Overall Study|Progressive disease|4|||
30736488|NCT00408434|58748100|FG003|Overall Study|Progressive disease|3|||
30736489|NCT00408434|58748101|FG004|Overall Study|Progressive disease|3|||
30736490|NCT00408434|58748102|FG005|Overall Study|Progressive disease|1|||
30736491|NCT00408434|58748103|FG006|Overall Study|Progressive disease|4|||
30736492|NCT00408434|58748097|FG000|Overall Study|Other|0|||
30736493|NCT00408434|58748098|FG001|Overall Study|Other|0|||
30736494|NCT00408434|58748099|FG002|Overall Study|Other|1|||
30736495|NCT00408434|58748100|FG003|Overall Study|Other|0|||
30736496|NCT00408434|58748101|FG004|Overall Study|Other|2|||
30736497|NCT00408434|58748102|FG005|Overall Study|Other|1|||
30736498|NCT00408434|58748103|FG006|Overall Study|Other|0|||
30736499|NCT00408434|58748097|FG000|Overall Study|Terminated by Investigator|0|||
30736500|NCT00408434|58748098|FG001|Overall Study|Terminated by Investigator|0|||
30736501|NCT00408434|58748099|FG002|Overall Study|Terminated by Investigator|0|||
30736502|NCT00408434|58748100|FG003|Overall Study|Terminated by Investigator|0|||
30736503|NCT00408434|58748101|FG004|Overall Study|Terminated by Investigator|1|||
30736504|NCT00408434|58748102|FG005|Overall Study|Terminated by Investigator|1|||
30736505|NCT00408434|58748103|FG006|Overall Study|Terminated by Investigator|0|||
30736506|NCT00418886|58748122|FG000|Overall Study|discontinue treatment survival follow up|90|||
30736507|NCT00418886|58748123|FG001|Overall Study|discontinue treatment survival follow up|91|||
30736508|NCT00418886|58748122|FG000|Overall Study|Death|122|||
30736509|NCT00418886|58748123|FG001|Overall Study|Death|147|||
30736510|NCT00418886|58748122|FG000|Overall Study|Withdrawal by Subject|9|||
30736511|NCT00418886|58748123|FG001|Overall Study|Withdrawal by Subject|10|||
30736512|NCT00418886|58748122|FG000|Overall Study|Lost to Follow-up|4|||
30736513|NCT00418886|58748123|FG001|Overall Study|Lost to Follow-up|6|||
30736514|NCT00418886|58748122|FG000|Overall Study|withdrawn due to other reason|1|||
30736515|NCT00418886|58748123|FG001|Overall Study|withdrawn due to other reason|0|||
30736516|NCT00418886|58748122|FG000|Overall Study|randomised but no treatment received|0|||
30736517|NCT00418886|58748123|FG001|Overall Study|randomised but no treatment received|1|||
30736518|NCT00418184|58748131|FG000|Double-blind Phase|Withdrawal by Subject|22|||
30736519|NCT00418184|58748132|FG001|Double-blind Phase|Withdrawal by Subject|9|||
30736520|NCT00418184|58748131|FG000|Double-blind Phase|Adverse Event|2|||
30736521|NCT00418184|58748132|FG001|Double-blind Phase|Adverse Event|1|||
30736522|NCT00418184|58748131|FG000|Double-blind Phase|Poor compliance|3|||
30900711|NCT02034435|58934234|FG000|Overall Study|Withdrawal by Subject|1|||
30900712|NCT02034435|58934235|FG001|Overall Study|Withdrawal by Subject|0|||
30900713|NCT02034435|58934236|FG002|Overall Study|Withdrawal by Subject|0|||
30900714|NCT02034435|58934237|FG003|Overall Study|Withdrawal by Subject|0|||
30900715|NCT02034435|58934234|FG000|Overall Study|Illness|0|||
30900716|NCT02034435|58934235|FG001|Overall Study|Illness|2|||
30736523|NCT00418184|58748132|FG001|Double-blind Phase|Poor compliance|1|||
30736524|NCT00407030|58748141|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
30736525|NCT00407030|58748142|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
30736526|NCT00407030|58748143|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
30736527|NCT00407030|58748141|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
30736528|NCT00407030|58748142|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
30736529|NCT00407030|58748143|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
30736530|NCT00407030|58748141|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
30736531|NCT00407030|58748142|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
30736532|NCT00407030|58748143|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
30736533|NCT00407030|58748141|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
30736534|NCT00407030|58748142|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
30736535|NCT00407030|58748143|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
30736536|NCT00407030|58748141|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
30736537|NCT00407030|58748142|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
30736538|NCT00407030|58748143|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
30736539|NCT00407030|58748141|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
30900717|NCT02034435|58934236|FG002|Overall Study|Illness|0|||
30900718|NCT02034435|58934237|FG003|Overall Study|Illness|0|||
30900719|NCT02034435|58934234|FG000|Overall Study|Inadequate IV access|1|||
30900720|NCT02034435|58934235|FG001|Overall Study|Inadequate IV access|0|||
30900721|NCT02034435|58934236|FG002|Overall Study|Inadequate IV access|0|||
30900722|NCT02034435|58934237|FG003|Overall Study|Inadequate IV access|1|||
30900723|NCT02033889|58934250|FG000|Overall Study|Adverse Event|3|||
30736540|NCT00407030|58748142|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
30736541|NCT00407030|58748143|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
30736542|NCT00407030|58748141|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
30736543|NCT00407030|58748142|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
30736544|NCT00407030|58748143|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
30736545|NCT00407030|58748141|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
30736546|NCT00407030|58748142|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
30736547|NCT00407030|58748143|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
30736548|NCT00407030|58748141|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
30736549|NCT00407030|58748142|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
30736550|NCT00407030|58748143|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
30736551|NCT00407030|58748141|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
30736552|NCT00407030|58748142|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
30736553|NCT00407030|58748143|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
30736554|NCT00407030|58748141|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
30736555|NCT00407030|58748142|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
30736556|NCT00407030|58748143|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
30736557|NCT00407030|58748141|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
30736558|NCT00407030|58748142|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
30736559|NCT00407030|58748143|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
30736560|NCT00407030|58748141|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
30736561|NCT00407030|58748142|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
30736562|NCT00407030|58748143|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
30736563|NCT00406718|58748156|FG000|Overall Study|Withdrawal by Subject|2|||
30736564|NCT00406718|58748157|FG001|Overall Study|Withdrawal by Subject|9|||
30736565|NCT00406718|58748158|FG002|Overall Study|Withdrawal by Subject|4|||
30736566|NCT00406718|58748156|FG000|Overall Study|Lost to Follow-up|2|||
30736567|NCT00406718|58748157|FG001|Overall Study|Lost to Follow-up|5|||
30736568|NCT00406718|58748158|FG002|Overall Study|Lost to Follow-up|4|||
30736569|NCT00406640|58748170|FG000|Acute Phase|Adverse Event|18|||
30736570|NCT00406640|58748171|FG001|Acute Phase|Adverse Event|13|||
30736571|NCT00406640|58748170|FG000|Acute Phase|Failed to Return|5|||
30736572|NCT00406640|58748171|FG001|Acute Phase|Failed to Return|1|||
30736573|NCT00406640|58748170|FG000|Acute Phase|Physician Decision|0|||
30736574|NCT00406640|58748171|FG001|Acute Phase|Physician Decision|1|||
30736575|NCT00406640|58748170|FG000|Acute Phase|Lost to Follow-up|7|||
30736576|NCT00406640|58748171|FG001|Acute Phase|Lost to Follow-up|4|||
30736577|NCT00406640|58748170|FG000|Acute Phase|Protocol deviation|4|||
30736578|NCT00406640|58748171|FG001|Acute Phase|Protocol deviation|10|||
30736579|NCT00406640|58748170|FG000|Acute Phase|Protocol Violation|3|||
30736580|NCT00406640|58748171|FG001|Acute Phase|Protocol Violation|2|||
30736581|NCT00406640|58748170|FG000|Acute Phase|Withdrawal by Subject|11|||
30736582|NCT00406640|58748171|FG001|Acute Phase|Withdrawal by Subject|9|||
30736583|NCT00406640|58748170|FG000|Acute Phase|Lack of Efficacy|3|||
30736584|NCT00406640|58748171|FG001|Acute Phase|Lack of Efficacy|3|||
30736585|NCT00406640|58748170|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
30736586|NCT00406640|58748171|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
30736587|NCT00406640|58748170|FG000|DB Continuation Phase for Responders|Death|1|||
30736588|NCT00406640|58748171|FG001|DB Continuation Phase for Responders|Death|0|||
30736589|NCT00406640|58748170|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
30736590|NCT00406640|58748171|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
30736591|NCT00406640|58748170|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
30736592|NCT00406640|58748171|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
30736593|NCT00406640|58748170|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
30736594|NCT00406640|58748171|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
30736595|NCT00406640|58748170|FG000|DB Continuation Phase for Responders|non-compliance|7|||
30736596|NCT00406640|58748171|FG001|DB Continuation Phase for Responders|non-compliance|5|||
30736597|NCT00406640|58748170|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
30736598|NCT00406640|58748171|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
30736599|NCT00406640|58748170|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
30736600|NCT00406640|58748171|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
30736601|NCT00406640|58748170|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
30736602|NCT00406640|58748171|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
30736603|NCT00406640|58748170|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
30736604|NCT00406640|58748171|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
30736605|NCT00406640|58748170|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
30736606|NCT00406640|58748171|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
30736607|NCT00406640|58748170|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
30736608|NCT00406640|58748171|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
30736609|NCT00406640|58748170|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
30736610|NCT00406640|58748171|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
30736611|NCT00406640|58748170|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
30736612|NCT00406640|58748171|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
30736613|NCT00406640|58748170|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
30736614|NCT00406640|58748171|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
30736615|NCT00406640|58748170|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
30736616|NCT00406640|58748171|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
30900724|NCT02033889|58934251|FG001|Overall Study|Adverse Event|1|||
30900725|NCT02033889|58934252|FG002|Overall Study|Adverse Event|3|||
30900726|NCT02033889|58934250|FG000|Overall Study|Death|3|||
30900727|NCT02033889|58934251|FG001|Overall Study|Death|1|||
30736617|NCT00394706|58748191|FG000|Overall Study|Withdrawal by Subject|2|||
30736618|NCT00394706|58748192|FG001|Overall Study|Withdrawal by Subject|0|||
30736619|NCT00394706|58748193|FG002|Overall Study|Withdrawal by Subject|1|||
30736620|NCT00394706|58748194|FG003|Overall Study|Withdrawal by Subject|0|||
30736621|NCT00394706|58748195|FG004|Overall Study|Withdrawal by Subject|0|||
30736622|NCT00394706|58748196|FG005|Overall Study|Withdrawal by Subject|2|||
30736623|NCT00394706|58748197|FG006|Overall Study|Withdrawal by Subject|1|||
30736624|NCT00394706|58748198|FG007|Overall Study|Withdrawal by Subject|0|||
30736625|NCT00394706|58748191|FG000|Overall Study|Lost to Follow-up|2|||
30736626|NCT00394706|58748192|FG001|Overall Study|Lost to Follow-up|2|||
30736627|NCT00394706|58748193|FG002|Overall Study|Lost to Follow-up|8|||
30736628|NCT00394706|58748194|FG003|Overall Study|Lost to Follow-up|1|||
30736629|NCT00394706|58748195|FG004|Overall Study|Lost to Follow-up|2|||
30736630|NCT00394706|58748196|FG005|Overall Study|Lost to Follow-up|5|||
30736631|NCT00394706|58748197|FG006|Overall Study|Lost to Follow-up|2|||
30736632|NCT00394706|58748198|FG007|Overall Study|Lost to Follow-up|0|||
30736633|NCT00394472|58748214|FG000|Overall Study|Protocol Violation|1|||
30736634|NCT00394472|58748215|FG001|Overall Study|Protocol Violation|3|||
30736635|NCT00394472|58748214|FG000|Overall Study|incorrect enrolment|4|||
30736636|NCT00394472|58748215|FG001|Overall Study|incorrect enrolment|2|||
30736637|NCT00394472|58748214|FG000|Overall Study|Adverse Event|4|||
30736638|NCT00394472|58748215|FG001|Overall Study|Adverse Event|2|||
30736639|NCT00394472|58748214|FG000|Overall Study|Withdrawal by Subject|0|||
30736640|NCT00394472|58748215|FG001|Overall Study|Withdrawal by Subject|2|||
30736641|NCT00394472|58748214|FG000|Overall Study|Physician Decision|0|||
30736642|NCT00394472|58748215|FG001|Overall Study|Physician Decision|1|||
30736643|NCT00394472|58748214|FG000|Overall Study|Lost to Follow-up|0|||
30736644|NCT00394472|58748215|FG001|Overall Study|Lost to Follow-up|1|||
30736645|NCT00419120|58748221|FG000|Long Term Follow up Period|study ongoing|10|||
30736646|NCT00395642|58748225|FG000|Overall Study|Death|4|||
30736647|NCT00395642|58748225|FG000|Overall Study|Lost to Follow-up|1|||
30736648|NCT00395642|58748225|FG000|Overall Study|Physician Decision|7|||
30736649|NCT00395642|58748225|FG000|Overall Study|Withdrawal by Subject|1|||
30736650|NCT00395486|58748231|FG000|Overall Study|Adverse Event|1|||
30736651|NCT00395486|58748232|FG001|Overall Study|Adverse Event|2|||
30736652|NCT00395486|58748231|FG000|Overall Study|Withdrawal by Subject|5|||
30736653|NCT00395486|58748232|FG001|Overall Study|Withdrawal by Subject|2|||
30736654|NCT00395486|58748231|FG000|Overall Study|Lost to Follow-up|0|||
30736655|NCT00395486|58748232|FG001|Overall Study|Lost to Follow-up|1|||
30736656|NCT00395018|58748238|FG000|On-Treatment|Death|4|||
30736657|NCT00395018|58748238|FG000|On-Treatment|Other Reason|2|||
30736658|NCT00395018|58748238|FG000|On-Treatment|Poor/non-compliance|2|||
30736659|NCT00395018|58748238|FG000|On-Treatment|Subject no longer meets study criteria|2|||
30736660|NCT00395018|58748238|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
30736661|NCT00395018|58748238|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
30736662|NCT00395018|58748238|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
30736663|NCT00375518|58748244|FG000|Overall Study|Withdrawal by Subject|2|||
30736664|NCT00375518|58748245|FG001|Overall Study|Withdrawal by Subject|10|||
30790965|NCT00151996|58804114|FG001|Overall Study|Withdrawal by Subject|1|||
30900728|NCT02033889|58934252|FG002|Overall Study|Death|2|||
30900729|NCT02033889|58934250|FG000|Overall Study|Excluded Medication|1|||
30900730|NCT02033889|58934251|FG001|Overall Study|Excluded Medication|1|||
30621853|NCT01154088|58633403|FG001|Overall Study|Lost to Follow-up|6|||
30621854|NCT01154088|58633404|FG002|Overall Study|Lost to Follow-up|7|||
30736665|NCT00375518|58748244|FG000|Overall Study|Patient Not Treated|6|||
30736666|NCT00375518|58748245|FG001|Overall Study|Patient Not Treated|6|||
30736667|NCT00375518|58748244|FG000|Overall Study|Death|0|||
30736668|NCT00375518|58748245|FG001|Overall Study|Death|1|||
30736669|NCT00256750|58748254|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
30736670|NCT00256750|58748255|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
30736671|NCT00256750|58748256|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
30736672|NCT00256750|58748254|FG000|Transplanted Pre-Treatment|Other|2|||
30736673|NCT00256750|58748255|FG001|Transplanted Pre-Treatment|Other|0|||
30736674|NCT00256750|58748256|FG002|Transplanted Pre-Treatment|Other|0|||
30900731|NCT02033889|58934252|FG002|Overall Study|Excluded Medication|0|||
30736675|NCT00256750|58748254|FG000|Transplanted Pre-Treatment|Death|1|||
30736676|NCT00256750|58748255|FG001|Transplanted Pre-Treatment|Death|0|||
30736677|NCT00256750|58748256|FG002|Transplanted Pre-Treatment|Death|0|||
30736678|NCT00256750|58748254|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
30736679|NCT00256750|58748255|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
30736680|NCT00256750|58748256|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
30736681|NCT00256750|58748254|FG000|Post-Transplant Treated (12 Months)|Death|3|||
30736682|NCT00256750|58748255|FG001|Post-Transplant Treated (12 Months)|Death|2|||
30736683|NCT00256750|58748256|FG002|Post-Transplant Treated (12 Months)|Death|4|||
30736684|NCT00256750|58748254|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
30736685|NCT00256750|58748255|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
30736686|NCT00256750|58748256|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
30736687|NCT00256750|58748254|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
30736688|NCT00256750|58748255|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
30736689|NCT00256750|58748256|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
30736690|NCT00256750|58748254|FG000|Post-Transplant Treated (12 Months)|Other|5|||
30736691|NCT00256750|58748255|FG001|Post-Transplant Treated (12 Months)|Other|4|||
30736692|NCT00256750|58748256|FG002|Post-Transplant Treated (12 Months)|Other|2|||
30736693|NCT00256750|58748254|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
30736694|NCT00256750|58748255|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
30736695|NCT00256750|58748256|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
30736696|NCT00256750|58748254|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
30736697|NCT00256750|58748255|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
30736698|NCT00256750|58748256|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
30736699|NCT00256750|58748254|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
30736700|NCT00256750|58748255|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
30736701|NCT00256750|58748256|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
30736702|NCT00256750|58748254|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
30736703|NCT00256750|58748255|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
30736704|NCT00256750|58748256|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
30736705|NCT00256750|58748254|FG000|Post-Transplant Treated (24 Months)|Death|3|||
30736706|NCT00256750|58748255|FG001|Post-Transplant Treated (24 Months)|Death|0|||
30736707|NCT00256750|58748256|FG002|Post-Transplant Treated (24 Months)|Death|0|||
30736708|NCT00256750|58748254|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
30736709|NCT00256750|58748255|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
30736710|NCT00256750|58748256|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
30736711|NCT00256750|58748254|FG000|Post-Transplant Treated (24 Months)|Other|2|||
30736712|NCT00256750|58748255|FG001|Post-Transplant Treated (24 Months)|Other|0|||
30736713|NCT00256750|58748256|FG002|Post-Transplant Treated (24 Months)|Other|1|||
30736714|NCT00256750|58748254|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
30736715|NCT00256750|58748255|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
30736716|NCT00256750|58748256|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
30736717|NCT00256750|58748254|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
30736718|NCT00256750|58748255|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
30736719|NCT00256750|58748256|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
30736720|NCT00256750|58748254|FG000|Post-Transplant Treated (36 Months)|Death|0|||
30736721|NCT00256750|58748255|FG001|Post-Transplant Treated (36 Months)|Death|2|||
30736722|NCT00256750|58748256|FG002|Post-Transplant Treated (36 Months)|Death|1|||
30736723|NCT00256750|58748254|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
30736724|NCT00256750|58748255|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
30736725|NCT00256750|58748256|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
30736726|NCT00256750|58748254|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
30736727|NCT00256750|58748255|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
30736728|NCT00256750|58748256|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
30736729|NCT00256750|58748254|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
30736730|NCT00256750|58748255|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
30736731|NCT00256750|58748256|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
30736732|NCT00256750|58748254|FG000|Post-Transplant Treated (36 Months)|Other|0|||
30736733|NCT00256750|58748255|FG001|Post-Transplant Treated (36 Months)|Other|1|||
30736734|NCT00256750|58748256|FG002|Post-Transplant Treated (36 Months)|Other|1|||
30736735|NCT00256750|58748254|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
30736736|NCT00256750|58748255|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
30736737|NCT00256750|58748256|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
30736738|NCT00256750|58748254|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
30736739|NCT00256750|58748255|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
30736740|NCT00256750|58748256|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
30736741|NCT00256750|58748254|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
30736742|NCT00256750|58748255|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
30736743|NCT00256750|58748256|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
30736744|NCT00256750|58748254|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
30736745|NCT00256750|58748255|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
30736746|NCT00256750|58748256|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
30736747|NCT00256750|58748254|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
30736748|NCT00256750|58748255|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
30736749|NCT00256750|58748256|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
30736750|NCT00256750|58748254|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
30736751|NCT00256750|58748255|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
30736752|NCT00256750|58748256|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
30736753|NCT00256750|58748254|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
30736754|NCT00256750|58748255|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
30736755|NCT00256750|58748256|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
30736756|NCT00256750|58748254|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
30736757|NCT00256750|58748255|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
30736758|NCT00256750|58748256|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
30736759|NCT00256750|58748254|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
30736760|NCT00256750|58748255|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
30736761|NCT00256750|58748256|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
30736762|NCT00279201|58748267|FG000|Initiation|Death|1|||
30736763|NCT00279201|58748268|FG001|Initiation|Death|5|||
30736764|NCT00279201|58748269|FG002|Initiation|Death|0|||
30736765|NCT00279201|58748270|FG003|Initiation|Death|0|||
30736766|NCT00279201|58748271|FG004|Initiation|Death|0|||
30736767|NCT00279201|58748272|FG005|Initiation|Death|0|||
30736768|NCT00279201|58748267|FG000|Initiation|Adverse Event|6|||
30736769|NCT00279201|58748268|FG001|Initiation|Adverse Event|15|||
30736770|NCT00279201|58748269|FG002|Initiation|Adverse Event|0|||
30736771|NCT00279201|58748270|FG003|Initiation|Adverse Event|0|||
30736772|NCT00279201|58748271|FG004|Initiation|Adverse Event|0|||
30736773|NCT00279201|58748272|FG005|Initiation|Adverse Event|0|||
30736774|NCT00279201|58748267|FG000|Initiation|Lost to Follow-up|42|||
30736775|NCT00279201|58748268|FG001|Initiation|Lost to Follow-up|41|||
30736776|NCT00279201|58748269|FG002|Initiation|Lost to Follow-up|0|||
30736777|NCT00279201|58748270|FG003|Initiation|Lost to Follow-up|0|||
30736778|NCT00279201|58748271|FG004|Initiation|Lost to Follow-up|0|||
30736779|NCT00279201|58748272|FG005|Initiation|Lost to Follow-up|0|||
30736780|NCT00279201|58748267|FG000|Initiation|Entry Criteria Exclusion|7|||
30736781|NCT00279201|58748268|FG001|Initiation|Entry Criteria Exclusion|9|||
30736782|NCT00279201|58748269|FG002|Initiation|Entry Criteria Exclusion|0|||
30736783|NCT00279201|58748270|FG003|Initiation|Entry Criteria Exclusion|0|||
30736784|NCT00279201|58748271|FG004|Initiation|Entry Criteria Exclusion|0|||
30736785|NCT00279201|58748272|FG005|Initiation|Entry Criteria Exclusion|0|||
30736786|NCT00279201|58748267|FG000|Initiation|Protocol Violation|9|||
30736787|NCT00279201|58748268|FG001|Initiation|Protocol Violation|10|||
30736788|NCT00279201|58748269|FG002|Initiation|Protocol Violation|0|||
30736789|NCT00279201|58748270|FG003|Initiation|Protocol Violation|0|||
30736790|NCT00279201|58748271|FG004|Initiation|Protocol Violation|0|||
30736791|NCT00279201|58748272|FG005|Initiation|Protocol Violation|0|||
30736792|NCT00279201|58748267|FG000|Initiation|Withdrawal by Subject|35|||
30736793|NCT00279201|58748268|FG001|Initiation|Withdrawal by Subject|41|||
30736794|NCT00279201|58748269|FG002|Initiation|Withdrawal by Subject|0|||
30736795|NCT00279201|58748270|FG003|Initiation|Withdrawal by Subject|0|||
30736796|NCT00279201|58748271|FG004|Initiation|Withdrawal by Subject|0|||
30736797|NCT00279201|58748272|FG005|Initiation|Withdrawal by Subject|0|||
30736798|NCT00279201|58748267|FG000|Initiation|Physician Decision|15|||
30736799|NCT00279201|58748268|FG001|Initiation|Physician Decision|18|||
30736800|NCT00279201|58748269|FG002|Initiation|Physician Decision|0|||
30736801|NCT00279201|58748270|FG003|Initiation|Physician Decision|0|||
30736802|NCT00279201|58748271|FG004|Initiation|Physician Decision|0|||
30736803|NCT00279201|58748272|FG005|Initiation|Physician Decision|0|||
30736804|NCT00279201|58748267|FG000|Initiation|Sponsor Decision|13|||
30736805|NCT00279201|58748268|FG001|Initiation|Sponsor Decision|5|||
30736806|NCT00279201|58748269|FG002|Initiation|Sponsor Decision|0|||
30736807|NCT00279201|58748270|FG003|Initiation|Sponsor Decision|0|||
30736808|NCT00279201|58748271|FG004|Initiation|Sponsor Decision|0|||
30736809|NCT00279201|58748272|FG005|Initiation|Sponsor Decision|0|||
30736810|NCT00279201|58748267|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
30736811|NCT00279201|58748268|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
30736812|NCT00279201|58748269|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
30736813|NCT00279201|58748270|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
30736814|NCT00279201|58748271|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
30736815|NCT00279201|58748272|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
30736816|NCT00279201|58748267|FG000|Maintenance|Lack of Efficacy|32|||
30736817|NCT00279201|58748268|FG001|Maintenance|Lack of Efficacy|30|||
30736818|NCT00279201|58748269|FG002|Maintenance|Lack of Efficacy|0|||
30900732|NCT02033889|58934250|FG000|Overall Study|Lost to Follow-up|8|||
30900733|NCT02033889|58934251|FG001|Overall Study|Lost to Follow-up|5|||
30900734|NCT02033889|58934252|FG002|Overall Study|Lost to Follow-up|6|||
30736819|NCT00279201|58748270|FG003|Maintenance|Lack of Efficacy|0|||
30736820|NCT00279201|58748271|FG004|Maintenance|Lack of Efficacy|0|||
30736821|NCT00279201|58748272|FG005|Maintenance|Lack of Efficacy|0|||
30736822|NCT00279201|58748267|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
30736823|NCT00279201|58748268|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
30736824|NCT00279201|58748269|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
30736825|NCT00279201|58748270|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
30736826|NCT00279201|58748271|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
30736827|NCT00279201|58748272|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
30736828|NCT00279201|58748267|FG000|Maintenance|Adverse Event|4|||
30736829|NCT00279201|58748268|FG001|Maintenance|Adverse Event|4|||
30736830|NCT00279201|58748269|FG002|Maintenance|Adverse Event|0|||
30736831|NCT00279201|58748270|FG003|Maintenance|Adverse Event|0|||
30736832|NCT00279201|58748271|FG004|Maintenance|Adverse Event|0|||
30736833|NCT00279201|58748272|FG005|Maintenance|Adverse Event|0|||
30736834|NCT00279201|58748267|FG000|Maintenance|Death|4|||
30736835|NCT00279201|58748268|FG001|Maintenance|Death|4|||
30736836|NCT00279201|58748269|FG002|Maintenance|Death|0|||
30736837|NCT00279201|58748270|FG003|Maintenance|Death|0|||
30736838|NCT00279201|58748271|FG004|Maintenance|Death|0|||
30736839|NCT00279201|58748272|FG005|Maintenance|Death|0|||
30900735|NCT02033889|58934250|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30900736|NCT02033889|58934251|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30900737|NCT02033889|58934252|FG002|Overall Study|Non-Compliance With Study Drug|0|||
30900738|NCT02033889|58934250|FG000|Overall Study|Physician Decision|0|||
30736840|NCT00279201|58748267|FG000|Maintenance|Lost to Follow-up|17|||
30736841|NCT00279201|58748268|FG001|Maintenance|Lost to Follow-up|13|||
30736842|NCT00279201|58748269|FG002|Maintenance|Lost to Follow-up|0|||
30736843|NCT00279201|58748270|FG003|Maintenance|Lost to Follow-up|0|||
30736844|NCT00279201|58748271|FG004|Maintenance|Lost to Follow-up|0|||
30736845|NCT00279201|58748272|FG005|Maintenance|Lost to Follow-up|0|||
30736846|NCT00279201|58748267|FG000|Maintenance|Entry Criteria Exclusion|1|||
30736847|NCT00279201|58748268|FG001|Maintenance|Entry Criteria Exclusion|4|||
30736848|NCT00279201|58748269|FG002|Maintenance|Entry Criteria Exclusion|0|||
30736849|NCT00279201|58748270|FG003|Maintenance|Entry Criteria Exclusion|0|||
30736850|NCT00279201|58748271|FG004|Maintenance|Entry Criteria Exclusion|0|||
30736851|NCT00279201|58748272|FG005|Maintenance|Entry Criteria Exclusion|0|||
30736852|NCT00279201|58748267|FG000|Maintenance|Protocol Violation|16|||
30736853|NCT00279201|58748268|FG001|Maintenance|Protocol Violation|24|||
30736854|NCT00279201|58748269|FG002|Maintenance|Protocol Violation|0|||
30736855|NCT00279201|58748270|FG003|Maintenance|Protocol Violation|0|||
30736856|NCT00279201|58748271|FG004|Maintenance|Protocol Violation|0|||
30736857|NCT00279201|58748272|FG005|Maintenance|Protocol Violation|0|||
30736858|NCT00279201|58748267|FG000|Maintenance|Withdrawal by Subject|18|||
30736859|NCT00279201|58748268|FG001|Maintenance|Withdrawal by Subject|18|||
30736860|NCT00279201|58748269|FG002|Maintenance|Withdrawal by Subject|0|||
30736861|NCT00279201|58748270|FG003|Maintenance|Withdrawal by Subject|0|||
30900739|NCT02033889|58934251|FG001|Overall Study|Physician Decision|1|||
30736862|NCT00279201|58748271|FG004|Maintenance|Withdrawal by Subject|0|||
30736863|NCT00279201|58748272|FG005|Maintenance|Withdrawal by Subject|0|||
30736864|NCT00279201|58748267|FG000|Maintenance|Physician Decision|9|||
30736865|NCT00279201|58748268|FG001|Maintenance|Physician Decision|9|||
30736866|NCT00279201|58748269|FG002|Maintenance|Physician Decision|0|||
30736867|NCT00279201|58748270|FG003|Maintenance|Physician Decision|0|||
30736868|NCT00279201|58748271|FG004|Maintenance|Physician Decision|0|||
30736869|NCT00279201|58748272|FG005|Maintenance|Physician Decision|0|||
30736870|NCT00279201|58748267|FG000|Maintenance|Sponsor Decision|4|||
30736871|NCT00279201|58748268|FG001|Maintenance|Sponsor Decision|0|||
30736872|NCT00279201|58748269|FG002|Maintenance|Sponsor Decision|0|||
30736873|NCT00279201|58748270|FG003|Maintenance|Sponsor Decision|0|||
30736874|NCT00279201|58748271|FG004|Maintenance|Sponsor Decision|0|||
30736875|NCT00279201|58748272|FG005|Maintenance|Sponsor Decision|0|||
30900740|NCT02033889|58934252|FG002|Overall Study|Physician Decision|1|||
30900741|NCT02033889|58934250|FG000|Overall Study|Participant moved|0|||
30900742|NCT02033889|58934251|FG001|Overall Study|Participant moved|1|||
30900743|NCT02033889|58934252|FG002|Overall Study|Participant moved|0|||
30900744|NCT02033889|58934250|FG000|Overall Study|Withdrawal by Subject|18|||
30900745|NCT02033889|58934251|FG001|Overall Study|Withdrawal by Subject|10|||
30900746|NCT02033889|58934252|FG002|Overall Study|Withdrawal by Subject|13|||
30900747|NCT02447003|58934262|FG000|Overall Study|Other|0|||
30900748|NCT02447003|58934263|FG001|Overall Study|Other|4|||
30900749|NCT02447003|58934262|FG000|Overall Study|Site discontinued|0|||
30900750|NCT02447003|58934263|FG001|Overall Study|Site discontinued|2|||
30900751|NCT02447003|58934262|FG000|Overall Study|Physician Decision|0|||
30900752|NCT02447003|58934263|FG001|Overall Study|Physician Decision|1|||
30900753|NCT02447003|58934262|FG000|Overall Study|Withdrawal by Subject|4|||
30900754|NCT02447003|58934263|FG001|Overall Study|Withdrawal by Subject|3|||
30900755|NCT02447003|58934262|FG000|Overall Study|Sponsor Decision|6|||
30900756|NCT02447003|58934263|FG001|Overall Study|Sponsor Decision|11|||
30900757|NCT02447003|58934262|FG000|Overall Study|Progressive Disease|1|||
30900758|NCT02447003|58934263|FG001|Overall Study|Progressive Disease|0|||
30736876|NCT00279201|58748267|FG000|Maintenance|HbA1c>7.5%|123|||
30736877|NCT00279201|58748268|FG001|Maintenance|HbA1c>7.5%|126|||
30736878|NCT00279201|58748269|FG002|Maintenance|HbA1c>7.5%|0|||
30736879|NCT00279201|58748270|FG003|Maintenance|HbA1c>7.5%|0|||
30736880|NCT00279201|58748271|FG004|Maintenance|HbA1c>7.5%|0|||
30736881|NCT00279201|58748272|FG005|Maintenance|HbA1c>7.5%|0|||
30736882|NCT00279201|58748267|FG000|Intensification Addendum|Withdrawal by Subject|0|||
30736883|NCT00279201|58748268|FG001|Intensification Addendum|Withdrawal by Subject|0|||
30736884|NCT00279201|58748269|FG002|Intensification Addendum|Withdrawal by Subject|12|||
30736885|NCT00279201|58748270|FG003|Intensification Addendum|Withdrawal by Subject|14|||
30736886|NCT00279201|58748271|FG004|Intensification Addendum|Withdrawal by Subject|9|||
30736887|NCT00279201|58748272|FG005|Intensification Addendum|Withdrawal by Subject|18|||
30736888|NCT00279201|58748267|FG000|Intensification Addendum|Lost to Follow-up|0|||
30736889|NCT00279201|58748268|FG001|Intensification Addendum|Lost to Follow-up|0|||
30736890|NCT00279201|58748269|FG002|Intensification Addendum|Lost to Follow-up|4|||
30736891|NCT00279201|58748270|FG003|Intensification Addendum|Lost to Follow-up|6|||
30736892|NCT00279201|58748271|FG004|Intensification Addendum|Lost to Follow-up|7|||
30736893|NCT00279201|58748272|FG005|Intensification Addendum|Lost to Follow-up|7|||
30736894|NCT00279201|58748267|FG000|Intensification Addendum|Protocol Violation|0|||
30736895|NCT00279201|58748268|FG001|Intensification Addendum|Protocol Violation|0|||
30736896|NCT00279201|58748269|FG002|Intensification Addendum|Protocol Violation|2|||
30736897|NCT00279201|58748270|FG003|Intensification Addendum|Protocol Violation|2|||
30736898|NCT00279201|58748271|FG004|Intensification Addendum|Protocol Violation|6|||
30736899|NCT00279201|58748272|FG005|Intensification Addendum|Protocol Violation|6|||
30736900|NCT00279201|58748267|FG000|Intensification Addendum|Adverse Event|0|||
30736901|NCT00279201|58748268|FG001|Intensification Addendum|Adverse Event|0|||
30736902|NCT00279201|58748269|FG002|Intensification Addendum|Adverse Event|0|||
30736903|NCT00279201|58748270|FG003|Intensification Addendum|Adverse Event|4|||
30736904|NCT00279201|58748271|FG004|Intensification Addendum|Adverse Event|1|||
30736905|NCT00279201|58748272|FG005|Intensification Addendum|Adverse Event|3|||
30736906|NCT00279201|58748267|FG000|Intensification Addendum|Physician Decision|0|||
30736907|NCT00279201|58748268|FG001|Intensification Addendum|Physician Decision|0|||
30736908|NCT00279201|58748269|FG002|Intensification Addendum|Physician Decision|4|||
30736909|NCT00279201|58748270|FG003|Intensification Addendum|Physician Decision|1|||
30736910|NCT00279201|58748271|FG004|Intensification Addendum|Physician Decision|3|||
30736911|NCT00279201|58748272|FG005|Intensification Addendum|Physician Decision|2|||
30736912|NCT00279201|58748267|FG000|Intensification Addendum|Sponsor Decision|0|||
30736913|NCT00279201|58748268|FG001|Intensification Addendum|Sponsor Decision|0|||
30736914|NCT00279201|58748269|FG002|Intensification Addendum|Sponsor Decision|0|||
30900759|NCT02447003|58934262|FG000|Overall Study|Lost to Follow-up|5|||
30790966|NCT00151996|58804113|FG000|Overall Study|Protocol Violation|1|||
30900760|NCT02447003|58934263|FG001|Overall Study|Lost to Follow-up|0|||
30736915|NCT00279201|58748270|FG003|Intensification Addendum|Sponsor Decision|0|||
30736916|NCT00279201|58748271|FG004|Intensification Addendum|Sponsor Decision|1|||
30736917|NCT00279201|58748272|FG005|Intensification Addendum|Sponsor Decision|1|||
30736918|NCT00279201|58748267|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
30736919|NCT00279201|58748268|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
30736920|NCT00279201|58748269|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
30736921|NCT00279201|58748270|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
30736922|NCT00279201|58748271|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
30736923|NCT00279201|58748272|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
30736924|NCT00279201|58748267|FG000|Intensification Addendum|Lack of Efficacy|0|||
30736925|NCT00279201|58748268|FG001|Intensification Addendum|Lack of Efficacy|0|||
30736926|NCT00279201|58748269|FG002|Intensification Addendum|Lack of Efficacy|0|||
30736927|NCT00279201|58748270|FG003|Intensification Addendum|Lack of Efficacy|1|||
30736928|NCT00279201|58748271|FG004|Intensification Addendum|Lack of Efficacy|1|||
30736929|NCT00279201|58748272|FG005|Intensification Addendum|Lack of Efficacy|0|||
30736930|NCT00279201|58748267|FG000|Intensification Addendum|Death|0|||
30736931|NCT00279201|58748268|FG001|Intensification Addendum|Death|0|||
30736932|NCT00279201|58748269|FG002|Intensification Addendum|Death|0|||
30736933|NCT00279201|58748270|FG003|Intensification Addendum|Death|0|||
30736934|NCT00279201|58748271|FG004|Intensification Addendum|Death|1|||
30736935|NCT00279201|58748272|FG005|Intensification Addendum|Death|0|||
30736936|NCT00203476|58748308|FG000|Overall Study|Lost to Follow-up|1|||
30736937|NCT00203476|58748309|FG001|Overall Study|Lost to Follow-up|0|||
30736938|NCT00203476|58748310|FG002|Overall Study|Lost to Follow-up|0|||
30736939|NCT00203476|58748308|FG000|Overall Study|Withdrawal by Subject|0|||
30736940|NCT00203476|58748309|FG001|Overall Study|Withdrawal by Subject|1|||
30736941|NCT00203476|58748310|FG002|Overall Study|Withdrawal by Subject|0|||
30736942|NCT00203242|58748318|FG000|Overall Study|Lost to Follow-up|1|||
30736943|NCT00200356|58748324|FG000|Overall Study|Lack of Efficacy|3|||
30736944|NCT00200356|58748325|FG001|Overall Study|Lack of Efficacy|3|||
30736945|NCT00200356|58748324|FG000|Overall Study|Protocol Violation|4|||
30736946|NCT00200356|58748325|FG001|Overall Study|Protocol Violation|4|||
30736947|NCT00200356|58748324|FG000|Overall Study|Nontreatment|1|||
30736948|NCT00200356|58748325|FG001|Overall Study|Nontreatment|0|||
30736949|NCT00227344|58748333|FG000|Overall Study|study terminated early|12|||
30736950|NCT00227344|58748334|FG001|Overall Study|study terminated early|5|||
30736951|NCT00227266|58748343|FG000|Overall Study|Withdrawal by Subject|0|||
30736952|NCT00227266|58748344|FG001|Overall Study|Withdrawal by Subject|0|||
30736953|NCT00227266|58748345|FG002|Overall Study|Withdrawal by Subject|1|||
30736954|NCT00227266|58748343|FG000|Overall Study|Protocol Violation|1|||
30736955|NCT00227266|58748344|FG001|Overall Study|Protocol Violation|0|||
30736956|NCT00227266|58748345|FG002|Overall Study|Protocol Violation|1|||
30736957|NCT00227266|58748343|FG000|Overall Study|Excessive weight gain|0|||
30736958|NCT00227266|58748344|FG001|Overall Study|Excessive weight gain|0|||
30736959|NCT00227266|58748345|FG002|Overall Study|Excessive weight gain|2|||
30736960|NCT00256282|58748356|FG000|Overall Study|Disease progression, relapse during acti|12|||
30736961|NCT00256282|58748356|FG000|Overall Study|Adverse Event|3|||
30736962|NCT00256282|58748356|FG000|Overall Study|Physician Decision|1|||
30736963|NCT00266877|58748363|FG000|Overall Study|Death|1|||
30736964|NCT00266877|58748364|FG001|Overall Study|Death|1|||
30736965|NCT00266877|58748365|FG002|Overall Study|Death|1|||
30736966|NCT00266877|58748363|FG000|Overall Study|Adverse Event|6|||
30736967|NCT00266877|58748364|FG001|Overall Study|Adverse Event|4|||
30736968|NCT00266877|58748365|FG002|Overall Study|Adverse Event|1|||
30736969|NCT00266877|58748363|FG000|Overall Study|Physician Decision|2|||
30736970|NCT00266877|58748364|FG001|Overall Study|Physician Decision|1|||
30736971|NCT00266877|58748365|FG002|Overall Study|Physician Decision|1|||
30736972|NCT00266877|58748363|FG000|Overall Study|Withdrawal by Subject|3|||
30736973|NCT00266877|58748364|FG001|Overall Study|Withdrawal by Subject|1|||
30736974|NCT00266877|58748365|FG002|Overall Study|Withdrawal by Subject|1|||
30736975|NCT00266877|58748363|FG000|Overall Study|Disease Progression|72|||
30736976|NCT00266877|58748364|FG001|Overall Study|Disease Progression|37|||
30736977|NCT00266877|58748365|FG002|Overall Study|Disease Progression|23|||
30736978|NCT00266877|58748363|FG000|Overall Study|Symptomatic Deterioration|6|||
30736979|NCT00266877|58748364|FG001|Overall Study|Symptomatic Deterioration|3|||
30736980|NCT00266877|58748365|FG002|Overall Study|Symptomatic Deterioration|1|||
30736981|NCT00266877|58748363|FG000|Overall Study|Hospitalization|1|||
30736982|NCT00266877|58748364|FG001|Overall Study|Hospitalization|0|||
30736983|NCT00266877|58748365|FG002|Overall Study|Hospitalization|0|||
30736984|NCT00266877|58748363|FG000|Overall Study|Concomitant Radiotherapy|0|||
30736985|NCT00266877|58748364|FG001|Overall Study|Concomitant Radiotherapy|1|||
30736986|NCT00266877|58748365|FG002|Overall Study|Concomitant Radiotherapy|0|||
30736987|NCT00256204|58748377|FG000|Overall Study|Adverse Event|10|||
30736988|NCT00256204|58748378|FG001|Overall Study|Adverse Event|14|||
30736989|NCT00256204|58748379|FG002|Overall Study|Adverse Event|16|||
30900761|NCT02447003|58934262|FG000|Overall Study|Death|154|||
30900762|NCT02447003|58934263|FG001|Overall Study|Death|63|||
30900763|NCT01844284|58934273|FG000|Overall Study|Lost to Follow-up|12|||
30736990|NCT00256204|58748380|FG003|Overall Study|Adverse Event|14|||
30736991|NCT00256204|58748377|FG000|Overall Study|Death|0|||
30736992|NCT00256204|58748378|FG001|Overall Study|Death|1|||
30736993|NCT00256204|58748379|FG002|Overall Study|Death|0|||
30736994|NCT00256204|58748380|FG003|Overall Study|Death|0|||
30736995|NCT00256204|58748377|FG000|Overall Study|Lost to Follow-up|1|||
30736996|NCT00256204|58748378|FG001|Overall Study|Lost to Follow-up|1|||
30736997|NCT00256204|58748379|FG002|Overall Study|Lost to Follow-up|1|||
30736998|NCT00256204|58748380|FG003|Overall Study|Lost to Follow-up|2|||
30736999|NCT00256204|58748377|FG000|Overall Study|Protocol Violation|1|||
30737000|NCT00256204|58748378|FG001|Overall Study|Protocol Violation|0|||
30737001|NCT00256204|58748379|FG002|Overall Study|Protocol Violation|2|||
30737002|NCT00256204|58748380|FG003|Overall Study|Protocol Violation|1|||
30737003|NCT00256204|58748377|FG000|Overall Study|Physician Decision|0|||
30737004|NCT00256204|58748378|FG001|Overall Study|Physician Decision|0|||
30737005|NCT00256204|58748379|FG002|Overall Study|Physician Decision|1|||
30737006|NCT00256204|58748380|FG003|Overall Study|Physician Decision|2|||
30737007|NCT00256204|58748377|FG000|Overall Study|Withdrawal by Subject|17|||
30737008|NCT00256204|58748378|FG001|Overall Study|Withdrawal by Subject|6|||
30737009|NCT00256204|58748379|FG002|Overall Study|Withdrawal by Subject|7|||
30737010|NCT00256204|58748380|FG003|Overall Study|Withdrawal by Subject|5|||
30737011|NCT00256204|58748377|FG000|Overall Study|Need for additional prohibited treatment|38|||
30737012|NCT00256204|58748378|FG001|Overall Study|Need for additional prohibited treatment|28|||
30737013|NCT00256204|58748379|FG002|Overall Study|Need for additional prohibited treatment|27|||
30737014|NCT00256204|58748380|FG003|Overall Study|Need for additional prohibited treatment|25|||
30737015|NCT00256126|58748395|FG000|Overall Study|Adverse Event|1|||
30737016|NCT00256126|58748396|FG001|Overall Study|Adverse Event|0|||
30737017|NCT00256126|58748395|FG000|Overall Study|Other|1|||
30737018|NCT00256126|58748396|FG001|Overall Study|Other|2|||
30737019|NCT00278889|58748405|FG000|Overall Study|Withdrawal by Subject|0|||
30737020|NCT00278889|58748406|FG001|Overall Study|Withdrawal by Subject|5|||
30737021|NCT00278889|58748407|FG002|Overall Study|Withdrawal by Subject|3|||
30737022|NCT00278889|58748405|FG000|Overall Study|Lost to Follow-up|1|||
30737023|NCT00278889|58748406|FG001|Overall Study|Lost to Follow-up|1|||
30737024|NCT00278889|58748407|FG002|Overall Study|Lost to Follow-up|0|||
30737025|NCT00278889|58748405|FG000|Overall Study|Death|24|||
30737026|NCT00278889|58748406|FG001|Overall Study|Death|21|||
30737027|NCT00278889|58748407|FG002|Overall Study|Death|17|||
30737028|NCT00278109|58748415|FG000|Overall Study|Adverse Event|3|||
30737029|NCT00278109|58748415|FG000|Overall Study|social circumstances|1|||
30737030|NCT00296517|58748421|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
30737031|NCT00296517|58748422|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
30737032|NCT00296517|58748421|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
30737033|NCT00296517|58748422|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
30737034|NCT00296517|58748421|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
30900764|NCT01844284|58934274|FG001|Overall Study|Lost to Follow-up|7|||
30900765|NCT02054715|58934282|FG000|Baseline/Follow-up 1|Refused|1|||
30900766|NCT02054715|58934283|FG001|Baseline/Follow-up 1|Refused|3|||
30900767|NCT02054715|58934282|FG000|Baseline/Follow-up 1|Medical|0|||
30737035|NCT00296517|58748422|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
30737036|NCT00296517|58748421|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
30737037|NCT00296517|58748422|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
30737038|NCT00296517|58748421|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
30737039|NCT00296517|58748422|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
30737040|NCT00296517|58748421|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
30737041|NCT00296517|58748422|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
30737042|NCT00296517|58748421|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
30737043|NCT00296517|58748422|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
30737044|NCT00296517|58748421|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
30737045|NCT00296517|58748422|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
30737046|NCT00296517|58748421|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
30737047|NCT00296517|58748422|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
30737048|NCT00224770|58748431|FG000|Overall Study|Lost to Follow-up|4|||
30737049|NCT00224770|58748432|FG001|Overall Study|Lost to Follow-up|2|||
30737050|NCT00224770|58748433|FG002|Overall Study|Lost to Follow-up|0|||
30737051|NCT00266409|58748446|FG000|Overall Study|Lack of Efficacy|2|||
30737052|NCT00266409|58748447|FG001|Overall Study|Lack of Efficacy|6|||
30737053|NCT00266409|58748448|FG002|Overall Study|Lack of Efficacy|1|||
30737054|NCT00266409|58748449|FG003|Overall Study|Lack of Efficacy|2|||
30737055|NCT00266409|58748446|FG000|Overall Study|Adverse Event|7|||
30737056|NCT00266409|58748447|FG001|Overall Study|Adverse Event|2|||
30737057|NCT00266409|58748448|FG002|Overall Study|Adverse Event|1|||
30737058|NCT00266409|58748449|FG003|Overall Study|Adverse Event|1|||
30737059|NCT00266409|58748446|FG000|Overall Study|Lost to Follow-up|18|||
30737060|NCT00266409|58748447|FG001|Overall Study|Lost to Follow-up|21|||
30737061|NCT00266409|58748448|FG002|Overall Study|Lost to Follow-up|6|||
30737062|NCT00266409|58748449|FG003|Overall Study|Lost to Follow-up|8|||
30737063|NCT00266409|58748446|FG000|Overall Study|Withdrawal by Subject|6|||
30737064|NCT00266409|58748447|FG001|Overall Study|Withdrawal by Subject|10|||
30737065|NCT00266409|58748448|FG002|Overall Study|Withdrawal by Subject|3|||
30737066|NCT00266409|58748449|FG003|Overall Study|Withdrawal by Subject|9|||
30737067|NCT00266409|58748446|FG000|Overall Study|Protocol Violation|5|||
30737068|NCT00266409|58748447|FG001|Overall Study|Protocol Violation|3|||
30900768|NCT02054715|58934283|FG001|Baseline/Follow-up 1|Medical|1|||
30900769|NCT02054715|58934282|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
30900770|NCT02054715|58934283|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
30900771|NCT02054715|58934282|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
30900772|NCT02054715|58934283|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
30900773|NCT02054715|58934282|FG000|Baseline/Follow-up 1|No Reason|0|||
30900774|NCT02054715|58934283|FG001|Baseline/Follow-up 1|No Reason|1|||
30900775|NCT02054715|58934282|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
30900776|NCT02054715|58934283|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
30900777|NCT02054715|58934282|FG000|Baseline/Follow-up 1|Ineligible|3|||
30900778|NCT02054715|58934283|FG001|Baseline/Follow-up 1|Ineligible|0|||
30900779|NCT02054715|58934282|FG000|Baseline/Follow-up 1|Hospitalization|1|||
30900780|NCT02054715|58934283|FG001|Baseline/Follow-up 1|Hospitalization|0|||
30737069|NCT00266409|58748448|FG002|Overall Study|Protocol Violation|4|||
30900781|NCT02054715|58934282|FG000|Baseline/Follow-up 1|Changed Mind|1|||
30900782|NCT02054715|58934283|FG001|Baseline/Follow-up 1|Changed Mind|0|||
30900783|NCT02054715|58934282|FG000|Follow-up 2|Lost to Followup|3|||
30900784|NCT02054715|58934283|FG001|Follow-up 2|Lost to Followup|1|||
30900785|NCT02054715|58934282|FG000|Follow-up 2|Refused|3|||
30900786|NCT02054715|58934283|FG001|Follow-up 2|Refused|2|||
30900787|NCT02054715|58934282|FG000|Follow-up 2|Followup Not Completed|3|||
30900788|NCT02054715|58934283|FG001|Follow-up 2|Followup Not Completed|4|||
30900789|NCT02054715|58934282|FG000|Follow-up 2|Ineligible|4|||
30900790|NCT02054715|58934283|FG001|Follow-up 2|Ineligible|5|||
30900791|NCT02054715|58934282|FG000|Follow-up 2|Death|3|||
30737070|NCT00266409|58748449|FG003|Overall Study|Protocol Violation|2|||
30737071|NCT00266409|58748446|FG000|Overall Study|Other|7|||
30737072|NCT00266409|58748447|FG001|Overall Study|Other|4|||
30737073|NCT00266409|58748448|FG002|Overall Study|Other|2|||
30900792|NCT02054715|58934283|FG001|Follow-up 2|Death|3|||
30900793|NCT02054715|58934282|FG000|Follow-up 2|Hospitalization|0|||
30900794|NCT02054715|58934283|FG001|Follow-up 2|Hospitalization|2|||
30900795|NCT02054715|58934282|FG000|Follow-up 2|Changed MD/Facility|0|||
30900796|NCT02054715|58934283|FG001|Follow-up 2|Changed MD/Facility|1|||
30900797|NCT02054715|58934282|FG000|Follow-up 2|Changed Mind|0|||
30900798|NCT02054715|58934283|FG001|Follow-up 2|Changed Mind|1|||
30737074|NCT00266409|58748449|FG003|Overall Study|Other|0|||
30737075|NCT00277095|58748459|FG000|Overall Study|Death|2|||
30737076|NCT00277095|58748459|FG000|Overall Study|Explanted|7|||
30737077|NCT00277095|58748459|FG000|Overall Study|Lost to Follow-up|2|||
30737078|NCT00277095|58748459|FG000|Overall Study|Missed Follow-up|9|||
30737079|NCT00277095|58748459|FG000|Overall Study|Physician Decision|1|||
30737080|NCT00265785|58748463|FG000|Overall Study|Adverse Event|4|||
30900799|NCT02054715|58934282|FG000|Follow-up 2|No Reason|2|||
30900800|NCT02054715|58934283|FG001|Follow-up 2|No Reason|0|||
30900801|NCT02054715|58934282|FG000|Follow-up 2|Treatment Change or Delay|1|||
30900802|NCT02054715|58934283|FG001|Follow-up 2|Treatment Change or Delay|0|||
30737081|NCT00265785|58748463|FG000|Overall Study|Withdrawal by Subject|3|||
30737082|NCT00265785|58748463|FG000|Overall Study|Progression/Relapse|15|||
30737083|NCT00265785|58748463|FG000|Overall Study|Not protocol specified|2|||
30737084|NCT00265785|58748463|FG000|Overall Study|Ineligible|1|||
30737085|NCT00265785|58748463|FG000|Overall Study|Did not receive protocol treatment|2|||
30737086|NCT00276159|58748467|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
30737087|NCT00265395|58748473|FG000|Overall Study|Adverse Event|3|||
30900803|NCT02446769|58934289|FG000|Screening Period|Screen Failure|11|||
30737088|NCT00265395|58748474|FG001|Overall Study|Adverse Event|6|||
30737089|NCT00265395|58748473|FG000|Overall Study|Lost to Follow-up|2|||
30900804|NCT02446769|58934290|FG001|Screening Period|Screen Failure|0|||
30900805|NCT02446769|58934291|FG002|Screening Period|Screen Failure|0|||
30900806|NCT02446769|58934289|FG000|Study Period|Randomized in Error|0|||
30900807|NCT02446769|58934290|FG001|Study Period|Randomized in Error|2|||
30900808|NCT02446769|58934291|FG002|Study Period|Randomized in Error|0|||
30900809|NCT02420093|58934300|FG000|Overall Study|Withdrawal by Subject|1|||
30900810|NCT02420093|58934301|FG001|Overall Study|Withdrawal by Subject|1|||
30900811|NCT02419937|58934309|FG000|Overall Study|Lost to Follow-up|1|||
30900812|NCT02419937|58934310|FG001|Overall Study|Lost to Follow-up|0|||
30900813|NCT02054481|58934320|FG000|Overall Study|Adverse Event|1|||
30900814|NCT02054481|58934321|FG001|Overall Study|Adverse Event|1|||
30900815|NCT02054481|58934322|FG002|Overall Study|Adverse Event|0|||
30900816|NCT02054481|58934323|FG003|Overall Study|Adverse Event|1|||
30900817|NCT02054481|58934320|FG000|Overall Study|Lost to Follow-up|1|||
30900818|NCT02054481|58934321|FG001|Overall Study|Lost to Follow-up|0|||
30900819|NCT02054481|58934322|FG002|Overall Study|Lost to Follow-up|0|||
30900820|NCT02054481|58934323|FG003|Overall Study|Lost to Follow-up|0|||
30900821|NCT02054481|58934320|FG000|Overall Study|Other reason|2|||
30900822|NCT02054481|58934321|FG001|Overall Study|Other reason|1|||
30900823|NCT02054481|58934322|FG002|Overall Study|Other reason|2|||
30900824|NCT02054481|58934323|FG003|Overall Study|Other reason|0|||
30900825|NCT01610752|58934337|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
30900826|NCT01610752|58934338|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
30900827|NCT01610752|58934339|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
30900828|NCT02054325|58934349|FG000|Overall Study|Lost to Follow-up|8|||
30900829|NCT02054325|58934350|FG001|Overall Study|Lost to Follow-up|5|||
30900830|NCT02446691|58934356|FG000|Overall Study|Withdrawal by Subject|2|||
30900831|NCT02446691|58934356|FG000|Overall Study|Lost to Follow-up|8|||
30900832|NCT02446691|58934356|FG000|Overall Study|Protocol Violation|1|||
30900833|NCT02091375|58934362|FG000|Overall Study|Adverse Event|8|||
30900834|NCT02091375|58934363|FG001|Overall Study|Adverse Event|1|||
30900835|NCT02091375|58934362|FG000|Overall Study|Lost to Follow-up|0|||
30900836|NCT02091375|58934363|FG001|Overall Study|Lost to Follow-up|1|||
30737090|NCT00265395|58748474|FG001|Overall Study|Lost to Follow-up|1|||
30737091|NCT00265395|58748473|FG000|Overall Study|Withdrawal by Subject|1|||
30737092|NCT00265395|58748474|FG001|Overall Study|Withdrawal by Subject|6|||
30737093|NCT00265395|58748473|FG000|Overall Study|Protocol Violation|2|||
30737094|NCT00265395|58748474|FG001|Overall Study|Protocol Violation|2|||
30737095|NCT00265395|58748473|FG000|Overall Study|Lack of Efficacy|0|||
30737096|NCT00265395|58748474|FG001|Overall Study|Lack of Efficacy|1|||
30737097|NCT00265395|58748473|FG000|Overall Study|Administrative|0|||
30737098|NCT00265395|58748474|FG001|Overall Study|Administrative|1|||
30737099|NCT00195442|58748479|FG000|Overall Study|Less than expected therapeutic effect|38|||
30737100|NCT00195442|58748479|FG000|Overall Study|Lost to Follow-up|27|||
30737101|NCT00195442|58748479|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
30737102|NCT00195442|58748479|FG000|Overall Study|Intermittent product shortage|21|||
30737103|NCT00195442|58748479|FG000|Overall Study|Death|7|||
30737104|NCT00195442|58748479|FG000|Overall Study|No reason specified|4|||
30737105|NCT00195442|58748479|FG000|Overall Study|Poor cooperation|2|||
30737106|NCT00195442|58748479|FG000|Overall Study|Other|14|||
30737107|NCT00275301|58748483|FG000|Overall Study|Adverse Event|5|||
30737108|NCT00251745|58748490|FG000|Overall Study|Adverse Event|7|||
30737109|NCT00251745|58748491|FG001|Overall Study|Adverse Event|9|||
30737110|NCT00251745|58748492|FG002|Overall Study|Adverse Event|11|||
30737111|NCT00251745|58748490|FG000|Overall Study|Lost to Follow-up|4|||
30737112|NCT00251745|58748491|FG001|Overall Study|Lost to Follow-up|2|||
30737113|NCT00251745|58748492|FG002|Overall Study|Lost to Follow-up|5|||
30737114|NCT00251745|58748490|FG000|Overall Study|Withdrawal by Subject|13|||
30737115|NCT00251745|58748491|FG001|Overall Study|Withdrawal by Subject|7|||
30737116|NCT00251745|58748492|FG002|Overall Study|Withdrawal by Subject|3|||
30737117|NCT00251745|58748490|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
30737118|NCT00251745|58748491|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
30737119|NCT00251745|58748492|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
30900837|NCT02091375|58934362|FG000|Overall Study|Withdrawal by Subject|0|||
30900838|NCT02091375|58934363|FG001|Overall Study|Withdrawal by Subject|1|||
30900839|NCT02091375|58934362|FG000|Overall Study|Withdrawn by the investigator|1|||
30737120|NCT00251745|58748490|FG000|Overall Study|Lack of Efficacy|3|||
30737121|NCT00251745|58748491|FG001|Overall Study|Lack of Efficacy|0|||
30737122|NCT00251745|58748492|FG002|Overall Study|Lack of Efficacy|0|||
30737123|NCT00251745|58748490|FG000|Overall Study|Noncompliant|0|||
30737124|NCT00251745|58748491|FG001|Overall Study|Noncompliant|2|||
30737125|NCT00251745|58748492|FG002|Overall Study|Noncompliant|2|||
30737126|NCT00251745|58748490|FG000|Overall Study|Pregnancy|0|||
30737127|NCT00251745|58748491|FG001|Overall Study|Pregnancy|1|||
30900840|NCT02091375|58934363|FG001|Overall Study|Withdrawn by the investigator|0|||
30900841|NCT02032875|58934371|FG000|Treatment Period|Adverse Event|1|||
30900842|NCT02032875|58934372|FG001|Treatment Period|Adverse Event|0|||
30900843|NCT02032875|58934371|FG000|Treatment Period|Liver transplant, No extension needed|0|||
30900844|NCT02032875|58934372|FG001|Treatment Period|Liver transplant, No extension needed|1|||
30737128|NCT00251745|58748492|FG002|Overall Study|Pregnancy|0|||
30737129|NCT00251745|58748490|FG000|Overall Study|Per Subject Request|0|||
30737130|NCT00251745|58748491|FG001|Overall Study|Per Subject Request|0|||
30737131|NCT00251745|58748492|FG002|Overall Study|Per Subject Request|1|||
30737132|NCT00251745|58748490|FG000|Overall Study|Per Investigator Request|1|||
30737133|NCT00251745|58748491|FG001|Overall Study|Per Investigator Request|0|||
30737134|NCT00251745|58748492|FG002|Overall Study|Per Investigator Request|0|||
30737135|NCT00255190|58748502|FG000|Overall Study|Adverse Event|17|||
30737136|NCT00255190|58748503|FG001|Overall Study|Adverse Event|36|||
30737137|NCT00255190|58748502|FG000|Overall Study|Protocol Violation|2|||
30737138|NCT00255190|58748503|FG001|Overall Study|Protocol Violation|2|||
30737139|NCT00255190|58748502|FG000|Overall Study|Lost to Follow-up|10|||
30737140|NCT00255190|58748503|FG001|Overall Study|Lost to Follow-up|27|||
30737141|NCT00255190|58748502|FG000|Overall Study|Withdrew Consent|17|||
30737142|NCT00255190|58748503|FG001|Overall Study|Withdrew Consent|48|||
30737143|NCT00255190|58748502|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
30737144|NCT00255190|58748503|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
30737145|NCT00255190|58748502|FG000|Overall Study|Erosive esophagitis not healed|0|||
30737146|NCT00255190|58748503|FG001|Overall Study|Erosive esophagitis not healed|20|||
30737147|NCT00255190|58748502|FG000|Overall Study|Various|4|||
30737148|NCT00255190|58748503|FG001|Overall Study|Various|23|||
30737149|NCT00359424|58748511|FG000|Overall Study|Death|99|||
30737150|NCT00359424|58748512|FG001|Overall Study|Death|58|||
30737151|NCT00359424|58748511|FG000|Overall Study|Lost to Follow-up|19|||
30737152|NCT00359424|58748512|FG001|Overall Study|Lost to Follow-up|7|||
30737153|NCT00359424|58748511|FG000|Overall Study|Withdrawal by Subject|10|||
30737154|NCT00359424|58748512|FG001|Overall Study|Withdrawal by Subject|2|||
30737155|NCT00359424|58748511|FG000|Overall Study|follow up not conducted|2|||
30900845|NCT02032875|58934371|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
30900846|NCT02032875|58934372|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
30900847|NCT02032875|58934371|FG000|Follow-up Period|Death|0|||
30900848|NCT02032875|58934372|FG001|Follow-up Period|Death|1|||
30900849|NCT02032875|58934371|FG000|Follow-up Period|Virologic Relapse|3|||
30900850|NCT02032875|58934372|FG001|Follow-up Period|Virologic Relapse|10|||
30900851|NCT02032407|58934379|FG000|Overall Study|Lost to Follow-up|2|||
30900852|NCT02032407|58934379|FG000|Overall Study|Pregnancy|1|||
30900853|NCT02032407|58934379|FG000|Overall Study|Other Miscellaneous Reasons|2|||
30900854|NCT01843972|58934397|FG000|Overall Study|Withdrawal by Subject|0|||
30900855|NCT01843972|58934398|FG001|Overall Study|Withdrawal by Subject|0|||
30900856|NCT01843972|58934399|FG002|Overall Study|Withdrawal by Subject|0|||
30900857|NCT01843972|58934400|FG003|Overall Study|Withdrawal by Subject|0|||
30900858|NCT01843972|58934401|FG004|Overall Study|Withdrawal by Subject|1|||
30900859|NCT01843972|58934402|FG005|Overall Study|Withdrawal by Subject|0|||
30900860|NCT01843972|58934403|FG006|Overall Study|Withdrawal by Subject|0|||
30900861|NCT01843972|58934404|FG007|Overall Study|Withdrawal by Subject|0|||
30900862|NCT01843972|58934405|FG008|Overall Study|Withdrawal by Subject|0|||
30900863|NCT01843972|58934406|FG009|Overall Study|Withdrawal by Subject|0|||
30900864|NCT01826422|58934444|FG000|Overall Study|Withdrawal by Subject|1|||
30900865|NCT01826422|58934445|FG001|Overall Study|Withdrawal by Subject|3|||
30900866|NCT01843660|58934451|FG000|Overall Study|Other|30|||
30900867|NCT02090283|58934458|FG000|Overall Study|Withdrawal by Subject|6|||
30900868|NCT02090283|58934459|FG001|Overall Study|Withdrawal by Subject|6|||
30900869|NCT02090283|58934460|FG002|Overall Study|Withdrawal by Subject|6|||
30900870|NCT02090283|58934458|FG000|Overall Study|Sponsor Terminated Study|6|||
30900871|NCT02090283|58934459|FG001|Overall Study|Sponsor Terminated Study|6|||
30900872|NCT02090283|58934460|FG002|Overall Study|Sponsor Terminated Study|1|||
30900873|NCT02090283|58934458|FG000|Overall Study|Lost to Follow-up|2|||
30900874|NCT02090283|58934459|FG001|Overall Study|Lost to Follow-up|2|||
30900875|NCT02090283|58934460|FG002|Overall Study|Lost to Follow-up|3|||
30900876|NCT02090283|58934458|FG000|Overall Study|Adverse Event|1|||
30737156|NCT00359424|58748512|FG001|Overall Study|follow up not conducted|0|||
30737157|NCT00255034|58748520|FG000|Overall Study|Withdrawal by Subject|15|||
30737158|NCT00255034|58748521|FG001|Overall Study|Withdrawal by Subject|38|||
30790967|NCT00151996|58804114|FG001|Overall Study|Protocol Violation|2|||
30790968|NCT00151996|58804113|FG000|Overall Study|Sponsor's decision|0|||
30737159|NCT00254566|58748529|FG000|Overall Study|Death|1|||
30737160|NCT00254566|58748530|FG001|Overall Study|Death|0|||
30737161|NCT00254566|58748529|FG000|Overall Study|Adverse Event|5|||
30900877|NCT02090283|58934459|FG001|Overall Study|Adverse Event|1|||
30900878|NCT02090283|58934460|FG002|Overall Study|Adverse Event|0|||
30900879|NCT02090283|58934458|FG000|Overall Study|Protocol Violation|2|||
30900880|NCT02090283|58934459|FG001|Overall Study|Protocol Violation|0|||
30737162|NCT00254566|58748530|FG001|Overall Study|Adverse Event|4|||
30900881|NCT02090283|58934460|FG002|Overall Study|Protocol Violation|0|||
30900882|NCT02032173|58934468|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
30900883|NCT02031471|58934472|FG000|24 Week Treatment Period|Adverse Event|6|||
30737163|NCT00254566|58748529|FG000|Overall Study|Lack of Efficacy|12|||
30737164|NCT00254566|58748530|FG001|Overall Study|Lack of Efficacy|9|||
30737165|NCT00254566|58748529|FG000|Overall Study|Other|1|||
30737166|NCT00254566|58748530|FG001|Overall Study|Other|5|||
30737167|NCT00254566|58748529|FG000|Overall Study|Withdrawal by Subject|5|||
30737168|NCT00254566|58748530|FG001|Overall Study|Withdrawal by Subject|6|||
30737169|NCT00254566|58748529|FG000|Overall Study|Lost to Follow-up|7|||
30737170|NCT00254566|58748530|FG001|Overall Study|Lost to Follow-up|2|||
30737171|NCT00358956|58748536|FG000|Overall Study|Adverse Event|3|||
30737172|NCT00358956|58748536|FG000|Overall Study|condition under investigation worsened|4|||
30737173|NCT00358956|58748536|FG000|Overall Study|Withdrawal by Subject|1|||
30737174|NCT03830892|58748542|FG000|Overall Study|Physician Decision|2|||
30737175|NCT03830892|58748543|FG001|Overall Study|Physician Decision|3|||
30737176|NCT03830892|58748542|FG000|Overall Study|Study terminated due to COVID|4|||
30737177|NCT03830892|58748543|FG001|Overall Study|Study terminated due to COVID|0|||
30737178|NCT03830892|58748542|FG000|Overall Study|Protocol Violation|0|||
30737179|NCT03830892|58748543|FG001|Overall Study|Protocol Violation|1|||
30737180|NCT03830892|58748542|FG000|Overall Study|Withdrawal by Subject|0|||
30737181|NCT03830892|58748543|FG001|Overall Study|Withdrawal by Subject|2|||
30737182|NCT00253630|58748549|FG000|Overall Study|ineligible|2|||
30737183|NCT00358644|58748553|FG000|Overall Study|Progressive Disease|21|||
30737184|NCT00358644|58748553|FG000|Overall Study|Adverse Event|7|||
30737185|NCT00358644|58748553|FG000|Overall Study|Death|11|||
30737186|NCT00358644|58748553|FG000|Overall Study|Withdrawal by Subject|4|||
30737187|NCT00358644|58748553|FG000|Overall Study|Physician Decision|6|||
30737188|NCT00358644|58748553|FG000|Overall Study|Patient not eligible for study|1|||
30737189|NCT00364182|58748560|FG000|First Intervention|Secondary prophylaxis|1|||
30737190|NCT00364182|58748561|FG001|First Intervention|Secondary prophylaxis|0|||
30737191|NCT00364182|58748562|FG002|First Intervention|Secondary prophylaxis|0|||
30737192|NCT00364182|58748560|FG000|First Intervention|Withdrawal by Subject|2|||
30737193|NCT00364182|58748561|FG001|First Intervention|Withdrawal by Subject|0|||
30737194|NCT00364182|58748562|FG002|First Intervention|Withdrawal by Subject|0|||
30737195|NCT00364182|58748560|FG000|Second Intervention|non-compliance|0|||
30737196|NCT00364182|58748561|FG001|Second Intervention|non-compliance|1|||
30737197|NCT00364182|58748562|FG002|Second Intervention|non-compliance|1|||
30737198|NCT00364182|58748560|FG000|Second Intervention|Protocol Violation|0|||
30737199|NCT00364182|58748561|FG001|Second Intervention|Protocol Violation|1|||
30737200|NCT00364182|58748562|FG002|Second Intervention|Protocol Violation|0|||
30737201|NCT00364182|58748560|FG000|Second Intervention|Adverse Event|0|||
30737202|NCT00364182|58748561|FG001|Second Intervention|Adverse Event|0|||
30737203|NCT00364182|58748562|FG002|Second Intervention|Adverse Event|1|||
30737204|NCT00364182|58748560|FG000|Third Intervention|non-compliance|0|||
30737205|NCT00364182|58748561|FG001|Third Intervention|non-compliance|1|||
30737206|NCT00364182|58748562|FG002|Third Intervention|non-compliance|0|||
30737207|NCT00364182|58748560|FG000|Third Intervention|Lost to Follow-up|0|||
30737208|NCT00364182|58748561|FG001|Third Intervention|Lost to Follow-up|0|||
30737209|NCT00364182|58748562|FG002|Third Intervention|Lost to Follow-up|1|||
30737210|NCT00369486|58748577|FG000|4-Week Visit|Missed visit|2|||
30737211|NCT00369486|58748578|FG001|4-Week Visit|Missed visit|2|||
30737212|NCT00369486|58748579|FG002|4-Week Visit|Missed visit|0|||
30737213|NCT00369486|58748580|FG003|4-Week Visit|Missed visit|2|||
30737214|NCT00369486|58748581|FG004|4-Week Visit|Missed visit|1|||
30737215|NCT00369486|58748577|FG000|4-Week Visit|Dropped|0|||
30737216|NCT00369486|58748578|FG001|4-Week Visit|Dropped|0|||
30737217|NCT00369486|58748579|FG002|4-Week Visit|Dropped|1|||
30737218|NCT00369486|58748580|FG003|4-Week Visit|Dropped|0|||
30737219|NCT00369486|58748581|FG004|4-Week Visit|Dropped|0|||
30900884|NCT02031471|58934472|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
30737220|NCT00369486|58748577|FG000|8-Week Visit|Missed visit|0|||
30737221|NCT00369486|58748578|FG001|8-Week Visit|Missed visit|1|||
30737222|NCT00369486|58748579|FG002|8-Week Visit|Missed visit|0|||
30737223|NCT00369486|58748580|FG003|8-Week Visit|Missed visit|0|||
30900885|NCT02031471|58934472|FG000|24 Week Treatment Period|Protocol Violation|1|||
30737224|NCT00369486|58748581|FG004|8-Week Visit|Missed visit|1|||
30737225|NCT00369486|58748577|FG000|8-Week Visit|Dropped|0|||
30737226|NCT00369486|58748578|FG001|8-Week Visit|Dropped|0|||
30737227|NCT00369486|58748579|FG002|8-Week Visit|Dropped|0|||
30900886|NCT02031471|58934472|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
30737228|NCT00369486|58748580|FG003|8-Week Visit|Dropped|1|||
30737229|NCT00369486|58748581|FG004|8-Week Visit|Dropped|0|||
30737230|NCT00369486|58748577|FG000|17-Week Visit|Missed visit|0|||
30737231|NCT00369486|58748578|FG001|17-Week Visit|Missed visit|0|||
30737232|NCT00369486|58748579|FG002|17-Week Visit|Missed visit|1|||
30737233|NCT00369486|58748580|FG003|17-Week Visit|Missed visit|1|||
30737234|NCT00369486|58748581|FG004|17-Week Visit|Missed visit|1|||
30737235|NCT00369486|58748577|FG000|34-Week Visit|Dropped|0|||
30737236|NCT00369486|58748578|FG001|34-Week Visit|Dropped|1|||
30737237|NCT00369486|58748579|FG002|34-Week Visit|Dropped|1|||
30737238|NCT00369486|58748580|FG003|34-Week Visit|Dropped|3|||
30900887|NCT02031471|58934472|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
30900888|NCT02031471|58934472|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
30900889|NCT02031471|58934472|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
30900890|NCT02461589|58934486|FG000|Overall Study|Withdrawal by Subject|5|||
30900891|NCT02461589|58934487|FG001|Overall Study|Withdrawal by Subject|1|||
30900892|NCT02461589|58934488|FG002|Overall Study|Withdrawal by Subject|3|||
30900893|NCT02461589|58934489|FG003|Overall Study|Withdrawal by Subject|2|||
30900894|NCT02461589|58934490|FG004|Overall Study|Withdrawal by Subject|1|||
30900895|NCT02461589|58934491|FG005|Overall Study|Withdrawal by Subject|2|||
30900896|NCT02461589|58934492|FG006|Overall Study|Withdrawal by Subject|1|||
30900897|NCT02461589|58934493|FG007|Overall Study|Withdrawal by Subject|3|||
30900898|NCT02461589|58934494|FG008|Overall Study|Withdrawal by Subject|3|||
30900899|NCT02461589|58934495|FG009|Overall Study|Withdrawal by Subject|1|||
30900900|NCT02461589|58934486|FG000|Overall Study|Lost to Follow-up|0|||
30900901|NCT02461589|58934487|FG001|Overall Study|Lost to Follow-up|0|||
30900902|NCT02461589|58934488|FG002|Overall Study|Lost to Follow-up|2|||
30900903|NCT02461589|58934489|FG003|Overall Study|Lost to Follow-up|3|||
30900904|NCT02461589|58934490|FG004|Overall Study|Lost to Follow-up|1|||
30900905|NCT02461589|58934491|FG005|Overall Study|Lost to Follow-up|1|||
30900906|NCT02461589|58934492|FG006|Overall Study|Lost to Follow-up|3|||
30900907|NCT02461589|58934493|FG007|Overall Study|Lost to Follow-up|1|||
30900908|NCT02461589|58934494|FG008|Overall Study|Lost to Follow-up|3|||
30900909|NCT02461589|58934495|FG009|Overall Study|Lost to Follow-up|1|||
30900910|NCT02461589|58934486|FG000|Overall Study|Death|0|||
30900911|NCT02461589|58934487|FG001|Overall Study|Death|0|||
30900912|NCT02461589|58934488|FG002|Overall Study|Death|0|||
30900913|NCT02461589|58934489|FG003|Overall Study|Death|0|||
30900914|NCT02461589|58934490|FG004|Overall Study|Death|0|||
30900915|NCT02461589|58934491|FG005|Overall Study|Death|0|||
30900916|NCT02461589|58934492|FG006|Overall Study|Death|0|||
30900917|NCT02461589|58934493|FG007|Overall Study|Death|1|||
30900918|NCT02461589|58934494|FG008|Overall Study|Death|0|||
30900919|NCT02461589|58934495|FG009|Overall Study|Death|0|||
30900920|NCT02461589|58934486|FG000|Overall Study|Unclassified|0|||
30737239|NCT00369486|58748581|FG004|34-Week Visit|Dropped|3|||
30737240|NCT00363480|58748593|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
30737241|NCT00363480|58748593|FG000|Overall Study|Adverse Event|4|||
30737242|NCT00363480|58748593|FG000|Overall Study|Lost to Follow-up|5|||
30737243|NCT00363480|58748593|FG000|Overall Study|Withdrawal by Subject|5|||
30737244|NCT00363480|58748593|FG000|Overall Study|Non-compliance of subject|1|||
30737245|NCT00363480|58748593|FG000|Overall Study|Participant discontinued on its own|1|||
30737246|NCT00363246|58748597|FG000|Overall Study|Death|40|||
30737247|NCT00363246|58748597|FG000|Overall Study|Withdrawal by Subject|19|||
30737248|NCT00363246|58748597|FG000|Overall Study|Lost to Follow-up|14|||
30737249|NCT00363246|58748597|FG000|Overall Study|Bad health|6|||
30737250|NCT00363246|58748597|FG000|Overall Study|Stopped using wheelchair|11|||
30737251|NCT00363246|58748597|FG000|Overall Study|Subject expressed security concerns|2|||
30737252|NCT00363246|58748597|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
30737253|NCT00223990|58748604|FG000|Overall Study|Moved from area|2|||
30737254|NCT00223990|58748605|FG001|Overall Study|Moved from area|1|||
30737255|NCT00223990|58748604|FG000|Overall Study|Withdrawal by Subject|4|||
30737256|NCT00223990|58748605|FG001|Overall Study|Withdrawal by Subject|8|||
30737257|NCT00223990|58748604|FG000|Overall Study|Lost to Follow-up|1|||
30737258|NCT00223990|58748605|FG001|Overall Study|Lost to Follow-up|0|||
30737259|NCT00221104|58748613|FG000|Overall Study|Adverse Event|1|||
30737260|NCT00221104|58748614|FG001|Overall Study|Adverse Event|0|||
30737261|NCT00221104|58748613|FG000|Overall Study|Physician Decision|1|||
30737262|NCT00221104|58748614|FG001|Overall Study|Physician Decision|0|||
30737263|NCT00221104|58748613|FG000|Overall Study|Protocol Violation|2|||
30737264|NCT00221104|58748614|FG001|Overall Study|Protocol Violation|0|||
30737265|NCT00221104|58748613|FG000|Overall Study|Withdrawal by Subject|42|||
30737266|NCT00221104|58748614|FG001|Overall Study|Withdrawal by Subject|29|||
30737267|NCT00221104|58748613|FG000|Overall Study|Others|37|||
30737268|NCT00221104|58748614|FG001|Overall Study|Others|47|||
30737269|NCT00189202|58748622|FG000|Overall Study|Physician Decision|5|||
30900921|NCT02461589|58934487|FG001|Overall Study|Unclassified|0|||
30900922|NCT02461589|58934488|FG002|Overall Study|Unclassified|0|||
30900923|NCT02461589|58934489|FG003|Overall Study|Unclassified|0|||
30900924|NCT02461589|58934490|FG004|Overall Study|Unclassified|0|||
30900925|NCT02461589|58934491|FG005|Overall Study|Unclassified|0|||
30621855|NCT01180049|58633415|FG000|Overall Study|Other|9|||
30737270|NCT00187486|58748626|FG000|Overall Study|Protocol Violation|1|||
30737271|NCT00220636|58748630|FG000|Overall Study|Withdrawal by Subject|4|||
30737272|NCT00362232|58748637|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
30737273|NCT00362232|58748638|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
30737274|NCT00362232|58748637|FG000|Treatment (12 +/- 2 Days)|Death|1|||
30900926|NCT02461589|58934492|FG006|Overall Study|Unclassified|1|||
30737275|NCT00362232|58748638|FG001|Treatment (12 +/- 2 Days)|Death|3|||
30737276|NCT00362232|58748637|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
30737277|NCT00362232|58748638|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
30737278|NCT00362232|58748637|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
30900927|NCT02461589|58934493|FG007|Overall Study|Unclassified|0|||
30900928|NCT02461589|58934494|FG008|Overall Study|Unclassified|0|||
30900929|NCT02461589|58934495|FG009|Overall Study|Unclassified|2|||
30900930|NCT02461589|58934486|FG000|Overall Study|Missing follow-up information|1|||
30900931|NCT02461589|58934487|FG001|Overall Study|Missing follow-up information|1|||
30900932|NCT02461589|58934488|FG002|Overall Study|Missing follow-up information|0|||
30900933|NCT02461589|58934489|FG003|Overall Study|Missing follow-up information|0|||
30900934|NCT02461589|58934490|FG004|Overall Study|Missing follow-up information|0|||
30900935|NCT02461589|58934491|FG005|Overall Study|Missing follow-up information|0|||
30900936|NCT02461589|58934492|FG006|Overall Study|Missing follow-up information|1|||
30900937|NCT02461589|58934493|FG007|Overall Study|Missing follow-up information|0|||
30900938|NCT02461589|58934494|FG008|Overall Study|Missing follow-up information|0|||
30900939|NCT02461589|58934495|FG009|Overall Study|Missing follow-up information|0|||
30900940|NCT02461589|58934486|FG000|Overall Study|Withdrawal from trial before exposure|0|||
30900941|NCT02461589|58934487|FG001|Overall Study|Withdrawal from trial before exposure|0|||
30900942|NCT02461589|58934488|FG002|Overall Study|Withdrawal from trial before exposure|0|||
30900943|NCT02461589|58934489|FG003|Overall Study|Withdrawal from trial before exposure|0|||
30900944|NCT02461589|58934490|FG004|Overall Study|Withdrawal from trial before exposure|0|||
30900945|NCT02461589|58934491|FG005|Overall Study|Withdrawal from trial before exposure|0|||
30900946|NCT02461589|58934492|FG006|Overall Study|Withdrawal from trial before exposure|0|||
30900947|NCT02461589|58934493|FG007|Overall Study|Withdrawal from trial before exposure|0|||
30900948|NCT02461589|58934494|FG008|Overall Study|Withdrawal from trial before exposure|0|||
30900949|NCT02461589|58934495|FG009|Overall Study|Withdrawal from trial before exposure|1|||
30900950|NCT02089737|58934517|FG000|Overall Study|Survey form not completed|5|||
30900951|NCT02089737|58934517|FG000|Overall Study|Not treated|1|||
30900952|NCT02460575|58934524|FG000|Overall Study|Lost to Follow-up|1|||
30900953|NCT02460575|58934525|FG001|Overall Study|Lost to Follow-up|0|||
30900954|NCT02089347|58934533|FG000|Overall Study|Protocol Violation|1|||
30900955|NCT02089347|58934534|FG001|Overall Study|Protocol Violation|0|||
30900956|NCT02445755|58934540|FG000|Overall Study|Withdrawal by Subject|2|||
30900957|NCT02445755|58934540|FG000|Overall Study|Protocol Violation|6|||
30900958|NCT02445755|58934540|FG000|Overall Study|Screen Failure|5|||
30900959|NCT02419469|58934547|FG000|Overall Study|Withdrawal by Subject|1|||
30900960|NCT02419313|58934551|FG000|First Intervention|Lost to Follow-up|2|||
30900961|NCT02419313|58934552|FG001|First Intervention|Lost to Follow-up|0|||
30900962|NCT02419313|58934551|FG000|Second Intervention|Lost to Follow-up|1|||
30737279|NCT00362232|58748638|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
30737280|NCT00362232|58748637|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
30737281|NCT00362232|58748638|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
30737282|NCT00362232|58748637|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
30737283|NCT00362232|58748638|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
30737284|NCT00362232|58748637|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
30737285|NCT00362232|58748638|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
30737286|NCT00362232|58748637|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
30737287|NCT00362232|58748638|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
30737288|NCT00362232|58748637|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
30737289|NCT00362232|58748638|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
30737290|NCT00362232|58748637|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
30737291|NCT00362232|58748638|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
30737292|NCT00362232|58748637|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
30737293|NCT00362232|58748638|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
30737294|NCT00362232|58748637|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
30737295|NCT00362232|58748638|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
30737296|NCT00362232|58748637|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
30737297|NCT00362232|58748638|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
30737298|NCT00219544|58748644|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
30737299|NCT00219544|58748645|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
30737300|NCT00219544|58748644|FG000|Single Blind Treatment Period|Adverse Event|9|||
30900963|NCT02419313|58934552|FG001|Second Intervention|Lost to Follow-up|0|||
30900964|NCT02419001|58934560|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
30900965|NCT02419001|58934561|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
30900966|NCT02031237|58934569|FG000|Overall Study|Death|1|||
30900967|NCT02031237|58934570|FG001|Overall Study|Death|5|||
30900968|NCT02031237|58934571|FG002|Overall Study|Death|0|||
30621856|NCT01180049|58633416|FG001|Overall Study|Other|7|||
30621857|NCT01180049|58633415|FG000|Overall Study|Lost to Follow-up|8|||
30737301|NCT00219544|58748645|FG001|Single Blind Treatment Period|Adverse Event|0|||
30737302|NCT00219544|58748644|FG000|Single Blind Treatment Period|Protocol Violation|4|||
30737303|NCT00219544|58748645|FG001|Single Blind Treatment Period|Protocol Violation|0|||
30737304|NCT00219544|58748644|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
30737305|NCT00219544|58748645|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
30737306|NCT00219544|58748644|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
30737307|NCT00219544|58748645|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
30737308|NCT00219544|58748644|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
30737309|NCT00219544|58748645|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
30737310|NCT00357552|58748653|FG000|Screening|Did not meet eligibility criteria|84|||
30737311|NCT00357552|58748653|FG000|Weeks 0 to 24|Death|1|||
30737312|NCT00357552|58748653|FG000|Weeks 24 to 104|Death|3|||
30737313|NCT00357552|58748653|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
30737314|NCT00187096|58748664|FG000|Overall Study|unacceptable toxicity|0|||
30737315|NCT00187096|58748665|FG001|Overall Study|unacceptable toxicity|0|||
30737316|NCT00187096|58748666|FG002|Overall Study|unacceptable toxicity|1|||
30737317|NCT00357396|58748676|FG000|Overall Study|Adverse Event|1|||
30737318|NCT00357396|58748677|FG001|Overall Study|Adverse Event|0|||
30737319|NCT00186628|58748682|FG000|Overall Study|Death|2|||
30737320|NCT00186628|58748682|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
30737321|NCT00368550|58748690|FG000|Overall Study|Adverse Event|7|||
30737322|NCT00368550|58748691|FG001|Overall Study|Adverse Event|4|||
30737323|NCT00368550|58748690|FG000|Overall Study|Lack of Efficacy|4|||
30737324|NCT00368550|58748691|FG001|Overall Study|Lack of Efficacy|9|||
30737325|NCT00368550|58748690|FG000|Overall Study|Withdrawal by Subject|17|||
30737326|NCT00368550|58748691|FG001|Overall Study|Withdrawal by Subject|10|||
30737327|NCT00368472|58748697|FG000|Overall Study|Adverse Event|22|||
30737328|NCT00368472|58748697|FG000|Overall Study|Medication non-compliance|4|||
30737329|NCT00368472|58748697|FG000|Overall Study|Protocol Violation|2|||
30737330|NCT00368472|58748697|FG000|Overall Study|Request of Investigator or Sponsor|3|||
30737331|NCT00368472|58748697|FG000|Overall Study|Withdrawal by Subject|40|||
30737332|NCT00368472|58748697|FG000|Overall Study|Diary non-compliance|1|||
30737333|NCT00368472|58748697|FG000|Overall Study|Other|32|||
30737334|NCT00368472|58748697|FG000|Overall Study|Missing Final Disposition Date|1|||
30737335|NCT00357006|58748704|FG000|Overall Study|Lost to Follow-up|1|||
30737336|NCT00357006|58748705|FG001|Overall Study|Lost to Follow-up|2|||
30737337|NCT00357006|58748706|FG002|Overall Study|Lost to Follow-up|1|||
30737338|NCT00357006|58748704|FG000|Overall Study|Withdrawal by Subject|1|||
30737339|NCT00357006|58748705|FG001|Overall Study|Withdrawal by Subject|3|||
30737340|NCT00357006|58748706|FG002|Overall Study|Withdrawal by Subject|2|||
30737341|NCT00165646|58748717|FG000|Overall Study|Adverse Event|1|||
30737342|NCT00165646|58748718|FG001|Overall Study|Adverse Event|1|||
30737343|NCT00165646|58748719|FG002|Overall Study|Adverse Event|1|||
30737344|NCT00165646|58748717|FG000|Overall Study|Lack of Efficacy|1|||
30737345|NCT00165646|58748718|FG001|Overall Study|Lack of Efficacy|2|||
30737346|NCT00165646|58748719|FG002|Overall Study|Lack of Efficacy|0|||
30737347|NCT00165646|58748717|FG000|Overall Study|Withdrawal by Subject|0|||
30737348|NCT00165646|58748718|FG001|Overall Study|Withdrawal by Subject|2|||
30737349|NCT00165646|58748719|FG002|Overall Study|Withdrawal by Subject|1|||
30737350|NCT00165646|58748717|FG000|Overall Study|Physician Decision|2|||
30737351|NCT00165646|58748718|FG001|Overall Study|Physician Decision|0|||
30737352|NCT00165646|58748719|FG002|Overall Study|Physician Decision|2|||
30737353|NCT00165646|58748717|FG000|Overall Study|Protocol Violation|1|||
30737354|NCT00165646|58748718|FG001|Overall Study|Protocol Violation|0|||
30737355|NCT00165646|58748719|FG002|Overall Study|Protocol Violation|0|||
30737356|NCT00367770|58748727|FG000|Overall Study|Adverse Event|1|||
30737357|NCT00367770|58748727|FG000|Overall Study|Withdrawal by Subject|1|||
30737358|NCT00185614|58748731|FG000|Inter-treatment Period|Physician Decision|1|||
30737359|NCT00185614|58748731|FG000|Inter-treatment Period|Relapse|2|||
30737360|NCT00185614|58748731|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
30737361|NCT00162370|58748735|FG000|Efficacy Population|Lost to Follow-up|51|||
30737362|NCT00361842|58748744|FG000|Overall Study|Withdrawal by Subject|2|||
30737363|NCT00361842|58748745|FG001|Overall Study|Withdrawal by Subject|3|||
30737364|NCT00361842|58748744|FG000|Overall Study|Death|2|||
30737365|NCT00361842|58748745|FG001|Overall Study|Death|1|||
30737366|NCT00361842|58748744|FG000|Overall Study|Disease progression|19|||
30737367|NCT00361842|58748745|FG001|Overall Study|Disease progression|20|||
30737368|NCT00361842|58748744|FG000|Overall Study|Adverse Event|2|||
30737369|NCT00361842|58748745|FG001|Overall Study|Adverse Event|3|||
30737370|NCT00361842|58748744|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
30737371|NCT00361842|58748745|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
30737372|NCT00361842|58748744|FG000|Overall Study|Other|1|||
30737373|NCT00361842|58748745|FG001|Overall Study|Other|0|||
30737374|NCT00361842|58748744|FG000|Overall Study|Other|0|||
30737375|NCT00361842|58748745|FG001|Overall Study|Other|2|||
30737376|NCT00361296|58748753|FG000|Overall Study|Physician Decision|1|||
30737377|NCT00361296|58748753|FG000|Overall Study|Lack of Efficacy|2|||
30737378|NCT00356148|58748759|FG000|Overall Study|Reoperation within 30 days|2|||
30737379|NCT00356148|58748760|FG001|Overall Study|Reoperation within 30 days|1|||
30737380|NCT00361218|58748767|FG000|Overall Study|Lost to Follow-up|11|||
30737381|NCT00361218|58748767|FG000|Overall Study|Personal Reasons|7|||
30737382|NCT00361218|58748767|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
30737383|NCT00367458|58748773|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
30737384|NCT00367458|58748774|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
30737385|NCT00162136|58748786|FG000|Overall Study|Adverse Event|1|||
30737386|NCT00162136|58748786|FG000|Overall Study|Death|1|||
30737387|NCT00162136|58748786|FG000|Overall Study|Disease Progression/Relapse|23|||
30737388|NCT00162136|58748786|FG000|Overall Study|Investigator Request|5|||
30737389|NCT00162136|58748786|FG000|Overall Study|Study Drug Toxicity|4|||
30737390|NCT00162136|58748786|FG000|Overall Study|Withdrawal by Subject|1|||
30737391|NCT00252694|58748812|FG000|Overall Study|Withdrawal by Subject|83|||
30737392|NCT00252694|58748813|FG001|Overall Study|Withdrawal by Subject|91|||
30737393|NCT00252694|58748812|FG000|Overall Study|Death|36|||
30737394|NCT00252694|58748813|FG001|Overall Study|Death|34|||
30737395|NCT00252694|58748812|FG000|Overall Study|Mostly Lost to Follow Up|8|||
30737396|NCT00252694|58748813|FG001|Overall Study|Mostly Lost to Follow Up|13|||
30737397|NCT00252694|58748812|FG000|Overall Study|Patient Moving|17|||
30737398|NCT00252694|58748813|FG001|Overall Study|Patient Moving|16|||
30737399|NCT00185458|58748819|FG000|Contraception Phase|Adverse Event|37|||
30737400|NCT00185458|58748819|FG000|Contraception Phase|Lost to Follow-up|10|||
30737401|NCT00185458|58748819|FG000|Contraception Phase|Protocol Violation|2|||
30737402|NCT00185458|58748819|FG000|Contraception Phase|Physician Decision|2|||
30737403|NCT00185458|58748819|FG000|Contraception Phase|Withdrawal by Subject|7|||
30737404|NCT00185458|58748819|FG000|HRT Phase|Adverse Event|18|||
30737405|NCT00185458|58748819|FG000|HRT Phase|Lost to Follow-up|4|||
30737406|NCT00185458|58748819|FG000|HRT Phase|Protocol Violation|2|||
30900969|NCT02031237|58934569|FG000|Overall Study|Physician Decision|0|||
30900970|NCT02031237|58934570|FG001|Overall Study|Physician Decision|1|||
30900971|NCT02031237|58934571|FG002|Overall Study|Physician Decision|0|||
30900972|NCT02031237|58934569|FG000|Overall Study|Withdrawal by Subject|2|||
30900973|NCT02031237|58934570|FG001|Overall Study|Withdrawal by Subject|2|||
30900974|NCT02031237|58934571|FG002|Overall Study|Withdrawal by Subject|0|||
30900975|NCT02031237|58934569|FG000|Overall Study|Protocol Violation|2|||
30900976|NCT02031237|58934570|FG001|Overall Study|Protocol Violation|6|||
30900977|NCT02031237|58934571|FG002|Overall Study|Protocol Violation|0|||
30900978|NCT02031237|58934569|FG000|Overall Study|Alternate Treatment Given|0|||
30900979|NCT02031237|58934570|FG001|Overall Study|Alternate Treatment Given|0|||
30900980|NCT02031237|58934571|FG002|Overall Study|Alternate Treatment Given|3|||
30900981|NCT02088957|58934578|FG000|Overall Study|Lack of Efficacy|1|||
30900982|NCT02088957|58934579|FG001|Overall Study|Lack of Efficacy|0|||
30900983|NCT02418845|58934587|FG000|Overall Study|Lost to Follow-up|7|||
30900984|NCT02418845|58934588|FG001|Overall Study|Lost to Follow-up|2|||
30900985|NCT02418845|58934587|FG000|Overall Study|Lack of Efficacy|0|||
30900986|NCT02418845|58934588|FG001|Overall Study|Lack of Efficacy|3|||
30900987|NCT02418845|58934587|FG000|Overall Study|Physician Decision|5|||
30900988|NCT02418845|58934588|FG001|Overall Study|Physician Decision|5|||
30900989|NCT02418845|58934587|FG000|Overall Study|Protocol Violation|1|||
30900990|NCT02418845|58934588|FG001|Overall Study|Protocol Violation|0|||
30900991|NCT02418845|58934587|FG000|Overall Study|Withdrawal by Subject|3|||
30900992|NCT02418845|58934588|FG001|Overall Study|Withdrawal by Subject|2|||
30900993|NCT02088177|58934594|FG000|Overall Study|Lost to Follow-up|3|||
30900994|NCT02030535|58934598|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
30737407|NCT00185458|58748819|FG000|HRT Phase|Withdrawal by Subject|3|||
30737408|NCT00185380|58748834|FG000|Overall Study|Adverse Event|41|||
30737409|NCT00185380|58748835|FG001|Overall Study|Adverse Event|43|||
30737410|NCT00185380|58748836|FG002|Overall Study|Adverse Event|48|||
30737411|NCT00185380|58748834|FG000|Overall Study|Lost to Follow-up|0|||
30737412|NCT00185380|58748835|FG001|Overall Study|Lost to Follow-up|4|||
30737413|NCT00185380|58748836|FG002|Overall Study|Lost to Follow-up|3|||
30737414|NCT00185380|58748834|FG000|Overall Study|Pregnancy|1|||
30737415|NCT00185380|58748835|FG001|Overall Study|Pregnancy|4|||
30900995|NCT02029989|58934614|FG000|Overall Study|Withdrawal by Subject|1|||
30900996|NCT02029989|58934615|FG001|Overall Study|Withdrawal by Subject|0|||
30737416|NCT00185380|58748836|FG002|Overall Study|Pregnancy|0|||
30737417|NCT00185380|58748834|FG000|Overall Study|Protocol Violation|2|||
30737418|NCT00185380|58748835|FG001|Overall Study|Protocol Violation|2|||
30737419|NCT00185380|58748836|FG002|Overall Study|Protocol Violation|1|||
30737420|NCT00185380|58748834|FG000|Overall Study|Withdrawal by Subject|1|||
30737421|NCT00185380|58748835|FG001|Overall Study|Withdrawal by Subject|2|||
30737422|NCT00185380|58748836|FG002|Overall Study|Withdrawal by Subject|0|||
30737423|NCT00185380|58748834|FG000|Overall Study|Failed insertion|1|||
30737424|NCT00185380|58748835|FG001|Overall Study|Failed insertion|1|||
30737425|NCT00185380|58748836|FG002|Overall Study|Failed insertion|2|||
30737426|NCT00185380|58748834|FG000|Overall Study|Planned pregnancy|9|||
30737427|NCT00185380|58748835|FG001|Overall Study|Planned pregnancy|12|||
30737428|NCT00185380|58748836|FG002|Overall Study|Planned pregnancy|12|||
30737429|NCT00185380|58748834|FG000|Overall Study|No need for contraception|3|||
30737430|NCT00185380|58748835|FG001|Overall Study|No need for contraception|3|||
30737431|NCT00185380|58748836|FG002|Overall Study|No need for contraception|3|||
30737432|NCT00185380|58748834|FG000|Overall Study|Could not attend visits|2|||
30737433|NCT00185380|58748835|FG001|Overall Study|Could not attend visits|0|||
30737434|NCT00185380|58748836|FG002|Overall Study|Could not attend visits|4|||
30737435|NCT00185380|58748834|FG000|Overall Study|personal reason|6|||
30900997|NCT02029989|58934614|FG000|Overall Study|Withdrawal: Fear of needles|1|||
30900998|NCT02029989|58934615|FG001|Overall Study|Withdrawal: Fear of needles|0|||
30900999|NCT02029989|58934614|FG000|Overall Study|Change of location|2|||
30901000|NCT02029989|58934615|FG001|Overall Study|Change of location|3|||
30901001|NCT02029989|58934614|FG000|Overall Study|Physician Decision|2|||
30901002|NCT02029989|58934615|FG001|Overall Study|Physician Decision|0|||
30901003|NCT02029989|58934614|FG000|Overall Study|Lost to Follow-up|9|||
30901004|NCT02029989|58934615|FG001|Overall Study|Lost to Follow-up|7|||
30901005|NCT02029989|58934614|FG000|Overall Study|Death|0|||
30901006|NCT02029989|58934615|FG001|Overall Study|Death|1|||
30901007|NCT02029989|58934614|FG000|Overall Study|Protocol Violation|1|||
30901008|NCT02029989|58934615|FG001|Overall Study|Protocol Violation|0|||
30901009|NCT02048241|58934623|FG000|Overall Study|Withdrawal by Subject|0|||
30901010|NCT02048241|58934624|FG001|Overall Study|Withdrawal by Subject|1|||
30901011|NCT02087943|58934633|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
30901012|NCT02087943|58934634|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
30901013|NCT02087943|58934635|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
30901014|NCT02087943|58934636|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
30901015|NCT02087943|58934637|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
30901016|NCT02087943|58934633|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
30901017|NCT02087943|58934634|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
30901018|NCT02087943|58934635|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
30901019|NCT02087943|58934636|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
30901020|NCT02087943|58934637|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
30737436|NCT00185380|58748835|FG001|Overall Study|personal reason|1|||
30737437|NCT00185380|58748836|FG002|Overall Study|personal reason|1|||
30737438|NCT00160654|58748844|FG000|Overall Study|Adverse Event|14|||
30737439|NCT00160654|58748844|FG000|Overall Study|Lack of Efficacy|4|||
30737440|NCT00160654|58748844|FG000|Overall Study|Lost to Follow-up|2|||
30737441|NCT00160654|58748844|FG000|Overall Study|Intake of expired drug|7|||
30737442|NCT00160654|58748844|FG000|Overall Study|Psychological trauma|1|||
30737443|NCT00160654|58748844|FG000|Overall Study|Sponsor decision|1|||
30737444|NCT00160654|58748844|FG000|Overall Study|Patient met exclusion criteria|1|||
30737445|NCT00160654|58748844|FG000|Overall Study|Patient decision|1|||
30737446|NCT00160654|58748844|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
30737447|NCT00160654|58748844|FG000|Overall Study|Met exclusion criteria|1|||
30737448|NCT00366678|58748850|FG000|Infant Series|Withdrawal by Subject|8|||
30737449|NCT00366678|58748851|FG001|Infant Series|Withdrawal by Subject|6|||
30737450|NCT00366678|58748852|FG002|Infant Series|Withdrawal by Subject|0|||
30737451|NCT00366678|58748850|FG000|Infant Series|Protocol Violation|4|||
30737452|NCT00366678|58748851|FG001|Infant Series|Protocol Violation|3|||
30737453|NCT00366678|58748852|FG002|Infant Series|Protocol Violation|0|||
30737454|NCT00366678|58748850|FG000|Infant Series|Failed to return|1|||
30901021|NCT02087943|58934633|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
30901022|NCT02087943|58934634|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
30737455|NCT00366678|58748851|FG001|Infant Series|Failed to return|1|||
30737456|NCT00366678|58748852|FG002|Infant Series|Failed to return|0|||
30737457|NCT00366678|58748850|FG000|Infant Series|Adverse Event|1|||
30737458|NCT00366678|58748851|FG001|Infant Series|Adverse Event|0|||
30737459|NCT00366678|58748852|FG002|Infant Series|Adverse Event|0|||
30737460|NCT00366678|58748850|FG000|After Infant|Withdrawal by Subject|8|||
30737461|NCT00366678|58748851|FG001|After Infant|Withdrawal by Subject|4|||
30737462|NCT00366678|58748852|FG002|After Infant|Withdrawal by Subject|0|||
30737463|NCT00366678|58748850|FG000|After Infant|Lost to Follow-up|2|||
30901023|NCT02087943|58934635|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
30901024|NCT02087943|58934636|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
30901025|NCT02087943|58934637|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
30901026|NCT02087943|58934633|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
30901027|NCT02087943|58934634|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
30901028|NCT02087943|58934635|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
30901029|NCT02087943|58934636|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
30901030|NCT02087943|58934637|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
30901031|NCT02087943|58934633|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
30901032|NCT02087943|58934634|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
30737464|NCT00366678|58748851|FG001|After Infant|Lost to Follow-up|1|||
30737465|NCT00366678|58748852|FG002|After Infant|Lost to Follow-up|0|||
30737466|NCT00366678|58748850|FG000|After Infant|Failed to return|5|||
30737467|NCT00366678|58748851|FG001|After Infant|Failed to return|5|||
30737468|NCT00366678|58748852|FG002|After Infant|Failed to return|0|||
30737469|NCT00366678|58748850|FG000|After Infant|Adverse Event|1|||
30737470|NCT00366678|58748851|FG001|After Infant|Adverse Event|0|||
30737471|NCT00366678|58748852|FG002|After Infant|Adverse Event|0|||
30737472|NCT00366678|58748850|FG000|After Infant|Protocol Violation|1|||
30737473|NCT00366678|58748851|FG001|After Infant|Protocol Violation|0|||
30737474|NCT00366678|58748852|FG002|After Infant|Protocol Violation|0|||
30737475|NCT00366678|58748850|FG000|Toddler Dose|Protocol Violation|2|||
30737476|NCT00366678|58748851|FG001|Toddler Dose|Protocol Violation|1|||
30737477|NCT00366678|58748852|FG002|Toddler Dose|Protocol Violation|0|||
30737478|NCT00366678|58748850|FG000|Toddler Dose|Failed to return|1|||
30737479|NCT00366678|58748851|FG001|Toddler Dose|Failed to return|0|||
30737480|NCT00366678|58748852|FG002|Toddler Dose|Failed to return|0|||
30737481|NCT00366678|58748850|FG000|Toddler Dose|Withdrawal by Subject|1|||
30737482|NCT00366678|58748851|FG001|Toddler Dose|Withdrawal by Subject|0|||
30737483|NCT00366678|58748852|FG002|Toddler Dose|Withdrawal by Subject|0|||
30737484|NCT00366678|58748850|FG000|Toddler Dose|protocol deviation|1|||
30737485|NCT00366678|58748851|FG001|Toddler Dose|protocol deviation|0|||
30737486|NCT00366678|58748852|FG002|Toddler Dose|protocol deviation|0|||
30737487|NCT00355368|58748899|FG000|Overall Study|Protocol Violation|8|||
30737488|NCT00355368|58748900|FG001|Overall Study|Protocol Violation|7|||
30737489|NCT00355368|58748899|FG000|Overall Study|cardiac arrest prior to intubation|2|||
30737490|NCT00355368|58748900|FG001|Overall Study|cardiac arrest prior to intubation|2|||
30737491|NCT00360282|58748906|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
30737492|NCT00360282|58748907|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
30737493|NCT00360282|58748908|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
30737494|NCT00360282|58748909|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
30737495|NCT00360282|58748906|FG000|Second Intervention|Adverse Event|0|||
30737496|NCT00360282|58748907|FG001|Second Intervention|Adverse Event|1|||
30737497|NCT00360282|58748908|FG002|Second Intervention|Adverse Event|0|||
30737498|NCT00360282|58748909|FG003|Second Intervention|Adverse Event|0|||
30737499|NCT00373958|58748919|FG000|Infant Series|Withdrawal by Subject|13|||
30737500|NCT00373958|58748920|FG001|Infant Series|Withdrawal by Subject|15|||
30737501|NCT00373958|58748919|FG000|Infant Series|Failed to return|8|||
30737502|NCT00373958|58748920|FG001|Infant Series|Failed to return|13|||
30737503|NCT00373958|58748919|FG000|Infant Series|Lost to Follow-up|6|||
30737504|NCT00373958|58748920|FG001|Infant Series|Lost to Follow-up|5|||
30737505|NCT00373958|58748919|FG000|Infant Series|Protocol Violation|3|||
30737506|NCT00373958|58748920|FG001|Infant Series|Protocol Violation|7|||
30737507|NCT00373958|58748919|FG000|Infant Series|Lost Kaiser coverage|4|||
30737508|NCT00373958|58748920|FG001|Infant Series|Lost Kaiser coverage|0|||
30737509|NCT00373958|58748919|FG000|Infant Series|Child relocated|1|||
30737510|NCT00373958|58748920|FG001|Infant Series|Child relocated|0|||
30737511|NCT00373958|58748919|FG000|Infant Series|Consent was not received|1|||
30737512|NCT00373958|58748920|FG001|Infant Series|Consent was not received|0|||
30737513|NCT00373958|58748919|FG000|Infant Series|Adverse Event|3|||
30737514|NCT00373958|58748920|FG001|Infant Series|Adverse Event|1|||
30901033|NCT02087943|58934635|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
30901034|NCT02087943|58934636|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
30737515|NCT00373958|58748919|FG000|Infant Series|Physician Decision|1|||
30737516|NCT00373958|58748920|FG001|Infant Series|Physician Decision|1|||
30737517|NCT00373958|58748919|FG000|Toddler Dose|Lost to Follow-up|5|||
30737518|NCT00373958|58748920|FG001|Toddler Dose|Lost to Follow-up|8|||
30737519|NCT00373958|58748919|FG000|Toddler Dose|Withdrawal by Subject|2|||
30737520|NCT00373958|58748920|FG001|Toddler Dose|Withdrawal by Subject|2|||
30737521|NCT00373958|58748919|FG000|Toddler Dose|Failed to return|1|||
30737522|NCT00373958|58748920|FG001|Toddler Dose|Failed to return|2|||
30737523|NCT00373958|58748919|FG000|Toddler Dose|Protocol Violation|0|||
30737524|NCT00373958|58748920|FG001|Toddler Dose|Protocol Violation|1|||
30737525|NCT00373958|58748919|FG000|Toddler Dose|Withdrawn after infant series|22|||
30737526|NCT00373958|58748920|FG001|Toddler Dose|Withdrawn after infant series|25|||
30737527|NCT00373880|58748949|FG000|Overall Study|Physician Decision|3|||
30737528|NCT00373880|58748949|FG000|Overall Study|Arrested|1|||
30737529|NCT00373880|58748949|FG000|Overall Study|Protocol Violation|14|||
30737530|NCT00184600|58748964|FG000|Overall Study|Adverse Event|9|||
30737531|NCT00184600|58748965|FG001|Overall Study|Adverse Event|0|||
30737532|NCT00184600|58748966|FG002|Overall Study|Adverse Event|5|||
30737533|NCT00184600|58748964|FG000|Overall Study|Death|3|||
30737534|NCT00184600|58748965|FG001|Overall Study|Death|9|||
30737535|NCT00184600|58748966|FG002|Overall Study|Death|7|||
30737536|NCT00184600|58748964|FG000|Overall Study|Lack of Efficacy|3|||
30737537|NCT00184600|58748965|FG001|Overall Study|Lack of Efficacy|1|||
30737538|NCT00184600|58748966|FG002|Overall Study|Lack of Efficacy|3|||
30737539|NCT00184600|58748964|FG000|Overall Study|Lost to Follow-up|4|||
30737540|NCT00184600|58748965|FG001|Overall Study|Lost to Follow-up|6|||
30737541|NCT00184600|58748966|FG002|Overall Study|Lost to Follow-up|1|||
30737542|NCT00184600|58748964|FG000|Overall Study|Protocol Violation|2|||
30737543|NCT00184600|58748965|FG001|Overall Study|Protocol Violation|2|||
30737544|NCT00184600|58748966|FG002|Overall Study|Protocol Violation|3|||
30737545|NCT00184600|58748964|FG000|Overall Study|Withdrawal by Subject|20|||
30737546|NCT00184600|58748965|FG001|Overall Study|Withdrawal by Subject|28|||
30737547|NCT00184600|58748966|FG002|Overall Study|Withdrawal by Subject|12|||
30737548|NCT00184600|58748964|FG000|Overall Study|Unclassified|4|||
30737549|NCT00184600|58748965|FG001|Overall Study|Unclassified|5|||
30737550|NCT00184600|58748966|FG002|Overall Study|Unclassified|3|||
30737551|NCT00265317|58748978|FG000|Lead-In|Objective progression or relapse|6|||
30737552|NCT00265317|58748979|FG001|Lead-In|Objective progression or relapse|11|||
30737553|NCT00265317|58748980|FG002|Lead-In|Objective progression or relapse|0|||
30737554|NCT00265317|58748981|FG003|Lead-In|Objective progression or relapse|0|||
30737555|NCT00265317|58748978|FG000|Lead-In|Adverse Event|2|||
30737556|NCT00265317|58748979|FG001|Lead-In|Adverse Event|1|||
30737557|NCT00265317|58748980|FG002|Lead-In|Adverse Event|0|||
30737558|NCT00265317|58748981|FG003|Lead-In|Adverse Event|0|||
30737559|NCT00265317|58748978|FG000|Lead-In|Death|3|||
30737560|NCT00265317|58748979|FG001|Lead-In|Death|5|||
30737561|NCT00265317|58748980|FG002|Lead-In|Death|0|||
30737562|NCT00265317|58748981|FG003|Lead-In|Death|0|||
30737563|NCT00265317|58748978|FG000|Lead-In|Withdrawal/other than adverse event|1|||
30737564|NCT00265317|58748979|FG001|Lead-In|Withdrawal/other than adverse event|0|||
30737565|NCT00265317|58748980|FG002|Lead-In|Withdrawal/other than adverse event|0|||
30737566|NCT00265317|58748981|FG003|Lead-In|Withdrawal/other than adverse event|0|||
30737567|NCT00265317|58748978|FG000|Phase 2|Objective progression or relapse|0|||
30737568|NCT00265317|58748979|FG001|Phase 2|Objective progression or relapse|0|||
30737569|NCT00265317|58748980|FG002|Phase 2|Objective progression or relapse|37|||
30737570|NCT00265317|58748981|FG003|Phase 2|Objective progression or relapse|38|||
30737571|NCT00265317|58748978|FG000|Phase 2|Global deterioration of health status|0|||
30737572|NCT00265317|58748979|FG001|Phase 2|Global deterioration of health status|0|||
30737573|NCT00265317|58748980|FG002|Phase 2|Global deterioration of health status|3|||
30737574|NCT00265317|58748981|FG003|Phase 2|Global deterioration of health status|0|||
30737575|NCT00265317|58748978|FG000|Phase 2|Adverse Event|0|||
30737576|NCT00265317|58748979|FG001|Phase 2|Adverse Event|0|||
30737577|NCT00265317|58748980|FG002|Phase 2|Adverse Event|7|||
30737578|NCT00265317|58748981|FG003|Phase 2|Adverse Event|5|||
30737579|NCT00265317|58748978|FG000|Phase 2|Death|0|||
30737580|NCT00265317|58748979|FG001|Phase 2|Death|0|||
30737581|NCT00265317|58748980|FG002|Phase 2|Death|12|||
30737582|NCT00265317|58748981|FG003|Phase 2|Death|15|||
30737583|NCT00265317|58748978|FG000|Phase 2|Protocol Violation|0|||
30737584|NCT00265317|58748979|FG001|Phase 2|Protocol Violation|0|||
30737585|NCT00265317|58748980|FG002|Phase 2|Protocol Violation|1|||
30737586|NCT00265317|58748981|FG003|Phase 2|Protocol Violation|4|||
30737587|NCT00265317|58748978|FG000|Phase 2|Lost to Follow-up|0|||
30737588|NCT00265317|58748979|FG001|Phase 2|Lost to Follow-up|0|||
30737589|NCT00265317|58748980|FG002|Phase 2|Lost to Follow-up|0|||
30737590|NCT00265317|58748981|FG003|Phase 2|Lost to Follow-up|1|||
30737591|NCT00265317|58748978|FG000|Phase 2|Withdrawal/other than adverse event|0|||
30737592|NCT00265317|58748979|FG001|Phase 2|Withdrawal/other than adverse event|0|||
30737593|NCT00265317|58748980|FG002|Phase 2|Withdrawal/other than adverse event|2|||
30737594|NCT00265317|58748981|FG003|Phase 2|Withdrawal/other than adverse event|1|||
30737595|NCT00265317|58748978|FG000|Phase 2|Study terminated by sponsor|0|||
30737596|NCT00265317|58748979|FG001|Phase 2|Study terminated by sponsor|0|||
30737597|NCT00265317|58748980|FG002|Phase 2|Study terminated by sponsor|1|||
30737598|NCT00265317|58748981|FG003|Phase 2|Study terminated by sponsor|0|||
30737599|NCT00265317|58748978|FG000|Phase 2|Other|0|||
30737600|NCT00265317|58748979|FG001|Phase 2|Other|0|||
30737601|NCT00265317|58748980|FG002|Phase 2|Other|1|||
30737602|NCT00265317|58748981|FG003|Phase 2|Other|1|||
30737603|NCT00373490|58749002|FG000|Overall Study|Adverse Event|0|||
30737604|NCT00373490|58749003|FG001|Overall Study|Adverse Event|1|||
30737605|NCT00373490|58749002|FG000|Overall Study|Lack of Efficacy|9|||
30737606|NCT00373490|58749003|FG001|Overall Study|Lack of Efficacy|4|||
30737607|NCT00373490|58749002|FG000|Overall Study|Withdrawal by Subject|0|||
30737608|NCT00373490|58749003|FG001|Overall Study|Withdrawal by Subject|1|||
30737609|NCT00251589|58749013|FG000|Overall Study|Adverse Event|5|||
30737610|NCT00251589|58749014|FG001|Overall Study|Adverse Event|1|||
30737611|NCT00251589|58749015|FG002|Overall Study|Adverse Event|2|||
30737612|NCT00251589|58749016|FG003|Overall Study|Adverse Event|1|||
30737613|NCT00251589|58749013|FG000|Overall Study|Withdrawal by Subject|1|||
30737614|NCT00251589|58749014|FG001|Overall Study|Withdrawal by Subject|1|||
30737615|NCT00251589|58749015|FG002|Overall Study|Withdrawal by Subject|0|||
30737616|NCT00251589|58749016|FG003|Overall Study|Withdrawal by Subject|0|||
30737617|NCT00251589|58749013|FG000|Overall Study|Discontinued due to progressive disease|9|||
30737618|NCT00251589|58749014|FG001|Overall Study|Discontinued due to progressive disease|1|||
30737619|NCT00251589|58749015|FG002|Overall Study|Discontinued due to progressive disease|0|||
30737620|NCT00251589|58749016|FG003|Overall Study|Discontinued due to progressive disease|1|||
30737621|NCT00265239|58749028|FG000|Overall Study|Adverse Event|2|||
30737622|NCT00265239|58749029|FG001|Overall Study|Adverse Event|1|||
30737623|NCT00350298|58749037|FG000|Overall Study|Death|7|||
30737624|NCT00350298|58749038|FG001|Overall Study|Death|8|||
30737625|NCT00350298|58749037|FG000|Overall Study|Lost to Follow-up|1|||
30737626|NCT00350298|58749038|FG001|Overall Study|Lost to Follow-up|2|||
30737627|NCT00350298|58749037|FG000|Overall Study|Withdrawal by Subject|1|||
30737628|NCT00350298|58749038|FG001|Overall Study|Withdrawal by Subject|3|||
30737629|NCT00159874|58749051|FG000|Overall Study|Adverse Event|2|||
30737630|NCT00159874|58749052|FG001|Overall Study|Adverse Event|2|||
30737631|NCT00159874|58749053|FG002|Overall Study|Adverse Event|5|||
30737632|NCT00159874|58749054|FG003|Overall Study|Adverse Event|1|||
30737633|NCT00159874|58749055|FG004|Overall Study|Adverse Event|1|||
30737634|NCT00159874|58749056|FG005|Overall Study|Adverse Event|2|||
30737635|NCT00159874|58749057|FG006|Overall Study|Adverse Event|0|||
30737636|NCT00159874|58749051|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
30737637|NCT00159874|58749052|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
30737638|NCT00159874|58749053|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
30737639|NCT00159874|58749054|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
30737640|NCT00159874|58749055|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
30737641|NCT00159874|58749056|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
30737642|NCT00159874|58749057|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
30737643|NCT00159874|58749051|FG000|Overall Study|Lack of Efficacy|2|||
30737644|NCT00159874|58749052|FG001|Overall Study|Lack of Efficacy|0|||
30737645|NCT00159874|58749053|FG002|Overall Study|Lack of Efficacy|1|||
30737646|NCT00159874|58749054|FG003|Overall Study|Lack of Efficacy|1|||
30737647|NCT00159874|58749055|FG004|Overall Study|Lack of Efficacy|0|||
30737648|NCT00159874|58749056|FG005|Overall Study|Lack of Efficacy|3|||
30737649|NCT00159874|58749057|FG006|Overall Study|Lack of Efficacy|0|||
30737650|NCT00159874|58749051|FG000|Overall Study|Lost to Follow-up|1|||
30737651|NCT00159874|58749052|FG001|Overall Study|Lost to Follow-up|0|||
30737652|NCT00159874|58749053|FG002|Overall Study|Lost to Follow-up|3|||
30737653|NCT00159874|58749054|FG003|Overall Study|Lost to Follow-up|0|||
30737654|NCT00159874|58749055|FG004|Overall Study|Lost to Follow-up|1|||
30737655|NCT00159874|58749056|FG005|Overall Study|Lost to Follow-up|2|||
30737656|NCT00159874|58749057|FG006|Overall Study|Lost to Follow-up|1|||
30737657|NCT00159874|58749051|FG000|Overall Study|Other|8|||
30737658|NCT00159874|58749052|FG001|Overall Study|Other|8|||
30737659|NCT00159874|58749053|FG002|Overall Study|Other|8|||
30737660|NCT00159874|58749054|FG003|Overall Study|Other|0|||
30737661|NCT00159874|58749055|FG004|Overall Study|Other|2|||
30737662|NCT00159874|58749056|FG005|Overall Study|Other|1|||
30737663|NCT00159874|58749057|FG006|Overall Study|Other|3|||
30737664|NCT00159874|58749051|FG000|Overall Study|Protocol Violation|0|||
30737665|NCT00159874|58749052|FG001|Overall Study|Protocol Violation|5|||
30737666|NCT00159874|58749053|FG002|Overall Study|Protocol Violation|2|||
30737667|NCT00159874|58749054|FG003|Overall Study|Protocol Violation|0|||
30737668|NCT00159874|58749055|FG004|Overall Study|Protocol Violation|0|||
30737669|NCT00159874|58749056|FG005|Overall Study|Protocol Violation|0|||
30737670|NCT00159874|58749057|FG006|Overall Study|Protocol Violation|0|||
30737671|NCT00159874|58749051|FG000|Overall Study|Death|3|||
30737672|NCT00159874|58749052|FG001|Overall Study|Death|8|||
30737673|NCT00159874|58749053|FG002|Overall Study|Death|15|||
30737674|NCT00159874|58749054|FG003|Overall Study|Death|0|||
30737675|NCT00159874|58749055|FG004|Overall Study|Death|1|||
30737676|NCT00159874|58749056|FG005|Overall Study|Death|2|||
30737677|NCT00159874|58749057|FG006|Overall Study|Death|0|||
30737678|NCT00159874|58749051|FG000|Overall Study|Withdrawal by Subject|2|||
30737679|NCT00159874|58749052|FG001|Overall Study|Withdrawal by Subject|6|||
30737680|NCT00159874|58749053|FG002|Overall Study|Withdrawal by Subject|8|||
30737681|NCT00159874|58749054|FG003|Overall Study|Withdrawal by Subject|4|||
30737682|NCT00159874|58749055|FG004|Overall Study|Withdrawal by Subject|3|||
30737683|NCT00159874|58749056|FG005|Overall Study|Withdrawal by Subject|2|||
30737684|NCT00159874|58749057|FG006|Overall Study|Withdrawal by Subject|1|||
30737685|NCT00159874|58749051|FG000|Overall Study|Pregnancy|1|||
30737686|NCT00159874|58749052|FG001|Overall Study|Pregnancy|1|||
30737687|NCT00159874|58749053|FG002|Overall Study|Pregnancy|0|||
30737688|NCT00159874|58749054|FG003|Overall Study|Pregnancy|0|||
30737689|NCT00159874|58749055|FG004|Overall Study|Pregnancy|0|||
30737690|NCT00159874|58749056|FG005|Overall Study|Pregnancy|0|||
30737691|NCT00159874|58749057|FG006|Overall Study|Pregnancy|0|||
30737692|NCT00349908|58749075|FG000|Overall Study|Withdrawal by Subject|0|||
30737693|NCT00349908|58749076|FG001|Overall Study|Withdrawal by Subject|4|||
30737694|NCT00184054|58749083|FG000|Overall Study|Adverse Event|1|||
30737695|NCT00183430|58749089|FG000|Overall Study|Adverse Event|1|||
30737696|NCT00183430|58749090|FG001|Overall Study|Adverse Event|0|||
30737697|NCT00183430|58749089|FG000|Overall Study|Lost to Follow-up|3|||
30737698|NCT00183430|58749090|FG001|Overall Study|Lost to Follow-up|0|||
30737699|NCT00183430|58749089|FG000|Overall Study|did not meet inclusion criteria|1|||
30737700|NCT00183430|58749090|FG001|Overall Study|did not meet inclusion criteria|0|||
30737701|NCT00183430|58749089|FG000|Overall Study|Withdrawal by Subject|1|||
30737702|NCT00183430|58749090|FG001|Overall Study|Withdrawal by Subject|0|||
30737703|NCT00183274|58749096|FG000|Phase 1: Open-Label|Adverse Event|31|||
30737704|NCT00183274|58749097|FG001|Phase 1: Open-Label|Adverse Event|0|||
30737705|NCT00183274|58749098|FG002|Phase 1: Open-Label|Adverse Event|0|||
30737706|NCT00183274|58749099|FG003|Phase 1: Open-Label|Adverse Event|0|||
30737707|NCT00183274|58749100|FG004|Phase 1: Open-Label|Adverse Event|0|||
30737708|NCT00183274|58749101|FG005|Phase 1: Open-Label|Adverse Event|0|||
30737709|NCT00183274|58749096|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
30737710|NCT00183274|58749097|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
30737711|NCT00183274|58749098|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
30737712|NCT00183274|58749099|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
30737713|NCT00183274|58749100|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
30737714|NCT00183274|58749101|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
30737715|NCT00183274|58749096|FG000|Phase 1: Open-Label|Protocol Violation|11|||
30737716|NCT00183274|58749097|FG001|Phase 1: Open-Label|Protocol Violation|0|||
30737717|NCT00183274|58749098|FG002|Phase 1: Open-Label|Protocol Violation|0|||
30737718|NCT00183274|58749099|FG003|Phase 1: Open-Label|Protocol Violation|0|||
30737719|NCT00183274|58749100|FG004|Phase 1: Open-Label|Protocol Violation|0|||
30737720|NCT00183274|58749101|FG005|Phase 1: Open-Label|Protocol Violation|0|||
30621858|NCT01180049|58633416|FG001|Overall Study|Lost to Follow-up|6|||
30737721|NCT00183274|58749096|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
30737722|NCT00183274|58749097|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
30737723|NCT00183274|58749098|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
30737724|NCT00183274|58749099|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
30737725|NCT00183274|58749100|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
30737726|NCT00183274|58749101|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
30737727|NCT00183274|58749096|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
30737728|NCT00183274|58749097|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
30737729|NCT00183274|58749098|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
30737730|NCT00183274|58749099|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
30737731|NCT00183274|58749100|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
30737732|NCT00183274|58749101|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
30737733|NCT00183274|58749096|FG000|Phase 1: Open-Label|Other|9|||
30737734|NCT00183274|58749097|FG001|Phase 1: Open-Label|Other|0|||
30737735|NCT00183274|58749098|FG002|Phase 1: Open-Label|Other|0|||
30737736|NCT00183274|58749099|FG003|Phase 1: Open-Label|Other|0|||
30737737|NCT00183274|58749100|FG004|Phase 1: Open-Label|Other|0|||
30737738|NCT00183274|58749101|FG005|Phase 1: Open-Label|Other|0|||
30737739|NCT00183274|58749096|FG000|Phase 2: Double-Blind|Relapsed|0|||
30737740|NCT00183274|58749097|FG001|Phase 2: Double-Blind|Relapsed|8|||
30737741|NCT00183274|58749098|FG002|Phase 2: Double-Blind|Relapsed|29|||
30737742|NCT00183274|58749099|FG003|Phase 2: Double-Blind|Relapsed|0|||
30737743|NCT00183274|58749100|FG004|Phase 2: Double-Blind|Relapsed|0|||
30901035|NCT02087943|58934637|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
30901036|NCT02087943|58934633|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
30901037|NCT02087943|58934634|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
30901038|NCT02087943|58934635|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
30901039|NCT02087943|58934636|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
30901040|NCT02087943|58934637|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
30901041|NCT02087943|58934633|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
30901042|NCT02087943|58934634|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
30901043|NCT02087943|58934635|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
30737744|NCT00183274|58749101|FG005|Phase 2: Double-Blind|Relapsed|0|||
30737745|NCT00183274|58749096|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
30737746|NCT00183274|58749097|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
30737747|NCT00183274|58749098|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
30737748|NCT00183274|58749099|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
30737749|NCT00183274|58749100|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
30737750|NCT00183274|58749101|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
30737751|NCT00183274|58749096|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
30737752|NCT00183274|58749097|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
30737753|NCT00183274|58749098|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
30737754|NCT00183274|58749099|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
30737755|NCT00183274|58749100|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
30737756|NCT00183274|58749101|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
30737757|NCT00183274|58749096|FG000|Phase 3: Double-Blind|Relapsed|0|||
30737758|NCT00183274|58749097|FG001|Phase 3: Double-Blind|Relapsed|0|||
30737759|NCT00183274|58749098|FG002|Phase 3: Double-Blind|Relapsed|0|||
30737760|NCT00183274|58749099|FG003|Phase 3: Double-Blind|Relapsed|1|||
30737761|NCT00183274|58749100|FG004|Phase 3: Double-Blind|Relapsed|11|||
30737762|NCT00183274|58749101|FG005|Phase 3: Double-Blind|Relapsed|2|||
30737763|NCT00183196|58749119|FG000|Overall Study|Withdrawal by Subject|18|||
30737764|NCT00183196|58749120|FG001|Overall Study|Withdrawal by Subject|11|||
30737765|NCT00183196|58749121|FG002|Overall Study|Withdrawal by Subject|13|||
30737766|NCT00183196|58749119|FG000|Overall Study|Adverse Event|1|||
30737767|NCT00183196|58749120|FG001|Overall Study|Adverse Event|2|||
30737768|NCT00183196|58749121|FG002|Overall Study|Adverse Event|2|||
30737769|NCT00183196|58749119|FG000|Overall Study|Legal event|1|||
30737770|NCT00183196|58749120|FG001|Overall Study|Legal event|1|||
30737771|NCT00183196|58749121|FG002|Overall Study|Legal event|1|||
30737772|NCT00183196|58749119|FG000|Overall Study|Required more intensive care|0|||
30737773|NCT00183196|58749120|FG001|Overall Study|Required more intensive care|1|||
30737774|NCT00183196|58749121|FG002|Overall Study|Required more intensive care|2|||
30737775|NCT00349752|58749131|FG000|Overall Study|Adverse Event|8|||
30737776|NCT00349752|58749132|FG001|Overall Study|Adverse Event|12|||
30737777|NCT00349752|58749131|FG000|Overall Study|Lack of Efficacy|37|||
30737778|NCT00349752|58749132|FG001|Overall Study|Lack of Efficacy|42|||
30737779|NCT00349752|58749131|FG000|Overall Study|Lost to Follow-up|4|||
30737780|NCT00349752|58749132|FG001|Overall Study|Lost to Follow-up|2|||
30737781|NCT00349752|58749131|FG000|Overall Study|Personal reasons|6|||
30737782|NCT00349752|58749132|FG001|Overall Study|Personal reasons|5|||
30737783|NCT00349752|58749131|FG000|Overall Study|Other: Required exclusionary medication|0|||
30737784|NCT00349752|58749132|FG001|Overall Study|Other: Required exclusionary medication|1|||
30737785|NCT00349752|58749131|FG000|Overall Study|Other: Non compliance|0|||
30737786|NCT00349752|58749132|FG001|Overall Study|Other: Non compliance|1|||
30737787|NCT00349752|58749131|FG000|Overall Study|Other: Patient stopped steroids|0|||
30737788|NCT00349752|58749132|FG001|Overall Study|Other: Patient stopped steroids|1|||
30790969|NCT00151996|58804114|FG001|Overall Study|Sponsor's decision|2|||
30901044|NCT02087943|58934636|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
30901045|NCT02087943|58934637|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
30737789|NCT00349752|58749131|FG000|Overall Study|Other: Patient's steroid use|1|||
30737790|NCT00349752|58749132|FG001|Overall Study|Other: Patient's steroid use|0|||
30737791|NCT00349752|58749131|FG000|Overall Study|Other: Ineligible|1|||
30737792|NCT00349752|58749132|FG001|Overall Study|Other: Ineligible|0|||
30737793|NCT00349752|58749131|FG000|Overall Study|Other: Inadvertently unblinded|1|||
30737794|NCT00349752|58749132|FG001|Overall Study|Other: Inadvertently unblinded|0|||
30737795|NCT00349752|58749131|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
30737796|NCT00349752|58749132|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
30737797|NCT00174460|58749140|FG000|Overall Study|Withdrawal by Subject|0|||
30737798|NCT00174460|58749141|FG001|Overall Study|Withdrawal by Subject|1|||
30737799|NCT00348816|58749148|FG000|Overall Study|Noncompliance with radiation treatment|1|||
30737800|NCT00265083|58749157|FG000|Overall Study|Adverse Event|5|||
30737801|NCT00265083|58749158|FG001|Overall Study|Adverse Event|13|||
30737802|NCT00265083|58749159|FG002|Overall Study|Adverse Event|15|||
30737803|NCT00265083|58749157|FG000|Overall Study|Lost to Follow-up|3|||
30737804|NCT00265083|58749158|FG001|Overall Study|Lost to Follow-up|4|||
30737805|NCT00265083|58749159|FG002|Overall Study|Lost to Follow-up|4|||
30737806|NCT00265083|58749157|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
30737807|NCT00265083|58749158|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
30737808|NCT00265083|58749159|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
30737809|NCT00265083|58749157|FG000|Overall Study|Other|1|||
30901046|NCT02087943|58934633|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
30901047|NCT02087943|58934634|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
30901048|NCT02087943|58934635|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
30901049|NCT02087943|58934636|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
30901050|NCT02087943|58934637|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
30901051|NCT02087943|58934633|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
30901052|NCT02087943|58934634|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
30901053|NCT02087943|58934635|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
30901054|NCT02087943|58934636|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
30901055|NCT02087943|58934637|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
30737810|NCT00265083|58749158|FG001|Overall Study|Other|12|||
30737811|NCT00265083|58749159|FG002|Overall Study|Other|9|||
30737812|NCT00264849|58749170|FG000|Overall Study|Adverse Event|7|||
30737813|NCT00264849|58749171|FG001|Overall Study|Adverse Event|2|||
30737814|NCT00264849|58749170|FG000|Overall Study|Withdrawal by Subject|7|||
30737815|NCT00264849|58749171|FG001|Overall Study|Withdrawal by Subject|11|||
30737816|NCT00264849|58749170|FG000|Overall Study|Protocol Violation|5|||
30737817|NCT00264849|58749171|FG001|Overall Study|Protocol Violation|3|||
30737818|NCT00264849|58749170|FG000|Overall Study|Lack of Efficacy|1|||
30737819|NCT00264849|58749171|FG001|Overall Study|Lack of Efficacy|6|||
30737820|NCT00264849|58749170|FG000|Overall Study|Lost to Follow-up|0|||
30737821|NCT00264849|58749171|FG001|Overall Study|Lost to Follow-up|2|||
30737822|NCT00264849|58749170|FG000|Overall Study|Death|0|||
30737823|NCT00264849|58749171|FG001|Overall Study|Death|1|||
30737824|NCT00264849|58749170|FG000|Overall Study|Administrative Problems|2|||
30737825|NCT00264849|58749171|FG001|Overall Study|Administrative Problems|0|||
30737826|NCT00211809|58749177|FG000|Overall Study|Lack of Efficacy|1|||
30737827|NCT00211809|58749177|FG000|Overall Study|Lost to Follow-up|2|||
30737828|NCT00211809|58749177|FG000|Overall Study|Pregnancy|1|||
30901056|NCT02087943|58934633|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
30901057|NCT02087943|58934634|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
30901058|NCT02087943|58934635|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
30901059|NCT02087943|58934636|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
30901060|NCT02087943|58934637|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
30737829|NCT00211809|58749177|FG000|Overall Study|side effects|2|||
30737830|NCT00129766|58749185|FG000|Overall Study|Death|3|||
30737831|NCT00129766|58749186|FG001|Overall Study|Death|8|||
30737832|NCT00129766|58749185|FG000|Overall Study|Withdrawal of consent|31|||
30901061|NCT02029521|58934651|FG000|Overall Study|Protocol Violation|1|||
30901062|NCT02029521|58934652|FG001|Overall Study|Protocol Violation|0|||
30901063|NCT02029521|58934651|FG000|Overall Study|Withdrawal by Subject|1|||
30737833|NCT00129766|58749186|FG001|Overall Study|Withdrawal of consent|30|||
30737834|NCT00129766|58749185|FG000|Overall Study|Lost to Follow-up|26|||
30737835|NCT00129766|58749186|FG001|Overall Study|Lost to Follow-up|21|||
30737836|NCT00150592|58749195|FG000|Overall Study|Adverse Event|4|||
30737837|NCT00150592|58749196|FG001|Overall Study|Adverse Event|1|||
30737838|NCT00150592|58749195|FG000|Overall Study|Protocol Violation|1|||
30737839|NCT00150592|58749196|FG001|Overall Study|Protocol Violation|0|||
30737840|NCT00150592|58749195|FG000|Overall Study|Withdrawal by Subject|1|||
30901064|NCT02029521|58934652|FG001|Overall Study|Withdrawal by Subject|1|||
30901065|NCT02443883|58934673|FG000|Overall Study|Adverse Event|0|||
30737841|NCT00150592|58749196|FG001|Overall Study|Withdrawal by Subject|2|||
30901066|NCT02443883|58934674|FG001|Overall Study|Adverse Event|1|||
30901067|NCT02443883|58934675|FG002|Overall Study|Adverse Event|0|||
30737842|NCT00150592|58749195|FG000|Overall Study|Non-compliance|1|||
30737843|NCT00150592|58749196|FG001|Overall Study|Non-compliance|0|||
30737844|NCT00149890|58749204|FG000|Overall Study|Adverse Event|1|||
30737845|NCT00149890|58749205|FG001|Overall Study|Adverse Event|8|||
30737846|NCT00149890|58749204|FG000|Overall Study|Lack of Efficacy|8|||
30737847|NCT00149890|58749205|FG001|Overall Study|Lack of Efficacy|9|||
30737848|NCT00149890|58749204|FG000|Overall Study|Protocol Violation|1|||
30737849|NCT00149890|58749205|FG001|Overall Study|Protocol Violation|0|||
30737850|NCT00149890|58749204|FG000|Overall Study|Lost to Follow-up|1|||
30737851|NCT00149890|58749205|FG001|Overall Study|Lost to Follow-up|0|||
30737852|NCT00149890|58749204|FG000|Overall Study|Graft Loss|2|||
30737853|NCT00149890|58749205|FG001|Overall Study|Graft Loss|1|||
30737854|NCT00174382|58749211|FG000|Overall Study|Death|2|||
30737855|NCT00174382|58749211|FG000|Overall Study|Adverse Event|19|||
30737856|NCT00174382|58749211|FG000|Overall Study|Withdrawal by Subject|6|||
30737857|NCT00174382|58749211|FG000|Overall Study|Protocol Violation|3|||
30737858|NCT00174382|58749211|FG000|Overall Study|Arrived early for last visit in error|1|||
30737859|NCT00174382|58749211|FG000|Overall Study|Subject felt pill not effective enough|1|||
30737860|NCT00174382|58749211|FG000|Overall Study|Lost to Follow-up|1|||
30737861|NCT00355134|58749220|FG000|Core Phase|Withdrawal by Subject|35|||
30737862|NCT00355134|58749221|FG001|Core Phase|Withdrawal by Subject|24|||
30737863|NCT00355134|58749222|FG002|Core Phase|Withdrawal by Subject|35|||
30737864|NCT00355134|58749223|FG003|Core Phase|Withdrawal by Subject|0|||
30737865|NCT00355134|58749224|FG004|Core Phase|Withdrawal by Subject|0|||
30737866|NCT00355134|58749220|FG000|Core Phase|Adverse Event|28|||
30737867|NCT00355134|58749221|FG001|Core Phase|Adverse Event|22|||
30737868|NCT00355134|58749222|FG002|Core Phase|Adverse Event|16|||
30737869|NCT00355134|58749223|FG003|Core Phase|Adverse Event|0|||
30737870|NCT00355134|58749224|FG004|Core Phase|Adverse Event|0|||
30737871|NCT00355134|58749220|FG000|Core Phase|Lost to Follow-up|17|||
30737872|NCT00355134|58749221|FG001|Core Phase|Lost to Follow-up|13|||
30737873|NCT00355134|58749222|FG002|Core Phase|Lost to Follow-up|21|||
30737874|NCT00355134|58749223|FG003|Core Phase|Lost to Follow-up|0|||
30737875|NCT00355134|58749224|FG004|Core Phase|Lost to Follow-up|0|||
30737876|NCT00355134|58749220|FG000|Core Phase|Abnormal laboratory value(s)|19|||
30737877|NCT00355134|58749221|FG001|Core Phase|Abnormal laboratory value(s)|14|||
30737878|NCT00355134|58749222|FG002|Core Phase|Abnormal laboratory value(s)|2|||
30737879|NCT00355134|58749223|FG003|Core Phase|Abnormal laboratory value(s)|0|||
30737880|NCT00355134|58749224|FG004|Core Phase|Abnormal laboratory value(s)|0|||
30737881|NCT00355134|58749220|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
30737882|NCT00355134|58749221|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
30737883|NCT00355134|58749222|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
30737884|NCT00355134|58749223|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
30737885|NCT00355134|58749224|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
30737886|NCT00355134|58749220|FG000|Core Phase|Administrative problems|5|||
30737887|NCT00355134|58749221|FG001|Core Phase|Administrative problems|3|||
30737888|NCT00355134|58749222|FG002|Core Phase|Administrative problems|5|||
30737889|NCT00355134|58749223|FG003|Core Phase|Administrative problems|0|||
30737890|NCT00355134|58749224|FG004|Core Phase|Administrative problems|0|||
30737891|NCT00355134|58749220|FG000|Core Phase|Protocol Violation|3|||
30737892|NCT00355134|58749221|FG001|Core Phase|Protocol Violation|2|||
30737893|NCT00355134|58749222|FG002|Core Phase|Protocol Violation|2|||
30737894|NCT00355134|58749223|FG003|Core Phase|Protocol Violation|0|||
30737895|NCT00355134|58749224|FG004|Core Phase|Protocol Violation|0|||
30737896|NCT00355134|58749220|FG000|Core Phase|Abnormal test procedure result(s)|1|||
30737897|NCT00355134|58749221|FG001|Core Phase|Abnormal test procedure result(s)|2|||
30737898|NCT00355134|58749222|FG002|Core Phase|Abnormal test procedure result(s)|1|||
30737899|NCT00355134|58749223|FG003|Core Phase|Abnormal test procedure result(s)|0|||
30737900|NCT00355134|58749224|FG004|Core Phase|Abnormal test procedure result(s)|0|||
30737901|NCT00355134|58749220|FG000|Core Phase|Condition no longer requires study drug|1|||
30737902|NCT00355134|58749221|FG001|Core Phase|Condition no longer requires study drug|0|||
30737903|NCT00355134|58749222|FG002|Core Phase|Condition no longer requires study drug|1|||
30737904|NCT00355134|58749223|FG003|Core Phase|Condition no longer requires study drug|0|||
30737905|NCT00355134|58749224|FG004|Core Phase|Condition no longer requires study drug|0|||
30737906|NCT00355134|58749220|FG000|Extension Phase|Withdrawal by Subject|7|||
30737907|NCT00355134|58749221|FG001|Extension Phase|Withdrawal by Subject|11|||
30737908|NCT00355134|58749222|FG002|Extension Phase|Withdrawal by Subject|0|||
30737909|NCT00355134|58749223|FG003|Extension Phase|Withdrawal by Subject|7|||
30737910|NCT00355134|58749224|FG004|Extension Phase|Withdrawal by Subject|5|||
30737911|NCT00355134|58749220|FG000|Extension Phase|Adverse Event|13|||
30737912|NCT00355134|58749221|FG001|Extension Phase|Adverse Event|9|||
30901068|NCT02443883|58934676|FG003|Overall Study|Adverse Event|0|||
30737913|NCT00355134|58749222|FG002|Extension Phase|Adverse Event|0|||
30737914|NCT00355134|58749223|FG003|Extension Phase|Adverse Event|3|||
30901069|NCT02443883|58934673|FG000|Overall Study|Lost to Follow-up|3|||
30737915|NCT00355134|58749224|FG004|Extension Phase|Adverse Event|5|||
30737916|NCT00355134|58749220|FG000|Extension Phase|Lost to Follow-up|2|||
30737917|NCT00355134|58749221|FG001|Extension Phase|Lost to Follow-up|6|||
30737918|NCT00355134|58749222|FG002|Extension Phase|Lost to Follow-up|0|||
30737919|NCT00355134|58749223|FG003|Extension Phase|Lost to Follow-up|2|||
30737920|NCT00355134|58749224|FG004|Extension Phase|Lost to Follow-up|4|||
30737921|NCT00355134|58749220|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
30737922|NCT00355134|58749221|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
30737923|NCT00355134|58749222|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
30737924|NCT00355134|58749223|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
30737925|NCT00355134|58749224|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
30737926|NCT00355134|58749220|FG000|Extension Phase|Administrative problems|2|||
30737927|NCT00355134|58749221|FG001|Extension Phase|Administrative problems|4|||
30901070|NCT02443883|58934674|FG001|Overall Study|Lost to Follow-up|2|||
30737928|NCT00355134|58749222|FG002|Extension Phase|Administrative problems|0|||
30737929|NCT00355134|58749223|FG003|Extension Phase|Administrative problems|1|||
30737930|NCT00355134|58749224|FG004|Extension Phase|Administrative problems|1|||
30737931|NCT00355134|58749220|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
30737932|NCT00355134|58749221|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
30737933|NCT00355134|58749222|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
30737934|NCT00355134|58749223|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
30737935|NCT00355134|58749224|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
30737936|NCT00355134|58749220|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
30737937|NCT00355134|58749221|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
30737938|NCT00355134|58749222|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
30737939|NCT00355134|58749223|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
30737940|NCT00355134|58749224|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
30737941|NCT00355134|58749220|FG000|Extension Phase|Protocol Violation|0|||
30737942|NCT00355134|58749221|FG001|Extension Phase|Protocol Violation|0|||
30737943|NCT00355134|58749222|FG002|Extension Phase|Protocol Violation|0|||
30737944|NCT00355134|58749223|FG003|Extension Phase|Protocol Violation|1|||
30737945|NCT00355134|58749224|FG004|Extension Phase|Protocol Violation|0|||
30737946|NCT00171730|58749234|FG000|Overall Study|Adverse Event|3|||
30737947|NCT00171730|58749234|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
30737948|NCT00171730|58749234|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
30737949|NCT00171730|58749234|FG000|Overall Study|Withdrawal by Subject|3|||
30737950|NCT00355056|58749246|FG000|Randomization Period|Early Termination|4|||
30737951|NCT00355056|58749247|FG001|Randomization Period|Early Termination|6|||
30737952|NCT00348348|58749263|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
30737953|NCT00348348|58749264|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
30737954|NCT00348348|58749263|FG000|Overall Study|Lack of Efficacy|1|||
30737955|NCT00348348|58749264|FG001|Overall Study|Lack of Efficacy|1|||
30737956|NCT00348348|58749263|FG000|Overall Study|Lost to Follow-up|8|||
30737957|NCT00348348|58749264|FG001|Overall Study|Lost to Follow-up|10|||
30737958|NCT00348348|58749263|FG000|Overall Study|Withdrawal by Subject|4|||
30737959|NCT00348348|58749264|FG001|Overall Study|Withdrawal by Subject|1|||
30737960|NCT00348348|58749263|FG000|Overall Study|Other|7|||
30737961|NCT00348348|58749264|FG001|Overall Study|Other|4|||
30737962|NCT00348348|58749263|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
30737963|NCT00348348|58749264|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
30737964|NCT00348348|58749263|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
30901071|NCT02443883|58934675|FG002|Overall Study|Lost to Follow-up|1|||
30901072|NCT02443883|58934676|FG003|Overall Study|Lost to Follow-up|0|||
30737965|NCT00348348|58749264|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
30737966|NCT00348348|58749263|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
30901073|NCT02443883|58934673|FG000|Overall Study|Physician Decision|1|||
30901074|NCT02443883|58934674|FG001|Overall Study|Physician Decision|1|||
30737967|NCT00348348|58749264|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
30737968|NCT00348348|58749263|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
30737969|NCT00348348|58749264|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
30737970|NCT00348348|58749263|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
30737971|NCT00348348|58749264|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
30737972|NCT00348348|58749263|FG000|Overall Study|Adverse event probably related to study|1|||
30737973|NCT00348348|58749264|FG001|Overall Study|Adverse event probably related to study|0|||
30737974|NCT00347958|58749270|FG000|Overall Study|Adverse Event|1|||
30737975|NCT00347958|58749270|FG000|Overall Study|Protocol Violation|2|||
30737976|NCT00347958|58749270|FG000|Overall Study|Withdrawal by Subject|1|||
30737977|NCT00354744|58749274|FG000|Overall Study|Adverse Event|2|||
30737978|NCT00354744|58749274|FG000|Overall Study|Death|2|||
30737979|NCT00354744|58749274|FG000|Overall Study|Lack of Efficacy|11|||
30737980|NCT00354744|58749274|FG000|Overall Study|Lost to Follow-up|2|||
30901075|NCT02443883|58934675|FG002|Overall Study|Physician Decision|0|||
30737981|NCT00354744|58749274|FG000|Overall Study|Physician Decision|11|||
30737982|NCT00354744|58749274|FG000|Overall Study|Withdrawal by Subject|14|||
30737983|NCT00373256|58749282|FG000|Overall Study|Adverse Event (AE)|1|||
30737984|NCT00373256|58749283|FG001|Overall Study|Adverse Event (AE)|5|||
30737985|NCT00373256|58749282|FG000|Overall Study|Lost to Follow-up|2|||
30737986|NCT00373256|58749283|FG001|Overall Study|Lost to Follow-up|1|||
30737987|NCT00373256|58749282|FG000|Overall Study|Death|9|||
30737988|NCT00373256|58749283|FG001|Overall Study|Death|8|||
30737989|NCT00373256|58749282|FG000|Overall Study|Objective Progression or Relapse|111|||
30737990|NCT00373256|58749283|FG001|Overall Study|Objective Progression or Relapse|104|||
30737991|NCT00373256|58749282|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
30737992|NCT00373256|58749283|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
30737993|NCT00373256|58749282|FG000|Overall Study|Other|73|||
30737994|NCT00373256|58749283|FG001|Overall Study|Other|107|||
30737995|NCT00373256|58749282|FG000|Overall Study|Protocol Violation|0|||
30737996|NCT00373256|58749283|FG001|Overall Study|Protocol Violation|2|||
30737997|NCT00373256|58749282|FG000|Overall Study|Study Terminated by Sponsor|41|||
30737998|NCT00373256|58749283|FG001|Overall Study|Study Terminated by Sponsor|13|||
30737999|NCT00394082|58749289|FG000|Overall Study|Unacceptable toxicity|15|||
30738000|NCT00394082|58749289|FG000|Overall Study|Adverse Event|4|||
30738001|NCT00394082|58749289|FG000|Overall Study|Physician Decision|4|||
30738002|NCT00394082|58749289|FG000|Overall Study|Withdrawal by Subject|2|||
30738003|NCT00394082|58749289|FG000|Overall Study|Other|1|||
30738004|NCT00393848|58749297|FG000|Overall Study|Surgical schedule|0|||
30738005|NCT00393848|58749298|FG001|Overall Study|Surgical schedule|0|||
30738006|NCT00393848|58749299|FG002|Overall Study|Surgical schedule|0|||
30738007|NCT00393848|58749300|FG003|Overall Study|Surgical schedule|1|||
30738008|NCT00393848|58749297|FG000|Overall Study|Personal reasons|0|||
30738009|NCT00393848|58749298|FG001|Overall Study|Personal reasons|0|||
30738010|NCT00393848|58749299|FG002|Overall Study|Personal reasons|2|||
30738011|NCT00393848|58749300|FG003|Overall Study|Personal reasons|0|||
30738012|NCT00393458|58749315|FG000|Overall Study|Adverse Event|35|||
30738013|NCT00393458|58749316|FG001|Overall Study|Adverse Event|24|||
30738014|NCT00393458|58749317|FG002|Overall Study|Adverse Event|40|||
30738015|NCT00393458|58749318|FG003|Overall Study|Adverse Event|35|||
30738016|NCT00393458|58749315|FG000|Overall Study|Subject withdrew consent|27|||
30738017|NCT00393458|58749316|FG001|Overall Study|Subject withdrew consent|40|||
30738018|NCT00393458|58749317|FG002|Overall Study|Subject withdrew consent|33|||
30738019|NCT00393458|58749318|FG003|Overall Study|Subject withdrew consent|50|||
30738020|NCT00393458|58749315|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
30738021|NCT00393458|58749316|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
30738022|NCT00393458|58749317|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
30738023|NCT00393458|58749318|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
30738024|NCT00393458|58749315|FG000|Overall Study|Protocol deviation|11|||
30738025|NCT00393458|58749316|FG001|Overall Study|Protocol deviation|11|||
30738026|NCT00393458|58749317|FG002|Overall Study|Protocol deviation|11|||
30738027|NCT00393458|58749318|FG003|Overall Study|Protocol deviation|10|||
30738028|NCT00393458|58749315|FG000|Overall Study|Administrative problems|7|||
30738029|NCT00393458|58749316|FG001|Overall Study|Administrative problems|8|||
30738030|NCT00393458|58749317|FG002|Overall Study|Administrative problems|5|||
30738031|NCT00393458|58749318|FG003|Overall Study|Administrative problems|2|||
30738032|NCT00393458|58749315|FG000|Overall Study|Lost to Follow-up|5|||
30738033|NCT00393458|58749316|FG001|Overall Study|Lost to Follow-up|6|||
30738034|NCT00393458|58749317|FG002|Overall Study|Lost to Follow-up|5|||
30738035|NCT00393458|58749318|FG003|Overall Study|Lost to Follow-up|3|||
30738036|NCT00393458|58749315|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30738037|NCT00393458|58749316|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30738038|NCT00393458|58749317|FG002|Overall Study|Abnormal laboratory value(s)|0|||
30738039|NCT00393458|58749318|FG003|Overall Study|Abnormal laboratory value(s)|0|||
30738040|NCT00393458|58749315|FG000|Overall Study|Death|1|||
30738041|NCT00393458|58749316|FG001|Overall Study|Death|1|||
30738042|NCT00393458|58749317|FG002|Overall Study|Death|5|||
30738043|NCT00393458|58749318|FG003|Overall Study|Death|5|||
30738044|NCT00393458|58749315|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30738045|NCT00393458|58749316|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30738046|NCT00393458|58749317|FG002|Overall Study|Abnormal test procedure result(s)|1|||
30738047|NCT00393458|58749318|FG003|Overall Study|Abnormal test procedure result(s)|2|||
30738048|NCT00393458|58749315|FG000|Overall Study|Subject no longer requires study drug|0|||
30738049|NCT00393458|58749316|FG001|Overall Study|Subject no longer requires study drug|1|||
30738050|NCT00393458|58749317|FG002|Overall Study|Subject no longer requires study drug|0|||
30738051|NCT00393458|58749318|FG003|Overall Study|Subject no longer requires study drug|0|||
30738052|NCT00417482|58749331|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
30738053|NCT00417482|58749332|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
30901076|NCT02443883|58934676|FG003|Overall Study|Physician Decision|3|||
30901077|NCT02443883|58934673|FG000|Overall Study|Withdrawal by Subject|1|||
30901078|NCT02443883|58934674|FG001|Overall Study|Withdrawal by Subject|0|||
30901079|NCT02443883|58934675|FG002|Overall Study|Withdrawal by Subject|0|||
30901080|NCT02443883|58934676|FG003|Overall Study|Withdrawal by Subject|2|||
30901081|NCT02443883|58934673|FG000|Overall Study|Randomized, but never treated|1|||
30901082|NCT02443883|58934674|FG001|Overall Study|Randomized, but never treated|0|||
30901083|NCT02443883|58934675|FG002|Overall Study|Randomized, but never treated|0|||
30901084|NCT02443883|58934676|FG003|Overall Study|Randomized, but never treated|0|||
30901085|NCT02460263|58934686|FG000|Transition Period|Withdrawal by Subject|1|||
30901086|NCT02460263|58934686|FG000|Transition Period|Death|1|||
30901087|NCT02443805|58934696|FG000|Overall Study|Adverse Event|100|||
30738054|NCT00417482|58749333|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
30738055|NCT00417482|58749331|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
30738056|NCT00417482|58749332|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
30738057|NCT00417482|58749333|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
30738058|NCT00417482|58749331|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
30738059|NCT00417482|58749332|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
30738060|NCT00417482|58749333|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
30738061|NCT00417482|58749331|FG000|Phase B 1st 16 Weeks|Death|1|||
30738062|NCT00417482|58749332|FG001|Phase B 1st 16 Weeks|Death|0|||
30738063|NCT00417482|58749333|FG002|Phase B 1st 16 Weeks|Death|0|||
30738064|NCT00417482|58749331|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
30738065|NCT00417482|58749332|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
30738066|NCT00417482|58749333|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
30738067|NCT00417482|58749331|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
30738068|NCT00417482|58749332|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
30738069|NCT00417482|58749333|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
30738070|NCT00417482|58749331|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
30738071|NCT00417482|58749332|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
30738072|NCT00417482|58749333|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
30738073|NCT00417482|58749331|FG000|Phase B 2nd 16 Weeks|Death|1|||
30738074|NCT00417482|58749332|FG001|Phase B 2nd 16 Weeks|Death|1|||
30738075|NCT00417482|58749333|FG002|Phase B 2nd 16 Weeks|Death|0|||
30738076|NCT00417248|58749347|FG000|Overall Study|Study Terminated|6|||
30738077|NCT00417248|58749347|FG000|Overall Study|Death|1|||
30738078|NCT00417248|58749347|FG000|Overall Study|Lack of Efficacy|1|||
30738079|NCT00392288|58749355|FG000|Overall Study|Adverse Event|17|||
30738080|NCT00392288|58749356|FG001|Overall Study|Adverse Event|7|||
30738081|NCT00392288|58749357|FG002|Overall Study|Adverse Event|8|||
30738082|NCT00392288|58749355|FG000|Overall Study|Lack of Efficacy|8|||
30738083|NCT00392288|58749356|FG001|Overall Study|Lack of Efficacy|5|||
30738084|NCT00392288|58749357|FG002|Overall Study|Lack of Efficacy|3|||
30738085|NCT00392288|58749355|FG000|Overall Study|Protocol Violation|1|||
30738086|NCT00392288|58749356|FG001|Overall Study|Protocol Violation|3|||
30738087|NCT00392288|58749357|FG002|Overall Study|Protocol Violation|1|||
30738088|NCT00392288|58749355|FG000|Overall Study|Lost to Follow-up|1|||
30738089|NCT00392288|58749356|FG001|Overall Study|Lost to Follow-up|1|||
30738090|NCT00392288|58749357|FG002|Overall Study|Lost to Follow-up|1|||
30738091|NCT00392288|58749355|FG000|Overall Study|Withdrawal by Subject|1|||
30738092|NCT00392288|58749356|FG001|Overall Study|Withdrawal by Subject|0|||
30738093|NCT00392288|58749357|FG002|Overall Study|Withdrawal by Subject|2|||
30738094|NCT00392288|58749355|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
30738095|NCT00392288|58749356|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
30738096|NCT00392288|58749357|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
30738097|NCT00392288|58749355|FG000|Overall Study|Other|3|||
30738098|NCT00392288|58749356|FG001|Overall Study|Other|4|||
30738099|NCT00392288|58749357|FG002|Overall Study|Other|1|||
30901088|NCT02443805|58934697|FG001|Overall Study|Adverse Event|18|||
30738100|NCT00417170|58749367|FG000|Overall Study|Adverse Event|1|||
30738101|NCT00417170|58749368|FG001|Overall Study|Adverse Event|1|||
30738102|NCT00417170|58749367|FG000|Overall Study|Withdrawal by Subject|1|||
30901089|NCT02443805|58934696|FG000|Overall Study|Withdrawal by Subject|73|||
30901090|NCT02443805|58934697|FG001|Overall Study|Withdrawal by Subject|74|||
30790970|NCT00830206|58804122|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
30790971|NCT00830206|58804123|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
30790972|NCT00829504|58804129|FG000|First Intervention|Adverse Event|1|||
30738103|NCT00417170|58749368|FG001|Overall Study|Withdrawal by Subject|1|||
30738104|NCT00417170|58749367|FG000|Overall Study|Lost to Follow-up|0|||
30738105|NCT00417170|58749368|FG001|Overall Study|Lost to Follow-up|1|||
30738106|NCT00392990|58749376|FG000|Treatment on Study|Adverse Event|3|||
30738107|NCT00392990|58749377|FG001|Treatment on Study|Adverse Event|1|||
30738108|NCT00392990|58749376|FG000|Follow up for 2 Years|Death|4|||
30738109|NCT00392990|58749377|FG001|Follow up for 2 Years|Death|0|||
30738110|NCT00249873|58749385|FG000|Overall Study|Not treated|7|||
30738111|NCT00249873|58749386|FG001|Overall Study|Not treated|8|||
30738112|NCT00249873|58749385|FG000|Overall Study|Significant thrombocytopenia|9|||
30738113|NCT00249873|58749386|FG001|Overall Study|Significant thrombocytopenia|8|||
30738114|NCT00249873|58749385|FG000|Overall Study|Severe allergic reaction|8|||
30738115|NCT00249873|58749386|FG001|Overall Study|Severe allergic reaction|1|||
30738116|NCT00249873|58749385|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
30738117|NCT00249873|58749386|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
30738118|NCT00249873|58749385|FG000|Overall Study|Other Serious Adverse Event|86|||
30738119|NCT00249873|58749386|FG001|Overall Study|Other Serious Adverse Event|97|||
30738120|NCT00249873|58749385|FG000|Overall Study|Qualifying condition not present|20|||
30738121|NCT00249873|58749386|FG001|Overall Study|Qualifying condition not present|23|||
30738122|NCT00249873|58749385|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
30738123|NCT00249873|58749386|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
30738124|NCT00249873|58749385|FG000|Overall Study|Withdrawal by Subject|504|||
30738125|NCT00249873|58749386|FG001|Overall Study|Withdrawal by Subject|466|||
30738126|NCT00249873|58749385|FG000|Overall Study|Lost to Follow-up|4|||
30738127|NCT00249873|58749386|FG001|Overall Study|Lost to Follow-up|7|||
30738128|NCT00249873|58749385|FG000|Overall Study|Minor bleeding|99|||
30738129|NCT00249873|58749386|FG001|Overall Study|Minor bleeding|37|||
30738130|NCT00249873|58749385|FG000|Overall Study|Non-compliance|41|||
30738131|NCT00249873|58749386|FG001|Overall Study|Non-compliance|46|||
30738132|NCT00249873|58749385|FG000|Overall Study|Other non serious Adverse Event|112|||
30901091|NCT02443805|58934696|FG000|Overall Study|Lost to Follow-up|19|||
30901092|NCT02443805|58934697|FG001|Overall Study|Lost to Follow-up|14|||
30901093|NCT02443805|58934696|FG000|Overall Study|Pregnancy|6|||
30901094|NCT02443805|58934697|FG001|Overall Study|Pregnancy|5|||
30901095|NCT02443805|58934696|FG000|Overall Study|Protocol Violation|2|||
30901096|NCT02443805|58934697|FG001|Overall Study|Protocol Violation|4|||
30901097|NCT02443805|58934696|FG000|Overall Study|Lack of Efficacy|1|||
30738133|NCT00249873|58749386|FG001|Overall Study|Other non serious Adverse Event|108|||
30738134|NCT00249873|58749385|FG000|Overall Study|Other contraindicated medication|1|||
30738135|NCT00249873|58749386|FG001|Overall Study|Other contraindicated medication|0|||
30738136|NCT00249873|58749385|FG000|Overall Study|Patient not wish to continue after May08|3|||
30738137|NCT00249873|58749386|FG001|Overall Study|Patient not wish to continue after May08|4|||
30738138|NCT00249873|58749385|FG000|Overall Study|Physician withdrew consent|59|||
30738139|NCT00249873|58749386|FG001|Overall Study|Physician withdrew consent|60|||
30738140|NCT00249873|58749385|FG000|Overall Study|Open label clopidogrel required|31|||
30738141|NCT00249873|58749386|FG001|Overall Study|Open label clopidogrel required|42|||
30738142|NCT00249873|58749385|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
30738143|NCT00249873|58749386|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
30738144|NCT00249873|58749385|FG000|Overall Study|Oral anticoagulant required|159|||
30738145|NCT00249873|58749386|FG001|Overall Study|Oral anticoagulant required|157|||
30738146|NCT00249873|58749385|FG000|Overall Study|Study drug intolerance|5|||
30738147|NCT00249873|58749386|FG001|Overall Study|Study drug intolerance|0|||
30738148|NCT00249873|58749385|FG000|Overall Study|Surgery/ procedure|9|||
30738149|NCT00249873|58749386|FG001|Overall Study|Surgery/ procedure|9|||
30738150|NCT00249873|58749385|FG000|Overall Study|Event related to cardiac condition|12|||
30738151|NCT00249873|58749386|FG001|Overall Study|Event related to cardiac condition|21|||
30738152|NCT00249873|58749385|FG000|Overall Study|Thromboembolic/outcome event|82|||
30738153|NCT00249873|58749386|FG001|Overall Study|Thromboembolic/outcome event|122|||
30621859|NCT01180049|58633415|FG000|Overall Study|Death|36|||
30738154|NCT00392210|58749394|FG000|First Voiding Trial|Physician Decision|2|||
30738155|NCT00392210|58749395|FG001|First Voiding Trial|Physician Decision|2|||
30738156|NCT00391976|58749404|FG000|Overall Study|Adverse Event|0|||
30738157|NCT00391976|58749405|FG001|Overall Study|Adverse Event|0|||
30738158|NCT00391976|58749406|FG002|Overall Study|Adverse Event|1|||
30738159|NCT00391976|58749404|FG000|Overall Study|Withdrawal of consent|0|||
30738160|NCT00391976|58749405|FG001|Overall Study|Withdrawal of consent|1|||
30738161|NCT00391976|58749406|FG002|Overall Study|Withdrawal of consent|1|||
30738162|NCT00391976|58749404|FG000|Overall Study|Lost to Follow-up|1|||
30738163|NCT00391976|58749405|FG001|Overall Study|Lost to Follow-up|2|||
30738164|NCT00391976|58749406|FG002|Overall Study|Lost to Follow-up|0|||
30738165|NCT00391976|58749404|FG000|Overall Study|Inappropriate enrollment|1|||
30738166|NCT00391976|58749405|FG001|Overall Study|Inappropriate enrollment|1|||
30738167|NCT00391976|58749406|FG002|Overall Study|Inappropriate enrollment|0|||
30901098|NCT02443805|58934697|FG001|Overall Study|Lack of Efficacy|1|||
30901099|NCT02443805|58934696|FG000|Overall Study|Non-compliance with study drug|6|||
30738168|NCT00391976|58749404|FG000|Overall Study|Protocol deviation/violation|4|||
30901100|NCT02443805|58934697|FG001|Overall Study|Non-compliance with study drug|4|||
30738169|NCT00391976|58749405|FG001|Overall Study|Protocol deviation/violation|2|||
30738170|NCT00391976|58749406|FG002|Overall Study|Protocol deviation/violation|1|||
30738171|NCT00391976|58749404|FG000|Overall Study|Recurrence/no eradication of infection|21|||
30738172|NCT00391976|58749405|FG001|Overall Study|Recurrence/no eradication of infection|19|||
30738173|NCT00391976|58749406|FG002|Overall Study|Recurrence/no eradication of infection|0|||
30738174|NCT00391976|58749404|FG000|Overall Study|Unable to classify|0|||
30738175|NCT00391976|58749405|FG001|Overall Study|Unable to classify|0|||
30738176|NCT00391976|58749406|FG002|Overall Study|Unable to classify|1|||
30738177|NCT00391976|58749404|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
30738178|NCT00391976|58749405|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
30738179|NCT00391976|58749406|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
30738180|NCT00391898|58749418|FG000|Overall Study|Adverse Event|3|||
30738181|NCT00391898|58749419|FG001|Overall Study|Adverse Event|0|||
30738182|NCT00391898|58749418|FG000|Overall Study|Other|8|||
30738183|NCT00391898|58749419|FG001|Overall Study|Other|10|||
30738184|NCT00391586|58749425|FG000|Overall Study|Progressive disease|13|||
30738185|NCT00391586|58749425|FG000|Overall Study|Adverse Event|5|||
30738186|NCT00391586|58749425|FG000|Overall Study|Physician Decision|2|||
30738187|NCT00391586|58749425|FG000|Overall Study|Death|4|||
30738188|NCT00391430|58749432|FG000|Overall Study|Withdrawal by Subject|3|||
30738189|NCT00391430|58749433|FG001|Overall Study|Withdrawal by Subject|0|||
30738190|NCT00391430|58749434|FG002|Overall Study|Withdrawal by Subject|12|||
30738191|NCT00391274|58749444|FG000|Overall Study|Death Due to Study Disease|55|||
30738192|NCT00391274|58749445|FG001|Overall Study|Death Due to Study Disease|45|||
30738193|NCT00391274|58749444|FG000|Overall Study|Lost to Follow-up|0|||
30738194|NCT00391274|58749445|FG001|Overall Study|Lost to Follow-up|3|||
30738195|NCT00391274|58749444|FG000|Overall Study|Physician Decision|4|||
30738196|NCT00391274|58749445|FG001|Overall Study|Physician Decision|2|||
30738197|NCT00391274|58749444|FG000|Overall Study|Withdrawal by Subject|0|||
30738198|NCT00391274|58749445|FG001|Overall Study|Withdrawal by Subject|3|||
30738199|NCT00391274|58749444|FG000|Overall Study|Death Due to Adverse Event|1|||
30738200|NCT00391274|58749445|FG001|Overall Study|Death Due to Adverse Event|3|||
30738201|NCT00391274|58749444|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
30738202|NCT00391274|58749445|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
30738203|NCT00391274|58749444|FG000|Overall Study|Death Not Study Related|0|||
30738204|NCT00391274|58749445|FG001|Overall Study|Death Not Study Related|1|||
30738205|NCT00391118|58749454|FG000|Overall Study|Adverse Event|3|||
30738206|NCT00391118|58749455|FG001|Overall Study|Adverse Event|10|||
30738207|NCT00391118|58749456|FG002|Overall Study|Adverse Event|7|||
30738208|NCT00391118|58749454|FG000|Overall Study|Lost to Follow-up|0|||
30738209|NCT00391118|58749455|FG001|Overall Study|Lost to Follow-up|2|||
30738210|NCT00391118|58749456|FG002|Overall Study|Lost to Follow-up|3|||
30738211|NCT00391118|58749454|FG000|Overall Study|Withdrawal by Subject|0|||
30738212|NCT00391118|58749455|FG001|Overall Study|Withdrawal by Subject|9|||
30738213|NCT00391118|58749456|FG002|Overall Study|Withdrawal by Subject|1|||
30738214|NCT00391118|58749454|FG000|Overall Study|Death|0|||
30738215|NCT00391118|58749455|FG001|Overall Study|Death|1|||
30738216|NCT00391118|58749456|FG002|Overall Study|Death|0|||
30738217|NCT00391118|58749454|FG000|Overall Study|Physician Decision|0|||
30738218|NCT00391118|58749455|FG001|Overall Study|Physician Decision|3|||
30738219|NCT00391118|58749456|FG002|Overall Study|Physician Decision|0|||
30738220|NCT00391118|58749454|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
30738221|NCT00391118|58749455|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
30738222|NCT00391118|58749456|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
30738223|NCT00391118|58749454|FG000|Overall Study|Progressive Disease|7|||
30738224|NCT00391118|58749455|FG001|Overall Study|Progressive Disease|26|||
30738225|NCT00391118|58749456|FG002|Overall Study|Progressive Disease|43|||
30738226|NCT00391118|58749454|FG000|Overall Study|Sponsor Decision|0|||
30901101|NCT02443805|58934696|FG000|Overall Study|Withdrawal by parent/guardian|3|||
30901102|NCT02443805|58934697|FG001|Overall Study|Withdrawal by parent/guardian|5|||
30901103|NCT02443805|58934696|FG000|Overall Study|Any other reason not above-mentioned|3|||
30901104|NCT02443805|58934697|FG001|Overall Study|Any other reason not above-mentioned|2|||
30901105|NCT01652885|58934703|FG000|Overall Study|Adverse Event|1|||
30621860|NCT01180049|58633416|FG001|Overall Study|Death|35|||
30738227|NCT00391118|58749455|FG001|Overall Study|Sponsor Decision|1|||
30738228|NCT00391118|58749456|FG002|Overall Study|Sponsor Decision|3|||
30901106|NCT02459951|58934707|FG000|Overall Study|Unable to meet holding requirement|1|||
30738229|NCT00391118|58749454|FG000|Overall Study|Protocol Violation|1|||
30738230|NCT00391118|58749455|FG001|Overall Study|Protocol Violation|0|||
30738231|NCT00391118|58749456|FG002|Overall Study|Protocol Violation|0|||
30738232|NCT00390884|58749469|FG000|Overall Study|Withdrawal by Subject|2|||
30738233|NCT00390884|58749470|FG001|Overall Study|Withdrawal by Subject|2|||
30738234|NCT00365846|58749476|FG000|Overall Study|Lost to Follow-up|1|||
30738235|NCT00264537|58749486|FG000|Overall Study|Death|0|||
30738236|NCT00264537|58749487|FG001|Overall Study|Death|3|||
30738237|NCT00264537|58749488|FG002|Overall Study|Death|3|||
30738238|NCT00264537|58749489|FG003|Overall Study|Death|2|||
30901107|NCT02087241|58934716|FG000|Overall Study|Death|2|||
30901108|NCT02087241|58934717|FG001|Overall Study|Death|1|||
30901109|NCT02087241|58934718|FG002|Overall Study|Death|1|||
30901110|NCT02087241|58934719|FG003|Overall Study|Death|1|||
30901111|NCT02087241|58934716|FG000|Overall Study|Withdrawal by Subject|1|||
30901112|NCT02087241|58934717|FG001|Overall Study|Withdrawal by Subject|0|||
30901113|NCT02087241|58934718|FG002|Overall Study|Withdrawal by Subject|0|||
30901114|NCT02087241|58934719|FG003|Overall Study|Withdrawal by Subject|1|||
30901115|NCT02087241|58934716|FG000|Overall Study|Progressive Disease|0|||
30901116|NCT02087241|58934717|FG001|Overall Study|Progressive Disease|0|||
30901117|NCT02087241|58934718|FG002|Overall Study|Progressive Disease|0|||
30901118|NCT02087241|58934719|FG003|Overall Study|Progressive Disease|1|||
30901119|NCT02087241|58934716|FG000|Overall Study|Study Terminated by Sponsor|0|||
30901120|NCT02087241|58934717|FG001|Overall Study|Study Terminated by Sponsor|2|||
30901121|NCT02087241|58934718|FG002|Overall Study|Study Terminated by Sponsor|0|||
30901122|NCT02087241|58934719|FG003|Overall Study|Study Terminated by Sponsor|4|||
30901123|NCT02087085|58934735|FG000|Overall Study|Adverse Event|10|||
30901124|NCT02087085|58934736|FG001|Overall Study|Adverse Event|14|||
30901125|NCT02087085|58934735|FG000|Overall Study|Lack of Efficacy|4|||
30901126|NCT02087085|58934736|FG001|Overall Study|Lack of Efficacy|3|||
30901127|NCT02087085|58934735|FG000|Overall Study|Lost to Follow-up|6|||
30901128|NCT02087085|58934736|FG001|Overall Study|Lost to Follow-up|4|||
30901129|NCT02087085|58934735|FG000|Overall Study|Withdrawal by Subject|9|||
30901130|NCT02087085|58934736|FG001|Overall Study|Withdrawal by Subject|11|||
30901131|NCT02087085|58934735|FG000|Overall Study|Protocol Violation|1|||
30901132|NCT02087085|58934736|FG001|Overall Study|Protocol Violation|0|||
30901133|NCT02087085|58934735|FG000|Overall Study|Study Terminated by Sponsor|87|||
30901134|NCT02087085|58934736|FG001|Overall Study|Study Terminated by Sponsor|80|||
30901135|NCT02087085|58934735|FG000|Overall Study|Other Miscellaneous Reasons|3|||
30901136|NCT02087085|58934736|FG001|Overall Study|Other Miscellaneous Reasons|4|||
30901137|NCT02443337|58934744|FG000|Overall Study|Adverse Event|0|||
30901138|NCT02443337|58934745|FG001|Overall Study|Adverse Event|1|||
30901139|NCT02443337|58934744|FG000|Overall Study|Clinical Progressive Disease|3|||
30901140|NCT02443337|58934745|FG001|Overall Study|Clinical Progressive Disease|0|||
30901141|NCT02443337|58934744|FG000|Overall Study|Withdrawal by Subject|2|||
30901142|NCT02443337|58934745|FG001|Overall Study|Withdrawal by Subject|1|||
30901143|NCT02443103|58934756|FG000|Overall Study|Adverse Event|2|||
30901144|NCT02443103|58934756|FG000|Overall Study|Noncompliance|1|||
30901145|NCT02022657|58934760|FG000|Overall Study|Withdrawal by Subject|2|||
30901146|NCT02022657|58934761|FG001|Overall Study|Withdrawal by Subject|0|||
30901147|NCT02022657|58934762|FG002|Overall Study|Withdrawal by Subject|1|||
30901148|NCT02022657|58934763|FG003|Overall Study|Withdrawal by Subject|0|||
30901149|NCT02022657|58934764|FG004|Overall Study|Withdrawal by Subject|0|||
30901150|NCT02022657|58934765|FG005|Overall Study|Withdrawal by Subject|0|||
30901151|NCT02022657|58934760|FG000|Overall Study|Physician Decision|0|||
30901152|NCT02022657|58934761|FG001|Overall Study|Physician Decision|0|||
30901153|NCT02022657|58934762|FG002|Overall Study|Physician Decision|0|||
30901154|NCT02022657|58934763|FG003|Overall Study|Physician Decision|0|||
30901155|NCT02022657|58934764|FG004|Overall Study|Physician Decision|0|||
30901156|NCT02022657|58934765|FG005|Overall Study|Physician Decision|1|||
30901157|NCT02418455|58934771|FG000|48-Week Treatment Period|Other- Not Specified|1|||
30901158|NCT02418455|58934771|FG000|Continuation Period|Sponsor Decision|7|||
30901159|NCT02417753|58934777|FG000|Overall Study|Death|1|||
30901160|NCT02417441|58934783|FG000|Overall Study|Inconclusive due to missing data|52|||
30738239|NCT00264537|58749486|FG000|Overall Study|Lost to Follow-up|3|||
30738240|NCT00264537|58749487|FG001|Overall Study|Lost to Follow-up|4|||
30738241|NCT00264537|58749488|FG002|Overall Study|Lost to Follow-up|7|||
30901161|NCT02417441|58934784|FG001|Overall Study|Inconclusive due to missing data|19|||
30901162|NCT02021643|58934797|FG000|Overall Study|Enrolled but Never Treated|1|||
30901163|NCT02021643|58934798|FG001|Overall Study|Enrolled but Never Treated|0|||
30901164|NCT02021643|58934799|FG002|Overall Study|Enrolled but Never Treated|0|||
30901165|NCT02021643|58934800|FG003|Overall Study|Enrolled but Never Treated|0|||
30901166|NCT02021643|58934797|FG000|Overall Study|Adverse Event|0|||
30738242|NCT00264537|58749489|FG003|Overall Study|Lost to Follow-up|6|||
30901167|NCT02021643|58934798|FG001|Overall Study|Adverse Event|1|||
30738243|NCT00264537|58749486|FG000|Overall Study|Adverse Event|21|||
30738244|NCT00264537|58749487|FG001|Overall Study|Adverse Event|32|||
30901168|NCT02021643|58934799|FG002|Overall Study|Adverse Event|0|||
30901169|NCT02021643|58934800|FG003|Overall Study|Adverse Event|0|||
30901170|NCT02021643|58934797|FG000|Overall Study|Death|0|||
30901171|NCT02021643|58934798|FG001|Overall Study|Death|1|||
30901172|NCT02021643|58934799|FG002|Overall Study|Death|0|||
30901173|NCT02021643|58934800|FG003|Overall Study|Death|0|||
30901174|NCT02021643|58934797|FG000|Overall Study|Investigator's Discretion|1|||
30901175|NCT02021643|58934798|FG001|Overall Study|Investigator's Discretion|0|||
30901176|NCT02021643|58934799|FG002|Overall Study|Investigator's Discretion|0|||
30901177|NCT02021643|58934800|FG003|Overall Study|Investigator's Discretion|0|||
30901178|NCT02021643|58934797|FG000|Overall Study|Lack of Efficacy|7|||
30738245|NCT00264537|58749488|FG002|Overall Study|Adverse Event|24|||
30738246|NCT00264537|58749489|FG003|Overall Study|Adverse Event|34|||
30738247|NCT00264537|58749486|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
30738248|NCT00264537|58749487|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
30738249|NCT00264537|58749488|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
30738250|NCT00264537|58749489|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
30738251|NCT00264537|58749486|FG000|Overall Study|Other|21|||
30738252|NCT00264537|58749487|FG001|Overall Study|Other|11|||
30738253|NCT00264537|58749488|FG002|Overall Study|Other|10|||
30738254|NCT00264537|58749489|FG003|Overall Study|Other|11|||
30738255|NCT00264537|58749486|FG000|Overall Study|Not treated|0|||
30738256|NCT00264537|58749487|FG001|Overall Study|Not treated|2|||
30738257|NCT00264537|58749488|FG002|Overall Study|Not treated|1|||
30738258|NCT00264537|58749489|FG003|Overall Study|Not treated|0|||
30738259|NCT00371462|58749503|FG000|Overall Study|Withdrawal by Subject|1|||
30738260|NCT00371462|58749504|FG001|Overall Study|Withdrawal by Subject|0|||
30738261|NCT00371462|58749503|FG000|Overall Study|Other|7|||
30738262|NCT00371462|58749504|FG001|Overall Study|Other|8|||
30738263|NCT00371150|58749512|FG000|Overall Study|Lost to Follow-up|3|||
30738264|NCT00371150|58749513|FG001|Overall Study|Lost to Follow-up|2|||
30738265|NCT00264303|58749525|FG000|Overall Study|Adverse Event|4|||
30738266|NCT00264303|58749526|FG001|Overall Study|Adverse Event|3|||
30738267|NCT00264303|58749525|FG000|Overall Study|Lack of Efficacy|10|||
30738268|NCT00264303|58749526|FG001|Overall Study|Lack of Efficacy|13|||
30738269|NCT00264303|58749525|FG000|Overall Study|Lost to Follow-up|3|||
30738270|NCT00264303|58749526|FG001|Overall Study|Lost to Follow-up|3|||
30738271|NCT00264303|58749525|FG000|Overall Study|Withdrawal by Subject|2|||
30738272|NCT00264303|58749526|FG001|Overall Study|Withdrawal by Subject|3|||
30738273|NCT00264303|58749525|FG000|Overall Study|Various reasons listed in study report|6|||
30738274|NCT00264303|58749526|FG001|Overall Study|Various reasons listed in study report|7|||
30738275|NCT00370682|58749535|FG000|Overall Study|Moved from area|0|||
30738276|NCT00370682|58749536|FG001|Overall Study|Moved from area|2|||
30738277|NCT00370682|58749537|FG002|Overall Study|Moved from area|0|||
30738278|NCT00370682|58749535|FG000|Overall Study|Lost to Follow-up|0|||
30738279|NCT00370682|58749536|FG001|Overall Study|Lost to Follow-up|1|||
30738280|NCT00370682|58749537|FG002|Overall Study|Lost to Follow-up|1|||
30738281|NCT00264147|58749554|FG000|Treatment I Period|Adverse Event|3|||
30738282|NCT00264147|58749555|FG001|Treatment I Period|Adverse Event|6|||
30738283|NCT00264147|58749556|FG002|Treatment I Period|Adverse Event|3|||
30738284|NCT00264147|58749557|FG003|Treatment I Period|Adverse Event|5|||
30738285|NCT00264147|58749558|FG004|Treatment I Period|Adverse Event|7|||
30738286|NCT00264147|58749559|FG005|Treatment I Period|Adverse Event|0|||
30738287|NCT00264147|58749554|FG000|Treatment I Period|Laboratory Adverse Event|0|||
30738288|NCT00264147|58749555|FG001|Treatment I Period|Laboratory Adverse Event|0|||
30738289|NCT00264147|58749556|FG002|Treatment I Period|Laboratory Adverse Event|0|||
30738290|NCT00264147|58749557|FG003|Treatment I Period|Laboratory Adverse Event|1|||
30738291|NCT00264147|58749558|FG004|Treatment I Period|Laboratory Adverse Event|0|||
30738292|NCT00264147|58749559|FG005|Treatment I Period|Laboratory Adverse Event|0|||
30738293|NCT00264147|58749554|FG000|Treatment I Period|Lack of Efficacy|6|||
30738294|NCT00264147|58749555|FG001|Treatment I Period|Lack of Efficacy|2|||
30738295|NCT00264147|58749556|FG002|Treatment I Period|Lack of Efficacy|8|||
30738296|NCT00264147|58749557|FG003|Treatment I Period|Lack of Efficacy|0|||
30738297|NCT00264147|58749558|FG004|Treatment I Period|Lack of Efficacy|1|||
30738298|NCT00264147|58749559|FG005|Treatment I Period|Lack of Efficacy|0|||
30738299|NCT00264147|58749554|FG000|Treatment I Period|Lost to Follow-up|1|||
30738300|NCT00264147|58749555|FG001|Treatment I Period|Lost to Follow-up|0|||
30738301|NCT00264147|58749556|FG002|Treatment I Period|Lost to Follow-up|0|||
30738302|NCT00264147|58749557|FG003|Treatment I Period|Lost to Follow-up|1|||
30738303|NCT00264147|58749558|FG004|Treatment I Period|Lost to Follow-up|1|||
30738304|NCT00264147|58749559|FG005|Treatment I Period|Lost to Follow-up|0|||
30738305|NCT00264147|58749554|FG000|Treatment I Period|Protocol Violation|2|||
30901179|NCT02021643|58934798|FG001|Overall Study|Lack of Efficacy|6|||
30738306|NCT00264147|58749555|FG001|Treatment I Period|Protocol Violation|2|||
30738307|NCT00264147|58749556|FG002|Treatment I Period|Protocol Violation|0|||
30738308|NCT00264147|58749557|FG003|Treatment I Period|Protocol Violation|0|||
30738309|NCT00264147|58749558|FG004|Treatment I Period|Protocol Violation|0|||
30738310|NCT00264147|58749559|FG005|Treatment I Period|Protocol Violation|0|||
30738311|NCT00264147|58749554|FG000|Treatment I Period|Withdrawal by Subject|2|||
30738312|NCT00264147|58749555|FG001|Treatment I Period|Withdrawal by Subject|0|||
30738313|NCT00264147|58749556|FG002|Treatment I Period|Withdrawal by Subject|0|||
30738314|NCT00264147|58749557|FG003|Treatment I Period|Withdrawal by Subject|2|||
30738315|NCT00264147|58749558|FG004|Treatment I Period|Withdrawal by Subject|2|||
30738316|NCT00264147|58749559|FG005|Treatment I Period|Withdrawal by Subject|0|||
30738317|NCT00264147|58749554|FG000|Treatment I Period|Patient out of town for an extended time|0|||
30738318|NCT00264147|58749555|FG001|Treatment I Period|Patient out of town for an extended time|1|||
30790973|NCT00829504|58804130|FG001|First Intervention|Adverse Event|0|||
30738319|NCT00264147|58749556|FG002|Treatment I Period|Patient out of town for an extended time|0|||
30738320|NCT00264147|58749557|FG003|Treatment I Period|Patient out of town for an extended time|0|||
30738321|NCT00264147|58749558|FG004|Treatment I Period|Patient out of town for an extended time|0|||
30738322|NCT00264147|58749559|FG005|Treatment I Period|Patient out of town for an extended time|0|||
30738323|NCT00264147|58749554|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
30738324|NCT00264147|58749555|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
30738325|NCT00264147|58749556|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
30738326|NCT00264147|58749557|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
30738327|NCT00264147|58749558|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
30738328|NCT00264147|58749559|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
30738329|NCT00264147|58749554|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
30738330|NCT00264147|58749555|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
30738331|NCT00264147|58749556|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
30738332|NCT00264147|58749557|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
30738333|NCT00264147|58749558|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
30738334|NCT00264147|58749559|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
30738335|NCT00264147|58749554|FG000|Treatment II Period|Adverse Event|0|||
30738336|NCT00264147|58749555|FG001|Treatment II Period|Adverse Event|0|||
30738337|NCT00264147|58749556|FG002|Treatment II Period|Adverse Event|0|||
30738338|NCT00264147|58749557|FG003|Treatment II Period|Adverse Event|0|||
30738339|NCT00264147|58749558|FG004|Treatment II Period|Adverse Event|9|||
30738340|NCT00264147|58749559|FG005|Treatment II Period|Adverse Event|9|||
30738341|NCT00264147|58749554|FG000|Treatment II Period|Laboratory Adverse Event|0|||
30738342|NCT00264147|58749555|FG001|Treatment II Period|Laboratory Adverse Event|0|||
30738343|NCT00264147|58749556|FG002|Treatment II Period|Laboratory Adverse Event|0|||
30738344|NCT00264147|58749557|FG003|Treatment II Period|Laboratory Adverse Event|0|||
30738345|NCT00264147|58749558|FG004|Treatment II Period|Laboratory Adverse Event|0|||
30738346|NCT00264147|58749559|FG005|Treatment II Period|Laboratory Adverse Event|1|||
30738347|NCT00264147|58749554|FG000|Treatment II Period|Lack of Efficacy|0|||
30738348|NCT00264147|58749555|FG001|Treatment II Period|Lack of Efficacy|0|||
30738349|NCT00264147|58749556|FG002|Treatment II Period|Lack of Efficacy|0|||
30738350|NCT00264147|58749557|FG003|Treatment II Period|Lack of Efficacy|0|||
30738351|NCT00264147|58749558|FG004|Treatment II Period|Lack of Efficacy|20|||
30738352|NCT00264147|58749559|FG005|Treatment II Period|Lack of Efficacy|19|||
30738353|NCT00264147|58749554|FG000|Treatment II Period|Lost to Follow-up|0|||
30738354|NCT00264147|58749555|FG001|Treatment II Period|Lost to Follow-up|0|||
30738355|NCT00264147|58749556|FG002|Treatment II Period|Lost to Follow-up|0|||
30738356|NCT00264147|58749557|FG003|Treatment II Period|Lost to Follow-up|0|||
30738357|NCT00264147|58749558|FG004|Treatment II Period|Lost to Follow-up|1|||
30738358|NCT00264147|58749559|FG005|Treatment II Period|Lost to Follow-up|1|||
30738359|NCT00264147|58749554|FG000|Treatment II Period|Withdrawal by Subject|0|||
30738360|NCT00264147|58749555|FG001|Treatment II Period|Withdrawal by Subject|0|||
30738361|NCT00264147|58749556|FG002|Treatment II Period|Withdrawal by Subject|0|||
30738362|NCT00264147|58749557|FG003|Treatment II Period|Withdrawal by Subject|0|||
30738363|NCT00264147|58749558|FG004|Treatment II Period|Withdrawal by Subject|3|||
30738364|NCT00264147|58749559|FG005|Treatment II Period|Withdrawal by Subject|2|||
30738365|NCT00264147|58749554|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
30738366|NCT00264147|58749555|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
30738367|NCT00264147|58749556|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
30738368|NCT00264147|58749557|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
30738369|NCT00264147|58749558|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
30738370|NCT00264147|58749559|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
30738371|NCT00263757|58749575|FG000|Overall Study|Withdrawal by Subject|5|||
30738372|NCT00263757|58749576|FG001|Overall Study|Withdrawal by Subject|4|||
30738373|NCT00263757|58749575|FG000|Overall Study|Screen failure|0|||
30738374|NCT00263757|58749576|FG001|Overall Study|Screen failure|1|||
30738375|NCT00263757|58749575|FG000|Overall Study|Adverse Event|3|||
30738376|NCT00263757|58749576|FG001|Overall Study|Adverse Event|3|||
30738377|NCT00263211|58749584|FG000|Overall Study|Death|1|||
30738378|NCT00263211|58749585|FG001|Overall Study|Death|0|||
30901180|NCT02021643|58934799|FG002|Overall Study|Lack of Efficacy|0|||
30901181|NCT02021643|58934800|FG003|Overall Study|Lack of Efficacy|12|||
30738379|NCT00263211|58749584|FG000|Overall Study|Withdrawal by Subject|3|||
30738380|NCT00263211|58749585|FG001|Overall Study|Withdrawal by Subject|0|||
30738381|NCT00263211|58749584|FG000|Overall Study|Protocol Violation|1|||
30738382|NCT00263211|58749585|FG001|Overall Study|Protocol Violation|0|||
30738383|NCT00263211|58749584|FG000|Overall Study|Disease Progression|0|||
30738384|NCT00263211|58749585|FG001|Overall Study|Disease Progression|1|||
30738385|NCT00248625|58749596|FG000|Overall Study|Withdrawal by Subject|0|||
30790974|NCT00829504|58804129|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
30790975|NCT00829504|58804130|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
30738386|NCT00248625|58749597|FG001|Overall Study|Withdrawal by Subject|2|||
30901182|NCT02021643|58934797|FG000|Overall Study|Lost to Follow-up|0|||
30738387|NCT00262821|58749605|FG000|Overall Study|Ineligible - wrong stage|0|||
30738388|NCT00262821|58749606|FG001|Overall Study|Ineligible - wrong stage|3|||
30738389|NCT00262821|58749605|FG000|Overall Study|Ineligible - wrong cell type|2|||
30738390|NCT00262821|58749606|FG001|Overall Study|Ineligible - wrong cell type|2|||
30738391|NCT00262821|58749605|FG000|Overall Study|Ineligible - wrong primary|0|||
30738392|NCT00262821|58749606|FG001|Overall Study|Ineligible - wrong primary|1|||
30738393|NCT00262821|58749605|FG000|Overall Study|Ineligible - inadequate pathology|1|||
30738394|NCT00262821|58749606|FG001|Overall Study|Ineligible - inadequate pathology|3|||
30738395|NCT00262821|58749605|FG000|Overall Study|Ineligible - elevated creatinine|0|||
30901183|NCT02021643|58934798|FG001|Overall Study|Lost to Follow-up|1|||
30738396|NCT00262821|58749606|FG001|Overall Study|Ineligible - elevated creatinine|2|||
30738397|NCT00262821|58749605|FG000|Overall Study|Ineligible - required test not done|1|||
30738398|NCT00262821|58749606|FG001|Overall Study|Ineligible - required test not done|4|||
30738399|NCT00262821|58749605|FG000|Overall Study|Inevaluable - inadequate data|0|||
30738400|NCT00262821|58749606|FG001|Overall Study|Inevaluable - inadequate data|4|||
30738401|NCT00262743|58749614|FG000|Overall Study|Adverse Event|0|||
30738402|NCT00262743|58749615|FG001|Overall Study|Adverse Event|9|||
30738403|NCT00262743|58749614|FG000|Overall Study|Disease progression|0|||
30738404|NCT00262743|58749615|FG001|Overall Study|Disease progression|3|||
30738405|NCT00262119|58749622|FG000|Overall Study|Lost to Follow-up|38|||
30738406|NCT00262119|58749623|FG001|Overall Study|Lost to Follow-up|51|||
30738407|NCT00262119|58749624|FG002|Overall Study|Lost to Follow-up|42|||
30738408|NCT00262119|58749622|FG000|Overall Study|Death|20|||
30738409|NCT00262119|58749623|FG001|Overall Study|Death|19|||
30738410|NCT00262119|58749624|FG002|Overall Study|Death|16|||
30738411|NCT00170950|58749634|FG000|Overall Study|Death|236|||
30738412|NCT00170950|58749635|FG001|Overall Study|Death|274|||
30738413|NCT00170950|58749634|FG000|Overall Study|Withdrawal by Subject|496|||
30738414|NCT00170950|58749635|FG001|Overall Study|Withdrawal by Subject|498|||
30738415|NCT00170950|58749634|FG000|Overall Study|Lost to Follow-up|134|||
30738416|NCT00170950|58749635|FG001|Overall Study|Lost to Follow-up|115|||
30738417|NCT00170950|58749634|FG000|Overall Study|Missing|2|||
30738418|NCT00170950|58749635|FG001|Overall Study|Missing|1|||
30901184|NCT02021643|58934799|FG002|Overall Study|Lost to Follow-up|0|||
30738419|NCT00170950|58749634|FG000|Overall Study|Termination Data Not Recorded|17|||
30738420|NCT00170950|58749635|FG001|Overall Study|Termination Data Not Recorded|22|||
30738421|NCT00239577|58749645|FG000|Primary Phase|Adverse Event|0|||
30738422|NCT00239577|58749646|FG001|Primary Phase|Adverse Event|0|||
30738423|NCT00239577|58749647|FG002|Primary Phase|Adverse Event|1|||
30738424|NCT00239577|58749648|FG003|Primary Phase|Adverse Event|0|||
30738425|NCT00239577|58749645|FG000|Primary Phase|Other|5|||
30738426|NCT00239577|58749646|FG001|Primary Phase|Other|3|||
30738427|NCT00239577|58749647|FG002|Primary Phase|Other|2|||
30738428|NCT00239577|58749648|FG003|Primary Phase|Other|0|||
30738429|NCT00262041|58749664|FG000|Overall Study|Withdrawal by Subject|0|||
30738430|NCT00262041|58749665|FG001|Overall Study|Withdrawal by Subject|3|||
30738431|NCT00262041|58749666|FG002|Overall Study|Withdrawal by Subject|1|||
30738432|NCT00262041|58749664|FG000|Overall Study|Lost to Follow-up|1|||
30738433|NCT00262041|58749665|FG001|Overall Study|Lost to Follow-up|1|||
30738434|NCT00262041|58749666|FG002|Overall Study|Lost to Follow-up|5|||
30738435|NCT00262041|58749664|FG000|Overall Study|Unable to classify|1|||
30738436|NCT00262041|58749665|FG001|Overall Study|Unable to classify|0|||
30738437|NCT00262041|58749666|FG002|Overall Study|Unable to classify|0|||
30738438|NCT00208767|58749682|FG000|Overall Study|Adverse Event|9|||
30738439|NCT00208767|58749683|FG001|Overall Study|Adverse Event|1|||
30738440|NCT00208767|58749682|FG000|Overall Study|Withdrawal by Subject|14|||
30738441|NCT00208767|58749683|FG001|Overall Study|Withdrawal by Subject|3|||
30738442|NCT00208767|58749682|FG000|Overall Study|Death|1|||
30738443|NCT00208767|58749683|FG001|Overall Study|Death|0|||
30738444|NCT00208767|58749682|FG000|Overall Study|Lost to Follow-up|3|||
30738445|NCT00208767|58749683|FG001|Overall Study|Lost to Follow-up|3|||
30738446|NCT00390806|58749691|FG000|Overall Study|Lost to Follow-up|7|||
30738447|NCT00390806|58749692|FG001|Overall Study|Lost to Follow-up|6|||
30790976|NCT00829504|58804129|FG000|Second Intervention|Physician Decision|1|||
30901185|NCT02021643|58934800|FG003|Overall Study|Lost to Follow-up|0|||
30901186|NCT02021643|58934797|FG000|Overall Study|Withdrew Consent|0|||
30901187|NCT02021643|58934798|FG001|Overall Study|Withdrew Consent|1|||
30738448|NCT00390806|58749691|FG000|Overall Study|Protocol Violation|2|||
30738449|NCT00390806|58749692|FG001|Overall Study|Protocol Violation|2|||
30901188|NCT02021643|58934799|FG002|Overall Study|Withdrew Consent|0|||
30901189|NCT02021643|58934800|FG003|Overall Study|Withdrew Consent|0|||
30738450|NCT00390806|58749691|FG000|Overall Study|Withdrawal by Subject|12|||
30738451|NCT00390806|58749692|FG001|Overall Study|Withdrawal by Subject|15|||
30738452|NCT00390806|58749691|FG000|Overall Study|Investigator Decision|4|||
30738453|NCT00390806|58749692|FG001|Overall Study|Investigator Decision|6|||
30738454|NCT00390806|58749691|FG000|Overall Study|Death|1|||
30738455|NCT00390806|58749692|FG001|Overall Study|Death|0|||
30738456|NCT00390806|58749691|FG000|Overall Study|Physician Decision|0|||
30738457|NCT00390806|58749692|FG001|Overall Study|Physician Decision|1|||
30901190|NCT02415959|58934821|FG000|Overall Study|Adverse Event|0|||
30901191|NCT02415959|58934822|FG001|Overall Study|Adverse Event|1|||
30738458|NCT00390806|58749691|FG000|Overall Study|Ongoing|4|||
30738459|NCT00390806|58749692|FG001|Overall Study|Ongoing|2|||
30738460|NCT00390572|58749700|FG000|Overall Study|Lost to Follow-up|8|||
30738461|NCT00390572|58749701|FG001|Overall Study|Lost to Follow-up|4|||
30738462|NCT00390572|58749700|FG000|Overall Study|health condition|0|||
30738463|NCT00390572|58749701|FG001|Overall Study|health condition|1|||
30738464|NCT00390416|58749711|FG000|Overall Study|Withdrawal by Subject|1|||
30738465|NCT00390416|58749711|FG000|Overall Study|Not treated|3|||
30738466|NCT00261495|58749717|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
30738467|NCT00261495|58749718|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
30738468|NCT00261495|58749717|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
30738469|NCT00261495|58749718|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
30738470|NCT00261495|58749717|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
30738471|NCT00261495|58749718|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
30738472|NCT00261495|58749717|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
30738473|NCT00261495|58749718|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
30738474|NCT00261495|58749717|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
30738475|NCT00261495|58749718|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
30738476|NCT00261495|58749717|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
30738477|NCT00261495|58749718|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
30738478|NCT00261495|58749717|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
30738479|NCT00261495|58749718|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
30738480|NCT00261495|58749717|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
30738481|NCT00261495|58749718|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
30738482|NCT00261495|58749717|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
30738483|NCT00261495|58749718|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
30738484|NCT00261495|58749717|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
30738485|NCT00261495|58749718|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
30738486|NCT00261495|58749717|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
30738487|NCT00261495|58749718|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
30738488|NCT00261495|58749717|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
30901192|NCT02415959|58934823|FG002|Overall Study|Adverse Event|0|||
30901193|NCT02415959|58934824|FG003|Overall Study|Adverse Event|0|||
30738489|NCT00261495|58749718|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
30738490|NCT00261495|58749717|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
30738491|NCT00261495|58749718|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
30738492|NCT00261495|58749717|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
30738493|NCT00261495|58749718|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
30738494|NCT00261495|58749717|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
30738495|NCT00261495|58749718|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
30738496|NCT00261495|58749717|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
30738497|NCT00261495|58749718|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
30738498|NCT00261495|58749717|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
30738499|NCT00261495|58749718|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
30738500|NCT00261495|58749717|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
30738501|NCT00261495|58749718|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
30738502|NCT00261495|58749717|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
30738503|NCT00261495|58749718|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
30738504|NCT00261495|58749717|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
30738505|NCT00261495|58749718|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
30738506|NCT00261495|58749717|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
30738507|NCT00261495|58749718|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
30738508|NCT00168844|58749727|FG000|Overall Study|Adverse Event|31|||
30738509|NCT00168844|58749728|FG001|Overall Study|Adverse Event|32|||
30738510|NCT00168844|58749729|FG002|Overall Study|Adverse Event|48|||
30901194|NCT02415959|58934825|FG004|Overall Study|Adverse Event|0|||
30901195|NCT02415959|58934821|FG000|Overall Study|Protocol Violation|0|||
30621861|NCT01147458|58633422|FG000|First Intervention|Study terminated by sponsor|8|||
30621862|NCT01147458|58633423|FG001|First Intervention|Study terminated by sponsor|8|||
30738511|NCT00168844|58749727|FG000|Overall Study|Lost to Follow-up|4|||
30738512|NCT00168844|58749728|FG001|Overall Study|Lost to Follow-up|5|||
30738513|NCT00168844|58749729|FG002|Overall Study|Lost to Follow-up|11|||
30738514|NCT00168844|58749727|FG000|Overall Study|Withdrawal by Subject|12|||
30738515|NCT00168844|58749728|FG001|Overall Study|Withdrawal by Subject|9|||
30738516|NCT00168844|58749729|FG002|Overall Study|Withdrawal by Subject|19|||
30738517|NCT00168844|58749727|FG000|Overall Study|Protocol Violation|2|||
30790977|NCT00829504|58804130|FG001|Second Intervention|Physician Decision|0|||
30621863|NCT01147458|58633424|FG002|First Intervention|Study terminated by sponsor|7|||
30738518|NCT00168844|58749728|FG001|Overall Study|Protocol Violation|2|||
30738519|NCT00168844|58749729|FG002|Overall Study|Protocol Violation|4|||
30738520|NCT00168844|58749727|FG000|Overall Study|Other|6|||
30738521|NCT00168844|58749728|FG001|Overall Study|Other|7|||
30738522|NCT00168844|58749729|FG002|Overall Study|Other|9|||
30738523|NCT00365456|58749737|FG000|Trial Period I (12 Months)|Adverse Event|84|||
30738524|NCT00365456|58749738|FG001|Trial Period I (12 Months)|Adverse Event|0|||
30738525|NCT00365456|58749737|FG000|Trial Period I (12 Months)|Non-compliance|3|||
30738526|NCT00365456|58749738|FG001|Trial Period I (12 Months)|Non-compliance|0|||
30738527|NCT00365456|58749737|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
30738528|NCT00365456|58749738|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
30738529|NCT00365456|58749737|FG000|Trial Period I (12 Months)|Other|11|||
30738530|NCT00365456|58749738|FG001|Trial Period I (12 Months)|Other|0|||
30738531|NCT00365456|58749737|FG000|Trial Period II (12 Months)|Adverse Event|0|||
30738532|NCT00365456|58749738|FG001|Trial Period II (12 Months)|Adverse Event|6|||
30738533|NCT00365456|58749737|FG000|Trial Period II (12 Months)|Non-compliance|0|||
30738534|NCT00365456|58749738|FG001|Trial Period II (12 Months)|Non-compliance|2|||
30738535|NCT00365456|58749737|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
30738536|NCT00365456|58749738|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
30738537|NCT00365456|58749737|FG000|Trial Period II (12 Months)|Other|0|||
30738538|NCT00365456|58749738|FG001|Trial Period II (12 Months)|Other|1|||
30738539|NCT00365456|58749737|FG000|Trial Period III (12 Months)|Adverse Event|13|||
30738540|NCT00365456|58749738|FG001|Trial Period III (12 Months)|Adverse Event|3|||
30738541|NCT00365456|58749737|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
30738542|NCT00365456|58749738|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
30738543|NCT00365456|58749737|FG000|Trial Period III (12 Months)|Other|1|||
30790978|NCT00829426|58804136|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
30738544|NCT00365456|58749738|FG001|Trial Period III (12 Months)|Other|1|||
30738545|NCT00147238|58749744|FG000|Overall Study|Inevaluable|8|||
30738546|NCT00206427|58749748|FG000|Overall Study|Adverse Event|2|||
30738547|NCT00146848|58749755|FG000|Pre-randomization|Death|19|||
30738548|NCT00146848|58749756|FG001|Pre-randomization|Death|0|||
30738549|NCT00146848|58749757|FG002|Pre-randomization|Death|0|||
30738550|NCT00146848|58749755|FG000|Pre-randomization|Lost to Follow-up|70|||
30738551|NCT00146848|58749756|FG001|Pre-randomization|Lost to Follow-up|0|||
30738552|NCT00146848|58749757|FG002|Pre-randomization|Lost to Follow-up|0|||
30738553|NCT00146848|58749755|FG000|Pre-randomization|Physician Decision|8|||
30738554|NCT00146848|58749756|FG001|Pre-randomization|Physician Decision|0|||
30738555|NCT00146848|58749757|FG002|Pre-randomization|Physician Decision|0|||
30738556|NCT00146848|58749755|FG000|Pre-randomization|Protocol Violation|172|||
30738557|NCT00146848|58749756|FG001|Pre-randomization|Protocol Violation|0|||
30738558|NCT00146848|58749757|FG002|Pre-randomization|Protocol Violation|0|||
30738559|NCT00146848|58749755|FG000|Pre-randomization|Withdrawal by Subject|40|||
30738560|NCT00146848|58749756|FG001|Pre-randomization|Withdrawal by Subject|0|||
30738561|NCT00146848|58749757|FG002|Pre-randomization|Withdrawal by Subject|0|||
30738562|NCT00146848|58749755|FG000|Post-randomization|Lost to Follow-up|12|||
30738563|NCT00146848|58749756|FG001|Post-randomization|Lost to Follow-up|15|||
30738564|NCT00146848|58749757|FG002|Post-randomization|Lost to Follow-up|12|||
30738565|NCT00146848|58749755|FG000|Post-randomization|Withdrawn|26|||
30738566|NCT00146848|58749756|FG001|Post-randomization|Withdrawn|32|||
30738567|NCT00146848|58749757|FG002|Post-randomization|Withdrawn|27|||
30738568|NCT00205881|58749765|FG000|Overall Study|Withdrawal by Subject|16|||
30738569|NCT00365378|58749772|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
30738570|NCT00365378|58749773|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
30738571|NCT00365378|58749774|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
30738572|NCT00365378|58749772|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
30738573|NCT00365378|58749773|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
30738574|NCT00365378|58749774|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
30738575|NCT00365378|58749772|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
30738576|NCT00365378|58749773|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
30738577|NCT00365378|58749774|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
30738578|NCT00365378|58749772|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
30738579|NCT00365378|58749773|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
30738580|NCT00365378|58749774|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
30738581|NCT00365378|58749772|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
30621864|NCT01147458|58633425|FG003|First Intervention|Study terminated by sponsor|8|||
30621865|NCT01147458|58633422|FG000|First Intervention|Protocol Violation|2|||
30621866|NCT01147458|58633423|FG001|First Intervention|Protocol Violation|3|||
30738582|NCT00365378|58749773|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
30738583|NCT00365378|58749774|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
30738584|NCT00365378|58749772|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
30738585|NCT00365378|58749773|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
30738586|NCT00365378|58749774|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
30738587|NCT00365378|58749772|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
30738588|NCT00365378|58749773|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
30738589|NCT00365378|58749774|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
30738590|NCT00365378|58749772|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
30738591|NCT00365378|58749773|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
30738592|NCT00365378|58749774|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
30738593|NCT00365378|58749772|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
30738594|NCT00365378|58749773|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
30738595|NCT00365378|58749774|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
30738596|NCT00365378|58749772|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
30738597|NCT00365378|58749773|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
30738598|NCT00365378|58749774|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
30738599|NCT00365378|58749772|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
30738600|NCT00365378|58749773|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
30738601|NCT00365378|58749774|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
30738602|NCT00365378|58749772|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
30738603|NCT00365378|58749773|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
30738604|NCT00365378|58749774|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
30738605|NCT00365378|58749772|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
30738606|NCT00365378|58749773|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
30738607|NCT00365378|58749774|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
30738608|NCT00365378|58749772|FG000|Extension|Adverse Event|0|||
30738609|NCT00365378|58749773|FG001|Extension|Adverse Event|0|||
30738610|NCT00365378|58749774|FG002|Extension|Adverse Event|1|||
30738611|NCT00365378|58749772|FG000|Extension|Moved|0|||
30738612|NCT00365378|58749773|FG001|Extension|Moved|0|||
30738613|NCT00365378|58749774|FG002|Extension|Moved|8|||
30738614|NCT00365378|58749772|FG000|Extension|Lost to Follow-up|0|||
30738615|NCT00365378|58749773|FG001|Extension|Lost to Follow-up|0|||
30738616|NCT00365378|58749774|FG002|Extension|Lost to Follow-up|57|||
30738617|NCT00365378|58749772|FG000|Extension|Protocol Violation|0|||
30738618|NCT00365378|58749773|FG001|Extension|Protocol Violation|0|||
30738619|NCT00365378|58749774|FG002|Extension|Protocol Violation|2|||
30738620|NCT00365378|58749772|FG000|Extension|Withdrawal by Subject|0|||
30738621|NCT00365378|58749773|FG001|Extension|Withdrawal by Subject|0|||
30738622|NCT00365378|58749774|FG002|Extension|Withdrawal by Subject|98|||
30738623|NCT00365378|58749772|FG000|Extension|Other|0|||
30738624|NCT00365378|58749773|FG001|Extension|Other|0|||
30738625|NCT00365378|58749774|FG002|Extension|Other|31|||
30738626|NCT00389324|58749781|FG000|Run-In Phase|Adverse Event|1|||
30738627|NCT00389324|58749781|FG000|Run-In Phase|Lost to Follow-up|1|||
30738628|NCT00389324|58749781|FG000|Run-In Phase|Withdrawal by Subject|1|||
30738629|NCT00389324|58749781|FG000|Subcutaneous Phase|Adverse Event|2|||
30738630|NCT00389324|58749781|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
30738631|NCT00389324|58749781|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
30738632|NCT00389324|58749781|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
30738633|NCT00365300|58749790|FG000|Open-label Phase|Adverse Event|4|||
30738634|NCT00365300|58749791|FG001|Open-label Phase|Adverse Event|0|||
30738635|NCT00365300|58749790|FG000|Open-label Phase|Failed to Return|1|||
30738636|NCT00365300|58749791|FG001|Open-label Phase|Failed to Return|0|||
30738637|NCT00365300|58749790|FG000|Open-label Phase|Physician Decision|1|||
30738638|NCT00365300|58749791|FG001|Open-label Phase|Physician Decision|0|||
30738639|NCT00365300|58749790|FG000|Open-label Phase|Noncompliance|9|||
30738640|NCT00365300|58749791|FG001|Open-label Phase|Noncompliance|0|||
30621867|NCT01147458|58633424|FG002|First Intervention|Protocol Violation|2|||
30621868|NCT01147458|58633425|FG003|First Intervention|Protocol Violation|3|||
30621869|NCT01147458|58633422|FG000|First Intervention|Withdrawal by Subject|3|||
30621870|NCT01147458|58633423|FG001|First Intervention|Withdrawal by Subject|0|||
30621871|NCT01147458|58633424|FG002|First Intervention|Withdrawal by Subject|1|||
30621872|NCT01147458|58633425|FG003|First Intervention|Withdrawal by Subject|0|||
30621873|NCT01147458|58633422|FG000|First Intervention|Adverse Event|0|||
30621874|NCT01147458|58633423|FG001|First Intervention|Adverse Event|3|||
30621875|NCT01147458|58633424|FG002|First Intervention|Adverse Event|2|||
30621876|NCT01147458|58633425|FG003|First Intervention|Adverse Event|3|||
30621877|NCT01147458|58633422|FG000|First Intervention|Other|1|||
30621878|NCT01147458|58633423|FG001|First Intervention|Other|2|||
30621879|NCT01147458|58633424|FG002|First Intervention|Other|0|||
30621880|NCT01147458|58633425|FG003|First Intervention|Other|0|||
30621881|NCT01147458|58633422|FG000|Second Intervention|Study terminated by sponsor|7|||
30738641|NCT00365300|58749790|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
30738642|NCT00365300|58749791|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
30738643|NCT00365300|58749790|FG000|Open-label Phase|Protocol Violation|1|||
30738644|NCT00365300|58749791|FG001|Open-label Phase|Protocol Violation|0|||
30621882|NCT01147458|58633423|FG001|Second Intervention|Study terminated by sponsor|5|||
30621883|NCT01147458|58633424|FG002|Second Intervention|Study terminated by sponsor|5|||
30621884|NCT01147458|58633425|FG003|Second Intervention|Study terminated by sponsor|3|||
30621885|NCT01147458|58633422|FG000|Second Intervention|Protocol Violation|0|||
30621886|NCT01147458|58633423|FG001|Second Intervention|Protocol Violation|1|||
30738645|NCT00365300|58749790|FG000|Open-label Phase|Lack of Efficacy|1|||
30738646|NCT00365300|58749791|FG001|Open-label Phase|Lack of Efficacy|0|||
30738647|NCT00365300|58749790|FG000|Open-label Phase|Patient skipped open label phase|1|||
30901196|NCT02415959|58934822|FG001|Overall Study|Protocol Violation|0|||
30621887|NCT01147458|58633424|FG002|Second Intervention|Protocol Violation|1|||
30621888|NCT01147458|58633425|FG003|Second Intervention|Protocol Violation|0|||
30621889|NCT01147458|58633422|FG000|Second Intervention|Withdrawal by Subject|0|||
30621890|NCT01147458|58633423|FG001|Second Intervention|Withdrawal by Subject|1|||
30621891|NCT01147458|58633424|FG002|Second Intervention|Withdrawal by Subject|0|||
30621892|NCT01147458|58633425|FG003|Second Intervention|Withdrawal by Subject|0|||
30621893|NCT01147458|58633422|FG000|Second Intervention|Adverse Event|2|||
30738648|NCT00365300|58749791|FG001|Open-label Phase|Patient skipped open label phase|0|||
30738649|NCT00365300|58749790|FG000|Double-blind Phase|Failed to return|1|||
30738650|NCT00365300|58749791|FG001|Double-blind Phase|Failed to return|0|||
30738651|NCT00365300|58749790|FG000|Double-blind Phase|Noncompliance|1|||
30738652|NCT00365300|58749791|FG001|Double-blind Phase|Noncompliance|1|||
30621894|NCT01147458|58633423|FG001|Second Intervention|Adverse Event|0|||
30621895|NCT01147458|58633424|FG002|Second Intervention|Adverse Event|1|||
30621896|NCT01147458|58633425|FG003|Second Intervention|Adverse Event|1|||
30738653|NCT00365300|58749790|FG000|Double-blind Phase|Withdrawal by Subject|0|||
30738654|NCT00365300|58749791|FG001|Double-blind Phase|Withdrawal by Subject|1|||
30738655|NCT00365300|58749790|FG000|Double-blind Phase|Protocol Violation|3|||
30738656|NCT00365300|58749791|FG001|Double-blind Phase|Protocol Violation|1|||
30738657|NCT00365300|58749790|FG000|Double-blind Phase|Lack of Efficacy|6|||
30738658|NCT00365300|58749791|FG001|Double-blind Phase|Lack of Efficacy|6|||
30738659|NCT00370292|58749802|FG000|Overall Study|Disease Progression|4|||
30738660|NCT00370292|58749802|FG000|Overall Study|Adverse Event|7|||
30738661|NCT00370292|58749802|FG000|Overall Study|Physician Decision|2|||
30621897|NCT01147458|58633422|FG000|Second Intervention|Other|0|||
30621898|NCT01147458|58633423|FG001|Second Intervention|Other|0|||
30621899|NCT01147458|58633424|FG002|Second Intervention|Other|1|||
30621900|NCT01147458|58633425|FG003|Second Intervention|Other|0|||
30621901|NCT01172808|58633441|FG000|Overall Study|Adverse Event|8|||
30621902|NCT01172808|58633442|FG001|Overall Study|Adverse Event|4|||
30621903|NCT01172808|58633443|FG002|Overall Study|Adverse Event|8|||
30621904|NCT01172808|58633444|FG003|Overall Study|Adverse Event|3|||
30621905|NCT01172808|58633441|FG000|Overall Study|Lack of Efficacy|1|||
30621906|NCT01172808|58633442|FG001|Overall Study|Lack of Efficacy|0|||
30621907|NCT01172808|58633443|FG002|Overall Study|Lack of Efficacy|0|||
30621908|NCT01172808|58633444|FG003|Overall Study|Lack of Efficacy|0|||
30621909|NCT01172808|58633441|FG000|Overall Study|Protocol Violation|2|||
30738662|NCT00369824|58749819|FG000|Overall Study|Adverse Event|0|||
30738663|NCT00369824|58749820|FG001|Overall Study|Adverse Event|2|||
30738664|NCT00369824|58749821|FG002|Overall Study|Adverse Event|0|||
30738665|NCT00369824|58749822|FG003|Overall Study|Adverse Event|0|||
30738666|NCT00369824|58749823|FG004|Overall Study|Adverse Event|1|||
30738667|NCT00369824|58749824|FG005|Overall Study|Adverse Event|0|||
30621910|NCT01172808|58633442|FG001|Overall Study|Protocol Violation|2|||
30621911|NCT01172808|58633443|FG002|Overall Study|Protocol Violation|2|||
30621912|NCT01172808|58633444|FG003|Overall Study|Protocol Violation|0|||
30621913|NCT01172808|58633441|FG000|Overall Study|Lost to Follow-up|0|||
30621914|NCT01172808|58633442|FG001|Overall Study|Lost to Follow-up|1|||
30621915|NCT01172808|58633443|FG002|Overall Study|Lost to Follow-up|1|||
30621916|NCT01172808|58633444|FG003|Overall Study|Lost to Follow-up|3|||
30621917|NCT01172808|58633441|FG000|Overall Study|Withdrawal by Subject|4|||
30621918|NCT01172808|58633442|FG001|Overall Study|Withdrawal by Subject|1|||
30621919|NCT01172808|58633443|FG002|Overall Study|Withdrawal by Subject|3|||
30621920|NCT01172808|58633444|FG003|Overall Study|Withdrawal by Subject|2|||
30901197|NCT02415959|58934823|FG002|Overall Study|Protocol Violation|0|||
30901198|NCT02415959|58934824|FG003|Overall Study|Protocol Violation|1|||
30901199|NCT02415959|58934825|FG004|Overall Study|Protocol Violation|0|||
30738668|NCT00369824|58749819|FG000|Overall Study|Protocol Violation|0|||
30738669|NCT00369824|58749820|FG001|Overall Study|Protocol Violation|1|||
30738670|NCT00369824|58749821|FG002|Overall Study|Protocol Violation|0|||
30738671|NCT00369824|58749822|FG003|Overall Study|Protocol Violation|1|||
30901200|NCT02021565|58934839|FG000|Baseline Through Intervention|Death|0|||
30901201|NCT02021565|58934840|FG001|Baseline Through Intervention|Death|1|||
30621921|NCT01172808|58633441|FG000|Overall Study|Other|6|||
30901202|NCT02021565|58934839|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
30738672|NCT00369824|58749823|FG004|Overall Study|Protocol Violation|1|||
30738673|NCT00369824|58749824|FG005|Overall Study|Protocol Violation|0|||
30621922|NCT01172808|58633442|FG001|Overall Study|Other|5|||
30621923|NCT01172808|58633443|FG002|Overall Study|Other|9|||
30621924|NCT01172808|58633444|FG003|Overall Study|Other|7|||
30621925|NCT04066491|58633457|FG000|Overall Study|Treatment ongoing|2|||
30738674|NCT00369824|58749819|FG000|Overall Study|Withdrawal by Subject|9|||
30901203|NCT02021565|58934840|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
30738675|NCT00369824|58749820|FG001|Overall Study|Withdrawal by Subject|5|||
30738676|NCT00369824|58749821|FG002|Overall Study|Withdrawal by Subject|5|||
30621926|NCT04066491|58633458|FG001|Overall Study|Treatment ongoing|72|||
30738677|NCT00369824|58749822|FG003|Overall Study|Withdrawal by Subject|4|||
30738678|NCT00369824|58749823|FG004|Overall Study|Withdrawal by Subject|6|||
30738679|NCT00369824|58749824|FG005|Overall Study|Withdrawal by Subject|2|||
30738680|NCT00369824|58749819|FG000|Overall Study|Lost to Follow-up|6|||
30738681|NCT00369824|58749820|FG001|Overall Study|Lost to Follow-up|11|||
30738682|NCT00369824|58749821|FG002|Overall Study|Lost to Follow-up|7|||
30738683|NCT00369824|58749822|FG003|Overall Study|Lost to Follow-up|8|||
30901204|NCT02021565|58934839|FG000|Baseline Through Intervention|Protocol Violation|0|||
30901205|NCT02021565|58934840|FG001|Baseline Through Intervention|Protocol Violation|7|||
30901206|NCT02021565|58934839|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
30901207|NCT02021565|58934840|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
30901208|NCT02021565|58934839|FG000|3-month Follow-up|Death|3|||
30901209|NCT02021565|58934840|FG001|3-month Follow-up|Death|0|||
30901210|NCT02021565|58934839|FG000|3-month Follow-up|Withdrawal by Subject|4|||
30901211|NCT02021565|58934840|FG001|3-month Follow-up|Withdrawal by Subject|0|||
30901212|NCT02021565|58934839|FG000|3-month Follow-up|Protocol Violation|3|||
30901213|NCT02021565|58934840|FG001|3-month Follow-up|Protocol Violation|2|||
30738684|NCT00369824|58749823|FG004|Overall Study|Lost to Follow-up|9|||
30738685|NCT00369824|58749824|FG005|Overall Study|Lost to Follow-up|6|||
30738686|NCT00369824|58749819|FG000|Overall Study|Other|0|||
30738687|NCT00369824|58749820|FG001|Overall Study|Other|0|||
30738688|NCT00369824|58749821|FG002|Overall Study|Other|0|||
30738689|NCT00369824|58749822|FG003|Overall Study|Other|2|||
30738690|NCT00369824|58749823|FG004|Overall Study|Other|1|||
30738691|NCT00369824|58749824|FG005|Overall Study|Other|3|||
30738692|NCT00369668|58749841|FG000|Overall Study|Lack of Efficacy|4|||
30738693|NCT00369668|58749842|FG001|Overall Study|Lack of Efficacy|5|||
30738694|NCT00369668|58749843|FG002|Overall Study|Lack of Efficacy|7|||
30738695|NCT00388154|58749854|FG000|Overall Study|Withdrawal by Subject|1|||
30738696|NCT00387764|58749858|FG000|Overall Study|Adverse Event|12|||
30738697|NCT00387764|58749858|FG000|Overall Study|Withdrawal by Subject|8|||
30738698|NCT00387764|58749858|FG000|Overall Study|Sponsor Terminated Study|1|||
30738699|NCT00387764|58749858|FG000|Overall Study|Physician Decision|1|||
30738700|NCT00387764|58749858|FG000|Overall Study|Other|2|||
30738701|NCT00387764|58749858|FG000|Overall Study|Death|7|||
30738702|NCT00386360|58749864|FG000|Overall Study|Adverse Event|4|||
30738703|NCT00386360|58749865|FG001|Overall Study|Adverse Event|2|||
30738704|NCT00386360|58749864|FG000|Overall Study|Physician Decision|2|||
30738705|NCT00386360|58749865|FG001|Overall Study|Physician Decision|2|||
30738706|NCT00386360|58749864|FG000|Overall Study|Lost to Follow-up|0|||
30738707|NCT00386360|58749865|FG001|Overall Study|Lost to Follow-up|2|||
30738708|NCT00386360|58749864|FG000|Overall Study|Protocol Violation|0|||
30738709|NCT00386360|58749865|FG001|Overall Study|Protocol Violation|3|||
30738710|NCT00386360|58749864|FG000|Overall Study|Withdrawal by Subject|3|||
30738711|NCT00386360|58749865|FG001|Overall Study|Withdrawal by Subject|6|||
30738712|NCT00386360|58749864|FG000|Overall Study|Did not take any study medication|0|||
30738713|NCT00386360|58749865|FG001|Overall Study|Did not take any study medication|2|||
30738714|NCT00369278|58749873|FG000|Overall Study|Adverse Event|14|||
30738715|NCT00369278|58749874|FG001|Overall Study|Adverse Event|11|||
30738716|NCT00369278|58749873|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
30738717|NCT00369278|58749874|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
30738718|NCT00369278|58749873|FG000|Overall Study|Protocol Violation|2|||
30738719|NCT00369278|58749874|FG001|Overall Study|Protocol Violation|1|||
30738720|NCT00369278|58749873|FG000|Overall Study|Withdrawal by Subject|2|||
30738721|NCT00369278|58749874|FG001|Overall Study|Withdrawal by Subject|2|||
30738722|NCT00369278|58749873|FG000|Overall Study|Lost to Follow-up|1|||
30738723|NCT00369278|58749874|FG001|Overall Study|Lost to Follow-up|0|||
30738724|NCT00369278|58749873|FG000|Overall Study|Graft loss|1|||
30738725|NCT00369278|58749874|FG001|Overall Study|Graft loss|2|||
30738726|NCT00529373|58749882|FG000|Base Study|Adverse Event|525|||
30738727|NCT00529373|58749883|FG001|Base Study|Adverse Event|470|||
30738728|NCT00529373|58749882|FG000|Base Study|Lack of Efficacy|16|||
30738729|NCT00529373|58749883|FG001|Base Study|Lack of Efficacy|75|||
30738730|NCT00529373|58749882|FG000|Base Study|Lost to Follow-up|221|||
30738731|NCT00529373|58749883|FG001|Base Study|Lost to Follow-up|208|||
30738732|NCT00529373|58749882|FG000|Base Study|Other Protocol Specified Criteria|19|||
30738733|NCT00529373|58749883|FG001|Base Study|Other Protocol Specified Criteria|20|||
30738734|NCT00529373|58749882|FG000|Base Study|Physician Decision|60|||
30738735|NCT00529373|58749883|FG001|Base Study|Physician Decision|52|||
30901214|NCT02021331|58934850|FG000|Overall Study|Adverse Event|0|||
30901215|NCT02021331|58934851|FG001|Overall Study|Adverse Event|2|||
30738736|NCT00529373|58749882|FG000|Base Study|Protocol Violation|48|||
30738737|NCT00529373|58749883|FG001|Base Study|Protocol Violation|38|||
30738738|NCT00529373|58749882|FG000|Base Study|Withdrawal by Subject|1062|||
30738739|NCT00529373|58749883|FG001|Base Study|Withdrawal by Subject|967|||
30738740|NCT00529373|58749882|FG000|Base Study|Did not continue into Extension|1795|||
30738741|NCT00529373|58749883|FG001|Base Study|Did not continue into Extension|2238|||
30738742|NCT00529373|58749882|FG000|First Extension Study|Adverse Event|162|||
30901216|NCT02085135|58934859|FG000|Overall Study|Adverse Event|4|||
30738743|NCT00529373|58749883|FG001|First Extension Study|Adverse Event|142|||
30738744|NCT00529373|58749882|FG000|First Extension Study|Lack of Efficacy|65|||
30901217|NCT02085135|58934860|FG001|Overall Study|Adverse Event|7|||
30901218|NCT02085135|58934859|FG000|Overall Study|Lost to Follow-up|2|||
30901219|NCT02085135|58934860|FG001|Overall Study|Lost to Follow-up|2|||
30901220|NCT02085135|58934859|FG000|Overall Study|Withdrawal by Subject|3|||
30901221|NCT02085135|58934860|FG001|Overall Study|Withdrawal by Subject|0|||
30901222|NCT02085135|58934859|FG000|Overall Study|Lack of Efficacy|2|||
30901223|NCT02085135|58934860|FG001|Overall Study|Lack of Efficacy|0|||
30901224|NCT02441309|58934869|FG000|Overall Study|Disease progression|2|||
30901225|NCT02441309|58934870|FG001|Overall Study|Disease progression|1|||
30901226|NCT02441309|58934871|FG002|Overall Study|Disease progression|2|||
30901227|NCT02441309|58934869|FG000|Overall Study|Adverse Event|0|||
30901228|NCT02441309|58934870|FG001|Overall Study|Adverse Event|1|||
30901229|NCT02441309|58934871|FG002|Overall Study|Adverse Event|0|||
30901230|NCT02441309|58934869|FG000|Overall Study|Withdrawal by Subject|1|||
30901231|NCT02441309|58934870|FG001|Overall Study|Withdrawal by Subject|0|||
30901232|NCT02441309|58934871|FG002|Overall Study|Withdrawal by Subject|1|||
30901233|NCT02027025|58934885|FG000|Overall Study|Adverse Event|0|||
30901234|NCT02027025|58934886|FG001|Overall Study|Adverse Event|1|||
30901235|NCT02027025|58934887|FG002|Overall Study|Adverse Event|1|||
30901236|NCT02027025|58934885|FG000|Overall Study|Protocol Violation|1|||
30901237|NCT02027025|58934886|FG001|Overall Study|Protocol Violation|0|||
30901238|NCT02027025|58934887|FG002|Overall Study|Protocol Violation|0|||
30901239|NCT02027025|58934885|FG000|Overall Study|Lost to Follow-up|0|||
30901240|NCT02027025|58934886|FG001|Overall Study|Lost to Follow-up|2|||
30901241|NCT02027025|58934887|FG002|Overall Study|Lost to Follow-up|0|||
30901242|NCT02027025|58934885|FG000|Overall Study|Withdrawal by Subject|0|||
30901243|NCT02027025|58934886|FG001|Overall Study|Withdrawal by Subject|1|||
30901244|NCT02027025|58934887|FG002|Overall Study|Withdrawal by Subject|0|||
30901245|NCT02027025|58934885|FG000|Overall Study|Sponsor's decision|0|||
30901246|NCT02027025|58934886|FG001|Overall Study|Sponsor's decision|1|||
30901247|NCT02027025|58934887|FG002|Overall Study|Sponsor's decision|0|||
30901248|NCT01652729|58934909|FG000|Overall Study|Withdrawal by Subject|14|||
30901249|NCT01652729|58934910|FG001|Overall Study|Withdrawal by Subject|7|||
30901250|NCT01652729|58934911|FG002|Overall Study|Withdrawal by Subject|7|||
30901251|NCT01652729|58934909|FG000|Overall Study|Adverse Event|4|||
30901252|NCT01652729|58934910|FG001|Overall Study|Adverse Event|0|||
30901253|NCT01652729|58934911|FG002|Overall Study|Adverse Event|3|||
30901254|NCT01652729|58934909|FG000|Overall Study|Physician Decision|1|||
30738745|NCT00529373|58749883|FG001|First Extension Study|Lack of Efficacy|427|||
30738746|NCT00529373|58749882|FG000|First Extension Study|Lost to Follow-up|41|||
30738747|NCT00529373|58749883|FG001|First Extension Study|Lost to Follow-up|37|||
30738748|NCT00529373|58749882|FG000|First Extension Study|Other|27|||
30738749|NCT00529373|58749883|FG001|First Extension Study|Other|47|||
30738750|NCT00529373|58749882|FG000|First Extension Study|Physician Decision|50|||
30738751|NCT00529373|58749883|FG001|First Extension Study|Physician Decision|45|||
30738752|NCT00529373|58749882|FG000|First Extension Study|Protocol Violation|16|||
30738753|NCT00529373|58749883|FG001|First Extension Study|Protocol Violation|13|||
30738754|NCT00529373|58749882|FG000|First Extension Study|Withdrawal by Subject|296|||
30738755|NCT00529373|58749883|FG001|First Extension Study|Withdrawal by Subject|287|||
30738756|NCT00529373|58749882|FG000|First Extension Study|Disposition record non-existing|0|||
30738757|NCT00529373|58749883|FG001|First Extension Study|Disposition record non-existing|1|||
30738758|NCT00529373|58749882|FG000|First Extension Study|Discontinued after 5 years completion|208|||
30738759|NCT00529373|58749883|FG001|First Extension Study|Discontinued after 5 years completion|346|||
30738760|NCT00529373|58749882|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
30738761|NCT00529373|58749883|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
30738762|NCT00529373|58749882|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
30738763|NCT00529373|58749883|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
30901255|NCT01652729|58934910|FG001|Overall Study|Physician Decision|0|||
30901256|NCT01652729|58934911|FG002|Overall Study|Physician Decision|1|||
30901257|NCT01652729|58934909|FG000|Overall Study|Protocol Violation|1|||
30901258|NCT01652729|58934910|FG001|Overall Study|Protocol Violation|0|||
30901259|NCT01652729|58934911|FG002|Overall Study|Protocol Violation|0|||
30901260|NCT01652729|58934909|FG000|Overall Study|Lost to Follow-up|6|||
30901261|NCT01652729|58934910|FG001|Overall Study|Lost to Follow-up|6|||
30901262|NCT01652729|58934911|FG002|Overall Study|Lost to Follow-up|3|||
30901263|NCT01652729|58934909|FG000|Overall Study|Administrative|1|||
30901264|NCT01652729|58934910|FG001|Overall Study|Administrative|0|||
30901265|NCT01652729|58934911|FG002|Overall Study|Administrative|0|||
30901266|NCT02083965|58934921|FG000|Treatment Period|Other|1|||
30901267|NCT02083965|58934922|FG001|Treatment Period|Other|0|||
30901268|NCT02438813|58934930|FG000|Overall Study|Patient Decision|59|||
30901269|NCT02438813|58934930|FG000|Overall Study|Patient Lost to Follow-Up|137|||
30901270|NCT02438813|58934930|FG000|Overall Study|Study Ended by Sponsor|80|||
30901271|NCT02438813|58934930|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
30738764|NCT00529373|58749882|FG000|Second Extension Study|Adverse Event|101|||
30738765|NCT00529373|58749883|FG001|Second Extension Study|Adverse Event|51|||
30738766|NCT00529373|58749882|FG000|Second Extension Study|Lack of Efficacy|7|||
30738767|NCT00529373|58749883|FG001|Second Extension Study|Lack of Efficacy|15|||
30738768|NCT00529373|58749882|FG000|Second Extension Study|Lost to Follow-up|18|||
30738769|NCT00529373|58749883|FG001|Second Extension Study|Lost to Follow-up|12|||
30738770|NCT00529373|58749882|FG000|Second Extension Study|Other|7|||
30738771|NCT00529373|58749883|FG001|Second Extension Study|Other|12|||
30738772|NCT00529373|58749882|FG000|Second Extension Study|Physician Decision|63|||
30738773|NCT00529373|58749883|FG001|Second Extension Study|Physician Decision|26|||
30738774|NCT00529373|58749882|FG000|Second Extension Study|Protocol Violation|2|||
30738775|NCT00529373|58749883|FG001|Second Extension Study|Protocol Violation|1|||
30738776|NCT00529373|58749882|FG000|Second Extension Study|Withdrawal by Subject|97|||
30738777|NCT00529373|58749883|FG001|Second Extension Study|Withdrawal by Subject|75|||
30738778|NCT00529373|58749882|FG000|Second Extension Study|Status Missing|5|||
30738779|NCT00529373|58749883|FG001|Second Extension Study|Status Missing|5|||
30738780|NCT00369122|58749897|FG000|Overall Study|Ineligible|10|||
30738781|NCT00369122|58749897|FG000|Overall Study|No protocol treatment|1|||
30738782|NCT03687125|58749903|FG000|Overall Study|Progressive Disease|2|||
30738783|NCT03687125|58749904|FG001|Overall Study|Progressive Disease|1|||
30738784|NCT03687125|58749903|FG000|Overall Study|Protocol Violation|1|||
30901272|NCT02437409|58934944|FG000|Overall Study|Withdrawal by Subject|3|||
30901273|NCT02437409|58934944|FG000|Overall Study|Screening failure|12|||
30901274|NCT02459093|58934951|FG000|Overall Study|Protocol Violation|6|||
30901275|NCT02459093|58934952|FG001|Overall Study|Protocol Violation|11|||
30738785|NCT03687125|58749904|FG001|Overall Study|Protocol Violation|0|||
30738786|NCT03872843|58749914|FG000|Overall Study|Lost to Follow-up|5|||
30901276|NCT02459093|58934951|FG000|Overall Study|Lost to Follow-up|6|||
30901277|NCT02459093|58934952|FG001|Overall Study|Lost to Follow-up|7|||
30901278|NCT02458469|58934958|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
30901279|NCT02458469|58934959|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
30901280|NCT02458469|58934960|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
30901281|NCT02458469|58934961|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
30901282|NCT02458469|58934962|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
30901283|NCT02458469|58934963|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
30901284|NCT02458469|58934958|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
30901285|NCT02458469|58934959|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
30901286|NCT02458469|58934960|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
30901287|NCT02458469|58934961|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
30901288|NCT02458469|58934962|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
30901289|NCT02458469|58934963|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
30901290|NCT02458469|58934958|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
30901291|NCT02458469|58934959|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
30901292|NCT02458469|58934960|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
30901293|NCT02458469|58934961|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
30901294|NCT02458469|58934962|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
30901295|NCT02458469|58934963|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
30901296|NCT01843348|58934974|FG000|Overall Study|Withdrawal by Subject|4|||
30901297|NCT01843348|58934975|FG001|Overall Study|Withdrawal by Subject|16|||
30901298|NCT01843348|58934976|FG002|Overall Study|Withdrawal by Subject|18|||
30901299|NCT01843348|58934974|FG000|Overall Study|Lost to Follow-up|5|||
30738787|NCT03872843|58749915|FG001|Overall Study|Lost to Follow-up|7|||
30738788|NCT00146770|58749923|FG000|Overall Study|Adverse Event|2|||
30738789|NCT00146770|58749924|FG001|Overall Study|Adverse Event|0|||
30738790|NCT00146770|58749923|FG000|Overall Study|Pregnancy|1|||
30901300|NCT01843348|58934975|FG001|Overall Study|Lost to Follow-up|4|||
30901301|NCT01843348|58934976|FG002|Overall Study|Lost to Follow-up|2|||
30901302|NCT01843348|58934974|FG000|Overall Study|Death|5|||
30901303|NCT01843348|58934975|FG001|Overall Study|Death|3|||
30901304|NCT01843348|58934976|FG002|Overall Study|Death|4|||
30901305|NCT01843348|58934974|FG000|Overall Study|Graft loss/retransplantation|5|||
30901306|NCT01843348|58934975|FG001|Overall Study|Graft loss/retransplantation|8|||
30901307|NCT01843348|58934976|FG002|Overall Study|Graft loss/retransplantation|11|||
30901308|NCT01843348|58934974|FG000|Overall Study|Various reasons|4|||
30901309|NCT01843348|58934975|FG001|Overall Study|Various reasons|9|||
30901310|NCT01843348|58934976|FG002|Overall Study|Various reasons|6|||
30901311|NCT01843192|58934989|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
30738791|NCT00146770|58749924|FG001|Overall Study|Pregnancy|0|||
30738792|NCT00146770|58749923|FG000|Overall Study|Withdrawal by Subject|2|||
30738793|NCT00146770|58749924|FG001|Overall Study|Withdrawal by Subject|0|||
30901312|NCT01843192|58934990|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
30738794|NCT03874013|58749932|FG000|Overall Study|Adverse Event|0|||
30738795|NCT03874013|58749933|FG001|Overall Study|Adverse Event|1|||
30738796|NCT00168064|58749941|FG000|Overall Study|Adverse Event|26|||
30738797|NCT00168064|58749942|FG001|Overall Study|Adverse Event|22|||
30738798|NCT00168064|58749941|FG000|Overall Study|Withdrawal by Subject|3|||
30738799|NCT00168064|58749942|FG001|Overall Study|Withdrawal by Subject|4|||
30738800|NCT00168064|58749941|FG000|Overall Study|Lack of Efficacy|4|||
30738801|NCT00168064|58749942|FG001|Overall Study|Lack of Efficacy|4|||
30901313|NCT01843192|58934991|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
30901314|NCT01825876|58934999|FG000|Period 2|Withdrawal by Subject|0|||
30901315|NCT01825876|58935000|FG001|Period 2|Withdrawal by Subject|1|||
30901316|NCT01842958|58935011|FG000|Overall Study|Lost to Follow-up|1|||
30901317|NCT01842958|58935012|FG001|Overall Study|Lost to Follow-up|1|||
30901318|NCT02413229|58935026|FG000|Overall Study|Adverse Event|0|||
30901319|NCT02413229|58935027|FG001|Overall Study|Adverse Event|0|||
30901320|NCT02413229|58935028|FG002|Overall Study|Adverse Event|0|||
30901321|NCT02413229|58935029|FG003|Overall Study|Adverse Event|1|||
30901322|NCT02413229|58935030|FG004|Overall Study|Adverse Event|0|||
30901323|NCT02413229|58935031|FG005|Overall Study|Adverse Event|0|||
30901324|NCT02413229|58935032|FG006|Overall Study|Adverse Event|0|||
30901325|NCT02413229|58935033|FG007|Overall Study|Adverse Event|1|||
30901326|NCT02413229|58935026|FG000|Overall Study|Lost to Follow-up|0|||
30901327|NCT02413229|58935027|FG001|Overall Study|Lost to Follow-up|0|||
30901328|NCT02413229|58935028|FG002|Overall Study|Lost to Follow-up|1|||
30901329|NCT02413229|58935029|FG003|Overall Study|Lost to Follow-up|0|||
30901330|NCT02413229|58935030|FG004|Overall Study|Lost to Follow-up|2|||
30901331|NCT02413229|58935031|FG005|Overall Study|Lost to Follow-up|0|||
30901332|NCT02413229|58935032|FG006|Overall Study|Lost to Follow-up|0|||
30901333|NCT02413229|58935033|FG007|Overall Study|Lost to Follow-up|0|||
30901334|NCT02413229|58935026|FG000|Overall Study|Withdrawal by Subject|1|||
30901335|NCT02413229|58935027|FG001|Overall Study|Withdrawal by Subject|1|||
30901336|NCT02413229|58935028|FG002|Overall Study|Withdrawal by Subject|0|||
30901337|NCT02413229|58935029|FG003|Overall Study|Withdrawal by Subject|0|||
30901338|NCT02413229|58935030|FG004|Overall Study|Withdrawal by Subject|1|||
30901339|NCT02413229|58935031|FG005|Overall Study|Withdrawal by Subject|0|||
30901340|NCT02413229|58935032|FG006|Overall Study|Withdrawal by Subject|0|||
30901341|NCT02413229|58935033|FG007|Overall Study|Withdrawal by Subject|2|||
30901342|NCT02413229|58935026|FG000|Overall Study|Progressive Disease|0|||
30901343|NCT02413229|58935027|FG001|Overall Study|Progressive Disease|0|||
30901344|NCT02413229|58935028|FG002|Overall Study|Progressive Disease|0|||
30901345|NCT02413229|58935029|FG003|Overall Study|Progressive Disease|0|||
30901346|NCT02413229|58935030|FG004|Overall Study|Progressive Disease|0|||
30901347|NCT02413229|58935031|FG005|Overall Study|Progressive Disease|0|||
30901348|NCT02413229|58935032|FG006|Overall Study|Progressive Disease|0|||
30901349|NCT02413229|58935033|FG007|Overall Study|Progressive Disease|1|||
30901350|NCT01825798|58935053|FG000|Overall Study|Adverse Event|1|||
30901351|NCT01825798|58935054|FG001|Overall Study|Adverse Event|5|||
30901352|NCT01825798|58935053|FG000|Overall Study|Lost to Follow-up|1|||
30738802|NCT00168064|58749941|FG000|Overall Study|Lost to Follow-up|4|||
30738803|NCT00168064|58749942|FG001|Overall Study|Lost to Follow-up|3|||
30738804|NCT00168064|58749941|FG000|Overall Study|Non-compliance|2|||
30738805|NCT00168064|58749942|FG001|Overall Study|Non-compliance|3|||
30738806|NCT00168064|58749941|FG000|Overall Study|Concurrent Illness|4|||
30738807|NCT00168064|58749942|FG001|Overall Study|Concurrent Illness|3|||
30738808|NCT00168064|58749941|FG000|Overall Study|Subject's Best interest|2|||
30738809|NCT00168064|58749942|FG001|Overall Study|Subject's Best interest|2|||
30738810|NCT00168064|58749941|FG000|Overall Study|Various|4|||
30738811|NCT00168064|58749942|FG001|Overall Study|Various|3|||
30738812|NCT00166114|58749952|FG000|Overall Study|Protocol Violation|2|||
30738813|NCT00166114|58749953|FG001|Overall Study|Protocol Violation|1|||
30738814|NCT00166114|58749952|FG000|Overall Study|Withdrawal by Subject|10|||
30738815|NCT00166114|58749953|FG001|Overall Study|Withdrawal by Subject|4|||
30901353|NCT01825798|58935054|FG001|Overall Study|Lost to Follow-up|0|||
30901354|NCT01824472|58935063|FG000|Overall Study|Lost to Follow-up|0|||
30901355|NCT01824472|58935064|FG001|Overall Study|Lost to Follow-up|0|||
30901356|NCT01824472|58935065|FG002|Overall Study|Lost to Follow-up|1|||
30901357|NCT01824472|58935063|FG000|Overall Study|Withdrawal by Subject|1|||
30738816|NCT00166114|58749952|FG000|Overall Study|Adverse Event|2|||
30901358|NCT01824472|58935064|FG001|Overall Study|Withdrawal by Subject|5|||
30738817|NCT00166114|58749953|FG001|Overall Study|Adverse Event|1|||
30901359|NCT01824472|58935065|FG002|Overall Study|Withdrawal by Subject|3|||
30901360|NCT01824472|58935063|FG000|Overall Study|Ineligible post randomization&screening|0|||
30738818|NCT03686969|58749961|FG000|Overall Study|Study terminated|1|||
30901361|NCT01824472|58935064|FG001|Overall Study|Ineligible post randomization&screening|2|||
30901362|NCT01824472|58935065|FG002|Overall Study|Ineligible post randomization&screening|0|||
30901363|NCT02412761|58935073|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
30901364|NCT02412761|58935074|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
30901365|NCT02412761|58935075|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
30738819|NCT03686969|58749962|FG001|Overall Study|Study terminated|0|||
30738820|NCT00145600|58749972|FG000|Overall Study|Death|1|||
30738821|NCT00145600|58749973|FG001|Overall Study|Death|2|||
30738822|NCT00145600|58749974|FG002|Overall Study|Death|2|||
30738823|NCT00145600|58749975|FG003|Overall Study|Death|6|||
30738824|NCT00145600|58749972|FG000|Overall Study|Ineligible|3|||
30738825|NCT00145600|58749973|FG001|Overall Study|Ineligible|0|||
30738826|NCT00145600|58749974|FG002|Overall Study|Ineligible|1|||
30738827|NCT00145600|58749975|FG003|Overall Study|Ineligible|5|||
30738828|NCT00145600|58749972|FG000|Overall Study|Lost to Follow-up|2|||
30738829|NCT00145600|58749973|FG001|Overall Study|Lost to Follow-up|6|||
30738830|NCT00145600|58749974|FG002|Overall Study|Lost to Follow-up|2|||
30738831|NCT00145600|58749975|FG003|Overall Study|Lost to Follow-up|4|||
30738832|NCT00145600|58749972|FG000|Overall Study|Noncompliance|1|||
30738833|NCT00145600|58749973|FG001|Overall Study|Noncompliance|0|||
30738834|NCT00145600|58749974|FG002|Overall Study|Noncompliance|0|||
30738835|NCT00145600|58749975|FG003|Overall Study|Noncompliance|0|||
30738836|NCT00145600|58749972|FG000|Overall Study|Withdrawal by Subject|1|||
30738837|NCT00145600|58749973|FG001|Overall Study|Withdrawal by Subject|2|||
30738838|NCT00145600|58749974|FG002|Overall Study|Withdrawal by Subject|0|||
30738839|NCT00145600|58749975|FG003|Overall Study|Withdrawal by Subject|1|||
30738840|NCT00129376|58749999|FG000|Overall Study|Adverse Event|1|||
30738841|NCT00129376|58749999|FG000|Overall Study|Lack of Efficacy|1|||
30738842|NCT00129220|58750006|FG000|Study Period II|Adverse Event|9|||
30738843|NCT00129220|58750007|FG001|Study Period II|Adverse Event|5|||
30738844|NCT00129220|58750008|FG002|Study Period II|Adverse Event|7|||
30790979|NCT00829426|58804137|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
30790980|NCT00152464|58804143|FG000|Overall Study|Adverse Event|3|||
30790981|NCT00152464|58804144|FG001|Overall Study|Adverse Event|6|||
30901366|NCT02412761|58935076|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
30621927|NCT04066491|58633459|FG002|Overall Study|Treatment ongoing|66|||
30738845|NCT00129220|58750006|FG000|Study Period II|Lack of Efficacy|15|||
30738846|NCT00129220|58750007|FG001|Study Period II|Lack of Efficacy|1|||
30901367|NCT02412761|58935077|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
30901368|NCT02412761|58935078|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
30901369|NCT01842334|58935088|FG000|Overall Study|Withdrawal by Subject|3|||
30901370|NCT01842334|58935089|FG001|Overall Study|Withdrawal by Subject|3|||
30901371|NCT01842334|58935088|FG000|Overall Study|Moved away mid-study|0|||
30901372|NCT01842334|58935089|FG001|Overall Study|Moved away mid-study|1|||
30901373|NCT02457611|58935095|FG000|Overall Study|Lost to Follow-up|3|||
30901374|NCT02457065|58935101|FG000|Overall Study|Lost to Follow-up|9|||
30901375|NCT02457065|58935102|FG001|Overall Study|Lost to Follow-up|11|||
30901376|NCT02083653|58935111|FG000|Overall Study|Randomized but not Treated|0|||
30901377|NCT02083653|58935112|FG001|Overall Study|Randomized but not Treated|2|||
30901378|NCT02083653|58935113|FG002|Overall Study|Randomized but not Treated|7|||
30738847|NCT00129220|58750008|FG002|Study Period II|Lack of Efficacy|28|||
30738848|NCT00129220|58750006|FG000|Study Period II|Entry Criteria Not Met|2|||
30901379|NCT02083653|58935111|FG000|Overall Study|Adverse Event|12|||
30738849|NCT00129220|58750007|FG001|Study Period II|Entry Criteria Not Met|0|||
30738850|NCT00129220|58750008|FG002|Study Period II|Entry Criteria Not Met|2|||
30738851|NCT00129220|58750006|FG000|Study Period II|Protocol Violation|4|||
30738852|NCT00129220|58750007|FG001|Study Period II|Protocol Violation|2|||
30790982|NCT00152464|58804143|FG000|Overall Study|Lost to Follow-up|8|||
30738853|NCT00129220|58750008|FG002|Study Period II|Protocol Violation|1|||
30738854|NCT00129220|58750006|FG000|Study Period II|Physician Decision|0|||
30738855|NCT00129220|58750007|FG001|Study Period II|Physician Decision|1|||
30738856|NCT00129220|58750008|FG002|Study Period II|Physician Decision|0|||
30738857|NCT00129220|58750006|FG000|Study Period II|Withdrawal by Subject|1|||
30738858|NCT00129220|58750007|FG001|Study Period II|Withdrawal by Subject|3|||
30738859|NCT00129220|58750008|FG002|Study Period II|Withdrawal by Subject|4|||
30738860|NCT00129220|58750006|FG000|Study Period II|Reason Not Specified|2|||
30738861|NCT00129220|58750007|FG001|Study Period II|Reason Not Specified|0|||
30738862|NCT00129220|58750008|FG002|Study Period II|Reason Not Specified|5|||
30738863|NCT00129220|58750006|FG000|Study Period III|Adverse Event|1|||
30738864|NCT00129220|58750007|FG001|Study Period III|Adverse Event|0|||
30738865|NCT00129220|58750008|FG002|Study Period III|Adverse Event|3|||
30738866|NCT00129220|58750006|FG000|Study Period III|Protocol Violation|1|||
30738867|NCT00129220|58750007|FG001|Study Period III|Protocol Violation|1|||
30738868|NCT00129220|58750008|FG002|Study Period III|Protocol Violation|2|||
30738869|NCT00129220|58750006|FG000|Study Period III|Withdrawal by Subject|1|||
30901380|NCT02083653|58935112|FG001|Overall Study|Adverse Event|5|||
30901381|NCT02083653|58935113|FG002|Overall Study|Adverse Event|4|||
30738870|NCT00129220|58750007|FG001|Study Period III|Withdrawal by Subject|0|||
30738871|NCT00129220|58750008|FG002|Study Period III|Withdrawal by Subject|3|||
30738872|NCT00129220|58750006|FG000|Study Period III|Sponsor Decision|1|||
30738873|NCT00129220|58750007|FG001|Study Period III|Sponsor Decision|0|||
30738874|NCT00129220|58750008|FG002|Study Period III|Sponsor Decision|0|||
30738875|NCT00129220|58750006|FG000|Study Period III|Reason Not Specified|9|||
30738876|NCT00129220|58750007|FG001|Study Period III|Reason Not Specified|0|||
30738877|NCT00129220|58750008|FG002|Study Period III|Reason Not Specified|2|||
30738878|NCT00128830|58750028|FG000|Overall Study|Adverse Event|10|||
30738879|NCT00128830|58750028|FG000|Overall Study|Withdrawal by Subject|14|||
30738880|NCT00128830|58750028|FG000|Overall Study|Lost to Follow-up|4|||
30738881|NCT00128830|58750028|FG000|Overall Study|Reached a virologic endpoint|29|||
30738882|NCT00128830|58750028|FG000|Overall Study|Non-compliant|4|||
30738883|NCT00128830|58750028|FG000|Overall Study|Discontinued or ineligible for study|2|||
30738884|NCT00128830|58750028|FG000|Overall Study|Other|9|||
30738885|NCT03686033|58750034|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
30738886|NCT03686033|58750035|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
30901382|NCT02083653|58935111|FG000|Overall Study|Lost to Follow-up|1|||
30901383|NCT02083653|58935112|FG001|Overall Study|Lost to Follow-up|0|||
30901384|NCT02083653|58935113|FG002|Overall Study|Lost to Follow-up|0|||
30901385|NCT02083653|58935111|FG000|Overall Study|Death|2|||
30738887|NCT03686033|58750036|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
30738888|NCT03686033|58750037|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
30738889|NCT03686033|58750038|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
30738890|NCT03686033|58750039|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
30738891|NCT00128206|58750055|FG000|Overall Study|Lost to Follow-up|137|||
30738892|NCT00128206|58750056|FG001|Overall Study|Lost to Follow-up|118|||
30738893|NCT00128206|58750055|FG000|Overall Study|Adverse Event|0|||
30738894|NCT00128206|58750056|FG001|Overall Study|Adverse Event|2|||
30738895|NCT03685643|58750064|FG000|Overall Study|Lost to Follow-up|14|||
30738896|NCT03685643|58750065|FG001|Overall Study|Lost to Follow-up|22|||
30738897|NCT03823378|58750077|FG000|Overall Study|Adverse Event|2|||
30790983|NCT00152464|58804144|FG001|Overall Study|Lost to Follow-up|4|||
30901386|NCT02083653|58935112|FG001|Overall Study|Death|2|||
30901387|NCT02083653|58935113|FG002|Overall Study|Death|2|||
30901388|NCT02083653|58935111|FG000|Overall Study|Progressive Disease|65|||
30738898|NCT03823378|58750078|FG001|Overall Study|Adverse Event|2|||
30738899|NCT03823378|58750079|FG002|Overall Study|Adverse Event|0|||
30738900|NCT03823378|58750080|FG003|Overall Study|Adverse Event|0|||
30738901|NCT03823378|58750081|FG004|Overall Study|Adverse Event|0|||
30738902|NCT03823378|58750082|FG005|Overall Study|Adverse Event|0|||
30901389|NCT02083653|58935112|FG001|Overall Study|Progressive Disease|73|||
30738903|NCT03823378|58750077|FG000|Overall Study|Lost to Follow-up|0|||
30738904|NCT03823378|58750078|FG001|Overall Study|Lost to Follow-up|1|||
30738905|NCT03823378|58750079|FG002|Overall Study|Lost to Follow-up|0|||
30738906|NCT03823378|58750080|FG003|Overall Study|Lost to Follow-up|0|||
30738907|NCT03823378|58750081|FG004|Overall Study|Lost to Follow-up|1|||
30738908|NCT03823378|58750082|FG005|Overall Study|Lost to Follow-up|0|||
30738909|NCT03823378|58750077|FG000|Overall Study|Withdrawal by Subject|0|||
30738910|NCT03823378|58750078|FG001|Overall Study|Withdrawal by Subject|1|||
30738911|NCT03823378|58750079|FG002|Overall Study|Withdrawal by Subject|4|||
30738912|NCT03823378|58750080|FG003|Overall Study|Withdrawal by Subject|2|||
30738913|NCT03823378|58750081|FG004|Overall Study|Withdrawal by Subject|0|||
30790984|NCT00152464|58804143|FG000|Overall Study|Protocol Violation|3|||
30738914|NCT03823378|58750082|FG005|Overall Study|Withdrawal by Subject|1|||
30738915|NCT03823378|58750077|FG000|Overall Study|Other, not specified|19|||
30901390|NCT02083653|58935113|FG002|Overall Study|Progressive Disease|63|||
30901391|NCT02083653|58935111|FG000|Overall Study|Withdrawal by Subject|2|||
30738916|NCT03823378|58750078|FG001|Overall Study|Other, not specified|12|||
30901392|NCT02083653|58935112|FG001|Overall Study|Withdrawal by Subject|1|||
30738917|NCT03823378|58750079|FG002|Overall Study|Other, not specified|6|||
30738918|NCT03823378|58750080|FG003|Overall Study|Other, not specified|8|||
30738919|NCT03823378|58750081|FG004|Overall Study|Other, not specified|17|||
30738920|NCT03823378|58750082|FG005|Overall Study|Other, not specified|7|||
30738921|NCT00142792|58750099|FG000|Overall Study|Death|0|||
30738922|NCT00142792|58750100|FG001|Overall Study|Death|0|||
30738923|NCT00142792|58750101|FG002|Overall Study|Death|1|||
30738924|NCT00142792|58750099|FG000|Overall Study|Withdrawal by Subject|3|||
30738925|NCT00142792|58750100|FG001|Overall Study|Withdrawal by Subject|2|||
30738926|NCT00142792|58750101|FG002|Overall Study|Withdrawal by Subject|3|||
30738927|NCT00142792|58750099|FG000|Overall Study|Lost to Follow-up|8|||
30738928|NCT00142792|58750100|FG001|Overall Study|Lost to Follow-up|11|||
30738929|NCT00142792|58750101|FG002|Overall Study|Lost to Follow-up|7|||
30738930|NCT00142792|58750099|FG000|Overall Study|No category|1|||
30738931|NCT00142792|58750100|FG001|Overall Study|No category|2|||
30738932|NCT00142792|58750101|FG002|Overall Study|No category|1|||
30738933|NCT00141778|58750112|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
30738934|NCT00141778|58750113|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
30738935|NCT00141778|58750114|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
30738936|NCT00141778|58750112|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
30621928|NCT04066491|58633457|FG000|Overall Study|Treatment completed/discontinued and in follow-up,|2|||
30738937|NCT00141778|58750113|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
30738938|NCT00141778|58750114|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
30738939|NCT00141778|58750112|FG000|Started Study Medication|Withdrawal by Subject|0|||
30738940|NCT00141778|58750113|FG001|Started Study Medication|Withdrawal by Subject|2|||
30738941|NCT00141778|58750114|FG002|Started Study Medication|Withdrawal by Subject|0|||
30738942|NCT00141778|58750112|FG000|Started Study Medication|Difficulty Swallowing|0|||
30738943|NCT00141778|58750113|FG001|Started Study Medication|Difficulty Swallowing|1|||
30738944|NCT00141778|58750114|FG002|Started Study Medication|Difficulty Swallowing|0|||
30738945|NCT00141778|58750112|FG000|Started Study Medication|Chest Discomfort|0|||
30738946|NCT00141778|58750113|FG001|Started Study Medication|Chest Discomfort|0|||
30738947|NCT00141778|58750114|FG002|Started Study Medication|Chest Discomfort|1|||
30738948|NCT00127660|58750126|FG000|Overall Study|Protocol Violation|3|||
30901393|NCT02083653|58935113|FG002|Overall Study|Withdrawal by Subject|2|||
30901394|NCT02083653|58935111|FG000|Overall Study|Other Events|0|||
30901395|NCT02083653|58935112|FG001|Overall Study|Other Events|2|||
30901396|NCT02083653|58935113|FG002|Overall Study|Other Events|2|||
30738949|NCT00127660|58750127|FG001|Overall Study|Protocol Violation|3|||
30738950|NCT00127660|58750128|FG002|Overall Study|Protocol Violation|5|||
30790985|NCT00152464|58804144|FG001|Overall Study|Protocol Violation|1|||
30738951|NCT00127660|58750129|FG003|Overall Study|Protocol Violation|0|||
30738952|NCT03817528|58750139|FG000|Overall Study|Withdrawal by Subject|1|||
30738953|NCT03817528|58750139|FG000|Overall Study|Adverse Event|2|||
30738954|NCT00115336|58750145|FG000|Overall Study|Hospital discharge before study drug|0|||
30738955|NCT00115336|58750146|FG001|Overall Study|Hospital discharge before study drug|1|||
30738956|NCT00205803|58750156|FG000|Infant Series|Lost to Follow-up|10|||
30738957|NCT00205803|58750157|FG001|Infant Series|Lost to Follow-up|4|||
30738958|NCT00205803|58750156|FG000|Infant Series|Withdrawal by Subject|2|||
30738959|NCT00205803|58750157|FG001|Infant Series|Withdrawal by Subject|5|||
30738960|NCT00205803|58750156|FG000|Infant Series|Physician Decision|3|||
30738961|NCT00205803|58750157|FG001|Infant Series|Physician Decision|1|||
30901397|NCT02083653|58935111|FG000|Overall Study|Reason Missing|0|||
30901398|NCT02083653|58935112|FG001|Overall Study|Reason Missing|0|||
30901399|NCT02083653|58935113|FG002|Overall Study|Reason Missing|4|||
30901400|NCT02436239|58935125|FG000|Open-Lable Treatment Period|Adverse Event|12|||
30901401|NCT02436239|58935126|FG001|Open-Lable Treatment Period|Adverse Event|3|||
30901402|NCT02436239|58935127|FG002|Open-Lable Treatment Period|Adverse Event|4|||
30901403|NCT02436239|58935128|FG003|Open-Lable Treatment Period|Adverse Event|2|||
30901404|NCT02436239|58935125|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
30901405|NCT02436239|58935126|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
30901406|NCT02436239|58935127|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
30901407|NCT02436239|58935128|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
30901408|NCT02436239|58935125|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
30901409|NCT02436239|58935126|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
30901410|NCT02436239|58935127|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
30901411|NCT02436239|58935128|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
30901412|NCT02436239|58935125|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
30738962|NCT00205803|58750156|FG000|Infant Series|Protocol Violation|1|||
30738963|NCT00205803|58750157|FG001|Infant Series|Protocol Violation|0|||
30738964|NCT00205803|58750156|FG000|Infant Series|Lost Kaiser coverage|0|||
30738965|NCT00205803|58750157|FG001|Infant Series|Lost Kaiser coverage|1|||
30738966|NCT00205803|58750156|FG000|Infant Series|Non-compliant|1|||
30738967|NCT00205803|58750157|FG001|Infant Series|Non-compliant|0|||
30738968|NCT00205803|58750156|FG000|Infant Series|Sponsor request|1|||
30738969|NCT00205803|58750157|FG001|Infant Series|Sponsor request|0|||
30738970|NCT00205803|58750156|FG000|After Infant Series|Adverse Event|1|||
30738971|NCT00205803|58750157|FG001|After Infant Series|Adverse Event|1|||
30738972|NCT00205803|58750156|FG000|After Infant Series|Protocol Violation|1|||
30738973|NCT00205803|58750157|FG001|After Infant Series|Protocol Violation|1|||
30738974|NCT00205803|58750156|FG000|After Infant Series|Lost to Follow-up|2|||
30738975|NCT00205803|58750157|FG001|After Infant Series|Lost to Follow-up|1|||
30738976|NCT00205803|58750156|FG000|After Infant Series|Physician Decision|3|||
30738977|NCT00205803|58750157|FG001|After Infant Series|Physician Decision|2|||
30738978|NCT00205803|58750156|FG000|After Infant Series|Withdrawal by Subject|1|||
30738979|NCT00205803|58750157|FG001|After Infant Series|Withdrawal by Subject|4|||
30738980|NCT00205803|58750156|FG000|After Infant Series|Other|10|||
30738981|NCT00205803|58750157|FG001|After Infant Series|Other|4|||
30738982|NCT00205803|58750156|FG000|Toddler Dose|Lost to Follow-up|2|||
30738983|NCT00205803|58750157|FG001|Toddler Dose|Lost to Follow-up|3|||
30738984|NCT00127192|58750186|FG000|Overall Study|Adverse Event|0|||
30738985|NCT00127192|58750187|FG001|Overall Study|Adverse Event|1|||
30738986|NCT00127192|58750188|FG002|Overall Study|Adverse Event|1|||
30738987|NCT00127192|58750189|FG003|Overall Study|Adverse Event|1|||
30738988|NCT00127192|58750190|FG004|Overall Study|Adverse Event|0|||
30738989|NCT00127192|58750186|FG000|Overall Study|Lack of Efficacy|2|||
30738990|NCT00127192|58750187|FG001|Overall Study|Lack of Efficacy|0|||
30738991|NCT00127192|58750188|FG002|Overall Study|Lack of Efficacy|0|||
30738992|NCT00127192|58750189|FG003|Overall Study|Lack of Efficacy|0|||
30738993|NCT00127192|58750190|FG004|Overall Study|Lack of Efficacy|2|||
30738994|NCT00127192|58750186|FG000|Overall Study|Withdrawal by Subject|0|||
30738995|NCT00127192|58750187|FG001|Overall Study|Withdrawal by Subject|0|||
30738996|NCT00127192|58750188|FG002|Overall Study|Withdrawal by Subject|1|||
30738997|NCT00127192|58750189|FG003|Overall Study|Withdrawal by Subject|0|||
30738998|NCT00127192|58750190|FG004|Overall Study|Withdrawal by Subject|3|||
30738999|NCT00127192|58750186|FG000|Overall Study|Adverse event in pre-treatment period|1|||
30739000|NCT00127192|58750187|FG001|Overall Study|Adverse event in pre-treatment period|0|||
30739001|NCT00127192|58750188|FG002|Overall Study|Adverse event in pre-treatment period|0|||
30739002|NCT00127192|58750189|FG003|Overall Study|Adverse event in pre-treatment period|0|||
30739003|NCT00127192|58750190|FG004|Overall Study|Adverse event in pre-treatment period|0|||
30739004|NCT00205179|58750204|FG000|Overall Study|Death|0|||
30739005|NCT00205179|58750205|FG001|Overall Study|Death|2|||
30739006|NCT00205179|58750204|FG000|Overall Study|Physician Decision|1|||
30901413|NCT02436239|58935126|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
30739007|NCT00205179|58750205|FG001|Overall Study|Physician Decision|1|||
30901414|NCT02436239|58935127|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
30739008|NCT00205179|58750204|FG000|Overall Study|Adverse Event|1|||
30739009|NCT00205179|58750205|FG001|Overall Study|Adverse Event|1|||
30739010|NCT00127036|58750214|FG000|Overall Study|Insufficient Data for Analysis|6|||
30739011|NCT00127036|58750215|FG001|Overall Study|Insufficient Data for Analysis|11|||
30739012|NCT00127036|58750214|FG000|Overall Study|Screen Failure|2|||
30739013|NCT00127036|58750215|FG001|Overall Study|Screen Failure|0|||
30739014|NCT00259857|58750223|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
30739015|NCT00259857|58750224|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
30739016|NCT00259857|58750223|FG000|24 Months Treatment|Lost to Follow-up|0|||
30739017|NCT00259857|58750224|FG001|24 Months Treatment|Lost to Follow-up|3|||
30739018|NCT00203307|58750232|FG000|First Intervention|Adverse Event|2|||
30739019|NCT00203307|58750233|FG001|First Intervention|Adverse Event|0|||
30739020|NCT00126568|58750239|FG000|Overall Study|Death|2|||
30739021|NCT00114634|58750244|FG000|Overall Study|failure to return forms|3|||
30739022|NCT00202839|58750252|FG000|Overall Study|Adverse Event|1|||
30739023|NCT00202839|58750253|FG001|Overall Study|Adverse Event|5|||
30739024|NCT00202839|58750252|FG000|Overall Study|Physician Decision|12|||
30739025|NCT00202839|58750253|FG001|Overall Study|Physician Decision|0|||
30739026|NCT00202839|58750252|FG000|Overall Study|Withdrawal by Subject|6|||
30739027|NCT00202839|58750253|FG001|Overall Study|Withdrawal by Subject|2|||
30739028|NCT00202839|58750252|FG000|Overall Study|Protocol Violation|2|||
30739029|NCT00202839|58750253|FG001|Overall Study|Protocol Violation|1|||
30739030|NCT00202839|58750252|FG000|Overall Study|Lost to Follow-up|3|||
30739031|NCT00202839|58750253|FG001|Overall Study|Lost to Follow-up|2|||
30739032|NCT00201201|58750261|FG000|Overall Study|Death|0|||
30739033|NCT00201201|58750262|FG001|Overall Study|Death|2|||
30739034|NCT00201201|58750261|FG000|Overall Study|Withdrawal by Subject|5|||
30739035|NCT00201201|58750262|FG001|Overall Study|Withdrawal by Subject|5|||
30901415|NCT02436239|58935128|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
30901416|NCT02436239|58935125|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
30901417|NCT02436239|58935126|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
30901418|NCT02436239|58935127|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
30901419|NCT02436239|58935128|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
30901420|NCT02436239|58935125|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
30901421|NCT02436239|58935126|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
30901422|NCT02436239|58935127|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
30901423|NCT02436239|58935128|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
30901424|NCT02436239|58935125|FG000|Open-Lable Treatment Period|Other Reason|1|||
30901425|NCT02436239|58935126|FG001|Open-Lable Treatment Period|Other Reason|1|||
30901426|NCT02436239|58935127|FG002|Open-Lable Treatment Period|Other Reason|0|||
30901427|NCT02436239|58935128|FG003|Open-Lable Treatment Period|Other Reason|0|||
30901428|NCT02436239|58935125|FG000|Down-Taper Period|Withdrawal by Subject|4|||
30901429|NCT02436239|58935126|FG001|Down-Taper Period|Withdrawal by Subject|4|||
30901430|NCT02436239|58935127|FG002|Down-Taper Period|Withdrawal by Subject|1|||
30901431|NCT02436239|58935128|FG003|Down-Taper Period|Withdrawal by Subject|2|||
30901432|NCT02026011|58935140|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
30739036|NCT00126490|58750268|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
30739037|NCT00346632|58750274|FG000|Overall Study|Progressive Disease|2|||
30739038|NCT00346632|58750275|FG001|Overall Study|Progressive Disease|2|||
30739039|NCT00346632|58750276|FG002|Overall Study|Progressive Disease|4|||
30739040|NCT00346632|58750277|FG003|Overall Study|Progressive Disease|3|||
30739041|NCT00346632|58750278|FG004|Overall Study|Progressive Disease|3|||
30739042|NCT00346632|58750279|FG005|Overall Study|Progressive Disease|1|||
30739043|NCT00346632|58750280|FG006|Overall Study|Progressive Disease|2|||
30739044|NCT00346632|58750281|FG007|Overall Study|Progressive Disease|2|||
30739045|NCT00346632|58750282|FG008|Overall Study|Progressive Disease|2|||
30739046|NCT00346632|58750283|FG009|Overall Study|Progressive Disease|2|||
30739047|NCT00346632|58750274|FG000|Overall Study|Adverse Event|0|||
30739048|NCT00346632|58750275|FG001|Overall Study|Adverse Event|0|||
30739049|NCT00346632|58750276|FG002|Overall Study|Adverse Event|0|||
30739050|NCT00346632|58750277|FG003|Overall Study|Adverse Event|0|||
30739051|NCT00346632|58750278|FG004|Overall Study|Adverse Event|1|||
30739052|NCT00346632|58750279|FG005|Overall Study|Adverse Event|1|||
30739053|NCT00346632|58750280|FG006|Overall Study|Adverse Event|1|||
30739054|NCT00346632|58750281|FG007|Overall Study|Adverse Event|0|||
30739055|NCT00346632|58750282|FG008|Overall Study|Adverse Event|0|||
30739056|NCT00346632|58750283|FG009|Overall Study|Adverse Event|0|||
30739057|NCT00346632|58750274|FG000|Overall Study|Death|0|||
30621929|NCT04066491|58633458|FG001|Overall Study|Treatment completed/discontinued and in follow-up,|39|||
30739058|NCT00346632|58750275|FG001|Overall Study|Death|0|||
30739059|NCT00346632|58750276|FG002|Overall Study|Death|1|||
30739060|NCT00346632|58750277|FG003|Overall Study|Death|0|||
30739061|NCT00346632|58750278|FG004|Overall Study|Death|0|||
30739062|NCT00346632|58750279|FG005|Overall Study|Death|0|||
30739063|NCT00346632|58750280|FG006|Overall Study|Death|0|||
30739064|NCT00346632|58750281|FG007|Overall Study|Death|0|||
30739065|NCT00346632|58750282|FG008|Overall Study|Death|0|||
30739066|NCT00346632|58750283|FG009|Overall Study|Death|0|||
30739067|NCT00346632|58750274|FG000|Overall Study|Protocol Violation|0|||
30739068|NCT00346632|58750275|FG001|Overall Study|Protocol Violation|0|||
30739069|NCT00346632|58750276|FG002|Overall Study|Protocol Violation|0|||
30739070|NCT00346632|58750277|FG003|Overall Study|Protocol Violation|0|||
30739071|NCT00346632|58750278|FG004|Overall Study|Protocol Violation|0|||
30739072|NCT00346632|58750279|FG005|Overall Study|Protocol Violation|0|||
30739073|NCT00346632|58750280|FG006|Overall Study|Protocol Violation|1|||
30739074|NCT00346632|58750281|FG007|Overall Study|Protocol Violation|0|||
30739075|NCT00346632|58750282|FG008|Overall Study|Protocol Violation|0|||
30739076|NCT00346632|58750283|FG009|Overall Study|Protocol Violation|0|||
30739077|NCT00346632|58750274|FG000|Overall Study|Withdrawal by Subject|0|||
30739078|NCT00346632|58750275|FG001|Overall Study|Withdrawal by Subject|0|||
30739079|NCT00346632|58750276|FG002|Overall Study|Withdrawal by Subject|0|||
30739080|NCT00346632|58750277|FG003|Overall Study|Withdrawal by Subject|0|||
30739081|NCT00346632|58750278|FG004|Overall Study|Withdrawal by Subject|0|||
30739082|NCT00346632|58750279|FG005|Overall Study|Withdrawal by Subject|0|||
30739083|NCT00346632|58750280|FG006|Overall Study|Withdrawal by Subject|1|||
30739084|NCT00346632|58750281|FG007|Overall Study|Withdrawal by Subject|0|||
30739085|NCT00346632|58750282|FG008|Overall Study|Withdrawal by Subject|0|||
30739086|NCT00346632|58750283|FG009|Overall Study|Withdrawal by Subject|0|||
30739087|NCT00346632|58750274|FG000|Overall Study|Switched to alternative treatment|0|||
30739088|NCT00346632|58750275|FG001|Overall Study|Switched to alternative treatment|0|||
30739089|NCT00346632|58750276|FG002|Overall Study|Switched to alternative treatment|1|||
30739090|NCT00346632|58750277|FG003|Overall Study|Switched to alternative treatment|0|||
30739091|NCT00346632|58750278|FG004|Overall Study|Switched to alternative treatment|0|||
30739092|NCT00346632|58750279|FG005|Overall Study|Switched to alternative treatment|0|||
30739093|NCT00346632|58750280|FG006|Overall Study|Switched to alternative treatment|0|||
30739094|NCT00346632|58750281|FG007|Overall Study|Switched to alternative treatment|0|||
30739095|NCT00346632|58750282|FG008|Overall Study|Switched to alternative treatment|0|||
30739096|NCT00346632|58750283|FG009|Overall Study|Switched to alternative treatment|0|||
30739097|NCT00346632|58750274|FG000|Overall Study|Not Stated|1|||
30739098|NCT00346632|58750275|FG001|Overall Study|Not Stated|1|||
30739099|NCT00346632|58750276|FG002|Overall Study|Not Stated|0|||
30739100|NCT00346632|58750277|FG003|Overall Study|Not Stated|0|||
30739101|NCT00346632|58750278|FG004|Overall Study|Not Stated|0|||
30739102|NCT00346632|58750279|FG005|Overall Study|Not Stated|0|||
30739103|NCT00346632|58750280|FG006|Overall Study|Not Stated|0|||
30739104|NCT00346632|58750281|FG007|Overall Study|Not Stated|2|||
30739105|NCT00346632|58750282|FG008|Overall Study|Not Stated|2|||
30739106|NCT00346632|58750283|FG009|Overall Study|Not Stated|1|||
30739107|NCT00200967|58750347|FG000|First Treatment Period|Withdrawal by Subject|5|||
30739108|NCT00200967|58750348|FG001|First Treatment Period|Withdrawal by Subject|1|||
30739109|NCT00200967|58750347|FG000|First Treatment Period|Pregnancy|1|||
30739110|NCT00200967|58750348|FG001|First Treatment Period|Pregnancy|0|||
30621930|NCT04066491|58633459|FG002|Overall Study|Treatment completed/discontinued and in follow-up,|41|||
30739111|NCT00200967|58750347|FG000|Wash-out Period|Lost to Follow-up|0|||
30739112|NCT00200967|58750348|FG001|Wash-out Period|Lost to Follow-up|1|||
30739113|NCT00200967|58750347|FG000|Second Treatment Period|Withdrawal by Subject|1|||
30739114|NCT00200967|58750348|FG001|Second Treatment Period|Withdrawal by Subject|2|||
30739115|NCT00200967|58750347|FG000|Run-out Period|Lost to Follow-up|1|||
30739116|NCT00200967|58750348|FG001|Run-out Period|Lost to Follow-up|0|||
30739117|NCT00354432|58750358|FG000|Overall Study|Adverse Event|3|||
30739118|NCT00354432|58750359|FG001|Overall Study|Adverse Event|1|||
30739119|NCT00354432|58750360|FG002|Overall Study|Adverse Event|5|||
30739120|NCT00354432|58750361|FG003|Overall Study|Adverse Event|5|||
30739121|NCT00354432|58750358|FG000|Overall Study|Off/Toxicity|3|||
30790986|NCT00152464|58804143|FG000|Overall Study|Withdrawal by Subject|21|||
30901433|NCT02026011|58935141|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
30739122|NCT00354432|58750359|FG001|Overall Study|Off/Toxicity|7|||
30739123|NCT00354432|58750360|FG002|Overall Study|Off/Toxicity|5|||
30739124|NCT00354432|58750361|FG003|Overall Study|Off/Toxicity|5|||
30739125|NCT00140140|58750374|FG000|Overall Study|Unacceptable toxicity|1|||
30901434|NCT02026011|58935140|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
30901435|NCT02026011|58935141|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
30901436|NCT02026011|58935140|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
30901437|NCT02026011|58935141|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
30901438|NCT02026011|58935140|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
30901439|NCT02026011|58935141|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
30901440|NCT02436005|58935150|FG000|Second Intervention|Adverse Event|0|||
30901441|NCT02436005|58935151|FG001|Second Intervention|Adverse Event|1|||
30901442|NCT02456909|58935159|FG000|Overall Study|Did not receive allocated intervention|24|||
30901443|NCT02456909|58935160|FG001|Overall Study|Did not receive allocated intervention|26|||
30739126|NCT00140140|58750375|FG001|Overall Study|Unacceptable toxicity|1|||
30739127|NCT00140140|58750376|FG002|Overall Study|Unacceptable toxicity|2|||
30739128|NCT00140140|58750374|FG000|Overall Study|Physician Decision|1|||
30739129|NCT00140140|58750375|FG001|Overall Study|Physician Decision|1|||
30739130|NCT00140140|58750376|FG002|Overall Study|Physician Decision|0|||
30739131|NCT00346398|58750385|FG000|Overall Study|Lost to Follow-up|3|||
30739132|NCT00346398|58750386|FG001|Overall Study|Lost to Follow-up|0|||
30739133|NCT00346398|58750385|FG000|Overall Study|Withdrawal by Subject|0|||
30739134|NCT00346398|58750386|FG001|Overall Study|Withdrawal by Subject|2|||
30739135|NCT00346164|58750396|FG000|Overall Study|Adverse Event|0|||
30739136|NCT00346164|58750397|FG001|Overall Study|Adverse Event|0|||
30739137|NCT00346164|58750398|FG002|Overall Study|Adverse Event|0|||
30739138|NCT00346164|58750399|FG003|Overall Study|Adverse Event|1|||
30739139|NCT00346164|58750396|FG000|Overall Study|Lack of Efficacy|0|||
30739140|NCT00346164|58750397|FG001|Overall Study|Lack of Efficacy|1|||
30739141|NCT00346164|58750398|FG002|Overall Study|Lack of Efficacy|7|||
30739142|NCT00346164|58750399|FG003|Overall Study|Lack of Efficacy|25|||
30739143|NCT00346164|58750396|FG000|Overall Study|Physician Decision|0|||
30739144|NCT00346164|58750397|FG001|Overall Study|Physician Decision|1|||
30739145|NCT00346164|58750398|FG002|Overall Study|Physician Decision|2|||
30739146|NCT00346164|58750399|FG003|Overall Study|Physician Decision|27|||
30739147|NCT00346164|58750396|FG000|Overall Study|Protocol Violation|6|||
30739148|NCT00346164|58750397|FG001|Overall Study|Protocol Violation|2|||
30739149|NCT00346164|58750398|FG002|Overall Study|Protocol Violation|10|||
30739150|NCT00346164|58750399|FG003|Overall Study|Protocol Violation|4|||
30739151|NCT00346164|58750396|FG000|Overall Study|Withdrawal by Subject|0|||
30739152|NCT00346164|58750397|FG001|Overall Study|Withdrawal by Subject|0|||
30739153|NCT00346164|58750398|FG002|Overall Study|Withdrawal by Subject|2|||
30739154|NCT00346164|58750399|FG003|Overall Study|Withdrawal by Subject|0|||
30739155|NCT00346164|58750396|FG000|Overall Study|Ineligible|11|||
30739156|NCT00346164|58750397|FG001|Overall Study|Ineligible|2|||
30739157|NCT00346164|58750398|FG002|Overall Study|Ineligible|2|||
30739158|NCT00346164|58750399|FG003|Overall Study|Ineligible|23|||
30739159|NCT00346164|58750396|FG000|Overall Study|Refusal of further protocol therapy|0|||
30739160|NCT00346164|58750397|FG001|Overall Study|Refusal of further protocol therapy|1|||
30790987|NCT00152464|58804144|FG001|Overall Study|Withdrawal by Subject|22|||
30739161|NCT00346164|58750398|FG002|Overall Study|Refusal of further protocol therapy|3|||
30739162|NCT00346164|58750399|FG003|Overall Study|Refusal of further protocol therapy|15|||
30739163|NCT00346164|58750396|FG000|Overall Study|Inability to start week 16 tx on time|0|||
30739164|NCT00346164|58750397|FG001|Overall Study|Inability to start week 16 tx on time|0|||
30739165|NCT00346164|58750398|FG002|Overall Study|Inability to start week 16 tx on time|0|||
30739166|NCT00346164|58750399|FG003|Overall Study|Inability to start week 16 tx on time|11|||
30739167|NCT00114244|58750427|FG000|Overall Study|Adverse Event|2|||
30739168|NCT00114244|58750428|FG001|Overall Study|Adverse Event|5|||
30739169|NCT00114244|58750427|FG000|Overall Study|Withdrawal by Subject|0|||
30739170|NCT00114244|58750428|FG001|Overall Study|Withdrawal by Subject|2|||
30739171|NCT00138658|58750434|FG000|Overall Study|Adverse Event|23|||
30739172|NCT00138658|58750434|FG000|Overall Study|Death|1|||
30739173|NCT00138658|58750434|FG000|Overall Study|Disease Progression|21|||
30739174|NCT00138658|58750434|FG000|Overall Study|Physician Decision|11|||
30739175|NCT00138658|58750434|FG000|Overall Study|Withdrawal by Subject|5|||
30739176|NCT00337662|58750443|FG000|Study Period II|Lost to Follow-up|0|||
30739177|NCT00337662|58750444|FG001|Study Period II|Lost to Follow-up|0|||
30739178|NCT00337662|58750445|FG002|Study Period II|Lost to Follow-up|0|||
30739179|NCT00337662|58750446|FG003|Study Period II|Lost to Follow-up|35|||
30739180|NCT00337662|58750443|FG000|Study Period II|Withdrawal by Subject|0|||
30739181|NCT00337662|58750444|FG001|Study Period II|Withdrawal by Subject|0|||
30739182|NCT00337662|58750445|FG002|Study Period II|Withdrawal by Subject|0|||
30739183|NCT00337662|58750446|FG003|Study Period II|Withdrawal by Subject|20|||
30739184|NCT00337662|58750443|FG000|Study Period II|Adverse Event|0|||
30739185|NCT00337662|58750444|FG001|Study Period II|Adverse Event|0|||
30739186|NCT00337662|58750445|FG002|Study Period II|Adverse Event|0|||
30739187|NCT00337662|58750446|FG003|Study Period II|Adverse Event|16|||
30739188|NCT00337662|58750443|FG000|Study Period II|Physician Decision|0|||
30739189|NCT00337662|58750444|FG001|Study Period II|Physician Decision|0|||
30739190|NCT00337662|58750445|FG002|Study Period II|Physician Decision|0|||
30739191|NCT00337662|58750446|FG003|Study Period II|Physician Decision|13|||
30739192|NCT00337662|58750443|FG000|Study Period II|Entry Criteria Not Met|0|||
30739193|NCT00337662|58750444|FG001|Study Period II|Entry Criteria Not Met|0|||
30739194|NCT00337662|58750445|FG002|Study Period II|Entry Criteria Not Met|0|||
30739195|NCT00337662|58750446|FG003|Study Period II|Entry Criteria Not Met|6|||
30739196|NCT00337662|58750443|FG000|Study Period II|Protocol Violation|0|||
30739197|NCT00337662|58750444|FG001|Study Period II|Protocol Violation|0|||
30739198|NCT00337662|58750445|FG002|Study Period II|Protocol Violation|0|||
30739199|NCT00337662|58750446|FG003|Study Period II|Protocol Violation|6|||
30739200|NCT00337662|58750443|FG000|Study Period II|Lack of Efficacy|0|||
30739201|NCT00337662|58750444|FG001|Study Period II|Lack of Efficacy|0|||
30739202|NCT00337662|58750445|FG002|Study Period II|Lack of Efficacy|0|||
30739203|NCT00337662|58750446|FG003|Study Period II|Lack of Efficacy|7|||
30739204|NCT00337662|58750443|FG000|Study Period II|Sponsor Decision|0|||
30739205|NCT00337662|58750444|FG001|Study Period II|Sponsor Decision|0|||
30739206|NCT00337662|58750445|FG002|Study Period II|Sponsor Decision|0|||
30739207|NCT00337662|58750446|FG003|Study Period II|Sponsor Decision|2|||
30739208|NCT00337662|58750443|FG000|Study Period II|Parent/Caregiver Decision|0|||
30739209|NCT00337662|58750444|FG001|Study Period II|Parent/Caregiver Decision|0|||
30739210|NCT00337662|58750445|FG002|Study Period II|Parent/Caregiver Decision|0|||
30739211|NCT00337662|58750446|FG003|Study Period II|Parent/Caregiver Decision|1|||
30739212|NCT00337662|58750443|FG000|Study Period III|Lost to Follow-up|14|||
30739213|NCT00337662|58750444|FG001|Study Period III|Lost to Follow-up|16|||
30739214|NCT00337662|58750445|FG002|Study Period III|Lost to Follow-up|14|||
30739215|NCT00337662|58750446|FG003|Study Period III|Lost to Follow-up|0|||
30739216|NCT00337662|58750443|FG000|Study Period III|Withdrawal by Subject|18|||
30739217|NCT00337662|58750444|FG001|Study Period III|Withdrawal by Subject|14|||
30739218|NCT00337662|58750445|FG002|Study Period III|Withdrawal by Subject|12|||
30739219|NCT00337662|58750446|FG003|Study Period III|Withdrawal by Subject|0|||
30739220|NCT00337662|58750443|FG000|Study Period III|Adverse Event|9|||
30739221|NCT00337662|58750444|FG001|Study Period III|Adverse Event|10|||
30739222|NCT00337662|58750445|FG002|Study Period III|Adverse Event|8|||
30739223|NCT00337662|58750446|FG003|Study Period III|Adverse Event|0|||
30739224|NCT00337662|58750443|FG000|Study Period III|Protocol Violation|3|||
30739225|NCT00337662|58750444|FG001|Study Period III|Protocol Violation|8|||
30739226|NCT00337662|58750445|FG002|Study Period III|Protocol Violation|2|||
30739227|NCT00337662|58750446|FG003|Study Period III|Protocol Violation|0|||
30739228|NCT00337662|58750443|FG000|Study Period III|Physician Decision|6|||
30739229|NCT00337662|58750444|FG001|Study Period III|Physician Decision|5|||
30739230|NCT00337662|58750445|FG002|Study Period III|Physician Decision|0|||
30739231|NCT00337662|58750446|FG003|Study Period III|Physician Decision|0|||
30739232|NCT00337662|58750443|FG000|Study Period III|Entry Criteria Not Met|4|||
30739233|NCT00337662|58750444|FG001|Study Period III|Entry Criteria Not Met|1|||
30739234|NCT00337662|58750445|FG002|Study Period III|Entry Criteria Not Met|3|||
30739235|NCT00337662|58750446|FG003|Study Period III|Entry Criteria Not Met|0|||
30739236|NCT00337662|58750443|FG000|Study Period III|Lack of Efficacy|4|||
30739237|NCT00337662|58750444|FG001|Study Period III|Lack of Efficacy|4|||
30739238|NCT00337662|58750445|FG002|Study Period III|Lack of Efficacy|2|||
30739239|NCT00337662|58750446|FG003|Study Period III|Lack of Efficacy|0|||
30739240|NCT00337662|58750443|FG000|Study Period III|Parent/Caregiver Decision|0|||
30739241|NCT00337662|58750444|FG001|Study Period III|Parent/Caregiver Decision|0|||
30739242|NCT00337662|58750445|FG002|Study Period III|Parent/Caregiver Decision|2|||
30739243|NCT00337662|58750446|FG003|Study Period III|Parent/Caregiver Decision|0|||
30739244|NCT00337662|58750443|FG000|Study Period III|Sponsor Decision|1|||
30739245|NCT00337662|58750444|FG001|Study Period III|Sponsor Decision|0|||
30739246|NCT00337662|58750445|FG002|Study Period III|Sponsor Decision|1|||
30739247|NCT00337662|58750446|FG003|Study Period III|Sponsor Decision|0|||
30739248|NCT00337662|58750443|FG000|Study Period III|Clinical Relapse|1|||
30739249|NCT00337662|58750444|FG001|Study Period III|Clinical Relapse|0|||
30739250|NCT00337662|58750445|FG002|Study Period III|Clinical Relapse|0|||
30739251|NCT00337662|58750446|FG003|Study Period III|Clinical Relapse|0|||
30739252|NCT00138424|58750461|FG000|Overall Study|Physician Decision|0|||
30739253|NCT00138424|58750462|FG001|Overall Study|Physician Decision|1|||
30739254|NCT00138424|58750463|FG002|Overall Study|Physician Decision|0|||
30739255|NCT00138424|58750464|FG003|Overall Study|Physician Decision|0|||
30739256|NCT00368966|58750478|FG000|Infant Series|Withdrawal by Subject|11|||
30739257|NCT00368966|58750479|FG001|Infant Series|Withdrawal by Subject|6|||
30739258|NCT00368966|58750478|FG000|Infant Series|Protocol Violation|2|||
30739259|NCT00368966|58750479|FG001|Infant Series|Protocol Violation|1|||
30739260|NCT00368966|58750478|FG000|Infant Series|Lost to Follow-up|2|||
30739261|NCT00368966|58750479|FG001|Infant Series|Lost to Follow-up|0|||
30739262|NCT00368966|58750478|FG000|Infant Series|Randomization error|0|||
30739263|NCT00368966|58750479|FG001|Infant Series|Randomization error|1|||
30739264|NCT00368966|58750478|FG000|Infant Series|Failed to meet eligibility criteria|0|||
30739265|NCT00368966|58750479|FG001|Infant Series|Failed to meet eligibility criteria|1|||
30739266|NCT00368966|58750478|FG000|Infant Series|Adverse Event|0|||
30739267|NCT00368966|58750479|FG001|Infant Series|Adverse Event|1|||
30739268|NCT00368966|58750478|FG000|Infant Series|Failed to return|1|||
30739269|NCT00368966|58750479|FG001|Infant Series|Failed to return|0|||
30739270|NCT00368966|58750478|FG000|After Infant|Failed to return|3|||
30739271|NCT00368966|58750479|FG001|After Infant|Failed to return|1|||
30739272|NCT00368966|58750478|FG000|After Infant|Adverse Event|1|||
30739273|NCT00368966|58750479|FG001|After Infant|Adverse Event|2|||
30739274|NCT00368966|58750478|FG000|After Infant|Withdrawal by Subject|1|||
30739275|NCT00368966|58750479|FG001|After Infant|Withdrawal by Subject|1|||
30739276|NCT00368966|58750478|FG000|After Infant|Death|1|||
30739277|NCT00368966|58750479|FG001|After Infant|Death|0|||
30739278|NCT00368966|58750478|FG000|After Infant|Lost to Follow-up|0|||
30739279|NCT00368966|58750479|FG001|After Infant|Lost to Follow-up|1|||
30739280|NCT00368966|58750478|FG000|Toddler Dose|Withdrawal by Subject|1|||
30739281|NCT00368966|58750479|FG001|Toddler Dose|Withdrawal by Subject|1|||
30739282|NCT00368966|58750478|FG000|Toddler Dose|Lost to Follow-up|0|||
30739283|NCT00368966|58750479|FG001|Toddler Dose|Lost to Follow-up|2|||
30739284|NCT00114166|58750512|FG000|Overall Study|Wrong primary|0|||
30739285|NCT00114166|58750513|FG001|Overall Study|Wrong primary|1|||
30739286|NCT00125242|58750523|FG000|Overall Study|did not qualify|7|||
30739287|NCT00125242|58750524|FG001|Overall Study|did not qualify|2|||
30739288|NCT00337428|58750531|FG000|Overall Study|Withdrawal by Subject|1|||
30739289|NCT00337428|58750532|FG001|Overall Study|Withdrawal by Subject|2|||
30739290|NCT00337428|58750531|FG000|Overall Study|Lack of Time|1|||
30739291|NCT00337428|58750532|FG001|Overall Study|Lack of Time|1|||
30739292|NCT00337428|58750531|FG000|Overall Study|Unwilling to Continue|1|||
30739293|NCT00337428|58750532|FG001|Overall Study|Unwilling to Continue|0|||
30739294|NCT00337428|58750531|FG000|Overall Study|Anorexia|1|||
30739295|NCT00337428|58750532|FG001|Overall Study|Anorexia|0|||
30739296|NCT00235989|58750542|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
30739297|NCT00235989|58750543|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
30739298|NCT00235989|58750544|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
30739299|NCT00235989|58750545|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
30739300|NCT00235989|58750546|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
30739301|NCT00235989|58750547|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
30739302|NCT00235989|58750542|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
30739303|NCT00235989|58750543|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
30739304|NCT00235989|58750544|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
30739305|NCT00235989|58750545|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
30739306|NCT00235989|58750546|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
30739307|NCT00235989|58750547|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
30739308|NCT00235989|58750542|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
30739309|NCT00235989|58750543|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
30739310|NCT00235989|58750544|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
30739311|NCT00235989|58750545|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
30739312|NCT00235989|58750546|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
30739313|NCT00235989|58750547|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
30739314|NCT00235989|58750542|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
30739315|NCT00235989|58750543|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
30739316|NCT00235989|58750544|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
30739317|NCT00235989|58750545|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
30739318|NCT00235989|58750546|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
30739319|NCT00235989|58750547|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
30739320|NCT00235989|58750542|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
30739321|NCT00235989|58750543|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
30739322|NCT00235989|58750544|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
30621931|NCT04066491|58633457|FG000|Overall Study|Randomized, not treated|0|||
30621932|NCT04066491|58633458|FG001|Overall Study|Randomized, not treated|0|||
30739323|NCT00235989|58750545|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
30739324|NCT00235989|58750546|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
30739325|NCT00235989|58750547|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
30739326|NCT00113386|58750559|FG000|Overall Study|Withdrawal by Subject|1|||
30739327|NCT00113386|58750560|FG001|Overall Study|Withdrawal by Subject|0|||
30739328|NCT00113386|58750559|FG000|Overall Study|Physician Decision|0|||
30739329|NCT00113386|58750560|FG001|Overall Study|Physician Decision|1|||
30901444|NCT02456909|58935159|FG000|Overall Study|Did not complete the primary outcome|0|||
30739330|NCT00113386|58750559|FG000|Overall Study|Toxicity|3|||
30739331|NCT00113386|58750560|FG001|Overall Study|Toxicity|0|||
30739332|NCT00113386|58750559|FG000|Overall Study|Ineligible|1|||
30739333|NCT00113386|58750560|FG001|Overall Study|Ineligible|2|||
30739334|NCT00113386|58750559|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
30739335|NCT00113386|58750560|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
30739336|NCT00353262|58750566|FG000|Overall Study|Adverse Event|8|||
30739337|NCT00353262|58750566|FG000|Overall Study|Withdrawal by Subject|2|||
30739338|NCT00353262|58750566|FG000|Overall Study|Insufficient Therapeutic Response|13|||
30739339|NCT00353262|58750566|FG000|Overall Study|Progression|1|||
30739340|NCT00353262|58750566|FG000|Overall Study|Surgery|4|||
30739341|NCT00353262|58750566|FG000|Overall Study|Break from Chemotherapy|1|||
30739342|NCT00337272|58750572|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
30739343|NCT00337272|58750573|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
30739344|NCT00337272|58750572|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
30739345|NCT00337272|58750573|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
30739346|NCT00337272|58750572|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
30739347|NCT00337272|58750573|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
30739348|NCT00337272|58750572|FG000|Treatment Period|Non-compliance|1|||
30739349|NCT00337272|58750573|FG001|Treatment Period|Non-compliance|1|||
30739350|NCT00337272|58750572|FG000|Treatment Period|Withdrawal by Subject|0|||
30739351|NCT00337272|58750573|FG001|Treatment Period|Withdrawal by Subject|1|||
30739352|NCT00337272|58750572|FG000|Withdrawal Period|Non-compliance|0|||
30739353|NCT00337272|58750573|FG001|Withdrawal Period|Non-compliance|1|||
30739354|NCT00125164|58750583|FG000|Overall Study|Adverse Event|0|||
30739355|NCT00125164|58750584|FG001|Overall Study|Adverse Event|0|||
30621933|NCT04066491|58633459|FG002|Overall Study|Randomized, not treated|2|||
30739356|NCT00125164|58750585|FG002|Overall Study|Adverse Event|2|||
30739357|NCT00125164|58750586|FG003|Overall Study|Adverse Event|4|||
30739358|NCT00125164|58750583|FG000|Overall Study|Lost to Follow-up|0|||
30739359|NCT00125164|58750584|FG001|Overall Study|Lost to Follow-up|0|||
30739360|NCT00125164|58750585|FG002|Overall Study|Lost to Follow-up|1|||
30739361|NCT00125164|58750586|FG003|Overall Study|Lost to Follow-up|1|||
30739362|NCT00125164|58750583|FG000|Overall Study|Withdrawal by Subject|2|||
30739363|NCT00125164|58750584|FG001|Overall Study|Withdrawal by Subject|0|||
30739364|NCT00125164|58750585|FG002|Overall Study|Withdrawal by Subject|1|||
30739365|NCT00125164|58750586|FG003|Overall Study|Withdrawal by Subject|1|||
30739366|NCT00136318|58750598|FG000|Overall Study|Adverse Event|5|||
30739367|NCT00136318|58750599|FG001|Overall Study|Adverse Event|5|||
30739368|NCT00136318|58750598|FG000|Overall Study|Withdrawal by Subject|2|||
30739369|NCT00136318|58750599|FG001|Overall Study|Withdrawal by Subject|2|||
30739370|NCT00136084|58750608|FG000|Overall Study|Death|12|||
30739371|NCT00136084|58750609|FG001|Overall Study|Death|5|||
30739372|NCT00136084|58750608|FG000|Overall Study|Unacceptable toxicity|8|||
30739373|NCT00136084|58750609|FG001|Overall Study|Unacceptable toxicity|11|||
30739374|NCT00136084|58750608|FG000|Overall Study|Relapse|20|||
30739375|NCT00136084|58750609|FG001|Overall Study|Relapse|23|||
30739376|NCT00136084|58750608|FG000|Overall Study|Lost to Follow-up|2|||
30739377|NCT00136084|58750609|FG001|Overall Study|Lost to Follow-up|0|||
30739378|NCT00136084|58750608|FG000|Overall Study|No Response|1|||
30739379|NCT00136084|58750609|FG001|Overall Study|No Response|2|||
30739380|NCT00136084|58750608|FG000|Overall Study|Withdrawal by Subject|5|||
30739381|NCT00136084|58750609|FG001|Overall Study|Withdrawal by Subject|1|||
30739382|NCT00364832|58750630|FG000|Core Period|Early Withdrawals|2|||
30739383|NCT00364832|58750631|FG001|Core Period|Early Withdrawals|2|||
30739384|NCT00364832|58750632|FG002|Core Period|Early Withdrawals|1|||
30739385|NCT00364832|58750633|FG003|Core Period|Early Withdrawals|1|||
30739386|NCT00364832|58750634|FG004|Core Period|Early Withdrawals|0|||
30739387|NCT00364832|58750635|FG005|Core Period|Early Withdrawals|0|||
30739388|NCT00364832|58750636|FG006|Core Period|Early Withdrawals|4|||
30739389|NCT00364832|58750637|FG007|Core Period|Early Withdrawals|1|||
30739390|NCT00364832|58750638|FG008|Core Period|Early Withdrawals|0|||
30901445|NCT02456909|58935160|FG001|Overall Study|Did not complete the primary outcome|1|||
30901446|NCT02025621|58935168|FG000|Overall Study|Withdrawal by Subject|1|||
30901447|NCT02025621|58935169|FG001|Overall Study|Withdrawal by Subject|0|||
30901448|NCT02025621|58935168|FG000|Overall Study|Death|0|||
30901449|NCT02025621|58935169|FG001|Overall Study|Death|1|||
30901450|NCT02025621|58935168|FG000|Overall Study|No longer eligible|10|||
30901451|NCT02025621|58935169|FG001|Overall Study|No longer eligible|15|||
30901452|NCT02025621|58935168|FG000|Overall Study|Surgery initiated before infusion|3|||
30901453|NCT02025621|58935169|FG001|Overall Study|Surgery initiated before infusion|3|||
30901454|NCT02020941|58935175|FG000|Overall Study|Adverse Event|1|||
30901455|NCT02020941|58935175|FG000|Overall Study|Physician Decision|2|||
30901456|NCT02020941|58935175|FG000|Overall Study|Withdrawal by Subject|1|||
30901457|NCT02020941|58935175|FG000|Overall Study|Disease Progression|4|||
30901458|NCT02024529|58935181|FG000|Overall Study|Withdrawal by Subject|11|||
30901459|NCT02024529|58935182|FG001|Overall Study|Withdrawal by Subject|21|||
30901460|NCT02024529|58935181|FG000|Overall Study|Lost to Follow-up|2|||
30739391|NCT00364832|58750639|FG009|Core Period|Early Withdrawals|0|||
30739392|NCT00364832|58750640|FG010|Core Period|Early Withdrawals|0|||
30739393|NCT00364832|58750641|FG011|Core Period|Early Withdrawals|0|||
30739394|NCT00364832|58750630|FG000|Extension Year 1|Early Withdrawals|0|||
30739395|NCT00364832|58750631|FG001|Extension Year 1|Early Withdrawals|0|||
30739396|NCT00364832|58750632|FG002|Extension Year 1|Early Withdrawals|0|||
30739397|NCT00364832|58750633|FG003|Extension Year 1|Early Withdrawals|0|||
30739398|NCT00364832|58750634|FG004|Extension Year 1|Early Withdrawals|0|||
30739399|NCT00364832|58750635|FG005|Extension Year 1|Early Withdrawals|0|||
30739400|NCT00364832|58750636|FG006|Extension Year 1|Early Withdrawals|0|||
30739401|NCT00364832|58750637|FG007|Extension Year 1|Early Withdrawals|0|||
30739402|NCT00364832|58750638|FG008|Extension Year 1|Early Withdrawals|0|||
30739403|NCT00364832|58750639|FG009|Extension Year 1|Early Withdrawals|4|||
30739404|NCT00364832|58750640|FG010|Extension Year 1|Early Withdrawals|2|||
30739405|NCT00364832|58750641|FG011|Extension Year 1|Early Withdrawals|10|||
30739406|NCT00364832|58750630|FG000|Extension Year 2|Early Withdrawals|0|||
30739407|NCT00364832|58750631|FG001|Extension Year 2|Early Withdrawals|0|||
30739408|NCT00364832|58750632|FG002|Extension Year 2|Early Withdrawals|0|||
30739409|NCT00364832|58750633|FG003|Extension Year 2|Early Withdrawals|0|||
30739410|NCT00364832|58750634|FG004|Extension Year 2|Early Withdrawals|0|||
30739411|NCT00364832|58750635|FG005|Extension Year 2|Early Withdrawals|0|||
30739412|NCT00364832|58750636|FG006|Extension Year 2|Early Withdrawals|0|||
30739413|NCT00364832|58750637|FG007|Extension Year 2|Early Withdrawals|0|||
30739414|NCT00364832|58750638|FG008|Extension Year 2|Early Withdrawals|0|||
30739415|NCT00364832|58750639|FG009|Extension Year 2|Early Withdrawals|5|||
30739416|NCT00364832|58750640|FG010|Extension Year 2|Early Withdrawals|5|||
30739417|NCT00364832|58750641|FG011|Extension Year 2|Early Withdrawals|3|||
30739418|NCT00235755|58750661|FG000|4-Week Titration Phase|Adverse Event|6|||
30739419|NCT00235755|58750662|FG001|4-Week Titration Phase|Adverse Event|14|||
30739420|NCT00235755|58750663|FG002|4-Week Titration Phase|Adverse Event|20|||
30739421|NCT00235755|58750661|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
30901461|NCT02024529|58935182|FG001|Overall Study|Lost to Follow-up|4|||
30901462|NCT02020863|58935190|FG000|Overall Study|Discovery of Metastatic disease|4|||
30901463|NCT02020863|58935190|FG000|Overall Study|Team chose not to place an a line|1|||
30901464|NCT01824394|58935197|FG000|Overall Study|Early Termination|1|||
30901465|NCT01824394|58935198|FG001|Overall Study|Early Termination|1|||
30901466|NCT01824394|58935199|FG002|Overall Study|Early Termination|3|||
30901467|NCT01824394|58935197|FG000|Overall Study|Withdrawn due to Study Termination|91|||
30739422|NCT00235755|58750662|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
30739423|NCT00235755|58750663|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
30739424|NCT00235755|58750661|FG000|4-Week Titration Phase|Protocol Violation|2|||
30739425|NCT00235755|58750662|FG001|4-Week Titration Phase|Protocol Violation|2|||
30739426|NCT00235755|58750663|FG002|4-Week Titration Phase|Protocol Violation|1|||
30739427|NCT00235755|58750661|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
30739428|NCT00235755|58750662|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
30739429|NCT00235755|58750663|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
30739430|NCT00235755|58750661|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
30739431|NCT00235755|58750662|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
30621934|NCT01151280|58633468|FG000|Overall Study|Adverse Event|1|||
30621935|NCT01151280|58633468|FG000|Overall Study|Lack of Efficacy|3|||
30739432|NCT00235755|58750663|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
30739433|NCT00235755|58750661|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
30739434|NCT00235755|58750662|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
30739435|NCT00235755|58750663|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
30739436|NCT00235755|58750661|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
30739437|NCT00235755|58750662|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
30901468|NCT01824394|58935198|FG001|Overall Study|Withdrawn due to Study Termination|83|||
30739438|NCT00235755|58750663|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
30739439|NCT00235755|58750661|FG000|12-Week Maintenance Phase|Adverse Event|8|||
30739440|NCT00235755|58750662|FG001|12-Week Maintenance Phase|Adverse Event|12|||
30739441|NCT00235755|58750663|FG002|12-Week Maintenance Phase|Adverse Event|26|||
30739442|NCT00235755|58750661|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
30739443|NCT00235755|58750662|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
30739444|NCT00235755|58750663|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
30739445|NCT00235755|58750661|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
30901469|NCT01824394|58935199|FG002|Overall Study|Withdrawn due to Study Termination|41|||
30901470|NCT01824394|58935197|FG000|Overall Study|Lost to Follow-up|0|||
30901471|NCT01824394|58935198|FG001|Overall Study|Lost to Follow-up|9|||
30901472|NCT01824394|58935199|FG002|Overall Study|Lost to Follow-up|3|||
30901473|NCT01824394|58935197|FG000|Overall Study|Death|3|||
30901474|NCT01824394|58935198|FG001|Overall Study|Death|2|||
30901475|NCT01824394|58935199|FG002|Overall Study|Death|4|||
30901476|NCT01824394|58935197|FG000|Overall Study|Discontinued Subjects|1|||
30901477|NCT01824394|58935198|FG001|Overall Study|Discontinued Subjects|1|||
30901478|NCT01824394|58935199|FG002|Overall Study|Discontinued Subjects|2|||
30901479|NCT01824394|58935197|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
30901480|NCT01824394|58935198|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
30739446|NCT00235755|58750662|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
30739447|NCT00235755|58750663|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
30739448|NCT00235755|58750661|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
30739449|NCT00235755|58750662|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
30901481|NCT01824394|58935199|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
30901482|NCT01823536|58935213|FG000|Overall Study|Lost to Follow-up|1|||
30739450|NCT00235755|58750663|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
30739451|NCT00235755|58750661|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
30739452|NCT00235755|58750662|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
30739453|NCT00235755|58750663|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
30739454|NCT00235755|58750661|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
30739455|NCT00235755|58750662|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
30739456|NCT00235755|58750663|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
30739457|NCT00337194|58750688|FG000|Overall Study|Adverse Event|5|||
30739458|NCT00337194|58750689|FG001|Overall Study|Adverse Event|1|||
30739459|NCT00337194|58750688|FG000|Overall Study|Death|2|||
30739460|NCT00337194|58750689|FG001|Overall Study|Death|0|||
30739461|NCT00337194|58750688|FG000|Overall Study|Withdrawal by Subject|1|||
30739462|NCT00337194|58750689|FG001|Overall Study|Withdrawal by Subject|0|||
30739463|NCT00337194|58750688|FG000|Overall Study|Disease progression|1|||
30739464|NCT00337194|58750689|FG001|Overall Study|Disease progression|2|||
30739465|NCT00337194|58750688|FG000|Overall Study|Subsequent non-protocol therapy|3|||
30739466|NCT00337194|58750689|FG001|Overall Study|Subsequent non-protocol therapy|1|||
30739467|NCT03826914|58750699|FG000|Overall Study|Withdrawal by Subject|1|||
30739468|NCT03826914|58750700|FG001|Overall Study|Withdrawal by Subject|1|||
30739469|NCT00385736|58750711|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
30739470|NCT00385736|58750712|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
30739471|NCT00385736|58750713|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
30739472|NCT00385736|58750711|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
30739473|NCT00385736|58750712|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
30739474|NCT00385736|58750713|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
30739475|NCT00385736|58750711|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
30790988|NCT00152464|58804143|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
30790989|NCT00152464|58804144|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
30739476|NCT00385736|58750712|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
30739477|NCT00385736|58750713|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
30739478|NCT00385736|58750711|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
30739479|NCT00385736|58750712|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
30739480|NCT00385736|58750713|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
30739481|NCT00385736|58750711|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
30739482|NCT00385736|58750712|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
30739483|NCT00385736|58750713|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
30739484|NCT00385736|58750711|FG000|Efficacy Analysis Set - Induction|Other|0|||
30739485|NCT00385736|58750712|FG001|Efficacy Analysis Set - Induction|Other|0|||
30739486|NCT00385736|58750713|FG002|Efficacy Analysis Set - Induction|Other|1|||
30739487|NCT00385736|58750711|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
30739488|NCT00385736|58750712|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
30739489|NCT00385736|58750713|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
30739490|NCT00385736|58750711|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
30739491|NCT00385736|58750712|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
30739492|NCT00385736|58750713|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
30739493|NCT00385736|58750711|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
30739494|NCT00385736|58750712|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
30739495|NCT00385736|58750713|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
30739496|NCT00385736|58750711|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
30739497|NCT00385736|58750712|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
30739498|NCT00385736|58750713|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
30739499|NCT00385736|58750711|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
30739500|NCT00385736|58750712|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
30739501|NCT00385736|58750713|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
30739502|NCT00385736|58750711|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
30739503|NCT00385736|58750712|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
30739504|NCT00385736|58750713|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
30739505|NCT00385736|58750711|FG000|Safety Analysis Set|Adverse Event|23|||
30739506|NCT00385736|58750712|FG001|Safety Analysis Set|Adverse Event|15|||
30739507|NCT00385736|58750713|FG002|Safety Analysis Set|Adverse Event|23|||
30739508|NCT00385736|58750711|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
30621936|NCT01149486|58633474|FG000|First Intervention|Adverse Event|0|||
30739509|NCT00385736|58750712|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
30739510|NCT00385736|58750713|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
30739511|NCT00385736|58750711|FG000|Safety Analysis Set|Lost to Follow-up|0|||
30739512|NCT00385736|58750712|FG001|Safety Analysis Set|Lost to Follow-up|2|||
30739513|NCT00385736|58750713|FG002|Safety Analysis Set|Lost to Follow-up|2|||
30739514|NCT00385736|58750711|FG000|Safety Analysis Set|Lack of Efficacy|38|||
30739515|NCT00385736|58750712|FG001|Safety Analysis Set|Lack of Efficacy|16|||
30739516|NCT00385736|58750713|FG002|Safety Analysis Set|Lack of Efficacy|31|||
30739517|NCT00385736|58750711|FG000|Safety Analysis Set|Protocol Violation|2|||
30739518|NCT00385736|58750712|FG001|Safety Analysis Set|Protocol Violation|1|||
30739519|NCT00385736|58750713|FG002|Safety Analysis Set|Protocol Violation|6|||
30739520|NCT00385736|58750711|FG000|Safety Analysis Set|Other|1|||
30739521|NCT00385736|58750712|FG001|Safety Analysis Set|Other|4|||
30739522|NCT00385736|58750713|FG002|Safety Analysis Set|Other|4|||
30739523|NCT00195819|58750724|FG000|Double-Blind|Withdrawal by Subject|1|||
30739524|NCT00195819|58750725|FG001|Double-Blind|Withdrawal by Subject|0|||
30739525|NCT00195819|58750724|FG000|Double-Blind|Moved|1|||
30739526|NCT00195819|58750725|FG001|Double-Blind|Moved|0|||
30739527|NCT00195819|58750724|FG000|Open-label|Adverse Event|0|||
30739528|NCT00195819|58750725|FG001|Open-label|Adverse Event|9|||
30739529|NCT00195819|58750724|FG000|Open-label|Lack of Efficacy|0|||
30739530|NCT00195819|58750725|FG001|Open-label|Lack of Efficacy|2|||
30739531|NCT00195819|58750724|FG000|Open-label|Pregnancy|0|||
30739532|NCT00195819|58750725|FG001|Open-label|Pregnancy|1|||
30739533|NCT00195819|58750724|FG000|Open-label|Protocol Violation|0|||
30739534|NCT00195819|58750725|FG001|Open-label|Protocol Violation|2|||
30739535|NCT00195819|58750724|FG000|Open-label|Moved|0|||
30739536|NCT00195819|58750725|FG001|Open-label|Moved|1|||
30739537|NCT00195819|58750724|FG000|Open-label|Withdrawal by Subject|0|||
30739538|NCT00195819|58750725|FG001|Open-label|Withdrawal by Subject|5|||
30739539|NCT00527735|58750740|FG000|Overall Study|Disease progression|47|||
30739540|NCT00527735|58750741|FG001|Overall Study|Disease progression|61|||
30739541|NCT00527735|58750742|FG002|Overall Study|Disease progression|53|||
30739542|NCT00527735|58750740|FG000|Overall Study|Death|23|||
30739543|NCT00527735|58750741|FG001|Overall Study|Death|13|||
30739544|NCT00527735|58750742|FG002|Overall Study|Death|15|||
30901483|NCT01823536|58935214|FG001|Overall Study|Lost to Follow-up|0|||
30739545|NCT00527735|58750740|FG000|Overall Study|Completed treatment in treatment phase|14|||
30739546|NCT00527735|58750741|FG001|Overall Study|Completed treatment in treatment phase|13|||
30901484|NCT01823536|58935215|FG002|Overall Study|Lost to Follow-up|0|||
30739547|NCT00527735|58750742|FG002|Overall Study|Completed treatment in treatment phase|18|||
30901485|NCT01823536|58935216|FG003|Overall Study|Lost to Follow-up|1|||
30901486|NCT01823536|58935217|FG004|Overall Study|Lost to Follow-up|1|||
30621937|NCT01149486|58633475|FG001|First Intervention|Adverse Event|1|||
30739548|NCT00527735|58750740|FG000|Overall Study|Adverse Event|10|||
30739549|NCT00527735|58750741|FG001|Overall Study|Adverse Event|6|||
30739550|NCT00527735|58750742|FG002|Overall Study|Adverse Event|7|||
30739551|NCT00527735|58750740|FG000|Overall Study|Not identified|5|||
30739552|NCT00527735|58750741|FG001|Overall Study|Not identified|5|||
30739553|NCT00527735|58750742|FG002|Overall Study|Not identified|5|||
30739554|NCT00527735|58750740|FG000|Overall Study|Withdrawal by Subject|5|||
30739555|NCT00527735|58750741|FG001|Overall Study|Withdrawal by Subject|4|||
30739556|NCT00527735|58750742|FG002|Overall Study|Withdrawal by Subject|3|||
30739557|NCT00527735|58750740|FG000|Overall Study|No longer met study criteria|2|||
30739558|NCT00527735|58750741|FG001|Overall Study|No longer met study criteria|2|||
30739559|NCT00527735|58750742|FG002|Overall Study|No longer met study criteria|1|||
30739560|NCT00527735|58750740|FG000|Overall Study|Lost to Follow-up|0|||
30739561|NCT00527735|58750741|FG001|Overall Study|Lost to Follow-up|0|||
30739562|NCT00527735|58750742|FG002|Overall Study|Lost to Follow-up|3|||
30739563|NCT00527735|58750740|FG000|Overall Study|Poor compliance or noncompliance|0|||
30739564|NCT00527735|58750741|FG001|Overall Study|Poor compliance or noncompliance|1|||
30739565|NCT00527735|58750742|FG002|Overall Study|Poor compliance or noncompliance|1|||
30739566|NCT00527735|58750740|FG000|Overall Study|Completed treatment during maintenance|2|||
30739567|NCT00527735|58750741|FG001|Overall Study|Completed treatment during maintenance|2|||
30739568|NCT00527735|58750742|FG002|Overall Study|Completed treatment during maintenance|1|||
30739569|NCT00336492|58750765|FG000|Overall Study|Adverse Event|4|||
30739570|NCT00336492|58750766|FG001|Overall Study|Adverse Event|3|||
30739571|NCT00336492|58750767|FG002|Overall Study|Adverse Event|6|||
30739572|NCT00336492|58750765|FG000|Overall Study|Lack of Efficacy|6|||
30739573|NCT00336492|58750766|FG001|Overall Study|Lack of Efficacy|1|||
30739574|NCT00336492|58750767|FG002|Overall Study|Lack of Efficacy|4|||
30739575|NCT00336492|58750765|FG000|Overall Study|Other|5|||
30739576|NCT00336492|58750766|FG001|Overall Study|Other|0|||
30739577|NCT00336492|58750767|FG002|Overall Study|Other|1|||
30790990|NCT00152464|58804143|FG000|Overall Study|Eczema deterioration|0|||
30739578|NCT00194025|58750775|FG000|Overall Study|Adverse Event|1|||
30739579|NCT00194025|58750775|FG000|Overall Study|non-adherence with study medication|4|||
30739580|NCT00368108|58750782|FG000|Overall Study|Adverse Event|38|||
30739581|NCT00368108|58750783|FG001|Overall Study|Adverse Event|26|||
30739582|NCT00368108|58750784|FG002|Overall Study|Adverse Event|44|||
30739583|NCT00368108|58750782|FG000|Overall Study|Abnormal Laboratory Value|0|||
30739584|NCT00368108|58750783|FG001|Overall Study|Abnormal Laboratory Value|0|||
30739585|NCT00368108|58750784|FG002|Overall Study|Abnormal Laboratory Value|3|||
30739586|NCT00368108|58750782|FG000|Overall Study|Protocol Violation|5|||
30739587|NCT00368108|58750783|FG001|Overall Study|Protocol Violation|9|||
30739588|NCT00368108|58750784|FG002|Overall Study|Protocol Violation|9|||
30739589|NCT00368108|58750782|FG000|Overall Study|Withdrawal by Subject|9|||
30739590|NCT00368108|58750783|FG001|Overall Study|Withdrawal by Subject|3|||
30739591|NCT00368108|58750784|FG002|Overall Study|Withdrawal by Subject|5|||
30739592|NCT00368108|58750782|FG000|Overall Study|Lack of Efficacy|7|||
30739593|NCT00368108|58750783|FG001|Overall Study|Lack of Efficacy|8|||
30739594|NCT00368108|58750784|FG002|Overall Study|Lack of Efficacy|5|||
30739595|NCT00368108|58750782|FG000|Overall Study|Physician Decision|2|||
30739596|NCT00368108|58750783|FG001|Overall Study|Physician Decision|0|||
30739597|NCT00368108|58750784|FG002|Overall Study|Physician Decision|1|||
30739598|NCT00368108|58750782|FG000|Overall Study|Other|3|||
30739599|NCT00368108|58750783|FG001|Overall Study|Other|7|||
30739600|NCT00368108|58750784|FG002|Overall Study|Other|1|||
30739601|NCT00364130|58750794|FG000|Intervention Period|Lost to Follow-up|4|||
30739602|NCT00364130|58750795|FG001|Intervention Period|Lost to Follow-up|3|||
30739603|NCT00364130|58750794|FG000|Intervention Period|Pregnancy|1|||
30739604|NCT00364130|58750795|FG001|Intervention Period|Pregnancy|0|||
30739605|NCT00364130|58750794|FG000|Intervention Period|Withdrawal by Subject|4|||
30739606|NCT00364130|58750795|FG001|Intervention Period|Withdrawal by Subject|5|||
30739607|NCT00364130|58750794|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
30739608|NCT00364130|58750795|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
30739609|NCT00521339|58750803|FG000|Treatment Phase|Adverse Event|2|||
30739610|NCT00521339|58750804|FG001|Treatment Phase|Adverse Event|0|||
30739611|NCT00521339|58750805|FG002|Treatment Phase|Adverse Event|0|||
30739612|NCT00521339|58750803|FG000|Treatment Phase|Intolerability to study drug|2|||
30739613|NCT00521339|58750804|FG001|Treatment Phase|Intolerability to study drug|0|||
30739614|NCT00521339|58750805|FG002|Treatment Phase|Intolerability to study drug|0|||
30739615|NCT00521339|58750803|FG000|Treatment Phase|Lack of Efficacy|3|||
30739616|NCT00521339|58750804|FG001|Treatment Phase|Lack of Efficacy|0|||
30739617|NCT00521339|58750805|FG002|Treatment Phase|Lack of Efficacy|0|||
30739618|NCT00521339|58750803|FG000|Treatment Phase|Withdrawal by Subject|3|||
30739619|NCT00521339|58750804|FG001|Treatment Phase|Withdrawal by Subject|0|||
30739620|NCT00521339|58750805|FG002|Treatment Phase|Withdrawal by Subject|0|||
30739621|NCT00521339|58750803|FG000|Treatment Phase|Lost to Follow-up|1|||
30739622|NCT00521339|58750804|FG001|Treatment Phase|Lost to Follow-up|0|||
30739623|NCT00521339|58750805|FG002|Treatment Phase|Lost to Follow-up|0|||
30739624|NCT00521339|58750803|FG000|Treatment Phase|Protocol Violation|1|||
30739625|NCT00521339|58750804|FG001|Treatment Phase|Protocol Violation|0|||
30739626|NCT00521339|58750805|FG002|Treatment Phase|Protocol Violation|0|||
30739627|NCT00521339|58750803|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
30739628|NCT00521339|58750804|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
30739629|NCT00521339|58750805|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
30739630|NCT00521339|58750803|FG000|Treatment Extension Phase|Death|0|||
30739631|NCT00521339|58750804|FG001|Treatment Extension Phase|Death|0|||
30739632|NCT00521339|58750805|FG002|Treatment Extension Phase|Death|1|||
30739633|NCT00363896|58750828|FG000|Overall Study|Withdrawal by Subject|29|||
30739634|NCT00363896|58750829|FG001|Overall Study|Withdrawal by Subject|16|||
30739635|NCT00363896|58750828|FG000|Overall Study|Adverse Event|24|||
30739636|NCT00363896|58750829|FG001|Overall Study|Adverse Event|13|||
30739637|NCT00363896|58750828|FG000|Overall Study|COPD exacerbation|13|||
30739638|NCT00363896|58750829|FG001|Overall Study|COPD exacerbation|7|||
30739639|NCT00363896|58750828|FG000|Overall Study|Lack of Efficacy|12|||
30739640|NCT00363896|58750829|FG001|Overall Study|Lack of Efficacy|8|||
30739641|NCT00363896|58750828|FG000|Overall Study|Protocol Violation|6|||
30739642|NCT00363896|58750829|FG001|Overall Study|Protocol Violation|1|||
30739643|NCT00363896|58750828|FG000|Overall Study|Lost to Follow-up|3|||
30739644|NCT00363896|58750829|FG001|Overall Study|Lost to Follow-up|0|||
30739645|NCT00363896|58750828|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
30739646|NCT00363896|58750829|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
30739647|NCT00363896|58750828|FG000|Overall Study|Other|1|||
30739648|NCT00363896|58750829|FG001|Overall Study|Other|2|||
30739649|NCT00527423|58750838|FG000|Overall Study|Protocol Violation|1|||
30739650|NCT00527423|58750838|FG000|Overall Study|Adverse Event|5|||
30739651|NCT00527423|58750838|FG000|Overall Study|Physician Decision|4|||
30739652|NCT00527423|58750838|FG000|Overall Study|Withdrawal by Subject|10|||
30739653|NCT00527423|58750838|FG000|Overall Study|Lost to Follow-up|4|||
30739654|NCT00527423|58750838|FG000|Overall Study|OTHER|4|||
30739655|NCT00527423|58750838|FG000|Overall Study|Death|9|||
30739656|NCT00527111|58750846|FG000|Overall Study|Adverse Event|14|||
30739657|NCT00527111|58750847|FG001|Overall Study|Adverse Event|13|||
30739658|NCT00527111|58750846|FG000|Overall Study|Death|0|||
30739659|NCT00527111|58750847|FG001|Overall Study|Death|1|||
30739660|NCT00527111|58750846|FG000|Overall Study|Investigator Request|2|||
30739661|NCT00527111|58750847|FG001|Overall Study|Investigator Request|1|||
30739662|NCT00527111|58750846|FG000|Overall Study|Patient Request|2|||
30739663|NCT00527111|58750847|FG001|Overall Study|Patient Request|5|||
30739664|NCT00527111|58750846|FG000|Overall Study|Other|2|||
30739665|NCT00527111|58750847|FG001|Overall Study|Other|2|||
30739666|NCT00336024|58750855|FG000|Overall Study|Death|2|||
30739667|NCT00336024|58750856|FG001|Overall Study|Death|1|||
30739668|NCT00336024|58750855|FG000|Overall Study|Physician Decision|4|||
30739669|NCT00336024|58750856|FG001|Overall Study|Physician Decision|1|||
30739670|NCT00336024|58750855|FG000|Overall Study|Protocol Violation|1|||
30621938|NCT00601705|58633481|FG000|Overall Study|Withdrawal by Subject|1|||
30621939|NCT01179737|58633490|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
30621940|NCT01179737|58633491|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
30739671|NCT00336024|58750856|FG001|Overall Study|Protocol Violation|0|||
30739672|NCT00336024|58750855|FG000|Overall Study|Withdrawal by Subject|1|||
30739673|NCT00336024|58750856|FG001|Overall Study|Withdrawal by Subject|2|||
30739674|NCT00336024|58750855|FG000|Overall Study|Failure to fulfill consolidation|1|||
30739675|NCT00336024|58750856|FG001|Overall Study|Failure to fulfill consolidation|1|||
30739676|NCT00336024|58750855|FG000|Overall Study|Progressive Disease|4|||
30739677|NCT00336024|58750856|FG001|Overall Study|Progressive Disease|7|||
30621941|NCT01179737|58633492|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
30739678|NCT00336024|58750855|FG000|Overall Study|Ineligible|7|||
30739679|NCT00336024|58750856|FG001|Overall Study|Ineligible|7|||
30739680|NCT00384956|58750862|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
30739681|NCT00367640|58750870|FG000|Overall Study|Adverse Event|3|||
30739682|NCT00367640|58750871|FG001|Overall Study|Adverse Event|6|||
30739683|NCT00367640|58750872|FG002|Overall Study|Adverse Event|8|||
30739684|NCT00367640|58750873|FG003|Overall Study|Adverse Event|0|||
30739685|NCT00367640|58750870|FG000|Overall Study|Withdrawal by Subject|8|||
30739686|NCT00367640|58750871|FG001|Overall Study|Withdrawal by Subject|11|||
30739687|NCT00367640|58750872|FG002|Overall Study|Withdrawal by Subject|8|||
30739688|NCT00367640|58750873|FG003|Overall Study|Withdrawal by Subject|6|||
30739689|NCT00367640|58750870|FG000|Overall Study|Any other reason not above-mentioned|7|||
30739690|NCT00367640|58750871|FG001|Overall Study|Any other reason not above-mentioned|5|||
30739691|NCT00367640|58750872|FG002|Overall Study|Any other reason not above-mentioned|3|||
30739692|NCT00367640|58750873|FG003|Overall Study|Any other reason not above-mentioned|4|||
30739693|NCT00367484|58750883|FG000|Overall Study|Adverse Event|7|||
30739694|NCT00367484|58750883|FG000|Overall Study|Withdrew informed consent|5|||
30739695|NCT00367484|58750883|FG000|Overall Study|Travel to USA|1|||
30739696|NCT00367484|58750883|FG000|Overall Study|Lost to Follow-up|1|||
30739697|NCT00367484|58750883|FG000|Overall Study|Protocol Violation|1|||
30739698|NCT00367484|58750883|FG000|Overall Study|The choice of the patient|1|||
30739699|NCT00367484|58750883|FG000|Overall Study|Lack of Efficacy|1|||
30739700|NCT00526799|58750889|FG000|Overall Study|Withdrawal by Subject|1|||
30739701|NCT00526799|58750890|FG001|Overall Study|Withdrawal by Subject|0|||
30739702|NCT00526799|58750889|FG000|Overall Study|Intercurrent Complicating Disease|0|||
30739703|NCT00526799|58750890|FG001|Overall Study|Intercurrent Complicating Disease|1|||
30739704|NCT00526331|58750896|FG000|Overall Study|Sponsor Termination|55|||
30739705|NCT00520481|58750902|FG000|Overall Study|Adverse Event|4|||
30739706|NCT00520481|58750903|FG001|Overall Study|Adverse Event|1|||
30739707|NCT00520481|58750902|FG000|Overall Study|Withdrawal by Subject|3|||
30739708|NCT00520481|58750903|FG001|Overall Study|Withdrawal by Subject|0|||
30739709|NCT00520403|58750911|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
30739710|NCT00520403|58750911|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
30739711|NCT00520403|58750911|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
30739712|NCT00520403|58750911|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
30739713|NCT00520403|58750911|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
30739714|NCT00520403|58750911|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
30739715|NCT00520403|58750911|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
30739716|NCT00520403|58750911|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
30739717|NCT00520013|58750918|FG000|Overall Study|Withdrawal by Subject|0|||
30739718|NCT00520013|58750919|FG001|Overall Study|Withdrawal by Subject|0|||
30739719|NCT00520013|58750920|FG002|Overall Study|Withdrawal by Subject|1|||
30739720|NCT00520013|58750918|FG000|Overall Study|Adverse Event|2|||
30739721|NCT00520013|58750919|FG001|Overall Study|Adverse Event|10|||
30739722|NCT00520013|58750920|FG002|Overall Study|Adverse Event|7|||
30739723|NCT00520013|58750918|FG000|Overall Study|Progressive Disease|7|||
30739724|NCT00520013|58750919|FG001|Overall Study|Progressive Disease|3|||
30739725|NCT00520013|58750920|FG002|Overall Study|Progressive Disease|0|||
30739726|NCT00520013|58750918|FG000|Overall Study|Clinical Progression|3|||
30739727|NCT00520013|58750919|FG001|Overall Study|Clinical Progression|1|||
30739728|NCT00520013|58750920|FG002|Overall Study|Clinical Progression|0|||
30739729|NCT00520013|58750918|FG000|Overall Study|Death|0|||
30739730|NCT00520013|58750919|FG001|Overall Study|Death|1|||
30739731|NCT00520013|58750920|FG002|Overall Study|Death|0|||
30739732|NCT00520013|58750918|FG000|Overall Study|Physician Decision|0|||
30739733|NCT00520013|58750919|FG001|Overall Study|Physician Decision|0|||
30739734|NCT00520013|58750920|FG002|Overall Study|Physician Decision|3|||
30739735|NCT00519779|58750928|FG000|Overall Study|Withdrawal by Subject|0|||
30739736|NCT00519779|58750929|FG001|Overall Study|Withdrawal by Subject|1|||
30739737|NCT00526097|58750937|FG000|Overall Study|Adverse Event|6|||
30739738|NCT00526097|58750938|FG001|Overall Study|Adverse Event|44|||
30739739|NCT00526097|58750937|FG000|Overall Study|Protocol Violation|4|||
30739740|NCT00526097|58750938|FG001|Overall Study|Protocol Violation|10|||
30739741|NCT00526097|58750937|FG000|Overall Study|Withdrawal by Subject|3|||
30739742|NCT00526097|58750938|FG001|Overall Study|Withdrawal by Subject|1|||
30901487|NCT01823536|58935218|FG005|Overall Study|Lost to Follow-up|0|||
30901488|NCT01823536|58935213|FG000|Overall Study|Protocol Violation|0|||
30739743|NCT00526097|58750937|FG000|Overall Study|Other|2|||
30739744|NCT00526097|58750938|FG001|Overall Study|Other|1|||
30901489|NCT01823536|58935214|FG001|Overall Study|Protocol Violation|1|||
30739745|NCT00525785|58750944|FG000|Overall Study|Withdrawal by Subject|1|||
30739746|NCT00525785|58750944|FG000|Overall Study|Lack of Efficacy|1|||
30739747|NCT00525785|58750944|FG000|Overall Study|Physician Decision|1|||
30739748|NCT00525161|58750948|FG000|Overall Study|Adverse Event|1|||
30739749|NCT00524771|58750954|FG000|Overall Study|Protocol Violation|220|||
30901490|NCT01823536|58935215|FG002|Overall Study|Protocol Violation|0|||
30901491|NCT01823536|58935216|FG003|Overall Study|Protocol Violation|0|||
30901492|NCT01823536|58935217|FG004|Overall Study|Protocol Violation|0|||
30739750|NCT00524771|58750955|FG001|Overall Study|Protocol Violation|585|||
30739751|NCT00135694|58750965|FG000|Overall Study|Adverse Event|17|||
30739752|NCT00135694|58750966|FG001|Overall Study|Adverse Event|4|||
30739753|NCT00135694|58750967|FG002|Overall Study|Adverse Event|0|||
30739754|NCT00135694|58750965|FG000|Overall Study|Death|14|||
30739755|NCT00135694|58750966|FG001|Overall Study|Death|1|||
30739756|NCT00135694|58750967|FG002|Overall Study|Death|2|||
30739757|NCT00135694|58750965|FG000|Overall Study|Lost to Follow-up|8|||
30739758|NCT00135694|58750966|FG001|Overall Study|Lost to Follow-up|7|||
30739759|NCT00135694|58750967|FG002|Overall Study|Lost to Follow-up|1|||
30739760|NCT00135694|58750965|FG000|Overall Study|Withdrawal by Subject|41|||
30739761|NCT00135694|58750966|FG001|Overall Study|Withdrawal by Subject|7|||
30739762|NCT00135694|58750967|FG002|Overall Study|Withdrawal by Subject|4|||
30739763|NCT00135694|58750965|FG000|Overall Study|Protocol Violation|19|||
30739764|NCT00135694|58750966|FG001|Overall Study|Protocol Violation|1|||
30739765|NCT00135694|58750967|FG002|Overall Study|Protocol Violation|0|||
30739766|NCT00135694|58750965|FG000|Overall Study|Hepatitis C related reasons|39|||
30739767|NCT00135694|58750966|FG001|Overall Study|Hepatitis C related reasons|1|||
30739768|NCT00135694|58750967|FG002|Overall Study|Hepatitis C related reasons|0|||
30739769|NCT00135694|58750965|FG000|Overall Study|Ineligible for Random assignment|42|||
30739770|NCT00135694|58750966|FG001|Overall Study|Ineligible for Random assignment|0|||
30739771|NCT00135694|58750967|FG002|Overall Study|Ineligible for Random assignment|0|||
30739772|NCT00524459|58750975|FG000|Overall Study|Withdrawal by Subject|1|||
30739773|NCT00524459|58750975|FG000|Overall Study|Other|1|||
30739774|NCT00519623|58750979|FG000|Overall Study|Adverse Event|1|||
30739775|NCT00519077|58750983|FG000|Overall Study|Death|6|||
30739776|NCT00519077|58750983|FG000|Overall Study|Other|2|||
30739777|NCT00124618|58750987|FG000|Overall Study|Ineligible|1|||
30739778|NCT00124462|58750993|FG000|Overall Study|Lost to Follow-up|3|||
30739779|NCT00124462|58750994|FG001|Overall Study|Lost to Follow-up|3|||
30901493|NCT01823536|58935218|FG005|Overall Study|Protocol Violation|0|||
30901494|NCT01823536|58935213|FG000|Overall Study|Withdrawal by Subject|1|||
30901495|NCT01823536|58935214|FG001|Overall Study|Withdrawal by Subject|1|||
30901496|NCT01823536|58935215|FG002|Overall Study|Withdrawal by Subject|0|||
30901497|NCT01823536|58935216|FG003|Overall Study|Withdrawal by Subject|0|||
30901498|NCT01823536|58935217|FG004|Overall Study|Withdrawal by Subject|0|||
30901499|NCT01823536|58935218|FG005|Overall Study|Withdrawal by Subject|0|||
30901500|NCT01823536|58935213|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
30901501|NCT01823536|58935214|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
30901502|NCT01823536|58935215|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
30901503|NCT01823536|58935216|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
30901504|NCT01823536|58935217|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
30901505|NCT01823536|58935218|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
30901506|NCT01823536|58935213|FG000|Overall Study|Met exclusion criterion No 6|0|||
30901507|NCT01823536|58935214|FG001|Overall Study|Met exclusion criterion No 6|0|||
30901508|NCT01823536|58935215|FG002|Overall Study|Met exclusion criterion No 6|0|||
30901509|NCT01823536|58935216|FG003|Overall Study|Met exclusion criterion No 6|1|||
30901510|NCT01823536|58935217|FG004|Overall Study|Met exclusion criterion No 6|0|||
30901511|NCT01823536|58935218|FG005|Overall Study|Met exclusion criterion No 6|0|||
30901512|NCT01823536|58935213|FG000|Overall Study|Subject moved out of the state|0|||
30901513|NCT01823536|58935214|FG001|Overall Study|Subject moved out of the state|0|||
30901514|NCT01823536|58935215|FG002|Overall Study|Subject moved out of the state|0|||
30901515|NCT01823536|58935216|FG003|Overall Study|Subject moved out of the state|0|||
30901516|NCT01823536|58935217|FG004|Overall Study|Subject moved out of the state|1|||
30901517|NCT01823536|58935218|FG005|Overall Study|Subject moved out of the state|0|||
30901518|NCT01841554|58935231|FG000|Overall Study|Death|7|||
30901519|NCT01841554|58935231|FG000|Overall Study|No Implantation|1|||
30739780|NCT00124462|58750993|FG000|Overall Study|Physician Decision|3|||
30739781|NCT00124462|58750994|FG001|Overall Study|Physician Decision|4|||
30739782|NCT00124462|58750993|FG000|Overall Study|Withdrawal by Subject|4|||
30739783|NCT00124462|58750994|FG001|Overall Study|Withdrawal by Subject|5|||
30739784|NCT00124462|58750993|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
30739785|NCT00124462|58750994|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
30739786|NCT00124072|58751004|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
30739787|NCT00124072|58751005|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
30901520|NCT01841554|58935231|FG000|Overall Study|Discontinued Follow Up|5|||
30901521|NCT01841554|58935231|FG000|Overall Study|Study exit due to secondary intervention|6|||
30901522|NCT01823224|58935237|FG000|Overall Study|Lost to Follow-up|5|||
30739788|NCT00124072|58751006|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
30901523|NCT01823224|58935238|FG001|Overall Study|Lost to Follow-up|6|||
30901524|NCT01823224|58935237|FG000|Overall Study|didn't qualify|1|||
30901525|NCT01823224|58935238|FG001|Overall Study|didn't qualify|2|||
30901526|NCT01823224|58935237|FG000|Overall Study|pharmacy error|0|||
30901527|NCT01823224|58935238|FG001|Overall Study|pharmacy error|1|||
30901528|NCT01823224|58935237|FG000|Overall Study|missed med dose|0|||
30739789|NCT00124072|58751007|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
30739790|NCT00124072|58751004|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
30739791|NCT00124072|58751005|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
30739792|NCT00124072|58751006|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
30739793|NCT00124072|58751007|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
30739794|NCT00124072|58751004|FG000|Overall Study|Death|499|||
30739795|NCT00124072|58751005|FG001|Overall Study|Death|484|||
30739796|NCT00124072|58751006|FG002|Overall Study|Death|471|||
30739797|NCT00124072|58751007|FG003|Overall Study|Death|480|||
30739798|NCT00362648|58751021|FG000|Overall Study|Adverse Event|12|||
30739799|NCT00362648|58751022|FG001|Overall Study|Adverse Event|21|||
30739800|NCT00362648|58751023|FG002|Overall Study|Adverse Event|1|||
30739801|NCT00362648|58751024|FG003|Overall Study|Adverse Event|0|||
30739802|NCT00362648|58751021|FG000|Overall Study|Lost to Follow-up|62|||
30739803|NCT00362648|58751022|FG001|Overall Study|Lost to Follow-up|69|||
30739804|NCT00362648|58751023|FG002|Overall Study|Lost to Follow-up|4|||
30739805|NCT00362648|58751024|FG003|Overall Study|Lost to Follow-up|3|||
30739806|NCT00362648|58751021|FG000|Overall Study|Protocol Violation|4|||
30739807|NCT00362648|58751022|FG001|Overall Study|Protocol Violation|2|||
30739808|NCT00362648|58751023|FG002|Overall Study|Protocol Violation|2|||
30739809|NCT00362648|58751024|FG003|Overall Study|Protocol Violation|2|||
30739810|NCT00362648|58751021|FG000|Overall Study|Withdrawal by Subject|48|||
30739811|NCT00362648|58751022|FG001|Overall Study|Withdrawal by Subject|42|||
30739812|NCT00362648|58751023|FG002|Overall Study|Withdrawal by Subject|2|||
30739813|NCT00362648|58751024|FG003|Overall Study|Withdrawal by Subject|6|||
30739814|NCT00524303|58751041|FG000|Overall Study|Lost to Follow-up|6|||
30739815|NCT00524303|58751042|FG001|Overall Study|Lost to Follow-up|0|||
30739816|NCT00524303|58751043|FG002|Overall Study|Lost to Follow-up|3|||
30739817|NCT00524303|58751041|FG000|Overall Study|Protocol Violation|0|||
30739818|NCT00524303|58751042|FG001|Overall Study|Protocol Violation|1|||
30739819|NCT00524303|58751043|FG002|Overall Study|Protocol Violation|1|||
30739820|NCT00524303|58751041|FG000|Overall Study|Withdrawal by Subject|3|||
30739821|NCT00524303|58751042|FG001|Overall Study|Withdrawal by Subject|0|||
30739822|NCT00524303|58751043|FG002|Overall Study|Withdrawal by Subject|4|||
30739823|NCT00524303|58751041|FG000|Overall Study|Death|0|||
30739824|NCT00524303|58751042|FG001|Overall Study|Death|2|||
30739825|NCT00524303|58751043|FG002|Overall Study|Death|3|||
30739826|NCT00524303|58751041|FG000|Overall Study|Adverse Event|1|||
30739827|NCT00524303|58751042|FG001|Overall Study|Adverse Event|2|||
30739828|NCT00524303|58751043|FG002|Overall Study|Adverse Event|3|||
30739829|NCT00524303|58751041|FG000|Overall Study|Did not Complete Study Dosing|1|||
30621942|NCT01179737|58633493|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
30901529|NCT01823224|58935238|FG001|Overall Study|missed med dose|1|||
30901530|NCT01823224|58935237|FG000|Overall Study|Withdrawal by Subject|0|||
30621943|NCT01179737|58633490|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
30739830|NCT00524303|58751042|FG001|Overall Study|Did not Complete Study Dosing|0|||
30739831|NCT00524303|58751043|FG002|Overall Study|Did not Complete Study Dosing|0|||
30739832|NCT00524303|58751041|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
30739833|NCT00524303|58751042|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
30739834|NCT00524303|58751043|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
30739835|NCT00524303|58751041|FG000|Overall Study|Disease Progression|0|||
30739836|NCT00524303|58751042|FG001|Overall Study|Disease Progression|4|||
30739837|NCT00524303|58751043|FG002|Overall Study|Disease Progression|1|||
30739838|NCT00524303|58751041|FG000|Overall Study|Disease Recurrence|0|||
30739839|NCT00524303|58751042|FG001|Overall Study|Disease Recurrence|1|||
30739840|NCT00524303|58751043|FG002|Overall Study|Disease Recurrence|0|||
30739841|NCT00524303|58751041|FG000|Overall Study|Sponsor Request|0|||
30739842|NCT00524303|58751042|FG001|Overall Study|Sponsor Request|0|||
30739843|NCT00524303|58751043|FG002|Overall Study|Sponsor Request|1|||
30739844|NCT00524303|58751041|FG000|Overall Study|Physician Decision|0|||
30739845|NCT00524303|58751042|FG001|Overall Study|Physician Decision|0|||
30739846|NCT00524303|58751043|FG002|Overall Study|Physician Decision|1|||
30739847|NCT00524303|58751041|FG000|Overall Study|Completed 5 years|0|||
30739848|NCT00524303|58751042|FG001|Overall Study|Completed 5 years|0|||
30739849|NCT00524303|58751043|FG002|Overall Study|Completed 5 years|1|||
30739850|NCT00335556|58751060|FG000|Overall Study|Death|0|||
30739851|NCT00335556|58751061|FG001|Overall Study|Death|5|||
30739852|NCT00335556|58751062|FG002|Overall Study|Death|0|||
30739853|NCT00335556|58751063|FG003|Overall Study|Death|0|||
30739854|NCT00335556|58751064|FG004|Overall Study|Death|1|||
30739855|NCT00335556|58751065|FG005|Overall Study|Death|0|||
30739856|NCT00335556|58751060|FG000|Overall Study|Lack of Efficacy|0|||
30739857|NCT00335556|58751061|FG001|Overall Study|Lack of Efficacy|19|||
30739858|NCT00335556|58751062|FG002|Overall Study|Lack of Efficacy|3|||
30739859|NCT00335556|58751063|FG003|Overall Study|Lack of Efficacy|3|||
30739860|NCT00335556|58751064|FG004|Overall Study|Lack of Efficacy|0|||
30739861|NCT00335556|58751065|FG005|Overall Study|Lack of Efficacy|1|||
30739862|NCT00335556|58751060|FG000|Overall Study|Physician Decision|0|||
30739863|NCT00335556|58751061|FG001|Overall Study|Physician Decision|6|||
30739864|NCT00335556|58751062|FG002|Overall Study|Physician Decision|2|||
30739865|NCT00335556|58751063|FG003|Overall Study|Physician Decision|1|||
30739866|NCT00335556|58751064|FG004|Overall Study|Physician Decision|0|||
30739867|NCT00335556|58751065|FG005|Overall Study|Physician Decision|0|||
30739868|NCT00335556|58751060|FG000|Overall Study|Ineligible|2|||
30739869|NCT00335556|58751061|FG001|Overall Study|Ineligible|0|||
30739870|NCT00335556|58751062|FG002|Overall Study|Ineligible|0|||
30739871|NCT00335556|58751063|FG003|Overall Study|Ineligible|0|||
30739872|NCT00335556|58751064|FG004|Overall Study|Ineligible|0|||
30739873|NCT00335556|58751065|FG005|Overall Study|Ineligible|0|||
30739874|NCT00335556|58751060|FG000|Overall Study|Refusal of further protocol therapy|0|||
30739875|NCT00335556|58751061|FG001|Overall Study|Refusal of further protocol therapy|4|||
30739876|NCT00335556|58751062|FG002|Overall Study|Refusal of further protocol therapy|0|||
30739877|NCT00335556|58751063|FG003|Overall Study|Refusal of further protocol therapy|1|||
30739878|NCT00335556|58751064|FG004|Overall Study|Refusal of further protocol therapy|0|||
30739879|NCT00335556|58751065|FG005|Overall Study|Refusal of further protocol therapy|0|||
30739880|NCT00518687|58751086|FG000|Overall Study|Adverse Event|201|||
30739881|NCT00518687|58751087|FG001|Overall Study|Adverse Event|177|||
30739882|NCT00518687|58751086|FG000|Overall Study|Lost to Follow-up|144|||
30739883|NCT00518687|58751087|FG001|Overall Study|Lost to Follow-up|155|||
30739884|NCT00518687|58751086|FG000|Overall Study|Physician Decision|42|||
30739885|NCT00518687|58751087|FG001|Overall Study|Physician Decision|48|||
30739886|NCT00518687|58751086|FG000|Overall Study|Progressive disease|2|||
30739887|NCT00518687|58751087|FG001|Overall Study|Progressive disease|2|||
30739888|NCT00518687|58751086|FG000|Overall Study|Protocol Violation|8|||
30739889|NCT00518687|58751087|FG001|Overall Study|Protocol Violation|10|||
30739890|NCT00518687|58751086|FG000|Overall Study|Study terminated by sponsor|930|||
30739891|NCT00518687|58751087|FG001|Overall Study|Study terminated by sponsor|918|||
30739892|NCT00518687|58751086|FG000|Overall Study|Withdrawal by Subject|110|||
30739893|NCT00518687|58751087|FG001|Overall Study|Withdrawal by Subject|110|||
30739894|NCT00134056|58751095|FG000|Randomization|Not eligible for assigned treatment|22|||
30739895|NCT00134056|58751096|FG001|Randomization|Not eligible for assigned treatment|20|||
30739896|NCT00134056|58751095|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
30739897|NCT00134056|58751096|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
30739898|NCT00134056|58751095|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
30739899|NCT00134056|58751096|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
30739900|NCT00134056|58751095|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
30901531|NCT01823224|58935238|FG001|Overall Study|Withdrawal by Subject|1|||
30739901|NCT00134056|58751096|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
30901532|NCT01840228|58935248|FG000|Overall Study|Lost to Follow-up|1|||
30901533|NCT01840228|58935249|FG001|Overall Study|Lost to Follow-up|1|||
30901534|NCT01839916|58935259|FG000|Overall Study|Death|9|||
30901535|NCT01839916|58935259|FG000|Overall Study|Physician Decision|17|||
30739902|NCT00134056|58751095|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
30901536|NCT01839916|58935259|FG000|Overall Study|Relapse|12|||
30901537|NCT01839916|58935259|FG000|Overall Study|GVHD|2|||
30739903|NCT00134056|58751096|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
30739904|NCT00518531|58751107|FG000|Treatment Period 1|Adverse Event|5|||
30739905|NCT00518531|58751108|FG001|Treatment Period 1|Adverse Event|0|||
30739906|NCT00518531|58751107|FG000|Treatment Period 1|Lost to Follow-up|5|||
30739907|NCT00518531|58751108|FG001|Treatment Period 1|Lost to Follow-up|3|||
30739908|NCT00518531|58751107|FG000|Treatment Period 1|Physician Decision|1|||
30739909|NCT00518531|58751108|FG001|Treatment Period 1|Physician Decision|0|||
30739910|NCT00518531|58751107|FG000|Treatment Period 1|Protocol Violation|2|||
30739911|NCT00518531|58751108|FG001|Treatment Period 1|Protocol Violation|0|||
30739912|NCT00518531|58751107|FG000|Treatment Period 1|Withdrawal by Subject|4|||
30739913|NCT00518531|58751108|FG001|Treatment Period 1|Withdrawal by Subject|6|||
30739914|NCT00518531|58751107|FG000|Treatment Period 1|Early crossover|1|||
30739915|NCT00518531|58751108|FG001|Treatment Period 1|Early crossover|3|||
30739916|NCT00518531|58751107|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30739917|NCT00518531|58751108|FG001|Treatment Period 2|Withdrawal by Subject|8|||
30739918|NCT00518531|58751107|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
30739919|NCT00518531|58751108|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
30739920|NCT00518531|58751107|FG000|Treatment Period 2|Adverse Event|1|||
30739921|NCT00518531|58751108|FG001|Treatment Period 2|Adverse Event|7|||
30739922|NCT00518531|58751107|FG000|Treatment Period 2|Protocol-specified criteria|0|||
30739923|NCT00518531|58751108|FG001|Treatment Period 2|Protocol-specified criteria|1|||
30739924|NCT00518531|58751107|FG000|Treatment Period 2|Non-compliance|1|||
30739925|NCT00518531|58751108|FG001|Treatment Period 2|Non-compliance|2|||
30739926|NCT00351468|58751116|FG000|Overall Study|Adverse Event|42|||
30739927|NCT00351468|58751116|FG000|Overall Study|Withdrawal by Subject|39|||
30739928|NCT00351468|58751116|FG000|Overall Study|Various -follow up w clinical team|39|||
30739929|NCT00351468|58751116|FG000|Overall Study|Lack of Efficacy|32|||
30739930|NCT00351468|58751116|FG000|Overall Study|Non-compliance|8|||
30739931|NCT00351468|58751116|FG000|Overall Study|Lost to Follow-up|4|||
30739932|NCT00351468|58751116|FG000|Overall Study|Protocol Violation|3|||
30739933|NCT00523991|58751123|FG000|Overall Study|Adverse Event|6|||
30739934|NCT00523991|58751124|FG001|Overall Study|Adverse Event|5|||
30739935|NCT00523991|58751123|FG000|Overall Study|Protocol Violation|1|||
30739936|NCT00523991|58751124|FG001|Overall Study|Protocol Violation|4|||
30739937|NCT00523991|58751123|FG000|Overall Study|Lost to Follow-up|4|||
30739938|NCT00523991|58751124|FG001|Overall Study|Lost to Follow-up|1|||
30739939|NCT00523991|58751123|FG000|Overall Study|Withdrawal by Subject|7|||
30739940|NCT00523991|58751124|FG001|Overall Study|Withdrawal by Subject|17|||
30739941|NCT00523991|58751123|FG000|Overall Study|Other reason (not specified)|3|||
30739942|NCT00523991|58751124|FG001|Overall Study|Other reason (not specified)|0|||
30739943|NCT00350844|58751130|FG000|Overall Study|Lost to Follow-up|1|||
30739944|NCT00345540|58751134|FG000|Overall Study|Withdrawal by Subject|1|||
30739945|NCT00335322|58751141|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
30739946|NCT00335322|58751142|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
30739947|NCT00335322|58751143|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
30739948|NCT00523367|58751154|FG000|Overall Study|19 screen failures|19|||
30739949|NCT00523367|58751154|FG000|Overall Study|4 Withdrawn by PI|4|||
30739950|NCT03755765|58751161|FG000|Overall Study|Withdrawal by Subject|2|||
30739951|NCT03755765|58751162|FG001|Overall Study|Withdrawal by Subject|4|||
30739952|NCT03755765|58751163|FG002|Overall Study|Withdrawal by Subject|4|||
30739953|NCT00344448|58751171|FG000|Screening|Withdrawal by Subject|0|||
30739954|NCT00344448|58751172|FG001|Screening|Withdrawal by Subject|1|||
30739955|NCT00344448|58751171|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
30739956|NCT00344448|58751172|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
30739957|NCT00344448|58751171|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
30739958|NCT00344448|58751172|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
30739959|NCT00344448|58751171|FG000|Open Label|Withdrawal by Subject|1|||
30739960|NCT00344448|58751172|FG001|Open Label|Withdrawal by Subject|1|||
30739961|NCT00344448|58751171|FG000|Open Label|Study terminated|1|||
30739962|NCT00344448|58751172|FG001|Open Label|Study terminated|0|||
30739963|NCT00324168|58751180|FG000|Overall Study|Lost to Follow-up|19|||
30739964|NCT00324168|58751181|FG001|Overall Study|Lost to Follow-up|18|||
30739965|NCT00324168|58751180|FG000|Overall Study|Death|3|||
30739966|NCT00324168|58751181|FG001|Overall Study|Death|3|||
30739967|NCT00324168|58751180|FG000|Overall Study|Patient did not visit in f/u window|6|||
30739968|NCT00324168|58751181|FG001|Overall Study|Patient did not visit in f/u window|9|||
30739969|NCT00517829|58751189|FG000|Overall Study|Adverse Event|22|||
30739970|NCT00517829|58751190|FG001|Overall Study|Adverse Event|34|||
30739971|NCT00517829|58751189|FG000|Overall Study|Disease Progression|39|||
30739972|NCT00517829|58751190|FG001|Overall Study|Disease Progression|32|||
30739973|NCT00517829|58751189|FG000|Overall Study|Patient Request|6|||
30739974|NCT00517829|58751190|FG001|Overall Study|Patient Request|5|||
30739975|NCT00517829|58751189|FG000|Overall Study|Investigator Request|5|||
30739976|NCT00517829|58751190|FG001|Overall Study|Investigator Request|3|||
30739977|NCT00517829|58751189|FG000|Overall Study|Other|3|||
30739978|NCT00517829|58751190|FG001|Overall Study|Other|1|||
30739979|NCT00343512|58751196|FG000|Overall Study|Withdrawal by Subject|2|||
30739980|NCT00334542|58751201|FG000|Overall Study|Adverse Event|3|||
30739981|NCT00334542|58751201|FG000|Overall Study|Withdrawal by Subject|1|||
30739982|NCT00334542|58751201|FG000|Overall Study|New cancer diagnosis|1|||
30739983|NCT00112294|58751208|FG000|Overall Study|Still on study|5|||
30739984|NCT00112294|58751209|FG001|Overall Study|Still on study|0|||
30739985|NCT00235443|58751221|FG000|Overall Study|Adverse Event|4|||
30739986|NCT00235443|58751222|FG001|Overall Study|Adverse Event|12|||
30739987|NCT00235443|58751223|FG002|Overall Study|Adverse Event|17|||
30739988|NCT00235443|58751224|FG003|Overall Study|Adverse Event|44|||
30739989|NCT00235443|58751225|FG004|Overall Study|Adverse Event|10|||
30739990|NCT00235443|58751226|FG005|Overall Study|Adverse Event|15|||
30739991|NCT00235443|58751221|FG000|Overall Study|Lack of Efficacy|0|||
30739992|NCT00235443|58751222|FG001|Overall Study|Lack of Efficacy|1|||
30739993|NCT00235443|58751223|FG002|Overall Study|Lack of Efficacy|5|||
30739994|NCT00235443|58751224|FG003|Overall Study|Lack of Efficacy|12|||
30739995|NCT00235443|58751225|FG004|Overall Study|Lack of Efficacy|2|||
30739996|NCT00235443|58751226|FG005|Overall Study|Lack of Efficacy|9|||
30739997|NCT00235443|58751221|FG000|Overall Study|Withdrawal by Subject|3|||
30739998|NCT00235443|58751222|FG001|Overall Study|Withdrawal by Subject|9|||
30739999|NCT00235443|58751223|FG002|Overall Study|Withdrawal by Subject|25|||
30740000|NCT00235443|58751224|FG003|Overall Study|Withdrawal by Subject|24|||
30740001|NCT00235443|58751225|FG004|Overall Study|Withdrawal by Subject|10|||
30740002|NCT00235443|58751226|FG005|Overall Study|Withdrawal by Subject|12|||
30740003|NCT00235443|58751221|FG000|Overall Study|Lost to Follow-up|0|||
30740004|NCT00235443|58751222|FG001|Overall Study|Lost to Follow-up|8|||
30740005|NCT00235443|58751223|FG002|Overall Study|Lost to Follow-up|6|||
30740006|NCT00235443|58751224|FG003|Overall Study|Lost to Follow-up|6|||
30740007|NCT00235443|58751225|FG004|Overall Study|Lost to Follow-up|4|||
30740008|NCT00235443|58751226|FG005|Overall Study|Lost to Follow-up|3|||
30740009|NCT00235443|58751221|FG000|Overall Study|Unsatisfactory compliance|0|||
30740010|NCT00235443|58751222|FG001|Overall Study|Unsatisfactory compliance|2|||
30740011|NCT00235443|58751223|FG002|Overall Study|Unsatisfactory compliance|3|||
30740012|NCT00235443|58751224|FG003|Overall Study|Unsatisfactory compliance|4|||
30740013|NCT00235443|58751225|FG004|Overall Study|Unsatisfactory compliance|1|||
30740014|NCT00235443|58751226|FG005|Overall Study|Unsatisfactory compliance|0|||
30740015|NCT00235443|58751221|FG000|Overall Study|Other reasons for premature termination|1|||
30740016|NCT00235443|58751222|FG001|Overall Study|Other reasons for premature termination|6|||
30740017|NCT00235443|58751223|FG002|Overall Study|Other reasons for premature termination|6|||
30740018|NCT00235443|58751224|FG003|Overall Study|Other reasons for premature termination|7|||
30740019|NCT00235443|58751225|FG004|Overall Study|Other reasons for premature termination|3|||
30740020|NCT00235443|58751226|FG005|Overall Study|Other reasons for premature termination|6|||
30740021|NCT00234039|58751242|FG000|Overall Study|Adverse Event|2|||
30740022|NCT00234039|58751242|FG000|Overall Study|Progression/relapse|34|||
30740023|NCT00234039|58751242|FG000|Overall Study|Other - Not Protocol Specified|3|||
30621944|NCT01179737|58633491|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
30621945|NCT01179737|58633492|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
30740024|NCT00234039|58751242|FG000|Overall Study|Ineligible|9|||
30740025|NCT00234039|58751242|FG000|Overall Study|No Protocol Treatment Received|2|||
30740026|NCT00323622|58751254|FG000|Overall Study|Other|30|||
30740027|NCT00323622|58751255|FG001|Overall Study|Other|91|||
30740028|NCT00323622|58751256|FG002|Overall Study|Other|4|||
30740029|NCT00323622|58751257|FG003|Overall Study|Other|12|||
30740030|NCT00323622|58751258|FG004|Overall Study|Other|32|||
30740031|NCT00323622|58751259|FG005|Overall Study|Other|74|||
30740032|NCT00323622|58751260|FG006|Overall Study|Other|5|||
30740033|NCT00323622|58751261|FG007|Overall Study|Other|13|||
30740034|NCT00323622|58751254|FG000|Overall Study|Death|1|||
30740035|NCT00323622|58751255|FG001|Overall Study|Death|1|||
30740036|NCT00323622|58751256|FG002|Overall Study|Death|0|||
30740037|NCT00323622|58751257|FG003|Overall Study|Death|0|||
30740038|NCT00323622|58751258|FG004|Overall Study|Death|7|||
30740039|NCT00323622|58751259|FG005|Overall Study|Death|0|||
30901538|NCT01839916|58935259|FG000|Overall Study|Graft Failure|1|||
30901539|NCT01823146|58935265|FG000|Overall Study|Withdrawal by Subject|0|||
30901540|NCT01823146|58935266|FG001|Overall Study|Withdrawal by Subject|1|||
30901541|NCT01823146|58935265|FG000|Overall Study|Lost to Follow-up|2|||
30901542|NCT01823146|58935266|FG001|Overall Study|Lost to Follow-up|1|||
30901543|NCT02083185|58935275|FG000|Overall Study|Lost to Follow-up|0|||
30740040|NCT00323622|58751260|FG006|Overall Study|Death|0|||
30740041|NCT00323622|58751261|FG007|Overall Study|Death|2|||
30740042|NCT00189423|58751289|FG000|Overall Study|Death|746|||
30740043|NCT00189423|58751290|FG001|Overall Study|Death|747|||
30740044|NCT00189423|58751289|FG000|Overall Study|Withdrawal by Subject|9|||
30740045|NCT00189423|58751290|FG001|Overall Study|Withdrawal by Subject|9|||
30740046|NCT00189423|58751289|FG000|Overall Study|Lost to Follow-up|10|||
30740047|NCT00189423|58751290|FG001|Overall Study|Lost to Follow-up|10|||
30740048|NCT00323310|58751296|FG000|Overall Study|Withdrawal by Subject|1|||
30740049|NCT00323310|58751296|FG000|Overall Study|a parent refused blood draw|1|||
30740050|NCT00323310|58751296|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
30740051|NCT00186537|58751303|FG000|Overall Study|Withdrawal by Subject|4|||
30740052|NCT00186537|58751304|FG001|Overall Study|Withdrawal by Subject|0|||
30740053|NCT00186537|58751305|FG002|Overall Study|Withdrawal by Subject|3|||
30901544|NCT02083185|58935276|FG001|Overall Study|Lost to Follow-up|3|||
30901545|NCT02083185|58935277|FG002|Overall Study|Lost to Follow-up|0|||
30740054|NCT00186537|58751303|FG000|Overall Study|ALT > 1.5 x ULN|3|||
30740055|NCT00186537|58751304|FG001|Overall Study|ALT > 1.5 x ULN|0|||
30740056|NCT00186537|58751305|FG002|Overall Study|ALT > 1.5 x ULN|0|||
30740057|NCT00517751|58751313|FG000|Overall Study|Death|3|||
30740058|NCT00517751|58751313|FG000|Overall Study|Withdrawal by Subject|37|||
30740059|NCT00517751|58751313|FG000|Overall Study|Lost to Follow-up|4|||
30901546|NCT02083185|58935275|FG000|Overall Study|Withdrawal by Subject|9|||
30901547|NCT02083185|58935276|FG001|Overall Study|Withdrawal by Subject|15|||
30901548|NCT02083185|58935277|FG002|Overall Study|Withdrawal by Subject|1|||
30901549|NCT02083185|58935275|FG000|Overall Study|Death|2|||
30901550|NCT02083185|58935276|FG001|Overall Study|Death|2|||
30901551|NCT02083185|58935277|FG002|Overall Study|Death|1|||
30740060|NCT00517751|58751313|FG000|Overall Study|patient not over due|6|||
30740061|NCT00517751|58751313|FG000|Overall Study|Patient not due for visit|76|||
30901552|NCT02083185|58935275|FG000|Overall Study|Reason not Specified|9|||
30901553|NCT02083185|58935276|FG001|Overall Study|Reason not Specified|6|||
30901554|NCT02083185|58935277|FG002|Overall Study|Reason not Specified|5|||
30901555|NCT02083185|58935275|FG000|Overall Study|Study Terminated by Sponsor|0|||
30901556|NCT02083185|58935276|FG001|Overall Study|Study Terminated by Sponsor|1|||
30901557|NCT02083185|58935277|FG002|Overall Study|Study Terminated by Sponsor|0|||
30901558|NCT02083185|58935275|FG000|Overall Study|Did not Receive Study Drug|0|||
30901559|NCT02083185|58935276|FG001|Overall Study|Did not Receive Study Drug|2|||
30740062|NCT00517751|58751313|FG000|Overall Study|Missing|3|||
30740063|NCT00322842|58751319|FG000|Overall Study|Withdrawal by Subject|0|||
30740064|NCT00322842|58751320|FG001|Overall Study|Withdrawal by Subject|1|||
30740065|NCT00322842|58751319|FG000|Overall Study|Lost to Follow-up|0|||
30740066|NCT00322842|58751320|FG001|Overall Study|Lost to Follow-up|1|||
30740067|NCT00322842|58751319|FG000|Overall Study|Refused transplant|1|||
30740068|NCT00322842|58751320|FG001|Overall Study|Refused transplant|0|||
30740069|NCT00322842|58751319|FG000|Overall Study|Death|1|||
30901560|NCT02083185|58935277|FG002|Overall Study|Did not Receive Study Drug|0|||
30901561|NCT02019927|58935291|FG000|Overall Study|Lost to Follow-up|2|||
30901562|NCT02019927|58935292|FG001|Overall Study|Lost to Follow-up|4|||
30901563|NCT02019927|58935293|FG002|Overall Study|Lost to Follow-up|1|||
30740070|NCT00322842|58751320|FG001|Overall Study|Death|0|||
30740071|NCT00255723|58751329|FG000|Overall Study|Adverse Event|1|||
30740072|NCT00255723|58751330|FG001|Overall Study|Adverse Event|1|||
30740073|NCT00255723|58751329|FG000|Overall Study|Death|0|||
30621946|NCT01179737|58633493|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
30740074|NCT00255723|58751330|FG001|Overall Study|Death|1|||
30740075|NCT00255723|58751329|FG000|Overall Study|Response Data Not Available|1|||
30621947|NCT01179737|58633490|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
30621948|NCT01179737|58633491|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
30621949|NCT01179737|58633492|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
30621950|NCT01179737|58633493|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
30621951|NCT01179737|58633490|FG000|Cohort 1 & Cohort 2|Death|0|||
30621952|NCT01179737|58633491|FG001|Cohort 1 & Cohort 2|Death|0|||
30621953|NCT01179737|58633492|FG002|Cohort 1 & Cohort 2|Death|1|||
30621954|NCT01179737|58633493|FG003|Cohort 1 & Cohort 2|Death|0|||
30621955|NCT01179737|58633490|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
30621956|NCT01179737|58633491|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
30621957|NCT01179737|58633492|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
30621958|NCT01179737|58633493|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
30621959|NCT01179737|58633490|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
30621960|NCT01179737|58633491|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
30621961|NCT01179737|58633492|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
30621962|NCT01179737|58633493|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
30621963|NCT01179737|58633490|FG000|Extension|The study was terminated|3|||
30621964|NCT01179737|58633491|FG001|Extension|The study was terminated|0|||
30621965|NCT01179737|58633492|FG002|Extension|The study was terminated|0|||
30621966|NCT01179737|58633493|FG003|Extension|The study was terminated|0|||
30621967|NCT00929110|58633505|FG000|Overall Study|Adverse Event|40|||
30621968|NCT00929110|58633506|FG001|Overall Study|Adverse Event|29|||
30621969|NCT00929110|58633507|FG002|Overall Study|Adverse Event|18|||
30621970|NCT00929110|58633505|FG000|Overall Study|Subject withdrew consent|40|||
30621971|NCT00929110|58633506|FG001|Overall Study|Subject withdrew consent|23|||
30621972|NCT00929110|58633507|FG002|Overall Study|Subject withdrew consent|26|||
30740076|NCT00255723|58751330|FG001|Overall Study|Response Data Not Available|0|||
30740077|NCT00132808|58751339|FG000|Stratum I|Adverse Event|2|||
30740078|NCT00132808|58751340|FG001|Stratum I|Adverse Event|1|||
30740079|NCT00132808|58751341|FG002|Stratum I|Adverse Event|0|||
30740080|NCT00132808|58751339|FG000|Stratum I|Lost to Follow-up|3|||
30740081|NCT00132808|58751340|FG001|Stratum I|Lost to Follow-up|4|||
30740082|NCT00132808|58751341|FG002|Stratum I|Lost to Follow-up|1|||
30740083|NCT00132808|58751339|FG000|Stratum I|Withdrawal by Subject|4|||
30740084|NCT00132808|58751340|FG001|Stratum I|Withdrawal by Subject|7|||
30740085|NCT00132808|58751341|FG002|Stratum I|Withdrawal by Subject|3|||
30740086|NCT00132808|58751339|FG000|Stratum I|Abnormal test procedure result (s)|0|||
30740087|NCT00132808|58751340|FG001|Stratum I|Abnormal test procedure result (s)|0|||
30740088|NCT00132808|58751341|FG002|Stratum I|Abnormal test procedure result (s)|1|||
30740089|NCT00132808|58751339|FG000|Stratum II|Adverse Event|1|||
30621973|NCT00929110|58633505|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
30621974|NCT00929110|58633506|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
30621975|NCT00929110|58633507|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
30621976|NCT00929110|58633505|FG000|Overall Study|Lost to Follow-up|7|||
30621977|NCT00929110|58633506|FG001|Overall Study|Lost to Follow-up|7|||
30790991|NCT00152464|58804144|FG001|Overall Study|Eczema deterioration|1|||
30621978|NCT00929110|58633507|FG002|Overall Study|Lost to Follow-up|3|||
30621979|NCT00929110|58633505|FG000|Overall Study|Protocol deviation|5|||
30740090|NCT00132808|58751340|FG001|Stratum II|Adverse Event|2|||
30740091|NCT00132808|58751341|FG002|Stratum II|Adverse Event|1|||
30740092|NCT00132808|58751339|FG000|Stratum II|Death|1|||
30740093|NCT00132808|58751340|FG001|Stratum II|Death|0|||
30740094|NCT00132808|58751341|FG002|Stratum II|Death|0|||
30740095|NCT00132808|58751339|FG000|Stratum II|Lost to Follow-up|2|||
30740096|NCT00132808|58751340|FG001|Stratum II|Lost to Follow-up|2|||
30740097|NCT00132808|58751341|FG002|Stratum II|Lost to Follow-up|1|||
30740098|NCT00132808|58751339|FG000|Stratum II|Protocol Violation|0|||
30740099|NCT00132808|58751340|FG001|Stratum II|Protocol Violation|2|||
30740100|NCT00132808|58751341|FG002|Stratum II|Protocol Violation|1|||
30740101|NCT00132808|58751339|FG000|Stratum II|Withdrawal by Subject|4|||
30740102|NCT00132808|58751340|FG001|Stratum II|Withdrawal by Subject|9|||
30740103|NCT00132808|58751341|FG002|Stratum II|Withdrawal by Subject|6|||
30740104|NCT00517361|58751349|FG000|Overall Study|Death|6|||
30740105|NCT00517361|58751349|FG000|Overall Study|The study was terminated|5|||
30740106|NCT00516893|58751353|FG000|Overall Study|Lost to Follow-up|4|||
30740107|NCT00516893|58751353|FG000|Overall Study|Adverse Event|3|||
30740108|NCT00516893|58751353|FG000|Overall Study|Withdrawal by Subject|2|||
30740109|NCT00516893|58751353|FG000|Overall Study|Noncompliance|2|||
30740110|NCT00516893|58751353|FG000|Overall Study|Death|1|||
30740111|NCT00516893|58751353|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
30740112|NCT00516893|58751353|FG000|Overall Study|Relocated|1|||
30740113|NCT00516893|58751353|FG000|Overall Study|Pregnancy|1|||
30740114|NCT00516893|58751353|FG000|Overall Study|Received Medication From Another Study|1|||
30740115|NCT00522431|58751357|FG000|Overall Study|Adverse Event|5|||
30740116|NCT00522431|58751357|FG000|Overall Study|Protocol Violation|2|||
30740117|NCT00522431|58751357|FG000|Overall Study|Withdrawal by Subject|2|||
30740118|NCT00522431|58751357|FG000|Overall Study|Subject non-compliance|1|||
30740119|NCT00522431|58751357|FG000|Overall Study|Other/unknown|1|||
30740120|NCT00185211|58751363|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
30740121|NCT00185211|58751364|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
30740122|NCT00185211|58751363|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
30740123|NCT00185211|58751364|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
30740124|NCT00185211|58751363|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
30740125|NCT00185211|58751364|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
30740126|NCT00185211|58751363|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
30740127|NCT00185211|58751364|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
30740128|NCT00185211|58751363|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
30740129|NCT00185211|58751364|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
30740130|NCT00185211|58751363|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
30740131|NCT00185211|58751364|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
30740132|NCT00185211|58751363|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
30740133|NCT00185211|58751364|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
30740134|NCT00185211|58751363|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
30740135|NCT00185211|58751364|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
30740136|NCT00185211|58751363|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
30740137|NCT00185211|58751364|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
30740138|NCT00185211|58751363|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
30740139|NCT00185211|58751364|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
30740140|NCT00185211|58751363|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
30901564|NCT02019927|58935294|FG003|Overall Study|Lost to Follow-up|2|||
30901565|NCT02019927|58935295|FG004|Overall Study|Lost to Follow-up|3|||
30901566|NCT02019927|58935296|FG005|Overall Study|Lost to Follow-up|1|||
30901567|NCT02412371|58935320|FG000|Overall Study|Withdrawal by Subject|0|||
30901568|NCT02412371|58935321|FG001|Overall Study|Withdrawal by Subject|2|||
30901569|NCT02412371|58935322|FG002|Overall Study|Withdrawal by Subject|0|||
30901570|NCT02412371|58935323|FG003|Overall Study|Withdrawal by Subject|1|||
30901571|NCT02412371|58935324|FG004|Overall Study|Withdrawal by Subject|1|||
30901572|NCT02412371|58935325|FG005|Overall Study|Withdrawal by Subject|0|||
30901573|NCT02412371|58935320|FG000|Overall Study|Sponsor Discontinued Study|1|||
30901574|NCT02412371|58935321|FG001|Overall Study|Sponsor Discontinued Study|4|||
30740141|NCT00185211|58751364|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
30740142|NCT00185211|58751363|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
30901575|NCT02412371|58935322|FG002|Overall Study|Sponsor Discontinued Study|6|||
30740143|NCT00185211|58751364|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
30740144|NCT00516737|58751373|FG000|Overall Study|Lost to Follow-up|2|||
30740145|NCT00516737|58751374|FG001|Overall Study|Lost to Follow-up|0|||
30740146|NCT00516737|58751373|FG000|Overall Study|Physician Decision|0|||
30740147|NCT00516737|58751374|FG001|Overall Study|Physician Decision|1|||
30901576|NCT02412371|58935323|FG003|Overall Study|Sponsor Discontinued Study|4|||
30901577|NCT02412371|58935324|FG004|Overall Study|Sponsor Discontinued Study|5|||
30901578|NCT02412371|58935325|FG005|Overall Study|Sponsor Discontinued Study|0|||
30740148|NCT00516737|58751373|FG000|Overall Study|Withdrawal by Subject|0|||
30740149|NCT00516737|58751374|FG001|Overall Study|Withdrawal by Subject|1|||
30740150|NCT00516737|58751373|FG000|Overall Study|Lack of Qualifying Event|9|||
30740151|NCT00516737|58751374|FG001|Overall Study|Lack of Qualifying Event|6|||
30740152|NCT00132730|58751384|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
30740153|NCT00132730|58751385|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
30740154|NCT00132730|58751386|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
30740155|NCT00132730|58751387|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
30740156|NCT00132730|58751388|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
30740157|NCT00132730|58751389|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
30740158|NCT00132730|58751384|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
30740159|NCT00132730|58751385|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
30740160|NCT00132730|58751386|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
30740161|NCT00132730|58751387|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
30740162|NCT00132730|58751388|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
30740163|NCT00132730|58751389|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
30740164|NCT00132730|58751384|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
30740165|NCT00132730|58751385|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
30740166|NCT00132730|58751386|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
30740167|NCT00132730|58751387|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
30740168|NCT00132730|58751388|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
30740169|NCT00132730|58751389|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
30740170|NCT00132730|58751384|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
30740171|NCT00132730|58751385|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
30740172|NCT00132730|58751386|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
30740173|NCT00132730|58751387|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
30740174|NCT00132730|58751388|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
30740175|NCT00132730|58751389|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
30740176|NCT00132730|58751384|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
30740177|NCT00132730|58751385|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
30740178|NCT00132730|58751386|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
30740179|NCT00132730|58751387|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
30740180|NCT00132730|58751388|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
30740181|NCT00132730|58751389|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
30740182|NCT00132730|58751384|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
30740183|NCT00132730|58751385|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
30740184|NCT00132730|58751386|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
30740185|NCT00132730|58751387|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
30740186|NCT00132730|58751388|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
30740187|NCT00132730|58751389|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
30740188|NCT00132730|58751384|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
30740189|NCT00132730|58751385|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
30740190|NCT00132730|58751386|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
30740191|NCT00132730|58751387|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
30740192|NCT00132730|58751388|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
30740193|NCT00132730|58751389|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
30740194|NCT00132730|58751384|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
30740195|NCT00132730|58751385|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
30740196|NCT00132730|58751386|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
30740197|NCT00132730|58751387|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
30740198|NCT00132730|58751388|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
30740199|NCT00132730|58751389|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
30740200|NCT00132730|58751384|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
30740201|NCT00132730|58751385|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
30901579|NCT02412371|58935320|FG000|Overall Study|Death|4|||
30901580|NCT02412371|58935321|FG001|Overall Study|Death|2|||
30901581|NCT02412371|58935322|FG002|Overall Study|Death|1|||
30901582|NCT02412371|58935323|FG003|Overall Study|Death|3|||
30901583|NCT02412371|58935324|FG004|Overall Study|Death|5|||
30901584|NCT02412371|58935325|FG005|Overall Study|Death|2|||
30740202|NCT00132730|58751386|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
30901585|NCT02412371|58935320|FG000|Overall Study|Other|2|||
30901586|NCT02412371|58935321|FG001|Overall Study|Other|1|||
30901587|NCT02412371|58935322|FG002|Overall Study|Other|0|||
30901588|NCT02412371|58935323|FG003|Overall Study|Other|0|||
30901589|NCT02412371|58935324|FG004|Overall Study|Other|1|||
30901590|NCT02412371|58935325|FG005|Overall Study|Other|3|||
30901591|NCT02411747|58935342|FG000|Overall Study|Withdrawal by Subject|1|||
30901592|NCT02411747|58935343|FG001|Overall Study|Withdrawal by Subject|0|||
30901593|NCT02411747|58935342|FG000|Overall Study|Protocol Violation|2|||
30901594|NCT02411747|58935343|FG001|Overall Study|Protocol Violation|4|||
30621980|NCT00929110|58633506|FG001|Overall Study|Protocol deviation|2|||
30621981|NCT00929110|58633507|FG002|Overall Study|Protocol deviation|4|||
30621982|NCT00929110|58633505|FG000|Overall Study|Administrative problems|4|||
30740203|NCT00132730|58751387|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
30740204|NCT00132730|58751388|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
30740205|NCT00132730|58751389|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
30740206|NCT00132730|58751384|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
30740207|NCT00132730|58751385|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
30740208|NCT00132730|58751386|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
30740209|NCT00132730|58751387|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
30740210|NCT00132730|58751388|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
30740211|NCT00132730|58751389|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
30740212|NCT00132730|58751384|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
30740213|NCT00132730|58751385|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
30740214|NCT00132730|58751386|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
30621983|NCT00929110|58633506|FG001|Overall Study|Administrative problems|1|||
30621984|NCT00929110|58633507|FG002|Overall Study|Administrative problems|2|||
30621985|NCT00929110|58633505|FG000|Overall Study|Death|2|||
30621986|NCT00929110|58633506|FG001|Overall Study|Death|2|||
30621987|NCT00929110|58633507|FG002|Overall Study|Death|2|||
30740215|NCT00132730|58751387|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
30740216|NCT00132730|58751388|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
30740217|NCT00132730|58751389|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
30740218|NCT00132730|58751384|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
30740219|NCT00132730|58751385|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
30740220|NCT00132730|58751386|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
30740221|NCT00132730|58751387|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
30740222|NCT00132730|58751388|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
30740223|NCT00132730|58751389|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
30740224|NCT00232557|58751405|FG000|Overall Study|Lost to Follow-up|3|||
30740225|NCT00232557|58751406|FG001|Overall Study|Lost to Follow-up|5|||
30740226|NCT00522275|58751412|FG000|Overall Study|Adverse Event|35|||
30740227|NCT00522275|58751412|FG000|Overall Study|Lack of Efficacy|80|||
30740228|NCT00522275|58751412|FG000|Overall Study|Subject withdrew consent|16|||
30740229|NCT00522275|58751412|FG000|Overall Study|Protocol deviation|1|||
30740230|NCT00522275|58751412|FG000|Overall Study|Unsatisfactory compliance|11|||
30740231|NCT00522275|58751412|FG000|Overall Study|Lost to Follow-up|8|||
30740232|NCT00522275|58751412|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
30740233|NCT00522275|58751412|FG000|Overall Study|Other: Subject is pregnant|2|||
30740234|NCT00522275|58751412|FG000|Overall Study|Other: Subject relocated|2|||
30740235|NCT00522275|58751412|FG000|Overall Study|Other: Subject arrested|1|||
30740236|NCT00522275|58751412|FG000|Overall Study|Other: Site / clinic closed|4|||
30740237|NCT00522275|58751412|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
30740238|NCT00522275|58751412|FG000|Overall Study|Other: Sponsor request|2|||
30740239|NCT00522275|58751412|FG000|Overall Study|Other: Subject ran out of medication|1|||
30740240|NCT00522275|58751412|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
30740241|NCT00522041|58751418|FG000|Overall Study|Adverse Event|9|||
30740242|NCT00522041|58751419|FG001|Overall Study|Adverse Event|3|||
30740243|NCT00522041|58751418|FG000|Overall Study|Protocol Violation|2|||
30740244|NCT00522041|58751419|FG001|Overall Study|Protocol Violation|0|||
30740245|NCT00522041|58751418|FG000|Overall Study|Lost to Follow-up|1|||
30740246|NCT00522041|58751419|FG001|Overall Study|Lost to Follow-up|4|||
30740247|NCT00522041|58751418|FG000|Overall Study|Voluntary withdrawal|5|||
30740248|NCT00522041|58751419|FG001|Overall Study|Voluntary withdrawal|4|||
30740249|NCT00522041|58751418|FG000|Overall Study|Did not receive treatment|0|||
30740250|NCT00522041|58751419|FG001|Overall Study|Did not receive treatment|1|||
30740251|NCT00122980|58751428|FG000|Overall Study|Death|0|||
30740252|NCT00122980|58751429|FG001|Overall Study|Death|1|||
30740253|NCT00122980|58751428|FG000|Overall Study|Physician Decision|2|||
30740254|NCT00122980|58751429|FG001|Overall Study|Physician Decision|0|||
30901595|NCT01822756|58935354|FG000|Overall Study|Adverse Event|0|||
30740255|NCT00122980|58751428|FG000|Overall Study|Protocol Violation|5|||
30901596|NCT01822756|58935355|FG001|Overall Study|Adverse Event|0|||
30901597|NCT01822756|58935356|FG002|Overall Study|Adverse Event|0|||
30621988|NCT00929110|58633505|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30621989|NCT00929110|58633506|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30740256|NCT00122980|58751429|FG001|Overall Study|Protocol Violation|1|||
30740257|NCT00122980|58751428|FG000|Overall Study|Withdrawal by Subject|2|||
30740258|NCT00122980|58751429|FG001|Overall Study|Withdrawal by Subject|3|||
30740259|NCT00122980|58751428|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
30740260|NCT00122980|58751429|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
30740261|NCT00122980|58751428|FG000|Overall Study|Study termination|27|||
30740262|NCT00122980|58751429|FG001|Overall Study|Study termination|35|||
30740263|NCT03868631|58751437|FG000|Baseline to Week 6|Adverse Event|0|||
30740264|NCT03868631|58751438|FG001|Baseline to Week 6|Adverse Event|3|||
30740265|NCT03868631|58751437|FG000|Baseline to Week 6|Protocol Violation|1|||
30740266|NCT03868631|58751438|FG001|Baseline to Week 6|Protocol Violation|1|||
30740267|NCT03868631|58751437|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
30740268|NCT03868631|58751438|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
30740269|NCT03868631|58751437|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
30740270|NCT03868631|58751438|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
30740271|NCT03868631|58751437|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
30740272|NCT03868631|58751438|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
30740273|NCT03868631|58751437|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
30740274|NCT03868631|58751438|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
30740275|NCT00340704|58751453|FG000|PK Study|Adverse Event|0|||
30740276|NCT00340704|58751454|FG001|PK Study|Adverse Event|1|||
30740277|NCT00340704|58751455|FG002|PK Study|Adverse Event|0|||
30740278|NCT00340704|58751456|FG003|PK Study|Adverse Event|0|||
30740279|NCT00340704|58751457|FG004|PK Study|Adverse Event|0|||
30740280|NCT00340704|58751458|FG005|PK Study|Adverse Event|0|||
30740281|NCT00340704|58751459|FG006|PK Study|Adverse Event|0|||
30740282|NCT00340704|58751460|FG007|PK Study|Adverse Event|0|||
30740283|NCT00340704|58751461|FG008|PK Study|Adverse Event|0|||
30740284|NCT00340704|58751453|FG000|PK Study|Not treated|0|||
30740285|NCT00340704|58751454|FG001|PK Study|Not treated|0|||
30740286|NCT00340704|58751455|FG002|PK Study|Not treated|1|||
30740287|NCT00340704|58751456|FG003|PK Study|Not treated|0|||
30740288|NCT00340704|58751457|FG004|PK Study|Not treated|0|||
30740289|NCT00340704|58751458|FG005|PK Study|Not treated|0|||
30740290|NCT00340704|58751459|FG006|PK Study|Not treated|0|||
30740291|NCT00340704|58751460|FG007|PK Study|Not treated|0|||
30740292|NCT00340704|58751461|FG008|PK Study|Not treated|0|||
30740293|NCT00340704|58751453|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
30740294|NCT00340704|58751454|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
30740295|NCT00340704|58751455|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
30740296|NCT00340704|58751456|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
30740297|NCT00340704|58751457|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
30740298|NCT00340704|58751458|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
30740299|NCT00340704|58751459|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
30740300|NCT00340704|58751460|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
30740301|NCT00340704|58751461|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
30740302|NCT00340704|58751453|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
30740303|NCT00340704|58751454|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
30740304|NCT00340704|58751455|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
30740305|NCT00340704|58751456|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
30740306|NCT00340704|58751457|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
30740307|NCT00340704|58751458|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
30740308|NCT00340704|58751459|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
30740309|NCT00340704|58751460|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
30740310|NCT00340704|58751461|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
30740311|NCT00340704|58751453|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
30740312|NCT00340704|58751454|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
30740313|NCT00340704|58751455|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
30740314|NCT00340704|58751456|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
30740315|NCT00340704|58751457|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
30740316|NCT00340704|58751458|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
30740317|NCT00340704|58751459|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
30740318|NCT00340704|58751460|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
30740319|NCT00340704|58751461|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
30740320|NCT00340704|58751453|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
30740321|NCT00340704|58751454|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
30740322|NCT00340704|58751455|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
30740323|NCT00340704|58751456|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
30790992|NCT00152464|58804143|FG000|Overall Study|Parent decision|1|||
30790993|NCT00152464|58804144|FG001|Overall Study|Parent decision|1|||
30790994|NCT00152464|58804143|FG000|Overall Study|Investigator decision|1|||
30740324|NCT00340704|58751457|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
30740325|NCT00340704|58751458|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
30740326|NCT00340704|58751459|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
30740327|NCT00340704|58751460|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
30740328|NCT00340704|58751461|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
30740329|NCT00132496|58751489|FG000|Overall Study|Withdrawal by Subject|1|||
30740330|NCT00132496|58751490|FG001|Overall Study|Withdrawal by Subject|2|||
30740331|NCT00132496|58751489|FG000|Overall Study|Physician Decision|1|||
30740332|NCT00132496|58751490|FG001|Overall Study|Physician Decision|0|||
30740333|NCT00231777|58751498|FG000|Overall Study|Lost to Follow-up|3|||
30740334|NCT00231777|58751499|FG001|Overall Study|Lost to Follow-up|0|||
30740335|NCT00231777|58751498|FG000|Overall Study|Other|3|||
30740336|NCT00231777|58751499|FG001|Overall Study|Other|2|||
30740337|NCT00231465|58751505|FG000|Overall Study|Completed only one cycle|1|||
30740338|NCT00231465|58751505|FG000|Overall Study|Did not have follow up CT scans|1|||
30740339|NCT00254397|58751513|FG000|Overall Study|Disease Progression|4|||
30740340|NCT00254397|58751514|FG001|Overall Study|Disease Progression|1|||
30740341|NCT00254397|58751515|FG002|Overall Study|Disease Progression|16|||
30740342|NCT00254397|58751516|FG003|Overall Study|Disease Progression|23|||
30740343|NCT00254397|58751513|FG000|Overall Study|Non-Compliant|0|||
30740344|NCT00254397|58751514|FG001|Overall Study|Non-Compliant|0|||
30740345|NCT00254397|58751515|FG002|Overall Study|Non-Compliant|0|||
30740346|NCT00254397|58751516|FG003|Overall Study|Non-Compliant|1|||
30740347|NCT00254397|58751513|FG000|Overall Study|Adverse Event|2|||
30740348|NCT00254397|58751514|FG001|Overall Study|Adverse Event|0|||
30740349|NCT00254397|58751515|FG002|Overall Study|Adverse Event|3|||
30740350|NCT00254397|58751516|FG003|Overall Study|Adverse Event|1|||
30740351|NCT00254163|58751527|FG000|Overall Study|Adverse Event|29|||
30901598|NCT01822756|58935357|FG003|Overall Study|Adverse Event|2|||
30901599|NCT01822756|58935358|FG004|Overall Study|Adverse Event|0|||
30901600|NCT01822756|58935354|FG000|Overall Study|Disease progression|11|||
30901601|NCT01822756|58935355|FG001|Overall Study|Disease progression|1|||
30901602|NCT01822756|58935356|FG002|Overall Study|Disease progression|7|||
30901603|NCT01822756|58935357|FG003|Overall Study|Disease progression|2|||
30901604|NCT01822756|58935358|FG004|Overall Study|Disease progression|6|||
30901605|NCT01822756|58935354|FG000|Overall Study|Death|2|||
30740352|NCT00254163|58751528|FG001|Overall Study|Adverse Event|26|||
30740353|NCT00254163|58751527|FG000|Overall Study|Patient request/withdrew consent|6|||
30740354|NCT00254163|58751528|FG001|Overall Study|Patient request/withdrew consent|4|||
30740355|NCT00254163|58751527|FG000|Overall Study|Investigator request|1|||
30740356|NCT00254163|58751528|FG001|Overall Study|Investigator request|3|||
30740357|NCT00254163|58751527|FG000|Overall Study|Failed entry|1|||
30740358|NCT00254163|58751528|FG001|Overall Study|Failed entry|3|||
30740359|NCT00254163|58751527|FG000|Overall Study|Progressive disease|0|||
30740360|NCT00254163|58751528|FG001|Overall Study|Progressive disease|1|||
30740361|NCT00254163|58751527|FG000|Overall Study|Death|0|||
30740362|NCT00254163|58751528|FG001|Overall Study|Death|1|||
30740363|NCT00254163|58751527|FG000|Overall Study|Other|8|||
30740364|NCT00254163|58751528|FG001|Overall Study|Other|8|||
30740365|NCT03869333|58751538|FG000|Overall Study|Lost to Follow-up|1|||
30740366|NCT03869333|58751539|FG001|Overall Study|Lost to Follow-up|0|||
30740367|NCT03869333|58751540|FG002|Overall Study|Lost to Follow-up|0|||
30740368|NCT03869333|58751541|FG003|Overall Study|Lost to Follow-up|0|||
30740369|NCT03869333|58751538|FG000|Overall Study|Pregnancy|1|||
30740370|NCT03869333|58751539|FG001|Overall Study|Pregnancy|0|||
30740371|NCT03869333|58751540|FG002|Overall Study|Pregnancy|0|||
30740372|NCT03869333|58751541|FG003|Overall Study|Pregnancy|0|||
30740373|NCT03869333|58751538|FG000|Overall Study|Physician Decision|0|||
30740374|NCT03869333|58751539|FG001|Overall Study|Physician Decision|1|||
30740375|NCT03869333|58751540|FG002|Overall Study|Physician Decision|0|||
30740376|NCT03869333|58751541|FG003|Overall Study|Physician Decision|0|||
30740377|NCT00110890|58751553|FG000|Overall Study|Adverse Event|30|||
30740378|NCT00110890|58751554|FG001|Overall Study|Adverse Event|7|||
30740379|NCT00110890|58751553|FG000|Overall Study|Death|16|||
30740380|NCT00110890|58751554|FG001|Overall Study|Death|9|||
30740381|NCT00110890|58751553|FG000|Overall Study|Lost to Follow-up|3|||
30740382|NCT00110890|58751554|FG001|Overall Study|Lost to Follow-up|1|||
30901606|NCT01822756|58935355|FG001|Overall Study|Death|2|||
30740383|NCT00110890|58751553|FG000|Overall Study|Physician Decision|4|||
30740384|NCT00110890|58751554|FG001|Overall Study|Physician Decision|5|||
30740385|NCT00110890|58751553|FG000|Overall Study|Withdrawal by Subject|17|||
30740386|NCT00110890|58751554|FG001|Overall Study|Withdrawal by Subject|5|||
30740387|NCT00110890|58751553|FG000|Overall Study|Protocol Deviation|1|||
30901607|NCT01822756|58935356|FG002|Overall Study|Death|1|||
30740388|NCT00110890|58751554|FG001|Overall Study|Protocol Deviation|0|||
30740389|NCT00110890|58751553|FG000|Overall Study|Noncompliance|10|||
30740390|NCT00110890|58751554|FG001|Overall Study|Noncompliance|0|||
30740391|NCT00110890|58751553|FG000|Overall Study|Kidney Transplant|16|||
30740392|NCT00110890|58751554|FG001|Overall Study|Kidney Transplant|12|||
30740393|NCT00110890|58751553|FG000|Overall Study|Invest. Product Commercially Available|217|||
30740394|NCT00110890|58751554|FG001|Overall Study|Invest. Product Commercially Available|110|||
30740395|NCT00110890|58751553|FG000|Overall Study|Other|34|||
30740396|NCT00110890|58751554|FG001|Overall Study|Other|23|||
30740397|NCT00110890|58751553|FG000|Overall Study|Ineligibility determined|3|||
30740398|NCT00110890|58751554|FG001|Overall Study|Ineligibility determined|0|||
30740399|NCT00110890|58751553|FG000|Overall Study|Requirement for alternative therapy|0|||
30740400|NCT00110890|58751554|FG001|Overall Study|Requirement for alternative therapy|1|||
30740401|NCT00110890|58751553|FG000|Overall Study|Disease progression|0|||
30740402|NCT00110890|58751554|FG001|Overall Study|Disease progression|1|||
30740403|NCT00110890|58751553|FG000|Overall Study|Parathyroidectomy|0|||
30740404|NCT00110890|58751554|FG001|Overall Study|Parathyroidectomy|1|||
30740405|NCT00110890|58751553|FG000|Overall Study|Did not enter follow-up phase|10|||
30740406|NCT00110890|58751554|FG001|Overall Study|Did not enter follow-up phase|4|||
30740407|NCT00182637|58751560|FG000|Overall Study|Adverse Event|2|||
30740408|NCT00182637|58751560|FG000|Overall Study|Disease Progression|1|||
30740409|NCT00182325|58751567|FG000|Overall Study|Lost to Follow-up|7|||
30740410|NCT00182325|58751568|FG001|Overall Study|Lost to Follow-up|7|||
30740411|NCT00182325|58751567|FG000|Overall Study|Miscarriage|5|||
30740412|NCT00182325|58751568|FG001|Overall Study|Miscarriage|3|||
30740413|NCT00182325|58751567|FG000|Overall Study|Did not complete survey|22|||
30740414|NCT00182325|58751568|FG001|Overall Study|Did not complete survey|43|||
30740415|NCT00122278|58751576|FG000|Overall Study|Lost to Follow-up|2|||
30740416|NCT00122278|58751577|FG001|Overall Study|Lost to Follow-up|0|||
30740417|NCT00182091|58751587|FG000|Overall Study|Withdrawal by Subject|1|||
30740418|NCT00182091|58751588|FG001|Overall Study|Withdrawal by Subject|0|||
30740419|NCT00182091|58751589|FG002|Overall Study|Withdrawal by Subject|0|||
30740420|NCT00182091|58751590|FG003|Overall Study|Withdrawal by Subject|0|||
30740421|NCT00181155|58751598|FG000|Overall Study|Physician Decision|1|||
30740422|NCT00181155|58751599|FG001|Overall Study|Physician Decision|0|||
30740423|NCT00181155|58751598|FG000|Overall Study|Withdrawal by Subject|1|||
30740424|NCT00181155|58751599|FG001|Overall Study|Withdrawal by Subject|0|||
30740425|NCT00322452|58751608|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30740426|NCT00322452|58751609|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
30740427|NCT00322452|58751608|FG000|Overall Study|Lost to Follow-up|5|||
30740428|NCT00322452|58751609|FG001|Overall Study|Lost to Follow-up|2|||
30740429|NCT00322452|58751608|FG000|Overall Study|Withdrawal by Subject|19|||
30740430|NCT00322452|58751609|FG001|Overall Study|Withdrawal by Subject|46|||
30740431|NCT00322452|58751608|FG000|Overall Study|Death|223|||
30740432|NCT00322452|58751609|FG001|Overall Study|Death|227|||
30740433|NCT00110812|58751618|FG000|Main Study|Death|0|||
30740434|NCT00110812|58751619|FG001|Main Study|Death|0|||
30740435|NCT00110812|58751620|FG002|Main Study|Death|2|||
30740436|NCT00110812|58751618|FG000|Main Study|Withdrawal by Subject|0|||
30740437|NCT00110812|58751619|FG001|Main Study|Withdrawal by Subject|0|||
30740438|NCT00110812|58751620|FG002|Main Study|Withdrawal by Subject|1|||
30740439|NCT00110812|58751618|FG000|Main Study|Lost to Follow-up|8|||
30740440|NCT00110812|58751619|FG001|Main Study|Lost to Follow-up|11|||
30740441|NCT00110812|58751620|FG002|Main Study|Lost to Follow-up|10|||
30740442|NCT00110812|58751618|FG000|Extended Follow-up|Death|1|||
30740443|NCT00110812|58751619|FG001|Extended Follow-up|Death|0|||
30740444|NCT00110812|58751620|FG002|Extended Follow-up|Death|3|||
30740445|NCT00110812|58751618|FG000|Extended Follow-up|Withdrawal by Subject|0|||
30740446|NCT00110812|58751619|FG001|Extended Follow-up|Withdrawal by Subject|1|||
30740447|NCT00110812|58751620|FG002|Extended Follow-up|Withdrawal by Subject|0|||
30740448|NCT00110812|58751618|FG000|Extended Follow-up|Lost to Follow-up|1|||
30740449|NCT00110812|58751619|FG001|Extended Follow-up|Lost to Follow-up|3|||
30740450|NCT00110812|58751620|FG002|Extended Follow-up|Lost to Follow-up|1|||
30740451|NCT00516269|58751635|FG000|Overall Study|Adverse Event|2|||
30740452|NCT00516269|58751636|FG001|Overall Study|Adverse Event|1|||
30740453|NCT00516269|58751635|FG000|Overall Study|Lost to Follow-up|0|||
30740454|NCT00516269|58751636|FG001|Overall Study|Lost to Follow-up|1|||
30740455|NCT00516269|58751635|FG000|Overall Study|Protocol Violation|0|||
30740456|NCT00516269|58751636|FG001|Overall Study|Protocol Violation|1|||
30740457|NCT00229203|58751644|FG000|Overall Study|Progressive disease|18|||
30740458|NCT00229203|58751645|FG001|Overall Study|Progressive disease|9|||
30740459|NCT00229203|58751644|FG000|Overall Study|Toxicity|6|||
30740460|NCT00229203|58751645|FG001|Overall Study|Toxicity|1|||
30740461|NCT00229203|58751644|FG000|Overall Study|Death|4|||
30740462|NCT00229203|58751645|FG001|Overall Study|Death|2|||
30740463|NCT00229203|58751644|FG000|Overall Study|Other|3|||
30740464|NCT00229203|58751645|FG001|Overall Study|Other|3|||
30740465|NCT00229203|58751644|FG000|Overall Study|Withdrawal by Subject|1|||
30740466|NCT00229203|58751645|FG001|Overall Study|Withdrawal by Subject|4|||
30740467|NCT00228813|58751651|FG000|Overall Study|Death|4|||
30740468|NCT00322374|58751658|FG000|Starting Dose|Physician Decision|2|||
30740469|NCT00322374|58751659|FG001|Starting Dose|Physician Decision|0|||
30740470|NCT00322374|58751660|FG002|Starting Dose|Physician Decision|0|||
30740471|NCT00322374|58751661|FG003|Starting Dose|Physician Decision|0|||
30740472|NCT00322374|58751658|FG000|Starting Dose|Study Drug Toxicity|4|||
30740473|NCT00322374|58751659|FG001|Starting Dose|Study Drug Toxicity|0|||
30740474|NCT00322374|58751660|FG002|Starting Dose|Study Drug Toxicity|0|||
30740475|NCT00322374|58751661|FG003|Starting Dose|Study Drug Toxicity|0|||
30740476|NCT00322374|58751658|FG000|First Escalation|Documented Disease Progression|0|||
30740477|NCT00322374|58751659|FG001|First Escalation|Documented Disease Progression|6|||
30740478|NCT00322374|58751660|FG002|First Escalation|Documented Disease Progression|0|||
30740479|NCT00322374|58751661|FG003|First Escalation|Documented Disease Progression|0|||
30740480|NCT00322374|58751658|FG000|First Escalation|Physician Decision|0|||
30740481|NCT00322374|58751659|FG001|First Escalation|Physician Decision|12|||
30740482|NCT00322374|58751660|FG002|First Escalation|Physician Decision|0|||
30740483|NCT00322374|58751661|FG003|First Escalation|Physician Decision|0|||
30740484|NCT00322374|58751658|FG000|First Escalation|Study Drug Toxicity|0|||
30740485|NCT00322374|58751659|FG001|First Escalation|Study Drug Toxicity|11|||
30740486|NCT00322374|58751660|FG002|First Escalation|Study Drug Toxicity|0|||
30740487|NCT00322374|58751661|FG003|First Escalation|Study Drug Toxicity|0|||
30740488|NCT00322374|58751658|FG000|First Escalation|Participant Request|0|||
30740489|NCT00322374|58751659|FG001|First Escalation|Participant Request|1|||
30901608|NCT01822756|58935357|FG003|Overall Study|Death|0|||
30901609|NCT01822756|58935358|FG004|Overall Study|Death|0|||
30901610|NCT01822756|58935354|FG000|Overall Study|Lost to Follow-up|1|||
30740490|NCT00322374|58751660|FG002|First Escalation|Participant Request|0|||
30740491|NCT00322374|58751661|FG003|First Escalation|Participant Request|0|||
30740492|NCT00322374|58751658|FG000|Second Escalation|Physician Decision|0|||
30740493|NCT00322374|58751659|FG001|Second Escalation|Physician Decision|0|||
30740494|NCT00322374|58751660|FG002|Second Escalation|Physician Decision|5|||
30740495|NCT00322374|58751661|FG003|Second Escalation|Physician Decision|0|||
30740496|NCT00322374|58751658|FG000|Second Escalation|Study Drug Toxicity|0|||
30740497|NCT00322374|58751659|FG001|Second Escalation|Study Drug Toxicity|0|||
30740498|NCT00322374|58751660|FG002|Second Escalation|Study Drug Toxicity|1|||
30740499|NCT00322374|58751661|FG003|Second Escalation|Study Drug Toxicity|0|||
30740500|NCT00174447|58751674|FG000|Overall Study|Adverse Event|19|||
30740501|NCT00174447|58751674|FG000|Overall Study|Withdrawal by Subject|15|||
30740502|NCT00174447|58751674|FG000|Overall Study|Protocol Violation|1|||
30740503|NCT00174447|58751674|FG000|Overall Study|Lack of Efficacy|1|||
30740504|NCT00174447|58751674|FG000|Overall Study|Administrative reason/Other|2|||
30740505|NCT00321984|58751681|FG000|Overall Study|Adverse Event|9|||
30740506|NCT00321984|58751682|FG001|Overall Study|Adverse Event|6|||
30740507|NCT00321984|58751683|FG002|Overall Study|Adverse Event|8|||
30740508|NCT00321984|58751681|FG000|Overall Study|Protocol Violation|0|||
30740509|NCT00321984|58751682|FG001|Overall Study|Protocol Violation|1|||
30740510|NCT00321984|58751683|FG002|Overall Study|Protocol Violation|1|||
30740511|NCT00321984|58751681|FG000|Overall Study|Lost to Follow-up|2|||
30740512|NCT00321984|58751682|FG001|Overall Study|Lost to Follow-up|4|||
30740513|NCT00321984|58751683|FG002|Overall Study|Lost to Follow-up|2|||
30740514|NCT00321984|58751681|FG000|Overall Study|Withdrawal by Subject|8|||
30740515|NCT00321984|58751682|FG001|Overall Study|Withdrawal by Subject|6|||
30740516|NCT00321984|58751683|FG002|Overall Study|Withdrawal by Subject|5|||
30740517|NCT00321984|58751681|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
30740518|NCT00321984|58751682|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
30740519|NCT00321984|58751683|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
30740520|NCT00321984|58751681|FG000|Overall Study|Lack of Efficacy|3|||
30740521|NCT00321984|58751682|FG001|Overall Study|Lack of Efficacy|1|||
30901611|NCT01822756|58935355|FG001|Overall Study|Lost to Follow-up|0|||
30901612|NCT01822756|58935356|FG002|Overall Study|Lost to Follow-up|1|||
30901613|NCT01822756|58935357|FG003|Overall Study|Lost to Follow-up|0|||
30901614|NCT01822756|58935358|FG004|Overall Study|Lost to Follow-up|1|||
30901615|NCT01822756|58935354|FG000|Overall Study|Physician Decision|0|||
30740522|NCT00321984|58751683|FG002|Overall Study|Lack of Efficacy|3|||
30740523|NCT00321984|58751681|FG000|Overall Study|Noncompliant|0|||
30901616|NCT01822756|58935355|FG001|Overall Study|Physician Decision|1|||
30740524|NCT00321984|58751682|FG001|Overall Study|Noncompliant|0|||
30740525|NCT00321984|58751683|FG002|Overall Study|Noncompliant|2|||
30740526|NCT00321984|58751681|FG000|Overall Study|Pregnancy|0|||
30740527|NCT00321984|58751682|FG001|Overall Study|Pregnancy|1|||
30740528|NCT00321984|58751683|FG002|Overall Study|Pregnancy|0|||
30740529|NCT00321984|58751681|FG000|Overall Study|Per Subject Request|1|||
30740530|NCT00321984|58751682|FG001|Overall Study|Per Subject Request|0|||
30740531|NCT00321984|58751683|FG002|Overall Study|Per Subject Request|0|||
30740532|NCT00321984|58751681|FG000|Overall Study|Per Investigator Request|1|||
30740533|NCT00321984|58751682|FG001|Overall Study|Per Investigator Request|0|||
30740534|NCT00321984|58751683|FG002|Overall Study|Per Investigator Request|0|||
30740535|NCT00321984|58751681|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
30901617|NCT01822756|58935356|FG002|Overall Study|Physician Decision|0|||
30740536|NCT00321984|58751682|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
30740537|NCT00321984|58751683|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
30740538|NCT00515099|58751693|FG000|Overall Study|Lost to Follow-up|0|||
30740539|NCT00515099|58751694|FG001|Overall Study|Lost to Follow-up|4|||
30740540|NCT00515099|58751693|FG000|Overall Study|Withdrawal by Subject|2|||
30740541|NCT00515099|58751694|FG001|Overall Study|Withdrawal by Subject|0|||
30740542|NCT00515099|58751693|FG000|Overall Study|IRB Recommendation|1|||
30740543|NCT00515099|58751694|FG001|Overall Study|IRB Recommendation|0|||
30740544|NCT00110266|58751700|FG000|Overall Study|Adverse Event|27|||
30740545|NCT00110266|58751700|FG000|Overall Study|Abnormal laboratory value|15|||
30740546|NCT00110266|58751700|FG000|Overall Study|Withdrawal by Subject|16|||
30740547|NCT00110266|58751700|FG000|Overall Study|Death|17|||
30740548|NCT00110266|58751700|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30740549|NCT00110266|58751700|FG000|Overall Study|Participant condition no longer requires study drug|1|||
30740550|NCT00174291|58751707|FG000|Overall Study|Lost to Follow-up|1|||
30740551|NCT00174291|58751708|FG001|Overall Study|Lost to Follow-up|1|||
30740552|NCT00174291|58751707|FG000|Overall Study|Protocol Violation|0|||
30740553|NCT00174291|58751708|FG001|Overall Study|Protocol Violation|2|||
30740554|NCT00174291|58751707|FG000|Overall Study|Study terminated by sponsor|1|||
30740555|NCT00174291|58751708|FG001|Overall Study|Study terminated by sponsor|0|||
30740556|NCT00174291|58751707|FG000|Overall Study|Withdrawal by Subject|3|||
30740557|NCT00174291|58751708|FG001|Overall Study|Withdrawal by Subject|3|||
30740558|NCT00366548|58751716|FG000|Infant Series|Adverse Event|1|||
30740559|NCT00366548|58751717|FG001|Infant Series|Adverse Event|3|||
30901618|NCT01822756|58935357|FG003|Overall Study|Physician Decision|0|||
30901619|NCT01822756|58935358|FG004|Overall Study|Physician Decision|0|||
30740560|NCT00366548|58751716|FG000|Infant Series|Protocol Violation|0|||
30740561|NCT00366548|58751717|FG001|Infant Series|Protocol Violation|1|||
30740562|NCT00366548|58751716|FG000|Infant Series|Withdrawal by Subject|3|||
30740563|NCT00366548|58751717|FG001|Infant Series|Withdrawal by Subject|1|||
30740564|NCT00366548|58751716|FG000|After Infant Series|Withdrawal by Subject|3|||
30740565|NCT00366548|58751717|FG001|After Infant Series|Withdrawal by Subject|1|||
30740566|NCT00366548|58751716|FG000|After Infant Series|Adverse Event|2|||
30901620|NCT01822756|58935354|FG000|Overall Study|disease progression & patient preference|2|||
30901621|NCT01822756|58935355|FG001|Overall Study|disease progression & patient preference|0|||
30901622|NCT01822756|58935356|FG002|Overall Study|disease progression & patient preference|1|||
30740567|NCT00366548|58751717|FG001|After Infant Series|Adverse Event|0|||
30740568|NCT00366548|58751716|FG000|After Infant Series|Lost to Follow-up|1|||
30740569|NCT00366548|58751717|FG001|After Infant Series|Lost to Follow-up|0|||
30740570|NCT00252057|58751743|FG000|Overall Study|Withdrawal by Subject|2|||
30740571|NCT00252057|58751744|FG001|Overall Study|Withdrawal by Subject|5|||
30740572|NCT00252057|58751743|FG000|Overall Study|Death|1|||
30740573|NCT00252057|58751744|FG001|Overall Study|Death|2|||
30740574|NCT00252057|58751743|FG000|Overall Study|Participant previously enrolled|0|||
30740575|NCT00252057|58751744|FG001|Overall Study|Participant previously enrolled|1|||
30740576|NCT00132028|58751750|FG000|Overall Study|Adverse Event|7|||
30901623|NCT01822756|58935357|FG003|Overall Study|disease progression & patient preference|0|||
30901624|NCT01822756|58935358|FG004|Overall Study|disease progression & patient preference|0|||
30901625|NCT01822678|58935373|FG000|Overall Study|Withdrawal by Subject|5|||
30901626|NCT01822678|58935374|FG001|Overall Study|Withdrawal by Subject|4|||
30901627|NCT01822678|58935375|FG002|Overall Study|Withdrawal by Subject|4|||
30901628|NCT01822678|58935373|FG000|Overall Study|Adverse Event|4|||
30901629|NCT01822678|58935374|FG001|Overall Study|Adverse Event|3|||
30901630|NCT01822678|58935375|FG002|Overall Study|Adverse Event|1|||
30901631|NCT01822678|58935373|FG000|Overall Study|Lack of Efficacy|3|||
30901632|NCT01822678|58935374|FG001|Overall Study|Lack of Efficacy|6|||
30901633|NCT01822678|58935375|FG002|Overall Study|Lack of Efficacy|5|||
30901634|NCT01822678|58935373|FG000|Overall Study|Lost to Follow-up|0|||
30901635|NCT01822678|58935374|FG001|Overall Study|Lost to Follow-up|2|||
30901636|NCT01822678|58935375|FG002|Overall Study|Lost to Follow-up|1|||
30901637|NCT01822366|58935387|FG000|Overall Study|Lost to Follow-up|5|||
30901638|NCT01822366|58935388|FG001|Overall Study|Lost to Follow-up|1|||
30901639|NCT01822366|58935389|FG002|Overall Study|Lost to Follow-up|5|||
30740577|NCT00132028|58751750|FG000|Overall Study|Death|2|||
30790995|NCT00152464|58804144|FG001|Overall Study|Investigator decision|0|||
30901640|NCT01822366|58935390|FG003|Overall Study|Lost to Follow-up|1|||
30740578|NCT00132028|58751750|FG000|Overall Study|Lack of Efficacy|11|||
30740579|NCT00132028|58751750|FG000|Overall Study|Withdrawal by Subject|2|||
30740580|NCT00132028|58751750|FG000|Overall Study|not eligible|2|||
30740581|NCT00132028|58751750|FG000|Overall Study|Physician Decision|3|||
30740582|NCT00131248|58751754|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
30740583|NCT00131248|58751755|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
30740584|NCT00362414|58751761|FG000|Overall Study|Death|2|||
30901641|NCT01822366|58935387|FG000|Overall Study|Withdrawal by Subject|0|||
30901642|NCT01822366|58935388|FG001|Overall Study|Withdrawal by Subject|6|||
30901643|NCT01822366|58935389|FG002|Overall Study|Withdrawal by Subject|0|||
30901644|NCT01822366|58935390|FG003|Overall Study|Withdrawal by Subject|6|||
30740585|NCT00362414|58751761|FG000|Overall Study|Adverse Event|1|||
30740586|NCT00096382|58751770|FG000|Overall Study|Not treated|1|||
30740587|NCT00096382|58751771|FG001|Overall Study|Not treated|0|||
30740588|NCT00096382|58751770|FG000|Overall Study|Death during treatment|1|||
30740589|NCT00096382|58751771|FG001|Overall Study|Death during treatment|0|||
30740590|NCT00359294|58751782|FG000|Overall Study|Progressive disease|1|||
30740591|NCT00359294|58751783|FG001|Overall Study|Progressive disease|1|||
30740592|NCT00359294|58751784|FG002|Overall Study|Progressive disease|2|||
30740593|NCT00359294|58751785|FG003|Overall Study|Progressive disease|3|||
30740594|NCT00359294|58751786|FG004|Overall Study|Progressive disease|2|||
30740595|NCT00359294|58751782|FG000|Overall Study|Withdrawal by Subject|0|||
30740596|NCT00359294|58751783|FG001|Overall Study|Withdrawal by Subject|0|||
30740597|NCT00359294|58751784|FG002|Overall Study|Withdrawal by Subject|0|||
30740598|NCT00359294|58751785|FG003|Overall Study|Withdrawal by Subject|0|||
30740599|NCT00359294|58751786|FG004|Overall Study|Withdrawal by Subject|1|||
30740600|NCT00359294|58751782|FG000|Overall Study|Not treated|0|||
30740601|NCT00359294|58751783|FG001|Overall Study|Not treated|0|||
30740602|NCT00359294|58751784|FG002|Overall Study|Not treated|0|||
30740603|NCT00359294|58751785|FG003|Overall Study|Not treated|1|||
30740604|NCT00359294|58751786|FG004|Overall Study|Not treated|0|||
30740605|NCT00359294|58751782|FG000|Overall Study|Physician Decision|0|||
30740606|NCT00359294|58751783|FG001|Overall Study|Physician Decision|0|||
30740607|NCT00359294|58751784|FG002|Overall Study|Physician Decision|1|||
30901645|NCT01822366|58935387|FG000|Overall Study|Partial Intervention Completion|0|||
30901646|NCT01822366|58935388|FG001|Overall Study|Partial Intervention Completion|15|||
30901647|NCT01822366|58935389|FG002|Overall Study|Partial Intervention Completion|0|||
30901648|NCT01822366|58935390|FG003|Overall Study|Partial Intervention Completion|15|||
30901649|NCT01838590|58935422|FG000|Overall Study|Lack of Efficacy|12|||
30901650|NCT01838590|58935423|FG001|Overall Study|Lack of Efficacy|4|||
30901651|NCT01838590|58935422|FG000|Overall Study|Lost to Follow-up|0|||
30740608|NCT00359294|58751785|FG003|Overall Study|Physician Decision|0|||
30740609|NCT00359294|58751786|FG004|Overall Study|Physician Decision|0|||
30740610|NCT00384332|58751796|FG000|Overall Study|Lost to Follow-up|4|||
30740611|NCT00384332|58751797|FG001|Overall Study|Lost to Follow-up|0|||
30740612|NCT00096226|58751805|FG000|Overall Study|Ineligible|2|||
30740613|NCT00096226|58751805|FG000|Overall Study|Protocol treatment not started|1|||
30901652|NCT01838590|58935423|FG001|Overall Study|Lost to Follow-up|1|||
30901653|NCT01611454|58935435|FG000|Overall Study|Lack of Efficacy|18|||
30901654|NCT01611454|58935436|FG001|Overall Study|Lack of Efficacy|10|||
30901655|NCT01611298|58935446|FG000|Overall Study|Relapsed|2|||
30901656|NCT01822132|58935452|FG000|Overall Study|Lost to Follow-up|4|||
30901657|NCT01822132|58935453|FG001|Overall Study|Lost to Follow-up|2|||
30901658|NCT01821898|58935467|FG000|Overall Study|Withdrawal by Subject|2|||
30901659|NCT01821898|58935468|FG001|Overall Study|Withdrawal by Subject|1|||
30740614|NCT00105508|58751811|FG000|Overall Study|Prephase Dropout|1|||
30740615|NCT00105508|58751812|FG001|Overall Study|Prephase Dropout|0|||
30740616|NCT00105508|58751811|FG000|Overall Study|Adverse Event|16|||
30740617|NCT00105508|58751812|FG001|Overall Study|Adverse Event|19|||
30740618|NCT00105508|58751811|FG000|Overall Study|Insufficient Efficacy|1|||
30740619|NCT00105508|58751812|FG001|Overall Study|Insufficient Efficacy|0|||
30740620|NCT00105508|58751811|FG000|Overall Study|Withdrawal by Subject|10|||
30740621|NCT00105508|58751812|FG001|Overall Study|Withdrawal by Subject|6|||
30740622|NCT00105508|58751811|FG000|Overall Study|Lost to Follow-up|3|||
30740623|NCT00105508|58751812|FG001|Overall Study|Lost to Follow-up|0|||
30740624|NCT00105508|58751811|FG000|Overall Study|Protocol Violation|1|||
30740625|NCT00105508|58751812|FG001|Overall Study|Protocol Violation|2|||
30740626|NCT00105508|58751811|FG000|Overall Study|Other|8|||
30740627|NCT00105508|58751812|FG001|Overall Study|Other|9|||
30740628|NCT00105196|58751820|FG000|Overall Study|Lack of Efficacy|2|||
30740629|NCT00105196|58751821|FG001|Overall Study|Lack of Efficacy|3|||
30740630|NCT00105196|58751820|FG000|Overall Study|Adverse Event|11|||
30740631|NCT00105196|58751821|FG001|Overall Study|Adverse Event|3|||
30740632|NCT00105196|58751820|FG000|Overall Study|Withdrawal by Subject|6|||
30740633|NCT00105196|58751821|FG001|Overall Study|Withdrawal by Subject|6|||
30740634|NCT00105196|58751820|FG000|Overall Study|Lost to Follow-up|3|||
30740635|NCT00105196|58751821|FG001|Overall Study|Lost to Follow-up|2|||
30740636|NCT00105196|58751820|FG000|Overall Study|Poor/noncompliance|3|||
30740637|NCT00105196|58751821|FG001|Overall Study|Poor/noncompliance|4|||
30740638|NCT00105196|58751820|FG000|Overall Study|Protocol Violation|5|||
30740639|NCT00105196|58751821|FG001|Overall Study|Protocol Violation|2|||
30740640|NCT00105196|58751820|FG000|Overall Study|pending surgery|0|||
30901660|NCT02411591|58935478|FG000|Overall Study|Adverse Event|0|||
30901661|NCT02411591|58935479|FG001|Overall Study|Adverse Event|4|||
30901662|NCT02411591|58935480|FG002|Overall Study|Adverse Event|2|||
30740641|NCT00105196|58751821|FG001|Overall Study|pending surgery|1|||
30740642|NCT00105196|58751820|FG000|Overall Study|marijuana use|0|||
30740643|NCT00105196|58751821|FG001|Overall Study|marijuana use|1|||
30740644|NCT00105196|58751820|FG000|Overall Study|Subject became unblinded|0|||
30740645|NCT00105196|58751821|FG001|Overall Study|Subject became unblinded|1|||
30740646|NCT03820024|58751829|FG000|Overall Study|Physician Decision|1|||
30740647|NCT03820024|58751830|FG001|Overall Study|Physician Decision|2|||
30740648|NCT03819634|58751836|FG000|Overall Study|Physician Decision|2|||
30740649|NCT00104572|58751843|FG000|Overall Study|Withdrawal by Subject|3|||
30740650|NCT00104572|58751844|FG001|Overall Study|Withdrawal by Subject|3|||
30740651|NCT00104572|58751845|FG002|Overall Study|Withdrawal by Subject|0|||
30740652|NCT00514943|58751855|FG000|Stage 1|Progressive disease|4|||
30740653|NCT00514943|58751856|FG001|Stage 1|Progressive disease|8|||
30740654|NCT00514943|58751855|FG000|Stage 1|Other Adverse Event|16|||
30740655|NCT00514943|58751856|FG001|Stage 1|Other Adverse Event|6|||
30740656|NCT00514943|58751855|FG000|Stage 1|Not treated|1|||
30740657|NCT00514943|58751856|FG001|Stage 1|Not treated|2|||
30740658|NCT00514943|58751855|FG000|Stage 1|Patient refused to continue study meds|8|||
30740659|NCT00514943|58751856|FG001|Stage 1|Patient refused to continue study meds|3|||
30740660|NCT00514943|58751855|FG000|Stage 1|Other than stated above|1|||
30740661|NCT00514943|58751856|FG001|Stage 1|Other than stated above|7|||
30740662|NCT00514943|58751855|FG000|Stage 2|Progressive disease|27|||
30740663|NCT00514943|58751856|FG001|Stage 2|Progressive disease|24|||
30740664|NCT00514943|58751855|FG000|Stage 2|Other Adverse Event|3|||
30740665|NCT00514943|58751856|FG001|Stage 2|Other Adverse Event|10|||
30740666|NCT00514943|58751855|FG000|Stage 2|Patient refused to continue study meds|2|||
30740667|NCT00514943|58751856|FG001|Stage 2|Patient refused to continue study meds|0|||
30740668|NCT00514943|58751855|FG000|Stage 2|Other than stated above|0|||
30740669|NCT00514943|58751856|FG001|Stage 2|Other than stated above|2|||
30740670|NCT03864653|58751877|FG000|Overall Study|Withdrawal by Subject|1|||
30740671|NCT00103402|58751883|FG000|Overall Study|Adverse Event|3|||
30740672|NCT00103402|58751884|FG001|Overall Study|Adverse Event|4|||
30740673|NCT00103402|58751883|FG000|Overall Study|Lost to Follow-up|8|||
30740674|NCT00103402|58751884|FG001|Overall Study|Lost to Follow-up|7|||
30740675|NCT00103402|58751883|FG000|Overall Study|Dissatisfied/No longer interested|6|||
30740676|NCT00103402|58751884|FG001|Overall Study|Dissatisfied/No longer interested|6|||
30740677|NCT00103402|58751883|FG000|Overall Study|Personal constraints/Other|5|||
30740678|NCT00103402|58751884|FG001|Overall Study|Personal constraints/Other|0|||
30740679|NCT03864341|58751890|FG000|Overall Study|Withdrawal by Subject|1|||
30901663|NCT02411591|58935478|FG000|Overall Study|Withdrawal by Subject|0|||
30901664|NCT02411591|58935479|FG001|Overall Study|Withdrawal by Subject|3|||
30901665|NCT02411591|58935480|FG002|Overall Study|Withdrawal by Subject|0|||
30901666|NCT02411591|58935478|FG000|Overall Study|Physician Decision|0|||
30901667|NCT02411591|58935479|FG001|Overall Study|Physician Decision|3|||
30740680|NCT01739309|58751894|FG000|Overall Study|On study treatment|3|||
30740681|NCT00095836|58751900|FG000|Overall Study|Lost to Follow-up|1|||
30740682|NCT00095836|58751900|FG000|Overall Study|Adverse Event|1|||
30740683|NCT00095836|58751900|FG000|Overall Study|Death|2|||
30740684|NCT00168831|58751907|FG000|Overall Study|Adverse Event|36|||
30740685|NCT00168831|58751908|FG001|Overall Study|Adverse Event|47|||
30740686|NCT00168831|58751909|FG002|Overall Study|Adverse Event|74|||
30740687|NCT00168831|58751907|FG000|Overall Study|Lost to Follow-up|5|||
30740688|NCT00168831|58751908|FG001|Overall Study|Lost to Follow-up|6|||
30740689|NCT00168831|58751909|FG002|Overall Study|Lost to Follow-up|4|||
30901668|NCT02411591|58935480|FG002|Overall Study|Physician Decision|1|||
30740690|NCT00168831|58751907|FG000|Overall Study|Withdrawal by Subject|7|||
30740691|NCT00168831|58751908|FG001|Overall Study|Withdrawal by Subject|14|||
30740692|NCT00168831|58751909|FG002|Overall Study|Withdrawal by Subject|19|||
30740693|NCT00168831|58751907|FG000|Overall Study|Protocol Violation|6|||
30740694|NCT00168831|58751908|FG001|Overall Study|Protocol Violation|11|||
30740695|NCT00168831|58751909|FG002|Overall Study|Protocol Violation|11|||
30901669|NCT02454959|58935496|FG000|Overall Study|Protocol-Specified Criteria|3|||
30740696|NCT00168831|58751907|FG000|Overall Study|Other|6|||
30740697|NCT00168831|58751908|FG001|Overall Study|Other|3|||
30901670|NCT02454959|58935496|FG000|Overall Study|Physician Decision|1|||
30901671|NCT02454959|58935496|FG000|Overall Study|Withdrawal by Subject|3|||
30901672|NCT02454959|58935496|FG000|Overall Study|Adverse Event|2|||
30740698|NCT00168831|58751909|FG002|Overall Study|Other|6|||
30740699|NCT00103012|58751920|FG000|Overall Study|Withdrawal by Subject|2|||
30740700|NCT00103012|58751921|FG001|Overall Study|Withdrawal by Subject|1|||
30740701|NCT00103012|58751922|FG002|Overall Study|Withdrawal by Subject|2|||
30740702|NCT00103012|58751920|FG000|Overall Study|Pregnancy|1|||
30740703|NCT00103012|58751921|FG001|Overall Study|Pregnancy|0|||
30740704|NCT00103012|58751922|FG002|Overall Study|Pregnancy|0|||
30740705|NCT00103012|58751920|FG000|Overall Study|Adverse Event|0|||
30740706|NCT00103012|58751921|FG001|Overall Study|Adverse Event|0|||
30740707|NCT00103012|58751922|FG002|Overall Study|Adverse Event|1|||
30740708|NCT00103012|58751920|FG000|Overall Study|Subject non-compliant with medications|0|||
30740709|NCT00103012|58751921|FG001|Overall Study|Subject non-compliant with medications|0|||
30740710|NCT00103012|58751922|FG002|Overall Study|Subject non-compliant with medications|1|||
30740711|NCT00512135|58751930|FG000|Overall Study|Not Treated|5|||
30740712|NCT00512135|58751930|FG000|Overall Study|Lack of Efficacy|2|||
30740713|NCT00512135|58751930|FG000|Overall Study|Adverse Event|6|||
30740714|NCT00512135|58751930|FG000|Overall Study|Withdrawal by Subject|22|||
30740715|NCT00512135|58751930|FG000|Overall Study|Lost to Follow-up|27|||
30740716|NCT00512135|58751930|FG000|Overall Study|Other|22|||
30740717|NCT00251979|58751937|FG000|Overall Study|Protocol Violation|3|||
30740718|NCT00251979|58751938|FG001|Overall Study|Protocol Violation|5|||
30740719|NCT00251979|58751937|FG000|Overall Study|Adverse Event|11|||
30740720|NCT00251979|58751938|FG001|Overall Study|Adverse Event|17|||
30740721|NCT00251979|58751937|FG000|Overall Study|Withdrawal by Subject|13|||
30740722|NCT00251979|58751938|FG001|Overall Study|Withdrawal by Subject|7|||
30740723|NCT00251979|58751937|FG000|Overall Study|Lost to Follow-up|8|||
30740724|NCT00251979|58751938|FG001|Overall Study|Lost to Follow-up|6|||
30740725|NCT00251979|58751937|FG000|Overall Study|Death|3|||
30740726|NCT00251979|58751938|FG001|Overall Study|Death|5|||
30740727|NCT00511901|58751946|FG000|Overall Study|Withdrawal by Subject|1|||
30740728|NCT00511901|58751947|FG001|Overall Study|Withdrawal by Subject|3|||
30740729|NCT03862625|58751955|FG000|Overall Study|Lost to Follow-up|0|||
30740730|NCT03862625|58751956|FG001|Overall Study|Lost to Follow-up|1|||
30740731|NCT00163215|58751962|FG000|Overall Study|Lack of Efficacy|3|||
30740732|NCT00163215|58751962|FG000|Overall Study|Withdrawal by Subject|5|||
30740733|NCT00163215|58751962|FG000|Overall Study|Other|7|||
30740734|NCT00228423|58751968|FG000|Overall Study|Adverse Event|2|||
30740735|NCT00228423|58751969|FG001|Overall Study|Adverse Event|5|||
30740736|NCT00228423|58751968|FG000|Overall Study|Withdrawal by Subject|7|||
30740737|NCT00228423|58751969|FG001|Overall Study|Withdrawal by Subject|3|||
30740738|NCT00228423|58751968|FG000|Overall Study|Protocol Violation|1|||
30740739|NCT00228423|58751969|FG001|Overall Study|Protocol Violation|3|||
30740740|NCT00228423|58751968|FG000|Overall Study|Physician Decision|0|||
30740741|NCT00228423|58751969|FG001|Overall Study|Physician Decision|1|||
30740742|NCT00511667|58751977|FG000|Overall Study|Adverse Event|1|||
30740743|NCT00511667|58751978|FG001|Overall Study|Adverse Event|0|||
30740744|NCT00511667|58751977|FG000|Overall Study|Protocol Violation|1|||
30740745|NCT00511667|58751978|FG001|Overall Study|Protocol Violation|1|||
30740746|NCT00511667|58751977|FG000|Overall Study|Withdrawal by Subject|2|||
30740747|NCT00511667|58751978|FG001|Overall Study|Withdrawal by Subject|0|||
30740748|NCT00511667|58751977|FG000|Overall Study|Site terminated|6|||
30901673|NCT01821118|58935504|FG000|Overall Study|Death|0|||
30901674|NCT01821118|58935505|FG001|Overall Study|Death|1|||
30901675|NCT01650779|58935511|FG000|Overall Study|Withdrawal by Subject|1|||
30901676|NCT02411201|58935515|FG000|Overall Study|Adverse Event|2|||
30901677|NCT02411201|58935515|FG000|Overall Study|Withdrawal by Subject|2|||
30901678|NCT02411201|58935515|FG000|Overall Study|Age group completed|2|||
30901679|NCT01838044|58935523|FG000|Overall Study|Adverse Event|4|||
30901680|NCT01838044|58935524|FG001|Overall Study|Adverse Event|6|||
30901681|NCT01838044|58935523|FG000|Overall Study|Protocol Violation|3|||
30901682|NCT01838044|58935524|FG001|Overall Study|Protocol Violation|3|||
30740749|NCT00511667|58751978|FG001|Overall Study|Site terminated|1|||
30740750|NCT00511667|58751977|FG000|Overall Study|Other|2|||
30740751|NCT00511667|58751978|FG001|Overall Study|Other|1|||
30901683|NCT01838044|58935523|FG000|Overall Study|Withdrawal by Subject|0|||
30901684|NCT01838044|58935524|FG001|Overall Study|Withdrawal by Subject|2|||
30740752|NCT00227877|58751994|FG000|Pre-visit Assessment|Technical difficulties|7|||
30740753|NCT00227877|58751995|FG001|Pre-visit Assessment|Technical difficulties|3|||
30740754|NCT00227877|58751996|FG002|Pre-visit Assessment|Technical difficulties|0|||
30740755|NCT00227877|58751997|FG003|Pre-visit Assessment|Technical difficulties|0|||
30740756|NCT00227877|58751994|FG000|Post-visit Checklist|Lost to Follow-up|24|||
30740757|NCT00227877|58751995|FG001|Post-visit Checklist|Lost to Follow-up|13|||
30740758|NCT00227877|58751996|FG002|Post-visit Checklist|Lost to Follow-up|1|||
30740759|NCT00227877|58751997|FG003|Post-visit Checklist|Lost to Follow-up|0|||
30740760|NCT00227877|58751994|FG000|3-months Follow-up|Completed late|135|||
30740761|NCT00227877|58751995|FG001|3-months Follow-up|Completed late|128|||
30740762|NCT00227877|58751996|FG002|3-months Follow-up|Completed late|34|||
30740763|NCT00227877|58751997|FG003|3-months Follow-up|Completed late|8|||
30740764|NCT00227877|58751994|FG000|3-months Follow-up|Lost to Follow-up|178|||
30740765|NCT00227877|58751995|FG001|3-months Follow-up|Lost to Follow-up|139|||
30740766|NCT00227877|58751996|FG002|3-months Follow-up|Lost to Follow-up|18|||
30740767|NCT00227877|58751997|FG003|3-months Follow-up|Lost to Follow-up|13|||
30740768|NCT00227877|58751994|FG000|12-months Follow-up|Completed late|78|||
30740769|NCT00227877|58751995|FG001|12-months Follow-up|Completed late|74|||
30740770|NCT00227877|58751996|FG002|12-months Follow-up|Completed late|1|||
30740771|NCT00227877|58751997|FG003|12-months Follow-up|Completed late|0|||
30740772|NCT00227877|58751994|FG000|12-months Follow-up|Lost to Follow-up|232|||
30740773|NCT00227877|58751995|FG001|12-months Follow-up|Lost to Follow-up|189|||
30740774|NCT00227877|58751996|FG002|12-months Follow-up|Lost to Follow-up|30|||
30740775|NCT00227877|58751997|FG003|12-months Follow-up|Lost to Follow-up|26|||
30740776|NCT00513695|58752009|FG000|Overall Study|Discontinued therapy|2|||
30740777|NCT00513695|58752009|FG000|Overall Study|Progression prior to surgery|3|||
30740778|NCT00162981|58752015|FG000|Overall Study|Adverse Event|2|||
30740779|NCT00162981|58752016|FG001|Overall Study|Adverse Event|5|||
30740780|NCT00162981|58752015|FG000|Overall Study|Withdrawal by Subject|1|||
30740781|NCT00162981|58752016|FG001|Overall Study|Withdrawal by Subject|1|||
30740782|NCT00162981|58752015|FG000|Overall Study|Physician Decision|1|||
30740783|NCT00162981|58752016|FG001|Overall Study|Physician Decision|0|||
30740784|NCT00511433|58752024|FG000|Overall Study|Adverse Event|5|||
30740785|NCT00511433|58752025|FG001|Overall Study|Adverse Event|0|||
30740786|NCT00511433|58752024|FG000|Overall Study|Other Reason|1|||
30740787|NCT00511433|58752025|FG001|Overall Study|Other Reason|1|||
30740788|NCT00099268|58752035|FG000|Overall Study|Withdrawal by Subject|46|||
30740789|NCT00099268|58752036|FG001|Overall Study|Withdrawal by Subject|28|||
30740790|NCT00099268|58752035|FG000|Overall Study|Adverse Event|19|||
30740791|NCT00099268|58752036|FG001|Overall Study|Adverse Event|19|||
30740792|NCT00099268|58752035|FG000|Overall Study|Protocol Violation|9|||
30740793|NCT00099268|58752036|FG001|Overall Study|Protocol Violation|8|||
30740794|NCT00099268|58752035|FG000|Overall Study|Lost to Follow-up|6|||
30740795|NCT00099268|58752036|FG001|Overall Study|Lost to Follow-up|4|||
30740796|NCT00099268|58752035|FG000|Overall Study|Lack of Efficacy|5|||
30740797|NCT00099268|58752036|FG001|Overall Study|Lack of Efficacy|18|||
30740798|NCT00099268|58752035|FG000|Overall Study|Administrative problems|4|||
30740799|NCT00099268|58752036|FG001|Overall Study|Administrative problems|4|||
30740800|NCT00099268|58752035|FG000|Overall Study|Death|3|||
30740801|NCT00099268|58752036|FG001|Overall Study|Death|1|||
30740802|NCT00511355|58752044|FG000|Overall Study|Adverse Event|4|||
30740803|NCT00511355|58752045|FG001|Overall Study|Adverse Event|4|||
30740804|NCT00511355|58752044|FG000|Overall Study|Pregnancy Wish|1|||
30740805|NCT00511355|58752045|FG001|Overall Study|Pregnancy Wish|0|||
30740806|NCT00511355|58752044|FG000|Overall Study|Lost to Follow-up|2|||
30740807|NCT00511355|58752045|FG001|Overall Study|Lost to Follow-up|1|||
30740808|NCT00511355|58752044|FG000|Overall Study|Other Reason|0|||
30901685|NCT01838044|58935523|FG000|Overall Study|Insufficient clinical response|1|||
30901686|NCT01838044|58935524|FG001|Overall Study|Insufficient clinical response|2|||
30901687|NCT01838044|58935523|FG000|Overall Study|Medication error without associated AE|0|||
30901688|NCT01838044|58935524|FG001|Overall Study|Medication error without associated AE|1|||
30901689|NCT01838044|58935523|FG000|Overall Study|Lost to Follow-up|0|||
30901690|NCT01838044|58935524|FG001|Overall Study|Lost to Follow-up|2|||
30901691|NCT02410811|58935535|FG000|Overall Study|Withdrawal by Subject|0|||
30901692|NCT02410811|58935536|FG001|Overall Study|Withdrawal by Subject|0|||
30901693|NCT02410811|58935537|FG002|Overall Study|Withdrawal by Subject|1|||
30740809|NCT00511355|58752045|FG001|Overall Study|Other Reason|1|||
30740810|NCT00511355|58752044|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
30790996|NCT00152464|58804143|FG000|Overall Study|Lack of Efficacy|1|||
30790997|NCT00152464|58804144|FG001|Overall Study|Lack of Efficacy|0|||
30901694|NCT02410811|58935538|FG003|Overall Study|Withdrawal by Subject|0|||
30901695|NCT02435381|58935548|FG000|Overall Study|Lost to Follow-up|2|||
30901696|NCT02435381|58935549|FG001|Overall Study|Lost to Follow-up|1|||
30740811|NCT00511355|58752045|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
30740812|NCT00511355|58752044|FG000|Overall Study|Withdrawal of informed consent|0|||
30740813|NCT00511355|58752045|FG001|Overall Study|Withdrawal of informed consent|1|||
30740814|NCT00511355|58752044|FG000|Overall Study|Other reason pre-treatment|0|||
30740815|NCT00511355|58752045|FG001|Overall Study|Other reason pre-treatment|1|||
30740816|NCT00095212|58752055|FG000|Overall Study|Withdrawal by Subject|1|||
30740817|NCT00095212|58752056|FG001|Overall Study|Withdrawal by Subject|3|||
30740818|NCT00120874|58752064|FG000|Overall Study|Death|0|||
30740819|NCT00120874|58752065|FG001|Overall Study|Death|1|||
30740820|NCT00120406|58752073|FG000|Overall Study|Death|9|||
30740821|NCT00120406|58752074|FG001|Overall Study|Death|4|||
30740822|NCT00120406|58752073|FG000|Overall Study|Withdrawal by Subject|5|||
30740823|NCT00120406|58752074|FG001|Overall Study|Withdrawal by Subject|7|||
30740824|NCT00120406|58752073|FG000|Overall Study|Lost to Follow-up|5|||
30740825|NCT00120406|58752074|FG001|Overall Study|Lost to Follow-up|2|||
30740826|NCT00120406|58752073|FG000|Overall Study|received non-study stent|0|||
30740827|NCT00120406|58752074|FG001|Overall Study|received non-study stent|2|||
30740828|NCT00120406|58752073|FG000|Overall Study|patient moved but has not withdrawn|0|||
30740829|NCT00120406|58752074|FG001|Overall Study|patient moved but has not withdrawn|1|||
30740830|NCT00120250|58752080|FG000|Overall Study|Lost to Follow-up|1|||
30740831|NCT00120250|58752081|FG001|Overall Study|Lost to Follow-up|1|||
30740832|NCT00120250|58752080|FG000|Overall Study|Protocol Violation|0|||
30740833|NCT00120250|58752081|FG001|Overall Study|Protocol Violation|1|||
30740834|NCT00511199|58752090|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
30740835|NCT00511199|58752091|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
30740836|NCT00511199|58752090|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
30740837|NCT00511199|58752091|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
30740838|NCT00511199|58752090|FG000|Overall Study|Withdrawal of Informed Consent|19|||
30740839|NCT00511199|58752091|FG001|Overall Study|Withdrawal of Informed Consent|4|||
30740840|NCT00511199|58752090|FG000|Overall Study|Pregnancy|6|||
30740841|NCT00511199|58752091|FG001|Overall Study|Pregnancy|3|||
30740842|NCT00511199|58752090|FG000|Overall Study|Pregnancy Wish|16|||
30740843|NCT00511199|58752091|FG001|Overall Study|Pregnancy Wish|8|||
30740844|NCT00511199|58752090|FG000|Overall Study|Lost to Follow-up|40|||
30740845|NCT00511199|58752091|FG001|Overall Study|Lost to Follow-up|17|||
30740846|NCT00511199|58752090|FG000|Overall Study|Other Reason|78|||
30740847|NCT00511199|58752091|FG001|Overall Study|Other Reason|37|||
30740848|NCT00384176|58752102|FG000|Overall Study|Death|239|||
30740849|NCT00384176|58752103|FG001|Overall Study|Death|247|||
30740850|NCT00384176|58752104|FG002|Overall Study|Death|105|||
30740851|NCT00384176|58752102|FG000|Overall Study|Withdrawal by Subject|52|||
30740852|NCT00384176|58752103|FG001|Overall Study|Withdrawal by Subject|48|||
30740853|NCT00384176|58752104|FG002|Overall Study|Withdrawal by Subject|22|||
30740854|NCT00384176|58752102|FG000|Overall Study|Lost to Follow-up|16|||
30740855|NCT00384176|58752103|FG001|Overall Study|Lost to Follow-up|18|||
30740856|NCT00384176|58752104|FG002|Overall Study|Lost to Follow-up|4|||
30740857|NCT00384176|58752102|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
30740858|NCT00384176|58752103|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
30740859|NCT00384176|58752104|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
30740860|NCT00384176|58752102|FG000|Overall Study|Longer QTC as Visit 1|1|||
30740861|NCT00384176|58752103|FG001|Overall Study|Longer QTC as Visit 1|0|||
30740862|NCT00384176|58752104|FG002|Overall Study|Longer QTC as Visit 1|0|||
30740863|NCT00384176|58752102|FG000|Overall Study|Toxicity of treatment|1|||
30740864|NCT00384176|58752103|FG001|Overall Study|Toxicity of treatment|0|||
30740865|NCT00384176|58752104|FG002|Overall Study|Toxicity of treatment|0|||
30740866|NCT00384176|58752102|FG000|Overall Study|Did not receive study treatment|0|||
30740867|NCT00384176|58752103|FG001|Overall Study|Did not receive study treatment|1|||
30740868|NCT00384176|58752104|FG002|Overall Study|Did not receive study treatment|1|||
30740869|NCT00384176|58752102|FG000|Overall Study|Physician Decision|0|||
30740870|NCT00384176|58752103|FG001|Overall Study|Physician Decision|2|||
30740871|NCT00384176|58752104|FG002|Overall Study|Physician Decision|0|||
30740872|NCT00384176|58752102|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
30740873|NCT00384176|58752103|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
30740874|NCT00384176|58752104|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
30740875|NCT00513305|58752114|FG000|Overall Study|Adverse Event|6|||
30740876|NCT00513305|58752115|FG001|Overall Study|Adverse Event|2|||
30740877|NCT00513305|58752114|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
30740878|NCT00513305|58752115|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
30740879|NCT00513305|58752114|FG000|Overall Study|Lack of Efficacy|8|||
30740880|NCT00513305|58752115|FG001|Overall Study|Lack of Efficacy|13|||
30740881|NCT00513305|58752114|FG000|Overall Study|Withdrawal by Subject|1|||
30740882|NCT00513305|58752115|FG001|Overall Study|Withdrawal by Subject|2|||
30740883|NCT00513305|58752114|FG000|Overall Study|Disease progression|8|||
30740884|NCT00513305|58752115|FG001|Overall Study|Disease progression|5|||
30740885|NCT00513305|58752114|FG000|Overall Study|Eligible for stem cell transplant|1|||
30740886|NCT00513305|58752115|FG001|Overall Study|Eligible for stem cell transplant|0|||
30740887|NCT00513305|58752114|FG000|Overall Study|Hematologic counts did not recover|1|||
30740888|NCT00513305|58752115|FG001|Overall Study|Hematologic counts did not recover|0|||
30740889|NCT00513305|58752114|FG000|Overall Study|Physician Decision|1|||
30740890|NCT00513305|58752115|FG001|Overall Study|Physician Decision|0|||
30740891|NCT00513305|58752114|FG000|Overall Study|Persistent hypocellularity|0|||
30740892|NCT00513305|58752115|FG001|Overall Study|Persistent hypocellularity|1|||
30740893|NCT00513305|58752114|FG000|Overall Study|Sponsor Decision|0|||
30740894|NCT00513305|58752115|FG001|Overall Study|Sponsor Decision|2|||
30740895|NCT00513071|58752121|FG000|Overall Study|Adverse Event|1|||
30740896|NCT00513071|58752121|FG000|Overall Study|Withdrawal by Subject|1|||
30740897|NCT00513071|58752121|FG000|Overall Study|Physician Decision|3|||
30740898|NCT00510887|58752125|FG000|Overall Study|Lost to Follow-up|1|||
30740899|NCT00358826|58752133|FG000|Core Study|Adverse Event|1|||
30740900|NCT00358826|58752134|FG001|Core Study|Adverse Event|3|||
30740901|NCT00358826|58752135|FG002|Core Study|Adverse Event|1|||
30740902|NCT00358826|58752136|FG003|Core Study|Adverse Event|1|||
30740903|NCT00358826|58752137|FG004|Core Study|Adverse Event|0|||
30740904|NCT00358826|58752138|FG005|Core Study|Adverse Event|0|||
30740905|NCT00358826|58752139|FG006|Core Study|Adverse Event|0|||
30740906|NCT00358826|58752140|FG007|Core Study|Adverse Event|0|||
30740907|NCT00358826|58752133|FG000|Core Study|Withdrawal by Subject|2|||
30740908|NCT00358826|58752134|FG001|Core Study|Withdrawal by Subject|2|||
30740909|NCT00358826|58752135|FG002|Core Study|Withdrawal by Subject|0|||
30740910|NCT00358826|58752136|FG003|Core Study|Withdrawal by Subject|0|||
30740911|NCT00358826|58752137|FG004|Core Study|Withdrawal by Subject|0|||
30740912|NCT00358826|58752138|FG005|Core Study|Withdrawal by Subject|0|||
30740913|NCT00358826|58752139|FG006|Core Study|Withdrawal by Subject|0|||
30740914|NCT00358826|58752140|FG007|Core Study|Withdrawal by Subject|0|||
30740915|NCT00358826|58752133|FG000|Core Study|Lost to Follow-up|0|||
30740916|NCT00358826|58752134|FG001|Core Study|Lost to Follow-up|0|||
30740917|NCT00358826|58752135|FG002|Core Study|Lost to Follow-up|0|||
30740918|NCT00358826|58752136|FG003|Core Study|Lost to Follow-up|1|||
30740919|NCT00358826|58752137|FG004|Core Study|Lost to Follow-up|0|||
30740920|NCT00358826|58752138|FG005|Core Study|Lost to Follow-up|0|||
30740921|NCT00358826|58752139|FG006|Core Study|Lost to Follow-up|0|||
30740922|NCT00358826|58752140|FG007|Core Study|Lost to Follow-up|0|||
30740923|NCT00358826|58752133|FG000|Core Study|Physician Decision|0|||
30740924|NCT00358826|58752134|FG001|Core Study|Physician Decision|0|||
30740925|NCT00358826|58752135|FG002|Core Study|Physician Decision|1|||
30740926|NCT00358826|58752136|FG003|Core Study|Physician Decision|0|||
30740927|NCT00358826|58752137|FG004|Core Study|Physician Decision|0|||
30740928|NCT00358826|58752138|FG005|Core Study|Physician Decision|0|||
30740929|NCT00358826|58752139|FG006|Core Study|Physician Decision|0|||
30740930|NCT00358826|58752140|FG007|Core Study|Physician Decision|0|||
30740931|NCT00358826|58752133|FG000|MDCT Substudy|Adverse Event|0|||
30740932|NCT00358826|58752134|FG001|MDCT Substudy|Adverse Event|0|||
30740933|NCT00358826|58752135|FG002|MDCT Substudy|Adverse Event|0|||
30740934|NCT00358826|58752136|FG003|MDCT Substudy|Adverse Event|0|||
30740935|NCT00358826|58752137|FG004|MDCT Substudy|Adverse Event|1|||
30740936|NCT00358826|58752138|FG005|MDCT Substudy|Adverse Event|0|||
30740937|NCT00358826|58752139|FG006|MDCT Substudy|Adverse Event|0|||
30740938|NCT00358826|58752140|FG007|MDCT Substudy|Adverse Event|0|||
30740939|NCT00358826|58752133|FG000|MDCT Substudy|Lost to Follow-up|0|||
30740940|NCT00358826|58752134|FG001|MDCT Substudy|Lost to Follow-up|0|||
30740941|NCT00358826|58752135|FG002|MDCT Substudy|Lost to Follow-up|0|||
30740942|NCT00358826|58752136|FG003|MDCT Substudy|Lost to Follow-up|0|||
30740943|NCT00358826|58752137|FG004|MDCT Substudy|Lost to Follow-up|0|||
30740944|NCT00358826|58752138|FG005|MDCT Substudy|Lost to Follow-up|1|||
30740945|NCT00358826|58752139|FG006|MDCT Substudy|Lost to Follow-up|0|||
30740946|NCT00358826|58752140|FG007|MDCT Substudy|Lost to Follow-up|0|||
30740947|NCT00358826|58752133|FG000|MDCT Substudy|Withdrawal by Subject|0|||
30740948|NCT00358826|58752134|FG001|MDCT Substudy|Withdrawal by Subject|0|||
30740949|NCT00358826|58752135|FG002|MDCT Substudy|Withdrawal by Subject|0|||
30740950|NCT00358826|58752136|FG003|MDCT Substudy|Withdrawal by Subject|0|||
30740951|NCT00358826|58752137|FG004|MDCT Substudy|Withdrawal by Subject|0|||
30740952|NCT00358826|58752138|FG005|MDCT Substudy|Withdrawal by Subject|1|||
30740953|NCT00358826|58752139|FG006|MDCT Substudy|Withdrawal by Subject|0|||
30740954|NCT00358826|58752140|FG007|MDCT Substudy|Withdrawal by Subject|0|||
30740955|NCT00510653|58752154|FG000|Overall Study|Withdrawal by Subject|8|||
30740956|NCT00510653|58752154|FG000|Overall Study|Monetary|3|||
30740957|NCT00362336|58752161|FG000|Overall Study|Serious Adverse Event|1|||
30740958|NCT00362336|58752162|FG001|Overall Study|Serious Adverse Event|0|||
30740959|NCT00362336|58752163|FG002|Overall Study|Serious Adverse Event|1|||
30740960|NCT00362336|58752161|FG000|Overall Study|Protocol Violation|0|||
30740961|NCT00362336|58752162|FG001|Overall Study|Protocol Violation|0|||
30790998|NCT00152464|58804143|FG000|Overall Study|Eczema poorly controlled|1|||
30790999|NCT00152464|58804144|FG001|Overall Study|Eczema poorly controlled|0|||
30791000|NCT00152464|58804143|FG000|Overall Study|Patient relocated|1|||
30740962|NCT00362336|58752163|FG002|Overall Study|Protocol Violation|1|||
30740963|NCT00362336|58752161|FG000|Overall Study|Lost to Follow-up|6|||
30740964|NCT00362336|58752162|FG001|Overall Study|Lost to Follow-up|4|||
30740965|NCT00362336|58752163|FG002|Overall Study|Lost to Follow-up|0|||
30740966|NCT00362336|58752161|FG000|Overall Study|Withdrawal by Subject|3|||
30740967|NCT00362336|58752162|FG001|Overall Study|Withdrawal by Subject|3|||
30740968|NCT00362336|58752163|FG002|Overall Study|Withdrawal by Subject|1|||
30740969|NCT00506285|58752180|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
30740970|NCT00506285|58752181|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
30740971|NCT00506285|58752180|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
30740972|NCT00506285|58752181|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
30740973|NCT00506285|58752180|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
30740974|NCT00506285|58752181|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
30740975|NCT00506285|58752180|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
30740976|NCT00506285|58752181|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
30740977|NCT00506285|58752180|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
30740978|NCT00506285|58752181|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
30740979|NCT00506129|58752189|FG000|Overall Study|Disease Progression/Relapse|15|||
30740980|NCT00506129|58752189|FG000|Overall Study|Death|7|||
30740981|NCT00358670|58752195|FG000|Overall Study|Adverse Event|26|||
30740982|NCT00358670|58752196|FG001|Overall Study|Adverse Event|29|||
30740983|NCT00358670|58752195|FG000|Overall Study|Lack of Efficacy|20|||
30740984|NCT00358670|58752196|FG001|Overall Study|Lack of Efficacy|23|||
30740985|NCT00358670|58752195|FG000|Overall Study|Protocol Violation|6|||
30740986|NCT00358670|58752196|FG001|Overall Study|Protocol Violation|9|||
30740987|NCT00358670|58752195|FG000|Overall Study|Lost to Follow-up|4|||
30740988|NCT00358670|58752196|FG001|Overall Study|Lost to Follow-up|5|||
30740989|NCT00358670|58752195|FG000|Overall Study|Withdrawal by Subject|13|||
30740990|NCT00358670|58752196|FG001|Overall Study|Withdrawal by Subject|24|||
30740991|NCT00358670|58752195|FG000|Overall Study|Protocol Defined Clinical Event|0|||
30740992|NCT00358670|58752196|FG001|Overall Study|Protocol Defined Clinical Event|1|||
30740993|NCT00358670|58752195|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
30621990|NCT00929110|58633507|FG002|Overall Study|Abnormal laboratory value(s)|0|||
30621991|NCT00929110|58633505|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30621992|NCT00929110|58633506|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30621993|NCT00929110|58633507|FG002|Overall Study|Abnormal test procedure result(s)|1|||
30621994|NCT00929110|58633505|FG000|Overall Study|Patient inability to use the device|0|||
30621995|NCT00929110|58633506|FG001|Overall Study|Patient inability to use the device|1|||
30740994|NCT00358670|58752196|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
30740995|NCT00358670|58752195|FG000|Overall Study|Administrative|153|||
30740996|NCT00358670|58752196|FG001|Overall Study|Administrative|125|||
30740997|NCT00505661|58752202|FG000|Overall Study|Not Eligible|4|||
30740998|NCT00383786|58752208|FG000|Overall Study|Protocol Violation|2|||
30740999|NCT00383786|58752209|FG001|Overall Study|Protocol Violation|6|||
30741000|NCT00383786|58752208|FG000|Overall Study|Withdrawal by Subject|2|||
30741001|NCT00383786|58752209|FG001|Overall Study|Withdrawal by Subject|5|||
30741002|NCT00383786|58752208|FG000|Overall Study|Physician Decision|0|||
30741003|NCT00383786|58752209|FG001|Overall Study|Physician Decision|1|||
30741004|NCT00383708|58752215|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
30741005|NCT00383708|58752215|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
30741006|NCT00383708|58752215|FG000|Run-in Period|Protocol Violation|4|||
30741007|NCT00383708|58752215|FG000|Run-in Period|Adverse Event|2|||
30741008|NCT00383708|58752215|FG000|Run-in Period|Claustrophobia|1|||
30741009|NCT00383708|58752215|FG000|Co-administration Period|Adverse Event|5|||
30741010|NCT00504881|58752222|FG000|Overall Study|Lack of Efficacy|1|||
30741011|NCT00504881|58752223|FG001|Overall Study|Lack of Efficacy|5|||
30741012|NCT00504881|58752222|FG000|Overall Study|Lost to Follow-up|0|||
30741013|NCT00504881|58752223|FG001|Overall Study|Lost to Follow-up|2|||
30741014|NCT00504881|58752222|FG000|Overall Study|Withdrawal by Subject|1|||
30741015|NCT00504881|58752223|FG001|Overall Study|Withdrawal by Subject|4|||
30741016|NCT00504881|58752222|FG000|Overall Study|Non-Compliance|1|||
30741017|NCT00504881|58752223|FG001|Overall Study|Non-Compliance|0|||
30741018|NCT00504881|58752222|FG000|Overall Study|No Birth Control|0|||
30741019|NCT00504881|58752223|FG001|Overall Study|No Birth Control|1|||
30741020|NCT00504881|58752222|FG000|Overall Study|Safety Visit not performed|0|||
30741021|NCT00504881|58752223|FG001|Overall Study|Safety Visit not performed|1|||
30741022|NCT00504881|58752222|FG000|Overall Study|AE, serious fatal|0|||
30741023|NCT00504881|58752223|FG001|Overall Study|AE, serious fatal|1|||
30741024|NCT00504881|58752222|FG000|Overall Study|SAE, non-fatal|2|||
30741025|NCT00504881|58752223|FG001|Overall Study|SAE, non-fatal|6|||
30741026|NCT00504881|58752222|FG000|Overall Study|AE, non-serious non-fatal|4|||
30741027|NCT00504881|58752223|FG001|Overall Study|AE, non-serious non-fatal|14|||
30741028|NCT00504881|58752222|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
30741029|NCT00504881|58752223|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
30741030|NCT00504881|58752222|FG000|Overall Study|AE of unknown type|1|||
30741031|NCT00504881|58752223|FG001|Overall Study|AE of unknown type|0|||
30791001|NCT00152464|58804144|FG001|Overall Study|Patient relocated|0|||
30741032|NCT00504725|58752233|FG000|Overall Study|Protocol Violation|1|||
30741033|NCT00504725|58752234|FG001|Overall Study|Protocol Violation|0|||
30741034|NCT00383240|58752244|FG000|Overall Study|Adverse Event|4|||
30741035|NCT00383240|58752245|FG001|Overall Study|Adverse Event|6|||
30741036|NCT00383240|58752246|FG002|Overall Study|Adverse Event|9|||
30741037|NCT00383240|58752247|FG003|Overall Study|Adverse Event|7|||
30741038|NCT00383240|58752244|FG000|Overall Study|Treatment Failure|8|||
30741039|NCT00383240|58752245|FG001|Overall Study|Treatment Failure|13|||
30741040|NCT00383240|58752246|FG002|Overall Study|Treatment Failure|47|||
30741041|NCT00383240|58752247|FG003|Overall Study|Treatment Failure|46|||
30741042|NCT00383240|58752244|FG000|Overall Study|Lost to Follow-up|3|||
30741043|NCT00383240|58752245|FG001|Overall Study|Lost to Follow-up|0|||
30741044|NCT00383240|58752246|FG002|Overall Study|Lost to Follow-up|0|||
30741045|NCT00383240|58752247|FG003|Overall Study|Lost to Follow-up|2|||
30741046|NCT00383240|58752244|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
30741047|NCT00383240|58752245|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
30741048|NCT00383240|58752246|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
30741049|NCT00383240|58752247|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
30741050|NCT00383240|58752244|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
30741051|NCT00383240|58752245|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
30741052|NCT00383240|58752246|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
30741053|NCT00383240|58752247|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
30741054|NCT00383240|58752244|FG000|Overall Study|Protocol Violation|4|||
30741055|NCT00383240|58752245|FG001|Overall Study|Protocol Violation|5|||
30741056|NCT00383240|58752246|FG002|Overall Study|Protocol Violation|9|||
30741057|NCT00383240|58752247|FG003|Overall Study|Protocol Violation|6|||
30741058|NCT00383240|58752244|FG000|Overall Study|Did not meet protocol eligibility|9|||
30741059|NCT00383240|58752245|FG001|Overall Study|Did not meet protocol eligibility|4|||
30741060|NCT00383240|58752246|FG002|Overall Study|Did not meet protocol eligibility|9|||
30741061|NCT00383240|58752247|FG003|Overall Study|Did not meet protocol eligibility|3|||
30741062|NCT00383240|58752244|FG000|Overall Study|Administrative|1|||
30741063|NCT00383240|58752245|FG001|Overall Study|Administrative|1|||
30741064|NCT00383240|58752246|FG002|Overall Study|Administrative|0|||
30741065|NCT00383240|58752247|FG003|Overall Study|Administrative|0|||
30741066|NCT00362180|58752267|FG000|Treated Period|Withdrawal by Subject|1|||
30741067|NCT00362180|58752268|FG001|Treated Period|Withdrawal by Subject|0|||
30741068|NCT00362180|58752269|FG002|Treated Period|Withdrawal by Subject|0|||
30741069|NCT00362180|58752270|FG003|Treated Period|Withdrawal by Subject|0|||
30741070|NCT00362180|58752271|FG004|Treated Period|Withdrawal by Subject|0|||
30741071|NCT00362180|58752272|FG005|Treated Period|Withdrawal by Subject|0|||
30741072|NCT00362180|58752273|FG006|Treated Period|Withdrawal by Subject|0|||
30741073|NCT00362180|58752274|FG007|Treated Period|Withdrawal by Subject|0|||
30741074|NCT00362180|58752275|FG008|Treated Period|Withdrawal by Subject|0|||
30741075|NCT00362180|58752267|FG000|Treated Period|Adverse Event|0|||
30741076|NCT00362180|58752268|FG001|Treated Period|Adverse Event|0|||
30741077|NCT00362180|58752269|FG002|Treated Period|Adverse Event|0|||
30741078|NCT00362180|58752270|FG003|Treated Period|Adverse Event|0|||
30741079|NCT00362180|58752271|FG004|Treated Period|Adverse Event|0|||
30741080|NCT00362180|58752272|FG005|Treated Period|Adverse Event|1|||
30741081|NCT00362180|58752273|FG006|Treated Period|Adverse Event|0|||
30741082|NCT00362180|58752274|FG007|Treated Period|Adverse Event|1|||
30741083|NCT00362180|58752275|FG008|Treated Period|Adverse Event|0|||
30741084|NCT00383162|58752293|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
30741085|NCT00383162|58752294|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
30741086|NCT00383162|58752293|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
30741087|NCT00383162|58752294|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
30741088|NCT00383162|58752293|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
30741089|NCT00383162|58752294|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
30741090|NCT00383162|58752293|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
30741091|NCT00383162|58752294|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
30741092|NCT00383162|58752293|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
30741093|NCT00383162|58752294|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
30741094|NCT00383162|58752293|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
30741095|NCT00383162|58752294|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
30741096|NCT00383162|58752293|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
30741097|NCT00383162|58752294|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
30741098|NCT00383162|58752293|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
30741099|NCT00383162|58752294|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
30741100|NCT00383162|58752293|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
30741101|NCT00383162|58752294|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
30741102|NCT00358436|58752302|FG000|Overall Study|Adverse Event|29|||
30741103|NCT00358436|58752303|FG001|Overall Study|Adverse Event|13|||
30741104|NCT00358436|58752302|FG000|Overall Study|Lack of Efficacy|34|||
30741105|NCT00358436|58752303|FG001|Overall Study|Lack of Efficacy|36|||
30741106|NCT00358436|58752302|FG000|Overall Study|Lost to Follow-up|11|||
30741107|NCT00358436|58752303|FG001|Overall Study|Lost to Follow-up|6|||
30741108|NCT00358436|58752302|FG000|Overall Study|Protocol Violation|8|||
30741109|NCT00358436|58752303|FG001|Overall Study|Protocol Violation|3|||
30741110|NCT00358436|58752302|FG000|Overall Study|Withdrawal by Subject|40|||
30741111|NCT00358436|58752303|FG001|Overall Study|Withdrawal by Subject|17|||
30741112|NCT00358436|58752302|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
30741113|NCT00358436|58752303|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
30741114|NCT00358436|58752302|FG000|Overall Study|COPD exacerbation|22|||
30741115|NCT00358436|58752303|FG001|Overall Study|COPD exacerbation|10|||
30741116|NCT00358436|58752302|FG000|Overall Study|Other|6|||
30741117|NCT00358436|58752303|FG001|Overall Study|Other|1|||
30741118|NCT00383084|58752313|FG000|Overall Study|Withdrawal by Subject|12|||
30741119|NCT00383084|58752314|FG001|Overall Study|Withdrawal by Subject|10|||
30741120|NCT00361634|58752320|FG000|Overall Study|Lost to Follow-up|1|||
30741121|NCT00361634|58752320|FG000|Overall Study|Withdrawal by Subject|1|||
30741122|NCT00357968|58752326|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
30741123|NCT00357968|58752327|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
30741124|NCT00357968|58752326|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
30741125|NCT00357968|58752327|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
30741126|NCT00357656|58752350|FG000|Overall Study|Other, No surgery performed|0|||
30741127|NCT00357656|58752351|FG001|Overall Study|Other, No surgery performed|3|||
30741128|NCT00357500|58752369|FG000|Overall Study|Adverse Event|3|||
30741129|NCT00357500|58752369|FG000|Overall Study|Withdrawal by Subject|5|||
30741130|NCT00357500|58752369|FG000|Overall Study|Progressive Disease|65|||
30741131|NCT00357500|58752369|FG000|Overall Study|Not Started Protocol Therapy|4|||
30741132|NCT00357110|58752375|FG000|Overall Study|Early study termination|5|||
30741133|NCT00357110|58752376|FG001|Overall Study|Early study termination|5|||
30741134|NCT00098722|58752385|FG000|Double Blind Phase|Adverse Event|7|||
30741135|NCT00098722|58752386|FG001|Double Blind Phase|Adverse Event|7|||
30741136|NCT00098722|58752387|FG002|Double Blind Phase|Adverse Event|3|||
30741137|NCT00098722|58752388|FG003|Double Blind Phase|Adverse Event|0|||
30741138|NCT00098722|58752389|FG004|Double Blind Phase|Adverse Event|0|||
30741139|NCT00098722|58752390|FG005|Double Blind Phase|Adverse Event|0|||
30741140|NCT00098722|58752391|FG006|Double Blind Phase|Adverse Event|0|||
30741141|NCT00098722|58752385|FG000|Double Blind Phase|Death|2|||
30741142|NCT00098722|58752386|FG001|Double Blind Phase|Death|5|||
30741143|NCT00098722|58752387|FG002|Double Blind Phase|Death|0|||
30741144|NCT00098722|58752388|FG003|Double Blind Phase|Death|0|||
30741145|NCT00098722|58752389|FG004|Double Blind Phase|Death|0|||
30741146|NCT00098722|58752390|FG005|Double Blind Phase|Death|0|||
30741147|NCT00098722|58752391|FG006|Double Blind Phase|Death|0|||
30741148|NCT00098722|58752385|FG000|Double Blind Phase|Lack of Efficacy|21|||
30741149|NCT00098722|58752386|FG001|Double Blind Phase|Lack of Efficacy|23|||
30741150|NCT00098722|58752387|FG002|Double Blind Phase|Lack of Efficacy|15|||
30741151|NCT00098722|58752388|FG003|Double Blind Phase|Lack of Efficacy|0|||
30741152|NCT00098722|58752389|FG004|Double Blind Phase|Lack of Efficacy|0|||
30741153|NCT00098722|58752390|FG005|Double Blind Phase|Lack of Efficacy|0|||
30741154|NCT00098722|58752391|FG006|Double Blind Phase|Lack of Efficacy|0|||
30741155|NCT00098722|58752385|FG000|Double Blind Phase|Participant defaulted|16|||
30741156|NCT00098722|58752386|FG001|Double Blind Phase|Participant defaulted|11|||
30741157|NCT00098722|58752387|FG002|Double Blind Phase|Participant defaulted|9|||
30741158|NCT00098722|58752388|FG003|Double Blind Phase|Participant defaulted|0|||
30741159|NCT00098722|58752389|FG004|Double Blind Phase|Participant defaulted|0|||
30741160|NCT00098722|58752390|FG005|Double Blind Phase|Participant defaulted|0|||
30741161|NCT00098722|58752391|FG006|Double Blind Phase|Participant defaulted|0|||
30741162|NCT00098722|58752385|FG000|Double Blind Phase|Pregnancy|1|||
30741163|NCT00098722|58752386|FG001|Double Blind Phase|Pregnancy|0|||
30741164|NCT00098722|58752387|FG002|Double Blind Phase|Pregnancy|0|||
30741165|NCT00098722|58752388|FG003|Double Blind Phase|Pregnancy|0|||
30741166|NCT00098722|58752389|FG004|Double Blind Phase|Pregnancy|0|||
30741167|NCT00098722|58752390|FG005|Double Blind Phase|Pregnancy|0|||
30741168|NCT00098722|58752391|FG006|Double Blind Phase|Pregnancy|0|||
30741169|NCT00098722|58752385|FG000|Double Blind Phase|Randomized, not treated|4|||
30741170|NCT00098722|58752386|FG001|Double Blind Phase|Randomized, not treated|3|||
30741171|NCT00098722|58752387|FG002|Double Blind Phase|Randomized, not treated|3|||
30741172|NCT00098722|58752388|FG003|Double Blind Phase|Randomized, not treated|0|||
30741173|NCT00098722|58752389|FG004|Double Blind Phase|Randomized, not treated|0|||
30741174|NCT00098722|58752390|FG005|Double Blind Phase|Randomized, not treated|0|||
30741175|NCT00098722|58752391|FG006|Double Blind Phase|Randomized, not treated|0|||
30741176|NCT00098722|58752385|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
30741177|NCT00098722|58752386|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
30741178|NCT00098722|58752387|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
30741179|NCT00098722|58752388|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
30741180|NCT00098722|58752389|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
30901697|NCT01837966|58935565|FG000|Overall Study|Withdrawal by Subject|2|||
30901698|NCT01837966|58935566|FG001|Overall Study|Withdrawal by Subject|1|||
30901699|NCT02435147|58935572|FG000|Overall Study|non-evaluable DXA scan|11|||
30901700|NCT02435069|58935576|FG000|Dose Response - First Intervention|Adverse Event|0|||
30901701|NCT02435069|58935577|FG001|Dose Response - First Intervention|Adverse Event|1|||
30901702|NCT02435069|58935578|FG002|Dose Response - First Intervention|Adverse Event|1|||
30901703|NCT02435069|58935579|FG003|Dose Response - First Intervention|Adverse Event|0|||
30901704|NCT02435069|58935580|FG004|Dose Response - First Intervention|Adverse Event|0|||
30901705|NCT02435069|58935576|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
30901706|NCT02435069|58935577|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
30901707|NCT02435069|58935578|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
30901708|NCT02435069|58935579|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
30901709|NCT02435069|58935580|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
30901710|NCT02454101|58935602|FG000|Overall Study|Adverse Event|2|||
30901711|NCT02454101|58935603|FG001|Overall Study|Adverse Event|3|||
30901712|NCT02454101|58935602|FG000|Overall Study|Lost to Follow-up|3|||
30901713|NCT02454101|58935603|FG001|Overall Study|Lost to Follow-up|4|||
30901714|NCT02409719|58935611|FG000|Overall Study|Lost to Follow-up|3|||
30901715|NCT02409719|58935612|FG001|Overall Study|Lost to Follow-up|3|||
30901716|NCT01820572|58935620|FG000|Randomization|Not Treated|2|||
30901717|NCT01820572|58935621|FG001|Randomization|Not Treated|1|||
30901718|NCT01820572|58935620|FG000|Treatment Period|Adverse Event|12|||
30901719|NCT01820572|58935621|FG001|Treatment Period|Adverse Event|7|||
30901720|NCT01820572|58935620|FG000|Treatment Period|Death|3|||
30901721|NCT01820572|58935621|FG001|Treatment Period|Death|3|||
30901722|NCT01820572|58935620|FG000|Treatment Period|Lack of Efficacy|1|||
30901723|NCT01820572|58935621|FG001|Treatment Period|Lack of Efficacy|0|||
30901724|NCT01820572|58935620|FG000|Treatment Period|poor/non compliance|0|||
30901725|NCT01820572|58935621|FG001|Treatment Period|poor/non compliance|3|||
30901726|NCT01820572|58935620|FG000|Treatment Period|request to discontinue|6|||
30901727|NCT01820572|58935621|FG001|Treatment Period|request to discontinue|11|||
30741181|NCT00098722|58752390|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
30741182|NCT00098722|58752391|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
30741183|NCT00098722|58752385|FG000|Double Blind Phase|Other|7|||
30741184|NCT00098722|58752386|FG001|Double Blind Phase|Other|8|||
30741185|NCT00098722|58752387|FG002|Double Blind Phase|Other|7|||
30741186|NCT00098722|58752388|FG003|Double Blind Phase|Other|0|||
30741187|NCT00098722|58752389|FG004|Double Blind Phase|Other|0|||
30741188|NCT00098722|58752390|FG005|Double Blind Phase|Other|0|||
30741189|NCT00098722|58752391|FG006|Double Blind Phase|Other|0|||
30741190|NCT00098722|58752385|FG000|Open Label Phase|Adverse Event|0|||
30741191|NCT00098722|58752386|FG001|Open Label Phase|Adverse Event|0|||
30741192|NCT00098722|58752387|FG002|Open Label Phase|Adverse Event|0|||
30741193|NCT00098722|58752388|FG003|Open Label Phase|Adverse Event|5|||
30741194|NCT00098722|58752389|FG004|Open Label Phase|Adverse Event|0|||
30741195|NCT00098722|58752390|FG005|Open Label Phase|Adverse Event|0|||
30741196|NCT00098722|58752391|FG006|Open Label Phase|Adverse Event|0|||
30741197|NCT00098722|58752385|FG000|Open Label Phase|Death|0|||
30741198|NCT00098722|58752386|FG001|Open Label Phase|Death|0|||
30741199|NCT00098722|58752387|FG002|Open Label Phase|Death|0|||
30741200|NCT00098722|58752388|FG003|Open Label Phase|Death|2|||
30741201|NCT00098722|58752389|FG004|Open Label Phase|Death|0|||
30741202|NCT00098722|58752390|FG005|Open Label Phase|Death|0|||
30741203|NCT00098722|58752391|FG006|Open Label Phase|Death|0|||
30741204|NCT00098722|58752385|FG000|Open Label Phase|Lack of Efficacy|0|||
30741205|NCT00098722|58752386|FG001|Open Label Phase|Lack of Efficacy|0|||
30741206|NCT00098722|58752387|FG002|Open Label Phase|Lack of Efficacy|0|||
30741207|NCT00098722|58752388|FG003|Open Label Phase|Lack of Efficacy|8|||
30741208|NCT00098722|58752389|FG004|Open Label Phase|Lack of Efficacy|0|||
30741209|NCT00098722|58752390|FG005|Open Label Phase|Lack of Efficacy|0|||
30741210|NCT00098722|58752391|FG006|Open Label Phase|Lack of Efficacy|0|||
30741211|NCT00098722|58752385|FG000|Open Label Phase|Pregnancy|0|||
30741212|NCT00098722|58752386|FG001|Open Label Phase|Pregnancy|0|||
30741213|NCT00098722|58752387|FG002|Open Label Phase|Pregnancy|0|||
30741214|NCT00098722|58752388|FG003|Open Label Phase|Pregnancy|1|||
30741215|NCT00098722|58752389|FG004|Open Label Phase|Pregnancy|0|||
30741216|NCT00098722|58752390|FG005|Open Label Phase|Pregnancy|0|||
30741217|NCT00098722|58752391|FG006|Open Label Phase|Pregnancy|0|||
30901728|NCT01820572|58935620|FG000|Treatment Period|No longer meets study criteria|3|||
30901729|NCT01820572|58935621|FG001|Treatment Period|No longer meets study criteria|10|||
30901730|NCT01820572|58935620|FG000|Treatment Period|withdrew consent|1|||
30901731|NCT01820572|58935621|FG001|Treatment Period|withdrew consent|2|||
30901732|NCT01820260|58935641|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901733|NCT01820260|58935642|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901734|NCT01820260|58935643|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901735|NCT01820260|58935644|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901736|NCT01820260|58935645|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901737|NCT01820260|58935646|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901738|NCT01820260|58935647|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
30901739|NCT01820260|58935648|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901740|NCT01820260|58935649|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901741|NCT01820260|58935650|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901742|NCT01820260|58935651|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901743|NCT01820260|58935652|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901744|NCT01820260|58935653|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901745|NCT01820260|58935654|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
30901746|NCT01820260|58935641|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901747|NCT01820260|58935642|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901748|NCT01820260|58935643|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901749|NCT01820260|58935644|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901750|NCT01820260|58935645|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901751|NCT01820260|58935646|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30741218|NCT00098722|58752385|FG000|Open Label Phase|Participant defaulted|0|||
30741219|NCT00098722|58752386|FG001|Open Label Phase|Participant defaulted|0|||
30741220|NCT00098722|58752387|FG002|Open Label Phase|Participant defaulted|0|||
30741221|NCT00098722|58752388|FG003|Open Label Phase|Participant defaulted|18|||
30741222|NCT00098722|58752389|FG004|Open Label Phase|Participant defaulted|0|||
30741223|NCT00098722|58752390|FG005|Open Label Phase|Participant defaulted|0|||
30741224|NCT00098722|58752391|FG006|Open Label Phase|Participant defaulted|0|||
30741225|NCT00098722|58752385|FG000|Open Label Phase|Ongoing at cut-off date|0|||
30741226|NCT00098722|58752386|FG001|Open Label Phase|Ongoing at cut-off date|0|||
30741227|NCT00098722|58752387|FG002|Open Label Phase|Ongoing at cut-off date|0|||
30741228|NCT00098722|58752388|FG003|Open Label Phase|Ongoing at cut-off date|220|||
30741229|NCT00098722|58752389|FG004|Open Label Phase|Ongoing at cut-off date|50|||
30741230|NCT00098722|58752390|FG005|Open Label Phase|Ongoing at cut-off date|0|||
30741231|NCT00098722|58752391|FG006|Open Label Phase|Ongoing at cut-off date|0|||
30741232|NCT00098722|58752385|FG000|Open Label Phase|Other|0|||
30741233|NCT00098722|58752386|FG001|Open Label Phase|Other|0|||
30741234|NCT00098722|58752387|FG002|Open Label Phase|Other|0|||
30741235|NCT00098722|58752388|FG003|Open Label Phase|Other|18|||
30741236|NCT00098722|58752389|FG004|Open Label Phase|Other|0|||
30741237|NCT00098722|58752390|FG005|Open Label Phase|Other|0|||
30741238|NCT00098722|58752391|FG006|Open Label Phase|Other|0|||
30741239|NCT00098722|58752385|FG000|Observation Phase|Death|0|||
30741240|NCT00098722|58752386|FG001|Observation Phase|Death|0|||
30741241|NCT00098722|58752387|FG002|Observation Phase|Death|0|||
30741242|NCT00098722|58752388|FG003|Observation Phase|Death|0|||
30741243|NCT00098722|58752389|FG004|Observation Phase|Death|0|||
30741244|NCT00098722|58752390|FG005|Observation Phase|Death|5|||
30741245|NCT00098722|58752391|FG006|Observation Phase|Death|3|||
30741246|NCT00098722|58752385|FG000|Observation Phase|Lack of Efficacy|0|||
30901752|NCT01820260|58935647|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901753|NCT01820260|58935648|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901754|NCT01820260|58935649|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901755|NCT01820260|58935650|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
30741247|NCT00098722|58752386|FG001|Observation Phase|Lack of Efficacy|0|||
30741248|NCT00098722|58752387|FG002|Observation Phase|Lack of Efficacy|0|||
30741249|NCT00098722|58752388|FG003|Observation Phase|Lack of Efficacy|0|||
30741250|NCT00098722|58752389|FG004|Observation Phase|Lack of Efficacy|0|||
30741251|NCT00098722|58752390|FG005|Observation Phase|Lack of Efficacy|2|||
30741252|NCT00098722|58752391|FG006|Observation Phase|Lack of Efficacy|0|||
30741253|NCT00098722|58752385|FG000|Observation Phase|Participant defaulted|0|||
30741254|NCT00098722|58752386|FG001|Observation Phase|Participant defaulted|0|||
30741255|NCT00098722|58752387|FG002|Observation Phase|Participant defaulted|0|||
30741256|NCT00098722|58752388|FG003|Observation Phase|Participant defaulted|0|||
30741257|NCT00098722|58752389|FG004|Observation Phase|Participant defaulted|0|||
30741258|NCT00098722|58752390|FG005|Observation Phase|Participant defaulted|17|||
30741259|NCT00098722|58752391|FG006|Observation Phase|Participant defaulted|4|||
30741260|NCT00098722|58752385|FG000|Observation Phase|Other|0|||
30741261|NCT00098722|58752386|FG001|Observation Phase|Other|0|||
30741262|NCT00098722|58752387|FG002|Observation Phase|Other|0|||
30901756|NCT01820260|58935651|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901757|NCT01820260|58935652|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901758|NCT01820260|58935653|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901759|NCT01820260|58935654|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
30901760|NCT01610596|58935692|FG000|Overall Study|Lost to Follow-up|0|||
30901761|NCT01610596|58935693|FG001|Overall Study|Lost to Follow-up|1|||
30901762|NCT01818700|58935699|FG000|Overall Study|Adverse Event|67|||
30901763|NCT01818700|58935699|FG000|Overall Study|Lack of Efficacy|2|||
30901764|NCT01818700|58935699|FG000|Overall Study|Lost to Follow-up|5|||
30901765|NCT01818700|58935699|FG000|Overall Study|Withdrawal by Subject|27|||
30901766|NCT01818700|58935699|FG000|Overall Study|Protocol Violation|2|||
30901767|NCT01818700|58935699|FG000|Overall Study|Other|1|||
30901768|NCT01817764|58935707|FG000|Overall Study|Adverse Event|7|||
30901769|NCT01817764|58935708|FG001|Overall Study|Adverse Event|10|||
30901770|NCT01817764|58935707|FG000|Overall Study|Lack of Efficacy|9|||
30901771|NCT01817764|58935708|FG001|Overall Study|Lack of Efficacy|7|||
30901772|NCT01817764|58935707|FG000|Overall Study|Protocol Violation|7|||
30741263|NCT00098722|58752388|FG003|Observation Phase|Other|0|||
30741264|NCT00098722|58752389|FG004|Observation Phase|Other|0|||
30741265|NCT00098722|58752390|FG005|Observation Phase|Other|21|||
30741266|NCT00098722|58752391|FG006|Observation Phase|Other|10|||
30741267|NCT00098254|58752403|FG000|Overall Study|Adverse Event|2|||
30901773|NCT01817764|58935708|FG001|Overall Study|Protocol Violation|5|||
30901774|NCT01817764|58935707|FG000|Overall Study|Lost to Follow-up|1|||
30901775|NCT01817764|58935708|FG001|Overall Study|Lost to Follow-up|4|||
30741268|NCT00098254|58752403|FG000|Overall Study|Death|1|||
30741269|NCT00095056|58752409|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
30741270|NCT00095056|58752410|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
30741271|NCT00095056|58752409|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
30741272|NCT00095056|58752410|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
30901776|NCT01817764|58935707|FG000|Overall Study|Withdrawal by Subject|10|||
30901777|NCT01817764|58935708|FG001|Overall Study|Withdrawal by Subject|12|||
30901778|NCT01803880|58935717|FG000|Overall Study|Adverse Event|1|||
30901779|NCT01803880|58935718|FG001|Overall Study|Adverse Event|0|||
30901780|NCT01803880|58935719|FG002|Overall Study|Adverse Event|0|||
30901781|NCT01803880|58935717|FG000|Overall Study|Withdrawal by Subject|1|||
30901782|NCT01803880|58935718|FG001|Overall Study|Withdrawal by Subject|1|||
30901783|NCT01803880|58935719|FG002|Overall Study|Withdrawal by Subject|4|||
30901784|NCT01803880|58935717|FG000|Overall Study|Physician Decision|0|||
30621996|NCT00929110|58633507|FG002|Overall Study|Patient inability to use the device|0|||
30741273|NCT00095056|58752409|FG000|Phase A (Weeks 0-12)|Death|1|||
30741274|NCT00095056|58752410|FG001|Phase A (Weeks 0-12)|Death|0|||
30741275|NCT00095056|58752409|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
30741276|NCT00095056|58752410|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
30741277|NCT00095056|58752409|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
30741278|NCT00095056|58752410|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
30741279|NCT00095056|58752409|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
30741280|NCT00095056|58752410|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
30741281|NCT00095056|58752409|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
30741282|NCT00095056|58752410|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
30741283|NCT00095056|58752409|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
30741284|NCT00095056|58752410|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
30621997|NCT01147068|58633522|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
30621998|NCT01147068|58633523|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
30621999|NCT01147068|58633524|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
30622000|NCT01147068|58633525|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
30622001|NCT01147068|58633526|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
30622002|NCT01147068|58633527|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
30622003|NCT01147068|58633528|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
30622004|NCT01147068|58633522|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
30622005|NCT01147068|58633523|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
30741285|NCT00095056|58752409|FG000|Phase B (Weeks 12-54)|Death|3|||
30741286|NCT00095056|58752410|FG001|Phase B (Weeks 12-54)|Death|1|||
30741287|NCT00095056|58752409|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
30741288|NCT00095056|58752410|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
30741289|NCT00095056|58752409|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
30741290|NCT00095056|58752410|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
30741291|NCT00098020|58752416|FG000|Overall Study|Adverse Event|2|||
30741292|NCT00098020|58752416|FG000|Overall Study|Lost to Follow-up|1|||
30741293|NCT00098020|58752416|FG000|Overall Study|elevated liver enzymes|1|||
30741294|NCT00098020|58752416|FG000|Overall Study|Low urine PCR|1|||
30741295|NCT00098020|58752416|FG000|Overall Study|Low epidermal growth factor receptor|1|||
30741296|NCT00381680|58752422|FG000|Overall Study|Adverse Event|9|||
30741297|NCT00381680|58752423|FG001|Overall Study|Adverse Event|3|||
30741298|NCT00381680|58752422|FG000|Overall Study|Death|10|||
30741299|NCT00381680|58752423|FG001|Overall Study|Death|7|||
30741300|NCT00381680|58752422|FG000|Overall Study|Lost to Follow-up|3|||
30741301|NCT00381680|58752423|FG001|Overall Study|Lost to Follow-up|2|||
30741302|NCT00381680|58752422|FG000|Overall Study|Physician Decision|25|||
30741303|NCT00381680|58752423|FG001|Overall Study|Physician Decision|6|||
30741304|NCT00381680|58752422|FG000|Overall Study|Withdrawal by Subject|3|||
30741305|NCT00381680|58752423|FG001|Overall Study|Withdrawal by Subject|1|||
30741306|NCT00381680|58752422|FG000|Overall Study|Entry onto another COG Trial|1|||
30741307|NCT00381680|58752423|FG001|Overall Study|Entry onto another COG Trial|2|||
30741308|NCT00381680|58752422|FG000|Overall Study|Alternative Therapy|11|||
30741309|NCT00381680|58752423|FG001|Overall Study|Alternative Therapy|5|||
30741310|NCT00381680|58752422|FG000|Overall Study|Secondary Malignancy|3|||
30741311|NCT00381680|58752423|FG001|Overall Study|Secondary Malignancy|0|||
30741312|NCT00381680|58752422|FG000|Overall Study|Delay initiation|1|||
30741313|NCT00381680|58752423|FG001|Overall Study|Delay initiation|0|||
30741314|NCT00381680|58752422|FG000|Overall Study|Stem Cell Transplant|26|||
30741315|NCT00381680|58752423|FG001|Overall Study|Stem Cell Transplant|10|||
30741316|NCT00381680|58752422|FG000|Overall Study|Relapse|18|||
30741317|NCT00381680|58752423|FG001|Overall Study|Relapse|9|||
30741318|NCT00381680|58752422|FG000|Overall Study|Induction Failure|4|||
30741319|NCT00381680|58752423|FG001|Overall Study|Induction Failure|1|||
30741320|NCT00381680|58752422|FG000|Overall Study|Progression|1|||
30741321|NCT00381680|58752423|FG001|Overall Study|Progression|1|||
30901785|NCT01803880|58935718|FG001|Overall Study|Physician Decision|0|||
30901786|NCT01803880|58935719|FG002|Overall Study|Physician Decision|1|||
30901787|NCT01803880|58935717|FG000|Overall Study|Unable to return for follow-up visits|0|||
30741322|NCT00381680|58752422|FG000|Overall Study|Other not otherwise specified|7|||
30741323|NCT00381680|58752423|FG001|Overall Study|Other not otherwise specified|2|||
30741324|NCT00381680|58752422|FG000|Overall Study|Ineligible|3|||
30741325|NCT00381680|58752423|FG001|Overall Study|Ineligible|1|||
30741326|NCT00360698|58752435|FG000|Run-In|Physician Decision|0|||
30741327|NCT00360698|58752436|FG001|Run-In|Physician Decision|1|||
30741328|NCT00360698|58752435|FG000|Run-In|Withdrawal by Subject|0|||
30741329|NCT00360698|58752436|FG001|Run-In|Withdrawal by Subject|2|||
30741330|NCT00360698|58752435|FG000|Run-In|Non compliance with treatment procedure|0|||
30741331|NCT00360698|58752436|FG001|Run-In|Non compliance with treatment procedure|1|||
30741332|NCT00360698|58752435|FG000|Run-In|Sponsor request|0|||
30741333|NCT00360698|58752436|FG001|Run-In|Sponsor request|2|||
30741334|NCT00360698|58752435|FG000|Run-In|Patient did not meet inclusion criteria|0|||
30741335|NCT00360698|58752436|FG001|Run-In|Patient did not meet inclusion criteria|1|||
30741336|NCT00360698|58752435|FG000|Run-In|Patient personal reasons|0|||
30741337|NCT00360698|58752436|FG001|Run-In|Patient personal reasons|2|||
30741338|NCT00360698|58752435|FG000|Run-In|Need of insulin with meals|0|||
30741339|NCT00360698|58752436|FG001|Run-In|Need of insulin with meals|1|||
30741340|NCT00360698|58752435|FG000|Treatment Period|Non compliance with treatment procedure|1|||
30741341|NCT00360698|58752436|FG001|Treatment Period|Non compliance with treatment procedure|0|||
30741342|NCT00360698|58752435|FG000|Treatment Period|Early termination by error|0|||
30741343|NCT00360698|58752436|FG001|Treatment Period|Early termination by error|1|||
30741344|NCT00380978|58752444|FG000|Overall Study|Refused allocated intervention|0|||
30741345|NCT00380978|58752445|FG001|Overall Study|Refused allocated intervention|6|||
30741346|NCT00380978|58752444|FG000|Overall Study|Wrong study envelope|0|||
30741347|NCT00380978|58752445|FG001|Overall Study|Wrong study envelope|2|||
30741348|NCT00380978|58752444|FG000|Overall Study|Allocation prior to analgesia request|1|||
30741349|NCT00380978|58752445|FG001|Overall Study|Allocation prior to analgesia request|2|||
30741350|NCT00380978|58752444|FG000|Overall Study|Parous patient|1|||
30741351|NCT00380978|58752445|FG001|Overall Study|Parous patient|0|||
30741352|NCT00162123|58752459|FG000|Overall Study|Disease progression|27|||
30741353|NCT00162123|58752460|FG001|Overall Study|Disease progression|19|||
30741354|NCT00162123|58752461|FG002|Overall Study|Disease progression|10|||
30741355|NCT00162123|58752462|FG003|Overall Study|Disease progression|4|||
30901788|NCT01803880|58935718|FG001|Overall Study|Unable to return for follow-up visits|1|||
30901789|NCT01803880|58935719|FG002|Overall Study|Unable to return for follow-up visits|2|||
30901790|NCT01803880|58935717|FG000|Overall Study|Lost to Follow-up|1|||
30901791|NCT01803880|58935718|FG001|Overall Study|Lost to Follow-up|2|||
30741356|NCT00162123|58752463|FG004|Overall Study|Disease progression|8|||
30741357|NCT00162123|58752464|FG005|Overall Study|Disease progression|3|||
30741358|NCT00162123|58752465|FG006|Overall Study|Disease progression|1|||
30741359|NCT00162123|58752466|FG007|Overall Study|Disease progression|0|||
30741360|NCT00162123|58752459|FG000|Overall Study|Study drug toxicity|6|||
30741361|NCT00162123|58752460|FG001|Overall Study|Study drug toxicity|1|||
30741362|NCT00162123|58752461|FG002|Overall Study|Study drug toxicity|5|||
30741363|NCT00162123|58752462|FG003|Overall Study|Study drug toxicity|0|||
30741364|NCT00162123|58752463|FG004|Overall Study|Study drug toxicity|4|||
30741365|NCT00162123|58752464|FG005|Overall Study|Study drug toxicity|1|||
30741366|NCT00162123|58752465|FG006|Overall Study|Study drug toxicity|1|||
30741367|NCT00162123|58752466|FG007|Overall Study|Study drug toxicity|0|||
30741368|NCT00162123|58752459|FG000|Overall Study|Death|3|||
30741369|NCT00162123|58752460|FG001|Overall Study|Death|3|||
30741370|NCT00162123|58752461|FG002|Overall Study|Death|1|||
30901792|NCT01803880|58935719|FG002|Overall Study|Lost to Follow-up|3|||
30901793|NCT01803880|58935717|FG000|Overall Study|Protocol Violation|1|||
30901794|NCT01803880|58935718|FG001|Overall Study|Protocol Violation|0|||
30901795|NCT01803880|58935719|FG002|Overall Study|Protocol Violation|0|||
30901796|NCT01803880|58935717|FG000|Overall Study|Early study termination|0|||
30741371|NCT00162123|58752462|FG003|Overall Study|Death|1|||
30741372|NCT00162123|58752463|FG004|Overall Study|Death|1|||
30741373|NCT00162123|58752464|FG005|Overall Study|Death|1|||
30901797|NCT01803880|58935718|FG001|Overall Study|Early study termination|6|||
30741374|NCT00162123|58752465|FG006|Overall Study|Death|0|||
30741375|NCT00162123|58752466|FG007|Overall Study|Death|0|||
30741376|NCT00162123|58752459|FG000|Overall Study|Withdrawal by Subject|2|||
30741377|NCT00162123|58752460|FG001|Overall Study|Withdrawal by Subject|0|||
30901798|NCT01803880|58935719|FG002|Overall Study|Early study termination|5|||
30901799|NCT01803880|58935717|FG000|Overall Study|Incomplete data entry by sites|2|||
30741378|NCT00162123|58752461|FG002|Overall Study|Withdrawal by Subject|2|||
30741379|NCT00162123|58752462|FG003|Overall Study|Withdrawal by Subject|1|||
30741380|NCT00162123|58752463|FG004|Overall Study|Withdrawal by Subject|1|||
30901800|NCT01803880|58935718|FG001|Overall Study|Incomplete data entry by sites|0|||
30741381|NCT00162123|58752464|FG005|Overall Study|Withdrawal by Subject|2|||
30791002|NCT00674440|58804150|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
30901801|NCT01803880|58935719|FG002|Overall Study|Incomplete data entry by sites|0|||
30901802|NCT01803646|58935731|FG000|Overall Study|Protocol Violation|1|||
30901803|NCT01803646|58935732|FG001|Overall Study|Protocol Violation|0|||
30741382|NCT00162123|58752465|FG006|Overall Study|Withdrawal by Subject|1|||
30741383|NCT00162123|58752466|FG007|Overall Study|Withdrawal by Subject|0|||
30741384|NCT00162123|58752459|FG000|Overall Study|Deterioration without progression|2|||
30741385|NCT00162123|58752460|FG001|Overall Study|Deterioration without progression|2|||
30741386|NCT00162123|58752461|FG002|Overall Study|Deterioration without progression|3|||
30741387|NCT00162123|58752462|FG003|Overall Study|Deterioration without progression|0|||
30901804|NCT01803646|58935731|FG000|Overall Study|Adverse Event|1|||
30901805|NCT01803646|58935732|FG001|Overall Study|Adverse Event|1|||
30901806|NCT01803646|58935731|FG000|Overall Study|Withdrawal by Subject|9|||
30901807|NCT01803646|58935732|FG001|Overall Study|Withdrawal by Subject|6|||
30901808|NCT01803646|58935731|FG000|Overall Study|Randomization error|1|||
30901809|NCT01803646|58935732|FG001|Overall Study|Randomization error|2|||
30901810|NCT01803646|58935731|FG000|Overall Study|Lost to Follow-up|5|||
30901811|NCT01803646|58935732|FG001|Overall Study|Lost to Follow-up|1|||
30901812|NCT01817530|58935746|FG000|Overall Study|Exclusionary Medication Received|0|||
30901813|NCT01817530|58935747|FG001|Overall Study|Exclusionary Medication Received|0|||
30901814|NCT01817530|58935748|FG002|Overall Study|Exclusionary Medication Received|0|||
30901815|NCT01817530|58935749|FG003|Overall Study|Exclusionary Medication Received|0|||
30901816|NCT01817530|58935750|FG004|Overall Study|Exclusionary Medication Received|1|||
30741388|NCT00162123|58752463|FG004|Overall Study|Deterioration without progression|1|||
30741389|NCT00162123|58752464|FG005|Overall Study|Deterioration without progression|0|||
30741390|NCT00162123|58752465|FG006|Overall Study|Deterioration without progression|0|||
30741391|NCT00162123|58752466|FG007|Overall Study|Deterioration without progression|0|||
30741392|NCT00162123|58752459|FG000|Overall Study|Adverse Event|1|||
30741393|NCT00162123|58752460|FG001|Overall Study|Adverse Event|2|||
30741394|NCT00162123|58752461|FG002|Overall Study|Adverse Event|0|||
30741395|NCT00162123|58752462|FG003|Overall Study|Adverse Event|2|||
30741396|NCT00162123|58752463|FG004|Overall Study|Adverse Event|1|||
30741397|NCT00162123|58752464|FG005|Overall Study|Adverse Event|0|||
30741398|NCT00162123|58752465|FG006|Overall Study|Adverse Event|0|||
30741399|NCT00162123|58752466|FG007|Overall Study|Adverse Event|0|||
30741400|NCT00162123|58752459|FG000|Overall Study|Not specified (before treatment)|2|||
30741401|NCT00162123|58752460|FG001|Overall Study|Not specified (before treatment)|0|||
30741402|NCT00162123|58752461|FG002|Overall Study|Not specified (before treatment)|0|||
30741403|NCT00162123|58752462|FG003|Overall Study|Not specified (before treatment)|0|||
30741404|NCT00162123|58752463|FG004|Overall Study|Not specified (before treatment)|12|||
30741405|NCT00162123|58752464|FG005|Overall Study|Not specified (before treatment)|1|||
30741406|NCT00162123|58752465|FG006|Overall Study|Not specified (before treatment)|0|||
30741407|NCT00162123|58752466|FG007|Overall Study|Not specified (before treatment)|0|||
30741408|NCT00162123|58752459|FG000|Overall Study|Not specified (after start of treatment)|0|||
30741409|NCT00162123|58752460|FG001|Overall Study|Not specified (after start of treatment)|0|||
30741410|NCT00162123|58752461|FG002|Overall Study|Not specified (after start of treatment)|0|||
30741411|NCT00162123|58752462|FG003|Overall Study|Not specified (after start of treatment)|0|||
30741412|NCT00162123|58752463|FG004|Overall Study|Not specified (after start of treatment)|3|||
30741413|NCT00162123|58752464|FG005|Overall Study|Not specified (after start of treatment)|0|||
30741414|NCT00162123|58752465|FG006|Overall Study|Not specified (after start of treatment)|0|||
30741415|NCT00162123|58752466|FG007|Overall Study|Not specified (after start of treatment)|0|||
30741416|NCT00162123|58752459|FG000|Overall Study|Physician Decision|1|||
30741417|NCT00162123|58752460|FG001|Overall Study|Physician Decision|2|||
30741418|NCT00162123|58752461|FG002|Overall Study|Physician Decision|0|||
30741419|NCT00162123|58752462|FG003|Overall Study|Physician Decision|0|||
30741420|NCT00162123|58752463|FG004|Overall Study|Physician Decision|0|||
30741421|NCT00162123|58752464|FG005|Overall Study|Physician Decision|1|||
30741422|NCT00162123|58752465|FG006|Overall Study|Physician Decision|1|||
30741423|NCT00162123|58752466|FG007|Overall Study|Physician Decision|0|||
30741424|NCT00162123|58752459|FG000|Overall Study|Tumor assessment only (not treated)|0|||
30741425|NCT00162123|58752460|FG001|Overall Study|Tumor assessment only (not treated)|0|||
30741426|NCT00162123|58752461|FG002|Overall Study|Tumor assessment only (not treated)|0|||
30741427|NCT00162123|58752462|FG003|Overall Study|Tumor assessment only (not treated)|0|||
30741428|NCT00162123|58752463|FG004|Overall Study|Tumor assessment only (not treated)|0|||
30741429|NCT00162123|58752464|FG005|Overall Study|Tumor assessment only (not treated)|0|||
30741430|NCT00162123|58752465|FG006|Overall Study|Tumor assessment only (not treated)|0|||
30741431|NCT00162123|58752466|FG007|Overall Study|Tumor assessment only (not treated)|1|||
30741432|NCT00162123|58752459|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
30901817|NCT01817530|58935751|FG005|Overall Study|Exclusionary Medication Received|0|||
30901818|NCT01817530|58935752|FG006|Overall Study|Exclusionary Medication Received|0|||
30901819|NCT01817530|58935753|FG007|Overall Study|Exclusionary Medication Received|0|||
30741433|NCT00162123|58752460|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
30901820|NCT01817530|58935746|FG000|Overall Study|Adverse Event|6|||
30741434|NCT00162123|58752461|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
30741435|NCT00162123|58752462|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
30741436|NCT00162123|58752463|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
30741437|NCT00162123|58752464|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
30741438|NCT00162123|58752465|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
30741439|NCT00162123|58752466|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
30741440|NCT00227721|58752485|FG000|Overall Study|On study, but never treated.|1|||
30741441|NCT00226941|58752493|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
30741442|NCT00226941|58752494|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
30901821|NCT01817530|58935747|FG001|Overall Study|Adverse Event|3|||
30791003|NCT00674440|58804150|FG000|Overall Study|did not have surgery, so unevaluable|7|||
30791004|NCT00674440|58804150|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
30791005|NCT02742766|58804174|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30791006|NCT02742766|58804175|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30791007|NCT02742766|58804176|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30791008|NCT02742766|58804177|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30791009|NCT02742766|58804178|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30791010|NCT02742766|58804179|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30791011|NCT02742766|58804180|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30901822|NCT01817530|58935748|FG002|Overall Study|Adverse Event|2|||
30901823|NCT01817530|58935749|FG003|Overall Study|Adverse Event|5|||
30901824|NCT01817530|58935750|FG004|Overall Study|Adverse Event|0|||
30901825|NCT01817530|58935751|FG005|Overall Study|Adverse Event|10|||
30901826|NCT01817530|58935752|FG006|Overall Study|Adverse Event|5|||
30741443|NCT00226941|58752495|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
30741444|NCT00226941|58752496|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
30741445|NCT00226941|58752493|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
30741446|NCT00226941|58752494|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
30901827|NCT01817530|58935753|FG007|Overall Study|Adverse Event|8|||
30901828|NCT01817530|58935746|FG000|Overall Study|Subject Noncompliant|3|||
30901829|NCT01817530|58935747|FG001|Overall Study|Subject Noncompliant|1|||
30901830|NCT01817530|58935748|FG002|Overall Study|Subject Noncompliant|0|||
30901831|NCT01817530|58935749|FG003|Overall Study|Subject Noncompliant|4|||
30901832|NCT01817530|58935750|FG004|Overall Study|Subject Noncompliant|0|||
30901833|NCT01817530|58935751|FG005|Overall Study|Subject Noncompliant|1|||
30901834|NCT01817530|58935752|FG006|Overall Study|Subject Noncompliant|1|||
30901835|NCT01817530|58935753|FG007|Overall Study|Subject Noncompliant|1|||
30901836|NCT01817530|58935746|FG000|Overall Study|Lack of Efficacy|1|||
30901837|NCT01817530|58935747|FG001|Overall Study|Lack of Efficacy|0|||
30901838|NCT01817530|58935748|FG002|Overall Study|Lack of Efficacy|0|||
30901839|NCT01817530|58935749|FG003|Overall Study|Lack of Efficacy|0|||
30901840|NCT01817530|58935750|FG004|Overall Study|Lack of Efficacy|0|||
30901841|NCT01817530|58935751|FG005|Overall Study|Lack of Efficacy|1|||
30901842|NCT01817530|58935752|FG006|Overall Study|Lack of Efficacy|0|||
30901843|NCT01817530|58935753|FG007|Overall Study|Lack of Efficacy|1|||
30901844|NCT01817530|58935746|FG000|Overall Study|Pregnancy|0|||
30901845|NCT01817530|58935747|FG001|Overall Study|Pregnancy|0|||
30901846|NCT01817530|58935748|FG002|Overall Study|Pregnancy|0|||
30901847|NCT01817530|58935749|FG003|Overall Study|Pregnancy|0|||
30741447|NCT00226941|58752495|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
30741448|NCT00226941|58752496|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
30741449|NCT00356408|58752516|FG000|Overall Study|Adverse Event|9|||
30741450|NCT00356408|58752516|FG000|Overall Study|Lack of Efficacy|36|||
30741451|NCT00356408|58752516|FG000|Overall Study|Lost to Follow-up|2|||
30741452|NCT00356408|58752516|FG000|Overall Study|Withdrawal by Subject|6|||
30741453|NCT00356408|58752516|FG000|Overall Study|Other: Principal investigator discretion|3|||
30741454|NCT00356408|58752516|FG000|Overall Study|Other: Sponsor request|1|||
30741455|NCT00356408|58752516|FG000|Overall Study|Other: Azathioprine stopped|1|||
30741456|NCT00356408|58752516|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
30741457|NCT00356408|58752516|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
30741458|NCT00509795|58752531|FG000|Overall Study|Adverse Event|4|||
30741459|NCT00509795|58752532|FG001|Overall Study|Adverse Event|3|||
30741460|NCT00509795|58752533|FG002|Overall Study|Adverse Event|5|||
30901848|NCT01817530|58935750|FG004|Overall Study|Pregnancy|0|||
30901849|NCT01817530|58935751|FG005|Overall Study|Pregnancy|1|||
30901850|NCT01817530|58935752|FG006|Overall Study|Pregnancy|0|||
30901851|NCT01817530|58935753|FG007|Overall Study|Pregnancy|0|||
30901852|NCT01817530|58935746|FG000|Overall Study|Other|0|||
30901853|NCT01817530|58935747|FG001|Overall Study|Other|1|||
30901854|NCT01817530|58935748|FG002|Overall Study|Other|0|||
30901855|NCT01817530|58935749|FG003|Overall Study|Other|0|||
30901856|NCT01817530|58935750|FG004|Overall Study|Other|1|||
30901857|NCT01817530|58935751|FG005|Overall Study|Other|0|||
30901858|NCT01817530|58935752|FG006|Overall Study|Other|5|||
30901859|NCT01817530|58935753|FG007|Overall Study|Other|0|||
30741461|NCT00509795|58752534|FG003|Overall Study|Adverse Event|4|||
30741462|NCT00509795|58752531|FG000|Overall Study|Death|3|||
30741463|NCT00509795|58752532|FG001|Overall Study|Death|1|||
30741464|NCT00509795|58752533|FG002|Overall Study|Death|2|||
30741465|NCT00509795|58752534|FG003|Overall Study|Death|7|||
30741466|NCT00509795|58752531|FG000|Overall Study|Lack of Efficacy|0|||
30741467|NCT00509795|58752532|FG001|Overall Study|Lack of Efficacy|0|||
30741468|NCT00509795|58752533|FG002|Overall Study|Lack of Efficacy|2|||
30741469|NCT00509795|58752534|FG003|Overall Study|Lack of Efficacy|2|||
30741470|NCT00509795|58752531|FG000|Overall Study|Lost to Follow-up|1|||
30741471|NCT00509795|58752532|FG001|Overall Study|Lost to Follow-up|2|||
30741472|NCT00509795|58752533|FG002|Overall Study|Lost to Follow-up|4|||
30741473|NCT00509795|58752534|FG003|Overall Study|Lost to Follow-up|4|||
30741474|NCT00509795|58752531|FG000|Overall Study|OTHER|1|||
30741475|NCT00509795|58752532|FG001|Overall Study|OTHER|0|||
30741476|NCT00509795|58752533|FG002|Overall Study|OTHER|4|||
30741477|NCT00509795|58752534|FG003|Overall Study|OTHER|1|||
30741478|NCT00509795|58752531|FG000|Overall Study|Protocol Violation|3|||
30741479|NCT00509795|58752532|FG001|Overall Study|Protocol Violation|0|||
30741480|NCT00509795|58752533|FG002|Overall Study|Protocol Violation|3|||
30741481|NCT00509795|58752534|FG003|Overall Study|Protocol Violation|1|||
30741482|NCT00509795|58752531|FG000|Overall Study|Withdrawal by Subject|10|||
30741483|NCT00509795|58752532|FG001|Overall Study|Withdrawal by Subject|5|||
30741484|NCT00509795|58752533|FG002|Overall Study|Withdrawal by Subject|7|||
30741485|NCT00509795|58752534|FG003|Overall Study|Withdrawal by Subject|8|||
30741486|NCT00165789|58752549|FG000|Overall Study|Adverse Event|0|||
30741487|NCT00165789|58752550|FG001|Overall Study|Adverse Event|3|||
30741488|NCT00165789|58752551|FG002|Overall Study|Adverse Event|0|||
30741489|NCT00165789|58752552|FG003|Overall Study|Adverse Event|12|||
30741490|NCT00165789|58752549|FG000|Overall Study|Withdrawal by Subject|0|||
30741491|NCT00165789|58752550|FG001|Overall Study|Withdrawal by Subject|1|||
30741492|NCT00165789|58752551|FG002|Overall Study|Withdrawal by Subject|1|||
30741493|NCT00165789|58752552|FG003|Overall Study|Withdrawal by Subject|2|||
30741494|NCT00504257|58752562|FG000|Overall Study|Withdrawal by Subject|2|||
30741495|NCT00504257|58752562|FG000|Overall Study|ineligible histology|2|||
30741496|NCT00509093|58752566|FG000|Overall Study|Adverse Event|10|||
30741497|NCT00509093|58752566|FG000|Overall Study|Disease Progression|9|||
30741498|NCT00509093|58752566|FG000|Overall Study|Transformed into MDS|1|||
30741499|NCT00509093|58752566|FG000|Overall Study|Withdrawal by Subject|3|||
30741500|NCT00509093|58752566|FG000|Overall Study|Physician Decision|1|||
30741501|NCT00160641|58752570|FG000|Overall Study|Adverse Event|102|||
30741502|NCT00160641|58752570|FG000|Overall Study|Withdrawal by Subject|87|||
30741503|NCT00160641|58752570|FG000|Overall Study|Lost to Follow-up|8|||
30741504|NCT00160641|58752570|FG000|Overall Study|Lack of Efficacy|12|||
30741505|NCT00160641|58752570|FG000|Overall Study|Protocol Violation|3|||
30741506|NCT00160641|58752570|FG000|Overall Study|Other|9|||
30741507|NCT00493025|58752574|FG000|Overall Study|Physician Decision|19|||
30741508|NCT00160563|58752582|FG000|Overall Study|Adverse Event|1|||
30741509|NCT00160563|58752583|FG001|Overall Study|Adverse Event|1|||
30741510|NCT00160563|58752584|FG002|Overall Study|Adverse Event|1|||
30741511|NCT00160563|58752582|FG000|Overall Study|Lost to Follow-up|1|||
30741512|NCT00160563|58752583|FG001|Overall Study|Lost to Follow-up|1|||
30741513|NCT00160563|58752584|FG002|Overall Study|Lost to Follow-up|2|||
30741514|NCT00160563|58752582|FG000|Overall Study|Protocol Violation|0|||
30741515|NCT00160563|58752583|FG001|Overall Study|Protocol Violation|0|||
30741516|NCT00160563|58752584|FG002|Overall Study|Protocol Violation|3|||
30741517|NCT00160563|58752582|FG000|Overall Study|Withdrawal by Subject|1|||
30741518|NCT00160563|58752583|FG001|Overall Study|Withdrawal by Subject|2|||
30741519|NCT00160563|58752584|FG002|Overall Study|Withdrawal by Subject|3|||
30741520|NCT00160563|58752582|FG000|Overall Study|Other (listed in the study report)|48|||
30741521|NCT00160563|58752583|FG001|Overall Study|Other (listed in the study report)|40|||
30741522|NCT00160563|58752584|FG002|Overall Study|Other (listed in the study report)|81|||
30741523|NCT00160563|58752582|FG000|Overall Study|Missing reason|0|||
30741524|NCT00160563|58752583|FG001|Overall Study|Missing reason|1|||
30741525|NCT00160563|58752584|FG002|Overall Study|Missing reason|0|||
30741526|NCT00380744|58752600|FG000|Overall Study|Death|0|||
30741527|NCT00380744|58752601|FG001|Overall Study|Death|0|||
30741528|NCT00380744|58752602|FG002|Overall Study|Death|0|||
30741529|NCT00380744|58752603|FG003|Overall Study|Death|0|||
30741530|NCT00380744|58752604|FG004|Overall Study|Death|0|||
30741531|NCT00380744|58752605|FG005|Overall Study|Death|0|||
30741532|NCT00380744|58752606|FG006|Overall Study|Death|1|||
30741533|NCT00380744|58752600|FG000|Overall Study|Withdrawal by Subject|1|||
30741534|NCT00380744|58752601|FG001|Overall Study|Withdrawal by Subject|0|||
30741535|NCT00380744|58752602|FG002|Overall Study|Withdrawal by Subject|0|||
30741536|NCT00380744|58752603|FG003|Overall Study|Withdrawal by Subject|0|||
30741537|NCT00380744|58752604|FG004|Overall Study|Withdrawal by Subject|0|||
30741538|NCT00380744|58752605|FG005|Overall Study|Withdrawal by Subject|0|||
30741539|NCT00380744|58752606|FG006|Overall Study|Withdrawal by Subject|0|||
30741540|NCT00380588|58752625|FG000|Overall Study|Unequivocal Disease Progression|25|||
30741541|NCT00380588|58752626|FG001|Overall Study|Unequivocal Disease Progression|34|||
30741542|NCT00380588|58752625|FG000|Overall Study|Next Cycle Not Started|4|||
30741543|NCT00380588|58752626|FG001|Overall Study|Next Cycle Not Started|0|||
30741544|NCT00380588|58752625|FG000|Overall Study|Adverse Event|7|||
30741545|NCT00380588|58752626|FG001|Overall Study|Adverse Event|3|||
30741546|NCT00380588|58752625|FG000|Overall Study|Withdrawal by Subject|1|||
30741547|NCT00380588|58752626|FG001|Overall Study|Withdrawal by Subject|3|||
30741548|NCT00380588|58752625|FG000|Overall Study|Physician Decision|2|||
30741549|NCT00380588|58752626|FG001|Overall Study|Physician Decision|0|||
30741550|NCT00379808|58752632|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
30741551|NCT00379808|58752633|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
30741552|NCT00355784|58752642|FG000|Overall Study|Withdrawal by Subject|0|||
30741553|NCT00355784|58752643|FG001|Overall Study|Withdrawal by Subject|0|||
30741554|NCT00355784|58752644|FG002|Overall Study|Withdrawal by Subject|2|||
30741555|NCT00355472|58752653|FG000|Overall Study|Physician Decision|1|||
30741556|NCT00492557|58752667|FG000|Overall Study|Subject request|12|||
30741557|NCT00492557|58752668|FG001|Overall Study|Subject request|11|||
30741558|NCT00492557|58752667|FG000|Overall Study|Protocol Violation|7|||
30741559|NCT00492557|58752668|FG001|Overall Study|Protocol Violation|8|||
30741560|NCT00492557|58752667|FG000|Overall Study|Other|2|||
30741561|NCT00492557|58752668|FG001|Overall Study|Other|2|||
30741562|NCT00492557|58752667|FG000|Overall Study|Death|1|||
30741563|NCT00492557|58752668|FG001|Overall Study|Death|1|||
30741564|NCT00492557|58752667|FG000|Overall Study|Adverse Event|1|||
30741565|NCT00492557|58752668|FG001|Overall Study|Adverse Event|0|||
30741566|NCT00492557|58752667|FG000|Overall Study|Failed to return|1|||
30901860|NCT01817530|58935746|FG000|Overall Study|Surgery or Invasive Intervention|1|||
30901861|NCT01817530|58935747|FG001|Overall Study|Surgery or Invasive Intervention|0|||
30901862|NCT01817530|58935748|FG002|Overall Study|Surgery or Invasive Intervention|0|||
30901863|NCT01817530|58935749|FG003|Overall Study|Surgery or Invasive Intervention|0|||
30741567|NCT00492557|58752668|FG001|Overall Study|Failed to return|0|||
30741568|NCT00492557|58752667|FG000|Overall Study|Lost to Follow-up|0|||
30741569|NCT00492557|58752668|FG001|Overall Study|Lost to Follow-up|1|||
30741570|NCT00508391|58752679|FG000|First Treatment|Withdrawal by Subject|6|||
30741571|NCT00508391|58752680|FG001|First Treatment|Withdrawal by Subject|3|||
30741572|NCT00508391|58752679|FG000|Second Treatment|Withdrawal by Subject|2|||
30741573|NCT00508391|58752680|FG001|Second Treatment|Withdrawal by Subject|0|||
30741574|NCT00508157|58752690|FG000|Overall Study|Adverse Event|0|||
30741575|NCT00508157|58752691|FG001|Overall Study|Adverse Event|1|||
30741576|NCT00508157|58752690|FG000|Overall Study|Subject Withdrew Consent|1|||
30741577|NCT00508157|58752691|FG001|Overall Study|Subject Withdrew Consent|0|||
30741578|NCT00508157|58752690|FG000|Overall Study|Lost to Follow-up|1|||
30741579|NCT00508157|58752691|FG001|Overall Study|Lost to Follow-up|0|||
30741580|NCT00508157|58752690|FG000|Overall Study|Subject no longer met study criteria|0|||
30741581|NCT00508157|58752691|FG001|Overall Study|Subject no longer met study criteria|1|||
30741582|NCT00508157|58752690|FG000|Overall Study|Other known cause|0|||
30741583|NCT00508157|58752691|FG001|Overall Study|Other known cause|1|||
30741584|NCT00378560|58752699|FG000|Overall Study|Adverse Event|1|||
30741585|NCT00378560|58752700|FG001|Overall Study|Adverse Event|0|||
30901864|NCT01817530|58935750|FG004|Overall Study|Surgery or Invasive Intervention|1|||
30901865|NCT01817530|58935751|FG005|Overall Study|Surgery or Invasive Intervention|1|||
30901866|NCT01817530|58935752|FG006|Overall Study|Surgery or Invasive Intervention|1|||
30901867|NCT01817530|58935753|FG007|Overall Study|Surgery or Invasive Intervention|0|||
30901868|NCT01817530|58935746|FG000|Overall Study|Consent Withdrawn by Subject|3|||
30901869|NCT01817530|58935747|FG001|Overall Study|Consent Withdrawn by Subject|4|||
30901870|NCT01817530|58935748|FG002|Overall Study|Consent Withdrawn by Subject|7|||
30901871|NCT01817530|58935749|FG003|Overall Study|Consent Withdrawn by Subject|3|||
30901872|NCT01817530|58935750|FG004|Overall Study|Consent Withdrawn by Subject|5|||
30741586|NCT00378560|58752699|FG000|Overall Study|Lost to Follow-up|24|||
30741587|NCT00378560|58752700|FG001|Overall Study|Lost to Follow-up|29|||
30741588|NCT00378560|58752699|FG000|Overall Study|Protocol Violation|2|||
30741589|NCT00378560|58752700|FG001|Overall Study|Protocol Violation|0|||
30741590|NCT00378560|58752699|FG000|Overall Study|Withdrawal by Subject|17|||
30741591|NCT00378560|58752700|FG001|Overall Study|Withdrawal by Subject|21|||
30741592|NCT00378560|58752699|FG000|Overall Study|Moved|4|||
30741593|NCT00378560|58752700|FG001|Overall Study|Moved|3|||
30741594|NCT00378560|58752699|FG000|Overall Study|Pregnancy|7|||
30741595|NCT00378560|58752700|FG001|Overall Study|Pregnancy|5|||
30741596|NCT00378560|58752699|FG000|Overall Study|Laboratory test values abnormal|1|||
30741597|NCT00378560|58752700|FG001|Overall Study|Laboratory test values abnormal|0|||
30741598|NCT00508001|58752709|FG000|Overall Study|Adverse Event|2|||
30741599|NCT00508001|58752710|FG001|Overall Study|Adverse Event|0|||
30741600|NCT00508001|58752711|FG002|Overall Study|Adverse Event|4|||
30741601|NCT00508001|58752709|FG000|Overall Study|condition under investigation worsened|13|||
30741602|NCT00508001|58752710|FG001|Overall Study|condition under investigation worsened|7|||
30741603|NCT00508001|58752711|FG002|Overall Study|condition under investigation worsened|1|||
30741604|NCT00508001|58752709|FG000|Overall Study|Death|0|||
30741605|NCT00508001|58752710|FG001|Overall Study|Death|1|||
30741606|NCT00508001|58752711|FG002|Overall Study|Death|1|||
30741607|NCT00508001|58752709|FG000|Overall Study|Withdrawal by Subject|4|||
30741608|NCT00508001|58752710|FG001|Overall Study|Withdrawal by Subject|4|||
30741609|NCT00508001|58752711|FG002|Overall Study|Withdrawal by Subject|1|||
30741610|NCT00507689|58752722|FG000|Pre-Randomization Period|Adverse Event|1|||
30741611|NCT00507689|58752723|FG001|Pre-Randomization Period|Adverse Event|0|||
30741612|NCT00507689|58752722|FG000|Pre-Randomization Period|Physician Decision|1|||
30741613|NCT00507689|58752723|FG001|Pre-Randomization Period|Physician Decision|0|||
30741614|NCT00507689|58752722|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
30741615|NCT00507689|58752723|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
30741616|NCT00507689|58752722|FG000|Randomized Period|Adverse Event|1|||
30741617|NCT00507689|58752723|FG001|Randomized Period|Adverse Event|1|||
30741618|NCT00507689|58752722|FG000|Randomized Period|Withdrawal by Subject|0|||
30741619|NCT00507689|58752723|FG001|Randomized Period|Withdrawal by Subject|1|||
30741620|NCT00491387|58752730|FG000|Overall Study|study terminated|20|||
30741621|NCT00491075|58752734|FG000|Overall Study|Withdrawal by Subject|1|||
30741622|NCT00491075|58752734|FG000|Overall Study|Physician Decision|1|||
30741623|NCT00507455|58752741|FG000|Overall Study|Adverse Event|3|||
30741624|NCT00507455|58752742|FG001|Overall Study|Adverse Event|3|||
30741625|NCT00507455|58752743|FG002|Overall Study|Adverse Event|6|||
30741626|NCT00507455|58752741|FG000|Overall Study|Withdrawal by Subject|2|||
30741627|NCT00507455|58752742|FG001|Overall Study|Withdrawal by Subject|1|||
30741628|NCT00507455|58752743|FG002|Overall Study|Withdrawal by Subject|2|||
30741629|NCT00507455|58752741|FG000|Overall Study|Protocol Violation|4|||
30741630|NCT00507455|58752742|FG001|Overall Study|Protocol Violation|1|||
30741631|NCT00507455|58752743|FG002|Overall Study|Protocol Violation|1|||
30741632|NCT00507455|58752741|FG000|Overall Study|Lost to Follow-up|2|||
30741633|NCT00507455|58752742|FG001|Overall Study|Lost to Follow-up|0|||
30741634|NCT00507455|58752743|FG002|Overall Study|Lost to Follow-up|2|||
30741635|NCT00507455|58752741|FG000|Overall Study|Lack of Efficacy|0|||
30741636|NCT00507455|58752742|FG001|Overall Study|Lack of Efficacy|1|||
30741637|NCT00507455|58752743|FG002|Overall Study|Lack of Efficacy|0|||
30741638|NCT00507455|58752741|FG000|Overall Study|Other - miscellaneous reason|1|||
30741639|NCT00507455|58752742|FG001|Overall Study|Other - miscellaneous reason|0|||
30741640|NCT00507455|58752743|FG002|Overall Study|Other - miscellaneous reason|1|||
30741641|NCT00506831|58752751|FG000|Overall Study|Death|1|||
30741642|NCT00506831|58752751|FG000|Overall Study|Withdrawal by Subject|1|||
30741643|NCT00506753|58752757|FG000|Overall Study|Lost to Follow-up|21|||
30741644|NCT00506753|58752758|FG001|Overall Study|Lost to Follow-up|15|||
30741645|NCT00490919|58752766|FG000|Open-label Run-in Period|Adverse Event|239|||
30741646|NCT00490919|58752767|FG001|Open-label Run-in Period|Adverse Event|0|||
30791012|NCT02742766|58804181|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30901873|NCT01817530|58935751|FG005|Overall Study|Consent Withdrawn by Subject|3|||
30901874|NCT01817530|58935752|FG006|Overall Study|Consent Withdrawn by Subject|3|||
30741647|NCT00490919|58752768|FG002|Open-label Run-in Period|Adverse Event|0|||
30741648|NCT00490919|58752766|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
30741649|NCT00490919|58752767|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
30741650|NCT00490919|58752768|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
30741651|NCT00490919|58752766|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
30741652|NCT00490919|58752767|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
30741653|NCT00490919|58752768|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
30741654|NCT00490919|58752766|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
30741655|NCT00490919|58752767|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
30741656|NCT00490919|58752768|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
30741657|NCT00490919|58752766|FG000|Open-label Run-in Period|Administrative|40|||
30741658|NCT00490919|58752767|FG001|Open-label Run-in Period|Administrative|0|||
30741659|NCT00490919|58752768|FG002|Open-label Run-in Period|Administrative|0|||
30741660|NCT00490919|58752766|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
30741661|NCT00490919|58752767|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
30741662|NCT00490919|58752768|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
30741663|NCT00490919|58752766|FG000|Double-blind Phase|Adverse Event|0|||
30741664|NCT00490919|58752767|FG001|Double-blind Phase|Adverse Event|40|||
30741665|NCT00490919|58752768|FG002|Double-blind Phase|Adverse Event|20|||
30901875|NCT01817530|58935753|FG007|Overall Study|Consent Withdrawn by Subject|10|||
30901876|NCT01817530|58935746|FG000|Overall Study|Lost to Follow-up|1|||
30901877|NCT01817530|58935747|FG001|Overall Study|Lost to Follow-up|4|||
30901878|NCT01817530|58935748|FG002|Overall Study|Lost to Follow-up|2|||
30901879|NCT01817530|58935749|FG003|Overall Study|Lost to Follow-up|1|||
30901880|NCT01817530|58935750|FG004|Overall Study|Lost to Follow-up|3|||
30741666|NCT00490919|58752766|FG000|Double-blind Phase|Withdrawal by Subject|0|||
30741667|NCT00490919|58752767|FG001|Double-blind Phase|Withdrawal by Subject|10|||
30741668|NCT00490919|58752768|FG002|Double-blind Phase|Withdrawal by Subject|11|||
30741669|NCT00490919|58752766|FG000|Double-blind Phase|Lost to Follow-up|0|||
30741670|NCT00490919|58752767|FG001|Double-blind Phase|Lost to Follow-up|8|||
30741671|NCT00490919|58752768|FG002|Double-blind Phase|Lost to Follow-up|11|||
30741672|NCT00490919|58752766|FG000|Double-blind Phase|Lack of Efficacy|0|||
30741673|NCT00490919|58752767|FG001|Double-blind Phase|Lack of Efficacy|22|||
30741674|NCT00490919|58752768|FG002|Double-blind Phase|Lack of Efficacy|36|||
30741675|NCT00490919|58752766|FG000|Double-blind Phase|Administrative|0|||
30741676|NCT00490919|58752767|FG001|Double-blind Phase|Administrative|6|||
30741677|NCT00490919|58752768|FG002|Double-blind Phase|Administrative|6|||
30741678|NCT00503867|58752775|FG000|Overall Study|Lost to Follow-up|1|||
30741679|NCT00503867|58752775|FG000|Overall Study|Adverse Event|1|||
30741680|NCT00503399|58752781|FG000|Overall Study|Death|2|||
30741681|NCT00503399|58752782|FG001|Overall Study|Death|1|||
30741682|NCT00503399|58752781|FG000|Overall Study|Protocol Violation|1|||
30741683|NCT00503399|58752782|FG001|Overall Study|Protocol Violation|0|||
30741684|NCT00503399|58752781|FG000|Overall Study|Withdrawal by Subject|4|||
30741685|NCT00503399|58752782|FG001|Overall Study|Withdrawal by Subject|2|||
30741686|NCT00503399|58752781|FG000|Overall Study|Adverse Event|0|||
30741687|NCT00503399|58752782|FG001|Overall Study|Adverse Event|3|||
30741688|NCT00503399|58752781|FG000|Overall Study|Lost to Follow-up|0|||
30741689|NCT00503399|58752782|FG001|Overall Study|Lost to Follow-up|2|||
30741690|NCT00506519|58752791|FG000|Overall Study|Death|4|||
30741691|NCT00506519|58752792|FG001|Overall Study|Death|6|||
30741692|NCT00506519|58752793|FG002|Overall Study|Death|0|||
30741693|NCT00506519|58752791|FG000|Overall Study|Adverse Event|1|||
30741694|NCT00506519|58752792|FG001|Overall Study|Adverse Event|0|||
30741695|NCT00506519|58752793|FG002|Overall Study|Adverse Event|0|||
30741696|NCT00503009|58752807|FG000|Overall Study|Protocol Violation|1|||
30741697|NCT00503009|58752808|FG001|Overall Study|Protocol Violation|0|||
30741698|NCT00503009|58752809|FG002|Overall Study|Protocol Violation|1|||
30741699|NCT00503009|58752807|FG000|Overall Study|Withdrawal by Subject|0|||
30741700|NCT00503009|58752808|FG001|Overall Study|Withdrawal by Subject|1|||
30741701|NCT00503009|58752809|FG002|Overall Study|Withdrawal by Subject|1|||
30741702|NCT00503009|58752807|FG000|Overall Study|Physician Decision|0|||
30741703|NCT00503009|58752808|FG001|Overall Study|Physician Decision|1|||
30741704|NCT00503009|58752809|FG002|Overall Study|Physician Decision|1|||
30741705|NCT00160251|58752823|FG000|Prior to Amendment 2|Adverse Event|2|||
30741706|NCT00160251|58752824|FG001|Prior to Amendment 2|Adverse Event|1|||
30741707|NCT00160251|58752825|FG002|Prior to Amendment 2|Adverse Event|3|||
30741708|NCT00160251|58752826|FG003|Prior to Amendment 2|Adverse Event|1|||
30741709|NCT00160251|58752827|FG004|Prior to Amendment 2|Adverse Event|1|||
30741710|NCT00160251|58752828|FG005|Prior to Amendment 2|Adverse Event|1|||
30741711|NCT00160251|58752829|FG006|Prior to Amendment 2|Adverse Event|1|||
30901881|NCT01817530|58935751|FG005|Overall Study|Lost to Follow-up|2|||
30901882|NCT01817530|58935752|FG006|Overall Study|Lost to Follow-up|8|||
30741712|NCT00160251|58752830|FG007|Prior to Amendment 2|Adverse Event|0|||
30741713|NCT00160251|58752823|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
30741714|NCT00160251|58752824|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
30741715|NCT00160251|58752825|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
30741716|NCT00160251|58752826|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
30741717|NCT00160251|58752827|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
30741718|NCT00160251|58752828|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
30741719|NCT00160251|58752829|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
30741720|NCT00160251|58752830|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
30741721|NCT00160251|58752823|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
30741722|NCT00160251|58752824|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
30741723|NCT00160251|58752825|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
30741724|NCT00160251|58752826|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
30741725|NCT00160251|58752827|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
30741726|NCT00160251|58752828|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
30741727|NCT00160251|58752829|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
30741728|NCT00160251|58752830|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
30741729|NCT00160251|58752823|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
30741730|NCT00160251|58752824|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
30741731|NCT00160251|58752825|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
30741732|NCT00160251|58752826|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
30741733|NCT00160251|58752827|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
30741734|NCT00160251|58752828|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
30741735|NCT00160251|58752829|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
30741736|NCT00160251|58752830|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
30741737|NCT00160251|58752823|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
30741738|NCT00160251|58752824|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
30741739|NCT00160251|58752825|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
30741740|NCT00160251|58752826|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
30741741|NCT00160251|58752827|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
30741742|NCT00160251|58752828|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
30741743|NCT00160251|58752829|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
30741744|NCT00160251|58752830|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
30741745|NCT00160251|58752823|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
30741746|NCT00160251|58752824|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
30741747|NCT00160251|58752825|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
30741748|NCT00160251|58752826|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
30741749|NCT00160251|58752827|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
30741750|NCT00160251|58752828|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
30741751|NCT00160251|58752829|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
30741752|NCT00160251|58752830|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
30741753|NCT00160251|58752823|FG000|Post-amendment 2|Adverse Event|0|||
30741754|NCT00160251|58752824|FG001|Post-amendment 2|Adverse Event|0|||
30741755|NCT00160251|58752825|FG002|Post-amendment 2|Adverse Event|0|||
30741756|NCT00160251|58752826|FG003|Post-amendment 2|Adverse Event|0|||
30741757|NCT00160251|58752827|FG004|Post-amendment 2|Adverse Event|0|||
30741758|NCT00160251|58752828|FG005|Post-amendment 2|Adverse Event|0|||
30741759|NCT00160251|58752829|FG006|Post-amendment 2|Adverse Event|0|||
30741760|NCT00160251|58752830|FG007|Post-amendment 2|Adverse Event|20|||
30741761|NCT00160251|58752823|FG000|Post-amendment 2|Lack of Efficacy|0|||
30741762|NCT00160251|58752824|FG001|Post-amendment 2|Lack of Efficacy|0|||
30741763|NCT00160251|58752825|FG002|Post-amendment 2|Lack of Efficacy|0|||
30741764|NCT00160251|58752826|FG003|Post-amendment 2|Lack of Efficacy|0|||
30741765|NCT00160251|58752827|FG004|Post-amendment 2|Lack of Efficacy|0|||
30741766|NCT00160251|58752828|FG005|Post-amendment 2|Lack of Efficacy|0|||
30741767|NCT00160251|58752829|FG006|Post-amendment 2|Lack of Efficacy|0|||
30741768|NCT00160251|58752830|FG007|Post-amendment 2|Lack of Efficacy|24|||
30741769|NCT00160251|58752823|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
30901883|NCT01817530|58935753|FG007|Overall Study|Lost to Follow-up|4|||
30901884|NCT01816984|58935771|FG000|Overall Study|declining health status|1|||
30901885|NCT01816906|58935777|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
30741770|NCT00160251|58752824|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
30741771|NCT00160251|58752825|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
30741772|NCT00160251|58752826|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
30741773|NCT00160251|58752827|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
30741774|NCT00160251|58752828|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
30741775|NCT00160251|58752829|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
30741776|NCT00160251|58752830|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
30741777|NCT00506441|58752887|FG000|Period 1; Open-label Period|Adverse Event|21|||
30741778|NCT00506441|58752888|FG001|Period 1; Open-label Period|Adverse Event|0|||
30741779|NCT00506441|58752887|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
30741780|NCT00506441|58752888|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
30741781|NCT00506441|58752887|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
30741782|NCT00506441|58752888|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
30741783|NCT00506441|58752887|FG000|Period 1; Open-label Period|Physician Decision|5|||
30741784|NCT00506441|58752888|FG001|Period 1; Open-label Period|Physician Decision|0|||
30741785|NCT00506441|58752887|FG000|Period 1; Open-label Period|Protocol Violation|9|||
30741786|NCT00506441|58752888|FG001|Period 1; Open-label Period|Protocol Violation|0|||
30901886|NCT01816906|58935778|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
30741787|NCT00506441|58752887|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
30741788|NCT00506441|58752888|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
30741789|NCT00506441|58752887|FG000|Period 1; Open-label Period|Other Reasons|13|||
30741790|NCT00506441|58752888|FG001|Period 1; Open-label Period|Other Reasons|0|||
30741791|NCT00506441|58752887|FG000|Period 2; Double-blind Period|Adverse Event|0|||
30741792|NCT00506441|58752888|FG001|Period 2; Double-blind Period|Adverse Event|1|||
30741793|NCT00506441|58752887|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
30741794|NCT00506441|58752888|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
30741795|NCT00506441|58752887|FG000|Period 2; Double-blind Period|Physician Decision|1|||
30741796|NCT00506441|58752888|FG001|Period 2; Double-blind Period|Physician Decision|1|||
30741797|NCT00506441|58752887|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
30741798|NCT00506441|58752888|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
30741799|NCT00506441|58752887|FG000|Period 2; Double-blind Period|Other Reason|1|||
30741800|NCT00506441|58752888|FG001|Period 2; Double-blind Period|Other Reason|1|||
30741801|NCT00378014|58752915|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
30741802|NCT00378014|58752916|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
30741803|NCT00378014|58752915|FG000|Core (Randomization to Month 11)|Graft loss|1|||
30741804|NCT00378014|58752916|FG001|Core (Randomization to Month 11)|Graft loss|2|||
30741805|NCT00378014|58752915|FG000|Core (Randomization to Month 11)|Death|5|||
30741806|NCT00378014|58752916|FG001|Core (Randomization to Month 11)|Death|3|||
30741807|NCT00378014|58752915|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
30741808|NCT00378014|58752916|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
30741809|NCT00378014|58752915|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
30741810|NCT00378014|58752916|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
30741811|NCT00378014|58752915|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
30741812|NCT00378014|58752916|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
30741813|NCT00378014|58752915|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
30741814|NCT00378014|58752916|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
30741815|NCT00378014|58752915|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
30741816|NCT00378014|58752916|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
30741817|NCT00378014|58752915|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
30741818|NCT00378014|58752916|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
30741819|NCT00378014|58752915|FG000|Extension (Month 12 to Month 59)|Death|1|||
30741820|NCT00378014|58752916|FG001|Extension (Month 12 to Month 59)|Death|2|||
30741821|NCT00378014|58752915|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
30741822|NCT00378014|58752916|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
30741823|NCT00378014|58752915|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
30741824|NCT00378014|58752916|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
30741825|NCT00378014|58752915|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
30741826|NCT00378014|58752916|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
30741827|NCT00378014|58752915|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
30741828|NCT00378014|58752916|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
30741829|NCT00485303|58752924|FG000|Overall Study|Adverse Event|5|||
30741830|NCT00485303|58752924|FG000|Overall Study|Progressive Disease|44|||
30741831|NCT00485303|58752924|FG000|Overall Study|Other|3|||
30741832|NCT00485303|58752924|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
30741833|NCT00485303|58752924|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
30741834|NCT00490841|58752928|FG000|Overall Study|Death|5|||
30741835|NCT00490841|58752928|FG000|Overall Study|Withdrawal by Subject|4|||
30741836|NCT00490841|58752928|FG000|Overall Study|Lost to Follow-up|1|||
30741837|NCT00490841|58752928|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
30741838|NCT00377858|58752935|FG000|Overall Study|Withdrawal by Subject|12|||
30741839|NCT00377858|58752936|FG001|Overall Study|Withdrawal by Subject|11|||
30741840|NCT00377858|58752935|FG000|Overall Study|Lost to Follow-up|6|||
30741841|NCT00377858|58752936|FG001|Overall Study|Lost to Follow-up|1|||
30741842|NCT00377858|58752935|FG000|Overall Study|Physician Decision|5|||
30741843|NCT00377858|58752936|FG001|Overall Study|Physician Decision|5|||
30741844|NCT00377858|58752935|FG000|Overall Study|Protocol Violation|3|||
30741845|NCT00377858|58752936|FG001|Overall Study|Protocol Violation|4|||
30741846|NCT00377858|58752935|FG000|Overall Study|Adverse Event|2|||
30741847|NCT00377858|58752936|FG001|Overall Study|Adverse Event|1|||
30741848|NCT00377858|58752935|FG000|Overall Study|Entry Criteria Not Met|2|||
30741849|NCT00377858|58752936|FG001|Overall Study|Entry Criteria Not Met|0|||
30741850|NCT00377858|58752935|FG000|Overall Study|Sponsor Decision|1|||
30741851|NCT00377858|58752936|FG001|Overall Study|Sponsor Decision|2|||
30741852|NCT00377858|58752935|FG000|Overall Study|Death|0|||
30741853|NCT00377858|58752936|FG001|Overall Study|Death|3|||
30741854|NCT00502775|58752945|FG000|Overall Study|Adverse Event|1|||
30741855|NCT00502775|58752946|FG001|Overall Study|Adverse Event|2|||
30741856|NCT00502775|58752947|FG002|Overall Study|Adverse Event|1|||
30741857|NCT00502775|58752945|FG000|Overall Study|Protocol Violation|1|||
30741858|NCT00502775|58752946|FG001|Overall Study|Protocol Violation|5|||
30741859|NCT00502775|58752947|FG002|Overall Study|Protocol Violation|2|||
30741860|NCT00502775|58752945|FG000|Overall Study|Withdrawal by Subject|1|||
30741861|NCT00502775|58752946|FG001|Overall Study|Withdrawal by Subject|1|||
30741862|NCT00502775|58752947|FG002|Overall Study|Withdrawal by Subject|2|||
30741863|NCT00502775|58752945|FG000|Overall Study|Sponsor Terminated Study|1|||
30741864|NCT00502775|58752946|FG001|Overall Study|Sponsor Terminated Study|0|||
30741865|NCT00502775|58752947|FG002|Overall Study|Sponsor Terminated Study|1|||
30741866|NCT00502775|58752945|FG000|Overall Study|Non-compliance with eDiary|4|||
30901887|NCT01816906|58935777|FG000|Six Months|Lost to Follow-up|14|||
30901888|NCT01816906|58935778|FG001|Six Months|Lost to Follow-up|16|||
30901889|NCT01816906|58935777|FG000|12 Months|Adverse Event|2|||
30741867|NCT00502775|58752946|FG001|Overall Study|Non-compliance with eDiary|1|||
30741868|NCT00502775|58752947|FG002|Overall Study|Non-compliance with eDiary|1|||
30741869|NCT00502775|58752945|FG000|Overall Study|Subject unable to swallow capsule|1|||
30741870|NCT00502775|58752946|FG001|Overall Study|Subject unable to swallow capsule|0|||
30741871|NCT00502775|58752947|FG002|Overall Study|Subject unable to swallow capsule|1|||
30741872|NCT00502775|58752945|FG000|Overall Study|Logpad compliance <80%|1|||
30741873|NCT00502775|58752946|FG001|Overall Study|Logpad compliance <80%|0|||
30741874|NCT00502775|58752947|FG002|Overall Study|Logpad compliance <80%|0|||
30741875|NCT00502775|58752945|FG000|Overall Study|Randomized in error|0|||
30741876|NCT00502775|58752946|FG001|Overall Study|Randomized in error|1|||
30741877|NCT00502775|58752947|FG002|Overall Study|Randomized in error|1|||
30741878|NCT00502775|58752945|FG000|Overall Study|Non-compliance|0|||
30741879|NCT00502775|58752946|FG001|Overall Study|Non-compliance|2|||
30741880|NCT00502775|58752947|FG002|Overall Study|Non-compliance|2|||
30741881|NCT00502775|58752945|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
30741882|NCT00502775|58752946|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
30741883|NCT00502775|58752947|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
30741884|NCT00502775|58752945|FG000|Overall Study|Declining pollen counts|0|||
30741885|NCT00502775|58752946|FG001|Overall Study|Declining pollen counts|1|||
30741886|NCT00502775|58752947|FG002|Overall Study|Declining pollen counts|1|||
30741887|NCT00502775|58752945|FG000|Overall Study|Subject in jail|0|||
30741888|NCT00502775|58752946|FG001|Overall Study|Subject in jail|1|||
30741889|NCT00502775|58752947|FG002|Overall Study|Subject in jail|0|||
30741890|NCT00502775|58752945|FG000|Overall Study|Subject took disallowed drug|0|||
30741891|NCT00502775|58752946|FG001|Overall Study|Subject took disallowed drug|0|||
30741892|NCT00502775|58752947|FG002|Overall Study|Subject took disallowed drug|1|||
30741893|NCT00502697|58752957|FG000|Overall Study|Withdrawal by Subject|3|||
30741894|NCT00502697|58752958|FG001|Overall Study|Withdrawal by Subject|1|||
30741895|NCT00502697|58752957|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
30741896|NCT00502697|58752958|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
30741897|NCT00502697|58752957|FG000|Overall Study|found not to meet eligibility criteria|3|||
30741898|NCT00502697|58752958|FG001|Overall Study|found not to meet eligibility criteria|4|||
30741899|NCT00502697|58752957|FG000|Overall Study|did not meet assignment criteria|4|||
30741900|NCT00502697|58752958|FG001|Overall Study|did not meet assignment criteria|2|||
30741901|NCT00485069|58752966|FG000|Overall Study|Adverse Event|10|||
30741902|NCT00485069|58752967|FG001|Overall Study|Adverse Event|4|||
30741903|NCT00485069|58752966|FG000|Overall Study|Lack of Efficacy|2|||
30741904|NCT00485069|58752967|FG001|Overall Study|Lack of Efficacy|1|||
30741905|NCT00485069|58752966|FG000|Overall Study|Protocol Violation|0|||
30741906|NCT00485069|58752967|FG001|Overall Study|Protocol Violation|1|||
30741907|NCT00485069|58752966|FG000|Overall Study|Withdrawal by Subject|6|||
30741908|NCT00485069|58752967|FG001|Overall Study|Withdrawal by Subject|6|||
30741909|NCT00355082|58752982|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
30741910|NCT00355082|58752983|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
30741911|NCT00355082|58752984|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
30741912|NCT00355082|58752982|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
30741913|NCT00355082|58752983|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
30741914|NCT00355082|58752984|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
30741915|NCT00355082|58752982|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
30741916|NCT00355082|58752983|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
30741917|NCT00355082|58752984|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
30741918|NCT00355082|58752982|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
30741919|NCT00355082|58752983|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
30741920|NCT00355082|58752984|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
30741921|NCT00355082|58752982|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
30741922|NCT00355082|58752983|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
30741923|NCT00355082|58752984|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
30741924|NCT00355082|58752982|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
30741925|NCT00355082|58752983|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
30741926|NCT00355082|58752984|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
30741927|NCT00355082|58752982|FG000|Continuation Phase|Adverse Event|2|||
30741928|NCT00355082|58752983|FG001|Continuation Phase|Adverse Event|0|||
30741929|NCT00355082|58752984|FG002|Continuation Phase|Adverse Event|1|||
30741930|NCT00355082|58752982|FG000|Continuation Phase|Lost to Follow-up|2|||
30741931|NCT00355082|58752983|FG001|Continuation Phase|Lost to Follow-up|0|||
30741932|NCT00355082|58752984|FG002|Continuation Phase|Lost to Follow-up|1|||
30741933|NCT00355082|58752982|FG000|Continuation Phase|Protocol Violation|1|||
30741934|NCT00355082|58752983|FG001|Continuation Phase|Protocol Violation|0|||
30741935|NCT00355082|58752984|FG002|Continuation Phase|Protocol Violation|1|||
30741936|NCT00355082|58752982|FG000|Continuation Phase|Withdrawal by Subject|4|||
30741937|NCT00355082|58752983|FG001|Continuation Phase|Withdrawal by Subject|0|||
30741938|NCT00355082|58752984|FG002|Continuation Phase|Withdrawal by Subject|0|||
30741939|NCT00355082|58752982|FG000|Continuation Phase|Lack of Efficacy|5|||
30741940|NCT00355082|58752983|FG001|Continuation Phase|Lack of Efficacy|0|||
30741941|NCT00355082|58752984|FG002|Continuation Phase|Lack of Efficacy|0|||
30741942|NCT00355082|58752982|FG000|Continuation Phase|Site Closed by Sponsor|8|||
30741943|NCT00355082|58752983|FG001|Continuation Phase|Site Closed by Sponsor|0|||
30741944|NCT00355082|58752984|FG002|Continuation Phase|Site Closed by Sponsor|0|||
30741945|NCT00355082|58752982|FG000|Continuation Phase|Scheduling Error|1|||
30741946|NCT00355082|58752983|FG001|Continuation Phase|Scheduling Error|0|||
30741947|NCT00355082|58752984|FG002|Continuation Phase|Scheduling Error|0|||
30741948|NCT00355082|58752982|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
30741949|NCT00355082|58752983|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
30741950|NCT00355082|58752984|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
30741951|NCT00502307|58752995|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
30741952|NCT00502307|58752996|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
30741953|NCT00502307|58752997|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
30741954|NCT00502307|58752995|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
30741955|NCT00502307|58752996|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
30741956|NCT00502307|58752997|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
30741957|NCT00502307|58752995|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
30741958|NCT00502307|58752996|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
30741959|NCT00502307|58752997|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
30741960|NCT00502307|58752995|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
30741961|NCT00502307|58752996|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
30741962|NCT00502307|58752997|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
30741963|NCT00502307|58752995|FG000|Maintenance Period|Progressive disease|80|||
30741964|NCT00502307|58752996|FG001|Maintenance Period|Progressive disease|0|||
30741965|NCT00502307|58752997|FG002|Maintenance Period|Progressive disease|0|||
30741966|NCT00502307|58752995|FG000|Maintenance Period|Discontinued due to other reasons|68|||
30741967|NCT00502307|58752996|FG001|Maintenance Period|Discontinued due to other reasons|0|||
30741968|NCT00502307|58752997|FG002|Maintenance Period|Discontinued due to other reasons|0|||
30741969|NCT00484679|58753014|FG000|Overall Study|Withdrawal by Subject|3|||
30741970|NCT00377312|58753020|FG000|Overall Study|Adverse Event|1|||
30741971|NCT00377312|58753021|FG001|Overall Study|Adverse Event|1|||
30741972|NCT00377234|58753029|FG000|Overall Study|Adverse Event|14|||
30741973|NCT00377234|58753030|FG001|Overall Study|Adverse Event|17|||
30741974|NCT00377234|58753029|FG000|Overall Study|Withdrawal by Subject|11|||
30741975|NCT00377234|58753030|FG001|Overall Study|Withdrawal by Subject|9|||
30741976|NCT00377234|58753029|FG000|Overall Study|Lost to Follow-up|4|||
30741977|NCT00377234|58753030|FG001|Overall Study|Lost to Follow-up|2|||
30741978|NCT00377234|58753029|FG000|Overall Study|Administrative|2|||
30741979|NCT00377234|58753030|FG001|Overall Study|Administrative|1|||
30741980|NCT00377234|58753029|FG000|Overall Study|Not assigned|3|||
30741981|NCT00377234|58753030|FG001|Overall Study|Not assigned|2|||
30741982|NCT00377156|58753044|FG000|Overall Study|Death|23|||
30741983|NCT00377156|58753045|FG001|Overall Study|Death|19|||
30741984|NCT00377156|58753044|FG000|Overall Study|Withdrawal by Subject|16|||
30741985|NCT00377156|58753045|FG001|Overall Study|Withdrawal by Subject|24|||
30741986|NCT00377156|58753044|FG000|Overall Study|Had follow-up <90 d|3|||
30741987|NCT00377156|58753045|FG001|Overall Study|Had follow-up <90 d|6|||
30741988|NCT00377156|58753044|FG000|Overall Study|Cancellation|1|||
30741989|NCT00377156|58753045|FG001|Overall Study|Cancellation|0|||
30741990|NCT00377156|58753044|FG000|Overall Study|Refused testing|0|||
30741991|NCT00377156|58753045|FG001|Overall Study|Refused testing|1|||
30741992|NCT00377156|58753044|FG000|Overall Study|Ineligible|0|||
30741993|NCT00377156|58753045|FG001|Overall Study|Ineligible|1|||
30741994|NCT00377156|58753044|FG000|Overall Study|Disability or language problem|0|||
30741995|NCT00377156|58753045|FG001|Overall Study|Disability or language problem|1|||
30741996|NCT00377156|58753044|FG000|Overall Study|Other|5|||
30741997|NCT00377156|58753045|FG001|Overall Study|Other|2|||
30741998|NCT00376688|58753053|FG000|Overall Study|Adverse Event|3|||
30741999|NCT00376688|58753053|FG000|Overall Study|Death|1|||
30742000|NCT00376532|58753059|FG000|Overall Study|Lack sufficient blood sample|6|||
30742001|NCT00376532|58753060|FG001|Overall Study|Lack sufficient blood sample|6|||
30742002|NCT00376220|58753068|FG000|Overall Study|Lost to Follow-up|7|||
30742003|NCT00376220|58753069|FG001|Overall Study|Lost to Follow-up|10|||
30742004|NCT00376220|58753068|FG000|Overall Study|Withdrawal by Subject|3|||
30742005|NCT00376220|58753069|FG001|Overall Study|Withdrawal by Subject|2|||
30742006|NCT00375752|58753077|FG000|Overall Study|Lack of Efficacy|4|||
30742007|NCT00375752|58753078|FG001|Overall Study|Lack of Efficacy|4|||
30742008|NCT00375752|58753077|FG000|Overall Study|Adverse Event|1|||
30742009|NCT00375752|58753078|FG001|Overall Study|Adverse Event|6|||
30901890|NCT01816906|58935778|FG001|12 Months|Adverse Event|2|||
30901891|NCT01816906|58935777|FG000|12 Months|Death|0|||
30901892|NCT01816906|58935778|FG001|12 Months|Death|2|||
30742010|NCT00375752|58753077|FG000|Overall Study|Withdrawal by Subject|6|||
30742011|NCT00375752|58753078|FG001|Overall Study|Withdrawal by Subject|1|||
30742012|NCT00375752|58753077|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
30742013|NCT00375752|58753078|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
30742014|NCT00375752|58753077|FG000|Overall Study|Protocol Violation|0|||
30742015|NCT00375752|58753078|FG001|Overall Study|Protocol Violation|2|||
30742016|NCT00375752|58753077|FG000|Overall Study|Administrative Problems|0|||
30742017|NCT00375752|58753078|FG001|Overall Study|Administrative Problems|1|||
30742018|NCT00484289|58753087|FG000|Long Term Phase|Adverse Event|1|||
30742019|NCT00484289|58753088|FG001|Long Term Phase|Adverse Event|17|||
30742020|NCT00484289|58753089|FG002|Long Term Phase|Adverse Event|5|||
30742021|NCT00484289|58753087|FG000|Long Term Phase|Withdrawal by Subject|0|||
30742022|NCT00484289|58753088|FG001|Long Term Phase|Withdrawal by Subject|7|||
30742023|NCT00484289|58753089|FG002|Long Term Phase|Withdrawal by Subject|6|||
30742024|NCT00484289|58753087|FG000|Long Term Phase|Inadequate response|2|||
30742025|NCT00484289|58753088|FG001|Long Term Phase|Inadequate response|7|||
30742026|NCT00484289|58753089|FG002|Long Term Phase|Inadequate response|4|||
30742027|NCT00484289|58753087|FG000|Long Term Phase|Other Reason|0|||
30742028|NCT00484289|58753088|FG001|Long Term Phase|Other Reason|5|||
30742029|NCT00484289|58753089|FG002|Long Term Phase|Other Reason|1|||
30742030|NCT00484289|58753087|FG000|Post Marketing Phase|Adverse Event|0|||
30742031|NCT00484289|58753088|FG001|Post Marketing Phase|Adverse Event|1|||
30742032|NCT00484289|58753089|FG002|Post Marketing Phase|Adverse Event|0|||
30742033|NCT00490529|58753098|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
30742034|NCT00490529|58753098|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
30901893|NCT01816906|58935777|FG000|12 Months|Lost to Follow-up|2|||
30901894|NCT01816906|58935778|FG001|12 Months|Lost to Follow-up|1|||
30901895|NCT01816594|58935787|FG000|Overall Study|Local Progress|0|||
30901896|NCT01816594|58935788|FG001|Overall Study|Local Progress|2|||
30901897|NCT01816594|58935787|FG000|Overall Study|Adverse Event|9|||
30901898|NCT01816594|58935788|FG001|Overall Study|Adverse Event|0|||
30901899|NCT01816594|58935787|FG000|Overall Study|Withdrawal by Subject|1|||
30901900|NCT01816594|58935788|FG001|Overall Study|Withdrawal by Subject|0|||
30901901|NCT01816594|58935787|FG000|Overall Study|Physician Decision|1|||
30901902|NCT01816594|58935788|FG001|Overall Study|Physician Decision|0|||
30622006|NCT01147068|58633524|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
30901903|NCT01802320|58935800|FG000|Overall Study|Death|1|||
30742035|NCT00490529|58753098|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
30742036|NCT00490529|58753098|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
30742037|NCT00490529|58753098|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
30742038|NCT00490529|58753098|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
30742039|NCT00333840|58753104|FG000|First-line Treatment Period|Adverse Event|38|||
30742040|NCT00333840|58753105|FG001|First-line Treatment Period|Adverse Event|37|||
30742041|NCT00333840|58753106|FG002|First-line Treatment Period|Adverse Event|0|||
30742042|NCT00333840|58753107|FG003|First-line Treatment Period|Adverse Event|0|||
30901904|NCT01802320|58935800|FG000|Overall Study|Withdrawal by Subject|1|||
30742043|NCT00333840|58753104|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
30742044|NCT00333840|58753105|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
30742045|NCT00333840|58753106|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
30742046|NCT00333840|58753107|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
30742047|NCT00333840|58753104|FG000|First-line Treatment Period|Abnormal procedure|2|||
30742048|NCT00333840|58753105|FG001|First-line Treatment Period|Abnormal procedure|0|||
30742049|NCT00333840|58753106|FG002|First-line Treatment Period|Abnormal procedure|0|||
30742050|NCT00333840|58753107|FG003|First-line Treatment Period|Abnormal procedure|0|||
30742051|NCT00333840|58753104|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
30742052|NCT00333840|58753105|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
30742053|NCT00333840|58753106|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
30742054|NCT00333840|58753107|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
30742055|NCT00333840|58753104|FG000|First-line Treatment Period|No longer required study drug|21|||
30742056|NCT00333840|58753105|FG001|First-line Treatment Period|No longer required study drug|8|||
30742057|NCT00333840|58753106|FG002|First-line Treatment Period|No longer required study drug|0|||
30742058|NCT00333840|58753107|FG003|First-line Treatment Period|No longer required study drug|0|||
30742059|NCT00333840|58753104|FG000|First-line Treatment Period|Protocol Violation|17|||
30742060|NCT00333840|58753105|FG001|First-line Treatment Period|Protocol Violation|17|||
30742061|NCT00333840|58753106|FG002|First-line Treatment Period|Protocol Violation|0|||
30742062|NCT00333840|58753107|FG003|First-line Treatment Period|Protocol Violation|0|||
30742063|NCT00333840|58753104|FG000|First-line Treatment Period|Subject withdrew consent|57|||
30742064|NCT00333840|58753105|FG001|First-line Treatment Period|Subject withdrew consent|77|||
30742065|NCT00333840|58753106|FG002|First-line Treatment Period|Subject withdrew consent|0|||
30742066|NCT00333840|58753107|FG003|First-line Treatment Period|Subject withdrew consent|0|||
30742067|NCT00333840|58753104|FG000|First-line Treatment Period|Lost to Follow-up|15|||
30742068|NCT00333840|58753105|FG001|First-line Treatment Period|Lost to Follow-up|6|||
30742069|NCT00333840|58753106|FG002|First-line Treatment Period|Lost to Follow-up|0|||
30742070|NCT00333840|58753107|FG003|First-line Treatment Period|Lost to Follow-up|0|||
30742071|NCT00333840|58753104|FG000|First-line Treatment Period|Administrative problems|12|||
30742072|NCT00333840|58753105|FG001|First-line Treatment Period|Administrative problems|6|||
30742073|NCT00333840|58753106|FG002|First-line Treatment Period|Administrative problems|0|||
30742074|NCT00333840|58753107|FG003|First-line Treatment Period|Administrative problems|0|||
30742075|NCT00333840|58753104|FG000|First-line Treatment Period|Death|19|||
30742076|NCT00333840|58753105|FG001|First-line Treatment Period|Death|2|||
30742077|NCT00333840|58753106|FG002|First-line Treatment Period|Death|0|||
30742078|NCT00333840|58753107|FG003|First-line Treatment Period|Death|0|||
30742079|NCT00333840|58753104|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
30742080|NCT00333840|58753105|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
30742081|NCT00333840|58753106|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
30742082|NCT00333840|58753107|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
30742083|NCT00333840|58753104|FG000|Second-line Treatment Period|Adverse Event|0|||
30742084|NCT00333840|58753105|FG001|Second-line Treatment Period|Adverse Event|0|||
30742085|NCT00333840|58753106|FG002|Second-line Treatment Period|Adverse Event|3|||
30742086|NCT00333840|58753107|FG003|Second-line Treatment Period|Adverse Event|34|||
30742087|NCT00333840|58753104|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
30742088|NCT00333840|58753105|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
30742089|NCT00333840|58753106|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
30742090|NCT00333840|58753107|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
30742091|NCT00333840|58753104|FG000|Second-line Treatment Period|Abnormal procedure|0|||
30742092|NCT00333840|58753105|FG001|Second-line Treatment Period|Abnormal procedure|0|||
30742093|NCT00333840|58753106|FG002|Second-line Treatment Period|Abnormal procedure|0|||
30742094|NCT00333840|58753107|FG003|Second-line Treatment Period|Abnormal procedure|1|||
30742095|NCT00333840|58753104|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
30742096|NCT00333840|58753105|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
30742097|NCT00333840|58753106|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
30742098|NCT00333840|58753107|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
30742099|NCT00333840|58753104|FG000|Second-line Treatment Period|No longer required study drug|0|||
30742100|NCT00333840|58753105|FG001|Second-line Treatment Period|No longer required study drug|0|||
30742101|NCT00333840|58753106|FG002|Second-line Treatment Period|No longer required study drug|1|||
30742102|NCT00333840|58753107|FG003|Second-line Treatment Period|No longer required study drug|14|||
30742103|NCT00333840|58753104|FG000|Second-line Treatment Period|Protocol Violation|0|||
30742104|NCT00333840|58753105|FG001|Second-line Treatment Period|Protocol Violation|0|||
30742105|NCT00333840|58753106|FG002|Second-line Treatment Period|Protocol Violation|1|||
30742106|NCT00333840|58753107|FG003|Second-line Treatment Period|Protocol Violation|10|||
30742107|NCT00333840|58753104|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
30742108|NCT00333840|58753105|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
30742109|NCT00333840|58753106|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
30742110|NCT00333840|58753107|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
30742111|NCT00333840|58753104|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
30742112|NCT00333840|58753105|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
30742113|NCT00333840|58753106|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
30901905|NCT02453711|58935813|FG000|Overall Study|Withdrawal by Subject|5|||
30742114|NCT00333840|58753107|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
30742115|NCT00333840|58753104|FG000|Second-line Treatment Period|Administrative problems|0|||
30742116|NCT00333840|58753105|FG001|Second-line Treatment Period|Administrative problems|0|||
30901906|NCT02453711|58935814|FG001|Overall Study|Withdrawal by Subject|4|||
30901907|NCT02453711|58935815|FG002|Overall Study|Withdrawal by Subject|6|||
30901908|NCT02453711|58935816|FG003|Overall Study|Withdrawal by Subject|4|||
30901909|NCT02453711|58935817|FG004|Overall Study|Withdrawal by Subject|1|||
30901910|NCT02453711|58935818|FG005|Overall Study|Withdrawal by Subject|1|||
30901911|NCT02453711|58935819|FG006|Overall Study|Withdrawal by Subject|0|||
30901912|NCT02453711|58935820|FG007|Overall Study|Withdrawal by Subject|1|||
30901913|NCT02453711|58935821|FG008|Overall Study|Withdrawal by Subject|7|||
30901914|NCT02453711|58935813|FG000|Overall Study|Lost to Follow-up|5|||
30901915|NCT02453711|58935814|FG001|Overall Study|Lost to Follow-up|3|||
30901916|NCT02453711|58935815|FG002|Overall Study|Lost to Follow-up|2|||
30901917|NCT02453711|58935816|FG003|Overall Study|Lost to Follow-up|3|||
30901918|NCT02453711|58935817|FG004|Overall Study|Lost to Follow-up|1|||
30901919|NCT02453711|58935818|FG005|Overall Study|Lost to Follow-up|5|||
30901920|NCT02453711|58935819|FG006|Overall Study|Lost to Follow-up|2|||
30901921|NCT02453711|58935820|FG007|Overall Study|Lost to Follow-up|6|||
30901922|NCT02453711|58935821|FG008|Overall Study|Lost to Follow-up|6|||
30901923|NCT02453711|58935813|FG000|Overall Study|Death|0|||
30901924|NCT02453711|58935814|FG001|Overall Study|Death|0|||
30901925|NCT02453711|58935815|FG002|Overall Study|Death|0|||
30901926|NCT02453711|58935816|FG003|Overall Study|Death|0|||
30901927|NCT02453711|58935817|FG004|Overall Study|Death|0|||
30901928|NCT02453711|58935818|FG005|Overall Study|Death|0|||
30901929|NCT02453711|58935819|FG006|Overall Study|Death|1|||
30901930|NCT02453711|58935820|FG007|Overall Study|Death|0|||
30901931|NCT02453711|58935821|FG008|Overall Study|Death|0|||
30901932|NCT02453711|58935813|FG000|Overall Study|Unclassified|1|||
30901933|NCT02453711|58935814|FG001|Overall Study|Unclassified|0|||
30901934|NCT02453711|58935815|FG002|Overall Study|Unclassified|1|||
30742117|NCT00333840|58753106|FG002|Second-line Treatment Period|Administrative problems|0|||
30742118|NCT00333840|58753107|FG003|Second-line Treatment Period|Administrative problems|7|||
30742119|NCT00333840|58753104|FG000|Second-line Treatment Period|Death|0|||
30742120|NCT00333840|58753105|FG001|Second-line Treatment Period|Death|0|||
30742121|NCT00333840|58753106|FG002|Second-line Treatment Period|Death|0|||
30742122|NCT00333840|58753107|FG003|Second-line Treatment Period|Death|9|||
30742123|NCT00490451|58753123|FG000|Overall Study|Adverse Event|3|||
30742124|NCT00490451|58753124|FG001|Overall Study|Adverse Event|3|||
30742125|NCT00490451|58753123|FG000|Overall Study|Death|3|||
30742126|NCT00490451|58753124|FG001|Overall Study|Death|1|||
30742127|NCT00490451|58753123|FG000|Overall Study|Withdrawal by Subject|2|||
30742128|NCT00490451|58753124|FG001|Overall Study|Withdrawal by Subject|0|||
30742129|NCT00490451|58753123|FG000|Overall Study|Investigator Decision|1|||
30742130|NCT00490451|58753124|FG001|Overall Study|Investigator Decision|0|||
30742131|NCT00490451|58753123|FG000|Overall Study|Protocol Violation|1|||
30742132|NCT00490451|58753124|FG001|Overall Study|Protocol Violation|0|||
30742133|NCT00490451|58753123|FG000|Overall Study|Progressive Disease|53|||
30742134|NCT00490451|58753124|FG001|Overall Study|Progressive Disease|34|||
30742135|NCT00321906|58753132|FG000|Overall Study|Adverse Event|36|||
30742136|NCT00321906|58753133|FG001|Overall Study|Adverse Event|44|||
30901935|NCT02453711|58935816|FG003|Overall Study|Unclassified|0|||
30901936|NCT02453711|58935817|FG004|Overall Study|Unclassified|0|||
30901937|NCT02453711|58935818|FG005|Overall Study|Unclassified|0|||
30901938|NCT02453711|58935819|FG006|Overall Study|Unclassified|0|||
30901939|NCT02453711|58935820|FG007|Overall Study|Unclassified|0|||
30901940|NCT02453711|58935821|FG008|Overall Study|Unclassified|0|||
30901941|NCT02453555|58935843|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
30742137|NCT00321906|58753132|FG000|Overall Study|Death|9|||
30901942|NCT02453555|58935844|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
30901943|NCT02453555|58935845|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
30901944|NCT02453555|58935846|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
30901945|NCT02453555|58935847|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
30742138|NCT00321906|58753133|FG001|Overall Study|Death|6|||
30742139|NCT00321906|58753132|FG000|Overall Study|Lost to Follow-up|1|||
30742140|NCT00321906|58753133|FG001|Overall Study|Lost to Follow-up|2|||
30742141|NCT00321906|58753132|FG000|Overall Study|Withdrawal by Subject|0|||
30742142|NCT00321906|58753133|FG001|Overall Study|Withdrawal by Subject|4|||
30742143|NCT00339144|58753142|FG000|Overall Study|Disease progression|5|||
30742144|NCT00339144|58753143|FG001|Overall Study|Disease progression|2|||
30742145|NCT00339144|58753144|FG002|Overall Study|Disease progression|2|||
30742146|NCT00339144|58753142|FG000|Overall Study|Study drug toxicity|3|||
30742147|NCT00339144|58753143|FG001|Overall Study|Study drug toxicity|1|||
30742148|NCT00339144|58753144|FG002|Overall Study|Study drug toxicity|1|||
30742149|NCT00339144|58753142|FG000|Overall Study|Participant's request to discontinuation|1|||
30742150|NCT00339144|58753143|FG001|Overall Study|Participant's request to discontinuation|0|||
30742151|NCT00339144|58753144|FG002|Overall Study|Participant's request to discontinuation|1|||
30742152|NCT00321828|58753153|FG000|Overall Study|Ineligible|3|||
30742153|NCT00321828|58753153|FG000|Overall Study|No follow up data|1|||
30742154|NCT00333138|58753160|FG000|Core Study (6 Months)|Adverse Event|4|||
30742155|NCT00333138|58753161|FG001|Core Study (6 Months)|Adverse Event|5|||
30742156|NCT00333138|58753162|FG002|Core Study (6 Months)|Adverse Event|8|||
30742157|NCT00333138|58753160|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
30742158|NCT00333138|58753161|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
30742159|NCT00333138|58753162|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
30742160|NCT00333138|58753160|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
30742161|NCT00333138|58753161|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
30742162|NCT00333138|58753162|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
30742163|NCT00333138|58753160|FG000|Core Study (6 Months)|Protocol Violation|1|||
30742164|NCT00333138|58753161|FG001|Core Study (6 Months)|Protocol Violation|0|||
30742165|NCT00333138|58753162|FG002|Core Study (6 Months)|Protocol Violation|1|||
30742166|NCT00333138|58753160|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
30742167|NCT00333138|58753161|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
30742168|NCT00333138|58753162|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
30742169|NCT00333138|58753160|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
30742170|NCT00333138|58753161|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
30742171|NCT00333138|58753162|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
30742172|NCT00333138|58753160|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
30742173|NCT00333138|58753161|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
30742174|NCT00333138|58753162|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
30742175|NCT00333138|58753160|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
30742176|NCT00333138|58753161|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
30742177|NCT00333138|58753162|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
30742178|NCT00333138|58753160|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
30742179|NCT00333138|58753161|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
30742180|NCT00333138|58753162|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
30742181|NCT00333138|58753160|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
30742182|NCT00333138|58753161|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
30742183|NCT00333138|58753162|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
30742184|NCT00333138|58753160|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
30742185|NCT00333138|58753161|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
30742186|NCT00333138|58753162|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
30742187|NCT00333138|58753160|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
30742188|NCT00333138|58753161|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
30742189|NCT00333138|58753162|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
30742190|NCT00333138|58753160|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
30742191|NCT00333138|58753161|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
30742192|NCT00333138|58753162|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
30742193|NCT00333138|58753160|FG000|Extension Study (Month6 to End of Study)|Death|0|||
30742194|NCT00333138|58753161|FG001|Extension Study (Month6 to End of Study)|Death|1|||
30742195|NCT00333138|58753162|FG002|Extension Study (Month6 to End of Study)|Death|0|||
30742196|NCT00332202|58753174|FG000|Overall Study|Adverse Event|72|||
30742197|NCT00332202|58753175|FG001|Overall Study|Adverse Event|28|||
30742198|NCT00332202|58753174|FG000|Overall Study|Lost to Follow-up|2|||
30742199|NCT00332202|58753175|FG001|Overall Study|Lost to Follow-up|1|||
30742200|NCT00332202|58753174|FG000|Overall Study|Physician Decision|6|||
30742201|NCT00332202|58753175|FG001|Overall Study|Physician Decision|8|||
30742202|NCT00332202|58753174|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
30742203|NCT00332202|58753175|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
30742204|NCT00332202|58753174|FG000|Overall Study|Protocol Violation|7|||
30791013|NCT02742766|58804182|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30742205|NCT00332202|58753175|FG001|Overall Study|Protocol Violation|2|||
30742206|NCT00332202|58753174|FG000|Overall Study|Sponsor Decision|1|||
30742207|NCT00332202|58753175|FG001|Overall Study|Sponsor Decision|2|||
30742208|NCT00332202|58753174|FG000|Overall Study|Withdrawal by Subject|36|||
30742209|NCT00332202|58753175|FG001|Overall Study|Withdrawal by Subject|17|||
30742210|NCT00332202|58753174|FG000|Overall Study|Progressive Disease|106|||
30742211|NCT00332202|58753175|FG001|Overall Study|Progressive Disease|60|||
30742212|NCT00332202|58753174|FG000|Overall Study|Death|5|||
30742213|NCT00332202|58753175|FG001|Overall Study|Death|2|||
30742214|NCT00331422|58753190|FG000|Overall Study|Did not receive entire study regimen|5|||
30742215|NCT00331344|58753195|FG000|Phase I|Adverse Event|0|||
30742216|NCT00331344|58753196|FG001|Phase I|Adverse Event|0|||
30742217|NCT00331344|58753197|FG002|Phase I|Adverse Event|0|||
30742218|NCT00331344|58753198|FG003|Phase I|Adverse Event|1|||
30742219|NCT00331344|58753199|FG004|Phase I|Adverse Event|2|||
30742220|NCT00331344|58753200|FG005|Phase I|Adverse Event|2|||
30742221|NCT00331344|58753201|FG006|Phase I|Adverse Event|0|||
30742222|NCT00331344|58753202|FG007|Phase I|Adverse Event|1|||
30742223|NCT00331344|58753203|FG008|Phase I|Adverse Event|0|||
30742224|NCT00331344|58753195|FG000|Phase II|Death|0|||
30742225|NCT00331344|58753196|FG001|Phase II|Death|0|||
30742226|NCT00331344|58753197|FG002|Phase II|Death|0|||
30742227|NCT00331344|58753198|FG003|Phase II|Death|0|||
30742228|NCT00331344|58753199|FG004|Phase II|Death|0|||
30742229|NCT00331344|58753200|FG005|Phase II|Death|0|||
30742230|NCT00331344|58753201|FG006|Phase II|Death|0|||
30742231|NCT00331344|58753202|FG007|Phase II|Death|0|||
30742232|NCT00331344|58753203|FG008|Phase II|Death|4|||
30742233|NCT00321672|58753220|FG000|Overall Study|Withdrawal by Subject|5|||
30742234|NCT00321672|58753221|FG001|Overall Study|Withdrawal by Subject|1|||
30742235|NCT00321672|58753222|FG002|Overall Study|Withdrawal by Subject|2|||
30901946|NCT02453555|58935848|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
30901947|NCT02453555|58935843|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
30901948|NCT02453555|58935844|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
30901949|NCT02453555|58935845|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
30901950|NCT02453555|58935846|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
30901951|NCT02453555|58935847|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
30901952|NCT02453555|58935848|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
30901953|NCT02453555|58935843|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
30901954|NCT02453555|58935844|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
30901955|NCT02453555|58935845|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
30901956|NCT02453555|58935846|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
30901957|NCT02453555|58935847|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
30901958|NCT02453555|58935848|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
30901959|NCT02453555|58935843|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
30901960|NCT02453555|58935844|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
30901961|NCT02453555|58935845|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
30901962|NCT02453555|58935846|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
30901963|NCT02453555|58935847|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
30901964|NCT02453555|58935848|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
30901965|NCT02453555|58935843|FG000|Extension Period|Adverse Event|0|||
30901966|NCT02453555|58935844|FG001|Extension Period|Adverse Event|0|||
30901967|NCT02453555|58935845|FG002|Extension Period|Adverse Event|1|||
30901968|NCT02453555|58935846|FG003|Extension Period|Adverse Event|2|||
30901969|NCT02453555|58935847|FG004|Extension Period|Adverse Event|1|||
30901970|NCT02453555|58935848|FG005|Extension Period|Adverse Event|1|||
30901971|NCT02453555|58935843|FG000|Extension Period|Protocol Violation|0|||
30901972|NCT02453555|58935844|FG001|Extension Period|Protocol Violation|0|||
30901973|NCT02453555|58935845|FG002|Extension Period|Protocol Violation|1|||
30901974|NCT02453555|58935846|FG003|Extension Period|Protocol Violation|0|||
30901975|NCT02453555|58935847|FG004|Extension Period|Protocol Violation|0|||
30901976|NCT02453555|58935848|FG005|Extension Period|Protocol Violation|0|||
30901977|NCT02453555|58935843|FG000|Extension Period|Withdrawal by Subject|0|||
30901978|NCT02453555|58935844|FG001|Extension Period|Withdrawal by Subject|0|||
30742236|NCT00321672|58753223|FG003|Overall Study|Withdrawal by Subject|0|||
30901979|NCT02453555|58935845|FG002|Extension Period|Withdrawal by Subject|1|||
30901980|NCT02453555|58935846|FG003|Extension Period|Withdrawal by Subject|0|||
30742237|NCT00321672|58753220|FG000|Overall Study|Noncompliance|1|||
30742238|NCT00321672|58753221|FG001|Overall Study|Noncompliance|2|||
30742239|NCT00321672|58753222|FG002|Overall Study|Noncompliance|1|||
30742240|NCT00321672|58753223|FG003|Overall Study|Noncompliance|0|||
30742241|NCT00321672|58753220|FG000|Overall Study|Adverse Event|1|||
30742242|NCT00321672|58753221|FG001|Overall Study|Adverse Event|1|||
30742243|NCT00321672|58753222|FG002|Overall Study|Adverse Event|0|||
30742244|NCT00321672|58753223|FG003|Overall Study|Adverse Event|0|||
30742245|NCT00321672|58753220|FG000|Overall Study|Lack of Efficacy|1|||
30901981|NCT02453555|58935847|FG004|Extension Period|Withdrawal by Subject|0|||
30901982|NCT02453555|58935848|FG005|Extension Period|Withdrawal by Subject|0|||
30901983|NCT02453321|58935861|FG000|Overall Study|Weakness|1|||
30901984|NCT02453321|58935862|FG001|Overall Study|Weakness|1|||
30901985|NCT02453321|58935863|FG002|Overall Study|Weakness|2|||
30742246|NCT00321672|58753221|FG001|Overall Study|Lack of Efficacy|1|||
30742247|NCT00321672|58753222|FG002|Overall Study|Lack of Efficacy|0|||
30742248|NCT00321672|58753223|FG003|Overall Study|Lack of Efficacy|0|||
30742249|NCT00321672|58753220|FG000|Overall Study|Lost to Follow-up|2|||
30742250|NCT00321672|58753221|FG001|Overall Study|Lost to Follow-up|0|||
30742251|NCT00321672|58753222|FG002|Overall Study|Lost to Follow-up|4|||
30742252|NCT00321672|58753223|FG003|Overall Study|Lost to Follow-up|2|||
30742253|NCT00321672|58753220|FG000|Overall Study|Death|1|||
30742254|NCT00321672|58753221|FG001|Overall Study|Death|0|||
30742255|NCT00321672|58753222|FG002|Overall Study|Death|0|||
30742256|NCT00321672|58753223|FG003|Overall Study|Death|0|||
30742257|NCT00321672|58753220|FG000|Overall Study|Too far to travel for visits|1|||
30742258|NCT00321672|58753221|FG001|Overall Study|Too far to travel for visits|0|||
30742259|NCT00321672|58753222|FG002|Overall Study|Too far to travel for visits|0|||
30742260|NCT00321672|58753223|FG003|Overall Study|Too far to travel for visits|0|||
30901986|NCT02453321|58935861|FG000|Overall Study|Deep Venous Thrombosis|0|||
30901987|NCT02453321|58935862|FG001|Overall Study|Deep Venous Thrombosis|1|||
30901988|NCT02453321|58935863|FG002|Overall Study|Deep Venous Thrombosis|0|||
30901989|NCT01610284|58935876|FG000|Randomization Phase|Adverse Event|1|||
30901990|NCT01610284|58935877|FG001|Randomization Phase|Adverse Event|0|||
30901991|NCT01610284|58935876|FG000|Randomization Phase|Physician Decision|1|||
30901992|NCT01610284|58935877|FG001|Randomization Phase|Physician Decision|1|||
30901993|NCT01610284|58935876|FG000|Randomization Phase|Death|0|||
30901994|NCT01610284|58935877|FG001|Randomization Phase|Death|1|||
30901995|NCT01610284|58935876|FG000|Treatment Phase|Adverse Event|80|||
30901996|NCT01610284|58935877|FG001|Treatment Phase|Adverse Event|12|||
30901997|NCT01610284|58935876|FG000|Treatment Phase|Lost to Follow-up|1|||
30901998|NCT01610284|58935877|FG001|Treatment Phase|Lost to Follow-up|0|||
30901999|NCT01610284|58935876|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
30902000|NCT01610284|58935877|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
30902001|NCT01610284|58935876|FG000|Treatment Phase|Physician Decision|27|||
30742261|NCT00321672|58753220|FG000|Overall Study|Incarcerated|0|||
30742262|NCT00321672|58753221|FG001|Overall Study|Incarcerated|0|||
30742263|NCT00321672|58753222|FG002|Overall Study|Incarcerated|2|||
30742264|NCT00321672|58753223|FG003|Overall Study|Incarcerated|0|||
30742265|NCT00321672|58753220|FG000|Overall Study|Moved out of state|0|||
30742266|NCT00321672|58753221|FG001|Overall Study|Moved out of state|1|||
30742267|NCT00321672|58753222|FG002|Overall Study|Moved out of state|1|||
30742268|NCT00321672|58753223|FG003|Overall Study|Moved out of state|0|||
30742269|NCT00321672|58753220|FG000|Overall Study|Protocol Violation|0|||
30742270|NCT00321672|58753221|FG001|Overall Study|Protocol Violation|0|||
30742271|NCT00321672|58753222|FG002|Overall Study|Protocol Violation|1|||
30742272|NCT00321672|58753223|FG003|Overall Study|Protocol Violation|0|||
30742273|NCT00321672|58753220|FG000|Overall Study|Diagnosis of testicular cancer|0|||
30742274|NCT00321672|58753221|FG001|Overall Study|Diagnosis of testicular cancer|1|||
30742275|NCT00321672|58753222|FG002|Overall Study|Diagnosis of testicular cancer|0|||
30742276|NCT00321672|58753223|FG003|Overall Study|Diagnosis of testicular cancer|0|||
30742277|NCT00321672|58753220|FG000|Overall Study|Extensive travel required for new job|0|||
30742278|NCT00321672|58753221|FG001|Overall Study|Extensive travel required for new job|1|||
30742279|NCT00321672|58753222|FG002|Overall Study|Extensive travel required for new job|0|||
30742280|NCT00321672|58753223|FG003|Overall Study|Extensive travel required for new job|0|||
30742281|NCT00321048|58753239|FG000|Overall Study|Withdrawal by Subject|6|||
30742282|NCT00321048|58753240|FG001|Overall Study|Withdrawal by Subject|8|||
30742283|NCT00330174|58753248|FG000|Overall Study|Withdrawal by Subject|7|||
30742284|NCT00330174|58753249|FG001|Overall Study|Withdrawal by Subject|7|||
30742285|NCT00330174|58753248|FG000|Overall Study|Lost to Follow-up|4|||
30742286|NCT00330174|58753249|FG001|Overall Study|Lost to Follow-up|1|||
30742287|NCT00330174|58753248|FG000|Overall Study|Clinical deterioration|1|||
30742288|NCT00330174|58753249|FG001|Overall Study|Clinical deterioration|2|||
30902002|NCT01610284|58935877|FG001|Treatment Phase|Physician Decision|24|||
30902003|NCT01610284|58935876|FG000|Treatment Phase|Progressive Disease|377|||
30902004|NCT01610284|58935877|FG001|Treatment Phase|Progressive Disease|486|||
30902005|NCT01610284|58935876|FG000|Treatment Phase|Protocol Deviation|2|||
30902006|NCT01610284|58935877|FG001|Treatment Phase|Protocol Deviation|3|||
30902007|NCT01610284|58935876|FG000|Treatment Phase|Study terminated by Sponsor|18|||
30742289|NCT00330174|58753248|FG000|Overall Study|Excessive missed visits|3|||
30742290|NCT00330174|58753249|FG001|Overall Study|Excessive missed visits|8|||
30742291|NCT00330174|58753248|FG000|Overall Study|Miscellaneous reasons|7|||
30742292|NCT00330174|58753249|FG001|Overall Study|Miscellaneous reasons|1|||
30742293|NCT00320424|58753255|FG000|Overall Study|Adverse Event|3|||
30902008|NCT01610284|58935877|FG001|Treatment Phase|Study terminated by Sponsor|15|||
30902009|NCT01610284|58935876|FG000|Treatment Phase|Subject/Guardian Decision|55|||
30902010|NCT01610284|58935877|FG001|Treatment Phase|Subject/Guardian Decision|23|||
30902011|NCT01610284|58935876|FG000|Treatment Phase|Death|6|||
30902012|NCT01610284|58935877|FG001|Treatment Phase|Death|5|||
30902013|NCT01610284|58935876|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
30902014|NCT01610284|58935877|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
30902015|NCT01610284|58935876|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
30902016|NCT01610284|58935877|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
30742294|NCT00320424|58753255|FG000|Overall Study|Other|3|||
30742295|NCT00338286|58753261|FG000|Overall Study|Withdrawal by Subject|50|||
30742296|NCT00338286|58753262|FG001|Overall Study|Withdrawal by Subject|54|||
30742297|NCT00338286|58753261|FG000|Overall Study|Lost to Follow-up|80|||
30742298|NCT00338286|58753262|FG001|Overall Study|Lost to Follow-up|66|||
30742299|NCT00338286|58753261|FG000|Overall Study|Other|103|||
30742300|NCT00338286|58753262|FG001|Overall Study|Other|93|||
30742301|NCT00329784|58753272|FG000|Overall Study|Lost to Follow-up|0|||
30742302|NCT00329784|58753273|FG001|Overall Study|Lost to Follow-up|1|||
30742303|NCT00329784|58753274|FG002|Overall Study|Lost to Follow-up|0|||
30742304|NCT00329784|58753275|FG003|Overall Study|Lost to Follow-up|0|||
30742305|NCT00329784|58753272|FG000|Overall Study|Withdrawal by Subject|4|||
30742306|NCT00329784|58753273|FG001|Overall Study|Withdrawal by Subject|2|||
30742307|NCT00329784|58753274|FG002|Overall Study|Withdrawal by Subject|0|||
30742308|NCT00329784|58753275|FG003|Overall Study|Withdrawal by Subject|0|||
30742309|NCT00329784|58753272|FG000|Overall Study|Other|1|||
30742310|NCT00329784|58753273|FG001|Overall Study|Other|2|||
30742311|NCT00329784|58753274|FG002|Overall Study|Other|0|||
30742312|NCT00329784|58753275|FG003|Overall Study|Other|0|||
30742313|NCT00337818|58753290|FG000|Overall Study|Lost to Follow-up|289|||
30742314|NCT00337818|58753291|FG001|Overall Study|Lost to Follow-up|91|||
30902017|NCT01610284|58935876|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
30742315|NCT00337818|58753292|FG002|Overall Study|Lost to Follow-up|107|||
30902018|NCT01610284|58935877|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
30742316|NCT00329550|58753303|FG000|Overall Study|Adverse Event|3|||
30742317|NCT00329550|58753304|FG001|Overall Study|Adverse Event|4|||
30742318|NCT00329550|58753305|FG002|Overall Study|Adverse Event|2|||
30742319|NCT00329550|58753303|FG000|Overall Study|Withdrawal of Consent|1|||
30902019|NCT01610284|58935876|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
30742320|NCT00329550|58753304|FG001|Overall Study|Withdrawal of Consent|0|||
30742321|NCT00329550|58753305|FG002|Overall Study|Withdrawal of Consent|1|||
30742322|NCT00329550|58753303|FG000|Overall Study|Due to Relocation|0|||
30742323|NCT00329550|58753304|FG001|Overall Study|Due to Relocation|0|||
30742324|NCT00329550|58753305|FG002|Overall Study|Due to Relocation|1|||
30742325|NCT00375674|58753317|FG000|Overall Study|Other|26|||
30742326|NCT00375674|58753318|FG001|Overall Study|Other|18|||
30742327|NCT00375674|58753317|FG000|Overall Study|Death|67|||
30742328|NCT00375674|58753318|FG001|Overall Study|Death|76|||
30742329|NCT00375674|58753317|FG000|Overall Study|Participants refused further follow-up|31|||
30742330|NCT00375674|58753318|FG001|Overall Study|Participants refused further follow-up|30|||
30742331|NCT00375674|58753317|FG000|Overall Study|Lost to Follow-up|17|||
30742332|NCT00375674|58753318|FG001|Overall Study|Lost to Follow-up|15|||
30742333|NCT00375674|58753317|FG000|Overall Study|Enrolled but not treated|3|||
30742334|NCT00375674|58753318|FG001|Overall Study|Enrolled but not treated|2|||
30742335|NCT00350402|58753326|FG000|Overall Study|Lost to Follow-up|1|||
30742336|NCT00350402|58753327|FG001|Overall Study|Lost to Follow-up|1|||
30742337|NCT00320190|58753341|FG000|First 12 Months|Completed but did not enter extension|5|||
30742338|NCT00320190|58753342|FG001|First 12 Months|Completed but did not enter extension|3|||
30742339|NCT00320190|58753341|FG000|First 12 Months|Sponsor terminated study|2|||
30742340|NCT00320190|58753342|FG001|First 12 Months|Sponsor terminated study|2|||
30742341|NCT00320190|58753341|FG000|First 12 Months|Lost to Follow-up|0|||
30742342|NCT00320190|58753342|FG001|First 12 Months|Lost to Follow-up|1|||
30742343|NCT00320190|58753341|FG000|First 12 Months|Enrollment failure|0|||
30742344|NCT00320190|58753342|FG001|First 12 Months|Enrollment failure|1|||
30742345|NCT00320190|58753341|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
30742346|NCT00320190|58753342|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
30742347|NCT00320190|58753341|FG000|First 12 Months|Investigator request|0|||
30742348|NCT00320190|58753342|FG001|First 12 Months|Investigator request|1|||
30742349|NCT00320190|58753341|FG000|First 12 Months|Study drug toxicity|0|||
30742350|NCT00320190|58753342|FG001|First 12 Months|Study drug toxicity|1|||
30742351|NCT00320190|58753341|FG000|First 12 Months|Withdrawal by Subject|0|||
30742352|NCT00320190|58753342|FG001|First 12 Months|Withdrawal by Subject|1|||
30742353|NCT00320190|58753341|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
30742354|NCT00320190|58753342|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
30742355|NCT00320190|58753341|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
30742356|NCT00320190|58753342|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
30742357|NCT00320190|58753341|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
30742358|NCT00320190|58753342|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
30742359|NCT00320112|58753350|FG000|Overall Study|Lost to Follow-up|3|||
30742360|NCT00320112|58753351|FG001|Overall Study|Lost to Follow-up|4|||
30742361|NCT00320112|58753350|FG000|Overall Study|Withdrawal by Subject|3|||
30742362|NCT00320112|58753351|FG001|Overall Study|Withdrawal by Subject|0|||
30742363|NCT00320112|58753350|FG000|Overall Study|Death|2|||
30742364|NCT00320112|58753351|FG001|Overall Study|Death|1|||
30742365|NCT00319956|58753365|FG000|Overall Study|Death|20|||
30742366|NCT00319956|58753366|FG001|Overall Study|Death|24|||
30742367|NCT00349622|58753374|FG000|Overall Study|Death|168|||
30742368|NCT00349622|58753375|FG001|Overall Study|Death|86|||
30742369|NCT00349622|58753374|FG000|Overall Study|Lost to Follow-up|5|||
30742370|NCT00349622|58753375|FG001|Overall Study|Lost to Follow-up|1|||
30742371|NCT00349622|58753374|FG000|Overall Study|Withdrawal by Subject|5|||
30742372|NCT00349622|58753375|FG001|Overall Study|Withdrawal by Subject|9|||
30742373|NCT00354614|58753381|FG000|Overall Study|Lack of Efficacy|28|||
30742374|NCT00360308|58753388|FG000|Overall Study|Adverse Event|15|||
30742375|NCT00360308|58753389|FG001|Overall Study|Adverse Event|14|||
30742376|NCT00360308|58753390|FG002|Overall Study|Adverse Event|25|||
30742377|NCT00360308|58753388|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
30742378|NCT00360308|58753389|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
30742379|NCT00360308|58753390|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
30742380|NCT00360308|58753388|FG000|Overall Study|Protocol Violation|2|||
30742381|NCT00360308|58753389|FG001|Overall Study|Protocol Violation|1|||
30742382|NCT00360308|58753390|FG002|Overall Study|Protocol Violation|2|||
30742383|NCT00360308|58753388|FG000|Overall Study|Withdrawal by Subject|11|||
30742384|NCT00360308|58753389|FG001|Overall Study|Withdrawal by Subject|7|||
30742385|NCT00360308|58753390|FG002|Overall Study|Withdrawal by Subject|14|||
30742386|NCT00360308|58753388|FG000|Overall Study|Lack of Efficacy|3|||
30742387|NCT00360308|58753389|FG001|Overall Study|Lack of Efficacy|0|||
30742388|NCT00360308|58753390|FG002|Overall Study|Lack of Efficacy|2|||
30742389|NCT00360308|58753388|FG000|Overall Study|Other|2|||
30742390|NCT00360308|58753389|FG001|Overall Study|Other|1|||
30742391|NCT00360308|58753390|FG002|Overall Study|Other|1|||
30742392|NCT00360308|58753388|FG000|Overall Study|Study termination by sponsor|43|||
30742393|NCT00360308|58753389|FG001|Overall Study|Study termination by sponsor|55|||
30742394|NCT00360308|58753390|FG002|Overall Study|Study termination by sponsor|44|||
30742395|NCT00348686|58753402|FG000|Overall Study|Withdrawal by Subject|45|||
30742396|NCT00348686|58753402|FG000|Overall Study|Adverse Event|5|||
30742397|NCT00348686|58753402|FG000|Overall Study|Protocol Violation|6|||
30742398|NCT00348686|58753402|FG000|Overall Study|Lost to Follow-up|2|||
30742399|NCT00348686|58753402|FG000|Overall Study|Multiple Reasons|8|||
30742400|NCT00360230|58753413|FG000|Overall Study|Withdrawal by Subject|1|||
30742401|NCT00360230|58753414|FG001|Overall Study|Withdrawal by Subject|1|||
30742402|NCT00360230|58753415|FG002|Overall Study|Withdrawal by Subject|0|||
30742403|NCT00360230|58753416|FG003|Overall Study|Withdrawal by Subject|1|||
30742404|NCT00360230|58753417|FG004|Overall Study|Withdrawal by Subject|1|||
30742405|NCT00360230|58753418|FG005|Overall Study|Withdrawal by Subject|1|||
30742406|NCT00360230|58753419|FG006|Overall Study|Withdrawal by Subject|0|||
30742407|NCT00360230|58753413|FG000|Overall Study|Migrated|4|||
30742408|NCT00360230|58753414|FG001|Overall Study|Migrated|1|||
30742409|NCT00360230|58753415|FG002|Overall Study|Migrated|3|||
30742410|NCT00360230|58753416|FG003|Overall Study|Migrated|1|||
30742411|NCT00360230|58753417|FG004|Overall Study|Migrated|4|||
30742412|NCT00360230|58753418|FG005|Overall Study|Migrated|1|||
30742413|NCT00360230|58753419|FG006|Overall Study|Migrated|1|||
30742414|NCT00360230|58753413|FG000|Overall Study|Other|1|||
30742415|NCT00360230|58753414|FG001|Overall Study|Other|0|||
30742416|NCT00360230|58753415|FG002|Overall Study|Other|0|||
30742417|NCT00360230|58753416|FG003|Overall Study|Other|0|||
30742418|NCT00360230|58753417|FG004|Overall Study|Other|0|||
30742419|NCT00360230|58753418|FG005|Overall Study|Other|0|||
30742420|NCT00360230|58753419|FG006|Overall Study|Other|0|||
30742421|NCT00360230|58753413|FG000|Overall Study|Protocol Violation|0|||
30742422|NCT00360230|58753414|FG001|Overall Study|Protocol Violation|0|||
30742423|NCT00360230|58753415|FG002|Overall Study|Protocol Violation|0|||
30742424|NCT00360230|58753416|FG003|Overall Study|Protocol Violation|0|||
30742425|NCT00360230|58753417|FG004|Overall Study|Protocol Violation|0|||
30742426|NCT00360230|58753418|FG005|Overall Study|Protocol Violation|1|||
30742427|NCT00360230|58753419|FG006|Overall Study|Protocol Violation|0|||
30742428|NCT00360230|58753413|FG000|Overall Study|Death|0|||
30742429|NCT00360230|58753414|FG001|Overall Study|Death|1|||
30742430|NCT00360230|58753415|FG002|Overall Study|Death|0|||
30742431|NCT00360230|58753416|FG003|Overall Study|Death|0|||
30742432|NCT00360230|58753417|FG004|Overall Study|Death|0|||
30742433|NCT00360230|58753418|FG005|Overall Study|Death|1|||
30742434|NCT00360230|58753419|FG006|Overall Study|Death|1|||
30742435|NCT00348374|58753439|FG000|Overall Study|Adverse Event|1|||
30742436|NCT00348374|58753440|FG001|Overall Study|Adverse Event|4|||
30742437|NCT00348374|58753439|FG000|Overall Study|Lost to Follow-up|1|||
30742438|NCT00348374|58753440|FG001|Overall Study|Lost to Follow-up|3|||
30742439|NCT00348374|58753439|FG000|Overall Study|Withdrawal by Subject|5|||
30742440|NCT00348374|58753440|FG001|Overall Study|Withdrawal by Subject|5|||
30742441|NCT00348374|58753439|FG000|Overall Study|Other|11|||
30742442|NCT00348374|58753440|FG001|Overall Study|Other|12|||
30742443|NCT00348374|58753439|FG000|Overall Study|ongoing at date of cutoff|1|||
30742444|NCT00348374|58753440|FG001|Overall Study|ongoing at date of cutoff|1|||
30742445|NCT00348374|58753439|FG000|Overall Study|randomized but did not receive treatment|0|||
30742446|NCT00348374|58753440|FG001|Overall Study|randomized but did not receive treatment|7|||
30742447|NCT00353366|58753447|FG000|Overall Study|Adverse Event|8|||
30742448|NCT00353366|58753447|FG000|Overall Study|Protocol Violation|12|||
30742449|NCT00353366|58753447|FG000|Overall Study|Withdrawal by Subject|12|||
30742450|NCT00353366|58753447|FG000|Overall Study|Lost to Follow-up|92|||
30742451|NCT00353366|58753447|FG000|Overall Study|Other|19|||
30742452|NCT00352664|58753453|FG000|Overall Study|Withdrawal by Subject|7|||
30742453|NCT00352664|58753454|FG001|Overall Study|Withdrawal by Subject|0|||
30742454|NCT00490139|58753464|FG000|Overall Study|Death|106|||
30742455|NCT00490139|58753465|FG001|Overall Study|Death|119|||
30742456|NCT00490139|58753466|FG002|Overall Study|Death|168|||
30742457|NCT00490139|58753467|FG003|Overall Study|Death|135|||
30742458|NCT00490139|58753464|FG000|Overall Study|Lost to Follow-up|56|||
30742459|NCT00490139|58753465|FG001|Overall Study|Lost to Follow-up|46|||
30742460|NCT00490139|58753466|FG002|Overall Study|Lost to Follow-up|58|||
30742461|NCT00490139|58753467|FG003|Overall Study|Lost to Follow-up|56|||
30742462|NCT00490139|58753464|FG000|Overall Study|Participant Withdrew Consent|146|||
30742463|NCT00490139|58753465|FG001|Overall Study|Participant Withdrew Consent|110|||
30742464|NCT00490139|58753466|FG002|Overall Study|Participant Withdrew Consent|208|||
30742465|NCT00490139|58753467|FG003|Overall Study|Participant Withdrew Consent|116|||
30742466|NCT00348140|58753482|FG000|Overall Study|Adverse Event|46|||
30742467|NCT00348140|58753483|FG001|Overall Study|Adverse Event|49|||
30742468|NCT00348140|58753484|FG002|Overall Study|Adverse Event|78|||
30742469|NCT00348140|58753482|FG000|Overall Study|Lost to Follow-up|4|||
30742470|NCT00348140|58753483|FG001|Overall Study|Lost to Follow-up|4|||
30742471|NCT00348140|58753484|FG002|Overall Study|Lost to Follow-up|4|||
30742472|NCT00348140|58753482|FG000|Overall Study|Protocol Violation|12|||
30742473|NCT00348140|58753483|FG001|Overall Study|Protocol Violation|13|||
30742474|NCT00348140|58753484|FG002|Overall Study|Protocol Violation|14|||
30742475|NCT00348140|58753482|FG000|Overall Study|Withdrawal by Subject|32|||
30742476|NCT00348140|58753483|FG001|Overall Study|Withdrawal by Subject|40|||
30742477|NCT00348140|58753484|FG002|Overall Study|Withdrawal by Subject|40|||
30742478|NCT00348140|58753482|FG000|Overall Study|Non-compliance|8|||
30742479|NCT00348140|58753483|FG001|Overall Study|Non-compliance|13|||
30742480|NCT00348140|58753484|FG002|Overall Study|Non-compliance|5|||
30742481|NCT00348140|58753482|FG000|Overall Study|Participant at risk due to study drug|2|||
30742482|NCT00348140|58753483|FG001|Overall Study|Participant at risk due to study drug|0|||
30742483|NCT00348140|58753484|FG002|Overall Study|Participant at risk due to study drug|0|||
30742484|NCT00348140|58753482|FG000|Overall Study|Conditional medication increased dose|1|||
30742485|NCT00348140|58753483|FG001|Overall Study|Conditional medication increased dose|0|||
30742486|NCT00348140|58753484|FG002|Overall Study|Conditional medication increased dose|0|||
30742487|NCT00348140|58753482|FG000|Overall Study|Caregiver related|4|||
30742488|NCT00348140|58753483|FG001|Overall Study|Caregiver related|7|||
30742489|NCT00348140|58753484|FG002|Overall Study|Caregiver related|3|||
30742490|NCT00348140|58753482|FG000|Overall Study|Participant hospitalised|3|||
30742491|NCT00348140|58753483|FG001|Overall Study|Participant hospitalised|0|||
30742492|NCT00348140|58753484|FG002|Overall Study|Participant hospitalised|0|||
30742493|NCT00348140|58753482|FG000|Overall Study|Efficacy related|1|||
30742494|NCT00348140|58753483|FG001|Overall Study|Efficacy related|1|||
30742495|NCT00348140|58753484|FG002|Overall Study|Efficacy related|0|||
30742496|NCT00348140|58753482|FG000|Overall Study|Administration related|3|||
30742497|NCT00348140|58753483|FG001|Overall Study|Administration related|1|||
30742498|NCT00348140|58753484|FG002|Overall Study|Administration related|1|||
30742499|NCT00348140|58753482|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
30742500|NCT00348140|58753483|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
30742501|NCT00348140|58753484|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
30742502|NCT00348140|58753482|FG000|Overall Study|Participant unwell|1|||
30742503|NCT00348140|58753483|FG001|Overall Study|Participant unwell|0|||
30742504|NCT00348140|58753484|FG002|Overall Study|Participant unwell|0|||
30742505|NCT00348140|58753482|FG000|Overall Study|Screen failure|1|||
30742506|NCT00348140|58753483|FG001|Overall Study|Screen failure|0|||
30742507|NCT00348140|58753484|FG002|Overall Study|Screen failure|0|||
30742508|NCT00348140|58753482|FG000|Overall Study|Investigator decided to discontinue|4|||
30742509|NCT00348140|58753483|FG001|Overall Study|Investigator decided to discontinue|1|||
30742510|NCT00348140|58753484|FG002|Overall Study|Investigator decided to discontinue|4|||
30742511|NCT00348140|58753482|FG000|Overall Study|Decided to discontinue on their own|1|||
30742512|NCT00348140|58753483|FG001|Overall Study|Decided to discontinue on their own|4|||
30742513|NCT00348140|58753484|FG002|Overall Study|Decided to discontinue on their own|1|||
30742514|NCT00348140|58753482|FG000|Overall Study|Use of prohibited drug|1|||
30742515|NCT00348140|58753483|FG001|Overall Study|Use of prohibited drug|0|||
30742516|NCT00348140|58753484|FG002|Overall Study|Use of prohibited drug|2|||
30742517|NCT00348140|58753482|FG000|Overall Study|Disease progression|1|||
30742518|NCT00348140|58753483|FG001|Overall Study|Disease progression|2|||
30742519|NCT00348140|58753484|FG002|Overall Study|Disease progression|5|||
30742520|NCT00348140|58753482|FG000|Overall Study|Increased risk of cardiac infarction|0|||
30742521|NCT00348140|58753483|FG001|Overall Study|Increased risk of cardiac infarction|1|||
30742522|NCT00348140|58753484|FG002|Overall Study|Increased risk of cardiac infarction|0|||
30742523|NCT00348140|58753482|FG000|Overall Study|Serious adverse event|0|||
30742524|NCT00348140|58753483|FG001|Overall Study|Serious adverse event|1|||
30742525|NCT00348140|58753484|FG002|Overall Study|Serious adverse event|0|||
30742526|NCT00348140|58753482|FG000|Overall Study|Abnormal ECG|0|||
30742527|NCT00348140|58753483|FG001|Overall Study|Abnormal ECG|1|||
30742528|NCT00348140|58753484|FG002|Overall Study|Abnormal ECG|3|||
30742529|NCT00348140|58753482|FG000|Overall Study|Participant died|0|||
30742530|NCT00348140|58753483|FG001|Overall Study|Participant died|1|||
30742531|NCT00348140|58753484|FG002|Overall Study|Participant died|0|||
30742532|NCT00348140|58753482|FG000|Overall Study|Exclusion criteria met|0|||
30742533|NCT00348140|58753483|FG001|Overall Study|Exclusion criteria met|0|||
30742534|NCT00348140|58753484|FG002|Overall Study|Exclusion criteria met|1|||
30742535|NCT00348140|58753482|FG000|Overall Study|Memory declined|0|||
30742536|NCT00348140|58753483|FG001|Overall Study|Memory declined|0|||
30742537|NCT00348140|58753484|FG002|Overall Study|Memory declined|1|||
30742538|NCT00490061|58753493|FG000|Overall Study|Physician Decision|1|||
30742539|NCT00483119|58753499|FG000|Overall Study|Adverse Event|0|||
30742540|NCT00483119|58753500|FG001|Overall Study|Adverse Event|1|||
30742541|NCT00483119|58753499|FG000|Overall Study|Physician Decision|1|||
30742542|NCT00483119|58753500|FG001|Overall Study|Physician Decision|0|||
30742543|NCT00483041|58753508|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
30742544|NCT00483041|58753509|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
30742545|NCT00501293|58753517|FG000|Optimization Period|Enrolled in error|1|||
30742546|NCT00501293|58753518|FG001|Optimization Period|Enrolled in error|0|||
30742547|NCT00501293|58753517|FG000|Maintenance Period|Withdrawal by Subject|14|||
30742548|NCT00501293|58753518|FG001|Maintenance Period|Withdrawal by Subject|13|||
30742549|NCT00501293|58753517|FG000|Maintenance Period|Lost to Follow-up|12|||
30742550|NCT00501293|58753518|FG001|Maintenance Period|Lost to Follow-up|7|||
30742551|NCT00501293|58753517|FG000|Maintenance Period|Adverse Event|6|||
30742552|NCT00501293|58753518|FG001|Maintenance Period|Adverse Event|6|||
30742553|NCT00501293|58753517|FG000|Maintenance Period|Protocol Violation|2|||
30742554|NCT00501293|58753518|FG001|Maintenance Period|Protocol Violation|1|||
30742555|NCT00501293|58753517|FG000|Maintenance Period|Lack of Efficacy|4|||
30742556|NCT00501293|58753518|FG001|Maintenance Period|Lack of Efficacy|1|||
30742557|NCT00501293|58753517|FG000|Maintenance Period|Noncompliant with study medication|5|||
30742558|NCT00501293|58753518|FG001|Maintenance Period|Noncompliant with study medication|0|||
30742559|NCT00501293|58753517|FG000|Maintenance Period|Went into rehabilitation|1|||
30742560|NCT00501293|58753518|FG001|Maintenance Period|Went into rehabilitation|0|||
30742561|NCT00501293|58753517|FG000|Maintenance Period|Would not wear patch|1|||
30742562|NCT00501293|58753518|FG001|Maintenance Period|Would not wear patch|0|||
30742563|NCT00501293|58753517|FG000|Maintenance Period|Application site reaction|1|||
30742564|NCT00501293|58753518|FG001|Maintenance Period|Application site reaction|0|||
30742565|NCT00482729|58753527|FG000|Overall Study|Adverse Event|29|||
30742566|NCT00482729|58753528|FG001|Overall Study|Adverse Event|33|||
30742567|NCT00482729|58753527|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
30742568|NCT00482729|58753528|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
30742569|NCT00482729|58753527|FG000|Overall Study|Hyperglycemia Criteria|7|||
30742570|NCT00482729|58753528|FG001|Overall Study|Hyperglycemia Criteria|5|||
30742571|NCT00482729|58753527|FG000|Overall Study|Lack of Efficacy|4|||
30742572|NCT00482729|58753528|FG001|Overall Study|Lack of Efficacy|16|||
30742573|NCT00482729|58753527|FG000|Overall Study|Lost to Follow-up|86|||
30742574|NCT00482729|58753528|FG001|Overall Study|Lost to Follow-up|66|||
30742575|NCT00482729|58753527|FG000|Overall Study|Physician Decision|10|||
30742576|NCT00482729|58753528|FG001|Overall Study|Physician Decision|7|||
30742577|NCT00482729|58753527|FG000|Overall Study|Pregnancy|4|||
30742578|NCT00482729|58753528|FG001|Overall Study|Pregnancy|2|||
30742579|NCT00482729|58753527|FG000|Overall Study|Protocol Violation|10|||
30742580|NCT00482729|58753528|FG001|Overall Study|Protocol Violation|18|||
30742581|NCT00482729|58753527|FG000|Overall Study|Withdrawal by Subject|67|||
30742582|NCT00482729|58753528|FG001|Overall Study|Withdrawal by Subject|69|||
30742583|NCT00359762|58753536|FG000|Period II|Adverse Event|17|||
30742584|NCT00359762|58753537|FG001|Period II|Adverse Event|0|||
30742585|NCT00359762|58753538|FG002|Period II|Adverse Event|0|||
30742586|NCT00359762|58753539|FG003|Period II|Adverse Event|0|||
30742587|NCT00359762|58753540|FG004|Period II|Adverse Event|49|||
30742588|NCT00359762|58753536|FG000|Period II|Protocol Violation|18|||
30742589|NCT00359762|58753537|FG001|Period II|Protocol Violation|0|||
30742590|NCT00359762|58753538|FG002|Period II|Protocol Violation|0|||
30742591|NCT00359762|58753539|FG003|Period II|Protocol Violation|0|||
30742592|NCT00359762|58753540|FG004|Period II|Protocol Violation|11|||
30742593|NCT00359762|58753536|FG000|Period II|Physician Decision|17|||
30742594|NCT00359762|58753537|FG001|Period II|Physician Decision|0|||
30742595|NCT00359762|58753538|FG002|Period II|Physician Decision|0|||
30742596|NCT00359762|58753539|FG003|Period II|Physician Decision|0|||
30742597|NCT00359762|58753540|FG004|Period II|Physician Decision|23|||
30742598|NCT00359762|58753536|FG000|Period II|Death|2|||
30742599|NCT00359762|58753537|FG001|Period II|Death|0|||
30742600|NCT00359762|58753538|FG002|Period II|Death|0|||
30742601|NCT00359762|58753539|FG003|Period II|Death|0|||
30742602|NCT00359762|58753540|FG004|Period II|Death|4|||
30742603|NCT00359762|58753536|FG000|Period II|Lack of Efficacy|11|||
30742604|NCT00359762|58753537|FG001|Period II|Lack of Efficacy|0|||
30742605|NCT00359762|58753538|FG002|Period II|Lack of Efficacy|0|||
30742606|NCT00359762|58753539|FG003|Period II|Lack of Efficacy|0|||
30742607|NCT00359762|58753540|FG004|Period II|Lack of Efficacy|8|||
30742608|NCT00359762|58753536|FG000|Period II|Lost to follow up|5|||
30742609|NCT00359762|58753537|FG001|Period II|Lost to follow up|0|||
30742610|NCT00359762|58753538|FG002|Period II|Lost to follow up|0|||
30742611|NCT00359762|58753539|FG003|Period II|Lost to follow up|0|||
30742612|NCT00359762|58753540|FG004|Period II|Lost to follow up|5|||
30742613|NCT00359762|58753536|FG000|Period II|Entry Criteria Not Met|8|||
30742614|NCT00359762|58753537|FG001|Period II|Entry Criteria Not Met|0|||
30742615|NCT00359762|58753538|FG002|Period II|Entry Criteria Not Met|0|||
30742616|NCT00359762|58753539|FG003|Period II|Entry Criteria Not Met|0|||
30742617|NCT00359762|58753540|FG004|Period II|Entry Criteria Not Met|4|||
30742618|NCT00359762|58753536|FG000|Period II|Subject Decision|50|||
30742619|NCT00359762|58753537|FG001|Period II|Subject Decision|0|||
30742620|NCT00359762|58753538|FG002|Period II|Subject Decision|0|||
30742621|NCT00359762|58753539|FG003|Period II|Subject Decision|0|||
30742622|NCT00359762|58753540|FG004|Period II|Subject Decision|70|||
30742623|NCT00359762|58753536|FG000|Period III|Protocol Violation|0|||
30742624|NCT00359762|58753537|FG001|Period III|Protocol Violation|5|||
30742625|NCT00359762|58753538|FG002|Period III|Protocol Violation|3|||
30742626|NCT00359762|58753539|FG003|Period III|Protocol Violation|8|||
30742627|NCT00359762|58753540|FG004|Period III|Protocol Violation|0|||
30742628|NCT00359762|58753536|FG000|Period III|Adverse Event|0|||
30742629|NCT00359762|58753537|FG001|Period III|Adverse Event|3|||
30742630|NCT00359762|58753538|FG002|Period III|Adverse Event|4|||
30742631|NCT00359762|58753539|FG003|Period III|Adverse Event|10|||
30742632|NCT00359762|58753540|FG004|Period III|Adverse Event|0|||
30742633|NCT00359762|58753536|FG000|Period III|Physician Decision|0|||
30742634|NCT00359762|58753537|FG001|Period III|Physician Decision|5|||
30742635|NCT00359762|58753538|FG002|Period III|Physician Decision|9|||
30742636|NCT00359762|58753539|FG003|Period III|Physician Decision|15|||
30742637|NCT00359762|58753540|FG004|Period III|Physician Decision|0|||
30742638|NCT00359762|58753536|FG000|Period III|Lack of Efficacy|0|||
30742639|NCT00359762|58753537|FG001|Period III|Lack of Efficacy|7|||
30742640|NCT00359762|58753538|FG002|Period III|Lack of Efficacy|5|||
30742641|NCT00359762|58753539|FG003|Period III|Lack of Efficacy|9|||
30742642|NCT00359762|58753540|FG004|Period III|Lack of Efficacy|0|||
30742643|NCT00359762|58753536|FG000|Period III|Lost to follow up|0|||
30742644|NCT00359762|58753537|FG001|Period III|Lost to follow up|1|||
30742645|NCT00359762|58753538|FG002|Period III|Lost to follow up|1|||
30742646|NCT00359762|58753539|FG003|Period III|Lost to follow up|2|||
30742647|NCT00359762|58753540|FG004|Period III|Lost to follow up|0|||
30742648|NCT00359762|58753536|FG000|Period III|Entry Criteria Not Met|0|||
30742649|NCT00359762|58753537|FG001|Period III|Entry Criteria Not Met|1|||
30742650|NCT00359762|58753538|FG002|Period III|Entry Criteria Not Met|0|||
30742651|NCT00359762|58753539|FG003|Period III|Entry Criteria Not Met|1|||
30742652|NCT00359762|58753540|FG004|Period III|Entry Criteria Not Met|0|||
30742653|NCT00359762|58753536|FG000|Period III|Subject Decision|0|||
30742654|NCT00359762|58753537|FG001|Period III|Subject Decision|7|||
30742655|NCT00359762|58753538|FG002|Period III|Subject Decision|8|||
30742656|NCT00359762|58753539|FG003|Period III|Subject Decision|20|||
30742657|NCT00359762|58753540|FG004|Period III|Subject Decision|0|||
30742658|NCT00347438|58753554|FG000|Overall Study|Withdrawal by Subject|1|||
30742659|NCT00347438|58753554|FG000|Overall Study|Physician Decision|1|||
30742660|NCT00329238|58753560|FG000|Overall Study|Adverse Event|147|||
30742661|NCT00329238|58753561|FG001|Overall Study|Adverse Event|129|||
30742662|NCT00329238|58753560|FG000|Overall Study|Protocol Violation|23|||
30742663|NCT00329238|58753561|FG001|Overall Study|Protocol Violation|34|||
30742664|NCT00329238|58753560|FG000|Overall Study|Lost to Follow-up|2|||
30742665|NCT00329238|58753561|FG001|Overall Study|Lost to Follow-up|6|||
30742666|NCT00329238|58753560|FG000|Overall Study|Withdrawal by Subject|64|||
30742667|NCT00329238|58753561|FG001|Overall Study|Withdrawal by Subject|58|||
30742668|NCT00329238|58753560|FG000|Overall Study|Other reason (not specified)|40|||
30742669|NCT00329238|58753561|FG001|Overall Study|Other reason (not specified)|54|||
30742670|NCT00329160|58753569|FG000|Overall Study|Adverse Event|27|||
30742671|NCT00329160|58753569|FG000|Overall Study|Withdrawal by Subject|13|||
30742672|NCT00329160|58753569|FG000|Overall Study|Protocol Violation|2|||
30742673|NCT00329160|58753569|FG000|Overall Study|Did not Receive Study Drug|1|||
30742674|NCT00329160|58753569|FG000|Overall Study|Incomplete IVUS|45|||
30742675|NCT00328926|58753576|FG000|Overall Study|Pregnancy|2|||
30742676|NCT00328926|58753577|FG001|Overall Study|Pregnancy|1|||
30742677|NCT00328926|58753578|FG002|Overall Study|Pregnancy|0|||
30742678|NCT00328926|58753576|FG000|Overall Study|Lost to Follow-up|0|||
30742679|NCT00328926|58753577|FG001|Overall Study|Lost to Follow-up|1|||
30742680|NCT00328926|58753578|FG002|Overall Study|Lost to Follow-up|0|||
30742681|NCT00328926|58753576|FG000|Overall Study|Death|0|||
30742682|NCT00328926|58753577|FG001|Overall Study|Death|0|||
30742683|NCT00328926|58753578|FG002|Overall Study|Death|1|||
30742684|NCT00328926|58753576|FG000|Overall Study|In vitro fertilization treatment|0|||
30742685|NCT00328926|58753577|FG001|Overall Study|In vitro fertilization treatment|0|||
30742686|NCT00328926|58753578|FG002|Overall Study|In vitro fertilization treatment|1|||
30742687|NCT00328926|58753576|FG000|Overall Study|Lack of ovarian response|0|||
30742688|NCT00328926|58753577|FG001|Overall Study|Lack of ovarian response|1|||
30742689|NCT00328926|58753578|FG002|Overall Study|Lack of ovarian response|0|||
30742690|NCT00319254|58753586|FG000|Overall Study|Withdrawal by Subject|4|||
30742691|NCT00319254|58753586|FG000|Overall Study|Death|46|||
30742692|NCT00319254|58753586|FG000|Overall Study|Lost to Follow-up|2|||
30742693|NCT00319254|58753586|FG000|Overall Study|Enrolled, Not Treated|2|||
30742694|NCT00319098|58753594|FG000|Overall Study|Serious adverse event|3|||
30742695|NCT00319098|58753595|FG001|Overall Study|Serious adverse event|0|||
30742696|NCT00319098|58753594|FG000|Overall Study|Adverse Event|20|||
30742697|NCT00319098|58753595|FG001|Overall Study|Adverse Event|1|||
30742698|NCT00319098|58753594|FG000|Overall Study|Withdrawal by Subject|37|||
30742699|NCT00319098|58753595|FG001|Overall Study|Withdrawal by Subject|8|||
30742700|NCT00319098|58753594|FG000|Overall Study|Migrated/moved from study area|2|||
30742701|NCT00319098|58753595|FG001|Overall Study|Migrated/moved from study area|1|||
30742702|NCT00319098|58753594|FG000|Overall Study|Lost to Follow-up|37|||
30742703|NCT00319098|58753595|FG001|Overall Study|Lost to Follow-up|13|||
30791014|NCT02742766|58804183|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30742704|NCT00319098|58753594|FG000|Overall Study|Others|33|||
30742705|NCT00319098|58753595|FG001|Overall Study|Others|8|||
30742706|NCT00319098|58753594|FG000|Overall Study|Protocol Violation|3|||
30742707|NCT00319098|58753595|FG001|Overall Study|Protocol Violation|1|||
30742708|NCT00347360|58753620|FG000|Overall Study|Adverse Event|1|||
30742709|NCT00347360|58753621|FG001|Overall Study|Adverse Event|2|||
30742710|NCT00347360|58753622|FG002|Overall Study|Adverse Event|0|||
30742711|NCT00347360|58753623|FG003|Overall Study|Adverse Event|4|||
30742712|NCT00347360|58753624|FG004|Overall Study|Adverse Event|1|||
30742713|NCT00347360|58753625|FG005|Overall Study|Adverse Event|2|||
30742714|NCT00347360|58753626|FG006|Overall Study|Adverse Event|2|||
30742715|NCT00347360|58753627|FG007|Overall Study|Adverse Event|0|||
30742716|NCT00347360|58753628|FG008|Overall Study|Adverse Event|2|||
30742717|NCT00347360|58753629|FG009|Overall Study|Adverse Event|3|||
30742718|NCT00347360|58753630|FG010|Overall Study|Adverse Event|3|||
30742719|NCT00347360|58753631|FG011|Overall Study|Adverse Event|1|||
30742720|NCT00347360|58753632|FG012|Overall Study|Adverse Event|3|||
30742721|NCT00347360|58753633|FG013|Overall Study|Adverse Event|2|||
30742722|NCT00347360|58753634|FG014|Overall Study|Adverse Event|2|||
30742723|NCT00347360|58753620|FG000|Overall Study|Lost to Follow-up|0|||
30742724|NCT00347360|58753621|FG001|Overall Study|Lost to Follow-up|0|||
30742725|NCT00347360|58753622|FG002|Overall Study|Lost to Follow-up|0|||
30742726|NCT00347360|58753623|FG003|Overall Study|Lost to Follow-up|2|||
30742727|NCT00347360|58753624|FG004|Overall Study|Lost to Follow-up|1|||
30742728|NCT00347360|58753625|FG005|Overall Study|Lost to Follow-up|1|||
30742729|NCT00347360|58753626|FG006|Overall Study|Lost to Follow-up|0|||
30742730|NCT00347360|58753627|FG007|Overall Study|Lost to Follow-up|1|||
30742731|NCT00347360|58753628|FG008|Overall Study|Lost to Follow-up|1|||
30742732|NCT00347360|58753629|FG009|Overall Study|Lost to Follow-up|2|||
30742733|NCT00347360|58753630|FG010|Overall Study|Lost to Follow-up|0|||
30742734|NCT00347360|58753631|FG011|Overall Study|Lost to Follow-up|0|||
30742735|NCT00347360|58753632|FG012|Overall Study|Lost to Follow-up|1|||
30742736|NCT00347360|58753633|FG013|Overall Study|Lost to Follow-up|0|||
30742737|NCT00347360|58753634|FG014|Overall Study|Lost to Follow-up|0|||
30742738|NCT00347360|58753620|FG000|Overall Study|Protocol Violation|2|||
30742739|NCT00347360|58753621|FG001|Overall Study|Protocol Violation|3|||
30742740|NCT00347360|58753622|FG002|Overall Study|Protocol Violation|1|||
30742741|NCT00347360|58753623|FG003|Overall Study|Protocol Violation|2|||
30742742|NCT00347360|58753624|FG004|Overall Study|Protocol Violation|1|||
30742743|NCT00347360|58753625|FG005|Overall Study|Protocol Violation|2|||
30742744|NCT00347360|58753626|FG006|Overall Study|Protocol Violation|0|||
30742745|NCT00347360|58753627|FG007|Overall Study|Protocol Violation|0|||
30742746|NCT00347360|58753628|FG008|Overall Study|Protocol Violation|1|||
30742747|NCT00347360|58753629|FG009|Overall Study|Protocol Violation|2|||
30742748|NCT00347360|58753630|FG010|Overall Study|Protocol Violation|0|||
30742749|NCT00347360|58753631|FG011|Overall Study|Protocol Violation|0|||
30742750|NCT00347360|58753632|FG012|Overall Study|Protocol Violation|0|||
30742751|NCT00347360|58753633|FG013|Overall Study|Protocol Violation|1|||
30742752|NCT00347360|58753634|FG014|Overall Study|Protocol Violation|0|||
30742753|NCT00347360|58753620|FG000|Overall Study|Withdrawal by Subject|0|||
30742754|NCT00347360|58753621|FG001|Overall Study|Withdrawal by Subject|1|||
30742755|NCT00347360|58753622|FG002|Overall Study|Withdrawal by Subject|2|||
30742756|NCT00347360|58753623|FG003|Overall Study|Withdrawal by Subject|4|||
30742757|NCT00347360|58753624|FG004|Overall Study|Withdrawal by Subject|1|||
30742758|NCT00347360|58753625|FG005|Overall Study|Withdrawal by Subject|2|||
30742759|NCT00347360|58753626|FG006|Overall Study|Withdrawal by Subject|1|||
30742760|NCT00347360|58753627|FG007|Overall Study|Withdrawal by Subject|1|||
30742761|NCT00347360|58753628|FG008|Overall Study|Withdrawal by Subject|1|||
30742762|NCT00347360|58753629|FG009|Overall Study|Withdrawal by Subject|1|||
30742763|NCT00347360|58753630|FG010|Overall Study|Withdrawal by Subject|0|||
30902020|NCT01610284|58935877|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
30902021|NCT01610284|58935876|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
30902022|NCT01610284|58935877|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
30902023|NCT01610284|58935876|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
30902024|NCT01610284|58935877|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
30902025|NCT02452463|58935886|FG000|Overall Study|Death|1|||
30902026|NCT02452463|58935887|FG001|Overall Study|Death|0|||
30902027|NCT02452463|58935888|FG002|Overall Study|Death|0|||
30902028|NCT02452463|58935886|FG000|Overall Study|Study Suspended|1|||
30902029|NCT02452463|58935887|FG001|Overall Study|Study Suspended|0|||
30902030|NCT02452463|58935888|FG002|Overall Study|Study Suspended|0|||
30902031|NCT02452463|58935886|FG000|Overall Study|Recommended by DSMB|0|||
30902032|NCT02452463|58935887|FG001|Overall Study|Recommended by DSMB|1|||
30902033|NCT02452463|58935888|FG002|Overall Study|Recommended by DSMB|0|||
30742764|NCT00347360|58753631|FG011|Overall Study|Withdrawal by Subject|3|||
30742765|NCT00347360|58753632|FG012|Overall Study|Withdrawal by Subject|4|||
30742766|NCT00347360|58753633|FG013|Overall Study|Withdrawal by Subject|2|||
30742767|NCT00347360|58753634|FG014|Overall Study|Withdrawal by Subject|1|||
30742768|NCT00347360|58753620|FG000|Overall Study|Lack of Efficacy|1|||
30902034|NCT02452463|58935886|FG000|Overall Study|Withdrawal by Subject|0|||
30742769|NCT00347360|58753621|FG001|Overall Study|Lack of Efficacy|1|||
30742770|NCT00347360|58753622|FG002|Overall Study|Lack of Efficacy|3|||
30742771|NCT00347360|58753623|FG003|Overall Study|Lack of Efficacy|1|||
30742772|NCT00347360|58753624|FG004|Overall Study|Lack of Efficacy|0|||
30742773|NCT00347360|58753625|FG005|Overall Study|Lack of Efficacy|1|||
30742774|NCT00347360|58753626|FG006|Overall Study|Lack of Efficacy|0|||
30742775|NCT00347360|58753627|FG007|Overall Study|Lack of Efficacy|1|||
30742776|NCT00347360|58753628|FG008|Overall Study|Lack of Efficacy|1|||
30742777|NCT00347360|58753629|FG009|Overall Study|Lack of Efficacy|0|||
30742778|NCT00347360|58753630|FG010|Overall Study|Lack of Efficacy|0|||
30742779|NCT00347360|58753631|FG011|Overall Study|Lack of Efficacy|0|||
30742780|NCT00347360|58753632|FG012|Overall Study|Lack of Efficacy|0|||
30742781|NCT00347360|58753633|FG013|Overall Study|Lack of Efficacy|0|||
30742782|NCT00347360|58753634|FG014|Overall Study|Lack of Efficacy|0|||
30742783|NCT00347360|58753620|FG000|Overall Study|Reason not listed/blank|1|||
30742784|NCT00347360|58753621|FG001|Overall Study|Reason not listed/blank|0|||
30742785|NCT00347360|58753622|FG002|Overall Study|Reason not listed/blank|0|||
30742786|NCT00347360|58753623|FG003|Overall Study|Reason not listed/blank|0|||
30742787|NCT00347360|58753624|FG004|Overall Study|Reason not listed/blank|0|||
30742788|NCT00347360|58753625|FG005|Overall Study|Reason not listed/blank|0|||
30742789|NCT00347360|58753626|FG006|Overall Study|Reason not listed/blank|1|||
30742790|NCT00347360|58753627|FG007|Overall Study|Reason not listed/blank|0|||
30742791|NCT00347360|58753628|FG008|Overall Study|Reason not listed/blank|0|||
30902035|NCT02452463|58935887|FG001|Overall Study|Withdrawal by Subject|1|||
30742792|NCT00347360|58753629|FG009|Overall Study|Reason not listed/blank|0|||
30742793|NCT00347360|58753630|FG010|Overall Study|Reason not listed/blank|0|||
30742794|NCT00347360|58753631|FG011|Overall Study|Reason not listed/blank|0|||
30742795|NCT00347360|58753632|FG012|Overall Study|Reason not listed/blank|0|||
30742796|NCT00347360|58753633|FG013|Overall Study|Reason not listed/blank|1|||
30742797|NCT00347360|58753634|FG014|Overall Study|Reason not listed/blank|0|||
30742798|NCT00347360|58753620|FG000|Overall Study|Per sponsors instruction|0|||
30742799|NCT00347360|58753621|FG001|Overall Study|Per sponsors instruction|1|||
30742800|NCT00347360|58753622|FG002|Overall Study|Per sponsors instruction|0|||
30742801|NCT00347360|58753623|FG003|Overall Study|Per sponsors instruction|0|||
30742802|NCT00347360|58753624|FG004|Overall Study|Per sponsors instruction|0|||
30742803|NCT00347360|58753625|FG005|Overall Study|Per sponsors instruction|0|||
30742804|NCT00347360|58753626|FG006|Overall Study|Per sponsors instruction|0|||
30742805|NCT00347360|58753627|FG007|Overall Study|Per sponsors instruction|0|||
30742806|NCT00347360|58753628|FG008|Overall Study|Per sponsors instruction|0|||
30742807|NCT00347360|58753629|FG009|Overall Study|Per sponsors instruction|0|||
30742808|NCT00347360|58753630|FG010|Overall Study|Per sponsors instruction|0|||
30742809|NCT00347360|58753631|FG011|Overall Study|Per sponsors instruction|0|||
30742810|NCT00347360|58753632|FG012|Overall Study|Per sponsors instruction|0|||
30742811|NCT00347360|58753633|FG013|Overall Study|Per sponsors instruction|0|||
30742812|NCT00347360|58753634|FG014|Overall Study|Per sponsors instruction|0|||
30742813|NCT00347360|58753620|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
30742814|NCT00347360|58753621|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
30742815|NCT00347360|58753622|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
30742816|NCT00347360|58753623|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
30742817|NCT00347360|58753624|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
30742818|NCT00347360|58753625|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
30742819|NCT00347360|58753626|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
30742820|NCT00347360|58753627|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
30742821|NCT00347360|58753628|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
30742822|NCT00347360|58753629|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
30742823|NCT00347360|58753630|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
30902036|NCT02452463|58935888|FG002|Overall Study|Withdrawal by Subject|0|||
30902037|NCT02432105|58935899|FG000|Overall Study|Lost to Follow-up|1|||
30902038|NCT02432105|58935900|FG001|Overall Study|Lost to Follow-up|1|||
30902039|NCT02432105|58935901|FG002|Overall Study|Lost to Follow-up|0|||
30622007|NCT01147068|58633525|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
30742824|NCT00347360|58753631|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
30742825|NCT00347360|58753632|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
30742826|NCT00347360|58753633|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
30902040|NCT02432105|58935899|FG000|Overall Study|Withdrawal by Subject|1|||
30902041|NCT02432105|58935900|FG001|Overall Study|Withdrawal by Subject|0|||
30902042|NCT02432105|58935901|FG002|Overall Study|Withdrawal by Subject|1|||
30902043|NCT02432105|58935899|FG000|Overall Study|Culture positive for yeast|0|||
30902044|NCT02432105|58935900|FG001|Overall Study|Culture positive for yeast|1|||
30902045|NCT02432105|58935901|FG002|Overall Study|Culture positive for yeast|0|||
30902046|NCT02432105|58935899|FG000|Overall Study|Randomized in error|0|||
30902047|NCT02432105|58935900|FG001|Overall Study|Randomized in error|0|||
30902048|NCT02432105|58935901|FG002|Overall Study|Randomized in error|2|||
30902049|NCT02431793|58935913|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
30902050|NCT02431793|58935914|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
30902051|NCT02431793|58935915|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
30902052|NCT02431793|58935913|FG000|Overall Study|Withdrawal by Subject|7|||
30742827|NCT00347360|58753634|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
30742828|NCT00347360|58753620|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
30742829|NCT00347360|58753621|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
30742830|NCT00347360|58753622|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
30742831|NCT00347360|58753623|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
30742832|NCT00347360|58753624|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
30742833|NCT00347360|58753625|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
30742834|NCT00347360|58753626|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
30742835|NCT00347360|58753627|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
30742836|NCT00347360|58753628|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
30742837|NCT00347360|58753629|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
30742838|NCT00347360|58753630|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
30742839|NCT00347360|58753631|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
30742840|NCT00347360|58753632|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
30742841|NCT00347360|58753633|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
30742842|NCT00347360|58753634|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
30742843|NCT00347360|58753620|FG000|Overall Study|Abnormal lab values|0|||
30742844|NCT00347360|58753621|FG001|Overall Study|Abnormal lab values|0|||
30742845|NCT00347360|58753622|FG002|Overall Study|Abnormal lab values|0|||
30742846|NCT00347360|58753623|FG003|Overall Study|Abnormal lab values|0|||
30742847|NCT00347360|58753624|FG004|Overall Study|Abnormal lab values|0|||
30742848|NCT00347360|58753625|FG005|Overall Study|Abnormal lab values|0|||
30742849|NCT00347360|58753626|FG006|Overall Study|Abnormal lab values|1|||
30742850|NCT00347360|58753627|FG007|Overall Study|Abnormal lab values|0|||
30742851|NCT00347360|58753628|FG008|Overall Study|Abnormal lab values|0|||
30742852|NCT00347360|58753629|FG009|Overall Study|Abnormal lab values|0|||
30742853|NCT00347360|58753630|FG010|Overall Study|Abnormal lab values|0|||
30742854|NCT00347360|58753631|FG011|Overall Study|Abnormal lab values|0|||
30742855|NCT00347360|58753632|FG012|Overall Study|Abnormal lab values|0|||
30742856|NCT00347360|58753633|FG013|Overall Study|Abnormal lab values|0|||
30742857|NCT00347360|58753634|FG014|Overall Study|Abnormal lab values|0|||
30742858|NCT00347360|58753620|FG000|Overall Study|PI recommended early withdrawal|0|||
30742859|NCT00347360|58753621|FG001|Overall Study|PI recommended early withdrawal|0|||
30742860|NCT00347360|58753622|FG002|Overall Study|PI recommended early withdrawal|0|||
30742861|NCT00347360|58753623|FG003|Overall Study|PI recommended early withdrawal|0|||
30742862|NCT00347360|58753624|FG004|Overall Study|PI recommended early withdrawal|0|||
30742863|NCT00347360|58753625|FG005|Overall Study|PI recommended early withdrawal|0|||
30742864|NCT00347360|58753626|FG006|Overall Study|PI recommended early withdrawal|0|||
30742865|NCT00347360|58753627|FG007|Overall Study|PI recommended early withdrawal|0|||
30742866|NCT00347360|58753628|FG008|Overall Study|PI recommended early withdrawal|0|||
30742867|NCT00347360|58753629|FG009|Overall Study|PI recommended early withdrawal|1|||
30742868|NCT00347360|58753630|FG010|Overall Study|PI recommended early withdrawal|0|||
30742869|NCT00347360|58753631|FG011|Overall Study|PI recommended early withdrawal|0|||
30742870|NCT00347360|58753632|FG012|Overall Study|PI recommended early withdrawal|0|||
30742871|NCT00347360|58753633|FG013|Overall Study|PI recommended early withdrawal|0|||
30742872|NCT00347360|58753634|FG014|Overall Study|PI recommended early withdrawal|0|||
30742873|NCT00347360|58753620|FG000|Overall Study|Did not meet criteria before ABPM|0|||
30742874|NCT00347360|58753621|FG001|Overall Study|Did not meet criteria before ABPM|0|||
30742875|NCT00347360|58753622|FG002|Overall Study|Did not meet criteria before ABPM|0|||
30742876|NCT00347360|58753623|FG003|Overall Study|Did not meet criteria before ABPM|0|||
30742877|NCT00347360|58753624|FG004|Overall Study|Did not meet criteria before ABPM|0|||
30742878|NCT00347360|58753625|FG005|Overall Study|Did not meet criteria before ABPM|0|||
30742879|NCT00347360|58753626|FG006|Overall Study|Did not meet criteria before ABPM|0|||
30742880|NCT00347360|58753627|FG007|Overall Study|Did not meet criteria before ABPM|0|||
30742881|NCT00347360|58753628|FG008|Overall Study|Did not meet criteria before ABPM|0|||
30902053|NCT02431793|58935914|FG001|Overall Study|Withdrawal by Subject|5|||
30742882|NCT00347360|58753629|FG009|Overall Study|Did not meet criteria before ABPM|0|||
30742883|NCT00347360|58753630|FG010|Overall Study|Did not meet criteria before ABPM|1|||
30742884|NCT00347360|58753631|FG011|Overall Study|Did not meet criteria before ABPM|0|||
30742885|NCT00347360|58753632|FG012|Overall Study|Did not meet criteria before ABPM|0|||
30742886|NCT00347360|58753633|FG013|Overall Study|Did not meet criteria before ABPM|0|||
30742887|NCT00347360|58753634|FG014|Overall Study|Did not meet criteria before ABPM|0|||
30742888|NCT00347360|58753620|FG000|Overall Study|Randomized in error|0|||
30742889|NCT00347360|58753621|FG001|Overall Study|Randomized in error|0|||
30742890|NCT00347360|58753622|FG002|Overall Study|Randomized in error|0|||
30742891|NCT00347360|58753623|FG003|Overall Study|Randomized in error|0|||
30742892|NCT00347360|58753624|FG004|Overall Study|Randomized in error|0|||
30742893|NCT00347360|58753625|FG005|Overall Study|Randomized in error|0|||
30742894|NCT00347360|58753626|FG006|Overall Study|Randomized in error|0|||
30742895|NCT00347360|58753627|FG007|Overall Study|Randomized in error|0|||
30742896|NCT00347360|58753628|FG008|Overall Study|Randomized in error|0|||
30742897|NCT00347360|58753629|FG009|Overall Study|Randomized in error|0|||
30742898|NCT00347360|58753630|FG010|Overall Study|Randomized in error|0|||
30742899|NCT00347360|58753631|FG011|Overall Study|Randomized in error|1|||
30742900|NCT00347360|58753632|FG012|Overall Study|Randomized in error|0|||
30742901|NCT00347360|58753633|FG013|Overall Study|Randomized in error|0|||
30742902|NCT00347360|58753634|FG014|Overall Study|Randomized in error|0|||
30742903|NCT00347360|58753620|FG000|Overall Study|Failed inclusion criteria #4|0|||
30742904|NCT00347360|58753621|FG001|Overall Study|Failed inclusion criteria #4|0|||
30742905|NCT00347360|58753622|FG002|Overall Study|Failed inclusion criteria #4|0|||
30742906|NCT00347360|58753623|FG003|Overall Study|Failed inclusion criteria #4|0|||
30742907|NCT00347360|58753624|FG004|Overall Study|Failed inclusion criteria #4|0|||
30742908|NCT00347360|58753625|FG005|Overall Study|Failed inclusion criteria #4|0|||
30742909|NCT00347360|58753626|FG006|Overall Study|Failed inclusion criteria #4|0|||
30742910|NCT00347360|58753627|FG007|Overall Study|Failed inclusion criteria #4|0|||
30742911|NCT00347360|58753628|FG008|Overall Study|Failed inclusion criteria #4|0|||
30742912|NCT00347360|58753629|FG009|Overall Study|Failed inclusion criteria #4|0|||
30742913|NCT00347360|58753630|FG010|Overall Study|Failed inclusion criteria #4|0|||
30742914|NCT00347360|58753631|FG011|Overall Study|Failed inclusion criteria #4|1|||
30742915|NCT00347360|58753632|FG012|Overall Study|Failed inclusion criteria #4|0|||
30742916|NCT00347360|58753633|FG013|Overall Study|Failed inclusion criteria #4|0|||
30742917|NCT00347360|58753634|FG014|Overall Study|Failed inclusion criteria #4|0|||
30742918|NCT00347360|58753620|FG000|Overall Study|Prolonged duration between visits|0|||
30742919|NCT00347360|58753621|FG001|Overall Study|Prolonged duration between visits|0|||
30742920|NCT00347360|58753622|FG002|Overall Study|Prolonged duration between visits|0|||
30742921|NCT00347360|58753623|FG003|Overall Study|Prolonged duration between visits|0|||
30742922|NCT00347360|58753624|FG004|Overall Study|Prolonged duration between visits|0|||
30742923|NCT00347360|58753625|FG005|Overall Study|Prolonged duration between visits|0|||
30742924|NCT00347360|58753626|FG006|Overall Study|Prolonged duration between visits|0|||
30742925|NCT00347360|58753627|FG007|Overall Study|Prolonged duration between visits|0|||
30742926|NCT00347360|58753628|FG008|Overall Study|Prolonged duration between visits|0|||
30742927|NCT00347360|58753629|FG009|Overall Study|Prolonged duration between visits|0|||
30742928|NCT00347360|58753630|FG010|Overall Study|Prolonged duration between visits|0|||
30742929|NCT00347360|58753631|FG011|Overall Study|Prolonged duration between visits|0|||
30742930|NCT00347360|58753632|FG012|Overall Study|Prolonged duration between visits|1|||
30742931|NCT00347360|58753633|FG013|Overall Study|Prolonged duration between visits|0|||
30742932|NCT00347360|58753634|FG014|Overall Study|Prolonged duration between visits|0|||
30742933|NCT00347360|58753620|FG000|Overall Study|Subject left town, ran out of study drug|0|||
30742934|NCT00347360|58753621|FG001|Overall Study|Subject left town, ran out of study drug|0|||
30742935|NCT00347360|58753622|FG002|Overall Study|Subject left town, ran out of study drug|0|||
30742936|NCT00347360|58753623|FG003|Overall Study|Subject left town, ran out of study drug|0|||
30742937|NCT00347360|58753624|FG004|Overall Study|Subject left town, ran out of study drug|0|||
30902054|NCT02431793|58935915|FG002|Overall Study|Withdrawal by Subject|5|||
30902055|NCT02431793|58935913|FG000|Overall Study|Lost to Follow-up|101|||
30902056|NCT02431793|58935914|FG001|Overall Study|Lost to Follow-up|122|||
30902057|NCT02431793|58935915|FG002|Overall Study|Lost to Follow-up|104|||
30902058|NCT01801930|58935927|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
30902059|NCT01801930|58935928|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
30902060|NCT01801930|58935929|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
30902061|NCT01801930|58935930|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
30902062|NCT01801930|58935927|FG000|Overall Study|DLT occurs|0|||
30902063|NCT01801930|58935928|FG001|Overall Study|DLT occurs|1|||
30902064|NCT01801930|58935929|FG002|Overall Study|DLT occurs|0|||
30902065|NCT01801930|58935930|FG003|Overall Study|DLT occurs|0|||
30902066|NCT01610206|58935942|FG000|Overall Study|Adverse Event|10|||
30902067|NCT01610206|58935943|FG001|Overall Study|Adverse Event|30|||
30902068|NCT01816048|58935949|FG000|Overall Study|Adverse Event|1|||
30902069|NCT01816048|58935949|FG000|Overall Study|Death|1|||
30902070|NCT01816048|58935949|FG000|Overall Study|Withdrawal by Subject|1|||
30902071|NCT01816048|58935949|FG000|Overall Study|Disease Progression|3|||
30742938|NCT00347360|58753625|FG005|Overall Study|Subject left town, ran out of study drug|0|||
30742939|NCT00347360|58753626|FG006|Overall Study|Subject left town, ran out of study drug|0|||
30742940|NCT00347360|58753627|FG007|Overall Study|Subject left town, ran out of study drug|0|||
30742941|NCT00347360|58753628|FG008|Overall Study|Subject left town, ran out of study drug|0|||
30742942|NCT00347360|58753629|FG009|Overall Study|Subject left town, ran out of study drug|0|||
30742943|NCT00347360|58753630|FG010|Overall Study|Subject left town, ran out of study drug|0|||
30742944|NCT00347360|58753631|FG011|Overall Study|Subject left town, ran out of study drug|0|||
30742945|NCT00347360|58753632|FG012|Overall Study|Subject left town, ran out of study drug|0|||
30742946|NCT00347360|58753633|FG013|Overall Study|Subject left town, ran out of study drug|1|||
30742947|NCT00347360|58753634|FG014|Overall Study|Subject left town, ran out of study drug|0|||
30742948|NCT00347360|58753620|FG000|Overall Study|Subject refuse to sign updated consent|0|||
30742949|NCT00347360|58753621|FG001|Overall Study|Subject refuse to sign updated consent|0|||
30742950|NCT00347360|58753622|FG002|Overall Study|Subject refuse to sign updated consent|0|||
30742951|NCT00347360|58753623|FG003|Overall Study|Subject refuse to sign updated consent|0|||
30742952|NCT00347360|58753624|FG004|Overall Study|Subject refuse to sign updated consent|0|||
30742953|NCT00347360|58753625|FG005|Overall Study|Subject refuse to sign updated consent|0|||
30742954|NCT00347360|58753626|FG006|Overall Study|Subject refuse to sign updated consent|0|||
30742955|NCT00347360|58753627|FG007|Overall Study|Subject refuse to sign updated consent|0|||
30742956|NCT00347360|58753628|FG008|Overall Study|Subject refuse to sign updated consent|0|||
30742957|NCT00347360|58753629|FG009|Overall Study|Subject refuse to sign updated consent|0|||
30742958|NCT00347360|58753630|FG010|Overall Study|Subject refuse to sign updated consent|0|||
30742959|NCT00347360|58753631|FG011|Overall Study|Subject refuse to sign updated consent|0|||
30902072|NCT01612858|58935956|FG000|Overall Study|Withdrawal by Subject|5|||
30902073|NCT01612858|58935957|FG001|Overall Study|Withdrawal by Subject|1|||
30902074|NCT01612780|58935963|FG000|Overall Study|Treatment not completed|1|||
30902075|NCT01612780|58935963|FG000|Overall Study|Withdrawal by Subject|5|||
30902076|NCT01612702|58935969|FG000|Overall Study|Protocol Violation|11|||
30902077|NCT01612702|58935970|FG001|Overall Study|Protocol Violation|11|||
30902078|NCT02431559|58935980|FG000|Overall Study|Adverse Event|0|||
30902079|NCT02431559|58935981|FG001|Overall Study|Adverse Event|1|||
30902080|NCT02431559|58935982|FG002|Overall Study|Adverse Event|0|||
30902081|NCT02431559|58935983|FG003|Overall Study|Adverse Event|4|||
30902082|NCT02431559|58935980|FG000|Overall Study|Progressive disease|2|||
30902083|NCT02431559|58935981|FG001|Overall Study|Progressive disease|1|||
30902084|NCT02431559|58935982|FG002|Overall Study|Progressive disease|4|||
30902085|NCT02431559|58935983|FG003|Overall Study|Progressive disease|22|||
30902086|NCT02431559|58935980|FG000|Overall Study|Withdrawal by Subject|0|||
30902087|NCT02431559|58935981|FG001|Overall Study|Withdrawal by Subject|1|||
30902088|NCT02431559|58935982|FG002|Overall Study|Withdrawal by Subject|0|||
30742960|NCT00347360|58753632|FG012|Overall Study|Subject refuse to sign updated consent|0|||
30902089|NCT02431559|58935983|FG003|Overall Study|Withdrawal by Subject|4|||
30902090|NCT02431559|58935980|FG000|Overall Study|Physician Decision|0|||
30902091|NCT02431559|58935981|FG001|Overall Study|Physician Decision|0|||
30902092|NCT02431559|58935982|FG002|Overall Study|Physician Decision|0|||
30902093|NCT02431559|58935983|FG003|Overall Study|Physician Decision|1|||
30902094|NCT02388269|58935997|FG000|Overall Study|Adverse Event|2|||
30742961|NCT00347360|58753633|FG013|Overall Study|Subject refuse to sign updated consent|0|||
30742962|NCT00347360|58753634|FG014|Overall Study|Subject refuse to sign updated consent|1|||
30742963|NCT00347360|58753620|FG000|Overall Study|Visits conflicted with new job|0|||
30742964|NCT00347360|58753621|FG001|Overall Study|Visits conflicted with new job|0|||
30742965|NCT00347360|58753622|FG002|Overall Study|Visits conflicted with new job|0|||
30742966|NCT00347360|58753623|FG003|Overall Study|Visits conflicted with new job|0|||
30742967|NCT00347360|58753624|FG004|Overall Study|Visits conflicted with new job|0|||
30742968|NCT00347360|58753625|FG005|Overall Study|Visits conflicted with new job|0|||
30742969|NCT00347360|58753626|FG006|Overall Study|Visits conflicted with new job|1|||
30742970|NCT00347360|58753627|FG007|Overall Study|Visits conflicted with new job|0|||
30742971|NCT00347360|58753628|FG008|Overall Study|Visits conflicted with new job|0|||
30742972|NCT00347360|58753629|FG009|Overall Study|Visits conflicted with new job|0|||
30742973|NCT00347360|58753630|FG010|Overall Study|Visits conflicted with new job|0|||
30742974|NCT00347360|58753631|FG011|Overall Study|Visits conflicted with new job|0|||
30742975|NCT00347360|58753632|FG012|Overall Study|Visits conflicted with new job|0|||
30742976|NCT00347360|58753633|FG013|Overall Study|Visits conflicted with new job|0|||
30742977|NCT00347360|58753634|FG014|Overall Study|Visits conflicted with new job|0|||
30742978|NCT00319020|58753668|FG000|Overall Study|Death|2|||
30742979|NCT00319020|58753669|FG001|Overall Study|Death|2|||
30742980|NCT00319020|58753668|FG000|Overall Study|Withdrawal by Subject|4|||
30742981|NCT00319020|58753669|FG001|Overall Study|Withdrawal by Subject|1|||
30742982|NCT00319020|58753668|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
30742983|NCT00319020|58753669|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
30742984|NCT00319020|58753668|FG000|Overall Study|Administrative reason|0|||
30742985|NCT00319020|58753669|FG001|Overall Study|Administrative reason|5|||
30742986|NCT00319020|58753668|FG000|Overall Study|Disease progression|0|||
30742987|NCT00319020|58753669|FG001|Overall Study|Disease progression|2|||
30742988|NCT00319020|58753668|FG000|Overall Study|Transplant|0|||
30742989|NCT00319020|58753669|FG001|Overall Study|Transplant|1|||
30742990|NCT00319020|58753668|FG000|Overall Study|Treatment failure|0|||
30742991|NCT00319020|58753669|FG001|Overall Study|Treatment failure|1|||
30742992|NCT00319020|58753668|FG000|Overall Study|Adverse Event|0|||
30742993|NCT00319020|58753669|FG001|Overall Study|Adverse Event|1|||
30742994|NCT00352118|58753677|FG000|Overall Study|Physician Decision|4|||
30742995|NCT00318474|58753683|FG000|Overall Study|Adverse Event|1|||
30742996|NCT00318474|58753684|FG001|Overall Study|Adverse Event|1|||
30742997|NCT00318474|58753683|FG000|Overall Study|Lost to Follow-up|0|||
30742998|NCT00318474|58753684|FG001|Overall Study|Lost to Follow-up|1|||
30742999|NCT00318474|58753683|FG000|Overall Study|Pregnancy|0|||
30743000|NCT00318474|58753684|FG001|Overall Study|Pregnancy|2|||
30743001|NCT00318474|58753683|FG000|Overall Study|Protocol Violation|1|||
30743002|NCT00318474|58753684|FG001|Overall Study|Protocol Violation|0|||
30743003|NCT00318474|58753683|FG000|Overall Study|Withdrawal by Subject|3|||
30743004|NCT00318474|58753684|FG001|Overall Study|Withdrawal by Subject|2|||
30743005|NCT00318474|58753683|FG000|Overall Study|Fall in GFR|3|||
30743006|NCT00318474|58753684|FG001|Overall Study|Fall in GFR|3|||
30743007|NCT00318474|58753683|FG000|Overall Study|Post-therapy hyperflycemia|0|||
30743008|NCT00318474|58753684|FG001|Overall Study|Post-therapy hyperflycemia|1|||
30743009|NCT00318474|58753683|FG000|Overall Study|Trial terminated|10|||
30902095|NCT02388269|58935998|FG001|Overall Study|Adverse Event|0|||
30743010|NCT00318474|58753684|FG001|Overall Study|Trial terminated|7|||
30743011|NCT00350870|58753694|FG000|Overall Study|Withdrawal by Subject|21|||
30743012|NCT00350870|58753695|FG001|Overall Study|Withdrawal by Subject|17|||
30743013|NCT00350870|58753696|FG002|Overall Study|Withdrawal by Subject|15|||
30743014|NCT00350870|58753697|FG003|Overall Study|Withdrawal by Subject|14|||
30902096|NCT02388269|58935999|FG002|Overall Study|Adverse Event|0|||
30902097|NCT02388269|58935997|FG000|Overall Study|Withdrawal by Subject|1|||
30902098|NCT02388269|58935998|FG001|Overall Study|Withdrawal by Subject|2|||
30902099|NCT02388269|58935999|FG002|Overall Study|Withdrawal by Subject|0|||
30743015|NCT00350870|58753694|FG000|Overall Study|Physician Decision|1|||
30743016|NCT00350870|58753695|FG001|Overall Study|Physician Decision|0|||
30743017|NCT00350870|58753696|FG002|Overall Study|Physician Decision|1|||
30743018|NCT00350870|58753697|FG003|Overall Study|Physician Decision|1|||
30743019|NCT00350792|58753707|FG000|Overall Study|Adverse Event|11|||
30743020|NCT00350792|58753707|FG000|Overall Study|Death from Study Disease|1|||
30743021|NCT00350792|58753707|FG000|Overall Study|Death from Study Drug Toxicity|1|||
30743022|NCT00350792|58753707|FG000|Overall Study|Death Not Study Drug Related|2|||
30743023|NCT00350792|58753707|FG000|Overall Study|Protocol Violation|1|||
30743024|NCT00350792|58753707|FG000|Overall Study|Withdrawal by Subject|4|||
30743025|NCT00350792|58753707|FG000|Overall Study|Physician Decision|2|||
30743026|NCT00350792|58753707|FG000|Overall Study|Lack of Efficacy|11|||
30743027|NCT00317772|58753715|FG000|Overall Study|Adverse Event|0|||
30743028|NCT00317772|58753716|FG001|Overall Study|Adverse Event|0|||
30743029|NCT00317772|58753717|FG002|Overall Study|Adverse Event|0|||
30743030|NCT00317772|58753718|FG003|Overall Study|Adverse Event|2|||
30743031|NCT00317772|58753715|FG000|Overall Study|Disease Progression|2|||
30743032|NCT00317772|58753716|FG001|Overall Study|Disease Progression|2|||
30743033|NCT00317772|58753717|FG002|Overall Study|Disease Progression|1|||
30743034|NCT00317772|58753718|FG003|Overall Study|Disease Progression|7|||
30743035|NCT00350636|58753731|FG000|Overall Study|Adverse Event|19|||
30743036|NCT00350636|58753732|FG001|Overall Study|Adverse Event|13|||
30743037|NCT00350636|58753731|FG000|Overall Study|Protocol Violation|1|||
30743038|NCT00350636|58753732|FG001|Overall Study|Protocol Violation|3|||
30743039|NCT00350636|58753731|FG000|Overall Study|Withdrawal by Subject|13|||
30743040|NCT00350636|58753732|FG001|Overall Study|Withdrawal by Subject|17|||
30743041|NCT00350636|58753731|FG000|Overall Study|Lost to Follow-up|9|||
30743042|NCT00350636|58753732|FG001|Overall Study|Lost to Follow-up|8|||
30743043|NCT00350636|58753731|FG000|Overall Study|Physician Decision|0|||
30743044|NCT00350636|58753732|FG001|Overall Study|Physician Decision|2|||
30743045|NCT00350636|58753731|FG000|Overall Study|Other|1|||
30743046|NCT00350636|58753732|FG001|Overall Study|Other|2|||
30743047|NCT00346268|58753740|FG000|Overall Study|Adverse Event|1|||
30743048|NCT00346268|58753741|FG001|Overall Study|Adverse Event|0|||
30743049|NCT00346268|58753740|FG000|Overall Study|Protocol Violation|1|||
30743050|NCT00346268|58753741|FG001|Overall Study|Protocol Violation|0|||
30743051|NCT00346268|58753740|FG000|Overall Study|Participant refused|0|||
30743052|NCT00346268|58753741|FG001|Overall Study|Participant refused|3|||
30743053|NCT00327444|58753749|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
30743054|NCT00327444|58753750|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
30743055|NCT00327444|58753749|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
30743056|NCT00327444|58753750|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
30743057|NCT00327444|58753749|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
30743058|NCT00327444|58753750|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
30743059|NCT00327444|58753749|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
30743060|NCT00327444|58753750|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
30743061|NCT00327444|58753749|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
30743062|NCT00327444|58753750|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
30743063|NCT00327444|58753749|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
30743064|NCT00327444|58753750|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
30743065|NCT00327444|58753749|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
30743066|NCT00327444|58753750|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
30743067|NCT00327444|58753749|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
30743068|NCT00327444|58753750|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
30743069|NCT00337610|58753760|FG000|Overall Study|Adverse Event|2|||
30743070|NCT00337610|58753761|FG001|Overall Study|Adverse Event|2|||
30743071|NCT00337610|58753760|FG000|Overall Study|Death|0|||
30743072|NCT00337610|58753761|FG001|Overall Study|Death|1|||
30743073|NCT00337610|58753760|FG000|Overall Study|Lack of Efficacy|6|||
30743074|NCT00337610|58753761|FG001|Overall Study|Lack of Efficacy|3|||
30743075|NCT00337610|58753760|FG000|Overall Study|Lost to Follow-up|3|||
30743076|NCT00337610|58753761|FG001|Overall Study|Lost to Follow-up|3|||
30743077|NCT00337610|58753760|FG000|Overall Study|Withdrawal by Subject|6|||
30743078|NCT00337610|58753761|FG001|Overall Study|Withdrawal by Subject|5|||
30743079|NCT00316914|58753769|FG000|Overall Study|Withdrawal by Subject|5|||
30743080|NCT00316914|58753770|FG001|Overall Study|Withdrawal by Subject|3|||
30743081|NCT00316914|58753769|FG000|Overall Study|Adverse Event|8|||
30743082|NCT00316914|58753770|FG001|Overall Study|Adverse Event|7|||
30743083|NCT00316914|58753769|FG000|Overall Study|Other Problems|6|||
30743084|NCT00316914|58753770|FG001|Overall Study|Other Problems|11|||
30743085|NCT00316914|58753769|FG000|Overall Study|Missing end of treatment documentation|14|||
30743086|NCT00316914|58753770|FG001|Overall Study|Missing end of treatment documentation|15|||
30743087|NCT00336284|58753778|FG000|Overall Study|Death|52|||
30743088|NCT00336284|58753779|FG001|Overall Study|Death|26|||
30743089|NCT00336284|58753778|FG000|Overall Study|Lost to Follow-up|82|||
30743090|NCT00336284|58753779|FG001|Overall Study|Lost to Follow-up|61|||
30743091|NCT00336284|58753778|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
30743092|NCT00336284|58753779|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
30743093|NCT00316602|58753787|FG000|Overall Study|Withdrawal by Subject|3|||
30743094|NCT00316602|58753788|FG001|Overall Study|Withdrawal by Subject|2|||
30743095|NCT00316602|58753787|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
30743096|NCT00316602|58753788|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
30743097|NCT00316602|58753787|FG000|Overall Study|Adverse Event|1|||
30743098|NCT00316602|58753788|FG001|Overall Study|Adverse Event|0|||
30743099|NCT00316602|58753787|FG000|Overall Study|Other|3|||
30743100|NCT00316602|58753788|FG001|Overall Study|Other|6|||
30743101|NCT00335972|58753796|FG000|Overall Study|not given treatments|0|||
30743102|NCT00335972|58753797|FG001|Overall Study|not given treatments|3|||
30743103|NCT00346034|58753803|FG000|Overall Study|Adverse Event|34|||
30743104|NCT00346034|58753803|FG000|Overall Study|Lack of Efficacy|8|||
30743105|NCT00346034|58753803|FG000|Overall Study|Withdrawal by Subject|13|||
30743106|NCT00346034|58753803|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
30743107|NCT00346034|58753803|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
30743108|NCT00345878|58753809|FG000|Overall Study|Adverse Event|1|||
30743109|NCT00345878|58753810|FG001|Overall Study|Adverse Event|0|||
30902100|NCT02388269|58935997|FG000|Overall Study|less than 50% stimulations|1|||
30902101|NCT02388269|58935998|FG001|Overall Study|less than 50% stimulations|0|||
30902102|NCT02388269|58935999|FG002|Overall Study|less than 50% stimulations|0|||
30902103|NCT02388269|58935997|FG000|Overall Study|no diary data|3|||
30743110|NCT00345878|58753809|FG000|Overall Study|Lost to Follow-up|2|||
30743111|NCT00345878|58753810|FG001|Overall Study|Lost to Follow-up|1|||
30743112|NCT00345878|58753809|FG000|Overall Study|Other|1|||
30743113|NCT00345878|58753810|FG001|Overall Study|Other|0|||
30743114|NCT00335738|58753818|FG000|Overall Study|Physician Decision|6|||
30743115|NCT00335738|58753819|FG001|Overall Study|Physician Decision|0|||
30743116|NCT00335738|58753818|FG000|Overall Study|Withdrawal by Subject|2|||
30743117|NCT00335738|58753819|FG001|Overall Study|Withdrawal by Subject|0|||
30743118|NCT00335738|58753818|FG000|Overall Study|Ineligible|3|||
30743119|NCT00335738|58753819|FG001|Overall Study|Ineligible|4|||
30743120|NCT00334958|58753837|FG000|Overall Study|Medication Noncompliance|0|||
30743121|NCT00334958|58753838|FG001|Overall Study|Medication Noncompliance|3|||
30743122|NCT00334958|58753837|FG000|Overall Study|Protocol Violation|2|||
30743123|NCT00334958|58753838|FG001|Overall Study|Protocol Violation|2|||
30743124|NCT00334958|58753837|FG000|Overall Study|Request of the investigator or sponsor|0|||
30743125|NCT00334958|58753838|FG001|Overall Study|Request of the investigator or sponsor|1|||
30743126|NCT00334958|58753837|FG000|Overall Study|Withdrawal by Subject|7|||
30743127|NCT00334958|58753838|FG001|Overall Study|Withdrawal by Subject|4|||
30743128|NCT00334958|58753837|FG000|Overall Study|Adverse Event|27|||
30743129|NCT00334958|58753838|FG001|Overall Study|Adverse Event|12|||
30743130|NCT00334958|58753837|FG000|Overall Study|Other|1|||
30743131|NCT00334958|58753838|FG001|Overall Study|Other|2|||
30743132|NCT00326898|58753847|FG000|Overall Study|Disease progression|52|||
30743133|NCT00326898|58753848|FG001|Overall Study|Disease progression|54|||
30743134|NCT00326898|58753849|FG002|Overall Study|Disease progression|102|||
30743135|NCT00326898|58753847|FG000|Overall Study|Adverse Event|124|||
30743136|NCT00326898|58753848|FG001|Overall Study|Adverse Event|128|||
30743137|NCT00326898|58753849|FG002|Overall Study|Adverse Event|33|||
30743138|NCT00326898|58753847|FG000|Overall Study|Death|2|||
30743139|NCT00326898|58753848|FG001|Overall Study|Death|0|||
30743140|NCT00326898|58753849|FG002|Overall Study|Death|0|||
30743141|NCT00326898|58753847|FG000|Overall Study|Withdrawal by Subject|134|||
30743142|NCT00326898|58753848|FG001|Overall Study|Withdrawal by Subject|128|||
30743143|NCT00326898|58753849|FG002|Overall Study|Withdrawal by Subject|32|||
30743144|NCT00326898|58753847|FG000|Overall Study|Alternative therapy|1|||
30743145|NCT00326898|58753848|FG001|Overall Study|Alternative therapy|0|||
30743146|NCT00326898|58753849|FG002|Overall Study|Alternative therapy|0|||
30743147|NCT00326898|58753847|FG000|Overall Study|Other complicating disease|5|||
30743148|NCT00326898|58753848|FG001|Overall Study|Other complicating disease|5|||
30743149|NCT00326898|58753849|FG002|Overall Study|Other complicating disease|4|||
30902104|NCT02388269|58935998|FG001|Overall Study|no diary data|0|||
30791015|NCT02742766|58804184|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30902105|NCT02388269|58935999|FG002|Overall Study|no diary data|0|||
30902106|NCT02388269|58935997|FG000|Overall Study|Protocol Violation|2|||
30902107|NCT02388269|58935998|FG001|Overall Study|Protocol Violation|0|||
30743150|NCT00326898|58753847|FG000|Overall Study|Other/Missing/Unknown|33|||
30743151|NCT00326898|58753848|FG001|Overall Study|Other/Missing/Unknown|28|||
30743152|NCT00326898|58753849|FG002|Overall Study|Other/Missing/Unknown|32|||
30743153|NCT00326118|58753859|FG000|Active Phase|Withdrawal by Subject|4|||
30902108|NCT02388269|58935999|FG002|Overall Study|Protocol Violation|0|||
30902109|NCT02388269|58935997|FG000|Overall Study|Screen Failure|0|||
30743154|NCT00326118|58753860|FG001|Active Phase|Withdrawal by Subject|1|||
30743155|NCT00334802|58753869|FG000|Overall Study|Progressive Disease|2|||
30743156|NCT00334802|58753870|FG001|Overall Study|Progressive Disease|24|||
30791016|NCT02742766|58804185|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30743157|NCT00334802|58753869|FG000|Overall Study|Toxicity|1|||
30743158|NCT00334802|58753870|FG001|Overall Study|Toxicity|5|||
30743159|NCT00334802|58753869|FG000|Overall Study|Lack of Efficacy|1|||
30743160|NCT00334802|58753870|FG001|Overall Study|Lack of Efficacy|3|||
30743161|NCT00334802|58753869|FG000|Overall Study|Patient Condition Aggrevated|1|||
30743162|NCT00334802|58753870|FG001|Overall Study|Patient Condition Aggrevated|0|||
30743163|NCT00334802|58753869|FG000|Overall Study|Physician Decision|1|||
30743164|NCT00334802|58753870|FG001|Overall Study|Physician Decision|0|||
30743165|NCT00334802|58753869|FG000|Overall Study|Withdrawal by Subject|0|||
30902110|NCT02388269|58935998|FG001|Overall Study|Screen Failure|0|||
30902111|NCT02388269|58935999|FG002|Overall Study|Screen Failure|10|||
30902112|NCT01652573|58936025|FG000|Overall Study|Adverse Event|0|||
30902113|NCT01652573|58936026|FG001|Overall Study|Adverse Event|1|||
30902114|NCT02388191|58936034|FG000|Overall Study|Patient did not receive IUD|1|||
30902115|NCT02388191|58936035|FG001|Overall Study|Patient did not receive IUD|0|||
30743166|NCT00334802|58753870|FG001|Overall Study|Withdrawal by Subject|4|||
30743167|NCT00334802|58753869|FG000|Overall Study|Adverse Event|0|||
30743168|NCT00334802|58753870|FG001|Overall Study|Adverse Event|3|||
30743169|NCT00334802|58753869|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
30743170|NCT00334802|58753870|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
30743171|NCT00307164|58753881|FG000|Overall Study|Death|1|||
30743172|NCT00307164|58753882|FG001|Overall Study|Death|0|||
30743173|NCT00307164|58753881|FG000|Overall Study|Severe debilitation, unable to continue|1|||
30743174|NCT00307164|58753882|FG001|Overall Study|Severe debilitation, unable to continue|0|||
30743175|NCT00307164|58753881|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
30902116|NCT01815736|58936043|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
30902117|NCT01815736|58936044|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
30902118|NCT01815736|58936043|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
30902119|NCT01815736|58936044|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
30902120|NCT01815736|58936043|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
30743176|NCT00307164|58753882|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
30743177|NCT00307164|58753881|FG000|Overall Study|Withdrawal by Subject|1|||
30743178|NCT00307164|58753882|FG001|Overall Study|Withdrawal by Subject|8|||
30743179|NCT00307164|58753881|FG000|Overall Study|Not compliant with requirements|4|||
30743180|NCT00307164|58753882|FG001|Overall Study|Not compliant with requirements|4|||
30743181|NCT00307164|58753881|FG000|Overall Study|Lost to Follow-up|6|||
30743182|NCT00307164|58753882|FG001|Overall Study|Lost to Follow-up|1|||
30743183|NCT03827564|58753890|FG000|Overall Study|Discontinued due to Study Termination|1|||
30743184|NCT03827564|58753891|FG001|Overall Study|Discontinued due to Study Termination|0|||
30743185|NCT00307086|58753897|FG000|Overall Study|ineligible|5|||
30743186|NCT00325416|58753903|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
30743187|NCT00325416|58753904|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
30743188|NCT00325416|58753903|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
30743189|NCT00325416|58753904|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
30743190|NCT00325416|58753903|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
30743191|NCT00325416|58753904|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
30743192|NCT00325416|58753903|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
30743193|NCT00325416|58753904|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
30743194|NCT00325416|58753903|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
30743195|NCT00325416|58753904|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
30743196|NCT00325416|58753903|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
30743197|NCT00325416|58753904|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
30743198|NCT00314808|58753910|FG000|Overall Study|Disease Progression without AE|4|||
30743199|NCT00314808|58753910|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
30743200|NCT00314574|58753916|FG000|Overall Study|Death|3|||
30743201|NCT00314574|58753917|FG001|Overall Study|Death|0|||
30902121|NCT01815736|58936044|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
30902122|NCT01815736|58936043|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
30902123|NCT01815736|58936044|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
30902124|NCT01815736|58936043|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
30743202|NCT00314574|58753916|FG000|Overall Study|Adverse Event|11|||
30743203|NCT00314574|58753917|FG001|Overall Study|Adverse Event|16|||
30743204|NCT00314574|58753916|FG000|Overall Study|Lost to Follow-up|19|||
30902125|NCT01815736|58936044|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
30743205|NCT00314574|58753917|FG001|Overall Study|Lost to Follow-up|25|||
30743206|NCT00314574|58753916|FG000|Overall Study|Withdrawal by Subject|33|||
30743207|NCT00314574|58753917|FG001|Overall Study|Withdrawal by Subject|22|||
30902126|NCT01815736|58936043|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
30902127|NCT01815736|58936044|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
30902128|NCT01815736|58936043|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
30902129|NCT01815736|58936044|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
30902130|NCT01815736|58936043|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
30902131|NCT01815736|58936044|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
30902132|NCT01815736|58936043|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
30902133|NCT01815736|58936044|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
30902134|NCT01815736|58936043|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
30902135|NCT01815736|58936044|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
30902136|NCT01815736|58936043|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
30902137|NCT01815736|58936044|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
30902138|NCT01815736|58936043|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
30902139|NCT01815736|58936044|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
30902140|NCT01815736|58936043|FG000|Extension Treatment Phase- After Week 96|Death|1|||
30743208|NCT00314574|58753916|FG000|Overall Study|Physician Decision|22|||
30743209|NCT00314574|58753917|FG001|Overall Study|Physician Decision|15|||
30743210|NCT00314574|58753916|FG000|Overall Study|Pregnancy|6|||
30743211|NCT00314574|58753917|FG001|Overall Study|Pregnancy|4|||
30743212|NCT00314574|58753916|FG000|Overall Study|Data unknown at database lock|0|||
30743213|NCT00314574|58753917|FG001|Overall Study|Data unknown at database lock|1|||
30743214|NCT00314340|58753923|FG000|Overall Study|lost interest|1|||
30743215|NCT00306852|58753931|FG000|Overall Study|Death|14|||
30743216|NCT00306852|58753932|FG001|Overall Study|Death|14|||
30743217|NCT00306852|58753931|FG000|Overall Study|Lost to Follow-up|15|||
30743218|NCT00306852|58753932|FG001|Overall Study|Lost to Follow-up|24|||
30743219|NCT00314262|58753938|FG000|Overall Study|Adverse Event|2|||
30743220|NCT00314262|58753938|FG000|Overall Study|Withdrawal by Subject|2|||
30743221|NCT00314262|58753938|FG000|Overall Study|Physician Decision|1|||
30743222|NCT00333866|58753946|FG000|Overall Study|Adverse Event|23|||
30743223|NCT00333866|58753947|FG001|Overall Study|Adverse Event|37|||
30743224|NCT00333866|58753948|FG002|Overall Study|Adverse Event|38|||
30743225|NCT00333866|58753949|FG003|Overall Study|Adverse Event|47|||
30743226|NCT00333866|58753946|FG000|Overall Study|Other|3|||
30743227|NCT00333866|58753947|FG001|Overall Study|Other|2|||
30743228|NCT00333866|58753948|FG002|Overall Study|Other|2|||
30743229|NCT00333866|58753949|FG003|Overall Study|Other|2|||
30743230|NCT00333866|58753946|FG000|Overall Study|Lack of Efficacy|8|||
30743231|NCT00333866|58753947|FG001|Overall Study|Lack of Efficacy|6|||
30743232|NCT00333866|58753948|FG002|Overall Study|Lack of Efficacy|3|||
30743233|NCT00333866|58753949|FG003|Overall Study|Lack of Efficacy|5|||
30743234|NCT00333866|58753946|FG000|Overall Study|Lost to Follow-up|1|||
30743235|NCT00333866|58753947|FG001|Overall Study|Lost to Follow-up|2|||
30743236|NCT00333866|58753948|FG002|Overall Study|Lost to Follow-up|2|||
30743237|NCT00333866|58753949|FG003|Overall Study|Lost to Follow-up|2|||
30743238|NCT00333866|58753946|FG000|Overall Study|Withdrawal by Subject|8|||
30743239|NCT00333866|58753947|FG001|Overall Study|Withdrawal by Subject|14|||
30743240|NCT00333866|58753948|FG002|Overall Study|Withdrawal by Subject|4|||
30743241|NCT00333866|58753949|FG003|Overall Study|Withdrawal by Subject|9|||
30743242|NCT00333866|58753946|FG000|Overall Study|Randomized but not Treated|5|||
30743243|NCT00333866|58753947|FG001|Overall Study|Randomized but not Treated|3|||
30743244|NCT00333866|58753948|FG002|Overall Study|Randomized but not Treated|2|||
30743245|NCT00333866|58753949|FG003|Overall Study|Randomized but not Treated|1|||
30743246|NCT00324740|58753959|FG000|Overall Study|Withdrawal by Subject|1|||
30743247|NCT00324740|58753960|FG001|Overall Study|Withdrawal by Subject|0|||
30743248|NCT00324740|58753961|FG002|Overall Study|Withdrawal by Subject|1|||
30743249|NCT00333788|58753968|FG000|Overall Study|Adverse Event|44|||
30743250|NCT00333788|58753968|FG000|Overall Study|Lack of Efficacy|80|||
30743251|NCT00333788|58753968|FG000|Overall Study|Lost to Follow-up|2|||
30743252|NCT00333788|58753968|FG000|Overall Study|Withdrawal by Subject|24|||
30743253|NCT00333788|58753968|FG000|Overall Study|Other: Non-compliance|2|||
30743254|NCT00333788|58753968|FG000|Overall Study|Other: Moved|2|||
30743255|NCT00333788|58753968|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
30743256|NCT00333788|58753968|FG000|Overall Study|Other: Investigator decision|1|||
30743257|NCT00333788|58753968|FG000|Overall Study|Other: Quality of life concern|1|||
30743258|NCT00333788|58753968|FG000|Overall Study|Other: Sponsor decision|1|||
30743259|NCT00333788|58753968|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
30743260|NCT00333788|58753968|FG000|Overall Study|Other: Medical monitor decision|1|||
30743261|NCT00333788|58753968|FG000|Overall Study|Other: Physician decision|1|||
30743262|NCT00333788|58753968|FG000|Overall Study|Other: Signed consent for another study|1|||
30743263|NCT00324116|58753972|FG000|Overall Study|Adverse Event|5|||
30743264|NCT00324116|58753972|FG000|Overall Study|Lack of Efficacy|17|||
30743265|NCT00324116|58753972|FG000|Overall Study|Withdrawal by Subject|5|||
30743266|NCT00324116|58753972|FG000|Overall Study|Other|5|||
30743267|NCT00332696|58753978|FG000|Overall Study|Death|24|||
30743268|NCT00332696|58753979|FG001|Overall Study|Death|14|||
30743269|NCT00332696|58753978|FG000|Overall Study|Insufficient therapeutic effect|4|||
30743270|NCT00332696|58753979|FG001|Overall Study|Insufficient therapeutic effect|11|||
30743271|NCT00332696|58753978|FG000|Overall Study|Adverse Event|1|||
30743272|NCT00332696|58753979|FG001|Overall Study|Adverse Event|2|||
30743273|NCT00332696|58753978|FG000|Overall Study|Condition does not justify treatment|0|||
30743274|NCT00332696|58753979|FG001|Overall Study|Condition does not justify treatment|2|||
30743275|NCT00332696|58753978|FG000|Overall Study|Lost to Follow-up|0|||
30743276|NCT00332696|58753979|FG001|Overall Study|Lost to Follow-up|1|||
30743277|NCT00332696|58753978|FG000|Overall Study|Withdrawal by Subject|1|||
30743278|NCT00332696|58753979|FG001|Overall Study|Withdrawal by Subject|0|||
30743279|NCT00313716|58753991|FG000|Overall Study|Death|3|||
30743280|NCT00313716|58753992|FG001|Overall Study|Death|2|||
30743281|NCT00313716|58753993|FG002|Overall Study|Death|9|||
30743282|NCT00313716|58753994|FG003|Overall Study|Death|3|||
30743283|NCT00313716|58753995|FG004|Overall Study|Death|5|||
30743284|NCT00313716|58753996|FG005|Overall Study|Death|9|||
30743285|NCT00313716|58753991|FG000|Overall Study|Lost to Follow-up|2|||
30743286|NCT00313716|58753992|FG001|Overall Study|Lost to Follow-up|5|||
30743287|NCT00313716|58753993|FG002|Overall Study|Lost to Follow-up|2|||
30743288|NCT00313716|58753994|FG003|Overall Study|Lost to Follow-up|1|||
30743289|NCT00313716|58753995|FG004|Overall Study|Lost to Follow-up|0|||
30743290|NCT00313716|58753996|FG005|Overall Study|Lost to Follow-up|4|||
30743291|NCT00313716|58753991|FG000|Overall Study|Withdrawal by Subject|0|||
30743292|NCT00313716|58753992|FG001|Overall Study|Withdrawal by Subject|1|||
30743293|NCT00313716|58753993|FG002|Overall Study|Withdrawal by Subject|1|||
30743294|NCT00313716|58753994|FG003|Overall Study|Withdrawal by Subject|0|||
30743295|NCT00313716|58753995|FG004|Overall Study|Withdrawal by Subject|1|||
30743296|NCT00313716|58753996|FG005|Overall Study|Withdrawal by Subject|0|||
30743297|NCT00313170|58754017|FG000|Overall Study|Death|2|||
30743298|NCT00313170|58754018|FG001|Overall Study|Death|4|||
30743299|NCT00313170|58754019|FG002|Overall Study|Death|2|||
30743300|NCT00313170|58754017|FG000|Overall Study|Adverse Event|1|||
30743301|NCT00313170|58754018|FG001|Overall Study|Adverse Event|2|||
30743302|NCT00313170|58754019|FG002|Overall Study|Adverse Event|0|||
30743303|NCT00313170|58754017|FG000|Overall Study|Disease progression|31|||
30902141|NCT01815736|58936044|FG001|Extension Treatment Phase- After Week 96|Death|0|||
30902142|NCT01651949|58936055|FG000|Overall Study|Unknown status|4|||
30743304|NCT00313170|58754018|FG001|Overall Study|Disease progression|26|||
30743305|NCT00313170|58754019|FG002|Overall Study|Disease progression|27|||
30743306|NCT00313170|58754017|FG000|Overall Study|Withdrawal by Subject|1|||
30743307|NCT00313170|58754018|FG001|Overall Study|Withdrawal by Subject|0|||
30743308|NCT00313170|58754019|FG002|Overall Study|Withdrawal by Subject|1|||
30743309|NCT00313170|58754017|FG000|Overall Study|Incorrect enrollment|0|||
30743310|NCT00313170|58754018|FG001|Overall Study|Incorrect enrollment|2|||
30743311|NCT00313170|58754019|FG002|Overall Study|Incorrect enrollment|1|||
30743312|NCT00313170|58754017|FG000|Overall Study|Lost to Follow-up|0|||
30902143|NCT01651949|58936056|FG001|Overall Study|Unknown status|4|||
30902144|NCT01651949|58936057|FG002|Overall Study|Unknown status|0|||
30743313|NCT00313170|58754018|FG001|Overall Study|Lost to Follow-up|0|||
30743314|NCT00313170|58754019|FG002|Overall Study|Lost to Follow-up|1|||
30743315|NCT00313170|58754017|FG000|Overall Study|Progression (investigators opinion)|1|||
30622008|NCT01147068|58633526|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
30622009|NCT01147068|58633527|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
30622010|NCT01147068|58633528|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
30622011|NCT01147068|58633522|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
30622012|NCT01147068|58633523|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
30743316|NCT00313170|58754018|FG001|Overall Study|Progression (investigators opinion)|0|||
30743317|NCT00313170|58754019|FG002|Overall Study|Progression (investigators opinion)|0|||
30743318|NCT00332462|58754028|FG000|Overall Study|Adverse Event|5|||
30743319|NCT00332462|58754028|FG000|Overall Study|Abnormal Lab Value|1|||
30743320|NCT00332462|58754028|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
30743321|NCT00332462|58754028|FG000|Overall Study|no longer requires study drug|1|||
30743322|NCT00332462|58754028|FG000|Overall Study|Death|3|||
30743323|NCT00332462|58754028|FG000|Overall Study|Graft Loss|2|||
30743324|NCT00324038|58754037|FG000|Overall Study|Adverse Event|38|||
30743325|NCT00324038|58754038|FG001|Overall Study|Adverse Event|23|||
30743326|NCT00324038|58754037|FG000|Overall Study|Lack of Efficacy|5|||
30743327|NCT00324038|58754038|FG001|Overall Study|Lack of Efficacy|13|||
30743328|NCT00324038|58754037|FG000|Overall Study|Lost to Follow-up|0|||
30902145|NCT01651949|58936055|FG000|Overall Study|Lost to Follow-up|30|||
30902146|NCT01651949|58936056|FG001|Overall Study|Lost to Follow-up|56|||
30743329|NCT00324038|58754038|FG001|Overall Study|Lost to Follow-up|2|||
30743330|NCT00324038|58754037|FG000|Overall Study|Other|6|||
30743331|NCT00324038|58754038|FG001|Overall Study|Other|13|||
30743332|NCT00159861|58754046|FG000|Core Study - 16 Weeks|Death|3|||
30743333|NCT00159861|58754047|FG001|Core Study - 16 Weeks|Death|0|||
30743334|NCT00159861|58754046|FG000|Core Study - 16 Weeks|Adverse Event|12|||
30743335|NCT00159861|58754047|FG001|Core Study - 16 Weeks|Adverse Event|6|||
30743336|NCT00159861|58754046|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
30743337|NCT00159861|58754047|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
30743338|NCT00159861|58754046|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
30743339|NCT00159861|58754047|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
30743340|NCT00159861|58754046|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
30743341|NCT00159861|58754047|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
30743342|NCT00159861|58754046|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
30743343|NCT00159861|58754047|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
30743344|NCT00159861|58754046|FG000|Extension Study - up to 3 Years|Death|24|||
30743345|NCT00159861|58754047|FG001|Extension Study - up to 3 Years|Death|28|||
30743346|NCT00159861|58754046|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
30743347|NCT00159861|58754047|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
30743348|NCT00159861|58754046|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
30743349|NCT00159861|58754047|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
30743350|NCT00159861|58754046|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
30743351|NCT00159861|58754047|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
30743352|NCT00159861|58754046|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
30743353|NCT00159861|58754047|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
30743354|NCT00331760|58754060|FG000|Overall Study|Ineligible / no protocol treatment|15|||
30743355|NCT00331760|58754061|FG001|Overall Study|Ineligible / no protocol treatment|8|||
30743356|NCT00225147|58754072|FG000|Open-label Phase|Lost to Follow-up|0|||
30743357|NCT00225147|58754073|FG001|Open-label Phase|Lost to Follow-up|0|||
30743358|NCT00225147|58754074|FG002|Open-label Phase|Lost to Follow-up|0|||
30743359|NCT00225147|58754075|FG003|Open-label Phase|Lost to Follow-up|4|||
30902147|NCT01651949|58936057|FG002|Overall Study|Lost to Follow-up|20|||
30902148|NCT01651949|58936055|FG000|Overall Study|Protocol Violation|0|||
30902149|NCT01651949|58936056|FG001|Overall Study|Protocol Violation|2|||
30902150|NCT01651949|58936057|FG002|Overall Study|Protocol Violation|1|||
30902151|NCT01651949|58936055|FG000|Overall Study|Physician Decision|0|||
30902152|NCT01651949|58936056|FG001|Overall Study|Physician Decision|2|||
30902153|NCT01651949|58936057|FG002|Overall Study|Physician Decision|0|||
30902154|NCT01651949|58936055|FG000|Overall Study|Adverse Event|0|||
30902155|NCT01651949|58936056|FG001|Overall Study|Adverse Event|2|||
30902156|NCT01651949|58936057|FG002|Overall Study|Adverse Event|1|||
30902157|NCT01651949|58936055|FG000|Overall Study|Screen failure|2|||
30902158|NCT01651949|58936056|FG001|Overall Study|Screen failure|2|||
30902159|NCT01651949|58936057|FG002|Overall Study|Screen failure|0|||
30902160|NCT01651949|58936055|FG000|Overall Study|Withdrawal by Subject|17|||
30902161|NCT01651949|58936056|FG001|Overall Study|Withdrawal by Subject|18|||
30902162|NCT01651949|58936057|FG002|Overall Study|Withdrawal by Subject|9|||
30902163|NCT02387957|58936068|FG000|Overall Study|The study was discontinued|21|||
30902164|NCT02387957|58936069|FG001|Overall Study|The study was discontinued|21|||
30902165|NCT02387957|58936070|FG002|Overall Study|The study was discontinued|20|||
30902166|NCT01800916|58936078|FG000|Test Period 1 (1 Week)|Convex product user|0|||
30902167|NCT01800916|58936079|FG001|Test Period 1 (1 Week)|Convex product user|0|||
30902168|NCT01800916|58936080|FG002|Test Period 1 (1 Week)|Convex product user|0|||
30902169|NCT01800916|58936081|FG003|Test Period 1 (1 Week)|Convex product user|1|||
30902170|NCT01800916|58936082|FG004|Test Period 1 (1 Week)|Convex product user|0|||
30902171|NCT01800916|58936083|FG005|Test Period 1 (1 Week)|Convex product user|0|||
30902172|NCT01800916|58936084|FG006|Test Period 1 (1 Week)|Convex product user|0|||
30622013|NCT01147068|58633524|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
30743360|NCT00225147|58754072|FG000|Open-label Phase|Withdrawal by Subject|0|||
30902173|NCT01800916|58936085|FG007|Test Period 1 (1 Week)|Convex product user|0|||
30743361|NCT00225147|58754073|FG001|Open-label Phase|Withdrawal by Subject|0|||
30743362|NCT00225147|58754074|FG002|Open-label Phase|Withdrawal by Subject|0|||
30743363|NCT00225147|58754075|FG003|Open-label Phase|Withdrawal by Subject|6|||
30743364|NCT00313014|58754090|FG000|Overall Study|Withdrawal by Subject|11|||
30743365|NCT00313014|58754091|FG001|Overall Study|Withdrawal by Subject|7|||
30743366|NCT00313014|58754092|FG002|Overall Study|Withdrawal by Subject|5|||
30902174|NCT01800916|58936086|FG008|Test Period 1 (1 Week)|Convex product user|0|||
30902175|NCT01800916|58936078|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
30902176|NCT01800916|58936079|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
30902177|NCT01800916|58936080|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
30902178|NCT01800916|58936081|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
30902179|NCT01800916|58936082|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
30902180|NCT01800916|58936083|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
30902181|NCT01800916|58936084|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
30902182|NCT01800916|58936085|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
30902183|NCT01800916|58936086|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
30743367|NCT00313014|58754090|FG000|Overall Study|Adverse Event|14|||
30743368|NCT00313014|58754091|FG001|Overall Study|Adverse Event|29|||
30743369|NCT00313014|58754092|FG002|Overall Study|Adverse Event|16|||
30743370|NCT00313014|58754090|FG000|Overall Study|Lost to Follow-up|7|||
30743371|NCT00313014|58754091|FG001|Overall Study|Lost to Follow-up|6|||
30743372|NCT00313014|58754092|FG002|Overall Study|Lost to Follow-up|10|||
30743373|NCT00313014|58754090|FG000|Overall Study|Administrative|9|||
30743374|NCT00313014|58754091|FG001|Overall Study|Administrative|6|||
30743375|NCT00313014|58754092|FG002|Overall Study|Administrative|14|||
30743376|NCT00313014|58754090|FG000|Overall Study|Lack of Efficacy|52|||
30743377|NCT00313014|58754091|FG001|Overall Study|Lack of Efficacy|25|||
30743378|NCT00313014|58754092|FG002|Overall Study|Lack of Efficacy|16|||
30743379|NCT00157209|58754103|FG000|Overall Study|Ongoing at data cut-off|10|||
30743380|NCT00157209|58754104|FG001|Overall Study|Ongoing at data cut-off|0|||
30743381|NCT00312858|58754112|FG000|Overall Study|Adverse Event|0|||
30743382|NCT00312858|58754113|FG001|Overall Study|Adverse Event|1|||
30743383|NCT00312858|58754112|FG000|Overall Study|Lost to Follow-up|25|||
30743384|NCT00312858|58754113|FG001|Overall Study|Lost to Follow-up|42|||
30743385|NCT00312858|58754112|FG000|Overall Study|Protocol Violation|3|||
30743386|NCT00312858|58754113|FG001|Overall Study|Protocol Violation|8|||
30902184|NCT01800058|58936096|FG000|Overall Study|Lost to Follow-up|1|||
30902185|NCT01815580|58936103|FG000|Overall Study|Lost to Follow-up|4|||
30743387|NCT00312858|58754112|FG000|Overall Study|Withdraw by Participant|20|||
30743388|NCT00312858|58754113|FG001|Overall Study|Withdraw by Participant|20|||
30743389|NCT00312858|58754112|FG000|Overall Study|Participant Moved|11|||
30743390|NCT00312858|58754113|FG001|Overall Study|Participant Moved|10|||
30743391|NCT00312858|58754112|FG000|Overall Study|Other|9|||
30743392|NCT00312858|58754113|FG001|Overall Study|Other|12|||
30743393|NCT00312702|58754122|FG000|Immunization Phase|Lost to Follow-up|0|||
30743394|NCT00312702|58754123|FG001|Immunization Phase|Lost to Follow-up|1|||
30743395|NCT00312702|58754124|FG002|Immunization Phase|Lost to Follow-up|0|||
30743396|NCT00156819|58754135|FG000|Overall Study|Lost to Follow-up|1|||
30743397|NCT00156819|58754136|FG001|Overall Study|Lost to Follow-up|1|||
30743398|NCT00156819|58754137|FG002|Overall Study|Lost to Follow-up|3|||
30743399|NCT03825042|58754147|FG000|Overall Study|Adverse Event|1|||
30743400|NCT03825042|58754148|FG001|Overall Study|Adverse Event|0|||
30743401|NCT03825042|58754147|FG000|Overall Study|Withdrawal by Subject|1|||
30743402|NCT03825042|58754148|FG001|Overall Study|Withdrawal by Subject|0|||
30743403|NCT00129987|58754156|FG000|1st Educational Session|Withdrawal by Subject|141|||
30743404|NCT00129987|58754157|FG001|1st Educational Session|Withdrawal by Subject|109|||
30743405|NCT00129987|58754156|FG000|1 Year|Withdrawal by Subject|32|||
30743406|NCT00129987|58754157|FG001|1 Year|Withdrawal by Subject|21|||
30743407|NCT00224133|58754163|FG000|Overall Study|Adverse Event|93|||
30743408|NCT00224133|58754163|FG000|Overall Study|Protocol Violation|6|||
30743409|NCT00224133|58754163|FG000|Overall Study|Withdrawal by Subject|33|||
30743410|NCT00224133|58754163|FG000|Overall Study|Lack of Efficacy|58|||
30743411|NCT00224133|58754163|FG000|Overall Study|Lost to Follow-up|21|||
30743412|NCT00224133|58754163|FG000|Overall Study|Physician Decision|1|||
30743413|NCT00224133|58754163|FG000|Overall Study|Other|14|||
30743414|NCT00224055|58754169|FG000|Overall Study|Adverse Event|9|||
30743415|NCT00224055|58754170|FG001|Overall Study|Adverse Event|3|||
30743416|NCT00224055|58754169|FG000|Overall Study|Lost to Follow-up|1|||
30743417|NCT00224055|58754170|FG001|Overall Study|Lost to Follow-up|2|||
30743418|NCT00224055|58754169|FG000|Overall Study|Protocol Violation|1|||
30743419|NCT00224055|58754170|FG001|Overall Study|Protocol Violation|1|||
30743420|NCT00224055|58754169|FG000|Overall Study|Inclusion Violation|3|||
30743421|NCT00224055|58754170|FG001|Overall Study|Inclusion Violation|6|||
30743422|NCT00224055|58754169|FG000|Overall Study|Withdrawal by Subject|0|||
30743423|NCT00224055|58754170|FG001|Overall Study|Withdrawal by Subject|2|||
30743424|NCT00224055|58754169|FG000|Overall Study|Other|1|||
30902186|NCT01815580|58936104|FG001|Overall Study|Lost to Follow-up|7|||
30743425|NCT00224055|58754170|FG001|Overall Study|Other|0|||
30743426|NCT00150969|58754178|FG000|24 Month Main Study|Adverse Event|3|||
30743427|NCT00150969|58754179|FG001|24 Month Main Study|Adverse Event|4|||
30743428|NCT00150969|58754178|FG000|24 Month Main Study|Death|1|||
30743429|NCT00150969|58754179|FG001|24 Month Main Study|Death|1|||
30743430|NCT00150969|58754178|FG000|24 Month Main Study|Lack of Efficacy|1|||
30743431|NCT00150969|58754179|FG001|24 Month Main Study|Lack of Efficacy|8|||
30902187|NCT01815580|58936103|FG000|Overall Study|Withdrawal by Subject|3|||
30743432|NCT00150969|58754178|FG000|24 Month Main Study|Lost to Follow-up|3|||
30743433|NCT00150969|58754179|FG001|24 Month Main Study|Lost to Follow-up|2|||
30743434|NCT00150969|58754178|FG000|24 Month Main Study|Protocol Violation|4|||
30743435|NCT00150969|58754179|FG001|24 Month Main Study|Protocol Violation|2|||
30743436|NCT00150969|58754178|FG000|24 Month Main Study|Withdrawal by Subject|7|||
30743437|NCT00150969|58754179|FG001|24 Month Main Study|Withdrawal by Subject|4|||
30743438|NCT00150969|58754178|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
30743439|NCT00150969|58754179|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
30743440|NCT00150969|58754178|FG000|24-48 Month Extension|Lack of Efficacy|0|||
30743441|NCT00150969|58754179|FG001|24-48 Month Extension|Lack of Efficacy|1|||
30743442|NCT00150969|58754178|FG000|24-48 Month Extension|Adverse Event|1|||
30743443|NCT00150969|58754179|FG001|24-48 Month Extension|Adverse Event|3|||
30743444|NCT00150969|58754178|FG000|24-48 Month Extension|Other Reason|81|||
30743445|NCT00150969|58754179|FG001|24-48 Month Extension|Other Reason|91|||
30743446|NCT00150345|58754188|FG000|Overall Study|Death|5|||
30743447|NCT00150345|58754189|FG001|Overall Study|Death|2|||
30743448|NCT00150345|58754188|FG000|Overall Study|Adverse Event|8|||
30743449|NCT00150345|58754189|FG001|Overall Study|Adverse Event|6|||
30743450|NCT00150345|58754188|FG000|Overall Study|Lack of Efficacy|5|||
30743451|NCT00150345|58754189|FG001|Overall Study|Lack of Efficacy|4|||
30743452|NCT00150345|58754188|FG000|Overall Study|Withdrawal by Subject|3|||
30743453|NCT00150345|58754189|FG001|Overall Study|Withdrawal by Subject|4|||
30743454|NCT00150345|58754188|FG000|Overall Study|Laboratory abnormality|1|||
30743455|NCT00150345|58754189|FG001|Overall Study|Laboratory abnormality|2|||
30743456|NCT00150345|58754188|FG000|Overall Study|Other|12|||
30743457|NCT00150345|58754189|FG001|Overall Study|Other|14|||
30743458|NCT00223977|58754199|FG000|Overall Study|Adverse Event|7|||
30743459|NCT00223977|58754200|FG001|Overall Study|Adverse Event|10|||
30743460|NCT00223977|58754201|FG002|Overall Study|Adverse Event|0|||
30743461|NCT00223977|58754199|FG000|Overall Study|Protocol Violation|0|||
30743462|NCT00223977|58754200|FG001|Overall Study|Protocol Violation|0|||
30743463|NCT00223977|58754201|FG002|Overall Study|Protocol Violation|1|||
30743464|NCT00223977|58754199|FG000|Overall Study|Withdrawal by Subject|1|||
30743465|NCT00223977|58754200|FG001|Overall Study|Withdrawal by Subject|1|||
30743466|NCT00223977|58754201|FG002|Overall Study|Withdrawal by Subject|2|||
30743467|NCT00223977|58754199|FG000|Overall Study|Other|1|||
30743468|NCT00223977|58754200|FG001|Overall Study|Other|0|||
30743469|NCT00223977|58754201|FG002|Overall Study|Other|0|||
30743470|NCT00148941|58754213|FG000|Overall Study|Lost to Follow-up|17|||
30743471|NCT00148941|58754214|FG001|Overall Study|Lost to Follow-up|24|||
30743472|NCT00148941|58754215|FG002|Overall Study|Lost to Follow-up|18|||
30743473|NCT00148941|58754216|FG003|Overall Study|Lost to Follow-up|22|||
30743474|NCT00148941|58754213|FG000|Overall Study|Withdrawal by Subject|1|||
30743475|NCT00148941|58754214|FG001|Overall Study|Withdrawal by Subject|0|||
30743476|NCT00148941|58754215|FG002|Overall Study|Withdrawal by Subject|1|||
30743477|NCT00148941|58754216|FG003|Overall Study|Withdrawal by Subject|0|||
30743478|NCT00148941|58754213|FG000|Overall Study|Other|0|||
30743479|NCT00148941|58754214|FG001|Overall Study|Other|0|||
30743480|NCT00148941|58754215|FG002|Overall Study|Other|1|||
30743481|NCT00148941|58754216|FG003|Overall Study|Other|2|||
30743482|NCT00148317|58754226|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
30743483|NCT00148317|58754226|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
30743484|NCT00148317|58754226|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
30743485|NCT00323882|58754238|FG000|Overall Study|Adverse Event|2|||
30743486|NCT00323882|58754239|FG001|Overall Study|Adverse Event|1|||
30743487|NCT00323882|58754240|FG002|Overall Study|Adverse Event|1|||
30743488|NCT00323882|58754241|FG003|Overall Study|Adverse Event|1|||
30743489|NCT00323882|58754242|FG004|Overall Study|Adverse Event|3|||
30743490|NCT00323882|58754238|FG000|Overall Study|Disease Progression|6|||
30743491|NCT00323882|58754239|FG001|Overall Study|Disease Progression|4|||
30743492|NCT00323882|58754240|FG002|Overall Study|Disease Progression|10|||
30743493|NCT00323882|58754241|FG003|Overall Study|Disease Progression|5|||
30743494|NCT00323882|58754242|FG004|Overall Study|Disease Progression|22|||
30743495|NCT00323882|58754238|FG000|Overall Study|Death|0|||
30743496|NCT00323882|58754239|FG001|Overall Study|Death|1|||
30743497|NCT00323882|58754240|FG002|Overall Study|Death|1|||
30743498|NCT00323882|58754241|FG003|Overall Study|Death|0|||
30902188|NCT01815580|58936104|FG001|Overall Study|Withdrawal by Subject|4|||
30902189|NCT01815580|58936103|FG000|Overall Study|Excluded from analysis|5|||
30743499|NCT00323882|58754242|FG004|Overall Study|Death|5|||
30743500|NCT00323882|58754238|FG000|Overall Study|Lost to Follow-up|0|||
30743501|NCT00323882|58754239|FG001|Overall Study|Lost to Follow-up|0|||
30743502|NCT00323882|58754240|FG002|Overall Study|Lost to Follow-up|1|||
30743503|NCT00323882|58754241|FG003|Overall Study|Lost to Follow-up|0|||
30743504|NCT00323882|58754242|FG004|Overall Study|Lost to Follow-up|1|||
30622014|NCT01147068|58633525|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
30743505|NCT00323882|58754238|FG000|Overall Study|Other|0|||
30743506|NCT00323882|58754239|FG001|Overall Study|Other|0|||
30743507|NCT00323882|58754240|FG002|Overall Study|Other|0|||
30743508|NCT00323882|58754241|FG003|Overall Study|Other|1|||
30743509|NCT00323882|58754242|FG004|Overall Study|Other|1|||
30743510|NCT00331682|58754263|FG000|Overall Study|Adverse Event|1|||
30743511|NCT00323492|58754269|FG000|Study Phase 1|Adverse Event|2|||
30743512|NCT00323492|58754270|FG001|Study Phase 1|Adverse Event|0|||
30743513|NCT00323492|58754271|FG002|Study Phase 1|Adverse Event|0|||
30743514|NCT00323492|58754269|FG000|Study Phase 2|Adverse Event|1|||
30743515|NCT00323492|58754270|FG001|Study Phase 2|Adverse Event|0|||
30743516|NCT00323492|58754271|FG002|Study Phase 2|Adverse Event|0|||
30743517|NCT00323492|58754269|FG000|Study Phase 2|Physician Decision|1|||
30743518|NCT00323492|58754270|FG001|Study Phase 2|Physician Decision|0|||
30743519|NCT00323492|58754271|FG002|Study Phase 2|Physician Decision|0|||
30743520|NCT00323492|58754269|FG000|Study Phase 2|Lost to Follow-up|1|||
30743521|NCT00323492|58754270|FG001|Study Phase 2|Lost to Follow-up|0|||
30743522|NCT00323492|58754271|FG002|Study Phase 2|Lost to Follow-up|0|||
30743523|NCT00323492|58754269|FG000|Study Phase 2|Withdrawal by Subject|0|||
30743524|NCT00323492|58754270|FG001|Study Phase 2|Withdrawal by Subject|1|||
30743525|NCT00323492|58754271|FG002|Study Phase 2|Withdrawal by Subject|0|||
30743526|NCT00323492|58754269|FG000|Study Phase 2|Noncompliance with study schedule|0|||
30743527|NCT00323492|58754270|FG001|Study Phase 2|Noncompliance with study schedule|0|||
30743528|NCT00323492|58754271|FG002|Study Phase 2|Noncompliance with study schedule|1|||
30743529|NCT00323492|58754269|FG000|Study Phase 2|Protocol Violation|1|||
30743530|NCT00323492|58754270|FG001|Study Phase 2|Protocol Violation|0|||
30743531|NCT00323492|58754271|FG002|Study Phase 2|Protocol Violation|0|||
30743532|NCT00331136|58754282|FG000|Overall Study|Adverse Event|3|||
30743533|NCT00331136|58754283|FG001|Overall Study|Adverse Event|5|||
30743534|NCT00331136|58754284|FG002|Overall Study|Adverse Event|0|||
30743535|NCT00331136|58754285|FG003|Overall Study|Adverse Event|1|||
30743536|NCT00331136|58754282|FG000|Overall Study|Withdrawal by Subject|0|||
30743537|NCT00331136|58754283|FG001|Overall Study|Withdrawal by Subject|1|||
30743538|NCT00331136|58754284|FG002|Overall Study|Withdrawal by Subject|0|||
30743539|NCT00331136|58754285|FG003|Overall Study|Withdrawal by Subject|0|||
30743540|NCT00331136|58754282|FG000|Overall Study|Lost to Follow-up|0|||
30743541|NCT00331136|58754283|FG001|Overall Study|Lost to Follow-up|1|||
30743542|NCT00331136|58754284|FG002|Overall Study|Lost to Follow-up|0|||
30743543|NCT00331136|58754285|FG003|Overall Study|Lost to Follow-up|0|||
30743544|NCT00331136|58754282|FG000|Overall Study|Protocol Violation|1|||
30743545|NCT00331136|58754283|FG001|Overall Study|Protocol Violation|0|||
30743546|NCT00331136|58754284|FG002|Overall Study|Protocol Violation|0|||
30743547|NCT00331136|58754285|FG003|Overall Study|Protocol Violation|0|||
30743548|NCT00331136|58754282|FG000|Overall Study|Not treated|1|||
30743549|NCT00331136|58754283|FG001|Overall Study|Not treated|0|||
30743550|NCT00331136|58754284|FG002|Overall Study|Not treated|0|||
30743551|NCT00331136|58754285|FG003|Overall Study|Not treated|0|||
30743552|NCT00323414|58754297|FG000|Overall Study|Withdrawal by Subject|0|||
30743553|NCT00323414|58754298|FG001|Overall Study|Withdrawal by Subject|1|||
30743554|NCT00330668|58754304|FG000|BID Dosing Period|Adverse Event|1|||
30743555|NCT00330668|58754304|FG000|BID Dosing Period|Lost to Follow-up|7|||
30743556|NCT00330668|58754304|FG000|BID Dosing Period|Non-Compliance|5|||
30743557|NCT00330668|58754304|FG000|BID Dosing Period|Withdrawal by Subject|19|||
30743558|NCT00330668|58754304|FG000|BID Dosing Period|Sponsor's decision|1|||
30743559|NCT00330668|58754304|FG000|BID Dosing Period|Other|3|||
30743560|NCT00330668|58754304|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
30743561|NCT00330668|58754304|FG000|QD Dosing Period|Other|1|||
30743562|NCT00330668|58754304|FG000|QD Dosing Period|Withdrawal by Subject|1|||
30743563|NCT00330668|58754304|FG000|QD Dosing Period|Lost to Follow-up|2|||
30743564|NCT00306384|58754311|FG000|Overall Study|Adverse Event|103|||
30743565|NCT00306384|58754312|FG001|Overall Study|Adverse Event|87|||
30743566|NCT00306384|58754313|FG002|Overall Study|Adverse Event|40|||
30743567|NCT00306384|58754311|FG000|Overall Study|Major protocol deviation|43|||
30743568|NCT00306384|58754312|FG001|Overall Study|Major protocol deviation|51|||
30743569|NCT00306384|58754313|FG002|Overall Study|Major protocol deviation|18|||
30743570|NCT00306384|58754311|FG000|Overall Study|Lost to Follow-up|57|||
30743571|NCT00306384|58754312|FG001|Overall Study|Lost to Follow-up|41|||
30743572|NCT00306384|58754313|FG002|Overall Study|Lost to Follow-up|35|||
30743573|NCT00306384|58754311|FG000|Overall Study|Voluntary withdrawal|199|||
30743574|NCT00306384|58754312|FG001|Overall Study|Voluntary withdrawal|187|||
30743575|NCT00306384|58754313|FG002|Overall Study|Voluntary withdrawal|91|||
30743576|NCT00306384|58754311|FG000|Overall Study|Study termination|1|||
30743577|NCT00306384|58754312|FG001|Overall Study|Study termination|0|||
30743578|NCT00306384|58754313|FG002|Overall Study|Study termination|1|||
30743579|NCT00306384|58754311|FG000|Overall Study|Pregnancy|3|||
30743580|NCT00306384|58754312|FG001|Overall Study|Pregnancy|1|||
30743581|NCT00306384|58754313|FG002|Overall Study|Pregnancy|1|||
30743582|NCT00306384|58754311|FG000|Overall Study|Lack of Efficacy|26|||
30743583|NCT00306384|58754312|FG001|Overall Study|Lack of Efficacy|40|||
30743584|NCT00306384|58754313|FG002|Overall Study|Lack of Efficacy|38|||
30743585|NCT00306384|58754311|FG000|Overall Study|Investigator discretion|28|||
30743586|NCT00306384|58754312|FG001|Overall Study|Investigator discretion|31|||
30743587|NCT00306384|58754313|FG002|Overall Study|Investigator discretion|21|||
30743588|NCT00306384|58754311|FG000|Overall Study|Other|80|||
30743589|NCT00306384|58754312|FG001|Overall Study|Other|70|||
30743590|NCT00306384|58754313|FG002|Overall Study|Other|32|||
30743591|NCT00306384|58754311|FG000|Overall Study|Site closure|2|||
30743592|NCT00306384|58754312|FG001|Overall Study|Site closure|0|||
30743593|NCT00306384|58754313|FG002|Overall Study|Site closure|0|||
30743594|NCT00305604|58754323|FG000|Overall Study|Adverse Event|6|||
30743595|NCT00305604|58754324|FG001|Overall Study|Adverse Event|3|||
30743596|NCT00305604|58754323|FG000|Overall Study|Lack of Efficacy|11|||
30743597|NCT00305604|58754324|FG001|Overall Study|Lack of Efficacy|18|||
30743598|NCT00305604|58754323|FG000|Overall Study|Lost to Follow-up|0|||
30743599|NCT00305604|58754324|FG001|Overall Study|Lost to Follow-up|4|||
30743600|NCT00305604|58754323|FG000|Overall Study|Protocol Violation|2|||
30743601|NCT00305604|58754324|FG001|Overall Study|Protocol Violation|1|||
30743602|NCT00305604|58754323|FG000|Overall Study|Withdrawal by Subject|12|||
30902190|NCT01815580|58936104|FG001|Overall Study|Excluded from analysis|4|||
30902191|NCT01799590|58936118|FG000|Overall Study|Adverse Event|13|||
30902192|NCT01799590|58936119|FG001|Overall Study|Adverse Event|7|||
30902193|NCT01799590|58936120|FG002|Overall Study|Adverse Event|5|||
30902194|NCT01799590|58936118|FG000|Overall Study|Pregnancy|2|||
30902195|NCT01799590|58936119|FG001|Overall Study|Pregnancy|0|||
30902196|NCT01799590|58936120|FG002|Overall Study|Pregnancy|0|||
30902197|NCT01799590|58936118|FG000|Overall Study|Lack of Efficacy|3|||
30902198|NCT01799590|58936119|FG001|Overall Study|Lack of Efficacy|1|||
30902199|NCT01799590|58936120|FG002|Overall Study|Lack of Efficacy|3|||
30902200|NCT01799590|58936118|FG000|Overall Study|Participants convenience|4|||
30902201|NCT01799590|58936119|FG001|Overall Study|Participants convenience|4|||
30902202|NCT01799590|58936120|FG002|Overall Study|Participants convenience|2|||
30902203|NCT01799590|58936118|FG000|Overall Study|Aggravation of complications|0|||
30902204|NCT01799590|58936119|FG001|Overall Study|Aggravation of complications|1|||
30902205|NCT01799590|58936120|FG002|Overall Study|Aggravation of complications|1|||
30902206|NCT01799590|58936118|FG000|Overall Study|Using drugs with restricted days of use|0|||
30902207|NCT01799590|58936119|FG001|Overall Study|Using drugs with restricted days of use|3|||
30902208|NCT01799590|58936120|FG002|Overall Study|Using drugs with restricted days of use|2|||
30902209|NCT01799590|58936118|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
30902210|NCT01799590|58936119|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
30902211|NCT01799590|58936120|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
30902212|NCT01799590|58936118|FG000|Overall Study|Other|3|||
30902213|NCT01799590|58936119|FG001|Overall Study|Other|0|||
30902214|NCT01799590|58936120|FG002|Overall Study|Other|1|||
30902215|NCT01815424|58936131|FG000|Week 0 to 16|Adverse Event|1|||
30902216|NCT01815424|58936132|FG001|Week 0 to 16|Adverse Event|3|||
30902217|NCT01815424|58936133|FG002|Week 0 to 16|Adverse Event|3|||
30902218|NCT01815424|58936134|FG003|Week 0 to 16|Adverse Event|0|||
30902219|NCT01815424|58936135|FG004|Week 0 to 16|Adverse Event|0|||
30902220|NCT01815424|58936131|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
30902221|NCT01815424|58936132|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
30902222|NCT01815424|58936133|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
30902223|NCT01815424|58936134|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
30902224|NCT01815424|58936135|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
30902225|NCT01815424|58936131|FG000|Week 0 to 16|Lost to Follow-up|0|||
30902226|NCT01815424|58936132|FG001|Week 0 to 16|Lost to Follow-up|1|||
30902227|NCT01815424|58936133|FG002|Week 0 to 16|Lost to Follow-up|0|||
30902228|NCT01815424|58936134|FG003|Week 0 to 16|Lost to Follow-up|0|||
30902229|NCT01815424|58936135|FG004|Week 0 to 16|Lost to Follow-up|0|||
30902230|NCT01815424|58936131|FG000|Week 0 to 16|Withdrawal by Subject|0|||
30622015|NCT01147068|58633526|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
30622016|NCT01147068|58633527|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
30622017|NCT01147068|58633528|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
30622018|NCT01147068|58633522|FG000|Subjects That Received 2nd Dose|Other|0|||
30743603|NCT00305604|58754324|FG001|Overall Study|Withdrawal by Subject|21|||
30743604|NCT00305604|58754323|FG000|Overall Study|Patient moved|1|||
30622019|NCT01147068|58633523|FG001|Subjects That Received 2nd Dose|Other|3|||
30622020|NCT01147068|58633524|FG002|Subjects That Received 2nd Dose|Other|3|||
30902231|NCT01815424|58936132|FG001|Week 0 to 16|Withdrawal by Subject|0|||
30902232|NCT01815424|58936133|FG002|Week 0 to 16|Withdrawal by Subject|1|||
30902233|NCT01815424|58936134|FG003|Week 0 to 16|Withdrawal by Subject|0|||
30902234|NCT01815424|58936135|FG004|Week 0 to 16|Withdrawal by Subject|0|||
30902235|NCT01815424|58936131|FG000|Week 0 to 16|Other|1|||
30902236|NCT01815424|58936132|FG001|Week 0 to 16|Other|0|||
30743605|NCT00305604|58754324|FG001|Overall Study|Patient moved|0|||
30902237|NCT01815424|58936133|FG002|Week 0 to 16|Other|3|||
30743606|NCT00501059|58754332|FG000|Overall Study|Protocol Violation|80|||
30902238|NCT01815424|58936134|FG003|Week 0 to 16|Other|0|||
30902239|NCT01815424|58936135|FG004|Week 0 to 16|Other|0|||
30902240|NCT01815424|58936131|FG000|Week 0 to 16|Protocol Violation|1|||
30902241|NCT01815424|58936132|FG001|Week 0 to 16|Protocol Violation|0|||
30902242|NCT01815424|58936133|FG002|Week 0 to 16|Protocol Violation|0|||
30902243|NCT01815424|58936134|FG003|Week 0 to 16|Protocol Violation|0|||
30902244|NCT01815424|58936135|FG004|Week 0 to 16|Protocol Violation|0|||
30902245|NCT01815424|58936131|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
30743607|NCT00501059|58754333|FG001|Overall Study|Protocol Violation|69|||
30902246|NCT01815424|58936132|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
30902247|NCT01815424|58936133|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
30902248|NCT01815424|58936134|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
30902249|NCT01815424|58936135|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
30902250|NCT01815424|58936131|FG000|Week 16 to 52|Other|0|||
30902251|NCT01815424|58936132|FG001|Week 16 to 52|Other|1|||
30902252|NCT01815424|58936133|FG002|Week 16 to 52|Other|0|||
30622021|NCT01147068|58633525|FG003|Subjects That Received 2nd Dose|Other|0|||
30743608|NCT00501059|58754332|FG000|Overall Study|Death|140|||
30743609|NCT00501059|58754333|FG001|Overall Study|Death|137|||
30743610|NCT00501059|58754332|FG000|Overall Study|Other|236|||
30743611|NCT00501059|58754333|FG001|Overall Study|Other|239|||
30743612|NCT00501059|58754332|FG000|Overall Study|Missing end-of-study page|91|||
30743613|NCT00501059|58754333|FG001|Overall Study|Missing end-of-study page|92|||
30743614|NCT00501059|58754332|FG000|Overall Study|Clinical endpoint reached|110|||
30743615|NCT00501059|58754333|FG001|Overall Study|Clinical endpoint reached|123|||
30743616|NCT00501059|58754332|FG000|Overall Study|Insufficient therapeutic effect|4|||
30743617|NCT00501059|58754333|FG001|Overall Study|Insufficient therapeutic effect|5|||
30743618|NCT00501059|58754332|FG000|Overall Study|Consent withdrawn by subject|817|||
30743619|NCT00501059|58754333|FG001|Overall Study|Consent withdrawn by subject|873|||
30743620|NCT00501059|58754332|FG000|Overall Study|Non-compliant with study treatment|23|||
30743621|NCT00501059|58754333|FG001|Overall Study|Non-compliant with study treatment|16|||
30743622|NCT00501059|58754332|FG000|Overall Study|Reason not given|3|||
30743623|NCT00501059|58754333|FG001|Overall Study|Reason not given|1|||
30743624|NCT00501059|58754332|FG000|Overall Study|Adverse Event|129|||
30743625|NCT00501059|58754333|FG001|Overall Study|Adverse Event|122|||
30743626|NCT00501059|58754332|FG000|Overall Study|Lost to Follow-up|210|||
30743627|NCT00501059|58754333|FG001|Overall Study|Lost to Follow-up|198|||
30743628|NCT00501059|58754332|FG000|Overall Study|Not treated|25|||
30743629|NCT00501059|58754333|FG001|Overall Study|Not treated|17|||
30743630|NCT00344318|58754345|FG000|Overall Study|Adverse Event|0|||
30743631|NCT00344318|58754346|FG001|Overall Study|Adverse Event|3|||
30743632|NCT00344318|58754347|FG002|Overall Study|Adverse Event|0|||
30743633|NCT00344318|58754348|FG003|Overall Study|Adverse Event|1|||
30743634|NCT00344318|58754345|FG000|Overall Study|Withdrawal by Subject|2|||
30743635|NCT00344318|58754346|FG001|Overall Study|Withdrawal by Subject|2|||
30743636|NCT00344318|58754347|FG002|Overall Study|Withdrawal by Subject|0|||
30743637|NCT00344318|58754348|FG003|Overall Study|Withdrawal by Subject|2|||
30743638|NCT00344318|58754345|FG000|Overall Study|Lost to Follow-up|2|||
30743639|NCT00344318|58754346|FG001|Overall Study|Lost to Follow-up|0|||
30743640|NCT00344318|58754347|FG002|Overall Study|Lost to Follow-up|1|||
30743641|NCT00344318|58754348|FG003|Overall Study|Lost to Follow-up|0|||
30743642|NCT00323258|58754362|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
30743643|NCT00323258|58754363|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
30743644|NCT00323258|58754362|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
30743645|NCT00323258|58754363|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
30743646|NCT00323258|58754362|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
30743647|NCT00323258|58754363|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
30743648|NCT00323258|58754362|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
30743649|NCT00323258|58754363|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
30743650|NCT00323258|58754362|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
30743651|NCT00323258|58754363|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
30743652|NCT00323258|58754362|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
30743653|NCT00323258|58754363|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
30743654|NCT00323258|58754362|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
30902253|NCT01815424|58936134|FG003|Week 16 to 52|Other|0|||
30902254|NCT01815424|58936135|FG004|Week 16 to 52|Other|0|||
30902255|NCT01815424|58936131|FG000|Week 16 to 52|Adverse Event|0|||
30743655|NCT00323258|58754363|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
30743656|NCT00322868|58754369|FG000|Overall Study|disease progression|1|||
30743657|NCT00322712|58754374|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
30743658|NCT00343382|58754381|FG000|Overall Study|Adverse Event|2|||
30743659|NCT00343382|58754382|FG001|Overall Study|Adverse Event|10|||
30743660|NCT00343382|58754383|FG002|Overall Study|Adverse Event|7|||
30902256|NCT01815424|58936132|FG001|Week 16 to 52|Adverse Event|0|||
30743661|NCT00343382|58754381|FG000|Overall Study|Withdrawal by Subject|1|||
30743662|NCT00343382|58754382|FG001|Overall Study|Withdrawal by Subject|2|||
30743663|NCT00343382|58754383|FG002|Overall Study|Withdrawal by Subject|6|||
30743664|NCT00343382|58754381|FG000|Overall Study|Other Reason Not Specified|1|||
30743665|NCT00343382|58754382|FG001|Overall Study|Other Reason Not Specified|2|||
30743666|NCT00343382|58754383|FG002|Overall Study|Other Reason Not Specified|4|||
30743667|NCT00481871|58754396|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
30743668|NCT00481871|58754397|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
30743669|NCT00481871|58754398|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
30743670|NCT00481871|58754399|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
30743671|NCT00481871|58754400|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
30743672|NCT00329420|58754411|FG000|Re-induction Phase|Lack of Efficacy|0|||
30743673|NCT00329420|58754412|FG001|Re-induction Phase|Lack of Efficacy|1|||
30743674|NCT00329420|58754413|FG002|Re-induction Phase|Lack of Efficacy|0|||
30743675|NCT00329420|58754411|FG000|Re-induction Phase|Withdrawal of Consent|0|||
30743676|NCT00329420|58754412|FG001|Re-induction Phase|Withdrawal of Consent|0|||
30743677|NCT00329420|58754413|FG002|Re-induction Phase|Withdrawal of Consent|1|||
30743678|NCT00329420|58754411|FG000|Re-induction Phase|Did not respond to re-induction|6|||
30743679|NCT00329420|58754412|FG001|Re-induction Phase|Did not respond to re-induction|5|||
30743680|NCT00329420|58754413|FG002|Re-induction Phase|Did not respond to re-induction|7|||
30743681|NCT00329420|58754411|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
30743682|NCT00329420|58754412|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
30743683|NCT00329420|58754413|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
30743684|NCT00329420|58754411|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
30743685|NCT00329420|58754412|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
30743686|NCT00329420|58754413|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
30743687|NCT00329420|58754411|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
30743688|NCT00329420|58754412|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
30743689|NCT00329420|58754413|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
30743690|NCT00329108|58754425|FG000|Overall Study|Adverse Event|2|||
30743691|NCT00329108|58754426|FG001|Overall Study|Adverse Event|2|||
30743692|NCT00329108|58754425|FG000|Overall Study|Lack of Efficacy|3|||
30743693|NCT00329108|58754426|FG001|Overall Study|Lack of Efficacy|3|||
30743694|NCT00329108|58754425|FG000|Overall Study|Withdrawal by Subject|0|||
30743695|NCT00329108|58754426|FG001|Overall Study|Withdrawal by Subject|2|||
30743696|NCT00329108|58754425|FG000|Overall Study|symptomatic deterioration|1|||
30743697|NCT00329108|58754426|FG001|Overall Study|symptomatic deterioration|1|||
30743698|NCT00329108|58754425|FG000|Overall Study|Subject no longer willing to participate|2|||
30743699|NCT00329108|58754426|FG001|Overall Study|Subject no longer willing to participate|2|||
30743700|NCT00329108|58754425|FG000|Overall Study|study terminated by sponsor|1|||
30743701|NCT00329108|58754426|FG001|Overall Study|study terminated by sponsor|0|||
30743702|NCT00329108|58754425|FG000|Overall Study|withdrew patient after SAE resolved|1|||
30743703|NCT00329108|58754426|FG001|Overall Study|withdrew patient after SAE resolved|0|||
30743704|NCT00329108|58754425|FG000|Overall Study|Protocol Violation|0|||
30743705|NCT00329108|58754426|FG001|Overall Study|Protocol Violation|2|||
30743706|NCT00329030|58754434|FG000|Overall Study|Withdrawal by Subject|1|||
30743707|NCT00329030|58754435|FG001|Overall Study|Withdrawal by Subject|3|||
30743708|NCT00329030|58754434|FG000|Overall Study|Progressive Disease|6|||
30743709|NCT00329030|58754435|FG001|Overall Study|Progressive Disease|2|||
30743710|NCT00329030|58754434|FG000|Overall Study|Ineligible Pathology|1|||
30743711|NCT00329030|58754435|FG001|Overall Study|Ineligible Pathology|1|||
30743712|NCT00328562|58754441|FG000|Overall Study|Disease progression|1|||
30743713|NCT00328172|58754450|FG000|Overall Study|Adverse Event|3|||
30791017|NCT02742766|58804186|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30743714|NCT00328172|58754451|FG001|Overall Study|Adverse Event|2|||
30743715|NCT00328172|58754452|FG002|Overall Study|Adverse Event|1|||
30743716|NCT00328172|58754453|FG003|Overall Study|Adverse Event|2|||
30743717|NCT00328172|58754454|FG004|Overall Study|Adverse Event|1|||
30743718|NCT00328172|58754450|FG000|Overall Study|Protocol Violation|0|||
30743719|NCT00328172|58754451|FG001|Overall Study|Protocol Violation|1|||
30743720|NCT00328172|58754452|FG002|Overall Study|Protocol Violation|1|||
30743721|NCT00328172|58754453|FG003|Overall Study|Protocol Violation|0|||
30743722|NCT00328172|58754454|FG004|Overall Study|Protocol Violation|0|||
30743723|NCT00328172|58754450|FG000|Overall Study|Lost to Follow-up|1|||
30743724|NCT00328172|58754451|FG001|Overall Study|Lost to Follow-up|1|||
30743725|NCT00328172|58754452|FG002|Overall Study|Lost to Follow-up|2|||
30743726|NCT00328172|58754453|FG003|Overall Study|Lost to Follow-up|1|||
30743727|NCT00328172|58754454|FG004|Overall Study|Lost to Follow-up|1|||
30743728|NCT00328172|58754450|FG000|Overall Study|Withdrawal by Subject|1|||
30743729|NCT00328172|58754451|FG001|Overall Study|Withdrawal by Subject|1|||
30743730|NCT00328172|58754452|FG002|Overall Study|Withdrawal by Subject|1|||
30743731|NCT00328172|58754453|FG003|Overall Study|Withdrawal by Subject|6|||
30743732|NCT00328172|58754454|FG004|Overall Study|Withdrawal by Subject|0|||
30743733|NCT00328172|58754450|FG000|Overall Study|Lack of Efficacy|14|||
30743734|NCT00328172|58754451|FG001|Overall Study|Lack of Efficacy|9|||
30743735|NCT00328172|58754452|FG002|Overall Study|Lack of Efficacy|4|||
30743736|NCT00328172|58754453|FG003|Overall Study|Lack of Efficacy|4|||
30743737|NCT00328172|58754454|FG004|Overall Study|Lack of Efficacy|3|||
30743738|NCT00328172|58754450|FG000|Overall Study|Other reason (not specified)|3|||
30743739|NCT00328172|58754451|FG001|Overall Study|Other reason (not specified)|0|||
30743740|NCT00328172|58754452|FG002|Overall Study|Other reason (not specified)|1|||
30743741|NCT00328172|58754453|FG003|Overall Study|Other reason (not specified)|0|||
30743742|NCT00328172|58754454|FG004|Overall Study|Other reason (not specified)|0|||
30743743|NCT00328094|58754468|FG000|Overall Study|Physician Decision|3|||
30743744|NCT00328094|58754469|FG001|Overall Study|Physician Decision|3|||
30743745|NCT00500903|58754478|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
30743746|NCT00500903|58754479|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
30622022|NCT01147068|58633526|FG004|Subjects That Received 2nd Dose|Other|1|||
30743747|NCT00500903|58754480|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
30743748|NCT00500903|58754478|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
30743749|NCT00500903|58754479|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
30743750|NCT00500903|58754480|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
30743751|NCT00500903|58754478|FG000|Overall Study|Progressive Disease|41|||
30743752|NCT00500903|58754479|FG001|Overall Study|Progressive Disease|2|||
30743753|NCT00500903|58754480|FG002|Overall Study|Progressive Disease|15|||
30743754|NCT00500903|58754478|FG000|Overall Study|Patient Declined Further Treatment|0|||
30743755|NCT00500903|58754479|FG001|Overall Study|Patient Declined Further Treatment|0|||
30743756|NCT00500903|58754480|FG002|Overall Study|Patient Declined Further Treatment|3|||
30743757|NCT00500903|58754478|FG000|Overall Study|Symptomatic Deterioration|2|||
30743758|NCT00500903|58754479|FG001|Overall Study|Symptomatic Deterioration|0|||
30743759|NCT00500903|58754480|FG002|Overall Study|Symptomatic Deterioration|0|||
30743760|NCT00500903|58754478|FG000|Overall Study|Reason Not Specified|10|||
30743761|NCT00500903|58754479|FG001|Overall Study|Reason Not Specified|0|||
30743762|NCT00500903|58754480|FG002|Overall Study|Reason Not Specified|2|||
30743763|NCT00295932|58754529|FG000|Overall Study|Not Treated|0|||
30743764|NCT00295932|58754530|FG001|Overall Study|Not Treated|0|||
30743765|NCT00295932|58754531|FG002|Overall Study|Not Treated|0|||
30743766|NCT00295932|58754532|FG003|Overall Study|Not Treated|0|||
30743767|NCT00295932|58754533|FG004|Overall Study|Not Treated|0|||
30743768|NCT00295932|58754534|FG005|Overall Study|Not Treated|0|||
30743769|NCT00295932|58754535|FG006|Overall Study|Not Treated|0|||
30743770|NCT00295932|58754536|FG007|Overall Study|Not Treated|0|||
30743771|NCT00295932|58754537|FG008|Overall Study|Not Treated|0|||
30743772|NCT00295932|58754538|FG009|Overall Study|Not Treated|0|||
30743773|NCT00295932|58754539|FG010|Overall Study|Not Treated|1|||
30743774|NCT00305448|58754568|FG000|Overall Study|Protocol Violation|0|||
30743775|NCT00305448|58754569|FG001|Overall Study|Protocol Violation|1|||
30743776|NCT00305448|58754570|FG002|Overall Study|Protocol Violation|0|||
30743777|NCT00305448|58754568|FG000|Overall Study|Withdrawal by Subject|2|||
30743778|NCT00305448|58754569|FG001|Overall Study|Withdrawal by Subject|0|||
30743779|NCT00305448|58754570|FG002|Overall Study|Withdrawal by Subject|1|||
30743780|NCT00305448|58754568|FG000|Overall Study|Adverse Event|1|||
30743781|NCT00305448|58754569|FG001|Overall Study|Adverse Event|0|||
30743782|NCT00305448|58754570|FG002|Overall Study|Adverse Event|1|||
30743783|NCT00305448|58754568|FG000|Overall Study|Disease Progression|27|||
30743784|NCT00305448|58754569|FG001|Overall Study|Disease Progression|31|||
30743785|NCT00305448|58754570|FG002|Overall Study|Disease Progression|28|||
30743786|NCT00305448|58754568|FG000|Overall Study|Subjective Disease Progression|1|||
30743787|NCT00305448|58754569|FG001|Overall Study|Subjective Disease Progression|2|||
30743788|NCT00305448|58754570|FG002|Overall Study|Subjective Disease Progression|2|||
30743789|NCT00305448|58754568|FG000|Overall Study|Tumor Marker Elevation|0|||
30743790|NCT00305448|58754569|FG001|Overall Study|Tumor Marker Elevation|0|||
30902257|NCT01815424|58936133|FG002|Week 16 to 52|Adverse Event|0|||
30902258|NCT01815424|58936134|FG003|Week 16 to 52|Adverse Event|0|||
30902259|NCT01815424|58936135|FG004|Week 16 to 52|Adverse Event|1|||
30902260|NCT01815424|58936131|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
30902261|NCT01815424|58936132|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
30902262|NCT01815424|58936133|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
30902263|NCT01815424|58936134|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
30902264|NCT01815424|58936135|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
30902265|NCT01815424|58936131|FG000|Week 16 to 52|Lost to Follow-up|0|||
30902266|NCT01815424|58936132|FG001|Week 16 to 52|Lost to Follow-up|2|||
30902267|NCT01815424|58936133|FG002|Week 16 to 52|Lost to Follow-up|0|||
30902268|NCT01815424|58936134|FG003|Week 16 to 52|Lost to Follow-up|2|||
30902269|NCT01815424|58936135|FG004|Week 16 to 52|Lost to Follow-up|1|||
30902270|NCT01815424|58936131|FG000|Week 16 to 52|Withdrawal by Subject|1|||
30902271|NCT01815424|58936132|FG001|Week 16 to 52|Withdrawal by Subject|2|||
30902272|NCT01815424|58936133|FG002|Week 16 to 52|Withdrawal by Subject|0|||
30743791|NCT00305448|58754570|FG002|Overall Study|Tumor Marker Elevation|1|||
30743792|NCT00305058|58754581|FG000|Overall Study|Participant too young|1|||
30743793|NCT00305058|58754582|FG001|Overall Study|Participant too young|0|||
30743794|NCT00305058|58754581|FG000|Overall Study|Missing data collection instrument|3|||
30743795|NCT00305058|58754582|FG001|Overall Study|Missing data collection instrument|2|||
30743796|NCT00305058|58754581|FG000|Overall Study|Missing outcome data|3|||
30743797|NCT00305058|58754582|FG001|Overall Study|Missing outcome data|2|||
30902273|NCT01815424|58936134|FG003|Week 16 to 52|Withdrawal by Subject|0|||
30743798|NCT00295854|58754591|FG000|Overall Study|Adverse Event|7|||
30743799|NCT00295854|58754592|FG001|Overall Study|Adverse Event|7|||
30902274|NCT01815424|58936135|FG004|Week 16 to 52|Withdrawal by Subject|0|||
30902275|NCT02431247|58936150|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
30902276|NCT02431247|58936151|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
30902277|NCT02431247|58936152|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
30902278|NCT02431247|58936150|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
30902279|NCT02431247|58936151|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
30902280|NCT02431247|58936152|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
30902281|NCT02431247|58936150|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
30902282|NCT02431247|58936151|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
30902283|NCT02431247|58936152|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
30902284|NCT02431247|58936150|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
30902285|NCT02431247|58936151|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
30902286|NCT02431247|58936152|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
30902287|NCT02431247|58936150|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
30902288|NCT02431247|58936151|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
30902289|NCT02431247|58936152|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
30902290|NCT02431247|58936150|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
30902291|NCT02431247|58936151|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
30902292|NCT02431247|58936152|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
30902293|NCT02431247|58936150|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
30902294|NCT02431247|58936151|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
30902295|NCT02431247|58936152|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
30902296|NCT02431247|58936150|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
30902297|NCT02431247|58936151|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
30902298|NCT02431247|58936152|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
30902299|NCT02431247|58936150|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
30902300|NCT02431247|58936151|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
30902301|NCT02431247|58936152|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
30902302|NCT02431247|58936150|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
30902303|NCT02431247|58936151|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
30902304|NCT02431247|58936152|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
30902305|NCT02431247|58936150|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
30902306|NCT02431247|58936151|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
30902307|NCT02431247|58936152|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
30902308|NCT02431247|58936150|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
30902309|NCT02431247|58936151|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
30902310|NCT02431247|58936152|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
30902311|NCT02431247|58936150|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
30902312|NCT02431247|58936151|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
30902313|NCT02431247|58936152|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
30902314|NCT02431247|58936150|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
30902315|NCT02431247|58936151|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
30902316|NCT02431247|58936152|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
30902317|NCT01814878|58936166|FG000|Overall Study|Adverse Event|16|||
30902318|NCT01814878|58936167|FG001|Overall Study|Adverse Event|5|||
30902319|NCT01814878|58936166|FG000|Overall Study|Withdrawal by Subject|20|||
30902320|NCT01814878|58936167|FG001|Overall Study|Withdrawal by Subject|16|||
30902321|NCT01814878|58936166|FG000|Overall Study|Protocol Violation|5|||
30902322|NCT01814878|58936167|FG001|Overall Study|Protocol Violation|5|||
30902323|NCT01814878|58936166|FG000|Overall Study|Physician Decision|3|||
30902324|NCT01814878|58936167|FG001|Overall Study|Physician Decision|1|||
30902325|NCT01814878|58936166|FG000|Overall Study|Screening failure (drop-out)|0|||
30902326|NCT01814878|58936167|FG001|Overall Study|Screening failure (drop-out)|3|||
30902327|NCT01814878|58936166|FG000|Overall Study|Other|2|||
30902328|NCT01814878|58936167|FG001|Overall Study|Other|0|||
30902329|NCT02407457|58936175|FG000|1 Month|Death|3|||
30902330|NCT02407457|58936176|FG001|1 Month|Death|0|||
30902331|NCT02407457|58936175|FG000|1 Month|Lost to Follow-up|1|||
30902332|NCT02407457|58936176|FG001|1 Month|Lost to Follow-up|1|||
30902333|NCT02407457|58936175|FG000|1 Month|missed visit|2|||
30902334|NCT02407457|58936176|FG001|1 Month|missed visit|6|||
30902335|NCT02407457|58936175|FG000|6-Month|Death|2|||
30902336|NCT02407457|58936176|FG001|6-Month|Death|8|||
30902337|NCT02407457|58936175|FG000|6-Month|Lost to Follow-up|2|||
30902338|NCT02407457|58936176|FG001|6-Month|Lost to Follow-up|2|||
30902339|NCT02407457|58936175|FG000|6-Month|missed visit|15|||
30902340|NCT02407457|58936176|FG001|6-Month|missed visit|12|||
30902341|NCT02407457|58936175|FG000|6-Month|Over Due|1|||
30902342|NCT02407457|58936176|FG001|6-Month|Over Due|2|||
30902343|NCT02407457|58936175|FG000|6-Month|Open Repair|0|||
30902344|NCT02407457|58936176|FG001|6-Month|Open Repair|1|||
30902345|NCT02407457|58936175|FG000|1 Year|Death|6|||
30902346|NCT02407457|58936176|FG001|1 Year|Death|11|||
30902347|NCT02407457|58936175|FG000|1 Year|Lost to Follow-up|3|||
30902348|NCT02407457|58936176|FG001|1 Year|Lost to Follow-up|2|||
30902349|NCT02407457|58936175|FG000|1 Year|Missed Visit|18|||
30902350|NCT02407457|58936176|FG001|1 Year|Missed Visit|10|||
30902351|NCT02407457|58936175|FG000|1 Year|Over Due|6|||
30902352|NCT02407457|58936176|FG001|1 Year|Over Due|4|||
30902353|NCT02407457|58936175|FG000|1 Year|Open Repair|0|||
30902354|NCT02407457|58936176|FG001|1 Year|Open Repair|1|||
30902355|NCT02407457|58936175|FG000|2-year|Death|14|||
30902356|NCT02407457|58936176|FG001|2-year|Death|8|||
30902357|NCT02407457|58936175|FG000|2-year|Lost to Follow-up|6|||
30902358|NCT02407457|58936176|FG001|2-year|Lost to Follow-up|9|||
30902359|NCT02407457|58936175|FG000|2-year|Missed Visit|13|||
30902360|NCT02407457|58936176|FG001|2-year|Missed Visit|11|||
30902361|NCT02407457|58936175|FG000|2-year|Over Due|1|||
30902362|NCT02407457|58936176|FG001|2-year|Over Due|5|||
30902363|NCT02407457|58936175|FG000|2-year|Open Repair|0|||
30902364|NCT02407457|58936176|FG001|2-year|Open Repair|2|||
30902365|NCT02407457|58936175|FG000|3-year|Death|11|||
30902366|NCT02407457|58936176|FG001|3-year|Death|10|||
30902367|NCT02407457|58936175|FG000|3-year|Lost to Follow-up|6|||
30902368|NCT02407457|58936176|FG001|3-year|Lost to Follow-up|9|||
30902369|NCT02407457|58936175|FG000|3-year|Missed Visit|21|||
30902370|NCT02407457|58936176|FG001|3-year|Missed Visit|16|||
30902371|NCT02407457|58936175|FG000|3-year|Over Due|4|||
30902372|NCT02407457|58936176|FG001|3-year|Over Due|3|||
30902373|NCT02407457|58936175|FG000|4-year|Death|14|||
30902374|NCT02407457|58936176|FG001|4-year|Death|7|||
30902375|NCT02407457|58936175|FG000|4-year|Lost to Follow-up|9|||
30902376|NCT02407457|58936176|FG001|4-year|Lost to Follow-up|12|||
30902377|NCT02407457|58936175|FG000|4-year|Over Due|10|||
30902378|NCT02407457|58936176|FG001|4-year|Over Due|5|||
30902379|NCT02407457|58936175|FG000|4-year|Missed Visit|13|||
30902380|NCT02407457|58936176|FG001|4-year|Missed Visit|13|||
30902381|NCT02407457|58936175|FG000|4-year|Pending visit|19|||
30902382|NCT02407457|58936176|FG001|4-year|Pending visit|14|||
30902383|NCT02407457|58936175|FG000|4-year|Not Due|16|||
30902384|NCT02407457|58936176|FG001|4-year|Not Due|10|||
30902385|NCT02407457|58936175|FG000|5-year|Death|6|||
30902386|NCT02407457|58936176|FG001|5-year|Death|1|||
30902387|NCT02407457|58936175|FG000|5-year|Lost to Follow-up|4|||
30902388|NCT02407457|58936176|FG001|5-year|Lost to Follow-up|4|||
30902389|NCT02407457|58936175|FG000|5-year|Missed Visit|10|||
30902390|NCT02407457|58936176|FG001|5-year|Missed Visit|9|||
30902391|NCT02407457|58936175|FG000|5-year|Pending Visit|18|||
30902392|NCT02407457|58936176|FG001|5-year|Pending Visit|17|||
30902393|NCT02407457|58936175|FG000|5-year|Not Due|54|||
30902394|NCT02407457|58936176|FG001|5-year|Not Due|46|||
30902395|NCT01814800|58936182|FG000|Overall Study|Adverse Event|2|||
30902396|NCT01814800|58936182|FG000|Overall Study|Pregnancy|1|||
30902397|NCT01814800|58936182|FG000|Overall Study|Sponsor decision|1|||
30902398|NCT01814800|58936182|FG000|Overall Study|Subject relocation|1|||
30902399|NCT01814332|58936188|FG000|Overall Study|Adverse Event|8|||
30902400|NCT01814332|58936189|FG001|Overall Study|Adverse Event|3|||
30902401|NCT01814332|58936188|FG000|Overall Study|Withdrawal by Subject|3|||
30902402|NCT01814332|58936189|FG001|Overall Study|Withdrawal by Subject|8|||
30902403|NCT01814332|58936188|FG000|Overall Study|Protocol Violation|0|||
30902404|NCT01814332|58936189|FG001|Overall Study|Protocol Violation|4|||
30902405|NCT01814332|58936188|FG000|Overall Study|Lost to Follow-up|5|||
30902406|NCT01814332|58936189|FG001|Overall Study|Lost to Follow-up|1|||
30902407|NCT02407223|58936198|FG000|Overall Study|Adverse Event|1|||
30622023|NCT01147068|58633527|FG005|Subjects That Received 2nd Dose|Other|0|||
30902408|NCT02407223|58936199|FG001|Overall Study|Adverse Event|0|||
30902409|NCT02407223|58936200|FG002|Overall Study|Adverse Event|1|||
30902410|NCT02407223|58936198|FG000|Overall Study|Lack of Efficacy|6|||
30622024|NCT01147068|58633528|FG006|Subjects That Received 2nd Dose|Other|0|||
30902411|NCT02407223|58936199|FG001|Overall Study|Lack of Efficacy|6|||
30902412|NCT02407223|58936200|FG002|Overall Study|Lack of Efficacy|4|||
30902413|NCT02407223|58936198|FG000|Overall Study|Lost to Follow-up|1|||
30902414|NCT02407223|58936199|FG001|Overall Study|Lost to Follow-up|0|||
30622025|NCT01147068|58633522|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
30902415|NCT02407223|58936200|FG002|Overall Study|Lost to Follow-up|2|||
30902416|NCT02407223|58936198|FG000|Overall Study|Withdrawal by Subject|2|||
30902417|NCT02407223|58936199|FG001|Overall Study|Withdrawal by Subject|4|||
30902418|NCT02407223|58936200|FG002|Overall Study|Withdrawal by Subject|4|||
30902419|NCT02407223|58936198|FG000|Overall Study|Study Terminated by Sponsor|77|||
30902420|NCT02407223|58936199|FG001|Overall Study|Study Terminated by Sponsor|80|||
30902421|NCT02407223|58936200|FG002|Overall Study|Study Terminated by Sponsor|86|||
30902422|NCT02407223|58936198|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
30902423|NCT02407223|58936199|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
30902424|NCT02407223|58936200|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
30902425|NCT02407223|58936198|FG000|Overall Study|Other|29|||
30902426|NCT02407223|58936199|FG001|Overall Study|Other|27|||
30902427|NCT02407223|58936200|FG002|Overall Study|Other|25|||
30902428|NCT01797562|58936210|FG000|Overall Study|Protocol Violation|5|||
30902429|NCT01813474|58936218|FG000|Overall Study|Withdrawal by Subject|0|||
30902430|NCT01813474|58936219|FG001|Overall Study|Withdrawal by Subject|0|||
30902431|NCT01813474|58936220|FG002|Overall Study|Withdrawal by Subject|1|||
30902432|NCT01813474|58936218|FG000|Overall Study|Adverse Event|1|||
30902433|NCT01813474|58936219|FG001|Overall Study|Adverse Event|1|||
30902434|NCT01813474|58936220|FG002|Overall Study|Adverse Event|0|||
30902435|NCT01813474|58936218|FG000|Overall Study|Lack of Efficacy|2|||
30902436|NCT01813474|58936219|FG001|Overall Study|Lack of Efficacy|6|||
30902437|NCT01813474|58936220|FG002|Overall Study|Lack of Efficacy|9|||
30902438|NCT01813474|58936218|FG000|Overall Study|Death|0|||
30902439|NCT01813474|58936219|FG001|Overall Study|Death|0|||
30902440|NCT01813474|58936220|FG002|Overall Study|Death|1|||
30902441|NCT01868542|58936231|FG000|Overall Study|Protocol Violation|0|||
30902442|NCT01868542|58936232|FG001|Overall Study|Protocol Violation|1|||
30902443|NCT01868542|58936231|FG000|Overall Study|Unclassified|0|||
30902444|NCT01868542|58936232|FG001|Overall Study|Unclassified|1|||
30902445|NCT01797094|58936240|FG000|Overall Study|Adverse Event|1|||
30902446|NCT01797094|58936241|FG001|Overall Study|Adverse Event|1|||
30902447|NCT01797094|58936240|FG000|Overall Study|Personal Reasons|4|||
30902448|NCT01797094|58936241|FG001|Overall Study|Personal Reasons|0|||
30902449|NCT01797094|58936240|FG000|Overall Study|Protocol Violation|0|||
30902450|NCT01797094|58936241|FG001|Overall Study|Protocol Violation|1|||
30743800|NCT00295854|58754593|FG002|Overall Study|Adverse Event|6|||
30743801|NCT00295854|58754591|FG000|Overall Study|Protocol Violation|1|||
30743802|NCT00295854|58754592|FG001|Overall Study|Protocol Violation|1|||
30743803|NCT00295854|58754593|FG002|Overall Study|Protocol Violation|1|||
30743804|NCT00295854|58754591|FG000|Overall Study|Lost to Follow-up|2|||
30743805|NCT00295854|58754592|FG001|Overall Study|Lost to Follow-up|0|||
30743806|NCT00295854|58754593|FG002|Overall Study|Lost to Follow-up|1|||
30743807|NCT00295854|58754591|FG000|Overall Study|Withdrawal by Subject|3|||
30743808|NCT00295854|58754592|FG001|Overall Study|Withdrawal by Subject|7|||
30743809|NCT00295854|58754593|FG002|Overall Study|Withdrawal by Subject|4|||
30743810|NCT00295854|58754591|FG000|Overall Study|did not continue to meet criteria|1|||
30743811|NCT00295854|58754592|FG001|Overall Study|did not continue to meet criteria|1|||
30743812|NCT00295854|58754593|FG002|Overall Study|did not continue to meet criteria|2|||
30743813|NCT00295854|58754591|FG000|Overall Study|required a prohibited medication|1|||
30743814|NCT00295854|58754592|FG001|Overall Study|required a prohibited medication|0|||
30743815|NCT00295854|58754593|FG002|Overall Study|required a prohibited medication|0|||
30743816|NCT00295854|58754591|FG000|Overall Study|Other|3|||
30743817|NCT00295854|58754592|FG001|Overall Study|Other|5|||
30743818|NCT00295854|58754593|FG002|Overall Study|Other|1|||
30743819|NCT00327470|58754603|FG000|Overall Study|Randomized, but not treated|0|||
30743820|NCT00327470|58754604|FG001|Overall Study|Randomized, but not treated|2|||
30743821|NCT00327470|58754603|FG000|Overall Study|Adverse Event|9|||
30743822|NCT00327470|58754604|FG001|Overall Study|Adverse Event|14|||
30743823|NCT00327470|58754603|FG000|Overall Study|Lack of Efficacy|7|||
30743824|NCT00327470|58754604|FG001|Overall Study|Lack of Efficacy|19|||
30743825|NCT00327470|58754603|FG000|Overall Study|Other|5|||
30743826|NCT00327470|58754604|FG001|Overall Study|Other|9|||
30743827|NCT00327470|58754603|FG000|Overall Study|Lost to Follow-up|1|||
30743828|NCT00327470|58754604|FG001|Overall Study|Lost to Follow-up|3|||
30743829|NCT00327470|58754603|FG000|Overall Study|Withdrawal by Subject|6|||
30743830|NCT00327470|58754604|FG001|Overall Study|Withdrawal by Subject|12|||
30743831|NCT00327470|58754603|FG000|Overall Study|Death|1|||
30743832|NCT00327470|58754604|FG001|Overall Study|Death|4|||
30743833|NCT00322556|58754610|FG000|Overall Study|Adverse Event|1|||
30743834|NCT00322556|58754610|FG000|Overall Study|Withdrawal by Subject|1|||
30743835|NCT00322556|58754610|FG000|Overall Study|Lost to Follow-up|3|||
30743836|NCT00322556|58754610|FG000|Overall Study|Other Reason|7|||
30743837|NCT00321932|58754619|FG000|Overall Study|Death|3|||
30743838|NCT00321932|58754620|FG001|Overall Study|Death|6|||
30743839|NCT00321932|58754619|FG000|Overall Study|Withdrawal by Subject|3|||
30743840|NCT00321932|58754620|FG001|Overall Study|Withdrawal by Subject|6|||
30902451|NCT01797094|58936240|FG000|Overall Study|Other Miscellaneous Reasons|1|||
30902452|NCT01797094|58936241|FG001|Overall Study|Other Miscellaneous Reasons|0|||
30902453|NCT02383589|58936249|FG000|Treatment Period|Adverse Event|1|||
30902454|NCT02383589|58936250|FG001|Treatment Period|Adverse Event|3|||
30902455|NCT02383589|58936249|FG000|Treatment Period|Lost to Follow-up|0|||
30902456|NCT02383589|58936250|FG001|Treatment Period|Lost to Follow-up|1|||
30902457|NCT02383589|58936249|FG000|Treatment Period|Withdrawal by Subject|0|||
30902458|NCT02383589|58936250|FG001|Treatment Period|Withdrawal by Subject|5|||
30743841|NCT00321932|58754619|FG000|Overall Study|Early relapse|2|||
30743842|NCT00321932|58754620|FG001|Overall Study|Early relapse|8|||
30743843|NCT00321932|58754619|FG000|Overall Study|Missing data|2|||
30743844|NCT00321932|58754620|FG001|Overall Study|Missing data|1|||
30902459|NCT02383589|58936249|FG000|Treatment Period|Non-compliance with study drug|0|||
30902460|NCT02383589|58936250|FG001|Treatment Period|Non-compliance with study drug|1|||
30743845|NCT00326612|58754629|FG000|Overall Study|They did not have a seizure requiring tx|129|||
30743846|NCT00326612|58754630|FG001|Overall Study|They did not have a seizure requiring tx|137|||
30743847|NCT00325130|58754642|FG000|Overall Study|Lost to Follow-up|6|||
30743848|NCT00325130|58754643|FG001|Overall Study|Lost to Follow-up|14|||
30743849|NCT00325130|58754642|FG000|Overall Study|Withdrawal by Subject|12|||
30743850|NCT00325130|58754643|FG001|Overall Study|Withdrawal by Subject|14|||
30743851|NCT00325130|58754642|FG000|Overall Study|Protocol Deviation|0|||
30743852|NCT00325130|58754643|FG001|Overall Study|Protocol Deviation|1|||
30743853|NCT00325130|58754642|FG000|Overall Study|Moved|0|||
30743854|NCT00325130|58754643|FG001|Overall Study|Moved|1|||
30743855|NCT00325130|58754642|FG000|Overall Study|Patient Discontinued for Other|1|||
30743856|NCT00325130|58754643|FG001|Overall Study|Patient Discontinued for Other|0|||
30743857|NCT00321854|58754651|FG000|Overall Study|Adverse Event|41|||
30743858|NCT00321854|58754652|FG001|Overall Study|Adverse Event|43|||
30743859|NCT00321854|58754651|FG000|Overall Study|Lack of Efficacy|9|||
30743860|NCT00321854|58754652|FG001|Overall Study|Lack of Efficacy|14|||
30743861|NCT00321854|58754651|FG000|Overall Study|Protocol Violation|6|||
30743862|NCT00321854|58754652|FG001|Overall Study|Protocol Violation|5|||
30743863|NCT00321854|58754651|FG000|Overall Study|Lost to Follow-up|0|||
30743864|NCT00321854|58754652|FG001|Overall Study|Lost to Follow-up|2|||
30743865|NCT00321854|58754651|FG000|Overall Study|Withdrawal by Subject|6|||
30743866|NCT00321854|58754652|FG001|Overall Study|Withdrawal by Subject|17|||
30743867|NCT00321854|58754651|FG000|Overall Study|Other|1|||
30743868|NCT00321854|58754652|FG001|Overall Study|Other|1|||
30743869|NCT00310388|58754660|FG000|Primary Reporting Phase|Adverse Event|101|||
30743870|NCT00310388|58754661|FG001|Primary Reporting Phase|Adverse Event|0|||
30743871|NCT00310388|58754660|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
30743872|NCT00310388|58754661|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
30743873|NCT00310388|58754660|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
30743874|NCT00310388|58754661|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
30743875|NCT00310388|58754660|FG000|Primary Reporting Phase|Protocol Violation|10|||
30743876|NCT00310388|58754661|FG001|Primary Reporting Phase|Protocol Violation|0|||
30743877|NCT00310388|58754660|FG000|Primary Reporting Phase|Pregnancy|3|||
30743878|NCT00310388|58754661|FG001|Primary Reporting Phase|Pregnancy|0|||
30743879|NCT00310388|58754660|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
30743880|NCT00310388|58754661|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
30743881|NCT00310388|58754660|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
30743882|NCT00310388|58754661|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
30743883|NCT00310388|58754660|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
30743884|NCT00310388|58754661|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
30743885|NCT00310388|58754660|FG000|Primary Reporting Phase|Physician Decision|2|||
30743886|NCT00310388|58754661|FG001|Primary Reporting Phase|Physician Decision|0|||
30743887|NCT00310388|58754660|FG000|Primary Reporting Phase|Request of the sponsor|19|||
30743888|NCT00310388|58754661|FG001|Primary Reporting Phase|Request of the sponsor|0|||
30743889|NCT00310388|58754660|FG000|Primary Reporting Phase|Failed to return|8|||
30743890|NCT00310388|58754661|FG001|Primary Reporting Phase|Failed to return|0|||
30743891|NCT00310388|58754660|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
30743892|NCT00310388|58754661|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
30743893|NCT00310388|58754660|FG000|Primary Reporting Phase|Participant request|2|||
30743894|NCT00310388|58754661|FG001|Primary Reporting Phase|Participant request|0|||
30743895|NCT00310388|58754660|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
30743896|NCT00310388|58754661|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
30743897|NCT00310388|58754660|FG000|Primary Reporting Phase|Discontinuation of study|1|||
30743898|NCT00310388|58754661|FG001|Primary Reporting Phase|Discontinuation of study|0|||
30743899|NCT00310388|58754660|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
30743900|NCT00310388|58754661|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
30743901|NCT00310388|58754660|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
30743902|NCT00310388|58754661|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
30743903|NCT00310388|58754660|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
30743904|NCT00310388|58754661|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
30743905|NCT00310388|58754660|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
30743906|NCT00310388|58754661|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
30743907|NCT00310388|58754660|FG000|Primary Reporting Phase|Participant passed away|1|||
30743908|NCT00310388|58754661|FG001|Primary Reporting Phase|Participant passed away|0|||
30743909|NCT00310388|58754660|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
30743910|NCT00310388|58754661|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
30743911|NCT00310388|58754660|FG000|Primary Reporting Phase|Missing|1|||
30743912|NCT00310388|58754661|FG001|Primary Reporting Phase|Missing|0|||
30902461|NCT02383589|58936249|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
30902462|NCT02383589|58936250|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
30902463|NCT02383589|58936249|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
30902464|NCT02383589|58936250|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
30902465|NCT02383589|58936249|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
30902466|NCT02383589|58936250|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
30902467|NCT01810432|58936258|FG000|Washout|Protocol Violation|0|||
30743913|NCT00310388|58754660|FG000|Primary Reporting Phase|Other|1|||
30743914|NCT00310388|58754661|FG001|Primary Reporting Phase|Other|0|||
30743915|NCT00310388|58754660|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
30743916|NCT00310388|58754661|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
30743917|NCT00310388|58754660|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
30743918|NCT00310388|58754661|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
30743919|NCT00310388|58754660|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
30743920|NCT00310388|58754661|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
30743921|NCT00310388|58754660|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
30743922|NCT00310388|58754661|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
30743923|NCT00500357|58754666|FG000|Overall Study|Death|1|||
30743924|NCT00309842|58754681|FG000|Overall Study|Lost to Follow-up|1|||
30743925|NCT00325754|58754687|FG000|Overall Study|Adverse Event|4|||
30743926|NCT00325754|58754688|FG001|Overall Study|Adverse Event|1|||
30743927|NCT00499889|58754694|FG000|Overall Study|Infection prior to treatment|1|||
30743928|NCT00309608|58754703|FG000|Overall Study|Adverse Event|1|||
30743929|NCT00309608|58754704|FG001|Overall Study|Adverse Event|5|||
30743930|NCT00309608|58754705|FG002|Overall Study|Adverse Event|3|||
30743931|NCT00309608|58754706|FG003|Overall Study|Adverse Event|2|||
30743932|NCT00309608|58754707|FG004|Overall Study|Adverse Event|3|||
30743933|NCT00309608|58754703|FG000|Overall Study|Protocol Violation|2|||
30743934|NCT00309608|58754704|FG001|Overall Study|Protocol Violation|0|||
30743935|NCT00309608|58754705|FG002|Overall Study|Protocol Violation|0|||
30743936|NCT00309608|58754706|FG003|Overall Study|Protocol Violation|0|||
30743937|NCT00309608|58754707|FG004|Overall Study|Protocol Violation|0|||
30743938|NCT00309608|58754703|FG000|Overall Study|Lost to Follow-up|0|||
30743939|NCT00309608|58754704|FG001|Overall Study|Lost to Follow-up|0|||
30743940|NCT00309608|58754705|FG002|Overall Study|Lost to Follow-up|2|||
30743941|NCT00309608|58754706|FG003|Overall Study|Lost to Follow-up|0|||
30743942|NCT00309608|58754707|FG004|Overall Study|Lost to Follow-up|1|||
30743943|NCT00309608|58754703|FG000|Overall Study|Withdrawal by Subject|1|||
30743944|NCT00309608|58754704|FG001|Overall Study|Withdrawal by Subject|4|||
30743945|NCT00309608|58754705|FG002|Overall Study|Withdrawal by Subject|2|||
30743946|NCT00309608|58754706|FG003|Overall Study|Withdrawal by Subject|0|||
30743947|NCT00309608|58754707|FG004|Overall Study|Withdrawal by Subject|0|||
30743948|NCT00309608|58754703|FG000|Overall Study|Other incl. Lack of efficacy|10|||
30743949|NCT00309608|58754704|FG001|Overall Study|Other incl. Lack of efficacy|4|||
30743950|NCT00309608|58754705|FG002|Overall Study|Other incl. Lack of efficacy|3|||
30743951|NCT00309608|58754706|FG003|Overall Study|Other incl. Lack of efficacy|4|||
30743952|NCT00309608|58754707|FG004|Overall Study|Other incl. Lack of efficacy|0|||
30743953|NCT00309452|58754721|FG000|Overall Study|Withdrawal by Subject|3|||
30743954|NCT00309452|58754722|FG001|Overall Study|Withdrawal by Subject|0|||
30743955|NCT00308750|58754731|FG000|Overall Study|Adverse Event|9|||
30743956|NCT00308750|58754732|FG001|Overall Study|Adverse Event|9|||
30743957|NCT00308750|58754733|FG002|Overall Study|Adverse Event|13|||
30743958|NCT00308750|58754731|FG000|Overall Study|Withdrawal by Subject|6|||
30743959|NCT00308750|58754732|FG001|Overall Study|Withdrawal by Subject|2|||
30743960|NCT00308750|58754733|FG002|Overall Study|Withdrawal by Subject|3|||
30743961|NCT00308750|58754731|FG000|Overall Study|Physician Decision|3|||
30743962|NCT00308750|58754732|FG001|Overall Study|Physician Decision|4|||
30743963|NCT00308750|58754733|FG002|Overall Study|Physician Decision|3|||
30743964|NCT00308750|58754731|FG000|Overall Study|Sponsor Decision|1|||
30743965|NCT00308750|58754732|FG001|Overall Study|Sponsor Decision|0|||
30743966|NCT00308750|58754733|FG002|Overall Study|Sponsor Decision|0|||
30743967|NCT00308750|58754731|FG000|Overall Study|Disease Progression|47|||
30743968|NCT00308750|58754732|FG001|Overall Study|Disease Progression|24|||
30743969|NCT00308750|58754733|FG002|Overall Study|Disease Progression|28|||
30743970|NCT00308750|58754731|FG000|Overall Study|Unrelated Complication|3|||
30743971|NCT00308750|58754732|FG001|Overall Study|Unrelated Complication|0|||
30743972|NCT00308750|58754733|FG002|Overall Study|Unrelated Complication|1|||
30743973|NCT00308750|58754731|FG000|Overall Study|Death|1|||
30743974|NCT00308750|58754732|FG001|Overall Study|Death|0|||
30743975|NCT00308750|58754733|FG002|Overall Study|Death|1|||
30743976|NCT00308750|58754731|FG000|Overall Study|Protocol Violation|1|||
30743977|NCT00308750|58754732|FG001|Overall Study|Protocol Violation|0|||
30743978|NCT00308750|58754733|FG002|Overall Study|Protocol Violation|0|||
30743979|NCT00308750|58754731|FG000|Overall Study|New Primary Disease Identified|1|||
30743980|NCT00308750|58754732|FG001|Overall Study|New Primary Disease Identified|1|||
30743981|NCT00308750|58754733|FG002|Overall Study|New Primary Disease Identified|0|||
30743982|NCT00489359|58754744|FG000|Overall Study|Death|0|||
30743983|NCT00489359|58754745|FG001|Overall Study|Death|2|||
30743984|NCT00489359|58754744|FG000|Overall Study|Progressive Disease|5|||
30743985|NCT00489359|58754745|FG001|Overall Study|Progressive Disease|6|||
30743986|NCT00489359|58754744|FG000|Overall Study|Lost to Follow-up|1|||
30743987|NCT00489359|58754745|FG001|Overall Study|Lost to Follow-up|0|||
30743988|NCT00489359|58754744|FG000|Overall Study|Withdrawal by Subject|1|||
30743989|NCT00489359|58754745|FG001|Overall Study|Withdrawal by Subject|5|||
30743990|NCT00489359|58754744|FG000|Overall Study|Adverse Event|0|||
30743991|NCT00489359|58754745|FG001|Overall Study|Adverse Event|16|||
30743992|NCT00481247|58754758|FG000|Overall Study|Death|0|||
30743993|NCT00481247|58754759|FG001|Overall Study|Death|1|||
30743994|NCT00481247|58754758|FG000|Overall Study|Disease progression|18|||
30743995|NCT00481247|58754759|FG001|Overall Study|Disease progression|22|||
30743996|NCT00481247|58754758|FG000|Overall Study|Intolerance|42|||
30743997|NCT00481247|58754759|FG001|Overall Study|Intolerance|17|||
30743998|NCT00481247|58754758|FG000|Overall Study|Treatment failure|10|||
30743999|NCT00481247|58754759|FG001|Overall Study|Treatment failure|14|||
30744000|NCT00481247|58754758|FG000|Overall Study|AE unrelated to study drug|13|||
30744001|NCT00481247|58754759|FG001|Overall Study|AE unrelated to study drug|4|||
30744002|NCT00481247|58754758|FG000|Overall Study|Withdrawal by Subject|8|||
30744003|NCT00481247|58754759|FG001|Overall Study|Withdrawal by Subject|13|||
30744004|NCT00481247|58754758|FG000|Overall Study|Pregnancy|2|||
30744005|NCT00481247|58754759|FG001|Overall Study|Pregnancy|1|||
30744006|NCT00481247|58754758|FG000|Overall Study|Lost to Follow-up|1|||
30744007|NCT00481247|58754759|FG001|Overall Study|Lost to Follow-up|2|||
30744008|NCT00481247|58754758|FG000|Overall Study|Poor compliance/noncompliance|1|||
30744009|NCT00481247|58754759|FG001|Overall Study|Poor compliance/noncompliance|7|||
30744010|NCT00481247|58754758|FG000|Overall Study|Administrative reason by sponsor|157|||
30744011|NCT00481247|58754759|FG001|Overall Study|Administrative reason by sponsor|162|||
30744012|NCT00481247|58754758|FG000|Overall Study|Varied|6|||
30744013|NCT00481247|58754759|FG001|Overall Study|Varied|15|||
30744014|NCT00481247|58754758|FG000|Overall Study|Did not receive treatment|1|||
30744015|NCT00481247|58754759|FG001|Overall Study|Did not receive treatment|2|||
30744016|NCT00480857|58754765|FG000|Overall Study|Lack of Efficacy|2|||
30744017|NCT00480779|58754771|FG000|Overall Study|Other|2|||
30744018|NCT00480779|58754772|FG001|Overall Study|Other|0|||
30744019|NCT00480779|58754771|FG000|Overall Study|Job and Health-related|0|||
30744020|NCT00480779|58754772|FG001|Overall Study|Job and Health-related|3|||
30744021|NCT00499031|58754778|FG000|Overall Study|Improper pre-protocol treatment|1|||
30744022|NCT00499031|58754778|FG000|Overall Study|Required test not done|1|||
30744023|NCT00499031|58754778|FG000|Overall Study|Never treated|1|||
30744024|NCT00498797|58754784|FG000|Overall Study|Withdrawal by Subject|4|||
30744025|NCT00498797|58754785|FG001|Overall Study|Withdrawal by Subject|2|||
30744026|NCT00498797|58754784|FG000|Overall Study|Adverse Event|12|||
30744027|NCT00498797|58754785|FG001|Overall Study|Adverse Event|5|||
30744028|NCT00498797|58754784|FG000|Overall Study|Condition under investigation worsened|19|||
30744029|NCT00498797|58754785|FG001|Overall Study|Condition under investigation worsened|21|||
30744030|NCT00498797|58754784|FG000|Overall Study|Other|3|||
30744031|NCT00498797|58754785|FG001|Overall Study|Other|1|||
30744032|NCT00498485|58754793|FG000|Overall Study|Adverse Event|1|||
30744033|NCT00498485|58754794|FG001|Overall Study|Adverse Event|5|||
30744034|NCT00480077|58754804|FG000|Overall Study|Death|19|||
30744035|NCT00480077|58754805|FG001|Overall Study|Death|15|||
30744036|NCT00480077|58754804|FG000|Overall Study|early exit|12|||
30744037|NCT00480077|58754805|FG001|Overall Study|early exit|11|||
30744038|NCT00498173|58754813|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
30744039|NCT00498173|58754814|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
30744040|NCT00498173|58754815|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
30744041|NCT00295620|58754825|FG000|Overall Study|Lost to Follow-up|9|||
30744042|NCT00295620|58754826|FG001|Overall Study|Lost to Follow-up|5|||
30744043|NCT00295620|58754825|FG000|Overall Study|Withdrawal by Subject|37|||
30744044|NCT00295620|58754826|FG001|Overall Study|Withdrawal by Subject|50|||
30744045|NCT00295620|58754825|FG000|Overall Study|Death|206|||
30744046|NCT00295620|58754826|FG001|Overall Study|Death|207|||
30744047|NCT00295620|58754825|FG000|Overall Study|Other reasons|10|||
30744048|NCT00295620|58754826|FG001|Overall Study|Other reasons|9|||
30744049|NCT00295620|58754825|FG000|Overall Study|Discontinuation by sponsor|580|||
30744050|NCT00295620|58754826|FG001|Overall Study|Discontinuation by sponsor|593|||
30744051|NCT00295620|58754825|FG000|Overall Study|Protocol Violation|30|||
30744052|NCT00295620|58754826|FG001|Overall Study|Protocol Violation|32|||
30744053|NCT00310440|58754834|FG000|Overall Study|Lost to Follow-up|17|||
30744054|NCT00310440|58754835|FG001|Overall Study|Lost to Follow-up|8|||
30744055|NCT00310440|58754834|FG000|Overall Study|Withdrawal by Subject|2|||
30744056|NCT00310440|58754835|FG001|Overall Study|Withdrawal by Subject|1|||
30744057|NCT00310440|58754834|FG000|Overall Study|Missed 12 Month Visit|7|||
30744058|NCT00310440|58754835|FG001|Overall Study|Missed 12 Month Visit|4|||
30744059|NCT00304356|58754841|FG000|Nitazoxanide|Physician Decision|5|||
30744060|NCT00304356|58754841|FG000|Nitazoxanide|Physician Decision|1|||
30744061|NCT00304356|58754841|FG000|Nitazoxanide|number is 0|1|||
30744062|NCT00304356|58754841|FG000|Nitazoxanide|Physician Decision|1|||
30744063|NCT00304356|58754841|FG000|Nitazoxanide|Physician Decision|1|||
30744064|NCT00304356|58754841|FG000|Nitazoxanide|Physician Decision|1|||
30744065|NCT00321620|58754847|FG000|Overall Study|Death|269|||
30744066|NCT00321620|58754848|FG001|Overall Study|Death|294|||
30744067|NCT00321620|58754847|FG000|Overall Study|Withdrawal by Subject|164|||
30744068|NCT00321620|58754848|FG001|Overall Study|Withdrawal by Subject|147|||
30744069|NCT00321620|58754847|FG000|Overall Study|Disease progression|113|||
30744070|NCT00321620|58754848|FG001|Overall Study|Disease progression|117|||
30744071|NCT00321620|58754847|FG000|Overall Study|Adverse Event|43|||
30744072|NCT00321620|58754848|FG001|Overall Study|Adverse Event|56|||
30744073|NCT00321620|58754847|FG000|Overall Study|Lost to Follow-up|13|||
30744074|NCT00321620|58754848|FG001|Overall Study|Lost to Follow-up|9|||
30744075|NCT00321620|58754847|FG000|Overall Study|Physician Decision|4|||
30744076|NCT00321620|58754848|FG001|Overall Study|Physician Decision|1|||
30744077|NCT00321620|58754847|FG000|Overall Study|Noncompliance|14|||
30744078|NCT00321620|58754848|FG001|Overall Study|Noncompliance|7|||
30744079|NCT00321620|58754847|FG000|Overall Study|Protocol deviation|4|||
30744080|NCT00321620|58754848|FG001|Overall Study|Protocol deviation|3|||
30744081|NCT00321620|58754847|FG000|Overall Study|Ineligibility determined|2|||
30744082|NCT00321620|58754848|FG001|Overall Study|Ineligibility determined|3|||
30744083|NCT00321620|58754847|FG000|Overall Study|Participant request|75|||
30744084|NCT00321620|58754848|FG001|Overall Study|Participant request|52|||
30744085|NCT00321620|58754847|FG000|Overall Study|Other|42|||
30744086|NCT00321620|58754848|FG001|Overall Study|Other|33|||
30744087|NCT00304278|58754854|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
30744088|NCT00304278|58754854|FG000|Overall Study|PT had medical condition preventing TX|1|||
30744089|NCT00291018|58754861|FG000|Overall Study|Not Consented or Declined PAS|12|||
30744090|NCT00291018|58754862|FG001|Overall Study|Not Consented or Declined PAS|15|||
30744091|NCT00291018|58754863|FG002|Overall Study|Not Consented or Declined PAS|15|||
30744092|NCT00291018|58754861|FG000|Overall Study|Death|3|||
30902468|NCT01810432|58936259|FG001|Washout|Protocol Violation|1|||
30902469|NCT01810432|58936258|FG000|Washout|Adverse Event|1|||
30902470|NCT01810432|58936259|FG001|Washout|Adverse Event|0|||
30902471|NCT01810432|58936258|FG000|Period 2|Withdrawal by Subject|2|||
30902472|NCT01810432|58936259|FG001|Period 2|Withdrawal by Subject|1|||
30902473|NCT01810432|58936258|FG000|Period 2|Physician Decision|1|||
30902474|NCT01810432|58936259|FG001|Period 2|Physician Decision|0|||
30902475|NCT01810432|58936258|FG000|Period 2|Lost to Follow-up|1|||
30902476|NCT01810432|58936259|FG001|Period 2|Lost to Follow-up|1|||
30902477|NCT01796860|58936265|FG000|Overall Study|Withdrawal by Subject|3|||
30902478|NCT01796548|58936269|FG000|Overall Study|Lost to Follow-up|1|||
30902479|NCT01796548|58936269|FG000|Overall Study|Other|2|||
30902480|NCT02406677|58936275|FG000|Overall Study|Death|16|||
30902481|NCT02406677|58936276|FG001|Overall Study|Death|8|||
30902482|NCT02406677|58936275|FG000|Overall Study|Discharged without P2Y12|1|||
30902483|NCT02406677|58936276|FG001|Overall Study|Discharged without P2Y12|3|||
30902484|NCT02406677|58936275|FG000|Overall Study|Discharged on prasugrel|283|||
30902485|NCT02406677|58936276|FG001|Overall Study|Discharged on prasugrel|587|||
30902486|NCT02406677|58936275|FG000|Overall Study|Withdrawal by Subject|1|||
30902487|NCT02406677|58936276|FG001|Overall Study|Withdrawal by Subject|0|||
30902488|NCT02404805|58936292|FG000|Overall Study|Withdrawal by Subject|1|||
30902489|NCT02404805|58936293|FG001|Overall Study|Withdrawal by Subject|0|||
30902490|NCT02404805|58936294|FG002|Overall Study|Withdrawal by Subject|0|||
30902491|NCT02404805|58936295|FG003|Overall Study|Withdrawal by Subject|0|||
30902492|NCT02404805|58936296|FG004|Overall Study|Withdrawal by Subject|0|||
30902493|NCT02404805|58936297|FG005|Overall Study|Withdrawal by Subject|0|||
30622026|NCT01147068|58633523|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
30744093|NCT00291018|58754862|FG001|Overall Study|Death|3|||
30744094|NCT00291018|58754863|FG002|Overall Study|Death|4|||
30744095|NCT00291018|58754861|FG000|Overall Study|Withdrawal by Subject|2|||
30744096|NCT00291018|58754862|FG001|Overall Study|Withdrawal by Subject|8|||
30744097|NCT00291018|58754863|FG002|Overall Study|Withdrawal by Subject|1|||
30791018|NCT02742766|58804187|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
30902494|NCT02430311|58936308|FG000|Part A|Adverse Event|0|||
30902495|NCT02430311|58936309|FG001|Part A|Adverse Event|1|||
30902496|NCT02430311|58936308|FG000|Part A|Withdrawal by Subject|1|||
30902497|NCT02430311|58936309|FG001|Part A|Withdrawal by Subject|0|||
30902498|NCT02430311|58936308|FG000|Part B|Meet study-specific withdrawal criteria|6|||
30902499|NCT02430311|58936309|FG001|Part B|Meet study-specific withdrawal criteria|6|||
30902500|NCT02430311|58936308|FG000|Part B|Withdrawal by Subject|2|||
30902501|NCT02430311|58936309|FG001|Part B|Withdrawal by Subject|2|||
30902502|NCT02430311|58936308|FG000|Part B|Adverse Event|1|||
30902503|NCT02430311|58936309|FG001|Part B|Adverse Event|0|||
30902504|NCT02430311|58936308|FG000|Part B|Death|1|||
30902505|NCT02430311|58936309|FG001|Part B|Death|0|||
30902506|NCT02383433|58936324|FG000|Overall Study|Disease progression|2|||
30902507|NCT02404649|58936330|FG000|Overall Study|Adverse Event|1|||
30902508|NCT02404649|58936331|FG001|Overall Study|Adverse Event|2|||
30902509|NCT02383355|58936339|FG000|Overall Study|Adverse Event|2|||
30902510|NCT02383355|58936340|FG001|Overall Study|Adverse Event|0|||
30902511|NCT02381795|58936346|FG000|Overall Study|Withdrawal by Subject|1|||
30902512|NCT02381795|58936346|FG000|Overall Study|Study Terminated|2|||
30902513|NCT02404493|58936352|FG000|Overall Study|Adverse Event|1|||
30902514|NCT02404493|58936353|FG001|Overall Study|Adverse Event|1|||
30902515|NCT02380859|58936361|FG000|Overall Study|Withdrawal by Subject|2|||
30902516|NCT02380859|58936362|FG001|Overall Study|Withdrawal by Subject|0|||
30744098|NCT00291018|58754861|FG000|Overall Study|Failures|5|||
30744099|NCT00291018|58754862|FG001|Overall Study|Failures|12|||
30902517|NCT02380703|58936370|FG000|Overall Study|Withdrawal by Subject|12|||
30902518|NCT02380703|58936371|FG001|Overall Study|Withdrawal by Subject|9|||
30902519|NCT02380703|58936370|FG000|Overall Study|Lost to Follow-up|12|||
30902520|NCT02380703|58936371|FG001|Overall Study|Lost to Follow-up|12|||
30902521|NCT02380703|58936370|FG000|Overall Study|Caregiver death|1|||
30902522|NCT02380703|58936371|FG001|Overall Study|Caregiver death|0|||
30902523|NCT02380703|58936370|FG000|Overall Study|Person with dementia (PWD) death|7|||
30902524|NCT02380703|58936371|FG001|Overall Study|Person with dementia (PWD) death|8|||
30902525|NCT02380703|58936370|FG000|Overall Study|Entered Long-term Care|4|||
30902526|NCT02380703|58936371|FG001|Overall Study|Entered Long-term Care|7|||
30902527|NCT02379923|58936377|FG000|Overall Study|Death|5|||
30902528|NCT02379221|58936384|FG000|Overall Study|Lost to Follow-up|1|||
30902529|NCT02404103|58936395|FG000|Overall Study|Adverse Event|1|||
30902530|NCT02404103|58936396|FG001|Overall Study|Adverse Event|0|||
30902531|NCT02404103|58936395|FG000|Overall Study|Lost to Follow-up|3|||
30902532|NCT02404103|58936396|FG001|Overall Study|Lost to Follow-up|3|||
30744100|NCT00291018|58754863|FG002|Overall Study|Failures|5|||
30744101|NCT00291018|58754861|FG000|Overall Study|Lost to Follow-up|3|||
30744102|NCT00291018|58754862|FG001|Overall Study|Lost to Follow-up|4|||
30744103|NCT00291018|58754863|FG002|Overall Study|Lost to Follow-up|18|||
30744104|NCT00320606|58754874|FG000|Overall Study|Adverse Event|1|||
30744105|NCT00320606|58754874|FG000|Overall Study|Protocol Violation|1|||
30744106|NCT00320606|58754874|FG000|Overall Study|Withdrawal by Subject|1|||
30744107|NCT00307736|58754879|FG000|Overall Study|Adverse Event|0|||
30744108|NCT00307736|58754880|FG001|Overall Study|Adverse Event|0|||
30744109|NCT00307736|58754881|FG002|Overall Study|Adverse Event|1|||
30744110|NCT00307736|58754882|FG003|Overall Study|Adverse Event|3|||
30744111|NCT00307736|58754879|FG000|Overall Study|Withdrawal by Subject|0|||
30744112|NCT00307736|58754880|FG001|Overall Study|Withdrawal by Subject|0|||
30744113|NCT00307736|58754881|FG002|Overall Study|Withdrawal by Subject|2|||
30744114|NCT00307736|58754882|FG003|Overall Study|Withdrawal by Subject|0|||
30744115|NCT00320528|58754896|FG000|Study Period II|Adverse Event|3|||
30744116|NCT00320528|58754897|FG001|Study Period II|Adverse Event|4|||
30744117|NCT00320528|58754898|FG002|Study Period II|Adverse Event|8|||
30744118|NCT00320528|58754896|FG000|Study Period II|Parent/Caregiver Decision|8|||
30744119|NCT00320528|58754897|FG001|Study Period II|Parent/Caregiver Decision|3|||
30744120|NCT00320528|58754898|FG002|Study Period II|Parent/Caregiver Decision|11|||
30744121|NCT00320528|58754896|FG000|Study Period II|Withdrawal by Subject|0|||
30744122|NCT00320528|58754897|FG001|Study Period II|Withdrawal by Subject|1|||
30744123|NCT00320528|58754898|FG002|Study Period II|Withdrawal by Subject|1|||
30744124|NCT00320528|58754896|FG000|Study Period II|Entry Criteria Exclusion|0|||
30744125|NCT00320528|58754897|FG001|Study Period II|Entry Criteria Exclusion|2|||
30744126|NCT00320528|58754898|FG002|Study Period II|Entry Criteria Exclusion|2|||
30744127|NCT00320528|58754896|FG000|Study Period III|Adverse Event|1|||
30902533|NCT02404025|58936412|FG000|Overall Study|Adverse Event|1|||
30744128|NCT00320528|58754897|FG001|Study Period III|Adverse Event|0|||
30744129|NCT00320528|58754898|FG002|Study Period III|Adverse Event|0|||
30744130|NCT00320528|58754896|FG000|Study Period III|Lost to Follow-up|1|||
30744131|NCT00320528|58754897|FG001|Study Period III|Lost to Follow-up|0|||
30744132|NCT00320528|58754898|FG002|Study Period III|Lost to Follow-up|0|||
30744133|NCT00320528|58754896|FG000|Study Period III|Withdrawal by Subject|1|||
30744134|NCT00320528|58754897|FG001|Study Period III|Withdrawal by Subject|1|||
30744135|NCT00320528|58754898|FG002|Study Period III|Withdrawal by Subject|2|||
30902534|NCT02404025|58936412|FG000|Overall Study|Lack of Efficacy|3|||
30902535|NCT02377817|58936418|FG000|Overall Study|Transportation/childcare barriers.|2|||
30902536|NCT02377817|58936419|FG001|Overall Study|Transportation/childcare barriers.|0|||
30902537|NCT02377817|58936418|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
30902538|NCT02377817|58936419|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
30902539|NCT02403635|58936427|FG000|Overall Study|Not eligible|9|||
30744136|NCT00320528|58754896|FG000|Study Period III|Lack of Efficacy|2|||
30744137|NCT00320528|58754897|FG001|Study Period III|Lack of Efficacy|0|||
30744138|NCT00320528|58754898|FG002|Study Period III|Lack of Efficacy|0|||
30744139|NCT00320528|58754896|FG000|Study Period III|Parent/Caregiver Decision|14|||
30744140|NCT00320528|58754897|FG001|Study Period III|Parent/Caregiver Decision|3|||
30744141|NCT00320528|58754898|FG002|Study Period III|Parent/Caregiver Decision|11|||
30744142|NCT00320528|58754896|FG000|Study Period III|Protocol Violation|0|||
30744143|NCT00320528|58754897|FG001|Study Period III|Protocol Violation|1|||
30744144|NCT00320528|58754898|FG002|Study Period III|Protocol Violation|0|||
30744145|NCT00320528|58754896|FG000|Study Period III|Physician Decision|0|||
30744146|NCT00320528|58754897|FG001|Study Period III|Physician Decision|1|||
30744147|NCT00320528|58754898|FG002|Study Period III|Physician Decision|2|||
30744148|NCT00320528|58754896|FG000|Study Period III|Sponsor Decision|0|||
30744149|NCT00320528|58754897|FG001|Study Period III|Sponsor Decision|0|||
30744150|NCT00320528|58754898|FG002|Study Period III|Sponsor Decision|1|||
30744151|NCT00320528|58754896|FG000|Study Period III|Atomoxetine Commercially Available|68|||
30744152|NCT00320528|58754897|FG001|Study Period III|Atomoxetine Commercially Available|25|||
30744153|NCT00320528|58754898|FG002|Study Period III|Atomoxetine Commercially Available|90|||
30744154|NCT00320372|58754909|FG000|Overall Study|Physician Decision|4|||
30744155|NCT00320372|58754910|FG001|Overall Study|Physician Decision|7|||
30744156|NCT00320372|58754909|FG000|Overall Study|Death|7|||
30744157|NCT00320372|58754910|FG001|Overall Study|Death|8|||
30744158|NCT00320372|58754909|FG000|Overall Study|Withdrawal by Subject|55|||
30744159|NCT00320372|58754910|FG001|Overall Study|Withdrawal by Subject|37|||
30744160|NCT00320372|58754909|FG000|Overall Study|Non-Compliance|40|||
30744161|NCT00320372|58754910|FG001|Overall Study|Non-Compliance|39|||
30744162|NCT00320372|58754909|FG000|Overall Study|Did not Meet (I/E)|3|||
30744163|NCT00320372|58754910|FG001|Overall Study|Did not Meet (I/E)|1|||
30744164|NCT00320372|58754909|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
30744165|NCT00320372|58754910|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
30744166|NCT00294762|58754926|FG000|Overall Study|Did not receive study treatment|3|||
30744167|NCT00294762|58754927|FG001|Overall Study|Did not receive study treatment|3|||
30744168|NCT00294684|58754935|FG000|Overall Study|Lost to Follow-up|5|||
30744169|NCT00294684|58754936|FG001|Overall Study|Lost to Follow-up|8|||
30744170|NCT00307034|58754944|FG000|Overall Study|Adverse Event|1|||
30744171|NCT00307034|58754945|FG001|Overall Study|Adverse Event|2|||
30744172|NCT00307034|58754944|FG000|Overall Study|Withdrawal by Subject|1|||
30744173|NCT00307034|58754945|FG001|Overall Study|Withdrawal by Subject|2|||
30744174|NCT00307034|58754944|FG000|Overall Study|Lost to Follow-up|0|||
30744175|NCT00307034|58754945|FG001|Overall Study|Lost to Follow-up|3|||
30744176|NCT00320216|58754956|FG000|Overall Study|Adverse Event|0|||
30744177|NCT00320216|58754957|FG001|Overall Study|Adverse Event|6|||
30744178|NCT00320216|58754958|FG002|Overall Study|Adverse Event|0|||
30744179|NCT00320216|58754959|FG003|Overall Study|Adverse Event|2|||
30744180|NCT00320216|58754960|FG004|Overall Study|Adverse Event|2|||
30744181|NCT00320216|58754956|FG000|Overall Study|Lack of Efficacy|6|||
30744182|NCT00320216|58754957|FG001|Overall Study|Lack of Efficacy|2|||
30744183|NCT00320216|58754958|FG002|Overall Study|Lack of Efficacy|1|||
30744184|NCT00320216|58754959|FG003|Overall Study|Lack of Efficacy|0|||
30744185|NCT00320216|58754960|FG004|Overall Study|Lack of Efficacy|1|||
30744186|NCT00320216|58754956|FG000|Overall Study|Lost to Follow-up|3|||
30744187|NCT00320216|58754957|FG001|Overall Study|Lost to Follow-up|0|||
30744188|NCT00320216|58754958|FG002|Overall Study|Lost to Follow-up|0|||
30744189|NCT00320216|58754959|FG003|Overall Study|Lost to Follow-up|0|||
30744190|NCT00320216|58754960|FG004|Overall Study|Lost to Follow-up|0|||
30744191|NCT00320216|58754956|FG000|Overall Study|Other|7|||
30744192|NCT00320216|58754957|FG001|Overall Study|Other|2|||
30744193|NCT00320216|58754958|FG002|Overall Study|Other|5|||
30744194|NCT00320216|58754959|FG003|Overall Study|Other|1|||
30744195|NCT00320216|58754960|FG004|Overall Study|Other|3|||
30744196|NCT00290706|58754981|FG000|Overall Study|Withdrawal by Subject|2|||
30744197|NCT00290706|58754982|FG001|Overall Study|Withdrawal by Subject|0|||
30744198|NCT00290706|58754983|FG002|Overall Study|Withdrawal by Subject|0|||
30744199|NCT00290706|58754984|FG003|Overall Study|Withdrawal by Subject|0|||
30744200|NCT00290706|58754981|FG000|Overall Study|Progressive Disease|3|||
30744201|NCT00290706|58754982|FG001|Overall Study|Progressive Disease|5|||
30744202|NCT00290706|58754983|FG002|Overall Study|Progressive Disease|4|||
30744203|NCT00290706|58754984|FG003|Overall Study|Progressive Disease|10|||
30744204|NCT00290706|58754981|FG000|Overall Study|Adverse Event|0|||
30744205|NCT00290706|58754982|FG001|Overall Study|Adverse Event|1|||
30744206|NCT00290706|58754983|FG002|Overall Study|Adverse Event|2|||
30744207|NCT00290706|58754984|FG003|Overall Study|Adverse Event|0|||
30744208|NCT00290706|58754981|FG000|Overall Study|Receive auto transplant or radiation|0|||
30744209|NCT00290706|58754982|FG001|Overall Study|Receive auto transplant or radiation|0|||
30744210|NCT00290706|58754983|FG002|Overall Study|Receive auto transplant or radiation|0|||
30744211|NCT00290706|58754984|FG003|Overall Study|Receive auto transplant or radiation|1|||
30744212|NCT00290706|58754981|FG000|Overall Study|Physician Decision|0|||
30744213|NCT00290706|58754982|FG001|Overall Study|Physician Decision|0|||
30744214|NCT00290706|58754983|FG002|Overall Study|Physician Decision|0|||
30744215|NCT00290706|58754984|FG003|Overall Study|Physician Decision|1|||
30744216|NCT00303186|58754995|FG000|Overall Study|Other|52|||
30744217|NCT00294060|58754999|FG000|Overall Study|Death|225|||
30744218|NCT00294060|58754999|FG000|Overall Study|Other|59|||
30744219|NCT00294060|58754999|FG000|Overall Study|Lost to Follow-up|55|||
30744220|NCT00294060|58754999|FG000|Overall Study|Withdrawal by Subject|11|||
30744221|NCT00294060|58754999|FG000|Overall Study|Physician Decision|797|||
30744222|NCT00294060|58754999|FG000|Overall Study|Medical condition|3|||
30744223|NCT00294060|58754999|FG000|Overall Study|Device explanted/not replaced|23|||
30744224|NCT00303108|58755006|FG000|Overall Study|Adverse Event|5|||
30744225|NCT00303108|58755007|FG001|Overall Study|Adverse Event|6|||
30744226|NCT00303108|58755008|FG002|Overall Study|Adverse Event|7|||
30744227|NCT00303108|58755006|FG000|Overall Study|Patient Request|4|||
30744228|NCT00303108|58755007|FG001|Overall Study|Patient Request|2|||
30744229|NCT00303108|58755008|FG002|Overall Study|Patient Request|8|||
30744230|NCT00303108|58755006|FG000|Overall Study|Failed Entry|1|||
30744231|NCT00303108|58755007|FG001|Overall Study|Failed Entry|0|||
30744232|NCT00303108|58755008|FG002|Overall Study|Failed Entry|1|||
30744233|NCT00303108|58755006|FG000|Overall Study|ineligible|2|||
30744234|NCT00303108|58755007|FG001|Overall Study|ineligible|1|||
30744235|NCT00303108|58755008|FG002|Overall Study|ineligible|0|||
30744236|NCT00302952|58755017|FG000|Overall Study|Physician Decision|1|||
30744237|NCT00302952|58755018|FG001|Overall Study|Physician Decision|1|||
30744238|NCT00302952|58755017|FG000|Overall Study|Withdrawal by Subject|2|||
30744239|NCT00302952|58755018|FG001|Overall Study|Withdrawal by Subject|3|||
30744240|NCT00302952|58755017|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
30744241|NCT00302952|58755018|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
30744242|NCT00302718|58755028|FG000|Overall Study|Participant left the hospital|1|||
30744243|NCT00302718|58755029|FG001|Overall Study|Participant left the hospital|0|||
30744244|NCT00302718|58755030|FG002|Overall Study|Participant left the hospital|0|||
30744245|NCT00302718|58755031|FG003|Overall Study|Participant left the hospital|1|||
30744246|NCT00302718|58755028|FG000|Overall Study|Withdrawal by Subject|0|||
30744247|NCT00302718|58755029|FG001|Overall Study|Withdrawal by Subject|1|||
30744248|NCT00302718|58755030|FG002|Overall Study|Withdrawal by Subject|0|||
30744249|NCT00302718|58755031|FG003|Overall Study|Withdrawal by Subject|0|||
30744250|NCT00302718|58755028|FG000|Overall Study|Participant left primary care setting|0|||
30744251|NCT00302718|58755029|FG001|Overall Study|Participant left primary care setting|0|||
30744252|NCT00302718|58755030|FG002|Overall Study|Participant left primary care setting|2|||
30744253|NCT00302718|58755031|FG003|Overall Study|Participant left primary care setting|1|||
30744254|NCT00302328|58755049|FG000|Overall Study|Physician Decision|0|||
30744255|NCT00302328|58755050|FG001|Overall Study|Physician Decision|1|||
30744256|NCT00302328|58755051|FG002|Overall Study|Physician Decision|0|||
30744257|NCT00301080|58755062|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
30744258|NCT00301080|58755063|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
30744259|NCT00301080|58755064|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
30744260|NCT00301080|58755065|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
30744261|NCT00301080|58755066|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
30744262|NCT00290238|58755077|FG000|Overall Study|Study terminated|27|||
30744263|NCT00290238|58755078|FG001|Overall Study|Study terminated|27|||
30744264|NCT00290238|58755077|FG000|Overall Study|Lost to Follow-up|0|||
30744265|NCT00290238|58755078|FG001|Overall Study|Lost to Follow-up|1|||
30744266|NCT00290238|58755077|FG000|Overall Study|Withdrawal by Subject|15|||
30744267|NCT00290238|58755078|FG001|Overall Study|Withdrawal by Subject|13|||
30744268|NCT00289848|58755086|FG000|Overall Study|Adverse Event|6|||
30744269|NCT00289848|58755087|FG001|Overall Study|Adverse Event|4|||
30744270|NCT00289848|58755086|FG000|Overall Study|Death|1|||
30744271|NCT00289848|58755087|FG001|Overall Study|Death|0|||
30744272|NCT00289848|58755086|FG000|Overall Study|Lack of Efficacy|20|||
30744273|NCT00289848|58755087|FG001|Overall Study|Lack of Efficacy|24|||
30744274|NCT00289848|58755086|FG000|Overall Study|Lost to Follow-up|3|||
30744275|NCT00289848|58755087|FG001|Overall Study|Lost to Follow-up|1|||
30744276|NCT00289848|58755086|FG000|Overall Study|Protocol Violation|5|||
30744277|NCT00289848|58755087|FG001|Overall Study|Protocol Violation|2|||
30744278|NCT00289848|58755086|FG000|Overall Study|Withdrawal by Subject|5|||
30744279|NCT00289848|58755087|FG001|Overall Study|Withdrawal by Subject|11|||
30744280|NCT00289848|58755086|FG000|Overall Study|Patient Moved|6|||
30744281|NCT00289848|58755087|FG001|Overall Study|Patient Moved|2|||
30744282|NCT00289848|58755086|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
30744283|NCT00289848|58755087|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
30744284|NCT00289770|58755093|FG000|Year 15|Withdrawal by Subject|1|||
30744285|NCT00289536|58755097|FG000|Period 3|Lost to Follow-up|0|||
30744286|NCT00289536|58755098|FG001|Period 3|Lost to Follow-up|0|||
30744287|NCT00289536|58755099|FG002|Period 3|Lost to Follow-up|1|||
30744288|NCT00289458|58755108|FG000|Overall Study|Death|1|||
30744289|NCT00289458|58755109|FG001|Overall Study|Death|0|||
30744290|NCT00289458|58755110|FG002|Overall Study|Death|0|||
30744291|NCT00289458|58755108|FG000|Overall Study|Physician Decision|3|||
30744292|NCT00289458|58755109|FG001|Overall Study|Physician Decision|4|||
30744293|NCT00289458|58755110|FG002|Overall Study|Physician Decision|2|||
30744294|NCT00289458|58755108|FG000|Overall Study|Withdrawal by Subject|2|||
30744295|NCT00289458|58755109|FG001|Overall Study|Withdrawal by Subject|2|||
30744296|NCT00289458|58755110|FG002|Overall Study|Withdrawal by Subject|4|||
30744297|NCT00288912|58755121|FG000|Overall Study|Developed exclusion criterion|4|||
30744298|NCT00288912|58755122|FG001|Overall Study|Developed exclusion criterion|6|||
30744299|NCT00288912|58755123|FG002|Overall Study|Developed exclusion criterion|7|||
30744300|NCT00288912|58755121|FG000|Overall Study|Lost to Follow-up|9|||
30744301|NCT00288912|58755122|FG001|Overall Study|Lost to Follow-up|6|||
30744302|NCT00288912|58755123|FG002|Overall Study|Lost to Follow-up|9|||
30744303|NCT00288912|58755121|FG000|Overall Study|Withdrawal by Subject|4|||
30744304|NCT00288912|58755122|FG001|Overall Study|Withdrawal by Subject|5|||
30744305|NCT00288912|58755123|FG002|Overall Study|Withdrawal by Subject|12|||
30744306|NCT00305864|58755135|FG000|Overall Study|Ineligible / No protocol treatment|0|||
30744307|NCT00305864|58755136|FG001|Overall Study|Ineligible / No protocol treatment|1|||
30744308|NCT00305864|58755137|FG002|Overall Study|Ineligible / No protocol treatment|1|||
30744309|NCT00305864|58755138|FG003|Overall Study|Ineligible / No protocol treatment|13|||
30744310|NCT00295880|58755148|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
30744311|NCT00295880|58755148|FG000|Overall Study|Unit randomization did not occur|1|||
30902540|NCT02402933|58936447|FG000|Overall Study|Withdrawal by Subject|4|||
30744312|NCT00319982|58755154|FG000|Overall Study|Withdrawal by Subject|1|||
30744313|NCT00319982|58755155|FG001|Overall Study|Withdrawal by Subject|0|||
30744314|NCT00319592|58755163|FG000|Overall Study|Protocol Violation|1|||
30744315|NCT00319592|58755164|FG001|Overall Study|Protocol Violation|0|||
30744316|NCT00319592|58755163|FG000|Overall Study|Physician Decision|0|||
30744317|NCT00319592|58755164|FG001|Overall Study|Physician Decision|1|||
30744318|NCT00295490|58755174|FG000|Overall Study|Protocol Violation|0|||
30744319|NCT00295490|58755175|FG001|Overall Study|Protocol Violation|0|||
30744320|NCT00295490|58755176|FG002|Overall Study|Protocol Violation|3|||
30744321|NCT00295490|58755177|FG003|Overall Study|Protocol Violation|3|||
30744322|NCT00295490|58755174|FG000|Overall Study|Withdrawal by Subject|0|||
30744323|NCT00295490|58755175|FG001|Overall Study|Withdrawal by Subject|2|||
30744324|NCT00295490|58755176|FG002|Overall Study|Withdrawal by Subject|0|||
30744325|NCT00295490|58755177|FG003|Overall Study|Withdrawal by Subject|1|||
30744326|NCT00295490|58755174|FG000|Overall Study|Lost to Follow-up|0|||
30744327|NCT00295490|58755175|FG001|Overall Study|Lost to Follow-up|0|||
30744328|NCT00295490|58755176|FG002|Overall Study|Lost to Follow-up|1|||
30744329|NCT00295490|58755177|FG003|Overall Study|Lost to Follow-up|0|||
30744330|NCT00295490|58755174|FG000|Overall Study|Adverse Event|1|||
30622027|NCT01147068|58633524|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
30744331|NCT00295490|58755175|FG001|Overall Study|Adverse Event|0|||
30744332|NCT00295490|58755176|FG002|Overall Study|Adverse Event|0|||
30744333|NCT00295490|58755177|FG003|Overall Study|Adverse Event|0|||
30744334|NCT00295490|58755174|FG000|Overall Study|Other|0|||
30744335|NCT00295490|58755175|FG001|Overall Study|Other|2|||
30744336|NCT00295490|58755176|FG002|Overall Study|Other|0|||
30902541|NCT02402933|58936447|FG000|Overall Study|Discontinued; Site Termination|10|||
30744337|NCT00295490|58755177|FG003|Overall Study|Other|1|||
30744338|NCT00305006|58755189|FG000|Overall Study|Withdrawal by Subject|1|||
30744339|NCT00305006|58755190|FG001|Overall Study|Withdrawal by Subject|0|||
30744340|NCT00305006|58755189|FG000|Overall Study|Failure to complete pretest|0|||
30744341|NCT00305006|58755190|FG001|Overall Study|Failure to complete pretest|1|||
30791019|NCT02742766|58804188|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30791020|NCT02742766|58804189|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30622028|NCT01147068|58633525|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
30744342|NCT00319436|58755198|FG000|Overall Study|Withdrawal by Subject|6|||
30744343|NCT00319436|58755199|FG001|Overall Study|Withdrawal by Subject|7|||
30744344|NCT00319046|58755205|FG000|Overall Study|withdrawal of subject's consent|7|||
30744345|NCT00319046|58755205|FG000|Overall Study|administrative reason|1|||
30744346|NCT00303602|58755211|FG000|Overall Study|Adverse Event|2|||
30744347|NCT00303602|58755212|FG001|Overall Study|Adverse Event|2|||
30744348|NCT00303602|58755211|FG000|Overall Study|Withdrawal by Subject|5|||
30744349|NCT00303602|58755212|FG001|Overall Study|Withdrawal by Subject|6|||
30744350|NCT00303602|58755211|FG000|Overall Study|Lost to Follow-up|5|||
30744351|NCT00303602|58755212|FG001|Overall Study|Lost to Follow-up|2|||
30744352|NCT00303602|58755211|FG000|Overall Study|Protocol entry criteria not met|2|||
30744353|NCT00303602|58755212|FG001|Overall Study|Protocol entry criteria not met|2|||
30902542|NCT01796470|58936456|FG000|Overall Study|Adverse Event|4|||
30902543|NCT01796470|58936457|FG001|Overall Study|Adverse Event|2|||
30902544|NCT01796470|58936458|FG002|Overall Study|Adverse Event|2|||
30902545|NCT01796470|58936459|FG003|Overall Study|Adverse Event|1|||
30902546|NCT01796470|58936460|FG004|Overall Study|Adverse Event|3|||
30902547|NCT01796470|58936456|FG000|Overall Study|Death|2|||
30902548|NCT01796470|58936457|FG001|Overall Study|Death|0|||
30902549|NCT01796470|58936458|FG002|Overall Study|Death|0|||
30902550|NCT01796470|58936459|FG003|Overall Study|Death|0|||
30902551|NCT01796470|58936460|FG004|Overall Study|Death|1|||
30744354|NCT00303602|58755211|FG000|Overall Study|Physician Decision|2|||
30744355|NCT00303602|58755212|FG001|Overall Study|Physician Decision|1|||
30744356|NCT00303602|58755211|FG000|Overall Study|Noncompliance|2|||
30744357|NCT00303602|58755212|FG001|Overall Study|Noncompliance|2|||
30744358|NCT00303602|58755211|FG000|Overall Study|Protocol Violation|1|||
30744359|NCT00303602|58755212|FG001|Overall Study|Protocol Violation|0|||
30744360|NCT00299130|58755221|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
30744361|NCT00299130|58755222|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
30744362|NCT00299130|58755223|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
30744363|NCT00299130|58755221|FG000|Treatment Period (up to 5 Years)|Death|1|||
30744364|NCT00299130|58755222|FG001|Treatment Period (up to 5 Years)|Death|3|||
30744365|NCT00299130|58755223|FG002|Treatment Period (up to 5 Years)|Death|1|||
30744366|NCT00299130|58755221|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
30744367|NCT00299130|58755222|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
30744368|NCT00299130|58755223|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
30744369|NCT00299130|58755221|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
30744370|NCT00299130|58755222|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
30744371|NCT00299130|58755223|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
30744372|NCT00299130|58755221|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
30744373|NCT00299130|58755222|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
30744374|NCT00299130|58755223|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
30902552|NCT01796470|58936456|FG000|Overall Study|Initiated New Therapy|9|||
30902553|NCT01796470|58936457|FG001|Overall Study|Initiated New Therapy|0|||
30902554|NCT01796470|58936458|FG002|Overall Study|Initiated New Therapy|0|||
30902555|NCT01796470|58936459|FG003|Overall Study|Initiated New Therapy|0|||
30902556|NCT01796470|58936460|FG004|Overall Study|Initiated New Therapy|2|||
30902557|NCT01796470|58936456|FG000|Overall Study|Lost to Follow-up|0|||
30902558|NCT01796470|58936457|FG001|Overall Study|Lost to Follow-up|1|||
30902559|NCT01796470|58936458|FG002|Overall Study|Lost to Follow-up|0|||
30902560|NCT01796470|58936459|FG003|Overall Study|Lost to Follow-up|0|||
30902561|NCT01796470|58936460|FG004|Overall Study|Lost to Follow-up|0|||
30902562|NCT01796470|58936456|FG000|Overall Study|Physician Decision|5|||
30902563|NCT01796470|58936457|FG001|Overall Study|Physician Decision|4|||
30902564|NCT01796470|58936458|FG002|Overall Study|Physician Decision|1|||
30902565|NCT01796470|58936459|FG003|Overall Study|Physician Decision|0|||
30902566|NCT01796470|58936460|FG004|Overall Study|Physician Decision|1|||
30902567|NCT01796470|58936456|FG000|Overall Study|Progressive Disease|7|||
30902568|NCT01796470|58936457|FG001|Overall Study|Progressive Disease|7|||
30902569|NCT01796470|58936458|FG002|Overall Study|Progressive Disease|3|||
30902570|NCT01796470|58936459|FG003|Overall Study|Progressive Disease|2|||
30902571|NCT01796470|58936460|FG004|Overall Study|Progressive Disease|0|||
30902572|NCT01796470|58936456|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
30744375|NCT00299130|58755221|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
30744376|NCT00299130|58755222|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
30744377|NCT00299130|58755223|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
30744378|NCT00299130|58755221|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
30744379|NCT00299130|58755222|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
30744380|NCT00299130|58755223|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
30744381|NCT00299130|58755221|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
30902573|NCT01796470|58936457|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
30902574|NCT01796470|58936458|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
30902575|NCT01796470|58936459|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
30902576|NCT01796470|58936460|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
30902577|NCT01796470|58936456|FG000|Overall Study|Withdrawal by Subject|7|||
30902578|NCT01796470|58936457|FG001|Overall Study|Withdrawal by Subject|0|||
30902579|NCT01796470|58936458|FG002|Overall Study|Withdrawal by Subject|0|||
30902580|NCT01796470|58936459|FG003|Overall Study|Withdrawal by Subject|0|||
30902581|NCT01796470|58936460|FG004|Overall Study|Withdrawal by Subject|1|||
30744382|NCT00299130|58755222|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
30744383|NCT00299130|58755223|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
30744384|NCT00299130|58755221|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
30744385|NCT00299130|58755222|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
30744386|NCT00299130|58755223|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
30744387|NCT00299130|58755221|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
30744388|NCT00299130|58755222|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
30744389|NCT00299130|58755223|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
30744390|NCT00299130|58755221|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
30744391|NCT00299130|58755222|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
30744392|NCT00299130|58755223|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
30744393|NCT00299130|58755221|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
30744394|NCT00299130|58755222|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
30744395|NCT00299130|58755223|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
30744396|NCT00299130|58755221|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
30744397|NCT00299130|58755222|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
30744398|NCT00299130|58755223|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
30744399|NCT00299130|58755221|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
30744400|NCT00299130|58755222|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
30744401|NCT00299130|58755223|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
30744402|NCT00299130|58755221|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
30744403|NCT00299130|58755222|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
30744404|NCT00299130|58755223|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
30744405|NCT00299130|58755221|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
30744406|NCT00299130|58755222|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
30744407|NCT00299130|58755223|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
30744408|NCT00299130|58755221|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
30744409|NCT00299130|58755222|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
30744410|NCT00299130|58755223|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
30744411|NCT00288054|58755238|FG000|Overall Study|Protocol Violation|2|||
30744412|NCT00288054|58755238|FG000|Overall Study|Lack of Efficacy|16|||
30744413|NCT00288054|58755238|FG000|Overall Study|Adverse Event|3|||
30744414|NCT00288054|58755238|FG000|Overall Study|Withdrawal by Subject|1|||
30744415|NCT00288054|58755238|FG000|Overall Study|Not protocol specified|2|||
30744416|NCT00287586|58755246|FG000|Overall Study|Withdrew Consent|19|||
30744417|NCT00287586|58755247|FG001|Overall Study|Withdrew Consent|30|||
30744418|NCT00287586|58755246|FG000|Overall Study|Lost to Follow-up|5|||
30744419|NCT00287586|58755247|FG001|Overall Study|Lost to Follow-up|4|||
30744420|NCT00287586|58755246|FG000|Overall Study|Death|2|||
30744421|NCT00287586|58755247|FG001|Overall Study|Death|3|||
30744422|NCT00287586|58755246|FG000|Overall Study|Elevated Hematocrit|3|||
30744423|NCT00287586|58755247|FG001|Overall Study|Elevated Hematocrit|0|||
30744424|NCT00287586|58755246|FG000|Overall Study|Rash|3|||
30744425|NCT00287586|58755247|FG001|Overall Study|Rash|0|||
30744426|NCT00287586|58755246|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
30744427|NCT00287586|58755247|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
30744428|NCT00287586|58755246|FG000|Overall Study|Stroke|2|||
30744429|NCT00287586|58755247|FG001|Overall Study|Stroke|0|||
30744430|NCT00287586|58755246|FG000|Overall Study|Myocardial Infarction|1|||
30744431|NCT00287586|58755247|FG001|Overall Study|Myocardial Infarction|0|||
30744432|NCT00287586|58755246|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
30744433|NCT00287586|58755247|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
30744434|NCT00287586|58755246|FG000|Overall Study|Cognitive Impairment|1|||
30744435|NCT00287586|58755247|FG001|Overall Study|Cognitive Impairment|0|||
30744436|NCT00287586|58755246|FG000|Overall Study|Pancreatic Cancer|1|||
30744437|NCT00287586|58755247|FG001|Overall Study|Pancreatic Cancer|3|||
30744438|NCT00287586|58755246|FG000|Overall Study|Sleep Apnea|1|||
30744439|NCT00287586|58755247|FG001|Overall Study|Sleep Apnea|0|||
30744440|NCT00287586|58755246|FG000|Overall Study|Shoulder Pain|1|||
30744441|NCT00287586|58755247|FG001|Overall Study|Shoulder Pain|0|||
30744442|NCT00287586|58755246|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
30744443|NCT00287586|58755247|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
30744444|NCT00287586|58755246|FG000|Overall Study|Nonadherence|1|||
30744445|NCT00287586|58755247|FG001|Overall Study|Nonadherence|1|||
30744446|NCT00287586|58755246|FG000|Overall Study|Enrolled in Another Study|1|||
30744447|NCT00287586|58755247|FG001|Overall Study|Enrolled in Another Study|0|||
30744448|NCT00287586|58755246|FG000|Overall Study|Major Depression|0|||
30744449|NCT00287586|58755247|FG001|Overall Study|Major Depression|2|||
30744450|NCT00287586|58755246|FG000|Overall Study|Lung Cancer|0|||
30744451|NCT00287586|58755247|FG001|Overall Study|Lung Cancer|2|||
30744452|NCT00287586|58755246|FG000|Overall Study|Elevated IPSS Score|0|||
30744453|NCT00287586|58755247|FG001|Overall Study|Elevated IPSS Score|1|||
30744454|NCT00287586|58755246|FG000|Overall Study|Retroperitoneal Cancer|0|||
30744455|NCT00287586|58755247|FG001|Overall Study|Retroperitoneal Cancer|1|||
30744456|NCT00287586|58755246|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
30744457|NCT00287586|58755247|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
30744458|NCT00287586|58755246|FG000|Overall Study|Mood Swings and Irritability|0|||
30744459|NCT00287586|58755247|FG001|Overall Study|Mood Swings and Irritability|1|||
30744460|NCT00287586|58755246|FG000|Overall Study|Bradycardia|0|||
30744461|NCT00287586|58755247|FG001|Overall Study|Bradycardia|1|||
30744462|NCT00287586|58755246|FG000|Overall Study|Itchy Swollen Eyes|0|||
30744463|NCT00287586|58755247|FG001|Overall Study|Itchy Swollen Eyes|1|||
30744464|NCT00287586|58755246|FG000|Overall Study|Recurrent Melanoma|0|||
30744465|NCT00287586|58755247|FG001|Overall Study|Recurrent Melanoma|1|||
30744466|NCT00287118|58755253|FG000|Overall Study|Adverse Event|30|||
30744467|NCT00287118|58755253|FG000|Overall Study|Death|1|||
30744468|NCT00287118|58755253|FG000|Overall Study|Lack of Efficacy|11|||
30902582|NCT01868074|58936478|FG000|Overall Study|Lost to Follow-up|3|||
30744469|NCT00287118|58755253|FG000|Overall Study|Lost to Follow-up|1|||
30744470|NCT00287118|58755253|FG000|Overall Study|Protocol Violation|2|||
30744471|NCT00287118|58755253|FG000|Overall Study|Other|7|||
30744472|NCT00293202|58755259|FG000|Overall Study|Withdrawal by Subject|1|||
30744473|NCT00293202|58755260|FG001|Overall Study|Withdrawal by Subject|2|||
30744474|NCT00293202|58755259|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
30744475|NCT00293202|58755260|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
30744476|NCT00293202|58755259|FG000|Overall Study|on-hold due to fistula maturation time|1|||
30744477|NCT00293202|58755260|FG001|Overall Study|on-hold due to fistula maturation time|0|||
30744478|NCT00298896|58755270|FG000|Overall Study|Death|3|||
30744479|NCT00298896|58755270|FG000|Overall Study|Physician Decision|2|||
30744480|NCT00298896|58755270|FG000|Overall Study|Intercurrent Illness|1|||
30902583|NCT01868074|58936479|FG001|Overall Study|Lost to Follow-up|2|||
30902584|NCT01868074|58936478|FG000|Overall Study|Withdrawal by Subject|4|||
30902585|NCT01868074|58936479|FG001|Overall Study|Withdrawal by Subject|2|||
30902586|NCT01810042|58936485|FG000|Overall Study|Lost to Follow-up|10|||
30902587|NCT02424539|58936492|FG000|Overall Study|Adverse Event|0|||
30902588|NCT02424539|58936493|FG001|Overall Study|Adverse Event|0|||
30902589|NCT02424539|58936494|FG002|Overall Study|Adverse Event|1|||
30902590|NCT02424539|58936492|FG000|Overall Study|Physician Decision|0|||
30902591|NCT02424539|58936493|FG001|Overall Study|Physician Decision|0|||
30902592|NCT02424539|58936494|FG002|Overall Study|Physician Decision|1|||
30902593|NCT02424539|58936492|FG000|Overall Study|Withdrawal by Subject|3|||
30902594|NCT02424539|58936493|FG001|Overall Study|Withdrawal by Subject|1|||
30902595|NCT02424539|58936494|FG002|Overall Study|Withdrawal by Subject|0|||
30902596|NCT02424539|58936492|FG000|Overall Study|Other: Reached stopping criteria|11|||
30902597|NCT02424539|58936493|FG001|Overall Study|Other: Reached stopping criteria|7|||
30902598|NCT02424539|58936494|FG002|Overall Study|Other: Reached stopping criteria|6|||
30902599|NCT01809262|58936502|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
30902600|NCT01809262|58936503|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
30902601|NCT01809262|58936504|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
30902602|NCT01809262|58936505|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
30902603|NCT01809262|58936506|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
30902604|NCT01809262|58936507|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
30902605|NCT01809262|58936508|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
30902606|NCT01809262|58936509|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
30902607|NCT01809262|58936510|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
30902608|NCT01809262|58936511|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
30902609|NCT01809262|58936502|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
30902610|NCT01809262|58936503|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
30744481|NCT00298896|58755270|FG000|Overall Study|Disease Progression|41|||
30744482|NCT00298896|58755270|FG000|Overall Study|Withdrawal by Subject|2|||
30744483|NCT00298896|58755270|FG000|Overall Study|Assigned to treatment in error|1|||
30744484|NCT00286494|58755277|FG000|Overall Study|Hyperglycemic rescue|12|||
30744485|NCT00286494|58755278|FG001|Overall Study|Hyperglycemic rescue|19|||
30744486|NCT00286494|58755279|FG002|Overall Study|Hyperglycemic rescue|18|||
30902611|NCT01809262|58936504|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
30902612|NCT01809262|58936505|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
30902613|NCT01809262|58936506|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
30902614|NCT01809262|58936507|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
30902615|NCT01809262|58936508|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
30902616|NCT01809262|58936509|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
30902617|NCT01809262|58936510|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
30902618|NCT01809262|58936511|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
30902619|NCT01808248|58936525|FG000|Overall Study|Lack of Efficacy|3|||
30902620|NCT01808248|58936525|FG000|Overall Study|Withdrawal by Subject|1|||
30902621|NCT01808248|58936525|FG000|Overall Study|Lost to Follow-up|1|||
30902622|NCT02424383|58936531|FG000|Overall Study|Withdrawal by Subject|32|||
30902623|NCT02424383|58936531|FG000|Overall Study|Death|170|||
30902624|NCT02424383|58936531|FG000|Overall Study|Sponsor's decision|3|||
30902625|NCT02424383|58936531|FG000|Overall Study|Investigator's decision|44|||
30902626|NCT02424383|58936531|FG000|Overall Study|Lost to Follow-up|81|||
30902627|NCT02424383|58936531|FG000|Overall Study|Other|7|||
30902628|NCT02424383|58936531|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
30902629|NCT01867294|58936539|FG000|Overall Study|Withdrawal by Subject|1|||
30902630|NCT01867294|58936540|FG001|Overall Study|Withdrawal by Subject|1|||
30902631|NCT01867294|58936541|FG002|Overall Study|Withdrawal by Subject|0|||
30902632|NCT01867294|58936542|FG003|Overall Study|Withdrawal by Subject|0|||
30902633|NCT02424149|58936552|FG000|Overall Study|surgery cancelled|2|||
30902634|NCT02424149|58936553|FG001|Overall Study|surgery cancelled|0|||
30902635|NCT02424149|58936552|FG000|Overall Study|Withdrawal by Subject|0|||
30902636|NCT02424149|58936553|FG001|Overall Study|Withdrawal by Subject|1|||
30902637|NCT02423291|58936559|FG000|Overall Study|Lack of Efficacy|14|||
30902638|NCT02423291|58936559|FG000|Overall Study|Adverse Event|1|||
30902639|NCT02401529|58936565|FG000|Overall Study|Lost to Follow-up|2|||
30902640|NCT02401529|58936566|FG001|Overall Study|Lost to Follow-up|1|||
30902641|NCT02401529|58936565|FG000|Overall Study|Physician Decision|2|||
30902642|NCT02401529|58936566|FG001|Overall Study|Physician Decision|6|||
30902643|NCT02401529|58936565|FG000|Overall Study|Protocol Violation|5|||
30902644|NCT02401529|58936566|FG001|Overall Study|Protocol Violation|0|||
30902645|NCT01867216|58936580|FG000|Overall Study|Withdrawal by Subject|2|||
30902646|NCT01867216|58936581|FG001|Overall Study|Withdrawal by Subject|0|||
30902647|NCT01867216|58936582|FG002|Overall Study|Withdrawal by Subject|0|||
30902648|NCT01867216|58936583|FG003|Overall Study|Withdrawal by Subject|0|||
30902649|NCT01867216|58936584|FG004|Overall Study|Withdrawal by Subject|1|||
30902650|NCT01867216|58936585|FG005|Overall Study|Withdrawal by Subject|0|||
30902651|NCT01867216|58936586|FG006|Overall Study|Withdrawal by Subject|1|||
30902652|NCT01867216|58936580|FG000|Overall Study|Physician Decision|1|||
30902653|NCT01867216|58936581|FG001|Overall Study|Physician Decision|0|||
30902654|NCT01867216|58936582|FG002|Overall Study|Physician Decision|0|||
30902655|NCT01867216|58936583|FG003|Overall Study|Physician Decision|0|||
30902656|NCT01867216|58936584|FG004|Overall Study|Physician Decision|0|||
30902657|NCT01867216|58936585|FG005|Overall Study|Physician Decision|0|||
30902658|NCT01867216|58936586|FG006|Overall Study|Physician Decision|0|||
30902659|NCT01867216|58936580|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
30902660|NCT01867216|58936581|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
30902661|NCT01867216|58936582|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
30902662|NCT01867216|58936583|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
30902663|NCT01867216|58936584|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
30902664|NCT01867216|58936585|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
30902665|NCT01867216|58936586|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
30902666|NCT01866826|58936608|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
30902667|NCT01866826|58936609|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
30902668|NCT01866826|58936608|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
30902669|NCT01866826|58936609|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
30902670|NCT01866826|58936608|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
30902671|NCT01866826|58936609|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
30902672|NCT01791244|58936626|FG000|Overall Study|Adverse Event|5|||
30902673|NCT01791244|58936627|FG001|Overall Study|Adverse Event|7|||
30902674|NCT01791244|58936626|FG000|Overall Study|Insufficient clinical response|10|||
30902675|NCT01791244|58936627|FG001|Overall Study|Insufficient clinical response|10|||
30902676|NCT01791244|58936626|FG000|Overall Study|Laboratory Abnormality|0|||
30902677|NCT01791244|58936627|FG001|Overall Study|Laboratory Abnormality|1|||
30902678|NCT01865812|58936635|FG000|Primary Treatment Phase|Adverse Event|2|||
30902679|NCT01865812|58936636|FG001|Primary Treatment Phase|Adverse Event|0|||
30902680|NCT01865812|58936635|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
30902681|NCT01865812|58936636|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
30902682|NCT01865812|58936635|FG000|Long-term Safety Extension Phase|Pruritus|0|||
30902683|NCT01865812|58936636|FG001|Long-term Safety Extension Phase|Pruritus|3|||
30902684|NCT01865812|58936635|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
30902685|NCT01865812|58936636|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
30902686|NCT01865812|58936635|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
30902687|NCT01865812|58936636|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
30744487|NCT00286494|58755277|FG000|Overall Study|Withdrawal by Subject|2|||
30744488|NCT00286494|58755278|FG001|Overall Study|Withdrawal by Subject|10|||
30744489|NCT00286494|58755279|FG002|Overall Study|Withdrawal by Subject|9|||
30744490|NCT00286494|58755277|FG000|Overall Study|Adverse Event|3|||
30744491|NCT00286494|58755278|FG001|Overall Study|Adverse Event|8|||
30744492|NCT00286494|58755279|FG002|Overall Study|Adverse Event|6|||
30744493|NCT00286494|58755277|FG000|Overall Study|Physician Decision|5|||
30744494|NCT00286494|58755278|FG001|Overall Study|Physician Decision|5|||
30744495|NCT00286494|58755279|FG002|Overall Study|Physician Decision|1|||
30744496|NCT00286494|58755277|FG000|Overall Study|Lost to Follow-up|3|||
30744497|NCT00286494|58755278|FG001|Overall Study|Lost to Follow-up|1|||
30744498|NCT00286494|58755279|FG002|Overall Study|Lost to Follow-up|3|||
30744499|NCT00286494|58755277|FG000|Overall Study|Protocol Violation|1|||
30744500|NCT00286494|58755278|FG001|Overall Study|Protocol Violation|1|||
30744501|NCT00286494|58755279|FG002|Overall Study|Protocol Violation|2|||
30744502|NCT00298740|58755287|FG000|Overall Study|Lack of Efficacy|6|||
30744503|NCT00298740|58755287|FG000|Overall Study|Withdrawal by Subject|3|||
30744504|NCT00285012|58755293|FG000|Assigned to Study Treatment (Tx)|Other|2|||
30744505|NCT00285012|58755294|FG001|Assigned to Study Treatment (Tx)|Other|3|||
30744506|NCT00285012|58755293|FG000|Received Study Tx|Death|2|||
30744507|NCT00285012|58755294|FG001|Received Study Tx|Death|1|||
30744508|NCT00285012|58755293|FG000|Received Study Tx|Adverse Event|5|||
30744509|NCT00285012|58755294|FG001|Received Study Tx|Adverse Event|11|||
30744510|NCT00285012|58755293|FG000|Received Study Tx|Lack of Efficacy|0|||
30744511|NCT00285012|58755294|FG001|Received Study Tx|Lack of Efficacy|3|||
30744512|NCT00285012|58755293|FG000|Received Study Tx|Lost to Follow-up|29|||
30744513|NCT00285012|58755294|FG001|Received Study Tx|Lost to Follow-up|31|||
30744514|NCT00285012|58755293|FG000|Received Study Tx|Withdrawal by Subject|31|||
30744515|NCT00285012|58755294|FG001|Received Study Tx|Withdrawal by Subject|43|||
30744516|NCT00285012|58755293|FG000|Received Study Tx|Other|5|||
30744517|NCT00285012|58755294|FG001|Received Study Tx|Other|5|||
30744518|NCT00284934|58755302|FG000|Overall Study|Adverse Event|1|||
30744519|NCT00284934|58755303|FG001|Overall Study|Adverse Event|2|||
30744520|NCT00284934|58755302|FG000|Overall Study|Other reasons|3|||
30744521|NCT00284934|58755303|FG001|Overall Study|Other reasons|1|||
30744522|NCT00284856|58755312|FG000|Overall Study|Adverse Event|3|||
30744523|NCT00284856|58755313|FG001|Overall Study|Adverse Event|3|||
30744524|NCT00284856|58755314|FG002|Overall Study|Adverse Event|3|||
30744525|NCT00284856|58755312|FG000|Overall Study|Lack of Efficacy|2|||
30744526|NCT00284856|58755313|FG001|Overall Study|Lack of Efficacy|1|||
30744527|NCT00284856|58755314|FG002|Overall Study|Lack of Efficacy|8|||
30744528|NCT00284856|58755312|FG000|Overall Study|Lost to Follow-up|25|||
30744529|NCT00284856|58755313|FG001|Overall Study|Lost to Follow-up|21|||
30744530|NCT00284856|58755314|FG002|Overall Study|Lost to Follow-up|22|||
30744531|NCT00284856|58755312|FG000|Overall Study|Protocol Violation|5|||
30744532|NCT00284856|58755313|FG001|Overall Study|Protocol Violation|4|||
30744533|NCT00284856|58755314|FG002|Overall Study|Protocol Violation|5|||
30744534|NCT00284856|58755312|FG000|Overall Study|Withdrawal by Subject|12|||
30744535|NCT00284856|58755313|FG001|Overall Study|Withdrawal by Subject|16|||
30744536|NCT00284856|58755314|FG002|Overall Study|Withdrawal by Subject|18|||
30744537|NCT00284856|58755312|FG000|Overall Study|Other|4|||
30744538|NCT00284856|58755313|FG001|Overall Study|Other|5|||
30744539|NCT00284856|58755314|FG002|Overall Study|Other|4|||
30744540|NCT00298272|58755324|FG000|Double-blind Phase|Adverse Event|2|||
30744541|NCT00298272|58755325|FG001|Double-blind Phase|Adverse Event|0|||
30744542|NCT00298272|58755324|FG000|Double-blind Phase|Failure to Return|2|||
30744543|NCT00298272|58755325|FG001|Double-blind Phase|Failure to Return|0|||
30744544|NCT00298272|58755324|FG000|Double-blind Phase|Protocol Violation|2|||
30744545|NCT00298272|58755325|FG001|Double-blind Phase|Protocol Violation|0|||
30744546|NCT00298272|58755324|FG000|Double-blind Phase|Withdrawal by Subject|2|||
30744547|NCT00298272|58755325|FG001|Double-blind Phase|Withdrawal by Subject|0|||
30744548|NCT00298272|58755324|FG000|Open Label Retreatment Phase|Adverse Event|1|||
30902688|NCT01808092|58936645|FG000|Overall Study|Death|39|||
30744549|NCT00298272|58755325|FG001|Open Label Retreatment Phase|Adverse Event|2|||
30744550|NCT00298272|58755324|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
30744551|NCT00298272|58755325|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
30744552|NCT00298272|58755324|FG000|Open Label Retreatment Phase|Failure to Return|1|||
30744553|NCT00298272|58755325|FG001|Open Label Retreatment Phase|Failure to Return|0|||
30744554|NCT00298272|58755324|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
30744555|NCT00298272|58755325|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
30744556|NCT00298272|58755324|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
30744557|NCT00298272|58755325|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
30902689|NCT01808092|58936646|FG001|Overall Study|Death|29|||
30744558|NCT00298272|58755324|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
30744559|NCT00298272|58755325|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
30744560|NCT00298272|58755324|FG000|Safety Follow-up Phase|Failure to Return|1|||
30744561|NCT00298272|58755325|FG001|Safety Follow-up Phase|Failure to Return|1|||
30744562|NCT00298272|58755324|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
30744563|NCT00298272|58755325|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
30744564|NCT00298272|58755324|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
30744565|NCT00298272|58755325|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
30744566|NCT00283842|58755339|FG000|Overall Study|Adverse Event|8|||
30744567|NCT00283842|58755340|FG001|Overall Study|Adverse Event|7|||
30744568|NCT00283842|58755341|FG002|Overall Study|Adverse Event|21|||
30744569|NCT00283842|58755342|FG003|Overall Study|Adverse Event|21|||
30744570|NCT00283842|58755343|FG004|Overall Study|Adverse Event|5|||
30744571|NCT00283842|58755339|FG000|Overall Study|Protocol Violation|1|||
30744572|NCT00283842|58755340|FG001|Overall Study|Protocol Violation|5|||
30744573|NCT00283842|58755341|FG002|Overall Study|Protocol Violation|4|||
30744574|NCT00283842|58755342|FG003|Overall Study|Protocol Violation|0|||
30744575|NCT00283842|58755343|FG004|Overall Study|Protocol Violation|0|||
30744576|NCT00283842|58755339|FG000|Overall Study|Protocol deviation|0|||
30744577|NCT00283842|58755340|FG001|Overall Study|Protocol deviation|0|||
30744578|NCT00283842|58755341|FG002|Overall Study|Protocol deviation|0|||
30744579|NCT00283842|58755342|FG003|Overall Study|Protocol deviation|0|||
30744580|NCT00283842|58755343|FG004|Overall Study|Protocol deviation|2|||
30744581|NCT00283842|58755339|FG000|Overall Study|Withdrawal by Subject|2|||
30744582|NCT00283842|58755340|FG001|Overall Study|Withdrawal by Subject|1|||
30744583|NCT00283842|58755341|FG002|Overall Study|Withdrawal by Subject|1|||
30744584|NCT00283842|58755342|FG003|Overall Study|Withdrawal by Subject|5|||
30902690|NCT01808092|58936645|FG000|Overall Study|Lost to Follow-up|3|||
30902691|NCT01808092|58936646|FG001|Overall Study|Lost to Follow-up|7|||
30902692|NCT01808092|58936645|FG000|Overall Study|Withdrawal by Subject|9|||
30902693|NCT01808092|58936646|FG001|Overall Study|Withdrawal by Subject|4|||
30902694|NCT01808092|58936645|FG000|Overall Study|Other Eligibility criteria|3|||
30744585|NCT00283842|58755343|FG004|Overall Study|Withdrawal by Subject|4|||
30744586|NCT00283842|58755339|FG000|Overall Study|Lack of Efficacy|1|||
30744587|NCT00283842|58755340|FG001|Overall Study|Lack of Efficacy|3|||
30744588|NCT00283842|58755341|FG002|Overall Study|Lack of Efficacy|1|||
30744589|NCT00283842|58755342|FG003|Overall Study|Lack of Efficacy|0|||
30744590|NCT00283842|58755343|FG004|Overall Study|Lack of Efficacy|3|||
30744591|NCT00283842|58755339|FG000|Overall Study|Lost to Follow-up|0|||
30744592|NCT00283842|58755340|FG001|Overall Study|Lost to Follow-up|2|||
30744593|NCT00283842|58755341|FG002|Overall Study|Lost to Follow-up|4|||
30744594|NCT00283842|58755342|FG003|Overall Study|Lost to Follow-up|1|||
30744595|NCT00283842|58755343|FG004|Overall Study|Lost to Follow-up|1|||
30744596|NCT00298038|58755357|FG000|Overall Study|Lost to Follow-up|0|||
30744597|NCT00298038|58755358|FG001|Overall Study|Lost to Follow-up|1|||
30744598|NCT00298038|58755357|FG000|Overall Study|Liver Transplant|0|||
30744599|NCT00298038|58755358|FG001|Overall Study|Liver Transplant|1|||
30744600|NCT00298038|58755357|FG000|Overall Study|Protocol Violation|1|||
30744601|NCT00298038|58755358|FG001|Overall Study|Protocol Violation|3|||
30791021|NCT02742766|58804190|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30791022|NCT02742766|58804191|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30791023|NCT02742766|58804192|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
30791024|NCT02742766|58804174|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791025|NCT02742766|58804175|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791026|NCT02742766|58804176|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791027|NCT02742766|58804177|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791028|NCT02742766|58804178|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791029|NCT02742766|58804179|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791030|NCT02742766|58804180|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
30902695|NCT01808092|58936646|FG001|Overall Study|Other Eligibility criteria|5|||
30902696|NCT01774084|58936654|FG000|Overall Study|Personal reasons|1|||
30902697|NCT01774084|58936655|FG001|Overall Study|Personal reasons|0|||
30744602|NCT00298038|58755357|FG000|Overall Study|Death|6|||
30744603|NCT00298038|58755358|FG001|Overall Study|Death|3|||
30744604|NCT00298038|58755357|FG000|Overall Study|Withdrawal by Subject|6|||
30744605|NCT00298038|58755358|FG001|Overall Study|Withdrawal by Subject|9|||
30744606|NCT00298038|58755357|FG000|Overall Study|Adverse Event|8|||
30791031|NCT02742766|58804181|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791032|NCT02742766|58804182|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
30744607|NCT00298038|58755358|FG001|Overall Study|Adverse Event|7|||
30744608|NCT00298038|58755357|FG000|Overall Study|Breakthrough overt HE episode|28|||
30902698|NCT01807234|58936667|FG000|Overall Study|Lost to Follow-up|2|||
30744609|NCT00298038|58755358|FG001|Overall Study|Breakthrough overt HE episode|69|||
30744610|NCT00298038|58755357|FG000|Overall Study|Noncompliance|1|||
30744611|NCT00298038|58755358|FG001|Overall Study|Noncompliance|0|||
30744612|NCT00298038|58755357|FG000|Overall Study|Cocaine Abuse|1|||
30744613|NCT00298038|58755358|FG001|Overall Study|Cocaine Abuse|0|||
30902699|NCT01807234|58936668|FG001|Overall Study|Lost to Follow-up|5|||
30791033|NCT02742766|58804183|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791034|NCT02742766|58804184|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791035|NCT02742766|58804185|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791036|NCT02742766|58804186|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
30791037|NCT02742766|58804187|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
30791038|NCT02742766|58804188|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791039|NCT02742766|58804189|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
30791040|NCT02742766|58804190|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791041|NCT02742766|58804191|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791042|NCT02742766|58804192|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
30791043|NCT01468922|58804270|FG000|Overall Study|Screening failure|0|||
30791044|NCT01468922|58804271|FG001|Overall Study|Screening failure|0|||
30791045|NCT01468922|58804272|FG002|Overall Study|Screening failure|0|||
30791046|NCT01468922|58804273|FG003|Overall Study|Screening failure|0|||
30791047|NCT01468922|58804274|FG004|Overall Study|Screening failure|0|||
30791048|NCT01468922|58804275|FG005|Overall Study|Screening failure|0|||
30791049|NCT01468922|58804276|FG006|Overall Study|Screening failure|0|||
30791050|NCT01468922|58804277|FG007|Overall Study|Screening failure|0|||
30791051|NCT01468922|58804278|FG008|Overall Study|Screening failure|1|||
30791052|NCT01468922|58804270|FG000|Overall Study|Per patient choice|1|||
30791053|NCT01468922|58804271|FG001|Overall Study|Per patient choice|0|||
30791054|NCT01468922|58804272|FG002|Overall Study|Per patient choice|0|||
30791055|NCT01468922|58804273|FG003|Overall Study|Per patient choice|0|||
30791056|NCT01468922|58804274|FG004|Overall Study|Per patient choice|0|||
30791057|NCT01468922|58804275|FG005|Overall Study|Per patient choice|0|||
30791058|NCT01468922|58804276|FG006|Overall Study|Per patient choice|0|||
30791059|NCT01468922|58804277|FG007|Overall Study|Per patient choice|0|||
30791060|NCT01468922|58804278|FG008|Overall Study|Per patient choice|0|||
30791061|NCT01468922|58804270|FG000|Overall Study|Switched to alternative treatment|1|||
30791062|NCT01468922|58804271|FG001|Overall Study|Switched to alternative treatment|0|||
30791063|NCT01468922|58804272|FG002|Overall Study|Switched to alternative treatment|0|||
30791064|NCT01468922|58804273|FG003|Overall Study|Switched to alternative treatment|0|||
30791065|NCT01468922|58804274|FG004|Overall Study|Switched to alternative treatment|1|||
30791066|NCT01468922|58804275|FG005|Overall Study|Switched to alternative treatment|0|||
30791067|NCT01468922|58804276|FG006|Overall Study|Switched to alternative treatment|0|||
30791068|NCT01468922|58804277|FG007|Overall Study|Switched to alternative treatment|0|||
30791069|NCT01468922|58804278|FG008|Overall Study|Switched to alternative treatment|0|||
30791070|NCT01468922|58804270|FG000|Overall Study|Enrolled on new protocol|0|||
30791071|NCT01468922|58804271|FG001|Overall Study|Enrolled on new protocol|0|||
30791072|NCT01468922|58804272|FG002|Overall Study|Enrolled on new protocol|0|||
30791073|NCT01468922|58804273|FG003|Overall Study|Enrolled on new protocol|0|||
30791074|NCT01468922|58804274|FG004|Overall Study|Enrolled on new protocol|1|||
30791075|NCT01468922|58804275|FG005|Overall Study|Enrolled on new protocol|0|||
30791076|NCT01468922|58804276|FG006|Overall Study|Enrolled on new protocol|0|||
30791077|NCT01468922|58804277|FG007|Overall Study|Enrolled on new protocol|0|||
30791078|NCT01468922|58804278|FG008|Overall Study|Enrolled on new protocol|0|||
30744614|NCT00298038|58755357|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
30744615|NCT00298038|58755358|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
30744616|NCT00283686|58755368|FG000|Overall Study|Death|1|||
30744617|NCT00283686|58755369|FG001|Overall Study|Death|1|||
30744618|NCT00283686|58755370|FG002|Overall Study|Death|1|||
30744619|NCT00283686|58755371|FG003|Overall Study|Death|0|||
30744620|NCT00283686|58755368|FG000|Overall Study|Lost to Follow-up|21|||
30744621|NCT00283686|58755369|FG001|Overall Study|Lost to Follow-up|31|||
30744622|NCT00283686|58755370|FG002|Overall Study|Lost to Follow-up|26|||
30744623|NCT00283686|58755371|FG003|Overall Study|Lost to Follow-up|20|||
30744624|NCT00283686|58755368|FG000|Overall Study|Less than full participation|7|||
30744625|NCT00283686|58755369|FG001|Overall Study|Less than full participation|9|||
30744626|NCT00283686|58755370|FG002|Overall Study|Less than full participation|6|||
30744627|NCT00283686|58755371|FG003|Overall Study|Less than full participation|12|||
30744628|NCT00297882|58755383|FG000|Day 14|Lack of Efficacy|12|||
30744629|NCT00297882|58755384|FG001|Day 14|Lack of Efficacy|49|||
30744630|NCT00297882|58755383|FG000|Day 28|Lost to Follow-up|13|||
30744631|NCT00297882|58755384|FG001|Day 28|Lost to Follow-up|23|||
30744632|NCT00297882|58755383|FG000|Day 28|Lack of Efficacy|3|||
30791079|NCT01468922|58804270|FG000|Overall Study|Adverse Event|0|||
30791080|NCT01468922|58804271|FG001|Overall Study|Adverse Event|0|||
30791081|NCT01468922|58804272|FG002|Overall Study|Adverse Event|0|||
30791082|NCT01468922|58804273|FG003|Overall Study|Adverse Event|0|||
30791083|NCT01468922|58804274|FG004|Overall Study|Adverse Event|0|||
30744633|NCT00297882|58755384|FG001|Day 28|Lack of Efficacy|0|||
30791084|NCT01468922|58804275|FG005|Overall Study|Adverse Event|0|||
30791085|NCT01468922|58804276|FG006|Overall Study|Adverse Event|0|||
30791086|NCT01468922|58804277|FG007|Overall Study|Adverse Event|1|||
30791087|NCT01468922|58804278|FG008|Overall Study|Adverse Event|0|||
30791088|NCT01468922|58804270|FG000|Overall Study|Infection of blood|0|||
30744634|NCT00297648|58755392|FG000|Overall Study|Adverse Event|13|||
30791089|NCT01468922|58804271|FG001|Overall Study|Infection of blood|0|||
30791090|NCT01468922|58804272|FG002|Overall Study|Infection of blood|0|||
30791091|NCT01468922|58804273|FG003|Overall Study|Infection of blood|0|||
30791092|NCT01468922|58804274|FG004|Overall Study|Infection of blood|0|||
30791093|NCT01468922|58804275|FG005|Overall Study|Infection of blood|0|||
30791094|NCT01468922|58804276|FG006|Overall Study|Infection of blood|0|||
30791095|NCT01468922|58804277|FG007|Overall Study|Infection of blood|1|||
30791096|NCT01468922|58804278|FG008|Overall Study|Infection of blood|0|||
30791097|NCT01468922|58804270|FG000|Overall Study|Patient choice - surgery|0|||
30791098|NCT01468922|58804271|FG001|Overall Study|Patient choice - surgery|0|||
30791099|NCT01468922|58804272|FG002|Overall Study|Patient choice - surgery|0|||
30791100|NCT01468922|58804273|FG003|Overall Study|Patient choice - surgery|0|||
30791101|NCT01468922|58804274|FG004|Overall Study|Patient choice - surgery|0|||
30791102|NCT01468922|58804275|FG005|Overall Study|Patient choice - surgery|0|||
30791103|NCT01468922|58804276|FG006|Overall Study|Patient choice - surgery|0|||
30791104|NCT01468922|58804277|FG007|Overall Study|Patient choice - surgery|1|||
30791105|NCT01468922|58804278|FG008|Overall Study|Patient choice - surgery|0|||
30791106|NCT01468922|58804270|FG000|Overall Study|Refused further treatment|0|||
30791107|NCT01468922|58804271|FG001|Overall Study|Refused further treatment|0|||
30791108|NCT01468922|58804272|FG002|Overall Study|Refused further treatment|0|||
30791109|NCT01468922|58804273|FG003|Overall Study|Refused further treatment|0|||
30791110|NCT01468922|58804274|FG004|Overall Study|Refused further treatment|0|||
30791111|NCT01468922|58804275|FG005|Overall Study|Refused further treatment|0|||
30791112|NCT01468922|58804276|FG006|Overall Study|Refused further treatment|0|||
30791113|NCT01468922|58804277|FG007|Overall Study|Refused further treatment|1|||
30791114|NCT01468922|58804278|FG008|Overall Study|Refused further treatment|0|||
30791115|NCT01381094|58804301|FG000|Overall Study|Adverse Event|1|||
30791116|NCT01381094|58804302|FG001|Overall Study|Adverse Event|2|||
30791117|NCT01381094|58804303|FG002|Overall Study|Adverse Event|0|||
30791118|NCT01381094|58804304|FG003|Overall Study|Adverse Event|1|||
30791119|NCT01381094|58804305|FG004|Overall Study|Adverse Event|0|||
30791120|NCT01381094|58804301|FG000|Overall Study|Lost to Follow-up|0|||
30791121|NCT01381094|58804302|FG001|Overall Study|Lost to Follow-up|0|||
30791122|NCT01381094|58804303|FG002|Overall Study|Lost to Follow-up|0|||
30791123|NCT01381094|58804304|FG003|Overall Study|Lost to Follow-up|0|||
30791124|NCT01381094|58804305|FG004|Overall Study|Lost to Follow-up|1|||
30791125|NCT01381094|58804301|FG000|Overall Study|Withdrawal of informed consent|0|||
30791126|NCT01381094|58804302|FG001|Overall Study|Withdrawal of informed consent|1|||
30791127|NCT01381094|58804303|FG002|Overall Study|Withdrawal of informed consent|0|||
30791128|NCT01381094|58804304|FG003|Overall Study|Withdrawal of informed consent|0|||
30791129|NCT01381094|58804305|FG004|Overall Study|Withdrawal of informed consent|0|||
30791130|NCT01381094|58804301|FG000|Overall Study|Participant given Aranesp injection|1|||
30791131|NCT01381094|58804302|FG001|Overall Study|Participant given Aranesp injection|0|||
30791132|NCT01381094|58804303|FG002|Overall Study|Participant given Aranesp injection|0|||
30791133|NCT01381094|58804304|FG003|Overall Study|Participant given Aranesp injection|0|||
30791134|NCT01381094|58804305|FG004|Overall Study|Participant given Aranesp injection|0|||
30791135|NCT03197558|58804317|FG000|Overall Study|Tubes not placed|1|||
30791136|NCT03197324|58804323|FG000|Overall Study|Adverse Event|0|||
30791137|NCT03197324|58804324|FG001|Overall Study|Adverse Event|1|||
30791138|NCT03162614|58804336|FG000|Overall Study|Lost to Follow-up|2|||
30791139|NCT03162614|58804337|FG001|Overall Study|Lost to Follow-up|1|||
30791140|NCT03162614|58804338|FG002|Overall Study|Lost to Follow-up|1|||
30791141|NCT03162614|58804339|FG003|Overall Study|Lost to Follow-up|1|||
30791142|NCT03162614|58804340|FG004|Overall Study|Lost to Follow-up|2|||
30791143|NCT03162614|58804341|FG005|Overall Study|Lost to Follow-up|0|||
30791144|NCT03162614|58804336|FG000|Overall Study|Protocol Violation|0|||
30791145|NCT03162614|58804337|FG001|Overall Study|Protocol Violation|1|||
30791146|NCT03162614|58804338|FG002|Overall Study|Protocol Violation|0|||
30791147|NCT03162614|58804339|FG003|Overall Study|Protocol Violation|1|||
30791148|NCT03162614|58804340|FG004|Overall Study|Protocol Violation|0|||
30791149|NCT03162614|58804341|FG005|Overall Study|Protocol Violation|0|||
30791150|NCT03162614|58804336|FG000|Overall Study|Withdrawal by Subject|2|||
30791151|NCT03162614|58804337|FG001|Overall Study|Withdrawal by Subject|1|||
30791152|NCT03162614|58804338|FG002|Overall Study|Withdrawal by Subject|1|||
30791153|NCT03162614|58804339|FG003|Overall Study|Withdrawal by Subject|1|||
30791154|NCT03162614|58804340|FG004|Overall Study|Withdrawal by Subject|0|||
30791155|NCT03162614|58804341|FG005|Overall Study|Withdrawal by Subject|0|||
30791156|NCT03162614|58804336|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
30791157|NCT03162614|58804337|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
30791158|NCT03162614|58804338|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
30791159|NCT03162614|58804339|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
30791160|NCT03162614|58804340|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
30791161|NCT03162614|58804341|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
30791162|NCT03160898|58804359|FG000|Overall Study|Adverse Event|4|||
30791163|NCT03160898|58804360|FG001|Overall Study|Adverse Event|8|||
30791164|NCT03160898|58804361|FG002|Overall Study|Adverse Event|7|||
30791165|NCT03160898|58804362|FG003|Overall Study|Adverse Event|10|||
30791166|NCT03160898|58804359|FG000|Overall Study|Death|1|||
30791167|NCT03160898|58804360|FG001|Overall Study|Death|0|||
30791168|NCT03160898|58804361|FG002|Overall Study|Death|0|||
30791169|NCT03160898|58804362|FG003|Overall Study|Death|1|||
30791170|NCT03160898|58804359|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
30791171|NCT03160898|58804360|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
30791172|NCT03160898|58804361|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
30791173|NCT03160898|58804362|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
30791174|NCT03160898|58804359|FG000|Overall Study|Lost to Follow-up|1|||
30791175|NCT03160898|58804360|FG001|Overall Study|Lost to Follow-up|1|||
30791176|NCT03160898|58804361|FG002|Overall Study|Lost to Follow-up|1|||
30791177|NCT03160898|58804362|FG003|Overall Study|Lost to Follow-up|2|||
30791178|NCT03160898|58804359|FG000|Overall Study|Physician Decision|1|||
30791179|NCT03160898|58804360|FG001|Overall Study|Physician Decision|0|||
30791180|NCT03160898|58804361|FG002|Overall Study|Physician Decision|0|||
30791181|NCT03160898|58804362|FG003|Overall Study|Physician Decision|1|||
30791182|NCT03160898|58804359|FG000|Overall Study|Progressive Disease|4|||
30791183|NCT03160898|58804360|FG001|Overall Study|Progressive Disease|1|||
30791184|NCT03160898|58804361|FG002|Overall Study|Progressive Disease|2|||
30791185|NCT03160898|58804362|FG003|Overall Study|Progressive Disease|1|||
30791186|NCT03160898|58804359|FG000|Overall Study|Protocol Violation|1|||
30791187|NCT03160898|58804360|FG001|Overall Study|Protocol Violation|0|||
30791188|NCT03160898|58804361|FG002|Overall Study|Protocol Violation|2|||
30791189|NCT03160898|58804362|FG003|Overall Study|Protocol Violation|0|||
30791190|NCT03160898|58804359|FG000|Overall Study|Sponsor Discretion|2|||
30791191|NCT03160898|58804360|FG001|Overall Study|Sponsor Discretion|0|||
30791192|NCT03160898|58804361|FG002|Overall Study|Sponsor Discretion|0|||
30791193|NCT03160898|58804362|FG003|Overall Study|Sponsor Discretion|0|||
30791194|NCT03160898|58804359|FG000|Overall Study|Withdrawal by Subject|1|||
30791195|NCT03160898|58804360|FG001|Overall Study|Withdrawal by Subject|3|||
30791196|NCT03160898|58804361|FG002|Overall Study|Withdrawal by Subject|2|||
30791197|NCT03160898|58804362|FG003|Overall Study|Withdrawal by Subject|1|||
30791198|NCT03160898|58804359|FG000|Overall Study|Other|2|||
30791199|NCT03160898|58804360|FG001|Overall Study|Other|0|||
30791200|NCT03160898|58804361|FG002|Overall Study|Other|2|||
30791201|NCT03160898|58804362|FG003|Overall Study|Other|2|||
30791202|NCT03193736|58804373|FG000|Overall Study|Death|2|||
30791203|NCT03193736|58804373|FG000|Overall Study|Withdrawal by Subject|1|||
30791204|NCT03193736|58804373|FG000|Overall Study|Lost to Follow-up|1|||
30791205|NCT03193736|58804373|FG000|Overall Study|implant not received|1|||
30791206|NCT03192488|58804390|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
30791207|NCT03192488|58804391|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
30791208|NCT03192488|58804392|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
30791209|NCT03192488|58804393|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
30791210|NCT03192488|58804394|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
30791211|NCT03192488|58804395|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
30791212|NCT03192488|58804390|FG000|Third Intervention (d1)|Adverse Event|0|||
30791213|NCT03192488|58804391|FG001|Third Intervention (d1)|Adverse Event|0|||
30791214|NCT03192488|58804392|FG002|Third Intervention (d1)|Adverse Event|0|||
30791215|NCT03192488|58804393|FG003|Third Intervention (d1)|Adverse Event|0|||
30791216|NCT03192488|58804394|FG004|Third Intervention (d1)|Adverse Event|1|||
30791217|NCT03192488|58804395|FG005|Third Intervention (d1)|Adverse Event|0|||
30791218|NCT03192176|58804417|FG000|Overall Study|Adverse Event|1|||
30791219|NCT03192176|58804418|FG001|Overall Study|Adverse Event|0|||
30791220|NCT03192176|58804419|FG002|Overall Study|Adverse Event|4|||
30791221|NCT03192176|58804420|FG003|Overall Study|Adverse Event|5|||
30791222|NCT03192176|58804421|FG004|Overall Study|Adverse Event|3|||
30791223|NCT03192176|58804422|FG005|Overall Study|Adverse Event|2|||
30791224|NCT03192176|58804423|FG006|Overall Study|Adverse Event|3|||
30791225|NCT03192176|58804424|FG007|Overall Study|Adverse Event|3|||
30791226|NCT03192176|58804417|FG000|Overall Study|Lost to Follow-up|0|||
30791227|NCT03192176|58804418|FG001|Overall Study|Lost to Follow-up|0|||
30791228|NCT03192176|58804419|FG002|Overall Study|Lost to Follow-up|1|||
30791229|NCT03192176|58804420|FG003|Overall Study|Lost to Follow-up|2|||
30791230|NCT03192176|58804421|FG004|Overall Study|Lost to Follow-up|3|||
30791231|NCT03192176|58804422|FG005|Overall Study|Lost to Follow-up|1|||
30791232|NCT03192176|58804423|FG006|Overall Study|Lost to Follow-up|1|||
30791233|NCT03192176|58804424|FG007|Overall Study|Lost to Follow-up|1|||
30791234|NCT03192176|58804417|FG000|Overall Study|Physician Decision|1|||
30791235|NCT03192176|58804418|FG001|Overall Study|Physician Decision|0|||
30791236|NCT03192176|58804419|FG002|Overall Study|Physician Decision|0|||
30791237|NCT03192176|58804420|FG003|Overall Study|Physician Decision|0|||
30791238|NCT03192176|58804421|FG004|Overall Study|Physician Decision|0|||
30791239|NCT03192176|58804422|FG005|Overall Study|Physician Decision|2|||
30791240|NCT03192176|58804423|FG006|Overall Study|Physician Decision|1|||
30791241|NCT03192176|58804424|FG007|Overall Study|Physician Decision|0|||
30791242|NCT03192176|58804417|FG000|Overall Study|Protocol Deviation|1|||
30791243|NCT03192176|58804418|FG001|Overall Study|Protocol Deviation|1|||
30791244|NCT03192176|58804419|FG002|Overall Study|Protocol Deviation|0|||
30791245|NCT03192176|58804420|FG003|Overall Study|Protocol Deviation|0|||
30791246|NCT03192176|58804421|FG004|Overall Study|Protocol Deviation|2|||
30791247|NCT03192176|58804422|FG005|Overall Study|Protocol Deviation|0|||
30791248|NCT03192176|58804423|FG006|Overall Study|Protocol Deviation|0|||
30791249|NCT03192176|58804424|FG007|Overall Study|Protocol Deviation|0|||
30791250|NCT03192176|58804417|FG000|Overall Study|Withdrawal by Subject|3|||
30744635|NCT00297648|58755392|FG000|Overall Study|Lack of Efficacy|18|||
30744636|NCT00297648|58755392|FG000|Overall Study|Lost to Follow-up|1|||
30744637|NCT00297648|58755392|FG000|Overall Study|Withdrawal by Subject|3|||
30744638|NCT00297648|58755392|FG000|Overall Study|Other: Incompliance|1|||
30744639|NCT00283296|58755396|FG000|Overall Study|in-home trial not completed|5|||
30744640|NCT00297492|58755404|FG000|Set Quit Date|Lost to Follow-up|7|||
30744641|NCT00297492|58755405|FG001|Set Quit Date|Lost to Follow-up|13|||
30744642|NCT00297492|58755406|FG002|Set Quit Date|Lost to Follow-up|5|||
30744643|NCT00297492|58755404|FG000|6 Month Follow-up|Lost to Follow-up|63|||
30744644|NCT00297492|58755405|FG001|6 Month Follow-up|Lost to Follow-up|49|||
30744645|NCT00297492|58755406|FG002|6 Month Follow-up|Lost to Follow-up|27|||
30791251|NCT03192176|58804418|FG001|Overall Study|Withdrawal by Subject|4|||
30791252|NCT03192176|58804419|FG002|Overall Study|Withdrawal by Subject|0|||
30791253|NCT03192176|58804420|FG003|Overall Study|Withdrawal by Subject|4|||
30791254|NCT03192176|58804421|FG004|Overall Study|Withdrawal by Subject|3|||
30791255|NCT03192176|58804422|FG005|Overall Study|Withdrawal by Subject|4|||
30902700|NCT01807234|58936669|FG002|Overall Study|Lost to Follow-up|1|||
30791256|NCT03192176|58804423|FG006|Overall Study|Withdrawal by Subject|4|||
30791257|NCT03192176|58804424|FG007|Overall Study|Withdrawal by Subject|2|||
30791258|NCT03192176|58804417|FG000|Overall Study|Miscellaneous|1|||
30744646|NCT00297258|58755414|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
30744647|NCT00297258|58755414|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
30791259|NCT03192176|58804418|FG001|Overall Study|Miscellaneous|0|||
30791260|NCT03192176|58804419|FG002|Overall Study|Miscellaneous|1|||
30791261|NCT03192176|58804420|FG003|Overall Study|Miscellaneous|1|||
30791262|NCT03192176|58804421|FG004|Overall Study|Miscellaneous|1|||
30791263|NCT03192176|58804422|FG005|Overall Study|Miscellaneous|2|||
30791264|NCT03192176|58804423|FG006|Overall Study|Miscellaneous|0|||
30791265|NCT03192176|58804424|FG007|Overall Study|Miscellaneous|1|||
30791266|NCT01642004|58804445|FG000|Randomization|Adverse Event unrelated to study drug|1|||
30791267|NCT01642004|58804446|FG001|Randomization|Adverse Event unrelated to study drug|0|||
30791268|NCT01642004|58804445|FG000|Randomization|Participant withdrew consent|1|||
30791269|NCT01642004|58804446|FG001|Randomization|Participant withdrew consent|6|||
30791270|NCT01642004|58804445|FG000|Randomization|No longer meets study criteria|2|||
30791271|NCT01642004|58804446|FG001|Randomization|No longer meets study criteria|2|||
30791272|NCT01642004|58804445|FG000|Treatment|Disease progression|95|||
30791273|NCT01642004|58804446|FG001|Treatment|Disease progression|79|||
30791274|NCT01642004|58804445|FG000|Treatment|Study drug toxicity|10|||
30744648|NCT00297258|58755414|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
30744649|NCT00297258|58755414|FG000|Overall Study|Intercurrent Illness|3|||
30744650|NCT00297258|58755414|FG000|Overall Study|Intercurrent Death|2|||
30744651|NCT00297258|58755414|FG000|Overall Study|Deteriorization of General Condition|1|||
30744652|NCT00297258|58755414|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
30744653|NCT00297258|58755414|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
30744654|NCT00297258|58755414|FG000|Overall Study|Switch to Commercial Treatment|1|||
30791275|NCT01642004|58804446|FG001|Treatment|Study drug toxicity|13|||
30791276|NCT01642004|58804445|FG000|Treatment|Death|1|||
30791277|NCT01642004|58804446|FG001|Treatment|Death|1|||
30791278|NCT01642004|58804445|FG000|Treatment|Adverse event unrelated to study drug|9|||
30791279|NCT01642004|58804446|FG001|Treatment|Adverse event unrelated to study drug|13|||
30791280|NCT01642004|58804445|FG000|Treatment|Maximum clinical benefit|1|||
30791281|NCT01642004|58804446|FG001|Treatment|Maximum clinical benefit|9|||
30791282|NCT01642004|58804445|FG000|Treatment|Poor/non-compliance|1|||
30791283|NCT01642004|58804446|FG001|Treatment|Poor/non-compliance|0|||
30791284|NCT01642004|58804445|FG000|Treatment|No longer meets study criteria|1|||
30791285|NCT01642004|58804446|FG001|Treatment|No longer meets study criteria|2|||
30791286|NCT01642004|58804445|FG000|Treatment|Other reasons|2|||
30791287|NCT01642004|58804446|FG001|Treatment|Other reasons|0|||
30791288|NCT01642004|58804445|FG000|Treatment|Not reported|0|||
30791289|NCT01642004|58804446|FG001|Treatment|Not reported|3|||
30791290|NCT01642004|58804445|FG000|Treatment|Participant request to discontinue study treatment|6|||
30791291|NCT01642004|58804446|FG001|Treatment|Participant request to discontinue study treatment|4|||
30791292|NCT01642004|58804445|FG000|Treatment|Participant withdrew consent|5|||
30791293|NCT01642004|58804446|FG001|Treatment|Participant withdrew consent|5|||
30791294|NCT00042289|58804502|FG000|Overall Study|Lost to Follow-up|3|||
30791295|NCT00042289|58804503|FG001|Overall Study|Lost to Follow-up|0|||
30791296|NCT00042289|58804504|FG002|Overall Study|Lost to Follow-up|0|||
30791297|NCT00042289|58804505|FG003|Overall Study|Lost to Follow-up|1|||
30791298|NCT00042289|58804506|FG004|Overall Study|Lost to Follow-up|3|||
30791299|NCT00042289|58804507|FG005|Overall Study|Lost to Follow-up|3|||
30791300|NCT00042289|58804508|FG006|Overall Study|Lost to Follow-up|6|||
30791301|NCT00042289|58804509|FG007|Overall Study|Lost to Follow-up|1|||
30791302|NCT00042289|58804510|FG008|Overall Study|Lost to Follow-up|1|||
30791303|NCT00042289|58804511|FG009|Overall Study|Lost to Follow-up|0|||
30791304|NCT00042289|58804512|FG010|Overall Study|Lost to Follow-up|0|||
30791305|NCT00042289|58804513|FG011|Overall Study|Lost to Follow-up|0|||
30791306|NCT00042289|58804514|FG012|Overall Study|Lost to Follow-up|0|||
30791307|NCT00042289|58804515|FG013|Overall Study|Lost to Follow-up|0|||
30791308|NCT00042289|58804516|FG014|Overall Study|Lost to Follow-up|0|||
30791309|NCT00042289|58804517|FG015|Overall Study|Lost to Follow-up|1|||
30791310|NCT00042289|58804518|FG016|Overall Study|Lost to Follow-up|1|||
30791311|NCT00042289|58804519|FG017|Overall Study|Lost to Follow-up|0|||
30791312|NCT00042289|58804520|FG018|Overall Study|Lost to Follow-up|3|||
30791313|NCT00042289|58804521|FG019|Overall Study|Lost to Follow-up|2|||
30791314|NCT00042289|58804522|FG020|Overall Study|Lost to Follow-up|0|||
30744655|NCT00297258|58755414|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
30791315|NCT00042289|58804523|FG021|Overall Study|Lost to Follow-up|0|||
30791316|NCT00042289|58804524|FG022|Overall Study|Lost to Follow-up|0|||
30791317|NCT00042289|58804525|FG023|Overall Study|Lost to Follow-up|0|||
30791318|NCT00042289|58804526|FG024|Overall Study|Lost to Follow-up|0|||
30791319|NCT00042289|58804527|FG025|Overall Study|Lost to Follow-up|0|||
30791320|NCT00042289|58804528|FG026|Overall Study|Lost to Follow-up|2|||
30791321|NCT00042289|58804529|FG027|Overall Study|Lost to Follow-up|2|||
30791322|NCT00042289|58804530|FG028|Overall Study|Lost to Follow-up|2|||
30791323|NCT00042289|58804531|FG029|Overall Study|Lost to Follow-up|0|||
30791324|NCT00042289|58804532|FG030|Overall Study|Lost to Follow-up|0|||
30791325|NCT00042289|58804533|FG031|Overall Study|Lost to Follow-up|2|||
30791326|NCT00042289|58804534|FG032|Overall Study|Lost to Follow-up|1|||
30791327|NCT00042289|58804535|FG033|Overall Study|Lost to Follow-up|1|||
30791328|NCT00042289|58804536|FG034|Overall Study|Lost to Follow-up|1|||
30791329|NCT00042289|58804537|FG035|Overall Study|Lost to Follow-up|2|||
30791330|NCT00042289|58804538|FG036|Overall Study|Lost to Follow-up|1|||
30791331|NCT00042289|58804539|FG037|Overall Study|Lost to Follow-up|1|||
30791332|NCT00042289|58804540|FG038|Overall Study|Lost to Follow-up|0|||
30791333|NCT00042289|58804541|FG039|Overall Study|Lost to Follow-up|5|||
30791334|NCT00042289|58804542|FG040|Overall Study|Lost to Follow-up|0|||
30791335|NCT00042289|58804543|FG041|Overall Study|Lost to Follow-up|2|||
30791336|NCT00042289|58804544|FG042|Overall Study|Lost to Follow-up|2|||
30791337|NCT00042289|58804545|FG043|Overall Study|Lost to Follow-up|0|||
30791338|NCT00042289|58804546|FG044|Overall Study|Lost to Follow-up|0|||
30791339|NCT00042289|58804547|FG045|Overall Study|Lost to Follow-up|1|||
30744656|NCT00496769|58755423|FG000|Double Blind|>=1 reason assigned per patient|558|||
30744657|NCT00496769|58755424|FG001|Double Blind|>=1 reason assigned per patient|649|||
30744658|NCT00496769|58755425|FG002|Double Blind|>=1 reason assigned per patient|0|||
30744659|NCT00496769|58755423|FG000|Open Label|>=1 reason assigned per patient|0|||
30744660|NCT00496769|58755424|FG001|Open Label|>=1 reason assigned per patient|0|||
30744661|NCT00496769|58755425|FG002|Open Label|>=1 reason assigned per patient|1011|||
30744662|NCT00478673|58755434|FG000|30-Days Post-Procedure|Death|2|||
30744663|NCT00478673|58755434|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
30744664|NCT00478673|58755434|FG000|30-Days Post-Procedure|Missed Visit|7|||
30744665|NCT00478673|58755434|FG000|12-Months Post-Procedure|Death|23|||
30744666|NCT00478673|58755434|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
30744667|NCT00478673|58755434|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
30902701|NCT01807234|58936670|FG003|Overall Study|Lost to Follow-up|1|||
30902702|NCT01807234|58936671|FG004|Overall Study|Lost to Follow-up|1|||
30902703|NCT01807234|58936672|FG005|Overall Study|Lost to Follow-up|2|||
30902704|NCT01807234|58936667|FG000|Overall Study|Withdrawal by Subject|3|||
30902705|NCT01807234|58936668|FG001|Overall Study|Withdrawal by Subject|1|||
30902706|NCT01807234|58936669|FG002|Overall Study|Withdrawal by Subject|1|||
30902707|NCT01807234|58936670|FG003|Overall Study|Withdrawal by Subject|1|||
30902708|NCT01807234|58936671|FG004|Overall Study|Withdrawal by Subject|2|||
30902709|NCT01807234|58936672|FG005|Overall Study|Withdrawal by Subject|1|||
30902710|NCT01807234|58936667|FG000|Overall Study|Lack of Efficacy|0|||
30902711|NCT01807234|58936668|FG001|Overall Study|Lack of Efficacy|0|||
30902712|NCT01807234|58936669|FG002|Overall Study|Lack of Efficacy|0|||
30902713|NCT01807234|58936670|FG003|Overall Study|Lack of Efficacy|0|||
30902714|NCT01807234|58936671|FG004|Overall Study|Lack of Efficacy|1|||
30902715|NCT01807234|58936672|FG005|Overall Study|Lack of Efficacy|1|||
30902716|NCT01790932|58936682|FG000|Overall Study|Disease Progression|41|||
30902717|NCT01790932|58936682|FG000|Overall Study|Adverse Event|7|||
30902718|NCT01790932|58936682|FG000|Overall Study|Physician Decision|1|||
30902719|NCT01790932|58936682|FG000|Overall Study|Withdrawal by Subject|1|||
30902720|NCT02377427|58936688|FG000|Part A (Up to Week 20)|Physician Decision|1|||
30902721|NCT02377427|58936689|FG001|Part A (Up to Week 20)|Physician Decision|0|||
30902722|NCT02377427|58936690|FG002|Part A (Up to Week 20)|Physician Decision|0|||
30902723|NCT02377427|58936691|FG003|Part A (Up to Week 20)|Physician Decision|0|||
30902724|NCT02377427|58936692|FG004|Part A (Up to Week 20)|Physician Decision|0|||
30902725|NCT02377427|58936688|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
30791340|NCT00042289|58804548|FG046|Overall Study|Lost to Follow-up|0|||
30791341|NCT00042289|58804502|FG000|Overall Study|Other reason|0|||
30902726|NCT02377427|58936689|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
30902727|NCT02377427|58936690|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
30902728|NCT02377427|58936691|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
30902729|NCT02377427|58936692|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
30744668|NCT00478673|58755434|FG000|12-Months Post-Procedure|Missed Visit|25|||
30744669|NCT00478673|58755434|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
30744670|NCT00488345|58755441|FG000|Overall Study|Adverse Event|0|||
30744671|NCT00488345|58755442|FG001|Overall Study|Adverse Event|1|||
30744672|NCT00488345|58755443|FG002|Overall Study|Adverse Event|1|||
30902730|NCT02377427|58936688|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
30902731|NCT02377427|58936689|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
30744673|NCT00488345|58755441|FG000|Overall Study|Unable to administer antibiotics at home|0|||
30791342|NCT00042289|58804503|FG001|Overall Study|Other reason|0|||
30791343|NCT00042289|58804504|FG002|Overall Study|Other reason|0|||
30791344|NCT00042289|58804505|FG003|Overall Study|Other reason|2|||
30791345|NCT00042289|58804506|FG004|Overall Study|Other reason|0|||
30791346|NCT00042289|58804507|FG005|Overall Study|Other reason|0|||
30791347|NCT00042289|58804508|FG006|Overall Study|Other reason|0|||
30791348|NCT00042289|58804509|FG007|Overall Study|Other reason|0|||
30791349|NCT00042289|58804510|FG008|Overall Study|Other reason|0|||
30791350|NCT00042289|58804511|FG009|Overall Study|Other reason|0|||
30902732|NCT02377427|58936690|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
30791351|NCT00042289|58804512|FG010|Overall Study|Other reason|0|||
30791352|NCT00042289|58804513|FG011|Overall Study|Other reason|0|||
30791353|NCT00042289|58804514|FG012|Overall Study|Other reason|0|||
30791354|NCT00042289|58804515|FG013|Overall Study|Other reason|0|||
30791355|NCT00042289|58804516|FG014|Overall Study|Other reason|0|||
30791356|NCT00042289|58804517|FG015|Overall Study|Other reason|0|||
30791357|NCT00042289|58804518|FG016|Overall Study|Other reason|0|||
30791358|NCT00042289|58804519|FG017|Overall Study|Other reason|0|||
30791359|NCT00042289|58804520|FG018|Overall Study|Other reason|1|||
30791360|NCT00042289|58804521|FG019|Overall Study|Other reason|0|||
30791361|NCT00042289|58804522|FG020|Overall Study|Other reason|0|||
30791362|NCT00042289|58804523|FG021|Overall Study|Other reason|0|||
30791363|NCT00042289|58804524|FG022|Overall Study|Other reason|0|||
30791364|NCT00042289|58804525|FG023|Overall Study|Other reason|1|||
30791365|NCT00042289|58804526|FG024|Overall Study|Other reason|0|||
30791366|NCT00042289|58804527|FG025|Overall Study|Other reason|0|||
30791367|NCT00042289|58804528|FG026|Overall Study|Other reason|1|||
30791368|NCT00042289|58804529|FG027|Overall Study|Other reason|0|||
30791369|NCT00042289|58804530|FG028|Overall Study|Other reason|3|||
30791370|NCT00042289|58804531|FG029|Overall Study|Other reason|0|||
30791371|NCT00042289|58804532|FG030|Overall Study|Other reason|0|||
30791372|NCT00042289|58804533|FG031|Overall Study|Other reason|1|||
30791373|NCT00042289|58804534|FG032|Overall Study|Other reason|0|||
30791374|NCT00042289|58804535|FG033|Overall Study|Other reason|1|||
30791375|NCT00042289|58804536|FG034|Overall Study|Other reason|0|||
30791376|NCT00042289|58804537|FG035|Overall Study|Other reason|2|||
30791377|NCT00042289|58804538|FG036|Overall Study|Other reason|0|||
30791378|NCT00042289|58804539|FG037|Overall Study|Other reason|0|||
30791379|NCT00042289|58804540|FG038|Overall Study|Other reason|0|||
30791380|NCT00042289|58804541|FG039|Overall Study|Other reason|0|||
30791381|NCT00042289|58804542|FG040|Overall Study|Other reason|0|||
30791382|NCT00042289|58804543|FG041|Overall Study|Other reason|0|||
30791383|NCT00042289|58804544|FG042|Overall Study|Other reason|0|||
30902733|NCT02377427|58936691|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
30902734|NCT02377427|58936692|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
30902735|NCT02377427|58936688|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
30902736|NCT02377427|58936689|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
30902737|NCT02377427|58936690|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
30902738|NCT02377427|58936691|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
30902739|NCT02377427|58936692|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
30902740|NCT02421887|58936707|FG000|Overall Study|Lost to Follow-up|5|||
30902741|NCT02421887|58936708|FG001|Overall Study|Lost to Follow-up|0|||
30902742|NCT02421887|58936707|FG000|Overall Study|Withdrawal by Subject|8|||
30902743|NCT02421887|58936708|FG001|Overall Study|Withdrawal by Subject|5|||
30902744|NCT02421887|58936707|FG000|Overall Study|Physician Decision|2|||
30902745|NCT02421887|58936708|FG001|Overall Study|Physician Decision|4|||
30902746|NCT02421887|58936707|FG000|Overall Study|Adverse Event|2|||
30902747|NCT02421887|58936708|FG001|Overall Study|Adverse Event|0|||
30902748|NCT01609582|58936716|FG000|Overall Study|Adverse Event|20|||
30902749|NCT01609582|58936717|FG001|Overall Study|Adverse Event|18|||
30902750|NCT01609582|58936716|FG000|Overall Study|Lost to Follow-up|10|||
30902751|NCT01609582|58936717|FG001|Overall Study|Lost to Follow-up|10|||
30902752|NCT01609582|58936716|FG000|Overall Study|Withdrawal by Subject|21|||
30902753|NCT01609582|58936717|FG001|Overall Study|Withdrawal by Subject|15|||
30902754|NCT01609582|58936716|FG000|Overall Study|Study Terminated by Sponsor|1543|||
30791384|NCT00042289|58804545|FG043|Overall Study|Other reason|1|||
30791385|NCT00042289|58804546|FG044|Overall Study|Other reason|0|||
30791386|NCT00042289|58804547|FG045|Overall Study|Other reason|0|||
30791387|NCT00042289|58804548|FG046|Overall Study|Other reason|0|||
30791388|NCT00042289|58804502|FG000|Overall Study|Severe debilitation, unable to continue|0|||
30791389|NCT00042289|58804503|FG001|Overall Study|Severe debilitation, unable to continue|0|||
30791390|NCT00042289|58804504|FG002|Overall Study|Severe debilitation, unable to continue|0|||
30791391|NCT00042289|58804505|FG003|Overall Study|Severe debilitation, unable to continue|0|||
30791392|NCT00042289|58804506|FG004|Overall Study|Severe debilitation, unable to continue|0|||
30791393|NCT00042289|58804507|FG005|Overall Study|Severe debilitation, unable to continue|0|||
30791394|NCT00042289|58804508|FG006|Overall Study|Severe debilitation, unable to continue|0|||
30791395|NCT00042289|58804509|FG007|Overall Study|Severe debilitation, unable to continue|0|||
30791396|NCT00042289|58804510|FG008|Overall Study|Severe debilitation, unable to continue|0|||
30791397|NCT00042289|58804511|FG009|Overall Study|Severe debilitation, unable to continue|0|||
30791398|NCT00042289|58804512|FG010|Overall Study|Severe debilitation, unable to continue|0|||
30791399|NCT00042289|58804513|FG011|Overall Study|Severe debilitation, unable to continue|0|||
30902755|NCT01609582|58936717|FG001|Overall Study|Study Terminated by Sponsor|1548|||
30902756|NCT01609582|58936716|FG000|Overall Study|Other|9|||
30744674|NCT00488345|58755442|FG001|Overall Study|Unable to administer antibiotics at home|1|||
30744675|NCT00488345|58755443|FG002|Overall Study|Unable to administer antibiotics at home|0|||
30744676|NCT00488345|58755441|FG000|Overall Study|Institutional Review Board review|0|||
30744677|NCT00488345|58755442|FG001|Overall Study|Institutional Review Board review|0|||
30744678|NCT00488345|58755443|FG002|Overall Study|Institutional Review Board review|1|||
30744679|NCT00488345|58755441|FG000|Overall Study|Surgical team recommendation|0|||
30744680|NCT00488345|58755442|FG001|Overall Study|Surgical team recommendation|1|||
30744681|NCT00488345|58755443|FG002|Overall Study|Surgical team recommendation|0|||
30744682|NCT00488345|58755441|FG000|Overall Study|Parent/legal guardian request|0|||
30744683|NCT00488345|58755442|FG001|Overall Study|Parent/legal guardian request|1|||
30744684|NCT00488345|58755443|FG002|Overall Study|Parent/legal guardian request|1|||
30744685|NCT00283062|58755456|FG000|Overall Study|Did not receive any study medication|5|||
30744686|NCT00283062|58755457|FG001|Overall Study|Did not receive any study medication|4|||
30744687|NCT00283062|58755458|FG002|Overall Study|Did not receive any study medication|36|||
30744688|NCT00283062|58755459|FG003|Overall Study|Did not receive any study medication|45|||
30744689|NCT00283062|58755456|FG000|Overall Study|Adverse Event|2|||
30744690|NCT00283062|58755457|FG001|Overall Study|Adverse Event|0|||
30744691|NCT00283062|58755458|FG002|Overall Study|Adverse Event|1|||
30744692|NCT00283062|58755459|FG003|Overall Study|Adverse Event|0|||
30744693|NCT00283062|58755456|FG000|Overall Study|Lost to Follow-up|1|||
30744694|NCT00283062|58755457|FG001|Overall Study|Lost to Follow-up|0|||
30744695|NCT00283062|58755458|FG002|Overall Study|Lost to Follow-up|1|||
30744696|NCT00283062|58755459|FG003|Overall Study|Lost to Follow-up|0|||
30744697|NCT00283062|58755456|FG000|Overall Study|Progressive disease|0|||
30744698|NCT00283062|58755457|FG001|Overall Study|Progressive disease|0|||
30744699|NCT00283062|58755458|FG002|Overall Study|Progressive disease|1|||
30744700|NCT00283062|58755459|FG003|Overall Study|Progressive disease|0|||
30744701|NCT00283062|58755456|FG000|Overall Study|Participant did not wish to continue|3|||
30744702|NCT00283062|58755457|FG001|Overall Study|Participant did not wish to continue|2|||
30744703|NCT00283062|58755458|FG002|Overall Study|Participant did not wish to continue|1|||
30744704|NCT00283062|58755459|FG003|Overall Study|Participant did not wish to continue|0|||
30744705|NCT00283062|58755456|FG000|Overall Study|Undefined|0|||
30791400|NCT00042289|58804514|FG012|Overall Study|Severe debilitation, unable to continue|0|||
30791401|NCT00042289|58804515|FG013|Overall Study|Severe debilitation, unable to continue|0|||
30791402|NCT00042289|58804516|FG014|Overall Study|Severe debilitation, unable to continue|0|||
30791403|NCT00042289|58804517|FG015|Overall Study|Severe debilitation, unable to continue|0|||
30791404|NCT00042289|58804518|FG016|Overall Study|Severe debilitation, unable to continue|0|||
30791405|NCT00042289|58804519|FG017|Overall Study|Severe debilitation, unable to continue|0|||
30791406|NCT00042289|58804520|FG018|Overall Study|Severe debilitation, unable to continue|0|||
30791407|NCT00042289|58804521|FG019|Overall Study|Severe debilitation, unable to continue|0|||
30791408|NCT00042289|58804522|FG020|Overall Study|Severe debilitation, unable to continue|0|||
30791409|NCT00042289|58804523|FG021|Overall Study|Severe debilitation, unable to continue|1|||
30744706|NCT00283062|58755457|FG001|Overall Study|Undefined|1|||
30744707|NCT00283062|58755458|FG002|Overall Study|Undefined|1|||
30791410|NCT00042289|58804524|FG022|Overall Study|Severe debilitation, unable to continue|0|||
30791411|NCT00042289|58804525|FG023|Overall Study|Severe debilitation, unable to continue|1|||
30791412|NCT00042289|58804526|FG024|Overall Study|Severe debilitation, unable to continue|0|||
30791413|NCT00042289|58804527|FG025|Overall Study|Severe debilitation, unable to continue|0|||
30744708|NCT00283062|58755459|FG003|Overall Study|Undefined|4|||
30744709|NCT00283062|58755456|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
30744710|NCT00283062|58755457|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
30744711|NCT00283062|58755458|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
30744712|NCT00283062|58755459|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
30744713|NCT00282984|58755471|FG000|Overall Study|Death|2|||
30744714|NCT00282984|58755472|FG001|Overall Study|Death|5|||
30744715|NCT00282984|58755471|FG000|Overall Study|Adverse Event|8|||
30791414|NCT00042289|58804528|FG026|Overall Study|Severe debilitation, unable to continue|0|||
30791415|NCT00042289|58804529|FG027|Overall Study|Severe debilitation, unable to continue|1|||
30791416|NCT00042289|58804530|FG028|Overall Study|Severe debilitation, unable to continue|0|||
30791417|NCT00042289|58804531|FG029|Overall Study|Severe debilitation, unable to continue|0|||
30791418|NCT00042289|58804532|FG030|Overall Study|Severe debilitation, unable to continue|0|||
30791419|NCT00042289|58804533|FG031|Overall Study|Severe debilitation, unable to continue|1|||
30791420|NCT00042289|58804534|FG032|Overall Study|Severe debilitation, unable to continue|1|||
30902757|NCT01609582|58936717|FG001|Overall Study|Other|10|||
30902758|NCT01609582|58936716|FG000|Overall Study|Randomized, but not treated|0|||
30744716|NCT00282984|58755472|FG001|Overall Study|Adverse Event|5|||
30744717|NCT00282984|58755471|FG000|Overall Study|Lack of Efficacy|0|||
30744718|NCT00282984|58755472|FG001|Overall Study|Lack of Efficacy|2|||
30791421|NCT00042289|58804535|FG033|Overall Study|Severe debilitation, unable to continue|0|||
30791422|NCT00042289|58804536|FG034|Overall Study|Severe debilitation, unable to continue|0|||
30791423|NCT00042289|58804537|FG035|Overall Study|Severe debilitation, unable to continue|0|||
30791424|NCT00042289|58804538|FG036|Overall Study|Severe debilitation, unable to continue|0|||
30791425|NCT00042289|58804539|FG037|Overall Study|Severe debilitation, unable to continue|0|||
30791426|NCT00042289|58804540|FG038|Overall Study|Severe debilitation, unable to continue|0|||
30791427|NCT00042289|58804541|FG039|Overall Study|Severe debilitation, unable to continue|0|||
30791428|NCT00042289|58804542|FG040|Overall Study|Severe debilitation, unable to continue|0|||
30791429|NCT00042289|58804543|FG041|Overall Study|Severe debilitation, unable to continue|0|||
30791430|NCT00042289|58804544|FG042|Overall Study|Severe debilitation, unable to continue|0|||
30791431|NCT00042289|58804545|FG043|Overall Study|Severe debilitation, unable to continue|0|||
30791432|NCT00042289|58804546|FG044|Overall Study|Severe debilitation, unable to continue|0|||
30791433|NCT00042289|58804547|FG045|Overall Study|Severe debilitation, unable to continue|0|||
30791434|NCT00042289|58804548|FG046|Overall Study|Severe debilitation, unable to continue|0|||
30791435|NCT00042289|58804502|FG000|Overall Study|Site closed|0|||
30791436|NCT00042289|58804503|FG001|Overall Study|Site closed|0|||
30791437|NCT00042289|58804504|FG002|Overall Study|Site closed|0|||
30791438|NCT00042289|58804505|FG003|Overall Study|Site closed|0|||
30791439|NCT00042289|58804506|FG004|Overall Study|Site closed|0|||
30791440|NCT00042289|58804507|FG005|Overall Study|Site closed|0|||
30791441|NCT00042289|58804508|FG006|Overall Study|Site closed|0|||
30791442|NCT00042289|58804509|FG007|Overall Study|Site closed|0|||
30791443|NCT00042289|58804510|FG008|Overall Study|Site closed|0|||
30791444|NCT00042289|58804511|FG009|Overall Study|Site closed|0|||
30791445|NCT00042289|58804512|FG010|Overall Study|Site closed|0|||
30791446|NCT00042289|58804513|FG011|Overall Study|Site closed|0|||
30791447|NCT00042289|58804514|FG012|Overall Study|Site closed|0|||
30902759|NCT01609582|58936717|FG001|Overall Study|Randomized, but not treated|3|||
30902760|NCT01789606|58936725|FG000|Overall Study|Participant not Purchased the Product|0|||
30902761|NCT01789606|58936726|FG001|Overall Study|Participant not Purchased the Product|20|||
30902762|NCT01789606|58936725|FG000|Overall Study|Withdrawal by Subject|0|||
30791448|NCT00042289|58804515|FG013|Overall Study|Site closed|0|||
30902763|NCT01789606|58936726|FG001|Overall Study|Withdrawal by Subject|1|||
30744719|NCT00282984|58755471|FG000|Overall Study|Lost to Follow-up|14|||
30744720|NCT00282984|58755472|FG001|Overall Study|Lost to Follow-up|10|||
30744721|NCT00282984|58755471|FG000|Overall Study|Withdrawal by Participant|22|||
30744722|NCT00282984|58755472|FG001|Overall Study|Withdrawal by Participant|34|||
30744723|NCT00282984|58755471|FG000|Overall Study|Participant stopped study medication|2|||
30744724|NCT00282984|58755472|FG001|Overall Study|Participant stopped study medication|2|||
30744725|NCT00282984|58755471|FG000|Overall Study|Participant only allowed phone follow-up|0|||
30744726|NCT00282984|58755472|FG001|Overall Study|Participant only allowed phone follow-up|1|||
30744727|NCT00282984|58755471|FG000|Overall Study|Participant used antipsychosis meds|0|||
30744728|NCT00282984|58755472|FG001|Overall Study|Participant used antipsychosis meds|1|||
30744729|NCT00282984|58755471|FG000|Overall Study|lack of motivation|1|||
30744730|NCT00282984|58755472|FG001|Overall Study|lack of motivation|0|||
30744731|NCT00282984|58755471|FG000|Overall Study|in prison|0|||
30744732|NCT00282984|58755472|FG001|Overall Study|in prison|1|||
30744733|NCT00282984|58755471|FG000|Overall Study|Protocol Violation|2|||
30744734|NCT00282984|58755472|FG001|Overall Study|Protocol Violation|0|||
30744735|NCT00282438|58755480|FG000|Overall Study|Lack of Efficacy|1|||
30744736|NCT00282438|58755481|FG001|Overall Study|Lack of Efficacy|0|||
30744737|NCT00282438|58755480|FG000|Overall Study|Death|0|||
30791449|NCT00042289|58804516|FG014|Overall Study|Site closed|0|||
30791450|NCT00042289|58804517|FG015|Overall Study|Site closed|0|||
30791451|NCT00042289|58804518|FG016|Overall Study|Site closed|0|||
30791452|NCT00042289|58804519|FG017|Overall Study|Site closed|0|||
30791453|NCT00042289|58804520|FG018|Overall Study|Site closed|0|||
30791454|NCT00042289|58804521|FG019|Overall Study|Site closed|0|||
30791455|NCT00042289|58804522|FG020|Overall Study|Site closed|0|||
30791456|NCT00042289|58804523|FG021|Overall Study|Site closed|0|||
30791457|NCT00042289|58804524|FG022|Overall Study|Site closed|0|||
30791458|NCT00042289|58804525|FG023|Overall Study|Site closed|0|||
30791459|NCT00042289|58804526|FG024|Overall Study|Site closed|0|||
30791460|NCT00042289|58804527|FG025|Overall Study|Site closed|0|||
30902764|NCT01789606|58936725|FG000|Overall Study|Ineligible|6|||
30902765|NCT01789606|58936726|FG001|Overall Study|Ineligible|2|||
30791461|NCT00042289|58804528|FG026|Overall Study|Site closed|0|||
30791462|NCT00042289|58804529|FG027|Overall Study|Site closed|0|||
30791463|NCT00042289|58804530|FG028|Overall Study|Site closed|0|||
30744738|NCT00282438|58755481|FG001|Overall Study|Death|1|||
30744739|NCT00296400|58755490|FG000|Overall Study|Adverse Event|7|||
30744740|NCT00296400|58755491|FG001|Overall Study|Adverse Event|7|||
30744741|NCT00296400|58755492|FG002|Overall Study|Adverse Event|7|||
30744742|NCT00296400|58755490|FG000|Overall Study|Withdrawal by Subject|5|||
30791464|NCT00042289|58804531|FG029|Overall Study|Site closed|0|||
30791465|NCT00042289|58804532|FG030|Overall Study|Site closed|0|||
30791466|NCT00042289|58804533|FG031|Overall Study|Site closed|3|||
30791467|NCT00042289|58804534|FG032|Overall Study|Site closed|0|||
30791468|NCT00042289|58804535|FG033|Overall Study|Site closed|0|||
30791469|NCT00042289|58804536|FG034|Overall Study|Site closed|0|||
30791470|NCT00042289|58804537|FG035|Overall Study|Site closed|0|||
30791471|NCT00042289|58804538|FG036|Overall Study|Site closed|1|||
30791472|NCT00042289|58804539|FG037|Overall Study|Site closed|0|||
30791473|NCT00042289|58804540|FG038|Overall Study|Site closed|0|||
30791474|NCT00042289|58804541|FG039|Overall Study|Site closed|0|||
30791475|NCT00042289|58804542|FG040|Overall Study|Site closed|0|||
30791476|NCT00042289|58804543|FG041|Overall Study|Site closed|0|||
30791477|NCT00042289|58804544|FG042|Overall Study|Site closed|1|||
30791478|NCT00042289|58804545|FG043|Overall Study|Site closed|0|||
30791479|NCT00042289|58804546|FG044|Overall Study|Site closed|0|||
30791480|NCT00042289|58804547|FG045|Overall Study|Site closed|0|||
30791481|NCT00042289|58804548|FG046|Overall Study|Site closed|0|||
30791482|NCT00042289|58804502|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
30791483|NCT00042289|58804503|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
30791484|NCT00042289|58804504|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
30791485|NCT00042289|58804505|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
30791486|NCT00042289|58804506|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
30791487|NCT00042289|58804507|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
30791488|NCT00042289|58804508|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
30791489|NCT00042289|58804509|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
30791490|NCT00042289|58804510|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
30791491|NCT00042289|58804511|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
30791492|NCT00042289|58804512|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
30791493|NCT00042289|58804513|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
30791494|NCT00042289|58804514|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
30791495|NCT00042289|58804515|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
30791496|NCT00042289|58804516|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
30791497|NCT00042289|58804517|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
30791498|NCT00042289|58804518|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
30791499|NCT00042289|58804519|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
30791500|NCT00042289|58804520|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
30791501|NCT00042289|58804521|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
30791502|NCT00042289|58804522|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
30791503|NCT00042289|58804523|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
30791504|NCT00042289|58804524|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
30791505|NCT00042289|58804525|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
30791506|NCT00042289|58804526|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
30791507|NCT00042289|58804527|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
30791508|NCT00042289|58804528|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
30791509|NCT00042289|58804529|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
30791510|NCT00042289|58804530|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
30791511|NCT00042289|58804531|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
30791512|NCT00042289|58804532|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
30791513|NCT00042289|58804533|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
30744743|NCT00296400|58755491|FG001|Overall Study|Withdrawal by Subject|6|||
30744744|NCT00296400|58755492|FG002|Overall Study|Withdrawal by Subject|2|||
30744745|NCT00296400|58755490|FG000|Overall Study|Incorrect enrollment|2|||
30744746|NCT00296400|58755491|FG001|Overall Study|Incorrect enrollment|0|||
30744747|NCT00296400|58755492|FG002|Overall Study|Incorrect enrollment|0|||
30744748|NCT00296400|58755490|FG000|Overall Study|Protocol Violation|1|||
30744749|NCT00296400|58755491|FG001|Overall Study|Protocol Violation|1|||
30744750|NCT00296400|58755492|FG002|Overall Study|Protocol Violation|1|||
30744751|NCT00296400|58755490|FG000|Overall Study|Lost to Follow-up|1|||
30744752|NCT00296400|58755491|FG001|Overall Study|Lost to Follow-up|1|||
30744753|NCT00296400|58755492|FG002|Overall Study|Lost to Follow-up|2|||
30744754|NCT00296400|58755490|FG000|Overall Study|Study specific discontinuation criteria|0|||
30744755|NCT00296400|58755491|FG001|Overall Study|Study specific discontinuation criteria|0|||
30744756|NCT00296400|58755492|FG002|Overall Study|Study specific discontinuation criteria|1|||
30744757|NCT00296400|58755490|FG000|Overall Study|Visit 10 was performed earlier|0|||
30744758|NCT00296400|58755491|FG001|Overall Study|Visit 10 was performed earlier|1|||
30744759|NCT00296400|58755492|FG002|Overall Study|Visit 10 was performed earlier|0|||
30744760|NCT00296400|58755490|FG000|Overall Study|Pregnancy|1|||
30744761|NCT00296400|58755491|FG001|Overall Study|Pregnancy|2|||
30744762|NCT00296400|58755492|FG002|Overall Study|Pregnancy|0|||
30744763|NCT00296244|58755505|FG000|Overall Study|Underwent retransplant|0|||
30744764|NCT00296244|58755506|FG001|Overall Study|Underwent retransplant|1|||
30744765|NCT00274716|58755523|FG000|Phase A|Other non-reported reason|4|||
30744766|NCT00274716|58755524|FG001|Phase A|Other non-reported reason|2|||
30744767|NCT00274716|58755525|FG002|Phase A|Other non-reported reason|1|||
30744768|NCT00274716|58755526|FG003|Phase A|Other non-reported reason|2|||
30744769|NCT00274716|58755527|FG004|Phase A|Other non-reported reason|0|||
30744770|NCT00274716|58755528|FG005|Phase A|Other non-reported reason|1|||
30744771|NCT00274716|58755523|FG000|Phase A|Participant moved|0|||
30744772|NCT00274716|58755524|FG001|Phase A|Participant moved|0|||
30744773|NCT00274716|58755525|FG002|Phase A|Participant moved|1|||
30744774|NCT00274716|58755526|FG003|Phase A|Participant moved|0|||
30744775|NCT00274716|58755527|FG004|Phase A|Participant moved|0|||
30744776|NCT00274716|58755528|FG005|Phase A|Participant moved|1|||
30744777|NCT00274716|58755523|FG000|Phase A|Site Terminated|0|||
30744778|NCT00274716|58755524|FG001|Phase A|Site Terminated|0|||
30744779|NCT00274716|58755525|FG002|Phase A|Site Terminated|0|||
30744780|NCT00274716|58755526|FG003|Phase A|Site Terminated|1|||
30744781|NCT00274716|58755527|FG004|Phase A|Site Terminated|0|||
30744782|NCT00274716|58755528|FG005|Phase A|Site Terminated|0|||
30744783|NCT00274716|58755523|FG000|Phase A|Protocol Violation|1|||
30744784|NCT00274716|58755524|FG001|Phase A|Protocol Violation|0|||
30744785|NCT00274716|58755525|FG002|Phase A|Protocol Violation|0|||
30744786|NCT00274716|58755526|FG003|Phase A|Protocol Violation|1|||
30744787|NCT00274716|58755527|FG004|Phase A|Protocol Violation|0|||
30744788|NCT00274716|58755528|FG005|Phase A|Protocol Violation|0|||
30744789|NCT00274716|58755523|FG000|Phase A|Met criteria for discontinuation|1|||
30744790|NCT00274716|58755524|FG001|Phase A|Met criteria for discontinuation|1|||
30744791|NCT00274716|58755525|FG002|Phase A|Met criteria for discontinuation|0|||
30744792|NCT00274716|58755526|FG003|Phase A|Met criteria for discontinuation|0|||
30744793|NCT00274716|58755527|FG004|Phase A|Met criteria for discontinuation|0|||
30744794|NCT00274716|58755528|FG005|Phase A|Met criteria for discontinuation|0|||
30744795|NCT00274716|58755523|FG000|Phase A|Withdrawal by Subject|2|||
30744796|NCT00274716|58755524|FG001|Phase A|Withdrawal by Subject|2|||
30744797|NCT00274716|58755525|FG002|Phase A|Withdrawal by Subject|1|||
30744798|NCT00274716|58755526|FG003|Phase A|Withdrawal by Subject|3|||
30744799|NCT00274716|58755527|FG004|Phase A|Withdrawal by Subject|0|||
30744800|NCT00274716|58755528|FG005|Phase A|Withdrawal by Subject|1|||
30744801|NCT00274716|58755523|FG000|Phase A|Adverse Event|2|||
30744802|NCT00274716|58755524|FG001|Phase A|Adverse Event|3|||
30744803|NCT00274716|58755525|FG002|Phase A|Adverse Event|3|||
30744804|NCT00274716|58755526|FG003|Phase A|Adverse Event|0|||
30744805|NCT00274716|58755527|FG004|Phase A|Adverse Event|2|||
30744806|NCT00274716|58755528|FG005|Phase A|Adverse Event|0|||
30744807|NCT00274716|58755523|FG000|Phase A|Completed but did not enter Phase B|1|||
30744808|NCT00274716|58755524|FG001|Phase A|Completed but did not enter Phase B|2|||
30744809|NCT00274716|58755525|FG002|Phase A|Completed but did not enter Phase B|2|||
30744810|NCT00274716|58755526|FG003|Phase A|Completed but did not enter Phase B|2|||
30744811|NCT00274716|58755527|FG004|Phase A|Completed but did not enter Phase B|1|||
30744812|NCT00274716|58755528|FG005|Phase A|Completed but did not enter Phase B|1|||
30744813|NCT00274716|58755523|FG000|Phase B|Adverse Event|0|||
30744814|NCT00274716|58755524|FG001|Phase B|Adverse Event|0|||
30744815|NCT00274716|58755525|FG002|Phase B|Adverse Event|2|||
30744816|NCT00274716|58755526|FG003|Phase B|Adverse Event|0|||
30744817|NCT00274716|58755527|FG004|Phase B|Adverse Event|0|||
30744818|NCT00274716|58755528|FG005|Phase B|Adverse Event|1|||
30744819|NCT00274716|58755523|FG000|Phase B|Protocol Violation|0|||
30744820|NCT00274716|58755524|FG001|Phase B|Protocol Violation|2|||
30744821|NCT00274716|58755525|FG002|Phase B|Protocol Violation|0|||
30791514|NCT00042289|58804534|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
30902766|NCT01789606|58936725|FG000|Overall Study|Administrative Reasons|17|||
30902767|NCT01789606|58936726|FG001|Overall Study|Administrative Reasons|6|||
30902768|NCT01789606|58936725|FG000|Overall Study|No Study Medication Taken|0|||
30902769|NCT01789606|58936726|FG001|Overall Study|No Study Medication Taken|1|||
30744822|NCT00274716|58755526|FG003|Phase B|Protocol Violation|0|||
30744823|NCT00274716|58755527|FG004|Phase B|Protocol Violation|0|||
30744824|NCT00274716|58755528|FG005|Phase B|Protocol Violation|0|||
30744825|NCT00274716|58755523|FG000|Phase B|Withdrawal by Subject|0|||
30744826|NCT00274716|58755524|FG001|Phase B|Withdrawal by Subject|1|||
30744827|NCT00274716|58755525|FG002|Phase B|Withdrawal by Subject|0|||
30744828|NCT00274716|58755526|FG003|Phase B|Withdrawal by Subject|0|||
30744829|NCT00274716|58755527|FG004|Phase B|Withdrawal by Subject|0|||
30744830|NCT00274716|58755528|FG005|Phase B|Withdrawal by Subject|0|||
30744831|NCT00274716|58755523|FG000|Phase B|Participant moved|1|||
30744832|NCT00274716|58755524|FG001|Phase B|Participant moved|0|||
30744833|NCT00274716|58755525|FG002|Phase B|Participant moved|0|||
30744834|NCT00274716|58755526|FG003|Phase B|Participant moved|0|||
30744835|NCT00274716|58755527|FG004|Phase B|Participant moved|0|||
30791515|NCT00042289|58804535|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
30791516|NCT00042289|58804536|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
30791517|NCT00042289|58804537|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
30791518|NCT00042289|58804538|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
30791519|NCT00042289|58804539|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
30791520|NCT00042289|58804540|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
30902770|NCT01789606|58936725|FG000|Overall Study|Protocol Violation|0|||
30902771|NCT01789606|58936726|FG001|Overall Study|Protocol Violation|55|||
30902772|NCT01789606|58936725|FG000|Overall Study|Adverse Event|0|||
30902773|NCT01789606|58936726|FG001|Overall Study|Adverse Event|3|||
30902774|NCT01789606|58936725|FG000|Overall Study|Lost to Follow-up|0|||
30902775|NCT01789606|58936726|FG001|Overall Study|Lost to Follow-up|14|||
30902776|NCT01789606|58936725|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
30902777|NCT01789606|58936726|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
30902778|NCT01788358|58936731|FG000|Overall Study|Other|11|||
30902779|NCT01788358|58936731|FG000|Overall Study|Logistical difficulties|1|||
30902780|NCT01788358|58936731|FG000|Overall Study|Lost to Follow-up|5|||
30902781|NCT01788358|58936731|FG000|Overall Study|Protocol Violation|3|||
30902782|NCT01788358|58936731|FG000|Overall Study|Withdrawal by Subject|26|||
30902783|NCT01788358|58936731|FG000|Overall Study|Lack of Efficacy|1|||
30902784|NCT01788358|58936731|FG000|Overall Study|Adverse Event|51|||
30744836|NCT00274716|58755528|FG005|Phase B|Participant moved|0|||
30744837|NCT00274716|58755523|FG000|Phase B|Other non-reported reason|0|||
30744838|NCT00274716|58755524|FG001|Phase B|Other non-reported reason|0|||
30744839|NCT00274716|58755525|FG002|Phase B|Other non-reported reason|1|||
30744840|NCT00274716|58755526|FG003|Phase B|Other non-reported reason|1|||
30744841|NCT00274716|58755527|FG004|Phase B|Other non-reported reason|0|||
30744842|NCT00274716|58755528|FG005|Phase B|Other non-reported reason|0|||
30744843|NCT00274716|58755523|FG000|Phase B|Lost to Follow-up|0|||
30744844|NCT00274716|58755524|FG001|Phase B|Lost to Follow-up|1|||
30744845|NCT00274716|58755525|FG002|Phase B|Lost to Follow-up|0|||
30744846|NCT00274716|58755526|FG003|Phase B|Lost to Follow-up|0|||
30744847|NCT00274716|58755527|FG004|Phase B|Lost to Follow-up|0|||
30744848|NCT00274716|58755528|FG005|Phase B|Lost to Follow-up|0|||
30744849|NCT00282048|58755546|FG000|Overall Study|Lack of Efficacy|30|||
30744850|NCT00282048|58755546|FG000|Overall Study|Adverse Event|22|||
30744851|NCT00282048|58755546|FG000|Overall Study|Withdrawal by Subject|1|||
30744852|NCT00282048|58755546|FG000|Overall Study|Other|8|||
30744853|NCT00282048|58755546|FG000|Overall Study|Ongoing|1|||
30744854|NCT00474539|58755552|FG000|Infant Series|Withdrawal by Subject|3|||
30744855|NCT00474539|58755553|FG001|Infant Series|Withdrawal by Subject|4|||
30744856|NCT00474539|58755552|FG000|Infant Series|Randomization error|5|||
30744857|NCT00474539|58755553|FG001|Infant Series|Randomization error|0|||
30744858|NCT00474539|58755552|FG000|Infant Series|Lost to Follow-up|2|||
30744859|NCT00474539|58755553|FG001|Infant Series|Lost to Follow-up|1|||
30744860|NCT00474539|58755552|FG000|Infant Series|Protocol Violation|0|||
30744861|NCT00474539|58755553|FG001|Infant Series|Protocol Violation|1|||
30744862|NCT00474539|58755552|FG000|After Infant Series|Lost to Follow-up|3|||
30744863|NCT00474539|58755553|FG001|After Infant Series|Lost to Follow-up|0|||
30744864|NCT00474539|58755552|FG000|After Infant Series|Withdrawal by Subject|1|||
30744865|NCT00474539|58755553|FG001|After Infant Series|Withdrawal by Subject|0|||
30744866|NCT00474539|58755552|FG000|Toddler Dose|Protocol Violation|1|||
30744867|NCT00474539|58755553|FG001|Toddler Dose|Protocol Violation|0|||
30744868|NCT00281580|58755600|FG000|Overall Study|Adverse Event|2|||
30744869|NCT00281580|58755601|FG001|Overall Study|Adverse Event|0|||
30902785|NCT01773226|58936735|FG000|Overall Study|Withdrawal by Subject|1|||
30902786|NCT01773070|58936739|FG000|Overall Study|Withdrawal by Subject|24|||
30744870|NCT00281580|58755602|FG002|Overall Study|Adverse Event|2|||
30744871|NCT00281580|58755603|FG003|Overall Study|Adverse Event|4|||
30744872|NCT00281580|58755604|FG004|Overall Study|Adverse Event|1|||
30744873|NCT00281580|58755605|FG005|Overall Study|Adverse Event|0|||
30902787|NCT01773070|58936739|FG000|Overall Study|Lost to Follow-up|39|||
30902788|NCT01773070|58936739|FG000|Overall Study|Other|15|||
30902789|NCT01773070|58936739|FG000|Overall Study|Death (unrelated to study procedures)|3|||
30902790|NCT01772368|58936743|FG000|Overall Study|Adverse Event|1|||
30902791|NCT01772368|58936743|FG000|Overall Study|Withdrawal by Subject|3|||
30902792|NCT01772368|58936743|FG000|Overall Study|Protocol Violation|2|||
30902793|NCT01772368|58936743|FG000|Overall Study|Other|1|||
30744874|NCT00281580|58755606|FG006|Overall Study|Adverse Event|1|||
30744875|NCT00281580|58755607|FG007|Overall Study|Adverse Event|0|||
30791521|NCT00042289|58804541|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
30791522|NCT00042289|58804542|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
30791523|NCT00042289|58804543|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
30791524|NCT00042289|58804544|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
30791525|NCT00042289|58804545|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
30791526|NCT00042289|58804546|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
30791527|NCT00042289|58804547|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
30791528|NCT00042289|58804548|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
30791529|NCT00042289|58804502|FG000|Overall Study|Protocol Violation|0|||
30791530|NCT00042289|58804503|FG001|Overall Study|Protocol Violation|0|||
30791531|NCT00042289|58804504|FG002|Overall Study|Protocol Violation|0|||
30791532|NCT00042289|58804505|FG003|Overall Study|Protocol Violation|0|||
30791533|NCT00042289|58804506|FG004|Overall Study|Protocol Violation|0|||
30791534|NCT00042289|58804507|FG005|Overall Study|Protocol Violation|1|||
30791535|NCT00042289|58804508|FG006|Overall Study|Protocol Violation|0|||
30791536|NCT00042289|58804509|FG007|Overall Study|Protocol Violation|1|||
30791537|NCT00042289|58804510|FG008|Overall Study|Protocol Violation|0|||
30791538|NCT00042289|58804511|FG009|Overall Study|Protocol Violation|0|||
30791539|NCT00042289|58804512|FG010|Overall Study|Protocol Violation|0|||
30791540|NCT00042289|58804513|FG011|Overall Study|Protocol Violation|0|||
30791541|NCT00042289|58804514|FG012|Overall Study|Protocol Violation|0|||
30791542|NCT00042289|58804515|FG013|Overall Study|Protocol Violation|0|||
30791543|NCT00042289|58804516|FG014|Overall Study|Protocol Violation|0|||
30791544|NCT00042289|58804517|FG015|Overall Study|Protocol Violation|0|||
30791545|NCT00042289|58804518|FG016|Overall Study|Protocol Violation|0|||
30744876|NCT00281580|58755608|FG008|Overall Study|Adverse Event|1|||
30744877|NCT00281580|58755609|FG009|Overall Study|Adverse Event|6|||
30744878|NCT00281580|58755610|FG010|Overall Study|Adverse Event|0|||
30744879|NCT00281580|58755611|FG011|Overall Study|Adverse Event|5|||
30744880|NCT00281580|58755612|FG012|Overall Study|Adverse Event|8|||
30744881|NCT00281580|58755613|FG013|Overall Study|Adverse Event|2|||
30744882|NCT00281580|58755614|FG014|Overall Study|Adverse Event|3|||
30744883|NCT00281580|58755615|FG015|Overall Study|Adverse Event|3|||
30744884|NCT00281580|58755600|FG000|Overall Study|Protocol Violation|0|||
30744885|NCT00281580|58755601|FG001|Overall Study|Protocol Violation|0|||
30744886|NCT00281580|58755602|FG002|Overall Study|Protocol Violation|1|||
30744887|NCT00281580|58755603|FG003|Overall Study|Protocol Violation|1|||
30744888|NCT00281580|58755604|FG004|Overall Study|Protocol Violation|0|||
30744889|NCT00281580|58755605|FG005|Overall Study|Protocol Violation|0|||
30744890|NCT00281580|58755606|FG006|Overall Study|Protocol Violation|1|||
30744891|NCT00281580|58755607|FG007|Overall Study|Protocol Violation|0|||
30744892|NCT00281580|58755608|FG008|Overall Study|Protocol Violation|2|||
30744893|NCT00281580|58755609|FG009|Overall Study|Protocol Violation|0|||
30744894|NCT00281580|58755610|FG010|Overall Study|Protocol Violation|1|||
30744895|NCT00281580|58755611|FG011|Overall Study|Protocol Violation|2|||
30744896|NCT00281580|58755612|FG012|Overall Study|Protocol Violation|0|||
30744897|NCT00281580|58755613|FG013|Overall Study|Protocol Violation|1|||
30744898|NCT00281580|58755614|FG014|Overall Study|Protocol Violation|1|||
30744899|NCT00281580|58755615|FG015|Overall Study|Protocol Violation|3|||
30744900|NCT00281580|58755600|FG000|Overall Study|Withdrawal by Subject|3|||
30902794|NCT01788046|58936761|FG000|Overall Study|Withdrawal by Subject|12|||
30744901|NCT00281580|58755601|FG001|Overall Study|Withdrawal by Subject|0|||
30744902|NCT00281580|58755602|FG002|Overall Study|Withdrawal by Subject|1|||
30744903|NCT00281580|58755603|FG003|Overall Study|Withdrawal by Subject|1|||
30791546|NCT00042289|58804519|FG017|Overall Study|Protocol Violation|0|||
30791547|NCT00042289|58804520|FG018|Overall Study|Protocol Violation|0|||
30791548|NCT00042289|58804521|FG019|Overall Study|Protocol Violation|0|||
30791549|NCT00042289|58804522|FG020|Overall Study|Protocol Violation|0|||
30902795|NCT01788046|58936762|FG001|Overall Study|Withdrawal by Subject|12|||
30902796|NCT01788046|58936761|FG000|Overall Study|Lost to Follow-up|12|||
30744904|NCT00281580|58755604|FG004|Overall Study|Withdrawal by Subject|1|||
30744905|NCT00281580|58755605|FG005|Overall Study|Withdrawal by Subject|2|||
30744906|NCT00281580|58755606|FG006|Overall Study|Withdrawal by Subject|2|||
30744907|NCT00281580|58755607|FG007|Overall Study|Withdrawal by Subject|0|||
30744908|NCT00281580|58755608|FG008|Overall Study|Withdrawal by Subject|1|||
30791550|NCT00042289|58804523|FG021|Overall Study|Protocol Violation|0|||
30791551|NCT00042289|58804524|FG022|Overall Study|Protocol Violation|0|||
30902797|NCT01788046|58936762|FG001|Overall Study|Lost to Follow-up|19|||
30744909|NCT00281580|58755609|FG009|Overall Study|Withdrawal by Subject|4|||
30744910|NCT00281580|58755610|FG010|Overall Study|Withdrawal by Subject|1|||
30744911|NCT00281580|58755611|FG011|Overall Study|Withdrawal by Subject|1|||
30744912|NCT00281580|58755612|FG012|Overall Study|Withdrawal by Subject|2|||
30744913|NCT00281580|58755613|FG013|Overall Study|Withdrawal by Subject|2|||
30744914|NCT00281580|58755614|FG014|Overall Study|Withdrawal by Subject|1|||
30744915|NCT00281580|58755615|FG015|Overall Study|Withdrawal by Subject|5|||
30744916|NCT00281580|58755600|FG000|Overall Study|Lack of Efficacy|2|||
30744917|NCT00281580|58755601|FG001|Overall Study|Lack of Efficacy|1|||
30744918|NCT00281580|58755602|FG002|Overall Study|Lack of Efficacy|1|||
30791552|NCT00042289|58804525|FG023|Overall Study|Protocol Violation|1|||
30791553|NCT00042289|58804526|FG024|Overall Study|Protocol Violation|1|||
30791554|NCT00042289|58804527|FG025|Overall Study|Protocol Violation|0|||
30791555|NCT00042289|58804528|FG026|Overall Study|Protocol Violation|2|||
30791556|NCT00042289|58804529|FG027|Overall Study|Protocol Violation|0|||
30791557|NCT00042289|58804530|FG028|Overall Study|Protocol Violation|0|||
30791558|NCT00042289|58804531|FG029|Overall Study|Protocol Violation|0|||
30791559|NCT00042289|58804532|FG030|Overall Study|Protocol Violation|1|||
30791560|NCT00042289|58804533|FG031|Overall Study|Protocol Violation|0|||
30791561|NCT00042289|58804534|FG032|Overall Study|Protocol Violation|0|||
30791562|NCT00042289|58804535|FG033|Overall Study|Protocol Violation|0|||
30791563|NCT00042289|58804536|FG034|Overall Study|Protocol Violation|0|||
30791564|NCT00042289|58804537|FG035|Overall Study|Protocol Violation|0|||
30791565|NCT00042289|58804538|FG036|Overall Study|Protocol Violation|0|||
30791566|NCT00042289|58804539|FG037|Overall Study|Protocol Violation|0|||
30791567|NCT00042289|58804540|FG038|Overall Study|Protocol Violation|0|||
30791568|NCT00042289|58804541|FG039|Overall Study|Protocol Violation|0|||
30791569|NCT00042289|58804542|FG040|Overall Study|Protocol Violation|0|||
30791570|NCT00042289|58804543|FG041|Overall Study|Protocol Violation|1|||
30791571|NCT00042289|58804544|FG042|Overall Study|Protocol Violation|1|||
30791572|NCT00042289|58804545|FG043|Overall Study|Protocol Violation|1|||
30791573|NCT00042289|58804546|FG044|Overall Study|Protocol Violation|0|||
30791574|NCT00042289|58804547|FG045|Overall Study|Protocol Violation|0|||
30791575|NCT00042289|58804548|FG046|Overall Study|Protocol Violation|0|||
30791576|NCT00042289|58804502|FG000|Overall Study|Withdrawal by Subject|4|||
30791577|NCT00042289|58804503|FG001|Overall Study|Withdrawal by Subject|1|||
30791578|NCT00042289|58804504|FG002|Overall Study|Withdrawal by Subject|0|||
30791579|NCT00042289|58804505|FG003|Overall Study|Withdrawal by Subject|2|||
30791580|NCT00042289|58804506|FG004|Overall Study|Withdrawal by Subject|0|||
30791581|NCT00042289|58804507|FG005|Overall Study|Withdrawal by Subject|2|||
30791582|NCT00042289|58804508|FG006|Overall Study|Withdrawal by Subject|0|||
30791583|NCT00042289|58804509|FG007|Overall Study|Withdrawal by Subject|0|||
30791584|NCT00042289|58804510|FG008|Overall Study|Withdrawal by Subject|0|||
30791585|NCT00042289|58804511|FG009|Overall Study|Withdrawal by Subject|1|||
30791586|NCT00042289|58804512|FG010|Overall Study|Withdrawal by Subject|0|||
30791587|NCT00042289|58804513|FG011|Overall Study|Withdrawal by Subject|0|||
30791588|NCT00042289|58804514|FG012|Overall Study|Withdrawal by Subject|2|||
30744919|NCT00281580|58755603|FG003|Overall Study|Lack of Efficacy|6|||
30744920|NCT00281580|58755604|FG004|Overall Study|Lack of Efficacy|2|||
30744921|NCT00281580|58755605|FG005|Overall Study|Lack of Efficacy|0|||
30744922|NCT00281580|58755606|FG006|Overall Study|Lack of Efficacy|0|||
30744923|NCT00281580|58755607|FG007|Overall Study|Lack of Efficacy|0|||
30744924|NCT00281580|58755608|FG008|Overall Study|Lack of Efficacy|0|||
30791589|NCT00042289|58804515|FG013|Overall Study|Withdrawal by Subject|0|||
30791590|NCT00042289|58804516|FG014|Overall Study|Withdrawal by Subject|0|||
30791591|NCT00042289|58804517|FG015|Overall Study|Withdrawal by Subject|0|||
30791592|NCT00042289|58804518|FG016|Overall Study|Withdrawal by Subject|0|||
30791593|NCT00042289|58804519|FG017|Overall Study|Withdrawal by Subject|0|||
30791594|NCT00042289|58804520|FG018|Overall Study|Withdrawal by Subject|0|||
30791595|NCT00042289|58804521|FG019|Overall Study|Withdrawal by Subject|0|||
30791596|NCT00042289|58804522|FG020|Overall Study|Withdrawal by Subject|0|||
30791597|NCT00042289|58804523|FG021|Overall Study|Withdrawal by Subject|1|||
30791598|NCT00042289|58804524|FG022|Overall Study|Withdrawal by Subject|1|||
30791599|NCT00042289|58804525|FG023|Overall Study|Withdrawal by Subject|1|||
30791600|NCT00042289|58804526|FG024|Overall Study|Withdrawal by Subject|0|||
30791601|NCT00042289|58804527|FG025|Overall Study|Withdrawal by Subject|0|||
30791602|NCT00042289|58804528|FG026|Overall Study|Withdrawal by Subject|1|||
30791603|NCT00042289|58804529|FG027|Overall Study|Withdrawal by Subject|0|||
30791604|NCT00042289|58804530|FG028|Overall Study|Withdrawal by Subject|2|||
30791605|NCT00042289|58804531|FG029|Overall Study|Withdrawal by Subject|0|||
30744925|NCT00281580|58755609|FG009|Overall Study|Lack of Efficacy|0|||
30744926|NCT00281580|58755610|FG010|Overall Study|Lack of Efficacy|0|||
30744927|NCT00281580|58755611|FG011|Overall Study|Lack of Efficacy|1|||
30744928|NCT00281580|58755612|FG012|Overall Study|Lack of Efficacy|0|||
30744929|NCT00281580|58755613|FG013|Overall Study|Lack of Efficacy|2|||
30744930|NCT00281580|58755614|FG014|Overall Study|Lack of Efficacy|1|||
30744931|NCT00281580|58755615|FG015|Overall Study|Lack of Efficacy|0|||
30744932|NCT00281580|58755600|FG000|Overall Study|Lost to Follow-up|0|||
30744933|NCT00281580|58755601|FG001|Overall Study|Lost to Follow-up|0|||
30744934|NCT00281580|58755602|FG002|Overall Study|Lost to Follow-up|0|||
30744935|NCT00281580|58755603|FG003|Overall Study|Lost to Follow-up|3|||
30744936|NCT00281580|58755604|FG004|Overall Study|Lost to Follow-up|0|||
30744937|NCT00281580|58755605|FG005|Overall Study|Lost to Follow-up|1|||
30744938|NCT00281580|58755606|FG006|Overall Study|Lost to Follow-up|0|||
30744939|NCT00281580|58755607|FG007|Overall Study|Lost to Follow-up|1|||
30744940|NCT00281580|58755608|FG008|Overall Study|Lost to Follow-up|2|||
30791606|NCT00042289|58804532|FG030|Overall Study|Withdrawal by Subject|0|||
30791607|NCT00042289|58804533|FG031|Overall Study|Withdrawal by Subject|1|||
30744941|NCT00281580|58755609|FG009|Overall Study|Lost to Follow-up|1|||
30791608|NCT00042289|58804534|FG032|Overall Study|Withdrawal by Subject|2|||
30791609|NCT00042289|58804535|FG033|Overall Study|Withdrawal by Subject|1|||
30791610|NCT00042289|58804536|FG034|Overall Study|Withdrawal by Subject|0|||
30791611|NCT00042289|58804537|FG035|Overall Study|Withdrawal by Subject|0|||
30791612|NCT00042289|58804538|FG036|Overall Study|Withdrawal by Subject|0|||
30791613|NCT00042289|58804539|FG037|Overall Study|Withdrawal by Subject|1|||
30791614|NCT00042289|58804540|FG038|Overall Study|Withdrawal by Subject|0|||
30791615|NCT00042289|58804541|FG039|Overall Study|Withdrawal by Subject|0|||
30791616|NCT00042289|58804542|FG040|Overall Study|Withdrawal by Subject|0|||
30791617|NCT00042289|58804543|FG041|Overall Study|Withdrawal by Subject|0|||
30791618|NCT00042289|58804544|FG042|Overall Study|Withdrawal by Subject|1|||
30791619|NCT00042289|58804545|FG043|Overall Study|Withdrawal by Subject|0|||
30791620|NCT00042289|58804546|FG044|Overall Study|Withdrawal by Subject|0|||
30791621|NCT00042289|58804547|FG045|Overall Study|Withdrawal by Subject|0|||
30791622|NCT00042289|58804548|FG046|Overall Study|Withdrawal by Subject|0|||
30791623|NCT02886728|58804720|FG000|Overall Study|Withdrew Consent|31|||
30791624|NCT02886728|58804721|FG001|Overall Study|Withdrew Consent|13|||
30791625|NCT02886728|58804722|FG002|Overall Study|Withdrew Consent|11|||
30791626|NCT02886728|58804723|FG003|Overall Study|Withdrew Consent|47|||
30791627|NCT02886728|58804720|FG000|Overall Study|Lost to Follow-up|12|||
30791628|NCT02886728|58804721|FG001|Overall Study|Lost to Follow-up|6|||
30791629|NCT02886728|58804722|FG002|Overall Study|Lost to Follow-up|13|||
30791630|NCT02886728|58804723|FG003|Overall Study|Lost to Follow-up|12|||
30791631|NCT02886728|58804720|FG000|Overall Study|Adverse Event|13|||
30791632|NCT02886728|58804721|FG001|Overall Study|Adverse Event|5|||
30791633|NCT02886728|58804722|FG002|Overall Study|Adverse Event|5|||
30791634|NCT02886728|58804723|FG003|Overall Study|Adverse Event|11|||
30791635|NCT02886728|58804720|FG000|Overall Study|Investigator's Discretion|11|||
30791636|NCT02886728|58804721|FG001|Overall Study|Investigator's Discretion|7|||
30791637|NCT02886728|58804722|FG002|Overall Study|Investigator's Discretion|5|||
30791638|NCT02886728|58804723|FG003|Overall Study|Investigator's Discretion|11|||
30791639|NCT02886728|58804720|FG000|Overall Study|Death|3|||
30791640|NCT02886728|58804721|FG001|Overall Study|Death|1|||
30791641|NCT02886728|58804722|FG002|Overall Study|Death|0|||
30791642|NCT02886728|58804723|FG003|Overall Study|Death|0|||
30791643|NCT02886728|58804720|FG000|Overall Study|Protocol Violation|0|||
30744942|NCT00281580|58755610|FG010|Overall Study|Lost to Follow-up|1|||
30744943|NCT00281580|58755611|FG011|Overall Study|Lost to Follow-up|0|||
30791644|NCT02886728|58804721|FG001|Overall Study|Protocol Violation|0|||
30791645|NCT02886728|58804722|FG002|Overall Study|Protocol Violation|0|||
30791646|NCT02886728|58804723|FG003|Overall Study|Protocol Violation|4|||
30791647|NCT02886728|58804720|FG000|Overall Study|Non-Compliance with Study Drug|1|||
30791648|NCT02886728|58804721|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30791649|NCT02886728|58804722|FG002|Overall Study|Non-Compliance with Study Drug|1|||
30791650|NCT02886728|58804723|FG003|Overall Study|Non-Compliance with Study Drug|0|||
30791651|NCT02886728|58804720|FG000|Overall Study|Pregnancy|0|||
30791652|NCT02886728|58804721|FG001|Overall Study|Pregnancy|0|||
30791653|NCT02886728|58804722|FG002|Overall Study|Pregnancy|1|||
30791654|NCT02886728|58804723|FG003|Overall Study|Pregnancy|0|||
30791655|NCT02886728|58804720|FG000|Overall Study|Randomized but Not Dosed|1|||
30791656|NCT02886728|58804721|FG001|Overall Study|Randomized but Not Dosed|0|||
30791657|NCT02886728|58804722|FG002|Overall Study|Randomized but Not Dosed|0|||
30791658|NCT02886728|58804723|FG003|Overall Study|Randomized but Not Dosed|2|||
30744944|NCT00281580|58755612|FG012|Overall Study|Lost to Follow-up|1|||
30744945|NCT00281580|58755613|FG013|Overall Study|Lost to Follow-up|0|||
30791659|NCT00039871|58804733|FG000|Overall Study|Adverse Event|165|||
30791660|NCT00039871|58804733|FG000|Overall Study|Lost to Follow-up|18|||
30791661|NCT00039871|58804733|FG000|Overall Study|Protocol Violation|24|||
30791662|NCT00039871|58804733|FG000|Overall Study|Withdrawal by Subject|97|||
30791663|NCT00039871|58804733|FG000|Overall Study|Did not meet eligibility criteria|11|||
30791664|NCT00039871|58804733|FG000|Overall Study|Administrative|1|||
30791665|NCT00039871|58804733|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
30791666|NCT00039871|58804733|FG000|Overall Study|Never entered follow-up|7|||
30791667|NCT00015457|58804737|FG000|First Intervention|Adverse Event|0|||
30791668|NCT00015457|58804738|FG001|First Intervention|Adverse Event|2|||
30791669|NCT00015457|58804737|FG000|First Intervention|Lack of Efficacy|0|||
30791670|NCT00015457|58804738|FG001|First Intervention|Lack of Efficacy|1|||
30791671|NCT00015457|58804737|FG000|Second Intervention|Withdrawal by Subject|1|||
30791672|NCT00015457|58804738|FG001|Second Intervention|Withdrawal by Subject|0|||
30791673|NCT03191630|58804751|FG000|Overall Study|Lost to Follow-up|7|||
30791674|NCT03191630|58804752|FG001|Overall Study|Lost to Follow-up|7|||
30791675|NCT03191552|58804763|FG000|Overall Study|Lost to Follow-up|1|||
30791676|NCT03191552|58804764|FG001|Overall Study|Lost to Follow-up|0|||
30791677|NCT03191552|58804765|FG002|Overall Study|Lost to Follow-up|0|||
30791678|NCT03191552|58804763|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
30791679|NCT03191552|58804764|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
30791680|NCT03191552|58804765|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
30791681|NCT03191396|58804779|FG000|Overall Study|Lost to Follow-up|0|||
30791682|NCT03191396|58804780|FG001|Overall Study|Lost to Follow-up|3|||
30791683|NCT03191396|58804779|FG000|Overall Study|Withdrawal by Subject|3|||
30791684|NCT03191396|58804780|FG001|Overall Study|Withdrawal by Subject|2|||
30791685|NCT00007345|58804788|FG000|Overall Study|Refused further treatment|0|||
30791686|NCT00007345|58804789|FG001|Overall Study|Refused further treatment|7|||
30791687|NCT00007345|58804788|FG000|Overall Study|Switched to alternative treatment|0|||
30791688|NCT00007345|58804789|FG001|Overall Study|Switched to alternative treatment|3|||
30791689|NCT00007345|58804788|FG000|Overall Study|Intercurrent illness|1|||
30791690|NCT00007345|58804789|FG001|Overall Study|Intercurrent illness|0|||
30791691|NCT00007345|58804788|FG000|Overall Study|Death on study|1|||
30791692|NCT00007345|58804789|FG001|Overall Study|Death on study|1|||
30791693|NCT03405662|58804797|FG000|Overall Study|COVID-19 restriction|1|||
30791694|NCT03405662|58804798|FG001|Overall Study|COVID-19 restriction|0|||
30791695|NCT03405662|58804797|FG000|Overall Study|unblinding|0|||
30791696|NCT03405662|58804798|FG001|Overall Study|unblinding|1|||
30791697|NCT03405662|58804797|FG000|Overall Study|placement in memory care facility|0|||
30902798|NCT01788046|58936761|FG000|Overall Study|Death|7|||
30902799|NCT01788046|58936762|FG001|Overall Study|Death|5|||
30902800|NCT01788046|58936761|FG000|Overall Study|Protocol Specified Criteria|25|||
30902801|NCT01788046|58936762|FG001|Overall Study|Protocol Specified Criteria|1|||
30902802|NCT01806298|58936768|FG000|Overall Study|Adverse Event|3|||
30902803|NCT01806298|58936768|FG000|Overall Study|Protocol Non-compliance|1|||
30902804|NCT01806298|58936768|FG000|Overall Study|Withdrawal by Subject|1|||
30902805|NCT01806298|58936768|FG000|Overall Study|Other|5|||
30902806|NCT01772134|58936775|FG000|Overall Study|Adverse Event|6|||
30902807|NCT01772134|58936776|FG001|Overall Study|Adverse Event|5|||
30902808|NCT01772134|58936777|FG002|Overall Study|Adverse Event|10|||
30902809|NCT01772134|58936775|FG000|Overall Study|Withdrew Consent|3|||
30744946|NCT00281580|58755614|FG014|Overall Study|Lost to Follow-up|0|||
30744947|NCT00281580|58755615|FG015|Overall Study|Lost to Follow-up|0|||
30744948|NCT00281580|58755600|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
30744949|NCT00281580|58755601|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
30744950|NCT00281580|58755602|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
30744951|NCT00281580|58755603|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
30744952|NCT00281580|58755604|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
30744953|NCT00281580|58755605|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
30744954|NCT00281580|58755606|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
30744955|NCT00281580|58755607|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
30744956|NCT00281580|58755608|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
30744957|NCT00281580|58755609|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
30744958|NCT00281580|58755610|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
30744959|NCT00281580|58755611|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
30744960|NCT00281580|58755612|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
30791698|NCT03405662|58804798|FG001|Overall Study|placement in memory care facility|2|||
30791699|NCT00031447|58804806|FG000|Overall Study|Lost to Follow-up|0|||
30791700|NCT00031447|58804807|FG001|Overall Study|Lost to Follow-up|1|||
30902810|NCT01772134|58936776|FG001|Overall Study|Withdrew Consent|1|||
30902811|NCT01772134|58936777|FG002|Overall Study|Withdrew Consent|5|||
30902812|NCT01772134|58936775|FG000|Overall Study|Lost to Follow-up|2|||
30902813|NCT01772134|58936776|FG001|Overall Study|Lost to Follow-up|0|||
30791701|NCT00031447|58804806|FG000|Overall Study|Non-compliant|1|||
30791702|NCT00031447|58804807|FG001|Overall Study|Non-compliant|1|||
30791703|NCT00031447|58804806|FG000|Overall Study|Re-activation of Disease|2|||
30791704|NCT00031447|58804807|FG001|Overall Study|Re-activation of Disease|1|||
30791705|NCT00031447|58804806|FG000|Overall Study|Disruption of blinded study drug supply|7|||
30791706|NCT00031447|58804807|FG001|Overall Study|Disruption of blinded study drug supply|4|||
30791707|NCT00006721|58804816|FG000|Overall Study|Adverse Event|0|||
30791708|NCT00006721|58804817|FG001|Overall Study|Adverse Event|4|||
30791709|NCT00006721|58804818|FG002|Overall Study|Adverse Event|4|||
30791710|NCT00006721|58804816|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
30791711|NCT00006721|58804817|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
30791712|NCT00006721|58804818|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
30791713|NCT00006721|58804816|FG000|Overall Study|Progression/Relapse|0|||
30791714|NCT00006721|58804817|FG001|Overall Study|Progression/Relapse|1|||
30791715|NCT00006721|58804818|FG002|Overall Study|Progression/Relapse|2|||
30791716|NCT00006721|58804816|FG000|Overall Study|Death|0|||
30791717|NCT00006721|58804817|FG001|Overall Study|Death|1|||
30791718|NCT00006721|58804818|FG002|Overall Study|Death|2|||
30791719|NCT00006721|58804816|FG000|Overall Study|Other - Not Protocol Specified|0|||
30791720|NCT00006721|58804817|FG001|Overall Study|Other - Not Protocol Specified|7|||
30791721|NCT00006721|58804818|FG002|Overall Study|Other - Not Protocol Specified|7|||
30791722|NCT00006721|58804816|FG000|Overall Study|Ineligible|2|||
30791723|NCT00006721|58804817|FG001|Overall Study|Ineligible|12|||
30791724|NCT00006721|58804818|FG002|Overall Study|Ineligible|10|||
30791725|NCT00006721|58804816|FG000|Overall Study|Eligible but no Treatment Received|1|||
30791726|NCT00006721|58804817|FG001|Overall Study|Eligible but no Treatment Received|0|||
30791727|NCT00006721|58804818|FG002|Overall Study|Eligible but no Treatment Received|0|||
30791728|NCT00006409|58804834|FG000|Baseline|Protocol Violation|48|||
30791729|NCT00006409|58804835|FG001|Baseline|Protocol Violation|70|||
30791730|NCT00006409|58804836|FG002|Baseline|Protocol Violation|0|||
30791731|NCT00006409|58804837|FG003|Baseline|Protocol Violation|0|||
30791732|NCT00006409|58804838|FG004|Baseline|Protocol Violation|0|||
30791733|NCT00006409|58804839|FG005|Baseline|Protocol Violation|0|||
30791734|NCT00006409|58804834|FG000|Post-2 Year Intervention|Protocol Violation|0|||
30791735|NCT00006409|58804835|FG001|Post-2 Year Intervention|Protocol Violation|0|||
30791736|NCT00006409|58804836|FG002|Post-2 Year Intervention|Protocol Violation|251|||
30791737|NCT00006409|58804837|FG003|Post-2 Year Intervention|Protocol Violation|168|||
30791738|NCT00006409|58804838|FG004|Post-2 Year Intervention|Protocol Violation|0|||
30791739|NCT00006409|58804839|FG005|Post-2 Year Intervention|Protocol Violation|0|||
30791740|NCT00006409|58804834|FG000|Post-3 Year Intervention|Protocol Violation|0|||
30791741|NCT00006409|58804835|FG001|Post-3 Year Intervention|Protocol Violation|0|||
30791742|NCT00006409|58804836|FG002|Post-3 Year Intervention|Protocol Violation|0|||
30902814|NCT01772134|58936777|FG002|Overall Study|Lost to Follow-up|0|||
30902815|NCT01772134|58936775|FG000|Overall Study|Protocol Deviation|4|||
30791743|NCT00006409|58804837|FG003|Post-3 Year Intervention|Protocol Violation|0|||
30791744|NCT00006409|58804838|FG004|Post-3 Year Intervention|Protocol Violation|62|||
30791745|NCT00006409|58804839|FG005|Post-3 Year Intervention|Protocol Violation|62|||
30791746|NCT00006289|58804855|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
30791747|NCT00006289|58804856|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
30791748|NCT00006289|58804855|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
30791749|NCT00006289|58804856|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
30791750|NCT00005947|58804874|FG000|Overall Study|Death|54|||
30791751|NCT00005947|58804875|FG001|Overall Study|Death|40|||
30902816|NCT01772134|58936776|FG001|Overall Study|Protocol Deviation|3|||
30791752|NCT00005947|58804874|FG000|Overall Study|Patient Refused to Continue|2|||
30791753|NCT00005947|58804875|FG001|Overall Study|Patient Refused to Continue|1|||
30791754|NCT00005947|58804874|FG000|Overall Study|Site Closure|1|||
30791755|NCT00005947|58804875|FG001|Overall Study|Site Closure|0|||
30791756|NCT00005047|58804887|FG000|Overall Study|Withdrawal by Subject|12|||
30791757|NCT00005047|58804888|FG001|Overall Study|Withdrawal by Subject|0|||
30791758|NCT00005047|58804889|FG002|Overall Study|Withdrawal by Subject|0|||
30791759|NCT00005047|58804890|FG003|Overall Study|Withdrawal by Subject|0|||
30902817|NCT01772134|58936777|FG002|Overall Study|Protocol Deviation|3|||
30902818|NCT01772134|58936775|FG000|Overall Study|Lack of Efficacy|11|||
30902819|NCT01772134|58936776|FG001|Overall Study|Lack of Efficacy|5|||
30791760|NCT00005047|58804887|FG000|Overall Study|Adverse Event|5|||
30791761|NCT00005047|58804888|FG001|Overall Study|Adverse Event|0|||
30791762|NCT00005047|58804889|FG002|Overall Study|Adverse Event|0|||
30791763|NCT00005047|58804890|FG003|Overall Study|Adverse Event|0|||
30902820|NCT01772134|58936777|FG002|Overall Study|Lack of Efficacy|3|||
30744961|NCT00281580|58755613|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
30744962|NCT00281580|58755614|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
30744963|NCT00281580|58755615|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
30744964|NCT00495755|58755684|FG000|Overall Study|Adverse Event|3|||
30744965|NCT00495677|58755696|FG000|Stage 1 (25 Days)|Adverse Event|0|||
30744966|NCT00495677|58755697|FG001|Stage 1 (25 Days)|Adverse Event|0|||
30744967|NCT00495677|58755698|FG002|Stage 1 (25 Days)|Adverse Event|1|||
30744968|NCT00495677|58755699|FG003|Stage 1 (25 Days)|Adverse Event|0|||
30744969|NCT00495677|58755700|FG004|Stage 1 (25 Days)|Adverse Event|0|||
30791764|NCT00005047|58804887|FG000|Overall Study|Lost to Follow-up|1|||
30791765|NCT00005047|58804888|FG001|Overall Study|Lost to Follow-up|0|||
30791766|NCT00005047|58804889|FG002|Overall Study|Lost to Follow-up|0|||
30791767|NCT00005047|58804890|FG003|Overall Study|Lost to Follow-up|0|||
30791768|NCT00005047|58804887|FG000|Overall Study|Lack of Efficacy|1|||
30791769|NCT00005047|58804888|FG001|Overall Study|Lack of Efficacy|0|||
30791770|NCT00005047|58804889|FG002|Overall Study|Lack of Efficacy|0|||
30791771|NCT00005047|58804890|FG003|Overall Study|Lack of Efficacy|0|||
30791772|NCT00003901|58804900|FG000|Overall Study|Adverse Event|1|||
30791773|NCT00003901|58804900|FG000|Overall Study|Withdrawal by Subject|1|||
30791774|NCT00003901|58804900|FG000|Overall Study|Ineligible|6|||
30791775|NCT00003901|58804900|FG000|Overall Study|CT Scan not within protocol requirement|2|||
30791776|NCT00003901|58804900|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
30791777|NCT00003901|58804900|FG000|Overall Study|Medical problems|6|||
30791778|NCT00003895|58804909|FG000|Overall Study|Adverse Event|4|||
30791779|NCT00003895|58804910|FG001|Overall Study|Adverse Event|0|||
30791780|NCT00003895|58804909|FG000|Overall Study|Lack of Efficacy|1|||
30791781|NCT00003895|58804910|FG001|Overall Study|Lack of Efficacy|1|||
30791782|NCT00003895|58804909|FG000|Overall Study|Patient Vacation|2|||
30791783|NCT00003895|58804910|FG001|Overall Study|Patient Vacation|0|||
30791784|NCT00003895|58804909|FG000|Overall Study|Withdrawal by Subject|0|||
30791785|NCT00003895|58804910|FG001|Overall Study|Withdrawal by Subject|3|||
30791786|NCT03800173|58804921|FG000|Overall Study|Lost to Follow-up|0|||
30791787|NCT03800173|58804922|FG001|Overall Study|Lost to Follow-up|0|||
30791788|NCT03800173|58804923|FG002|Overall Study|Lost to Follow-up|0|||
30791789|NCT03800173|58804924|FG003|Overall Study|Lost to Follow-up|0|||
30791790|NCT03800173|58804925|FG004|Overall Study|Lost to Follow-up|1|||
30791791|NCT00003631|58804944|FG000|Overall Study|Patient not treated|1|||
30791792|NCT00003631|58804945|FG001|Overall Study|Patient not treated|0|||
30791793|NCT00003631|58804946|FG002|Overall Study|Patient not treated|1|||
30791794|NCT00003631|58804944|FG000|Overall Study|Protocol Violation|1|||
30791795|NCT00003631|58804945|FG001|Overall Study|Protocol Violation|0|||
30791796|NCT00003631|58804946|FG002|Overall Study|Protocol Violation|0|||
30791797|NCT00003631|58804944|FG000|Overall Study|Adverse Event|1|||
30791798|NCT00003631|58804945|FG001|Overall Study|Adverse Event|1|||
30791799|NCT00003631|58804946|FG002|Overall Study|Adverse Event|5|||
30791800|NCT00003631|58804944|FG000|Overall Study|Death|0|||
30791801|NCT00003631|58804945|FG001|Overall Study|Death|0|||
30791802|NCT00003631|58804946|FG002|Overall Study|Death|1|||
30791803|NCT00003631|58804944|FG000|Overall Study|Evaluable for toxicity only|0|||
30791804|NCT00003631|58804945|FG001|Overall Study|Evaluable for toxicity only|0|||
30791805|NCT00003631|58804946|FG002|Overall Study|Evaluable for toxicity only|2|||
30791806|NCT00003535|58804954|FG000|Overall Study|Not evaluable|5|||
30791807|NCT00003511|58804958|FG000|Overall Study|Not evaluable|4|||
30791808|NCT00003499|58804962|FG000|Overall Study|Not evaluable|8|||
30791809|NCT00003487|58804966|FG000|Overall Study|Not evaluable|2|||
30791810|NCT00003475|58804970|FG000|Overall Study|Not evaluable|13|||
30791811|NCT00003457|58804975|FG000|Overall Study|Not evaluable|9|||
30791812|NCT00030901|58804981|FG000|Initial Registration|Ineligible|167|||
30791813|NCT00030901|58804982|FG001|Initial Registration|Ineligible|0|||
30791814|NCT00030901|58804983|FG002|Initial Registration|Ineligible|0|||
30791815|NCT00030901|58804981|FG000|Randomization|Adverse Event|0|||
30791816|NCT00030901|58804982|FG001|Randomization|Adverse Event|11|||
30791817|NCT00030901|58804983|FG002|Randomization|Adverse Event|7|||
30791818|NCT00030901|58804981|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
30791819|NCT00030901|58804982|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
30791820|NCT00030901|58804983|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
30791821|NCT00030901|58804981|FG000|Randomization|Progression/Relapse|0|||
30791822|NCT00030901|58804982|FG001|Randomization|Progression/Relapse|22|||
30791823|NCT00030901|58804983|FG002|Randomization|Progression/Relapse|21|||
30791824|NCT00030901|58804981|FG000|Randomization|Death|0|||
30791825|NCT00030901|58804982|FG001|Randomization|Death|1|||
30791826|NCT00030901|58804983|FG002|Randomization|Death|3|||
30791827|NCT00030901|58804981|FG000|Randomization|Other|0|||
30791828|NCT00030901|58804982|FG001|Randomization|Other|36|||
30791829|NCT00030901|58804983|FG002|Randomization|Other|33|||
30791830|NCT00030901|58804981|FG000|Randomization|Ineligible|0|||
30791831|NCT00030901|58804982|FG001|Randomization|Ineligible|15|||
30791832|NCT00030901|58804983|FG002|Randomization|Ineligible|14|||
30791833|NCT00003199|58804989|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
30791834|NCT00003199|58804989|FG000|Overall Study|Lack of insurance clearance|2|||
30791835|NCT00003199|58804989|FG000|Overall Study|Screen fail|15|||
30791836|NCT00030823|58804993|FG000|Overall Study|Withdrawal by Subject|1|||
30791837|NCT00001849|58804997|FG000|Overall Study|Death|4|||
30791838|NCT00001849|58804997|FG000|Overall Study|Lost to Follow-up|2|||
30791839|NCT00001849|58804997|FG000|Overall Study|Withdrawal by Subject|2|||
30791840|NCT00001849|58804997|FG000|Overall Study|tumor remained occult|6|||
30791841|NCT01342952|58805014|FG000|Overall Study|Adverse Event|0|||
30791842|NCT01342952|58805015|FG001|Overall Study|Adverse Event|5|||
30791843|NCT01342952|58805016|FG002|Overall Study|Adverse Event|1|||
30791844|NCT01342952|58805017|FG003|Overall Study|Adverse Event|0|||
30791845|NCT01342952|58805014|FG000|Overall Study|Lost to Follow-up|0|||
30791846|NCT01342952|58805015|FG001|Overall Study|Lost to Follow-up|2|||
30791847|NCT01342952|58805016|FG002|Overall Study|Lost to Follow-up|0|||
30791848|NCT01342952|58805017|FG003|Overall Study|Lost to Follow-up|0|||
30791849|NCT01342952|58805014|FG000|Overall Study|Withdrawal by Subject|1|||
30791850|NCT01342952|58805015|FG001|Overall Study|Withdrawal by Subject|1|||
30791851|NCT01342952|58805016|FG002|Overall Study|Withdrawal by Subject|0|||
30791852|NCT01342952|58805017|FG003|Overall Study|Withdrawal by Subject|0|||
30791853|NCT01342952|58805014|FG000|Overall Study|Physician Decision|3|||
30791854|NCT01342952|58805015|FG001|Overall Study|Physician Decision|3|||
30791855|NCT01342952|58805016|FG002|Overall Study|Physician Decision|1|||
30791856|NCT01342952|58805017|FG003|Overall Study|Physician Decision|0|||
30791857|NCT02886884|58805044|FG000|Follow-up|Withdrawal by Subject|0|||
30791858|NCT02886884|58805045|FG001|Follow-up|Withdrawal by Subject|0|||
30791859|NCT02886884|58805046|FG002|Follow-up|Withdrawal by Subject|0|||
30791860|NCT02886884|58805047|FG003|Follow-up|Withdrawal by Subject|1|||
30791861|NCT01240694|58805066|FG000|Overall Study|Adverse Event|9|||
30791862|NCT01240694|58805066|FG000|Overall Study|Lack of Efficacy|6|||
30791863|NCT01240694|58805066|FG000|Overall Study|Withdrawal by Subject|6|||
30791864|NCT01240694|58805066|FG000|Overall Study|Protocol Violation|2|||
30791865|NCT01240694|58805066|FG000|Overall Study|Lost to Follow-up|2|||
30791866|NCT01240694|58805066|FG000|Overall Study|Other than specified|3|||
30791867|NCT01240694|58805066|FG000|Overall Study|Withdrawn due to early study termination|107|||
30791872|NCT03162224|58805077|FG000|Overall Study|Death|4|||
30791873|NCT03162224|58805078|FG001|Overall Study|Death|5|||
30791874|NCT03162224|58805079|FG002|Overall Study|Death|8|||
30791875|NCT03162224|58805077|FG000|Overall Study|Withdrawal by Subject|1|||
30791876|NCT03162224|58805078|FG001|Overall Study|Withdrawal by Subject|0|||
30791877|NCT03162224|58805079|FG002|Overall Study|Withdrawal by Subject|1|||
30791878|NCT03162224|58805077|FG000|Overall Study|Lost to Follow-up|0|||
30791879|NCT03162224|58805078|FG001|Overall Study|Lost to Follow-up|1|||
30791880|NCT03162224|58805079|FG002|Overall Study|Lost to Follow-up|0|||
30791881|NCT03162224|58805077|FG000|Overall Study|Other|6|||
30902821|NCT01772134|58936775|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
30902822|NCT01772134|58936776|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
30902823|NCT01772134|58936777|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
30791882|NCT03162224|58805078|FG001|Overall Study|Other|2|||
30791883|NCT03162224|58805079|FG002|Overall Study|Other|1|||
30791884|NCT02886338|58805118|FG000|Overall Study|Withdrawal by Subject|1|||
30791885|NCT00004124|58805124|FG000|Overall Study|Received no protocol therapy|12|||
30791886|NCT00004124|58805125|FG001|Overall Study|Received no protocol therapy|20|||
30791887|NCT00383552|58805135|FG000|Overall Study|Adverse Event|7|||
30791888|NCT00383552|58805136|FG001|Overall Study|Adverse Event|6|||
30791889|NCT00383552|58805137|FG002|Overall Study|Adverse Event|9|||
30791890|NCT00383552|58805138|FG003|Overall Study|Adverse Event|6|||
30791891|NCT00383552|58805135|FG000|Overall Study|Lack of Efficacy|4|||
30791892|NCT00383552|58805136|FG001|Overall Study|Lack of Efficacy|13|||
30791893|NCT00383552|58805137|FG002|Overall Study|Lack of Efficacy|29|||
30791894|NCT00383552|58805138|FG003|Overall Study|Lack of Efficacy|42|||
30791895|NCT00383552|58805135|FG000|Overall Study|Lost to Follow-up|0|||
30791896|NCT00383552|58805136|FG001|Overall Study|Lost to Follow-up|1|||
30791897|NCT00383552|58805137|FG002|Overall Study|Lost to Follow-up|5|||
30791898|NCT00383552|58805138|FG003|Overall Study|Lost to Follow-up|1|||
30791899|NCT00383552|58805135|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
30791900|NCT00383552|58805136|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
30791901|NCT00383552|58805137|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
30791902|NCT00383552|58805138|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
30791903|NCT00383552|58805135|FG000|Overall Study|Did not wish to continue (related)|1|||
30791904|NCT00383552|58805136|FG001|Overall Study|Did not wish to continue (related)|0|||
30791905|NCT00383552|58805137|FG002|Overall Study|Did not wish to continue (related)|2|||
30791906|NCT00383552|58805138|FG003|Overall Study|Did not wish to continue (related)|3|||
30791907|NCT00383552|58805135|FG000|Overall Study|Noncompliance with the protocol|11|||
30902824|NCT01772134|58936775|FG000|Overall Study|Randomized Study Medication Not Received|2|||
30902825|NCT01772134|58936776|FG001|Overall Study|Randomized Study Medication Not Received|0|||
30902826|NCT01772134|58936777|FG002|Overall Study|Randomized Study Medication Not Received|1|||
30902827|NCT01994889|58936788|FG000|Overall Study|Adverse Event|5|||
30902828|NCT01994889|58936789|FG001|Overall Study|Adverse Event|12|||
30902829|NCT01994889|58936790|FG002|Overall Study|Adverse Event|11|||
30902830|NCT01994889|58936788|FG000|Overall Study|Cardiac Device Implantation|0|||
30902831|NCT01994889|58936789|FG001|Overall Study|Cardiac Device Implantation|2|||
30902832|NCT01994889|58936790|FG002|Overall Study|Cardiac Device Implantation|0|||
30902833|NCT01994889|58936788|FG000|Overall Study|Organ Transplantation|1|||
30902834|NCT01994889|58936789|FG001|Overall Study|Organ Transplantation|5|||
30902835|NCT01994889|58936790|FG002|Overall Study|Organ Transplantation|5|||
30902836|NCT01994889|58936788|FG000|Overall Study|No longer willing to participate|8|||
30902837|NCT01994889|58936789|FG001|Overall Study|No longer willing to participate|17|||
30902838|NCT01994889|58936790|FG002|Overall Study|No longer willing to participate|37|||
30902839|NCT01994889|58936788|FG000|Overall Study|Lost to Follow-up|0|||
30902840|NCT01994889|58936789|FG001|Overall Study|Lost to Follow-up|1|||
30902841|NCT01994889|58936790|FG002|Overall Study|Lost to Follow-up|0|||
30902842|NCT01994889|58936788|FG000|Overall Study|Protocol Violation|0|||
30902843|NCT01994889|58936789|FG001|Overall Study|Protocol Violation|1|||
30902844|NCT01994889|58936790|FG002|Overall Study|Protocol Violation|1|||
30902845|NCT01994889|58936788|FG000|Overall Study|Death|14|||
30902846|NCT01994889|58936789|FG001|Overall Study|Death|25|||
30902847|NCT01994889|58936790|FG002|Overall Study|Death|38|||
30902848|NCT02082483|58936799|FG000|Overall Study|Lost to Follow-up|1|||
30902849|NCT02082483|58936800|FG001|Overall Study|Lost to Follow-up|1|||
30902850|NCT02082483|58936799|FG000|Overall Study|Withdrawal by Subject|2|||
30902851|NCT02082483|58936800|FG001|Overall Study|Withdrawal by Subject|1|||
30902852|NCT02082483|58936799|FG000|Overall Study|Physician Decision|1|||
30902853|NCT02082483|58936800|FG001|Overall Study|Physician Decision|1|||
30902854|NCT02082483|58936799|FG000|Overall Study|Death|2|||
30902855|NCT02082483|58936800|FG001|Overall Study|Death|3|||
30902856|NCT02017899|58936813|FG000|Overall Study|Withdrawal by Subject|0|||
30902857|NCT02017899|58936814|FG001|Overall Study|Withdrawal by Subject|0|||
30902858|NCT02017899|58936815|FG002|Overall Study|Withdrawal by Subject|0|||
30902859|NCT02017899|58936816|FG003|Overall Study|Withdrawal by Subject|1|||
30902860|NCT02017899|58936817|FG004|Overall Study|Withdrawal by Subject|1|||
30902861|NCT02017899|58936818|FG005|Overall Study|Withdrawal by Subject|0|||
30902862|NCT01993329|58936838|FG000|Period 2|Adverse Event|0|||
30902863|NCT01993329|58936839|FG001|Period 2|Adverse Event|0|||
30902864|NCT01993329|58936840|FG002|Period 2|Adverse Event|0|||
30902865|NCT01993329|58936841|FG003|Period 2|Adverse Event|0|||
30902866|NCT01993329|58936842|FG004|Period 2|Adverse Event|0|||
30902867|NCT01993329|58936843|FG005|Period 2|Adverse Event|1|||
30902868|NCT01993329|58936838|FG000|Wash-out|Personal reasons|0|||
30902869|NCT01993329|58936839|FG001|Wash-out|Personal reasons|1|||
30902870|NCT01993329|58936840|FG002|Wash-out|Personal reasons|0|||
30902871|NCT01993329|58936841|FG003|Wash-out|Personal reasons|0|||
30902872|NCT01993329|58936842|FG004|Wash-out|Personal reasons|0|||
30902873|NCT01993329|58936843|FG005|Wash-out|Personal reasons|0|||
30902874|NCT02016183|58936855|FG000|Overall Study|Case Report Forms Uncollected|13|||
30902875|NCT02016183|58936855|FG000|Overall Study|Protocol Violation|52|||
30902876|NCT02377349|58936861|FG000|Overall Study|Serious Adverse Event|1|||
30902877|NCT02377349|58936862|FG001|Overall Study|Serious Adverse Event|0|||
30902878|NCT02377349|58936861|FG000|Overall Study|Protocol Violation|3|||
30791908|NCT00383552|58805136|FG001|Overall Study|Noncompliance with the protocol|6|||
30791909|NCT00383552|58805137|FG002|Overall Study|Noncompliance with the protocol|8|||
30791910|NCT00383552|58805138|FG003|Overall Study|Noncompliance with the protocol|10|||
30791911|NCT00383552|58805135|FG000|Overall Study|Did not meet protocol eligibility|8|||
30791912|NCT00383552|58805136|FG001|Overall Study|Did not meet protocol eligibility|6|||
30791913|NCT00383552|58805137|FG002|Overall Study|Did not meet protocol eligibility|2|||
30791914|NCT00383552|58805138|FG003|Overall Study|Did not meet protocol eligibility|3|||
30791915|NCT00383552|58805135|FG000|Overall Study|Administrative|1|||
30791916|NCT00383552|58805136|FG001|Overall Study|Administrative|0|||
30791917|NCT00383552|58805137|FG002|Overall Study|Administrative|1|||
30791918|NCT00383552|58805138|FG003|Overall Study|Administrative|1|||
30791919|NCT03158012|58805155|FG000|Overall Study|Withdrawal by Subject|0|||
30791920|NCT03158012|58805156|FG001|Overall Study|Withdrawal by Subject|1|||
30791921|NCT01776424|58805165|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
30791922|NCT01776424|58805166|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
30902879|NCT02377349|58936862|FG001|Overall Study|Protocol Violation|2|||
30902880|NCT02377349|58936861|FG000|Overall Study|Withdrawal by Subject|5|||
30902881|NCT02377349|58936862|FG001|Overall Study|Withdrawal by Subject|3|||
30902882|NCT02377349|58936861|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
30902883|NCT02377349|58936862|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
30902884|NCT02377349|58936861|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
30902885|NCT02377349|58936862|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
30902886|NCT02377349|58936861|FG000|Overall Study|Other|0|||
30902887|NCT02377349|58936862|FG001|Overall Study|Other|1|||
30902888|NCT02421419|58936880|FG000|Overall Study|Physician Decision|0|||
30902889|NCT02421419|58936881|FG001|Overall Study|Physician Decision|0|||
30902890|NCT02421419|58936882|FG002|Overall Study|Physician Decision|1|||
30902891|NCT02420717|58936893|FG000|Overall Study|Did not receive all study medication|2|||
30902892|NCT02420717|58936894|FG001|Overall Study|Did not receive all study medication|0|||
30902893|NCT02420717|58936895|FG002|Overall Study|Did not receive all study medication|0|||
30902894|NCT02016105|58936905|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
30902895|NCT02016105|58936906|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
30902896|NCT02016105|58936907|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
30902897|NCT02016105|58936908|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
30902898|NCT02016105|58936909|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
30902899|NCT02016105|58936910|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
30902900|NCT02016105|58936905|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
30902901|NCT02016105|58936906|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
30902902|NCT02016105|58936907|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
30902903|NCT02016105|58936908|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
30902904|NCT02016105|58936909|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
30902905|NCT02016105|58936910|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
30902906|NCT02016105|58936905|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
30902907|NCT02016105|58936906|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
30902908|NCT02016105|58936907|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
30902909|NCT02016105|58936908|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
30902910|NCT02016105|58936909|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
30902911|NCT02016105|58936910|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
30902912|NCT02016105|58936905|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
30902913|NCT02016105|58936906|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
30902914|NCT02016105|58936907|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
30791923|NCT01776424|58805167|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
30791924|NCT01776424|58805165|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
30902915|NCT02016105|58936908|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
30902916|NCT02016105|58936909|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
30902917|NCT02016105|58936910|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
30791925|NCT01776424|58805166|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
30791926|NCT01776424|58805167|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
30791927|NCT01776424|58805165|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
30791928|NCT01776424|58805166|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
30791929|NCT01776424|58805167|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
30791930|NCT01776424|58805165|FG000|LTOLE Part (Open Label)|Refused|5|||
30791931|NCT01776424|58805166|FG001|LTOLE Part (Open Label)|Refused|2|||
30791932|NCT01776424|58805167|FG002|LTOLE Part (Open Label)|Refused|11|||
30791933|NCT01776424|58805165|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
30791934|NCT01776424|58805166|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
30791935|NCT01776424|58805167|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
30902918|NCT02016105|58936905|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
30902919|NCT02016105|58936906|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
30902920|NCT02016105|58936907|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
30902921|NCT02016105|58936908|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
30902922|NCT02016105|58936909|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
30902923|NCT02016105|58936910|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
30902924|NCT02016105|58936905|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
30902925|NCT02016105|58936906|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
30622029|NCT01147068|58633526|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
30791936|NCT03799627|58805193|FG000|Overall Study|Adverse Event|1|||
30791937|NCT03799627|58805194|FG001|Overall Study|Adverse Event|2|||
30791938|NCT03799627|58805195|FG002|Overall Study|Adverse Event|0|||
30791939|NCT03799627|58805196|FG003|Overall Study|Adverse Event|0|||
30791940|NCT03799627|58805197|FG004|Overall Study|Adverse Event|2|||
30791941|NCT03799627|58805198|FG005|Overall Study|Adverse Event|5|||
30791942|NCT03799627|58805199|FG006|Overall Study|Adverse Event|0|||
30791943|NCT03799627|58805200|FG007|Overall Study|Adverse Event|2|||
30791944|NCT03799627|58805201|FG008|Overall Study|Adverse Event|0|||
30791945|NCT03799627|58805193|FG000|Overall Study|Physician Decision|2|||
30791946|NCT03799627|58805194|FG001|Overall Study|Physician Decision|2|||
30791947|NCT03799627|58805195|FG002|Overall Study|Physician Decision|0|||
30791948|NCT03799627|58805196|FG003|Overall Study|Physician Decision|0|||
30791949|NCT03799627|58805197|FG004|Overall Study|Physician Decision|2|||
30902926|NCT02016105|58936907|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
30902927|NCT02016105|58936908|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
30902928|NCT02016105|58936909|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
30902929|NCT02016105|58936910|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
30902930|NCT02016105|58936905|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
30902931|NCT02016105|58936906|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
30902932|NCT02016105|58936907|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
30902933|NCT02016105|58936908|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
30902934|NCT02016105|58936909|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
30791950|NCT03799627|58805198|FG005|Overall Study|Physician Decision|2|||
30791951|NCT03799627|58805199|FG006|Overall Study|Physician Decision|0|||
30791952|NCT03799627|58805200|FG007|Overall Study|Physician Decision|0|||
30791953|NCT03799627|58805201|FG008|Overall Study|Physician Decision|0|||
30902935|NCT02016105|58936910|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
30902936|NCT02016105|58936905|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
30902937|NCT02016105|58936906|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
30744970|NCT00495677|58755701|FG005|Stage 1 (25 Days)|Adverse Event|0|||
30744971|NCT00495677|58755702|FG006|Stage 1 (25 Days)|Adverse Event|0|||
30744972|NCT00495521|58755720|FG000|Overall Study|Physician Decision|0|||
30744973|NCT00495521|58755721|FG001|Overall Study|Physician Decision|1|||
30744974|NCT00273858|58755727|FG000|Overall Study|Not completed 24 month observation time|334|||
30744975|NCT00273858|58755727|FG000|Overall Study|Lost to Follow-up|101|||
30744976|NCT00273858|58755727|FG000|Overall Study|Withdrawal by Subject|21|||
30744977|NCT00273858|58755727|FG000|Overall Study|Adverse Event|81|||
30744978|NCT00494507|58755735|FG000|Double-Blind Phase|Adverse Event|2|||
30744979|NCT00494507|58755736|FG001|Double-Blind Phase|Adverse Event|0|||
30744980|NCT00494507|58755737|FG002|Double-Blind Phase|Adverse Event|1|||
30744981|NCT00494507|58755738|FG003|Double-Blind Phase|Adverse Event|0|||
30744982|NCT00494507|58755735|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
30744983|NCT00494507|58755736|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
30744984|NCT00494507|58755737|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
30744985|NCT00494507|58755738|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
30744986|NCT00494507|58755735|FG000|Double-Blind Phase|Subject Non-compliance|0|||
30744987|NCT00494507|58755736|FG001|Double-Blind Phase|Subject Non-compliance|0|||
30791954|NCT03799627|58805193|FG000|Overall Study|Withdrawal by Subject|1|||
30791955|NCT03799627|58805194|FG001|Overall Study|Withdrawal by Subject|1|||
30791956|NCT03799627|58805195|FG002|Overall Study|Withdrawal by Subject|0|||
30791957|NCT03799627|58805196|FG003|Overall Study|Withdrawal by Subject|2|||
30791958|NCT03799627|58805197|FG004|Overall Study|Withdrawal by Subject|0|||
30791959|NCT03799627|58805198|FG005|Overall Study|Withdrawal by Subject|3|||
30791960|NCT03799627|58805199|FG006|Overall Study|Withdrawal by Subject|0|||
30791961|NCT03799627|58805200|FG007|Overall Study|Withdrawal by Subject|0|||
30791962|NCT03799627|58805201|FG008|Overall Study|Withdrawal by Subject|0|||
30791963|NCT03799627|58805193|FG000|Overall Study|Lack of Efficacy|0|||
30791964|NCT03799627|58805194|FG001|Overall Study|Lack of Efficacy|0|||
30791965|NCT03799627|58805195|FG002|Overall Study|Lack of Efficacy|0|||
30791966|NCT03799627|58805196|FG003|Overall Study|Lack of Efficacy|1|||
30791967|NCT03799627|58805197|FG004|Overall Study|Lack of Efficacy|0|||
30791968|NCT03799627|58805198|FG005|Overall Study|Lack of Efficacy|0|||
30791969|NCT03799627|58805199|FG006|Overall Study|Lack of Efficacy|0|||
30791970|NCT03799627|58805200|FG007|Overall Study|Lack of Efficacy|0|||
30791971|NCT03799627|58805201|FG008|Overall Study|Lack of Efficacy|0|||
30791972|NCT03799627|58805193|FG000|Overall Study|Lost to Follow-up|0|||
30791973|NCT03799627|58805194|FG001|Overall Study|Lost to Follow-up|0|||
30791974|NCT03799627|58805195|FG002|Overall Study|Lost to Follow-up|0|||
30791975|NCT03799627|58805196|FG003|Overall Study|Lost to Follow-up|0|||
30791976|NCT03799627|58805197|FG004|Overall Study|Lost to Follow-up|0|||
30791977|NCT03799627|58805198|FG005|Overall Study|Lost to Follow-up|0|||
30791978|NCT03799627|58805199|FG006|Overall Study|Lost to Follow-up|1|||
30902938|NCT02016105|58936907|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
30902939|NCT02016105|58936908|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
30791979|NCT03799627|58805200|FG007|Overall Study|Lost to Follow-up|0|||
30791980|NCT03799627|58805201|FG008|Overall Study|Lost to Follow-up|1|||
30791981|NCT03799627|58805193|FG000|Overall Study|Death|0|||
30791982|NCT03799627|58805194|FG001|Overall Study|Death|0|||
30791983|NCT03799627|58805195|FG002|Overall Study|Death|0|||
30791984|NCT03799627|58805196|FG003|Overall Study|Death|1|||
30791985|NCT03799627|58805197|FG004|Overall Study|Death|0|||
30791986|NCT03799627|58805198|FG005|Overall Study|Death|0|||
30791987|NCT03799627|58805199|FG006|Overall Study|Death|0|||
30791988|NCT03799627|58805200|FG007|Overall Study|Death|0|||
30791989|NCT03799627|58805201|FG008|Overall Study|Death|0|||
30791990|NCT03799627|58805193|FG000|Overall Study|Study Drug Put on Hold|1|||
30791991|NCT03799627|58805194|FG001|Overall Study|Study Drug Put on Hold|0|||
30791992|NCT03799627|58805195|FG002|Overall Study|Study Drug Put on Hold|0|||
30791993|NCT03799627|58805196|FG003|Overall Study|Study Drug Put on Hold|0|||
30791994|NCT03799627|58805197|FG004|Overall Study|Study Drug Put on Hold|0|||
30791995|NCT03799627|58805198|FG005|Overall Study|Study Drug Put on Hold|0|||
30791996|NCT03799627|58805199|FG006|Overall Study|Study Drug Put on Hold|0|||
30791997|NCT03799627|58805200|FG007|Overall Study|Study Drug Put on Hold|0|||
30791998|NCT03799627|58805201|FG008|Overall Study|Study Drug Put on Hold|0|||
30791999|NCT03799627|58805193|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
30792000|NCT03799627|58805194|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
30792001|NCT03799627|58805195|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
30792002|NCT03799627|58805196|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
30792003|NCT03799627|58805197|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
30792004|NCT03799627|58805198|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
30792005|NCT03799627|58805199|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
30792006|NCT03799627|58805200|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
30792007|NCT03799627|58805201|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
30792008|NCT03799627|58805193|FG000|Overall Study|Kidney Transplantation|1|||
30792009|NCT03799627|58805194|FG001|Overall Study|Kidney Transplantation|0|||
30792010|NCT03799627|58805195|FG002|Overall Study|Kidney Transplantation|0|||
30792011|NCT03799627|58805196|FG003|Overall Study|Kidney Transplantation|1|||
30792012|NCT03799627|58805197|FG004|Overall Study|Kidney Transplantation|1|||
30792013|NCT03799627|58805198|FG005|Overall Study|Kidney Transplantation|0|||
30792014|NCT03799627|58805199|FG006|Overall Study|Kidney Transplantation|0|||
30792015|NCT03799627|58805200|FG007|Overall Study|Kidney Transplantation|0|||
30792016|NCT03799627|58805201|FG008|Overall Study|Kidney Transplantation|0|||
30792017|NCT03799627|58805193|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
30792018|NCT03799627|58805194|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
30792019|NCT03799627|58805195|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
30792020|NCT03799627|58805196|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
30792021|NCT03799627|58805197|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
30792022|NCT03799627|58805198|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
30792023|NCT03799627|58805199|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
30792024|NCT03799627|58805200|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
30792025|NCT03799627|58805201|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
30792026|NCT03799627|58805193|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
30792027|NCT03799627|58805194|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
30792028|NCT03799627|58805195|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
30792029|NCT03799627|58805196|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
30792030|NCT03799627|58805197|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
30792031|NCT03799627|58805198|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
30792032|NCT03799627|58805199|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
30792033|NCT03799627|58805200|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
30792034|NCT03799627|58805201|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
30792035|NCT03799627|58805193|FG000|Overall Study|Met Exclusion Criteria|0|||
30792036|NCT03799627|58805194|FG001|Overall Study|Met Exclusion Criteria|0|||
30792037|NCT03799627|58805195|FG002|Overall Study|Met Exclusion Criteria|0|||
30792038|NCT03799627|58805196|FG003|Overall Study|Met Exclusion Criteria|1|||
30792039|NCT03799627|58805197|FG004|Overall Study|Met Exclusion Criteria|0|||
30792040|NCT03799627|58805198|FG005|Overall Study|Met Exclusion Criteria|0|||
30792041|NCT03799627|58805199|FG006|Overall Study|Met Exclusion Criteria|0|||
30792042|NCT03799627|58805200|FG007|Overall Study|Met Exclusion Criteria|0|||
30792043|NCT03799627|58805201|FG008|Overall Study|Met Exclusion Criteria|0|||
30792044|NCT03799627|58805193|FG000|Overall Study|Investigational Product Noncompliance|0|||
30792045|NCT03799627|58805194|FG001|Overall Study|Investigational Product Noncompliance|0|||
30792046|NCT03799627|58805195|FG002|Overall Study|Investigational Product Noncompliance|0|||
30792047|NCT03799627|58805196|FG003|Overall Study|Investigational Product Noncompliance|1|||
30792048|NCT03799627|58805197|FG004|Overall Study|Investigational Product Noncompliance|0|||
30792049|NCT03799627|58805198|FG005|Overall Study|Investigational Product Noncompliance|0|||
30792050|NCT03799627|58805199|FG006|Overall Study|Investigational Product Noncompliance|0|||
30792051|NCT03799627|58805200|FG007|Overall Study|Investigational Product Noncompliance|0|||
30792052|NCT03799627|58805201|FG008|Overall Study|Investigational Product Noncompliance|0|||
30792053|NCT03799627|58805193|FG000|Overall Study|Participant Relocation|0|||
30792054|NCT03799627|58805194|FG001|Overall Study|Participant Relocation|0|||
30792055|NCT03799627|58805195|FG002|Overall Study|Participant Relocation|0|||
30792056|NCT03799627|58805196|FG003|Overall Study|Participant Relocation|1|||
30902940|NCT02016105|58936909|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
30902941|NCT02016105|58936910|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
30902942|NCT02016105|58936905|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
30902943|NCT02016105|58936906|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
30902944|NCT02016105|58936907|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
30902945|NCT02016105|58936908|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
30902946|NCT02016105|58936909|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
30902947|NCT02016105|58936910|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
30902948|NCT02016105|58936905|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
30902949|NCT02016105|58936906|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
30902950|NCT02016105|58936907|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
30902951|NCT02016105|58936908|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
30902952|NCT02016105|58936909|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
30902953|NCT02016105|58936910|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
30902954|NCT02016105|58936905|FG000|TREATMENT PERIOD 2|Death|0|||
30902955|NCT02016105|58936906|FG001|TREATMENT PERIOD 2|Death|0|||
30902956|NCT02016105|58936907|FG002|TREATMENT PERIOD 2|Death|0|||
30902957|NCT02016105|58936908|FG003|TREATMENT PERIOD 2|Death|0|||
30902958|NCT02016105|58936909|FG004|TREATMENT PERIOD 2|Death|0|||
30902959|NCT02016105|58936910|FG005|TREATMENT PERIOD 2|Death|1|||
30902960|NCT02016105|58936905|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
30902961|NCT02016105|58936906|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
30902962|NCT02016105|58936907|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
30902963|NCT02016105|58936908|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
30902964|NCT02016105|58936909|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
30902965|NCT02016105|58936910|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
30902966|NCT02016105|58936905|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
30902967|NCT02016105|58936906|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
30902968|NCT02016105|58936907|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
30902969|NCT02016105|58936908|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
30902970|NCT02016105|58936909|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
30902971|NCT02016105|58936910|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
30902972|NCT02016105|58936905|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
30902973|NCT02016105|58936906|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
30902974|NCT02016105|58936907|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
30792057|NCT03799627|58805197|FG004|Overall Study|Participant Relocation|0|||
30792058|NCT03799627|58805198|FG005|Overall Study|Participant Relocation|1|||
30792059|NCT03799627|58805199|FG006|Overall Study|Participant Relocation|0|||
30902975|NCT02016105|58936908|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
30902976|NCT02016105|58936909|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
30902977|NCT02016105|58936910|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
30792060|NCT03799627|58805200|FG007|Overall Study|Participant Relocation|0|||
30792061|NCT03799627|58805201|FG008|Overall Study|Participant Relocation|0|||
30792062|NCT03799627|58805193|FG000|Overall Study|Eurofin Issue|0|||
30792063|NCT03799627|58805194|FG001|Overall Study|Eurofin Issue|0|||
30792064|NCT03799627|58805195|FG002|Overall Study|Eurofin Issue|0|||
30792065|NCT03799627|58805196|FG003|Overall Study|Eurofin Issue|0|||
30792066|NCT03799627|58805197|FG004|Overall Study|Eurofin Issue|1|||
30792067|NCT03799627|58805198|FG005|Overall Study|Eurofin Issue|0|||
30792068|NCT03799627|58805199|FG006|Overall Study|Eurofin Issue|0|||
30792069|NCT03799627|58805200|FG007|Overall Study|Eurofin Issue|0|||
30792070|NCT03799627|58805201|FG008|Overall Study|Eurofin Issue|0|||
30792071|NCT03799627|58805193|FG000|Overall Study|Noncompliance with Site Instructions|0|||
30792072|NCT03799627|58805194|FG001|Overall Study|Noncompliance with Site Instructions|0|||
30792073|NCT03799627|58805195|FG002|Overall Study|Noncompliance with Site Instructions|0|||
30792074|NCT03799627|58805196|FG003|Overall Study|Noncompliance with Site Instructions|0|||
30792075|NCT03799627|58805197|FG004|Overall Study|Noncompliance with Site Instructions|1|||
30792076|NCT03799627|58805198|FG005|Overall Study|Noncompliance with Site Instructions|0|||
30792077|NCT03799627|58805199|FG006|Overall Study|Noncompliance with Site Instructions|0|||
30792078|NCT03799627|58805200|FG007|Overall Study|Noncompliance with Site Instructions|0|||
30792079|NCT03799627|58805201|FG008|Overall Study|Noncompliance with Site Instructions|0|||
30792080|NCT03799627|58805193|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
30792081|NCT03799627|58805194|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
30792082|NCT03799627|58805195|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
30792083|NCT03799627|58805196|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
30792084|NCT03799627|58805197|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
30792085|NCT03799627|58805198|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
30792086|NCT03799627|58805199|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
30792087|NCT03799627|58805200|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
30902978|NCT02016105|58936905|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
30902979|NCT02016105|58936906|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
30792088|NCT03799627|58805201|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
30792089|NCT03799627|58805193|FG000|Overall Study|Changes In Hemoglobin Values|1|||
30792090|NCT03799627|58805194|FG001|Overall Study|Changes In Hemoglobin Values|2|||
30792091|NCT03799627|58805195|FG002|Overall Study|Changes In Hemoglobin Values|1|||
30792092|NCT03799627|58805196|FG003|Overall Study|Changes In Hemoglobin Values|0|||
30792093|NCT03799627|58805197|FG004|Overall Study|Changes In Hemoglobin Values|0|||
30792094|NCT03799627|58805198|FG005|Overall Study|Changes In Hemoglobin Values|2|||
30792095|NCT03799627|58805199|FG006|Overall Study|Changes In Hemoglobin Values|1|||
30792096|NCT03799627|58805200|FG007|Overall Study|Changes In Hemoglobin Values|0|||
30792097|NCT03799627|58805201|FG008|Overall Study|Changes In Hemoglobin Values|1|||
30792098|NCT00756574|58805242|FG000|Overall Study|Withdrawal by Subject|9|||
30792099|NCT00756574|58805243|FG001|Overall Study|Withdrawal by Subject|7|||
30792100|NCT00756574|58805242|FG000|Overall Study|Lost to Follow-up|4|||
30792101|NCT00756574|58805243|FG001|Overall Study|Lost to Follow-up|4|||
30792102|NCT02743780|58805252|FG000|Part 3 (7 Days)|Adverse Event|0|||
30792103|NCT02743780|58805253|FG001|Part 3 (7 Days)|Adverse Event|0|||
30902980|NCT02016105|58936907|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
30902981|NCT02016105|58936908|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
30792104|NCT02743780|58805254|FG002|Part 3 (7 Days)|Adverse Event|1|||
30792105|NCT02743780|58805255|FG003|Part 3 (7 Days)|Adverse Event|0|||
30792106|NCT02743780|58805256|FG004|Part 3 (7 Days)|Adverse Event|0|||
30792107|NCT02880956|58805280|FG000|Overall Study|Adverse Event|3|||
30792108|NCT02880956|58805281|FG001|Overall Study|Adverse Event|6|||
30792109|NCT02880956|58805282|FG002|Overall Study|Adverse Event|5|||
30792110|NCT02880956|58805283|FG003|Overall Study|Adverse Event|4|||
30792111|NCT02880956|58805280|FG000|Overall Study|Withdrawal by Subject|9|||
30792112|NCT02880956|58805281|FG001|Overall Study|Withdrawal by Subject|4|||
30792113|NCT02880956|58805282|FG002|Overall Study|Withdrawal by Subject|6|||
30792114|NCT02880956|58805283|FG003|Overall Study|Withdrawal by Subject|11|||
30792115|NCT02880956|58805280|FG000|Overall Study|Lost to Follow-up|0|||
30792116|NCT02880956|58805281|FG001|Overall Study|Lost to Follow-up|1|||
30792117|NCT02880956|58805282|FG002|Overall Study|Lost to Follow-up|0|||
30792118|NCT02880956|58805283|FG003|Overall Study|Lost to Follow-up|0|||
30792119|NCT02880956|58805280|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
30792120|NCT02880956|58805281|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
30744988|NCT00494507|58755737|FG002|Double-Blind Phase|Subject Non-compliance|1|||
30744989|NCT00494507|58755738|FG003|Double-Blind Phase|Subject Non-compliance|0|||
30744990|NCT00494507|58755735|FG000|Double-Blind Phase|Negative DNA test|0|||
30744991|NCT00494507|58755736|FG001|Double-Blind Phase|Negative DNA test|0|||
30744992|NCT00494507|58755737|FG002|Double-Blind Phase|Negative DNA test|0|||
30744993|NCT00494507|58755738|FG003|Double-Blind Phase|Negative DNA test|1|||
30744994|NCT00494507|58755735|FG000|Open-Label Phase|Adverse Event|0|||
30792121|NCT02880956|58805282|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
30792122|NCT02880956|58805283|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
30792123|NCT02880956|58805280|FG000|Overall Study|Other, Not Specified|4|||
30792124|NCT02880956|58805281|FG001|Overall Study|Other, Not Specified|2|||
30792125|NCT02880956|58805282|FG002|Overall Study|Other, Not Specified|0|||
30792126|NCT02880956|58805283|FG003|Overall Study|Other, Not Specified|3|||
30792127|NCT01352416|58805300|FG000|Overall Study|Physician Decision|1|||
30792128|NCT01352416|58805301|FG001|Overall Study|Physician Decision|2|||
30792129|NCT01352416|58805302|FG002|Overall Study|Physician Decision|2|||
30792130|NCT01352416|58805303|FG003|Overall Study|Physician Decision|1|||
30792131|NCT00439738|58805315|FG000|Overall Study|Withdrawal by Subject|16|||
30792132|NCT00439738|58805316|FG001|Overall Study|Withdrawal by Subject|13|||
30792133|NCT00439738|58805315|FG000|Overall Study|Adverse Event|6|||
30792134|NCT00439738|58805316|FG001|Overall Study|Adverse Event|4|||
30792135|NCT00439738|58805315|FG000|Overall Study|Lost to Follow-up|5|||
30792136|NCT00439738|58805316|FG001|Overall Study|Lost to Follow-up|6|||
30792137|NCT00439738|58805315|FG000|Overall Study|Protocol Violation|6|||
30792138|NCT00439738|58805316|FG001|Overall Study|Protocol Violation|3|||
30792139|NCT00439738|58805315|FG000|Overall Study|Lack of Efficacy|2|||
30792140|NCT00439738|58805316|FG001|Overall Study|Lack of Efficacy|2|||
30792141|NCT00439738|58805315|FG000|Overall Study|Abnormal Lab Values|1|||
30792142|NCT00439738|58805316|FG001|Overall Study|Abnormal Lab Values|0|||
30792143|NCT00338104|58805323|FG000|Overall Study|Protocol Violation|2|||
30792144|NCT00338104|58805324|FG001|Overall Study|Protocol Violation|1|||
30792145|NCT00338104|58805325|FG002|Overall Study|Protocol Violation|3|||
30792146|NCT05091307|58805334|FG000|Overall Study|Death|0|||
30792147|NCT05091307|58805335|FG001|Overall Study|Death|0|||
30792148|NCT05091307|58805336|FG002|Overall Study|Death|1|||
30792149|NCT05091307|58805337|FG003|Overall Study|Death|0|||
30792150|NCT05091307|58805334|FG000|Overall Study|Lost to Follow-up|33|||
30902982|NCT02016105|58936909|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
30902983|NCT02016105|58936910|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
30902984|NCT02016105|58936905|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
30902985|NCT02016105|58936906|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
30902986|NCT02016105|58936907|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
30902987|NCT02016105|58936908|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
30902988|NCT02016105|58936909|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
30902989|NCT02016105|58936910|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
30902990|NCT02016105|58936905|FG000|EXTENSION PERIOD|Adverse Event|0|||
30902991|NCT02016105|58936906|FG001|EXTENSION PERIOD|Adverse Event|0|||
30902992|NCT02016105|58936907|FG002|EXTENSION PERIOD|Adverse Event|2|||
30902993|NCT02016105|58936908|FG003|EXTENSION PERIOD|Adverse Event|0|||
30902994|NCT02016105|58936909|FG004|EXTENSION PERIOD|Adverse Event|1|||
30744995|NCT00494507|58755736|FG001|Open-Label Phase|Adverse Event|1|||
30792151|NCT05091307|58805335|FG001|Overall Study|Lost to Follow-up|33|||
30792152|NCT05091307|58805336|FG002|Overall Study|Lost to Follow-up|2|||
30792153|NCT05091307|58805337|FG003|Overall Study|Lost to Follow-up|0|||
30792154|NCT05091307|58805334|FG000|Overall Study|Physician Decision|1|||
30792155|NCT05091307|58805335|FG001|Overall Study|Physician Decision|0|||
30792156|NCT05091307|58805336|FG002|Overall Study|Physician Decision|0|||
30792157|NCT05091307|58805337|FG003|Overall Study|Physician Decision|0|||
30902995|NCT02016105|58936910|FG005|EXTENSION PERIOD|Adverse Event|0|||
30902996|NCT02016105|58936905|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
30902997|NCT02016105|58936906|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
30792158|NCT05091307|58805334|FG000|Overall Study|Protocol Violation|1|||
30792159|NCT05091307|58805335|FG001|Overall Study|Protocol Violation|0|||
30792160|NCT05091307|58805336|FG002|Overall Study|Protocol Violation|0|||
30792161|NCT05091307|58805337|FG003|Overall Study|Protocol Violation|0|||
30792162|NCT05091307|58805334|FG000|Overall Study|Withdrawal by Subject|16|||
30792163|NCT05091307|58805335|FG001|Overall Study|Withdrawal by Subject|16|||
30792164|NCT05091307|58805336|FG002|Overall Study|Withdrawal by Subject|0|||
30744996|NCT00494507|58755737|FG002|Open-Label Phase|Adverse Event|5|||
30744997|NCT00494507|58755738|FG003|Open-Label Phase|Adverse Event|3|||
30744998|NCT00494507|58755735|FG000|Open-Label Phase|Worsening Disease|0|||
30744999|NCT00494507|58755736|FG001|Open-Label Phase|Worsening Disease|0|||
30745000|NCT00494507|58755737|FG002|Open-Label Phase|Worsening Disease|0|||
30745001|NCT00494507|58755738|FG003|Open-Label Phase|Worsening Disease|2|||
30745002|NCT00292188|58755760|FG000|Single-Blind|Adverse Event|14|||
30745003|NCT00292188|58755761|FG001|Single-Blind|Adverse Event|0|||
30745004|NCT00292188|58755762|FG002|Single-Blind|Adverse Event|0|||
30745005|NCT00292188|58755760|FG000|Single-Blind|Lack of Efficacy|2|||
30745006|NCT00292188|58755761|FG001|Single-Blind|Lack of Efficacy|0|||
30745007|NCT00292188|58755762|FG002|Single-Blind|Lack of Efficacy|0|||
30745008|NCT00292188|58755760|FG000|Single-Blind|Laboratory Abnormality|5|||
30745009|NCT00292188|58755761|FG001|Single-Blind|Laboratory Abnormality|0|||
30745010|NCT00292188|58755762|FG002|Single-Blind|Laboratory Abnormality|0|||
30745011|NCT00292188|58755760|FG000|Single-Blind|Lost to Follow-up|3|||
30745012|NCT00292188|58755761|FG001|Single-Blind|Lost to Follow-up|0|||
30745013|NCT00292188|58755762|FG002|Single-Blind|Lost to Follow-up|0|||
30745014|NCT00292188|58755760|FG000|Single-Blind|Other|77|||
30745015|NCT00292188|58755761|FG001|Single-Blind|Other|0|||
30745016|NCT00292188|58755762|FG002|Single-Blind|Other|0|||
30745017|NCT00292188|58755760|FG000|Single-Blind|Withdrawal by Subject|12|||
30745018|NCT00292188|58755761|FG001|Single-Blind|Withdrawal by Subject|0|||
30745019|NCT00292188|58755762|FG002|Single-Blind|Withdrawal by Subject|0|||
30745020|NCT00292188|58755760|FG000|Single-Blind|Did not receive treatment|1|||
30745021|NCT00292188|58755761|FG001|Single-Blind|Did not receive treatment|0|||
30792165|NCT05091307|58805337|FG003|Overall Study|Withdrawal by Subject|1|||
30792166|NCT05091307|58805334|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
30792167|NCT05091307|58805335|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
30792168|NCT05091307|58805336|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
30792169|NCT05091307|58805337|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
30792170|NCT05091307|58805334|FG000|Overall Study|Initiated Prohibited Medication|1|||
30792171|NCT05091307|58805335|FG001|Overall Study|Initiated Prohibited Medication|0|||
30745022|NCT00292188|58755762|FG002|Single-Blind|Did not receive treatment|0|||
30745023|NCT00292188|58755760|FG000|Double-Blind|Adverse Event|0|||
30792172|NCT05091307|58805336|FG002|Overall Study|Initiated Prohibited Medication|0|||
30745024|NCT00292188|58755761|FG001|Double-Blind|Adverse Event|25|||
30745025|NCT00292188|58755762|FG002|Double-Blind|Adverse Event|9|||
30745026|NCT00292188|58755760|FG000|Double-Blind|Lack of Efficacy|0|||
30745027|NCT00292188|58755761|FG001|Double-Blind|Lack of Efficacy|2|||
30745028|NCT00292188|58755762|FG002|Double-Blind|Lack of Efficacy|12|||
30745029|NCT00292188|58755760|FG000|Double-Blind|Lost to Follow-up|0|||
30745030|NCT00292188|58755761|FG001|Double-Blind|Lost to Follow-up|1|||
30745031|NCT00292188|58755762|FG002|Double-Blind|Lost to Follow-up|0|||
30745032|NCT00292188|58755760|FG000|Double-Blind|Other|0|||
30792173|NCT05091307|58805337|FG003|Overall Study|Initiated Prohibited Medication|0|||
30792174|NCT05091307|58805334|FG000|Overall Study|Other|4|||
30792175|NCT05091307|58805335|FG001|Overall Study|Other|4|||
30902998|NCT02016105|58936907|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
30902999|NCT02016105|58936908|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
30903000|NCT02016105|58936909|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
30903001|NCT02016105|58936910|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
30903002|NCT02016105|58936905|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
30903003|NCT02016105|58936906|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
30903004|NCT02016105|58936907|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
30903005|NCT02016105|58936908|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
30903006|NCT02016105|58936909|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
30903007|NCT02016105|58936910|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
30903008|NCT02016105|58936905|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
30903009|NCT02016105|58936906|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
30903010|NCT02016105|58936907|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
30903011|NCT02016105|58936908|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
30903012|NCT02016105|58936909|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
30903013|NCT02016105|58936910|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
30903014|NCT02400905|58936924|FG000|Overall Study|Death|24|||
30903015|NCT02400905|58936924|FG000|Overall Study|Lost to Follow-up|18|||
30903016|NCT02400905|58936924|FG000|Overall Study|Withdrawal by Subject|16|||
30903017|NCT02400905|58936924|FG000|Overall Study|Physician Decision|4|||
30903018|NCT02400905|58936924|FG000|Overall Study|Other|1|||
30903019|NCT02400749|58936931|FG000|Week 0 -16|Withdrawal by Subject|5|||
30745033|NCT00292188|58755761|FG001|Double-Blind|Other|3|||
30745034|NCT00292188|58755762|FG002|Double-Blind|Other|4|||
30745035|NCT00292188|58755760|FG000|Double-Blind|Withdrawal by Subject|0|||
30745036|NCT00292188|58755761|FG001|Double-Blind|Withdrawal by Subject|0|||
30745037|NCT00292188|58755762|FG002|Double-Blind|Withdrawal by Subject|3|||
30745038|NCT00292188|58755760|FG000|Double-Blind|Laboratory Abnormality|0|||
30745039|NCT00292188|58755761|FG001|Double-Blind|Laboratory Abnormality|0|||
30745040|NCT00292188|58755762|FG002|Double-Blind|Laboratory Abnormality|1|||
30745041|NCT00272844|58755769|FG000|Overall Study|Withdrawal by Subject|5|||
30745042|NCT00271596|58755775|FG000|Overall Study|Protocol Violation|1|||
30745043|NCT00271596|58755776|FG001|Overall Study|Protocol Violation|0|||
30745044|NCT00271596|58755775|FG000|Overall Study|Withdrawal by Subject|0|||
30745045|NCT00271596|58755776|FG001|Overall Study|Withdrawal by Subject|1|||
30745046|NCT00291642|58755787|FG000|Overall Study|Adverse Event|1|||
30745047|NCT00291642|58755788|FG001|Overall Study|Adverse Event|0|||
30745048|NCT00291642|58755789|FG002|Overall Study|Adverse Event|1|||
30745049|NCT00291642|58755790|FG003|Overall Study|Adverse Event|0|||
30745050|NCT00291642|58755791|FG004|Overall Study|Adverse Event|1|||
30745051|NCT00291642|58755787|FG000|Overall Study|Patient missed visit|0|||
30745052|NCT00291642|58755788|FG001|Overall Study|Patient missed visit|0|||
30745053|NCT00291642|58755789|FG002|Overall Study|Patient missed visit|1|||
30745054|NCT00291642|58755790|FG003|Overall Study|Patient missed visit|0|||
30792176|NCT05091307|58805336|FG002|Overall Study|Other|0|||
30792177|NCT05091307|58805337|FG003|Overall Study|Other|0|||
30792178|NCT05091307|58805334|FG000|Overall Study|Randomized but not vaccinated|0|||
30792179|NCT05091307|58805335|FG001|Overall Study|Randomized but not vaccinated|2|||
30792180|NCT05091307|58805336|FG002|Overall Study|Randomized but not vaccinated|0|||
30792181|NCT05091307|58805337|FG003|Overall Study|Randomized but not vaccinated|0|||
30792182|NCT04538950|58805349|FG000|Overall Study|Pulmonary Issues|2|||
30792183|NCT04538950|58805349|FG000|Overall Study|illness|2|||
30792184|NCT04446377|58805355|FG000|Overall Study|Withdrawal by Subject|6|||
30792185|NCT04446377|58805356|FG001|Overall Study|Withdrawal by Subject|1|||
30792186|NCT04446377|58805355|FG000|Overall Study|Physician Decision|1|||
30792187|NCT04446377|58805356|FG001|Overall Study|Physician Decision|1|||
30792188|NCT04446377|58805355|FG000|Overall Study|Lost to Follow-up|0|||
30792189|NCT04446377|58805356|FG001|Overall Study|Lost to Follow-up|2|||
30792190|NCT04446377|58805355|FG000|Overall Study|Not eligible|0|||
30792191|NCT04446377|58805356|FG001|Overall Study|Not eligible|1|||
30745055|NCT00291642|58755791|FG004|Overall Study|Patient missed visit|0|||
30745056|NCT00291642|58755787|FG000|Overall Study|Intake of prohibited medication|1|||
30745057|NCT00291642|58755788|FG001|Overall Study|Intake of prohibited medication|0|||
30745058|NCT00291642|58755789|FG002|Overall Study|Intake of prohibited medication|0|||
30903020|NCT02400749|58936932|FG001|Week 0 -16|Withdrawal by Subject|5|||
30745059|NCT00291642|58755790|FG003|Overall Study|Intake of prohibited medication|0|||
30792192|NCT04398368|58805366|FG000|Overall Study|Withdrawal by Subject|2|||
30792193|NCT04275297|58805372|FG000|Overall Study|Lost to Follow-up|1|||
30792194|NCT04275297|58805373|FG001|Overall Study|Lost to Follow-up|1|||
30792195|NCT04247282|58805383|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
30792196|NCT04247282|58805384|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
30792197|NCT04247282|58805385|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
30792198|NCT04247282|58805386|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
30792199|NCT04247282|58805383|FG000|Overall Study|Refused further treatment|0|||
30792200|NCT04247282|58805384|FG001|Overall Study|Refused further treatment|1|||
30792201|NCT04247282|58805385|FG002|Overall Study|Refused further treatment|0|||
30792202|NCT04247282|58805386|FG003|Overall Study|Refused further treatment|0|||
30792203|NCT04224688|58805397|FG000|Overall Study|Withdrawal by Subject|1|||
30792204|NCT04224688|58805398|FG001|Overall Study|Withdrawal by Subject|3|||
30792205|NCT04224688|58805397|FG000|Overall Study|Lack of Efficacy|1|||
30792206|NCT04224688|58805398|FG001|Overall Study|Lack of Efficacy|1|||
30792207|NCT04224688|58805397|FG000|Overall Study|Adverse event, not fatal|0|||
30792208|NCT04224688|58805398|FG001|Overall Study|Adverse event, not fatal|2|||
30792209|NCT04224688|58805397|FG000|Overall Study|COVID-19|0|||
30903021|NCT02400749|58936931|FG000|Week 0 -16|Adverse Event|3|||
30903022|NCT02400749|58936932|FG001|Week 0 -16|Adverse Event|1|||
30903023|NCT02400749|58936931|FG000|Week 0 -16|Lost to Follow-up|2|||
30903024|NCT02400749|58936932|FG001|Week 0 -16|Lost to Follow-up|0|||
30903025|NCT02400749|58936931|FG000|Week 0 -16|Protocol Violation|1|||
30903026|NCT02400749|58936932|FG001|Week 0 -16|Protocol Violation|0|||
30903027|NCT02400749|58936931|FG000|Week 17 - 32|Withdrawal by Subject|3|||
30903028|NCT02400749|58936932|FG001|Week 17 - 32|Withdrawal by Subject|2|||
30792210|NCT04224688|58805398|FG001|Overall Study|COVID-19|1|||
30792211|NCT04200456|58805406|FG000|Overall Study|Physician Decision|0|||
30792212|NCT04200456|58805407|FG001|Overall Study|Physician Decision|1|||
30792213|NCT04200456|58805406|FG000|Overall Study|Withdrawal by Subject|2|||
30792214|NCT04200456|58805407|FG001|Overall Study|Withdrawal by Subject|2|||
30792215|NCT04200456|58805406|FG000|Overall Study|Lack of Efficacy|1|||
30792216|NCT04200456|58805407|FG001|Overall Study|Lack of Efficacy|1|||
30792217|NCT04200456|58805406|FG000|Overall Study|Adverse event, non-fatal|0|||
30792218|NCT04200456|58805407|FG001|Overall Study|Adverse event, non-fatal|1|||
30792219|NCT04200456|58805406|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
30792220|NCT04200456|58805407|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
30792221|NCT03766685|58805417|FG000|Overall Study|Lost to Follow-up|1|||
30792222|NCT03766685|58805418|FG001|Overall Study|Lost to Follow-up|1|||
30792223|NCT03766685|58805419|FG002|Overall Study|Lost to Follow-up|0|||
30792224|NCT03766685|58805420|FG003|Overall Study|Lost to Follow-up|0|||
30792225|NCT03766685|58805417|FG000|Overall Study|Adverse Event, not fatal|0|||
30792226|NCT03766685|58805418|FG001|Overall Study|Adverse Event, not fatal|1|||
30792227|NCT03766685|58805419|FG002|Overall Study|Adverse Event, not fatal|0|||
30792228|NCT03766685|58805420|FG003|Overall Study|Adverse Event, not fatal|1|||
30792229|NCT03766685|58805417|FG000|Overall Study|Withdrawal by Subject|0|||
30792230|NCT03766685|58805418|FG001|Overall Study|Withdrawal by Subject|2|||
30792231|NCT03766685|58805419|FG002|Overall Study|Withdrawal by Subject|0|||
30792232|NCT03766685|58805420|FG003|Overall Study|Withdrawal by Subject|0|||
30792233|NCT03766685|58805417|FG000|Overall Study|Protocol Violation|0|||
30792234|NCT03766685|58805418|FG001|Overall Study|Protocol Violation|1|||
30792235|NCT03766685|58805419|FG002|Overall Study|Protocol Violation|0|||
30792236|NCT03766685|58805420|FG003|Overall Study|Protocol Violation|0|||
30792237|NCT03766685|58805417|FG000|Overall Study|Non-compliance|0|||
30792238|NCT03766685|58805418|FG001|Overall Study|Non-compliance|2|||
30792239|NCT03766685|58805419|FG002|Overall Study|Non-compliance|0|||
30792240|NCT03766685|58805420|FG003|Overall Study|Non-compliance|0|||
30792241|NCT03654274|58805434|FG000|Overall Study|Adverse Event|19|||
30792242|NCT03654274|58805435|FG001|Overall Study|Adverse Event|23|||
30792243|NCT03654274|58805436|FG002|Overall Study|Adverse Event|24|||
30792244|NCT03654274|58805434|FG000|Overall Study|Protocol Deviation|0|||
30792245|NCT03654274|58805435|FG001|Overall Study|Protocol Deviation|2|||
30792246|NCT03654274|58805436|FG002|Overall Study|Protocol Deviation|0|||
30903029|NCT02400749|58936931|FG000|Week 17 - 32|Adverse Event|2|||
30903030|NCT02400749|58936932|FG001|Week 17 - 32|Adverse Event|1|||
30792247|NCT03654274|58805434|FG000|Overall Study|Lost to Follow-up|8|||
30792248|NCT03654274|58805435|FG001|Overall Study|Lost to Follow-up|6|||
30792249|NCT03654274|58805436|FG002|Overall Study|Lost to Follow-up|5|||
30903031|NCT02420327|58936938|FG000|Overall Study|Adverse Event|7|||
30903032|NCT02420327|58936938|FG000|Overall Study|Pregnancy|1|||
30903033|NCT02420327|58936938|FG000|Overall Study|Withdrawal by Subject|6|||
30792250|NCT03654274|58805434|FG000|Overall Study|Withdrawal by Subject|46|||
30792251|NCT03654274|58805435|FG001|Overall Study|Withdrawal by Subject|25|||
30792252|NCT03654274|58805436|FG002|Overall Study|Withdrawal by Subject|33|||
30792253|NCT03654274|58805434|FG000|Overall Study|Lack of Efficacy|4|||
30903034|NCT02420327|58936938|FG000|Overall Study|Lost to Follow-up|1|||
30903035|NCT02420327|58936938|FG000|Overall Study|Protocol Violation|1|||
30792254|NCT03654274|58805435|FG001|Overall Study|Lack of Efficacy|5|||
30792255|NCT03654274|58805436|FG002|Overall Study|Lack of Efficacy|7|||
30792256|NCT03654274|58805434|FG000|Overall Study|Pregnancy|2|||
30792257|NCT03654274|58805435|FG001|Overall Study|Pregnancy|2|||
30792258|NCT03654274|58805436|FG002|Overall Study|Pregnancy|1|||
30792259|NCT03654274|58805434|FG000|Overall Study|Other|27|||
30792260|NCT03654274|58805435|FG001|Overall Study|Other|29|||
30792261|NCT03654274|58805436|FG002|Overall Study|Other|32|||
30792262|NCT03654274|58805434|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
30745060|NCT00291642|58755791|FG004|Overall Study|Intake of prohibited medication|0|||
30745061|NCT00280566|58755805|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
30745062|NCT00280566|58755806|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
30745063|NCT00280566|58755807|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
30745064|NCT00280566|58755805|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
30745065|NCT00280566|58755806|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
30745066|NCT00280566|58755807|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
30745067|NCT00280566|58755805|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
30745068|NCT00280566|58755806|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
30745069|NCT00280566|58755807|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
30745070|NCT00280566|58755805|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
30745071|NCT00280566|58755806|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
30792263|NCT03654274|58805435|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
30792264|NCT03654274|58805436|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
30792265|NCT03592641|58805448|FG000|Overall Study|Withdrawal by Subject|1|||
30792266|NCT03533686|58805458|FG000|Overall Study|Withdrawal by Subject|1|||
30745072|NCT00280566|58755807|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
30745073|NCT00280566|58755805|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
30745074|NCT00280566|58755806|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
30745075|NCT00280566|58755807|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
30745076|NCT00280566|58755805|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
30745077|NCT00280566|58755806|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
30745078|NCT00280566|58755807|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
30745079|NCT00280566|58755805|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
30745080|NCT00280566|58755806|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
30745081|NCT00280566|58755807|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
30745082|NCT00280566|58755805|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
30745083|NCT00280566|58755806|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
30745084|NCT00280566|58755807|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
30745085|NCT00280566|58755805|FG000|Period 2 Double Blind|Adverse Event|0|||
30745086|NCT00280566|58755806|FG001|Period 2 Double Blind|Adverse Event|11|||
30745087|NCT00280566|58755807|FG002|Period 2 Double Blind|Adverse Event|15|||
30745088|NCT00280566|58755805|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
30745089|NCT00280566|58755806|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
30745090|NCT00280566|58755807|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
30745091|NCT00280566|58755805|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
30745092|NCT00280566|58755806|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
30745093|NCT00280566|58755807|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
30745094|NCT00280566|58755805|FG000|Period 2 Double Blind|miscellaneous|0|||
30745095|NCT00280566|58755806|FG001|Period 2 Double Blind|miscellaneous|10|||
30745096|NCT00280566|58755807|FG002|Period 2 Double Blind|miscellaneous|5|||
30745097|NCT00270894|58755814|FG000|Overall Study|Adverse Event|1|||
30745098|NCT00270894|58755814|FG000|Overall Study|Withdrawal by Subject|1|||
30745099|NCT00317642|58755820|FG000|Overall Study|Not Received Either Study Drug|1|||
30745100|NCT00317642|58755821|FG001|Overall Study|Not Received Either Study Drug|3|||
30745101|NCT00317642|58755820|FG000|Overall Study|Physician Decision|15|||
30745102|NCT00317642|58755821|FG001|Overall Study|Physician Decision|7|||
30792267|NCT03533686|58805459|FG001|Overall Study|Withdrawal by Subject|0|||
30792268|NCT03533686|58805460|FG002|Overall Study|Withdrawal by Subject|0|||
30792269|NCT03533686|58805461|FG003|Overall Study|Withdrawal by Subject|3|||
30745103|NCT00317642|58755820|FG000|Overall Study|Participant declined treatment|14|||
30745104|NCT00317642|58755821|FG001|Overall Study|Participant declined treatment|3|||
30745105|NCT00317642|58755820|FG000|Overall Study|Adverse Event|17|||
30745106|NCT00317642|58755821|FG001|Overall Study|Adverse Event|5|||
30745107|NCT00317642|58755820|FG000|Overall Study|Treatment Failure|56|||
30745108|NCT00317642|58755821|FG001|Overall Study|Treatment Failure|102|||
30745109|NCT00317642|58755820|FG000|Overall Study|Disease Recurrence|1|||
30745110|NCT00317642|58755821|FG001|Overall Study|Disease Recurrence|2|||
30745111|NCT00317642|58755820|FG000|Overall Study|Death|14|||
30745112|NCT00317642|58755821|FG001|Overall Study|Death|7|||
30745113|NCT00317642|58755820|FG000|Overall Study|Not Continue to Consolidation|2|||
30745114|NCT00317642|58755821|FG001|Overall Study|Not Continue to Consolidation|0|||
30745115|NCT00317642|58755820|FG000|Overall Study|Withdrawal by Subject|0|||
30745116|NCT00317642|58755821|FG001|Overall Study|Withdrawal by Subject|1|||
30745117|NCT00317642|58755820|FG000|Overall Study|Referred For Transplantation|1|||
30745118|NCT00317642|58755821|FG001|Overall Study|Referred For Transplantation|0|||
30792270|NCT03533686|58805462|FG004|Overall Study|Withdrawal by Subject|5|||
30792271|NCT03533686|58805463|FG005|Overall Study|Withdrawal by Subject|1|||
30792272|NCT03533686|58805458|FG000|Overall Study|Lost to Follow-up|0|||
30792273|NCT03533686|58805459|FG001|Overall Study|Lost to Follow-up|1|||
30792274|NCT03533686|58805460|FG002|Overall Study|Lost to Follow-up|0|||
30792275|NCT03533686|58805461|FG003|Overall Study|Lost to Follow-up|0|||
30792276|NCT03533686|58805462|FG004|Overall Study|Lost to Follow-up|2|||
30792277|NCT03533686|58805463|FG005|Overall Study|Lost to Follow-up|0|||
30792278|NCT03533686|58805458|FG000|Overall Study|Screen Failure|0|||
30792279|NCT03533686|58805459|FG001|Overall Study|Screen Failure|0|||
30792280|NCT03533686|58805460|FG002|Overall Study|Screen Failure|0|||
30792281|NCT03533686|58805461|FG003|Overall Study|Screen Failure|2|||
30792282|NCT03533686|58805462|FG004|Overall Study|Screen Failure|0|||
30792283|NCT03533686|58805463|FG005|Overall Study|Screen Failure|0|||
30792284|NCT03154359|58805521|FG000|Overall Study|Adverse Event|1|||
30792285|NCT03154359|58805521|FG000|Overall Study|Lack of Efficacy|2|||
30792286|NCT03154359|58805521|FG000|Overall Study|Lost to Follow-up|3|||
30792287|NCT03154359|58805521|FG000|Overall Study|Physician Decision|3|||
30792288|NCT03154359|58805521|FG000|Overall Study|Protocol Violation|4|||
30792289|NCT03154359|58805521|FG000|Overall Study|Withdrawal by Subject|5|||
30903036|NCT02374853|58936950|FG000|Overall Study|Surgery Cancelled|5|||
30903037|NCT02374853|58936951|FG001|Overall Study|Surgery Cancelled|11|||
30903038|NCT02015793|58936959|FG000|Overall Study|Adverse Event|3|||
30745119|NCT00317642|58755820|FG000|Overall Study|AML Not Centrally Confirmed|1|||
30745120|NCT00317642|58755821|FG001|Overall Study|AML Not Centrally Confirmed|5|||
30903039|NCT02015793|58936960|FG001|Overall Study|Adverse Event|3|||
30903040|NCT02015793|58936959|FG000|Overall Study|Withdrawal by Subject|1|||
30903041|NCT02015793|58936960|FG001|Overall Study|Withdrawal by Subject|1|||
30745121|NCT00295022|58755837|FG000|Overall Study|Adverse Event|1|||
30745122|NCT00295022|58755838|FG001|Overall Study|Adverse Event|1|||
30792290|NCT03154359|58805521|FG000|Overall Study|Disruption of study due to COVID-19|4|||
30792291|NCT03135834|58805540|FG000|Stage 1|Adverse Event|1|||
30792292|NCT03135834|58805541|FG001|Stage 1|Adverse Event|2|||
30792293|NCT03135834|58805542|FG002|Stage 1|Adverse Event|2|||
30792294|NCT03135834|58805543|FG003|Stage 1|Adverse Event|1|||
30792295|NCT03135834|58805540|FG000|Stage 1|Death|1|||
30792296|NCT03135834|58805541|FG001|Stage 1|Death|0|||
30792297|NCT03135834|58805542|FG002|Stage 1|Death|0|||
30792298|NCT03135834|58805543|FG003|Stage 1|Death|0|||
30792299|NCT03135834|58805540|FG000|Stage 1|Lost to Follow-up|17|||
30792300|NCT03135834|58805541|FG001|Stage 1|Lost to Follow-up|24|||
30792301|NCT03135834|58805542|FG002|Stage 1|Lost to Follow-up|21|||
30792302|NCT03135834|58805543|FG003|Stage 1|Lost to Follow-up|38|||
30792303|NCT03135834|58805540|FG000|Stage 1|No longer met eligibility criteria|1|||
30792304|NCT03135834|58805541|FG001|Stage 1|No longer met eligibility criteria|6|||
30792305|NCT03135834|58805542|FG002|Stage 1|No longer met eligibility criteria|2|||
30792306|NCT03135834|58805543|FG003|Stage 1|No longer met eligibility criteria|5|||
30792307|NCT03135834|58805540|FG000|Stage 1|Other|0|||
30792308|NCT03135834|58805541|FG001|Stage 1|Other|2|||
30792309|NCT03135834|58805542|FG002|Stage 1|Other|1|||
30792310|NCT03135834|58805543|FG003|Stage 1|Other|0|||
30792311|NCT03135834|58805540|FG000|Stage 1|Physician Decision|0|||
30792312|NCT03135834|58805541|FG001|Stage 1|Physician Decision|1|||
30903042|NCT02347631|58936974|FG000|First Intervention (2 Months)|Adverse Event|1|||
30903043|NCT02347631|58936975|FG001|First Intervention (2 Months)|Adverse Event|1|||
30903044|NCT02347631|58936974|FG000|First Intervention (2 Months)|Pregnancy|1|||
30745123|NCT00295022|58755839|FG002|Overall Study|Adverse Event|2|||
30745124|NCT00295022|58755837|FG000|Overall Study|Lost to Follow-up|0|||
30745125|NCT00295022|58755838|FG001|Overall Study|Lost to Follow-up|0|||
30745126|NCT00295022|58755839|FG002|Overall Study|Lost to Follow-up|1|||
30792313|NCT03135834|58805542|FG002|Stage 1|Physician Decision|0|||
30792314|NCT03135834|58805543|FG003|Stage 1|Physician Decision|0|||
30792315|NCT03135834|58805540|FG000|Stage 1|Pregnancy|0|||
30792316|NCT03135834|58805541|FG001|Stage 1|Pregnancy|4|||
30792317|NCT03135834|58805542|FG002|Stage 1|Pregnancy|2|||
30792318|NCT03135834|58805543|FG003|Stage 1|Pregnancy|4|||
30792319|NCT03135834|58805540|FG000|Stage 1|Protocol Violation|1|||
30792320|NCT03135834|58805541|FG001|Stage 1|Protocol Violation|1|||
30792321|NCT03135834|58805542|FG002|Stage 1|Protocol Violation|2|||
30792322|NCT03135834|58805543|FG003|Stage 1|Protocol Violation|1|||
30903045|NCT02347631|58936975|FG001|First Intervention (2 Months)|Pregnancy|0|||
30903046|NCT02347631|58936974|FG000|First Intervention (2 Months)|Moved out of area|0|||
30903047|NCT02347631|58936975|FG001|First Intervention (2 Months)|Moved out of area|2|||
30903048|NCT02347631|58936974|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
30903049|NCT02347631|58936975|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
30903050|NCT02347631|58936974|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
30903051|NCT02347631|58936975|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
30903052|NCT02347631|58936974|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
30903053|NCT02347631|58936975|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
30903054|NCT02347631|58936974|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
30903055|NCT02347631|58936975|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
30903056|NCT02347631|58936974|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
30903057|NCT02347631|58936975|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
30903058|NCT02015637|58936985|FG000|Overall Study|Lost to Follow-up|3|||
30903059|NCT02015637|58936986|FG001|Overall Study|Lost to Follow-up|5|||
30903060|NCT02015637|58936985|FG000|Overall Study|Adverse Event|3|||
30903061|NCT02015637|58936986|FG001|Overall Study|Adverse Event|0|||
30903062|NCT02015637|58936985|FG000|Overall Study|Did not take study drug|2|||
30903063|NCT02015637|58936986|FG001|Overall Study|Did not take study drug|0|||
30903064|NCT02347085|58936992|FG000|Overall Study|Adverse Event|2|||
30903065|NCT02347085|58936992|FG000|Overall Study|Lack of Efficacy|1|||
30903066|NCT02347085|58936992|FG000|Overall Study|Withdrawal by Subject|4|||
30903067|NCT02347085|58936992|FG000|Overall Study|Lost to Follow-up|1|||
30903068|NCT02347085|58936992|FG000|Overall Study|Protocol Criteria|2|||
30903069|NCT02374463|58937000|FG000|Overall Study|Withdrawal by Subject|3|||
30903070|NCT02374463|58937001|FG001|Overall Study|Withdrawal by Subject|3|||
30622030|NCT01147068|58633527|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
30622031|NCT01147068|58633528|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
30622032|NCT01147068|58633522|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
30622033|NCT01147068|58633523|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
30622034|NCT01147068|58633524|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
30622035|NCT01147068|58633525|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
30622036|NCT01147068|58633526|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
30622037|NCT01147068|58633527|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
30622038|NCT01147068|58633528|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
30622039|NCT01147068|58633522|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
30622040|NCT01147068|58633523|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
30745127|NCT00295022|58755837|FG000|Overall Study|Withdrawal by Subject|0|||
30745128|NCT00295022|58755838|FG001|Overall Study|Withdrawal by Subject|0|||
30745129|NCT00295022|58755839|FG002|Overall Study|Withdrawal by Subject|2|||
30745130|NCT00303446|58755851|FG000|Overall Study|Withdrawal by Subject|2|||
30745131|NCT00303446|58755852|FG001|Overall Study|Withdrawal by Subject|2|||
30745132|NCT00303446|58755851|FG000|Overall Study|Death|0|||
30792323|NCT03135834|58805540|FG000|Stage 1|Withdrawal by parent/guardian|2|||
30792324|NCT03135834|58805541|FG001|Stage 1|Withdrawal by parent/guardian|10|||
30792325|NCT03135834|58805542|FG002|Stage 1|Withdrawal by parent/guardian|2|||
30792326|NCT03135834|58805543|FG003|Stage 1|Withdrawal by parent/guardian|1|||
30792327|NCT03135834|58805540|FG000|Stage 1|Withdrawal by Subject|16|||
30792328|NCT03135834|58805541|FG001|Stage 1|Withdrawal by Subject|22|||
30792329|NCT03135834|58805542|FG002|Stage 1|Withdrawal by Subject|7|||
30792330|NCT03135834|58805543|FG003|Stage 1|Withdrawal by Subject|10|||
30745133|NCT00303446|58755852|FG001|Overall Study|Death|1|||
30745134|NCT00303446|58755851|FG000|Overall Study|Physician Decision|0|||
30745135|NCT00303446|58755852|FG001|Overall Study|Physician Decision|1|||
30792331|NCT03135834|58805540|FG000|Stage 1|Randomized but not Vaccinated|0|||
30792332|NCT03135834|58805541|FG001|Stage 1|Randomized but not Vaccinated|3|||
30792333|NCT03135834|58805542|FG002|Stage 1|Randomized but not Vaccinated|1|||
30792334|NCT03135834|58805543|FG003|Stage 1|Randomized but not Vaccinated|6|||
30792335|NCT03135834|58805540|FG000|Stage 2|Lost to Follow-up|0|||
30792336|NCT03135834|58805541|FG001|Stage 2|Lost to Follow-up|1|||
30792337|NCT03135834|58805542|FG002|Stage 2|Lost to Follow-up|0|||
30903071|NCT02015481|58937008|FG000|Overall Study|Death|1|||
30903072|NCT02374307|58937015|FG000|3-months Follow-up|Lost to Follow-up|1|||
30622041|NCT01147068|58633524|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
30622042|NCT01147068|58633525|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
30622043|NCT01147068|58633526|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
30622044|NCT01147068|58633527|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
30622045|NCT01147068|58633528|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
30745136|NCT00316706|58755860|FG000|Overall Study|Lost to Follow-up|38|||
30745137|NCT00316706|58755861|FG001|Overall Study|Lost to Follow-up|48|||
30745138|NCT00291486|58755872|FG000|Overall Study|Adverse Event|0|||
30792338|NCT03135834|58805543|FG003|Stage 2|Lost to Follow-up|0|||
30792339|NCT03135834|58805540|FG000|Stage 2|Withdrawal by Subject|0|||
30792340|NCT03135834|58805541|FG001|Stage 2|Withdrawal by Subject|1|||
30745139|NCT00291486|58755873|FG001|Overall Study|Adverse Event|3|||
30745140|NCT00291486|58755874|FG002|Overall Study|Adverse Event|0|||
30792341|NCT03135834|58805542|FG002|Stage 2|Withdrawal by Subject|0|||
30792342|NCT03135834|58805543|FG003|Stage 2|Withdrawal by Subject|0|||
30792343|NCT03135834|58805540|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
30903073|NCT02374307|58937016|FG001|3-months Follow-up|Lost to Follow-up|2|||
30903074|NCT02374307|58937015|FG000|3-months Follow-up|Withdrawal by Subject|1|||
30903075|NCT02374307|58937016|FG001|3-months Follow-up|Withdrawal by Subject|4|||
30903076|NCT02374307|58937015|FG000|3-months Follow-up|Death|1|||
30903077|NCT02374307|58937016|FG001|3-months Follow-up|Death|2|||
30903078|NCT02374307|58937015|FG000|3-months Follow-up|Missed first follow-up|5|||
30903079|NCT02374307|58937016|FG001|3-months Follow-up|Missed first follow-up|1|||
30903080|NCT02374307|58937015|FG000|6-months Follow-up|Lost to Follow-up|1|||
30903081|NCT02374307|58937016|FG001|6-months Follow-up|Lost to Follow-up|2|||
30903082|NCT02374307|58937015|FG000|6-months Follow-up|Death|2|||
30792344|NCT03135834|58805541|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
30792345|NCT03135834|58805542|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
30792346|NCT03135834|58805543|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
30792347|NCT03135834|58805540|FG000|Stage 2|Did not receive Booster Vaccination|1|||
30792348|NCT03135834|58805541|FG001|Stage 2|Did not receive Booster Vaccination|1|||
30792349|NCT03135834|58805542|FG002|Stage 2|Did not receive Booster Vaccination|0|||
30792350|NCT03135834|58805543|FG003|Stage 2|Did not receive Booster Vaccination|0|||
30792351|NCT03130777|58805576|FG000|Overall Study|Death|0|||
30792352|NCT03130777|58805577|FG001|Overall Study|Death|1|||
30792353|NCT03130777|58805576|FG000|Overall Study|Did not meet eligibility criteria|1|||
30792354|NCT03130777|58805577|FG001|Overall Study|Did not meet eligibility criteria|0|||
30903083|NCT02374307|58937016|FG001|6-months Follow-up|Death|1|||
30903084|NCT02374307|58937015|FG000|6-months Follow-up|Withdrawal by Subject|0|||
30903085|NCT02374307|58937016|FG001|6-months Follow-up|Withdrawal by Subject|3|||
30903086|NCT02397473|58937024|FG000|Treatment Phase|Adverse Event|1|||
30903087|NCT02397473|58937025|FG001|Treatment Phase|Adverse Event|2|||
30903088|NCT02397473|58937024|FG000|Treatment Phase|Lack of Efficacy|8|||
30903089|NCT02397473|58937025|FG001|Treatment Phase|Lack of Efficacy|1|||
30903090|NCT02397473|58937024|FG000|Treatment Phase|Lost to Follow-up|1|||
30903091|NCT02397473|58937025|FG001|Treatment Phase|Lost to Follow-up|0|||
30903092|NCT02397473|58937024|FG000|Treatment Phase|Withdrawal by Subject|2|||
30903093|NCT02397473|58937025|FG001|Treatment Phase|Withdrawal by Subject|1|||
30903094|NCT02397473|58937024|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
30903095|NCT02397473|58937025|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
30903096|NCT02397473|58937024|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
30903097|NCT02397473|58937025|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
30903098|NCT02397473|58937024|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
30903099|NCT02397473|58937025|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
30903100|NCT02397473|58937024|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
30903101|NCT02397473|58937025|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
30903102|NCT02397473|58937024|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
30903103|NCT02397473|58937025|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
30903104|NCT02344745|58937036|FG000|Overall Study|Data collection sheets were lost|2|||
30903105|NCT02344745|58937037|FG001|Overall Study|Data collection sheets were lost|0|||
30903106|NCT02370641|58937045|FG000|Overall Study|dropped study|4|||
30903107|NCT02370641|58937046|FG001|Overall Study|dropped study|2|||
30903108|NCT01621191|58937052|FG000|Overall Study|Adverse Event|9|||
30903109|NCT01621191|58937052|FG000|Overall Study|Withdrawal by Subject|8|||
30745141|NCT00291486|58755875|FG003|Overall Study|Adverse Event|1|||
30745142|NCT00291486|58755876|FG004|Overall Study|Adverse Event|0|||
30745143|NCT00291486|58755872|FG000|Overall Study|Withdrawal by Subject|0|||
30745144|NCT00291486|58755873|FG001|Overall Study|Withdrawal by Subject|0|||
30745145|NCT00291486|58755874|FG002|Overall Study|Withdrawal by Subject|0|||
30745146|NCT00291486|58755875|FG003|Overall Study|Withdrawal by Subject|0|||
30745147|NCT00291486|58755876|FG004|Overall Study|Withdrawal by Subject|1|||
30745148|NCT00291486|58755872|FG000|Overall Study|Disease progression|1|||
30745149|NCT00291486|58755873|FG001|Overall Study|Disease progression|0|||
30745150|NCT00291486|58755874|FG002|Overall Study|Disease progression|1|||
30745151|NCT00291486|58755875|FG003|Overall Study|Disease progression|0|||
30745152|NCT00291486|58755876|FG004|Overall Study|Disease progression|0|||
30745153|NCT00301964|58755897|FG000|Overall Study|Second primary|2|||
30745154|NCT00301964|58755897|FG000|Overall Study|Wrong primary|1|||
30903110|NCT01621191|58937052|FG000|Overall Study|Lack of Efficacy|6|||
30745155|NCT00301964|58755897|FG000|Overall Study|Inadequate pathology|1|||
30745156|NCT00268242|58755907|FG000|Overall Study|Death|1|||
30903111|NCT01621191|58937052|FG000|Overall Study|Lost to Follow-up|1|||
30903112|NCT01621191|58937052|FG000|Overall Study|Site Removed From Study|1|||
30903113|NCT02343263|58937060|FG000|Overall Study|Physician Decision|5|||
30745157|NCT00294554|58755913|FG000|Overall Study|Lack of Efficacy|0|||
30903114|NCT02343263|58937061|FG001|Overall Study|Physician Decision|3|||
30903115|NCT02343263|58937062|FG002|Overall Study|Physician Decision|1|||
30903116|NCT02081859|58937076|FG000|Overall Study|No fertilization|2|||
30903117|NCT02081859|58937077|FG001|Overall Study|No fertilization|2|||
30903118|NCT02081859|58937076|FG000|Overall Study|No sperm|1|||
30903119|NCT02081859|58937077|FG001|Overall Study|No sperm|0|||
30903120|NCT02081859|58937076|FG000|Overall Study|Unanticipated freeze all cycle|2|||
30903121|NCT02081859|58937077|FG001|Overall Study|Unanticipated freeze all cycle|6|||
30903122|NCT02081859|58937076|FG000|Overall Study|< 4 embryos|27|||
30903123|NCT02081859|58937077|FG001|Overall Study|< 4 embryos|23|||
30903124|NCT02081859|58937076|FG000|Overall Study|Other reasons|2|||
30903125|NCT02081859|58937077|FG001|Overall Study|Other reasons|0|||
30903126|NCT02342639|58937085|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
30903127|NCT02342639|58937086|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
30903128|NCT02342639|58937085|FG000|Overall Study|Protocol Violation|0|||
30903129|NCT02342639|58937086|FG001|Overall Study|Protocol Violation|2|||
30903130|NCT01625091|58937096|FG000|Intervention|Death|1|||
30903131|NCT01625091|58937097|FG001|Intervention|Death|1|||
30903132|NCT01625091|58937096|FG000|Intervention|Withdrawal by Subject|4|||
30903133|NCT01625091|58937097|FG001|Intervention|Withdrawal by Subject|1|||
30903134|NCT01625091|58937096|FG000|Intervention|Adverse Event|0|||
30903135|NCT01625091|58937097|FG001|Intervention|Adverse Event|2|||
30903136|NCT01625091|58937096|FG000|Intervention|Lost to Follow-up|4|||
30903137|NCT01625091|58937097|FG001|Intervention|Lost to Follow-up|4|||
30903138|NCT01625091|58937096|FG000|Intervention|Study termination|2|||
30903139|NCT01625091|58937097|FG001|Intervention|Study termination|3|||
30903140|NCT01625091|58937096|FG000|Post-intervention|Death|0|||
30903141|NCT01625091|58937097|FG001|Post-intervention|Death|1|||
30903142|NCT01625091|58937096|FG000|Post-intervention|Lost to Follow-up|2|||
30903143|NCT01625091|58937097|FG001|Post-intervention|Lost to Follow-up|0|||
30903144|NCT01625091|58937096|FG000|Post-intervention|Study termination|2|||
30903145|NCT01625091|58937097|FG001|Post-intervention|Study termination|1|||
30903146|NCT02396849|58937105|FG000|Overall Study|Lost to Follow-up|1|||
30792385|NCT02207725|58805627|FG000|Overall Study|Did Not Receive Treatment|0|||
30792386|NCT02207725|58805628|FG001|Overall Study|Did Not Receive Treatment|1|||
30903147|NCT02396849|58937106|FG001|Overall Study|Lost to Follow-up|1|||
30903148|NCT02396849|58937105|FG000|Overall Study|Did not tolerate intervention|1|||
30903149|NCT02396849|58937106|FG001|Overall Study|Did not tolerate intervention|1|||
30903150|NCT02370251|58937114|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
30903151|NCT02370251|58937114|FG000|Overall Study|Death|4|||
30903152|NCT02396537|58937120|FG000|Overall Study|Protocol Violation|0|||
30903153|NCT02396537|58937121|FG001|Overall Study|Protocol Violation|1|||
30903154|NCT02342171|58937129|FG000|Overall Study|Death|4|||
30792387|NCT02207725|58805629|FG002|Overall Study|Did Not Receive Treatment|1|||
30792388|NCT02207725|58805630|FG003|Overall Study|Did Not Receive Treatment|1|||
30792389|NCT01802632|58805653|FG000|Overall Study|Death|28|||
30792390|NCT01802632|58805654|FG001|Overall Study|Death|1|||
30792391|NCT01802632|58805655|FG002|Overall Study|Death|38|||
30792392|NCT01802632|58805656|FG003|Overall Study|Death|0|||
30792393|NCT01802632|58805657|FG004|Overall Study|Death|2|||
30792394|NCT01802632|58805658|FG005|Overall Study|Death|0|||
30792395|NCT01802632|58805653|FG000|Overall Study|Withdrawal by Subject|4|||
30792396|NCT01802632|58805654|FG001|Overall Study|Withdrawal by Subject|2|||
30792397|NCT01802632|58805655|FG002|Overall Study|Withdrawal by Subject|7|||
30792398|NCT01802632|58805656|FG003|Overall Study|Withdrawal by Subject|3|||
30792399|NCT01802632|58805657|FG004|Overall Study|Withdrawal by Subject|0|||
30792400|NCT01802632|58805658|FG005|Overall Study|Withdrawal by Subject|1|||
30792401|NCT01802632|58805653|FG000|Overall Study|Objective Disease Progression|1|||
30792402|NCT01802632|58805654|FG001|Overall Study|Objective Disease Progression|12|||
30792403|NCT01802632|58805655|FG002|Overall Study|Objective Disease Progression|104|||
30792404|NCT01802632|58805656|FG003|Overall Study|Objective Disease Progression|6|||
30792405|NCT01802632|58805657|FG004|Overall Study|Objective Disease Progression|4|||
30792406|NCT01802632|58805658|FG005|Overall Study|Objective Disease Progression|4|||
30792407|NCT01802632|58805653|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
30792408|NCT01802632|58805654|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
30792409|NCT01802632|58805655|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
30792410|NCT01802632|58805656|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
30792411|NCT01802632|58805657|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
30792412|NCT01802632|58805658|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
30792413|NCT01802632|58805653|FG000|Overall Study|Other (not specified)|0|||
30792414|NCT01802632|58805654|FG001|Overall Study|Other (not specified)|0|||
30792415|NCT01802632|58805655|FG002|Overall Study|Other (not specified)|7|||
30792416|NCT01802632|58805656|FG003|Overall Study|Other (not specified)|1|||
30792417|NCT01802632|58805657|FG004|Overall Study|Other (not specified)|0|||
30792418|NCT01802632|58805658|FG005|Overall Study|Other (not specified)|1|||
30792419|NCT00968799|58805687|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
30792420|NCT02883452|58805697|FG000|Overall Study|Withdrawal by Subject|1|||
30792421|NCT02883452|58805698|FG001|Overall Study|Withdrawal by Subject|1|||
30792422|NCT02883452|58805699|FG002|Overall Study|Withdrawal by Subject|3|||
30792423|NCT02883452|58805700|FG003|Overall Study|Withdrawal by Subject|0|||
30792424|NCT02883452|58805701|FG004|Overall Study|Withdrawal by Subject|2|||
30792425|NCT02883452|58805702|FG005|Overall Study|Withdrawal by Subject|5|||
30745158|NCT00294554|58755914|FG001|Overall Study|Lack of Efficacy|1|||
30745159|NCT00294554|58755913|FG000|Overall Study|Physician Decision|0|||
30745160|NCT00294554|58755914|FG001|Overall Study|Physician Decision|1|||
30745161|NCT00294398|58755922|FG000|Overall Study|Lost to Follow-up|21|||
30745162|NCT00294398|58755923|FG001|Overall Study|Lost to Follow-up|26|||
30745163|NCT00279708|58755931|FG000|Overall Study|Withdrawal by Subject|2|||
30745164|NCT00279708|58755932|FG001|Overall Study|Withdrawal by Subject|3|||
30745165|NCT00279708|58755931|FG000|Overall Study|Adverse Event|1|||
30745166|NCT00279708|58755932|FG001|Overall Study|Adverse Event|1|||
30745167|NCT00299702|58755940|FG000|Overall Study|Death|1|||
30745168|NCT00299702|58755941|FG001|Overall Study|Death|0|||
30745169|NCT00299702|58755940|FG000|Overall Study|Adverse Event|0|||
30745170|NCT00299702|58755941|FG001|Overall Study|Adverse Event|4|||
30745171|NCT00299702|58755940|FG000|Overall Study|Lost to Follow-up|18|||
30745172|NCT00299702|58755941|FG001|Overall Study|Lost to Follow-up|10|||
30745173|NCT00299702|58755940|FG000|Overall Study|Withdrawal by Subject|25|||
30745174|NCT00299702|58755941|FG001|Overall Study|Withdrawal by Subject|23|||
30745175|NCT00299702|58755940|FG000|Overall Study|Pregnancy|0|||
30745176|NCT00299702|58755941|FG001|Overall Study|Pregnancy|1|||
30745177|NCT00299702|58755940|FG000|Overall Study|Insufficient Response|4|||
30745178|NCT00299702|58755941|FG001|Overall Study|Insufficient Response|3|||
30745179|NCT00299702|58755940|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
30745180|NCT00299702|58755941|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
30745181|NCT00291330|58755949|FG000|Overall Study|Adverse Event|47|||
30745182|NCT00291330|58755950|FG001|Overall Study|Adverse Event|40|||
30745183|NCT00291330|58755949|FG000|Overall Study|Protocol Violation|13|||
30745184|NCT00291330|58755950|FG001|Overall Study|Protocol Violation|20|||
30745185|NCT00291330|58755949|FG000|Overall Study|Lost to Follow-up|16|||
30745186|NCT00291330|58755950|FG001|Overall Study|Lost to Follow-up|11|||
30792426|NCT02883452|58805697|FG000|Overall Study|Disease progression|1|||
30792427|NCT02883452|58805698|FG001|Overall Study|Disease progression|0|||
30792428|NCT02883452|58805699|FG002|Overall Study|Disease progression|0|||
30792429|NCT02883452|58805700|FG003|Overall Study|Disease progression|1|||
30792430|NCT02883452|58805701|FG004|Overall Study|Disease progression|4|||
30792431|NCT02883452|58805702|FG005|Overall Study|Disease progression|5|||
30792432|NCT02883452|58805697|FG000|Overall Study|Adverse Event|2|||
30792433|NCT02883452|58805698|FG001|Overall Study|Adverse Event|1|||
30792434|NCT02883452|58805699|FG002|Overall Study|Adverse Event|1|||
30792435|NCT02883452|58805700|FG003|Overall Study|Adverse Event|1|||
30792436|NCT02883452|58805701|FG004|Overall Study|Adverse Event|1|||
30792437|NCT02883452|58805702|FG005|Overall Study|Adverse Event|3|||
30792438|NCT02883452|58805697|FG000|Overall Study|Physician Decision|0|||
30792439|NCT02883452|58805698|FG001|Overall Study|Physician Decision|0|||
30792440|NCT02883452|58805699|FG002|Overall Study|Physician Decision|0|||
30792441|NCT02883452|58805700|FG003|Overall Study|Physician Decision|0|||
30745187|NCT00291330|58755949|FG000|Overall Study|Withdrawal by Subject|22|||
30745188|NCT00291330|58755950|FG001|Overall Study|Withdrawal by Subject|25|||
30745189|NCT00291330|58755949|FG000|Overall Study|Other|3|||
30745190|NCT00291330|58755950|FG001|Overall Study|Other|1|||
30745191|NCT00267150|58755956|FG000|Overall Study|Adverse Event|1|||
30745192|NCT00278148|58755960|FG000|Phase II - Expansion Phase|Disease progression|0|||
30745193|NCT00278148|58755961|FG001|Phase II - Expansion Phase|Disease progression|0|||
30745194|NCT00278148|58755962|FG002|Phase II - Expansion Phase|Disease progression|4|||
30745195|NCT00278148|58755960|FG000|Phase II - Expansion Phase|Adverse Event|0|||
30745196|NCT00278148|58755961|FG001|Phase II - Expansion Phase|Adverse Event|0|||
30745197|NCT00278148|58755962|FG002|Phase II - Expansion Phase|Adverse Event|2|||
30745198|NCT00299546|58755972|FG000|Overall Study|Death|3|||
30745199|NCT00299546|58755973|FG001|Overall Study|Death|2|||
30745200|NCT00299546|58755974|FG002|Overall Study|Death|0|||
30745201|NCT00299546|58755972|FG000|Overall Study|Lost to Follow-up|2|||
30745202|NCT00299546|58755973|FG001|Overall Study|Lost to Follow-up|2|||
30792442|NCT02883452|58805701|FG004|Overall Study|Physician Decision|4|||
30792443|NCT02883452|58805702|FG005|Overall Study|Physician Decision|1|||
30792444|NCT02883452|58805697|FG000|Overall Study|Death|1|||
30792445|NCT02883452|58805698|FG001|Overall Study|Death|0|||
30792446|NCT02883452|58805699|FG002|Overall Study|Death|1|||
30792447|NCT02883452|58805700|FG003|Overall Study|Death|0|||
30792448|NCT02883452|58805701|FG004|Overall Study|Death|0|||
30792449|NCT02883452|58805702|FG005|Overall Study|Death|0|||
30792450|NCT02883452|58805697|FG000|Overall Study|Other|0|||
30792451|NCT02883452|58805698|FG001|Overall Study|Other|0|||
30792452|NCT02883452|58805699|FG002|Overall Study|Other|0|||
30792453|NCT02883452|58805700|FG003|Overall Study|Other|0|||
30792454|NCT02883452|58805701|FG004|Overall Study|Other|0|||
30792455|NCT02883452|58805702|FG005|Overall Study|Other|1|||
30792456|NCT00151372|58805719|FG000|Overall Study|Death|12|||
30792457|NCT00151372|58805720|FG001|Overall Study|Death|11|||
30792458|NCT00151372|58805719|FG000|Overall Study|Lost to Follow-up|5|||
30792459|NCT00151372|58805720|FG001|Overall Study|Lost to Follow-up|5|||
30792460|NCT00151372|58805719|FG000|Overall Study|Too sick medically to continue|5|||
30745203|NCT00299546|58755974|FG002|Overall Study|Lost to Follow-up|5|||
30745204|NCT00299546|58755972|FG000|Overall Study|Adverse Event|37|||
30745205|NCT00299546|58755973|FG001|Overall Study|Adverse Event|22|||
30745206|NCT00299546|58755974|FG002|Overall Study|Adverse Event|27|||
30745207|NCT00299546|58755972|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
30745208|NCT00299546|58755973|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
30745209|NCT00299546|58755974|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
30745210|NCT00299546|58755972|FG000|Overall Study|Other|24|||
30792461|NCT00151372|58805720|FG001|Overall Study|Too sick medically to continue|6|||
30792462|NCT00151372|58805719|FG000|Overall Study|Withdrawal by Subject|7|||
30792463|NCT00151372|58805720|FG001|Overall Study|Withdrawal by Subject|7|||
30792464|NCT02603809|58805732|FG000|Overall Study|Withdrawal by Subject|4|||
30792465|NCT02603809|58805733|FG001|Overall Study|Withdrawal by Subject|1|||
30792466|NCT02603809|58805734|FG002|Overall Study|Withdrawal by Subject|2|||
30792467|NCT02603809|58805735|FG003|Overall Study|Withdrawal by Subject|3|||
30792468|NCT02603809|58805736|FG004|Overall Study|Withdrawal by Subject|3|||
30792469|NCT02603809|58805737|FG005|Overall Study|Withdrawal by Subject|4|||
30792470|NCT02603809|58805732|FG000|Overall Study|Lost to Follow-up|2|||
30792471|NCT02603809|58805733|FG001|Overall Study|Lost to Follow-up|3|||
30792472|NCT02603809|58805734|FG002|Overall Study|Lost to Follow-up|1|||
30792473|NCT02603809|58805735|FG003|Overall Study|Lost to Follow-up|4|||
30792474|NCT02603809|58805736|FG004|Overall Study|Lost to Follow-up|2|||
30792475|NCT02603809|58805737|FG005|Overall Study|Lost to Follow-up|2|||
30792476|NCT02603809|58805732|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
30792477|NCT02603809|58805733|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
30792478|NCT02603809|58805734|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
30745211|NCT00299546|58755973|FG001|Overall Study|Other|26|||
30745212|NCT00299546|58755974|FG002|Overall Study|Other|19|||
30745213|NCT00299546|58755972|FG000|Overall Study|Not treated|0|||
30745214|NCT00299546|58755973|FG001|Overall Study|Not treated|1|||
30792479|NCT02603809|58805735|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
30792480|NCT02603809|58805736|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
30792481|NCT02603809|58805737|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
30792482|NCT02603809|58805732|FG000|Overall Study|Physician Decision|0|||
30792483|NCT02603809|58805733|FG001|Overall Study|Physician Decision|0|||
30792484|NCT02603809|58805734|FG002|Overall Study|Physician Decision|0|||
30792485|NCT02603809|58805735|FG003|Overall Study|Physician Decision|1|||
30792486|NCT02603809|58805736|FG004|Overall Study|Physician Decision|2|||
30792487|NCT02603809|58805737|FG005|Overall Study|Physician Decision|1|||
30792488|NCT02603809|58805732|FG000|Overall Study|Adverse Event|3|||
30792489|NCT02603809|58805733|FG001|Overall Study|Adverse Event|0|||
30792490|NCT02603809|58805734|FG002|Overall Study|Adverse Event|2|||
30792491|NCT02603809|58805735|FG003|Overall Study|Adverse Event|2|||
30792492|NCT02603809|58805736|FG004|Overall Study|Adverse Event|1|||
30792493|NCT02603809|58805737|FG005|Overall Study|Adverse Event|1|||
30792494|NCT02603809|58805732|FG000|Overall Study|Lack of Efficacy|0|||
30792495|NCT02603809|58805733|FG001|Overall Study|Lack of Efficacy|1|||
30792496|NCT02603809|58805734|FG002|Overall Study|Lack of Efficacy|0|||
30745215|NCT00299546|58755974|FG002|Overall Study|Not treated|1|||
30745216|NCT00299156|58755986|FG000|Period 2 (Randomized)|Screen Failure|0|||
30745217|NCT00299156|58755987|FG001|Period 2 (Randomized)|Screen Failure|1|||
30745218|NCT00299156|58755988|FG002|Period 2 (Randomized)|Screen Failure|0|||
30745219|NCT00277212|58755996|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
30745220|NCT00277212|58755997|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
30792497|NCT02603809|58805735|FG003|Overall Study|Lack of Efficacy|0|||
30792498|NCT02603809|58805736|FG004|Overall Study|Lack of Efficacy|0|||
30792499|NCT02603809|58805737|FG005|Overall Study|Lack of Efficacy|1|||
30792500|NCT02741596|58805768|FG000|Overall Study|Adverse Event|1|||
30745221|NCT00277212|58755998|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
30745222|NCT00277212|58755996|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
30745223|NCT00277212|58755997|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
30745224|NCT00277212|58755998|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
30792501|NCT02741596|58805769|FG001|Overall Study|Adverse Event|5|||
30792502|NCT02741596|58805768|FG000|Overall Study|Lost to Follow-up|1|||
30792503|NCT02741596|58805769|FG001|Overall Study|Lost to Follow-up|1|||
30792504|NCT02741596|58805768|FG000|Overall Study|Physician Decision|2|||
30792505|NCT02741596|58805769|FG001|Overall Study|Physician Decision|1|||
30792506|NCT02741596|58805768|FG000|Overall Study|Pregnancy|3|||
30792507|NCT02741596|58805769|FG001|Overall Study|Pregnancy|1|||
30903155|NCT02342171|58937130|FG001|Overall Study|Death|87|||
30903156|NCT02342171|58937129|FG000|Overall Study|Received favipiravir|10|||
30903157|NCT02342171|58937130|FG001|Overall Study|Received favipiravir|0|||
30903158|NCT02342171|58937129|FG000|Overall Study|Missing cycle treshold value|1|||
30903159|NCT02342171|58937130|FG001|Overall Study|Missing cycle treshold value|0|||
30903160|NCT02342171|58937129|FG000|Overall Study|Unknown outcome|0|||
30903161|NCT02342171|58937130|FG001|Overall Study|Unknown outcome|1|||
30903162|NCT02342171|58937129|FG000|Overall Study|Missing age data|0|||
30903163|NCT02342171|58937130|FG001|Overall Study|Missing age data|1|||
30903164|NCT01624467|58937135|FG000|Overall Study|Withdrawal by Subject|2|||
30903165|NCT01624467|58937135|FG000|Overall Study|Lost to Follow-up|1|||
30903166|NCT01624467|58937135|FG000|Overall Study|Adverse Event|7|||
30903167|NCT01624467|58937135|FG000|Overall Study|Progressive Disease|19|||
30903168|NCT01624467|58937135|FG000|Overall Study|Per Sponsor Requirement|1|||
30903169|NCT01624467|58937135|FG000|Overall Study|Subject Withdrew from Treatment|1|||
30903170|NCT01624233|58937141|FG000|Period 2 - Induction|Adverse Event|1|||
30903171|NCT01624233|58937141|FG000|Period 3 - Maintenance|Adverse Event|2|||
30903172|NCT01624233|58937141|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
30903173|NCT01624233|58937141|FG000|Period 3 - Maintenance|Physician Decision|2|||
30903174|NCT01624233|58937141|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
30903175|NCT01624233|58937141|FG000|Period 4 - Drug Free Period|Relapsed|61|||
30745225|NCT00277212|58755996|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
30745226|NCT00277212|58755997|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
30745227|NCT00277212|58755998|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
30792508|NCT02741596|58805768|FG000|Overall Study|Other (Unspecified)|0|||
30792509|NCT02741596|58805769|FG001|Overall Study|Other (Unspecified)|3|||
30792510|NCT02741596|58805768|FG000|Overall Study|Subject withdrawn-Other|17|||
30792511|NCT02741596|58805769|FG001|Overall Study|Subject withdrawn-Other|4|||
30792512|NCT02741596|58805768|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
30792513|NCT02741596|58805769|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
30792514|NCT03147248|58805781|FG000|Overall Study|Adverse Event|0|||
30792515|NCT03147248|58805782|FG001|Overall Study|Adverse Event|2|||
30792516|NCT03147248|58805783|FG002|Overall Study|Adverse Event|2|||
30792517|NCT03147248|58805784|FG003|Overall Study|Adverse Event|2|||
30792518|NCT03147248|58805785|FG004|Overall Study|Adverse Event|6|||
30792519|NCT03147248|58805786|FG005|Overall Study|Adverse Event|11|||
30792520|NCT03147248|58805781|FG000|Overall Study|Disease progression|1|||
30903176|NCT01624233|58937141|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
30903177|NCT01624233|58937141|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
30903178|NCT01624233|58937141|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
30903179|NCT01624233|58937141|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
30792521|NCT03147248|58805782|FG001|Overall Study|Disease progression|0|||
30903180|NCT01624233|58937141|FG000|Period 6: Follow-up|Adverse Event|3|||
30792522|NCT03147248|58805783|FG002|Overall Study|Disease progression|0|||
30903181|NCT01624233|58937141|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
30903182|NCT01624233|58937141|FG000|Period 6: Follow-up|Physician Decision|1|||
30903183|NCT01624233|58937141|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
30903184|NCT01993017|58937152|FG000|Overall Study|Death|23|||
30903185|NCT01993017|58937153|FG001|Overall Study|Death|26|||
30903186|NCT01993017|58937154|FG002|Overall Study|Death|18|||
30903187|NCT01993017|58937152|FG000|Overall Study|Could not be contacted|43|||
30903188|NCT01993017|58937153|FG001|Overall Study|Could not be contacted|42|||
30903189|NCT01993017|58937154|FG002|Overall Study|Could not be contacted|38|||
30903190|NCT01993017|58937152|FG000|Overall Study|Dropped out|19|||
30903191|NCT01993017|58937153|FG001|Overall Study|Dropped out|6|||
30903192|NCT01993017|58937154|FG002|Overall Study|Dropped out|11|||
30903193|NCT01993017|58937152|FG000|Overall Study|Other reasons|17|||
30903194|NCT01993017|58937153|FG001|Overall Study|Other reasons|11|||
30903195|NCT01993017|58937154|FG002|Overall Study|Other reasons|7|||
30903196|NCT01993017|58937152|FG000|Overall Study|Ineligible after randomization|4|||
30903197|NCT01993017|58937153|FG001|Overall Study|Ineligible after randomization|5|||
30903198|NCT01993017|58937154|FG002|Overall Study|Ineligible after randomization|5|||
30903199|NCT01992549|58937163|FG000|Overall Study|Lost to Follow-up|2|||
30903200|NCT01992549|58937163|FG000|Overall Study|Serious Adverse Event|1|||
30903201|NCT01992549|58937163|FG000|Overall Study|Product Switch to Extend Half Life|1|||
30903202|NCT01992159|58937177|FG000|Overall Study|Withdrawal by Subject|4|||
30903203|NCT01992159|58937178|FG001|Overall Study|Withdrawal by Subject|7|||
30903204|NCT01992159|58937179|FG002|Overall Study|Withdrawal by Subject|0|||
30903205|NCT01992159|58937180|FG003|Overall Study|Withdrawal by Subject|3|||
30903206|NCT01992159|58937177|FG000|Overall Study|Adverse Event|0|||
30903207|NCT01992159|58937178|FG001|Overall Study|Adverse Event|1|||
30903208|NCT01992159|58937179|FG002|Overall Study|Adverse Event|0|||
30903209|NCT01992159|58937180|FG003|Overall Study|Adverse Event|1|||
30903210|NCT01992159|58937177|FG000|Overall Study|Death|0|||
30903211|NCT01992159|58937178|FG001|Overall Study|Death|0|||
30903212|NCT01992159|58937179|FG002|Overall Study|Death|1|||
30903213|NCT01992159|58937180|FG003|Overall Study|Death|0|||
30903214|NCT01988493|58937195|FG000|Overall Study|Randomized but not treated|0|||
30903215|NCT01988493|58937196|FG001|Overall Study|Randomized but not treated|0|||
30903216|NCT01988493|58937197|FG002|Overall Study|Randomized but not treated|0|||
30903217|NCT01988493|58937198|FG003|Overall Study|Randomized but not treated|0|||
30903218|NCT01988493|58937199|FG004|Overall Study|Randomized but not treated|1|||
30903219|NCT02081079|58937215|FG000|Overall Study|Lack of Efficacy|3|||
30903220|NCT02081079|58937216|FG001|Overall Study|Lack of Efficacy|2|||
30903221|NCT02081079|58937215|FG000|Overall Study|Lost to Follow-up|1|||
30903222|NCT02081079|58937216|FG001|Overall Study|Lost to Follow-up|0|||
30903223|NCT02081001|58937228|FG000|Overall Study|Adverse Event|0|||
30745228|NCT00277212|58755996|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
30745229|NCT00277212|58755997|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
30745230|NCT00277212|58755998|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
30903224|NCT02081001|58937229|FG001|Overall Study|Adverse Event|0|||
30903225|NCT02081001|58937230|FG002|Overall Study|Adverse Event|0|||
30903226|NCT02081001|58937231|FG003|Overall Study|Adverse Event|0|||
30903227|NCT02081001|58937232|FG004|Overall Study|Adverse Event|1|||
30903228|NCT02081001|58937233|FG005|Overall Study|Adverse Event|0|||
30903229|NCT02081001|58937234|FG006|Overall Study|Adverse Event|0|||
30903230|NCT02081001|58937235|FG007|Overall Study|Adverse Event|0|||
30903231|NCT02081001|58937236|FG008|Overall Study|Adverse Event|0|||
30903232|NCT02081001|58937237|FG009|Overall Study|Adverse Event|0|||
30903233|NCT02081001|58937238|FG010|Overall Study|Adverse Event|0|||
30903234|NCT02081001|58937239|FG011|Overall Study|Adverse Event|0|||
30903235|NCT02080221|58937250|FG000|Overall Study|Withdrawal by Subject|1|||
30903236|NCT02080221|58937250|FG000|Overall Study|Clinical Progression of Disease|1|||
30903237|NCT02079909|58937257|FG000|Overall Study|Adverse Event|23|||
30903238|NCT02079909|58937258|FG001|Overall Study|Adverse Event|23|||
30903239|NCT02079909|58937259|FG002|Overall Study|Adverse Event|7|||
30903240|NCT02079909|58937257|FG000|Overall Study|Withdrawal by Subject|9|||
30903241|NCT02079909|58937258|FG001|Overall Study|Withdrawal by Subject|17|||
30903242|NCT02079909|58937259|FG002|Overall Study|Withdrawal by Subject|4|||
30903243|NCT02079909|58937257|FG000|Overall Study|Lost to Follow-up|2|||
30903244|NCT02079909|58937258|FG001|Overall Study|Lost to Follow-up|3|||
30903245|NCT02079909|58937259|FG002|Overall Study|Lost to Follow-up|1|||
30903246|NCT02079909|58937257|FG000|Overall Study|Death|2|||
30903247|NCT02079909|58937258|FG001|Overall Study|Death|2|||
30903248|NCT02079909|58937259|FG002|Overall Study|Death|0|||
30903249|NCT02079909|58937257|FG000|Overall Study|Lack of Efficacy|0|||
30903250|NCT02079909|58937258|FG001|Overall Study|Lack of Efficacy|0|||
30903251|NCT02079909|58937259|FG002|Overall Study|Lack of Efficacy|1|||
30903252|NCT02079909|58937257|FG000|Overall Study|Protocol Violation|0|||
30903253|NCT02079909|58937258|FG001|Overall Study|Protocol Violation|1|||
30903254|NCT02079909|58937259|FG002|Overall Study|Protocol Violation|1|||
30903255|NCT02079909|58937257|FG000|Overall Study|Physician Decision|0|||
30903256|NCT02079909|58937258|FG001|Overall Study|Physician Decision|1|||
30903257|NCT02079909|58937259|FG002|Overall Study|Physician Decision|1|||
30903258|NCT02079909|58937257|FG000|Overall Study|Relocation etc.|2|||
30903259|NCT02079909|58937258|FG001|Overall Study|Relocation etc.|2|||
30903260|NCT02079909|58937259|FG002|Overall Study|Relocation etc.|3|||
30903261|NCT02014467|58937269|FG000|Overall Study|Adverse Event|4|||
30903262|NCT02014467|58937270|FG001|Overall Study|Adverse Event|0|||
30903263|NCT02014467|58937269|FG000|Overall Study|Protocol Violation|3|||
30903264|NCT02014467|58937270|FG001|Overall Study|Protocol Violation|0|||
30903265|NCT02014467|58937269|FG000|Overall Study|Physician Decision|2|||
30903266|NCT02014467|58937270|FG001|Overall Study|Physician Decision|3|||
30903267|NCT02014467|58937269|FG000|Overall Study|Withdrawal by Subject|16|||
30903268|NCT02014467|58937270|FG001|Overall Study|Withdrawal by Subject|4|||
30903269|NCT02013765|58937276|FG000|Overall Study|Trial was terminated by sponsor|1|||
30903270|NCT02013687|58937284|FG000|Overall Study|Lost to Follow-up|0|||
30903271|NCT02013687|58937285|FG001|Overall Study|Lost to Follow-up|0|||
30903272|NCT02013687|58937286|FG002|Overall Study|Lost to Follow-up|1|||
30903273|NCT02013687|58937287|FG003|Overall Study|Lost to Follow-up|0|||
30903274|NCT02013687|58937284|FG000|Overall Study|Protocol Violation|0|||
30903275|NCT02013687|58937285|FG001|Overall Study|Protocol Violation|0|||
30903276|NCT02013687|58937286|FG002|Overall Study|Protocol Violation|0|||
30903277|NCT02013687|58937287|FG003|Overall Study|Protocol Violation|1|||
30903278|NCT02013687|58937284|FG000|Overall Study|Withdrawal by Subject|0|||
30903279|NCT02013687|58937285|FG001|Overall Study|Withdrawal by Subject|0|||
30903280|NCT02013687|58937286|FG002|Overall Study|Withdrawal by Subject|0|||
30903281|NCT02013687|58937287|FG003|Overall Study|Withdrawal by Subject|1|||
30903282|NCT02013687|58937284|FG000|Overall Study|Missed visits due to patient travel|0|||
30903283|NCT02013687|58937285|FG001|Overall Study|Missed visits due to patient travel|0|||
30903284|NCT02013687|58937286|FG002|Overall Study|Missed visits due to patient travel|1|||
30903285|NCT02013687|58937287|FG003|Overall Study|Missed visits due to patient travel|0|||
30903286|NCT02013609|58937301|FG000|Overall Study|Withdrawal by Subject|9|||
30903287|NCT02013609|58937301|FG000|Overall Study|Lost to Follow-up|3|||
30903288|NCT02013609|58937301|FG000|Overall Study|Adverse Event|3|||
30903289|NCT02013609|58937301|FG000|Overall Study|Met Withdrawal Criteria|3|||
30903290|NCT01988337|58937305|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
30903291|NCT02013531|58937311|FG000|Overall Study|Lost to Follow-up|3|||
30903292|NCT02013531|58937311|FG000|Overall Study|Met Withdrawal Criteria|1|||
30903293|NCT02013531|58937311|FG000|Overall Study|Withdrawal by Subject|1|||
30903294|NCT01988103|58937318|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
30903295|NCT01988103|58937319|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
30903296|NCT01988103|58937320|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
30903297|NCT01988103|58937321|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
30903298|NCT01988103|58937322|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
30903299|NCT01988103|58937318|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
30903300|NCT01988103|58937319|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
30903301|NCT01988103|58937320|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
30903302|NCT01988103|58937321|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
30903303|NCT01988103|58937322|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
30903304|NCT01988103|58937318|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
30903305|NCT01988103|58937319|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
30903306|NCT01988103|58937320|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
30903307|NCT01988103|58937321|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
30903308|NCT01988103|58937322|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
30903309|NCT01988103|58937318|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
30903310|NCT01988103|58937319|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
30903311|NCT01988103|58937320|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
30903312|NCT01988103|58937321|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
30903313|NCT01988103|58937322|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
30903314|NCT01988103|58937318|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
30903315|NCT01988103|58937319|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
30903316|NCT01988103|58937320|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
30903317|NCT01988103|58937321|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
30903318|NCT01988103|58937322|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
30903319|NCT01988103|58937318|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
30903320|NCT01988103|58937319|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
30903321|NCT01988103|58937320|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
30903322|NCT01988103|58937321|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
30903323|NCT01988103|58937322|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
30903324|NCT01988103|58937318|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
30903325|NCT01988103|58937319|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
30903326|NCT01988103|58937320|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
30903327|NCT01988103|58937321|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
30903328|NCT01988103|58937322|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
30903329|NCT02013375|58937337|FG000|Overall Study|Did not engraft|1|||
30622046|NCT01146912|58633551|FG000|Overall Study|Already received influenza vaccination|817|||
30622047|NCT01146912|58633552|FG001|Overall Study|Already received influenza vaccination|822|||
30622048|NCT01146912|58633553|FG002|Overall Study|Already received influenza vaccination|13|||
30622049|NCT01146912|58633554|FG003|Overall Study|Already received influenza vaccination|15|||
30622050|NCT01146912|58633555|FG004|Overall Study|Already received influenza vaccination|41|||
30622051|NCT01146912|58633556|FG005|Overall Study|Already received influenza vaccination|61|||
30622052|NCT01146912|58633557|FG006|Overall Study|Already received influenza vaccination|56|||
30622053|NCT01146912|58633558|FG007|Overall Study|Already received influenza vaccination|0|||
30622054|NCT01146912|58633551|FG000|Overall Study|< 14 weeks gestational age|0|||
30622055|NCT01146912|58633552|FG001|Overall Study|< 14 weeks gestational age|0|||
30622056|NCT01146912|58633553|FG002|Overall Study|< 14 weeks gestational age|3|||
30622057|NCT01146912|58633554|FG003|Overall Study|< 14 weeks gestational age|2|||
30622058|NCT01146912|58633555|FG004|Overall Study|< 14 weeks gestational age|0|||
30622059|NCT01146912|58633556|FG005|Overall Study|< 14 weeks gestational age|0|||
30622060|NCT01146912|58633557|FG006|Overall Study|< 14 weeks gestational age|0|||
30622061|NCT01146912|58633558|FG007|Overall Study|< 14 weeks gestational age|0|||
30622062|NCT01146912|58633551|FG000|Overall Study|Duplicate patient|0|||
30622063|NCT01146912|58633552|FG001|Overall Study|Duplicate patient|0|||
30622064|NCT01146912|58633553|FG002|Overall Study|Duplicate patient|1|||
30622065|NCT01146912|58633554|FG003|Overall Study|Duplicate patient|0|||
30622066|NCT01146912|58633555|FG004|Overall Study|Duplicate patient|0|||
30622067|NCT01146912|58633556|FG005|Overall Study|Duplicate patient|0|||
30622068|NCT01146912|58633557|FG006|Overall Study|Duplicate patient|0|||
30622069|NCT01146912|58633558|FG007|Overall Study|Duplicate patient|0|||
30622070|NCT01134042|58633580|FG000|Overall Study|Adverse Event|3|||
30622071|NCT01134042|58633581|FG001|Overall Study|Adverse Event|7|||
30622072|NCT01134042|58633582|FG002|Overall Study|Adverse Event|2|||
30622073|NCT01134042|58633580|FG000|Overall Study|Lack of Efficacy|21|||
30622074|NCT01134042|58633581|FG001|Overall Study|Lack of Efficacy|6|||
30622075|NCT01134042|58633582|FG002|Overall Study|Lack of Efficacy|18|||
30622076|NCT01134042|58633580|FG000|Overall Study|Protocol Violation|5|||
30622077|NCT01134042|58633581|FG001|Overall Study|Protocol Violation|3|||
30622078|NCT01134042|58633582|FG002|Overall Study|Protocol Violation|5|||
30622079|NCT01134042|58633580|FG000|Overall Study|Lost to Follow-up|2|||
30903330|NCT02013375|58937337|FG000|Overall Study|Did not engraft|1|||
30903331|NCT02079519|58937342|FG000|Overall Study|Disease Progression|9|||
30903332|NCT02079519|58937342|FG000|Overall Study|Adverse Event|1|||
30903333|NCT01987557|58937349|FG000|Overall Study|Protocol Violation|1|||
30903334|NCT01987557|58937350|FG001|Overall Study|Protocol Violation|0|||
30622080|NCT01134042|58633581|FG001|Overall Study|Lost to Follow-up|0|||
30792523|NCT03147248|58805784|FG003|Overall Study|Disease progression|0|||
30792524|NCT03147248|58805785|FG004|Overall Study|Disease progression|0|||
30745231|NCT00277212|58755996|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
30745232|NCT00277212|58755997|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
30745233|NCT00277212|58755998|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
30745234|NCT00277212|58755996|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
30745235|NCT00277212|58755997|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
30745236|NCT00277212|58755998|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
30792525|NCT03147248|58805786|FG005|Overall Study|Disease progression|2|||
30792526|NCT03147248|58805781|FG000|Overall Study|Withdrawal by Subject|0|||
30792527|NCT03147248|58805782|FG001|Overall Study|Withdrawal by Subject|0|||
30792528|NCT03147248|58805783|FG002|Overall Study|Withdrawal by Subject|0|||
30792529|NCT03147248|58805784|FG003|Overall Study|Withdrawal by Subject|0|||
30792530|NCT03147248|58805785|FG004|Overall Study|Withdrawal by Subject|12|||
30792531|NCT03147248|58805786|FG005|Overall Study|Withdrawal by Subject|9|||
30792532|NCT03147248|58805781|FG000|Overall Study|Protocol Violation|0|||
30792533|NCT03147248|58805782|FG001|Overall Study|Protocol Violation|0|||
30903335|NCT01987557|58937351|FG002|Overall Study|Protocol Violation|1|||
30792534|NCT03147248|58805783|FG002|Overall Study|Protocol Violation|0|||
30792535|NCT03147248|58805784|FG003|Overall Study|Protocol Violation|0|||
30792536|NCT03147248|58805785|FG004|Overall Study|Protocol Violation|2|||
30792537|NCT03147248|58805786|FG005|Overall Study|Protocol Violation|0|||
30792538|NCT03147248|58805781|FG000|Overall Study|Lost to Follow-up|0|||
30792539|NCT03147248|58805782|FG001|Overall Study|Lost to Follow-up|0|||
30792540|NCT03147248|58805783|FG002|Overall Study|Lost to Follow-up|0|||
30792541|NCT03147248|58805784|FG003|Overall Study|Lost to Follow-up|0|||
30792542|NCT03147248|58805785|FG004|Overall Study|Lost to Follow-up|2|||
30792543|NCT03147248|58805786|FG005|Overall Study|Lost to Follow-up|0|||
30792544|NCT03147248|58805781|FG000|Overall Study|Pregnancy|0|||
30792545|NCT03147248|58805782|FG001|Overall Study|Pregnancy|0|||
30792546|NCT03147248|58805783|FG002|Overall Study|Pregnancy|0|||
30792547|NCT03147248|58805784|FG003|Overall Study|Pregnancy|0|||
30792548|NCT03147248|58805785|FG004|Overall Study|Pregnancy|1|||
30792549|NCT03147248|58805786|FG005|Overall Study|Pregnancy|0|||
30792550|NCT03147248|58805781|FG000|Overall Study|Death|0|||
30792551|NCT03147248|58805782|FG001|Overall Study|Death|0|||
30792552|NCT03147248|58805783|FG002|Overall Study|Death|0|||
30792553|NCT03147248|58805784|FG003|Overall Study|Death|0|||
30903336|NCT01987557|58937349|FG000|Overall Study|Withdrawal by Subject|2|||
30903337|NCT01987557|58937350|FG001|Overall Study|Withdrawal by Subject|1|||
30903338|NCT01987557|58937351|FG002|Overall Study|Withdrawal by Subject|2|||
30903339|NCT01987557|58937349|FG000|Overall Study|Adverse Event|0|||
30745237|NCT00277212|58755996|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
30745238|NCT00277212|58755997|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
30745239|NCT00277212|58755998|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
30745240|NCT00277212|58755996|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
30745241|NCT00277212|58755997|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
30745242|NCT00277212|58755998|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
30745243|NCT00277212|58755996|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
30745244|NCT00277212|58755997|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
30903340|NCT01987557|58937350|FG001|Overall Study|Adverse Event|2|||
30792554|NCT03147248|58805785|FG004|Overall Study|Death|0|||
30792555|NCT03147248|58805786|FG005|Overall Study|Death|4|||
30792556|NCT03147248|58805781|FG000|Overall Study|Physician Decision|0|||
30792557|NCT03147248|58805782|FG001|Overall Study|Physician Decision|0|||
30792558|NCT03147248|58805783|FG002|Overall Study|Physician Decision|0|||
30903341|NCT01987557|58937351|FG002|Overall Study|Adverse Event|0|||
30903342|NCT02078817|58937359|FG000|Overall Study|Withdrawal by Subject|1|||
30903343|NCT02011893|58937363|FG000|Enrollment to Randomization|Adverse Event|2|||
30903344|NCT02011893|58937364|FG001|Enrollment to Randomization|Adverse Event|0|||
30903345|NCT02011893|58937365|FG002|Enrollment to Randomization|Adverse Event|0|||
30903346|NCT02011893|58937363|FG000|Enrollment to Randomization|Physician Decision|10|||
30903347|NCT02011893|58937364|FG001|Enrollment to Randomization|Physician Decision|0|||
30903348|NCT02011893|58937365|FG002|Enrollment to Randomization|Physician Decision|0|||
30903349|NCT02011893|58937363|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
30903350|NCT02011893|58937364|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
30903351|NCT02011893|58937365|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
30903352|NCT02011893|58937363|FG000|Enrollment to Randomization|Screening Failure|29|||
30903353|NCT02011893|58937364|FG001|Enrollment to Randomization|Screening Failure|0|||
30903354|NCT02011893|58937365|FG002|Enrollment to Randomization|Screening Failure|0|||
30903355|NCT02011893|58937363|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
30903356|NCT02011893|58937364|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
30903357|NCT02011893|58937365|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
30903358|NCT02011893|58937363|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
30903359|NCT02011893|58937364|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
30903360|NCT02011893|58937365|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
30903361|NCT02011893|58937363|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
30903362|NCT02011893|58937364|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
30903363|NCT02011893|58937365|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
30903364|NCT02011893|58937363|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
30903365|NCT02011893|58937364|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
30903366|NCT02011893|58937365|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
30903367|NCT02011893|58937363|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
30903368|NCT02011893|58937364|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
30903369|NCT02011893|58937365|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
30903370|NCT02011113|58937370|FG000|Overall Study|Adverse Event|4|||
30903371|NCT02011113|58937370|FG000|Overall Study|Disease Progression (DP)|16|||
30903372|NCT02011113|58937370|FG000|Overall Study|Death|1|||
30903373|NCT02011113|58937370|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
30903374|NCT02011113|58937370|FG000|Overall Study|Investigator's judgement- DP|3|||
30903375|NCT02011113|58937370|FG000|Overall Study|Study terminated by sponsor|11|||
30903376|NCT01807156|58937375|FG000|Overall Study|Physician Decision|1|||
30903377|NCT01987479|58937379|FG000|Overall Study|Protocol Violation|1|||
30903378|NCT01987479|58937379|FG000|Overall Study|Physician Decision|2|||
30903379|NCT01987479|58937379|FG000|Overall Study|Participant/legal guardian decision|1|||
30903380|NCT01987479|58937379|FG000|Overall Study|Other|5|||
30903381|NCT01987479|58937379|FG000|Overall Study|Lost to Follow-up|1|||
30903382|NCT01987479|58937379|FG000|Overall Study|Adverse Event|7|||
30903383|NCT01620489|58937385|FG000|Overall Study|Adverse Event|17|||
30903384|NCT01620489|58937386|FG001|Overall Study|Adverse Event|4|||
30903385|NCT01620489|58937385|FG000|Overall Study|Protocol Violation|0|||
30903386|NCT01620489|58937386|FG001|Overall Study|Protocol Violation|3|||
30903387|NCT01620489|58937385|FG000|Overall Study|Withdrawal Criteria|17|||
30903388|NCT01620489|58937386|FG001|Overall Study|Withdrawal Criteria|25|||
30903389|NCT01620489|58937385|FG000|Overall Study|Unclassified|1|||
30903390|NCT01620489|58937386|FG001|Overall Study|Unclassified|2|||
30903391|NCT02076165|58937394|FG000|Overall Study|Lost to Follow-up|7|||
30903392|NCT02076165|58937395|FG001|Overall Study|Lost to Follow-up|5|||
30903393|NCT02076165|58937394|FG000|Overall Study|Refused follow-up assessment|1|||
30903394|NCT02076165|58937395|FG001|Overall Study|Refused follow-up assessment|1|||
30903395|NCT01620255|58937406|FG000|Overall Study|Withdrawal by Subject|4|||
30903396|NCT01620255|58937407|FG001|Overall Study|Withdrawal by Subject|1|||
30745245|NCT00277212|58755998|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
30745246|NCT00277212|58755996|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
30745247|NCT00277212|58755997|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
30745248|NCT00277212|58755998|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
30745249|NCT00277212|58755996|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
30745250|NCT00277212|58755997|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
30903397|NCT01620255|58937408|FG002|Overall Study|Withdrawal by Subject|1|||
30903398|NCT01620255|58937409|FG003|Overall Study|Withdrawal by Subject|2|||
30903399|NCT01620255|58937410|FG004|Overall Study|Withdrawal by Subject|4|||
30745251|NCT00277212|58755998|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
30903400|NCT01620255|58937406|FG000|Overall Study|Participant underwent fecal transplant|0|||
30903401|NCT01620255|58937407|FG001|Overall Study|Participant underwent fecal transplant|0|||
30903402|NCT01620255|58937408|FG002|Overall Study|Participant underwent fecal transplant|1|||
30903403|NCT01620255|58937409|FG003|Overall Study|Participant underwent fecal transplant|0|||
30903404|NCT01620255|58937410|FG004|Overall Study|Participant underwent fecal transplant|0|||
30903405|NCT01620255|58937406|FG000|Overall Study|Non-compliance|0|||
30903406|NCT01620255|58937407|FG001|Overall Study|Non-compliance|1|||
30903407|NCT01620255|58937408|FG002|Overall Study|Non-compliance|0|||
30903408|NCT01620255|58937409|FG003|Overall Study|Non-compliance|0|||
30745252|NCT00277212|58755996|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
30745253|NCT00277212|58755997|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
30745254|NCT00277212|58755998|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
30745255|NCT00277212|58755996|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
30745256|NCT00277212|58755997|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
30745257|NCT00277212|58755998|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
30745258|NCT00277212|58755996|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
30903409|NCT01620255|58937410|FG004|Overall Study|Non-compliance|0|||
30903410|NCT01620255|58937406|FG000|Overall Study|Adverse Event|0|||
30745259|NCT00277212|58755997|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
30745260|NCT00277212|58755998|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
30745261|NCT00277212|58755996|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
30745262|NCT00277212|58755997|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
30745263|NCT00277212|58755998|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
30745264|NCT00277212|58755996|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
30745265|NCT00277212|58755997|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
30745266|NCT00277212|58755998|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
30745267|NCT00277212|58755996|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
30745268|NCT00277212|58755997|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
30745269|NCT00277212|58755998|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
30745270|NCT00277212|58755996|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
30745271|NCT00277212|58755997|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
30745272|NCT00277212|58755998|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
30745273|NCT00276744|58756006|FG000|PART A|Reason unknown|98|||
30745274|NCT00251316|58756012|FG000|Overall Study|Physician Decision|2|||
30745275|NCT00251316|58756013|FG001|Overall Study|Physician Decision|3|||
30745276|NCT00293462|58756022|FG000|Overall Study|Withdrawal by Subject|4|||
30745277|NCT00293462|58756023|FG001|Overall Study|Withdrawal by Subject|3|||
30745278|NCT00293462|58756024|FG002|Overall Study|Withdrawal by Subject|8|||
30745279|NCT00293462|58756022|FG000|Overall Study|Death|1|||
30745280|NCT00293462|58756023|FG001|Overall Study|Death|0|||
30745281|NCT00293462|58756024|FG002|Overall Study|Death|0|||
30745282|NCT00293462|58756022|FG000|Overall Study|Lost to Follow-up|0|||
30745283|NCT00293462|58756023|FG001|Overall Study|Lost to Follow-up|1|||
30745284|NCT00293462|58756024|FG002|Overall Study|Lost to Follow-up|0|||
30745285|NCT00293462|58756022|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
30745286|NCT00293462|58756023|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
30745287|NCT00293462|58756024|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
30745288|NCT00293462|58756022|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
30745289|NCT00293462|58756023|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
30745290|NCT00293462|58756024|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
30745291|NCT00293462|58756022|FG000|Overall Study|Refuse Radiation Treatment|1|||
30745292|NCT00293462|58756023|FG001|Overall Study|Refuse Radiation Treatment|0|||
30745293|NCT00293462|58756024|FG002|Overall Study|Refuse Radiation Treatment|0|||
30745294|NCT00293462|58756022|FG000|Overall Study|No Show|0|||
30745295|NCT00293462|58756023|FG001|Overall Study|No Show|0|||
30745296|NCT00293462|58756024|FG002|Overall Study|No Show|1|||
30745297|NCT00293462|58756022|FG000|Overall Study|Went back to his home country|0|||
30745298|NCT00293462|58756023|FG001|Overall Study|Went back to his home country|0|||
30745299|NCT00293462|58756024|FG002|Overall Study|Went back to his home country|1|||
30745300|NCT00293462|58756022|FG000|Overall Study|Blood clot after chemotherapy|0|||
30745301|NCT00293462|58756023|FG001|Overall Study|Blood clot after chemotherapy|0|||
30745302|NCT00293462|58756024|FG002|Overall Study|Blood clot after chemotherapy|1|||
30745303|NCT00293462|58756022|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
30745304|NCT00293462|58756023|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
30745305|NCT00293462|58756024|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
30745306|NCT00293462|58756022|FG000|Overall Study|Possible Tracheostomy leakage|0|||
30745307|NCT00293462|58756023|FG001|Overall Study|Possible Tracheostomy leakage|1|||
30903411|NCT01620255|58937407|FG001|Overall Study|Adverse Event|4|||
30903412|NCT01620255|58937408|FG002|Overall Study|Adverse Event|0|||
30903413|NCT01620255|58937409|FG003|Overall Study|Adverse Event|1|||
30903414|NCT01620255|58937410|FG004|Overall Study|Adverse Event|1|||
30792559|NCT03147248|58805784|FG003|Overall Study|Physician Decision|0|||
30792560|NCT03147248|58805785|FG004|Overall Study|Physician Decision|2|||
30792561|NCT03147248|58805786|FG005|Overall Study|Physician Decision|4|||
30792562|NCT03147248|58805781|FG000|Overall Study|Prolonged Dosing Interval|0|||
30792563|NCT03147248|58805782|FG001|Overall Study|Prolonged Dosing Interval|0|||
30792564|NCT03147248|58805783|FG002|Overall Study|Prolonged Dosing Interval|0|||
30792565|NCT03147248|58805784|FG003|Overall Study|Prolonged Dosing Interval|0|||
30792566|NCT03147248|58805785|FG004|Overall Study|Prolonged Dosing Interval|1|||
30792567|NCT03147248|58805786|FG005|Overall Study|Prolonged Dosing Interval|1|||
30792568|NCT03796039|58805802|FG000|Overall Study|Death|2|||
30792569|NCT03796039|58805803|FG001|Overall Study|Death|1|||
30792570|NCT03796039|58805802|FG000|Overall Study|Withdrawal by Subject|7|||
30792571|NCT03796039|58805803|FG001|Overall Study|Withdrawal by Subject|4|||
30792572|NCT03151304|58805809|FG000|Overall Study|Termination of study by Sponsor|23|||
30792573|NCT03151304|58805809|FG000|Overall Study|missing|3|||
30792574|NCT03151304|58805809|FG000|Overall Study|Withdrawal by Subject|8|||
30792575|NCT03151304|58805809|FG000|Overall Study|multiple reasons|30|||
30792576|NCT03152552|58805818|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
30792577|NCT03152552|58805819|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
30792578|NCT03152552|58805820|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
30792579|NCT03152552|58805821|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
30792580|NCT03152552|58805822|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
30792581|NCT03152552|58805818|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
30792582|NCT03152552|58805819|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
30792583|NCT03152552|58805820|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
30792584|NCT03152552|58805821|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
30792585|NCT03152552|58805822|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
30792586|NCT03152552|58805818|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
30792587|NCT03152552|58805819|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
30792588|NCT03152552|58805820|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
30792589|NCT03152552|58805821|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
30792590|NCT03152552|58805822|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
30792591|NCT03152552|58805818|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30792592|NCT03152552|58805819|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30792593|NCT03152552|58805820|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
30792594|NCT03152552|58805821|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30792595|NCT03152552|58805822|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30792596|NCT03152552|58805818|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
30792597|NCT03152552|58805819|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
30792598|NCT03152552|58805820|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
30792599|NCT03152552|58805821|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
30792600|NCT03152552|58805822|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
30792601|NCT03152552|58805818|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
30792602|NCT03152552|58805819|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
30903415|NCT01620255|58937406|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
30903416|NCT01620255|58937407|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
30903417|NCT01620255|58937408|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
30903418|NCT01620255|58937409|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
30903419|NCT01620255|58937410|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
30903420|NCT02010567|58937427|FG000|Overall Study|Adverse Event|0|||
30903421|NCT02010567|58937428|FG001|Overall Study|Adverse Event|0|||
30903422|NCT02010567|58937429|FG002|Overall Study|Adverse Event|1|||
30622081|NCT01134042|58633582|FG002|Overall Study|Lost to Follow-up|1|||
30622082|NCT01134042|58633580|FG000|Overall Study|Physician Decision|4|||
30745308|NCT00293462|58756024|FG002|Overall Study|Possible Tracheostomy leakage|0|||
30745309|NCT00293462|58756022|FG000|Overall Study|Low radiation dose in oral cavity|0|||
30745310|NCT00293462|58756023|FG001|Overall Study|Low radiation dose in oral cavity|1|||
30745311|NCT00293462|58756024|FG002|Overall Study|Low radiation dose in oral cavity|0|||
30745312|NCT00293462|58756022|FG000|Overall Study|Physician Decision|0|||
30745313|NCT00293462|58756023|FG001|Overall Study|Physician Decision|1|||
30745314|NCT00293462|58756024|FG002|Overall Study|Physician Decision|0|||
30745315|NCT00316082|58756037|FG000|Overall Study|Lack of Efficacy|2|||
30745316|NCT00316082|58756038|FG001|Overall Study|Lack of Efficacy|3|||
30745317|NCT00316082|58756039|FG002|Overall Study|Lack of Efficacy|3|||
30745318|NCT00316082|58756040|FG003|Overall Study|Lack of Efficacy|4|||
30792603|NCT03152552|58805820|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
30792604|NCT03152552|58805821|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
30792605|NCT03152552|58805822|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
30792606|NCT03152552|58805818|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
30903423|NCT02010567|58937430|FG003|Overall Study|Adverse Event|0|||
30903424|NCT02010567|58937431|FG004|Overall Study|Adverse Event|1|||
30622083|NCT01134042|58633581|FG001|Overall Study|Physician Decision|8|||
30745319|NCT00316082|58756041|FG004|Overall Study|Lack of Efficacy|6|||
30903425|NCT01806064|58937446|FG000|Overall Study|Randomized Not Enrolled|0|||
30903426|NCT01806064|58937447|FG001|Overall Study|Randomized Not Enrolled|0|||
30903427|NCT01806064|58937448|FG002|Overall Study|Randomized Not Enrolled|0|||
30903428|NCT01806064|58937449|FG003|Overall Study|Randomized Not Enrolled|1|||
30903429|NCT01806064|58937450|FG004|Overall Study|Randomized Not Enrolled|2|||
30903430|NCT01804582|58937468|FG000|Overall Study|Lost to Follow-up|47|||
30903431|NCT01804582|58937469|FG001|Overall Study|Lost to Follow-up|56|||
30903432|NCT01804582|58937468|FG000|Overall Study|Physician Decision|2|||
30903433|NCT01804582|58937469|FG001|Overall Study|Physician Decision|0|||
30903434|NCT01787188|58937479|FG000|Overall Study|Adverse Event|2|||
30903435|NCT01787188|58937480|FG001|Overall Study|Adverse Event|4|||
30903436|NCT01787188|58937481|FG002|Overall Study|Adverse Event|6|||
30903437|NCT01787188|58937479|FG000|Overall Study|Lack of Efficacy|7|||
30903438|NCT01787188|58937480|FG001|Overall Study|Lack of Efficacy|3|||
30903439|NCT01787188|58937481|FG002|Overall Study|Lack of Efficacy|5|||
30903440|NCT01787188|58937479|FG000|Overall Study|Non-compliance with Study Drug|0|||
30903441|NCT01787188|58937480|FG001|Overall Study|Non-compliance with Study Drug|1|||
30903442|NCT01787188|58937481|FG002|Overall Study|Non-compliance with Study Drug|0|||
30903443|NCT01787188|58937479|FG000|Overall Study|Withdrawal by Subject|4|||
30903444|NCT01787188|58937480|FG001|Overall Study|Withdrawal by Subject|3|||
30903445|NCT01787188|58937481|FG002|Overall Study|Withdrawal by Subject|2|||
30903446|NCT01787188|58937479|FG000|Overall Study|Protocol Violation|3|||
30903447|NCT01787188|58937480|FG001|Overall Study|Protocol Violation|2|||
30903448|NCT01787188|58937481|FG002|Overall Study|Protocol Violation|3|||
30903449|NCT01787188|58937479|FG000|Overall Study|Lost to Follow-up|1|||
30903450|NCT01787188|58937480|FG001|Overall Study|Lost to Follow-up|2|||
30792607|NCT03152552|58805819|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
30792608|NCT03152552|58805820|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
30792609|NCT03152552|58805821|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
30792610|NCT03152552|58805822|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
30792611|NCT03151226|58805835|FG000|Overall Study|Withdrawal by Subject|2|||
30792612|NCT03151226|58805835|FG000|Overall Study|not wear device correctly|1|||
30792613|NCT03151148|58805841|FG000|Overall Study|Lost to Follow-up|1|||
30792614|NCT03151148|58805842|FG001|Overall Study|Lost to Follow-up|0|||
30792615|NCT03151148|58805841|FG000|Overall Study|Withdrawal by Subject|1|||
30792616|NCT03151148|58805842|FG001|Overall Study|Withdrawal by Subject|0|||
30792617|NCT02741518|58805851|FG000|Overall Study|Withdrawal by Subject|1|||
30792618|NCT02741518|58805852|FG001|Overall Study|Withdrawal by Subject|1|||
30792619|NCT03145766|58805863|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
30792620|NCT03145766|58805864|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
30792621|NCT03145766|58805865|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
30792622|NCT03145766|58805866|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
30792623|NCT03145766|58805867|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
30792624|NCT03145766|58805863|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
30792625|NCT03145766|58805864|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
30792626|NCT03145766|58805865|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
30792627|NCT03145766|58805866|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
30792628|NCT03145766|58805867|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
30792629|NCT03145766|58805863|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
30792630|NCT03145766|58805864|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
30792631|NCT03145766|58805865|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
30792632|NCT03145766|58805866|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
30792633|NCT03145766|58805867|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
30792634|NCT03145766|58805863|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
30792635|NCT03145766|58805864|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
30792636|NCT03145766|58805865|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
30792637|NCT03145766|58805866|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
30792638|NCT03145766|58805867|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
30792639|NCT03145766|58805863|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
30792640|NCT03145766|58805864|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
30792641|NCT03145766|58805865|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
30903451|NCT01787188|58937481|FG002|Overall Study|Lost to Follow-up|2|||
30903452|NCT01787188|58937479|FG000|Overall Study|Other, including patient moved|0|||
30903453|NCT01787188|58937480|FG001|Overall Study|Other, including patient moved|3|||
30903454|NCT01787188|58937481|FG002|Overall Study|Other, including patient moved|0|||
30903455|NCT01787032|58937495|FG000|Overall Study|Protocol Violation|0|||
30903456|NCT01787032|58937496|FG001|Overall Study|Protocol Violation|0|||
30903457|NCT01787032|58937497|FG002|Overall Study|Protocol Violation|0|||
30903458|NCT01787032|58937498|FG003|Overall Study|Protocol Violation|0|||
30792642|NCT03145766|58805866|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
30792643|NCT03145766|58805867|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
30792644|NCT03145766|58805863|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
30792645|NCT03145766|58805864|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
30792646|NCT03145766|58805865|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
30792647|NCT03145766|58805866|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
30792648|NCT03145766|58805867|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
30792649|NCT03145766|58805863|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
30792650|NCT03145766|58805864|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
30792651|NCT03145766|58805865|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
30792652|NCT03145766|58805866|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
30792653|NCT03145766|58805867|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
30792654|NCT03145064|58805880|FG000|Overall Study|Death|24|||
30792655|NCT03145064|58805880|FG000|Overall Study|Lost to Follow-up|3|||
30792656|NCT03145064|58805880|FG000|Overall Study|Withdrawal by Subject|6|||
30792657|NCT03145064|58805880|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
30792658|NCT03145064|58805880|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
30792659|NCT03787615|58805905|FG000|Overall Study|Withdrawal by Subject|2|||
30792660|NCT03787615|58805905|FG000|Overall Study|Lost to Follow-up|2|||
30792661|NCT03784963|58805914|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
30792662|NCT03784963|58805915|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
30792663|NCT03784963|58805916|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
30792664|NCT03784963|58805917|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
30792665|NCT03787303|58805927|FG000|Overall Study|Death|1|||
30792666|NCT03787303|58805927|FG000|Overall Study|Premature Termination of Study|1|||
30792667|NCT04170296|58805933|FG000|Overall Study|Adverse Event|1|||
30792668|NCT04170296|58805934|FG001|Overall Study|Adverse Event|0|||
30792669|NCT04170296|58805933|FG000|Overall Study|Withdrawal by Subject|3|||
30792670|NCT04170296|58805934|FG001|Overall Study|Withdrawal by Subject|2|||
30792671|NCT04170296|58805933|FG000|Overall Study|Lost to Follow-up|4|||
30792672|NCT04170296|58805934|FG001|Overall Study|Lost to Follow-up|2|||
30792673|NCT03141788|58805961|FG000|Overall Study|Lost to Follow-up|1|||
30792674|NCT03141788|58805961|FG000|Overall Study|Protocol Violation|3|||
30792675|NCT03141788|58805961|FG000|Overall Study|Withdrawal by Subject|4|||
30792676|NCT03781375|58805970|FG000|Double-blind Phase|Adverse Event|0|||
30792677|NCT03781375|58805971|FG001|Double-blind Phase|Adverse Event|1|||
30792678|NCT03781375|58805970|FG000|Double-blind Phase|Lack of Response|6|||
30792679|NCT03781375|58805971|FG001|Double-blind Phase|Lack of Response|2|||
30792680|NCT03781375|58805970|FG000|Double-blind Phase|Other|1|||
30792681|NCT03781375|58805971|FG001|Double-blind Phase|Other|3|||
30792682|NCT03781375|58805970|FG000|Open-label Phase|Protocol Issues|0|||
30792683|NCT03781375|58805971|FG001|Open-label Phase|Protocol Issues|1|||
30792684|NCT03781375|58805970|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
30792685|NCT03781375|58805971|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
30792686|NCT03781375|58805970|FG000|Open-label Phase|Other|2|||
30792687|NCT03781375|58805971|FG001|Open-label Phase|Other|2|||
30792688|NCT03779503|58805978|FG000|First Intervention|Adverse Event|0|||
30792689|NCT03779503|58805979|FG001|First Intervention|Adverse Event|1|||
30792690|NCT03779503|58805978|FG000|First Intervention|Withdrawal by Subject|1|||
30792691|NCT03779503|58805979|FG001|First Intervention|Withdrawal by Subject|0|||
30792692|NCT03150056|58805991|FG000|Overall Study|Withdrawal by Subject|0|||
30792693|NCT03150056|58805992|FG001|Overall Study|Withdrawal by Subject|0|||
30792694|NCT03150056|58805993|FG002|Overall Study|Withdrawal by Subject|0|||
30792695|NCT03150056|58805994|FG003|Overall Study|Withdrawal by Subject|0|||
30792696|NCT03150056|58805995|FG004|Overall Study|Withdrawal by Subject|0|||
30792697|NCT03150056|58805996|FG005|Overall Study|Withdrawal by Subject|2|||
30792698|NCT03150056|58805991|FG000|Overall Study|Study terminated by Sponsor|1|||
30792699|NCT03150056|58805992|FG001|Overall Study|Study terminated by Sponsor|3|||
30792700|NCT03150056|58805993|FG002|Overall Study|Study terminated by Sponsor|1|||
30745320|NCT00316082|58756037|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
30745321|NCT00316082|58756038|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
30745322|NCT00316082|58756039|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
30745323|NCT00316082|58756040|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
30745324|NCT00316082|58756041|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
30745325|NCT00316082|58756037|FG000|Overall Study|Lost to Follow-up|7|||
30745326|NCT00316082|58756038|FG001|Overall Study|Lost to Follow-up|6|||
30745327|NCT00316082|58756039|FG002|Overall Study|Lost to Follow-up|7|||
30745328|NCT00316082|58756040|FG003|Overall Study|Lost to Follow-up|8|||
30745329|NCT00316082|58756041|FG004|Overall Study|Lost to Follow-up|6|||
30745330|NCT00316082|58756037|FG000|Overall Study|Poor/noncompliance|6|||
30792701|NCT03150056|58805994|FG003|Overall Study|Study terminated by Sponsor|1|||
30792702|NCT03150056|58805995|FG004|Overall Study|Study terminated by Sponsor|5|||
30792703|NCT03150056|58805996|FG005|Overall Study|Study terminated by Sponsor|6|||
30792704|NCT03150056|58805991|FG000|Overall Study|Death|9|||
30792705|NCT03150056|58805992|FG001|Overall Study|Death|2|||
30792706|NCT03150056|58805993|FG002|Overall Study|Death|2|||
30792707|NCT03150056|58805994|FG003|Overall Study|Death|7|||
30792708|NCT03150056|58805995|FG004|Overall Study|Death|8|||
30792709|NCT03150056|58805996|FG005|Overall Study|Death|10|||
30792710|NCT02640664|58806016|FG000|Epoch 1|Withdrawal of informed consent|1|||
30792711|NCT02640664|58806017|FG001|Epoch 1|Withdrawal of informed consent|0|||
30792712|NCT02640664|58806018|FG002|Epoch 1|Withdrawal of informed consent|0|||
30792713|NCT02640664|58806016|FG000|Epoch 1|Death|0|||
30792714|NCT02640664|58806017|FG001|Epoch 1|Death|0|||
30792715|NCT02640664|58806018|FG002|Epoch 1|Death|1|||
30792716|NCT02640664|58806016|FG000|Epoch 2|Withdrawal of informed consent|3|||
30792717|NCT02640664|58806017|FG001|Epoch 2|Withdrawal of informed consent|4|||
30792718|NCT02640664|58806018|FG002|Epoch 2|Withdrawal of informed consent|2|||
30792719|NCT02640664|58806016|FG000|Epoch 2|Subject/guardian decision|0|||
30792720|NCT02640664|58806017|FG001|Epoch 2|Subject/guardian decision|2|||
30792721|NCT02640664|58806018|FG002|Epoch 2|Subject/guardian decision|2|||
30792722|NCT02640664|58806016|FG000|Epoch 2|Lost to Follow-up|3|||
30792723|NCT02640664|58806017|FG001|Epoch 2|Lost to Follow-up|4|||
30792724|NCT02640664|58806018|FG002|Epoch 2|Lost to Follow-up|1|||
30792725|NCT02640664|58806016|FG000|Epoch 2|Death|0|||
30792726|NCT02640664|58806017|FG001|Epoch 2|Death|0|||
30792727|NCT02640664|58806018|FG002|Epoch 2|Death|1|||
30792728|NCT00812006|58806030|FG000|Overall Study|Lost to Follow-up|0|||
30792729|NCT00812006|58806031|FG001|Overall Study|Lost to Follow-up|0|||
30792730|NCT00812006|58806032|FG002|Overall Study|Lost to Follow-up|2|||
30792731|NCT00812006|58806030|FG000|Overall Study|Physician Decision|0|||
30792732|NCT00812006|58806031|FG001|Overall Study|Physician Decision|0|||
30792733|NCT00812006|58806032|FG002|Overall Study|Physician Decision|1|||
30792734|NCT00812006|58806030|FG000|Overall Study|Withdrawal by Subject|2|||
30792735|NCT00812006|58806031|FG001|Overall Study|Withdrawal by Subject|1|||
30792736|NCT00812006|58806032|FG002|Overall Study|Withdrawal by Subject|1|||
30792737|NCT00812006|58806030|FG000|Overall Study|Lack of Qualifying Event|4|||
30792738|NCT00812006|58806031|FG001|Overall Study|Lack of Qualifying Event|2|||
30792739|NCT00812006|58806032|FG002|Overall Study|Lack of Qualifying Event|2|||
30792740|NCT03772327|58806047|FG000|Overall Study|Lost to Follow-up|3|||
30792741|NCT03772327|58806048|FG001|Overall Study|Lost to Follow-up|4|||
30792742|NCT03772327|58806047|FG000|Overall Study|Withdrawal by Subject|2|||
30792743|NCT03772327|58806048|FG001|Overall Study|Withdrawal by Subject|3|||
30792744|NCT04364763|58806091|FG000|Overall Study|Death|1|||
30792745|NCT04364763|58806092|FG001|Overall Study|Death|2|||
30792746|NCT04364763|58806091|FG000|Overall Study|Lost to Follow-up|1|||
30792747|NCT04364763|58806092|FG001|Overall Study|Lost to Follow-up|0|||
30792748|NCT04247815|58806109|FG000|Overall Study|Adverse Event|1|||
30792749|NCT04247815|58806110|FG001|Overall Study|Adverse Event|0|||
30792750|NCT04247815|58806109|FG000|Overall Study|Withdrawal by Subject|1|||
30792751|NCT04247815|58806110|FG001|Overall Study|Withdrawal by Subject|0|||
30792752|NCT04247815|58806109|FG000|Overall Study|Protocol Violation|0|||
30792753|NCT04247815|58806110|FG001|Overall Study|Protocol Violation|1|||
30792754|NCT03432819|58806145|FG000|Overall Study|Lost to Follow-up|2|||
30792755|NCT03432819|58806146|FG001|Overall Study|Lost to Follow-up|2|||
30792756|NCT03432819|58806145|FG000|Overall Study|Withdrawal by Subject|5|||
30745331|NCT00316082|58756038|FG001|Overall Study|Poor/noncompliance|1|||
30745332|NCT00316082|58756039|FG002|Overall Study|Poor/noncompliance|4|||
30745333|NCT00316082|58756040|FG003|Overall Study|Poor/noncompliance|1|||
30745334|NCT00316082|58756041|FG004|Overall Study|Poor/noncompliance|4|||
30745335|NCT00316082|58756037|FG000|Overall Study|Adverse Event|4|||
30745336|NCT00316082|58756038|FG001|Overall Study|Adverse Event|2|||
30745337|NCT00316082|58756039|FG002|Overall Study|Adverse Event|5|||
30745338|NCT00316082|58756040|FG003|Overall Study|Adverse Event|1|||
30745339|NCT00316082|58756041|FG004|Overall Study|Adverse Event|3|||
30745340|NCT00316082|58756037|FG000|Overall Study|Subject no longer meets study criteria|3|||
30745341|NCT00316082|58756038|FG001|Overall Study|Subject no longer meets study criteria|1|||
30745342|NCT00316082|58756039|FG002|Overall Study|Subject no longer meets study criteria|2|||
30792757|NCT03432819|58806146|FG001|Overall Study|Withdrawal by Subject|3|||
30792758|NCT03272347|58806165|FG000|Overall Study|Death|0|||
30745343|NCT00316082|58756040|FG003|Overall Study|Subject no longer meets study criteria|2|||
30745344|NCT00316082|58756041|FG004|Overall Study|Subject no longer meets study criteria|1|||
30745345|NCT00316082|58756037|FG000|Overall Study|Physician Decision|1|||
30745346|NCT00316082|58756038|FG001|Overall Study|Physician Decision|1|||
30745347|NCT00316082|58756039|FG002|Overall Study|Physician Decision|2|||
30792759|NCT03272347|58806166|FG001|Overall Study|Death|0|||
30792760|NCT03272347|58806167|FG002|Overall Study|Death|0|||
30792761|NCT03272347|58806168|FG003|Overall Study|Death|1|||
30792762|NCT03272347|58806165|FG000|Overall Study|Lost to Follow-up|1|||
30792763|NCT03272347|58806166|FG001|Overall Study|Lost to Follow-up|3|||
30792764|NCT03272347|58806167|FG002|Overall Study|Lost to Follow-up|5|||
30792765|NCT03272347|58806168|FG003|Overall Study|Lost to Follow-up|1|||
30792766|NCT03272347|58806165|FG000|Overall Study|Physician Decision|4|||
30792767|NCT03272347|58806166|FG001|Overall Study|Physician Decision|2|||
30792768|NCT03272347|58806167|FG002|Overall Study|Physician Decision|5|||
30792769|NCT03272347|58806168|FG003|Overall Study|Physician Decision|4|||
30792770|NCT03272347|58806165|FG000|Overall Study|Screen Failure|1|||
30792771|NCT03272347|58806166|FG001|Overall Study|Screen Failure|0|||
30792772|NCT03272347|58806167|FG002|Overall Study|Screen Failure|0|||
30792773|NCT03272347|58806168|FG003|Overall Study|Screen Failure|0|||
30792774|NCT03272347|58806165|FG000|Overall Study|Withdrawal by Subject|5|||
30792775|NCT03272347|58806166|FG001|Overall Study|Withdrawal by Subject|1|||
30792776|NCT03272347|58806167|FG002|Overall Study|Withdrawal by Subject|2|||
30792777|NCT03272347|58806168|FG003|Overall Study|Withdrawal by Subject|1|||
30792778|NCT03259568|58806190|FG000|Overall Study|Participant performance was low|3|||
30792779|NCT03239470|58806200|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
30792780|NCT03239470|58806201|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
30792781|NCT03167723|58806207|FG000|Overall Study|Protocol Violation|4|||
30792782|NCT03167723|58806208|FG001|Overall Study|Protocol Violation|6|||
30792783|NCT03103152|58806220|FG000|Overall Study|Physician Decision|5|||
30792784|NCT03103152|58806221|FG001|Overall Study|Physician Decision|2|||
30792785|NCT03103152|58806222|FG002|Overall Study|Physician Decision|6|||
30792786|NCT03103152|58806223|FG003|Overall Study|Physician Decision|3|||
30792787|NCT03103152|58806224|FG004|Overall Study|Physician Decision|3|||
30792788|NCT03103152|58806225|FG005|Overall Study|Physician Decision|1|||
30792789|NCT03103152|58806220|FG000|Overall Study|Protocol Violation|2|||
30792790|NCT03103152|58806221|FG001|Overall Study|Protocol Violation|2|||
30792791|NCT03103152|58806222|FG002|Overall Study|Protocol Violation|1|||
30792792|NCT03103152|58806223|FG003|Overall Study|Protocol Violation|2|||
30792793|NCT03103152|58806224|FG004|Overall Study|Protocol Violation|1|||
30792794|NCT03103152|58806225|FG005|Overall Study|Protocol Violation|1|||
30792795|NCT03103152|58806220|FG000|Overall Study|Inter-current illness|0|||
30792796|NCT03103152|58806221|FG001|Overall Study|Inter-current illness|0|||
30792797|NCT03103152|58806222|FG002|Overall Study|Inter-current illness|1|||
30792798|NCT03103152|58806223|FG003|Overall Study|Inter-current illness|0|||
30792799|NCT03103152|58806224|FG004|Overall Study|Inter-current illness|0|||
30792800|NCT03103152|58806225|FG005|Overall Study|Inter-current illness|0|||
30792801|NCT03103152|58806220|FG000|Overall Study|Death|0|||
30792802|NCT03103152|58806221|FG001|Overall Study|Death|1|||
30792803|NCT03103152|58806222|FG002|Overall Study|Death|0|||
30792804|NCT03103152|58806223|FG003|Overall Study|Death|0|||
30792805|NCT03103152|58806224|FG004|Overall Study|Death|0|||
30792806|NCT03103152|58806225|FG005|Overall Study|Death|0|||
30792807|NCT03103152|58806220|FG000|Overall Study|Adverse Event|0|||
30792808|NCT03103152|58806221|FG001|Overall Study|Adverse Event|0|||
30792809|NCT03103152|58806222|FG002|Overall Study|Adverse Event|1|||
30792810|NCT03103152|58806223|FG003|Overall Study|Adverse Event|0|||
30792811|NCT03103152|58806224|FG004|Overall Study|Adverse Event|0|||
30792812|NCT03103152|58806225|FG005|Overall Study|Adverse Event|1|||
30792813|NCT03103152|58806220|FG000|Overall Study|Withdrawal by Subject|1|||
30792814|NCT03103152|58806221|FG001|Overall Study|Withdrawal by Subject|0|||
30792815|NCT03103152|58806222|FG002|Overall Study|Withdrawal by Subject|1|||
30792816|NCT03103152|58806223|FG003|Overall Study|Withdrawal by Subject|1|||
30792817|NCT03103152|58806224|FG004|Overall Study|Withdrawal by Subject|1|||
30792818|NCT03103152|58806225|FG005|Overall Study|Withdrawal by Subject|1|||
30792819|NCT03103152|58806220|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
30792820|NCT03103152|58806221|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
30792821|NCT03103152|58806222|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
30792822|NCT03103152|58806223|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
30792823|NCT03103152|58806224|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
30792824|NCT03103152|58806225|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
30792825|NCT03103152|58806220|FG000|Overall Study|Unacceptable side effects|0|||
30792826|NCT03103152|58806221|FG001|Overall Study|Unacceptable side effects|0|||
30792827|NCT03103152|58806222|FG002|Overall Study|Unacceptable side effects|0|||
30792828|NCT03103152|58806223|FG003|Overall Study|Unacceptable side effects|0|||
30792829|NCT03103152|58806224|FG004|Overall Study|Unacceptable side effects|0|||
30792830|NCT03103152|58806225|FG005|Overall Study|Unacceptable side effects|1|||
30792831|NCT03103152|58806220|FG000|Overall Study|Lost to Follow-up|0|||
30792832|NCT03103152|58806221|FG001|Overall Study|Lost to Follow-up|1|||
30792833|NCT03103152|58806222|FG002|Overall Study|Lost to Follow-up|0|||
30792834|NCT03103152|58806223|FG003|Overall Study|Lost to Follow-up|1|||
30792835|NCT03103152|58806224|FG004|Overall Study|Lost to Follow-up|0|||
30792836|NCT03103152|58806225|FG005|Overall Study|Lost to Follow-up|1|||
30792837|NCT03103152|58806220|FG000|Overall Study|Testicular pain|0|||
30792838|NCT03103152|58806221|FG001|Overall Study|Testicular pain|0|||
30792839|NCT03103152|58806222|FG002|Overall Study|Testicular pain|0|||
30792840|NCT03103152|58806223|FG003|Overall Study|Testicular pain|1|||
30792841|NCT03103152|58806224|FG004|Overall Study|Testicular pain|0|||
30792842|NCT03103152|58806225|FG005|Overall Study|Testicular pain|0|||
30792843|NCT03033901|58806239|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
30792844|NCT03033901|58806239|FG000|Overall Study|Refused PSG|23|||
30792845|NCT03033901|58806239|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
30792846|NCT03033901|58806239|FG000|Overall Study|Missing Oximetry Data|3|||
30792847|NCT02603887|58806282|FG000|Stage 1|Adverse Event|4|||
30792848|NCT02603887|58806282|FG000|Stage 1|Disease progression|1|||
30792849|NCT02603887|58806282|FG000|Stage 2|FDA guidance|1|||
30792850|NCT02315196|58806295|FG000|Overall Study|Withdrew consent|9|||
30792851|NCT02059005|58806301|FG000|Overall Study|Death|1|||
30792852|NCT02059005|58806302|FG001|Overall Study|Death|3|||
30792853|NCT02059005|58806301|FG000|Overall Study|Lost to Follow-up|19|||
30792854|NCT02059005|58806302|FG001|Overall Study|Lost to Follow-up|19|||
30792855|NCT02059005|58806301|FG000|Overall Study|Incarceration|0|||
30792856|NCT02059005|58806302|FG001|Overall Study|Incarceration|1|||
30792857|NCT02059005|58806301|FG000|Overall Study|Inpatient|0|||
30792858|NCT02059005|58806302|FG001|Overall Study|Inpatient|1|||
30792859|NCT01393821|58806312|FG000|Overall Study|Cancel|1|||
30792860|NCT01393821|58806313|FG001|Overall Study|Cancel|1|||
30792861|NCT01393821|58806312|FG000|Overall Study|not evaluable for primary endpoint|4|||
30792862|NCT01393821|58806313|FG001|Overall Study|not evaluable for primary endpoint|2|||
30792863|NCT00496873|58806325|FG000|Overall Study|Ineligible|2|||
30792864|NCT00496873|58806325|FG000|Overall Study|Death|2|||
30792865|NCT00496873|58806325|FG000|Overall Study|Withdrawal by Subject|3|||
30792866|NCT00492778|58806331|FG000|Overall Study|Ineligible by Pathology Review|8|||
30792867|NCT00492778|58806332|FG001|Overall Study|Ineligible by Pathology Review|1|||
30792868|NCT03775681|58806366|FG000|Overall Study|Physician Decision|3|||
30792869|NCT03774823|58806372|FG000|Overall Study|Withdrawal by Subject|1|||
30792870|NCT03774823|58806373|FG001|Overall Study|Withdrawal by Subject|1|||
30792871|NCT03149042|58806379|FG000|Overall Study|Invasive FFR not performed|21|||
30792872|NCT03149042|58806379|FG000|Overall Study|Poor CT Image Quality|1|||
30792873|NCT03149042|58806379|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
30792874|NCT03774433|58806384|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
30792875|NCT03136484|58806390|FG000|Overall Study|Withdrawal by Subject|19|||
30792876|NCT03136484|58806391|FG001|Overall Study|Withdrawal by Subject|14|||
30792877|NCT03136484|58806390|FG000|Overall Study|Lost to Follow-up|7|||
30792878|NCT03136484|58806391|FG001|Overall Study|Lost to Follow-up|8|||
30792879|NCT03136484|58806390|FG000|Overall Study|Death|1|||
30792880|NCT03136484|58806391|FG001|Overall Study|Death|0|||
30792881|NCT03922711|58806400|FG000|Overall Study|Adverse Event|3|||
30792882|NCT03922711|58806401|FG001|Overall Study|Adverse Event|2|||
30792883|NCT03922711|58806402|FG002|Overall Study|Adverse Event|2|||
30792884|NCT03922711|58806400|FG000|Overall Study|Protocol Violation|1|||
30792885|NCT03922711|58806401|FG001|Overall Study|Protocol Violation|0|||
30792886|NCT03922711|58806402|FG002|Overall Study|Protocol Violation|0|||
30792887|NCT03922711|58806400|FG000|Overall Study|Withdrawal by Subject|0|||
30792888|NCT03922711|58806401|FG001|Overall Study|Withdrawal by Subject|3|||
30792889|NCT03922711|58806402|FG002|Overall Study|Withdrawal by Subject|1|||
30792890|NCT03922711|58806400|FG000|Overall Study|Not further specified|0|||
30792891|NCT03922711|58806401|FG001|Overall Study|Not further specified|0|||
30792892|NCT03922711|58806402|FG002|Overall Study|Not further specified|1|||
30792893|NCT02877680|58806411|FG000|Overall Study|Lost to Follow-up|1|||
30792894|NCT02877680|58806412|FG001|Overall Study|Lost to Follow-up|1|||
30792895|NCT03141086|58806424|FG000|Overall Study|Study Terminated By Sponsor|1|||
30792896|NCT03141086|58806425|FG001|Overall Study|Study Terminated By Sponsor|1|||
30792897|NCT03141086|58806424|FG000|Overall Study|Withdrawal by Subject|0|||
30792898|NCT03141086|58806425|FG001|Overall Study|Withdrawal by Subject|1|||
30792899|NCT03141086|58806424|FG000|Overall Study|Protocol Violation|0|||
30792900|NCT03141086|58806425|FG001|Overall Study|Protocol Violation|1|||
30792901|NCT03141086|58806424|FG000|Overall Study|Adverse Event|0|||
30903459|NCT01787032|58937499|FG004|Overall Study|Protocol Violation|1|||
30792902|NCT03141086|58806425|FG001|Overall Study|Adverse Event|2|||
30792903|NCT03135548|58806434|FG000|Overall Study|Lost to Follow-up|3|||
30792904|NCT03135548|58806435|FG001|Overall Study|Lost to Follow-up|0|||
30792905|NCT03135548|58806436|FG002|Overall Study|Lost to Follow-up|0|||
30792906|NCT03135548|58806434|FG000|Overall Study|Withdrawal by Subject|2|||
30792907|NCT03135548|58806435|FG001|Overall Study|Withdrawal by Subject|2|||
30903460|NCT01787032|58937500|FG005|Overall Study|Protocol Violation|1|||
30903461|NCT01737268|58937510|FG000|Overall Study|Adverse Event|6|||
30792908|NCT03135548|58806436|FG002|Overall Study|Withdrawal by Subject|1|||
30792909|NCT03135548|58806434|FG000|Overall Study|Other than listed|0|||
30792910|NCT03135548|58806435|FG001|Overall Study|Other than listed|2|||
30792911|NCT03135548|58806436|FG002|Overall Study|Other than listed|2|||
30792912|NCT03134222|58806447|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
30792913|NCT03134222|58806448|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
30903462|NCT01737268|58937510|FG000|Overall Study|Worsening of Target Disease|2|||
30792914|NCT03134222|58806449|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
30792915|NCT03134222|58806450|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
30792916|NCT03134222|58806451|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
30792917|NCT03134222|58806447|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
30792918|NCT03134222|58806448|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
30792919|NCT03134222|58806449|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
30792920|NCT03134222|58806450|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
30792921|NCT03134222|58806451|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
30792922|NCT03134222|58806447|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
30792923|NCT03134222|58806448|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
30792924|NCT03134222|58806449|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
30792925|NCT03134222|58806450|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
30792926|NCT03134222|58806451|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
30792927|NCT03134222|58806447|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
30792928|NCT03134222|58806448|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
30792929|NCT03134222|58806449|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
30792930|NCT03134222|58806450|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
30792931|NCT03134222|58806451|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
30792932|NCT03134222|58806447|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
30792933|NCT03134222|58806448|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
30792934|NCT03134222|58806449|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
30792935|NCT03134222|58806450|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
30792936|NCT03134222|58806451|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
30792937|NCT03134222|58806447|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
30792938|NCT03134222|58806448|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
30792939|NCT03134222|58806449|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
30792940|NCT03134222|58806450|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
30792941|NCT03134222|58806451|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
30792942|NCT03134222|58806447|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
30903463|NCT01737268|58937510|FG000|Overall Study|In consideration of the patient's safety|1|||
30903464|NCT01769404|58937515|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
30903465|NCT01769404|58937516|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
30903466|NCT01769404|58937515|FG000|Treatment Period 1|Withdrawal by Subject|3|||
30903467|NCT01769404|58937516|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30903468|NCT01769404|58937515|FG000|Treatment Period 1|Sponsor decision|1|||
30622084|NCT01134042|58633582|FG002|Overall Study|Physician Decision|1|||
30622085|NCT01134042|58633580|FG000|Overall Study|Withdrawal by Subject|13|||
30622086|NCT01134042|58633581|FG001|Overall Study|Withdrawal by Subject|4|||
30622087|NCT01134042|58633582|FG002|Overall Study|Withdrawal by Subject|7|||
30745348|NCT00316082|58756040|FG003|Overall Study|Physician Decision|1|||
30745349|NCT00316082|58756041|FG004|Overall Study|Physician Decision|1|||
30745350|NCT00316082|58756037|FG000|Overall Study|Death|0|||
30745351|NCT00316082|58756038|FG001|Overall Study|Death|0|||
30745352|NCT00316082|58756039|FG002|Overall Study|Death|1|||
30745353|NCT00316082|58756040|FG003|Overall Study|Death|0|||
30745354|NCT00316082|58756041|FG004|Overall Study|Death|0|||
30745355|NCT00316082|58756037|FG000|Overall Study|Administrative reason by sponsor|0|||
30745356|NCT00316082|58756038|FG001|Overall Study|Administrative reason by sponsor|0|||
30745357|NCT00316082|58756039|FG002|Overall Study|Administrative reason by sponsor|1|||
30745358|NCT00316082|58756040|FG003|Overall Study|Administrative reason by sponsor|0|||
30745359|NCT00316082|58756041|FG004|Overall Study|Administrative reason by sponsor|0|||
30745360|NCT00316004|58756060|FG000|Overall Study|Subject was not given study fluid.|14|||
30745361|NCT00316004|58756061|FG001|Overall Study|Subject was not given study fluid.|14|||
30745362|NCT00316004|58756062|FG002|Overall Study|Subject was not given study fluid.|21|||
30745363|NCT00298766|58756070|FG000|Overall Study|Adverse Event|18|||
30745364|NCT00298766|58756070|FG000|Overall Study|Death|2|||
30903469|NCT01769404|58937516|FG001|Treatment Period 1|Sponsor decision|0|||
30622088|NCT01179347|58633593|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
30622089|NCT01179347|58633594|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
30622090|NCT01179347|58633593|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
30622091|NCT01179347|58633594|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
30622092|NCT01179347|58633593|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
30622093|NCT01179347|58633594|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
30622094|NCT01179347|58633593|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
30745365|NCT00298766|58756070|FG000|Overall Study|Withdrawal by Subject|9|||
30745366|NCT00298766|58756070|FG000|Overall Study|Treatment ongoing|4|||
30745367|NCT00298766|58756070|FG000|Overall Study|Progression of amyloid markers|4|||
30745368|NCT00298766|58756070|FG000|Overall Study|Deterioration in KPS and organ function|1|||
30745369|NCT00298766|58756070|FG000|Overall Study|Subjects overall condition deterioration|4|||
30745370|NCT00298766|58756070|FG000|Overall Study|Other|4|||
30622095|NCT01179347|58633594|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
30622096|NCT01179347|58633593|FG000|Double-blind Period (12 Weeks)|Other|2|||
30622097|NCT01179347|58633594|FG001|Double-blind Period (12 Weeks)|Other|4|||
30622098|NCT01179347|58633593|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
30622099|NCT01179347|58633594|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
30622100|NCT01179347|58633593|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
30622101|NCT01179347|58633594|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
30622102|NCT01179347|58633593|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
30622103|NCT01179347|58633594|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
30622104|NCT01179347|58633593|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
30622105|NCT01179347|58633594|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
30622106|NCT01179347|58633593|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
30622107|NCT01179347|58633594|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
30622108|NCT01179347|58633593|FG000|Open-label Period (12 Weeks)|Other|7|||
30792943|NCT03134222|58806448|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
30792944|NCT03134222|58806449|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
30792945|NCT03134222|58806450|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
30792946|NCT03134222|58806451|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
30792947|NCT03134222|58806447|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
30792948|NCT03134222|58806448|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
30792949|NCT03134222|58806449|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
30792950|NCT03134222|58806450|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
30792951|NCT03134222|58806451|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
30792952|NCT03769753|58806461|FG000|Overall Study|Not Treated|6|||
30792953|NCT03769753|58806461|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
30792954|NCT03263923|58806476|FG000|Overall Study|Withdrawal by Subject|10|||
30792955|NCT03263923|58806477|FG001|Overall Study|Withdrawal by Subject|8|||
30792956|NCT03263923|58806476|FG000|Overall Study|Lost to Follow-up|15|||
30792957|NCT03263923|58806477|FG001|Overall Study|Lost to Follow-up|13|||
30792958|NCT03139604|58806487|FG000|Overall Study|Other|7|||
30903470|NCT01769404|58937515|FG000|Treatment Period 2|Sponsor decision|7|||
30903471|NCT01769404|58937516|FG001|Treatment Period 2|Sponsor decision|0|||
30903472|NCT01769326|58937528|FG000|Overall Study|Lost to Follow-up|1|||
30903473|NCT01769326|58937529|FG001|Overall Study|Lost to Follow-up|2|||
30903474|NCT01769326|58937530|FG002|Overall Study|Lost to Follow-up|0|||
30903475|NCT01769326|58937531|FG003|Overall Study|Lost to Follow-up|0|||
30903476|NCT01769326|58937528|FG000|Overall Study|unrelated injry|1|||
30903477|NCT01769326|58937529|FG001|Overall Study|unrelated injry|1|||
30903478|NCT01769326|58937530|FG002|Overall Study|unrelated injry|0|||
30903479|NCT01769326|58937531|FG003|Overall Study|unrelated injry|0|||
30745371|NCT00315458|58756076|FG000|Overall Study|Administrative|0|||
30745372|NCT00315458|58756077|FG001|Overall Study|Administrative|3|||
30745373|NCT00315458|58756078|FG002|Overall Study|Administrative|8|||
30745374|NCT00315458|58756079|FG003|Overall Study|Administrative|21|||
30745375|NCT00315458|58756076|FG000|Overall Study|Adverse Event|2|||
30745376|NCT00315458|58756077|FG001|Overall Study|Adverse Event|4|||
30745377|NCT00315458|58756078|FG002|Overall Study|Adverse Event|23|||
30745378|NCT00315458|58756079|FG003|Overall Study|Adverse Event|3|||
30745379|NCT00315458|58756076|FG000|Overall Study|Lost to Follow-up|1|||
30745380|NCT00315458|58756077|FG001|Overall Study|Lost to Follow-up|2|||
30745381|NCT00315458|58756078|FG002|Overall Study|Lost to Follow-up|0|||
30745382|NCT00315458|58756079|FG003|Overall Study|Lost to Follow-up|2|||
30745383|NCT00315458|58756076|FG000|Overall Study|Withdrawal by Subject|0|||
30745384|NCT00315458|58756077|FG001|Overall Study|Withdrawal by Subject|3|||
30745385|NCT00315458|58756078|FG002|Overall Study|Withdrawal by Subject|0|||
30745386|NCT00315458|58756079|FG003|Overall Study|Withdrawal by Subject|2|||
30745387|NCT00315458|58756076|FG000|Overall Study|Lack of Efficacy|0|||
30745388|NCT00315458|58756077|FG001|Overall Study|Lack of Efficacy|0|||
30745389|NCT00315458|58756078|FG002|Overall Study|Lack of Efficacy|20|||
30745390|NCT00315458|58756079|FG003|Overall Study|Lack of Efficacy|1|||
30745391|NCT00315458|58756076|FG000|Overall Study|Did not qualify|0|||
30745392|NCT00315458|58756077|FG001|Overall Study|Did not qualify|0|||
30745393|NCT00315458|58756078|FG002|Overall Study|Did not qualify|1|||
30745394|NCT00315458|58756079|FG003|Overall Study|Did not qualify|0|||
30745395|NCT00293384|58756089|FG000|Overall Study|Non-compliance|2|||
30745396|NCT00293384|58756089|FG000|Overall Study|Missed dosage/study drug|1|||
30745397|NCT00293384|58756089|FG000|Overall Study|Ineligible|2|||
30745398|NCT00297830|58756096|FG000|6 Month Visit|Death|1|||
30745399|NCT00297830|58756097|FG001|6 Month Visit|Death|0|||
30745400|NCT00297830|58756098|FG002|6 Month Visit|Death|2|||
30745401|NCT00297830|58756096|FG000|6 Month Visit|Withdrawal by Subject|2|||
30745402|NCT00297830|58756097|FG001|6 Month Visit|Withdrawal by Subject|1|||
30745403|NCT00297830|58756098|FG002|6 Month Visit|Withdrawal by Subject|1|||
30792959|NCT03139604|58806488|FG001|Overall Study|Other|3|||
30792960|NCT03139604|58806487|FG000|Overall Study|Withdrawal by Subject|16|||
30792961|NCT03139604|58806488|FG001|Overall Study|Withdrawal by Subject|17|||
30792962|NCT03139604|58806487|FG000|Overall Study|Physician Decision|1|||
30792963|NCT03139604|58806488|FG001|Overall Study|Physician Decision|2|||
30792964|NCT03139604|58806487|FG000|Overall Study|Lost to Follow-up|3|||
30792965|NCT03139604|58806488|FG001|Overall Study|Lost to Follow-up|1|||
30792966|NCT03139604|58806487|FG000|Overall Study|Death|65|||
30792967|NCT03139604|58806488|FG001|Overall Study|Death|67|||
30792968|NCT03139604|58806487|FG000|Overall Study|Study Terminated by Sponsor|122|||
30792969|NCT03139604|58806488|FG001|Overall Study|Study Terminated by Sponsor|127|||
30792970|NCT03139604|58806487|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
30792971|NCT03139604|58806488|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
30792972|NCT03139448|58806497|FG000|Overall Study|Lack of Efficacy|6|||
30792973|NCT03139448|58806498|FG001|Overall Study|Lack of Efficacy|7|||
30792974|NCT03139448|58806497|FG000|Overall Study|Location of procedure changed|2|||
30792975|NCT03139448|58806498|FG001|Overall Study|Location of procedure changed|8|||
30792976|NCT03139448|58806497|FG000|Overall Study|Withdrawal by Subject|3|||
30792977|NCT03139448|58806498|FG001|Overall Study|Withdrawal by Subject|6|||
30792978|NCT03139448|58806497|FG000|Overall Study|Screen fail|1|||
30792979|NCT03139448|58806498|FG001|Overall Study|Screen fail|3|||
30792980|NCT03139448|58806497|FG000|Overall Study|Physician Decision|0|||
30792981|NCT03139448|58806498|FG001|Overall Study|Physician Decision|2|||
30792982|NCT02875340|58806504|FG000|Overall Study|Death|2|||
30792983|NCT02875340|58806504|FG000|Overall Study|Withdrawal by Subject|2|||
30792984|NCT02875340|58806504|FG000|Overall Study|Physician Decision|3|||
30792985|NCT02875340|58806504|FG000|Overall Study|Adverse Event|1|||
30792986|NCT03237325|58806516|FG000|Overall Study|Lost to Follow-up|3|||
30792987|NCT03237325|58806517|FG001|Overall Study|Lost to Follow-up|5|||
30792988|NCT03237325|58806516|FG000|Overall Study|Physician Decision|2|||
30792989|NCT03237325|58806517|FG001|Overall Study|Physician Decision|4|||
30792990|NCT03237325|58806516|FG000|Overall Study|Withdrawal by Subject|9|||
30792991|NCT03237325|58806517|FG001|Overall Study|Withdrawal by Subject|12|||
30792992|NCT03237325|58806516|FG000|Overall Study|Noncompliance with Study Procedures|1|||
30792993|NCT03237325|58806517|FG001|Overall Study|Noncompliance with Study Procedures|1|||
30792994|NCT03237325|58806516|FG000|Overall Study|Termination by Sponsor|0|||
30792995|NCT03237325|58806517|FG001|Overall Study|Termination by Sponsor|1|||
30792996|NCT03237325|58806516|FG000|Overall Study|Reason other than described|0|||
30792997|NCT03237325|58806517|FG001|Overall Study|Reason other than described|2|||
30792998|NCT03113383|58806523|FG000|Overall Study|Death|4|||
30792999|NCT03113383|58806524|FG001|Overall Study|Death|0|||
30793000|NCT03131960|58806545|FG000|Overall Study|Adverse Event|0|||
30793001|NCT03131960|58806546|FG001|Overall Study|Adverse Event|1|||
30793002|NCT03225170|58806555|FG000|Overall Study|Lost to Follow-up|4|||
30793003|NCT03225170|58806556|FG001|Overall Study|Lost to Follow-up|4|||
30793004|NCT03225170|58806557|FG002|Overall Study|Lost to Follow-up|0|||
30793005|NCT03225170|58806555|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
30793006|NCT03225170|58806556|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
30793007|NCT03225170|58806557|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
30793008|NCT02115139|58806563|FG000|Overall Study|Protocol Violation|1|||
30793009|NCT02115139|58806563|FG000|Overall Study|treatment discontinuation|6|||
30793010|NCT01763827|58806611|FG000|Overall Study|Withdrawal by Subject|1|||
30793011|NCT01763827|58806612|FG001|Overall Study|Withdrawal by Subject|0|||
30793012|NCT01763827|58806613|FG002|Overall Study|Withdrawal by Subject|0|||
30793013|NCT01763827|58806614|FG003|Overall Study|Withdrawal by Subject|0|||
30793014|NCT01763827|58806615|FG004|Overall Study|Withdrawal by Subject|2|||
30793015|NCT01763827|58806616|FG005|Overall Study|Withdrawal by Subject|0|||
30793016|NCT01763827|58806611|FG000|Overall Study|Decision by sponsor|2|||
30793017|NCT01763827|58806612|FG001|Overall Study|Decision by sponsor|0|||
30793018|NCT01763827|58806613|FG002|Overall Study|Decision by sponsor|3|||
30793019|NCT01763827|58806614|FG003|Overall Study|Decision by sponsor|0|||
30793020|NCT01763827|58806615|FG004|Overall Study|Decision by sponsor|2|||
30793021|NCT01763827|58806616|FG005|Overall Study|Decision by sponsor|1|||
30793022|NCT01763827|58806611|FG000|Overall Study|Lost to Follow-up|0|||
30793023|NCT01763827|58806612|FG001|Overall Study|Lost to Follow-up|1|||
30793024|NCT01763827|58806613|FG002|Overall Study|Lost to Follow-up|1|||
30793025|NCT01763827|58806614|FG003|Overall Study|Lost to Follow-up|1|||
30793026|NCT01763827|58806615|FG004|Overall Study|Lost to Follow-up|2|||
30793027|NCT01763827|58806616|FG005|Overall Study|Lost to Follow-up|1|||
30793028|NCT01732783|58806669|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
30793029|NCT01732783|58806670|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
30793030|NCT01732783|58806671|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
30793031|NCT01732783|58806669|FG000|Overall Study|Death|13|||
30793032|NCT01732783|58806670|FG001|Overall Study|Death|4|||
30793033|NCT01732783|58806671|FG002|Overall Study|Death|1|||
30745404|NCT00297830|58756096|FG000|6 Month Visit|Adverse Event|0|||
30745405|NCT00297830|58756097|FG001|6 Month Visit|Adverse Event|1|||
30745406|NCT00297830|58756098|FG002|6 Month Visit|Adverse Event|0|||
30745407|NCT00297830|58756096|FG000|12 Month Visit|Lost to Follow-up|1|||
30745408|NCT00297830|58756097|FG001|12 Month Visit|Lost to Follow-up|0|||
30745409|NCT00297830|58756098|FG002|12 Month Visit|Lost to Follow-up|0|||
30903480|NCT01769326|58937528|FG000|Overall Study|got a job|0|||
30903481|NCT01769326|58937529|FG001|Overall Study|got a job|1|||
30903482|NCT01769326|58937530|FG002|Overall Study|got a job|0|||
30903483|NCT01769326|58937531|FG003|Overall Study|got a job|0|||
30903484|NCT01769326|58937528|FG000|Overall Study|Got sick and could not complete study|0|||
30903485|NCT01769326|58937529|FG001|Overall Study|Got sick and could not complete study|0|||
30903486|NCT01769326|58937530|FG002|Overall Study|Got sick and could not complete study|1|||
30903487|NCT01769326|58937531|FG003|Overall Study|Got sick and could not complete study|0|||
30903488|NCT01786564|58937541|FG000|Overall Study|Lost to Follow-up|47|||
30745410|NCT00297830|58756096|FG000|12 Month Visit|Adverse Event|0|||
30745411|NCT00297830|58756097|FG001|12 Month Visit|Adverse Event|3|||
30745412|NCT00297830|58756098|FG002|12 Month Visit|Adverse Event|0|||
30745413|NCT00297830|58756096|FG000|12 Month Visit|Withdrawal by Subject|0|||
30745414|NCT00297830|58756097|FG001|12 Month Visit|Withdrawal by Subject|3|||
30745415|NCT00297830|58756098|FG002|12 Month Visit|Withdrawal by Subject|0|||
30903489|NCT01786564|58937541|FG000|Overall Study|Ineligible|17|||
30745416|NCT00296816|58756108|FG000|Overall Study|Disease Progression|37|||
30745417|NCT00296816|58756108|FG000|Overall Study|Adverse Event|18|||
30745418|NCT00296816|58756108|FG000|Overall Study|Investigator/Participant request|5|||
30745419|NCT00296816|58756108|FG000|Overall Study|Non-compliance|1|||
30745420|NCT00296816|58756108|FG000|Overall Study|Missing for end of treatment|4|||
30745421|NCT00296816|58756108|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
30745422|NCT00296816|58756108|FG000|Overall Study|Poor performance status|1|||
30745423|NCT00296816|58756108|FG000|Overall Study|Relocation to Florida|1|||
30745424|NCT00296816|58756108|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
30793034|NCT01732783|58806669|FG000|Overall Study|Lost to Follow-up|7|||
30903490|NCT01786330|58937547|FG000|Overall Study|Withdrawal by Subject|0|||
30903491|NCT01786330|58937548|FG001|Overall Study|Withdrawal by Subject|1|||
30903492|NCT01786330|58937547|FG000|Overall Study|Lost to Follow-up|0|||
30903493|NCT01786330|58937548|FG001|Overall Study|Lost to Follow-up|1|||
30903494|NCT01786330|58937547|FG000|Overall Study|Excluded intraoperatively|0|||
30903495|NCT01786330|58937548|FG001|Overall Study|Excluded intraoperatively|1|||
30903496|NCT01786330|58937547|FG000|Overall Study|Protocol Violation|1|||
30903497|NCT01786330|58937548|FG001|Overall Study|Protocol Violation|0|||
30903498|NCT01786174|58937556|FG000|Overall Study|Discontinued Study Drug|2|||
30903499|NCT01786174|58937557|FG001|Overall Study|Discontinued Study Drug|0|||
30793035|NCT01732783|58806670|FG001|Overall Study|Lost to Follow-up|1|||
30793036|NCT01732783|58806671|FG002|Overall Study|Lost to Follow-up|1|||
30793037|NCT01732783|58806669|FG000|Overall Study|Administrative Decision|8|||
30793038|NCT01732783|58806670|FG001|Overall Study|Administrative Decision|2|||
30793039|NCT01732783|58806671|FG002|Overall Study|Administrative Decision|1|||
30793040|NCT01732783|58806669|FG000|Overall Study|Withdrawal by Subject|1|||
30793041|NCT01732783|58806670|FG001|Overall Study|Withdrawal by Subject|0|||
30793042|NCT01732783|58806671|FG002|Overall Study|Withdrawal by Subject|0|||
30793043|NCT02787850|58806698|FG000|Overall Study|Withdrawal by Subject|0|||
30793044|NCT02787850|58806699|FG001|Overall Study|Withdrawal by Subject|1|||
30793045|NCT01375777|58806723|FG000|Overall Study|Withdrawal by Subject|0|||
30793046|NCT01375777|58806724|FG001|Overall Study|Withdrawal by Subject|2|||
30793047|NCT01375777|58806725|FG002|Overall Study|Withdrawal by Subject|1|||
30793048|NCT01375777|58806726|FG003|Overall Study|Withdrawal by Subject|0|||
30793049|NCT01375777|58806727|FG004|Overall Study|Withdrawal by Subject|1|||
30793050|NCT01375777|58806728|FG005|Overall Study|Withdrawal by Subject|1|||
30793051|NCT01375777|58806729|FG006|Overall Study|Withdrawal by Subject|1|||
30793052|NCT01375777|58806730|FG007|Overall Study|Withdrawal by Subject|2|||
30793053|NCT01375777|58806731|FG008|Overall Study|Withdrawal by Subject|1|||
30793054|NCT01375777|58806723|FG000|Overall Study|Lost to Follow-up|1|||
30793055|NCT01375777|58806724|FG001|Overall Study|Lost to Follow-up|0|||
30793056|NCT01375777|58806725|FG002|Overall Study|Lost to Follow-up|0|||
30793057|NCT01375777|58806726|FG003|Overall Study|Lost to Follow-up|0|||
30793058|NCT01375777|58806727|FG004|Overall Study|Lost to Follow-up|0|||
30793059|NCT01375777|58806728|FG005|Overall Study|Lost to Follow-up|0|||
30793060|NCT01375777|58806729|FG006|Overall Study|Lost to Follow-up|1|||
30793061|NCT01375777|58806730|FG007|Overall Study|Lost to Follow-up|0|||
30793062|NCT01375777|58806731|FG008|Overall Study|Lost to Follow-up|0|||
30793063|NCT01375777|58806723|FG000|Overall Study|Other|1|||
30793064|NCT01375777|58806724|FG001|Overall Study|Other|1|||
30793065|NCT01375777|58806725|FG002|Overall Study|Other|0|||
30793066|NCT01375777|58806726|FG003|Overall Study|Other|0|||
30793067|NCT01375777|58806727|FG004|Overall Study|Other|0|||
30793068|NCT01375777|58806728|FG005|Overall Study|Other|0|||
30793069|NCT01375777|58806729|FG006|Overall Study|Other|0|||
30793070|NCT01375777|58806730|FG007|Overall Study|Other|0|||
30793071|NCT01375777|58806731|FG008|Overall Study|Other|1|||
30793072|NCT02431702|58806751|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
30793073|NCT02431702|58806752|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
30903500|NCT01736566|58937568|FG000|Long Term Follow-up|Still collecting data|42|||
30903501|NCT01736566|58937569|FG001|Long Term Follow-up|Still collecting data|0|||
30903502|NCT01736566|58937570|FG002|Long Term Follow-up|Still collecting data|49|||
30622109|NCT01179347|58633594|FG001|Open-label Period (12 Weeks)|Other|4|||
30793074|NCT02431702|58806753|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
30903503|NCT01736566|58937571|FG003|Long Term Follow-up|Still collecting data|0|||
30793075|NCT02431702|58806754|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
30793076|NCT02431702|58806755|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
30622110|NCT01146288|58633604|FG000|First Intervention(1 Day)|Adverse Event|0|||
30793077|NCT02431702|58806756|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
30793078|NCT02431702|58806757|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
30793079|NCT02431702|58806751|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
30793080|NCT02431702|58806752|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
30793081|NCT02431702|58806753|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
30903504|NCT01736566|58937572|FG004|Long Term Follow-up|Still collecting data|1|||
30903505|NCT01768858|58937597|FG000|Overall Study|Lost to Follow-up|9|||
30903506|NCT01768858|58937597|FG000|Overall Study|Lack of Efficacy|8|||
30793082|NCT02431702|58806754|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
30793083|NCT02431702|58806755|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
30793084|NCT02431702|58806756|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
30793085|NCT02431702|58806757|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
30793086|NCT02431702|58806751|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
30793087|NCT02431702|58806752|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
30793088|NCT02431702|58806753|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
30793089|NCT02431702|58806754|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
30793090|NCT02431702|58806755|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
30793091|NCT02431702|58806756|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
30793092|NCT02431702|58806757|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
30793093|NCT02431702|58806751|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
30793094|NCT02431702|58806752|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
30793095|NCT02431702|58806753|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
30903507|NCT01768858|58937597|FG000|Overall Study|Serious Adverse Event|1|||
30903508|NCT01768858|58937597|FG000|Overall Study|Participant moved to Germany|1|||
30903509|NCT01768858|58937597|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
30903510|NCT01768858|58937597|FG000|Overall Study|Exanthema|1|||
30903511|NCT01768858|58937597|FG000|Overall Study|Withdrawal by Subject|1|||
30745425|NCT00296816|58756108|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
30745426|NCT00296816|58756108|FG000|Overall Study|Neuropathy/patient preference|1|||
30793096|NCT02431702|58806754|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
30793097|NCT02431702|58806755|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
30793098|NCT02431702|58806756|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
30793099|NCT02431702|58806757|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
30793100|NCT02431702|58806751|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
30793101|NCT02431702|58806752|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
30793102|NCT02431702|58806753|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
30793103|NCT02431702|58806754|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
30793104|NCT02431702|58806755|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
30793105|NCT02431702|58806756|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
30793106|NCT02431702|58806757|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
30745427|NCT00296816|58756108|FG000|Overall Study|Proteinuria|1|||
30745428|NCT00296816|58756108|FG000|Overall Study|ineligibility due to radiation treatment|1|||
30745429|NCT00314132|58756114|FG000|Overall Study|Lost to Follow-up|3|||
30793107|NCT02431702|58806751|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
30793108|NCT02431702|58806752|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
30793109|NCT02431702|58806753|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
30793110|NCT02431702|58806754|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
30793111|NCT02431702|58806755|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
30793112|NCT02431702|58806756|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
30793113|NCT02431702|58806757|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
30793114|NCT02431702|58806751|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
30793115|NCT02431702|58806752|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
30793116|NCT02431702|58806753|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
30793117|NCT02431702|58806754|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
30793118|NCT02431702|58806755|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
30793119|NCT02431702|58806756|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
30793120|NCT02431702|58806757|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
30793121|NCT02431702|58806751|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
30793122|NCT02431702|58806752|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
30793123|NCT02431702|58806753|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
30793124|NCT02431702|58806754|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
30793125|NCT02431702|58806755|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
30793126|NCT02431702|58806756|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
30793127|NCT02431702|58806757|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
30793128|NCT02431702|58806751|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
30793129|NCT02431702|58806752|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
30745430|NCT00314132|58756115|FG001|Overall Study|Lost to Follow-up|13|||
30745431|NCT00314132|58756114|FG000|Overall Study|Withdrawal by Subject|3|||
30745432|NCT00314132|58756115|FG001|Overall Study|Withdrawal by Subject|5|||
30793130|NCT02431702|58806753|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
30793131|NCT02431702|58806754|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
30793132|NCT02431702|58806755|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
30793133|NCT02431702|58806756|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
30793134|NCT02431702|58806757|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
30793135|NCT02431702|58806751|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
30793136|NCT02431702|58806752|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
30793137|NCT02431702|58806753|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
30793138|NCT02431702|58806754|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
30793139|NCT02431702|58806755|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
30793140|NCT02431702|58806756|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
30793141|NCT02431702|58806757|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
30793142|NCT02431702|58806751|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
30793143|NCT02431702|58806752|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
30793144|NCT02431702|58806753|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
30793145|NCT02431702|58806754|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
30793146|NCT02431702|58806755|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
30793147|NCT02431702|58806756|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
30793148|NCT02431702|58806757|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
30793149|NCT02431702|58806751|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
30793150|NCT02431702|58806752|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
30793151|NCT02431702|58806753|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
30793152|NCT02431702|58806754|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
30793153|NCT02431702|58806755|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
30793154|NCT02431702|58806756|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
30793155|NCT02431702|58806757|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
30793156|NCT02431702|58806751|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
30793157|NCT02431702|58806752|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
30793158|NCT02431702|58806753|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
30793159|NCT02431702|58806754|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
30745433|NCT00314132|58756114|FG000|Overall Study|Adverse Event|1|||
30745434|NCT00314132|58756115|FG001|Overall Study|Adverse Event|0|||
30745435|NCT00314132|58756114|FG000|Overall Study|Physician Decision|1|||
30745436|NCT00314132|58756115|FG001|Overall Study|Physician Decision|0|||
30745437|NCT00097786|58756127|FG000|Overall Study|lost to follow-up for all-cause death|296|||
30745438|NCT00097786|58756128|FG001|Overall Study|lost to follow-up for all-cause death|292|||
30745439|NCT00097786|58756129|FG002|Overall Study|lost to follow-up for all-cause death|313|||
30745440|NCT00097786|58756130|FG003|Overall Study|lost to follow-up for all-cause death|310|||
30793160|NCT02431702|58806755|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
30745441|NCT00117988|58756140|FG000|Overall Study|Death|3|||
30793161|NCT02431702|58806756|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
30745442|NCT00117988|58756140|FG000|Overall Study|Adverse Event|1|||
30745443|NCT00117676|58756146|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
30745444|NCT00117676|58756147|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
30745445|NCT00117676|58756146|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
30745446|NCT00117676|58756147|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
30745447|NCT00117676|58756146|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
30745448|NCT00117676|58756147|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
30745449|NCT00117676|58756146|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
30745450|NCT00117676|58756147|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
30745451|NCT00117676|58756146|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
30793162|NCT02431702|58806757|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
30793163|NCT02431702|58806751|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
30793164|NCT02431702|58806752|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
30793165|NCT02431702|58806753|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
30793166|NCT02431702|58806754|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
30745452|NCT00117676|58756147|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
30745453|NCT00117676|58756146|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
30793167|NCT02431702|58806755|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
30903512|NCT01736254|58937601|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
30903513|NCT01736254|58937601|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
30903514|NCT01767376|58937612|FG000|Overall Study|Lost to Follow-up|3|||
30903515|NCT01767376|58937613|FG001|Overall Study|Lost to Follow-up|2|||
30745454|NCT00117676|58756147|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
30745455|NCT00117676|58756146|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
30745456|NCT00117676|58756147|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
30745457|NCT00117676|58756146|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
30745458|NCT00117676|58756147|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
30745459|NCT00117676|58756146|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
30745460|NCT00117676|58756147|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
30745461|NCT00117676|58756146|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
30745462|NCT00117676|58756147|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
30745463|NCT00117676|58756146|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
30745464|NCT00117676|58756147|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
30745465|NCT00117676|58756146|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
30745466|NCT00117676|58756147|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
30745467|NCT00117676|58756146|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
30745468|NCT00117676|58756147|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
30745469|NCT00117676|58756146|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
30745470|NCT00117676|58756147|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
30745471|NCT00117676|58756146|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
30745472|NCT00117676|58756147|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
30745473|NCT00117676|58756146|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
30745474|NCT00117676|58756147|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
30745475|NCT00117676|58756146|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
30745476|NCT00117676|58756147|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
30745477|NCT00117676|58756146|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
30745478|NCT00117676|58756147|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
30745479|NCT00117676|58756146|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
30745480|NCT00117676|58756147|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
30745481|NCT00117676|58756146|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
30745482|NCT00117676|58756147|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
30745483|NCT00117676|58756146|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
30745484|NCT00117676|58756147|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
30745485|NCT00117676|58756146|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
30745486|NCT00117676|58756147|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
30745487|NCT00117676|58756146|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
30745488|NCT00117676|58756147|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
30745489|NCT00117676|58756146|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
30745490|NCT00117676|58756147|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
30745491|NCT00117676|58756146|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
30745492|NCT00117676|58756147|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
30745493|NCT00117676|58756146|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
30745494|NCT00117676|58756147|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
30745495|NCT00117676|58756146|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
30745496|NCT00117676|58756147|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
30745497|NCT00117676|58756146|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
30745498|NCT00117676|58756147|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
30745499|NCT00117676|58756146|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
30745500|NCT00117676|58756147|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
30745501|NCT00117676|58756146|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
30745502|NCT00117676|58756147|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
30745503|NCT00117676|58756146|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
30745504|NCT00117676|58756147|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
30745505|NCT00117676|58756146|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
30745506|NCT00117676|58756147|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
30745507|NCT00117676|58756146|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
30745508|NCT00117676|58756147|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
30745509|NCT00117676|58756146|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
30745510|NCT00117676|58756147|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
30745511|NCT00117676|58756146|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
30745512|NCT00117676|58756147|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
30745513|NCT00251004|58756161|FG000|Overall Study|Withdrawal by Subject|23|||
30745514|NCT00251004|58756162|FG001|Overall Study|Withdrawal by Subject|16|||
30745515|NCT00251004|58756163|FG002|Overall Study|Withdrawal by Subject|14|||
30745516|NCT00251004|58756161|FG000|Overall Study|Death|9|||
30745517|NCT00251004|58756162|FG001|Overall Study|Death|10|||
30745518|NCT00251004|58756163|FG002|Overall Study|Death|8|||
30745519|NCT00251004|58756161|FG000|Overall Study|Lost to Follow-up|1|||
30745520|NCT00251004|58756162|FG001|Overall Study|Lost to Follow-up|2|||
30745521|NCT00251004|58756163|FG002|Overall Study|Lost to Follow-up|1|||
30745522|NCT00251004|58756161|FG000|Overall Study|Graft Loss|12|||
30745523|NCT00251004|58756162|FG001|Overall Study|Graft Loss|13|||
30745524|NCT00251004|58756163|FG002|Overall Study|Graft Loss|8|||
30745525|NCT00275340|58756173|FG000|Overall Study|Lost to Follow-up|2|||
30745526|NCT00275340|58756174|FG001|Overall Study|Lost to Follow-up|4|||
30745527|NCT00275262|58756180|FG000|Overall Study|Adverse Event|2|||
30745528|NCT00275262|58756181|FG001|Overall Study|Adverse Event|0|||
30745529|NCT00275262|58756180|FG000|Overall Study|Disease progression|2|||
30745530|NCT00275262|58756181|FG001|Overall Study|Disease progression|5|||
30745531|NCT00275262|58756180|FG000|Overall Study|Lost to Follow-up|0|||
30745532|NCT00275262|58756181|FG001|Overall Study|Lost to Follow-up|2|||
30745533|NCT00275262|58756180|FG000|Overall Study|Protocol Violation|0|||
30745534|NCT00275262|58756181|FG001|Overall Study|Protocol Violation|2|||
30745535|NCT00275262|58756180|FG000|Overall Study|Death|1|||
30745536|NCT00275262|58756181|FG001|Overall Study|Death|0|||
30745537|NCT00275262|58756180|FG000|Overall Study|Started Chemotherapy|1|||
30745538|NCT00275262|58756181|FG001|Overall Study|Started Chemotherapy|0|||
30745539|NCT00275028|58756187|FG000|Overall Study|Withdrew consent before treatment began|1|||
30745540|NCT00275028|58756187|FG000|Overall Study|Withdrawal by Subject|5|||
30745541|NCT00275028|58756187|FG000|Overall Study|Adverse Event|9|||
30745542|NCT00275028|58756187|FG000|Overall Study|Progressive Disease|30|||
30745543|NCT00275028|58756187|FG000|Overall Study|Physician Decision|2|||
30745544|NCT00471497|58756194|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
30745545|NCT00471497|58756195|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
30745546|NCT00471497|58756196|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
30745547|NCT00471497|58756194|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
30745548|NCT00471497|58756195|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
30745549|NCT00471497|58756196|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
30745550|NCT00471497|58756194|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
30745551|NCT00471497|58756195|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
30745552|NCT00471497|58756196|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
30745553|NCT00471497|58756194|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
30745554|NCT00471497|58756195|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
30745555|NCT00471497|58756196|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
30745556|NCT00471497|58756194|FG000|Core Treatment Phase|Lost to Follow-up|6|||
30745557|NCT00471497|58756195|FG001|Core Treatment Phase|Lost to Follow-up|6|||
30745558|NCT00471497|58756196|FG002|Core Treatment Phase|Lost to Follow-up|3|||
30745559|NCT00471497|58756194|FG000|Core Treatment Phase|Death|3|||
30745560|NCT00471497|58756195|FG001|Core Treatment Phase|Death|9|||
30745561|NCT00471497|58756196|FG002|Core Treatment Phase|Death|3|||
30745562|NCT00471497|58756194|FG000|Core Treatment Phase|Disease Progression|10|||
30745563|NCT00471497|58756195|FG001|Core Treatment Phase|Disease Progression|2|||
30745564|NCT00471497|58756196|FG002|Core Treatment Phase|Disease Progression|4|||
30745565|NCT00471497|58756194|FG000|Core Treatment Phase|Protocol Violation|6|||
30745566|NCT00471497|58756195|FG001|Core Treatment Phase|Protocol Violation|15|||
30745567|NCT00471497|58756196|FG002|Core Treatment Phase|Protocol Violation|11|||
30745568|NCT00471497|58756194|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
30793168|NCT02431702|58806756|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
30793169|NCT02431702|58806757|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
30793170|NCT02431702|58806751|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
30793171|NCT02431702|58806752|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
30793172|NCT02431702|58806753|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
30793173|NCT02431702|58806754|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
30793174|NCT02431702|58806755|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
30793175|NCT02431702|58806756|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
30793176|NCT02431702|58806757|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
30793177|NCT02086552|58806790|FG000|Overall Study|Withdrawal by Subject|1|||
30793178|NCT03131570|58806835|FG000|Overall Study|Adverse Event|1|||
30903516|NCT01767376|58937614|FG002|Overall Study|Lost to Follow-up|0|||
30903517|NCT01767376|58937612|FG000|Overall Study|Withdrawal by Subject|1|||
30622111|NCT01146288|58633605|FG001|First Intervention(1 Day)|Adverse Event|1|||
30745569|NCT00471497|58756195|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
30903518|NCT01767376|58937613|FG001|Overall Study|Withdrawal by Subject|1|||
30745570|NCT00471497|58756196|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
30793179|NCT03131570|58806836|FG001|Overall Study|Adverse Event|0|||
30903519|NCT01767376|58937614|FG002|Overall Study|Withdrawal by Subject|0|||
30745571|NCT00471497|58756194|FG000|Core Treatment Phase|Administrative problems|14|||
30745572|NCT00471497|58756195|FG001|Core Treatment Phase|Administrative problems|14|||
30745573|NCT00471497|58756196|FG002|Core Treatment Phase|Administrative problems|12|||
30745574|NCT00471497|58756194|FG000|Core Treatment Phase|Adverse Event|43|||
30745575|NCT00471497|58756195|FG001|Core Treatment Phase|Adverse Event|53|||
30793180|NCT02930018|58806846|FG000|Overall Study|Lost to Follow-up|1|||
30793181|NCT02930018|58806847|FG001|Overall Study|Lost to Follow-up|1|||
30793182|NCT02930018|58806846|FG000|Overall Study|Withdrawal by Subject|5|||
30793183|NCT02930018|58806847|FG001|Overall Study|Withdrawal by Subject|2|||
30793184|NCT02875028|58806855|FG000|Washout Period|Withdrawal by Subject|0|||
30793185|NCT02875028|58806856|FG001|Washout Period|Withdrawal by Subject|1|||
30793186|NCT00943618|58806867|FG000|Overall Study|Lost to Follow-up|38|||
30793187|NCT00943618|58806868|FG001|Overall Study|Lost to Follow-up|48|||
30793188|NCT00943618|58806869|FG002|Overall Study|Lost to Follow-up|20|||
30793189|NCT00943618|58806867|FG000|Overall Study|Discontinued Medication|17|||
30793190|NCT00943618|58806868|FG001|Overall Study|Discontinued Medication|29|||
30793191|NCT00943618|58806869|FG002|Overall Study|Discontinued Medication|11|||
30745576|NCT00471497|58756196|FG002|Core Treatment Phase|Adverse Event|89|||
30745577|NCT00471497|58756194|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
30745578|NCT00471497|58756195|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
30745579|NCT00471497|58756196|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
30745580|NCT00471497|58756194|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
30745581|NCT00471497|58756195|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
30745582|NCT00471497|58756196|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
30745583|NCT00471497|58756194|FG000|Extension Phase|Adverse Event|9|||
30745584|NCT00471497|58756195|FG001|Extension Phase|Adverse Event|5|||
30793192|NCT02710084|58806892|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
30793193|NCT02710084|58806893|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
30793194|NCT02849990|58806900|FG000|Overall Study|Adverse Event|1|||
30793195|NCT02849990|58806900|FG000|Overall Study|Withdrawal by Subject|1|||
30793196|NCT02017964|58806904|FG000|Overall Study|Patient deemed ineligible|1|||
30793197|NCT01956110|58806910|FG000|Overall Study|Protocol Violation|25|||
30793198|NCT01956110|58806911|FG001|Overall Study|Protocol Violation|11|||
30793199|NCT01956110|58806910|FG000|Overall Study|Adverse Event|9|||
30793200|NCT01956110|58806911|FG001|Overall Study|Adverse Event|10|||
30793201|NCT01956110|58806910|FG000|Overall Study|Personal reasons|1|||
30793202|NCT01956110|58806911|FG001|Overall Study|Personal reasons|1|||
30793203|NCT03116828|58806942|FG000|Overall Study|Adverse Event|1|||
30793204|NCT03116828|58806943|FG001|Overall Study|Adverse Event|10|||
30793205|NCT03116828|58806942|FG000|Overall Study|Withdrawal by Subject|4|||
30793206|NCT03116828|58806943|FG001|Overall Study|Withdrawal by Subject|8|||
30793207|NCT03116828|58806942|FG000|Overall Study|OTHER|3|||
30793208|NCT03116828|58806943|FG001|Overall Study|OTHER|3|||
30793209|NCT03938272|58806951|FG000|Overall Study|Withdrawal by Subject|1|||
30793210|NCT03938272|58806952|FG001|Overall Study|Withdrawal by Subject|0|||
30793211|NCT03938272|58806951|FG000|Overall Study|Physician Decision|0|||
30793212|NCT03938272|58806952|FG001|Overall Study|Physician Decision|2|||
30793213|NCT03938272|58806951|FG000|Overall Study|Study termination by sponsor|10|||
30793214|NCT03938272|58806952|FG001|Overall Study|Study termination by sponsor|8|||
30793215|NCT02565914|58806958|FG000|Overall Study|Adverse Event|17|||
30793216|NCT02565914|58806958|FG000|Overall Study|Withdrawal of consent (not due to AE)|25|||
30793217|NCT02565914|58806958|FG000|Overall Study|Lost to Follow-up|12|||
30793218|NCT02565914|58806958|FG000|Overall Study|Death (not treatment emergent)|1|||
30793219|NCT02565914|58806958|FG000|Overall Study|Other noncompliance|6|||
30793220|NCT02565914|58806958|FG000|Overall Study|Physician Decision|6|||
30793221|NCT02565914|58806958|FG000|Overall Study|Parent study termination by sponsor|1|||
30793222|NCT02565914|58806958|FG000|Overall Study|Commercial drug available|5|||
30793223|NCT02565914|58806958|FG000|Overall Study|Other|18|||
30793224|NCT02565914|58806958|FG000|Overall Study|Enrolled, but did not receive study drug|2|||
30793225|NCT03126344|58806982|FG000|Overall Study|Lost to Follow-up|0|||
30793226|NCT03126344|58806983|FG001|Overall Study|Lost to Follow-up|0|||
30793227|NCT03126344|58806984|FG002|Overall Study|Lost to Follow-up|5|||
30793228|NCT03115112|58807005|FG000|Overall Study|Adverse Event|5|||
30793229|NCT03115112|58807006|FG001|Overall Study|Adverse Event|1|||
30793230|NCT03115112|58807005|FG000|Overall Study|Withdrawal by Subject|4|||
30793231|NCT03115112|58807006|FG001|Overall Study|Withdrawal by Subject|2|||
30793232|NCT03115112|58807005|FG000|Overall Study|Lost to Follow-up|0|||
30793233|NCT03115112|58807006|FG001|Overall Study|Lost to Follow-up|1|||
30745585|NCT00471497|58756196|FG002|Extension Phase|Adverse Event|1|||
30793234|NCT03115112|58807005|FG000|Overall Study|Death|1|||
30793235|NCT03115112|58807006|FG001|Overall Study|Death|0|||
30793236|NCT03115112|58807005|FG000|Overall Study|Pregnancy|1|||
30793237|NCT03115112|58807006|FG001|Overall Study|Pregnancy|0|||
30793238|NCT03115112|58807005|FG000|Overall Study|Site closure|1|||
30793239|NCT03115112|58807006|FG001|Overall Study|Site closure|1|||
30793240|NCT03556358|58807025|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
30793241|NCT03556358|58807026|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
30793242|NCT03556358|58807025|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
30793243|NCT03556358|58807026|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
30793244|NCT03556358|58807025|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
30793245|NCT03556358|58807026|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
30793246|NCT03556358|58807025|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
30793247|NCT03556358|58807026|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
30793248|NCT03556358|58807025|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
30793249|NCT03556358|58807026|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
30793250|NCT03556358|58807025|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
30793251|NCT03556358|58807026|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
30793252|NCT03556358|58807025|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
30793253|NCT03556358|58807026|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
30793254|NCT04490018|58807040|FG000|Overall Study|Protocol Violation|0|||
30793255|NCT04490018|58807041|FG001|Overall Study|Protocol Violation|2|||
30793256|NCT04490018|58807042|FG002|Overall Study|Protocol Violation|1|||
30793257|NCT04490018|58807040|FG000|Overall Study|Lost to Follow-up|2|||
30793258|NCT04490018|58807041|FG001|Overall Study|Lost to Follow-up|2|||
30793259|NCT04490018|58807042|FG002|Overall Study|Lost to Follow-up|0|||
30793260|NCT04490018|58807040|FG000|Overall Study|Withdrawal by Subject|2|||
30793261|NCT04490018|58807041|FG001|Overall Study|Withdrawal by Subject|1|||
30793262|NCT04490018|58807042|FG002|Overall Study|Withdrawal by Subject|0|||
30793263|NCT04490018|58807040|FG000|Overall Study|Withdrawal by parent/guardian|2|||
30793264|NCT04490018|58807041|FG001|Overall Study|Withdrawal by parent/guardian|3|||
30793265|NCT04490018|58807042|FG002|Overall Study|Withdrawal by parent/guardian|0|||
30793266|NCT03118934|58807068|FG000|Overall Study|Adverse Event|0|||
30793267|NCT03118934|58807069|FG001|Overall Study|Adverse Event|0|||
30793268|NCT03118934|58807070|FG002|Overall Study|Adverse Event|0|||
30793269|NCT03118934|58807071|FG003|Overall Study|Adverse Event|0|||
30793270|NCT03118934|58807072|FG004|Overall Study|Adverse Event|0|||
30793271|NCT03118934|58807073|FG005|Overall Study|Adverse Event|1|||
30793272|NCT03118934|58807068|FG000|Overall Study|Physician Decision|0|||
30793273|NCT03118934|58807069|FG001|Overall Study|Physician Decision|0|||
30793274|NCT03118934|58807070|FG002|Overall Study|Physician Decision|0|||
30793275|NCT03118934|58807071|FG003|Overall Study|Physician Decision|0|||
30793276|NCT03118934|58807072|FG004|Overall Study|Physician Decision|0|||
30793277|NCT03118934|58807073|FG005|Overall Study|Physician Decision|1|||
30793278|NCT03118934|58807068|FG000|Overall Study|Discontinued prior to exposure|0|||
30793279|NCT03118934|58807069|FG001|Overall Study|Discontinued prior to exposure|1|||
30793280|NCT03118934|58807070|FG002|Overall Study|Discontinued prior to exposure|1|||
30793281|NCT03118934|58807071|FG003|Overall Study|Discontinued prior to exposure|1|||
30793282|NCT03118934|58807072|FG004|Overall Study|Discontinued prior to exposure|2|||
30793283|NCT03118934|58807073|FG005|Overall Study|Discontinued prior to exposure|0|||
30793284|NCT03114488|58807083|FG000|Time Period 2|Withdrawal by Subject|1|||
30793285|NCT03114488|58807084|FG001|Time Period 2|Withdrawal by Subject|3|||
30793286|NCT03135262|58807103|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
30793287|NCT03135262|58807104|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
30793288|NCT03135262|58807105|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
30793289|NCT03135262|58807106|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
30793290|NCT03135262|58807107|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
30793291|NCT03135262|58807103|FG000|Overall Study|Progression of disease|0|||
30793292|NCT03135262|58807104|FG001|Overall Study|Progression of disease|0|||
30793293|NCT03135262|58807105|FG002|Overall Study|Progression of disease|0|||
30793294|NCT03135262|58807106|FG003|Overall Study|Progression of disease|1|||
30793295|NCT03135262|58807107|FG004|Overall Study|Progression of disease|0|||
30793296|NCT03135262|58807103|FG000|Overall Study|Death|6|||
30793297|NCT03135262|58807104|FG001|Overall Study|Death|2|||
30793298|NCT03135262|58807105|FG002|Overall Study|Death|2|||
30793299|NCT03135262|58807106|FG003|Overall Study|Death|2|||
30793300|NCT03135262|58807107|FG004|Overall Study|Death|0|||
30793301|NCT03135262|58807103|FG000|Overall Study|Withdrawal by Subject|0|||
30793302|NCT03135262|58807104|FG001|Overall Study|Withdrawal by Subject|0|||
30793303|NCT03135262|58807105|FG002|Overall Study|Withdrawal by Subject|1|||
30793304|NCT03135262|58807106|FG003|Overall Study|Withdrawal by Subject|0|||
30793305|NCT03135262|58807107|FG004|Overall Study|Withdrawal by Subject|1|||
30793306|NCT03135262|58807103|FG000|Overall Study|Study terminated by sponsor|2|||
30793307|NCT03135262|58807104|FG001|Overall Study|Study terminated by sponsor|4|||
30793308|NCT03135262|58807105|FG002|Overall Study|Study terminated by sponsor|4|||
30793309|NCT03135262|58807106|FG003|Overall Study|Study terminated by sponsor|3|||
30793310|NCT03135262|58807107|FG004|Overall Study|Study terminated by sponsor|0|||
30903520|NCT01767142|58937624|FG000|Overall Study|Lost to Follow-up|3|||
30793311|NCT03535194|58807142|FG000|Induction Period|Adverse Event|2|||
30793312|NCT03535194|58807143|FG001|Induction Period|Adverse Event|2|||
30793313|NCT03535194|58807144|FG002|Induction Period|Adverse Event|1|||
30793314|NCT03535194|58807145|FG003|Induction Period|Adverse Event|3|||
30793315|NCT03535194|58807146|FG004|Induction Period|Adverse Event|0|||
30793316|NCT03535194|58807142|FG000|Induction Period|Death|0|||
30793317|NCT03535194|58807143|FG001|Induction Period|Death|1|||
30793318|NCT03535194|58807144|FG002|Induction Period|Death|0|||
30793319|NCT03535194|58807145|FG003|Induction Period|Death|0|||
30903521|NCT01785628|58937630|FG000|Overall Study|Lost to Follow-up|2|||
30903522|NCT01785628|58937631|FG001|Overall Study|Lost to Follow-up|3|||
30903523|NCT01785472|58937640|FG000|Overall Study|Adverse Event|5|||
30793320|NCT03535194|58807146|FG004|Induction Period|Death|0|||
30793321|NCT03535194|58807142|FG000|Induction Period|Lack of Efficacy|1|||
30793322|NCT03535194|58807143|FG001|Induction Period|Lack of Efficacy|3|||
30793323|NCT03535194|58807144|FG002|Induction Period|Lack of Efficacy|2|||
30793324|NCT03535194|58807145|FG003|Induction Period|Lack of Efficacy|2|||
30793325|NCT03535194|58807146|FG004|Induction Period|Lack of Efficacy|0|||
30793326|NCT03535194|58807142|FG000|Induction Period|Lost to Follow-up|3|||
30793327|NCT03535194|58807143|FG001|Induction Period|Lost to Follow-up|5|||
30793328|NCT03535194|58807144|FG002|Induction Period|Lost to Follow-up|2|||
30793329|NCT03535194|58807145|FG003|Induction Period|Lost to Follow-up|3|||
30793330|NCT03535194|58807146|FG004|Induction Period|Lost to Follow-up|0|||
30793331|NCT03535194|58807142|FG000|Induction Period|Physician Decision|1|||
30793332|NCT03535194|58807143|FG001|Induction Period|Physician Decision|1|||
30793333|NCT03535194|58807144|FG002|Induction Period|Physician Decision|0|||
30793334|NCT03535194|58807145|FG003|Induction Period|Physician Decision|0|||
30793335|NCT03535194|58807146|FG004|Induction Period|Physician Decision|0|||
30793336|NCT03535194|58807142|FG000|Induction Period|Protocol Violation|1|||
30793337|NCT03535194|58807143|FG001|Induction Period|Protocol Violation|0|||
30793338|NCT03535194|58807144|FG002|Induction Period|Protocol Violation|0|||
30793339|NCT03535194|58807145|FG003|Induction Period|Protocol Violation|1|||
30793340|NCT03535194|58807146|FG004|Induction Period|Protocol Violation|0|||
30793341|NCT03535194|58807142|FG000|Induction Period|Screen Failure|0|||
30793342|NCT03535194|58807143|FG001|Induction Period|Screen Failure|1|||
30793343|NCT03535194|58807144|FG002|Induction Period|Screen Failure|0|||
30793344|NCT03535194|58807145|FG003|Induction Period|Screen Failure|0|||
30793345|NCT03535194|58807146|FG004|Induction Period|Screen Failure|0|||
30793346|NCT03535194|58807142|FG000|Induction Period|Withdrawal by Subject|3|||
30793347|NCT03535194|58807143|FG001|Induction Period|Withdrawal by Subject|4|||
30793348|NCT03535194|58807144|FG002|Induction Period|Withdrawal by Subject|3|||
30793349|NCT03535194|58807145|FG003|Induction Period|Withdrawal by Subject|2|||
30793350|NCT03535194|58807146|FG004|Induction Period|Withdrawal by Subject|0|||
30793351|NCT03535194|58807142|FG000|Maintenance Period|Adverse Event|6|||
30793352|NCT03535194|58807143|FG001|Maintenance Period|Adverse Event|5|||
30793353|NCT03535194|58807144|FG002|Maintenance Period|Adverse Event|1|||
30793354|NCT03535194|58807145|FG003|Maintenance Period|Adverse Event|11|||
30793355|NCT03535194|58807146|FG004|Maintenance Period|Adverse Event|4|||
30793356|NCT03535194|58807142|FG000|Maintenance Period|Lack of Efficacy|3|||
30793357|NCT03535194|58807143|FG001|Maintenance Period|Lack of Efficacy|2|||
30793358|NCT03535194|58807144|FG002|Maintenance Period|Lack of Efficacy|5|||
30903524|NCT01785472|58937641|FG001|Overall Study|Adverse Event|4|||
30903525|NCT01785472|58937642|FG002|Overall Study|Adverse Event|6|||
30903526|NCT01785472|58937640|FG000|Overall Study|Lack of Efficacy|2|||
30903527|NCT01785472|58937641|FG001|Overall Study|Lack of Efficacy|0|||
30903528|NCT01785472|58937642|FG002|Overall Study|Lack of Efficacy|1|||
30903529|NCT01785472|58937640|FG000|Overall Study|Lost to Follow-up|1|||
30903530|NCT01785472|58937641|FG001|Overall Study|Lost to Follow-up|2|||
30903531|NCT01785472|58937642|FG002|Overall Study|Lost to Follow-up|0|||
30903532|NCT01785472|58937640|FG000|Overall Study|Physician Decision|1|||
30903533|NCT01785472|58937641|FG001|Overall Study|Physician Decision|1|||
30903534|NCT01785472|58937642|FG002|Overall Study|Physician Decision|1|||
30903535|NCT01785472|58937640|FG000|Overall Study|Protocol deviation|0|||
30903536|NCT01785472|58937641|FG001|Overall Study|Protocol deviation|2|||
30903537|NCT01785472|58937642|FG002|Overall Study|Protocol deviation|2|||
30903538|NCT01785472|58937640|FG000|Overall Study|Subject/guardian decision|15|||
30903539|NCT01785472|58937641|FG001|Overall Study|Subject/guardian decision|10|||
30622112|NCT01146054|58633612|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
30903540|NCT01785472|58937642|FG002|Overall Study|Subject/guardian decision|11|||
30903541|NCT01785472|58937640|FG000|Overall Study|Technical problems|0|||
30622113|NCT01146054|58633612|FG000|Overall Study|Rapid tumor progression|2|||
30793359|NCT03535194|58807145|FG003|Maintenance Period|Lack of Efficacy|9|||
30793360|NCT03535194|58807146|FG004|Maintenance Period|Lack of Efficacy|0|||
30793361|NCT03535194|58807142|FG000|Maintenance Period|Lost to Follow-up|4|||
30793362|NCT03535194|58807143|FG001|Maintenance Period|Lost to Follow-up|2|||
30793363|NCT03535194|58807144|FG002|Maintenance Period|Lost to Follow-up|1|||
30793364|NCT03535194|58807145|FG003|Maintenance Period|Lost to Follow-up|5|||
30793365|NCT03535194|58807146|FG004|Maintenance Period|Lost to Follow-up|2|||
30793366|NCT03535194|58807142|FG000|Maintenance Period|Other|1|||
30793367|NCT03535194|58807143|FG001|Maintenance Period|Other|2|||
30903542|NCT01785472|58937641|FG001|Overall Study|Technical problems|0|||
30903543|NCT01785472|58937642|FG002|Overall Study|Technical problems|1|||
30793368|NCT03535194|58807144|FG002|Maintenance Period|Other|0|||
30903544|NCT01785160|58937652|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
30903545|NCT01785160|58937652|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
30793369|NCT03535194|58807145|FG003|Maintenance Period|Other|0|||
30793370|NCT03535194|58807146|FG004|Maintenance Period|Other|0|||
30793371|NCT03535194|58807142|FG000|Maintenance Period|Physician Decision|1|||
30793372|NCT03535194|58807143|FG001|Maintenance Period|Physician Decision|2|||
30793373|NCT03535194|58807144|FG002|Maintenance Period|Physician Decision|0|||
30793374|NCT03535194|58807145|FG003|Maintenance Period|Physician Decision|2|||
30793375|NCT03535194|58807146|FG004|Maintenance Period|Physician Decision|0|||
30793376|NCT03535194|58807142|FG000|Maintenance Period|Pregnancy|0|||
30793377|NCT03535194|58807143|FG001|Maintenance Period|Pregnancy|0|||
30793378|NCT03535194|58807144|FG002|Maintenance Period|Pregnancy|0|||
30793379|NCT03535194|58807145|FG003|Maintenance Period|Pregnancy|2|||
30793380|NCT03535194|58807146|FG004|Maintenance Period|Pregnancy|0|||
30793381|NCT03535194|58807142|FG000|Maintenance Period|Protocol Violation|0|||
30793382|NCT03535194|58807143|FG001|Maintenance Period|Protocol Violation|1|||
30793383|NCT03535194|58807144|FG002|Maintenance Period|Protocol Violation|0|||
30793384|NCT03535194|58807145|FG003|Maintenance Period|Protocol Violation|0|||
30793385|NCT03535194|58807146|FG004|Maintenance Period|Protocol Violation|0|||
30793386|NCT03535194|58807142|FG000|Maintenance Period|Withdrawal by Subject|7|||
30793387|NCT03535194|58807143|FG001|Maintenance Period|Withdrawal by Subject|2|||
30793388|NCT03535194|58807144|FG002|Maintenance Period|Withdrawal by Subject|1|||
30793389|NCT03535194|58807145|FG003|Maintenance Period|Withdrawal by Subject|8|||
30793390|NCT03535194|58807146|FG004|Maintenance Period|Withdrawal by Subject|0|||
30793391|NCT03535194|58807142|FG000|Post-Treatment Followup Period|Adverse Event|4|||
30793392|NCT03535194|58807143|FG001|Post-Treatment Followup Period|Adverse Event|5|||
30793393|NCT03535194|58807144|FG002|Post-Treatment Followup Period|Adverse Event|1|||
30793394|NCT03535194|58807145|FG003|Post-Treatment Followup Period|Adverse Event|8|||
30793395|NCT03535194|58807146|FG004|Post-Treatment Followup Period|Adverse Event|0|||
30793396|NCT03535194|58807142|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
30793397|NCT03535194|58807143|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
30793398|NCT03535194|58807144|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
30793399|NCT03535194|58807145|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
30793400|NCT03535194|58807146|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
30793401|NCT03535194|58807142|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
30793402|NCT03535194|58807143|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
30793403|NCT03535194|58807144|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
30793404|NCT03535194|58807145|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
30793405|NCT03535194|58807146|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
30793406|NCT03535194|58807142|FG000|Post-Treatment Followup Period|Other|1|||
30793407|NCT03535194|58807143|FG001|Post-Treatment Followup Period|Other|0|||
30793408|NCT03535194|58807144|FG002|Post-Treatment Followup Period|Other|0|||
30903546|NCT01736176|58937658|FG000|Overall Study|Adverse Event|3|||
30793409|NCT03535194|58807145|FG003|Post-Treatment Followup Period|Other|5|||
30793410|NCT03535194|58807146|FG004|Post-Treatment Followup Period|Other|0|||
30793411|NCT03535194|58807142|FG000|Post-Treatment Followup Period|Physician Decision|0|||
30793412|NCT03535194|58807143|FG001|Post-Treatment Followup Period|Physician Decision|2|||
30793413|NCT03535194|58807144|FG002|Post-Treatment Followup Period|Physician Decision|1|||
30793414|NCT03535194|58807145|FG003|Post-Treatment Followup Period|Physician Decision|1|||
30903547|NCT01736176|58937658|FG000|Overall Study|Withdrawal by Subject|4|||
30903548|NCT01736176|58937658|FG000|Overall Study|Lack of Efficacy|3|||
30903549|NCT01736176|58937658|FG000|Overall Study|Unable to Complete PEG Placement|1|||
30903550|NCT01735630|58937668|FG000|Overall Study|Adverse Event|8|||
30903551|NCT01735630|58937669|FG001|Overall Study|Adverse Event|7|||
30903552|NCT01735630|58937668|FG000|Overall Study|Lost to Follow-up|1|||
30903553|NCT01735630|58937669|FG001|Overall Study|Lost to Follow-up|0|||
30903554|NCT01735630|58937668|FG000|Overall Study|Physician Decision|0|||
30903555|NCT01735630|58937669|FG001|Overall Study|Physician Decision|1|||
30903556|NCT01735630|58937668|FG000|Overall Study|Sponsor Decision|2|||
30903557|NCT01735630|58937669|FG001|Overall Study|Sponsor Decision|1|||
30903558|NCT01735630|58937668|FG000|Overall Study|Withdrawal by Subject|7|||
30903559|NCT01735630|58937669|FG001|Overall Study|Withdrawal by Subject|9|||
30903560|NCT01735396|58937675|FG000|Overall Study|not evaluable|1|||
30622114|NCT01146054|58633612|FG000|Overall Study|Other illness precluded treatment|2|||
30622115|NCT01146054|58633612|FG000|Overall Study|Lost to Follow-up|1|||
30793415|NCT03535194|58807146|FG004|Post-Treatment Followup Period|Physician Decision|0|||
30793416|NCT03535194|58807142|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
30793417|NCT03535194|58807143|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
30793418|NCT03535194|58807144|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
30793419|NCT03535194|58807145|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
30793420|NCT03535194|58807146|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30793421|NCT03559530|58807170|FG000|Overall Study|non-location of medical records|44|||
30903561|NCT01766206|58937679|FG000|Overall Study|Withdrawal by Subject|22|||
30903562|NCT01766206|58937679|FG000|Overall Study|Lost to Follow-up|10|||
30903563|NCT01766206|58937679|FG000|Overall Study|Inappropriate enrollment|18|||
30903564|NCT01766206|58937679|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
30793422|NCT03559530|58807171|FG001|Overall Study|non-location of medical records|0|||
30793423|NCT03559530|58807170|FG000|Overall Study|culture results not considered for treat|29|||
30793424|NCT03559530|58807171|FG001|Overall Study|culture results not considered for treat|0|||
30903565|NCT01734850|58937686|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
30903566|NCT01734850|58937687|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
30903567|NCT01734850|58937688|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
30903568|NCT01734850|58937686|FG000|Overall Study|Not infused due to manufacturing failure|0|||
30903569|NCT01734850|58937687|FG001|Overall Study|Not infused due to manufacturing failure|0|||
30903570|NCT01734850|58937688|FG002|Overall Study|Not infused due to manufacturing failure|1|||
30903571|NCT01766050|58937699|FG000|Overall Study|Adverse Event|1|||
30903572|NCT01766050|58937699|FG000|Overall Study|Lost to Follow-up|1|||
30903573|NCT01766050|58937699|FG000|Overall Study|Withdrawal by Subject|2|||
30903574|NCT02341625|58937727|FG000|Overall Study|Disease Progression|2|||
30903575|NCT02341625|58937728|FG001|Overall Study|Disease Progression|2|||
30903576|NCT02341625|58937729|FG002|Overall Study|Disease Progression|3|||
30903577|NCT02341625|58937730|FG003|Overall Study|Disease Progression|6|||
30903578|NCT02341625|58937731|FG004|Overall Study|Disease Progression|7|||
30793425|NCT03559530|58807170|FG000|Overall Study|duplicate cases|8|||
30793426|NCT03559530|58807171|FG001|Overall Study|duplicate cases|0|||
30793427|NCT03559530|58807170|FG000|Overall Study|other species of Acinetobacte|7|||
30793428|NCT03559530|58807171|FG001|Overall Study|other species of Acinetobacte|0|||
30793429|NCT03559530|58807170|FG000|Overall Study|contamination / colonization|3|||
30793430|NCT03559530|58807171|FG001|Overall Study|contamination / colonization|0|||
30793431|NCT03124784|58807199|FG000|Overall Study|Adverse Event|1|||
30793432|NCT03124784|58807199|FG000|Overall Study|Computer/Equip Malfunction|1|||
30793433|NCT03531840|58807207|FG000|Overall Study|Death on study|3|||
30793434|NCT03531840|58807208|FG001|Overall Study|Death on study|2|||
30793435|NCT03531840|58807209|FG002|Overall Study|Death on study|1|||
30793436|NCT03531840|58807210|FG003|Overall Study|Death on study|2|||
30745586|NCT00471497|58756194|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
30745587|NCT00471497|58756195|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
30745588|NCT00471497|58756196|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
30745589|NCT00471497|58756194|FG000|Extension Phase|Withdrawal by Subject|3|||
30745590|NCT00471497|58756195|FG001|Extension Phase|Withdrawal by Subject|1|||
30793437|NCT03531840|58807207|FG000|Overall Study|Death during follow up|2|||
30793438|NCT03531840|58807208|FG001|Overall Study|Death during follow up|3|||
30793439|NCT03531840|58807209|FG002|Overall Study|Death during follow up|4|||
30793440|NCT03531840|58807210|FG003|Overall Study|Death during follow up|1|||
30793441|NCT03110900|58807227|FG000|Overall Study|Sponsor withdrew|1|||
30793442|NCT03110900|58807228|FG001|Overall Study|Sponsor withdrew|1|||
30745591|NCT00471497|58756196|FG002|Extension Phase|Withdrawal by Subject|0|||
30745592|NCT00471497|58756194|FG000|Extension Phase|Lost to Follow-up|2|||
30745593|NCT00471497|58756195|FG001|Extension Phase|Lost to Follow-up|0|||
30745594|NCT00471497|58756196|FG002|Extension Phase|Lost to Follow-up|0|||
30745595|NCT00471497|58756194|FG000|Extension Phase|Death|1|||
30745596|NCT00471497|58756195|FG001|Extension Phase|Death|0|||
30793443|NCT03867734|58807234|FG000|Overall Study|Lost to Follow-up|2|||
30793444|NCT03446456|58807244|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
30745597|NCT00471497|58756196|FG002|Extension Phase|Death|0|||
30745598|NCT00471497|58756194|FG000|Extension Phase|Disease progression|2|||
30745599|NCT00471497|58756195|FG001|Extension Phase|Disease progression|0|||
30745600|NCT00471497|58756196|FG002|Extension Phase|Disease progression|0|||
30745601|NCT00471497|58756194|FG000|Extension Phase|Protocol Violation|2|||
30745602|NCT00471497|58756195|FG001|Extension Phase|Protocol Violation|2|||
30745603|NCT00471497|58756196|FG002|Extension Phase|Protocol Violation|0|||
30745604|NCT00493649|58756207|FG000|Overall Study|Adverse Event|44|||
30745605|NCT00493649|58756207|FG000|Overall Study|Patient Request|21|||
30745606|NCT00493649|58756207|FG000|Overall Study|Investigator Request|2|||
30745607|NCT00493649|58756207|FG000|Overall Study|Disease Progression|1|||
30745608|NCT00493649|58756207|FG000|Overall Study|Lost to Follow-up|1|||
30745609|NCT00493649|58756207|FG000|Overall Study|Other|13|||
30903579|NCT02341625|58937732|FG005|Overall Study|Disease Progression|7|||
30903580|NCT02341625|58937733|FG006|Overall Study|Disease Progression|28|||
30745610|NCT00471107|58756217|FG000|Overall Study|Technical problems/data loss|3|||
30745611|NCT00471107|58756218|FG001|Overall Study|Technical problems/data loss|1|||
30745612|NCT00471107|58756219|FG002|Overall Study|Technical problems/data loss|3|||
30903581|NCT02341625|58937734|FG007|Overall Study|Disease Progression|5|||
30903582|NCT02341625|58937735|FG008|Overall Study|Disease Progression|4|||
30903583|NCT02341625|58937736|FG009|Overall Study|Disease Progression|19|||
30793445|NCT03446456|58807245|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
30793446|NCT03446456|58807244|FG000|Overall Study|Lost to Follow-up|1|||
30793447|NCT03446456|58807245|FG001|Overall Study|Lost to Follow-up|3|||
30793448|NCT03446456|58807244|FG000|Overall Study|Participant failed the toxicology test|1|||
30793449|NCT03446456|58807245|FG001|Overall Study|Participant failed the toxicology test|0|||
30745613|NCT00488033|58756229|FG000|Overall Study|Withdrawal by Subject|1|||
30745614|NCT00488033|58756230|FG001|Overall Study|Withdrawal by Subject|0|||
30745615|NCT00117598|58756239|FG000|Prior to Treatment Cross Over|Death|40|||
30745616|NCT00117598|58756240|FG001|Prior to Treatment Cross Over|Death|41|||
30745617|NCT00117598|58756241|FG002|Prior to Treatment Cross Over|Death|37|||
30745618|NCT00117598|58756242|FG003|Prior to Treatment Cross Over|Death|0|||
30745619|NCT00117598|58756243|FG004|Prior to Treatment Cross Over|Death|0|||
30745620|NCT00117598|58756239|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
30745621|NCT00117598|58756240|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
30745622|NCT00117598|58756241|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
30745623|NCT00117598|58756242|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
30745624|NCT00117598|58756243|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
30745625|NCT00117598|58756239|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
30793450|NCT03446456|58807244|FG000|Overall Study|Break down of the experimental equipment|1|||
30793451|NCT03446456|58807245|FG001|Overall Study|Break down of the experimental equipment|0|||
30793452|NCT03495102|58807254|FG000|Overall Study|Adverse Event|5|||
30793453|NCT03495102|58807255|FG001|Overall Study|Adverse Event|7|||
30793454|NCT03495102|58807256|FG002|Overall Study|Adverse Event|10|||
30793455|NCT03495102|58807254|FG000|Overall Study|Death|3|||
30793456|NCT03495102|58807255|FG001|Overall Study|Death|4|||
30793457|NCT03495102|58807256|FG002|Overall Study|Death|4|||
30793458|NCT03495102|58807254|FG000|Overall Study|Lost to Follow-up|15|||
30793459|NCT03495102|58807255|FG001|Overall Study|Lost to Follow-up|16|||
30793460|NCT03495102|58807256|FG002|Overall Study|Lost to Follow-up|17|||
30793461|NCT03495102|58807254|FG000|Overall Study|Physician Decision|2|||
30793462|NCT03495102|58807255|FG001|Overall Study|Physician Decision|0|||
30793463|NCT03495102|58807256|FG002|Overall Study|Physician Decision|2|||
30793464|NCT03495102|58807254|FG000|Overall Study|Withdrawal by Subject|25|||
30793465|NCT03495102|58807255|FG001|Overall Study|Withdrawal by Subject|36|||
30793466|NCT03495102|58807256|FG002|Overall Study|Withdrawal by Subject|18|||
30793467|NCT03495102|58807254|FG000|Overall Study|Protocol Violation|1|||
30793468|NCT03495102|58807255|FG001|Overall Study|Protocol Violation|1|||
30793469|NCT03495102|58807256|FG002|Overall Study|Protocol Violation|0|||
30793470|NCT03495102|58807254|FG000|Overall Study|Site Closure|3|||
30793471|NCT03495102|58807255|FG001|Overall Study|Site Closure|1|||
30793472|NCT03495102|58807256|FG002|Overall Study|Site Closure|2|||
30793473|NCT03495102|58807254|FG000|Overall Study|Non-compliance|1|||
30793474|NCT03495102|58807255|FG001|Overall Study|Non-compliance|0|||
30793475|NCT03495102|58807256|FG002|Overall Study|Non-compliance|0|||
30793476|NCT03495102|58807254|FG000|Overall Study|Participant Duplicated at Another Site|0|||
30793477|NCT03495102|58807255|FG001|Overall Study|Participant Duplicated at Another Site|0|||
30793478|NCT03495102|58807256|FG002|Overall Study|Participant Duplicated at Another Site|1|||
30793479|NCT03495102|58807254|FG000|Overall Study|Primary Care Physician Recommendation|0|||
30793480|NCT03495102|58807255|FG001|Overall Study|Primary Care Physician Recommendation|1|||
30793481|NCT03495102|58807256|FG002|Overall Study|Primary Care Physician Recommendation|0|||
30793482|NCT03495102|58807254|FG000|Overall Study|Relocated to Another Country|0|||
30793483|NCT03495102|58807255|FG001|Overall Study|Relocated to Another Country|1|||
30793484|NCT03495102|58807256|FG002|Overall Study|Relocated to Another Country|0|||
30793485|NCT03495102|58807254|FG000|Overall Study|Participant was in Rehabilitation|1|||
30793486|NCT03495102|58807255|FG001|Overall Study|Participant was in Rehabilitation|0|||
30793487|NCT03495102|58807256|FG002|Overall Study|Participant was in Rehabilitation|0|||
30793488|NCT03105362|58807264|FG000|Overall Study|Withdrawal by Subject|1|||
30793489|NCT03105362|58807264|FG000|Overall Study|Lost to Follow-up|1|||
30745626|NCT00117598|58756240|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
30745627|NCT00117598|58756241|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
30793490|NCT03559218|58807273|FG000|Overall Study|Withdrawal by Subject|1|||
30793491|NCT03559218|58807274|FG001|Overall Study|Withdrawal by Subject|0|||
30745628|NCT00117598|58756242|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
30745629|NCT00117598|58756243|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
30793492|NCT03104816|58807283|FG000|Overall Study|Lack of Efficacy|0|||
30793493|NCT03104816|58807284|FG001|Overall Study|Lack of Efficacy|2|||
30793494|NCT03104816|58807285|FG002|Overall Study|Lack of Efficacy|0|||
30793495|NCT03104816|58807283|FG000|Overall Study|Protocol Violation|2|||
30793496|NCT03104816|58807284|FG001|Overall Study|Protocol Violation|0|||
30793497|NCT03104816|58807285|FG002|Overall Study|Protocol Violation|2|||
30793498|NCT03559062|58807296|FG000|Overall Study|Other|0|||
30793499|NCT03559062|58807297|FG001|Overall Study|Other|1|||
30793500|NCT03559062|58807298|FG002|Overall Study|Other|0|||
30793501|NCT00089791|58807309|FG000|Overall Study|Physician Decision|6|||
30793502|NCT00089791|58807310|FG001|Overall Study|Physician Decision|3|||
30793503|NCT00089791|58807309|FG000|Overall Study|Adverse Event|81|||
30793504|NCT00089791|58807310|FG001|Overall Study|Adverse Event|93|||
30793505|NCT00089791|58807309|FG000|Overall Study|Withdrawal by Subject|403|||
30793506|NCT00089791|58807310|FG001|Overall Study|Withdrawal by Subject|344|||
30745630|NCT00117598|58756239|FG000|Prior to Treatment Cross Over|Other|15|||
30745631|NCT00117598|58756240|FG001|Prior to Treatment Cross Over|Other|9|||
30745632|NCT00117598|58756241|FG002|Prior to Treatment Cross Over|Other|9|||
30745633|NCT00117598|58756242|FG003|Prior to Treatment Cross Over|Other|0|||
30745634|NCT00117598|58756243|FG004|Prior to Treatment Cross Over|Other|0|||
30745635|NCT00117598|58756239|FG000|After Treament Cross Over|Death|0|||
30793507|NCT00089791|58807309|FG000|Overall Study|Death|78|||
30793508|NCT00089791|58807310|FG001|Overall Study|Death|62|||
30793509|NCT00089791|58807309|FG000|Overall Study|Disease progression|7|||
30793510|NCT00089791|58807310|FG001|Overall Study|Disease progression|3|||
30793511|NCT00089791|58807309|FG000|Overall Study|Ineligibility determined|12|||
30793512|NCT00089791|58807310|FG001|Overall Study|Ineligibility determined|9|||
30793513|NCT00089791|58807309|FG000|Overall Study|Lost to Follow-up|57|||
30793514|NCT00089791|58807310|FG001|Overall Study|Lost to Follow-up|57|||
30793515|NCT00089791|58807309|FG000|Overall Study|Noncompliance|17|||
30793516|NCT00089791|58807310|FG001|Overall Study|Noncompliance|13|||
30793517|NCT00089791|58807309|FG000|Overall Study|Other|20|||
30793518|NCT00089791|58807310|FG001|Overall Study|Other|32|||
30793519|NCT00089791|58807309|FG000|Overall Study|Protocol deviation|12|||
30793520|NCT00089791|58807310|FG001|Overall Study|Protocol deviation|10|||
30793521|NCT00089791|58807309|FG000|Overall Study|Requirement for alternative therapy|7|||
30793522|NCT00089791|58807310|FG001|Overall Study|Requirement for alternative therapy|4|||
30793523|NCT03558672|58807316|FG000|Overall Study|Study Early Termination|10|||
30793524|NCT03558516|58807322|FG000|Overall Study|Protocol Violation|2|||
30793525|NCT03558516|58807323|FG001|Overall Study|Protocol Violation|2|||
30793526|NCT03557970|58807331|FG000|Overall Study|Study closure|1|||
30793527|NCT03557970|58807332|FG001|Overall Study|Study closure|0|||
30793528|NCT03557970|58807331|FG000|Overall Study|Physician Decision|0|||
30793529|NCT03557970|58807332|FG001|Overall Study|Physician Decision|1|||
30903584|NCT02341625|58937727|FG000|Overall Study|Study Drug Toxicity|0|||
30903585|NCT02341625|58937728|FG001|Overall Study|Study Drug Toxicity|0|||
30903586|NCT02341625|58937729|FG002|Overall Study|Study Drug Toxicity|0|||
30903587|NCT02341625|58937730|FG003|Overall Study|Study Drug Toxicity|1|||
30903588|NCT02341625|58937731|FG004|Overall Study|Study Drug Toxicity|0|||
30903589|NCT02341625|58937732|FG005|Overall Study|Study Drug Toxicity|3|||
30903590|NCT02341625|58937733|FG006|Overall Study|Study Drug Toxicity|10|||
30903591|NCT02341625|58937734|FG007|Overall Study|Study Drug Toxicity|0|||
30903592|NCT02341625|58937735|FG008|Overall Study|Study Drug Toxicity|0|||
30903593|NCT02341625|58937736|FG009|Overall Study|Study Drug Toxicity|3|||
30903594|NCT02341625|58937727|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
30903595|NCT02341625|58937728|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
30903596|NCT02341625|58937729|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
30745636|NCT00117598|58756240|FG001|After Treament Cross Over|Death|0|||
30745637|NCT00117598|58756241|FG002|After Treament Cross Over|Death|0|||
30745638|NCT00117598|58756242|FG003|After Treament Cross Over|Death|1|||
30745639|NCT00117598|58756243|FG004|After Treament Cross Over|Death|2|||
30745640|NCT00117598|58756239|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
30745641|NCT00117598|58756240|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
30745642|NCT00117598|58756241|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
30745643|NCT00117598|58756242|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
30745644|NCT00117598|58756243|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
30793530|NCT03557970|58807331|FG000|Overall Study|Death|0|||
30903597|NCT02341625|58937730|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
30903598|NCT02341625|58937731|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
30903599|NCT02341625|58937732|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
30903600|NCT02341625|58937733|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
30903601|NCT02341625|58937734|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
30745645|NCT00117598|58756239|FG000|After Treament Cross Over|Other|0|||
30745646|NCT00117598|58756240|FG001|After Treament Cross Over|Other|0|||
30745647|NCT00117598|58756241|FG002|After Treament Cross Over|Other|0|||
30793531|NCT03557970|58807332|FG001|Overall Study|Death|1|||
30793532|NCT02815280|58807340|FG000|Double-Blind Phase|Adverse Event|1|||
30793533|NCT02815280|58807341|FG001|Double-Blind Phase|Adverse Event|1|||
30793534|NCT02815280|58807340|FG000|Double-Blind Phase|Lost to Follow-up|10|||
30793535|NCT02815280|58807341|FG001|Double-Blind Phase|Lost to Follow-up|9|||
30903602|NCT02341625|58937735|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
30903603|NCT02341625|58937736|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
30903604|NCT02341625|58937727|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
30903605|NCT02341625|58937728|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
30903606|NCT02341625|58937729|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
30903607|NCT02341625|58937730|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
30903608|NCT02341625|58937731|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
30903609|NCT02341625|58937732|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
30903610|NCT02341625|58937733|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
30793536|NCT02815280|58807340|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
30793537|NCT02815280|58807341|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
30793538|NCT02815280|58807340|FG000|Double-Blind Phase|Protocol Violation|2|||
30793539|NCT02815280|58807341|FG001|Double-Blind Phase|Protocol Violation|2|||
30793540|NCT02815280|58807340|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
30793541|NCT02815280|58807341|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
30793542|NCT02815280|58807340|FG000|Open-Label Phase|Adverse Event|2|||
30793543|NCT02815280|58807341|FG001|Open-Label Phase|Adverse Event|3|||
30793544|NCT02815280|58807340|FG000|Open-Label Phase|Lost to Follow-up|18|||
30793545|NCT02815280|58807341|FG001|Open-Label Phase|Lost to Follow-up|9|||
30793546|NCT02815280|58807340|FG000|Open-Label Phase|Withdrawal by Subject|33|||
30793547|NCT02815280|58807341|FG001|Open-Label Phase|Withdrawal by Subject|18|||
30793548|NCT02815280|58807340|FG000|Open-Label Phase|Protocol Violation|3|||
30793549|NCT02815280|58807341|FG001|Open-Label Phase|Protocol Violation|0|||
30793550|NCT02815280|58807340|FG000|Open-Label Phase|Administrative|26|||
30793551|NCT02815280|58807341|FG001|Open-Label Phase|Administrative|12|||
30793552|NCT02815280|58807340|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
30793553|NCT02815280|58807341|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
30793554|NCT02737930|58807353|FG000|Overall Study|Withdrawal by Subject|0|||
30793555|NCT02737930|58807354|FG001|Overall Study|Withdrawal by Subject|1|||
30793556|NCT03493698|58807360|FG000|Treatment Period C|Adverse Event|1|||
30793557|NCT03493698|58807360|FG000|Treatment Period C|Withdrawal by Subject|1|||
30793558|NCT02737852|58807374|FG000|Overall Study|Withdrawal by Subject|2|||
30793559|NCT03528174|58807378|FG000|Overall Study|Adverse Event|1|||
30793560|NCT03528174|58807378|FG000|Overall Study|sensors dislodged|1|||
30793561|NCT03109184|58807388|FG000|Overall Study|Lost to Follow-up|6|||
30793562|NCT03109184|58807389|FG001|Overall Study|Lost to Follow-up|6|||
30793563|NCT03109184|58807388|FG000|Overall Study|Withdrawal by Subject|1|||
30793564|NCT03109184|58807389|FG001|Overall Study|Withdrawal by Subject|1|||
30793565|NCT03493542|58807407|FG000|Overall Study|Ongoing|2|||
30793566|NCT03493542|58807408|FG001|Overall Study|Ongoing|3|||
30793567|NCT03493542|58807407|FG000|Overall Study|Withdrawal by parent or guardian|3|||
30793568|NCT03493542|58807408|FG001|Overall Study|Withdrawal by parent or guardian|0|||
30793569|NCT03493542|58807407|FG000|Overall Study|Withdrawal by Subject|2|||
30793570|NCT03493542|58807408|FG001|Overall Study|Withdrawal by Subject|6|||
30793571|NCT03493386|58807416|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
30793572|NCT03493386|58807417|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
30793573|NCT03493386|58807418|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
30793574|NCT03493386|58807419|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
30793575|NCT03478644|58807438|FG000|Phase 2|Withdrawal by Subject|2|||
30793576|NCT03478644|58807439|FG001|Phase 2|Withdrawal by Subject|1|||
30793577|NCT03478644|58807438|FG000|Phase 2|Lost to Follow-up|1|||
30793578|NCT03478644|58807439|FG001|Phase 2|Lost to Follow-up|0|||
30793579|NCT03527550|58807447|FG000|Overall Study|Lost to Follow-up|4|||
30793580|NCT03527550|58807448|FG001|Overall Study|Lost to Follow-up|2|||
30793581|NCT03527550|58807447|FG000|Overall Study|Withdrawal by Subject|4|||
30793582|NCT03527550|58807448|FG001|Overall Study|Withdrawal by Subject|1|||
30793583|NCT03527550|58807447|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
30903611|NCT02341625|58937734|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
30903612|NCT02341625|58937735|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
30903613|NCT02341625|58937736|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
30903614|NCT02341625|58937727|FG000|Overall Study|Participant Withdrew Consent|0|||
30903615|NCT02341625|58937728|FG001|Overall Study|Participant Withdrew Consent|0|||
30903616|NCT02341625|58937729|FG002|Overall Study|Participant Withdrew Consent|0|||
30903617|NCT02341625|58937730|FG003|Overall Study|Participant Withdrew Consent|1|||
30903618|NCT02341625|58937731|FG004|Overall Study|Participant Withdrew Consent|0|||
30903619|NCT02341625|58937732|FG005|Overall Study|Participant Withdrew Consent|0|||
30903620|NCT02341625|58937733|FG006|Overall Study|Participant Withdrew Consent|0|||
30903621|NCT02341625|58937734|FG007|Overall Study|Participant Withdrew Consent|0|||
30903622|NCT02341625|58937735|FG008|Overall Study|Participant Withdrew Consent|0|||
30903623|NCT02341625|58937736|FG009|Overall Study|Participant Withdrew Consent|0|||
30903624|NCT02341625|58937727|FG000|Overall Study|Completed Treatment as per Protocol|0|||
30903625|NCT02341625|58937728|FG001|Overall Study|Completed Treatment as per Protocol|0|||
30903626|NCT02341625|58937729|FG002|Overall Study|Completed Treatment as per Protocol|0|||
30903627|NCT02341625|58937730|FG003|Overall Study|Completed Treatment as per Protocol|0|||
30903628|NCT02341625|58937731|FG004|Overall Study|Completed Treatment as per Protocol|0|||
30903629|NCT02341625|58937732|FG005|Overall Study|Completed Treatment as per Protocol|0|||
30903630|NCT02341625|58937733|FG006|Overall Study|Completed Treatment as per Protocol|0|||
30903631|NCT02341625|58937734|FG007|Overall Study|Completed Treatment as per Protocol|0|||
30903632|NCT02341625|58937735|FG008|Overall Study|Completed Treatment as per Protocol|0|||
30903633|NCT02341625|58937736|FG009|Overall Study|Completed Treatment as per Protocol|1|||
30903634|NCT02341625|58937727|FG000|Overall Study|Other Reasons|0|||
30903635|NCT02341625|58937728|FG001|Overall Study|Other Reasons|0|||
30903636|NCT02341625|58937729|FG002|Overall Study|Other Reasons|0|||
30903637|NCT02341625|58937730|FG003|Overall Study|Other Reasons|0|||
30903638|NCT02341625|58937731|FG004|Overall Study|Other Reasons|1|||
30903639|NCT02341625|58937732|FG005|Overall Study|Other Reasons|0|||
30903640|NCT02341625|58937733|FG006|Overall Study|Other Reasons|5|||
30903641|NCT02341625|58937734|FG007|Overall Study|Other Reasons|0|||
30903642|NCT02341625|58937735|FG008|Overall Study|Other Reasons|0|||
30903643|NCT02341625|58937736|FG009|Overall Study|Other Reasons|2|||
30903644|NCT02341625|58937727|FG000|Overall Study|Not Reported|0|||
30903645|NCT02341625|58937728|FG001|Overall Study|Not Reported|0|||
30903646|NCT02341625|58937729|FG002|Overall Study|Not Reported|0|||
30793584|NCT03527550|58807448|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
30793585|NCT03475056|58807458|FG000|Overall Study|Lost to Follow-up|0|||
30903647|NCT02341625|58937730|FG003|Overall Study|Not Reported|0|||
30903648|NCT02341625|58937731|FG004|Overall Study|Not Reported|0|||
30903649|NCT02341625|58937732|FG005|Overall Study|Not Reported|0|||
30903650|NCT02341625|58937733|FG006|Overall Study|Not Reported|0|||
30903651|NCT02341625|58937734|FG007|Overall Study|Not Reported|0|||
30903652|NCT02341625|58937735|FG008|Overall Study|Not Reported|0|||
30903653|NCT02341625|58937736|FG009|Overall Study|Not Reported|3|||
30903654|NCT02370095|58937783|FG000|Overall Study|Withdrawal by Subject|0|||
30903655|NCT02370095|58937784|FG001|Overall Study|Withdrawal by Subject|1|||
30903656|NCT01783678|58937796|FG000|Overall Study|Randomized but Not Treated|0|||
30903657|NCT01783678|58937797|FG001|Overall Study|Randomized but Not Treated|0|||
30903658|NCT01783678|58937798|FG002|Overall Study|Randomized but Not Treated|0|||
30903659|NCT01783678|58937799|FG003|Overall Study|Randomized but Not Treated|1|||
30903660|NCT01783678|58937800|FG004|Overall Study|Randomized but Not Treated|0|||
30793586|NCT03475056|58807459|FG001|Overall Study|Lost to Follow-up|1|||
30793587|NCT03475056|58807458|FG000|Overall Study|Moved from Area|0|||
30793588|NCT03475056|58807459|FG001|Overall Study|Moved from Area|2|||
30793589|NCT00938912|58807466|FG000|Overall Study|Withdrawal by Subject|28|||
30793590|NCT00938912|58807466|FG000|Overall Study|Lost to Follow-up|4|||
30793591|NCT00938912|58807466|FG000|Overall Study|Lack of Efficacy|43|||
30903661|NCT01783678|58937801|FG005|Overall Study|Randomized but Not Treated|0|||
30903662|NCT01783678|58937796|FG000|Overall Study|Lack of Efficacy|1|||
30622116|NCT01145898|58633618|FG000|3-year Treatment|medication change by treating physician|3|||
30903663|NCT01783678|58937797|FG001|Overall Study|Lack of Efficacy|13|||
30903664|NCT01783678|58937798|FG002|Overall Study|Lack of Efficacy|1|||
30622117|NCT01145898|58633619|FG001|3-year Treatment|medication change by treating physician|16|||
30622118|NCT01133418|58633626|FG000|Overall Study|Lost to Follow-up|5|||
30903665|NCT01783678|58937799|FG003|Overall Study|Lack of Efficacy|3|||
30903666|NCT01783678|58937800|FG004|Overall Study|Lack of Efficacy|6|||
30903667|NCT01783678|58937801|FG005|Overall Study|Lack of Efficacy|5|||
30903668|NCT01783678|58937796|FG000|Overall Study|Lost to Follow-up|0|||
30903669|NCT01783678|58937797|FG001|Overall Study|Lost to Follow-up|4|||
30903670|NCT01783678|58937798|FG002|Overall Study|Lost to Follow-up|0|||
30903671|NCT01783678|58937799|FG003|Overall Study|Lost to Follow-up|2|||
30903672|NCT01783678|58937800|FG004|Overall Study|Lost to Follow-up|1|||
30903673|NCT01783678|58937801|FG005|Overall Study|Lost to Follow-up|0|||
30903674|NCT01783678|58937796|FG000|Overall Study|Withdrew Consent|1|||
30903675|NCT01783678|58937797|FG001|Overall Study|Withdrew Consent|1|||
30903676|NCT01783678|58937798|FG002|Overall Study|Withdrew Consent|0|||
30903677|NCT01783678|58937799|FG003|Overall Study|Withdrew Consent|2|||
30903678|NCT01783678|58937800|FG004|Overall Study|Withdrew Consent|0|||
30903679|NCT01783678|58937801|FG005|Overall Study|Withdrew Consent|0|||
30903680|NCT01734772|58937818|FG000|Overall Study|Adverse Event|1|||
30903681|NCT01734772|58937819|FG001|Overall Study|Adverse Event|2|||
30903682|NCT01734772|58937818|FG000|Overall Study|Withdrawal by Subject|0|||
30903683|NCT01734772|58937819|FG001|Overall Study|Withdrawal by Subject|1|||
30903684|NCT02340221|58937833|FG000|Overall Study|Death|100|||
30903685|NCT02340221|58937834|FG001|Overall Study|Death|197|||
30903686|NCT02340221|58937833|FG000|Overall Study|Withdrawal by Participant|24|||
30903687|NCT02340221|58937834|FG001|Overall Study|Withdrawal by Participant|37|||
30903688|NCT02340221|58937833|FG000|Overall Study|Lost to Follow-up|4|||
30903689|NCT02340221|58937834|FG001|Overall Study|Lost to Follow-up|15|||
30903690|NCT02340221|58937833|FG000|Overall Study|Reason Not Specified|85|||
30903691|NCT02340221|58937834|FG001|Overall Study|Reason Not Specified|165|||
30903692|NCT02340221|58937833|FG000|Overall Study|Study Terminated by Sponsor|1|||
30903693|NCT02340221|58937834|FG001|Overall Study|Study Terminated by Sponsor|3|||
30903694|NCT02339909|58937844|FG000|Overall Study|Became ineligible after randomisation|89|||
30793592|NCT00938912|58807466|FG000|Overall Study|Adverse event, non-fatal|24|||
30793593|NCT00938912|58807466|FG000|Overall Study|Adverse event, fatal|1|||
30793594|NCT00938912|58807466|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
30903695|NCT02339909|58937845|FG001|Overall Study|Became ineligible after randomisation|63|||
30903696|NCT02339909|58937846|FG002|Overall Study|Became ineligible after randomisation|71|||
30903697|NCT02395133|58937858|FG000|Overall Study|Adverse Event|4|||
30903698|NCT02395133|58937859|FG001|Overall Study|Adverse Event|1|||
30903699|NCT02395133|58937860|FG002|Overall Study|Adverse Event|3|||
30903700|NCT02395133|58937861|FG003|Overall Study|Adverse Event|0|||
30903701|NCT02395133|58937858|FG000|Overall Study|Lack of Efficacy|1|||
30903702|NCT02395133|58937859|FG001|Overall Study|Lack of Efficacy|0|||
30903703|NCT02395133|58937860|FG002|Overall Study|Lack of Efficacy|1|||
30903704|NCT02395133|58937861|FG003|Overall Study|Lack of Efficacy|1|||
30903705|NCT02395133|58937858|FG000|Overall Study|Protocol Violation|1|||
30903706|NCT02395133|58937859|FG001|Overall Study|Protocol Violation|1|||
30903707|NCT02395133|58937860|FG002|Overall Study|Protocol Violation|0|||
30903708|NCT02395133|58937861|FG003|Overall Study|Protocol Violation|3|||
30903709|NCT02395133|58937858|FG000|Overall Study|Lost to Follow-up|0|||
30903710|NCT02395133|58937859|FG001|Overall Study|Lost to Follow-up|1|||
30903711|NCT02395133|58937860|FG002|Overall Study|Lost to Follow-up|1|||
30903712|NCT02395133|58937861|FG003|Overall Study|Lost to Follow-up|0|||
30793595|NCT00938912|58807466|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
30793596|NCT00938912|58807466|FG000|Overall Study|Participant needed prohibit medication|1|||
30793597|NCT00938912|58807466|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
30793598|NCT00938912|58807466|FG000|Overall Study|Did not meet Eligibility criteria|1|||
30793599|NCT00938912|58807466|FG000|Overall Study|Participant relocated not related to AE|1|||
30793600|NCT00938912|58807466|FG000|Overall Study|Participant moved to another city|1|||
30793601|NCT00938912|58807466|FG000|Overall Study|Participant experienced break through seizures|1|||
30793602|NCT00938912|58807466|FG000|Overall Study|No longer wished to participate in the study|1|||
30793603|NCT00938912|58807466|FG000|Overall Study|Protocol Deviation|2|||
30793604|NCT03473808|58807473|FG000|Overall Study|Withdrawal by Subject|1|||
30793605|NCT03473340|58807479|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
30793606|NCT03473340|58807480|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
30793607|NCT03473340|58807479|FG000|Overall Study|Withdrawal by Subject|1|||
30793608|NCT03473340|58807480|FG001|Overall Study|Withdrawal by Subject|0|||
30793609|NCT03473340|58807479|FG000|Overall Study|Lost to Follow-up|1|||
30793610|NCT03473340|58807480|FG001|Overall Study|Lost to Follow-up|2|||
30793611|NCT03490032|58807489|FG000|Overall Study|family issue (child custody)|1|||
30793612|NCT03490032|58807490|FG001|Overall Study|family issue (child custody)|0|||
30793613|NCT03490032|58807491|FG002|Overall Study|family issue (child custody)|0|||
30793614|NCT03489720|58807511|FG000|Overall Study|Withdrawal by Subject|2|||
30903713|NCT02395133|58937858|FG000|Overall Study|Pregnancy|0|||
30903714|NCT02395133|58937859|FG001|Overall Study|Pregnancy|0|||
30903715|NCT02395133|58937860|FG002|Overall Study|Pregnancy|3|||
30903716|NCT02395133|58937861|FG003|Overall Study|Pregnancy|0|||
30903717|NCT02395133|58937858|FG000|Overall Study|Consent withdrawn with no reason given|1|||
30903718|NCT02395133|58937859|FG001|Overall Study|Consent withdrawn with no reason given|3|||
30903719|NCT02395133|58937860|FG002|Overall Study|Consent withdrawn with no reason given|0|||
30903720|NCT02395133|58937861|FG003|Overall Study|Consent withdrawn with no reason given|2|||
30903721|NCT02395133|58937858|FG000|Overall Study|Consent withdrawn with personal reason|0|||
30903722|NCT02395133|58937859|FG001|Overall Study|Consent withdrawn with personal reason|1|||
30903723|NCT02395133|58937860|FG002|Overall Study|Consent withdrawn with personal reason|0|||
30903724|NCT02395133|58937861|FG003|Overall Study|Consent withdrawn with personal reason|3|||
30903725|NCT02395133|58937858|FG000|Overall Study|Sponsor decision|2|||
30903726|NCT02395133|58937859|FG001|Overall Study|Sponsor decision|0|||
30903727|NCT02395133|58937860|FG002|Overall Study|Sponsor decision|0|||
30903728|NCT02395133|58937861|FG003|Overall Study|Sponsor decision|1|||
30903729|NCT02395133|58937858|FG000|Overall Study|Other than specified above|5|||
30903730|NCT02395133|58937859|FG001|Overall Study|Other than specified above|2|||
30903731|NCT02395133|58937860|FG002|Overall Study|Other than specified above|2|||
30903732|NCT02395133|58937861|FG003|Overall Study|Other than specified above|4|||
30903733|NCT02395055|58937873|FG000|Overall Study|Withdrawal by Subject|7|||
30903734|NCT02395055|58937874|FG001|Overall Study|Withdrawal by Subject|3|||
30903735|NCT02369159|58937882|FG000|Overall Study|Adverse Event|0|||
30903736|NCT02369159|58937883|FG001|Overall Study|Adverse Event|1|||
30903737|NCT02369159|58937882|FG000|Overall Study|Lost to Follow-up|1|||
30903738|NCT02369159|58937883|FG001|Overall Study|Lost to Follow-up|1|||
30903739|NCT02369159|58937882|FG000|Overall Study|Withdrawal by Subject|7|||
30903740|NCT02369159|58937883|FG001|Overall Study|Withdrawal by Subject|0|||
30903741|NCT02368691|58937900|FG000|Overall Study|Death|13|||
30903742|NCT02368691|58937900|FG000|Overall Study|Lack of Efficacy|15|||
30903743|NCT02368691|58937900|FG000|Overall Study|Physician Decision|4|||
30903744|NCT02394665|58937907|FG000|Overall Study|Physician Decision|1|||
30903745|NCT02394665|58937908|FG001|Overall Study|Physician Decision|0|||
30903746|NCT02394665|58937909|FG002|Overall Study|Physician Decision|0|||
30903747|NCT02367911|58937919|FG000|Overall Study|Withdrawal by Subject|3|||
30903748|NCT02367911|58937920|FG001|Overall Study|Withdrawal by Subject|2|||
30903749|NCT02367911|58937919|FG000|Overall Study|Lost to Follow-up|2|||
30903750|NCT02367911|58937920|FG001|Overall Study|Lost to Follow-up|2|||
30903751|NCT02339285|58937929|FG000|Overall Study|Withdrawal by Subject|0|||
30903752|NCT02339285|58937930|FG001|Overall Study|Withdrawal by Subject|1|||
30903753|NCT02339285|58937931|FG002|Overall Study|Withdrawal by Subject|1|||
30903754|NCT02339285|58937929|FG000|Overall Study|Lost to Follow-up|1|||
30903755|NCT02339285|58937930|FG001|Overall Study|Lost to Follow-up|1|||
30903756|NCT02339285|58937931|FG002|Overall Study|Lost to Follow-up|1|||
30903757|NCT02339285|58937929|FG000|Overall Study|Protocol Deviation|0|||
30745648|NCT00117598|58756242|FG003|After Treament Cross Over|Other|1|||
30745649|NCT00117598|58756243|FG004|After Treament Cross Over|Other|2|||
30745650|NCT00469859|58756255|FG000|Overall Study|Inevaluable|0|||
30745651|NCT00469859|58756256|FG001|Overall Study|Inevaluable|2|||
30745652|NCT00093808|58756262|FG000|Overall Study|Cancel participation before receiving tx|1|||
30745653|NCT00093808|58756262|FG000|Overall Study|Protocol Violation|1|||
30745654|NCT00469079|58756269|FG000|Overall Study|Lack of Efficacy|3|||
30745655|NCT00469079|58756270|FG001|Overall Study|Lack of Efficacy|8|||
30745656|NCT00469079|58756271|FG002|Overall Study|Lack of Efficacy|5|||
30745657|NCT00469079|58756269|FG000|Overall Study|Adverse Event|1|||
30793615|NCT03489720|58807512|FG001|Overall Study|Withdrawal by Subject|0|||
30793616|NCT03527160|58807524|FG000|Overall Study|No urine collected|13|||
30793617|NCT03527160|58807524|FG000|Overall Study|No clinical serum creatinine collected|6|||
30745658|NCT00469079|58756270|FG001|Overall Study|Adverse Event|3|||
30745659|NCT00469079|58756271|FG002|Overall Study|Adverse Event|2|||
30745660|NCT00469079|58756269|FG000|Overall Study|Lost to Follow-up|4|||
30745661|NCT00469079|58756270|FG001|Overall Study|Lost to Follow-up|8|||
30745662|NCT00469079|58756271|FG002|Overall Study|Lost to Follow-up|10|||
30745663|NCT00469079|58756269|FG000|Overall Study|Withdrawal by Subject|1|||
30745664|NCT00469079|58756270|FG001|Overall Study|Withdrawal by Subject|2|||
30745665|NCT00469079|58756271|FG002|Overall Study|Withdrawal by Subject|2|||
30745666|NCT00469079|58756269|FG000|Overall Study|Ineligible|0|||
30745667|NCT00469079|58756270|FG001|Overall Study|Ineligible|1|||
30793618|NCT03527160|58807524|FG000|Overall Study|Did not meet inclusion|2|||
30793619|NCT03739138|58807534|FG000|Overall Study|Death|0|||
30793620|NCT03739138|58807535|FG001|Overall Study|Death|7|||
30793621|NCT03739138|58807536|FG002|Overall Study|Death|4|||
30745668|NCT00469079|58756271|FG002|Overall Study|Ineligible|0|||
30793622|NCT03739138|58807537|FG003|Overall Study|Death|13|||
30793623|NCT03739138|58807538|FG004|Overall Study|Death|0|||
30903758|NCT02339285|58937930|FG001|Overall Study|Protocol Deviation|1|||
30903759|NCT02339285|58937931|FG002|Overall Study|Protocol Deviation|0|||
30903760|NCT02367833|58937942|FG000|Overall Study|Withdrawal by Subject|1|||
30903761|NCT02367833|58937943|FG001|Overall Study|Withdrawal by Subject|1|||
30903762|NCT02367833|58937944|FG002|Overall Study|Withdrawal by Subject|0|||
30903763|NCT02367521|58937954|FG000|Overall Study|severe headache after intervention|2|||
30903764|NCT02367521|58937955|FG001|Overall Study|severe headache after intervention|0|||
30903765|NCT02367521|58937954|FG000|Overall Study|unable to find transportation|2|||
30903766|NCT02367521|58937955|FG001|Overall Study|unable to find transportation|0|||
30793624|NCT03739138|58807534|FG000|Overall Study|Lost to Follow-up|0|||
30793625|NCT03739138|58807535|FG001|Overall Study|Lost to Follow-up|0|||
30745669|NCT00093496|58756287|FG000|Overall Study|Protocol Violation|1|||
30745670|NCT00093496|58756288|FG001|Overall Study|Protocol Violation|3|||
30745671|NCT00117286|58756295|FG000|Overall Study|Adverse Event|12|||
30745672|NCT00117286|58756296|FG001|Overall Study|Adverse Event|6|||
30745673|NCT00117286|58756295|FG000|Overall Study|Lost to Follow-up|2|||
30745674|NCT00117286|58756296|FG001|Overall Study|Lost to Follow-up|0|||
30745675|NCT00117286|58756295|FG000|Overall Study|Protocol Violation|3|||
30745676|NCT00117286|58756296|FG001|Overall Study|Protocol Violation|3|||
30745677|NCT00117286|58756295|FG000|Overall Study|Withdrawal by Subject|6|||
30745678|NCT00117286|58756296|FG001|Overall Study|Withdrawal by Subject|2|||
30745679|NCT00117286|58756295|FG000|Overall Study|Physician Decision|3|||
30745680|NCT00117286|58756296|FG001|Overall Study|Physician Decision|7|||
30745681|NCT00117286|58756295|FG000|Overall Study|Lack of Efficacy|2|||
30745682|NCT00117286|58756296|FG001|Overall Study|Lack of Efficacy|1|||
30745683|NCT00117286|58756295|FG000|Overall Study|Research site closing|0|||
30745684|NCT00117286|58756296|FG001|Overall Study|Research site closing|2|||
30745685|NCT00265122|58756308|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
30745686|NCT00265122|58756309|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
30745687|NCT00265122|58756310|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
30745688|NCT00265122|58756311|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
30745689|NCT00265122|58756312|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
30793626|NCT03739138|58807536|FG002|Overall Study|Lost to Follow-up|1|||
30793627|NCT03739138|58807537|FG003|Overall Study|Lost to Follow-up|0|||
30793628|NCT03739138|58807538|FG004|Overall Study|Lost to Follow-up|0|||
30793629|NCT03739138|58807534|FG000|Overall Study|Study Terminated By Sponsor|0|||
30622119|NCT01133418|58633627|FG001|Overall Study|Lost to Follow-up|6|||
30622120|NCT00931918|58633635|FG000|Overall Study|Adverse Event|4|||
30903767|NCT02338193|58937964|FG000|Overall Study|Withdrawal by Subject|0|||
30903768|NCT02338193|58937965|FG001|Overall Study|Withdrawal by Subject|0|||
30745690|NCT00265122|58756313|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
30745691|NCT00265122|58756308|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
30745692|NCT00265122|58756309|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
30622121|NCT00931918|58633636|FG001|Overall Study|Adverse Event|6|||
30622122|NCT00931918|58633635|FG000|Overall Study|Progressive Disease|2|||
30745693|NCT00265122|58756310|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
30793630|NCT03739138|58807535|FG001|Overall Study|Study Terminated By Sponsor|0|||
30793631|NCT03739138|58807536|FG002|Overall Study|Study Terminated By Sponsor|0|||
30793632|NCT03739138|58807537|FG003|Overall Study|Study Terminated By Sponsor|4|||
30793633|NCT03739138|58807538|FG004|Overall Study|Study Terminated By Sponsor|0|||
30793634|NCT03739138|58807534|FG000|Overall Study|Withdrawal by Subject|0|||
30793635|NCT03739138|58807535|FG001|Overall Study|Withdrawal by Subject|0|||
30793636|NCT03739138|58807536|FG002|Overall Study|Withdrawal by Subject|0|||
30793637|NCT03739138|58807537|FG003|Overall Study|Withdrawal by Subject|1|||
30793638|NCT03739138|58807538|FG004|Overall Study|Withdrawal by Subject|0|||
30793639|NCT03472326|58807548|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
30793640|NCT03472326|58807549|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
30793641|NCT03472326|58807550|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
30793642|NCT03472326|58807551|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
30793643|NCT03472326|58807548|FG000|Part 2: Combination Therapy|Pregnancy|0|||
30793644|NCT03472326|58807549|FG001|Part 2: Combination Therapy|Pregnancy|0|||
30793645|NCT03472326|58807550|FG002|Part 2: Combination Therapy|Pregnancy|0|||
30793646|NCT03472326|58807551|FG003|Part 2: Combination Therapy|Pregnancy|1|||
30793647|NCT02737618|58807560|FG000|Overall Study|Withdrawal by Subject|9|||
30793648|NCT03472014|58807564|FG000|Overall Study|Lost to Follow-up|4|||
30793649|NCT03526458|58807570|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
30793650|NCT03526458|58807571|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
30793651|NCT03526458|58807570|FG000|Overall Study|Stone passed, surgery cancelled|2|||
30793652|NCT03526458|58807571|FG001|Overall Study|Stone passed, surgery cancelled|1|||
30793653|NCT03526458|58807570|FG000|Overall Study|Withdrawal by Subject|1|||
30793654|NCT03526458|58807571|FG001|Overall Study|Withdrawal by Subject|0|||
30793655|NCT03526458|58807570|FG000|Overall Study|Physician Decision|2|||
30793656|NCT03526458|58807571|FG001|Overall Study|Physician Decision|1|||
30793657|NCT03526458|58807570|FG000|Overall Study|Lack of equipment|1|||
30793658|NCT03526458|58807571|FG001|Overall Study|Lack of equipment|1|||
30793659|NCT03488238|58807577|FG000|Overall Study|Equipment malfunction|1|||
30745694|NCT00265122|58756311|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
30745695|NCT00265122|58756312|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
30793660|NCT03488238|58807577|FG000|Overall Study|Adverse Event|1|||
30793661|NCT03525834|58807581|FG000|Overall Study|Progressive disease|1|||
30793662|NCT03525444|58807623|FG000|Overall Study|Adverse Event|0|||
30793663|NCT03525444|58807624|FG001|Overall Study|Adverse Event|1|||
30793664|NCT03525444|58807623|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
30793665|NCT03525444|58807624|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
30903769|NCT02338193|58937966|FG002|Overall Study|Withdrawal by Subject|2|||
30793666|NCT03525444|58807623|FG000|Overall Study|Other|0|||
30793667|NCT03525444|58807624|FG001|Overall Study|Other|1|||
30793668|NCT03487848|58807631|FG000|Overall Study|Lost to Follow-up|1|||
30793669|NCT03524664|58807637|FG000|Overall Study|Withdrawal by Subject|1|||
30793670|NCT03524664|58807638|FG001|Overall Study|Withdrawal by Subject|2|||
30793671|NCT03524664|58807637|FG000|Overall Study|Lost to Follow-up|4|||
30793672|NCT03524664|58807638|FG001|Overall Study|Lost to Follow-up|13|||
30793673|NCT04377620|58807647|FG000|Overall Study|Death|42|||
30793674|NCT04377620|58807648|FG001|Overall Study|Death|48|||
30793675|NCT04377620|58807649|FG002|Overall Study|Death|36|||
30793676|NCT04377620|58807647|FG000|Overall Study|Withdrawal by Subject|0|||
30793677|NCT04377620|58807648|FG001|Overall Study|Withdrawal by Subject|2|||
30793678|NCT04377620|58807649|FG002|Overall Study|Withdrawal by Subject|0|||
30793679|NCT03486834|58807661|FG000|Overall Study|Withdrawal by Subject|46|||
30793680|NCT03486834|58807662|FG001|Overall Study|Withdrawal by Subject|46|||
30793681|NCT03486834|58807663|FG002|Overall Study|Withdrawal by Subject|52|||
30793682|NCT03486834|58807661|FG000|Overall Study|Adverse Event|8|||
30793683|NCT03486834|58807662|FG001|Overall Study|Adverse Event|7|||
30793684|NCT03486834|58807663|FG002|Overall Study|Adverse Event|0|||
30793685|NCT03486834|58807661|FG000|Overall Study|Lost to Follow-up|41|||
30793686|NCT03486834|58807662|FG001|Overall Study|Lost to Follow-up|24|||
30793687|NCT03486834|58807663|FG002|Overall Study|Lost to Follow-up|39|||
30793688|NCT03486834|58807661|FG000|Overall Study|Non-compliance with Study Drug|2|||
30793689|NCT03486834|58807662|FG001|Overall Study|Non-compliance with Study Drug|2|||
30793690|NCT03486834|58807663|FG002|Overall Study|Non-compliance with Study Drug|0|||
30793691|NCT03486834|58807661|FG000|Overall Study|Physician Decision|5|||
30793692|NCT03486834|58807662|FG001|Overall Study|Physician Decision|2|||
30793693|NCT03486834|58807663|FG002|Overall Study|Physician Decision|3|||
30793694|NCT03486834|58807661|FG000|Overall Study|Pregnancy|10|||
30793695|NCT03486834|58807662|FG001|Overall Study|Pregnancy|12|||
30793696|NCT03486834|58807663|FG002|Overall Study|Pregnancy|12|||
30793697|NCT03486834|58807661|FG000|Overall Study|Protocol Deviation|2|||
30793698|NCT03486834|58807662|FG001|Overall Study|Protocol Deviation|3|||
30793699|NCT03486834|58807663|FG002|Overall Study|Protocol Deviation|3|||
30793700|NCT03486834|58807661|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
30793701|NCT03486834|58807662|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
30793702|NCT03486834|58807663|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
30903770|NCT02338193|58937964|FG000|Overall Study|Pregnancy|0|||
30903771|NCT02338193|58937965|FG001|Overall Study|Pregnancy|1|||
30903772|NCT02338193|58937966|FG002|Overall Study|Pregnancy|1|||
30745696|NCT00265122|58756313|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
30745697|NCT00265122|58756308|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
30745698|NCT00265122|58756309|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
30745699|NCT00265122|58756310|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
30745700|NCT00265122|58756311|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
30745701|NCT00265122|58756312|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
30745702|NCT00265122|58756313|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
30745703|NCT00265122|58756308|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
30745704|NCT00265122|58756309|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
30745705|NCT00265122|58756310|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
30745706|NCT00265122|58756311|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
30745707|NCT00265122|58756312|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
30745708|NCT00265122|58756313|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
30745709|NCT00265122|58756308|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
30745710|NCT00265122|58756309|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
30745711|NCT00265122|58756310|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
30745712|NCT00265122|58756311|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
30745713|NCT00265122|58756312|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
30745714|NCT00265122|58756313|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
30745715|NCT00265122|58756308|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
30745716|NCT00265122|58756309|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
30745717|NCT00265122|58756310|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
30745718|NCT00265122|58756311|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
30745719|NCT00265122|58756312|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
30745720|NCT00265122|58756313|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
30745721|NCT00116584|58756334|FG000|Overall Study|Withdrawal by Subject|1|||
30745722|NCT00116584|58756335|FG001|Overall Study|Withdrawal by Subject|0|||
30793703|NCT03486834|58807661|FG000|Overall Study|Randomized but not treated|4|||
30793704|NCT03486834|58807662|FG001|Overall Study|Randomized but not treated|4|||
30793705|NCT03486834|58807663|FG002|Overall Study|Randomized but not treated|1|||
30793706|NCT03522948|58807673|FG000|Overall Study|Lost to Follow-up|1|||
30793707|NCT03406078|58807679|FG000|Overall Study|Death|1|||
30793708|NCT03406078|58807680|FG001|Overall Study|Death|0|||
30793709|NCT03406078|58807679|FG000|Overall Study|Lost to Follow-up|0|||
30903773|NCT02338193|58937964|FG000|Overall Study|Noncompliant with visits|2|||
30793710|NCT03406078|58807680|FG001|Overall Study|Lost to Follow-up|1|||
30793711|NCT03406078|58807679|FG000|Overall Study|Withdrawal by Subject|5|||
30793712|NCT03406078|58807680|FG001|Overall Study|Withdrawal by Subject|2|||
30793713|NCT03634033|58807693|FG000|Overall Study|Did not have a post-assessment|384|||
30793714|NCT03634033|58807694|FG001|Overall Study|Did not have a post-assessment|291|||
30903774|NCT02338193|58937965|FG001|Overall Study|Noncompliant with visits|2|||
30903775|NCT02338193|58937966|FG002|Overall Study|Noncompliant with visits|7|||
30793715|NCT03634033|58807695|FG002|Overall Study|Did not have a post-assessment|114|||
30793716|NCT03634033|58807696|FG003|Overall Study|Did not have a post-assessment|161|||
30793717|NCT03634033|58807697|FG004|Overall Study|Did not have a post-assessment|5|||
30793718|NCT03634033|58807698|FG005|Overall Study|Did not have a post-assessment|0|||
30793719|NCT03634033|58807699|FG006|Overall Study|Did not have a post-assessment|0|||
30793720|NCT03634033|58807693|FG000|Overall Study|Death|0|||
30793721|NCT03634033|58807694|FG001|Overall Study|Death|0|||
30793722|NCT03634033|58807695|FG002|Overall Study|Death|0|||
30793723|NCT03634033|58807696|FG003|Overall Study|Death|0|||
30903776|NCT02338193|58937964|FG000|Overall Study|moved out of state|0|||
30903777|NCT02338193|58937965|FG001|Overall Study|moved out of state|1|||
30903778|NCT02338193|58937966|FG002|Overall Study|moved out of state|0|||
30903779|NCT02338193|58937964|FG000|Overall Study|intolerant of side effects|1|||
30793724|NCT03634033|58807697|FG004|Overall Study|Death|0|||
30793725|NCT03634033|58807698|FG005|Overall Study|Death|7|||
30793726|NCT03634033|58807699|FG006|Overall Study|Death|7|||
30793727|NCT03634033|58807693|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
30903780|NCT02338193|58937965|FG001|Overall Study|intolerant of side effects|0|||
30903781|NCT02338193|58937966|FG002|Overall Study|intolerant of side effects|0|||
30903782|NCT01783444|58937977|FG000|Treatment Phase|Adverse Event|9|||
30903783|NCT01783444|58937978|FG001|Treatment Phase|Adverse Event|20|||
30903784|NCT01783444|58937979|FG002|Treatment Phase|Adverse Event|19|||
30903785|NCT01783444|58937977|FG000|Treatment Phase|Disease Progression|76|||
30793728|NCT03634033|58807694|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
30903786|NCT01783444|58937978|FG001|Treatment Phase|Disease Progression|66|||
30903787|NCT01783444|58937979|FG002|Treatment Phase|Disease Progression|64|||
30903788|NCT01783444|58937977|FG000|Treatment Phase|Death|2|||
30903789|NCT01783444|58937978|FG001|Treatment Phase|Death|2|||
30903790|NCT01783444|58937979|FG002|Treatment Phase|Death|2|||
30903791|NCT01783444|58937977|FG000|Treatment Phase|Protocol Violation|1|||
30903792|NCT01783444|58937978|FG001|Treatment Phase|Protocol Violation|1|||
30903793|NCT01783444|58937979|FG002|Treatment Phase|Protocol Violation|2|||
30903794|NCT01783444|58937977|FG000|Treatment Phase|Withdrawal by Subject|6|||
30793729|NCT03634033|58807695|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
30793730|NCT03634033|58807696|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
30903795|NCT01783444|58937978|FG001|Treatment Phase|Withdrawal by Subject|8|||
30903796|NCT01783444|58937979|FG002|Treatment Phase|Withdrawal by Subject|9|||
30903797|NCT01783444|58937977|FG000|Treatment Phase|Administrative problems|2|||
30793731|NCT03634033|58807697|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
30903798|NCT01783444|58937978|FG001|Treatment Phase|Administrative problems|0|||
30903799|NCT01783444|58937979|FG002|Treatment Phase|Administrative problems|1|||
30793732|NCT03634033|58807698|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
30793733|NCT03634033|58807699|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
30903800|NCT01783444|58937977|FG000|Treatment Phase|Physician Decision|8|||
30903801|NCT01783444|58937978|FG001|Treatment Phase|Physician Decision|6|||
30903802|NCT01783444|58937979|FG002|Treatment Phase|Physician Decision|5|||
30903803|NCT01783444|58937977|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
30903804|NCT01783444|58937978|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
30903805|NCT01783444|58937979|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
30903806|NCT01783444|58937977|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
30903807|NCT01783444|58937978|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
30903808|NCT01783444|58937979|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
30903809|NCT01783444|58937977|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
30903810|NCT01783444|58937978|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
30903811|NCT01783444|58937979|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
30793734|NCT03634033|58807693|FG000|Overall Study|Lost to Follow-up|0|||
30793735|NCT03634033|58807694|FG001|Overall Study|Lost to Follow-up|0|||
30793736|NCT03634033|58807695|FG002|Overall Study|Lost to Follow-up|0|||
30793737|NCT03634033|58807696|FG003|Overall Study|Lost to Follow-up|0|||
30793738|NCT03634033|58807697|FG004|Overall Study|Lost to Follow-up|0|||
30793739|NCT03634033|58807698|FG005|Overall Study|Lost to Follow-up|1|||
30793740|NCT03634033|58807699|FG006|Overall Study|Lost to Follow-up|2|||
30793741|NCT03634033|58807693|FG000|Overall Study|Withdrawal by Subject|0|||
30793742|NCT03634033|58807694|FG001|Overall Study|Withdrawal by Subject|0|||
30793743|NCT03634033|58807695|FG002|Overall Study|Withdrawal by Subject|0|||
30793744|NCT03634033|58807696|FG003|Overall Study|Withdrawal by Subject|0|||
30793745|NCT03634033|58807697|FG004|Overall Study|Withdrawal by Subject|0|||
30793746|NCT03634033|58807698|FG005|Overall Study|Withdrawal by Subject|0|||
30793747|NCT03634033|58807699|FG006|Overall Study|Withdrawal by Subject|1|||
30793748|NCT03103100|58807733|FG000|Overall Study|Adverse Event|1|||
30793749|NCT03103100|58807734|FG001|Overall Study|Adverse Event|0|||
30793750|NCT03103100|58807735|FG002|Overall Study|Adverse Event|0|||
30793751|NCT03103100|58807733|FG000|Overall Study|Physician Decision|1|||
30793752|NCT03103100|58807734|FG001|Overall Study|Physician Decision|0|||
30793753|NCT03103100|58807735|FG002|Overall Study|Physician Decision|2|||
30793754|NCT03438006|58807743|FG000|Overall Study|Adverse Event|1|||
30793755|NCT03438006|58807743|FG000|Overall Study|Lost to Follow-up|67|||
30793756|NCT03438006|58807743|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
30793757|NCT03438006|58807743|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
30793758|NCT04206020|58807749|FG000|Overall Study|Adverse Event|1|||
30793759|NCT04206020|58807750|FG001|Overall Study|Adverse Event|4|||
30793760|NCT04206020|58807749|FG000|Overall Study|Protocol Violation|2|||
30793761|NCT04206020|58807750|FG001|Overall Study|Protocol Violation|0|||
30793762|NCT04206020|58807749|FG000|Overall Study|Withdrawal by Subject|2|||
30793763|NCT04206020|58807750|FG001|Overall Study|Withdrawal by Subject|0|||
30793764|NCT04206020|58807749|FG000|Overall Study|Lost to Follow-up|2|||
30793765|NCT04206020|58807750|FG001|Overall Study|Lost to Follow-up|0|||
30793766|NCT04206020|58807749|FG000|Overall Study|Pregnancy|0|||
30793767|NCT04206020|58807750|FG001|Overall Study|Pregnancy|1|||
30793768|NCT04206020|58807749|FG000|Overall Study|Unable to attend visits|1|||
30793769|NCT04206020|58807750|FG001|Overall Study|Unable to attend visits|2|||
30793770|NCT03466086|58807756|FG000|Period 1|Sponsor decision due to study timeline|1|||
30793771|NCT03466086|58807757|FG001|Period 1|Sponsor decision due to study timeline|0|||
30793772|NCT03466086|58807756|FG000|Period 1|Withdrawal by Subject|1|||
30793773|NCT03466086|58807757|FG001|Period 1|Withdrawal by Subject|0|||
30793774|NCT03101462|58807765|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
30793775|NCT03101462|58807766|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
30793776|NCT02873936|58807775|FG000|Overall Study|Withdrew Consent|4|||
30793777|NCT02873936|58807776|FG001|Overall Study|Withdrew Consent|11|||
30793778|NCT02873936|58807777|FG002|Overall Study|Withdrew Consent|20|||
30793779|NCT02873936|58807775|FG000|Overall Study|Investigator's Discretion|3|||
30793780|NCT02873936|58807776|FG001|Overall Study|Investigator's Discretion|5|||
30793781|NCT02873936|58807777|FG002|Overall Study|Investigator's Discretion|4|||
30793782|NCT02873936|58807775|FG000|Overall Study|Adverse Event|3|||
30903812|NCT01783444|58937977|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
30793783|NCT02873936|58807776|FG001|Overall Study|Adverse Event|5|||
30793784|NCT02873936|58807777|FG002|Overall Study|Adverse Event|3|||
30793785|NCT02873936|58807775|FG000|Overall Study|Protocol Violation|0|||
30793786|NCT02873936|58807776|FG001|Overall Study|Protocol Violation|1|||
30793787|NCT02873936|58807777|FG002|Overall Study|Protocol Violation|3|||
30793788|NCT02873936|58807775|FG000|Overall Study|Lost to Follow-up|1|||
30793789|NCT02873936|58807776|FG001|Overall Study|Lost to Follow-up|1|||
30793790|NCT02873936|58807777|FG002|Overall Study|Lost to Follow-up|1|||
30793791|NCT02873936|58807775|FG000|Overall Study|Non-compliance With Study Drug|1|||
30793792|NCT02873936|58807776|FG001|Overall Study|Non-compliance With Study Drug|0|||
30793793|NCT02873936|58807777|FG002|Overall Study|Non-compliance With Study Drug|1|||
30793794|NCT02873936|58807775|FG000|Overall Study|Randomized but not Dosed|1|||
30793795|NCT02873936|58807776|FG001|Overall Study|Randomized but not Dosed|0|||
30793796|NCT02873936|58807777|FG002|Overall Study|Randomized but not Dosed|0|||
30793797|NCT02874794|58807787|FG000|Overall Study|Physician Decision|3|||
30793798|NCT02874794|58807788|FG001|Overall Study|Physician Decision|2|||
30793799|NCT02874794|58807787|FG000|Overall Study|Withdrawal by Subject|2|||
30793800|NCT02874794|58807788|FG001|Overall Study|Withdrawal by Subject|8|||
30793801|NCT02874794|58807787|FG000|Overall Study|Death|2|||
30793802|NCT02874794|58807788|FG001|Overall Study|Death|1|||
30793803|NCT03102710|58807800|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
30793804|NCT03102710|58807801|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
30793805|NCT03102710|58807802|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
30793806|NCT03102710|58807800|FG000|Overall Study|Technical issues during final MRI scan|0|||
30793807|NCT03102710|58807801|FG001|Overall Study|Technical issues during final MRI scan|1|||
30793808|NCT03102710|58807802|FG002|Overall Study|Technical issues during final MRI scan|0|||
30793809|NCT03102710|58807800|FG000|Overall Study|Nausea during MRI scan|0|||
30793810|NCT03102710|58807801|FG001|Overall Study|Nausea during MRI scan|1|||
30793811|NCT03102710|58807802|FG002|Overall Study|Nausea during MRI scan|0|||
30793812|NCT03102710|58807800|FG000|Overall Study|Subject unable to attend final session|0|||
30793813|NCT03102710|58807801|FG001|Overall Study|Subject unable to attend final session|1|||
30793814|NCT03102710|58807802|FG002|Overall Study|Subject unable to attend final session|0|||
30793815|NCT03101150|58807812|FG000|Overall Study|Lost to Follow-up|2|||
30793816|NCT03101150|58807813|FG001|Overall Study|Lost to Follow-up|4|||
30793817|NCT03101150|58807812|FG000|Overall Study|Miscarriage|3|||
30793818|NCT03101150|58807813|FG001|Overall Study|Miscarriage|6|||
30793819|NCT03101930|58807822|FG000|Overall Study|Withdrawal by Subject|2|||
30793820|NCT03101930|58807823|FG001|Overall Study|Withdrawal by Subject|1|||
30793821|NCT03101930|58807824|FG002|Overall Study|Withdrawal by Subject|2|||
30793822|NCT02928848|58807834|FG000|Arm 2|Withdrawal by Subject|1|||
30793823|NCT02928848|58807835|FG001|Arm 2|Withdrawal by Subject|0|||
30793824|NCT02928770|58807843|FG000|Overall Study|Withdrawal by Subject|2|||
30793825|NCT03100838|58807847|FG000|Overall Study|Adverse Event|1|||
30793826|NCT03100838|58807848|FG001|Overall Study|Adverse Event|0|||
30793827|NCT03100838|58807849|FG002|Overall Study|Adverse Event|0|||
30793828|NCT03100838|58807850|FG003|Overall Study|Adverse Event|0|||
30793829|NCT03100838|58807847|FG000|Overall Study|Physician Decision|1|||
30793830|NCT03100838|58807848|FG001|Overall Study|Physician Decision|1|||
30793831|NCT03100838|58807849|FG002|Overall Study|Physician Decision|1|||
30793832|NCT03100838|58807850|FG003|Overall Study|Physician Decision|1|||
30793833|NCT03100838|58807847|FG000|Overall Study|Pregnancy|0|||
30793834|NCT03100838|58807848|FG001|Overall Study|Pregnancy|1|||
30793835|NCT03100838|58807849|FG002|Overall Study|Pregnancy|0|||
30793836|NCT03100838|58807850|FG003|Overall Study|Pregnancy|0|||
30793837|NCT03100838|58807847|FG000|Overall Study|Lost to Follow-up|0|||
30793838|NCT03100838|58807848|FG001|Overall Study|Lost to Follow-up|0|||
30793839|NCT03100838|58807849|FG002|Overall Study|Lost to Follow-up|1|||
30793840|NCT03100838|58807850|FG003|Overall Study|Lost to Follow-up|0|||
30793841|NCT03480750|58807866|FG000|Overall Study|Withdrawal by Subject|0|||
30793842|NCT03480750|58807867|FG001|Overall Study|Withdrawal by Subject|1|||
30793843|NCT03480750|58807868|FG002|Overall Study|Withdrawal by Subject|0|||
30793844|NCT03480750|58807869|FG003|Overall Study|Withdrawal by Subject|0|||
30793845|NCT03480750|58807870|FG004|Overall Study|Withdrawal by Subject|0|||
30793846|NCT03480750|58807871|FG005|Overall Study|Withdrawal by Subject|0|||
30793847|NCT03480750|58807866|FG000|Overall Study|The interruption in Trientine shippment|0|||
30793848|NCT03480750|58807867|FG001|Overall Study|The interruption in Trientine shippment|0|||
30793849|NCT03480750|58807868|FG002|Overall Study|The interruption in Trientine shippment|0|||
30793850|NCT03480750|58807869|FG003|Overall Study|The interruption in Trientine shippment|0|||
30793851|NCT03480750|58807870|FG004|Overall Study|The interruption in Trientine shippment|0|||
30903813|NCT01783444|58937978|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
30903814|NCT01783444|58937979|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
30903815|NCT01783444|58937977|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
30793852|NCT03480750|58807871|FG005|Overall Study|The interruption in Trientine shippment|1|||
30793853|NCT03462030|58807896|FG000|Overall Study|Withdrawal by Subject|1|||
30793854|NCT03462030|58807897|FG001|Overall Study|Withdrawal by Subject|1|||
30793855|NCT03412734|58807905|FG000|Overall Study|Incorrect labeling of samples|2|||
30793856|NCT03412734|58807906|FG001|Overall Study|Incorrect labeling of samples|0|||
30793857|NCT03412734|58807905|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
30793858|NCT03412734|58807906|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
30793859|NCT02374814|58807918|FG000|Overall Study|Lost to Follow-up|1|||
30793860|NCT02374814|58807919|FG001|Overall Study|Lost to Follow-up|1|||
30793861|NCT02374814|58807920|FG002|Overall Study|Lost to Follow-up|0|||
30793862|NCT02374814|58807921|FG003|Overall Study|Lost to Follow-up|1|||
30793863|NCT02374814|58807922|FG004|Overall Study|Lost to Follow-up|0|||
30793864|NCT02374814|58807923|FG005|Overall Study|Lost to Follow-up|0|||
30793865|NCT02374814|58807918|FG000|Overall Study|Withdrawal by Subject|0|||
30793866|NCT02374814|58807919|FG001|Overall Study|Withdrawal by Subject|0|||
30793867|NCT02374814|58807920|FG002|Overall Study|Withdrawal by Subject|1|||
30793868|NCT02374814|58807921|FG003|Overall Study|Withdrawal by Subject|1|||
30793869|NCT02374814|58807922|FG004|Overall Study|Withdrawal by Subject|0|||
30793870|NCT02374814|58807923|FG005|Overall Study|Withdrawal by Subject|0|||
30793871|NCT04608344|58807947|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
30793872|NCT04608344|58807948|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
30793873|NCT04608344|58807947|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
30793874|NCT04608344|58807948|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
30793875|NCT03433482|58807966|FG000|Overall Study|Lost to Follow-up|1|||
30793876|NCT03433482|58807967|FG001|Overall Study|Lost to Follow-up|0|||
30793877|NCT03433482|58807968|FG002|Overall Study|Lost to Follow-up|1|||
30793878|NCT03433482|58807969|FG003|Overall Study|Lost to Follow-up|1|||
30793879|NCT03433482|58807966|FG000|Overall Study|Withdrawal by Subject|0|||
30793880|NCT03433482|58807967|FG001|Overall Study|Withdrawal by Subject|0|||
30793881|NCT03433482|58807968|FG002|Overall Study|Withdrawal by Subject|1|||
30793882|NCT03433482|58807969|FG003|Overall Study|Withdrawal by Subject|0|||
30793883|NCT03433482|58807966|FG000|Overall Study|Unknown reason|0|||
30793884|NCT03433482|58807967|FG001|Overall Study|Unknown reason|0|||
30793885|NCT03433482|58807968|FG002|Overall Study|Unknown reason|2|||
30793886|NCT03433482|58807969|FG003|Overall Study|Unknown reason|0|||
30903816|NCT01783444|58937978|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
30903817|NCT01783444|58937979|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
30903818|NCT01783444|58937977|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
30903819|NCT01783444|58937978|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
30903820|NCT01783444|58937979|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
30903821|NCT02367131|58937988|FG000|Overall Study|Adverse Event|64|||
30903822|NCT02367131|58937988|FG000|Overall Study|No visit since the first visit|4|||
30903823|NCT02367131|58937988|FG000|Overall Study|Request by patient|54|||
30903824|NCT02367131|58937988|FG000|Overall Study|Improvement/remission|2|||
30903825|NCT02367131|58937988|FG000|Overall Study|No change/progressive disease|78|||
30793887|NCT03432858|58807982|FG000|Overall Study|Protocol Violation|2|||
30793888|NCT03432858|58807983|FG001|Overall Study|Protocol Violation|1|||
30793889|NCT03432858|58807984|FG002|Overall Study|Protocol Violation|9|||
30793890|NCT03432858|58807982|FG000|Overall Study|Withdrawal by Subject|0|||
30793891|NCT03432858|58807983|FG001|Overall Study|Withdrawal by Subject|1|||
30793892|NCT03432858|58807984|FG002|Overall Study|Withdrawal by Subject|1|||
30793893|NCT03432858|58807982|FG000|Overall Study|Procedure canceled/rescheduled|0|||
30793894|NCT03432858|58807983|FG001|Overall Study|Procedure canceled/rescheduled|9|||
30793895|NCT03432858|58807984|FG002|Overall Study|Procedure canceled/rescheduled|6|||
30793896|NCT03432858|58807982|FG000|Overall Study|Required postop mobilization with splinting|0|||
30793897|NCT03432858|58807983|FG001|Overall Study|Required postop mobilization with splinting|0|||
30793898|NCT03432858|58807984|FG002|Overall Study|Required postop mobilization with splinting|1|||
30793899|NCT03432390|58807994|FG000|Apnea Period|Protocol Violation|2|||
30793900|NCT03432390|58807995|FG001|Apnea Period|Protocol Violation|2|||
30793901|NCT03456960|58808007|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
30793902|NCT03456960|58808008|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
30793903|NCT03456960|58808009|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
30793904|NCT03456960|58808010|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
30793905|NCT03456960|58808011|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
30793906|NCT03456960|58808012|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
30793907|NCT03456960|58808007|FG000|Period 2 (1 Day)|Adverse Event|1|||
30793908|NCT03456960|58808008|FG001|Period 2 (1 Day)|Adverse Event|0|||
30793909|NCT03456960|58808009|FG002|Period 2 (1 Day)|Adverse Event|0|||
30793910|NCT03456960|58808010|FG003|Period 2 (1 Day)|Adverse Event|1|||
30793911|NCT03456960|58808011|FG004|Period 2 (1 Day)|Adverse Event|0|||
30793912|NCT03456960|58808012|FG005|Period 2 (1 Day)|Adverse Event|0|||
30903826|NCT02367131|58937988|FG000|Overall Study|Other than stated above|20|||
30745723|NCT00116584|58756334|FG000|Overall Study|Protocol Violation|1|||
30745724|NCT00116584|58756335|FG001|Overall Study|Protocol Violation|1|||
30745725|NCT00096538|58756341|FG000|Overall Study|Withdrawal by Subject|1|||
30745726|NCT00239928|58756345|FG000|Overall Study|Lack of Efficacy|1|||
30745727|NCT00239928|58756345|FG000|Overall Study|Adverse Event|4|||
30745728|NCT00239928|58756345|FG000|Overall Study|Not need to continue study|3|||
30745729|NCT00239928|58756345|FG000|Overall Study|Withdrawal by Subject|2|||
30745730|NCT00116428|58756351|FG000|Overall Study|Withdrawal by Subject|2|||
30745731|NCT00116428|58756352|FG001|Overall Study|Withdrawal by Subject|5|||
30745732|NCT00116428|58756351|FG000|Overall Study|Did not meet inclusion criteria|1|||
30745733|NCT00116428|58756352|FG001|Overall Study|Did not meet inclusion criteria|0|||
30745734|NCT00468845|58756364|FG000|Overall Study|Adverse Event|9|||
30745735|NCT00468845|58756365|FG001|Overall Study|Adverse Event|14|||
30793913|NCT03430986|58808030|FG000|24-week Control Period|Adverse Event|1|||
30793914|NCT03430986|58808031|FG001|24-week Control Period|Adverse Event|0|||
30793915|NCT03430986|58808030|FG000|24-week Control Period|Lost to Follow-up|2|||
30793916|NCT03430986|58808031|FG001|24-week Control Period|Lost to Follow-up|2|||
30793917|NCT03430986|58808030|FG000|24-week Control Period|Withdrawal by Participant|5|||
30793918|NCT03430986|58808031|FG001|24-week Control Period|Withdrawal by Participant|0|||
30793919|NCT03430986|58808030|FG000|24-week Control Period|Protocol Deviation|0|||
30793920|NCT03430986|58808031|FG001|24-week Control Period|Protocol Deviation|2|||
30793921|NCT03430986|58808030|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
30793922|NCT03430986|58808031|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
30793923|NCT03430986|58808030|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
30793924|NCT03430986|58808031|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
30793925|NCT03448536|58808042|FG000|Overall Study|Protocol Violation|2|||
30793926|NCT03448536|58808043|FG001|Overall Study|Protocol Violation|0|||
30793927|NCT03448536|58808042|FG000|Overall Study|Pregnancy|1|||
30793928|NCT03448536|58808043|FG001|Overall Study|Pregnancy|0|||
30793929|NCT03448536|58808042|FG000|Overall Study|Withdrawal by Subject|1|||
30793930|NCT03448536|58808043|FG001|Overall Study|Withdrawal by Subject|2|||
30793931|NCT03448536|58808042|FG000|Overall Study|Lost to Follow-up|3|||
30793932|NCT03448536|58808043|FG001|Overall Study|Lost to Follow-up|2|||
30793933|NCT03448536|58808042|FG000|Overall Study|Inadequate pain reporter|1|||
30793934|NCT03448536|58808043|FG001|Overall Study|Inadequate pain reporter|0|||
30793935|NCT03448536|58808042|FG000|Overall Study|Other|3|||
30793936|NCT03448536|58808043|FG001|Overall Study|Other|0|||
30793937|NCT03448536|58808042|FG000|Overall Study|Physician Decision|1|||
30793938|NCT03448536|58808043|FG001|Overall Study|Physician Decision|0|||
30793939|NCT03448224|58808051|FG000|Overall Study|Provided same answer to every question|1|||
30793940|NCT03448224|58808052|FG001|Overall Study|Provided same answer to every question|0|||
30793941|NCT03424044|58808058|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
30793942|NCT03424044|58808059|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
30793943|NCT03424044|58808060|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
30793944|NCT03424044|58808061|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
30793945|NCT03424044|58808062|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
30793946|NCT03424044|58808063|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
30793947|NCT03424044|58808064|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
30793948|NCT03424044|58808065|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
30793949|NCT03424044|58808066|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
30793950|NCT03424044|58808058|FG000|First Intervention (76 Hours)|Adverse Event|0|||
30793951|NCT03424044|58808059|FG001|First Intervention (76 Hours)|Adverse Event|0|||
30793952|NCT03424044|58808060|FG002|First Intervention (76 Hours)|Adverse Event|0|||
30793953|NCT03424044|58808061|FG003|First Intervention (76 Hours)|Adverse Event|0|||
30793954|NCT03424044|58808062|FG004|First Intervention (76 Hours)|Adverse Event|1|||
30793955|NCT03424044|58808063|FG005|First Intervention (76 Hours)|Adverse Event|0|||
30793956|NCT03424044|58808064|FG006|First Intervention (76 Hours)|Adverse Event|0|||
30793957|NCT03424044|58808065|FG007|First Intervention (76 Hours)|Adverse Event|0|||
30793958|NCT03424044|58808066|FG008|First Intervention (76 Hours)|Adverse Event|0|||
30793959|NCT03424044|58808058|FG000|First Intervention (76 Hours)|device issues|0|||
30793960|NCT03424044|58808059|FG001|First Intervention (76 Hours)|device issues|0|||
30793961|NCT03424044|58808060|FG002|First Intervention (76 Hours)|device issues|0|||
30793962|NCT03424044|58808061|FG003|First Intervention (76 Hours)|device issues|0|||
30793963|NCT03424044|58808062|FG004|First Intervention (76 Hours)|device issues|0|||
30793964|NCT03424044|58808063|FG005|First Intervention (76 Hours)|device issues|0|||
30793965|NCT03424044|58808064|FG006|First Intervention (76 Hours)|device issues|1|||
30793966|NCT03424044|58808065|FG007|First Intervention (76 Hours)|device issues|1|||
30793967|NCT03424044|58808066|FG008|First Intervention (76 Hours)|device issues|1|||
30793968|NCT03424044|58808058|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
30793969|NCT03424044|58808059|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
30793970|NCT03424044|58808060|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
30793971|NCT03424044|58808061|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
30793972|NCT03424044|58808062|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
30793973|NCT03424044|58808063|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
30793974|NCT03424044|58808064|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
30793975|NCT03424044|58808065|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
30793976|NCT03424044|58808066|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
30793977|NCT03424044|58808058|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
30793978|NCT03424044|58808059|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
30793979|NCT03424044|58808060|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
30793980|NCT03424044|58808061|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
30793981|NCT03424044|58808062|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
30793982|NCT03424044|58808063|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
30793983|NCT03424044|58808064|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
30793984|NCT03424044|58808065|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
30793985|NCT03424044|58808066|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
30793986|NCT03422250|58808080|FG000|Intervention|Adverse Event|0|||
30793987|NCT03422250|58808081|FG001|Intervention|Adverse Event|1|||
30793988|NCT03422250|58808082|FG002|Intervention|Adverse Event|0|||
30793989|NCT03422250|58808083|FG003|Intervention|Adverse Event|1|||
30793990|NCT03422250|58808080|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
30793991|NCT03422250|58808081|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
30793992|NCT03422250|58808082|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
30793993|NCT03422250|58808083|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
30793994|NCT03422250|58808080|FG000|Follow-up|Withdrawal by Subject|0|||
30793995|NCT03422250|58808081|FG001|Follow-up|Withdrawal by Subject|0|||
30793996|NCT03422250|58808082|FG002|Follow-up|Withdrawal by Subject|0|||
30793997|NCT03422250|58808083|FG003|Follow-up|Withdrawal by Subject|1|||
30793998|NCT03422250|58808080|FG000|Follow-up|Adverse Event|0|||
30793999|NCT03422250|58808081|FG001|Follow-up|Adverse Event|0|||
30794000|NCT03422250|58808082|FG002|Follow-up|Adverse Event|0|||
30794001|NCT03422250|58808083|FG003|Follow-up|Adverse Event|1|||
30794002|NCT01266031|58808098|FG000|Overall Study|Not treated|0|||
30794003|NCT01266031|58808099|FG001|Overall Study|Not treated|3|||
30794004|NCT01266031|58808100|FG002|Overall Study|Not treated|2|||
30794005|NCT00075725|58808131|FG000|Overall Study|Adverse Event|6|||
30794006|NCT00075725|58808132|FG001|Overall Study|Adverse Event|6|||
30794007|NCT00075725|58808133|FG002|Overall Study|Adverse Event|20|||
30794008|NCT00075725|58808134|FG003|Overall Study|Adverse Event|8|||
30794009|NCT00075725|58808135|FG004|Overall Study|Adverse Event|4|||
30794010|NCT00075725|58808136|FG005|Overall Study|Adverse Event|38|||
30794011|NCT00075725|58808137|FG006|Overall Study|Adverse Event|3|||
30794012|NCT00075725|58808138|FG007|Overall Study|Adverse Event|51|||
30794013|NCT00075725|58808139|FG008|Overall Study|Adverse Event|15|||
30794014|NCT00075725|58808140|FG009|Overall Study|Adverse Event|4|||
30794015|NCT00075725|58808141|FG010|Overall Study|Adverse Event|2|||
30794016|NCT00075725|58808142|FG011|Overall Study|Adverse Event|2|||
30794017|NCT00075725|58808131|FG000|Overall Study|Death|3|||
30794018|NCT00075725|58808132|FG001|Overall Study|Death|5|||
30794019|NCT00075725|58808133|FG002|Overall Study|Death|10|||
30794020|NCT00075725|58808134|FG003|Overall Study|Death|2|||
30794021|NCT00075725|58808135|FG004|Overall Study|Death|3|||
30794022|NCT00075725|58808136|FG005|Overall Study|Death|25|||
30794023|NCT00075725|58808137|FG006|Overall Study|Death|4|||
30794024|NCT00075725|58808138|FG007|Overall Study|Death|22|||
30794025|NCT00075725|58808139|FG008|Overall Study|Death|14|||
30794026|NCT00075725|58808140|FG009|Overall Study|Death|4|||
30794027|NCT00075725|58808141|FG010|Overall Study|Death|3|||
30794028|NCT00075725|58808142|FG011|Overall Study|Death|0|||
30794029|NCT00075725|58808131|FG000|Overall Study|Lost to Follow-up|1|||
30794030|NCT00075725|58808132|FG001|Overall Study|Lost to Follow-up|1|||
30794031|NCT00075725|58808133|FG002|Overall Study|Lost to Follow-up|4|||
30794032|NCT00075725|58808134|FG003|Overall Study|Lost to Follow-up|1|||
30794033|NCT00075725|58808135|FG004|Overall Study|Lost to Follow-up|0|||
30794034|NCT00075725|58808136|FG005|Overall Study|Lost to Follow-up|13|||
30794035|NCT00075725|58808137|FG006|Overall Study|Lost to Follow-up|2|||
30794036|NCT00075725|58808138|FG007|Overall Study|Lost to Follow-up|4|||
30794037|NCT00075725|58808139|FG008|Overall Study|Lost to Follow-up|1|||
30794038|NCT00075725|58808140|FG009|Overall Study|Lost to Follow-up|0|||
30794039|NCT00075725|58808141|FG010|Overall Study|Lost to Follow-up|0|||
30794040|NCT00075725|58808142|FG011|Overall Study|Lost to Follow-up|0|||
30794041|NCT00075725|58808131|FG000|Overall Study|Physician Decision|2|||
30794042|NCT00075725|58808132|FG001|Overall Study|Physician Decision|6|||
30794043|NCT00075725|58808133|FG002|Overall Study|Physician Decision|5|||
30794044|NCT00075725|58808134|FG003|Overall Study|Physician Decision|8|||
30794045|NCT00075725|58808135|FG004|Overall Study|Physician Decision|4|||
30794046|NCT00075725|58808136|FG005|Overall Study|Physician Decision|19|||
30794047|NCT00075725|58808137|FG006|Overall Study|Physician Decision|3|||
30794048|NCT00075725|58808138|FG007|Overall Study|Physician Decision|17|||
30794049|NCT00075725|58808139|FG008|Overall Study|Physician Decision|5|||
30794050|NCT00075725|58808140|FG009|Overall Study|Physician Decision|0|||
30794051|NCT00075725|58808141|FG010|Overall Study|Physician Decision|1|||
30903827|NCT02394275|58937992|FG000|Overall Study|Adverse Event|22|||
30903828|NCT02394275|58937992|FG000|Overall Study|Lost to Follow-up|7|||
30794052|NCT00075725|58808142|FG011|Overall Study|Physician Decision|0|||
30794053|NCT00075725|58808131|FG000|Overall Study|Pregnancy|0|||
30794054|NCT00075725|58808132|FG001|Overall Study|Pregnancy|0|||
30794055|NCT00075725|58808133|FG002|Overall Study|Pregnancy|0|||
30794056|NCT00075725|58808134|FG003|Overall Study|Pregnancy|0|||
30794057|NCT00075725|58808135|FG004|Overall Study|Pregnancy|0|||
30794058|NCT00075725|58808136|FG005|Overall Study|Pregnancy|1|||
30794059|NCT00075725|58808137|FG006|Overall Study|Pregnancy|0|||
30794060|NCT00075725|58808138|FG007|Overall Study|Pregnancy|1|||
30794061|NCT00075725|58808139|FG008|Overall Study|Pregnancy|0|||
30794062|NCT00075725|58808140|FG009|Overall Study|Pregnancy|0|||
30794063|NCT00075725|58808141|FG010|Overall Study|Pregnancy|0|||
30794064|NCT00075725|58808142|FG011|Overall Study|Pregnancy|0|||
30794065|NCT00075725|58808131|FG000|Overall Study|Protocol Violation|1|||
30794066|NCT00075725|58808132|FG001|Overall Study|Protocol Violation|1|||
30794067|NCT00075725|58808133|FG002|Overall Study|Protocol Violation|0|||
30794068|NCT00075725|58808134|FG003|Overall Study|Protocol Violation|3|||
30794069|NCT00075725|58808135|FG004|Overall Study|Protocol Violation|3|||
30794070|NCT00075725|58808136|FG005|Overall Study|Protocol Violation|2|||
30794071|NCT00075725|58808137|FG006|Overall Study|Protocol Violation|1|||
30794072|NCT00075725|58808138|FG007|Overall Study|Protocol Violation|2|||
30794073|NCT00075725|58808139|FG008|Overall Study|Protocol Violation|3|||
30794074|NCT00075725|58808140|FG009|Overall Study|Protocol Violation|0|||
30794075|NCT00075725|58808141|FG010|Overall Study|Protocol Violation|0|||
30794076|NCT00075725|58808142|FG011|Overall Study|Protocol Violation|1|||
30794077|NCT00075725|58808131|FG000|Overall Study|Withdrawal by Subject|12|||
30794078|NCT00075725|58808132|FG001|Overall Study|Withdrawal by Subject|3|||
30794079|NCT00075725|58808133|FG002|Overall Study|Withdrawal by Subject|6|||
30745736|NCT00468845|58756366|FG002|Overall Study|Adverse Event|11|||
30745737|NCT00468845|58756364|FG000|Overall Study|Lost to Follow-up|2|||
30745738|NCT00468845|58756365|FG001|Overall Study|Lost to Follow-up|1|||
30745739|NCT00468845|58756366|FG002|Overall Study|Lost to Follow-up|2|||
30745740|NCT00468845|58756364|FG000|Overall Study|Other|4|||
30745741|NCT00468845|58756365|FG001|Overall Study|Other|9|||
30745742|NCT00468845|58756366|FG002|Overall Study|Other|5|||
30745743|NCT00468845|58756364|FG000|Overall Study|No longer willing to participate|5|||
30745744|NCT00468845|58756365|FG001|Overall Study|No longer willing to participate|6|||
30745745|NCT00468845|58756366|FG002|Overall Study|No longer willing to participate|10|||
30745746|NCT00468845|58756364|FG000|Overall Study|Randomized, not treated|1|||
30745747|NCT00468845|58756365|FG001|Overall Study|Randomized, not treated|4|||
30745748|NCT00468845|58756366|FG002|Overall Study|Randomized, not treated|2|||
30745749|NCT00468299|58756376|FG000|Overall Study|Withdrawal by Subject|0|||
30622123|NCT00931918|58633636|FG001|Overall Study|Progressive Disease|1|||
30745750|NCT00468299|58756377|FG001|Overall Study|Withdrawal by Subject|1|||
30794080|NCT00075725|58808134|FG003|Overall Study|Withdrawal by Subject|10|||
30794081|NCT00075725|58808135|FG004|Overall Study|Withdrawal by Subject|6|||
30794082|NCT00075725|58808136|FG005|Overall Study|Withdrawal by Subject|27|||
30794083|NCT00075725|58808137|FG006|Overall Study|Withdrawal by Subject|7|||
30794084|NCT00075725|58808138|FG007|Overall Study|Withdrawal by Subject|31|||
30794085|NCT00075725|58808139|FG008|Overall Study|Withdrawal by Subject|10|||
30794086|NCT00075725|58808140|FG009|Overall Study|Withdrawal by Subject|2|||
30794087|NCT00075725|58808141|FG010|Overall Study|Withdrawal by Subject|0|||
30794088|NCT00075725|58808142|FG011|Overall Study|Withdrawal by Subject|0|||
30794089|NCT00075725|58808131|FG000|Overall Study|Disease Progression, all other reasons|17|||
30794090|NCT00075725|58808132|FG001|Overall Study|Disease Progression, all other reasons|5|||
30794091|NCT00075725|58808133|FG002|Overall Study|Disease Progression, all other reasons|33|||
30794092|NCT00075725|58808134|FG003|Overall Study|Disease Progression, all other reasons|6|||
30794093|NCT00075725|58808135|FG004|Overall Study|Disease Progression, all other reasons|21|||
30794094|NCT00075725|58808136|FG005|Overall Study|Disease Progression, all other reasons|59|||
30794095|NCT00075725|58808137|FG006|Overall Study|Disease Progression, all other reasons|20|||
30794096|NCT00075725|58808138|FG007|Overall Study|Disease Progression, all other reasons|46|||
30794097|NCT00075725|58808139|FG008|Overall Study|Disease Progression, all other reasons|21|||
30794098|NCT00075725|58808140|FG009|Overall Study|Disease Progression, all other reasons|4|||
30794099|NCT00075725|58808141|FG010|Overall Study|Disease Progression, all other reasons|0|||
30794100|NCT00075725|58808142|FG011|Overall Study|Disease Progression, all other reasons|5|||
30794101|NCT00075725|58808131|FG000|Overall Study|Patient off treatment|0|||
30794102|NCT00075725|58808132|FG001|Overall Study|Patient off treatment|0|||
30794103|NCT00075725|58808133|FG002|Overall Study|Patient off treatment|1|||
30903829|NCT01608724|58937997|FG000|Overall Study|Withdrawal by Subject|131|||
30794104|NCT00075725|58808134|FG003|Overall Study|Patient off treatment|2|||
30794105|NCT00075725|58808135|FG004|Overall Study|Patient off treatment|1|||
30794106|NCT00075725|58808136|FG005|Overall Study|Patient off treatment|0|||
30794107|NCT00075725|58808137|FG006|Overall Study|Patient off treatment|0|||
30794108|NCT00075725|58808138|FG007|Overall Study|Patient off treatment|2|||
30794109|NCT00075725|58808139|FG008|Overall Study|Patient off treatment|1|||
30794110|NCT00075725|58808140|FG009|Overall Study|Patient off treatment|0|||
30794111|NCT00075725|58808141|FG010|Overall Study|Patient off treatment|0|||
30745751|NCT00468143|58756385|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
30794112|NCT00075725|58808142|FG011|Overall Study|Patient off treatment|0|||
30794113|NCT00075725|58808131|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
30794114|NCT00075725|58808132|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
30794115|NCT00075725|58808133|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
30794116|NCT00075725|58808134|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
30794117|NCT00075725|58808135|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
30794118|NCT00075725|58808136|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
30794119|NCT00075725|58808137|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
30794120|NCT00075725|58808138|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
30794121|NCT00075725|58808139|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
30794122|NCT00075725|58808140|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
30794123|NCT00075725|58808141|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
30794124|NCT00075725|58808142|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
30794125|NCT00075725|58808131|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
30903830|NCT01608724|58937997|FG000|Overall Study|Lost to Follow-up|41|||
30903831|NCT01608724|58937997|FG000|Overall Study|Study-specific discontinuation criteria|32|||
30903832|NCT01608724|58937997|FG000|Overall Study|Adverse Event|29|||
30903833|NCT01608724|58937997|FG000|Overall Study|Protocol Violation|6|||
30903834|NCT01608724|58937997|FG000|Overall Study|bood sugar too high, etc.|3|||
30903835|NCT01608724|58937997|FG000|Overall Study|Safety reasons|1|||
30903836|NCT02366195|58938001|FG000|Overall Study|Protocol-specified criteria|3|||
30745752|NCT00468143|58756386|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
30745753|NCT00468143|58756385|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
30745754|NCT00468143|58756386|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
30745755|NCT00467831|58756392|FG000|Overall Study|Death|2|||
30745756|NCT00467831|58756392|FG000|Overall Study|Withdrawal by Subject|1|||
30745757|NCT00467753|58756398|FG000|Overall Study|Lost to Follow-up|1|||
30745758|NCT00467753|58756399|FG001|Overall Study|Lost to Follow-up|2|||
30745759|NCT00467753|58756398|FG000|Overall Study|Adverse Event|2|||
30745760|NCT00467753|58756399|FG001|Overall Study|Adverse Event|0|||
30745761|NCT00116272|58756411|FG000|Overall Study|Lost to Follow-up|11|||
30745762|NCT00116272|58756412|FG001|Overall Study|Lost to Follow-up|6|||
30745763|NCT00467597|58756424|FG000|Overall Study|Withdrawal by Subject|2|||
30745764|NCT00467597|58756425|FG001|Overall Study|Withdrawal by Subject|0|||
30745765|NCT00115804|58756435|FG000|Overall Study|Adverse Event|2|||
30745766|NCT00467519|58756443|FG000|Overall Study|Protocol Violation|8|||
30745767|NCT00467519|58756444|FG001|Overall Study|Protocol Violation|4|||
30745768|NCT00467519|58756443|FG000|Overall Study|Lost to Follow-up|2|||
30903837|NCT02366195|58938001|FG000|Overall Study|Withdrawal by Subject|9|||
30903838|NCT02366195|58938001|FG000|Overall Study|Lost to Follow-up|1|||
30745769|NCT00467519|58756444|FG001|Overall Study|Lost to Follow-up|9|||
30794126|NCT00075725|58808132|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
30794127|NCT00075725|58808133|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
30794128|NCT00075725|58808134|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
30794129|NCT00075725|58808135|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
30794130|NCT00075725|58808136|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
30794131|NCT00075725|58808137|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
30794132|NCT00075725|58808138|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
30794133|NCT00075725|58808139|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
30794134|NCT00075725|58808140|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
30794135|NCT00075725|58808141|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
30794136|NCT00075725|58808142|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
30794137|NCT00075725|58808131|FG000|Overall Study|Pt non compliant with therapy|2|||
30794138|NCT00075725|58808132|FG001|Overall Study|Pt non compliant with therapy|1|||
30794139|NCT00075725|58808133|FG002|Overall Study|Pt non compliant with therapy|1|||
30794140|NCT00075725|58808134|FG003|Overall Study|Pt non compliant with therapy|0|||
30794141|NCT00075725|58808135|FG004|Overall Study|Pt non compliant with therapy|2|||
30794142|NCT00075725|58808136|FG005|Overall Study|Pt non compliant with therapy|14|||
30794143|NCT00075725|58808137|FG006|Overall Study|Pt non compliant with therapy|2|||
30794144|NCT00075725|58808138|FG007|Overall Study|Pt non compliant with therapy|5|||
30903839|NCT02366195|58938001|FG000|Overall Study|Death|41|||
30903840|NCT02364947|58938008|FG000|Overall Study|Withdrawal by Subject|10|||
30903841|NCT02364947|58938009|FG001|Overall Study|Withdrawal by Subject|8|||
30903842|NCT02364947|58938010|FG002|Overall Study|Withdrawal by Subject|9|||
30903843|NCT02364947|58938008|FG000|Overall Study|Adverse Event|45|||
30903844|NCT02364947|58938009|FG001|Overall Study|Adverse Event|33|||
30903845|NCT02364947|58938010|FG002|Overall Study|Adverse Event|11|||
30903846|NCT02364947|58938008|FG000|Overall Study|Protocol Violation|1|||
30903847|NCT02364947|58938009|FG001|Overall Study|Protocol Violation|1|||
30903848|NCT02364947|58938010|FG002|Overall Study|Protocol Violation|1|||
30903849|NCT02364947|58938008|FG000|Overall Study|Physician Decision|3|||
30903850|NCT02364947|58938009|FG001|Overall Study|Physician Decision|2|||
30903851|NCT02364947|58938010|FG002|Overall Study|Physician Decision|5|||
30903852|NCT02364947|58938008|FG000|Overall Study|Death|0|||
30903853|NCT02364947|58938009|FG001|Overall Study|Death|1|||
30903854|NCT02364947|58938010|FG002|Overall Study|Death|0|||
30903855|NCT02392481|58938022|FG000|Overall Study|Adverse Event|0|||
30903856|NCT02392481|58938023|FG001|Overall Study|Adverse Event|0|||
30903857|NCT02392481|58938024|FG002|Overall Study|Adverse Event|1|||
30903858|NCT02392481|58938025|FG003|Overall Study|Adverse Event|2|||
30903859|NCT02392481|58938022|FG000|Overall Study|Withdrawal by Subject|0|||
30903860|NCT02392481|58938023|FG001|Overall Study|Withdrawal by Subject|0|||
30903861|NCT02392481|58938024|FG002|Overall Study|Withdrawal by Subject|1|||
30903862|NCT02392481|58938025|FG003|Overall Study|Withdrawal by Subject|0|||
30903863|NCT02392403|58938035|FG000|Overall Study|Adverse Event|1|||
30903864|NCT02392403|58938035|FG000|Overall Study|Death|1|||
30903865|NCT02392403|58938035|FG000|Overall Study|Withdrawal by Subject|1|||
30903866|NCT02392247|58938039|FG000|Overall Study|Withdrawal by Subject|1|||
30903867|NCT02392247|58938039|FG000|Overall Study|Surgery cancelled; no data|1|||
30903868|NCT02337725|58938045|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
30903869|NCT02337725|58938046|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
30903870|NCT02337725|58938045|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
30903871|NCT02337725|58938046|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
30903872|NCT02337725|58938045|FG000|Overall Study|Major Protocol Deviation|0|||
30903873|NCT02337725|58938046|FG001|Overall Study|Major Protocol Deviation|1|||
30903874|NCT02337725|58938045|FG000|Overall Study|Voluntary Withdrawal|14|||
30903875|NCT02337725|58938046|FG001|Overall Study|Voluntary Withdrawal|3|||
30903876|NCT02337725|58938045|FG000|Overall Study|Lack of Efficacy|4|||
30903877|NCT02337725|58938046|FG001|Overall Study|Lack of Efficacy|0|||
30903878|NCT02337491|58938054|FG000|Overall Study|Death|1|||
30903879|NCT02337491|58938055|FG001|Overall Study|Death|1|||
30794145|NCT00075725|58808139|FG008|Overall Study|Pt non compliant with therapy|3|||
30794146|NCT00075725|58808140|FG009|Overall Study|Pt non compliant with therapy|0|||
30903880|NCT02337491|58938054|FG000|Overall Study|Adverse Event|0|||
30903881|NCT02337491|58938055|FG001|Overall Study|Adverse Event|1|||
30903882|NCT02337491|58938054|FG000|Overall Study|Withdrawal by Subject|3|||
30903883|NCT02337491|58938055|FG001|Overall Study|Withdrawal by Subject|0|||
30903884|NCT02337491|58938054|FG000|Overall Study|Progressive Disease|44|||
30903885|NCT02337491|58938055|FG001|Overall Study|Progressive Disease|28|||
30903886|NCT02337491|58938054|FG000|Overall Study|On Treatment|2|||
30903887|NCT02337491|58938055|FG001|Overall Study|On Treatment|0|||
30903888|NCT01765582|58938065|FG000|Overall Study|Other|3|||
30903889|NCT01765582|58938066|FG001|Overall Study|Other|6|||
30903890|NCT01765582|58938067|FG002|Overall Study|Other|9|||
30903891|NCT01765582|58938065|FG000|Overall Study|Lost to Follow-up|2|||
30903892|NCT01765582|58938066|FG001|Overall Study|Lost to Follow-up|2|||
30903893|NCT01765582|58938067|FG002|Overall Study|Lost to Follow-up|1|||
30903894|NCT01765582|58938065|FG000|Overall Study|Death|31|||
30903895|NCT01765582|58938066|FG001|Overall Study|Death|36|||
30903896|NCT01765582|58938067|FG002|Overall Study|Death|33|||
30903897|NCT01765582|58938065|FG000|Overall Study|Sponsor Decision|46|||
30903898|NCT01765582|58938066|FG001|Overall Study|Sponsor Decision|42|||
30903899|NCT01765582|58938067|FG002|Overall Study|Sponsor Decision|42|||
30903900|NCT01765582|58938065|FG000|Overall Study|Withdrawal of Consent|11|||
30903901|NCT01765582|58938066|FG001|Overall Study|Withdrawal of Consent|6|||
30903902|NCT01765582|58938067|FG002|Overall Study|Withdrawal of Consent|10|||
30903903|NCT01649375|58938079|FG000|Up to Week 16|Adverse Event|2|||
30903904|NCT01649375|58938080|FG001|Up to Week 16|Adverse Event|5|||
30903905|NCT01649375|58938081|FG002|Up to Week 16|Adverse Event|4|||
30903906|NCT01649375|58938082|FG003|Up to Week 16|Adverse Event|0|||
30903907|NCT01649375|58938083|FG004|Up to Week 16|Adverse Event|0|||
30903908|NCT01649375|58938079|FG000|Up to Week 16|Lack of Efficacy|0|||
30903909|NCT01649375|58938080|FG001|Up to Week 16|Lack of Efficacy|0|||
30903910|NCT01649375|58938081|FG002|Up to Week 16|Lack of Efficacy|1|||
30903911|NCT01649375|58938082|FG003|Up to Week 16|Lack of Efficacy|0|||
30903912|NCT01649375|58938083|FG004|Up to Week 16|Lack of Efficacy|0|||
30903913|NCT01649375|58938079|FG000|Up to Week 16|Physician Decision|0|||
30903914|NCT01649375|58938080|FG001|Up to Week 16|Physician Decision|0|||
30903915|NCT01649375|58938081|FG002|Up to Week 16|Physician Decision|1|||
30903916|NCT01649375|58938082|FG003|Up to Week 16|Physician Decision|0|||
30794147|NCT00075725|58808141|FG010|Overall Study|Pt non compliant with therapy|0|||
30794148|NCT00075725|58808142|FG011|Overall Study|Pt non compliant with therapy|0|||
30794149|NCT00075725|58808131|FG000|Overall Study|Pt age out of range for treatment|0|||
30794150|NCT00075725|58808132|FG001|Overall Study|Pt age out of range for treatment|1|||
30794151|NCT00075725|58808133|FG002|Overall Study|Pt age out of range for treatment|0|||
30794152|NCT00075725|58808134|FG003|Overall Study|Pt age out of range for treatment|0|||
30794153|NCT00075725|58808135|FG004|Overall Study|Pt age out of range for treatment|0|||
30794154|NCT00075725|58808136|FG005|Overall Study|Pt age out of range for treatment|1|||
30794155|NCT00075725|58808137|FG006|Overall Study|Pt age out of range for treatment|0|||
30794156|NCT00075725|58808138|FG007|Overall Study|Pt age out of range for treatment|1|||
30794157|NCT00075725|58808139|FG008|Overall Study|Pt age out of range for treatment|0|||
30794158|NCT00075725|58808140|FG009|Overall Study|Pt age out of range for treatment|0|||
30794159|NCT00075725|58808141|FG010|Overall Study|Pt age out of range for treatment|0|||
30794160|NCT00075725|58808142|FG011|Overall Study|Pt age out of range for treatment|0|||
30794161|NCT00075725|58808131|FG000|Overall Study|Insurance issues|0|||
30794162|NCT00075725|58808132|FG001|Overall Study|Insurance issues|1|||
30794163|NCT00075725|58808133|FG002|Overall Study|Insurance issues|0|||
30794164|NCT00075725|58808134|FG003|Overall Study|Insurance issues|1|||
30794165|NCT00075725|58808135|FG004|Overall Study|Insurance issues|1|||
30794166|NCT00075725|58808136|FG005|Overall Study|Insurance issues|1|||
30794167|NCT00075725|58808137|FG006|Overall Study|Insurance issues|0|||
30794168|NCT00075725|58808138|FG007|Overall Study|Insurance issues|1|||
30794169|NCT00075725|58808139|FG008|Overall Study|Insurance issues|0|||
30794170|NCT00075725|58808140|FG009|Overall Study|Insurance issues|0|||
30794171|NCT00075725|58808141|FG010|Overall Study|Insurance issues|0|||
30794172|NCT00075725|58808142|FG011|Overall Study|Insurance issues|0|||
30794173|NCT00075725|58808131|FG000|Overall Study|MRD positive after extended ind|0|||
30794174|NCT00075725|58808132|FG001|Overall Study|MRD positive after extended ind|1|||
30794175|NCT00075725|58808133|FG002|Overall Study|MRD positive after extended ind|1|||
30794176|NCT00075725|58808134|FG003|Overall Study|MRD positive after extended ind|0|||
30794177|NCT00075725|58808135|FG004|Overall Study|MRD positive after extended ind|1|||
30794178|NCT00075725|58808136|FG005|Overall Study|MRD positive after extended ind|2|||
30794179|NCT00075725|58808137|FG006|Overall Study|MRD positive after extended ind|0|||
30794180|NCT00075725|58808138|FG007|Overall Study|MRD positive after extended ind|1|||
30794181|NCT00075725|58808139|FG008|Overall Study|MRD positive after extended ind|0|||
30794182|NCT00075725|58808140|FG009|Overall Study|MRD positive after extended ind|0|||
30794183|NCT00075725|58808141|FG010|Overall Study|MRD positive after extended ind|0|||
30794184|NCT00075725|58808142|FG011|Overall Study|MRD positive after extended ind|0|||
30794185|NCT00075725|58808131|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
30903917|NCT01649375|58938083|FG004|Up to Week 16|Physician Decision|0|||
30903918|NCT01649375|58938079|FG000|Up to Week 16|Withdrawal by Subject|2|||
30903919|NCT01649375|58938080|FG001|Up to Week 16|Withdrawal by Subject|1|||
30903920|NCT01649375|58938081|FG002|Up to Week 16|Withdrawal by Subject|2|||
30903921|NCT01649375|58938082|FG003|Up to Week 16|Withdrawal by Subject|0|||
30903922|NCT01649375|58938083|FG004|Up to Week 16|Withdrawal by Subject|0|||
30903923|NCT01649375|58938079|FG000|Up to Week 16|Death|1|||
30903924|NCT01649375|58938080|FG001|Up to Week 16|Death|0|||
30903925|NCT01649375|58938081|FG002|Up to Week 16|Death|0|||
30903926|NCT01649375|58938082|FG003|Up to Week 16|Death|0|||
30903927|NCT01649375|58938083|FG004|Up to Week 16|Death|0|||
30903928|NCT01649375|58938079|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
30903929|NCT01649375|58938080|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
30903930|NCT01649375|58938081|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
30903931|NCT01649375|58938082|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
30903932|NCT01649375|58938083|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
30903933|NCT01649375|58938079|FG000|Week 16 up to Week 260|Non-compliance|0|||
30903934|NCT01649375|58938080|FG001|Week 16 up to Week 260|Non-compliance|1|||
30903935|NCT01649375|58938081|FG002|Week 16 up to Week 260|Non-compliance|0|||
30903936|NCT01649375|58938082|FG003|Week 16 up to Week 260|Non-compliance|1|||
30903937|NCT01649375|58938083|FG004|Week 16 up to Week 260|Non-compliance|0|||
30903938|NCT01649375|58938079|FG000|Week 16 up to Week 260|Physician Decision|0|||
30903939|NCT01649375|58938080|FG001|Week 16 up to Week 260|Physician Decision|2|||
30903940|NCT01649375|58938081|FG002|Week 16 up to Week 260|Physician Decision|0|||
30903941|NCT01649375|58938082|FG003|Week 16 up to Week 260|Physician Decision|0|||
30903942|NCT01649375|58938083|FG004|Week 16 up to Week 260|Physician Decision|0|||
30903943|NCT01649375|58938079|FG000|Week 16 up to Week 260|Technical issues|0|||
30903944|NCT01649375|58938080|FG001|Week 16 up to Week 260|Technical issues|1|||
30903945|NCT01649375|58938081|FG002|Week 16 up to Week 260|Technical issues|0|||
30903946|NCT01649375|58938082|FG003|Week 16 up to Week 260|Technical issues|1|||
30903947|NCT01649375|58938083|FG004|Week 16 up to Week 260|Technical issues|0|||
30794186|NCT00075725|58808132|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
30622124|NCT00931918|58633635|FG000|Overall Study|Symptomatic Deterioration|1|||
30622125|NCT00931918|58633636|FG001|Overall Study|Symptomatic Deterioration|0|||
30622126|NCT00931918|58633635|FG000|Overall Study|Withdrawal by Patient|3|||
30794187|NCT00075725|58808133|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
30794188|NCT00075725|58808134|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
30794189|NCT00075725|58808135|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
30794190|NCT00075725|58808136|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
30794191|NCT00075725|58808137|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
30622127|NCT00931918|58633636|FG001|Overall Study|Withdrawal by Patient|4|||
30622128|NCT00931918|58633635|FG000|Overall Study|Other Reason not Specified|4|||
30903948|NCT01649375|58938079|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
30622129|NCT00931918|58633636|FG001|Overall Study|Other Reason not Specified|4|||
30903949|NCT01649375|58938080|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
30794192|NCT00075725|58808138|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
30794193|NCT00075725|58808139|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
30794194|NCT00075725|58808140|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
30794195|NCT00075725|58808141|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
30794196|NCT00075725|58808142|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
30794197|NCT00075725|58808131|FG000|Overall Study|Inevaluable|1|||
30794198|NCT00075725|58808132|FG001|Overall Study|Inevaluable|1|||
30794199|NCT00075725|58808133|FG002|Overall Study|Inevaluable|4|||
30794200|NCT00075725|58808134|FG003|Overall Study|Inevaluable|2|||
30794201|NCT00075725|58808135|FG004|Overall Study|Inevaluable|2|||
30794202|NCT00075725|58808136|FG005|Overall Study|Inevaluable|9|||
30794203|NCT00075725|58808137|FG006|Overall Study|Inevaluable|1|||
30794204|NCT00075725|58808138|FG007|Overall Study|Inevaluable|11|||
30794205|NCT00075725|58808139|FG008|Overall Study|Inevaluable|2|||
30794206|NCT00075725|58808140|FG009|Overall Study|Inevaluable|0|||
30794207|NCT00075725|58808141|FG010|Overall Study|Inevaluable|1|||
30903950|NCT01649375|58938081|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
30794208|NCT00075725|58808142|FG011|Overall Study|Inevaluable|0|||
30794209|NCT00075725|58808131|FG000|Overall Study|Other|4|||
30794210|NCT00075725|58808132|FG001|Overall Study|Other|2|||
30794211|NCT00075725|58808133|FG002|Overall Study|Other|1|||
30794212|NCT00075725|58808134|FG003|Overall Study|Other|1|||
30794213|NCT00075725|58808135|FG004|Overall Study|Other|1|||
30794214|NCT00075725|58808136|FG005|Overall Study|Other|4|||
30794215|NCT00075725|58808137|FG006|Overall Study|Other|2|||
30903951|NCT01649375|58938082|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
30903952|NCT01649375|58938083|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
30903953|NCT01649375|58938079|FG000|Week 16 up to Week 260|Death|1|||
30903954|NCT01649375|58938080|FG001|Week 16 up to Week 260|Death|1|||
30903955|NCT01649375|58938081|FG002|Week 16 up to Week 260|Death|0|||
30903956|NCT01649375|58938082|FG003|Week 16 up to Week 260|Death|0|||
30903957|NCT01649375|58938083|FG004|Week 16 up to Week 260|Death|0|||
30903958|NCT01649375|58938079|FG000|Week 16 up to Week 260|Adverse Event|5|||
30794216|NCT00075725|58808138|FG007|Overall Study|Other|9|||
30794217|NCT00075725|58808139|FG008|Overall Study|Other|2|||
30903959|NCT01649375|58938080|FG001|Week 16 up to Week 260|Adverse Event|2|||
30794218|NCT00075725|58808140|FG009|Overall Study|Other|1|||
30794219|NCT00075725|58808141|FG010|Overall Study|Other|0|||
30794220|NCT00075725|58808142|FG011|Overall Study|Other|3|||
30794221|NCT00075725|58808131|FG000|Overall Study|Pt trying to find a BM donor|0|||
30794222|NCT00075725|58808132|FG001|Overall Study|Pt trying to find a BM donor|1|||
30794223|NCT00075725|58808133|FG002|Overall Study|Pt trying to find a BM donor|0|||
30794224|NCT00075725|58808134|FG003|Overall Study|Pt trying to find a BM donor|0|||
30794225|NCT00075725|58808135|FG004|Overall Study|Pt trying to find a BM donor|0|||
30794226|NCT00075725|58808136|FG005|Overall Study|Pt trying to find a BM donor|0|||
30794227|NCT00075725|58808137|FG006|Overall Study|Pt trying to find a BM donor|0|||
30794228|NCT00075725|58808138|FG007|Overall Study|Pt trying to find a BM donor|0|||
30794229|NCT00075725|58808139|FG008|Overall Study|Pt trying to find a BM donor|0|||
30794230|NCT00075725|58808140|FG009|Overall Study|Pt trying to find a BM donor|0|||
30794231|NCT00075725|58808141|FG010|Overall Study|Pt trying to find a BM donor|0|||
30794232|NCT00075725|58808142|FG011|Overall Study|Pt trying to find a BM donor|0|||
30794233|NCT00075725|58808131|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
30794234|NCT00075725|58808132|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
30794235|NCT00075725|58808133|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
30794236|NCT00075725|58808134|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
30794237|NCT00075725|58808135|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
30794238|NCT00075725|58808136|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
30794239|NCT00075725|58808137|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
30794240|NCT00075725|58808138|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
30794241|NCT00075725|58808139|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
30794242|NCT00075725|58808140|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
30794243|NCT00075725|58808141|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
30794244|NCT00075725|58808142|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
30794245|NCT00075725|58808131|FG000|Overall Study|Unsuccessful institutional transfer|0|||
30794246|NCT00075725|58808132|FG001|Overall Study|Unsuccessful institutional transfer|0|||
30794247|NCT00075725|58808133|FG002|Overall Study|Unsuccessful institutional transfer|2|||
30794248|NCT00075725|58808134|FG003|Overall Study|Unsuccessful institutional transfer|0|||
30794249|NCT00075725|58808135|FG004|Overall Study|Unsuccessful institutional transfer|0|||
30794250|NCT00075725|58808136|FG005|Overall Study|Unsuccessful institutional transfer|0|||
30794251|NCT00075725|58808137|FG006|Overall Study|Unsuccessful institutional transfer|0|||
30794252|NCT00075725|58808138|FG007|Overall Study|Unsuccessful institutional transfer|0|||
30794253|NCT00075725|58808139|FG008|Overall Study|Unsuccessful institutional transfer|0|||
30794254|NCT00075725|58808140|FG009|Overall Study|Unsuccessful institutional transfer|1|||
30794255|NCT00075725|58808141|FG010|Overall Study|Unsuccessful institutional transfer|0|||
30794256|NCT00075725|58808142|FG011|Overall Study|Unsuccessful institutional transfer|0|||
30794257|NCT00075725|58808131|FG000|Overall Study|specimen(s) not submitted|0|||
30794258|NCT00075725|58808132|FG001|Overall Study|specimen(s) not submitted|0|||
30794259|NCT00075725|58808133|FG002|Overall Study|specimen(s) not submitted|2|||
30794260|NCT00075725|58808134|FG003|Overall Study|specimen(s) not submitted|0|||
30794261|NCT00075725|58808135|FG004|Overall Study|specimen(s) not submitted|0|||
30794262|NCT00075725|58808136|FG005|Overall Study|specimen(s) not submitted|0|||
30794263|NCT00075725|58808137|FG006|Overall Study|specimen(s) not submitted|0|||
30745770|NCT00467519|58756443|FG000|Overall Study|Withdrawal by Subject|4|||
30745771|NCT00467519|58756444|FG001|Overall Study|Withdrawal by Subject|10|||
30745772|NCT00264810|58756452|FG000|Baseline|Withdrawal by Subject|10|||
30745773|NCT00264810|58756453|FG001|Baseline|Withdrawal by Subject|10|||
30745774|NCT00264810|58756452|FG000|Baseline|Physician Decision|7|||
30745775|NCT00264810|58756453|FG001|Baseline|Physician Decision|8|||
30745776|NCT00264810|58756452|FG000|Baseline|Subject Compliance Failure|3|||
30745777|NCT00264810|58756453|FG001|Baseline|Subject Compliance Failure|3|||
30745778|NCT00264810|58756452|FG000|Baseline|Insufficient Seizure Frequency|2|||
30745779|NCT00264810|58756453|FG001|Baseline|Insufficient Seizure Frequency|2|||
30745780|NCT00264810|58756452|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
30745781|NCT00264810|58756453|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
30745782|NCT00264810|58756452|FG000|Baseline|Other|0|||
30745783|NCT00264810|58756453|FG001|Baseline|Other|1|||
30745784|NCT00264810|58756452|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
30745785|NCT00264810|58756453|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
30745786|NCT00264810|58756452|FG000|Stimulation Optimization Period|Death|0|||
30745787|NCT00264810|58756453|FG001|Stimulation Optimization Period|Death|1|||
30745788|NCT00264810|58756452|FG000|Blinded Evaluation Period|Explant due to infection|1|||
30745789|NCT00264810|58756453|FG001|Blinded Evaluation Period|Explant due to infection|1|||
30745790|NCT00264810|58756452|FG000|Open Label Evaluation Period|Explant due to infection|1|||
30745791|NCT00264810|58756453|FG001|Open Label Evaluation Period|Explant due to infection|1|||
30745792|NCT00264810|58756452|FG000|Open Label Evaluation Period|Death|3|||
30745793|NCT00264810|58756453|FG001|Open Label Evaluation Period|Death|2|||
30745794|NCT00264810|58756452|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
30794264|NCT00075725|58808138|FG007|Overall Study|specimen(s) not submitted|0|||
30745795|NCT00264810|58756453|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
30794265|NCT00075725|58808139|FG008|Overall Study|specimen(s) not submitted|0|||
30794266|NCT00075725|58808140|FG009|Overall Study|specimen(s) not submitted|0|||
30794267|NCT00075725|58808141|FG010|Overall Study|specimen(s) not submitted|0|||
30794268|NCT00075725|58808142|FG011|Overall Study|specimen(s) not submitted|0|||
30794269|NCT00075725|58808131|FG000|Overall Study|Pt went to transplant|0|||
30794270|NCT00075725|58808132|FG001|Overall Study|Pt went to transplant|0|||
30794271|NCT00075725|58808133|FG002|Overall Study|Pt went to transplant|0|||
30794272|NCT00075725|58808134|FG003|Overall Study|Pt went to transplant|1|||
30745796|NCT00467363|58756463|FG000|Overall Study|Lost to Follow-up|80|||
30794273|NCT00075725|58808135|FG004|Overall Study|Pt went to transplant|0|||
30794274|NCT00075725|58808136|FG005|Overall Study|Pt went to transplant|1|||
30794275|NCT00075725|58808137|FG006|Overall Study|Pt went to transplant|0|||
30794276|NCT00075725|58808138|FG007|Overall Study|Pt went to transplant|0|||
30794277|NCT00075725|58808139|FG008|Overall Study|Pt went to transplant|0|||
30903960|NCT01649375|58938081|FG002|Week 16 up to Week 260|Adverse Event|0|||
30903961|NCT01649375|58938082|FG003|Week 16 up to Week 260|Adverse Event|3|||
30903962|NCT01649375|58938083|FG004|Week 16 up to Week 260|Adverse Event|2|||
30903963|NCT02336555|58938093|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30903964|NCT02336555|58938094|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
30903965|NCT02336555|58938093|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
30903966|NCT02336555|58938094|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
30903967|NCT02336555|58938093|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
30903968|NCT02336555|58938094|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
30903969|NCT01648283|58938100|FG000|Overall Study|Withdrawal by Subject|14|||
30794278|NCT00075725|58808140|FG009|Overall Study|Pt went to transplant|0|||
30794279|NCT00075725|58808141|FG010|Overall Study|Pt went to transplant|0|||
30794280|NCT00075725|58808142|FG011|Overall Study|Pt went to transplant|0|||
30794281|NCT00075725|58808131|FG000|Overall Study|Pt received additional steroids|0|||
30794282|NCT00075725|58808132|FG001|Overall Study|Pt received additional steroids|0|||
30794283|NCT00075725|58808133|FG002|Overall Study|Pt received additional steroids|0|||
30794284|NCT00075725|58808134|FG003|Overall Study|Pt received additional steroids|1|||
30794285|NCT00075725|58808135|FG004|Overall Study|Pt received additional steroids|0|||
30794286|NCT00075725|58808136|FG005|Overall Study|Pt received additional steroids|0|||
30794287|NCT00075725|58808137|FG006|Overall Study|Pt received additional steroids|0|||
30794288|NCT00075725|58808138|FG007|Overall Study|Pt received additional steroids|0|||
30794289|NCT00075725|58808139|FG008|Overall Study|Pt received additional steroids|0|||
30794290|NCT00075725|58808140|FG009|Overall Study|Pt received additional steroids|0|||
30794291|NCT00075725|58808141|FG010|Overall Study|Pt received additional steroids|0|||
30794292|NCT00075725|58808142|FG011|Overall Study|Pt received additional steroids|0|||
30794293|NCT00075725|58808131|FG000|Overall Study|Pt relocated|0|||
30794294|NCT00075725|58808132|FG001|Overall Study|Pt relocated|0|||
30794295|NCT00075725|58808133|FG002|Overall Study|Pt relocated|0|||
30794296|NCT00075725|58808134|FG003|Overall Study|Pt relocated|2|||
30794297|NCT00075725|58808135|FG004|Overall Study|Pt relocated|0|||
30794298|NCT00075725|58808136|FG005|Overall Study|Pt relocated|1|||
30794299|NCT00075725|58808137|FG006|Overall Study|Pt relocated|1|||
30794300|NCT00075725|58808138|FG007|Overall Study|Pt relocated|2|||
30794301|NCT00075725|58808139|FG008|Overall Study|Pt relocated|1|||
30745797|NCT00467363|58756464|FG001|Overall Study|Lost to Follow-up|70|||
30794302|NCT00075725|58808140|FG009|Overall Study|Pt relocated|0|||
30794303|NCT00075725|58808141|FG010|Overall Study|Pt relocated|0|||
30794304|NCT00075725|58808142|FG011|Overall Study|Pt relocated|0|||
30794305|NCT00075725|58808131|FG000|Overall Study|Institution Terminated|0|||
30622130|NCT00931918|58633635|FG000|Overall Study|Did not receive study drug|3|||
30622131|NCT00931918|58633636|FG001|Overall Study|Did not receive study drug|2|||
30745798|NCT00091390|58756470|FG000|Overall Study|Protocol Violation|1|||
30745799|NCT00091390|58756470|FG000|Overall Study|No protocol treatment|3|||
30745800|NCT00239226|58756478|FG000|Overall Study|permAF during stabilization period|0|||
30745801|NCT00239226|58756479|FG001|Overall Study|permAF during stabilization period|0|||
30745802|NCT00239226|58756480|FG002|Overall Study|permAF during stabilization period|0|||
30745803|NCT00239226|58756481|FG003|Overall Study|permAF during stabilization period|3|||
30794306|NCT00075725|58808132|FG001|Overall Study|Institution Terminated|0|||
30794307|NCT00075725|58808133|FG002|Overall Study|Institution Terminated|0|||
30794308|NCT00075725|58808134|FG003|Overall Study|Institution Terminated|0|||
30794309|NCT00075725|58808135|FG004|Overall Study|Institution Terminated|1|||
30794310|NCT00075725|58808136|FG005|Overall Study|Institution Terminated|0|||
30794311|NCT00075725|58808137|FG006|Overall Study|Institution Terminated|0|||
30903970|NCT01649297|58938111|FG000|Overall Study|Adverse Event|5|||
30794312|NCT00075725|58808138|FG007|Overall Study|Institution Terminated|3|||
30794313|NCT00075725|58808139|FG008|Overall Study|Institution Terminated|0|||
30794314|NCT00075725|58808140|FG009|Overall Study|Institution Terminated|0|||
30622132|NCT01179191|58633642|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
30745804|NCT00239226|58756478|FG000|Overall Study|Lost to Follow-up|1|||
30745805|NCT00239226|58756479|FG001|Overall Study|Lost to Follow-up|0|||
30745806|NCT00239226|58756480|FG002|Overall Study|Lost to Follow-up|1|||
30745807|NCT00239226|58756481|FG003|Overall Study|Lost to Follow-up|0|||
30745808|NCT00467285|58756493|FG000|Overall Study|Lost to Follow-up|4|||
30745809|NCT00467285|58756494|FG001|Overall Study|Lost to Follow-up|4|||
30745810|NCT00264576|58756504|FG000|Overall Study|Lost to Follow-up|1|||
30745811|NCT00264576|58756505|FG001|Overall Study|Lost to Follow-up|1|||
30745812|NCT00466505|58756512|FG000|Overall Study|disease progression|13|||
30745813|NCT00466505|58756512|FG000|Overall Study|Adverse Event|4|||
30903971|NCT01649297|58938112|FG001|Overall Study|Adverse Event|5|||
30903972|NCT01649297|58938113|FG002|Overall Study|Adverse Event|4|||
30903973|NCT01649297|58938114|FG003|Overall Study|Adverse Event|13|||
30903974|NCT01649297|58938115|FG004|Overall Study|Adverse Event|1|||
30745814|NCT00467051|58756516|FG000|Overall Study|Adverse Event|2|||
30745815|NCT00264498|58756523|FG000|Randomized Treatment|Death|0|||
30745816|NCT00264498|58756524|FG001|Randomized Treatment|Death|3|||
30794315|NCT00075725|58808141|FG010|Overall Study|Institution Terminated|0|||
30794316|NCT00075725|58808142|FG011|Overall Study|Institution Terminated|0|||
30794317|NCT00075725|58808131|FG000|Overall Study|Study Closure|1|||
30794318|NCT00075725|58808132|FG001|Overall Study|Study Closure|0|||
30794319|NCT00075725|58808133|FG002|Overall Study|Study Closure|0|||
30794320|NCT00075725|58808134|FG003|Overall Study|Study Closure|0|||
30794321|NCT00075725|58808135|FG004|Overall Study|Study Closure|1|||
30794322|NCT00075725|58808136|FG005|Overall Study|Study Closure|3|||
30794323|NCT00075725|58808137|FG006|Overall Study|Study Closure|0|||
30794324|NCT00075725|58808138|FG007|Overall Study|Study Closure|1|||
30794325|NCT00075725|58808139|FG008|Overall Study|Study Closure|0|||
30794326|NCT00075725|58808140|FG009|Overall Study|Study Closure|0|||
30794327|NCT00075725|58808141|FG010|Overall Study|Study Closure|0|||
30794328|NCT00075725|58808142|FG011|Overall Study|Study Closure|0|||
30794329|NCT00075725|58808131|FG000|Overall Study|Other complications|0|||
30794330|NCT00075725|58808132|FG001|Overall Study|Other complications|0|||
30794331|NCT00075725|58808133|FG002|Overall Study|Other complications|0|||
30794332|NCT00075725|58808134|FG003|Overall Study|Other complications|0|||
30794333|NCT00075725|58808135|FG004|Overall Study|Other complications|0|||
30794334|NCT00075725|58808136|FG005|Overall Study|Other complications|1|||
30794335|NCT00075725|58808137|FG006|Overall Study|Other complications|0|||
30794336|NCT00075725|58808138|FG007|Overall Study|Other complications|0|||
30794337|NCT00075725|58808139|FG008|Overall Study|Other complications|0|||
30794338|NCT00075725|58808140|FG009|Overall Study|Other complications|0|||
30794339|NCT00075725|58808141|FG010|Overall Study|Other complications|0|||
30794340|NCT00075725|58808142|FG011|Overall Study|Other complications|0|||
30794341|NCT00075725|58808131|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
30794342|NCT00075725|58808132|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
30794343|NCT00075725|58808133|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
30794344|NCT00075725|58808134|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
30794345|NCT00075725|58808135|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
30794346|NCT00075725|58808136|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
30794347|NCT00075725|58808137|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
30794348|NCT00075725|58808138|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
30903975|NCT01649297|58938111|FG000|Overall Study|Lack of Efficacy|0|||
30745817|NCT00264498|58756523|FG000|Randomized Treatment|Withdrawal by Subject|0|||
30745818|NCT00264498|58756524|FG001|Randomized Treatment|Withdrawal by Subject|1|||
30794349|NCT00075725|58808139|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
30903976|NCT01649297|58938112|FG001|Overall Study|Lack of Efficacy|0|||
30622133|NCT01179191|58633642|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
30903977|NCT01649297|58938113|FG002|Overall Study|Lack of Efficacy|0|||
30794350|NCT00075725|58808140|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
30794351|NCT00075725|58808141|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
30794352|NCT00075725|58808142|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
30794353|NCT00075725|58808131|FG000|Overall Study|Pt incarcerated|0|||
30794354|NCT00075725|58808132|FG001|Overall Study|Pt incarcerated|0|||
30794355|NCT00075725|58808133|FG002|Overall Study|Pt incarcerated|0|||
30794356|NCT00075725|58808134|FG003|Overall Study|Pt incarcerated|0|||
30794357|NCT00075725|58808135|FG004|Overall Study|Pt incarcerated|0|||
30794358|NCT00075725|58808136|FG005|Overall Study|Pt incarcerated|0|||
30794359|NCT00075725|58808137|FG006|Overall Study|Pt incarcerated|0|||
30794360|NCT00075725|58808138|FG007|Overall Study|Pt incarcerated|1|||
30794361|NCT00075725|58808139|FG008|Overall Study|Pt incarcerated|0|||
30794362|NCT00075725|58808140|FG009|Overall Study|Pt incarcerated|0|||
30794363|NCT00075725|58808141|FG010|Overall Study|Pt incarcerated|0|||
30794364|NCT00075725|58808142|FG011|Overall Study|Pt incarcerated|0|||
30794365|NCT02953782|58808181|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
30794366|NCT02953782|58808182|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
30794367|NCT02953782|58808183|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
30794368|NCT02953782|58808184|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
30794369|NCT02953782|58808185|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
30794370|NCT02953782|58808186|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
30794371|NCT02953782|58808187|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
30794372|NCT02953782|58808188|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
30794373|NCT02953782|58808181|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
30794374|NCT02953782|58808182|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
30794375|NCT02953782|58808183|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
30794376|NCT02953782|58808184|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
30794377|NCT02953782|58808185|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
30794378|NCT02953782|58808186|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
30794379|NCT02953782|58808187|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
30794380|NCT02953782|58808188|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
30794381|NCT02953782|58808181|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
30794382|NCT02953782|58808182|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
30794383|NCT02953782|58808183|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
30794384|NCT02953782|58808184|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
30794385|NCT02953782|58808185|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
30794386|NCT02953782|58808186|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
30794387|NCT02953782|58808187|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
30794388|NCT02953782|58808188|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
30794389|NCT02953782|58808181|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
30794390|NCT02953782|58808182|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
30794391|NCT02953782|58808183|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
30794392|NCT02953782|58808184|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
30903978|NCT01649297|58938114|FG003|Overall Study|Lack of Efficacy|0|||
30622134|NCT01179191|58633642|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
30794393|NCT02953782|58808185|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
30794394|NCT02953782|58808186|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
30903979|NCT01649297|58938115|FG004|Overall Study|Lack of Efficacy|1|||
30903980|NCT01649297|58938111|FG000|Overall Study|Non compliant with Protocol|1|||
30622135|NCT01179191|58633642|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
30903981|NCT01649297|58938112|FG001|Overall Study|Non compliant with Protocol|0|||
30794395|NCT02953782|58808187|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
30903982|NCT01649297|58938113|FG002|Overall Study|Non compliant with Protocol|3|||
30903983|NCT01649297|58938114|FG003|Overall Study|Non compliant with Protocol|2|||
30794396|NCT02953782|58808188|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
30794397|NCT02953782|58808181|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
30794398|NCT02953782|58808182|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
30794399|NCT02953782|58808183|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
30903984|NCT01649297|58938115|FG004|Overall Study|Non compliant with Protocol|1|||
30903985|NCT01649297|58938111|FG000|Overall Study|Lost to Follow-up|1|||
30903986|NCT01649297|58938112|FG001|Overall Study|Lost to Follow-up|1|||
30903987|NCT01649297|58938113|FG002|Overall Study|Lost to Follow-up|4|||
30903988|NCT01649297|58938114|FG003|Overall Study|Lost to Follow-up|3|||
30794400|NCT02953782|58808184|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
30903989|NCT01649297|58938115|FG004|Overall Study|Lost to Follow-up|0|||
30903990|NCT01649297|58938111|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
30903991|NCT01649297|58938112|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
30903992|NCT01649297|58938113|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
30903993|NCT01649297|58938114|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
30794401|NCT02953782|58808185|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
30794402|NCT02953782|58808186|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
30794403|NCT02953782|58808187|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
30794404|NCT02953782|58808188|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
30794405|NCT02953782|58808181|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
30794406|NCT02953782|58808182|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
30794407|NCT02953782|58808183|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
30794408|NCT02953782|58808184|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
30794409|NCT02953782|58808185|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
30794410|NCT02953782|58808186|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
30794411|NCT02953782|58808187|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
30794412|NCT02953782|58808188|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
30794413|NCT02953782|58808181|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
30794414|NCT02953782|58808182|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
30794415|NCT02953782|58808183|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
30794416|NCT02953782|58808184|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
30794417|NCT02953782|58808185|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
30794418|NCT02953782|58808186|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
30794419|NCT02953782|58808187|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
30794420|NCT02953782|58808188|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
30794421|NCT02953782|58808181|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
30794422|NCT02953782|58808182|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
30794423|NCT02953782|58808183|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
30794424|NCT02953782|58808184|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
30794425|NCT02953782|58808185|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
30794426|NCT02953782|58808186|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
30794427|NCT02953782|58808187|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
30794428|NCT02953782|58808188|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
30794429|NCT03760081|58808211|FG000|Overall Study|Miscellaneous|0|||
30794430|NCT03760081|58808212|FG001|Overall Study|Miscellaneous|1|||
30794431|NCT03760081|58808211|FG000|Overall Study|Progressive Disease|5|||
30794432|NCT03760081|58808212|FG001|Overall Study|Progressive Disease|10|||
30794433|NCT03760081|58808211|FG000|Overall Study|Death|1|||
30794434|NCT03760081|58808212|FG001|Overall Study|Death|1|||
30794435|NCT03422172|58808220|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
30794436|NCT03422172|58808220|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
30794437|NCT03422172|58808220|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
30794438|NCT00057863|58808229|FG000|Overall Study|Death|1|||
30794439|NCT00057863|58808229|FG000|Overall Study|Withdrawal by Subject|2|||
30794440|NCT00075023|58808235|FG000|Pilot Study|Physician Decision|1|||
30794441|NCT00075023|58808236|FG001|Pilot Study|Physician Decision|2|||
30794442|NCT00075023|58808235|FG000|Pilot Study|Withdrawal by Subject|1|||
30794443|NCT00075023|58808236|FG001|Pilot Study|Withdrawal by Subject|0|||
30794444|NCT00074711|58808245|FG000|Overall Study|Withdrawal by Subject|1|||
30903994|NCT01649297|58938115|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
30794445|NCT00074711|58808246|FG001|Overall Study|Withdrawal by Subject|1|||
30794446|NCT00074711|58808245|FG000|Overall Study|Lost to Follow-up|10|||
30903995|NCT01649297|58938111|FG000|Overall Study|For other reason|4|||
30903996|NCT01649297|58938112|FG001|Overall Study|For other reason|1|||
30794447|NCT00074711|58808246|FG001|Overall Study|Lost to Follow-up|8|||
30794448|NCT00074711|58808245|FG000|Overall Study|Participant stopped study drug|4|||
30794449|NCT00074711|58808246|FG001|Overall Study|Participant stopped study drug|6|||
30794450|NCT03420300|58808252|FG000|Overall Study|Death|2|||
30794451|NCT03419598|58808256|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
30794452|NCT03407430|58808264|FG000|Washout|Protocol Violation|1|||
30794453|NCT03407430|58808265|FG001|Washout|Protocol Violation|0|||
30794454|NCT03407118|58808278|FG000|Period 2|Withdrawal by Subject|1|||
30794455|NCT03407118|58808279|FG001|Period 2|Withdrawal by Subject|0|||
30794456|NCT03406962|58808285|FG000|Overall Study|Death|2|||
30903997|NCT01649297|58938113|FG002|Overall Study|For other reason|2|||
30903998|NCT01649297|58938114|FG003|Overall Study|For other reason|0|||
30903999|NCT01649297|58938115|FG004|Overall Study|For other reason|0|||
30745819|NCT00264498|58756523|FG000|Randomized Treatment|Objective disease Progression|13|||
30745820|NCT00264498|58756524|FG001|Randomized Treatment|Objective disease Progression|14|||
30745821|NCT00264498|58756523|FG000|Randomized Treatment|Physician Decision|1|||
30745822|NCT00264498|58756524|FG001|Randomized Treatment|Physician Decision|0|||
30745823|NCT00264498|58756523|FG000|Randomized Treatment|Incorrectly randomized|1|||
30745824|NCT00264498|58756524|FG001|Randomized Treatment|Incorrectly randomized|0|||
30745825|NCT00264498|58756523|FG000|Randomized Treatment|Study Closure|1|||
30745826|NCT00264498|58756524|FG001|Randomized Treatment|Study Closure|0|||
30745827|NCT00264498|58756523|FG000|Randomized Treatment|Protocol Violation|1|||
30745828|NCT00264498|58756524|FG001|Randomized Treatment|Protocol Violation|0|||
30745829|NCT00264498|58756523|FG000|Crossover Treatment|Death|1|||
30745830|NCT00264498|58756524|FG001|Crossover Treatment|Death|3|||
30745831|NCT00264498|58756523|FG000|Crossover Treatment|Objective disease progression|4|||
30745832|NCT00264498|58756524|FG001|Crossover Treatment|Objective disease progression|5|||
30745833|NCT00264498|58756523|FG000|Crossover Treatment|Study closure|0|||
30745834|NCT00264498|58756524|FG001|Crossover Treatment|Study closure|1|||
30745835|NCT00264498|58756523|FG000|Crossover Treatment|Withdrawal by Subject|1|||
30745836|NCT00264498|58756524|FG001|Crossover Treatment|Withdrawal by Subject|0|||
30745837|NCT00466193|58756532|FG000|Overall Study|Adverse Event|0|||
30745838|NCT00466193|58756533|FG001|Overall Study|Adverse Event|1|||
30745839|NCT00466193|58756532|FG000|Overall Study|Lost to Follow-up|2|||
30745840|NCT00466193|58756533|FG001|Overall Study|Lost to Follow-up|4|||
30745841|NCT00466193|58756532|FG000|Overall Study|Physician Decision|1|||
30745842|NCT00466193|58756533|FG001|Overall Study|Physician Decision|0|||
30745843|NCT00466193|58756532|FG000|Overall Study|Protocol Violation|1|||
30745844|NCT00466193|58756533|FG001|Overall Study|Protocol Violation|1|||
30794457|NCT03406962|58808285|FG000|Overall Study|Adverse Event|1|||
30745845|NCT00466193|58756532|FG000|Overall Study|Withdrawal by Subject|7|||
30745846|NCT00466193|58756533|FG001|Overall Study|Withdrawal by Subject|2|||
30904000|NCT01648205|58938127|FG000|Placebo|Pregnancy|1|||
30794458|NCT03406260|58808296|FG000|Period 1|Adverse Event|0|||
30794459|NCT03406260|58808297|FG001|Period 1|Adverse Event|0|||
30794460|NCT03406260|58808298|FG002|Period 1|Adverse Event|0|||
30794461|NCT03406260|58808299|FG003|Period 1|Adverse Event|0|||
30794462|NCT03406260|58808300|FG004|Period 1|Adverse Event|1|||
30794463|NCT03406260|58808301|FG005|Period 1|Adverse Event|0|||
30794464|NCT03419364|58808314|FG000|Overall Study|Delivery due to maternal condition|2|||
30904001|NCT01648205|58938127|FG000|Placebo|Withdrawal by Subject|1|||
30904002|NCT01648205|58938127|FG000|Placebo|Protocol Violation|2|||
30904003|NCT01648205|58938127|FG000|Ranolazine|Death|1|||
30745847|NCT00466193|58756532|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
30745848|NCT00466193|58756533|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
30745849|NCT00263562|58756541|FG000|Overall Study|Protocol Violation|3|||
30745850|NCT00263562|58756542|FG001|Overall Study|Protocol Violation|0|||
30745851|NCT00454181|58756552|FG000|Overall Study|Adverse Event|1|||
30745852|NCT00454181|58756553|FG001|Overall Study|Adverse Event|1|||
30745853|NCT00454181|58756552|FG000|Overall Study|Lost to Follow-up|11|||
30745854|NCT00454181|58756553|FG001|Overall Study|Lost to Follow-up|1|||
30745855|NCT00454181|58756552|FG000|Overall Study|Protocol Violation|1|||
30745856|NCT00454181|58756553|FG001|Overall Study|Protocol Violation|1|||
30745857|NCT00454181|58756552|FG000|Overall Study|Withdrawal by Subject|2|||
30745858|NCT00454181|58756553|FG001|Overall Study|Withdrawal by Subject|0|||
30745859|NCT00237744|58756562|FG000|Overall Study|Withdrawal by Subject|3|||
30745860|NCT00237744|58756563|FG001|Overall Study|Withdrawal by Subject|1|||
30745861|NCT00237744|58756564|FG002|Overall Study|Withdrawal by Subject|0|||
30745862|NCT00237042|58756578|FG000|Treatment|Became ineligible post-randomization|0|||
30745863|NCT00237042|58756579|FG001|Treatment|Became ineligible post-randomization|1|||
30745864|NCT00237042|58756580|FG002|Treatment|Became ineligible post-randomization|16|||
30745865|NCT00237042|58756578|FG000|Treatment|Moved out of state|1|||
30745866|NCT00237042|58756579|FG001|Treatment|Moved out of state|1|||
30745867|NCT00237042|58756580|FG002|Treatment|Moved out of state|1|||
30745868|NCT00237042|58756578|FG000|Treatment|Completed no treatment|5|||
30745869|NCT00237042|58756579|FG001|Treatment|Completed no treatment|5|||
30745870|NCT00237042|58756580|FG002|Treatment|Completed no treatment|21|||
30745871|NCT00237042|58756578|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
30745872|NCT00237042|58756579|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
30745873|NCT00237042|58756580|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
30745874|NCT00237042|58756578|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
30745875|NCT00237042|58756579|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
30745876|NCT00237042|58756580|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
30745877|NCT00465647|58756592|FG000|Overall Study|Administrative|2|||
30745878|NCT00465647|58756593|FG001|Overall Study|Administrative|2|||
30745879|NCT00465647|58756594|FG002|Overall Study|Administrative|3|||
30745880|NCT00465647|58756595|FG003|Overall Study|Administrative|2|||
30745881|NCT00465647|58756592|FG000|Overall Study|Adverse Event|2|||
30745882|NCT00465647|58756593|FG001|Overall Study|Adverse Event|0|||
30745883|NCT00465647|58756594|FG002|Overall Study|Adverse Event|3|||
30904004|NCT01648205|58938127|FG000|Ranolazine|Withdrawal by Subject|1|||
30904005|NCT01648205|58938127|FG000|Ranolazine|Protocol Violation|3|||
30745884|NCT00465647|58756595|FG003|Overall Study|Adverse Event|2|||
30745885|NCT00465647|58756592|FG000|Overall Study|Withdrawal by Subject|1|||
30745886|NCT00465647|58756593|FG001|Overall Study|Withdrawal by Subject|2|||
30745887|NCT00465647|58756594|FG002|Overall Study|Withdrawal by Subject|2|||
30745888|NCT00465647|58756595|FG003|Overall Study|Withdrawal by Subject|7|||
30745889|NCT00465647|58756592|FG000|Overall Study|"The other reasons included loss of IV"|8|||
30745890|NCT00465647|58756593|FG001|Overall Study|"The other reasons included loss of IV"|4|||
30745891|NCT00465647|58756594|FG002|Overall Study|"The other reasons included loss of IV"|3|||
30745892|NCT00465647|58756595|FG003|Overall Study|"The other reasons included loss of IV"|2|||
30745893|NCT00465569|58756617|FG000|Overall Study|persistent eczema during dose escalation|1|||
30745894|NCT00465569|58756618|FG001|Overall Study|persistent eczema during dose escalation|0|||
30745895|NCT00090766|58756627|FG000|Overall Study|Nephrectomy Planned|0|||
30745896|NCT00090766|58756628|FG001|Overall Study|Nephrectomy Planned|0|||
30745897|NCT00090766|58756629|FG002|Overall Study|Nephrectomy Planned|1|||
30745898|NCT00090766|58756627|FG000|Overall Study|Death|1|||
30745899|NCT00090766|58756628|FG001|Overall Study|Death|0|||
30745900|NCT00090766|58756629|FG002|Overall Study|Death|0|||
30794465|NCT03419364|58808315|FG001|Overall Study|Delivery due to maternal condition|0|||
30794466|NCT03419364|58808316|FG002|Overall Study|Delivery due to maternal condition|0|||
30794467|NCT02954172|58808326|FG000|Overall Study|Protocol Violation|3|||
30794468|NCT02954172|58808327|FG001|Overall Study|Protocol Violation|0|||
30794469|NCT02954172|58808326|FG000|Overall Study|allergic reaction|2|||
30794470|NCT02954172|58808327|FG001|Overall Study|allergic reaction|1|||
30794471|NCT02954172|58808326|FG000|Overall Study|non-measurable lesions at baseline|1|||
30745901|NCT00090766|58756627|FG000|Overall Study|Admin|0|||
30745902|NCT00090766|58756628|FG001|Overall Study|Admin|2|||
30745903|NCT00090766|58756629|FG002|Overall Study|Admin|0|||
30745904|NCT00090766|58756627|FG000|Overall Study|Lost to Follow-up|2|||
30745905|NCT00090766|58756628|FG001|Overall Study|Lost to Follow-up|0|||
30745906|NCT00090766|58756629|FG002|Overall Study|Lost to Follow-up|2|||
30745907|NCT00465179|58756639|FG000|Overall Study|Adverse Event|4|||
30745908|NCT00465179|58756639|FG000|Overall Study|Withdrawal by Subject|2|||
30745909|NCT00465179|58756639|FG000|Overall Study|Progression of Disease|47|||
30745910|NCT00465101|58756643|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
30745911|NCT00465101|58756643|FG000|Overall Study|Change in health precluded follow up|4|||
30745912|NCT00465101|58756643|FG000|Overall Study|Did not meet study criteria|4|||
30745913|NCT00465101|58756643|FG000|Overall Study|Lost to Follow-up|5|||
30745914|NCT00465101|58756643|FG000|Overall Study|Other|6|||
30745915|NCT00465101|58756643|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
30745916|NCT00465101|58756643|FG000|Overall Study|Patient postponed procedure|1|||
30745917|NCT00465101|58756643|FG000|Overall Study|Site closed due to IRB expiration|1|||
30745918|NCT00465101|58756643|FG000|Overall Study|Unable to obtain IRB approval|1|||
30745919|NCT00465101|58756643|FG000|Overall Study|Death|3|||
30745920|NCT00465101|58756643|FG000|Overall Study|Withdrawal by Subject|25|||
30745921|NCT00465101|58756643|FG000|Overall Study|Physician Decision|1|||
30745922|NCT00465101|58756643|FG000|Overall Study|Withdrew consent prior to procedure|3|||
30794472|NCT02954172|58808327|FG001|Overall Study|non-measurable lesions at baseline|2|||
30794473|NCT02953938|58808336|FG000|Overall Study|Adverse Event|0|||
30794474|NCT02953938|58808337|FG001|Overall Study|Adverse Event|1|||
30794475|NCT02953938|58808336|FG000|Overall Study|Withdrawal by Subject|1|||
30794476|NCT02953938|58808337|FG001|Overall Study|Withdrawal by Subject|1|||
30904006|NCT02391545|58938137|FG000|Overall Study|Death|0|||
30904007|NCT02391545|58938138|FG001|Overall Study|Death|2|||
30904008|NCT02391545|58938137|FG000|Overall Study|Lost to Follow-up|0|||
30794477|NCT03758443|58808348|FG000|Induction Period|Adverse Event|2|||
30794478|NCT03758443|58808349|FG001|Induction Period|Adverse Event|4|||
30794479|NCT03758443|58808350|FG002|Induction Period|Adverse Event|2|||
30622136|NCT01179191|58633642|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
30622137|NCT01179191|58633642|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
30794480|NCT03758443|58808351|FG003|Induction Period|Adverse Event|3|||
30794481|NCT03758443|58808348|FG000|Induction Period|Physician Decision|1|||
30794482|NCT03758443|58808349|FG001|Induction Period|Physician Decision|1|||
30794483|NCT03758443|58808350|FG002|Induction Period|Physician Decision|3|||
30794484|NCT03758443|58808351|FG003|Induction Period|Physician Decision|0|||
30794485|NCT03758443|58808348|FG000|Induction Period|Protocol Violation|0|||
30794486|NCT03758443|58808349|FG001|Induction Period|Protocol Violation|0|||
30794487|NCT03758443|58808350|FG002|Induction Period|Protocol Violation|0|||
30794488|NCT03758443|58808351|FG003|Induction Period|Protocol Violation|1|||
30794489|NCT03758443|58808348|FG000|Induction Period|Withdrawal by Subject|3|||
30794490|NCT03758443|58808349|FG001|Induction Period|Withdrawal by Subject|2|||
30794491|NCT03758443|58808350|FG002|Induction Period|Withdrawal by Subject|2|||
30794492|NCT03758443|58808351|FG003|Induction Period|Withdrawal by Subject|4|||
30794493|NCT03758443|58808348|FG000|Extended Induction Period|Adverse Event|1|||
30794494|NCT03758443|58808349|FG001|Extended Induction Period|Adverse Event|1|||
30794495|NCT03758443|58808350|FG002|Extended Induction Period|Adverse Event|0|||
30794496|NCT03758443|58808351|FG003|Extended Induction Period|Adverse Event|1|||
30794497|NCT03758443|58808348|FG000|Extended Induction Period|Lost to Follow-up|1|||
30794498|NCT03758443|58808349|FG001|Extended Induction Period|Lost to Follow-up|0|||
30794499|NCT03758443|58808350|FG002|Extended Induction Period|Lost to Follow-up|0|||
30794500|NCT03758443|58808351|FG003|Extended Induction Period|Lost to Follow-up|0|||
30904009|NCT02391545|58938138|FG001|Overall Study|Lost to Follow-up|1|||
30904010|NCT02391545|58938137|FG000|Overall Study|Termination of study by sponsor|20|||
30904011|NCT02391545|58938138|FG001|Overall Study|Termination of study by sponsor|20|||
30904012|NCT02391545|58938137|FG000|Overall Study|Withdrawal by Subject|0|||
30794501|NCT03758443|58808348|FG000|Extended Induction Period|Physician Decision|2|||
30794502|NCT03758443|58808349|FG001|Extended Induction Period|Physician Decision|1|||
30794503|NCT03758443|58808350|FG002|Extended Induction Period|Physician Decision|2|||
30794504|NCT03758443|58808351|FG003|Extended Induction Period|Physician Decision|2|||
30794505|NCT03758443|58808348|FG000|Extended Induction Period|Protocol Violation|0|||
30794506|NCT03758443|58808349|FG001|Extended Induction Period|Protocol Violation|0|||
30794507|NCT03758443|58808350|FG002|Extended Induction Period|Protocol Violation|0|||
30794508|NCT03758443|58808351|FG003|Extended Induction Period|Protocol Violation|1|||
30794509|NCT03758443|58808348|FG000|Extended Induction Period|Withdrawal by Subject|8|||
30794510|NCT03758443|58808349|FG001|Extended Induction Period|Withdrawal by Subject|1|||
30904013|NCT02391545|58938138|FG001|Overall Study|Withdrawal by Subject|1|||
30904014|NCT02391545|58938137|FG000|Overall Study|Other Reasons|6|||
30904015|NCT02391545|58938138|FG001|Overall Study|Other Reasons|4|||
30904016|NCT02362451|58938147|FG000|Overall Study|Withdrawal by Subject|0|||
30904017|NCT02362451|58938148|FG001|Overall Study|Withdrawal by Subject|1|||
30904018|NCT02362451|58938147|FG000|Overall Study|Lack of Efficacy|2|||
30904019|NCT02362451|58938148|FG001|Overall Study|Lack of Efficacy|0|||
30904020|NCT02362451|58938147|FG000|Overall Study|Progression|1|||
30904021|NCT02362451|58938148|FG001|Overall Study|Progression|0|||
30904022|NCT02362451|58938147|FG000|Overall Study|Participant chose other therapy.|1|||
30904023|NCT02362451|58938148|FG001|Overall Study|Participant chose other therapy.|0|||
30904024|NCT01734382|58938157|FG000|Part 1|Adverse Event|2|||
30904025|NCT01734382|58938158|FG001|Part 1|Adverse Event|0|||
30904026|NCT01734382|58938159|FG002|Part 1|Adverse Event|0|||
30904027|NCT01734382|58938157|FG000|Part 2|Adverse Event|0|||
30904028|NCT01734382|58938158|FG001|Part 2|Adverse Event|0|||
30904029|NCT01734382|58938159|FG002|Part 2|Adverse Event|1|||
30904030|NCT01734382|58938157|FG000|Part 2|Lack of Efficacy|0|||
30904031|NCT01734382|58938158|FG001|Part 2|Lack of Efficacy|1|||
30904032|NCT01734382|58938159|FG002|Part 2|Lack of Efficacy|1|||
30904033|NCT01734382|58938157|FG000|Part 2|Other|0|||
30904034|NCT01734382|58938158|FG001|Part 2|Other|0|||
30904035|NCT01734382|58938159|FG002|Part 2|Other|1|||
30904036|NCT01734382|58938157|FG000|Part 2|Physician Decision|0|||
30904037|NCT01734382|58938158|FG001|Part 2|Physician Decision|0|||
30904038|NCT01734382|58938159|FG002|Part 2|Physician Decision|3|||
30904039|NCT01734382|58938157|FG000|Part 2|Protocol Violation|0|||
30904040|NCT01734382|58938158|FG001|Part 2|Protocol Violation|1|||
30904041|NCT01734382|58938159|FG002|Part 2|Protocol Violation|0|||
30904042|NCT01734382|58938157|FG000|Part 2|Withdrawal by Subject|0|||
30904043|NCT01734382|58938158|FG001|Part 2|Withdrawal by Subject|0|||
30904044|NCT01734382|58938159|FG002|Part 2|Withdrawal by Subject|1|||
30904045|NCT02391311|58938173|FG000|Overall Study|Lost to Follow-up|2|||
30904046|NCT02391311|58938174|FG001|Overall Study|Lost to Follow-up|1|||
30904047|NCT02391311|58938173|FG000|Overall Study|deemed ineligible after baseline|1|||
30904048|NCT02391311|58938174|FG001|Overall Study|deemed ineligible after baseline|1|||
30904049|NCT01765426|58938184|FG000|Overall Study|Lost to Follow-up|0|||
30904050|NCT01765426|58938185|FG001|Overall Study|Lost to Follow-up|1|||
30904051|NCT01765426|58938186|FG002|Overall Study|Lost to Follow-up|0|||
30904052|NCT01765426|58938187|FG003|Overall Study|Lost to Follow-up|0|||
30904053|NCT01765270|58938199|FG000|Overall Study|Physician Decision|1|||
30904054|NCT01765270|58938200|FG001|Overall Study|Physician Decision|0|||
30904055|NCT01765270|58938199|FG000|Overall Study|Withdrawal by Subject|0|||
30622138|NCT01179191|58633642|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
30622139|NCT01179191|58633642|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
30622140|NCT01179191|58633642|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
30794511|NCT03758443|58808350|FG002|Extended Induction Period|Withdrawal by Subject|7|||
30794512|NCT03758443|58808351|FG003|Extended Induction Period|Withdrawal by Subject|3|||
30794513|NCT03758443|58808348|FG000|Extended Induction Period|Miscellaneous|1|||
30794514|NCT03758443|58808349|FG001|Extended Induction Period|Miscellaneous|0|||
30794515|NCT03758443|58808350|FG002|Extended Induction Period|Miscellaneous|0|||
30794516|NCT03758443|58808351|FG003|Extended Induction Period|Miscellaneous|0|||
30794517|NCT03758443|58808348|FG000|Maintenance Period|Adverse Event|1|||
30794518|NCT03758443|58808349|FG001|Maintenance Period|Adverse Event|2|||
30794519|NCT03758443|58808350|FG002|Maintenance Period|Adverse Event|0|||
30794520|NCT03758443|58808351|FG003|Maintenance Period|Adverse Event|0|||
30794521|NCT03758443|58808348|FG000|Maintenance Period|Lost to Follow-up|0|||
30794522|NCT03758443|58808349|FG001|Maintenance Period|Lost to Follow-up|0|||
30794523|NCT03758443|58808350|FG002|Maintenance Period|Lost to Follow-up|0|||
30794524|NCT03758443|58808351|FG003|Maintenance Period|Lost to Follow-up|1|||
30794525|NCT03758443|58808348|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
30904056|NCT01765270|58938200|FG001|Overall Study|Withdrawal by Subject|1|||
30904057|NCT01733758|58938211|FG000|Overall Study|Adverse Event|5|||
30904058|NCT01733758|58938212|FG001|Overall Study|Adverse Event|7|||
30904059|NCT01733758|58938213|FG002|Overall Study|Adverse Event|8|||
30904060|NCT01733758|58938214|FG003|Overall Study|Adverse Event|1|||
30904061|NCT01733758|58938211|FG000|Overall Study|Withdrawal by Subject|1|||
30904062|NCT01733758|58938212|FG001|Overall Study|Withdrawal by Subject|1|||
30904063|NCT01733758|58938213|FG002|Overall Study|Withdrawal by Subject|5|||
30904064|NCT01733758|58938214|FG003|Overall Study|Withdrawal by Subject|3|||
30904065|NCT01733758|58938211|FG000|Overall Study|Persistent Hyperglycemia|3|||
30904066|NCT01733758|58938212|FG001|Overall Study|Persistent Hyperglycemia|2|||
30794526|NCT03758443|58808349|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
30794527|NCT03758443|58808350|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
30904067|NCT01733758|58938213|FG002|Overall Study|Persistent Hyperglycemia|0|||
30904068|NCT01733758|58938214|FG003|Overall Study|Persistent Hyperglycemia|0|||
30904069|NCT01733758|58938211|FG000|Overall Study|Protocol Violation|0|||
30904070|NCT01733758|58938212|FG001|Overall Study|Protocol Violation|1|||
30904071|NCT01733758|58938213|FG002|Overall Study|Protocol Violation|2|||
30904072|NCT01733758|58938214|FG003|Overall Study|Protocol Violation|2|||
30904073|NCT01733758|58938211|FG000|Overall Study|Non-compliance|1|||
30904074|NCT01733758|58938212|FG001|Overall Study|Non-compliance|0|||
30904075|NCT01733758|58938213|FG002|Overall Study|Non-compliance|0|||
30904076|NCT01733758|58938214|FG003|Overall Study|Non-compliance|0|||
30904077|NCT01733758|58938211|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
30904078|NCT01733758|58938212|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
30904079|NCT01733758|58938213|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
30904080|NCT01733758|58938214|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
30904081|NCT01733758|58938211|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
30794528|NCT03758443|58808351|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
30794529|NCT03758443|58808348|FG000|Maintenance Period|Protocol Violation|0|||
30794530|NCT03758443|58808349|FG001|Maintenance Period|Protocol Violation|1|||
30794531|NCT03758443|58808350|FG002|Maintenance Period|Protocol Violation|0|||
30794532|NCT03758443|58808351|FG003|Maintenance Period|Protocol Violation|0|||
30794533|NCT03758443|58808348|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
30794534|NCT03758443|58808349|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
30794535|NCT03758443|58808350|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
30794536|NCT03758443|58808351|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
30794537|NCT03758443|58808348|FG000|Maintenance Period|Withdrawal by Subject|1|||
30794538|NCT03758443|58808349|FG001|Maintenance Period|Withdrawal by Subject|0|||
30794539|NCT03758443|58808350|FG002|Maintenance Period|Withdrawal by Subject|1|||
30794540|NCT03758443|58808351|FG003|Maintenance Period|Withdrawal by Subject|1|||
30794541|NCT03758443|58808348|FG000|Maintenance Period|Miscellaneous|0|||
30794542|NCT03758443|58808349|FG001|Maintenance Period|Miscellaneous|0|||
30794543|NCT03758443|58808350|FG002|Maintenance Period|Miscellaneous|1|||
30794544|NCT03758443|58808351|FG003|Maintenance Period|Miscellaneous|0|||
30794545|NCT03442764|58808373|FG000|Overall Study|Adverse Event|1|||
30794546|NCT03442764|58808374|FG001|Overall Study|Adverse Event|0|||
30794547|NCT03442764|58808375|FG002|Overall Study|Adverse Event|0|||
30794548|NCT03442296|58808386|FG000|3 Month Follow-up|Death|3|||
30794549|NCT03442296|58808387|FG001|3 Month Follow-up|Death|1|||
30794550|NCT03442296|58808386|FG000|3 Month Follow-up|Lost to Follow-up|1|||
30794551|NCT03442296|58808387|FG001|3 Month Follow-up|Lost to Follow-up|1|||
30745923|NCT00084136|58756672|FG000|PI Comparison|Death|10|||
30745924|NCT00084136|58756673|FG001|PI Comparison|Death|9|||
30745925|NCT00084136|58756674|FG002|PI Comparison|Death|0|||
30794552|NCT03442296|58808386|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
30794553|NCT03442296|58808387|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
30794554|NCT03442296|58808386|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
30794555|NCT03442296|58808387|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
30794556|NCT03442296|58808386|FG000|12 Month Follow-up|Incomplete measurement|1|||
30794557|NCT03442296|58808387|FG001|12 Month Follow-up|Incomplete measurement|1|||
30794558|NCT03441984|58808395|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
30794559|NCT03441984|58808396|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
30794560|NCT03441984|58808397|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
30794561|NCT03441984|58808398|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
30794562|NCT03441984|58808399|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
30794563|NCT03441984|58808400|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
30904082|NCT01733758|58938212|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
30745926|NCT00084136|58756672|FG000|PI Comparison|Lost to Follow-up|11|||
30745927|NCT00084136|58756673|FG001|PI Comparison|Lost to Follow-up|8|||
30745928|NCT00084136|58756674|FG002|PI Comparison|Lost to Follow-up|0|||
30745929|NCT00084136|58756672|FG000|PI Comparison|Withdrawal by Subject|33|||
30745930|NCT00084136|58756673|FG001|PI Comparison|Withdrawal by Subject|30|||
30794564|NCT03441984|58808401|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
30745931|NCT00084136|58756674|FG002|PI Comparison|Withdrawal by Subject|0|||
30794565|NCT03441984|58808402|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
30794566|NCT03441984|58808403|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
30904083|NCT01733758|58938213|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
30904084|NCT01733758|58938214|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
30904085|NCT01607554|58938226|FG000|Overall Study|Disease progression|2|||
30794567|NCT03441984|58808404|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
30794568|NCT03441984|58808405|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
30794569|NCT03441984|58808406|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
30794570|NCT03441360|58808424|FG000|Overall Study|Radiological disease progression|5|||
30794571|NCT03441360|58808425|FG001|Overall Study|Radiological disease progression|6|||
30794572|NCT03441360|58808426|FG002|Overall Study|Radiological disease progression|4|||
30794573|NCT03441360|58808424|FG000|Overall Study|Clinical disease progression|2|||
30794574|NCT03441360|58808425|FG001|Overall Study|Clinical disease progression|2|||
30794575|NCT03441360|58808426|FG002|Overall Study|Clinical disease progression|0|||
30794576|NCT03441360|58808424|FG000|Overall Study|Adverse Event|1|||
30794577|NCT03441360|58808425|FG001|Overall Study|Adverse Event|0|||
30794578|NCT03441360|58808426|FG002|Overall Study|Adverse Event|1|||
30794579|NCT01347840|58808434|FG000|Overall Study|Withdrawal by Subject|1|||
30794580|NCT01347762|58808442|FG000|Overall Study|Lost to Follow-up|0|||
30794581|NCT01347762|58808443|FG001|Overall Study|Lost to Follow-up|1|||
30794582|NCT01347762|58808444|FG002|Overall Study|Lost to Follow-up|6|||
30794583|NCT01347762|58808445|FG003|Overall Study|Lost to Follow-up|5|||
30794584|NCT01347762|58808442|FG000|Overall Study|Withdrawal by Subject|4|||
30794585|NCT01347762|58808443|FG001|Overall Study|Withdrawal by Subject|1|||
30794586|NCT01347762|58808444|FG002|Overall Study|Withdrawal by Subject|3|||
30794587|NCT01347762|58808445|FG003|Overall Study|Withdrawal by Subject|3|||
30794588|NCT03438396|58808455|FG000|Overall Study|Reason Not Specified|9|||
30794589|NCT03438396|58808455|FG000|Overall Study|Withdrawal by Subject|5|||
30794590|NCT03438396|58808455|FG000|Overall Study|Lost to Follow-up|2|||
30794591|NCT03438396|58808455|FG000|Overall Study|Death|85|||
30794592|NCT03438396|58808455|FG000|Overall Study|Not treated|1|||
30794593|NCT00073307|58808461|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
30794594|NCT00073307|58808462|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
30794595|NCT00073307|58808463|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
30794596|NCT00073307|58808461|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
30794597|NCT00073307|58808462|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
30794598|NCT00073307|58808463|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
30794599|NCT00073307|58808461|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
30794600|NCT00073307|58808462|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
30794601|NCT00073307|58808463|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
30794602|NCT00073307|58808461|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
30794603|NCT00073307|58808462|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
30794604|NCT00073307|58808463|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
30794605|NCT00073307|58808461|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
30794606|NCT00073307|58808462|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
30794607|NCT00073307|58808463|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
30794608|NCT00073307|58808461|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
30794609|NCT00073307|58808462|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
30794610|NCT00073307|58808463|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
30794611|NCT00073307|58808461|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
30794612|NCT00073307|58808462|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
30794613|NCT00073307|58808463|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
30794614|NCT00073307|58808461|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
30794615|NCT00073307|58808462|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
30794616|NCT00073307|58808463|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
30904086|NCT01607476|58938233|FG000|Overall Study|Withdrawal by Subject|1|||
30904087|NCT01607476|58938234|FG001|Overall Study|Withdrawal by Subject|0|||
30904088|NCT01607476|58938235|FG002|Overall Study|Withdrawal by Subject|1|||
30904089|NCT01607476|58938233|FG000|Overall Study|Lost to Follow-up|0|||
30904090|NCT01607476|58938234|FG001|Overall Study|Lost to Follow-up|0|||
30904091|NCT01607476|58938235|FG002|Overall Study|Lost to Follow-up|2|||
30904092|NCT01765192|58938245|FG000|Treatment Period 1|Adverse Event|0|||
30745932|NCT00084136|58756672|FG000|PI Comparison|Clinic site closed|1|||
30745933|NCT00084136|58756673|FG001|PI Comparison|Clinic site closed|0|||
30745934|NCT00084136|58756674|FG002|PI Comparison|Clinic site closed|0|||
30745935|NCT00084136|58756672|FG000|NRTI Comparison|Death|20|||
30745936|NCT00084136|58756673|FG001|NRTI Comparison|Death|0|||
30745937|NCT00084136|58756674|FG002|NRTI Comparison|Death|18|||
30745938|NCT00084136|58756672|FG000|NRTI Comparison|Lost to Follow-up|14|||
30745939|NCT00084136|58756673|FG001|NRTI Comparison|Lost to Follow-up|0|||
30745940|NCT00084136|58756674|FG002|NRTI Comparison|Lost to Follow-up|12|||
30745941|NCT00084136|58756672|FG000|NRTI Comparison|Withdrawal by Subject|54|||
30745942|NCT00084136|58756673|FG001|NRTI Comparison|Withdrawal by Subject|0|||
30745943|NCT00084136|58756674|FG002|NRTI Comparison|Withdrawal by Subject|38|||
30904093|NCT01765192|58938246|FG001|Treatment Period 1|Adverse Event|1|||
30904094|NCT01765192|58938245|FG000|Washout Period|Voluntary Withdrawal|1|||
30904095|NCT01765192|58938246|FG001|Washout Period|Voluntary Withdrawal|1|||
30904096|NCT01765192|58938245|FG000|Washout Period|Reason not specified|1|||
30745944|NCT00084136|58756672|FG000|NRTI Comparison|Clinic site closed|12|||
30794617|NCT00073307|58808461|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
30794618|NCT00073307|58808462|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
30794619|NCT00073307|58808463|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
30794620|NCT00073307|58808461|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
30794621|NCT00073307|58808462|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
30794622|NCT00073307|58808463|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
30794623|NCT00073307|58808461|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
30794624|NCT00073307|58808462|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
30794625|NCT00073307|58808463|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
30794626|NCT00073307|58808461|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
30794627|NCT00073307|58808462|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
30794628|NCT00073307|58808463|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
30794629|NCT00073307|58808461|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
30794630|NCT00073307|58808462|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
30794631|NCT00073307|58808463|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
30794632|NCT00073307|58808461|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
30794633|NCT00073307|58808462|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
30794634|NCT00073307|58808463|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
30794635|NCT00073307|58808461|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
30794636|NCT00073307|58808462|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
30794637|NCT00073307|58808463|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
30794638|NCT00073307|58808461|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
30794639|NCT00073307|58808462|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
30794640|NCT00073307|58808463|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
30794641|NCT00073307|58808461|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
30794642|NCT00073307|58808462|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
30794643|NCT00073307|58808463|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
30794644|NCT00073307|58808461|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
30794645|NCT00073307|58808462|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
30794646|NCT00073307|58808463|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
30794647|NCT00073307|58808461|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
30794648|NCT00073307|58808462|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
30794649|NCT00073307|58808463|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
30794650|NCT03388164|58808474|FG000|Overall Study|Withdrawal by Subject|3|||
30794651|NCT03388164|58808475|FG001|Overall Study|Withdrawal by Subject|1|||
30794652|NCT03403374|58808481|FG000|Overall Study|Lost to Follow-up|1|||
30794653|NCT03387462|58808485|FG000|Overall Study|Lost to Follow-up|1|||
30794654|NCT03756883|58808492|FG000|Overall Study|Adverse Event|2|||
30794655|NCT03756883|58808493|FG001|Overall Study|Adverse Event|2|||
30794656|NCT03756883|58808494|FG002|Overall Study|Adverse Event|2|||
30794657|NCT03756883|58808492|FG000|Overall Study|Lack of Efficacy|0|||
30794658|NCT03756883|58808493|FG001|Overall Study|Lack of Efficacy|1|||
30794659|NCT03756883|58808494|FG002|Overall Study|Lack of Efficacy|2|||
30794660|NCT03756883|58808492|FG000|Overall Study|Lost to Follow-up|3|||
30794661|NCT03756883|58808493|FG001|Overall Study|Lost to Follow-up|3|||
30794662|NCT03756883|58808494|FG002|Overall Study|Lost to Follow-up|0|||
30794663|NCT03756883|58808492|FG000|Overall Study|Protocol Violation|2|||
30904097|NCT01765192|58938246|FG001|Washout Period|Reason not specified|0|||
30904098|NCT01765192|58938245|FG000|Treatment Period 2|Reason not specified|0|||
30745945|NCT00084136|58756673|FG001|NRTI Comparison|Clinic site closed|0|||
30745946|NCT00084136|58756674|FG002|NRTI Comparison|Clinic site closed|14|||
30745947|NCT00084136|58756672|FG000|NRTI Comparison|Not reason above|1|||
30745948|NCT00084136|58756673|FG001|NRTI Comparison|Not reason above|0|||
30745949|NCT00084136|58756674|FG002|NRTI Comparison|Not reason above|0|||
30745950|NCT03812380|58756685|FG000|Overall Study|Protocol Violation|3|||
30745951|NCT03812380|58756686|FG001|Overall Study|Protocol Violation|3|||
30745952|NCT03812380|58756685|FG000|Overall Study|Withdrawal by Subject|5|||
30745953|NCT03812380|58756686|FG001|Overall Study|Withdrawal by Subject|4|||
30745954|NCT03812380|58756685|FG000|Overall Study|Early termination of study|14|||
30745955|NCT03812380|58756686|FG001|Overall Study|Early termination of study|14|||
30745956|NCT00464945|58756694|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
30745957|NCT00464945|58756695|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
30794664|NCT03756883|58808493|FG001|Overall Study|Protocol Violation|0|||
30794665|NCT03756883|58808494|FG002|Overall Study|Protocol Violation|1|||
30794666|NCT03756883|58808492|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
30794667|NCT03756883|58808493|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
30794668|NCT03756883|58808494|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
30794669|NCT03756883|58808492|FG000|Overall Study|Withdrawal by Subject|4|||
30794670|NCT03756883|58808493|FG001|Overall Study|Withdrawal by Subject|1|||
30794671|NCT03756883|58808494|FG002|Overall Study|Withdrawal by Subject|0|||
30794672|NCT03756883|58808492|FG000|Overall Study|Other Reasons|2|||
30794673|NCT03756883|58808493|FG001|Overall Study|Other Reasons|4|||
30794674|NCT03756883|58808494|FG002|Overall Study|Other Reasons|0|||
30794675|NCT03386994|58808505|FG000|Overall Study|Lung transplant|1|||
30794676|NCT03386994|58808505|FG000|Overall Study|Adverse Event|14|||
30794677|NCT03386994|58808505|FG000|Overall Study|Lost to Follow-up|4|||
30794678|NCT03386994|58808505|FG000|Overall Study|Withdrawal by Subject|3|||
30794679|NCT03386994|58808505|FG000|Overall Study|Death|16|||
30794680|NCT03756571|58808522|FG000|Overall Study|Lost to Follow-up|1|||
30794681|NCT03756571|58808523|FG001|Overall Study|Lost to Follow-up|1|||
30794682|NCT03386448|58808531|FG000|Overall Study|Adverse Event|0|||
30794683|NCT03386448|58808532|FG001|Overall Study|Adverse Event|2|||
30794684|NCT02951988|58808541|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
30794685|NCT02951988|58808542|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
30794686|NCT02951988|58808543|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
30794687|NCT02951988|58808544|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
30794688|NCT02951988|58808541|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
30794689|NCT02951988|58808542|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
30794690|NCT02951988|58808543|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
30794691|NCT02951988|58808544|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
30794692|NCT02951988|58808541|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
30794693|NCT02951988|58808542|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
30794694|NCT02951988|58808543|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
30794695|NCT02951988|58808544|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
30794696|NCT02951988|58808541|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
30794697|NCT02951988|58808542|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
30794698|NCT02951988|58808543|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
30794699|NCT02951988|58808544|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
30794700|NCT02951988|58808541|FG000|Open-Label Treatment Period|Protocol Violation|22|||
30794701|NCT02951988|58808542|FG001|Open-Label Treatment Period|Protocol Violation|0|||
30794702|NCT02951988|58808543|FG002|Open-Label Treatment Period|Protocol Violation|0|||
30794703|NCT02951988|58808544|FG003|Open-Label Treatment Period|Protocol Violation|0|||
30794704|NCT02951988|58808541|FG000|Open-Label Treatment Period|Pregnancy|2|||
30794705|NCT02951988|58808542|FG001|Open-Label Treatment Period|Pregnancy|0|||
30794706|NCT02951988|58808543|FG002|Open-Label Treatment Period|Pregnancy|0|||
30794707|NCT02951988|58808544|FG003|Open-Label Treatment Period|Pregnancy|0|||
30794708|NCT02951988|58808541|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
30794709|NCT02951988|58808542|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
30794710|NCT02951988|58808543|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
30794711|NCT02951988|58808544|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
30794712|NCT02951988|58808541|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
30794713|NCT02951988|58808542|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
30794714|NCT02951988|58808543|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
30794715|NCT02951988|58808544|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
30794716|NCT02951988|58808541|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
30745958|NCT00464945|58756694|FG000|Infant Series|Protocol Violation|1|||
30745959|NCT00464945|58756695|FG001|Infant Series|Protocol Violation|0|||
30745960|NCT00464945|58756694|FG000|Infant Series|Lost to Follow-up|1|||
30745961|NCT00464945|58756695|FG001|Infant Series|Lost to Follow-up|0|||
30745962|NCT00464945|58756694|FG000|After Infant Series|Withdrawal by Subject|0|||
30745963|NCT00464945|58756695|FG001|After Infant Series|Withdrawal by Subject|2|||
30745964|NCT00464945|58756694|FG000|Toddler Dose|Lost to Follow-up|0|||
30745965|NCT00464945|58756695|FG001|Toddler Dose|Lost to Follow-up|1|||
30745966|NCT00464087|58756720|FG000|Overall Study|No PCI per inclusion criteria|0|||
30745967|NCT00464087|58756721|FG001|Overall Study|No PCI per inclusion criteria|0|||
30745968|NCT00464087|58756722|FG002|Overall Study|No PCI per inclusion criteria|29|||
30745969|NCT00452699|58756732|FG000|Overall Study|Adverse Event|10|||
30745970|NCT00452699|58756733|FG001|Overall Study|Adverse Event|3|||
30745971|NCT00452699|58756732|FG000|Overall Study|Lack of Efficacy|6|||
30745972|NCT00452699|58756733|FG001|Overall Study|Lack of Efficacy|4|||
30745973|NCT00452699|58756732|FG000|Overall Study|Lost to Follow-up|6|||
30745974|NCT00452699|58756733|FG001|Overall Study|Lost to Follow-up|9|||
30745975|NCT00452699|58756732|FG000|Overall Study|Protocol Violation|21|||
30904099|NCT01765192|58938246|FG001|Treatment Period 2|Reason not specified|2|||
30904100|NCT01765192|58938245|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
30904101|NCT01765192|58938246|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
30904102|NCT01733680|58938254|FG000|Overall Study|Withdrawal by Subject|0|||
30904103|NCT01733680|58938255|FG001|Overall Study|Withdrawal by Subject|1|||
30904104|NCT02348216|58938272|FG000|Overall Study|Death|4|||
30745976|NCT00452699|58756733|FG001|Overall Study|Protocol Violation|25|||
30745977|NCT00452699|58756732|FG000|Overall Study|Withdrawal by Subject|26|||
30745978|NCT00452699|58756733|FG001|Overall Study|Withdrawal by Subject|25|||
30745979|NCT00452699|58756732|FG000|Overall Study|Other|12|||
30745980|NCT00452699|58756733|FG001|Overall Study|Other|7|||
30745981|NCT00069784|58756741|FG000|Overall Study|Adverse Event|105|||
30745982|NCT00069784|58756742|FG001|Overall Study|Adverse Event|0|||
30745983|NCT00069784|58756741|FG000|Overall Study|Withdrawal by Subject|1090|||
30745984|NCT00069784|58756742|FG001|Overall Study|Withdrawal by Subject|0|||
30745985|NCT00069784|58756741|FG000|Overall Study|Other|17|||
30745986|NCT00069784|58756742|FG001|Overall Study|Other|0|||
30745987|NCT03811834|58756748|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
30745988|NCT00090610|58756763|FG000|Overall Study|Withdrawal by Subject|1|||
30745989|NCT00090610|58756764|FG001|Overall Study|Withdrawal by Subject|1|||
30745990|NCT00463385|58756774|FG000|Overall Study|Other|4|||
30745991|NCT00463385|58756775|FG001|Overall Study|Other|3|||
30745992|NCT00463385|58756776|FG002|Overall Study|Other|6|||
30745993|NCT00463385|58756777|FG003|Overall Study|Other|4|||
30745994|NCT00463385|58756774|FG000|Overall Study|Adverse Event|5|||
30745995|NCT00463385|58756775|FG001|Overall Study|Adverse Event|8|||
30745996|NCT00463385|58756776|FG002|Overall Study|Adverse Event|4|||
30745997|NCT00463385|58756777|FG003|Overall Study|Adverse Event|2|||
30745998|NCT00463385|58756774|FG000|Overall Study|Lack of Efficacy|6|||
30745999|NCT00463385|58756775|FG001|Overall Study|Lack of Efficacy|6|||
30746000|NCT00463385|58756776|FG002|Overall Study|Lack of Efficacy|7|||
30746001|NCT00463385|58756777|FG003|Overall Study|Lack of Efficacy|9|||
30746002|NCT00463385|58756774|FG000|Overall Study|Withdrawal by Subject|3|||
30746003|NCT00463385|58756775|FG001|Overall Study|Withdrawal by Subject|3|||
30904105|NCT02348216|58938273|FG001|Overall Study|Death|27|||
30746004|NCT00463385|58756776|FG002|Overall Study|Withdrawal by Subject|3|||
30794717|NCT02951988|58808542|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
30794718|NCT02951988|58808543|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
30794719|NCT02951988|58808544|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
30794720|NCT02951988|58808541|FG000|Open-Label Treatment Period|Adverse Event|45|||
30794721|NCT02951988|58808542|FG001|Open-Label Treatment Period|Adverse Event|0|||
30794722|NCT02951988|58808543|FG002|Open-Label Treatment Period|Adverse Event|0|||
30794723|NCT02951988|58808544|FG003|Open-Label Treatment Period|Adverse Event|0|||
30794724|NCT02951988|58808541|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
30794725|NCT02951988|58808542|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
30794726|NCT02951988|58808543|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
30794727|NCT02951988|58808544|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
30794728|NCT02951988|58808541|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
30794729|NCT02951988|58808542|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
30794730|NCT02951988|58808543|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
30794731|NCT02951988|58808544|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
30794732|NCT02951988|58808541|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
30794733|NCT02951988|58808542|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
30794734|NCT02951988|58808543|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
30794735|NCT02951988|58808544|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
30746005|NCT00463385|58756777|FG003|Overall Study|Withdrawal by Subject|4|||
30746006|NCT00463385|58756774|FG000|Overall Study|Lost to Follow-up|0|||
30746007|NCT00463385|58756775|FG001|Overall Study|Lost to Follow-up|0|||
30794736|NCT02951988|58808541|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
30794737|NCT02951988|58808542|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
30794738|NCT02951988|58808543|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
30794739|NCT02951988|58808544|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
30794740|NCT02951988|58808541|FG000|Double-Blind Treatment Period|Pregnancy|0|||
30794741|NCT02951988|58808542|FG001|Double-Blind Treatment Period|Pregnancy|1|||
30794742|NCT02951988|58808543|FG002|Double-Blind Treatment Period|Pregnancy|1|||
30794743|NCT02951988|58808544|FG003|Double-Blind Treatment Period|Pregnancy|0|||
30794744|NCT02951988|58808541|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
30794745|NCT02951988|58808542|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
30794746|NCT02951988|58808543|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
30794747|NCT02951988|58808544|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
30794748|NCT02951988|58808541|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30794749|NCT02951988|58808542|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
30794750|NCT02951988|58808543|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
30794751|NCT02951988|58808544|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
30794752|NCT02951988|58808541|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30794753|NCT02951988|58808542|FG001|Double-Blind Treatment Period|Adverse Event|8|||
30794754|NCT02951988|58808543|FG002|Double-Blind Treatment Period|Adverse Event|3|||
30794755|NCT02951988|58808544|FG003|Double-Blind Treatment Period|Adverse Event|6|||
30794756|NCT02951988|58808541|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
30794757|NCT02951988|58808542|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
30794758|NCT02951988|58808543|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
30794759|NCT02951988|58808544|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
30794760|NCT00009737|58808556|FG000|Overall Study|Adverse Event|112|||
30794761|NCT00009737|58808557|FG001|Overall Study|Adverse Event|75|||
30794762|NCT00009737|58808556|FG000|Overall Study|Death|4|||
30794763|NCT00009737|58808557|FG001|Overall Study|Death|6|||
30794764|NCT00009737|58808556|FG000|Overall Study|Lack of Efficacy|17|||
30794765|NCT00009737|58808557|FG001|Overall Study|Lack of Efficacy|15|||
30746008|NCT00463385|58756776|FG002|Overall Study|Lost to Follow-up|0|||
30746009|NCT00463385|58756777|FG003|Overall Study|Lost to Follow-up|1|||
30746010|NCT00463385|58756774|FG000|Overall Study|Death|2|||
30746011|NCT00463385|58756775|FG001|Overall Study|Death|1|||
30746012|NCT00463385|58756776|FG002|Overall Study|Death|2|||
30794766|NCT00009737|58808556|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
30794767|NCT00009737|58808557|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
30794768|NCT00009737|58808556|FG000|Overall Study|Other Protocol Violation|1|||
30794769|NCT00009737|58808557|FG001|Overall Study|Other Protocol Violation|0|||
30794770|NCT00009737|58808556|FG000|Overall Study|Refused Treatment|15|||
30794771|NCT00009737|58808557|FG001|Overall Study|Refused Treatment|16|||
30904106|NCT02348216|58938274|FG002|Overall Study|Death|3|||
30746013|NCT00463385|58756777|FG003|Overall Study|Death|0|||
30746014|NCT00463385|58756774|FG000|Overall Study|Missing|2|||
30794772|NCT00009737|58808556|FG000|Overall Study|Lost to Follow-up|1|||
30794773|NCT00009737|58808557|FG001|Overall Study|Lost to Follow-up|1|||
30794774|NCT00009737|58808556|FG000|Overall Study|Administrative/Other Reasons|7|||
30794775|NCT00009737|58808557|FG001|Overall Study|Administrative/Other Reasons|1|||
30794776|NCT03417102|58808565|FG000|Overall Study|Adverse Event|0|||
30794777|NCT03417102|58808566|FG001|Overall Study|Adverse Event|1|||
30794778|NCT03417102|58808565|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
30794779|NCT03417102|58808566|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
30794780|NCT03417102|58808565|FG000|Overall Study|Other|0|||
30794781|NCT03417102|58808566|FG001|Overall Study|Other|1|||
30794782|NCT03417024|58808572|FG000|Overall Study|Study Termination prior to follow-up|11|||
30794783|NCT03417024|58808572|FG000|Overall Study|Physician Decision|2|||
30794784|NCT00028769|58808576|FG000|Overall Study|Adverse Event|2|||
30794785|NCT00028769|58808576|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
30794786|NCT00028769|58808576|FG000|Overall Study|Progression or Death|31|||
30794787|NCT00028769|58808576|FG000|Overall Study|Other - Not Protocol Specified|1|||
30794788|NCT00028769|58808576|FG000|Overall Study|Ineligible|5|||
30794789|NCT00028769|58808576|FG000|Overall Study|Not Analyzable|1|||
30794790|NCT02953314|58808582|FG000|Overall Study|Adverse Event|0|||
30794791|NCT02953314|58808583|FG001|Overall Study|Adverse Event|1|||
30794792|NCT02953314|58808582|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
30794793|NCT02953314|58808583|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
30794794|NCT03402750|58808591|FG000|Overall Study|Lost to Follow-up|2|||
30794795|NCT03402750|58808592|FG001|Overall Study|Lost to Follow-up|1|||
30794796|NCT00007475|58808601|FG000|Overall Study|Withdrawal by Subject|1|||
30794797|NCT00007475|58808602|FG001|Overall Study|Withdrawal by Subject|0|||
30794798|NCT00007475|58808603|FG002|Overall Study|Withdrawal by Subject|0|||
30794799|NCT00007475|58808604|FG003|Overall Study|Withdrawal by Subject|0|||
30794800|NCT00007475|58808601|FG000|Overall Study|Adverse Event|3|||
30794801|NCT00007475|58808602|FG001|Overall Study|Adverse Event|0|||
30794802|NCT00007475|58808603|FG002|Overall Study|Adverse Event|0|||
30794803|NCT00007475|58808604|FG003|Overall Study|Adverse Event|0|||
30794804|NCT00025883|58808616|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
30794805|NCT00025883|58808616|FG000|Overall Study|no baseline data|1|||
30794806|NCT00025883|58808616|FG000|Overall Study|Death|1|||
30794807|NCT00025883|58808616|FG000|Overall Study|Adverse Event|1|||
30794808|NCT00025883|58808616|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
30794809|NCT00072293|58808623|FG000|Overall Study|Lost to Follow-up|1|||
30794810|NCT00072293|58808624|FG001|Overall Study|Lost to Follow-up|1|||
30794811|NCT00072293|58808623|FG000|Overall Study|Withdrawal by Subject|0|||
30794812|NCT00072293|58808624|FG001|Overall Study|Withdrawal by Subject|1|||
30794813|NCT03753763|58808632|FG000|Overall Study|Adverse Event|2|||
30794814|NCT03753763|58808633|FG001|Overall Study|Adverse Event|0|||
30794815|NCT03753763|58808632|FG000|Overall Study|Withdrawal by Subject|3|||
30794816|NCT03753763|58808633|FG001|Overall Study|Withdrawal by Subject|1|||
30794817|NCT03753763|58808632|FG000|Overall Study|clinical deterioration|1|||
30794818|NCT03753763|58808633|FG001|Overall Study|clinical deterioration|0|||
30794819|NCT03384966|58808642|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
30794820|NCT03384966|58808643|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
30794821|NCT03384966|58808644|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
30794822|NCT03384966|58808642|FG000|Follow-up Period|Adverse Event|1|||
30794823|NCT03384966|58808643|FG001|Follow-up Period|Adverse Event|0|||
30794824|NCT03384966|58808644|FG002|Follow-up Period|Adverse Event|0|||
30794825|NCT03402126|58808661|FG000|Overall Study|Lost to Follow-up|6|||
30794826|NCT03402126|58808661|FG000|Overall Study|Protocol Violation|10|||
30794827|NCT03402126|58808661|FG000|Overall Study|Sponsor request/Study termination|29|||
30794828|NCT03402126|58808661|FG000|Overall Study|Study product no longer in use|1|||
30794829|NCT03402126|58808661|FG000|Overall Study|Technical problems|1|||
30794830|NCT03402126|58808661|FG000|Overall Study|Withdrawal by Subject|6|||
30794831|NCT03402126|58808661|FG000|Overall Study|Physician Decision|2|||
30794832|NCT03402126|58808661|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
30794833|NCT03402126|58808661|FG000|Overall Study|Death|4|||
30794834|NCT03355326|58808667|FG000|Overall Study|Protocol Violation|3|||
30794835|NCT03355326|58808668|FG001|Overall Study|Protocol Violation|3|||
30794836|NCT03353220|58808674|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
30794837|NCT03353220|58808675|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
30794838|NCT03751657|58808683|FG000|Overall Study|Physician Decision|0|||
30794839|NCT03751657|58808684|FG001|Overall Study|Physician Decision|1|||
30794840|NCT03751657|58808683|FG000|Overall Study|Withdrawal by Subject|1|||
30794841|NCT03751657|58808684|FG001|Overall Study|Withdrawal by Subject|1|||
30794842|NCT03751657|58808683|FG000|Overall Study|Lost to Follow-up|2|||
30794843|NCT03751657|58808684|FG001|Overall Study|Lost to Follow-up|1|||
30794844|NCT00025259|58808697|FG000|Overall Study|Death|1|||
30794845|NCT00025259|58808698|FG001|Overall Study|Death|3|||
30794846|NCT00025259|58808699|FG002|Overall Study|Death|0|||
30794847|NCT00025259|58808700|FG003|Overall Study|Death|3|||
30794848|NCT00025259|58808701|FG004|Overall Study|Death|0|||
30794849|NCT00025259|58808702|FG005|Overall Study|Death|1|||
30794850|NCT00025259|58808703|FG006|Overall Study|Death|2|||
30794851|NCT00025259|58808697|FG000|Overall Study|Lack of Efficacy|2|||
30794852|NCT00025259|58808698|FG001|Overall Study|Lack of Efficacy|46|||
30794853|NCT00025259|58808699|FG002|Overall Study|Lack of Efficacy|60|||
30794854|NCT00025259|58808700|FG003|Overall Study|Lack of Efficacy|78|||
30794855|NCT00025259|58808701|FG004|Overall Study|Lack of Efficacy|11|||
30794856|NCT00025259|58808702|FG005|Overall Study|Lack of Efficacy|30|||
30794857|NCT00025259|58808703|FG006|Overall Study|Lack of Efficacy|38|||
30794858|NCT00025259|58808697|FG000|Overall Study|Lost to Follow-up|2|||
30794859|NCT00025259|58808698|FG001|Overall Study|Lost to Follow-up|9|||
30794860|NCT00025259|58808699|FG002|Overall Study|Lost to Follow-up|13|||
30794861|NCT00025259|58808700|FG003|Overall Study|Lost to Follow-up|13|||
30794862|NCT00025259|58808701|FG004|Overall Study|Lost to Follow-up|1|||
30794863|NCT00025259|58808702|FG005|Overall Study|Lost to Follow-up|3|||
30794864|NCT00025259|58808703|FG006|Overall Study|Lost to Follow-up|1|||
30794865|NCT00025259|58808697|FG000|Overall Study|Physician Decision|12|||
30794866|NCT00025259|58808698|FG001|Overall Study|Physician Decision|1|||
30794867|NCT00025259|58808699|FG002|Overall Study|Physician Decision|0|||
30794868|NCT00025259|58808700|FG003|Overall Study|Physician Decision|5|||
30794869|NCT00025259|58808701|FG004|Overall Study|Physician Decision|4|||
30794870|NCT00025259|58808702|FG005|Overall Study|Physician Decision|2|||
30794871|NCT00025259|58808703|FG006|Overall Study|Physician Decision|1|||
30794872|NCT00025259|58808697|FG000|Overall Study|Protocol Violation|3|||
30794873|NCT00025259|58808698|FG001|Overall Study|Protocol Violation|2|||
30794874|NCT00025259|58808699|FG002|Overall Study|Protocol Violation|2|||
30794875|NCT00025259|58808700|FG003|Overall Study|Protocol Violation|1|||
30794876|NCT00025259|58808701|FG004|Overall Study|Protocol Violation|2|||
30794877|NCT00025259|58808702|FG005|Overall Study|Protocol Violation|1|||
30794878|NCT00025259|58808703|FG006|Overall Study|Protocol Violation|3|||
30794879|NCT00025259|58808697|FG000|Overall Study|Withdrawal by Subject|9|||
30794880|NCT00025259|58808698|FG001|Overall Study|Withdrawal by Subject|27|||
30794881|NCT00025259|58808699|FG002|Overall Study|Withdrawal by Subject|6|||
30794882|NCT00025259|58808700|FG003|Overall Study|Withdrawal by Subject|14|||
30794883|NCT00025259|58808701|FG004|Overall Study|Withdrawal by Subject|11|||
30794884|NCT00025259|58808702|FG005|Overall Study|Withdrawal by Subject|8|||
30794885|NCT00025259|58808703|FG006|Overall Study|Withdrawal by Subject|3|||
30794886|NCT00025259|58808697|FG000|Overall Study|Ineligible|14|||
30794887|NCT00025259|58808698|FG001|Overall Study|Ineligible|1|||
30794888|NCT00025259|58808699|FG002|Overall Study|Ineligible|0|||
30794889|NCT00025259|58808700|FG003|Overall Study|Ineligible|0|||
30794890|NCT00025259|58808701|FG004|Overall Study|Ineligible|6|||
30794891|NCT00025259|58808702|FG005|Overall Study|Ineligible|0|||
30794892|NCT00025259|58808703|FG006|Overall Study|Ineligible|1|||
30904107|NCT02348216|58938275|FG003|Overall Study|Death|18|||
30904108|NCT02348216|58938276|FG004|Overall Study|Death|9|||
30904109|NCT02348216|58938277|FG005|Overall Study|Death|23|||
30904110|NCT02348216|58938278|FG006|Overall Study|Death|6|||
30904111|NCT02348216|58938272|FG000|Overall Study|Full consent withdrawal|0|||
30904112|NCT02348216|58938273|FG001|Overall Study|Full consent withdrawal|0|||
30794893|NCT00025259|58808697|FG000|Overall Study|Randomization error|1|||
30794894|NCT00025259|58808698|FG001|Overall Study|Randomization error|0|||
30794895|NCT00025259|58808699|FG002|Overall Study|Randomization error|0|||
30794896|NCT00025259|58808700|FG003|Overall Study|Randomization error|0|||
30904113|NCT02348216|58938274|FG002|Overall Study|Full consent withdrawal|0|||
30904114|NCT02348216|58938275|FG003|Overall Study|Full consent withdrawal|1|||
30904115|NCT02348216|58938276|FG004|Overall Study|Full consent withdrawal|0|||
30794897|NCT00025259|58808701|FG004|Overall Study|Randomization error|1|||
30794898|NCT00025259|58808702|FG005|Overall Study|Randomization error|7|||
30794899|NCT00025259|58808703|FG006|Overall Study|Randomization error|2|||
30794900|NCT00025259|58808697|FG000|Overall Study|Adverse Event|1|||
30794901|NCT00025259|58808698|FG001|Overall Study|Adverse Event|0|||
30794902|NCT00025259|58808699|FG002|Overall Study|Adverse Event|0|||
30794903|NCT00025259|58808700|FG003|Overall Study|Adverse Event|0|||
30794904|NCT00025259|58808701|FG004|Overall Study|Adverse Event|0|||
30794905|NCT00025259|58808702|FG005|Overall Study|Adverse Event|0|||
30794906|NCT00025259|58808703|FG006|Overall Study|Adverse Event|0|||
30794907|NCT03351738|58808728|FG000|Overall Study|Withdrawal by Subject|0|||
30794908|NCT03351738|58808729|FG001|Overall Study|Withdrawal by Subject|1|||
30794909|NCT03351738|58808730|FG002|Overall Study|Withdrawal by Subject|0|||
30904116|NCT02348216|58938277|FG005|Overall Study|Full consent withdrawal|0|||
30794910|NCT03351738|58808731|FG003|Overall Study|Withdrawal by Subject|1|||
30794911|NCT03351738|58808732|FG004|Overall Study|Withdrawal by Subject|0|||
30794912|NCT03351738|58808733|FG005|Overall Study|Withdrawal by Subject|0|||
30904117|NCT02348216|58938278|FG006|Overall Study|Full consent withdrawal|1|||
30794913|NCT03351114|58808752|FG000|Overall Study|Withdrawal by Subject|1|||
30794914|NCT03350256|58808756|FG000|Overall Study|Inclusion/exclusion violation|4|||
30794915|NCT03350256|58808756|FG000|Overall Study|Recommended for other therapies|2|||
30794916|NCT03350256|58808756|FG000|Overall Study|Protocol Violation|3|||
30794917|NCT03350256|58808756|FG000|Overall Study|Non compliance|2|||
30794918|NCT03350256|58808756|FG000|Overall Study|Denial by insurance|1|||
30794919|NCT03350256|58808756|FG000|Overall Study|Adverse Event|2|||
30794920|NCT03350256|58808756|FG000|Overall Study|Trial failure|12|||
30794921|NCT03350256|58808756|FG000|Overall Study|Did not proceed to permanent implant|3|||
30794922|NCT03350256|58808756|FG000|Overall Study|Withdrawal by Subject|3|||
30794923|NCT03350256|58808756|FG000|Overall Study|Subject moving out of state|1|||
30794924|NCT03350256|58808756|FG000|Overall Study|Lost to Follow-up|1|||
30794925|NCT03350256|58808756|FG000|Overall Study|Lack of Efficacy|2|||
30794926|NCT00024167|58808763|FG000|Overall Study|Death|53|||
30794927|NCT00024167|58808764|FG001|Overall Study|Death|47|||
30794928|NCT00022763|58808773|FG000|Overall Study|Adverse Event|1|||
30794929|NCT00022763|58808774|FG001|Overall Study|Adverse Event|2|||
30794930|NCT00022763|58808773|FG000|Overall Study|Injection Site Reactions|0|||
30794931|NCT00022763|58808774|FG001|Overall Study|Injection Site Reactions|2|||
30794932|NCT00022763|58808773|FG000|Overall Study|Death|0|||
30794933|NCT00022763|58808774|FG001|Overall Study|Death|1|||
30794934|NCT00022763|58808773|FG000|Overall Study|Lost to Follow-up|0|||
30794935|NCT00022763|58808774|FG001|Overall Study|Lost to Follow-up|3|||
30904118|NCT02348216|58938272|FG000|Overall Study|Lost to Follow-up|0|||
30904119|NCT02348216|58938273|FG001|Overall Study|Lost to Follow-up|0|||
30904120|NCT02348216|58938274|FG002|Overall Study|Lost to Follow-up|0|||
30904121|NCT02348216|58938275|FG003|Overall Study|Lost to Follow-up|0|||
30904122|NCT02348216|58938276|FG004|Overall Study|Lost to Follow-up|0|||
30904123|NCT02348216|58938277|FG005|Overall Study|Lost to Follow-up|0|||
30904124|NCT02348216|58938278|FG006|Overall Study|Lost to Follow-up|1|||
30904125|NCT02348216|58938272|FG000|Overall Study|Still on study|3|||
30904126|NCT02348216|58938273|FG001|Overall Study|Still on study|50|||
30904127|NCT02348216|58938274|FG002|Overall Study|Still on study|21|||
30904128|NCT02348216|58938275|FG003|Overall Study|Still on study|19|||
30904129|NCT02348216|58938276|FG004|Overall Study|Still on study|32|||
30904130|NCT02348216|58938277|FG005|Overall Study|Still on study|27|||
30904131|NCT02348216|58938278|FG006|Overall Study|Still on study|32|||
30904132|NCT02348216|58938272|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
30622141|NCT01179191|58633642|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
30622142|NCT01179191|58633642|FG000|Maintenance Phase (8 Weeks)|Other|66|||
30904133|NCT02348216|58938273|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
30904134|NCT02348216|58938274|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
30904135|NCT02348216|58938275|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
30904136|NCT02348216|58938276|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
30904137|NCT02348216|58938277|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
30904138|NCT02348216|58938278|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
30904139|NCT02336165|58938321|FG000|Overall Study|Death|3|||
30904140|NCT02336165|58938322|FG001|Overall Study|Death|0|||
30904141|NCT02336165|58938323|FG002|Overall Study|Death|0|||
30904142|NCT02336165|58938324|FG003|Overall Study|Death|0|||
30746015|NCT00463385|58756775|FG001|Overall Study|Missing|0|||
30746016|NCT00463385|58756776|FG002|Overall Study|Missing|0|||
30746017|NCT00463385|58756777|FG003|Overall Study|Missing|2|||
30746018|NCT00463385|58756774|FG000|Overall Study|1 participant received commercial drug|0|||
30746019|NCT00463385|58756775|FG001|Overall Study|1 participant received commercial drug|1|||
30746020|NCT00463385|58756776|FG002|Overall Study|1 participant received commercial drug|0|||
30746021|NCT00463385|58756777|FG003|Overall Study|1 participant received commercial drug|0|||
30746022|NCT00463229|58756797|FG000|Overall Study|Lost to Follow-up|5|||
30794936|NCT00022763|58808773|FG000|Overall Study|Withdrawal by Subject|4|||
30794937|NCT00022763|58808774|FG001|Overall Study|Withdrawal by Subject|7|||
30794938|NCT00022763|58808773|FG000|Overall Study|Insufficient Therapy|1|||
30904143|NCT02336165|58938325|FG004|Overall Study|Death|1|||
30904144|NCT02336165|58938321|FG000|Overall Study|Physician Decision|2|||
30622143|NCT01169844|58633648|FG000|Overall Study|Adverse Event|0|||
30746023|NCT00463229|58756798|FG001|Overall Study|Lost to Follow-up|7|||
30794939|NCT00022763|58808774|FG001|Overall Study|Insufficient Therapy|0|||
30794940|NCT00022763|58808773|FG000|Overall Study|Admin|3|||
30794941|NCT00022763|58808774|FG001|Overall Study|Admin|2|||
30794942|NCT00071513|58808781|FG000|Intervention Component|Withdrawal by Subject|2|||
30904145|NCT02336165|58938322|FG001|Overall Study|Physician Decision|2|||
30904146|NCT02336165|58938323|FG002|Overall Study|Physician Decision|1|||
30904147|NCT02336165|58938324|FG003|Overall Study|Physician Decision|1|||
30904148|NCT02336165|58938325|FG004|Overall Study|Physician Decision|0|||
30794943|NCT00071513|58808782|FG001|Intervention Component|Withdrawal by Subject|3|||
30794944|NCT00071513|58808781|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
30904149|NCT02336165|58938321|FG000|Overall Study|Withdrawal by Subject|0|||
30904150|NCT02336165|58938322|FG001|Overall Study|Withdrawal by Subject|0|||
30904151|NCT02336165|58938323|FG002|Overall Study|Withdrawal by Subject|1|||
30904152|NCT02336165|58938324|FG003|Overall Study|Withdrawal by Subject|0|||
30904153|NCT02336165|58938325|FG004|Overall Study|Withdrawal by Subject|1|||
30904154|NCT02336165|58938321|FG000|Overall Study|Adverse Event|4|||
30904155|NCT02336165|58938322|FG001|Overall Study|Adverse Event|1|||
30904156|NCT02336165|58938323|FG002|Overall Study|Adverse Event|2|||
30904157|NCT02336165|58938324|FG003|Overall Study|Adverse Event|4|||
30904158|NCT02336165|58938325|FG004|Overall Study|Adverse Event|1|||
30904159|NCT02336165|58938321|FG000|Overall Study|Progressive disease|23|||
30904160|NCT02336165|58938322|FG001|Overall Study|Progressive disease|22|||
30904161|NCT02336165|58938323|FG002|Overall Study|Progressive disease|27|||
30904162|NCT02336165|58938324|FG003|Overall Study|Progressive disease|24|||
30904163|NCT02336165|58938325|FG004|Overall Study|Progressive disease|19|||
30904164|NCT02336165|58938321|FG000|Overall Study|Non-compliance|1|||
30904165|NCT02336165|58938322|FG001|Overall Study|Non-compliance|0|||
30904166|NCT02336165|58938323|FG002|Overall Study|Non-compliance|0|||
30904167|NCT02336165|58938324|FG003|Overall Study|Non-compliance|1|||
30904168|NCT02336165|58938325|FG004|Overall Study|Non-compliance|0|||
30904169|NCT02336165|58938321|FG000|Overall Study|Other|1|||
30904170|NCT02336165|58938322|FG001|Overall Study|Other|0|||
30904171|NCT02336165|58938323|FG002|Overall Study|Other|0|||
30904172|NCT02336165|58938324|FG003|Overall Study|Other|1|||
30904173|NCT02336165|58938325|FG004|Overall Study|Other|0|||
30904174|NCT02360111|58938341|FG000|Overall Study|Death|2|||
30904175|NCT02334683|58938347|FG000|First 12 Week Period|Lost to Follow-up|1|||
30904176|NCT02334683|58938348|FG001|First 12 Week Period|Lost to Follow-up|0|||
30904177|NCT02334683|58938347|FG000|Second 12 Week Period|Adverse Event|0|||
30904178|NCT02334683|58938348|FG001|Second 12 Week Period|Adverse Event|1|||
30904179|NCT02319044|58938357|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
30904180|NCT02319044|58938358|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
30904181|NCT02319044|58938359|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
30904182|NCT02319044|58938357|FG000|Overall Study|Withdrawal by Subject|3|||
30904183|NCT02319044|58938358|FG001|Overall Study|Withdrawal by Subject|3|||
30904184|NCT02319044|58938359|FG002|Overall Study|Withdrawal by Subject|6|||
30904185|NCT02319044|58938357|FG000|Overall Study|Condition under investigation worsened|100|||
30904186|NCT02319044|58938358|FG001|Overall Study|Condition under investigation worsened|50|||
30904187|NCT02319044|58938359|FG002|Overall Study|Condition under investigation worsened|46|||
30904188|NCT02319044|58938357|FG000|Overall Study|Adverse Event|17|||
30904189|NCT02319044|58938358|FG001|Overall Study|Adverse Event|2|||
30904190|NCT02319044|58938359|FG002|Overall Study|Adverse Event|8|||
30904191|NCT02319044|58938357|FG000|Overall Study|Study specific discontinuation criteria|2|||
30904192|NCT02319044|58938358|FG001|Overall Study|Study specific discontinuation criteria|2|||
30904193|NCT02319044|58938359|FG002|Overall Study|Study specific discontinuation criteria|1|||
30904194|NCT02319044|58938357|FG000|Overall Study|Not treated|0|||
30904195|NCT02319044|58938358|FG001|Overall Study|Not treated|2|||
30904196|NCT02319044|58938359|FG002|Overall Study|Not treated|2|||
30904197|NCT01649765|58938370|FG000|Overall Study|Adverse Event|5|||
30904198|NCT01649765|58938371|FG001|Overall Study|Adverse Event|3|||
30904199|NCT01649765|58938370|FG000|Overall Study|Lack of Efficacy|1|||
30904200|NCT01649765|58938371|FG001|Overall Study|Lack of Efficacy|1|||
30904201|NCT01649765|58938370|FG000|Overall Study|Physician Decision|0|||
30746024|NCT00463229|58756797|FG000|Overall Study|Death|4|||
30746025|NCT00463229|58756798|FG001|Overall Study|Death|3|||
30746026|NCT03839693|58756808|FG000|Overall Study|Lost to Follow-up|0|||
30746027|NCT03839693|58756809|FG001|Overall Study|Lost to Follow-up|2|||
30746028|NCT03839693|58756810|FG002|Overall Study|Lost to Follow-up|2|||
30746029|NCT03839693|58756808|FG000|Overall Study|Withdrawal by Subject|1|||
30746030|NCT03839693|58756809|FG001|Overall Study|Withdrawal by Subject|0|||
30746031|NCT03839693|58756810|FG002|Overall Study|Withdrawal by Subject|2|||
30746032|NCT03839693|58756808|FG000|Overall Study|subject moved out of the area|1|||
30746033|NCT03839693|58756809|FG001|Overall Study|subject moved out of the area|0|||
30746034|NCT03839693|58756810|FG002|Overall Study|subject moved out of the area|0|||
30746035|NCT00068692|58756823|FG000|Step 1: Registration|Disese progression/relapse|5|||
30904202|NCT01649765|58938371|FG001|Overall Study|Physician Decision|3|||
30904203|NCT01649765|58938370|FG000|Overall Study|Protocol Violation|1|||
30904204|NCT01649765|58938371|FG001|Overall Study|Protocol Violation|0|||
30904205|NCT01649765|58938370|FG000|Overall Study|Withdrawal by Subject|2|||
30904206|NCT01649765|58938371|FG001|Overall Study|Withdrawal by Subject|1|||
30904207|NCT02317562|58938378|FG000|Overall Study|Physician Decision|1|||
30904208|NCT02317562|58938378|FG000|Overall Study|early termination of the study|8|||
30904209|NCT02317562|58938378|FG000|Overall Study|Lack of Efficacy|4|||
30794945|NCT00071513|58808782|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
30794946|NCT00006389|58808790|FG000|Overall Study|Adverse Event|1|||
30794947|NCT00006305|58808799|FG000|Overall Study|Withdrawal by Subject|17|||
30794948|NCT00006305|58808800|FG001|Overall Study|Withdrawal by Subject|10|||
30794949|NCT00006305|58808801|FG002|Overall Study|Withdrawal by Subject|15|||
30794950|NCT00006305|58808802|FG003|Overall Study|Withdrawal by Subject|14|||
30794951|NCT03529773|58808852|FG000|Overall Study|Adverse Event|0|||
30794952|NCT03529773|58808853|FG001|Overall Study|Adverse Event|0|||
30794953|NCT03529773|58808854|FG002|Overall Study|Adverse Event|0|||
30794954|NCT03529773|58808855|FG003|Overall Study|Adverse Event|0|||
30794955|NCT03529773|58808856|FG004|Overall Study|Adverse Event|0|||
30794956|NCT03529773|58808857|FG005|Overall Study|Adverse Event|0|||
30794957|NCT03529773|58808858|FG006|Overall Study|Adverse Event|0|||
30794958|NCT03529773|58808859|FG007|Overall Study|Adverse Event|0|||
30794959|NCT03529773|58808860|FG008|Overall Study|Adverse Event|0|||
30794960|NCT03529773|58808861|FG009|Overall Study|Adverse Event|0|||
30794961|NCT03529773|58808862|FG010|Overall Study|Adverse Event|0|||
30794962|NCT03529773|58808863|FG011|Overall Study|Adverse Event|0|||
30794963|NCT03529773|58808864|FG012|Overall Study|Adverse Event|0|||
30794964|NCT03529773|58808865|FG013|Overall Study|Adverse Event|0|||
30794965|NCT03529773|58808866|FG014|Overall Study|Adverse Event|0|||
30794966|NCT03529773|58808867|FG015|Overall Study|Adverse Event|0|||
30794967|NCT03529773|58808868|FG016|Overall Study|Adverse Event|0|||
30794968|NCT03529773|58808869|FG017|Overall Study|Adverse Event|0|||
30794969|NCT03529773|58808870|FG018|Overall Study|Adverse Event|0|||
30794970|NCT03529773|58808871|FG019|Overall Study|Adverse Event|0|||
30794971|NCT03529773|58808872|FG020|Overall Study|Adverse Event|0|||
30904210|NCT02317562|58938378|FG000|Overall Study|Withdrawal by Subject|1|||
30904211|NCT02317016|58938382|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
30904212|NCT02317016|58938382|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
30904213|NCT02317016|58938382|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
30794972|NCT03529773|58808873|FG021|Overall Study|Adverse Event|0|||
30794973|NCT03529773|58808874|FG022|Overall Study|Adverse Event|0|||
30794974|NCT03529773|58808875|FG023|Overall Study|Adverse Event|0|||
30794975|NCT03529773|58808876|FG024|Overall Study|Adverse Event|0|||
30794976|NCT03529773|58808877|FG025|Overall Study|Adverse Event|0|||
30794977|NCT03529773|58808878|FG026|Overall Study|Adverse Event|0|||
30794978|NCT03529773|58808879|FG027|Overall Study|Adverse Event|0|||
30794979|NCT03529773|58808880|FG028|Overall Study|Adverse Event|0|||
30794980|NCT03529773|58808881|FG029|Overall Study|Adverse Event|0|||
30794981|NCT03529773|58808882|FG030|Overall Study|Adverse Event|1|||
30794982|NCT03529773|58808883|FG031|Overall Study|Adverse Event|0|||
30794983|NCT03529773|58808884|FG032|Overall Study|Adverse Event|0|||
30794984|NCT03529773|58808885|FG033|Overall Study|Adverse Event|0|||
30794985|NCT03529773|58808886|FG034|Overall Study|Adverse Event|0|||
30794986|NCT03529773|58808887|FG035|Overall Study|Adverse Event|1|||
30794987|NCT03529773|58808888|FG036|Overall Study|Adverse Event|0|||
30794988|NCT03529773|58808889|FG037|Overall Study|Adverse Event|0|||
30794989|NCT03529773|58808890|FG038|Overall Study|Adverse Event|1|||
30794990|NCT03529773|58808891|FG039|Overall Study|Adverse Event|1|||
30794991|NCT03529773|58808852|FG000|Overall Study|Death|0|||
30794992|NCT03529773|58808853|FG001|Overall Study|Death|0|||
30794993|NCT03529773|58808854|FG002|Overall Study|Death|0|||
30794994|NCT03529773|58808855|FG003|Overall Study|Death|0|||
30794995|NCT03529773|58808856|FG004|Overall Study|Death|0|||
30794996|NCT03529773|58808857|FG005|Overall Study|Death|0|||
30794997|NCT03529773|58808858|FG006|Overall Study|Death|0|||
30794998|NCT03529773|58808859|FG007|Overall Study|Death|0|||
30794999|NCT03529773|58808860|FG008|Overall Study|Death|0|||
30795000|NCT03529773|58808861|FG009|Overall Study|Death|0|||
30795001|NCT03529773|58808862|FG010|Overall Study|Death|0|||
30795002|NCT03529773|58808863|FG011|Overall Study|Death|0|||
30795003|NCT03529773|58808864|FG012|Overall Study|Death|1|||
30795004|NCT03529773|58808865|FG013|Overall Study|Death|0|||
30795005|NCT03529773|58808866|FG014|Overall Study|Death|0|||
30795006|NCT03529773|58808867|FG015|Overall Study|Death|0|||
30795007|NCT03529773|58808868|FG016|Overall Study|Death|0|||
30795008|NCT03529773|58808869|FG017|Overall Study|Death|0|||
30795009|NCT03529773|58808870|FG018|Overall Study|Death|0|||
30795010|NCT03529773|58808871|FG019|Overall Study|Death|1|||
30795011|NCT03529773|58808872|FG020|Overall Study|Death|0|||
30795012|NCT03529773|58808873|FG021|Overall Study|Death|0|||
30795013|NCT03529773|58808874|FG022|Overall Study|Death|1|||
30795014|NCT03529773|58808875|FG023|Overall Study|Death|0|||
30795015|NCT03529773|58808876|FG024|Overall Study|Death|0|||
30795016|NCT03529773|58808877|FG025|Overall Study|Death|0|||
30795017|NCT03529773|58808878|FG026|Overall Study|Death|0|||
30795018|NCT03529773|58808879|FG027|Overall Study|Death|0|||
30795019|NCT03529773|58808880|FG028|Overall Study|Death|0|||
30795020|NCT03529773|58808881|FG029|Overall Study|Death|0|||
30795021|NCT03529773|58808882|FG030|Overall Study|Death|0|||
30795022|NCT03529773|58808883|FG031|Overall Study|Death|0|||
30795023|NCT03529773|58808884|FG032|Overall Study|Death|0|||
30795024|NCT03529773|58808885|FG033|Overall Study|Death|1|||
30795025|NCT03529773|58808886|FG034|Overall Study|Death|1|||
30795026|NCT03529773|58808887|FG035|Overall Study|Death|0|||
30795027|NCT03529773|58808888|FG036|Overall Study|Death|1|||
30795028|NCT03529773|58808889|FG037|Overall Study|Death|0|||
30795029|NCT03529773|58808890|FG038|Overall Study|Death|0|||
30795030|NCT03529773|58808891|FG039|Overall Study|Death|0|||
30795031|NCT03529773|58808852|FG000|Overall Study|Lost to Follow-up|0|||
30795032|NCT03529773|58808853|FG001|Overall Study|Lost to Follow-up|0|||
30795033|NCT03529773|58808854|FG002|Overall Study|Lost to Follow-up|1|||
30795034|NCT03529773|58808855|FG003|Overall Study|Lost to Follow-up|0|||
30795035|NCT03529773|58808856|FG004|Overall Study|Lost to Follow-up|1|||
30795036|NCT03529773|58808857|FG005|Overall Study|Lost to Follow-up|1|||
30795037|NCT03529773|58808858|FG006|Overall Study|Lost to Follow-up|0|||
30795038|NCT03529773|58808859|FG007|Overall Study|Lost to Follow-up|0|||
30795039|NCT03529773|58808860|FG008|Overall Study|Lost to Follow-up|0|||
30795040|NCT03529773|58808861|FG009|Overall Study|Lost to Follow-up|0|||
30795041|NCT03529773|58808862|FG010|Overall Study|Lost to Follow-up|0|||
30795042|NCT03529773|58808863|FG011|Overall Study|Lost to Follow-up|0|||
30795043|NCT03529773|58808864|FG012|Overall Study|Lost to Follow-up|0|||
30948480|NCT01976741|58994455|FG002|Overall Study|Withdrawal by Subject|1|||
30795044|NCT03529773|58808865|FG013|Overall Study|Lost to Follow-up|1|||
30795045|NCT03529773|58808866|FG014|Overall Study|Lost to Follow-up|4|||
30795046|NCT03529773|58808867|FG015|Overall Study|Lost to Follow-up|1|||
30795047|NCT03529773|58808868|FG016|Overall Study|Lost to Follow-up|1|||
30795048|NCT03529773|58808869|FG017|Overall Study|Lost to Follow-up|0|||
30795049|NCT03529773|58808870|FG018|Overall Study|Lost to Follow-up|1|||
30795050|NCT03529773|58808871|FG019|Overall Study|Lost to Follow-up|1|||
30795051|NCT03529773|58808872|FG020|Overall Study|Lost to Follow-up|2|||
30795052|NCT03529773|58808873|FG021|Overall Study|Lost to Follow-up|4|||
30795053|NCT03529773|58808874|FG022|Overall Study|Lost to Follow-up|3|||
30795054|NCT03529773|58808875|FG023|Overall Study|Lost to Follow-up|4|||
30795055|NCT03529773|58808876|FG024|Overall Study|Lost to Follow-up|3|||
30795056|NCT03529773|58808877|FG025|Overall Study|Lost to Follow-up|5|||
30795057|NCT03529773|58808878|FG026|Overall Study|Lost to Follow-up|5|||
30795058|NCT03529773|58808879|FG027|Overall Study|Lost to Follow-up|0|||
30795059|NCT03529773|58808880|FG028|Overall Study|Lost to Follow-up|0|||
30795060|NCT03529773|58808881|FG029|Overall Study|Lost to Follow-up|0|||
30795061|NCT03529773|58808882|FG030|Overall Study|Lost to Follow-up|1|||
30795062|NCT03529773|58808883|FG031|Overall Study|Lost to Follow-up|0|||
30795063|NCT03529773|58808884|FG032|Overall Study|Lost to Follow-up|0|||
30795064|NCT03529773|58808885|FG033|Overall Study|Lost to Follow-up|1|||
30795065|NCT03529773|58808886|FG034|Overall Study|Lost to Follow-up|1|||
30795066|NCT03529773|58808887|FG035|Overall Study|Lost to Follow-up|0|||
30795067|NCT03529773|58808888|FG036|Overall Study|Lost to Follow-up|0|||
30795068|NCT03529773|58808889|FG037|Overall Study|Lost to Follow-up|3|||
30795069|NCT03529773|58808890|FG038|Overall Study|Lost to Follow-up|1|||
30795070|NCT03529773|58808891|FG039|Overall Study|Lost to Follow-up|1|||
30795071|NCT03529773|58808852|FG000|Overall Study|No longer meets eligibility criteria|0|||
30795072|NCT03529773|58808853|FG001|Overall Study|No longer meets eligibility criteria|0|||
30746036|NCT00068692|58756824|FG001|Step 1: Registration|Disese progression/relapse|0|||
30746037|NCT00068692|58756825|FG002|Step 1: Registration|Disese progression/relapse|0|||
30746038|NCT00068692|58756826|FG003|Step 1: Registration|Disese progression/relapse|0|||
30746039|NCT00068692|58756827|FG004|Step 1: Registration|Disese progression/relapse|0|||
30746040|NCT00068692|58756828|FG005|Step 1: Registration|Disese progression/relapse|0|||
30746041|NCT00068692|58756829|FG006|Step 1: Registration|Disese progression/relapse|0|||
30746042|NCT00068692|58756830|FG007|Step 1: Registration|Disese progression/relapse|0|||
30746043|NCT00068692|58756823|FG000|Step 1: Registration|Adverse Event|7|||
30746044|NCT00068692|58756824|FG001|Step 1: Registration|Adverse Event|0|||
30746045|NCT00068692|58756825|FG002|Step 1: Registration|Adverse Event|0|||
30746046|NCT00068692|58756826|FG003|Step 1: Registration|Adverse Event|0|||
30746047|NCT00068692|58756827|FG004|Step 1: Registration|Adverse Event|0|||
30746048|NCT00068692|58756828|FG005|Step 1: Registration|Adverse Event|0|||
30746049|NCT00068692|58756829|FG006|Step 1: Registration|Adverse Event|0|||
30746050|NCT00068692|58756830|FG007|Step 1: Registration|Adverse Event|0|||
30795073|NCT03529773|58808854|FG002|Overall Study|No longer meets eligibility criteria|0|||
30795074|NCT03529773|58808855|FG003|Overall Study|No longer meets eligibility criteria|0|||
30795075|NCT03529773|58808856|FG004|Overall Study|No longer meets eligibility criteria|0|||
30795076|NCT03529773|58808857|FG005|Overall Study|No longer meets eligibility criteria|0|||
30795077|NCT03529773|58808858|FG006|Overall Study|No longer meets eligibility criteria|0|||
30795078|NCT03529773|58808859|FG007|Overall Study|No longer meets eligibility criteria|0|||
30795079|NCT03529773|58808860|FG008|Overall Study|No longer meets eligibility criteria|0|||
30795080|NCT03529773|58808861|FG009|Overall Study|No longer meets eligibility criteria|0|||
30795081|NCT03529773|58808862|FG010|Overall Study|No longer meets eligibility criteria|0|||
30795082|NCT03529773|58808863|FG011|Overall Study|No longer meets eligibility criteria|0|||
30795083|NCT03529773|58808864|FG012|Overall Study|No longer meets eligibility criteria|0|||
30795084|NCT03529773|58808865|FG013|Overall Study|No longer meets eligibility criteria|0|||
30795085|NCT03529773|58808866|FG014|Overall Study|No longer meets eligibility criteria|0|||
30795086|NCT03529773|58808867|FG015|Overall Study|No longer meets eligibility criteria|0|||
30795087|NCT03529773|58808868|FG016|Overall Study|No longer meets eligibility criteria|0|||
30795088|NCT03529773|58808869|FG017|Overall Study|No longer meets eligibility criteria|0|||
30795089|NCT03529773|58808870|FG018|Overall Study|No longer meets eligibility criteria|0|||
30795090|NCT03529773|58808871|FG019|Overall Study|No longer meets eligibility criteria|0|||
30795091|NCT03529773|58808872|FG020|Overall Study|No longer meets eligibility criteria|0|||
30795092|NCT03529773|58808873|FG021|Overall Study|No longer meets eligibility criteria|0|||
30795093|NCT03529773|58808874|FG022|Overall Study|No longer meets eligibility criteria|1|||
30795094|NCT03529773|58808875|FG023|Overall Study|No longer meets eligibility criteria|0|||
30795095|NCT03529773|58808876|FG024|Overall Study|No longer meets eligibility criteria|0|||
30795096|NCT03529773|58808877|FG025|Overall Study|No longer meets eligibility criteria|0|||
30795097|NCT03529773|58808878|FG026|Overall Study|No longer meets eligibility criteria|0|||
30795098|NCT03529773|58808879|FG027|Overall Study|No longer meets eligibility criteria|0|||
30795099|NCT03529773|58808880|FG028|Overall Study|No longer meets eligibility criteria|0|||
30795100|NCT03529773|58808881|FG029|Overall Study|No longer meets eligibility criteria|0|||
30795101|NCT03529773|58808882|FG030|Overall Study|No longer meets eligibility criteria|0|||
30795102|NCT03529773|58808883|FG031|Overall Study|No longer meets eligibility criteria|0|||
30795103|NCT03529773|58808884|FG032|Overall Study|No longer meets eligibility criteria|0|||
30795104|NCT03529773|58808885|FG033|Overall Study|No longer meets eligibility criteria|0|||
30795105|NCT03529773|58808886|FG034|Overall Study|No longer meets eligibility criteria|0|||
30795106|NCT03529773|58808887|FG035|Overall Study|No longer meets eligibility criteria|0|||
30795107|NCT03529773|58808888|FG036|Overall Study|No longer meets eligibility criteria|0|||
30795108|NCT03529773|58808889|FG037|Overall Study|No longer meets eligibility criteria|0|||
30795109|NCT03529773|58808890|FG038|Overall Study|No longer meets eligibility criteria|1|||
30795110|NCT03529773|58808891|FG039|Overall Study|No longer meets eligibility criteria|0|||
30795111|NCT03529773|58808852|FG000|Overall Study|Other|0|||
30795112|NCT03529773|58808853|FG001|Overall Study|Other|0|||
30795113|NCT03529773|58808854|FG002|Overall Study|Other|0|||
30795114|NCT03529773|58808855|FG003|Overall Study|Other|0|||
30795115|NCT03529773|58808856|FG004|Overall Study|Other|0|||
30795116|NCT03529773|58808857|FG005|Overall Study|Other|0|||
30795117|NCT03529773|58808858|FG006|Overall Study|Other|0|||
30795118|NCT03529773|58808859|FG007|Overall Study|Other|0|||
30795119|NCT03529773|58808860|FG008|Overall Study|Other|0|||
30795120|NCT03529773|58808861|FG009|Overall Study|Other|0|||
30795121|NCT03529773|58808862|FG010|Overall Study|Other|0|||
30795122|NCT03529773|58808863|FG011|Overall Study|Other|0|||
30795123|NCT03529773|58808864|FG012|Overall Study|Other|1|||
30795124|NCT03529773|58808865|FG013|Overall Study|Other|0|||
30795125|NCT03529773|58808866|FG014|Overall Study|Other|2|||
30795126|NCT03529773|58808867|FG015|Overall Study|Other|0|||
30795127|NCT03529773|58808868|FG016|Overall Study|Other|0|||
30795128|NCT03529773|58808869|FG017|Overall Study|Other|3|||
30795129|NCT03529773|58808870|FG018|Overall Study|Other|0|||
30795130|NCT03529773|58808871|FG019|Overall Study|Other|0|||
30795131|NCT03529773|58808872|FG020|Overall Study|Other|1|||
30795132|NCT03529773|58808873|FG021|Overall Study|Other|0|||
30795133|NCT03529773|58808874|FG022|Overall Study|Other|1|||
30795134|NCT03529773|58808875|FG023|Overall Study|Other|0|||
30795135|NCT03529773|58808876|FG024|Overall Study|Other|3|||
30795136|NCT03529773|58808877|FG025|Overall Study|Other|2|||
30795137|NCT03529773|58808878|FG026|Overall Study|Other|2|||
30795138|NCT03529773|58808879|FG027|Overall Study|Other|0|||
30795139|NCT03529773|58808880|FG028|Overall Study|Other|0|||
30795140|NCT03529773|58808881|FG029|Overall Study|Other|0|||
30795141|NCT03529773|58808882|FG030|Overall Study|Other|0|||
30795142|NCT03529773|58808883|FG031|Overall Study|Other|0|||
30795143|NCT03529773|58808884|FG032|Overall Study|Other|0|||
30795144|NCT03529773|58808885|FG033|Overall Study|Other|0|||
30795145|NCT03529773|58808886|FG034|Overall Study|Other|1|||
30795146|NCT03529773|58808887|FG035|Overall Study|Other|1|||
30795147|NCT03529773|58808888|FG036|Overall Study|Other|0|||
30795148|NCT03529773|58808889|FG037|Overall Study|Other|0|||
30795149|NCT03529773|58808890|FG038|Overall Study|Other|0|||
30795150|NCT03529773|58808891|FG039|Overall Study|Other|0|||
30795151|NCT03529773|58808852|FG000|Overall Study|Physician Decision|0|||
30795152|NCT03529773|58808853|FG001|Overall Study|Physician Decision|0|||
30795153|NCT03529773|58808854|FG002|Overall Study|Physician Decision|0|||
30795154|NCT03529773|58808855|FG003|Overall Study|Physician Decision|0|||
30795155|NCT03529773|58808856|FG004|Overall Study|Physician Decision|0|||
30795156|NCT03529773|58808857|FG005|Overall Study|Physician Decision|0|||
30795157|NCT03529773|58808858|FG006|Overall Study|Physician Decision|0|||
30795158|NCT03529773|58808859|FG007|Overall Study|Physician Decision|0|||
30795159|NCT03529773|58808860|FG008|Overall Study|Physician Decision|0|||
30795160|NCT03529773|58808861|FG009|Overall Study|Physician Decision|0|||
30795161|NCT03529773|58808862|FG010|Overall Study|Physician Decision|0|||
30795162|NCT03529773|58808863|FG011|Overall Study|Physician Decision|0|||
30795163|NCT03529773|58808864|FG012|Overall Study|Physician Decision|0|||
30795164|NCT03529773|58808865|FG013|Overall Study|Physician Decision|0|||
30795165|NCT03529773|58808866|FG014|Overall Study|Physician Decision|0|||
30795166|NCT03529773|58808867|FG015|Overall Study|Physician Decision|0|||
30795167|NCT03529773|58808868|FG016|Overall Study|Physician Decision|0|||
30795168|NCT03529773|58808869|FG017|Overall Study|Physician Decision|0|||
30795169|NCT03529773|58808870|FG018|Overall Study|Physician Decision|0|||
30795170|NCT03529773|58808871|FG019|Overall Study|Physician Decision|1|||
30795171|NCT03529773|58808872|FG020|Overall Study|Physician Decision|1|||
30795172|NCT03529773|58808873|FG021|Overall Study|Physician Decision|0|||
30795173|NCT03529773|58808874|FG022|Overall Study|Physician Decision|0|||
30795174|NCT03529773|58808875|FG023|Overall Study|Physician Decision|0|||
30795175|NCT03529773|58808876|FG024|Overall Study|Physician Decision|0|||
30795176|NCT03529773|58808877|FG025|Overall Study|Physician Decision|0|||
30795177|NCT03529773|58808878|FG026|Overall Study|Physician Decision|0|||
30795178|NCT03529773|58808879|FG027|Overall Study|Physician Decision|0|||
30795179|NCT03529773|58808880|FG028|Overall Study|Physician Decision|0|||
30795180|NCT03529773|58808881|FG029|Overall Study|Physician Decision|0|||
30795181|NCT03529773|58808882|FG030|Overall Study|Physician Decision|0|||
30795182|NCT03529773|58808883|FG031|Overall Study|Physician Decision|0|||
30795183|NCT03529773|58808884|FG032|Overall Study|Physician Decision|0|||
30795184|NCT03529773|58808885|FG033|Overall Study|Physician Decision|0|||
30795185|NCT03529773|58808886|FG034|Overall Study|Physician Decision|0|||
30795186|NCT03529773|58808887|FG035|Overall Study|Physician Decision|0|||
30795187|NCT03529773|58808888|FG036|Overall Study|Physician Decision|0|||
30795188|NCT03529773|58808889|FG037|Overall Study|Physician Decision|0|||
30795189|NCT03529773|58808890|FG038|Overall Study|Physician Decision|0|||
30795190|NCT03529773|58808891|FG039|Overall Study|Physician Decision|0|||
30795191|NCT03529773|58808852|FG000|Overall Study|Protocol Violation|0|||
30795192|NCT03529773|58808853|FG001|Overall Study|Protocol Violation|0|||
30795193|NCT03529773|58808854|FG002|Overall Study|Protocol Violation|0|||
30795194|NCT03529773|58808855|FG003|Overall Study|Protocol Violation|0|||
30795195|NCT03529773|58808856|FG004|Overall Study|Protocol Violation|0|||
30795196|NCT03529773|58808857|FG005|Overall Study|Protocol Violation|0|||
30795197|NCT03529773|58808858|FG006|Overall Study|Protocol Violation|0|||
30795198|NCT03529773|58808859|FG007|Overall Study|Protocol Violation|0|||
30795199|NCT03529773|58808860|FG008|Overall Study|Protocol Violation|0|||
30795200|NCT03529773|58808861|FG009|Overall Study|Protocol Violation|0|||
30795201|NCT03529773|58808862|FG010|Overall Study|Protocol Violation|0|||
30795202|NCT03529773|58808863|FG011|Overall Study|Protocol Violation|0|||
30795203|NCT03529773|58808864|FG012|Overall Study|Protocol Violation|0|||
30795204|NCT03529773|58808865|FG013|Overall Study|Protocol Violation|0|||
30795205|NCT03529773|58808866|FG014|Overall Study|Protocol Violation|0|||
30795206|NCT03529773|58808867|FG015|Overall Study|Protocol Violation|0|||
30795207|NCT03529773|58808868|FG016|Overall Study|Protocol Violation|0|||
30795208|NCT03529773|58808869|FG017|Overall Study|Protocol Violation|0|||
30795209|NCT03529773|58808870|FG018|Overall Study|Protocol Violation|0|||
30795210|NCT03529773|58808871|FG019|Overall Study|Protocol Violation|0|||
30795211|NCT03529773|58808872|FG020|Overall Study|Protocol Violation|0|||
30795212|NCT03529773|58808873|FG021|Overall Study|Protocol Violation|0|||
30795213|NCT03529773|58808874|FG022|Overall Study|Protocol Violation|0|||
30795214|NCT03529773|58808875|FG023|Overall Study|Protocol Violation|0|||
30795215|NCT03529773|58808876|FG024|Overall Study|Protocol Violation|0|||
30795216|NCT03529773|58808877|FG025|Overall Study|Protocol Violation|0|||
30795217|NCT03529773|58808878|FG026|Overall Study|Protocol Violation|0|||
30795218|NCT03529773|58808879|FG027|Overall Study|Protocol Violation|0|||
30795219|NCT03529773|58808880|FG028|Overall Study|Protocol Violation|0|||
30795220|NCT03529773|58808881|FG029|Overall Study|Protocol Violation|0|||
30795221|NCT03529773|58808882|FG030|Overall Study|Protocol Violation|1|||
30795222|NCT03529773|58808883|FG031|Overall Study|Protocol Violation|0|||
30795223|NCT03529773|58808884|FG032|Overall Study|Protocol Violation|0|||
30795224|NCT03529773|58808885|FG033|Overall Study|Protocol Violation|0|||
30795225|NCT03529773|58808886|FG034|Overall Study|Protocol Violation|0|||
30795226|NCT03529773|58808887|FG035|Overall Study|Protocol Violation|0|||
30795227|NCT03529773|58808888|FG036|Overall Study|Protocol Violation|0|||
30795228|NCT03529773|58808889|FG037|Overall Study|Protocol Violation|0|||
30795229|NCT03529773|58808890|FG038|Overall Study|Protocol Violation|0|||
30795230|NCT03529773|58808891|FG039|Overall Study|Protocol Violation|0|||
30746051|NCT00068692|58756823|FG000|Step 1: Registration|Death|1|||
30746052|NCT00068692|58756824|FG001|Step 1: Registration|Death|0|||
30746053|NCT00068692|58756825|FG002|Step 1: Registration|Death|0|||
30746054|NCT00068692|58756826|FG003|Step 1: Registration|Death|0|||
30746055|NCT00068692|58756827|FG004|Step 1: Registration|Death|0|||
30746056|NCT00068692|58756828|FG005|Step 1: Registration|Death|0|||
30746057|NCT00068692|58756829|FG006|Step 1: Registration|Death|0|||
30746058|NCT00068692|58756830|FG007|Step 1: Registration|Death|0|||
30746059|NCT00068692|58756823|FG000|Step 1: Registration|Withdrawal by Subject|11|||
30746060|NCT00068692|58756824|FG001|Step 1: Registration|Withdrawal by Subject|0|||
30746061|NCT00068692|58756825|FG002|Step 1: Registration|Withdrawal by Subject|0|||
30746062|NCT00068692|58756826|FG003|Step 1: Registration|Withdrawal by Subject|0|||
30746063|NCT00068692|58756827|FG004|Step 1: Registration|Withdrawal by Subject|0|||
30746064|NCT00068692|58756828|FG005|Step 1: Registration|Withdrawal by Subject|0|||
30746065|NCT00068692|58756829|FG006|Step 1: Registration|Withdrawal by Subject|0|||
30746066|NCT00068692|58756830|FG007|Step 1: Registration|Withdrawal by Subject|0|||
30746067|NCT00068692|58756823|FG000|Step 1: Registration|Alternative therapy|2|||
30746068|NCT00068692|58756824|FG001|Step 1: Registration|Alternative therapy|0|||
30746069|NCT00068692|58756825|FG002|Step 1: Registration|Alternative therapy|0|||
30746070|NCT00068692|58756826|FG003|Step 1: Registration|Alternative therapy|0|||
30746071|NCT00068692|58756827|FG004|Step 1: Registration|Alternative therapy|0|||
30746072|NCT00068692|58756828|FG005|Step 1: Registration|Alternative therapy|0|||
30746073|NCT00068692|58756829|FG006|Step 1: Registration|Alternative therapy|0|||
30746074|NCT00068692|58756830|FG007|Step 1: Registration|Alternative therapy|0|||
30746075|NCT00068692|58756823|FG000|Step 1: Registration|Complicating disease|2|||
30746076|NCT00068692|58756824|FG001|Step 1: Registration|Complicating disease|0|||
30746077|NCT00068692|58756825|FG002|Step 1: Registration|Complicating disease|0|||
30746078|NCT00068692|58756826|FG003|Step 1: Registration|Complicating disease|0|||
30746079|NCT00068692|58756827|FG004|Step 1: Registration|Complicating disease|0|||
30746080|NCT00068692|58756828|FG005|Step 1: Registration|Complicating disease|0|||
30746081|NCT00068692|58756829|FG006|Step 1: Registration|Complicating disease|0|||
30746082|NCT00068692|58756830|FG007|Step 1: Registration|Complicating disease|0|||
30746083|NCT00068692|58756823|FG000|Step 1: Registration|Protocol Violation|1|||
30746084|NCT00068692|58756824|FG001|Step 1: Registration|Protocol Violation|0|||
30746085|NCT00068692|58756825|FG002|Step 1: Registration|Protocol Violation|0|||
30746086|NCT00068692|58756826|FG003|Step 1: Registration|Protocol Violation|0|||
30746087|NCT00068692|58756827|FG004|Step 1: Registration|Protocol Violation|0|||
30746088|NCT00068692|58756828|FG005|Step 1: Registration|Protocol Violation|0|||
30746089|NCT00068692|58756829|FG006|Step 1: Registration|Protocol Violation|0|||
30746090|NCT00068692|58756830|FG007|Step 1: Registration|Protocol Violation|0|||
30746091|NCT00068692|58756823|FG000|Step 1: Registration|Not eligible|6|||
30746092|NCT00068692|58756824|FG001|Step 1: Registration|Not eligible|0|||
30746093|NCT00068692|58756825|FG002|Step 1: Registration|Not eligible|0|||
30746094|NCT00068692|58756826|FG003|Step 1: Registration|Not eligible|0|||
30746095|NCT00068692|58756827|FG004|Step 1: Registration|Not eligible|0|||
30746096|NCT00068692|58756828|FG005|Step 1: Registration|Not eligible|0|||
30746097|NCT00068692|58756829|FG006|Step 1: Registration|Not eligible|0|||
30746098|NCT00068692|58756830|FG007|Step 1: Registration|Not eligible|0|||
30746099|NCT00068692|58756823|FG000|Step 1: Registration|Other|2|||
30746100|NCT00068692|58756824|FG001|Step 1: Registration|Other|0|||
30746101|NCT00068692|58756825|FG002|Step 1: Registration|Other|0|||
30746102|NCT00068692|58756826|FG003|Step 1: Registration|Other|0|||
30746103|NCT00068692|58756827|FG004|Step 1: Registration|Other|0|||
30795231|NCT03529773|58808852|FG000|Overall Study|Withdrawal by Subject|0|||
30746104|NCT00068692|58756828|FG005|Step 1: Registration|Other|0|||
30746105|NCT00068692|58756829|FG006|Step 1: Registration|Other|0|||
30746106|NCT00068692|58756830|FG007|Step 1: Registration|Other|0|||
30746107|NCT00068692|58756823|FG000|Step 1: Registration|Not start protocol therapy|3|||
30746108|NCT00068692|58756824|FG001|Step 1: Registration|Not start protocol therapy|0|||
30746109|NCT00068692|58756825|FG002|Step 1: Registration|Not start protocol therapy|0|||
30746110|NCT00068692|58756826|FG003|Step 1: Registration|Not start protocol therapy|0|||
30746111|NCT00068692|58756827|FG004|Step 1: Registration|Not start protocol therapy|0|||
30746112|NCT00068692|58756828|FG005|Step 1: Registration|Not start protocol therapy|0|||
30746113|NCT00068692|58756829|FG006|Step 1: Registration|Not start protocol therapy|0|||
30746114|NCT00068692|58756830|FG007|Step 1: Registration|Not start protocol therapy|0|||
30746115|NCT00068692|58756823|FG000|Step 1: Registration|Registered but not randomized|0|||
30746116|NCT00068692|58756824|FG001|Step 1: Registration|Registered but not randomized|1|||
30746117|NCT00068692|58756825|FG002|Step 1: Registration|Registered but not randomized|0|||
30746118|NCT00068692|58756826|FG003|Step 1: Registration|Registered but not randomized|0|||
30746119|NCT00068692|58756827|FG004|Step 1: Registration|Registered but not randomized|0|||
30746120|NCT00068692|58756828|FG005|Step 1: Registration|Registered but not randomized|0|||
30746121|NCT00068692|58756829|FG006|Step 1: Registration|Registered but not randomized|0|||
30746122|NCT00068692|58756830|FG007|Step 1: Registration|Registered but not randomized|0|||
30746123|NCT00068692|58756823|FG000|Step 2: Randomization|Disesae progression/replase|0|||
30746124|NCT00068692|58756824|FG001|Step 2: Randomization|Disesae progression/replase|0|||
30746125|NCT00068692|58756825|FG002|Step 2: Randomization|Disesae progression/replase|1|||
30746126|NCT00068692|58756826|FG003|Step 2: Randomization|Disesae progression/replase|1|||
30746127|NCT00068692|58756827|FG004|Step 2: Randomization|Disesae progression/replase|0|||
30746128|NCT00068692|58756828|FG005|Step 2: Randomization|Disesae progression/replase|0|||
30746129|NCT00068692|58756829|FG006|Step 2: Randomization|Disesae progression/replase|0|||
30746130|NCT00068692|58756830|FG007|Step 2: Randomization|Disesae progression/replase|0|||
30746131|NCT00068692|58756823|FG000|Step 2: Randomization|Adverse Event|0|||
30746132|NCT00068692|58756824|FG001|Step 2: Randomization|Adverse Event|0|||
30746133|NCT00068692|58756825|FG002|Step 2: Randomization|Adverse Event|4|||
30746134|NCT00068692|58756826|FG003|Step 2: Randomization|Adverse Event|2|||
30746135|NCT00068692|58756827|FG004|Step 2: Randomization|Adverse Event|2|||
30746136|NCT00068692|58756828|FG005|Step 2: Randomization|Adverse Event|3|||
30746137|NCT00068692|58756829|FG006|Step 2: Randomization|Adverse Event|4|||
30746138|NCT00068692|58756830|FG007|Step 2: Randomization|Adverse Event|4|||
30746139|NCT00068692|58756823|FG000|Step 2: Randomization|Death|0|||
30795232|NCT03529773|58808853|FG001|Overall Study|Withdrawal by Subject|0|||
30904214|NCT02317016|58938382|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
30904215|NCT02317016|58938382|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
30746140|NCT00068692|58756824|FG001|Step 2: Randomization|Death|0|||
30746141|NCT00068692|58756825|FG002|Step 2: Randomization|Death|0|||
30746142|NCT00068692|58756826|FG003|Step 2: Randomization|Death|0|||
30746143|NCT00068692|58756827|FG004|Step 2: Randomization|Death|1|||
30746144|NCT00068692|58756828|FG005|Step 2: Randomization|Death|0|||
30746145|NCT00068692|58756829|FG006|Step 2: Randomization|Death|0|||
30746146|NCT00068692|58756830|FG007|Step 2: Randomization|Death|1|||
30795233|NCT03529773|58808854|FG002|Overall Study|Withdrawal by Subject|0|||
30795234|NCT03529773|58808855|FG003|Overall Study|Withdrawal by Subject|0|||
30795235|NCT03529773|58808856|FG004|Overall Study|Withdrawal by Subject|0|||
30795236|NCT03529773|58808857|FG005|Overall Study|Withdrawal by Subject|0|||
30795237|NCT03529773|58808858|FG006|Overall Study|Withdrawal by Subject|0|||
30795238|NCT03529773|58808859|FG007|Overall Study|Withdrawal by Subject|1|||
30795239|NCT03529773|58808860|FG008|Overall Study|Withdrawal by Subject|0|||
30795240|NCT03529773|58808861|FG009|Overall Study|Withdrawal by Subject|1|||
30795241|NCT03529773|58808862|FG010|Overall Study|Withdrawal by Subject|1|||
30795242|NCT03529773|58808863|FG011|Overall Study|Withdrawal by Subject|0|||
30795243|NCT03529773|58808864|FG012|Overall Study|Withdrawal by Subject|0|||
30795244|NCT03529773|58808865|FG013|Overall Study|Withdrawal by Subject|0|||
30795245|NCT03529773|58808866|FG014|Overall Study|Withdrawal by Subject|0|||
30795246|NCT03529773|58808867|FG015|Overall Study|Withdrawal by Subject|3|||
30795247|NCT03529773|58808868|FG016|Overall Study|Withdrawal by Subject|0|||
30795248|NCT03529773|58808869|FG017|Overall Study|Withdrawal by Subject|2|||
30795249|NCT03529773|58808870|FG018|Overall Study|Withdrawal by Subject|3|||
30795250|NCT03529773|58808871|FG019|Overall Study|Withdrawal by Subject|1|||
30795251|NCT03529773|58808872|FG020|Overall Study|Withdrawal by Subject|3|||
30795252|NCT03529773|58808873|FG021|Overall Study|Withdrawal by Subject|1|||
30795253|NCT03529773|58808874|FG022|Overall Study|Withdrawal by Subject|1|||
30795254|NCT03529773|58808875|FG023|Overall Study|Withdrawal by Subject|2|||
30795255|NCT03529773|58808876|FG024|Overall Study|Withdrawal by Subject|2|||
30795256|NCT03529773|58808877|FG025|Overall Study|Withdrawal by Subject|4|||
30795257|NCT03529773|58808878|FG026|Overall Study|Withdrawal by Subject|2|||
30795258|NCT03529773|58808879|FG027|Overall Study|Withdrawal by Subject|1|||
30795259|NCT03529773|58808880|FG028|Overall Study|Withdrawal by Subject|1|||
30795260|NCT03529773|58808881|FG029|Overall Study|Withdrawal by Subject|0|||
30795261|NCT03529773|58808882|FG030|Overall Study|Withdrawal by Subject|0|||
30795262|NCT03529773|58808883|FG031|Overall Study|Withdrawal by Subject|0|||
30795263|NCT03529773|58808884|FG032|Overall Study|Withdrawal by Subject|0|||
30795264|NCT03529773|58808885|FG033|Overall Study|Withdrawal by Subject|0|||
30795265|NCT03529773|58808886|FG034|Overall Study|Withdrawal by Subject|1|||
30795266|NCT03529773|58808887|FG035|Overall Study|Withdrawal by Subject|2|||
30795267|NCT03529773|58808888|FG036|Overall Study|Withdrawal by Subject|0|||
30904216|NCT02317016|58938382|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
30904217|NCT02317016|58938382|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
30904218|NCT02311478|58938390|FG000|Overall Study|Withdrawal by Subject|1|||
30904219|NCT02311478|58938390|FG000|Overall Study|Lost to Follow-up|5|||
30904220|NCT02311478|58938390|FG000|Overall Study|Failed IUD Insertion|1|||
30904221|NCT02388932|58938395|FG000|Overall Study|Death|1|||
30904222|NCT02388776|58938400|FG000|Overall Study|Death|1|||
30904223|NCT02388776|58938400|FG000|Overall Study|Lost to Follow-up|1|||
30904224|NCT02316548|58938407|FG000|Overall Study|Protocol Violation|0|||
30904225|NCT02316548|58938408|FG001|Overall Study|Protocol Violation|1|||
30904226|NCT02281760|58938414|FG000|Overall Study|Withdrawal by Subject|1|||
30904227|NCT02390531|58938426|FG000|Overall Study|Death|0|||
30904228|NCT02390531|58938427|FG001|Overall Study|Death|2|||
30904229|NCT02390531|58938428|FG002|Overall Study|Death|0|||
30904230|NCT02390531|58938429|FG003|Overall Study|Death|1|||
30904231|NCT02390531|58938430|FG004|Overall Study|Death|0|||
30904232|NCT02390531|58938431|FG005|Overall Study|Death|0|||
30795268|NCT03529773|58808889|FG037|Overall Study|Withdrawal by Subject|2|||
30904233|NCT02390531|58938432|FG006|Overall Study|Death|0|||
30904234|NCT02390531|58938433|FG007|Overall Study|Death|1|||
30904235|NCT02390531|58938426|FG000|Overall Study|Protocol Violation|0|||
30904236|NCT02390531|58938427|FG001|Overall Study|Protocol Violation|0|||
30795269|NCT03529773|58808890|FG038|Overall Study|Withdrawal by Subject|1|||
30795270|NCT03529773|58808891|FG039|Overall Study|Withdrawal by Subject|1|||
30795271|NCT03529773|58808852|FG000|Overall Study|Screen Failure|0|||
30795272|NCT03529773|58808853|FG001|Overall Study|Screen Failure|0|||
30795273|NCT03529773|58808854|FG002|Overall Study|Screen Failure|0|||
30795274|NCT03529773|58808855|FG003|Overall Study|Screen Failure|0|||
30795275|NCT03529773|58808856|FG004|Overall Study|Screen Failure|0|||
30795276|NCT03529773|58808857|FG005|Overall Study|Screen Failure|0|||
30795277|NCT03529773|58808858|FG006|Overall Study|Screen Failure|0|||
30795278|NCT03529773|58808859|FG007|Overall Study|Screen Failure|0|||
30795279|NCT03529773|58808860|FG008|Overall Study|Screen Failure|0|||
30795280|NCT03529773|58808861|FG009|Overall Study|Screen Failure|0|||
30795281|NCT03529773|58808862|FG010|Overall Study|Screen Failure|0|||
30904237|NCT02390531|58938428|FG002|Overall Study|Protocol Violation|0|||
30795282|NCT03529773|58808863|FG011|Overall Study|Screen Failure|0|||
30795283|NCT03529773|58808864|FG012|Overall Study|Screen Failure|0|||
30795284|NCT03529773|58808865|FG013|Overall Study|Screen Failure|0|||
30795285|NCT03529773|58808866|FG014|Overall Study|Screen Failure|0|||
30795286|NCT03529773|58808867|FG015|Overall Study|Screen Failure|0|||
30795287|NCT03529773|58808868|FG016|Overall Study|Screen Failure|0|||
30795288|NCT03529773|58808869|FG017|Overall Study|Screen Failure|0|||
30795289|NCT03529773|58808870|FG018|Overall Study|Screen Failure|0|||
30795290|NCT03529773|58808871|FG019|Overall Study|Screen Failure|0|||
30795291|NCT03529773|58808872|FG020|Overall Study|Screen Failure|0|||
30795292|NCT03529773|58808873|FG021|Overall Study|Screen Failure|0|||
30795293|NCT03529773|58808874|FG022|Overall Study|Screen Failure|0|||
30795294|NCT03529773|58808875|FG023|Overall Study|Screen Failure|0|||
30795295|NCT03529773|58808876|FG024|Overall Study|Screen Failure|0|||
30795296|NCT03529773|58808877|FG025|Overall Study|Screen Failure|0|||
30795297|NCT03529773|58808878|FG026|Overall Study|Screen Failure|0|||
30795298|NCT03529773|58808879|FG027|Overall Study|Screen Failure|0|||
30795299|NCT03529773|58808880|FG028|Overall Study|Screen Failure|0|||
30795300|NCT03529773|58808881|FG029|Overall Study|Screen Failure|0|||
30795301|NCT03529773|58808882|FG030|Overall Study|Screen Failure|0|||
30795302|NCT03529773|58808883|FG031|Overall Study|Screen Failure|0|||
30795303|NCT03529773|58808884|FG032|Overall Study|Screen Failure|0|||
30795304|NCT03529773|58808885|FG033|Overall Study|Screen Failure|0|||
30795305|NCT03529773|58808886|FG034|Overall Study|Screen Failure|0|||
30795306|NCT03529773|58808887|FG035|Overall Study|Screen Failure|0|||
30795307|NCT03529773|58808888|FG036|Overall Study|Screen Failure|1|||
30795308|NCT03529773|58808889|FG037|Overall Study|Screen Failure|1|||
30795309|NCT03529773|58808890|FG038|Overall Study|Screen Failure|0|||
30795310|NCT03529773|58808891|FG039|Overall Study|Screen Failure|1|||
30795311|NCT03529773|58808852|FG000|Overall Study|Randomized but not vaccinated|0|||
30795312|NCT03529773|58808853|FG001|Overall Study|Randomized but not vaccinated|0|||
30795313|NCT03529773|58808854|FG002|Overall Study|Randomized but not vaccinated|0|||
30795314|NCT03529773|58808855|FG003|Overall Study|Randomized but not vaccinated|0|||
30795315|NCT03529773|58808856|FG004|Overall Study|Randomized but not vaccinated|0|||
30795316|NCT03529773|58808857|FG005|Overall Study|Randomized but not vaccinated|0|||
30795317|NCT03529773|58808858|FG006|Overall Study|Randomized but not vaccinated|0|||
30795318|NCT03529773|58808859|FG007|Overall Study|Randomized but not vaccinated|0|||
30795319|NCT03529773|58808860|FG008|Overall Study|Randomized but not vaccinated|0|||
30795320|NCT03529773|58808861|FG009|Overall Study|Randomized but not vaccinated|0|||
30795321|NCT03529773|58808862|FG010|Overall Study|Randomized but not vaccinated|0|||
30795322|NCT03529773|58808863|FG011|Overall Study|Randomized but not vaccinated|0|||
30795323|NCT03529773|58808864|FG012|Overall Study|Randomized but not vaccinated|0|||
30795324|NCT03529773|58808865|FG013|Overall Study|Randomized but not vaccinated|0|||
30795325|NCT03529773|58808866|FG014|Overall Study|Randomized but not vaccinated|0|||
30795326|NCT03529773|58808867|FG015|Overall Study|Randomized but not vaccinated|0|||
30904238|NCT02390531|58938429|FG003|Overall Study|Protocol Violation|0|||
30904239|NCT02390531|58938430|FG004|Overall Study|Protocol Violation|1|||
30904240|NCT02390531|58938431|FG005|Overall Study|Protocol Violation|0|||
30795327|NCT03529773|58808868|FG016|Overall Study|Randomized but not vaccinated|0|||
30795328|NCT03529773|58808869|FG017|Overall Study|Randomized but not vaccinated|1|||
30795329|NCT03529773|58808870|FG018|Overall Study|Randomized but not vaccinated|0|||
30795330|NCT03529773|58808871|FG019|Overall Study|Randomized but not vaccinated|0|||
30795331|NCT03529773|58808872|FG020|Overall Study|Randomized but not vaccinated|0|||
30795332|NCT03529773|58808873|FG021|Overall Study|Randomized but not vaccinated|0|||
30795333|NCT03529773|58808874|FG022|Overall Study|Randomized but not vaccinated|0|||
30795334|NCT03529773|58808875|FG023|Overall Study|Randomized but not vaccinated|0|||
30795335|NCT03529773|58808876|FG024|Overall Study|Randomized but not vaccinated|0|||
30795336|NCT03529773|58808877|FG025|Overall Study|Randomized but not vaccinated|0|||
30795337|NCT03529773|58808878|FG026|Overall Study|Randomized but not vaccinated|0|||
30795338|NCT03529773|58808879|FG027|Overall Study|Randomized but not vaccinated|1|||
30795339|NCT03529773|58808880|FG028|Overall Study|Randomized but not vaccinated|0|||
30795340|NCT03529773|58808881|FG029|Overall Study|Randomized but not vaccinated|0|||
30795341|NCT03529773|58808882|FG030|Overall Study|Randomized but not vaccinated|0|||
30795342|NCT03529773|58808883|FG031|Overall Study|Randomized but not vaccinated|0|||
30795343|NCT03529773|58808884|FG032|Overall Study|Randomized but not vaccinated|0|||
30795344|NCT03529773|58808885|FG033|Overall Study|Randomized but not vaccinated|0|||
30795345|NCT03529773|58808886|FG034|Overall Study|Randomized but not vaccinated|0|||
30795346|NCT03529773|58808887|FG035|Overall Study|Randomized but not vaccinated|0|||
30795347|NCT03529773|58808888|FG036|Overall Study|Randomized but not vaccinated|0|||
30795348|NCT03529773|58808889|FG037|Overall Study|Randomized but not vaccinated|0|||
30795349|NCT03529773|58808890|FG038|Overall Study|Randomized but not vaccinated|0|||
30795350|NCT03529773|58808891|FG039|Overall Study|Randomized but not vaccinated|0|||
30795351|NCT03799211|58808996|FG000|Overall Study|Lost to Follow-up|2|||
30795352|NCT03799211|58808997|FG001|Overall Study|Lost to Follow-up|13|||
30795353|NCT03799211|58808996|FG000|Overall Study|Withdrawal by Subject|2|||
30795354|NCT03799211|58808997|FG001|Overall Study|Withdrawal by Subject|0|||
30795355|NCT03349710|58809009|FG000|Treatment Period|Death|0|||
30795356|NCT03349710|58809010|FG001|Treatment Period|Death|0|||
30795357|NCT03349710|58809011|FG002|Treatment Period|Death|1|||
30795358|NCT03349710|58809012|FG003|Treatment Period|Death|0|||
30795359|NCT03349710|58809009|FG000|Treatment Period|Disease Progression|0|||
30795360|NCT03349710|58809010|FG001|Treatment Period|Disease Progression|2|||
30795361|NCT03349710|58809011|FG002|Treatment Period|Disease Progression|0|||
30795362|NCT03349710|58809012|FG003|Treatment Period|Disease Progression|1|||
30795363|NCT03349710|58809009|FG000|Treatment Period|Study Drug Toxicity|1|||
30795364|NCT03349710|58809010|FG001|Treatment Period|Study Drug Toxicity|0|||
30795365|NCT03349710|58809011|FG002|Treatment Period|Study Drug Toxicity|1|||
30795366|NCT03349710|58809012|FG003|Treatment Period|Study Drug Toxicity|1|||
30795367|NCT03349710|58809009|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
30795368|NCT03349710|58809010|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
30795369|NCT03349710|58809011|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
30795370|NCT03349710|58809012|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
30795371|NCT03349710|58809009|FG000|Treatment Period|admin reason by sponsor|0|||
30795372|NCT03349710|58809010|FG001|Treatment Period|admin reason by sponsor|7|||
30795373|NCT03349710|58809011|FG002|Treatment Period|admin reason by sponsor|0|||
30795374|NCT03349710|58809012|FG003|Treatment Period|admin reason by sponsor|19|||
30795375|NCT03349710|58809009|FG000|Treatment Period|Other Reason|2|||
30795376|NCT03349710|58809010|FG001|Treatment Period|Other Reason|0|||
30795377|NCT03349710|58809011|FG002|Treatment Period|Other Reason|2|||
30795378|NCT03349710|58809012|FG003|Treatment Period|Other Reason|1|||
30795379|NCT03349710|58809009|FG000|Treatment Period|completed|6|||
30795380|NCT03349710|58809010|FG001|Treatment Period|completed|0|||
30795381|NCT03349710|58809011|FG002|Treatment Period|completed|18|||
30795382|NCT03349710|58809012|FG003|Treatment Period|completed|1|||
30795383|NCT03349710|58809009|FG000|Treatment Period|participant request to discontinue|0|||
30795384|NCT03349710|58809010|FG001|Treatment Period|participant request to discontinue|0|||
30795385|NCT03349710|58809011|FG002|Treatment Period|participant request to discontinue|4|||
30795386|NCT03349710|58809012|FG003|Treatment Period|participant request to discontinue|0|||
30795387|NCT03349710|58809009|FG000|Treatment Period|participant withdrew consent|1|||
30795388|NCT03349710|58809010|FG001|Treatment Period|participant withdrew consent|0|||
30795389|NCT03349710|58809011|FG002|Treatment Period|participant withdrew consent|0|||
30795390|NCT03349710|58809012|FG003|Treatment Period|participant withdrew consent|0|||
30795391|NCT03511053|58809022|FG000|Overall Study|Withdrawal by Subject|1|||
30795392|NCT03377634|58809028|FG000|Study Period|Adverse Event|1|||
30795393|NCT03377634|58809029|FG001|Study Period|Adverse Event|0|||
30795394|NCT03377634|58809028|FG000|Study Period|Withdrawal by Subject|1|||
30795395|NCT03377634|58809029|FG001|Study Period|Withdrawal by Subject|0|||
30795396|NCT03528369|58809038|FG000|Overall Study|Withdrawal by Subject|2|||
30795397|NCT03528369|58809039|FG001|Overall Study|Withdrawal by Subject|0|||
30795398|NCT03528369|58809040|FG002|Overall Study|Withdrawal by Subject|0|||
30795399|NCT03528369|58809038|FG000|Overall Study|Lost to Follow-up|1|||
30795400|NCT03528369|58809039|FG001|Overall Study|Lost to Follow-up|0|||
30795401|NCT03528369|58809040|FG002|Overall Study|Lost to Follow-up|0|||
30795402|NCT03528369|58809038|FG000|Overall Study|Adverse Event|0|||
30795403|NCT03528369|58809039|FG001|Overall Study|Adverse Event|1|||
30795404|NCT03528369|58809040|FG002|Overall Study|Adverse Event|0|||
30795405|NCT00006011|58809051|FG000|Overall Study|Disease progression|13|||
30795406|NCT00006011|58809052|FG001|Overall Study|Disease progression|6|||
30795407|NCT00006011|58809053|FG002|Overall Study|Disease progression|26|||
30795408|NCT00006011|58809051|FG000|Overall Study|Refused further treatment|15|||
30795409|NCT00006011|58809052|FG001|Overall Study|Refused further treatment|13|||
30795410|NCT00006011|58809053|FG002|Overall Study|Refused further treatment|26|||
30795411|NCT00006011|58809051|FG000|Overall Study|Adverse Event|15|||
30795412|NCT00006011|58809052|FG001|Overall Study|Adverse Event|39|||
30795413|NCT00006011|58809053|FG002|Overall Study|Adverse Event|5|||
30795414|NCT00006011|58809051|FG000|Overall Study|Death|0|||
30795415|NCT00006011|58809052|FG001|Overall Study|Death|1|||
30795416|NCT00006011|58809053|FG002|Overall Study|Death|2|||
30795417|NCT00006011|58809051|FG000|Overall Study|Other|4|||
30795418|NCT00006011|58809052|FG001|Overall Study|Other|2|||
30795419|NCT00006011|58809053|FG002|Overall Study|Other|5|||
30795420|NCT00006011|58809051|FG000|Overall Study|Ineligible|18|||
30795421|NCT00006011|58809052|FG001|Overall Study|Ineligible|16|||
30795422|NCT00006011|58809053|FG002|Overall Study|Ineligible|9|||
30795423|NCT03377556|58809059|FG000|Overall Study|Adverse Event|5|||
30795424|NCT03377556|58809059|FG000|Overall Study|Refusal unrelated to adverse events|1|||
30795425|NCT03377556|58809059|FG000|Overall Study|Progression/relapse|38|||
30795426|NCT03377556|58809059|FG000|Overall Study|Death|3|||
30795427|NCT03750955|58809065|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
30795428|NCT03750955|58809066|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
30795429|NCT03750955|58809065|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
30795430|NCT03750955|58809066|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
30795431|NCT00005879|58809076|FG000|Overall Study|Withdrawal by Subject|8|||
30795432|NCT00005879|58809077|FG001|Overall Study|Withdrawal by Subject|10|||
30795433|NCT03583359|58809085|FG000|Overall Study|Withdrawal by Subject|15|||
30795434|NCT03583359|58809086|FG001|Overall Study|Withdrawal by Subject|6|||
30795435|NCT03583359|58809085|FG000|Overall Study|Lost to Follow-up|12|||
30795436|NCT03583359|58809086|FG001|Overall Study|Lost to Follow-up|3|||
30795437|NCT03583359|58809085|FG000|Overall Study|Adverse Event|0|||
30795438|NCT03583359|58809086|FG001|Overall Study|Adverse Event|1|||
30795439|NCT03583359|58809085|FG000|Overall Study|Protocol Violation|0|||
30795440|NCT03583359|58809086|FG001|Overall Study|Protocol Violation|1|||
30795441|NCT03583359|58809085|FG000|Overall Study|Other|2|||
30795442|NCT03583359|58809086|FG001|Overall Study|Other|1|||
30795443|NCT03510663|58809100|FG000|Overall Study|Withdrawal by Subject|0|||
30795444|NCT03510663|58809101|FG001|Overall Study|Withdrawal by Subject|1|||
30904241|NCT02390531|58938432|FG006|Overall Study|Protocol Violation|2|||
30904242|NCT02390531|58938433|FG007|Overall Study|Protocol Violation|0|||
30904243|NCT02390219|58938469|FG000|Overall Study|Death|1|||
30904244|NCT02390219|58938469|FG000|Overall Study|Physician Decision|1|||
30795445|NCT03510663|58809102|FG002|Overall Study|Withdrawal by Subject|0|||
30795446|NCT03510663|58809103|FG003|Overall Study|Withdrawal by Subject|0|||
30795447|NCT03510663|58809104|FG004|Overall Study|Withdrawal by Subject|0|||
30795448|NCT03510663|58809105|FG005|Overall Study|Withdrawal by Subject|0|||
30795449|NCT03510663|58809106|FG006|Overall Study|Withdrawal by Subject|0|||
30795450|NCT03510663|58809107|FG007|Overall Study|Withdrawal by Subject|0|||
30795451|NCT03510273|58809117|FG000|Overall Study|Withdrawal by Subject|2|||
30795452|NCT03510273|58809117|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
30795453|NCT03510273|58809117|FG000|Overall Study|Moved away from study area|4|||
30904245|NCT02390219|58938469|FG000|Overall Study|Adverse Event|6|||
30904246|NCT02390219|58938469|FG000|Overall Study|Withdrawal by Subject|1|||
30904247|NCT02390219|58938469|FG000|Overall Study|Lost to Follow-up|2|||
30795454|NCT03582813|58809127|FG000|Overall Study|Lost to Follow-up|18|||
30795455|NCT03582813|58809128|FG001|Overall Study|Lost to Follow-up|21|||
30795456|NCT03582813|58809127|FG000|Overall Study|Withdrawal by Subject|1|||
30795457|NCT03582813|58809128|FG001|Overall Study|Withdrawal by Subject|0|||
30795458|NCT03480009|58809138|FG000|Overall Study|Lost to Follow-up|4|||
30795459|NCT03480009|58809139|FG001|Overall Study|Lost to Follow-up|5|||
30795460|NCT03480009|58809140|FG002|Overall Study|Lost to Follow-up|4|||
30795461|NCT03480009|58809141|FG003|Overall Study|Lost to Follow-up|0|||
30795462|NCT03399786|58809156|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
30904248|NCT02390219|58938469|FG000|Overall Study|Other|2|||
30904249|NCT02334215|58938476|FG000|Overall Study|Death|1|||
30795463|NCT03399786|58809157|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
30795464|NCT03399786|58809158|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
30795465|NCT03399786|58809159|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
30795466|NCT03399786|58809156|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
30795467|NCT03399786|58809157|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
30795468|NCT03399786|58809158|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
30795469|NCT03399786|58809159|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
30795470|NCT03399786|58809156|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
30795471|NCT03399786|58809157|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
30795472|NCT03399786|58809158|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
30795473|NCT03399786|58809159|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
30795474|NCT03505593|58809167|FG000|Overall Study|Withdrawal by Subject|1|||
30795475|NCT03505593|58809167|FG000|Overall Study|Died before procedure|1|||
30795476|NCT03505593|58809167|FG000|Overall Study|Anatomical abnormality|1|||
30795477|NCT03505593|58809167|FG000|Overall Study|Unable to pass through esophagus|1|||
30795478|NCT03505593|58809167|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
30795479|NCT03504189|58809171|FG000|Overall Study|Withdrawal by Subject|1|||
30795480|NCT03504189|58809171|FG000|Overall Study|Screening Failure|1|||
30795481|NCT03504189|58809171|FG000|Overall Study|Device Failure|2|||
30795482|NCT03374358|58809182|FG000|Overall Study|Withdrawal by Subject|0|||
30795483|NCT03374358|58809183|FG001|Overall Study|Withdrawal by Subject|2|||
30795484|NCT03372096|58809189|FG000|Overall Study|Study Closed|8|||
30795485|NCT00004859|58809198|FG000|Overall Study|Lack of Efficacy|43|||
30795486|NCT00004859|58809199|FG001|Overall Study|Lack of Efficacy|113|||
30795487|NCT00004859|58809198|FG000|Overall Study|Adverse Event|31|||
30795488|NCT00004859|58809199|FG001|Overall Study|Adverse Event|93|||
30795489|NCT00004859|58809198|FG000|Overall Study|Death|5|||
30795490|NCT00004859|58809199|FG001|Overall Study|Death|5|||
30795491|NCT00004859|58809198|FG000|Overall Study|Withdrawal by Subject|7|||
30795492|NCT00004859|58809199|FG001|Overall Study|Withdrawal by Subject|33|||
30795493|NCT00004859|58809198|FG000|Overall Study|Protocol Violation|2|||
30795494|NCT00004859|58809199|FG001|Overall Study|Protocol Violation|2|||
30795495|NCT00004859|58809198|FG000|Overall Study|other disease|0|||
30795496|NCT00004859|58809199|FG001|Overall Study|other disease|3|||
30795497|NCT00004859|58809198|FG000|Overall Study|error|3|||
30795498|NCT00004859|58809199|FG001|Overall Study|error|1|||
30795499|NCT00004859|58809198|FG000|Overall Study|missing data|14|||
30795500|NCT00004859|58809199|FG001|Overall Study|missing data|11|||
30795501|NCT00004859|58809198|FG000|Overall Study|Other|13|||
30795502|NCT00004859|58809199|FG001|Overall Study|Other|21|||
30795503|NCT03500679|58809209|FG000|Overall Study|Lost to Follow-up|6|||
30795504|NCT03500679|58809210|FG001|Overall Study|Lost to Follow-up|3|||
30795505|NCT03500679|58809209|FG000|Overall Study|Withdrawal by Subject|3|||
30795506|NCT03500679|58809210|FG001|Overall Study|Withdrawal by Subject|0|||
30795507|NCT03348930|58809216|FG000|Washout (1 Week)|Lost to Follow-up|1|||
30795508|NCT03348930|58809217|FG001|Washout (1 Week)|Lost to Follow-up|1|||
30795509|NCT03500211|58809225|FG000|Overall Study|Withdrawal by Subject|1|||
30795510|NCT03500211|58809226|FG001|Overall Study|Withdrawal by Subject|1|||
30795511|NCT03478683|58809234|FG000|Overall Study|Adverse Event|5|||
30795512|NCT03478683|58809235|FG001|Overall Study|Adverse Event|3|||
30795513|NCT03478683|58809234|FG000|Overall Study|Lost to Follow-up|0|||
30795514|NCT03478683|58809235|FG001|Overall Study|Lost to Follow-up|5|||
30795515|NCT03478683|58809234|FG000|Overall Study|Physician Decision|1|||
30795516|NCT03478683|58809235|FG001|Overall Study|Physician Decision|3|||
30795517|NCT03478683|58809234|FG000|Overall Study|Withdrawal by Subject|7|||
30795518|NCT03478683|58809235|FG001|Overall Study|Withdrawal by Subject|7|||
30795519|NCT03478371|58809241|FG000|Overall Study|non-compliance|1|||
30795520|NCT03478371|58809241|FG000|Overall Study|Lost to Follow-up|4|||
30795521|NCT03477903|58809251|FG000|Overall Study|Study Terminated by Sponsor|1|||
30795522|NCT03475875|58809255|FG000|Period 1|Lost to Follow-up|1|||
30795523|NCT03475875|58809256|FG001|Period 1|Lost to Follow-up|0|||
30795524|NCT03475875|58809255|FG000|Period 1|Adverse Event|2|||
30795525|NCT03475875|58809256|FG001|Period 1|Adverse Event|1|||
30795526|NCT03475875|58809255|FG000|Period 2|Adverse Event|3|||
30795527|NCT03475875|58809256|FG001|Period 2|Adverse Event|0|||
30795528|NCT03475875|58809255|FG000|Period 2|Protocol Violation|0|||
30795529|NCT03475875|58809256|FG001|Period 2|Protocol Violation|1|||
30795530|NCT03474081|58809264|FG000|Overall Study|Adverse Event|6|||
30795531|NCT03474081|58809265|FG001|Overall Study|Adverse Event|3|||
30795532|NCT03474081|58809264|FG000|Overall Study|Lost to Follow-up|2|||
30795533|NCT03474081|58809265|FG001|Overall Study|Lost to Follow-up|1|||
30795534|NCT03474081|58809264|FG000|Overall Study|Physician Decision|3|||
30795535|NCT03474081|58809265|FG001|Overall Study|Physician Decision|2|||
30795536|NCT03474081|58809264|FG000|Overall Study|Withdrawal by Subject|5|||
30795537|NCT03474081|58809265|FG001|Overall Study|Withdrawal by Subject|7|||
30795538|NCT03474081|58809264|FG000|Overall Study|Investigator site closed|1|||
30904250|NCT02334215|58938477|FG001|Overall Study|Death|1|||
30795539|NCT03474081|58809265|FG001|Overall Study|Investigator site closed|0|||
30795540|NCT03346434|58809277|FG000|Overall Study|Randomized in Error|0|||
30795541|NCT03346434|58809278|FG001|Overall Study|Randomized in Error|0|||
30795542|NCT03346434|58809279|FG002|Overall Study|Randomized in Error|0|||
30795543|NCT03346434|58809280|FG003|Overall Study|Randomized in Error|0|||
30795544|NCT03346434|58809281|FG004|Overall Study|Randomized in Error|1|||
30795545|NCT03346434|58809282|FG005|Overall Study|Randomized in Error|0|||
30795546|NCT03346434|58809277|FG000|Overall Study|Withdrawal by Subject|0|||
30795547|NCT03346434|58809278|FG001|Overall Study|Withdrawal by Subject|0|||
30795548|NCT03346434|58809279|FG002|Overall Study|Withdrawal by Subject|1|||
30795549|NCT03346434|58809280|FG003|Overall Study|Withdrawal by Subject|0|||
30795550|NCT03346434|58809281|FG004|Overall Study|Withdrawal by Subject|1|||
30795551|NCT03346434|58809282|FG005|Overall Study|Withdrawal by Subject|0|||
30795552|NCT03346434|58809277|FG000|Overall Study|Lost to Follow-up|0|||
30795553|NCT03346434|58809278|FG001|Overall Study|Lost to Follow-up|0|||
30795554|NCT03346434|58809279|FG002|Overall Study|Lost to Follow-up|0|||
30795555|NCT03346434|58809280|FG003|Overall Study|Lost to Follow-up|0|||
30795556|NCT03346434|58809281|FG004|Overall Study|Lost to Follow-up|1|||
30795557|NCT03346434|58809282|FG005|Overall Study|Lost to Follow-up|1|||
30795558|NCT03346434|58809277|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
30795559|NCT03346434|58809278|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
30795560|NCT03346434|58809279|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
30795561|NCT03346434|58809280|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
30795562|NCT03346434|58809281|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
30795563|NCT03346434|58809282|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
30795564|NCT03393000|58809300|FG000|Overall Study|Death|11|||
30795565|NCT03393000|58809300|FG000|Overall Study|Withdrawal by Subject|2|||
30795566|NCT03393000|58809300|FG000|Overall Study|Physician Decision|1|||
30795567|NCT03370770|58809304|FG000|Overall Study|Patient was followed in another hospital center|1|||
30795568|NCT03370770|58809304|FG000|Overall Study|Progressive Disease|98|||
30795569|NCT03370770|58809304|FG000|Overall Study|Adverse Event|2|||
30795570|NCT03370770|58809304|FG000|Overall Study|Death|5|||
30795571|NCT03473301|58809311|FG000|Overall Study|Protocol Violation|4|||
30795572|NCT03473301|58809312|FG001|Overall Study|Protocol Violation|0|||
30795573|NCT03473301|58809313|FG002|Overall Study|Protocol Violation|0|||
30795574|NCT03473301|58809311|FG000|Overall Study|Withdrawal by Subject|0|||
30795575|NCT03473301|58809312|FG001|Overall Study|Withdrawal by Subject|1|||
30795576|NCT03473301|58809313|FG002|Overall Study|Withdrawal by Subject|0|||
30795577|NCT03473301|58809311|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
30795578|NCT03473301|58809312|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
30795579|NCT03473301|58809313|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
30795580|NCT03390426|58809325|FG000|Overall Study|Protocol Violation|0|||
30795581|NCT03390426|58809326|FG001|Overall Study|Protocol Violation|1|||
30795582|NCT03472521|58809334|FG000|Overall Study|Lost to Follow-up|3|||
30795583|NCT03472521|58809335|FG001|Overall Study|Lost to Follow-up|2|||
30795584|NCT03472521|58809334|FG000|Overall Study|Discontinued intervention|3|||
30795585|NCT03472521|58809335|FG001|Overall Study|Discontinued intervention|1|||
30795586|NCT02906020|58809351|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
30795587|NCT02906020|58809352|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
30795588|NCT02906020|58809353|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
30795589|NCT02906020|58809354|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
30795590|NCT02906020|58809355|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
30795591|NCT02906020|58809356|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
30795592|NCT02906020|58809357|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
30795593|NCT02906020|58809358|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
30795594|NCT02906020|58809359|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
30795595|NCT02906020|58809360|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
30795596|NCT02906020|58809361|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
30795597|NCT02906020|58809362|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
30795598|NCT02906020|58809363|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
30795599|NCT02906020|58809364|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
30795600|NCT02906020|58809365|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
30795601|NCT02906020|58809366|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
30795602|NCT02906020|58809351|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795603|NCT02906020|58809352|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795604|NCT02906020|58809353|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795605|NCT02906020|58809354|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795606|NCT02906020|58809355|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795607|NCT02906020|58809356|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795608|NCT02906020|58809357|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795609|NCT02906020|58809358|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30904251|NCT02334215|58938478|FG002|Overall Study|Death|0|||
30904252|NCT02334215|58938476|FG000|Overall Study|Lost to Follow-up|1|||
30795610|NCT02906020|58809359|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
30795611|NCT02906020|58809360|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
30795612|NCT02906020|58809361|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795613|NCT02906020|58809362|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795614|NCT02906020|58809363|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795615|NCT02906020|58809364|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795616|NCT02906020|58809365|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795617|NCT02906020|58809366|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
30795618|NCT02906020|58809351|FG000|Part 2: Double-blind Treatment Period|Other|0|||
30795619|NCT02906020|58809352|FG001|Part 2: Double-blind Treatment Period|Other|0|||
30795620|NCT02906020|58809353|FG002|Part 2: Double-blind Treatment Period|Other|0|||
30795621|NCT02906020|58809354|FG003|Part 2: Double-blind Treatment Period|Other|0|||
30795622|NCT02906020|58809355|FG004|Part 2: Double-blind Treatment Period|Other|0|||
30795623|NCT02906020|58809356|FG005|Part 2: Double-blind Treatment Period|Other|0|||
30795624|NCT02906020|58809357|FG006|Part 2: Double-blind Treatment Period|Other|0|||
30795625|NCT02906020|58809358|FG007|Part 2: Double-blind Treatment Period|Other|0|||
30795626|NCT02906020|58809359|FG008|Part 2: Double-blind Treatment Period|Other|6|||
30795627|NCT02906020|58809360|FG009|Part 2: Double-blind Treatment Period|Other|10|||
30795628|NCT02906020|58809361|FG010|Part 2: Double-blind Treatment Period|Other|0|||
30795629|NCT02906020|58809362|FG011|Part 2: Double-blind Treatment Period|Other|0|||
30795630|NCT02906020|58809363|FG012|Part 2: Double-blind Treatment Period|Other|0|||
30795631|NCT02906020|58809364|FG013|Part 2: Double-blind Treatment Period|Other|0|||
30795632|NCT02906020|58809365|FG014|Part 2: Double-blind Treatment Period|Other|0|||
30795633|NCT02906020|58809366|FG015|Part 2: Double-blind Treatment Period|Other|0|||
30795634|NCT02906020|58809351|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795635|NCT02906020|58809352|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795636|NCT02906020|58809353|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30904253|NCT02334215|58938477|FG001|Overall Study|Lost to Follow-up|0|||
30904254|NCT02334215|58938478|FG002|Overall Study|Lost to Follow-up|4|||
30904255|NCT02334215|58938476|FG000|Overall Study|Withdrawal by Subject|2|||
30904256|NCT02334215|58938477|FG001|Overall Study|Withdrawal by Subject|2|||
30904257|NCT02334215|58938478|FG002|Overall Study|Withdrawal by Subject|1|||
30904258|NCT02334215|58938476|FG000|Overall Study|Not released from incarceration on time|3|||
30904259|NCT02334215|58938477|FG001|Overall Study|Not released from incarceration on time|3|||
30904260|NCT02334215|58938478|FG002|Overall Study|Not released from incarceration on time|3|||
30904261|NCT02334215|58938476|FG000|Overall Study|Incarcerated|0|||
30904262|NCT02334215|58938477|FG001|Overall Study|Incarcerated|0|||
30904263|NCT02334215|58938478|FG002|Overall Study|Incarcerated|7|||
30904264|NCT02359877|58938490|FG000|Overall Study|Withdrawal by Subject|1|||
30904265|NCT02359877|58938491|FG001|Overall Study|Withdrawal by Subject|0|||
30904266|NCT02359877|58938492|FG002|Overall Study|Withdrawal by Subject|0|||
30904267|NCT02359877|58938493|FG003|Overall Study|Withdrawal by Subject|2|||
30904268|NCT02359877|58938490|FG000|Overall Study|Adverse Event|0|||
30904269|NCT02359877|58938491|FG001|Overall Study|Adverse Event|0|||
30904270|NCT02359877|58938492|FG002|Overall Study|Adverse Event|0|||
30904271|NCT02359877|58938493|FG003|Overall Study|Adverse Event|1|||
30904272|NCT02389829|58938523|FG000|Overall Study|Lost to Follow-up|0|||
30904273|NCT02389829|58938524|FG001|Overall Study|Lost to Follow-up|1|||
30795637|NCT02906020|58809354|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795638|NCT02906020|58809355|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795639|NCT02906020|58809356|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795640|NCT02906020|58809357|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795641|NCT02906020|58809358|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795642|NCT02906020|58809359|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795643|NCT02906020|58809360|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795644|NCT02906020|58809361|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795645|NCT02906020|58809362|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795646|NCT02906020|58809363|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
30795647|NCT02906020|58809364|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
30795648|NCT02906020|58809365|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795649|NCT02906020|58809366|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
30795650|NCT02906020|58809351|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30904274|NCT02358863|58938530|FG000|Overall Study|Physician Decision|3|||
30904275|NCT02358473|58938534|FG000|Overall Study|Disease Progession|6|||
30795651|NCT02906020|58809352|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30795652|NCT02906020|58809353|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30795653|NCT02906020|58809354|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30795654|NCT02906020|58809355|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30795655|NCT02906020|58809356|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30904276|NCT02358473|58938534|FG000|Overall Study|Adverse Event|3|||
30904277|NCT02358473|58938534|FG000|Overall Study|Withdrawal by Subject|2|||
30795656|NCT02906020|58809357|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30795657|NCT02906020|58809358|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30795658|NCT02906020|58809359|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30795659|NCT02906020|58809360|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30795660|NCT02906020|58809361|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30795661|NCT02906020|58809362|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30795662|NCT02906020|58809363|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
30795663|NCT02906020|58809364|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
30795664|NCT02906020|58809365|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
30795665|NCT02906020|58809366|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
30795666|NCT02906020|58809351|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795667|NCT02906020|58809352|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795668|NCT02906020|58809353|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795669|NCT02906020|58809354|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795670|NCT02906020|58809355|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795671|NCT02906020|58809356|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795672|NCT02906020|58809357|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795673|NCT02906020|58809358|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795674|NCT02906020|58809359|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795675|NCT02906020|58809360|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795676|NCT02906020|58809361|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795677|NCT02906020|58809362|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795678|NCT02906020|58809363|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
30795679|NCT02906020|58809364|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
30795680|NCT02906020|58809365|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795681|NCT02906020|58809366|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
30795682|NCT02906020|58809351|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795683|NCT02906020|58809352|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795684|NCT02906020|58809353|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795685|NCT02906020|58809354|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795686|NCT02906020|58809355|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795687|NCT02906020|58809356|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795688|NCT02906020|58809357|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795689|NCT02906020|58809358|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795690|NCT02906020|58809359|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795691|NCT02906020|58809360|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795692|NCT02906020|58809361|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795693|NCT02906020|58809362|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795694|NCT02906020|58809363|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
30795695|NCT02906020|58809364|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
30795696|NCT02906020|58809365|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795697|NCT02906020|58809366|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
30795698|NCT02906020|58809351|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795699|NCT02906020|58809352|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795700|NCT02906020|58809353|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795701|NCT02906020|58809354|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795702|NCT02906020|58809355|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795703|NCT02906020|58809356|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795704|NCT02906020|58809357|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795705|NCT02906020|58809358|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795706|NCT02906020|58809359|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795707|NCT02906020|58809360|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795708|NCT02906020|58809361|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795709|NCT02906020|58809362|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
30795710|NCT02906020|58809363|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
30795711|NCT02906020|58809364|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
30795712|NCT02906020|58809365|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
30795713|NCT02906020|58809366|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
30795714|NCT02906020|58809351|FG000|Part 2: Long-term Follow-up Period|Other|0|||
30795715|NCT02906020|58809352|FG001|Part 2: Long-term Follow-up Period|Other|0|||
30795716|NCT02906020|58809353|FG002|Part 2: Long-term Follow-up Period|Other|0|||
30795717|NCT02906020|58809354|FG003|Part 2: Long-term Follow-up Period|Other|0|||
30795718|NCT02906020|58809355|FG004|Part 2: Long-term Follow-up Period|Other|0|||
30795719|NCT02906020|58809356|FG005|Part 2: Long-term Follow-up Period|Other|0|||
30795720|NCT02906020|58809357|FG006|Part 2: Long-term Follow-up Period|Other|0|||
30795721|NCT02906020|58809358|FG007|Part 2: Long-term Follow-up Period|Other|0|||
30795722|NCT02906020|58809359|FG008|Part 2: Long-term Follow-up Period|Other|0|||
30795723|NCT02906020|58809360|FG009|Part 2: Long-term Follow-up Period|Other|0|||
30795724|NCT02906020|58809361|FG010|Part 2: Long-term Follow-up Period|Other|0|||
30795725|NCT02906020|58809362|FG011|Part 2: Long-term Follow-up Period|Other|0|||
30795726|NCT02906020|58809363|FG012|Part 2: Long-term Follow-up Period|Other|13|||
30795727|NCT02906020|58809364|FG013|Part 2: Long-term Follow-up Period|Other|8|||
30795728|NCT02906020|58809365|FG014|Part 2: Long-term Follow-up Period|Other|3|||
30795729|NCT02906020|58809366|FG015|Part 2: Long-term Follow-up Period|Other|2|||
30795730|NCT03499353|58809394|FG000|Treatment|Adverse Event|3|||
30795731|NCT03499353|58809394|FG000|Treatment|Progressive Disease|10|||
30795732|NCT03499353|58809394|FG000|Treatment|Other|1|||
30795733|NCT03499353|58809394|FG000|Treatment|Withdrawal by Subject|2|||
30795734|NCT03499353|58809394|FG000|Long-Term Follow-up|Death|2|||
30795735|NCT03499353|58809394|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
30795736|NCT03499353|58809394|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
30795737|NCT03368664|58809398|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
30795738|NCT03368664|58809398|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
30904278|NCT02358473|58938534|FG000|Overall Study|Physician Decision|2|||
30904279|NCT02357459|58938541|FG000|Overall Study|Adverse Event|0|||
30904280|NCT02357459|58938542|FG001|Overall Study|Adverse Event|1|||
30904281|NCT02357459|58938543|FG002|Overall Study|Adverse Event|1|||
30904282|NCT02357459|58938541|FG000|Overall Study|Withdrawal by Subject|5|||
30904283|NCT02357459|58938542|FG001|Overall Study|Withdrawal by Subject|3|||
30904284|NCT02357459|58938543|FG002|Overall Study|Withdrawal by Subject|3|||
30904285|NCT02357459|58938541|FG000|Overall Study|Physician Decision|0|||
30904286|NCT02357459|58938542|FG001|Overall Study|Physician Decision|2|||
30904287|NCT02357459|58938543|FG002|Overall Study|Physician Decision|0|||
30904288|NCT02357459|58938541|FG000|Overall Study|Protocol Violation|1|||
30904289|NCT02357459|58938542|FG001|Overall Study|Protocol Violation|1|||
30904290|NCT02357459|58938543|FG002|Overall Study|Protocol Violation|0|||
30904291|NCT02357459|58938541|FG000|Overall Study|Lost to Follow-up|1|||
30904292|NCT02357459|58938542|FG001|Overall Study|Lost to Follow-up|3|||
30795739|NCT03368664|58809398|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
30795740|NCT03368664|58809398|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
30795741|NCT00004259|58809410|FG000|Overall Study|Protocol Violation|1|||
30795742|NCT00004259|58809411|FG001|Overall Study|Protocol Violation|2|||
30795743|NCT00004259|58809412|FG002|Overall Study|Protocol Violation|0|||
30795744|NCT00004259|58809413|FG003|Overall Study|Protocol Violation|0|||
30795745|NCT00004259|58809410|FG000|Overall Study|Withdrawal by Subject|0|||
30795746|NCT00004259|58809411|FG001|Overall Study|Withdrawal by Subject|2|||
30795747|NCT00004259|58809412|FG002|Overall Study|Withdrawal by Subject|0|||
30795748|NCT00004259|58809413|FG003|Overall Study|Withdrawal by Subject|0|||
30795749|NCT03365934|58809437|FG000|Overall Study|Adverse Event|1|||
30795750|NCT03365934|58809437|FG000|Overall Study|Withdrawal by Subject|1|||
30904293|NCT02357459|58938543|FG002|Overall Study|Lost to Follow-up|0|||
30904294|NCT02357459|58938541|FG000|Overall Study|Lack of Efficacy|7|||
30904295|NCT02357459|58938542|FG001|Overall Study|Lack of Efficacy|4|||
30904296|NCT02357459|58938543|FG002|Overall Study|Lack of Efficacy|4|||
30904297|NCT02357459|58938541|FG000|Overall Study|Patient Relocated|2|||
30904298|NCT02357459|58938542|FG001|Overall Study|Patient Relocated|0|||
30795751|NCT03468855|58809446|FG000|Overall Study|Adverse Event|2|||
30795752|NCT03468855|58809446|FG000|Overall Study|Lost to Follow-up|5|||
30795753|NCT03468855|58809446|FG000|Overall Study|Withdrawal by Subject|3|||
30795754|NCT03468855|58809446|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
30795755|NCT03738865|58809452|FG000|Overall Study|Withdrawal by Subject|3|||
30795756|NCT03738865|58809453|FG001|Overall Study|Withdrawal by Subject|3|||
30795757|NCT03738865|58809452|FG000|Overall Study|Adverse Event|2|||
30795758|NCT03738865|58809453|FG001|Overall Study|Adverse Event|0|||
30795759|NCT03738865|58809452|FG000|Overall Study|Physician Decision|0|||
30904299|NCT02357459|58938543|FG002|Overall Study|Patient Relocated|0|||
30904300|NCT02357459|58938541|FG000|Overall Study|Instruction from PCP|1|||
30904301|NCT02357459|58938542|FG001|Overall Study|Instruction from PCP|0|||
30795760|NCT03738865|58809453|FG001|Overall Study|Physician Decision|1|||
30795761|NCT03524157|58809462|FG000|Overall Study|cytology not readable|0|||
30795762|NCT03524157|58809463|FG001|Overall Study|cytology not readable|0|||
30795763|NCT03524157|58809464|FG002|Overall Study|cytology not readable|1|||
30795764|NCT03437733|58809478|FG000|Overall Study|Eligibility criteria not met|0|||
30904302|NCT02357459|58938543|FG002|Overall Study|Instruction from PCP|0|||
30904303|NCT02357459|58938541|FG000|Overall Study|Incarceration|0|||
30904304|NCT02357459|58938542|FG001|Overall Study|Incarceration|0|||
30904305|NCT02357459|58938543|FG002|Overall Study|Incarceration|1|||
30904306|NCT02357459|58938541|FG000|Overall Study|Pre-planned Knee surgery|0|||
30904307|NCT02357459|58938542|FG001|Overall Study|Pre-planned Knee surgery|0|||
30904308|NCT02357459|58938543|FG002|Overall Study|Pre-planned Knee surgery|2|||
30795765|NCT03437733|58809479|FG001|Overall Study|Eligibility criteria not met|3|||
30795766|NCT03468543|58809487|FG000|Overall Study|Protocol stopping rules met|3|||
30795767|NCT03467763|58809491|FG000|Overall Study|Lost to Follow-up|1|||
30795768|NCT03467763|58809491|FG000|Overall Study|Protocol Violation|2|||
30795769|NCT00004031|58809499|FG000|Overall Study|Adverse Event|5|||
30795770|NCT00004031|58809500|FG001|Overall Study|Adverse Event|0|||
30795771|NCT00004031|58809499|FG000|Overall Study|Refusal unrelated to adverse events|2|||
30795772|NCT00004031|58809500|FG001|Overall Study|Refusal unrelated to adverse events|11|||
30795773|NCT00004031|58809499|FG000|Overall Study|Progression/relapse|9|||
30795774|NCT00004031|58809500|FG001|Overall Study|Progression/relapse|4|||
30795775|NCT00004031|58809499|FG000|Overall Study|Death|3|||
30795776|NCT00004031|58809500|FG001|Overall Study|Death|1|||
30795777|NCT00004031|58809499|FG000|Overall Study|Other- not protocol specified|3|||
30795778|NCT00004031|58809500|FG001|Overall Study|Other- not protocol specified|3|||
30795779|NCT00004031|58809499|FG000|Overall Study|Reason under review|3|||
30795780|NCT00004031|58809500|FG001|Overall Study|Reason under review|2|||
30904309|NCT02357459|58938541|FG000|Overall Study|Job Commitments|0|||
30904310|NCT02357459|58938542|FG001|Overall Study|Job Commitments|0|||
30904311|NCT02357459|58938543|FG002|Overall Study|Job Commitments|1|||
30904312|NCT02332889|58938554|FG000|Overall Study|Physician Decision|1|||
30904313|NCT02357147|58938560|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
30904314|NCT02357147|58938561|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
30795781|NCT03467217|58809510|FG000|Overall Study|Trial stopped early|5|||
30795782|NCT03467217|58809511|FG001|Overall Study|Trial stopped early|2|||
30795783|NCT03467217|58809510|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
30795784|NCT03467217|58809511|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
30795785|NCT03467217|58809510|FG000|Overall Study|Lost to Follow-up|0|||
30795786|NCT03467217|58809511|FG001|Overall Study|Lost to Follow-up|2|||
30795787|NCT00003875|58809517|FG000|Overall Study|Screen Failed|1|||
30795788|NCT03495453|58809523|FG000|Overall Study|Withdrawal by Subject|0|||
30795789|NCT03495453|58809524|FG001|Overall Study|Withdrawal by Subject|1|||
30795790|NCT03364686|58809530|FG000|Overall Study|Physician Decision|2|||
30795791|NCT03437577|58809537|FG000|Pre-Randomization|Withdrawal by Subject|0|||
30795792|NCT03437577|58809538|FG001|Pre-Randomization|Withdrawal by Subject|0|||
30795793|NCT03437577|58809539|FG002|Pre-Randomization|Withdrawal by Subject|10|||
30795794|NCT03437577|58809537|FG000|Post-Randomization|Physician Decision|0|||
30795795|NCT03437577|58809538|FG001|Post-Randomization|Physician Decision|2|||
30795796|NCT03437577|58809539|FG002|Post-Randomization|Physician Decision|0|||
30795797|NCT03336528|58809547|FG000|Overall Study|Protocol Violation|1|||
30795798|NCT03336528|58809548|FG001|Overall Study|Protocol Violation|1|||
30795799|NCT03336528|58809547|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
30795800|NCT03336528|58809548|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
30795801|NCT03336528|58809547|FG000|Overall Study|Did not receive study medication|1|||
30795802|NCT03336528|58809548|FG001|Overall Study|Did not receive study medication|2|||
30795803|NCT03364608|58809556|FG000|Overall Study|Withdrawal by Subject|4|||
30795804|NCT03364608|58809556|FG000|Overall Study|Protocol Violation|2|||
30795805|NCT03364608|58809556|FG000|Overall Study|Lost to Follow-up|2|||
30795806|NCT00003869|58809570|FG000|Overall Study|Adverse Event|14|||
30795807|NCT00003869|58809571|FG001|Overall Study|Adverse Event|3|||
30795808|NCT00003869|58809570|FG000|Overall Study|Withdrawal by Subject|21|||
30795809|NCT00003869|58809571|FG001|Overall Study|Withdrawal by Subject|3|||
30795810|NCT00003869|58809570|FG000|Overall Study|Death|1|||
30795811|NCT00003869|58809571|FG001|Overall Study|Death|2|||
30904315|NCT02357147|58938560|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
30904316|NCT02357147|58938561|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
30904317|NCT02357147|58938560|FG000|Combination Treatment Phase|Investigator Discretion|1|||
30904318|NCT02357147|58938561|FG001|Combination Treatment Phase|Investigator Discretion|1|||
30904319|NCT02357147|58938560|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
30904320|NCT02357147|58938561|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
30904321|NCT02357147|58938560|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
30904322|NCT02357147|58938561|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
30904323|NCT02357147|58938560|FG000|Combination Treatment Phase|Adverse Event|12|||
30795812|NCT00003869|58809570|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
30795813|NCT00003869|58809571|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
30795814|NCT03344640|58809579|FG000|Overall Study|Adverse Event|1|||
30795815|NCT03344640|58809580|FG001|Overall Study|Adverse Event|0|||
30795816|NCT03344640|58809579|FG000|Overall Study|Physician Decision|1|||
30795817|NCT03344640|58809580|FG001|Overall Study|Physician Decision|1|||
30795818|NCT03344640|58809579|FG000|Overall Study|Withdrawal by Subject|1|||
30795819|NCT03344640|58809580|FG001|Overall Study|Withdrawal by Subject|2|||
30795820|NCT03344640|58809579|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
30904324|NCT02357147|58938561|FG001|Combination Treatment Phase|Adverse Event|4|||
30795821|NCT03344640|58809580|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
30795822|NCT03344562|58809588|FG000|Overall Study|Withdrawal by Subject|2|||
30795823|NCT03344562|58809589|FG001|Overall Study|Withdrawal by Subject|0|||
30795824|NCT00003659|58809595|FG000|Overall Study|Withdrawal by Subject|3|||
30795825|NCT03494985|58809603|FG000|Overall Study|Adverse Event|3|||
30795826|NCT03494985|58809604|FG001|Overall Study|Adverse Event|2|||
30795827|NCT03494985|58809605|FG002|Overall Study|Adverse Event|3|||
30795828|NCT03494985|58809606|FG003|Overall Study|Adverse Event|0|||
30795829|NCT03494985|58809603|FG000|Overall Study|Other (Withdrawal of consent)|2|||
30795830|NCT03494985|58809604|FG001|Overall Study|Other (Withdrawal of consent)|3|||
30795831|NCT03494985|58809605|FG002|Overall Study|Other (Withdrawal of consent)|2|||
30795832|NCT03494985|58809606|FG003|Overall Study|Other (Withdrawal of consent)|5|||
30795833|NCT03494985|58809603|FG000|Overall Study|Other (Not specified)|0|||
30795834|NCT03494985|58809604|FG001|Overall Study|Other (Not specified)|1|||
30622144|NCT01169844|58633649|FG001|Overall Study|Adverse Event|1|||
30622145|NCT01169844|58633648|FG000|Overall Study|Patient withdrew consent|4|||
30795835|NCT03494985|58809605|FG002|Overall Study|Other (Not specified)|1|||
30795836|NCT03494985|58809606|FG003|Overall Study|Other (Not specified)|0|||
30795837|NCT03437265|58809616|FG000|Overall Study|Protocol Violation|6|||
30795838|NCT00003509|58809620|FG000|Overall Study|Not evaluable|5|||
30795839|NCT03344172|58809626|FG000|Overall Study|Received <1 dose of treatment|1|||
30795840|NCT03344172|58809627|FG001|Overall Study|Received <1 dose of treatment|0|||
30795841|NCT03465891|58809635|FG000|Overall Study|Withdrawal by Subject|0|||
30795842|NCT03465891|58809636|FG001|Overall Study|Withdrawal by Subject|1|||
30795843|NCT03465891|58809635|FG000|Overall Study|Disease progression|1|||
30795844|NCT03465891|58809636|FG001|Overall Study|Disease progression|0|||
30795845|NCT03363906|58809642|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
30795846|NCT03363906|58809643|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
30795847|NCT03363906|58809642|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
30795848|NCT03363906|58809643|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
30795849|NCT03363906|58809642|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
30795850|NCT03363906|58809643|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
30795851|NCT03363906|58809642|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
30795852|NCT03363906|58809643|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
30795853|NCT00003473|58809649|FG000|Overall Study|Three patients were not evaluable.|3|||
30795854|NCT03343626|58809661|FG000|Overall Study|Lost to Follow-up|4|||
30795855|NCT03343626|58809662|FG001|Overall Study|Lost to Follow-up|3|||
30795856|NCT03343626|58809663|FG002|Overall Study|Lost to Follow-up|2|||
30795857|NCT03343626|58809664|FG003|Overall Study|Lost to Follow-up|5|||
30795858|NCT03343626|58809665|FG004|Overall Study|Lost to Follow-up|4|||
30795859|NCT03343626|58809666|FG005|Overall Study|Lost to Follow-up|4|||
30795860|NCT03343626|58809667|FG006|Overall Study|Lost to Follow-up|4|||
30795861|NCT03343626|58809668|FG007|Overall Study|Lost to Follow-up|7|||
30795862|NCT03343626|58809661|FG000|Overall Study|Withdrawal of Consent|2|||
30795863|NCT03343626|58809662|FG001|Overall Study|Withdrawal of Consent|1|||
30795864|NCT03343626|58809663|FG002|Overall Study|Withdrawal of Consent|0|||
30795865|NCT03343626|58809664|FG003|Overall Study|Withdrawal of Consent|3|||
30795866|NCT03343626|58809665|FG004|Overall Study|Withdrawal of Consent|3|||
30904325|NCT02357147|58938560|FG000|Combination Treatment Phase|Death|1|||
30746147|NCT00068692|58756823|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
30746148|NCT00068692|58756824|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
30746149|NCT00068692|58756825|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
30746150|NCT00068692|58756826|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
30746151|NCT00068692|58756827|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
30746152|NCT00068692|58756828|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
30746153|NCT00068692|58756829|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
30746154|NCT00068692|58756830|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
30746155|NCT00068692|58756823|FG000|Step 2: Randomization|alternative therapy|0|||
30746156|NCT00068692|58756824|FG001|Step 2: Randomization|alternative therapy|0|||
30746157|NCT00068692|58756825|FG002|Step 2: Randomization|alternative therapy|0|||
30746158|NCT00068692|58756826|FG003|Step 2: Randomization|alternative therapy|1|||
30746159|NCT00068692|58756827|FG004|Step 2: Randomization|alternative therapy|1|||
30746160|NCT00068692|58756828|FG005|Step 2: Randomization|alternative therapy|0|||
30746161|NCT00068692|58756829|FG006|Step 2: Randomization|alternative therapy|0|||
30746162|NCT00068692|58756830|FG007|Step 2: Randomization|alternative therapy|0|||
30746163|NCT00068692|58756823|FG000|Step 2: Randomization|Physician Decision|0|||
30746164|NCT00068692|58756824|FG001|Step 2: Randomization|Physician Decision|0|||
30746165|NCT00068692|58756825|FG002|Step 2: Randomization|Physician Decision|0|||
30746166|NCT00068692|58756826|FG003|Step 2: Randomization|Physician Decision|1|||
30795867|NCT03343626|58809666|FG005|Overall Study|Withdrawal of Consent|1|||
30904326|NCT02357147|58938561|FG001|Combination Treatment Phase|Death|1|||
30746167|NCT00068692|58756827|FG004|Step 2: Randomization|Physician Decision|1|||
30746168|NCT00068692|58756828|FG005|Step 2: Randomization|Physician Decision|0|||
30746169|NCT00068692|58756829|FG006|Step 2: Randomization|Physician Decision|0|||
30904327|NCT02357147|58938560|FG000|Combination Treatment Phase|Sponsor Decision|0|||
30904328|NCT02357147|58938561|FG001|Combination Treatment Phase|Sponsor Decision|12|||
30904329|NCT02357147|58938560|FG000|Combination Treatment Phase|Other|1|||
30622146|NCT01169844|58633649|FG001|Overall Study|Patient withdrew consent|0|||
30622147|NCT01169844|58633648|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30904330|NCT02357147|58938561|FG001|Combination Treatment Phase|Other|0|||
30904331|NCT02357147|58938560|FG000|Combination Treatment Phase|Not treated|0|||
30904332|NCT02357147|58938561|FG001|Combination Treatment Phase|Not treated|2|||
30904333|NCT02357147|58938560|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
30904334|NCT02357147|58938561|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
30904335|NCT02357147|58938560|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
30904336|NCT02357147|58938561|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
30904337|NCT02357147|58938560|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
30904338|NCT02357147|58938561|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
30904339|NCT02357147|58938560|FG000|Maintenance Treatment Phase|Adverse Event|0|||
30904340|NCT02357147|58938561|FG001|Maintenance Treatment Phase|Adverse Event|3|||
30904341|NCT02357147|58938560|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
30904342|NCT02357147|58938561|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
30904343|NCT02357147|58938560|FG000|Maintenance Treatment Phase|Not Treated|1|||
30904344|NCT02357147|58938561|FG001|Maintenance Treatment Phase|Not Treated|0|||
30904345|NCT02356211|58938573|FG000|Overall Study|Withdrawal by Subject|2|||
30904346|NCT02356211|58938574|FG001|Overall Study|Withdrawal by Subject|2|||
30904347|NCT02356211|58938573|FG000|Overall Study|ineligible|1|||
30904348|NCT02356211|58938574|FG001|Overall Study|ineligible|8|||
30904349|NCT02332655|58938580|FG000|Overall Study|Lack of Efficacy|1|||
30904350|NCT02388737|58938587|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
30904351|NCT02388737|58938588|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
30904352|NCT02388737|58938589|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
30904353|NCT02388737|58938587|FG000|Overall Study|Major Protocol Deviation|18|||
30904354|NCT02388737|58938588|FG001|Overall Study|Major Protocol Deviation|25|||
30904355|NCT02388737|58938589|FG002|Overall Study|Major Protocol Deviation|22|||
30904356|NCT02388737|58938587|FG000|Overall Study|Lost to Follow-up|5|||
30904357|NCT02388737|58938588|FG001|Overall Study|Lost to Follow-up|1|||
30904358|NCT02388737|58938589|FG002|Overall Study|Lost to Follow-up|4|||
30904359|NCT02388737|58938587|FG000|Overall Study|Voluntary Withdrawal|10|||
30795868|NCT03343626|58809667|FG006|Overall Study|Withdrawal of Consent|1|||
30795869|NCT03343626|58809668|FG007|Overall Study|Withdrawal of Consent|2|||
30795870|NCT03343626|58809661|FG000|Overall Study|Reason not Specified|0|||
30795871|NCT03343626|58809662|FG001|Overall Study|Reason not Specified|1|||
30795872|NCT03343626|58809663|FG002|Overall Study|Reason not Specified|0|||
30795873|NCT03343626|58809664|FG003|Overall Study|Reason not Specified|0|||
30795874|NCT03343626|58809665|FG004|Overall Study|Reason not Specified|0|||
30795875|NCT03343626|58809666|FG005|Overall Study|Reason not Specified|0|||
30795876|NCT03343626|58809667|FG006|Overall Study|Reason not Specified|0|||
30795877|NCT03343626|58809668|FG007|Overall Study|Reason not Specified|1|||
30795878|NCT03343626|58809661|FG000|Overall Study|Data Entry Error|0|||
30795879|NCT03343626|58809662|FG001|Overall Study|Data Entry Error|0|||
30795880|NCT03343626|58809663|FG002|Overall Study|Data Entry Error|0|||
30795881|NCT03343626|58809664|FG003|Overall Study|Data Entry Error|0|||
30795882|NCT03343626|58809665|FG004|Overall Study|Data Entry Error|0|||
30795883|NCT03343626|58809666|FG005|Overall Study|Data Entry Error|0|||
30795884|NCT03343626|58809667|FG006|Overall Study|Data Entry Error|0|||
30795885|NCT03343626|58809668|FG007|Overall Study|Data Entry Error|1|||
30795886|NCT03334422|58809693|FG000|Overall Study|Adverse Event|1|||
30795887|NCT03334422|58809694|FG001|Overall Study|Adverse Event|3|||
30795888|NCT03334422|58809695|FG002|Overall Study|Adverse Event|2|||
30795889|NCT03334422|58809696|FG003|Overall Study|Adverse Event|2|||
30795890|NCT03334422|58809693|FG000|Overall Study|Lack of Efficacy|10|||
30795891|NCT03334422|58809694|FG001|Overall Study|Lack of Efficacy|2|||
30795892|NCT03334422|58809695|FG002|Overall Study|Lack of Efficacy|7|||
30795893|NCT03334422|58809696|FG003|Overall Study|Lack of Efficacy|3|||
30795894|NCT03334422|58809693|FG000|Overall Study|Withdrawal by Subject|8|||
30795895|NCT03334422|58809694|FG001|Overall Study|Withdrawal by Subject|3|||
30795896|NCT03334422|58809695|FG002|Overall Study|Withdrawal by Subject|1|||
30795897|NCT03334422|58809696|FG003|Overall Study|Withdrawal by Subject|0|||
30795898|NCT03334422|58809693|FG000|Overall Study|Lost to Follow-up|0|||
30795899|NCT03334422|58809694|FG001|Overall Study|Lost to Follow-up|0|||
30795900|NCT03334422|58809695|FG002|Overall Study|Lost to Follow-up|0|||
30795901|NCT03334422|58809696|FG003|Overall Study|Lost to Follow-up|1|||
30795902|NCT03334422|58809693|FG000|Overall Study|Inability to obtain laboratory samples|0|||
30795903|NCT03334422|58809694|FG001|Overall Study|Inability to obtain laboratory samples|1|||
30795904|NCT03334422|58809695|FG002|Overall Study|Inability to obtain laboratory samples|0|||
30795905|NCT03334422|58809696|FG003|Overall Study|Inability to obtain laboratory samples|0|||
30795906|NCT03334422|58809693|FG000|Overall Study|Pregnancy|0|||
30795907|NCT03334422|58809694|FG001|Overall Study|Pregnancy|1|||
30795908|NCT03334422|58809695|FG002|Overall Study|Pregnancy|0|||
30795909|NCT03334422|58809696|FG003|Overall Study|Pregnancy|0|||
30795910|NCT03362190|58809715|FG000|Overall Study|Adverse Event|0|||
30795911|NCT03362190|58809716|FG001|Overall Study|Adverse Event|0|||
30795912|NCT03362190|58809717|FG002|Overall Study|Adverse Event|0|||
30795913|NCT03362190|58809718|FG003|Overall Study|Adverse Event|1|||
30795914|NCT03362190|58809715|FG000|Overall Study|Withdrawal by Subject|0|||
30795915|NCT03362190|58809716|FG001|Overall Study|Withdrawal by Subject|0|||
30795916|NCT03362190|58809717|FG002|Overall Study|Withdrawal by Subject|0|||
30795917|NCT03362190|58809718|FG003|Overall Study|Withdrawal by Subject|1|||
30795918|NCT02323126|58809734|FG000|Overall Study|Patient / guardian decision|0|||
30795919|NCT02323126|58809735|FG001|Overall Study|Patient / guardian decision|1|||
30795920|NCT02323126|58809736|FG002|Overall Study|Patient / guardian decision|2|||
30795921|NCT02323126|58809734|FG000|Overall Study|Progressive disease|14|||
30795922|NCT02323126|58809735|FG001|Overall Study|Progressive disease|8|||
30795923|NCT02323126|58809736|FG002|Overall Study|Progressive disease|14|||
30795924|NCT02323126|58809734|FG000|Overall Study|Physician Decision|0|||
30795925|NCT02323126|58809735|FG001|Overall Study|Physician Decision|1|||
30795926|NCT02323126|58809736|FG002|Overall Study|Physician Decision|3|||
30795927|NCT02323126|58809734|FG000|Overall Study|Death|1|||
30795928|NCT02323126|58809735|FG001|Overall Study|Death|1|||
30904360|NCT02388737|58938588|FG001|Overall Study|Voluntary Withdrawal|18|||
30795929|NCT02323126|58809736|FG002|Overall Study|Death|4|||
30795930|NCT02323126|58809734|FG000|Overall Study|Adverse Event|3|||
30795931|NCT02323126|58809735|FG001|Overall Study|Adverse Event|5|||
30795932|NCT02323126|58809736|FG002|Overall Study|Adverse Event|7|||
30795933|NCT03491553|58809753|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
30795934|NCT03491553|58809754|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
30795935|NCT03491553|58809755|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
30795936|NCT03491553|58809756|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
30795937|NCT03491553|58809757|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
30795938|NCT03491553|58809758|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
30795939|NCT03491553|58809753|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
30904361|NCT02388737|58938589|FG002|Overall Study|Voluntary Withdrawal|17|||
30904362|NCT02388737|58938587|FG000|Overall Study|Lack of Efficacy|3|||
30904363|NCT02388737|58938588|FG001|Overall Study|Lack of Efficacy|0|||
30904364|NCT02388737|58938589|FG002|Overall Study|Lack of Efficacy|3|||
30904365|NCT02388737|58938587|FG000|Overall Study|Reason Not Specified|5|||
30904366|NCT02388737|58938588|FG001|Overall Study|Reason Not Specified|5|||
30904367|NCT02388737|58938589|FG002|Overall Study|Reason Not Specified|4|||
30904368|NCT02355743|58938597|FG000|Overall Study|Withdrawal by Subject|1|||
30904369|NCT02355743|58938597|FG000|Overall Study|Lost to Follow-up|1|||
30904370|NCT02388347|58938606|FG000|Overall Study|Withdrawal by Subject|0|||
30904371|NCT02388347|58938607|FG001|Overall Study|Withdrawal by Subject|0|||
30904372|NCT02388347|58938608|FG002|Overall Study|Withdrawal by Subject|1|||
30904373|NCT02388347|58938609|FG003|Overall Study|Withdrawal by Subject|0|||
30904374|NCT02388347|58938610|FG004|Overall Study|Withdrawal by Subject|0|||
30904375|NCT02355665|58938628|FG000|Overall Study|Adverse Event|16|||
30904376|NCT02355665|58938629|FG001|Overall Study|Adverse Event|24|||
30904377|NCT02355665|58938628|FG000|Overall Study|Protocol Violation|2|||
30904378|NCT02355665|58938629|FG001|Overall Study|Protocol Violation|0|||
30904379|NCT02355665|58938628|FG000|Overall Study|Withdrawal by Subject|90|||
30904380|NCT02355665|58938629|FG001|Overall Study|Withdrawal by Subject|100|||
30904381|NCT02355665|58938628|FG000|Overall Study|Lost to Follow-up|131|||
30904382|NCT02355665|58938629|FG001|Overall Study|Lost to Follow-up|103|||
30904383|NCT02355665|58938628|FG000|Overall Study|Death|4|||
30904384|NCT02355665|58938629|FG001|Overall Study|Death|2|||
30904385|NCT02355665|58938628|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
30904386|NCT02355665|58938629|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
30904387|NCT02010255|58938649|FG000|Overall Study|Death|0|||
30904388|NCT02010255|58938650|FG001|Overall Study|Death|1|||
30746170|NCT00068692|58756830|FG007|Step 2: Randomization|Physician Decision|0|||
30746171|NCT00068692|58756823|FG000|Step 2: Randomization|Other|0|||
30746172|NCT00068692|58756824|FG001|Step 2: Randomization|Other|0|||
30746173|NCT00068692|58756825|FG002|Step 2: Randomization|Other|0|||
30746174|NCT00068692|58756826|FG003|Step 2: Randomization|Other|1|||
30746175|NCT00068692|58756827|FG004|Step 2: Randomization|Other|0|||
30746176|NCT00068692|58756828|FG005|Step 2: Randomization|Other|1|||
30746177|NCT00068692|58756829|FG006|Step 2: Randomization|Other|0|||
30746178|NCT00068692|58756830|FG007|Step 2: Randomization|Other|0|||
30746179|NCT00068692|58756823|FG000|Step 2: Randomization|never start protocol therapy|0|||
30746180|NCT00068692|58756824|FG001|Step 2: Randomization|never start protocol therapy|0|||
30746181|NCT00068692|58756825|FG002|Step 2: Randomization|never start protocol therapy|1|||
30746182|NCT00068692|58756826|FG003|Step 2: Randomization|never start protocol therapy|0|||
30746183|NCT00068692|58756827|FG004|Step 2: Randomization|never start protocol therapy|1|||
30746184|NCT00068692|58756828|FG005|Step 2: Randomization|never start protocol therapy|0|||
30746185|NCT00068692|58756829|FG006|Step 2: Randomization|never start protocol therapy|0|||
30746186|NCT00068692|58756830|FG007|Step 2: Randomization|never start protocol therapy|0|||
30746187|NCT00463151|58756847|FG000|Overall Study|Adverse Event|0|||
30746188|NCT00463151|58756848|FG001|Overall Study|Adverse Event|0|||
30746189|NCT00463151|58756849|FG002|Overall Study|Adverse Event|1|||
30746190|NCT00463151|58756850|FG003|Overall Study|Adverse Event|0|||
30746191|NCT00463151|58756847|FG000|Overall Study|Lack of Efficacy|2|||
30746192|NCT00463151|58756848|FG001|Overall Study|Lack of Efficacy|5|||
30746193|NCT00463151|58756849|FG002|Overall Study|Lack of Efficacy|2|||
30746194|NCT00463151|58756850|FG003|Overall Study|Lack of Efficacy|5|||
30746195|NCT00463151|58756847|FG000|Overall Study|Protocol Violation|0|||
30746196|NCT00463151|58756848|FG001|Overall Study|Protocol Violation|0|||
30746197|NCT00463151|58756849|FG002|Overall Study|Protocol Violation|0|||
30746198|NCT00463151|58756850|FG003|Overall Study|Protocol Violation|1|||
30746199|NCT00463151|58756847|FG000|Overall Study|Withdrawal by Subject|0|||
30746200|NCT00463151|58756848|FG001|Overall Study|Withdrawal by Subject|0|||
30746201|NCT00463151|58756849|FG002|Overall Study|Withdrawal by Subject|0|||
30746202|NCT00463151|58756850|FG003|Overall Study|Withdrawal by Subject|1|||
30746203|NCT00068380|58756860|FG000|Overall Study|Withdrawal by Subject|3|||
30746204|NCT00068380|58756860|FG000|Overall Study|Adverse Event|2|||
30746205|NCT00067990|58756866|FG000|Overall Study|Death|5|||
30904389|NCT02010255|58938651|FG002|Overall Study|Death|4|||
30904390|NCT02010255|58938652|FG003|Overall Study|Death|4|||
30746206|NCT00067990|58756867|FG001|Overall Study|Death|7|||
30904391|NCT02010255|58938653|FG004|Overall Study|Death|2|||
30904392|NCT02010255|58938654|FG005|Overall Study|Death|0|||
30904393|NCT02010255|58938655|FG006|Overall Study|Death|1|||
30904394|NCT02010255|58938656|FG007|Overall Study|Death|1|||
30904395|NCT02010255|58938657|FG008|Overall Study|Death|1|||
30904396|NCT02010255|58938658|FG009|Overall Study|Death|0|||
30795940|NCT03491553|58809754|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
30795941|NCT03491553|58809755|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
30795942|NCT03491553|58809756|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
30795943|NCT03491553|58809757|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
30795944|NCT03491553|58809758|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
30795945|NCT00003377|58809779|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
30795946|NCT00003377|58809780|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
30795947|NCT00003377|58809781|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
30795948|NCT00003377|58809782|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
30795949|NCT00003377|58809783|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
30795950|NCT00003377|58809779|FG000|Period II|Ureteral stent complications|0|||
30795951|NCT00003377|58809780|FG001|Period II|Ureteral stent complications|0|||
30795952|NCT00003377|58809781|FG002|Period II|Ureteral stent complications|0|||
30795953|NCT00003377|58809782|FG003|Period II|Ureteral stent complications|0|||
30795954|NCT00003377|58809783|FG004|Period II|Ureteral stent complications|1|||
30795955|NCT00651742|58809796|FG000|Overall Study|Objective Disease Progression|22|||
30795956|NCT00651742|58809796|FG000|Overall Study|Toxicity|3|||
30795957|NCT00651742|58809796|FG000|Overall Study|Investigator Judgment|1|||
30795958|NCT00651742|58809796|FG000|Overall Study|Withdrawal of Consent|1|||
30795959|NCT00651742|58809796|FG000|Overall Study|Enrolled but not treated|1|||
30795960|NCT00002651|58809802|FG000|Induction|Adverse Event|44|||
30795961|NCT00002651|58809803|FG001|Induction|Adverse Event|0|||
30795962|NCT00002651|58809804|FG002|Induction|Adverse Event|0|||
30795963|NCT00002651|58809802|FG000|Induction|Refusal unrelated to adverse event|50|||
30795964|NCT00002651|58809803|FG001|Induction|Refusal unrelated to adverse event|0|||
30795965|NCT00002651|58809804|FG002|Induction|Refusal unrelated to adverse event|0|||
30795966|NCT00002651|58809802|FG000|Induction|Progression/relapse|274|||
30795967|NCT00002651|58809803|FG001|Induction|Progression/relapse|0|||
30795968|NCT00002651|58809804|FG002|Induction|Progression/relapse|0|||
30795969|NCT00002651|58809802|FG000|Induction|Death|62|||
30795970|NCT00002651|58809803|FG001|Induction|Death|0|||
30795971|NCT00002651|58809804|FG002|Induction|Death|0|||
30904397|NCT02010255|58938659|FG010|Overall Study|Death|1|||
30904398|NCT02010255|58938660|FG011|Overall Study|Death|1|||
30904399|NCT02010255|58938661|FG012|Overall Study|Death|0|||
30904400|NCT02010255|58938662|FG013|Overall Study|Death|0|||
30904401|NCT02010255|58938649|FG000|Overall Study|Lack of Efficacy|4|||
30904402|NCT02010255|58938650|FG001|Overall Study|Lack of Efficacy|1|||
30904403|NCT02010255|58938651|FG002|Overall Study|Lack of Efficacy|2|||
30904404|NCT02010255|58938652|FG003|Overall Study|Lack of Efficacy|1|||
30904405|NCT02010255|58938653|FG004|Overall Study|Lack of Efficacy|1|||
30904406|NCT02010255|58938654|FG005|Overall Study|Lack of Efficacy|0|||
30904407|NCT02010255|58938655|FG006|Overall Study|Lack of Efficacy|0|||
30904408|NCT02010255|58938656|FG007|Overall Study|Lack of Efficacy|0|||
30904409|NCT02010255|58938657|FG008|Overall Study|Lack of Efficacy|0|||
30904410|NCT02010255|58938658|FG009|Overall Study|Lack of Efficacy|0|||
30904411|NCT02010255|58938659|FG010|Overall Study|Lack of Efficacy|1|||
30904412|NCT02010255|58938660|FG011|Overall Study|Lack of Efficacy|0|||
30904413|NCT02010255|58938661|FG012|Overall Study|Lack of Efficacy|0|||
30904414|NCT02010255|58938662|FG013|Overall Study|Lack of Efficacy|0|||
30904415|NCT02010255|58938649|FG000|Overall Study|Withdrew Consent|1|||
30904416|NCT02010255|58938650|FG001|Overall Study|Withdrew Consent|0|||
30904417|NCT02010255|58938651|FG002|Overall Study|Withdrew Consent|0|||
30904418|NCT02010255|58938652|FG003|Overall Study|Withdrew Consent|1|||
30904419|NCT02010255|58938653|FG004|Overall Study|Withdrew Consent|0|||
30795972|NCT00002651|58809802|FG000|Induction|Other|823|||
30795973|NCT00002651|58809803|FG001|Induction|Other|0|||
30795974|NCT00002651|58809804|FG002|Induction|Other|0|||
30795975|NCT00002651|58809802|FG000|Induction|not eligible|90|||
30795976|NCT00002651|58809803|FG001|Induction|not eligible|0|||
30795977|NCT00002651|58809804|FG002|Induction|not eligible|0|||
30795978|NCT00002651|58809802|FG000|Consolidation and Randomization|Adverse Event|0|||
30795979|NCT00002651|58809803|FG001|Consolidation and Randomization|Adverse Event|36|||
30795980|NCT00002651|58809804|FG002|Consolidation and Randomization|Adverse Event|14|||
30904420|NCT02010255|58938654|FG005|Overall Study|Withdrew Consent|0|||
30904421|NCT02010255|58938655|FG006|Overall Study|Withdrew Consent|0|||
30904422|NCT02010255|58938656|FG007|Overall Study|Withdrew Consent|0|||
30904423|NCT02010255|58938657|FG008|Overall Study|Withdrew Consent|0|||
30904424|NCT02010255|58938658|FG009|Overall Study|Withdrew Consent|0|||
30904425|NCT02010255|58938659|FG010|Overall Study|Withdrew Consent|0|||
30795981|NCT00002651|58809802|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
30795982|NCT00002651|58809803|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
30795983|NCT00002651|58809804|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
30795984|NCT00002651|58809802|FG000|Consolidation and Randomization|Progression/relapse|0|||
30795985|NCT00002651|58809803|FG001|Consolidation and Randomization|Progression/relapse|295|||
30795986|NCT00002651|58809804|FG002|Consolidation and Randomization|Progression/relapse|298|||
30795987|NCT00002651|58809802|FG000|Consolidation and Randomization|Death|0|||
30904426|NCT02010255|58938660|FG011|Overall Study|Withdrew Consent|0|||
30904427|NCT02010255|58938661|FG012|Overall Study|Withdrew Consent|0|||
30904428|NCT02010255|58938662|FG013|Overall Study|Withdrew Consent|0|||
30904429|NCT02010255|58938649|FG000|Overall Study|Adverse Event|1|||
30904430|NCT02010255|58938650|FG001|Overall Study|Adverse Event|0|||
30904431|NCT02010255|58938651|FG002|Overall Study|Adverse Event|0|||
30795988|NCT00002651|58809803|FG001|Consolidation and Randomization|Death|38|||
30795989|NCT00002651|58809804|FG002|Consolidation and Randomization|Death|48|||
30795990|NCT00002651|58809802|FG000|Consolidation and Randomization|Other|0|||
30795991|NCT00002651|58809803|FG001|Consolidation and Randomization|Other|314|||
30795992|NCT00002651|58809804|FG002|Consolidation and Randomization|Other|313|||
30795993|NCT00002651|58809802|FG000|Consolidation and Randomization|not eligible|0|||
30795994|NCT00002651|58809803|FG001|Consolidation and Randomization|not eligible|102|||
30795995|NCT00002651|58809804|FG002|Consolidation and Randomization|not eligible|112|||
30795996|NCT00002597|58809814|FG000|Overall Study|Protocol Violation|19|||
30795997|NCT00002597|58809815|FG001|Overall Study|Protocol Violation|17|||
30904432|NCT02010255|58938652|FG003|Overall Study|Adverse Event|0|||
30904433|NCT02010255|58938653|FG004|Overall Study|Adverse Event|0|||
30904434|NCT02010255|58938654|FG005|Overall Study|Adverse Event|0|||
30904435|NCT02010255|58938655|FG006|Overall Study|Adverse Event|0|||
30904436|NCT02010255|58938656|FG007|Overall Study|Adverse Event|0|||
30904437|NCT02010255|58938657|FG008|Overall Study|Adverse Event|0|||
30904438|NCT02010255|58938658|FG009|Overall Study|Adverse Event|0|||
30904439|NCT02010255|58938659|FG010|Overall Study|Adverse Event|0|||
30795998|NCT00002597|58809814|FG000|Overall Study|Withdrawal by Subject|7|||
30795999|NCT00002597|58809815|FG001|Overall Study|Withdrawal by Subject|6|||
30796000|NCT03435081|58809824|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
30796001|NCT03435081|58809825|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
30796002|NCT03435081|58809826|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
30796003|NCT03435081|58809824|FG000|Week 0 to Week 16|Adverse Event|2|||
30796004|NCT03435081|58809825|FG001|Week 0 to Week 16|Adverse Event|2|||
30796005|NCT03435081|58809826|FG002|Week 0 to Week 16|Adverse Event|2|||
30796006|NCT03435081|58809824|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
30796007|NCT03435081|58809825|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
30796008|NCT03435081|58809826|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
30796009|NCT03435081|58809824|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
30904440|NCT02010255|58938660|FG011|Overall Study|Adverse Event|0|||
30904441|NCT02010255|58938661|FG012|Overall Study|Adverse Event|0|||
30904442|NCT02010255|58938662|FG013|Overall Study|Adverse Event|0|||
30746207|NCT00067990|58756866|FG000|Overall Study|ESRD, Non IF/TA|1|||
30746208|NCT00067990|58756867|FG001|Overall Study|ESRD, Non IF/TA|3|||
30746209|NCT00067990|58756866|FG000|Overall Study|Withdrawal by Subject|4|||
30746210|NCT00067990|58756867|FG001|Overall Study|Withdrawal by Subject|12|||
30746211|NCT00090220|58756875|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
30746212|NCT00090220|58756876|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
30746213|NCT00090220|58756877|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
30746214|NCT00090220|58756878|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
30746215|NCT00090220|58756879|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
30746216|NCT00090220|58756880|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
30746217|NCT00090220|58756875|FG000|Base Study Vaccination Period|Adverse Event|6|||
30746218|NCT00090220|58756876|FG001|Base Study Vaccination Period|Adverse Event|1|||
30746219|NCT00090220|58756877|FG002|Base Study Vaccination Period|Adverse Event|0|||
30746220|NCT00090220|58756878|FG003|Base Study Vaccination Period|Adverse Event|0|||
30746221|NCT00090220|58756879|FG004|Base Study Vaccination Period|Adverse Event|0|||
30746222|NCT00090220|58756880|FG005|Base Study Vaccination Period|Adverse Event|0|||
30746223|NCT00090220|58756875|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
30746224|NCT00090220|58756876|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
30746225|NCT00090220|58756877|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
30746226|NCT00090220|58756878|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
30746227|NCT00090220|58756879|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
30746228|NCT00090220|58756880|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
30746229|NCT00090220|58756875|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
30746230|NCT00090220|58756876|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
30746231|NCT00090220|58756877|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
30746232|NCT00090220|58756878|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
30746233|NCT00090220|58756879|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
30746234|NCT00090220|58756880|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
30746235|NCT00090220|58756875|FG000|Base Study Vaccination Period|Patient Moved|6|||
30746236|NCT00090220|58756876|FG001|Base Study Vaccination Period|Patient Moved|2|||
30904443|NCT02010255|58938649|FG000|Overall Study|Lost to Follow-up|0|||
30904444|NCT02010255|58938650|FG001|Overall Study|Lost to Follow-up|0|||
30904445|NCT02010255|58938651|FG002|Overall Study|Lost to Follow-up|1|||
30796010|NCT03435081|58809825|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
30796011|NCT03435081|58809826|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
30904446|NCT02010255|58938652|FG003|Overall Study|Lost to Follow-up|0|||
30796012|NCT03435081|58809824|FG000|Week 0 to Week 16|Pregnancy|1|||
30796013|NCT03435081|58809825|FG001|Week 0 to Week 16|Pregnancy|0|||
30796014|NCT03435081|58809826|FG002|Week 0 to Week 16|Pregnancy|0|||
30796015|NCT03435081|58809824|FG000|Week 0 to Week 16|Non-compliance|1|||
30796016|NCT03435081|58809825|FG001|Week 0 to Week 16|Non-compliance|0|||
30796017|NCT03435081|58809826|FG002|Week 0 to Week 16|Non-compliance|2|||
30796018|NCT03435081|58809824|FG000|Week 0 to Week 16|Inadequate Response|0|||
30796019|NCT03435081|58809825|FG001|Week 0 to Week 16|Inadequate Response|1|||
30796020|NCT03435081|58809826|FG002|Week 0 to Week 16|Inadequate Response|0|||
30796021|NCT03435081|58809824|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
30796022|NCT03435081|58809825|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
30796023|NCT03435081|58809826|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
30904447|NCT02010255|58938653|FG004|Overall Study|Lost to Follow-up|1|||
30904448|NCT02010255|58938654|FG005|Overall Study|Lost to Follow-up|0|||
30904449|NCT02010255|58938655|FG006|Overall Study|Lost to Follow-up|0|||
30904450|NCT02010255|58938656|FG007|Overall Study|Lost to Follow-up|0|||
30904451|NCT02010255|58938657|FG008|Overall Study|Lost to Follow-up|0|||
30904452|NCT02010255|58938658|FG009|Overall Study|Lost to Follow-up|0|||
30904453|NCT02010255|58938659|FG010|Overall Study|Lost to Follow-up|0|||
30904454|NCT02010255|58938660|FG011|Overall Study|Lost to Follow-up|0|||
30904455|NCT02010255|58938661|FG012|Overall Study|Lost to Follow-up|0|||
30904456|NCT02010255|58938662|FG013|Overall Study|Lost to Follow-up|0|||
30904457|NCT02010255|58938649|FG000|Overall Study|Randomized but Not Treated|0|||
30904458|NCT02010255|58938650|FG001|Overall Study|Randomized but Not Treated|0|||
30904459|NCT02010255|58938651|FG002|Overall Study|Randomized but Not Treated|0|||
30904460|NCT02010255|58938652|FG003|Overall Study|Randomized but Not Treated|0|||
30904461|NCT02010255|58938653|FG004|Overall Study|Randomized but Not Treated|0|||
30904462|NCT02010255|58938654|FG005|Overall Study|Randomized but Not Treated|0|||
30904463|NCT02010255|58938655|FG006|Overall Study|Randomized but Not Treated|0|||
30904464|NCT02010255|58938656|FG007|Overall Study|Randomized but Not Treated|0|||
30904465|NCT02010255|58938657|FG008|Overall Study|Randomized but Not Treated|0|||
30904466|NCT02010255|58938658|FG009|Overall Study|Randomized but Not Treated|0|||
30904467|NCT02010255|58938659|FG010|Overall Study|Randomized but Not Treated|0|||
30904468|NCT02010255|58938660|FG011|Overall Study|Randomized but Not Treated|0|||
30904469|NCT02010255|58938661|FG012|Overall Study|Randomized but Not Treated|0|||
30904470|NCT02010255|58938662|FG013|Overall Study|Randomized but Not Treated|1|||
30904471|NCT02354417|58938717|FG000|Overall Study|Physician Decision|1|||
30904472|NCT02332187|58938723|FG000|Overall Study|Withdrawal by Subject|2|||
30904473|NCT02332187|58938724|FG001|Overall Study|Withdrawal by Subject|2|||
30904474|NCT02332187|58938723|FG000|Overall Study|Adverse Event|0|||
30904475|NCT02332187|58938724|FG001|Overall Study|Adverse Event|1|||
30904476|NCT02330549|58938732|FG000|Overall Study|Adverse Event|1|||
30904477|NCT02330549|58938733|FG001|Overall Study|Adverse Event|0|||
30904478|NCT02330549|58938732|FG000|Overall Study|Subject withdrew consent|2|||
30904479|NCT02330549|58938733|FG001|Overall Study|Subject withdrew consent|1|||
30904480|NCT02330549|58938732|FG000|Overall Study|Failure to meet randomization criteria|1|||
30904481|NCT02330549|58938733|FG001|Overall Study|Failure to meet randomization criteria|0|||
30904482|NCT02009865|58938741|FG000|Overall Study|Adverse Event|0|||
30904483|NCT02009865|58938742|FG001|Overall Study|Adverse Event|2|||
30904484|NCT02009865|58938741|FG000|Overall Study|Protocol Violation|0|||
30904485|NCT02009865|58938742|FG001|Overall Study|Protocol Violation|2|||
30904486|NCT02009865|58938741|FG000|Overall Study|Withdrawal by Subject|1|||
30904487|NCT02009865|58938742|FG001|Overall Study|Withdrawal by Subject|1|||
30904488|NCT01620177|58938748|FG000|Overall Study|Failure at Screening Visit|43|||
30904489|NCT01620177|58938748|FG000|Overall Study|Withdrawal by Subject|26|||
30904490|NCT01620177|58938748|FG000|Overall Study|Lost to Follow-up|7|||
30904491|NCT01620177|58938748|FG000|Overall Study|Physician Decision|2|||
30904492|NCT01620177|58938748|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
30904493|NCT02075541|58938767|FG000|Overall Study|Serious Adverse Event|1|||
30904494|NCT02075541|58938768|FG001|Overall Study|Serious Adverse Event|4|||
30904495|NCT02075541|58938767|FG000|Overall Study|Protocol Violation|1|||
30904496|NCT02075541|58938768|FG001|Overall Study|Protocol Violation|0|||
30904497|NCT02075541|58938767|FG000|Overall Study|Withdrawal by Subject|1|||
30796024|NCT03435081|58809824|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
30904498|NCT02075541|58938768|FG001|Overall Study|Withdrawal by Subject|3|||
30904499|NCT02075541|58938767|FG000|Overall Study|Sponsor study termination|0|||
30904500|NCT02075541|58938768|FG001|Overall Study|Sponsor study termination|1|||
30904501|NCT02075541|58938767|FG000|Overall Study|Other- unable to perform study procedure|1|||
30796025|NCT03435081|58809825|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
30796026|NCT03435081|58809826|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
30904502|NCT02075541|58938768|FG001|Overall Study|Other- unable to perform study procedure|0|||
30904503|NCT02330081|58938774|FG000|Overall Study|Adverse Event|1|||
30904504|NCT02330081|58938774|FG000|Overall Study|Donation did not meet criteria|1|||
30904505|NCT02330081|58938774|FG000|Overall Study|Protocol Violation|6|||
30904506|NCT01986855|58938784|FG000|Overall Study|Adverse Event|1|||
30904507|NCT01986855|58938785|FG001|Overall Study|Adverse Event|0|||
30904508|NCT01986855|58938786|FG002|Overall Study|Adverse Event|0|||
30796027|NCT03435081|58809824|FG000|Week 16 to Week 104|Adverse Event|1|||
30796028|NCT03435081|58809825|FG001|Week 16 to Week 104|Adverse Event|0|||
30796029|NCT03435081|58809826|FG002|Week 16 to Week 104|Adverse Event|2|||
30796030|NCT03435081|58809824|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
30796031|NCT03435081|58809825|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
30796032|NCT03435081|58809826|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
30796033|NCT03435081|58809824|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
30796034|NCT03435081|58809825|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
30796035|NCT03435081|58809826|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
30796036|NCT03435081|58809824|FG000|Week 16 to Week 104|Non--Compliance|0|||
30796037|NCT03435081|58809825|FG001|Week 16 to Week 104|Non--Compliance|0|||
30796038|NCT03435081|58809826|FG002|Week 16 to Week 104|Non--Compliance|1|||
30796039|NCT02738008|58809841|FG000|Overall Study|Study Terminated by Sponsor|1|||
30796040|NCT02738008|58809842|FG001|Overall Study|Study Terminated by Sponsor|5|||
30796041|NCT02738008|58809843|FG002|Overall Study|Study Terminated by Sponsor|3|||
30796042|NCT02738008|58809841|FG000|Overall Study|Adverse Event|0|||
30796043|NCT02738008|58809842|FG001|Overall Study|Adverse Event|1|||
30796044|NCT02738008|58809843|FG002|Overall Study|Adverse Event|2|||
30796045|NCT03489369|58809855|FG000|Overall Study|Documented Progressive Disease|3|||
30796046|NCT03489369|58809856|FG001|Overall Study|Documented Progressive Disease|2|||
30796047|NCT03489369|58809857|FG002|Overall Study|Documented Progressive Disease|3|||
30796048|NCT03489369|58809858|FG003|Overall Study|Documented Progressive Disease|6|||
30796049|NCT03489369|58809855|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
30796050|NCT03489369|58809856|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
30796051|NCT03489369|58809857|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
30796052|NCT03489369|58809858|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
30796053|NCT03257254|58809868|FG000|Overall Study|Withdrawal by Subject|7|||
30796054|NCT03257254|58809868|FG000|Overall Study|Lost to Follow-up|9|||
30796055|NCT03257254|58809868|FG000|Overall Study|Study discontinued by sponsor|5|||
30796056|NCT03738475|58809874|FG000|Overall Study|Participant Non-Compliance|1|||
30796057|NCT03738475|58809875|FG001|Overall Study|Participant Non-Compliance|0|||
30796058|NCT03084718|58809886|FG000|Overall Study|Withdrawal by Subject|4|||
30796059|NCT03084718|58809887|FG001|Overall Study|Withdrawal by Subject|3|||
30796060|NCT03084718|58809888|FG002|Overall Study|Withdrawal by Subject|4|||
30796061|NCT03084718|58809889|FG003|Overall Study|Withdrawal by Subject|0|||
30796062|NCT03084718|58809890|FG004|Overall Study|Withdrawal by Subject|0|||
30796063|NCT03084718|58809886|FG000|Overall Study|Physician Decision|1|||
30796064|NCT03084718|58809887|FG001|Overall Study|Physician Decision|0|||
30796065|NCT03084718|58809888|FG002|Overall Study|Physician Decision|0|||
30796066|NCT03084718|58809889|FG003|Overall Study|Physician Decision|0|||
30796067|NCT03084718|58809890|FG004|Overall Study|Physician Decision|0|||
30796068|NCT03084718|58809886|FG000|Overall Study|Adverse Event|3|||
30796069|NCT03084718|58809887|FG001|Overall Study|Adverse Event|5|||
30796070|NCT03084718|58809888|FG002|Overall Study|Adverse Event|5|||
30796071|NCT03084718|58809889|FG003|Overall Study|Adverse Event|8|||
30796072|NCT03084718|58809890|FG004|Overall Study|Adverse Event|2|||
30796073|NCT03084718|58809886|FG000|Overall Study|Lack of Efficacy|2|||
30796074|NCT03084718|58809887|FG001|Overall Study|Lack of Efficacy|0|||
30796075|NCT03084718|58809888|FG002|Overall Study|Lack of Efficacy|1|||
30796076|NCT03084718|58809889|FG003|Overall Study|Lack of Efficacy|4|||
30796077|NCT03084718|58809890|FG004|Overall Study|Lack of Efficacy|0|||
30796078|NCT03084718|58809886|FG000|Overall Study|Lost to Follow-up|0|||
30796079|NCT03084718|58809887|FG001|Overall Study|Lost to Follow-up|1|||
30796080|NCT03084718|58809888|FG002|Overall Study|Lost to Follow-up|0|||
30796081|NCT03084718|58809889|FG003|Overall Study|Lost to Follow-up|0|||
30796082|NCT03084718|58809890|FG004|Overall Study|Lost to Follow-up|2|||
30796083|NCT03084718|58809886|FG000|Overall Study|Protocol Violation|0|||
30796084|NCT03084718|58809887|FG001|Overall Study|Protocol Violation|0|||
30796085|NCT03084718|58809888|FG002|Overall Study|Protocol Violation|1|||
30796086|NCT03084718|58809889|FG003|Overall Study|Protocol Violation|0|||
30796087|NCT03084718|58809890|FG004|Overall Study|Protocol Violation|0|||
30796088|NCT03084718|58809886|FG000|Overall Study|Death|0|||
30796089|NCT03084718|58809887|FG001|Overall Study|Death|1|||
30796090|NCT03084718|58809888|FG002|Overall Study|Death|0|||
30796091|NCT03084718|58809889|FG003|Overall Study|Death|0|||
30796092|NCT03084718|58809890|FG004|Overall Study|Death|0|||
30796093|NCT03084718|58809886|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
30796094|NCT03084718|58809887|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
30904509|NCT01986855|58938784|FG000|Overall Study|Death|3|||
30796095|NCT03084718|58809888|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
30796096|NCT03084718|58809889|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
30796097|NCT03084718|58809890|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
30796098|NCT04321252|58809914|FG000|Overall Study|Withdrawal by Subject|0|||
30904510|NCT01986855|58938785|FG001|Overall Study|Death|4|||
30796099|NCT04321252|58809915|FG001|Overall Study|Withdrawal by Subject|0|||
30796100|NCT04321252|58809916|FG002|Overall Study|Withdrawal by Subject|0|||
30796101|NCT04321252|58809917|FG003|Overall Study|Withdrawal by Subject|0|||
30796102|NCT04321252|58809918|FG004|Overall Study|Withdrawal by Subject|0|||
30796103|NCT04321252|58809919|FG005|Overall Study|Withdrawal by Subject|1|||
30796104|NCT04321252|58809920|FG006|Overall Study|Withdrawal by Subject|0|||
30796105|NCT04321252|58809921|FG007|Overall Study|Withdrawal by Subject|0|||
30796106|NCT04321252|58809922|FG008|Overall Study|Withdrawal by Subject|0|||
30796107|NCT03433677|58809954|FG000|Period 1|Protocol Violation|1|||
30796108|NCT03433677|58809955|FG001|Period 1|Protocol Violation|0|||
30796109|NCT03433677|58809954|FG000|Period 2|Withdrawal by Subject|1|||
30796110|NCT03433677|58809955|FG001|Period 2|Withdrawal by Subject|1|||
30796111|NCT02492711|58809965|FG000|Overall Study|Adverse Event|9|||
30796112|NCT02492711|58809966|FG001|Overall Study|Adverse Event|9|||
30796113|NCT02492711|58809967|FG002|Overall Study|Adverse Event|2|||
30796114|NCT02492711|58809965|FG000|Overall Study|Death|3|||
30796115|NCT02492711|58809966|FG001|Overall Study|Death|3|||
30796116|NCT02492711|58809967|FG002|Overall Study|Death|0|||
30796117|NCT02492711|58809965|FG000|Overall Study|Withdrawal by Subject|10|||
30796118|NCT02492711|58809966|FG001|Overall Study|Withdrawal by Subject|16|||
30796119|NCT02492711|58809967|FG002|Overall Study|Withdrawal by Subject|5|||
30796120|NCT02492711|58809965|FG000|Overall Study|Physician Decision|10|||
30796121|NCT02492711|58809966|FG001|Overall Study|Physician Decision|6|||
30796122|NCT02492711|58809967|FG002|Overall Study|Physician Decision|4|||
30796123|NCT02492711|58809965|FG000|Overall Study|Lost to Follow-up|0|||
30796124|NCT02492711|58809966|FG001|Overall Study|Lost to Follow-up|0|||
30796125|NCT02492711|58809967|FG002|Overall Study|Lost to Follow-up|1|||
30796126|NCT02492711|58809965|FG000|Overall Study|study treatment delay|2|||
30796127|NCT02492711|58809966|FG001|Overall Study|study treatment delay|1|||
30796128|NCT02492711|58809967|FG002|Overall Study|study treatment delay|0|||
30796129|NCT02492711|58809965|FG000|Overall Study|change in chemotherapy|0|||
30796130|NCT02492711|58809966|FG001|Overall Study|change in chemotherapy|1|||
30796131|NCT02492711|58809967|FG002|Overall Study|change in chemotherapy|0|||
30796132|NCT02492711|58809965|FG000|Overall Study|never treated|2|||
30796133|NCT02492711|58809966|FG001|Overall Study|never treated|4|||
30796134|NCT02492711|58809967|FG002|Overall Study|never treated|0|||
30796135|NCT02492711|58809965|FG000|Overall Study|Other|0|||
30796136|NCT02492711|58809966|FG001|Overall Study|Other|0|||
30796137|NCT02492711|58809967|FG002|Overall Study|Other|1|||
30796138|NCT01147822|58809982|FG000|Overall Study|Death|66|||
30796139|NCT01147822|58809983|FG001|Overall Study|Death|59|||
30796140|NCT01147822|58809982|FG000|Overall Study|Protocol Violation|0|||
30796141|NCT01147822|58809983|FG001|Overall Study|Protocol Violation|1|||
30796142|NCT01147822|58809982|FG000|Overall Study|Lost to Follow-up|3|||
30796143|NCT01147822|58809983|FG001|Overall Study|Lost to Follow-up|2|||
30796144|NCT01147822|58809982|FG000|Overall Study|Physician Decision|0|||
30796145|NCT01147822|58809983|FG001|Overall Study|Physician Decision|2|||
30796146|NCT01147822|58809982|FG000|Overall Study|Withdrawal by Subject|8|||
30796147|NCT01147822|58809983|FG001|Overall Study|Withdrawal by Subject|13|||
30904511|NCT01986855|58938786|FG002|Overall Study|Death|4|||
30904512|NCT01986855|58938784|FG000|Overall Study|Lost to Follow-up|2|||
30904513|NCT01986855|58938785|FG001|Overall Study|Lost to Follow-up|1|||
30904514|NCT01986855|58938786|FG002|Overall Study|Lost to Follow-up|0|||
30904515|NCT01986855|58938784|FG000|Overall Study|Screen Failure|0|||
30796148|NCT01147822|58809982|FG000|Overall Study|Not Completed/Ongoing|111|||
30796149|NCT01147822|58809983|FG001|Overall Study|Not Completed/Ongoing|102|||
30796150|NCT03431337|58809991|FG000|Overall Study|Lost to Follow-up|21|||
30796151|NCT03431337|58809992|FG001|Overall Study|Lost to Follow-up|19|||
30796152|NCT03431337|58809991|FG000|Overall Study|Withdrawal by Subject|8|||
30796153|NCT03431337|58809992|FG001|Overall Study|Withdrawal by Subject|3|||
30796154|NCT03738241|58810012|FG000|Overall Study|Withdrawal by Subject|0|||
30796155|NCT03738241|58810013|FG001|Overall Study|Withdrawal by Subject|0|||
30796156|NCT03738241|58810014|FG002|Overall Study|Withdrawal by Subject|0|||
30796157|NCT03738241|58810015|FG003|Overall Study|Withdrawal by Subject|0|||
30796158|NCT03738241|58810016|FG004|Overall Study|Withdrawal by Subject|0|||
30796159|NCT03738241|58810017|FG005|Overall Study|Withdrawal by Subject|0|||
30796160|NCT03738241|58810018|FG006|Overall Study|Withdrawal by Subject|0|||
30796161|NCT03738241|58810019|FG007|Overall Study|Withdrawal by Subject|0|||
30796162|NCT03738241|58810020|FG008|Overall Study|Withdrawal by Subject|0|||
30796163|NCT03738241|58810021|FG009|Overall Study|Withdrawal by Subject|1|||
30796164|NCT03738241|58810012|FG000|Overall Study|Physician Decision|0|||
30796165|NCT03738241|58810013|FG001|Overall Study|Physician Decision|0|||
30796166|NCT03738241|58810014|FG002|Overall Study|Physician Decision|0|||
30796167|NCT03738241|58810015|FG003|Overall Study|Physician Decision|0|||
30796168|NCT03738241|58810016|FG004|Overall Study|Physician Decision|0|||
30796169|NCT03738241|58810017|FG005|Overall Study|Physician Decision|0|||
30796170|NCT03738241|58810018|FG006|Overall Study|Physician Decision|0|||
30904516|NCT01986855|58938785|FG001|Overall Study|Screen Failure|1|||
30796171|NCT03738241|58810019|FG007|Overall Study|Physician Decision|0|||
30796172|NCT03738241|58810020|FG008|Overall Study|Physician Decision|1|||
30796173|NCT03738241|58810021|FG009|Overall Study|Physician Decision|0|||
30796174|NCT03738241|58810012|FG000|Overall Study|Adverse Event|1|||
30796175|NCT03738241|58810013|FG001|Overall Study|Adverse Event|0|||
30796176|NCT03738241|58810014|FG002|Overall Study|Adverse Event|0|||
30796177|NCT03738241|58810015|FG003|Overall Study|Adverse Event|0|||
30796178|NCT03738241|58810016|FG004|Overall Study|Adverse Event|0|||
30796179|NCT03738241|58810017|FG005|Overall Study|Adverse Event|0|||
30796180|NCT03738241|58810018|FG006|Overall Study|Adverse Event|0|||
30796181|NCT03738241|58810019|FG007|Overall Study|Adverse Event|0|||
30796182|NCT03738241|58810020|FG008|Overall Study|Adverse Event|0|||
30796183|NCT03738241|58810021|FG009|Overall Study|Adverse Event|0|||
30796184|NCT03430245|58810043|FG000|Overall Study|Withdrawal by Subject|6|||
30796185|NCT03430245|58810043|FG000|Overall Study|Lost to Follow-up|1|||
30796186|NCT03461289|58810047|FG000|Overall Study|Death|1|||
30796187|NCT03452943|58810053|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
30796188|NCT03452943|58810054|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
30796189|NCT03452943|58810053|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
30904517|NCT01986855|58938786|FG002|Overall Study|Screen Failure|0|||
30904518|NCT01986855|58938784|FG000|Overall Study|Participant Moved|0|||
30904519|NCT01986855|58938785|FG001|Overall Study|Participant Moved|0|||
30904520|NCT01986855|58938786|FG002|Overall Study|Participant Moved|2|||
30904521|NCT01986855|58938784|FG000|Overall Study|Withdrawal by Subject|7|||
30904522|NCT01986855|58938785|FG001|Overall Study|Withdrawal by Subject|8|||
30904523|NCT01986855|58938786|FG002|Overall Study|Withdrawal by Subject|5|||
30904524|NCT02075463|58938794|FG000|Overall Study|Adverse Event|3|||
30904525|NCT02075463|58938794|FG000|Overall Study|Par. reached stopping criteria|4|||
30904526|NCT02075463|58938794|FG000|Overall Study|Withdrawal by Subject|1|||
30904527|NCT02353871|58938801|FG000|Overall Study|Protocol deviation|0|||
30904528|NCT02353871|58938802|FG001|Overall Study|Protocol deviation|1|||
30904529|NCT02353871|58938801|FG000|Overall Study|Consent withdrawn|1|||
30904530|NCT02353871|58938802|FG001|Overall Study|Consent withdrawn|8|||
30904531|NCT02353871|58938801|FG000|Overall Study|Lost to Follow-up|2|||
30904532|NCT02353871|58938802|FG001|Overall Study|Lost to Follow-up|0|||
30904533|NCT02009397|58938808|FG000|Overall Study|Protocol Violation|6|||
30904534|NCT02009397|58938808|FG000|Overall Study|Death|8|||
30904535|NCT02009397|58938808|FG000|Overall Study|Lost to Follow-up|6|||
30904536|NCT02312219|58938814|FG000|Overall Study|Withdrawal by Subject|1|||
30746237|NCT00090220|58756877|FG002|Base Study Vaccination Period|Patient Moved|0|||
30746238|NCT00090220|58756878|FG003|Base Study Vaccination Period|Patient Moved|0|||
30746239|NCT00090220|58756879|FG004|Base Study Vaccination Period|Patient Moved|0|||
30746240|NCT00090220|58756880|FG005|Base Study Vaccination Period|Patient Moved|0|||
30746241|NCT00090220|58756875|FG000|Base Study Vaccination Period|Other|4|||
30746242|NCT00090220|58756876|FG001|Base Study Vaccination Period|Other|4|||
30746243|NCT00090220|58756877|FG002|Base Study Vaccination Period|Other|0|||
30746244|NCT00090220|58756878|FG003|Base Study Vaccination Period|Other|0|||
30746245|NCT00090220|58756879|FG004|Base Study Vaccination Period|Other|0|||
30746246|NCT00090220|58756880|FG005|Base Study Vaccination Period|Other|0|||
30746247|NCT00090220|58756875|FG000|Base Study Follow-up Period|Adverse Event|6|||
30746248|NCT00090220|58756876|FG001|Base Study Follow-up Period|Adverse Event|1|||
30746249|NCT00090220|58756877|FG002|Base Study Follow-up Period|Adverse Event|0|||
30746250|NCT00090220|58756878|FG003|Base Study Follow-up Period|Adverse Event|0|||
30746251|NCT00090220|58756879|FG004|Base Study Follow-up Period|Adverse Event|0|||
30746252|NCT00090220|58756880|FG005|Base Study Follow-up Period|Adverse Event|0|||
30746253|NCT00090220|58756875|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
30746254|NCT00090220|58756876|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
30746255|NCT00090220|58756877|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
30746256|NCT00090220|58756878|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
30746257|NCT00090220|58756879|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
30746258|NCT00090220|58756880|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
30746259|NCT00090220|58756875|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
30746260|NCT00090220|58756876|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
30746261|NCT00090220|58756877|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
30746262|NCT00090220|58756878|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
30746263|NCT00090220|58756879|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
30746264|NCT00090220|58756880|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
30746265|NCT00090220|58756875|FG000|Base Study Follow-up Period|Patient Moved|20|||
30746266|NCT00090220|58756876|FG001|Base Study Follow-up Period|Patient Moved|28|||
30746267|NCT00090220|58756877|FG002|Base Study Follow-up Period|Patient Moved|0|||
30746268|NCT00090220|58756878|FG003|Base Study Follow-up Period|Patient Moved|0|||
30746269|NCT00090220|58756879|FG004|Base Study Follow-up Period|Patient Moved|0|||
30746270|NCT00090220|58756880|FG005|Base Study Follow-up Period|Patient Moved|0|||
30746271|NCT00090220|58756875|FG000|Base Study Follow-up Period|Other|19|||
30796190|NCT03452943|58810054|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
30904537|NCT02312219|58938815|FG001|Overall Study|Withdrawal by Subject|2|||
30746272|NCT00090220|58756876|FG001|Base Study Follow-up Period|Other|21|||
30746273|NCT00090220|58756877|FG002|Base Study Follow-up Period|Other|0|||
30746274|NCT00090220|58756878|FG003|Base Study Follow-up Period|Other|0|||
30746275|NCT00090220|58756879|FG004|Base Study Follow-up Period|Other|0|||
30746276|NCT00090220|58756880|FG005|Base Study Follow-up Period|Other|0|||
30746277|NCT00090220|58756875|FG000|Extension 1 (EXT1)|Adverse Event|0|||
30746278|NCT00090220|58756876|FG001|Extension 1 (EXT1)|Adverse Event|0|||
30746279|NCT00090220|58756877|FG002|Extension 1 (EXT1)|Adverse Event|4|||
30796191|NCT03452943|58810053|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
30904538|NCT02312219|58938814|FG000|Overall Study|could not schedule imaging in time|0|||
30904539|NCT02312219|58938815|FG001|Overall Study|could not schedule imaging in time|2|||
30904540|NCT02312219|58938814|FG000|Overall Study|Other|0|||
30904541|NCT02312219|58938815|FG001|Overall Study|Other|1|||
30796192|NCT03452943|58810054|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
30796193|NCT03452943|58810053|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
30796194|NCT03452943|58810054|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
30796195|NCT03452943|58810053|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
30796196|NCT03452943|58810054|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
30796197|NCT03452943|58810053|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
30796198|NCT03452943|58810054|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
30796199|NCT03481725|58810062|FG000|Overall Study|Withdrawal by Subject|1|||
30796200|NCT03481725|58810063|FG001|Overall Study|Withdrawal by Subject|0|||
30796201|NCT03480243|58810071|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
30622148|NCT01169844|58633649|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30622149|NCT01132482|58633657|FG000|Overall Study|Adverse Event|1|||
30622150|NCT01132482|58633658|FG001|Overall Study|Adverse Event|0|||
30622151|NCT00931762|58633664|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
30622152|NCT00931762|58633664|FG000|Overall Study|Administrative Problems|5|||
30622153|NCT00931762|58633664|FG000|Overall Study|Death|1|||
30622154|NCT00931762|58633664|FG000|Overall Study|Disease Progression|3|||
30622155|NCT00931762|58633664|FG000|Overall Study|Adverse Event (s)|11|||
30622156|NCT00931762|58633664|FG000|Overall Study|Subject withdrew consent|13|||
30622157|NCT01132326|58633668|FG000|Overall Study|Lack of Efficacy|25|||
30622158|NCT01132326|58633668|FG000|Overall Study|Adverse Event|37|||
30622159|NCT01132326|58633668|FG000|Overall Study|Protocol Violation|1|||
30746280|NCT00090220|58756878|FG003|Extension 1 (EXT1)|Adverse Event|0|||
30746281|NCT00090220|58756879|FG004|Extension 1 (EXT1)|Adverse Event|0|||
30796202|NCT03480243|58810071|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
30796203|NCT03426345|58810086|FG000|Overall Study|Adverse Event|4|||
30796204|NCT03426345|58810087|FG001|Overall Study|Adverse Event|4|||
30796205|NCT03426345|58810086|FG000|Overall Study|Lack of Efficacy|1|||
30796206|NCT03426345|58810087|FG001|Overall Study|Lack of Efficacy|0|||
30796207|NCT03426345|58810086|FG000|Overall Study|Withdrawal by Subject|5|||
30796208|NCT03426345|58810087|FG001|Overall Study|Withdrawal by Subject|6|||
30796209|NCT03426345|58810086|FG000|Overall Study|Lost to Follow-up|3|||
30796210|NCT03426345|58810087|FG001|Overall Study|Lost to Follow-up|1|||
30796211|NCT03426345|58810086|FG000|Overall Study|Protocol Deviation|3|||
30796212|NCT03426345|58810087|FG001|Overall Study|Protocol Deviation|4|||
30796213|NCT03426345|58810086|FG000|Overall Study|Reason Not Specified|1|||
30796214|NCT03426345|58810087|FG001|Overall Study|Reason Not Specified|2|||
30796215|NCT03426345|58810086|FG000|Overall Study|Missing Completion Status|1|||
30796216|NCT03426345|58810087|FG001|Overall Study|Missing Completion Status|0|||
30796217|NCT03426267|58810096|FG000|Overall Study|Physician Decision|1|||
30796218|NCT03426267|58810097|FG001|Overall Study|Physician Decision|4|||
30796219|NCT03426267|58810096|FG000|Overall Study|Lost to Follow-up|1|||
30796220|NCT03426267|58810097|FG001|Overall Study|Lost to Follow-up|0|||
30796221|NCT03426267|58810096|FG000|Overall Study|Withdrawal by Subject|4|||
30796222|NCT03426267|58810097|FG001|Overall Study|Withdrawal by Subject|10|||
30796223|NCT03426267|58810096|FG000|Overall Study|Protocol Violation|1|||
30796224|NCT03426267|58810097|FG001|Overall Study|Protocol Violation|3|||
30796225|NCT03426267|58810096|FG000|Overall Study|Adverse Event|9|||
30622160|NCT01132326|58633668|FG000|Overall Study|Lost to Follow-up|16|||
30746282|NCT00090220|58756880|FG005|Extension 1 (EXT1)|Adverse Event|0|||
30746283|NCT00090220|58756875|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
30746284|NCT00090220|58756876|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
30746285|NCT00090220|58756877|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
30746286|NCT00090220|58756878|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
30746287|NCT00090220|58756879|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
30746288|NCT00090220|58756880|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
30746289|NCT00090220|58756875|FG000|Extension 1 (EXT1)|Moved|0|||
30746290|NCT00090220|58756876|FG001|Extension 1 (EXT1)|Moved|0|||
30746291|NCT00090220|58756877|FG002|Extension 1 (EXT1)|Moved|2|||
30746292|NCT00090220|58756878|FG003|Extension 1 (EXT1)|Moved|1|||
30746293|NCT00090220|58756879|FG004|Extension 1 (EXT1)|Moved|0|||
30796226|NCT03426267|58810097|FG001|Overall Study|Adverse Event|27|||
30796227|NCT03426267|58810096|FG000|Overall Study|Prohibited Treatment Intake|2|||
30796228|NCT03426267|58810097|FG001|Overall Study|Prohibited Treatment Intake|3|||
30796229|NCT03426267|58810096|FG000|Overall Study|Lack of Efficacy|0|||
30796230|NCT03426267|58810097|FG001|Overall Study|Lack of Efficacy|25|||
30796231|NCT03426267|58810096|FG000|Overall Study|other|3|||
30796232|NCT03426267|58810097|FG001|Overall Study|other|0|||
30796233|NCT03412929|58810103|FG000|Overall Study|Protocol Violation|3|||
30746294|NCT00090220|58756880|FG005|Extension 1 (EXT1)|Moved|0|||
30746295|NCT00090220|58756875|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
30622161|NCT01132326|58633668|FG000|Overall Study|Withdrawal by Subject|40|||
30746296|NCT00090220|58756876|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
30796234|NCT03451773|58810109|FG000|Overall Study|Death on study|1|||
30796235|NCT03451773|58810110|FG001|Overall Study|Death on study|5|||
30796236|NCT03451773|58810109|FG000|Overall Study|Death during follow-up period|0|||
30796237|NCT03451773|58810110|FG001|Overall Study|Death during follow-up period|1|||
30796238|NCT03425253|58810117|FG000|Overall Study|Adverse Event|2|||
30796239|NCT03425253|58810117|FG000|Overall Study|Lost to Follow-up|3|||
30796240|NCT03425253|58810117|FG000|Overall Study|Withdrew Consent|6|||
30796241|NCT03425253|58810117|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
30796242|NCT03424239|58810122|FG000|Overall Study|Withdrawal by Subject|2|||
30796243|NCT03451071|58810126|FG000|First Vaccine|Withdrawal by Subject|1|||
30796244|NCT03451071|58810126|FG000|Second Vaccine|Lost to Follow-up|19|||
30796245|NCT03451071|58810126|FG000|Third Vaccine|Lost to Follow-up|22|||
30796246|NCT03451071|58810126|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
30796247|NCT03449979|58810134|FG000|Overall Study|Technical difficulty|0|||
30796248|NCT03449979|58810135|FG001|Overall Study|Technical difficulty|0|||
30796249|NCT03449979|58810136|FG002|Overall Study|Technical difficulty|0|||
30796250|NCT03449979|58810137|FG003|Overall Study|Technical difficulty|1|||
30796251|NCT03449199|58810150|FG000|Overall Study|Lost to Follow-up|1|||
30796252|NCT03449199|58810151|FG001|Overall Study|Lost to Follow-up|1|||
30796253|NCT03449199|58810152|FG002|Overall Study|Lost to Follow-up|0|||
30796254|NCT03449199|58810150|FG000|Overall Study|Protocol Deviation|0|||
30796255|NCT03449199|58810151|FG001|Overall Study|Protocol Deviation|0|||
30796256|NCT03449199|58810152|FG002|Overall Study|Protocol Deviation|1|||
30796257|NCT03449199|58810150|FG000|Overall Study|Withdrawal by Subject|0|||
30796258|NCT03449199|58810151|FG001|Overall Study|Withdrawal by Subject|0|||
30796259|NCT03449199|58810152|FG002|Overall Study|Withdrawal by Subject|1|||
30796260|NCT03421431|58810166|FG000|Overall Study|Adverse Event|2|||
30796261|NCT03421431|58810167|FG001|Overall Study|Adverse Event|1|||
30796262|NCT03421431|58810168|FG002|Overall Study|Adverse Event|12|||
30796263|NCT03421431|58810166|FG000|Overall Study|Lost to Follow-up|1|||
30796264|NCT03421431|58810167|FG001|Overall Study|Lost to Follow-up|1|||
30796265|NCT03421431|58810168|FG002|Overall Study|Lost to Follow-up|1|||
30796266|NCT03421431|58810166|FG000|Overall Study|Withdrawal by Subject|3|||
30904542|NCT02312219|58938814|FG000|Overall Study|Not randomized. Ineligible|0|||
30904543|NCT02312219|58938815|FG001|Overall Study|Not randomized. Ineligible|1|||
30796267|NCT03421431|58810167|FG001|Overall Study|Withdrawal by Subject|2|||
30796268|NCT03421431|58810168|FG002|Overall Study|Withdrawal by Subject|1|||
30796269|NCT03421431|58810166|FG000|Overall Study|Protocol Violation|0|||
30796270|NCT03421431|58810167|FG001|Overall Study|Protocol Violation|1|||
30796271|NCT03421431|58810168|FG002|Overall Study|Protocol Violation|0|||
30796272|NCT03421431|58810166|FG000|Overall Study|Participant met Stopping Rules|0|||
30796273|NCT03421431|58810167|FG001|Overall Study|Participant met Stopping Rules|1|||
30796274|NCT03421431|58810168|FG002|Overall Study|Participant met Stopping Rules|0|||
30796275|NCT03448419|58810180|FG000|Overall Study|Adverse Event|10|||
30796276|NCT03448419|58810181|FG001|Overall Study|Adverse Event|9|||
30796277|NCT03448419|58810180|FG000|Overall Study|Lost to Follow-up|0|||
30796278|NCT03448419|58810181|FG001|Overall Study|Lost to Follow-up|2|||
30796279|NCT03448419|58810180|FG000|Overall Study|Withdrawal by Subject|3|||
30904544|NCT01986231|58938821|FG000|Overall Study|Adverse Event|1|||
30796280|NCT03448419|58810181|FG001|Overall Study|Withdrawal by Subject|1|||
30796281|NCT03448419|58810180|FG000|Overall Study|Not treated|0|||
30904545|NCT02312063|58938827|FG000|Overall Study|Withdrawal by Subject|0|||
30904546|NCT02312063|58938828|FG001|Overall Study|Withdrawal by Subject|1|||
30904547|NCT02353169|58938839|FG000|Overall Study|QTc > 450 msec|1|||
30904548|NCT02353169|58938840|FG001|Overall Study|QTc > 450 msec|1|||
30904549|NCT02353169|58938841|FG002|Overall Study|QTc > 450 msec|1|||
30904550|NCT02353169|58938842|FG003|Overall Study|QTc > 450 msec|1|||
30796282|NCT03448419|58810181|FG001|Overall Study|Not treated|1|||
30796283|NCT03448419|58810180|FG000|Overall Study|Patient did not attend all visits|0|||
30796284|NCT03448419|58810181|FG001|Overall Study|Patient did not attend all visits|2|||
30796285|NCT03448419|58810180|FG000|Overall Study|Withdrawn by Sponsor|0|||
30796286|NCT03448419|58810181|FG001|Overall Study|Withdrawn by Sponsor|1|||
30796287|NCT03419403|58810192|FG000|Overall Study|Withdrawal by Subject|5|||
30796288|NCT03419403|58810193|FG001|Overall Study|Withdrawal by Subject|2|||
30796289|NCT03419403|58810194|FG002|Overall Study|Withdrawal by Subject|5|||
30796290|NCT03419403|58810195|FG003|Overall Study|Withdrawal by Subject|1|||
30904551|NCT02353169|58938839|FG000|Overall Study|OR team declined|2|||
30796291|NCT03419403|58810192|FG000|Overall Study|Progressive disease (per protocol)|0|||
30796292|NCT03419403|58810193|FG001|Overall Study|Progressive disease (per protocol)|2|||
30796293|NCT03419403|58810194|FG002|Overall Study|Progressive disease (per protocol)|2|||
30796294|NCT03419403|58810195|FG003|Overall Study|Progressive disease (per protocol)|0|||
30796295|NCT03419403|58810192|FG000|Overall Study|Other, not specified|6|||
30796296|NCT03419403|58810193|FG001|Overall Study|Other, not specified|4|||
30904552|NCT02353169|58938840|FG001|Overall Study|OR team declined|0|||
30904553|NCT02353169|58938841|FG002|Overall Study|OR team declined|0|||
30904554|NCT02353169|58938842|FG003|Overall Study|OR team declined|0|||
30796297|NCT03419403|58810194|FG002|Overall Study|Other, not specified|5|||
30796298|NCT03419403|58810195|FG003|Overall Study|Other, not specified|1|||
30796299|NCT03419403|58810192|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
30796300|NCT03419403|58810193|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
30904555|NCT02353169|58938839|FG000|Overall Study|Inhalational induction|0|||
30904556|NCT02353169|58938840|FG001|Overall Study|Inhalational induction|2|||
30904557|NCT02353169|58938841|FG002|Overall Study|Inhalational induction|0|||
30904558|NCT02353169|58938842|FG003|Overall Study|Inhalational induction|0|||
30904559|NCT02353169|58938839|FG000|Overall Study|ECG data error|0|||
30904560|NCT02353169|58938840|FG001|Overall Study|ECG data error|3|||
30904561|NCT02353169|58938841|FG002|Overall Study|ECG data error|2|||
30904562|NCT02353169|58938842|FG003|Overall Study|ECG data error|2|||
30904563|NCT02353169|58938839|FG000|Overall Study|Pre-op medication|0|||
30904564|NCT02353169|58938840|FG001|Overall Study|Pre-op medication|0|||
30904565|NCT02353169|58938841|FG002|Overall Study|Pre-op medication|1|||
30904566|NCT02353169|58938842|FG003|Overall Study|Pre-op medication|0|||
30904567|NCT02009163|58938852|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
30904568|NCT02009163|58938853|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
30796301|NCT03419403|58810194|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
30796302|NCT03419403|58810195|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
30796303|NCT03447249|58810205|FG000|Overall Study|Adverse Event|1|||
30796304|NCT03447249|58810206|FG001|Overall Study|Adverse Event|0|||
30622162|NCT01132326|58633668|FG000|Overall Study|Physician Decision|10|||
30746297|NCT00090220|58756877|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
30746298|NCT00090220|58756878|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
30746299|NCT00090220|58756879|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
30746300|NCT00090220|58756880|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
30746301|NCT00090220|58756875|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
30796305|NCT03447249|58810205|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
30796306|NCT03447249|58810206|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
30796307|NCT03447249|58810205|FG000|Overall Study|Other|3|||
30796308|NCT03447249|58810206|FG001|Overall Study|Other|0|||
30796309|NCT03418545|58810216|FG000|Overall Study|Withdrawal by Participant|2|||
30796310|NCT03418545|58810217|FG001|Overall Study|Withdrawal by Participant|4|||
30796311|NCT03418545|58810216|FG000|Overall Study|Lost to Follow-up|3|||
30796312|NCT03418545|58810217|FG001|Overall Study|Lost to Follow-up|5|||
30796313|NCT03418545|58810216|FG000|Overall Study|Reason Not Specified|0|||
30796314|NCT03418545|58810217|FG001|Overall Study|Reason Not Specified|1|||
30796315|NCT03418545|58810216|FG000|Overall Study|Missing Completion Status|0|||
30796316|NCT03418545|58810217|FG001|Overall Study|Missing Completion Status|1|||
30796317|NCT03446781|58810228|FG000|Overall Study|Lost to Follow-up|11|||
30796318|NCT03446781|58810229|FG001|Overall Study|Lost to Follow-up|5|||
30796319|NCT03446781|58810228|FG000|Overall Study|Withdrawal by Subject|9|||
30796320|NCT03446781|58810229|FG001|Overall Study|Withdrawal by Subject|7|||
30796321|NCT03446781|58810228|FG000|Overall Study|Adverse Event|8|||
30796322|NCT03446781|58810229|FG001|Overall Study|Adverse Event|2|||
30796323|NCT03446781|58810228|FG000|Overall Study|Protocol Violation|0|||
30796324|NCT03446781|58810229|FG001|Overall Study|Protocol Violation|3|||
30796325|NCT03445065|58810261|FG000|Overall Study|Withdrawal by Subject|3|||
30746302|NCT00090220|58756876|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
30746303|NCT00090220|58756877|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
30746304|NCT00090220|58756878|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
30746305|NCT00090220|58756879|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
30746306|NCT00090220|58756880|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
30746307|NCT00090220|58756875|FG000|Extension 1 (EXT1)|Other reason|0|||
30746308|NCT00090220|58756876|FG001|Extension 1 (EXT1)|Other reason|0|||
30746309|NCT00090220|58756877|FG002|Extension 1 (EXT1)|Other reason|2|||
30746310|NCT00090220|58756878|FG003|Extension 1 (EXT1)|Other reason|0|||
30746311|NCT00090220|58756879|FG004|Extension 1 (EXT1)|Other reason|0|||
30746312|NCT00090220|58756880|FG005|Extension 1 (EXT1)|Other reason|0|||
30746313|NCT00090220|58756875|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
30746314|NCT00090220|58756876|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
30746315|NCT00090220|58756877|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
30746316|NCT00090220|58756878|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
30746317|NCT00090220|58756879|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
30746318|NCT00090220|58756880|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
30746319|NCT00090220|58756875|FG000|Long-term Follow-up (EXT2)|Death|0|||
30746320|NCT00090220|58756876|FG001|Long-term Follow-up (EXT2)|Death|0|||
30746321|NCT00090220|58756877|FG002|Long-term Follow-up (EXT2)|Death|0|||
30746322|NCT00090220|58756878|FG003|Long-term Follow-up (EXT2)|Death|0|||
30746323|NCT00090220|58756879|FG004|Long-term Follow-up (EXT2)|Death|1|||
30796326|NCT03445065|58810262|FG001|Overall Study|Withdrawal by Subject|6|||
30796327|NCT03445065|58810263|FG002|Overall Study|Withdrawal by Subject|2|||
30904569|NCT02009163|58938854|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
30904570|NCT02009163|58938852|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
30904571|NCT02009163|58938853|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
30904572|NCT02009163|58938854|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
30904573|NCT02009163|58938852|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
30622163|NCT01132326|58633668|FG000|Overall Study|Study Termination|80|||
30746324|NCT00090220|58756880|FG005|Long-term Follow-up (EXT2)|Death|1|||
30796328|NCT03445065|58810264|FG003|Overall Study|Withdrawal by Subject|2|||
30796329|NCT03445065|58810261|FG000|Overall Study|Other|4|||
30796330|NCT03445065|58810262|FG001|Overall Study|Other|3|||
30904574|NCT02009163|58938853|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
30904575|NCT02009163|58938854|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
30904576|NCT02009163|58938852|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
30904577|NCT02009163|58938853|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
30904578|NCT02009163|58938854|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
30904579|NCT02009163|58938852|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
30904580|NCT02009163|58938853|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
30904581|NCT02009163|58938854|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
30904582|NCT02009163|58938852|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
30904583|NCT02009163|58938853|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
30904584|NCT02009163|58938854|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
30904585|NCT02009163|58938852|FG000|Open-label Period (Non-randomized)|Other|13|||
30904586|NCT02009163|58938853|FG001|Open-label Period (Non-randomized)|Other|0|||
30904587|NCT02009163|58938854|FG002|Open-label Period (Non-randomized)|Other|0|||
30904588|NCT02009163|58938852|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
30904589|NCT02009163|58938853|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
30904590|NCT02009163|58938854|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
30904591|NCT02009163|58938852|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
30904592|NCT02009163|58938853|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
30904593|NCT02009163|58938854|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
30796331|NCT03445065|58810263|FG002|Overall Study|Other|3|||
30796332|NCT03445065|58810264|FG003|Overall Study|Other|1|||
30796333|NCT01224106|58810289|FG000|Double-Blind Treatment Phase|Death|3|||
30796334|NCT01224106|58810290|FG001|Double-Blind Treatment Phase|Death|0|||
30904594|NCT02009163|58938852|FG000|Randomized-withdrawal Period|Adverse Event|0|||
30904595|NCT02009163|58938853|FG001|Randomized-withdrawal Period|Adverse Event|0|||
30904596|NCT02009163|58938854|FG002|Randomized-withdrawal Period|Adverse Event|6|||
30904597|NCT02009163|58938852|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
30796335|NCT01224106|58810291|FG002|Double-Blind Treatment Phase|Death|0|||
30796336|NCT01224106|58810292|FG003|Double-Blind Treatment Phase|Death|0|||
30796337|NCT01224106|58810293|FG004|Double-Blind Treatment Phase|Death|0|||
30796338|NCT01224106|58810289|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
30796339|NCT01224106|58810290|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
30796340|NCT01224106|58810291|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
30796341|NCT01224106|58810292|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
30796342|NCT01224106|58810293|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
30796343|NCT01224106|58810289|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
30796344|NCT01224106|58810290|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
30796345|NCT01224106|58810291|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
30796346|NCT01224106|58810292|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
30796347|NCT01224106|58810293|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
30796348|NCT01224106|58810289|FG000|Double-Blind Treatment Phase|Other|0|||
30796349|NCT01224106|58810290|FG001|Double-Blind Treatment Phase|Other|0|||
30796350|NCT01224106|58810291|FG002|Double-Blind Treatment Phase|Other|1|||
30796351|NCT01224106|58810292|FG003|Double-Blind Treatment Phase|Other|0|||
30796352|NCT01224106|58810293|FG004|Double-Blind Treatment Phase|Other|0|||
30796353|NCT01224106|58810289|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
30796354|NCT01224106|58810290|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
30796355|NCT01224106|58810291|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
30796356|NCT01224106|58810292|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
30904598|NCT02009163|58938853|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
30904599|NCT02009163|58938854|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
30746325|NCT00090220|58756875|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
30746326|NCT00090220|58756876|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
30746327|NCT00090220|58756877|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
30746328|NCT00090220|58756878|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
30746329|NCT00090220|58756879|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
30746330|NCT00090220|58756880|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
30746331|NCT00090220|58756875|FG000|Long-term Follow-up (EXT2)|Other|0|||
30746332|NCT00090220|58756876|FG001|Long-term Follow-up (EXT2)|Other|0|||
30746333|NCT00090220|58756877|FG002|Long-term Follow-up (EXT2)|Other|0|||
30746334|NCT00090220|58756878|FG003|Long-term Follow-up (EXT2)|Other|0|||
30796357|NCT01224106|58810293|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
30796358|NCT01224106|58810289|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
30904600|NCT02009163|58938852|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
30904601|NCT02009163|58938853|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
30796359|NCT01224106|58810290|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
30796360|NCT01224106|58810291|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
30796361|NCT01224106|58810292|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
30796362|NCT01224106|58810293|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
30796363|NCT01224106|58810289|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
30796364|NCT01224106|58810290|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
30796365|NCT01224106|58810291|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
30796366|NCT01224106|58810292|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
30796367|NCT01224106|58810293|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
30796368|NCT01224106|58810289|FG000|Open-Label Extension (OLE) Phase|Death|0|||
30796369|NCT01224106|58810290|FG001|Open-Label Extension (OLE) Phase|Death|0|||
30796370|NCT01224106|58810291|FG002|Open-Label Extension (OLE) Phase|Death|0|||
30796371|NCT01224106|58810292|FG003|Open-Label Extension (OLE) Phase|Death|1|||
30796372|NCT01224106|58810293|FG004|Open-Label Extension (OLE) Phase|Death|3|||
30796373|NCT01224106|58810289|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
30796374|NCT01224106|58810290|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
30796375|NCT01224106|58810291|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
30796376|NCT01224106|58810292|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
30796377|NCT01224106|58810293|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
30796378|NCT01224106|58810289|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
30796379|NCT01224106|58810290|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
30796380|NCT01224106|58810291|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
30622164|NCT01132326|58633668|FG000|Overall Study|Declining Health|1|||
30622165|NCT01132326|58633668|FG000|Overall Study|Pregnancy|1|||
30622166|NCT01132326|58633668|FG000|Overall Study|Caregiver Withdrew Consent|1|||
30622167|NCT01132326|58633668|FG000|Overall Study|Death|5|||
30622168|NCT01132326|58633668|FG000|Overall Study|Subject Unable to Come To Visits|1|||
30622169|NCT01178411|58633672|FG000|Overall Study|Adverse Event|5|||
30622170|NCT01178411|58633672|FG000|Overall Study|Withdrawal by Subject|4|||
30746335|NCT00090220|58756879|FG004|Long-term Follow-up (EXT2)|Other|1|||
30746336|NCT00090220|58756880|FG005|Long-term Follow-up (EXT2)|Other|0|||
30796381|NCT01224106|58810292|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
30796382|NCT01224106|58810293|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
30796383|NCT01224106|58810289|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
30796384|NCT01224106|58810290|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
30796385|NCT01224106|58810291|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
30796386|NCT01224106|58810292|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
30796387|NCT01224106|58810293|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
30904602|NCT02009163|58938854|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
30904603|NCT02009163|58938852|FG000|Randomized-withdrawal Period|Pregnancy|0|||
30904604|NCT02009163|58938853|FG001|Randomized-withdrawal Period|Pregnancy|0|||
30904605|NCT02009163|58938854|FG002|Randomized-withdrawal Period|Pregnancy|2|||
30904606|NCT02009163|58938852|FG000|Randomized-withdrawal Period|Other|0|||
30746337|NCT00263328|58756900|FG000|Overall Study|Death|0|||
30746338|NCT00263328|58756901|FG001|Overall Study|Death|0|||
30746339|NCT00263328|58756902|FG002|Overall Study|Death|1|||
30746340|NCT00263328|58756900|FG000|Overall Study|Lost to Follow-up|1|||
30746341|NCT00263328|58756901|FG001|Overall Study|Lost to Follow-up|1|||
30746342|NCT00263328|58756902|FG002|Overall Study|Lost to Follow-up|0|||
30746343|NCT00263328|58756900|FG000|Overall Study|Withdrawal by Subject|3|||
30746344|NCT00263328|58756901|FG001|Overall Study|Withdrawal by Subject|0|||
30746345|NCT00263328|58756902|FG002|Overall Study|Withdrawal by Subject|1|||
30746346|NCT00263328|58756900|FG000|Overall Study|Other|3|||
30746347|NCT00263328|58756901|FG001|Overall Study|Other|0|||
30746348|NCT00263328|58756902|FG002|Overall Study|Other|1|||
30746349|NCT00263328|58756900|FG000|Overall Study|Adverse Event|1|||
30746350|NCT00263328|58756901|FG001|Overall Study|Adverse Event|1|||
30746351|NCT00263328|58756902|FG002|Overall Study|Adverse Event|4|||
30746352|NCT00262860|58756912|FG000|Overall Study|Adverse Event|2|||
30796388|NCT01224106|58810289|FG000|Open-Label Extension (OLE) Phase|Other|0|||
30904607|NCT02009163|58938853|FG001|Randomized-withdrawal Period|Other|9|||
30622171|NCT01178411|58633672|FG000|Overall Study|Protocol Violation|1|||
30622172|NCT01178411|58633672|FG000|Overall Study|Progressive disease per RECIST|32|||
30746353|NCT00236184|58756918|FG000|Overall Study|Adverse Event|5|||
30746354|NCT00236184|58756919|FG001|Overall Study|Adverse Event|2|||
30746355|NCT00236184|58756918|FG000|Overall Study|Lack of Efficacy|0|||
30746356|NCT00236184|58756919|FG001|Overall Study|Lack of Efficacy|1|||
30746357|NCT00236184|58756918|FG000|Overall Study|Lost to Follow-up|3|||
30796389|NCT01224106|58810290|FG001|Open-Label Extension (OLE) Phase|Other|0|||
30796390|NCT01224106|58810291|FG002|Open-Label Extension (OLE) Phase|Other|0|||
30796391|NCT01224106|58810292|FG003|Open-Label Extension (OLE) Phase|Other|5|||
30796392|NCT01224106|58810293|FG004|Open-Label Extension (OLE) Phase|Other|3|||
30796393|NCT03409107|58810313|FG000|Overall Study|Withdrawal by Subject|4|||
30796394|NCT03409107|58810314|FG001|Overall Study|Withdrawal by Subject|2|||
30796395|NCT03409107|58810313|FG000|Overall Study|Physician Decision|1|||
30796396|NCT03409107|58810314|FG001|Overall Study|Physician Decision|0|||
30746358|NCT00236184|58756919|FG001|Overall Study|Lost to Follow-up|4|||
30746359|NCT00236184|58756918|FG000|Overall Study|Physician Decision|1|||
30746360|NCT00236184|58756919|FG001|Overall Study|Physician Decision|1|||
30746361|NCT00236184|58756918|FG000|Overall Study|Withdrawal by Subject|3|||
30796397|NCT03409107|58810313|FG000|Overall Study|Lost to Follow-up|7|||
30796398|NCT03409107|58810314|FG001|Overall Study|Lost to Follow-up|2|||
30796399|NCT03409107|58810313|FG000|Overall Study|Adverse Event|5|||
30622173|NCT01178411|58633672|FG000|Overall Study|Progressive disease per clinician|9|||
30746362|NCT00236184|58756919|FG001|Overall Study|Withdrawal by Subject|0|||
30746363|NCT00236184|58756918|FG000|Overall Study|Protocol Violation|3|||
30746364|NCT00236184|58756919|FG001|Overall Study|Protocol Violation|0|||
30796400|NCT03409107|58810314|FG001|Overall Study|Adverse Event|3|||
30796401|NCT03408873|58810328|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
30796402|NCT03408873|58810328|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
30796403|NCT03408873|58810328|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
30796404|NCT03408873|58810328|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
30796405|NCT03408873|58810328|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
30796406|NCT03408873|58810328|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
30796407|NCT03780959|58810335|FG000|Part 1|Adverse Event|1|||
30796408|NCT03780959|58810336|FG001|Part 1|Adverse Event|0|||
30796409|NCT03780959|58810337|FG002|Part 1|Adverse Event|0|||
30796410|NCT03780959|58810335|FG000|Part 1|Withdrawal by Subject|1|||
30796411|NCT03780959|58810336|FG001|Part 1|Withdrawal by Subject|0|||
30796412|NCT03780959|58810337|FG002|Part 1|Withdrawal by Subject|0|||
30796413|NCT03780959|58810335|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
30796414|NCT03780959|58810336|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
30796415|NCT03780959|58810337|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
30796416|NCT03780959|58810335|FG000|Part 1|Response Status|2|||
30796417|NCT03780959|58810336|FG001|Part 1|Response Status|0|||
30796418|NCT03780959|58810337|FG002|Part 1|Response Status|0|||
30796419|NCT03780959|58810335|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
30796420|NCT03780959|58810336|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
30796421|NCT03780959|58810337|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
30796422|NCT03780959|58810335|FG000|Part 2|Response Status|0|||
30796423|NCT03780959|58810336|FG001|Part 2|Response Status|18|||
30796424|NCT03780959|58810337|FG002|Part 2|Response Status|6|||
30796425|NCT03408639|58810349|FG000|Overall Study|Death|5|||
30796426|NCT03408639|58810350|FG001|Overall Study|Death|5|||
30796427|NCT03408639|58810349|FG000|Overall Study|Lost to Follow-up|1|||
30796428|NCT03408639|58810350|FG001|Overall Study|Lost to Follow-up|4|||
30796429|NCT03408639|58810349|FG000|Overall Study|Withdrawal by Subject|2|||
30796430|NCT03408639|58810350|FG001|Overall Study|Withdrawal by Subject|7|||
30796431|NCT03408639|58810349|FG000|Overall Study|Physician Decision|3|||
30746365|NCT00236184|58756918|FG000|Overall Study|non-compliance with study drug|2|||
30746366|NCT00236184|58756919|FG001|Overall Study|non-compliance with study drug|1|||
30746367|NCT00236184|58756918|FG000|Overall Study|other|1|||
30746368|NCT00236184|58756919|FG001|Overall Study|other|2|||
30746369|NCT00296504|58756933|FG000|Interim Analysis|Withdrawal by Subject|8|||
30746370|NCT00296504|58756934|FG001|Interim Analysis|Withdrawal by Subject|0|||
30796432|NCT03408639|58810350|FG001|Overall Study|Physician Decision|6|||
30746371|NCT00296504|58756935|FG002|Interim Analysis|Withdrawal by Subject|12|||
30796433|NCT03810235|58810358|FG000|Overall Study|Withdrawal by Subject|2|||
30796434|NCT03810235|58810359|FG001|Overall Study|Withdrawal by Subject|0|||
30796435|NCT03408483|58810368|FG000|Overall Study|Physician Decision|3|||
30796436|NCT03408483|58810369|FG001|Overall Study|Physician Decision|3|||
30746372|NCT00296504|58756936|FG003|Interim Analysis|Withdrawal by Subject|0|||
30746373|NCT00296504|58756937|FG004|Interim Analysis|Withdrawal by Subject|5|||
30746374|NCT00296504|58756938|FG005|Interim Analysis|Withdrawal by Subject|5|||
30796437|NCT03408483|58810368|FG000|Overall Study|Lost to Follow-up|3|||
30796438|NCT03408483|58810369|FG001|Overall Study|Lost to Follow-up|0|||
30796439|NCT03777917|58810377|FG000|Overall Study|Withdrawal by Subject|1|||
30796440|NCT03777917|58810378|FG001|Overall Study|Withdrawal by Subject|0|||
30796441|NCT03777917|58810377|FG000|Overall Study|Physician Decision|1|||
30796442|NCT03777917|58810378|FG001|Overall Study|Physician Decision|0|||
30796443|NCT03777917|58810377|FG000|Overall Study|Lost to Follow-up|6|||
30796444|NCT03777917|58810378|FG001|Overall Study|Lost to Follow-up|2|||
30796445|NCT03777917|58810377|FG000|Overall Study|Other|1|||
30796446|NCT03777917|58810378|FG001|Overall Study|Other|0|||
30796447|NCT03777059|58810389|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
30796448|NCT03777059|58810390|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
30796449|NCT03777059|58810391|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
30796450|NCT03777059|58810392|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
30796451|NCT03777059|58810389|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
30796452|NCT03777059|58810390|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
30796453|NCT03777059|58810391|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
30796454|NCT03777059|58810392|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
30796455|NCT03777059|58810389|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
30796456|NCT03777059|58810390|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
30796457|NCT03777059|58810391|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
30796458|NCT03777059|58810392|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
30796459|NCT03777059|58810389|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
30796460|NCT03777059|58810390|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
30796461|NCT03777059|58810391|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
30796462|NCT03777059|58810392|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
30796463|NCT03777059|58810389|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
30796464|NCT03777059|58810390|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
30796465|NCT03777059|58810391|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
30796466|NCT03777059|58810392|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
30796467|NCT03777059|58810389|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
30796468|NCT03777059|58810390|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
30796469|NCT03777059|58810391|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
30796470|NCT03777059|58810392|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
30796471|NCT03777059|58810389|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
30796472|NCT03777059|58810390|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
30796473|NCT03777059|58810391|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
30796474|NCT03777059|58810392|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
30796475|NCT03777059|58810389|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
30796476|NCT03777059|58810390|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
30796477|NCT03777059|58810391|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
30796478|NCT03777059|58810392|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
30796479|NCT03777059|58810389|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
30796480|NCT03777059|58810390|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
30746375|NCT00296504|58756939|FG006|Interim Analysis|Withdrawal by Subject|9|||
30746376|NCT00296504|58756940|FG007|Interim Analysis|Withdrawal by Subject|3|||
30746377|NCT00296504|58756941|FG008|Interim Analysis|Withdrawal by Subject|0|||
30746378|NCT00296504|58756933|FG000|Interim Analysis|Lost to Follow-up|13|||
30746379|NCT00296504|58756934|FG001|Interim Analysis|Lost to Follow-up|3|||
30746380|NCT00296504|58756935|FG002|Interim Analysis|Lost to Follow-up|26|||
30746381|NCT00296504|58756936|FG003|Interim Analysis|Lost to Follow-up|8|||
30746382|NCT00296504|58756937|FG004|Interim Analysis|Lost to Follow-up|14|||
30746383|NCT00296504|58756938|FG005|Interim Analysis|Lost to Follow-up|4|||
30746384|NCT00296504|58756939|FG006|Interim Analysis|Lost to Follow-up|11|||
30746385|NCT00296504|58756940|FG007|Interim Analysis|Lost to Follow-up|4|||
30746386|NCT00296504|58756941|FG008|Interim Analysis|Lost to Follow-up|0|||
30746387|NCT00296504|58756933|FG000|Interim Analysis|Clinical Progression|1|||
30746388|NCT00296504|58756934|FG001|Interim Analysis|Clinical Progression|0|||
30746389|NCT00296504|58756935|FG002|Interim Analysis|Clinical Progression|1|||
30746390|NCT00296504|58756936|FG003|Interim Analysis|Clinical Progression|1|||
30746391|NCT00296504|58756937|FG004|Interim Analysis|Clinical Progression|0|||
30746392|NCT00296504|58756938|FG005|Interim Analysis|Clinical Progression|2|||
30746393|NCT00296504|58756939|FG006|Interim Analysis|Clinical Progression|1|||
30746394|NCT00296504|58756940|FG007|Interim Analysis|Clinical Progression|2|||
30746395|NCT00296504|58756941|FG008|Interim Analysis|Clinical Progression|0|||
30746396|NCT00296504|58756933|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
30746397|NCT00296504|58756934|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
30746398|NCT00296504|58756935|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
30746399|NCT00296504|58756936|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
30796481|NCT03777059|58810391|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
30796482|NCT03777059|58810392|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
30796483|NCT03777059|58810389|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
30796484|NCT03777059|58810390|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
30796485|NCT03777059|58810391|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
30796486|NCT03777059|58810392|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
30904608|NCT02009163|58938854|FG002|Randomized-withdrawal Period|Other|5|||
30904609|NCT01983969|58938867|FG000|Overall Study|Disease Progression|0|||
30904610|NCT01983969|58938868|FG001|Overall Study|Disease Progression|1|||
30904611|NCT01983969|58938869|FG002|Overall Study|Disease Progression|0|||
30904612|NCT02008773|58938885|FG000|Overall Study|Adverse Event|3|||
30904613|NCT02008773|58938886|FG001|Overall Study|Adverse Event|3|||
30904614|NCT02008773|58938887|FG002|Overall Study|Adverse Event|1|||
30904615|NCT02008773|58938888|FG003|Overall Study|Adverse Event|2|||
30904616|NCT02008773|58938885|FG000|Overall Study|Medication Non-compliance|2|||
30904617|NCT02008773|58938886|FG001|Overall Study|Medication Non-compliance|1|||
30904618|NCT02008773|58938887|FG002|Overall Study|Medication Non-compliance|3|||
30904619|NCT02008773|58938888|FG003|Overall Study|Medication Non-compliance|2|||
30904620|NCT02008773|58938885|FG000|Overall Study|Withdrawal by Subject|8|||
30904621|NCT02008773|58938886|FG001|Overall Study|Withdrawal by Subject|4|||
30904622|NCT02008773|58938887|FG002|Overall Study|Withdrawal by Subject|7|||
30904623|NCT02008773|58938888|FG003|Overall Study|Withdrawal by Subject|6|||
30904624|NCT02008773|58938885|FG000|Overall Study|Lost to Follow-up|0|||
30904625|NCT02008773|58938886|FG001|Overall Study|Lost to Follow-up|1|||
30746400|NCT00296504|58756937|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
30746401|NCT00296504|58756938|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
30746402|NCT00296504|58756939|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
30746403|NCT00296504|58756940|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
30746404|NCT00296504|58756941|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
30746405|NCT00296504|58756933|FG000|Interim Analysis|Adverse Event|0|||
30746406|NCT00296504|58756934|FG001|Interim Analysis|Adverse Event|0|||
30746407|NCT00296504|58756935|FG002|Interim Analysis|Adverse Event|13|||
30746408|NCT00296504|58756936|FG003|Interim Analysis|Adverse Event|4|||
30746409|NCT00296504|58756937|FG004|Interim Analysis|Adverse Event|6|||
30746410|NCT00296504|58756938|FG005|Interim Analysis|Adverse Event|3|||
30746411|NCT00296504|58756939|FG006|Interim Analysis|Adverse Event|4|||
30746412|NCT00296504|58756940|FG007|Interim Analysis|Adverse Event|5|||
30746413|NCT00296504|58756941|FG008|Interim Analysis|Adverse Event|0|||
30746414|NCT00296504|58756933|FG000|Interim Analysis|Protocol Violation|0|||
30746415|NCT00296504|58756934|FG001|Interim Analysis|Protocol Violation|0|||
30746416|NCT00296504|58756935|FG002|Interim Analysis|Protocol Violation|2|||
30746417|NCT00296504|58756936|FG003|Interim Analysis|Protocol Violation|0|||
30746418|NCT00296504|58756937|FG004|Interim Analysis|Protocol Violation|1|||
30746419|NCT00296504|58756938|FG005|Interim Analysis|Protocol Violation|0|||
30746420|NCT00296504|58756939|FG006|Interim Analysis|Protocol Violation|0|||
30746421|NCT00296504|58756940|FG007|Interim Analysis|Protocol Violation|1|||
30746422|NCT00296504|58756941|FG008|Interim Analysis|Protocol Violation|0|||
30746423|NCT00296504|58756933|FG000|Interim Analysis|Insufficient CD4 Response|0|||
30904626|NCT02008773|58938887|FG002|Overall Study|Lost to Follow-up|3|||
30904627|NCT02008773|58938888|FG003|Overall Study|Lost to Follow-up|2|||
30904628|NCT02257567|58938907|FG000|Overall Study|Adverse Event|0|||
30904629|NCT02257567|58938908|FG001|Overall Study|Adverse Event|0|||
30904630|NCT02257567|58938909|FG002|Overall Study|Adverse Event|0|||
30904631|NCT02257567|58938910|FG003|Overall Study|Adverse Event|1|||
30796487|NCT03777059|58810389|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
30796488|NCT03777059|58810390|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
30796489|NCT03777059|58810391|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
30796490|NCT03777059|58810392|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
30796491|NCT03100058|58810411|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
30796492|NCT03100058|58810412|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
30796493|NCT03100058|58810413|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
30796494|NCT03100058|58810414|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
30796495|NCT03100058|58810415|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
30796496|NCT03100058|58810416|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
30796497|NCT03100058|58810417|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
30796498|NCT03100058|58810418|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
30796499|NCT03100058|58810419|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
30796500|NCT03100058|58810420|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
30796501|NCT03100058|58810421|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
30796502|NCT03100058|58810422|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
30796503|NCT03100058|58810423|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
30796504|NCT03100058|58810411|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
30796505|NCT03100058|58810412|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
30796506|NCT03100058|58810413|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
30796507|NCT03100058|58810414|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
30796508|NCT03100058|58810415|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
30796509|NCT03100058|58810416|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
30796510|NCT03100058|58810417|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
30796511|NCT03100058|58810418|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
30796512|NCT03100058|58810419|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
30796513|NCT03100058|58810420|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
30796514|NCT03100058|58810421|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
30796515|NCT03100058|58810422|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
30796516|NCT03100058|58810423|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
30796517|NCT03100058|58810411|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
30796518|NCT03100058|58810412|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
30796519|NCT03100058|58810413|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
30796520|NCT03100058|58810414|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
30796521|NCT03100058|58810415|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
30796522|NCT03100058|58810416|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
30904632|NCT02257567|58938911|FG004|Overall Study|Adverse Event|1|||
30904633|NCT02257567|58938912|FG005|Overall Study|Adverse Event|0|||
30904634|NCT02257567|58938913|FG006|Overall Study|Adverse Event|0|||
30904635|NCT02257567|58938914|FG007|Overall Study|Adverse Event|0|||
30904636|NCT02257567|58938915|FG008|Overall Study|Adverse Event|1|||
30796523|NCT03100058|58810417|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
30796524|NCT03100058|58810418|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
30796525|NCT03100058|58810419|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
30796526|NCT03100058|58810420|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
30796527|NCT03100058|58810421|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
30796528|NCT03100058|58810422|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
30796529|NCT03100058|58810423|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
30796530|NCT03100058|58810411|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
30796531|NCT03100058|58810412|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
30796532|NCT03100058|58810413|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
30796533|NCT03100058|58810414|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
30796534|NCT03100058|58810415|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
30796535|NCT03100058|58810416|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
30796536|NCT03100058|58810417|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
30796537|NCT03100058|58810418|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
30796538|NCT03100058|58810419|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
30904637|NCT02257567|58938916|FG009|Overall Study|Adverse Event|0|||
30904638|NCT02257567|58938917|FG010|Overall Study|Adverse Event|0|||
30904639|NCT02257567|58938907|FG000|Overall Study|Death|2|||
30904640|NCT02257567|58938908|FG001|Overall Study|Death|2|||
30796539|NCT03100058|58810420|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
30796540|NCT03100058|58810421|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
30796541|NCT03100058|58810422|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
30796542|NCT03100058|58810423|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
30796543|NCT03100058|58810411|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
30796544|NCT03100058|58810412|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
30796545|NCT03100058|58810413|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
30796546|NCT03100058|58810414|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
30796547|NCT03100058|58810415|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
30796548|NCT03100058|58810416|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
30796549|NCT03100058|58810417|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
30796550|NCT03100058|58810418|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
30796551|NCT03100058|58810419|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
30796552|NCT03100058|58810420|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
30796553|NCT03100058|58810421|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
30796554|NCT03100058|58810422|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
30796555|NCT03100058|58810423|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
30796556|NCT03100058|58810411|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
30796557|NCT03100058|58810412|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
30796558|NCT03100058|58810413|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
30796559|NCT03100058|58810414|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
30796560|NCT03100058|58810415|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
30796561|NCT03100058|58810416|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
30796562|NCT03100058|58810417|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
30796563|NCT03100058|58810418|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
30796564|NCT03100058|58810419|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
30796565|NCT03100058|58810420|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
30796566|NCT03100058|58810421|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
30796567|NCT03100058|58810422|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
30796568|NCT03100058|58810423|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
30796569|NCT03100058|58810411|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796570|NCT03100058|58810412|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
30796571|NCT03100058|58810413|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796572|NCT03100058|58810414|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796573|NCT03100058|58810415|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796574|NCT03100058|58810416|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796575|NCT03100058|58810417|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796576|NCT03100058|58810418|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796577|NCT03100058|58810419|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796578|NCT03100058|58810420|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796579|NCT03100058|58810421|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796580|NCT03100058|58810422|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796581|NCT03100058|58810423|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
30796582|NCT03100058|58810411|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
30796583|NCT03100058|58810412|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796584|NCT03100058|58810413|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796585|NCT03100058|58810414|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796586|NCT03100058|58810415|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796587|NCT03100058|58810416|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796588|NCT03100058|58810417|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796589|NCT03100058|58810418|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796590|NCT03100058|58810419|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796591|NCT03100058|58810420|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796592|NCT03100058|58810421|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796593|NCT03100058|58810422|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796594|NCT03100058|58810423|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
30796595|NCT03100058|58810411|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796596|NCT03100058|58810412|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796597|NCT03100058|58810413|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796598|NCT03100058|58810414|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796599|NCT03100058|58810415|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796600|NCT03100058|58810416|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796601|NCT03100058|58810417|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
30796602|NCT03100058|58810418|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796603|NCT03100058|58810419|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796604|NCT03100058|58810420|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796605|NCT03100058|58810421|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796606|NCT03100058|58810422|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796607|NCT03100058|58810423|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
30796608|NCT03100058|58810411|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
30796609|NCT03100058|58810412|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
30796610|NCT03100058|58810413|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
30796611|NCT03100058|58810414|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
30796612|NCT03100058|58810415|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
30796613|NCT03100058|58810416|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
30796614|NCT03100058|58810417|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
30796615|NCT03100058|58810418|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
30796616|NCT03100058|58810419|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
30796617|NCT03100058|58810420|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
30796618|NCT03100058|58810421|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
30796619|NCT03100058|58810422|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
30796620|NCT03100058|58810423|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
30796621|NCT03100058|58810411|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
30796622|NCT03100058|58810412|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
30796623|NCT03100058|58810413|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
30796624|NCT03100058|58810414|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
30796625|NCT03100058|58810415|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
30904641|NCT02257567|58938909|FG002|Overall Study|Death|2|||
30904642|NCT02257567|58938910|FG003|Overall Study|Death|4|||
30904643|NCT02257567|58938911|FG004|Overall Study|Death|15|||
30904644|NCT02257567|58938912|FG005|Overall Study|Death|11|||
30904645|NCT02257567|58938913|FG006|Overall Study|Death|26|||
30904646|NCT02257567|58938914|FG007|Overall Study|Death|30|||
30904647|NCT02257567|58938915|FG008|Overall Study|Death|2|||
30904648|NCT02257567|58938916|FG009|Overall Study|Death|18|||
30904649|NCT02257567|58938917|FG010|Overall Study|Death|65|||
30904650|NCT02257567|58938907|FG000|Overall Study|Lost to Follow-up|0|||
30904651|NCT02257567|58938908|FG001|Overall Study|Lost to Follow-up|0|||
30904652|NCT02257567|58938909|FG002|Overall Study|Lost to Follow-up|0|||
30904653|NCT02257567|58938910|FG003|Overall Study|Lost to Follow-up|0|||
30904654|NCT02257567|58938911|FG004|Overall Study|Lost to Follow-up|2|||
30904655|NCT02257567|58938912|FG005|Overall Study|Lost to Follow-up|2|||
30904656|NCT02257567|58938913|FG006|Overall Study|Lost to Follow-up|0|||
30904657|NCT02257567|58938914|FG007|Overall Study|Lost to Follow-up|0|||
30904658|NCT02257567|58938915|FG008|Overall Study|Lost to Follow-up|0|||
30904659|NCT02257567|58938916|FG009|Overall Study|Lost to Follow-up|1|||
30904660|NCT02257567|58938917|FG010|Overall Study|Lost to Follow-up|1|||
30904661|NCT02257567|58938907|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
30904662|NCT02257567|58938908|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
30904663|NCT02257567|58938909|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
30904664|NCT02257567|58938910|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
30904665|NCT02257567|58938911|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
30904666|NCT02257567|58938912|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
30746424|NCT00296504|58756934|FG001|Interim Analysis|Insufficient CD4 Response|0|||
30746425|NCT00296504|58756935|FG002|Interim Analysis|Insufficient CD4 Response|0|||
30746426|NCT00296504|58756936|FG003|Interim Analysis|Insufficient CD4 Response|0|||
30746427|NCT00296504|58756937|FG004|Interim Analysis|Insufficient CD4 Response|1|||
30746428|NCT00296504|58756938|FG005|Interim Analysis|Insufficient CD4 Response|1|||
30746429|NCT00296504|58756939|FG006|Interim Analysis|Insufficient CD4 Response|0|||
30746430|NCT00296504|58756940|FG007|Interim Analysis|Insufficient CD4 Response|0|||
30746431|NCT00296504|58756941|FG008|Interim Analysis|Insufficient CD4 Response|0|||
30746432|NCT00296504|58756933|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
30746433|NCT00296504|58756934|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
30746434|NCT00296504|58756935|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
30746435|NCT00296504|58756936|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
30746436|NCT00296504|58756937|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
30746437|NCT00296504|58756938|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
30746438|NCT00296504|58756939|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
30746439|NCT00296504|58756940|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
30746440|NCT00296504|58756941|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
30746441|NCT00296504|58756933|FG000|Interim Analysis|Pregnancy|4|||
30746442|NCT00296504|58756934|FG001|Interim Analysis|Pregnancy|1|||
30746443|NCT00296504|58756935|FG002|Interim Analysis|Pregnancy|4|||
30746444|NCT00296504|58756936|FG003|Interim Analysis|Pregnancy|2|||
30746445|NCT00296504|58756937|FG004|Interim Analysis|Pregnancy|0|||
30796626|NCT03100058|58810416|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
30796627|NCT03100058|58810417|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
30796628|NCT03100058|58810418|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
30796629|NCT03100058|58810419|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
30796630|NCT03100058|58810420|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
30796631|NCT03100058|58810421|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
30796632|NCT03100058|58810422|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
30796633|NCT03100058|58810423|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
30796634|NCT03100058|58810411|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
30796635|NCT03100058|58810412|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
30796636|NCT03100058|58810413|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
30796637|NCT03100058|58810414|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
30796638|NCT03100058|58810415|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
30796639|NCT03100058|58810416|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
30796640|NCT03100058|58810417|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
30796641|NCT03100058|58810418|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
30796642|NCT03100058|58810419|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
30796643|NCT03100058|58810420|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
30796644|NCT03100058|58810421|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
30796645|NCT03100058|58810422|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
30796646|NCT03100058|58810423|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
30796647|NCT03100058|58810411|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30796648|NCT03100058|58810412|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30796649|NCT03100058|58810413|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30796650|NCT03100058|58810414|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30796651|NCT03100058|58810415|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30796652|NCT03100058|58810416|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30796653|NCT03100058|58810417|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30796654|NCT03100058|58810418|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30796655|NCT03100058|58810419|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30796656|NCT03100058|58810420|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30796657|NCT03100058|58810421|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
30796658|NCT03100058|58810422|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30796659|NCT03100058|58810423|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
30904667|NCT02257567|58938913|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
30904668|NCT02257567|58938914|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
30904669|NCT02257567|58938915|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
30796660|NCT03100058|58810411|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796661|NCT03100058|58810412|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796662|NCT03100058|58810413|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796663|NCT03100058|58810414|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796664|NCT03100058|58810415|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796665|NCT03100058|58810416|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796666|NCT03100058|58810417|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796667|NCT03100058|58810418|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796668|NCT03100058|58810419|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796669|NCT03100058|58810420|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796670|NCT03100058|58810421|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796671|NCT03100058|58810422|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
30796672|NCT03100058|58810423|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
30796673|NCT03100058|58810411|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796674|NCT03100058|58810412|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796675|NCT03100058|58810413|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796676|NCT03100058|58810414|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796677|NCT03100058|58810415|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796678|NCT03100058|58810416|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796679|NCT03100058|58810417|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796680|NCT03100058|58810418|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796681|NCT03100058|58810419|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796682|NCT03100058|58810420|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
30796683|NCT03100058|58810421|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796684|NCT03100058|58810422|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796685|NCT03100058|58810423|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
30796686|NCT02871778|58810469|FG000|Part A: Treatment Period 1|Adverse Event|1|||
30796687|NCT02871778|58810470|FG001|Part A: Treatment Period 1|Adverse Event|1|||
30796688|NCT02871778|58810471|FG002|Part A: Treatment Period 1|Adverse Event|1|||
30796689|NCT02871778|58810472|FG003|Part A: Treatment Period 1|Adverse Event|0|||
30796690|NCT02871778|58810473|FG004|Part A: Treatment Period 1|Adverse Event|0|||
30796691|NCT02871778|58810474|FG005|Part A: Treatment Period 1|Adverse Event|0|||
30796692|NCT02871778|58810475|FG006|Part A: Treatment Period 1|Adverse Event|0|||
30796693|NCT02871778|58810476|FG007|Part A: Treatment Period 1|Adverse Event|0|||
30796694|NCT02871778|58810469|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
30796695|NCT02871778|58810470|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
30796696|NCT02871778|58810471|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
30796697|NCT02871778|58810472|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
30796698|NCT02871778|58810473|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
30796699|NCT02871778|58810474|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
30796700|NCT02871778|58810475|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
30796701|NCT02871778|58810476|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
30796702|NCT02871778|58810469|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
30796703|NCT02871778|58810470|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
30796704|NCT02871778|58810471|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
30796705|NCT02871778|58810472|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
30796706|NCT02871778|58810473|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
30796707|NCT02871778|58810474|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
30796708|NCT02871778|58810475|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
30796709|NCT02871778|58810476|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
30796710|NCT02871778|58810469|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
30796711|NCT02871778|58810470|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
30796712|NCT02871778|58810471|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
30796713|NCT02871778|58810472|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
30796714|NCT02871778|58810473|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
30796715|NCT02871778|58810474|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
30796716|NCT02871778|58810475|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
30796717|NCT02871778|58810476|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
30796718|NCT02871778|58810469|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
30796719|NCT02871778|58810470|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
30796720|NCT02871778|58810471|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
30796721|NCT02871778|58810472|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
30796722|NCT02871778|58810473|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
30796723|NCT02871778|58810474|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
30796724|NCT02871778|58810475|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
30904670|NCT02257567|58938916|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
30904671|NCT02257567|58938917|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
30746446|NCT00296504|58756938|FG005|Interim Analysis|Pregnancy|1|||
30746447|NCT00296504|58756939|FG006|Interim Analysis|Pregnancy|1|||
30746448|NCT00296504|58756940|FG007|Interim Analysis|Pregnancy|1|||
30746449|NCT00296504|58756941|FG008|Interim Analysis|Pregnancy|0|||
30746450|NCT00296504|58756933|FG000|Interim Analysis|Death|1|||
30746451|NCT00296504|58756934|FG001|Interim Analysis|Death|0|||
30746452|NCT00296504|58756935|FG002|Interim Analysis|Death|3|||
30746453|NCT00296504|58756936|FG003|Interim Analysis|Death|0|||
30746454|NCT00296504|58756937|FG004|Interim Analysis|Death|0|||
30746455|NCT00296504|58756938|FG005|Interim Analysis|Death|0|||
30746456|NCT00296504|58756939|FG006|Interim Analysis|Death|0|||
30746457|NCT00296504|58756940|FG007|Interim Analysis|Death|0|||
30746458|NCT00296504|58756941|FG008|Interim Analysis|Death|0|||
30746459|NCT00296504|58756933|FG000|Interim Analysis|Participant Non-compliant|0|||
30746460|NCT00296504|58756934|FG001|Interim Analysis|Participant Non-compliant|1|||
30746461|NCT00296504|58756935|FG002|Interim Analysis|Participant Non-compliant|2|||
30746462|NCT00296504|58756936|FG003|Interim Analysis|Participant Non-compliant|1|||
30746463|NCT00296504|58756937|FG004|Interim Analysis|Participant Non-compliant|1|||
30746464|NCT00296504|58756938|FG005|Interim Analysis|Participant Non-compliant|3|||
30796725|NCT02871778|58810476|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
30796726|NCT02871778|58810469|FG000|Part A: Treatment Period 2|Adverse Event|2|||
30796727|NCT02871778|58810470|FG001|Part A: Treatment Period 2|Adverse Event|2|||
30796728|NCT02871778|58810471|FG002|Part A: Treatment Period 2|Adverse Event|0|||
30796729|NCT02871778|58810472|FG003|Part A: Treatment Period 2|Adverse Event|0|||
30796730|NCT02871778|58810473|FG004|Part A: Treatment Period 2|Adverse Event|0|||
30796731|NCT02871778|58810474|FG005|Part A: Treatment Period 2|Adverse Event|0|||
30796732|NCT02871778|58810475|FG006|Part A: Treatment Period 2|Adverse Event|0|||
30796733|NCT02871778|58810476|FG007|Part A: Treatment Period 2|Adverse Event|0|||
30796734|NCT02871778|58810469|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
30796735|NCT02871778|58810470|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
30796736|NCT02871778|58810471|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
30796737|NCT02871778|58810472|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
30796738|NCT02871778|58810473|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
30796739|NCT02871778|58810474|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
30796740|NCT02871778|58810475|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
30796741|NCT02871778|58810476|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
30796742|NCT02871778|58810469|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
30796743|NCT02871778|58810470|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
30796744|NCT02871778|58810471|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
30796745|NCT02871778|58810472|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
30796746|NCT02871778|58810473|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
30796747|NCT02871778|58810474|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
30796748|NCT02871778|58810475|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
30796749|NCT02871778|58810476|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
30796750|NCT02871778|58810469|FG000|Part B: Treatment Period 3|Adverse Event|0|||
30796751|NCT02871778|58810470|FG001|Part B: Treatment Period 3|Adverse Event|0|||
30796752|NCT02871778|58810471|FG002|Part B: Treatment Period 3|Adverse Event|0|||
30796753|NCT02871778|58810472|FG003|Part B: Treatment Period 3|Adverse Event|0|||
30796754|NCT02871778|58810473|FG004|Part B: Treatment Period 3|Adverse Event|1|||
30796755|NCT02871778|58810474|FG005|Part B: Treatment Period 3|Adverse Event|1|||
30796756|NCT02871778|58810475|FG006|Part B: Treatment Period 3|Adverse Event|1|||
30796757|NCT02871778|58810476|FG007|Part B: Treatment Period 3|Adverse Event|0|||
30843549|NCT02101853|58869612|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
30843550|NCT02101853|58869613|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
30843551|NCT02101853|58869614|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
30843552|NCT02101853|58869615|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
30843553|NCT02101853|58869616|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
30843554|NCT02101853|58869617|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
30843555|NCT02101853|58869612|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
30843556|NCT02101853|58869613|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
30843557|NCT02101853|58869614|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
30843558|NCT02101853|58869615|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
30843559|NCT02101853|58869616|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
30843560|NCT02101853|58869617|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
30843561|NCT02101853|58869612|FG000|Post Induction Randomization|Adverse Event|0|||
30843562|NCT02101853|58869613|FG001|Post Induction Randomization|Adverse Event|3|||
30843563|NCT02101853|58869614|FG002|Post Induction Randomization|Adverse Event|8|||
30843564|NCT02101853|58869615|FG003|Post Induction Randomization|Adverse Event|4|||
30843565|NCT02101853|58869616|FG004|Post Induction Randomization|Adverse Event|4|||
30843566|NCT02101853|58869617|FG005|Post Induction Randomization|Adverse Event|0|||
30843567|NCT02101853|58869612|FG000|Post Induction Randomization|Death|0|||
30904672|NCT02257567|58938907|FG000|Overall Study|Physician Decision|0|||
30904673|NCT02257567|58938908|FG001|Overall Study|Physician Decision|0|||
30904674|NCT02257567|58938909|FG002|Overall Study|Physician Decision|0|||
30904675|NCT02257567|58938910|FG003|Overall Study|Physician Decision|0|||
30904676|NCT02257567|58938911|FG004|Overall Study|Physician Decision|0|||
30904677|NCT02257567|58938912|FG005|Overall Study|Physician Decision|0|||
30904678|NCT02257567|58938913|FG006|Overall Study|Physician Decision|0|||
30904679|NCT02257567|58938914|FG007|Overall Study|Physician Decision|2|||
30904680|NCT02257567|58938915|FG008|Overall Study|Physician Decision|0|||
30904681|NCT02257567|58938916|FG009|Overall Study|Physician Decision|1|||
30904682|NCT02257567|58938917|FG010|Overall Study|Physician Decision|0|||
30904683|NCT02257567|58938907|FG000|Overall Study|Withdrawal by Subject|0|||
30904684|NCT02257567|58938908|FG001|Overall Study|Withdrawal by Subject|0|||
30904685|NCT02257567|58938909|FG002|Overall Study|Withdrawal by Subject|2|||
30904686|NCT02257567|58938910|FG003|Overall Study|Withdrawal by Subject|0|||
30796758|NCT01471444|58810509|FG000|Overall Study|Physician Decision|3|||
30796759|NCT01471444|58810510|FG001|Overall Study|Physician Decision|2|||
30796760|NCT01471444|58810509|FG000|Overall Study|Withdrawal by Subject|0|||
30796761|NCT01471444|58810510|FG001|Overall Study|Withdrawal by Subject|1|||
30796762|NCT03443427|58810528|FG000|Overall Study|Adverse Event|2|||
30796763|NCT03443427|58810529|FG001|Overall Study|Adverse Event|3|||
30796764|NCT03443427|58810528|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
30796765|NCT03443427|58810529|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
30796766|NCT03443427|58810528|FG000|Overall Study|Other|4|||
30796767|NCT03443427|58810529|FG001|Overall Study|Other|6|||
30796768|NCT03417219|58810537|FG000|Overall Study|Lost to Follow-up|0|||
30796769|NCT03417219|58810538|FG001|Overall Study|Lost to Follow-up|3|||
30796770|NCT02953821|58810546|FG000|Overall Study|Adverse Event|0|||
30796771|NCT02953821|58810547|FG001|Overall Study|Adverse Event|4|||
30796772|NCT02953821|58810546|FG000|Overall Study|Death|1|||
30796773|NCT02953821|58810547|FG001|Overall Study|Death|0|||
30796774|NCT02953821|58810546|FG000|Overall Study|Progressive Disease|5|||
30796775|NCT02953821|58810547|FG001|Overall Study|Progressive Disease|1|||
30796776|NCT02953821|58810546|FG000|Overall Study|Lost to Follow-up|2|||
30796777|NCT02953821|58810547|FG001|Overall Study|Lost to Follow-up|0|||
30796778|NCT02953821|58810546|FG000|Overall Study|Physician Decision|1|||
30796779|NCT02953821|58810547|FG001|Overall Study|Physician Decision|1|||
30796780|NCT02953821|58810546|FG000|Overall Study|Withdrawal by Subject|3|||
30796781|NCT02953821|58810547|FG001|Overall Study|Withdrawal by Subject|3|||
30796782|NCT02953821|58810546|FG000|Overall Study|Change of address|0|||
30796783|NCT02953821|58810547|FG001|Overall Study|Change of address|1|||
30796784|NCT02953821|58810546|FG000|Overall Study|Lack of Efficacy|1|||
30796785|NCT02953821|58810547|FG001|Overall Study|Lack of Efficacy|0|||
30796786|NCT02953821|58810546|FG000|Overall Study|Out of state for indeterminate time|0|||
30796787|NCT02953821|58810547|FG001|Overall Study|Out of state for indeterminate time|1|||
30796788|NCT02953821|58810546|FG000|Overall Study|No improvement|0|||
30796789|NCT02953821|58810547|FG001|Overall Study|No improvement|1|||
30796790|NCT02953821|58810546|FG000|Overall Study|Refused follow-up visit|2|||
30796791|NCT02953821|58810547|FG001|Overall Study|Refused follow-up visit|1|||
30796792|NCT03783923|58810557|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
30796793|NCT03783923|58810558|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
30796794|NCT03783923|58810557|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
30796795|NCT03783923|58810558|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
30796796|NCT03783923|58810557|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
30796797|NCT03783923|58810558|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
30796798|NCT03783923|58810557|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
30796799|NCT03783923|58810558|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
30796800|NCT03783923|58810557|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
30904687|NCT02257567|58938911|FG004|Overall Study|Withdrawal by Subject|0|||
30904688|NCT02257567|58938912|FG005|Overall Study|Withdrawal by Subject|6|||
30904689|NCT02257567|58938913|FG006|Overall Study|Withdrawal by Subject|6|||
30904690|NCT02257567|58938914|FG007|Overall Study|Withdrawal by Subject|6|||
30904691|NCT02257567|58938915|FG008|Overall Study|Withdrawal by Subject|1|||
30904692|NCT02257567|58938916|FG009|Overall Study|Withdrawal by Subject|1|||
30904693|NCT02257567|58938917|FG010|Overall Study|Withdrawal by Subject|10|||
30904694|NCT01642615|58938974|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
30904695|NCT01642615|58938975|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
30904696|NCT01642615|58938976|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
30904697|NCT01642615|58938974|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
30904698|NCT01642615|58938975|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
30904699|NCT01642615|58938976|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
30904700|NCT01642615|58938974|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
30904701|NCT01642615|58938975|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
30904702|NCT01642615|58938976|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
30904703|NCT01642615|58938974|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
30904704|NCT01642615|58938975|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
30904705|NCT01642615|58938976|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
30904706|NCT01642615|58938974|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
30904707|NCT01642615|58938975|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
30796801|NCT03783923|58810558|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
30796802|NCT03417141|58810562|FG000|Overall Study|Withdrawal by Subject|1|||
30796803|NCT03417141|58810562|FG000|Overall Study|Protocol Violation|3|||
30904708|NCT01642615|58938976|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
30796804|NCT03724981|58810570|FG000|First Device|Protocol Violation|1|||
30796805|NCT03724981|58810571|FG001|First Device|Protocol Violation|1|||
30796806|NCT03442569|58810579|FG000|Overall Study|Subject was ineligible after enrollment|1|||
30796807|NCT01347879|58810585|FG000|Overall Study|Adverse Event|0|||
30904709|NCT01642615|58938974|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
30904710|NCT01642615|58938975|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
30904711|NCT01642615|58938976|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
30904712|NCT01642615|58938974|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
30904713|NCT01642615|58938975|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
30904714|NCT01642615|58938976|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
30904715|NCT01642615|58938974|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
30904716|NCT01642615|58938975|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
30904717|NCT01642615|58938976|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
30904718|NCT01642615|58938974|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
30904719|NCT01642615|58938975|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
30904720|NCT01642615|58938976|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
30904721|NCT02311361|58938988|FG000|Overall Study|Did not receive treatment|0|||
30904722|NCT02311361|58938989|FG001|Overall Study|Did not receive treatment|1|||
30796808|NCT01347879|58810586|FG001|Overall Study|Adverse Event|12|||
30796809|NCT01347879|58810585|FG000|Overall Study|Lost to Follow-up|2|||
30796810|NCT01347879|58810586|FG001|Overall Study|Lost to Follow-up|0|||
30796811|NCT01347879|58810585|FG000|Overall Study|Withdrawal by Subject|3|||
30796812|NCT01347879|58810586|FG001|Overall Study|Withdrawal by Subject|2|||
30796813|NCT01347879|58810585|FG000|Overall Study|Other|2|||
30796814|NCT01347879|58810586|FG001|Overall Study|Other|3|||
30796815|NCT03441789|58810603|FG000|Overall Study|Withdrawal by Subject|1|||
30796816|NCT03441789|58810604|FG001|Overall Study|Withdrawal by Subject|1|||
30904723|NCT02311361|58938990|FG002|Overall Study|Did not receive treatment|0|||
30904724|NCT02311361|58938991|FG003|Overall Study|Did not receive treatment|1|||
30904725|NCT02352779|58939008|FG000|Overall Study|Personal Issues|1|||
30904726|NCT02352779|58939009|FG001|Overall Study|Personal Issues|1|||
30796817|NCT03441789|58810603|FG000|Overall Study|Adverse Event|0|||
30796818|NCT03441789|58810604|FG001|Overall Study|Adverse Event|1|||
30904727|NCT02352779|58939010|FG002|Overall Study|Personal Issues|0|||
30904728|NCT02352779|58939008|FG000|Overall Study|Too Many Forms|2|||
30904729|NCT02352779|58939009|FG001|Overall Study|Too Many Forms|0|||
30904730|NCT02352779|58939010|FG002|Overall Study|Too Many Forms|0|||
30904731|NCT02352779|58939008|FG000|Overall Study|Feeling Overwhelmed|1|||
30904732|NCT02352779|58939009|FG001|Overall Study|Feeling Overwhelmed|0|||
30904733|NCT02352779|58939010|FG002|Overall Study|Feeling Overwhelmed|0|||
30904734|NCT02352779|58939008|FG000|Overall Study|Disliked Intervention|1|||
30904735|NCT02352779|58939009|FG001|Overall Study|Disliked Intervention|0|||
30904736|NCT02352779|58939010|FG002|Overall Study|Disliked Intervention|0|||
30904737|NCT02352779|58939008|FG000|Overall Study|Changed Mind|1|||
30904738|NCT02352779|58939009|FG001|Overall Study|Changed Mind|0|||
30904739|NCT02352779|58939010|FG002|Overall Study|Changed Mind|0|||
30904740|NCT02352779|58939008|FG000|Overall Study|Study Related Symptoms|1|||
30904741|NCT02352779|58939009|FG001|Overall Study|Study Related Symptoms|0|||
30904742|NCT02352779|58939010|FG002|Overall Study|Study Related Symptoms|0|||
30746465|NCT00296504|58756939|FG006|Interim Analysis|Participant Non-compliant|6|||
30746466|NCT00296504|58756940|FG007|Interim Analysis|Participant Non-compliant|2|||
30746467|NCT00296504|58756941|FG008|Interim Analysis|Participant Non-compliant|0|||
30746468|NCT00296504|58756933|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
30746469|NCT00296504|58756934|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
30746470|NCT00296504|58756935|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
30746471|NCT00296504|58756936|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
30746472|NCT00296504|58756937|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
30746473|NCT00296504|58756938|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
30746474|NCT00296504|58756939|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
30746475|NCT00296504|58756940|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
30746476|NCT00296504|58756941|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
30746477|NCT00296504|58756933|FG000|Interim Analysis|To Simplify Treatment|0|||
30746478|NCT00296504|58756934|FG001|Interim Analysis|To Simplify Treatment|0|||
30746479|NCT00296504|58756935|FG002|Interim Analysis|To Simplify Treatment|1|||
30746480|NCT00296504|58756936|FG003|Interim Analysis|To Simplify Treatment|0|||
30746481|NCT00296504|58756937|FG004|Interim Analysis|To Simplify Treatment|0|||
30904743|NCT02352779|58939008|FG000|Overall Study|Absence of Symptoms|1|||
30904744|NCT02352779|58939009|FG001|Overall Study|Absence of Symptoms|0|||
30904745|NCT02352779|58939010|FG002|Overall Study|Absence of Symptoms|0|||
30904746|NCT02352779|58939008|FG000|Overall Study|Other Medical Reason|0|||
30746482|NCT00296504|58756938|FG005|Interim Analysis|To Simplify Treatment|0|||
30746483|NCT00296504|58756939|FG006|Interim Analysis|To Simplify Treatment|2|||
30746484|NCT00296504|58756940|FG007|Interim Analysis|To Simplify Treatment|0|||
30796819|NCT03441789|58810603|FG000|Overall Study|Protocol Violation|0|||
30796820|NCT03441789|58810604|FG001|Overall Study|Protocol Violation|1|||
30796821|NCT03441789|58810603|FG000|Overall Study|Lost to Follow-up|0|||
30796822|NCT03441789|58810604|FG001|Overall Study|Lost to Follow-up|1|||
30904747|NCT02352779|58939009|FG001|Overall Study|Other Medical Reason|0|||
30904748|NCT02352779|58939010|FG002|Overall Study|Other Medical Reason|1|||
30904749|NCT02352779|58939008|FG000|Overall Study|No Reason|0|||
30904750|NCT02352779|58939009|FG001|Overall Study|No Reason|0|||
30904751|NCT02352779|58939010|FG002|Overall Study|No Reason|1|||
30904752|NCT02257489|58939027|FG000|Overall Study|Withdrawal by Subject|0|||
30904753|NCT02257489|58939028|FG001|Overall Study|Withdrawal by Subject|0|||
30904754|NCT02257489|58939029|FG002|Overall Study|Withdrawal by Subject|0|||
30904755|NCT02257489|58939030|FG003|Overall Study|Withdrawal by Subject|1|||
30904756|NCT02257489|58939031|FG004|Overall Study|Withdrawal by Subject|0|||
30904757|NCT02257489|58939032|FG005|Overall Study|Withdrawal by Subject|0|||
30904758|NCT02257489|58939033|FG006|Overall Study|Withdrawal by Subject|0|||
30904759|NCT02257489|58939034|FG007|Overall Study|Withdrawal by Subject|0|||
30904760|NCT02257489|58939035|FG008|Overall Study|Withdrawal by Subject|0|||
30904761|NCT02329223|58939058|FG000|Overall Study|Withdrawal by Subject|1|||
30904762|NCT02329223|58939059|FG001|Overall Study|Withdrawal by Subject|2|||
30904763|NCT02329223|58939060|FG002|Overall Study|Withdrawal by Subject|5|||
30904764|NCT02329223|58939058|FG000|Overall Study|Physician Decision|0|||
30904765|NCT02329223|58939059|FG001|Overall Study|Physician Decision|0|||
30904766|NCT02329223|58939060|FG002|Overall Study|Physician Decision|1|||
30904767|NCT02329223|58939058|FG000|Overall Study|Adverse Event|0|||
30904768|NCT02329223|58939059|FG001|Overall Study|Adverse Event|1|||
30904769|NCT02329223|58939060|FG002|Overall Study|Adverse Event|0|||
30904770|NCT01641601|58939070|FG000|Overall Study|Study discontinued.|3|||
30904771|NCT01641601|58939071|FG001|Overall Study|Study discontinued.|5|||
30904772|NCT02350127|58939079|FG000|4-Month Assessment|Withdrawal by Subject|10|||
30904773|NCT02350127|58939080|FG001|4-Month Assessment|Withdrawal by Subject|9|||
30904774|NCT02350127|58939079|FG000|4-Month Assessment|Death|1|||
30904775|NCT02350127|58939080|FG001|4-Month Assessment|Death|0|||
30904776|NCT02350127|58939079|FG000|8-Month Assessment|Death|1|||
30904777|NCT02350127|58939080|FG001|8-Month Assessment|Death|1|||
30904778|NCT02350127|58939079|FG000|8-Month Assessment|Withdrawal by Subject|5|||
30904779|NCT02350127|58939080|FG001|8-Month Assessment|Withdrawal by Subject|8|||
30796823|NCT03387735|58810616|FG000|Overall Study|Lost to Follow-up|4|||
30796824|NCT03387735|58810617|FG001|Overall Study|Lost to Follow-up|8|||
30796825|NCT03387735|58810616|FG000|Overall Study|Death|4|||
30796826|NCT03387735|58810617|FG001|Overall Study|Death|8|||
30796827|NCT03439137|58810625|FG000|Overall Study|Adverse Event|16|||
30796828|NCT03439137|58810626|FG001|Overall Study|Adverse Event|12|||
30796829|NCT03439137|58810625|FG000|Overall Study|Physician Decision|0|||
30796830|NCT03439137|58810626|FG001|Overall Study|Physician Decision|5|||
30796831|NCT03439137|58810625|FG000|Overall Study|Withdrawal by Subject|14|||
30796832|NCT03439137|58810626|FG001|Overall Study|Withdrawal by Subject|4|||
30796833|NCT03439137|58810625|FG000|Overall Study|Conducting rescue therapy|2|||
30796834|NCT03439137|58810626|FG001|Overall Study|Conducting rescue therapy|1|||
30796835|NCT03439137|58810625|FG000|Overall Study|Difficult to control Hb|10|||
30796836|NCT03439137|58810626|FG001|Overall Study|Difficult to control Hb|2|||
30796837|NCT03439137|58810625|FG000|Overall Study|Initiation of a renal transplant|0|||
30796838|NCT03439137|58810626|FG001|Overall Study|Initiation of a renal transplant|2|||
30796839|NCT04055090|58810634|FG000|Overall Study|screen failure|1|||
30796840|NCT04055090|58810635|FG001|Overall Study|screen failure|0|||
30796841|NCT04055090|58810634|FG000|Overall Study|Withdrawal by Subject|1|||
30796842|NCT04055090|58810635|FG001|Overall Study|Withdrawal by Subject|0|||
30796843|NCT03403413|58810658|FG000|Overall Study|Lack of Efficacy|2|||
30796844|NCT03354663|58810673|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
30796845|NCT03354663|58810673|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
30796846|NCT03354663|58810673|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
30796847|NCT03354663|58810673|FG000|Completed 30-day Visit|Missed Visit|1|||
30796848|NCT03721705|58810683|FG000|Overall Study|Adverse Event|2|||
30796849|NCT03721705|58810684|FG001|Overall Study|Adverse Event|0|||
30796850|NCT03721705|58810683|FG000|Overall Study|Withdrawal by Subject|4|||
30796851|NCT03721705|58810684|FG001|Overall Study|Withdrawal by Subject|10|||
30796852|NCT03721705|58810683|FG000|Overall Study|No Suitable Study Partner|1|||
30796853|NCT03721705|58810684|FG001|Overall Study|No Suitable Study Partner|0|||
30796854|NCT03721705|58810683|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
30796855|NCT03721705|58810684|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
30796856|NCT03721705|58810683|FG000|Overall Study|Death|0|||
30904780|NCT02256553|58939087|FG000|Period I|Adverse Event|5|||
30904781|NCT02256553|58939087|FG000|Period I|Protocol Violation|1|||
30904782|NCT02256553|58939087|FG000|Period II|Adverse Event|1|||
30904783|NCT02256553|58939087|FG000|Period II|Subject Moved|1|||
30904784|NCT02256553|58939087|FG000|Period III|Adverse Event|3|||
30904785|NCT02349425|58939097|FG000|Period 1|Adverse Event|1|||
30796857|NCT03721705|58810684|FG001|Overall Study|Death|1|||
30796858|NCT03720847|58810690|FG000|Washout|Physician Decision|1|||
30796859|NCT03720847|58810691|FG001|Washout|Physician Decision|2|||
30796860|NCT02631070|58810700|FG000|Overall Study|Withdrawal by Subject|35|||
30796861|NCT02631070|58810701|FG001|Overall Study|Withdrawal by Subject|13|||
30796862|NCT02631070|58810700|FG000|Overall Study|Death|45|||
30796863|NCT02631070|58810701|FG001|Overall Study|Death|24|||
30796864|NCT02631070|58810700|FG000|Overall Study|Lost to Follow-up|5|||
30796865|NCT02631070|58810701|FG001|Overall Study|Lost to Follow-up|1|||
30796866|NCT02631070|58810700|FG000|Overall Study|Transition to rollover protocol|52|||
30796867|NCT02631070|58810701|FG001|Overall Study|Transition to rollover protocol|21|||
30796868|NCT02631070|58810700|FG000|Overall Study|Other reasons|12|||
30796869|NCT02631070|58810701|FG001|Overall Study|Other reasons|5|||
30796870|NCT00741988|58810709|FG000|Overall Study|Adverse Event|2|||
30796871|NCT00741988|58810710|FG001|Overall Study|Adverse Event|4|||
30796872|NCT00741988|58810709|FG000|Overall Study|Lack of Efficacy|2|||
30796873|NCT00741988|58810710|FG001|Overall Study|Lack of Efficacy|0|||
30796874|NCT03354429|58810718|FG000|Overall Study|Withdrawal by Subject|8|||
30796875|NCT03354429|58810719|FG001|Overall Study|Withdrawal by Subject|7|||
30796876|NCT03354429|58810718|FG000|Overall Study|Lost to Follow-up|1|||
30796877|NCT03354429|58810719|FG001|Overall Study|Lost to Follow-up|0|||
30796878|NCT03352713|58810725|FG000|Overall Study|Lost to Follow-up|8|||
30796879|NCT03352713|58810725|FG000|Overall Study|Withdrawn by investigator|5|||
30796880|NCT03352713|58810725|FG000|Overall Study|Completed 0 EMAs|8|||
30796881|NCT03352713|58810725|FG000|Overall Study|Device incompatible/stolen|5|||
30796882|NCT03901144|58810729|FG000|Overall Study|Lost to Follow-up|1|||
30904786|NCT02349425|58939098|FG001|Period 1|Adverse Event|1|||
30904787|NCT02349425|58939099|FG002|Period 1|Adverse Event|0|||
30904788|NCT02349425|58939100|FG003|Period 1|Adverse Event|0|||
30796883|NCT03901144|58810730|FG001|Overall Study|Lost to Follow-up|1|||
30796884|NCT03901144|58810731|FG002|Overall Study|Lost to Follow-up|1|||
30796885|NCT03901144|58810732|FG003|Overall Study|Lost to Follow-up|1|||
30796886|NCT02952261|58810744|FG000|Overall Study|Withdrawal by Subject|4|||
30796887|NCT02952261|58810745|FG001|Overall Study|Withdrawal by Subject|5|||
30796888|NCT02952261|58810744|FG000|Overall Study|Protocol Violation|1|||
30796889|NCT02952261|58810745|FG001|Overall Study|Protocol Violation|0|||
30796890|NCT03384693|58810751|FG000|Overall Study|Adverse Event|3|||
30904789|NCT02349425|58939097|FG000|Period 2|Adverse Event|0|||
30904790|NCT02349425|58939098|FG001|Period 2|Adverse Event|1|||
30904791|NCT02349425|58939099|FG002|Period 2|Adverse Event|1|||
30904792|NCT02349425|58939100|FG003|Period 2|Adverse Event|0|||
30622174|NCT01178411|58633672|FG000|Overall Study|Physician Decision|6|||
30746485|NCT00296504|58756941|FG008|Interim Analysis|To Simplify Treatment|0|||
30746486|NCT00296504|58756933|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
30746487|NCT00296504|58756934|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
30746488|NCT00296504|58756935|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
30746489|NCT00296504|58756936|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
30746490|NCT00296504|58756937|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
30746491|NCT00296504|58756938|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
30746492|NCT00296504|58756939|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
30746493|NCT00296504|58756940|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
30746494|NCT00296504|58756941|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
30746495|NCT00296504|58756933|FG000|Interim Analysis|Participant Moved|1|||
30796891|NCT03718429|58810763|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
30796892|NCT03718429|58810764|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
30796893|NCT03718429|58810765|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
30796894|NCT03718429|58810766|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
30904793|NCT02310581|58939142|FG000|Overall Study|Adverse Event|1|||
30904794|NCT02310581|58939143|FG001|Overall Study|Adverse Event|1|||
30796895|NCT01285102|58810786|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
30796896|NCT03382899|58810820|FG000|Overall Study|Ineligibility Determined|0|||
30796897|NCT03382899|58810821|FG001|Overall Study|Ineligibility Determined|1|||
30796898|NCT03382899|58810820|FG000|Overall Study|Lost to Follow-up|0|||
30796899|NCT03382899|58810821|FG001|Overall Study|Lost to Follow-up|1|||
30796900|NCT03382899|58810820|FG000|Overall Study|Sponsor's decision|31|||
30796901|NCT03382899|58810821|FG001|Overall Study|Sponsor's decision|28|||
30796902|NCT03382899|58810820|FG000|Overall Study|Withdrawal by Subject|0|||
30904795|NCT02310581|58939144|FG002|Overall Study|Adverse Event|1|||
30796903|NCT03382899|58810821|FG001|Overall Study|Withdrawal by Subject|5|||
30796904|NCT00709852|58810827|FG000|Period 1|Adverse Event|2|||
30796905|NCT00709852|58810828|FG001|Period 1|Adverse Event|0|||
30796906|NCT00709852|58810827|FG000|Period 1|Withdrawal by Subject|4|||
30796907|NCT00709852|58810828|FG001|Period 1|Withdrawal by Subject|2|||
30796908|NCT00709852|58810827|FG000|Period 1|Protocol Violation|1|||
30796909|NCT00709852|58810828|FG001|Period 1|Protocol Violation|0|||
30796910|NCT00709852|58810827|FG000|Period 1|Defective scanner|0|||
30796911|NCT00709852|58810828|FG001|Period 1|Defective scanner|1|||
30796912|NCT00709852|58810827|FG000|Period 1|Lost to Follow-up|1|||
30796913|NCT00709852|58810828|FG001|Period 1|Lost to Follow-up|0|||
30796914|NCT00709852|58810827|FG000|Period 2|Protocol Violation|4|||
30904796|NCT02310581|58939145|FG003|Overall Study|Adverse Event|0|||
30904797|NCT02310581|58939142|FG000|Overall Study|Withdrawal by Subject|2|||
30904798|NCT02310581|58939143|FG001|Overall Study|Withdrawal by Subject|1|||
30904799|NCT02310581|58939144|FG002|Overall Study|Withdrawal by Subject|0|||
30904800|NCT02310581|58939145|FG003|Overall Study|Withdrawal by Subject|1|||
30904801|NCT02309723|58939158|FG000|Overall Study|Withdrawal by Subject|24|||
30904802|NCT02309723|58939159|FG001|Overall Study|Withdrawal by Subject|23|||
30904803|NCT02309723|58939160|FG002|Overall Study|Withdrawal by Subject|24|||
30904804|NCT02309411|58939171|FG000|Overall Study|Physician Decision|1|||
30904805|NCT02309411|58939172|FG001|Overall Study|Physician Decision|0|||
30904806|NCT02309411|58939173|FG002|Overall Study|Physician Decision|0|||
30904807|NCT02309411|58939171|FG000|Overall Study|Withdrawal by Subject|1|||
30904808|NCT02309411|58939172|FG001|Overall Study|Withdrawal by Subject|1|||
30904809|NCT02309411|58939173|FG002|Overall Study|Withdrawal by Subject|0|||
30904810|NCT02008227|58939182|FG000|Overall Study|Lost to Follow-up|7|||
30904811|NCT02008227|58939183|FG001|Overall Study|Lost to Follow-up|9|||
30904812|NCT02008227|58939182|FG000|Overall Study|Death|494|||
30796915|NCT00709852|58810828|FG001|Period 2|Protocol Violation|1|||
30796916|NCT00709852|58810827|FG000|Period 2|Adverse Event|1|||
30796917|NCT00709852|58810828|FG001|Period 2|Adverse Event|1|||
30796918|NCT00709852|58810827|FG000|Period 2|Lost to Follow-up|1|||
30796919|NCT00709852|58810828|FG001|Period 2|Lost to Follow-up|0|||
30796920|NCT00709852|58810827|FG000|Period 2|No 72-hour follow-up|3|||
30796921|NCT00709852|58810828|FG001|Period 2|No 72-hour follow-up|0|||
30796922|NCT03382041|58810845|FG000|Overall Study|Consent Form Lost|2|||
30796923|NCT03382041|58810846|FG001|Overall Study|Consent Form Lost|1|||
30796924|NCT03382041|58810845|FG000|Overall Study|Withdrawal by Subject|1|||
30796925|NCT03382041|58810846|FG001|Overall Study|Withdrawal by Subject|4|||
30796926|NCT03382041|58810845|FG000|Overall Study|Lost to Follow-up|1|||
30796927|NCT03382041|58810846|FG001|Overall Study|Lost to Follow-up|4|||
30796928|NCT03351231|58810852|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
30796929|NCT03351231|58810852|FG000|Combination Therapy Period|Disease progression|2|||
30796930|NCT03351231|58810852|FG000|Combination Therapy Period|Study drug toxicity|1|||
30796931|NCT03351231|58810852|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
30796932|NCT03351231|58810852|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
30796933|NCT03351231|58810852|FG000|Safety Follow-Up Period|Other reason|2|||
30796934|NCT03381339|58810858|FG000|Overall Study|Protocol Violation|4|||
30796935|NCT03381339|58810859|FG001|Overall Study|Protocol Violation|3|||
30796936|NCT03381339|58810858|FG000|Overall Study|Lost to Follow-up|0|||
30796937|NCT03381339|58810859|FG001|Overall Study|Lost to Follow-up|1|||
30796938|NCT03401229|58810867|FG000|Overall Study|Lost to Follow-up|2|||
30904813|NCT02008227|58939183|FG001|Overall Study|Death|485|||
30796939|NCT03401229|58810868|FG001|Overall Study|Lost to Follow-up|1|||
30796940|NCT03401229|58810867|FG000|Overall Study|Other|1|||
30796941|NCT03401229|58810868|FG001|Overall Study|Other|3|||
30796942|NCT03401229|58810867|FG000|Overall Study|Adverse Event|8|||
30796943|NCT03401229|58810868|FG001|Overall Study|Adverse Event|6|||
30796944|NCT03401229|58810867|FG000|Overall Study|Withdrawal by Subject|29|||
30796945|NCT03401229|58810868|FG001|Overall Study|Withdrawal by Subject|26|||
30904814|NCT02008227|58939182|FG000|Overall Study|Withdrawal by Subject|67|||
30904815|NCT02008227|58939183|FG001|Overall Study|Withdrawal by Subject|36|||
30904816|NCT02008227|58939182|FG000|Overall Study|Study Terminated By Sponsor|44|||
30904817|NCT02008227|58939183|FG001|Overall Study|Study Terminated By Sponsor|83|||
30796946|NCT03401229|58810867|FG000|Overall Study|COVID-19|0|||
30796947|NCT03401229|58810868|FG001|Overall Study|COVID-19|1|||
30796948|NCT03349515|58810876|FG000|Overall Study|Lack of Efficacy|2|||
30796949|NCT03349515|58810877|FG001|Overall Study|Lack of Efficacy|0|||
30796950|NCT03349515|58810876|FG000|Overall Study|Physician Decision|3|||
30796951|NCT03349515|58810877|FG001|Overall Study|Physician Decision|1|||
30796952|NCT03349437|58810883|FG000|Screening|Screen Fail|4|||
30796953|NCT03349437|58810884|FG001|Screening|Screen Fail|0|||
30796954|NCT03349437|58810885|FG002|Screening|Screen Fail|0|||
30796955|NCT03349437|58810883|FG000|Screening|Withdrawn|1|||
30796956|NCT03349437|58810884|FG001|Screening|Withdrawn|0|||
30796957|NCT03349437|58810885|FG002|Screening|Withdrawn|0|||
30796958|NCT03380091|58810894|FG000|Overall Study|Withdrawal by Subject|2|||
30796959|NCT03380091|58810895|FG001|Overall Study|Withdrawal by Subject|1|||
30796960|NCT03379233|58810905|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
30796961|NCT03379233|58810906|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
30796962|NCT01377922|58810914|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
30796963|NCT01377922|58810915|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
30796964|NCT03372603|58810921|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
30796965|NCT03372603|58810922|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
30796966|NCT03372603|58810921|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
30796967|NCT03372603|58810922|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
30796968|NCT01377844|58810930|FG000|Overall Study|Withdrawal by Subject|25|||
30796969|NCT01377844|58810931|FG001|Overall Study|Withdrawal by Subject|28|||
30796970|NCT01377844|58810930|FG000|Overall Study|Protocol Violation|2|||
30796971|NCT01377844|58810931|FG001|Overall Study|Protocol Violation|3|||
30796972|NCT01377844|58810930|FG000|Overall Study|Adverse Event|3|||
30796973|NCT01377844|58810931|FG001|Overall Study|Adverse Event|0|||
30796974|NCT01377844|58810930|FG000|Overall Study|Physician Decision|6|||
30796975|NCT01377844|58810931|FG001|Overall Study|Physician Decision|3|||
30796976|NCT01377844|58810930|FG000|Overall Study|Study terminated by Sponsor|0|||
30796977|NCT01377844|58810931|FG001|Overall Study|Study terminated by Sponsor|1|||
30796978|NCT03372369|58810940|FG000|Qualification Period|Withdrawal by Subject|16|||
30796979|NCT03372369|58810941|FG001|Qualification Period|Withdrawal by Subject|13|||
30796980|NCT03372369|58810940|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
30796981|NCT03372369|58810941|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
30796982|NCT03372369|58810940|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
30796983|NCT03372369|58810941|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
30796984|NCT03371355|58810951|FG000|Overall Study|Investigator judgment|0|||
30796985|NCT03371355|58810952|FG001|Overall Study|Investigator judgment|0|||
30796986|NCT03371355|58810953|FG002|Overall Study|Investigator judgment|1|||
30796987|NCT03371355|58810954|FG003|Overall Study|Investigator judgment|1|||
30796988|NCT03371355|58810951|FG000|Overall Study|Voluntary withdrawal|1|||
30796989|NCT03371355|58810952|FG001|Overall Study|Voluntary withdrawal|0|||
30796990|NCT03371355|58810953|FG002|Overall Study|Voluntary withdrawal|1|||
30796991|NCT03371355|58810954|FG003|Overall Study|Voluntary withdrawal|2|||
30796992|NCT03371355|58810951|FG000|Overall Study|Adverse Event|0|||
30796993|NCT03371355|58810952|FG001|Overall Study|Adverse Event|1|||
30796994|NCT03371355|58810953|FG002|Overall Study|Adverse Event|2|||
30796995|NCT03371355|58810954|FG003|Overall Study|Adverse Event|3|||
30796996|NCT03371355|58810951|FG000|Overall Study|Reason not Specified|0|||
30796997|NCT03371355|58810952|FG001|Overall Study|Reason not Specified|1|||
30796998|NCT03371355|58810953|FG002|Overall Study|Reason not Specified|0|||
30796999|NCT03371355|58810954|FG003|Overall Study|Reason not Specified|1|||
30797000|NCT03370419|58810968|FG000|Overall Study|Lost to Follow-up|16|||
30797001|NCT03369951|58810976|FG000|Overall Study|Withdrawal by Subject|3|||
30797002|NCT03369951|58810976|FG000|Overall Study|Death|1|||
30797003|NCT03369951|58810976|FG000|Overall Study|Lost to Follow-up|1|||
30797004|NCT03369951|58810976|FG000|Overall Study|Protocol Violation|1|||
30797005|NCT04040192|58810980|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
30797006|NCT04040192|58810981|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
30797007|NCT04040192|58810982|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
30797008|NCT04040192|58810980|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
30797009|NCT04040192|58810981|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
30797010|NCT04040192|58810982|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
30797011|NCT04040192|58810980|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
30797012|NCT04040192|58810981|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
30797013|NCT04040192|58810982|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
30797014|NCT04040192|58810980|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
30797015|NCT04040192|58810981|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
30797016|NCT04040192|58810982|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
30797017|NCT04040192|58810980|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
30797018|NCT04040192|58810981|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
30797019|NCT04040192|58810982|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
30797020|NCT04040192|58810980|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
30797021|NCT04040192|58810981|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
30797022|NCT04040192|58810982|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
30797023|NCT04040192|58810980|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
30797024|NCT04040192|58810981|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
30797025|NCT04040192|58810982|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
30797026|NCT04040192|58810980|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
30797027|NCT04040192|58810981|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
30797028|NCT04040192|58810982|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
30797029|NCT04040192|58810980|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
30797030|NCT04040192|58810981|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
30797031|NCT04040192|58810982|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
30797032|NCT04040192|58810980|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
30797033|NCT04040192|58810981|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
30797034|NCT04040192|58810982|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
30797035|NCT04040192|58810980|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
30797036|NCT04040192|58810981|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
30797037|NCT04040192|58810982|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
30797038|NCT04040192|58810980|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
30797039|NCT04040192|58810981|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
30797040|NCT04040192|58810982|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
30797041|NCT04040192|58810980|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
30797042|NCT04040192|58810981|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
30797043|NCT04040192|58810982|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
30797044|NCT04040192|58810980|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
30797045|NCT04040192|58810981|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
30797046|NCT04040192|58810982|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
30797047|NCT04040192|58810980|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
30797048|NCT04040192|58810981|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
30797049|NCT04040192|58810982|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
30797050|NCT04040192|58810980|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
30797051|NCT04040192|58810981|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
30797052|NCT04040192|58810982|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
30797053|NCT04040192|58810980|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
30797054|NCT04040192|58810981|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
30797055|NCT04040192|58810982|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
30797056|NCT03368859|58811006|FG000|Overall Study|Withdrew Consent|5|||
30797057|NCT03368859|58811007|FG001|Overall Study|Withdrew Consent|4|||
30797058|NCT03368859|58811006|FG000|Overall Study|Death|12|||
30797059|NCT03368859|58811007|FG001|Overall Study|Death|6|||
30797060|NCT03368859|58811006|FG000|Overall Study|Study terminated by Sponsor|18|||
30797061|NCT03368859|58811007|FG001|Overall Study|Study terminated by Sponsor|23|||
30797062|NCT03368859|58811006|FG000|Overall Study|Other|1|||
30797063|NCT03368859|58811007|FG001|Overall Study|Other|1|||
30797064|NCT03096314|58811021|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
30797065|NCT03096314|58811022|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
30797066|NCT03335163|58811028|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
30797067|NCT03335163|58811028|FG000|Overall Study|Withdrawal by Subject|18|||
30797068|NCT03364335|58811054|FG000|Overall Study|Adverse Event|3|||
30797069|NCT03364335|58811055|FG001|Overall Study|Adverse Event|4|||
30797070|NCT03364335|58811056|FG002|Overall Study|Adverse Event|1|||
30797071|NCT03364335|58811057|FG003|Overall Study|Adverse Event|2|||
30797072|NCT03364335|58811058|FG004|Overall Study|Adverse Event|0|||
30797073|NCT03364335|58811054|FG000|Overall Study|Lost to Follow-up|7|||
30797074|NCT03364335|58811055|FG001|Overall Study|Lost to Follow-up|7|||
30797075|NCT03364335|58811056|FG002|Overall Study|Lost to Follow-up|10|||
30797076|NCT03364335|58811057|FG003|Overall Study|Lost to Follow-up|11|||
30797077|NCT03364335|58811058|FG004|Overall Study|Lost to Follow-up|11|||
30797078|NCT03334695|58811081|FG000|Overall Study|Lost to Follow-up|3|||
30797079|NCT03334695|58811082|FG001|Overall Study|Lost to Follow-up|3|||
30904818|NCT02006979|58939192|FG000|Overall Study|Withdrawal by Subject|1|||
30904819|NCT02006979|58939193|FG001|Overall Study|Withdrawal by Subject|1|||
30904820|NCT02006979|58939192|FG000|Overall Study|Protocol Violation|0|||
30904821|NCT02006979|58939193|FG001|Overall Study|Protocol Violation|1|||
30904822|NCT02348723|58939201|FG000|Overall Study|No ablation|21|||
30904823|NCT02348723|58939202|FG001|Overall Study|No ablation|20|||
30904824|NCT02348723|58939201|FG000|Overall Study|Non-compliant with Protocol|1|||
30904825|NCT02348723|58939202|FG001|Overall Study|Non-compliant with Protocol|0|||
30904826|NCT02348723|58939201|FG000|Overall Study|Lost to Follow-up|1|||
30904827|NCT02348723|58939202|FG001|Overall Study|Lost to Follow-up|1|||
30904828|NCT02348723|58939201|FG000|Overall Study|Consent withdrawn|1|||
30904829|NCT02348723|58939202|FG001|Overall Study|Consent withdrawn|3|||
30904830|NCT02348723|58939201|FG000|Overall Study|Reason other than specified|1|||
30904831|NCT02348723|58939202|FG001|Overall Study|Reason other than specified|1|||
30904832|NCT02348723|58939201|FG000|Overall Study|Adverse Event|3|||
30904833|NCT02348723|58939202|FG001|Overall Study|Adverse Event|1|||
30904834|NCT01967277|58939210|FG000|Overall Study|Lost to Follow-up|1|||
30904835|NCT01967277|58939211|FG001|Overall Study|Lost to Follow-up|2|||
30904836|NCT01967277|58939210|FG000|Overall Study|Unrelated illness|0|||
30904837|NCT01967277|58939211|FG001|Overall Study|Unrelated illness|1|||
30904838|NCT02326883|58939220|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
30904839|NCT02326883|58939221|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
30904840|NCT02326883|58939222|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
30904841|NCT02006667|58939230|FG000|Overall Study|Adverse Event|3|||
30904842|NCT02006667|58939230|FG000|Overall Study|Death|2|||
30904843|NCT02006667|58939230|FG000|Overall Study|Withdrawal by Subject|1|||
30904844|NCT01983111|58939236|FG000|Overall Study|Withdrawal by Subject|8|||
30904845|NCT01983111|58939237|FG001|Overall Study|Withdrawal by Subject|6|||
30904846|NCT01983111|58939236|FG000|Overall Study|Adverse Event|4|||
30904847|NCT01983111|58939237|FG001|Overall Study|Adverse Event|0|||
30797080|NCT03334695|58811081|FG000|Overall Study|Physician Decision|1|||
30797081|NCT03334695|58811082|FG001|Overall Study|Physician Decision|2|||
30797082|NCT03334695|58811081|FG000|Overall Study|Protocol Violation|0|||
30797083|NCT03334695|58811082|FG001|Overall Study|Protocol Violation|1|||
30797084|NCT03364023|58811090|FG000|Overall Study|Lost to Follow-up|3|||
30797085|NCT03364023|58811090|FG000|Overall Study|Death|14|||
30797086|NCT03764813|58811114|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
30797087|NCT03764813|58811115|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
30797088|NCT03764813|58811116|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
30797089|NCT03764813|58811117|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
30797090|NCT03363321|58811138|FG000|Overall Study|Withdrawal by Subject|0|||
30797091|NCT03363321|58811139|FG001|Overall Study|Withdrawal by Subject|1|||
30797092|NCT03363321|58811140|FG002|Overall Study|Withdrawal by Subject|0|||
30797093|NCT03363321|58811141|FG003|Overall Study|Withdrawal by Subject|1|||
30797094|NCT03363321|58811142|FG004|Overall Study|Withdrawal by Subject|0|||
30797095|NCT03361605|58811155|FG000|Overall Study|Analyzable data not available|3|||
30797096|NCT03829046|58811161|FG000|Overall Study|Withdrawal by Subject|1|||
30797097|NCT03829046|58811162|FG001|Overall Study|Withdrawal by Subject|0|||
30797098|NCT03361293|58811170|FG000|Overall Study|Lost to Follow-up|0|||
30797099|NCT03361293|58811171|FG001|Overall Study|Lost to Follow-up|2|||
30797100|NCT03361293|58811170|FG000|Overall Study|Withdrawal by Subject|1|||
30797101|NCT03361293|58811171|FG001|Overall Study|Withdrawal by Subject|3|||
30797102|NCT03361137|58811182|FG000|Overall Study|Reason not specified|1|||
30797103|NCT03361137|58811183|FG001|Overall Study|Reason not specified|0|||
30797104|NCT03361137|58811184|FG002|Overall Study|Reason not specified|0|||
30797105|NCT03361137|58811185|FG003|Overall Study|Reason not specified|0|||
30797106|NCT03361137|58811186|FG004|Overall Study|Reason not specified|0|||
30797107|NCT03360747|58811200|FG000|Overall Study|Voluntary Withdrawal|1|||
30797108|NCT03359811|58811206|FG000|Overall Study|Protocol Violation|2|||
30797109|NCT03359811|58811207|FG001|Overall Study|Protocol Violation|0|||
30797110|NCT03728426|58811214|FG000|Overall Study|Death|3|||
30797111|NCT02095678|58811220|FG000|Overall Study|Withdrawal by Subject|0|||
30797112|NCT02095678|58811221|FG001|Overall Study|Withdrawal by Subject|1|||
30797113|NCT02095678|58811220|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
30797114|NCT02095678|58811221|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
30797115|NCT02095678|58811220|FG000|Overall Study|lesion impacted by previous treatment|1|||
30797116|NCT02095678|58811221|FG001|Overall Study|lesion impacted by previous treatment|1|||
30797117|NCT02095678|58811220|FG000|Overall Study|No Confirmed Diagnosis|0|||
30904848|NCT01983111|58939236|FG000|Overall Study|Protocol Violation|0|||
30904849|NCT01983111|58939237|FG001|Overall Study|Protocol Violation|1|||
30904850|NCT02348489|58939245|FG000|Overall Study|Death|336|||
30904851|NCT02348489|58939246|FG001|Overall Study|Death|335|||
30904852|NCT02348489|58939245|FG000|Overall Study|Withdrawal by Subject|14|||
30797118|NCT02095678|58811221|FG001|Overall Study|No Confirmed Diagnosis|3|||
30797119|NCT02095678|58811220|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
30797120|NCT02095678|58811221|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
30797121|NCT02095678|58811220|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
30797122|NCT02095678|58811221|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
30797123|NCT03763877|58811234|FG000|Overall Study|Withdrawal by Subject|3|||
30797124|NCT03763877|58811235|FG001|Overall Study|Withdrawal by Subject|1|||
30797125|NCT03763877|58811236|FG002|Overall Study|Withdrawal by Subject|3|||
30797126|NCT03763877|58811237|FG003|Overall Study|Withdrawal by Subject|4|||
30797127|NCT03763877|58811234|FG000|Overall Study|Adverse Event|1|||
30797128|NCT03763877|58811235|FG001|Overall Study|Adverse Event|1|||
30797129|NCT03763877|58811236|FG002|Overall Study|Adverse Event|3|||
30797130|NCT03763877|58811237|FG003|Overall Study|Adverse Event|1|||
30797131|NCT03763877|58811234|FG000|Overall Study|Protocol Violation|1|||
30797132|NCT03763877|58811235|FG001|Overall Study|Protocol Violation|1|||
30797133|NCT03763877|58811236|FG002|Overall Study|Protocol Violation|0|||
30797134|NCT03763877|58811237|FG003|Overall Study|Protocol Violation|0|||
30797135|NCT03763877|58811234|FG000|Overall Study|Lost to Follow-up|0|||
30797136|NCT03763877|58811235|FG001|Overall Study|Lost to Follow-up|1|||
30797137|NCT03763877|58811236|FG002|Overall Study|Lost to Follow-up|1|||
30797138|NCT03763877|58811237|FG003|Overall Study|Lost to Follow-up|0|||
30797139|NCT03358407|58811270|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
30797140|NCT03358407|58811271|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
30797141|NCT03358407|58811272|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
30797142|NCT03358407|58811273|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
30797143|NCT03358407|58811274|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
30904853|NCT02348489|58939246|FG001|Overall Study|Withdrawal by Subject|27|||
30904854|NCT02348489|58939245|FG000|Overall Study|Lost to Follow-up|3|||
30904855|NCT02348489|58939246|FG001|Overall Study|Lost to Follow-up|5|||
30904856|NCT02309099|58939256|FG000|Overall Study|Adverse Event|2|||
30797144|NCT03358407|58811275|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
30797145|NCT03358407|58811276|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
30797146|NCT03358407|58811277|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
30797147|NCT03358407|58811278|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
30797148|NCT03358407|58811279|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
30797149|NCT03358407|58811270|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797150|NCT03358407|58811271|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797151|NCT03358407|58811272|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797152|NCT03358407|58811273|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797153|NCT03358407|58811274|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
30797154|NCT03358407|58811275|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797155|NCT03358407|58811276|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797156|NCT03358407|58811277|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797157|NCT03358407|58811278|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30904857|NCT02309099|58939257|FG001|Overall Study|Adverse Event|0|||
30904858|NCT01966107|58939265|FG000|Overall Study|excluded from FAS|21|||
30904859|NCT01966107|58939266|FG001|Overall Study|excluded from FAS|20|||
30904860|NCT01966107|58939265|FG000|Overall Study|discontinued treatment|345|||
30904861|NCT01966107|58939266|FG001|Overall Study|discontinued treatment|372|||
30904862|NCT01966107|58939265|FG000|Overall Study|due to study closure|164|||
30904863|NCT01966107|58939266|FG001|Overall Study|due to study closure|186|||
30797158|NCT03358407|58811279|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797159|NCT03358407|58811270|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
30797160|NCT03358407|58811271|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
30797161|NCT03358407|58811272|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
30797162|NCT03358407|58811273|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
30797163|NCT03358407|58811274|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
30797164|NCT03358407|58811275|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
30797165|NCT03358407|58811276|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
30904864|NCT01966107|58939265|FG000|Overall Study|withdrew from the study|272|||
30904865|NCT01966107|58939266|FG001|Overall Study|withdrew from the study|303|||
30904866|NCT02347943|58939275|FG000|Overall Study|Study was cancelled|140|||
30904867|NCT02347943|58939276|FG001|Overall Study|Study was cancelled|67|||
30904868|NCT02347943|58939277|FG002|Overall Study|Study was cancelled|45|||
30904869|NCT01982331|58939287|FG000|Received Vaccination 2|Adverse Event|1|||
30904870|NCT01982331|58939288|FG001|Received Vaccination 2|Adverse Event|2|||
30904871|NCT01982331|58939287|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
30904872|NCT01982331|58939288|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
30904873|NCT01982331|58939287|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
30904874|NCT01982331|58939288|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
30904875|NCT02326025|58939296|FG000|Overall Study|Adverse Event|3|||
30904876|NCT02326025|58939297|FG001|Overall Study|Adverse Event|0|||
30904877|NCT02326025|58939296|FG000|Overall Study|Physician Decision|1|||
30904878|NCT02326025|58939297|FG001|Overall Study|Physician Decision|2|||
30904879|NCT02326025|58939296|FG000|Overall Study|Physician and Participant Decision|1|||
30904880|NCT02326025|58939297|FG001|Overall Study|Physician and Participant Decision|0|||
30904881|NCT02326025|58939296|FG000|Overall Study|Withdrawal by Subject|0|||
30904882|NCT02326025|58939297|FG001|Overall Study|Withdrawal by Subject|2|||
30904883|NCT02326025|58939296|FG000|Overall Study|Protocol Violation|0|||
30904884|NCT02326025|58939297|FG001|Overall Study|Protocol Violation|1|||
30904885|NCT01619865|58939316|FG000|Overall Study|Adverse Event|1|||
30904886|NCT01619865|58939316|FG000|Overall Study|Death|2|||
30904887|NCT01619865|58939316|FG000|Overall Study|subject not able to comply|1|||
30904888|NCT02006121|58939323|FG000|Double Blind Phase|Adverse Event|6|||
30904889|NCT02006121|58939324|FG001|Double Blind Phase|Adverse Event|0|||
30904890|NCT02006121|58939323|FG000|Double Blind Phase|Lack of Efficacy|1|||
30904891|NCT02006121|58939324|FG001|Double Blind Phase|Lack of Efficacy|16|||
30904892|NCT02006121|58939323|FG000|Double Blind Phase|Withdrawal by Subject|3|||
30904893|NCT02006121|58939324|FG001|Double Blind Phase|Withdrawal by Subject|4|||
30904894|NCT02006121|58939323|FG000|Double Blind Phase|Non-compliance with study drug|1|||
30904895|NCT02006121|58939324|FG001|Double Blind Phase|Non-compliance with study drug|3|||
30904896|NCT02006121|58939323|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
30797166|NCT03358407|58811277|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
30797167|NCT03358407|58811278|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
30797168|NCT03358407|58811279|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
30797169|NCT03358407|58811270|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
30797170|NCT03358407|58811271|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
30797171|NCT03358407|58811272|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
30797172|NCT03358407|58811273|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
30797173|NCT03358407|58811274|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
30797174|NCT03358407|58811275|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
30797175|NCT03358407|58811276|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
30797176|NCT03358407|58811277|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
30797177|NCT03358407|58811278|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
30797178|NCT03358407|58811279|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
30797179|NCT03358407|58811270|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797180|NCT03358407|58811271|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797181|NCT03358407|58811272|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797182|NCT03358407|58811273|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797183|NCT03358407|58811274|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797184|NCT03358407|58811275|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
30797185|NCT03358407|58811276|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
30904897|NCT02006121|58939324|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
30904898|NCT02006121|58939323|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
30904899|NCT02006121|58939324|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
30904900|NCT02006121|58939323|FG000|Open Label Phase|Adverse Event|15|||
30904901|NCT02006121|58939324|FG001|Open Label Phase|Adverse Event|0|||
30797186|NCT03358407|58811277|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30904902|NCT02006121|58939323|FG000|Open Label Phase|Lack of Efficacy|2|||
30904903|NCT02006121|58939324|FG001|Open Label Phase|Lack of Efficacy|0|||
30904904|NCT02006121|58939323|FG000|Open Label Phase|Protocol Violation|2|||
30797187|NCT03358407|58811278|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797188|NCT03358407|58811279|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
30797189|NCT03358407|58811270|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
30797190|NCT03358407|58811271|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
30797191|NCT03358407|58811272|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
30797192|NCT03358407|58811273|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
30797193|NCT03358407|58811274|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
30797194|NCT03358407|58811275|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
30797195|NCT03358407|58811276|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
30797196|NCT03358407|58811277|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
30797197|NCT03358407|58811278|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
30797198|NCT03358407|58811279|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
30797199|NCT02950545|58811321|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
30797200|NCT02950545|58811322|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
30797201|NCT02950545|58811323|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
30797202|NCT02950545|58811324|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
30797203|NCT02950545|58811325|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
30797204|NCT02950545|58811326|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
30797205|NCT02950545|58811321|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
30797206|NCT02950545|58811322|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
30797207|NCT02950545|58811323|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
30797208|NCT02950545|58811324|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
30797209|NCT02950545|58811325|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
30797210|NCT02950545|58811326|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
30797211|NCT02950545|58811321|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
30797212|NCT02950545|58811322|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
30797213|NCT02950545|58811323|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
30797214|NCT02950545|58811324|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
30797215|NCT02950545|58811325|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
30797216|NCT02950545|58811326|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
30797217|NCT02950545|58811321|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
30797218|NCT02950545|58811322|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
30797219|NCT02950545|58811323|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
30797220|NCT02950545|58811324|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
30797221|NCT02950545|58811325|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
30797222|NCT02950545|58811326|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
30797223|NCT02950545|58811321|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
30797224|NCT02950545|58811322|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
30797225|NCT02950545|58811323|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
30797226|NCT02950545|58811324|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
30797227|NCT02950545|58811325|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
30797228|NCT02950545|58811326|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
30797229|NCT03358329|58811332|FG000|Overall Study|Lost to Follow-up|2|||
30797230|NCT03358329|58811332|FG000|Overall Study|Withdrawal by Subject|2|||
30797231|NCT03357471|58811348|FG000|Overall Study|Adverse Event|1|||
30797232|NCT03357471|58811349|FG001|Overall Study|Adverse Event|0|||
30797233|NCT03357471|58811348|FG000|Overall Study|Lost to Follow-up|1|||
30797234|NCT03357471|58811349|FG001|Overall Study|Lost to Follow-up|0|||
30797235|NCT03356145|58811357|FG000|Overall Study|Withdrawal by Subject|2|||
30797236|NCT03356145|58811358|FG001|Overall Study|Withdrawal by Subject|1|||
30797237|NCT03356145|58811357|FG000|Overall Study|Did not meet inclusion criteria|1|||
30797238|NCT03356145|58811358|FG001|Overall Study|Did not meet inclusion criteria|0|||
30797239|NCT03342963|58811368|FG000|Overall Study|Adverse Event|1|||
30797240|NCT03342963|58811369|FG001|Overall Study|Adverse Event|2|||
30797241|NCT03342963|58811370|FG002|Overall Study|Adverse Event|0|||
30797242|NCT03342963|58811371|FG003|Overall Study|Adverse Event|0|||
30797243|NCT03342963|58811368|FG000|Overall Study|Withdrawal by Subject|1|||
30797244|NCT03342963|58811369|FG001|Overall Study|Withdrawal by Subject|0|||
30797245|NCT03342963|58811370|FG002|Overall Study|Withdrawal by Subject|0|||
30797246|NCT03342963|58811371|FG003|Overall Study|Withdrawal by Subject|0|||
30797247|NCT03361956|58811386|FG000|Overall Study|Adverse Event|1|||
30797248|NCT03361956|58811387|FG001|Overall Study|Adverse Event|0|||
30797249|NCT03361956|58811388|FG002|Overall Study|Adverse Event|1|||
30797250|NCT03361956|58811389|FG003|Overall Study|Adverse Event|1|||
30797251|NCT03361956|58811390|FG004|Overall Study|Adverse Event|0|||
30797252|NCT03361956|58811386|FG000|Overall Study|Other|0|||
30797253|NCT03361956|58811387|FG001|Overall Study|Other|0|||
30797254|NCT03361956|58811388|FG002|Overall Study|Other|0|||
30904905|NCT02006121|58939324|FG001|Open Label Phase|Protocol Violation|0|||
30904906|NCT02006121|58939323|FG000|Open Label Phase|Withdrawal by Subject|3|||
30904907|NCT02006121|58939324|FG001|Open Label Phase|Withdrawal by Subject|0|||
30904908|NCT02006121|58939323|FG000|Open Label Phase|Non-compliance with study drug|3|||
30904909|NCT02006121|58939324|FG001|Open Label Phase|Non-compliance with study drug|0|||
30904910|NCT02005887|58939336|FG000|Overall Study|Protocol Violation|0|||
30904911|NCT02005887|58939337|FG001|Overall Study|Protocol Violation|2|||
30904912|NCT01982253|58939346|FG000|Overall Study|Withdrawal by Subject|1|||
30904913|NCT01982253|58939347|FG001|Overall Study|Withdrawal by Subject|0|||
30904914|NCT01982253|58939348|FG002|Overall Study|Withdrawal by Subject|0|||
30904915|NCT01982253|58939346|FG000|Overall Study|Study terminated by sponsor|1|||
30904916|NCT01982253|58939347|FG001|Overall Study|Study terminated by sponsor|4|||
30904917|NCT01982253|58939348|FG002|Overall Study|Study terminated by sponsor|4|||
30904918|NCT01619787|58939358|FG000|Overall Study|Lost to Follow-up|5|||
30904919|NCT01981473|58939367|FG000|Overall Study|Incorrect diagnosis of RA|0|||
30904920|NCT01981473|58939368|FG001|Overall Study|Incorrect diagnosis of RA|0|||
30904921|NCT01981473|58939369|FG002|Overall Study|Incorrect diagnosis of RA|1|||
30904922|NCT01981473|58939367|FG000|Overall Study|Received treatment for < 6 months|0|||
30904923|NCT01981473|58939368|FG001|Overall Study|Received treatment for < 6 months|0|||
30904924|NCT01981473|58939369|FG002|Overall Study|Received treatment for < 6 months|1|||
30904925|NCT01981473|58939367|FG000|Overall Study|Received treatment for >24 months|2|||
30904926|NCT01981473|58939368|FG001|Overall Study|Received treatment for >24 months|0|||
30904927|NCT01981473|58939369|FG002|Overall Study|Received treatment for >24 months|6|||
30904928|NCT02005029|58939382|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
30904929|NCT02005029|58939383|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
30904930|NCT02325791|58939411|FG000|Overall Study|Adverse Event|0|||
30904931|NCT02325791|58939412|FG001|Overall Study|Adverse Event|1|||
30904932|NCT02325791|58939413|FG002|Overall Study|Adverse Event|1|||
30904933|NCT02325791|58939414|FG003|Overall Study|Adverse Event|0|||
30904934|NCT02325791|58939411|FG000|Overall Study|Death|0|||
30904935|NCT02325791|58939412|FG001|Overall Study|Death|3|||
30904936|NCT02325791|58939413|FG002|Overall Study|Death|0|||
30904937|NCT02325791|58939414|FG003|Overall Study|Death|1|||
30904938|NCT02325791|58939411|FG000|Overall Study|Lost to Follow-up|0|||
30904939|NCT02325791|58939412|FG001|Overall Study|Lost to Follow-up|15|||
30904940|NCT02325791|58939413|FG002|Overall Study|Lost to Follow-up|14|||
30904941|NCT02325791|58939414|FG003|Overall Study|Lost to Follow-up|9|||
30904942|NCT02325791|58939411|FG000|Overall Study|Physician Decision|0|||
30904943|NCT02325791|58939412|FG001|Overall Study|Physician Decision|1|||
30904944|NCT02325791|58939413|FG002|Overall Study|Physician Decision|1|||
30904945|NCT02325791|58939414|FG003|Overall Study|Physician Decision|0|||
30904946|NCT02325791|58939411|FG000|Overall Study|Protocol Violation|0|||
30904947|NCT02325791|58939412|FG001|Overall Study|Protocol Violation|0|||
30904948|NCT02325791|58939413|FG002|Overall Study|Protocol Violation|1|||
30904949|NCT02325791|58939414|FG003|Overall Study|Protocol Violation|0|||
30904950|NCT02325791|58939411|FG000|Overall Study|Withdrawal by Subject|0|||
30904951|NCT02325791|58939412|FG001|Overall Study|Withdrawal by Subject|5|||
30904952|NCT02325791|58939413|FG002|Overall Study|Withdrawal by Subject|8|||
30904953|NCT02325791|58939414|FG003|Overall Study|Withdrawal by Subject|16|||
30904954|NCT02004873|58939427|FG000|Overall Study|Implant unsuccessful|6|||
30904955|NCT02004873|58939427|FG000|Overall Study|Awaiting 6-month visit|390|||
30904956|NCT02004873|58939427|FG000|Overall Study|Missed 6-month visit|4|||
30904957|NCT02004873|58939427|FG000|Overall Study|Death|23|||
30904958|NCT02004873|58939427|FG000|Overall Study|Withdrawal by Subject|1|||
30904959|NCT02347787|58939436|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
30904960|NCT02347787|58939437|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
30904961|NCT02347787|58939436|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
30904962|NCT02347787|58939437|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
30904963|NCT02347787|58939436|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
30904964|NCT02347787|58939437|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
30904965|NCT02347787|58939436|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
30904966|NCT02347787|58939437|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
30904967|NCT01979835|58939448|FG000|Primary Outcome SA Measurment|failed insertion|18|||
30904968|NCT01979835|58939448|FG000|Follow-up|Lost to Follow-up|32|||
30622175|NCT01178411|58633672|FG000|Overall Study|Death|1|||
30797255|NCT03361956|58811389|FG003|Overall Study|Other|1|||
30797256|NCT03361956|58811390|FG004|Overall Study|Other|0|||
30904969|NCT02282345|58939454|FG000|Overall Study|Progression|0|||
30904970|NCT02282345|58939455|FG001|Overall Study|Progression|1|||
30904971|NCT01732822|58939466|FG000|Overall Study|Withdrawal by Subject|123|||
30904972|NCT01732822|58939467|FG001|Overall Study|Withdrawal by Subject|113|||
30904973|NCT02004093|58939497|FG000|Overall Study|Death|2|||
30904974|NCT02004093|58939498|FG001|Overall Study|Death|1|||
30904975|NCT02004093|58939497|FG000|Overall Study|Lack of Efficacy|66|||
30904976|NCT02004093|58939498|FG001|Overall Study|Lack of Efficacy|62|||
30904977|NCT02004093|58939497|FG000|Overall Study|Protocol Violation|0|||
30904978|NCT02004093|58939498|FG001|Overall Study|Protocol Violation|1|||
30904979|NCT02004093|58939497|FG000|Overall Study|Lost to Follow-up|0|||
30904980|NCT02004093|58939498|FG001|Overall Study|Lost to Follow-up|1|||
30904981|NCT02004093|58939497|FG000|Overall Study|Withdrawal by Subject|3|||
30904982|NCT02004093|58939498|FG001|Overall Study|Withdrawal by Subject|7|||
30904983|NCT02004093|58939497|FG000|Overall Study|Other|3|||
30904984|NCT02004093|58939498|FG001|Overall Study|Other|1|||
30622176|NCT01178411|58633672|FG000|Overall Study|No reason provided|1|||
30904985|NCT01641367|58939513|FG000|Cohorts|Death|18|||
30904986|NCT01641367|58939514|FG001|Cohorts|Death|1|||
30904987|NCT01641367|58939515|FG002|Cohorts|Death|2|||
30904988|NCT01641367|58939516|FG003|Cohorts|Death|0|||
30904989|NCT01641367|58939517|FG004|Cohorts|Death|1|||
30904990|NCT01641367|58939518|FG005|Cohorts|Death|1|||
30904991|NCT01641367|58939519|FG006|Cohorts|Death|0|||
30904992|NCT01641367|58939520|FG007|Cohorts|Death|0|||
30904993|NCT01641367|58939513|FG000|Cohorts|Lost to Follow-up|16|||
30904994|NCT01641367|58939514|FG001|Cohorts|Lost to Follow-up|0|||
30904995|NCT01641367|58939515|FG002|Cohorts|Lost to Follow-up|2|||
30904996|NCT01641367|58939516|FG003|Cohorts|Lost to Follow-up|0|||
30904997|NCT01641367|58939517|FG004|Cohorts|Lost to Follow-up|2|||
30904998|NCT01641367|58939518|FG005|Cohorts|Lost to Follow-up|0|||
30904999|NCT01641367|58939519|FG006|Cohorts|Lost to Follow-up|0|||
30905000|NCT01641367|58939520|FG007|Cohorts|Lost to Follow-up|0|||
30905001|NCT01641367|58939513|FG000|Randomized Adherence Intervention|Death|0|||
30905002|NCT01641367|58939514|FG001|Randomized Adherence Intervention|Death|0|||
30905003|NCT01641367|58939515|FG002|Randomized Adherence Intervention|Death|0|||
30905004|NCT01641367|58939516|FG003|Randomized Adherence Intervention|Death|0|||
30905005|NCT01641367|58939517|FG004|Randomized Adherence Intervention|Death|0|||
30905006|NCT01641367|58939518|FG005|Randomized Adherence Intervention|Death|0|||
30905007|NCT01641367|58939519|FG006|Randomized Adherence Intervention|Death|11|||
30905008|NCT01641367|58939520|FG007|Randomized Adherence Intervention|Death|12|||
30622177|NCT01178411|58633672|FG000|Overall Study|Drug manufacturing ended|1|||
30622178|NCT01145508|58633678|FG000|Overall Study|Adverse Event|1|||
30797257|NCT03361956|58811386|FG000|Overall Study|Withdrawal by Subject|2|||
30797258|NCT03361956|58811387|FG001|Overall Study|Withdrawal by Subject|2|||
30797259|NCT03361956|58811388|FG002|Overall Study|Withdrawal by Subject|2|||
30797260|NCT03361956|58811389|FG003|Overall Study|Withdrawal by Subject|0|||
30797261|NCT03361956|58811390|FG004|Overall Study|Withdrawal by Subject|3|||
30797262|NCT03361956|58811386|FG000|Overall Study|Disease Relapse|0|||
30797263|NCT03361956|58811387|FG001|Overall Study|Disease Relapse|0|||
30797264|NCT03361956|58811388|FG002|Overall Study|Disease Relapse|1|||
30797265|NCT03361956|58811389|FG003|Overall Study|Disease Relapse|0|||
30797266|NCT03361956|58811390|FG004|Overall Study|Disease Relapse|0|||
30797267|NCT03361956|58811386|FG000|Overall Study|Physician Decision|0|||
30797268|NCT03361956|58811387|FG001|Overall Study|Physician Decision|2|||
30797269|NCT03361956|58811388|FG002|Overall Study|Physician Decision|0|||
30797270|NCT03361956|58811389|FG003|Overall Study|Physician Decision|1|||
30797271|NCT03361956|58811390|FG004|Overall Study|Physician Decision|0|||
30797272|NCT03361956|58811386|FG000|Overall Study|Lost to Follow-up|0|||
30797273|NCT03361956|58811387|FG001|Overall Study|Lost to Follow-up|0|||
30797274|NCT03361956|58811388|FG002|Overall Study|Lost to Follow-up|1|||
30797275|NCT03361956|58811389|FG003|Overall Study|Lost to Follow-up|1|||
30797276|NCT03361956|58811390|FG004|Overall Study|Lost to Follow-up|2|||
30797277|NCT03361176|58811461|FG000|Overall Study|Lost to Follow-up|1|||
30797278|NCT03361176|58811462|FG001|Overall Study|Lost to Follow-up|2|||
30797279|NCT03361176|58811461|FG000|Overall Study|Adverse Event|0|||
30797280|NCT03361176|58811462|FG001|Overall Study|Adverse Event|2|||
30797281|NCT03361176|58811461|FG000|Overall Study|Withdrawal by Subject|0|||
30797282|NCT03361176|58811462|FG001|Overall Study|Withdrawal by Subject|1|||
30797283|NCT05283499|58811470|FG000|Overall Study|Did not receive intervention|1|||
30797284|NCT05283499|58811471|FG001|Overall Study|Did not receive intervention|2|||
30797285|NCT05271175|58811480|FG000|One Week Follow up|Lost to Follow-up|10|||
30797286|NCT05271175|58811481|FG001|One Week Follow up|Lost to Follow-up|7|||
30797287|NCT05271175|58811482|FG002|One Week Follow up|Lost to Follow-up|5|||
30797288|NCT05271175|58811480|FG000|One Month Follow up|Lost to Follow-up|12|||
30797289|NCT05271175|58811481|FG001|One Month Follow up|Lost to Follow-up|7|||
30797290|NCT05271175|58811482|FG002|One Month Follow up|Lost to Follow-up|9|||
30797291|NCT05271175|58811480|FG000|Six Months Follow up|Lost to Follow-up|8|||
30797292|NCT05271175|58811481|FG001|Six Months Follow up|Lost to Follow-up|2|||
30797293|NCT05271175|58811482|FG002|Six Months Follow up|Lost to Follow-up|2|||
30905009|NCT01641367|58939513|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
30905010|NCT01641367|58939514|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
30905011|NCT01641367|58939515|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
30905012|NCT01641367|58939516|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
30905013|NCT01641367|58939517|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
30905014|NCT01641367|58939518|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
30797294|NCT03098030|58811494|FG000|Overall Study|Death|10|||
30797295|NCT03098030|58811495|FG001|Overall Study|Death|156|||
30797296|NCT03098030|58811496|FG002|Overall Study|Death|156|||
30797297|NCT03098030|58811497|FG003|Overall Study|Death|82|||
30797298|NCT03098030|58811494|FG000|Overall Study|Withdrawal by Subject|0|||
30797299|NCT03098030|58811495|FG001|Overall Study|Withdrawal by Subject|7|||
30797300|NCT03098030|58811496|FG002|Overall Study|Withdrawal by Subject|8|||
30797301|NCT03098030|58811497|FG003|Overall Study|Withdrawal by Subject|2|||
30797302|NCT03098030|58811494|FG000|Overall Study|Lost to Follow-up|0|||
30797303|NCT03098030|58811495|FG001|Overall Study|Lost to Follow-up|0|||
30905015|NCT01641367|58939519|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
30905016|NCT01641367|58939520|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
30905017|NCT02325713|58939559|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905018|NCT02325713|58939560|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905019|NCT02325713|58939561|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905020|NCT02325713|58939562|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905021|NCT02325713|58939563|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905022|NCT02325713|58939564|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905023|NCT02325713|58939565|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905024|NCT02325713|58939566|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905025|NCT02325713|58939567|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905026|NCT02325713|58939568|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905027|NCT02325713|58939569|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
30905028|NCT02325713|58939570|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905029|NCT02325713|58939571|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905030|NCT02325713|58939572|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905031|NCT02325713|58939573|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905032|NCT02325713|58939574|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
30905033|NCT02325713|58939559|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
30905034|NCT02325713|58939560|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905035|NCT02325713|58939561|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905036|NCT02325713|58939562|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905037|NCT02325713|58939563|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905038|NCT02325713|58939564|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905039|NCT02325713|58939565|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905040|NCT02325713|58939566|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905041|NCT02325713|58939567|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905042|NCT02325713|58939568|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905043|NCT02325713|58939569|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905044|NCT02325713|58939570|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905045|NCT02325713|58939571|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30797304|NCT03098030|58811496|FG002|Overall Study|Lost to Follow-up|2|||
30797305|NCT03098030|58811497|FG003|Overall Study|Lost to Follow-up|1|||
30797306|NCT03341637|58811508|FG000|Overall Study|Lost to Follow-up|1|||
30797307|NCT03341637|58811509|FG001|Overall Study|Lost to Follow-up|0|||
30797308|NCT03341637|58811508|FG000|Overall Study|Withdrawal by Subject|3|||
30797309|NCT03341637|58811509|FG001|Overall Study|Withdrawal by Subject|3|||
30797310|NCT03341637|58811508|FG000|Overall Study|Reason not Specified|1|||
30797311|NCT03341637|58811509|FG001|Overall Study|Reason not Specified|1|||
30797312|NCT01378858|58811517|FG000|Overall Study|Withdrawal by Subject|4|||
30797313|NCT01378858|58811518|FG001|Overall Study|Withdrawal by Subject|4|||
30797314|NCT02891850|58811526|FG000|Overall Study|Adverse Event|3|||
30797315|NCT02891850|58811527|FG001|Overall Study|Adverse Event|0|||
30797316|NCT02891850|58811526|FG000|Overall Study|Death|0|||
30797317|NCT02891850|58811527|FG001|Overall Study|Death|4|||
30797318|NCT02891850|58811526|FG000|Overall Study|Physician Decision|1|||
30797319|NCT02891850|58811527|FG001|Overall Study|Physician Decision|0|||
30797320|NCT02891850|58811526|FG000|Overall Study|Pregnancy|1|||
30797321|NCT02891850|58811527|FG001|Overall Study|Pregnancy|0|||
30797322|NCT02891850|58811526|FG000|Overall Study|Withdrawal by Subject|2|||
30797323|NCT02891850|58811527|FG001|Overall Study|Withdrawal by Subject|3|||
30797324|NCT05594173|58811533|FG000|Overall Study|Adverse Event|1|||
30797325|NCT05594173|58811533|FG000|Overall Study|COVID-19 Pandemic|2|||
30797326|NCT03339999|58811546|FG000|Overall Study|Adverse Event|1|||
30797327|NCT03339999|58811547|FG001|Overall Study|Adverse Event|2|||
30797328|NCT03339999|58811548|FG002|Overall Study|Adverse Event|2|||
30797329|NCT03339999|58811549|FG003|Overall Study|Adverse Event|1|||
30797330|NCT03339999|58811546|FG000|Overall Study|Lack of Efficacy|0|||
30797331|NCT03339999|58811547|FG001|Overall Study|Lack of Efficacy|1|||
30905046|NCT02325713|58939572|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905047|NCT02325713|58939573|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30797332|NCT03339999|58811548|FG002|Overall Study|Lack of Efficacy|0|||
30797333|NCT03339999|58811549|FG003|Overall Study|Lack of Efficacy|0|||
30797334|NCT03339999|58811546|FG000|Overall Study|Lost to Follow-up|0|||
30797335|NCT03339999|58811547|FG001|Overall Study|Lost to Follow-up|0|||
30797336|NCT03339999|58811548|FG002|Overall Study|Lost to Follow-up|0|||
30797337|NCT03339999|58811549|FG003|Overall Study|Lost to Follow-up|1|||
30797338|NCT03339999|58811546|FG000|Overall Study|Study Terminated by Sponsor|6|||
30797339|NCT03339999|58811547|FG001|Overall Study|Study Terminated by Sponsor|3|||
30797340|NCT03339999|58811548|FG002|Overall Study|Study Terminated by Sponsor|4|||
30797341|NCT03339999|58811549|FG003|Overall Study|Study Terminated by Sponsor|3|||
30797342|NCT03339453|58811562|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
30797343|NCT03339453|58811563|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
30797344|NCT03359850|58811607|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
30797345|NCT03359850|58811608|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
30797346|NCT03359850|58811607|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
30797347|NCT03359850|58811608|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
30797348|NCT03359850|58811607|FG000|Extension Phase (Up to 28 Months)|Death|2|||
30797349|NCT03359850|58811608|FG001|Extension Phase (Up to 28 Months)|Death|4|||
30797350|NCT03359850|58811607|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
30797351|NCT03359850|58811608|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
30797352|NCT03359850|58811607|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
30797353|NCT03359850|58811608|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
30797354|NCT00114140|58811627|FG000|Overall Study|Protocol Violation|7|||
30797355|NCT03712345|58811641|FG000|Overall Study|Failure to meet randomization criteria|0|||
30905048|NCT02325713|58939574|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
30905049|NCT02325713|58939559|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905050|NCT02325713|58939560|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905051|NCT02325713|58939561|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905052|NCT02325713|58939562|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905053|NCT02325713|58939563|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905054|NCT02325713|58939564|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905055|NCT02325713|58939565|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905056|NCT02325713|58939566|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905057|NCT02325713|58939567|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905058|NCT02325713|58939568|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
30746496|NCT00296504|58756934|FG001|Interim Analysis|Participant Moved|0|||
30746497|NCT00296504|58756935|FG002|Interim Analysis|Participant Moved|1|||
30746498|NCT00296504|58756936|FG003|Interim Analysis|Participant Moved|0|||
30746499|NCT00296504|58756937|FG004|Interim Analysis|Participant Moved|0|||
30746500|NCT00296504|58756938|FG005|Interim Analysis|Participant Moved|1|||
30746501|NCT00296504|58756939|FG006|Interim Analysis|Participant Moved|1|||
30746502|NCT00296504|58756940|FG007|Interim Analysis|Participant Moved|0|||
30746503|NCT00296504|58756941|FG008|Interim Analysis|Participant Moved|0|||
30746504|NCT00296504|58756933|FG000|Interim Analysis|Participant Was Incarcerated|2|||
30905059|NCT02325713|58939569|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905060|NCT02325713|58939570|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905061|NCT02325713|58939571|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905062|NCT02325713|58939572|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905063|NCT02325713|58939573|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905064|NCT02325713|58939574|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
30905065|NCT02325401|58939589|FG000|Overall Study|Withdrawal by Subject|0|||
30905066|NCT02325401|58939590|FG001|Overall Study|Withdrawal by Subject|1|||
30797356|NCT03712345|58811642|FG001|Overall Study|Failure to meet randomization criteria|0|||
30797357|NCT03712345|58811643|FG002|Overall Study|Failure to meet randomization criteria|1|||
30797358|NCT03358290|58811656|FG000|Overall Study|Study discontinued by Sponsor|0|||
30905067|NCT02325401|58939591|FG002|Overall Study|Withdrawal by Subject|1|||
30746505|NCT00296504|58756934|FG001|Interim Analysis|Participant Was Incarcerated|0|||
30746506|NCT00296504|58756935|FG002|Interim Analysis|Participant Was Incarcerated|1|||
30905068|NCT02324699|58939605|FG000|Overall Study|study terminated|1|||
30905069|NCT01764256|58939613|FG000|Received All Vaccinations|Adverse Event|1|||
30905070|NCT01764256|58939614|FG001|Received All Vaccinations|Adverse Event|1|||
30797359|NCT03358290|58811657|FG001|Overall Study|Study discontinued by Sponsor|1|||
30797360|NCT03358290|58811658|FG002|Overall Study|Study discontinued by Sponsor|1|||
30797361|NCT03358290|58811659|FG003|Overall Study|Study discontinued by Sponsor|0|||
30797362|NCT03358290|58811660|FG004|Overall Study|Study discontinued by Sponsor|0|||
30797363|NCT03358290|58811656|FG000|Overall Study|Adverse Event|0|||
30797364|NCT03358290|58811657|FG001|Overall Study|Adverse Event|0|||
30797365|NCT03358290|58811658|FG002|Overall Study|Adverse Event|1|||
30797366|NCT03358290|58811659|FG003|Overall Study|Adverse Event|2|||
30797367|NCT03358290|58811660|FG004|Overall Study|Adverse Event|0|||
30797368|NCT03358290|58811656|FG000|Overall Study|Withdrawal by Subject|0|||
30797369|NCT03358290|58811657|FG001|Overall Study|Withdrawal by Subject|0|||
30797370|NCT03358290|58811658|FG002|Overall Study|Withdrawal by Subject|0|||
30797371|NCT03358290|58811659|FG003|Overall Study|Withdrawal by Subject|0|||
30797372|NCT03358290|58811660|FG004|Overall Study|Withdrawal by Subject|1|||
30797373|NCT03089216|58811676|FG000|Overall Study|Adverse Event|0|||
30797374|NCT03089216|58811677|FG001|Overall Study|Adverse Event|0|||
30797375|NCT03089216|58811678|FG002|Overall Study|Adverse Event|0|||
30797376|NCT03089216|58811679|FG003|Overall Study|Adverse Event|1|||
30905071|NCT01764256|58939615|FG002|Received All Vaccinations|Adverse Event|0|||
30797377|NCT03339726|58811696|FG000|Overall Study|Withdrawal by Subject|1|||
30797378|NCT03339726|58811697|FG001|Overall Study|Withdrawal by Subject|0|||
30797379|NCT03339726|58811698|FG002|Overall Study|Withdrawal by Subject|0|||
30797380|NCT03339726|58811696|FG000|Overall Study|Lost to Follow-up|0|||
30797381|NCT03339726|58811697|FG001|Overall Study|Lost to Follow-up|1|||
30905072|NCT01764256|58939616|FG003|Received All Vaccinations|Adverse Event|0|||
30905073|NCT01764256|58939613|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
30905074|NCT01764256|58939614|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
30905075|NCT01764256|58939615|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
30905076|NCT01764256|58939616|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
30905077|NCT01764256|58939613|FG000|Received All Vaccinations|Lost to Follow-up|1|||
30905078|NCT01764256|58939614|FG001|Received All Vaccinations|Lost to Follow-up|0|||
30905079|NCT01764256|58939615|FG002|Received All Vaccinations|Lost to Follow-up|0|||
30905080|NCT01764256|58939616|FG003|Received All Vaccinations|Lost to Follow-up|0|||
30905081|NCT01764256|58939613|FG000|Completed Study|Lost to Follow-up|0|||
30905082|NCT01764256|58939614|FG001|Completed Study|Lost to Follow-up|0|||
30905083|NCT01764256|58939615|FG002|Completed Study|Lost to Follow-up|0|||
30905084|NCT01764256|58939616|FG003|Completed Study|Lost to Follow-up|1|||
30905085|NCT01979523|58939632|FG000|Overall Study|Withdrawal by Subject|1|||
30905086|NCT01979523|58939633|FG001|Overall Study|Withdrawal by Subject|0|||
30905087|NCT02255461|58939645|FG000|Overall Study|Adverse Event|0|||
30905088|NCT02255461|58939646|FG001|Overall Study|Adverse Event|1|||
30746507|NCT00296504|58756936|FG003|Interim Analysis|Participant Was Incarcerated|0|||
30746508|NCT00296504|58756937|FG004|Interim Analysis|Participant Was Incarcerated|0|||
30905089|NCT02255461|58939647|FG002|Overall Study|Adverse Event|0|||
30905090|NCT02255461|58939648|FG003|Overall Study|Adverse Event|0|||
30905091|NCT02255461|58939649|FG004|Overall Study|Adverse Event|1|||
30905092|NCT02255461|58939645|FG000|Overall Study|Withdrawal by Subject|0|||
30746509|NCT00296504|58756938|FG005|Interim Analysis|Participant Was Incarcerated|0|||
30746510|NCT00296504|58756939|FG006|Interim Analysis|Participant Was Incarcerated|0|||
30746511|NCT00296504|58756940|FG007|Interim Analysis|Participant Was Incarcerated|0|||
30746512|NCT00296504|58756941|FG008|Interim Analysis|Participant Was Incarcerated|0|||
30746513|NCT00296504|58756933|FG000|Interim Analysis|Resistance to FPV|0|||
30797382|NCT03339726|58811698|FG002|Overall Study|Lost to Follow-up|0|||
30797383|NCT03339297|58811708|FG000|Overall Study|Relapse of Hematologic Disease|1|||
30797384|NCT03339297|58811709|FG001|Overall Study|Relapse of Hematologic Disease|0|||
30797385|NCT03339297|58811708|FG000|Overall Study|Death|10|||
30797386|NCT03339297|58811709|FG001|Overall Study|Death|7|||
30797387|NCT03339297|58811708|FG000|Overall Study|Hepatic Candidosis|1|||
30797388|NCT03339297|58811709|FG001|Overall Study|Hepatic Candidosis|0|||
30797389|NCT03339297|58811708|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
30797390|NCT03339297|58811709|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
30797391|NCT03339297|58811708|FG000|Overall Study|Consent Withdrawn by Participant|3|||
30797392|NCT03339297|58811709|FG001|Overall Study|Consent Withdrawn by Participant|3|||
30797393|NCT03339297|58811708|FG000|Overall Study|Disease Relapse|2|||
30797394|NCT03339297|58811709|FG001|Overall Study|Disease Relapse|0|||
30797395|NCT03339297|58811708|FG000|Overall Study|Physician Decision|1|||
30797396|NCT03339297|58811709|FG001|Overall Study|Physician Decision|1|||
30797397|NCT03339297|58811708|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
30797398|NCT03339297|58811709|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
30797399|NCT03339297|58811708|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
30797400|NCT03339297|58811709|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
30797401|NCT03339297|58811708|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
30797402|NCT03339297|58811709|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
30797403|NCT03339297|58811708|FG000|Overall Study|Adverse Event, Non-fatal|1|||
30797404|NCT03339297|58811709|FG001|Overall Study|Adverse Event, Non-fatal|0|||
30797405|NCT03339297|58811708|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
30797406|NCT03339297|58811709|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
30797407|NCT03339297|58811708|FG000|Overall Study|Patient Was Not Eligible|1|||
30797408|NCT03339297|58811709|FG001|Overall Study|Patient Was Not Eligible|0|||
30797409|NCT03713281|58811735|FG000|Overall Study|Lens handling difficuluties|2|||
30797410|NCT03713281|58811735|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
30797411|NCT03339219|58811739|FG000|Overall Study|Death|12|||
30797412|NCT03339219|58811739|FG000|Overall Study|Site Terminated by Sponsor|22|||
30797413|NCT03339219|58811739|FG000|Overall Study|Withdrawal by Subject|1|||
30797414|NCT03338673|58811745|FG000|Overall Study|Lost to Follow-up|1|||
30797415|NCT03338673|58811746|FG001|Overall Study|Lost to Follow-up|1|||
30797416|NCT02949024|58811754|FG000|Overall Study|Withdrawal by Subject|0|||
30797417|NCT02949024|58811755|FG001|Overall Study|Withdrawal by Subject|1|||
30797418|NCT03093428|58811765|FG000|Overall Study|Not eligible for treatment|2|||
30797419|NCT03093428|58811766|FG001|Overall Study|Not eligible for treatment|1|||
30797420|NCT03093428|58811765|FG000|Overall Study|Progression|14|||
30797421|NCT03093428|58811766|FG001|Overall Study|Progression|4|||
30797422|NCT03093428|58811765|FG000|Overall Study|Death|1|||
30797423|NCT03093428|58811766|FG001|Overall Study|Death|0|||
30797424|NCT03093428|58811765|FG000|Overall Study|Adverse Event|1|||
30797425|NCT03093428|58811766|FG001|Overall Study|Adverse Event|0|||
30797426|NCT03093428|58811765|FG000|Overall Study|Withdrawal by Subject|1|||
30797427|NCT03093428|58811766|FG001|Overall Study|Withdrawal by Subject|1|||
30797428|NCT02735980|58811775|FG000|Overall Study|Adverse Event|0|||
30797429|NCT02735980|58811776|FG001|Overall Study|Adverse Event|4|||
30797430|NCT02735980|58811777|FG002|Overall Study|Adverse Event|1|||
30797431|NCT02735980|58811775|FG000|Overall Study|Death|5|||
30797432|NCT02735980|58811776|FG001|Overall Study|Death|4|||
30797433|NCT02735980|58811777|FG002|Overall Study|Death|0|||
30797434|NCT02735980|58811775|FG000|Overall Study|Physician Decision|3|||
30797435|NCT02735980|58811776|FG001|Overall Study|Physician Decision|1|||
30797436|NCT02735980|58811777|FG002|Overall Study|Physician Decision|0|||
30797437|NCT02735980|58811775|FG000|Overall Study|Screen failure|1|||
30797438|NCT02735980|58811776|FG001|Overall Study|Screen failure|0|||
30797439|NCT02735980|58811777|FG002|Overall Study|Screen failure|0|||
30797440|NCT02735980|58811775|FG000|Overall Study|Withdrawal by Subject|1|||
30797441|NCT02735980|58811776|FG001|Overall Study|Withdrawal by Subject|2|||
30797442|NCT02735980|58811777|FG002|Overall Study|Withdrawal by Subject|0|||
30797443|NCT03338400|58811792|FG000|Overall Study|Lost to Follow-up|1|||
30797444|NCT03338400|58811793|FG001|Overall Study|Lost to Follow-up|2|||
30797445|NCT03337113|58811811|FG000|Overall Study|Adverse Event|1|||
30797446|NCT03337113|58811812|FG001|Overall Study|Adverse Event|1|||
30797447|NCT03337113|58811813|FG002|Overall Study|Adverse Event|0|||
30797448|NCT03337113|58811814|FG003|Overall Study|Adverse Event|1|||
30797449|NCT03337113|58811811|FG000|Overall Study|Physician Decision|0|||
30797450|NCT03337113|58811812|FG001|Overall Study|Physician Decision|2|||
30797451|NCT03337113|58811813|FG002|Overall Study|Physician Decision|0|||
30797452|NCT03337113|58811814|FG003|Overall Study|Physician Decision|1|||
30797453|NCT03337113|58811811|FG000|Overall Study|Withdrawal by Subject|0|||
30797454|NCT03337113|58811812|FG001|Overall Study|Withdrawal by Subject|0|||
30797455|NCT03337113|58811813|FG002|Overall Study|Withdrawal by Subject|1|||
30797456|NCT03337113|58811814|FG003|Overall Study|Withdrawal by Subject|0|||
30797457|NCT03092726|58811826|FG000|Overall Study|Adverse Event|3|||
30797458|NCT03092726|58811827|FG001|Overall Study|Adverse Event|10|||
30797459|NCT03092726|58811826|FG000|Overall Study|Lack of Efficacy|0|||
30797460|NCT03092726|58811827|FG001|Overall Study|Lack of Efficacy|1|||
30797461|NCT03092726|58811826|FG000|Overall Study|Lost to Follow-up|1|||
30797462|NCT03092726|58811827|FG001|Overall Study|Lost to Follow-up|0|||
30797463|NCT03092726|58811826|FG000|Overall Study|Withdrawal by Subject|5|||
30797464|NCT03092726|58811827|FG001|Overall Study|Withdrawal by Subject|3|||
30797465|NCT03338010|58811835|FG000|Overall Study|Withdrawal by Subject|14|||
30797466|NCT03338010|58811836|FG001|Overall Study|Withdrawal by Subject|8|||
30797467|NCT03338010|58811835|FG000|Overall Study|Lost to Follow-up|4|||
30797468|NCT03338010|58811836|FG001|Overall Study|Lost to Follow-up|2|||
30797469|NCT03338010|58811835|FG000|Overall Study|Adverse Event|3|||
30797470|NCT03338010|58811836|FG001|Overall Study|Adverse Event|2|||
30797471|NCT03338010|58811835|FG000|Overall Study|Physician Decision|2|||
30797472|NCT03338010|58811836|FG001|Overall Study|Physician Decision|2|||
30797473|NCT03338010|58811835|FG000|Overall Study|Non-Compliance with Study Drug|0|||
30797474|NCT03338010|58811836|FG001|Overall Study|Non-Compliance with Study Drug|3|||
30797475|NCT03338010|58811835|FG000|Overall Study|Protocol Violation|0|||
30797476|NCT03338010|58811836|FG001|Overall Study|Protocol Violation|1|||
30797477|NCT03337542|58811842|FG000|Overall Study|Withdrew Consent|17|||
30797478|NCT03337542|58811842|FG000|Overall Study|Allergic Adverse Event|1|||
30797479|NCT03337542|58811842|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
30797480|NCT03337542|58811842|FG000|Overall Study|Lost to Follow-up|1|||
30797481|NCT03337542|58811842|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
30797482|NCT01328548|58811849|FG000|Overall Study|Death|3|||
30797483|NCT01328548|58811850|FG001|Overall Study|Death|0|||
30797484|NCT01328548|58811849|FG000|Overall Study|Protocol Violation|1|||
30797485|NCT01328548|58811850|FG001|Overall Study|Protocol Violation|0|||
30797486|NCT03337308|58811888|FG000|Overall Study|Adverse Event|2|||
30797487|NCT03337308|58811889|FG001|Overall Study|Adverse Event|3|||
30797488|NCT03337308|58811890|FG002|Overall Study|Adverse Event|3|||
30797489|NCT03337308|58811891|FG003|Overall Study|Adverse Event|1|||
30797490|NCT03337308|58811888|FG000|Overall Study|Lost to Follow-up|1|||
30797491|NCT03337308|58811889|FG001|Overall Study|Lost to Follow-up|2|||
30797492|NCT03337308|58811890|FG002|Overall Study|Lost to Follow-up|0|||
30797493|NCT03337308|58811891|FG003|Overall Study|Lost to Follow-up|0|||
30797494|NCT03337308|58811888|FG000|Overall Study|Withdrawal by Subject|2|||
30797495|NCT03337308|58811889|FG001|Overall Study|Withdrawal by Subject|1|||
30797496|NCT03337308|58811890|FG002|Overall Study|Withdrawal by Subject|2|||
30797497|NCT03337308|58811891|FG003|Overall Study|Withdrawal by Subject|1|||
30797498|NCT03337308|58811888|FG000|Overall Study|Protocol Violation|0|||
30797499|NCT03337308|58811889|FG001|Overall Study|Protocol Violation|1|||
30797500|NCT03337308|58811890|FG002|Overall Study|Protocol Violation|0|||
30797501|NCT03337308|58811891|FG003|Overall Study|Protocol Violation|0|||
30797502|NCT03337152|58811903|FG000|Overall Study|Physician Decision|1|||
30797503|NCT03337152|58811904|FG001|Overall Study|Physician Decision|0|||
30797504|NCT03337152|58811903|FG000|Overall Study|Lost to Follow-up|1|||
30797505|NCT03337152|58811904|FG001|Overall Study|Lost to Follow-up|3|||
30797506|NCT03337152|58811903|FG000|Overall Study|Adverse Event|3|||
30797507|NCT03337152|58811904|FG001|Overall Study|Adverse Event|1|||
30797508|NCT03337152|58811903|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
30797509|NCT03337152|58811904|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
30797510|NCT03710161|58811918|FG000|Overall Study|Study halted due to COVID pandemic|3|||
30797511|NCT03710161|58811919|FG001|Overall Study|Study halted due to COVID pandemic|2|||
30797512|NCT03091400|58811927|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
30797513|NCT03091400|58811928|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
30797514|NCT01318993|58811934|FG000|Overall Study|Adverse Event|53|||
30797515|NCT01318993|58811934|FG000|Overall Study|Lack of Efficacy|121|||
30797516|NCT01318993|58811934|FG000|Overall Study|Protocol Violation|3|||
30797517|NCT01318993|58811934|FG000|Overall Study|Protocol based stopping criteria|6|||
30797518|NCT01318993|58811934|FG000|Overall Study|Study closed or terminated|174|||
30797519|NCT01318993|58811934|FG000|Overall Study|Lost to Follow-up|4|||
30797520|NCT01318993|58811934|FG000|Overall Study|Physician Decision|13|||
30797521|NCT01318993|58811934|FG000|Overall Study|Withdrawal by Subject|24|||
30797522|NCT03090152|58811941|FG000|Overall Study|Withdrawal by Subject|0|||
30797523|NCT03090152|58811942|FG001|Overall Study|Withdrawal by Subject|2|||
30797524|NCT03090152|58811943|FG002|Overall Study|Withdrawal by Subject|1|||
30797525|NCT03090152|58811941|FG000|Overall Study|Surgery Canceled|1|||
30797526|NCT03090152|58811942|FG001|Overall Study|Surgery Canceled|0|||
30797527|NCT03090152|58811943|FG002|Overall Study|Surgery Canceled|0|||
30797528|NCT03090152|58811941|FG000|Overall Study|Epidural catheter could not be placed|0|||
30797529|NCT03090152|58811942|FG001|Overall Study|Epidural catheter could not be placed|2|||
30797530|NCT03090152|58811943|FG002|Overall Study|Epidural catheter could not be placed|0|||
30797531|NCT04252287|58811953|FG000|Overall Study|Death|5|||
30797532|NCT04252287|58811954|FG001|Overall Study|Death|3|||
30797533|NCT04252287|58811953|FG000|Overall Study|Lost to Follow-up|4|||
30797534|NCT04252287|58811954|FG001|Overall Study|Lost to Follow-up|6|||
30797535|NCT04252287|58811953|FG000|Overall Study|Withdrawal by Subject|19|||
30797536|NCT04252287|58811954|FG001|Overall Study|Withdrawal by Subject|16|||
30797537|NCT04252287|58811953|FG000|Overall Study|Protocol Violation|3|||
30797538|NCT04252287|58811954|FG001|Overall Study|Protocol Violation|4|||
30797539|NCT02735200|58811966|FG000|Overall Study|Lost to Follow-up|0|||
30797540|NCT02735200|58811967|FG001|Overall Study|Lost to Follow-up|5|||
30797541|NCT02735200|58811966|FG000|Overall Study|Withdrawal by Subject|8|||
30797542|NCT02735200|58811967|FG001|Overall Study|Withdrawal by Subject|0|||
30797543|NCT02946918|58811975|FG000|Overall Study|Patient unblinded himself|1|||
30797544|NCT02946918|58811976|FG001|Overall Study|Patient unblinded himself|0|||
30905093|NCT02255461|58939646|FG001|Overall Study|Withdrawal by Subject|0|||
30905094|NCT02255461|58939647|FG002|Overall Study|Withdrawal by Subject|1|||
30905095|NCT02255461|58939648|FG003|Overall Study|Withdrawal by Subject|0|||
30905096|NCT02255461|58939649|FG004|Overall Study|Withdrawal by Subject|1|||
30905097|NCT02255461|58939645|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
30905098|NCT02255461|58939646|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
30905099|NCT02255461|58939647|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
30905100|NCT02255461|58939648|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
30905101|NCT02255461|58939649|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
30905102|NCT02255149|58939666|FG000|Overall Study|Lost to Follow-up|2|||
30905103|NCT02255149|58939666|FG000|Overall Study|Withdrawal by Subject|1|||
30905104|NCT02255149|58939666|FG000|Overall Study|Withdrawal by PI|1|||
30905105|NCT02255149|58939666|FG000|Overall Study|Implant Failure|1|||
30905106|NCT01764022|58939672|FG000|Overall Study|Death|3|||
30905107|NCT01764022|58939673|FG001|Overall Study|Death|5|||
30905108|NCT01764022|58939672|FG000|Overall Study|Withdrawal by Subject|2|||
30905109|NCT01764022|58939673|FG001|Overall Study|Withdrawal by Subject|6|||
30797545|NCT02946918|58811975|FG000|Overall Study|Physician Decision|0|||
30797546|NCT02946918|58811976|FG001|Overall Study|Physician Decision|2|||
30797547|NCT02946918|58811975|FG000|Overall Study|Ran out of study medication|0|||
30797548|NCT02946918|58811976|FG001|Overall Study|Ran out of study medication|1|||
30797549|NCT02734810|58811997|FG000|Overall Study|Adverse Event|1|||
30797550|NCT02734810|58811998|FG001|Overall Study|Adverse Event|0|||
30797551|NCT02734810|58811997|FG000|Overall Study|Lack of Efficacy|1|||
30797552|NCT02734810|58811998|FG001|Overall Study|Lack of Efficacy|0|||
30797553|NCT03656068|58812023|FG000|Overall Study|Withdrawal by Subject|4|||
30797554|NCT03656068|58812023|FG000|Overall Study|Adverse Event|1|||
30797555|NCT02944383|58812030|FG000|Overall Study|Lost to Follow-up|0|||
30797556|NCT02944383|58812031|FG001|Overall Study|Lost to Follow-up|0|||
30797557|NCT02944383|58812032|FG002|Overall Study|Lost to Follow-up|1|||
30905110|NCT01764022|58939672|FG000|Overall Study|Lack of Efficacy|0|||
30905111|NCT01764022|58939673|FG001|Overall Study|Lack of Efficacy|1|||
30797558|NCT02944383|58812030|FG000|Overall Study|Withdrawal by Subject|1|||
30797559|NCT02944383|58812031|FG001|Overall Study|Withdrawal by Subject|0|||
30797560|NCT02944383|58812032|FG002|Overall Study|Withdrawal by Subject|0|||
30797561|NCT03768089|58812060|FG000|Part A|Lost to Follow-up|0|||
30797562|NCT03768089|58812061|FG001|Part A|Lost to Follow-up|0|||
30797563|NCT03768089|58812062|FG002|Part A|Lost to Follow-up|0|||
30797564|NCT03768089|58812063|FG003|Part A|Lost to Follow-up|0|||
30797565|NCT03768089|58812064|FG004|Part A|Lost to Follow-up|1|||
30797566|NCT03768089|58812065|FG005|Part A|Lost to Follow-up|0|||
30797567|NCT03768089|58812066|FG006|Part A|Lost to Follow-up|0|||
30905112|NCT01764022|58939672|FG000|Overall Study|Physician Decision|0|||
30905113|NCT01764022|58939673|FG001|Overall Study|Physician Decision|2|||
30905114|NCT01764022|58939672|FG000|Overall Study|Lost to Follow-up|2|||
30797568|NCT03768089|58812067|FG007|Part A|Lost to Follow-up|0|||
30905115|NCT01764022|58939673|FG001|Overall Study|Lost to Follow-up|0|||
30905116|NCT01764022|58939672|FG000|Overall Study|Protocol Violation|1|||
30905117|NCT01764022|58939673|FG001|Overall Study|Protocol Violation|0|||
30905118|NCT02003391|58939683|FG000|Overall Study|Withdrawal by Subject|2|||
30905119|NCT02003391|58939684|FG001|Overall Study|Withdrawal by Subject|1|||
30905120|NCT02003391|58939683|FG000|Overall Study|Protocol Violation|0|||
30905121|NCT02003391|58939684|FG001|Overall Study|Protocol Violation|1|||
30905122|NCT02003391|58939683|FG000|Overall Study|Adverse Event|1|||
30797569|NCT03768089|58812068|FG008|Part A|Lost to Follow-up|0|||
30797570|NCT03768089|58812069|FG009|Part A|Lost to Follow-up|0|||
30797571|NCT03768089|58812070|FG010|Part A|Lost to Follow-up|0|||
30797572|NCT03768089|58812071|FG011|Part A|Lost to Follow-up|0|||
30797573|NCT03768089|58812072|FG012|Part A|Lost to Follow-up|0|||
30797574|NCT03768089|58812073|FG013|Part A|Lost to Follow-up|0|||
30797575|NCT03768089|58812074|FG014|Part A|Lost to Follow-up|0|||
30797576|NCT03768089|58812075|FG015|Part A|Lost to Follow-up|0|||
30797577|NCT03768089|58812076|FG016|Part A|Lost to Follow-up|0|||
30797578|NCT03768089|58812077|FG017|Part A|Lost to Follow-up|0|||
30797579|NCT03768089|58812060|FG000|Part C|Randomized, Never Dosed|0|||
30797580|NCT03768089|58812061|FG001|Part C|Randomized, Never Dosed|0|||
30797581|NCT03768089|58812062|FG002|Part C|Randomized, Never Dosed|0|||
30797582|NCT03768089|58812063|FG003|Part C|Randomized, Never Dosed|0|||
30797583|NCT03768089|58812064|FG004|Part C|Randomized, Never Dosed|0|||
30797584|NCT03768089|58812065|FG005|Part C|Randomized, Never Dosed|0|||
30797585|NCT03768089|58812066|FG006|Part C|Randomized, Never Dosed|0|||
30797586|NCT03768089|58812067|FG007|Part C|Randomized, Never Dosed|0|||
30797587|NCT03768089|58812068|FG008|Part C|Randomized, Never Dosed|0|||
30797588|NCT03768089|58812069|FG009|Part C|Randomized, Never Dosed|0|||
30797589|NCT03768089|58812070|FG010|Part C|Randomized, Never Dosed|0|||
30797590|NCT03768089|58812071|FG011|Part C|Randomized, Never Dosed|0|||
30797591|NCT03768089|58812072|FG012|Part C|Randomized, Never Dosed|0|||
30797592|NCT03768089|58812073|FG013|Part C|Randomized, Never Dosed|0|||
30797593|NCT03768089|58812074|FG014|Part C|Randomized, Never Dosed|1|||
30797594|NCT03768089|58812075|FG015|Part C|Randomized, Never Dosed|0|||
30905123|NCT02003391|58939684|FG001|Overall Study|Adverse Event|0|||
30905124|NCT02254681|58939690|FG000|Overall Study|Lack of Efficacy|6|||
30905125|NCT01965327|58939695|FG000|Overall Study|Physician Decision|2|||
30905126|NCT02002689|58939699|FG000|Overall Study|Disease Progression|7|||
30905127|NCT02002689|58939699|FG000|Overall Study|Adverse Event|3|||
30905128|NCT01639729|58939703|FG000|Overall Study|Withdrawal by Subject|1|||
30797595|NCT03768089|58812076|FG016|Part C|Randomized, Never Dosed|0|||
30797596|NCT03768089|58812077|FG017|Part C|Randomized, Never Dosed|0|||
30797597|NCT03086330|58812138|FG000|Overall Study|Withdrawal by Subject|3|||
30797598|NCT03086330|58812139|FG001|Overall Study|Withdrawal by Subject|2|||
30905129|NCT01639729|58939704|FG001|Overall Study|Withdrawal by Subject|0|||
30905130|NCT01639729|58939705|FG002|Overall Study|Withdrawal by Subject|1|||
30905131|NCT01639729|58939706|FG003|Overall Study|Withdrawal by Subject|1|||
30905132|NCT01639729|58939707|FG004|Overall Study|Withdrawal by Subject|0|||
30905133|NCT01639729|58939708|FG005|Overall Study|Withdrawal by Subject|0|||
30797599|NCT03086330|58812138|FG000|Overall Study|Lost to Follow-up|1|||
30797600|NCT03086330|58812139|FG001|Overall Study|Lost to Follow-up|2|||
30797601|NCT02943993|58812171|FG000|Overall Study|Withdrawal by Subject|52|||
30797602|NCT02943993|58812171|FG000|Overall Study|Transfer to another institution|6|||
30797603|NCT02943993|58812171|FG000|Overall Study|Lost to Follow-up|135|||
30797604|NCT02943993|58812171|FG000|Overall Study|Death|98|||
30905134|NCT02002533|58939720|FG000|Overall Study|Withdrawal by Subject|6|||
30905135|NCT02002533|58939721|FG001|Overall Study|Withdrawal by Subject|13|||
30797605|NCT02943993|58812171|FG000|Overall Study|Other reason for premature termination|32|||
30797606|NCT02943993|58812171|FG000|Overall Study|Missing reason for termination|7|||
30797607|NCT02943447|58812195|FG000|Blinded Study Phase|Withdrew Consent|1|||
30797608|NCT02943447|58812196|FG001|Blinded Study Phase|Withdrew Consent|2|||
30797609|NCT02943447|58812197|FG002|Blinded Study Phase|Withdrew Consent|1|||
30797610|NCT02943447|58812195|FG000|Blinded Study Phase|Adverse Event|3|||
30797611|NCT02943447|58812196|FG001|Blinded Study Phase|Adverse Event|0|||
30797612|NCT02943447|58812197|FG002|Blinded Study Phase|Adverse Event|0|||
30797613|NCT02943447|58812195|FG000|Blinded Study Phase|Investigator's discretion|1|||
30797614|NCT02943447|58812196|FG001|Blinded Study Phase|Investigator's discretion|0|||
30797615|NCT02943447|58812197|FG002|Blinded Study Phase|Investigator's discretion|0|||
30797616|NCT02943447|58812195|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
30797617|NCT02943447|58812196|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
30797618|NCT02943447|58812197|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
30797619|NCT02943447|58812195|FG000|Open-Label Extension Phase|Adverse Event|4|||
30797620|NCT02943447|58812196|FG001|Open-Label Extension Phase|Adverse Event|7|||
30797621|NCT02943447|58812197|FG002|Open-Label Extension Phase|Adverse Event|3|||
30797622|NCT02943447|58812195|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
30797623|NCT02943447|58812196|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
30797624|NCT02943447|58812197|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
30797625|NCT02943447|58812195|FG000|Open-Label Extension Phase|Withdrew consent|1|||
30797626|NCT02943447|58812196|FG001|Open-Label Extension Phase|Withdrew consent|1|||
30797627|NCT02943447|58812197|FG002|Open-Label Extension Phase|Withdrew consent|1|||
30797628|NCT02943447|58812195|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
30797629|NCT02943447|58812196|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
30797630|NCT02943447|58812197|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
30797631|NCT02844777|58812226|FG000|Overall Study|Withdrawal by Subject|2|||
30797632|NCT02844777|58812227|FG001|Overall Study|Withdrawal by Subject|0|||
30797633|NCT02844777|58812228|FG002|Overall Study|Withdrawal by Subject|0|||
30797634|NCT04003142|58812239|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
30797635|NCT04003142|58812240|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
30797636|NCT04003142|58812241|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
30797637|NCT04003142|58812242|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
30797638|NCT04003142|58812243|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
30797639|NCT04003142|58812239|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
30797640|NCT04003142|58812240|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
30797641|NCT04003142|58812241|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
30797642|NCT04003142|58812242|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
30797643|NCT04003142|58812243|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
30797644|NCT04003142|58812239|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
30797645|NCT04003142|58812240|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
30797646|NCT04003142|58812241|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
30797647|NCT04003142|58812242|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
30797648|NCT04003142|58812243|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
30797649|NCT04003142|58812239|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
30797650|NCT04003142|58812240|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
30797651|NCT04003142|58812241|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
30797652|NCT04003142|58812242|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
30797653|NCT04003142|58812243|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
30797654|NCT04003142|58812239|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
30797655|NCT04003142|58812240|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
30797656|NCT04003142|58812241|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
30797657|NCT04003142|58812242|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
30797658|NCT04003142|58812243|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
30797659|NCT04003142|58812239|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
30797660|NCT04003142|58812240|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
30797661|NCT04003142|58812241|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
30797662|NCT04003142|58812242|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
30797663|NCT04003142|58812243|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
30797664|NCT04003142|58812239|FG000|Extension Period (40 Weeks)|Death|0|||
30797665|NCT04003142|58812240|FG001|Extension Period (40 Weeks)|Death|0|||
30797666|NCT04003142|58812241|FG002|Extension Period (40 Weeks)|Death|0|||
30797667|NCT04003142|58812242|FG003|Extension Period (40 Weeks)|Death|0|||
30797668|NCT04003142|58812243|FG004|Extension Period (40 Weeks)|Death|1|||
30797669|NCT04003142|58812239|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
30797670|NCT04003142|58812240|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
30797671|NCT04003142|58812241|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
30797672|NCT04003142|58812242|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
30797673|NCT04003142|58812243|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
30797674|NCT04003142|58812239|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
30905136|NCT02002533|58939720|FG000|Overall Study|Protocol Violation|0|||
30797675|NCT04003142|58812240|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
30797676|NCT04003142|58812241|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
30797677|NCT04003142|58812242|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
30797678|NCT04003142|58812243|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
30797679|NCT04003142|58812239|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
30797680|NCT04003142|58812240|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
30797681|NCT04003142|58812241|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
30797682|NCT04003142|58812242|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
30797683|NCT04003142|58812243|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
30797684|NCT04003142|58812239|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
30797685|NCT04003142|58812240|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
30797686|NCT04003142|58812241|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
30797687|NCT04003142|58812242|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
30797688|NCT04003142|58812243|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
30797689|NCT02612337|58812263|FG000|Overall Study|Lack of Efficacy|1|||
30797690|NCT02612337|58812264|FG001|Overall Study|Lack of Efficacy|0|||
30797691|NCT02612337|58812263|FG000|Overall Study|Withdrawal by Subject|2|||
30797692|NCT02612337|58812264|FG001|Overall Study|Withdrawal by Subject|2|||
30797693|NCT02612337|58812263|FG000|Overall Study|Did not receive study drug|0|||
30797694|NCT02612337|58812264|FG001|Overall Study|Did not receive study drug|1|||
30797695|NCT03532451|58812278|FG000|Overall Study|Withdrawal by Subject|0|||
30797696|NCT03532451|58812279|FG001|Overall Study|Withdrawal by Subject|1|||
30797697|NCT03532451|58812278|FG000|Overall Study|Progression prior to the surgery|1|||
30797698|NCT03532451|58812279|FG001|Overall Study|Progression prior to the surgery|0|||
30797699|NCT03085238|58812285|FG000|Overall Study|Adverse Event|2|||
30797700|NCT03085238|58812285|FG000|Overall Study|Death|2|||
30797701|NCT03383666|58812298|FG000|Overall Study|Withdrawal by Subject|2|||
30797702|NCT03383666|58812298|FG000|Overall Study|Lost to Follow-up|2|||
30797703|NCT03086018|58812302|FG000|Final Testing for End of Trial|Adverse Event|1|||
30797704|NCT03086018|58812302|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
30797705|NCT03319953|58812312|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
30797706|NCT03319953|58812313|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
30797707|NCT03319953|58812314|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
30797708|NCT03319953|58812315|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
30797709|NCT03319953|58812312|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
30746514|NCT00296504|58756934|FG001|Interim Analysis|Resistance to FPV|0|||
30746515|NCT00296504|58756935|FG002|Interim Analysis|Resistance to FPV|1|||
30746516|NCT00296504|58756936|FG003|Interim Analysis|Resistance to FPV|0|||
30746517|NCT00296504|58756937|FG004|Interim Analysis|Resistance to FPV|0|||
30746518|NCT00296504|58756938|FG005|Interim Analysis|Resistance to FPV|0|||
30746519|NCT00296504|58756939|FG006|Interim Analysis|Resistance to FPV|0|||
30746520|NCT00296504|58756940|FG007|Interim Analysis|Resistance to FPV|0|||
30746521|NCT00296504|58756941|FG008|Interim Analysis|Resistance to FPV|0|||
30746522|NCT00296504|58756933|FG000|Interim Analysis|Physician Decision|0|||
30746523|NCT00296504|58756934|FG001|Interim Analysis|Physician Decision|0|||
30746524|NCT00296504|58756935|FG002|Interim Analysis|Physician Decision|1|||
30746525|NCT00296504|58756936|FG003|Interim Analysis|Physician Decision|0|||
30746526|NCT00296504|58756937|FG004|Interim Analysis|Physician Decision|0|||
30746527|NCT00296504|58756938|FG005|Interim Analysis|Physician Decision|0|||
30746528|NCT00296504|58756939|FG006|Interim Analysis|Physician Decision|0|||
30746529|NCT00296504|58756940|FG007|Interim Analysis|Physician Decision|0|||
30746530|NCT00296504|58756941|FG008|Interim Analysis|Physician Decision|0|||
30746531|NCT00296504|58756933|FG000|Interim Analysis|Principle Investigator Discretion|2|||
30746532|NCT00296504|58756934|FG001|Interim Analysis|Principle Investigator Discretion|0|||
30746533|NCT00296504|58756935|FG002|Interim Analysis|Principle Investigator Discretion|1|||
30746534|NCT00296504|58756936|FG003|Interim Analysis|Principle Investigator Discretion|1|||
30746535|NCT00296504|58756937|FG004|Interim Analysis|Principle Investigator Discretion|0|||
30746536|NCT00296504|58756938|FG005|Interim Analysis|Principle Investigator Discretion|0|||
30746537|NCT00296504|58756939|FG006|Interim Analysis|Principle Investigator Discretion|0|||
30746538|NCT00296504|58756940|FG007|Interim Analysis|Principle Investigator Discretion|0|||
30797710|NCT03319953|58812313|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
30746539|NCT00296504|58756941|FG008|Interim Analysis|Principle Investigator Discretion|0|||
30797711|NCT03319953|58812314|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
30797712|NCT03319953|58812315|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
30797713|NCT02927834|58812326|FG000|Overall Study|Lost to Follow-up|1|||
30746540|NCT00296504|58756933|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
30746541|NCT00296504|58756934|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
30746542|NCT00296504|58756935|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
30797714|NCT02927834|58812327|FG001|Overall Study|Lost to Follow-up|2|||
30797715|NCT02927834|58812328|FG002|Overall Study|Lost to Follow-up|2|||
30797716|NCT01964547|58812342|FG000|Overall Study|Adverse Event|8|||
30797717|NCT01964547|58812343|FG001|Overall Study|Adverse Event|2|||
30797718|NCT01964547|58812342|FG000|Overall Study|Withdrawal by Subject|4|||
30797719|NCT01964547|58812343|FG001|Overall Study|Withdrawal by Subject|7|||
30797720|NCT01964547|58812342|FG000|Overall Study|Lost to Follow-up|0|||
30797721|NCT01964547|58812343|FG001|Overall Study|Lost to Follow-up|1|||
30797722|NCT01964547|58812342|FG000|Overall Study|Withdrawal by Investigator|0|||
30797723|NCT01964547|58812343|FG001|Overall Study|Withdrawal by Investigator|1|||
30797724|NCT03319719|58812349|FG000|Overall Study|Lost to Follow-up|1|||
30797725|NCT03318783|58812357|FG000|Overall Study|Withdrawal by Subject|0|||
30797726|NCT03318783|58812358|FG001|Overall Study|Withdrawal by Subject|1|||
30797727|NCT03318783|58812357|FG000|Overall Study|Death|0|||
30797728|NCT03318783|58812358|FG001|Overall Study|Death|1|||
30797729|NCT01313689|58812369|FG000|24-Week Randomization 1|Adverse Event|10|||
30797730|NCT01313689|58812370|FG001|24-Week Randomization 1|Adverse Event|5|||
30797731|NCT01313689|58812371|FG002|24-Week Randomization 1|Adverse Event|0|||
30797732|NCT01313689|58812372|FG003|24-Week Randomization 1|Adverse Event|0|||
30797733|NCT01313689|58812373|FG004|24-Week Randomization 1|Adverse Event|0|||
30797734|NCT01313689|58812369|FG000|24-Week Randomization 1|Physician Decision|4|||
30797735|NCT01313689|58812370|FG001|24-Week Randomization 1|Physician Decision|5|||
30797736|NCT01313689|58812371|FG002|24-Week Randomization 1|Physician Decision|0|||
30797737|NCT01313689|58812372|FG003|24-Week Randomization 1|Physician Decision|0|||
30797738|NCT01313689|58812373|FG004|24-Week Randomization 1|Physician Decision|0|||
30797739|NCT01313689|58812369|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
30797740|NCT01313689|58812370|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
30797741|NCT01313689|58812371|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
30797742|NCT01313689|58812372|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
30797743|NCT01313689|58812373|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
30797744|NCT01313689|58812369|FG000|24-Week Randomization 2|Adverse Event|0|||
30797745|NCT01313689|58812370|FG001|24-Week Randomization 2|Adverse Event|0|||
30797746|NCT01313689|58812371|FG002|24-Week Randomization 2|Adverse Event|2|||
30797747|NCT01313689|58812372|FG003|24-Week Randomization 2|Adverse Event|0|||
30797748|NCT01313689|58812373|FG004|24-Week Randomization 2|Adverse Event|8|||
30797749|NCT01313689|58812369|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
30797750|NCT01313689|58812370|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
30797751|NCT01313689|58812371|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
30797752|NCT01313689|58812372|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
30797753|NCT01313689|58812373|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
30797754|NCT01313689|58812369|FG000|24-Week Randomization 2|Physician Decision|0|||
30797755|NCT01313689|58812370|FG001|24-Week Randomization 2|Physician Decision|0|||
30905137|NCT02002533|58939721|FG001|Overall Study|Protocol Violation|1|||
30905138|NCT02002533|58939720|FG000|Overall Study|Adverse Event|0|||
30905139|NCT02002533|58939721|FG001|Overall Study|Adverse Event|3|||
30905140|NCT02002533|58939720|FG000|Overall Study|Lost to Follow-up|0|||
30905141|NCT02002533|58939721|FG001|Overall Study|Lost to Follow-up|1|||
30905142|NCT02002221|58939730|FG000|Overall Study|Adverse Event|2|||
30905143|NCT02002221|58939731|FG001|Overall Study|Adverse Event|1|||
30905144|NCT02002221|58939730|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30746543|NCT00296504|58756936|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
30746544|NCT00296504|58756937|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
30746545|NCT00296504|58756938|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
30746546|NCT00296504|58756939|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
30746547|NCT00296504|58756940|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
30746548|NCT00296504|58756941|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
30746549|NCT00296504|58756933|FG000|Interim Analysis|Non-adherence|2|||
30746550|NCT00296504|58756934|FG001|Interim Analysis|Non-adherence|0|||
30797756|NCT01313689|58812371|FG002|24-Week Randomization 2|Physician Decision|0|||
30905145|NCT02002221|58939731|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30905146|NCT02002221|58939730|FG000|Overall Study|Patient withdrew consent|0|||
30905147|NCT02002221|58939731|FG001|Overall Study|Patient withdrew consent|1|||
30905148|NCT01639495|58939737|FG000|Overall Study|Lost to Follow-up|6|||
30622179|NCT01145508|58633679|FG001|Overall Study|Adverse Event|0|||
30622180|NCT01145508|58633678|FG000|Overall Study|Death|1|||
30622181|NCT01145508|58633679|FG001|Overall Study|Death|0|||
30797757|NCT01313689|58812372|FG003|24-Week Randomization 2|Physician Decision|0|||
30797758|NCT01313689|58812373|FG004|24-Week Randomization 2|Physician Decision|4|||
30622182|NCT01145508|58633678|FG000|Overall Study|Physician Decision|2|||
30746551|NCT00296504|58756935|FG002|Interim Analysis|Non-adherence|0|||
30746552|NCT00296504|58756936|FG003|Interim Analysis|Non-adherence|0|||
30797759|NCT03318315|58812395|FG000|Overall Study|Lost to Follow-up|3|||
30797760|NCT03318315|58812396|FG001|Overall Study|Lost to Follow-up|2|||
30797761|NCT03318315|58812397|FG002|Overall Study|Lost to Follow-up|1|||
30905149|NCT01639495|58939737|FG000|Overall Study|Consented but didn't have study catheter|4|||
30905150|NCT01639495|58939737|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
30905151|NCT01639495|58939737|FG000|Overall Study|No radiofrequency energy applied|2|||
30905152|NCT02001987|58939741|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
30905153|NCT02001987|58939741|FG000|Core Study Period (24 Weeks)|Death|1|||
30905154|NCT02001987|58939741|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
30905155|NCT02001987|58939741|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
30905156|NCT02001987|58939741|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
30905157|NCT02001987|58939741|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
30905158|NCT02001987|58939741|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
30905159|NCT02001987|58939741|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
30905160|NCT02001987|58939741|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
30905161|NCT02001987|58939741|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
30905162|NCT02001987|58939741|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
30905163|NCT02001987|58939741|FG000|LTE Period (52 Weeks)|Other|3|||
30905164|NCT01363765|58939752|FG000|Overall Study|non-diagnostic|2621|||
30905165|NCT01363765|58939753|FG001|Overall Study|non-diagnostic|1124|||
30905166|NCT01363765|58939752|FG000|Overall Study|duplicate records|736|||
30797762|NCT03318315|58812395|FG000|Overall Study|Protocol Violation|1|||
30797763|NCT03318315|58812396|FG001|Overall Study|Protocol Violation|1|||
30797764|NCT03318315|58812397|FG002|Overall Study|Protocol Violation|1|||
30797765|NCT03318315|58812395|FG000|Overall Study|Withdrawal by Subject|0|||
30797766|NCT03318315|58812396|FG001|Overall Study|Withdrawal by Subject|0|||
30797767|NCT03318315|58812397|FG002|Overall Study|Withdrawal by Subject|2|||
30797768|NCT04460183|58812408|FG000|Overall Study|Lost to Follow-up|3|||
30797769|NCT04460183|58812409|FG001|Overall Study|Lost to Follow-up|1|||
30797770|NCT04460183|58812408|FG000|Overall Study|Withdrawal by Subject|1|||
30797771|NCT04460183|58812409|FG001|Overall Study|Withdrawal by Subject|0|||
30797772|NCT03710083|58812415|FG000|Overall Study|Withdrawal by Subject|2|||
30797773|NCT03710083|58812415|FG000|Overall Study|Unsuccessful Procedure|1|||
30797774|NCT03318003|58812421|FG000|Overall Study|Withdrawal by Subject|1|||
30797775|NCT03318003|58812422|FG001|Overall Study|Withdrawal by Subject|1|||
30797776|NCT03318003|58812421|FG000|Overall Study|fetal loss|0|||
30797777|NCT03318003|58812422|FG001|Overall Study|fetal loss|1|||
30797778|NCT03317379|58812431|FG000|Overall Study|Lost to Follow-up|0|||
30797779|NCT03317379|58812432|FG001|Overall Study|Lost to Follow-up|3|||
30797780|NCT03317379|58812433|FG002|Overall Study|Lost to Follow-up|2|||
30797781|NCT03316911|58812443|FG000|Overall Study|Lost to Follow-up|33|||
30797782|NCT03316911|58812444|FG001|Overall Study|Lost to Follow-up|29|||
30797783|NCT01106391|58812450|FG000|Overall Study|Death|12|||
30797784|NCT01106391|58812450|FG000|Overall Study|Withdrawal by Subject|7|||
30797785|NCT03316131|58812454|FG000|Treatment Period 2|Protocol deviation|1|||
30797786|NCT03316131|58812455|FG001|Treatment Period 2|Protocol deviation|0|||
30797787|NCT03301415|58812461|FG000|Overall Study|Lost to Follow-up|2|||
30797788|NCT03301415|58812461|FG000|Overall Study|Unable to comply with visit schedule|2|||
30797789|NCT02732938|58812467|FG000|Overall Study|Death|0|||
30797790|NCT02732938|58812468|FG001|Overall Study|Death|11|||
30797791|NCT02732938|58812469|FG002|Overall Study|Death|0|||
30797792|NCT02732938|58812467|FG000|Overall Study|Randomized but did not receive treatment|0|||
30797793|NCT02732938|58812468|FG001|Overall Study|Randomized but did not receive treatment|1|||
30797794|NCT02732938|58812469|FG002|Overall Study|Randomized but did not receive treatment|0|||
30797795|NCT02732938|58812467|FG000|Overall Study|Refused further follow-up|1|||
30797796|NCT02732938|58812468|FG001|Overall Study|Refused further follow-up|0|||
30797797|NCT02732938|58812469|FG002|Overall Study|Refused further follow-up|0|||
30797798|NCT02732938|58812467|FG000|Overall Study|Study terminated by sponsor|3|||
30797799|NCT02732938|58812468|FG001|Overall Study|Study terminated by sponsor|6|||
30797800|NCT02732938|58812469|FG002|Overall Study|Study terminated by sponsor|0|||
30797801|NCT04647721|58812477|FG000|Overall Study|Withdrawal by Subject|0|||
30797802|NCT04647721|58812478|FG001|Overall Study|Withdrawal by Subject|2|||
30797803|NCT04647721|58812477|FG000|Overall Study|Lost to Follow-up|2|||
30905167|NCT01363765|58939753|FG001|Overall Study|duplicate records|3177|||
30905168|NCT01363765|58939752|FG000|Overall Study|non-resident|156|||
30905169|NCT01363765|58939753|FG001|Overall Study|non-resident|76|||
30905170|NCT01363765|58939752|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
30905171|NCT01363765|58939753|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
30905172|NCT01363765|58939752|FG000|Overall Study|smear during intervention|2170|||
30622183|NCT01145508|58633679|FG001|Overall Study|Physician Decision|1|||
30622184|NCT01145508|58633678|FG000|Overall Study|Never started treatment|1|||
30797804|NCT04647721|58812478|FG001|Overall Study|Lost to Follow-up|0|||
30797805|NCT03718000|58812499|FG000|Overall Study|Relocation|2|||
30797806|NCT03718000|58812500|FG001|Overall Study|Relocation|4|||
30797807|NCT03718000|58812499|FG000|Overall Study|Pregnancy|0|||
30797808|NCT03718000|58812500|FG001|Overall Study|Pregnancy|1|||
30905173|NCT01363765|58939753|FG001|Overall Study|smear during intervention|0|||
30905174|NCT02001051|58939763|FG000|Overall Study|Deemed not eligible following enrollment|0|||
30905175|NCT02001051|58939764|FG001|Overall Study|Deemed not eligible following enrollment|1|||
30905176|NCT01763164|58939772|FG000|Treatment Phase|Participant/Guardian decision|26|||
30905177|NCT01763164|58939773|FG001|Treatment Phase|Participant/Guardian decision|14|||
30905178|NCT01763164|58939772|FG000|Treatment Phase|Protocol Violation|1|||
30905179|NCT01763164|58939773|FG001|Treatment Phase|Protocol Violation|1|||
30905180|NCT01763164|58939772|FG000|Treatment Phase|Progressive Disease|142|||
30905181|NCT01763164|58939773|FG001|Treatment Phase|Progressive Disease|76|||
30905182|NCT01763164|58939772|FG000|Treatment Phase|Physician Decision|24|||
30905183|NCT01763164|58939773|FG001|Treatment Phase|Physician Decision|13|||
30905184|NCT01763164|58939772|FG000|Treatment Phase|Death|10|||
30905185|NCT01763164|58939773|FG001|Treatment Phase|Death|1|||
30905186|NCT01763164|58939772|FG000|Treatment Phase|Adverse Event|66|||
30905187|NCT01763164|58939773|FG001|Treatment Phase|Adverse Event|8|||
30905188|NCT01763164|58939772|FG000|Treatment Phase|Randomized but not Treated|0|||
30905189|NCT01763164|58939773|FG001|Treatment Phase|Randomized but not Treated|19|||
30905190|NCT01763164|58939772|FG000|Treatment Phase|Other|0|||
30905191|NCT01763164|58939773|FG001|Treatment Phase|Other|1|||
30905192|NCT01763164|58939772|FG000|Follow up Phase|New therapy for study indication|12|||
30905193|NCT01763164|58939773|FG001|Follow up Phase|New therapy for study indication|3|||
30905194|NCT01763164|58939772|FG000|Follow up Phase|Death|21|||
30905195|NCT01763164|58939773|FG001|Follow up Phase|Death|4|||
30905196|NCT01763164|58939772|FG000|Follow up Phase|Subject/guardian decision|9|||
30905197|NCT01763164|58939773|FG001|Follow up Phase|Subject/guardian decision|2|||
30905198|NCT01763164|58939772|FG000|Follow up Phase|Progressive disease|127|||
30905199|NCT01763164|58939773|FG001|Follow up Phase|Progressive disease|62|||
30905200|NCT01763164|58939772|FG000|Follow up Phase|Physician Decision|10|||
30905201|NCT01763164|58939773|FG001|Follow up Phase|Physician Decision|3|||
30905202|NCT01763164|58939772|FG000|Follow up Phase|Lost to Follow-up|1|||
30905203|NCT01763164|58939773|FG001|Follow up Phase|Lost to Follow-up|0|||
30905204|NCT01763164|58939772|FG000|Follow up Phase|Adverse Event|17|||
30905205|NCT01763164|58939773|FG001|Follow up Phase|Adverse Event|1|||
30905206|NCT01782742|58939781|FG000|Double-blind Treatment Phase|Adverse Event|1|||
30905207|NCT01782742|58939782|FG001|Double-blind Treatment Phase|Adverse Event|0|||
30905208|NCT01782664|58939796|FG000|Overall Study|Adverse Event|2|||
30905209|NCT01782664|58939797|FG001|Overall Study|Adverse Event|2|||
30905210|NCT01782664|58939798|FG002|Overall Study|Adverse Event|2|||
30622185|NCT01145508|58633679|FG001|Overall Study|Never started treatment|1|||
30622186|NCT00931528|58633687|FG000|Overall Study|Protocol Violation|9|||
30622187|NCT00931528|58633688|FG001|Overall Study|Protocol Violation|12|||
30622188|NCT00931528|58633687|FG000|Overall Study|Withdrawal by Subject|4|||
30622189|NCT00931528|58633688|FG001|Overall Study|Withdrawal by Subject|12|||
30622190|NCT00931528|58633687|FG000|Overall Study|Lost to Follow-up|6|||
30622191|NCT00931528|58633688|FG001|Overall Study|Lost to Follow-up|13|||
30622192|NCT00931528|58633687|FG000|Overall Study|Assessment outside of Time Frame|22|||
30622193|NCT00931528|58633688|FG001|Overall Study|Assessment outside of Time Frame|23|||
30622194|NCT00975195|58633697|FG000|Overall Study|Adverse Event|108|||
30905211|NCT01782664|58939799|FG003|Overall Study|Adverse Event|2|||
30905212|NCT01782664|58939800|FG004|Overall Study|Adverse Event|0|||
30905213|NCT01782664|58939801|FG005|Overall Study|Adverse Event|0|||
30905214|NCT01782664|58939796|FG000|Overall Study|Lack of Efficacy|2|||
30905215|NCT01782664|58939797|FG001|Overall Study|Lack of Efficacy|0|||
30905216|NCT01782664|58939798|FG002|Overall Study|Lack of Efficacy|2|||
30905217|NCT01782664|58939799|FG003|Overall Study|Lack of Efficacy|2|||
30905218|NCT01782664|58939800|FG004|Overall Study|Lack of Efficacy|0|||
30905219|NCT01782664|58939801|FG005|Overall Study|Lack of Efficacy|0|||
30905220|NCT01782664|58939796|FG000|Overall Study|Protocol Violation|0|||
30905221|NCT01782664|58939797|FG001|Overall Study|Protocol Violation|1|||
30905222|NCT01782664|58939798|FG002|Overall Study|Protocol Violation|0|||
30905223|NCT01782664|58939799|FG003|Overall Study|Protocol Violation|1|||
30905224|NCT01782664|58939800|FG004|Overall Study|Protocol Violation|0|||
30905225|NCT01782664|58939801|FG005|Overall Study|Protocol Violation|0|||
30905226|NCT01782664|58939796|FG000|Overall Study|Withdrawal by Subject|2|||
30905227|NCT01782664|58939797|FG001|Overall Study|Withdrawal by Subject|2|||
30905228|NCT01782664|58939798|FG002|Overall Study|Withdrawal by Subject|0|||
30905229|NCT01782664|58939799|FG003|Overall Study|Withdrawal by Subject|0|||
30905230|NCT01782664|58939800|FG004|Overall Study|Withdrawal by Subject|0|||
30905231|NCT01782664|58939801|FG005|Overall Study|Withdrawal by Subject|0|||
30905232|NCT01732588|58939818|FG000|First Intervention (7 Days)|Adverse Event|0|||
30622195|NCT00975195|58633698|FG001|Overall Study|Adverse Event|101|||
30622196|NCT00975195|58633697|FG000|Overall Study|Lack of Efficacy|6|||
30905233|NCT01732588|58939819|FG001|First Intervention (7 Days)|Adverse Event|1|||
30905234|NCT01732588|58939820|FG002|First Intervention (7 Days)|Adverse Event|0|||
30905235|NCT01781962|58939828|FG000|Overall Study|Other Miscellaneous Reasons|5|||
30905236|NCT01639339|58939834|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
30905237|NCT01639339|58939835|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
30905238|NCT01639339|58939834|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
30905239|NCT01639339|58939835|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
30905240|NCT01639339|58939834|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
30905241|NCT01639339|58939835|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
30905242|NCT01639339|58939834|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
30905243|NCT01639339|58939835|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
30905244|NCT01639339|58939834|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
30905245|NCT01639339|58939835|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
30905246|NCT01639339|58939834|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
30797809|NCT03063203|58812507|FG000|Overall Study|Chose alternative therapy|3|||
30797810|NCT03063203|58812507|FG000|Overall Study|Death|2|||
30797811|NCT03063203|58812507|FG000|Overall Study|Disease progression|4|||
30797812|NCT03063203|58812507|FG000|Overall Study|Physician Decision|5|||
30797813|NCT02891226|58812526|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
30797814|NCT02891226|58812527|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
30797815|NCT02891226|58812528|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
30797816|NCT02891226|58812529|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30797817|NCT02891226|58812530|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30797818|NCT02891226|58812531|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30797819|NCT02891226|58812532|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30797820|NCT02891226|58812533|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30797821|NCT02891226|58812534|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30905247|NCT01639339|58939835|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
30905248|NCT01639339|58939834|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
30905249|NCT01639339|58939835|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
30905250|NCT01639339|58939834|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
30905251|NCT01639339|58939835|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
30905252|NCT01639339|58939834|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
30905253|NCT01639339|58939835|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
30905254|NCT01639339|58939834|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
30905255|NCT01639339|58939835|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
30905256|NCT02000817|58939849|FG000|Overall Study|Withdrawal by Subject|2|||
30905257|NCT02000817|58939850|FG001|Overall Study|Withdrawal by Subject|0|||
30905258|NCT02000817|58939851|FG002|Overall Study|Withdrawal by Subject|0|||
30905259|NCT02000817|58939852|FG003|Overall Study|Withdrawal by Subject|0|||
30905260|NCT02000817|58939849|FG000|Overall Study|Adverse Event|0|||
30905261|NCT02000817|58939850|FG001|Overall Study|Adverse Event|1|||
30905262|NCT02000817|58939851|FG002|Overall Study|Adverse Event|0|||
30905263|NCT02000817|58939852|FG003|Overall Study|Adverse Event|0|||
30905264|NCT02000817|58939849|FG000|Overall Study|Lost to Follow-up|0|||
30905265|NCT02000817|58939850|FG001|Overall Study|Lost to Follow-up|0|||
30905266|NCT02000817|58939851|FG002|Overall Study|Lost to Follow-up|1|||
30905267|NCT02000817|58939852|FG003|Overall Study|Lost to Follow-up|0|||
30905268|NCT01641133|58939868|FG000|Overall Study|Protocol Violation|0|||
30905269|NCT01641133|58939869|FG001|Overall Study|Protocol Violation|1|||
30905270|NCT01641133|58939870|FG002|Overall Study|Protocol Violation|1|||
30905271|NCT01641133|58939868|FG000|Overall Study|Migrated/moved from study area|5|||
30905272|NCT01641133|58939869|FG001|Overall Study|Migrated/moved from study area|3|||
30905273|NCT01641133|58939870|FG002|Overall Study|Migrated/moved from study area|1|||
30905274|NCT01641133|58939868|FG000|Overall Study|Adverse Event|0|||
30905275|NCT01641133|58939869|FG001|Overall Study|Adverse Event|0|||
30905276|NCT01641133|58939870|FG002|Overall Study|Adverse Event|1|||
30905277|NCT01641133|58939868|FG000|Overall Study|Withdrawal by Subject|5|||
30905278|NCT01641133|58939869|FG001|Overall Study|Withdrawal by Subject|3|||
30905279|NCT01641133|58939870|FG002|Overall Study|Withdrawal by Subject|3|||
30905280|NCT01641133|58939868|FG000|Overall Study|Lost to Follow-up|0|||
30905281|NCT01641133|58939869|FG001|Overall Study|Lost to Follow-up|2|||
30905282|NCT01641133|58939870|FG002|Overall Study|Lost to Follow-up|2|||
30905283|NCT02000427|58939878|FG000|Overall Study|Death|22|||
30905284|NCT01600885|58939882|FG000|First Period|Adverse Event|1|||
30905285|NCT01600885|58939883|FG001|First Period|Adverse Event|1|||
30905286|NCT01600885|58939882|FG000|First Period|moved out of area|1|||
30905287|NCT01600885|58939883|FG001|First Period|moved out of area|0|||
30905288|NCT01732510|58939896|FG000|Overall Study|Adverse Event|0|||
30905289|NCT01732510|58939897|FG001|Overall Study|Adverse Event|1|||
30905290|NCT01732510|58939898|FG002|Overall Study|Adverse Event|1|||
30905291|NCT01732510|58939899|FG003|Overall Study|Adverse Event|0|||
30622197|NCT00975195|58633698|FG001|Overall Study|Lack of Efficacy|6|||
30797822|NCT02891226|58812535|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30905292|NCT01732510|58939900|FG004|Overall Study|Adverse Event|0|||
30622198|NCT00975195|58633697|FG000|Overall Study|Protocol Violation|27|||
30797823|NCT02891226|58812536|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30905293|NCT01732510|58939901|FG005|Overall Study|Adverse Event|0|||
30905294|NCT01732510|58939902|FG006|Overall Study|Adverse Event|1|||
30905295|NCT01732510|58939896|FG000|Overall Study|Protocol Violation|0|||
30905296|NCT01732510|58939897|FG001|Overall Study|Protocol Violation|0|||
30905297|NCT01732510|58939898|FG002|Overall Study|Protocol Violation|0|||
30905298|NCT01732510|58939899|FG003|Overall Study|Protocol Violation|1|||
30905299|NCT01732510|58939900|FG004|Overall Study|Protocol Violation|0|||
30905300|NCT01732510|58939901|FG005|Overall Study|Protocol Violation|0|||
30797824|NCT02891226|58812537|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30797825|NCT02891226|58812538|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30797826|NCT02891226|58812539|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30797827|NCT02891226|58812540|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30746553|NCT00296504|58756937|FG004|Interim Analysis|Non-adherence|1|||
30797828|NCT02891226|58812541|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
30797829|NCT02891226|58812526|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
30797830|NCT02891226|58812527|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
30797831|NCT02891226|58812528|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30797832|NCT02891226|58812529|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30797833|NCT02891226|58812530|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30797834|NCT02891226|58812531|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30797835|NCT02891226|58812532|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30797836|NCT02891226|58812533|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30797837|NCT02891226|58812534|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30905301|NCT01732510|58939902|FG006|Overall Study|Protocol Violation|0|||
30905302|NCT01732510|58939896|FG000|Overall Study|Withdrawal by Subject|1|||
30905303|NCT01732510|58939897|FG001|Overall Study|Withdrawal by Subject|3|||
30905304|NCT01732510|58939898|FG002|Overall Study|Withdrawal by Subject|2|||
30905305|NCT01732510|58939899|FG003|Overall Study|Withdrawal by Subject|1|||
30905306|NCT01732510|58939900|FG004|Overall Study|Withdrawal by Subject|5|||
30905307|NCT01732510|58939901|FG005|Overall Study|Withdrawal by Subject|0|||
30905308|NCT01732510|58939902|FG006|Overall Study|Withdrawal by Subject|1|||
30905309|NCT01732510|58939896|FG000|Overall Study|Lost to Follow-up|0|||
30905310|NCT01732510|58939897|FG001|Overall Study|Lost to Follow-up|0|||
30905311|NCT01732510|58939898|FG002|Overall Study|Lost to Follow-up|1|||
30905312|NCT01732510|58939899|FG003|Overall Study|Lost to Follow-up|1|||
30905313|NCT01732510|58939900|FG004|Overall Study|Lost to Follow-up|0|||
30905314|NCT01732510|58939901|FG005|Overall Study|Lost to Follow-up|1|||
30797838|NCT02891226|58812535|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30905315|NCT01732510|58939902|FG006|Overall Study|Lost to Follow-up|0|||
30905316|NCT01732510|58939896|FG000|Overall Study|Physician Decision|0|||
30622199|NCT00975195|58633698|FG001|Overall Study|Protocol Violation|23|||
30746554|NCT00296504|58756938|FG005|Interim Analysis|Non-adherence|0|||
30746555|NCT00296504|58756939|FG006|Interim Analysis|Non-adherence|0|||
30746556|NCT00296504|58756940|FG007|Interim Analysis|Non-adherence|1|||
30746557|NCT00296504|58756941|FG008|Interim Analysis|Non-adherence|0|||
30746558|NCT00296504|58756933|FG000|Interim Analysis|Site Closing|1|||
30746559|NCT00296504|58756934|FG001|Interim Analysis|Site Closing|0|||
30746560|NCT00296504|58756935|FG002|Interim Analysis|Site Closing|0|||
30746561|NCT00296504|58756936|FG003|Interim Analysis|Site Closing|0|||
30746562|NCT00296504|58756937|FG004|Interim Analysis|Site Closing|0|||
30746563|NCT00296504|58756938|FG005|Interim Analysis|Site Closing|1|||
30746564|NCT00296504|58756939|FG006|Interim Analysis|Site Closing|2|||
30746565|NCT00296504|58756940|FG007|Interim Analysis|Site Closing|0|||
30746566|NCT00296504|58756941|FG008|Interim Analysis|Site Closing|0|||
30797839|NCT02891226|58812536|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30797840|NCT02891226|58812537|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30905317|NCT01732510|58939897|FG001|Overall Study|Physician Decision|1|||
30905318|NCT01732510|58939898|FG002|Overall Study|Physician Decision|0|||
30905319|NCT01732510|58939899|FG003|Overall Study|Physician Decision|0|||
30905320|NCT01732510|58939900|FG004|Overall Study|Physician Decision|0|||
30905321|NCT01732510|58939901|FG005|Overall Study|Physician Decision|0|||
30905322|NCT01732510|58939902|FG006|Overall Study|Physician Decision|0|||
30905323|NCT01732510|58939896|FG000|Overall Study|Pregnancy|0|||
30905324|NCT01732510|58939897|FG001|Overall Study|Pregnancy|0|||
30905325|NCT01732510|58939898|FG002|Overall Study|Pregnancy|0|||
30905326|NCT01732510|58939899|FG003|Overall Study|Pregnancy|1|||
30905327|NCT01732510|58939900|FG004|Overall Study|Pregnancy|0|||
30905328|NCT01732510|58939901|FG005|Overall Study|Pregnancy|0|||
30905329|NCT01732510|58939902|FG006|Overall Study|Pregnancy|0|||
30905330|NCT01732510|58939896|FG000|Overall Study|Study Terminated By Sponsor|0|||
30905331|NCT01732510|58939897|FG001|Overall Study|Study Terminated By Sponsor|0|||
30905332|NCT01732510|58939898|FG002|Overall Study|Study Terminated By Sponsor|0|||
30905333|NCT01732510|58939899|FG003|Overall Study|Study Terminated By Sponsor|1|||
30905334|NCT01732510|58939900|FG004|Overall Study|Study Terminated By Sponsor|0|||
30905335|NCT01732510|58939901|FG005|Overall Study|Study Terminated By Sponsor|12|||
30797841|NCT02891226|58812538|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30797842|NCT02891226|58812539|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30797843|NCT02891226|58812540|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30797844|NCT02891226|58812541|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
30797845|NCT02891226|58812526|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797846|NCT02891226|58812527|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797847|NCT02891226|58812528|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797848|NCT02891226|58812529|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
30797849|NCT02891226|58812530|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797850|NCT02891226|58812531|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797851|NCT02891226|58812532|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797852|NCT02891226|58812533|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797853|NCT02891226|58812534|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797854|NCT02891226|58812535|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797855|NCT02891226|58812536|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797856|NCT02891226|58812537|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797857|NCT02891226|58812538|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797858|NCT02891226|58812539|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797859|NCT02891226|58812540|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797860|NCT02891226|58812541|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
30797861|NCT02891226|58812526|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797862|NCT02891226|58812527|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797863|NCT02891226|58812528|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
30797864|NCT02891226|58812529|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797865|NCT02891226|58812530|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797866|NCT02891226|58812531|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797867|NCT02891226|58812532|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797868|NCT02891226|58812533|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797869|NCT02891226|58812534|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797870|NCT02891226|58812535|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797871|NCT02891226|58812536|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797872|NCT02891226|58812537|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797873|NCT02891226|58812538|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797874|NCT02891226|58812539|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797875|NCT02891226|58812540|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797876|NCT02891226|58812541|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
30797877|NCT02891226|58812526|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797878|NCT02891226|58812527|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797879|NCT02891226|58812528|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797880|NCT02891226|58812529|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
30797881|NCT02891226|58812530|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797882|NCT02891226|58812531|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797883|NCT02891226|58812532|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797884|NCT02891226|58812533|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797885|NCT02891226|58812534|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797886|NCT02891226|58812535|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797887|NCT02891226|58812536|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797888|NCT02891226|58812537|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797889|NCT02891226|58812538|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797890|NCT02891226|58812539|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797891|NCT02891226|58812540|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797892|NCT02891226|58812541|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
30797893|NCT02891226|58812526|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797894|NCT02891226|58812527|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797895|NCT02891226|58812528|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797896|NCT02891226|58812529|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
30905336|NCT01732510|58939902|FG006|Overall Study|Study Terminated By Sponsor|6|||
30905337|NCT01637077|58939923|FG000|Overall Study|Cancel|1|||
30905338|NCT01637077|58939924|FG001|Overall Study|Cancel|1|||
30797897|NCT02891226|58812530|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30905339|NCT01637077|58939923|FG000|Overall Study|Withdrawal by Subject|1|||
30797898|NCT02891226|58812531|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797899|NCT02891226|58812532|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797900|NCT02891226|58812533|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797901|NCT02891226|58812534|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797902|NCT02891226|58812535|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797903|NCT02891226|58812536|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797904|NCT02891226|58812537|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797905|NCT02891226|58812538|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797906|NCT02891226|58812539|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797907|NCT02891226|58812540|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797908|NCT02891226|58812541|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
30797909|NCT02891226|58812526|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797910|NCT02891226|58812527|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797911|NCT02891226|58812528|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797912|NCT02891226|58812529|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797913|NCT02891226|58812530|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797914|NCT02891226|58812531|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797915|NCT02891226|58812532|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
30905340|NCT01637077|58939924|FG001|Overall Study|Withdrawal by Subject|0|||
30905341|NCT01637077|58939923|FG000|Overall Study|No cycle 1 questionnaire data|2|||
30905342|NCT01637077|58939924|FG001|Overall Study|No cycle 1 questionnaire data|0|||
30905343|NCT02308163|58939934|FG000|Overall Study|Not fulfill eligible criteria|1|||
30905344|NCT02308163|58939935|FG001|Overall Study|Not fulfill eligible criteria|2|||
30905345|NCT02308163|58939936|FG002|Overall Study|Not fulfill eligible criteria|0|||
30905346|NCT02308163|58939937|FG003|Overall Study|Not fulfill eligible criteria|1|||
30905347|NCT02308163|58939938|FG004|Overall Study|Not fulfill eligible criteria|1|||
30905348|NCT02308163|58939934|FG000|Overall Study|Adverse Event|9|||
30797916|NCT02891226|58812533|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
30797917|NCT02891226|58812534|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
30797918|NCT02891226|58812535|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
30797919|NCT02891226|58812536|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797920|NCT02891226|58812537|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797921|NCT02891226|58812538|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797922|NCT02891226|58812539|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797923|NCT02891226|58812540|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797924|NCT02891226|58812541|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
30797925|NCT02891226|58812526|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797926|NCT02891226|58812527|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797927|NCT02891226|58812528|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797928|NCT02891226|58812529|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797929|NCT02891226|58812530|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797930|NCT02891226|58812531|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
30797931|NCT02891226|58812532|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797932|NCT02891226|58812533|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797933|NCT02891226|58812534|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797934|NCT02891226|58812535|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
30797935|NCT02891226|58812536|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797936|NCT02891226|58812537|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797937|NCT02891226|58812538|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797938|NCT02891226|58812539|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797939|NCT02891226|58812540|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797940|NCT02891226|58812541|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
30797941|NCT02891226|58812526|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30797942|NCT02891226|58812527|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30797943|NCT02891226|58812528|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30797944|NCT02891226|58812529|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30797945|NCT02891226|58812530|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30797946|NCT02891226|58812531|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30797947|NCT02891226|58812532|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
30797948|NCT02891226|58812533|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
30797949|NCT02891226|58812534|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
30905349|NCT02308163|58939935|FG001|Overall Study|Adverse Event|5|||
30797950|NCT02891226|58812535|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
30797951|NCT02891226|58812536|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30797952|NCT02891226|58812537|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30797953|NCT02891226|58812538|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30797954|NCT02891226|58812539|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30797955|NCT02891226|58812540|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30797956|NCT02891226|58812541|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
30905350|NCT02308163|58939936|FG002|Overall Study|Adverse Event|2|||
30797957|NCT02891226|58812526|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797958|NCT02891226|58812527|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797959|NCT02891226|58812528|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797960|NCT02891226|58812529|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797961|NCT02891226|58812530|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
30797962|NCT02891226|58812531|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797963|NCT02891226|58812532|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797964|NCT02891226|58812533|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797965|NCT02891226|58812534|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797966|NCT02891226|58812535|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797967|NCT02891226|58812536|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797968|NCT02891226|58812537|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797969|NCT02891226|58812538|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797970|NCT02891226|58812539|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30905351|NCT02308163|58939937|FG003|Overall Study|Adverse Event|2|||
30905352|NCT02308163|58939938|FG004|Overall Study|Adverse Event|11|||
30905353|NCT02308163|58939934|FG000|Overall Study|Lack of Efficacy|11|||
30905354|NCT02308163|58939935|FG001|Overall Study|Lack of Efficacy|3|||
30905355|NCT02308163|58939936|FG002|Overall Study|Lack of Efficacy|8|||
30905356|NCT02308163|58939937|FG003|Overall Study|Lack of Efficacy|4|||
30905357|NCT02308163|58939938|FG004|Overall Study|Lack of Efficacy|6|||
30905358|NCT02308163|58939934|FG000|Overall Study|Withdrawal of consent|2|||
30797971|NCT02891226|58812540|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797972|NCT02891226|58812541|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
30797973|NCT02891226|58812526|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797974|NCT02891226|58812527|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797975|NCT02891226|58812528|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797976|NCT02891226|58812529|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797977|NCT02891226|58812530|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797978|NCT02891226|58812531|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797979|NCT02891226|58812532|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
30797980|NCT02891226|58812533|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797981|NCT02891226|58812534|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797982|NCT02891226|58812535|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797983|NCT02891226|58812536|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797984|NCT02891226|58812537|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797985|NCT02891226|58812538|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797986|NCT02891226|58812539|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30905359|NCT02308163|58939935|FG001|Overall Study|Withdrawal of consent|3|||
30905360|NCT02308163|58939936|FG002|Overall Study|Withdrawal of consent|0|||
30746567|NCT00296504|58756933|FG000|Interim Analysis|Lack of Personnel at Site|1|||
30746568|NCT00296504|58756934|FG001|Interim Analysis|Lack of Personnel at Site|0|||
30746569|NCT00296504|58756935|FG002|Interim Analysis|Lack of Personnel at Site|0|||
30746570|NCT00296504|58756936|FG003|Interim Analysis|Lack of Personnel at Site|0|||
30746571|NCT00296504|58756937|FG004|Interim Analysis|Lack of Personnel at Site|0|||
30746572|NCT00296504|58756938|FG005|Interim Analysis|Lack of Personnel at Site|0|||
30746573|NCT00296504|58756939|FG006|Interim Analysis|Lack of Personnel at Site|0|||
30746574|NCT00296504|58756940|FG007|Interim Analysis|Lack of Personnel at Site|0|||
30746575|NCT00296504|58756941|FG008|Interim Analysis|Lack of Personnel at Site|0|||
30746576|NCT00296504|58756933|FG000|Interim Analysis|Missed Schedule Date|1|||
30746577|NCT00296504|58756934|FG001|Interim Analysis|Missed Schedule Date|0|||
30746578|NCT00296504|58756935|FG002|Interim Analysis|Missed Schedule Date|0|||
30746579|NCT00296504|58756936|FG003|Interim Analysis|Missed Schedule Date|0|||
30746580|NCT00296504|58756937|FG004|Interim Analysis|Missed Schedule Date|0|||
30746581|NCT00296504|58756938|FG005|Interim Analysis|Missed Schedule Date|0|||
30746582|NCT00296504|58756939|FG006|Interim Analysis|Missed Schedule Date|0|||
30797987|NCT02891226|58812540|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797988|NCT02891226|58812541|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
30797989|NCT02891226|58812526|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30797990|NCT02891226|58812527|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30797991|NCT02891226|58812528|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30797992|NCT02891226|58812529|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30797993|NCT02891226|58812530|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30797994|NCT02891226|58812531|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30797995|NCT02891226|58812532|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30797996|NCT02891226|58812533|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
30797997|NCT02891226|58812534|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
30797998|NCT02891226|58812535|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
30797999|NCT02891226|58812536|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30798000|NCT02891226|58812537|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30798001|NCT02891226|58812538|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30798002|NCT02891226|58812539|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30798003|NCT02891226|58812540|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30798004|NCT02891226|58812541|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
30798005|NCT02891226|58812526|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798006|NCT02891226|58812527|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798007|NCT02891226|58812528|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798008|NCT02891226|58812529|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798009|NCT02891226|58812530|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798010|NCT02891226|58812531|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798011|NCT02891226|58812532|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798012|NCT02891226|58812533|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
30798013|NCT02891226|58812534|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798014|NCT02891226|58812535|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798015|NCT02891226|58812536|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798016|NCT02891226|58812537|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798017|NCT02891226|58812538|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798018|NCT02891226|58812539|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798019|NCT02891226|58812540|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798020|NCT02891226|58812541|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
30798021|NCT02891226|58812526|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798022|NCT02891226|58812527|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798023|NCT02891226|58812528|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798024|NCT02891226|58812529|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798025|NCT02891226|58812530|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798026|NCT02891226|58812531|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798027|NCT02891226|58812532|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798028|NCT02891226|58812533|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798029|NCT02891226|58812534|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
30798030|NCT02891226|58812535|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798031|NCT02891226|58812536|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798032|NCT02891226|58812537|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798033|NCT02891226|58812538|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798034|NCT02891226|58812539|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798035|NCT02891226|58812540|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798036|NCT02891226|58812541|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
30798037|NCT02891226|58812526|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798038|NCT02891226|58812527|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798039|NCT02891226|58812528|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798040|NCT02891226|58812529|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798041|NCT02891226|58812530|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798042|NCT02891226|58812531|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798043|NCT02891226|58812532|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798044|NCT02891226|58812533|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798045|NCT02891226|58812534|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798046|NCT02891226|58812535|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
30798047|NCT02891226|58812536|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798048|NCT02891226|58812537|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798049|NCT02891226|58812538|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798050|NCT02891226|58812539|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798051|NCT02891226|58812540|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798052|NCT02891226|58812541|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
30798053|NCT02891226|58812526|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798054|NCT02891226|58812527|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30905361|NCT02308163|58939937|FG003|Overall Study|Withdrawal of consent|2|||
30905362|NCT02308163|58939938|FG004|Overall Study|Withdrawal of consent|6|||
30905363|NCT02308163|58939934|FG000|Overall Study|Protocol Violation|3|||
30905364|NCT02308163|58939935|FG001|Overall Study|Protocol Violation|3|||
30905365|NCT02308163|58939936|FG002|Overall Study|Protocol Violation|3|||
30905366|NCT02308163|58939937|FG003|Overall Study|Protocol Violation|2|||
30905367|NCT02308163|58939938|FG004|Overall Study|Protocol Violation|5|||
30905368|NCT02308163|58939934|FG000|Overall Study|Lab data met discontinuation criteria|3|||
30798055|NCT02891226|58812528|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798056|NCT02891226|58812529|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798057|NCT02891226|58812530|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798058|NCT02891226|58812531|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798059|NCT02891226|58812532|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30905369|NCT02308163|58939935|FG001|Overall Study|Lab data met discontinuation criteria|0|||
30905370|NCT02308163|58939936|FG002|Overall Study|Lab data met discontinuation criteria|0|||
30905371|NCT02308163|58939937|FG003|Overall Study|Lab data met discontinuation criteria|2|||
30905372|NCT02308163|58939938|FG004|Overall Study|Lab data met discontinuation criteria|0|||
30905373|NCT02308163|58939934|FG000|Overall Study|Miscellaneous|2|||
30905374|NCT02308163|58939935|FG001|Overall Study|Miscellaneous|2|||
30905375|NCT02308163|58939936|FG002|Overall Study|Miscellaneous|1|||
30905376|NCT02308163|58939937|FG003|Overall Study|Miscellaneous|0|||
30905377|NCT02308163|58939938|FG004|Overall Study|Miscellaneous|5|||
30905378|NCT02000115|58939968|FG000|Overall Study|Death|56|||
30905379|NCT02000115|58939969|FG001|Overall Study|Death|45|||
30905380|NCT02000115|58939970|FG002|Overall Study|Death|0|||
30905381|NCT02000115|58939971|FG003|Overall Study|Death|0|||
30905382|NCT02000115|58939968|FG000|Overall Study|Missed Visit|6|||
30905383|NCT02000115|58939969|FG001|Overall Study|Missed Visit|8|||
30905384|NCT02000115|58939970|FG002|Overall Study|Missed Visit|1|||
30905385|NCT02000115|58939971|FG003|Overall Study|Missed Visit|0|||
30905386|NCT02000115|58939968|FG000|Overall Study|Protocol Violation|2|||
30905387|NCT02000115|58939969|FG001|Overall Study|Protocol Violation|1|||
30905388|NCT02000115|58939970|FG002|Overall Study|Protocol Violation|0|||
30905389|NCT02000115|58939971|FG003|Overall Study|Protocol Violation|0|||
30905390|NCT02000115|58939968|FG000|Overall Study|Physician Decision|2|||
30905391|NCT02000115|58939969|FG001|Overall Study|Physician Decision|0|||
30905392|NCT02000115|58939970|FG002|Overall Study|Physician Decision|0|||
30905393|NCT02000115|58939971|FG003|Overall Study|Physician Decision|0|||
30905394|NCT02000115|58939968|FG000|Overall Study|Withdrawal by Subject|11|||
30905395|NCT02000115|58939969|FG001|Overall Study|Withdrawal by Subject|11|||
30905396|NCT02000115|58939970|FG002|Overall Study|Withdrawal by Subject|0|||
30905397|NCT02000115|58939971|FG003|Overall Study|Withdrawal by Subject|0|||
30905398|NCT02000115|58939968|FG000|Overall Study|Lost to Follow-up|0|||
30905399|NCT02000115|58939969|FG001|Overall Study|Lost to Follow-up|1|||
30905400|NCT02000115|58939970|FG002|Overall Study|Lost to Follow-up|0|||
30905401|NCT02000115|58939971|FG003|Overall Study|Lost to Follow-up|0|||
30905402|NCT02000115|58939968|FG000|Overall Study|Non-compliance|2|||
30798060|NCT02891226|58812533|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798061|NCT02891226|58812534|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798062|NCT02891226|58812535|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
30798063|NCT02891226|58812536|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798064|NCT02891226|58812537|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798065|NCT02891226|58812538|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798066|NCT02891226|58812539|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798067|NCT02891226|58812540|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798068|NCT02891226|58812541|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
30798069|NCT02891226|58812526|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798070|NCT02891226|58812527|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798071|NCT02891226|58812528|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798072|NCT02891226|58812529|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798073|NCT02891226|58812530|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30905403|NCT02000115|58939969|FG001|Overall Study|Non-compliance|1|||
30905404|NCT02000115|58939970|FG002|Overall Study|Non-compliance|0|||
30905405|NCT02000115|58939971|FG003|Overall Study|Non-compliance|0|||
30905406|NCT02000115|58939968|FG000|Overall Study|Withdrawn on day of randomization|0|||
30905407|NCT02000115|58939969|FG001|Overall Study|Withdrawn on day of randomization|1|||
30905408|NCT02000115|58939970|FG002|Overall Study|Withdrawn on day of randomization|0|||
30798074|NCT02891226|58812531|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798075|NCT02891226|58812532|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798076|NCT02891226|58812533|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798077|NCT02891226|58812534|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798078|NCT02891226|58812535|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798079|NCT02891226|58812536|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
30798080|NCT02891226|58812537|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798081|NCT02891226|58812538|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798082|NCT02891226|58812539|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798083|NCT02891226|58812540|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798084|NCT02891226|58812541|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
30798085|NCT02891226|58812526|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798086|NCT02891226|58812527|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798087|NCT02891226|58812528|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798088|NCT02891226|58812529|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798089|NCT02891226|58812530|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798090|NCT02891226|58812531|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30905409|NCT02000115|58939971|FG003|Overall Study|Withdrawn on day of randomization|0|||
30798091|NCT02891226|58812532|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798092|NCT02891226|58812533|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798093|NCT02891226|58812534|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798094|NCT02891226|58812535|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798095|NCT02891226|58812536|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
30798096|NCT02891226|58812537|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798097|NCT02891226|58812538|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798098|NCT02891226|58812539|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798099|NCT02891226|58812540|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798100|NCT02891226|58812541|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
30798101|NCT02891226|58812526|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798102|NCT02891226|58812527|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798103|NCT02891226|58812528|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798104|NCT02891226|58812529|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798105|NCT02891226|58812530|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798106|NCT02891226|58812531|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798107|NCT02891226|58812532|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798108|NCT02891226|58812533|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30905410|NCT02000115|58939968|FG000|Overall Study|Still on Study|0|||
30798109|NCT02891226|58812534|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798110|NCT02891226|58812535|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798111|NCT02891226|58812536|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
30798112|NCT02891226|58812537|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798113|NCT02891226|58812538|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798114|NCT02891226|58812539|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798115|NCT02891226|58812540|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798116|NCT02891226|58812541|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
30798117|NCT02891226|58812526|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798118|NCT02891226|58812527|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798119|NCT02891226|58812528|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798120|NCT02891226|58812529|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798121|NCT02891226|58812530|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798122|NCT02891226|58812531|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798123|NCT02891226|58812532|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798124|NCT02891226|58812533|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798125|NCT02891226|58812534|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798126|NCT02891226|58812535|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798127|NCT02891226|58812536|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
30798128|NCT02891226|58812537|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798129|NCT02891226|58812538|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798130|NCT02891226|58812539|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798131|NCT02891226|58812540|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798132|NCT02891226|58812541|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
30798133|NCT02891226|58812526|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798134|NCT02891226|58812527|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798135|NCT02891226|58812528|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798136|NCT02891226|58812529|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30905411|NCT02000115|58939969|FG001|Overall Study|Still on Study|0|||
30905412|NCT02000115|58939970|FG002|Overall Study|Still on Study|0|||
30798137|NCT02891226|58812530|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798138|NCT02891226|58812531|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798139|NCT02891226|58812532|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798140|NCT02891226|58812533|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798141|NCT02891226|58812534|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798142|NCT02891226|58812535|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798143|NCT02891226|58812536|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
30798144|NCT02891226|58812537|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798145|NCT02891226|58812538|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798146|NCT02891226|58812539|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798147|NCT02891226|58812540|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798148|NCT02891226|58812541|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
30798149|NCT02891226|58812526|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798150|NCT02891226|58812527|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798151|NCT02891226|58812528|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798152|NCT02891226|58812529|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798153|NCT02891226|58812530|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798154|NCT02891226|58812531|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798155|NCT02891226|58812532|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798156|NCT02891226|58812533|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798157|NCT02891226|58812534|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798158|NCT02891226|58812535|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798159|NCT02891226|58812536|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
30798160|NCT02891226|58812537|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798161|NCT02891226|58812538|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30622200|NCT00975195|58633697|FG000|Overall Study|Lost to Follow-up|9|||
30622201|NCT00975195|58633698|FG001|Overall Study|Lost to Follow-up|7|||
30622202|NCT00975195|58633697|FG000|Overall Study|Withdrawal by Subject|48|||
30622203|NCT00975195|58633698|FG001|Overall Study|Withdrawal by Subject|61|||
30622204|NCT00975195|58633697|FG000|Overall Study|Other reason not defined above|29|||
30622205|NCT00975195|58633698|FG001|Overall Study|Other reason not defined above|33|||
30622206|NCT00975195|58633697|FG000|Overall Study|Not treated|1|||
30622207|NCT00975195|58633698|FG001|Overall Study|Not treated|2|||
30622208|NCT01145352|58633704|FG000|Overall Study|Found to have been registered twice|6|||
30622209|NCT01145352|58633704|FG000|Overall Study|Treated before marketing approval|4|||
30798162|NCT02891226|58812539|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798163|NCT02891226|58812540|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798164|NCT02891226|58812541|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
30798165|NCT02891226|58812526|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798166|NCT02891226|58812527|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798167|NCT02891226|58812528|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798168|NCT02891226|58812529|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798169|NCT02891226|58812530|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798170|NCT02891226|58812531|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798171|NCT02891226|58812532|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798172|NCT02891226|58812533|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798173|NCT02891226|58812534|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798174|NCT02891226|58812535|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798175|NCT02891226|58812536|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
30905413|NCT02000115|58939971|FG003|Overall Study|Still on Study|53|||
30905414|NCT01999335|58939985|FG000|Overall Study|Discontinued before receiving treatment|0|||
30622210|NCT01145352|58633704|FG000|Overall Study|Syringe formulation was used|1|||
30798176|NCT02891226|58812537|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798177|NCT02891226|58812538|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798178|NCT02891226|58812539|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798179|NCT02891226|58812540|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798180|NCT02891226|58812541|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
30798181|NCT02891226|58812526|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798182|NCT02891226|58812527|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798183|NCT02891226|58812528|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798184|NCT02891226|58812529|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798185|NCT02891226|58812530|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798186|NCT02891226|58812531|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798187|NCT02891226|58812532|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798188|NCT02891226|58812533|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798189|NCT02891226|58812534|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798190|NCT02891226|58812535|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798191|NCT02891226|58812536|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
30798192|NCT02891226|58812537|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798193|NCT02891226|58812538|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798194|NCT02891226|58812539|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798195|NCT02891226|58812540|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798196|NCT02891226|58812541|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
30798197|NCT02891226|58812526|FG000|Follow-up Period|Withdrawal by Subject|0|||
30798198|NCT02891226|58812527|FG001|Follow-up Period|Withdrawal by Subject|0|||
30798199|NCT02891226|58812528|FG002|Follow-up Period|Withdrawal by Subject|0|||
30798200|NCT02891226|58812529|FG003|Follow-up Period|Withdrawal by Subject|0|||
30798201|NCT02891226|58812530|FG004|Follow-up Period|Withdrawal by Subject|0|||
30798202|NCT02891226|58812531|FG005|Follow-up Period|Withdrawal by Subject|0|||
30798203|NCT02891226|58812532|FG006|Follow-up Period|Withdrawal by Subject|0|||
30798204|NCT02891226|58812533|FG007|Follow-up Period|Withdrawal by Subject|0|||
30798205|NCT02891226|58812534|FG008|Follow-up Period|Withdrawal by Subject|0|||
30798206|NCT02891226|58812535|FG009|Follow-up Period|Withdrawal by Subject|0|||
30798207|NCT02891226|58812536|FG010|Follow-up Period|Withdrawal by Subject|0|||
30798208|NCT02891226|58812537|FG011|Follow-up Period|Withdrawal by Subject|1|||
30905415|NCT01999335|58939986|FG001|Overall Study|Discontinued before receiving treatment|0|||
30905416|NCT01999335|58939987|FG002|Overall Study|Discontinued before receiving treatment|0|||
30905417|NCT01999335|58939988|FG003|Overall Study|Discontinued before receiving treatment|0|||
30905418|NCT01999335|58939989|FG004|Overall Study|Discontinued before receiving treatment|2|||
30746583|NCT00296504|58756940|FG007|Interim Analysis|Missed Schedule Date|0|||
30746584|NCT00296504|58756941|FG008|Interim Analysis|Missed Schedule Date|0|||
30746585|NCT00296504|58756933|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
30746586|NCT00296504|58756934|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
30746587|NCT00296504|58756935|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
30746588|NCT00296504|58756936|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
30746589|NCT00296504|58756937|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
30746590|NCT00296504|58756938|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
30746591|NCT00296504|58756939|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
30746592|NCT00296504|58756940|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
30746593|NCT00296504|58756941|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
30746594|NCT00296504|58756933|FG000|Interim Analysis|Participant Stopped|0|||
30746595|NCT00296504|58756934|FG001|Interim Analysis|Participant Stopped|0|||
30746596|NCT00296504|58756935|FG002|Interim Analysis|Participant Stopped|0|||
30798209|NCT02891226|58812538|FG012|Follow-up Period|Withdrawal by Subject|0|||
30798210|NCT02891226|58812539|FG013|Follow-up Period|Withdrawal by Subject|0|||
30798211|NCT02891226|58812540|FG014|Follow-up Period|Withdrawal by Subject|1|||
30798212|NCT02891226|58812541|FG015|Follow-up Period|Withdrawal by Subject|1|||
30798213|NCT03612856|58812568|FG000|Pre-dose Period|Physician Decision|0|||
30798214|NCT03612856|58812569|FG001|Pre-dose Period|Physician Decision|1|||
30798215|NCT03612856|58812570|FG002|Pre-dose Period|Physician Decision|1|||
30798216|NCT03612856|58812568|FG000|Pre-dose Period|Withdrawal by Subject|0|||
30798217|NCT03612856|58812569|FG001|Pre-dose Period|Withdrawal by Subject|1|||
30798218|NCT03612856|58812570|FG002|Pre-dose Period|Withdrawal by Subject|0|||
30798219|NCT03333837|58812583|FG000|Overall Study|Adverse Event|2|||
30798220|NCT03333837|58812584|FG001|Overall Study|Adverse Event|1|||
30798221|NCT03333837|58812585|FG002|Overall Study|Adverse Event|1|||
30798222|NCT03333837|58812586|FG003|Overall Study|Adverse Event|1|||
30798223|NCT03333837|58812587|FG004|Overall Study|Adverse Event|0|||
30798224|NCT03333837|58812583|FG000|Overall Study|Caregiver withdrew|0|||
30798225|NCT03333837|58812584|FG001|Overall Study|Caregiver withdrew|2|||
30798226|NCT03333837|58812585|FG002|Overall Study|Caregiver withdrew|1|||
30798227|NCT03333837|58812586|FG003|Overall Study|Caregiver withdrew|0|||
30798228|NCT03333837|58812587|FG004|Overall Study|Caregiver withdrew|0|||
30798229|NCT03333837|58812583|FG000|Overall Study|Withdrawal by Subject|0|||
30798230|NCT03333837|58812584|FG001|Overall Study|Withdrawal by Subject|0|||
30798231|NCT03333837|58812585|FG002|Overall Study|Withdrawal by Subject|1|||
30798232|NCT03333837|58812586|FG003|Overall Study|Withdrawal by Subject|1|||
30798233|NCT03333837|58812587|FG004|Overall Study|Withdrawal by Subject|3|||
30798234|NCT03333837|58812583|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
30798235|NCT03333837|58812584|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
30798236|NCT03333837|58812585|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
30798237|NCT03333837|58812586|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
30798238|NCT03333837|58812587|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
30905419|NCT01978119|58940004|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
30905420|NCT01978119|58940005|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
30905421|NCT01978119|58940004|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
30905422|NCT01978119|58940005|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
30905423|NCT01978119|58940004|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30905424|NCT01978119|58940005|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
30905425|NCT01999179|58940011|FG000|Overall Study|Adverse Event|1|||
30905426|NCT01999179|58940011|FG000|Overall Study|Lost to Follow-up|1|||
30905427|NCT01999179|58940011|FG000|Overall Study|Change in Therapy|3|||
30905428|NCT01999179|58940011|FG000|Overall Study|New catheter|2|||
30905429|NCT01977729|58940015|FG000|Overall Study|Study terminated|1|||
30905430|NCT01998477|58940023|FG000|Overall Study|Lost to Follow-up|4|||
30905431|NCT01998477|58940024|FG001|Overall Study|Lost to Follow-up|5|||
30905432|NCT01998477|58940023|FG000|Overall Study|Withdrawal by Subject|6|||
30905433|NCT01998477|58940024|FG001|Overall Study|Withdrawal by Subject|0|||
30905434|NCT01998399|58940057|FG000|Overall Study|Lost to Follow-up|1|||
30905435|NCT01998399|58940058|FG001|Overall Study|Lost to Follow-up|3|||
30746597|NCT00296504|58756936|FG003|Interim Analysis|Participant Stopped|0|||
30905436|NCT01998399|58940057|FG000|Overall Study|Death|4|||
30905437|NCT01998399|58940058|FG001|Overall Study|Death|2|||
30905438|NCT01998399|58940057|FG000|Overall Study|Study stopped before dosing completed|3|||
30905439|NCT01998399|58940058|FG001|Overall Study|Study stopped before dosing completed|3|||
30905440|NCT01998399|58940057|FG000|Overall Study|Withdrawal by Subject|0|||
30905441|NCT01998399|58940058|FG001|Overall Study|Withdrawal by Subject|1|||
30905442|NCT01781572|58940075|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
30905443|NCT01781572|58940076|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
30905444|NCT01781572|58940077|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
30905445|NCT01781572|58940075|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
30905446|NCT01781572|58940076|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
30905447|NCT01781572|58940077|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
30905448|NCT01781572|58940075|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
30905449|NCT01781572|58940076|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
30905450|NCT01781572|58940077|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
30746598|NCT00296504|58756937|FG004|Interim Analysis|Participant Stopped|1|||
30746599|NCT00296504|58756938|FG005|Interim Analysis|Participant Stopped|0|||
30746600|NCT00296504|58756939|FG006|Interim Analysis|Participant Stopped|0|||
30746601|NCT00296504|58756940|FG007|Interim Analysis|Participant Stopped|0|||
30746602|NCT00296504|58756941|FG008|Interim Analysis|Participant Stopped|0|||
30746603|NCT00296504|58756933|FG000|Interim Analysis|Physician and Participant Decision|0|||
30746604|NCT00296504|58756934|FG001|Interim Analysis|Physician and Participant Decision|0|||
30746605|NCT00296504|58756935|FG002|Interim Analysis|Physician and Participant Decision|0|||
30746606|NCT00296504|58756936|FG003|Interim Analysis|Physician and Participant Decision|0|||
30746607|NCT00296504|58756937|FG004|Interim Analysis|Physician and Participant Decision|0|||
30905451|NCT01781572|58940075|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
30905452|NCT01781572|58940076|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
30905453|NCT01781572|58940077|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
30905454|NCT01781572|58940075|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
30905455|NCT01781572|58940076|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
30905456|NCT01781572|58940077|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
30905457|NCT01781572|58940075|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
30905458|NCT01781572|58940076|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
30905459|NCT01781572|58940077|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
30905460|NCT01781572|58940075|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
30905461|NCT01781572|58940076|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
30905462|NCT01781572|58940077|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
30905463|NCT01781572|58940075|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
30905464|NCT01781572|58940076|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
30905465|NCT01781572|58940077|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
30905466|NCT01781572|58940075|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
30905467|NCT01781572|58940076|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
30905468|NCT01781572|58940077|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
30905469|NCT01781572|58940075|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
30905470|NCT01781572|58940076|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
30905471|NCT01781572|58940077|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
30905472|NCT01781572|58940075|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
30905473|NCT01781572|58940076|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
30905474|NCT01781572|58940077|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
30905475|NCT01781572|58940075|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
30905476|NCT01781572|58940076|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
30905477|NCT01781572|58940077|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
30798239|NCT03708211|58812605|FG000|Overall Study|Progressive Disease|10|||
30798240|NCT03708211|58812606|FG001|Overall Study|Progressive Disease|7|||
30798241|NCT03708211|58812605|FG000|Overall Study|Withdrawal by Subject|0|||
30798242|NCT03708211|58812606|FG001|Overall Study|Withdrawal by Subject|1|||
30798243|NCT03708211|58812605|FG000|Overall Study|Other|2|||
30905478|NCT01781572|58940075|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
30905479|NCT01781572|58940076|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
30622211|NCT01178099|58633712|FG000|Overall Study|Physician Decision|0|||
30622212|NCT01178099|58633713|FG001|Overall Study|Physician Decision|1|||
30622213|NCT01169532|58633723|FG000|Overall Study|Withdrawal by Subject|1|||
30622214|NCT00928564|58633729|FG000|Overall Study|Lost to Follow-up|6|||
30622215|NCT00928564|58633730|FG001|Overall Study|Lost to Follow-up|0|||
30622216|NCT01177943|58633738|FG000|First Intervention|Withdrawal by Subject|2|||
30622217|NCT01177943|58633739|FG001|First Intervention|Withdrawal by Subject|0|||
30622218|NCT01131312|58633748|FG000|Overall Study|Lost to Follow-up|425|||
30622219|NCT01131312|58633749|FG001|Overall Study|Lost to Follow-up|229|||
30622220|NCT01131312|58633750|FG002|Overall Study|Lost to Follow-up|351|||
30622221|NCT01177787|58633758|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
30905480|NCT01781572|58940077|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
30905481|NCT01781572|58940075|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
30905482|NCT01781572|58940076|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
30905483|NCT01781572|58940077|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
30905484|NCT01781572|58940075|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
30905485|NCT01781572|58940076|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
30622222|NCT01177787|58633758|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
30622223|NCT01177787|58633758|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
30622224|NCT00928486|58633770|FG000|Overall Study|Adverse Event|2|||
30622225|NCT00928486|58633770|FG000|Overall Study|Disease Progression|7|||
30905486|NCT01781572|58940077|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
30622226|NCT00928486|58633770|FG000|Overall Study|Withdrawal by Subject|1|||
30622227|NCT01168596|58633776|FG000|Overall Study|Withdrawal by Subject|3|||
30622228|NCT01168596|58633777|FG001|Overall Study|Withdrawal by Subject|1|||
30798244|NCT03708211|58812606|FG001|Overall Study|Other|0|||
30622229|NCT01177553|58633785|FG000|Overall Study|babies not yet 6 months of age|1|||
30622230|NCT01177553|58633786|FG001|Overall Study|babies not yet 6 months of age|0|||
30622231|NCT00928408|58633792|FG000|Overall Study|Other|2|||
30798245|NCT02948634|58812616|FG000|Overall Study|Lack of efficacy and study suspended|10|||
30798246|NCT02948634|58812617|FG001|Overall Study|Lack of efficacy and study suspended|2|||
30798247|NCT02945046|58812626|FG000|Overall Study|Adverse Event|1|||
30798248|NCT02945046|58812627|FG001|Overall Study|Adverse Event|0|||
30798249|NCT02945046|58812628|FG002|Overall Study|Adverse Event|2|||
30798250|NCT02945046|58812626|FG000|Overall Study|Withdrawal by Subject|3|||
30798251|NCT02945046|58812627|FG001|Overall Study|Withdrawal by Subject|3|||
30798252|NCT02945046|58812628|FG002|Overall Study|Withdrawal by Subject|3|||
30798253|NCT02945046|58812626|FG000|Overall Study|Protocol Violation|2|||
30798254|NCT02945046|58812627|FG001|Overall Study|Protocol Violation|3|||
30798255|NCT02945046|58812628|FG002|Overall Study|Protocol Violation|2|||
30798256|NCT02945046|58812626|FG000|Overall Study|Lost to Follow-up|1|||
30798257|NCT02945046|58812627|FG001|Overall Study|Lost to Follow-up|1|||
30798258|NCT02945046|58812628|FG002|Overall Study|Lost to Follow-up|0|||
30798259|NCT02945046|58812626|FG000|Overall Study|Lack of Efficacy|1|||
30798260|NCT02945046|58812627|FG001|Overall Study|Lack of Efficacy|2|||
30798261|NCT02945046|58812628|FG002|Overall Study|Lack of Efficacy|1|||
30798262|NCT02945046|58812626|FG000|Overall Study|Other than specified|5|||
30798263|NCT02945046|58812627|FG001|Overall Study|Other than specified|4|||
30798264|NCT02945046|58812628|FG002|Overall Study|Other than specified|7|||
30798265|NCT03705793|58812638|FG000|Overall Study|Lost to Follow-up|3|||
30798266|NCT03705793|58812639|FG001|Overall Study|Lost to Follow-up|4|||
30798267|NCT03705793|58812638|FG000|Overall Study|Withdrawal by Subject|2|||
30798268|NCT03705793|58812639|FG001|Overall Study|Withdrawal by Subject|1|||
30798269|NCT02944968|58812658|FG000|Overall Study|Subject excluded before study procedure|1|||
30798270|NCT02944968|58812658|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
30798271|NCT03761797|58812662|FG000|Overall Study|Changing hospital|11|||
30798272|NCT03761797|58812662|FG000|Overall Study|Improvement/remission|6|||
30798273|NCT03761797|58812662|FG000|Overall Study|Withdrawal by Subject|19|||
30798274|NCT03761797|58812662|FG000|Overall Study|Lost to Follow-up|33|||
30798275|NCT03761797|58812662|FG000|Overall Study|Adverse Event|37|||
30798276|NCT03761797|58812662|FG000|Overall Study|Case report form (CRF) not collected|5|||
30798277|NCT03761797|58812662|FG000|Overall Study|No patient visit after entry|13|||
30622232|NCT00928408|58633792|FG000|Overall Study|Withdrawal by Subject|4|||
30798278|NCT03761797|58812662|FG000|Overall Study|Switch to other diabetes medication|10|||
30798279|NCT03761797|58812662|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
30798280|NCT03761797|58812662|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
30798281|NCT03761797|58812662|FG000|Overall Study|Insufficient effectives|2|||
30798282|NCT03761797|58812662|FG000|Overall Study|Excessive alcohol intake|1|||
30798283|NCT02944656|58812668|FG000|Overall Study|No longer eligible|3|||
30798284|NCT02944656|58812669|FG001|Overall Study|No longer eligible|0|||
30798285|NCT02944656|58812668|FG000|Overall Study|Lost to Follow-up|7|||
30798286|NCT02944656|58812669|FG001|Overall Study|Lost to Follow-up|10|||
30798287|NCT02713529|58812682|FG000|Overall Study|Withdrawal by Subject|3|||
30798288|NCT02713529|58812683|FG001|Overall Study|Withdrawal by Subject|1|||
30798289|NCT02713529|58812684|FG002|Overall Study|Withdrawal by Subject|4|||
30798290|NCT02713529|58812685|FG003|Overall Study|Withdrawal by Subject|2|||
30798291|NCT02713529|58812686|FG004|Overall Study|Withdrawal by Subject|0|||
30798292|NCT02713529|58812687|FG005|Overall Study|Withdrawal by Subject|1|||
30798293|NCT02713529|58812688|FG006|Overall Study|Withdrawal by Subject|1|||
30798294|NCT02713529|58812682|FG000|Overall Study|Lost to Follow-up|1|||
30798295|NCT02713529|58812683|FG001|Overall Study|Lost to Follow-up|0|||
30798296|NCT02713529|58812684|FG002|Overall Study|Lost to Follow-up|1|||
30798297|NCT02713529|58812685|FG003|Overall Study|Lost to Follow-up|0|||
30798298|NCT02713529|58812686|FG004|Overall Study|Lost to Follow-up|0|||
30798299|NCT02713529|58812687|FG005|Overall Study|Lost to Follow-up|0|||
30798300|NCT02713529|58812688|FG006|Overall Study|Lost to Follow-up|0|||
30798301|NCT02713529|58812682|FG000|Overall Study|Death|3|||
30798302|NCT02713529|58812683|FG001|Overall Study|Death|3|||
30798303|NCT02713529|58812684|FG002|Overall Study|Death|26|||
30798304|NCT02713529|58812685|FG003|Overall Study|Death|27|||
30905487|NCT01781572|58940075|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
30905488|NCT01781572|58940076|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
30905489|NCT01781572|58940077|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
30905490|NCT01781572|58940075|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
30798305|NCT02713529|58812686|FG004|Overall Study|Death|3|||
30798306|NCT02713529|58812687|FG005|Overall Study|Death|13|||
30798307|NCT02713529|58812688|FG006|Overall Study|Death|3|||
30798308|NCT03707821|58812714|FG000|Overall Study|Protocol Violation|0|||
30798309|NCT03707821|58812715|FG001|Overall Study|Protocol Violation|1|||
30798310|NCT03707821|58812714|FG000|Overall Study|Unsatisfactory Visual Response|1|||
30798311|NCT03707821|58812715|FG001|Overall Study|Unsatisfactory Visual Response|0|||
30798312|NCT03707821|58812714|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
30798313|NCT03707821|58812715|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
30798314|NCT04546581|58812723|FG000|Overall Study|Adverse Event|9|||
30798315|NCT04546581|58812724|FG001|Overall Study|Adverse Event|3|||
30798316|NCT04546581|58812723|FG000|Overall Study|Physician Decision|0|||
30798317|NCT04546581|58812724|FG001|Overall Study|Physician Decision|1|||
30798318|NCT04546581|58812723|FG000|Overall Study|Protocol Violation|1|||
30798319|NCT04546581|58812724|FG001|Overall Study|Protocol Violation|2|||
30798320|NCT04546581|58812723|FG000|Overall Study|Withdrawal by Subject|3|||
30798321|NCT04546581|58812724|FG001|Overall Study|Withdrawal by Subject|7|||
30798322|NCT03707587|58812732|FG000|Overall Study|Death|0|||
30798323|NCT03707587|58812733|FG001|Overall Study|Death|1|||
30798324|NCT03312933|58812743|FG000|Overall Study|Protocol Violation|15|||
30798325|NCT03312933|58812743|FG000|Overall Study|Lost to Follow-up|36|||
30798326|NCT03312933|58812743|FG000|Overall Study|Withdrawal by Subject|3|||
30798327|NCT02561273|58812749|FG000|Overall Study|Protocol Violation|1|||
30798328|NCT02561273|58812750|FG001|Overall Study|Protocol Violation|0|||
30798329|NCT03312543|58812760|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
30798330|NCT03312543|58812761|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
30798331|NCT03312543|58812760|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
30798332|NCT03312543|58812761|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
30798333|NCT03312543|58812760|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
30798334|NCT03312543|58812761|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
30798335|NCT03312543|58812760|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
30798336|NCT03312543|58812761|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
30798337|NCT03312543|58812760|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
30798338|NCT03312543|58812761|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
30798339|NCT03312543|58812760|FG000|Regression (Week 12 to Week 24)|Death|0|||
30798340|NCT03312543|58812761|FG001|Regression (Week 12 to Week 24)|Death|1|||
30798341|NCT02392559|58812790|FG000|Overall Study|Withdrawal by Subject|0|||
30798342|NCT02392559|58812791|FG001|Overall Study|Withdrawal by Subject|1|||
30798343|NCT03332589|58812805|FG000|Overall Study|Lack of Efficacy|2|||
30798344|NCT03332589|58812806|FG001|Overall Study|Lack of Efficacy|0|||
30798345|NCT03332589|58812807|FG002|Overall Study|Lack of Efficacy|0|||
30798346|NCT03332589|58812805|FG000|Overall Study|Adverse Event|1|||
30798347|NCT03332589|58812806|FG001|Overall Study|Adverse Event|0|||
30798348|NCT03332589|58812807|FG002|Overall Study|Adverse Event|0|||
30798349|NCT03332589|58812805|FG000|Overall Study|Death|1|||
30798350|NCT03332589|58812806|FG001|Overall Study|Death|0|||
30798351|NCT03332589|58812807|FG002|Overall Study|Death|0|||
30798352|NCT00458003|58812817|FG000|Overall Study|Non protocol spinal anesthesia|1|||
30798353|NCT00458003|58812818|FG001|Overall Study|Non protocol spinal anesthesia|1|||
30798354|NCT02061293|58812828|FG000|Overall Study|Elevated Blood Pressure|1|||
30798355|NCT02061293|58812829|FG001|Overall Study|Elevated Blood Pressure|1|||
30798356|NCT02913612|58812839|FG000|Overall Study|Lost to Follow-up|6|||
30798357|NCT02913612|58812840|FG001|Overall Study|Lost to Follow-up|5|||
30798358|NCT02913612|58812841|FG002|Overall Study|Lost to Follow-up|2|||
30798359|NCT02913612|58812842|FG003|Overall Study|Lost to Follow-up|0|||
30798360|NCT02913612|58812839|FG000|Overall Study|Physician Decision|1|||
30798361|NCT02913612|58812840|FG001|Overall Study|Physician Decision|4|||
30798362|NCT02913612|58812841|FG002|Overall Study|Physician Decision|1|||
30798363|NCT02913612|58812842|FG003|Overall Study|Physician Decision|0|||
30798364|NCT02913612|58812839|FG000|Overall Study|Withdrawal by Subject|2|||
30798365|NCT02913612|58812840|FG001|Overall Study|Withdrawal by Subject|4|||
30798366|NCT02913612|58812841|FG002|Overall Study|Withdrawal by Subject|0|||
30798367|NCT02913612|58812842|FG003|Overall Study|Withdrawal by Subject|0|||
30798368|NCT02913612|58812839|FG000|Overall Study|Hemangioma resolved|1|||
30798369|NCT02913612|58812840|FG001|Overall Study|Hemangioma resolved|0|||
30798370|NCT02913612|58812841|FG002|Overall Study|Hemangioma resolved|0|||
30798371|NCT02913612|58812842|FG003|Overall Study|Hemangioma resolved|0|||
30798372|NCT02913612|58812839|FG000|Overall Study|Local IRB decision|1|||
30798373|NCT02913612|58812840|FG001|Overall Study|Local IRB decision|0|||
30746608|NCT00296504|58756938|FG005|Interim Analysis|Physician and Participant Decision|1|||
30798374|NCT02913612|58812841|FG002|Overall Study|Local IRB decision|0|||
30798375|NCT02913612|58812842|FG003|Overall Study|Local IRB decision|0|||
30798376|NCT02913612|58812839|FG000|Overall Study|Study drug non-compliance|1|||
30798377|NCT02913612|58812840|FG001|Overall Study|Study drug non-compliance|1|||
30798378|NCT02913612|58812841|FG002|Overall Study|Study drug non-compliance|0|||
30798379|NCT02913612|58812842|FG003|Overall Study|Study drug non-compliance|0|||
30798380|NCT02913612|58812839|FG000|Overall Study|Insurance issues|0|||
30798381|NCT02913612|58812840|FG001|Overall Study|Insurance issues|1|||
30798382|NCT02913612|58812841|FG002|Overall Study|Insurance issues|0|||
30798383|NCT02913612|58812842|FG003|Overall Study|Insurance issues|0|||
30746609|NCT00296504|58756939|FG006|Interim Analysis|Physician and Participant Decision|0|||
30746610|NCT00296504|58756940|FG007|Interim Analysis|Physician and Participant Decision|0|||
30746611|NCT00296504|58756941|FG008|Interim Analysis|Physician and Participant Decision|0|||
30798384|NCT02913612|58812839|FG000|Overall Study|Needed to treat second hemangioma|0|||
30798385|NCT02913612|58812840|FG001|Overall Study|Needed to treat second hemangioma|1|||
30798386|NCT02913612|58812841|FG002|Overall Study|Needed to treat second hemangioma|0|||
30798387|NCT02913612|58812842|FG003|Overall Study|Needed to treat second hemangioma|0|||
30798388|NCT02913612|58812839|FG000|Overall Study|Study completion criteria not met|0|||
30798389|NCT02913612|58812840|FG001|Overall Study|Study completion criteria not met|1|||
30798390|NCT02913612|58812841|FG002|Overall Study|Study completion criteria not met|0|||
30798391|NCT02913612|58812842|FG003|Overall Study|Study completion criteria not met|0|||
30798392|NCT02913612|58812839|FG000|Overall Study|Ineligible|0|||
30798393|NCT02913612|58812840|FG001|Overall Study|Ineligible|1|||
30798394|NCT02913612|58812841|FG002|Overall Study|Ineligible|0|||
30798395|NCT02913612|58812842|FG003|Overall Study|Ineligible|0|||
30798396|NCT03312231|58812856|FG000|Overall Study|Lost to Follow-up|2|||
30746612|NCT00296504|58756933|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
30746613|NCT00296504|58756934|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
30746614|NCT00296504|58756935|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
30746615|NCT00296504|58756936|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
30746616|NCT00296504|58756937|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
30746617|NCT00296504|58756938|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
30746618|NCT00296504|58756939|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
30798397|NCT03312231|58812857|FG001|Overall Study|Lost to Follow-up|6|||
30798398|NCT03312231|58812858|FG002|Overall Study|Lost to Follow-up|1|||
30798399|NCT03312231|58812859|FG003|Overall Study|Lost to Follow-up|3|||
30798400|NCT03312231|58812860|FG004|Overall Study|Lost to Follow-up|1|||
30798401|NCT03312231|58812856|FG000|Overall Study|Withdrawal by Subject|0|||
30798402|NCT03312231|58812857|FG001|Overall Study|Withdrawal by Subject|3|||
30798403|NCT03312231|58812858|FG002|Overall Study|Withdrawal by Subject|1|||
30798404|NCT03312231|58812859|FG003|Overall Study|Withdrawal by Subject|0|||
30798405|NCT03312231|58812860|FG004|Overall Study|Withdrawal by Subject|0|||
30798406|NCT03312231|58812856|FG000|Overall Study|Death|0|||
30798407|NCT03312231|58812857|FG001|Overall Study|Death|1|||
30798408|NCT03312231|58812858|FG002|Overall Study|Death|1|||
30798409|NCT03312231|58812859|FG003|Overall Study|Death|0|||
30798410|NCT03312231|58812860|FG004|Overall Study|Death|0|||
30798411|NCT03312231|58812856|FG000|Overall Study|Study Vaccination not Received|1|||
30798412|NCT03312231|58812857|FG001|Overall Study|Study Vaccination not Received|1|||
30798413|NCT03312231|58812858|FG002|Overall Study|Study Vaccination not Received|1|||
30798414|NCT03312231|58812859|FG003|Overall Study|Study Vaccination not Received|0|||
30798415|NCT03312231|58812860|FG004|Overall Study|Study Vaccination not Received|0|||
30798416|NCT03323736|58812875|FG000|Overall Study|Screen Failure|14|||
30798417|NCT03323736|58812876|FG001|Overall Study|Screen Failure|9|||
30798418|NCT03323736|58812877|FG002|Overall Study|Screen Failure|1|||
30798419|NCT03323736|58812875|FG000|Overall Study|Withdrawal Before Treatment|3|||
30798420|NCT03323736|58812876|FG001|Overall Study|Withdrawal Before Treatment|1|||
30798421|NCT03323736|58812877|FG002|Overall Study|Withdrawal Before Treatment|1|||
30798422|NCT03323736|58812875|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
30798423|NCT03323736|58812876|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
30798424|NCT03323736|58812877|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
30798425|NCT03311841|58812892|FG000|14-day Wash-out|Adverse Event|0|||
30798426|NCT03311841|58812893|FG001|14-day Wash-out|Adverse Event|1|||
30798427|NCT03311841|58812894|FG002|14-day Wash-out|Adverse Event|0|||
30798428|NCT03311841|58812895|FG003|14-day Wash-out|Adverse Event|0|||
30798429|NCT03311841|58812896|FG004|14-day Wash-out|Adverse Event|0|||
30798430|NCT03311841|58812892|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
30798431|NCT03311841|58812893|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
30798432|NCT03311841|58812894|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
30798433|NCT03311841|58812895|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
30798434|NCT03311841|58812896|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
30798435|NCT03311373|58812929|FG000|Overall Study|Adverse Event|1|||
30798436|NCT03311373|58812929|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
30798437|NCT03311373|58812929|FG000|Overall Study|Lost to Follow-up|1|||
30798438|NCT03311373|58812929|FG000|Overall Study|Physician Decision|1|||
30798439|NCT03311373|58812929|FG000|Overall Study|Withdrawal by Subject|3|||
30798440|NCT01155375|58812941|FG000|Overall Study|Adverse Event|1|||
30798441|NCT01155375|58812942|FG001|Overall Study|Adverse Event|0|||
30798442|NCT00628095|58812960|FG000|Overall Study|Adverse Event|5|||
30798443|NCT00628095|58812961|FG001|Overall Study|Adverse Event|3|||
30798444|NCT00628095|58812960|FG000|Overall Study|Lack of Efficacy|0|||
30798445|NCT00628095|58812961|FG001|Overall Study|Lack of Efficacy|3|||
30798446|NCT00628095|58812960|FG000|Overall Study|Withdrawal by Subject|2|||
30905491|NCT01781572|58940076|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
30905492|NCT01781572|58940077|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
30746619|NCT00296504|58756940|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
30746620|NCT00296504|58756941|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
30746621|NCT00296504|58756933|FG000|Interim Analysis|Study Ended|0|||
30746622|NCT00296504|58756934|FG001|Interim Analysis|Study Ended|0|||
30746623|NCT00296504|58756935|FG002|Interim Analysis|Study Ended|0|||
30746624|NCT00296504|58756936|FG003|Interim Analysis|Study Ended|0|||
30746625|NCT00296504|58756937|FG004|Interim Analysis|Study Ended|0|||
30746626|NCT00296504|58756938|FG005|Interim Analysis|Study Ended|0|||
30746627|NCT00296504|58756939|FG006|Interim Analysis|Study Ended|1|||
30746628|NCT00296504|58756940|FG007|Interim Analysis|Study Ended|0|||
30798447|NCT00628095|58812961|FG001|Overall Study|Withdrawal by Subject|0|||
30798448|NCT00628095|58812960|FG000|Overall Study|Other|0|||
30798449|NCT00628095|58812961|FG001|Overall Study|Other|1|||
30798450|NCT02889861|58812969|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
30798451|NCT03325881|58812980|FG000|Overall Study|Protocol Violation|0|||
30798452|NCT03325881|58812981|FG001|Overall Study|Protocol Violation|1|||
30798453|NCT03325881|58812980|FG000|Overall Study|Withdrawal by Subject|0|||
30798454|NCT03325881|58812981|FG001|Overall Study|Withdrawal by Subject|2|||
30798455|NCT03325881|58812980|FG000|Overall Study|Lack of Efficacy|2|||
30798456|NCT03325881|58812981|FG001|Overall Study|Lack of Efficacy|0|||
30798457|NCT03325881|58812980|FG000|Overall Study|Not treated|1|||
30798458|NCT03325881|58812981|FG001|Overall Study|Not treated|0|||
30798459|NCT02887989|58812991|FG000|Overall Study|Withdrawal by Subject|8|||
30798460|NCT02887989|58812992|FG001|Overall Study|Withdrawal by Subject|11|||
30798461|NCT02887989|58812991|FG000|Overall Study|Death|1|||
30798462|NCT02887989|58812992|FG001|Overall Study|Death|0|||
30798463|NCT02887521|58813000|FG000|Overall Study|Withdrawal by Subject|0|||
30798464|NCT02887521|58813001|FG001|Overall Study|Withdrawal by Subject|3|||
30798465|NCT03305055|58813009|FG000|Overall Study|Withdrawal by Subject|0|||
30798466|NCT03305055|58813010|FG001|Overall Study|Withdrawal by Subject|1|||
30798467|NCT03305055|58813009|FG000|Overall Study|Adverse Event|1|||
30798468|NCT03305055|58813010|FG001|Overall Study|Adverse Event|1|||
30798469|NCT02763189|58813018|FG000|Overall Study|Device failure|0|||
30798470|NCT02763189|58813019|FG001|Overall Study|Device failure|2|||
30746629|NCT00296504|58756941|FG008|Interim Analysis|Study Ended|0|||
30746630|NCT00296504|58756933|FG000|Interim Analysis|Participant Needed Interferon|0|||
30746631|NCT00296504|58756934|FG001|Interim Analysis|Participant Needed Interferon|0|||
30746632|NCT00296504|58756935|FG002|Interim Analysis|Participant Needed Interferon|0|||
30746633|NCT00296504|58756936|FG003|Interim Analysis|Participant Needed Interferon|0|||
30746634|NCT00296504|58756937|FG004|Interim Analysis|Participant Needed Interferon|0|||
30746635|NCT00296504|58756938|FG005|Interim Analysis|Participant Needed Interferon|0|||
30746636|NCT00296504|58756939|FG006|Interim Analysis|Participant Needed Interferon|0|||
30746637|NCT00296504|58756940|FG007|Interim Analysis|Participant Needed Interferon|1|||
30746638|NCT00296504|58756941|FG008|Interim Analysis|Participant Needed Interferon|0|||
30746639|NCT00296504|58756933|FG000|Interim Analysis|Ongoing|32|||
30746640|NCT00296504|58756934|FG001|Interim Analysis|Ongoing|12|||
30746641|NCT00296504|58756935|FG002|Interim Analysis|Ongoing|16|||
30746642|NCT00296504|58756936|FG003|Interim Analysis|Ongoing|22|||
30746643|NCT00296504|58756937|FG004|Interim Analysis|Ongoing|0|||
30746644|NCT00296504|58756938|FG005|Interim Analysis|Ongoing|0|||
30746645|NCT00296504|58756939|FG006|Interim Analysis|Ongoing|30|||
30746646|NCT00296504|58756940|FG007|Interim Analysis|Ongoing|1|||
30746647|NCT00296504|58756941|FG008|Interim Analysis|Ongoing|0|||
30746648|NCT00296504|58756933|FG000|Final Analysis|Withdrawal by Subject|0|||
30746649|NCT00296504|58756934|FG001|Final Analysis|Withdrawal by Subject|0|||
30746650|NCT00296504|58756935|FG002|Final Analysis|Withdrawal by Subject|0|||
30746651|NCT00296504|58756936|FG003|Final Analysis|Withdrawal by Subject|0|||
30746652|NCT00296504|58756937|FG004|Final Analysis|Withdrawal by Subject|0|||
30746653|NCT00296504|58756938|FG005|Final Analysis|Withdrawal by Subject|0|||
30746654|NCT00296504|58756939|FG006|Final Analysis|Withdrawal by Subject|0|||
30798471|NCT03273387|58813027|FG000|Overall Study|Death|2|||
30798472|NCT03273387|58813028|FG001|Overall Study|Death|2|||
30746655|NCT00296504|58756940|FG007|Final Analysis|Withdrawal by Subject|0|||
30746656|NCT00296504|58756941|FG008|Final Analysis|Withdrawal by Subject|1|||
30746657|NCT00296504|58756933|FG000|Final Analysis|Lost to Follow-up|0|||
30746658|NCT00296504|58756934|FG001|Final Analysis|Lost to Follow-up|0|||
30746659|NCT00296504|58756935|FG002|Final Analysis|Lost to Follow-up|0|||
30746660|NCT00296504|58756936|FG003|Final Analysis|Lost to Follow-up|0|||
30746661|NCT00296504|58756937|FG004|Final Analysis|Lost to Follow-up|0|||
30798473|NCT03273387|58813027|FG000|Overall Study|Withdrawal by Subject|1|||
30798474|NCT03273387|58813028|FG001|Overall Study|Withdrawal by Subject|1|||
30798475|NCT01328080|58813034|FG000|Overall Study|Lost to Follow-up|5|||
30798476|NCT02649946|58813053|FG000|Overall Study|Withdrawal by Subject|1|||
30798477|NCT02649946|58813054|FG001|Overall Study|Withdrawal by Subject|1|||
30798478|NCT02649946|58813053|FG000|Overall Study|Death|7|||
30798479|NCT02649946|58813054|FG001|Overall Study|Death|9|||
30798480|NCT02649946|58813053|FG000|Overall Study|Physician Decision|1|||
30798481|NCT02649946|58813054|FG001|Overall Study|Physician Decision|0|||
30798482|NCT02649946|58813053|FG000|Overall Study|Lost to Follow-up|2|||
30798483|NCT02649946|58813054|FG001|Overall Study|Lost to Follow-up|1|||
30798484|NCT02649946|58813053|FG000|Overall Study|Erroneously enrolled|1|||
30798485|NCT02649946|58813054|FG001|Overall Study|Erroneously enrolled|0|||
30798486|NCT02649946|58813053|FG000|Overall Study|Missed 6-month follow-up visit|0|||
30798487|NCT02649946|58813054|FG001|Overall Study|Missed 6-month follow-up visit|4|||
30798488|NCT03273153|58813062|FG000|Overall Study|Adverse Event|1|||
30798489|NCT03273153|58813063|FG001|Overall Study|Adverse Event|2|||
30746662|NCT00296504|58756938|FG005|Final Analysis|Lost to Follow-up|0|||
30746663|NCT00296504|58756939|FG006|Final Analysis|Lost to Follow-up|0|||
30746664|NCT00296504|58756940|FG007|Final Analysis|Lost to Follow-up|0|||
30798490|NCT03273153|58813062|FG000|Overall Study|Missing|0|||
30798491|NCT03273153|58813063|FG001|Overall Study|Missing|2|||
30798492|NCT03273153|58813062|FG000|Overall Study|Other|3|||
30905493|NCT01781572|58940075|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
30905494|NCT01781572|58940076|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
30905495|NCT01781572|58940077|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
30905496|NCT01977651|58940106|FG000|4 Month Treatment Period|Adverse Event|34|||
30905497|NCT01977651|58940106|FG000|4 Month Treatment Period|Death|3|||
30905498|NCT01977651|58940106|FG000|4 Month Treatment Period|Progressive Disease|43|||
30905499|NCT01977651|58940106|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
30905500|NCT01977651|58940106|FG000|4 Month Treatment Period|Physician Decision|4|||
30905501|NCT01977651|58940106|FG000|1 Year Extension Period|Adverse Event|14|||
30905502|NCT01977651|58940106|FG000|1 Year Extension Period|Death|10|||
30905503|NCT01977651|58940106|FG000|1 Year Extension Period|Lost to Follow-up|2|||
30746665|NCT00296504|58756941|FG008|Final Analysis|Lost to Follow-up|5|||
30746666|NCT00296504|58756933|FG000|Final Analysis|Insufficient Viral Load Response|0|||
30746667|NCT00296504|58756934|FG001|Final Analysis|Insufficient Viral Load Response|0|||
30746668|NCT00296504|58756935|FG002|Final Analysis|Insufficient Viral Load Response|0|||
30746669|NCT00296504|58756936|FG003|Final Analysis|Insufficient Viral Load Response|0|||
30798493|NCT03273153|58813063|FG001|Overall Study|Other|2|||
30798494|NCT03273153|58813062|FG000|Overall Study|Symptomatic Deterioration|0|||
30798495|NCT03273153|58813063|FG001|Overall Study|Symptomatic Deterioration|1|||
30798496|NCT03273153|58813062|FG000|Overall Study|Progressive Disease|6|||
30798497|NCT03273153|58813063|FG001|Overall Study|Progressive Disease|5|||
30798498|NCT03273153|58813062|FG000|Overall Study|Physician Decision|1|||
30798499|NCT03273153|58813063|FG001|Overall Study|Physician Decision|3|||
30798500|NCT03273153|58813062|FG000|Overall Study|Study Terminated by Sponsor|112|||
30798501|NCT03273153|58813063|FG001|Overall Study|Study Terminated by Sponsor|102|||
30798502|NCT03273153|58813062|FG000|Overall Study|Withdrawal by Subject|26|||
30798503|NCT03273153|58813063|FG001|Overall Study|Withdrawal by Subject|25|||
30798504|NCT03273153|58813062|FG000|Overall Study|Protocol Deviation|3|||
30798505|NCT03273153|58813063|FG001|Overall Study|Protocol Deviation|0|||
30798506|NCT03273153|58813062|FG000|Overall Study|Lost to Follow-up|6|||
30798507|NCT03273153|58813063|FG001|Overall Study|Lost to Follow-up|11|||
30798508|NCT03273153|58813062|FG000|Overall Study|Death|66|||
30798509|NCT03273153|58813063|FG001|Overall Study|Death|69|||
30798510|NCT03323034|58813075|FG000|Overall Study|Lack of Efficacy|5|||
30798511|NCT03323034|58813076|FG001|Overall Study|Lack of Efficacy|5|||
30798512|NCT03323034|58813077|FG002|Overall Study|Lack of Efficacy|6|||
30798513|NCT03323034|58813078|FG003|Overall Study|Lack of Efficacy|5|||
30798514|NCT03323034|58813079|FG004|Overall Study|Lack of Efficacy|5|||
30798515|NCT03323034|58813075|FG000|Overall Study|Physician Decision|0|||
30622233|NCT00928408|58633792|FG000|Overall Study|Death|5|||
30746670|NCT00296504|58756937|FG004|Final Analysis|Insufficient Viral Load Response|0|||
30746671|NCT00296504|58756938|FG005|Final Analysis|Insufficient Viral Load Response|0|||
30746672|NCT00296504|58756939|FG006|Final Analysis|Insufficient Viral Load Response|0|||
30746673|NCT00296504|58756940|FG007|Final Analysis|Insufficient Viral Load Response|0|||
30746674|NCT00296504|58756941|FG008|Final Analysis|Insufficient Viral Load Response|6|||
30746675|NCT00296504|58756933|FG000|Final Analysis|Adverse Event|0|||
30746676|NCT00296504|58756934|FG001|Final Analysis|Adverse Event|0|||
30746677|NCT00296504|58756935|FG002|Final Analysis|Adverse Event|0|||
30746678|NCT00296504|58756936|FG003|Final Analysis|Adverse Event|0|||
30746679|NCT00296504|58756937|FG004|Final Analysis|Adverse Event|0|||
30746680|NCT00296504|58756938|FG005|Final Analysis|Adverse Event|0|||
30746681|NCT00296504|58756939|FG006|Final Analysis|Adverse Event|0|||
30746682|NCT00296504|58756940|FG007|Final Analysis|Adverse Event|0|||
30746683|NCT00296504|58756941|FG008|Final Analysis|Adverse Event|2|||
30746684|NCT00296504|58756933|FG000|Final Analysis|Pregnancy|0|||
30746685|NCT00296504|58756934|FG001|Final Analysis|Pregnancy|0|||
30746686|NCT00296504|58756935|FG002|Final Analysis|Pregnancy|0|||
30746687|NCT00296504|58756936|FG003|Final Analysis|Pregnancy|0|||
30746688|NCT00296504|58756937|FG004|Final Analysis|Pregnancy|0|||
30746689|NCT00296504|58756938|FG005|Final Analysis|Pregnancy|0|||
30746690|NCT00296504|58756939|FG006|Final Analysis|Pregnancy|0|||
30746691|NCT00296504|58756940|FG007|Final Analysis|Pregnancy|0|||
30746692|NCT00296504|58756941|FG008|Final Analysis|Pregnancy|4|||
30746693|NCT00296504|58756933|FG000|Final Analysis|Tuberculosis|0|||
30746694|NCT00296504|58756934|FG001|Final Analysis|Tuberculosis|0|||
30746695|NCT00296504|58756935|FG002|Final Analysis|Tuberculosis|0|||
30746696|NCT00296504|58756936|FG003|Final Analysis|Tuberculosis|0|||
30746697|NCT00296504|58756937|FG004|Final Analysis|Tuberculosis|0|||
30746698|NCT00296504|58756938|FG005|Final Analysis|Tuberculosis|0|||
30746699|NCT00296504|58756939|FG006|Final Analysis|Tuberculosis|0|||
30746700|NCT00296504|58756940|FG007|Final Analysis|Tuberculosis|0|||
30746701|NCT00296504|58756941|FG008|Final Analysis|Tuberculosis|1|||
30746702|NCT00296504|58756933|FG000|Final Analysis|Participant Moved to Another Country|0|||
30746703|NCT00296504|58756934|FG001|Final Analysis|Participant Moved to Another Country|0|||
30746704|NCT00296504|58756935|FG002|Final Analysis|Participant Moved to Another Country|0|||
30746705|NCT00296504|58756936|FG003|Final Analysis|Participant Moved to Another Country|0|||
30746706|NCT00296504|58756937|FG004|Final Analysis|Participant Moved to Another Country|0|||
30746707|NCT00296504|58756938|FG005|Final Analysis|Participant Moved to Another Country|0|||
30746708|NCT00296504|58756939|FG006|Final Analysis|Participant Moved to Another Country|0|||
30746709|NCT00296504|58756940|FG007|Final Analysis|Participant Moved to Another Country|0|||
30622234|NCT00928408|58633792|FG000|Overall Study|Lost to Follow-up|12|||
30746710|NCT00296504|58756941|FG008|Final Analysis|Participant Moved to Another Country|1|||
30746711|NCT00296504|58756933|FG000|Final Analysis|Poor Adherence|0|||
30746712|NCT00296504|58756934|FG001|Final Analysis|Poor Adherence|0|||
30798516|NCT03323034|58813076|FG001|Overall Study|Physician Decision|0|||
30798517|NCT03323034|58813077|FG002|Overall Study|Physician Decision|0|||
30798518|NCT03323034|58813078|FG003|Overall Study|Physician Decision|0|||
30798519|NCT03323034|58813079|FG004|Overall Study|Physician Decision|1|||
30798520|NCT03323034|58813075|FG000|Overall Study|Withdrawal by Subject|1|||
30798521|NCT03323034|58813076|FG001|Overall Study|Withdrawal by Subject|1|||
30798522|NCT03323034|58813077|FG002|Overall Study|Withdrawal by Subject|0|||
30798523|NCT03323034|58813078|FG003|Overall Study|Withdrawal by Subject|1|||
30798524|NCT03323034|58813079|FG004|Overall Study|Withdrawal by Subject|0|||
30798525|NCT03270657|58813110|FG000|Overall Study|Withdrawal by Subject|1|||
30798526|NCT03303417|58813114|FG000|Overall Study|Withdrawal by Subject|1|||
30798527|NCT03303417|58813115|FG001|Overall Study|Withdrawal by Subject|1|||
30798528|NCT02943564|58813124|FG000|Overall Study|Miscellaneous Reasons|0|||
30798529|NCT02943564|58813125|FG001|Overall Study|Miscellaneous Reasons|0|||
30798530|NCT02943564|58813126|FG002|Overall Study|Miscellaneous Reasons|3|||
30798531|NCT02943564|58813124|FG000|Overall Study|Site terminated by sponsor|0|||
30798532|NCT02943564|58813125|FG001|Overall Study|Site terminated by sponsor|1|||
30905504|NCT01977651|58940106|FG000|1 Year Extension Period|Progressive Disease|86|||
30905505|NCT01977651|58940106|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
30905506|NCT01977651|58940106|FG000|1 Year Extension Period|Physician Decision|6|||
30905507|NCT01977651|58940106|FG000|1 Year Extension Period|Miscellaneous|1|||
30746713|NCT00296504|58756935|FG002|Final Analysis|Poor Adherence|0|||
30746714|NCT00296504|58756936|FG003|Final Analysis|Poor Adherence|0|||
30746715|NCT00296504|58756937|FG004|Final Analysis|Poor Adherence|0|||
30746716|NCT00296504|58756938|FG005|Final Analysis|Poor Adherence|0|||
30746717|NCT00296504|58756939|FG006|Final Analysis|Poor Adherence|0|||
30746718|NCT00296504|58756940|FG007|Final Analysis|Poor Adherence|0|||
30746719|NCT00296504|58756941|FG008|Final Analysis|Poor Adherence|1|||
30746720|NCT00313820|58756968|FG000|Assigned to Treatment|Other|1|||
30746721|NCT00313820|58756969|FG001|Assigned to Treatment|Other|0|||
30746722|NCT00313820|58756968|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
30746723|NCT00313820|58756969|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
30746724|NCT00313820|58756968|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
30746725|NCT00313820|58756969|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
30746726|NCT00313820|58756968|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
30746727|NCT00313820|58756969|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
30746728|NCT00313820|58756968|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
30746729|NCT00313820|58756969|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
30905508|NCT01977651|58940106|FG000|Post 1 Year Extension Period|Adverse Event|5|||
30905509|NCT01977651|58940106|FG000|Post 1 Year Extension Period|Death|13|||
30905510|NCT01977651|58940106|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
30905511|NCT01977651|58940106|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
30905512|NCT01977651|58940106|FG000|Post 1 Year Extension Period|Physician Decision|4|||
30905513|NCT01977651|58940106|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
30905514|NCT01998243|58940112|FG000|Overall Study|Pregnancy|0|||
30905515|NCT01998243|58940113|FG001|Overall Study|Pregnancy|1|||
30905516|NCT01998243|58940112|FG000|Overall Study|Protocol Violation|5|||
30905517|NCT01998243|58940113|FG001|Overall Study|Protocol Violation|2|||
30905518|NCT01998243|58940112|FG000|Overall Study|Withdrawal by Subject|3|||
30905519|NCT01998243|58940113|FG001|Overall Study|Withdrawal by Subject|4|||
30905520|NCT01977573|58940125|FG000|Overall Study|Adverse Event|7|||
30905521|NCT01977573|58940126|FG001|Overall Study|Adverse Event|0|||
30905522|NCT01977573|58940127|FG002|Overall Study|Adverse Event|2|||
30905523|NCT01977573|58940128|FG003|Overall Study|Adverse Event|1|||
30905524|NCT01977573|58940125|FG000|Overall Study|Lost to Follow-up|1|||
30905525|NCT01977573|58940126|FG001|Overall Study|Lost to Follow-up|0|||
30905526|NCT01977573|58940127|FG002|Overall Study|Lost to Follow-up|0|||
30905527|NCT01977573|58940128|FG003|Overall Study|Lost to Follow-up|1|||
30746730|NCT00313820|58756968|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
30746731|NCT00313820|58756969|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
30746732|NCT00462761|58756975|FG000|Overall Study|Adverse Event|6|||
30746733|NCT00462761|58756975|FG000|Overall Study|Withdrawal by Subject|9|||
30798533|NCT02943564|58813126|FG002|Overall Study|Site terminated by sponsor|0|||
30905528|NCT01977573|58940125|FG000|Overall Study|Physician Decision|1|||
30905529|NCT01977573|58940126|FG001|Overall Study|Physician Decision|0|||
30905530|NCT01977573|58940127|FG002|Overall Study|Physician Decision|0|||
30905531|NCT01977573|58940128|FG003|Overall Study|Physician Decision|0|||
30905532|NCT01977573|58940125|FG000|Overall Study|Protocol Violation|3|||
30798534|NCT02943564|58813124|FG000|Overall Study|Non-compliance with study drug|0|||
30798535|NCT02943564|58813125|FG001|Overall Study|Non-compliance with study drug|1|||
30798536|NCT02943564|58813126|FG002|Overall Study|Non-compliance with study drug|0|||
30798537|NCT02943564|58813124|FG000|Overall Study|Pregnancy|0|||
30798538|NCT02943564|58813125|FG001|Overall Study|Pregnancy|1|||
30798539|NCT02943564|58813126|FG002|Overall Study|Pregnancy|1|||
30798540|NCT02943564|58813124|FG000|Overall Study|Protocol Violation|2|||
30798541|NCT02943564|58813125|FG001|Overall Study|Protocol Violation|2|||
30798542|NCT02943564|58813126|FG002|Overall Study|Protocol Violation|2|||
30798543|NCT02943564|58813124|FG000|Overall Study|Lost to Follow-up|1|||
30798544|NCT02943564|58813125|FG001|Overall Study|Lost to Follow-up|0|||
30798545|NCT02943564|58813126|FG002|Overall Study|Lost to Follow-up|0|||
30798546|NCT02943564|58813124|FG000|Overall Study|Withdrawal by Subject|6|||
30798547|NCT02943564|58813125|FG001|Overall Study|Withdrawal by Subject|5|||
30798548|NCT02943564|58813126|FG002|Overall Study|Withdrawal by Subject|2|||
30798549|NCT02943564|58813124|FG000|Overall Study|Adverse Event|1|||
30798550|NCT02943564|58813125|FG001|Overall Study|Adverse Event|2|||
30798551|NCT02943564|58813126|FG002|Overall Study|Adverse Event|1|||
30798552|NCT02943564|58813124|FG000|Overall Study|Lack of Efficacy|0|||
30798553|NCT02943564|58813125|FG001|Overall Study|Lack of Efficacy|1|||
30798554|NCT02943564|58813126|FG002|Overall Study|Lack of Efficacy|0|||
30798555|NCT03268941|58813138|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
30798556|NCT03268941|58813139|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
30798557|NCT03268941|58813140|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
30798558|NCT03268941|58813141|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
30798559|NCT03268941|58813142|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
30798560|NCT03268941|58813143|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
30798561|NCT03268941|58813144|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
30798562|NCT03268941|58813138|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
30798563|NCT03268941|58813139|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
30798564|NCT03268941|58813140|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
30798565|NCT03268941|58813141|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
30798566|NCT03268941|58813142|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
30798567|NCT03268941|58813143|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
30798568|NCT03268941|58813144|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
30798569|NCT03268941|58813138|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
30798570|NCT03268941|58813139|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
30798571|NCT03268941|58813140|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
30798572|NCT03268941|58813141|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
30798573|NCT03268941|58813142|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
30798574|NCT03268941|58813143|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
30798575|NCT03268941|58813144|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
30798576|NCT03268941|58813138|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
30798577|NCT03268941|58813139|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
30905533|NCT01977573|58940126|FG001|Overall Study|Protocol Violation|1|||
30622235|NCT00928252|58633796|FG000|Overall Study|Physician Decision|3|||
30622236|NCT01177007|58633802|FG000|Overall Study|Lost to Follow-up|2|||
30622237|NCT01177007|58633802|FG000|Overall Study|Death|4|||
30622238|NCT01177007|58633802|FG000|Overall Study|Entered hospice care|5|||
30622239|NCT01177007|58633802|FG000|Overall Study|Required additional Y90 treatment|6|||
30622240|NCT01177007|58633802|FG000|Overall Study|Change in treatment modality|21|||
30622241|NCT00930982|58633810|FG000|Overall Study|Adverse Event|19|||
30622242|NCT00930982|58633811|FG001|Overall Study|Adverse Event|23|||
30622243|NCT00930982|58633810|FG000|Overall Study|Protocol Violation|1|||
30622244|NCT00930982|58633811|FG001|Overall Study|Protocol Violation|5|||
30746734|NCT00462761|58756975|FG000|Overall Study|Physician Decision|5|||
30746735|NCT00462761|58756975|FG000|Overall Study|Disease progression|43|||
30746736|NCT00462761|58756975|FG000|Overall Study|Death|12|||
30746737|NCT00462761|58756975|FG000|Overall Study|Other|1|||
30746738|NCT00235872|58757007|FG000|Overall Study|Adverse Event|34|||
30746739|NCT00235872|58757007|FG000|Overall Study|Death|1|||
30746740|NCT00235872|58757007|FG000|Overall Study|Lost to Follow-up|1|||
30746741|NCT00235872|58757007|FG000|Overall Study|Withdrawal by Subject|50|||
30746742|NCT00235872|58757007|FG000|Overall Study|Administrative reason|61|||
30746743|NCT00461981|58757013|FG000|Overall Study|Lost to Follow-up|9|||
30746744|NCT00461981|58757014|FG001|Overall Study|Lost to Follow-up|6|||
30746745|NCT00461981|58757013|FG000|Overall Study|Withdrawal by Subject|2|||
30746746|NCT00461981|58757014|FG001|Overall Study|Withdrawal by Subject|3|||
30798578|NCT03268941|58813140|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
30798579|NCT03268941|58813141|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
30622245|NCT00930982|58633810|FG000|Overall Study|Withdrawal by Subject|1|||
30746747|NCT00296036|58757022|FG000|Overall Study|Withdrawal by Subject|1|||
30746748|NCT00296036|58757023|FG001|Overall Study|Withdrawal by Subject|0|||
30905534|NCT01977573|58940127|FG002|Overall Study|Protocol Violation|0|||
30905535|NCT01977573|58940128|FG003|Overall Study|Protocol Violation|0|||
30905536|NCT01977573|58940125|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
30905537|NCT01977573|58940126|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
30905538|NCT01977573|58940127|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
30905539|NCT01977573|58940128|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
30622246|NCT00930982|58633811|FG001|Overall Study|Withdrawal by Subject|1|||
30622247|NCT01176773|58633817|FG000|Overall Study|Screen Failure|2|||
30622248|NCT01176773|58633817|FG000|Overall Study|Withdrew consent|1|||
30622249|NCT00928018|58633824|FG000|Overall Study|Withdrawal by Subject|1|||
30622250|NCT00928018|58633825|FG001|Overall Study|Withdrawal by Subject|0|||
30622251|NCT00927940|58633835|FG000|Overall Study|Death|1|||
30622252|NCT00927862|58633842|FG000|Overall Study|Missing data needed for endpt analyses|27|||
30622253|NCT00927862|58633843|FG001|Overall Study|Missing data needed for endpt analyses|45|||
30622254|NCT00976989|58633854|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
30622255|NCT00976989|58633855|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
30622256|NCT00976989|58633856|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
30622257|NCT00976989|58633854|FG000|Overall Study|Death|5|||
30905540|NCT01977573|58940125|FG000|Overall Study|Withdrawal by Subject|6|||
30905541|NCT01977573|58940126|FG001|Overall Study|Withdrawal by Subject|1|||
30905542|NCT01977573|58940127|FG002|Overall Study|Withdrawal by Subject|1|||
30622258|NCT00976989|58633855|FG001|Overall Study|Death|7|||
30622259|NCT00976989|58633856|FG002|Overall Study|Death|10|||
30622260|NCT00976989|58633854|FG000|Overall Study|Refused Treatment|4|||
30622261|NCT00976989|58633855|FG001|Overall Study|Refused Treatment|3|||
30622262|NCT00976989|58633856|FG002|Overall Study|Refused Treatment|5|||
30746749|NCT00296036|58757024|FG002|Overall Study|Withdrawal by Subject|2|||
30798580|NCT03268941|58813142|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
30798581|NCT03268941|58813143|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
30798582|NCT03268941|58813144|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
30798583|NCT03268941|58813138|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
30798584|NCT03268941|58813139|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
30798585|NCT03268941|58813140|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
30798586|NCT03268941|58813141|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
30798587|NCT03268941|58813142|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
30746750|NCT00296036|58757025|FG003|Overall Study|Withdrawal by Subject|1|||
30746751|NCT00296036|58757026|FG004|Overall Study|Withdrawal by Subject|2|||
30746752|NCT00296036|58757027|FG005|Overall Study|Withdrawal by Subject|1|||
30746753|NCT00296036|58757022|FG000|Overall Study|Protocol Violation|0|||
30746754|NCT00296036|58757023|FG001|Overall Study|Protocol Violation|0|||
30746755|NCT00296036|58757024|FG002|Overall Study|Protocol Violation|0|||
30746756|NCT00296036|58757025|FG003|Overall Study|Protocol Violation|0|||
30746757|NCT00296036|58757026|FG004|Overall Study|Protocol Violation|0|||
30746758|NCT00296036|58757027|FG005|Overall Study|Protocol Violation|3|||
30746759|NCT00089674|58757046|FG000|Overall Study|Physician Decision|4|||
30746760|NCT00089674|58757047|FG001|Overall Study|Physician Decision|2|||
30746761|NCT00089674|58757046|FG000|Overall Study|Adverse Event|23|||
30746762|NCT00089674|58757047|FG001|Overall Study|Adverse Event|29|||
30746763|NCT00089674|58757046|FG000|Overall Study|Withdrawal by Subject|143|||
30746764|NCT00089674|58757047|FG001|Overall Study|Withdrawal by Subject|127|||
30746765|NCT00089674|58757046|FG000|Overall Study|Death|43|||
30746766|NCT00089674|58757047|FG001|Overall Study|Death|43|||
30746767|NCT00089674|58757046|FG000|Overall Study|Disease progression|21|||
30746768|NCT00089674|58757047|FG001|Overall Study|Disease progression|23|||
30746769|NCT00089674|58757046|FG000|Overall Study|Ineligibility determined|8|||
30746770|NCT00089674|58757047|FG001|Overall Study|Ineligibility determined|10|||
30746771|NCT00089674|58757046|FG000|Overall Study|Lost to Follow-up|21|||
30746772|NCT00089674|58757047|FG001|Overall Study|Lost to Follow-up|17|||
30746773|NCT00089674|58757046|FG000|Overall Study|Noncompliance|7|||
30746774|NCT00089674|58757047|FG001|Overall Study|Noncompliance|3|||
30746775|NCT00089674|58757046|FG000|Overall Study|Other|5|||
30746776|NCT00089674|58757047|FG001|Overall Study|Other|9|||
30746777|NCT00089674|58757046|FG000|Overall Study|Requirement for alternative therapy|14|||
30746778|NCT00089674|58757047|FG001|Overall Study|Requirement for alternative therapy|4|||
30746779|NCT00313586|58757057|FG000|Overall Study|Disease progression|14|||
30746780|NCT00313586|58757058|FG001|Overall Study|Disease progression|19|||
30746781|NCT00313586|58757059|FG002|Overall Study|Disease progression|10|||
30798588|NCT03268941|58813143|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
30798589|NCT03268941|58813144|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
30798590|NCT03245619|58813221|FG000|Part A (Up to Day 22)|Physician Decision|4|||
30905543|NCT01977573|58940128|FG003|Overall Study|Withdrawal by Subject|1|||
30746782|NCT00313586|58757060|FG003|Overall Study|Disease progression|3|||
30622263|NCT00976989|58633854|FG000|Overall Study|Failure to Return|2|||
30746783|NCT00313586|58757057|FG000|Overall Study|Adverse Event|12|||
30746784|NCT00313586|58757058|FG001|Overall Study|Adverse Event|18|||
30746785|NCT00313586|58757059|FG002|Overall Study|Adverse Event|3|||
30798591|NCT03245619|58813222|FG001|Part A (Up to Day 22)|Physician Decision|6|||
30798592|NCT03245619|58813223|FG002|Part A (Up to Day 22)|Physician Decision|6|||
30798593|NCT03245619|58813224|FG003|Part A (Up to Day 22)|Physician Decision|0|||
30798594|NCT03245619|58813225|FG004|Part A (Up to Day 22)|Physician Decision|0|||
30798595|NCT03245619|58813226|FG005|Part A (Up to Day 22)|Physician Decision|0|||
30798596|NCT03245619|58813227|FG006|Part A (Up to Day 22)|Physician Decision|0|||
30798597|NCT03245619|58813228|FG007|Part A (Up to Day 22)|Physician Decision|0|||
30798598|NCT03245619|58813229|FG008|Part A (Up to Day 22)|Physician Decision|0|||
30798599|NCT03245619|58813230|FG009|Part A (Up to Day 22)|Physician Decision|0|||
30798600|NCT03245619|58813231|FG010|Part A (Up to Day 22)|Physician Decision|0|||
30798601|NCT03245619|58813232|FG011|Part A (Up to Day 22)|Physician Decision|0|||
30798602|NCT03245619|58813233|FG012|Part A (Up to Day 22)|Physician Decision|0|||
30798603|NCT03245619|58813234|FG013|Part A (Up to Day 22)|Physician Decision|0|||
30798604|NCT03245619|58813235|FG014|Part A (Up to Day 22)|Physician Decision|0|||
30798605|NCT03245619|58813236|FG015|Part A (Up to Day 22)|Physician Decision|0|||
30798606|NCT03245619|58813237|FG016|Part A (Up to Day 22)|Physician Decision|0|||
30798607|NCT04472650|58813298|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
30798608|NCT04472650|58813299|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
30798609|NCT02606461|58813311|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
30798610|NCT02606461|58813312|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
30798611|NCT02606461|58813313|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
30798612|NCT02606461|58813314|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
30905544|NCT01963767|58940141|FG000|Overall Study|Withdrawal by Subject|4|||
30905545|NCT01963767|58940142|FG001|Overall Study|Withdrawal by Subject|2|||
30905546|NCT01963767|58940141|FG000|Overall Study|Adverse Event|2|||
30905547|NCT01963767|58940142|FG001|Overall Study|Adverse Event|0|||
30905548|NCT01761292|58940151|FG000|Part 1|Adverse Event|1|||
30905549|NCT01761292|58940151|FG000|Part 1|not receiving treatment in Part 1|1|||
30905550|NCT01761292|58940151|FG000|Extension 1|Withdrawal by Subject|1|||
30905551|NCT01731886|58940164|FG000|Overall Study|Death|1|||
30905552|NCT01731886|58940165|FG001|Overall Study|Death|0|||
30905553|NCT01731886|58940164|FG000|Overall Study|Never started treatment|0|||
30905554|NCT01731886|58940165|FG001|Overall Study|Never started treatment|1|||
30905555|NCT01731886|58940164|FG000|Overall Study|Non-compliant|1|||
30798613|NCT02606461|58813315|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
30798614|NCT02606461|58813316|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
30905556|NCT01731886|58940165|FG001|Overall Study|Non-compliant|0|||
30905557|NCT01759420|58940172|FG000|Overall Study|Screen failure|5|||
30798615|NCT03321396|58813331|FG000|Overall Study|Physician Decision|1|||
30798616|NCT03244917|58813337|FG000|Overall Study|Lost to Follow-up|2|||
30798617|NCT03244917|58813338|FG001|Overall Study|Lost to Follow-up|2|||
30798618|NCT03321006|58813346|FG000|Overall Study|Death|1|||
30798619|NCT03321006|58813347|FG001|Overall Study|Death|0|||
30798620|NCT03321006|58813346|FG000|Overall Study|Lack of Efficacy|1|||
30798621|NCT03321006|58813347|FG001|Overall Study|Lack of Efficacy|0|||
30798622|NCT02593123|58813364|FG000|Overall Study|Physician Decision|2|||
30798623|NCT02593123|58813365|FG001|Overall Study|Physician Decision|1|||
30798624|NCT02593123|58813364|FG000|Overall Study|Relapse|1|||
30798625|NCT02593123|58813365|FG001|Overall Study|Relapse|1|||
30798626|NCT03302559|58813373|FG000|Overall Study|Adverse Event|2|||
30798627|NCT03302559|58813373|FG000|Overall Study|Lost to Follow-up|1|||
30798628|NCT03302559|58813373|FG000|Overall Study|Withdrew Consent|3|||
30798629|NCT03302247|58813377|FG000|Overall Study|the study has closed prematurely|2|||
30798630|NCT03302247|58813377|FG000|Overall Study|Death|1|||
30798631|NCT04993339|58813383|FG000|Overall Study|Lost to Follow-up|0|||
30798632|NCT04993339|58813384|FG001|Overall Study|Lost to Follow-up|1|||
30798633|NCT04993339|58813383|FG000|Overall Study|no MRI scan|3|||
30798634|NCT04993339|58813384|FG001|Overall Study|no MRI scan|1|||
30798635|NCT04974697|58813392|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
30798636|NCT04974697|58813392|FG000|Overall Study|Lens discomfort|1|||
30798637|NCT03265119|58813400|FG000|Overall Study|Adverse Event|2|||
30798638|NCT03265119|58813401|FG001|Overall Study|Adverse Event|1|||
30798639|NCT03265119|58813400|FG000|Overall Study|Lack of Efficacy|3|||
30798640|NCT03265119|58813401|FG001|Overall Study|Lack of Efficacy|0|||
30798641|NCT03265119|58813400|FG000|Overall Study|Protocol Violation|1|||
30798642|NCT03265119|58813401|FG001|Overall Study|Protocol Violation|2|||
30798643|NCT03265119|58813400|FG000|Overall Study|Withdrawal by Subject|2|||
30905558|NCT01759420|58940172|FG000|Overall Study|Inaccurate EKG machine readings|1|||
30905559|NCT01781026|58940176|FG000|Overall Study|Lack of Efficacy|2|||
30798644|NCT03265119|58813401|FG001|Overall Study|Withdrawal by Subject|4|||
30905560|NCT01607398|58940182|FG000|Overall Study|Adverse Event|0|||
30905561|NCT01607398|58940183|FG001|Overall Study|Adverse Event|2|||
30798645|NCT03265119|58813400|FG000|Overall Study|Lost to Follow-up|1|||
30798646|NCT03265119|58813401|FG001|Overall Study|Lost to Follow-up|0|||
30798647|NCT03265119|58813400|FG000|Overall Study|Lack of Compliance|1|||
30798648|NCT03265119|58813401|FG001|Overall Study|Lack of Compliance|0|||
30798649|NCT04952701|58813407|FG000|Control Lens|Physician Decision|4|||
30798650|NCT04952701|58813407|FG000|Test Lens|Physician Decision|1|||
30798651|NCT04723173|58813413|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
30798652|NCT04919317|58813427|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
30798653|NCT04919317|58813428|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
30798654|NCT04919317|58813427|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
30798655|NCT04919317|58813428|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
30798656|NCT04919161|58813436|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
30798657|NCT04919161|58813437|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
30798658|NCT04919161|58813436|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
30798659|NCT04919161|58813437|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
30798660|NCT04919161|58813436|FG000|Overall Study|Acute ankle sprain after session 1|0|||
30798661|NCT04919161|58813437|FG001|Overall Study|Acute ankle sprain after session 1|1|||
30798662|NCT03262389|58813465|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
30798663|NCT03262389|58813465|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
30798664|NCT03262389|58813465|FG000|Overall Study|opted out of PET/MR|1|||
30798665|NCT03262233|58813473|FG000|Overall Study|Withdrawal by Subject|12|||
30798666|NCT03262233|58813474|FG001|Overall Study|Withdrawal by Subject|8|||
30798667|NCT03262233|58813475|FG002|Overall Study|Withdrawal by Subject|21|||
30798668|NCT03262233|58813476|FG003|Overall Study|Withdrawal by Subject|13|||
30798669|NCT03262233|58813473|FG000|Overall Study|Declined due to shock|1|||
30798670|NCT03262233|58813474|FG001|Overall Study|Declined due to shock|2|||
30798671|NCT03262233|58813475|FG002|Overall Study|Declined due to shock|2|||
30798672|NCT03262233|58813476|FG003|Overall Study|Declined due to shock|3|||
30798673|NCT03262233|58813473|FG000|Overall Study|Protocol Violation|5|||
30798674|NCT03262233|58813474|FG001|Overall Study|Protocol Violation|10|||
30798675|NCT03262233|58813475|FG002|Overall Study|Protocol Violation|2|||
30798676|NCT03262233|58813476|FG003|Overall Study|Protocol Violation|13|||
30798677|NCT03262233|58813473|FG000|Overall Study|data collection artifact|0|||
30798678|NCT03262233|58813474|FG001|Overall Study|data collection artifact|1|||
30798679|NCT03262233|58813475|FG002|Overall Study|data collection artifact|0|||
30798680|NCT03262233|58813476|FG003|Overall Study|data collection artifact|0|||
30798681|NCT03261531|58813487|FG000|Overall Study|Withdrawal by Subject|4|||
30798682|NCT04151290|58813491|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
30798683|NCT03260205|58813510|FG000|Overall Study|Adverse Event|2|||
30798684|NCT03260205|58813511|FG001|Overall Study|Adverse Event|0|||
30798685|NCT03260205|58813512|FG002|Overall Study|Adverse Event|2|||
30798686|NCT03260205|58813513|FG003|Overall Study|Adverse Event|2|||
30798687|NCT03260205|58813514|FG004|Overall Study|Adverse Event|4|||
30798688|NCT03260205|58813510|FG000|Overall Study|Lost to Follow-up|2|||
30798689|NCT03260205|58813511|FG001|Overall Study|Lost to Follow-up|2|||
30798690|NCT03260205|58813512|FG002|Overall Study|Lost to Follow-up|1|||
30798691|NCT03260205|58813513|FG003|Overall Study|Lost to Follow-up|1|||
30798692|NCT03260205|58813514|FG004|Overall Study|Lost to Follow-up|5|||
30798693|NCT03260205|58813510|FG000|Overall Study|Protocol Violation|0|||
30798694|NCT03260205|58813511|FG001|Overall Study|Protocol Violation|0|||
30798695|NCT03260205|58813512|FG002|Overall Study|Protocol Violation|2|||
30798696|NCT03260205|58813513|FG003|Overall Study|Protocol Violation|0|||
30798697|NCT03260205|58813514|FG004|Overall Study|Protocol Violation|1|||
30746786|NCT00313586|58757060|FG003|Overall Study|Adverse Event|10|||
30746787|NCT00313586|58757057|FG000|Overall Study|Death|11|||
30746788|NCT00313586|58757058|FG001|Overall Study|Death|8|||
30746789|NCT00313586|58757059|FG002|Overall Study|Death|1|||
30746790|NCT00313586|58757060|FG003|Overall Study|Death|7|||
30746791|NCT00313586|58757057|FG000|Overall Study|Withdrawal by Subject|13|||
30746792|NCT00313586|58757058|FG001|Overall Study|Withdrawal by Subject|6|||
30746793|NCT00313586|58757059|FG002|Overall Study|Withdrawal by Subject|6|||
30746794|NCT00313586|58757060|FG003|Overall Study|Withdrawal by Subject|2|||
30746795|NCT00313586|58757057|FG000|Overall Study|Alternative therapy|3|||
30746796|NCT00313586|58757058|FG001|Overall Study|Alternative therapy|6|||
30746797|NCT00313586|58757059|FG002|Overall Study|Alternative therapy|2|||
30746798|NCT00313586|58757060|FG003|Overall Study|Alternative therapy|0|||
30746799|NCT00313586|58757057|FG000|Overall Study|Other complicating disease|2|||
30746800|NCT00313586|58757058|FG001|Overall Study|Other complicating disease|2|||
30746801|NCT00313586|58757059|FG002|Overall Study|Other complicating disease|0|||
30746802|NCT00313586|58757060|FG003|Overall Study|Other complicating disease|0|||
30746803|NCT00313586|58757057|FG000|Overall Study|Did not achieve HI-major/better response|10|||
30798698|NCT03260205|58813510|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
30798699|NCT03260205|58813511|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
30798700|NCT03260205|58813512|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
30798701|NCT03260205|58813513|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
30746804|NCT00313586|58757058|FG001|Overall Study|Did not achieve HI-major/better response|7|||
30798702|NCT03260205|58813514|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
30798703|NCT03260205|58813510|FG000|Overall Study|Other: Unspecified|0|||
30798704|NCT03260205|58813511|FG001|Overall Study|Other: Unspecified|0|||
30798705|NCT03260205|58813512|FG002|Overall Study|Other: Unspecified|3|||
30798706|NCT03260205|58813513|FG003|Overall Study|Other: Unspecified|1|||
30798707|NCT03260205|58813514|FG004|Overall Study|Other: Unspecified|1|||
30798708|NCT03260205|58813510|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
30798709|NCT03260205|58813511|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
30798710|NCT03260205|58813512|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
30798711|NCT03260205|58813513|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
30798712|NCT03260205|58813514|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
30798713|NCT04666441|58813539|FG000|Overall Study|Lost to Follow-up|1|||
30798714|NCT04666441|58813540|FG001|Overall Study|Lost to Follow-up|4|||
30798715|NCT04666441|58813541|FG002|Overall Study|Lost to Follow-up|1|||
30798716|NCT04666441|58813542|FG003|Overall Study|Lost to Follow-up|3|||
30798717|NCT04666441|58813543|FG004|Overall Study|Lost to Follow-up|0|||
30798718|NCT04666441|58813544|FG005|Overall Study|Lost to Follow-up|2|||
30798719|NCT04666441|58813545|FG006|Overall Study|Lost to Follow-up|2|||
30798720|NCT04666441|58813546|FG007|Overall Study|Lost to Follow-up|2|||
30798721|NCT04666441|58813539|FG000|Overall Study|Subject Decision|1|||
30798722|NCT04666441|58813540|FG001|Overall Study|Subject Decision|1|||
30798723|NCT04666441|58813541|FG002|Overall Study|Subject Decision|3|||
30798724|NCT04666441|58813542|FG003|Overall Study|Subject Decision|1|||
30798725|NCT04666441|58813543|FG004|Overall Study|Subject Decision|0|||
30798726|NCT04666441|58813544|FG005|Overall Study|Subject Decision|1|||
30798727|NCT04666441|58813545|FG006|Overall Study|Subject Decision|3|||
30798728|NCT04666441|58813546|FG007|Overall Study|Subject Decision|2|||
30798729|NCT03320850|58813583|FG000|Overall Study|Lost to Follow-up|0|||
30798730|NCT03320850|58813584|FG001|Overall Study|Lost to Follow-up|0|||
30798731|NCT03320850|58813585|FG002|Overall Study|Lost to Follow-up|0|||
30798732|NCT03320850|58813586|FG003|Overall Study|Lost to Follow-up|0|||
30798733|NCT03320850|58813587|FG004|Overall Study|Lost to Follow-up|1|||
30798734|NCT03320850|58813588|FG005|Overall Study|Lost to Follow-up|2|||
30798735|NCT03320850|58813589|FG006|Overall Study|Lost to Follow-up|2|||
30798736|NCT03320850|58813590|FG007|Overall Study|Lost to Follow-up|0|||
30798737|NCT03320850|58813591|FG008|Overall Study|Lost to Follow-up|6|||
30798738|NCT03320850|58813592|FG009|Overall Study|Lost to Follow-up|4|||
30798739|NCT03320850|58813583|FG000|Overall Study|Withdrawal by Subject|0|||
30798740|NCT03320850|58813584|FG001|Overall Study|Withdrawal by Subject|0|||
30798741|NCT03320850|58813585|FG002|Overall Study|Withdrawal by Subject|0|||
30798742|NCT03320850|58813586|FG003|Overall Study|Withdrawal by Subject|0|||
30798743|NCT03320850|58813587|FG004|Overall Study|Withdrawal by Subject|1|||
30798744|NCT03320850|58813588|FG005|Overall Study|Withdrawal by Subject|2|||
30798745|NCT03320850|58813589|FG006|Overall Study|Withdrawal by Subject|4|||
30798746|NCT03320850|58813590|FG007|Overall Study|Withdrawal by Subject|5|||
30622264|NCT00976989|58633855|FG001|Overall Study|Failure to Return|1|||
30622265|NCT00976989|58633856|FG002|Overall Study|Failure to Return|0|||
30622266|NCT00976989|58633854|FG000|Overall Study|Recurrence of Disease|0|||
30622267|NCT00976989|58633855|FG001|Overall Study|Recurrence of Disease|1|||
30622268|NCT00976989|58633856|FG002|Overall Study|Recurrence of Disease|0|||
30622269|NCT00976989|58633854|FG000|Overall Study|Other|1|||
30746805|NCT00313586|58757059|FG002|Overall Study|Did not achieve HI-major/better response|2|||
30746806|NCT00313586|58757060|FG003|Overall Study|Did not achieve HI-major/better response|1|||
30746807|NCT00313586|58757057|FG000|Overall Study|Physician Decision|2|||
30746808|NCT00313586|58757058|FG001|Overall Study|Physician Decision|1|||
30746809|NCT00313586|58757059|FG002|Overall Study|Physician Decision|0|||
30746810|NCT00313586|58757060|FG003|Overall Study|Physician Decision|0|||
30746811|NCT00313586|58757057|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
30746812|NCT00313586|58757058|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
30746813|NCT00313586|58757059|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
30746814|NCT00313586|58757060|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
30746815|NCT00313586|58757057|FG000|Overall Study|Lost insurance|0|||
30746816|NCT00313586|58757058|FG001|Overall Study|Lost insurance|1|||
30746817|NCT00313586|58757059|FG002|Overall Study|Lost insurance|0|||
30746818|NCT00313586|58757060|FG003|Overall Study|Lost insurance|0|||
30746819|NCT00313586|58757057|FG000|Overall Study|Moved|0|||
30798747|NCT03320850|58813591|FG008|Overall Study|Withdrawal by Subject|2|||
30798748|NCT03320850|58813592|FG009|Overall Study|Withdrawal by Subject|1|||
30798749|NCT03320850|58813583|FG000|Overall Study|Lack of Efficacy|0|||
30798750|NCT03320850|58813584|FG001|Overall Study|Lack of Efficacy|0|||
30798751|NCT03320850|58813585|FG002|Overall Study|Lack of Efficacy|0|||
30798752|NCT03320850|58813586|FG003|Overall Study|Lack of Efficacy|1|||
30798753|NCT03320850|58813587|FG004|Overall Study|Lack of Efficacy|0|||
30798754|NCT03320850|58813588|FG005|Overall Study|Lack of Efficacy|1|||
30798755|NCT03320850|58813589|FG006|Overall Study|Lack of Efficacy|0|||
30798756|NCT03320850|58813590|FG007|Overall Study|Lack of Efficacy|2|||
30622270|NCT00976989|58633855|FG001|Overall Study|Other|0|||
30798757|NCT03320850|58813591|FG008|Overall Study|Lack of Efficacy|0|||
30798758|NCT03320850|58813592|FG009|Overall Study|Lack of Efficacy|3|||
30798759|NCT03320850|58813583|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
30798760|NCT03320850|58813584|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
30798761|NCT03320850|58813585|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
30798762|NCT03320850|58813586|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
30798763|NCT03320850|58813587|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
30798764|NCT03320850|58813588|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
30798765|NCT03320850|58813589|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
30798766|NCT03320850|58813590|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
30798767|NCT03320850|58813591|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
30798768|NCT03320850|58813592|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
30798769|NCT03320850|58813583|FG000|Overall Study|Adverse Event|0|||
30798770|NCT03320850|58813584|FG001|Overall Study|Adverse Event|0|||
30798771|NCT03320850|58813585|FG002|Overall Study|Adverse Event|0|||
30798772|NCT03320850|58813586|FG003|Overall Study|Adverse Event|0|||
30798773|NCT03320850|58813587|FG004|Overall Study|Adverse Event|0|||
30798774|NCT03320850|58813588|FG005|Overall Study|Adverse Event|2|||
30798775|NCT03320850|58813589|FG006|Overall Study|Adverse Event|1|||
30798776|NCT03320850|58813590|FG007|Overall Study|Adverse Event|0|||
30798777|NCT03320850|58813591|FG008|Overall Study|Adverse Event|2|||
30798778|NCT03320850|58813592|FG009|Overall Study|Adverse Event|0|||
30798779|NCT03320850|58813583|FG000|Overall Study|Reason Not Specified|0|||
30798780|NCT03320850|58813584|FG001|Overall Study|Reason Not Specified|0|||
30798781|NCT03320850|58813585|FG002|Overall Study|Reason Not Specified|0|||
30798782|NCT03320850|58813586|FG003|Overall Study|Reason Not Specified|0|||
30798783|NCT03320850|58813587|FG004|Overall Study|Reason Not Specified|0|||
30798784|NCT03320850|58813588|FG005|Overall Study|Reason Not Specified|1|||
30798785|NCT03320850|58813589|FG006|Overall Study|Reason Not Specified|0|||
30798786|NCT03320850|58813590|FG007|Overall Study|Reason Not Specified|0|||
30798787|NCT03320850|58813591|FG008|Overall Study|Reason Not Specified|0|||
30798788|NCT03320850|58813592|FG009|Overall Study|Reason Not Specified|1|||
30798789|NCT03301623|58813621|FG000|Overall Study|Death|3|||
30905562|NCT01607398|58940182|FG000|Overall Study|Severe COPD|2|||
30905563|NCT01607398|58940183|FG001|Overall Study|Severe COPD|0|||
30905564|NCT01779856|58940189|FG000|Overall Study|Withdrawal by Subject|15|||
30905565|NCT01779856|58940189|FG000|Overall Study|Death|3|||
30905566|NCT01779856|58940189|FG000|Overall Study|Physician Decision|1|||
30905567|NCT01779856|58940189|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
30905568|NCT01779856|58940189|FG000|Overall Study|Delays in scheduling implant|1|||
30905569|NCT01779856|58940189|FG000|Overall Study|Subject ineligible for Implant|2|||
30905570|NCT01729156|58940203|FG000|Overall Study|Withdrawal by Subject|1|||
30905571|NCT01729156|58940204|FG001|Overall Study|Withdrawal by Subject|0|||
30905572|NCT01729156|58940205|FG002|Overall Study|Withdrawal by Subject|0|||
30905573|NCT01779700|58940216|FG000|Overall Study|Adverse Event|4|||
30905574|NCT01779700|58940217|FG001|Overall Study|Adverse Event|3|||
30905575|NCT01779700|58940216|FG000|Overall Study|Withdrawal by Subject|0|||
30905576|NCT01779700|58940217|FG001|Overall Study|Withdrawal by Subject|2|||
30905577|NCT01778530|58940223|FG000|Overall Study|Progression on study|1|||
30905578|NCT01778530|58940223|FG000|Overall Study|Adverse event/side effect|1|||
30905579|NCT01778062|58940229|FG000|Overall Study|Adverse Event|1|||
30905580|NCT01778062|58940230|FG001|Overall Study|Adverse Event|3|||
30905581|NCT01778062|58940229|FG000|Overall Study|Consent Withdrawal|1|||
30905582|NCT01778062|58940230|FG001|Overall Study|Consent Withdrawal|5|||
30905583|NCT01778062|58940229|FG000|Overall Study|major protocol deviation|4|||
30905584|NCT01778062|58940230|FG001|Overall Study|major protocol deviation|3|||
30905585|NCT01759264|58940236|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
30905586|NCT01759264|58940236|FG000|Overall Study|Adverse Event|1|||
30905587|NCT01759264|58940236|FG000|Overall Study|Other|2|||
30905588|NCT01759264|58940236|FG000|Overall Study|Lost to Follow-up|2|||
30905589|NCT01759264|58940236|FG000|Overall Study|Withdrawal by Subject|3|||
30905590|NCT01759264|58940236|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
30905591|NCT01757704|58940243|FG000|Overall Study|Protocol Violation|1|||
30905592|NCT01757704|58940244|FG001|Overall Study|Protocol Violation|3|||
30746820|NCT00313586|58757058|FG001|Overall Study|Moved|1|||
30746821|NCT00313586|58757059|FG002|Overall Study|Moved|0|||
30746822|NCT00313586|58757060|FG003|Overall Study|Moved|0|||
30746823|NCT00313586|58757057|FG000|Overall Study|Death before starting treatment|1|||
30746824|NCT00313586|58757058|FG001|Overall Study|Death before starting treatment|0|||
30746825|NCT00313586|58757059|FG002|Overall Study|Death before starting treatment|0|||
30746826|NCT00313586|58757060|FG003|Overall Study|Death before starting treatment|0|||
30746827|NCT00312572|58757070|FG000|Overall Study|Adverse Event|10|||
30746828|NCT00312572|58757071|FG001|Overall Study|Adverse Event|16|||
30798790|NCT03301623|58813622|FG001|Overall Study|Death|1|||
30798791|NCT03301623|58813621|FG000|Overall Study|Withdrawal by Subject|11|||
30905593|NCT01757392|58940250|FG000|Overall Study|Withdrawal by Subject|1|||
30905594|NCT01757392|58940250|FG000|Overall Study|Screen Fail|3|||
30798792|NCT03301623|58813622|FG001|Overall Study|Withdrawal by Subject|13|||
30798793|NCT03301623|58813621|FG000|Overall Study|Lost to Follow-up|3|||
30798794|NCT03301623|58813622|FG001|Overall Study|Lost to Follow-up|1|||
30798795|NCT03319212|58813630|FG000|Overall Study|Discontinued as moving out of local area|0|||
30798796|NCT03319212|58813631|FG001|Overall Study|Discontinued as moving out of local area|1|||
30798797|NCT03319212|58813630|FG000|Overall Study|Adverse Event|2|||
30798798|NCT03319212|58813631|FG001|Overall Study|Adverse Event|2|||
30798799|NCT03319212|58813630|FG000|Overall Study|Withdrawal by Subject|0|||
30798800|NCT03319212|58813631|FG001|Overall Study|Withdrawal by Subject|1|||
30798801|NCT03319212|58813630|FG000|Overall Study|Lost to Follow-up|0|||
30798802|NCT03319212|58813631|FG001|Overall Study|Lost to Follow-up|1|||
30798803|NCT03319212|58813630|FG000|Overall Study|Physician Decision|1|||
30798804|NCT03319212|58813631|FG001|Overall Study|Physician Decision|0|||
30798805|NCT04656691|58813636|FG000|Overall Study|Adverse Event|1|||
30798806|NCT03301155|58813642|FG000|Overall Study|Сompliance with exclusion criteria|8|||
30798807|NCT03301155|58813643|FG001|Overall Study|Сompliance with exclusion criteria|7|||
30798808|NCT01952730|58813649|FG000|Overall Study|FDA shut down core lab used by study|1|||
30798809|NCT03316170|58813655|FG000|Overall Study|Death|1|||
30798810|NCT03316170|58813656|FG001|Overall Study|Death|0|||
30798811|NCT03316170|58813655|FG000|Overall Study|Lost to Follow-up|6|||
30798812|NCT03316170|58813656|FG001|Overall Study|Lost to Follow-up|7|||
30798813|NCT03257865|58813665|FG000|Overall Study|Adverse Event|4|||
30798814|NCT03257865|58813666|FG001|Overall Study|Adverse Event|8|||
30798815|NCT03257865|58813665|FG000|Overall Study|Lack of Efficacy|1|||
30798816|NCT03257865|58813666|FG001|Overall Study|Lack of Efficacy|2|||
30798817|NCT03257865|58813665|FG000|Overall Study|Non-compliance with Study Drug|0|||
30798818|NCT03257865|58813666|FG001|Overall Study|Non-compliance with Study Drug|2|||
30798819|NCT03257865|58813665|FG000|Overall Study|Withdrawal by Subject|23|||
30798820|NCT03257865|58813666|FG001|Overall Study|Withdrawal by Subject|17|||
30798821|NCT03257865|58813665|FG000|Overall Study|Physician Decision|3|||
30798822|NCT03257865|58813666|FG001|Overall Study|Physician Decision|1|||
30798823|NCT03257865|58813665|FG000|Overall Study|Other|0|||
30798824|NCT03257865|58813666|FG001|Overall Study|Other|1|||
30798825|NCT03257865|58813665|FG000|Overall Study|Lost to Follow-up|4|||
30798826|NCT03257865|58813666|FG001|Overall Study|Lost to Follow-up|4|||
30798827|NCT04617847|58813674|FG000|Overall Study|Withdrawal by Subject|1|||
30798828|NCT04617847|58813675|FG001|Overall Study|Withdrawal by Subject|0|||
30798829|NCT04617847|58813674|FG000|Overall Study|Adverse Event|0|||
30798830|NCT04617847|58813675|FG001|Overall Study|Adverse Event|2|||
30798831|NCT04617847|58813674|FG000|Overall Study|Death|0|||
30798832|NCT04617847|58813675|FG001|Overall Study|Death|1|||
30798833|NCT04617847|58813674|FG000|Overall Study|Termination of Study by Sponsor|2|||
30798834|NCT04617847|58813675|FG001|Overall Study|Termination of Study by Sponsor|21|||
30798835|NCT04615507|58813685|FG000|Period 1|Covid-19 exposure|2|||
30798836|NCT04615507|58813686|FG001|Period 1|Covid-19 exposure|1|||
30798837|NCT04615507|58813685|FG000|Period 2|Covid-19 exposure|0|||
30798838|NCT04615507|58813686|FG001|Period 2|Covid-19 exposure|1|||
30798839|NCT04615507|58813685|FG000|Period 2|Protocol Violation|1|||
30798840|NCT04615507|58813686|FG001|Period 2|Protocol Violation|0|||
30798841|NCT04615507|58813685|FG000|Period 2|Withdrawal by Subject|1|||
30798842|NCT04615507|58813686|FG001|Period 2|Withdrawal by Subject|0|||
30798843|NCT04615507|58813685|FG000|Period 2|Adverse Event|0|||
30798844|NCT04615507|58813686|FG001|Period 2|Adverse Event|1|||
30905595|NCT01756846|58940256|FG000|Overall Study|Lost to Follow-up|5|||
30905596|NCT01756846|58940257|FG001|Overall Study|Lost to Follow-up|10|||
30905597|NCT01756846|58940256|FG000|Overall Study|Withdrawal by Subject|1|||
30905598|NCT01756846|58940257|FG001|Overall Study|Withdrawal by Subject|2|||
30905599|NCT01963611|58940268|FG000|Overall Study|Adverse Event|1|||
30905600|NCT01963611|58940269|FG001|Overall Study|Adverse Event|1|||
30905601|NCT01963611|58940270|FG002|Overall Study|Adverse Event|3|||
30798845|NCT04615507|58813685|FG000|Period 3|Covid-19 exposure|0|||
30798846|NCT04615507|58813686|FG001|Period 3|Covid-19 exposure|1|||
30798847|NCT04120233|58813698|FG000|Overall Study|Adverse Event|0|||
30798848|NCT04120233|58813699|FG001|Overall Study|Adverse Event|0|||
30798849|NCT04120233|58813700|FG002|Overall Study|Adverse Event|0|||
30798850|NCT04120233|58813701|FG003|Overall Study|Adverse Event|0|||
30798851|NCT04120233|58813702|FG004|Overall Study|Adverse Event|1|||
30798852|NCT04120233|58813703|FG005|Overall Study|Adverse Event|0|||
30798853|NCT01610700|58813719|FG000|Overall Study|Adverse Event|3|||
30798854|NCT01610700|58813720|FG001|Overall Study|Adverse Event|1|||
30798855|NCT01610700|58813719|FG000|Overall Study|Withdrawal by Subject|0|||
30798856|NCT01610700|58813720|FG001|Overall Study|Withdrawal by Subject|1|||
30798857|NCT01610700|58813719|FG000|Overall Study|subject took one dose of street cannabis|0|||
30798858|NCT01610700|58813720|FG001|Overall Study|subject took one dose of street cannabis|1|||
30798859|NCT03256851|58813729|FG000|Overall Study|Withdrawal by Subject|1|||
30905602|NCT01963611|58940271|FG003|Overall Study|Adverse Event|4|||
30798860|NCT03256851|58813730|FG001|Overall Study|Withdrawal by Subject|0|||
30798861|NCT04837807|58813736|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
30798862|NCT04837807|58813737|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
30798863|NCT03256695|58813743|FG000|Overall Study|Adverse Event|8|||
30798864|NCT03256695|58813743|FG000|Overall Study|Death|2|||
30798865|NCT03256695|58813743|FG000|Overall Study|Withdrawal by Subject|14|||
30798866|NCT03256695|58813743|FG000|Overall Study|Non-compliance with study drug|1|||
30798867|NCT03256695|58813743|FG000|Overall Study|Lost to Follow-up|3|||
30798868|NCT03256695|58813743|FG000|Overall Study|Lack of Efficacy|3|||
30798869|NCT03256695|58813743|FG000|Overall Study|Protocol Violation|5|||
30798870|NCT03256695|58813743|FG000|Overall Study|Other than specified|3|||
30798871|NCT03305016|58813747|FG000|Overall Study|Withdrawal by Subject|2|||
30798872|NCT03297021|58813754|FG000|Overall Study|Incomplete/illegible data sheet|4|||
30798873|NCT03297021|58813755|FG001|Overall Study|Incomplete/illegible data sheet|2|||
30798874|NCT03297021|58813756|FG002|Overall Study|Incomplete/illegible data sheet|3|||
30798875|NCT03297021|58813754|FG000|Overall Study|Missing Post-Op Data|1|||
30798876|NCT03297021|58813755|FG001|Overall Study|Missing Post-Op Data|2|||
30798877|NCT03297021|58813756|FG002|Overall Study|Missing Post-Op Data|1|||
30798878|NCT04820491|58813766|FG000|Overall Study|Withdrawal by Subject|1|||
30798879|NCT04820491|58813767|FG001|Overall Study|Withdrawal by Subject|0|||
30798880|NCT01988571|58813775|FG000|Overall Study|Death|3|||
30798881|NCT01988571|58813776|FG001|Overall Study|Death|1|||
30798882|NCT01988571|58813775|FG000|Overall Study|Physician Decision|2|||
30798883|NCT01988571|58813776|FG001|Overall Study|Physician Decision|1|||
30798884|NCT01988571|58813775|FG000|Overall Study|Lost to Follow-up|3|||
30798885|NCT01988571|58813776|FG001|Overall Study|Lost to Follow-up|0|||
30798886|NCT01988571|58813775|FG000|Overall Study|Withdrawal by Subject|31|||
30798887|NCT01988571|58813776|FG001|Overall Study|Withdrawal by Subject|33|||
30798888|NCT04794751|58813782|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
30798889|NCT04794751|58813783|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
30798890|NCT04794751|58813782|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
30798891|NCT04794751|58813783|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
30798892|NCT04794751|58813782|FG000|Period 1|Protocol Violation|0|||
30798893|NCT04794751|58813783|FG001|Period 1|Protocol Violation|2|||
30798894|NCT04794751|58813782|FG000|Period 1|Withdrawal by Subject|0|||
30798895|NCT04794751|58813783|FG001|Period 1|Withdrawal by Subject|1|||
30798896|NCT04794751|58813782|FG000|Period 2|Withdrawal by Subject|0|||
30798897|NCT04794751|58813783|FG001|Period 2|Withdrawal by Subject|1|||
30798898|NCT04794751|58813782|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
30798899|NCT04794751|58813783|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
30798900|NCT04794751|58813782|FG000|Period 2|Protocol Violation|1|||
30798901|NCT04794751|58813783|FG001|Period 2|Protocol Violation|0|||
30798902|NCT04578457|58813798|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
30798903|NCT04578457|58813798|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
30798904|NCT04578457|58813798|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
30798905|NCT04578457|58813798|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
30798906|NCT03334188|58813808|FG000|Overall Study|Withdrawal by Subject|0|||
30798907|NCT03334188|58813809|FG001|Overall Study|Withdrawal by Subject|1|||
30798908|NCT03334188|58813808|FG000|Overall Study|Death|1|||
30798909|NCT03334188|58813809|FG001|Overall Study|Death|0|||
30798910|NCT03334188|58813808|FG000|Overall Study|Never had qualifying clinic visit|7|||
30798911|NCT03334188|58813809|FG001|Overall Study|Never had qualifying clinic visit|7|||
30798912|NCT03333876|58813818|FG000|Screening Period|Screen Failure|4|||
30798913|NCT03333876|58813818|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
30798914|NCT03333876|58813818|FG000|Mandibular Advancement|Adverse Event|2|||
30798915|NCT03333876|58813818|FG000|Mandibular Advancement|Product Damage|2|||
30798916|NCT03294681|58813831|FG000|Overall Study|Withdrawal by Subject|1|||
30798917|NCT01140867|58813835|FG000|Overall Study|Adverse Event|22|||
30798918|NCT01140867|58813835|FG000|Overall Study|Lack of Efficacy|3|||
30798919|NCT01140867|58813835|FG000|Overall Study|Lost to Follow-up|2|||
30798920|NCT01140867|58813835|FG000|Overall Study|Withdrawal by Subject|1|||
30798921|NCT01140867|58813835|FG000|Overall Study|Protocol Violation|1|||
30798922|NCT01140867|58813835|FG000|Overall Study|Uncooperative patient|2|||
30798923|NCT01140867|58813835|FG000|Overall Study|Medication Noncompliance|2|||
30798924|NCT04572997|58813839|FG000|Overall Study|Adverse Event|1|||
30798925|NCT02943096|58813849|FG000|Overall Study|Lack of Efficacy|0|||
30798926|NCT02943096|58813850|FG001|Overall Study|Lack of Efficacy|1|||
30798927|NCT04571515|58813861|FG000|Overall Study|Physician Decision|0|||
30798928|NCT04571515|58813862|FG001|Overall Study|Physician Decision|0|||
30798929|NCT04571515|58813863|FG002|Overall Study|Physician Decision|0|||
30798930|NCT04571515|58813864|FG003|Overall Study|Physician Decision|0|||
30798931|NCT04571515|58813865|FG004|Overall Study|Physician Decision|1|||
30798932|NCT04571515|58813861|FG000|Overall Study|Withdrawal by Subject|0|||
30798933|NCT04571515|58813862|FG001|Overall Study|Withdrawal by Subject|0|||
30798934|NCT04571515|58813863|FG002|Overall Study|Withdrawal by Subject|0|||
30798935|NCT04571515|58813864|FG003|Overall Study|Withdrawal by Subject|0|||
30798936|NCT04571515|58813865|FG004|Overall Study|Withdrawal by Subject|1|||
30798937|NCT04571515|58813861|FG000|Overall Study|insufficient pain|1|||
30798938|NCT04571515|58813862|FG001|Overall Study|insufficient pain|0|||
30798939|NCT04571515|58813863|FG002|Overall Study|insufficient pain|0|||
30798940|NCT04571515|58813864|FG003|Overall Study|insufficient pain|0|||
30798941|NCT04571515|58813865|FG004|Overall Study|insufficient pain|1|||
30798942|NCT03292653|58813880|FG000|Overall Study|Adverse Event|0|||
30798943|NCT03292653|58813881|FG001|Overall Study|Adverse Event|0|||
30798944|NCT03292653|58813882|FG002|Overall Study|Adverse Event|1|||
30798945|NCT03292653|58813880|FG000|Overall Study|Did not Receive Treatment|1|||
30798946|NCT03292653|58813881|FG001|Overall Study|Did not Receive Treatment|0|||
30798947|NCT03292653|58813882|FG002|Overall Study|Did not Receive Treatment|0|||
30798948|NCT03858634|58813893|FG000|Overall Study|Withdrawal by Subject|1|||
30798949|NCT03858634|58813894|FG001|Overall Study|Withdrawal by Subject|0|||
30798950|NCT03858634|58813893|FG000|Overall Study|Adverse Event|1|||
30798951|NCT03858634|58813894|FG001|Overall Study|Adverse Event|0|||
30798952|NCT03858634|58813893|FG000|Overall Study|Lost to Follow-up|0|||
30798953|NCT03858634|58813894|FG001|Overall Study|Lost to Follow-up|1|||
30798954|NCT03858634|58813893|FG000|Overall Study|Other, Not Specified|1|||
30798955|NCT03858634|58813894|FG001|Overall Study|Other, Not Specified|1|||
30798956|NCT02891070|58813910|FG000|Overall Study|Adverse Event|1|||
30798957|NCT02891070|58813911|FG001|Overall Study|Adverse Event|0|||
30798958|NCT02891070|58813910|FG000|Overall Study|Physician Decision|0|||
30798959|NCT02891070|58813911|FG001|Overall Study|Physician Decision|1|||
30905603|NCT01963611|58940272|FG004|Overall Study|Adverse Event|3|||
30905604|NCT01963611|58940268|FG000|Overall Study|Protocol Violation|0|||
30798960|NCT02891070|58813910|FG000|Overall Study|Lost to Follow-up|4|||
30798961|NCT02891070|58813911|FG001|Overall Study|Lost to Follow-up|4|||
30798962|NCT02891070|58813910|FG000|Overall Study|Other|1|||
30798963|NCT02891070|58813911|FG001|Overall Study|Other|0|||
30798964|NCT02891070|58813910|FG000|Overall Study|Protocol Violation|0|||
30798965|NCT02891070|58813911|FG001|Overall Study|Protocol Violation|1|||
30798966|NCT02891070|58813910|FG000|Overall Study|Withdrawal by Subject|1|||
30798967|NCT02891070|58813911|FG001|Overall Study|Withdrawal by Subject|2|||
30798968|NCT02891070|58813910|FG000|Overall Study|Death|3|||
30798969|NCT02891070|58813911|FG001|Overall Study|Death|0|||
30798970|NCT03255291|58813923|FG000|Overall Study|Determined to be ineligible|10|||
30798971|NCT03255291|58813924|FG001|Overall Study|Determined to be ineligible|12|||
30798972|NCT03255291|58813925|FG002|Overall Study|Determined to be ineligible|6|||
30798973|NCT03255291|58813926|FG003|Overall Study|Determined to be ineligible|6|||
30798974|NCT03255291|58813927|FG004|Overall Study|Determined to be ineligible|5|||
30798975|NCT03255291|58813928|FG005|Overall Study|Determined to be ineligible|10|||
30905605|NCT01963611|58940269|FG001|Overall Study|Protocol Violation|0|||
30905606|NCT01963611|58940270|FG002|Overall Study|Protocol Violation|0|||
30905607|NCT01963611|58940271|FG003|Overall Study|Protocol Violation|1|||
30905608|NCT01963611|58940272|FG004|Overall Study|Protocol Violation|0|||
30905609|NCT01963611|58940268|FG000|Overall Study|Lack of Efficacy|0|||
30798976|NCT03255291|58813923|FG000|Overall Study|Baseline data collection issues|3|||
30798977|NCT03255291|58813924|FG001|Overall Study|Baseline data collection issues|0|||
30798978|NCT03255291|58813925|FG002|Overall Study|Baseline data collection issues|0|||
30798979|NCT03255291|58813926|FG003|Overall Study|Baseline data collection issues|0|||
30798980|NCT03255291|58813927|FG004|Overall Study|Baseline data collection issues|2|||
30798981|NCT03255291|58813928|FG005|Overall Study|Baseline data collection issues|0|||
30798982|NCT00381381|58813946|FG000|Overall Study|Adverse Event|3|||
30798983|NCT00381381|58813946|FG000|Overall Study|Lost to Follow-up|52|||
30798984|NCT00381381|58813946|FG000|Overall Study|Withdrawal by Subject|9|||
30798985|NCT02939937|58813952|FG000|Overall Study|Adverse Event|5|||
30798986|NCT02939937|58813953|FG001|Overall Study|Adverse Event|0|||
30798987|NCT02939937|58813952|FG000|Overall Study|Lost to Follow-up|1|||
30798988|NCT02939937|58813953|FG001|Overall Study|Lost to Follow-up|3|||
30798989|NCT02939079|58813961|FG000|Overall Study|Adverse Event|2|||
30798990|NCT02939079|58813962|FG001|Overall Study|Adverse Event|1|||
30798991|NCT02939079|58813961|FG000|Overall Study|Lost to Follow-up|0|||
30798992|NCT02939079|58813962|FG001|Overall Study|Lost to Follow-up|2|||
30798993|NCT02939079|58813961|FG000|Overall Study|Protocol Violation|1|||
30798994|NCT02939079|58813962|FG001|Overall Study|Protocol Violation|0|||
30798995|NCT02939079|58813961|FG000|Overall Study|Withdrawal by Subject|0|||
30798996|NCT02939079|58813962|FG001|Overall Study|Withdrawal by Subject|1|||
30905610|NCT01963611|58940269|FG001|Overall Study|Lack of Efficacy|0|||
30798997|NCT02939079|58813961|FG000|Overall Study|relapse during the study|1|||
30798998|NCT02939079|58813962|FG001|Overall Study|relapse during the study|1|||
30798999|NCT04562155|58813972|FG000|Overall Study|COVID-19 pandemic|0|||
30799000|NCT04562155|58813973|FG001|Overall Study|COVID-19 pandemic|0|||
30799001|NCT04562155|58813974|FG002|Overall Study|COVID-19 pandemic|0|||
30799002|NCT04562155|58813975|FG003|Overall Study|COVID-19 pandemic|1|||
30799003|NCT04562155|58813972|FG000|Overall Study|Adverse Event|7|||
30799004|NCT04562155|58813973|FG001|Overall Study|Adverse Event|3|||
30799005|NCT04562155|58813974|FG002|Overall Study|Adverse Event|8|||
30799006|NCT04562155|58813975|FG003|Overall Study|Adverse Event|1|||
30799007|NCT04562155|58813972|FG000|Overall Study|Withdrawal by Subject|3|||
30799008|NCT04562155|58813973|FG001|Overall Study|Withdrawal by Subject|6|||
30799009|NCT04562155|58813974|FG002|Overall Study|Withdrawal by Subject|3|||
30799010|NCT04562155|58813975|FG003|Overall Study|Withdrawal by Subject|3|||
30799011|NCT04562155|58813972|FG000|Overall Study|Participant personal reason|1|||
30799012|NCT04562155|58813973|FG001|Overall Study|Participant personal reason|0|||
30799013|NCT04562155|58813974|FG002|Overall Study|Participant personal reason|2|||
30799014|NCT04562155|58813975|FG003|Overall Study|Participant personal reason|1|||
30799015|NCT03313050|58813989|FG000|Stage 2: 12 Months|Adverse Event|0|||
30799016|NCT03313050|58813990|FG001|Stage 2: 12 Months|Adverse Event|0|||
30799017|NCT03313050|58813991|FG002|Stage 2: 12 Months|Adverse Event|0|||
30799018|NCT03313050|58813992|FG003|Stage 2: 12 Months|Adverse Event|1|||
30799019|NCT03313050|58813989|FG000|Stage 2: 12 Months|Death|0|||
30799020|NCT03313050|58813990|FG001|Stage 2: 12 Months|Death|0|||
30799021|NCT03313050|58813991|FG002|Stage 2: 12 Months|Death|3|||
30799022|NCT03313050|58813992|FG003|Stage 2: 12 Months|Death|0|||
30799023|NCT03313050|58813989|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
30799024|NCT03313050|58813990|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
30799025|NCT03313050|58813991|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
30799026|NCT03313050|58813992|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
30799027|NCT03313050|58813989|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
30799028|NCT03313050|58813990|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
30799029|NCT03313050|58813991|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
30799030|NCT03313050|58813992|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
30799031|NCT03313050|58813989|FG000|Stage 2: 12 Months|Protocol deviation|0|||
30905611|NCT01963611|58940270|FG002|Overall Study|Lack of Efficacy|0|||
30905612|NCT01963611|58940271|FG003|Overall Study|Lack of Efficacy|1|||
30905613|NCT01963611|58940272|FG004|Overall Study|Lack of Efficacy|0|||
30905614|NCT01963611|58940268|FG000|Overall Study|Withdrawal by Subject|3|||
30905615|NCT01963611|58940269|FG001|Overall Study|Withdrawal by Subject|2|||
30905616|NCT01963611|58940270|FG002|Overall Study|Withdrawal by Subject|1|||
30905617|NCT01963611|58940271|FG003|Overall Study|Withdrawal by Subject|1|||
30905618|NCT01963611|58940272|FG004|Overall Study|Withdrawal by Subject|3|||
30622271|NCT00976989|58633856|FG002|Overall Study|Other|1|||
30905619|NCT01963611|58940268|FG000|Overall Study|Other|47|||
30905620|NCT01963611|58940269|FG001|Overall Study|Other|46|||
30799032|NCT03313050|58813990|FG001|Stage 2: 12 Months|Protocol deviation|0|||
30799033|NCT03313050|58813991|FG002|Stage 2: 12 Months|Protocol deviation|7|||
30905621|NCT01963611|58940270|FG002|Overall Study|Other|48|||
30905622|NCT01963611|58940271|FG003|Overall Study|Other|45|||
30799034|NCT03313050|58813992|FG003|Stage 2: 12 Months|Protocol deviation|7|||
30799035|NCT03313050|58813989|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
30799036|NCT03313050|58813990|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
30799037|NCT03313050|58813991|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
30905623|NCT01963611|58940272|FG004|Overall Study|Other|45|||
30799038|NCT03313050|58813992|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
30799039|NCT03313050|58813989|FG000|Stage 2: 12 Months|Other|0|||
30799040|NCT03313050|58813990|FG001|Stage 2: 12 Months|Other|0|||
30746829|NCT00312572|58757070|FG000|Overall Study|Lost to Follow-up|1|||
30746830|NCT00312572|58757071|FG001|Overall Study|Lost to Follow-up|1|||
30746831|NCT00312572|58757070|FG000|Overall Study|Administrative|4|||
30746832|NCT00312572|58757071|FG001|Overall Study|Administrative|2|||
30746833|NCT00312572|58757070|FG000|Overall Study|Lack of Efficacy|1|||
30746834|NCT00312572|58757071|FG001|Overall Study|Lack of Efficacy|2|||
30746835|NCT00290888|58757081|FG000|Overall Study|Physician Decision|3|||
30746836|NCT00290888|58757082|FG001|Overall Study|Physician Decision|1|||
30746837|NCT00290732|58757091|FG000|Overall Study|Inability to instill drug intraductally.|0|||
30746838|NCT00290732|58757092|FG001|Overall Study|Inability to instill drug intraductally.|1|||
30746839|NCT00290732|58757093|FG002|Overall Study|Inability to instill drug intraductally.|1|||
30799041|NCT03313050|58813991|FG002|Stage 2: 12 Months|Other|0|||
30799042|NCT03313050|58813992|FG003|Stage 2: 12 Months|Other|1|||
30799043|NCT04755595|58814011|FG000|Overall Study|Lost to Follow-up|1|||
30799044|NCT04749745|58814016|FG000|Overall Study|Withdrawal by Subject|1|||
30799045|NCT04749745|58814017|FG001|Overall Study|Withdrawal by Subject|0|||
30799046|NCT03257436|58814023|FG000|Overall Study|Withdrawal by Subject|76|||
30799047|NCT03257436|58814023|FG000|Overall Study|Death|19|||
30799048|NCT04748341|58814029|FG000|Overall Study|Lost to Follow-up|1|||
30799049|NCT04748341|58814030|FG001|Overall Study|Lost to Follow-up|1|||
30799050|NCT01328002|58814036|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
30799051|NCT01328002|58814037|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
30622272|NCT00927784|58633866|FG000|Overall Study|Death|1|||
30622273|NCT00927784|58633867|FG001|Overall Study|Death|0|||
30622274|NCT00927784|58633866|FG000|Overall Study|Withdrawal by Subject|1|||
30622275|NCT00927784|58633867|FG001|Overall Study|Withdrawal by Subject|0|||
30622276|NCT05056987|58633884|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
30622277|NCT05056987|58633885|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
30622278|NCT05056987|58633884|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
30622279|NCT05056987|58633885|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
30622280|NCT04654468|58633894|FG000|Overall Study|Death|1|||
30622281|NCT04654468|58633894|FG000|Overall Study|Ongoing in the Study|50|||
30622282|NCT03439852|58633922|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
30622283|NCT03439852|58633923|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
30799052|NCT01328002|58814036|FG000|Open-Label Period|Adverse Event|8|||
30799053|NCT01328002|58814037|FG001|Open-Label Period|Adverse Event|0|||
30799054|NCT01328002|58814036|FG000|Open-Label Period|Lack of Efficacy|3|||
30799055|NCT01328002|58814037|FG001|Open-Label Period|Lack of Efficacy|0|||
30799056|NCT01328002|58814036|FG000|Open-Label Period|Protocol Violation|2|||
30799057|NCT01328002|58814037|FG001|Open-Label Period|Protocol Violation|0|||
30799058|NCT01328002|58814036|FG000|Open-Label Period|Withdrawal by Subject|9|||
30799059|NCT01328002|58814037|FG001|Open-Label Period|Withdrawal by Subject|0|||
30799060|NCT01328002|58814036|FG000|Open-Label Period|Lost to Follow-up|6|||
30799061|NCT01328002|58814037|FG001|Open-Label Period|Lost to Follow-up|0|||
30799062|NCT01328002|58814036|FG000|Open-Label Period|Other Reason|2|||
30799063|NCT01328002|58814037|FG001|Open-Label Period|Other Reason|0|||
30799064|NCT01328002|58814036|FG000|Double-Blind Period|Adverse Event|1|||
30799065|NCT01328002|58814037|FG001|Double-Blind Period|Adverse Event|0|||
30799066|NCT01328002|58814036|FG000|Double-Blind Period|Lack of Efficacy|1|||
30799067|NCT01328002|58814037|FG001|Double-Blind Period|Lack of Efficacy|0|||
30799068|NCT02579265|58814046|FG000|Overall Study|Weaned off earlier than 28 days|44|||
30799069|NCT02579265|58814047|FG001|Overall Study|Weaned off earlier than 28 days|43|||
30799070|NCT02579265|58814046|FG000|Overall Study|Adverse Event|2|||
30799071|NCT02579265|58814047|FG001|Overall Study|Adverse Event|0|||
30905624|NCT01975701|58940285|FG000|Overall Study|Lost to Follow-up|1|||
30905625|NCT01975701|58940285|FG000|Overall Study|Death|23|||
30746840|NCT00290732|58757094|FG003|Overall Study|Inability to instill drug intraductally.|0|||
30799072|NCT02579265|58814046|FG000|Overall Study|Any other reason not specified|0|||
30799073|NCT02579265|58814047|FG001|Overall Study|Any other reason not specified|2|||
30799074|NCT02579265|58814046|FG000|Overall Study|Withdrawal by Subject|2|||
30799075|NCT02579265|58814047|FG001|Overall Study|Withdrawal by Subject|0|||
30799076|NCT02579265|58814046|FG000|Overall Study|Physician Decision|1|||
30799077|NCT02579265|58814047|FG001|Overall Study|Physician Decision|0|||
30799078|NCT02579265|58814046|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
30799079|NCT02579265|58814047|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
30799080|NCT03289533|58814053|FG000|Overall Study|Death|12|||
30799081|NCT03289533|58814053|FG000|Overall Study|Terminated from study by sponsor|10|||
30799082|NCT04727749|58814059|FG000|Overall Study|Lost to Follow-up|10|||
30799083|NCT04727749|58814060|FG001|Overall Study|Lost to Follow-up|3|||
30799084|NCT04547023|58814070|FG000|Overall Study|Did Not Receive Intervention|3|||
30799085|NCT04547023|58814071|FG001|Overall Study|Did Not Receive Intervention|2|||
30799086|NCT04547023|58814070|FG000|Overall Study|Lost to Follow-up|1|||
30799087|NCT04547023|58814071|FG001|Overall Study|Lost to Follow-up|1|||
30799088|NCT03697993|58814081|FG000|Overall Study|Became Ineligible after Enrollment|1|||
30799089|NCT03697993|58814082|FG001|Overall Study|Became Ineligible after Enrollment|3|||
30799090|NCT03697993|58814081|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
30799091|NCT03697993|58814082|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
30799092|NCT03697993|58814081|FG000|Overall Study|Lost to Follow-up|3|||
30799093|NCT03697993|58814082|FG001|Overall Study|Lost to Follow-up|0|||
30799094|NCT03697993|58814081|FG000|Overall Study|Physician Decision|4|||
30799095|NCT03697993|58814082|FG001|Overall Study|Physician Decision|0|||
30799096|NCT03697993|58814081|FG000|Overall Study|Initial Urine Culture Negative|0|||
30799097|NCT03697993|58814082|FG001|Overall Study|Initial Urine Culture Negative|1|||
30799098|NCT03289455|58814092|FG000|Overall Study|Death|1|||
30799099|NCT03289455|58814093|FG001|Overall Study|Death|0|||
30799100|NCT03289455|58814094|FG002|Overall Study|Death|0|||
30799101|NCT03289455|58814092|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
30799102|NCT03289455|58814093|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
30799103|NCT03289455|58814094|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
30746841|NCT00290732|58757095|FG004|Overall Study|Inability to instill drug intraductally.|0|||
30746842|NCT00312494|58757111|FG000|Overall Study|Randomized; not treated with study drug|9|||
30746843|NCT00312494|58757112|FG001|Overall Study|Randomized; not treated with study drug|10|||
30746844|NCT00312494|58757113|FG002|Overall Study|Randomized; not treated with study drug|5|||
30746845|NCT00312494|58757111|FG000|Overall Study|Adverse Event|33|||
30746846|NCT00312494|58757112|FG001|Overall Study|Adverse Event|15|||
30746847|NCT00312494|58757113|FG002|Overall Study|Adverse Event|11|||
30746848|NCT00312494|58757111|FG000|Overall Study|Lack of Efficacy|4|||
30746849|NCT00312494|58757112|FG001|Overall Study|Lack of Efficacy|6|||
30746850|NCT00312494|58757113|FG002|Overall Study|Lack of Efficacy|8|||
30746851|NCT00312494|58757111|FG000|Overall Study|Laboratory abnormality|1|||
30746852|NCT00312494|58757112|FG001|Overall Study|Laboratory abnormality|0|||
30746853|NCT00312494|58757113|FG002|Overall Study|Laboratory abnormality|0|||
30746854|NCT00312494|58757111|FG000|Overall Study|Lost to Follow-up|8|||
30799104|NCT03289455|58814092|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
30799105|NCT03289455|58814093|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
30799106|NCT03289455|58814094|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
30799107|NCT03289455|58814092|FG000|Overall Study|Progressive disease|3|||
30799108|NCT03289455|58814093|FG001|Overall Study|Progressive disease|4|||
30799109|NCT03289455|58814094|FG002|Overall Study|Progressive disease|5|||
30799110|NCT04484857|58814103|FG000|Overall Study|Adverse Event|2|||
30799111|NCT04484857|58814103|FG000|Overall Study|Death|10|||
30799112|NCT04484857|58814103|FG000|Overall Study|Withdrawal by Subject|3|||
30622284|NCT03439852|58633922|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
30799113|NCT04484857|58814103|FG000|Overall Study|Transferred/Relocation|5|||
30799114|NCT04484857|58814103|FG000|Overall Study|Kidney Transplant|7|||
30799115|NCT04484857|58814103|FG000|Overall Study|Other than specified|4|||
30799116|NCT04484857|58814103|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
30799117|NCT04095793|58814107|FG000|Overall Study|Adverse Event|3|||
30799118|NCT04095793|58814107|FG000|Overall Study|Study Terminated by Sponsor|103|||
30799119|NCT04095793|58814107|FG000|Overall Study|Withdrawal by Subject|4|||
30799120|NCT04482439|58814111|FG000|Overall Study|Lost to Follow-up|1|||
30799121|NCT04482439|58814111|FG000|Overall Study|Unrelated illness|1|||
30799122|NCT04535947|58814118|FG000|Overall Study|Adverse Event|1|||
30799123|NCT04535947|58814119|FG001|Overall Study|Adverse Event|4|||
30799124|NCT04535947|58814118|FG000|Overall Study|Other reasons not specified|2|||
30799125|NCT04535947|58814119|FG001|Overall Study|Other reasons not specified|0|||
30799126|NCT04535947|58814118|FG000|Overall Study|Withdrawal by Subject|1|||
30799127|NCT04535947|58814119|FG001|Overall Study|Withdrawal by Subject|1|||
30799128|NCT04474405|58814131|FG000|Overall Study|Withdrawal by Subject|0|||
30799129|NCT04474405|58814132|FG001|Overall Study|Withdrawal by Subject|0|||
30799130|NCT04474405|58814133|FG002|Overall Study|Withdrawal by Subject|1|||
30799131|NCT04474405|58814134|FG003|Overall Study|Withdrawal by Subject|0|||
30799132|NCT04474405|58814135|FG004|Overall Study|Withdrawal by Subject|1|||
30799133|NCT04474405|58814136|FG005|Overall Study|Withdrawal by Subject|0|||
30799134|NCT04474405|58814131|FG000|Overall Study|Other|0|||
30799135|NCT04474405|58814132|FG001|Overall Study|Other|0|||
30799136|NCT04474405|58814133|FG002|Overall Study|Other|0|||
30799137|NCT04474405|58814134|FG003|Overall Study|Other|0|||
30799138|NCT04474405|58814135|FG004|Overall Study|Other|3|||
30799139|NCT04474405|58814136|FG005|Overall Study|Other|0|||
30799140|NCT04531813|58814150|FG000|Overall Study|Protocol Violation|1|||
30799141|NCT04531813|58814150|FG000|Overall Study|Withdrawal by Subject|1|||
30799142|NCT03538444|58814156|FG000|Overall Study|opioid withdrawal|1|||
30799143|NCT03538444|58814157|FG001|Overall Study|opioid withdrawal|0|||
30799144|NCT01199302|58814167|FG000|Overall Study|Adverse Event|1|||
30799145|NCT01199302|58814168|FG001|Overall Study|Adverse Event|1|||
30799146|NCT01199302|58814169|FG002|Overall Study|Adverse Event|2|||
30799147|NCT01199302|58814170|FG003|Overall Study|Adverse Event|0|||
30799148|NCT01199302|58814167|FG000|Overall Study|Withdrawal by Subject|2|||
30799149|NCT01199302|58814168|FG001|Overall Study|Withdrawal by Subject|2|||
30799150|NCT01199302|58814169|FG002|Overall Study|Withdrawal by Subject|3|||
30799151|NCT01199302|58814170|FG003|Overall Study|Withdrawal by Subject|0|||
30799152|NCT01199302|58814167|FG000|Overall Study|Disease Progression|3|||
30799153|NCT01199302|58814168|FG001|Overall Study|Disease Progression|4|||
30799154|NCT01199302|58814169|FG002|Overall Study|Disease Progression|4|||
30799155|NCT01199302|58814170|FG003|Overall Study|Disease Progression|2|||
30799156|NCT01199302|58814167|FG000|Overall Study|Study Termination|13|||
30799157|NCT01199302|58814168|FG001|Overall Study|Study Termination|8|||
30799158|NCT01199302|58814169|FG002|Overall Study|Study Termination|11|||
30799159|NCT01199302|58814170|FG003|Overall Study|Study Termination|9|||
30799160|NCT01199302|58814167|FG000|Overall Study|Lost to Follow-up|0|||
30799161|NCT01199302|58814168|FG001|Overall Study|Lost to Follow-up|1|||
30799162|NCT01199302|58814169|FG002|Overall Study|Lost to Follow-up|0|||
30799163|NCT01199302|58814170|FG003|Overall Study|Lost to Follow-up|0|||
30799164|NCT01199302|58814167|FG000|Overall Study|Other|1|||
30799165|NCT01199302|58814168|FG001|Overall Study|Other|0|||
30799166|NCT01199302|58814169|FG002|Overall Study|Other|0|||
30799167|NCT01199302|58814170|FG003|Overall Study|Other|0|||
30799168|NCT03332784|58814197|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799169|NCT03332784|58814198|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
30799170|NCT03332784|58814199|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799171|NCT03332784|58814200|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799172|NCT03332784|58814201|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799173|NCT03332784|58814202|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799174|NCT03332784|58814203|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799175|NCT03332784|58814204|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799176|NCT03332784|58814205|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799177|NCT03332784|58814206|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799178|NCT03332784|58814207|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799179|NCT03332784|58814208|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799180|NCT03332784|58814209|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30905626|NCT01975701|58940285|FG000|Overall Study|Physician Decision|1|||
30905627|NCT01962987|58940292|FG000|Overall Study|Adverse Event|4|||
30905628|NCT01962987|58940293|FG001|Overall Study|Adverse Event|4|||
30905629|NCT01962987|58940294|FG002|Overall Study|Adverse Event|0|||
30905630|NCT01962987|58940292|FG000|Overall Study|Lost to Follow-up|0|||
30905631|NCT01962987|58940293|FG001|Overall Study|Lost to Follow-up|0|||
30905632|NCT01962987|58940294|FG002|Overall Study|Lost to Follow-up|1|||
30905633|NCT01962987|58940292|FG000|Overall Study|Non compliance with dosing requirements|4|||
30905634|NCT01962987|58940293|FG001|Overall Study|Non compliance with dosing requirements|2|||
30905635|NCT01962987|58940294|FG002|Overall Study|Non compliance with dosing requirements|0|||
30905636|NCT01962987|58940292|FG000|Overall Study|Miscellaneous|1|||
30905637|NCT01962987|58940293|FG001|Overall Study|Miscellaneous|9|||
30905638|NCT01962987|58940294|FG002|Overall Study|Miscellaneous|2|||
30905639|NCT01962987|58940292|FG000|Overall Study|Restricted medication|5|||
30905640|NCT01962987|58940293|FG001|Overall Study|Restricted medication|1|||
30905641|NCT01962987|58940294|FG002|Overall Study|Restricted medication|1|||
30905642|NCT01962987|58940292|FG000|Overall Study|Serious Adverse Event|1|||
30905643|NCT01962987|58940293|FG001|Overall Study|Serious Adverse Event|0|||
30905644|NCT01962987|58940294|FG002|Overall Study|Serious Adverse Event|0|||
30905645|NCT01962987|58940292|FG000|Overall Study|Withdrawal by Subject|11|||
30905646|NCT01962987|58940293|FG001|Overall Study|Withdrawal by Subject|10|||
30905647|NCT01962987|58940294|FG002|Overall Study|Withdrawal by Subject|6|||
30905648|NCT01962987|58940292|FG000|Overall Study|Randomized in Error|4|||
30905649|NCT01962987|58940293|FG001|Overall Study|Randomized in Error|2|||
30905650|NCT01962987|58940294|FG002|Overall Study|Randomized in Error|2|||
30905651|NCT01962441|58940305|FG000|Randomized Period|Randomized but Never Treated|4|||
30905652|NCT01962441|58940306|FG001|Randomized Period|Randomized but Never Treated|2|||
30905653|NCT01962441|58940307|FG002|Randomized Period|Randomized but Never Treated|3|||
30905654|NCT01962441|58940305|FG000|Randomized Period|Lost to Follow-up|2|||
30905655|NCT01962441|58940306|FG001|Randomized Period|Lost to Follow-up|4|||
30905656|NCT01962441|58940307|FG002|Randomized Period|Lost to Follow-up|4|||
30905657|NCT01962441|58940305|FG000|Randomized Period|Withdrew Consent|3|||
30905658|NCT01962441|58940306|FG001|Randomized Period|Withdrew Consent|3|||
30905659|NCT01962441|58940307|FG002|Randomized Period|Withdrew Consent|2|||
30905660|NCT01962441|58940305|FG000|Randomized Period|Adverse Event|1|||
30905661|NCT01962441|58940306|FG001|Randomized Period|Adverse Event|1|||
30905662|NCT01962441|58940307|FG002|Randomized Period|Adverse Event|0|||
30905663|NCT01962441|58940305|FG000|Randomized Period|Death|0|||
30905664|NCT01962441|58940306|FG001|Randomized Period|Death|0|||
30905665|NCT01962441|58940307|FG002|Randomized Period|Death|2|||
30905666|NCT01962441|58940305|FG000|Randomized Period|Protocol Violation|0|||
30905667|NCT01962441|58940306|FG001|Randomized Period|Protocol Violation|1|||
30905668|NCT01962441|58940307|FG002|Randomized Period|Protocol Violation|0|||
30905669|NCT01962441|58940305|FG000|Retreatment Substudy|Lack of Efficacy|1|||
30622285|NCT03439852|58633923|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
30905670|NCT01962441|58940306|FG001|Retreatment Substudy|Lack of Efficacy|0|||
30799181|NCT03332784|58814210|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799182|NCT03332784|58814211|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
30799183|NCT03332784|58814212|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799184|NCT03332784|58814213|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799185|NCT03332784|58814214|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799186|NCT03332784|58814215|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799187|NCT03332784|58814216|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
30799188|NCT04465357|58814280|FG000|Overall Study|Adverse Event|2|||
30799189|NCT04465357|58814280|FG000|Overall Study|Lack of Efficacy|1|||
30799190|NCT04465357|58814280|FG000|Overall Study|Lost to Follow-up|2|||
30799191|NCT04465357|58814280|FG000|Overall Study|Withdrawal by Subject|6|||
30799192|NCT04465357|58814280|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
30905671|NCT01962441|58940307|FG002|Retreatment Substudy|Lack of Efficacy|0|||
30905672|NCT01962441|58940305|FG000|Retreatment Substudy|Lost to Follow-up|1|||
30905673|NCT01962441|58940306|FG001|Retreatment Substudy|Lost to Follow-up|0|||
30905674|NCT01962441|58940307|FG002|Retreatment Substudy|Lost to Follow-up|0|||
30905675|NCT01638013|58940319|FG000|Overall Study|Adverse Event|36|||
30799193|NCT03332628|58814284|FG000|Overall Study|Physician Decision|2|||
30799194|NCT04516759|58814291|FG000|Overall Study|Withdrawal by Subject|1|||
30905676|NCT01638013|58940320|FG001|Overall Study|Adverse Event|29|||
30905677|NCT01638013|58940321|FG002|Overall Study|Adverse Event|48|||
30905678|NCT01638013|58940319|FG000|Overall Study|Lack of Efficacy|39|||
30799195|NCT04516759|58814292|FG001|Overall Study|Withdrawal by Subject|1|||
30799196|NCT04516759|58814291|FG000|Overall Study|Other|0|||
30799197|NCT04516759|58814292|FG001|Overall Study|Other|1|||
30799198|NCT03332160|58814300|FG000|Overall Study|Withdrawal by Subject|1|||
30799199|NCT03332160|58814301|FG001|Overall Study|Withdrawal by Subject|1|||
30799200|NCT03332160|58814300|FG000|Overall Study|Adverse Event|0|||
30799201|NCT03332160|58814301|FG001|Overall Study|Adverse Event|1|||
30799202|NCT03332160|58814300|FG000|Overall Study|Developed Exclusion Criteria|0|||
30799203|NCT03332160|58814301|FG001|Overall Study|Developed Exclusion Criteria|1|||
30799204|NCT03332160|58814300|FG000|Overall Study|Non-adherence to treatment|0|||
30799205|NCT03332160|58814301|FG001|Overall Study|Non-adherence to treatment|2|||
30799206|NCT03312114|58814308|FG000|Overall Study|All the five enrolled dropped out of the|5|||
30799207|NCT03694327|58814315|FG000|Overall Study|Lost to Follow-up|13|||
30799208|NCT03694327|58814316|FG001|Overall Study|Lost to Follow-up|23|||
30799209|NCT03330288|58814324|FG000|Overall Study|Other reason|1|||
30799210|NCT03330288|58814325|FG001|Overall Study|Other reason|1|||
30799211|NCT03330288|58814324|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
30799212|NCT03330288|58814325|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
30799213|NCT03330288|58814324|FG000|Overall Study|Adverse Event|1|||
30799214|NCT03330288|58814325|FG001|Overall Study|Adverse Event|0|||
30799215|NCT03330288|58814324|FG000|Overall Study|Withdrawal by Subject|1|||
30799216|NCT03330288|58814325|FG001|Overall Study|Withdrawal by Subject|0|||
30799217|NCT03330288|58814324|FG000|Overall Study|Lost to Follow-up|26|||
30799218|NCT03330288|58814325|FG001|Overall Study|Lost to Follow-up|7|||
30799219|NCT03084536|58814334|FG000|Overall Study|Determined to be ineligible|0|||
30799220|NCT03084536|58814335|FG001|Overall Study|Determined to be ineligible|0|||
30799221|NCT03084536|58814336|FG002|Overall Study|Determined to be ineligible|16|||
30799222|NCT03084536|58814334|FG000|Overall Study|Withdrawal by Subject|0|||
30799223|NCT03084536|58814335|FG001|Overall Study|Withdrawal by Subject|0|||
30799224|NCT03084536|58814336|FG002|Overall Study|Withdrawal by Subject|4|||
30799225|NCT03084536|58814334|FG000|Overall Study|Physician Decision|0|||
30799226|NCT03084536|58814335|FG001|Overall Study|Physician Decision|0|||
30799227|NCT03084536|58814336|FG002|Overall Study|Physician Decision|3|||
30799228|NCT03084536|58814334|FG000|Overall Study|Death|0|||
30799229|NCT03084536|58814335|FG001|Overall Study|Death|0|||
30799230|NCT03084536|58814336|FG002|Overall Study|Death|1|||
30799231|NCT03084536|58814334|FG000|Overall Study|Lost to Follow-up|0|||
30799232|NCT03084536|58814335|FG001|Overall Study|Lost to Follow-up|0|||
30799233|NCT03084536|58814336|FG002|Overall Study|Lost to Follow-up|1|||
30799234|NCT03084536|58814334|FG000|Overall Study|Protocol Violation|0|||
30799235|NCT03084536|58814335|FG001|Overall Study|Protocol Violation|0|||
30799236|NCT03084536|58814336|FG002|Overall Study|Protocol Violation|1|||
30799237|NCT03084536|58814334|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
30799238|NCT03084536|58814335|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
30799239|NCT03084536|58814336|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
30799240|NCT05291936|58814343|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
30799241|NCT05291936|58814344|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
30799242|NCT05291936|58814343|FG000|Period 1|Withdrew Consent during study|1|||
30799243|NCT05291936|58814344|FG001|Period 1|Withdrew Consent during study|0|||
30905679|NCT01638013|58940320|FG001|Overall Study|Lack of Efficacy|11|||
30746855|NCT00312494|58757112|FG001|Overall Study|Lost to Follow-up|8|||
30746856|NCT00312494|58757113|FG002|Overall Study|Lost to Follow-up|8|||
30746857|NCT00312494|58757111|FG000|Overall Study|Withdrawal by Subject|6|||
30746858|NCT00312494|58757112|FG001|Overall Study|Withdrawal by Subject|9|||
30746859|NCT00312494|58757113|FG002|Overall Study|Withdrawal by Subject|10|||
30746860|NCT00312494|58757111|FG000|Overall Study|Other|10|||
30746861|NCT00312494|58757112|FG001|Overall Study|Other|10|||
30746862|NCT00312494|58757113|FG002|Overall Study|Other|1|||
30746863|NCT00312338|58757123|FG000|Overall Study|Adverse Event|7|||
30746864|NCT00312338|58757124|FG001|Overall Study|Adverse Event|2|||
30746865|NCT00312338|58757123|FG000|Overall Study|Lost to Follow-up|9|||
30746866|NCT00312338|58757124|FG001|Overall Study|Lost to Follow-up|1|||
30746867|NCT00312338|58757123|FG000|Overall Study|Withdrawal by Subject|4|||
30746868|NCT00312338|58757124|FG001|Overall Study|Withdrawal by Subject|0|||
30746869|NCT00312338|58757123|FG000|Overall Study|Subsequent infection|2|||
30746870|NCT00312338|58757124|FG001|Overall Study|Subsequent infection|0|||
30746871|NCT00290498|58757132|FG000|Overall Study|Death|2|||
30746872|NCT00290498|58757133|FG001|Overall Study|Death|0|||
30746873|NCT00290498|58757132|FG000|Overall Study|Physician Decision|1|||
30746874|NCT00290498|58757133|FG001|Overall Study|Physician Decision|0|||
30746875|NCT00290498|58757132|FG000|Overall Study|Withdrawal by Subject|1|||
30799244|NCT05291936|58814343|FG000|Period 2|Adverse Event|0|||
30799245|NCT05291936|58814344|FG001|Period 2|Adverse Event|1|||
30799246|NCT05291936|58814343|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
30799247|NCT05291936|58814344|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
30799248|NCT03289143|58814354|FG000|Overall Study|Caregiver Unavailability|1|||
30799249|NCT03289143|58814355|FG001|Overall Study|Caregiver Unavailability|1|||
30799250|NCT03289143|58814356|FG002|Overall Study|Caregiver Unavailability|0|||
30799251|NCT03289143|58814357|FG003|Overall Study|Caregiver Unavailability|0|||
30799252|NCT03289143|58814354|FG000|Overall Study|Research Department Closure|0|||
30799253|NCT03289143|58814355|FG001|Overall Study|Research Department Closure|0|||
30799254|NCT03289143|58814356|FG002|Overall Study|Research Department Closure|1|||
30799255|NCT03289143|58814357|FG003|Overall Study|Research Department Closure|0|||
30799256|NCT03289143|58814354|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
30799257|NCT03289143|58814355|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
30799258|NCT03289143|58814356|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
30799259|NCT03289143|58814357|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
30799260|NCT03289143|58814354|FG000|Overall Study|Medical Monitor Decision|1|||
30799261|NCT03289143|58814355|FG001|Overall Study|Medical Monitor Decision|0|||
30799262|NCT03289143|58814356|FG002|Overall Study|Medical Monitor Decision|0|||
30799263|NCT03289143|58814357|FG003|Overall Study|Medical Monitor Decision|0|||
30799264|NCT03289143|58814354|FG000|Overall Study|Participant Non-Compliance|0|||
30799265|NCT03289143|58814355|FG001|Overall Study|Participant Non-Compliance|0|||
30799266|NCT03289143|58814356|FG002|Overall Study|Participant Non-Compliance|1|||
30799267|NCT03289143|58814357|FG003|Overall Study|Participant Non-Compliance|0|||
30799268|NCT03289143|58814354|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
30799269|NCT03289143|58814355|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
30799270|NCT03289143|58814356|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
30799271|NCT03289143|58814357|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
30799272|NCT03289143|58814354|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
30799273|NCT03289143|58814355|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
30799274|NCT03289143|58814356|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
30799275|NCT03289143|58814357|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
30799276|NCT03289143|58814354|FG000|Overall Study|Caregiver Passed Away|1|||
30799277|NCT03289143|58814355|FG001|Overall Study|Caregiver Passed Away|0|||
30799278|NCT03289143|58814356|FG002|Overall Study|Caregiver Passed Away|0|||
30799279|NCT03289143|58814357|FG003|Overall Study|Caregiver Passed Away|0|||
30799280|NCT03289143|58814354|FG000|Overall Study|Physician Decision|0|||
30799281|NCT03289143|58814355|FG001|Overall Study|Physician Decision|2|||
30799282|NCT03289143|58814356|FG002|Overall Study|Physician Decision|2|||
30799283|NCT03289143|58814357|FG003|Overall Study|Physician Decision|2|||
30799284|NCT03289143|58814354|FG000|Overall Study|Protocol Deviation|2|||
30799285|NCT03289143|58814355|FG001|Overall Study|Protocol Deviation|1|||
30799286|NCT03289143|58814356|FG002|Overall Study|Protocol Deviation|3|||
30799287|NCT03289143|58814357|FG003|Overall Study|Protocol Deviation|1|||
30905680|NCT01638013|58940321|FG002|Overall Study|Lack of Efficacy|14|||
30905681|NCT01638013|58940319|FG000|Overall Study|Protocol Violation|10|||
30905682|NCT01638013|58940320|FG001|Overall Study|Protocol Violation|7|||
30905683|NCT01638013|58940321|FG002|Overall Study|Protocol Violation|11|||
30905684|NCT01638013|58940319|FG000|Overall Study|Met discontinuation criteria|4|||
30905685|NCT01638013|58940320|FG001|Overall Study|Met discontinuation criteria|0|||
30905686|NCT01638013|58940321|FG002|Overall Study|Met discontinuation criteria|7|||
30905687|NCT01638013|58940319|FG000|Overall Study|Subject Lost to Follow up|1|||
30905688|NCT01638013|58940320|FG001|Overall Study|Subject Lost to Follow up|0|||
30905689|NCT01638013|58940321|FG002|Overall Study|Subject Lost to Follow up|1|||
30905690|NCT01638013|58940319|FG000|Overall Study|Miscellaneous|25|||
30905691|NCT01638013|58940320|FG001|Overall Study|Miscellaneous|19|||
30905692|NCT01638013|58940321|FG002|Overall Study|Miscellaneous|23|||
30905693|NCT01638013|58940319|FG000|Overall Study|Withdrawal of Consent|16|||
30905694|NCT01638013|58940320|FG001|Overall Study|Withdrawal of Consent|12|||
30799288|NCT03289143|58814354|FG000|Overall Study|Study Terminated By Sponsor|101|||
30799289|NCT03289143|58814355|FG001|Overall Study|Study Terminated By Sponsor|75|||
30799290|NCT03289143|58814356|FG002|Overall Study|Study Terminated By Sponsor|100|||
30799291|NCT03289143|58814357|FG003|Overall Study|Study Terminated By Sponsor|69|||
30799292|NCT03289143|58814354|FG000|Overall Study|Withdrawal by Subject|14|||
30799293|NCT03289143|58814355|FG001|Overall Study|Withdrawal by Subject|6|||
30905695|NCT01638013|58940321|FG002|Overall Study|Withdrawal of Consent|16|||
30905696|NCT01638013|58940319|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
30905697|NCT01638013|58940320|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
30905698|NCT01638013|58940321|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
30905699|NCT01637623|58940336|FG000|Overall Study|Lost to Follow-up|0|||
30905700|NCT01637623|58940337|FG001|Overall Study|Lost to Follow-up|0|||
30905701|NCT01637623|58940338|FG002|Overall Study|Lost to Follow-up|2|||
30905702|NCT01637623|58940336|FG000|Overall Study|Physician Decision|1|||
30905703|NCT01637623|58940337|FG001|Overall Study|Physician Decision|0|||
30905704|NCT01637623|58940338|FG002|Overall Study|Physician Decision|1|||
30799294|NCT03289143|58814356|FG002|Overall Study|Withdrawal by Subject|14|||
30799295|NCT03289143|58814357|FG003|Overall Study|Withdrawal by Subject|12|||
30799296|NCT03289143|58814354|FG000|Overall Study|Adverse Event|10|||
30799297|NCT03289143|58814355|FG001|Overall Study|Adverse Event|7|||
30799298|NCT03289143|58814356|FG002|Overall Study|Adverse Event|6|||
30799299|NCT03289143|58814357|FG003|Overall Study|Adverse Event|5|||
30799300|NCT03289143|58814354|FG000|Overall Study|Death|2|||
30799301|NCT03289143|58814355|FG001|Overall Study|Death|0|||
30799302|NCT03289143|58814356|FG002|Overall Study|Death|2|||
30799303|NCT03289143|58814357|FG003|Overall Study|Death|1|||
30799304|NCT03289143|58814354|FG000|Overall Study|Lost to Follow-up|2|||
30799305|NCT03289143|58814355|FG001|Overall Study|Lost to Follow-up|1|||
30799306|NCT03289143|58814356|FG002|Overall Study|Lost to Follow-up|1|||
30799307|NCT03289143|58814357|FG003|Overall Study|Lost to Follow-up|0|||
30799308|NCT03289143|58814354|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
30799309|NCT03289143|58814355|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
30799310|NCT03289143|58814356|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
30799311|NCT03289143|58814357|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
30799312|NCT03289143|58814354|FG000|Overall Study|Withdrawal by Caregiver|0|||
30799313|NCT03289143|58814355|FG001|Overall Study|Withdrawal by Caregiver|1|||
30799314|NCT03289143|58814356|FG002|Overall Study|Withdrawal by Caregiver|0|||
30799315|NCT03289143|58814357|FG003|Overall Study|Withdrawal by Caregiver|0|||
30799316|NCT03289143|58814354|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
30799317|NCT03289143|58814355|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
30799318|NCT03289143|58814356|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
30799319|NCT03289143|58814357|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
30799320|NCT03289143|58814354|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
30799321|NCT03289143|58814355|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
30799322|NCT03289143|58814356|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
30799323|NCT03289143|58814357|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
30799324|NCT03311724|58814376|FG000|Overall Study|Physician Decision|0|||
30799325|NCT03311724|58814377|FG001|Overall Study|Physician Decision|0|||
30799326|NCT03311724|58814378|FG002|Overall Study|Physician Decision|0|||
30799327|NCT03311724|58814379|FG003|Overall Study|Physician Decision|1|||
30799328|NCT03311724|58814376|FG000|Overall Study|Protocol Violation|1|||
30799329|NCT03311724|58814377|FG001|Overall Study|Protocol Violation|0|||
30799330|NCT03311724|58814378|FG002|Overall Study|Protocol Violation|1|||
30799331|NCT03311724|58814379|FG003|Overall Study|Protocol Violation|0|||
30799332|NCT03311724|58814376|FG000|Overall Study|Withdrawal by Subject|1|||
30799333|NCT03311724|58814377|FG001|Overall Study|Withdrawal by Subject|1|||
30799334|NCT03311724|58814378|FG002|Overall Study|Withdrawal by Subject|0|||
30799335|NCT03311724|58814379|FG003|Overall Study|Withdrawal by Subject|0|||
30905705|NCT01962207|58940350|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
30799336|NCT03311724|58814376|FG000|Overall Study|Lost to Follow-up|1|||
30799337|NCT03311724|58814377|FG001|Overall Study|Lost to Follow-up|0|||
30799338|NCT03311724|58814378|FG002|Overall Study|Lost to Follow-up|0|||
30799339|NCT03311724|58814379|FG003|Overall Study|Lost to Follow-up|0|||
30905706|NCT01962207|58940351|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
30799340|NCT03311724|58814376|FG000|Overall Study|Sponsor Decision|0|||
30905707|NCT01962207|58940352|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
30622286|NCT03439852|58633922|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
30799341|NCT03311724|58814377|FG001|Overall Study|Sponsor Decision|0|||
30799342|NCT03311724|58814378|FG002|Overall Study|Sponsor Decision|1|||
30799343|NCT03311724|58814379|FG003|Overall Study|Sponsor Decision|0|||
30799344|NCT03311646|58814401|FG000|Overall Study|Physician Decision|1|||
30799345|NCT03311646|58814401|FG000|Overall Study|Withdrawal by Subject|5|||
30799346|NCT03311646|58814401|FG000|Overall Study|Lost to Follow-up|5|||
30905708|NCT01962207|58940353|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
30622287|NCT03439852|58633923|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
30746876|NCT00290498|58757133|FG001|Overall Study|Withdrawal by Subject|0|||
30746877|NCT00290498|58757132|FG000|Overall Study|Ineligible|3|||
30746878|NCT00290498|58757133|FG001|Overall Study|Ineligible|0|||
30746879|NCT00290498|58757132|FG000|Overall Study|Non-Compliance|1|||
30746880|NCT00290498|58757133|FG001|Overall Study|Non-Compliance|0|||
30746881|NCT00451451|58757144|FG000|Overall Study|Adverse Event|11|||
30746882|NCT00451451|58757145|FG001|Overall Study|Adverse Event|21|||
30746883|NCT00451451|58757146|FG002|Overall Study|Adverse Event|26|||
30746884|NCT00451451|58757147|FG003|Overall Study|Adverse Event|10|||
30746885|NCT00451451|58757144|FG000|Overall Study|Lost to Follow-up|11|||
30746886|NCT00451451|58757145|FG001|Overall Study|Lost to Follow-up|9|||
30746887|NCT00451451|58757146|FG002|Overall Study|Lost to Follow-up|8|||
30746888|NCT00451451|58757147|FG003|Overall Study|Lost to Follow-up|11|||
30746889|NCT00451451|58757144|FG000|Overall Study|Consent Withdrawn|14|||
30746890|NCT00451451|58757145|FG001|Overall Study|Consent Withdrawn|9|||
30746891|NCT00451451|58757146|FG002|Overall Study|Consent Withdrawn|17|||
30746892|NCT00451451|58757147|FG003|Overall Study|Consent Withdrawn|17|||
30746893|NCT00451451|58757144|FG000|Overall Study|Investigator Decision|6|||
30799347|NCT03311646|58814401|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
30799348|NCT01672892|58814408|FG000|Overall Study|Protocol Violation|7|||
30799349|NCT01672892|58814409|FG001|Overall Study|Protocol Violation|3|||
30799350|NCT03288987|58814420|FG000|Overall Study|Protocol Violation|10|||
30799351|NCT03288987|58814421|FG001|Overall Study|Protocol Violation|4|||
30799352|NCT02939781|58814427|FG000|Overall Study|Protocol Violation|8|||
30799353|NCT02939781|58814427|FG000|Overall Study|Withdrawal by Subject|1|||
30799354|NCT03083990|58814443|FG000|Overall Study|Adverse Event|1|||
30799355|NCT03083990|58814444|FG001|Overall Study|Adverse Event|0|||
30799356|NCT03252015|58814462|FG000|Overall Study|Withdrawal by Subject|0|||
30799357|NCT03252015|58814463|FG001|Overall Study|Withdrawal by Subject|1|||
30799358|NCT03252015|58814464|FG002|Overall Study|Withdrawal by Subject|1|||
30799359|NCT03252015|58814465|FG003|Overall Study|Withdrawal by Subject|0|||
30799360|NCT03252015|58814462|FG000|Overall Study|Adverse Event|1|||
30799361|NCT03252015|58814463|FG001|Overall Study|Adverse Event|0|||
30799362|NCT03252015|58814464|FG002|Overall Study|Adverse Event|0|||
30799363|NCT03252015|58814465|FG003|Overall Study|Adverse Event|1|||
30799364|NCT03083132|58814491|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
30799365|NCT03083132|58814492|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
30799366|NCT03083132|58814491|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
30799367|NCT03083132|58814492|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
30799368|NCT03083132|58814491|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
30799369|NCT03083132|58814492|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
30799370|NCT03683823|58814500|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
30799371|NCT03683823|58814501|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
30799372|NCT03683823|58814500|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
30799373|NCT03683823|58814501|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
30799374|NCT03683823|58814500|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
30799375|NCT03683823|58814501|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
30799376|NCT03285711|58814509|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
30799377|NCT03285711|58814510|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
30799378|NCT03285711|58814511|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
30799379|NCT03285711|58814512|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
30799380|NCT03285711|58814509|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
30799381|NCT03285711|58814510|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
30799382|NCT03285711|58814511|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
30799383|NCT03285711|58814512|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
30799384|NCT03285711|58814509|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
30799385|NCT03285711|58814510|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
30799386|NCT03285711|58814511|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
30905709|NCT01962207|58940350|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
30905710|NCT01962207|58940351|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
30905711|NCT01962207|58940352|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
30905712|NCT01962207|58940353|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
30905713|NCT01962207|58940350|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
30905714|NCT01962207|58940351|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
30905715|NCT01962207|58940352|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
30905716|NCT01962207|58940353|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
30905717|NCT01962207|58940350|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
30905718|NCT01962207|58940351|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
30905719|NCT01962207|58940352|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
30905720|NCT01962207|58940353|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
30905721|NCT01962207|58940350|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
30905722|NCT01962207|58940351|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
30905723|NCT01962207|58940352|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
30905724|NCT01962207|58940353|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
30905725|NCT01962207|58940350|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
30905726|NCT01962207|58940351|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
30905727|NCT01962207|58940352|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
30905728|NCT01962207|58940353|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
30622288|NCT03355300|58633934|FG000|Overall Study|Physician Decision|0|||
30799387|NCT03285711|58814512|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
30799388|NCT03285711|58814509|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
30799389|NCT03285711|58814510|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
30799390|NCT03285711|58814511|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
30799391|NCT03285711|58814512|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
30799392|NCT02927366|58814524|FG000|Overall Study|Adverse Event|1|||
30799393|NCT02927366|58814525|FG001|Overall Study|Adverse Event|0|||
30905729|NCT01995825|58940369|FG000|Overall Study|Withdrawal by Subject|1|||
30905730|NCT01995825|58940370|FG001|Overall Study|Withdrawal by Subject|0|||
30905731|NCT01995357|58940376|FG000|Period 5|Lack of Efficacy|1|||
30799394|NCT02927366|58814524|FG000|Overall Study|Patient schedule|1|||
30799395|NCT02927366|58814525|FG001|Overall Study|Patient schedule|0|||
30799396|NCT03249909|58814534|FG000|Overall Study|Withdrawal by Subject|3|||
30799397|NCT03249909|58814535|FG001|Overall Study|Withdrawal by Subject|0|||
30799398|NCT03249909|58814536|FG002|Overall Study|Withdrawal by Subject|0|||
30799399|NCT03249909|58814534|FG000|Overall Study|Adverse Event|3|||
30799400|NCT03249909|58814535|FG001|Overall Study|Adverse Event|0|||
30799401|NCT03249909|58814536|FG002|Overall Study|Adverse Event|0|||
30622289|NCT03355300|58633935|FG001|Overall Study|Physician Decision|1|||
30799402|NCT03249909|58814534|FG000|Overall Study|Lost to Follow-up|0|||
30799403|NCT03249909|58814535|FG001|Overall Study|Lost to Follow-up|1|||
30799404|NCT03249909|58814536|FG002|Overall Study|Lost to Follow-up|0|||
30799405|NCT03081884|58814547|FG000|Overall Study|deferred prostate cancer treatment|1|||
30799406|NCT03081884|58814547|FG000|Overall Study|metastasis managed with systemic therapy|3|||
30799407|NCT03077438|58814554|FG000|Overall Study|Protocol Violation|3|||
30799408|NCT03077438|58814555|FG001|Overall Study|Protocol Violation|5|||
30799409|NCT03077438|58814554|FG000|Overall Study|Withdrawal by Subject|3|||
30799410|NCT03077438|58814555|FG001|Overall Study|Withdrawal by Subject|6|||
30799411|NCT03077438|58814554|FG000|Overall Study|Lost to Follow-up|6|||
30799412|NCT03077438|58814555|FG001|Overall Study|Lost to Follow-up|3|||
30799413|NCT03076970|58814565|FG000|Washout Period 2|Adverse Event|0|||
30799414|NCT03076970|58814566|FG001|Washout Period 2|Adverse Event|0|||
30799415|NCT03076970|58814567|FG002|Washout Period 2|Adverse Event|0|||
30799416|NCT03076970|58814568|FG003|Washout Period 2|Adverse Event|0|||
30799417|NCT03076970|58814569|FG004|Washout Period 2|Adverse Event|1|||
30799418|NCT03076970|58814570|FG005|Washout Period 2|Adverse Event|0|||
30799419|NCT03076970|58814565|FG000|Period 3|Withdrawal by Subject|0|||
30799420|NCT03076970|58814566|FG001|Period 3|Withdrawal by Subject|0|||
30799421|NCT03076970|58814567|FG002|Period 3|Withdrawal by Subject|0|||
30799422|NCT03076970|58814568|FG003|Period 3|Withdrawal by Subject|0|||
30799423|NCT03076970|58814569|FG004|Period 3|Withdrawal by Subject|0|||
30799424|NCT03076970|58814570|FG005|Period 3|Withdrawal by Subject|1|||
30799425|NCT03076970|58814565|FG000|Period 3|Failure to meet I/E criteria|0|||
30799426|NCT03076970|58814566|FG001|Period 3|Failure to meet I/E criteria|0|||
30799427|NCT03076970|58814567|FG002|Period 3|Failure to meet I/E criteria|0|||
30799428|NCT03076970|58814568|FG003|Period 3|Failure to meet I/E criteria|0|||
30799429|NCT03076970|58814569|FG004|Period 3|Failure to meet I/E criteria|1|||
30799430|NCT03076970|58814570|FG005|Period 3|Failure to meet I/E criteria|0|||
30799431|NCT00726596|58814583|FG000|Overall Study|Adverse Event|2|||
30799432|NCT00726596|58814584|FG001|Overall Study|Adverse Event|1|||
30799433|NCT00726596|58814583|FG000|Overall Study|Withdrawal by Subject|3|||
30799434|NCT00726596|58814584|FG001|Overall Study|Withdrawal by Subject|3|||
30799435|NCT02890992|58814607|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
30799436|NCT02890992|58814608|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
30905732|NCT01995357|58940377|FG001|Period 5|Lack of Efficacy|0|||
30799437|NCT02890992|58814609|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
30799438|NCT02890992|58814610|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
30799439|NCT02890992|58814611|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
30799440|NCT02890992|58814612|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
30799441|NCT02890992|58814613|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
30905733|NCT01995357|58940378|FG002|Period 5|Lack of Efficacy|0|||
30905734|NCT01995357|58940379|FG003|Period 5|Lack of Efficacy|0|||
30622290|NCT03355300|58633934|FG000|Overall Study|Lack of Efficacy|2|||
30799442|NCT02890992|58814614|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
30905735|NCT01995357|58940380|FG004|Period 5|Lack of Efficacy|0|||
30905736|NCT01995357|58940381|FG005|Period 5|Lack of Efficacy|0|||
30905737|NCT01995357|58940376|FG000|Period 5|Adverse Event|1|||
30905738|NCT01995357|58940377|FG001|Period 5|Adverse Event|0|||
30799443|NCT02890992|58814607|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
30799444|NCT02890992|58814608|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
30905739|NCT01995357|58940378|FG002|Period 5|Adverse Event|1|||
30905740|NCT01995357|58940379|FG003|Period 5|Adverse Event|0|||
30905741|NCT01995357|58940380|FG004|Period 5|Adverse Event|0|||
30905742|NCT01995357|58940381|FG005|Period 5|Adverse Event|0|||
30905743|NCT01638559|58940397|FG000|Overall Study|Lost to Follow-up|1|||
30905744|NCT01638559|58940397|FG000|Overall Study|Withdrawal by Subject|1|||
30905745|NCT01638559|58940397|FG000|Overall Study|Subject declined to travel for biopsy|1|||
30905746|NCT01756456|58940418|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
30905747|NCT01756456|58940419|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
30799445|NCT02890992|58814609|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
30799446|NCT02890992|58814610|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
30799447|NCT02890992|58814611|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
30799448|NCT02890992|58814612|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
30799449|NCT02890992|58814613|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
30799450|NCT02890992|58814614|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
30799451|NCT02890992|58814607|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
30799452|NCT02890992|58814608|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
30799453|NCT02890992|58814609|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
30799454|NCT02890992|58814610|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
30799455|NCT02890992|58814611|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
30799456|NCT02890992|58814612|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
30799457|NCT02890992|58814613|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
30799458|NCT02890992|58814614|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
30799459|NCT03076190|58814659|FG000|Overall Study|Lost to Follow-up|9|||
30799460|NCT03076190|58814660|FG001|Overall Study|Lost to Follow-up|34|||
30799461|NCT03076190|58814659|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
30799462|NCT03076190|58814660|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
30799463|NCT03329196|58814671|FG000|Overall Study|Adverse Event|10|||
30799464|NCT03329196|58814672|FG001|Overall Study|Adverse Event|5|||
30799465|NCT03329196|58814671|FG000|Overall Study|Physician Decision|2|||
30799466|NCT03329196|58814672|FG001|Overall Study|Physician Decision|2|||
30799467|NCT03329196|58814671|FG000|Overall Study|Withdrawal by Subject|11|||
30799468|NCT03329196|58814672|FG001|Overall Study|Withdrawal by Subject|3|||
30905748|NCT01756456|58940420|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
30905749|NCT01756456|58940421|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
30905750|NCT01756456|58940422|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
30905751|NCT01756456|58940423|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
30905752|NCT01756456|58940418|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
30905753|NCT01756456|58940419|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
30905754|NCT01756456|58940420|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
30905755|NCT01756456|58940421|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
30905756|NCT01756456|58940422|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
30905757|NCT01756456|58940423|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
30905758|NCT01756456|58940418|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
30905759|NCT01756456|58940419|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
30746894|NCT00451451|58757145|FG001|Overall Study|Investigator Decision|2|||
30746895|NCT00451451|58757146|FG002|Overall Study|Investigator Decision|1|||
30746896|NCT00451451|58757147|FG003|Overall Study|Investigator Decision|2|||
30746897|NCT00451451|58757144|FG000|Overall Study|Subject Non-Compliance|8|||
30746898|NCT00451451|58757145|FG001|Overall Study|Subject Non-Compliance|4|||
30746899|NCT00451451|58757146|FG002|Overall Study|Subject Non-Compliance|3|||
30746900|NCT00451451|58757147|FG003|Overall Study|Subject Non-Compliance|3|||
30746901|NCT00451451|58757144|FG000|Overall Study|Death|1|||
30746902|NCT00451451|58757145|FG001|Overall Study|Death|0|||
30746903|NCT00451451|58757146|FG002|Overall Study|Death|0|||
30746904|NCT00451451|58757147|FG003|Overall Study|Death|1|||
30746905|NCT00451451|58757144|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
30746906|NCT00451451|58757145|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
30799469|NCT03329196|58814671|FG000|Overall Study|Hepatic function abnormalities|0|||
30905760|NCT01756456|58940420|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
30905761|NCT01756456|58940421|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
30746907|NCT00451451|58757146|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
30799470|NCT03329196|58814672|FG001|Overall Study|Hepatic function abnormalities|1|||
30905762|NCT01756456|58940422|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
30905763|NCT01756456|58940423|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
30746908|NCT00451451|58757147|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
30799471|NCT03329196|58814671|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
30799472|NCT03329196|58814672|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
30799473|NCT03329196|58814671|FG000|Overall Study|Difficult to control Hb|2|||
30799474|NCT03329196|58814672|FG001|Overall Study|Difficult to control Hb|3|||
30799475|NCT03329196|58814671|FG000|Overall Study|Dialysis or renal transplant|13|||
30799476|NCT03329196|58814672|FG001|Overall Study|Dialysis or renal transplant|15|||
30799477|NCT03328182|58814678|FG000|Overall Study|Withdrawal by Subject|1|||
30799478|NCT03328182|58814678|FG000|Overall Study|Protocol Violation|2|||
30799479|NCT03328182|58814678|FG000|Overall Study|No Product Evaluated|1|||
30799480|NCT03327402|58814682|FG000|Overall Study|Withdrawal by Subject|1|||
30799481|NCT03327402|58814682|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
30799482|NCT03075878|58814686|FG000|Overall Study|Physician Decision|1|||
30799483|NCT03326856|58814695|FG000|Overall Study|Lost to Follow-up|1|||
30799484|NCT03326856|58814696|FG001|Overall Study|Lost to Follow-up|1|||
30799485|NCT03326856|58814697|FG002|Overall Study|Lost to Follow-up|0|||
30799486|NCT03326856|58814698|FG003|Overall Study|Lost to Follow-up|0|||
30799487|NCT03326856|58814699|FG004|Overall Study|Lost to Follow-up|0|||
30799488|NCT03309696|58814713|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
30799489|NCT03309696|58814714|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
30799490|NCT03309696|58814715|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
30799491|NCT03309696|58814716|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
30799492|NCT03075644|58814730|FG000|Overall Study|Withdrawal by Subject|1|||
30799493|NCT03075644|58814731|FG001|Overall Study|Withdrawal by Subject|1|||
30799494|NCT03075410|58814747|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
30799495|NCT03075410|58814748|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
30799496|NCT03075410|58814749|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
30799497|NCT03075410|58814750|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
30799498|NCT03075410|58814751|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
30799499|NCT03075410|58814752|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
30799500|NCT03075410|58814753|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
30799501|NCT03075410|58814754|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
30799502|NCT03075410|58814755|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
30799503|NCT03075410|58814747|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
30799504|NCT03075410|58814748|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
30799505|NCT03075410|58814749|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
30799506|NCT03075410|58814750|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
30799507|NCT03075410|58814751|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
30799508|NCT03075410|58814752|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
30799509|NCT03075410|58814753|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
30799510|NCT03075410|58814754|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
30799511|NCT03075410|58814755|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
30799512|NCT03071276|58814797|FG000|Overall Study|Adverse Event|1|||
30799513|NCT03071276|58814797|FG000|Overall Study|Lack of Efficacy|14|||
30799514|NCT03074162|58814807|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
30905764|NCT01756456|58940418|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
30905765|NCT01756456|58940419|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
30905766|NCT01756456|58940420|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
30905767|NCT01756456|58940421|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
30905768|NCT01756456|58940422|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
30905769|NCT01756456|58940423|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
30905770|NCT01756456|58940418|FG000|Treatment Period: Phase I/II|Other causes|0|||
30905771|NCT01756456|58940419|FG001|Treatment Period: Phase I/II|Other causes|0|||
30905772|NCT01756456|58940420|FG002|Treatment Period: Phase I/II|Other causes|0|||
30799515|NCT03074162|58814808|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
30905773|NCT01756456|58940421|FG003|Treatment Period: Phase I/II|Other causes|1|||
30905774|NCT01756456|58940422|FG004|Treatment Period: Phase I/II|Other causes|2|||
30799516|NCT03074162|58814809|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
30799517|NCT03074162|58814810|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
30799518|NCT03074162|58814811|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
30799519|NCT03074162|58814812|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
30799520|NCT03074162|58814807|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
30799521|NCT03074162|58814808|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
30799522|NCT03074162|58814809|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
30799523|NCT03074162|58814810|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
30799524|NCT03074162|58814811|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
30799525|NCT03074162|58814812|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
30799526|NCT03074162|58814807|FG000|Period 3|Withdrawal by Subject|1|||
30799527|NCT03074162|58814808|FG001|Period 3|Withdrawal by Subject|0|||
30799528|NCT03074162|58814809|FG002|Period 3|Withdrawal by Subject|0|||
30799529|NCT03074162|58814810|FG003|Period 3|Withdrawal by Subject|0|||
30799530|NCT03074162|58814811|FG004|Period 3|Withdrawal by Subject|1|||
30799531|NCT03074162|58814812|FG005|Period 3|Withdrawal by Subject|0|||
30799532|NCT03070964|58814820|FG000|Overall Study|Progressive disease|8|||
30799533|NCT03070964|58814820|FG000|Overall Study|Treatment-unrelated adverse event|2|||
30799534|NCT03070964|58814820|FG000|Overall Study|Never treated|1|||
30799535|NCT03070964|58814820|FG000|Overall Study|Physician Decision|1|||
30799536|NCT03070964|58814820|FG000|Overall Study|Withdrawal by Subject|1|||
30799537|NCT03070964|58814820|FG000|Overall Study|Adverse Event|1|||
30799538|NCT04065074|58814824|FG000|Overall Study|Adverse Event|1|||
30799539|NCT04065074|58814824|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
30799540|NCT02888106|58814834|FG000|Overall Study|Withdrawal by Subject|1|||
30799541|NCT02888106|58814835|FG001|Overall Study|Withdrawal by Subject|2|||
30799542|NCT02888106|58814836|FG002|Overall Study|Withdrawal by Subject|0|||
30799543|NCT02888106|58814837|FG003|Overall Study|Withdrawal by Subject|1|||
30799544|NCT02888106|58814838|FG004|Overall Study|Withdrawal by Subject|0|||
30799545|NCT02888106|58814839|FG005|Overall Study|Withdrawal by Subject|0|||
30799546|NCT02888106|58814834|FG000|Overall Study|Lost to Follow-up|1|||
30799547|NCT02888106|58814835|FG001|Overall Study|Lost to Follow-up|0|||
30799548|NCT02888106|58814836|FG002|Overall Study|Lost to Follow-up|0|||
30799549|NCT02888106|58814837|FG003|Overall Study|Lost to Follow-up|1|||
30799550|NCT02888106|58814838|FG004|Overall Study|Lost to Follow-up|0|||
30799551|NCT02888106|58814839|FG005|Overall Study|Lost to Follow-up|1|||
30799552|NCT02888106|58814834|FG000|Overall Study|Adverse Event|2|||
30799553|NCT02888106|58814835|FG001|Overall Study|Adverse Event|0|||
30799554|NCT02888106|58814836|FG002|Overall Study|Adverse Event|0|||
30905775|NCT01756456|58940423|FG005|Treatment Period: Phase I/II|Other causes|2|||
30905776|NCT01756456|58940418|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
30905777|NCT01756456|58940419|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
30799555|NCT02888106|58814837|FG003|Overall Study|Adverse Event|0|||
30799556|NCT02888106|58814838|FG004|Overall Study|Adverse Event|0|||
30799557|NCT02888106|58814839|FG005|Overall Study|Adverse Event|0|||
30799558|NCT02888106|58814834|FG000|Overall Study|Withdrawal of consent|0|||
30799559|NCT02888106|58814835|FG001|Overall Study|Withdrawal of consent|0|||
30799560|NCT02888106|58814836|FG002|Overall Study|Withdrawal of consent|0|||
30799561|NCT02888106|58814837|FG003|Overall Study|Withdrawal of consent|0|||
30799562|NCT02888106|58814838|FG004|Overall Study|Withdrawal of consent|1|||
30799563|NCT02888106|58814839|FG005|Overall Study|Withdrawal of consent|0|||
30799564|NCT02888106|58814834|FG000|Overall Study|Pregnancy|1|||
30799565|NCT02888106|58814835|FG001|Overall Study|Pregnancy|0|||
30799566|NCT02888106|58814836|FG002|Overall Study|Pregnancy|0|||
30799567|NCT02888106|58814837|FG003|Overall Study|Pregnancy|0|||
30799568|NCT02888106|58814838|FG004|Overall Study|Pregnancy|0|||
30799569|NCT02888106|58814839|FG005|Overall Study|Pregnancy|0|||
30799570|NCT03793010|58814861|FG000|Overall Study|Withdrawal by Subject|5|||
30799571|NCT03793010|58814862|FG001|Overall Study|Withdrawal by Subject|7|||
30799572|NCT03793010|58814861|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
30799573|NCT03793010|58814862|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
30799574|NCT03793010|58814861|FG000|Overall Study|Lost to Follow-up|1|||
30799575|NCT03793010|58814862|FG001|Overall Study|Lost to Follow-up|2|||
30799576|NCT03793010|58814861|FG000|Overall Study|Patient couldn't sit still for injection|1|||
30799577|NCT03793010|58814862|FG001|Overall Study|Patient couldn't sit still for injection|0|||
30799578|NCT03793010|58814861|FG000|Overall Study|Withdrew to pursue other treatment|1|||
30799579|NCT03793010|58814862|FG001|Overall Study|Withdrew to pursue other treatment|0|||
30799580|NCT03793010|58814861|FG000|Overall Study|Did not meet eligibility criteria|1|||
30799581|NCT03793010|58814862|FG001|Overall Study|Did not meet eligibility criteria|0|||
30799582|NCT03304626|58814870|FG000|Overall Study|Adverse Event|1|||
30799583|NCT03304626|58814871|FG001|Overall Study|Adverse Event|0|||
30799584|NCT03304626|58814870|FG000|Overall Study|Lack of Efficacy|1|||
30799585|NCT03304626|58814871|FG001|Overall Study|Lack of Efficacy|1|||
30905778|NCT01756456|58940420|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
30905779|NCT01756456|58940421|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
30799586|NCT03274986|58814880|FG000|Overall Study|Withdrawal by Subject|0|||
30799587|NCT03274986|58814881|FG001|Overall Study|Withdrawal by Subject|1|||
30799588|NCT03274986|58814880|FG000|Overall Study|Lost to Follow-up|0|||
30799589|NCT03274986|58814881|FG001|Overall Study|Lost to Follow-up|1|||
30905780|NCT01756456|58940422|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
30905781|NCT01756456|58940423|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
30905782|NCT01756456|58940418|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
30905783|NCT01756456|58940419|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
30905784|NCT01756456|58940420|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
30905785|NCT01756456|58940421|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
30905786|NCT01756456|58940422|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
30905787|NCT01756456|58940423|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
30905788|NCT01756456|58940418|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
30905789|NCT01756456|58940419|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
30905790|NCT01756456|58940420|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
30905791|NCT01756456|58940421|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
30905792|NCT01756456|58940422|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
30905793|NCT01756456|58940423|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
30905794|NCT01756456|58940418|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
30905795|NCT01756456|58940419|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
30905796|NCT01756456|58940420|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
30905797|NCT01756456|58940421|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
30905798|NCT01756456|58940422|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
30905799|NCT01756456|58940423|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
30905800|NCT01756456|58940418|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
30905801|NCT01756456|58940419|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
30905802|NCT01756456|58940420|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
30905803|NCT01756456|58940421|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
30799590|NCT02919306|58814896|FG000|Overall Study|Withdrawal by Subject|1|||
30799591|NCT02919306|58814897|FG001|Overall Study|Withdrawal by Subject|0|||
30799592|NCT02919306|58814896|FG000|Overall Study|Protocol Violation|1|||
30799593|NCT02919306|58814897|FG001|Overall Study|Protocol Violation|0|||
30799594|NCT03274440|58814903|FG000|Overall Study|Time commitment too great|1|||
30799595|NCT03274440|58814904|FG001|Overall Study|Time commitment too great|0|||
30799596|NCT03274440|58814905|FG002|Overall Study|Time commitment too great|0|||
30799597|NCT03274440|58814906|FG003|Overall Study|Time commitment too great|1|||
30799598|NCT03274440|58814907|FG004|Overall Study|Time commitment too great|0|||
30799599|NCT03274440|58814908|FG005|Overall Study|Time commitment too great|0|||
30799600|NCT03268746|58814916|FG000|Overall Study|Withdrawal by Subject|1|||
30799601|NCT03268590|58814927|FG000|Overall Study|Previously unknown exclusion criteria|1|||
30799602|NCT03267576|58814936|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
30799603|NCT03267576|58814937|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
30799604|NCT03267576|58814936|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
30799605|NCT03267576|58814937|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
30799606|NCT03267264|58814947|FG000|Overall Study|Withdrawal by Subject|1|||
30905804|NCT01756456|58940422|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
30905805|NCT01756456|58940423|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
30905806|NCT01756456|58940418|FG000|Follow Up Period Phase I/II|Other causes|0|||
30905807|NCT01756456|58940419|FG001|Follow Up Period Phase I/II|Other causes|0|||
30905808|NCT01756456|58940420|FG002|Follow Up Period Phase I/II|Other causes|0|||
30905809|NCT01756456|58940421|FG003|Follow Up Period Phase I/II|Other causes|1|||
30905810|NCT01756456|58940422|FG004|Follow Up Period Phase I/II|Other causes|3|||
30905811|NCT01756456|58940423|FG005|Follow Up Period Phase I/II|Other causes|5|||
30905812|NCT01756300|58940446|FG000|Overall Study|Death|1|||
30905813|NCT01756300|58940446|FG000|Overall Study|Withdrawal by Subject|1|||
30905814|NCT01995201|58940469|FG000|From Baseline Until Week 24|Adverse Event|4|||
30905815|NCT01995201|58940470|FG001|From Baseline Until Week 24|Adverse Event|15|||
30905816|NCT01995201|58940471|FG002|From Baseline Until Week 24|Adverse Event|0|||
30905817|NCT01995201|58940472|FG003|From Baseline Until Week 24|Adverse Event|0|||
30905818|NCT01995201|58940473|FG004|From Baseline Until Week 24|Adverse Event|0|||
30905819|NCT01995201|58940474|FG005|From Baseline Until Week 24|Adverse Event|0|||
30746909|NCT03824912|58757162|FG000|Overall Study|Lost to Follow-up|18|||
30746910|NCT03824912|58757163|FG001|Overall Study|Lost to Follow-up|15|||
30746911|NCT03824912|58757164|FG002|Overall Study|Lost to Follow-up|8|||
30746912|NCT03824912|58757162|FG000|Overall Study|Negative Baseline Culture Result|118|||
30746913|NCT03824912|58757163|FG001|Overall Study|Negative Baseline Culture Result|112|||
30746914|NCT03824912|58757164|FG002|Overall Study|Negative Baseline Culture Result|57|||
30746915|NCT03824912|58757162|FG000|Overall Study|Non-Compliance with Study Drug|0|||
30746916|NCT03824912|58757163|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30746917|NCT03824912|58757164|FG002|Overall Study|Non-Compliance with Study Drug|1|||
30746918|NCT03824912|58757162|FG000|Overall Study|Protocol Violation|1|||
30746919|NCT03824912|58757163|FG001|Overall Study|Protocol Violation|4|||
30746920|NCT03824912|58757164|FG002|Overall Study|Protocol Violation|1|||
30746921|NCT03824912|58757162|FG000|Overall Study|Withdrawal by Subject|3|||
30746922|NCT03824912|58757163|FG001|Overall Study|Withdrawal by Subject|2|||
30746923|NCT03824912|58757164|FG002|Overall Study|Withdrawal by Subject|1|||
30746924|NCT03824912|58757162|FG000|Overall Study|Participation in another study|0|||
30746925|NCT03824912|58757163|FG001|Overall Study|Participation in another study|1|||
30746926|NCT03824912|58757164|FG002|Overall Study|Participation in another study|0|||
30746927|NCT00461123|58757174|FG000|Overall Study|Adverse Event|1|||
30746928|NCT00461123|58757175|FG001|Overall Study|Adverse Event|0|||
30746929|NCT00461123|58757174|FG000|Overall Study|Lost to Follow-up|1|||
30746930|NCT00461123|58757175|FG001|Overall Study|Lost to Follow-up|1|||
30746931|NCT00461123|58757174|FG000|Overall Study|Protocol Violation|3|||
30746932|NCT00461123|58757175|FG001|Overall Study|Protocol Violation|2|||
30746933|NCT00461123|58757174|FG000|Overall Study|Withdrawal by Subject|1|||
30746934|NCT00461123|58757175|FG001|Overall Study|Withdrawal by Subject|3|||
30746935|NCT00290342|58757183|FG000|Overall Study|Other|0|||
30746936|NCT00290342|58757184|FG001|Overall Study|Other|1|||
30746937|NCT00290342|58757183|FG000|Overall Study|Withdrawal by Subject|6|||
30746938|NCT00290342|58757184|FG001|Overall Study|Withdrawal by Subject|4|||
30746939|NCT00290342|58757183|FG000|Overall Study|Lost to Follow-up|1|||
30746940|NCT00290342|58757184|FG001|Overall Study|Lost to Follow-up|0|||
30746941|NCT00460811|58757195|FG000|Overall Study|Adverse Event|4|||
30746942|NCT00460811|58757196|FG001|Overall Study|Adverse Event|6|||
30746943|NCT00460811|58757197|FG002|Overall Study|Adverse Event|3|||
30746944|NCT00460811|58757198|FG003|Overall Study|Adverse Event|10|||
30746945|NCT00460811|58757199|FG004|Overall Study|Adverse Event|2|||
30746946|NCT00460811|58757195|FG000|Overall Study|Noncompliance|1|||
30746947|NCT00460811|58757196|FG001|Overall Study|Noncompliance|0|||
30746948|NCT00460811|58757197|FG002|Overall Study|Noncompliance|0|||
30746949|NCT00460811|58757198|FG003|Overall Study|Noncompliance|2|||
30746950|NCT00460811|58757199|FG004|Overall Study|Noncompliance|1|||
30746951|NCT00460811|58757195|FG000|Overall Study|Withdrawal by Subject|7|||
30746952|NCT00460811|58757196|FG001|Overall Study|Withdrawal by Subject|7|||
30746953|NCT00460811|58757197|FG002|Overall Study|Withdrawal by Subject|6|||
30746954|NCT00460811|58757198|FG003|Overall Study|Withdrawal by Subject|3|||
30746955|NCT00460811|58757199|FG004|Overall Study|Withdrawal by Subject|11|||
30746956|NCT00460811|58757195|FG000|Overall Study|Physician Decision|1|||
30799607|NCT03267264|58814948|FG001|Overall Study|Withdrawal by Subject|0|||
30799608|NCT03267264|58814949|FG002|Overall Study|Withdrawal by Subject|2|||
30905820|NCT01995201|58940475|FG006|From Baseline Until Week 24|Adverse Event|0|||
30905821|NCT01995201|58940469|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
30905822|NCT01995201|58940470|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
30799609|NCT03267264|58814950|FG003|Overall Study|Withdrawal by Subject|4|||
30799610|NCT03244800|58814967|FG000|Overall Study|Adverse Event|0|||
30799611|NCT03244800|58814968|FG001|Overall Study|Adverse Event|1|||
30799612|NCT03244800|58814969|FG002|Overall Study|Adverse Event|0|||
30799613|NCT03244800|58814970|FG003|Overall Study|Adverse Event|1|||
30799614|NCT03244800|58814967|FG000|Overall Study|Withdrew treatment|0|||
30799615|NCT03244800|58814968|FG001|Overall Study|Withdrew treatment|0|||
30799616|NCT03244800|58814969|FG002|Overall Study|Withdrew treatment|0|||
30799617|NCT03244800|58814970|FG003|Overall Study|Withdrew treatment|1|||
30799618|NCT04516291|58814991|FG000|Treatment Period (24 Weeks)|Other|1|||
30799619|NCT04516291|58814992|FG001|Treatment Period (24 Weeks)|Other|0|||
30799620|NCT04516291|58814993|FG002|Treatment Period (24 Weeks)|Other|0|||
30799621|NCT04516291|58814994|FG003|Treatment Period (24 Weeks)|Other|2|||
30799622|NCT04516291|58814995|FG004|Treatment Period (24 Weeks)|Other|2|||
30799623|NCT04516291|58814996|FG005|Treatment Period (24 Weeks)|Other|4|||
30799624|NCT04516291|58814997|FG006|Treatment Period (24 Weeks)|Other|2|||
30799625|NCT04516291|58814998|FG007|Treatment Period (24 Weeks)|Other|0|||
30799626|NCT04516291|58814991|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
30799627|NCT04516291|58814992|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
30799628|NCT04516291|58814993|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
30799629|NCT04516291|58814994|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
30799630|NCT04516291|58814995|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
30799631|NCT04516291|58814996|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
30799632|NCT04516291|58814997|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
30799633|NCT04516291|58814998|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
30799634|NCT04516291|58814991|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
30799635|NCT04516291|58814992|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
30799636|NCT04516291|58814993|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
30799637|NCT04516291|58814994|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
30799638|NCT04516291|58814995|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
30799639|NCT04516291|58814996|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
30799640|NCT04516291|58814997|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
30799641|NCT04516291|58814998|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
30799642|NCT04516291|58814991|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30799643|NCT04516291|58814992|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
30799644|NCT04516291|58814993|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30799645|NCT04516291|58814994|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30799646|NCT04516291|58814995|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30799647|NCT04516291|58814996|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30799648|NCT04516291|58814997|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30799649|NCT04516291|58814998|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30799650|NCT04516291|58814991|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
30799651|NCT04516291|58814992|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
30799652|NCT04516291|58814993|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
30746957|NCT00460811|58757196|FG001|Overall Study|Physician Decision|0|||
30746958|NCT00460811|58757197|FG002|Overall Study|Physician Decision|0|||
30746959|NCT00460811|58757198|FG003|Overall Study|Physician Decision|0|||
30746960|NCT00460811|58757199|FG004|Overall Study|Physician Decision|0|||
30746961|NCT00460811|58757195|FG000|Overall Study|Lost to Follow-up|3|||
30746962|NCT00460811|58757196|FG001|Overall Study|Lost to Follow-up|2|||
30746963|NCT00460811|58757197|FG002|Overall Study|Lost to Follow-up|5|||
30746964|NCT00460811|58757198|FG003|Overall Study|Lost to Follow-up|3|||
30746965|NCT00460811|58757199|FG004|Overall Study|Lost to Follow-up|6|||
30746966|NCT00290186|58757218|FG000|Overall Study|Adverse Event|1|||
30746967|NCT00290186|58757219|FG001|Overall Study|Adverse Event|1|||
30746968|NCT00290186|58757218|FG000|Overall Study|Lost to Follow-up|3|||
30746969|NCT00290186|58757219|FG001|Overall Study|Lost to Follow-up|2|||
30746970|NCT00290186|58757218|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
30746971|NCT00290186|58757219|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
30746972|NCT00290186|58757218|FG000|Overall Study|Withdrawal by Subject|0|||
30746973|NCT00290186|58757219|FG001|Overall Study|Withdrawal by Subject|1|||
30746974|NCT00460655|58757229|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
30746975|NCT00460655|58757230|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
30746976|NCT00460655|58757231|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
30746977|NCT00460655|58757232|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
30746978|NCT00460655|58757229|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
30799653|NCT04516291|58814994|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
30799654|NCT04516291|58814995|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
30799655|NCT04516291|58814996|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
30799656|NCT04516291|58814997|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
30799657|NCT04516291|58814998|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
30799658|NCT04516291|58814991|FG000|Follow-up Period (12 Weeks)|Other|0|||
30799659|NCT04516291|58814992|FG001|Follow-up Period (12 Weeks)|Other|1|||
30799660|NCT04516291|58814993|FG002|Follow-up Period (12 Weeks)|Other|0|||
30799661|NCT04516291|58814994|FG003|Follow-up Period (12 Weeks)|Other|2|||
30799662|NCT04516291|58814995|FG004|Follow-up Period (12 Weeks)|Other|0|||
30905823|NCT01995201|58940471|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
30905824|NCT01995201|58940472|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
30905825|NCT01995201|58940473|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
30905826|NCT01995201|58940474|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
30905827|NCT01995201|58940475|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
30905828|NCT01995201|58940469|FG000|From Baseline Until Week 24|Death|0|||
30905829|NCT01995201|58940470|FG001|From Baseline Until Week 24|Death|1|||
30905830|NCT01995201|58940471|FG002|From Baseline Until Week 24|Death|0|||
30905831|NCT01995201|58940472|FG003|From Baseline Until Week 24|Death|0|||
30905832|NCT01995201|58940473|FG004|From Baseline Until Week 24|Death|0|||
30905833|NCT01995201|58940474|FG005|From Baseline Until Week 24|Death|0|||
30905834|NCT01995201|58940475|FG006|From Baseline Until Week 24|Death|0|||
30905835|NCT01995201|58940469|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
30905836|NCT01995201|58940470|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
30905837|NCT01995201|58940471|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
30905838|NCT01995201|58940472|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
30905839|NCT01995201|58940473|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
30799663|NCT04516291|58814996|FG005|Follow-up Period (12 Weeks)|Other|0|||
30799664|NCT04516291|58814997|FG006|Follow-up Period (12 Weeks)|Other|0|||
30799665|NCT04516291|58814998|FG007|Follow-up Period (12 Weeks)|Other|0|||
30799666|NCT04516291|58814991|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
30799667|NCT04516291|58814992|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
30799668|NCT04516291|58814993|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
30799669|NCT04516291|58814994|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
30799670|NCT04516291|58814995|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
30799671|NCT04516291|58814996|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
30799672|NCT04516291|58814997|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
30799673|NCT04516291|58814998|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
30799674|NCT04516291|58814991|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
30799675|NCT04516291|58814992|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
30799676|NCT04516291|58814993|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
30799677|NCT04516291|58814994|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
30799678|NCT04516291|58814995|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
30799679|NCT04516291|58814996|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
30799680|NCT04516291|58814997|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
30799681|NCT04516291|58814998|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
30799682|NCT03243630|58815016|FG000|Overall Study|Protocol Violation|1|||
30799683|NCT03243630|58815016|FG000|Overall Study|Physician Decision|1|||
30799684|NCT04450381|58815024|FG000|Overall Study|Protocol Violation|4|||
30799685|NCT04450381|58815024|FG000|Overall Study|Wrong device setting|2|||
30799686|NCT03068468|58815030|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
30799687|NCT03068468|58815031|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
30799688|NCT03068468|58815032|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
30799689|NCT03068468|58815033|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
30799690|NCT03068468|58815030|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
30799691|NCT03068468|58815031|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
30799692|NCT03068468|58815032|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
30799693|NCT03068468|58815033|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
30799694|NCT03068468|58815030|FG000|Placebo-Controlled Period|Adverse Event|16|||
30799695|NCT03068468|58815031|FG001|Placebo-Controlled Period|Adverse Event|21|||
30799696|NCT03068468|58815032|FG002|Placebo-Controlled Period|Adverse Event|0|||
30799697|NCT03068468|58815033|FG003|Placebo-Controlled Period|Adverse Event|0|||
30799698|NCT03068468|58815030|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
30799699|NCT03068468|58815031|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
30799700|NCT03068468|58815032|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
30799701|NCT03068468|58815033|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
30799702|NCT03068468|58815030|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
30799703|NCT03068468|58815031|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
30799704|NCT03068468|58815032|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
30905840|NCT01995201|58940474|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
30905841|NCT01995201|58940475|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
30799705|NCT03068468|58815033|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
30799706|NCT03068468|58815030|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
30799707|NCT03068468|58815031|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
30799708|NCT03068468|58815032|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
30799709|NCT03068468|58815033|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
30799710|NCT03068468|58815030|FG000|Placebo-Controlled Period|Death|0|||
30799711|NCT03068468|58815031|FG001|Placebo-Controlled Period|Death|1|||
30799712|NCT03068468|58815032|FG002|Placebo-Controlled Period|Death|0|||
30799713|NCT03068468|58815033|FG003|Placebo-Controlled Period|Death|0|||
30799714|NCT03068468|58815030|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
30799715|NCT03068468|58815031|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
30799716|NCT03068468|58815032|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
30799717|NCT03068468|58815033|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
30799718|NCT03068468|58815030|FG000|Open-Label Extension Period|Adverse Event|0|||
30799719|NCT03068468|58815031|FG001|Open-Label Extension Period|Adverse Event|0|||
30799720|NCT03068468|58815032|FG002|Open-Label Extension Period|Adverse Event|13|||
30799721|NCT03068468|58815033|FG003|Open-Label Extension Period|Adverse Event|17|||
30799722|NCT03068468|58815030|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
30799723|NCT03068468|58815031|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
30799724|NCT03068468|58815032|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
30799725|NCT03068468|58815033|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
30799726|NCT03068468|58815030|FG000|Open-Label Extension Period|Death|0|||
30799727|NCT03068468|58815031|FG001|Open-Label Extension Period|Death|0|||
30799728|NCT03068468|58815032|FG002|Open-Label Extension Period|Death|0|||
30799729|NCT03068468|58815033|FG003|Open-Label Extension Period|Death|1|||
30799730|NCT03068468|58815030|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
30799731|NCT03068468|58815031|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
30799732|NCT03068468|58815032|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
30799733|NCT03068468|58815033|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
30799734|NCT03068468|58815030|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
30799735|NCT03068468|58815031|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
30799736|NCT03068468|58815032|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
30799737|NCT03068468|58815033|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
30799738|NCT03068468|58815030|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
30799739|NCT03068468|58815031|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
30799740|NCT03068468|58815032|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
30799741|NCT03068468|58815033|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
30799742|NCT03068468|58815030|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
30799743|NCT03068468|58815031|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
30799744|NCT03068468|58815032|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
30799745|NCT03068468|58815033|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
30799746|NCT03068468|58815030|FG000|Open-Label Extension Period|Reason not Specified|0|||
30799747|NCT03068468|58815031|FG001|Open-Label Extension Period|Reason not Specified|0|||
30799748|NCT03068468|58815032|FG002|Open-Label Extension Period|Reason not Specified|1|||
30799749|NCT03068468|58815033|FG003|Open-Label Extension Period|Reason not Specified|4|||
30799750|NCT04512001|58815043|FG000|Week 0 to Week 24|Adverse Event|14|||
30799751|NCT04512001|58815044|FG001|Week 0 to Week 24|Adverse Event|10|||
30799752|NCT04512001|58815045|FG002|Week 0 to Week 24|Adverse Event|0|||
30799753|NCT04512001|58815046|FG003|Week 0 to Week 24|Adverse Event|0|||
30799754|NCT04512001|58815047|FG004|Week 0 to Week 24|Adverse Event|0|||
30799755|NCT04512001|58815043|FG000|Week 0 to Week 24|Death|0|||
30799756|NCT04512001|58815044|FG001|Week 0 to Week 24|Death|2|||
30799757|NCT04512001|58815045|FG002|Week 0 to Week 24|Death|0|||
30799758|NCT04512001|58815046|FG003|Week 0 to Week 24|Death|0|||
30799759|NCT04512001|58815047|FG004|Week 0 to Week 24|Death|0|||
30799760|NCT04512001|58815043|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
30799761|NCT04512001|58815044|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
30799762|NCT04512001|58815045|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
30799763|NCT04512001|58815046|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
30799764|NCT04512001|58815047|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
30799765|NCT04512001|58815043|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
30799766|NCT04512001|58815044|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
30799767|NCT04512001|58815045|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
30799768|NCT04512001|58815046|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
30799769|NCT04512001|58815047|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
30799770|NCT04512001|58815043|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
30799771|NCT04512001|58815044|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
30799772|NCT04512001|58815045|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
30799773|NCT04512001|58815046|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
30799774|NCT04512001|58815047|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
30799775|NCT04512001|58815043|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
30799776|NCT04512001|58815044|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
30799777|NCT04512001|58815045|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
30799778|NCT04512001|58815046|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
30799779|NCT04512001|58815047|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
30799780|NCT04512001|58815043|FG000|Week 24 to Week 63|Adverse Event|0|||
30799781|NCT04512001|58815044|FG001|Week 24 to Week 63|Adverse Event|0|||
30799782|NCT04512001|58815045|FG002|Week 24 to Week 63|Adverse Event|13|||
30799783|NCT04512001|58815046|FG003|Week 24 to Week 63|Adverse Event|8|||
30799784|NCT04512001|58815047|FG004|Week 24 to Week 63|Adverse Event|6|||
30799785|NCT04512001|58815043|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
30799786|NCT04512001|58815044|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
30799787|NCT04512001|58815045|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
30799788|NCT04512001|58815046|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
30799789|NCT04512001|58815047|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
30799790|NCT04512001|58815043|FG000|Week 24 to Week 63|Death|0|||
30799791|NCT04512001|58815044|FG001|Week 24 to Week 63|Death|0|||
30799792|NCT04512001|58815045|FG002|Week 24 to Week 63|Death|0|||
30799793|NCT04512001|58815046|FG003|Week 24 to Week 63|Death|1|||
30799794|NCT04512001|58815047|FG004|Week 24 to Week 63|Death|1|||
30799795|NCT04512001|58815043|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
30799796|NCT04512001|58815044|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
30799797|NCT04512001|58815045|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
30799798|NCT04512001|58815046|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
30799799|NCT04512001|58815047|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
30799800|NCT04512001|58815043|FG000|Week 24 to Week 63|Miscellaneous|0|||
30799801|NCT04512001|58815044|FG001|Week 24 to Week 63|Miscellaneous|0|||
30799802|NCT04512001|58815045|FG002|Week 24 to Week 63|Miscellaneous|3|||
30799803|NCT04512001|58815046|FG003|Week 24 to Week 63|Miscellaneous|2|||
30799804|NCT04512001|58815047|FG004|Week 24 to Week 63|Miscellaneous|1|||
30799805|NCT04447417|58815062|FG000|Overall Study|Withdrawal by Subject|1|||
30799806|NCT04447417|58815063|FG001|Overall Study|Withdrawal by Subject|0|||
30799807|NCT04447417|58815062|FG000|Overall Study|Failure to meet inclusion criteria|1|||
30799808|NCT04447417|58815063|FG001|Overall Study|Failure to meet inclusion criteria|0|||
30799809|NCT04447417|58815062|FG000|Overall Study|Lost to Follow-up|1|||
30799810|NCT04447417|58815063|FG001|Overall Study|Lost to Follow-up|0|||
30799811|NCT02787044|58815071|FG000|Overall Study|Lost to Follow-up|15|||
30799812|NCT02787044|58815072|FG001|Overall Study|Lost to Follow-up|19|||
30799813|NCT01345019|58815084|FG000|Blinded Treatment Phase|Death|147|||
30799814|NCT01345019|58815085|FG001|Blinded Treatment Phase|Death|137|||
30799815|NCT01345019|58815084|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
30799816|NCT01345019|58815085|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
30799817|NCT01345019|58815084|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
30799818|NCT01345019|58815085|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
30799819|NCT01345019|58815084|FG000|Blinded Treatment Phase|Disease Progression|12|||
30799820|NCT01345019|58815085|FG001|Blinded Treatment Phase|Disease Progression|10|||
30799821|NCT01345019|58815084|FG000|Blinded Treatment Phase|Adverse Event|6|||
30799822|NCT01345019|58815085|FG001|Blinded Treatment Phase|Adverse Event|13|||
30799823|NCT01345019|58815084|FG000|Blinded Treatment Phase|Administrative Decision|10|||
30799824|NCT01345019|58815085|FG001|Blinded Treatment Phase|Administrative Decision|8|||
30799825|NCT01345019|58815084|FG000|Blinded Treatment Phase|Noncompliance|5|||
30799826|NCT01345019|58815085|FG001|Blinded Treatment Phase|Noncompliance|3|||
30799827|NCT01345019|58815084|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
30799828|NCT01345019|58815085|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
30799829|NCT01345019|58815084|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
30799830|NCT01345019|58815085|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
30799831|NCT01345019|58815084|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
30799832|NCT01345019|58815085|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
30799833|NCT01345019|58815084|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
30799834|NCT01345019|58815085|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
30799835|NCT01345019|58815084|FG000|Open Label Treatment Phase|Death|49|||
30799836|NCT01345019|58815085|FG001|Open Label Treatment Phase|Death|48|||
30799837|NCT01345019|58815084|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
30799838|NCT01345019|58815085|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
30799839|NCT01345019|58815084|FG000|Open Label Treatment Phase|Adverse Event|30|||
30799840|NCT01345019|58815085|FG001|Open Label Treatment Phase|Adverse Event|51|||
30799841|NCT01345019|58815084|FG000|Open Label Treatment Phase|Administrative Decision|30|||
30799842|NCT01345019|58815085|FG001|Open Label Treatment Phase|Administrative Decision|15|||
30799843|NCT01345019|58815084|FG000|Open Label Treatment Phase|Disease Progression|17|||
30799844|NCT01345019|58815085|FG001|Open Label Treatment Phase|Disease Progression|18|||
30799845|NCT01345019|58815084|FG000|Open Label Treatment Phase|Noncompliance|5|||
30799846|NCT01345019|58815085|FG001|Open Label Treatment Phase|Noncompliance|4|||
30799847|NCT01345019|58815084|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
30799848|NCT01345019|58815085|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
30799849|NCT01345019|58815084|FG000|Open Label Treatment Phase|Pregnancy|1|||
30799850|NCT01345019|58815085|FG001|Open Label Treatment Phase|Pregnancy|0|||
30799851|NCT01345019|58815084|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
30799852|NCT01345019|58815085|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
30799853|NCT01345019|58815084|FG000|Open Label Treatment Phase|Protocol Violation|0|||
30799854|NCT01345019|58815085|FG001|Open Label Treatment Phase|Protocol Violation|1|||
30799855|NCT04507867|58815095|FG000|Overall Study|Death|7|||
30799856|NCT04507867|58815096|FG001|Overall Study|Death|1|||
30799857|NCT03069716|58815120|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
30799858|NCT03069716|58815121|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
30799859|NCT03069716|58815122|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
30799860|NCT03069716|58815120|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
30799861|NCT03069716|58815121|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
30799862|NCT03069716|58815122|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
30799863|NCT03069716|58815120|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
30799864|NCT03069716|58815121|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
30746979|NCT00460655|58757230|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
30746980|NCT00460655|58757231|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
30746981|NCT00460655|58757232|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
30746982|NCT00460655|58757229|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
30746983|NCT00460655|58757230|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
30746984|NCT00460655|58757231|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
30746985|NCT00460655|58757232|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
30746986|NCT00460655|58757229|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
30746987|NCT00460655|58757230|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
30746988|NCT00460655|58757231|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
30746989|NCT00460655|58757232|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
30746990|NCT00460655|58757229|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
30746991|NCT00460655|58757230|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
30746992|NCT00460655|58757231|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
30746993|NCT00460655|58757232|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
30746994|NCT00460655|58757229|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
30746995|NCT00460655|58757230|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
30746996|NCT00460655|58757231|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
30746997|NCT00460655|58757232|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
30746998|NCT00460577|58757244|FG000|Overall Study|Protocol Violation|2|||
30746999|NCT00460577|58757245|FG001|Overall Study|Protocol Violation|6|||
30747000|NCT00289016|58757251|FG000|Overall Study|Disease Progression|29|||
30747001|NCT00289016|58757251|FG000|Overall Study|Death|2|||
30747002|NCT00289016|58757251|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
30747003|NCT00289016|58757251|FG000|Overall Study|Withdrawal by Subject|2|||
30747004|NCT00289016|58757251|FG000|Overall Study|Adverse Event|1|||
30747005|NCT00289016|58757251|FG000|Overall Study|Other|1|||
30747006|NCT00288860|58757257|FG000|Overall Study|Did not complete intake|4|||
30747007|NCT00288860|58757258|FG001|Overall Study|Did not complete intake|8|||
30747008|NCT00288860|58757257|FG000|Overall Study|Death|4|||
30747009|NCT00288860|58757258|FG001|Overall Study|Death|3|||
30747010|NCT00288860|58757257|FG000|Overall Study|Withdrawal by Subject|20|||
30799865|NCT03069716|58815122|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
30799866|NCT03069716|58815120|FG000|Randomized Treatment|Withdrawal by Subject|0|||
30799867|NCT03069716|58815121|FG001|Randomized Treatment|Withdrawal by Subject|2|||
30747011|NCT00288860|58757258|FG001|Overall Study|Withdrawal by Subject|15|||
30799868|NCT03069716|58815122|FG002|Randomized Treatment|Withdrawal by Subject|0|||
30799869|NCT03693625|58815135|FG000|Overall Study|Adverse Event|2|||
30799870|NCT03693625|58815136|FG001|Overall Study|Adverse Event|0|||
30799871|NCT03693625|58815135|FG000|Overall Study|Study Terminated By Sponsor|20|||
30799872|NCT03693625|58815136|FG001|Overall Study|Study Terminated By Sponsor|7|||
30799873|NCT03693625|58815135|FG000|Overall Study|Withdrawal by Subject|1|||
30799874|NCT03693625|58815136|FG001|Overall Study|Withdrawal by Subject|1|||
30799875|NCT01265537|58815144|FG000|Overall Study|Adverse Event|2|||
30799876|NCT01265537|58815145|FG001|Overall Study|Adverse Event|1|||
30799877|NCT01265537|58815144|FG000|Overall Study|Physician Decision|0|||
30799878|NCT01265537|58815145|FG001|Overall Study|Physician Decision|1|||
30799879|NCT04396639|58815151|FG000|Overall Study|Withdrawal by Subject|1|||
30799880|NCT04396639|58815151|FG000|Overall Study|Other|1|||
30799881|NCT04432298|58815157|FG000|Overall Study|Other than specified|1|||
30799882|NCT04432298|58815158|FG001|Overall Study|Other than specified|0|||
30799883|NCT04432298|58815157|FG000|Overall Study|Lost to Follow-up|0|||
30799884|NCT04432298|58815158|FG001|Overall Study|Lost to Follow-up|1|||
30799885|NCT04432298|58815157|FG000|Overall Study|Death|3|||
30799886|NCT04432298|58815158|FG001|Overall Study|Death|2|||
30799887|NCT04432298|58815157|FG000|Overall Study|Withdrawal by Subject|2|||
30799888|NCT04432298|58815158|FG001|Overall Study|Withdrawal by Subject|0|||
30799889|NCT04167085|58815166|FG000|Baseline|Withdrawal by Subject|2|||
30799890|NCT04167085|58815167|FG001|Baseline|Withdrawal by Subject|1|||
30799891|NCT04167085|58815166|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
30799892|NCT04167085|58815167|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
30799893|NCT04162795|58815173|FG000|Overall Study|Other|16|||
30799894|NCT04162795|58815173|FG000|Overall Study|Screen failures|10|||
30799895|NCT03069482|58815179|FG000|Overall Study|Lost to Follow-up|0|||
30799896|NCT03069482|58815180|FG001|Overall Study|Lost to Follow-up|1|||
30799897|NCT03069482|58815179|FG000|Overall Study|Physician Decision|1|||
30799898|NCT03069482|58815180|FG001|Overall Study|Physician Decision|0|||
30747012|NCT00288860|58757257|FG000|Overall Study|Lost to Follow-up|74|||
30747013|NCT00288860|58757258|FG001|Overall Study|Lost to Follow-up|71|||
30747014|NCT00288704|58757270|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
30747015|NCT00288704|58757271|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
30747016|NCT00288704|58757272|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
30799899|NCT03266172|58815192|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
30799900|NCT03266172|58815193|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
30799901|NCT03266172|58815194|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
30799902|NCT03266172|58815192|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
30799903|NCT03266172|58815193|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
30799904|NCT03266172|58815194|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
30799905|NCT03266172|58815192|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
30799906|NCT03266172|58815193|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
30799907|NCT03266172|58815194|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
30799908|NCT03266172|58815192|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
30799909|NCT03266172|58815193|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
30747017|NCT00288704|58757270|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
30747018|NCT00288704|58757271|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
30747019|NCT00288704|58757272|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
30747020|NCT00288704|58757270|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
30747021|NCT00288704|58757271|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
30747022|NCT00288704|58757272|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
30747023|NCT00288704|58757270|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
30747024|NCT00288704|58757271|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
30747025|NCT00288704|58757272|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
30747026|NCT00288704|58757270|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
30747027|NCT00288704|58757271|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
30747028|NCT00288704|58757272|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
30747029|NCT00288704|58757270|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
30747030|NCT00288704|58757271|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
30799910|NCT03266172|58815194|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
30799911|NCT03266172|58815192|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
30799912|NCT03266172|58815193|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
30799913|NCT03266172|58815194|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
30747031|NCT00288704|58757272|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
30747032|NCT00288704|58757270|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
30747033|NCT00288704|58757271|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
30747034|NCT00288704|58757272|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
30747035|NCT00288626|58757279|FG000|Overall Study|Death|3|||
30747036|NCT00288626|58757279|FG000|Overall Study|Withdrawal by Subject|4|||
30747037|NCT00087490|58757287|FG000|Overall Study|Death|6|||
30747038|NCT00087490|58757288|FG001|Overall Study|Death|4|||
30747039|NCT00087490|58757287|FG000|Overall Study|Adverse Event|3|||
30747040|NCT00087490|58757288|FG001|Overall Study|Adverse Event|8|||
30747041|NCT00087490|58757287|FG000|Overall Study|Lack of Efficacy|0|||
30747042|NCT00087490|58757288|FG001|Overall Study|Lack of Efficacy|2|||
30747043|NCT00087490|58757287|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
30747044|NCT00087490|58757288|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
30747045|NCT00087490|58757287|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
30747046|NCT00087490|58757288|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
30747047|NCT00087490|58757287|FG000|Overall Study|Randomized but not treated|7|||
30747048|NCT00087490|58757288|FG001|Overall Study|Randomized but not treated|18|||
30747049|NCT00087178|58757296|FG000|Overall Study|No follow up data|5|||
30747050|NCT00087178|58757297|FG001|Overall Study|No follow up data|15|||
30799914|NCT03266172|58815192|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
30799915|NCT03266172|58815193|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
30799916|NCT03266172|58815194|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
30799917|NCT04356937|58815246|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
30799918|NCT04356937|58815247|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
30622291|NCT03355300|58633935|FG001|Overall Study|Lack of Efficacy|1|||
30622292|NCT03355300|58633934|FG000|Overall Study|Other reason|1|||
30799919|NCT03301740|58815259|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
30799920|NCT03301740|58815260|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
30799921|NCT03301740|58815259|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
30799922|NCT03301740|58815260|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
30799923|NCT04355767|58815268|FG000|Overall Study|Withdrawal by Subject|2|||
30799924|NCT04355767|58815269|FG001|Overall Study|Withdrawal by Subject|2|||
30799925|NCT04355767|58815268|FG000|Overall Study|Death|5|||
30799926|NCT04355767|58815269|FG001|Overall Study|Death|1|||
30799927|NCT00882050|58815278|FG000|Overall Study|Physician Decision|1|||
30799928|NCT00882050|58815279|FG001|Overall Study|Physician Decision|0|||
30799929|NCT00882050|58815280|FG002|Overall Study|Physician Decision|0|||
30799930|NCT03266094|58815288|FG000|Overall Study|Lost to Follow-up|1|||
30799931|NCT03266094|58815288|FG000|Overall Study|Withdrawal by Subject|1|||
30799932|NCT04161079|58815294|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
30799933|NCT03243084|58815304|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
30799934|NCT03243084|58815305|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
30799935|NCT04353817|58815314|FG000|Overall Study|Adverse Event|0|||
30799936|NCT04353817|58815315|FG001|Overall Study|Adverse Event|1|||
30799937|NCT00159588|58815324|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
30799938|NCT00159588|58815325|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
30799939|NCT00159588|58815326|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
30799940|NCT03265938|58815337|FG000|Overall Study|Withdrawal by Subject|1|||
30799941|NCT03265938|58815337|FG000|Overall Study|Physician Decision|1|||
30799942|NCT03265938|58815337|FG000|Overall Study|friable mass|6|||
30799943|NCT04353037|58815346|FG000|Overall Study|Lost to Follow-up|0|||
30622293|NCT03355300|58633935|FG001|Overall Study|Other reason|0|||
30622294|NCT03332056|58633943|FG000|Overall Study|Incomplete questionnaires|8|||
30747051|NCT00087178|58757296|FG000|Overall Study|No clinical assessment|1|||
30747052|NCT00087178|58757297|FG001|Overall Study|No clinical assessment|2|||
30747053|NCT00087178|58757296|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
30747054|NCT00087178|58757297|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
30799944|NCT04353037|58815347|FG001|Overall Study|Lost to Follow-up|1|||
30799945|NCT04353037|58815348|FG002|Overall Study|Lost to Follow-up|2|||
30799946|NCT04353037|58815349|FG003|Overall Study|Lost to Follow-up|3|||
30799947|NCT04353037|58815346|FG000|Overall Study|Withdrawal by Subject|0|||
30799948|NCT04353037|58815347|FG001|Overall Study|Withdrawal by Subject|2|||
30799949|NCT04353037|58815348|FG002|Overall Study|Withdrawal by Subject|3|||
30799950|NCT04353037|58815349|FG003|Overall Study|Withdrawal by Subject|5|||
30799951|NCT04353037|58815346|FG000|Overall Study|Adverse Event|0|||
30799952|NCT04353037|58815347|FG001|Overall Study|Adverse Event|0|||
30799953|NCT04353037|58815348|FG002|Overall Study|Adverse Event|2|||
30799954|NCT04353037|58815349|FG003|Overall Study|Adverse Event|0|||
30799955|NCT04353037|58815346|FG000|Overall Study|Exposure Change|0|||
30799956|NCT04353037|58815347|FG001|Overall Study|Exposure Change|0|||
30799957|NCT04353037|58815348|FG002|Overall Study|Exposure Change|0|||
30799958|NCT04353037|58815349|FG003|Overall Study|Exposure Change|2|||
30799959|NCT04349917|58815363|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
30799960|NCT04349917|58815364|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
30799961|NCT04349917|58815363|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
30799962|NCT04349917|58815364|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
30799963|NCT04156399|58815371|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
30799964|NCT04156399|58815371|FG000|Overall Study|study suspension due to COVID pandemic|3|||
30799965|NCT03300570|58815377|FG000|Overall Study|Adverse Event|0|||
30799966|NCT03300570|58815378|FG001|Overall Study|Adverse Event|1|||
30799967|NCT03300570|58815377|FG000|Overall Study|Withdrawal by Subject|1|||
30799968|NCT03300570|58815378|FG001|Overall Study|Withdrawal by Subject|0|||
30799969|NCT03300570|58815377|FG000|Overall Study|Inadequate bowel prep|1|||
30799970|NCT03300570|58815378|FG001|Overall Study|Inadequate bowel prep|0|||
30799971|NCT04154605|58815387|FG000|Overall Study|Procedure Canceled|1|||
30799972|NCT04154605|58815388|FG001|Overall Study|Procedure Canceled|1|||
30799973|NCT04154605|58815387|FG000|Overall Study|Missed follow up|1|||
30799974|NCT04154605|58815388|FG001|Overall Study|Missed follow up|1|||
30799975|NCT04154605|58815387|FG000|Overall Study|Withdrawal by Subject|1|||
30799976|NCT04154605|58815388|FG001|Overall Study|Withdrawal by Subject|0|||
30799977|NCT03264456|58815394|FG000|Overall Study|Withdrawal by Subject|3|||
30799978|NCT03264456|58815394|FG000|Overall Study|Lost to Follow-up|1|||
30799979|NCT03853694|58815401|FG000|Overall Study|Protocol Violation|3|||
30799980|NCT03853694|58815402|FG001|Overall Study|Protocol Violation|5|||
30799981|NCT03853694|58815403|FG002|Overall Study|Protocol Violation|3|||
30799982|NCT03853694|58815401|FG000|Overall Study|Delivered early|0|||
30799983|NCT03853694|58815402|FG001|Overall Study|Delivered early|1|||
30799984|NCT03853694|58815403|FG002|Overall Study|Delivered early|0|||
30799985|NCT03853694|58815401|FG000|Overall Study|not suitable to proceed|0|||
30799986|NCT03853694|58815402|FG001|Overall Study|not suitable to proceed|1|||
30799987|NCT03853694|58815403|FG002|Overall Study|not suitable to proceed|0|||
30799988|NCT03853694|58815401|FG000|Overall Study|difficult surgery|0|||
30799989|NCT03853694|58815402|FG001|Overall Study|difficult surgery|0|||
30799990|NCT03853694|58815403|FG002|Overall Study|difficult surgery|1|||
30905842|NCT01995201|58940469|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
30905843|NCT01995201|58940470|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
30905844|NCT01995201|58940471|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
30905845|NCT01995201|58940472|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
30905846|NCT01995201|58940473|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
30905847|NCT01995201|58940474|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
30799991|NCT03853694|58815401|FG000|Overall Study|Lost to Follow-up|0|||
30905848|NCT01995201|58940475|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
30905849|NCT01995201|58940469|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
30905850|NCT01995201|58940470|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
30905851|NCT01995201|58940471|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
30747055|NCT00288080|58757305|FG000|Overall Study|Withdrawal by Subject|1|||
30747056|NCT00288080|58757306|FG001|Overall Study|Withdrawal by Subject|3|||
30747057|NCT00288080|58757305|FG000|Overall Study|Protocol Violation|25|||
30747058|NCT00288080|58757306|FG001|Overall Study|Protocol Violation|20|||
30747059|NCT00287690|58757314|FG000|Overall Study|Protocol Violation|20|||
30747060|NCT00287690|58757315|FG001|Overall Study|Protocol Violation|26|||
30747061|NCT00286754|58757324|FG000|Overall Study|Adverse Event|2|||
30747062|NCT00286754|58757325|FG001|Overall Study|Adverse Event|2|||
30747063|NCT00286754|58757326|FG002|Overall Study|Adverse Event|3|||
30747064|NCT00286754|58757324|FG000|Overall Study|Withdrawal by Subject|6|||
30747065|NCT00286754|58757325|FG001|Overall Study|Withdrawal by Subject|2|||
30747066|NCT00286754|58757326|FG002|Overall Study|Withdrawal by Subject|0|||
30747067|NCT00286754|58757324|FG000|Overall Study|Lost to Follow-up|12|||
30747068|NCT00286754|58757325|FG001|Overall Study|Lost to Follow-up|14|||
30747069|NCT00286754|58757326|FG002|Overall Study|Lost to Follow-up|6|||
30747070|NCT00286754|58757324|FG000|Overall Study|Moved out of state|0|||
30747071|NCT00286754|58757325|FG001|Overall Study|Moved out of state|0|||
30747072|NCT00286754|58757326|FG002|Overall Study|Moved out of state|1|||
30747073|NCT00066742|58757340|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
30747074|NCT00066742|58757340|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
30799992|NCT03853694|58815402|FG001|Overall Study|Lost to Follow-up|1|||
30799993|NCT03853694|58815403|FG002|Overall Study|Lost to Follow-up|0|||
30799994|NCT03853694|58815401|FG000|Overall Study|Withdrawal by Subject|0|||
30799995|NCT03853694|58815402|FG001|Overall Study|Withdrawal by Subject|1|||
30799996|NCT03853694|58815403|FG002|Overall Study|Withdrawal by Subject|0|||
30799997|NCT04154293|58815414|FG000|Overall Study|Withdrawal by Subject|2|||
30905852|NCT01995201|58940472|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
30747075|NCT00066742|58757340|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
30747076|NCT00066742|58757340|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
30799998|NCT04154293|58815415|FG001|Overall Study|Withdrawal by Subject|3|||
30799999|NCT04154293|58815416|FG002|Overall Study|Withdrawal by Subject|1|||
30905853|NCT01995201|58940473|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
30905854|NCT01995201|58940474|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
30905855|NCT01995201|58940475|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
30905856|NCT01995201|58940469|FG000|From Baseline Until Week 24|Physician Decision|0|||
30905857|NCT01995201|58940470|FG001|From Baseline Until Week 24|Physician Decision|2|||
30905858|NCT01995201|58940471|FG002|From Baseline Until Week 24|Physician Decision|0|||
30905859|NCT01995201|58940472|FG003|From Baseline Until Week 24|Physician Decision|0|||
30905860|NCT01995201|58940473|FG004|From Baseline Until Week 24|Physician Decision|0|||
30905861|NCT01995201|58940474|FG005|From Baseline Until Week 24|Physician Decision|0|||
30905862|NCT01995201|58940475|FG006|From Baseline Until Week 24|Physician Decision|0|||
30905863|NCT01995201|58940469|FG000|From Baseline Until Week 24|Protocol Violation|0|||
30905864|NCT01995201|58940470|FG001|From Baseline Until Week 24|Protocol Violation|9|||
30905865|NCT01995201|58940471|FG002|From Baseline Until Week 24|Protocol Violation|0|||
30905866|NCT01995201|58940472|FG003|From Baseline Until Week 24|Protocol Violation|0|||
30905867|NCT01995201|58940473|FG004|From Baseline Until Week 24|Protocol Violation|0|||
30905868|NCT01995201|58940474|FG005|From Baseline Until Week 24|Protocol Violation|0|||
30905869|NCT01995201|58940475|FG006|From Baseline Until Week 24|Protocol Violation|0|||
30905870|NCT01995201|58940469|FG000|From Week 24 Until Week 48|Adverse Event|0|||
30905871|NCT01995201|58940470|FG001|From Week 24 Until Week 48|Adverse Event|0|||
30905872|NCT01995201|58940471|FG002|From Week 24 Until Week 48|Adverse Event|2|||
30905873|NCT01995201|58940472|FG003|From Week 24 Until Week 48|Adverse Event|1|||
30905874|NCT01995201|58940473|FG004|From Week 24 Until Week 48|Adverse Event|1|||
30905875|NCT01995201|58940474|FG005|From Week 24 Until Week 48|Adverse Event|3|||
30905876|NCT01995201|58940475|FG006|From Week 24 Until Week 48|Adverse Event|1|||
30905877|NCT01995201|58940469|FG000|From Week 24 Until Week 48|Death|0|||
30905878|NCT01995201|58940470|FG001|From Week 24 Until Week 48|Death|0|||
30905879|NCT01995201|58940471|FG002|From Week 24 Until Week 48|Death|0|||
30905880|NCT01995201|58940472|FG003|From Week 24 Until Week 48|Death|0|||
30905881|NCT01995201|58940473|FG004|From Week 24 Until Week 48|Death|0|||
30905882|NCT01995201|58940474|FG005|From Week 24 Until Week 48|Death|2|||
30905883|NCT01995201|58940475|FG006|From Week 24 Until Week 48|Death|0|||
30905884|NCT01995201|58940469|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
30905885|NCT01995201|58940470|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
30905886|NCT01995201|58940471|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
30905887|NCT01995201|58940472|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
30905888|NCT01995201|58940473|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
30905889|NCT01995201|58940474|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
30905890|NCT01995201|58940475|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
30905891|NCT01995201|58940469|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
30905892|NCT01995201|58940470|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
30905893|NCT01995201|58940471|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
30905894|NCT01995201|58940472|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
30905895|NCT01995201|58940473|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
30905896|NCT01995201|58940474|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
30905897|NCT01995201|58940475|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
30905898|NCT01995201|58940469|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
30905899|NCT01995201|58940470|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
30905900|NCT01995201|58940471|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
30905901|NCT01995201|58940472|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
30905902|NCT01995201|58940473|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
30905903|NCT01995201|58940474|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
30905904|NCT01995201|58940475|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
30905905|NCT01995201|58940469|FG000|From Week 24 Until Week 48|Physician Decision|0|||
30905906|NCT01995201|58940470|FG001|From Week 24 Until Week 48|Physician Decision|0|||
30905907|NCT01995201|58940471|FG002|From Week 24 Until Week 48|Physician Decision|0|||
30905908|NCT01995201|58940472|FG003|From Week 24 Until Week 48|Physician Decision|0|||
30905909|NCT01995201|58940473|FG004|From Week 24 Until Week 48|Physician Decision|1|||
30905910|NCT01995201|58940474|FG005|From Week 24 Until Week 48|Physician Decision|0|||
30905911|NCT01995201|58940475|FG006|From Week 24 Until Week 48|Physician Decision|0|||
30905912|NCT01995201|58940469|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
30905913|NCT01995201|58940470|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
30905914|NCT01995201|58940471|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
30905915|NCT01995201|58940472|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
30905916|NCT01995201|58940473|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
30905917|NCT01995201|58940474|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
30905918|NCT01995201|58940475|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
30905919|NCT01728454|58940499|FG000|Stage 1 and 2|Pregnancy|1|||
30905920|NCT01728454|58940500|FG001|Stage 1 and 2|Pregnancy|0|||
30905921|NCT01728454|58940501|FG002|Stage 1 and 2|Pregnancy|0|||
30905922|NCT01728454|58940499|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
30905923|NCT01728454|58940500|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
30800000|NCT04154293|58815414|FG000|Overall Study|Physician Decision|0|||
30905924|NCT01728454|58940501|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
30905925|NCT01728454|58940499|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
30905926|NCT01728454|58940500|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
30905927|NCT01728454|58940501|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
30905928|NCT01728454|58940499|FG000|Stage 1 and 2|Lost to Follow-up|1|||
30905929|NCT01728454|58940500|FG001|Stage 1 and 2|Lost to Follow-up|1|||
30800001|NCT04154293|58815415|FG001|Overall Study|Physician Decision|0|||
30800002|NCT04154293|58815416|FG002|Overall Study|Physician Decision|1|||
30800003|NCT04342897|58815426|FG000|Overall Study|Death|7|||
30800004|NCT04342897|58815427|FG001|Overall Study|Death|4|||
30800005|NCT04342897|58815426|FG000|Overall Study|Lost to Follow-up|6|||
30800006|NCT04342897|58815427|FG001|Overall Study|Lost to Follow-up|6|||
30800007|NCT04342897|58815426|FG000|Overall Study|Withdrawal by Subject|1|||
30800008|NCT04342897|58815427|FG001|Overall Study|Withdrawal by Subject|2|||
30800009|NCT04340557|58815435|FG000|Overall Study|Transferred to ICU and/or death|1|||
30800010|NCT04340557|58815436|FG001|Overall Study|Transferred to ICU and/or death|2|||
30747077|NCT00066742|58757340|FG000|Induction Chemoradiotherapy|Ineligible|3|||
30747078|NCT00066742|58757340|FG000|Consolidation Chemotherapy|not protocol specified|1|||
30747079|NCT00066742|58757340|FG000|Consolidation Chemotherapy|Ineligible|2|||
30747080|NCT00460265|58757348|FG000|Overall Study|Lost to Follow-up|14|||
30747081|NCT00460265|58757349|FG001|Overall Study|Lost to Follow-up|15|||
30747082|NCT00460265|58757348|FG000|Overall Study|Physician Decision|1|||
30747083|NCT00460265|58757349|FG001|Overall Study|Physician Decision|2|||
30747084|NCT00460265|58757348|FG000|Overall Study|Withdrawal by Subject|10|||
30747085|NCT00460265|58757349|FG001|Overall Study|Withdrawal by Subject|25|||
30747086|NCT00460265|58757348|FG000|Overall Study|Ongoing|60|||
30747087|NCT00460265|58757349|FG001|Overall Study|Ongoing|47|||
30747088|NCT00460109|58757355|FG000|Overall Study|Death|1|||
30747089|NCT00065260|58757361|FG000|Overall Study|Death|0|||
30747090|NCT00065260|58757362|FG001|Overall Study|Death|1|||
30800011|NCT04382053|58815444|FG000|Overall Study|Death|6|||
30800012|NCT04382053|58815445|FG001|Overall Study|Death|8|||
30800013|NCT04382053|58815444|FG000|Overall Study|Lost to Follow-up|0|||
30800014|NCT04382053|58815445|FG001|Overall Study|Lost to Follow-up|2|||
30800015|NCT04382053|58815444|FG000|Overall Study|Protocol Deviation|1|||
30800016|NCT04382053|58815445|FG001|Overall Study|Protocol Deviation|2|||
30800017|NCT04382053|58815444|FG000|Overall Study|Withdrawal by Subject|2|||
30800018|NCT04382053|58815445|FG001|Overall Study|Withdrawal by Subject|1|||
30800019|NCT03066830|58815454|FG000|Overall Study|At the Participant's own Request|16|||
30800020|NCT03066830|58815455|FG001|Overall Study|At the Participant's own Request|17|||
30800021|NCT03066830|58815454|FG000|Overall Study|Other|3|||
30800022|NCT03066830|58815455|FG001|Overall Study|Other|0|||
30800023|NCT03066830|58815454|FG000|Overall Study|Poor Compliance to Protocol|1|||
30800024|NCT03066830|58815455|FG001|Overall Study|Poor Compliance to Protocol|0|||
30800025|NCT03066830|58815454|FG000|Overall Study|Adverse Event|2|||
30800026|NCT03066830|58815455|FG001|Overall Study|Adverse Event|2|||
30800027|NCT03066830|58815454|FG000|Overall Study|Lost to Follow-up|11|||
30800028|NCT03066830|58815455|FG001|Overall Study|Lost to Follow-up|3|||
30800029|NCT04380961|58815464|FG000|Overall Study|Lost to Follow-up|17|||
30800030|NCT04380961|58815465|FG001|Overall Study|Lost to Follow-up|11|||
30800031|NCT04380961|58815464|FG000|Overall Study|Withdrawal by Subject|3|||
30800032|NCT04380961|58815465|FG001|Overall Study|Withdrawal by Subject|0|||
30800033|NCT04380961|58815464|FG000|Overall Study|Death|22|||
30800034|NCT04380961|58815465|FG001|Overall Study|Death|16|||
30800035|NCT04380961|58815464|FG000|Overall Study|Other|1|||
30800036|NCT04380961|58815465|FG001|Overall Study|Other|0|||
30800037|NCT04380961|58815464|FG000|Overall Study|Randomized but Not Treated|1|||
30800038|NCT04380961|58815465|FG001|Overall Study|Randomized but Not Treated|2|||
30800039|NCT04331899|58815475|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
30800040|NCT04331899|58815476|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
30800041|NCT03063632|58815484|FG000|Overall Study|Death|4|||
30800042|NCT03063632|58815485|FG001|Overall Study|Death|6|||
30905930|NCT01728454|58940501|FG002|Stage 1 and 2|Lost to Follow-up|0|||
30905931|NCT01728454|58940499|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
30905932|NCT01728454|58940500|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
30747091|NCT00460031|58757368|FG000|Overall Study|Adverse Event|5|||
30747092|NCT00460031|58757368|FG000|Overall Study|Withdrawal by Subject|5|||
30747093|NCT00460031|58757368|FG000|Overall Study|Death|1|||
30800043|NCT03063632|58815484|FG000|Overall Study|Lost to Follow-up|0|||
30800044|NCT03063632|58815485|FG001|Overall Study|Lost to Follow-up|1|||
30800045|NCT03063632|58815484|FG000|Overall Study|Withdrawal by Subject|0|||
30747094|NCT00451217|58757376|FG000|Overall Study|Lost to Follow-up|0|||
30800046|NCT03063632|58815485|FG001|Overall Study|Withdrawal by Subject|2|||
30800047|NCT03063632|58815484|FG000|Overall Study|Physician Decision|2|||
30800048|NCT03063632|58815485|FG001|Overall Study|Physician Decision|0|||
30800049|NCT03063632|58815484|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
30800050|NCT03063632|58815485|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
30905933|NCT01728454|58940501|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
30800051|NCT04328467|58815496|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
30800052|NCT04328467|58815497|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
30622295|NCT03332056|58633944|FG001|Overall Study|Incomplete questionnaires|9|||
30747095|NCT00451217|58757377|FG001|Overall Study|Lost to Follow-up|1|||
30747096|NCT00451217|58757378|FG002|Overall Study|Lost to Follow-up|1|||
30747097|NCT00451217|58757379|FG003|Overall Study|Lost to Follow-up|1|||
30747098|NCT00451217|58757376|FG000|Overall Study|Withdrawal by Subject|1|||
30747099|NCT00451217|58757377|FG001|Overall Study|Withdrawal by Subject|0|||
30747100|NCT00451217|58757378|FG002|Overall Study|Withdrawal by Subject|0|||
30747101|NCT00451217|58757379|FG003|Overall Study|Withdrawal by Subject|0|||
30747102|NCT00451217|58757376|FG000|Overall Study|Not Treated|1|||
30747103|NCT00451217|58757377|FG001|Overall Study|Not Treated|1|||
30747104|NCT00451217|58757378|FG002|Overall Study|Not Treated|3|||
30747105|NCT00451217|58757379|FG003|Overall Study|Not Treated|4|||
30747106|NCT00459953|58757391|FG000|Overall Study|not analyzed-household member in study|1|||
30747107|NCT00459953|58757392|FG001|Overall Study|not analyzed-household member in study|1|||
30747108|NCT00459875|58757398|FG000|Overall Study|Ineligible participant|1|||
30747109|NCT00459875|58757398|FG000|Overall Study|Adverse Event|2|||
30747110|NCT00311402|58757404|FG000|Overall Study|Adverse Event|118|||
30747111|NCT00311402|58757405|FG001|Overall Study|Adverse Event|105|||
30747112|NCT00311402|58757404|FG000|Overall Study|Lost to Follow-up|0|||
30747113|NCT00311402|58757405|FG001|Overall Study|Lost to Follow-up|3|||
30747114|NCT00311402|58757404|FG000|Overall Study|Withdrawal by Subject|17|||
30747115|NCT00311402|58757405|FG001|Overall Study|Withdrawal by Subject|18|||
30747116|NCT00311402|58757404|FG000|Overall Study|Lack of Efficacy|58|||
30747117|NCT00311402|58757405|FG001|Overall Study|Lack of Efficacy|42|||
30747118|NCT00311402|58757404|FG000|Overall Study|Protocol Violation|7|||
30747119|NCT00311402|58757405|FG001|Overall Study|Protocol Violation|6|||
30747120|NCT00311402|58757404|FG000|Overall Study|IRB's rejection etc.|10|||
30747121|NCT00311402|58757405|FG001|Overall Study|IRB's rejection etc.|3|||
30747122|NCT00450749|58757414|FG000|Overall Study|Withdrawal by Subject|0|||
30747123|NCT00450749|58757415|FG001|Overall Study|Withdrawal by Subject|0|||
30747124|NCT00450749|58757416|FG002|Overall Study|Withdrawal by Subject|2|||
30747125|NCT00450749|58757414|FG000|Overall Study|Noncompliant|0|||
30747126|NCT00450749|58757415|FG001|Overall Study|Noncompliant|1|||
30747127|NCT00450749|58757416|FG002|Overall Study|Noncompliant|0|||
30747128|NCT00292370|58757427|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
30747129|NCT00292370|58757428|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
30747130|NCT00292370|58757429|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
30747131|NCT00292370|58757427|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
30747132|NCT00292370|58757428|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
30747133|NCT00292370|58757429|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
30747134|NCT00292370|58757427|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
30747135|NCT00292370|58757428|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
30747136|NCT00292370|58757429|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
30747137|NCT00292370|58757427|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
30747138|NCT00292370|58757428|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
30747139|NCT00292370|58757429|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
30747140|NCT00292370|58757427|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
30747141|NCT00292370|58757428|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
30747142|NCT00292370|58757429|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
30747143|NCT00292370|58757427|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
30747144|NCT00292370|58757428|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
30747145|NCT00292370|58757429|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
30747146|NCT00065182|58757438|FG000|Overall Study|Adverse Event|24|||
30747147|NCT00065182|58757439|FG001|Overall Study|Adverse Event|17|||
30747148|NCT00065182|58757438|FG000|Overall Study|Lost to Follow-up|0|||
30622296|NCT03332056|58633943|FG000|Overall Study|Passed stone prior to surgery date|1|||
30622297|NCT03332056|58633944|FG001|Overall Study|Passed stone prior to surgery date|0|||
30622298|NCT03332056|58633943|FG000|Overall Study|Did not require a ureteral stent|0|||
30622299|NCT03332056|58633944|FG001|Overall Study|Did not require a ureteral stent|1|||
30622300|NCT03093350|58633950|FG000|Overall Study|Death|1|||
30622301|NCT03093350|58633950|FG000|Overall Study|Signed consent, never began treartment|1|||
30622302|NCT02901041|58633956|FG000|Overall Study|Withdrawal by PI|4|||
30622303|NCT02901041|58633957|FG001|Overall Study|Withdrawal by PI|8|||
30622304|NCT02901041|58633956|FG000|Overall Study|Withdrawal by Subject|7|||
30622305|NCT02901041|58633957|FG001|Overall Study|Withdrawal by Subject|3|||
30622306|NCT02547987|58633991|FG000|Overall Study|Withdrawal by Subject|1|||
30622307|NCT02547987|58633991|FG000|Overall Study|Adverse Event|2|||
30622308|NCT02513199|58633995|FG000|Treatment|Death|1|||
30747149|NCT00065182|58757439|FG001|Overall Study|Lost to Follow-up|4|||
30622309|NCT02513199|58633995|FG000|Treatment|Lost to Follow-up|1|||
30747150|NCT00065182|58757438|FG000|Overall Study|Protocol Violation|3|||
30622310|NCT02513199|58633995|FG000|Follow-Up|Death|11|||
30800053|NCT04328467|58815498|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
30800054|NCT04328077|58815510|FG000|Overall Study|Lost to Follow-up|0|||
30800055|NCT04328077|58815511|FG001|Overall Study|Lost to Follow-up|1|||
30905934|NCT01728454|58940499|FG000|Stage 3|Reason Missing|0|||
30905935|NCT01728454|58940500|FG001|Stage 3|Reason Missing|0|||
30800056|NCT04328077|58815512|FG002|Overall Study|Lost to Follow-up|0|||
30800057|NCT04328077|58815513|FG003|Overall Study|Lost to Follow-up|0|||
30800058|NCT04328077|58815510|FG000|Overall Study|Withdrawal by Subject|0|||
30800059|NCT04328077|58815511|FG001|Overall Study|Withdrawal by Subject|1|||
30800060|NCT04328077|58815512|FG002|Overall Study|Withdrawal by Subject|1|||
30800061|NCT04328077|58815513|FG003|Overall Study|Withdrawal by Subject|3|||
30800062|NCT03691831|58815531|FG000|Overall Study|Lost to Follow-up|16|||
30800063|NCT03691831|58815532|FG001|Overall Study|Lost to Follow-up|12|||
30800064|NCT03691831|58815531|FG000|Overall Study|Withdrawal by Subject|9|||
30800065|NCT03691831|58815532|FG001|Overall Study|Withdrawal by Subject|17|||
30800066|NCT03691831|58815531|FG000|Overall Study|Investigator Decision|2|||
30800067|NCT03691831|58815532|FG001|Overall Study|Investigator Decision|2|||
30800068|NCT04320745|58815549|FG000|Overall Study|Adverse Event|26|||
30800069|NCT04320745|58815549|FG000|Overall Study|Withdrawal by Subject|4|||
30800070|NCT04320745|58815549|FG000|Overall Study|Lost to Follow-up|12|||
30800071|NCT04320745|58815549|FG000|Overall Study|Protocol Deviation|2|||
30800072|NCT04320745|58815549|FG000|Overall Study|Non-compliance With Study Drug|2|||
30905936|NCT01728454|58940501|FG002|Stage 3|Reason Missing|1|||
30905937|NCT01728454|58940499|FG000|Stage 3|Subject Required Other Treatment|0|||
30905938|NCT01728454|58940500|FG001|Stage 3|Subject Required Other Treatment|1|||
30905939|NCT01728454|58940501|FG002|Stage 3|Subject Required Other Treatment|0|||
30905940|NCT01728454|58940499|FG000|Stage 3|Pregnancy|1|||
30905941|NCT01728454|58940500|FG001|Stage 3|Pregnancy|0|||
30800073|NCT04320745|58815549|FG000|Overall Study|Reason Not Specified|1|||
30800074|NCT03063086|58815553|FG000|Overall Study|technical problems|1|||
30800075|NCT03063086|58815554|FG001|Overall Study|technical problems|0|||
30800076|NCT03063086|58815555|FG002|Overall Study|technical problems|0|||
30800077|NCT03063086|58815556|FG003|Overall Study|technical problems|0|||
30905942|NCT01728454|58940501|FG002|Stage 3|Pregnancy|0|||
30905943|NCT01728454|58940499|FG000|Stage 3|Withdrew Consent|1|||
30905944|NCT01728454|58940500|FG001|Stage 3|Withdrew Consent|0|||
30905945|NCT01728454|58940501|FG002|Stage 3|Withdrew Consent|1|||
30622311|NCT02181413|58634002|FG000|Overall Study|Adverse Event|7|||
30622312|NCT02181413|58634003|FG001|Overall Study|Adverse Event|24|||
30622313|NCT02181413|58634002|FG000|Overall Study|Progressive Disease|121|||
30622314|NCT02181413|58634003|FG001|Overall Study|Progressive Disease|143|||
30622315|NCT02181413|58634002|FG000|Overall Study|Withdrawal by Subject|5|||
30622316|NCT02181413|58634003|FG001|Overall Study|Withdrawal by Subject|8|||
30905946|NCT01728454|58940499|FG000|Stage 3|Non-compliance with Protocol|0|||
30905947|NCT01728454|58940500|FG001|Stage 3|Non-compliance with Protocol|0|||
30905948|NCT01728454|58940501|FG002|Stage 3|Non-compliance with Protocol|1|||
30905949|NCT01728454|58940499|FG000|Stage 3|Lost to Follow-up|0|||
30905950|NCT01728454|58940500|FG001|Stage 3|Lost to Follow-up|3|||
30905951|NCT01728454|58940501|FG002|Stage 3|Lost to Follow-up|1|||
30622317|NCT02181413|58634002|FG000|Overall Study|Reason Not Specified|19|||
30622318|NCT02181413|58634003|FG001|Overall Study|Reason Not Specified|20|||
30747151|NCT00065182|58757439|FG001|Overall Study|Protocol Violation|4|||
30747152|NCT00065182|58757438|FG000|Overall Study|Serious adverse events (SAE)|1|||
30747153|NCT00065182|58757439|FG001|Overall Study|Serious adverse events (SAE)|0|||
30747154|NCT00065182|58757438|FG000|Overall Study|Sponsor Decision|11|||
30747155|NCT00065182|58757439|FG001|Overall Study|Sponsor Decision|7|||
30747156|NCT00065182|58757438|FG000|Overall Study|Withdrawal by Subject|8|||
30747157|NCT00065182|58757439|FG001|Overall Study|Withdrawal by Subject|3|||
30747158|NCT00065182|58757438|FG000|Overall Study|No clinical benefit|1|||
30747159|NCT00065182|58757439|FG001|Overall Study|No clinical benefit|0|||
30747160|NCT00065182|58757438|FG000|Overall Study|Death|0|||
30747161|NCT00065182|58757439|FG001|Overall Study|Death|1|||
30747162|NCT00065182|58757438|FG000|Overall Study|Decline in Status|0|||
30747163|NCT00065182|58757439|FG001|Overall Study|Decline in Status|1|||
30747164|NCT00064792|58757447|FG000|Overall Study|Withdrawal by Subject|2|||
30747165|NCT00064792|58757448|FG001|Overall Study|Withdrawal by Subject|0|||
30800078|NCT03063086|58815557|FG004|Overall Study|technical problems|0|||
30800079|NCT03063086|58815558|FG005|Overall Study|technical problems|0|||
30800080|NCT03063086|58815553|FG000|Overall Study|Adverse Event|1|||
30800081|NCT03063086|58815554|FG001|Overall Study|Adverse Event|1|||
30905952|NCT01728454|58940499|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
30905953|NCT01728454|58940500|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
30905954|NCT01728454|58940501|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
30622319|NCT02181413|58634002|FG000|Overall Study|Ongoing Study Treatment|0|||
30747166|NCT00064792|58757447|FG000|Overall Study|Adverse Event|3|||
30800082|NCT03063086|58815555|FG002|Overall Study|Adverse Event|1|||
30800083|NCT03063086|58815556|FG003|Overall Study|Adverse Event|1|||
30800084|NCT03063086|58815557|FG004|Overall Study|Adverse Event|0|||
30747167|NCT00064792|58757448|FG001|Overall Study|Adverse Event|0|||
30747168|NCT00450437|58757456|FG000|Overall Study|Withdrawal by Subject|10|||
30747169|NCT00450437|58757457|FG001|Overall Study|Withdrawal by Subject|2|||
30747170|NCT00450437|58757458|FG002|Overall Study|Withdrawal by Subject|0|||
30747171|NCT00450437|58757459|FG003|Overall Study|Withdrawal by Subject|1|||
30747172|NCT00450437|58757456|FG000|Overall Study|Lost to Follow-up|31|||
30800085|NCT03063086|58815558|FG005|Overall Study|Adverse Event|0|||
30800086|NCT03063086|58815553|FG000|Overall Study|subject/guardian decision|1|||
30800087|NCT03063086|58815554|FG001|Overall Study|subject/guardian decision|0|||
30800088|NCT03063086|58815555|FG002|Overall Study|subject/guardian decision|0|||
30747173|NCT00450437|58757457|FG001|Overall Study|Lost to Follow-up|12|||
30747174|NCT00450437|58757458|FG002|Overall Study|Lost to Follow-up|19|||
30747175|NCT00450437|58757459|FG003|Overall Study|Lost to Follow-up|9|||
30747176|NCT00450437|58757456|FG000|Overall Study|Protocol Violation|0|||
30747177|NCT00450437|58757457|FG001|Overall Study|Protocol Violation|1|||
30747178|NCT00450437|58757458|FG002|Overall Study|Protocol Violation|0|||
30747179|NCT00450437|58757459|FG003|Overall Study|Protocol Violation|1|||
30747180|NCT00450437|58757456|FG000|Overall Study|Inappropriate enrollment|4|||
30747181|NCT00450437|58757457|FG001|Overall Study|Inappropriate enrollment|1|||
30747182|NCT00450437|58757458|FG002|Overall Study|Inappropriate enrollment|3|||
30747183|NCT00450437|58757459|FG003|Overall Study|Inappropriate enrollment|0|||
30747184|NCT00450437|58757456|FG000|Overall Study|Administrative reason|0|||
30747185|NCT00450437|58757457|FG001|Overall Study|Administrative reason|0|||
30747186|NCT00450437|58757458|FG002|Overall Study|Administrative reason|1|||
30800089|NCT03063086|58815556|FG003|Overall Study|subject/guardian decision|0|||
30800090|NCT03063086|58815557|FG004|Overall Study|subject/guardian decision|0|||
30800091|NCT03063086|58815558|FG005|Overall Study|subject/guardian decision|0|||
30800092|NCT03063086|58815553|FG000|Overall Study|Non-compliance with study treatment|0|||
30800093|NCT03063086|58815554|FG001|Overall Study|Non-compliance with study treatment|0|||
30800094|NCT03063086|58815555|FG002|Overall Study|Non-compliance with study treatment|0|||
30800095|NCT03063086|58815556|FG003|Overall Study|Non-compliance with study treatment|1|||
30800096|NCT03063086|58815557|FG004|Overall Study|Non-compliance with study treatment|0|||
30800097|NCT03063086|58815558|FG005|Overall Study|Non-compliance with study treatment|1|||
30800098|NCT03063086|58815553|FG000|Overall Study|Physician Decision|0|||
30800099|NCT03063086|58815554|FG001|Overall Study|Physician Decision|0|||
30800100|NCT03063086|58815555|FG002|Overall Study|Physician Decision|0|||
30800101|NCT03063086|58815556|FG003|Overall Study|Physician Decision|1|||
30800102|NCT03063086|58815557|FG004|Overall Study|Physician Decision|0|||
30800103|NCT03063086|58815558|FG005|Overall Study|Physician Decision|0|||
30800104|NCT04128007|58815569|FG000|Overall Study|Withdrawal by Subject|9|||
30747187|NCT00450437|58757459|FG003|Overall Study|Administrative reason|0|||
30747188|NCT00450437|58757456|FG000|Overall Study|Unable to Classify|1|||
30800105|NCT04128007|58815570|FG001|Overall Study|Withdrawal by Subject|6|||
30800106|NCT04128007|58815569|FG000|Overall Study|Protocol Violation|1|||
30800107|NCT04128007|58815570|FG001|Overall Study|Protocol Violation|0|||
30800108|NCT04128007|58815569|FG000|Overall Study|Lost to Follow-up|8|||
30747189|NCT00450437|58757457|FG001|Overall Study|Unable to Classify|0|||
30747190|NCT00450437|58757458|FG002|Overall Study|Unable to Classify|1|||
30747191|NCT00450437|58757459|FG003|Overall Study|Unable to Classify|0|||
30747192|NCT00286442|58757476|FG000|Overall Study|Hyperglycemic Rescue|19|||
30747193|NCT00286442|58757477|FG001|Overall Study|Hyperglycemic Rescue|17|||
30800109|NCT04128007|58815570|FG001|Overall Study|Lost to Follow-up|7|||
30800110|NCT04128007|58815569|FG000|Overall Study|Adverse Event|5|||
30800111|NCT04128007|58815570|FG001|Overall Study|Adverse Event|2|||
30800112|NCT04128007|58815569|FG000|Overall Study|Not reported|0|||
30800113|NCT04128007|58815570|FG001|Overall Study|Not reported|2|||
30800114|NCT04318093|58815578|FG000|Overall Study|Adverse Event|2|||
30800115|NCT04318093|58815579|FG001|Overall Study|Adverse Event|2|||
30800116|NCT04318093|58815578|FG000|Overall Study|Participant withdrew consent|1|||
30800117|NCT04318093|58815579|FG001|Overall Study|Participant withdrew consent|0|||
30800118|NCT04318093|58815578|FG000|Overall Study|Other reasons|0|||
30800119|NCT04318093|58815579|FG001|Overall Study|Other reasons|1|||
30800120|NCT04123405|58815590|FG000|Overall Study|Adverse Event|1|||
30800121|NCT04123405|58815591|FG001|Overall Study|Adverse Event|2|||
30800122|NCT04123405|58815592|FG002|Overall Study|Adverse Event|3|||
30800123|NCT04123405|58815593|FG003|Overall Study|Adverse Event|3|||
30800124|NCT04123405|58815590|FG000|Overall Study|Exclusion criteria met|1|||
30800125|NCT04123405|58815591|FG001|Overall Study|Exclusion criteria met|2|||
30800126|NCT04123405|58815592|FG002|Overall Study|Exclusion criteria met|0|||
30800127|NCT04123405|58815593|FG003|Overall Study|Exclusion criteria met|2|||
30800128|NCT04123405|58815590|FG000|Overall Study|Withdrawal by Subject|1|||
30800129|NCT04123405|58815591|FG001|Overall Study|Withdrawal by Subject|3|||
30800130|NCT04123405|58815592|FG002|Overall Study|Withdrawal by Subject|0|||
30800131|NCT04123405|58815593|FG003|Overall Study|Withdrawal by Subject|2|||
30800132|NCT04123405|58815590|FG000|Overall Study|Contact to subject lost|0|||
30800133|NCT04123405|58815591|FG001|Overall Study|Contact to subject lost|0|||
30800134|NCT04123405|58815592|FG002|Overall Study|Contact to subject lost|0|||
30800135|NCT04123405|58815593|FG003|Overall Study|Contact to subject lost|1|||
30800136|NCT04123405|58815590|FG000|Overall Study|screening failure|1|||
30800137|NCT04123405|58815591|FG001|Overall Study|screening failure|0|||
30800138|NCT04123405|58815592|FG002|Overall Study|screening failure|0|||
30800139|NCT04123405|58815593|FG003|Overall Study|screening failure|0|||
30800140|NCT04314037|58815622|FG000|Treatment Period 2|Adverse Event|1|||
30800141|NCT04314037|58815623|FG001|Treatment Period 2|Adverse Event|0|||
30800142|NCT04314037|58815622|FG000|Treatment Period 3|Protocol Violation|1|||
30800143|NCT04314037|58815623|FG001|Treatment Period 3|Protocol Violation|0|||
30747194|NCT00286442|58757478|FG002|Overall Study|Hyperglycemic Rescue|25|||
30747195|NCT00286442|58757476|FG000|Overall Study|Adverse Event|7|||
30747196|NCT00286442|58757477|FG001|Overall Study|Adverse Event|6|||
30747197|NCT00286442|58757478|FG002|Overall Study|Adverse Event|1|||
30747198|NCT00286442|58757476|FG000|Overall Study|Protocol Violation|2|||
30747199|NCT00286442|58757477|FG001|Overall Study|Protocol Violation|4|||
30800144|NCT04314037|58815622|FG000|Treatment Period 3|Adverse Event|0|||
30800145|NCT04314037|58815623|FG001|Treatment Period 3|Adverse Event|1|||
30800146|NCT03056300|58815639|FG000|Overall Study|Surgical reason per study protocol|3|||
30800147|NCT03061214|58815646|FG000|Overall Study|Withdrawal by Subject|21|||
30800148|NCT03061214|58815647|FG001|Overall Study|Withdrawal by Subject|26|||
30800149|NCT03061214|58815648|FG002|Overall Study|Withdrawal by Subject|9|||
30800150|NCT03061214|58815646|FG000|Overall Study|Lost to Follow-up|3|||
30800151|NCT03061214|58815647|FG001|Overall Study|Lost to Follow-up|1|||
30800152|NCT03061214|58815648|FG002|Overall Study|Lost to Follow-up|1|||
30800153|NCT03061214|58815646|FG000|Overall Study|Death|1|||
30800154|NCT03061214|58815647|FG001|Overall Study|Death|1|||
30800155|NCT03061214|58815648|FG002|Overall Study|Death|0|||
30800156|NCT04115839|58815659|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
30800157|NCT04115839|58815660|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
30800158|NCT04115839|58815661|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
30800159|NCT04115839|58815662|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
30800160|NCT04115839|58815663|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
30800161|NCT04115839|58815664|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
30800162|NCT04115839|58815665|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
30800163|NCT04115839|58815659|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
30800164|NCT04115839|58815660|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
30800165|NCT04115839|58815661|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
30800166|NCT04115839|58815662|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
30800167|NCT04115839|58815663|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
30800168|NCT04115839|58815664|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
30800169|NCT04115839|58815665|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
30800170|NCT04115839|58815659|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
30800171|NCT04115839|58815660|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
30800172|NCT04115839|58815661|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
30800173|NCT04115839|58815662|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
30800174|NCT04115839|58815663|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
30800175|NCT04115839|58815664|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
30800176|NCT04115839|58815665|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
30800177|NCT04115839|58815659|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
30800178|NCT04115839|58815660|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
30800179|NCT04115839|58815661|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
30800180|NCT04115839|58815662|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
30800181|NCT04115839|58815663|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
30800182|NCT04115839|58815664|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
30800183|NCT04115839|58815665|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
30800184|NCT04115839|58815659|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
30800185|NCT04115839|58815660|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
30800186|NCT04115839|58815661|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
30800187|NCT04115839|58815662|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
30800188|NCT04115839|58815663|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
30800189|NCT04115839|58815664|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
30800190|NCT04115839|58815665|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
30800191|NCT04115839|58815659|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
30800192|NCT04115839|58815660|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
30800193|NCT04115839|58815661|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
30800194|NCT04115839|58815662|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
30800195|NCT04115839|58815663|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
30800196|NCT04115839|58815664|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
30747200|NCT00286442|58757478|FG002|Overall Study|Protocol Violation|2|||
30747201|NCT00286442|58757476|FG000|Overall Study|Lost to Follow-up|5|||
30747202|NCT00286442|58757477|FG001|Overall Study|Lost to Follow-up|2|||
30747203|NCT00286442|58757478|FG002|Overall Study|Lost to Follow-up|1|||
30747204|NCT00286442|58757476|FG000|Overall Study|Physician Decision|1|||
30747205|NCT00286442|58757477|FG001|Overall Study|Physician Decision|1|||
30747206|NCT00286442|58757478|FG002|Overall Study|Physician Decision|1|||
30747207|NCT00286442|58757476|FG000|Overall Study|Administrative Error|1|||
30747208|NCT00286442|58757477|FG001|Overall Study|Administrative Error|1|||
30747209|NCT00286442|58757478|FG002|Overall Study|Administrative Error|0|||
30747210|NCT00286442|58757476|FG000|Overall Study|Withdrawal by Subject|2|||
30747211|NCT00286442|58757477|FG001|Overall Study|Withdrawal by Subject|14|||
30747212|NCT00286442|58757478|FG002|Overall Study|Withdrawal by Subject|2|||
30747213|NCT00063934|58757486|FG000|Overall Study|Ineligible|1|||
30747214|NCT00458783|58757492|FG000|Overall Study|Protocol Violation|1228|||
30747215|NCT00458783|58757493|FG001|Overall Study|Protocol Violation|1220|||
30747216|NCT00063154|58757499|FG000|Overall Study|Disease progression|27|||
30747217|NCT00063154|58757499|FG000|Overall Study|Adverse Event|2|||
30747218|NCT00063154|58757499|FG000|Overall Study|Physician Decision|10|||
30747219|NCT00063154|58757499|FG000|Overall Study|Death|3|||
30747220|NCT00063154|58757499|FG000|Overall Study|Reason unspecified|1|||
30800197|NCT04115839|58815665|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
30800198|NCT01561430|58815694|FG000|Overall Study|Adverse Event|0|||
30747221|NCT00063154|58757499|FG000|Overall Study|Did not receive treatment|8|||
30747222|NCT00311168|58757505|FG000|First Intervention|Withdrawal by Subject|2|||
30747223|NCT00311168|58757506|FG001|First Intervention|Withdrawal by Subject|2|||
30747224|NCT00311168|58757505|FG000|First Intervention|Lost to Follow-up|1|||
30747225|NCT00311168|58757506|FG001|First Intervention|Lost to Follow-up|1|||
30747226|NCT00311168|58757505|FG000|First Intervention|Protocol Violation|1|||
30800199|NCT01561430|58815695|FG001|Overall Study|Adverse Event|0|||
30800200|NCT01561430|58815696|FG002|Overall Study|Adverse Event|3|||
30800201|NCT01561430|58815697|FG003|Overall Study|Adverse Event|1|||
30800202|NCT01561430|58815694|FG000|Overall Study|Withdrawal by Subject|0|||
30800203|NCT01561430|58815695|FG001|Overall Study|Withdrawal by Subject|0|||
30800204|NCT01561430|58815696|FG002|Overall Study|Withdrawal by Subject|1|||
30800205|NCT01561430|58815697|FG003|Overall Study|Withdrawal by Subject|0|||
30800206|NCT01561430|58815694|FG000|Overall Study|Physician Decision|0|||
30800207|NCT01561430|58815695|FG001|Overall Study|Physician Decision|1|||
30800208|NCT01561430|58815696|FG002|Overall Study|Physician Decision|0|||
30800209|NCT01561430|58815697|FG003|Overall Study|Physician Decision|0|||
30800210|NCT01561430|58815694|FG000|Overall Study|Sponsor Decision|1|||
30800211|NCT01561430|58815695|FG001|Overall Study|Sponsor Decision|14|||
30800212|NCT01561430|58815696|FG002|Overall Study|Sponsor Decision|13|||
30800213|NCT01561430|58815697|FG003|Overall Study|Sponsor Decision|12|||
30800214|NCT03000530|58815733|FG000|Overall Study|Adverse Event|0|||
30800215|NCT03000530|58815734|FG001|Overall Study|Adverse Event|0|||
30800216|NCT03000530|58815735|FG002|Overall Study|Adverse Event|2|||
30800217|NCT03000530|58815733|FG000|Overall Study|Lost to Follow-up|0|||
30800218|NCT03000530|58815734|FG001|Overall Study|Lost to Follow-up|3|||
30800219|NCT03000530|58815735|FG002|Overall Study|Lost to Follow-up|1|||
30800220|NCT03000530|58815733|FG000|Overall Study|Withdrawal by Subject|0|||
30800221|NCT03000530|58815734|FG001|Overall Study|Withdrawal by Subject|2|||
30800222|NCT03000530|58815735|FG002|Overall Study|Withdrawal by Subject|1|||
30800223|NCT03060512|58815748|FG000|Overall Study|Adverse Event|4|||
30800224|NCT03060512|58815749|FG001|Overall Study|Adverse Event|6|||
30800225|NCT03060512|58815748|FG000|Overall Study|Lost to Follow-up|1|||
30800226|NCT03060512|58815749|FG001|Overall Study|Lost to Follow-up|1|||
30800227|NCT03060512|58815748|FG000|Overall Study|Withdrawal by Subject|1|||
30800228|NCT03060512|58815749|FG001|Overall Study|Withdrawal by Subject|0|||
30800229|NCT03060512|58815748|FG000|Overall Study|Non-compliance with study medication|1|||
30800230|NCT03060512|58815749|FG001|Overall Study|Non-compliance with study medication|2|||
30800231|NCT02539160|58815837|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
30800232|NCT02539160|58815838|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
30800233|NCT02539160|58815839|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
30800234|NCT02539160|58815840|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
30800235|NCT02539160|58815837|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
30800236|NCT02539160|58815838|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
30800237|NCT02539160|58815839|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
30747227|NCT00311168|58757506|FG001|First Intervention|Protocol Violation|1|||
30747228|NCT00311168|58757505|FG000|First Intervention|Adverse Event|1|||
30747229|NCT00311168|58757506|FG001|First Intervention|Adverse Event|0|||
30747230|NCT00311168|58757505|FG000|First Intervention|Other|2|||
30747231|NCT00311168|58757506|FG001|First Intervention|Other|2|||
30747232|NCT00311168|58757505|FG000|Second Intervention|Lost to Follow-up|9|||
30800238|NCT02539160|58815840|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
30800239|NCT02539160|58815837|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
30800240|NCT02539160|58815838|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
30800241|NCT02539160|58815839|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
30800242|NCT02539160|58815840|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
30800243|NCT04292899|58815854|FG000|Overall Study|Death|21|||
30800244|NCT04292899|58815855|FG001|Overall Study|Death|28|||
30800245|NCT04292899|58815856|FG002|Overall Study|Death|188|||
30800246|NCT04292899|58815857|FG003|Overall Study|Death|371|||
30747233|NCT00311168|58757506|FG001|Second Intervention|Lost to Follow-up|2|||
30747234|NCT00311168|58757505|FG000|Second Intervention|Withdrawal by Subject|0|||
30747235|NCT00311168|58757506|FG001|Second Intervention|Withdrawal by Subject|1|||
30747236|NCT00311168|58757505|FG000|Second Intervention|Other|1|||
30747237|NCT00311168|58757506|FG001|Second Intervention|Other|1|||
30747238|NCT00458705|58757514|FG000|Overall Study|Adverse Event|4|||
30747239|NCT00458705|58757514|FG000|Overall Study|Not Treated|1|||
30747240|NCT00062374|58757518|FG000|Overall Study|Not treated|12|||
30800247|NCT04292899|58815854|FG000|Overall Study|Lost to Follow-up|8|||
30800248|NCT04292899|58815855|FG001|Overall Study|Lost to Follow-up|4|||
30800249|NCT04292899|58815856|FG002|Overall Study|Lost to Follow-up|22|||
30800250|NCT04292899|58815857|FG003|Overall Study|Lost to Follow-up|235|||
30800251|NCT04292899|58815854|FG000|Overall Study|Withdrew consent|1|||
30800252|NCT04292899|58815855|FG001|Overall Study|Withdrew consent|0|||
30800253|NCT04292899|58815856|FG002|Overall Study|Withdrew consent|11|||
30800254|NCT04292899|58815857|FG003|Overall Study|Withdrew consent|32|||
30800255|NCT04292899|58815854|FG000|Overall Study|Adverse Event|2|||
30800256|NCT04292899|58815855|FG001|Overall Study|Adverse Event|1|||
30800257|NCT04292899|58815856|FG002|Overall Study|Adverse Event|2|||
30800258|NCT04292899|58815857|FG003|Overall Study|Adverse Event|2|||
30800259|NCT04292899|58815854|FG000|Overall Study|Investigator's Discretion|0|||
30800260|NCT04292899|58815855|FG001|Overall Study|Investigator's Discretion|0|||
30800261|NCT04292899|58815856|FG002|Overall Study|Investigator's Discretion|0|||
30800262|NCT04292899|58815857|FG003|Overall Study|Investigator's Discretion|3|||
30800263|NCT04292899|58815854|FG000|Overall Study|Non-compliance With Study Drug|0|||
30800264|NCT04292899|58815855|FG001|Overall Study|Non-compliance With Study Drug|0|||
30747241|NCT00285818|58757524|FG000|Overall Study|Withdrawal by Subject|3|||
30747242|NCT00285818|58757525|FG001|Overall Study|Withdrawal by Subject|2|||
30747243|NCT00285818|58757524|FG000|Overall Study|Lost to Follow-up|1|||
30747244|NCT00285818|58757525|FG001|Overall Study|Lost to Follow-up|0|||
30747245|NCT00285584|58757533|FG000|Month 3|Lost to Follow-up|3|||
30747246|NCT00285584|58757534|FG001|Month 3|Lost to Follow-up|3|||
30747247|NCT00285584|58757533|FG000|Month 3|Withdrawal by Subject|1|||
30747248|NCT00285584|58757534|FG001|Month 3|Withdrawal by Subject|0|||
30747249|NCT00285584|58757533|FG000|Month 6|Lost to Follow-up|0|||
30747250|NCT00285584|58757534|FG001|Month 6|Lost to Follow-up|1|||
30747251|NCT03807700|58757546|FG000|Overall Study|Withdrawal by Subject|2|||
30747252|NCT03807700|58757547|FG001|Overall Study|Withdrawal by Subject|1|||
30747253|NCT00291668|58757557|FG000|Overall Study|Lack of Efficacy|1|||
30800265|NCT04292899|58815856|FG002|Overall Study|Non-compliance With Study Drug|0|||
30800266|NCT04292899|58815857|FG003|Overall Study|Non-compliance With Study Drug|1|||
30800267|NCT04292899|58815854|FG000|Overall Study|Protocol Violation|0|||
30905955|NCT01636687|58940515|FG000|Induction Period|Withdrawal by Subject|1|||
30905956|NCT01636687|58940516|FG001|Induction Period|Withdrawal by Subject|0|||
30905957|NCT01636687|58940517|FG002|Induction Period|Withdrawal by Subject|0|||
30905958|NCT01636687|58940518|FG003|Induction Period|Withdrawal by Subject|0|||
30800268|NCT04292899|58815855|FG001|Overall Study|Protocol Violation|0|||
30800269|NCT04292899|58815856|FG002|Overall Study|Protocol Violation|0|||
30800270|NCT04292899|58815857|FG003|Overall Study|Protocol Violation|1|||
30800271|NCT03241173|58815876|FG000|Overall Study|Death|3|||
30800272|NCT03241173|58815877|FG001|Overall Study|Death|2|||
30800273|NCT03241173|58815878|FG002|Overall Study|Death|4|||
30800274|NCT03241173|58815879|FG003|Overall Study|Death|4|||
30800275|NCT03241173|58815880|FG004|Overall Study|Death|2|||
30800276|NCT03241173|58815881|FG005|Overall Study|Death|2|||
30800277|NCT03241173|58815882|FG006|Overall Study|Death|3|||
30800278|NCT03241173|58815883|FG007|Overall Study|Death|1|||
30800279|NCT03241173|58815884|FG008|Overall Study|Death|0|||
30800280|NCT03241173|58815885|FG009|Overall Study|Death|5|||
30800281|NCT03241173|58815886|FG010|Overall Study|Death|4|||
30800282|NCT03241173|58815887|FG011|Overall Study|Death|3|||
30800283|NCT03241173|58815888|FG012|Overall Study|Death|0|||
30800284|NCT03241173|58815889|FG013|Overall Study|Death|0|||
30800285|NCT03241173|58815890|FG014|Overall Study|Death|0|||
30800286|NCT03241173|58815876|FG000|Overall Study|Withdrawal by Subject|0|||
30800287|NCT03241173|58815877|FG001|Overall Study|Withdrawal by Subject|0|||
30800288|NCT03241173|58815878|FG002|Overall Study|Withdrawal by Subject|1|||
30800289|NCT03241173|58815879|FG003|Overall Study|Withdrawal by Subject|0|||
30800290|NCT03241173|58815880|FG004|Overall Study|Withdrawal by Subject|0|||
30800291|NCT03241173|58815881|FG005|Overall Study|Withdrawal by Subject|1|||
30800292|NCT03241173|58815882|FG006|Overall Study|Withdrawal by Subject|0|||
30800293|NCT03241173|58815883|FG007|Overall Study|Withdrawal by Subject|0|||
30800294|NCT03241173|58815884|FG008|Overall Study|Withdrawal by Subject|0|||
30800295|NCT03241173|58815885|FG009|Overall Study|Withdrawal by Subject|0|||
30800296|NCT03241173|58815886|FG010|Overall Study|Withdrawal by Subject|0|||
30800297|NCT03241173|58815887|FG011|Overall Study|Withdrawal by Subject|0|||
30800298|NCT03241173|58815888|FG012|Overall Study|Withdrawal by Subject|0|||
30800299|NCT03241173|58815889|FG013|Overall Study|Withdrawal by Subject|0|||
30800300|NCT03241173|58815890|FG014|Overall Study|Withdrawal by Subject|0|||
30905959|NCT01636687|58940519|FG004|Induction Period|Withdrawal by Subject|0|||
30905960|NCT01636687|58940515|FG000|Induction Period|Adverse Event|1|||
30747254|NCT00291668|58757558|FG001|Overall Study|Lack of Efficacy|0|||
30747255|NCT00291668|58757559|FG002|Overall Study|Lack of Efficacy|0|||
30800301|NCT03241173|58815876|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
30800302|NCT03241173|58815877|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
30800303|NCT03241173|58815878|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
30800304|NCT03241173|58815879|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
30800305|NCT03241173|58815880|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
30800306|NCT03241173|58815881|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
30800307|NCT03241173|58815882|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
30905961|NCT01636687|58940516|FG001|Induction Period|Adverse Event|0|||
30747256|NCT00291668|58757557|FG000|Overall Study|SAE, non-fatal|1|||
30905962|NCT01636687|58940517|FG002|Induction Period|Adverse Event|0|||
30800308|NCT03241173|58815883|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
30905963|NCT01636687|58940518|FG003|Induction Period|Adverse Event|0|||
30800309|NCT03241173|58815884|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
30800310|NCT03241173|58815885|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
30800311|NCT03241173|58815886|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
30800312|NCT03241173|58815887|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
30800313|NCT03241173|58815888|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
30800314|NCT03241173|58815889|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
30800315|NCT03241173|58815890|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
30800316|NCT03241173|58815876|FG000|Overall Study|Lost to Follow-up|0|||
30800317|NCT03241173|58815877|FG001|Overall Study|Lost to Follow-up|0|||
30800318|NCT03241173|58815878|FG002|Overall Study|Lost to Follow-up|0|||
30800319|NCT03241173|58815879|FG003|Overall Study|Lost to Follow-up|0|||
30800320|NCT03241173|58815880|FG004|Overall Study|Lost to Follow-up|1|||
30800321|NCT03241173|58815881|FG005|Overall Study|Lost to Follow-up|0|||
30800322|NCT03241173|58815882|FG006|Overall Study|Lost to Follow-up|0|||
30800323|NCT03241173|58815883|FG007|Overall Study|Lost to Follow-up|0|||
30800324|NCT03241173|58815884|FG008|Overall Study|Lost to Follow-up|0|||
30800325|NCT03241173|58815885|FG009|Overall Study|Lost to Follow-up|1|||
30905964|NCT01636687|58940519|FG004|Induction Period|Adverse Event|1|||
30905965|NCT01636687|58940515|FG000|Induction Period|Lack of Efficacy|0|||
30905966|NCT01636687|58940516|FG001|Induction Period|Lack of Efficacy|0|||
30905967|NCT01636687|58940517|FG002|Induction Period|Lack of Efficacy|0|||
30905968|NCT01636687|58940518|FG003|Induction Period|Lack of Efficacy|0|||
30905969|NCT01636687|58940519|FG004|Induction Period|Lack of Efficacy|1|||
30905970|NCT01636687|58940515|FG000|Induction Period|Physician Decision|1|||
30905971|NCT01636687|58940516|FG001|Induction Period|Physician Decision|0|||
30905972|NCT01636687|58940517|FG002|Induction Period|Physician Decision|0|||
30905973|NCT01636687|58940518|FG003|Induction Period|Physician Decision|0|||
30905974|NCT01636687|58940519|FG004|Induction Period|Physician Decision|0|||
30905975|NCT01636687|58940515|FG000|Maintenance Period|Withdrawal by Subject|2|||
30905976|NCT01636687|58940516|FG001|Maintenance Period|Withdrawal by Subject|0|||
30905977|NCT01636687|58940517|FG002|Maintenance Period|Withdrawal by Subject|2|||
30905978|NCT01636687|58940518|FG003|Maintenance Period|Withdrawal by Subject|0|||
30905979|NCT01636687|58940519|FG004|Maintenance Period|Withdrawal by Subject|0|||
30905980|NCT01636687|58940515|FG000|Maintenance Period|Adverse Event|1|||
30905981|NCT01636687|58940516|FG001|Maintenance Period|Adverse Event|0|||
30905982|NCT01636687|58940517|FG002|Maintenance Period|Adverse Event|0|||
30747257|NCT00291668|58757558|FG001|Overall Study|SAE, non-fatal|1|||
30747258|NCT00291668|58757559|FG002|Overall Study|SAE, non-fatal|1|||
30747259|NCT00291668|58757557|FG000|Overall Study|AE, non-serious non-fatal|1|||
30747260|NCT00291668|58757558|FG001|Overall Study|AE, non-serious non-fatal|0|||
30747261|NCT00291668|58757559|FG002|Overall Study|AE, non-serious non-fatal|0|||
30747262|NCT00291668|58757557|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
30747263|NCT00291668|58757558|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
30747264|NCT00291668|58757559|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
30747265|NCT00458393|58757569|FG000|Overall Study|Withdrawal by Subject|67|||
30747266|NCT00458393|58757570|FG001|Overall Study|Withdrawal by Subject|80|||
30747267|NCT00458393|58757569|FG000|Overall Study|Physician Decision|31|||
30747268|NCT00458393|58757570|FG001|Overall Study|Physician Decision|22|||
30800326|NCT03241173|58815886|FG010|Overall Study|Lost to Follow-up|0|||
30800327|NCT03241173|58815887|FG011|Overall Study|Lost to Follow-up|0|||
30800328|NCT03241173|58815888|FG012|Overall Study|Lost to Follow-up|0|||
30905983|NCT01636687|58940518|FG003|Maintenance Period|Adverse Event|0|||
30905984|NCT01636687|58940519|FG004|Maintenance Period|Adverse Event|0|||
30905985|NCT01636687|58940515|FG000|Maintenance Period|Lack of Efficacy|4|||
30905986|NCT01636687|58940516|FG001|Maintenance Period|Lack of Efficacy|1|||
30905987|NCT01636687|58940517|FG002|Maintenance Period|Lack of Efficacy|0|||
30800329|NCT03241173|58815889|FG013|Overall Study|Lost to Follow-up|0|||
30905988|NCT01636687|58940518|FG003|Maintenance Period|Lack of Efficacy|0|||
30905989|NCT01636687|58940519|FG004|Maintenance Period|Lack of Efficacy|0|||
30905990|NCT01636687|58940515|FG000|Maintenance Period|Lost to Follow-up|1|||
30905991|NCT01636687|58940516|FG001|Maintenance Period|Lost to Follow-up|1|||
30800330|NCT03241173|58815890|FG014|Overall Study|Lost to Follow-up|0|||
30800331|NCT03264066|58815924|FG000|Overall Study|Adverse Event|1|||
30800332|NCT03264066|58815925|FG001|Overall Study|Adverse Event|1|||
30800333|NCT03264066|58815926|FG002|Overall Study|Adverse Event|0|||
30800334|NCT03264066|58815927|FG003|Overall Study|Adverse Event|0|||
30800335|NCT03264066|58815928|FG004|Overall Study|Adverse Event|0|||
30800336|NCT03264066|58815929|FG005|Overall Study|Adverse Event|0|||
30800337|NCT03264066|58815924|FG000|Overall Study|Death|12|||
30747269|NCT00458393|58757569|FG000|Overall Study|Relocated|77|||
30747270|NCT00458393|58757570|FG001|Overall Study|Relocated|81|||
30800338|NCT03264066|58815925|FG001|Overall Study|Death|12|||
30800339|NCT03264066|58815926|FG002|Overall Study|Death|8|||
30800340|NCT03264066|58815927|FG003|Overall Study|Death|10|||
30800341|NCT03264066|58815928|FG004|Overall Study|Death|6|||
30800342|NCT03264066|58815929|FG005|Overall Study|Death|1|||
30800343|NCT03264066|58815924|FG000|Overall Study|Lost to Follow-up|1|||
30800344|NCT03264066|58815925|FG001|Overall Study|Lost to Follow-up|0|||
30800345|NCT03264066|58815926|FG002|Overall Study|Lost to Follow-up|0|||
30800346|NCT03264066|58815927|FG003|Overall Study|Lost to Follow-up|0|||
30800347|NCT03264066|58815928|FG004|Overall Study|Lost to Follow-up|0|||
30905992|NCT01636687|58940517|FG002|Maintenance Period|Lost to Follow-up|0|||
30747271|NCT00458393|58757569|FG000|Overall Study|Lost to Follow-up|115|||
30800348|NCT03264066|58815929|FG005|Overall Study|Lost to Follow-up|0|||
30800349|NCT03264066|58815924|FG000|Overall Study|Progressive Disease|0|||
30800350|NCT03264066|58815925|FG001|Overall Study|Progressive Disease|2|||
30800351|NCT03264066|58815926|FG002|Overall Study|Progressive Disease|1|||
30800352|NCT03264066|58815927|FG003|Overall Study|Progressive Disease|0|||
30800353|NCT03264066|58815928|FG004|Overall Study|Progressive Disease|0|||
30800354|NCT03264066|58815929|FG005|Overall Study|Progressive Disease|0|||
30800355|NCT03264066|58815924|FG000|Overall Study|Study Terminated by Sponsor|5|||
30800356|NCT03264066|58815925|FG001|Overall Study|Study Terminated by Sponsor|5|||
30800357|NCT03264066|58815926|FG002|Overall Study|Study Terminated by Sponsor|8|||
30800358|NCT03264066|58815927|FG003|Overall Study|Study Terminated by Sponsor|5|||
30800359|NCT03264066|58815928|FG004|Overall Study|Study Terminated by Sponsor|1|||
30800360|NCT03264066|58815929|FG005|Overall Study|Study Terminated by Sponsor|2|||
30905993|NCT01636687|58940518|FG003|Maintenance Period|Lost to Follow-up|0|||
30905994|NCT01636687|58940519|FG004|Maintenance Period|Lost to Follow-up|1|||
30747272|NCT00458393|58757570|FG001|Overall Study|Lost to Follow-up|92|||
30747273|NCT00458393|58757569|FG000|Overall Study|Sites marked other on the form.|19|||
30747274|NCT00458393|58757570|FG001|Overall Study|Sites marked other on the form.|20|||
30747275|NCT00310856|58757581|FG000|Overall Study|Withdrawal by Subject|2|||
30747276|NCT00310856|58757582|FG001|Overall Study|Withdrawal by Subject|2|||
30747277|NCT00310856|58757583|FG002|Overall Study|Withdrawal by Subject|2|||
30747278|NCT00310856|58757581|FG000|Overall Study|Lost to Follow-up|1|||
30747279|NCT00310856|58757582|FG001|Overall Study|Lost to Follow-up|2|||
30747280|NCT00310856|58757583|FG002|Overall Study|Lost to Follow-up|6|||
30747281|NCT00310856|58757581|FG000|Overall Study|Inappropriate enrollment|1|||
30747282|NCT00310856|58757582|FG001|Overall Study|Inappropriate enrollment|1|||
30747283|NCT00310856|58757583|FG002|Overall Study|Inappropriate enrollment|0|||
30747284|NCT00310856|58757581|FG000|Overall Study|Unable to classify|1|||
30747285|NCT00310856|58757582|FG001|Overall Study|Unable to classify|0|||
30747286|NCT00310856|58757583|FG002|Overall Study|Unable to classify|0|||
30747287|NCT00283712|58757594|FG000|Overall Study|Death|0|||
30747288|NCT00283712|58757595|FG001|Overall Study|Death|1|||
30747289|NCT00048724|58757603|FG000|Overall Study|Adverse Event|53|||
30747290|NCT00048724|58757604|FG001|Overall Study|Adverse Event|12|||
30747291|NCT00048724|58757603|FG000|Overall Study|Withdrawal by Subject|34|||
30800361|NCT03264066|58815924|FG000|Overall Study|Withdrawal by Subject|1|||
30800362|NCT03264066|58815925|FG001|Overall Study|Withdrawal by Subject|0|||
30747292|NCT00048724|58757604|FG001|Overall Study|Withdrawal by Subject|54|||
30747293|NCT00048724|58757603|FG000|Overall Study|Lost to Follow-up|5|||
30747294|NCT00048724|58757604|FG001|Overall Study|Lost to Follow-up|5|||
30747295|NCT00048724|58757603|FG000|Overall Study|Protocol-defined Clinical Event|17|||
30800363|NCT03264066|58815926|FG002|Overall Study|Withdrawal by Subject|0|||
30800364|NCT03264066|58815927|FG003|Overall Study|Withdrawal by Subject|5|||
30800365|NCT03264066|58815928|FG004|Overall Study|Withdrawal by Subject|0|||
30800366|NCT03264066|58815929|FG005|Overall Study|Withdrawal by Subject|0|||
30800367|NCT03759041|58815947|FG000|Overall Study|Withdrawal by Subject|4|||
30800368|NCT03759041|58815948|FG001|Overall Study|Withdrawal by Subject|10|||
30800369|NCT03759041|58815949|FG002|Overall Study|Withdrawal by Subject|10|||
30800370|NCT03759041|58815947|FG000|Overall Study|Adverse Event|1|||
30800371|NCT03759041|58815948|FG001|Overall Study|Adverse Event|3|||
30800372|NCT03759041|58815949|FG002|Overall Study|Adverse Event|4|||
30800373|NCT03759041|58815947|FG000|Overall Study|Lack of Efficacy|0|||
30800374|NCT03759041|58815948|FG001|Overall Study|Lack of Efficacy|0|||
30800375|NCT03759041|58815949|FG002|Overall Study|Lack of Efficacy|1|||
30800376|NCT03759041|58815947|FG000|Overall Study|Study Terminated by Sponsor|15|||
30800377|NCT03759041|58815948|FG001|Overall Study|Study Terminated by Sponsor|16|||
30800378|NCT03759041|58815949|FG002|Overall Study|Study Terminated by Sponsor|10|||
30800379|NCT03759041|58815947|FG000|Overall Study|Other reason for discontinuation|0|||
30800380|NCT03759041|58815948|FG001|Overall Study|Other reason for discontinuation|2|||
30800381|NCT03759041|58815949|FG002|Overall Study|Other reason for discontinuation|1|||
30800382|NCT03759041|58815947|FG000|Overall Study|Lost to Follow-up|7|||
30905995|NCT01636687|58940515|FG000|Maintenance Period|Physician Decision|0|||
30905996|NCT01636687|58940516|FG001|Maintenance Period|Physician Decision|0|||
30905997|NCT01636687|58940517|FG002|Maintenance Period|Physician Decision|0|||
30905998|NCT01636687|58940518|FG003|Maintenance Period|Physician Decision|0|||
30905999|NCT01636687|58940519|FG004|Maintenance Period|Physician Decision|1|||
30906000|NCT01636687|58940515|FG000|Extension Period|technical problems|0|||
30747296|NCT00048724|58757604|FG001|Overall Study|Protocol-defined Clinical Event|32|||
30747297|NCT00048724|58757603|FG000|Overall Study|Noncompliance With Protocol|4|||
30800383|NCT03759041|58815948|FG001|Overall Study|Lost to Follow-up|2|||
30800384|NCT03759041|58815949|FG002|Overall Study|Lost to Follow-up|2|||
30800385|NCT03759041|58815947|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
30800386|NCT03759041|58815948|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
30800387|NCT03759041|58815949|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
30800388|NCT04110145|58815962|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
30800389|NCT04110145|58815963|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
30800390|NCT04110145|58815964|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
30800391|NCT04110145|58815965|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
30800392|NCT04110145|58815966|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
30800393|NCT02477618|58815980|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
30800394|NCT02477618|58815981|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
30800395|NCT02477618|58815980|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
30800396|NCT02477618|58815981|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
30800397|NCT02477618|58815980|FG000|Overall Study|Adverse Event|1|||
30800398|NCT02477618|58815981|FG001|Overall Study|Adverse Event|1|||
30747298|NCT00048724|58757604|FG001|Overall Study|Noncompliance With Protocol|12|||
30747299|NCT00048724|58757603|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
30747300|NCT00048724|58757604|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
30747301|NCT00048724|58757603|FG000|Overall Study|Administrative|1|||
30747302|NCT00048724|58757604|FG001|Overall Study|Administrative|1|||
30747303|NCT00449033|58757612|FG000|Treatment Period|Adverse Event|117|||
30747304|NCT00449033|58757613|FG001|Treatment Period|Adverse Event|83|||
30747305|NCT00449033|58757612|FG000|Treatment Period|Death|21|||
30747306|NCT00449033|58757613|FG001|Treatment Period|Death|12|||
30747307|NCT00449033|58757612|FG000|Treatment Period|Lost to Follow-up|0|||
30747308|NCT00449033|58757613|FG001|Treatment Period|Lost to Follow-up|2|||
30747309|NCT00449033|58757612|FG000|Treatment Period|Physician Decision|4|||
30747310|NCT00449033|58757613|FG001|Treatment Period|Physician Decision|5|||
30747311|NCT00449033|58757612|FG000|Treatment Period|Protocol Violation|8|||
30747312|NCT00449033|58757613|FG001|Treatment Period|Protocol Violation|7|||
30747313|NCT00449033|58757612|FG000|Treatment Period|Disease Progression|231|||
30747314|NCT00449033|58757613|FG001|Treatment Period|Disease Progression|288|||
30747315|NCT00449033|58757612|FG000|Treatment Period|Consent Withdrawn|36|||
30747316|NCT00449033|58757613|FG001|Treatment Period|Consent Withdrawn|20|||
30800399|NCT02477618|58815980|FG000|Overall Study|Transferred Away from Study Site|1|||
30800400|NCT02477618|58815981|FG001|Overall Study|Transferred Away from Study Site|0|||
30800401|NCT02477618|58815980|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
30906001|NCT01636687|58940516|FG001|Extension Period|technical problems|1|||
30906002|NCT01636687|58940517|FG002|Extension Period|technical problems|2|||
30906003|NCT01636687|58940518|FG003|Extension Period|technical problems|1|||
30800402|NCT02477618|58815981|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
30800403|NCT04102501|58815989|FG000|Overall Study|Withdrawal by Subject|7|||
30800404|NCT04102501|58815990|FG001|Overall Study|Withdrawal by Subject|9|||
30800405|NCT04102501|58815989|FG000|Overall Study|Adverse Event|1|||
30800406|NCT04102501|58815990|FG001|Overall Study|Adverse Event|3|||
30800407|NCT03285477|58816000|FG000|Treatment and Response Assessment Period|Death|1|||
30800408|NCT03285477|58816001|FG001|Treatment and Response Assessment Period|Death|0|||
30800409|NCT03285477|58816000|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
30800410|NCT03285477|58816001|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
30800411|NCT03285477|58816000|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
30800412|NCT03285477|58816001|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
30800413|NCT03285477|58816000|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
30800414|NCT03285477|58816001|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
30800415|NCT03285477|58816000|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
30800416|NCT03285477|58816001|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
30800417|NCT04289623|58816018|FG000|Wave 1 Emails|Email was not delivered|268|||
30800418|NCT04289623|58816019|FG001|Wave 1 Emails|Email was not delivered|257|||
30800419|NCT04289623|58816020|FG002|Wave 1 Emails|Email was not delivered|0|||
30800420|NCT04289623|58816021|FG003|Wave 1 Emails|Email was not delivered|0|||
30800421|NCT04289623|58816022|FG004|Wave 1 Emails|Email was not delivered|0|||
30800422|NCT04289623|58816023|FG005|Wave 1 Emails|Email was not delivered|0|||
30800423|NCT03248037|58816039|FG000|Overall Study|Withdrawal by Subject|6|||
30800424|NCT03248037|58816040|FG001|Overall Study|Withdrawal by Subject|9|||
30800425|NCT03248037|58816039|FG000|Overall Study|Adverse Event|15|||
30800426|NCT03248037|58816040|FG001|Overall Study|Adverse Event|0|||
30800427|NCT04287517|58816055|FG000|Overall Study|Withdrawal by Subject|1|||
30800428|NCT04287517|58816056|FG001|Overall Study|Withdrawal by Subject|1|||
30800429|NCT03284229|58816062|FG000|Overall Study|Lost to Follow-up|3|||
30800430|NCT03242928|58816069|FG000|Overall Study|Adverse Event|2|||
30800431|NCT03242928|58816070|FG001|Overall Study|Adverse Event|1|||
30800432|NCT03242928|58816069|FG000|Overall Study|Lost to Follow-up|2|||
30800433|NCT03242928|58816070|FG001|Overall Study|Lost to Follow-up|0|||
30800434|NCT03242928|58816069|FG000|Overall Study|Physician Decision|0|||
30800435|NCT03242928|58816070|FG001|Overall Study|Physician Decision|1|||
30800436|NCT03242928|58816069|FG000|Overall Study|Withdrawal by Subject|5|||
30800437|NCT03242928|58816070|FG001|Overall Study|Withdrawal by Subject|3|||
30800438|NCT03300024|58816078|FG000|Overall Study|Physician Decision|4|||
30800439|NCT03300024|58816079|FG001|Overall Study|Physician Decision|6|||
30800440|NCT04276207|58816087|FG000|Period 1|Withdrawal by Subject|0|||
30800441|NCT04276207|58816088|FG001|Period 1|Withdrawal by Subject|1|||
30800442|NCT03282357|58816094|FG000|Overall Study|Lost to Follow-up|3|||
30800443|NCT03282357|58816094|FG000|Overall Study|Withdrawal by Subject|4|||
30800444|NCT03282357|58816094|FG000|Overall Study|Adverse Event|1|||
30800445|NCT03282357|58816094|FG000|Overall Study|Other|9|||
30800446|NCT04272775|58816101|FG000|Overall Study|Study Terminated by Sponsor|1|||
30800447|NCT04272775|58816102|FG001|Overall Study|Study Terminated by Sponsor|0|||
30800448|NCT04272775|58816101|FG000|Overall Study|Protocol Violation|0|||
30800449|NCT04272775|58816102|FG001|Overall Study|Protocol Violation|1|||
30800450|NCT04272775|58816101|FG000|Overall Study|Symptomatic Deterioration|1|||
30800451|NCT04272775|58816102|FG001|Overall Study|Symptomatic Deterioration|1|||
30800452|NCT04272775|58816101|FG000|Overall Study|Withdrawal by Subject|1|||
30800453|NCT04272775|58816102|FG001|Overall Study|Withdrawal by Subject|2|||
30800454|NCT04272775|58816101|FG000|Overall Study|Adverse Event|1|||
30800455|NCT04272775|58816102|FG001|Overall Study|Adverse Event|2|||
30800456|NCT04272775|58816101|FG000|Overall Study|Progressive Disease|3|||
30800457|NCT04272775|58816102|FG001|Overall Study|Progressive Disease|1|||
30800458|NCT03232983|58816108|FG000|Period 1|Physician Decision|0|||
30800459|NCT03232983|58816109|FG001|Period 1|Physician Decision|0|||
30800460|NCT03232983|58816110|FG002|Period 1|Physician Decision|1|||
30800461|NCT03232983|58816111|FG003|Period 1|Physician Decision|0|||
30800462|NCT03232983|58816108|FG000|Washout Period 2|Physician Decision|0|||
30800463|NCT03232983|58816109|FG001|Washout Period 2|Physician Decision|0|||
30800464|NCT03232983|58816110|FG002|Washout Period 2|Physician Decision|1|||
30906004|NCT01636687|58940519|FG004|Extension Period|technical problems|0|||
30800465|NCT03232983|58816111|FG003|Washout Period 2|Physician Decision|0|||
30800466|NCT03232983|58816108|FG000|Washout Period 2|Withdrawal by Subject|0|||
30800467|NCT03232983|58816109|FG001|Washout Period 2|Withdrawal by Subject|0|||
30800468|NCT03232983|58816110|FG002|Washout Period 2|Withdrawal by Subject|0|||
30800469|NCT03232983|58816111|FG003|Washout Period 2|Withdrawal by Subject|1|||
30800470|NCT03232983|58816108|FG000|Period 4|Withdrawal by Subject|1|||
30800471|NCT03232983|58816109|FG001|Period 4|Withdrawal by Subject|0|||
30800472|NCT03232983|58816110|FG002|Period 4|Withdrawal by Subject|0|||
30800473|NCT03232983|58816111|FG003|Period 4|Withdrawal by Subject|0|||
30906005|NCT01636687|58940515|FG000|Extension Period|Adverse Event|4|||
30800474|NCT04102345|58816125|FG000|Overall Study|Withdrawal by Subject|1|||
30800475|NCT04102345|58816126|FG001|Overall Study|Withdrawal by Subject|0|||
30800476|NCT04271605|58816132|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
30800477|NCT03299244|58816138|FG000|Overall Study|Withdrawal by Subject|34|||
30800478|NCT03299244|58816139|FG001|Overall Study|Withdrawal by Subject|29|||
30800479|NCT03299244|58816138|FG000|Overall Study|Decision by Sponsor|4|||
30800480|NCT03299244|58816139|FG001|Overall Study|Decision by Sponsor|5|||
30800481|NCT03299244|58816138|FG000|Overall Study|Death|9|||
30800482|NCT03299244|58816139|FG001|Overall Study|Death|4|||
30800483|NCT03757715|58816148|FG000|Overall Study|Lost to Follow-up|4|||
30906006|NCT01636687|58940516|FG001|Extension Period|Adverse Event|3|||
30906007|NCT01636687|58940517|FG002|Extension Period|Adverse Event|2|||
30906008|NCT01636687|58940518|FG003|Extension Period|Adverse Event|1|||
30906009|NCT01636687|58940519|FG004|Extension Period|Adverse Event|0|||
30906010|NCT01636687|58940515|FG000|Extension Period|Lack of Efficacy|7|||
30906011|NCT01636687|58940516|FG001|Extension Period|Lack of Efficacy|0|||
30800484|NCT03757715|58816149|FG001|Overall Study|Lost to Follow-up|9|||
30800485|NCT03757715|58816148|FG000|Overall Study|Withdrawal by Subject|1|||
30800486|NCT03757715|58816149|FG001|Overall Study|Withdrawal by Subject|1|||
30800487|NCT03281577|58816159|FG000|Overall Study|Adverse Event|0|||
30800488|NCT03281577|58816160|FG001|Overall Study|Adverse Event|0|||
30800489|NCT03281577|58816161|FG002|Overall Study|Adverse Event|0|||
30800490|NCT03281577|58816162|FG003|Overall Study|Adverse Event|1|||
30800491|NCT03281577|58816159|FG000|Overall Study|Withdrawal by Subject|1|||
30800492|NCT03281577|58816160|FG001|Overall Study|Withdrawal by Subject|0|||
30800493|NCT03281577|58816161|FG002|Overall Study|Withdrawal by Subject|0|||
30800494|NCT03281577|58816162|FG003|Overall Study|Withdrawal by Subject|0|||
30800495|NCT04098367|58816178|FG000|Overall Study|Adverse Event|0|||
30800496|NCT04098367|58816179|FG001|Overall Study|Adverse Event|0|||
30800497|NCT04098367|58816180|FG002|Overall Study|Adverse Event|1|||
30800498|NCT04098367|58816178|FG000|Overall Study|Lost to Follow-up|1|||
30800499|NCT04098367|58816179|FG001|Overall Study|Lost to Follow-up|5|||
30800500|NCT04098367|58816180|FG002|Overall Study|Lost to Follow-up|2|||
30800501|NCT04098367|58816178|FG000|Overall Study|Withdrawal by Subject|0|||
30800502|NCT04098367|58816179|FG001|Overall Study|Withdrawal by Subject|0|||
30800503|NCT04098367|58816180|FG002|Overall Study|Withdrawal by Subject|1|||
30800504|NCT04098367|58816178|FG000|Overall Study|Sick . Could not attend visit|1|||
30800505|NCT04098367|58816179|FG001|Overall Study|Sick . Could not attend visit|0|||
30800506|NCT04098367|58816180|FG002|Overall Study|Sick . Could not attend visit|0|||
30800507|NCT03759587|58816195|FG000|Overall Study|Ongoing|19|||
30800508|NCT04091659|58816201|FG000|Overall Study|Protocol Violation|3|||
30906012|NCT01636687|58940517|FG002|Extension Period|Lack of Efficacy|2|||
30906013|NCT01636687|58940518|FG003|Extension Period|Lack of Efficacy|1|||
30906014|NCT01636687|58940519|FG004|Extension Period|Lack of Efficacy|0|||
30906015|NCT01636687|58940515|FG000|Extension Period|Lost to Follow-up|1|||
30800509|NCT04091659|58816202|FG001|Overall Study|Protocol Violation|0|||
30800510|NCT04091659|58816201|FG000|Overall Study|Lost to Follow-up|0|||
30800511|NCT04091659|58816202|FG001|Overall Study|Lost to Follow-up|1|||
30800512|NCT04256785|58816239|FG000|Overall Study|Adverse Event|8|||
30800513|NCT04256785|58816240|FG001|Overall Study|Adverse Event|6|||
30800514|NCT04256785|58816239|FG000|Overall Study|Lack of Efficacy|3|||
30800515|NCT04256785|58816240|FG001|Overall Study|Lack of Efficacy|4|||
30800516|NCT04256785|58816239|FG000|Overall Study|Lost to Follow-up|7|||
30800517|NCT04256785|58816240|FG001|Overall Study|Lost to Follow-up|7|||
30800518|NCT04256785|58816239|FG000|Overall Study|Protocol Violation|1|||
30800519|NCT04256785|58816240|FG001|Overall Study|Protocol Violation|0|||
30800520|NCT04256785|58816239|FG000|Overall Study|Withdrawal by Subject|4|||
30800521|NCT04256785|58816240|FG001|Overall Study|Withdrawal by Subject|1|||
30800522|NCT04256785|58816239|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
30800523|NCT04256785|58816240|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
30800524|NCT02959918|58816262|FG000|Overall Study|Adverse Event|1|||
30800525|NCT02959918|58816263|FG001|Overall Study|Adverse Event|1|||
30800526|NCT02959918|58816264|FG002|Overall Study|Adverse Event|2|||
30800527|NCT02959918|58816265|FG003|Overall Study|Adverse Event|0|||
30800528|NCT02959918|58816266|FG004|Overall Study|Adverse Event|0|||
30800529|NCT02959918|58816267|FG005|Overall Study|Adverse Event|2|||
30800530|NCT02959918|58816268|FG006|Overall Study|Adverse Event|2|||
30800531|NCT02959918|58816269|FG007|Overall Study|Adverse Event|1|||
30800532|NCT02959918|58816270|FG008|Overall Study|Adverse Event|2|||
30800533|NCT02959918|58816271|FG009|Overall Study|Adverse Event|1|||
30800534|NCT02959918|58816272|FG010|Overall Study|Adverse Event|1|||
30800535|NCT02959918|58816273|FG011|Overall Study|Adverse Event|3|||
30800536|NCT02959918|58816274|FG012|Overall Study|Adverse Event|2|||
30800537|NCT02959918|58816275|FG013|Overall Study|Adverse Event|4|||
30906016|NCT01636687|58940516|FG001|Extension Period|Lost to Follow-up|0|||
30800538|NCT02959918|58816262|FG000|Overall Study|Lost to Follow-up|0|||
30800539|NCT02959918|58816263|FG001|Overall Study|Lost to Follow-up|0|||
30800540|NCT02959918|58816264|FG002|Overall Study|Lost to Follow-up|0|||
30800541|NCT02959918|58816265|FG003|Overall Study|Lost to Follow-up|0|||
30800542|NCT02959918|58816266|FG004|Overall Study|Lost to Follow-up|0|||
30800543|NCT02959918|58816267|FG005|Overall Study|Lost to Follow-up|0|||
30800544|NCT02959918|58816268|FG006|Overall Study|Lost to Follow-up|0|||
30800545|NCT02959918|58816269|FG007|Overall Study|Lost to Follow-up|0|||
30800546|NCT02959918|58816270|FG008|Overall Study|Lost to Follow-up|0|||
30800547|NCT02959918|58816271|FG009|Overall Study|Lost to Follow-up|1|||
30800548|NCT02959918|58816272|FG010|Overall Study|Lost to Follow-up|0|||
30800549|NCT02959918|58816273|FG011|Overall Study|Lost to Follow-up|0|||
30800550|NCT02959918|58816274|FG012|Overall Study|Lost to Follow-up|1|||
30800551|NCT02959918|58816275|FG013|Overall Study|Lost to Follow-up|0|||
30800552|NCT02959918|58816262|FG000|Overall Study|Withdrawal by Subject|0|||
30800553|NCT02959918|58816263|FG001|Overall Study|Withdrawal by Subject|0|||
30800554|NCT02959918|58816264|FG002|Overall Study|Withdrawal by Subject|1|||
30800555|NCT02959918|58816265|FG003|Overall Study|Withdrawal by Subject|2|||
30800556|NCT02959918|58816266|FG004|Overall Study|Withdrawal by Subject|0|||
30800557|NCT02959918|58816267|FG005|Overall Study|Withdrawal by Subject|0|||
30800558|NCT02959918|58816268|FG006|Overall Study|Withdrawal by Subject|1|||
30800559|NCT02959918|58816269|FG007|Overall Study|Withdrawal by Subject|0|||
30800560|NCT02959918|58816270|FG008|Overall Study|Withdrawal by Subject|1|||
30800561|NCT02959918|58816271|FG009|Overall Study|Withdrawal by Subject|1|||
30800562|NCT02959918|58816272|FG010|Overall Study|Withdrawal by Subject|2|||
30800563|NCT02959918|58816273|FG011|Overall Study|Withdrawal by Subject|3|||
30800564|NCT02959918|58816274|FG012|Overall Study|Withdrawal by Subject|1|||
30800565|NCT02959918|58816275|FG013|Overall Study|Withdrawal by Subject|1|||
30800566|NCT02959918|58816262|FG000|Overall Study|Protocol Violation|0|||
30800567|NCT02959918|58816263|FG001|Overall Study|Protocol Violation|0|||
30800568|NCT02959918|58816264|FG002|Overall Study|Protocol Violation|1|||
30800569|NCT02959918|58816265|FG003|Overall Study|Protocol Violation|0|||
30906017|NCT01636687|58940517|FG002|Extension Period|Lost to Follow-up|1|||
30906018|NCT01636687|58940518|FG003|Extension Period|Lost to Follow-up|0|||
30800570|NCT02959918|58816266|FG004|Overall Study|Protocol Violation|0|||
30800571|NCT02959918|58816267|FG005|Overall Study|Protocol Violation|1|||
30800572|NCT02959918|58816268|FG006|Overall Study|Protocol Violation|0|||
30800573|NCT02959918|58816269|FG007|Overall Study|Protocol Violation|0|||
30800574|NCT02959918|58816270|FG008|Overall Study|Protocol Violation|2|||
30800575|NCT02959918|58816271|FG009|Overall Study|Protocol Violation|1|||
30800576|NCT02959918|58816272|FG010|Overall Study|Protocol Violation|0|||
30800577|NCT02959918|58816273|FG011|Overall Study|Protocol Violation|1|||
30800578|NCT02959918|58816274|FG012|Overall Study|Protocol Violation|1|||
30800579|NCT02959918|58816275|FG013|Overall Study|Protocol Violation|0|||
30800580|NCT02959918|58816262|FG000|Overall Study|Stopping Rule Met|1|||
30800581|NCT02959918|58816263|FG001|Overall Study|Stopping Rule Met|0|||
30800582|NCT02959918|58816264|FG002|Overall Study|Stopping Rule Met|3|||
30800583|NCT02959918|58816265|FG003|Overall Study|Stopping Rule Met|4|||
30800584|NCT02959918|58816266|FG004|Overall Study|Stopping Rule Met|5|||
30800585|NCT02959918|58816267|FG005|Overall Study|Stopping Rule Met|3|||
30800586|NCT02959918|58816268|FG006|Overall Study|Stopping Rule Met|2|||
30800587|NCT02959918|58816269|FG007|Overall Study|Stopping Rule Met|4|||
30800588|NCT02959918|58816270|FG008|Overall Study|Stopping Rule Met|1|||
30906019|NCT01636687|58940519|FG004|Extension Period|Lost to Follow-up|0|||
30906020|NCT01636687|58940515|FG000|Extension Period|Physician Decision|1|||
30906021|NCT01636687|58940516|FG001|Extension Period|Physician Decision|0|||
30906022|NCT01636687|58940517|FG002|Extension Period|Physician Decision|0|||
30906023|NCT01636687|58940518|FG003|Extension Period|Physician Decision|1|||
30906024|NCT01636687|58940519|FG004|Extension Period|Physician Decision|0|||
30906025|NCT01636687|58940515|FG000|Extension Period|study terminated by sponsor|33|||
30906026|NCT01636687|58940516|FG001|Extension Period|study terminated by sponsor|50|||
30906027|NCT01636687|58940517|FG002|Extension Period|study terminated by sponsor|17|||
30800589|NCT02959918|58816271|FG009|Overall Study|Stopping Rule Met|1|||
30800590|NCT02959918|58816272|FG010|Overall Study|Stopping Rule Met|3|||
30800591|NCT02959918|58816273|FG011|Overall Study|Stopping Rule Met|5|||
30800592|NCT02959918|58816274|FG012|Overall Study|Stopping Rule Met|2|||
30622320|NCT02181413|58634003|FG001|Overall Study|Ongoing Study Treatment|1|||
30800593|NCT02959918|58816275|FG013|Overall Study|Stopping Rule Met|1|||
30800594|NCT02959918|58816262|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
30800595|NCT02959918|58816263|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
30800596|NCT02959918|58816264|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
30800597|NCT02959918|58816265|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
30800598|NCT02959918|58816266|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
30800599|NCT02959918|58816267|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
30800600|NCT02959918|58816268|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
30800601|NCT02959918|58816269|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
30906028|NCT01636687|58940518|FG003|Extension Period|study terminated by sponsor|23|||
30906029|NCT01636687|58940519|FG004|Extension Period|study terminated by sponsor|0|||
30906030|NCT01636687|58940515|FG000|Extension Period|Withdrawal by Subject|1|||
30906031|NCT01636687|58940516|FG001|Extension Period|Withdrawal by Subject|0|||
30906032|NCT01636687|58940517|FG002|Extension Period|Withdrawal by Subject|1|||
30906033|NCT01636687|58940518|FG003|Extension Period|Withdrawal by Subject|1|||
30906034|NCT01636687|58940519|FG004|Extension Period|Withdrawal by Subject|0|||
30906035|NCT01636687|58940515|FG000|Follow-up Period|Withdrawal by Subject|1|||
30906036|NCT01636687|58940516|FG001|Follow-up Period|Withdrawal by Subject|0|||
30906037|NCT01636687|58940517|FG002|Follow-up Period|Withdrawal by Subject|0|||
30906038|NCT01636687|58940518|FG003|Follow-up Period|Withdrawal by Subject|0|||
30906039|NCT01636687|58940519|FG004|Follow-up Period|Withdrawal by Subject|1|||
30906040|NCT01634659|58940539|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
30906041|NCT01634659|58940540|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
30906042|NCT01634659|58940539|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
30906043|NCT01634659|58940540|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
30906044|NCT04863248|58940552|FG000|Overall Study|Sponsor Terminated|4|||
30906045|NCT04863248|58940553|FG001|Overall Study|Sponsor Terminated|1|||
30906046|NCT04863248|58940552|FG000|Overall Study|Death|0|||
30906047|NCT04863248|58940553|FG001|Overall Study|Death|1|||
30906048|NCT04863248|58940552|FG000|Overall Study|Withdrawal by Subject|0|||
30906049|NCT04863248|58940553|FG001|Overall Study|Withdrawal by Subject|1|||
30906050|NCT04498832|58940561|FG000|Overall Study|Adverse Event|1|||
30906051|NCT04498832|58940562|FG001|Overall Study|Adverse Event|3|||
30906052|NCT04498832|58940561|FG000|Overall Study|Withdrawal by Subject|0|||
30906053|NCT04498832|58940562|FG001|Overall Study|Withdrawal by Subject|1|||
30906054|NCT04285229|58940570|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
30906055|NCT04285229|58940571|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30906056|NCT04285229|58940572|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30906057|NCT04285229|58940573|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30906058|NCT04285229|58940574|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30906059|NCT04285229|58940575|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30906060|NCT04285229|58940570|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
30906061|NCT04285229|58940571|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
30906062|NCT04285229|58940572|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
30906063|NCT04285229|58940573|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
30906064|NCT04285229|58940574|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
30906065|NCT04285229|58940575|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
30906066|NCT04285229|58940570|FG000|Extended Treatment Period|Adverse Event|0|||
30906067|NCT04285229|58940571|FG001|Extended Treatment Period|Adverse Event|0|||
30906068|NCT04285229|58940572|FG002|Extended Treatment Period|Adverse Event|0|||
30906069|NCT04285229|58940573|FG003|Extended Treatment Period|Adverse Event|1|||
30906070|NCT04285229|58940574|FG004|Extended Treatment Period|Adverse Event|0|||
30906071|NCT04285229|58940575|FG005|Extended Treatment Period|Adverse Event|0|||
30906072|NCT04285229|58940570|FG000|Extended Treatment Period|Physician Decision|0|||
30747317|NCT00449033|58757612|FG000|Treatment Period|Amended Protocol Criteria|22|||
30747318|NCT00449033|58757613|FG001|Treatment Period|Amended Protocol Criteria|18|||
30747319|NCT00449033|58757612|FG000|Treatment Period|Non-compliance|7|||
30747320|NCT00449033|58757613|FG001|Treatment Period|Non-compliance|8|||
30747321|NCT00449033|58757612|FG000|Treatment Period|Second Malignancy|0|||
30747322|NCT00449033|58757613|FG001|Treatment Period|Second Malignancy|1|||
30747323|NCT00449033|58757612|FG000|Treatment Period|Reason Missing|0|||
30747324|NCT00449033|58757613|FG001|Treatment Period|Reason Missing|4|||
30747325|NCT00449033|58757612|FG000|Treatment Period|Treatment Ongoing|6|||
30747326|NCT00449033|58757613|FG001|Treatment Period|Treatment Ongoing|4|||
30747327|NCT00449033|58757612|FG000|Follow-up Period|Death|299|||
30747328|NCT00449033|58757613|FG001|Follow-up Period|Death|311|||
30747329|NCT00449033|58757612|FG000|Follow-up Period|Lost to Follow-up|6|||
30747330|NCT00449033|58757613|FG001|Follow-up Period|Lost to Follow-up|10|||
30906073|NCT04285229|58940571|FG001|Extended Treatment Period|Physician Decision|0|||
30747331|NCT00449033|58757612|FG000|Follow-up Period|Reason Missing|120|||
30906074|NCT04285229|58940572|FG002|Extended Treatment Period|Physician Decision|1|||
30906075|NCT04285229|58940573|FG003|Extended Treatment Period|Physician Decision|0|||
30906076|NCT04285229|58940574|FG004|Extended Treatment Period|Physician Decision|0|||
30747332|NCT00449033|58757613|FG001|Follow-up Period|Reason Missing|113|||
30747333|NCT00448019|58757619|FG000|Overall Study|Withdrawal by Subject|3|||
30800602|NCT02959918|58816270|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
30800603|NCT02959918|58816271|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
30800604|NCT02959918|58816272|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
30800605|NCT02959918|58816273|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
30800606|NCT02959918|58816274|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
30800607|NCT02959918|58816275|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
30800608|NCT02959918|58816262|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800609|NCT02959918|58816263|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30906077|NCT04285229|58940575|FG005|Extended Treatment Period|Physician Decision|0|||
30906078|NCT04285229|58940570|FG000|Follow-up Period|Adverse Event|0|||
30906079|NCT04285229|58940571|FG001|Follow-up Period|Adverse Event|0|||
30906080|NCT04285229|58940572|FG002|Follow-up Period|Adverse Event|0|||
30906081|NCT04285229|58940573|FG003|Follow-up Period|Adverse Event|0|||
30906082|NCT04285229|58940574|FG004|Follow-up Period|Adverse Event|1|||
30906083|NCT04285229|58940575|FG005|Follow-up Period|Adverse Event|4|||
30906084|NCT04285229|58940570|FG000|Follow-up Period|Withdrawal by Subject|0|||
30906085|NCT04285229|58940571|FG001|Follow-up Period|Withdrawal by Subject|0|||
30906086|NCT04285229|58940572|FG002|Follow-up Period|Withdrawal by Subject|0|||
30906087|NCT04285229|58940573|FG003|Follow-up Period|Withdrawal by Subject|0|||
30906088|NCT04285229|58940574|FG004|Follow-up Period|Withdrawal by Subject|0|||
30800610|NCT02959918|58816264|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800611|NCT02959918|58816265|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800612|NCT02959918|58816266|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800613|NCT02959918|58816267|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800614|NCT02959918|58816268|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800615|NCT02959918|58816269|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
30800616|NCT02959918|58816270|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800617|NCT02959918|58816271|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800618|NCT02959918|58816272|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800619|NCT02959918|58816273|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800620|NCT02959918|58816274|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800621|NCT02959918|58816275|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
30800622|NCT02959918|58816262|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800623|NCT02959918|58816263|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800624|NCT02959918|58816264|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800625|NCT02959918|58816265|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800626|NCT02959918|58816266|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800627|NCT02959918|58816267|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800628|NCT02959918|58816268|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800629|NCT02959918|58816269|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800630|NCT02959918|58816270|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
30800631|NCT02959918|58816271|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800632|NCT02959918|58816272|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800633|NCT02959918|58816273|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800634|NCT02959918|58816274|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800635|NCT02959918|58816275|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
30800636|NCT02959918|58816262|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800637|NCT02959918|58816263|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30906089|NCT04285229|58940575|FG005|Follow-up Period|Withdrawal by Subject|5|||
30906090|NCT04285229|58940570|FG000|Follow-up Period|Covid-19|0|||
30800638|NCT02959918|58816264|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800639|NCT02959918|58816265|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800640|NCT02959918|58816266|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800641|NCT02959918|58816267|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800642|NCT02959918|58816268|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800643|NCT02959918|58816269|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800644|NCT02959918|58816270|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800645|NCT02959918|58816271|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
30800646|NCT02959918|58816272|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800647|NCT02959918|58816273|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800648|NCT02959918|58816274|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800649|NCT02959918|58816275|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
30800650|NCT03263442|58816310|FG000|Inpatient Phase|Death|1|||
30800651|NCT03263442|58816311|FG001|Inpatient Phase|Death|0|||
30800652|NCT03263442|58816310|FG000|Inpatient Phase|Withdrawal by Subject|1|||
30800653|NCT03263442|58816311|FG001|Inpatient Phase|Withdrawal by Subject|0|||
30800654|NCT03263442|58816310|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
30800655|NCT03263442|58816311|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
30800656|NCT03263442|58816310|FG000|1-month Follow-Up|Lost to Follow-up|1|||
30800657|NCT03263442|58816311|FG001|1-month Follow-Up|Lost to Follow-up|0|||
30800658|NCT03263442|58816310|FG000|3-month Follow-Up|Lost to Follow-up|1|||
30800659|NCT03263442|58816311|FG001|3-month Follow-Up|Lost to Follow-up|3|||
30800660|NCT03263442|58816310|FG000|6-month Follow-Up|Lost to Follow-up|2|||
30800661|NCT03263442|58816311|FG001|6-month Follow-Up|Lost to Follow-up|2|||
30800662|NCT04245709|58816319|FG000|Overall Study|Adverse Event|13|||
30800663|NCT04245709|58816319|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
30906091|NCT04285229|58940571|FG001|Follow-up Period|Covid-19|0|||
30906092|NCT04285229|58940572|FG002|Follow-up Period|Covid-19|0|||
30906093|NCT04285229|58940573|FG003|Follow-up Period|Covid-19|0|||
30906094|NCT04285229|58940574|FG004|Follow-up Period|Covid-19|0|||
30906095|NCT04285229|58940575|FG005|Follow-up Period|Covid-19|2|||
30906096|NCT04285229|58940570|FG000|Follow-up Period|Physician Decision|0|||
30906097|NCT04285229|58940571|FG001|Follow-up Period|Physician Decision|0|||
30906098|NCT04285229|58940572|FG002|Follow-up Period|Physician Decision|0|||
30800664|NCT04091581|58816325|FG000|Overall Study|Lost to Follow-up|0|||
30800665|NCT04091581|58816326|FG001|Overall Study|Lost to Follow-up|1|||
30800666|NCT02940522|58816334|FG000|Overall Study|Lost to Follow-up|1|||
30800667|NCT02940522|58816335|FG001|Overall Study|Lost to Follow-up|2|||
30800668|NCT02940522|58816334|FG000|Overall Study|Withdrawal by Subject|1|||
30800669|NCT02940522|58816335|FG001|Overall Study|Withdrawal by Subject|0|||
30800670|NCT03262038|58816343|FG000|Overall Study|Withdrawal by Subject|0|||
30800671|NCT03262038|58816344|FG001|Overall Study|Withdrawal by Subject|1|||
30800672|NCT02472964|58816352|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
30800673|NCT02472964|58816353|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
30800674|NCT02472964|58816352|FG000|Part 1 (up to Week 24)|disease progression|58|||
30800675|NCT02472964|58816353|FG001|Part 1 (up to Week 24)|disease progression|47|||
30800676|NCT02472964|58816352|FG000|Part 1 (up to Week 24)|Death|3|||
30800677|NCT02472964|58816353|FG001|Part 1 (up to Week 24)|Death|6|||
30800678|NCT02472964|58816352|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
30800679|NCT02472964|58816353|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
30800680|NCT02472964|58816352|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
30800681|NCT02472964|58816353|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
30800682|NCT02472964|58816352|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
30800683|NCT02472964|58816353|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
30800684|NCT02472964|58816352|FG000|Part 1 (up to Week 24)|Other|2|||
30800685|NCT02472964|58816353|FG001|Part 1 (up to Week 24)|Other|1|||
30800686|NCT02472964|58816352|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
30800687|NCT02472964|58816353|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
30800688|NCT02472964|58816352|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
30800689|NCT02472964|58816353|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
30800690|NCT02472964|58816352|FG000|Part 2 (Week 24-week 48)|Death|0|||
30800691|NCT02472964|58816353|FG001|Part 2 (Week 24-week 48)|Death|1|||
30800692|NCT02472964|58816352|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
30800693|NCT02472964|58816353|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
30800694|NCT02472964|58816352|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
30800695|NCT02472964|58816353|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
30800696|NCT02472964|58816352|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
30800697|NCT02472964|58816353|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
30906099|NCT04285229|58940573|FG003|Follow-up Period|Physician Decision|0|||
30800698|NCT02472964|58816352|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
30800699|NCT02472964|58816353|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
30800700|NCT04079803|58816366|FG000|Overall Study|Withdrawal by Subject|0|||
30800701|NCT04079803|58816367|FG001|Overall Study|Withdrawal by Subject|0|||
30800702|NCT04079803|58816368|FG002|Overall Study|Withdrawal by Subject|1|||
30800703|NCT03278613|58816396|FG000|Overall Study|Lost to Follow-up|3|||
30800704|NCT03278613|58816397|FG001|Overall Study|Lost to Follow-up|1|||
30800705|NCT03761147|58816405|FG000|Overall Study|Withdrawal by Subject|6|||
30800706|NCT03761147|58816406|FG001|Overall Study|Withdrawal by Subject|1|||
30800707|NCT03761147|58816405|FG000|Overall Study|Adverse Event|1|||
30800708|NCT03761147|58816406|FG001|Overall Study|Adverse Event|3|||
30800709|NCT04076917|58816412|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
30800710|NCT04076917|58816412|FG000|Overall Study|Study closure|13|||
30800711|NCT04076917|58816412|FG000|Overall Study|Physician Decision|3|||
30800712|NCT04076917|58816412|FG000|Overall Study|Death|1|||
30800713|NCT04076917|58816412|FG000|Overall Study|Lost to Follow-up|1|||
30800714|NCT04076917|58816412|FG000|Overall Study|Withdrawal by Subject|1|||
30800715|NCT04076917|58816412|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
30800716|NCT04222699|58816416|FG000|Overall Study|Lost to Follow-up|2|||
30800717|NCT02731690|58816429|FG000|Overall Study|Adverse Event|1|||
30800718|NCT02731690|58816429|FG000|Overall Study|Withdrawal by Subject|3|||
30800719|NCT02731690|58816429|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
30800720|NCT04075513|58816435|FG000|Overall Study|Withdrawal by Subject|2|||
30800721|NCT04075513|58816436|FG001|Overall Study|Withdrawal by Subject|2|||
30800722|NCT04075513|58816435|FG000|Overall Study|Lack of Efficacy|1|||
30800723|NCT04075513|58816436|FG001|Overall Study|Lack of Efficacy|0|||
30800724|NCT04075513|58816435|FG000|Overall Study|Lost to Follow-up|4|||
30800725|NCT04075513|58816436|FG001|Overall Study|Lost to Follow-up|2|||
30800726|NCT04075513|58816435|FG000|Overall Study|Switch to insulin pump|1|||
30800727|NCT04075513|58816436|FG001|Overall Study|Switch to insulin pump|0|||
30800728|NCT04073407|58816444|FG000|Part 1|Withdrawal by Subject|1|||
30800729|NCT04073407|58816445|FG001|Part 1|Withdrawal by Subject|0|||
30800730|NCT04073407|58816444|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
30800731|NCT04073407|58816445|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
30800732|NCT04073407|58816444|FG000|Part 2|Withdrawal by Subject|0|||
30800733|NCT04073407|58816445|FG001|Part 2|Withdrawal by Subject|1|||
30800734|NCT02778204|58816455|FG000|Overall Study|Adverse Event|1|||
30800735|NCT02778204|58816456|FG001|Overall Study|Adverse Event|0|||
30800736|NCT02778204|58816457|FG002|Overall Study|Adverse Event|0|||
30800737|NCT02778204|58816458|FG003|Overall Study|Adverse Event|0|||
30800738|NCT02778204|58816455|FG000|Overall Study|Withdrawal by Subject|0|||
30800739|NCT02778204|58816456|FG001|Overall Study|Withdrawal by Subject|0|||
30800740|NCT02778204|58816457|FG002|Overall Study|Withdrawal by Subject|1|||
30800741|NCT02778204|58816458|FG003|Overall Study|Withdrawal by Subject|2|||
30800742|NCT02778204|58816455|FG000|Overall Study|Lost to Follow-up|1|||
30800743|NCT02778204|58816456|FG001|Overall Study|Lost to Follow-up|0|||
30800744|NCT02778204|58816457|FG002|Overall Study|Lost to Follow-up|2|||
30800745|NCT02778204|58816458|FG003|Overall Study|Lost to Follow-up|1|||
30800746|NCT02778204|58816455|FG000|Overall Study|Protocol Violation|0|||
30800747|NCT02778204|58816456|FG001|Overall Study|Protocol Violation|0|||
30800748|NCT02778204|58816457|FG002|Overall Study|Protocol Violation|1|||
30800749|NCT02778204|58816458|FG003|Overall Study|Protocol Violation|0|||
30800750|NCT02778204|58816455|FG000|Overall Study|Eligibility Violation|0|||
30800751|NCT02778204|58816456|FG001|Overall Study|Eligibility Violation|0|||
30800752|NCT02778204|58816457|FG002|Overall Study|Eligibility Violation|0|||
30800753|NCT02778204|58816458|FG003|Overall Study|Eligibility Violation|1|||
30800754|NCT04072159|58816472|FG000|Overall Study|Lost to Follow-up|6|||
30800755|NCT04072159|58816473|FG001|Overall Study|Lost to Follow-up|6|||
30800756|NCT04072159|58816472|FG000|Overall Study|Withdrawal by Subject|2|||
30800757|NCT04072159|58816473|FG001|Overall Study|Withdrawal by Subject|0|||
30800758|NCT03232281|58816483|FG000|Overall Study|Adverse Event|1|||
30800759|NCT03232281|58816484|FG001|Overall Study|Adverse Event|1|||
30800760|NCT03232281|58816483|FG000|Overall Study|Withdrawal by Subject|5|||
30800761|NCT03232281|58816484|FG001|Overall Study|Withdrawal by Subject|4|||
30800762|NCT03232281|58816483|FG000|Overall Study|Protocol Deviation|1|||
30800763|NCT03232281|58816484|FG001|Overall Study|Protocol Deviation|1|||
30800764|NCT04071301|58816490|FG000|Overall Study|Withdrawal by Subject|6|||
30800765|NCT04071301|58816490|FG000|Overall Study|Death|1|||
30800766|NCT03261336|58816494|FG000|Overall Study|Adverse Event|1|||
30800767|NCT00462748|58816501|FG000|Overall Study|Adverse Event|7|||
30800768|NCT00462748|58816502|FG001|Overall Study|Adverse Event|5|||
30800769|NCT00462748|58816503|FG002|Overall Study|Adverse Event|9|||
30800770|NCT00462748|58816501|FG000|Overall Study|Protocol Violation|0|||
30800771|NCT00462748|58816502|FG001|Overall Study|Protocol Violation|2|||
30800772|NCT00462748|58816503|FG002|Overall Study|Protocol Violation|1|||
30800773|NCT00462748|58816501|FG000|Overall Study|Withdrew consent|3|||
30800774|NCT00462748|58816502|FG001|Overall Study|Withdrew consent|3|||
30800775|NCT00462748|58816503|FG002|Overall Study|Withdrew consent|0|||
30800776|NCT00462748|58816501|FG000|Overall Study|Lost to Follow-up|1|||
30800777|NCT00462748|58816502|FG001|Overall Study|Lost to Follow-up|1|||
30800778|NCT00462748|58816503|FG002|Overall Study|Lost to Follow-up|1|||
30800779|NCT00462748|58816501|FG000|Overall Study|Discontinued after 41 days Rx|1|||
30800780|NCT00462748|58816502|FG001|Overall Study|Discontinued after 41 days Rx|0|||
30800781|NCT00462748|58816503|FG002|Overall Study|Discontinued after 41 days Rx|0|||
30800782|NCT04206085|58816514|FG000|Overall Study|Lost to Follow-up|0|||
30800783|NCT04206085|58816515|FG001|Overall Study|Lost to Follow-up|1|||
30800784|NCT04206085|58816516|FG002|Overall Study|Lost to Follow-up|0|||
30800785|NCT04206085|58816514|FG000|Overall Study|Lost to Follow-up|0|||
30800786|NCT04206085|58816515|FG001|Overall Study|Lost to Follow-up|0|||
30800787|NCT04206085|58816516|FG002|Overall Study|Lost to Follow-up|1|||
30800788|NCT04202497|58816524|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
30800789|NCT04202497|58816525|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
30800790|NCT04202497|58816526|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
30800791|NCT04202497|58816527|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
30800792|NCT03297294|58816543|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
30800793|NCT03297294|58816544|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
30800794|NCT03297294|58816545|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
30800795|NCT03297294|58816546|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
30800796|NCT03297294|58816547|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
30800797|NCT03297294|58816543|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
30906100|NCT04285229|58940574|FG004|Follow-up Period|Physician Decision|0|||
30906101|NCT04285229|58940575|FG005|Follow-up Period|Physician Decision|1|||
30906102|NCT04263454|58940592|FG000|Overall Study|Adverse Event|0|||
30906103|NCT04263454|58940593|FG001|Overall Study|Adverse Event|2|||
30906104|NCT04263454|58940592|FG000|Overall Study|Physician Decision|3|||
30906105|NCT04263454|58940593|FG001|Overall Study|Physician Decision|5|||
30906106|NCT04263454|58940592|FG000|Overall Study|Poor Data Quality|0|||
30906107|NCT04263454|58940593|FG001|Overall Study|Poor Data Quality|1|||
30800798|NCT03297294|58816544|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
30800799|NCT03297294|58816545|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
30800800|NCT03297294|58816546|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
30800801|NCT03297294|58816547|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
30906108|NCT04155463|58940603|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
30800802|NCT03297294|58816543|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
30800803|NCT03297294|58816544|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
30800804|NCT03297294|58816545|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
30800805|NCT03297294|58816546|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
30800806|NCT03297294|58816547|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
30800807|NCT03297294|58816543|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
30800808|NCT03297294|58816544|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
30800809|NCT03297294|58816545|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
30800810|NCT03297294|58816546|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
30800811|NCT03297294|58816547|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
30906109|NCT04155463|58940604|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
30906110|NCT04056611|58940610|FG000|Overall Study|Physician Decision|1|||
30906111|NCT04001803|58940614|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
30906112|NCT04001803|58940614|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
30906113|NCT04001803|58940614|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
30906114|NCT04001803|58940614|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
30906115|NCT04001803|58940614|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
30747334|NCT00448019|58757619|FG000|Overall Study|Disease progression|1|||
30747335|NCT00448019|58757619|FG000|Overall Study|Death|2|||
30747336|NCT00448019|58757619|FG000|Overall Study|Insurance Issues|1|||
30747337|NCT00457691|58757625|FG000|Overall Study|Adverse Event|4|||
30747338|NCT00457691|58757626|FG001|Overall Study|Adverse Event|1|||
30747339|NCT00457691|58757625|FG000|Overall Study|Death|163|||
30747340|NCT00457691|58757626|FG001|Overall Study|Death|148|||
30747341|NCT00457691|58757625|FG000|Overall Study|Protocol Violation|1|||
30800812|NCT03297294|58816543|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
30800813|NCT03297294|58816544|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
30906116|NCT04001803|58940614|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
30906117|NCT04001803|58940614|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
30622321|NCT02181413|58634002|FG000|Overall Study|Lost to Follow-up|0|||
30747342|NCT00457691|58757626|FG001|Overall Study|Protocol Violation|3|||
30747343|NCT00457691|58757625|FG000|Overall Study|Lost to Follow-up|23|||
30747344|NCT00457691|58757626|FG001|Overall Study|Lost to Follow-up|14|||
30747345|NCT00457691|58757625|FG000|Overall Study|Study terminated by Sponsor|1|||
30906118|NCT04001803|58940614|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
30906119|NCT04001803|58940614|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
30800814|NCT03297294|58816545|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
30800815|NCT03297294|58816546|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
30800816|NCT03297294|58816547|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
30800817|NCT03238911|58816561|FG000|Overall Study|Withdrawal by Subject|1|||
30800818|NCT03238911|58816562|FG001|Overall Study|Withdrawal by Subject|2|||
30800819|NCT03238911|58816561|FG000|Overall Study|Lost to Follow-up|2|||
30800820|NCT03238911|58816562|FG001|Overall Study|Lost to Follow-up|1|||
30800821|NCT00418834|58816571|FG000|Overall Study|Adverse Event|16|||
30800822|NCT00418834|58816572|FG001|Overall Study|Adverse Event|9|||
30800823|NCT00418834|58816571|FG000|Overall Study|Lost to Follow-up|0|||
30800824|NCT00418834|58816572|FG001|Overall Study|Lost to Follow-up|1|||
30906120|NCT04001803|58940614|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
30906121|NCT03768427|58940623|FG000|Overall Study|Death|0|||
30906122|NCT03768427|58940624|FG001|Overall Study|Death|0|||
30906123|NCT03768427|58940625|FG002|Overall Study|Death|1|||
30906124|NCT03768427|58940626|FG003|Overall Study|Death|0|||
30906125|NCT03768427|58940623|FG000|Overall Study|Lost to Follow-up|2|||
30906126|NCT03768427|58940624|FG001|Overall Study|Lost to Follow-up|0|||
30906127|NCT03768427|58940625|FG002|Overall Study|Lost to Follow-up|0|||
30906128|NCT03768427|58940626|FG003|Overall Study|Lost to Follow-up|0|||
30906129|NCT03768427|58940623|FG000|Overall Study|Physician Decision|3|||
30906130|NCT03768427|58940624|FG001|Overall Study|Physician Decision|2|||
30906131|NCT03768427|58940625|FG002|Overall Study|Physician Decision|4|||
30906132|NCT03768427|58940626|FG003|Overall Study|Physician Decision|4|||
30906133|NCT03768427|58940623|FG000|Overall Study|Withdrawal by Subject|7|||
30906134|NCT03768427|58940624|FG001|Overall Study|Withdrawal by Subject|2|||
30906135|NCT03768427|58940625|FG002|Overall Study|Withdrawal by Subject|6|||
30906136|NCT03768427|58940626|FG003|Overall Study|Withdrawal by Subject|7|||
30906137|NCT03595228|58940640|FG000|Overall Study|Death|2|||
30906138|NCT03595228|58940640|FG000|Overall Study|Lack of Efficacy|13|||
30906139|NCT03595228|58940640|FG000|Overall Study|Withdrawal by Subject|3|||
30906140|NCT03595228|58940640|FG000|Overall Study|Withdrawal by Sponsor|1|||
30906141|NCT03572933|58940646|FG000|Overall Study|Adverse Event|4|||
30906142|NCT03572933|58940647|FG001|Overall Study|Adverse Event|1|||
30747346|NCT00457691|58757626|FG001|Overall Study|Study terminated by Sponsor|1|||
30747347|NCT00457691|58757625|FG000|Overall Study|Subject refused (reason other than AE)|14|||
30747348|NCT00457691|58757626|FG001|Overall Study|Subject refused (reason other than AE)|19|||
30747349|NCT00457691|58757625|FG000|Overall Study|Disease progression, study terminated|180|||
30747350|NCT00457691|58757626|FG001|Overall Study|Disease progression, study terminated|196|||
30747351|NCT00457301|58757634|FG000|Overall Study|Withdrawal by Subject|3|||
30747352|NCT00457301|58757635|FG001|Overall Study|Withdrawal by Subject|3|||
30747353|NCT00457301|58757634|FG000|Overall Study|Censored out of the study|15|||
30747354|NCT00457301|58757635|FG001|Overall Study|Censored out of the study|14|||
30747355|NCT00457301|58757634|FG000|Overall Study|Death|5|||
30800825|NCT00418834|58816571|FG000|Overall Study|Protocol Violation|4|||
30800826|NCT00418834|58816572|FG001|Overall Study|Protocol Violation|3|||
30800827|NCT00418834|58816571|FG000|Overall Study|Withdrawal by Subject|3|||
30800828|NCT00418834|58816572|FG001|Overall Study|Withdrawal by Subject|7|||
30800829|NCT03276975|58816580|FG000|Overall Study|Withdrawal by Subject|1|||
30800830|NCT03276975|58816581|FG001|Overall Study|Withdrawal by Subject|0|||
30906143|NCT03572933|58940646|FG000|Overall Study|Withdrawal by Subject|0|||
30906144|NCT03572933|58940647|FG001|Overall Study|Withdrawal by Subject|1|||
30906145|NCT03558152|58940658|FG000|Overall Study|Adverse Event|0|||
30906146|NCT03558152|58940659|FG001|Overall Study|Adverse Event|0|||
30906147|NCT03558152|58940660|FG002|Overall Study|Adverse Event|1|||
30906148|NCT03558152|58940661|FG003|Overall Study|Adverse Event|1|||
30906149|NCT03558152|58940662|FG004|Overall Study|Adverse Event|2|||
30800831|NCT03297216|58816589|FG000|Overall Study|Death|0|||
30800832|NCT03297216|58816590|FG001|Overall Study|Death|1|||
30800833|NCT03297216|58816589|FG000|Overall Study|Miscarriage|0|||
30800834|NCT03297216|58816590|FG001|Overall Study|Miscarriage|2|||
30800835|NCT03297216|58816589|FG000|Overall Study|Lost to Follow-up|3|||
30800836|NCT03297216|58816590|FG001|Overall Study|Lost to Follow-up|2|||
30800837|NCT03260868|58816605|FG000|Overall Study|Poor Compliance to Protocol|0|||
30800838|NCT03260868|58816606|FG001|Overall Study|Poor Compliance to Protocol|2|||
30906150|NCT03558152|58940663|FG005|Overall Study|Adverse Event|1|||
30906151|NCT03558152|58940664|FG006|Overall Study|Adverse Event|1|||
30906152|NCT03558152|58940665|FG007|Overall Study|Adverse Event|0|||
30906153|NCT03558152|58940658|FG000|Overall Study|Death|0|||
30906154|NCT03558152|58940659|FG001|Overall Study|Death|0|||
30906155|NCT03558152|58940660|FG002|Overall Study|Death|0|||
30906156|NCT03558152|58940661|FG003|Overall Study|Death|0|||
30906157|NCT03558152|58940662|FG004|Overall Study|Death|1|||
30906158|NCT03558152|58940663|FG005|Overall Study|Death|0|||
30906159|NCT03558152|58940664|FG006|Overall Study|Death|0|||
30906160|NCT03558152|58940665|FG007|Overall Study|Death|0|||
30906161|NCT03558152|58940658|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
30906162|NCT03558152|58940659|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
30906163|NCT03558152|58940660|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
30906164|NCT03558152|58940661|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
30906165|NCT03558152|58940662|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
30800839|NCT03260868|58816605|FG000|Overall Study|Study Terminated By Sponsor|2|||
30906166|NCT03558152|58940663|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
30906167|NCT03558152|58940664|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
30906168|NCT03558152|58940665|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
30906169|NCT03558152|58940658|FG000|Overall Study|Miscalculation in mmcs|0|||
30906170|NCT03558152|58940659|FG001|Overall Study|Miscalculation in mmcs|0|||
30906171|NCT03558152|58940660|FG002|Overall Study|Miscalculation in mmcs|0|||
30906172|NCT03558152|58940661|FG003|Overall Study|Miscalculation in mmcs|0|||
30906173|NCT03558152|58940662|FG004|Overall Study|Miscalculation in mmcs|0|||
30906174|NCT03558152|58940663|FG005|Overall Study|Miscalculation in mmcs|0|||
30906175|NCT03558152|58940664|FG006|Overall Study|Miscalculation in mmcs|1|||
30906176|NCT03558152|58940665|FG007|Overall Study|Miscalculation in mmcs|0|||
30906177|NCT03558152|58940658|FG000|Overall Study|Mistake in calculation|0|||
30906178|NCT03558152|58940659|FG001|Overall Study|Mistake in calculation|0|||
30906179|NCT03558152|58940660|FG002|Overall Study|Mistake in calculation|0|||
30906180|NCT03558152|58940661|FG003|Overall Study|Mistake in calculation|1|||
30906181|NCT03558152|58940662|FG004|Overall Study|Mistake in calculation|0|||
30906182|NCT03558152|58940663|FG005|Overall Study|Mistake in calculation|0|||
30906183|NCT03558152|58940664|FG006|Overall Study|Mistake in calculation|0|||
30906184|NCT03558152|58940665|FG007|Overall Study|Mistake in calculation|0|||
30906185|NCT03558152|58940658|FG000|Overall Study|Mistake in evaluation of disease status|0|||
30906186|NCT03558152|58940659|FG001|Overall Study|Mistake in evaluation of disease status|0|||
30906187|NCT03558152|58940660|FG002|Overall Study|Mistake in evaluation of disease status|0|||
30800840|NCT03260868|58816606|FG001|Overall Study|Study Terminated By Sponsor|1|||
30800841|NCT03260868|58816605|FG000|Overall Study|Other than specified above|1|||
30800842|NCT03260868|58816606|FG001|Overall Study|Other than specified above|0|||
30800843|NCT03293394|58816614|FG000|Follow-up (6 Months)|Adverse Event|4|||
30800844|NCT03293394|58816615|FG001|Follow-up (6 Months)|Adverse Event|2|||
30800845|NCT03259308|58816624|FG000|Overall Study|Adverse Event|5|||
30800846|NCT03259308|58816625|FG001|Overall Study|Adverse Event|4|||
30800847|NCT03259308|58816626|FG002|Overall Study|Adverse Event|1|||
30800848|NCT03259308|58816624|FG000|Overall Study|Withdrawal by Subject|2|||
30800849|NCT03259308|58816625|FG001|Overall Study|Withdrawal by Subject|1|||
30800850|NCT03259308|58816626|FG002|Overall Study|Withdrawal by Subject|3|||
30800851|NCT03259308|58816624|FG000|Overall Study|Lost to Follow-up|0|||
30800852|NCT03259308|58816625|FG001|Overall Study|Lost to Follow-up|0|||
30800853|NCT03259308|58816626|FG002|Overall Study|Lost to Follow-up|1|||
30800854|NCT03259308|58816624|FG000|Overall Study|Pregnancy|0|||
30800855|NCT03259308|58816625|FG001|Overall Study|Pregnancy|0|||
30800856|NCT03259308|58816626|FG002|Overall Study|Pregnancy|1|||
30800857|NCT03259308|58816624|FG000|Overall Study|Protocol Deviation|0|||
30800858|NCT03259308|58816625|FG001|Overall Study|Protocol Deviation|3|||
30906188|NCT03558152|58940661|FG003|Overall Study|Mistake in evaluation of disease status|0|||
30906189|NCT03558152|58940662|FG004|Overall Study|Mistake in evaluation of disease status|0|||
30906190|NCT03558152|58940663|FG005|Overall Study|Mistake in evaluation of disease status|0|||
30800859|NCT03259308|58816626|FG002|Overall Study|Protocol Deviation|0|||
30906191|NCT03558152|58940664|FG006|Overall Study|Mistake in evaluation of disease status|0|||
30906192|NCT03558152|58940665|FG007|Overall Study|Mistake in evaluation of disease status|1|||
30800860|NCT03259308|58816624|FG000|Overall Study|Lack of Efficacy|0|||
30906193|NCT03558152|58940658|FG000|Overall Study|Physician Decision|0|||
30800861|NCT03259308|58816625|FG001|Overall Study|Lack of Efficacy|0|||
30800862|NCT03259308|58816626|FG002|Overall Study|Lack of Efficacy|1|||
30906194|NCT03558152|58940659|FG001|Overall Study|Physician Decision|0|||
30906195|NCT03558152|58940660|FG002|Overall Study|Physician Decision|0|||
30906196|NCT03558152|58940661|FG003|Overall Study|Physician Decision|0|||
30906197|NCT03558152|58940662|FG004|Overall Study|Physician Decision|0|||
30906198|NCT03558152|58940663|FG005|Overall Study|Physician Decision|0|||
30906199|NCT03558152|58940664|FG006|Overall Study|Physician Decision|1|||
30906200|NCT03558152|58940665|FG007|Overall Study|Physician Decision|0|||
30906201|NCT03558152|58940658|FG000|Overall Study|Withdrawal by Subject|2|||
30906202|NCT03558152|58940659|FG001|Overall Study|Withdrawal by Subject|3|||
30906203|NCT03558152|58940660|FG002|Overall Study|Withdrawal by Subject|2|||
30906204|NCT03558152|58940661|FG003|Overall Study|Withdrawal by Subject|1|||
30906205|NCT03558152|58940662|FG004|Overall Study|Withdrawal by Subject|1|||
30906206|NCT03558152|58940663|FG005|Overall Study|Withdrawal by Subject|1|||
30906207|NCT03558152|58940664|FG006|Overall Study|Withdrawal by Subject|3|||
30906208|NCT03558152|58940665|FG007|Overall Study|Withdrawal by Subject|2|||
30906209|NCT03558152|58940658|FG000|Overall Study|Lack of Efficacy|11|||
30906210|NCT03558152|58940659|FG001|Overall Study|Lack of Efficacy|11|||
30906211|NCT03558152|58940660|FG002|Overall Study|Lack of Efficacy|10|||
30906212|NCT03558152|58940661|FG003|Overall Study|Lack of Efficacy|11|||
30906213|NCT03558152|58940662|FG004|Overall Study|Lack of Efficacy|14|||
30906214|NCT03558152|58940663|FG005|Overall Study|Lack of Efficacy|12|||
30906215|NCT03558152|58940664|FG006|Overall Study|Lack of Efficacy|14|||
30906216|NCT03558152|58940665|FG007|Overall Study|Lack of Efficacy|13|||
30906217|NCT03558152|58940658|FG000|Overall Study|Protocol Violation|1|||
30800863|NCT03258762|58816636|FG000|Overall Study|Lost to Follow-up|0|||
30800864|NCT03258762|58816637|FG001|Overall Study|Lost to Follow-up|1|||
30800865|NCT04502589|58816646|FG000|Overall Study|Physician Decision|1|||
30800866|NCT04502589|58816647|FG001|Overall Study|Physician Decision|0|||
30800867|NCT03291288|58816653|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
30800868|NCT03291288|58816654|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
30906218|NCT03558152|58940659|FG001|Overall Study|Protocol Violation|1|||
30906219|NCT03558152|58940660|FG002|Overall Study|Protocol Violation|0|||
30906220|NCT03558152|58940661|FG003|Overall Study|Protocol Violation|1|||
30906221|NCT03558152|58940662|FG004|Overall Study|Protocol Violation|1|||
30906222|NCT03558152|58940663|FG005|Overall Study|Protocol Violation|0|||
30906223|NCT03558152|58940664|FG006|Overall Study|Protocol Violation|2|||
30906224|NCT03558152|58940665|FG007|Overall Study|Protocol Violation|0|||
30906225|NCT03461406|58940705|FG000|Overall Study|Death|1|||
30906226|NCT03461406|58940706|FG001|Overall Study|Death|2|||
30906227|NCT03461406|58940705|FG000|Overall Study|Consent Withdrawn by Participant|0|||
30906228|NCT03461406|58940706|FG001|Overall Study|Consent Withdrawn by Participant|1|||
30906229|NCT03461406|58940705|FG000|Overall Study|Screen Failure|3|||
30906230|NCT03461406|58940706|FG001|Overall Study|Screen Failure|1|||
30906231|NCT03461406|58940705|FG000|Overall Study|Reason not Specified|1|||
30906232|NCT03461406|58940706|FG001|Overall Study|Reason not Specified|3|||
30906233|NCT03461406|58940705|FG000|Overall Study|Lost to Follow-up|3|||
30906234|NCT03461406|58940706|FG001|Overall Study|Lost to Follow-up|0|||
30906235|NCT03408899|58940721|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
30906236|NCT02528643|58940746|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
30906237|NCT02528643|58940747|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
30906238|NCT02528643|58940746|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
30906239|NCT02528643|58940747|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
30906240|NCT02528643|58940746|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
30906241|NCT02528643|58940747|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
30906242|NCT02528643|58940746|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
30906243|NCT02528643|58940747|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
30906244|NCT02528643|58940746|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
30906245|NCT02528643|58940747|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
30906246|NCT02528643|58940746|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
30906247|NCT02528643|58940747|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
30906248|NCT02528643|58940746|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
30906249|NCT02528643|58940747|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
30906250|NCT02175680|58940790|FG000|Overall Study|non-compliance|1|||
30906251|NCT02175680|58940790|FG000|Overall Study|other non-medical reason|1|||
30906252|NCT01983462|58940804|FG000|Overall Study|Adverse Event|1|||
30906253|NCT01983462|58940805|FG001|Overall Study|Adverse Event|0|||
30906254|NCT01983462|58940806|FG002|Overall Study|Adverse Event|0|||
30906255|NCT01559935|58940837|FG000|Car Phase|Toxicity|4|||
30906256|NCT01559935|58940837|FG000|Car Phase|Death|1|||
30906257|NCT01559935|58940837|FG000|Car Phase|Lack of Efficacy|2|||
30906258|NCT01559935|58940837|FG000|Car Phase|Lost to Follow-up|1|||
30906259|NCT01559935|58940837|FG000|Car Phase|Physician Decision|1|||
30906260|NCT01559935|58940837|FG000|Car Phase|Withdrawal by Subject|2|||
30906261|NCT01559935|58940837|FG000|Car Phase|Per protocol|1|||
30906262|NCT01559935|58940837|FG000|Car Phase|Insurance|1|||
30906263|NCT01559935|58940837|FG000|Car Phase|non-compliance|1|||
30906264|NCT01559935|58940837|FG000|BiRD Phase|Toxicity|1|||
30906265|NCT01559935|58940837|FG000|BiRD Phase|Lack of Efficacy|1|||
30906266|NCT01559935|58940837|FG000|BiRD Phase|Withdrawal by Subject|2|||
30906267|NCT01559935|58940837|FG000|Maintenance Phase|Remains on study|28|||
30906268|NCT01559935|58940837|FG000|Maintenance Phase|Toxicity|1|||
30906269|NCT01559935|58940837|FG000|Maintenance Phase|Lack of Efficacy|18|||
30906270|NCT01559935|58940837|FG000|Maintenance Phase|Withdrawal by Subject|5|||
30906271|NCT01559935|58940837|FG000|Maintenance Phase|Non-compliance|2|||
30747356|NCT00457301|58757635|FG001|Overall Study|Death|7|||
30747357|NCT00456755|58757643|FG000|Overall Study|Lost to Follow-up|2|||
30747358|NCT00456755|58757644|FG001|Overall Study|Lost to Follow-up|1|||
30747359|NCT00447005|58757650|FG000|Overall Study|Adverse Event|1|||
30747360|NCT00447005|58757650|FG000|Overall Study|Lack of Efficacy|11|||
30747361|NCT00446849|58757654|FG000|Acute Phase|Lack of Efficacy|64|||
30747362|NCT00446849|58757654|FG000|Acute Phase|Protocol Violation|10|||
30747363|NCT00446849|58757654|FG000|Acute Phase|Consent withdrawn|4|||
30747364|NCT00446849|58757654|FG000|Acute Phase|Lost to Follow-up|2|||
30747365|NCT00446849|58757654|FG000|Acute Phase|Physician Decision|1|||
30747366|NCT00446849|58757654|FG000|Acute Phase|noncompliance|1|||
30747367|NCT00446849|58757654|FG000|Maintenance Phase|Lack of Efficacy|40|||
30747368|NCT00446849|58757654|FG000|Maintenance Phase|Protocol Violation|7|||
30747369|NCT00446849|58757654|FG000|Maintenance Phase|Adverse Event|6|||
30747370|NCT00446849|58757654|FG000|Maintenance Phase|Consent withdrawn|5|||
30747371|NCT00446849|58757654|FG000|Maintenance Phase|Lost to Follow-up|3|||
30906272|NCT00981058|58940843|FG000|Overall Study|Adverse Event|1|||
30906273|NCT00981058|58940844|FG001|Overall Study|Adverse Event|1|||
30906274|NCT00981058|58940843|FG000|Overall Study|Progressive Disease|61|||
30906275|NCT00981058|58940844|FG001|Overall Study|Progressive Disease|49|||
30906276|NCT00981058|58940843|FG000|Overall Study|Lost to Follow-up|16|||
30906277|NCT00981058|58940844|FG001|Overall Study|Lost to Follow-up|15|||
30906278|NCT00981058|58940843|FG000|Overall Study|New Anticancer Therapy|6|||
30747372|NCT00446849|58757654|FG000|Maintenance Phase|Pregnancy|1|||
30747373|NCT00446849|58757654|FG000|Maintenance Phase|noncompliance|2|||
30747374|NCT00446849|58757654|FG000|Maintenance Phase|prohibited medication use|2|||
30747375|NCT00446849|58757654|FG000|Maintenance Phase|antibiotic use|1|||
30747376|NCT00446849|58757654|FG000|Maintenance Phase|study closure|1|||
30800869|NCT03291288|58816653|FG000|Drug-drug Interaction Phase|Disease progression|1|||
30800870|NCT03291288|58816654|FG001|Drug-drug Interaction Phase|Disease progression|0|||
30800871|NCT03291288|58816653|FG000|Drug-drug Interaction Phase|Other|3|||
30800872|NCT03291288|58816654|FG001|Drug-drug Interaction Phase|Other|0|||
30800873|NCT03291288|58816653|FG000|Pexidartinib Only|Ongoing|0|||
30800874|NCT03291288|58816654|FG001|Pexidartinib Only|Ongoing|2|||
30800875|NCT03257358|58816679|FG000|Overall Study|Adverse Event|25|||
30800876|NCT03257358|58816680|FG001|Overall Study|Adverse Event|12|||
30800877|NCT03257358|58816679|FG000|Overall Study|Lack of Efficacy|1|||
30800878|NCT03257358|58816680|FG001|Overall Study|Lack of Efficacy|1|||
30800879|NCT03257358|58816679|FG000|Overall Study|Lost to Follow-up|12|||
30800880|NCT03257358|58816680|FG001|Overall Study|Lost to Follow-up|4|||
30800881|NCT03257358|58816679|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
30800882|NCT03257358|58816680|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
30800883|NCT03257358|58816679|FG000|Overall Study|Physician Decision|2|||
30800884|NCT03257358|58816680|FG001|Overall Study|Physician Decision|2|||
30800885|NCT03257358|58816679|FG000|Overall Study|Protocol Violation|5|||
30800886|NCT03257358|58816680|FG001|Overall Study|Protocol Violation|3|||
30800887|NCT03257358|58816679|FG000|Overall Study|Technical problems|4|||
30906279|NCT00981058|58940844|FG001|Overall Study|New Anticancer Therapy|6|||
30906280|NCT00981058|58940843|FG000|Overall Study|Noncompliance|1|||
30906281|NCT00981058|58940844|FG001|Overall Study|Noncompliance|0|||
30906282|NCT00981058|58940843|FG000|Overall Study|Radiologist Error|0|||
30906283|NCT00981058|58940844|FG001|Overall Study|Radiologist Error|1|||
30906284|NCT00981058|58940843|FG000|Overall Study|Randomization Error|1|||
30747377|NCT00446849|58757654|FG000|Maintenance Phase|hydrocodone use|1|||
30747378|NCT00446849|58757654|FG000|Maintenance Phase|concomitant medication use|1|||
30747379|NCT00446459|58757659|FG000|8 Months|Protocol Violation|12|||
30747380|NCT00446459|58757659|FG000|12 Months|Protocol Violation|4|||
30747381|NCT00446459|58757659|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
30747382|NCT00456599|58757663|FG000|Overall Study|Non-compliance|1|||
30747383|NCT00456599|58757663|FG000|Overall Study|Withdrawal by Subject|2|||
30747384|NCT00456521|58757669|FG000|Overall Study|Adverse Event|150|||
30747385|NCT00456521|58757670|FG001|Overall Study|Adverse Event|25|||
30747386|NCT00456521|58757669|FG000|Overall Study|Withdrawal by Subject|43|||
30747387|NCT00456521|58757670|FG001|Overall Study|Withdrawal by Subject|24|||
30747388|NCT00456521|58757669|FG000|Overall Study|Lost to Follow-up|22|||
30747389|NCT00456521|58757670|FG001|Overall Study|Lost to Follow-up|17|||
30747390|NCT00456521|58757669|FG000|Overall Study|Lack of Efficacy|3|||
30747391|NCT00456521|58757670|FG001|Overall Study|Lack of Efficacy|6|||
30747392|NCT00456521|58757669|FG000|Overall Study|Protocol Violation|4|||
30747393|NCT00456521|58757670|FG001|Overall Study|Protocol Violation|0|||
30747394|NCT00456521|58757669|FG000|Overall Study|Pregnancy|1|||
30747395|NCT00456521|58757670|FG001|Overall Study|Pregnancy|1|||
30747396|NCT00456521|58757669|FG000|Overall Study|Drug non-compliance, moved, other|26|||
30747397|NCT00456521|58757670|FG001|Overall Study|Drug non-compliance, moved, other|11|||
30747398|NCT00456365|58757679|FG000|Overall Study|Lost to Follow-up|1|||
30747399|NCT00456365|58757680|FG001|Overall Study|Lost to Follow-up|3|||
30747400|NCT00456365|58757679|FG000|Overall Study|Withdrawal by Subject|4|||
30747401|NCT00456365|58757680|FG001|Overall Study|Withdrawal by Subject|7|||
30747402|NCT00456365|58757679|FG000|Overall Study|Pregnancy|1|||
30747403|NCT00456365|58757680|FG001|Overall Study|Pregnancy|1|||
30747404|NCT00456365|58757679|FG000|Overall Study|oncologic diagnosis|1|||
30747405|NCT00456365|58757680|FG001|Overall Study|oncologic diagnosis|1|||
30747406|NCT00455741|58757690|FG000|Overall Study|Physician Decision|0|||
30747407|NCT00455741|58757691|FG001|Overall Study|Physician Decision|1|||
30747408|NCT00445679|58757711|FG000|Overall Study|Adverse Event|22|||
30747409|NCT00445679|58757712|FG001|Overall Study|Adverse Event|12|||
30747410|NCT00445679|58757713|FG002|Overall Study|Adverse Event|30|||
30747411|NCT00445679|58757714|FG003|Overall Study|Adverse Event|19|||
30747412|NCT00445679|58757711|FG000|Overall Study|Failed to return|1|||
30747413|NCT00445679|58757712|FG001|Overall Study|Failed to return|3|||
30747414|NCT00445679|58757713|FG002|Overall Study|Failed to return|2|||
30747415|NCT00445679|58757714|FG003|Overall Study|Failed to return|2|||
30747416|NCT00445679|58757711|FG000|Overall Study|Physician Decision|0|||
30747417|NCT00445679|58757712|FG001|Overall Study|Physician Decision|0|||
30747418|NCT00445679|58757713|FG002|Overall Study|Physician Decision|1|||
30747419|NCT00445679|58757714|FG003|Overall Study|Physician Decision|0|||
30747420|NCT00445679|58757711|FG000|Overall Study|Lost to Follow-up|10|||
30747421|NCT00445679|58757712|FG001|Overall Study|Lost to Follow-up|6|||
30747422|NCT00445679|58757713|FG002|Overall Study|Lost to Follow-up|6|||
30747423|NCT00445679|58757714|FG003|Overall Study|Lost to Follow-up|5|||
30747424|NCT00445679|58757711|FG000|Overall Study|Compliance|3|||
30747425|NCT00445679|58757712|FG001|Overall Study|Compliance|2|||
30747426|NCT00445679|58757713|FG002|Overall Study|Compliance|1|||
30906285|NCT00981058|58940844|FG001|Overall Study|Randomization Error|2|||
30747427|NCT00445679|58757714|FG003|Overall Study|Compliance|2|||
30800888|NCT03257358|58816680|FG001|Overall Study|Technical problems|1|||
30800889|NCT03257358|58816679|FG000|Overall Study|Withdrawal by Subject|8|||
30800890|NCT03257358|58816680|FG001|Overall Study|Withdrawal by Subject|3|||
30800891|NCT03257358|58816679|FG000|Overall Study|Withdrawal of informed consent|9|||
30800892|NCT03257358|58816680|FG001|Overall Study|Withdrawal of informed consent|5|||
30800893|NCT03257358|58816679|FG000|Overall Study|New therapy for study indication|1|||
30800894|NCT03257358|58816680|FG001|Overall Study|New therapy for study indication|0|||
30800895|NCT03257358|58816679|FG000|Overall Study|No longer requires treatment|0|||
30800896|NCT03257358|58816680|FG001|Overall Study|No longer requires treatment|1|||
30800897|NCT02936037|58816688|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
30800898|NCT02936037|58816689|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
30800899|NCT02936037|58816688|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
30800900|NCT02936037|58816689|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
30800901|NCT02936037|58816688|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
30800902|NCT02936037|58816689|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
30800903|NCT02936037|58816688|FG000|Double-Blind Treatment Period|Death|0|||
30800904|NCT02936037|58816689|FG001|Double-Blind Treatment Period|Death|1|||
30800905|NCT02936037|58816688|FG000|Double-Blind Treatment Period|Adverse Event|11|||
30800906|NCT02936037|58816689|FG001|Double-Blind Treatment Period|Adverse Event|11|||
30800907|NCT02936037|58816688|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
30800908|NCT02936037|58816689|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
30800909|NCT02936037|58816688|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
30800910|NCT02936037|58816689|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
30800911|NCT02936037|58816688|FG000|Open Label Extension|Adverse Event|0|||
30906286|NCT00981058|58940843|FG000|Overall Study|Withdrawal by Subject|25|||
30906287|NCT00981058|58940844|FG001|Overall Study|Withdrawal by Subject|23|||
30800912|NCT02936037|58816689|FG001|Open Label Extension|Adverse Event|3|||
30800913|NCT02936037|58816688|FG000|Open Label Extension|Other|0|||
30800914|NCT02936037|58816689|FG001|Open Label Extension|Other|3|||
30800915|NCT02936037|58816688|FG000|Open Label Extension|Withdrawal by Subject|0|||
30906288|NCT00981058|58940843|FG000|Overall Study|On study treatment at conclusion|9|||
30906289|NCT00981058|58940844|FG001|Overall Study|On study treatment at conclusion|0|||
30906290|NCT00565851|58940858|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
30906291|NCT00565851|58940859|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
30906292|NCT00565851|58940860|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
30906293|NCT00565851|58940861|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
30906294|NCT00565851|58940862|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
30906295|NCT00565851|58940863|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
30906296|NCT00565851|58940864|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
30906297|NCT00565851|58940865|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
30906298|NCT00565851|58940858|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
30906299|NCT00565851|58940859|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
30906300|NCT00565851|58940860|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
30906301|NCT00565851|58940861|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
30906302|NCT00565851|58940862|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
30906303|NCT00565851|58940863|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
30906304|NCT00565851|58940864|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
30906305|NCT00565851|58940865|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
30906306|NCT00305227|58940889|FG000|Overall Study|Lost to Follow-up|7|||
30906307|NCT00305227|58940890|FG001|Overall Study|Lost to Follow-up|6|||
30906308|NCT01599793|58940898|FG000|Overall Study|Adverse Event|2|||
30906309|NCT01755598|58940913|FG000|Overall Study|Other|109|||
30906310|NCT01755598|58940914|FG001|Overall Study|Other|109|||
30906311|NCT01755598|58940913|FG000|Overall Study|Lost to Follow-up|32|||
30906312|NCT01755598|58940914|FG001|Overall Study|Lost to Follow-up|43|||
30906313|NCT01755598|58940913|FG000|Overall Study|Migrated/moved from study area|76|||
30906314|NCT01755598|58940914|FG001|Overall Study|Migrated/moved from study area|65|||
30906315|NCT01755598|58940913|FG000|Overall Study|Withdrawal by Subject|22|||
30906316|NCT01755598|58940914|FG001|Overall Study|Withdrawal by Subject|31|||
30906317|NCT01755598|58940913|FG000|Overall Study|Protocol Violation|7|||
30906318|NCT01755598|58940914|FG001|Overall Study|Protocol Violation|7|||
30906319|NCT01755598|58940913|FG000|Overall Study|Adverse Event|19|||
30906320|NCT01755598|58940914|FG001|Overall Study|Adverse Event|28|||
30906321|NCT01606306|58940926|FG000|Overall Study|Lack of Efficacy|2|||
30800916|NCT02936037|58816689|FG001|Open Label Extension|Withdrawal by Subject|4|||
30800917|NCT03288714|58816697|FG000|Overall Study|Lost to Follow-up|2|||
30800918|NCT03288714|58816698|FG001|Overall Study|Lost to Follow-up|1|||
30800919|NCT03288714|58816697|FG000|Overall Study|Non-compliance with study schedule|2|||
30800920|NCT03288714|58816698|FG001|Overall Study|Non-compliance with study schedule|0|||
30800921|NCT03288714|58816697|FG000|Overall Study|Withdrawal by Subject|3|||
30800922|NCT03288714|58816698|FG001|Overall Study|Withdrawal by Subject|1|||
30906322|NCT01606306|58940927|FG001|Overall Study|Lack of Efficacy|1|||
30906323|NCT01606306|58940928|FG002|Overall Study|Lack of Efficacy|4|||
30906324|NCT01606306|58940929|FG003|Overall Study|Lack of Efficacy|4|||
30800923|NCT03288714|58816697|FG000|Overall Study|Clinical Worsening|2|||
30906325|NCT01606306|58940930|FG004|Overall Study|Lack of Efficacy|1|||
30906326|NCT01606306|58940931|FG005|Overall Study|Lack of Efficacy|2|||
30906327|NCT01606306|58940926|FG000|Overall Study|Adverse Event|1|||
30906328|NCT01606306|58940927|FG001|Overall Study|Adverse Event|0|||
30906329|NCT01606306|58940928|FG002|Overall Study|Adverse Event|1|||
30906330|NCT01606306|58940929|FG003|Overall Study|Adverse Event|1|||
30906331|NCT01606306|58940930|FG004|Overall Study|Adverse Event|2|||
30906332|NCT01606306|58940931|FG005|Overall Study|Adverse Event|0|||
30800924|NCT03288714|58816698|FG001|Overall Study|Clinical Worsening|1|||
30800925|NCT03288714|58816697|FG000|Overall Study|Adverse Event|1|||
30800926|NCT03288714|58816698|FG001|Overall Study|Adverse Event|0|||
30800927|NCT04068181|58816710|FG000|Overall Study|Withdrawal by Subject|2|||
30800928|NCT04068181|58816711|FG001|Overall Study|Withdrawal by Subject|0|||
30800929|NCT04068181|58816712|FG002|Overall Study|Withdrawal by Subject|0|||
30800930|NCT04068181|58816713|FG003|Overall Study|Withdrawal by Subject|0|||
30800931|NCT04068181|58816710|FG000|Overall Study|Lost to Follow-up|1|||
30800932|NCT04068181|58816711|FG001|Overall Study|Lost to Follow-up|0|||
30800933|NCT04068181|58816712|FG002|Overall Study|Lost to Follow-up|0|||
30800934|NCT04068181|58816713|FG003|Overall Study|Lost to Follow-up|0|||
30800935|NCT04068181|58816710|FG000|Overall Study|Death|8|||
30800936|NCT04068181|58816711|FG001|Overall Study|Death|8|||
30800937|NCT04068181|58816712|FG002|Overall Study|Death|4|||
30800938|NCT04068181|58816713|FG003|Overall Study|Death|2|||
30800939|NCT04068181|58816710|FG000|Overall Study|Continuing Study|16|||
30800940|NCT04068181|58816711|FG001|Overall Study|Continuing Study|7|||
30800941|NCT04068181|58816712|FG002|Overall Study|Continuing Study|11|||
30800942|NCT04068181|58816713|FG003|Overall Study|Continuing Study|13|||
30800943|NCT03256578|58816725|FG000|Overall Study|Excluded Post Randomization|66|||
30800944|NCT03256578|58816726|FG001|Overall Study|Excluded Post Randomization|56|||
30800945|NCT03227445|58816732|FG000|Period 1 (28 Days)|Adverse Event|1|||
30800946|NCT03227445|58816733|FG001|Period 1 (28 Days)|Adverse Event|2|||
30800947|NCT03227445|58816734|FG002|Period 1 (28 Days)|Adverse Event|0|||
30906333|NCT01606306|58940926|FG000|Overall Study|Lost to Follow-up|7|||
30906334|NCT01606306|58940927|FG001|Overall Study|Lost to Follow-up|4|||
30906335|NCT01606306|58940928|FG002|Overall Study|Lost to Follow-up|5|||
30906336|NCT01606306|58940929|FG003|Overall Study|Lost to Follow-up|4|||
30622322|NCT02181413|58634003|FG001|Overall Study|Lost to Follow-up|1|||
30800948|NCT03227445|58816735|FG003|Period 1 (28 Days)|Adverse Event|1|||
30800949|NCT03227445|58816732|FG000|Period 1 (28 Days)|Protocol Violation|1|||
30800950|NCT03227445|58816733|FG001|Period 1 (28 Days)|Protocol Violation|0|||
30800951|NCT03227445|58816734|FG002|Period 1 (28 Days)|Protocol Violation|0|||
30800952|NCT03227445|58816735|FG003|Period 1 (28 Days)|Protocol Violation|0|||
30800953|NCT03227445|58816732|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
30800954|NCT03227445|58816733|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
30800955|NCT03227445|58816734|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
30800956|NCT03227445|58816735|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
30800957|NCT03227445|58816732|FG000|Period 2 (28 Days)|Adverse Event|1|||
30800958|NCT03227445|58816733|FG001|Period 2 (28 Days)|Adverse Event|0|||
30800959|NCT03227445|58816734|FG002|Period 2 (28 Days)|Adverse Event|2|||
30800960|NCT03227445|58816735|FG003|Period 2 (28 Days)|Adverse Event|1|||
30800961|NCT03227445|58816732|FG000|Period 2 (28 Days)|Protocol Violation|0|||
30800962|NCT03227445|58816733|FG001|Period 2 (28 Days)|Protocol Violation|0|||
30800963|NCT03227445|58816734|FG002|Period 2 (28 Days)|Protocol Violation|0|||
30800964|NCT03227445|58816735|FG003|Period 2 (28 Days)|Protocol Violation|1|||
30800965|NCT03227445|58816732|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
30800966|NCT03227445|58816733|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
30800967|NCT03227445|58816734|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
30800968|NCT03227445|58816735|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
30800969|NCT04067401|58816746|FG000|Overall Study|Withdrawal by Subject|7|||
30800970|NCT04067401|58816747|FG001|Overall Study|Withdrawal by Subject|0|||
30800971|NCT04067401|58816746|FG000|Overall Study|no data provided|1|||
30622323|NCT02151981|58634011|FG000|Overall Study|Death|184|||
30800972|NCT04067401|58816747|FG001|Overall Study|no data provided|0|||
30800973|NCT04194151|58816759|FG000|Overall Study|Physician Decision|1|||
30906337|NCT01606306|58940930|FG004|Overall Study|Lost to Follow-up|3|||
30906338|NCT01606306|58940931|FG005|Overall Study|Lost to Follow-up|5|||
30906339|NCT01606306|58940926|FG000|Overall Study|Withdrawal by Subject|4|||
30622324|NCT02151981|58634012|FG001|Overall Study|Death|88|||
30800974|NCT04194151|58816760|FG001|Overall Study|Physician Decision|1|||
30800975|NCT04194151|58816761|FG002|Overall Study|Physician Decision|1|||
30800976|NCT04194151|58816762|FG003|Overall Study|Physician Decision|1|||
30800977|NCT04194151|58816763|FG004|Overall Study|Physician Decision|0|||
30800978|NCT04194151|58816764|FG005|Overall Study|Physician Decision|1|||
30800979|NCT04194151|58816759|FG000|Overall Study|Monitorization problem|0|||
30800980|NCT04194151|58816760|FG001|Overall Study|Monitorization problem|1|||
30800981|NCT04194151|58816761|FG002|Overall Study|Monitorization problem|0|||
30906340|NCT01606306|58940927|FG001|Overall Study|Withdrawal by Subject|3|||
30800982|NCT04194151|58816762|FG003|Overall Study|Monitorization problem|0|||
30800983|NCT04194151|58816763|FG004|Overall Study|Monitorization problem|0|||
30800984|NCT04194151|58816764|FG005|Overall Study|Monitorization problem|0|||
30800985|NCT03820323|58816780|FG000|Overall Study|Lost to Follow-up|2|||
30800986|NCT03820323|58816781|FG001|Overall Study|Lost to Follow-up|1|||
30800987|NCT03820323|58816780|FG000|Overall Study|Missed 12-month visit|22|||
30800988|NCT03820323|58816781|FG001|Overall Study|Missed 12-month visit|14|||
30800989|NCT03820323|58816780|FG000|Overall Study|Death|2|||
30800990|NCT03820323|58816781|FG001|Overall Study|Death|1|||
30800991|NCT03820323|58816780|FG000|Overall Study|Transferred out|13|||
30800992|NCT03820323|58816781|FG001|Overall Study|Transferred out|11|||
30800993|NCT03820323|58816780|FG000|Overall Study|Terminated|0|||
30800994|NCT03820323|58816781|FG001|Overall Study|Terminated|3|||
30800995|NCT03820323|58816780|FG000|Overall Study|Withdrawal by Subject|1|||
30800996|NCT03820323|58816781|FG001|Overall Study|Withdrawal by Subject|6|||
30800997|NCT03287622|58816796|FG000|Overall Study|Withdrawal by Subject|1|||
30800998|NCT03287622|58816797|FG001|Overall Study|Withdrawal by Subject|0|||
30800999|NCT03287622|58816796|FG000|Overall Study|Lost to Follow-up|27|||
30801000|NCT03287622|58816797|FG001|Overall Study|Lost to Follow-up|15|||
30801001|NCT03287622|58816796|FG000|Overall Study|No prescripion after surgery|28|||
30801002|NCT03287622|58816797|FG001|Overall Study|No prescripion after surgery|31|||
30801003|NCT03287622|58816796|FG000|Overall Study|prolonged Length of stay|2|||
30801004|NCT03287622|58816797|FG001|Overall Study|prolonged Length of stay|0|||
30801005|NCT03287622|58816796|FG000|Overall Study|surgery related|0|||
30801006|NCT03287622|58816797|FG001|Overall Study|surgery related|2|||
30801007|NCT04063657|58816812|FG000|Overall Study|Lost to Follow-up|1|||
30801008|NCT04063657|58816813|FG001|Overall Study|Lost to Follow-up|0|||
30906341|NCT01606306|58940928|FG002|Overall Study|Withdrawal by Subject|4|||
30906342|NCT01606306|58940929|FG003|Overall Study|Withdrawal by Subject|4|||
30906343|NCT01606306|58940930|FG004|Overall Study|Withdrawal by Subject|5|||
30906344|NCT01606306|58940931|FG005|Overall Study|Withdrawal by Subject|4|||
30906345|NCT01606306|58940926|FG000|Overall Study|Physician Decision|1|||
30906346|NCT01606306|58940927|FG001|Overall Study|Physician Decision|2|||
30906347|NCT01606306|58940928|FG002|Overall Study|Physician Decision|0|||
30906348|NCT01606306|58940929|FG003|Overall Study|Physician Decision|0|||
30906349|NCT01606306|58940930|FG004|Overall Study|Physician Decision|0|||
30906350|NCT01606306|58940931|FG005|Overall Study|Physician Decision|0|||
30906351|NCT01754194|58940939|FG000|Overall Study|Lost to Follow-up|39|||
30906352|NCT01754194|58940940|FG001|Overall Study|Lost to Follow-up|14|||
30801009|NCT04058353|58816830|FG000|Overall Study|Adverse Event|2|||
30801010|NCT04058353|58816831|FG001|Overall Study|Adverse Event|1|||
30801011|NCT04058353|58816830|FG000|Overall Study|Physician Decision|1|||
30801012|NCT04058353|58816831|FG001|Overall Study|Physician Decision|0|||
30801013|NCT04058353|58816830|FG000|Overall Study|Other|1|||
30801014|NCT04058353|58816831|FG001|Overall Study|Other|0|||
30801015|NCT03226353|58816838|FG000|Overall Study|Withdrawal by Subject|1|||
30801016|NCT03226353|58816838|FG000|Overall Study|Screen Failure|5|||
30801017|NCT02730598|58816847|FG000|Overall Study|Withdrawal by Subject|3|||
30801018|NCT02730598|58816848|FG001|Overall Study|Withdrawal by Subject|3|||
30801019|NCT02730598|58816847|FG000|Overall Study|Protocol Violation|0|||
30801020|NCT02730598|58816848|FG001|Overall Study|Protocol Violation|1|||
30747428|NCT00445679|58757711|FG000|Overall Study|Withdrawal of Informed Consent|0|||
30747429|NCT00445679|58757712|FG001|Overall Study|Withdrawal of Informed Consent|0|||
30747430|NCT00445679|58757713|FG002|Overall Study|Withdrawal of Informed Consent|1|||
30747431|NCT00445679|58757714|FG003|Overall Study|Withdrawal of Informed Consent|0|||
30747432|NCT00445679|58757711|FG000|Overall Study|Protocol Violation|2|||
30747433|NCT00445679|58757712|FG001|Overall Study|Protocol Violation|3|||
30747434|NCT00445679|58757713|FG002|Overall Study|Protocol Violation|3|||
30747435|NCT00445679|58757714|FG003|Overall Study|Protocol Violation|1|||
30747436|NCT00445679|58757711|FG000|Overall Study|Withdrawal by Subject|8|||
30747437|NCT00445679|58757712|FG001|Overall Study|Withdrawal by Subject|14|||
30801021|NCT02730598|58816847|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
30801022|NCT02730598|58816848|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
30801023|NCT03226275|58816858|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
30801024|NCT03226275|58816859|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
30843568|NCT02101853|58869613|FG001|Post Induction Randomization|Death|9|||
30843569|NCT02101853|58869614|FG002|Post Induction Randomization|Death|2|||
30843570|NCT02101853|58869615|FG003|Post Induction Randomization|Death|2|||
30843571|NCT02101853|58869616|FG004|Post Induction Randomization|Death|0|||
30843572|NCT02101853|58869617|FG005|Post Induction Randomization|Death|0|||
30843573|NCT02101853|58869612|FG000|Post Induction Randomization|Lack of Efficacy|0|||
30843574|NCT02101853|58869613|FG001|Post Induction Randomization|Lack of Efficacy|14|||
30843575|NCT02101853|58869614|FG002|Post Induction Randomization|Lack of Efficacy|23|||
30843576|NCT02101853|58869615|FG003|Post Induction Randomization|Lack of Efficacy|18|||
30843577|NCT02101853|58869616|FG004|Post Induction Randomization|Lack of Efficacy|21|||
30906353|NCT01754194|58940939|FG000|Overall Study|Withdrawal by Subject|4|||
30906354|NCT01754194|58940940|FG001|Overall Study|Withdrawal by Subject|5|||
30906355|NCT01754194|58940939|FG000|Overall Study|Other|9|||
30801025|NCT03226275|58816860|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
30801026|NCT03226275|58816861|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
30801027|NCT03226275|58816858|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
30801028|NCT03226275|58816859|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
30801029|NCT03226275|58816860|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
30801030|NCT03226275|58816861|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
30801031|NCT04189081|58816874|FG000|Overall Study|Lost to Follow-up|1|||
30801032|NCT04189081|58816875|FG001|Overall Study|Lost to Follow-up|0|||
30801033|NCT04189081|58816876|FG002|Overall Study|Lost to Follow-up|0|||
30801034|NCT04189081|58816874|FG000|Overall Study|Withdrawal by Subject|0|||
30801035|NCT04189081|58816875|FG001|Overall Study|Withdrawal by Subject|0|||
30801036|NCT04189081|58816876|FG002|Overall Study|Withdrawal by Subject|1|||
30801037|NCT04187989|58816886|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
30801038|NCT04187989|58816887|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
30801039|NCT04187989|58816886|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
30801040|NCT04187989|58816887|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
30801041|NCT01150890|58816897|FG000|Overall Study|Other|0|||
30801042|NCT01150890|58816898|FG001|Overall Study|Other|1|||
30801043|NCT01150890|58816899|FG002|Overall Study|Other|0|||
30801044|NCT01150890|58816900|FG003|Overall Study|Other|2|||
30747438|NCT00445679|58757713|FG002|Overall Study|Withdrawal by Subject|20|||
30747439|NCT00445679|58757714|FG003|Overall Study|Withdrawal by Subject|18|||
30747440|NCT00445679|58757711|FG000|Overall Study|Lack of Efficacy|2|||
30747441|NCT00445679|58757712|FG001|Overall Study|Lack of Efficacy|6|||
30801045|NCT01150890|58816897|FG000|Overall Study|Pregnancy|0|||
30801046|NCT01150890|58816898|FG001|Overall Study|Pregnancy|0|||
30801047|NCT01150890|58816899|FG002|Overall Study|Pregnancy|0|||
30801048|NCT01150890|58816900|FG003|Overall Study|Pregnancy|1|||
30801049|NCT01150890|58816897|FG000|Overall Study|Administrative Decision|4|||
30801050|NCT01150890|58816898|FG001|Overall Study|Administrative Decision|4|||
30747442|NCT00445679|58757713|FG002|Overall Study|Lack of Efficacy|2|||
30747443|NCT00445679|58757714|FG003|Overall Study|Lack of Efficacy|0|||
30747444|NCT00455429|58757728|FG000|Overall Study|Study Terminated by Sponsor|0|||
30747445|NCT00455429|58757729|FG001|Overall Study|Study Terminated by Sponsor|0|||
30747446|NCT00455429|58757730|FG002|Overall Study|Study Terminated by Sponsor|0|||
30747447|NCT00455429|58757731|FG003|Overall Study|Study Terminated by Sponsor|3|||
30747448|NCT00455429|58757728|FG000|Overall Study|Lost to Follow-up|1|||
30747449|NCT00455429|58757729|FG001|Overall Study|Lost to Follow-up|0|||
30747450|NCT00455429|58757730|FG002|Overall Study|Lost to Follow-up|0|||
30747451|NCT00455429|58757731|FG003|Overall Study|Lost to Follow-up|3|||
30747452|NCT00455429|58757728|FG000|Overall Study|Withdrawal by Subject|0|||
30747453|NCT00455429|58757729|FG001|Overall Study|Withdrawal by Subject|1|||
30747454|NCT00455429|58757730|FG002|Overall Study|Withdrawal by Subject|1|||
30747455|NCT00455429|58757731|FG003|Overall Study|Withdrawal by Subject|0|||
30747456|NCT00455429|58757728|FG000|Overall Study|Lack of Efficacy|0|||
30747457|NCT00455429|58757729|FG001|Overall Study|Lack of Efficacy|1|||
30747458|NCT00455429|58757730|FG002|Overall Study|Lack of Efficacy|0|||
30747459|NCT00455429|58757731|FG003|Overall Study|Lack of Efficacy|1|||
30747460|NCT00455429|58757728|FG000|Overall Study|Adverse Event|0|||
30747461|NCT00455429|58757729|FG001|Overall Study|Adverse Event|1|||
30747462|NCT00455429|58757730|FG002|Overall Study|Adverse Event|0|||
30801051|NCT01150890|58816899|FG002|Overall Study|Administrative Decision|5|||
30801052|NCT01150890|58816900|FG003|Overall Study|Administrative Decision|6|||
30801053|NCT01150890|58816897|FG000|Overall Study|Ineligibility determined|0|||
30801054|NCT01150890|58816898|FG001|Overall Study|Ineligibility determined|1|||
30801055|NCT01150890|58816899|FG002|Overall Study|Ineligibility determined|0|||
30801056|NCT01150890|58816900|FG003|Overall Study|Ineligibility determined|0|||
30801057|NCT01150890|58816897|FG000|Overall Study|Adverse Event|0|||
30801058|NCT01150890|58816898|FG001|Overall Study|Adverse Event|0|||
30801059|NCT01150890|58816899|FG002|Overall Study|Adverse Event|2|||
30801060|NCT01150890|58816900|FG003|Overall Study|Adverse Event|0|||
30906356|NCT01754194|58940940|FG001|Overall Study|Other|8|||
30801061|NCT01150890|58816897|FG000|Overall Study|Withdrawal by Subject|0|||
30906357|NCT01753570|58940951|FG000|Overall Study|Adverse Event|1|||
30747463|NCT00455429|58757731|FG003|Overall Study|Adverse Event|3|||
30747464|NCT00455429|58757728|FG000|Overall Study|Randomly assigned but not treated|0|||
30747465|NCT00455429|58757729|FG001|Overall Study|Randomly assigned but not treated|0|||
30747466|NCT00455429|58757730|FG002|Overall Study|Randomly assigned but not treated|0|||
30747467|NCT00455429|58757731|FG003|Overall Study|Randomly assigned but not treated|2|||
30747468|NCT00455429|58757728|FG000|Overall Study|Personal Reason|1|||
30747469|NCT00455429|58757729|FG001|Overall Study|Personal Reason|0|||
30747470|NCT00455429|58757730|FG002|Overall Study|Personal Reason|0|||
30747471|NCT00455429|58757731|FG003|Overall Study|Personal Reason|0|||
30747472|NCT00455429|58757728|FG000|Overall Study|Non-compliance|0|||
30747473|NCT00455429|58757729|FG001|Overall Study|Non-compliance|0|||
30747474|NCT00455429|58757730|FG002|Overall Study|Non-compliance|0|||
30747475|NCT00455429|58757731|FG003|Overall Study|Non-compliance|1|||
30747476|NCT00455429|58757728|FG000|Overall Study|Other|0|||
30747477|NCT00455429|58757729|FG001|Overall Study|Other|2|||
30747478|NCT00455429|58757730|FG002|Overall Study|Other|0|||
30747479|NCT00455429|58757731|FG003|Overall Study|Other|1|||
30747480|NCT00445601|58757746|FG000|Overall Study|Withdrawal by Subject|11|||
30747481|NCT00445601|58757747|FG001|Overall Study|Withdrawal by Subject|11|||
30747482|NCT00445601|58757746|FG000|Overall Study|TURBT Complication|12|||
30747483|NCT00445601|58757747|FG001|Overall Study|TURBT Complication|8|||
30747484|NCT00445601|58757746|FG000|Overall Study|Incorrect Disease Status|6|||
30747485|NCT00445601|58757747|FG001|Overall Study|Incorrect Disease Status|6|||
30747486|NCT00445601|58757746|FG000|Overall Study|Drug Delivery Issue|2|||
30747487|NCT00445601|58757747|FG001|Overall Study|Drug Delivery Issue|2|||
30801062|NCT01150890|58816898|FG001|Overall Study|Withdrawal by Subject|0|||
30801063|NCT01150890|58816899|FG002|Overall Study|Withdrawal by Subject|2|||
30801064|NCT01150890|58816900|FG003|Overall Study|Withdrawal by Subject|1|||
30747488|NCT00445601|58757746|FG000|Overall Study|Adverse Event|2|||
30747489|NCT00445601|58757747|FG001|Overall Study|Adverse Event|0|||
30801065|NCT01150890|58816897|FG000|Overall Study|Disease progression|0|||
30801066|NCT01150890|58816898|FG001|Overall Study|Disease progression|7|||
30801067|NCT01150890|58816899|FG002|Overall Study|Disease progression|3|||
30801068|NCT01150890|58816900|FG003|Overall Study|Disease progression|7|||
30801069|NCT04057573|58816915|FG000|24-Week Double-Blind Period|Adverse Event|2|||
30801070|NCT04057573|58816916|FG001|24-Week Double-Blind Period|Adverse Event|0|||
30801071|NCT04057573|58816917|FG002|24-Week Double-Blind Period|Adverse Event|0|||
30801072|NCT04057573|58816918|FG003|24-Week Double-Blind Period|Adverse Event|0|||
30801073|NCT04057573|58816915|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
30801074|NCT04057573|58816916|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
30801075|NCT04057573|58816917|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
30801076|NCT04057573|58816918|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
30801077|NCT04057573|58816915|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
30801078|NCT04057573|58816916|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
30801079|NCT04057573|58816917|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
30801080|NCT04057573|58816918|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
30801081|NCT04057573|58816915|FG000|24-Week Double-Blind Period|Physician Decision|1|||
30801082|NCT04057573|58816916|FG001|24-Week Double-Blind Period|Physician Decision|0|||
30801083|NCT04057573|58816917|FG002|24-Week Double-Blind Period|Physician Decision|0|||
30801084|NCT04057573|58816918|FG003|24-Week Double-Blind Period|Physician Decision|0|||
30801085|NCT04057573|58816915|FG000|24-Week Double-Blind Period|Pregnancy|1|||
30801086|NCT04057573|58816916|FG001|24-Week Double-Blind Period|Pregnancy|0|||
30801087|NCT04057573|58816917|FG002|24-Week Double-Blind Period|Pregnancy|0|||
30801088|NCT04057573|58816918|FG003|24-Week Double-Blind Period|Pregnancy|0|||
30801089|NCT04057573|58816915|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
30801090|NCT04057573|58816916|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
30801091|NCT04057573|58816917|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
30801092|NCT04057573|58816918|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
30801093|NCT04057573|58816915|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
30801094|NCT04057573|58816916|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
30801095|NCT04057573|58816917|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
30906358|NCT01753570|58940952|FG001|Overall Study|Adverse Event|0|||
30906359|NCT01753570|58940953|FG002|Overall Study|Adverse Event|1|||
30906360|NCT01753570|58940951|FG000|Overall Study|Physician Decision|0|||
30906361|NCT01753570|58940952|FG001|Overall Study|Physician Decision|1|||
30622325|NCT02151981|58634011|FG000|Overall Study|Lost to Follow-up|7|||
30622326|NCT02151981|58634012|FG001|Overall Study|Lost to Follow-up|1|||
30622327|NCT02151981|58634011|FG000|Overall Study|Withdrawal by Subject|27|||
30622328|NCT02151981|58634012|FG001|Overall Study|Withdrawal by Subject|21|||
30622329|NCT02151981|58634011|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
30622330|NCT02151981|58634012|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
30622331|NCT02151981|58634011|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30747490|NCT00445601|58757746|FG000|Overall Study|Death prior to TURBT|0|||
30747491|NCT00445601|58757747|FG001|Overall Study|Death prior to TURBT|1|||
30747492|NCT00444587|58757759|FG000|Overall Study|Death|2|||
30747493|NCT00444587|58757760|FG001|Overall Study|Death|1|||
30747494|NCT00444587|58757759|FG000|Overall Study|Progression of the disease|73|||
30801096|NCT04057573|58816918|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
30801097|NCT04057573|58816915|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
30801098|NCT04057573|58816916|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
30906362|NCT01753570|58940953|FG002|Overall Study|Physician Decision|0|||
30906363|NCT01753570|58940951|FG000|Overall Study|Withdrawal by Subject|1|||
30801099|NCT04057573|58816917|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
30801100|NCT04057573|58816918|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
30801101|NCT04057573|58816915|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
30801102|NCT04057573|58816916|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
30801103|NCT04057573|58816917|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
30801104|NCT04057573|58816918|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
30801105|NCT04057573|58816915|FG000|24-Week Double-Blind Period|Not Treated|1|||
30801106|NCT04057573|58816916|FG001|24-Week Double-Blind Period|Not Treated|0|||
30801107|NCT04057573|58816917|FG002|24-Week Double-Blind Period|Not Treated|0|||
30801108|NCT04057573|58816918|FG003|24-Week Double-Blind Period|Not Treated|0|||
30801109|NCT04057573|58816915|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
30801110|NCT04057573|58816916|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
30801111|NCT04057573|58816917|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
30801112|NCT04057573|58816918|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
30801113|NCT04057573|58816915|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
30801114|NCT04057573|58816916|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
30801115|NCT04057573|58816917|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
30801116|NCT04057573|58816918|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
30801117|NCT04057573|58816915|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
30801118|NCT04057573|58816916|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
30801119|NCT04057573|58816917|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
30801120|NCT04057573|58816918|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
30801121|NCT04057573|58816915|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
30801122|NCT04057573|58816916|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
30801123|NCT04057573|58816917|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
30801124|NCT04057573|58816918|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
30801125|NCT04057573|58816915|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
30801126|NCT04057573|58816916|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
30801127|NCT04057573|58816917|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
30801128|NCT04057573|58816918|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
30801129|NCT04054765|58816931|FG000|Baseline|Withdrawal by Subject|5|||
30801130|NCT04054765|58816932|FG001|Baseline|Withdrawal by Subject|3|||
30801131|NCT04054765|58816931|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
30801132|NCT04054765|58816932|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
30801133|NCT04054765|58816931|FG000|3-month Follow up|Withdrawal by Subject|0|||
30801134|NCT04054765|58816932|FG001|3-month Follow up|Withdrawal by Subject|3|||
30801135|NCT04054765|58816931|FG000|6-month Follow up|Lost to Follow-up|32|||
30801136|NCT04054765|58816932|FG001|6-month Follow up|Lost to Follow-up|32|||
30801137|NCT04179721|58816940|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
30801138|NCT04179721|58816941|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
30801139|NCT04179721|58816940|FG000|Overall Study|Lost to Follow-up|0|||
30801140|NCT04179721|58816941|FG001|Overall Study|Lost to Follow-up|1|||
30801141|NCT03286218|58816947|FG000|Qualification Phase Period 1|Adverse Event|1|||
30801142|NCT03286218|58816948|FG001|Qualification Phase Period 1|Adverse Event|0|||
30801143|NCT03286218|58816949|FG002|Qualification Phase Period 1|Adverse Event|0|||
30801144|NCT03286218|58816950|FG003|Qualification Phase Period 1|Adverse Event|0|||
30801145|NCT03286218|58816951|FG004|Qualification Phase Period 1|Adverse Event|0|||
30801146|NCT03286218|58816952|FG005|Qualification Phase Period 1|Adverse Event|0|||
30801147|NCT03286218|58816953|FG006|Qualification Phase Period 1|Adverse Event|0|||
30801148|NCT03286218|58816954|FG007|Qualification Phase Period 1|Adverse Event|0|||
30801149|NCT03286218|58816955|FG008|Qualification Phase Period 1|Adverse Event|0|||
30801150|NCT03286218|58816956|FG009|Qualification Phase Period 1|Adverse Event|0|||
30801151|NCT03286218|58816957|FG010|Qualification Phase Period 1|Adverse Event|0|||
30801152|NCT03286218|58816958|FG011|Qualification Phase Period 1|Adverse Event|0|||
30801153|NCT03286218|58816947|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
30801154|NCT03286218|58816948|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
30801155|NCT03286218|58816949|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
30906364|NCT01753570|58940952|FG001|Overall Study|Withdrawal by Subject|4|||
30906365|NCT01753570|58940953|FG002|Overall Study|Withdrawal by Subject|0|||
30906366|NCT01753336|58940962|FG000|Overall Study|Patient decision|12|||
30906367|NCT01753336|58940962|FG000|Overall Study|Lost to Follow-up|3|||
30801156|NCT03286218|58816950|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
30801157|NCT03286218|58816951|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
30801158|NCT03286218|58816952|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
30801159|NCT03286218|58816953|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
30801160|NCT03286218|58816954|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
30801161|NCT03286218|58816955|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
30801162|NCT03286218|58816956|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
30801163|NCT03286218|58816957|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
30801164|NCT03286218|58816958|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
30801165|NCT03286218|58816947|FG000|Qualification Phase Period 2|Adverse Event|0|||
30801166|NCT03286218|58816948|FG001|Qualification Phase Period 2|Adverse Event|1|||
30801167|NCT03286218|58816949|FG002|Qualification Phase Period 2|Adverse Event|0|||
30801168|NCT03286218|58816950|FG003|Qualification Phase Period 2|Adverse Event|0|||
30801169|NCT03286218|58816951|FG004|Qualification Phase Period 2|Adverse Event|0|||
30801170|NCT03286218|58816952|FG005|Qualification Phase Period 2|Adverse Event|0|||
30801171|NCT03286218|58816953|FG006|Qualification Phase Period 2|Adverse Event|0|||
30801172|NCT03286218|58816954|FG007|Qualification Phase Period 2|Adverse Event|0|||
30801173|NCT03286218|58816955|FG008|Qualification Phase Period 2|Adverse Event|0|||
30801174|NCT03286218|58816956|FG009|Qualification Phase Period 2|Adverse Event|0|||
30801175|NCT03286218|58816957|FG010|Qualification Phase Period 2|Adverse Event|0|||
30801176|NCT03286218|58816958|FG011|Qualification Phase Period 2|Adverse Event|0|||
30801177|NCT03286218|58816947|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
30801178|NCT03286218|58816948|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
30801179|NCT03286218|58816949|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
30801180|NCT03286218|58816950|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
30801181|NCT03286218|58816951|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
30801182|NCT03286218|58816952|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
30801183|NCT03286218|58816953|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
30801184|NCT03286218|58816954|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
30801185|NCT03286218|58816955|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
30801186|NCT03286218|58816956|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
30801187|NCT03286218|58816957|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
30801188|NCT03286218|58816958|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
30801189|NCT03286218|58816947|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
30801190|NCT03286218|58816948|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
30801191|NCT03286218|58816949|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
30906368|NCT01753336|58940962|FG000|Overall Study|Physician Decision|2|||
30801192|NCT03286218|58816950|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
30801193|NCT03286218|58816951|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
30801194|NCT03286218|58816952|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
30801195|NCT03286218|58816953|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
30801196|NCT03286218|58816954|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
30801197|NCT03286218|58816955|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
30801198|NCT03286218|58816956|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
30622332|NCT02151981|58634012|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
30622333|NCT02151981|58634011|FG000|Overall Study|Patient had no clinical benefit|1|||
30801199|NCT03286218|58816957|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
30801200|NCT03286218|58816958|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
30801201|NCT03286218|58816947|FG000|Qualification Phase Period 2|Protocol Violation|2|||
30801202|NCT03286218|58816948|FG001|Qualification Phase Period 2|Protocol Violation|0|||
30801203|NCT03286218|58816949|FG002|Qualification Phase Period 2|Protocol Violation|0|||
30801204|NCT03286218|58816950|FG003|Qualification Phase Period 2|Protocol Violation|0|||
30801205|NCT03286218|58816951|FG004|Qualification Phase Period 2|Protocol Violation|0|||
30801206|NCT03286218|58816952|FG005|Qualification Phase Period 2|Protocol Violation|0|||
30801207|NCT03286218|58816953|FG006|Qualification Phase Period 2|Protocol Violation|0|||
30801208|NCT03286218|58816954|FG007|Qualification Phase Period 2|Protocol Violation|0|||
30801209|NCT03286218|58816955|FG008|Qualification Phase Period 2|Protocol Violation|0|||
30801210|NCT03286218|58816956|FG009|Qualification Phase Period 2|Protocol Violation|0|||
30801211|NCT03286218|58816957|FG010|Qualification Phase Period 2|Protocol Violation|0|||
30801212|NCT03286218|58816958|FG011|Qualification Phase Period 2|Protocol Violation|0|||
30801213|NCT03286218|58816947|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
30801214|NCT03286218|58816948|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
30906369|NCT01753336|58940962|FG000|Overall Study|Sponsor's decision|2|||
30906370|NCT01753336|58940962|FG000|Overall Study|Withdrawal by Subject|1|||
30801215|NCT03286218|58816949|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
30801216|NCT03286218|58816950|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
30906371|NCT01777282|58940971|FG000|Overall Study|Persistent Hyperglycemia|0|||
30801217|NCT03286218|58816951|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
30906372|NCT01777282|58940972|FG001|Overall Study|Persistent Hyperglycemia|0|||
30906373|NCT01777282|58940973|FG002|Overall Study|Persistent Hyperglycemia|1|||
30906374|NCT01777282|58940974|FG003|Overall Study|Persistent Hyperglycemia|0|||
30801218|NCT03286218|58816952|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
30801219|NCT03286218|58816953|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
30801220|NCT03286218|58816954|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
30801221|NCT03286218|58816955|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
30801222|NCT03286218|58816956|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
30801223|NCT03286218|58816957|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
30801224|NCT03286218|58816958|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
30801225|NCT03286218|58816947|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
30801226|NCT03286218|58816948|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
30801227|NCT03286218|58816949|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
30801228|NCT03286218|58816950|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
30801229|NCT03286218|58816951|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
30801230|NCT03286218|58816952|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
30801231|NCT03286218|58816953|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
30801232|NCT03286218|58816954|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
30801233|NCT03286218|58816955|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
30801234|NCT03286218|58816956|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
30801235|NCT03286218|58816957|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
30801236|NCT03286218|58816958|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
30801237|NCT03286218|58816947|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
30801238|NCT03286218|58816948|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
30801239|NCT03286218|58816949|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
30801240|NCT03286218|58816950|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
30906375|NCT01777282|58940975|FG004|Overall Study|Persistent Hyperglycemia|0|||
30906376|NCT01777282|58940971|FG000|Overall Study|New Antidiabetic Medication|0|||
30906377|NCT01777282|58940972|FG001|Overall Study|New Antidiabetic Medication|0|||
30906378|NCT01777282|58940973|FG002|Overall Study|New Antidiabetic Medication|1|||
30906379|NCT01777282|58940974|FG003|Overall Study|New Antidiabetic Medication|0|||
30906380|NCT01777282|58940975|FG004|Overall Study|New Antidiabetic Medication|0|||
30906381|NCT01777282|58940971|FG000|Overall Study|Adverse Event|4|||
30906382|NCT01777282|58940972|FG001|Overall Study|Adverse Event|4|||
30906383|NCT01777282|58940973|FG002|Overall Study|Adverse Event|2|||
30906384|NCT01777282|58940974|FG003|Overall Study|Adverse Event|1|||
30747495|NCT00444587|58757760|FG001|Overall Study|Progression of the disease|8|||
30747496|NCT00444587|58757759|FG000|Overall Study|Refused treatment/did not cooperate|4|||
30747497|NCT00444587|58757760|FG001|Overall Study|Refused treatment/did not cooperate|1|||
30747498|NCT00444587|58757759|FG000|Overall Study|Investigator decision|3|||
30747499|NCT00444587|58757760|FG001|Overall Study|Investigator decision|0|||
30747500|NCT00444587|58757759|FG000|Overall Study|Protocol Violation|1|||
30747501|NCT00444587|58757760|FG001|Overall Study|Protocol Violation|0|||
30747502|NCT00444587|58757759|FG000|Overall Study|Missing|0|||
30747503|NCT00444587|58757760|FG001|Overall Study|Missing|5|||
30747504|NCT00455195|58757770|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
30747505|NCT00455195|58757771|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
30747506|NCT00455195|58757770|FG000|Double-blind Study AGLU02704|Death|1|||
30747507|NCT00455195|58757771|FG001|Double-blind Study AGLU02704|Death|0|||
30747508|NCT00455195|58757770|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
30747509|NCT00455195|58757771|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
30747510|NCT00455195|58757770|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
30747511|NCT00455195|58757771|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
30747512|NCT00235716|58757781|FG000|Overall Study|Death|26|||
30747513|NCT00235716|58757782|FG001|Overall Study|Death|39|||
30747514|NCT00235716|58757783|FG002|Overall Study|Death|32|||
30747515|NCT00235716|58757784|FG003|Overall Study|Death|31|||
30747516|NCT00235716|58757781|FG000|Overall Study|Withdrawal by Subject|23|||
30747517|NCT00235716|58757782|FG001|Overall Study|Withdrawal by Subject|19|||
30747518|NCT00235716|58757783|FG002|Overall Study|Withdrawal by Subject|17|||
30747519|NCT00235716|58757784|FG003|Overall Study|Withdrawal by Subject|18|||
30747520|NCT00235716|58757781|FG000|Overall Study|Lost to Follow-up|12|||
30747521|NCT00235716|58757782|FG001|Overall Study|Lost to Follow-up|7|||
30747522|NCT00235716|58757783|FG002|Overall Study|Lost to Follow-up|14|||
30747523|NCT00235716|58757784|FG003|Overall Study|Lost to Follow-up|10|||
30747524|NCT00235716|58757781|FG000|Overall Study|Adverse Event|1|||
30747525|NCT00235716|58757782|FG001|Overall Study|Adverse Event|1|||
30747526|NCT00235716|58757783|FG002|Overall Study|Adverse Event|1|||
30747527|NCT00235716|58757784|FG003|Overall Study|Adverse Event|0|||
30747528|NCT00235716|58757781|FG000|Overall Study|Physician Decision|0|||
30747529|NCT00235716|58757782|FG001|Overall Study|Physician Decision|1|||
30747530|NCT00235716|58757783|FG002|Overall Study|Physician Decision|1|||
30747531|NCT00235716|58757784|FG003|Overall Study|Physician Decision|3|||
30906385|NCT01777282|58940975|FG004|Overall Study|Adverse Event|3|||
30906386|NCT01777282|58940971|FG000|Overall Study|Withdrawal by Subject|4|||
30906387|NCT01777282|58940972|FG001|Overall Study|Withdrawal by Subject|0|||
30906388|NCT01777282|58940973|FG002|Overall Study|Withdrawal by Subject|0|||
30906389|NCT01777282|58940974|FG003|Overall Study|Withdrawal by Subject|1|||
30906390|NCT01777282|58940975|FG004|Overall Study|Withdrawal by Subject|2|||
30906391|NCT01777282|58940971|FG000|Overall Study|Protocol Violation|2|||
30906392|NCT01777282|58940972|FG001|Overall Study|Protocol Violation|0|||
30801241|NCT03286218|58816951|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
30801242|NCT03286218|58816952|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
30801243|NCT03286218|58816953|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
30801244|NCT03286218|58816954|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
30801245|NCT03286218|58816955|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
30801246|NCT03286218|58816956|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
30801247|NCT03286218|58816957|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
30801248|NCT03286218|58816958|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
30801249|NCT03224325|58816992|FG000|Overall Study|Adverse Event|1|||
30801250|NCT03224325|58816993|FG001|Overall Study|Adverse Event|0|||
30801251|NCT03224325|58816994|FG002|Overall Study|Adverse Event|0|||
30801252|NCT03224325|58816995|FG003|Overall Study|Adverse Event|0|||
30801253|NCT03224325|58816996|FG004|Overall Study|Adverse Event|0|||
30801254|NCT03224325|58816997|FG005|Overall Study|Adverse Event|0|||
30801255|NCT03224325|58816998|FG006|Overall Study|Adverse Event|1|||
30801256|NCT03224325|58816992|FG000|Overall Study|Withdrawal by Subject|0|||
30801257|NCT03224325|58816993|FG001|Overall Study|Withdrawal by Subject|0|||
30801258|NCT03224325|58816994|FG002|Overall Study|Withdrawal by Subject|0|||
30801259|NCT03224325|58816995|FG003|Overall Study|Withdrawal by Subject|1|||
30801260|NCT03224325|58816996|FG004|Overall Study|Withdrawal by Subject|0|||
30801261|NCT03224325|58816997|FG005|Overall Study|Withdrawal by Subject|0|||
30801262|NCT03224325|58816998|FG006|Overall Study|Withdrawal by Subject|0|||
30801263|NCT04016779|58817022|FG000|Overall Study|Adverse Event|9|||
30801264|NCT04016779|58817023|FG001|Overall Study|Adverse Event|17|||
30906393|NCT01777282|58940973|FG002|Overall Study|Protocol Violation|1|||
30906394|NCT01777282|58940974|FG003|Overall Study|Protocol Violation|0|||
30801265|NCT04016779|58817022|FG000|Overall Study|Lack of Efficacy|4|||
30801266|NCT04016779|58817023|FG001|Overall Study|Lack of Efficacy|1|||
30801267|NCT04016779|58817022|FG000|Overall Study|Lost to Follow-up|5|||
30906395|NCT01777282|58940975|FG004|Overall Study|Protocol Violation|2|||
30906396|NCT01777282|58940971|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
30906397|NCT01777282|58940972|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
30906398|NCT01777282|58940973|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
30906399|NCT01777282|58940974|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
30906400|NCT01777282|58940975|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
30801268|NCT04016779|58817023|FG001|Overall Study|Lost to Follow-up|14|||
30801269|NCT04016779|58817022|FG000|Overall Study|Physician Decision|1|||
30801270|NCT04016779|58817023|FG001|Overall Study|Physician Decision|3|||
30801271|NCT04016779|58817022|FG000|Overall Study|Withdrawal by Subject|6|||
30801272|NCT04016779|58817023|FG001|Overall Study|Withdrawal by Subject|8|||
30801273|NCT04016779|58817022|FG000|Overall Study|Non-compliance with Study Drug|2|||
30801274|NCT04016779|58817023|FG001|Overall Study|Non-compliance with Study Drug|3|||
30801275|NCT04016779|58817022|FG000|Overall Study|Other, Multiple categories|17|||
30801276|NCT04016779|58817023|FG001|Overall Study|Other, Multiple categories|17|||
30801277|NCT02857426|58817033|FG000|Overall Study|Disease progression|34|||
30906401|NCT01975389|58940989|FG000|Overall Study|Adverse Event|10|||
30906402|NCT01975389|58940990|FG001|Overall Study|Adverse Event|6|||
30906403|NCT01975389|58940989|FG000|Overall Study|Death|61|||
30906404|NCT01975389|58940990|FG001|Overall Study|Death|54|||
30906405|NCT01975389|58940989|FG000|Overall Study|Lost to Follow-up|81|||
30906406|NCT01975389|58940990|FG001|Overall Study|Lost to Follow-up|86|||
30906407|NCT01975389|58940989|FG000|Overall Study|Withdrawal by Subject|90|||
30906408|NCT01975389|58940990|FG001|Overall Study|Withdrawal by Subject|76|||
30906409|NCT01975389|58940989|FG000|Overall Study|Other|6|||
30906410|NCT01975389|58940990|FG001|Overall Study|Other|9|||
30906411|NCT01975389|58940989|FG000|Overall Study|Randomized, not treated|4|||
30906412|NCT01975389|58940990|FG001|Overall Study|Randomized, not treated|5|||
30906413|NCT01974141|58940998|FG000|Overall Study|Other Reasons|28|||
30801278|NCT02857426|58817034|FG001|Overall Study|Disease progression|13|||
30906414|NCT01974141|58940999|FG001|Overall Study|Other Reasons|18|||
30906415|NCT01974141|58940998|FG000|Overall Study|Protocol Violation|2|||
30801279|NCT02857426|58817033|FG000|Overall Study|Study drug toxicity|4|||
30801280|NCT02857426|58817034|FG001|Overall Study|Study drug toxicity|1|||
30801281|NCT02857426|58817033|FG000|Overall Study|Death|1|||
30906416|NCT01974141|58940999|FG001|Overall Study|Protocol Violation|6|||
30906417|NCT01974141|58940998|FG000|Overall Study|Personal Reasons|21|||
30906418|NCT01974141|58940999|FG001|Overall Study|Personal Reasons|20|||
30906419|NCT01974141|58940998|FG000|Overall Study|Lost to Follow-up|38|||
30801282|NCT02857426|58817034|FG001|Overall Study|Death|0|||
30801283|NCT02857426|58817033|FG000|Overall Study|Adverse event unrelated to study drug|6|||
30801284|NCT02857426|58817034|FG001|Overall Study|Adverse event unrelated to study drug|2|||
30801285|NCT02857426|58817033|FG000|Overall Study|Participant withdrew consent|1|||
30801286|NCT02857426|58817034|FG001|Overall Study|Participant withdrew consent|1|||
30801287|NCT02857426|58817033|FG000|Overall Study|Maximum clinical benefit|1|||
30801288|NCT02857426|58817034|FG001|Overall Study|Maximum clinical benefit|0|||
30801289|NCT02857426|58817033|FG000|Overall Study|Completed treatment|0|||
30906420|NCT01974141|58940999|FG001|Overall Study|Lost to Follow-up|29|||
30906421|NCT01974141|58940998|FG000|Overall Study|Pregnancy|3|||
30801290|NCT02857426|58817034|FG001|Overall Study|Completed treatment|2|||
30906422|NCT01974141|58940999|FG001|Overall Study|Pregnancy|3|||
30801291|NCT01127256|58817042|FG000|Overall Study|Adverse Event|13|||
30801292|NCT01127256|58817043|FG001|Overall Study|Adverse Event|13|||
30801293|NCT01127256|58817042|FG000|Overall Study|Lack of Efficacy|4|||
30801294|NCT01127256|58817043|FG001|Overall Study|Lack of Efficacy|0|||
30801295|NCT01127256|58817042|FG000|Overall Study|Lost to Follow-up|16|||
30801296|NCT01127256|58817043|FG001|Overall Study|Lost to Follow-up|17|||
30801297|NCT01127256|58817042|FG000|Overall Study|Withdrawal by Subject|5|||
30801298|NCT01127256|58817043|FG001|Overall Study|Withdrawal by Subject|9|||
30801299|NCT01127256|58817042|FG000|Overall Study|Protocol Violation|1|||
30801300|NCT01127256|58817043|FG001|Overall Study|Protocol Violation|0|||
30801301|NCT03668613|58817051|FG000|Overall Study|Adverse Event|0|||
30801302|NCT03668613|58817052|FG001|Overall Study|Adverse Event|2|||
30801303|NCT03668613|58817051|FG000|Overall Study|Lack of Efficacy|0|||
30801304|NCT03668613|58817052|FG001|Overall Study|Lack of Efficacy|1|||
30801305|NCT04016311|58817061|FG000|Overall Study|Withdrawal by Subject|1|||
30801306|NCT04016311|58817062|FG001|Overall Study|Withdrawal by Subject|0|||
30801307|NCT04052425|58817072|FG000|24-Week Double-blind Period|Adverse Event|0|||
30801308|NCT04052425|58817073|FG001|24-Week Double-blind Period|Adverse Event|1|||
30801309|NCT04052425|58817074|FG002|24-Week Double-blind Period|Adverse Event|0|||
30801310|NCT04052425|58817075|FG003|24-Week Double-blind Period|Adverse Event|0|||
30801311|NCT04052425|58817072|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
30801312|NCT04052425|58817073|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
30801313|NCT04052425|58817074|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
30801314|NCT04052425|58817075|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
30801315|NCT04052425|58817072|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
30801316|NCT04052425|58817073|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
30801317|NCT04052425|58817074|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
30801318|NCT04052425|58817075|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
30801319|NCT04052425|58817072|FG000|24-Week Double-blind Period|Physician Decision|1|||
30801320|NCT04052425|58817073|FG001|24-Week Double-blind Period|Physician Decision|0|||
30801321|NCT04052425|58817074|FG002|24-Week Double-blind Period|Physician Decision|0|||
30801322|NCT04052425|58817075|FG003|24-Week Double-blind Period|Physician Decision|0|||
30801323|NCT04052425|58817072|FG000|24-Week Double-blind Period|Protocol Violation|1|||
30801324|NCT04052425|58817073|FG001|24-Week Double-blind Period|Protocol Violation|0|||
30801325|NCT04052425|58817074|FG002|24-Week Double-blind Period|Protocol Violation|0|||
30906423|NCT01974141|58940998|FG000|Overall Study|Lack of Efficacy|0|||
30906424|NCT01974141|58940999|FG001|Overall Study|Lack of Efficacy|1|||
30906425|NCT01974141|58940998|FG000|Overall Study|Adverse Event|4|||
30747532|NCT00274742|58757800|FG000|Overall Study|Adverse Event|0|||
30747533|NCT00274742|58757801|FG001|Overall Study|Adverse Event|4|||
30747534|NCT00274742|58757802|FG002|Overall Study|Adverse Event|1|||
30747535|NCT00274742|58757803|FG003|Overall Study|Adverse Event|4|||
30747536|NCT00274742|58757804|FG004|Overall Study|Adverse Event|12|||
30747537|NCT00274742|58757805|FG005|Overall Study|Adverse Event|3|||
30747538|NCT00274742|58757800|FG000|Overall Study|Lost to Follow-up|0|||
30747539|NCT00274742|58757801|FG001|Overall Study|Lost to Follow-up|0|||
30747540|NCT00274742|58757802|FG002|Overall Study|Lost to Follow-up|0|||
30747541|NCT00274742|58757803|FG003|Overall Study|Lost to Follow-up|0|||
30747542|NCT00274742|58757804|FG004|Overall Study|Lost to Follow-up|1|||
30747543|NCT00274742|58757805|FG005|Overall Study|Lost to Follow-up|0|||
30801326|NCT04052425|58817075|FG003|24-Week Double-blind Period|Protocol Violation|0|||
30801327|NCT04052425|58817072|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
30801328|NCT04052425|58817073|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
30801329|NCT04052425|58817074|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
30801330|NCT04052425|58817075|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
30906426|NCT01974141|58940999|FG001|Overall Study|Adverse Event|5|||
30906427|NCT01945593|58941009|FG000|Overall Study|Adverse Event|0|||
30747544|NCT00274742|58757800|FG000|Overall Study|End of Study|0|||
30747545|NCT00274742|58757801|FG001|Overall Study|End of Study|0|||
30747546|NCT00274742|58757802|FG002|Overall Study|End of Study|0|||
30747547|NCT00274742|58757803|FG003|Overall Study|End of Study|1|||
30801331|NCT04052425|58817072|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
30801332|NCT04052425|58817073|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
30801333|NCT04052425|58817074|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
30801334|NCT04052425|58817075|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
30801335|NCT04052425|58817072|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
30801336|NCT04052425|58817073|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
30801337|NCT04052425|58817074|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
30801338|NCT04052425|58817075|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
30801339|NCT04052425|58817072|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
30801340|NCT04052425|58817073|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
30801341|NCT04052425|58817074|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
30801342|NCT04052425|58817075|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
30801343|NCT04052425|58817072|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
30801344|NCT04052425|58817073|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
30801345|NCT04052425|58817074|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
30801346|NCT04052425|58817075|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
30801347|NCT04052425|58817072|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
30801348|NCT04052425|58817073|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
30801349|NCT04052425|58817074|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
30801350|NCT04052425|58817075|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
30801351|NCT04052425|58817072|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
30801352|NCT04052425|58817073|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
30801353|NCT04052425|58817074|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
30801354|NCT04052425|58817075|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
30801355|NCT04052425|58817072|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
30801356|NCT04052425|58817073|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
30801357|NCT04052425|58817074|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
30801358|NCT04052425|58817075|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
30801359|NCT04052425|58817072|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
30801360|NCT04052425|58817073|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
30801361|NCT04052425|58817074|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
30801362|NCT04052425|58817075|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
30801363|NCT03235089|58817085|FG000|Overall Study|Lost to Follow-up|1|||
30801364|NCT03235089|58817086|FG001|Overall Study|Lost to Follow-up|1|||
30801365|NCT03235089|58817085|FG000|Overall Study|Physician Decision|2|||
30801366|NCT03235089|58817086|FG001|Overall Study|Physician Decision|2|||
30801367|NCT04013191|58817095|FG000|Overall Study|Adverse Event|1|||
30801368|NCT04013191|58817096|FG001|Overall Study|Adverse Event|0|||
30801369|NCT03285594|58817109|FG000|Overall Study|At the Participant's Own Request|10|||
30801370|NCT03285594|58817110|FG001|Overall Study|At the Participant's Own Request|5|||
30801371|NCT03285594|58817111|FG002|Overall Study|At the Participant's Own Request|21|||
30801372|NCT03285594|58817109|FG000|Overall Study|Adverse Event|2|||
30801373|NCT03285594|58817110|FG001|Overall Study|Adverse Event|2|||
30801374|NCT03285594|58817111|FG002|Overall Study|Adverse Event|6|||
30747548|NCT00274742|58757804|FG004|Overall Study|End of Study|0|||
30747549|NCT00274742|58757805|FG005|Overall Study|End of Study|0|||
30747550|NCT00274742|58757800|FG000|Overall Study|Disease Progression|0|||
30747551|NCT00274742|58757801|FG001|Overall Study|Disease Progression|1|||
30801375|NCT03285594|58817109|FG000|Overall Study|Poor Compliance to Protocol|0|||
30801376|NCT03285594|58817110|FG001|Overall Study|Poor Compliance to Protocol|0|||
30801377|NCT03285594|58817111|FG002|Overall Study|Poor Compliance to Protocol|1|||
30747552|NCT00274742|58757802|FG002|Overall Study|Disease Progression|1|||
30747553|NCT00274742|58757803|FG003|Overall Study|Disease Progression|0|||
30747554|NCT00274742|58757804|FG004|Overall Study|Disease Progression|1|||
30747555|NCT00274742|58757805|FG005|Overall Study|Disease Progression|0|||
30747556|NCT00274742|58757800|FG000|Overall Study|Other|0|||
30747557|NCT00274742|58757801|FG001|Overall Study|Other|3|||
30747558|NCT00274742|58757802|FG002|Overall Study|Other|0|||
30747559|NCT00274742|58757803|FG003|Overall Study|Other|0|||
30747560|NCT00274742|58757804|FG004|Overall Study|Other|2|||
30747561|NCT00274742|58757805|FG005|Overall Study|Other|0|||
30747562|NCT00262314|58757825|FG000|Overall Study|Changing physicians|38|||
30801378|NCT03285594|58817109|FG000|Overall Study|Lost to Follow-up|0|||
30747563|NCT00262314|58757825|FG000|Overall Study|Death|12|||
30747564|NCT00262314|58757825|FG000|Overall Study|Patient's decision|92|||
30747565|NCT00262314|58757825|FG000|Overall Study|Other|95|||
30747566|NCT00262314|58757825|FG000|Overall Study|Lost to Follow-up|70|||
30906428|NCT01945593|58941010|FG001|Overall Study|Adverse Event|0|||
30906429|NCT01945593|58941011|FG002|Overall Study|Adverse Event|0|||
30906430|NCT01945593|58941012|FG003|Overall Study|Adverse Event|5|||
30906431|NCT01945593|58941009|FG000|Overall Study|Physician Decision|0|||
30801379|NCT03285594|58817110|FG001|Overall Study|Lost to Follow-up|0|||
30801380|NCT03285594|58817111|FG002|Overall Study|Lost to Follow-up|1|||
30801381|NCT03285594|58817109|FG000|Overall Study|Reason Not Specified|3|||
30801382|NCT03285594|58817110|FG001|Overall Study|Reason Not Specified|4|||
30801383|NCT03285594|58817111|FG002|Overall Study|Reason Not Specified|8|||
30801384|NCT03234465|58817122|FG000|Overall Study|Adverse Event|4|||
30801385|NCT03234465|58817123|FG001|Overall Study|Adverse Event|2|||
30801386|NCT03234465|58817122|FG000|Overall Study|Death|0|||
30801387|NCT03234465|58817123|FG001|Overall Study|Death|1|||
30801388|NCT03234465|58817122|FG000|Overall Study|Lost to Follow-up|1|||
30801389|NCT03234465|58817123|FG001|Overall Study|Lost to Follow-up|1|||
30801390|NCT03234465|58817122|FG000|Overall Study|Withdrawal by Subject|12|||
30801391|NCT03234465|58817123|FG001|Overall Study|Withdrawal by Subject|27|||
30801392|NCT03234465|58817122|FG000|Overall Study|Symptomatic deterioration|0|||
30801393|NCT03234465|58817123|FG001|Overall Study|Symptomatic deterioration|1|||
30801394|NCT03234465|58817122|FG000|Overall Study|Non-compliance|2|||
30801395|NCT03234465|58817123|FG001|Overall Study|Non-compliance|0|||
30801396|NCT03234465|58817122|FG000|Overall Study|Other|14|||
30801397|NCT03234465|58817123|FG001|Overall Study|Other|8|||
30801398|NCT03290131|58817132|FG000|Overall Study|Adverse Event|22|||
30801399|NCT03290131|58817133|FG001|Overall Study|Adverse Event|57|||
30801400|NCT03290131|58817134|FG002|Overall Study|Adverse Event|11|||
30801401|NCT03290131|58817132|FG000|Overall Study|Withdrawal by Subject|18|||
30801402|NCT03290131|58817133|FG001|Overall Study|Withdrawal by Subject|13|||
30801403|NCT03290131|58817134|FG002|Overall Study|Withdrawal by Subject|8|||
30801404|NCT03290131|58817132|FG000|Overall Study|MS Relapse|2|||
30801405|NCT03290131|58817133|FG001|Overall Study|MS Relapse|1|||
30801406|NCT03290131|58817134|FG002|Overall Study|MS Relapse|0|||
30801407|NCT03290131|58817132|FG000|Overall Study|Unknown reason|0|||
30801408|NCT03290131|58817133|FG001|Overall Study|Unknown reason|1|||
30801409|NCT03290131|58817134|FG002|Overall Study|Unknown reason|0|||
30801410|NCT04050865|58817145|FG000|Overall Study|Adverse Event|1|||
30801411|NCT04050865|58817146|FG001|Overall Study|Adverse Event|0|||
30801412|NCT04050865|58817145|FG000|Overall Study|no insert|1|||
30801413|NCT04050865|58817146|FG001|Overall Study|no insert|0|||
30801414|NCT04050865|58817145|FG000|Overall Study|Only 1 insert|2|||
30801415|NCT04050865|58817146|FG001|Overall Study|Only 1 insert|3|||
30801416|NCT04050865|58817145|FG000|Overall Study|Physician Decision|0|||
30801417|NCT04050865|58817146|FG001|Overall Study|Physician Decision|1|||
30801418|NCT04050865|58817145|FG000|Overall Study|Withdrawal by Subject|0|||
30801419|NCT04050865|58817146|FG001|Overall Study|Withdrawal by Subject|1|||
30801420|NCT03283566|58817154|FG000|Overall Study|Lost to Follow-up|1|||
30801421|NCT03283566|58817155|FG001|Overall Study|Lost to Follow-up|2|||
30801422|NCT03210519|58817163|FG000|Overall Study|Adverse Event|2|||
30801423|NCT03210519|58817164|FG001|Overall Study|Adverse Event|0|||
30801424|NCT04048681|58817170|FG000|Overall Study|family emergency|0|||
30801425|NCT04048681|58817171|FG001|Overall Study|family emergency|0|||
30906432|NCT01945593|58941010|FG001|Overall Study|Physician Decision|0|||
30906433|NCT01945593|58941011|FG002|Overall Study|Physician Decision|1|||
30906434|NCT01945593|58941012|FG003|Overall Study|Physician Decision|1|||
30906435|NCT01945593|58941009|FG000|Overall Study|Withdrawal by Subject|0|||
30906436|NCT01945593|58941010|FG001|Overall Study|Withdrawal by Subject|2|||
30906437|NCT01945593|58941011|FG002|Overall Study|Withdrawal by Subject|0|||
30906438|NCT01945593|58941012|FG003|Overall Study|Withdrawal by Subject|4|||
30906439|NCT01945593|58941009|FG000|Overall Study|Protocol Violation|0|||
30801426|NCT04048681|58817172|FG002|Overall Study|family emergency|0|||
30801427|NCT04048681|58817173|FG003|Overall Study|family emergency|1|||
30801428|NCT04048681|58817174|FG004|Overall Study|family emergency|0|||
30801429|NCT04007107|58817182|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
30801430|NCT04007107|58817183|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
30801431|NCT04007107|58817184|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
30801432|NCT04007107|58817185|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
30801433|NCT04046341|58817190|FG000|Overall Study|Lost to Follow-up|2|||
30801434|NCT04046341|58817190|FG000|Overall Study|Withdrawal by Subject|1|||
30801435|NCT03233529|58817194|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
30801436|NCT03233529|58817194|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
30801437|NCT04006171|58817204|FG000|Overall Study|Withdrawal by Subject|8|||
30906440|NCT01945593|58941010|FG001|Overall Study|Protocol Violation|2|||
30801438|NCT04006171|58817205|FG001|Overall Study|Withdrawal by Subject|7|||
30801439|NCT04006171|58817204|FG000|Overall Study|missing serum samples|2|||
30801440|NCT04006171|58817205|FG001|Overall Study|missing serum samples|2|||
30906441|NCT01945593|58941011|FG002|Overall Study|Protocol Violation|1|||
30906442|NCT01945593|58941012|FG003|Overall Study|Protocol Violation|3|||
30906443|NCT01945593|58941009|FG000|Overall Study|Death|0|||
30906444|NCT01945593|58941010|FG001|Overall Study|Death|0|||
30906445|NCT01945593|58941011|FG002|Overall Study|Death|1|||
30906446|NCT01945593|58941012|FG003|Overall Study|Death|0|||
30906447|NCT01945593|58941009|FG000|Overall Study|Other: Terminated|0|||
30906448|NCT01945593|58941010|FG001|Overall Study|Other: Terminated|0|||
30906449|NCT01945593|58941011|FG002|Overall Study|Other: Terminated|0|||
30906450|NCT01945593|58941012|FG003|Overall Study|Other: Terminated|1|||
30801441|NCT04006171|58817204|FG000|Overall Study|insufficient sample volume|2|||
30801442|NCT04006171|58817205|FG001|Overall Study|insufficient sample volume|3|||
30801443|NCT04043143|58817218|FG000|Overall Study|Lost to Follow-up|5|||
30801444|NCT04043143|58817219|FG001|Overall Study|Lost to Follow-up|5|||
30801445|NCT04043143|58817218|FG000|Overall Study|screen failure|1|||
30801446|NCT04043143|58817219|FG001|Overall Study|screen failure|0|||
30801447|NCT03283098|58817227|FG000|Overall Study|Withdrawal by Subject|0|||
30801448|NCT03283098|58817228|FG001|Overall Study|Withdrawal by Subject|1|||
30801449|NCT03655951|58817236|FG000|Overall Study|Lost to Follow-up|39|||
30801450|NCT03655951|58817237|FG001|Overall Study|Lost to Follow-up|20|||
30801451|NCT03655951|58817236|FG000|Overall Study|Withdrawal by Subject|0|||
30801452|NCT03655951|58817237|FG001|Overall Study|Withdrawal by Subject|1|||
30801453|NCT02527798|58817249|FG000|Overall Study|Physician Decision|1|||
30801454|NCT02527798|58817250|FG001|Overall Study|Physician Decision|0|||
30801455|NCT02527798|58817251|FG002|Overall Study|Physician Decision|1|||
30801456|NCT02527798|58817252|FG003|Overall Study|Physician Decision|1|||
30801457|NCT02527798|58817253|FG004|Overall Study|Physician Decision|0|||
30801458|NCT02527798|58817254|FG005|Overall Study|Physician Decision|0|||
30801459|NCT02527798|58817249|FG000|Overall Study|Death|0|||
30801460|NCT02527798|58817250|FG001|Overall Study|Death|0|||
30801461|NCT02527798|58817251|FG002|Overall Study|Death|1|||
30801462|NCT02527798|58817252|FG003|Overall Study|Death|0|||
30801463|NCT02527798|58817253|FG004|Overall Study|Death|0|||
30801464|NCT02527798|58817254|FG005|Overall Study|Death|0|||
30801465|NCT02527798|58817249|FG000|Overall Study|Withdrawal by Subject|0|||
30801466|NCT02527798|58817250|FG001|Overall Study|Withdrawal by Subject|1|||
30801467|NCT02527798|58817251|FG002|Overall Study|Withdrawal by Subject|2|||
30801468|NCT02527798|58817252|FG003|Overall Study|Withdrawal by Subject|0|||
30801469|NCT02527798|58817253|FG004|Overall Study|Withdrawal by Subject|0|||
30801470|NCT02527798|58817254|FG005|Overall Study|Withdrawal by Subject|0|||
30906451|NCT01945593|58941009|FG000|Overall Study|Other: Surgical Procedure|0|||
30747567|NCT00262314|58757825|FG000|Overall Study|Administrative withdrawal|30|||
30801471|NCT02527798|58817249|FG000|Overall Study|Reason undisclosed|1|||
30801472|NCT02527798|58817250|FG001|Overall Study|Reason undisclosed|0|||
30801473|NCT02527798|58817251|FG002|Overall Study|Reason undisclosed|1|||
30801474|NCT02527798|58817252|FG003|Overall Study|Reason undisclosed|0|||
30801475|NCT02527798|58817253|FG004|Overall Study|Reason undisclosed|0|||
30801476|NCT02527798|58817254|FG005|Overall Study|Reason undisclosed|0|||
30801477|NCT02527798|58817249|FG000|Overall Study|Did not receive intervention|1|||
30801478|NCT02527798|58817250|FG001|Overall Study|Did not receive intervention|1|||
30801479|NCT02527798|58817251|FG002|Overall Study|Did not receive intervention|0|||
30801480|NCT02527798|58817252|FG003|Overall Study|Did not receive intervention|0|||
30801481|NCT02527798|58817253|FG004|Overall Study|Did not receive intervention|0|||
30801482|NCT02527798|58817254|FG005|Overall Study|Did not receive intervention|0|||
30801483|NCT03188991|58817285|FG000|Overall Study|Withdrawal by Subject|0|||
30801484|NCT03188991|58817286|FG001|Overall Study|Withdrawal by Subject|0|||
30801485|NCT03188991|58817287|FG002|Overall Study|Withdrawal by Subject|0|||
30801486|NCT03188991|58817288|FG003|Overall Study|Withdrawal by Subject|1|||
30801487|NCT03857542|58817300|FG000|Overall Study|Adverse Event|1|||
30801488|NCT03857542|58817301|FG001|Overall Study|Adverse Event|3|||
30801489|NCT03857542|58817300|FG000|Overall Study|Withdrawal by Subject|2|||
30801490|NCT03857542|58817301|FG001|Overall Study|Withdrawal by Subject|1|||
30801491|NCT03857542|58817300|FG000|Overall Study|Lost to Follow-up|2|||
30747568|NCT00283400|58757833|FG000|Overall Study|Withdrawal by Subject|1|||
30747569|NCT00283400|58757834|FG001|Overall Study|Withdrawal by Subject|1|||
30747570|NCT00283400|58757835|FG002|Overall Study|Withdrawal by Subject|0|||
30747571|NCT00283400|58757836|FG003|Overall Study|Withdrawal by Subject|0|||
30747572|NCT00283400|58757833|FG000|Overall Study|Death|1|||
30747573|NCT00283400|58757834|FG001|Overall Study|Death|0|||
30747574|NCT00283400|58757835|FG002|Overall Study|Death|1|||
30747575|NCT00283400|58757836|FG003|Overall Study|Death|0|||
30747576|NCT00444275|58757849|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
30747577|NCT00444275|58757850|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
30747578|NCT00444275|58757851|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
30801492|NCT03857542|58817301|FG001|Overall Study|Lost to Follow-up|1|||
30801493|NCT03857542|58817300|FG000|Overall Study|Reason not Specified|1|||
30906452|NCT01945593|58941010|FG001|Overall Study|Other: Surgical Procedure|2|||
30906453|NCT01945593|58941011|FG002|Overall Study|Other: Surgical Procedure|0|||
30906454|NCT01945593|58941012|FG003|Overall Study|Other: Surgical Procedure|6|||
30906455|NCT01945593|58941009|FG000|Overall Study|Other: Screen Failure|0|||
30801494|NCT03857542|58817301|FG001|Overall Study|Reason not Specified|0|||
30801495|NCT03209973|58817308|FG000|Overall Study|Withdrawal by Subject|7|||
30801496|NCT03209973|58817308|FG000|Overall Study|Lost to Follow-up|2|||
30801497|NCT03209973|58817308|FG000|Overall Study|Death|8|||
30801498|NCT03209973|58817308|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
30801499|NCT03209973|58817308|FG000|Overall Study|Sponsor Decision|18|||
30801500|NCT03209973|58817308|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
30801501|NCT03209973|58817308|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
30801502|NCT03751631|58817314|FG000|Overall Study|Withdrawal by Subject|0|||
30801503|NCT03751631|58817315|FG001|Overall Study|Withdrawal by Subject|0|||
30801504|NCT03751631|58817316|FG002|Overall Study|Withdrawal by Subject|1|||
30801505|NCT03751631|58817317|FG003|Overall Study|Withdrawal by Subject|1|||
30801506|NCT03751631|58817318|FG004|Overall Study|Withdrawal by Subject|0|||
30801507|NCT03751631|58817319|FG005|Overall Study|Withdrawal by Subject|0|||
30801508|NCT03688711|58817332|FG000|Overall Study|Withdrawal by Subject|0|||
30801509|NCT03688711|58817333|FG001|Overall Study|Withdrawal by Subject|1|||
30801510|NCT03188055|58817341|FG000|Overall Study|Unavailable for training|0|||
30801511|NCT03188055|58817342|FG001|Overall Study|Unavailable for training|0|||
30801512|NCT03188055|58817343|FG002|Overall Study|Unavailable for training|19|||
30801513|NCT03188055|58817344|FG003|Overall Study|Unavailable for training|0|||
30801514|NCT03188055|58817345|FG004|Overall Study|Unavailable for training|0|||
30801515|NCT03188055|58817346|FG005|Overall Study|Unavailable for training||||
30801516|NCT03188055|58817341|FG000|Overall Study|Lost to Follow-up|0|||
30801517|NCT03188055|58817342|FG001|Overall Study|Lost to Follow-up|18|||
30801518|NCT03188055|58817343|FG002|Overall Study|Lost to Follow-up|0|||
30801519|NCT03188055|58817344|FG003|Overall Study|Lost to Follow-up|11|||
30801520|NCT03188055|58817345|FG004|Overall Study|Lost to Follow-up|0|||
30801521|NCT03188055|58817346|FG005|Overall Study|Lost to Follow-up||||
30801522|NCT03188055|58817341|FG000|Overall Study|Withdrawal by Subject|0|||
30801523|NCT03188055|58817342|FG001|Overall Study|Withdrawal by Subject|1|||
30801524|NCT03188055|58817343|FG002|Overall Study|Withdrawal by Subject|0|||
30801525|NCT03188055|58817344|FG003|Overall Study|Withdrawal by Subject|1|||
30801526|NCT03188055|58817345|FG004|Overall Study|Withdrawal by Subject|0|||
30801527|NCT03188055|58817346|FG005|Overall Study|Withdrawal by Subject||||
30801528|NCT04035577|58817357|FG000|Overall Study|Lost to Follow-up|1|||
30801529|NCT04035577|58817357|FG000|Overall Study|Withdrawal by Subject|1|||
30801530|NCT03655717|58817385|FG000|Overall Study|Withdrawal by Subject|4|||
30801531|NCT03655717|58817386|FG001|Overall Study|Withdrawal by Subject|8|||
30801532|NCT03655717|58817387|FG002|Overall Study|Withdrawal by Subject|1|||
30801533|NCT03655717|58817388|FG003|Overall Study|Withdrawal by Subject|0|||
30801534|NCT03655717|58817389|FG004|Overall Study|Withdrawal by Subject|0|||
30801535|NCT03655717|58817390|FG005|Overall Study|Withdrawal by Subject|1|||
30801536|NCT03655717|58817391|FG006|Overall Study|Withdrawal by Subject|3|||
30801537|NCT03655717|58817392|FG007|Overall Study|Withdrawal by Subject|1|||
30801538|NCT03655717|58817393|FG008|Overall Study|Withdrawal by Subject|2|||
30801539|NCT03655717|58817394|FG009|Overall Study|Withdrawal by Subject|0|||
30801540|NCT03655717|58817395|FG010|Overall Study|Withdrawal by Subject|0|||
30801541|NCT03655717|58817396|FG011|Overall Study|Withdrawal by Subject|1|||
30801542|NCT03655717|58817397|FG012|Overall Study|Withdrawal by Subject|0|||
30801543|NCT03655717|58817398|FG013|Overall Study|Withdrawal by Subject|3|||
30801544|NCT03655717|58817399|FG014|Overall Study|Withdrawal by Subject|0|||
30801545|NCT03655717|58817400|FG015|Overall Study|Withdrawal by Subject|1|||
30801546|NCT03655717|58817401|FG016|Overall Study|Withdrawal by Subject|0|||
30801547|NCT03655717|58817402|FG017|Overall Study|Withdrawal by Subject|0|||
30801548|NCT03655717|58817403|FG018|Overall Study|Withdrawal by Subject|1|||
30801549|NCT03655717|58817404|FG019|Overall Study|Withdrawal by Subject|0|||
30801550|NCT03655717|58817405|FG020|Overall Study|Withdrawal by Subject|0|||
30747579|NCT00444275|58757852|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
30747580|NCT00444275|58757853|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
30747581|NCT00444275|58757849|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
30747582|NCT00444275|58757850|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
30747583|NCT00444275|58757851|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
30747584|NCT00444275|58757852|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
30747585|NCT00444275|58757853|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
30747586|NCT00444275|58757849|FG000|Maintenance Treatment Phase|Adverse Event|0|||
30801551|NCT03655717|58817406|FG021|Overall Study|Withdrawal by Subject|1|||
30801552|NCT03655717|58817407|FG022|Overall Study|Withdrawal by Subject|2|||
30801553|NCT03655717|58817408|FG023|Overall Study|Withdrawal by Subject|1|||
30801554|NCT03655717|58817409|FG024|Overall Study|Withdrawal by Subject|1|||
30906456|NCT01945593|58941010|FG001|Overall Study|Other: Screen Failure|2|||
30747587|NCT00444275|58757850|FG001|Maintenance Treatment Phase|Adverse Event|0|||
30801555|NCT03655717|58817410|FG025|Overall Study|Withdrawal by Subject|0|||
30801556|NCT03655717|58817385|FG000|Overall Study|Physician Decision|3|||
30906457|NCT01945593|58941011|FG002|Overall Study|Other: Screen Failure|0|||
30801557|NCT03655717|58817386|FG001|Overall Study|Physician Decision|3|||
30801558|NCT03655717|58817387|FG002|Overall Study|Physician Decision|0|||
30801559|NCT03655717|58817388|FG003|Overall Study|Physician Decision|0|||
30801560|NCT03655717|58817389|FG004|Overall Study|Physician Decision|0|||
30801561|NCT03655717|58817390|FG005|Overall Study|Physician Decision|0|||
30801562|NCT03655717|58817391|FG006|Overall Study|Physician Decision|0|||
30801563|NCT03655717|58817392|FG007|Overall Study|Physician Decision|0|||
30801564|NCT03655717|58817393|FG008|Overall Study|Physician Decision|0|||
30801565|NCT03655717|58817394|FG009|Overall Study|Physician Decision|1|||
30801566|NCT03655717|58817395|FG010|Overall Study|Physician Decision|0|||
30801567|NCT03655717|58817396|FG011|Overall Study|Physician Decision|0|||
30801568|NCT03655717|58817397|FG012|Overall Study|Physician Decision|0|||
30801569|NCT03655717|58817398|FG013|Overall Study|Physician Decision|0|||
30801570|NCT03655717|58817399|FG014|Overall Study|Physician Decision|0|||
30801571|NCT03655717|58817400|FG015|Overall Study|Physician Decision|0|||
30801572|NCT03655717|58817401|FG016|Overall Study|Physician Decision|0|||
30801573|NCT03655717|58817402|FG017|Overall Study|Physician Decision|0|||
30801574|NCT03655717|58817403|FG018|Overall Study|Physician Decision|0|||
30801575|NCT03655717|58817404|FG019|Overall Study|Physician Decision|1|||
30801576|NCT03655717|58817405|FG020|Overall Study|Physician Decision|0|||
30801577|NCT03655717|58817406|FG021|Overall Study|Physician Decision|0|||
30801578|NCT03655717|58817407|FG022|Overall Study|Physician Decision|0|||
30801579|NCT03655717|58817408|FG023|Overall Study|Physician Decision|1|||
30801580|NCT03655717|58817409|FG024|Overall Study|Physician Decision|0|||
30801581|NCT03655717|58817410|FG025|Overall Study|Physician Decision|0|||
30801582|NCT03655717|58817385|FG000|Overall Study|Lost to Follow-up|3|||
30801583|NCT03655717|58817386|FG001|Overall Study|Lost to Follow-up|1|||
30801584|NCT03655717|58817387|FG002|Overall Study|Lost to Follow-up|0|||
30801585|NCT03655717|58817388|FG003|Overall Study|Lost to Follow-up|1|||
30801586|NCT03655717|58817389|FG004|Overall Study|Lost to Follow-up|0|||
30801587|NCT03655717|58817390|FG005|Overall Study|Lost to Follow-up|1|||
30801588|NCT03655717|58817391|FG006|Overall Study|Lost to Follow-up|0|||
30801589|NCT03655717|58817392|FG007|Overall Study|Lost to Follow-up|0|||
30801590|NCT03655717|58817393|FG008|Overall Study|Lost to Follow-up|0|||
30801591|NCT03655717|58817394|FG009|Overall Study|Lost to Follow-up|0|||
30801592|NCT03655717|58817395|FG010|Overall Study|Lost to Follow-up|0|||
30801593|NCT03655717|58817396|FG011|Overall Study|Lost to Follow-up|1|||
30801594|NCT03655717|58817397|FG012|Overall Study|Lost to Follow-up|0|||
30801595|NCT03655717|58817398|FG013|Overall Study|Lost to Follow-up|0|||
30801596|NCT03655717|58817399|FG014|Overall Study|Lost to Follow-up|0|||
30801597|NCT03655717|58817400|FG015|Overall Study|Lost to Follow-up|0|||
30801598|NCT03655717|58817401|FG016|Overall Study|Lost to Follow-up|0|||
30801599|NCT03655717|58817402|FG017|Overall Study|Lost to Follow-up|0|||
30801600|NCT03655717|58817403|FG018|Overall Study|Lost to Follow-up|0|||
30801601|NCT03655717|58817404|FG019|Overall Study|Lost to Follow-up|0|||
30906458|NCT01945593|58941012|FG003|Overall Study|Other: Screen Failure|0|||
30906459|NCT01945281|58941029|FG000|Overall Study|Adverse Event|1|||
30747588|NCT00444275|58757851|FG002|Maintenance Treatment Phase|Adverse Event|3|||
30747589|NCT00444275|58757852|FG003|Maintenance Treatment Phase|Adverse Event|2|||
30801602|NCT03655717|58817405|FG020|Overall Study|Lost to Follow-up|0|||
30801603|NCT03655717|58817406|FG021|Overall Study|Lost to Follow-up|0|||
30801604|NCT03655717|58817407|FG022|Overall Study|Lost to Follow-up|0|||
30801605|NCT03655717|58817408|FG023|Overall Study|Lost to Follow-up|0|||
30906460|NCT01945281|58941030|FG001|Overall Study|Adverse Event|0|||
30747590|NCT00444275|58757853|FG004|Maintenance Treatment Phase|Adverse Event|13|||
30747591|NCT00444275|58757849|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
30747592|NCT00444275|58757850|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
30747593|NCT00444275|58757851|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
30747594|NCT00444275|58757852|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
30747595|NCT00444275|58757853|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
30747596|NCT00444275|58757849|FG000|Maintenance Treatment Phase|Patient's wish|0|||
30747597|NCT00444275|58757850|FG001|Maintenance Treatment Phase|Patient's wish|0|||
30747598|NCT00444275|58757851|FG002|Maintenance Treatment Phase|Patient's wish|19|||
30747599|NCT00444275|58757852|FG003|Maintenance Treatment Phase|Patient's wish|9|||
30801606|NCT03655717|58817409|FG024|Overall Study|Lost to Follow-up|0|||
30801607|NCT03655717|58817410|FG025|Overall Study|Lost to Follow-up|0|||
30801608|NCT04032613|58817426|FG000|Overall Study|Did not complete post-program assessment|5|||
30801609|NCT04032613|58817427|FG001|Overall Study|Did not complete post-program assessment|2|||
30801610|NCT04000165|58817433|FG000|Overall Study|Physician Decision|1|||
30801611|NCT04000165|58817433|FG000|Overall Study|Withdrawal by Subject|1|||
30801612|NCT03187197|58817440|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
30801613|NCT03187197|58817441|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
30801614|NCT03187197|58817442|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
30801615|NCT03187197|58817440|FG000|Overall Study|Withdrawal by Subject|8|||
30801616|NCT03187197|58817441|FG001|Overall Study|Withdrawal by Subject|63|||
30801617|NCT03187197|58817442|FG002|Overall Study|Withdrawal by Subject|4|||
30801618|NCT03187197|58817440|FG000|Overall Study|Lost to Follow-up|1|||
30801619|NCT03187197|58817441|FG001|Overall Study|Lost to Follow-up|60|||
30801620|NCT03187197|58817442|FG002|Overall Study|Lost to Follow-up|7|||
30801621|NCT03187197|58817440|FG000|Overall Study|Adverse Event|6|||
30801622|NCT03187197|58817441|FG001|Overall Study|Adverse Event|29|||
30801623|NCT03187197|58817442|FG002|Overall Study|Adverse Event|0|||
30801624|NCT03187197|58817440|FG000|Overall Study|Death|0|||
30801625|NCT03187197|58817441|FG001|Overall Study|Death|11|||
30801626|NCT03187197|58817442|FG002|Overall Study|Death|0|||
30801627|NCT03187197|58817440|FG000|Overall Study|Administrative problem|1|||
30801628|NCT03187197|58817441|FG001|Overall Study|Administrative problem|1|||
30801629|NCT03187197|58817442|FG002|Overall Study|Administrative problem|0|||
30801630|NCT03187197|58817440|FG000|Overall Study|Reason not listed|2|||
30801631|NCT03187197|58817441|FG001|Overall Study|Reason not listed|54|||
30801632|NCT03187197|58817442|FG002|Overall Study|Reason not listed|1|||
30801633|NCT03187197|58817440|FG000|Overall Study|Missing|1|||
30801634|NCT03187197|58817441|FG001|Overall Study|Missing|32|||
30801635|NCT03187197|58817442|FG002|Overall Study|Missing|3|||
30801636|NCT03187197|58817440|FG000|Overall Study|Status missing|2|||
30801637|NCT03187197|58817441|FG001|Overall Study|Status missing|33|||
30801638|NCT03187197|58817442|FG002|Overall Study|Status missing|3|||
30801639|NCT03187197|58817440|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
30801640|NCT03187197|58817441|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
30801641|NCT03187197|58817442|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
30801642|NCT04000009|58817450|FG000|Overall Study|Adverse Event|13|||
30801643|NCT04000009|58817450|FG000|Overall Study|Lack of Efficacy|7|||
30801644|NCT04000009|58817450|FG000|Overall Study|Lost to Follow-up|8|||
30801645|NCT04000009|58817450|FG000|Overall Study|Noncompliance with study drug|4|||
30801646|NCT04000009|58817450|FG000|Overall Study|Physician Decision|1|||
30801647|NCT04000009|58817450|FG000|Overall Study|Use of prohibited medication|3|||
30801648|NCT04000009|58817450|FG000|Overall Study|Pregnancy|1|||
30801649|NCT04000009|58817450|FG000|Overall Study|Withdrawal by Subject|22|||
30801650|NCT04000009|58817450|FG000|Overall Study|Study terminated by sponsor|98|||
30801651|NCT04000009|58817450|FG000|Overall Study|Not further specified|8|||
30801652|NCT03282240|58817457|FG000|Overall Study|Adverse Event|2|||
30801653|NCT03282240|58817458|FG001|Overall Study|Adverse Event|2|||
30801654|NCT03282240|58817459|FG002|Overall Study|Adverse Event|0|||
30801655|NCT03282240|58817457|FG000|Overall Study|Lost to Follow-up|3|||
30801656|NCT03282240|58817458|FG001|Overall Study|Lost to Follow-up|0|||
30801657|NCT03282240|58817459|FG002|Overall Study|Lost to Follow-up|0|||
30801658|NCT03282240|58817457|FG000|Overall Study|Protocol Deviation|4|||
30801659|NCT03282240|58817458|FG001|Overall Study|Protocol Deviation|1|||
30801660|NCT03282240|58817459|FG002|Overall Study|Protocol Deviation|2|||
30801661|NCT03282240|58817457|FG000|Overall Study|Withdrawal by Subject|1|||
30801662|NCT03282240|58817458|FG001|Overall Study|Withdrawal by Subject|0|||
30801663|NCT03282240|58817459|FG002|Overall Study|Withdrawal by Subject|1|||
30801664|NCT03185949|58817472|FG000|ITT Analysis|Withdrawal by Subject|4|||
30801665|NCT03185949|58817473|FG001|ITT Analysis|Withdrawal by Subject|3|||
30801666|NCT03185949|58817472|FG000|PP Analysis|Protocol Violation|2|||
30801667|NCT03185949|58817473|FG001|PP Analysis|Protocol Violation|2|||
30801668|NCT03185949|58817472|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
30801669|NCT03185949|58817473|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
30801670|NCT03655405|58817483|FG000|Overall Study|Death after initial data collection|4|||
30801671|NCT03655405|58817484|FG001|Overall Study|Death after initial data collection|2|||
30747600|NCT00444275|58757853|FG004|Maintenance Treatment Phase|Patient's wish|20|||
30747601|NCT00444275|58757849|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
30747602|NCT00444275|58757850|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
30747603|NCT00444275|58757851|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
30747604|NCT00444275|58757852|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
30747605|NCT00444275|58757853|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
30747606|NCT00444275|58757849|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
30747607|NCT00444275|58757850|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
30747608|NCT00444275|58757851|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
30801672|NCT03655405|58817483|FG000|Overall Study|Died before initial data collection|1|||
30801673|NCT03655405|58817484|FG001|Overall Study|Died before initial data collection|2|||
30801674|NCT03655405|58817483|FG000|Overall Study|Protocol Violation|0|||
30801675|NCT03655405|58817484|FG001|Overall Study|Protocol Violation|1|||
30801676|NCT03510598|58817490|FG000|Overall Study|Withdrawal by Subject|1|||
30801677|NCT03222141|58817494|FG000|Overall Study|Death|15|||
30747609|NCT00444275|58757852|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
30801678|NCT03222141|58817494|FG000|Overall Study|Lost to Follow-up|3|||
30801679|NCT04029961|58817501|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
30801680|NCT04029961|58817502|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
30801681|NCT04029961|58817501|FG000|Overall Study|Change in Treatment Course|0|||
30801682|NCT04029961|58817502|FG001|Overall Study|Change in Treatment Course|1|||
30801683|NCT03997825|58817508|FG000|Overall Study|Death|3|||
30801684|NCT03997825|58817508|FG000|Overall Study|Lost to Follow-up|10|||
30801685|NCT03997825|58817508|FG000|Overall Study|Withdrawal by Subject|3|||
30801686|NCT03997825|58817508|FG000|Overall Study|Refused participation|1|||
30801687|NCT04024891|58817514|FG000|Overall Study|Pregnancy|0|||
30801688|NCT04024891|58817515|FG001|Overall Study|Pregnancy|1|||
30801689|NCT03250182|58817521|FG000|Overall Study|Withdrawal by Subject|1|||
30801690|NCT03993379|58817529|FG000|Overall Study|The study was terminated early due to business decision.|0|||
30801691|NCT03993379|58817530|FG001|Overall Study|The study was terminated early due to business decision.|2|||
30801692|NCT03993379|58817531|FG002|Overall Study|The study was terminated early due to business decision.|0|||
30801693|NCT03993379|58817532|FG003|Overall Study|The study was terminated early due to business decision.|0|||
30801694|NCT03993379|58817529|FG000|Overall Study|Withdrawal by Subject|0|||
30801695|NCT03993379|58817530|FG001|Overall Study|Withdrawal by Subject|1|||
30747610|NCT00444275|58757853|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
30747611|NCT00454805|58757870|FG000|Overall Study|Withdrawal by Subject|9|||
30747612|NCT00454805|58757871|FG001|Overall Study|Withdrawal by Subject|2|||
30747613|NCT00454805|58757870|FG000|Overall Study|Death|0|||
30747614|NCT00454805|58757871|FG001|Overall Study|Death|2|||
30747615|NCT00454805|58757870|FG000|Overall Study|Disease progression|16|||
30747616|NCT00454805|58757871|FG001|Overall Study|Disease progression|19|||
30747617|NCT00454805|58757870|FG000|Overall Study|In order to begin radiotherapy|1|||
30747618|NCT00454805|58757871|FG001|Overall Study|In order to begin radiotherapy|0|||
30747619|NCT00283244|58757880|FG000|Overall Study|Adverse Event|0|||
30747620|NCT00283244|58757881|FG001|Overall Study|Adverse Event|8|||
30747621|NCT00283244|58757882|FG002|Overall Study|Adverse Event|11|||
30747622|NCT00283244|58757880|FG000|Overall Study|Death|4|||
30747623|NCT00283244|58757881|FG001|Overall Study|Death|3|||
30747624|NCT00283244|58757882|FG002|Overall Study|Death|2|||
30747625|NCT00283244|58757880|FG000|Overall Study|Lack of Efficacy|8|||
30747626|NCT00283244|58757881|FG001|Overall Study|Lack of Efficacy|32|||
30747627|NCT00283244|58757882|FG002|Overall Study|Lack of Efficacy|26|||
30801696|NCT03993379|58817531|FG002|Overall Study|Withdrawal by Subject|0|||
30801697|NCT03993379|58817532|FG003|Overall Study|Withdrawal by Subject|0|||
30801698|NCT03370120|58817542|FG000|Overall Study|Adverse event, non-fatal|24|||
30801699|NCT03370120|58817542|FG000|Overall Study|Withdrawal by Subject|6|||
30801700|NCT03370120|58817542|FG000|Overall Study|Lost to Follow-up|1|||
30801701|NCT03370120|58817542|FG000|Overall Study|Lack of Efficacy|37|||
30801702|NCT03370120|58817542|FG000|Overall Study|Per sponsor's instructions|1|||
30801703|NCT03370120|58817542|FG000|Overall Study|Study was terminated by parent company UCB|2|||
30801704|NCT03370120|58817542|FG000|Overall Study|The study was ended by the promoter|3|||
30801705|NCT03370120|58817542|FG000|Overall Study|Discontinuation of drug development|3|||
30801706|NCT03370120|58817542|FG000|Overall Study|End of project|2|||
30801707|NCT03370120|58817542|FG000|Overall Study|Premature study closure|2|||
30801708|NCT03370120|58817542|FG000|Overall Study|Premature program termination|1|||
30801709|NCT03370120|58817542|FG000|Overall Study|Premature study termination|7|||
30801710|NCT03370120|58817542|FG000|Overall Study|Trial terminated by sponsor|2|||
30801711|NCT03370120|58817542|FG000|Overall Study|Trial discontinued by sponsor|2|||
30801712|NCT03370120|58817542|FG000|Overall Study|Study ended|15|||
30801713|NCT03370120|58817542|FG000|Overall Study|Clinical trial has been cancelled|1|||
30801714|NCT03370120|58817542|FG000|Overall Study|End of study per sponsor decision|2|||
30801715|NCT03370120|58817542|FG000|Overall Study|Promoter's decision|2|||
30801716|NCT03370120|58817542|FG000|Overall Study|The trial has been suspended|3|||
30801717|NCT03370120|58817542|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
30801718|NCT03370120|58817542|FG000|Overall Study|Early termination by order of sponsor|2|||
30801719|NCT03370120|58817542|FG000|Overall Study|Discontinuation of the study|5|||
30801720|NCT03370120|58817542|FG000|Overall Study|End of clinical trial discontinuation|1|||
30801721|NCT03370120|58817542|FG000|Overall Study|Because the clinical trial ended halfway|4|||
30747628|NCT00283244|58757880|FG000|Overall Study|Withdrawal by Subject|1|||
30747629|NCT00283244|58757881|FG001|Overall Study|Withdrawal by Subject|2|||
30801722|NCT03370120|58817542|FG000|Overall Study|Development discontinued|5|||
30801723|NCT03370120|58817542|FG000|Overall Study|Padsenovil program closed|3|||
30801724|NCT03370120|58817542|FG000|Overall Study|End of project|2|||
30801725|NCT03370120|58817542|FG000|Overall Study|Termination of project|1|||
30801726|NCT03370120|58817542|FG000|Overall Study|The study was interrupted by sponsor|4|||
30801727|NCT03370120|58817542|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
30747630|NCT00283244|58757882|FG002|Overall Study|Withdrawal by Subject|2|||
30747631|NCT00283244|58757880|FG000|Overall Study|Physician Decision|0|||
30622334|NCT02151981|58634012|FG001|Overall Study|Patient had no clinical benefit|0|||
30747632|NCT00283244|58757881|FG001|Overall Study|Physician Decision|0|||
30747633|NCT00283244|58757882|FG002|Overall Study|Physician Decision|1|||
30747634|NCT00283244|58757880|FG000|Overall Study|Medical illness (other complicating dz)|4|||
30747635|NCT00283244|58757881|FG001|Overall Study|Medical illness (other complicating dz)|3|||
30747636|NCT00283244|58757882|FG002|Overall Study|Medical illness (other complicating dz)|6|||
30747637|NCT00283244|58757880|FG000|Overall Study|Clinical deterioration|1|||
30801728|NCT03370120|58817542|FG000|Overall Study|End of sponsor decision|1|||
30801729|NCT03370120|58817542|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
30801730|NCT03370120|58817542|FG000|Overall Study|Early termination of studies|5|||
30801731|NCT03370120|58817542|FG000|Overall Study|This study is ended early|1|||
30801732|NCT03370120|58817542|FG000|Overall Study|End of padsevonil program|2|||
30801733|NCT03370120|58817542|FG000|Overall Study|Decision of sponsor|6|||
30801734|NCT03370120|58817542|FG000|Overall Study|Asked by the sponsor|3|||
30801735|NCT03370120|58817542|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
30801736|NCT03370120|58817542|FG000|Overall Study|PI decision poor compliance from participant|1|||
30801737|NCT03370120|58817542|FG000|Overall Study|Promoter ended the study|3|||
30801738|NCT03370120|58817542|FG000|Overall Study|Premature study close by sponsor's decision|4|||
30801739|NCT03370120|58817542|FG000|Overall Study|Study terminated by sponsor|33|||
30801740|NCT03370120|58817542|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
30801741|NCT03370120|58817542|FG000|Overall Study|Sponsor decision to terminate study|63|||
30801742|NCT03370120|58817542|FG000|Overall Study|Program closure|3|||
30801743|NCT03370120|58817542|FG000|Overall Study|Study ended prematurely|1|||
30801744|NCT03370120|58817542|FG000|Overall Study|Study stopped by sponsor|2|||
30801745|NCT03370120|58817542|FG000|Overall Study|Program termination|55|||
30801746|NCT03370120|58817542|FG000|Overall Study|Sponsor decision|62|||
30801747|NCT03370120|58817542|FG000|Overall Study|Sponsor study closure|10|||
30801748|NCT03247686|58817550|FG000|Overall Study|Withdrawal by Subject|1|||
30801749|NCT03247686|58817551|FG001|Overall Study|Withdrawal by Subject|2|||
30801750|NCT03990649|58817562|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
30801751|NCT03990649|58817563|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
30801752|NCT03990649|58817564|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
30801753|NCT03990649|58817562|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
30801754|NCT03990649|58817563|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
30801755|NCT03990649|58817564|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
30801756|NCT03990649|58817562|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
30801757|NCT03990649|58817563|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
30801758|NCT03990649|58817564|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
30801759|NCT03990649|58817562|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
30801760|NCT03990649|58817563|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
30801761|NCT03990649|58817564|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
30801762|NCT03990649|58817562|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
30801763|NCT03990649|58817563|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
30801764|NCT03990649|58817564|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
30801765|NCT03990649|58817562|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
30801766|NCT03990649|58817563|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
30801767|NCT03990649|58817564|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
30801768|NCT03990649|58817562|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
30801769|NCT03990649|58817563|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
30801770|NCT03990649|58817564|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
30801771|NCT03185481|58817571|FG000|Overall Study|Adverse Event|1|||
30801772|NCT03185481|58817571|FG000|Overall Study|Study Terminated by Sponsor|4|||
30801773|NCT03652675|58817577|FG000|Overall Study|Lost to Follow-up|4|||
30801774|NCT03652675|58817578|FG001|Overall Study|Lost to Follow-up|4|||
30801775|NCT03241368|58817584|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
30801776|NCT03241368|58817584|FG000|Overall Study|Lost to Follow-up|1|||
30801777|NCT03241368|58817584|FG000|Overall Study|Physician Decision|6|||
30801778|NCT03241368|58817584|FG000|Overall Study|Withdrawal by Subject|6|||
30801779|NCT03241368|58817584|FG000|Overall Study|Protocol Violation|1|||
30801780|NCT03220581|58817591|FG000|Overall Study|Withdrawal by Subject|0|||
30801781|NCT03220581|58817592|FG001|Overall Study|Withdrawal by Subject|1|||
30747638|NCT00283244|58757881|FG001|Overall Study|Clinical deterioration|3|||
30747639|NCT00283244|58757882|FG002|Overall Study|Clinical deterioration|3|||
30747640|NCT00282464|58757893|FG000|Overall Study|Adverse Event|26|||
30747641|NCT00282464|58757894|FG001|Overall Study|Adverse Event|20|||
30747642|NCT00282464|58757893|FG000|Overall Study|Lack of Efficacy|8|||
30747643|NCT00282464|58757894|FG001|Overall Study|Lack of Efficacy|8|||
30747644|NCT00282464|58757893|FG000|Overall Study|Lost to Follow-up|10|||
30747645|NCT00282464|58757894|FG001|Overall Study|Lost to Follow-up|10|||
30747646|NCT00282464|58757893|FG000|Overall Study|Withdrawal by Subject|24|||
30747647|NCT00282464|58757894|FG001|Overall Study|Withdrawal by Subject|10|||
30801782|NCT03220581|58817591|FG000|Overall Study|Lost to Follow-up|3|||
30801783|NCT03220581|58817592|FG001|Overall Study|Lost to Follow-up|6|||
30801784|NCT02954575|58817600|FG000|Overall Study|Withdrawal by Subject|2|||
30801785|NCT02954575|58817600|FG000|Overall Study|Adverse Event|1|||
30747648|NCT00282464|58757893|FG000|Overall Study|laboratory abnormality|1|||
30747649|NCT00282464|58757894|FG001|Overall Study|laboratory abnormality|2|||
30801786|NCT03184701|58817608|FG000|Overall Study|Death|3|||
30622335|NCT02151981|58634011|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
30801787|NCT03184701|58817608|FG000|Overall Study|Physician Decision|3|||
30801788|NCT03184701|58817608|FG000|Overall Study|Withdrawal by Subject|6|||
30801789|NCT03184701|58817608|FG000|Overall Study|Lost to Follow-up|5|||
30801790|NCT03247530|58817615|FG000|Overall Study|Withdrawal by caregiver|19|||
30801791|NCT03247530|58817616|FG001|Overall Study|Withdrawal by caregiver|8|||
30801792|NCT03247530|58817617|FG002|Overall Study|Withdrawal by caregiver|10|||
30801793|NCT03247530|58817615|FG000|Overall Study|Lost to Follow-up|3|||
30801794|NCT03247530|58817616|FG001|Overall Study|Lost to Follow-up|9|||
30801795|NCT03247530|58817617|FG002|Overall Study|Lost to Follow-up|6|||
30801796|NCT03247530|58817615|FG000|Overall Study|Adverse Event|2|||
30801797|NCT03247530|58817616|FG001|Overall Study|Adverse Event|5|||
30801798|NCT03247530|58817617|FG002|Overall Study|Adverse Event|2|||
30906461|NCT01945281|58941029|FG000|Overall Study|Death|3|||
30906462|NCT01945281|58941030|FG001|Overall Study|Death|3|||
30906463|NCT01945281|58941029|FG000|Overall Study|Physician Decision|1|||
30906464|NCT01945281|58941030|FG001|Overall Study|Physician Decision|1|||
30906465|NCT01945281|58941029|FG000|Overall Study|Technical Problems|1|||
30906466|NCT01945281|58941030|FG001|Overall Study|Technical Problems|0|||
30906467|NCT01961349|58941039|FG000|Overall Study|Withdrawal by Subject|1|||
30906468|NCT01961349|58941040|FG001|Overall Study|Withdrawal by Subject|4|||
30906469|NCT01961349|58941041|FG002|Overall Study|Withdrawal by Subject|0|||
30906470|NCT01961349|58941039|FG000|Overall Study|Adverse Event|0|||
30906471|NCT01961349|58941040|FG001|Overall Study|Adverse Event|0|||
30906472|NCT01961349|58941041|FG002|Overall Study|Adverse Event|1|||
30906473|NCT01961349|58941039|FG000|Overall Study|registration error, personal reason etc|2|||
30906474|NCT01961349|58941040|FG001|Overall Study|registration error, personal reason etc|2|||
30906475|NCT01961349|58941041|FG002|Overall Study|registration error, personal reason etc|1|||
30906476|NCT01973595|58941053|FG000|Washout|Withdrawal by Subject|1|||
30906477|NCT01973595|58941054|FG001|Washout|Withdrawal by Subject|0|||
30906478|NCT01973595|58941055|FG002|Washout|Withdrawal by Subject|1|||
30906479|NCT01973595|58941056|FG003|Washout|Withdrawal by Subject|0|||
30906480|NCT01944969|58941067|FG000|Overall Study|Adverse Event|1|||
30906481|NCT01944969|58941067|FG000|Overall Study|Lack of Efficacy|1|||
30906482|NCT01944969|58941067|FG000|Overall Study|Non-compliance with IMP|1|||
30906483|NCT01944969|58941067|FG000|Overall Study|Administrative or other reasons|23|||
30906484|NCT01961115|58941076|FG000|Overall Study|Disease Progression|1|||
30906485|NCT01961115|58941077|FG001|Overall Study|Disease Progression|0|||
30906486|NCT01961115|58941078|FG002|Overall Study|Disease Progression|3|||
30906487|NCT01961115|58941076|FG000|Overall Study|Adverse Event|1|||
30906488|NCT01961115|58941077|FG001|Overall Study|Adverse Event|0|||
30906489|NCT01961115|58941078|FG002|Overall Study|Adverse Event|1|||
30906490|NCT01973439|58941086|FG000|Overall Study|Lost samples from one PK Day|2|||
30906491|NCT01973439|58941086|FG000|Overall Study|Vomiting after commencing once daily|1|||
30906492|NCT01973439|58941086|FG000|Overall Study|PK curve incomplete|2|||
30906493|NCT01973283|58941090|FG000|Overall Study|Lost to Follow-up|4|||
30906494|NCT01943799|58941100|FG000|Overall Study|Lost to Follow-up|0|||
30906495|NCT01943799|58941101|FG001|Overall Study|Lost to Follow-up|1|||
30906496|NCT01943799|58941102|FG002|Overall Study|Lost to Follow-up|1|||
30906497|NCT01943799|58941103|FG003|Overall Study|Lost to Follow-up|0|||
30906498|NCT01943799|58941100|FG000|Overall Study|Protocol Violation|1|||
30906499|NCT01943799|58941101|FG001|Overall Study|Protocol Violation|0|||
30906500|NCT01943799|58941102|FG002|Overall Study|Protocol Violation|0|||
30906501|NCT01943799|58941103|FG003|Overall Study|Protocol Violation|0|||
30747650|NCT00282464|58757893|FG000|Overall Study|Protocol Violation|0|||
30747651|NCT00282464|58757894|FG001|Overall Study|Protocol Violation|7|||
30747652|NCT00282464|58757893|FG000|Overall Study|Patient moved|1|||
30747653|NCT00282464|58757894|FG001|Overall Study|Patient moved|0|||
30747654|NCT00282464|58757893|FG000|Overall Study|patient non-compliant|3|||
30747655|NCT00282464|58757894|FG001|Overall Study|patient non-compliant|0|||
30747656|NCT00282464|58757893|FG000|Overall Study|patient no show|0|||
30747657|NCT00282464|58757894|FG001|Overall Study|patient no show|1|||
30747658|NCT00282464|58757893|FG000|Overall Study|patient incarcerated|0|||
30747659|NCT00282464|58757894|FG001|Overall Study|patient incarcerated|1|||
30747660|NCT00282464|58757893|FG000|Overall Study|family crisis|0|||
30801799|NCT03247530|58817615|FG000|Overall Study|Failure to follow procedure|1|||
30906502|NCT01943799|58941100|FG000|Overall Study|Withdrawal by Subject|4|||
30906503|NCT01943799|58941101|FG001|Overall Study|Withdrawal by Subject|2|||
30906504|NCT01943799|58941102|FG002|Overall Study|Withdrawal by Subject|1|||
30906505|NCT01943799|58941103|FG003|Overall Study|Withdrawal by Subject|0|||
30747661|NCT00282464|58757894|FG001|Overall Study|family crisis|1|||
30747662|NCT00282464|58757893|FG000|Overall Study|dispensed wrong kit|0|||
30801800|NCT03247530|58817616|FG001|Overall Study|Failure to follow procedure|1|||
30906506|NCT01972659|58941115|FG000|Overall Study|Protocol Violation|2|||
30906507|NCT01972659|58941116|FG001|Overall Study|Protocol Violation|2|||
30906508|NCT01972659|58941115|FG000|Overall Study|problems realted to acceleromyograph|2|||
30906509|NCT01972659|58941116|FG001|Overall Study|problems realted to acceleromyograph|1|||
30906510|NCT01971723|58941124|FG000|Overall Study|Withdrawal by Subject|1|||
30801801|NCT03247530|58817617|FG002|Overall Study|Failure to follow procedure|1|||
30801802|NCT03247530|58817615|FG000|Overall Study|Withdrawal by Subject|1|||
30801803|NCT03247530|58817616|FG001|Overall Study|Withdrawal by Subject|1|||
30801804|NCT03247530|58817617|FG002|Overall Study|Withdrawal by Subject|0|||
30801805|NCT03247530|58817615|FG000|Overall Study|Study medication misuse|0|||
30801806|NCT03247530|58817616|FG001|Overall Study|Study medication misuse|1|||
30801807|NCT03247530|58817617|FG002|Overall Study|Study medication misuse|0|||
30801808|NCT03247530|58817615|FG000|Overall Study|Other, multiple categories|1|||
30801809|NCT03247530|58817616|FG001|Overall Study|Other, multiple categories|3|||
30801810|NCT03247530|58817617|FG002|Overall Study|Other, multiple categories|1|||
30801811|NCT03246672|58817628|FG000|Overall Study|Lost to Follow-up|2|||
30801812|NCT03983317|58817632|FG000|Overall Study|Physician Decision|5|||
30801813|NCT03207243|58817638|FG000|Overall Study|Adverse Event|2|||
30801814|NCT03207243|58817639|FG001|Overall Study|Adverse Event|2|||
30801815|NCT03207243|58817638|FG000|Overall Study|Loss of Asthma Control|47|||
30801816|NCT03207243|58817639|FG001|Overall Study|Loss of Asthma Control|31|||
30801817|NCT03207243|58817638|FG000|Overall Study|Withdrawal by Subject|2|||
30801818|NCT03207243|58817639|FG001|Overall Study|Withdrawal by Subject|4|||
30801819|NCT03207243|58817638|FG000|Overall Study|Physician Decision|1|||
30801820|NCT03207243|58817639|FG001|Overall Study|Physician Decision|1|||
30801821|NCT03207243|58817638|FG000|Overall Study|Lost to Follow-up|0|||
30801822|NCT03207243|58817639|FG001|Overall Study|Lost to Follow-up|1|||
30801823|NCT03207243|58817638|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
30801824|NCT03207243|58817639|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
30801825|NCT03207243|58817638|FG000|Overall Study|Protocol Violation|0|||
30906511|NCT01971723|58941125|FG001|Overall Study|Withdrawal by Subject|1|||
30801826|NCT03207243|58817639|FG001|Overall Study|Protocol Violation|3|||
30801827|NCT03982069|58817650|FG000|Overall Study|Lost to Follow-up|5|||
30801828|NCT03982069|58817651|FG001|Overall Study|Lost to Follow-up|5|||
30801829|NCT03982069|58817652|FG002|Overall Study|Lost to Follow-up|3|||
30801830|NCT03982069|58817653|FG003|Overall Study|Lost to Follow-up|5|||
30801831|NCT03982069|58817650|FG000|Overall Study|Physician Decision|0|||
30801832|NCT03982069|58817651|FG001|Overall Study|Physician Decision|1|||
30801833|NCT03982069|58817652|FG002|Overall Study|Physician Decision|0|||
30801834|NCT03982069|58817653|FG003|Overall Study|Physician Decision|0|||
30801835|NCT03982069|58817650|FG000|Overall Study|Withdrawal by Subject|2|||
30801836|NCT03982069|58817651|FG001|Overall Study|Withdrawal by Subject|1|||
30801837|NCT03982069|58817652|FG002|Overall Study|Withdrawal by Subject|5|||
30801838|NCT03982069|58817653|FG003|Overall Study|Withdrawal by Subject|2|||
30801839|NCT03982069|58817650|FG000|Overall Study|Specimen loss|3|||
30801840|NCT03982069|58817651|FG001|Overall Study|Specimen loss|3|||
30622336|NCT02151981|58634012|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
30622337|NCT02151981|58634011|FG000|Overall Study|Study terminated|0|||
30622338|NCT02151981|58634012|FG001|Overall Study|Study terminated|1|||
30622339|NCT02097134|58634018|FG000|Overall Study|Physician Decision|4|||
30801841|NCT03982069|58817652|FG002|Overall Study|Specimen loss|1|||
30801842|NCT03982069|58817653|FG003|Overall Study|Specimen loss|1|||
30801843|NCT02937870|58817661|FG000|Overall Study|Adverse Event|1|||
30801844|NCT02937870|58817661|FG000|Overall Study|Protocol Deviation|2|||
30801845|NCT03629041|58817675|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
30801846|NCT03629041|58817676|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
30801847|NCT03629041|58817677|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
30801848|NCT03629041|58817678|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
30801849|NCT03219723|58817696|FG000|Overall Study|Case Report Forms Uncollected|6|||
30801850|NCT03219723|58817696|FG000|Overall Study|Protocol Deviation|4|||
30801851|NCT03628417|58817700|FG000|Overall Study|Death|1|||
30801852|NCT03628417|58817701|FG001|Overall Study|Death|1|||
30801853|NCT03184077|58817713|FG000|Overall Study|Lost to Follow-up|21|||
30801854|NCT03184077|58817714|FG001|Overall Study|Lost to Follow-up|21|||
30801855|NCT03245736|58817720|FG000|Overall Study|Adverse Event|1|||
30801856|NCT03245736|58817720|FG000|Overall Study|Progressive Disease|4|||
30801857|NCT02954887|58817724|FG000|Overall Study|Withdrawal by Subject|3|||
30801858|NCT02954887|58817724|FG000|Overall Study|Lack of Efficacy|3|||
30622340|NCT02097134|58634018|FG000|Overall Study|Non-Protocol Therapy|1|||
30801859|NCT02954887|58817724|FG000|Overall Study|Other|1|||
30801860|NCT03183063|58817731|FG000|Overall Study|Withdrawal by Subject|2|||
30622341|NCT02097134|58634018|FG000|Overall Study|Progressive Disease|3|||
30801861|NCT03183063|58817732|FG001|Overall Study|Withdrawal by Subject|0|||
30801862|NCT03183063|58817733|FG002|Overall Study|Withdrawal by Subject|0|||
30801863|NCT03183063|58817731|FG000|Overall Study|Physician Decision|3|||
30801864|NCT03183063|58817732|FG001|Overall Study|Physician Decision|4|||
30801865|NCT03183063|58817733|FG002|Overall Study|Physician Decision|4|||
30801866|NCT03182829|58817749|FG000|Overall Study|Protocol Violation|12|||
30801867|NCT03182829|58817750|FG001|Overall Study|Protocol Violation|12|||
30801868|NCT03182829|58817749|FG000|Overall Study|Other|4|||
30801869|NCT03182829|58817750|FG001|Overall Study|Other|3|||
30801870|NCT03278028|58817758|FG000|Overall Study|Lost to Follow-up|1|||
30801871|NCT03278028|58817759|FG001|Overall Study|Lost to Follow-up|0|||
30801872|NCT03278028|58817758|FG000|Overall Study|Withdrawal by Subject|3|||
30801873|NCT03278028|58817759|FG001|Overall Study|Withdrawal by Subject|1|||
30801874|NCT03278028|58817758|FG000|Overall Study|Pregnancy|0|||
30801875|NCT03278028|58817759|FG001|Overall Study|Pregnancy|1|||
30801876|NCT03181503|58817767|FG000|Overall Study|Adverse Event|2|||
30801877|NCT03181503|58817768|FG001|Overall Study|Adverse Event|2|||
30801878|NCT03181503|58817767|FG000|Overall Study|Protocol Violation|1|||
30801879|NCT03181503|58817768|FG001|Overall Study|Protocol Violation|0|||
30801880|NCT03181503|58817767|FG000|Overall Study|Withdrawal by Subject|3|||
30801881|NCT03181503|58817768|FG001|Overall Study|Withdrawal by Subject|0|||
30801882|NCT03181503|58817767|FG000|Overall Study|Lost to Follow-up|1|||
30801883|NCT03181503|58817768|FG001|Overall Study|Lost to Follow-up|1|||
30801884|NCT03277794|58817779|FG000|Overall Study|Lost to Follow-up|2|||
30801885|NCT03277794|58817780|FG001|Overall Study|Lost to Follow-up|4|||
30801886|NCT03277794|58817779|FG000|Overall Study|Withdrew due to high acuity|1|||
30801887|NCT03277794|58817780|FG001|Overall Study|Withdrew due to high acuity|0|||
30801888|NCT03276078|58817787|FG000|Overall Study|Adverse Event|1|||
30801889|NCT03180801|58817794|FG000|Overall Study|Physician Decision|3|||
30801890|NCT03180801|58817795|FG001|Overall Study|Physician Decision|3|||
30747663|NCT00282464|58757894|FG001|Overall Study|dispensed wrong kit|1|||
30747664|NCT00282464|58757893|FG000|Overall Study|dropped due to missed visits|0|||
30747665|NCT00282464|58757894|FG001|Overall Study|dropped due to missed visits|1|||
30747666|NCT00273182|58757900|FG000|Overall Study|Death|450|||
30747667|NCT00273182|58757900|FG000|Overall Study|Lost to Follow-up|88|||
30747668|NCT00273182|58757900|FG000|Overall Study|Withdrawal by Subject|257|||
30747669|NCT00273182|58757900|FG000|Overall Study|Device/System Explant|154|||
30747670|NCT00273182|58757900|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
30747671|NCT00209274|58757907|FG000|Overall Study|Missed visit|3|||
30747672|NCT00209274|58757908|FG001|Overall Study|Missed visit|2|||
30801891|NCT03180801|58817796|FG002|Overall Study|Physician Decision|1|||
30801892|NCT03180801|58817794|FG000|Overall Study|Non-compliance|1|||
30801893|NCT03180801|58817795|FG001|Overall Study|Non-compliance|4|||
30801894|NCT03180801|58817796|FG002|Overall Study|Non-compliance|0|||
30801895|NCT03180801|58817794|FG000|Overall Study|Inoculation Target Reached|1|||
30801896|NCT03180801|58817795|FG001|Overall Study|Inoculation Target Reached|1|||
30801897|NCT03180801|58817796|FG002|Overall Study|Inoculation Target Reached|3|||
30906512|NCT01971723|58941124|FG000|Overall Study|Protocol Violation|1|||
30906513|NCT01971723|58941125|FG001|Overall Study|Protocol Violation|2|||
30906514|NCT01942785|58941131|FG000|Overall Study|Adverse Event|2|||
30906515|NCT01942785|58941131|FG000|Overall Study|Withdrawal by Subject|1|||
30906516|NCT01942785|58941131|FG000|Overall Study|Protocol Violation|1|||
30906517|NCT01774786|58941139|FG000|Overall Study|Death|300|||
30906518|NCT01774786|58941140|FG001|Overall Study|Death|319|||
30747673|NCT00209274|58757907|FG000|Overall Study|Death|32|||
30747674|NCT00209274|58757908|FG001|Overall Study|Death|15|||
30747675|NCT00209274|58757907|FG000|Overall Study|Withdrawal by Subject|30|||
30747676|NCT00209274|58757908|FG001|Overall Study|Withdrawal by Subject|15|||
30747677|NCT00209274|58757907|FG000|Overall Study|Randomized not treated (RNT)|6|||
30747678|NCT00209274|58757908|FG001|Overall Study|Randomized not treated (RNT)|15|||
30747679|NCT03841331|58757916|FG000|Overall Study|Withdrawal by Subject|4|||
30906519|NCT01774786|58941139|FG000|Overall Study|Lost to Follow-up|6|||
30906520|NCT01774786|58941140|FG001|Overall Study|Lost to Follow-up|7|||
30906521|NCT01774786|58941139|FG000|Overall Study|Withdrawal by Subject|18|||
30906522|NCT01774786|58941140|FG001|Overall Study|Withdrawal by Subject|14|||
30906523|NCT01774786|58941139|FG000|Overall Study|Physician Decision|2|||
30906524|NCT01774786|58941140|FG001|Overall Study|Physician Decision|0|||
30906525|NCT01774786|58941139|FG000|Overall Study|Non-compliance|0|||
30906526|NCT01774786|58941140|FG001|Overall Study|Non-compliance|1|||
30906527|NCT01774786|58941139|FG000|Overall Study|Reason Not Specified|2|||
30906528|NCT01774786|58941140|FG001|Overall Study|Reason Not Specified|5|||
30747680|NCT03841331|58757917|FG001|Overall Study|Withdrawal by Subject|9|||
30747681|NCT03841331|58757916|FG000|Overall Study|Lost to Follow-up|5|||
30801898|NCT03180801|58817794|FG000|Overall Study|Adverse Event|1|||
30801899|NCT03180801|58817795|FG001|Overall Study|Adverse Event|0|||
30906529|NCT01960725|58941148|FG000|Overall Study|Lost to Follow-up|4|||
30747682|NCT03841331|58757917|FG001|Overall Study|Lost to Follow-up|1|||
30747683|NCT00262080|58757926|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
30747684|NCT00262080|58757927|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
30747685|NCT00262080|58757928|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
30747686|NCT00262080|58757926|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
30747687|NCT00262080|58757927|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
30801900|NCT03180801|58817796|FG002|Overall Study|Adverse Event|2|||
30906530|NCT01960725|58941149|FG001|Overall Study|Lost to Follow-up|3|||
30906531|NCT01960725|58941148|FG000|Overall Study|Withdrawal by Subject|1|||
30906532|NCT01960725|58941149|FG001|Overall Study|Withdrawal by Subject|0|||
30906533|NCT01960725|58941148|FG000|Overall Study|unable to obtain blood sample|1|||
30906534|NCT01960725|58941149|FG001|Overall Study|unable to obtain blood sample|2|||
30906535|NCT01942161|58941158|FG000|Overall Study|Adverse Event|1|||
30906536|NCT01942161|58941159|FG001|Overall Study|Adverse Event|2|||
30906537|NCT01942161|58941160|FG002|Overall Study|Adverse Event|5|||
30906538|NCT01942161|58941158|FG000|Overall Study|Physician Decision|3|||
30747688|NCT00262080|58757928|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
30747689|NCT00262080|58757926|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
30747690|NCT00262080|58757927|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
30747691|NCT00262080|58757928|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
30747692|NCT00262080|58757926|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
30801901|NCT03180801|58817794|FG000|Overall Study|Withdrawal by Subject|2|||
30801902|NCT03180801|58817795|FG001|Overall Study|Withdrawal by Subject|2|||
30801903|NCT03180801|58817796|FG002|Overall Study|Withdrawal by Subject|1|||
30801904|NCT03180801|58817794|FG000|Overall Study|Lost to Follow-up|0|||
30801905|NCT03180801|58817795|FG001|Overall Study|Lost to Follow-up|2|||
30801906|NCT03180801|58817796|FG002|Overall Study|Lost to Follow-up|3|||
30801907|NCT03742271|58817807|FG000|Overall Study|Unsatisfactory Visual Response|1|||
30801908|NCT03742271|58817807|FG000|Overall Study|Withdrawal by Subject|3|||
30801909|NCT03742271|58817807|FG000|Overall Study|Lost to Follow-up|4|||
30801910|NCT03742271|58817807|FG000|Overall Study|Failed Insertion & removal|3|||
30801911|NCT03742271|58817807|FG000|Overall Study|Protocol Violation|1|||
30801912|NCT03214224|58817811|FG000|Overall Study|Protocol Violation|1|||
30801913|NCT03214224|58817811|FG000|Overall Study|Withdrawal by Subject|2|||
30801914|NCT03214224|58817811|FG000|Overall Study|Practice controls or therapists|6|||
30801915|NCT03180645|58817818|FG000|Overall Study|Adverse Event|0|||
30801916|NCT03180645|58817819|FG001|Overall Study|Adverse Event|1|||
30801917|NCT03180645|58817820|FG002|Overall Study|Adverse Event|2|||
30801918|NCT03750695|58817832|FG000|Overall Study|Lost to Follow-up|0|||
30801919|NCT03750695|58817833|FG001|Overall Study|Lost to Follow-up|1|||
30801920|NCT03231228|58817846|FG000|Overall Study|Lost to Follow-up|2|||
30801921|NCT03231228|58817847|FG001|Overall Study|Lost to Follow-up|0|||
30801922|NCT03231228|58817846|FG000|Overall Study|Physician Decision|1|||
30801923|NCT03231228|58817847|FG001|Overall Study|Physician Decision|0|||
30801924|NCT03213366|58817855|FG000|Overall Study|Lost to Follow-up|9|||
30801925|NCT03213366|58817856|FG001|Overall Study|Lost to Follow-up|4|||
30801926|NCT03213210|58817862|FG000|Overall Study|Lost to Follow-up|2|||
30801927|NCT03213210|58817862|FG000|Overall Study|Study termination|3|||
30801928|NCT02932878|58817868|FG000|Overall Study|Due to Lab Results|2|||
30801929|NCT02932878|58817869|FG001|Overall Study|Due to Lab Results|1|||
30801930|NCT03230292|58817875|FG000|Overall Study|Adverse Event|1|||
30801931|NCT03230292|58817875|FG000|Overall Study|Protocol Violation|1|||
30801932|NCT03230292|58817875|FG000|Overall Study|Lost to Follow-up|1|||
30801933|NCT03230292|58817875|FG000|Overall Study|Withdrawal by Subject|3|||
30801934|NCT03228420|58817887|FG000|Overall Study|Lost to Follow-up|5|||
30801935|NCT03228420|58817888|FG001|Overall Study|Lost to Follow-up|3|||
30801936|NCT03228420|58817887|FG000|Overall Study|Withdrawal by Subject|10|||
30801937|NCT03228420|58817888|FG001|Overall Study|Withdrawal by Subject|0|||
30801938|NCT03228420|58817887|FG000|Overall Study|Adverse Event|5|||
30801939|NCT03228420|58817888|FG001|Overall Study|Adverse Event|2|||
30801940|NCT03117049|58817896|FG000|Overall Study|Continued the follow-up period|109|||
30801941|NCT03117049|58817897|FG001|Overall Study|Continued the follow-up period|129|||
30801942|NCT03117049|58817896|FG000|Overall Study|Died|82|||
30801943|NCT03117049|58817897|FG001|Overall Study|Died|93|||
30747693|NCT00262080|58757927|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
30747694|NCT00262080|58757928|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
30747695|NCT00262080|58757926|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
30747696|NCT00262080|58757927|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
30747697|NCT00262080|58757928|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
30747698|NCT00262080|58757926|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
30801944|NCT03117049|58817896|FG000|Overall Study|Consent withdrawal|7|||
30801945|NCT03117049|58817897|FG001|Overall Study|Consent withdrawal|6|||
30801946|NCT03117049|58817896|FG000|Overall Study|Missing contact|3|||
30801947|NCT03117049|58817897|FG001|Overall Study|Missing contact|3|||
30801948|NCT03746483|58817905|FG000|Overall Study|Adverse Event|0|||
30801949|NCT03746483|58817906|FG001|Overall Study|Adverse Event|1|||
30801950|NCT03746483|58817905|FG000|Overall Study|Lack of Efficacy|3|||
30801951|NCT03746483|58817906|FG001|Overall Study|Lack of Efficacy|2|||
30801952|NCT03746483|58817905|FG000|Overall Study|Lost to Follow-up|1|||
30801953|NCT03746483|58817906|FG001|Overall Study|Lost to Follow-up|0|||
30801954|NCT03746483|58817905|FG000|Overall Study|Protocol Violation|2|||
30801955|NCT03746483|58817906|FG001|Overall Study|Protocol Violation|0|||
30906539|NCT01942161|58941159|FG001|Overall Study|Physician Decision|1|||
30906540|NCT01942161|58941160|FG002|Overall Study|Physician Decision|0|||
30747699|NCT00262080|58757927|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
30906541|NCT01942161|58941158|FG000|Overall Study|Protocol Violation|1|||
30801956|NCT03746405|58817916|FG000|Overall Study|Withdrawal by Subject|3|||
30801957|NCT03746405|58817917|FG001|Overall Study|Withdrawal by Subject|0|||
30801958|NCT03746405|58817916|FG000|Overall Study|technical difficulties|0|||
30801959|NCT03746405|58817917|FG001|Overall Study|technical difficulties|2|||
30801960|NCT03226392|58817925|FG000|Overall Study|Protocol Deviation|1|||
30801961|NCT03226392|58817926|FG001|Overall Study|Protocol Deviation|0|||
30801962|NCT03226392|58817925|FG000|Overall Study|Physician Decision|1|||
30801963|NCT03226392|58817926|FG001|Overall Study|Physician Decision|0|||
30801964|NCT03226392|58817925|FG000|Overall Study|Lost to Follow-up|1|||
30801965|NCT03226392|58817926|FG001|Overall Study|Lost to Follow-up|0|||
30801966|NCT03226392|58817925|FG000|Overall Study|Adverse Event|1|||
30801967|NCT03226392|58817926|FG001|Overall Study|Adverse Event|0|||
30801968|NCT03226392|58817925|FG000|Overall Study|Technical Problems|0|||
30801969|NCT03226392|58817926|FG001|Overall Study|Technical Problems|2|||
30801970|NCT03226392|58817925|FG000|Overall Study|Subject/Guardian Decision|7|||
30801971|NCT03226392|58817926|FG001|Overall Study|Subject/Guardian Decision|6|||
30801972|NCT03205371|58817944|FG000|Overall Study|Withdrawal by Subject|4|||
30801973|NCT03205371|58817945|FG001|Overall Study|Withdrawal by Subject|1|||
30801974|NCT03205371|58817946|FG002|Overall Study|Withdrawal by Subject|0|||
30801975|NCT03205371|58817947|FG003|Overall Study|Withdrawal by Subject|0|||
30801976|NCT03205371|58817948|FG004|Overall Study|Withdrawal by Subject|0|||
30801977|NCT03205371|58817949|FG005|Overall Study|Withdrawal by Subject|0|||
30801978|NCT03205371|58817950|FG006|Overall Study|Withdrawal by Subject|4|||
30801979|NCT03205371|58817951|FG007|Overall Study|Withdrawal by Subject|0|||
30801980|NCT03205371|58817952|FG008|Overall Study|Withdrawal by Subject|2|||
30801981|NCT03205371|58817953|FG009|Overall Study|Withdrawal by Subject|0|||
30801982|NCT03205371|58817954|FG010|Overall Study|Withdrawal by Subject|0|||
30801983|NCT03205371|58817955|FG011|Overall Study|Withdrawal by Subject|1|||
30801984|NCT03205371|58817944|FG000|Overall Study|Lost to Follow-up|0|||
30801985|NCT03205371|58817945|FG001|Overall Study|Lost to Follow-up|0|||
30801986|NCT03205371|58817946|FG002|Overall Study|Lost to Follow-up|0|||
30801987|NCT03205371|58817947|FG003|Overall Study|Lost to Follow-up|0|||
30801988|NCT03205371|58817948|FG004|Overall Study|Lost to Follow-up|0|||
30801989|NCT03205371|58817949|FG005|Overall Study|Lost to Follow-up|0|||
30801990|NCT03205371|58817950|FG006|Overall Study|Lost to Follow-up|5|||
30801991|NCT03205371|58817951|FG007|Overall Study|Lost to Follow-up|2|||
30801992|NCT03205371|58817952|FG008|Overall Study|Lost to Follow-up|3|||
30801993|NCT03205371|58817953|FG009|Overall Study|Lost to Follow-up|0|||
30801994|NCT03205371|58817954|FG010|Overall Study|Lost to Follow-up|0|||
30801995|NCT03205371|58817955|FG011|Overall Study|Lost to Follow-up|0|||
30801996|NCT03205371|58817944|FG000|Overall Study|Protocol Violation|0|||
30801997|NCT03205371|58817945|FG001|Overall Study|Protocol Violation|0|||
30801998|NCT03205371|58817946|FG002|Overall Study|Protocol Violation|0|||
30801999|NCT03205371|58817947|FG003|Overall Study|Protocol Violation|0|||
30802000|NCT03205371|58817948|FG004|Overall Study|Protocol Violation|0|||
30802001|NCT03205371|58817949|FG005|Overall Study|Protocol Violation|0|||
30802002|NCT03205371|58817950|FG006|Overall Study|Protocol Violation|1|||
30802003|NCT03205371|58817951|FG007|Overall Study|Protocol Violation|0|||
30802004|NCT03205371|58817952|FG008|Overall Study|Protocol Violation|0|||
30802005|NCT03205371|58817953|FG009|Overall Study|Protocol Violation|0|||
30802006|NCT03205371|58817954|FG010|Overall Study|Protocol Violation|0|||
30906542|NCT01942161|58941159|FG001|Overall Study|Protocol Violation|0|||
30906543|NCT01942161|58941160|FG002|Overall Study|Protocol Violation|0|||
30622342|NCT02097134|58634018|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
30747700|NCT00262080|58757928|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
30747701|NCT00282308|58757938|FG000|Treatment Period|Lost to Follow-up|1|||
30747702|NCT00282308|58757939|FG001|Treatment Period|Lost to Follow-up|0|||
30747703|NCT00282308|58757940|FG002|Treatment Period|Lost to Follow-up|0|||
30747704|NCT00282308|58757938|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
30747705|NCT00282308|58757939|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
30747706|NCT00282308|58757940|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
30747707|NCT00282308|58757938|FG000|Treatment Period|Adverse Event|0|||
30747708|NCT00282308|58757939|FG001|Treatment Period|Adverse Event|2|||
30747709|NCT00282308|58757940|FG002|Treatment Period|Adverse Event|0|||
30747710|NCT00282308|58757938|FG000|Treatment Period|Not Treated with Study Drug|1|||
30802007|NCT03205371|58817955|FG011|Overall Study|Protocol Violation|0|||
30802008|NCT03205371|58817944|FG000|Overall Study|Adverse Event|0|||
30802009|NCT03205371|58817945|FG001|Overall Study|Adverse Event|0|||
30802010|NCT03205371|58817946|FG002|Overall Study|Adverse Event|0|||
30802011|NCT03205371|58817947|FG003|Overall Study|Adverse Event|0|||
30802012|NCT03205371|58817948|FG004|Overall Study|Adverse Event|0|||
30802013|NCT03205371|58817949|FG005|Overall Study|Adverse Event|0|||
30747711|NCT00282308|58757939|FG001|Treatment Period|Not Treated with Study Drug|0|||
30802014|NCT03205371|58817950|FG006|Overall Study|Adverse Event|0|||
30802015|NCT03205371|58817951|FG007|Overall Study|Adverse Event|1|||
30802016|NCT03205371|58817952|FG008|Overall Study|Adverse Event|0|||
30802017|NCT03205371|58817953|FG009|Overall Study|Adverse Event|0|||
30802018|NCT03205371|58817954|FG010|Overall Study|Adverse Event|0|||
30802019|NCT03205371|58817955|FG011|Overall Study|Adverse Event|0|||
30802020|NCT03682705|58818007|FG000|Overall Study|Adverse Event|1|||
30802021|NCT03682705|58818008|FG001|Overall Study|Adverse Event|1|||
30802022|NCT03682705|58818009|FG002|Overall Study|Adverse Event|1|||
30802023|NCT03682705|58818010|FG003|Overall Study|Adverse Event|0|||
30802024|NCT03682705|58818011|FG004|Overall Study|Adverse Event|1|||
30802025|NCT03682705|58818012|FG005|Overall Study|Adverse Event|1|||
30802026|NCT03682705|58818007|FG000|Overall Study|Withdrawal by Subject|1|||
30802027|NCT03682705|58818008|FG001|Overall Study|Withdrawal by Subject|3|||
30802028|NCT03682705|58818009|FG002|Overall Study|Withdrawal by Subject|2|||
30802029|NCT03682705|58818010|FG003|Overall Study|Withdrawal by Subject|4|||
30802030|NCT03682705|58818011|FG004|Overall Study|Withdrawal by Subject|0|||
30802031|NCT03682705|58818012|FG005|Overall Study|Withdrawal by Subject|1|||
30802032|NCT03682705|58818007|FG000|Overall Study|Other, not specified|0|||
30802033|NCT03682705|58818008|FG001|Overall Study|Other, not specified|0|||
30802034|NCT03682705|58818009|FG002|Overall Study|Other, not specified|0|||
30802035|NCT03682705|58818010|FG003|Overall Study|Other, not specified|1|||
30802036|NCT03682705|58818011|FG004|Overall Study|Other, not specified|2|||
30802037|NCT03682705|58818012|FG005|Overall Study|Other, not specified|0|||
30802038|NCT03682705|58818007|FG000|Overall Study|Lost to Follow-up|0|||
30802039|NCT03682705|58818008|FG001|Overall Study|Lost to Follow-up|0|||
30802040|NCT03682705|58818009|FG002|Overall Study|Lost to Follow-up|0|||
30802041|NCT03682705|58818010|FG003|Overall Study|Lost to Follow-up|0|||
30802042|NCT03682705|58818011|FG004|Overall Study|Lost to Follow-up|3|||
30802043|NCT03682705|58818012|FG005|Overall Study|Lost to Follow-up|0|||
30802044|NCT03179787|58818026|FG000|Overall Study|Lost to Follow-up|15|||
30802045|NCT03179787|58818026|FG000|Overall Study|Case report failures|2|||
30802046|NCT03179787|58818026|FG000|Overall Study|Treatment not administered|1|||
30802047|NCT03745937|58818034|FG000|Overall Study|Withdrawal by Subject|0|||
30802048|NCT03745937|58818035|FG001|Overall Study|Withdrawal by Subject|0|||
30802049|NCT03745937|58818036|FG002|Overall Study|Withdrawal by Subject|0|||
30802050|NCT03745937|58818037|FG003|Overall Study|Withdrawal by Subject|1|||
30802051|NCT03745937|58818034|FG000|Overall Study|Not-specifed|0|||
30802052|NCT03745937|58818035|FG001|Overall Study|Not-specifed|1|||
30802053|NCT03745937|58818036|FG002|Overall Study|Not-specifed|0|||
30802054|NCT03745937|58818037|FG003|Overall Study|Not-specifed|1|||
30802055|NCT02956057|58818054|FG000|Overall Study|Discontinued intervention|14|||
30802056|NCT02956057|58818055|FG001|Overall Study|Discontinued intervention|10|||
30802057|NCT02956057|58818056|FG002|Overall Study|Discontinued intervention|7|||
30802058|NCT02956057|58818057|FG003|Overall Study|Discontinued intervention|14|||
30802059|NCT02956057|58818058|FG004|Overall Study|Discontinued intervention|4|||
30802060|NCT02956057|58818059|FG005|Overall Study|Discontinued intervention|17|||
30802061|NCT02956057|58818054|FG000|Overall Study|Lost to Follow-up|0|||
30802062|NCT02956057|58818055|FG001|Overall Study|Lost to Follow-up|2|||
30802063|NCT02956057|58818056|FG002|Overall Study|Lost to Follow-up|1|||
30802064|NCT02956057|58818057|FG003|Overall Study|Lost to Follow-up|1|||
30802065|NCT02956057|58818058|FG004|Overall Study|Lost to Follow-up|1|||
30802066|NCT02956057|58818059|FG005|Overall Study|Lost to Follow-up|0|||
30802067|NCT03179319|58818075|FG000|Overall Study|Lost to Follow-up|6|||
30802068|NCT03179319|58818076|FG001|Overall Study|Lost to Follow-up|0|||
30802069|NCT03627091|58818085|FG000|Overall Study|Adverse Event|0|||
30802070|NCT03627091|58818086|FG001|Overall Study|Adverse Event|0|||
30802071|NCT03627091|58818087|FG002|Overall Study|Adverse Event|2|||
30802072|NCT03627091|58818085|FG000|Overall Study|Withdrawal by Subject|2|||
30802073|NCT03627091|58818086|FG001|Overall Study|Withdrawal by Subject|0|||
30802074|NCT03627091|58818087|FG002|Overall Study|Withdrawal by Subject|2|||
30802075|NCT03627091|58818085|FG000|Overall Study|Physician Decision|2|||
30802076|NCT03627091|58818086|FG001|Overall Study|Physician Decision|0|||
30802077|NCT03627091|58818087|FG002|Overall Study|Physician Decision|0|||
30802078|NCT03627091|58818085|FG000|Overall Study|Site terminated by sponsor|0|||
30802079|NCT03627091|58818086|FG001|Overall Study|Site terminated by sponsor|1|||
30802080|NCT03627091|58818087|FG002|Overall Study|Site terminated by sponsor|0|||
30802081|NCT03627091|58818085|FG000|Overall Study|Disease relapse|7|||
30802082|NCT03627091|58818086|FG001|Overall Study|Disease relapse|5|||
30802083|NCT03627091|58818087|FG002|Overall Study|Disease relapse|1|||
30802084|NCT03627091|58818085|FG000|Overall Study|Other|1|||
30802085|NCT03627091|58818086|FG001|Overall Study|Other|0|||
30802086|NCT03627091|58818087|FG002|Overall Study|Other|0|||
30802087|NCT04237584|58818100|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
30802088|NCT04237584|58818101|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
30802089|NCT04237584|58818102|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
30802090|NCT04237584|58818103|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
30802091|NCT04237584|58818100|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
30802092|NCT04237584|58818101|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
30802093|NCT04237584|58818102|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
30802094|NCT04237584|58818103|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
30802095|NCT04237584|58818100|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
30802096|NCT04237584|58818101|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
30802097|NCT04237584|58818102|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
30802098|NCT04237584|58818103|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
30802099|NCT04237584|58818100|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
30802100|NCT04237584|58818101|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
30802101|NCT04237584|58818102|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
30802102|NCT04237584|58818103|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
30802103|NCT04237584|58818100|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
30802104|NCT04237584|58818101|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
30802105|NCT04237584|58818102|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
30802106|NCT04237584|58818103|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
30802107|NCT03224598|58818120|FG000|Overall Study|Lost to Follow-up|0|||
30802108|NCT03224598|58818121|FG001|Overall Study|Lost to Follow-up|2|||
30802109|NCT03224598|58818122|FG002|Overall Study|Lost to Follow-up|0|||
30802110|NCT03224598|58818120|FG000|Overall Study|Other|0|||
30802111|NCT03224598|58818121|FG001|Overall Study|Other|1|||
30906544|NCT01942161|58941158|FG000|Overall Study|Withdrawal by Subject|3|||
30906545|NCT01942161|58941159|FG001|Overall Study|Withdrawal by Subject|3|||
30906546|NCT01942161|58941160|FG002|Overall Study|Withdrawal by Subject|1|||
30906547|NCT01971645|58941171|FG000|Overall Study|Adverse Event|1|||
30906548|NCT01971645|58941172|FG001|Overall Study|Adverse Event|0|||
30906549|NCT01971645|58941173|FG002|Overall Study|Adverse Event|0|||
30802112|NCT03224598|58818122|FG002|Overall Study|Other|0|||
30802113|NCT03681691|58818132|FG000|Overall Study|COVID|1|||
30802114|NCT03681691|58818133|FG001|Overall Study|COVID|0|||
30802115|NCT03681691|58818132|FG000|Overall Study|prolonged bleeding|1|||
30802116|NCT03681691|58818133|FG001|Overall Study|prolonged bleeding|0|||
30906550|NCT01971645|58941171|FG000|Overall Study|Lost to Follow-up|1|||
30906551|NCT01971645|58941172|FG001|Overall Study|Lost to Follow-up|0|||
30802117|NCT03681691|58818132|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
30802118|NCT03681691|58818133|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
30802119|NCT02935842|58818145|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
30802120|NCT02935842|58818146|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
30802121|NCT02935842|58818147|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
30802122|NCT02935842|58818148|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
30802123|NCT02935842|58818145|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
30802124|NCT02935842|58818146|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
30802125|NCT02935842|58818147|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
30802126|NCT02935842|58818148|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
30802127|NCT02935842|58818145|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
30802128|NCT02935842|58818146|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
30802129|NCT02935842|58818147|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
30802130|NCT02935842|58818148|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
30802131|NCT02935842|58818145|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
30802132|NCT02935842|58818146|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
30802133|NCT02935842|58818147|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
30802134|NCT02935842|58818148|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
30802135|NCT02935842|58818145|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
30802136|NCT02935842|58818146|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
30802137|NCT02935842|58818147|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
30802138|NCT02935842|58818148|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
30802139|NCT01064479|58818167|FG000|Overall Study|Death|10|||
30802140|NCT01064479|58818168|FG001|Overall Study|Death|11|||
30802141|NCT01064479|58818167|FG000|Overall Study|Withdrawal by Subject|2|||
30802142|NCT01064479|58818168|FG001|Overall Study|Withdrawal by Subject|2|||
30802143|NCT01064479|58818167|FG000|Overall Study|Disease progression|1|||
30906552|NCT01971645|58941173|FG002|Overall Study|Lost to Follow-up|1|||
30906553|NCT01971645|58941171|FG000|Overall Study|Protocol Violation|0|||
30906554|NCT01971645|58941172|FG001|Overall Study|Protocol Violation|0|||
30906555|NCT01971645|58941173|FG002|Overall Study|Protocol Violation|1|||
30906556|NCT01941537|58941183|FG000|Overall Study|Lack of Efficacy|1|||
30906557|NCT01941537|58941184|FG001|Overall Study|Lack of Efficacy|2|||
30906558|NCT01941537|58941183|FG000|Overall Study|Lost to Follow-up|1|||
30906559|NCT01941537|58941184|FG001|Overall Study|Lost to Follow-up|0|||
30906560|NCT01941537|58941183|FG000|Overall Study|Pregnancy|1|||
30906561|NCT01941537|58941184|FG001|Overall Study|Pregnancy|0|||
30906562|NCT01941537|58941183|FG000|Overall Study|Adverse Event|1|||
30747712|NCT00282308|58757940|FG002|Treatment Period|Not Treated with Study Drug|0|||
30747713|NCT00282308|58757938|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
30747714|NCT00282308|58757939|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
30747715|NCT00282308|58757940|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
30747716|NCT00282308|58757938|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
30747717|NCT00282308|58757939|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
30747718|NCT00282308|58757940|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
30747719|NCT00282308|58757938|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
30906563|NCT01941537|58941184|FG001|Overall Study|Adverse Event|0|||
30906564|NCT01941537|58941183|FG000|Overall Study|Withdrawal by Subject|0|||
30802144|NCT01064479|58818168|FG001|Overall Study|Disease progression|1|||
30802145|NCT01064479|58818167|FG000|Overall Study|Toxicity|1|||
30802146|NCT01064479|58818168|FG001|Overall Study|Toxicity|1|||
30802147|NCT01064479|58818167|FG000|Overall Study|Other|1|||
30802148|NCT01064479|58818168|FG001|Overall Study|Other|2|||
30802149|NCT03680911|58818176|FG000|At Home Treatment|Study Termination|3|||
30802150|NCT03680911|58818177|FG001|At Home Treatment|Study Termination|0|||
30802151|NCT03680911|58818176|FG000|At Home Treatment|Lost to Follow-up|0|||
30802152|NCT03680911|58818177|FG001|At Home Treatment|Lost to Follow-up|1|||
30802153|NCT03680911|58818176|FG000|At Home Treatment|Withdrawal by Subject|0|||
30802154|NCT03680911|58818177|FG001|At Home Treatment|Withdrawal by Subject|2|||
30802155|NCT03680911|58818176|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
30802156|NCT03680911|58818177|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
30802157|NCT03224130|58818185|FG000|Overall Study|consent issue|0|||
30802158|NCT03224130|58818186|FG001|Overall Study|consent issue|1|||
30802159|NCT03680521|58818194|FG000|Overall Study|Ongoing in long-term follow up|7|||
30802160|NCT03680521|58818195|FG001|Overall Study|Ongoing in long-term follow up|11|||
30802161|NCT03679741|58818204|FG000|Period 1|No longer meet eligibility criteria|1|||
30802162|NCT03679741|58818205|FG001|Period 1|No longer meet eligibility criteria|0|||
30802163|NCT03679741|58818204|FG000|Period 1|Lost to Follow-up|0|||
30802164|NCT03679741|58818205|FG001|Period 1|Lost to Follow-up|1|||
30802165|NCT03679741|58818204|FG000|Period 1|Adverse Event|1|||
30802166|NCT03679741|58818205|FG001|Period 1|Adverse Event|1|||
30802167|NCT03679741|58818204|FG000|Period 1|Withdrawal by Subject|0|||
30802168|NCT03679741|58818205|FG001|Period 1|Withdrawal by Subject|1|||
30802169|NCT03679741|58818204|FG000|Period 2|Adverse Event|2|||
30802170|NCT03679741|58818205|FG001|Period 2|Adverse Event|1|||
30802171|NCT03679741|58818204|FG000|Period 2|Withdrawal by Subject|1|||
30802172|NCT03679741|58818205|FG001|Period 2|Withdrawal by Subject|1|||
30802173|NCT03678103|58818211|FG000|Overall Study|Withdrawn prior to completion|4|||
30802174|NCT03649477|58818218|FG000|Overall Study|Adverse Event|2|||
30802175|NCT03649477|58818219|FG001|Overall Study|Adverse Event|0|||
30802176|NCT03649477|58818220|FG002|Overall Study|Adverse Event|0|||
30802177|NCT03677869|58818228|FG000|Overall Study|Withdrawal by Subject|1|||
30802178|NCT03677401|58818234|FG000|Overall Study|Adverse Event|4|||
30802179|NCT03677401|58818235|FG001|Overall Study|Adverse Event|14|||
30802180|NCT03677401|58818234|FG000|Overall Study|Lack of Efficacy|3|||
30802181|NCT03677401|58818235|FG001|Overall Study|Lack of Efficacy|1|||
30802182|NCT03677401|58818234|FG000|Overall Study|Withdrawal by Subject|2|||
30802183|NCT03677401|58818235|FG001|Overall Study|Withdrawal by Subject|2|||
30802184|NCT03677401|58818234|FG000|Overall Study|Sponsor decision|0|||
30802185|NCT03677401|58818235|FG001|Overall Study|Sponsor decision|1|||
30802186|NCT03677401|58818234|FG000|Overall Study|Reason Unspecified|1|||
30802187|NCT03677401|58818235|FG001|Overall Study|Reason Unspecified|0|||
30802188|NCT03218787|58818241|FG000|Overall Study|Lost to Follow-up|12|||
30802189|NCT03218787|58818241|FG000|Overall Study|Withdrawal by Subject|72|||
30802190|NCT03218787|58818241|FG000|Overall Study|Physician Decision|11|||
30802191|NCT03218787|58818241|FG000|Overall Study|Death|111|||
30802192|NCT01348087|58818245|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
30906565|NCT01941537|58941184|FG001|Overall Study|Withdrawal by Subject|1|||
30906566|NCT01971567|58941193|FG000|Overall Study|Withdrawal by Subject|3|||
30906567|NCT01971567|58941194|FG001|Overall Study|Withdrawal by Subject|2|||
30906568|NCT01971567|58941193|FG000|Overall Study|Lost to Follow-up|1|||
30906569|NCT01971567|58941194|FG001|Overall Study|Lost to Follow-up|0|||
30906570|NCT01960413|58941202|FG000|Overall Study|Withdrawal by Subject|1|||
30906571|NCT01960413|58941203|FG001|Overall Study|Withdrawal by Subject|1|||
30906572|NCT01960413|58941202|FG000|Overall Study|Physician Decision|1|||
30906573|NCT01960413|58941203|FG001|Overall Study|Physician Decision|0|||
30906574|NCT01960413|58941202|FG000|Overall Study|Lost to Follow-up|2|||
30906575|NCT01960413|58941203|FG001|Overall Study|Lost to Follow-up|0|||
30906576|NCT01970475|58941211|FG000|Overall Study|Withdrawal by Subject|11|||
30802193|NCT01348087|58818245|FG000|Overall Study|Administrative problems|79|||
30802194|NCT01348087|58818245|FG000|Overall Study|protocol deviation|1|||
30802195|NCT01348087|58818245|FG000|Overall Study|Lost to Follow-up|1|||
30802196|NCT01348087|58818245|FG000|Overall Study|Subject withdrew consent|7|||
30802197|NCT01348087|58818245|FG000|Overall Study|Adverse Event|25|||
30802198|NCT01347931|58818259|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
30802199|NCT03645421|58818269|FG000|Overall Study|Adverse Event|0|||
30802200|NCT03645421|58818270|FG001|Overall Study|Adverse Event|0|||
30906577|NCT01970475|58941212|FG001|Overall Study|Withdrawal by Subject|6|||
30906578|NCT01970475|58941211|FG000|Overall Study|Adverse Event|7|||
30802201|NCT03645421|58818271|FG002|Overall Study|Adverse Event|4|||
30802202|NCT03645421|58818272|FG003|Overall Study|Adverse Event|1|||
30802203|NCT03645421|58818269|FG000|Overall Study|Withdrawal by patient|0|||
30802204|NCT03645421|58818270|FG001|Overall Study|Withdrawal by patient|0|||
30906579|NCT01970475|58941212|FG001|Overall Study|Adverse Event|3|||
30906580|NCT01970475|58941211|FG000|Overall Study|Lost to Follow-up|2|||
30906581|NCT01970475|58941212|FG001|Overall Study|Lost to Follow-up|2|||
30802205|NCT03645421|58818271|FG002|Overall Study|Withdrawal by patient|0|||
30802206|NCT03645421|58818272|FG003|Overall Study|Withdrawal by patient|3|||
30802207|NCT03645421|58818269|FG000|Overall Study|Study specific withdrawal criteria|0|||
30802208|NCT03645421|58818270|FG001|Overall Study|Study specific withdrawal criteria|0|||
30802209|NCT03645421|58818271|FG002|Overall Study|Study specific withdrawal criteria|1|||
30802210|NCT03645421|58818272|FG003|Overall Study|Study specific withdrawal criteria|0|||
30802211|NCT03207750|58818287|FG000|Overall Study|Adverse Event|3|||
30802212|NCT03207750|58818288|FG001|Overall Study|Adverse Event|2|||
30802213|NCT03207750|58818287|FG000|Overall Study|Lost to Follow-up|21|||
30802214|NCT03207750|58818288|FG001|Overall Study|Lost to Follow-up|29|||
30802215|NCT03207750|58818287|FG000|Overall Study|Protocol Violation|0|||
30802216|NCT03207750|58818288|FG001|Overall Study|Protocol Violation|1|||
30802217|NCT03207750|58818287|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
30802218|NCT03207750|58818288|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
30802219|NCT03207750|58818287|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
30802220|NCT03207750|58818288|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
30802221|NCT03207750|58818287|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
30802222|NCT03207750|58818288|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
30802223|NCT03207750|58818287|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
30802224|NCT03207750|58818288|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
30802225|NCT03207750|58818287|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
30802226|NCT03207750|58818288|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
30802227|NCT03674281|58818297|FG000|Overall Study|screen failure|2|||
30802228|NCT03674281|58818298|FG001|Overall Study|screen failure|0|||
30802229|NCT03674281|58818299|FG002|Overall Study|screen failure|0|||
30802230|NCT03674281|58818297|FG000|Overall Study|Withdrawal by Subject|1|||
30802231|NCT03674281|58818298|FG001|Overall Study|Withdrawal by Subject|3|||
30802232|NCT03674281|58818299|FG002|Overall Study|Withdrawal by Subject|3|||
30802233|NCT03673345|58818323|FG000|Overall Study|Lost to Follow-up|1|||
30802234|NCT03673345|58818324|FG001|Overall Study|Lost to Follow-up|0|||
30802235|NCT03673345|58818325|FG002|Overall Study|Lost to Follow-up|3|||
30802236|NCT03673345|58818326|FG003|Overall Study|Lost to Follow-up|3|||
30802237|NCT03673345|58818327|FG004|Overall Study|Lost to Follow-up|2|||
30802238|NCT03673345|58818328|FG005|Overall Study|Lost to Follow-up|1|||
30802239|NCT03673345|58818329|FG006|Overall Study|Lost to Follow-up|0|||
30802240|NCT03673345|58818330|FG007|Overall Study|Lost to Follow-up|0|||
30802241|NCT03673345|58818323|FG000|Overall Study|Withdrawal by Subject|1|||
30802242|NCT03673345|58818324|FG001|Overall Study|Withdrawal by Subject|0|||
30802243|NCT03673345|58818325|FG002|Overall Study|Withdrawal by Subject|4|||
30802244|NCT03673345|58818326|FG003|Overall Study|Withdrawal by Subject|2|||
30802245|NCT03673345|58818327|FG004|Overall Study|Withdrawal by Subject|0|||
30802246|NCT03673345|58818328|FG005|Overall Study|Withdrawal by Subject|0|||
30802247|NCT03673345|58818329|FG006|Overall Study|Withdrawal by Subject|0|||
30802248|NCT03673345|58818330|FG007|Overall Study|Withdrawal by Subject|0|||
30802249|NCT03673345|58818323|FG000|Overall Study|Physician Decision|0|||
30802250|NCT03673345|58818324|FG001|Overall Study|Physician Decision|0|||
30802251|NCT03673345|58818325|FG002|Overall Study|Physician Decision|2|||
30802252|NCT03673345|58818326|FG003|Overall Study|Physician Decision|0|||
30802253|NCT03673345|58818327|FG004|Overall Study|Physician Decision|0|||
30802254|NCT03673345|58818328|FG005|Overall Study|Physician Decision|0|||
30802255|NCT03673345|58818329|FG006|Overall Study|Physician Decision|0|||
30802256|NCT03673345|58818330|FG007|Overall Study|Physician Decision|0|||
30802257|NCT03223662|58818348|FG000|Overall Study|Physician Decision|1|||
30802258|NCT03223662|58818348|FG000|Overall Study|Study closure|1|||
30802259|NCT03672097|58818352|FG000|Period 1|Withdrawal by Subject|2|||
30802260|NCT03672097|58818352|FG000|Period 1|Adverse Event|1|||
30802261|NCT03672097|58818352|FG000|Period 1|Did not receive treatment|1|||
30802262|NCT03672097|58818352|FG000|Period 2|Withdrawal by Subject|3|||
30802263|NCT03672097|58818352|FG000|Period 2|Other|1|||
30802264|NCT03847896|58818361|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
30802265|NCT03847896|58818362|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
30802266|NCT03847896|58818363|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
30802267|NCT03847896|58818364|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
30802268|NCT03847896|58818365|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
30802269|NCT03847896|58818361|FG000|Overall Study|Withdrawal by Subject|2|||
30802270|NCT03847896|58818362|FG001|Overall Study|Withdrawal by Subject|10|||
30802271|NCT03847896|58818363|FG002|Overall Study|Withdrawal by Subject|5|||
30802272|NCT03847896|58818364|FG003|Overall Study|Withdrawal by Subject|9|||
30802273|NCT03847896|58818365|FG004|Overall Study|Withdrawal by Subject|8|||
30802274|NCT03847896|58818361|FG000|Overall Study|Withdrawal by parent/guardian|0|||
30802275|NCT03847896|58818362|FG001|Overall Study|Withdrawal by parent/guardian|0|||
30802276|NCT03847896|58818363|FG002|Overall Study|Withdrawal by parent/guardian|1|||
30802277|NCT03847896|58818364|FG003|Overall Study|Withdrawal by parent/guardian|0|||
30802278|NCT03847896|58818365|FG004|Overall Study|Withdrawal by parent/guardian|0|||
30802279|NCT03847896|58818361|FG000|Overall Study|Adverse Event|2|||
30802280|NCT03847896|58818362|FG001|Overall Study|Adverse Event|1|||
30802281|NCT03847896|58818363|FG002|Overall Study|Adverse Event|3|||
30802282|NCT03847896|58818364|FG003|Overall Study|Adverse Event|2|||
30802283|NCT03847896|58818365|FG004|Overall Study|Adverse Event|4|||
30802284|NCT03847896|58818361|FG000|Overall Study|A severe exacerbation event|0|||
30802285|NCT03847896|58818362|FG001|Overall Study|A severe exacerbation event|0|||
30802286|NCT03847896|58818363|FG002|Overall Study|A severe exacerbation event|0|||
30802287|NCT03847896|58818364|FG003|Overall Study|A severe exacerbation event|0|||
30802288|NCT03847896|58818365|FG004|Overall Study|A severe exacerbation event|3|||
30802289|NCT03847896|58818361|FG000|Overall Study|Protocol Violation|0|||
30802290|NCT03847896|58818362|FG001|Overall Study|Protocol Violation|2|||
30802291|NCT03847896|58818363|FG002|Overall Study|Protocol Violation|1|||
30802292|NCT03847896|58818364|FG003|Overall Study|Protocol Violation|0|||
30802293|NCT03847896|58818365|FG004|Overall Study|Protocol Violation|2|||
30802294|NCT03847896|58818361|FG000|Overall Study|Lost to Follow-up|0|||
30802295|NCT03847896|58818362|FG001|Overall Study|Lost to Follow-up|0|||
30802296|NCT03847896|58818363|FG002|Overall Study|Lost to Follow-up|0|||
30802297|NCT03847896|58818364|FG003|Overall Study|Lost to Follow-up|1|||
30802298|NCT03847896|58818365|FG004|Overall Study|Lost to Follow-up|0|||
30802299|NCT03847896|58818361|FG000|Overall Study|Condition under investigation worsened|0|||
30802300|NCT03847896|58818362|FG001|Overall Study|Condition under investigation worsened|0|||
30802301|NCT03847896|58818363|FG002|Overall Study|Condition under investigation worsened|0|||
30802302|NCT03847896|58818364|FG003|Overall Study|Condition under investigation worsened|1|||
30802303|NCT03847896|58818365|FG004|Overall Study|Condition under investigation worsened|1|||
30802304|NCT03847896|58818361|FG000|Overall Study|Lack of Efficacy|0|||
30802305|NCT03847896|58818362|FG001|Overall Study|Lack of Efficacy|0|||
30802306|NCT03847896|58818363|FG002|Overall Study|Lack of Efficacy|0|||
30802307|NCT03847896|58818364|FG003|Overall Study|Lack of Efficacy|2|||
30802308|NCT03847896|58818365|FG004|Overall Study|Lack of Efficacy|2|||
30802309|NCT03847896|58818361|FG000|Overall Study|Other reasons|3|||
30802310|NCT03847896|58818362|FG001|Overall Study|Other reasons|3|||
30802311|NCT03847896|58818363|FG002|Overall Study|Other reasons|1|||
30802312|NCT03847896|58818364|FG003|Overall Study|Other reasons|2|||
30802313|NCT03847896|58818365|FG004|Overall Study|Other reasons|1|||
30802314|NCT03670537|58818377|FG000|Overall Study|Protocol Violation|1|||
30802315|NCT03619837|58818381|FG000|Screening|received organs from HCV-negative donors|47|||
30802316|NCT03619837|58818381|FG000|Screening|died on the wait-list|2|||
30802317|NCT03619837|58818381|FG000|Screening|remained on the wait list|40|||
30802318|NCT03619837|58818381|FG000|Screening|didn't meet eligibility criteria|3|||
30802319|NCT03619837|58818381|FG000|Screening|withdrew consent|2|||
30802320|NCT03619837|58818381|FG000|Screening|never listed for HCV-viremic donor|1|||
30802321|NCT03619837|58818381|FG000|Screening|developed exclusion criteria|2|||
30802322|NCT03619837|58818381|FG000|Screening|excluded by the investigator due to non-compliance|1|||
30802323|NCT03206970|58818385|FG000|Overall Study|Death|21|||
30802324|NCT03206970|58818385|FG000|Overall Study|Withdrawal by Subject|13|||
30802325|NCT03206970|58818385|FG000|Overall Study|Lost to Follow-up|3|||
30802326|NCT03206970|58818385|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
30802327|NCT03644173|58818389|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
30802328|NCT03644173|58818389|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
30802329|NCT03644173|58818389|FG000|Participants at the 1-month Follow up|Death|2|||
30802330|NCT03644173|58818389|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
30802331|NCT03178851|58818397|FG000|Overall Study|Death|48|||
30802332|NCT03178851|58818398|FG001|Overall Study|Death|2|||
30802333|NCT03178851|58818399|FG002|Overall Study|Death|25|||
30802334|NCT03178851|58818397|FG000|Overall Study|Withdrawal by Subject|8|||
30802335|NCT03178851|58818398|FG001|Overall Study|Withdrawal by Subject|0|||
30802336|NCT03178851|58818399|FG002|Overall Study|Withdrawal by Subject|0|||
30802337|NCT03178851|58818397|FG000|Overall Study|Lost to Follow-up|5|||
30906582|NCT01970475|58941211|FG000|Overall Study|Protocol Violation|1|||
30906583|NCT01970475|58941212|FG001|Overall Study|Protocol Violation|0|||
30906584|NCT01939977|58941220|FG000|Overall Study|Adverse Event|4|||
30802338|NCT03178851|58818398|FG001|Overall Study|Lost to Follow-up|2|||
30802339|NCT03178851|58818399|FG002|Overall Study|Lost to Follow-up|0|||
30802340|NCT03178851|58818397|FG000|Overall Study|Adverse Event|0|||
30802341|NCT03178851|58818398|FG001|Overall Study|Adverse Event|0|||
30802342|NCT03178851|58818399|FG002|Overall Study|Adverse Event|1|||
30802343|NCT03178851|58818397|FG000|Overall Study|Study Termination by Sponsor|31|||
30906585|NCT01939977|58941221|FG001|Overall Study|Adverse Event|3|||
30802344|NCT03178851|58818398|FG001|Overall Study|Study Termination by Sponsor|7|||
30802345|NCT03178851|58818399|FG002|Overall Study|Study Termination by Sponsor|26|||
30906586|NCT01939977|58941220|FG000|Overall Study|Lack of Efficacy|3|||
30802346|NCT03643159|58818410|FG000|Overall Study|Adverse Event|1|||
30802347|NCT03643159|58818410|FG000|Overall Study|Withdrawal by Subject|1|||
30802348|NCT03205566|58818417|FG000|Phase 1|Protocol Violation|1|||
30802349|NCT03205566|58818418|FG001|Phase 1|Protocol Violation|1|||
30802350|NCT02935452|58818430|FG000|Overall Study|work and life commintment|3|||
30802351|NCT02935452|58818431|FG001|Overall Study|work and life commintment|1|||
30802352|NCT03178773|58818439|FG000|Overall Study|Death|0|||
30802353|NCT03178773|58818440|FG001|Overall Study|Death|1|||
30802354|NCT03178773|58818439|FG000|Overall Study|Lost to Follow-up|29|||
30802355|NCT03178773|58818440|FG001|Overall Study|Lost to Follow-up|25|||
30802356|NCT03178773|58818439|FG000|Overall Study|Withdrawal by Subject|10|||
30802357|NCT03178773|58818440|FG001|Overall Study|Withdrawal by Subject|14|||
30802358|NCT03713034|58818449|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
30802359|NCT03713034|58818450|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
30802360|NCT03218397|58818460|FG000|Overall Study|Prior positive blood culture|8|||
30802361|NCT03218397|58818461|FG001|Overall Study|Prior positive blood culture|13|||
30802362|NCT03218397|58818460|FG000|Overall Study|Comfort care|8|||
30802363|NCT03218397|58818461|FG001|Overall Study|Comfort care|5|||
30802364|NCT03218397|58818460|FG000|Overall Study|Comfort care and positive blood culture|1|||
30802365|NCT03218397|58818461|FG001|Overall Study|Comfort care and positive blood culture|0|||
30802366|NCT03218397|58818460|FG000|Overall Study|Comfort care and mixed culture|0|||
30802367|NCT03218397|58818461|FG001|Overall Study|Comfort care and mixed culture|1|||
30802368|NCT03218397|58818460|FG000|Overall Study|Mixed culture|2|||
30802369|NCT03218397|58818461|FG001|Overall Study|Mixed culture|2|||
30802370|NCT03218397|58818460|FG000|Overall Study|Inaccessible hospital records|2|||
30802371|NCT03218397|58818461|FG001|Overall Study|Inaccessible hospital records|5|||
30802372|NCT03218397|58818460|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
30802373|NCT03218397|58818461|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
30802374|NCT03218397|58818460|FG000|Overall Study|Randomized during laboratory off hours|2|||
30802375|NCT03218397|58818461|FG001|Overall Study|Randomized during laboratory off hours|1|||
30802376|NCT03618823|58818469|FG000|Overall Study|Lost to Follow-up|63|||
30802377|NCT03618823|58818470|FG001|Overall Study|Lost to Follow-up|61|||
30802378|NCT03640507|58818482|FG000|Overall Study|Withdrawal by Subject|0|||
30802379|NCT03640507|58818483|FG001|Overall Study|Withdrawal by Subject|0|||
30802380|NCT03640507|58818484|FG002|Overall Study|Withdrawal by Subject|1|||
30802381|NCT02937636|58818494|FG000|Overall Study|Other (Not specified)|3|||
30802382|NCT02937636|58818495|FG001|Overall Study|Other (Not specified)|2|||
30802383|NCT03638635|58818504|FG000|Initial Hospitalization|Study terminated prematurely|0|||
30802384|NCT03638635|58818505|FG001|Initial Hospitalization|Study terminated prematurely|1|||
30802385|NCT03638635|58818504|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
30802386|NCT03638635|58818505|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
30802387|NCT03638635|58818504|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
30802388|NCT03638635|58818505|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
30906587|NCT01939977|58941221|FG001|Overall Study|Lack of Efficacy|0|||
30906588|NCT01939977|58941220|FG000|Overall Study|Physician Decision|1|||
30906589|NCT01939977|58941221|FG001|Overall Study|Physician Decision|1|||
30906590|NCT01939977|58941220|FG000|Overall Study|Withdrawal by Subject|0|||
30802389|NCT03204981|58818511|FG000|Overall Study|Physician Decision|2|||
30802390|NCT03204981|58818511|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
30802391|NCT03205488|58818520|FG000|Overall Study|Adverse Event|1|||
30906591|NCT01939977|58941221|FG001|Overall Study|Withdrawal by Subject|2|||
30906592|NCT01939977|58941220|FG000|Overall Study|Did not meet inclusion criteria|1|||
30906593|NCT01939977|58941221|FG001|Overall Study|Did not meet inclusion criteria|0|||
30906594|NCT01939977|58941220|FG000|Overall Study|Did not receive study medication|0|||
30906595|NCT01939977|58941221|FG001|Overall Study|Did not receive study medication|1|||
30906596|NCT01939899|58941232|FG000|Lead-in Dose Finding Phase|Death|0|||
30906597|NCT01939899|58941233|FG001|Lead-in Dose Finding Phase|Death|3|||
30906598|NCT01939899|58941234|FG002|Lead-in Dose Finding Phase|Death|1|||
30906599|NCT01939899|58941235|FG003|Lead-in Dose Finding Phase|Death|0|||
30906600|NCT01939899|58941236|FG004|Lead-in Dose Finding Phase|Death|0|||
30906601|NCT01939899|58941232|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
30906602|NCT01939899|58941233|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
30906603|NCT01939899|58941234|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
30802392|NCT03205488|58818521|FG001|Overall Study|Adverse Event|2|||
30906604|NCT01939899|58941235|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
30906605|NCT01939899|58941236|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
30906606|NCT01939899|58941232|FG000|Lead-in Dose Finding Phase|Other|0|||
30802393|NCT03205488|58818522|FG002|Overall Study|Adverse Event|4|||
30802394|NCT03205488|58818520|FG000|Overall Study|Protocol Violation|0|||
30802395|NCT03205488|58818521|FG001|Overall Study|Protocol Violation|0|||
30802396|NCT03205488|58818522|FG002|Overall Study|Protocol Violation|1|||
30802397|NCT03204279|58818536|FG000|Overall Study|Withdrawal by Subject|0|||
30802398|NCT03204279|58818537|FG001|Overall Study|Withdrawal by Subject|1|||
30906607|NCT01939899|58941233|FG001|Lead-in Dose Finding Phase|Other|0|||
30802399|NCT03173547|58818546|FG000|Overall Study|Adverse Event|2|||
30802400|NCT03173547|58818547|FG001|Overall Study|Adverse Event|0|||
30802401|NCT03173547|58818546|FG000|Overall Study|Withdrawal by Subject|2|||
30802402|NCT03173547|58818547|FG001|Overall Study|Withdrawal by Subject|2|||
30802403|NCT02954653|58818555|FG000|Overall Study|Death|3|||
30802404|NCT02954653|58818556|FG001|Overall Study|Death|1|||
30802405|NCT02954653|58818557|FG002|Overall Study|Death|0|||
30802406|NCT02954653|58818558|FG003|Overall Study|Death|0|||
30802407|NCT02954653|58818559|FG004|Overall Study|Death|0|||
30802408|NCT02954653|58818560|FG005|Overall Study|Death|0|||
30802409|NCT02954653|58818561|FG006|Overall Study|Death|0|||
30802410|NCT02954653|58818562|FG007|Overall Study|Death|0|||
30802411|NCT02954653|58818563|FG008|Overall Study|Death|0|||
30802412|NCT02954653|58818555|FG000|Overall Study|Randomized but did not receive treatment|1|||
30802413|NCT02954653|58818556|FG001|Overall Study|Randomized but did not receive treatment|0|||
30802414|NCT02954653|58818557|FG002|Overall Study|Randomized but did not receive treatment|0|||
30802415|NCT02954653|58818558|FG003|Overall Study|Randomized but did not receive treatment|0|||
30802416|NCT02954653|58818559|FG004|Overall Study|Randomized but did not receive treatment|0|||
30802417|NCT02954653|58818560|FG005|Overall Study|Randomized but did not receive treatment|0|||
30802418|NCT02954653|58818561|FG006|Overall Study|Randomized but did not receive treatment|0|||
30802419|NCT02954653|58818562|FG007|Overall Study|Randomized but did not receive treatment|0|||
30802420|NCT02954653|58818563|FG008|Overall Study|Randomized but did not receive treatment|0|||
30802421|NCT02954653|58818555|FG000|Overall Study|Started another anti-cancer therapy|0|||
30802422|NCT02954653|58818556|FG001|Overall Study|Started another anti-cancer therapy|1|||
30802423|NCT02954653|58818557|FG002|Overall Study|Started another anti-cancer therapy|0|||
30802424|NCT02954653|58818558|FG003|Overall Study|Started another anti-cancer therapy|0|||
30802425|NCT02954653|58818559|FG004|Overall Study|Started another anti-cancer therapy|0|||
30802426|NCT02954653|58818560|FG005|Overall Study|Started another anti-cancer therapy|0|||
30802427|NCT02954653|58818561|FG006|Overall Study|Started another anti-cancer therapy|0|||
30802428|NCT02954653|58818562|FG007|Overall Study|Started another anti-cancer therapy|0|||
30802429|NCT02954653|58818563|FG008|Overall Study|Started another anti-cancer therapy|0|||
30802430|NCT02954653|58818555|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
30802431|NCT02954653|58818556|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
30802432|NCT02954653|58818557|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
30802433|NCT02954653|58818558|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
30802434|NCT02954653|58818559|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
30802435|NCT02954653|58818560|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
30802436|NCT02954653|58818561|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
30802437|NCT02954653|58818562|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
30802438|NCT02954653|58818563|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
30802439|NCT03173313|58818577|FG000|Overall Study|Lost to Follow-up|2|||
30802440|NCT03173313|58818578|FG001|Overall Study|Lost to Follow-up|3|||
30802441|NCT03173313|58818577|FG000|Overall Study|Withdrawal by Subject|0|||
30802442|NCT03173313|58818578|FG001|Overall Study|Withdrawal by Subject|1|||
30802443|NCT03173313|58818577|FG000|Overall Study|Death|5|||
30802444|NCT03173313|58818578|FG001|Overall Study|Death|0|||
30802445|NCT03173313|58818577|FG000|Overall Study|Physician Decision|1|||
30802446|NCT03173313|58818578|FG001|Overall Study|Physician Decision|0|||
30802447|NCT03173313|58818577|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
30802448|NCT03173313|58818578|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
30802449|NCT03173313|58818577|FG000|Overall Study|Bone Fracture|1|||
30802450|NCT03173313|58818578|FG001|Overall Study|Bone Fracture|0|||
30802451|NCT03215667|58818584|FG000|Overall Study|Physician Decision|4|||
30802452|NCT03634579|58818588|FG000|Overall Study|study termination|9|||
30747720|NCT00282308|58757939|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
30747721|NCT00282308|58757940|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
30747722|NCT00282308|58757938|FG000|Safety Follow-up Period|Adverse Event|0|||
30747723|NCT00282308|58757939|FG001|Safety Follow-up Period|Adverse Event|0|||
30747724|NCT00282308|58757940|FG002|Safety Follow-up Period|Adverse Event|1|||
30747725|NCT00282308|58757938|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
30747726|NCT00282308|58757939|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
30747727|NCT00282308|58757940|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
30747728|NCT00282308|58757938|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
30747729|NCT00282308|58757939|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
30747730|NCT00282308|58757940|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
30747731|NCT00282308|58757938|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
30747732|NCT00282308|58757939|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
30747733|NCT00282308|58757940|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
30747734|NCT00282152|58757952|FG000|Overall Study|Withdrawal by Subject|1|||
30747735|NCT00282152|58757953|FG001|Overall Study|Withdrawal by Subject|0|||
30747736|NCT00281840|58757960|FG000|Overall Study|Adverse Event|12|||
30802453|NCT02730208|58818594|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
30802454|NCT02730208|58818595|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
30802455|NCT01291511|58818603|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
30802456|NCT01291511|58818604|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
30802457|NCT01291511|58818603|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
30802458|NCT01291511|58818604|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
30802459|NCT01291511|58818603|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
30802460|NCT01291511|58818604|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
30802461|NCT01291511|58818603|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
30802462|NCT01291511|58818604|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
30802463|NCT01291511|58818603|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
30802464|NCT01291511|58818604|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
30802465|NCT01291511|58818603|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
30802466|NCT01291511|58818604|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
30802467|NCT01291511|58818603|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
30802468|NCT01291511|58818604|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
30802469|NCT01291511|58818603|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
30802470|NCT01291511|58818604|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
30802471|NCT01291511|58818603|FG000|Cross-Titration and Stabilization Phase|Death|1|||
30802472|NCT01291511|58818604|FG001|Cross-Titration and Stabilization Phase|Death|0|||
30802473|NCT01291511|58818603|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
30802474|NCT01291511|58818604|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
30802475|NCT01291511|58818603|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
30802476|NCT01291511|58818604|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
30802477|NCT01291511|58818603|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
30802478|NCT01291511|58818604|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
30802479|NCT01291511|58818603|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
30802480|NCT01291511|58818604|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
30802481|NCT01291511|58818603|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
30802482|NCT01291511|58818604|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
30802483|NCT01291511|58818603|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
30802484|NCT01291511|58818604|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
30802485|NCT01291511|58818603|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
30802486|NCT01291511|58818604|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
30802487|NCT01291511|58818603|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
30802488|NCT01291511|58818604|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
30802489|NCT01291511|58818603|FG000|Double-blind Relapse Prevention Phase|Death|1|||
30802490|NCT01291511|58818604|FG001|Double-blind Relapse Prevention Phase|Death|0|||
30802491|NCT03170349|58818611|FG000|At 30 Days Follow-up|Death|1|||
30802492|NCT03170349|58818611|FG000|At 6 Months Follow-up|Death|3|||
30802493|NCT03170349|58818611|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
30802494|NCT03170349|58818611|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
30802495|NCT03170349|58818611|FG000|At 1 Year Follow-up|Death|6|||
30802496|NCT03170349|58818611|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
30802497|NCT03201900|58818615|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
30802498|NCT03201900|58818615|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
30802499|NCT03201900|58818615|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
30802500|NCT03201900|58818615|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
30802501|NCT03201900|58818615|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
30802502|NCT03201900|58818615|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
30802503|NCT03201900|58818615|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
30802504|NCT03201900|58818615|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
30802505|NCT03201900|58818615|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
30802506|NCT03201900|58818615|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
30802507|NCT03201900|58818615|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
30802508|NCT03201900|58818615|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
30802509|NCT03201900|58818615|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
30747737|NCT00281840|58757960|FG000|Overall Study|Physician Decision|6|||
30747738|NCT00281840|58757960|FG000|Overall Study|Withdrawal by Subject|3|||
30747739|NCT00281840|58757960|FG000|Overall Study|Disease Progression|2|||
30747740|NCT00281840|58757960|FG000|Overall Study|exceed maximum delay in treatment|1|||
30747741|NCT00281840|58757960|FG000|Overall Study|Complicating Disease|1|||
30747742|NCT00281684|58757969|FG000|Overall Study|Lost to Follow-up|0|||
30747743|NCT00281684|58757970|FG001|Overall Study|Lost to Follow-up|0|||
30747744|NCT00281684|58757971|FG002|Overall Study|Lost to Follow-up|1|||
30747745|NCT00281684|58757972|FG003|Overall Study|Lost to Follow-up|0|||
30802510|NCT03170271|58818630|FG000|Overall Study|Adverse Event|7|||
30802511|NCT03170271|58818631|FG001|Overall Study|Adverse Event|2|||
30802512|NCT03170271|58818630|FG000|Overall Study|Lost to Follow-up|0|||
30802513|NCT03170271|58818631|FG001|Overall Study|Lost to Follow-up|1|||
30802514|NCT03170271|58818630|FG000|Overall Study|Physician Decision|1|||
30802515|NCT03170271|58818631|FG001|Overall Study|Physician Decision|0|||
30802516|NCT03170271|58818630|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
30802517|NCT03170271|58818631|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
30802518|NCT03170271|58818630|FG000|Overall Study|Withdrawal by Subject|17|||
30802519|NCT03170271|58818631|FG001|Overall Study|Withdrawal by Subject|5|||
30802520|NCT03170271|58818630|FG000|Overall Study|Other|2|||
30802521|NCT03170271|58818631|FG001|Overall Study|Other|2|||
30802522|NCT03170271|58818630|FG000|Overall Study|Randomized in error|4|||
30802523|NCT03170271|58818631|FG001|Overall Study|Randomized in error|0|||
30802524|NCT03613129|58818641|FG000|Pre-treatment Assessment|Protocol Violation|2|||
30802525|NCT03613129|58818642|FG001|Pre-treatment Assessment|Protocol Violation|0|||
30802526|NCT03613129|58818643|FG002|Pre-treatment Assessment|Protocol Violation|0|||
30802527|NCT03613129|58818644|FG003|Pre-treatment Assessment|Protocol Violation|0|||
30802528|NCT03613129|58818645|FG004|Pre-treatment Assessment|Protocol Violation|0|||
30802529|NCT03613129|58818641|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
30802530|NCT03613129|58818642|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
30802531|NCT03613129|58818643|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
30802532|NCT03613129|58818644|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
30802533|NCT03613129|58818645|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
30802534|NCT03235284|58818660|FG000|Overall Study|Adverse Event|1|||
30802535|NCT03235284|58818661|FG001|Overall Study|Adverse Event|2|||
30802536|NCT03235284|58818662|FG002|Overall Study|Adverse Event|1|||
30802537|NCT03170193|58818677|FG000|Overall Study|Withdrawal by Subject|0|||
30802538|NCT03170193|58818678|FG001|Overall Study|Withdrawal by Subject|0|||
30802539|NCT03170193|58818679|FG002|Overall Study|Withdrawal by Subject|0|||
30802540|NCT03170193|58818680|FG003|Overall Study|Withdrawal by Subject|1|||
30802541|NCT03170193|58818681|FG004|Overall Study|Withdrawal by Subject|0|||
30802542|NCT03170193|58818682|FG005|Overall Study|Withdrawal by Subject|0|||
30802543|NCT03170193|58818683|FG006|Overall Study|Withdrawal by Subject|0|||
30802544|NCT03170193|58818677|FG000|Overall Study|Lost to Follow-up|1|||
30802545|NCT03170193|58818678|FG001|Overall Study|Lost to Follow-up|1|||
30802546|NCT03170193|58818679|FG002|Overall Study|Lost to Follow-up|0|||
30802547|NCT03170193|58818680|FG003|Overall Study|Lost to Follow-up|0|||
30802548|NCT03170193|58818681|FG004|Overall Study|Lost to Follow-up|0|||
30802549|NCT03170193|58818682|FG005|Overall Study|Lost to Follow-up|0|||
30802550|NCT03170193|58818683|FG006|Overall Study|Lost to Follow-up|0|||
30802551|NCT03633331|58818705|FG000|Overall Study|Withdrawal by Subject|1|||
30802552|NCT03201003|58818711|FG000|Overall Study|Adverse Event|14|||
30802553|NCT03201003|58818712|FG001|Overall Study|Adverse Event|1|||
30802554|NCT03201003|58818711|FG000|Overall Study|Other reasons|5|||
30802555|NCT03201003|58818712|FG001|Overall Study|Other reasons|1|||
30802556|NCT03201003|58818711|FG000|Overall Study|Withdrawal by Subject|4|||
30802557|NCT03201003|58818712|FG001|Overall Study|Withdrawal by Subject|1|||
30802558|NCT03201003|58818711|FG000|Overall Study|Lost to Follow-up|2|||
30802559|NCT03201003|58818712|FG001|Overall Study|Lost to Follow-up|0|||
30802560|NCT03201003|58818711|FG000|Overall Study|Protocol Violation|1|||
30802561|NCT03201003|58818712|FG001|Overall Study|Protocol Violation|0|||
30802562|NCT03166215|58818720|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
30802563|NCT03166215|58818721|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
30802564|NCT03166215|58818722|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
30802565|NCT03166215|58818720|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
30802566|NCT03166215|58818721|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
30802567|NCT03166215|58818722|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
30802568|NCT03168711|58818744|FG000|Overall Study|Adverse Event|2|||
30802569|NCT03168711|58818745|FG001|Overall Study|Adverse Event|0|||
30802570|NCT03168711|58818744|FG000|Overall Study|Withdrawal by Subject|0|||
30802571|NCT03168711|58818745|FG001|Overall Study|Withdrawal by Subject|1|||
30802572|NCT03168711|58818744|FG000|Overall Study|Death|0|||
30802573|NCT03168711|58818745|FG001|Overall Study|Death|1|||
30802574|NCT03738215|58818754|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
30802575|NCT03738215|58818755|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
30802576|NCT03738215|58818756|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
30802577|NCT03738215|58818754|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
30802578|NCT03738215|58818755|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
30802579|NCT03738215|58818756|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
30802580|NCT03738215|58818754|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
30802581|NCT03738215|58818755|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
30802582|NCT03738215|58818756|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
30802583|NCT03738215|58818754|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
30802584|NCT03738215|58818755|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
30802585|NCT03738215|58818756|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
30802586|NCT03738215|58818754|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
30802587|NCT03738215|58818755|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
30802588|NCT03738215|58818756|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
30802589|NCT03738215|58818754|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
30802590|NCT03738215|58818755|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
30906608|NCT01939899|58941234|FG002|Lead-in Dose Finding Phase|Other|1|||
30906609|NCT01939899|58941235|FG003|Lead-in Dose Finding Phase|Other|0|||
30906610|NCT01939899|58941236|FG004|Lead-in Dose Finding Phase|Other|0|||
30906611|NCT01939899|58941232|FG000|Phase 2|Withdrawal by Subject|0|||
30906612|NCT01939899|58941233|FG001|Phase 2|Withdrawal by Subject|0|||
30906613|NCT01939899|58941234|FG002|Phase 2|Withdrawal by Subject|0|||
30906614|NCT01939899|58941235|FG003|Phase 2|Withdrawal by Subject|2|||
30906615|NCT01939899|58941236|FG004|Phase 2|Withdrawal by Subject|0|||
30906616|NCT01939899|58941232|FG000|Phase 2|Disease Progression|0|||
30906617|NCT01939899|58941233|FG001|Phase 2|Disease Progression|0|||
30906618|NCT01939899|58941234|FG002|Phase 2|Disease Progression|0|||
30906619|NCT01939899|58941235|FG003|Phase 2|Disease Progression|9|||
30906620|NCT01939899|58941236|FG004|Phase 2|Disease Progression|1|||
30906621|NCT01970397|58941256|FG000|Overall Study|Adverse Event|0|||
30906622|NCT01970397|58941257|FG001|Overall Study|Adverse Event|1|||
30906623|NCT01970397|58941256|FG000|Overall Study|Lost to Follow-up|0|||
30906624|NCT01970397|58941257|FG001|Overall Study|Lost to Follow-up|1|||
30906625|NCT01970397|58941256|FG000|Overall Study|Personal Reasons|1|||
30906626|NCT01970397|58941257|FG001|Overall Study|Personal Reasons|2|||
30906627|NCT01970397|58941256|FG000|Overall Study|Protocol Violation|1|||
30802591|NCT03738215|58818756|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
30802592|NCT03738215|58818754|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
30906628|NCT01970397|58941257|FG001|Overall Study|Protocol Violation|1|||
30906629|NCT01970241|58941265|FG000|Overall Study|Withdrawal by Subject|2|||
30906630|NCT01970241|58941266|FG001|Overall Study|Withdrawal by Subject|0|||
30906631|NCT01970241|58941265|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
30906632|NCT01970241|58941266|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
30747746|NCT00281684|58757969|FG000|Overall Study|Withdrawal by Subject|1|||
30747747|NCT00281684|58757970|FG001|Overall Study|Withdrawal by Subject|0|||
30747748|NCT00281684|58757971|FG002|Overall Study|Withdrawal by Subject|0|||
30747749|NCT00281684|58757972|FG003|Overall Study|Withdrawal by Subject|0|||
30747750|NCT00272792|58757986|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
30747751|NCT00272792|58757987|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
30747752|NCT00272792|58757986|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
30747753|NCT00272792|58757987|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
30747754|NCT00272792|58757986|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
30802593|NCT03738215|58818755|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
30802594|NCT03738215|58818756|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
30802595|NCT03738215|58818754|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
30802596|NCT03738215|58818755|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
30802597|NCT03738215|58818756|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
30802598|NCT03738215|58818754|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
30802599|NCT03738215|58818755|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
30802600|NCT03738215|58818756|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
30802601|NCT03738215|58818754|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
30802602|NCT03738215|58818755|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
30802603|NCT03738215|58818756|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
30802604|NCT03199911|58818766|FG000|Overall Study|Lost to Follow-up|5|||
30802605|NCT03199911|58818767|FG001|Overall Study|Lost to Follow-up|5|||
30802606|NCT03199911|58818766|FG000|Overall Study|Did not proceed with surgery|2|||
30802607|NCT03199911|58818767|FG001|Overall Study|Did not proceed with surgery|1|||
30802608|NCT03736967|58818777|FG000|Overall Study|Withdrawal by Subject|26|||
30802609|NCT03736967|58818778|FG001|Overall Study|Withdrawal by Subject|25|||
30802610|NCT03736967|58818779|FG002|Overall Study|Withdrawal by Subject|23|||
30802611|NCT03736967|58818780|FG003|Overall Study|Withdrawal by Subject|26|||
30802612|NCT03736967|58818777|FG000|Overall Study|Lost to Follow-up|3|||
30802613|NCT03736967|58818778|FG001|Overall Study|Lost to Follow-up|2|||
30802614|NCT03736967|58818779|FG002|Overall Study|Lost to Follow-up|1|||
30802615|NCT03736967|58818780|FG003|Overall Study|Lost to Follow-up|1|||
30906633|NCT01939353|58941274|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
30906634|NCT01939353|58941274|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
30906635|NCT01939353|58941274|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
30906636|NCT01939353|58941274|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
30747755|NCT00272792|58757987|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
30802616|NCT03736967|58818777|FG000|Overall Study|Physician Decision|1|||
30802617|NCT03736967|58818778|FG001|Overall Study|Physician Decision|0|||
30802618|NCT03736967|58818779|FG002|Overall Study|Physician Decision|0|||
30802619|NCT03736967|58818780|FG003|Overall Study|Physician Decision|1|||
30802620|NCT03736967|58818777|FG000|Overall Study|Adverse Event|0|||
30802621|NCT03736967|58818778|FG001|Overall Study|Adverse Event|1|||
30802622|NCT03736967|58818779|FG002|Overall Study|Adverse Event|0|||
30802623|NCT03736967|58818780|FG003|Overall Study|Adverse Event|1|||
30802624|NCT03736967|58818777|FG000|Overall Study|Death|0|||
30802625|NCT03736967|58818778|FG001|Overall Study|Death|0|||
30802626|NCT03736967|58818779|FG002|Overall Study|Death|0|||
30802627|NCT03736967|58818780|FG003|Overall Study|Death|1|||
30802628|NCT03736967|58818777|FG000|Overall Study|Randomized but never treated|1|||
30906637|NCT01939353|58941274|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
30906638|NCT01970007|58941278|FG000|Overall Study|Death|5|||
30906639|NCT01970007|58941278|FG000|Overall Study|Withdrawal by Subject|23|||
30906640|NCT01970007|58941278|FG000|Overall Study|Lost to Follow-up|24|||
30906641|NCT01970007|58941278|FG000|Overall Study|"Other endpoint"|3|||
30906642|NCT01728376|58941288|FG000|Overall Study|Adverse Event|1|||
30906643|NCT01728376|58941289|FG001|Overall Study|Adverse Event|1|||
30906644|NCT01728376|58941290|FG002|Overall Study|Adverse Event|1|||
30906645|NCT01728376|58941291|FG003|Overall Study|Adverse Event|1|||
30906646|NCT01728376|58941292|FG004|Overall Study|Adverse Event|1|||
30906647|NCT01728376|58941293|FG005|Overall Study|Adverse Event|0|||
30906648|NCT01728376|58941288|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
30906649|NCT01728376|58941289|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
30906650|NCT01728376|58941290|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
30906651|NCT01728376|58941291|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
30906652|NCT01728376|58941292|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
30802629|NCT03736967|58818778|FG001|Overall Study|Randomized but never treated|0|||
30802630|NCT03736967|58818779|FG002|Overall Study|Randomized but never treated|0|||
30802631|NCT03736967|58818780|FG003|Overall Study|Randomized but never treated|0|||
30843578|NCT02101853|58869617|FG005|Post Induction Randomization|Lack of Efficacy|0|||
30843579|NCT02101853|58869612|FG000|Post Induction Randomization|Physician Decision|0|||
30843580|NCT02101853|58869613|FG001|Post Induction Randomization|Physician Decision|43|||
30843581|NCT02101853|58869614|FG002|Post Induction Randomization|Physician Decision|23|||
30843582|NCT02101853|58869615|FG003|Post Induction Randomization|Physician Decision|14|||
30843583|NCT02101853|58869616|FG004|Post Induction Randomization|Physician Decision|14|||
30843584|NCT02101853|58869617|FG005|Post Induction Randomization|Physician Decision|0|||
30843585|NCT02101853|58869612|FG000|Post Induction Randomization|Protocol Violation|0|||
30906653|NCT01728376|58941293|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
30906654|NCT01728376|58941288|FG000|Overall Study|No relevant bacteria|2|||
30906655|NCT01728376|58941289|FG001|Overall Study|No relevant bacteria|0|||
30906656|NCT01728376|58941290|FG002|Overall Study|No relevant bacteria|0|||
30906657|NCT01728376|58941291|FG003|Overall Study|No relevant bacteria|0|||
30906658|NCT01728376|58941292|FG004|Overall Study|No relevant bacteria|1|||
30906659|NCT01728376|58941293|FG005|Overall Study|No relevant bacteria|1|||
30906660|NCT01728376|58941288|FG000|Overall Study|Did not receive treatment|0|||
30906661|NCT01728376|58941289|FG001|Overall Study|Did not receive treatment|1|||
30906662|NCT01728376|58941290|FG002|Overall Study|Did not receive treatment|0|||
30906663|NCT01728376|58941291|FG003|Overall Study|Did not receive treatment|0|||
30906664|NCT01728376|58941292|FG004|Overall Study|Did not receive treatment|0|||
30906665|NCT01728376|58941293|FG005|Overall Study|Did not receive treatment|0|||
30906666|NCT01728376|58941288|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
30906667|NCT01728376|58941289|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
30906668|NCT01728376|58941290|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
30906669|NCT01728376|58941291|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
30906670|NCT01728376|58941292|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
30906671|NCT01728376|58941293|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
30906672|NCT01708174|58941310|FG000|Treatment Period|Withdrawal by Subject|1|||
30906673|NCT01708174|58941311|FG001|Treatment Period|Withdrawal by Subject|0|||
30906674|NCT01708174|58941312|FG002|Treatment Period|Withdrawal by Subject|0|||
30906675|NCT01708174|58941310|FG000|Treatment Period|Progressive disease|0|||
30906676|NCT01708174|58941311|FG001|Treatment Period|Progressive disease|1|||
30906677|NCT01708174|58941312|FG002|Treatment Period|Progressive disease|0|||
30906678|NCT01708174|58941310|FG000|Treatment Period|Death|0|||
30906679|NCT01708174|58941311|FG001|Treatment Period|Death|0|||
30906680|NCT01708174|58941312|FG002|Treatment Period|Death|1|||
30906681|NCT01708174|58941310|FG000|Treatment Period|Adverse Event|0|||
30906682|NCT01708174|58941311|FG001|Treatment Period|Adverse Event|1|||
30906683|NCT01708174|58941312|FG002|Treatment Period|Adverse Event|0|||
30906684|NCT02488759|58941327|FG000|Overall Study|Disease progression|74|||
30906685|NCT02488759|58941328|FG001|Overall Study|Disease progression|110|||
30906686|NCT02488759|58941329|FG002|Overall Study|Disease progression|62|||
30906687|NCT02488759|58941330|FG003|Overall Study|Disease progression|7|||
30906688|NCT02488759|58941331|FG004|Overall Study|Disease progression|4|||
30906689|NCT02488759|58941332|FG005|Overall Study|Disease progression|2|||
30906690|NCT02488759|58941327|FG000|Overall Study|Study drug toxicity|11|||
30906691|NCT02488759|58941328|FG001|Overall Study|Study drug toxicity|33|||
30906692|NCT02488759|58941329|FG002|Overall Study|Study drug toxicity|31|||
30906693|NCT02488759|58941330|FG003|Overall Study|Study drug toxicity|0|||
30906694|NCT02488759|58941331|FG004|Overall Study|Study drug toxicity|0|||
30906695|NCT02488759|58941332|FG005|Overall Study|Study drug toxicity|2|||
30906696|NCT02488759|58941327|FG000|Overall Study|Adverse event unrelated to study drug|9|||
30906697|NCT02488759|58941328|FG001|Overall Study|Adverse event unrelated to study drug|11|||
30906698|NCT02488759|58941329|FG002|Overall Study|Adverse event unrelated to study drug|7|||
30906699|NCT02488759|58941330|FG003|Overall Study|Adverse event unrelated to study drug|0|||
30906700|NCT02488759|58941331|FG004|Overall Study|Adverse event unrelated to study drug|1|||
30906701|NCT02488759|58941332|FG005|Overall Study|Adverse event unrelated to study drug|0|||
30906702|NCT02488759|58941327|FG000|Overall Study|Participant request to discontinue study treatment|7|||
30906703|NCT02488759|58941328|FG001|Overall Study|Participant request to discontinue study treatment|8|||
30906704|NCT02488759|58941329|FG002|Overall Study|Participant request to discontinue study treatment|4|||
30906705|NCT02488759|58941330|FG003|Overall Study|Participant request to discontinue study treatment|0|||
30906706|NCT02488759|58941331|FG004|Overall Study|Participant request to discontinue study treatment|0|||
30906707|NCT02488759|58941332|FG005|Overall Study|Participant request to discontinue study treatment|0|||
30906708|NCT02488759|58941327|FG000|Overall Study|Withdrawal by Subject|2|||
30906709|NCT02488759|58941328|FG001|Overall Study|Withdrawal by Subject|0|||
30906710|NCT02488759|58941329|FG002|Overall Study|Withdrawal by Subject|3|||
30906711|NCT02488759|58941330|FG003|Overall Study|Withdrawal by Subject|0|||
30906712|NCT02488759|58941331|FG004|Overall Study|Withdrawal by Subject|0|||
30906713|NCT02488759|58941332|FG005|Overall Study|Withdrawal by Subject|2|||
30906714|NCT02488759|58941327|FG000|Overall Study|Lost to Follow-up|0|||
30906715|NCT02488759|58941328|FG001|Overall Study|Lost to Follow-up|1|||
30906716|NCT02488759|58941329|FG002|Overall Study|Lost to Follow-up|2|||
30906717|NCT02488759|58941330|FG003|Overall Study|Lost to Follow-up|0|||
30906718|NCT02488759|58941331|FG004|Overall Study|Lost to Follow-up|0|||
30906719|NCT02488759|58941332|FG005|Overall Study|Lost to Follow-up|0|||
30906720|NCT02488759|58941327|FG000|Overall Study|Maximum clinical benefit|3|||
30906721|NCT02488759|58941328|FG001|Overall Study|Maximum clinical benefit|0|||
30906722|NCT02488759|58941329|FG002|Overall Study|Maximum clinical benefit|1|||
30906723|NCT02488759|58941330|FG003|Overall Study|Maximum clinical benefit|0|||
30906724|NCT02488759|58941331|FG004|Overall Study|Maximum clinical benefit|0|||
30906725|NCT02488759|58941332|FG005|Overall Study|Maximum clinical benefit|0|||
30906726|NCT02488759|58941327|FG000|Overall Study|Completed treatment|0|||
30906727|NCT02488759|58941328|FG001|Overall Study|Completed treatment|0|||
30906728|NCT02488759|58941329|FG002|Overall Study|Completed treatment|0|||
30906729|NCT02488759|58941330|FG003|Overall Study|Completed treatment|0|||
30906730|NCT02488759|58941331|FG004|Overall Study|Completed treatment|0|||
30906731|NCT02488759|58941332|FG005|Overall Study|Completed treatment|116|||
30906732|NCT02488759|58941327|FG000|Overall Study|Other reasons|5|||
30906733|NCT02488759|58941328|FG001|Overall Study|Other reasons|32|||
30906734|NCT02488759|58941329|FG002|Overall Study|Other reasons|21|||
30906735|NCT02488759|58941330|FG003|Overall Study|Other reasons|1|||
30906736|NCT02488759|58941331|FG004|Overall Study|Other reasons|1|||
30906737|NCT02488759|58941332|FG005|Overall Study|Other reasons|1|||
30906738|NCT01605916|58941351|FG000|Overall Study|Adverse Event|1|||
30906739|NCT01605916|58941352|FG001|Overall Study|Adverse Event|0|||
30906740|NCT01605916|58941353|FG002|Overall Study|Adverse Event|0|||
30906741|NCT01605916|58941354|FG003|Overall Study|Adverse Event|1|||
30906742|NCT01605916|58941355|FG004|Overall Study|Adverse Event|0|||
30906743|NCT01605916|58941351|FG000|Overall Study|Lack of Efficacy|2|||
30906744|NCT01605916|58941352|FG001|Overall Study|Lack of Efficacy|3|||
30906745|NCT01605916|58941353|FG002|Overall Study|Lack of Efficacy|3|||
30906746|NCT01605916|58941354|FG003|Overall Study|Lack of Efficacy|5|||
30906747|NCT01605916|58941355|FG004|Overall Study|Lack of Efficacy|4|||
30906748|NCT01605916|58941351|FG000|Overall Study|Withdrawal by Subject|1|||
30906749|NCT01605916|58941352|FG001|Overall Study|Withdrawal by Subject|1|||
30906750|NCT01605916|58941353|FG002|Overall Study|Withdrawal by Subject|0|||
30906751|NCT01605916|58941354|FG003|Overall Study|Withdrawal by Subject|0|||
30906752|NCT01605916|58941355|FG004|Overall Study|Withdrawal by Subject|2|||
30906753|NCT01635283|58941368|FG000|Overall Study|Tumor Progression|3|||
30906754|NCT01635283|58941368|FG000|Overall Study|Lost to Follow-up|1|||
30906755|NCT01707004|58941375|FG000|Overall Study|Physician Decision|3|||
30906756|NCT01939197|58941387|FG000|Overall Study|Withdrawal by Subject|1|||
30906757|NCT01939197|58941388|FG001|Overall Study|Withdrawal by Subject|0|||
30906758|NCT01939197|58941389|FG002|Overall Study|Withdrawal by Subject|0|||
30906759|NCT01939197|58941390|FG003|Overall Study|Withdrawal by Subject|0|||
30906760|NCT01939197|58941391|FG004|Overall Study|Withdrawal by Subject|1|||
30906761|NCT01939197|58941392|FG005|Overall Study|Withdrawal by Subject|0|||
30906762|NCT01939197|58941393|FG006|Overall Study|Withdrawal by Subject|0|||
30906763|NCT01939197|58941387|FG000|Overall Study|Lost to Follow-up|0|||
30906764|NCT01939197|58941388|FG001|Overall Study|Lost to Follow-up|1|||
30906765|NCT01939197|58941389|FG002|Overall Study|Lost to Follow-up|0|||
30906766|NCT01939197|58941390|FG003|Overall Study|Lost to Follow-up|1|||
30906767|NCT01939197|58941391|FG004|Overall Study|Lost to Follow-up|3|||
30906768|NCT01939197|58941392|FG005|Overall Study|Lost to Follow-up|1|||
30906769|NCT01939197|58941393|FG006|Overall Study|Lost to Follow-up|2|||
30906770|NCT01969851|58941426|FG000|Overall Study|Adverse Event|0|||
30906771|NCT01969851|58941427|FG001|Overall Study|Adverse Event|0|||
30906772|NCT01969851|58941428|FG002|Overall Study|Adverse Event|3|||
30906773|NCT01969851|58941426|FG000|Overall Study|Lack of Efficacy|0|||
30906774|NCT01969851|58941427|FG001|Overall Study|Lack of Efficacy|3|||
30906775|NCT01969851|58941428|FG002|Overall Study|Lack of Efficacy|1|||
30747756|NCT00272792|58757986|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
30747757|NCT00272792|58757987|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
30906776|NCT01969851|58941426|FG000|Overall Study|Withdrawal by Subject|1|||
30906777|NCT01969851|58941427|FG001|Overall Study|Withdrawal by Subject|0|||
30906778|NCT01969851|58941428|FG002|Overall Study|Withdrawal by Subject|1|||
30906779|NCT01969851|58941426|FG000|Overall Study|No effective dose in Titration period|0|||
30906780|NCT01969851|58941427|FG001|Overall Study|No effective dose in Titration period|0|||
30906781|NCT01969851|58941428|FG002|Overall Study|No effective dose in Titration period|1|||
30906782|NCT01969851|58941426|FG000|Overall Study|Sponsor decision|0|||
30906783|NCT01969851|58941427|FG001|Overall Study|Sponsor decision|0|||
30906784|NCT01969851|58941428|FG002|Overall Study|Sponsor decision|1|||
30906785|NCT01938573|58941436|FG000|Overall Study|Lack of Efficacy|1|||
30906786|NCT01938573|58941437|FG001|Overall Study|Lack of Efficacy|0|||
30906787|NCT01938573|58941436|FG000|Overall Study|Operation at other hospital|1|||
30906788|NCT01938573|58941437|FG001|Overall Study|Operation at other hospital|0|||
30906789|NCT01937871|58941445|FG000|Overall Study|Adverse Event|6|||
30906790|NCT01937871|58941446|FG001|Overall Study|Adverse Event|6|||
30906791|NCT01937871|58941447|FG002|Overall Study|Adverse Event|2|||
30906792|NCT01937871|58941445|FG000|Overall Study|Lost to Follow-up|8|||
30906793|NCT01937871|58941446|FG001|Overall Study|Lost to Follow-up|2|||
30906794|NCT01937871|58941447|FG002|Overall Study|Lost to Follow-up|4|||
30906795|NCT01937871|58941445|FG000|Overall Study|Withdrawal by Subject|9|||
30906796|NCT01937871|58941446|FG001|Overall Study|Withdrawal by Subject|6|||
30906797|NCT01937871|58941447|FG002|Overall Study|Withdrawal by Subject|4|||
30906798|NCT01937871|58941445|FG000|Overall Study|Physician Decision|0|||
30906799|NCT01937871|58941446|FG001|Overall Study|Physician Decision|1|||
30906800|NCT01937871|58941447|FG002|Overall Study|Physician Decision|0|||
30906801|NCT01937871|58941445|FG000|Overall Study|Entry Criteria Not Met|1|||
30906802|NCT01937871|58941446|FG001|Overall Study|Entry Criteria Not Met|2|||
30906803|NCT01937871|58941447|FG002|Overall Study|Entry Criteria Not Met|1|||
30906804|NCT01269463|58941479|FG000|First Intervention|Withdrawal by Subject|1|||
30906805|NCT01269463|58941480|FG001|First Intervention|Withdrawal by Subject|0|||
30906806|NCT01269463|58941479|FG000|First Intervention|Adverse Event|1|||
30906807|NCT01269463|58941480|FG001|First Intervention|Adverse Event|0|||
30906808|NCT01269463|58941479|FG000|First Intervention|Lack of Efficacy|0|||
30906809|NCT01269463|58941480|FG001|First Intervention|Lack of Efficacy|1|||
30906810|NCT01269463|58941479|FG000|First Intervention|Physician Decision|0|||
30906811|NCT01269463|58941480|FG001|First Intervention|Physician Decision|1|||
30906812|NCT01706926|58941495|FG000|Overall Study|Lost to Follow-up|0|||
30906813|NCT01706926|58941496|FG001|Overall Study|Lost to Follow-up|0|||
30906814|NCT01706926|58941497|FG002|Overall Study|Lost to Follow-up|1|||
30906815|NCT01706926|58941498|FG003|Overall Study|Lost to Follow-up|0|||
30906816|NCT01706926|58941495|FG000|Overall Study|Withdrawal by Subject|2|||
30906817|NCT01706926|58941496|FG001|Overall Study|Withdrawal by Subject|0|||
30906818|NCT01706926|58941497|FG002|Overall Study|Withdrawal by Subject|1|||
30906819|NCT01706926|58941498|FG003|Overall Study|Withdrawal by Subject|2|||
30906820|NCT01706926|58941495|FG000|Overall Study|Other|4|||
30906821|NCT01706926|58941496|FG001|Overall Study|Other|4|||
30906822|NCT01706926|58941497|FG002|Overall Study|Other|4|||
30906823|NCT01706926|58941498|FG003|Overall Study|Other|3|||
30906824|NCT01634113|58941514|FG000|Overall Study|Not treated|0|||
30906825|NCT01634113|58941515|FG001|Overall Study|Not treated|0|||
30906826|NCT01634113|58941516|FG002|Overall Study|Not treated|1|||
30906827|NCT01706770|58941526|FG000|Overall Study|Lost to Follow-up|1|||
30906828|NCT01706770|58941527|FG001|Overall Study|Lost to Follow-up|0|||
30906829|NCT01706770|58941526|FG000|Overall Study|Physician Decision|1|||
30906830|NCT01706770|58941527|FG001|Overall Study|Physician Decision|0|||
30906831|NCT01937715|58941538|FG000|Overall Study|Death|0|||
30906832|NCT01937715|58941539|FG001|Overall Study|Death|0|||
30906833|NCT01937715|58941540|FG002|Overall Study|Death|0|||
30906834|NCT01937715|58941541|FG003|Overall Study|Death|1|||
30906835|NCT01937715|58941542|FG004|Overall Study|Death|0|||
30906836|NCT01937715|58941538|FG000|Overall Study|Withdrawal by Subject|0|||
30906837|NCT01937715|58941539|FG001|Overall Study|Withdrawal by Subject|1|||
30906838|NCT01937715|58941540|FG002|Overall Study|Withdrawal by Subject|0|||
30906839|NCT01937715|58941541|FG003|Overall Study|Withdrawal by Subject|0|||
30906840|NCT01937715|58941542|FG004|Overall Study|Withdrawal by Subject|2|||
30906841|NCT01937715|58941538|FG000|Overall Study|Other|0|||
30906842|NCT01937715|58941539|FG001|Overall Study|Other|0|||
30906843|NCT01937715|58941540|FG002|Overall Study|Other|0|||
30906844|NCT01937715|58941541|FG003|Overall Study|Other|3|||
30906845|NCT01937715|58941542|FG004|Overall Study|Other|0|||
30906846|NCT01937559|58941557|FG000|Overall Study|Physician Decision|3|||
30906847|NCT01937559|58941558|FG001|Overall Study|Physician Decision|3|||
30906848|NCT01937559|58941559|FG002|Overall Study|Physician Decision|0|||
30906849|NCT01937559|58941557|FG000|Overall Study|Withdrawal by Subject|6|||
30906850|NCT01937559|58941558|FG001|Overall Study|Withdrawal by Subject|4|||
30906851|NCT01937559|58941559|FG002|Overall Study|Withdrawal by Subject|0|||
30906852|NCT01937559|58941557|FG000|Overall Study|screen fail|2|||
30906853|NCT01937559|58941558|FG001|Overall Study|screen fail|4|||
30906854|NCT01937559|58941559|FG002|Overall Study|screen fail|0|||
30906855|NCT01960257|58941571|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
30906856|NCT01960257|58941572|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
30906857|NCT01960257|58941573|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
30906858|NCT01960257|58941571|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
30906859|NCT01960257|58941572|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
30906860|NCT01960257|58941573|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
30906861|NCT01960257|58941571|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
30906862|NCT01960257|58941572|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
30906863|NCT01960257|58941573|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
30906864|NCT01918371|58941585|FG000|Overall Study|Missing Data|1|||
30906865|NCT01918371|58941586|FG001|Overall Study|Missing Data|1|||
30906866|NCT01917747|58941594|FG000|Overall Study|Withdrawal by Subject|1|||
30906867|NCT01917747|58941595|FG001|Overall Study|Withdrawal by Subject|2|||
30906868|NCT01917747|58941594|FG000|Overall Study|Lost to Follow-up|18|||
30906869|NCT01917747|58941595|FG001|Overall Study|Lost to Follow-up|9|||
30906870|NCT01597791|58941607|FG000|Overall Study|Physician Decision|2|||
30906871|NCT01597791|58941608|FG001|Overall Study|Physician Decision|1|||
30906872|NCT01597791|58941607|FG000|Overall Study|Cesarean Section|6|||
30906873|NCT01597791|58941608|FG001|Overall Study|Cesarean Section|7|||
30906874|NCT01597791|58941607|FG000|Overall Study|Subject withdrawal|0|||
30906875|NCT01597791|58941608|FG001|Overall Study|Subject withdrawal|1|||
30906876|NCT01597791|58941607|FG000|Overall Study|Protocol Violation|0|||
30906877|NCT01597791|58941608|FG001|Overall Study|Protocol Violation|1|||
30906878|NCT01916967|58941617|FG000|Overall Study|Adverse Event|0|||
30906879|NCT01916967|58941618|FG001|Overall Study|Adverse Event|0|||
30906880|NCT01916967|58941619|FG002|Overall Study|Adverse Event|2|||
30906881|NCT01916967|58941617|FG000|Overall Study|Lack of Efficacy|0|||
30906882|NCT01916967|58941618|FG001|Overall Study|Lack of Efficacy|0|||
30906883|NCT01916967|58941619|FG002|Overall Study|Lack of Efficacy|6|||
30906884|NCT01916967|58941617|FG000|Overall Study|Physician Decision|0|||
30906885|NCT01916967|58941618|FG001|Overall Study|Physician Decision|0|||
30906886|NCT01916967|58941619|FG002|Overall Study|Physician Decision|1|||
30906887|NCT01916967|58941617|FG000|Overall Study|Protocol Violation|0|||
30906888|NCT01916967|58941618|FG001|Overall Study|Protocol Violation|1|||
30906889|NCT01916967|58941619|FG002|Overall Study|Protocol Violation|0|||
30906890|NCT01936623|58941631|FG000|Overall Study|Lost to Follow-up|0|||
30906891|NCT01936623|58941632|FG001|Overall Study|Lost to Follow-up|5|||
30906892|NCT01959243|58941640|FG000|Overall Study|Investigator Decision|3|||
30906893|NCT01959243|58941641|FG001|Overall Study|Investigator Decision|0|||
30906894|NCT01959243|58941640|FG000|Overall Study|Adverse Event|5|||
30906895|NCT01959243|58941641|FG001|Overall Study|Adverse Event|2|||
30906896|NCT01959243|58941640|FG000|Overall Study|Administrative reasons|2|||
30906897|NCT01959243|58941641|FG001|Overall Study|Administrative reasons|1|||
30906898|NCT01959243|58941640|FG000|Overall Study|Lost to Follow-up|3|||
30906899|NCT01959243|58941641|FG001|Overall Study|Lost to Follow-up|1|||
30906900|NCT01959165|58941651|FG000|Overall Study|Adverse Event|0|||
30906901|NCT01959165|58941652|FG001|Overall Study|Adverse Event|0|||
30906902|NCT01959165|58941653|FG002|Overall Study|Adverse Event|0|||
30906903|NCT01959165|58941654|FG003|Overall Study|Adverse Event|1|||
30906904|NCT01959165|58941651|FG000|Overall Study|Lack of Efficacy|1|||
30906905|NCT01959165|58941652|FG001|Overall Study|Lack of Efficacy|0|||
30906906|NCT01959165|58941653|FG002|Overall Study|Lack of Efficacy|0|||
30906907|NCT01959165|58941654|FG003|Overall Study|Lack of Efficacy|0|||
30906908|NCT01959165|58941651|FG000|Overall Study|overdose|0|||
30906909|NCT01959165|58941652|FG001|Overall Study|overdose|0|||
30906910|NCT01959165|58941653|FG002|Overall Study|overdose|0|||
30906911|NCT01959165|58941654|FG003|Overall Study|overdose|1|||
30906912|NCT01959165|58941651|FG000|Overall Study|Welfare recipient|0|||
30906913|NCT01959165|58941652|FG001|Overall Study|Welfare recipient|1|||
30906914|NCT01959165|58941653|FG002|Overall Study|Welfare recipient|0|||
30906915|NCT01959165|58941654|FG003|Overall Study|Welfare recipient|0|||
30906916|NCT01916109|58941664|FG000|Overall Study|Withdrawal by Subject|1|||
30906917|NCT01915095|58941675|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
30906918|NCT01915095|58941676|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
30906919|NCT01915095|58941677|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
30906920|NCT01915095|58941678|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
30906921|NCT01915095|58941679|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
30906922|NCT01958619|58941704|FG000|Overall Study|Protocol Violation|2|||
30906923|NCT01958619|58941705|FG001|Overall Study|Protocol Violation|0|||
30906924|NCT01958619|58941706|FG002|Overall Study|Protocol Violation|1|||
30747758|NCT00048568|58757995|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
30747759|NCT00048568|58757996|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
30906925|NCT01958619|58941707|FG003|Overall Study|Protocol Violation|0|||
30906926|NCT01752634|58941723|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
30906927|NCT01752634|58941724|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
30906928|NCT01752634|58941725|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
30906929|NCT01752634|58941726|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
30906930|NCT01752634|58941727|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
30906931|NCT01752634|58941728|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
30906932|NCT01752634|58941723|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
30906933|NCT01752634|58941724|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
30906934|NCT01752634|58941725|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
30906935|NCT01752634|58941726|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
30906936|NCT01752634|58941727|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
30906937|NCT01752634|58941728|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
30906938|NCT01752634|58941723|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
30906939|NCT01752634|58941724|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
30906940|NCT01752634|58941725|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
30906941|NCT01752634|58941726|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
30906942|NCT01752634|58941727|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
30906943|NCT01752634|58941728|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
30906944|NCT01752634|58941723|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
30906945|NCT01752634|58941724|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
30906946|NCT01752634|58941725|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
30906947|NCT01752634|58941726|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
30906948|NCT01752634|58941727|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
30906949|NCT01752634|58941728|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
30906950|NCT01752634|58941723|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
30906951|NCT01752634|58941724|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
30906952|NCT01752634|58941725|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
30906953|NCT01752634|58941726|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
30906954|NCT01752634|58941727|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
30906955|NCT01752634|58941728|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
30906956|NCT01752634|58941723|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
30906957|NCT01752634|58941724|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
30906958|NCT01752634|58941725|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
30906959|NCT01752634|58941726|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
30906960|NCT01752634|58941727|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
30906961|NCT01752634|58941728|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
30906962|NCT01752634|58941723|FG000|Week 24 to Week 260|Physician Decision|1|||
30906963|NCT01752634|58941724|FG001|Week 24 to Week 260|Physician Decision|2|||
30906964|NCT01752634|58941725|FG002|Week 24 to Week 260|Physician Decision|4|||
30906965|NCT01752634|58941726|FG003|Week 24 to Week 260|Physician Decision|2|||
30906966|NCT01752634|58941727|FG004|Week 24 to Week 260|Physician Decision|1|||
30906967|NCT01752634|58941728|FG005|Week 24 to Week 260|Physician Decision|0|||
30906968|NCT01752634|58941723|FG000|Week 24 to Week 260|Death|0|||
30906969|NCT01752634|58941724|FG001|Week 24 to Week 260|Death|1|||
30906970|NCT01752634|58941725|FG002|Week 24 to Week 260|Death|0|||
30906971|NCT01752634|58941726|FG003|Week 24 to Week 260|Death|0|||
30906972|NCT01752634|58941727|FG004|Week 24 to Week 260|Death|0|||
30906973|NCT01752634|58941728|FG005|Week 24 to Week 260|Death|0|||
30906974|NCT01752634|58941723|FG000|Week 24 to Week 260|Pregnancy|0|||
30906975|NCT01752634|58941724|FG001|Week 24 to Week 260|Pregnancy|0|||
30906976|NCT01752634|58941725|FG002|Week 24 to Week 260|Pregnancy|1|||
30906977|NCT01752634|58941726|FG003|Week 24 to Week 260|Pregnancy|0|||
30906978|NCT01752634|58941727|FG004|Week 24 to Week 260|Pregnancy|0|||
30906979|NCT01752634|58941728|FG005|Week 24 to Week 260|Pregnancy|0|||
30906980|NCT01752634|58941723|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
30906981|NCT01752634|58941724|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
30906982|NCT01752634|58941725|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
30747760|NCT00048568|58757997|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
30747761|NCT00048568|58757995|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
30747762|NCT00048568|58757996|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
30747763|NCT00048568|58757997|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
30747764|NCT00048568|58757995|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
30747765|NCT00048568|58757996|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
30747766|NCT00048568|58757997|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
30747767|NCT00048568|58757995|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
30747768|NCT00048568|58757996|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
30747769|NCT00048568|58757997|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
30747770|NCT00048568|58757995|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
30747771|NCT00048568|58757996|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
30747772|NCT00048568|58757997|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
30747773|NCT00048568|58757995|FG000|Double-Blind Period Days 170 to 365|Death|1|||
30747774|NCT00048568|58757996|FG001|Double-Blind Period Days 170 to 365|Death|1|||
30747775|NCT00048568|58757997|FG002|Double-Blind Period Days 170 to 365|Death|0|||
30747776|NCT00048568|58757995|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
30747777|NCT00048568|58757996|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
30747778|NCT00048568|58757997|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
30747779|NCT00048568|58757995|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
30747780|NCT00048568|58757996|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
30747781|NCT00048568|58757997|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
30747782|NCT00048568|58757995|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
30747783|NCT00048568|58757996|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
30747784|NCT00048568|58757997|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
30747785|NCT00048568|58757995|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
30747786|NCT00048568|58757996|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
30906983|NCT01752634|58941726|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
30906984|NCT01752634|58941727|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
30906985|NCT01752634|58941728|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
30906986|NCT01752634|58941723|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
30906987|NCT01752634|58941724|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
30906988|NCT01752634|58941725|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
30906989|NCT01752634|58941726|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
30906990|NCT01752634|58941727|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
30906991|NCT01752634|58941728|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
30906992|NCT01752634|58941723|FG000|Week 24 to Week 260|Adverse Event|4|||
30906993|NCT01752634|58941724|FG001|Week 24 to Week 260|Adverse Event|8|||
30906994|NCT01752634|58941725|FG002|Week 24 to Week 260|Adverse Event|8|||
30906995|NCT01752634|58941726|FG003|Week 24 to Week 260|Adverse Event|4|||
30906996|NCT01752634|58941727|FG004|Week 24 to Week 260|Adverse Event|2|||
30906997|NCT01752634|58941728|FG005|Week 24 to Week 260|Adverse Event|0|||
30906998|NCT01933113|58941738|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
30906999|NCT01726270|58941742|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
30907000|NCT01726270|58941742|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
30907001|NCT01726270|58941742|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
30907002|NCT01726270|58941742|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
30907003|NCT01726270|58941742|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
30907004|NCT01726270|58941742|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
30907005|NCT00942331|58941750|FG000|Overall Study|Did not start treatment|15|||
30907006|NCT00942331|58941751|FG001|Overall Study|Did not start treatment|22|||
30907007|NCT01914393|58941760|FG000|Overall Study|Protocol Violation|11|||
30907008|NCT01914393|58941761|FG001|Overall Study|Protocol Violation|3|||
30907009|NCT01914393|58941762|FG002|Overall Study|Protocol Violation|19|||
30907010|NCT01914393|58941760|FG000|Overall Study|Lack of Efficacy|11|||
30907011|NCT01914393|58941761|FG001|Overall Study|Lack of Efficacy|16|||
30907012|NCT01914393|58941762|FG002|Overall Study|Lack of Efficacy|5|||
30907013|NCT01914393|58941760|FG000|Overall Study|no reason given|14|||
30907014|NCT01914393|58941761|FG001|Overall Study|no reason given|8|||
30907015|NCT01914393|58941762|FG002|Overall Study|no reason given|16|||
30907016|NCT01914393|58941760|FG000|Overall Study|Adverse Event|29|||
30907017|NCT01914393|58941761|FG001|Overall Study|Adverse Event|18|||
30907018|NCT01914393|58941762|FG002|Overall Study|Adverse Event|31|||
30907019|NCT01914393|58941760|FG000|Overall Study|Withdrawal by Subject|38|||
30907020|NCT01914393|58941761|FG001|Overall Study|Withdrawal by Subject|20|||
30907021|NCT01914393|58941762|FG002|Overall Study|Withdrawal by Subject|47|||
30907022|NCT01914393|58941760|FG000|Overall Study|Lost to Follow-up|12|||
30907023|NCT01914393|58941761|FG001|Overall Study|Lost to Follow-up|6|||
30907024|NCT01914393|58941762|FG002|Overall Study|Lost to Follow-up|19|||
30907025|NCT01914393|58941760|FG000|Overall Study|subject never dosed|0|||
30907026|NCT01914393|58941761|FG001|Overall Study|subject never dosed|0|||
30907027|NCT01914393|58941762|FG002|Overall Study|subject never dosed|1|||
30907028|NCT01931865|58941774|FG000|Overall Study|Lost to Follow-up|2|||
30907029|NCT01931865|58941774|FG000|Overall Study|Withdrawal by Subject|2|||
30907030|NCT01617447|58941781|FG000|Overall Study|Adverse Event|0|||
30907031|NCT01617447|58941782|FG001|Overall Study|Adverse Event|1|||
30907032|NCT01617447|58941781|FG000|Overall Study|Physician Decision|0|||
30907033|NCT01617447|58941782|FG001|Overall Study|Physician Decision|2|||
30907034|NCT00432679|58941790|FG000|Overall Study|Adverse Event|2|||
30747787|NCT00048568|58757997|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
30907035|NCT00432679|58941791|FG001|Overall Study|Adverse Event|1|||
30907036|NCT00432679|58941790|FG000|Overall Study|Withdrawal by Subject|3|||
30907037|NCT00432679|58941791|FG001|Overall Study|Withdrawal by Subject|2|||
30907038|NCT01600105|58941799|FG000|Total Participants|Withdrawal by Subject|1|||
30907039|NCT01600105|58941800|FG001|Total Participants|Withdrawal by Subject|0|||
30907040|NCT01600105|58941799|FG000|Total Participants|No images in PACS|10|||
30907041|NCT01600105|58941800|FG001|Total Participants|No images in PACS|0|||
30907042|NCT01600105|58941799|FG000|Total Participants|Insufficient image quality|30|||
30907043|NCT01600105|58941800|FG001|Total Participants|Insufficient image quality|10|||
30907044|NCT01600105|58941799|FG000|Sub Study I|Insufficient image quality|0|||
30907045|NCT01600105|58941800|FG001|Sub Study I|Insufficient image quality|10|||
30907046|NCT01600105|58941799|FG000|Sub Study II|Withdrawal by Subject|1|||
30907047|NCT01600105|58941800|FG001|Sub Study II|Withdrawal by Subject|0|||
30907048|NCT01600105|58941799|FG000|Sub Study II|No images in PACS|1|||
30907049|NCT01600105|58941800|FG001|Sub Study II|No images in PACS|0|||
30907050|NCT01600105|58941799|FG000|Sub Study II|Insufficient image quality|3|||
30907051|NCT01600105|58941800|FG001|Sub Study II|Insufficient image quality|0|||
30907052|NCT01600105|58941799|FG000|Sub Study III|Insufficient image quality|5|||
30907053|NCT01600105|58941800|FG001|Sub Study III|Insufficient image quality|0|||
30907054|NCT01600105|58941799|FG000|Sub Study V|Poor Image Quality|2|||
30907055|NCT01600105|58941800|FG001|Sub Study V|Poor Image Quality|0|||
30907056|NCT02246647|58941812|FG000|Overall Study|Withdrawal by Subject|1|||
30907057|NCT02246647|58941813|FG001|Overall Study|Withdrawal by Subject|1|||
30907058|NCT02244619|58941835|FG000|Overall Study|Did not receive study intervention|8|||
30907059|NCT02244619|58941836|FG001|Overall Study|Did not receive study intervention|21|||
30907060|NCT02243371|58941844|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
30907061|NCT02243371|58941845|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
30907062|NCT02243371|58941844|FG000|Overall Study|Death (unrelated)|2|||
30907063|NCT02243371|58941845|FG001|Overall Study|Death (unrelated)|4|||
30907064|NCT02243371|58941844|FG000|Overall Study|Adverse Event (unrelated)|0|||
30907065|NCT02243371|58941845|FG001|Overall Study|Adverse Event (unrelated)|1|||
30907066|NCT02243371|58941844|FG000|Overall Study|Lack of Clinical Benefit|0|||
30907067|NCT02243371|58941845|FG001|Overall Study|Lack of Clinical Benefit|1|||
30907068|NCT02243371|58941844|FG000|Overall Study|Withdrawal by Subject|0|||
30907069|NCT02243371|58941845|FG001|Overall Study|Withdrawal by Subject|2|||
30907070|NCT01931475|58941853|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
30907071|NCT01931475|58941854|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
30907072|NCT01931475|58941853|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
30907073|NCT01931475|58941854|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
30907074|NCT01931475|58941853|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
30907075|NCT01931475|58941854|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
30907076|NCT01931475|58941853|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
30907077|NCT01931475|58941854|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
30907078|NCT01931475|58941853|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
30907079|NCT01931475|58941854|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
30907080|NCT01931475|58941853|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
30907081|NCT01931475|58941854|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
30907082|NCT01931475|58941853|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
30907083|NCT01931475|58941854|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
30907084|NCT01931475|58941853|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
30907085|NCT01931475|58941854|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
30907086|NCT01931475|58941853|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
30907087|NCT01931475|58941854|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
30907088|NCT01931475|58941853|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
30907089|NCT01931475|58941854|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
30907090|NCT01931475|58941853|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
30907091|NCT01931475|58941854|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
30907092|NCT01931397|58941865|FG000|Overall Study|Physician Decision|2|||
30907093|NCT01931397|58941865|FG000|Overall Study|Withdrawal by Subject|8|||
30907094|NCT01931397|58941865|FG000|Overall Study|moved out of state|1|||
30907095|NCT01929993|58941875|FG000|Overall Study|Protocol Violation|4|||
30907096|NCT01929993|58941876|FG001|Overall Study|Protocol Violation|6|||
30907097|NCT01929993|58941875|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
30907098|NCT01929993|58941876|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
30907099|NCT01912599|58941884|FG000|Overall Study|Withdrawal by Subject|0|||
30907100|NCT01912599|58941885|FG001|Overall Study|Withdrawal by Subject|1|||
30907101|NCT01929681|58941893|FG000|Overall Study|Withdrawal by Subject|1|||
30907102|NCT01929681|58941894|FG001|Overall Study|Withdrawal by Subject|0|||
30907103|NCT01929681|58941893|FG000|Overall Study|Physician Decision|1|||
30907104|NCT01929681|58941894|FG001|Overall Study|Physician Decision|1|||
30907105|NCT01646177|58941904|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
30747788|NCT00048568|58757995|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
30907106|NCT01646177|58941905|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
30907107|NCT01646177|58941906|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
30907108|NCT01646177|58941907|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
30907109|NCT01646177|58941908|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
30907110|NCT01646177|58941909|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
30907111|NCT01646177|58941910|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
30907112|NCT01646177|58941911|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
30907113|NCT01646177|58941912|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
30907114|NCT01646177|58941913|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
30907115|NCT01646177|58941914|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
30907116|NCT01646177|58941915|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
30907117|NCT01646177|58941904|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
30907118|NCT01646177|58941905|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
30907119|NCT01646177|58941906|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
30907120|NCT01646177|58941907|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
30907121|NCT01646177|58941908|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
30907122|NCT01646177|58941909|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
30907123|NCT01646177|58941910|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
30907124|NCT01646177|58941911|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
30907125|NCT01646177|58941912|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
30907126|NCT01646177|58941913|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
30907127|NCT01646177|58941914|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
30907128|NCT01646177|58941915|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
30907129|NCT01646177|58941904|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
30907130|NCT01646177|58941905|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
30907131|NCT01646177|58941906|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
30907132|NCT01646177|58941907|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
30907133|NCT01646177|58941908|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
30907134|NCT01646177|58941909|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
30907135|NCT01646177|58941910|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
30907136|NCT01646177|58941911|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
30907137|NCT01646177|58941912|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
30907138|NCT01646177|58941913|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
30907139|NCT01646177|58941914|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
30907140|NCT01646177|58941915|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
30907141|NCT01646177|58941904|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
30907142|NCT01646177|58941905|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
30907143|NCT01646177|58941906|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
30907144|NCT01646177|58941907|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
30907145|NCT01646177|58941908|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
30907146|NCT01646177|58941909|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
30907147|NCT01646177|58941910|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
30907148|NCT01646177|58941911|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
30907149|NCT01646177|58941912|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
30907150|NCT01646177|58941913|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
30907151|NCT01646177|58941914|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
30907152|NCT01646177|58941915|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
30907153|NCT01646177|58941904|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
30907154|NCT01646177|58941905|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
30907155|NCT01646177|58941906|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
30907156|NCT01646177|58941907|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
30907157|NCT01646177|58941908|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
30907158|NCT01646177|58941909|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
30843586|NCT02101853|58869613|FG001|Post Induction Randomization|Protocol Violation|3|||
30843587|NCT02101853|58869614|FG002|Post Induction Randomization|Protocol Violation|0|||
30843588|NCT02101853|58869615|FG003|Post Induction Randomization|Protocol Violation|0|||
30843589|NCT02101853|58869616|FG004|Post Induction Randomization|Protocol Violation|0|||
30843590|NCT02101853|58869617|FG005|Post Induction Randomization|Protocol Violation|0|||
30843591|NCT02101853|58869612|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
30843592|NCT02101853|58869613|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
30843593|NCT02101853|58869614|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
30843594|NCT02101853|58869615|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
30843595|NCT02101853|58869616|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
30907159|NCT01646177|58941910|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
30907160|NCT01646177|58941911|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
30907161|NCT01646177|58941912|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
30907162|NCT01646177|58941913|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
30907163|NCT01646177|58941914|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
30907164|NCT01646177|58941915|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
30907165|NCT01646177|58941904|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
30907166|NCT01646177|58941905|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
30907167|NCT01646177|58941906|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
30907168|NCT01646177|58941907|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
30907169|NCT01646177|58941908|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
30907170|NCT01646177|58941909|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
30907171|NCT01646177|58941910|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
30907172|NCT01646177|58941911|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
30907173|NCT01646177|58941912|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
30907174|NCT01646177|58941913|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
30907175|NCT01646177|58941914|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
30907176|NCT01646177|58941915|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
30907177|NCT01646177|58941904|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
30907178|NCT01646177|58941905|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
30907179|NCT01646177|58941906|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
30907180|NCT01646177|58941907|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
30907181|NCT01646177|58941908|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
30907182|NCT01646177|58941909|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
30907183|NCT01646177|58941910|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
30907184|NCT01646177|58941911|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
30907185|NCT01646177|58941912|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
30907186|NCT01646177|58941913|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
30907187|NCT01646177|58941914|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
30907188|NCT01646177|58941915|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
30907189|NCT01646177|58941904|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
30907190|NCT01646177|58941905|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
30907191|NCT01646177|58941906|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
30907192|NCT01646177|58941907|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
30907193|NCT01646177|58941908|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
30907194|NCT01646177|58941909|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
30907195|NCT01646177|58941910|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
30907196|NCT01646177|58941911|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
30907197|NCT01646177|58941912|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
30907198|NCT01646177|58941913|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
30907199|NCT01646177|58941914|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
30907200|NCT01646177|58941915|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
30907201|NCT01646177|58941904|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
30907202|NCT01646177|58941905|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
30907203|NCT01646177|58941906|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
30907204|NCT01646177|58941907|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
30907205|NCT01646177|58941908|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
30907206|NCT01646177|58941909|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
30907207|NCT01646177|58941910|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
30907208|NCT01646177|58941911|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
30907209|NCT01646177|58941912|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
30907210|NCT01646177|58941913|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
30907211|NCT01646177|58941914|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
30907212|NCT01646177|58941915|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
30907213|NCT01646177|58941904|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
30907214|NCT01646177|58941905|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
30907215|NCT01646177|58941906|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
30907216|NCT01646177|58941907|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
30907217|NCT01646177|58941908|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
30907218|NCT01646177|58941909|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
30907219|NCT01646177|58941910|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
30907220|NCT01646177|58941911|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
30907221|NCT01646177|58941912|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
30907222|NCT01646177|58941913|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
30907223|NCT01646177|58941914|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
30907224|NCT01646177|58941915|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
30907225|NCT01646177|58941904|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
30907226|NCT01646177|58941905|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
30907227|NCT01646177|58941906|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
30802632|NCT03168555|58818793|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
30802633|NCT03168555|58818793|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
30802634|NCT03168555|58818793|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
30907228|NCT01646177|58941907|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
30907229|NCT01646177|58941908|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
30907230|NCT01646177|58941909|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
30907231|NCT01646177|58941910|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
30907232|NCT01646177|58941911|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
30907233|NCT01646177|58941912|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
30907234|NCT01646177|58941913|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
30907235|NCT01646177|58941914|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
30907236|NCT01646177|58941915|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
30907237|NCT01646177|58941904|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
30907238|NCT01646177|58941905|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
30907239|NCT01646177|58941906|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
30907240|NCT01646177|58941907|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
30907241|NCT01646177|58941908|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
30907242|NCT01646177|58941909|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
30907243|NCT01646177|58941910|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
30907244|NCT01646177|58941911|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
30907245|NCT01646177|58941912|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
30907246|NCT01646177|58941913|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
30907247|NCT01646177|58941914|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
30907248|NCT01646177|58941915|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
30907249|NCT01646177|58941904|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
30907250|NCT01646177|58941905|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
30907251|NCT01646177|58941906|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
30907252|NCT01646177|58941907|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
30907253|NCT01646177|58941908|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
30907254|NCT01646177|58941909|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
30907255|NCT01646177|58941910|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
30907256|NCT01646177|58941911|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
30907257|NCT01646177|58941912|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
30907258|NCT01646177|58941913|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
30802635|NCT03168555|58818793|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
30907259|NCT01646177|58941914|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
30907260|NCT01646177|58941915|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
30907261|NCT01646177|58941904|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
30907262|NCT01646177|58941905|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
30907263|NCT01646177|58941906|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
30907264|NCT01646177|58941907|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
30907265|NCT01646177|58941908|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
30907266|NCT01646177|58941909|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
30907267|NCT01646177|58941910|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
30907268|NCT01646177|58941911|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
30802636|NCT03235050|58818805|FG000|Overall Study|Adverse Event|0|||
30802637|NCT03235050|58818806|FG001|Overall Study|Adverse Event|0|||
30802638|NCT03235050|58818807|FG002|Overall Study|Adverse Event|1|||
30907269|NCT01646177|58941912|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
30907270|NCT01646177|58941913|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
30907271|NCT01646177|58941914|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
30907272|NCT01646177|58941915|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
30907273|NCT01646177|58941904|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
30907274|NCT01646177|58941905|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
30907275|NCT01646177|58941906|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
30907276|NCT01646177|58941907|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
30907277|NCT01646177|58941908|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
30907278|NCT01646177|58941909|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
30907279|NCT01646177|58941910|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
30907280|NCT01646177|58941911|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
30907281|NCT01646177|58941912|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
30907282|NCT01646177|58941913|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
30907283|NCT01646177|58941914|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
30907284|NCT01646177|58941915|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
30907285|NCT01646177|58941904|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
30907286|NCT01646177|58941905|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
30907287|NCT01646177|58941906|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
30907288|NCT01646177|58941907|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
30907289|NCT01646177|58941908|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
30907290|NCT01646177|58941909|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
30907291|NCT01646177|58941910|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
30907292|NCT01646177|58941911|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
30907293|NCT01646177|58941912|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
30907294|NCT01646177|58941913|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
30907295|NCT01646177|58941914|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
30907296|NCT01646177|58941915|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
30907297|NCT01646177|58941904|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
30907298|NCT01646177|58941905|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
30907299|NCT01646177|58941906|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
30907300|NCT01646177|58941907|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
30907301|NCT01646177|58941908|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
30907302|NCT01646177|58941909|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
30907303|NCT01646177|58941910|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
30907304|NCT01646177|58941911|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
30907305|NCT01646177|58941912|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
30907306|NCT01646177|58941913|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
30907307|NCT01646177|58941914|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
30907308|NCT01646177|58941915|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
30907309|NCT01646177|58941904|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
30907310|NCT01646177|58941905|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
30907311|NCT01646177|58941906|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
30907312|NCT01646177|58941907|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
30907313|NCT01646177|58941908|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
30907314|NCT01646177|58941909|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
30907315|NCT01646177|58941910|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
30907316|NCT01646177|58941911|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
30907317|NCT01646177|58941912|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
30907318|NCT01646177|58941913|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
30907319|NCT01646177|58941914|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
30907320|NCT01646177|58941915|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
30907321|NCT01646177|58941904|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
30907322|NCT01646177|58941905|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
30907323|NCT01646177|58941906|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
30907324|NCT01646177|58941907|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
30907325|NCT01646177|58941908|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
30907326|NCT01646177|58941909|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
30907327|NCT01646177|58941910|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
30907328|NCT01646177|58941911|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
30907329|NCT01646177|58941912|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
30802639|NCT03235050|58818808|FG003|Overall Study|Adverse Event|4|||
30802640|NCT03235050|58818809|FG004|Overall Study|Adverse Event|1|||
30802641|NCT03235050|58818805|FG000|Overall Study|Death|0|||
30802642|NCT03235050|58818806|FG001|Overall Study|Death|0|||
30802643|NCT03235050|58818807|FG002|Overall Study|Death|0|||
30802644|NCT03235050|58818808|FG003|Overall Study|Death|2|||
30802645|NCT03235050|58818809|FG004|Overall Study|Death|1|||
30802646|NCT03235050|58818805|FG000|Overall Study|Lost to Follow-up|1|||
30802647|NCT03235050|58818806|FG001|Overall Study|Lost to Follow-up|2|||
30802648|NCT03235050|58818807|FG002|Overall Study|Lost to Follow-up|1|||
30802649|NCT03235050|58818808|FG003|Overall Study|Lost to Follow-up|2|||
30802650|NCT03235050|58818809|FG004|Overall Study|Lost to Follow-up|0|||
30802651|NCT03235050|58818805|FG000|Overall Study|Withdrawal by Subject|3|||
30802652|NCT03235050|58818806|FG001|Overall Study|Withdrawal by Subject|2|||
30802653|NCT03235050|58818807|FG002|Overall Study|Withdrawal by Subject|2|||
30802654|NCT03235050|58818808|FG003|Overall Study|Withdrawal by Subject|5|||
30802655|NCT03235050|58818809|FG004|Overall Study|Withdrawal by Subject|7|||
30802656|NCT03235050|58818805|FG000|Overall Study|Other reasons|0|||
30802657|NCT03235050|58818806|FG001|Overall Study|Other reasons|1|||
30802658|NCT03235050|58818807|FG002|Overall Study|Other reasons|0|||
30802659|NCT03235050|58818808|FG003|Overall Study|Other reasons|1|||
30802660|NCT03235050|58818809|FG004|Overall Study|Other reasons|2|||
30802661|NCT04502212|58818838|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
30802662|NCT04502212|58818838|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
30802663|NCT03167619|58818845|FG000|Overall Study|Death|11|||
30802664|NCT03167619|58818846|FG001|Overall Study|Death|8|||
30802665|NCT03167619|58818845|FG000|Overall Study|Withdrawal by Subject|1|||
30802666|NCT03167619|58818846|FG001|Overall Study|Withdrawal by Subject|2|||
30802667|NCT03167619|58818845|FG000|Overall Study|Physician Decision|0|||
30802668|NCT03167619|58818846|FG001|Overall Study|Physician Decision|1|||
30802669|NCT03578809|58818856|FG000|Overall Study|Death|0|||
30802670|NCT03578809|58818857|FG001|Overall Study|Death|2|||
30802671|NCT03578809|58818858|FG002|Overall Study|Death|0|||
30802672|NCT03578809|58818859|FG003|Overall Study|Death|1|||
30802673|NCT03578809|58818856|FG000|Overall Study|Lost to Follow-up|0|||
30802674|NCT03578809|58818857|FG001|Overall Study|Lost to Follow-up|1|||
30802675|NCT03578809|58818858|FG002|Overall Study|Lost to Follow-up|0|||
30802676|NCT03578809|58818859|FG003|Overall Study|Lost to Follow-up|0|||
30802677|NCT03578809|58818856|FG000|Overall Study|Withdrawal by Subject|3|||
30802678|NCT03578809|58818857|FG001|Overall Study|Withdrawal by Subject|5|||
30802679|NCT03578809|58818858|FG002|Overall Study|Withdrawal by Subject|2|||
30802680|NCT03578809|58818859|FG003|Overall Study|Withdrawal by Subject|0|||
30802681|NCT03578809|58818856|FG000|Overall Study|Other|3|||
30802682|NCT03578809|58818857|FG001|Overall Study|Other|6|||
30802683|NCT03578809|58818858|FG002|Overall Study|Other|2|||
30802684|NCT03578809|58818859|FG003|Overall Study|Other|8|||
30802685|NCT03198507|58818874|FG000|Overall Study|Withdrawal by Subject|1|||
30802686|NCT03198507|58818875|FG001|Overall Study|Withdrawal by Subject|0|||
30802687|NCT03610165|58818883|FG000|Overall Study|Device didn't work|0|||
30802688|NCT03610165|58818884|FG001|Overall Study|Device didn't work|1|||
30802689|NCT03609619|58818892|FG000|Overall Study|Adverse Event|1|||
30802690|NCT03609619|58818893|FG001|Overall Study|Adverse Event|0|||
30802691|NCT03609619|58818892|FG000|Overall Study|Lack of Efficacy|1|||
30802692|NCT03609619|58818893|FG001|Overall Study|Lack of Efficacy|2|||
30802693|NCT03609619|58818892|FG000|Overall Study|Protocol Violation|5|||
30802694|NCT03609619|58818893|FG001|Overall Study|Protocol Violation|0|||
30802695|NCT03609619|58818892|FG000|Overall Study|Withdrawal by Subject|2|||
30802696|NCT03609619|58818893|FG001|Overall Study|Withdrawal by Subject|3|||
30802697|NCT03609619|58818892|FG000|Overall Study|Lost to Follow-up|1|||
30802698|NCT03609619|58818893|FG001|Overall Study|Lost to Follow-up|1|||
30802699|NCT03167151|58818902|FG000|Overall Study|Withdrawal by Subject|1|||
30802700|NCT03167151|58818903|FG001|Overall Study|Withdrawal by Subject|0|||
30802701|NCT03167151|58818904|FG002|Overall Study|Withdrawal by Subject|0|||
30802702|NCT03167151|58818902|FG000|Overall Study|No evidence of tumour at surgery|0|||
30802703|NCT03167151|58818903|FG001|Overall Study|No evidence of tumour at surgery|1|||
30802704|NCT03167151|58818904|FG002|Overall Study|No evidence of tumour at surgery|1|||
30802705|NCT03660943|58818914|FG000|Overall Study|Adverse Event|5|||
30802706|NCT03660943|58818915|FG001|Overall Study|Adverse Event|3|||
30802707|NCT03660943|58818914|FG000|Overall Study|Death|0|||
30802708|NCT03660943|58818915|FG001|Overall Study|Death|2|||
30802709|NCT03660943|58818914|FG000|Overall Study|Lost to Follow-up|7|||
30802710|NCT03660943|58818915|FG001|Overall Study|Lost to Follow-up|3|||
30802711|NCT03660943|58818914|FG000|Overall Study|Protocol Violation|3|||
30802712|NCT03660943|58818915|FG001|Overall Study|Protocol Violation|5|||
30802713|NCT03660943|58818914|FG000|Overall Study|Withdrawal by Subject|8|||
30802714|NCT03660943|58818915|FG001|Overall Study|Withdrawal by Subject|15|||
30802715|NCT03660943|58818914|FG000|Overall Study|Lack of Efficacy|9|||
30907330|NCT01646177|58941913|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
30907331|NCT01646177|58941914|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
30907332|NCT01646177|58941915|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
30907333|NCT01646177|58941904|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
30907334|NCT01646177|58941905|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
30907335|NCT01646177|58941906|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
30907336|NCT01646177|58941907|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
30907337|NCT01646177|58941908|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
30907338|NCT01646177|58941909|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
30907339|NCT01646177|58941910|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
30907340|NCT01646177|58941911|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
30907341|NCT01646177|58941912|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
30907342|NCT01646177|58941913|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
30907343|NCT01646177|58941914|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
30907344|NCT01646177|58941915|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
30907345|NCT01646177|58941904|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
30907346|NCT01646177|58941905|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
30907347|NCT01646177|58941906|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
30802716|NCT03660943|58818915|FG001|Overall Study|Lack of Efficacy|12|||
30802717|NCT03660943|58818914|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
30802718|NCT03660943|58818915|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
30802719|NCT03167073|58818923|FG000|Overall Study|Stillbirth|1|||
30802720|NCT03167073|58818924|FG001|Overall Study|Stillbirth|0|||
30802721|NCT03657277|58818930|FG000|Overall Study|Physician Decision|2|||
30802722|NCT03657277|58818930|FG000|Overall Study|Lost to Follow-up|1|||
30802723|NCT03657277|58818930|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
30802724|NCT03197883|58818936|FG000|Overall Study|Adverse Event|1|||
30802725|NCT03197883|58818937|FG001|Overall Study|Adverse Event|1|||
30802726|NCT03197883|58818936|FG000|Overall Study|Lost to Follow-up|1|||
30802727|NCT03197883|58818937|FG001|Overall Study|Lost to Follow-up|0|||
30802728|NCT03197883|58818936|FG000|Overall Study|Protocol Violation|1|||
30802729|NCT03197883|58818937|FG001|Overall Study|Protocol Violation|0|||
30802730|NCT03197883|58818936|FG000|Overall Study|Other (Not Specified)|0|||
30802731|NCT03197883|58818937|FG001|Overall Study|Other (Not Specified)|5|||
30802732|NCT03234036|58818946|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
30802733|NCT03234036|58818947|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
30802734|NCT03234036|58818948|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
30802735|NCT03234036|58818949|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
30802736|NCT03606109|58818967|FG000|Overall Study|Lost to Follow-up|2|||
30802737|NCT03606109|58818968|FG001|Overall Study|Lost to Follow-up|1|||
30802738|NCT03768336|58818974|FG000|Overall Study|Lost to Follow-up|3|||
30802739|NCT03768336|58818975|FG001|Overall Study|Lost to Follow-up|2|||
30802740|NCT03768336|58818974|FG000|Overall Study|Became Ineligible|2|||
30802741|NCT03768336|58818975|FG001|Overall Study|Became Ineligible|0|||
30802742|NCT03768336|58818974|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
30802743|NCT03768336|58818975|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
30802744|NCT03768336|58818974|FG000|Overall Study|Missed final survey (post-treatment|0|||
30802745|NCT03768336|58818975|FG001|Overall Study|Missed final survey (post-treatment|1|||
30802746|NCT02729896|58818985|FG000|Overall Study|Death|0|||
30802747|NCT02729896|58818986|FG001|Overall Study|Death|2|||
30802748|NCT02729896|58818987|FG002|Overall Study|Death|13|||
30802749|NCT02729896|58818985|FG000|Overall Study|Lost to Follow-up|0|||
30802750|NCT02729896|58818986|FG001|Overall Study|Lost to Follow-up|2|||
30802751|NCT02729896|58818987|FG002|Overall Study|Lost to Follow-up|3|||
30802752|NCT02729896|58818985|FG000|Overall Study|Other|0|||
30802753|NCT02729896|58818986|FG001|Overall Study|Other|2|||
30802754|NCT02729896|58818987|FG002|Overall Study|Other|0|||
30802755|NCT02729896|58818985|FG000|Overall Study|Physician Decision|1|||
30802756|NCT02729896|58818986|FG001|Overall Study|Physician Decision|2|||
30802757|NCT02729896|58818987|FG002|Overall Study|Physician Decision|3|||
30802758|NCT02729896|58818985|FG000|Overall Study|Progressive Disease|0|||
30802759|NCT02729896|58818986|FG001|Overall Study|Progressive Disease|1|||
30802760|NCT02729896|58818987|FG002|Overall Study|Progressive Disease|0|||
30802761|NCT02729896|58818985|FG000|Overall Study|Withdrawal by Subject|1|||
30802762|NCT02729896|58818986|FG001|Overall Study|Withdrawal by Subject|0|||
30802763|NCT02729896|58818987|FG002|Overall Study|Withdrawal by Subject|3|||
30802764|NCT03575065|58818998|FG000|Overall Study|Death|31|||
30802765|NCT03575065|58818999|FG001|Overall Study|Death|12|||
30802766|NCT03575065|58818998|FG000|Overall Study|Sponsor's Decision|28|||
30802767|NCT03575065|58818999|FG001|Overall Study|Sponsor's Decision|13|||
30802768|NCT03575065|58818998|FG000|Overall Study|Withdrawal by Subject|2|||
30802769|NCT03575065|58818999|FG001|Overall Study|Withdrawal by Subject|1|||
30802770|NCT03575065|58818998|FG000|Overall Study|Lost to Follow-up|1|||
30802771|NCT03575065|58818999|FG001|Overall Study|Lost to Follow-up|0|||
30802772|NCT03514134|58819008|FG000|Overall Study|Lost to Follow-up|0|||
30802773|NCT03514134|58819009|FG001|Overall Study|Lost to Follow-up|1|||
30802774|NCT03188718|58819015|FG000|Overall Study|Participant noncompliance|4|||
30802775|NCT03188718|58819015|FG000|Overall Study|Withdrawal by Subject|1|||
30802776|NCT03188718|58819015|FG000|Overall Study|Device failure|3|||
30802777|NCT03574753|58819019|FG000|Overall Study|Adverse Event|3|||
30802778|NCT03574753|58819019|FG000|Overall Study|Progression/relapse|19|||
30802779|NCT03574753|58819019|FG000|Overall Study|Death|1|||
30802780|NCT03573505|58819026|FG000|Overall Study|Adverse Event|1|||
30802781|NCT03573505|58819027|FG001|Overall Study|Adverse Event|1|||
30802782|NCT03573505|58819026|FG000|Overall Study|Consent withdrawn|0|||
30747789|NCT00048568|58757996|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
30747790|NCT00048568|58757997|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
30747791|NCT00048568|58757995|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
30747792|NCT00048568|58757996|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
30747793|NCT00048568|58757997|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
30747794|NCT00048568|58757995|FG000|Open-Label Period|Death|0|||
30747795|NCT00048568|58757996|FG001|Open-Label Period|Death|0|||
30747796|NCT00048568|58757997|FG002|Open-Label Period|Death|13|||
30747797|NCT00048568|58757995|FG000|Open-Label Period|Adverse Event|0|||
30747798|NCT00048568|58757996|FG001|Open-Label Period|Adverse Event|0|||
30747799|NCT00048568|58757997|FG002|Open-Label Period|Adverse Event|49|||
30747800|NCT00048568|58757995|FG000|Open-Label Period|Lack of Efficacy|0|||
30747801|NCT00048568|58757996|FG001|Open-Label Period|Lack of Efficacy|0|||
30747802|NCT00048568|58757997|FG002|Open-Label Period|Lack of Efficacy|32|||
30802783|NCT03573505|58819027|FG001|Overall Study|Consent withdrawn|1|||
30802784|NCT03573505|58819026|FG000|Overall Study|Disease progression|0|||
30802785|NCT03573505|58819027|FG001|Overall Study|Disease progression|1|||
30802786|NCT03573505|58819026|FG000|Overall Study|Site Terminated by Sponsor|1|||
30802787|NCT03573505|58819027|FG001|Overall Study|Site Terminated by Sponsor|1|||
30802788|NCT03573505|58819026|FG000|Overall Study|Study terminated by sponsor|50|||
30802789|NCT03573505|58819027|FG001|Overall Study|Study terminated by sponsor|45|||
30747803|NCT00048568|58757995|FG000|Open-Label Period|Withdrawal by Subject|0|||
30747804|NCT00048568|58757996|FG001|Open-Label Period|Withdrawal by Subject|0|||
30747805|NCT00048568|58757997|FG002|Open-Label Period|Withdrawal by Subject|26|||
30802790|NCT03573505|58819026|FG000|Overall Study|Reason not specified|0|||
30802791|NCT03573505|58819027|FG001|Overall Study|Reason not specified|1|||
30802792|NCT03573505|58819026|FG000|Overall Study|Death|0|||
30802793|NCT03573505|58819027|FG001|Overall Study|Death|4|||
30802794|NCT01376908|58819036|FG000|Overall Study|Protocol Violation|1|||
30802795|NCT01376908|58819037|FG001|Overall Study|Protocol Violation|1|||
30802796|NCT01376908|58819036|FG000|Overall Study|Withdrawal by Subject|1|||
30802797|NCT01376908|58819037|FG001|Overall Study|Withdrawal by Subject|2|||
30802798|NCT02668653|58819052|FG000|Overall Study|Refractory disease|41|||
30802799|NCT02668653|58819053|FG001|Overall Study|Refractory disease|70|||
30802800|NCT02668653|58819052|FG000|Overall Study|Relapse|44|||
30802801|NCT02668653|58819053|FG001|Overall Study|Relapse|65|||
30802802|NCT02668653|58819052|FG000|Overall Study|Adverse Event|58|||
30802803|NCT02668653|58819053|FG001|Overall Study|Adverse Event|23|||
30802804|NCT02668653|58819052|FG000|Overall Study|Subject decision to stop study drug|25|||
30802805|NCT02668653|58819053|FG001|Overall Study|Subject decision to stop study drug|23|||
30802806|NCT02668653|58819052|FG000|Overall Study|Other reasons not specified|16|||
30802807|NCT02668653|58819053|FG001|Overall Study|Other reasons not specified|11|||
30802808|NCT02668653|58819052|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
30802809|NCT02668653|58819053|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
30802810|NCT02668653|58819052|FG000|Overall Study|Investigator decision|10|||
30802811|NCT02668653|58819053|FG001|Overall Study|Investigator decision|7|||
30802812|NCT02668653|58819052|FG000|Overall Study|Failure to meet continuation criteria|5|||
30802813|NCT02668653|58819053|FG001|Overall Study|Failure to meet continuation criteria|12|||
30802814|NCT02668653|58819052|FG000|Overall Study|Lost to Follow-up|1|||
30802815|NCT02668653|58819053|FG001|Overall Study|Lost to Follow-up|0|||
30802816|NCT02668653|58819052|FG000|Overall Study|Pregnancy|0|||
30802817|NCT02668653|58819053|FG001|Overall Study|Pregnancy|1|||
30802818|NCT02668653|58819052|FG000|Overall Study|Death|0|||
30802819|NCT02668653|58819053|FG001|Overall Study|Death|1|||
30802820|NCT03736031|58819061|FG000|Overall Study|Death|2|||
30802821|NCT03736031|58819062|FG001|Overall Study|Death|4|||
30802822|NCT03736031|58819061|FG000|Overall Study|Lost to Follow-up|21|||
30802823|NCT03736031|58819062|FG001|Overall Study|Lost to Follow-up|2|||
30802824|NCT03736031|58819061|FG000|Overall Study|Withdrawal by Subject|9|||
30802825|NCT03736031|58819062|FG001|Overall Study|Withdrawal by Subject|0|||
30802826|NCT03555565|58819068|FG000|Overall Study|Case Report Forms Uncollected|2|||
30802827|NCT03555565|58819068|FG000|Overall Study|Protocol Deviation|13|||
30802828|NCT03602053|58819075|FG000|Overall Study|Withdrawal by Subject|7|||
30802829|NCT03602053|58819076|FG001|Overall Study|Withdrawal by Subject|9|||
30802830|NCT03602053|58819077|FG002|Overall Study|Withdrawal by Subject|7|||
30802831|NCT03602053|58819075|FG000|Overall Study|Lost to Follow-up|5|||
30802832|NCT03602053|58819076|FG001|Overall Study|Lost to Follow-up|6|||
30747806|NCT00048568|58757995|FG000|Open-Label Period|Pregnancy|0|||
30747807|NCT00048568|58757996|FG001|Open-Label Period|Pregnancy|0|||
30747808|NCT00048568|58757997|FG002|Open-Label Period|Pregnancy|5|||
30747809|NCT00048568|58757995|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
30747810|NCT00048568|58757996|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
30747811|NCT00048568|58757997|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
30747812|NCT00048568|58757995|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
30802833|NCT03602053|58819077|FG002|Overall Study|Lost to Follow-up|0|||
30802834|NCT03602053|58819075|FG000|Overall Study|Protocol Violation|3|||
30802835|NCT03602053|58819076|FG001|Overall Study|Protocol Violation|0|||
30802836|NCT03602053|58819077|FG002|Overall Study|Protocol Violation|4|||
30802837|NCT03602053|58819075|FG000|Overall Study|Physician Decision|1|||
30802838|NCT03602053|58819076|FG001|Overall Study|Physician Decision|0|||
30747813|NCT00048568|58757996|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
30802839|NCT03602053|58819077|FG002|Overall Study|Physician Decision|0|||
30802840|NCT03602053|58819075|FG000|Overall Study|migration|2|||
30802841|NCT03602053|58819076|FG001|Overall Study|migration|3|||
30802842|NCT03602053|58819077|FG002|Overall Study|migration|0|||
30802843|NCT03602053|58819075|FG000|Overall Study|Other|1|||
30802844|NCT03602053|58819076|FG001|Overall Study|Other|0|||
30802845|NCT03602053|58819077|FG002|Overall Study|Other|0|||
30802846|NCT04831515|58819089|FG000|First Intervention|Adverse Event|0|||
30802847|NCT04831515|58819090|FG001|First Intervention|Adverse Event|1|||
30802848|NCT03554629|58819096|FG000|Overall Study|Inadequate data|6|||
30802849|NCT03196791|58819126|FG000|Overall Study|Protocol Violation|7|||
30802850|NCT03196791|58819127|FG001|Overall Study|Protocol Violation|3|||
30802851|NCT03196791|58819126|FG000|Overall Study|Withdrawal by Subject|3|||
30802852|NCT03196791|58819127|FG001|Overall Study|Withdrawal by Subject|2|||
30802853|NCT03196635|58819133|FG000|Overall Study|Withdrawal by Subject|1|||
30802854|NCT03194217|58819155|FG000|Overall Study|Adverse Event|0|||
30802855|NCT03194217|58819156|FG001|Overall Study|Adverse Event|2|||
30802856|NCT03194217|58819157|FG002|Overall Study|Adverse Event|3|||
30802857|NCT03194217|58819158|FG003|Overall Study|Adverse Event|3|||
30802858|NCT03194217|58819155|FG000|Overall Study|Failure to meet randomisation criteria|0|||
30802859|NCT03194217|58819156|FG001|Overall Study|Failure to meet randomisation criteria|0|||
30802860|NCT03194217|58819157|FG002|Overall Study|Failure to meet randomisation criteria|0|||
30802861|NCT03194217|58819158|FG003|Overall Study|Failure to meet randomisation criteria|1|||
30802862|NCT03194217|58819155|FG000|Overall Study|Other|0|||
30802863|NCT03194217|58819156|FG001|Overall Study|Other|1|||
30802864|NCT03194217|58819157|FG002|Overall Study|Other|1|||
30802865|NCT03194217|58819158|FG003|Overall Study|Other|0|||
30802866|NCT00709618|58819168|FG000|Overall Study|Withdrawal by Subject|4|||
30802867|NCT00709618|58819168|FG000|Overall Study|Lost to Follow-up|1|||
30802868|NCT00709618|58819168|FG000|Overall Study|Study Closed/Terminated|25|||
30802869|NCT03193047|58819174|FG000|Overall Study|Physician Decision|1|||
30802870|NCT03193047|58819175|FG001|Overall Study|Physician Decision|0|||
30802871|NCT03193047|58819174|FG000|Overall Study|Participant Left State|1|||
30802872|NCT03193047|58819175|FG001|Overall Study|Participant Left State|0|||
30802873|NCT02918019|58819187|FG000|Overall Study|Death|0|||
30802874|NCT02918019|58819188|FG001|Overall Study|Death|0|||
30802875|NCT02918019|58819189|FG002|Overall Study|Death|1|||
30802876|NCT02918019|58819190|FG003|Overall Study|Death|0|||
30802877|NCT02918019|58819187|FG000|Overall Study|Lost to Follow-up|1|||
30802878|NCT02918019|58819188|FG001|Overall Study|Lost to Follow-up|1|||
30802879|NCT02918019|58819189|FG002|Overall Study|Lost to Follow-up|0|||
30802880|NCT02918019|58819190|FG003|Overall Study|Lost to Follow-up|1|||
30802881|NCT02918019|58819187|FG000|Overall Study|Principal investigator request|0|||
30802882|NCT02918019|58819188|FG001|Overall Study|Principal investigator request|0|||
30802883|NCT02918019|58819189|FG002|Overall Study|Principal investigator request|0|||
30802884|NCT02918019|58819190|FG003|Overall Study|Principal investigator request|1|||
30802885|NCT02918019|58819187|FG000|Overall Study|Physician Decision|1|||
30802886|NCT02918019|58819188|FG001|Overall Study|Physician Decision|3|||
30802887|NCT02918019|58819189|FG002|Overall Study|Physician Decision|2|||
30802888|NCT02918019|58819190|FG003|Overall Study|Physician Decision|0|||
30802889|NCT02918019|58819187|FG000|Overall Study|Protocol deviation|1|||
30802890|NCT02918019|58819188|FG001|Overall Study|Protocol deviation|1|||
30802891|NCT02918019|58819189|FG002|Overall Study|Protocol deviation|0|||
30802892|NCT02918019|58819190|FG003|Overall Study|Protocol deviation|2|||
30802893|NCT02918019|58819187|FG000|Overall Study|Withdrawal by Subject|3|||
30802894|NCT02918019|58819188|FG001|Overall Study|Withdrawal by Subject|4|||
30802895|NCT02918019|58819189|FG002|Overall Study|Withdrawal by Subject|6|||
30802896|NCT02918019|58819190|FG003|Overall Study|Withdrawal by Subject|4|||
30802897|NCT02918019|58819187|FG000|Overall Study|Adverse Event|0|||
30802898|NCT02918019|58819188|FG001|Overall Study|Adverse Event|1|||
30802899|NCT02918019|58819189|FG002|Overall Study|Adverse Event|0|||
30907348|NCT01646177|58941907|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
30802900|NCT02918019|58819190|FG003|Overall Study|Adverse Event|1|||
30802901|NCT03055988|58819208|FG000|Period 1|Adverse Event|0|||
30802902|NCT03055988|58819209|FG001|Period 1|Adverse Event|1|||
30802903|NCT03055988|58819208|FG000|Period 1|Lost to Follow-up|1|||
30802904|NCT03055988|58819209|FG001|Period 1|Lost to Follow-up|0|||
30802905|NCT03055988|58819208|FG000|Period 1|Withdrawal by Subject|0|||
30802906|NCT03055988|58819209|FG001|Period 1|Withdrawal by Subject|4|||
30802907|NCT03055988|58819208|FG000|Period 2|Adverse Event|0|||
30802908|NCT03055988|58819209|FG001|Period 2|Adverse Event|1|||
30802909|NCT03055988|58819208|FG000|Period 2|Other than listed|1|||
30802910|NCT03055988|58819209|FG001|Period 2|Other than listed|1|||
30802911|NCT01250912|58819215|FG000|Overall Study|Lost to Follow-up|1|||
30802912|NCT03733301|58819225|FG000|Overall Study|Screen Fail|1|||
30802913|NCT03733301|58819226|FG001|Overall Study|Screen Fail|0|||
30802914|NCT03733301|58819227|FG002|Overall Study|Screen Fail|0|||
30802915|NCT03733301|58819225|FG000|Overall Study|Non-compliance|1|||
30802916|NCT03733301|58819226|FG001|Overall Study|Non-compliance|0|||
30802917|NCT03733301|58819227|FG002|Overall Study|Non-compliance|0|||
30907349|NCT01646177|58941908|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
30907350|NCT01646177|58941909|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
30907351|NCT01646177|58941910|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
30907352|NCT01646177|58941911|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
30907353|NCT01646177|58941912|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
30907354|NCT01646177|58941913|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
30907355|NCT01646177|58941914|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
30907356|NCT01646177|58941915|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
30907357|NCT01646177|58941904|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
30907358|NCT01646177|58941905|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
30907359|NCT01646177|58941906|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
30907360|NCT01646177|58941907|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
30907361|NCT01646177|58941908|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
30907362|NCT01646177|58941909|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
30907363|NCT01646177|58941910|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
30907364|NCT01646177|58941911|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
30907365|NCT01646177|58941912|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
30907366|NCT01646177|58941913|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
30907367|NCT01646177|58941914|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
30907368|NCT01646177|58941915|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
30907369|NCT01646177|58941904|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
30907370|NCT01646177|58941905|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
30907371|NCT01646177|58941906|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
30907372|NCT01646177|58941907|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
30907373|NCT01646177|58941908|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
30907374|NCT01646177|58941909|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
30907375|NCT01646177|58941910|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
30907376|NCT01646177|58941911|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
30907377|NCT01646177|58941912|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
30907378|NCT01646177|58941913|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
30907379|NCT01646177|58941914|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
30907380|NCT01646177|58941915|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
30907381|NCT01646177|58941904|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
30907382|NCT01646177|58941905|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
30802918|NCT03733301|58819225|FG000|Overall Study|Lack of Efficacy|2|||
30802919|NCT03733301|58819226|FG001|Overall Study|Lack of Efficacy|3|||
30802920|NCT03733301|58819227|FG002|Overall Study|Lack of Efficacy|0|||
30802921|NCT03733301|58819225|FG000|Overall Study|Adverse Event|0|||
30802922|NCT03733301|58819226|FG001|Overall Study|Adverse Event|1|||
30802923|NCT03733301|58819227|FG002|Overall Study|Adverse Event|3|||
30802924|NCT03733301|58819225|FG000|Overall Study|Withdrawal by Subject|3|||
30802925|NCT03733301|58819226|FG001|Overall Study|Withdrawal by Subject|5|||
30907383|NCT01646177|58941906|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
30907384|NCT01646177|58941907|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
30907385|NCT01646177|58941908|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
30907386|NCT01646177|58941909|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
30907387|NCT01646177|58941910|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
30907388|NCT01646177|58941911|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
30907389|NCT01646177|58941912|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
30907390|NCT01646177|58941913|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
30907391|NCT01646177|58941914|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
30907392|NCT01646177|58941915|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
30907393|NCT01646177|58941904|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
30907394|NCT01646177|58941905|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
30907395|NCT01646177|58941906|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
30907396|NCT01646177|58941907|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
30907397|NCT01646177|58941908|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
30907398|NCT01646177|58941909|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
30907399|NCT01646177|58941910|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
30907400|NCT01646177|58941911|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
30907401|NCT01646177|58941912|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
30907402|NCT01646177|58941913|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
30907403|NCT01646177|58941914|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
30907404|NCT01646177|58941915|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
30907405|NCT01646177|58941904|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
30907406|NCT01646177|58941905|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
30907407|NCT01646177|58941906|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
30907408|NCT01646177|58941907|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
30907409|NCT01646177|58941908|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
30907410|NCT01646177|58941909|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
30907411|NCT01646177|58941910|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
30907412|NCT01646177|58941911|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
30907413|NCT01646177|58941912|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
30907414|NCT01646177|58941913|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
30907415|NCT01646177|58941914|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
30907416|NCT01646177|58941915|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
30907417|NCT01646177|58941904|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
30907418|NCT01646177|58941905|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
30907419|NCT01646177|58941906|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
30907420|NCT01646177|58941907|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
30907421|NCT01646177|58941908|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
30907422|NCT01646177|58941909|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
30907423|NCT01646177|58941910|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
30907424|NCT01646177|58941911|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
30802926|NCT03733301|58819227|FG002|Overall Study|Withdrawal by Subject|1|||
30802927|NCT02871297|58819236|FG000|Overall Study|Adverse Event|34|||
30802928|NCT02871297|58819236|FG000|Overall Study|Lack of Efficacy|10|||
30802929|NCT02871297|58819236|FG000|Overall Study|Non-compliance with study drug|15|||
30802930|NCT02871297|58819236|FG000|Overall Study|Protocol Violation|3|||
30802931|NCT02871297|58819236|FG000|Overall Study|Withdrawal by Subject|20|||
30802932|NCT02871297|58819236|FG000|Overall Study|Lost to Follow-up|13|||
30802933|NCT02871297|58819236|FG000|Overall Study|Rolled over to 13546A|2|||
30802934|NCT02871297|58819236|FG000|Overall Study|Other than specified|39|||
30802935|NCT03554005|58819246|FG000|Overall Study|Not in participant's best interest|0|||
30802936|NCT03554005|58819247|FG001|Overall Study|Not in participant's best interest|0|||
30802937|NCT03554005|58819248|FG002|Overall Study|Not in participant's best interest|0|||
30802938|NCT03554005|58819249|FG003|Overall Study|Not in participant's best interest|0|||
30802939|NCT03554005|58819250|FG004|Overall Study|Not in participant's best interest|0|||
30802940|NCT03554005|58819251|FG005|Overall Study|Not in participant's best interest|1|||
30802941|NCT03554005|58819246|FG000|Overall Study|Disease Progression|1|||
30802942|NCT03554005|58819247|FG001|Overall Study|Disease Progression|1|||
30802943|NCT03554005|58819248|FG002|Overall Study|Disease Progression|1|||
30802944|NCT03554005|58819249|FG003|Overall Study|Disease Progression|1|||
30802945|NCT03554005|58819250|FG004|Overall Study|Disease Progression|5|||
30802946|NCT03554005|58819251|FG005|Overall Study|Disease Progression|6|||
30802947|NCT03554005|58819246|FG000|Overall Study|Adverse Event|0|||
30802948|NCT03554005|58819247|FG001|Overall Study|Adverse Event|0|||
30802949|NCT03554005|58819248|FG002|Overall Study|Adverse Event|0|||
30802950|NCT03554005|58819249|FG003|Overall Study|Adverse Event|0|||
30802951|NCT03554005|58819250|FG004|Overall Study|Adverse Event|0|||
30802952|NCT03554005|58819251|FG005|Overall Study|Adverse Event|3|||
30802953|NCT03554005|58819246|FG000|Overall Study|Physician Decision|0|||
30802954|NCT03554005|58819247|FG001|Overall Study|Physician Decision|0|||
30802955|NCT03554005|58819248|FG002|Overall Study|Physician Decision|0|||
30802956|NCT03554005|58819249|FG003|Overall Study|Physician Decision|0|||
30802957|NCT03554005|58819250|FG004|Overall Study|Physician Decision|1|||
30802958|NCT03554005|58819251|FG005|Overall Study|Physician Decision|0|||
30802959|NCT03554005|58819246|FG000|Overall Study|Other|0|||
30802960|NCT03554005|58819247|FG001|Overall Study|Other|0|||
30802961|NCT03554005|58819248|FG002|Overall Study|Other|0|||
30802962|NCT03554005|58819249|FG003|Overall Study|Other|0|||
30802963|NCT03554005|58819250|FG004|Overall Study|Other|0|||
30802964|NCT03554005|58819251|FG005|Overall Study|Other|1|||
30802965|NCT00709228|58819265|FG000|Overall Study|Not treated|14|||
30802966|NCT00709228|58819265|FG000|Overall Study|Eligibility criteria not met|281|||
30802967|NCT00709228|58819265|FG000|Overall Study|Adverse events|2|||
30802968|NCT00709228|58819265|FG000|Overall Study|Discontinued treatment|14|||
30802969|NCT00709228|58819265|FG000|Overall Study|Did not enter follow-up|4|||
30907425|NCT01646177|58941912|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
30802970|NCT00709228|58819265|FG000|Overall Study|Discontinued follow-up|5|||
30802971|NCT00709228|58819265|FG000|Overall Study|Disease progression|1|||
30802972|NCT00709228|58819265|FG000|Overall Study|Lost to Follow-up|6|||
30802973|NCT00709228|58819265|FG000|Overall Study|Non-compliance|5|||
30802974|NCT03219372|58819271|FG000|Overall Study|Withdrawal by Subject|1|||
30802975|NCT03219372|58819272|FG001|Overall Study|Withdrawal by Subject|0|||
30802976|NCT03056690|58819287|FG000|Overall Study|Adverse Event|3|||
30802977|NCT03056690|58819288|FG001|Overall Study|Adverse Event|2|||
30802978|NCT03056690|58819287|FG000|Overall Study|Lack of Efficacy|1|||
30802979|NCT03056690|58819288|FG001|Overall Study|Lack of Efficacy|2|||
30802980|NCT03056690|58819287|FG000|Overall Study|Lost to Follow-up|3|||
30802981|NCT03056690|58819288|FG001|Overall Study|Lost to Follow-up|2|||
30802982|NCT03056690|58819287|FG000|Overall Study|Protocol Violation|2|||
30802983|NCT03056690|58819288|FG001|Overall Study|Protocol Violation|2|||
30802984|NCT03056690|58819287|FG000|Overall Study|Withdrawal by Subject|3|||
30802985|NCT03056690|58819288|FG001|Overall Study|Withdrawal by Subject|6|||
30802986|NCT03056690|58819287|FG000|Overall Study|Non-compliance with Study Drug|1|||
30802987|NCT03056690|58819288|FG001|Overall Study|Non-compliance with Study Drug|0|||
30802988|NCT03056690|58819287|FG000|Overall Study|Miscellaneous|1|||
30802989|NCT03056690|58819288|FG001|Overall Study|Miscellaneous|2|||
30802990|NCT03191799|58819294|FG000|Overall Study|Withdrawal by Subject|4|||
30802991|NCT03191799|58819294|FG000|Overall Study|Physician Decision|2|||
30802992|NCT03191799|58819294|FG000|Overall Study|Lost to Follow-up|1|||
30802993|NCT03191799|58819294|FG000|Overall Study|Death|2|||
30802994|NCT00708916|58819298|FG000|Overall Study|Subject Noncompliance|2|||
30802995|NCT00708916|58819298|FG000|Overall Study|Adverse Event|2|||
30802996|NCT02352753|58819303|FG000|6-Month Dosing Period|Decision by sponsor|2|||
30802997|NCT02352753|58819303|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
30802998|NCT02352753|58819303|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
30802999|NCT02352753|58819303|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
30803000|NCT02352753|58819303|FG000|3-Month Dosing Period|Decision by sponsor|14|||
30803001|NCT02352753|58819303|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
30803002|NCT04532294|58819314|FG000|Overall Study|Withdrawal by Subject|0|||
30803003|NCT04532294|58819315|FG001|Overall Study|Withdrawal by Subject|0|||
30803004|NCT04532294|58819316|FG002|Overall Study|Withdrawal by Subject|1|||
30803005|NCT04532294|58819314|FG000|Overall Study|Participants Not Dosed|0|||
30803006|NCT04532294|58819315|FG001|Overall Study|Participants Not Dosed|0|||
30803007|NCT04532294|58819316|FG002|Overall Study|Participants Not Dosed|2|||
30803008|NCT03197766|58819328|FG000|Overall Study|Withdrawal by Subject|2|||
30803009|NCT03197766|58819329|FG001|Overall Study|Withdrawal by Subject|0|||
30803010|NCT03738332|58819335|FG000|Overall Study|Withdrawal by Subject|1|||
30803011|NCT03173456|58819345|FG000|Baseline|Medication dispensing system malfunction'|0|||
30803012|NCT03173456|58819346|FG001|Baseline|Medication dispensing system malfunction'|1|||
30803013|NCT03173456|58819347|FG002|Baseline|Medication dispensing system malfunction'|0|||
30803014|NCT03173456|58819348|FG003|Baseline|Medication dispensing system malfunction'|0|||
30803015|NCT03173456|58819349|FG004|Baseline|Medication dispensing system malfunction'|2|||
30803016|NCT03173456|58819345|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
30803017|NCT03173456|58819346|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
30803018|NCT03173456|58819347|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
30803019|NCT03173456|58819348|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
30803020|NCT03173456|58819349|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
30803021|NCT03197376|58819372|FG000|Primary and Booster Phase|Adverse Event|0|||
30803022|NCT03197376|58819373|FG001|Primary and Booster Phase|Adverse Event|0|||
30803023|NCT03197376|58819374|FG002|Primary and Booster Phase|Adverse Event|0|||
30803024|NCT03197376|58819375|FG003|Primary and Booster Phase|Adverse Event|1|||
30803025|NCT03197376|58819372|FG000|Primary and Booster Phase|Death|1|||
30803026|NCT03197376|58819373|FG001|Primary and Booster Phase|Death|0|||
30803027|NCT03197376|58819374|FG002|Primary and Booster Phase|Death|0|||
30803028|NCT03197376|58819375|FG003|Primary and Booster Phase|Death|2|||
30803029|NCT03197376|58819372|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
30803030|NCT03197376|58819373|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
30803031|NCT03197376|58819374|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
30803032|NCT03197376|58819375|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
30803033|NCT03197376|58819372|FG000|Primary and Booster Phase|Physician Decision|1|||
30803034|NCT03197376|58819373|FG001|Primary and Booster Phase|Physician Decision|0|||
30803035|NCT03197376|58819374|FG002|Primary and Booster Phase|Physician Decision|1|||
30803036|NCT03197376|58819375|FG003|Primary and Booster Phase|Physician Decision|3|||
30803037|NCT03197376|58819372|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
30803038|NCT03197376|58819373|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
30803039|NCT03197376|58819374|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
30803040|NCT03197376|58819375|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
30803041|NCT03197376|58819372|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
30803042|NCT03197376|58819373|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
30803043|NCT03197376|58819374|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
30803044|NCT03197376|58819375|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
30803045|NCT03197376|58819372|FG000|Primary and Booster Phase|Not vaccine related|1|||
30803046|NCT03197376|58819373|FG001|Primary and Booster Phase|Not vaccine related|2|||
30803047|NCT03197376|58819374|FG002|Primary and Booster Phase|Not vaccine related|0|||
30803048|NCT03197376|58819375|FG003|Primary and Booster Phase|Not vaccine related|6|||
30803049|NCT03197376|58819372|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
30803050|NCT03197376|58819373|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
30803051|NCT03197376|58819374|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
30803052|NCT03197376|58819375|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
30803053|NCT03197376|58819372|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
30803054|NCT03197376|58819373|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
30803055|NCT03197376|58819374|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
30803056|NCT03197376|58819375|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
30803057|NCT03197376|58819372|FG000|Immune Persistence Phase|Not vaccine related|1|||
30803058|NCT03197376|58819373|FG001|Immune Persistence Phase|Not vaccine related|0|||
30803059|NCT03197376|58819374|FG002|Immune Persistence Phase|Not vaccine related|1|||
30803060|NCT03197376|58819375|FG003|Immune Persistence Phase|Not vaccine related|1|||
30803061|NCT03600805|58819412|FG000|Overall Study|Adverse Event|2|||
30803062|NCT03600805|58819413|FG001|Overall Study|Adverse Event|1|||
30803063|NCT03600805|58819414|FG002|Overall Study|Adverse Event|1|||
30803064|NCT03600805|58819415|FG003|Overall Study|Adverse Event|7|||
30803065|NCT03600805|58819412|FG000|Overall Study|Lack of Efficacy|2|||
30803066|NCT03600805|58819413|FG001|Overall Study|Lack of Efficacy|1|||
30803067|NCT03600805|58819414|FG002|Overall Study|Lack of Efficacy|0|||
30803068|NCT03600805|58819415|FG003|Overall Study|Lack of Efficacy|0|||
30803069|NCT03600805|58819412|FG000|Overall Study|Withdrawal by Subject|1|||
30803070|NCT03600805|58819413|FG001|Overall Study|Withdrawal by Subject|0|||
30803071|NCT03600805|58819414|FG002|Overall Study|Withdrawal by Subject|0|||
30803072|NCT03600805|58819415|FG003|Overall Study|Withdrawal by Subject|1|||
30803073|NCT03600805|58819412|FG000|Overall Study|Other unspecified|14|||
30803074|NCT03600805|58819413|FG001|Overall Study|Other unspecified|6|||
30803075|NCT03600805|58819414|FG002|Overall Study|Other unspecified|7|||
30803076|NCT03600805|58819415|FG003|Overall Study|Other unspecified|11|||
30803077|NCT02729740|58819427|FG000|Overall Study|Early Termination|130|||
30803078|NCT02729740|58819427|FG000|Overall Study|Other|1|||
30803079|NCT03196284|58819437|FG000|Main Part|Withdrawal by Subject|0|||
30803080|NCT03196284|58819438|FG001|Main Part|Withdrawal by Subject|1|||
30803081|NCT03196284|58819439|FG002|Main Part|Withdrawal by Subject|0|||
30803082|NCT03196284|58819437|FG000|Extension Part|Lack of Efficacy|0|||
30803083|NCT03196284|58819438|FG001|Extension Part|Lack of Efficacy|0|||
30747814|NCT00048568|58757997|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
30747815|NCT00048568|58757995|FG000|Open-Label Period|Unknown Reasons|0|||
30747816|NCT00048568|58757996|FG001|Open-Label Period|Unknown Reasons|0|||
30747817|NCT00048568|58757997|FG002|Open-Label Period|Unknown Reasons|25|||
30747818|NCT00048568|58757995|FG000|Open-Label Period|Lost to Follow-up|0|||
30747819|NCT00048568|58757996|FG001|Open-Label Period|Lost to Follow-up|0|||
30747820|NCT00048568|58757997|FG002|Open-Label Period|Lost to Follow-up|7|||
30747821|NCT00262002|58758025|FG000|Overall Study|Adverse Event|2|||
30747822|NCT00262002|58758026|FG001|Overall Study|Adverse Event|1|||
30747823|NCT00262002|58758027|FG002|Overall Study|Adverse Event|0|||
30747824|NCT00262002|58758028|FG003|Overall Study|Adverse Event|0|||
30747825|NCT00262002|58758029|FG004|Overall Study|Adverse Event|0|||
30747826|NCT00262002|58758030|FG005|Overall Study|Adverse Event|1|||
30747827|NCT00262002|58758031|FG006|Overall Study|Adverse Event|0|||
30747828|NCT00262002|58758025|FG000|Overall Study|Withdrawal by Subject|4|||
30747829|NCT00262002|58758026|FG001|Overall Study|Withdrawal by Subject|2|||
30747830|NCT00262002|58758027|FG002|Overall Study|Withdrawal by Subject|0|||
30747831|NCT00262002|58758028|FG003|Overall Study|Withdrawal by Subject|1|||
30747832|NCT00262002|58758029|FG004|Overall Study|Withdrawal by Subject|2|||
30747833|NCT00262002|58758030|FG005|Overall Study|Withdrawal by Subject|2|||
30747834|NCT00262002|58758031|FG006|Overall Study|Withdrawal by Subject|2|||
30747835|NCT00262002|58758025|FG000|Overall Study|Lost to Follow-up|2|||
30747836|NCT00262002|58758026|FG001|Overall Study|Lost to Follow-up|0|||
30747837|NCT00262002|58758027|FG002|Overall Study|Lost to Follow-up|0|||
30747838|NCT00262002|58758028|FG003|Overall Study|Lost to Follow-up|2|||
30747839|NCT00262002|58758029|FG004|Overall Study|Lost to Follow-up|0|||
30747840|NCT00262002|58758030|FG005|Overall Study|Lost to Follow-up|1|||
30747841|NCT00262002|58758031|FG006|Overall Study|Lost to Follow-up|0|||
30747842|NCT00262002|58758025|FG000|Overall Study|Inapropriate enrollment|0|||
30747843|NCT00262002|58758026|FG001|Overall Study|Inapropriate enrollment|1|||
30803084|NCT03196284|58819439|FG002|Extension Part|Lack of Efficacy|1|||
30747844|NCT00262002|58758027|FG002|Overall Study|Inapropriate enrollment|0|||
30747845|NCT00262002|58758028|FG003|Overall Study|Inapropriate enrollment|0|||
30747846|NCT00262002|58758029|FG004|Overall Study|Inapropriate enrollment|0|||
30747847|NCT00262002|58758030|FG005|Overall Study|Inapropriate enrollment|0|||
30803085|NCT03196284|58819437|FG000|Extension Part|Withdrawal by Subject|0|||
30803086|NCT03196284|58819438|FG001|Extension Part|Withdrawal by Subject|0|||
30803087|NCT03196284|58819439|FG002|Extension Part|Withdrawal by Subject|1|||
30803088|NCT03196284|58819437|FG000|Extension Part|Physician Decision|0|||
30803089|NCT03196284|58819438|FG001|Extension Part|Physician Decision|0|||
30803090|NCT03196284|58819439|FG002|Extension Part|Physician Decision|1|||
30803091|NCT03730961|58819461|FG000|Overall Study|Adverse Event|0|||
30803092|NCT03730961|58819462|FG001|Overall Study|Adverse Event|1|||
30803093|NCT01078454|58819470|FG000|Overall Study|Adverse Event|1|||
30803094|NCT01078454|58819471|FG001|Overall Study|Adverse Event|1|||
30803095|NCT01078454|58819470|FG000|Overall Study|Death|0|||
30803096|NCT01078454|58819471|FG001|Overall Study|Death|1|||
30803097|NCT03345004|58819488|FG000|Overall Study|Physician Decision|1|||
30803098|NCT03345004|58819489|FG001|Overall Study|Physician Decision|0|||
30803099|NCT03345004|58819488|FG000|Overall Study|Withdrawal by Subject|0|||
30803100|NCT03345004|58819489|FG001|Overall Study|Withdrawal by Subject|1|||
30803101|NCT03552757|58819500|FG000|Overall Study|Withdrawal by Subject|10|||
30803102|NCT03552757|58819501|FG001|Overall Study|Withdrawal by Subject|5|||
30803103|NCT03552757|58819502|FG002|Overall Study|Withdrawal by Subject|12|||
30803104|NCT03552757|58819500|FG000|Overall Study|Lost to Follow-up|2|||
30803105|NCT03552757|58819501|FG001|Overall Study|Lost to Follow-up|7|||
30803106|NCT03552757|58819502|FG002|Overall Study|Lost to Follow-up|7|||
30803107|NCT03552757|58819500|FG000|Overall Study|Death|1|||
30803108|NCT03552757|58819501|FG001|Overall Study|Death|1|||
30907426|NCT01646177|58941913|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
30803109|NCT03552757|58819502|FG002|Overall Study|Death|1|||
30803110|NCT03730103|58819515|FG000|Overall Study|Did not meet inclusion criteria|0|||
30803111|NCT03730103|58819516|FG001|Overall Study|Did not meet inclusion criteria|5|||
30803112|NCT03727841|58819524|FG000|Overall Study|Physician Decision|3|||
30803113|NCT03727841|58819525|FG001|Overall Study|Physician Decision|1|||
30803114|NCT03552523|58819531|FG000|Overall Study|Withdrawal by Subject|1|||
30803115|NCT03552523|58819532|FG001|Overall Study|Withdrawal by Subject|1|||
30803116|NCT03345550|58819540|FG000|Overall Study|Withdrawal by Subject|1|||
30803117|NCT03345550|58819541|FG001|Overall Study|Withdrawal by Subject|0|||
30803118|NCT03345550|58819540|FG000|Overall Study|Lost to Follow-up|4|||
30803119|NCT03345550|58819541|FG001|Overall Study|Lost to Follow-up|5|||
30803120|NCT03186378|58819549|FG000|Overall Study|Lost to Follow-up|1|||
30803121|NCT03186378|58819550|FG001|Overall Study|Lost to Follow-up|0|||
30803122|NCT00687596|58819558|FG000|Overall Study|Adverse Event (AE)|10|||
30803123|NCT00687596|58819559|FG001|Overall Study|Adverse Event (AE)|3|||
30803124|NCT00687596|58819558|FG000|Overall Study|Radiological Disease Progression|6|||
30803125|NCT00687596|58819559|FG001|Overall Study|Radiological Disease Progression|2|||
30803126|NCT00687596|58819558|FG000|Overall Study|Clinical Disease Progression|1|||
30803127|NCT00687596|58819559|FG001|Overall Study|Clinical Disease Progression|3|||
30907427|NCT01646177|58941914|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
30907428|NCT01646177|58941915|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
30907429|NCT01912287|58941938|FG000|Overall Study|Ineligible|1|||
30907430|NCT01912287|58941939|FG001|Overall Study|Ineligible|0|||
30907431|NCT01912287|58941940|FG002|Overall Study|Ineligible|1|||
30907432|NCT01912287|58941938|FG000|Overall Study|No-show|0|||
30907433|NCT01912287|58941939|FG001|Overall Study|No-show|0|||
30803128|NCT00687596|58819558|FG000|Overall Study|Investigator Discretion|3|||
30803129|NCT00687596|58819559|FG001|Overall Study|Investigator Discretion|1|||
30803130|NCT00687596|58819558|FG000|Overall Study|Sponsor Terminated Study|6|||
30803131|NCT00687596|58819559|FG001|Overall Study|Sponsor Terminated Study|17|||
30803132|NCT02892409|58819567|FG000|Overall Study|Adverse Event|1|||
30803133|NCT02892409|58819568|FG001|Overall Study|Adverse Event|0|||
30803134|NCT02892409|58819567|FG000|Overall Study|Withdrawal by Subject|2|||
30803135|NCT02892409|58819568|FG001|Overall Study|Withdrawal by Subject|1|||
30803136|NCT03219216|58819576|FG000|Overall Study|Lost to Follow-up|0|||
30803137|NCT03219216|58819577|FG001|Overall Study|Lost to Follow-up|1|||
30803138|NCT03195660|58819591|FG000|Overall Study|The study was terminated|2|||
30803139|NCT03194490|58819597|FG000|Overall Study|Lost to Follow-up|1|||
30803140|NCT03194490|58819598|FG001|Overall Study|Lost to Follow-up|3|||
30803141|NCT03194490|58819597|FG000|Overall Study|participant developed specific neck pain|1|||
30803142|NCT03194490|58819598|FG001|Overall Study|participant developed specific neck pain|0|||
30803143|NCT03217968|58819605|FG000|Overall Study|Withdrawal by Subject|4|||
30803144|NCT03217968|58819605|FG000|Overall Study|Lost to Follow-up|1|||
30907434|NCT01912287|58941940|FG002|Overall Study|No-show|1|||
30803145|NCT03217968|58819605|FG000|Overall Study|Protocol Violation|6|||
30803146|NCT03192306|58819611|FG000|Overall Study|Did not treat cold sore during study|149|||
30803147|NCT03192306|58819612|FG001|Overall Study|Did not treat cold sore during study|143|||
30803148|NCT03192306|58819611|FG000|Overall Study|Withdrawal by Subject|1|||
30803149|NCT03192306|58819612|FG001|Overall Study|Withdrawal by Subject|1|||
30803150|NCT03192306|58819611|FG000|Overall Study|Lost to Follow-up|1|||
30803151|NCT03192306|58819612|FG001|Overall Study|Lost to Follow-up|0|||
30803152|NCT03192306|58819611|FG000|Overall Study|Protocol Violation|1|||
30803153|NCT03192306|58819612|FG001|Overall Study|Protocol Violation|1|||
30803154|NCT03216954|58819635|FG000|Overall Study|Adverse Event|0|||
30803155|NCT03216954|58819636|FG001|Overall Study|Adverse Event|0|||
30803156|NCT03216954|58819637|FG002|Overall Study|Adverse Event|1|||
30803157|NCT03216954|58819638|FG003|Overall Study|Adverse Event|0|||
30803158|NCT03216954|58819639|FG004|Overall Study|Adverse Event|1|||
30803159|NCT03216954|58819635|FG000|Overall Study|Withdrawal by Subject|2|||
30803160|NCT03216954|58819636|FG001|Overall Study|Withdrawal by Subject|0|||
30803161|NCT03216954|58819637|FG002|Overall Study|Withdrawal by Subject|0|||
30803162|NCT03216954|58819638|FG003|Overall Study|Withdrawal by Subject|0|||
30803163|NCT03216954|58819639|FG004|Overall Study|Withdrawal by Subject|0|||
30803164|NCT03216954|58819635|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
30803165|NCT03216954|58819636|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
30803166|NCT03216954|58819637|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
30803167|NCT03216954|58819638|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
30803168|NCT03216954|58819639|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
30803169|NCT03599089|58819651|FG000|Overall Study|Lost to Follow-up|1|||
30803170|NCT03599089|58819652|FG001|Overall Study|Lost to Follow-up|0|||
30803171|NCT03599089|58819653|FG002|Overall Study|Lost to Follow-up|0|||
30803172|NCT03599089|58819654|FG003|Overall Study|Lost to Follow-up|0|||
30803173|NCT03599089|58819651|FG000|Overall Study|Withdrawal by Subject|2|||
30803174|NCT03599089|58819652|FG001|Overall Study|Withdrawal by Subject|1|||
30803175|NCT03599089|58819653|FG002|Overall Study|Withdrawal by Subject|0|||
30803176|NCT03599089|58819654|FG003|Overall Study|Withdrawal by Subject|0|||
30803177|NCT03599089|58819651|FG000|Overall Study|Lack of Efficacy|0|||
30803178|NCT03599089|58819652|FG001|Overall Study|Lack of Efficacy|0|||
30803179|NCT03599089|58819653|FG002|Overall Study|Lack of Efficacy|1|||
30803180|NCT03599089|58819654|FG003|Overall Study|Lack of Efficacy|2|||
30803181|NCT03192150|58819666|FG000|Overall Study|Adverse Event|14|||
30803182|NCT03192150|58819667|FG001|Overall Study|Adverse Event|12|||
30803183|NCT03192150|58819666|FG000|Overall Study|Lack of Efficacy|23|||
30803184|NCT03192150|58819667|FG001|Overall Study|Lack of Efficacy|30|||
30803185|NCT03192150|58819666|FG000|Overall Study|Lost to Follow-up|1|||
30803186|NCT03192150|58819667|FG001|Overall Study|Lost to Follow-up|1|||
30803187|NCT03192150|58819666|FG000|Overall Study|Withdrawal by Subject|4|||
30803188|NCT03192150|58819667|FG001|Overall Study|Withdrawal by Subject|2|||
30803189|NCT03192150|58819666|FG000|Overall Study|Protocol Violation|5|||
30803190|NCT03192150|58819667|FG001|Overall Study|Protocol Violation|2|||
30803191|NCT03192150|58819666|FG000|Overall Study|Surgery Canceled|6|||
30803192|NCT03192150|58819667|FG001|Overall Study|Surgery Canceled|2|||
30803193|NCT03192150|58819666|FG000|Overall Study|Other-Various Administrative Reasons|2|||
30803194|NCT03192150|58819667|FG001|Overall Study|Other-Various Administrative Reasons|5|||
30803195|NCT03597529|58819675|FG000|Overall Study|Lost to Follow-up|10|||
30803196|NCT03597529|58819676|FG001|Overall Study|Lost to Follow-up|12|||
30803197|NCT03597529|58819675|FG000|Overall Study|Physician Decision|3|||
30803198|NCT03597529|58819676|FG001|Overall Study|Physician Decision|1|||
30803199|NCT03597529|58819675|FG000|Overall Study|Withdrawal by Subject|6|||
30803200|NCT03597529|58819676|FG001|Overall Study|Withdrawal by Subject|3|||
30803201|NCT03597529|58819675|FG000|Overall Study|Non-compliant with study activities|1|||
30803202|NCT03597529|58819676|FG001|Overall Study|Non-compliant with study activities|2|||
30803203|NCT03180528|58819682|FG000|Overall Study|Adverse Event|1|||
30803204|NCT03180528|58819682|FG000|Overall Study|Withdrawal by Subject|1|||
30803205|NCT03180528|58819682|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
30803206|NCT03597295|58819686|FG000|Overall Study|Death|70|||
30803207|NCT03597295|58819686|FG000|Overall Study|Lost to Follow-up|7|||
30803208|NCT03180138|58819693|FG000|Overall Study|Mobile-phone could not be verified|2|||
30803209|NCT03180138|58819694|FG001|Overall Study|Mobile-phone could not be verified|13|||
30803210|NCT03180138|58819695|FG002|Overall Study|Mobile-phone could not be verified|15|||
30803211|NCT03180138|58819693|FG000|Overall Study|No prior immunization records|17|||
30803212|NCT03180138|58819694|FG001|Overall Study|No prior immunization records|0|||
30803213|NCT03180138|58819695|FG002|Overall Study|No prior immunization records|6|||
30803214|NCT03180138|58819693|FG000|Overall Study|Found to be >24 mon after randomization|3|||
30803215|NCT03180138|58819694|FG001|Overall Study|Found to be >24 mon after randomization|0|||
30803216|NCT03180138|58819695|FG002|Overall Study|Found to be >24 mon after randomization|3|||
30803217|NCT03597139|58819705|FG000|Overall Study|Adverse Event|3|||
30803218|NCT03597139|58819706|FG001|Overall Study|Adverse Event|0|||
30803219|NCT03597139|58819705|FG000|Overall Study|Protocol Non-compliance|1|||
30803220|NCT03597139|58819706|FG001|Overall Study|Protocol Non-compliance|0|||
30803221|NCT03179202|58819712|FG000|Overall Study|Screen Failure|67|||
30803222|NCT03179202|58819712|FG000|Overall Study|Subject Lost to Follow Up|12|||
30803223|NCT03179202|58819712|FG000|Overall Study|Withdrawal by Subject|7|||
30803224|NCT03179202|58819712|FG000|Overall Study|Adverse Event|3|||
30803225|NCT03179202|58819712|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
30803226|NCT03179202|58819712|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
30803227|NCT00708214|58819721|FG000|Overall Study|Other Adverse Event|3|||
30803228|NCT00708214|58819722|FG001|Overall Study|Other Adverse Event|6|||
30803229|NCT00708214|58819723|FG002|Overall Study|Other Adverse Event|2|||
30803230|NCT00708214|58819721|FG000|Overall Study|Other|0|||
30803231|NCT00708214|58819722|FG001|Overall Study|Other|1|||
30803232|NCT00708214|58819723|FG002|Overall Study|Other|1|||
30803233|NCT00708214|58819721|FG000|Overall Study|Progressive Disease|4|||
30803234|NCT00708214|58819722|FG001|Overall Study|Progressive Disease|6|||
30803235|NCT00708214|58819723|FG002|Overall Study|Progressive Disease|5|||
30803236|NCT03570697|58819738|FG000|Overall Study|Lost to Follow-up|0|||
30803237|NCT03570697|58819739|FG001|Overall Study|Lost to Follow-up|1|||
30803238|NCT03570697|58819738|FG000|Overall Study|Death|2|||
30803239|NCT03570697|58819739|FG001|Overall Study|Death|0|||
30803240|NCT03570697|58819738|FG000|Overall Study|Withdrawal by Subject|4|||
30803241|NCT03570697|58819739|FG001|Overall Study|Withdrawal by Subject|2|||
30803242|NCT03569371|58819756|FG000|Overall Study|Lack of Efficacy|1|||
30803243|NCT03569371|58819756|FG000|Overall Study|Lost to Follow-up|1|||
30803244|NCT03569371|58819756|FG000|Overall Study|Adverse Event|1|||
30803245|NCT01318070|58819763|FG000|Overall Study|Adverse Event|1|||
30803246|NCT01318070|58819764|FG001|Overall Study|Adverse Event|1|||
30803247|NCT01318070|58819765|FG002|Overall Study|Adverse Event|5|||
30803248|NCT01318070|58819763|FG000|Overall Study|Withdrawal by Subject|0|||
30803249|NCT01318070|58819764|FG001|Overall Study|Withdrawal by Subject|1|||
30803250|NCT01318070|58819765|FG002|Overall Study|Withdrawal by Subject|1|||
30803251|NCT01318070|58819763|FG000|Overall Study|Lack of Efficacy|0|||
30803252|NCT01318070|58819764|FG001|Overall Study|Lack of Efficacy|0|||
30803253|NCT01318070|58819765|FG002|Overall Study|Lack of Efficacy|1|||
30803254|NCT01318070|58819763|FG000|Overall Study|Principal Investigator Discretion|1|||
30803255|NCT01318070|58819764|FG001|Overall Study|Principal Investigator Discretion|0|||
30803256|NCT01318070|58819765|FG002|Overall Study|Principal Investigator Discretion|0|||
30803257|NCT02895295|58819776|FG000|Overall Study|Survey Non-response|71|||
30803258|NCT02895295|58819777|FG001|Overall Study|Survey Non-response|94|||
30803259|NCT02895295|58819778|FG002|Overall Study|Survey Non-response|92|||
30803260|NCT00245960|58819788|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
30803261|NCT00245960|58819789|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
30803262|NCT00245960|58819788|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
30803263|NCT00245960|58819789|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
30803264|NCT00245960|58819788|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
30803265|NCT00245960|58819789|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
30803266|NCT00245960|58819788|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
30803267|NCT00245960|58819789|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
30803268|NCT00245960|58819788|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
30803269|NCT00245960|58819789|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
30803270|NCT00245960|58819788|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
30803271|NCT00245960|58819789|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
30803272|NCT00245960|58819788|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
30803273|NCT00245960|58819789|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
30803274|NCT00245960|58819788|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
30803275|NCT00245960|58819789|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
30803276|NCT00245960|58819788|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
30803277|NCT00245960|58819789|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
30803278|NCT00245960|58819788|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
30803279|NCT00245960|58819789|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
30803280|NCT00245960|58819788|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
30803281|NCT00245960|58819789|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
30803282|NCT00245960|58819788|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
30803283|NCT00245960|58819789|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
30803284|NCT02729194|58819795|FG000|Overall Study|Withdrawal by Subject|3|||
30907435|NCT01912287|58941938|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
30907436|NCT01912287|58941939|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
30907437|NCT01912287|58941940|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
30907438|NCT01912287|58941938|FG000|Overall Study|Felt treatment no longer needed|0|||
30907439|NCT01912287|58941939|FG001|Overall Study|Felt treatment no longer needed|1|||
30907440|NCT01912287|58941940|FG002|Overall Study|Felt treatment no longer needed|0|||
30907441|NCT01912287|58941938|FG000|Overall Study|Life circumstances|4|||
30907442|NCT01912287|58941939|FG001|Overall Study|Life circumstances|2|||
30907443|NCT01912287|58941940|FG002|Overall Study|Life circumstances|0|||
30803285|NCT03178266|58819801|FG000|Overall Study|Death|0|||
30803286|NCT03178266|58819802|FG001|Overall Study|Death|1|||
30803287|NCT03178266|58819801|FG000|Overall Study|Disont. Early|0|||
30803288|NCT03178266|58819802|FG001|Overall Study|Disont. Early|1|||
30907444|NCT01912287|58941938|FG000|Overall Study|Lost Interest|1|||
30907445|NCT01912287|58941939|FG001|Overall Study|Lost Interest|0|||
30907446|NCT01912287|58941940|FG002|Overall Study|Lost Interest|0|||
30907447|NCT01912287|58941938|FG000|Overall Study|Uknown reason - subject drop out|5|||
30907448|NCT01912287|58941939|FG001|Overall Study|Uknown reason - subject drop out|7|||
30803289|NCT03178266|58819801|FG000|Overall Study|Withdrawal by Subject|0|||
30803290|NCT03178266|58819802|FG001|Overall Study|Withdrawal by Subject|2|||
30803291|NCT03548935|58819810|FG000|Overall Study|Withdrawal by Subject|26|||
30803292|NCT03548935|58819811|FG001|Overall Study|Withdrawal by Subject|17|||
30803293|NCT03548935|58819810|FG000|Overall Study|Lost to Follow-up|39|||
30803294|NCT03548935|58819811|FG001|Overall Study|Lost to Follow-up|28|||
30803295|NCT03548935|58819810|FG000|Overall Study|Death|1|||
30803296|NCT03548935|58819811|FG001|Overall Study|Death|1|||
30907449|NCT01912287|58941940|FG002|Overall Study|Uknown reason - subject drop out|3|||
30803297|NCT03547687|58819817|FG000|Overall Study|Withdrawal by Subject|1|||
30803298|NCT03547687|58819817|FG000|Overall Study|Death|1|||
30803299|NCT03547531|58819823|FG000|Overall Study|not coming in data collection : sick|2|||
30803300|NCT03547531|58819824|FG001|Overall Study|not coming in data collection : sick|2|||
30803301|NCT03547531|58819823|FG000|Overall Study|having family occasion|0|||
30803302|NCT03547531|58819824|FG001|Overall Study|having family occasion|2|||
30803303|NCT03566485|58819832|FG000|Overall Study|Disease progression|5|||
30803304|NCT03566485|58819833|FG001|Overall Study|Disease progression|4|||
30803305|NCT03566485|58819832|FG000|Overall Study|Clinical progression|0|||
30803306|NCT03566485|58819833|FG001|Overall Study|Clinical progression|1|||
30803307|NCT03566485|58819832|FG000|Overall Study|Toxicity|0|||
30803308|NCT03566485|58819833|FG001|Overall Study|Toxicity|2|||
30803309|NCT03176238|58819841|FG000|Overall Study|Unacceptable AEs|15|||
30803310|NCT03176238|58819842|FG001|Overall Study|Unacceptable AEs|8|||
30803311|NCT03176238|58819841|FG000|Overall Study|Abnormal lab value(s)|2|||
30803312|NCT03176238|58819842|FG001|Overall Study|Abnormal lab value(s)|0|||
30803313|NCT03176238|58819841|FG000|Overall Study|Inter-current illness|0|||
30803314|NCT03176238|58819842|FG001|Overall Study|Inter-current illness|1|||
30803315|NCT03176238|58819841|FG000|Overall Study|Consent withdrawal|14|||
30803316|NCT03176238|58819842|FG001|Overall Study|Consent withdrawal|2|||
30803317|NCT03176238|58819841|FG000|Overall Study|Lost to Follow-up|3|||
30803318|NCT03176238|58819842|FG001|Overall Study|Lost to Follow-up|0|||
30803319|NCT03176238|58819841|FG000|Overall Study|Administrative problems|1|||
30803320|NCT03176238|58819842|FG001|Overall Study|Administrative problems|0|||
30803321|NCT03176238|58819841|FG000|Overall Study|Death|3|||
30803322|NCT03176238|58819842|FG001|Overall Study|Death|0|||
30803323|NCT03176238|58819841|FG000|Overall Study|Disease Progression|133|||
30803324|NCT03176238|58819842|FG001|Overall Study|Disease Progression|22|||
30803325|NCT03176238|58819841|FG000|Overall Study|Tx duration completed per EAP|0|||
30803326|NCT03176238|58819842|FG001|Overall Study|Tx duration completed per EAP|1|||
30803327|NCT03176238|58819841|FG000|Overall Study|Patient is switched to commercial drug|16|||
30803328|NCT03176238|58819842|FG001|Overall Study|Patient is switched to commercial drug|1|||
30803329|NCT03176238|58819841|FG000|Overall Study|Protocol Violation|1|||
30803330|NCT03176238|58819842|FG001|Overall Study|Protocol Violation|0|||
30803331|NCT03176238|58819841|FG000|Overall Study|Changes in the patient's condition|2|||
30747848|NCT00262002|58758031|FG006|Overall Study|Inapropriate enrollment|0|||
30747849|NCT00262002|58758025|FG000|Overall Study|Protocol Violation|3|||
30747850|NCT00262002|58758026|FG001|Overall Study|Protocol Violation|2|||
30747851|NCT00262002|58758027|FG002|Overall Study|Protocol Violation|0|||
30747852|NCT00262002|58758028|FG003|Overall Study|Protocol Violation|2|||
30747853|NCT00262002|58758029|FG004|Overall Study|Protocol Violation|5|||
30747854|NCT00262002|58758030|FG005|Overall Study|Protocol Violation|3|||
30747855|NCT00262002|58758031|FG006|Overall Study|Protocol Violation|2|||
30747856|NCT00262002|58758025|FG000|Overall Study|Unable to classify|0|||
30747857|NCT00262002|58758026|FG001|Overall Study|Unable to classify|0|||
30747858|NCT00262002|58758027|FG002|Overall Study|Unable to classify|0|||
30747859|NCT00262002|58758028|FG003|Overall Study|Unable to classify|0|||
30747860|NCT00262002|58758029|FG004|Overall Study|Unable to classify|0|||
30747861|NCT00262002|58758030|FG005|Overall Study|Unable to classify|0|||
30747862|NCT00262002|58758031|FG006|Overall Study|Unable to classify|2|||
30747863|NCT00281528|58758099|FG000|Overall Study|Progressive Disease|28|||
30747864|NCT00281528|58758100|FG001|Overall Study|Progressive Disease|18|||
30747865|NCT00281528|58758101|FG002|Overall Study|Progressive Disease|27|||
30747866|NCT00281528|58758099|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
30747867|NCT00281528|58758100|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
30747868|NCT00281528|58758101|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
30747869|NCT00281528|58758099|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
30747870|NCT00281528|58758100|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
30747871|NCT00281528|58758101|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
30747872|NCT00281528|58758099|FG000|Overall Study|Physician Decision|11|||
30747873|NCT00281528|58758100|FG001|Overall Study|Physician Decision|4|||
30747874|NCT00281528|58758101|FG002|Overall Study|Physician Decision|5|||
30747875|NCT00281528|58758099|FG000|Overall Study|Protocol Violation|1|||
30803332|NCT03176238|58819842|FG001|Overall Study|Changes in the patient's condition|1|||
30803333|NCT03176238|58819841|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
30803334|NCT03176238|58819842|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
30622355|NCT00999804|58634049|FG000|Overall Study|Lack of Efficacy|9|||
30747876|NCT00281528|58758100|FG001|Overall Study|Protocol Violation|0|||
30747877|NCT00281528|58758101|FG002|Overall Study|Protocol Violation|1|||
30747878|NCT00281528|58758099|FG000|Overall Study|Withdrawal by Subject|5|||
30747879|NCT00281528|58758100|FG001|Overall Study|Withdrawal by Subject|5|||
30747880|NCT00281528|58758101|FG002|Overall Study|Withdrawal by Subject|7|||
30747881|NCT00281528|58758099|FG000|Overall Study|Other|6|||
30803335|NCT03565315|58819856|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
30803336|NCT03565315|58819857|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
30803337|NCT03565315|58819858|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
30803338|NCT03565315|58819859|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
30803339|NCT03565237|58819882|FG000|Overall Study|Non-compliance of Investigational Product|1|||
30803340|NCT03565237|58819882|FG000|Overall Study|Physician Decision|1|||
30803341|NCT01345682|58819888|FG000|Overall Study|Progressive disease per RECIST|226|||
30803342|NCT01345682|58819889|FG001|Overall Study|Progressive disease per RECIST|93|||
30803343|NCT01345682|58819888|FG000|Overall Study|Worsening of underlying cancer disease|23|||
30803344|NCT01345682|58819889|FG001|Overall Study|Worsening of underlying cancer disease|12|||
30803345|NCT01345682|58819888|FG000|Overall Study|Adverse Event|51|||
30803346|NCT01345682|58819889|FG001|Overall Study|Adverse Event|41|||
30803347|NCT01345682|58819888|FG000|Overall Study|Non-compliance with protocol|0|||
30803348|NCT01345682|58819889|FG001|Overall Study|Non-compliance with protocol|1|||
30803349|NCT01345682|58819888|FG000|Overall Study|Lost to Follow-up|0|||
30803350|NCT01345682|58819889|FG001|Overall Study|Lost to Follow-up|1|||
30803351|NCT01345682|58819888|FG000|Overall Study|Refused to continue trial medication|16|||
30803352|NCT01345682|58819889|FG001|Overall Study|Refused to continue trial medication|9|||
30803353|NCT01345682|58819888|FG000|Overall Study|Not treated|2|||
30803354|NCT01345682|58819889|FG001|Overall Study|Not treated|1|||
30803355|NCT01345682|58819888|FG000|Overall Study|Reason other than those specified above|4|||
30803356|NCT01345682|58819889|FG001|Overall Study|Reason other than those specified above|3|||
30803357|NCT03562117|58819898|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
30803358|NCT03562117|58819899|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
30803359|NCT03562117|58819900|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
30747882|NCT00281528|58758100|FG001|Overall Study|Other|3|||
30747883|NCT00281528|58758101|FG002|Overall Study|Other|5|||
30747884|NCT00280748|58758109|FG000|Overall Study|Decline in performance|3|||
30747885|NCT00280748|58758109|FG000|Overall Study|Extra-cranial disease progression|1|||
30747886|NCT00271856|58758115|FG000|Overall Study|Withdrawal by Subject|1|||
30747887|NCT00271856|58758116|FG001|Overall Study|Withdrawal by Subject|7|||
30747888|NCT00271856|58758115|FG000|Overall Study|Lost to Follow-up|10|||
30747889|NCT00271856|58758116|FG001|Overall Study|Lost to Follow-up|11|||
30747890|NCT00061048|58758122|FG000|Overall Study|Adverse Event|2|||
30747891|NCT00061048|58758122|FG000|Overall Study|disease progression|20|||
30747892|NCT00270998|58758129|FG000|3 Month Follow-up|Adverse Event|1|||
30747893|NCT00270998|58758130|FG001|3 Month Follow-up|Adverse Event|0|||
30747894|NCT00270998|58758131|FG002|3 Month Follow-up|Adverse Event|0|||
30747895|NCT00270998|58758129|FG000|3 Month Follow-up|Lack of Efficacy|1|||
30747896|NCT00270998|58758130|FG001|3 Month Follow-up|Lack of Efficacy|2|||
30747897|NCT00270998|58758131|FG002|3 Month Follow-up|Lack of Efficacy|1|||
30747898|NCT00270998|58758129|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
30747899|NCT00270998|58758130|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
30747900|NCT00270998|58758131|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
30803360|NCT03561883|58819910|FG000|Overall Study|Adverse Event|10|||
30803361|NCT03561883|58819911|FG001|Overall Study|Adverse Event|13|||
30803362|NCT03561883|58819910|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30803363|NCT03561883|58819911|FG001|Overall Study|Non-Compliance With Study Drug|2|||
30803364|NCT03561883|58819910|FG000|Overall Study|Protocol Violation|2|||
30803365|NCT03561883|58819911|FG001|Overall Study|Protocol Violation|3|||
30803366|NCT03561883|58819910|FG000|Overall Study|Withdrawal by Subject|14|||
30803367|NCT03561883|58819911|FG001|Overall Study|Withdrawal by Subject|6|||
30803368|NCT03561883|58819910|FG000|Overall Study|Lost to Follow-up|2|||
30803369|NCT03561883|58819911|FG001|Overall Study|Lost to Follow-up|6|||
30803370|NCT03561883|58819910|FG000|Overall Study|Study Terminated by Sponsor|12|||
30803371|NCT03561883|58819911|FG001|Overall Study|Study Terminated by Sponsor|11|||
30803372|NCT03561883|58819910|FG000|Overall Study|Physician Decision|1|||
30803373|NCT03561883|58819911|FG001|Overall Study|Physician Decision|0|||
30803374|NCT03561883|58819910|FG000|Overall Study|Randomized by Mistake|1|||
30803375|NCT03561883|58819911|FG001|Overall Study|Randomized by Mistake|0|||
30803376|NCT03561883|58819910|FG000|Overall Study|Other, Not Specified|3|||
30803377|NCT03561883|58819911|FG001|Overall Study|Other, Not Specified|2|||
30803378|NCT03546907|58819919|FG000|Overall Study|Lack of Efficacy|1|||
30803379|NCT03546907|58819920|FG001|Overall Study|Lack of Efficacy|1|||
30803380|NCT03546907|58819919|FG000|Overall Study|Withdrawal by Subject|8|||
30803381|NCT03546907|58819920|FG001|Overall Study|Withdrawal by Subject|9|||
30803382|NCT03546907|58819919|FG000|Overall Study|Adverse events (AEs)|7|||
30803383|NCT03546907|58819920|FG001|Overall Study|Adverse events (AEs)|10|||
30803384|NCT03546907|58819919|FG000|Overall Study|Other-unspecified|1|||
30747901|NCT00270998|58758129|FG000|3 Month Follow-up|Pessary did not fit|12|||
30747902|NCT00270998|58758130|FG001|3 Month Follow-up|Pessary did not fit|0|||
30747903|NCT00270998|58758131|FG002|3 Month Follow-up|Pessary did not fit|0|||
30747904|NCT00270998|58758129|FG000|3 Month Follow-up|Personal/family health|1|||
30747905|NCT00270998|58758130|FG001|3 Month Follow-up|Personal/family health|1|||
30803385|NCT03546907|58819920|FG001|Overall Study|Other-unspecified|1|||
30803386|NCT01318382|58819926|FG000|Overall Study|Physician Decision|2|||
30803387|NCT01318382|58819926|FG000|Overall Study|Device Malfunction|10|||
30803388|NCT01318382|58819926|FG000|Overall Study|Protocol Violation|1|||
30803389|NCT03053180|58819944|FG000|Overall Study|Failure to Return|1|||
30803390|NCT03560869|58819948|FG000|Overall Study|Withdrawal by Subject|3|||
30907450|NCT01912287|58941938|FG000|Overall Study|Missed Assesment|1|||
30907451|NCT01912287|58941939|FG001|Overall Study|Missed Assesment|1|||
30907452|NCT01912287|58941940|FG002|Overall Study|Missed Assesment|1|||
30907453|NCT01912287|58941938|FG000|Overall Study|Scheduling/change in availability|17|||
30747906|NCT00270998|58758131|FG002|3 Month Follow-up|Personal/family health|0|||
30747907|NCT00270998|58758129|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
30747908|NCT00270998|58758130|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
30747909|NCT00270998|58758131|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
30747910|NCT00270998|58758129|FG000|12 Month Follow-up|Lack of Efficacy|5|||
30747911|NCT00270998|58758130|FG001|12 Month Follow-up|Lack of Efficacy|4|||
30747912|NCT00270998|58758131|FG002|12 Month Follow-up|Lack of Efficacy|3|||
30747913|NCT00270998|58758129|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
30747914|NCT00270998|58758130|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
30747915|NCT00270998|58758131|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
30747916|NCT00270998|58758129|FG000|12 Month Follow-up|Pessary did not fit|1|||
30747917|NCT00270998|58758130|FG001|12 Month Follow-up|Pessary did not fit|0|||
30747918|NCT00270998|58758131|FG002|12 Month Follow-up|Pessary did not fit|0|||
30747919|NCT00270998|58758129|FG000|12 Month Follow-up|Personal/family health|0|||
30747920|NCT00270998|58758130|FG001|12 Month Follow-up|Personal/family health|5|||
30747921|NCT00270998|58758131|FG002|12 Month Follow-up|Personal/family health|1|||
30747922|NCT00270998|58758129|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
30747923|NCT00270998|58758130|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
30747924|NCT00270998|58758131|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
30747925|NCT00279812|58758147|FG000|Overall Study|Protocol Violation|1|||
30747926|NCT00279812|58758148|FG001|Overall Study|Protocol Violation|1|||
30747927|NCT00279812|58758149|FG002|Overall Study|Protocol Violation|0|||
30747928|NCT00279812|58758150|FG003|Overall Study|Protocol Violation|0|||
30747929|NCT00279812|58758151|FG004|Overall Study|Protocol Violation|1|||
30747930|NCT00279812|58758152|FG005|Overall Study|Protocol Violation|0|||
30747931|NCT00279812|58758147|FG000|Overall Study|Withdrawal by Subject|0|||
30747932|NCT00279812|58758148|FG001|Overall Study|Withdrawal by Subject|4|||
30747933|NCT00279812|58758149|FG002|Overall Study|Withdrawal by Subject|2|||
30747934|NCT00279812|58758150|FG003|Overall Study|Withdrawal by Subject|0|||
30747935|NCT00279812|58758151|FG004|Overall Study|Withdrawal by Subject|0|||
30747936|NCT00279812|58758152|FG005|Overall Study|Withdrawal by Subject|0|||
30747937|NCT00279812|58758147|FG000|Overall Study|Adverse Event|0|||
30747938|NCT00279812|58758148|FG001|Overall Study|Adverse Event|1|||
30747939|NCT00279812|58758149|FG002|Overall Study|Adverse Event|1|||
30747940|NCT00279812|58758150|FG003|Overall Study|Adverse Event|0|||
30747941|NCT00279812|58758151|FG004|Overall Study|Adverse Event|2|||
30747942|NCT00279812|58758152|FG005|Overall Study|Adverse Event|1|||
30747943|NCT00207714|58758171|FG000|Overall Study|Adverse Event|6|||
30747944|NCT00207714|58758172|FG001|Overall Study|Adverse Event|2|||
30747945|NCT00207714|58758173|FG002|Overall Study|Adverse Event|4|||
30747946|NCT00207714|58758174|FG003|Overall Study|Adverse Event|3|||
30747947|NCT00207714|58758175|FG004|Overall Study|Adverse Event|1|||
30907454|NCT01912287|58941939|FG001|Overall Study|Scheduling/change in availability|10|||
30803391|NCT03560869|58819949|FG001|Overall Study|Withdrawal by Subject|4|||
30803392|NCT03560869|58819948|FG000|Overall Study|Screening failure|4|||
30803393|NCT03560869|58819949|FG001|Overall Study|Screening failure|4|||
30803394|NCT03560869|58819948|FG000|Overall Study|Withdrawal by PI|0|||
30803395|NCT03560869|58819949|FG001|Overall Study|Withdrawal by PI|1|||
30803396|NCT03590743|58819957|FG000|Overall Study|Withdrawal by Subject|0|||
30803397|NCT03590743|58819958|FG001|Overall Study|Withdrawal by Subject|1|||
30803398|NCT03053102|58819964|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
30803399|NCT03053102|58819964|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
30803400|NCT03589885|58819972|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
30803401|NCT03589885|58819973|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
30803402|NCT03589885|58819974|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
30803403|NCT03589885|58819975|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
30803404|NCT03589885|58819976|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
30803405|NCT03589885|58819972|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
30803406|NCT03589885|58819973|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
30803407|NCT03589885|58819974|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
30803408|NCT03589885|58819975|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
30803409|NCT03589885|58819976|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
30803410|NCT03589885|58819972|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
30803411|NCT03589885|58819973|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
30803412|NCT03589885|58819974|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
30622356|NCT00999804|58634050|FG001|Overall Study|Lack of Efficacy|2|||
30803413|NCT03589885|58819975|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
30803414|NCT03589885|58819976|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
30803415|NCT03589885|58819972|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
30803416|NCT03589885|58819973|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
30803417|NCT03589885|58819974|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
30803418|NCT03589885|58819975|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
30803419|NCT03589885|58819976|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
30803420|NCT03589885|58819972|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
30803421|NCT03589885|58819973|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
30803422|NCT03589885|58819974|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
30803423|NCT03589885|58819975|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
30803424|NCT03589885|58819976|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
30803425|NCT03589885|58819972|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
30803426|NCT03589885|58819973|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
30803427|NCT03589885|58819974|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
30803428|NCT03589885|58819975|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
30803429|NCT03589885|58819976|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
30803430|NCT03589885|58819972|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
30803431|NCT03589885|58819973|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
30803432|NCT03589885|58819974|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
30803433|NCT03589885|58819975|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
30803434|NCT03589885|58819976|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
30803435|NCT03589885|58819972|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
30803436|NCT03589885|58819973|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
30803437|NCT03589885|58819974|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
30803438|NCT03589885|58819975|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
30907455|NCT01912287|58941940|FG002|Overall Study|Scheduling/change in availability|8|||
30907456|NCT01929135|58941950|FG000|Overall Study|Lost to Follow-up|1|||
30907457|NCT01929135|58941951|FG001|Overall Study|Lost to Follow-up|1|||
30907458|NCT01911819|58941962|FG000|Overall Study|Adverse Event|0|||
30907459|NCT01911819|58941963|FG001|Overall Study|Adverse Event|1|||
30907460|NCT01911819|58941964|FG002|Overall Study|Adverse Event|0|||
30803439|NCT03589885|58819976|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
30803440|NCT03545503|58819996|FG000|Overall Study|Protocol Violation|14|||
30803441|NCT03545503|58819997|FG001|Overall Study|Protocol Violation|16|||
30803442|NCT03545113|58820005|FG000|Overall Study|Surgery Cancelled|1|||
30803443|NCT03545113|58820006|FG001|Overall Study|Surgery Cancelled|0|||
30803444|NCT03545113|58820005|FG000|Overall Study|Death|1|||
30803445|NCT03545113|58820006|FG001|Overall Study|Death|0|||
30803446|NCT03545113|58820005|FG000|Overall Study|Adverse Event|2|||
30803447|NCT03545113|58820006|FG001|Overall Study|Adverse Event|0|||
30803448|NCT03545113|58820005|FG000|Overall Study|Received different surgery|1|||
30907461|NCT01911819|58941962|FG000|Overall Study|Withdrawal by Subject|1|||
30907462|NCT01911819|58941963|FG001|Overall Study|Withdrawal by Subject|1|||
30907463|NCT01911819|58941964|FG002|Overall Study|Withdrawal by Subject|0|||
30907464|NCT02280863|58941974|FG000|Integrated Platform|Met stopping criteria|0|||
30907465|NCT02280863|58941975|FG001|Integrated Platform|Met stopping criteria|1|||
30803449|NCT03545113|58820006|FG001|Overall Study|Received different surgery|0|||
30803450|NCT03214380|58820018|FG000|Lead-in|Adverse Event|3|||
30803451|NCT03214380|58820019|FG001|Lead-in|Adverse Event|0|||
30803452|NCT03214380|58820020|FG002|Lead-in|Adverse Event|0|||
30803453|NCT03214380|58820021|FG003|Lead-in|Adverse Event|1|||
30803454|NCT03214380|58820022|FG004|Lead-in|Adverse Event|0|||
30803455|NCT03214380|58820023|FG005|Lead-in|Adverse Event|0|||
30803456|NCT03214380|58820018|FG000|Lead-in|Lost to Follow-up|4|||
30803457|NCT03214380|58820019|FG001|Lead-in|Lost to Follow-up|0|||
30803458|NCT03214380|58820020|FG002|Lead-in|Lost to Follow-up|0|||
30803459|NCT03214380|58820021|FG003|Lead-in|Lost to Follow-up|1|||
30803460|NCT03214380|58820022|FG004|Lead-in|Lost to Follow-up|0|||
30803461|NCT03214380|58820023|FG005|Lead-in|Lost to Follow-up|0|||
30803462|NCT03214380|58820018|FG000|Lead-in|Eligibility Criteria|3|||
30803463|NCT03214380|58820019|FG001|Lead-in|Eligibility Criteria|0|||
30803464|NCT03214380|58820020|FG002|Lead-in|Eligibility Criteria|0|||
30803465|NCT03214380|58820021|FG003|Lead-in|Eligibility Criteria|0|||
30803466|NCT03214380|58820022|FG004|Lead-in|Eligibility Criteria|0|||
30803467|NCT03214380|58820023|FG005|Lead-in|Eligibility Criteria|0|||
30803468|NCT03214380|58820018|FG000|Lead-in|Physician Decision|6|||
30803469|NCT03214380|58820019|FG001|Lead-in|Physician Decision|0|||
30803470|NCT03214380|58820020|FG002|Lead-in|Physician Decision|0|||
30803471|NCT03214380|58820021|FG003|Lead-in|Physician Decision|0|||
30803472|NCT03214380|58820022|FG004|Lead-in|Physician Decision|0|||
30803473|NCT03214380|58820023|FG005|Lead-in|Physician Decision|0|||
30907466|NCT01911429|58941988|FG000|Overall Study|Adverse Event|5|||
30907467|NCT01911429|58941989|FG001|Overall Study|Adverse Event|3|||
30907468|NCT01911429|58941990|FG002|Overall Study|Adverse Event|9|||
30622357|NCT00999804|58634049|FG000|Overall Study|Adverse Event|4|||
30803474|NCT03214380|58820018|FG000|Lead-in|Protocol Deviation|7|||
30803475|NCT03214380|58820019|FG001|Lead-in|Protocol Deviation|0|||
30803476|NCT03214380|58820020|FG002|Lead-in|Protocol Deviation|0|||
30803477|NCT03214380|58820021|FG003|Lead-in|Protocol Deviation|3|||
30803478|NCT03214380|58820022|FG004|Lead-in|Protocol Deviation|0|||
30803479|NCT03214380|58820023|FG005|Lead-in|Protocol Deviation|0|||
30803480|NCT03214380|58820018|FG000|Lead-in|Withdrawal by Subject|41|||
30803481|NCT03214380|58820019|FG001|Lead-in|Withdrawal by Subject|0|||
30803482|NCT03214380|58820020|FG002|Lead-in|Withdrawal by Subject|0|||
30803483|NCT03214380|58820021|FG003|Lead-in|Withdrawal by Subject|14|||
30803484|NCT03214380|58820022|FG004|Lead-in|Withdrawal by Subject|0|||
30803485|NCT03214380|58820023|FG005|Lead-in|Withdrawal by Subject|0|||
30803486|NCT03214380|58820018|FG000|Lead-in|Family Emergency|1|||
30803487|NCT03214380|58820019|FG001|Lead-in|Family Emergency|0|||
30803488|NCT03214380|58820020|FG002|Lead-in|Family Emergency|0|||
30803489|NCT03214380|58820021|FG003|Lead-in|Family Emergency|0|||
30803490|NCT03214380|58820022|FG004|Lead-in|Family Emergency|0|||
30803491|NCT03214380|58820023|FG005|Lead-in|Family Emergency|0|||
30803492|NCT03214380|58820018|FG000|Lead-in|Natural Disaster|9|||
30803493|NCT03214380|58820019|FG001|Lead-in|Natural Disaster|0|||
30803494|NCT03214380|58820020|FG002|Lead-in|Natural Disaster|0|||
30803495|NCT03214380|58820021|FG003|Lead-in|Natural Disaster|0|||
30803496|NCT03214380|58820022|FG004|Lead-in|Natural Disaster|0|||
30803497|NCT03214380|58820023|FG005|Lead-in|Natural Disaster|0|||
30803498|NCT03214380|58820018|FG000|Lead-in|Non Compliance|1|||
30803499|NCT03214380|58820019|FG001|Lead-in|Non Compliance|0|||
30803500|NCT03214380|58820020|FG002|Lead-in|Non Compliance|0|||
30803501|NCT03214380|58820021|FG003|Lead-in|Non Compliance|0|||
30803502|NCT03214380|58820022|FG004|Lead-in|Non Compliance|0|||
30907469|NCT01911429|58941988|FG000|Overall Study|Lack of Efficacy|1|||
30907470|NCT01911429|58941989|FG001|Overall Study|Lack of Efficacy|2|||
30907471|NCT01911429|58941990|FG002|Overall Study|Lack of Efficacy|4|||
30907472|NCT01911429|58941988|FG000|Overall Study|Lost to Follow-up|0|||
30907473|NCT01911429|58941989|FG001|Overall Study|Lost to Follow-up|0|||
30907474|NCT01911429|58941990|FG002|Overall Study|Lost to Follow-up|1|||
30907475|NCT01911429|58941988|FG000|Overall Study|Protocol Violation|0|||
30907476|NCT01911429|58941989|FG001|Overall Study|Protocol Violation|0|||
30907477|NCT01911429|58941990|FG002|Overall Study|Protocol Violation|1|||
30907478|NCT01911429|58941988|FG000|Overall Study|Withdrawal by Subject|5|||
30907479|NCT01911429|58941989|FG001|Overall Study|Withdrawal by Subject|5|||
30907480|NCT01911429|58941990|FG002|Overall Study|Withdrawal by Subject|4|||
30907481|NCT01911429|58941988|FG000|Overall Study|Accidental randomization|0|||
30907482|NCT01911429|58941989|FG001|Overall Study|Accidental randomization|0|||
30907483|NCT01911429|58941990|FG002|Overall Study|Accidental randomization|1|||
30907484|NCT01911429|58941988|FG000|Overall Study|subject left study|1|||
30907485|NCT01911429|58941989|FG001|Overall Study|subject left study|0|||
30747948|NCT00207714|58758171|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
30747949|NCT00207714|58758172|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
30747950|NCT00207714|58758173|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
30747951|NCT00207714|58758174|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
30747952|NCT00207714|58758175|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
30803503|NCT03214380|58820023|FG005|Lead-in|Non Compliance|0|||
30803504|NCT03214380|58820018|FG000|Lead-in|Participant Schedule|2|||
30803505|NCT03214380|58820019|FG001|Lead-in|Participant Schedule|0|||
30803506|NCT03214380|58820020|FG002|Lead-in|Participant Schedule|0|||
30803507|NCT03214380|58820021|FG003|Lead-in|Participant Schedule|0|||
30803508|NCT03214380|58820022|FG004|Lead-in|Participant Schedule|0|||
30747953|NCT00207714|58758171|FG000|Overall Study|Other|3|||
30747954|NCT00207714|58758172|FG001|Overall Study|Other|2|||
30747955|NCT00207714|58758173|FG002|Overall Study|Other|5|||
30747956|NCT00207714|58758174|FG003|Overall Study|Other|1|||
30747957|NCT00207714|58758175|FG004|Overall Study|Other|0|||
30803509|NCT03214380|58820023|FG005|Lead-in|Participant Schedule|0|||
30803510|NCT03214380|58820018|FG000|Treatment Period|Adverse Event|0|||
30803511|NCT03214380|58820019|FG001|Treatment Period|Adverse Event|1|||
30803512|NCT03214380|58820020|FG002|Treatment Period|Adverse Event|1|||
30803513|NCT03214380|58820021|FG003|Treatment Period|Adverse Event|0|||
30803514|NCT03214380|58820022|FG004|Treatment Period|Adverse Event|1|||
30803515|NCT03214380|58820023|FG005|Treatment Period|Adverse Event|0|||
30803516|NCT03214380|58820018|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
30803517|NCT03214380|58820019|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
30907486|NCT01911429|58941990|FG002|Overall Study|subject left study|0|||
30907487|NCT02324465|58942000|FG000|Overall Study|device failure|0|||
30907488|NCT02324465|58942001|FG001|Overall Study|device failure|1|||
30803518|NCT03214380|58820020|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
30747958|NCT00207090|58758194|FG000|Overall Study|Study drug toxicity|3|||
30803519|NCT03214380|58820021|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
30803520|NCT03214380|58820022|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
30907489|NCT02324153|58942009|FG000|Overall Study|Withdrawal by Subject|4|||
30803521|NCT03214380|58820023|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
30803522|NCT03214380|58820018|FG000|Treatment Period|Withdrawal by Subject|0|||
30803523|NCT03214380|58820019|FG001|Treatment Period|Withdrawal by Subject|10|||
30803524|NCT03214380|58820020|FG002|Treatment Period|Withdrawal by Subject|8|||
30803525|NCT03214380|58820021|FG003|Treatment Period|Withdrawal by Subject|0|||
30803526|NCT03214380|58820022|FG004|Treatment Period|Withdrawal by Subject|7|||
30803527|NCT03214380|58820023|FG005|Treatment Period|Withdrawal by Subject|11|||
30803528|NCT03214380|58820018|FG000|Treatment Period|Death|0|||
30803529|NCT03214380|58820019|FG001|Treatment Period|Death|1|||
30803530|NCT03214380|58820020|FG002|Treatment Period|Death|2|||
30803531|NCT03214380|58820021|FG003|Treatment Period|Death|0|||
30803532|NCT03214380|58820022|FG004|Treatment Period|Death|0|||
30803533|NCT03214380|58820023|FG005|Treatment Period|Death|0|||
30803534|NCT03214380|58820018|FG000|Treatment Period|Lost to Follow-up|0|||
30803535|NCT03214380|58820019|FG001|Treatment Period|Lost to Follow-up|6|||
30803536|NCT03214380|58820020|FG002|Treatment Period|Lost to Follow-up|3|||
30803537|NCT03214380|58820021|FG003|Treatment Period|Lost to Follow-up|0|||
30803538|NCT03214380|58820022|FG004|Treatment Period|Lost to Follow-up|0|||
30803539|NCT03214380|58820023|FG005|Treatment Period|Lost to Follow-up|0|||
30803540|NCT03214380|58820018|FG000|Treatment Period|Participant schedule|0|||
30803541|NCT03214380|58820019|FG001|Treatment Period|Participant schedule|0|||
30803542|NCT03214380|58820020|FG002|Treatment Period|Participant schedule|1|||
30747959|NCT00207090|58758194|FG000|Overall Study|Chest wall mass larger|1|||
30747960|NCT00207090|58758194|FG000|Overall Study|Disease progression/relapse|2|||
30747961|NCT00207090|58758194|FG000|Overall Study|Physician Decision|1|||
30747962|NCT00059332|58758205|FG000|Overall Study|Withdrawal by Subject|2|||
30747963|NCT00059332|58758206|FG001|Overall Study|Withdrawal by Subject|1|||
30747964|NCT00059332|58758205|FG000|Overall Study|Lost to Follow-up|1|||
30747965|NCT00059332|58758206|FG001|Overall Study|Lost to Follow-up|1|||
30747966|NCT00233454|58758212|FG000|Overall Study|Death|6|||
30747967|NCT00047320|58758216|FG000|Overall Study|Lack of Efficacy|8|||
30747968|NCT00047320|58758216|FG000|Overall Study|Lost to Follow-up|1|||
30747969|NCT00047320|58758216|FG000|Overall Study|Physician Decision|8|||
30747970|NCT00047320|58758216|FG000|Overall Study|Withdrawal by Subject|9|||
30747971|NCT00047320|58758216|FG000|Overall Study|Ineligible|2|||
30747972|NCT00233064|58758222|FG000|Overall Study|Lost to Follow-up|7|||
30747973|NCT00233064|58758223|FG001|Overall Study|Lost to Follow-up|7|||
30747974|NCT00233064|58758222|FG000|Overall Study|Withdrawal by Subject|5|||
30747975|NCT00233064|58758223|FG001|Overall Study|Withdrawal by Subject|3|||
30747976|NCT00233064|58758222|FG000|Overall Study|Death|0|||
30747977|NCT00233064|58758223|FG001|Overall Study|Death|1|||
30747978|NCT00233064|58758222|FG000|Overall Study|Relocation|0|||
30747979|NCT00233064|58758223|FG001|Overall Study|Relocation|1|||
30747980|NCT00233064|58758222|FG000|Overall Study|Protocol Violation|1|||
30747981|NCT00233064|58758223|FG001|Overall Study|Protocol Violation|0|||
30747982|NCT00233064|58758222|FG000|Overall Study|Moved to Dom. Republic|1|||
30747983|NCT00233064|58758223|FG001|Overall Study|Moved to Dom. Republic|0|||
30747984|NCT00268892|58758233|FG000|Overall Study|Adverse Event|14|||
30747985|NCT00268892|58758234|FG001|Overall Study|Adverse Event|17|||
30747986|NCT00268892|58758235|FG002|Overall Study|Adverse Event|20|||
30747987|NCT00268892|58758233|FG000|Overall Study|Lack of Efficacy|1|||
30747988|NCT00268892|58758234|FG001|Overall Study|Lack of Efficacy|3|||
30747989|NCT00268892|58758235|FG002|Overall Study|Lack of Efficacy|0|||
30747990|NCT00268892|58758233|FG000|Overall Study|Withdrawal by Subject|14|||
30747991|NCT00268892|58758234|FG001|Overall Study|Withdrawal by Subject|15|||
30747992|NCT00268892|58758235|FG002|Overall Study|Withdrawal by Subject|13|||
30747993|NCT00268892|58758233|FG000|Overall Study|Physician Decision|0|||
30747994|NCT00268892|58758234|FG001|Overall Study|Physician Decision|1|||
30747995|NCT00268892|58758235|FG002|Overall Study|Physician Decision|0|||
30747996|NCT00268892|58758233|FG000|Overall Study|Lost to Follow-up|5|||
30747997|NCT00268892|58758234|FG001|Overall Study|Lost to Follow-up|2|||
30747998|NCT00268892|58758235|FG002|Overall Study|Lost to Follow-up|4|||
30747999|NCT00268892|58758233|FG000|Overall Study|Protocol Violation|0|||
30748000|NCT00268892|58758234|FG001|Overall Study|Protocol Violation|1|||
30803543|NCT03214380|58820021|FG003|Treatment Period|Participant schedule|0|||
30803544|NCT03214380|58820022|FG004|Treatment Period|Participant schedule|0|||
30803545|NCT03214380|58820023|FG005|Treatment Period|Participant schedule|0|||
30803546|NCT03214380|58820018|FG000|Treatment Period|Treatment Interruption|0|||
30803547|NCT03214380|58820019|FG001|Treatment Period|Treatment Interruption|0|||
30748001|NCT00268892|58758235|FG002|Overall Study|Protocol Violation|0|||
30748002|NCT00268892|58758233|FG000|Overall Study|Disease Progression|1|||
30748003|NCT00268892|58758234|FG001|Overall Study|Disease Progression|1|||
30748004|NCT00268892|58758235|FG002|Overall Study|Disease Progression|0|||
30748005|NCT00268892|58758233|FG000|Overall Study|Trial Site Closed|4|||
30748006|NCT00268892|58758234|FG001|Overall Study|Trial Site Closed|2|||
30748007|NCT00268892|58758235|FG002|Overall Study|Trial Site Closed|2|||
30748008|NCT00206076|58758245|FG000|Overall Study|Physician Decision|2|||
30748009|NCT00206076|58758246|FG001|Overall Study|Physician Decision|0|||
30748010|NCT00206076|58758245|FG000|Overall Study|Withdrawal by Subject|1|||
30803548|NCT03214380|58820020|FG002|Treatment Period|Treatment Interruption|1|||
30803549|NCT03214380|58820021|FG003|Treatment Period|Treatment Interruption|0|||
30803550|NCT03214380|58820022|FG004|Treatment Period|Treatment Interruption|0|||
30803551|NCT03214380|58820023|FG005|Treatment Period|Treatment Interruption|0|||
30803552|NCT02674464|58820037|FG000|Overall Study|Death|10|||
30803553|NCT02674464|58820038|FG001|Overall Study|Death|21|||
30803554|NCT02674464|58820037|FG000|Overall Study|Withdrawal by Subject|24|||
30803555|NCT02674464|58820038|FG001|Overall Study|Withdrawal by Subject|44|||
30803556|NCT02674464|58820037|FG000|Overall Study|Lost to Follow-up|97|||
30803557|NCT02674464|58820038|FG001|Overall Study|Lost to Follow-up|92|||
30803558|NCT02674464|58820037|FG000|Overall Study|Outside survey window|6|||
30803559|NCT02674464|58820038|FG001|Overall Study|Outside survey window|3|||
30803560|NCT03172026|58820046|FG000|Overall Study|Withdrawal by Subject|1|||
30803561|NCT03172026|58820047|FG001|Overall Study|Withdrawal by Subject|0|||
30803562|NCT03172026|58820046|FG000|Overall Study|COVID restrictions|1|||
30803563|NCT03172026|58820047|FG001|Overall Study|COVID restrictions|0|||
30803564|NCT01343888|58820057|FG000|Overall Study|Adverse Event|12|||
30803565|NCT01343888|58820058|FG001|Overall Study|Adverse Event|22|||
30803566|NCT01343888|58820059|FG002|Overall Study|Adverse Event|5|||
30803567|NCT01343888|58820057|FG000|Overall Study|Lack of Efficacy|9|||
30803568|NCT01343888|58820058|FG001|Overall Study|Lack of Efficacy|9|||
30803569|NCT01343888|58820059|FG002|Overall Study|Lack of Efficacy|13|||
30803570|NCT01343888|58820057|FG000|Overall Study|Lost to Follow-up|0|||
30803571|NCT01343888|58820058|FG001|Overall Study|Lost to Follow-up|2|||
30803572|NCT01343888|58820059|FG002|Overall Study|Lost to Follow-up|1|||
30803573|NCT01343888|58820057|FG000|Overall Study|Protocol Violation|0|||
30748011|NCT00206076|58758246|FG001|Overall Study|Withdrawal by Subject|1|||
30748012|NCT00278954|58758254|FG000|Overall Study|Adverse Event|3|||
30748013|NCT00278954|58758254|FG000|Overall Study|Lost to Follow-up|1|||
30748014|NCT00278954|58758254|FG000|Overall Study|Withdrawal by Subject|1|||
30748015|NCT00278564|58758258|FG000|Overall Study|Lack of Efficacy|4|||
30748016|NCT00268346|58758264|FG000|Overall Study|Adverse Event|0|||
30748017|NCT00268346|58758265|FG001|Overall Study|Adverse Event|1|||
30748018|NCT00268346|58758264|FG000|Overall Study|Death|0|||
30748019|NCT00268346|58758265|FG001|Overall Study|Death|1|||
30748020|NCT00268346|58758264|FG000|Overall Study|Withdrawal by Subject|0|||
30748021|NCT00268346|58758265|FG001|Overall Study|Withdrawal by Subject|1|||
30748022|NCT00203892|58758274|FG000|Overall Study|Physician Decision|1|||
30748023|NCT00203892|58758275|FG001|Overall Study|Physician Decision|2|||
30748024|NCT00203892|58758276|FG002|Overall Study|Physician Decision|0|||
30748025|NCT00203892|58758274|FG000|Overall Study|Death|1|||
30748026|NCT00203892|58758275|FG001|Overall Study|Death|0|||
30748027|NCT00203892|58758276|FG002|Overall Study|Death|0|||
30748028|NCT00250718|58758284|FG000|Overall Study|Death|1|||
30748029|NCT00250718|58758284|FG000|Overall Study|Adverse Event|1|||
30748030|NCT00250718|58758284|FG000|Overall Study|Withdrawal by Subject|1|||
30748031|NCT00276614|58758288|FG000|Overall Study|Progression of disease under study|3|||
30748032|NCT00276458|58758294|FG000|Overall Study|Adverse Event|0|||
30748033|NCT00276458|58758295|FG001|Overall Study|Adverse Event|2|||
30748034|NCT00276458|58758294|FG000|Overall Study|Lost to Follow-up|2|||
30748035|NCT00276458|58758295|FG001|Overall Study|Lost to Follow-up|2|||
30748036|NCT00276458|58758294|FG000|Overall Study|Protocol Violation|4|||
30748037|NCT00276458|58758295|FG001|Overall Study|Protocol Violation|3|||
30748038|NCT00276380|58758303|FG000|Overall Study|Adverse Event|5|||
30748039|NCT00276380|58758304|FG001|Overall Study|Adverse Event|3|||
30748040|NCT00276380|58758303|FG000|Overall Study|Lost to Follow-up|1|||
30748041|NCT00276380|58758304|FG001|Overall Study|Lost to Follow-up|1|||
30748042|NCT00276380|58758303|FG000|Overall Study|Withdrawal by Subject|3|||
30748043|NCT00276380|58758304|FG001|Overall Study|Withdrawal by Subject|6|||
30748044|NCT00276380|58758303|FG000|Overall Study|Death|5|||
30748045|NCT00276380|58758304|FG001|Overall Study|Death|3|||
30748046|NCT00276380|58758303|FG000|Overall Study|Abnormal aPPT Levels|0|||
30748047|NCT00276380|58758304|FG001|Overall Study|Abnormal aPPT Levels|1|||
30748048|NCT00267956|58758313|FG000|Controlled Period|Adverse Event|4|||
30803574|NCT01343888|58820058|FG001|Overall Study|Protocol Violation|2|||
30803575|NCT01343888|58820059|FG002|Overall Study|Protocol Violation|0|||
30803576|NCT01343888|58820057|FG000|Overall Study|Withdrawal by Subject|4|||
30803577|NCT01343888|58820058|FG001|Overall Study|Withdrawal by Subject|4|||
30803578|NCT01343888|58820059|FG002|Overall Study|Withdrawal by Subject|2|||
30803579|NCT01343888|58820057|FG000|Overall Study|other than stated above|0|||
30803580|NCT01343888|58820058|FG001|Overall Study|other than stated above|0|||
30748049|NCT00267956|58758314|FG001|Controlled Period|Adverse Event|1|||
30748050|NCT00267956|58758315|FG002|Controlled Period|Adverse Event|0|||
30748051|NCT00267956|58758316|FG003|Controlled Period|Adverse Event|0|||
30748052|NCT00267956|58758313|FG000|Controlled Period|Lack of Efficacy|4|||
30748053|NCT00267956|58758314|FG001|Controlled Period|Lack of Efficacy|2|||
30748054|NCT00267956|58758315|FG002|Controlled Period|Lack of Efficacy|0|||
30748055|NCT00267956|58758316|FG003|Controlled Period|Lack of Efficacy|0|||
30748056|NCT00267956|58758313|FG000|Controlled Period|Lost to Follow-up|2|||
30803581|NCT01343888|58820059|FG002|Overall Study|other than stated above|1|||
30803582|NCT03589807|58820073|FG000|Overall Study|Lost to Follow-up|0|||
30803583|NCT03589807|58820074|FG001|Overall Study|Lost to Follow-up|2|||
30803584|NCT03589807|58820075|FG002|Overall Study|Lost to Follow-up|2|||
30803585|NCT03589807|58820076|FG003|Overall Study|Lost to Follow-up|3|||
30803586|NCT03589807|58820077|FG004|Overall Study|Lost to Follow-up|1|||
30803587|NCT03589807|58820078|FG005|Overall Study|Lost to Follow-up|1|||
30803588|NCT03589807|58820073|FG000|Overall Study|Withdrawal by Subject|0|||
30803589|NCT03589807|58820074|FG001|Overall Study|Withdrawal by Subject|5|||
30803590|NCT03589807|58820075|FG002|Overall Study|Withdrawal by Subject|0|||
30803591|NCT03589807|58820076|FG003|Overall Study|Withdrawal by Subject|0|||
30803592|NCT03589807|58820077|FG004|Overall Study|Withdrawal by Subject|0|||
30803593|NCT03589807|58820078|FG005|Overall Study|Withdrawal by Subject|0|||
30803594|NCT03589807|58820073|FG000|Overall Study|Protocol Violation|0|||
30803595|NCT03589807|58820074|FG001|Overall Study|Protocol Violation|0|||
30803596|NCT03589807|58820075|FG002|Overall Study|Protocol Violation|0|||
30803597|NCT03589807|58820076|FG003|Overall Study|Protocol Violation|1|||
30803598|NCT03589807|58820077|FG004|Overall Study|Protocol Violation|0|||
30803599|NCT03589807|58820078|FG005|Overall Study|Protocol Violation|0|||
30803600|NCT03589807|58820073|FG000|Overall Study|Enrolled but treatment not administered|0|||
30803601|NCT03589807|58820074|FG001|Overall Study|Enrolled but treatment not administered|0|||
30803602|NCT03589807|58820075|FG002|Overall Study|Enrolled but treatment not administered|0|||
30803603|NCT03589807|58820076|FG003|Overall Study|Enrolled but treatment not administered|0|||
30803604|NCT03589807|58820077|FG004|Overall Study|Enrolled but treatment not administered|1|||
30803605|NCT03589807|58820078|FG005|Overall Study|Enrolled but treatment not administered|0|||
30803606|NCT03544333|58820097|FG000|Overall Study|Withdrawal by Subject|1|||
30803607|NCT03544333|58820098|FG001|Overall Study|Withdrawal by Subject|0|||
30803608|NCT03560245|58820106|FG000|Overall Study|Withdrawal by Subject|3|||
30803609|NCT03560245|58820107|FG001|Overall Study|Withdrawal by Subject|2|||
30803610|NCT03560245|58820106|FG000|Overall Study|Adverse Event|1|||
30803611|NCT03560245|58820107|FG001|Overall Study|Adverse Event|1|||
30803612|NCT03560245|58820106|FG000|Overall Study|Protocol Violation|1|||
30803613|NCT03560245|58820107|FG001|Overall Study|Protocol Violation|0|||
30803614|NCT03560245|58820106|FG000|Overall Study|Death|0|||
30803615|NCT03560245|58820107|FG001|Overall Study|Death|1|||
30803616|NCT03560245|58820106|FG000|Overall Study|Lost to Follow-up|0|||
30803617|NCT03560245|58820107|FG001|Overall Study|Lost to Follow-up|1|||
30803618|NCT03560245|58820106|FG000|Overall Study|Physician Decision|0|||
30803619|NCT03560245|58820107|FG001|Overall Study|Physician Decision|1|||
30803620|NCT03560245|58820106|FG000|Overall Study|Other|0|||
30803621|NCT03560245|58820107|FG001|Overall Study|Other|1|||
30803622|NCT00707434|58820115|FG000|Overall Study|Adverse Event|1|||
30803623|NCT03054428|58820122|FG000|Overall Study|Physician Decision|0|||
30803624|NCT03054428|58820123|FG001|Overall Study|Physician Decision|1|||
30803625|NCT03054428|58820124|FG002|Overall Study|Physician Decision|1|||
30803626|NCT03054428|58820122|FG000|Overall Study|Lack of Efficacy|3|||
30748057|NCT00267956|58758314|FG001|Controlled Period|Lost to Follow-up|0|||
30748058|NCT00267956|58758315|FG002|Controlled Period|Lost to Follow-up|0|||
30748059|NCT00267956|58758316|FG003|Controlled Period|Lost to Follow-up|0|||
30748060|NCT00267956|58758313|FG000|Controlled Period|Withdrew consent|3|||
30748061|NCT00267956|58758314|FG001|Controlled Period|Withdrew consent|1|||
30748062|NCT00267956|58758315|FG002|Controlled Period|Withdrew consent|0|||
30748063|NCT00267956|58758316|FG003|Controlled Period|Withdrew consent|0|||
30748064|NCT00267956|58758313|FG000|After Controlled Period|Adverse Event|0|||
30748065|NCT00267956|58758314|FG001|After Controlled Period|Adverse Event|0|||
30748066|NCT00267956|58758315|FG002|After Controlled Period|Adverse Event|2|||
30748067|NCT00267956|58758316|FG003|After Controlled Period|Adverse Event|1|||
30748068|NCT00267956|58758313|FG000|After Controlled Period|Lack of Efficacy|0|||
30748069|NCT00267956|58758314|FG001|After Controlled Period|Lack of Efficacy|0|||
30748070|NCT00267956|58758315|FG002|After Controlled Period|Lack of Efficacy|1|||
30748071|NCT00267956|58758316|FG003|After Controlled Period|Lack of Efficacy|1|||
30748072|NCT00267956|58758313|FG000|After Controlled Period|Lost to Follow-up|0|||
30748073|NCT00267956|58758314|FG001|After Controlled Period|Lost to Follow-up|0|||
30748074|NCT00267956|58758315|FG002|After Controlled Period|Lost to Follow-up|1|||
30748075|NCT00267956|58758316|FG003|After Controlled Period|Lost to Follow-up|0|||
30803627|NCT03054428|58820123|FG001|Overall Study|Lack of Efficacy|1|||
30748076|NCT00267956|58758313|FG000|After Controlled Period|Withdrew consent|0|||
30803628|NCT03054428|58820124|FG002|Overall Study|Lack of Efficacy|0|||
30803629|NCT03054428|58820122|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
30803630|NCT03054428|58820123|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
30803631|NCT03054428|58820124|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
30803632|NCT03054428|58820122|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
30803633|NCT03054428|58820123|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
30803634|NCT03054428|58820124|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
30803635|NCT03054428|58820122|FG000|Overall Study|Transitioned to OLE study|76|||
30748077|NCT00267956|58758314|FG001|After Controlled Period|Withdrew consent|0|||
30907490|NCT02324153|58942010|FG001|Overall Study|Withdrawal by Subject|1|||
30907491|NCT02324153|58942009|FG000|Overall Study|Surgery postponed after randomization|3|||
30907492|NCT02324153|58942010|FG001|Overall Study|Surgery postponed after randomization|0|||
30907493|NCT02324153|58942009|FG000|Overall Study|Developed delirium preoperatively|1|||
30907494|NCT02324153|58942010|FG001|Overall Study|Developed delirium preoperatively|0|||
30907495|NCT02280473|58942018|FG000|Overall Study|Adverse Event|1|||
30907496|NCT02280473|58942019|FG001|Overall Study|Adverse Event|1|||
30907497|NCT02280473|58942018|FG000|Overall Study|Lack of Efficacy|0|||
30907498|NCT02280473|58942019|FG001|Overall Study|Lack of Efficacy|1|||
30907499|NCT02280473|58942018|FG000|Overall Study|Lost to Follow-up|0|||
30907500|NCT02280473|58942019|FG001|Overall Study|Lost to Follow-up|1|||
30907501|NCT01911273|58942027|FG000|Overall Study|Progression of Disease|1|||
30907502|NCT01911273|58942028|FG001|Overall Study|Progression of Disease|0|||
30907503|NCT01911273|58942027|FG000|Overall Study|Withdrawal by Subject|0|||
30907504|NCT01911273|58942028|FG001|Overall Study|Withdrawal by Subject|2|||
30907505|NCT02308007|58942037|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
30803636|NCT03054428|58820123|FG001|Overall Study|Transitioned to OLE study|76|||
30803637|NCT03054428|58820124|FG002|Overall Study|Transitioned to OLE study|73|||
30803638|NCT03054428|58820122|FG000|Overall Study|Withdrawal by Subject|3|||
30803639|NCT03054428|58820123|FG001|Overall Study|Withdrawal by Subject|2|||
30803640|NCT03054428|58820124|FG002|Overall Study|Withdrawal by Subject|3|||
30803641|NCT03054428|58820122|FG000|Overall Study|Lost to Follow-up|0|||
30803642|NCT03054428|58820123|FG001|Overall Study|Lost to Follow-up|0|||
30803643|NCT03054428|58820124|FG002|Overall Study|Lost to Follow-up|1|||
30803644|NCT03558997|58820136|FG000|Overall Study|Adverse Event|0|||
30748078|NCT00267956|58758315|FG002|After Controlled Period|Withdrew consent|1|||
30748079|NCT00267956|58758316|FG003|After Controlled Period|Withdrew consent|0|||
30748080|NCT00267488|58758324|FG000|Overall Study|Sponsor Terminated Study|9|||
30748081|NCT00267488|58758324|FG000|Overall Study|Protocol Violation|1|||
30748082|NCT00267488|58758324|FG000|Overall Study|Other (Disease Progression)|1|||
30748083|NCT00058552|58758330|FG000|Overall Study|Died prior to receiving treatment|4|||
30748084|NCT00058552|58758331|FG001|Overall Study|Died prior to receiving treatment|2|||
30748085|NCT00058552|58758330|FG000|Overall Study|Disease progression|52|||
30748086|NCT00058552|58758331|FG001|Overall Study|Disease progression|44|||
30748087|NCT00058552|58758330|FG000|Overall Study|Adverse Event|4|||
30803645|NCT03558997|58820137|FG001|Overall Study|Adverse Event|2|||
30803646|NCT03558997|58820138|FG002|Overall Study|Adverse Event|5|||
30622358|NCT00999804|58634050|FG001|Overall Study|Adverse Event|3|||
30622359|NCT00999804|58634049|FG000|Overall Study|Withdrawal by Subject|4|||
30803647|NCT03558997|58820139|FG003|Overall Study|Adverse Event|1|||
30622360|NCT00999804|58634050|FG001|Overall Study|Withdrawal by Subject|0|||
30748088|NCT00058552|58758331|FG001|Overall Study|Adverse Event|2|||
30748089|NCT00058552|58758330|FG000|Overall Study|Withdrawal by Subject|3|||
30748090|NCT00058552|58758331|FG001|Overall Study|Withdrawal by Subject|5|||
30907506|NCT02308007|58942038|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
30622361|NCT00999804|58634049|FG000|Overall Study|Death|1|||
30803648|NCT03558997|58820136|FG000|Overall Study|Physician Decision|0|||
30803649|NCT03558997|58820137|FG001|Overall Study|Physician Decision|0|||
30803650|NCT03558997|58820138|FG002|Overall Study|Physician Decision|1|||
30803651|NCT03558997|58820139|FG003|Overall Study|Physician Decision|0|||
30803652|NCT03558997|58820136|FG000|Overall Study|Withdrawal by Subject|1|||
30803653|NCT03558997|58820137|FG001|Overall Study|Withdrawal by Subject|0|||
30803654|NCT03558997|58820138|FG002|Overall Study|Withdrawal by Subject|1|||
30803655|NCT03558997|58820139|FG003|Overall Study|Withdrawal by Subject|1|||
30803656|NCT03558997|58820136|FG000|Overall Study|Lost to Follow-up|0|||
30803657|NCT03558997|58820137|FG001|Overall Study|Lost to Follow-up|0|||
30803658|NCT03558997|58820138|FG002|Overall Study|Lost to Follow-up|1|||
30803659|NCT03558997|58820139|FG003|Overall Study|Lost to Follow-up|0|||
30803660|NCT03052400|58820154|FG000|Overall Study|Lost to Follow-up|1|||
30803661|NCT03052400|58820155|FG001|Overall Study|Lost to Follow-up|0|||
30803662|NCT03052400|58820154|FG000|Overall Study|Withdrawal by Subject|0|||
30803663|NCT03052400|58820155|FG001|Overall Study|Withdrawal by Subject|1|||
30803664|NCT03538951|58820163|FG000|Overall Study|Withdrawal by Subject|1|||
30803665|NCT03538951|58820164|FG001|Overall Study|Withdrawal by Subject|2|||
30803666|NCT03052322|58820172|FG000|Overall Study|Other un-specified|1|||
30803667|NCT03052322|58820173|FG001|Overall Study|Other un-specified|2|||
30803668|NCT03052322|58820172|FG000|Overall Study|Withdrawal by Subject|10|||
30803669|NCT03052322|58820173|FG001|Overall Study|Withdrawal by Subject|9|||
30803670|NCT03052322|58820172|FG000|Overall Study|Death|0|||
30803671|NCT03052322|58820173|FG001|Overall Study|Death|2|||
30803672|NCT03052322|58820172|FG000|Overall Study|Lack of Efficacy|1|||
30803673|NCT03052322|58820173|FG001|Overall Study|Lack of Efficacy|2|||
30803674|NCT03052322|58820172|FG000|Overall Study|Protocol Violation|1|||
30803675|NCT03052322|58820173|FG001|Overall Study|Protocol Violation|0|||
30803676|NCT03052322|58820172|FG000|Overall Study|Lost to Follow-up|2|||
30803677|NCT03052322|58820173|FG001|Overall Study|Lost to Follow-up|4|||
30803678|NCT03052322|58820172|FG000|Overall Study|Adverse Event|6|||
30803679|NCT03052322|58820173|FG001|Overall Study|Adverse Event|13|||
30803680|NCT03521791|58820181|FG000|Overall Study|Protocol Violation|7|||
30803681|NCT03521791|58820182|FG001|Overall Study|Protocol Violation|17|||
30803682|NCT03521635|58820190|FG000|Overall Study|Adverse Event|1|||
30803683|NCT03521635|58820191|FG001|Overall Study|Adverse Event|1|||
30803684|NCT03521635|58820190|FG000|Overall Study|Refused to complete study visit|1|||
30803685|NCT03521635|58820191|FG001|Overall Study|Refused to complete study visit|0|||
30803686|NCT03521635|58820190|FG000|Overall Study|Refused to continue trial medication|2|||
30803687|NCT03521635|58820191|FG001|Overall Study|Refused to continue trial medication|2|||
30803688|NCT03521635|58820190|FG000|Overall Study|Lost to Follow-up|0|||
30803689|NCT03521635|58820191|FG001|Overall Study|Lost to Follow-up|1|||
30803690|NCT03521635|58820190|FG000|Overall Study|Meet exclusion criteria|0|||
30803691|NCT03521635|58820191|FG001|Overall Study|Meet exclusion criteria|1|||
30803692|NCT03521635|58820190|FG000|Overall Study|Patient not taken study medicine|0|||
30803693|NCT03521635|58820191|FG001|Overall Study|Patient not taken study medicine|1|||
30803694|NCT03170544|58820209|FG000|Part 1|Lost to Follow-up|1|||
30803695|NCT03170544|58820210|FG001|Part 1|Lost to Follow-up|0|||
30622362|NCT00999804|58634050|FG001|Overall Study|Death|0|||
30803696|NCT03170544|58820211|FG002|Part 1|Lost to Follow-up|0|||
30803697|NCT03170544|58820212|FG003|Part 1|Lost to Follow-up|0|||
30803698|NCT03170544|58820213|FG004|Part 1|Lost to Follow-up|0|||
30803699|NCT03170544|58820214|FG005|Part 1|Lost to Follow-up|0|||
30803700|NCT03170544|58820215|FG006|Part 1|Lost to Follow-up|0|||
30803701|NCT03170544|58820216|FG007|Part 1|Lost to Follow-up|0|||
30803702|NCT03170544|58820217|FG008|Part 1|Lost to Follow-up|0|||
30803703|NCT03170544|58820218|FG009|Part 1|Lost to Follow-up|0|||
30803704|NCT03170544|58820219|FG010|Part 1|Lost to Follow-up|0|||
30803705|NCT03170544|58820220|FG011|Part 1|Lost to Follow-up|0|||
30803706|NCT03170544|58820209|FG000|Part 1|Not treated|0|||
30803707|NCT03170544|58820210|FG001|Part 1|Not treated|0|||
30803708|NCT03170544|58820211|FG002|Part 1|Not treated|0|||
30803709|NCT03170544|58820212|FG003|Part 1|Not treated|1|||
30803710|NCT03170544|58820213|FG004|Part 1|Not treated|0|||
30803711|NCT03170544|58820214|FG005|Part 1|Not treated|0|||
30803712|NCT03170544|58820215|FG006|Part 1|Not treated|0|||
30803713|NCT03170544|58820216|FG007|Part 1|Not treated|0|||
30803714|NCT03170544|58820217|FG008|Part 1|Not treated|0|||
30803715|NCT03170544|58820218|FG009|Part 1|Not treated|0|||
30803716|NCT03170544|58820219|FG010|Part 1|Not treated|0|||
30803717|NCT03170544|58820220|FG011|Part 1|Not treated|0|||
30803718|NCT03582943|58820305|FG000|Allocated to Groups|Withdrawal by Subject|1|||
30803719|NCT03582943|58820306|FG001|Allocated to Groups|Withdrawal by Subject|1|||
30748091|NCT00058552|58758330|FG000|Overall Study|Physician Decision|2|||
30748092|NCT00058552|58758331|FG001|Overall Study|Physician Decision|5|||
30748093|NCT00058552|58758330|FG000|Overall Study|Clinical disease progression|0|||
30748094|NCT00058552|58758331|FG001|Overall Study|Clinical disease progression|4|||
30748095|NCT00044512|58758339|FG000|Follow Up|Lost to Follow-up|2|||
30748096|NCT03805438|58758343|FG000|Overall Study|Lack of Efficacy|1|||
30748097|NCT03805438|58758343|FG000|Overall Study|Protocol Violation|1|||
30748098|NCT00147537|58758351|FG000|Phase 1b|Death|0|||
30748099|NCT00147537|58758352|FG001|Phase 1b|Death|1|||
30748100|NCT00147537|58758353|FG002|Phase 1b|Death|2|||
30748101|NCT00147537|58758354|FG003|Phase 1b|Death|1|||
30748102|NCT00147537|58758355|FG004|Phase 1b|Death|2|||
30748103|NCT00147537|58758356|FG005|Phase 1b|Death|2|||
30748104|NCT00147537|58758357|FG006|Phase 1b|Death|1|||
30748105|NCT00147537|58758358|FG007|Phase 1b|Death|3|||
30748106|NCT00147537|58758359|FG008|Phase 1b|Death|9|||
30748107|NCT00147537|58758360|FG009|Phase 1b|Death|0|||
30748108|NCT00147537|58758361|FG010|Phase 1b|Death|0|||
30748109|NCT00147537|58758351|FG000|Phase 1b|Lost to Follow-up|2|||
30748110|NCT00147537|58758352|FG001|Phase 1b|Lost to Follow-up|1|||
30748111|NCT00147537|58758353|FG002|Phase 1b|Lost to Follow-up|0|||
30748112|NCT00147537|58758354|FG003|Phase 1b|Lost to Follow-up|0|||
30748113|NCT00147537|58758355|FG004|Phase 1b|Lost to Follow-up|0|||
30748114|NCT00147537|58758356|FG005|Phase 1b|Lost to Follow-up|0|||
30748115|NCT00147537|58758357|FG006|Phase 1b|Lost to Follow-up|2|||
30748116|NCT00147537|58758358|FG007|Phase 1b|Lost to Follow-up|0|||
30748117|NCT00147537|58758359|FG008|Phase 1b|Lost to Follow-up|1|||
30748118|NCT00147537|58758360|FG009|Phase 1b|Lost to Follow-up|0|||
30748119|NCT00147537|58758361|FG010|Phase 1b|Lost to Follow-up|0|||
30748120|NCT00147537|58758351|FG000|Phase 1b|Other|0|||
30748121|NCT00147537|58758352|FG001|Phase 1b|Other|0|||
30748122|NCT00147537|58758353|FG002|Phase 1b|Other|2|||
30748123|NCT00147537|58758354|FG003|Phase 1b|Other|1|||
30748124|NCT00147537|58758355|FG004|Phase 1b|Other|1|||
30748125|NCT00147537|58758356|FG005|Phase 1b|Other|1|||
30748126|NCT00147537|58758357|FG006|Phase 1b|Other|14|||
30748127|NCT00147537|58758358|FG007|Phase 1b|Other|4|||
30748128|NCT00147537|58758359|FG008|Phase 1b|Other|4|||
30748129|NCT00147537|58758360|FG009|Phase 1b|Other|0|||
30748130|NCT00147537|58758361|FG010|Phase 1b|Other|0|||
30748131|NCT00147537|58758351|FG000|Phase 1b|Withdrawal by Subject|0|||
30748132|NCT00147537|58758352|FG001|Phase 1b|Withdrawal by Subject|0|||
30748133|NCT00147537|58758353|FG002|Phase 1b|Withdrawal by Subject|0|||
30748134|NCT00147537|58758354|FG003|Phase 1b|Withdrawal by Subject|0|||
30748135|NCT00147537|58758355|FG004|Phase 1b|Withdrawal by Subject|0|||
30748136|NCT00147537|58758356|FG005|Phase 1b|Withdrawal by Subject|0|||
30748137|NCT00147537|58758357|FG006|Phase 1b|Withdrawal by Subject|0|||
30803720|NCT03582943|58820305|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
30803721|NCT03582943|58820306|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
30803722|NCT03582943|58820305|FG000|Analyzed|Protocol Violation|4|||
30803723|NCT03582943|58820306|FG001|Analyzed|Protocol Violation|1|||
30803724|NCT03532009|58820314|FG000|Overall Study|Other|1|||
30803725|NCT03532009|58820315|FG001|Overall Study|Other|1|||
30803726|NCT03532009|58820314|FG000|Overall Study|Death|1|||
30803727|NCT03532009|58820315|FG001|Overall Study|Death|1|||
30803728|NCT03532009|58820314|FG000|Overall Study|Withdrawal by Patient|0|||
30803729|NCT03532009|58820315|FG001|Overall Study|Withdrawal by Patient|2|||
30803730|NCT03520387|58820326|FG000|Pre-Randomization|Withdrawal by Subject|1|||
30803731|NCT03520387|58820327|FG001|Pre-Randomization|Withdrawal by Subject|0|||
30803732|NCT03520387|58820328|FG002|Pre-Randomization|Withdrawal by Subject|0|||
30803733|NCT03520387|58820329|FG003|Pre-Randomization|Withdrawal by Subject|0|||
30803734|NCT03520387|58820330|FG004|Pre-Randomization|Withdrawal by Subject|0|||
30803735|NCT03520387|58820326|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
30803736|NCT03520387|58820327|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
30803737|NCT03520387|58820328|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
30803738|NCT03520387|58820329|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
30803739|NCT03520387|58820330|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
30803740|NCT03170232|58820343|FG000|Overall Study|Adverse Event|0|||
30803741|NCT03170232|58820344|FG001|Overall Study|Adverse Event|1|||
30803742|NCT03170232|58820343|FG000|Overall Study|Protocol Violation|0|||
30803743|NCT03170232|58820344|FG001|Overall Study|Protocol Violation|1|||
30803744|NCT03170232|58820343|FG000|Overall Study|Lack of Efficacy|0|||
30803745|NCT03170232|58820344|FG001|Overall Study|Lack of Efficacy|1|||
30803746|NCT03170232|58820343|FG000|Overall Study|Study closed/terminated|26|||
30803747|NCT03170232|58820344|FG001|Overall Study|Study closed/terminated|23|||
30803748|NCT03170232|58820343|FG000|Overall Study|Lost to Follow-up|1|||
30803749|NCT03170232|58820344|FG001|Overall Study|Lost to Follow-up|0|||
30803750|NCT03170232|58820343|FG000|Overall Study|Withdrawal by Subject|0|||
30803751|NCT03170232|58820344|FG001|Overall Study|Withdrawal by Subject|1|||
30803752|NCT03519919|58820350|FG000|Overall Study|Withdrawal by Subject|1|||
30803753|NCT03519919|58820350|FG000|Overall Study|Lack of Efficacy|1|||
30803754|NCT03519919|58820350|FG000|Overall Study|Screen Failure|1|||
30803755|NCT03478969|58820383|FG000|Overall Study|Withdrawal by Subject|4|||
30803756|NCT03478969|58820384|FG001|Overall Study|Withdrawal by Subject|7|||
30803757|NCT03478969|58820385|FG002|Overall Study|Withdrawal by Subject|6|||
30803758|NCT03478969|58820383|FG000|Overall Study|Adverse Event|2|||
30803759|NCT03478969|58820384|FG001|Overall Study|Adverse Event|0|||
30803760|NCT03478969|58820385|FG002|Overall Study|Adverse Event|1|||
30803761|NCT03478969|58820383|FG000|Overall Study|Pregnancy|1|||
30803762|NCT03478969|58820384|FG001|Overall Study|Pregnancy|0|||
30803763|NCT03478969|58820385|FG002|Overall Study|Pregnancy|0|||
30803764|NCT03478969|58820383|FG000|Overall Study|Personal Reasons|1|||
30803765|NCT03478969|58820384|FG001|Overall Study|Personal Reasons|0|||
30803766|NCT03478969|58820385|FG002|Overall Study|Personal Reasons|1|||
30803767|NCT03478969|58820383|FG000|Overall Study|Covid-19|1|||
30803768|NCT03478969|58820384|FG001|Overall Study|Covid-19|4|||
30803769|NCT03478969|58820385|FG002|Overall Study|Covid-19|3|||
30803770|NCT03478969|58820383|FG000|Overall Study|Multiple Reasons|0|||
30803771|NCT03478969|58820384|FG001|Overall Study|Multiple Reasons|1|||
30803772|NCT03478969|58820385|FG002|Overall Study|Multiple Reasons|1|||
30803773|NCT03478969|58820383|FG000|Overall Study|Eligibility Criteria|0|||
30803774|NCT03478969|58820384|FG001|Overall Study|Eligibility Criteria|0|||
30803775|NCT03478969|58820385|FG002|Overall Study|Eligibility Criteria|5|||
30803776|NCT03478969|58820383|FG000|Overall Study|Lost to Follow-up|0|||
30803777|NCT03478969|58820384|FG001|Overall Study|Lost to Follow-up|0|||
30803778|NCT03478969|58820385|FG002|Overall Study|Lost to Follow-up|1|||
30803779|NCT04823949|58820416|FG000|Overall Study|Withdrawal by Subject|0|||
30803780|NCT04823949|58820417|FG001|Overall Study|Withdrawal by Subject|4|||
30803781|NCT04823949|58820416|FG000|Overall Study|Physician Decision|0|||
30803782|NCT04823949|58820417|FG001|Overall Study|Physician Decision|1|||
30803783|NCT04499482|58820432|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
30803784|NCT04408794|58820451|FG000|Overall Study|Adverse Event|43|||
30803785|NCT04408794|58820451|FG000|Overall Study|Infrequent study drug usage|43|||
30803786|NCT04408794|58820451|FG000|Overall Study|Lack of Efficacy|61|||
30803787|NCT04408794|58820451|FG000|Overall Study|Lost to Follow-up|33|||
30803788|NCT04408794|58820451|FG000|Overall Study|Non-compliance|6|||
30803789|NCT04408794|58820451|FG000|Overall Study|Physician Decision|1|||
30803790|NCT04408794|58820451|FG000|Overall Study|Pregnancy|6|||
30803791|NCT04408794|58820451|FG000|Overall Study|Protocol Deviation|9|||
30803792|NCT04408794|58820451|FG000|Overall Study|Sheehan-STS Result|1|||
30803793|NCT04408794|58820451|FG000|Overall Study|Withdrawal by Subject|57|||
30803794|NCT04408794|58820451|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
30803795|NCT04408794|58820451|FG000|Overall Study|Never Treated Migraine|5|||
30803796|NCT04305405|58820486|FG000|Overall Study|Withdrawal by parent/guardian|0|||
30803797|NCT04305405|58820487|FG001|Overall Study|Withdrawal by parent/guardian|1|||
30803798|NCT03668119|58820504|FG000|Pre-treatment|Disease Progression|1|||
30803799|NCT03668119|58820505|FG001|Pre-treatment|Disease Progression|0|||
30803800|NCT03668119|58820504|FG000|Treatment|Disease Progression|75|||
30803801|NCT03668119|58820505|FG001|Treatment|Disease Progression|55|||
30803802|NCT03668119|58820504|FG000|Treatment|Study drug toxicity|19|||
30803803|NCT03668119|58820505|FG001|Treatment|Study drug toxicity|1|||
30803804|NCT03668119|58820504|FG000|Treatment|Death|3|||
30803805|NCT03668119|58820505|FG001|Treatment|Death|0|||
30803806|NCT03668119|58820504|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
30803807|NCT03668119|58820505|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
30803808|NCT03668119|58820504|FG000|Treatment|Withdrawal by Subject|2|||
30803809|NCT03668119|58820505|FG001|Treatment|Withdrawal by Subject|1|||
30803810|NCT03668119|58820504|FG000|Treatment|Participant request to discontinue study treatment|3|||
30803811|NCT03668119|58820505|FG001|Treatment|Participant request to discontinue study treatment|1|||
30803812|NCT03668119|58820504|FG000|Treatment|Maximum Clinical Benefit|0|||
30803813|NCT03668119|58820505|FG001|Treatment|Maximum Clinical Benefit|1|||
30803814|NCT03668119|58820504|FG000|Treatment|Participants completed treatment|20|||
30803815|NCT03668119|58820505|FG001|Treatment|Participants completed treatment|8|||
30803816|NCT03668119|58820504|FG000|Treatment|Other reasons|1|||
30803817|NCT03668119|58820505|FG001|Treatment|Other reasons|2|||
30803818|NCT03543410|58820520|FG000|Overall Study|Adverse Event|10|||
30803819|NCT03543410|58820521|FG001|Overall Study|Adverse Event|8|||
30803820|NCT03543410|58820522|FG002|Overall Study|Adverse Event|2|||
30803821|NCT03543410|58820520|FG000|Overall Study|Lack of Efficacy|0|||
30803822|NCT03543410|58820521|FG001|Overall Study|Lack of Efficacy|1|||
30803823|NCT03543410|58820522|FG002|Overall Study|Lack of Efficacy|0|||
30803824|NCT03543410|58820520|FG000|Overall Study|Lost to Follow-up|0|||
30803825|NCT03543410|58820521|FG001|Overall Study|Lost to Follow-up|1|||
30803826|NCT03543410|58820522|FG002|Overall Study|Lost to Follow-up|0|||
30803827|NCT03543410|58820520|FG000|Overall Study|Withdrawal by Subject|5|||
30803828|NCT03543410|58820521|FG001|Overall Study|Withdrawal by Subject|2|||
30803829|NCT03543410|58820522|FG002|Overall Study|Withdrawal by Subject|8|||
30803830|NCT03543410|58820520|FG000|Overall Study|Protocol Violation|0|||
30803831|NCT03543410|58820521|FG001|Overall Study|Protocol Violation|1|||
30803832|NCT03543410|58820522|FG002|Overall Study|Protocol Violation|0|||
30803833|NCT03543410|58820520|FG000|Overall Study|Due to COVID-19|4|||
30803834|NCT03543410|58820521|FG001|Overall Study|Due to COVID-19|0|||
30803835|NCT03543410|58820522|FG002|Overall Study|Due to COVID-19|2|||
30803836|NCT03543410|58820520|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
30803837|NCT03543410|58820521|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
30803838|NCT03543410|58820522|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
30803839|NCT03543410|58820520|FG000|Overall Study|Not Due to COVID-19|2|||
30803840|NCT03543410|58820521|FG001|Overall Study|Not Due to COVID-19|0|||
30803841|NCT03543410|58820522|FG002|Overall Study|Not Due to COVID-19|1|||
30803842|NCT03294590|58820532|FG000|Overall Study|Lost to Follow-up|105|||
30803843|NCT03294590|58820533|FG001|Overall Study|Lost to Follow-up|107|||
30803844|NCT02908074|58820547|FG000|Overall Study|sponsor/ICON decision|0|||
30803845|NCT02908074|58820548|FG001|Overall Study|sponsor/ICON decision|0|||
30803846|NCT02908074|58820549|FG002|Overall Study|sponsor/ICON decision|1|||
30803847|NCT02908074|58820550|FG003|Overall Study|sponsor/ICON decision|0|||
30803848|NCT02908074|58820551|FG004|Overall Study|sponsor/ICON decision|0|||
30803849|NCT02908074|58820552|FG005|Overall Study|sponsor/ICON decision|0|||
30803850|NCT02908074|58820547|FG000|Overall Study|Protocol Violation|0|||
30803851|NCT02908074|58820548|FG001|Overall Study|Protocol Violation|1|||
30803852|NCT02908074|58820549|FG002|Overall Study|Protocol Violation|0|||
30803853|NCT02908074|58820550|FG003|Overall Study|Protocol Violation|0|||
30803854|NCT02908074|58820551|FG004|Overall Study|Protocol Violation|0|||
30803855|NCT02908074|58820552|FG005|Overall Study|Protocol Violation|0|||
30803856|NCT02908074|58820547|FG000|Overall Study|Adverse Event|5|||
30803857|NCT02908074|58820548|FG001|Overall Study|Adverse Event|2|||
30803858|NCT02908074|58820549|FG002|Overall Study|Adverse Event|0|||
30803859|NCT02908074|58820550|FG003|Overall Study|Adverse Event|0|||
30907507|NCT02308007|58942039|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
30907508|NCT02308007|58942037|FG000|Overall Study|Positive for STD at Baseline|7|||
30907509|NCT02308007|58942038|FG001|Overall Study|Positive for STD at Baseline|11|||
30907510|NCT02308007|58942039|FG002|Overall Study|Positive for STD at Baseline|7|||
30907511|NCT02308007|58942037|FG000|Overall Study|Lost to Follow-up|3|||
30907512|NCT02308007|58942038|FG001|Overall Study|Lost to Follow-up|0|||
30622363|NCT00999804|58634049|FG000|Overall Study|Ineligible|3|||
30622364|NCT00999804|58634050|FG001|Overall Study|Ineligible|0|||
30803860|NCT02908074|58820551|FG004|Overall Study|Adverse Event|1|||
30803861|NCT02908074|58820552|FG005|Overall Study|Adverse Event|0|||
30803862|NCT02908074|58820547|FG000|Overall Study|AESI|1|||
30803863|NCT02908074|58820548|FG001|Overall Study|AESI|0|||
30803864|NCT02908074|58820549|FG002|Overall Study|AESI|1|||
30803865|NCT02908074|58820550|FG003|Overall Study|AESI|0|||
30907513|NCT02308007|58942039|FG002|Overall Study|Lost to Follow-up|1|||
30803866|NCT02908074|58820551|FG004|Overall Study|AESI|1|||
30803867|NCT02908074|58820552|FG005|Overall Study|AESI|0|||
30803868|NCT02908074|58820547|FG000|Overall Study|Discontinuation criteria per protocol|0|||
30803869|NCT02908074|58820548|FG001|Overall Study|Discontinuation criteria per protocol|0|||
30803870|NCT02908074|58820549|FG002|Overall Study|Discontinuation criteria per protocol|1|||
30803871|NCT02908074|58820550|FG003|Overall Study|Discontinuation criteria per protocol|0|||
30803872|NCT02908074|58820551|FG004|Overall Study|Discontinuation criteria per protocol|0|||
30803873|NCT02908074|58820552|FG005|Overall Study|Discontinuation criteria per protocol|1|||
30803874|NCT02908074|58820547|FG000|Overall Study|Withdrawal by Subject|3|||
30803875|NCT02908074|58820548|FG001|Overall Study|Withdrawal by Subject|2|||
30803876|NCT02908074|58820549|FG002|Overall Study|Withdrawal by Subject|2|||
30803877|NCT02908074|58820550|FG003|Overall Study|Withdrawal by Subject|2|||
30803878|NCT02908074|58820551|FG004|Overall Study|Withdrawal by Subject|2|||
30803879|NCT02908074|58820552|FG005|Overall Study|Withdrawal by Subject|2|||
30803880|NCT02908074|58820547|FG000|Overall Study|Lost to Follow-up|0|||
30803881|NCT02908074|58820548|FG001|Overall Study|Lost to Follow-up|1|||
30803882|NCT02908074|58820549|FG002|Overall Study|Lost to Follow-up|1|||
30803883|NCT02908074|58820550|FG003|Overall Study|Lost to Follow-up|1|||
30803884|NCT02908074|58820551|FG004|Overall Study|Lost to Follow-up|0|||
30803885|NCT02908074|58820552|FG005|Overall Study|Lost to Follow-up|1|||
30803886|NCT02907359|58820571|FG000|Overall Study|Death|234|||
30803887|NCT02907359|58820572|FG001|Overall Study|Death|117|||
30803888|NCT02907359|58820571|FG000|Overall Study|Withdrawal by Subject|6|||
30803889|NCT02907359|58820572|FG001|Overall Study|Withdrawal by Subject|11|||
30803890|NCT02907359|58820571|FG000|Overall Study|Lost to Follow-up|1|||
30803891|NCT02907359|58820572|FG001|Overall Study|Lost to Follow-up|0|||
30803892|NCT02714205|58820580|FG000|Overall Study|Cannot tolerate medication|1|||
30803893|NCT02714205|58820581|FG001|Overall Study|Cannot tolerate medication|0|||
30803894|NCT02714205|58820580|FG000|Overall Study|Adverse Event|2|||
30803895|NCT02714205|58820581|FG001|Overall Study|Adverse Event|0|||
30803896|NCT02714205|58820580|FG000|Overall Study|Too busy|1|||
30803897|NCT02714205|58820581|FG001|Overall Study|Too busy|0|||
30803898|NCT02714205|58820580|FG000|Overall Study|Incomplete outcome data|0|||
30803899|NCT02714205|58820581|FG001|Overall Study|Incomplete outcome data|1|||
30803900|NCT02152995|58820605|FG000|Overall Study|Withdrawal by Subject|1|||
30803901|NCT02152995|58820606|FG001|Overall Study|Withdrawal by Subject|0|||
30803902|NCT00583752|58820615|FG000|Overall Study|Lost to Follow-up|5|||
30803903|NCT00583752|58820616|FG001|Overall Study|Lost to Follow-up|5|||
30803904|NCT02318784|58820623|FG000|Overall Study|Adverse Event|13|||
30803905|NCT02318784|58820623|FG000|Overall Study|Death|2|||
30803906|NCT02318784|58820623|FG000|Overall Study|Progressive Disease|37|||
30803907|NCT02318784|58820623|FG000|Overall Study|Withdrawal by Subject|10|||
30803908|NCT03170154|58820638|FG000|Overall Study|Lost to Follow-up|4|||
30803909|NCT03170154|58820638|FG000|Overall Study|Death|2|||
30803910|NCT03170154|58820638|FG000|Overall Study|Withdrawal by Subject|2|||
30803911|NCT03518125|58820653|FG000|Overall Study|Lost to Follow-up|0|||
30803912|NCT03518125|58820654|FG001|Overall Study|Lost to Follow-up|2|||
30803913|NCT03518125|58820655|FG002|Overall Study|Lost to Follow-up|0|||
30803914|NCT03518125|58820656|FG003|Overall Study|Lost to Follow-up|0|||
30803915|NCT03518125|58820657|FG004|Overall Study|Lost to Follow-up|3|||
30803916|NCT03518125|58820658|FG005|Overall Study|Lost to Follow-up|5|||
30803917|NCT03518125|58820653|FG000|Overall Study|Physician Decision|0|||
30803918|NCT03518125|58820654|FG001|Overall Study|Physician Decision|1|||
30803919|NCT03518125|58820655|FG002|Overall Study|Physician Decision|0|||
30803920|NCT03518125|58820656|FG003|Overall Study|Physician Decision|0|||
30803921|NCT03518125|58820657|FG004|Overall Study|Physician Decision|0|||
30803922|NCT03518125|58820658|FG005|Overall Study|Physician Decision|0|||
30803923|NCT03518125|58820653|FG000|Overall Study|Withdrawal by Subject|1|||
30803924|NCT03518125|58820654|FG001|Overall Study|Withdrawal by Subject|1|||
30803925|NCT03518125|58820655|FG002|Overall Study|Withdrawal by Subject|0|||
30803926|NCT03518125|58820656|FG003|Overall Study|Withdrawal by Subject|1|||
30803927|NCT03518125|58820657|FG004|Overall Study|Withdrawal by Subject|1|||
30803928|NCT03518125|58820658|FG005|Overall Study|Withdrawal by Subject|3|||
30803929|NCT03518125|58820653|FG000|Overall Study|Missed Day 394 Visit|1|||
30803930|NCT03518125|58820654|FG001|Overall Study|Missed Day 394 Visit|0|||
30803931|NCT03518125|58820655|FG002|Overall Study|Missed Day 394 Visit|0|||
30803932|NCT03518125|58820656|FG003|Overall Study|Missed Day 394 Visit|0|||
30803933|NCT03518125|58820657|FG004|Overall Study|Missed Day 394 Visit|0|||
30803934|NCT03518125|58820658|FG005|Overall Study|Missed Day 394 Visit|0|||
30803935|NCT03169530|58820675|FG000|Overall Study|Study ended by NIH|15|||
30803936|NCT03169530|58820676|FG001|Overall Study|Study ended by NIH|17|||
30803937|NCT03478891|58820694|FG000|Overall Study|Enrolled, but product never administered|0|||
30803938|NCT03478891|58820695|FG001|Overall Study|Enrolled, but product never administered|0|||
30803939|NCT03478891|58820696|FG002|Overall Study|Enrolled, but product never administered|1|||
30803940|NCT03478891|58820694|FG000|Overall Study|Moved from area|0|||
30803941|NCT03478891|58820695|FG001|Overall Study|Moved from area|0|||
30803942|NCT03478891|58820696|FG002|Overall Study|Moved from area|1|||
30803943|NCT03478891|58820694|FG000|Overall Study|Lost to Follow-up|1|||
30803944|NCT03478891|58820695|FG001|Overall Study|Lost to Follow-up|0|||
30803945|NCT03478891|58820696|FG002|Overall Study|Lost to Follow-up|1|||
30803946|NCT01585103|58820708|FG000|Overall Study|Unable to swallow Cytosponge|6|||
30803947|NCT03168906|58820714|FG000|Overall Study|Lack of Efficacy|6|||
30803948|NCT03168906|58820715|FG001|Overall Study|Lack of Efficacy|6|||
30803949|NCT00706966|58820722|FG000|Overall Study|Adverse Event|1|||
30803950|NCT03478657|58820756|FG000|Overall Study|Withdrawal by Subject|0|||
30803951|NCT03478657|58820757|FG001|Overall Study|Withdrawal by Subject|1|||
30803952|NCT03515941|58820765|FG000|Overall Study|Adverse Event|1|||
30803953|NCT03515941|58820766|FG001|Overall Study|Adverse Event|0|||
30803954|NCT03011034|58820774|FG000|Overall Study|Adverse Event|1|||
30803955|NCT03011034|58820775|FG001|Overall Study|Adverse Event|0|||
30803956|NCT03515629|58820783|FG000|Overall Study|Death|0|||
30803957|NCT03515629|58820784|FG001|Overall Study|Death|1|||
30803958|NCT03515629|58820785|FG002|Overall Study|Death|1|||
30803959|NCT03515629|58820783|FG000|Overall Study|Progressive disease|0|||
30803960|NCT03515629|58820784|FG001|Overall Study|Progressive disease|1|||
30803961|NCT03515629|58820785|FG002|Overall Study|Progressive disease|0|||
30803962|NCT03512353|58820794|FG000|Overall Study|Sponsor Decision|3|||
30803963|NCT03512353|58820794|FG000|Overall Study|Death|1|||
30803964|NCT03512275|58820802|FG000|Overall Study|Withdrawal by Subject|1|||
30803965|NCT03512275|58820803|FG001|Overall Study|Withdrawal by Subject|3|||
30803966|NCT03512275|58820802|FG000|Overall Study|Physician Decision|0|||
30803967|NCT03512275|58820803|FG001|Overall Study|Physician Decision|1|||
30803968|NCT03512275|58820802|FG000|Overall Study|Lost to Follow-up|0|||
30803969|NCT03512275|58820803|FG001|Overall Study|Lost to Follow-up|3|||
30803970|NCT03512275|58820802|FG000|Overall Study|Other|1|||
30803971|NCT03512275|58820803|FG001|Overall Study|Other|0|||
30803972|NCT03473197|58820809|FG000|Overall Study|Adverse Event|4|||
30803973|NCT03473197|58820809|FG000|Overall Study|Lost to Follow-up|1|||
30803974|NCT03473197|58820809|FG000|Overall Study|Withdrawal by Subject|5|||
30803975|NCT03511105|58820815|FG000|Overall Study|Adverse Event|1|||
30803976|NCT03511105|58820816|FG001|Overall Study|Adverse Event|0|||
30803977|NCT03511105|58820815|FG000|Overall Study|Withdrew consent|1|||
30803978|NCT03511105|58820816|FG001|Overall Study|Withdrew consent|0|||
30803979|NCT03510715|58820836|FG000|Overall Study|Adverse Event|1|||
30803980|NCT03510715|58820837|FG001|Overall Study|Adverse Event|0|||
30803981|NCT03508843|58820844|FG000|Overall Study|Withdrawal by Subject|1|||
30803982|NCT03508843|58820844|FG000|Overall Study|technical difficulties|2|||
30803983|NCT03508609|58820848|FG000|Overall Study|Withdrawal by Subject|1|||
30803984|NCT03054350|58820858|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
30803985|NCT03054350|58820859|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
30803986|NCT03054350|58820860|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
30803987|NCT03054350|58820861|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
30803988|NCT03054350|58820862|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
30803989|NCT03054350|58820863|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
30803990|NCT03054350|58820858|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
30803991|NCT03054350|58820859|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
30803992|NCT03054350|58820860|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
30803993|NCT03054350|58820861|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
30803994|NCT03054350|58820862|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
30803995|NCT03054350|58820863|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
30803996|NCT03054350|58820858|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
30803997|NCT03054350|58820859|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
30907514|NCT02278367|58942049|FG000|Overall Study|Physician Decision|5|||
30748138|NCT00147537|58758358|FG007|Phase 1b|Withdrawal by Subject|0|||
30748139|NCT00147537|58758359|FG008|Phase 1b|Withdrawal by Subject|2|||
30748140|NCT00147537|58758360|FG009|Phase 1b|Withdrawal by Subject|0|||
30748141|NCT00147537|58758361|FG010|Phase 1b|Withdrawal by Subject|0|||
30748142|NCT00147537|58758351|FG000|Phase 1b|Randomized but not treated|0|||
30748143|NCT00147537|58758352|FG001|Phase 1b|Randomized but not treated|0|||
30748144|NCT00147537|58758353|FG002|Phase 1b|Randomized but not treated|0|||
30748145|NCT00147537|58758354|FG003|Phase 1b|Randomized but not treated|0|||
30748146|NCT00147537|58758355|FG004|Phase 1b|Randomized but not treated|0|||
30748147|NCT00147537|58758356|FG005|Phase 1b|Randomized but not treated|0|||
30748148|NCT00147537|58758357|FG006|Phase 1b|Randomized but not treated|1|||
30748149|NCT00147537|58758358|FG007|Phase 1b|Randomized but not treated|0|||
30748150|NCT00147537|58758359|FG008|Phase 1b|Randomized but not treated|1|||
30748151|NCT00147537|58758360|FG009|Phase 1b|Randomized but not treated|0|||
30748152|NCT00147537|58758361|FG010|Phase 1b|Randomized but not treated|0|||
30748153|NCT00147537|58758351|FG000|Phase 2|Death|0|||
30748154|NCT00147537|58758352|FG001|Phase 2|Death|0|||
30803998|NCT03054350|58820860|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
30803999|NCT03054350|58820861|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
30804000|NCT03054350|58820862|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
30804001|NCT03054350|58820863|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
30804002|NCT03054350|58820858|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
30804003|NCT03054350|58820859|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
30804004|NCT03054350|58820860|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
30804005|NCT03054350|58820861|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
30804006|NCT03054350|58820862|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
30804007|NCT03054350|58820863|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
30804008|NCT03528577|58820894|FG000|Sequence 1|Failed Spirometry|1|||
30804009|NCT03528577|58820894|FG000|Sequence 1|Restricted medication|1|||
30804010|NCT03528577|58820894|FG000|Sequence 2|Adverse Event|1|||
30804011|NCT03528577|58820894|FG000|Sequence 2|Withdrawal by Subject|1|||
30804012|NCT03528577|58820894|FG000|Sequence 2|Failed Spirometry|1|||
30804013|NCT03528577|58820894|FG000|Sequence 3|Failed Spirometry|1|||
30804014|NCT03528577|58820894|FG000|Sequence 4|Failed Spirometry|2|||
30804015|NCT03528577|58820894|FG000|Sequence 4|Adverse Event|1|||
30804016|NCT00706654|58820904|FG000|Conversion Phase|Lost to Follow-up|4|||
30748155|NCT00147537|58758353|FG002|Phase 2|Death|0|||
30804017|NCT00706654|58820905|FG001|Conversion Phase|Lost to Follow-up|0|||
30748156|NCT00147537|58758354|FG003|Phase 2|Death|0|||
30804018|NCT00706654|58820906|FG002|Conversion Phase|Lost to Follow-up|0|||
30804019|NCT00706654|58820907|FG003|Conversion Phase|Lost to Follow-up|0|||
30804020|NCT00706654|58820904|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
30804021|NCT00706654|58820905|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
30804022|NCT00706654|58820906|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
30804023|NCT00706654|58820907|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
30804024|NCT00706654|58820904|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
30804025|NCT00706654|58820905|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
30804026|NCT00706654|58820906|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
30804027|NCT00706654|58820907|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
30804028|NCT00706654|58820904|FG000|Conversion Phase|Withdrawn by Investigator|14|||
30804029|NCT00706654|58820905|FG001|Conversion Phase|Withdrawn by Investigator|0|||
30804030|NCT00706654|58820906|FG002|Conversion Phase|Withdrawn by Investigator|0|||
30804031|NCT00706654|58820907|FG003|Conversion Phase|Withdrawn by Investigator|0|||
30804032|NCT00706654|58820904|FG000|Conversion Phase|Withdrew Consent|38|||
30804033|NCT00706654|58820905|FG001|Conversion Phase|Withdrew Consent|0|||
30804034|NCT00706654|58820906|FG002|Conversion Phase|Withdrew Consent|0|||
30804035|NCT00706654|58820907|FG003|Conversion Phase|Withdrew Consent|0|||
30804036|NCT00706654|58820904|FG000|Conversion Phase|Adverse Event|18|||
30804037|NCT00706654|58820905|FG001|Conversion Phase|Adverse Event|0|||
30804038|NCT00706654|58820906|FG002|Conversion Phase|Adverse Event|0|||
30804039|NCT00706654|58820907|FG003|Conversion Phase|Adverse Event|0|||
30804040|NCT00706654|58820904|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
30804041|NCT00706654|58820905|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
30804042|NCT00706654|58820906|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
30804043|NCT00706654|58820907|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
30804044|NCT00706654|58820904|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
30804045|NCT00706654|58820905|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
30804046|NCT00706654|58820906|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
30804047|NCT00706654|58820907|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
30804048|NCT00706654|58820904|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
30804049|NCT00706654|58820905|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
30804050|NCT00706654|58820906|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
30804051|NCT00706654|58820907|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
30804052|NCT00706654|58820904|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
30804053|NCT00706654|58820905|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
30804054|NCT00706654|58820906|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
30804055|NCT00706654|58820907|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
30804056|NCT00706654|58820904|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
30804057|NCT00706654|58820905|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
30804058|NCT00706654|58820906|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
30804059|NCT00706654|58820907|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
30804060|NCT00706654|58820904|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
30804061|NCT00706654|58820905|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
30804062|NCT00706654|58820906|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
30804063|NCT00706654|58820907|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
30804064|NCT00706654|58820904|FG000|Oral Stabilization Phase|Withdrew consent|55|||
30804065|NCT00706654|58820905|FG001|Oral Stabilization Phase|Withdrew consent|0|||
30804066|NCT00706654|58820906|FG002|Oral Stabilization Phase|Withdrew consent|0|||
30804067|NCT00706654|58820907|FG003|Oral Stabilization Phase|Withdrew consent|0|||
30804068|NCT00706654|58820904|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
30804069|NCT00706654|58820905|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
30804070|NCT00706654|58820906|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
30804071|NCT00706654|58820907|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
30804072|NCT00706654|58820904|FG000|Oral Stabilization Phase|Adverse Event|21|||
30804073|NCT00706654|58820905|FG001|Oral Stabilization Phase|Adverse Event|0|||
30804074|NCT00706654|58820906|FG002|Oral Stabilization Phase|Adverse Event|0|||
30804075|NCT00706654|58820907|FG003|Oral Stabilization Phase|Adverse Event|0|||
30804076|NCT00706654|58820904|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
30804077|NCT00706654|58820905|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
30804078|NCT00706654|58820906|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
30804079|NCT00706654|58820907|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
30804080|NCT00706654|58820904|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
30804081|NCT00706654|58820905|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
30804082|NCT00706654|58820906|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
30804083|NCT00706654|58820907|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
30804084|NCT00706654|58820904|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
30804085|NCT00706654|58820905|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
30804086|NCT00706654|58820906|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
30804087|NCT00706654|58820907|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
30804088|NCT00706654|58820904|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
30804089|NCT00706654|58820905|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
30804090|NCT00706654|58820906|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
30804091|NCT00706654|58820907|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
30804092|NCT00706654|58820904|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
30804093|NCT00706654|58820905|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
30804094|NCT00706654|58820906|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
30804095|NCT00706654|58820907|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
30804096|NCT00706654|58820904|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
30804097|NCT00706654|58820905|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
30804098|NCT00706654|58820906|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
30804099|NCT00706654|58820907|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
30804100|NCT00706654|58820904|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
30804101|NCT00706654|58820905|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
30804102|NCT00706654|58820906|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
30804103|NCT00706654|58820907|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
30804104|NCT00706654|58820904|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
30804105|NCT00706654|58820905|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
30804106|NCT00706654|58820906|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
30804107|NCT00706654|58820907|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
30804108|NCT00706654|58820904|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
30804109|NCT00706654|58820905|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
30804110|NCT00706654|58820906|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
30804111|NCT00706654|58820907|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
30804112|NCT00706654|58820904|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
30804113|NCT00706654|58820905|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
30804114|NCT00706654|58820906|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
30804115|NCT00706654|58820907|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
30804116|NCT03471871|58820919|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
30804117|NCT03471871|58820920|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
30804118|NCT03471871|58820921|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
30804119|NCT03471871|58820922|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
30804120|NCT03471871|58820923|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
30804121|NCT03471871|58820919|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
30804122|NCT03471871|58820920|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
30804123|NCT03471871|58820921|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
30804124|NCT03471871|58820922|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
30804125|NCT03471871|58820923|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
30804126|NCT03471871|58820919|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
30804127|NCT03471871|58820920|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
30804128|NCT03471871|58820921|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
30804129|NCT03471871|58820922|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
30804130|NCT03471871|58820923|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
30804131|NCT03471871|58820919|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
30804132|NCT03471871|58820920|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
30804133|NCT03471871|58820921|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
30804134|NCT03471871|58820922|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
30804135|NCT03471871|58820923|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
30907515|NCT02278367|58942050|FG001|Overall Study|Physician Decision|0|||
30748157|NCT00147537|58758355|FG004|Phase 2|Death|0|||
30748158|NCT00147537|58758356|FG005|Phase 2|Death|0|||
30748159|NCT00147537|58758357|FG006|Phase 2|Death|0|||
30748160|NCT00147537|58758358|FG007|Phase 2|Death|0|||
30748161|NCT00147537|58758359|FG008|Phase 2|Death|0|||
30748162|NCT00147537|58758360|FG009|Phase 2|Death|85|||
30748163|NCT00147537|58758361|FG010|Phase 2|Death|31|||
30748164|NCT00147537|58758351|FG000|Phase 2|Lost to Follow-up|0|||
30748165|NCT00147537|58758352|FG001|Phase 2|Lost to Follow-up|0|||
30748166|NCT00147537|58758353|FG002|Phase 2|Lost to Follow-up|0|||
30748167|NCT00147537|58758354|FG003|Phase 2|Lost to Follow-up|0|||
30748168|NCT00147537|58758355|FG004|Phase 2|Lost to Follow-up|0|||
30748169|NCT00147537|58758356|FG005|Phase 2|Lost to Follow-up|0|||
30748170|NCT00147537|58758357|FG006|Phase 2|Lost to Follow-up|0|||
30748171|NCT00147537|58758358|FG007|Phase 2|Lost to Follow-up|0|||
30748172|NCT00147537|58758359|FG008|Phase 2|Lost to Follow-up|0|||
30748173|NCT00147537|58758360|FG009|Phase 2|Lost to Follow-up|12|||
30748174|NCT00147537|58758361|FG010|Phase 2|Lost to Follow-up|4|||
30804136|NCT03471871|58820919|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
30804137|NCT03471871|58820920|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
30804138|NCT03471871|58820921|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
30804139|NCT03471871|58820922|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
30804140|NCT03471871|58820923|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
30804141|NCT01957176|58820941|FG000|Overall Study|Adverse Event|2|||
30804142|NCT01957176|58820942|FG001|Overall Study|Adverse Event|0|||
30804143|NCT01957176|58820941|FG000|Overall Study|Physician Decision|2|||
30804144|NCT01957176|58820942|FG001|Overall Study|Physician Decision|1|||
30804145|NCT01957176|58820941|FG000|Overall Study|Withdrawal by Subject|1|||
30804146|NCT01957176|58820942|FG001|Overall Study|Withdrawal by Subject|0|||
30804147|NCT03527173|58820951|FG000|Overall Study|Lost to Follow-up|4|||
30804148|NCT03527173|58820952|FG001|Overall Study|Lost to Follow-up|2|||
30804149|NCT03527173|58820951|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
30804150|NCT03527173|58820952|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
30804151|NCT03527173|58820951|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
30804152|NCT03527173|58820952|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
30804153|NCT03527173|58820951|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
30804154|NCT03527173|58820952|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
30804155|NCT00707980|58820958|FG000|Overall Study|Adverse Event|49|||
30804156|NCT00707980|58820958|FG000|Overall Study|Lack of Efficacy|35|||
30804157|NCT00707980|58820958|FG000|Overall Study|Non-Compliance with Study Drug|28|||
30804158|NCT00707980|58820958|FG000|Overall Study|Protocol Deviations|19|||
30804159|NCT00707980|58820958|FG000|Overall Study|Withdrawal of Consent|81|||
30804160|NCT00707980|58820958|FG000|Overall Study|Lost to Follow-up|59|||
30804161|NCT00707980|58820958|FG000|Overall Study|Other|39|||
30804162|NCT03506425|58820965|FG000|Overall Study|Adverse Event|1|||
30804163|NCT03506425|58820966|FG001|Overall Study|Adverse Event|3|||
30804164|NCT03506425|58820967|FG002|Overall Study|Adverse Event|0|||
30804165|NCT03506425|58820965|FG000|Overall Study|Death|1|||
30804166|NCT03506425|58820966|FG001|Overall Study|Death|0|||
30804167|NCT03506425|58820967|FG002|Overall Study|Death|0|||
30804168|NCT03506425|58820965|FG000|Overall Study|Withdrawal by Subject|0|||
30804169|NCT03506425|58820966|FG001|Overall Study|Withdrawal by Subject|0|||
30804170|NCT03506425|58820967|FG002|Overall Study|Withdrawal by Subject|1|||
30804171|NCT03051620|58820976|FG000|Overall Study|Lost to Follow-up|6|||
30804172|NCT03051620|58820976|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
30804173|NCT03053492|58820982|FG000|Overall Study|Adverse Event|1|||
30804174|NCT03053492|58820983|FG001|Overall Study|Adverse Event|1|||
30804175|NCT03053492|58820982|FG000|Overall Study|Withdrawal by Subject|7|||
30804176|NCT03053492|58820983|FG001|Overall Study|Withdrawal by Subject|5|||
30804177|NCT04239872|58820989|FG000|Overall Study|Lost to Follow-up|0|||
30804178|NCT04239872|58820990|FG001|Overall Study|Lost to Follow-up|1|||
30804179|NCT03164772|58820998|FG000|Overall Study|Death|4|||
30804180|NCT03164772|58820999|FG001|Overall Study|Death|2|||
30804181|NCT03164772|58820998|FG000|Overall Study|Adverse Event|1|||
30804182|NCT03164772|58820999|FG001|Overall Study|Adverse Event|4|||
30804183|NCT03164772|58820998|FG000|Overall Study|Progressive Disease|11|||
30804184|NCT03164772|58820999|FG001|Overall Study|Progressive Disease|21|||
30804185|NCT03164772|58820998|FG000|Overall Study|Physician Decision|2|||
30804186|NCT03164772|58820999|FG001|Overall Study|Physician Decision|0|||
30804187|NCT03164772|58820998|FG000|Overall Study|Withdrawal by Subject|0|||
30804188|NCT03164772|58820999|FG001|Overall Study|Withdrawal by Subject|4|||
30804189|NCT03050450|58821022|FG000|Overall Study|Physician Decision|1|||
30804190|NCT03050450|58821023|FG001|Overall Study|Physician Decision|0|||
30804191|NCT03050450|58821024|FG002|Overall Study|Physician Decision|0|||
30804192|NCT03050450|58821025|FG003|Overall Study|Physician Decision|0|||
30804193|NCT03050450|58821026|FG004|Overall Study|Physician Decision|0|||
30804194|NCT03505021|58821040|FG000|Overall Study|Protocol Violation|1|||
30804195|NCT03505021|58821041|FG001|Overall Study|Protocol Violation|0|||
30907516|NCT02278367|58942049|FG000|Overall Study|Withdrawal by Subject|5|||
30907517|NCT02278367|58942050|FG001|Overall Study|Withdrawal by Subject|0|||
30804196|NCT03505021|58821040|FG000|Overall Study|Death|9|||
30804197|NCT03505021|58821041|FG001|Overall Study|Death|8|||
30804198|NCT03505021|58821040|FG000|Overall Study|Consent withdrawn by subject|6|||
30804199|NCT03505021|58821041|FG001|Overall Study|Consent withdrawn by subject|1|||
30804200|NCT03505021|58821040|FG000|Overall Study|Lost to Follow-up|5|||
30804201|NCT03505021|58821041|FG001|Overall Study|Lost to Follow-up|3|||
30804202|NCT03505021|58821040|FG000|Overall Study|Adverse Event|26|||
30804203|NCT03505021|58821041|FG001|Overall Study|Adverse Event|9|||
30804204|NCT03505021|58821040|FG000|Overall Study|Disease progression|33|||
30804205|NCT03505021|58821041|FG001|Overall Study|Disease progression|17|||
30804206|NCT03505021|58821040|FG000|Overall Study|Other|11|||
30907518|NCT01910181|58942056|FG000|Overall Study|Death|37|||
30748175|NCT00147537|58758351|FG000|Phase 2|Other|0|||
30748176|NCT00147537|58758352|FG001|Phase 2|Other|0|||
30748177|NCT00147537|58758353|FG002|Phase 2|Other|0|||
30907519|NCT01910181|58942056|FG000|Overall Study|Lost to Follow-up|3|||
30907520|NCT01910181|58942056|FG000|Overall Study|Study Terminated by Sponsor|6|||
30907521|NCT01957215|58942063|FG000|Overall Study|Adverse Event|2|||
30907522|NCT01957215|58942064|FG001|Overall Study|Adverse Event|2|||
30907523|NCT01957215|58942063|FG000|Overall Study|Lost to Follow-up|3|||
30907524|NCT01957215|58942064|FG001|Overall Study|Lost to Follow-up|3|||
30907525|NCT01957215|58942063|FG000|Overall Study|Protocol Violation|1|||
30907526|NCT01957215|58942064|FG001|Overall Study|Protocol Violation|2|||
30907527|NCT01957215|58942063|FG000|Overall Study|Withdrawal by Subject|7|||
30907528|NCT01957215|58942064|FG001|Overall Study|Withdrawal by Subject|5|||
30907529|NCT02322749|58942074|FG000|Period 2|Adverse Event|0|||
30907530|NCT02322749|58942075|FG001|Period 2|Adverse Event|0|||
30907531|NCT02322749|58942076|FG002|Period 2|Adverse Event|0|||
30907532|NCT02322749|58942077|FG003|Period 2|Adverse Event|1|||
30907533|NCT02322749|58942078|FG004|Period 2|Adverse Event|0|||
30907534|NCT02322749|58942079|FG005|Period 2|Adverse Event|0|||
30907535|NCT02322749|58942074|FG000|Period 2|Withdrawal by Subject|0|||
30907536|NCT02322749|58942075|FG001|Period 2|Withdrawal by Subject|0|||
30907537|NCT02322749|58942076|FG002|Period 2|Withdrawal by Subject|0|||
30907538|NCT02322749|58942077|FG003|Period 2|Withdrawal by Subject|1|||
30907539|NCT02322749|58942078|FG004|Period 2|Withdrawal by Subject|0|||
30907540|NCT02322749|58942079|FG005|Period 2|Withdrawal by Subject|0|||
30907541|NCT02322749|58942074|FG000|Period 3|Withdrawal by Subject|0|||
30907542|NCT02322749|58942075|FG001|Period 3|Withdrawal by Subject|0|||
30907543|NCT02322749|58942076|FG002|Period 3|Withdrawal by Subject|1|||
30907544|NCT02322749|58942077|FG003|Period 3|Withdrawal by Subject|0|||
30907545|NCT02322749|58942078|FG004|Period 3|Withdrawal by Subject|0|||
30907546|NCT02322749|58942079|FG005|Period 3|Withdrawal by Subject|0|||
30907547|NCT01957137|58942088|FG000|Randomized Portion|Adverse Event|1|||
30907548|NCT01957137|58942088|FG000|Randomized Portion|Withdrawal by Subject|1|||
30907549|NCT01928433|58942103|FG000|Overall Study|Adverse Event|5|||
30907550|NCT01928433|58942104|FG001|Overall Study|Adverse Event|2|||
30907551|NCT01928433|58942105|FG002|Overall Study|Adverse Event|5|||
30907552|NCT01928433|58942103|FG000|Overall Study|Protocol Violation|0|||
30907553|NCT01928433|58942104|FG001|Overall Study|Protocol Violation|0|||
30907554|NCT01928433|58942105|FG002|Overall Study|Protocol Violation|2|||
30907555|NCT01928433|58942103|FG000|Overall Study|Lack of Efficacy|5|||
30907556|NCT01928433|58942104|FG001|Overall Study|Lack of Efficacy|4|||
30907557|NCT01928433|58942105|FG002|Overall Study|Lack of Efficacy|4|||
30907558|NCT01928433|58942103|FG000|Overall Study|Withdrawal by Subject|0|||
30907559|NCT01928433|58942104|FG001|Overall Study|Withdrawal by Subject|4|||
30907560|NCT01928433|58942105|FG002|Overall Study|Withdrawal by Subject|0|||
30907561|NCT01928433|58942103|FG000|Overall Study|Negative screening urine culture|7|||
30907562|NCT01928433|58942104|FG001|Overall Study|Negative screening urine culture|6|||
30907563|NCT01928433|58942105|FG002|Overall Study|Negative screening urine culture|10|||
30907564|NCT01928433|58942103|FG000|Overall Study|Lost to Follow-up|0|||
30907565|NCT01928433|58942104|FG001|Overall Study|Lost to Follow-up|2|||
30907566|NCT01928433|58942105|FG002|Overall Study|Lost to Follow-up|3|||
30907567|NCT01928433|58942103|FG000|Overall Study|Other reasons|3|||
30907568|NCT01928433|58942104|FG001|Overall Study|Other reasons|3|||
30907569|NCT01928433|58942105|FG002|Overall Study|Other reasons|4|||
30907570|NCT02322281|58942119|FG000|Overall Study|Progressive Disease|42|||
30907571|NCT02322281|58942120|FG001|Overall Study|Progressive Disease|14|||
30907572|NCT02322281|58942121|FG002|Overall Study|Progressive Disease|49|||
30907573|NCT02322281|58942119|FG000|Overall Study|Adverse Event|3|||
30907574|NCT02322281|58942120|FG001|Overall Study|Adverse Event|4|||
30907575|NCT02322281|58942121|FG002|Overall Study|Adverse Event|6|||
30907576|NCT02322281|58942119|FG000|Overall Study|Death|3|||
30907577|NCT02322281|58942120|FG001|Overall Study|Death|3|||
30907578|NCT02322281|58942121|FG002|Overall Study|Death|3|||
30907579|NCT02322281|58942119|FG000|Overall Study|Withdrawal by Subject|1|||
30907580|NCT02322281|58942120|FG001|Overall Study|Withdrawal by Subject|1|||
30907581|NCT02322281|58942121|FG002|Overall Study|Withdrawal by Subject|6|||
30907582|NCT02322281|58942119|FG000|Overall Study|Physician Decision|2|||
30907583|NCT02322281|58942120|FG001|Overall Study|Physician Decision|0|||
30907584|NCT02322281|58942121|FG002|Overall Study|Physician Decision|5|||
30907585|NCT02322281|58942119|FG000|Overall Study|Study Terminated by Sponsor|2|||
30907586|NCT02322281|58942120|FG001|Overall Study|Study Terminated by Sponsor|0|||
30907587|NCT02322281|58942121|FG002|Overall Study|Study Terminated by Sponsor|0|||
30907588|NCT02322281|58942119|FG000|Overall Study|Missing|0|||
30907589|NCT02322281|58942120|FG001|Overall Study|Missing|0|||
30907590|NCT02322281|58942121|FG002|Overall Study|Missing|1|||
30907591|NCT02322281|58942119|FG000|Overall Study|Miscellaneous|0|||
30907592|NCT02322281|58942120|FG001|Overall Study|Miscellaneous|0|||
30748178|NCT00147537|58758354|FG003|Phase 2|Other|0|||
30907593|NCT02322281|58942121|FG002|Overall Study|Miscellaneous|4|||
30907594|NCT02322125|58942131|FG000|Overall Study|Withdrawal by Subject|2|||
30907595|NCT02243293|58942152|FG000|Overall Study|Adverse Event|1|||
30907596|NCT02243293|58942153|FG001|Overall Study|Adverse Event|0|||
30907597|NCT02243293|58942154|FG002|Overall Study|Adverse Event|0|||
30907598|NCT02243293|58942155|FG003|Overall Study|Adverse Event|0|||
30907599|NCT02243293|58942156|FG004|Overall Study|Adverse Event|0|||
30907600|NCT02243293|58942157|FG005|Overall Study|Adverse Event|0|||
30907601|NCT02243293|58942158|FG006|Overall Study|Adverse Event|0|||
30907602|NCT02243293|58942159|FG007|Overall Study|Adverse Event|0|||
30907603|NCT02243293|58942160|FG008|Overall Study|Adverse Event|0|||
30907604|NCT02243293|58942161|FG009|Overall Study|Adverse Event|0|||
30907605|NCT02243293|58942162|FG010|Overall Study|Adverse Event|0|||
30907606|NCT02243293|58942163|FG011|Overall Study|Adverse Event|0|||
30907607|NCT02243293|58942164|FG012|Overall Study|Adverse Event|0|||
30907608|NCT02243293|58942165|FG013|Overall Study|Adverse Event|0|||
30907609|NCT02243293|58942166|FG014|Overall Study|Adverse Event|0|||
30907610|NCT02243293|58942167|FG015|Overall Study|Adverse Event|1|||
30907611|NCT02243293|58942168|FG016|Overall Study|Adverse Event|0|||
30907612|NCT02243293|58942169|FG017|Overall Study|Adverse Event|0|||
30907613|NCT02243293|58942170|FG018|Overall Study|Adverse Event|0|||
30907614|NCT02243293|58942171|FG019|Overall Study|Adverse Event|0|||
30907615|NCT02243293|58942172|FG020|Overall Study|Adverse Event|1|||
30907616|NCT02243293|58942173|FG021|Overall Study|Adverse Event|0|||
30907617|NCT02243293|58942152|FG000|Overall Study|Withdrawal by Subject|1|||
30907618|NCT02243293|58942153|FG001|Overall Study|Withdrawal by Subject|0|||
30907619|NCT02243293|58942154|FG002|Overall Study|Withdrawal by Subject|0|||
30907620|NCT02243293|58942155|FG003|Overall Study|Withdrawal by Subject|0|||
30907621|NCT02243293|58942156|FG004|Overall Study|Withdrawal by Subject|0|||
30907622|NCT02243293|58942157|FG005|Overall Study|Withdrawal by Subject|0|||
30907623|NCT02243293|58942158|FG006|Overall Study|Withdrawal by Subject|0|||
30907624|NCT02243293|58942159|FG007|Overall Study|Withdrawal by Subject|0|||
30907625|NCT02243293|58942160|FG008|Overall Study|Withdrawal by Subject|0|||
30907626|NCT02243293|58942161|FG009|Overall Study|Withdrawal by Subject|1|||
30907627|NCT02243293|58942162|FG010|Overall Study|Withdrawal by Subject|0|||
30907628|NCT02243293|58942163|FG011|Overall Study|Withdrawal by Subject|1|||
30907629|NCT02243293|58942164|FG012|Overall Study|Withdrawal by Subject|0|||
30907630|NCT02243293|58942165|FG013|Overall Study|Withdrawal by Subject|0|||
30907631|NCT02243293|58942166|FG014|Overall Study|Withdrawal by Subject|0|||
30907632|NCT02243293|58942167|FG015|Overall Study|Withdrawal by Subject|0|||
30907633|NCT02243293|58942168|FG016|Overall Study|Withdrawal by Subject|0|||
30907634|NCT02243293|58942169|FG017|Overall Study|Withdrawal by Subject|0|||
30804207|NCT03505021|58821041|FG001|Overall Study|Other|5|||
30804208|NCT03505021|58821040|FG000|Overall Study|Personal reason|21|||
30804209|NCT03505021|58821041|FG001|Overall Study|Personal reason|12|||
30804210|NCT03050372|58821047|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
30804211|NCT03050372|58821048|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
30804212|NCT03050372|58821047|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
30804213|NCT03050372|58821048|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
30804214|NCT03470545|58821055|FG000|Overall Study|Death|0|||
30804215|NCT03470545|58821056|FG001|Overall Study|Death|1|||
30804216|NCT03470545|58821055|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
30804217|NCT03470545|58821056|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
30804218|NCT03470545|58821055|FG000|Overall Study|Adverse Event|2|||
30907635|NCT02243293|58942170|FG018|Overall Study|Withdrawal by Subject|0|||
30907636|NCT02243293|58942171|FG019|Overall Study|Withdrawal by Subject|0|||
30907637|NCT02243293|58942172|FG020|Overall Study|Withdrawal by Subject|0|||
30907638|NCT02243293|58942173|FG021|Overall Study|Withdrawal by Subject|1|||
30907639|NCT02243293|58942152|FG000|Overall Study|Lost to Follow-up|0|||
30907640|NCT02243293|58942153|FG001|Overall Study|Lost to Follow-up|1|||
30907641|NCT02243293|58942154|FG002|Overall Study|Lost to Follow-up|1|||
30907642|NCT02243293|58942155|FG003|Overall Study|Lost to Follow-up|1|||
30907643|NCT02243293|58942156|FG004|Overall Study|Lost to Follow-up|0|||
30907644|NCT02243293|58942157|FG005|Overall Study|Lost to Follow-up|0|||
30907645|NCT02243293|58942158|FG006|Overall Study|Lost to Follow-up|3|||
30907646|NCT02243293|58942159|FG007|Overall Study|Lost to Follow-up|0|||
30907647|NCT02243293|58942160|FG008|Overall Study|Lost to Follow-up|0|||
30907648|NCT02243293|58942161|FG009|Overall Study|Lost to Follow-up|0|||
30907649|NCT02243293|58942162|FG010|Overall Study|Lost to Follow-up|0|||
30804219|NCT03470545|58821056|FG001|Overall Study|Adverse Event|0|||
30804220|NCT03470545|58821055|FG000|Overall Study|Withdrawal by Subject|1|||
30907650|NCT02243293|58942163|FG011|Overall Study|Lost to Follow-up|2|||
30907651|NCT02243293|58942164|FG012|Overall Study|Lost to Follow-up|0|||
30907652|NCT02243293|58942165|FG013|Overall Study|Lost to Follow-up|0|||
30907653|NCT02243293|58942166|FG014|Overall Study|Lost to Follow-up|0|||
30907654|NCT02243293|58942167|FG015|Overall Study|Lost to Follow-up|0|||
30907655|NCT02243293|58942168|FG016|Overall Study|Lost to Follow-up|3|||
30907656|NCT02243293|58942169|FG017|Overall Study|Lost to Follow-up|1|||
30907657|NCT02243293|58942170|FG018|Overall Study|Lost to Follow-up|0|||
30907658|NCT02243293|58942171|FG019|Overall Study|Lost to Follow-up|0|||
30907659|NCT02243293|58942172|FG020|Overall Study|Lost to Follow-up|1|||
30907660|NCT02243293|58942173|FG021|Overall Study|Lost to Follow-up|2|||
30907661|NCT02243293|58942152|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
30907662|NCT02243293|58942153|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
30907663|NCT02243293|58942154|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
30907664|NCT02243293|58942155|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
30907665|NCT02243293|58942156|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
30907666|NCT02243293|58942157|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
30907667|NCT02243293|58942158|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
30907668|NCT02243293|58942159|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
30907669|NCT02243293|58942160|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
30907670|NCT02243293|58942161|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
30907671|NCT02243293|58942162|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
30907672|NCT02243293|58942163|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
30907673|NCT02243293|58942164|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
30907674|NCT02243293|58942165|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
30907675|NCT02243293|58942166|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
30907676|NCT02243293|58942167|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
30907677|NCT02243293|58942168|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
30907678|NCT02243293|58942169|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
30907679|NCT02243293|58942170|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
30907680|NCT02243293|58942171|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
30907681|NCT02243293|58942172|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
30907682|NCT02243293|58942173|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
30907683|NCT02243293|58942152|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
30907684|NCT02243293|58942153|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
30907685|NCT02243293|58942154|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
30907686|NCT02243293|58942155|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
30907687|NCT02243293|58942156|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
30907688|NCT02243293|58942157|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
30907689|NCT02243293|58942158|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
30907690|NCT02243293|58942159|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
30907691|NCT02243293|58942160|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
30907692|NCT02243293|58942161|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
30907693|NCT02243293|58942162|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
30907694|NCT02243293|58942163|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
30907695|NCT02243293|58942164|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
30907696|NCT02243293|58942165|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
30907697|NCT02243293|58942166|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
30907698|NCT02243293|58942167|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
30907699|NCT02243293|58942168|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
30907700|NCT02243293|58942169|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
30907701|NCT02243293|58942170|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
30907702|NCT02243293|58942171|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
30907703|NCT02243293|58942172|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
30907704|NCT02243293|58942173|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
30907705|NCT02322047|58942214|FG000|Overall Study|Physician Decision|1|||
30907706|NCT02322047|58942215|FG001|Overall Study|Physician Decision|0|||
30907707|NCT02322047|58942216|FG002|Overall Study|Physician Decision|0|||
30907708|NCT02322047|58942217|FG003|Overall Study|Physician Decision|0|||
30907709|NCT02322047|58942214|FG000|Overall Study|Withdrawal by Subject|1|||
30907710|NCT02322047|58942215|FG001|Overall Study|Withdrawal by Subject|0|||
30907711|NCT02322047|58942216|FG002|Overall Study|Withdrawal by Subject|0|||
30907712|NCT02322047|58942217|FG003|Overall Study|Withdrawal by Subject|1|||
30907713|NCT02322047|58942214|FG000|Overall Study|Adverse Event|0|||
30907714|NCT02322047|58942215|FG001|Overall Study|Adverse Event|1|||
30907715|NCT02322047|58942216|FG002|Overall Study|Adverse Event|0|||
30907716|NCT02322047|58942217|FG003|Overall Study|Adverse Event|0|||
30907717|NCT02322047|58942214|FG000|Overall Study|Lost to Follow-up|0|||
30907718|NCT02322047|58942215|FG001|Overall Study|Lost to Follow-up|0|||
30907719|NCT02322047|58942216|FG002|Overall Study|Lost to Follow-up|1|||
30907720|NCT02322047|58942217|FG003|Overall Study|Lost to Follow-up|1|||
30907721|NCT02254291|58942230|FG000|Overall Study|Withdrawal by Subject|0|||
30907722|NCT02254291|58942231|FG001|Overall Study|Withdrawal by Subject|3|||
30907723|NCT02254291|58942232|FG002|Overall Study|Withdrawal by Subject|1|||
30907724|NCT02254291|58942230|FG000|Overall Study|Missing follow-up information|0|||
30907725|NCT02254291|58942231|FG001|Overall Study|Missing follow-up information|0|||
30907726|NCT02254291|58942232|FG002|Overall Study|Missing follow-up information|1|||
30907727|NCT02253433|58942242|FG000|Overall Study|Unable to Contact|9|||
30907728|NCT02253433|58942243|FG001|Overall Study|Unable to Contact|16|||
30907729|NCT02253433|58942242|FG000|Overall Study|Death|1|||
30907730|NCT02253433|58942243|FG001|Overall Study|Death|1|||
30907731|NCT02253433|58942242|FG000|Overall Study|No Longer Interested|3|||
30907732|NCT02253433|58942243|FG001|Overall Study|No Longer Interested|15|||
30907733|NCT02253433|58942242|FG000|Overall Study|Out of Study Area|2|||
30907734|NCT02253433|58942243|FG001|Overall Study|Out of Study Area|7|||
30907735|NCT02253433|58942242|FG000|Overall Study|Uncomfortable with home visitors|0|||
30907736|NCT02253433|58942243|FG001|Overall Study|Uncomfortable with home visitors|3|||
30907737|NCT02253433|58942242|FG000|Overall Study|Unstable Housing/Homeless|0|||
30907738|NCT02253433|58942243|FG001|Overall Study|Unstable Housing/Homeless|7|||
30907739|NCT02253433|58942242|FG000|Overall Study|Too Busy|0|||
30907740|NCT02253433|58942243|FG001|Overall Study|Too Busy|4|||
30907741|NCT02253433|58942242|FG000|Overall Study|Medical or Other Concerns|1|||
30907742|NCT02253433|58942243|FG001|Overall Study|Medical or Other Concerns|2|||
30907743|NCT02242981|58942250|FG000|Overall Study|Withdrawal by Subject|1|||
30907744|NCT02277743|58942257|FG000|Overall Study|Protocol Violation|1|||
30907745|NCT02277743|58942258|FG001|Overall Study|Protocol Violation|1|||
30907746|NCT02277743|58942259|FG002|Overall Study|Protocol Violation|1|||
30907747|NCT02277743|58942257|FG000|Overall Study|Adverse Event|10|||
30907748|NCT02277743|58942258|FG001|Overall Study|Adverse Event|6|||
30907749|NCT02277743|58942259|FG002|Overall Study|Adverse Event|6|||
30907750|NCT02277743|58942257|FG000|Overall Study|Lack of Efficacy|11|||
30907751|NCT02277743|58942258|FG001|Overall Study|Lack of Efficacy|4|||
30907752|NCT02277743|58942259|FG002|Overall Study|Lack of Efficacy|3|||
30907753|NCT02277743|58942257|FG000|Overall Study|Other than specified above|18|||
30907754|NCT02277743|58942258|FG001|Overall Study|Other than specified above|5|||
30907755|NCT02277743|58942259|FG002|Overall Study|Other than specified above|16|||
30907756|NCT02242903|58942274|FG000|Overall Study|Withdrawal by Subject|1|||
30907757|NCT02242903|58942275|FG001|Overall Study|Withdrawal by Subject|0|||
30907758|NCT02242903|58942276|FG002|Overall Study|Withdrawal by Subject|0|||
30907759|NCT02242903|58942277|FG003|Overall Study|Withdrawal by Subject|0|||
30907760|NCT02242903|58942278|FG004|Overall Study|Withdrawal by Subject|0|||
30907761|NCT02242903|58942279|FG005|Overall Study|Withdrawal by Subject|0|||
30907762|NCT02242903|58942280|FG006|Overall Study|Withdrawal by Subject|0|||
30907763|NCT02320721|58942304|FG000|Overall Study|Adverse Event|6|||
30907764|NCT02320721|58942305|FG001|Overall Study|Adverse Event|6|||
30907765|NCT02320721|58942304|FG000|Overall Study|Lack of Efficacy|2|||
30907766|NCT02320721|58942305|FG001|Overall Study|Lack of Efficacy|0|||
30907767|NCT02320721|58942304|FG000|Overall Study|Poor compliance to protocol|3|||
30907768|NCT02320721|58942305|FG001|Overall Study|Poor compliance to protocol|7|||
30907769|NCT02320721|58942304|FG000|Overall Study|Randomized but not treated|0|||
30907770|NCT02320721|58942305|FG001|Overall Study|Randomized but not treated|1|||
30907771|NCT02320721|58942304|FG000|Overall Study|Hypoglycemia|1|||
30907772|NCT02320721|58942305|FG001|Overall Study|Hypoglycemia|0|||
30907773|NCT02320721|58942304|FG000|Overall Study|Other than specified above|15|||
30907774|NCT02320721|58942305|FG001|Overall Study|Other than specified above|20|||
30907775|NCT02320487|58942311|FG000|Overall Study|Reason not Specified|1|||
30907776|NCT02320487|58942311|FG000|Overall Study|Physician Decision|5|||
30907777|NCT02320487|58942311|FG000|Overall Study|Withdrawal by Subject|1|||
30907778|NCT02320487|58942311|FG000|Overall Study|Death|3|||
30907779|NCT02320487|58942311|FG000|Overall Study|Adverse Event|11|||
30907780|NCT02277119|58942318|FG000|Overall Study|Lack of Efficacy|1|||
30907781|NCT02277119|58942319|FG001|Overall Study|Lack of Efficacy|1|||
30907782|NCT02277119|58942320|FG002|Overall Study|Lack of Efficacy|1|||
30907783|NCT02277119|58942318|FG000|Overall Study|Protocol Violation|2|||
30907784|NCT02277119|58942319|FG001|Overall Study|Protocol Violation|3|||
30907785|NCT02277119|58942320|FG002|Overall Study|Protocol Violation|7|||
30907786|NCT02320253|58942331|FG000|Overall Study|Withdrawal by Subject|3|||
30907787|NCT02320253|58942332|FG001|Overall Study|Withdrawal by Subject|0|||
30907788|NCT02320253|58942333|FG002|Overall Study|Withdrawal by Subject|0|||
30907789|NCT02320253|58942331|FG000|Overall Study|Lost to Follow-up|2|||
30907790|NCT02320253|58942332|FG001|Overall Study|Lost to Follow-up|2|||
30907791|NCT02320253|58942333|FG002|Overall Study|Lost to Follow-up|1|||
30907792|NCT02320253|58942331|FG000|Overall Study|Death|1|||
30907793|NCT02320253|58942332|FG001|Overall Study|Death|0|||
30907794|NCT02320253|58942333|FG002|Overall Study|Death|1|||
30907795|NCT02276807|58942343|FG000|Overall Study|Withdrawal by Subject|8|||
30907796|NCT02276807|58942344|FG001|Overall Study|Withdrawal by Subject|7|||
30907797|NCT02276807|58942343|FG000|Overall Study|Lost to Follow-up|10|||
30907798|NCT02276807|58942344|FG001|Overall Study|Lost to Follow-up|10|||
30907799|NCT02252965|58942352|FG000|Overall Study|Adverse Event|9|||
30907800|NCT02252965|58942353|FG001|Overall Study|Adverse Event|14|||
30907801|NCT02252965|58942352|FG000|Overall Study|Lost to Follow-up|16|||
30907802|NCT02252965|58942353|FG001|Overall Study|Lost to Follow-up|8|||
30907803|NCT02252965|58942352|FG000|Overall Study|Protocol Violation|4|||
30907804|NCT02252965|58942353|FG001|Overall Study|Protocol Violation|5|||
30907805|NCT02252965|58942352|FG000|Overall Study|Lack of Efficacy|0|||
30907806|NCT02252965|58942353|FG001|Overall Study|Lack of Efficacy|2|||
30907807|NCT02252965|58942352|FG000|Overall Study|Withdrawal by Subject|7|||
30907808|NCT02252965|58942353|FG001|Overall Study|Withdrawal by Subject|9|||
30907809|NCT02252965|58942352|FG000|Overall Study|Other|4|||
30907810|NCT02252965|58942353|FG001|Overall Study|Other|5|||
30907811|NCT02242435|58942363|FG000|Overall Study|Lost to Follow-up|3|||
30907812|NCT02242435|58942364|FG001|Overall Study|Lost to Follow-up|4|||
30907813|NCT02242435|58942363|FG000|Overall Study|Adverse Event|3|||
30907814|NCT02242435|58942364|FG001|Overall Study|Adverse Event|2|||
30907815|NCT02242435|58942363|FG000|Overall Study|Withdrawal by Subject|13|||
30907816|NCT02242435|58942364|FG001|Overall Study|Withdrawal by Subject|8|||
30907817|NCT02242435|58942363|FG000|Overall Study|Death|0|||
30907818|NCT02242435|58942364|FG001|Overall Study|Death|1|||
30907819|NCT02242435|58942363|FG000|Overall Study|Protocol Violation|1|||
30907820|NCT02242435|58942364|FG001|Overall Study|Protocol Violation|0|||
30907821|NCT02242435|58942363|FG000|Overall Study|Physician Decision|0|||
30907822|NCT02242435|58942364|FG001|Overall Study|Physician Decision|1|||
30907823|NCT02251717|58942372|FG000|Overall Study|Adverse Event|0|||
30907824|NCT02251717|58942373|FG001|Overall Study|Adverse Event|1|||
30907825|NCT02251717|58942372|FG000|Overall Study|Withdrew Consent|1|||
30907826|NCT02251717|58942373|FG001|Overall Study|Withdrew Consent|0|||
30907827|NCT02242201|58942382|FG000|Overall Study|preoperative identified neuropathy|2|||
30907828|NCT02242201|58942383|FG001|Overall Study|preoperative identified neuropathy|0|||
30907829|NCT02242201|58942384|FG002|Overall Study|preoperative identified neuropathy|0|||
30907830|NCT02242201|58942382|FG000|Overall Study|planned post-op anticoagulation|1|||
30907831|NCT02242201|58942383|FG001|Overall Study|planned post-op anticoagulation|0|||
30907832|NCT02242201|58942384|FG002|Overall Study|planned post-op anticoagulation|0|||
30907833|NCT02242201|58942382|FG000|Overall Study|changed surgical procedure|1|||
30907834|NCT02242201|58942383|FG001|Overall Study|changed surgical procedure|0|||
30907835|NCT02242201|58942384|FG002|Overall Study|changed surgical procedure|0|||
30907836|NCT02242201|58942382|FG000|Overall Study|postponed surgery|0|||
30907837|NCT02242201|58942383|FG001|Overall Study|postponed surgery|0|||
30907838|NCT02242201|58942384|FG002|Overall Study|postponed surgery|1|||
30907839|NCT02242201|58942382|FG000|Overall Study|preoperative opioid consumption|0|||
30907840|NCT02242201|58942383|FG001|Overall Study|preoperative opioid consumption|1|||
30907841|NCT02242201|58942384|FG002|Overall Study|preoperative opioid consumption|0|||
30907842|NCT02242045|58942392|FG000|Overall Study|Investigator's Discretion|1|||
30907843|NCT02242045|58942392|FG000|Overall Study|Progressive Disease|2|||
30907844|NCT02242045|58942392|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
30907845|NCT02242045|58942392|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
30907846|NCT02241889|58942396|FG000|Overall Study|device issues|0|||
30907847|NCT02241889|58942397|FG001|Overall Study|device issues|0|||
30907848|NCT02241889|58942398|FG002|Overall Study|device issues|1|||
30907849|NCT02241889|58942399|FG003|Overall Study|device issues|0|||
30907850|NCT02241889|58942400|FG004|Overall Study|device issues|0|||
30907851|NCT02241889|58942401|FG005|Overall Study|device issues|0|||
30907852|NCT02241889|58942396|FG000|Overall Study|Withdrawal by Subject|0|||
30907853|NCT02241889|58942397|FG001|Overall Study|Withdrawal by Subject|0|||
30907854|NCT02241889|58942398|FG002|Overall Study|Withdrawal by Subject|0|||
30907855|NCT02241889|58942399|FG003|Overall Study|Withdrawal by Subject|0|||
30907856|NCT02241889|58942400|FG004|Overall Study|Withdrawal by Subject|0|||
30907857|NCT02241889|58942401|FG005|Overall Study|Withdrawal by Subject|1|||
30907858|NCT02241733|58942411|FG000|Overall Study|Lost to Follow-up|9|||
30907859|NCT02241733|58942412|FG001|Overall Study|Lost to Follow-up|4|||
30907860|NCT02241733|58942411|FG000|Overall Study|Physician Decision|6|||
30907861|NCT02241733|58942412|FG001|Overall Study|Physician Decision|2|||
30907862|NCT02241733|58942411|FG000|Overall Study|Withdrawal by Subject|0|||
30907863|NCT02241733|58942412|FG001|Overall Study|Withdrawal by Subject|2|||
30907864|NCT02241733|58942411|FG000|Overall Study|Death|0|||
30907865|NCT02241733|58942412|FG001|Overall Study|Death|2|||
30907866|NCT02241343|58942418|FG000|Overall Study|Adverse Event|1|||
30907867|NCT02241187|58942423|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
30748179|NCT00147537|58758355|FG004|Phase 2|Other|0|||
30907868|NCT02249767|58942430|FG000|Overall Study|Did not use medication|8|||
30907869|NCT02249767|58942431|FG001|Overall Study|Did not use medication|9|||
30907870|NCT02249767|58942432|FG002|Overall Study|Did not use medication|8|||
30907871|NCT02239939|58942442|FG000|Overall Study|Adverse Event|1|||
30907872|NCT02239939|58942443|FG001|Overall Study|Adverse Event|0|||
30907873|NCT02239939|58942442|FG000|Overall Study|Withdrawal by Subject|1|||
30907874|NCT02239939|58942443|FG001|Overall Study|Withdrawal by Subject|1|||
30907875|NCT02239939|58942442|FG000|Overall Study|Lost to Follow-up|0|||
30907876|NCT02239939|58942443|FG001|Overall Study|Lost to Follow-up|1|||
30907877|NCT02248675|58942453|FG000|Overall Study|Lost to Follow-up|3|||
30907878|NCT02248675|58942454|FG001|Overall Study|Lost to Follow-up|1|||
30907879|NCT02238379|58942462|FG000|Overall Study|Lost to Follow-up|1|||
30907880|NCT02238379|58942463|FG001|Overall Study|Lost to Follow-up|0|||
30907881|NCT02238067|58942469|FG000|Overall Study|Not completed survey at Month 6|45|||
30907882|NCT02237911|58942476|FG000|Overall Study|Withdrawal by Subject|4|||
30907883|NCT02237911|58942477|FG001|Overall Study|Withdrawal by Subject|7|||
30907884|NCT02237911|58942478|FG002|Overall Study|Withdrawal by Subject|2|||
30907885|NCT02237911|58942476|FG000|Overall Study|Lost to Follow-up|3|||
30907886|NCT02237911|58942477|FG001|Overall Study|Lost to Follow-up|1|||
30907887|NCT02237911|58942478|FG002|Overall Study|Lost to Follow-up|1|||
30907888|NCT02234479|58942488|FG000|Overall Study|Withdrawal by Subject|1|||
30907889|NCT02234479|58942489|FG001|Overall Study|Withdrawal by Subject|3|||
30907890|NCT02207491|58942497|FG000|Overall Study|Adverse Event|20|||
30907891|NCT02207491|58942498|FG001|Overall Study|Adverse Event|4|||
30907892|NCT02207491|58942497|FG000|Overall Study|Withdrawal by Subject|3|||
30907893|NCT02207491|58942498|FG001|Overall Study|Withdrawal by Subject|2|||
30907894|NCT02207491|58942497|FG000|Overall Study|Non-compliant|0|||
30907895|NCT02207491|58942498|FG001|Overall Study|Non-compliant|1|||
30907896|NCT02207491|58942497|FG000|Overall Study|Lost to Follow-up|0|||
30907897|NCT02207491|58942498|FG001|Overall Study|Lost to Follow-up|1|||
30907898|NCT02207491|58942497|FG000|Overall Study|Lack of Efficacy|3|||
30907899|NCT02207491|58942498|FG001|Overall Study|Lack of Efficacy|0|||
30907900|NCT02207491|58942497|FG000|Overall Study|Physician Decision|2|||
30907901|NCT02207491|58942498|FG001|Overall Study|Physician Decision|0|||
30907902|NCT02207491|58942497|FG000|Overall Study|Protocol Violation|3|||
30907903|NCT02207491|58942498|FG001|Overall Study|Protocol Violation|5|||
30907904|NCT02315066|58942518|FG000|Overall Study|Lost to Follow-up|0|||
30907905|NCT02315066|58942519|FG001|Overall Study|Lost to Follow-up|1|||
30907906|NCT02315066|58942520|FG002|Overall Study|Lost to Follow-up|1|||
30907907|NCT02315066|58942521|FG003|Overall Study|Lost to Follow-up|0|||
30907908|NCT02315066|58942522|FG004|Overall Study|Lost to Follow-up|1|||
30907909|NCT02315066|58942523|FG005|Overall Study|Lost to Follow-up|0|||
30907910|NCT02315066|58942524|FG006|Overall Study|Lost to Follow-up|2|||
30907911|NCT02315066|58942525|FG007|Overall Study|Lost to Follow-up|1|||
30907912|NCT02315066|58942526|FG008|Overall Study|Lost to Follow-up|0|||
30907913|NCT02315066|58942527|FG009|Overall Study|Lost to Follow-up|0|||
30907914|NCT02315066|58942528|FG010|Overall Study|Lost to Follow-up|1|||
30907915|NCT02315066|58942529|FG011|Overall Study|Lost to Follow-up|2|||
30907916|NCT02315066|58942530|FG012|Overall Study|Lost to Follow-up|0|||
30907917|NCT02315066|58942531|FG013|Overall Study|Lost to Follow-up|4|||
30907918|NCT02315066|58942518|FG000|Overall Study|Death|2|||
30907919|NCT02315066|58942519|FG001|Overall Study|Death|7|||
30907920|NCT02315066|58942520|FG002|Overall Study|Death|6|||
30907921|NCT02315066|58942521|FG003|Overall Study|Death|11|||
30907922|NCT02315066|58942522|FG004|Overall Study|Death|10|||
30748180|NCT00147537|58758356|FG005|Phase 2|Other|0|||
30748181|NCT00147537|58758357|FG006|Phase 2|Other|0|||
30748182|NCT00147537|58758358|FG007|Phase 2|Other|0|||
30748183|NCT00147537|58758359|FG008|Phase 2|Other|0|||
30748184|NCT00147537|58758360|FG009|Phase 2|Other|47|||
30748185|NCT00147537|58758361|FG010|Phase 2|Other|12|||
30748186|NCT00147537|58758351|FG000|Phase 2|Withdrawal by Subject|0|||
30748187|NCT00147537|58758352|FG001|Phase 2|Withdrawal by Subject|0|||
30907923|NCT02315066|58942523|FG005|Overall Study|Death|3|||
30907924|NCT02315066|58942524|FG006|Overall Study|Death|9|||
30907925|NCT02315066|58942525|FG007|Overall Study|Death|9|||
30907926|NCT02315066|58942526|FG008|Overall Study|Death|10|||
30907927|NCT02315066|58942527|FG009|Overall Study|Death|8|||
30907928|NCT02315066|58942528|FG010|Overall Study|Death|10|||
30907929|NCT02315066|58942529|FG011|Overall Study|Death|7|||
30907930|NCT02315066|58942530|FG012|Overall Study|Death|8|||
30907931|NCT02315066|58942531|FG013|Overall Study|Death|21|||
30748188|NCT00147537|58758353|FG002|Phase 2|Withdrawal by Subject|0|||
30907932|NCT02315066|58942518|FG000|Overall Study|Other|0|||
30907933|NCT02315066|58942519|FG001|Overall Study|Other|0|||
30907934|NCT02315066|58942520|FG002|Overall Study|Other|0|||
30748189|NCT00147537|58758354|FG003|Phase 2|Withdrawal by Subject|0|||
30907935|NCT02315066|58942521|FG003|Overall Study|Other|0|||
30907936|NCT02315066|58942522|FG004|Overall Study|Other|0|||
30907937|NCT02315066|58942523|FG005|Overall Study|Other|0|||
30907938|NCT02315066|58942524|FG006|Overall Study|Other|0|||
30907939|NCT02315066|58942525|FG007|Overall Study|Other|1|||
30907940|NCT02315066|58942526|FG008|Overall Study|Other|1|||
30907941|NCT02315066|58942527|FG009|Overall Study|Other|2|||
30907942|NCT02315066|58942528|FG010|Overall Study|Other|0|||
30907943|NCT02315066|58942529|FG011|Overall Study|Other|0|||
30907944|NCT02315066|58942530|FG012|Overall Study|Other|0|||
30907945|NCT02315066|58942531|FG013|Overall Study|Other|0|||
30907946|NCT02315066|58942518|FG000|Overall Study|Subject refused further follow-up|0|||
30907947|NCT02315066|58942519|FG001|Overall Study|Subject refused further follow-up|2|||
30907948|NCT02315066|58942520|FG002|Overall Study|Subject refused further follow-up|2|||
30907949|NCT02315066|58942521|FG003|Overall Study|Subject refused further follow-up|0|||
30907950|NCT02315066|58942522|FG004|Overall Study|Subject refused further follow-up|0|||
30907951|NCT02315066|58942523|FG005|Overall Study|Subject refused further follow-up|0|||
30907952|NCT02315066|58942524|FG006|Overall Study|Subject refused further follow-up|2|||
30907953|NCT02315066|58942525|FG007|Overall Study|Subject refused further follow-up|3|||
30907954|NCT02315066|58942526|FG008|Overall Study|Subject refused further follow-up|0|||
30748190|NCT00147537|58758355|FG004|Phase 2|Withdrawal by Subject|0|||
30804221|NCT03470545|58821056|FG001|Overall Study|Withdrawal by Subject|1|||
30804222|NCT03470545|58821055|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
30804223|NCT03470545|58821056|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
30804224|NCT03163446|58821065|FG000|Overall Study|Unable to return for Day 180 visit|2|||
30804225|NCT03163446|58821066|FG001|Overall Study|Unable to return for Day 180 visit|0|||
30804226|NCT03163446|58821065|FG000|Overall Study|Withdrawal by Subject|2|||
30804227|NCT03163446|58821066|FG001|Overall Study|Withdrawal by Subject|6|||
30804228|NCT03163446|58821065|FG000|Overall Study|Death|16|||
30804229|NCT03163446|58821066|FG001|Overall Study|Death|5|||
30804230|NCT03163446|58821065|FG000|Overall Study|Lost to Follow-up|6|||
30804231|NCT03163446|58821066|FG001|Overall Study|Lost to Follow-up|5|||
30804232|NCT03163446|58821065|FG000|Overall Study|Physician Decision|1|||
30804233|NCT03163446|58821066|FG001|Overall Study|Physician Decision|1|||
30804234|NCT03163446|58821065|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
30804235|NCT03163446|58821066|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
30804236|NCT03722485|58821080|FG000|Overall Study|Withdrawal by Subject|1|||
30804237|NCT03722485|58821081|FG001|Overall Study|Withdrawal by Subject|0|||
30804238|NCT03722485|58821080|FG000|Overall Study|Adverse Event|0|||
30804239|NCT03722485|58821081|FG001|Overall Study|Adverse Event|2|||
30804240|NCT03722485|58821080|FG000|Overall Study|subject discharged prior to study completion|1|||
30804241|NCT03722485|58821081|FG001|Overall Study|subject discharged prior to study completion|5|||
30804242|NCT03722485|58821080|FG000|Overall Study|eligibility criteria not met|2|||
30804243|NCT03722485|58821081|FG001|Overall Study|eligibility criteria not met|0|||
30804244|NCT03047720|58821111|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
30804245|NCT03047720|58821112|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
30804246|NCT03626168|58821137|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
30804247|NCT03626168|58821138|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
30804248|NCT03626168|58821137|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
30748191|NCT00147537|58758356|FG005|Phase 2|Withdrawal by Subject|0|||
30748192|NCT00147537|58758357|FG006|Phase 2|Withdrawal by Subject|0|||
30748193|NCT00147537|58758358|FG007|Phase 2|Withdrawal by Subject|0|||
30748194|NCT00147537|58758359|FG008|Phase 2|Withdrawal by Subject|0|||
30748195|NCT00147537|58758360|FG009|Phase 2|Withdrawal by Subject|16|||
30748196|NCT00147537|58758361|FG010|Phase 2|Withdrawal by Subject|4|||
30748197|NCT00147537|58758351|FG000|Phase 2|Randomized but not treated|0|||
30748198|NCT00147537|58758352|FG001|Phase 2|Randomized but not treated|0|||
30804249|NCT03626168|58821138|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
30804250|NCT03626168|58821137|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
30907955|NCT02315066|58942527|FG009|Overall Study|Subject refused further follow-up|1|||
30804251|NCT03626168|58821138|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
30804252|NCT02966873|58821146|FG000|Overall Study|Lost to Follow-up|16|||
30907956|NCT02315066|58942528|FG010|Overall Study|Subject refused further follow-up|1|||
30907957|NCT02315066|58942529|FG011|Overall Study|Subject refused further follow-up|2|||
30907958|NCT02315066|58942530|FG012|Overall Study|Subject refused further follow-up|2|||
30748199|NCT00147537|58758353|FG002|Phase 2|Randomized but not treated|0|||
30804253|NCT02966873|58821147|FG001|Overall Study|Lost to Follow-up|15|||
30804254|NCT01389024|58821155|FG000|Overall Study|Withdrawal by Subject|0|||
30804255|NCT01389024|58821156|FG001|Overall Study|Withdrawal by Subject|1|||
30804256|NCT01389024|58821155|FG000|Overall Study|Lost to Follow-up|1|||
30804257|NCT01389024|58821156|FG001|Overall Study|Lost to Follow-up|0|||
30804258|NCT03050060|58821166|FG000|Overall Study|Adverse Event|7|||
30804259|NCT03050060|58821166|FG000|Overall Study|Withdrawal by Subject|1|||
30804260|NCT03050060|58821166|FG000|Overall Study|Progression|7|||
30804261|NCT00706342|58821179|FG000|Overall Study|Adverse Event|3|||
30804262|NCT00706342|58821179|FG000|Overall Study|Not responding to treatment|2|||
30804263|NCT00706342|58821179|FG000|Overall Study|Withdrawn due to failure to respond|1|||
30804264|NCT00706342|58821179|FG000|Overall Study|Death|1|||
30804265|NCT00706342|58821179|FG000|Overall Study|Withdrew from the study on his own.|1|||
30804266|NCT00706342|58821179|FG000|Overall Study|Investigator discretion|2|||
30804267|NCT00706342|58821179|FG000|Overall Study|Non-responder Week 12|1|||
30804268|NCT00706342|58821179|FG000|Overall Study|Ongoing|6|||
30804269|NCT00706342|58821179|FG000|Overall Study|WIthdrawal of consent|1|||
30804270|NCT03049748|58821185|FG000|Overall Study|Lost to Follow-up|1|||
30804271|NCT03049748|58821186|FG001|Overall Study|Lost to Follow-up|0|||
30804272|NCT03049748|58821185|FG000|Overall Study|Death|3|||
30804273|NCT03049748|58821186|FG001|Overall Study|Death|0|||
30804274|NCT03049748|58821185|FG000|Overall Study|Withdrawal by Subject|0|||
30804275|NCT03049748|58821186|FG001|Overall Study|Withdrawal by Subject|3|||
30804276|NCT03049748|58821185|FG000|Overall Study|Protocol Violation|0|||
30804277|NCT03049748|58821186|FG001|Overall Study|Protocol Violation|2|||
30804278|NCT03049748|58821185|FG000|Overall Study|Moved out of state (relocation)|0|||
30804279|NCT03049748|58821186|FG001|Overall Study|Moved out of state (relocation)|1|||
30804280|NCT03501277|58821200|FG000|Intervention Period 1 (4 Days)|Other|0|||
30804281|NCT03501277|58821201|FG001|Intervention Period 1 (4 Days)|Other|0|||
30804282|NCT03501277|58821202|FG002|Intervention Period 1 (4 Days)|Other|1|||
30804283|NCT03501277|58821203|FG003|Intervention Period 1 (4 Days)|Other|0|||
30804284|NCT03501277|58821200|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
30804285|NCT03501277|58821201|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
30804286|NCT03501277|58821202|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
30804287|NCT03501277|58821203|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
30804288|NCT03501277|58821200|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
30748200|NCT00147537|58758354|FG003|Phase 2|Randomized but not treated|0|||
30748201|NCT00147537|58758355|FG004|Phase 2|Randomized but not treated|0|||
30748202|NCT00147537|58758356|FG005|Phase 2|Randomized but not treated|0|||
30748203|NCT00147537|58758357|FG006|Phase 2|Randomized but not treated|0|||
30748204|NCT00147537|58758358|FG007|Phase 2|Randomized but not treated|0|||
30748205|NCT00147537|58758359|FG008|Phase 2|Randomized but not treated|0|||
30748206|NCT00147537|58758360|FG009|Phase 2|Randomized but not treated|1|||
30748207|NCT00147537|58758361|FG010|Phase 2|Randomized but not treated|1|||
30748208|NCT00222729|58758406|FG000|Overall Study|Adverse Event|3|||
30748209|NCT00147225|58758416|FG000|Overall Study|Withdrawal by Subject|1|||
30748210|NCT00147225|58758417|FG001|Overall Study|Withdrawal by Subject|0|||
30748211|NCT00147225|58758418|FG002|Overall Study|Withdrawal by Subject|1|||
30748212|NCT00147225|58758419|FG003|Overall Study|Withdrawal by Subject|0|||
30748213|NCT00147225|58758420|FG004|Overall Study|Withdrawal by Subject|0|||
30748214|NCT00147225|58758421|FG005|Overall Study|Withdrawal by Subject|1|||
30748215|NCT00147225|58758416|FG000|Overall Study|Adverse Event|0|||
30748216|NCT00147225|58758417|FG001|Overall Study|Adverse Event|0|||
30748217|NCT00147225|58758418|FG002|Overall Study|Adverse Event|1|||
30748218|NCT00147225|58758419|FG003|Overall Study|Adverse Event|1|||
30748219|NCT00147225|58758420|FG004|Overall Study|Adverse Event|0|||
30804289|NCT03501277|58821201|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
30804290|NCT03501277|58821202|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
30804291|NCT03501277|58821203|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
30804292|NCT03501277|58821200|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
30804293|NCT03501277|58821201|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
30804294|NCT03501277|58821202|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
30804295|NCT03501277|58821203|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
30804296|NCT03500419|58821215|FG000|Overall Study|Withdrawal by Subject|2|||
30804297|NCT03500419|58821216|FG001|Overall Study|Withdrawal by Subject|25|||
30804298|NCT03500341|58821222|FG000|Overall Study|Withdrawn prior to Completion|2|||
30804299|NCT01316900|58821243|FG000|Overall Study|Adverse Event|10|||
30804300|NCT01316900|58821244|FG001|Overall Study|Adverse Event|10|||
30804301|NCT01316900|58821245|FG002|Overall Study|Adverse Event|15|||
30804302|NCT01316900|58821246|FG003|Overall Study|Adverse Event|9|||
30804303|NCT01316900|58821243|FG000|Overall Study|Lack of Efficacy|17|||
30804304|NCT01316900|58821244|FG001|Overall Study|Lack of Efficacy|9|||
30804305|NCT01316900|58821245|FG002|Overall Study|Lack of Efficacy|5|||
30804306|NCT01316900|58821246|FG003|Overall Study|Lack of Efficacy|7|||
30804307|NCT01316900|58821243|FG000|Overall Study|Protocol Violation|7|||
30804308|NCT01316900|58821244|FG001|Overall Study|Protocol Violation|1|||
30804309|NCT01316900|58821245|FG002|Overall Study|Protocol Violation|4|||
30804310|NCT01316900|58821246|FG003|Overall Study|Protocol Violation|0|||
30804311|NCT01316900|58821243|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
30804312|NCT01316900|58821244|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
30804313|NCT01316900|58821245|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
30804314|NCT01316900|58821246|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
30804315|NCT01316900|58821243|FG000|Overall Study|Lost to Follow-up|1|||
30804316|NCT01316900|58821244|FG001|Overall Study|Lost to Follow-up|0|||
30804317|NCT01316900|58821245|FG002|Overall Study|Lost to Follow-up|1|||
30804318|NCT01316900|58821246|FG003|Overall Study|Lost to Follow-up|1|||
30804319|NCT01316900|58821243|FG000|Overall Study|Withdrawal by Subject|7|||
30804320|NCT01316900|58821244|FG001|Overall Study|Withdrawal by Subject|8|||
30804321|NCT01316900|58821245|FG002|Overall Study|Withdrawal by Subject|6|||
30804322|NCT01316900|58821246|FG003|Overall Study|Withdrawal by Subject|9|||
30804323|NCT03714815|58821256|FG000|Overall Study|Physician Decision|2|||
30804324|NCT03714815|58821256|FG000|Overall Study|Withdrawal by Subject|2|||
30804325|NCT03714815|58821256|FG000|Overall Study|Death|11|||
30804326|NCT00936390|58821262|FG000|Overall Study|Protocol Violation|21|||
30804327|NCT00936390|58821263|FG001|Overall Study|Protocol Violation|25|||
30804328|NCT03499873|58821274|FG000|Overall Study|Withdrawal by Subject|4|||
30804329|NCT03499873|58821275|FG001|Overall Study|Withdrawal by Subject|6|||
30804330|NCT03499873|58821276|FG002|Overall Study|Withdrawal by Subject|1|||
30804331|NCT03499873|58821274|FG000|Overall Study|Subjects condition worsened|0|||
30804332|NCT03499873|58821275|FG001|Overall Study|Subjects condition worsened|3|||
30907959|NCT02315066|58942531|FG013|Overall Study|Subject refused further follow-up|4|||
30748220|NCT00147225|58758421|FG005|Overall Study|Adverse Event|0|||
30748221|NCT00147225|58758416|FG000|Overall Study|Screen Failure|0|||
30748222|NCT00147225|58758417|FG001|Overall Study|Screen Failure|0|||
30748223|NCT00147225|58758418|FG002|Overall Study|Screen Failure|0|||
30748224|NCT00147225|58758419|FG003|Overall Study|Screen Failure|0|||
30748225|NCT00147225|58758420|FG004|Overall Study|Screen Failure|1|||
30748226|NCT00147225|58758421|FG005|Overall Study|Screen Failure|0|||
30748227|NCT00147225|58758416|FG000|Overall Study|Chemotherapy Changed|0|||
30748228|NCT00147225|58758417|FG001|Overall Study|Chemotherapy Changed|0|||
30748229|NCT00147225|58758418|FG002|Overall Study|Chemotherapy Changed|0|||
30748230|NCT00147225|58758419|FG003|Overall Study|Chemotherapy Changed|0|||
30748231|NCT00147225|58758420|FG004|Overall Study|Chemotherapy Changed|0|||
30748232|NCT00147225|58758421|FG005|Overall Study|Chemotherapy Changed|1|||
30748233|NCT00222105|58758435|FG000|Overall Study|Removed due to wrong diagnosis|1|||
30748234|NCT00222105|58758435|FG000|Overall Study|Withdrawal by Subject|1|||
30748235|NCT00222105|58758435|FG000|Overall Study|Adverse Event|8|||
30748236|NCT00222105|58758435|FG000|Overall Study|Treatment delays|2|||
30748237|NCT00222105|58758435|FG000|Overall Study|Death|2|||
30748238|NCT00146757|58758439|FG000|Overall Study|Death|1|||
30748239|NCT00146757|58758440|FG001|Overall Study|Death|0|||
30748240|NCT00146757|58758439|FG000|Overall Study|Adverse Event|1|||
30748241|NCT00146757|58758440|FG001|Overall Study|Adverse Event|0|||
30748242|NCT00267098|58758454|FG000|Overall Study|Death|0|||
30748243|NCT00267098|58758455|FG001|Overall Study|Death|0|||
30804333|NCT03499873|58821276|FG002|Overall Study|Subjects condition worsened|11|||
30804334|NCT03499873|58821274|FG000|Overall Study|Adverse Event|8|||
30804335|NCT03499873|58821275|FG001|Overall Study|Adverse Event|3|||
30804336|NCT03499873|58821276|FG002|Overall Study|Adverse Event|6|||
30804337|NCT03499873|58821274|FG000|Overall Study|Physician Decision|1|||
30804338|NCT03499873|58821275|FG001|Overall Study|Physician Decision|0|||
30804339|NCT03499873|58821276|FG002|Overall Study|Physician Decision|0|||
30804340|NCT03499873|58821274|FG000|Overall Study|Administrative reasons|0|||
30804341|NCT03499873|58821275|FG001|Overall Study|Administrative reasons|1|||
30804342|NCT03499873|58821276|FG002|Overall Study|Administrative reasons|0|||
30804343|NCT03499873|58821274|FG000|Overall Study|Concomitant therapy|5|||
30804344|NCT03499873|58821275|FG001|Overall Study|Concomitant therapy|4|||
30804345|NCT03499873|58821276|FG002|Overall Study|Concomitant therapy|7|||
30804346|NCT03499873|58821274|FG000|Overall Study|Miscellaneous|1|||
30804347|NCT03499873|58821275|FG001|Overall Study|Miscellaneous|2|||
30804348|NCT03499873|58821276|FG002|Overall Study|Miscellaneous|2|||
30804349|NCT03499873|58821274|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
30804350|NCT03499873|58821275|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
30804351|NCT03499873|58821276|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
30804352|NCT03467971|58821286|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30804353|NCT03467971|58821287|FG001|Treatment Period 2|Withdrawal by Subject|1|||
30804354|NCT03049280|58821303|FG000|Overall Study|Physician Decision|1|||
30804355|NCT03048500|58821309|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
30804356|NCT03048500|58821309|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
30804357|NCT03048500|58821309|FG000|Reached 1st Response/Continued Treatment|Death|1|||
30804358|NCT03048500|58821309|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
30804359|NCT03048500|58821309|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
30804360|NCT03048500|58821309|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
30804361|NCT03048500|58821309|FG000|Follow up for 3 Years|Death|12|||
30804362|NCT00908076|58821315|FG000|Overall Study|Lack of Efficacy|1|||
30804363|NCT00908076|58821316|FG001|Overall Study|Lack of Efficacy|1|||
30804364|NCT03467425|58821324|FG000|Overall Study|Adverse Event|9|||
30804365|NCT03467425|58821325|FG001|Overall Study|Adverse Event|9|||
30804366|NCT03467425|58821324|FG000|Overall Study|Lack of Efficacy|3|||
30804367|NCT03467425|58821325|FG001|Overall Study|Lack of Efficacy|1|||
30804368|NCT03467425|58821324|FG000|Overall Study|Protocol Violation|0|||
30804369|NCT03467425|58821325|FG001|Overall Study|Protocol Violation|1|||
30907960|NCT02315066|58942518|FG000|Overall Study|Study ongoing at date of cut-off|0|||
30907961|NCT02315066|58942519|FG001|Overall Study|Study ongoing at date of cut-off|0|||
30907962|NCT02315066|58942520|FG002|Overall Study|Study ongoing at date of cut-off|0|||
30804370|NCT03467425|58821324|FG000|Overall Study|Lost to Follow-up|18|||
30804371|NCT03467425|58821325|FG001|Overall Study|Lost to Follow-up|25|||
30804372|NCT03467425|58821324|FG000|Overall Study|Physician Decision|2|||
30804373|NCT03467425|58821325|FG001|Overall Study|Physician Decision|1|||
30804374|NCT03467425|58821324|FG000|Overall Study|Withdrawal by Subject|15|||
30804375|NCT03467425|58821325|FG001|Overall Study|Withdrawal by Subject|17|||
30804376|NCT02886702|58821334|FG000|Overall Study|Other|4|||
30804377|NCT02886702|58821335|FG001|Overall Study|Other|3|||
30804378|NCT02886702|58821336|FG002|Overall Study|Other|9|||
30804379|NCT02886702|58821334|FG000|Overall Study|Withdrawal by Subject|24|||
30804380|NCT02886702|58821335|FG001|Overall Study|Withdrawal by Subject|18|||
30804381|NCT02886702|58821336|FG002|Overall Study|Withdrawal by Subject|22|||
30804382|NCT02886702|58821334|FG000|Overall Study|Significant Worsening of Condition|0|||
30907963|NCT02315066|58942521|FG003|Overall Study|Study ongoing at date of cut-off|0|||
30907964|NCT02315066|58942522|FG004|Overall Study|Study ongoing at date of cut-off|0|||
30907965|NCT02315066|58942523|FG005|Overall Study|Study ongoing at date of cut-off|0|||
30907966|NCT02315066|58942524|FG006|Overall Study|Study ongoing at date of cut-off|0|||
30907967|NCT02315066|58942525|FG007|Overall Study|Study ongoing at date of cut-off|0|||
30907968|NCT02315066|58942526|FG008|Overall Study|Study ongoing at date of cut-off|0|||
30907969|NCT02315066|58942527|FG009|Overall Study|Study ongoing at date of cut-off|0|||
30907970|NCT02315066|58942528|FG010|Overall Study|Study ongoing at date of cut-off|0|||
30907971|NCT02315066|58942529|FG011|Overall Study|Study ongoing at date of cut-off|0|||
30907972|NCT02315066|58942530|FG012|Overall Study|Study ongoing at date of cut-off|0|||
30748244|NCT00267098|58758456|FG002|Overall Study|Death|57|||
30748245|NCT00267098|58758457|FG003|Overall Study|Death|66|||
30748246|NCT00267098|58758458|FG004|Overall Study|Death|14|||
30748247|NCT00267098|58758459|FG005|Overall Study|Death|23|||
30748248|NCT00267098|58758460|FG006|Overall Study|Death|28|||
30748249|NCT00267098|58758461|FG007|Overall Study|Death|9|||
30748250|NCT00267098|58758454|FG000|Overall Study|Lost to Follow-up|0|||
30748251|NCT00267098|58758455|FG001|Overall Study|Lost to Follow-up|0|||
30804383|NCT02886702|58821335|FG001|Overall Study|Significant Worsening of Condition|1|||
30804384|NCT02886702|58821336|FG002|Overall Study|Significant Worsening of Condition|0|||
30804385|NCT02886702|58821334|FG000|Overall Study|Protocol Violation|2|||
30804386|NCT02886702|58821335|FG001|Overall Study|Protocol Violation|2|||
30804387|NCT02886702|58821336|FG002|Overall Study|Protocol Violation|1|||
30748252|NCT00267098|58758456|FG002|Overall Study|Lost to Follow-up|6|||
30748253|NCT00267098|58758457|FG003|Overall Study|Lost to Follow-up|5|||
30804388|NCT02886702|58821334|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30804389|NCT02886702|58821335|FG001|Overall Study|Non-Compliance With Study Drug|1|||
30804390|NCT02886702|58821336|FG002|Overall Study|Non-Compliance With Study Drug|4|||
30804391|NCT02886702|58821334|FG000|Overall Study|Lost to Follow-up|11|||
30804392|NCT02886702|58821335|FG001|Overall Study|Lost to Follow-up|13|||
30804393|NCT02886702|58821336|FG002|Overall Study|Lost to Follow-up|8|||
30804394|NCT02886702|58821334|FG000|Overall Study|Lack of Efficacy|3|||
30804395|NCT02886702|58821335|FG001|Overall Study|Lack of Efficacy|4|||
30804396|NCT02886702|58821336|FG002|Overall Study|Lack of Efficacy|5|||
30804397|NCT02886702|58821334|FG000|Overall Study|Adverse Event|4|||
30804398|NCT02886702|58821335|FG001|Overall Study|Adverse Event|9|||
30804399|NCT02886702|58821336|FG002|Overall Study|Adverse Event|3|||
30804400|NCT02886702|58821334|FG000|Overall Study|Administrative Reasons|0|||
30804401|NCT02886702|58821335|FG001|Overall Study|Administrative Reasons|0|||
30804402|NCT02886702|58821336|FG002|Overall Study|Administrative Reasons|1|||
30804403|NCT03498313|58821350|FG000|Experimental Period 1|Adverse Event|1|||
30804404|NCT03498313|58821351|FG001|Experimental Period 1|Adverse Event|0|||
30804405|NCT03498313|58821352|FG002|Experimental Period 1|Adverse Event|0|||
30804406|NCT03498313|58821353|FG003|Experimental Period 1|Adverse Event|1|||
30804407|NCT03498313|58821354|FG004|Experimental Period 1|Adverse Event|0|||
30804408|NCT03498313|58821355|FG005|Experimental Period 1|Adverse Event|0|||
30804409|NCT03498313|58821350|FG000|Experimental Period 1|Withdrawal by Subject|0|||
30804410|NCT03498313|58821351|FG001|Experimental Period 1|Withdrawal by Subject|1|||
30804411|NCT03498313|58821352|FG002|Experimental Period 1|Withdrawal by Subject|0|||
30804412|NCT03498313|58821353|FG003|Experimental Period 1|Withdrawal by Subject|0|||
30804413|NCT03498313|58821354|FG004|Experimental Period 1|Withdrawal by Subject|0|||
30804414|NCT03498313|58821355|FG005|Experimental Period 1|Withdrawal by Subject|0|||
30804415|NCT03498313|58821350|FG000|Washout Period 1|Anovulation|1|||
30804416|NCT03498313|58821351|FG001|Washout Period 1|Anovulation|0|||
30804417|NCT03498313|58821352|FG002|Washout Period 1|Anovulation|0|||
30804418|NCT03498313|58821353|FG003|Washout Period 1|Anovulation|0|||
30804419|NCT03498313|58821354|FG004|Washout Period 1|Anovulation|0|||
30804420|NCT03498313|58821355|FG005|Washout Period 1|Anovulation|0|||
30804421|NCT03498313|58821350|FG000|Washout Period 1|Withdrawal by Subject|0|||
30804422|NCT03498313|58821351|FG001|Washout Period 1|Withdrawal by Subject|3|||
30804423|NCT03498313|58821352|FG002|Washout Period 1|Withdrawal by Subject|0|||
30804424|NCT03498313|58821353|FG003|Washout Period 1|Withdrawal by Subject|1|||
30804425|NCT03498313|58821354|FG004|Washout Period 1|Withdrawal by Subject|0|||
30804426|NCT03498313|58821355|FG005|Washout Period 1|Withdrawal by Subject|1|||
30907973|NCT02315066|58942531|FG013|Overall Study|Study ongoing at date of cut-off|1|||
30804427|NCT03498313|58821350|FG000|Experimental Period 2|Adverse Event|0|||
30804428|NCT03498313|58821351|FG001|Experimental Period 2|Adverse Event|0|||
30804429|NCT03498313|58821352|FG002|Experimental Period 2|Adverse Event|0|||
30804430|NCT03498313|58821353|FG003|Experimental Period 2|Adverse Event|0|||
30804431|NCT03498313|58821354|FG004|Experimental Period 2|Adverse Event|1|||
30804432|NCT03498313|58821355|FG005|Experimental Period 2|Adverse Event|2|||
30804433|NCT03498313|58821350|FG000|Washout Period 2|Physician Decision|1|||
30804434|NCT03498313|58821351|FG001|Washout Period 2|Physician Decision|0|||
30804435|NCT03498313|58821352|FG002|Washout Period 2|Physician Decision|0|||
30804436|NCT03498313|58821353|FG003|Washout Period 2|Physician Decision|1|||
30804437|NCT03498313|58821354|FG004|Washout Period 2|Physician Decision|0|||
30804438|NCT03498313|58821355|FG005|Washout Period 2|Physician Decision|1|||
30804439|NCT03498313|58821350|FG000|Washout Period 2|Withdrawal by Subject|3|||
30804440|NCT03498313|58821351|FG001|Washout Period 2|Withdrawal by Subject|2|||
30804441|NCT03498313|58821352|FG002|Washout Period 2|Withdrawal by Subject|0|||
30804442|NCT03498313|58821353|FG003|Washout Period 2|Withdrawal by Subject|0|||
30804443|NCT03498313|58821354|FG004|Washout Period 2|Withdrawal by Subject|2|||
30804444|NCT03498313|58821355|FG005|Washout Period 2|Withdrawal by Subject|0|||
30804445|NCT03498313|58821350|FG000|Washout Period 2|Anovulation|0|||
30804446|NCT03498313|58821351|FG001|Washout Period 2|Anovulation|0|||
30804447|NCT03498313|58821352|FG002|Washout Period 2|Anovulation|0|||
30804448|NCT03498313|58821353|FG003|Washout Period 2|Anovulation|0|||
30804449|NCT03498313|58821354|FG004|Washout Period 2|Anovulation|0|||
30804450|NCT03498313|58821355|FG005|Washout Period 2|Anovulation|1|||
30804451|NCT02601014|58821365|FG000|Overall Study|Adverse Event|3|||
30804452|NCT02601014|58821366|FG001|Overall Study|Adverse Event|3|||
30804453|NCT02601014|58821365|FG000|Overall Study|Death|3|||
30804454|NCT02601014|58821366|FG001|Overall Study|Death|1|||
30804455|NCT02601014|58821365|FG000|Overall Study|Disease progression|4|||
30804456|NCT02601014|58821366|FG001|Overall Study|Disease progression|8|||
30804457|NCT01307046|58821374|FG000|Overall Study|Adverse Event|3|||
30804458|NCT01307046|58821375|FG001|Overall Study|Adverse Event|3|||
30804459|NCT01307046|58821374|FG000|Overall Study|Lack of Efficacy|0|||
30804460|NCT01307046|58821375|FG001|Overall Study|Lack of Efficacy|2|||
30804461|NCT01307046|58821374|FG000|Overall Study|Physician Decision|2|||
30804462|NCT01307046|58821375|FG001|Overall Study|Physician Decision|0|||
30804463|NCT01307046|58821374|FG000|Overall Study|Withdrawal by Subject|1|||
30804464|NCT01307046|58821375|FG001|Overall Study|Withdrawal by Subject|1|||
30804465|NCT01307046|58821374|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
30804466|NCT01307046|58821375|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
30804467|NCT01307046|58821374|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
30804468|NCT01307046|58821375|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
30804469|NCT03495817|58821381|FG000|26 Week Open Label|Adverse Event|3|||
30804470|NCT03495817|58821381|FG000|26 Week Open Label|Withdrawal by Subject|4|||
30804471|NCT03495817|58821381|FG000|26 Week Open Label|Lost to Follow-up|1|||
30804472|NCT03495817|58821381|FG000|26 Week Extension|Lost to Follow-up|2|||
30804473|NCT02886624|58821385|FG000|12-week Post Treatment Follow-up|Death|1|||
30804474|NCT02886624|58821385|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
30804475|NCT02963766|58821392|FG000|Double-Blind Period|Adverse Event|1|||
30622365|NCT00927472|58634062|FG000|Overall Study|Withdrawal by Subject|10|||
30804476|NCT02963766|58821393|FG001|Double-Blind Period|Adverse Event|0|||
30804477|NCT02963766|58821394|FG002|Double-Blind Period|Adverse Event|1|||
30804478|NCT02963766|58821392|FG000|Double-Blind Period|Physician Decision|1|||
30622366|NCT00927472|58634063|FG001|Overall Study|Withdrawal by Subject|11|||
30804479|NCT02963766|58821393|FG001|Double-Blind Period|Physician Decision|0|||
30804480|NCT02963766|58821394|FG002|Double-Blind Period|Physician Decision|0|||
30804481|NCT02963766|58821392|FG000|Double-Blind Period|Withdrawal by Subject|1|||
30804482|NCT02963766|58821393|FG001|Double-Blind Period|Withdrawal by Subject|1|||
30804483|NCT02963766|58821394|FG002|Double-Blind Period|Withdrawal by Subject|0|||
30804484|NCT02963766|58821392|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
30804485|NCT02963766|58821393|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
30804486|NCT02963766|58821394|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
30804487|NCT02963766|58821392|FG000|Double-Blind Period|Protocol Violation|1|||
30804488|NCT02963766|58821393|FG001|Double-Blind Period|Protocol Violation|0|||
30804489|NCT02963766|58821394|FG002|Double-Blind Period|Protocol Violation|0|||
30804490|NCT02963766|58821392|FG000|Double-Blind Period|Lost to Follow-up|0|||
30804491|NCT02963766|58821393|FG001|Double-Blind Period|Lost to Follow-up|1|||
30804492|NCT02963766|58821394|FG002|Double-Blind Period|Lost to Follow-up|0|||
30804493|NCT02963766|58821392|FG000|Open Label Extension (OLE)|Physician Decision|1|||
30804494|NCT02963766|58821393|FG001|Open Label Extension (OLE)|Physician Decision|2|||
30804495|NCT02963766|58821394|FG002|Open Label Extension (OLE)|Physician Decision|2|||
30804496|NCT02963766|58821392|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
30804497|NCT02963766|58821393|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
30804498|NCT02963766|58821394|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
30804499|NCT04839965|58821414|FG000|Overall Study|Death|6|||
30804500|NCT04839965|58821415|FG001|Overall Study|Death|6|||
30804501|NCT04839965|58821414|FG000|Overall Study|Lost to Follow-up|1|||
30804502|NCT04839965|58821415|FG001|Overall Study|Lost to Follow-up|0|||
30804503|NCT03466099|58821424|FG000|Overall Study|Adverse Event|1|||
30804504|NCT03466099|58821425|FG001|Overall Study|Adverse Event|1|||
30804505|NCT03466099|58821426|FG002|Overall Study|Adverse Event|1|||
30804506|NCT03466099|58821424|FG000|Overall Study|Withdrawal by Subject|2|||
30804507|NCT03466099|58821425|FG001|Overall Study|Withdrawal by Subject|3|||
30804508|NCT03466099|58821426|FG002|Overall Study|Withdrawal by Subject|1|||
30804509|NCT03466099|58821424|FG000|Overall Study|Use of rescue medication|8|||
30804510|NCT03466099|58821425|FG001|Overall Study|Use of rescue medication|9|||
30804511|NCT03466099|58821426|FG002|Overall Study|Use of rescue medication|13|||
30804512|NCT03466099|58821424|FG000|Overall Study|Rescued without meeting criteria|4|||
30804513|NCT03466099|58821425|FG001|Overall Study|Rescued without meeting criteria|1|||
30804514|NCT03466099|58821426|FG002|Overall Study|Rescued without meeting criteria|1|||
30804515|NCT03466099|58821424|FG000|Overall Study|Subject compliance|2|||
30804516|NCT03466099|58821425|FG001|Overall Study|Subject compliance|0|||
30804517|NCT03466099|58821426|FG002|Overall Study|Subject compliance|0|||
30804518|NCT03466099|58821424|FG000|Overall Study|Worsening disease|0|||
30804519|NCT03466099|58821425|FG001|Overall Study|Worsening disease|0|||
30804520|NCT03466099|58821426|FG002|Overall Study|Worsening disease|1|||
30804521|NCT00739674|58821436|FG000|Overall Study|Screening failures|19|||
30804522|NCT00739674|58821437|FG001|Overall Study|Screening failures|17|||
30804523|NCT00739674|58821436|FG000|Overall Study|Site 212 removal|19|||
30804524|NCT00739674|58821437|FG001|Overall Study|Site 212 removal|13|||
30804525|NCT00739674|58821436|FG000|Overall Study|No follow-up data|33|||
30804526|NCT00739674|58821437|FG001|Overall Study|No follow-up data|18|||
30804527|NCT00739674|58821436|FG000|Overall Study|Dietician consultation >30 days|1|||
30804528|NCT00739674|58821437|FG001|Overall Study|Dietician consultation >30 days|9|||
30804529|NCT00739674|58821436|FG000|Overall Study|Adverse Event|22|||
30804530|NCT00739674|58821437|FG001|Overall Study|Adverse Event|13|||
30804531|NCT00739674|58821436|FG000|Overall Study|Death|1|||
30804532|NCT00739674|58821437|FG001|Overall Study|Death|0|||
30804533|NCT00739674|58821436|FG000|Overall Study|Lack of Efficacy|1|||
30804534|NCT00739674|58821437|FG001|Overall Study|Lack of Efficacy|0|||
30622367|NCT00927472|58634062|FG000|Overall Study|Lost to Follow-up|1|||
30804535|NCT00739674|58821436|FG000|Overall Study|Lost to Follow-up|52|||
30804536|NCT00739674|58821437|FG001|Overall Study|Lost to Follow-up|30|||
30804537|NCT00739674|58821436|FG000|Overall Study|Protocol Violation|5|||
30804538|NCT00739674|58821437|FG001|Overall Study|Protocol Violation|5|||
30804539|NCT00739674|58821436|FG000|Overall Study|Withdrawal by Subject|9|||
30804540|NCT00739674|58821437|FG001|Overall Study|Withdrawal by Subject|9|||
30804541|NCT00739674|58821436|FG000|Overall Study|Reason missing|2|||
30804542|NCT00739674|58821437|FG001|Overall Study|Reason missing|0|||
30804543|NCT00739674|58821436|FG000|Overall Study|Clinic closed|6|||
30804544|NCT00739674|58821437|FG001|Overall Study|Clinic closed|4|||
30804545|NCT00739674|58821436|FG000|Overall Study|Patient moved|3|||
30804546|NCT00739674|58821437|FG001|Overall Study|Patient moved|2|||
30804547|NCT00739674|58821436|FG000|Overall Study|Non compliant|4|||
30804548|NCT00739674|58821437|FG001|Overall Study|Non compliant|0|||
30804549|NCT00739674|58821436|FG000|Overall Study|Unable to attend visit|3|||
30804550|NCT00739674|58821437|FG001|Overall Study|Unable to attend visit|1|||
30804551|NCT00739674|58821436|FG000|Overall Study|Home monitoring off meds|1|||
30804552|NCT00739674|58821437|FG001|Overall Study|Home monitoring off meds|0|||
30804553|NCT00739674|58821436|FG000|Overall Study|Erectile dysfunction|0|||
30804554|NCT00739674|58821437|FG001|Overall Study|Erectile dysfunction|1|||
30804555|NCT03494725|58821445|FG000|Overall Study|Withdrawal by Subject|0|||
30804556|NCT03494725|58821446|FG001|Overall Study|Withdrawal by Subject|2|||
30804557|NCT03494725|58821445|FG000|Overall Study|Antibiotic use|1|||
30804558|NCT03494725|58821446|FG001|Overall Study|Antibiotic use|0|||
30804559|NCT00705718|58821460|FG000|Overall Study|Death|6|||
30804560|NCT00705718|58821461|FG001|Overall Study|Death|6|||
30804561|NCT00705718|58821460|FG000|Overall Study|Not due for Visit|0|||
30804562|NCT00705718|58821461|FG001|Overall Study|Not due for Visit|12|||
30804563|NCT00705718|58821460|FG000|Overall Study|Follow up not done|1|||
30804564|NCT00705718|58821461|FG001|Overall Study|Follow up not done|4|||
30804565|NCT03435211|58821476|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
30804566|NCT03465709|58821489|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
30804567|NCT03465709|58821489|FG000|Overall Study|Withdrawal by Subject|3|||
30804568|NCT03435055|58821495|FG000|Screening|Physician Decision|2|||
30804569|NCT03435055|58821495|FG000|Received Intervention|Did not complete nitrous administration|3|||
30804570|NCT03434977|58821508|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
30804571|NCT03434977|58821509|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
30804572|NCT03434119|58821517|FG000|Overall Study|Randomized but not treated|1|||
30804573|NCT03434119|58821518|FG001|Overall Study|Randomized but not treated|0|||
30804574|NCT03434119|58821517|FG000|Overall Study|Adverse Event|1|||
30804575|NCT03434119|58821518|FG001|Overall Study|Adverse Event|0|||
30804576|NCT03434119|58821517|FG000|Overall Study|Poor Compliance to Protocol|0|||
30804577|NCT03434119|58821518|FG001|Overall Study|Poor Compliance to Protocol|1|||
30804578|NCT03434119|58821517|FG000|Overall Study|Study Terminated by Sponsor|91|||
30804579|NCT03434119|58821518|FG001|Overall Study|Study Terminated by Sponsor|102|||
30804580|NCT03434119|58821517|FG000|Overall Study|Withdrawal by Subject|7|||
30804581|NCT03434119|58821518|FG001|Overall Study|Withdrawal by Subject|5|||
30804582|NCT03434119|58821517|FG000|Overall Study|Other than specified|7|||
30804583|NCT03434119|58821518|FG001|Overall Study|Other than specified|5|||
30804584|NCT00378378|58821527|FG000|Overall Study|Withdrawal by Subject|0|||
30804585|NCT00378378|58821528|FG001|Overall Study|Withdrawal by Subject|1|||
30804586|NCT00378378|58821529|FG002|Overall Study|Withdrawal by Subject|0|||
30804587|NCT00378378|58821527|FG000|Overall Study|Treatment Failure|0|||
30804588|NCT00378378|58821528|FG001|Overall Study|Treatment Failure|0|||
30804589|NCT00378378|58821529|FG002|Overall Study|Treatment Failure|1|||
30804590|NCT00378378|58821527|FG000|Overall Study|Non-compliance with protocol|0|||
30804591|NCT00378378|58821528|FG001|Overall Study|Non-compliance with protocol|0|||
30804592|NCT00378378|58821529|FG002|Overall Study|Non-compliance with protocol|1|||
30804593|NCT03490981|58821539|FG000|Overall Study|Lost to Follow-up|1|||
30804594|NCT03490981|58821540|FG001|Overall Study|Lost to Follow-up|2|||
30804595|NCT03160716|58821546|FG000|Overall Study|Lost to Follow-up|1|||
30804596|NCT03713021|58821550|FG000|Overall Study|Did not have CT sim scan available|6|||
30804597|NCT03713021|58821550|FG000|Overall Study|Not eligible|4|||
30804598|NCT03713021|58821550|FG000|Overall Study|Issues with TraceIT markers|5|||
30804599|NCT03160560|58821558|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
30804600|NCT03160560|58821559|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
30804601|NCT03160560|58821560|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
30804602|NCT03160560|58821561|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
30804603|NCT03160560|58821558|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
30804604|NCT03160560|58821559|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
30804605|NCT03160560|58821560|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
30804606|NCT03160560|58821561|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
30804607|NCT03489343|58821578|FG000|Overall Study|Documented progressive disease|1|||
30804608|NCT03489343|58821579|FG001|Overall Study|Documented progressive disease|0|||
30804609|NCT03489343|58821580|FG002|Overall Study|Documented progressive disease|3|||
30804610|NCT03489343|58821581|FG003|Overall Study|Documented progressive disease|1|||
30804611|NCT03489343|58821582|FG004|Overall Study|Documented progressive disease|3|||
30804612|NCT03489343|58821583|FG005|Overall Study|Documented progressive disease|5|||
30804613|NCT03489343|58821584|FG006|Overall Study|Documented progressive disease|4|||
30804614|NCT03489343|58821578|FG000|Overall Study|Adverse Event|0|||
30804615|NCT03489343|58821579|FG001|Overall Study|Adverse Event|1|||
30804616|NCT03489343|58821580|FG002|Overall Study|Adverse Event|0|||
30804617|NCT03489343|58821581|FG003|Overall Study|Adverse Event|0|||
30804618|NCT03489343|58821582|FG004|Overall Study|Adverse Event|0|||
30804619|NCT03489343|58821583|FG005|Overall Study|Adverse Event|1|||
30804620|NCT03489343|58821584|FG006|Overall Study|Adverse Event|0|||
30804621|NCT03489343|58821578|FG000|Overall Study|Withdrawal by Subject|0|||
30804622|NCT03489343|58821579|FG001|Overall Study|Withdrawal by Subject|0|||
30804623|NCT03489343|58821580|FG002|Overall Study|Withdrawal by Subject|0|||
30804624|NCT03489343|58821581|FG003|Overall Study|Withdrawal by Subject|1|||
30804625|NCT03489343|58821582|FG004|Overall Study|Withdrawal by Subject|0|||
30907974|NCT02207413|58942567|FG000|Overall Study|Withdrawal by Subject|1|||
30907975|NCT02207413|58942568|FG001|Overall Study|Withdrawal by Subject|0|||
30804626|NCT03489343|58821583|FG005|Overall Study|Withdrawal by Subject|1|||
30804627|NCT03489343|58821584|FG006|Overall Study|Withdrawal by Subject|1|||
30804628|NCT03489343|58821578|FG000|Overall Study|Clinical progression|0|||
30804629|NCT03489343|58821579|FG001|Overall Study|Clinical progression|0|||
30804630|NCT03489343|58821580|FG002|Overall Study|Clinical progression|0|||
30804631|NCT03489343|58821581|FG003|Overall Study|Clinical progression|1|||
30804632|NCT03489343|58821582|FG004|Overall Study|Clinical progression|0|||
30804633|NCT03489343|58821583|FG005|Overall Study|Clinical progression|0|||
30804634|NCT03489343|58821584|FG006|Overall Study|Clinical progression|1|||
30804635|NCT03489109|58821602|FG000|Overall Study|Lost to Follow-up|1|||
30804636|NCT03489109|58821603|FG001|Overall Study|Lost to Follow-up|2|||
30804637|NCT03709823|58821615|FG000|Overall Study|Adverse Event|0|||
30804638|NCT03709823|58821616|FG001|Overall Study|Adverse Event|0|||
30804639|NCT03709823|58821617|FG002|Overall Study|Adverse Event|1|||
30804640|NCT03709823|58821618|FG003|Overall Study|Adverse Event|0|||
30804641|NCT03709823|58821619|FG004|Overall Study|Adverse Event|0|||
30804642|NCT03709823|58821620|FG005|Overall Study|Adverse Event|0|||
30804643|NCT03709823|58821615|FG000|Overall Study|Lost to Follow-up|2|||
30804644|NCT03709823|58821616|FG001|Overall Study|Lost to Follow-up|2|||
30804645|NCT03709823|58821617|FG002|Overall Study|Lost to Follow-up|2|||
30804646|NCT03709823|58821618|FG003|Overall Study|Lost to Follow-up|1|||
30804647|NCT03709823|58821619|FG004|Overall Study|Lost to Follow-up|1|||
30804648|NCT03709823|58821620|FG005|Overall Study|Lost to Follow-up|0|||
30804649|NCT03709823|58821615|FG000|Overall Study|Withdrawal by Subject|1|||
30804650|NCT03709823|58821616|FG001|Overall Study|Withdrawal by Subject|3|||
30804651|NCT03709823|58821617|FG002|Overall Study|Withdrawal by Subject|0|||
30804652|NCT03709823|58821618|FG003|Overall Study|Withdrawal by Subject|0|||
30804653|NCT03709823|58821619|FG004|Overall Study|Withdrawal by Subject|0|||
30804654|NCT03709823|58821620|FG005|Overall Study|Withdrawal by Subject|0|||
30804655|NCT03709823|58821615|FG000|Overall Study|Other, Not Specified|0|||
30804656|NCT03709823|58821616|FG001|Overall Study|Other, Not Specified|0|||
30804657|NCT03709823|58821617|FG002|Overall Study|Other, Not Specified|0|||
30804658|NCT03709823|58821618|FG003|Overall Study|Other, Not Specified|1|||
30804659|NCT03709823|58821619|FG004|Overall Study|Other, Not Specified|0|||
30804660|NCT03709823|58821620|FG005|Overall Study|Other, Not Specified|0|||
30804661|NCT03488563|58821640|FG000|Overall Study|Lost to Follow-up|7|||
30804662|NCT03488563|58821641|FG001|Overall Study|Lost to Follow-up|6|||
30804663|NCT03488563|58821642|FG002|Overall Study|Lost to Follow-up|7|||
30804664|NCT03488563|58821640|FG000|Overall Study|Withdrawal by Subject|8|||
30804665|NCT03488563|58821641|FG001|Overall Study|Withdrawal by Subject|7|||
30804666|NCT03488563|58821642|FG002|Overall Study|Withdrawal by Subject|7|||
30804667|NCT03488563|58821640|FG000|Overall Study|Physician Decision|0|||
30804668|NCT03488563|58821641|FG001|Overall Study|Physician Decision|0|||
30907976|NCT02207413|58942569|FG002|Overall Study|Withdrawal by Subject|0|||
30804669|NCT03488563|58821642|FG002|Overall Study|Physician Decision|1|||
30804670|NCT03488563|58821640|FG000|Overall Study|Protocol Violation|3|||
30804671|NCT03488563|58821641|FG001|Overall Study|Protocol Violation|2|||
30804672|NCT03488563|58821642|FG002|Overall Study|Protocol Violation|6|||
30804673|NCT03488563|58821640|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
30804674|NCT03488563|58821641|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
30804675|NCT03488563|58821642|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
30804676|NCT03488563|58821640|FG000|Overall Study|Use of prohibited medication|2|||
30804677|NCT03488563|58821641|FG001|Overall Study|Use of prohibited medication|0|||
30804678|NCT03488563|58821642|FG002|Overall Study|Use of prohibited medication|0|||
30804679|NCT03488563|58821640|FG000|Overall Study|Adverse Event|1|||
30804680|NCT03488563|58821641|FG001|Overall Study|Adverse Event|0|||
30804681|NCT03488563|58821642|FG002|Overall Study|Adverse Event|1|||
30804682|NCT03488563|58821640|FG000|Overall Study|Subject returned for ET visit|0|||
30804683|NCT03488563|58821641|FG001|Overall Study|Subject returned for ET visit|1|||
30804684|NCT03488563|58821642|FG002|Overall Study|Subject returned for ET visit|0|||
30804685|NCT03488563|58821640|FG000|Overall Study|Sponsor's decision|0|||
30804686|NCT03488563|58821641|FG001|Overall Study|Sponsor's decision|0|||
30804687|NCT03488563|58821642|FG002|Overall Study|Sponsor's decision|1|||
30804688|NCT00706030|58821656|FG000|Overall Study|Disease Progression|4|||
30804689|NCT00706030|58821657|FG001|Overall Study|Disease Progression|6|||
30804690|NCT00706030|58821658|FG002|Overall Study|Disease Progression|46|||
30804691|NCT00706030|58821659|FG003|Overall Study|Disease Progression|12|||
30804692|NCT00706030|58821656|FG000|Overall Study|Adverse Event|1|||
30804693|NCT00706030|58821657|FG001|Overall Study|Adverse Event|0|||
30804694|NCT00706030|58821658|FG002|Overall Study|Adverse Event|4|||
30804695|NCT00706030|58821659|FG003|Overall Study|Adverse Event|2|||
30804696|NCT00706030|58821656|FG000|Overall Study|Withdrawal by Subject|1|||
30804697|NCT00706030|58821657|FG001|Overall Study|Withdrawal by Subject|0|||
30804698|NCT00706030|58821658|FG002|Overall Study|Withdrawal by Subject|2|||
30804699|NCT00706030|58821659|FG003|Overall Study|Withdrawal by Subject|0|||
30804700|NCT00706030|58821656|FG000|Overall Study|Physician Decision|0|||
30804701|NCT00706030|58821657|FG001|Overall Study|Physician Decision|0|||
30804702|NCT00706030|58821658|FG002|Overall Study|Physician Decision|2|||
30804703|NCT00706030|58821659|FG003|Overall Study|Physician Decision|0|||
30804704|NCT00706030|58821656|FG000|Overall Study|Not recorded|0|||
30804705|NCT00706030|58821657|FG001|Overall Study|Not recorded|0|||
30748254|NCT00267098|58758458|FG004|Overall Study|Lost to Follow-up|2|||
30748255|NCT00267098|58758459|FG005|Overall Study|Lost to Follow-up|3|||
30748256|NCT00267098|58758460|FG006|Overall Study|Lost to Follow-up|1|||
30748257|NCT00267098|58758461|FG007|Overall Study|Lost to Follow-up|1|||
30748258|NCT00267098|58758454|FG000|Overall Study|Withdrawal by Subject|8|||
30748259|NCT00267098|58758455|FG001|Overall Study|Withdrawal by Subject|0|||
30748260|NCT00267098|58758456|FG002|Overall Study|Withdrawal by Subject|24|||
30748261|NCT00267098|58758457|FG003|Overall Study|Withdrawal by Subject|21|||
30748262|NCT00267098|58758458|FG004|Overall Study|Withdrawal by Subject|12|||
30748263|NCT00267098|58758459|FG005|Overall Study|Withdrawal by Subject|9|||
30748264|NCT00267098|58758460|FG006|Overall Study|Withdrawal by Subject|12|||
30748265|NCT00267098|58758461|FG007|Overall Study|Withdrawal by Subject|5|||
30748266|NCT00267098|58758454|FG000|Overall Study|Physician Decision|5|||
30748267|NCT00267098|58758455|FG001|Overall Study|Physician Decision|0|||
30748268|NCT00267098|58758456|FG002|Overall Study|Physician Decision|7|||
30748269|NCT00267098|58758457|FG003|Overall Study|Physician Decision|11|||
30748270|NCT00267098|58758458|FG004|Overall Study|Physician Decision|5|||
30748271|NCT00267098|58758459|FG005|Overall Study|Physician Decision|4|||
30748272|NCT00267098|58758460|FG006|Overall Study|Physician Decision|3|||
30748273|NCT00267098|58758461|FG007|Overall Study|Physician Decision|0|||
30748274|NCT00267098|58758454|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
30748275|NCT00267098|58758455|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30748276|NCT00267098|58758456|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30748277|NCT00267098|58758457|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30748278|NCT00267098|58758458|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
30748279|NCT00267098|58758459|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30748280|NCT00267098|58758460|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30748281|NCT00267098|58758461|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30748282|NCT00267098|58758454|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
30748283|NCT00267098|58758455|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
30748284|NCT00267098|58758456|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
30748285|NCT00267098|58758457|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
30748286|NCT00267098|58758458|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
30748287|NCT00267098|58758459|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
30748288|NCT00267098|58758460|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
30748289|NCT00267098|58758461|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
30748290|NCT00267098|58758454|FG000|Overall Study|Site closure|0|||
30748291|NCT00267098|58758455|FG001|Overall Study|Site closure|0|||
30748292|NCT00267098|58758456|FG002|Overall Study|Site closure|0|||
30804706|NCT00706030|58821658|FG002|Overall Study|Not recorded|2|||
30804707|NCT00706030|58821659|FG003|Overall Study|Not recorded|0|||
30804708|NCT00706030|58821656|FG000|Overall Study|Protocol Violation|0|||
30804709|NCT00706030|58821657|FG001|Overall Study|Protocol Violation|0|||
30804710|NCT00706030|58821658|FG002|Overall Study|Protocol Violation|1|||
30748293|NCT00267098|58758457|FG003|Overall Study|Site closure|1|||
30748294|NCT00267098|58758458|FG004|Overall Study|Site closure|0|||
30748295|NCT00267098|58758459|FG005|Overall Study|Site closure|1|||
30748296|NCT00267098|58758460|FG006|Overall Study|Site closure|1|||
30748297|NCT00267098|58758461|FG007|Overall Study|Site closure|0|||
30804711|NCT00706030|58821659|FG003|Overall Study|Protocol Violation|1|||
30804712|NCT00706030|58821656|FG000|Overall Study|Failed to return|0|||
30907977|NCT02207413|58942570|FG003|Overall Study|Withdrawal by Subject|0|||
30907978|NCT02207413|58942571|FG004|Overall Study|Withdrawal by Subject|3|||
30907979|NCT02207413|58942572|FG005|Overall Study|Withdrawal by Subject|7|||
30907980|NCT02207413|58942567|FG000|Overall Study|Lost to Follow-up|0|||
30907981|NCT02207413|58942568|FG001|Overall Study|Lost to Follow-up|0|||
30907982|NCT02207413|58942569|FG002|Overall Study|Lost to Follow-up|0|||
30748298|NCT00267098|58758454|FG000|Overall Study|Explanted Medtronic device|0|||
30748299|NCT00267098|58758455|FG001|Overall Study|Explanted Medtronic device|0|||
30748300|NCT00267098|58758456|FG002|Overall Study|Explanted Medtronic device|0|||
30748301|NCT00267098|58758457|FG003|Overall Study|Explanted Medtronic device|1|||
30748302|NCT00267098|58758458|FG004|Overall Study|Explanted Medtronic device|0|||
30748303|NCT00267098|58758459|FG005|Overall Study|Explanted Medtronic device|0|||
30748304|NCT00267098|58758460|FG006|Overall Study|Explanted Medtronic device|0|||
30748305|NCT00267098|58758461|FG007|Overall Study|Explanted Medtronic device|0|||
30748306|NCT00267098|58758454|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
30748307|NCT00267098|58758455|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
30748308|NCT00267098|58758456|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
30748309|NCT00267098|58758457|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
30748310|NCT00267098|58758458|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
30748311|NCT00267098|58758459|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
30748312|NCT00267098|58758460|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
30748313|NCT00267098|58758461|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
30748314|NCT00267098|58758454|FG000|Overall Study|Subject listed for heart transplant|0|||
30748315|NCT00267098|58758455|FG001|Overall Study|Subject listed for heart transplant|0|||
30748316|NCT00267098|58758456|FG002|Overall Study|Subject listed for heart transplant|0|||
30748317|NCT00267098|58758457|FG003|Overall Study|Subject listed for heart transplant|0|||
30748318|NCT00267098|58758458|FG004|Overall Study|Subject listed for heart transplant|0|||
30748319|NCT00267098|58758459|FG005|Overall Study|Subject listed for heart transplant|0|||
30748320|NCT00267098|58758460|FG006|Overall Study|Subject listed for heart transplant|1|||
30748321|NCT00267098|58758461|FG007|Overall Study|Subject listed for heart transplant|0|||
30748322|NCT00267098|58758454|FG000|Overall Study|Sponsor withdrew subject|0|||
30748323|NCT00267098|58758455|FG001|Overall Study|Sponsor withdrew subject|0|||
30748324|NCT00267098|58758456|FG002|Overall Study|Sponsor withdrew subject|0|||
30748325|NCT00267098|58758457|FG003|Overall Study|Sponsor withdrew subject|1|||
30748326|NCT00267098|58758458|FG004|Overall Study|Sponsor withdrew subject|0|||
30748327|NCT00267098|58758459|FG005|Overall Study|Sponsor withdrew subject|0|||
30748328|NCT00267098|58758460|FG006|Overall Study|Sponsor withdrew subject|0|||
30748329|NCT00267098|58758461|FG007|Overall Study|Sponsor withdrew subject|0|||
30748330|NCT00247676|58758484|FG000|Overall Study|Death|5|||
30748331|NCT00247676|58758484|FG000|Overall Study|Adverse Event|11|||
30748332|NCT00247676|58758484|FG000|Overall Study|Lack of Efficacy|15|||
30748333|NCT00247676|58758484|FG000|Overall Study|Other|3|||
30748334|NCT00247676|58758484|FG000|Overall Study|Withdrawal by Subject|2|||
30748335|NCT00267020|58758490|FG000|Overall Study|Adverse Event|22|||
30748336|NCT00267020|58758491|FG001|Overall Study|Adverse Event|5|||
30748337|NCT00267020|58758490|FG000|Overall Study|Death|2|||
30748338|NCT00267020|58758491|FG001|Overall Study|Death|1|||
30748339|NCT00267020|58758490|FG000|Overall Study|Withdrawal by Subject|17|||
30748340|NCT00267020|58758491|FG001|Overall Study|Withdrawal by Subject|7|||
30748341|NCT00267020|58758490|FG000|Overall Study|Physician Decision|3|||
30748342|NCT00267020|58758491|FG001|Overall Study|Physician Decision|2|||
30748343|NCT00267020|58758490|FG000|Overall Study|Disease Progression|39|||
30748344|NCT00267020|58758491|FG001|Overall Study|Disease Progression|25|||
30748345|NCT00267020|58758490|FG000|Overall Study|Unrelated Complication|1|||
30907983|NCT02207413|58942570|FG003|Overall Study|Lost to Follow-up|1|||
30907984|NCT02207413|58942571|FG004|Overall Study|Lost to Follow-up|1|||
30748346|NCT00267020|58758491|FG001|Overall Study|Unrelated Complication|1|||
30748347|NCT00267020|58758490|FG000|Overall Study|Sponsor Request|1|||
30748348|NCT00267020|58758491|FG001|Overall Study|Sponsor Request|0|||
30748349|NCT00267020|58758490|FG000|Overall Study|Other|1|||
30748350|NCT00267020|58758491|FG001|Overall Study|Other|2|||
30748351|NCT00242216|58758499|FG000|Overall Study|Lost to Follow-up|12|||
30748352|NCT00242216|58758500|FG001|Overall Study|Lost to Follow-up|17|||
30804713|NCT00706030|58821657|FG001|Overall Study|Failed to return|0|||
30804714|NCT00706030|58821658|FG002|Overall Study|Failed to return|1|||
30804715|NCT00706030|58821659|FG003|Overall Study|Failed to return|0|||
30804716|NCT00706030|58821656|FG000|Overall Study|Symptomatic Deterioration|0|||
30804717|NCT00706030|58821657|FG001|Overall Study|Symptomatic Deterioration|0|||
30804718|NCT00706030|58821658|FG002|Overall Study|Symptomatic Deterioration|1|||
30804719|NCT00706030|58821659|FG003|Overall Study|Symptomatic Deterioration|0|||
30804720|NCT00706030|58821656|FG000|Overall Study|No treatment received|0|||
30804721|NCT00706030|58821657|FG001|Overall Study|No treatment received|0|||
30804722|NCT00706030|58821658|FG002|Overall Study|No treatment received|0|||
30804723|NCT00706030|58821659|FG003|Overall Study|No treatment received|1|||
30804724|NCT00706030|58821656|FG000|Overall Study|Death|0|||
30804725|NCT00706030|58821657|FG001|Overall Study|Death|0|||
30804726|NCT00706030|58821658|FG002|Overall Study|Death|1|||
30804727|NCT00706030|58821659|FG003|Overall Study|Death|0|||
30804728|NCT03488251|58821674|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
30804729|NCT03488251|58821675|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
30804730|NCT03488251|58821676|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
30804731|NCT03488251|58821677|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
30804732|NCT03488251|58821674|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
30804733|NCT03488251|58821675|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
30804734|NCT03488251|58821676|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
30804735|NCT03488251|58821677|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
30804736|NCT03488251|58821674|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
30804737|NCT03488251|58821675|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
30804738|NCT03488251|58821676|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
30804739|NCT03488251|58821677|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
30804740|NCT03488251|58821674|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
30804741|NCT03488251|58821675|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
30804742|NCT03488251|58821676|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
30804743|NCT03488251|58821677|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
30804744|NCT03488251|58821674|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
30804745|NCT03488251|58821675|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
30804746|NCT03488251|58821676|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
30804747|NCT03488251|58821677|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
30804748|NCT02727322|58821690|FG000|Overall Study|Withdrawal by Subject|1|||
30804749|NCT02727322|58821691|FG001|Overall Study|Withdrawal by Subject|1|||
30804750|NCT02727322|58821690|FG000|Overall Study|Protocol Violation|1|||
30804751|NCT02727322|58821691|FG001|Overall Study|Protocol Violation|0|||
30804752|NCT03431857|58821701|FG000|Overall Study|Death|6|||
30804753|NCT03431857|58821701|FG000|Overall Study|Lost to Follow-up|41|||
30804754|NCT03431857|58821701|FG000|Overall Study|Adverse Event|6|||
30804755|NCT03431857|58821701|FG000|Overall Study|Withdrawal by Subject|1|||
30622368|NCT00927472|58634063|FG001|Overall Study|Lost to Follow-up|6|||
30804756|NCT03487549|58821707|FG000|Overall Study|Protocol Violation|0|||
30804757|NCT03487549|58821708|FG001|Overall Study|Protocol Violation|1|||
30804758|NCT03487549|58821707|FG000|Overall Study|Lost to Follow-up|2|||
30804759|NCT03487549|58821708|FG001|Overall Study|Lost to Follow-up|1|||
30804760|NCT03487549|58821707|FG000|Overall Study|Withdrawal by Subject|2|||
30804761|NCT03487549|58821708|FG001|Overall Study|Withdrawal by Subject|0|||
30804762|NCT03464383|58821717|FG000|Overall Study|Lost to Follow-up|1|||
30804763|NCT03464383|58821718|FG001|Overall Study|Lost to Follow-up|0|||
30804764|NCT03464383|58821719|FG002|Overall Study|Lost to Follow-up|0|||
30804765|NCT03464383|58821717|FG000|Overall Study|Withdrawal by Subject|0|||
30804766|NCT03464383|58821718|FG001|Overall Study|Withdrawal by Subject|1|||
30804767|NCT03464383|58821719|FG002|Overall Study|Withdrawal by Subject|0|||
30804768|NCT01444092|58821728|FG000|Overall Study|Adverse Event|8|||
30622369|NCT00927472|58634062|FG000|Overall Study|Protocol Violation|0|||
30804769|NCT01444092|58821728|FG000|Overall Study|Protocol Violation|1|||
30804770|NCT01444092|58821728|FG000|Overall Study|Withdrawal by Subject|1|||
30804771|NCT01444092|58821728|FG000|Overall Study|Other Eligibility criteria|7|||
30804772|NCT01265784|58821735|FG000|Overall Study|Lost to Follow-up|5|||
30804773|NCT01265784|58821736|FG001|Overall Study|Lost to Follow-up|3|||
30804774|NCT01265784|58821737|FG002|Overall Study|Lost to Follow-up|2|||
30804775|NCT01265784|58821735|FG000|Overall Study|Withdrawal by Subject|0|||
30804776|NCT01265784|58821736|FG001|Overall Study|Withdrawal by Subject|5|||
30804777|NCT01265784|58821737|FG002|Overall Study|Withdrawal by Subject|0|||
30804778|NCT01265784|58821735|FG000|Overall Study|Physician Decision|1|||
30804779|NCT01265784|58821736|FG001|Overall Study|Physician Decision|0|||
30907985|NCT02207413|58942572|FG005|Overall Study|Lost to Follow-up|5|||
30907986|NCT02207413|58942567|FG000|Overall Study|Adverse Event|0|||
30907987|NCT02207413|58942568|FG001|Overall Study|Adverse Event|0|||
30907988|NCT02207413|58942569|FG002|Overall Study|Adverse Event|0|||
30804780|NCT01265784|58821737|FG002|Overall Study|Physician Decision|1|||
30907989|NCT02207413|58942570|FG003|Overall Study|Adverse Event|0|||
30748353|NCT00242216|58758499|FG000|Overall Study|Death|4|||
30748354|NCT00242216|58758500|FG001|Overall Study|Death|2|||
30748355|NCT00242216|58758499|FG000|Overall Study|Lack of Efficacy|1|||
30748356|NCT00242216|58758500|FG001|Overall Study|Lack of Efficacy|2|||
30748357|NCT00242216|58758499|FG000|Overall Study|no medicaiton dispensed|1|||
30748358|NCT00242216|58758500|FG001|Overall Study|no medicaiton dispensed|1|||
30748359|NCT00240110|58758508|FG000|Overall Study|Lost to Follow-up|6|||
30748360|NCT00240110|58758509|FG001|Overall Study|Lost to Follow-up|7|||
30748361|NCT00239720|58758519|FG000|Overall Study|Adverse Event|1|||
30748362|NCT00239720|58758520|FG001|Overall Study|Adverse Event|0|||
30748363|NCT00239720|58758519|FG000|Overall Study|Lost to Follow-up|0|||
30748364|NCT00239720|58758520|FG001|Overall Study|Lost to Follow-up|1|||
30748365|NCT00266864|58758528|FG000|Overall Study|Lost to Follow-up|4|||
30748366|NCT00266864|58758529|FG001|Overall Study|Lost to Follow-up|1|||
30748367|NCT00266864|58758528|FG000|Overall Study|Withdrawal by Subject|1|||
30748368|NCT00266864|58758529|FG001|Overall Study|Withdrawal by Subject|1|||
30748369|NCT00266708|58758537|FG000|Overall Study|No renal function|1|||
30748370|NCT00266708|58758538|FG001|Overall Study|No renal function|1|||
30748371|NCT00266708|58758537|FG000|Overall Study|Refused biopsy|3|||
30748372|NCT00266708|58758538|FG001|Overall Study|Refused biopsy|6|||
30748373|NCT00266708|58758537|FG000|Overall Study|Asthma|0|||
30748374|NCT00266708|58758538|FG001|Overall Study|Asthma|2|||
30748375|NCT00266630|58758546|FG000|Overall Study|Adverse Event|8|||
30748376|NCT00266630|58758547|FG001|Overall Study|Adverse Event|6|||
30748377|NCT00266630|58758546|FG000|Overall Study|Lack of Efficacy|1|||
30748378|NCT00266630|58758547|FG001|Overall Study|Lack of Efficacy|4|||
30748379|NCT00266630|58758546|FG000|Overall Study|Entry Criteria not met|1|||
30748380|NCT00266630|58758547|FG001|Overall Study|Entry Criteria not met|0|||
30748381|NCT00266630|58758546|FG000|Overall Study|Protocol Violation|1|||
30748382|NCT00266630|58758547|FG001|Overall Study|Protocol Violation|3|||
30748383|NCT00266630|58758546|FG000|Overall Study|Physician Decision|1|||
30748384|NCT00266630|58758547|FG001|Overall Study|Physician Decision|2|||
30748385|NCT00266630|58758546|FG000|Overall Study|Withdrawal by Subject|10|||
30748386|NCT00266630|58758547|FG001|Overall Study|Withdrawal by Subject|2|||
30748387|NCT00266630|58758546|FG000|Overall Study|Lost to Follow-up|1|||
30748388|NCT00266630|58758547|FG001|Overall Study|Lost to Follow-up|0|||
30748389|NCT00266630|58758546|FG000|Overall Study|Other|19|||
30748390|NCT00266630|58758547|FG001|Overall Study|Other|11|||
30748391|NCT00129129|58758558|FG000|Primary Phase|Adverse Event|2|||
30748392|NCT00129129|58758559|FG001|Primary Phase|Adverse Event|1|||
30748393|NCT00129129|58758560|FG002|Primary Phase|Adverse Event|0|||
30748394|NCT00129129|58758561|FG003|Primary Phase|Adverse Event|0|||
30748395|NCT00129129|58758562|FG004|Primary Phase|Adverse Event|0|||
30804781|NCT01265784|58821735|FG000|Overall Study|Adverse Event|1|||
30748396|NCT00129129|58758558|FG000|Primary Phase|Withdrawal by Subject|12|||
30748397|NCT00129129|58758559|FG001|Primary Phase|Withdrawal by Subject|10|||
30748398|NCT00129129|58758560|FG002|Primary Phase|Withdrawal by Subject|0|||
30748399|NCT00129129|58758561|FG003|Primary Phase|Withdrawal by Subject|0|||
30748400|NCT00129129|58758562|FG004|Primary Phase|Withdrawal by Subject|0|||
30748401|NCT00129129|58758558|FG000|Primary Phase|Migration from study area|1|||
30907990|NCT02207413|58942571|FG004|Overall Study|Adverse Event|2|||
30804782|NCT01265784|58821736|FG001|Overall Study|Adverse Event|0|||
30804783|NCT01265784|58821737|FG002|Overall Study|Adverse Event|0|||
30804784|NCT01265784|58821735|FG000|Overall Study|Death|3|||
30804785|NCT01265784|58821736|FG001|Overall Study|Death|0|||
30804786|NCT01265784|58821737|FG002|Overall Study|Death|0|||
30804787|NCT01265784|58821735|FG000|Overall Study|Protocol Violation|2|||
30804788|NCT01265784|58821736|FG001|Overall Study|Protocol Violation|0|||
30804789|NCT01265784|58821737|FG002|Overall Study|Protocol Violation|0|||
30804790|NCT01265784|58821735|FG000|Overall Study|Incorrectly Randomized|0|||
30804791|NCT01265784|58821736|FG001|Overall Study|Incorrectly Randomized|0|||
30804792|NCT01265784|58821737|FG002|Overall Study|Incorrectly Randomized|1|||
30804793|NCT03156504|58821745|FG000|Overall Study|Withdrawal by Subject|1|||
30804794|NCT03159468|58821755|FG000|Overall Study|Withdrawal by Subject|0|||
30804795|NCT03159468|58821756|FG001|Overall Study|Withdrawal by Subject|0|||
30804796|NCT03159468|58821757|FG002|Overall Study|Withdrawal by Subject|3|||
30804797|NCT03159468|58821758|FG003|Overall Study|Withdrawal by Subject|0|||
30804798|NCT03159468|58821759|FG004|Overall Study|Withdrawal by Subject|0|||
30804799|NCT03159468|58821760|FG005|Overall Study|Withdrawal by Subject|0|||
30804800|NCT03430063|58821777|FG000|Overall Study|Adverse Event|0|||
30804801|NCT03430063|58821778|FG001|Overall Study|Adverse Event|1|||
30804802|NCT03430063|58821779|FG002|Overall Study|Adverse Event|0|||
30804803|NCT03430063|58821777|FG000|Overall Study|Death|3|||
30804804|NCT03430063|58821778|FG001|Overall Study|Death|2|||
30804805|NCT03430063|58821779|FG002|Overall Study|Death|3|||
30804806|NCT03430063|58821777|FG000|Overall Study|Lost to Follow-up|0|||
30804807|NCT03430063|58821778|FG001|Overall Study|Lost to Follow-up|1|||
30804808|NCT03430063|58821779|FG002|Overall Study|Lost to Follow-up|0|||
30804809|NCT03430063|58821777|FG000|Overall Study|Withdrawal by Subject|0|||
30804810|NCT03430063|58821778|FG001|Overall Study|Withdrawal by Subject|0|||
30804811|NCT03430063|58821779|FG002|Overall Study|Withdrawal by Subject|1|||
30804812|NCT03430063|58821777|FG000|Overall Study|Withdrawal of consent|3|||
30804813|NCT03430063|58821778|FG001|Overall Study|Withdrawal of consent|1|||
30804814|NCT03430063|58821779|FG002|Overall Study|Withdrawal of consent|2|||
30907991|NCT02207413|58942572|FG005|Overall Study|Adverse Event|1|||
30907992|NCT02207413|58942567|FG000|Overall Study|Migrated/moved from study area|0|||
30907993|NCT02207413|58942568|FG001|Overall Study|Migrated/moved from study area|0|||
30907994|NCT02207413|58942569|FG002|Overall Study|Migrated/moved from study area|0|||
30907995|NCT02207413|58942570|FG003|Overall Study|Migrated/moved from study area|0|||
30907996|NCT02207413|58942571|FG004|Overall Study|Migrated/moved from study area|1|||
30907997|NCT02207413|58942572|FG005|Overall Study|Migrated/moved from study area|0|||
30907998|NCT02309372|58942594|FG000|Overall Study|Lost to Follow-up|3|||
30907999|NCT02309372|58942595|FG001|Overall Study|Lost to Follow-up|2|||
30908000|NCT02276027|58942605|FG000|Overall Study|Death|1|||
30908001|NCT02276027|58942606|FG001|Overall Study|Death|0|||
30908002|NCT02276027|58942607|FG002|Overall Study|Death|0|||
30908003|NCT02276027|58942608|FG003|Overall Study|Death|2|||
30908004|NCT02276027|58942605|FG000|Overall Study|Physician Decision|0|||
30908005|NCT02276027|58942606|FG001|Overall Study|Physician Decision|0|||
30908006|NCT02276027|58942607|FG002|Overall Study|Physician Decision|0|||
30908007|NCT02276027|58942608|FG003|Overall Study|Physician Decision|1|||
30748402|NCT00129129|58758559|FG001|Primary Phase|Migration from study area|3|||
30748403|NCT00129129|58758560|FG002|Primary Phase|Migration from study area|0|||
30748404|NCT00129129|58758561|FG003|Primary Phase|Migration from study area|0|||
30748405|NCT00129129|58758562|FG004|Primary Phase|Migration from study area|0|||
30748406|NCT00129129|58758558|FG000|Primary Phase|Lost to Follow-up|8|||
30748407|NCT00129129|58758559|FG001|Primary Phase|Lost to Follow-up|6|||
30748408|NCT00129129|58758560|FG002|Primary Phase|Lost to Follow-up|0|||
30804815|NCT03430063|58821777|FG000|Overall Study|Progressive disease|1|||
30908008|NCT02276027|58942605|FG000|Overall Study|Progressive disease|1|||
30908009|NCT02276027|58942606|FG001|Overall Study|Progressive disease|13|||
30908010|NCT02276027|58942607|FG002|Overall Study|Progressive disease|12|||
30908011|NCT02276027|58942608|FG003|Overall Study|Progressive disease|14|||
30908012|NCT02276027|58942605|FG000|Overall Study|Subject/guardian decision|0|||
30804816|NCT03430063|58821778|FG001|Overall Study|Progressive disease|2|||
30908013|NCT02276027|58942606|FG001|Overall Study|Subject/guardian decision|1|||
30908014|NCT02276027|58942607|FG002|Overall Study|Subject/guardian decision|0|||
30908015|NCT02276027|58942608|FG003|Overall Study|Subject/guardian decision|3|||
30908016|NCT02276027|58942605|FG000|Overall Study|Adverse Event|0|||
30908017|NCT02276027|58942606|FG001|Overall Study|Adverse Event|2|||
30908018|NCT02276027|58942607|FG002|Overall Study|Adverse Event|8|||
30908019|NCT02276027|58942608|FG003|Overall Study|Adverse Event|2|||
30804817|NCT03430063|58821779|FG002|Overall Study|Progressive disease|1|||
30804818|NCT03430063|58821777|FG000|Overall Study|Other un-specified|1|||
30748409|NCT00129129|58758561|FG003|Primary Phase|Lost to Follow-up|0|||
30804819|NCT03430063|58821778|FG001|Overall Study|Other un-specified|1|||
30804820|NCT03430063|58821779|FG002|Overall Study|Other un-specified|0|||
30908020|NCT02309294|58942618|FG000|Overall Study|Withdrawal by Subject|2|||
30908021|NCT02233543|58942622|FG000|Period 1|Withdrawal by Subject|1|||
30908022|NCT02233543|58942623|FG001|Period 1|Withdrawal by Subject|0|||
30908023|NCT02233543|58942622|FG000|Period 1|Participants required other treatment.|2|||
30908024|NCT02233543|58942623|FG001|Period 1|Participants required other treatment.|3|||
30908025|NCT02233543|58942622|FG000|Period 2|Adverse Event|1|||
30908026|NCT02233543|58942623|FG001|Period 2|Adverse Event|0|||
30908027|NCT02233543|58942622|FG000|Period 2|Participant required other treatment.|0|||
30908028|NCT02233543|58942623|FG001|Period 2|Participant required other treatment.|1|||
30908029|NCT02233543|58942622|FG000|Period 2|COPD exacerbation|1|||
30908030|NCT02233543|58942623|FG001|Period 2|COPD exacerbation|0|||
30908031|NCT02309138|58942631|FG000|Overall Study|Withdrawal by Subject|44|||
30908032|NCT02309138|58942632|FG001|Overall Study|Withdrawal by Subject|15|||
30908033|NCT02309138|58942631|FG000|Overall Study|Protocol Violation|4|||
30908034|NCT02309138|58942632|FG001|Overall Study|Protocol Violation|2|||
30804821|NCT03430063|58821777|FG000|Overall Study|Randomized, but never treated|0|||
30804822|NCT03430063|58821778|FG001|Overall Study|Randomized, but never treated|0|||
30804823|NCT03430063|58821779|FG002|Overall Study|Randomized, but never treated|1|||
30804824|NCT03158220|58821790|FG000|Overall Study|Screen Failure|0|||
30804825|NCT03158220|58821791|FG001|Overall Study|Screen Failure|1|||
30804826|NCT03158220|58821790|FG000|Overall Study|Withdrawal by Subject|8|||
30804827|NCT03158220|58821791|FG001|Overall Study|Withdrawal by Subject|9|||
30804828|NCT03158220|58821790|FG000|Overall Study|Status unknown|0|||
30804829|NCT03158220|58821791|FG001|Overall Study|Status unknown|1|||
30804830|NCT03158220|58821790|FG000|Overall Study|Lost to Follow-up|8|||
30804831|NCT03158220|58821791|FG001|Overall Study|Lost to Follow-up|5|||
30804832|NCT03158220|58821790|FG000|Overall Study|Physician Decision|1|||
30804833|NCT03158220|58821791|FG001|Overall Study|Physician Decision|0|||
30804834|NCT03156270|58821797|FG000|Overall Study|Failed pre-treatment screening|1|||
30804835|NCT03156270|58821797|FG000|Overall Study|Lost to Follow-up|1|||
30804836|NCT03429049|58821805|FG000|Overall Study|Adverse Event|2|||
30804837|NCT03429049|58821806|FG001|Overall Study|Adverse Event|3|||
30804838|NCT03429049|58821805|FG000|Overall Study|Death|0|||
30804839|NCT03429049|58821806|FG001|Overall Study|Death|1|||
30804840|NCT03429049|58821805|FG000|Overall Study|Lack of Efficacy|4|||
30804841|NCT03429049|58821806|FG001|Overall Study|Lack of Efficacy|2|||
30804842|NCT03429049|58821805|FG000|Overall Study|Lost to Follow-up|9|||
30804843|NCT03429049|58821806|FG001|Overall Study|Lost to Follow-up|8|||
30804844|NCT03429049|58821805|FG000|Overall Study|Physician Decision|1|||
30804845|NCT03429049|58821806|FG001|Overall Study|Physician Decision|0|||
30804846|NCT03429049|58821805|FG000|Overall Study|Protocol Violation|3|||
30804847|NCT03429049|58821806|FG001|Overall Study|Protocol Violation|0|||
30804848|NCT03429049|58821805|FG000|Overall Study|Sponsor Decision|2|||
30804849|NCT03429049|58821806|FG001|Overall Study|Sponsor Decision|0|||
30804850|NCT03429049|58821805|FG000|Overall Study|Withdrawal by Subject|4|||
30804851|NCT03429049|58821806|FG001|Overall Study|Withdrawal by Subject|20|||
30804852|NCT03429049|58821805|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
30804853|NCT03429049|58821806|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
30804854|NCT03428815|58821814|FG000|Overall Study|Lost to Follow-up|2|||
30804855|NCT03428815|58821815|FG001|Overall Study|Lost to Follow-up|2|||
30804856|NCT03428815|58821814|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
30804857|NCT03428815|58821815|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
30804858|NCT03428815|58821814|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
30804859|NCT03428815|58821815|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
30804860|NCT03155724|58821821|FG000|Overall Study|Death|3|||
30804861|NCT03155724|58821821|FG000|Overall Study|Physician Decision|1|||
30804862|NCT03155724|58821821|FG000|Overall Study|Study closure|7|||
30804863|NCT03426787|58821825|FG000|Overall Study|Withdrawal by Subject|6|||
30804864|NCT03426787|58821825|FG000|Overall Study|Lost to Follow-up|7|||
30804865|NCT03426787|58821825|FG000|Overall Study|Unrelated to intervention death|1|||
30804866|NCT03426631|58821835|FG000|Overall Study|Lost to Follow-up|0|||
30804867|NCT03426631|58821836|FG001|Overall Study|Lost to Follow-up|1|||
30804868|NCT03484429|58821844|FG000|Overall Study|Withdrawal by Subject|1|||
30908035|NCT02309138|58942631|FG000|Overall Study|delivered before visit 2|0|||
30908036|NCT02309138|58942632|FG001|Overall Study|delivered before visit 2|1|||
30908037|NCT02233309|58942648|FG000|Overall Study|Physician Decision|5|||
30804869|NCT03484429|58821845|FG001|Overall Study|Withdrawal by Subject|0|||
30804870|NCT03484429|58821844|FG000|Overall Study|Adverse Event|2|||
30804871|NCT03484429|58821845|FG001|Overall Study|Adverse Event|0|||
30804872|NCT03484273|58821851|FG000|Overall Study|Equipment Malfunction|1|||
30908038|NCT02204917|58942652|FG000|Overall Study|Protocol Violation|1|||
30908039|NCT02280044|58942661|FG000|Overall Study|Planned alternate|0|||
30908040|NCT02280044|58942662|FG001|Overall Study|Planned alternate|2|||
30804873|NCT03484273|58821851|FG000|Overall Study|Data excluded from analysis|1|||
30804874|NCT02724592|58821865|FG000|Overall Study|Lost to Follow-up|4|||
30908041|NCT02308748|58942668|FG000|Period 1|Withdrawal by Subject|0|||
30804875|NCT02724592|58821866|FG001|Overall Study|Lost to Follow-up|1|||
30804876|NCT03154476|58821874|FG000|Overall Study|Lost to Follow-up|4|||
30908042|NCT02308748|58942669|FG001|Period 1|Withdrawal by Subject|0|||
30908043|NCT02308748|58942670|FG002|Period 1|Withdrawal by Subject|1|||
30804877|NCT03154476|58821875|FG001|Overall Study|Lost to Follow-up|4|||
30804878|NCT02726074|58821881|FG000|Overall Study|Withdrawal by Subject|4|||
30804879|NCT02726074|58821881|FG000|Overall Study|Adverse Event|14|||
30804880|NCT02726074|58821881|FG000|Overall Study|Protocol Violation|3|||
30804881|NCT02726074|58821881|FG000|Overall Study|Lost to Follow-up|2|||
30804882|NCT02726074|58821881|FG000|Overall Study|Others|3|||
30804883|NCT03482635|58821889|FG000|Overall Study|Lack of Efficacy|0|||
30804884|NCT03482635|58821890|FG001|Overall Study|Lack of Efficacy|0|||
30804885|NCT03482635|58821891|FG002|Overall Study|Lack of Efficacy|1|||
30804886|NCT03482635|58821892|FG003|Overall Study|Lack of Efficacy|3|||
30804887|NCT03482635|58821889|FG000|Overall Study|Adverse Event|2|||
30804888|NCT03482635|58821890|FG001|Overall Study|Adverse Event|2|||
30804889|NCT03482635|58821891|FG002|Overall Study|Adverse Event|0|||
30804890|NCT03482635|58821892|FG003|Overall Study|Adverse Event|3|||
30804891|NCT03482635|58821889|FG000|Overall Study|Withdrawal by Subject|2|||
30804892|NCT03482635|58821890|FG001|Overall Study|Withdrawal by Subject|1|||
30804893|NCT03482635|58821891|FG002|Overall Study|Withdrawal by Subject|0|||
30804894|NCT03482635|58821892|FG003|Overall Study|Withdrawal by Subject|1|||
30804895|NCT03482635|58821889|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
30804896|NCT03482635|58821890|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
30804897|NCT03482635|58821891|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
30804898|NCT03482635|58821892|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
30804899|NCT03482635|58821889|FG000|Overall Study|Not treated|0|||
30804900|NCT03482635|58821890|FG001|Overall Study|Not treated|0|||
30804901|NCT03482635|58821891|FG002|Overall Study|Not treated|0|||
30804902|NCT03482635|58821892|FG003|Overall Study|Not treated|1|||
30804903|NCT03712787|58821906|FG000|Overall Study|Adverse Event|2|||
30804904|NCT03712787|58821907|FG001|Overall Study|Adverse Event|3|||
30804905|NCT03712787|58821908|FG002|Overall Study|Adverse Event|0|||
30748410|NCT00129129|58758562|FG004|Primary Phase|Lost to Follow-up|0|||
30748411|NCT00129129|58758558|FG000|Primary Phase|Other|2|||
30748412|NCT00129129|58758559|FG001|Primary Phase|Other|5|||
30748413|NCT00129129|58758560|FG002|Primary Phase|Other|0|||
30748414|NCT00129129|58758561|FG003|Primary Phase|Other|0|||
30748415|NCT00129129|58758562|FG004|Primary Phase|Other|0|||
30748416|NCT00129129|58758558|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
30748417|NCT00129129|58758559|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
30748418|NCT00129129|58758560|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
30748419|NCT00129129|58758561|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
30748420|NCT00129129|58758562|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
30748421|NCT00129129|58758558|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
30748422|NCT00129129|58758559|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
30748423|NCT00129129|58758560|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
30748424|NCT00129129|58758561|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
30748425|NCT00129129|58758562|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
30748426|NCT00129129|58758558|FG000|Fourth Dose Phase|Migration from study area|0|||
30748427|NCT00129129|58758559|FG001|Fourth Dose Phase|Migration from study area|0|||
30748428|NCT00129129|58758560|FG002|Fourth Dose Phase|Migration from study area|0|||
30804906|NCT03712787|58821909|FG003|Overall Study|Adverse Event|4|||
30804907|NCT03712787|58821906|FG000|Overall Study|Withdrawal by Subject|4|||
30804908|NCT03712787|58821907|FG001|Overall Study|Withdrawal by Subject|14|||
30804909|NCT03712787|58821908|FG002|Overall Study|Withdrawal by Subject|12|||
30804910|NCT03712787|58821909|FG003|Overall Study|Withdrawal by Subject|8|||
30804911|NCT03712787|58821906|FG000|Overall Study|Lost to Follow-up|1|||
30804912|NCT03712787|58821907|FG001|Overall Study|Lost to Follow-up|1|||
30748429|NCT00129129|58758561|FG003|Fourth Dose Phase|Migration from study area|0|||
30804913|NCT03712787|58821908|FG002|Overall Study|Lost to Follow-up|2|||
30804914|NCT03712787|58821909|FG003|Overall Study|Lost to Follow-up|1|||
30804915|NCT03712787|58821906|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
30804916|NCT03712787|58821907|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
30804917|NCT03712787|58821908|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
30804918|NCT03712787|58821909|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
30804919|NCT03712787|58821906|FG000|Overall Study|COVID-19 Infection|0|||
30804920|NCT03712787|58821907|FG001|Overall Study|COVID-19 Infection|1|||
30804921|NCT03712787|58821908|FG002|Overall Study|COVID-19 Infection|0|||
30622370|NCT00927472|58634063|FG001|Overall Study|Protocol Violation|1|||
30804922|NCT03712787|58821909|FG003|Overall Study|COVID-19 Infection|0|||
30804923|NCT03712787|58821906|FG000|Overall Study|Other, Not Specified|79|||
30622371|NCT00927472|58634062|FG000|Overall Study|Post treatment Assessment out of window|0|||
30804924|NCT03712787|58821907|FG001|Overall Study|Other, Not Specified|77|||
30804925|NCT03712787|58821908|FG002|Overall Study|Other, Not Specified|74|||
30804926|NCT03712787|58821909|FG003|Overall Study|Other, Not Specified|78|||
30804927|NCT03048422|58821941|FG000|Overall Study|Death|1|||
30908044|NCT02308748|58942671|FG003|Period 1|Withdrawal by Subject|0|||
30908045|NCT02308748|58942672|FG004|Period 1|Withdrawal by Subject|0|||
30622372|NCT00927472|58634063|FG001|Overall Study|Post treatment Assessment out of window|4|||
30908046|NCT02308748|58942673|FG005|Period 1|Withdrawal by Subject|0|||
30748430|NCT00129129|58758562|FG004|Fourth Dose Phase|Migration from study area|2|||
30748431|NCT00129129|58758558|FG000|Fourth Dose Phase|Other|0|||
30748432|NCT00129129|58758559|FG001|Fourth Dose Phase|Other|0|||
30748433|NCT00129129|58758560|FG002|Fourth Dose Phase|Other|0|||
30748434|NCT00129129|58758561|FG003|Fourth Dose Phase|Other|1|||
30748435|NCT00129129|58758562|FG004|Fourth Dose Phase|Other|1|||
30748436|NCT00129129|58758558|FG000|Fourth Dose Phase|Protocol Violation|0|||
30748437|NCT00129129|58758559|FG001|Fourth Dose Phase|Protocol Violation|0|||
30804928|NCT03048422|58821942|FG001|Overall Study|Death|0|||
30804929|NCT03048422|58821943|FG002|Overall Study|Death|0|||
30804930|NCT03048422|58821941|FG000|Overall Study|Lost to Follow-up|5|||
30804931|NCT03048422|58821942|FG001|Overall Study|Lost to Follow-up|0|||
30804932|NCT03048422|58821943|FG002|Overall Study|Lost to Follow-up|1|||
30748438|NCT00129129|58758560|FG002|Fourth Dose Phase|Protocol Violation|0|||
30748439|NCT00129129|58758561|FG003|Fourth Dose Phase|Protocol Violation|1|||
30748440|NCT00129129|58758562|FG004|Fourth Dose Phase|Protocol Violation|0|||
30748441|NCT00221403|58758585|FG000|Overall Study|Protocol Violation|1|||
30748442|NCT00221403|58758586|FG001|Overall Study|Protocol Violation|0|||
30748443|NCT00221403|58758587|FG002|Overall Study|Protocol Violation|0|||
30748444|NCT00221403|58758585|FG000|Overall Study|Physician Decision|1|||
30748445|NCT00221403|58758586|FG001|Overall Study|Physician Decision|0|||
30748446|NCT00221403|58758587|FG002|Overall Study|Physician Decision|0|||
30748447|NCT00221403|58758585|FG000|Overall Study|Withdrawal by Subject|0|||
30748448|NCT00221403|58758586|FG001|Overall Study|Withdrawal by Subject|3|||
30748449|NCT00221403|58758587|FG002|Overall Study|Withdrawal by Subject|0|||
30748450|NCT00221403|58758585|FG000|Overall Study|Lack of Efficacy|0|||
30748451|NCT00221403|58758586|FG001|Overall Study|Lack of Efficacy|1|||
30748452|NCT00221403|58758587|FG002|Overall Study|Lack of Efficacy|0|||
30748453|NCT00221403|58758585|FG000|Overall Study|Adverse Event|0|||
30748454|NCT00221403|58758586|FG001|Overall Study|Adverse Event|1|||
30748455|NCT00221403|58758587|FG002|Overall Study|Adverse Event|0|||
30748456|NCT00145977|58758597|FG000|Overall Study|Lack of Efficacy|0|||
30748457|NCT00145977|58758598|FG001|Overall Study|Lack of Efficacy|4|||
30748458|NCT00145977|58758597|FG000|Overall Study|Lost to Follow-up|1|||
30748459|NCT00145977|58758598|FG001|Overall Study|Lost to Follow-up|0|||
30748460|NCT00145977|58758597|FG000|Overall Study|Withdrawal by Subject|1|||
30748461|NCT00145977|58758598|FG001|Overall Study|Withdrawal by Subject|0|||
30748462|NCT00238238|58758607|FG000|Overall Study|Withdrawal by Subject|0|||
30748463|NCT00238238|58758608|FG001|Overall Study|Withdrawal by Subject|3|||
30748464|NCT00238238|58758609|FG002|Overall Study|Withdrawal by Subject|0|||
30804933|NCT03048422|58821941|FG000|Overall Study|Withdrawal by Subject|5|||
30748465|NCT00128661|58758619|FG000|Overall Study|Adverse Event|14|||
30748466|NCT00128661|58758620|FG001|Overall Study|Adverse Event|11|||
30748467|NCT00128661|58758619|FG000|Overall Study|Lost to Follow-up|10|||
30804934|NCT03048422|58821942|FG001|Overall Study|Withdrawal by Subject|7|||
30804935|NCT03048422|58821943|FG002|Overall Study|Withdrawal by Subject|4|||
30804936|NCT03048422|58821941|FG000|Overall Study|Moved|3|||
30804937|NCT03048422|58821942|FG001|Overall Study|Moved|2|||
30804938|NCT03048422|58821943|FG002|Overall Study|Moved|2|||
30804939|NCT03048422|58821941|FG000|Overall Study|Noncompliant with Study Requirements|2|||
30804940|NCT03048422|58821942|FG001|Overall Study|Noncompliant with Study Requirements|1|||
30804941|NCT03048422|58821943|FG002|Overall Study|Noncompliant with Study Requirements|2|||
30804942|NCT03048422|58821941|FG000|Overall Study|Not Able to Get to Clinic|1|||
30804943|NCT03048422|58821942|FG001|Overall Study|Not Able to Get to Clinic|0|||
30804944|NCT03048422|58821943|FG002|Overall Study|Not Able to Get to Clinic|0|||
30804945|NCT04664855|58821963|FG000|Overall Study|Withdrawal by Subject|0|||
30804946|NCT04664855|58821964|FG001|Overall Study|Withdrawal by Subject|2|||
30804947|NCT04664153|58821974|FG000|Overall Study|Lack of Efficacy|0|||
30804948|NCT04664153|58821975|FG001|Overall Study|Lack of Efficacy|0|||
30804949|NCT04664153|58821976|FG002|Overall Study|Lack of Efficacy|1|||
30804950|NCT04664153|58821977|FG003|Overall Study|Lack of Efficacy|0|||
30804951|NCT04664153|58821974|FG000|Overall Study|Physician Decision|0|||
30804952|NCT04664153|58821975|FG001|Overall Study|Physician Decision|0|||
30804953|NCT04664153|58821976|FG002|Overall Study|Physician Decision|1|||
30804954|NCT04664153|58821977|FG003|Overall Study|Physician Decision|0|||
30804955|NCT04664153|58821974|FG000|Overall Study|Withdrawal by Subject|3|||
30804956|NCT04664153|58821975|FG001|Overall Study|Withdrawal by Subject|2|||
30804957|NCT04664153|58821976|FG002|Overall Study|Withdrawal by Subject|1|||
30804958|NCT04664153|58821977|FG003|Overall Study|Withdrawal by Subject|2|||
30804959|NCT04664153|58821974|FG000|Overall Study|Other|0|||
30908047|NCT02308748|58942674|FG006|Period 1|Withdrawal by Subject|0|||
30908048|NCT02308748|58942675|FG007|Period 1|Withdrawal by Subject|0|||
30908049|NCT02308748|58942676|FG008|Period 1|Withdrawal by Subject|0|||
30804960|NCT04664153|58821975|FG001|Overall Study|Other|1|||
30804961|NCT04664153|58821976|FG002|Overall Study|Other|0|||
30804962|NCT04664153|58821977|FG003|Overall Study|Other|0|||
30804963|NCT04664153|58821974|FG000|Overall Study|Adverse Event|4|||
30804964|NCT04664153|58821975|FG001|Overall Study|Adverse Event|0|||
30804965|NCT04664153|58821976|FG002|Overall Study|Adverse Event|1|||
30804966|NCT04664153|58821977|FG003|Overall Study|Adverse Event|0|||
30804967|NCT04663295|58821989|FG000|Run-in Period|Withdrawal by Subject|3|||
30804968|NCT04663295|58821989|FG000|Overall Study Period|Pregnancy|1|||
30804969|NCT04663295|58821989|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
30804970|NCT04228445|58822000|FG000|Overall Study|Lost to Follow-up|1|||
30804971|NCT04228445|58822001|FG001|Overall Study|Lost to Follow-up|1|||
30804972|NCT04228445|58822000|FG000|Overall Study|Physician Decision|1|||
30804973|NCT04228445|58822001|FG001|Overall Study|Physician Decision|2|||
30804974|NCT04228445|58822000|FG000|Overall Study|Withdrawal by Subject|0|||
30804975|NCT04228445|58822001|FG001|Overall Study|Withdrawal by Subject|1|||
30804976|NCT04228445|58822000|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
30804977|NCT04228445|58822001|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
30804978|NCT04641299|58822013|FG000|Overall Study|Adverse Event|0|||
30804979|NCT04641299|58822014|FG001|Overall Study|Adverse Event|0|||
30804980|NCT04641299|58822015|FG002|Overall Study|Adverse Event|2|||
30804981|NCT04641299|58822016|FG003|Overall Study|Adverse Event|0|||
30804982|NCT04641299|58822013|FG000|Overall Study|Lost to Follow-up|0|||
30804983|NCT04641299|58822014|FG001|Overall Study|Lost to Follow-up|1|||
30804984|NCT04641299|58822015|FG002|Overall Study|Lost to Follow-up|0|||
30804985|NCT04641299|58822016|FG003|Overall Study|Lost to Follow-up|0|||
30804986|NCT04641299|58822013|FG000|Overall Study|Withdrawal by Subject|1|||
30804987|NCT04641299|58822014|FG001|Overall Study|Withdrawal by Subject|0|||
30804988|NCT04641299|58822015|FG002|Overall Study|Withdrawal by Subject|0|||
30804989|NCT04641299|58822016|FG003|Overall Study|Withdrawal by Subject|0|||
30804990|NCT04641299|58822013|FG000|Overall Study|Reason not given|1|||
30908050|NCT02308748|58942677|FG009|Period 1|Withdrawal by Subject|0|||
30908051|NCT02308748|58942668|FG000|Period 2|Adverse Event|0|||
30804991|NCT04641299|58822014|FG001|Overall Study|Reason not given|0|||
30804992|NCT04641299|58822015|FG002|Overall Study|Reason not given|0|||
30804993|NCT04641299|58822016|FG003|Overall Study|Reason not given|0|||
30804994|NCT03703817|58822032|FG000|Overall Study|Not meeting eligibility criteria|7|||
30804995|NCT03703817|58822033|FG001|Overall Study|Not meeting eligibility criteria|4|||
30804996|NCT03698591|58822041|FG000|Overall Study|Withdrawal by Subject|2|||
30804997|NCT03698591|58822042|FG001|Overall Study|Withdrawal by Subject|2|||
30804998|NCT03698591|58822041|FG000|Overall Study|Failed drug screen|1|||
30804999|NCT03698591|58822042|FG001|Overall Study|Failed drug screen|1|||
30805000|NCT03698591|58822041|FG000|Overall Study|Failed health screen|0|||
30908052|NCT02308748|58942669|FG001|Period 2|Adverse Event|0|||
30908053|NCT02308748|58942670|FG002|Period 2|Adverse Event|0|||
30908054|NCT02308748|58942671|FG003|Period 2|Adverse Event|0|||
30622373|NCT00927394|58634071|FG000|Overall Study|Adverse Event|14|||
30908055|NCT02308748|58942672|FG004|Period 2|Adverse Event|0|||
30805001|NCT03698591|58822042|FG001|Overall Study|Failed health screen|1|||
30805002|NCT03698591|58822041|FG000|Overall Study|Ineligible for financial compensation|1|||
30805003|NCT03698591|58822042|FG001|Overall Study|Ineligible for financial compensation|0|||
30805004|NCT03698591|58822041|FG000|Overall Study|Equipment Error|1|||
30805005|NCT03698591|58822042|FG001|Overall Study|Equipment Error|0|||
30805006|NCT03698591|58822041|FG000|Overall Study|Could not establish TMS dosage|0|||
30805007|NCT03698591|58822042|FG001|Overall Study|Could not establish TMS dosage|1|||
30805008|NCT04606199|58822048|FG000|Overall Study|Withdrawal by Subject|2|||
30805009|NCT05085665|58822054|FG000|Overall Study|Physician Decision|2|||
30805010|NCT05017493|58822060|FG000|Overall Study|Withdrawal by Subject|26|||
30805011|NCT05017493|58822061|FG001|Overall Study|Withdrawal by Subject|0|||
30805012|NCT05017493|58822060|FG000|Overall Study|Physician Decision|15|||
30805013|NCT05017493|58822061|FG001|Overall Study|Physician Decision|0|||
30805014|NCT05017493|58822060|FG000|Overall Study|Protocol Violation|81|||
30805015|NCT05017493|58822061|FG001|Overall Study|Protocol Violation|0|||
30805016|NCT04599803|58822067|FG000|Overall Study|Withdrawal by Subject|5|||
30805017|NCT04599803|58822067|FG000|Overall Study|Lost to Follow-up|26|||
30805018|NCT05002985|58822071|FG000|Overall Study|Withdrawal by Subject|1|||
30805019|NCT04580303|58822077|FG000|Overall Study|Adverse Event|0|||
30805020|NCT04580303|58822078|FG001|Overall Study|Adverse Event|1|||
30805021|NCT04580303|58822079|FG002|Overall Study|Adverse Event|0|||
30805022|NCT04580303|58822080|FG003|Overall Study|Adverse Event|0|||
30805023|NCT04580303|58822077|FG000|Overall Study|Withdrawal by Subject|0|||
30805024|NCT04580303|58822078|FG001|Overall Study|Withdrawal by Subject|0|||
30805025|NCT04580303|58822079|FG002|Overall Study|Withdrawal by Subject|1|||
30805026|NCT04580303|58822080|FG003|Overall Study|Withdrawal by Subject|0|||
30805027|NCT04577183|58822090|FG000|Overall Study|Death|1|||
30805028|NCT04577183|58822090|FG000|Overall Study|Withdrawal by Subject|3|||
30805029|NCT04577183|58822090|FG000|Overall Study|Early termination|2|||
30805030|NCT04574999|58822096|FG000|Overall Study|Adverse Event|1|||
30805031|NCT04574999|58822097|FG001|Overall Study|Adverse Event|0|||
30805032|NCT04574999|58822096|FG000|Overall Study|Lack of Efficacy|2|||
30805033|NCT04574999|58822097|FG001|Overall Study|Lack of Efficacy|3|||
30805034|NCT04574999|58822096|FG000|Overall Study|Protocol Violation|1|||
30805035|NCT04574999|58822097|FG001|Overall Study|Protocol Violation|0|||
30805036|NCT04574999|58822096|FG000|Overall Study|Withdrawal by Subject|2|||
30805037|NCT04574999|58822097|FG001|Overall Study|Withdrawal by Subject|2|||
30805038|NCT04574999|58822096|FG000|Overall Study|Lost to Follow-up|1|||
30805039|NCT04574999|58822097|FG001|Overall Study|Lost to Follow-up|0|||
30805040|NCT04574999|58822096|FG000|Overall Study|Personal problems|1|||
30805041|NCT04574999|58822097|FG001|Overall Study|Personal problems|0|||
30805042|NCT04574999|58822096|FG000|Overall Study|Previous planned surgery|1|||
30805043|NCT04574999|58822097|FG001|Overall Study|Previous planned surgery|0|||
30805044|NCT04565249|58822107|FG000|Overall Study|Death|0|||
30805045|NCT04565249|58822108|FG001|Overall Study|Death|0|||
30805046|NCT04565249|58822109|FG002|Overall Study|Death|0|||
30805047|NCT04565249|58822110|FG003|Overall Study|Death|1|||
30805048|NCT04942925|58822122|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
30805049|NCT04942925|58822123|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
30805050|NCT04942925|58822122|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
30805051|NCT04942925|58822123|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
30805052|NCT04854707|58822135|FG000|Overall Study|Lack of Efficacy|78|||
30805053|NCT04854707|58822136|FG001|Overall Study|Lack of Efficacy|59|||
30805054|NCT04854707|58822137|FG002|Overall Study|Lack of Efficacy|30|||
30805055|NCT04557371|58822152|FG000|Overall Study|Covid-19-related|0|||
30805056|NCT04557371|58822153|FG001|Overall Study|Covid-19-related|1|||
30805057|NCT04557371|58822154|FG002|Overall Study|Covid-19-related|0|||
30805058|NCT04557371|58822152|FG000|Overall Study|Withdrawal by Subject|0|||
30805059|NCT04557371|58822153|FG001|Overall Study|Withdrawal by Subject|1|||
30805060|NCT04557371|58822154|FG002|Overall Study|Withdrawal by Subject|0|||
30805061|NCT04557371|58822152|FG000|Overall Study|Adverse Event|1|||
30805062|NCT04557371|58822153|FG001|Overall Study|Adverse Event|0|||
30805063|NCT04557371|58822154|FG002|Overall Study|Adverse Event|0|||
30805064|NCT04821245|58822162|FG000|Overall Study|Withdrawal by Subject|3|||
30805065|NCT04821245|58822162|FG000|Overall Study|Physician Decision|1|||
30805066|NCT04821245|58822162|FG000|Overall Study|Protocol Violation|5|||
30805067|NCT04539275|58822170|FG000|Overall Study|Death|2|||
30805068|NCT04539275|58822171|FG001|Overall Study|Death|4|||
30805069|NCT04539275|58822170|FG000|Overall Study|Lost to Follow-up|1|||
30805070|NCT04539275|58822171|FG001|Overall Study|Lost to Follow-up|1|||
30805071|NCT04539275|58822170|FG000|Overall Study|Withdrawal by Subject|3|||
30805072|NCT04539275|58822171|FG001|Overall Study|Withdrawal by Subject|0|||
30805073|NCT04784897|58822180|FG000|Overall Study|Death|4|||
30805074|NCT04784897|58822181|FG001|Overall Study|Death|2|||
30805075|NCT04784897|58822182|FG002|Overall Study|Death|1|||
30805076|NCT04784897|58822180|FG000|Overall Study|Withdrawal by Subject|0|||
30805077|NCT04784897|58822181|FG001|Overall Study|Withdrawal by Subject|0|||
30805078|NCT04784897|58822182|FG002|Overall Study|Withdrawal by Subject|1|||
30805079|NCT02780804|58822196|FG000|Overall Study|Death|1|||
30805080|NCT02780804|58822197|FG001|Overall Study|Death|0|||
30805081|NCT02780804|58822198|FG002|Overall Study|Death|0|||
30805082|NCT02780804|58822196|FG000|Overall Study|Lack of Efficacy|5|||
30805083|NCT02780804|58822197|FG001|Overall Study|Lack of Efficacy|8|||
30908056|NCT02308748|58942673|FG005|Period 2|Adverse Event|0|||
30908057|NCT02308748|58942674|FG006|Period 2|Adverse Event|0|||
30908058|NCT02308748|58942675|FG007|Period 2|Adverse Event|1|||
30908059|NCT02308748|58942676|FG008|Period 2|Adverse Event|0|||
30805084|NCT02780804|58822198|FG002|Overall Study|Lack of Efficacy|4|||
30805085|NCT02780804|58822196|FG000|Overall Study|Physician Decision|0|||
30805086|NCT02780804|58822197|FG001|Overall Study|Physician Decision|0|||
30805087|NCT02780804|58822198|FG002|Overall Study|Physician Decision|2|||
30805088|NCT02780804|58822196|FG000|Overall Study|Withdrawal by Subject|0|||
30805089|NCT02780804|58822197|FG001|Overall Study|Withdrawal by Subject|1|||
30908060|NCT02308748|58942677|FG009|Period 2|Adverse Event|0|||
30908061|NCT02308748|58942668|FG000|Period 3|Protocol Violation|0|||
30908062|NCT02308748|58942669|FG001|Period 3|Protocol Violation|0|||
30908063|NCT02308748|58942670|FG002|Period 3|Protocol Violation|0|||
30908064|NCT02308748|58942671|FG003|Period 3|Protocol Violation|0|||
30805090|NCT02780804|58822198|FG002|Overall Study|Withdrawal by Subject|0|||
30805091|NCT04537949|58822215|FG000|Overall Study|personal reasons not related to the IMP|1|||
30805092|NCT04537949|58822216|FG001|Overall Study|personal reasons not related to the IMP|0|||
30805093|NCT04537949|58822217|FG002|Overall Study|personal reasons not related to the IMP|0|||
30805094|NCT04537949|58822218|FG003|Overall Study|personal reasons not related to the IMP|0|||
30805095|NCT04537949|58822219|FG004|Overall Study|personal reasons not related to the IMP|0|||
30805096|NCT04537949|58822220|FG005|Overall Study|personal reasons not related to the IMP|0|||
30805097|NCT04537949|58822221|FG006|Overall Study|personal reasons not related to the IMP|0|||
30805098|NCT04537949|58822222|FG007|Overall Study|personal reasons not related to the IMP|0|||
30805099|NCT04532099|58822243|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
30805100|NCT04532099|58822244|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
30805101|NCT04532099|58822245|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
30805102|NCT03041792|58822259|FG000|Overall Study|Adverse Event|4|||
30805103|NCT03041792|58822260|FG001|Overall Study|Adverse Event|0|||
30805104|NCT03041792|58822259|FG000|Overall Study|Death in the family|0|||
30805105|NCT03041792|58822260|FG001|Overall Study|Death in the family|2|||
30805106|NCT03041792|58822259|FG000|Overall Study|Randomized but not treated|0|||
30805107|NCT03041792|58822260|FG001|Overall Study|Randomized but not treated|1|||
30805108|NCT04507763|58822266|FG000|Overall Study|Participants did not meet entrance criteria|201|||
30805109|NCT03045302|58822273|FG000|Overall Study|Pre-treatment adverse event|1|||
30805110|NCT00705484|58822279|FG000|Overall Study|Adverse Event|28|||
30805111|NCT00705484|58822280|FG001|Overall Study|Adverse Event|27|||
30805112|NCT00705484|58822279|FG000|Overall Study|Lost to Follow-up|169|||
30805113|NCT00705484|58822280|FG001|Overall Study|Lost to Follow-up|250|||
30805114|NCT00705484|58822279|FG000|Overall Study|Withdrawal by Subject|96|||
30805115|NCT00705484|58822280|FG001|Overall Study|Withdrawal by Subject|72|||
30805116|NCT00705484|58822279|FG000|Overall Study|Administrative|89|||
30805117|NCT00705484|58822280|FG001|Overall Study|Administrative|59|||
30805118|NCT04523831|58822290|FG000|Overall Study|Lost to Follow-up|15|||
30805119|NCT04523831|58822291|FG001|Overall Study|Lost to Follow-up|17|||
30805120|NCT04523831|58822290|FG000|Overall Study|Death|0|||
30805121|NCT04523831|58822291|FG001|Overall Study|Death|3|||
30805122|NCT04523831|58822290|FG000|Overall Study|Adverse Event|2|||
30805123|NCT04523831|58822291|FG001|Overall Study|Adverse Event|0|||
30805124|NCT04707664|58822302|FG000|Overall Study|Adverse Event|2|||
30805125|NCT04707664|58822303|FG001|Overall Study|Adverse Event|0|||
30805126|NCT04707664|58822302|FG000|Overall Study|Death|1|||
30805127|NCT04707664|58822303|FG001|Overall Study|Death|2|||
30805128|NCT04707664|58822302|FG000|Overall Study|Withdrawal by Subject|13|||
30805129|NCT04707664|58822303|FG001|Overall Study|Withdrawal by Subject|21|||
30805130|NCT04707664|58822302|FG000|Overall Study|Lost to Follow-up|11|||
30805131|NCT04707664|58822303|FG001|Overall Study|Lost to Follow-up|13|||
30805132|NCT04707664|58822302|FG000|Overall Study|Not treated|2|||
30805133|NCT04707664|58822303|FG001|Overall Study|Not treated|0|||
30805134|NCT01316276|58822309|FG000|Overall Study|Death|1|||
30908065|NCT02308748|58942672|FG004|Period 3|Protocol Violation|0|||
30908066|NCT02308748|58942673|FG005|Period 3|Protocol Violation|0|||
30908067|NCT02308748|58942674|FG006|Period 3|Protocol Violation|0|||
30805135|NCT01316276|58822309|FG000|Overall Study|Adverse Event|19|||
30805136|NCT01316276|58822309|FG000|Overall Study|Withdrawal of consent|24|||
30805137|NCT01316276|58822309|FG000|Overall Study|Lost to Follow-up|1|||
30908068|NCT02308748|58942675|FG007|Period 3|Protocol Violation|0|||
30908069|NCT02308748|58942676|FG008|Period 3|Protocol Violation|0|||
30908070|NCT02308748|58942677|FG009|Period 3|Protocol Violation|1|||
30805138|NCT01316276|58822309|FG000|Overall Study|Other|22|||
30805139|NCT04668989|58822314|FG000|First Intervention|Covid-19 related self-isolation|0|||
30805140|NCT04668989|58822315|FG001|First Intervention|Covid-19 related self-isolation|1|||
30805141|NCT04668989|58822314|FG000|Second Intervention|Adverse Event|0|||
30805142|NCT04668989|58822315|FG001|Second Intervention|Adverse Event|1|||
30805143|NCT03700385|58822321|FG000|Overall Study|Lost to Follow-up|1|||
30622374|NCT00927394|58634072|FG001|Overall Study|Adverse Event|9|||
30622375|NCT00927394|58634071|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
30622376|NCT00927394|58634072|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
30805144|NCT04498403|58822327|FG000|Overall Study|Adverse Event|1|||
30805145|NCT04498403|58822328|FG001|Overall Study|Adverse Event|0|||
30805146|NCT04498403|58822327|FG000|Overall Study|Study Terminated By Sponsor|29|||
30805147|NCT04498403|58822328|FG001|Overall Study|Study Terminated By Sponsor|10|||
30805148|NCT04362137|58822336|FG000|Overall Study|Death|9|||
30805149|NCT04362137|58822337|FG001|Overall Study|Death|3|||
30805150|NCT04362137|58822336|FG000|Overall Study|Patient decision|6|||
30805151|NCT04362137|58822337|FG001|Overall Study|Patient decision|3|||
30805152|NCT04362137|58822336|FG000|Overall Study|Adverse Event|1|||
30805153|NCT04362137|58822337|FG001|Overall Study|Adverse Event|0|||
30805154|NCT04362137|58822336|FG000|Overall Study|Lost to Follow-up|1|||
30805155|NCT04362137|58822337|FG001|Overall Study|Lost to Follow-up|0|||
30805156|NCT04362137|58822336|FG000|Overall Study|Protocol deviation|1|||
30805157|NCT04362137|58822337|FG001|Overall Study|Protocol deviation|0|||
30805158|NCT05099380|58822345|FG000|Overall Study|Subject enrolled in error|1|||
30805159|NCT05099380|58822346|FG001|Overall Study|Subject enrolled in error|0|||
30805160|NCT05099380|58822345|FG000|Overall Study|Study Procedure|1|||
30805161|NCT05099380|58822346|FG001|Overall Study|Study Procedure|0|||
30805162|NCT05099380|58822345|FG000|Overall Study|Protocol Violation|1|||
30805163|NCT05099380|58822346|FG001|Overall Study|Protocol Violation|0|||
30805164|NCT05099380|58822345|FG000|Overall Study|Adverse Event|1|||
30805165|NCT05099380|58822346|FG001|Overall Study|Adverse Event|1|||
30805166|NCT05099380|58822345|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
30805167|NCT05099380|58822346|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
30805168|NCT03614728|58822356|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
30805169|NCT03614728|58822357|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
30805170|NCT03614728|58822358|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
30805171|NCT03614728|58822359|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
30908071|NCT02308748|58942668|FG000|Period 5|Adverse Event|1|||
30908072|NCT02308748|58942669|FG001|Period 5|Adverse Event|0|||
30908073|NCT02308748|58942670|FG002|Period 5|Adverse Event|0|||
30908074|NCT02308748|58942671|FG003|Period 5|Adverse Event|0|||
30908075|NCT02308748|58942672|FG004|Period 5|Adverse Event|0|||
30908076|NCT02308748|58942673|FG005|Period 5|Adverse Event|0|||
30908077|NCT02308748|58942674|FG006|Period 5|Adverse Event|0|||
30908078|NCT02308748|58942675|FG007|Period 5|Adverse Event|0|||
30908079|NCT02308748|58942676|FG008|Period 5|Adverse Event|1|||
30908080|NCT02308748|58942677|FG009|Period 5|Adverse Event|0|||
30908081|NCT01646216|58942691|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
30908082|NCT01646216|58942692|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
30908083|NCT01646216|58942691|FG000|Overall Study|Did not complete training|0|||
30908084|NCT01646216|58942692|FG001|Overall Study|Did not complete training|2|||
30908085|NCT01646216|58942691|FG000|Overall Study|Investigator decision|1|||
30908086|NCT01646216|58942692|FG001|Overall Study|Investigator decision|1|||
30805172|NCT03614728|58822356|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
30805173|NCT03614728|58822357|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
30805174|NCT03614728|58822358|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
30805175|NCT03614728|58822359|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
30805176|NCT03154086|58822382|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30805177|NCT03154086|58822383|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30805178|NCT03154086|58822384|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30908087|NCT02308124|58942705|FG000|Overall Study|Lost to Follow-up|6|||
30908088|NCT02308124|58942706|FG001|Overall Study|Lost to Follow-up|6|||
30908089|NCT02308124|58942707|FG002|Overall Study|Lost to Follow-up|6|||
30908090|NCT02308124|58942705|FG000|Overall Study|Adverse Event|0|||
30908091|NCT02308124|58942706|FG001|Overall Study|Adverse Event|2|||
30805179|NCT03154086|58822385|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
30805180|NCT03154086|58822386|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30908092|NCT02308124|58942707|FG002|Overall Study|Adverse Event|2|||
30908093|NCT02232061|58942715|FG000|Overall Study|Administrative problems|1|||
30908094|NCT02232061|58942715|FG000|Overall Study|Withdrawal by Subject|1|||
30908095|NCT02275481|58942721|FG000|Overall Study|Death|2|||
30908096|NCT02275481|58942722|FG001|Overall Study|Death|1|||
30908097|NCT02275481|58942721|FG000|Overall Study|Lost to Follow-up|2|||
30908098|NCT02275481|58942722|FG001|Overall Study|Lost to Follow-up|0|||
30908099|NCT02275481|58942721|FG000|Overall Study|Withdrawal by Subject|3|||
30622377|NCT00927394|58634071|FG000|Overall Study|Withdrawal by Subject|20|||
30622378|NCT00927394|58634072|FG001|Overall Study|Withdrawal by Subject|24|||
30622379|NCT00927394|58634071|FG000|Overall Study|Lost to Follow-up|8|||
30908100|NCT02275481|58942722|FG001|Overall Study|Withdrawal by Subject|0|||
30908101|NCT02275481|58942721|FG000|Overall Study|all other reasons combined|2|||
30908102|NCT02275481|58942722|FG001|Overall Study|all other reasons combined|1|||
30908103|NCT02275481|58942721|FG000|Overall Study|Physician Decision|0|||
30908104|NCT02275481|58942722|FG001|Overall Study|Physician Decision|1|||
30908105|NCT02204449|58942730|FG000|Overall Study|Lost to Follow-up|7|||
30908106|NCT02204449|58942731|FG001|Overall Study|Lost to Follow-up|9|||
30908107|NCT02204449|58942730|FG000|Overall Study|Death|0|||
30908108|NCT02204449|58942731|FG001|Overall Study|Death|1|||
30908109|NCT02204449|58942730|FG000|Overall Study|Withdrawal by Subject|0|||
30908110|NCT02204449|58942731|FG001|Overall Study|Withdrawal by Subject|1|||
30908111|NCT02308046|58942739|FG000|Overall Study|Negative yeast culture at Baseline|32|||
30908112|NCT02308046|58942740|FG001|Overall Study|Negative yeast culture at Baseline|33|||
30908113|NCT02308046|58942739|FG000|Overall Study|Positive for STD at Baseline|1|||
30908114|NCT02308046|58942740|FG001|Overall Study|Positive for STD at Baseline|2|||
30908115|NCT02308046|58942739|FG000|Overall Study|Lost to Follow-up|1|||
30908116|NCT02308046|58942740|FG001|Overall Study|Lost to Follow-up|3|||
30908117|NCT02318693|58942748|FG000|Overall Study|Protocol Violation|0|||
30908118|NCT02318693|58942749|FG001|Overall Study|Protocol Violation|1|||
30908119|NCT02230891|58942758|FG000|Baseline|Did not meet inclusion|0|||
30908120|NCT02230891|58942759|FG001|Baseline|Did not meet inclusion|1|||
30908121|NCT02230891|58942760|FG002|Baseline|Did not meet inclusion|1|||
30908122|NCT02230891|58942758|FG000|2 Week|Withdrawal by Subject|2|||
30908123|NCT02230891|58942759|FG001|2 Week|Withdrawal by Subject|2|||
30805181|NCT03154086|58822387|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30805182|NCT03154086|58822388|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30805183|NCT03154086|58822389|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30805184|NCT03154086|58822390|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30805185|NCT03154086|58822391|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30805186|NCT03154086|58822392|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30748468|NCT00128661|58758620|FG001|Overall Study|Lost to Follow-up|7|||
30748469|NCT00128661|58758619|FG000|Overall Study|Withdrawal by Subject|243|||
30748470|NCT00128661|58758620|FG001|Overall Study|Withdrawal by Subject|232|||
30748471|NCT00128661|58758619|FG000|Overall Study|Other|7|||
30748472|NCT00128661|58758620|FG001|Overall Study|Other|8|||
30748473|NCT00145509|58758628|FG000|Overall Study|Adverse Event|10|||
30748474|NCT00145509|58758629|FG001|Overall Study|Adverse Event|3|||
30805187|NCT03154086|58822393|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30805188|NCT03154086|58822394|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30908124|NCT02230891|58942760|FG002|2 Week|Withdrawal by Subject|0|||
30908125|NCT02230891|58942758|FG000|2 Week|Consent withdrawn|1|||
30908126|NCT02230891|58942759|FG001|2 Week|Consent withdrawn|0|||
30908127|NCT02230891|58942760|FG002|2 Week|Consent withdrawn|0|||
30908128|NCT02230891|58942758|FG000|6 Month|Withdrawal by Subject|1|||
30908129|NCT02230891|58942759|FG001|6 Month|Withdrawal by Subject|1|||
30908130|NCT02230891|58942760|FG002|6 Month|Withdrawal by Subject|1|||
30908131|NCT02230891|58942758|FG000|6 Month|Physician Decision|0|||
30908132|NCT02230891|58942759|FG001|6 Month|Physician Decision|2|||
30908133|NCT02230891|58942760|FG002|6 Month|Physician Decision|0|||
30908134|NCT02230891|58942758|FG000|12 Month|Death|1|||
30908135|NCT02230891|58942759|FG001|12 Month|Death|0|||
30908136|NCT02230891|58942760|FG002|12 Month|Death|0|||
30748475|NCT00145509|58758628|FG000|Overall Study|Lack of Efficacy|3|||
30748476|NCT00145509|58758629|FG001|Overall Study|Lack of Efficacy|1|||
30805189|NCT03154086|58822395|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30805190|NCT03154086|58822396|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
30805191|NCT03154086|58822382|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30908137|NCT02230891|58942758|FG000|12 Month|Lost to Follow-up|0|||
30908138|NCT02230891|58942759|FG001|12 Month|Lost to Follow-up|1|||
30908139|NCT02230891|58942760|FG002|12 Month|Lost to Follow-up|0|||
30908140|NCT02230891|58942758|FG000|12 Month|Withdrawal by Subject|0|||
30908141|NCT02230891|58942759|FG001|12 Month|Withdrawal by Subject|2|||
30908142|NCT02230891|58942760|FG002|12 Month|Withdrawal by Subject|0|||
30908143|NCT02230891|58942758|FG000|18 Month End of Study|Death|0|||
30908144|NCT02230891|58942759|FG001|18 Month End of Study|Death|0|||
30908145|NCT02230891|58942760|FG002|18 Month End of Study|Death|1|||
30748477|NCT00145509|58758628|FG000|Overall Study|Lost to Follow-up|5|||
30748478|NCT00145509|58758629|FG001|Overall Study|Lost to Follow-up|9|||
30748479|NCT00145509|58758628|FG000|Overall Study|Withdrew Consent|2|||
30908146|NCT02230891|58942758|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
30908147|NCT02230891|58942759|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
30908148|NCT02230891|58942760|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
30908149|NCT01646138|58942775|FG000|Overall Study|Lost to Follow-up|0|||
30908150|NCT01646138|58942776|FG001|Overall Study|Lost to Follow-up|0|||
30908151|NCT01646138|58942777|FG002|Overall Study|Lost to Follow-up|0|||
30908152|NCT01646138|58942778|FG003|Overall Study|Lost to Follow-up|0|||
30908153|NCT01646138|58942779|FG004|Overall Study|Lost to Follow-up|2|||
30908154|NCT02204371|58942791|FG000|Overall Study|Adverse Event|1|||
30908155|NCT02274857|58942797|FG000|Overall Study|Adverse Event|1|||
30908156|NCT02274857|58942798|FG001|Overall Study|Adverse Event|0|||
30908157|NCT02274857|58942797|FG000|Overall Study|Death|1|||
30908158|NCT02274857|58942798|FG001|Overall Study|Death|2|||
30908159|NCT02274857|58942797|FG000|Overall Study|Lost to Follow-up|3|||
30908160|NCT02274857|58942798|FG001|Overall Study|Lost to Follow-up|0|||
30908161|NCT02274857|58942797|FG000|Overall Study|Physician Decision|2|||
30908162|NCT02274857|58942798|FG001|Overall Study|Physician Decision|0|||
30908163|NCT02274857|58942797|FG000|Overall Study|Trial screen failure|0|||
30908164|NCT02274857|58942798|FG001|Overall Study|Trial screen failure|2|||
30908165|NCT02274857|58942797|FG000|Overall Study|Withdrawal by Subject|11|||
30908166|NCT02274857|58942798|FG001|Overall Study|Withdrawal by Subject|2|||
30908167|NCT02274857|58942797|FG000|Overall Study|Other|2|||
30908168|NCT02274857|58942798|FG001|Overall Study|Other|0|||
30908169|NCT02302859|58942807|FG000|Overall Study|Lost Phone|1|||
30908170|NCT02302859|58942808|FG001|Overall Study|Lost Phone|1|||
30908171|NCT02302859|58942807|FG000|Overall Study|Withdrawal by Subject|0|||
30908172|NCT02302859|58942808|FG001|Overall Study|Withdrawal by Subject|1|||
30908173|NCT02274311|58942814|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
30908174|NCT02316353|58942822|FG000|Overall Study|Pregnancy|1|||
30908175|NCT02316353|58942823|FG001|Overall Study|Pregnancy|3|||
30908176|NCT02316353|58942822|FG000|Overall Study|Adverse Event|1|||
30908177|NCT02316353|58942823|FG001|Overall Study|Adverse Event|3|||
30908178|NCT02316353|58942822|FG000|Overall Study|Withdrawal by Subject|6|||
30908179|NCT02316353|58942823|FG001|Overall Study|Withdrawal by Subject|2|||
30908180|NCT02273141|58942834|FG000|Overall Study|Adverse Event|0|||
30908181|NCT02273141|58942835|FG001|Overall Study|Adverse Event|1|||
30908182|NCT02273141|58942834|FG000|Overall Study|Lost to Follow-up|1|||
30908183|NCT02273141|58942835|FG001|Overall Study|Lost to Follow-up|3|||
30908184|NCT02273141|58942834|FG000|Overall Study|Withdrawal by Subject|10|||
30908185|NCT02273141|58942835|FG001|Overall Study|Withdrawal by Subject|15|||
30908186|NCT02273141|58942834|FG000|Overall Study|Various|6|||
30908187|NCT02273141|58942835|FG001|Overall Study|Various|6|||
30908188|NCT02314052|58942841|FG000|Cycle One|Adverse Event|0|||
30908189|NCT02314052|58942842|FG001|Cycle One|Adverse Event|0|||
30908190|NCT02314052|58942843|FG002|Cycle One|Adverse Event|0|||
30908191|NCT02314052|58942844|FG003|Cycle One|Adverse Event|1|||
30908192|NCT02314052|58942845|FG004|Cycle One|Adverse Event|0|||
30908193|NCT02314052|58942846|FG005|Cycle One|Adverse Event|0|||
30908194|NCT02279732|58942862|FG000|Overall Study|Death|23|||
30908195|NCT02279732|58942863|FG001|Overall Study|Death|20|||
30908196|NCT02279732|58942862|FG000|Overall Study|Disease Progression|13|||
30908197|NCT02279732|58942863|FG001|Overall Study|Disease Progression|3|||
30908198|NCT02279732|58942862|FG000|Overall Study|Withdrawal by Subject|2|||
30908199|NCT02279732|58942863|FG001|Overall Study|Withdrawal by Subject|7|||
30908200|NCT02279732|58942862|FG000|Overall Study|Adverse Event|1|||
30908201|NCT02279732|58942863|FG001|Overall Study|Adverse Event|2|||
30908202|NCT02279732|58942862|FG000|Overall Study|Administrative Reason By Sponsor|0|||
30908203|NCT02279732|58942863|FG001|Overall Study|Administrative Reason By Sponsor|2|||
30908204|NCT02279732|58942862|FG000|Overall Study|Study Drug Toxicity|2|||
30908205|NCT02279732|58942863|FG001|Overall Study|Study Drug Toxicity|0|||
30908206|NCT02279732|58942862|FG000|Overall Study|Lost to Follow-up|0|||
30908207|NCT02279732|58942863|FG001|Overall Study|Lost to Follow-up|1|||
30908208|NCT02279732|58942862|FG000|Overall Study|Maximum Clinical Benefit|1|||
30908209|NCT02279732|58942863|FG001|Overall Study|Maximum Clinical Benefit|0|||
30908210|NCT02279732|58942862|FG000|Overall Study|Subject Requested to Discontinue|0|||
30908211|NCT02279732|58942863|FG001|Overall Study|Subject Requested to Discontinue|1|||
30908212|NCT02279732|58942862|FG000|Overall Study|Other|53|||
30908213|NCT02279732|58942863|FG001|Overall Study|Other|67|||
30908214|NCT02279732|58942862|FG000|Overall Study|Other|3|||
30908215|NCT02279732|58942863|FG001|Overall Study|Other|3|||
30908216|NCT02279498|58942871|FG000|Overall Study|Adverse Event|3|||
30908217|NCT02279498|58942872|FG001|Overall Study|Adverse Event|0|||
30908218|NCT02279498|58942871|FG000|Overall Study|Lack of Efficacy|4|||
30908219|NCT02279498|58942872|FG001|Overall Study|Lack of Efficacy|0|||
30748480|NCT00145509|58758629|FG001|Overall Study|Withdrew Consent|7|||
30748481|NCT00145509|58758628|FG000|Overall Study|Reason not provided|2|||
30748482|NCT00145509|58758629|FG001|Overall Study|Reason not provided|1|||
30748483|NCT00145119|58758635|FG000|Overall Study|Death|45|||
30748484|NCT00220779|58758642|FG000|Overall Study|Adverse Event|1|||
30748485|NCT00220779|58758643|FG001|Overall Study|Adverse Event|0|||
30748486|NCT00220779|58758644|FG002|Overall Study|Adverse Event|0|||
30908220|NCT02279498|58942871|FG000|Overall Study|Lost to Follow-up|0|||
30748487|NCT00220779|58758642|FG000|Overall Study|Withdrawal by Subject|1|||
30908221|NCT02279498|58942872|FG001|Overall Study|Lost to Follow-up|1|||
30908222|NCT02279498|58942871|FG000|Overall Study|Withdrawal by Subject|9|||
30908223|NCT02279498|58942872|FG001|Overall Study|Withdrawal by Subject|2|||
30908224|NCT02279498|58942871|FG000|Overall Study|Undefined|2|||
30805192|NCT03154086|58822383|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
30805193|NCT03154086|58822384|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805194|NCT03154086|58822385|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805195|NCT03154086|58822386|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805196|NCT03154086|58822387|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805197|NCT03154086|58822388|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805198|NCT03154086|58822389|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805199|NCT03154086|58822390|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805200|NCT03154086|58822391|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805201|NCT03154086|58822392|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805202|NCT03154086|58822393|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805203|NCT03154086|58822394|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805204|NCT03154086|58822395|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805205|NCT03154086|58822396|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
30805206|NCT03154086|58822382|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805207|NCT03154086|58822383|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805208|NCT03154086|58822384|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
30805209|NCT03154086|58822385|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805210|NCT03154086|58822386|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805211|NCT03154086|58822387|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805212|NCT03154086|58822388|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805213|NCT03154086|58822389|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805214|NCT03154086|58822390|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805215|NCT03154086|58822391|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805216|NCT03154086|58822392|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805217|NCT03154086|58822393|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805218|NCT03154086|58822394|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805219|NCT03154086|58822395|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805220|NCT03154086|58822396|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
30805221|NCT03154086|58822382|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
30805222|NCT03154086|58822383|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805223|NCT03154086|58822384|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805224|NCT03154086|58822385|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805225|NCT03154086|58822386|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805226|NCT03154086|58822387|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805227|NCT03154086|58822388|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805228|NCT03154086|58822389|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805229|NCT03154086|58822390|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805230|NCT03154086|58822391|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805231|NCT03154086|58822392|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805232|NCT03154086|58822393|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805233|NCT03154086|58822394|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805234|NCT03154086|58822395|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805235|NCT03154086|58822396|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
30805236|NCT03154086|58822382|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805237|NCT03154086|58822383|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805238|NCT03154086|58822384|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805239|NCT03154086|58822385|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805240|NCT03154086|58822386|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30908225|NCT02279498|58942872|FG001|Overall Study|Undefined|1|||
30908226|NCT02307266|58942882|FG000|Overall Study|Adverse Event|3|||
30748488|NCT00220779|58758643|FG001|Overall Study|Withdrawal by Subject|4|||
30748489|NCT00220779|58758644|FG002|Overall Study|Withdrawal by Subject|1|||
30748490|NCT00220779|58758642|FG000|Overall Study|Non-compliance|1|||
30748491|NCT00220779|58758643|FG001|Overall Study|Non-compliance|0|||
30748492|NCT00220779|58758644|FG002|Overall Study|Non-compliance|0|||
30748493|NCT00220779|58758642|FG000|Overall Study|Too time consuming|1|||
30748494|NCT00220779|58758643|FG001|Overall Study|Too time consuming|0|||
30805241|NCT03154086|58822387|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805242|NCT03154086|58822388|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805243|NCT03154086|58822389|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805244|NCT03154086|58822390|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
30805245|NCT03154086|58822391|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30748495|NCT00220779|58758644|FG002|Overall Study|Too time consuming|0|||
30748496|NCT00220779|58758642|FG000|Overall Study|Pregnancy|0|||
30748497|NCT00220779|58758643|FG001|Overall Study|Pregnancy|0|||
30748498|NCT00220779|58758644|FG002|Overall Study|Pregnancy|2|||
30748499|NCT00220779|58758642|FG000|Overall Study|Lack of Efficacy|3|||
30805246|NCT03154086|58822392|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805247|NCT03154086|58822393|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805248|NCT03154086|58822394|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805249|NCT03154086|58822395|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805250|NCT03154086|58822396|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
30805251|NCT03154086|58822382|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805252|NCT03154086|58822383|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805253|NCT03154086|58822384|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805254|NCT03154086|58822385|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805255|NCT03154086|58822386|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805256|NCT03154086|58822387|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805257|NCT03154086|58822388|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805258|NCT03154086|58822389|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
30805259|NCT03154086|58822390|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805260|NCT03154086|58822391|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805261|NCT03154086|58822392|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805262|NCT03154086|58822393|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805263|NCT03154086|58822394|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805264|NCT03154086|58822395|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805265|NCT03154086|58822396|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
30805266|NCT03154086|58822382|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
30805267|NCT03154086|58822383|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
30805268|NCT03154086|58822384|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
30805269|NCT03154086|58822385|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
30805270|NCT03154086|58822386|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
30805271|NCT03154086|58822387|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
30805272|NCT03154086|58822388|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
30805273|NCT03154086|58822389|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
30805274|NCT03154086|58822390|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
30805275|NCT03154086|58822391|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
30805276|NCT03154086|58822392|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
30805277|NCT03154086|58822393|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
30805278|NCT03154086|58822394|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
30805279|NCT03154086|58822395|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
30805280|NCT03154086|58822396|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
30805281|NCT02723344|58822459|FG000|Overall Study|Lost to Follow-up|0|||
30908227|NCT02307266|58942883|FG001|Overall Study|Adverse Event|1|||
30908228|NCT02307266|58942884|FG002|Overall Study|Adverse Event|5|||
30908229|NCT02307266|58942882|FG000|Overall Study|Withdrawal by Subject|2|||
30748500|NCT00220779|58758643|FG001|Overall Study|Lack of Efficacy|0|||
30748501|NCT00220779|58758644|FG002|Overall Study|Lack of Efficacy|1|||
30748502|NCT00207740|58758656|FG000|Overall Study|Adverse Event|4|||
30748503|NCT00207740|58758657|FG001|Overall Study|Adverse Event|14|||
30748504|NCT00207740|58758658|FG002|Overall Study|Adverse Event|14|||
30748505|NCT00207740|58758659|FG003|Overall Study|Adverse Event|11|||
30748506|NCT00207740|58758656|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30805282|NCT02723344|58822460|FG001|Overall Study|Lost to Follow-up|4|||
30805283|NCT02723188|58822469|FG000|Overall Study|Withdrawal by Subject|1|||
30805284|NCT02723188|58822470|FG001|Overall Study|Withdrawal by Subject|0|||
30805285|NCT02723188|58822471|FG002|Overall Study|Withdrawal by Subject|0|||
30805286|NCT00705406|58822481|FG000|Overall Study|Lost to Follow-up|3|||
30805287|NCT00705406|58822482|FG001|Overall Study|Lost to Follow-up|3|||
30748507|NCT00207740|58758657|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30748508|NCT00207740|58758658|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
30805288|NCT00705406|58822481|FG000|Overall Study|Did not receive study drug|1|||
30805289|NCT00705406|58822482|FG001|Overall Study|Did not receive study drug|2|||
30805290|NCT03155178|58822493|FG000|Overall Study|Did not meet treatment day baseline|7|||
30805291|NCT03155178|58822494|FG001|Overall Study|Did not meet treatment day baseline|7|||
30805292|NCT03155178|58822495|FG002|Overall Study|Did not meet treatment day baseline|7|||
30805293|NCT03155178|58822496|FG003|Overall Study|Did not meet treatment day baseline|7|||
30805294|NCT00705250|58822520|FG000|Overall Study|Withdrawal by Subject|1|||
30805295|NCT00705250|58822520|FG000|Overall Study|Patient died in car accident|1|||
30805296|NCT03078192|58822526|FG000|Overall Study|Withdrawal by Subject|2|||
30805297|NCT03078192|58822527|FG001|Overall Study|Withdrawal by Subject|1|||
30805298|NCT03078192|58822526|FG000|Overall Study|screen failure|0|||
30805299|NCT03078192|58822527|FG001|Overall Study|screen failure|3|||
30805300|NCT00703846|58822533|FG000|Overall Study|Adverse Event|8|||
30908230|NCT02307266|58942883|FG001|Overall Study|Withdrawal by Subject|0|||
30908231|NCT02307266|58942884|FG002|Overall Study|Withdrawal by Subject|1|||
30908232|NCT02307266|58942882|FG000|Overall Study|Lost to Follow-up|3|||
30908233|NCT02307266|58942883|FG001|Overall Study|Lost to Follow-up|0|||
30748509|NCT00207740|58758659|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
30748510|NCT00207740|58758656|FG000|Overall Study|Lost to Follow-up|0|||
30748511|NCT00207740|58758657|FG001|Overall Study|Lost to Follow-up|2|||
30748512|NCT00207740|58758658|FG002|Overall Study|Lost to Follow-up|1|||
30748513|NCT00207740|58758659|FG003|Overall Study|Lost to Follow-up|1|||
30748514|NCT00207740|58758656|FG000|Overall Study|Death|0|||
30748515|NCT00207740|58758657|FG001|Overall Study|Death|0|||
30748516|NCT00207740|58758658|FG002|Overall Study|Death|0|||
30748517|NCT00207740|58758659|FG003|Overall Study|Death|1|||
30748518|NCT00207740|58758656|FG000|Overall Study|Sponsor Directive|22|||
30748519|NCT00207740|58758657|FG001|Overall Study|Sponsor Directive|15|||
30748520|NCT00207740|58758658|FG002|Overall Study|Sponsor Directive|16|||
30748521|NCT00207740|58758659|FG003|Overall Study|Sponsor Directive|21|||
30748522|NCT00207740|58758656|FG000|Overall Study|Other|2|||
30748523|NCT00207740|58758657|FG001|Overall Study|Other|10|||
30748524|NCT00207740|58758658|FG002|Overall Study|Other|7|||
30748525|NCT00207740|58758659|FG003|Overall Study|Other|5|||
30748526|NCT00265382|58758673|FG000|Overall Study|Adverse Event|21|||
30748527|NCT00265382|58758673|FG000|Overall Study|Laboratory Abnormality|1|||
30748528|NCT00265382|58758673|FG000|Overall Study|Lost to Follow-up|3|||
30748529|NCT00265382|58758673|FG000|Overall Study|Lack of Efficacy|6|||
30748530|NCT00265382|58758673|FG000|Overall Study|Miscellaneous|6|||
30748531|NCT00265382|58758673|FG000|Overall Study|Withdrawal by Subject|13|||
30748532|NCT00265382|58758673|FG000|Overall Study|Study terminated by sponsor|94|||
30748533|NCT00265382|58758673|FG000|Overall Study|Death|1|||
30748534|NCT00206726|58758677|FG000|Overall Study|Delayed recovery of blood counts|1|||
30748535|NCT00206726|58758677|FG000|Overall Study|Progressive disease or relapsed disease|18|||
30748536|NCT00206726|58758677|FG000|Overall Study|Placed on new protocol|1|||
30748537|NCT00206726|58758677|FG000|Overall Study|Bone marrow transplant|1|||
30748538|NCT00206726|58758677|FG000|Overall Study|Adverse Event|17|||
30748539|NCT00206726|58758677|FG000|Overall Study|Death|4|||
30748540|NCT00206726|58758677|FG000|Overall Study|Protocol Violation|1|||
30748541|NCT00206726|58758677|FG000|Overall Study|Withdrawal by Subject|8|||
30748542|NCT00237692|58758685|FG000|Overall Study|Lost to Follow-up|9|||
30748543|NCT00237692|58758686|FG001|Overall Study|Lost to Follow-up|3|||
30748544|NCT00237692|58758687|FG002|Overall Study|Lost to Follow-up|5|||
30748545|NCT00237692|58758688|FG003|Overall Study|Lost to Follow-up|3|||
30748546|NCT00237692|58758685|FG000|Overall Study|Death|1|||
30748547|NCT00237692|58758686|FG001|Overall Study|Death|2|||
30748548|NCT00237692|58758687|FG002|Overall Study|Death|2|||
30748549|NCT00237692|58758688|FG003|Overall Study|Death|3|||
30748550|NCT00237692|58758685|FG000|Overall Study|Excluded - did not meet criteria|4|||
30748551|NCT00237692|58758686|FG001|Overall Study|Excluded - did not meet criteria|3|||
30748552|NCT00237692|58758687|FG002|Overall Study|Excluded - did not meet criteria|5|||
30748553|NCT00237692|58758688|FG003|Overall Study|Excluded - did not meet criteria|9|||
30748554|NCT00237692|58758685|FG000|Overall Study|Withdrawal by Subject|4|||
30748555|NCT00237692|58758686|FG001|Overall Study|Withdrawal by Subject|6|||
30748556|NCT00237692|58758687|FG002|Overall Study|Withdrawal by Subject|10|||
30748557|NCT00237692|58758688|FG003|Overall Study|Withdrawal by Subject|4|||
30748558|NCT00237458|58758698|FG000|Overall Study|Lack of Efficacy|1|||
30748559|NCT00237458|58758698|FG000|Overall Study|Adverse Event|1|||
30908234|NCT02307266|58942884|FG002|Overall Study|Lost to Follow-up|0|||
30908235|NCT02279420|58942892|FG000|Overall Study|Lost to Follow-up|23|||
30748560|NCT00237458|58758698|FG000|Overall Study|Withdrawal by Subject|1|||
30748561|NCT00265148|58758704|FG000|Overall Study|Adverse Event|2|||
30748562|NCT00265148|58758705|FG001|Overall Study|Adverse Event|2|||
30748563|NCT00265148|58758704|FG000|Overall Study|Lack of Efficacy|0|||
30748564|NCT00265148|58758705|FG001|Overall Study|Lack of Efficacy|2|||
30748565|NCT00265148|58758704|FG000|Overall Study|Protocol Violation|3|||
30748566|NCT00265148|58758705|FG001|Overall Study|Protocol Violation|2|||
30748567|NCT00265148|58758704|FG000|Overall Study|Lost to Follow-up|0|||
30748568|NCT00265148|58758705|FG001|Overall Study|Lost to Follow-up|1|||
30805301|NCT00703846|58822533|FG000|Overall Study|Lost to Follow-up|55|||
30805302|NCT00703846|58822533|FG000|Overall Study|Lack of Efficacy|15|||
30805303|NCT00703846|58822533|FG000|Overall Study|Noncompliance with Study Treatment|2|||
30805304|NCT00703846|58822533|FG000|Overall Study|Withdrawal by Subject|40|||
30805305|NCT00703846|58822533|FG000|Overall Study|Death|1|||
30805306|NCT00703846|58822533|FG000|Overall Study|Other|14|||
30805307|NCT00703846|58822533|FG000|Overall Study|Did Not Receive Study Drug|2|||
30805308|NCT01314872|58822548|FG000|Treatment Period 1|Protocol Violation|2|||
30805309|NCT01314872|58822549|FG001|Treatment Period 1|Protocol Violation|1|||
30805310|NCT01314872|58822550|FG002|Treatment Period 1|Protocol Violation|1|||
30805311|NCT01314872|58822551|FG003|Treatment Period 1|Protocol Violation|0|||
30805312|NCT01314872|58822552|FG004|Treatment Period 1|Protocol Violation|1|||
30805313|NCT01314872|58822553|FG005|Treatment Period 1|Protocol Violation|0|||
30805314|NCT01314872|58822554|FG006|Treatment Period 1|Protocol Violation|0|||
30805315|NCT01314872|58822555|FG007|Treatment Period 1|Protocol Violation|0|||
30908236|NCT02278952|58942896|FG000|Overall Study|Insufficient Sample|6|||
30908237|NCT02278328|58942906|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
30908238|NCT02278328|58942907|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
30908239|NCT02278328|58942908|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
30805316|NCT01314872|58822556|FG008|Treatment Period 1|Protocol Violation|0|||
30805317|NCT01314872|58822557|FG009|Treatment Period 1|Protocol Violation|1|||
30805318|NCT01314872|58822558|FG010|Treatment Period 1|Protocol Violation|1|||
30805319|NCT01314872|58822559|FG011|Treatment Period 1|Protocol Violation|0|||
30805320|NCT01314872|58822560|FG012|Treatment Period 1|Protocol Violation|0|||
30805321|NCT01314872|58822561|FG013|Treatment Period 1|Protocol Violation|0|||
30805322|NCT01314872|58822562|FG014|Treatment Period 1|Protocol Violation|0|||
30805323|NCT01314872|58822548|FG000|Treatment Period 1|Physician Decision|0|||
30908240|NCT02278328|58942906|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
30908241|NCT02278328|58942907|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
30908242|NCT02278328|58942908|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
30908243|NCT02278328|58942906|FG000|Neuropsych Screening|incomplete consent|0|||
30908244|NCT02278328|58942907|FG001|Neuropsych Screening|incomplete consent|0|||
30908245|NCT02278328|58942908|FG002|Neuropsych Screening|incomplete consent|2|||
30908246|NCT02314637|58942916|FG000|Overall Study|Adverse Event|4|||
30908247|NCT02314637|58942917|FG001|Overall Study|Adverse Event|8|||
30908248|NCT02314637|58942916|FG000|Overall Study|Lack of Efficacy|1|||
30908249|NCT02314637|58942917|FG001|Overall Study|Lack of Efficacy|0|||
30908250|NCT02314637|58942916|FG000|Overall Study|Physician Decision|5|||
30908251|NCT02314637|58942917|FG001|Overall Study|Physician Decision|2|||
30908252|NCT02314637|58942916|FG000|Overall Study|Withdrawal by Subject|5|||
30908253|NCT02314637|58942917|FG001|Overall Study|Withdrawal by Subject|4|||
30908254|NCT02314637|58942916|FG000|Overall Study|Other Reason|1|||
30805324|NCT01314872|58822549|FG001|Treatment Period 1|Physician Decision|1|||
30805325|NCT01314872|58822550|FG002|Treatment Period 1|Physician Decision|0|||
30805326|NCT01314872|58822551|FG003|Treatment Period 1|Physician Decision|1|||
30805327|NCT01314872|58822552|FG004|Treatment Period 1|Physician Decision|0|||
30805328|NCT01314872|58822553|FG005|Treatment Period 1|Physician Decision|0|||
30805329|NCT01314872|58822554|FG006|Treatment Period 1|Physician Decision|0|||
30805330|NCT01314872|58822555|FG007|Treatment Period 1|Physician Decision|0|||
30805331|NCT01314872|58822556|FG008|Treatment Period 1|Physician Decision|0|||
30805332|NCT01314872|58822557|FG009|Treatment Period 1|Physician Decision|1|||
30805333|NCT01314872|58822558|FG010|Treatment Period 1|Physician Decision|0|||
30805334|NCT01314872|58822559|FG011|Treatment Period 1|Physician Decision|0|||
30805335|NCT01314872|58822560|FG012|Treatment Period 1|Physician Decision|0|||
30805336|NCT01314872|58822561|FG013|Treatment Period 1|Physician Decision|0|||
30908255|NCT02314637|58942917|FG001|Overall Study|Other Reason|0|||
30805337|NCT01314872|58822562|FG014|Treatment Period 1|Physician Decision|0|||
30805338|NCT01314872|58822548|FG000|Treatment Period 1|Lack of Efficacy|1|||
30805339|NCT01314872|58822549|FG001|Treatment Period 1|Lack of Efficacy|0|||
30805340|NCT01314872|58822550|FG002|Treatment Period 1|Lack of Efficacy|0|||
30805341|NCT01314872|58822551|FG003|Treatment Period 1|Lack of Efficacy|0|||
30805342|NCT01314872|58822552|FG004|Treatment Period 1|Lack of Efficacy|0|||
30805343|NCT01314872|58822553|FG005|Treatment Period 1|Lack of Efficacy|1|||
30805344|NCT01314872|58822554|FG006|Treatment Period 1|Lack of Efficacy|0|||
30805345|NCT01314872|58822555|FG007|Treatment Period 1|Lack of Efficacy|2|||
30805346|NCT01314872|58822556|FG008|Treatment Period 1|Lack of Efficacy|0|||
30805347|NCT01314872|58822557|FG009|Treatment Period 1|Lack of Efficacy|0|||
30805348|NCT01314872|58822558|FG010|Treatment Period 1|Lack of Efficacy|0|||
30805349|NCT01314872|58822559|FG011|Treatment Period 1|Lack of Efficacy|0|||
30908256|NCT01646645|58942923|FG000|Overall Study|No Treated|1|||
30908257|NCT01646645|58942923|FG000|Overall Study|Inevaluable Donor|29|||
30908258|NCT02272985|58942927|FG000|Overall Study|Withdrawal by Subject|1|||
30805350|NCT01314872|58822560|FG012|Treatment Period 1|Lack of Efficacy|0|||
30805351|NCT01314872|58822561|FG013|Treatment Period 1|Lack of Efficacy|0|||
30805352|NCT01314872|58822562|FG014|Treatment Period 1|Lack of Efficacy|0|||
30805353|NCT01314872|58822548|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
30805354|NCT01314872|58822549|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
30805355|NCT01314872|58822550|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
30805356|NCT01314872|58822551|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
30805357|NCT01314872|58822552|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
30805358|NCT01314872|58822553|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
30805359|NCT01314872|58822554|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
30805360|NCT01314872|58822555|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
30805361|NCT01314872|58822556|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
30805362|NCT01314872|58822557|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
30805363|NCT01314872|58822558|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
30805364|NCT01314872|58822559|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
30805365|NCT01314872|58822560|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
30805366|NCT01314872|58822561|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
30805367|NCT01314872|58822562|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
30805368|NCT01314872|58822548|FG000|Treatment Period 1|Withdrawal by Subject|3|||
30805369|NCT01314872|58822549|FG001|Treatment Period 1|Withdrawal by Subject|1|||
30805370|NCT01314872|58822550|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30805371|NCT01314872|58822551|FG003|Treatment Period 1|Withdrawal by Subject|2|||
30908259|NCT02272985|58942927|FG000|Overall Study|hip fracture|1|||
30908260|NCT02272985|58942927|FG000|Overall Study|kidney transplantation|1|||
30908261|NCT01644149|58942934|FG000|Overall Study|Withdrawal by Subject|1|||
30908262|NCT01644149|58942935|FG001|Overall Study|Withdrawal by Subject|0|||
30908263|NCT01644149|58942934|FG000|Overall Study|Lost to Follow-up|3|||
30908264|NCT01644149|58942935|FG001|Overall Study|Lost to Follow-up|1|||
30908265|NCT02313233|58942944|FG000|Overall Study|Withdrawal by Subject|1|||
30908266|NCT02313233|58942945|FG001|Overall Study|Withdrawal by Subject|2|||
30908267|NCT02313233|58942944|FG000|Overall Study|Administrative reason|1|||
30908268|NCT02313233|58942945|FG001|Overall Study|Administrative reason|1|||
30908269|NCT02305238|58942956|FG000|Overall Study|Death|2|||
30908270|NCT02305238|58942957|FG001|Overall Study|Death|1|||
30805372|NCT01314872|58822552|FG004|Treatment Period 1|Withdrawal by Subject|3|||
30805373|NCT01314872|58822553|FG005|Treatment Period 1|Withdrawal by Subject|1|||
30805374|NCT01314872|58822554|FG006|Treatment Period 1|Withdrawal by Subject|3|||
30805375|NCT01314872|58822555|FG007|Treatment Period 1|Withdrawal by Subject|2|||
30805376|NCT01314872|58822556|FG008|Treatment Period 1|Withdrawal by Subject|2|||
30805377|NCT01314872|58822557|FG009|Treatment Period 1|Withdrawal by Subject|2|||
30805378|NCT01314872|58822558|FG010|Treatment Period 1|Withdrawal by Subject|1|||
30805379|NCT01314872|58822559|FG011|Treatment Period 1|Withdrawal by Subject|0|||
30805380|NCT01314872|58822560|FG012|Treatment Period 1|Withdrawal by Subject|0|||
30805381|NCT01314872|58822561|FG013|Treatment Period 1|Withdrawal by Subject|0|||
30805382|NCT01314872|58822562|FG014|Treatment Period 1|Withdrawal by Subject|0|||
30805383|NCT01314872|58822548|FG000|Treatment Period 1|Lost to Follow-up|0|||
30805384|NCT01314872|58822549|FG001|Treatment Period 1|Lost to Follow-up|1|||
30805385|NCT01314872|58822550|FG002|Treatment Period 1|Lost to Follow-up|2|||
30805386|NCT01314872|58822551|FG003|Treatment Period 1|Lost to Follow-up|2|||
30805387|NCT01314872|58822552|FG004|Treatment Period 1|Lost to Follow-up|1|||
30805388|NCT01314872|58822553|FG005|Treatment Period 1|Lost to Follow-up|1|||
30805389|NCT01314872|58822554|FG006|Treatment Period 1|Lost to Follow-up|1|||
30805390|NCT01314872|58822555|FG007|Treatment Period 1|Lost to Follow-up|1|||
30805391|NCT01314872|58822556|FG008|Treatment Period 1|Lost to Follow-up|1|||
30805392|NCT01314872|58822557|FG009|Treatment Period 1|Lost to Follow-up|0|||
30805393|NCT01314872|58822558|FG010|Treatment Period 1|Lost to Follow-up|0|||
30805394|NCT01314872|58822559|FG011|Treatment Period 1|Lost to Follow-up|0|||
30805395|NCT01314872|58822560|FG012|Treatment Period 1|Lost to Follow-up|0|||
30805396|NCT01314872|58822561|FG013|Treatment Period 1|Lost to Follow-up|0|||
30805397|NCT01314872|58822562|FG014|Treatment Period 1|Lost to Follow-up|0|||
30805398|NCT01314872|58822548|FG000|Period 2|Protocol Violation|0|||
30805399|NCT01314872|58822549|FG001|Period 2|Protocol Violation|0|||
30805400|NCT01314872|58822550|FG002|Period 2|Protocol Violation|0|||
30805401|NCT01314872|58822551|FG003|Period 2|Protocol Violation|0|||
30805402|NCT01314872|58822552|FG004|Period 2|Protocol Violation|0|||
30805403|NCT01314872|58822553|FG005|Period 2|Protocol Violation|0|||
30805404|NCT01314872|58822554|FG006|Period 2|Protocol Violation|0|||
30805405|NCT01314872|58822555|FG007|Period 2|Protocol Violation|0|||
30805406|NCT01314872|58822556|FG008|Period 2|Protocol Violation|0|||
30908271|NCT02305238|58942958|FG002|Overall Study|Death|0|||
30908272|NCT02305238|58942956|FG000|Overall Study|Progressive disease|4|||
30805407|NCT01314872|58822557|FG009|Period 2|Protocol Violation|0|||
30805408|NCT01314872|58822558|FG010|Period 2|Protocol Violation|0|||
30805409|NCT01314872|58822559|FG011|Period 2|Protocol Violation|3|||
30805410|NCT01314872|58822560|FG012|Period 2|Protocol Violation|3|||
30805411|NCT01314872|58822561|FG013|Period 2|Protocol Violation|2|||
30805412|NCT01314872|58822562|FG014|Period 2|Protocol Violation|0|||
30908273|NCT02305238|58942957|FG001|Overall Study|Progressive disease|4|||
30805413|NCT01314872|58822548|FG000|Period 2|Non-compliance with study drug|0|||
30908274|NCT02305238|58942958|FG002|Overall Study|Progressive disease|0|||
30805414|NCT01314872|58822549|FG001|Period 2|Non-compliance with study drug|0|||
30805415|NCT01314872|58822550|FG002|Period 2|Non-compliance with study drug|0|||
30805416|NCT01314872|58822551|FG003|Period 2|Non-compliance with study drug|0|||
30805417|NCT01314872|58822552|FG004|Period 2|Non-compliance with study drug|0|||
30805418|NCT01314872|58822553|FG005|Period 2|Non-compliance with study drug|0|||
30805419|NCT01314872|58822554|FG006|Period 2|Non-compliance with study drug|0|||
30805420|NCT01314872|58822555|FG007|Period 2|Non-compliance with study drug|0|||
30805421|NCT01314872|58822556|FG008|Period 2|Non-compliance with study drug|0|||
30805422|NCT01314872|58822557|FG009|Period 2|Non-compliance with study drug|0|||
30805423|NCT01314872|58822558|FG010|Period 2|Non-compliance with study drug|0|||
30805424|NCT01314872|58822559|FG011|Period 2|Non-compliance with study drug|3|||
30805425|NCT01314872|58822560|FG012|Period 2|Non-compliance with study drug|3|||
30805426|NCT01314872|58822561|FG013|Period 2|Non-compliance with study drug|1|||
30805427|NCT01314872|58822562|FG014|Period 2|Non-compliance with study drug|2|||
30805428|NCT01314872|58822548|FG000|Period 2|Lack of Efficacy|0|||
30805429|NCT01314872|58822549|FG001|Period 2|Lack of Efficacy|0|||
30805430|NCT01314872|58822550|FG002|Period 2|Lack of Efficacy|0|||
30805431|NCT01314872|58822551|FG003|Period 2|Lack of Efficacy|0|||
30805432|NCT01314872|58822552|FG004|Period 2|Lack of Efficacy|0|||
30805433|NCT01314872|58822553|FG005|Period 2|Lack of Efficacy|0|||
30805434|NCT01314872|58822554|FG006|Period 2|Lack of Efficacy|0|||
30805435|NCT01314872|58822555|FG007|Period 2|Lack of Efficacy|0|||
30805436|NCT01314872|58822556|FG008|Period 2|Lack of Efficacy|0|||
30805437|NCT01314872|58822557|FG009|Period 2|Lack of Efficacy|0|||
30805438|NCT01314872|58822558|FG010|Period 2|Lack of Efficacy|0|||
30805439|NCT01314872|58822559|FG011|Period 2|Lack of Efficacy|7|||
30805440|NCT01314872|58822560|FG012|Period 2|Lack of Efficacy|12|||
30805441|NCT01314872|58822561|FG013|Period 2|Lack of Efficacy|9|||
30805442|NCT01314872|58822562|FG014|Period 2|Lack of Efficacy|2|||
30805443|NCT01314872|58822548|FG000|Period 2|Pregnancy|0|||
30805444|NCT01314872|58822549|FG001|Period 2|Pregnancy|0|||
30805445|NCT01314872|58822550|FG002|Period 2|Pregnancy|0|||
30805446|NCT01314872|58822551|FG003|Period 2|Pregnancy|0|||
30805447|NCT01314872|58822552|FG004|Period 2|Pregnancy|0|||
30805448|NCT01314872|58822553|FG005|Period 2|Pregnancy|0|||
30805449|NCT01314872|58822554|FG006|Period 2|Pregnancy|0|||
30908275|NCT02305238|58942956|FG000|Overall Study|Logistical difficulties|1|||
30805450|NCT01314872|58822555|FG007|Period 2|Pregnancy|0|||
30805451|NCT01314872|58822556|FG008|Period 2|Pregnancy|0|||
30805452|NCT01314872|58822557|FG009|Period 2|Pregnancy|0|||
30805453|NCT01314872|58822558|FG010|Period 2|Pregnancy|0|||
30805454|NCT01314872|58822559|FG011|Period 2|Pregnancy|0|||
30805455|NCT01314872|58822560|FG012|Period 2|Pregnancy|0|||
30805456|NCT01314872|58822561|FG013|Period 2|Pregnancy|0|||
30805457|NCT01314872|58822562|FG014|Period 2|Pregnancy|1|||
30805458|NCT01314872|58822548|FG000|Period 2|Study terminated by Sponsor|0|||
30805459|NCT01314872|58822549|FG001|Period 2|Study terminated by Sponsor|0|||
30805460|NCT01314872|58822550|FG002|Period 2|Study terminated by Sponsor|0|||
30805461|NCT01314872|58822551|FG003|Period 2|Study terminated by Sponsor|0|||
30805462|NCT01314872|58822552|FG004|Period 2|Study terminated by Sponsor|0|||
30805463|NCT01314872|58822553|FG005|Period 2|Study terminated by Sponsor|0|||
30805464|NCT01314872|58822554|FG006|Period 2|Study terminated by Sponsor|0|||
30805465|NCT01314872|58822555|FG007|Period 2|Study terminated by Sponsor|0|||
30805466|NCT01314872|58822556|FG008|Period 2|Study terminated by Sponsor|0|||
30805467|NCT01314872|58822557|FG009|Period 2|Study terminated by Sponsor|0|||
30805468|NCT01314872|58822558|FG010|Period 2|Study terminated by Sponsor|0|||
30805469|NCT01314872|58822559|FG011|Period 2|Study terminated by Sponsor|2|||
30805470|NCT01314872|58822560|FG012|Period 2|Study terminated by Sponsor|2|||
30805471|NCT01314872|58822561|FG013|Period 2|Study terminated by Sponsor|3|||
30805472|NCT01314872|58822562|FG014|Period 2|Study terminated by Sponsor|0|||
30805473|NCT01314872|58822548|FG000|Period 2|Adverse event, non-fatal|0|||
30805474|NCT01314872|58822549|FG001|Period 2|Adverse event, non-fatal|0|||
30805475|NCT01314872|58822550|FG002|Period 2|Adverse event, non-fatal|0|||
30805476|NCT01314872|58822551|FG003|Period 2|Adverse event, non-fatal|0|||
30908276|NCT02305238|58942957|FG001|Overall Study|Logistical difficulties|3|||
30805477|NCT01314872|58822552|FG004|Period 2|Adverse event, non-fatal|0|||
30805478|NCT01314872|58822553|FG005|Period 2|Adverse event, non-fatal|0|||
30805479|NCT01314872|58822554|FG006|Period 2|Adverse event, non-fatal|0|||
30805480|NCT01314872|58822555|FG007|Period 2|Adverse event, non-fatal|0|||
30805481|NCT01314872|58822556|FG008|Period 2|Adverse event, non-fatal|0|||
30908277|NCT02305238|58942958|FG002|Overall Study|Logistical difficulties|0|||
30805482|NCT01314872|58822557|FG009|Period 2|Adverse event, non-fatal|0|||
30805483|NCT01314872|58822558|FG010|Period 2|Adverse event, non-fatal|0|||
30805484|NCT01314872|58822559|FG011|Period 2|Adverse event, non-fatal|13|||
30805485|NCT01314872|58822560|FG012|Period 2|Adverse event, non-fatal|16|||
30805486|NCT01314872|58822561|FG013|Period 2|Adverse event, non-fatal|24|||
30805487|NCT01314872|58822562|FG014|Period 2|Adverse event, non-fatal|9|||
30805488|NCT01314872|58822548|FG000|Period 2|Withdrawal by Subject|0|||
30805489|NCT01314872|58822549|FG001|Period 2|Withdrawal by Subject|0|||
30805490|NCT01314872|58822550|FG002|Period 2|Withdrawal by Subject|0|||
30805491|NCT01314872|58822551|FG003|Period 2|Withdrawal by Subject|0|||
30805492|NCT01314872|58822552|FG004|Period 2|Withdrawal by Subject|0|||
30805493|NCT01314872|58822553|FG005|Period 2|Withdrawal by Subject|0|||
30805494|NCT01314872|58822554|FG006|Period 2|Withdrawal by Subject|0|||
30805495|NCT01314872|58822555|FG007|Period 2|Withdrawal by Subject|0|||
30805496|NCT01314872|58822556|FG008|Period 2|Withdrawal by Subject|0|||
30805497|NCT01314872|58822557|FG009|Period 2|Withdrawal by Subject|0|||
30805498|NCT01314872|58822558|FG010|Period 2|Withdrawal by Subject|0|||
30805499|NCT01314872|58822559|FG011|Period 2|Withdrawal by Subject|14|||
30805500|NCT01314872|58822560|FG012|Period 2|Withdrawal by Subject|17|||
30805501|NCT01314872|58822561|FG013|Period 2|Withdrawal by Subject|12|||
30908278|NCT02305238|58942956|FG000|Overall Study|Protocol Violation|0|||
30908279|NCT02305238|58942957|FG001|Overall Study|Protocol Violation|3|||
30908280|NCT02305238|58942958|FG002|Overall Study|Protocol Violation|0|||
30908281|NCT02305238|58942956|FG000|Overall Study|Physician Decision|2|||
30908282|NCT02305238|58942957|FG001|Overall Study|Physician Decision|1|||
30908283|NCT02305238|58942958|FG002|Overall Study|Physician Decision|0|||
30908284|NCT02305238|58942956|FG000|Overall Study|Adverse Event|4|||
30908285|NCT02305238|58942957|FG001|Overall Study|Adverse Event|2|||
30805502|NCT01314872|58822562|FG014|Period 2|Withdrawal by Subject|4|||
30805503|NCT01314872|58822548|FG000|Period 2|Lost to Follow-up|0|||
30805504|NCT01314872|58822549|FG001|Period 2|Lost to Follow-up|0|||
30805505|NCT01314872|58822550|FG002|Period 2|Lost to Follow-up|0|||
30805506|NCT01314872|58822551|FG003|Period 2|Lost to Follow-up|0|||
30805507|NCT01314872|58822552|FG004|Period 2|Lost to Follow-up|0|||
30805508|NCT01314872|58822553|FG005|Period 2|Lost to Follow-up|0|||
30805509|NCT01314872|58822554|FG006|Period 2|Lost to Follow-up|0|||
30805510|NCT01314872|58822555|FG007|Period 2|Lost to Follow-up|0|||
30805511|NCT01314872|58822556|FG008|Period 2|Lost to Follow-up|0|||
30805512|NCT01314872|58822557|FG009|Period 2|Lost to Follow-up|0|||
30805513|NCT01314872|58822558|FG010|Period 2|Lost to Follow-up|0|||
30805514|NCT01314872|58822559|FG011|Period 2|Lost to Follow-up|6|||
30805515|NCT01314872|58822560|FG012|Period 2|Lost to Follow-up|7|||
30805516|NCT01314872|58822561|FG013|Period 2|Lost to Follow-up|2|||
30805517|NCT01314872|58822562|FG014|Period 2|Lost to Follow-up|6|||
30805518|NCT00703924|58822596|FG000|Overall Study|Withdrawal by Subject|1|||
30805519|NCT00703924|58822597|FG001|Overall Study|Withdrawal by Subject|1|||
30805520|NCT03152526|58822609|FG000|Overall Study|Withdrawal by Subject|0|||
30805521|NCT03152526|58822610|FG001|Overall Study|Withdrawal by Subject|1|||
30805522|NCT03149328|58822618|FG000|Overall Study|Withdrawal by Subject|30|||
30805523|NCT03149328|58822619|FG001|Overall Study|Withdrawal by Subject|26|||
30805524|NCT03149328|58822618|FG000|Overall Study|Changed Dialysis Modality|18|||
30805525|NCT03149328|58822619|FG001|Overall Study|Changed Dialysis Modality|1|||
30805526|NCT03149328|58822618|FG000|Overall Study|Transplant|9|||
30805527|NCT03149328|58822619|FG001|Overall Study|Transplant|1|||
30908286|NCT02305238|58942958|FG002|Overall Study|Adverse Event|0|||
30805528|NCT03149328|58822618|FG000|Overall Study|Lost to Follow-up|25|||
30805529|NCT03149328|58822619|FG001|Overall Study|Lost to Follow-up|16|||
30805530|NCT03149328|58822618|FG000|Overall Study|Left Study Site|1|||
30805531|NCT03149328|58822619|FG001|Overall Study|Left Study Site|2|||
30805532|NCT03149328|58822618|FG000|Overall Study|Language Barrier|1|||
30805533|NCT03149328|58822619|FG001|Overall Study|Language Barrier|0|||
30805534|NCT04296942|58822668|FG000|Overall Study|Study closure by sponsor|1|||
30805535|NCT04296942|58822669|FG001|Overall Study|Study closure by sponsor|0|||
30805536|NCT04296942|58822670|FG002|Overall Study|Study closure by sponsor|0|||
30805537|NCT01315028|58822726|FG000|Overall Study|Lost to Follow-up|1|||
30805538|NCT01315028|58822727|FG001|Overall Study|Lost to Follow-up|0|||
30805539|NCT01315028|58822726|FG000|Overall Study|Death|0|||
30805540|NCT01315028|58822727|FG001|Overall Study|Death|1|||
30805541|NCT02720536|58822733|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
30805542|NCT02720536|58822733|FG000|Overall Study|PR - pregnancy|2|||
30908287|NCT02305238|58942956|FG000|Overall Study|Withdrawal by Subject|3|||
30908288|NCT02305238|58942957|FG001|Overall Study|Withdrawal by Subject|4|||
30805543|NCT02720536|58822733|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
30805544|NCT02720536|58822733|FG000|Overall Study|PR - death|1|||
30805545|NCT02720536|58822733|FG000|Overall Study|PR - adverse event|1|||
30805546|NCT02720536|58822733|FG000|Overall Study|PR - abnormal lab value(s)|1|||
30805547|NCT02720536|58822733|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
30622380|NCT00927394|58634072|FG001|Overall Study|Lost to Follow-up|14|||
30622381|NCT00927394|58634071|FG000|Overall Study|Administrative Problem|1|||
30622382|NCT00927394|58634072|FG001|Overall Study|Administrative Problem|0|||
30622383|NCT00927394|58634071|FG000|Overall Study|Death|1|||
30622384|NCT00927394|58634072|FG001|Overall Study|Death|1|||
30622385|NCT00927394|58634071|FG000|Overall Study|Protocol deviation|16|||
30622386|NCT00927394|58634072|FG001|Overall Study|Protocol deviation|13|||
30622387|NCT00927394|58634071|FG000|Overall Study|Randomized in error|0|||
30622388|NCT00927394|58634072|FG001|Overall Study|Randomized in error|1|||
30622389|NCT00976911|58634081|FG000|Overall Study|Withdrawal by Subject|4|||
30622390|NCT00976911|58634082|FG001|Overall Study|Withdrawal by Subject|6|||
30622391|NCT00976911|58634081|FG000|Overall Study|Death|138|||
30622392|NCT00976911|58634082|FG001|Overall Study|Death|126|||
30622393|NCT00976911|58634081|FG000|Overall Study|Adverse Event|0|||
30622394|NCT00976911|58634082|FG001|Overall Study|Adverse Event|1|||
30622395|NCT00976911|58634081|FG000|Overall Study|Protocol Violation|2|||
30622396|NCT00976911|58634082|FG001|Overall Study|Protocol Violation|0|||
30622397|NCT00976911|58634081|FG000|Overall Study|Other|8|||
30622398|NCT00976911|58634082|FG001|Overall Study|Other|9|||
30622399|NCT00976911|58634081|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
30622400|NCT00976911|58634082|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
30622401|NCT00934648|58634088|FG000|Overall Study|Failure to return|8|||
30622402|NCT00934648|58634088|FG000|Overall Study|Withdrawal by Subject|1|||
30622403|NCT01175213|58634096|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
30622404|NCT01175213|58634097|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
30622405|NCT01175213|58634096|FG000|IGSC, 10%/rHuPH20|Death|1|||
30622406|NCT01175213|58634097|FG001|IGSC, 10%/rHuPH20|Death|0|||
30622407|NCT01175213|58634096|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
30622408|NCT01175213|58634097|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
30622409|NCT01175213|58634096|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
30622410|NCT01175213|58634097|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
30622411|NCT01175213|58634096|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
30622412|NCT01175213|58634097|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
30622413|NCT01175213|58634096|FG000|Safety Follow-up|Adverse Event|1|||
30622414|NCT01175213|58634097|FG001|Safety Follow-up|Adverse Event|0|||
30622415|NCT00974259|58634108|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
30622416|NCT00974259|58634109|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
30622417|NCT00927082|58634119|FG000|Overall Study|Lost to Follow-up|9|||
30805548|NCT03168438|58822745|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
30805549|NCT03168438|58822746|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
30805550|NCT03137784|58822753|FG000|Overall Study|Adverse Event|1|||
30805551|NCT03137784|58822754|FG001|Overall Study|Adverse Event|1|||
30805552|NCT03137784|58822755|FG002|Overall Study|Adverse Event|0|||
30805553|NCT03137784|58822756|FG003|Overall Study|Adverse Event|0|||
30805554|NCT03137784|58822757|FG004|Overall Study|Adverse Event|0|||
30805555|NCT03137784|58822758|FG005|Overall Study|Adverse Event|0|||
30805556|NCT03137784|58822753|FG000|Overall Study|Subject/guardian decision|1|||
30805557|NCT03137784|58822754|FG001|Overall Study|Subject/guardian decision|0|||
30805558|NCT03137784|58822755|FG002|Overall Study|Subject/guardian decision|0|||
30805559|NCT03137784|58822756|FG003|Overall Study|Subject/guardian decision|0|||
30805560|NCT03137784|58822757|FG004|Overall Study|Subject/guardian decision|0|||
30805561|NCT03137784|58822758|FG005|Overall Study|Subject/guardian decision|0|||
30805562|NCT03137784|58822753|FG000|Overall Study|Non-compliance with study treatment|0|||
30805563|NCT03137784|58822754|FG001|Overall Study|Non-compliance with study treatment|0|||
30805564|NCT03137784|58822755|FG002|Overall Study|Non-compliance with study treatment|0|||
30805565|NCT03137784|58822756|FG003|Overall Study|Non-compliance with study treatment|0|||
30805566|NCT03137784|58822757|FG004|Overall Study|Non-compliance with study treatment|1|||
30805567|NCT03137784|58822758|FG005|Overall Study|Non-compliance with study treatment|0|||
30805568|NCT01314716|58822768|FG000|Double-Blind Phase|Randomized but not treated|1|||
30805569|NCT01314716|58822769|FG001|Double-Blind Phase|Randomized but not treated|1|||
30805570|NCT01314716|58822768|FG000|Double-Blind Phase|Adverse Event|10|||
30805571|NCT01314716|58822769|FG001|Double-Blind Phase|Adverse Event|4|||
30805572|NCT01314716|58822768|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
30622418|NCT00927082|58634120|FG001|Overall Study|Lost to Follow-up|8|||
30622419|NCT00927082|58634121|FG002|Overall Study|Lost to Follow-up|12|||
30622420|NCT00927082|58634122|FG003|Overall Study|Lost to Follow-up|16|||
30622421|NCT00927082|58634119|FG000|Overall Study|Withdrawal by Subject|3|||
30622422|NCT00927082|58634120|FG001|Overall Study|Withdrawal by Subject|2|||
30622423|NCT00927082|58634121|FG002|Overall Study|Withdrawal by Subject|7|||
30622424|NCT00927082|58634122|FG003|Overall Study|Withdrawal by Subject|2|||
30805573|NCT01314716|58822769|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
30908289|NCT02305238|58942958|FG002|Overall Study|Withdrawal by Subject|0|||
30908290|NCT02305238|58942956|FG000|Overall Study|Randomized failure|0|||
30908291|NCT02305238|58942957|FG001|Overall Study|Randomized failure|0|||
30908292|NCT02305238|58942958|FG002|Overall Study|Randomized failure|8|||
30908293|NCT02305238|58942956|FG000|Overall Study|Required procedure failed|0|||
30908294|NCT02305238|58942957|FG001|Overall Study|Required procedure failed|1|||
30908295|NCT02305238|58942958|FG002|Overall Study|Required procedure failed|0|||
30908296|NCT02313155|58942967|FG000|Overall Study|Lost to Follow-up|0|||
30908297|NCT02313155|58942968|FG001|Overall Study|Lost to Follow-up|1|||
30908298|NCT02204293|58942976|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
30908299|NCT02204293|58942977|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
30908300|NCT02204293|58942978|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
30908301|NCT02204293|58942979|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
30908302|NCT02204293|58942980|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
30908303|NCT02204293|58942981|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
30908304|NCT02204293|58942976|FG000|Core Study Part I|Adverse Event|1|||
30908305|NCT02204293|58942977|FG001|Core Study Part I|Adverse Event|0|||
30908306|NCT02204293|58942978|FG002|Core Study Part I|Adverse Event|0|||
30908307|NCT02204293|58942979|FG003|Core Study Part I|Adverse Event|0|||
30908308|NCT02204293|58942980|FG004|Core Study Part I|Adverse Event|0|||
30908309|NCT02204293|58942981|FG005|Core Study Part I|Adverse Event|0|||
30908310|NCT02204293|58942976|FG000|Core Study Part I|Physician Decision|0|||
30908311|NCT02204293|58942977|FG001|Core Study Part I|Physician Decision|3|||
30908312|NCT02204293|58942978|FG002|Core Study Part I|Physician Decision|0|||
30908313|NCT02204293|58942979|FG003|Core Study Part I|Physician Decision|0|||
30748569|NCT00265148|58758704|FG000|Overall Study|Withdrawal by Subject|2|||
30748570|NCT00265148|58758705|FG001|Overall Study|Withdrawal by Subject|1|||
30748571|NCT00265148|58758704|FG000|Overall Study|Physician Decision|1|||
30748572|NCT00265148|58758705|FG001|Overall Study|Physician Decision|0|||
30748573|NCT00265148|58758704|FG000|Overall Study|Increasing frailty|0|||
30748574|NCT00265148|58758705|FG001|Overall Study|Increasing frailty|1|||
30748575|NCT00265148|58758704|FG000|Overall Study|Subject chose to change of the dose|1|||
30748576|NCT00265148|58758705|FG001|Overall Study|Subject chose to change of the dose|0|||
30748577|NCT00043186|58758721|FG000|Overall Study|Physician Decision|0|||
30748578|NCT00043186|58758722|FG001|Overall Study|Physician Decision|0|||
30748579|NCT00043186|58758723|FG002|Overall Study|Physician Decision|3|||
30748580|NCT00043186|58758724|FG003|Overall Study|Physician Decision|0|||
30748581|NCT00043186|58758725|FG004|Overall Study|Physician Decision|1|||
30748582|NCT00043186|58758726|FG005|Overall Study|Physician Decision|0|||
30748583|NCT00043186|58758727|FG006|Overall Study|Physician Decision|0|||
30748584|NCT00043186|58758728|FG007|Overall Study|Physician Decision|1|||
30748585|NCT00043186|58758729|FG008|Overall Study|Physician Decision|1|||
30748586|NCT00043186|58758721|FG000|Overall Study|Adverse Event|2|||
30748587|NCT00043186|58758722|FG001|Overall Study|Adverse Event|2|||
30748588|NCT00043186|58758723|FG002|Overall Study|Adverse Event|2|||
30748589|NCT00043186|58758724|FG003|Overall Study|Adverse Event|3|||
30748590|NCT00043186|58758725|FG004|Overall Study|Adverse Event|2|||
30748591|NCT00043186|58758726|FG005|Overall Study|Adverse Event|1|||
30748592|NCT00043186|58758727|FG006|Overall Study|Adverse Event|2|||
30748593|NCT00043186|58758728|FG007|Overall Study|Adverse Event|1|||
30748594|NCT00043186|58758729|FG008|Overall Study|Adverse Event|3|||
30748595|NCT00043186|58758721|FG000|Overall Study|Withdrawal by Subject|11|||
30748596|NCT00043186|58758722|FG001|Overall Study|Withdrawal by Subject|8|||
30748597|NCT00043186|58758723|FG002|Overall Study|Withdrawal by Subject|11|||
30748598|NCT00043186|58758724|FG003|Overall Study|Withdrawal by Subject|13|||
30748599|NCT00043186|58758725|FG004|Overall Study|Withdrawal by Subject|14|||
30748600|NCT00043186|58758726|FG005|Overall Study|Withdrawal by Subject|6|||
30748601|NCT00043186|58758727|FG006|Overall Study|Withdrawal by Subject|12|||
30748602|NCT00043186|58758728|FG007|Overall Study|Withdrawal by Subject|9|||
30748603|NCT00043186|58758729|FG008|Overall Study|Withdrawal by Subject|10|||
30748604|NCT00043186|58758721|FG000|Overall Study|Death|0|||
30748605|NCT00043186|58758722|FG001|Overall Study|Death|0|||
30908314|NCT02204293|58942980|FG004|Core Study Part I|Physician Decision|0|||
30908315|NCT02204293|58942981|FG005|Core Study Part I|Physician Decision|0|||
30908316|NCT02204293|58942976|FG000|LTE Phase|Study Suspended|0|||
30908317|NCT02204293|58942977|FG001|LTE Phase|Study Suspended|0|||
30908318|NCT02204293|58942978|FG002|LTE Phase|Study Suspended|0|||
30908319|NCT02204293|58942979|FG003|LTE Phase|Study Suspended|0|||
30908320|NCT02204293|58942980|FG004|LTE Phase|Study Suspended|0|||
30748606|NCT00043186|58758723|FG002|Overall Study|Death|1|||
30748607|NCT00043186|58758724|FG003|Overall Study|Death|0|||
30748608|NCT00043186|58758725|FG004|Overall Study|Death|0|||
30748609|NCT00043186|58758726|FG005|Overall Study|Death|0|||
30748610|NCT00043186|58758727|FG006|Overall Study|Death|2|||
30748611|NCT00043186|58758728|FG007|Overall Study|Death|0|||
30748612|NCT00043186|58758729|FG008|Overall Study|Death|0|||
30748613|NCT00043186|58758721|FG000|Overall Study|Disease progression|1|||
30748614|NCT00043186|58758722|FG001|Overall Study|Disease progression|0|||
30748615|NCT00043186|58758723|FG002|Overall Study|Disease progression|0|||
30805574|NCT01314716|58822768|FG000|Double-Blind Phase|Lost to Follow-up|0|||
30805575|NCT01314716|58822769|FG001|Double-Blind Phase|Lost to Follow-up|1|||
30805576|NCT01314716|58822768|FG000|Double-Blind Phase|Sponsor request|1|||
30805577|NCT01314716|58822769|FG001|Double-Blind Phase|Sponsor request|2|||
30908321|NCT02204293|58942981|FG005|LTE Phase|Study Suspended|7|||
30908322|NCT02304926|58942997|FG000|Overall Study|Lost to Follow-up|2|||
30908323|NCT02304926|58942998|FG001|Overall Study|Lost to Follow-up|1|||
30908324|NCT01646255|58943008|FG000|Overall Study|Adverse Event|7|||
30908325|NCT01646255|58943009|FG001|Overall Study|Adverse Event|8|||
30908326|NCT01646255|58943008|FG000|Overall Study|Lack of Efficacy|2|||
30908327|NCT01646255|58943009|FG001|Overall Study|Lack of Efficacy|0|||
30908328|NCT01646255|58943008|FG000|Overall Study|Withdrawal by Subject|10|||
30908329|NCT01646255|58943009|FG001|Overall Study|Withdrawal by Subject|6|||
30805578|NCT01314716|58822768|FG000|Double-Blind Phase|Physician Decision|0|||
30805579|NCT01314716|58822769|FG001|Double-Blind Phase|Physician Decision|1|||
30805580|NCT01314716|58822768|FG000|Open-Label Phase|Adverse Event|4|||
30805581|NCT01314716|58822769|FG001|Open-Label Phase|Adverse Event|6|||
30805582|NCT01314716|58822768|FG000|Open-Label Phase|Withdrawal by Subject|1|||
30805583|NCT01314716|58822769|FG001|Open-Label Phase|Withdrawal by Subject|2|||
30622425|NCT00927082|58634119|FG000|Overall Study|Death|0|||
30622426|NCT00927082|58634120|FG001|Overall Study|Death|0|||
30622427|NCT00927082|58634121|FG002|Overall Study|Death|1|||
30622428|NCT00927082|58634122|FG003|Overall Study|Death|0|||
30622429|NCT00927082|58634119|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
30622430|NCT00927082|58634120|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
30622431|NCT00927082|58634121|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
30622432|NCT00927082|58634122|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
30622433|NCT00976677|58634138|FG000|Overall Study|Adverse Event|1|||
30622434|NCT00976677|58634139|FG001|Overall Study|Adverse Event|0|||
30622435|NCT00976677|58634138|FG000|Overall Study|Withdrawal by Subject|0|||
30622436|NCT00976677|58634139|FG001|Overall Study|Withdrawal by Subject|2|||
30622437|NCT00976677|58634138|FG000|Overall Study|Disease progression|1|||
30622438|NCT00976677|58634139|FG001|Overall Study|Disease progression|1|||
30622439|NCT00976677|58634138|FG000|Overall Study|Trial unblinded|2|||
30622440|NCT00976677|58634139|FG001|Overall Study|Trial unblinded|2|||
30622441|NCT00976677|58634138|FG000|Overall Study|Unknown/Missing|1|||
30805584|NCT01314716|58822768|FG000|Open-Label Phase|Physician Decision|5|||
30805585|NCT01314716|58822769|FG001|Open-Label Phase|Physician Decision|4|||
30805586|NCT03144180|58822779|FG000|Overall Study|STAT Delivery|1|||
30805587|NCT03144180|58822780|FG001|Overall Study|STAT Delivery|1|||
30805588|NCT03144180|58822779|FG000|Overall Study|Provider forgot to fill out forms|1|||
30805589|NCT03144180|58822780|FG001|Overall Study|Provider forgot to fill out forms|3|||
30805590|NCT03144180|58822779|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
30805591|NCT03144180|58822780|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
30805592|NCT03144180|58822779|FG000|Overall Study|Scrub tech removed tube cap|0|||
30805593|NCT03144180|58822780|FG001|Overall Study|Scrub tech removed tube cap|1|||
30805594|NCT01465334|58822790|FG000|Overall Study|Disease Progression|1|||
30805595|NCT01465334|58822791|FG001|Overall Study|Disease Progression|0|||
30805596|NCT01465334|58822790|FG000|Overall Study|Adverse Event|1|||
30805597|NCT01465334|58822791|FG001|Overall Study|Adverse Event|0|||
30805598|NCT01465334|58822790|FG000|Overall Study|Richter's transformation|0|||
30805599|NCT01465334|58822791|FG001|Overall Study|Richter's transformation|3|||
30805600|NCT01465334|58822790|FG000|Overall Study|Refractory Disease|0|||
30805601|NCT01465334|58822791|FG001|Overall Study|Refractory Disease|3|||
30805602|NCT00702208|58822797|FG000|Overall Study|Lost to Follow-up|28|||
30805603|NCT00702208|58822797|FG000|Overall Study|Did not self-lavage|1|||
30805604|NCT00702208|58822797|FG000|Overall Study|Unsatisfactory colposcopy|2|||
30805605|NCT02718898|58822814|FG000|Blinded Treatment Period|Adverse Event|5|||
30805606|NCT02718898|58822815|FG001|Blinded Treatment Period|Adverse Event|1|||
30805607|NCT02718898|58822816|FG002|Blinded Treatment Period|Adverse Event|0|||
30805608|NCT02718898|58822817|FG003|Blinded Treatment Period|Adverse Event|0|||
30805609|NCT02718898|58822818|FG004|Blinded Treatment Period|Adverse Event|0|||
30805610|NCT02718898|58822819|FG005|Blinded Treatment Period|Adverse Event|0|||
30908330|NCT01646255|58943008|FG000|Overall Study|Compliance is not well|1|||
30908331|NCT01646255|58943009|FG001|Overall Study|Compliance is not well|0|||
30908332|NCT01646255|58943008|FG000|Overall Study|Inclusion Criteria Deviation|1|||
30805611|NCT02718898|58822820|FG006|Blinded Treatment Period|Adverse Event|0|||
30622442|NCT00976677|58634139|FG001|Overall Study|Unknown/Missing|0|||
30622443|NCT00926536|58634147|FG000|Overall Study|Physician Decision|1|||
30805612|NCT02718898|58822814|FG000|Blinded Treatment Period|Physician Decision|1|||
30908333|NCT01646255|58943009|FG001|Overall Study|Inclusion Criteria Deviation|0|||
30622444|NCT00926536|58634148|FG001|Overall Study|Physician Decision|2|||
30805613|NCT02718898|58822815|FG001|Blinded Treatment Period|Physician Decision|0|||
30805614|NCT02718898|58822816|FG002|Blinded Treatment Period|Physician Decision|0|||
30805615|NCT02718898|58822817|FG003|Blinded Treatment Period|Physician Decision|0|||
30805616|NCT02718898|58822818|FG004|Blinded Treatment Period|Physician Decision|0|||
30805617|NCT02718898|58822819|FG005|Blinded Treatment Period|Physician Decision|0|||
30805618|NCT02718898|58822820|FG006|Blinded Treatment Period|Physician Decision|0|||
30805619|NCT02718898|58822814|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
30908334|NCT02304380|58943022|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
30908335|NCT02304380|58943023|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
30805620|NCT02718898|58822815|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
30805621|NCT02718898|58822816|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
30805622|NCT02718898|58822817|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
30805623|NCT02718898|58822818|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
30805624|NCT02718898|58822819|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
30805625|NCT02718898|58822820|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
30805626|NCT02718898|58822814|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
30805627|NCT02718898|58822815|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
30805628|NCT02718898|58822816|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
30805629|NCT02718898|58822817|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
30805630|NCT02718898|58822818|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
30805631|NCT02718898|58822819|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
30805632|NCT02718898|58822820|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
30805633|NCT02718898|58822814|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
30805634|NCT02718898|58822815|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
30805635|NCT02718898|58822816|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
30805636|NCT02718898|58822817|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
30805637|NCT02718898|58822818|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
30805638|NCT02718898|58822819|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
30805639|NCT02718898|58822820|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
30805640|NCT02718898|58822814|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
30805641|NCT02718898|58822815|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
30805642|NCT02718898|58822816|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
30805643|NCT02718898|58822817|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
30805644|NCT02718898|58822818|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
30805645|NCT02718898|58822819|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
30908336|NCT02304380|58943024|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
30908337|NCT02304380|58943025|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
30908338|NCT02304380|58943026|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
30908339|NCT02304380|58943027|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
30908340|NCT02203591|58943049|FG000|Overall Study|Did not meet treatment day baseline|147|||
30908341|NCT02203591|58943050|FG001|Overall Study|Did not meet treatment day baseline|141|||
30908342|NCT02203591|58943051|FG002|Overall Study|Did not meet treatment day baseline|150|||
30908343|NCT02203591|58943052|FG003|Overall Study|Did not meet treatment day baseline|45|||
30908344|NCT02203591|58943053|FG004|Overall Study|Did not meet treatment day baseline|33|||
30908345|NCT02203591|58943054|FG005|Overall Study|Did not meet treatment day baseline|35|||
30908346|NCT02203591|58943055|FG006|Overall Study|Did not meet treatment day baseline|29|||
30908347|NCT02203591|58943056|FG007|Overall Study|Did not meet treatment day baseline|12|||
30908348|NCT02203591|58943049|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
30908349|NCT02203591|58943050|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
30908350|NCT02203591|58943051|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
30908351|NCT02203591|58943052|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
30908352|NCT02203591|58943053|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
30908353|NCT02203591|58943054|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
30908354|NCT02203591|58943055|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
30908355|NCT02203591|58943056|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
30908356|NCT01642277|58943080|FG000|Overall Study|Adverse Event|10|||
30908357|NCT01642277|58943081|FG001|Overall Study|Adverse Event|0|||
30908358|NCT01642277|58943080|FG000|Overall Study|Physician Decision|2|||
30908359|NCT01642277|58943081|FG001|Overall Study|Physician Decision|0|||
30908360|NCT01642277|58943080|FG000|Overall Study|Protocol Violation|1|||
30908361|NCT01642277|58943081|FG001|Overall Study|Protocol Violation|0|||
30908362|NCT01642277|58943080|FG000|Overall Study|Withdrawal by Subject|11|||
30908363|NCT01642277|58943081|FG001|Overall Study|Withdrawal by Subject|0|||
30908364|NCT02230189|58943091|FG000|Overall Study|Withdrawal by Subject|3|||
30908365|NCT02230189|58943092|FG001|Overall Study|Withdrawal by Subject|0|||
30908366|NCT02230189|58943093|FG002|Overall Study|Withdrawal by Subject|1|||
30805646|NCT02718898|58822820|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
30805647|NCT02718898|58822814|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
30908367|NCT02230189|58943091|FG000|Overall Study|Lost to Follow-up|1|||
30805648|NCT02718898|58822815|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
30805649|NCT02718898|58822816|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
30805650|NCT02718898|58822817|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
30908368|NCT02230189|58943092|FG001|Overall Study|Lost to Follow-up|0|||
30908369|NCT02230189|58943093|FG002|Overall Study|Lost to Follow-up|0|||
30908370|NCT02230189|58943091|FG000|Overall Study|Physician Decision|1|||
30908371|NCT02230189|58943092|FG001|Overall Study|Physician Decision|0|||
30908372|NCT02230189|58943093|FG002|Overall Study|Physician Decision|0|||
30908373|NCT02304302|58943104|FG000|Overall Study|Adverse Event|2|||
30908374|NCT02304302|58943105|FG001|Overall Study|Adverse Event|3|||
30908375|NCT02304302|58943104|FG000|Overall Study|Lost to Follow-up|1|||
30805651|NCT02718898|58822818|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
30805652|NCT02718898|58822819|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
30908376|NCT02304302|58943105|FG001|Overall Study|Lost to Follow-up|4|||
30908377|NCT02304302|58943104|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
30908378|NCT02304302|58943105|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
30908379|NCT02276612|58943117|FG000|Overall Study|Death|1|||
30908380|NCT02276612|58943118|FG001|Overall Study|Death|0|||
30908381|NCT02276612|58943117|FG000|Overall Study|Pregnancy|1|||
30908382|NCT02276612|58943118|FG001|Overall Study|Pregnancy|0|||
30805653|NCT02718898|58822820|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
30805654|NCT02718898|58822814|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
30805655|NCT02718898|58822815|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
30805656|NCT02718898|58822816|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
30805657|NCT02718898|58822817|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
30805658|NCT02718898|58822818|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
30805659|NCT02718898|58822819|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
30805660|NCT02718898|58822820|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
30805661|NCT02718898|58822814|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
30805662|NCT02718898|58822815|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
30805663|NCT02718898|58822816|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
30805664|NCT02718898|58822817|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
30805665|NCT02718898|58822818|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
30805666|NCT02718898|58822819|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
30805667|NCT02718898|58822820|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
30805668|NCT02718898|58822814|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
30805669|NCT02718898|58822815|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
30805670|NCT02718898|58822816|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
30805671|NCT02718898|58822817|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
30805672|NCT02718898|58822818|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
30805673|NCT02718898|58822819|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
30805674|NCT02718898|58822820|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
30805675|NCT02718898|58822814|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
30805676|NCT02718898|58822815|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
30805677|NCT02718898|58822816|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
30805678|NCT02718898|58822817|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
30805679|NCT02718898|58822818|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
30805680|NCT02718898|58822819|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
30805681|NCT02718898|58822820|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
30805682|NCT02718898|58822814|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
30805683|NCT02718898|58822815|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
30805684|NCT02718898|58822816|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
30805685|NCT02718898|58822817|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
30805686|NCT02718898|58822818|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
30805687|NCT02718898|58822819|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
30805688|NCT02718898|58822820|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
30805689|NCT02718898|58822814|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
30805690|NCT02718898|58822815|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
30805691|NCT02718898|58822816|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
30805692|NCT02718898|58822817|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
30805693|NCT02718898|58822818|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
30805694|NCT02718898|58822819|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
30805695|NCT02718898|58822820|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
30908383|NCT02276612|58943117|FG000|Overall Study|Withdrew Consent|1|||
30908384|NCT02276612|58943118|FG001|Overall Study|Withdrew Consent|0|||
30908385|NCT02276612|58943117|FG000|Overall Study|Lost to Follow-up|1|||
30908386|NCT02276612|58943118|FG001|Overall Study|Lost to Follow-up|0|||
30908387|NCT02301143|58943124|FG000|Induction Period|Enrolled But Not Treated|1|||
30908388|NCT02301143|58943125|FG001|Induction Period|Enrolled But Not Treated|0|||
30908389|NCT02301143|58943124|FG000|Induction Period|Death|1|||
30908390|NCT02301143|58943125|FG001|Induction Period|Death|0|||
30908391|NCT02301143|58943124|FG000|Induction Period|Adverse Event|22|||
30805696|NCT03143166|58822837|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
30805697|NCT02879994|58822843|FG000|Overall Study|off treatment early|7|||
30805698|NCT02879994|58822843|FG000|Overall Study|Adverse Event|2|||
30908392|NCT02301143|58943125|FG001|Induction Period|Adverse Event|0|||
30908393|NCT02301143|58943124|FG000|Induction Period|Progressive Disease|8|||
30908394|NCT02301143|58943125|FG001|Induction Period|Progressive Disease|0|||
30908395|NCT02301143|58943124|FG000|Induction Period|Withdrawal by Subject|3|||
30908396|NCT02301143|58943125|FG001|Induction Period|Withdrawal by Subject|0|||
30908397|NCT02301143|58943124|FG000|Induction Period|Noncompliance with Study Drug|1|||
30805699|NCT02879994|58822843|FG000|Overall Study|Death|2|||
30805700|NCT03142932|58822849|FG000|Overall Study|Lost to Follow-up|2|||
30805701|NCT03142932|58822850|FG001|Overall Study|Lost to Follow-up|11|||
30805702|NCT00702052|58822856|FG000|Overall Study|Adverse Event|23|||
30805703|NCT00702052|58822856|FG000|Overall Study|Disease Progression|30|||
30805704|NCT00702052|58822856|FG000|Overall Study|Withdrawal by Subject|5|||
30805705|NCT03140280|58822860|FG000|Overall Study|Physician Decision|5|||
30805706|NCT03136380|58822866|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
30805707|NCT03136380|58822867|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
30805708|NCT03136380|58822868|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
30805709|NCT03136380|58822869|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
30805710|NCT03136380|58822870|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
30805711|NCT03136068|58822890|FG000|Overall Study|Lost to Follow-up|1|||
30805712|NCT03136068|58822891|FG001|Overall Study|Lost to Follow-up|1|||
30805713|NCT03136068|58822890|FG000|Overall Study|Protocol Violation|1|||
30805714|NCT03136068|58822891|FG001|Overall Study|Protocol Violation|0|||
30805715|NCT02585232|58822899|FG000|Overall Study|Lost to Follow-up|8|||
30805716|NCT02585232|58822900|FG001|Overall Study|Lost to Follow-up|8|||
30805717|NCT02585232|58822899|FG000|Overall Study|Withdrawal by Subject|4|||
30805718|NCT02585232|58822900|FG001|Overall Study|Withdrawal by Subject|8|||
30805719|NCT03377790|58822929|FG000|Overall Study|Withdrawal by Subject|1|||
30805720|NCT03377790|58822930|FG001|Overall Study|Withdrawal by Subject|0|||
30805721|NCT03377790|58822929|FG000|Overall Study|Adverse Event|1|||
30805722|NCT03377790|58822930|FG001|Overall Study|Adverse Event|0|||
30908398|NCT02301143|58943125|FG001|Induction Period|Noncompliance with Study Drug|0|||
30908399|NCT02301143|58943124|FG000|Induction Period|Physician Decision|4|||
30908400|NCT02301143|58943125|FG001|Induction Period|Physician Decision|0|||
30908401|NCT02301143|58943124|FG000|Induction Period|Symptomatic Deterioration|2|||
30908402|NCT02301143|58943125|FG001|Induction Period|Symptomatic Deterioration|0|||
30908403|NCT02301143|58943124|FG000|Induction Period|Protocol Violation|2|||
30908404|NCT02301143|58943125|FG001|Induction Period|Protocol Violation|0|||
30908405|NCT02301143|58943124|FG000|Induction Period|Other|1|||
30908406|NCT02301143|58943125|FG001|Induction Period|Other|0|||
30908407|NCT02301143|58943124|FG000|Investigator's Choice|Adverse Event|0|||
30805723|NCT03377790|58822929|FG000|Overall Study|Lost to Follow-up|0|||
30805724|NCT03377790|58822930|FG001|Overall Study|Lost to Follow-up|2|||
30805725|NCT03377790|58822929|FG000|Overall Study|Randomized but not treated|1|||
30805726|NCT03377790|58822930|FG001|Overall Study|Randomized but not treated|0|||
30805727|NCT03377790|58822929|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
30805728|NCT03377790|58822930|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
30805729|NCT02717494|58822939|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
30908408|NCT02301143|58943125|FG001|Investigator's Choice|Adverse Event|3|||
30748616|NCT00043186|58758724|FG003|Overall Study|Disease progression|3|||
30748617|NCT00043186|58758725|FG004|Overall Study|Disease progression|0|||
30748618|NCT00043186|58758726|FG005|Overall Study|Disease progression|0|||
30748619|NCT00043186|58758727|FG006|Overall Study|Disease progression|0|||
30748620|NCT00043186|58758728|FG007|Overall Study|Disease progression|4|||
30748621|NCT00043186|58758729|FG008|Overall Study|Disease progression|0|||
30748622|NCT00043186|58758721|FG000|Overall Study|Ineligibility determined|0|||
30748623|NCT00043186|58758722|FG001|Overall Study|Ineligibility determined|0|||
30805730|NCT02717494|58822940|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
30805731|NCT02717494|58822941|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
30748624|NCT00043186|58758723|FG002|Overall Study|Ineligibility determined|0|||
30805732|NCT02717494|58822939|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
30908409|NCT02301143|58943124|FG000|Investigator's Choice|Progressive Disease|0|||
30908410|NCT02301143|58943125|FG001|Investigator's Choice|Progressive Disease|3|||
30805733|NCT02717494|58822940|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
30805734|NCT02717494|58822941|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
30805735|NCT02717494|58822939|FG000|First Intervention (Step 1)|Death|0|||
30805736|NCT02717494|58822940|FG001|First Intervention (Step 1)|Death|0|||
30908411|NCT02301143|58943124|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
30908412|NCT02301143|58943125|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
30805737|NCT02717494|58822941|FG002|First Intervention (Step 1)|Death|1|||
30805738|NCT02717494|58822939|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
30805739|NCT02717494|58822940|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
30805740|NCT02717494|58822941|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
30805741|NCT01844856|58822969|FG000|Overall Study|Lost to Follow-up|15|||
30805742|NCT01844856|58822970|FG001|Overall Study|Lost to Follow-up|3|||
30908413|NCT02301143|58943124|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
30908414|NCT02301143|58943125|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
30748625|NCT00043186|58758724|FG003|Overall Study|Ineligibility determined|0|||
30908415|NCT02301143|58943124|FG000|Investigator's Choice|Other|0|||
30908416|NCT02301143|58943125|FG001|Investigator's Choice|Other|1|||
30908417|NCT02301143|58943124|FG000|Investigator's Choice|Unresectable Surgery|0|||
30908418|NCT02301143|58943125|FG001|Investigator's Choice|Unresectable Surgery|1|||
30908419|NCT02276222|58943138|FG000|Overall Study|Adverse Event|62|||
30908420|NCT02276222|58943139|FG001|Overall Study|Adverse Event|11|||
30908421|NCT02276222|58943138|FG000|Overall Study|Death|3|||
30908422|NCT02276222|58943139|FG001|Overall Study|Death|4|||
30748626|NCT00043186|58758725|FG004|Overall Study|Ineligibility determined|0|||
30748627|NCT00043186|58758726|FG005|Overall Study|Ineligibility determined|0|||
30748628|NCT00043186|58758727|FG006|Overall Study|Ineligibility determined|0|||
30748629|NCT00043186|58758728|FG007|Overall Study|Ineligibility determined|0|||
30748630|NCT00043186|58758729|FG008|Overall Study|Ineligibility determined|1|||
30748631|NCT00043186|58758721|FG000|Overall Study|Lost to Follow-up|3|||
30748632|NCT00043186|58758722|FG001|Overall Study|Lost to Follow-up|5|||
30748633|NCT00043186|58758723|FG002|Overall Study|Lost to Follow-up|1|||
30748634|NCT00043186|58758724|FG003|Overall Study|Lost to Follow-up|1|||
30748635|NCT00043186|58758725|FG004|Overall Study|Lost to Follow-up|1|||
30748636|NCT00043186|58758726|FG005|Overall Study|Lost to Follow-up|1|||
30748637|NCT00043186|58758727|FG006|Overall Study|Lost to Follow-up|1|||
30748638|NCT00043186|58758728|FG007|Overall Study|Lost to Follow-up|1|||
30748639|NCT00043186|58758729|FG008|Overall Study|Lost to Follow-up|2|||
30748640|NCT00043186|58758721|FG000|Overall Study|Noncompliance|0|||
30748641|NCT00043186|58758722|FG001|Overall Study|Noncompliance|0|||
30748642|NCT00043186|58758723|FG002|Overall Study|Noncompliance|1|||
30748643|NCT00043186|58758724|FG003|Overall Study|Noncompliance|1|||
30748644|NCT00043186|58758725|FG004|Overall Study|Noncompliance|0|||
30748645|NCT00043186|58758726|FG005|Overall Study|Noncompliance|0|||
30748646|NCT00043186|58758727|FG006|Overall Study|Noncompliance|0|||
30748647|NCT00043186|58758728|FG007|Overall Study|Noncompliance|0|||
30748648|NCT00043186|58758729|FG008|Overall Study|Noncompliance|0|||
30748649|NCT00043186|58758721|FG000|Overall Study|Other|0|||
30805743|NCT01844856|58822969|FG000|Overall Study|Adverse Event|3|||
30805744|NCT01844856|58822970|FG001|Overall Study|Adverse Event|6|||
30908423|NCT02276222|58943138|FG000|Overall Study|Lack of Efficacy|13|||
30908424|NCT02276222|58943139|FG001|Overall Study|Lack of Efficacy|3|||
30748650|NCT00043186|58758722|FG001|Overall Study|Other|0|||
30748651|NCT00043186|58758723|FG002|Overall Study|Other|1|||
30748652|NCT00043186|58758724|FG003|Overall Study|Other|1|||
30805745|NCT01844856|58822969|FG000|Overall Study|Withdrawal by Subject|3|||
30908425|NCT02276222|58943138|FG000|Overall Study|Protocol Violation|3|||
30622445|NCT00923260|58634156|FG000|Overall Study|Lost to Follow-up|1|||
30748653|NCT00043186|58758725|FG004|Overall Study|Other|0|||
30748654|NCT00043186|58758726|FG005|Overall Study|Other|0|||
30805746|NCT01844856|58822970|FG001|Overall Study|Withdrawal by Subject|2|||
30805747|NCT01844856|58822969|FG000|Overall Study|Noncompliance|2|||
30805748|NCT01844856|58822970|FG001|Overall Study|Noncompliance|3|||
30805749|NCT01844856|58822969|FG000|Overall Study|Enterococcus Resistant|0|||
30805750|NCT01844856|58822970|FG001|Overall Study|Enterococcus Resistant|1|||
30805751|NCT01844856|58822969|FG000|Overall Study|Inadvertently Not Scheduled|1|||
30805752|NCT01844856|58822970|FG001|Overall Study|Inadvertently Not Scheduled|0|||
30805753|NCT01844856|58822969|FG000|Overall Study|Randomized but was a Screen Failure|0|||
30805754|NCT01844856|58822970|FG001|Overall Study|Randomized but was a Screen Failure|1|||
30805755|NCT03135210|58823006|FG000|Overall Study|Death|0|||
30805756|NCT03135210|58823007|FG001|Overall Study|Death|1|||
30805757|NCT00701662|58823013|FG000|Overall Study|Lack of Efficacy|1|||
30805758|NCT02878590|58823017|FG000|Overall Study|Withdrawal by Subject|2|||
30805759|NCT04634409|58823048|FG000|Overall Study|Death|0|||
30805760|NCT04634409|58823049|FG001|Overall Study|Death|0|||
30805761|NCT04634409|58823050|FG002|Overall Study|Death|0|||
30805762|NCT04634409|58823051|FG003|Overall Study|Death|0|||
30805763|NCT04634409|58823052|FG004|Overall Study|Death|0|||
30805764|NCT04634409|58823053|FG005|Overall Study|Death|0|||
30805765|NCT04634409|58823054|FG006|Overall Study|Death|0|||
30805766|NCT04634409|58823055|FG007|Overall Study|Death|0|||
30805767|NCT04634409|58823056|FG008|Overall Study|Death|0|||
30805768|NCT04634409|58823057|FG009|Overall Study|Death|0|||
30805769|NCT04634409|58823058|FG010|Overall Study|Death|1|||
30805770|NCT04634409|58823059|FG011|Overall Study|Death|0|||
30805771|NCT04634409|58823060|FG012|Overall Study|Death|1|||
30805772|NCT04634409|58823061|FG013|Overall Study|Death|0|||
30805773|NCT04634409|58823062|FG014|Overall Study|Death|0|||
30805774|NCT04634409|58823063|FG015|Overall Study|Death|0|||
30805775|NCT04634409|58823064|FG016|Overall Study|Death|0|||
30805776|NCT04634409|58823065|FG017|Overall Study|Death|0|||
30805777|NCT04634409|58823066|FG018|Overall Study|Death|0|||
30805778|NCT04634409|58823067|FG019|Overall Study|Death|0|||
30805779|NCT04634409|58823068|FG020|Overall Study|Death|0|||
30805780|NCT04634409|58823069|FG021|Overall Study|Death|0|||
30805781|NCT04634409|58823070|FG022|Overall Study|Death|0|||
30805782|NCT04634409|58823071|FG023|Overall Study|Death|0|||
30805783|NCT04634409|58823072|FG024|Overall Study|Death|0|||
30805784|NCT04634409|58823073|FG025|Overall Study|Death|0|||
30748655|NCT00043186|58758727|FG006|Overall Study|Other|0|||
30805785|NCT04634409|58823074|FG026|Overall Study|Death|0|||
30805786|NCT04634409|58823048|FG000|Overall Study|Adverse Event|0|||
30805787|NCT04634409|58823049|FG001|Overall Study|Adverse Event|0|||
30805788|NCT04634409|58823050|FG002|Overall Study|Adverse Event|1|||
30805789|NCT04634409|58823051|FG003|Overall Study|Adverse Event|0|||
30748656|NCT00043186|58758728|FG007|Overall Study|Other|0|||
30748657|NCT00043186|58758729|FG008|Overall Study|Other|0|||
30748658|NCT00041470|58758750|FG000|Overall Study|Loss of Funding|38|||
30748659|NCT00206102|58758756|FG000|Overall Study|Adverse Event|119|||
30748660|NCT00206102|58758757|FG001|Overall Study|Adverse Event|82|||
30748661|NCT00206102|58758756|FG000|Overall Study|Protocol Violation|0|||
30748662|NCT00206102|58758757|FG001|Overall Study|Protocol Violation|2|||
30748663|NCT00206102|58758756|FG000|Overall Study|Lack of therapeutic response|16|||
30748664|NCT00206102|58758757|FG001|Overall Study|Lack of therapeutic response|11|||
30748665|NCT00206102|58758756|FG000|Overall Study|Lost to Follow-up|95|||
30748666|NCT00206102|58758757|FG001|Overall Study|Lost to Follow-up|66|||
30748667|NCT00206102|58758756|FG000|Overall Study|Withdrawal by Subject|118|||
30748668|NCT00206102|58758757|FG001|Overall Study|Withdrawal by Subject|101|||
30748669|NCT00206102|58758756|FG000|Overall Study|Study-specific discontinuation criteria|18|||
30748670|NCT00206102|58758757|FG001|Overall Study|Study-specific discontinuation criteria|17|||
30805790|NCT04634409|58823052|FG004|Overall Study|Adverse Event|0|||
30805791|NCT04634409|58823053|FG005|Overall Study|Adverse Event|1|||
30805792|NCT04634409|58823054|FG006|Overall Study|Adverse Event|0|||
30748671|NCT00206102|58758756|FG000|Overall Study|None of those categories|42|||
30748672|NCT00206102|58758757|FG001|Overall Study|None of those categories|36|||
30748673|NCT00041080|58758765|FG000|Overall Study|Adverse Event|21|||
30748674|NCT00041080|58758766|FG001|Overall Study|Adverse Event|1|||
30805793|NCT04634409|58823055|FG007|Overall Study|Adverse Event|0|||
30805794|NCT04634409|58823056|FG008|Overall Study|Adverse Event|0|||
30805795|NCT04634409|58823057|FG009|Overall Study|Adverse Event|0|||
30805796|NCT04634409|58823058|FG010|Overall Study|Adverse Event|0|||
30805797|NCT04634409|58823059|FG011|Overall Study|Adverse Event|0|||
30805798|NCT04634409|58823060|FG012|Overall Study|Adverse Event|0|||
30805799|NCT04634409|58823061|FG013|Overall Study|Adverse Event|0|||
30805800|NCT04634409|58823062|FG014|Overall Study|Adverse Event|0|||
30805801|NCT04634409|58823063|FG015|Overall Study|Adverse Event|0|||
30805802|NCT04634409|58823064|FG016|Overall Study|Adverse Event|0|||
30805803|NCT04634409|58823065|FG017|Overall Study|Adverse Event|0|||
30805804|NCT04634409|58823066|FG018|Overall Study|Adverse Event|0|||
30805805|NCT04634409|58823067|FG019|Overall Study|Adverse Event|0|||
30805806|NCT04634409|58823068|FG020|Overall Study|Adverse Event|0|||
30908426|NCT02276222|58943139|FG001|Overall Study|Protocol Violation|2|||
30908427|NCT02276222|58943138|FG000|Overall Study|Withdrawal by Subject|79|||
30908428|NCT02276222|58943139|FG001|Overall Study|Withdrawal by Subject|33|||
30908429|NCT02276222|58943138|FG000|Overall Study|non compliance with study medication|6|||
30908430|NCT02276222|58943139|FG001|Overall Study|non compliance with study medication|2|||
30908431|NCT02276222|58943138|FG000|Overall Study|sponsor decision|0|||
30908432|NCT02276222|58943139|FG001|Overall Study|sponsor decision|3|||
30908433|NCT02276222|58943138|FG000|Overall Study|Lost to Follow-up|15|||
30908434|NCT02276222|58943139|FG001|Overall Study|Lost to Follow-up|5|||
30908435|NCT02276222|58943138|FG000|Overall Study|Physician Decision|2|||
30908436|NCT02276222|58943139|FG001|Overall Study|Physician Decision|1|||
30908437|NCT02276222|58943138|FG000|Overall Study|sheduling conflict|1|||
30908438|NCT02276222|58943139|FG001|Overall Study|sheduling conflict|0|||
30908439|NCT02276222|58943138|FG000|Overall Study|subject withdrew after randomization|1|||
30908440|NCT02276222|58943139|FG001|Overall Study|subject withdrew after randomization|0|||
30908441|NCT02275364|58943145|FG000|Period 1|Withdrawal by Subject|1|||
30908442|NCT02275364|58943146|FG001|Period 1|Withdrawal by Subject|0|||
30908443|NCT02275364|58943145|FG000|Period 1|Other reason|1|||
30908444|NCT02275364|58943146|FG001|Period 1|Other reason|0|||
30908445|NCT02275052|58943163|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30908446|NCT02275052|58943164|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
30908447|NCT02275052|58943165|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30908448|NCT02275052|58943166|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30908449|NCT02275052|58943163|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
30908450|NCT02275052|58943164|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
30908451|NCT02275052|58943165|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
30908452|NCT02275052|58943166|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
30908453|NCT02275052|58943163|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
30908454|NCT02275052|58943164|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
30908455|NCT02275052|58943165|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
30908456|NCT02275052|58943166|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
30908457|NCT02275052|58943163|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
30908458|NCT02275052|58943164|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
30908459|NCT02275052|58943165|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
30908460|NCT02275052|58943166|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
30908461|NCT02275052|58943163|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
30908462|NCT02275052|58943164|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
30908463|NCT02275052|58943165|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
30908464|NCT02275052|58943166|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
30908465|NCT02275052|58943163|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
30908466|NCT02275052|58943164|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
30908467|NCT02275052|58943165|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
30908468|NCT02275052|58943166|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
30908469|NCT02275052|58943163|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
30908470|NCT02275052|58943164|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
30908471|NCT02275052|58943165|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
30908472|NCT02275052|58943166|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
30908473|NCT02275052|58943163|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
30908474|NCT02275052|58943164|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
30908475|NCT02275052|58943165|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
30908476|NCT02275052|58943166|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
30908477|NCT02275052|58943163|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30908478|NCT02275052|58943164|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30908479|NCT02275052|58943165|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
30908480|NCT02275052|58943166|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
30908481|NCT02275052|58943163|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
30908482|NCT02275052|58943164|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
30908483|NCT02275052|58943165|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
30908484|NCT02275052|58943166|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
30908485|NCT02275052|58943163|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
30908486|NCT02275052|58943164|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
30908487|NCT02275052|58943165|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
30908488|NCT02275052|58943166|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
30908489|NCT02274038|58943172|FG000|Overall Study|Death|1|||
30908490|NCT02300558|58943178|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
30908491|NCT02300558|58943178|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
30908492|NCT02300558|58943178|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
30805807|NCT04634409|58823069|FG021|Overall Study|Adverse Event|0|||
30805808|NCT04634409|58823070|FG022|Overall Study|Adverse Event|0|||
30805809|NCT04634409|58823071|FG023|Overall Study|Adverse Event|0|||
30805810|NCT04634409|58823072|FG024|Overall Study|Adverse Event|0|||
30805811|NCT04634409|58823073|FG025|Overall Study|Adverse Event|0|||
30805812|NCT04634409|58823074|FG026|Overall Study|Adverse Event|0|||
30805813|NCT04634409|58823048|FG000|Overall Study|Lost to Follow-up|3|||
30805814|NCT04634409|58823049|FG001|Overall Study|Lost to Follow-up|1|||
30805815|NCT04634409|58823050|FG002|Overall Study|Lost to Follow-up|1|||
30805816|NCT04634409|58823051|FG003|Overall Study|Lost to Follow-up|3|||
30805817|NCT04634409|58823052|FG004|Overall Study|Lost to Follow-up|1|||
30805818|NCT04634409|58823053|FG005|Overall Study|Lost to Follow-up|1|||
30805819|NCT04634409|58823054|FG006|Overall Study|Lost to Follow-up|1|||
30805820|NCT04634409|58823055|FG007|Overall Study|Lost to Follow-up|3|||
30805821|NCT04634409|58823056|FG008|Overall Study|Lost to Follow-up|3|||
30805822|NCT04634409|58823057|FG009|Overall Study|Lost to Follow-up|11|||
30805823|NCT04634409|58823058|FG010|Overall Study|Lost to Follow-up|8|||
30805824|NCT04634409|58823059|FG011|Overall Study|Lost to Follow-up|15|||
30805825|NCT04634409|58823060|FG012|Overall Study|Lost to Follow-up|3|||
30805826|NCT04634409|58823061|FG013|Overall Study|Lost to Follow-up|2|||
30805827|NCT04634409|58823062|FG014|Overall Study|Lost to Follow-up|7|||
30805828|NCT04634409|58823063|FG015|Overall Study|Lost to Follow-up|0|||
30805829|NCT04634409|58823064|FG016|Overall Study|Lost to Follow-up|0|||
30805830|NCT04634409|58823065|FG017|Overall Study|Lost to Follow-up|0|||
30805831|NCT04634409|58823066|FG018|Overall Study|Lost to Follow-up|0|||
30805832|NCT04634409|58823067|FG019|Overall Study|Lost to Follow-up|0|||
30805833|NCT04634409|58823068|FG020|Overall Study|Lost to Follow-up|0|||
30805834|NCT04634409|58823069|FG021|Overall Study|Lost to Follow-up|0|||
30805835|NCT04634409|58823070|FG022|Overall Study|Lost to Follow-up|0|||
30805836|NCT04634409|58823071|FG023|Overall Study|Lost to Follow-up|0|||
30805837|NCT04634409|58823072|FG024|Overall Study|Lost to Follow-up|0|||
30805838|NCT04634409|58823073|FG025|Overall Study|Lost to Follow-up|0|||
30805839|NCT04634409|58823074|FG026|Overall Study|Lost to Follow-up|0|||
30805840|NCT04634409|58823048|FG000|Overall Study|Withdrawal by Subject|3|||
30805841|NCT04634409|58823049|FG001|Overall Study|Withdrawal by Subject|1|||
30805842|NCT04634409|58823050|FG002|Overall Study|Withdrawal by Subject|6|||
30805843|NCT04634409|58823051|FG003|Overall Study|Withdrawal by Subject|4|||
30805844|NCT04634409|58823052|FG004|Overall Study|Withdrawal by Subject|2|||
30805845|NCT04634409|58823053|FG005|Overall Study|Withdrawal by Subject|0|||
30805846|NCT04634409|58823054|FG006|Overall Study|Withdrawal by Subject|0|||
30805847|NCT04634409|58823055|FG007|Overall Study|Withdrawal by Subject|2|||
30805848|NCT04634409|58823056|FG008|Overall Study|Withdrawal by Subject|3|||
30805849|NCT04634409|58823057|FG009|Overall Study|Withdrawal by Subject|2|||
30805850|NCT04634409|58823058|FG010|Overall Study|Withdrawal by Subject|3|||
30805851|NCT04634409|58823059|FG011|Overall Study|Withdrawal by Subject|2|||
30805852|NCT04634409|58823060|FG012|Overall Study|Withdrawal by Subject|2|||
30805853|NCT04634409|58823061|FG013|Overall Study|Withdrawal by Subject|1|||
30805854|NCT04634409|58823062|FG014|Overall Study|Withdrawal by Subject|5|||
30748675|NCT00041080|58758765|FG000|Overall Study|Withdrawal by Subject|6|||
30748676|NCT00041080|58758766|FG001|Overall Study|Withdrawal by Subject|6|||
30748677|NCT00041080|58758765|FG000|Overall Study|Concommitant Illness/Other|1|||
30748678|NCT00041080|58758766|FG001|Overall Study|Concommitant Illness/Other|2|||
30748679|NCT00041080|58758765|FG000|Overall Study|Did not start therapy|1|||
30748680|NCT00041080|58758766|FG001|Overall Study|Did not start therapy|1|||
30748681|NCT00041080|58758765|FG000|Overall Study|Ineligible|1|||
30748682|NCT00041080|58758766|FG001|Overall Study|Ineligible|0|||
30748683|NCT00205712|58758774|FG000|Overall Study|Lost to Follow-up|0|||
30748684|NCT00205712|58758775|FG001|Overall Study|Lost to Follow-up|1|||
30805855|NCT04634409|58823063|FG015|Overall Study|Withdrawal by Subject|0|||
30805856|NCT04634409|58823064|FG016|Overall Study|Withdrawal by Subject|0|||
30805857|NCT04634409|58823065|FG017|Overall Study|Withdrawal by Subject|1|||
30805858|NCT04634409|58823066|FG018|Overall Study|Withdrawal by Subject|0|||
30805859|NCT04634409|58823067|FG019|Overall Study|Withdrawal by Subject|0|||
30805860|NCT04634409|58823068|FG020|Overall Study|Withdrawal by Subject|0|||
30805861|NCT04634409|58823069|FG021|Overall Study|Withdrawal by Subject|0|||
30805862|NCT04634409|58823070|FG022|Overall Study|Withdrawal by Subject|0|||
30805863|NCT04634409|58823071|FG023|Overall Study|Withdrawal by Subject|1|||
30805864|NCT04634409|58823072|FG024|Overall Study|Withdrawal by Subject|0|||
30805865|NCT04634409|58823073|FG025|Overall Study|Withdrawal by Subject|0|||
30805866|NCT04634409|58823074|FG026|Overall Study|Withdrawal by Subject|0|||
30805867|NCT04634409|58823048|FG000|Overall Study|Other - As reported by Investigator|1|||
30805868|NCT04634409|58823049|FG001|Overall Study|Other - As reported by Investigator|0|||
30805869|NCT04634409|58823050|FG002|Overall Study|Other - As reported by Investigator|0|||
30805870|NCT04634409|58823051|FG003|Overall Study|Other - As reported by Investigator|0|||
30805871|NCT04634409|58823052|FG004|Overall Study|Other - As reported by Investigator|0|||
30805872|NCT04634409|58823053|FG005|Overall Study|Other - As reported by Investigator|0|||
30805873|NCT04634409|58823054|FG006|Overall Study|Other - As reported by Investigator|0|||
30805874|NCT04634409|58823055|FG007|Overall Study|Other - As reported by Investigator|6|||
30805875|NCT04634409|58823056|FG008|Overall Study|Other - As reported by Investigator|4|||
30805876|NCT04634409|58823057|FG009|Overall Study|Other - As reported by Investigator|0|||
30805877|NCT04634409|58823058|FG010|Overall Study|Other - As reported by Investigator|1|||
30805878|NCT04634409|58823059|FG011|Overall Study|Other - As reported by Investigator|2|||
30805879|NCT04634409|58823060|FG012|Overall Study|Other - As reported by Investigator|2|||
30805880|NCT04634409|58823061|FG013|Overall Study|Other - As reported by Investigator|1|||
30805881|NCT04634409|58823062|FG014|Overall Study|Other - As reported by Investigator|0|||
30805882|NCT04634409|58823063|FG015|Overall Study|Other - As reported by Investigator|0|||
30805883|NCT04634409|58823064|FG016|Overall Study|Other - As reported by Investigator|0|||
30805884|NCT04634409|58823065|FG017|Overall Study|Other - As reported by Investigator|0|||
30805885|NCT04634409|58823066|FG018|Overall Study|Other - As reported by Investigator|0|||
30805886|NCT04634409|58823067|FG019|Overall Study|Other - As reported by Investigator|0|||
30805887|NCT04634409|58823068|FG020|Overall Study|Other - As reported by Investigator|0|||
30805888|NCT04634409|58823069|FG021|Overall Study|Other - As reported by Investigator|0|||
30805889|NCT04634409|58823070|FG022|Overall Study|Other - As reported by Investigator|0|||
30805890|NCT04634409|58823071|FG023|Overall Study|Other - As reported by Investigator|0|||
30805891|NCT04634409|58823072|FG024|Overall Study|Other - As reported by Investigator|0|||
30805892|NCT04634409|58823073|FG025|Overall Study|Other - As reported by Investigator|0|||
30908493|NCT02300558|58943178|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
30908494|NCT02273960|58943190|FG000|Short Term Period|Lost to Follow-up|1|||
30805893|NCT04634409|58823074|FG026|Overall Study|Other - As reported by Investigator|0|||
30805894|NCT00005780|58823152|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
30805895|NCT01978938|58823161|FG000|Overall Study|Lost to Follow-up|12|||
30805896|NCT01978938|58823162|FG001|Overall Study|Lost to Follow-up|6|||
30805897|NCT01978938|58823161|FG000|Overall Study|Withdrawal by Subject|8|||
30805898|NCT01978938|58823162|FG001|Overall Study|Withdrawal by Subject|4|||
30805899|NCT01978938|58823161|FG000|Overall Study|Adverse Event, non-fatal|2|||
30805900|NCT01978938|58823162|FG001|Overall Study|Adverse Event, non-fatal|1|||
30805901|NCT01978938|58823161|FG000|Overall Study|Participant noncompliance|1|||
30805902|NCT01978938|58823162|FG001|Overall Study|Participant noncompliance|1|||
30805903|NCT01978938|58823161|FG000|Overall Study|Did not meet inclusion criteria|0|||
30805904|NCT01978938|58823162|FG001|Overall Study|Did not meet inclusion criteria|1|||
30805905|NCT01978938|58823161|FG000|Overall Study|Previously scheduled procedure|0|||
30805906|NCT01978938|58823162|FG001|Overall Study|Previously scheduled procedure|1|||
30805907|NCT03041090|58823170|FG000|Overall Study|technical error|0|||
30805908|NCT03041090|58823171|FG001|Overall Study|technical error|3|||
30805909|NCT00116142|58823179|FG000|Overall Study|Adverse Event|8|||
30805910|NCT00116142|58823180|FG001|Overall Study|Adverse Event|7|||
30805911|NCT00116142|58823179|FG000|Overall Study|Protocol Violation|2|||
30908495|NCT02273960|58943191|FG001|Short Term Period|Lost to Follow-up|0|||
30805912|NCT00116142|58823180|FG001|Overall Study|Protocol Violation|1|||
30908496|NCT02273960|58943192|FG002|Short Term Period|Lost to Follow-up|0|||
30805913|NCT00116142|58823179|FG000|Overall Study|Withdrawal by Subject|5|||
30908497|NCT02273960|58943193|FG003|Short Term Period|Lost to Follow-up|0|||
30805914|NCT00116142|58823180|FG001|Overall Study|Withdrawal by Subject|5|||
30805915|NCT00116142|58823179|FG000|Overall Study|Physician Decision|3|||
30805916|NCT00116142|58823180|FG001|Overall Study|Physician Decision|1|||
30805917|NCT00116142|58823179|FG000|Overall Study|Delayed Radiation Therapy|1|||
30805918|NCT00116142|58823180|FG001|Overall Study|Delayed Radiation Therapy|0|||
30908498|NCT02273960|58943190|FG000|Short Term Period|Lack of Efficacy|0|||
30908499|NCT02273960|58943191|FG001|Short Term Period|Lack of Efficacy|0|||
30908500|NCT02273960|58943192|FG002|Short Term Period|Lack of Efficacy|0|||
30908501|NCT02273960|58943193|FG003|Short Term Period|Lack of Efficacy|1|||
30908502|NCT02273960|58943190|FG000|Short Term Period|ST complete, not entering LTE|4|||
30908503|NCT02273960|58943191|FG001|Short Term Period|ST complete, not entering LTE|6|||
30908504|NCT02273960|58943192|FG002|Short Term Period|ST complete, not entering LTE|4|||
30908505|NCT02273960|58943193|FG003|Short Term Period|ST complete, not entering LTE|5|||
30805919|NCT00116142|58823179|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
30805920|NCT00116142|58823180|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
30805921|NCT00116142|58823179|FG000|Overall Study|Patient stopped due to depression|0|||
30805922|NCT00116142|58823180|FG001|Overall Study|Patient stopped due to depression|1|||
30805923|NCT00116142|58823179|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
30805924|NCT00116142|58823180|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
30805925|NCT00116142|58823179|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
30805926|NCT00116142|58823180|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
30805927|NCT00116142|58823179|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
30805928|NCT00116142|58823180|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
30805929|NCT03135522|58823191|FG000|Overall Study|Adverse Event|1|||
30805930|NCT03135522|58823192|FG001|Overall Study|Adverse Event|0|||
30805931|NCT02875080|58823215|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
30805932|NCT02875080|58823216|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
30805933|NCT02875080|58823217|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
30805934|NCT03129360|58823228|FG000|Overall Study|Did not meet entry criteria|0|||
30805935|NCT03129360|58823229|FG001|Overall Study|Did not meet entry criteria|2|||
30805936|NCT03129360|58823230|FG002|Overall Study|Did not meet entry criteria|1|||
30805937|NCT03129360|58823228|FG000|Overall Study|Excluded due to motion in scanner|1|||
30805938|NCT03129360|58823229|FG001|Overall Study|Excluded due to motion in scanner|0|||
30805939|NCT03129360|58823230|FG002|Overall Study|Excluded due to motion in scanner|0|||
30805940|NCT03165045|58823238|FG000|Visit 1|No registration after visit 1|9|||
30805941|NCT03165045|58823238|FG000|Visit 1|No treatment documented|10|||
30805942|NCT03165045|58823238|FG000|Visit 1|No visit 1|10|||
30908506|NCT02273960|58943190|FG000|Long Term Extension|Death|0|||
30908507|NCT02273960|58943191|FG001|Long Term Extension|Death|0|||
30908508|NCT02273960|58943192|FG002|Long Term Extension|Death|0|||
30908509|NCT02273960|58943193|FG003|Long Term Extension|Death|1|||
30908510|NCT01646021|58943205|FG000|Overall Study|Death|77|||
30908511|NCT01646021|58943206|FG001|Overall Study|Death|83|||
30908512|NCT01646021|58943205|FG000|Overall Study|Study Terminated by Sponsor|50|||
30908513|NCT01646021|58943206|FG001|Overall Study|Study Terminated by Sponsor|41|||
30908514|NCT01646021|58943205|FG000|Overall Study|Lost to Follow-up|2|||
30908515|NCT01646021|58943206|FG001|Overall Study|Lost to Follow-up|2|||
30908516|NCT01646021|58943205|FG000|Overall Study|Withdrawal by Subject|10|||
30908517|NCT01646021|58943206|FG001|Overall Study|Withdrawal by Subject|15|||
30908518|NCT01750918|58943223|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
30908519|NCT01750918|58943224|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
30748685|NCT00203294|58758785|FG000|Overall Study|Withdrawal by Subject|8|||
30748686|NCT00203294|58758786|FG001|Overall Study|Withdrawal by Subject|13|||
30748687|NCT00264290|58758794|FG000|Intervention (8 Weeks)|Adverse Event|1|||
30748688|NCT00264290|58758795|FG001|Intervention (8 Weeks)|Adverse Event|0|||
30748689|NCT00234494|58758805|FG000|Overall Study|Protocol Violation|2|||
30748690|NCT00234104|58758813|FG000|Overall Study|Adverse Event|4|||
30748691|NCT00234104|58758814|FG001|Overall Study|Adverse Event|0|||
30748692|NCT00234104|58758815|FG002|Overall Study|Adverse Event|3|||
30748693|NCT00234104|58758816|FG003|Overall Study|Adverse Event|5|||
30748694|NCT00234104|58758813|FG000|Overall Study|Protocol Violation|0|||
30748695|NCT00234104|58758814|FG001|Overall Study|Protocol Violation|0|||
30748696|NCT00234104|58758815|FG002|Overall Study|Protocol Violation|0|||
30748697|NCT00234104|58758816|FG003|Overall Study|Protocol Violation|1|||
30748698|NCT00234104|58758813|FG000|Overall Study|Physician Decision|0|||
30748699|NCT00234104|58758814|FG001|Overall Study|Physician Decision|1|||
30748700|NCT00234104|58758815|FG002|Overall Study|Physician Decision|2|||
30748701|NCT00234104|58758816|FG003|Overall Study|Physician Decision|2|||
30748702|NCT00263666|58758828|FG000|Overall Study|Adverse Event|6|||
30748703|NCT00263666|58758829|FG001|Overall Study|Adverse Event|8|||
30748704|NCT00263666|58758828|FG000|Overall Study|Lost to Follow-up|1|||
30748705|NCT00263666|58758829|FG001|Overall Study|Lost to Follow-up|2|||
30748706|NCT00263666|58758828|FG000|Overall Study|Withdrawal by Subject|0|||
30748707|NCT00263666|58758829|FG001|Overall Study|Withdrawal by Subject|1|||
30748708|NCT00195338|58758835|FG000|Overall Study|Lost to Follow-up|2|||
30748709|NCT00195338|58758835|FG000|Overall Study|Adverse Event|5|||
30748710|NCT00195338|58758835|FG000|Overall Study|Lack of Efficacy|1|||
30748711|NCT00195338|58758835|FG000|Overall Study|Early closure of the site|4|||
30805943|NCT03165045|58823238|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
30805944|NCT03165045|58823238|FG000|Visit 2|No available total CCQ score at all|29|||
30805945|NCT03165045|58823238|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
30805946|NCT01928199|58823246|FG000|Overall Study|Lost to Follow-up|2|||
30805947|NCT01928199|58823247|FG001|Overall Study|Lost to Follow-up|1|||
30805948|NCT01928199|58823246|FG000|Overall Study|Withdrawal by Subject|3|||
30805949|NCT01928199|58823247|FG001|Overall Study|Withdrawal by Subject|5|||
30805950|NCT03128892|58823253|FG000|Overall Study|Withdrawal by Subject|2|||
30805951|NCT03128892|58823253|FG000|Overall Study|Physician Decision|1|||
30805952|NCT03039686|58823269|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
30805953|NCT03039686|58823270|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
30805954|NCT03039686|58823271|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
30805955|NCT03039686|58823269|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
30805956|NCT03039686|58823270|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
30805957|NCT03039686|58823271|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
30805958|NCT03039686|58823269|FG000|Double-blind Period|Withdrawal by Subject|2|||
30805959|NCT03039686|58823270|FG001|Double-blind Period|Withdrawal by Subject|2|||
30805960|NCT03039686|58823271|FG002|Double-blind Period|Withdrawal by Subject|1|||
30805961|NCT03039686|58823269|FG000|Double-blind Period|Death|0|||
30805962|NCT03039686|58823270|FG001|Double-blind Period|Death|0|||
30805963|NCT03039686|58823271|FG002|Double-blind Period|Death|1|||
30805964|NCT03039686|58823269|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
30805965|NCT03039686|58823270|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
30805966|NCT03039686|58823271|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
30805967|NCT03039686|58823269|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
30805968|NCT03039686|58823270|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
30805969|NCT03039686|58823271|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
30805970|NCT03039686|58823269|FG000|Open Label Period|Withdrawal by Subject|0|||
30908520|NCT01750918|58943225|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
30908521|NCT01750918|58943226|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
30908522|NCT01750918|58943227|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
30908523|NCT01750918|58943228|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
30908524|NCT01750918|58943229|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
30908525|NCT01750918|58943230|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
30908526|NCT01750918|58943223|FG000|Overall Study|Lost to Follow-up|0|||
30908527|NCT01750918|58943224|FG001|Overall Study|Lost to Follow-up|0|||
30908528|NCT01750918|58943225|FG002|Overall Study|Lost to Follow-up|2|||
30908529|NCT01750918|58943226|FG003|Overall Study|Lost to Follow-up|2|||
30908530|NCT01750918|58943227|FG004|Overall Study|Lost to Follow-up|0|||
30908531|NCT01750918|58943228|FG005|Overall Study|Lost to Follow-up|0|||
30908532|NCT01750918|58943229|FG006|Overall Study|Lost to Follow-up|0|||
30908533|NCT01750918|58943230|FG007|Overall Study|Lost to Follow-up|1|||
30908534|NCT01750918|58943223|FG000|Overall Study|Withdrawal by Subject|0|||
30805971|NCT03039686|58823270|FG001|Open Label Period|Withdrawal by Subject|3|||
30805972|NCT03039686|58823271|FG002|Open Label Period|Withdrawal by Subject|1|||
30805973|NCT01822275|58823289|FG000|Overall Study|Withdrawal by Subject|3|||
30805974|NCT01822275|58823289|FG000|Overall Study|Adverse Event|3|||
30805975|NCT01822275|58823289|FG000|Overall Study|Progression|14|||
30805976|NCT01822275|58823289|FG000|Overall Study|Physician Decision|2|||
30805977|NCT01656434|58823301|FG000|Overall Study|Adverse Event|199|||
30805978|NCT01656434|58823302|FG001|Overall Study|Adverse Event|63|||
30805979|NCT01656434|58823301|FG000|Overall Study|Enrollment terminated at trial site|2|||
30805980|NCT01656434|58823302|FG001|Overall Study|Enrollment terminated at trial site|0|||
30805981|NCT01656434|58823301|FG000|Overall Study|Lost to Follow-up|309|||
30805982|NCT01656434|58823302|FG001|Overall Study|Lost to Follow-up|76|||
30805983|NCT01656434|58823301|FG000|Overall Study|Site discontinued study participation|24|||
30805984|NCT01656434|58823302|FG001|Overall Study|Site discontinued study participation|9|||
30805985|NCT01656434|58823301|FG000|Overall Study|Screen failure|2|||
30805986|NCT01656434|58823302|FG001|Overall Study|Screen failure|0|||
30805987|NCT01656434|58823301|FG000|Overall Study|Protocol Violation|7|||
30805988|NCT01656434|58823302|FG001|Overall Study|Protocol Violation|0|||
30805989|NCT01656434|58823301|FG000|Overall Study|Pregnancy wish|18|||
30805990|NCT01656434|58823302|FG001|Overall Study|Pregnancy wish|6|||
30805991|NCT01656434|58823301|FG000|Overall Study|Pregnancy|45|||
30805992|NCT01656434|58823302|FG001|Overall Study|Pregnancy|10|||
30805993|NCT01656434|58823301|FG000|Overall Study|Physician Decision|7|||
30805994|NCT01656434|58823302|FG001|Overall Study|Physician Decision|2|||
30805995|NCT01656434|58823301|FG000|Overall Study|Non-compliance with study drug|48|||
30908535|NCT01750918|58943224|FG001|Overall Study|Withdrawal by Subject|0|||
30805996|NCT01656434|58823302|FG001|Overall Study|Non-compliance with study drug|9|||
30805997|NCT01656434|58823301|FG000|Overall Study|Study terminated by sponsor|1501|||
30805998|NCT01656434|58823302|FG001|Overall Study|Study terminated by sponsor|348|||
30805999|NCT01656434|58823301|FG000|Overall Study|Participant discontinued; drug related|13|||
30806000|NCT01656434|58823302|FG001|Overall Study|Participant discontinued; drug related|4|||
30908536|NCT01750918|58943225|FG002|Overall Study|Withdrawal by Subject|1|||
30908537|NCT01750918|58943226|FG003|Overall Study|Withdrawal by Subject|2|||
30908538|NCT01750918|58943227|FG004|Overall Study|Withdrawal by Subject|1|||
30908539|NCT01750918|58943228|FG005|Overall Study|Withdrawal by Subject|1|||
30908540|NCT01750918|58943229|FG006|Overall Study|Withdrawal by Subject|2|||
30908541|NCT01750918|58943230|FG007|Overall Study|Withdrawal by Subject|2|||
30908542|NCT02300987|58943262|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
30908543|NCT02300987|58943263|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
30908544|NCT02300987|58943262|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
30908545|NCT02300987|58943263|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
30908546|NCT02300987|58943262|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
30908547|NCT02300987|58943263|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
30908548|NCT02300987|58943262|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
30908549|NCT02300987|58943263|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
30908550|NCT02300987|58943262|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
30908551|NCT02300987|58943263|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
30908552|NCT01750840|58943270|FG000|Overall Study|Lost to Follow-up|4|||
30908553|NCT01606228|58943275|FG000|Overall Study|Lost to Follow-up|20|||
30908554|NCT01606228|58943275|FG000|Overall Study|Withdrawal by Subject|3|||
30908555|NCT01606228|58943275|FG000|Overall Study|Non-compliant|3|||
30908556|NCT01606228|58943275|FG000|Overall Study|Lack of Efficacy|2|||
30908557|NCT01606228|58943275|FG000|Overall Study|Adverse Event|1|||
30908558|NCT01706536|58943284|FG000|Overall Study|Withdrawal by Subject|1|||
30908559|NCT01706536|58943285|FG001|Overall Study|Withdrawal by Subject|0|||
30806001|NCT01656434|58823301|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
30806002|NCT01656434|58823302|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
30806003|NCT01656434|58823301|FG000|Overall Study|Non-compliance with protocol|39|||
30806004|NCT01656434|58823302|FG001|Overall Study|Non-compliance with protocol|15|||
30806005|NCT01656434|58823301|FG000|Overall Study|Participant moved|40|||
30806006|NCT01656434|58823302|FG001|Overall Study|Participant moved|12|||
30806007|NCT01656434|58823301|FG000|Overall Study|Participant withdrew consent|28|||
30806008|NCT01656434|58823302|FG001|Overall Study|Participant withdrew consent|9|||
30806009|NCT01656434|58823301|FG000|Overall Study|Withdrawal by Subject|64|||
30806010|NCT01656434|58823302|FG001|Overall Study|Withdrawal by Subject|7|||
30806011|NCT02931396|58823310|FG000|Overall Study|Lost to Follow-up|3|||
30806012|NCT02931396|58823311|FG001|Overall Study|Lost to Follow-up|0|||
30806013|NCT02931396|58823310|FG000|Overall Study|Withdrawal by Subject|2|||
30806014|NCT02931396|58823311|FG001|Overall Study|Withdrawal by Subject|0|||
30806015|NCT03037580|58823319|FG000|Overall Study|Withdrawal by Subject|3|||
30806016|NCT03037580|58823320|FG001|Overall Study|Withdrawal by Subject|0|||
30806017|NCT03037580|58823319|FG000|Overall Study|Adverse Event|1|||
30806018|NCT03037580|58823320|FG001|Overall Study|Adverse Event|0|||
30806019|NCT03037580|58823319|FG000|Overall Study|Study Terminated by Sponsor|12|||
30806020|NCT03037580|58823320|FG001|Overall Study|Study Terminated by Sponsor|15|||
30806021|NCT03037580|58823319|FG000|Overall Study|Death|0|||
30806022|NCT03037580|58823320|FG001|Overall Study|Death|1|||
30806023|NCT01755195|58823326|FG000|Overall Study|Participant noncompliance|2|||
30806024|NCT01755195|58823326|FG000|Overall Study|Switched to alternative treatment|4|||
30806025|NCT01755195|58823326|FG000|Overall Study|Withdrawal by Subject|1|||
30806026|NCT01755195|58823326|FG000|Overall Study|Participant refused to start treatment|1|||
30806027|NCT01755195|58823326|FG000|Overall Study|Participant has been consented for another trial|1|||
30806028|NCT01755195|58823326|FG000|Overall Study|Refused further treatment|3|||
30806029|NCT01755195|58823326|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
30806030|NCT00897104|58823333|FG000|Overall Study|Lost to Follow-up|12|||
30806031|NCT00897104|58823334|FG001|Overall Study|Lost to Follow-up|17|||
30806032|NCT00897104|58823335|FG002|Overall Study|Lost to Follow-up|2|||
30806033|NCT00897104|58823333|FG000|Overall Study|Pregnancy|0|||
30806034|NCT00897104|58823334|FG001|Overall Study|Pregnancy|1|||
30806035|NCT00897104|58823335|FG002|Overall Study|Pregnancy|0|||
30806036|NCT00897104|58823333|FG000|Overall Study|Protocol Violation|0|||
30806037|NCT00897104|58823334|FG001|Overall Study|Protocol Violation|1|||
30908560|NCT01706536|58943286|FG002|Overall Study|Withdrawal by Subject|1|||
30806038|NCT00897104|58823335|FG002|Overall Study|Protocol Violation|0|||
30806039|NCT00897104|58823333|FG000|Overall Study|Withdrawal by Subject|23|||
30806040|NCT00897104|58823334|FG001|Overall Study|Withdrawal by Subject|27|||
30806041|NCT00897104|58823335|FG002|Overall Study|Withdrawal by Subject|3|||
30908561|NCT01706536|58943287|FG003|Overall Study|Withdrawal by Subject|0|||
30806042|NCT00897104|58823333|FG000|Overall Study|Abnormal Prestudy Labs|2|||
30806043|NCT00897104|58823334|FG001|Overall Study|Abnormal Prestudy Labs|0|||
30806044|NCT00897104|58823335|FG002|Overall Study|Abnormal Prestudy Labs|0|||
30806045|NCT00897104|58823333|FG000|Overall Study|Abnormal Baseline ECG|2|||
30806046|NCT00897104|58823334|FG001|Overall Study|Abnormal Baseline ECG|2|||
30806047|NCT00897104|58823335|FG002|Overall Study|Abnormal Baseline ECG|0|||
30806048|NCT00897104|58823333|FG000|Overall Study|Need for Concom. Med.|0|||
30806049|NCT00897104|58823334|FG001|Overall Study|Need for Concom. Med.|1|||
30806050|NCT00897104|58823335|FG002|Overall Study|Need for Concom. Med.|1|||
30806051|NCT00897104|58823333|FG000|Overall Study|Lack of Migraine Attack|20|||
30806052|NCT00897104|58823334|FG001|Overall Study|Lack of Migraine Attack|22|||
30806053|NCT00897104|58823335|FG002|Overall Study|Lack of Migraine Attack|1|||
30806054|NCT00897104|58823333|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
30806055|NCT00897104|58823334|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
30806056|NCT00897104|58823335|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
30806057|NCT00897104|58823333|FG000|Overall Study|Other|3|||
30806058|NCT00897104|58823334|FG001|Overall Study|Other|0|||
30806059|NCT00897104|58823335|FG002|Overall Study|Other|0|||
30806060|NCT00897104|58823333|FG000|Overall Study|Protocol Violation|1|||
30806061|NCT00897104|58823334|FG001|Overall Study|Protocol Violation|0|||
30806062|NCT00897104|58823335|FG002|Overall Study|Protocol Violation|0|||
30806063|NCT00897104|58823333|FG000|Overall Study|Withdrawal by Subject|0|||
30806064|NCT00897104|58823334|FG001|Overall Study|Withdrawal by Subject|0|||
30806065|NCT00897104|58823335|FG002|Overall Study|Withdrawal by Subject|1|||
30806066|NCT01339689|58823345|FG000|Overall Study|Adverse Event|1|||
30806067|NCT01339689|58823346|FG001|Overall Study|Adverse Event|2|||
30806068|NCT01339689|58823345|FG000|Overall Study|Lost to Follow-up|9|||
30806069|NCT01339689|58823346|FG001|Overall Study|Lost to Follow-up|3|||
30806070|NCT01339689|58823345|FG000|Overall Study|Withdrawal by Subject|3|||
30806071|NCT01339689|58823346|FG001|Overall Study|Withdrawal by Subject|0|||
30806072|NCT01339689|58823345|FG000|Overall Study|Noncompliance|1|||
30806073|NCT01339689|58823346|FG001|Overall Study|Noncompliance|0|||
30806074|NCT01339689|58823345|FG000|Overall Study|Relocated out of area|0|||
30806075|NCT01339689|58823346|FG001|Overall Study|Relocated out of area|1|||
30806076|NCT01339689|58823345|FG000|Overall Study|Other|2|||
30806077|NCT01339689|58823346|FG001|Overall Study|Other|2|||
30806078|NCT01339689|58823345|FG000|Overall Study|multiple reasons|1|||
30806079|NCT01339689|58823346|FG001|Overall Study|multiple reasons|1|||
30806080|NCT03038126|58823354|FG000|Overall Study|Death|1|||
30806081|NCT03038126|58823355|FG001|Overall Study|Death|1|||
30806082|NCT03038126|58823354|FG000|Overall Study|Withdrawal by Subject|5|||
30806083|NCT03038126|58823355|FG001|Overall Study|Withdrawal by Subject|0|||
30806084|NCT03038126|58823354|FG000|Overall Study|Lost to Follow-up|0|||
30806085|NCT03038126|58823355|FG001|Overall Study|Lost to Follow-up|1|||
30806086|NCT03038126|58823354|FG000|Overall Study|Long Term Hospitalization|2|||
30806087|NCT03038126|58823355|FG001|Overall Study|Long Term Hospitalization|0|||
30806088|NCT03038126|58823354|FG000|Overall Study|Too Ill to Participate|1|||
30806089|NCT03038126|58823355|FG001|Overall Study|Too Ill to Participate|2|||
30806090|NCT00696878|58823373|FG000|Overall Study|Adverse Event|8|||
30806091|NCT00696878|58823373|FG000|Overall Study|Withdrawal by Subject|87|||
30806092|NCT00696878|58823373|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
30806093|NCT00696878|58823373|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
30806094|NCT00696878|58823373|FG000|Overall Study|Trial stopped|32|||
30806095|NCT00696878|58823373|FG000|Overall Study|Other reason (not specified)|55|||
30806096|NCT00696800|58823379|FG000|Overall Study|Adverse Event|16|||
30806097|NCT00696800|58823380|FG001|Overall Study|Adverse Event|3|||
30806098|NCT00696800|58823379|FG000|Overall Study|Insufficient compliance with medication|2|||
30806099|NCT00696800|58823380|FG001|Overall Study|Insufficient compliance with medication|1|||
30806100|NCT00696800|58823379|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
30806101|NCT00696800|58823380|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
30806102|NCT00696800|58823379|FG000|Overall Study|Insufficient ovarian response|4|||
30806103|NCT00696800|58823380|FG001|Overall Study|Insufficient ovarian response|1|||
30806104|NCT00696800|58823379|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
30806105|NCT00696800|58823380|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
30806106|NCT00696800|58823379|FG000|Overall Study|Too high ovarian response|6|||
30806107|NCT00696800|58823380|FG001|Overall Study|Too high ovarian response|1|||
30806108|NCT00696800|58823379|FG000|Overall Study|No/too few/bad quality oocytes|4|||
30806109|NCT00696800|58823380|FG001|Overall Study|No/too few/bad quality oocytes|3|||
30806110|NCT00696800|58823379|FG000|Overall Study|No/abnormal fertilization|11|||
30806111|NCT00696800|58823380|FG001|Overall Study|No/abnormal fertilization|13|||
30806112|NCT00696800|58823379|FG000|Overall Study|No/too few/bad quality embryos|24|||
30806113|NCT00696800|58823380|FG001|Overall Study|No/too few/bad quality embryos|18|||
30806114|NCT00696800|58823379|FG000|Overall Study|Other Reasons|5|||
30806115|NCT00696800|58823380|FG001|Overall Study|Other Reasons|3|||
30806116|NCT00696800|58823379|FG000|Overall Study|Not treated|1|||
30806117|NCT00696800|58823380|FG001|Overall Study|Not treated|2|||
30806118|NCT00289874|58823388|FG000|Overall Study|Adverse Event|1|||
30806119|NCT00289874|58823389|FG001|Overall Study|Adverse Event|5|||
30806120|NCT00289874|58823388|FG000|Overall Study|Lost to Follow-up|1|||
30806121|NCT00289874|58823389|FG001|Overall Study|Lost to Follow-up|1|||
30806122|NCT00289874|58823388|FG000|Overall Study|Protocol Violation|3|||
30806123|NCT00289874|58823389|FG001|Overall Study|Protocol Violation|2|||
30806124|NCT00289874|58823388|FG000|Overall Study|Did not meet eligibility|1|||
30806125|NCT00289874|58823389|FG001|Overall Study|Did not meet eligibility|0|||
30806126|NCT00245570|58823395|FG000|Washout Between Periods III and IV|Adverse Event|0|||
30806127|NCT00245570|58823396|FG001|Washout Between Periods III and IV|Adverse Event|1|||
30806128|NCT00245570|58823397|FG002|Washout Between Periods III and IV|Adverse Event|0|||
30806129|NCT00245570|58823398|FG003|Washout Between Periods III and IV|Adverse Event|0|||
30806130|NCT00245570|58823399|FG004|Washout Between Periods III and IV|Adverse Event|0|||
30806131|NCT00245570|58823400|FG005|Washout Between Periods III and IV|Adverse Event|0|||
30806132|NCT03512210|58823428|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
30806133|NCT03512210|58823428|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
30806134|NCT03512210|58823428|FG000|Step 2:Post-MINMON|Death|2|||
30806135|NCT03512210|58823428|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
30806136|NCT03512210|58823428|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
30806137|NCT00383721|58823437|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
30806138|NCT00383721|58823438|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
30806139|NCT00383721|58823439|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
30806140|NCT00383721|58823440|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
30806141|NCT00383721|58823441|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
30806142|NCT00383721|58823437|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
30806143|NCT00383721|58823438|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
30806144|NCT00383721|58823439|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
30806145|NCT00383721|58823440|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
30806146|NCT00383721|58823441|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
30806147|NCT00383721|58823437|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
30806148|NCT00383721|58823438|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
30806149|NCT00383721|58823439|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
30806150|NCT00383721|58823440|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
30806151|NCT00383721|58823441|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
30806152|NCT00383721|58823437|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
30806153|NCT00383721|58823438|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
30806154|NCT00383721|58823439|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
30806155|NCT00383721|58823440|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
30806156|NCT00383721|58823441|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
30806157|NCT00383721|58823437|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
30806158|NCT00383721|58823438|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
30806159|NCT00383721|58823439|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
30806160|NCT00383721|58823440|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
30806161|NCT00383721|58823441|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
30806162|NCT00383721|58823437|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
30806163|NCT00383721|58823438|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
30806164|NCT00383721|58823439|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
30748712|NCT00035932|58758842|FG000|Overall Study|Adverse Event|10|||
30748713|NCT00035932|58758843|FG001|Overall Study|Adverse Event|9|||
30748714|NCT00035932|58758844|FG002|Overall Study|Adverse Event|9|||
30748715|NCT00035932|58758842|FG000|Overall Study|Death|0|||
30748716|NCT00035932|58758843|FG001|Overall Study|Death|0|||
30748717|NCT00035932|58758844|FG002|Overall Study|Death|1|||
30748718|NCT00035932|58758842|FG000|Overall Study|Disease Progression / Relapse|1|||
30748719|NCT00035932|58758843|FG001|Overall Study|Disease Progression / Relapse|1|||
30748720|NCT00035932|58758844|FG002|Overall Study|Disease Progression / Relapse|0|||
30748721|NCT00035932|58758842|FG000|Overall Study|Lost to Follow-up|4|||
30748722|NCT00035932|58758843|FG001|Overall Study|Lost to Follow-up|4|||
30748723|NCT00035932|58758844|FG002|Overall Study|Lost to Follow-up|3|||
30748724|NCT00035932|58758842|FG000|Overall Study|Noncompliance|6|||
30748725|NCT00035932|58758843|FG001|Overall Study|Noncompliance|7|||
30748726|NCT00035932|58758844|FG002|Overall Study|Noncompliance|6|||
30748727|NCT00035932|58758842|FG000|Overall Study|Protocol Violation While on Study|0|||
30748728|NCT00035932|58758843|FG001|Overall Study|Protocol Violation While on Study|1|||
30748729|NCT00035932|58758844|FG002|Overall Study|Protocol Violation While on Study|2|||
30748730|NCT00035932|58758842|FG000|Overall Study|Withdrawal by Subject|1|||
30806165|NCT00383721|58823440|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
30806166|NCT00383721|58823441|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
30806167|NCT00383721|58823437|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
30806168|NCT00383721|58823438|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
30806169|NCT00383721|58823439|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
30806170|NCT00383721|58823440|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
30806171|NCT00383721|58823441|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
30806172|NCT00383721|58823437|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
30806173|NCT00383721|58823438|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
30806174|NCT00383721|58823439|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
30806175|NCT00383721|58823440|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
30806176|NCT00383721|58823441|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
30806177|NCT00383721|58823437|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
30806178|NCT00383721|58823438|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
30806179|NCT00383721|58823439|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
30806180|NCT00383721|58823440|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
30806181|NCT00383721|58823441|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
30806182|NCT00383721|58823437|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
30806183|NCT00383721|58823438|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
30806184|NCT00383721|58823439|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
30806185|NCT00383721|58823440|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
30806186|NCT00383721|58823441|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
30806187|NCT00383721|58823437|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
30806188|NCT00383721|58823438|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
30806189|NCT00383721|58823439|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
30806190|NCT00383721|58823440|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
30806191|NCT00383721|58823441|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
30806192|NCT00383721|58823437|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
30806193|NCT00383721|58823438|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
30806194|NCT00383721|58823439|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
30806195|NCT00383721|58823440|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
30806196|NCT00383721|58823441|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
30806197|NCT00383721|58823437|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
30806198|NCT00383721|58823438|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
30806199|NCT00383721|58823439|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
30806200|NCT00383721|58823440|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
30806201|NCT00383721|58823441|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
30806202|NCT00383721|58823437|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
30806203|NCT00383721|58823438|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
30806204|NCT00383721|58823439|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
30806205|NCT00383721|58823440|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
30806206|NCT00383721|58823441|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
30806207|NCT00383721|58823437|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
30806208|NCT00383721|58823438|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
30806209|NCT00383721|58823439|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
30806210|NCT00383721|58823440|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
30806211|NCT00383721|58823441|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
30806212|NCT00383721|58823437|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
30806213|NCT00383721|58823438|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
30806214|NCT00383721|58823439|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
30806215|NCT00383721|58823440|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
30806216|NCT00383721|58823441|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
30806217|NCT00383721|58823437|FG000|26-Week Treatment Safety Extension|Administrative|1|||
30806218|NCT00383721|58823438|FG001|26-Week Treatment Safety Extension|Administrative|2|||
30806219|NCT00383721|58823439|FG002|26-Week Treatment Safety Extension|Administrative|3|||
30806220|NCT00383721|58823440|FG003|26-Week Treatment Safety Extension|Administrative|1|||
30806221|NCT00383721|58823441|FG004|26-Week Treatment Safety Extension|Administrative|0|||
30806222|NCT03035942|58823469|FG000|Overall Study|Adverse Event|8|||
30806223|NCT03035942|58823470|FG001|Overall Study|Adverse Event|4|||
30806224|NCT03035942|58823471|FG002|Overall Study|Adverse Event|5|||
30806225|NCT02616146|58823483|FG000|Overall Study|Adverse Event|64|||
30806226|NCT02616146|58823484|FG001|Overall Study|Adverse Event|24|||
30908562|NCT01706536|58943288|FG004|Overall Study|Withdrawal by Subject|0|||
30908563|NCT01706536|58943284|FG000|Overall Study|Adverse Event|2|||
30908564|NCT01706536|58943285|FG001|Overall Study|Adverse Event|3|||
30908565|NCT01706536|58943286|FG002|Overall Study|Adverse Event|4|||
30748731|NCT00035932|58758843|FG001|Overall Study|Withdrawal by Subject|5|||
30748732|NCT00035932|58758844|FG002|Overall Study|Withdrawal by Subject|0|||
30748733|NCT00035932|58758842|FG000|Overall Study|Study Termination by Sponsor|1|||
30748734|NCT00035932|58758843|FG001|Overall Study|Study Termination by Sponsor|0|||
30748735|NCT00035932|58758844|FG002|Overall Study|Study Termination by Sponsor|0|||
30748736|NCT00035932|58758842|FG000|Overall Study|Lack of Efficacy|33|||
30748737|NCT00035932|58758843|FG001|Overall Study|Lack of Efficacy|33|||
30748738|NCT00035932|58758844|FG002|Overall Study|Lack of Efficacy|28|||
30748739|NCT00022516|58758859|FG000|Overall Study|Adverse Event|0|||
30748740|NCT00022516|58758860|FG001|Overall Study|Adverse Event|59|||
30748741|NCT00022516|58758859|FG000|Overall Study|Lack of Efficacy|0|||
30748742|NCT00022516|58758860|FG001|Overall Study|Lack of Efficacy|27|||
30748743|NCT00022516|58758859|FG000|Overall Study|Physician Decision|0|||
30748744|NCT00022516|58758860|FG001|Overall Study|Physician Decision|1|||
30748745|NCT00022516|58758859|FG000|Overall Study|Protocol Violation|1|||
30748746|NCT00022516|58758860|FG001|Overall Study|Protocol Violation|3|||
30748747|NCT00022516|58758859|FG000|Overall Study|Withdrawal by Subject|2|||
30748748|NCT00022516|58758860|FG001|Overall Study|Withdrawal by Subject|113|||
30748749|NCT00022516|58758859|FG000|Overall Study|Incomplete documentation|0|||
30748750|NCT00022516|58758860|FG001|Overall Study|Incomplete documentation|27|||
30748751|NCT00033514|58758868|FG000|Overall Study|Lost to Follow-up|1|||
30748752|NCT00033514|58758869|FG001|Overall Study|Lost to Follow-up|1|||
30748753|NCT00033514|58758868|FG000|Overall Study|Withdrawal by Subject|0|||
30748754|NCT00033514|58758869|FG001|Overall Study|Withdrawal by Subject|3|||
30748755|NCT00006916|58758876|FG000|Overall Study|Device not inserted|4|||
30748756|NCT00006916|58758876|FG000|Overall Study|Complication of device insertion|1|||
30748757|NCT00454649|58758890|FG000|Overall Study|Lack of Efficacy|2|||
30748758|NCT00454649|58758891|FG001|Overall Study|Lack of Efficacy|2|||
30748759|NCT00454649|58758892|FG002|Overall Study|Lack of Efficacy|10|||
30748760|NCT00454649|58758893|FG003|Overall Study|Lack of Efficacy|3|||
30748761|NCT00454649|58758894|FG004|Overall Study|Lack of Efficacy|0|||
30748762|NCT00454649|58758895|FG005|Overall Study|Lack of Efficacy|4|||
30748763|NCT00454649|58758896|FG006|Overall Study|Lack of Efficacy|5|||
30748764|NCT00454649|58758897|FG007|Overall Study|Lack of Efficacy|13|||
30748765|NCT00454649|58758898|FG008|Overall Study|Lack of Efficacy|10|||
30748766|NCT00454649|58758899|FG009|Overall Study|Lack of Efficacy|2|||
30748767|NCT00454649|58758890|FG000|Overall Study|Adverse Event|0|||
30748768|NCT00454649|58758891|FG001|Overall Study|Adverse Event|1|||
30748769|NCT00454649|58758892|FG002|Overall Study|Adverse Event|3|||
30748770|NCT00454649|58758893|FG003|Overall Study|Adverse Event|0|||
30748771|NCT00454649|58758894|FG004|Overall Study|Adverse Event|1|||
30748772|NCT00454649|58758895|FG005|Overall Study|Adverse Event|2|||
30748773|NCT00454649|58758896|FG006|Overall Study|Adverse Event|3|||
30748774|NCT00454649|58758897|FG007|Overall Study|Adverse Event|4|||
30748775|NCT00454649|58758898|FG008|Overall Study|Adverse Event|6|||
30908566|NCT01706536|58943287|FG003|Overall Study|Adverse Event|3|||
30908567|NCT01706536|58943288|FG004|Overall Study|Adverse Event|2|||
30908568|NCT01706536|58943284|FG000|Overall Study|Lack of Efficacy|1|||
30908569|NCT01706536|58943285|FG001|Overall Study|Lack of Efficacy|0|||
30908570|NCT01706536|58943286|FG002|Overall Study|Lack of Efficacy|0|||
30908571|NCT01706536|58943287|FG003|Overall Study|Lack of Efficacy|1|||
30908572|NCT01706536|58943288|FG004|Overall Study|Lack of Efficacy|0|||
30908573|NCT01706536|58943284|FG000|Overall Study|non compliance|0|||
30908574|NCT01706536|58943285|FG001|Overall Study|non compliance|1|||
30908575|NCT01706536|58943286|FG002|Overall Study|non compliance|0|||
30908576|NCT01706536|58943287|FG003|Overall Study|non compliance|0|||
30908577|NCT01706536|58943288|FG004|Overall Study|non compliance|0|||
30908578|NCT02269943|58943303|FG000|Treatment Period|Death|0|||
30908579|NCT02269943|58943304|FG001|Treatment Period|Death|1|||
30806227|NCT02616146|58823483|FG000|Overall Study|Lost to Follow-up|23|||
30806228|NCT02616146|58823484|FG001|Overall Study|Lost to Follow-up|13|||
30806229|NCT02616146|58823483|FG000|Overall Study|Non-compliance with study protocol|2|||
30806230|NCT02616146|58823484|FG001|Overall Study|Non-compliance with study protocol|0|||
30806231|NCT02616146|58823483|FG000|Overall Study|Non-compliance with study drug|4|||
30806232|NCT02616146|58823484|FG001|Overall Study|Non-compliance with study drug|2|||
30806233|NCT02616146|58823483|FG000|Overall Study|Pregnancy|2|||
30806234|NCT02616146|58823484|FG001|Overall Study|Pregnancy|2|||
30806235|NCT02616146|58823483|FG000|Overall Study|Pregnancy wish|3|||
30806236|NCT02616146|58823484|FG001|Overall Study|Pregnancy wish|0|||
30806237|NCT02616146|58823483|FG000|Overall Study|Protocol Violation|6|||
30806238|NCT02616146|58823484|FG001|Overall Study|Protocol Violation|3|||
30806239|NCT02616146|58823483|FG000|Overall Study|Study terminated by sponsor|1372|||
30806240|NCT02616146|58823484|FG001|Overall Study|Study terminated by sponsor|432|||
30806241|NCT02616146|58823483|FG000|Overall Study|Participant moved|4|||
30806242|NCT02616146|58823484|FG001|Overall Study|Participant moved|3|||
30806243|NCT02616146|58823483|FG000|Overall Study|Withdrawal by Subject|30|||
30806244|NCT02616146|58823484|FG001|Overall Study|Withdrawal by Subject|24|||
30806245|NCT02616146|58823483|FG000|Overall Study|Physician Decision|2|||
30806246|NCT02616146|58823484|FG001|Overall Study|Physician Decision|1|||
30806247|NCT04850313|58823492|FG000|Overall Study|Withdrawal by Subject|0|||
30806248|NCT04850313|58823493|FG001|Overall Study|Withdrawal by Subject|1|||
30806249|NCT03035864|58823501|FG000|Treatment Period|Adverse Event|1|||
30806250|NCT03035864|58823502|FG001|Treatment Period|Adverse Event|0|||
30806251|NCT03035864|58823501|FG000|Treatment Period|Other|3|||
30806252|NCT03035864|58823502|FG001|Treatment Period|Other|1|||
30806253|NCT03035864|58823501|FG000|Follow-up Period|Adverse Event|1|||
30806254|NCT03035864|58823502|FG001|Follow-up Period|Adverse Event|0|||
30806255|NCT03035864|58823501|FG000|Follow-up Period|Lost to Follow-up|6|||
30806256|NCT03035864|58823502|FG001|Follow-up Period|Lost to Follow-up|2|||
30806257|NCT03035864|58823501|FG000|Follow-up Period|Physician Decision|1|||
30806258|NCT03035864|58823502|FG001|Follow-up Period|Physician Decision|0|||
30806259|NCT03035864|58823501|FG000|Follow-up Period|Other|3|||
30806260|NCT03035864|58823502|FG001|Follow-up Period|Other|2|||
30806261|NCT02885181|58823520|FG000|Overall Study|Investigator's Discretion|0|||
30806262|NCT02885181|58823521|FG001|Overall Study|Investigator's Discretion|1|||
30806263|NCT02885181|58823522|FG002|Overall Study|Investigator's Discretion|0|||
30806264|NCT02885181|58823523|FG003|Overall Study|Investigator's Discretion|1|||
30748776|NCT00454649|58758899|FG009|Overall Study|Adverse Event|2|||
30748777|NCT00454649|58758890|FG000|Overall Study|Lost to Follow-up|0|||
30748778|NCT00454649|58758891|FG001|Overall Study|Lost to Follow-up|0|||
30806265|NCT02885181|58823520|FG000|Overall Study|Adverse Event|0|||
30806266|NCT02885181|58823521|FG001|Overall Study|Adverse Event|0|||
30748779|NCT00454649|58758892|FG002|Overall Study|Lost to Follow-up|1|||
30748780|NCT00454649|58758893|FG003|Overall Study|Lost to Follow-up|0|||
30748781|NCT00454649|58758894|FG004|Overall Study|Lost to Follow-up|0|||
30748782|NCT00454649|58758895|FG005|Overall Study|Lost to Follow-up|0|||
30748783|NCT00454649|58758896|FG006|Overall Study|Lost to Follow-up|1|||
30748784|NCT00454649|58758897|FG007|Overall Study|Lost to Follow-up|0|||
30748785|NCT00454649|58758898|FG008|Overall Study|Lost to Follow-up|0|||
30806267|NCT02885181|58823522|FG002|Overall Study|Adverse Event|0|||
30806268|NCT02885181|58823523|FG003|Overall Study|Adverse Event|1|||
30806269|NCT02885181|58823520|FG000|Overall Study|Withdrawal by Subject|0|||
30806270|NCT02885181|58823521|FG001|Overall Study|Withdrawal by Subject|0|||
30806271|NCT02885181|58823522|FG002|Overall Study|Withdrawal by Subject|0|||
30908580|NCT02269943|58943303|FG000|Treatment Period|Adverse Event|1|||
30806272|NCT02885181|58823523|FG003|Overall Study|Withdrawal by Subject|1|||
30806273|NCT02884089|58823537|FG000|Period 1|Dosing error|2|||
30806274|NCT02884089|58823538|FG001|Period 1|Dosing error|2|||
30806275|NCT02884089|58823539|FG002|Period 1|Dosing error|0|||
30806276|NCT02884089|58823540|FG003|Period 1|Dosing error|0|||
30806277|NCT02884089|58823537|FG000|Washout Period 1|Lost to Follow-up|0|||
30806278|NCT02884089|58823538|FG001|Washout Period 1|Lost to Follow-up|1|||
30806279|NCT02884089|58823539|FG002|Washout Period 1|Lost to Follow-up|0|||
30806280|NCT02884089|58823540|FG003|Washout Period 1|Lost to Follow-up|1|||
30806281|NCT02884089|58823537|FG000|Washout Period 1|Withdrawal by Subject|0|||
30806282|NCT02884089|58823538|FG001|Washout Period 1|Withdrawal by Subject|1|||
30806283|NCT02884089|58823539|FG002|Washout Period 1|Withdrawal by Subject|0|||
30806284|NCT02884089|58823540|FG003|Washout Period 1|Withdrawal by Subject|0|||
30806285|NCT02884089|58823537|FG000|Period 2|Adverse Event|1|||
30806286|NCT02884089|58823538|FG001|Period 2|Adverse Event|0|||
30806287|NCT02884089|58823539|FG002|Period 2|Adverse Event|0|||
30806288|NCT02884089|58823540|FG003|Period 2|Adverse Event|0|||
30806289|NCT02884089|58823537|FG000|Period 3|Withdrawal by Subject|0|||
30806290|NCT02884089|58823538|FG001|Period 3|Withdrawal by Subject|0|||
30806291|NCT02884089|58823539|FG002|Period 3|Withdrawal by Subject|1|||
30806292|NCT02884089|58823540|FG003|Period 3|Withdrawal by Subject|0|||
30806293|NCT02884089|58823537|FG000|Washout Period 3|Withdrawal by Subject|0|||
30806294|NCT02884089|58823538|FG001|Washout Period 3|Withdrawal by Subject|0|||
30806295|NCT02884089|58823539|FG002|Washout Period 3|Withdrawal by Subject|1|||
30806296|NCT02884089|58823540|FG003|Washout Period 3|Withdrawal by Subject|0|||
30806297|NCT02884089|58823537|FG000|Washout Period 3|Lost to Follow-up|0|||
30806298|NCT02884089|58823538|FG001|Washout Period 3|Lost to Follow-up|0|||
30806299|NCT02884089|58823539|FG002|Washout Period 3|Lost to Follow-up|0|||
30748786|NCT00454649|58758899|FG009|Overall Study|Lost to Follow-up|0|||
30748787|NCT00454649|58758890|FG000|Overall Study|Other|1|||
30748788|NCT00454649|58758891|FG001|Overall Study|Other|1|||
30748789|NCT00454649|58758892|FG002|Overall Study|Other|5|||
30748790|NCT00454649|58758893|FG003|Overall Study|Other|3|||
30748791|NCT00454649|58758894|FG004|Overall Study|Other|0|||
30748792|NCT00454649|58758895|FG005|Overall Study|Other|0|||
30748793|NCT00454649|58758896|FG006|Overall Study|Other|0|||
30748794|NCT00454649|58758897|FG007|Overall Study|Other|0|||
30748795|NCT00454649|58758898|FG008|Overall Study|Other|3|||
30748796|NCT00454649|58758899|FG009|Overall Study|Other|1|||
30748797|NCT00454649|58758890|FG000|Overall Study|Withdrawal by Subject|0|||
30748798|NCT00454649|58758891|FG001|Overall Study|Withdrawal by Subject|0|||
30748799|NCT00454649|58758892|FG002|Overall Study|Withdrawal by Subject|0|||
30748800|NCT00454649|58758893|FG003|Overall Study|Withdrawal by Subject|0|||
30748801|NCT00454649|58758894|FG004|Overall Study|Withdrawal by Subject|0|||
30748802|NCT00454649|58758895|FG005|Overall Study|Withdrawal by Subject|1|||
30748803|NCT00454649|58758896|FG006|Overall Study|Withdrawal by Subject|0|||
30748804|NCT00454649|58758897|FG007|Overall Study|Withdrawal by Subject|2|||
30748805|NCT00454649|58758898|FG008|Overall Study|Withdrawal by Subject|1|||
30748806|NCT00454649|58758899|FG009|Overall Study|Withdrawal by Subject|0|||
30748807|NCT00454571|58758942|FG000|Overall Study|Adverse Event|2|||
30748808|NCT00454571|58758943|FG001|Overall Study|Adverse Event|0|||
30748809|NCT00454571|58758942|FG000|Overall Study|Physician Decision|0|||
30748810|NCT00454571|58758943|FG001|Overall Study|Physician Decision|1|||
30748811|NCT00454571|58758942|FG000|Overall Study|Protocol Violation|1|||
30748812|NCT00454571|58758943|FG001|Overall Study|Protocol Violation|0|||
30748813|NCT00454571|58758942|FG000|Overall Study|Withdrawal by Subject|10|||
30748814|NCT00454571|58758943|FG001|Overall Study|Withdrawal by Subject|5|||
30748815|NCT03837743|58758949|FG000|Overall Study|Adverse Event|1|||
30748816|NCT03837743|58758949|FG000|Overall Study|Withdrawal by Subject|2|||
30748817|NCT03836729|58758957|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
30748818|NCT00443729|58758967|FG000|Overall Study|Never Treated|0|||
30748819|NCT00443729|58758968|FG001|Overall Study|Never Treated|1|||
30748820|NCT00443729|58758967|FG000|Overall Study|Lack of Efficacy|4|||
30748821|NCT00443729|58758968|FG001|Overall Study|Lack of Efficacy|2|||
30748822|NCT00443729|58758967|FG000|Overall Study|Lost to Follow-up|0|||
30748823|NCT00443729|58758968|FG001|Overall Study|Lost to Follow-up|1|||
30806300|NCT02884089|58823540|FG003|Washout Period 3|Lost to Follow-up|1|||
30806301|NCT02884089|58823537|FG000|Period 4|Withdrawal by Subject|0|||
30806302|NCT02884089|58823538|FG001|Period 4|Withdrawal by Subject|1|||
30806303|NCT02884089|58823539|FG002|Period 4|Withdrawal by Subject|0|||
30806304|NCT02884089|58823540|FG003|Period 4|Withdrawal by Subject|0|||
30806305|NCT02884089|58823537|FG000|Period 4|Lost to Follow-up|1|||
30806306|NCT02884089|58823538|FG001|Period 4|Lost to Follow-up|0|||
30806307|NCT02884089|58823539|FG002|Period 4|Lost to Follow-up|0|||
30806308|NCT02884089|58823540|FG003|Period 4|Lost to Follow-up|0|||
30806309|NCT02884089|58823537|FG000|Follow-up Visit|Withdrawal by Subject|1|||
30806310|NCT02884089|58823538|FG001|Follow-up Visit|Withdrawal by Subject|0|||
30806311|NCT02884089|58823539|FG002|Follow-up Visit|Withdrawal by Subject|0|||
30806312|NCT02884089|58823540|FG003|Follow-up Visit|Withdrawal by Subject|1|||
30806313|NCT02809677|58823550|FG000|Overall Study|Withdrawal by Subject|8|||
30806314|NCT02881047|58823555|FG000|Overall Study|Adverse Event|1|||
30806315|NCT02881047|58823555|FG000|Overall Study|Withdrawal by Subject|1|||
30806316|NCT03157089|58823561|FG000|Overall Study|Treated only with pembrolizumab|1|||
30806317|NCT03157089|58823562|FG001|Overall Study|Treated only with pembrolizumab|0|||
30806318|NCT03157089|58823561|FG000|Overall Study|Adverse Event|5|||
30806319|NCT03157089|58823562|FG001|Overall Study|Adverse Event|4|||
30806320|NCT03157089|58823561|FG000|Overall Study|Progressive disease|6|||
30806321|NCT03157089|58823562|FG001|Overall Study|Progressive disease|8|||
30806322|NCT03158727|58823571|FG000|Overall Study|Withdrawal by Subject|2|||
30806323|NCT03158727|58823572|FG001|Overall Study|Withdrawal by Subject|6|||
30806324|NCT03158727|58823571|FG000|Overall Study|Death|11|||
30806325|NCT03158727|58823572|FG001|Overall Study|Death|12|||
30806326|NCT03158727|58823571|FG000|Overall Study|Lost to Follow-up|1|||
30806327|NCT03158727|58823572|FG001|Overall Study|Lost to Follow-up|0|||
30806328|NCT03158727|58823571|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
30806329|NCT03158727|58823572|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
30806330|NCT03158727|58823571|FG000|Overall Study|Visit 11 not done by mistake|0|||
30806331|NCT03158727|58823572|FG001|Overall Study|Visit 11 not done by mistake|1|||
30806332|NCT03158727|58823571|FG000|Overall Study|Enrolled, not treated|1|||
30806333|NCT03158727|58823572|FG001|Overall Study|Enrolled, not treated|0|||
30806334|NCT00089895|58823580|FG000|Overall Study|Consent Withdrawn|11|||
30806335|NCT00089895|58823581|FG001|Overall Study|Consent Withdrawn|14|||
30806336|NCT00089895|58823580|FG000|Overall Study|Technical reason|7|||
30806337|NCT00089895|58823581|FG001|Overall Study|Technical reason|2|||
30806338|NCT00089895|58823580|FG000|Overall Study|Surgery|0|||
30806339|NCT00089895|58823581|FG001|Overall Study|Surgery|1|||
30806340|NCT00089895|58823580|FG000|Overall Study|Bleeding|0|||
30806341|NCT00089895|58823581|FG001|Overall Study|Bleeding|2|||
30806342|NCT00089895|58823580|FG000|Overall Study|Physician Decision|3|||
30806343|NCT00089895|58823581|FG001|Overall Study|Physician Decision|7|||
30806344|NCT00089895|58823580|FG000|Overall Study|Exclusion criteria met|6|||
30806345|NCT00089895|58823581|FG001|Overall Study|Exclusion criteria met|6|||
30806346|NCT00089895|58823580|FG000|Overall Study|Not otherwise specified|4|||
30806347|NCT00089895|58823581|FG001|Overall Study|Not otherwise specified|8|||
30806348|NCT00089895|58823580|FG000|Overall Study|Missing|4|||
30806349|NCT00089895|58823581|FG001|Overall Study|Missing|2|||
30806350|NCT02714218|58823590|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30806351|NCT02714218|58823591|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
30806352|NCT02714218|58823592|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30806353|NCT02714218|58823590|FG000|Pre-Treatment Period|Other reasons|0|||
30806354|NCT02714218|58823591|FG001|Pre-Treatment Period|Other reasons|1|||
30806355|NCT02714218|58823592|FG002|Pre-Treatment Period|Other reasons|0|||
30806356|NCT02714218|58823590|FG000|Treatment Period|Disease Progression|55|||
30806357|NCT02714218|58823591|FG001|Treatment Period|Disease Progression|52|||
30806358|NCT02714218|58823592|FG002|Treatment Period|Disease Progression|14|||
30806359|NCT02714218|58823590|FG000|Treatment Period|Study drug toxicity|46|||
30806360|NCT02714218|58823591|FG001|Treatment Period|Study drug toxicity|70|||
30806361|NCT02714218|58823592|FG002|Treatment Period|Study drug toxicity|6|||
30806362|NCT02714218|58823590|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
30806363|NCT02714218|58823591|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
30806364|NCT02714218|58823592|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
30806365|NCT02714218|58823590|FG000|Treatment Period|Request to discontinue treatment|1|||
30806366|NCT02714218|58823591|FG001|Treatment Period|Request to discontinue treatment|4|||
30806367|NCT02714218|58823592|FG002|Treatment Period|Request to discontinue treatment|1|||
30806368|NCT02714218|58823590|FG000|Treatment Period|Participant withdrew consent|2|||
30806369|NCT02714218|58823591|FG001|Treatment Period|Participant withdrew consent|2|||
30806370|NCT02714218|58823592|FG002|Treatment Period|Participant withdrew consent|0|||
30806371|NCT02714218|58823590|FG000|Treatment Period|Maximum clinical benefit|4|||
30806372|NCT02714218|58823591|FG001|Treatment Period|Maximum clinical benefit|2|||
30806373|NCT02714218|58823592|FG002|Treatment Period|Maximum clinical benefit|0|||
30806374|NCT02714218|58823590|FG000|Treatment Period|Administrative reason by sponsor|2|||
30806375|NCT02714218|58823591|FG001|Treatment Period|Administrative reason by sponsor|1|||
30806376|NCT02714218|58823592|FG002|Treatment Period|Administrative reason by sponsor|0|||
30806377|NCT02714218|58823590|FG000|Treatment Period|Other reasons|6|||
30806378|NCT02714218|58823591|FG001|Treatment Period|Other reasons|6|||
30806379|NCT02714218|58823592|FG002|Treatment Period|Other reasons|0|||
30806380|NCT02714218|58823590|FG000|Treatment Period|Completed treatment as per protocol|36|||
30806381|NCT02714218|58823591|FG001|Treatment Period|Completed treatment as per protocol|27|||
30806382|NCT02714218|58823592|FG002|Treatment Period|Completed treatment as per protocol|3|||
30806383|NCT02714218|58823590|FG000|Treatment Period|Not reported|9|||
30806384|NCT02714218|58823591|FG001|Treatment Period|Not reported|6|||
30806385|NCT02714218|58823592|FG002|Treatment Period|Not reported|0|||
30806386|NCT03154047|58823599|FG000|Overall Study|Death|1|||
30806387|NCT03154047|58823599|FG000|Overall Study|Study terminated by sponsor|76|||
30806388|NCT03154047|58823599|FG000|Overall Study|Withdrawal by Subject|3|||
30806389|NCT03156621|58823605|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
30806390|NCT03156621|58823606|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
30806391|NCT03156621|58823605|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
30806392|NCT03156621|58823606|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
30806393|NCT03156543|58823617|FG000|Overall Study|Withdrawal by Subject|1|||
30806394|NCT03156543|58823618|FG001|Overall Study|Withdrawal by Subject|0|||
30806395|NCT02713594|58823626|FG000|Overall Study|Withdrawal by Subject|32|||
30806396|NCT02713594|58823627|FG001|Overall Study|Withdrawal by Subject|22|||
30806397|NCT02713594|58823626|FG000|Overall Study|Lost to Follow-up|358|||
30806398|NCT02713594|58823627|FG001|Overall Study|Lost to Follow-up|374|||
30806399|NCT03152019|58823637|FG000|Overall Study|Adverse Event|0|||
30806400|NCT03152019|58823638|FG001|Overall Study|Adverse Event|1|||
30806401|NCT02714062|58823651|FG000|Overall Study|Adverse Event|0|||
30806402|NCT02714062|58823652|FG001|Overall Study|Adverse Event|0|||
30806403|NCT02714062|58823653|FG002|Overall Study|Adverse Event|2|||
30806404|NCT02714062|58823651|FG000|Overall Study|Withdrawal by Subject|1|||
30806405|NCT02714062|58823652|FG001|Overall Study|Withdrawal by Subject|0|||
30806406|NCT02714062|58823653|FG002|Overall Study|Withdrawal by Subject|1|||
30806407|NCT02714062|58823651|FG000|Overall Study|Protocol Violation|0|||
30806408|NCT02714062|58823652|FG001|Overall Study|Protocol Violation|1|||
30806409|NCT02714062|58823653|FG002|Overall Study|Protocol Violation|0|||
30806410|NCT03151395|58823663|FG000|Overall Study|Adverse Event|2|||
30806411|NCT03151395|58823663|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
30806412|NCT03151395|58823663|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
30806413|NCT03151395|58823663|FG000|Overall Study|Unspecified reason|4|||
30806414|NCT02713828|58823669|FG000|Overall Study|Death|2|||
30806415|NCT02713828|58823670|FG001|Overall Study|Death|0|||
30806416|NCT02713828|58823669|FG000|Overall Study|Withdrawal by Subject|1|||
30806417|NCT02713828|58823670|FG001|Overall Study|Withdrawal by Subject|0|||
30806418|NCT02713828|58823669|FG000|Overall Study|study terminated but patient allowed to|2|||
30806419|NCT02713828|58823670|FG001|Overall Study|study terminated but patient allowed to|0|||
30806420|NCT02876328|58823699|FG000|Overall Study|Death|2|||
30806421|NCT02876328|58823700|FG001|Overall Study|Death|1|||
30806422|NCT02876328|58823701|FG002|Overall Study|Death|3|||
30806423|NCT02876328|58823702|FG003|Overall Study|Death|0|||
30806424|NCT02876328|58823703|FG004|Overall Study|Death|0|||
30806425|NCT02876328|58823704|FG005|Overall Study|Death|0|||
30806426|NCT02876328|58823705|FG006|Overall Study|Death|1|||
30806427|NCT02876328|58823706|FG007|Overall Study|Death|3|||
30806428|NCT02876328|58823707|FG008|Overall Study|Death|0|||
30806429|NCT02876328|58823708|FG009|Overall Study|Death|1|||
30806430|NCT02876328|58823709|FG010|Overall Study|Death|1|||
30806431|NCT02876328|58823710|FG011|Overall Study|Death|0|||
30806432|NCT02876328|58823711|FG012|Overall Study|Death|0|||
30806433|NCT02876328|58823712|FG013|Overall Study|Death|0|||
30806434|NCT02876328|58823713|FG014|Overall Study|Death|0|||
30806435|NCT02876328|58823714|FG015|Overall Study|Death|0|||
30806436|NCT02876328|58823715|FG016|Overall Study|Death|1|||
30806437|NCT02876328|58823716|FG017|Overall Study|Death|1|||
30806438|NCT02876328|58823717|FG018|Overall Study|Death|0|||
30806439|NCT02876328|58823718|FG019|Overall Study|Death|0|||
30806440|NCT02876328|58823719|FG020|Overall Study|Death|0|||
30806441|NCT02876328|58823720|FG021|Overall Study|Death|1|||
30806442|NCT02876328|58823721|FG022|Overall Study|Death|0|||
30806443|NCT02876328|58823722|FG023|Overall Study|Death|0|||
30806444|NCT02876328|58823699|FG000|Overall Study|Withdrawal by Subject|0|||
30806445|NCT02876328|58823700|FG001|Overall Study|Withdrawal by Subject|2|||
30806446|NCT02876328|58823701|FG002|Overall Study|Withdrawal by Subject|3|||
30806447|NCT02876328|58823702|FG003|Overall Study|Withdrawal by Subject|3|||
30748824|NCT00443729|58758967|FG000|Overall Study|Physician Decision|2|||
30748825|NCT00443729|58758968|FG001|Overall Study|Physician Decision|1|||
30908581|NCT02269943|58943304|FG001|Treatment Period|Adverse Event|10|||
30908582|NCT02269943|58943303|FG000|Treatment Period|Progressive Disease|5|||
30908583|NCT02269943|58943304|FG001|Treatment Period|Progressive Disease|17|||
30908584|NCT02269943|58943303|FG000|Treatment Period|Symptomatic Deterioration|0|||
30908585|NCT02269943|58943304|FG001|Treatment Period|Symptomatic Deterioration|2|||
30908586|NCT02269943|58943303|FG000|Follow-Up Survival Period|Death|3|||
30908587|NCT02269943|58943304|FG001|Follow-Up Survival Period|Death|16|||
30908588|NCT02269943|58943303|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
30908589|NCT02269943|58943304|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
30908590|NCT02269943|58943303|FG000|Follow-Up Survival Period|Alive|2|||
30908591|NCT02269943|58943304|FG001|Follow-Up Survival Period|Alive|8|||
30908592|NCT01706458|58943312|FG000|Overall Study|Physician Decision|3|||
30908593|NCT01706458|58943313|FG001|Overall Study|Physician Decision|4|||
30908594|NCT02269787|58943321|FG000|Overall Study|Lost to Follow-up|20|||
30908595|NCT02269787|58943322|FG001|Overall Study|Lost to Follow-up|6|||
30908596|NCT02269787|58943321|FG000|Overall Study|Death|2|||
30908597|NCT02269787|58943322|FG001|Overall Study|Death|3|||
30908598|NCT02269787|58943321|FG000|Overall Study|Incapacitated|0|||
30908599|NCT02269787|58943322|FG001|Overall Study|Incapacitated|1|||
30908600|NCT01605370|58943330|FG000|Overall Study|Adverse Event|1|||
30908601|NCT01605370|58943331|FG001|Overall Study|Adverse Event|0|||
30908602|NCT02269709|58943337|FG000|Time of Enrollment|Withdrawal by Subject|3|||
30908603|NCT02269709|58943337|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
30908604|NCT02269709|58943337|FG000|Six Month Follow-up|Lost to Follow-up|12|||
30748826|NCT00443729|58758967|FG000|Overall Study|Protocol Violation|1|||
30748827|NCT00443729|58758968|FG001|Overall Study|Protocol Violation|1|||
30908605|NCT02269475|58943344|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
30908606|NCT02269475|58943345|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
30908607|NCT02269475|58943344|FG000|Overall Study|Withdrawal by Subject|0|||
30908608|NCT02269475|58943345|FG001|Overall Study|Withdrawal by Subject|1|||
30908609|NCT01605136|58943354|FG000|Study Period|Withdrawal by Subject|2|||
30748828|NCT00443729|58758967|FG000|Overall Study|Withdrawal by Subject|3|||
30748829|NCT00443729|58758968|FG001|Overall Study|Withdrawal by Subject|1|||
30748830|NCT00443651|58758976|FG000|Overall Study|Death|1|||
30748831|NCT00443651|58758977|FG001|Overall Study|Death|5|||
30748832|NCT00443651|58758976|FG000|Overall Study|Adverse Event|5|||
30748833|NCT00443651|58758977|FG001|Overall Study|Adverse Event|6|||
30748834|NCT00443651|58758976|FG000|Overall Study|Lost to Follow-up|18|||
30748835|NCT00443651|58758977|FG001|Overall Study|Lost to Follow-up|12|||
30806448|NCT02876328|58823703|FG004|Overall Study|Withdrawal by Subject|0|||
30806449|NCT02876328|58823704|FG005|Overall Study|Withdrawal by Subject|1|||
30806450|NCT02876328|58823705|FG006|Overall Study|Withdrawal by Subject|0|||
30806451|NCT02876328|58823706|FG007|Overall Study|Withdrawal by Subject|1|||
30806452|NCT02876328|58823707|FG008|Overall Study|Withdrawal by Subject|1|||
30806453|NCT02876328|58823708|FG009|Overall Study|Withdrawal by Subject|2|||
30908610|NCT01605136|58943355|FG001|Study Period|Withdrawal by Subject|0|||
30908611|NCT01605136|58943354|FG000|Study Period|Physician Decision|1|||
30908612|NCT01605136|58943355|FG001|Study Period|Physician Decision|1|||
30908613|NCT01605136|58943354|FG000|Study Period|Lost to Follow-up|0|||
30908614|NCT01605136|58943355|FG001|Study Period|Lost to Follow-up|2|||
30806454|NCT02876328|58823709|FG010|Overall Study|Withdrawal by Subject|0|||
30806455|NCT02876328|58823710|FG011|Overall Study|Withdrawal by Subject|0|||
30908615|NCT01605136|58943354|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
30908616|NCT01605136|58943355|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
30908617|NCT01706146|58943361|FG000|Overall Study|Withdrawal by Subject|1|||
30908618|NCT01706146|58943361|FG000|Overall Study|Adverse Event|3|||
30908619|NCT01706146|58943361|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
30908620|NCT02269241|58943365|FG000|Overall Study|Lost to Follow-up|269|||
30908621|NCT02269241|58943365|FG000|Overall Study|Withdrawal by Subject|155|||
30908622|NCT02269241|58943365|FG000|Overall Study|Protocol Violation|1|||
30908623|NCT02269241|58943365|FG000|Overall Study|Physician Decision|7|||
30908624|NCT02269241|58943365|FG000|Overall Study|Pregnancy|15|||
30908625|NCT02269241|58943365|FG000|Overall Study|Wish for pregnancy|5|||
30908626|NCT02269241|58943365|FG000|Overall Study|Development of an exclusion criteria|16|||
30908627|NCT02269241|58943365|FG000|Overall Study|Adverse Event|113|||
30908628|NCT02269241|58943365|FG000|Overall Study|At the specific request of the sponsor|20|||
30908629|NCT02269241|58943365|FG000|Overall Study|Several reasons not classified|53|||
30908630|NCT02269241|58943365|FG000|Overall Study|Screening failures|546|||
30908631|NCT01750684|58943372|FG000|Overall Study|Death|1|||
30908632|NCT01750684|58943373|FG001|Overall Study|Death|0|||
30908633|NCT01750684|58943372|FG000|Overall Study|Non-compliance with Study Drug|0|||
30908634|NCT01750684|58943373|FG001|Overall Study|Non-compliance with Study Drug|1|||
30908635|NCT01750684|58943372|FG000|Overall Study|Withdrawn by Sponsor|0|||
30908636|NCT01750684|58943373|FG001|Overall Study|Withdrawn by Sponsor|1|||
30908637|NCT01750684|58943372|FG000|Overall Study|Protocol Violation|1|||
30908638|NCT01750684|58943373|FG001|Overall Study|Protocol Violation|0|||
30908639|NCT01750294|58943380|FG000|Overall Study|Withdrawal by Subject|1|||
30908640|NCT01750294|58943380|FG000|Overall Study|Safety Endpoint|1|||
30908641|NCT01749982|58943388|FG000|Overall Study|Physician Decision|0|||
30908642|NCT01749982|58943389|FG001|Overall Study|Physician Decision|0|||
30908643|NCT01749982|58943390|FG002|Overall Study|Physician Decision|0|||
30908644|NCT01749982|58943391|FG003|Overall Study|Physician Decision|1|||
30806456|NCT02876328|58823711|FG012|Overall Study|Withdrawal by Subject|0|||
30806457|NCT02876328|58823712|FG013|Overall Study|Withdrawal by Subject|0|||
30908645|NCT01749982|58943388|FG000|Overall Study|Lost to Follow-up|0|||
30908646|NCT01749982|58943389|FG001|Overall Study|Lost to Follow-up|0|||
30908647|NCT01749982|58943390|FG002|Overall Study|Lost to Follow-up|0|||
30908648|NCT01749982|58943391|FG003|Overall Study|Lost to Follow-up|1|||
30908649|NCT01749982|58943388|FG000|Overall Study|Withdrawal by Subject|0|||
30908650|NCT01749982|58943389|FG001|Overall Study|Withdrawal by Subject|0|||
30806458|NCT02876328|58823713|FG014|Overall Study|Withdrawal by Subject|0|||
30806459|NCT02876328|58823714|FG015|Overall Study|Withdrawal by Subject|0|||
30806460|NCT02876328|58823715|FG016|Overall Study|Withdrawal by Subject|1|||
30806461|NCT02876328|58823716|FG017|Overall Study|Withdrawal by Subject|3|||
30806462|NCT02876328|58823717|FG018|Overall Study|Withdrawal by Subject|0|||
30806463|NCT02876328|58823718|FG019|Overall Study|Withdrawal by Subject|0|||
30806464|NCT02876328|58823719|FG020|Overall Study|Withdrawal by Subject|1|||
30806465|NCT02876328|58823720|FG021|Overall Study|Withdrawal by Subject|0|||
30806466|NCT02876328|58823721|FG022|Overall Study|Withdrawal by Subject|0|||
30806467|NCT02876328|58823722|FG023|Overall Study|Withdrawal by Subject|0|||
30806468|NCT02876328|58823699|FG000|Overall Study|Missed 12 Month Visit|15|||
30806469|NCT02876328|58823700|FG001|Overall Study|Missed 12 Month Visit|10|||
30806470|NCT02876328|58823701|FG002|Overall Study|Missed 12 Month Visit|11|||
30806471|NCT02876328|58823702|FG003|Overall Study|Missed 12 Month Visit|6|||
30806472|NCT02876328|58823703|FG004|Overall Study|Missed 12 Month Visit|10|||
30806473|NCT02876328|58823704|FG005|Overall Study|Missed 12 Month Visit|14|||
30806474|NCT02876328|58823705|FG006|Overall Study|Missed 12 Month Visit|3|||
30806475|NCT02876328|58823706|FG007|Overall Study|Missed 12 Month Visit|8|||
30806476|NCT02876328|58823707|FG008|Overall Study|Missed 12 Month Visit|9|||
30806477|NCT02876328|58823708|FG009|Overall Study|Missed 12 Month Visit|5|||
30806478|NCT02876328|58823709|FG010|Overall Study|Missed 12 Month Visit|4|||
30806479|NCT02876328|58823710|FG011|Overall Study|Missed 12 Month Visit|1|||
30806480|NCT02876328|58823711|FG012|Overall Study|Missed 12 Month Visit|5|||
30806481|NCT02876328|58823712|FG013|Overall Study|Missed 12 Month Visit|4|||
30806482|NCT02876328|58823713|FG014|Overall Study|Missed 12 Month Visit|4|||
30806483|NCT02876328|58823714|FG015|Overall Study|Missed 12 Month Visit|4|||
30806484|NCT02876328|58823715|FG016|Overall Study|Missed 12 Month Visit|3|||
30806485|NCT02876328|58823716|FG017|Overall Study|Missed 12 Month Visit|6|||
30806486|NCT02876328|58823717|FG018|Overall Study|Missed 12 Month Visit|2|||
30908651|NCT01749982|58943390|FG002|Overall Study|Withdrawal by Subject|0|||
30908652|NCT01749982|58943391|FG003|Overall Study|Withdrawal by Subject|1|||
30908653|NCT02269163|58943403|FG000|Overall Study|Lost to Follow-up|1|||
30908654|NCT02269163|58943404|FG001|Overall Study|Lost to Follow-up|0|||
30908655|NCT02269163|58943403|FG000|Overall Study|Major protocol violation|0|||
30908656|NCT02269163|58943404|FG001|Overall Study|Major protocol violation|1|||
30806487|NCT02876328|58823718|FG019|Overall Study|Missed 12 Month Visit|2|||
30806488|NCT02876328|58823719|FG020|Overall Study|Missed 12 Month Visit|11|||
30806489|NCT02876328|58823720|FG021|Overall Study|Missed 12 Month Visit|7|||
30806490|NCT02876328|58823721|FG022|Overall Study|Missed 12 Month Visit|1|||
30908657|NCT02269163|58943403|FG000|Overall Study|Other|2|||
30908658|NCT02269163|58943404|FG001|Overall Study|Other|2|||
30908659|NCT02269163|58943403|FG000|Overall Study|Withdrawal by Subject|0|||
30908660|NCT02269163|58943404|FG001|Overall Study|Withdrawal by Subject|3|||
30806491|NCT02876328|58823722|FG023|Overall Study|Missed 12 Month Visit|0|||
30806492|NCT02875860|58823750|FG000|Overall Study|Withdrawal by Subject|0|||
30806493|NCT02875860|58823751|FG001|Overall Study|Withdrawal by Subject|1|||
30806494|NCT02875392|58823759|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
30806495|NCT02875392|58823760|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
30806496|NCT03127644|58823769|FG000|Overall Study|Study-specific withdrawal criteria|0|||
30806497|NCT03127644|58823770|FG001|Overall Study|Study-specific withdrawal criteria|0|||
30806498|NCT03127644|58823771|FG002|Overall Study|Study-specific withdrawal criteria|2|||
30806499|NCT03965962|58823785|FG000|Overall Study|Adverse Event|1|||
30806500|NCT03965962|58823786|FG001|Overall Study|Adverse Event|0|||
30806501|NCT03965962|58823787|FG002|Overall Study|Adverse Event|0|||
30806502|NCT03965962|58823788|FG003|Overall Study|Adverse Event|0|||
30806503|NCT03965962|58823785|FG000|Overall Study|Protocol Violation|21|||
30806504|NCT03965962|58823786|FG001|Overall Study|Protocol Violation|4|||
30806505|NCT03965962|58823787|FG002|Overall Study|Protocol Violation|10|||
30806506|NCT03965962|58823788|FG003|Overall Study|Protocol Violation|5|||
30806507|NCT03965962|58823785|FG000|Overall Study|Lost to Follow-up|0|||
30806508|NCT03965962|58823786|FG001|Overall Study|Lost to Follow-up|1|||
30806509|NCT03965962|58823787|FG002|Overall Study|Lost to Follow-up|0|||
30806510|NCT03965962|58823788|FG003|Overall Study|Lost to Follow-up|0|||
30806511|NCT03965962|58823785|FG000|Overall Study|Withdrawal by Subject|3|||
30806512|NCT03965962|58823786|FG001|Overall Study|Withdrawal by Subject|0|||
30806513|NCT03965962|58823787|FG002|Overall Study|Withdrawal by Subject|0|||
30806514|NCT03965962|58823788|FG003|Overall Study|Withdrawal by Subject|1|||
30806515|NCT03151551|58823800|FG000|Open-Label Treatment Period|Adverse Event|0|||
30806516|NCT03151551|58823801|FG001|Open-Label Treatment Period|Adverse Event|2|||
30806517|NCT03151551|58823800|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
30806518|NCT03151551|58823801|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
30806519|NCT03151551|58823800|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
30806520|NCT03151551|58823801|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
30806521|NCT03151551|58823800|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
30806522|NCT03151551|58823801|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
30806523|NCT03151551|58823800|FG000|Open-Label Treatment Period|Physician Decision|3|||
30806524|NCT03151551|58823801|FG001|Open-Label Treatment Period|Physician Decision|0|||
30806525|NCT03151551|58823800|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
30806526|NCT03151551|58823801|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
30806527|NCT03151551|58823800|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
30806528|NCT03151551|58823801|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
30806529|NCT03151551|58823800|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
30806530|NCT03151551|58823801|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
30806531|NCT03151551|58823800|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
30806532|NCT03151551|58823801|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
30806533|NCT03151551|58823800|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
30806534|NCT03151551|58823801|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
30806535|NCT03147495|58823811|FG000|Overall Study|Physician Decision|0|||
30806536|NCT03147495|58823812|FG001|Overall Study|Physician Decision|6|||
30806537|NCT03126786|58823820|FG000|Overall Study|Adverse Event|3|||
30806538|NCT03126786|58823821|FG001|Overall Study|Adverse Event|0|||
30806539|NCT03126786|58823820|FG000|Overall Study|Lost to Follow-up|0|||
30806540|NCT03126786|58823821|FG001|Overall Study|Lost to Follow-up|1|||
30806541|NCT03126786|58823820|FG000|Overall Study|Withdrawal by Subject|3|||
30806542|NCT03126786|58823821|FG001|Overall Study|Withdrawal by Subject|1|||
30806543|NCT03146403|58823829|FG000|Overall Study|Withdrawal by Subject|0|||
30806544|NCT03146403|58823830|FG001|Overall Study|Withdrawal by Subject|3|||
30806545|NCT03146403|58823829|FG000|Overall Study|Lost to Follow-up|2|||
30806546|NCT03146403|58823830|FG001|Overall Study|Lost to Follow-up|0|||
30806547|NCT02713204|58823839|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
30806548|NCT02713204|58823840|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
30806549|NCT02713204|58823841|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
30806550|NCT02713204|58823842|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
30806551|NCT02713204|58823843|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
30806552|NCT02713204|58823844|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
30806553|NCT02713204|58823845|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
30806554|NCT02713204|58823846|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
30806555|NCT02713204|58823839|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30806556|NCT02713204|58823840|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30806557|NCT02713204|58823841|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
30806558|NCT02713204|58823842|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30806559|NCT02713204|58823843|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30806560|NCT02713204|58823844|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30806561|NCT02713204|58823845|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30806562|NCT02713204|58823846|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30806563|NCT02713204|58823839|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30806564|NCT02713204|58823840|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
30806565|NCT02713204|58823841|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30806566|NCT02713204|58823842|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30806567|NCT02713204|58823843|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30806568|NCT02713204|58823844|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30806569|NCT02713204|58823845|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30806570|NCT02713204|58823846|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30806571|NCT02713204|58823839|FG000|From Week 12 up to Week 36|Adverse Event|1|||
30806572|NCT02713204|58823840|FG001|From Week 12 up to Week 36|Adverse Event|0|||
30806573|NCT02713204|58823841|FG002|From Week 12 up to Week 36|Adverse Event|0|||
30806574|NCT02713204|58823842|FG003|From Week 12 up to Week 36|Adverse Event|1|||
30806575|NCT02713204|58823843|FG004|From Week 12 up to Week 36|Adverse Event|1|||
30806576|NCT02713204|58823844|FG005|From Week 12 up to Week 36|Adverse Event|0|||
30806577|NCT02713204|58823845|FG006|From Week 12 up to Week 36|Adverse Event|2|||
30806578|NCT02713204|58823846|FG007|From Week 12 up to Week 36|Adverse Event|1|||
30806579|NCT02713204|58823839|FG000|From Week 12 up to Week 36|Death|0|||
30806580|NCT02713204|58823840|FG001|From Week 12 up to Week 36|Death|0|||
30806581|NCT02713204|58823841|FG002|From Week 12 up to Week 36|Death|0|||
30806582|NCT02713204|58823842|FG003|From Week 12 up to Week 36|Death|1|||
30806583|NCT02713204|58823843|FG004|From Week 12 up to Week 36|Death|0|||
30806584|NCT02713204|58823844|FG005|From Week 12 up to Week 36|Death|1|||
30806585|NCT02713204|58823845|FG006|From Week 12 up to Week 36|Death|0|||
30806586|NCT02713204|58823846|FG007|From Week 12 up to Week 36|Death|3|||
30806587|NCT02713204|58823839|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
30806588|NCT02713204|58823840|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
30806589|NCT02713204|58823841|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
30806590|NCT02713204|58823842|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
30806591|NCT02713204|58823843|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
30806592|NCT02713204|58823844|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
30806593|NCT02713204|58823845|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
30806594|NCT02713204|58823846|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
30806595|NCT02713204|58823839|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
30806596|NCT02713204|58823840|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
30806597|NCT02713204|58823841|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
30806598|NCT02713204|58823842|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
30806599|NCT02713204|58823843|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
30806600|NCT02713204|58823844|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
30806601|NCT02713204|58823845|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
30806602|NCT02713204|58823846|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
30806603|NCT03695172|58823866|FG000|Overall Study|Withdrawal by Subject|1|||
30806604|NCT03695172|58823867|FG001|Overall Study|Withdrawal by Subject|1|||
30806605|NCT03695172|58823868|FG002|Overall Study|Withdrawal by Subject|0|||
30806606|NCT03721107|58823880|FG000|Overall Study|Adverse Event|1|||
30806607|NCT03721107|58823881|FG001|Overall Study|Adverse Event|1|||
30806608|NCT03721107|58823882|FG002|Overall Study|Adverse Event|6|||
30806609|NCT03721107|58823883|FG003|Overall Study|Adverse Event|5|||
30806610|NCT03721107|58823880|FG000|Overall Study|Lost to Follow-up|2|||
30806611|NCT03721107|58823881|FG001|Overall Study|Lost to Follow-up|0|||
30806612|NCT03721107|58823882|FG002|Overall Study|Lost to Follow-up|3|||
30806613|NCT03721107|58823883|FG003|Overall Study|Lost to Follow-up|0|||
30806614|NCT03721107|58823880|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
30806615|NCT03721107|58823881|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
30806616|NCT03721107|58823882|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
30806617|NCT03721107|58823883|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
30806618|NCT03721107|58823880|FG000|Overall Study|Physician Decision|0|||
30806619|NCT03721107|58823881|FG001|Overall Study|Physician Decision|1|||
30806620|NCT03721107|58823882|FG002|Overall Study|Physician Decision|0|||
30806621|NCT03721107|58823883|FG003|Overall Study|Physician Decision|0|||
30806622|NCT03721107|58823880|FG000|Overall Study|Pregnancy|0|||
30806623|NCT03721107|58823881|FG001|Overall Study|Pregnancy|0|||
30806624|NCT03721107|58823882|FG002|Overall Study|Pregnancy|1|||
30806625|NCT03721107|58823883|FG003|Overall Study|Pregnancy|0|||
30806626|NCT03721107|58823880|FG000|Overall Study|Withdrawal by Subject|1|||
30806627|NCT03721107|58823881|FG001|Overall Study|Withdrawal by Subject|1|||
30806628|NCT03721107|58823882|FG002|Overall Study|Withdrawal by Subject|5|||
30806629|NCT03721107|58823883|FG003|Overall Study|Withdrawal by Subject|5|||
30806630|NCT03721107|58823880|FG000|Overall Study|Other|1|||
30806631|NCT03721107|58823881|FG001|Overall Study|Other|0|||
30806632|NCT03721107|58823882|FG002|Overall Study|Other|0|||
30806633|NCT03721107|58823883|FG003|Overall Study|Other|1|||
30806634|NCT03052920|58823902|FG000|Overall Study|Withdrawal by Subject|1|||
30806635|NCT02930226|58823912|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
30806636|NCT02930226|58823913|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
30806637|NCT02930226|58823914|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
30806638|NCT02930226|58823915|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
30806639|NCT02930226|58823916|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
30806640|NCT02930226|58823917|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
30806641|NCT02722434|58823954|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
30806642|NCT02722434|58823955|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
30806643|NCT02722434|58823954|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
30806644|NCT02722434|58823955|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
30806645|NCT03539601|58823965|FG000|Overall Study|Withdraw by parent/guardian|1|||
30806646|NCT03539601|58823966|FG001|Overall Study|Withdraw by parent/guardian|0|||
30806647|NCT03539601|58823967|FG002|Overall Study|Withdraw by parent/guardian|1|||
30806648|NCT03539601|58823968|FG003|Overall Study|Withdraw by parent/guardian|0|||
30806649|NCT03539601|58823965|FG000|Overall Study|Adverse Event|0|||
30806650|NCT03539601|58823966|FG001|Overall Study|Adverse Event|2|||
30806651|NCT03539601|58823967|FG002|Overall Study|Adverse Event|0|||
30806652|NCT03539601|58823968|FG003|Overall Study|Adverse Event|0|||
30806653|NCT03539601|58823965|FG000|Overall Study|Lost to Follow-up|2|||
30806654|NCT03539601|58823966|FG001|Overall Study|Lost to Follow-up|4|||
30806655|NCT03539601|58823967|FG002|Overall Study|Lost to Follow-up|5|||
30806656|NCT03539601|58823968|FG003|Overall Study|Lost to Follow-up|0|||
30806657|NCT03539601|58823965|FG000|Overall Study|Withdrawal by Subject|2|||
30806658|NCT03539601|58823966|FG001|Overall Study|Withdrawal by Subject|0|||
30806659|NCT03539601|58823967|FG002|Overall Study|Withdrawal by Subject|0|||
30806660|NCT03539601|58823968|FG003|Overall Study|Withdrawal by Subject|1|||
30806661|NCT03539601|58823965|FG000|Overall Study|Randomized but not treated|1|||
30806662|NCT03539601|58823966|FG001|Overall Study|Randomized but not treated|1|||
30806663|NCT03539601|58823967|FG002|Overall Study|Randomized but not treated|0|||
30806664|NCT03539601|58823968|FG003|Overall Study|Randomized but not treated|0|||
30806665|NCT00700804|58823988|FG000|Overall Study|Withdrawal by Subject|1|||
30806666|NCT00700804|58823989|FG001|Overall Study|Withdrawal by Subject|2|||
30806667|NCT00700804|58823988|FG000|Overall Study|Protocol Violation|1|||
30806668|NCT00700804|58823989|FG001|Overall Study|Protocol Violation|1|||
30806669|NCT00700804|58823988|FG000|Overall Study|Loose Stools|1|||
30806670|NCT00700804|58823989|FG001|Overall Study|Loose Stools|1|||
30806671|NCT02903823|58823995|FG000|Overall Study|Physician Decision|5|||
30806672|NCT02903823|58823995|FG000|Overall Study|Could not advance catheter|1|||
30806673|NCT02903823|58823995|FG000|Overall Study|Catheter dislodgement|1|||
30806674|NCT00832455|58824024|FG000|Overall Study|Adverse Event|13|||
30806675|NCT00832455|58824024|FG000|Overall Study|Lost to Follow-up|26|||
30806676|NCT00832455|58824024|FG000|Overall Study|Protocol Violation|4|||
30806677|NCT00832455|58824024|FG000|Overall Study|Withdrawal by Subject|17|||
30806678|NCT00832455|58824024|FG000|Overall Study|Screening Failure|2|||
30806679|NCT00832455|58824024|FG000|Overall Study|Stopped Medication|4|||
30806680|NCT00832455|58824024|FG000|Overall Study|Parent misunderstood study|1|||
30806681|NCT00832455|58824024|FG000|Overall Study|Parent dissatisfied|1|||
30806682|NCT00832455|58824024|FG000|Overall Study|No improvement|3|||
30806683|NCT00832455|58824024|FG000|Overall Study|Patient moved|1|||
30806684|NCT00687531|58824037|FG000|Overall Study|Did not meet protocol eligibility|104|||
30806685|NCT00687531|58824037|FG000|Overall Study|Adverse Event|5|||
30806686|NCT00687531|58824037|FG000|Overall Study|Lost to Follow-up|26|||
30806687|NCT00423579|58824043|FG000|Overall Study|Lost to Follow-up|3|||
30806688|NCT00423579|58824044|FG001|Overall Study|Lost to Follow-up|0|||
30806689|NCT00423579|58824043|FG000|Overall Study|Protocol Violation|1|||
30806690|NCT00423579|58824044|FG001|Overall Study|Protocol Violation|3|||
30806691|NCT00423579|58824043|FG000|Overall Study|Diagnosis of diabetes|0|||
30806692|NCT00423579|58824044|FG001|Overall Study|Diagnosis of diabetes|1|||
30806693|NCT03268005|58824052|FG000|Overall Study|Death|2|||
30806694|NCT03268005|58824053|FG001|Overall Study|Death|1|||
30806695|NCT03268005|58824052|FG000|Overall Study|Lost to Follow-up|2|||
30806696|NCT03268005|58824053|FG001|Overall Study|Lost to Follow-up|2|||
30806697|NCT03268005|58824052|FG000|Overall Study|Withdrawal by Subject|11|||
30806698|NCT03268005|58824053|FG001|Overall Study|Withdrawal by Subject|11|||
30806699|NCT03149055|58824059|FG000|Overall Study|Not treated|4|||
30806700|NCT03137121|58824074|FG000|Overall Study|Withdrawal by Subject|0|||
30806701|NCT03137121|58824075|FG001|Overall Study|Withdrawal by Subject|1|||
30806702|NCT00700570|58824118|FG000|Overall Study|Adverse Event|2|||
30806703|NCT00700570|58824119|FG001|Overall Study|Adverse Event|6|||
30806704|NCT00700570|58824118|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
30806705|NCT00700570|58824119|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
30908661|NCT02269163|58943403|FG000|Overall Study|Physician Decision|0|||
30908662|NCT02269163|58943404|FG001|Overall Study|Physician Decision|1|||
30908663|NCT01749826|58943414|FG000|Overall Study|Study Terminated|20|||
30908664|NCT01749826|58943415|FG001|Overall Study|Study Terminated|0|||
30908665|NCT02300129|58943421|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
30908666|NCT02300129|58943422|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
30908667|NCT02300129|58943423|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
30908668|NCT02300129|58943424|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
30908669|NCT02300129|58943421|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
30908670|NCT02300129|58943422|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
30908671|NCT02300129|58943423|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
30908672|NCT02300129|58943424|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
30908673|NCT02300129|58943421|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
30908674|NCT02300129|58943422|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
30908675|NCT02300129|58943423|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
30908676|NCT02300129|58943424|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
30908677|NCT02267135|58943436|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
30908678|NCT02267135|58943437|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
30908679|NCT02267135|58943436|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
30908680|NCT02267135|58943437|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
30908681|NCT02267135|58943436|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
30908682|NCT02267135|58943437|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
30908683|NCT02267135|58943436|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
30908684|NCT02267135|58943437|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
30908685|NCT02267135|58943436|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
30908686|NCT02267135|58943437|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
30908687|NCT02299427|58943448|FG000|Overall Study|Withdrawal by Subject|1|||
30908688|NCT02299427|58943449|FG001|Overall Study|Withdrawal by Subject|0|||
30908689|NCT02299427|58943448|FG000|Overall Study|Lost to Follow-up|1|||
30908690|NCT02299427|58943449|FG001|Overall Study|Lost to Follow-up|3|||
30908691|NCT02299427|58943448|FG000|Overall Study|not adherent to dog website use|21|||
30908692|NCT02299427|58943449|FG001|Overall Study|not adherent to dog website use|0|||
30908693|NCT01724866|58943459|FG000|Overall Study|Adverse Event|0|||
30908694|NCT01724866|58943460|FG001|Overall Study|Adverse Event|0|||
30908695|NCT01724866|58943461|FG002|Overall Study|Adverse Event|1|||
30908696|NCT01724866|58943462|FG003|Overall Study|Adverse Event|1|||
30908697|NCT01724866|58943459|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
30908698|NCT01724866|58943460|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
30908699|NCT01724866|58943461|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
30908700|NCT01724866|58943462|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
30908701|NCT01724866|58943459|FG000|Overall Study|Investigator's Discretion|0|||
30908702|NCT01724866|58943460|FG001|Overall Study|Investigator's Discretion|1|||
30908703|NCT01724866|58943461|FG002|Overall Study|Investigator's Discretion|1|||
30908704|NCT01724866|58943462|FG003|Overall Study|Investigator's Discretion|0|||
30908705|NCT01724866|58943459|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
30908706|NCT01724866|58943460|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
30908707|NCT01724866|58943461|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
30908708|NCT01724866|58943462|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
30908709|NCT01724866|58943459|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
30908710|NCT01724866|58943460|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
30908711|NCT01724866|58943461|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
30908712|NCT01724866|58943462|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
30908713|NCT02266433|58943474|FG000|Overall Study|Lost to Follow-up|54|||
30908714|NCT02266433|58943475|FG001|Overall Study|Lost to Follow-up|46|||
30908715|NCT02266433|58943474|FG000|Overall Study|Withdrawal by Subject|5|||
30908716|NCT02266433|58943475|FG001|Overall Study|Withdrawal by Subject|7|||
30908717|NCT01748890|58943482|FG000|Overall Study|Insufficient recruitment for analysis|4|||
30908718|NCT01747876|58943489|FG000|Overall Study|Adverse Event|1|||
30908719|NCT01747876|58943490|FG001|Overall Study|Adverse Event|0|||
30908720|NCT01747876|58943491|FG002|Overall Study|Adverse Event|2|||
30908721|NCT01747876|58943489|FG000|Overall Study|Withdrawal by Subject|0|||
30908722|NCT01747876|58943490|FG001|Overall Study|Withdrawal by Subject|1|||
30908723|NCT01747876|58943491|FG002|Overall Study|Withdrawal by Subject|1|||
30908724|NCT01747876|58943489|FG000|Overall Study|Disease progression|4|||
30908725|NCT01747876|58943490|FG001|Overall Study|Disease progression|13|||
30908726|NCT01747876|58943491|FG002|Overall Study|Disease progression|8|||
30908727|NCT01747876|58943489|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
30748836|NCT00443651|58758976|FG000|Overall Study|Patient's/Guardian's Decision|58|||
30908728|NCT01747876|58943490|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
30908729|NCT01747876|58943491|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
30908730|NCT02273726|58943504|FG000|Overall Study|Death|70|||
30908731|NCT02273726|58943505|FG001|Overall Study|Death|62|||
30908732|NCT02273726|58943504|FG000|Overall Study|Withdrawal by Subject|41|||
30908733|NCT02273726|58943505|FG001|Overall Study|Withdrawal by Subject|29|||
30908734|NCT02273726|58943504|FG000|Overall Study|Kidney transplant|31|||
30908735|NCT02273726|58943505|FG001|Overall Study|Kidney transplant|39|||
30908736|NCT02273726|58943504|FG000|Overall Study|Physician Decision|30|||
30908737|NCT02273726|58943505|FG001|Overall Study|Physician Decision|15|||
30908738|NCT02273726|58943504|FG000|Overall Study|Adverse Event|27|||
30908739|NCT02273726|58943505|FG001|Overall Study|Adverse Event|9|||
30908740|NCT02273726|58943504|FG000|Overall Study|Lost to Follow-up|6|||
30908741|NCT02273726|58943505|FG001|Overall Study|Lost to Follow-up|3|||
30806706|NCT00700570|58824118|FG000|Overall Study|Disease Progression|8|||
30806707|NCT00700570|58824119|FG001|Overall Study|Disease Progression|11|||
30806708|NCT00700570|58824118|FG000|Overall Study|Withdrawal by Subject|1|||
30806709|NCT00700570|58824119|FG001|Overall Study|Withdrawal by Subject|6|||
30806710|NCT02874924|58824137|FG000|Overall Study|Adverse Event|2|||
30806711|NCT02874924|58824138|FG001|Overall Study|Adverse Event|0|||
30806712|NCT02874924|58824139|FG002|Overall Study|Adverse Event|0|||
30806713|NCT02874924|58824137|FG000|Overall Study|Withdrawal by Subject|1|||
30806714|NCT02874924|58824138|FG001|Overall Study|Withdrawal by Subject|0|||
30806715|NCT02874924|58824139|FG002|Overall Study|Withdrawal by Subject|0|||
30806716|NCT04425863|58824150|FG000|Overall Study|Death|0|||
30806717|NCT04425863|58824151|FG001|Overall Study|Death|0|||
30806718|NCT04425863|58824152|FG002|Overall Study|Death|1|||
30806719|NCT04360187|58824174|FG000|Double-Blind Treatment|Adverse Event|9|||
30806720|NCT04360187|58824175|FG001|Double-Blind Treatment|Adverse Event|11|||
30806721|NCT04360187|58824174|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
30806722|NCT04360187|58824175|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
30806723|NCT04360187|58824174|FG000|Double-Blind Treatment|Physician Decision|1|||
30806724|NCT04360187|58824175|FG001|Double-Blind Treatment|Physician Decision|0|||
30806725|NCT04360187|58824174|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
30806726|NCT04360187|58824175|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
30806727|NCT04360187|58824174|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
30806728|NCT04360187|58824175|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
30806729|NCT04360187|58824174|FG000|Follow-Up|Lost to Follow-up|1|||
30806730|NCT04360187|58824175|FG001|Follow-Up|Lost to Follow-up|0|||
30806731|NCT04498169|58824183|FG000|Study Completion|Adverse Event|1|||
30806732|NCT04498169|58824184|FG001|Study Completion|Adverse Event|1|||
30806733|NCT03695393|58824192|FG000|Overall Study|Death|3|||
30806734|NCT03695393|58824193|FG001|Overall Study|Death|1|||
30806735|NCT03695393|58824192|FG000|Overall Study|Lost to Follow-up|0|||
30908742|NCT02273726|58943504|FG000|Overall Study|Lack of Efficacy|6|||
30908743|NCT02273726|58943505|FG001|Overall Study|Lack of Efficacy|1|||
30908744|NCT02273726|58943504|FG000|Overall Study|Protocol Violation|4|||
30908745|NCT02273726|58943505|FG001|Overall Study|Protocol Violation|0|||
30908746|NCT02273726|58943504|FG000|Overall Study|Other than specified|28|||
30908747|NCT02273726|58943505|FG001|Overall Study|Other than specified|30|||
30908748|NCT01723228|58943513|FG000|Overall Study|Adverse Event|2|||
30908749|NCT01723228|58943514|FG001|Overall Study|Adverse Event|6|||
30806736|NCT03695393|58824193|FG001|Overall Study|Lost to Follow-up|1|||
30806737|NCT03694925|58824202|FG000|Overall Study|Inadequate laboratory testing|0|||
30806738|NCT03694925|58824203|FG001|Overall Study|Inadequate laboratory testing|3|||
30806739|NCT03694925|58824204|FG002|Overall Study|Inadequate laboratory testing|0|||
30806740|NCT04258020|58824216|FG000|Overall Study|Withdrawal by Subject|1|||
30806741|NCT04258020|58824217|FG001|Overall Study|Withdrawal by Subject|0|||
30806742|NCT04495283|58824226|FG000|Overall Study|Physician Decision|0|||
30806743|NCT04495283|58824227|FG001|Overall Study|Physician Decision|0|||
30806744|NCT04495283|58824228|FG002|Overall Study|Physician Decision|1|||
30806745|NCT04495283|58824226|FG000|Overall Study|Withdrawal by Subject|0|||
30806746|NCT04495283|58824227|FG001|Overall Study|Withdrawal by Subject|1|||
30806747|NCT04495283|58824228|FG002|Overall Study|Withdrawal by Subject|1|||
30806748|NCT04495283|58824226|FG000|Overall Study|Other|1|||
30806749|NCT04495283|58824227|FG001|Overall Study|Other|0|||
30908750|NCT01723228|58943513|FG000|Overall Study|Withdrawal by Subject|2|||
30908751|NCT01723228|58943514|FG001|Overall Study|Withdrawal by Subject|1|||
30806750|NCT04495283|58824228|FG002|Overall Study|Other|1|||
30806751|NCT03117738|58824241|FG000|Overall Study|Withdrawal by Subject|3|||
30806752|NCT03117738|58824242|FG001|Overall Study|Withdrawal by Subject|1|||
30806753|NCT03117738|58824241|FG000|Overall Study|Lost to Follow-up|1|||
30806754|NCT03117738|58824242|FG001|Overall Study|Lost to Follow-up|4|||
30908752|NCT01723228|58943513|FG000|Overall Study|Protocol Violation|0|||
30908753|NCT01723228|58943514|FG001|Overall Study|Protocol Violation|2|||
30908754|NCT01723228|58943513|FG000|Overall Study|Lost to Follow-up|2|||
30806755|NCT04234464|58824250|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
30806756|NCT04234464|58824251|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
30806757|NCT03123588|58824259|FG000|Overall Study|Study Terminated by Sponsor|2|||
30806758|NCT03123588|58824260|FG001|Overall Study|Study Terminated by Sponsor|5|||
30806759|NCT03123588|58824259|FG000|Overall Study|Withdrawal by Subject|1|||
30806760|NCT03123588|58824260|FG001|Overall Study|Withdrawal by Subject|0|||
30806761|NCT03123588|58824259|FG000|Overall Study|Adverse Event|1|||
30806762|NCT03123588|58824260|FG001|Overall Study|Adverse Event|0|||
30806763|NCT03123588|58824259|FG000|Overall Study|Physician Decision|2|||
30806764|NCT03123588|58824260|FG001|Overall Study|Physician Decision|1|||
30806765|NCT03123354|58824267|FG000|Overall Study|Physician Decision|6|||
30806766|NCT04421027|58824273|FG000|Treatment Period|Adverse Event|5|||
30806767|NCT04421027|58824274|FG001|Treatment Period|Adverse Event|3|||
30806768|NCT04421027|58824275|FG002|Treatment Period|Adverse Event|0|||
30806769|NCT04421027|58824276|FG003|Treatment Period|Adverse Event|0|||
30806770|NCT04421027|58824273|FG000|Treatment Period|Death|98|||
30806771|NCT04421027|58824274|FG001|Treatment Period|Death|61|||
30806772|NCT04421027|58824275|FG002|Treatment Period|Death|0|||
30806773|NCT04421027|58824276|FG003|Treatment Period|Death|0|||
30806774|NCT04421027|58824273|FG000|Treatment Period|Lost to Follow-up|22|||
30806775|NCT04421027|58824274|FG001|Treatment Period|Lost to Follow-up|20|||
30806776|NCT04421027|58824275|FG002|Treatment Period|Lost to Follow-up|0|||
30806777|NCT04421027|58824276|FG003|Treatment Period|Lost to Follow-up|0|||
30806778|NCT04421027|58824273|FG000|Treatment Period|Other-Unknown|15|||
30806779|NCT04421027|58824274|FG001|Treatment Period|Other-Unknown|9|||
30806780|NCT04421027|58824275|FG002|Treatment Period|Other-Unknown|0|||
30806781|NCT04421027|58824276|FG003|Treatment Period|Other-Unknown|0|||
30806782|NCT04421027|58824273|FG000|Treatment Period|Physician Decision|1|||
30806783|NCT04421027|58824274|FG001|Treatment Period|Physician Decision|1|||
30806784|NCT04421027|58824275|FG002|Treatment Period|Physician Decision|0|||
30908755|NCT01723228|58943514|FG001|Overall Study|Lost to Follow-up|1|||
30908756|NCT01723228|58943513|FG000|Overall Study|Other|2|||
30806785|NCT04421027|58824276|FG003|Treatment Period|Physician Decision|0|||
30806786|NCT04421027|58824273|FG000|Treatment Period|Withdrawal by Subject|7|||
30806787|NCT04421027|58824274|FG001|Treatment Period|Withdrawal by Subject|12|||
30806788|NCT04421027|58824275|FG002|Treatment Period|Withdrawal by Subject|0|||
30806789|NCT04421027|58824276|FG003|Treatment Period|Withdrawal by Subject|0|||
30806790|NCT04421027|58824273|FG000|Treatment Period|Randomized Not Dosed|9|||
30806791|NCT04421027|58824274|FG001|Treatment Period|Randomized Not Dosed|14|||
30806792|NCT04421027|58824275|FG002|Treatment Period|Randomized Not Dosed|0|||
30806793|NCT04421027|58824276|FG003|Treatment Period|Randomized Not Dosed|0|||
30806794|NCT04421027|58824273|FG000|Follow-Up Period|Adverse Event|0|||
30806795|NCT04421027|58824274|FG001|Follow-Up Period|Adverse Event|0|||
30806796|NCT04421027|58824275|FG002|Follow-Up Period|Adverse Event|0|||
30806797|NCT04421027|58824276|FG003|Follow-Up Period|Adverse Event|3|||
30806798|NCT04421027|58824273|FG000|Follow-Up Period|Death|0|||
30806799|NCT04421027|58824274|FG001|Follow-Up Period|Death|0|||
30806800|NCT04421027|58824275|FG002|Follow-Up Period|Death|16|||
30806801|NCT04421027|58824276|FG003|Follow-Up Period|Death|17|||
30806802|NCT04421027|58824273|FG000|Follow-Up Period|Lost to Follow-up|0|||
30806803|NCT04421027|58824274|FG001|Follow-Up Period|Lost to Follow-up|0|||
30806804|NCT04421027|58824275|FG002|Follow-Up Period|Lost to Follow-up|7|||
30806805|NCT04421027|58824276|FG003|Follow-Up Period|Lost to Follow-up|7|||
30806806|NCT04421027|58824273|FG000|Follow-Up Period|Protocol Deviation|0|||
30806807|NCT04421027|58824274|FG001|Follow-Up Period|Protocol Deviation|0|||
30806808|NCT04421027|58824275|FG002|Follow-Up Period|Protocol Deviation|1|||
30806809|NCT04421027|58824276|FG003|Follow-Up Period|Protocol Deviation|0|||
30806810|NCT04421027|58824273|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
30806811|NCT04421027|58824274|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
30806812|NCT04421027|58824275|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
30806813|NCT04421027|58824276|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
30806814|NCT04421027|58824273|FG000|Follow-Up Period|Left message, participant did not call back|0|||
30908757|NCT01723228|58943514|FG001|Overall Study|Other|1|||
30908758|NCT02273180|58943522|FG000|Overall Study|Adverse Event|2|||
30806815|NCT04421027|58824274|FG001|Follow-Up Period|Left message, participant did not call back|0|||
30806816|NCT04421027|58824275|FG002|Follow-Up Period|Left message, participant did not call back|0|||
30806817|NCT04421027|58824276|FG003|Follow-Up Period|Left message, participant did not call back|1|||
30908759|NCT02273180|58943523|FG001|Overall Study|Adverse Event|2|||
30806818|NCT04421027|58824273|FG000|Follow-Up Period|Participant died|0|||
30806819|NCT04421027|58824274|FG001|Follow-Up Period|Participant died|0|||
30806820|NCT04421027|58824275|FG002|Follow-Up Period|Participant died|0|||
30806821|NCT04421027|58824276|FG003|Follow-Up Period|Participant died|1|||
30908760|NCT02273180|58943522|FG000|Overall Study|Lack of Efficacy|1|||
30806822|NCT04421027|58824273|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
30806823|NCT04421027|58824274|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
30806824|NCT04421027|58824275|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
30806825|NCT04421027|58824276|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
30806826|NCT04419311|58824286|FG000|Overall Study|Lost to Follow-up|1|||
30806827|NCT04419311|58824287|FG001|Overall Study|Lost to Follow-up|0|||
30806828|NCT04411667|58824297|FG000|Overall Study|Physician Decision|1|||
30806829|NCT04411667|58824298|FG001|Overall Study|Physician Decision|0|||
30806830|NCT04358549|58824306|FG000|Overall Study|Adverse Event|0|||
30806831|NCT04358549|58824307|FG001|Overall Study|Adverse Event|1|||
30806832|NCT04358549|58824306|FG000|Overall Study|Death|1|||
30806833|NCT04358549|58824307|FG001|Overall Study|Death|0|||
30806834|NCT04358549|58824306|FG000|Overall Study|Lost to Follow-up|2|||
30806835|NCT04358549|58824307|FG001|Overall Study|Lost to Follow-up|1|||
30806836|NCT04358549|58824306|FG000|Overall Study|Withdrawal by Subject|6|||
30806837|NCT04358549|58824307|FG001|Overall Study|Withdrawal by Subject|6|||
30806838|NCT04358549|58824306|FG000|Overall Study|Start remdesivir|1|||
30806839|NCT04358549|58824307|FG001|Overall Study|Start remdesivir|0|||
30806840|NCT00700180|58824315|FG000|Overall Study|Death|99|||
30806841|NCT00700180|58824316|FG001|Overall Study|Death|114|||
30908761|NCT02273180|58943523|FG001|Overall Study|Lack of Efficacy|0|||
30908762|NCT02273180|58943522|FG000|Overall Study|Protocol Violation|1|||
30806842|NCT00700180|58824315|FG000|Overall Study|Alive on treatment|5|||
30806843|NCT00700180|58824316|FG001|Overall Study|Alive on treatment|3|||
30806844|NCT00700180|58824315|FG000|Overall Study|Alive in follow-up|46|||
30806845|NCT00700180|58824316|FG001|Overall Study|Alive in follow-up|27|||
30806846|NCT00700180|58824315|FG000|Overall Study|Lost to Follow-up|4|||
30806847|NCT00700180|58824316|FG001|Overall Study|Lost to Follow-up|5|||
30806848|NCT00238420|58824324|FG000|Overall Study|Protocol Violation|1|||
30806849|NCT00238420|58824325|FG001|Overall Study|Protocol Violation|1|||
30806850|NCT04492475|58824333|FG000|Overall Study|Enrolled but not treated|8|||
30806851|NCT04492475|58824334|FG001|Overall Study|Enrolled but not treated|8|||
30806852|NCT04492475|58824333|FG000|Overall Study|Withdrawal by Subject|4|||
30806853|NCT04492475|58824334|FG001|Overall Study|Withdrawal by Subject|0|||
30806854|NCT04492475|58824333|FG000|Overall Study|Became ineligible after enrollment|2|||
30806855|NCT04492475|58824334|FG001|Overall Study|Became ineligible after enrollment|0|||
30806856|NCT04486235|58824349|FG000|Overall Study|Pregnancy|1|||
30806857|NCT04486235|58824350|FG001|Overall Study|Pregnancy|0|||
30806858|NCT04486235|58824349|FG000|Overall Study|Lost to Follow-up|1|||
30806859|NCT04486235|58824350|FG001|Overall Study|Lost to Follow-up|0|||
30806860|NCT04358081|58824360|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
30806861|NCT04358081|58824361|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
30806862|NCT04358081|58824362|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
30806863|NCT04358081|58824360|FG000|Treatment Phase of Study|Adverse Event|1|||
30806864|NCT04358081|58824361|FG001|Treatment Phase of Study|Adverse Event|0|||
30806865|NCT04358081|58824362|FG002|Treatment Phase of Study|Adverse Event|1|||
30806866|NCT04358081|58824360|FG000|Treatment Phase of Study|Physician Decision|2|||
30806867|NCT04358081|58824361|FG001|Treatment Phase of Study|Physician Decision|0|||
30806868|NCT04358081|58824362|FG002|Treatment Phase of Study|Physician Decision|1|||
30806869|NCT04358081|58824360|FG000|Treatment Phase of Study|Protocol Violation|1|||
30806870|NCT04358081|58824361|FG001|Treatment Phase of Study|Protocol Violation|0|||
30806871|NCT04358081|58824362|FG002|Treatment Phase of Study|Protocol Violation|0|||
30806872|NCT04358081|58824360|FG000|Study Completion Phase|Death|0|||
30806873|NCT04358081|58824361|FG001|Study Completion Phase|Death|0|||
30806874|NCT04358081|58824362|FG002|Study Completion Phase|Death|1|||
30806875|NCT04358081|58824360|FG000|Study Completion Phase|Lost to Follow-up|1|||
30806876|NCT04358081|58824361|FG001|Study Completion Phase|Lost to Follow-up|0|||
30908763|NCT02273180|58943523|FG001|Overall Study|Protocol Violation|7|||
30908764|NCT02273180|58943522|FG000|Overall Study|Randomized but not treated|1|||
30748837|NCT00443651|58758977|FG001|Overall Study|Patient's/Guardian's Decision|30|||
30748838|NCT00443651|58758976|FG000|Overall Study|Physician Decision|13|||
30748839|NCT00443651|58758977|FG001|Overall Study|Physician Decision|4|||
30748840|NCT00443651|58758976|FG000|Overall Study|Pregnancy|0|||
30748841|NCT00443651|58758977|FG001|Overall Study|Pregnancy|1|||
30748842|NCT00443261|58758983|FG000|Overall Study|Death|1|||
30748843|NCT00439517|58758989|FG000|Overall Study|Subject on treatment|1|||
30748844|NCT00439517|58758990|FG001|Overall Study|Subject on treatment|0|||
30748845|NCT00439517|58758989|FG000|Overall Study|Subject in survival follow-up|1|||
30748846|NCT00439517|58758990|FG001|Overall Study|Subject in survival follow-up|0|||
30748847|NCT00438815|58758996|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
30806877|NCT04358081|58824362|FG002|Study Completion Phase|Lost to Follow-up|1|||
30806878|NCT04355663|58824375|FG000|Overall Study|Physician Decision|2|||
30806879|NCT04355663|58824376|FG001|Overall Study|Physician Decision|7|||
30806880|NCT04355663|58824377|FG002|Overall Study|Physician Decision|0|||
30806881|NCT04355663|58824375|FG000|Overall Study|Adverse Event|0|||
30806882|NCT04355663|58824376|FG001|Overall Study|Adverse Event|0|||
30806883|NCT04355663|58824377|FG002|Overall Study|Adverse Event|1|||
30806884|NCT04355663|58824375|FG000|Overall Study|Withdrawal by Subject|0|||
30806885|NCT04355663|58824376|FG001|Overall Study|Withdrawal by Subject|8|||
30806886|NCT04355663|58824377|FG002|Overall Study|Withdrawal by Subject|3|||
30806887|NCT04345367|58824387|FG000|Overall Study|Other|3|||
30806888|NCT04345367|58824388|FG001|Overall Study|Other|4|||
30806889|NCT04345367|58824387|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
30806890|NCT04345367|58824388|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
30806891|NCT04345367|58824387|FG000|Overall Study|Withdrawal by Subject|11|||
30908765|NCT02273180|58943523|FG001|Overall Study|Randomized but not treated|0|||
30908766|NCT02273180|58943522|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
30908767|NCT02273180|58943523|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
30908768|NCT02273180|58943522|FG000|Overall Study|Other than specified above|21|||
30908769|NCT02273180|58943523|FG001|Overall Study|Other than specified above|10|||
30908770|NCT01746862|58943531|FG000|Overall Study|Withdrawal by Subject|1|||
30748848|NCT00438815|58758996|FG000|Overall Study|3-month follow-up no longer required|12|||
30748849|NCT00438815|58758996|FG000|Overall Study|Noncompliance with protocol requirements|9|||
30748850|NCT00438815|58758996|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
30748851|NCT00438815|58758996|FG000|Overall Study|Lost to Follow-up|6|||
30748852|NCT00438815|58758996|FG000|Overall Study|Withdrawal by Subject|6|||
30748853|NCT00438815|58758996|FG000|Overall Study|Death|1|||
30748854|NCT00438659|58759002|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
30748855|NCT00438659|58759003|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
30748856|NCT00438659|58759002|FG000|Overall Study|Cancel|5|||
30748857|NCT00438659|58759003|FG001|Overall Study|Cancel|2|||
30748858|NCT00437645|58759012|FG000|Overall Study|Adverse Event|15|||
30748859|NCT00437645|58759013|FG001|Overall Study|Adverse Event|84|||
30748860|NCT00437645|58759012|FG000|Overall Study|Withdrawal by Subject|10|||
30806892|NCT04345367|58824388|FG001|Overall Study|Withdrawal by Subject|11|||
30806893|NCT04345367|58824387|FG000|Overall Study|Protocol Violation|4|||
30806894|NCT04345367|58824388|FG001|Overall Study|Protocol Violation|3|||
30908771|NCT01746862|58943532|FG001|Overall Study|Withdrawal by Subject|1|||
30908772|NCT01746862|58943531|FG000|Overall Study|Protocol Violation|1|||
30908773|NCT01746862|58943532|FG001|Overall Study|Protocol Violation|0|||
30908774|NCT01746862|58943531|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
30908775|NCT01746862|58943532|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
30908776|NCT01746862|58943531|FG000|Overall Study|Entered puberty during the study|1|||
30908777|NCT01746862|58943532|FG001|Overall Study|Entered puberty during the study|0|||
30908778|NCT01745848|58943539|FG000|Overall Study|Adverse Event|6|||
30908779|NCT01745380|58943545|FG000|Overall Study|Lost to Follow-up|1|||
30908780|NCT01745380|58943546|FG001|Overall Study|Lost to Follow-up|0|||
30908781|NCT01745380|58943545|FG000|Overall Study|Lack of Efficacy|0|||
30908782|NCT01745380|58943546|FG001|Overall Study|Lack of Efficacy|1|||
30908783|NCT01745146|58943554|FG000|Overall Study|Withdrawal by Subject|1|||
30908784|NCT01745146|58943555|FG001|Overall Study|Withdrawal by Subject|3|||
30908785|NCT01745146|58943554|FG000|Overall Study|Lost to Follow-up|2|||
30806895|NCT04345367|58824387|FG000|Overall Study|Lost to Follow-up|2|||
30806896|NCT04345367|58824388|FG001|Overall Study|Lost to Follow-up|4|||
30806897|NCT04345367|58824387|FG000|Overall Study|Lack of Efficacy|2|||
30908786|NCT01745146|58943555|FG001|Overall Study|Lost to Follow-up|0|||
30908787|NCT02203513|58943567|FG000|Overall Study|Refused further treatment|2|||
30908788|NCT02203513|58943568|FG001|Overall Study|Refused further treatment|0|||
30908789|NCT02203513|58943569|FG002|Overall Study|Refused further treatment|1|||
30908790|NCT02203513|58943570|FG003|Overall Study|Refused further treatment|0|||
30908791|NCT02203513|58943571|FG004|Overall Study|Refused further treatment|0|||
30806898|NCT04345367|58824388|FG001|Overall Study|Lack of Efficacy|0|||
30806899|NCT04345367|58824387|FG000|Overall Study|Death|2|||
30806900|NCT04345367|58824388|FG001|Overall Study|Death|0|||
30806901|NCT04345367|58824387|FG000|Overall Study|Adverse Event|10|||
30806902|NCT04345367|58824388|FG001|Overall Study|Adverse Event|9|||
30806903|NCT04404725|58824394|FG000|First Intervention|Withdrawal by Subject|0|||
30806904|NCT04404725|58824395|FG001|First Intervention|Withdrawal by Subject|2|||
30806905|NCT04404725|58824394|FG000|Second Intervention|Adverse Event|1|||
30806906|NCT04404725|58824395|FG001|Second Intervention|Adverse Event|1|||
30806907|NCT04404725|58824394|FG000|Second Intervention|Withdrawal by Subject|0|||
30806908|NCT04404725|58824395|FG001|Second Intervention|Withdrawal by Subject|1|||
30806909|NCT04343261|58824401|FG000|Overall Study|Adverse Event|1|||
30806910|NCT04343261|58824401|FG000|Overall Study|received inadequate amount of antibodies|7|||
30806911|NCT04336475|58824407|FG000|Overall Study|pain|1|||
30806912|NCT04336475|58824408|FG001|Overall Study|pain|0|||
30806913|NCT04336475|58824407|FG000|Overall Study|upper respiratory infection|1|||
30806914|NCT04336475|58824408|FG001|Overall Study|upper respiratory infection|0|||
30806915|NCT04336475|58824407|FG000|Overall Study|Lost to Follow-up|0|||
30806916|NCT04336475|58824408|FG001|Overall Study|Lost to Follow-up|2|||
30806917|NCT04335929|58824414|FG000|Overall Study|Lost to Follow-up|10|||
30806918|NCT04333199|58824421|FG000|Evaluated Patients|Lost to Follow-up|0|||
30806919|NCT04333199|58824422|FG001|Evaluated Patients|Lost to Follow-up|1|||
30806920|NCT04333199|58824423|FG002|Evaluated Patients|Lost to Follow-up|2|||
30806921|NCT04332419|58824432|FG000|Overall Study|Withdrawal by Subject|1|||
30806922|NCT04330157|58824436|FG000|Overall Study|Protocol Violation|4|||
30806923|NCT04330157|58824436|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
30806924|NCT04329923|58824451|FG000|Overall Study|Withdrawal by Subject|1|||
30806925|NCT04329923|58824452|FG001|Overall Study|Withdrawal by Subject|4|||
30806926|NCT04329923|58824453|FG002|Overall Study|Withdrawal by Subject|1|||
30806927|NCT04329923|58824454|FG003|Overall Study|Withdrawal by Subject|1|||
30908792|NCT02203513|58943567|FG000|Overall Study|Switched to alternative treatment|3|||
30908793|NCT02203513|58943568|FG001|Overall Study|Switched to alternative treatment|4|||
30908794|NCT02203513|58943569|FG002|Overall Study|Switched to alternative treatment|0|||
30908795|NCT02203513|58943570|FG003|Overall Study|Switched to alternative treatment|0|||
30908796|NCT02203513|58943571|FG004|Overall Study|Switched to alternative treatment|4|||
30908797|NCT02203513|58943567|FG000|Overall Study|Did not receive investigational product (IP)|0|||
30908798|NCT02203513|58943568|FG001|Overall Study|Did not receive investigational product (IP)|1|||
30908799|NCT02203513|58943569|FG002|Overall Study|Did not receive investigational product (IP)|0|||
30908800|NCT02203513|58943570|FG003|Overall Study|Did not receive investigational product (IP)|0|||
30806928|NCT04329923|58824455|FG004|Overall Study|Withdrawal by Subject|1|||
30908801|NCT02203513|58943571|FG004|Overall Study|Did not receive investigational product (IP)|0|||
30908802|NCT02203513|58943567|FG000|Overall Study|Death (unrelated to study therapy)|1|||
30806929|NCT04329923|58824456|FG005|Overall Study|Withdrawal by Subject|1|||
30806930|NCT04329923|58824451|FG000|Overall Study|early termination of study|0|||
30806931|NCT04329923|58824452|FG001|Overall Study|early termination of study|0|||
30908803|NCT02203513|58943568|FG001|Overall Study|Death (unrelated to study therapy)|3|||
30908804|NCT02203513|58943569|FG002|Overall Study|Death (unrelated to study therapy)|1|||
30908805|NCT02203513|58943570|FG003|Overall Study|Death (unrelated to study therapy)|0|||
30908806|NCT02203513|58943571|FG004|Overall Study|Death (unrelated to study therapy)|2|||
30908807|NCT02203513|58943567|FG000|Overall Study|Lost to Follow-up|0|||
30908808|NCT02203513|58943568|FG001|Overall Study|Lost to Follow-up|0|||
30908809|NCT02203513|58943569|FG002|Overall Study|Lost to Follow-up|1|||
30908810|NCT02203513|58943570|FG003|Overall Study|Lost to Follow-up|1|||
30806932|NCT04329923|58824453|FG002|Overall Study|early termination of study|0|||
30908811|NCT02203513|58943571|FG004|Overall Study|Lost to Follow-up|0|||
30908812|NCT02299934|58943585|FG000|Overall Study|Termination of study|13|||
30806933|NCT04329923|58824454|FG003|Overall Study|early termination of study|0|||
30806934|NCT04329923|58824455|FG004|Overall Study|early termination of study|1|||
30806935|NCT04329923|58824456|FG005|Overall Study|early termination of study|2|||
30806936|NCT04329923|58824451|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
30806937|NCT04329923|58824452|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
30806938|NCT04329923|58824453|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
30806939|NCT04329923|58824454|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
30806940|NCT04329923|58824455|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
30806941|NCT04329923|58824456|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
30806942|NCT04403399|58824472|FG000|Period 2|Physician Decision|0|||
30806943|NCT04403399|58824473|FG001|Period 2|Physician Decision|1|||
30806944|NCT04401293|58824481|FG000|Overall Study|Withdrawal by Subject|1|||
30806945|NCT04401293|58824482|FG001|Overall Study|Withdrawal by Subject|3|||
30806946|NCT04319159|58824490|FG000|Overall Study|Screening failure|13|||
30806947|NCT04319159|58824490|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
30806948|NCT04319159|58824490|FG000|Overall Study|Withdrawal by Subject|1|||
30806949|NCT04318535|58824496|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
30806950|NCT04318535|58824497|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
30806951|NCT04318535|58824498|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
30806952|NCT04454567|58824509|FG000|Overall Study|Study Terminated by Sponsor|1|||
30806953|NCT04454567|58824510|FG001|Overall Study|Study Terminated by Sponsor|1|||
30806954|NCT04449341|58824518|FG000|Overall Study|Protocol Violation|1|||
30806955|NCT04449341|58824519|FG001|Overall Study|Protocol Violation|0|||
30806956|NCT04448561|58824527|FG000|Overall Study|Noncompliance|1|||
30806957|NCT04448561|58824528|FG001|Overall Study|Noncompliance|0|||
30806958|NCT04308239|58824544|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
30806959|NCT04308239|58824545|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
30806960|NCT04308239|58824544|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
30806961|NCT04308239|58824545|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
30806962|NCT04308239|58824544|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
30806963|NCT04308239|58824545|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
30806964|NCT04308239|58824544|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
30806965|NCT04308239|58824545|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
30806966|NCT04302545|58824557|FG000|Overall Study|Lost to Follow-up|3|||
30806967|NCT04302545|58824558|FG001|Overall Study|Lost to Follow-up|4|||
30806968|NCT04297241|58824575|FG000|Overall Study|Withdrawal by Subject|1|||
30806969|NCT04297241|58824575|FG000|Overall Study|Adverse Event|1|||
30806970|NCT04297241|58824575|FG000|Overall Study|Physician Decision|3|||
30806971|NCT04292171|58824591|FG000|Overall Study|Pharmacy error|2|||
30806972|NCT04292171|58824592|FG001|Overall Study|Pharmacy error|0|||
30806973|NCT04292171|58824591|FG000|Overall Study|Delivered prior to procedure|0|||
30806974|NCT04292171|58824592|FG001|Overall Study|Delivered prior to procedure|1|||
30806975|NCT04393493|58824600|FG000|First 4 Days of Intervention|Early improvement|5|||
30806976|NCT04393493|58824601|FG001|First 4 Days of Intervention|Early improvement|7|||
30806977|NCT04280705|58824611|FG000|Overall Study|Enrolled but not treated|4|||
30806978|NCT04280705|58824612|FG001|Overall Study|Enrolled but not treated|10|||
30806979|NCT04280705|58824611|FG000|Overall Study|Physician Decision|1|||
30806980|NCT04280705|58824612|FG001|Overall Study|Physician Decision|0|||
30806981|NCT04280705|58824611|FG000|Overall Study|Withdrawal by Subject|7|||
30806982|NCT04280705|58824612|FG001|Overall Study|Withdrawal by Subject|9|||
30806983|NCT04280705|58824611|FG000|Overall Study|Adverse Event|0|||
30806984|NCT04280705|58824612|FG001|Overall Study|Adverse Event|4|||
30908813|NCT01703260|58943592|FG000|Overall Study|Adverse Event|1|||
30806985|NCT04280705|58824611|FG000|Overall Study|Transferred to another hospital|1|||
30908814|NCT01703260|58943593|FG001|Overall Study|Adverse Event|2|||
30908815|NCT01703260|58943594|FG002|Overall Study|Adverse Event|2|||
30908816|NCT01703260|58943592|FG000|Overall Study|Lost to Follow-up|1|||
30622446|NCT00923260|58634157|FG001|Overall Study|Lost to Follow-up|1|||
30806986|NCT04280705|58824612|FG001|Overall Study|Transferred to another hospital|1|||
30908817|NCT01703260|58943593|FG001|Overall Study|Lost to Follow-up|0|||
30908818|NCT01703260|58943594|FG002|Overall Study|Lost to Follow-up|0|||
30622447|NCT00934102|58634163|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
30806987|NCT02077166|58824625|FG000|Overall Study|Death|6|||
30806988|NCT02077166|58824626|FG001|Overall Study|Death|7|||
30806989|NCT02077166|58824627|FG002|Overall Study|Death|5|||
30806990|NCT02077166|58824628|FG003|Overall Study|Death|6|||
30806991|NCT02077166|58824629|FG004|Overall Study|Death|4|||
30806992|NCT02077166|58824630|FG005|Overall Study|Death|32|||
30806993|NCT02077166|58824631|FG006|Overall Study|Death|22|||
30806994|NCT02077166|58824625|FG000|Overall Study|Study Closure by Sponsor|3|||
30806995|NCT02077166|58824626|FG001|Overall Study|Study Closure by Sponsor|0|||
30806996|NCT02077166|58824627|FG002|Overall Study|Study Closure by Sponsor|2|||
30806997|NCT02077166|58824628|FG003|Overall Study|Study Closure by Sponsor|2|||
30806998|NCT02077166|58824629|FG004|Overall Study|Study Closure by Sponsor|2|||
30806999|NCT02077166|58824630|FG005|Overall Study|Study Closure by Sponsor|12|||
30807000|NCT02077166|58824631|FG006|Overall Study|Study Closure by Sponsor|4|||
30807001|NCT02077166|58824625|FG000|Overall Study|Lost to Follow-up|0|||
30807002|NCT02077166|58824626|FG001|Overall Study|Lost to Follow-up|0|||
30807003|NCT02077166|58824627|FG002|Overall Study|Lost to Follow-up|0|||
30807004|NCT02077166|58824628|FG003|Overall Study|Lost to Follow-up|0|||
30807005|NCT02077166|58824629|FG004|Overall Study|Lost to Follow-up|0|||
30807006|NCT02077166|58824630|FG005|Overall Study|Lost to Follow-up|1|||
30807007|NCT02077166|58824631|FG006|Overall Study|Lost to Follow-up|0|||
30807008|NCT02077166|58824625|FG000|Overall Study|Withdrawal by Subject|3|||
30807009|NCT02077166|58824626|FG001|Overall Study|Withdrawal by Subject|0|||
30807010|NCT02077166|58824627|FG002|Overall Study|Withdrawal by Subject|1|||
30807011|NCT02077166|58824628|FG003|Overall Study|Withdrawal by Subject|1|||
30807012|NCT02077166|58824629|FG004|Overall Study|Withdrawal by Subject|1|||
30807013|NCT02077166|58824630|FG005|Overall Study|Withdrawal by Subject|3|||
30807014|NCT02077166|58824631|FG006|Overall Study|Withdrawal by Subject|0|||
30807015|NCT02077166|58824625|FG000|Overall Study|Other, Not Specified|0|||
30807016|NCT02077166|58824626|FG001|Overall Study|Other, Not Specified|0|||
30807017|NCT02077166|58824627|FG002|Overall Study|Other, Not Specified|1|||
30807018|NCT02077166|58824628|FG003|Overall Study|Other, Not Specified|0|||
30807019|NCT02077166|58824629|FG004|Overall Study|Other, Not Specified|1|||
30807020|NCT02077166|58824630|FG005|Overall Study|Other, Not Specified|7|||
30807021|NCT02077166|58824631|FG006|Overall Study|Other, Not Specified|8|||
30807022|NCT04273217|58824658|FG000|Overall Study|Lost to Follow-up|0|||
30807023|NCT04273217|58824659|FG001|Overall Study|Lost to Follow-up|0|||
30807024|NCT04273217|58824660|FG002|Overall Study|Lost to Follow-up|0|||
30807025|NCT04273217|58824661|FG003|Overall Study|Lost to Follow-up|0|||
30807026|NCT04273217|58824662|FG004|Overall Study|Lost to Follow-up|0|||
30807027|NCT04273217|58824663|FG005|Overall Study|Lost to Follow-up|1|||
30807028|NCT04273217|58824658|FG000|Overall Study|Participant non-compliance|0|||
30807029|NCT04273217|58824659|FG001|Overall Study|Participant non-compliance|0|||
30807030|NCT04273217|58824660|FG002|Overall Study|Participant non-compliance|0|||
30807031|NCT04273217|58824661|FG003|Overall Study|Participant non-compliance|0|||
30807032|NCT04273217|58824662|FG004|Overall Study|Participant non-compliance|1|||
30807033|NCT04273217|58824663|FG005|Overall Study|Participant non-compliance|0|||
30807034|NCT04273217|58824658|FG000|Overall Study|Positive urine drug screen|1|||
30807035|NCT04273217|58824659|FG001|Overall Study|Positive urine drug screen|0|||
30807036|NCT04273217|58824660|FG002|Overall Study|Positive urine drug screen|1|||
30807037|NCT04273217|58824661|FG003|Overall Study|Positive urine drug screen|0|||
30807038|NCT04273217|58824662|FG004|Overall Study|Positive urine drug screen|0|||
30807039|NCT04273217|58824663|FG005|Overall Study|Positive urine drug screen|1|||
30807040|NCT04384523|58824683|FG000|Overall Study|Lost to Follow-up|0|||
30807041|NCT04384523|58824684|FG001|Overall Study|Lost to Follow-up|0|||
30807042|NCT04384523|58824685|FG002|Overall Study|Lost to Follow-up|0|||
30807043|NCT04384523|58824686|FG003|Overall Study|Lost to Follow-up|0|||
30807044|NCT04384523|58824687|FG004|Overall Study|Lost to Follow-up|0|||
30908819|NCT01703260|58943592|FG000|Overall Study|Withdrawal by Subject|0|||
30908820|NCT01703260|58943593|FG001|Overall Study|Withdrawal by Subject|0|||
30908821|NCT01703260|58943594|FG002|Overall Study|Withdrawal by Subject|1|||
30908822|NCT01703260|58943592|FG000|Overall Study|Study Termination|1|||
30908823|NCT01703260|58943593|FG001|Overall Study|Study Termination|2|||
30807045|NCT04384523|58824688|FG005|Overall Study|Lost to Follow-up|1|||
30807046|NCT04384523|58824683|FG000|Overall Study|Protocol Violation|0|||
30807047|NCT04384523|58824684|FG001|Overall Study|Protocol Violation|1|||
30807048|NCT04384523|58824685|FG002|Overall Study|Protocol Violation|0|||
30807049|NCT04384523|58824686|FG003|Overall Study|Protocol Violation|0|||
30807050|NCT04384523|58824687|FG004|Overall Study|Protocol Violation|0|||
30807051|NCT04384523|58824688|FG005|Overall Study|Protocol Violation|0|||
30908824|NCT01703260|58943594|FG002|Overall Study|Study Termination|0|||
30807052|NCT04384523|58824683|FG000|Overall Study|Withdrawal by Subject|1|||
30807053|NCT04384523|58824684|FG001|Overall Study|Withdrawal by Subject|0|||
30807054|NCT04384523|58824685|FG002|Overall Study|Withdrawal by Subject|0|||
30807055|NCT04384523|58824686|FG003|Overall Study|Withdrawal by Subject|0|||
30908825|NCT02203357|58943605|FG000|Overall Study|Lost to Follow-up|58|||
30807056|NCT04384523|58824687|FG004|Overall Study|Withdrawal by Subject|0|||
30807057|NCT04384523|58824688|FG005|Overall Study|Withdrawal by Subject|0|||
30908826|NCT02203357|58943606|FG001|Overall Study|Lost to Follow-up|66|||
30908827|NCT02203357|58943607|FG002|Overall Study|Lost to Follow-up|70|||
30908828|NCT02299388|58943620|FG000|Overall Study|Withdrawal by Subject|0|||
30908829|NCT02299388|58943621|FG001|Overall Study|Withdrawal by Subject|1|||
30807058|NCT04382651|58824723|FG000|Overall Study|Death|26|||
30807059|NCT04382651|58824724|FG001|Overall Study|Death|23|||
30908830|NCT02202577|58943629|FG000|Overall Study|Lost to Follow-up|6|||
30908831|NCT02202577|58943630|FG001|Overall Study|Lost to Follow-up|16|||
30908832|NCT02202577|58943629|FG000|Overall Study|Protocol Violation|7|||
30908833|NCT02202577|58943630|FG001|Overall Study|Protocol Violation|3|||
30908834|NCT02299076|58943638|FG000|Overall Study|Fraudulent Entries|20|||
30908835|NCT02299076|58943639|FG001|Overall Study|Fraudulent Entries|14|||
30908836|NCT01723072|58943647|FG000|Overall Study|Withdrawal by Subject|7|||
30908837|NCT01723072|58943648|FG001|Overall Study|Withdrawal by Subject|13|||
30908838|NCT01723072|58943647|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
30908839|NCT01723072|58943648|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
30908840|NCT01723072|58943647|FG000|Overall Study|Other|4|||
30908841|NCT01723072|58943648|FG001|Overall Study|Other|3|||
30807060|NCT04382651|58824723|FG000|Overall Study|Lost to Follow-up|3|||
30807061|NCT04382651|58824724|FG001|Overall Study|Lost to Follow-up|4|||
30807062|NCT04382651|58824723|FG000|Overall Study|Withdrawal by Subject|2|||
30807063|NCT04382651|58824724|FG001|Overall Study|Withdrawal by Subject|0|||
30807064|NCT04382651|58824723|FG000|Overall Study|Physician Decision|0|||
30807065|NCT04382651|58824724|FG001|Overall Study|Physician Decision|1|||
30807066|NCT04238663|58824739|FG000|Overall Study|Lost to Follow-up|0|||
30807067|NCT04238663|58824740|FG001|Overall Study|Lost to Follow-up|1|||
30807068|NCT04238663|58824741|FG002|Overall Study|Lost to Follow-up|0|||
30807069|NCT03442088|58824749|FG000|Overall Study|Adverse Event|1|||
30807070|NCT03442088|58824749|FG000|Overall Study|Lack of Efficacy|2|||
30807071|NCT03442088|58824749|FG000|Overall Study|Lost to Follow-up|2|||
30807072|NCT04223687|58824755|FG000|Overall Study|Missing primary outcome|1|||
30807073|NCT04223687|58824756|FG001|Overall Study|Missing primary outcome|0|||
30807074|NCT03722576|58824762|FG000|Overall Study|Withdrawal by Subject|3|||
30807075|NCT03722576|58824762|FG000|Overall Study|Adverse Event|2|||
30807076|NCT03722576|58824762|FG000|Overall Study|Physician Decision|1|||
30807077|NCT03722576|58824762|FG000|Overall Study|Lost to Follow-up|1|||
30807078|NCT03693989|58824768|FG000|Overall Study|Protocol Violation|3|||
30807079|NCT03693989|58824769|FG001|Overall Study|Protocol Violation|4|||
30807080|NCT04206293|58824775|FG000|Overall Study|Consent withdrawal|1|||
30807081|NCT02727998|58824782|FG000|Overall Study|Lost to Follow-up|3|||
30807082|NCT02727998|58824783|FG001|Overall Study|Lost to Follow-up|3|||
30807083|NCT02727998|58824782|FG000|Overall Study|Withdrawal by Subject|0|||
30807084|NCT02727998|58824783|FG001|Overall Study|Withdrawal by Subject|1|||
30807085|NCT04366349|58824795|FG000|Overall Study|Withdrawal by Subject|1|||
30807086|NCT04366349|58824796|FG001|Overall Study|Withdrawal by Subject|0|||
30807087|NCT04366349|58824797|FG002|Overall Study|Withdrawal by Subject|0|||
30807088|NCT04366349|58824798|FG003|Overall Study|Withdrawal by Subject|0|||
30807089|NCT04366349|58824799|FG004|Overall Study|Withdrawal by Subject|0|||
30807090|NCT04366349|58824800|FG005|Overall Study|Withdrawal by Subject|0|||
30807091|NCT04179461|58824818|FG000|Overall Study|Lost to Follow-up|4|||
30807092|NCT04017611|58824822|FG000|Overall Study|Withdrawn prior to completion|1|||
30807093|NCT04172831|58824837|FG000|Overall Study|Adverse Event|21|||
30807094|NCT04172831|58824838|FG001|Overall Study|Adverse Event|9|||
30807095|NCT04172831|58824837|FG000|Overall Study|Lack of Efficacy|2|||
30807096|NCT04172831|58824838|FG001|Overall Study|Lack of Efficacy|8|||
30807097|NCT04172831|58824837|FG000|Overall Study|Physician Decision|0|||
30807098|NCT04172831|58824838|FG001|Overall Study|Physician Decision|1|||
30807099|NCT04172831|58824837|FG000|Overall Study|Withdrawal by Subject|12|||
30807100|NCT04172831|58824838|FG001|Overall Study|Withdrawal by Subject|11|||
30807101|NCT04172831|58824837|FG000|Overall Study|Lost to Follow-up|4|||
30807102|NCT04172831|58824838|FG001|Overall Study|Lost to Follow-up|9|||
30807103|NCT04172831|58824837|FG000|Overall Study|COVID-19 related crisis|3|||
30807104|NCT04172831|58824838|FG001|Overall Study|COVID-19 related crisis|3|||
30807105|NCT04172831|58824837|FG000|Overall Study|Subject non-compliance|1|||
30807106|NCT04172831|58824838|FG001|Overall Study|Subject non-compliance|1|||
30807107|NCT04172831|58824837|FG000|Overall Study|Family emergency|1|||
30807108|NCT04172831|58824838|FG001|Overall Study|Family emergency|0|||
30908842|NCT01722994|58943656|FG000|Overall Study|Missing data|25|||
30908843|NCT01722994|58943657|FG001|Overall Study|Missing data|17|||
30908844|NCT02228395|58943665|FG000|First Intervention Period|No longer willing to participate|1|||
30807109|NCT04165031|58824855|FG000|Overall Study|Adverse Event|1|||
30807110|NCT04165031|58824856|FG001|Overall Study|Adverse Event|1|||
30807111|NCT04165031|58824857|FG002|Overall Study|Adverse Event|0|||
30807112|NCT04165031|58824858|FG003|Overall Study|Adverse Event|0|||
30807113|NCT04165031|58824859|FG004|Overall Study|Adverse Event|0|||
30807114|NCT04165031|58824860|FG005|Overall Study|Adverse Event|0|||
30807115|NCT04165031|58824855|FG000|Overall Study|Withdrawal by Subject|0|||
30807116|NCT04165031|58824856|FG001|Overall Study|Withdrawal by Subject|0|||
30807117|NCT04165031|58824857|FG002|Overall Study|Withdrawal by Subject|1|||
30807118|NCT04165031|58824858|FG003|Overall Study|Withdrawal by Subject|0|||
30807119|NCT04165031|58824859|FG004|Overall Study|Withdrawal by Subject|0|||
30807120|NCT04165031|58824860|FG005|Overall Study|Withdrawal by Subject|0|||
30807121|NCT02712424|58824877|FG000|Overall Study|Lost to Follow-up|34|||
30807122|NCT02712424|58824878|FG001|Overall Study|Lost to Follow-up|32|||
30807123|NCT02968004|58824886|FG000|Overall Study|Adverse Event|1|||
30807124|NCT02968004|58824887|FG001|Overall Study|Adverse Event|0|||
30807125|NCT02968004|58824886|FG000|Overall Study|Withdrawal by Subject|0|||
30807126|NCT02968004|58824887|FG001|Overall Study|Withdrawal by Subject|1|||
30807127|NCT03034772|58824895|FG000|Overall Study|Adverse Event|0|||
30807128|NCT03034772|58824896|FG001|Overall Study|Adverse Event|1|||
30807129|NCT03034772|58824895|FG000|Overall Study|Withdrawal by Subject|0|||
30807130|NCT03034772|58824896|FG001|Overall Study|Withdrawal by Subject|1|||
30807131|NCT03032198|58824902|FG000|Overall Study|Screen Fail|1|||
30807132|NCT02431364|58824911|FG000|Overall Study|Adverse Event|0|||
30807133|NCT02431364|58824912|FG001|Overall Study|Adverse Event|1|||
30807134|NCT02431364|58824913|FG002|Overall Study|Adverse Event|0|||
30807135|NCT02431364|58824914|FG003|Overall Study|Adverse Event|0|||
30807136|NCT02431364|58824915|FG004|Overall Study|Adverse Event|0|||
30807137|NCT02431364|58824911|FG000|Overall Study|Randomized but never treated|0|||
30807138|NCT02431364|58824912|FG001|Overall Study|Randomized but never treated|0|||
30807139|NCT02431364|58824913|FG002|Overall Study|Randomized but never treated|0|||
30807140|NCT02431364|58824914|FG003|Overall Study|Randomized but never treated|1|||
30807141|NCT02431364|58824915|FG004|Overall Study|Randomized but never treated|0|||
30807142|NCT03034460|58824933|FG000|Overall Study|Adverse Event|0|||
30807143|NCT03034460|58824934|FG001|Overall Study|Adverse Event|1|||
30807144|NCT03034460|58824933|FG000|Overall Study|Withdrawal by Subject|2|||
30807145|NCT03034460|58824934|FG001|Overall Study|Withdrawal by Subject|2|||
30908845|NCT02228395|58943666|FG001|First Intervention Period|No longer willing to participate|0|||
30908846|NCT02228395|58943667|FG002|First Intervention Period|No longer willing to participate|0|||
30908847|NCT02228395|58943665|FG000|First Intervention Period|Unable to comply with study dates|0|||
30908848|NCT02228395|58943666|FG001|First Intervention Period|Unable to comply with study dates|1|||
30908849|NCT02228395|58943667|FG002|First Intervention Period|Unable to comply with study dates|1|||
30908850|NCT02170051|58943679|FG000|Overall Study|Withdrawal by Subject|10|||
30807146|NCT03034460|58824933|FG000|Overall Study|Personal Reasons|1|||
30807147|NCT03034460|58824934|FG001|Overall Study|Personal Reasons|0|||
30807148|NCT04162769|58824947|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
30807149|NCT04162769|58824948|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
30807150|NCT04162769|58824949|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
30807151|NCT04162769|58824950|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
30807152|NCT04162769|58824947|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
30807153|NCT04162769|58824948|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
30807154|NCT04162769|58824949|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
30807155|NCT04162769|58824950|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
30807156|NCT04162769|58824947|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
30807157|NCT04162769|58824948|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
30807158|NCT04162769|58824949|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
30807159|NCT04162769|58824950|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
30807160|NCT04162769|58824947|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
30807161|NCT04162769|58824948|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
30807162|NCT04162769|58824949|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
30807163|NCT04162769|58824950|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
30807164|NCT04162769|58824947|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
30807165|NCT04162769|58824948|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
30807166|NCT04162769|58824949|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
30807167|NCT04162769|58824950|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
30807168|NCT04162769|58824947|FG000|Double-blind Treatment (12-Week)|Other|0|||
30807169|NCT04162769|58824948|FG001|Double-blind Treatment (12-Week)|Other|1|||
30807170|NCT04162769|58824949|FG002|Double-blind Treatment (12-Week)|Other|1|||
30807171|NCT04162769|58824950|FG003|Double-blind Treatment (12-Week)|Other|0|||
30807172|NCT04162769|58824947|FG000|OLE Period (52-Week)|Adverse Event|0|||
30807173|NCT04162769|58824948|FG001|OLE Period (52-Week)|Adverse Event|0|||
30807174|NCT04162769|58824949|FG002|OLE Period (52-Week)|Adverse Event|0|||
30807175|NCT04162769|58824950|FG003|OLE Period (52-Week)|Adverse Event|5|||
30908851|NCT02170051|58943680|FG001|Overall Study|Withdrawal by Subject|10|||
30908852|NCT02170051|58943679|FG000|Overall Study|Lost to Follow-up|1|||
30908853|NCT02170051|58943680|FG001|Overall Study|Lost to Follow-up|3|||
30807176|NCT04162769|58824947|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
30807177|NCT04162769|58824948|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
30807178|NCT04162769|58824949|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
30807179|NCT04162769|58824950|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
30807180|NCT04162769|58824947|FG000|OLE Period (52-Week)|Physician Decision|0|||
30807181|NCT04162769|58824948|FG001|OLE Period (52-Week)|Physician Decision|0|||
30807182|NCT04162769|58824949|FG002|OLE Period (52-Week)|Physician Decision|0|||
30807183|NCT04162769|58824950|FG003|OLE Period (52-Week)|Physician Decision|1|||
30807184|NCT04162769|58824947|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
30807185|NCT04162769|58824948|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
30908854|NCT02169739|58943688|FG000|Overall Study|Lost to Follow-up|0|||
30908855|NCT02169739|58943689|FG001|Overall Study|Lost to Follow-up|4|||
30908856|NCT02169505|58943696|FG000|Overall Study|Withdrawal by Subject|1|||
30908857|NCT01909791|58943703|FG000|Overall Study|Death|9|||
30908858|NCT01909791|58943704|FG001|Overall Study|Death|8|||
30908859|NCT01909791|58943705|FG002|Overall Study|Death|4|||
30908860|NCT01909791|58943703|FG000|Overall Study|Withdrawal by Subject|5|||
30908861|NCT01909791|58943704|FG001|Overall Study|Withdrawal by Subject|9|||
30908862|NCT01909791|58943705|FG002|Overall Study|Withdrawal by Subject|13|||
30807186|NCT04162769|58824949|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
30807187|NCT04162769|58824950|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
30807188|NCT04162769|58824947|FG000|OLE Period (52-Week)|Protocol deviation|0|||
30807189|NCT04162769|58824948|FG001|OLE Period (52-Week)|Protocol deviation|0|||
30807190|NCT04162769|58824949|FG002|OLE Period (52-Week)|Protocol deviation|0|||
30807191|NCT04162769|58824950|FG003|OLE Period (52-Week)|Protocol deviation|2|||
30807192|NCT04161131|58824961|FG000|Overall Study|Ineligible|2|||
30807193|NCT04161131|58824961|FG000|Overall Study|Lost to Follow-up|4|||
30807194|NCT04155047|58824967|FG000|Overall Study|Adverse Event|1|||
30807195|NCT04155047|58824968|FG001|Overall Study|Adverse Event|0|||
30807196|NCT04155047|58824967|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
30807197|NCT04155047|58824968|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
30807198|NCT04152083|58824976|FG000|Overall Study|Lost to Follow-up|2|||
30807199|NCT04152083|58824977|FG001|Overall Study|Lost to Follow-up|1|||
30807200|NCT04152083|58824976|FG000|Overall Study|Adverse Event|1|||
30807201|NCT04152083|58824977|FG001|Overall Study|Adverse Event|0|||
30807202|NCT04152083|58824976|FG000|Overall Study|Randomized but not treated|3|||
30807203|NCT04152083|58824977|FG001|Overall Study|Randomized but not treated|2|||
30807204|NCT02711956|58824998|FG000|Overall Study|Adverse Event|0|||
30807205|NCT02711956|58824999|FG001|Overall Study|Adverse Event|0|||
30807206|NCT02711956|58825000|FG002|Overall Study|Adverse Event|0|||
30807207|NCT02711956|58825001|FG003|Overall Study|Adverse Event|1|||
30807208|NCT02711956|58825002|FG004|Overall Study|Adverse Event|2|||
30807209|NCT02711956|58825003|FG005|Overall Study|Adverse Event|0|||
30807210|NCT02711956|58825004|FG006|Overall Study|Adverse Event|0|||
30807211|NCT02711956|58825005|FG007|Overall Study|Adverse Event|1|||
30807212|NCT02711956|58825006|FG008|Overall Study|Adverse Event|1|||
30807213|NCT02711956|58825007|FG009|Overall Study|Adverse Event|1|||
30807214|NCT02711956|58825008|FG010|Overall Study|Adverse Event|1|||
30807215|NCT02711956|58825009|FG011|Overall Study|Adverse Event|0|||
30807216|NCT02711956|58825010|FG012|Overall Study|Adverse Event|0|||
30807217|NCT02711956|58825011|FG013|Overall Study|Adverse Event|0|||
30807218|NCT02711956|58825012|FG014|Overall Study|Adverse Event|2|||
30807219|NCT02711956|58824998|FG000|Overall Study|Physician Decision|0|||
30807220|NCT02711956|58824999|FG001|Overall Study|Physician Decision|0|||
30807221|NCT02711956|58825000|FG002|Overall Study|Physician Decision|0|||
30807222|NCT02711956|58825001|FG003|Overall Study|Physician Decision|2|||
30807223|NCT02711956|58825002|FG004|Overall Study|Physician Decision|0|||
30807224|NCT02711956|58825003|FG005|Overall Study|Physician Decision|0|||
30807225|NCT02711956|58825004|FG006|Overall Study|Physician Decision|0|||
30807226|NCT02711956|58825005|FG007|Overall Study|Physician Decision|0|||
30748861|NCT00437645|58759013|FG001|Overall Study|Withdrawal by Subject|22|||
30748862|NCT00437645|58759012|FG000|Overall Study|Protocol Violation|3|||
30748863|NCT00437645|58759013|FG001|Overall Study|Protocol Violation|3|||
30748864|NCT00437645|58759012|FG000|Overall Study|Lost to Follow-up|2|||
30748865|NCT00437645|58759013|FG001|Overall Study|Lost to Follow-up|3|||
30748866|NCT00437645|58759012|FG000|Overall Study|Administrative problems|2|||
30748867|NCT00437645|58759013|FG001|Overall Study|Administrative problems|1|||
30748868|NCT00437645|58759012|FG000|Overall Study|Lack of Efficacy|2|||
30748869|NCT00437645|58759013|FG001|Overall Study|Lack of Efficacy|1|||
30807227|NCT02711956|58825006|FG008|Overall Study|Physician Decision|0|||
30908863|NCT01909791|58943703|FG000|Overall Study|Lost to Follow-up|5|||
30748870|NCT00437645|58759012|FG000|Overall Study|Condition no longer requires study drug|1|||
30908864|NCT01909791|58943704|FG001|Overall Study|Lost to Follow-up|11|||
30748871|NCT00437645|58759013|FG001|Overall Study|Condition no longer requires study drug|1|||
30807228|NCT02711956|58825007|FG009|Overall Study|Physician Decision|0|||
30807229|NCT02711956|58825008|FG010|Overall Study|Physician Decision|0|||
30807230|NCT02711956|58825009|FG011|Overall Study|Physician Decision|0|||
30807231|NCT02711956|58825010|FG012|Overall Study|Physician Decision|0|||
30807232|NCT02711956|58825011|FG013|Overall Study|Physician Decision|0|||
30807233|NCT02711956|58825012|FG014|Overall Study|Physician Decision|0|||
30807234|NCT02711956|58824998|FG000|Overall Study|Withdrawal by Subject|0|||
30807235|NCT02711956|58824999|FG001|Overall Study|Withdrawal by Subject|0|||
30807236|NCT02711956|58825000|FG002|Overall Study|Withdrawal by Subject|0|||
30807237|NCT02711956|58825001|FG003|Overall Study|Withdrawal by Subject|0|||
30807238|NCT02711956|58825002|FG004|Overall Study|Withdrawal by Subject|0|||
30807239|NCT02711956|58825003|FG005|Overall Study|Withdrawal by Subject|0|||
30807240|NCT02711956|58825004|FG006|Overall Study|Withdrawal by Subject|1|||
30807241|NCT02711956|58825005|FG007|Overall Study|Withdrawal by Subject|0|||
30807242|NCT02711956|58825006|FG008|Overall Study|Withdrawal by Subject|0|||
30807243|NCT02711956|58825007|FG009|Overall Study|Withdrawal by Subject|0|||
30807244|NCT02711956|58825008|FG010|Overall Study|Withdrawal by Subject|0|||
30807245|NCT02711956|58825009|FG011|Overall Study|Withdrawal by Subject|1|||
30807246|NCT02711956|58825010|FG012|Overall Study|Withdrawal by Subject|6|||
30807247|NCT02711956|58825011|FG013|Overall Study|Withdrawal by Subject|0|||
30748872|NCT00437489|58759021|FG000|Overall Study|Study terminated by sponsor|23|||
30807248|NCT02711956|58825012|FG014|Overall Study|Withdrawal by Subject|1|||
30807249|NCT02711956|58824998|FG000|Overall Study|Clinical progression|1|||
30807250|NCT02711956|58824999|FG001|Overall Study|Clinical progression|0|||
30807251|NCT02711956|58825000|FG002|Overall Study|Clinical progression|0|||
30807252|NCT02711956|58825001|FG003|Overall Study|Clinical progression|0|||
30807253|NCT02711956|58825002|FG004|Overall Study|Clinical progression|0|||
30807254|NCT02711956|58825003|FG005|Overall Study|Clinical progression|0|||
30807255|NCT02711956|58825004|FG006|Overall Study|Clinical progression|1|||
30807256|NCT02711956|58825005|FG007|Overall Study|Clinical progression|0|||
30807257|NCT02711956|58825006|FG008|Overall Study|Clinical progression|1|||
30807258|NCT02711956|58825007|FG009|Overall Study|Clinical progression|0|||
30807259|NCT02711956|58825008|FG010|Overall Study|Clinical progression|0|||
30748873|NCT00437489|58759022|FG001|Overall Study|Study terminated by sponsor|21|||
30807260|NCT02711956|58825009|FG011|Overall Study|Clinical progression|2|||
30807261|NCT02711956|58825010|FG012|Overall Study|Clinical progression|4|||
30807262|NCT02711956|58825011|FG013|Overall Study|Clinical progression|1|||
30807263|NCT02711956|58825012|FG014|Overall Study|Clinical progression|1|||
30807264|NCT02711956|58824998|FG000|Overall Study|Radiographic progression|1|||
30807265|NCT02711956|58824999|FG001|Overall Study|Radiographic progression|1|||
30807266|NCT02711956|58825000|FG002|Overall Study|Radiographic progression|2|||
30807267|NCT02711956|58825001|FG003|Overall Study|Radiographic progression|0|||
30807268|NCT02711956|58825002|FG004|Overall Study|Radiographic progression|1|||
30807269|NCT02711956|58825003|FG005|Overall Study|Radiographic progression|0|||
30807270|NCT02711956|58825004|FG006|Overall Study|Radiographic progression|0|||
30807271|NCT02711956|58825005|FG007|Overall Study|Radiographic progression|0|||
30807272|NCT02711956|58825006|FG008|Overall Study|Radiographic progression|2|||
30807273|NCT02711956|58825007|FG009|Overall Study|Radiographic progression|1|||
30807274|NCT02711956|58825008|FG010|Overall Study|Radiographic progression|0|||
30807275|NCT02711956|58825009|FG011|Overall Study|Radiographic progression|5|||
30807276|NCT02711956|58825010|FG012|Overall Study|Radiographic progression|3|||
30807277|NCT02711956|58825011|FG013|Overall Study|Radiographic progression|0|||
30807278|NCT02711956|58825012|FG014|Overall Study|Radiographic progression|1|||
30807279|NCT02711956|58824998|FG000|Overall Study|PSA progression with clinical progression|0|||
30807280|NCT02711956|58824999|FG001|Overall Study|PSA progression with clinical progression|0|||
30807281|NCT02711956|58825000|FG002|Overall Study|PSA progression with clinical progression|0|||
30807282|NCT02711956|58825001|FG003|Overall Study|PSA progression with clinical progression|0|||
30807283|NCT02711956|58825002|FG004|Overall Study|PSA progression with clinical progression|1|||
30807284|NCT02711956|58825003|FG005|Overall Study|PSA progression with clinical progression|0|||
30807285|NCT02711956|58825004|FG006|Overall Study|PSA progression with clinical progression|0|||
30748874|NCT00437489|58759021|FG000|Overall Study|Lost to Follow-up|0|||
30748875|NCT00437489|58759022|FG001|Overall Study|Lost to Follow-up|1|||
30748876|NCT00442559|58759030|FG000|Overall Study|Lost to Follow-up|32|||
30748877|NCT00442559|58759031|FG001|Overall Study|Lost to Follow-up|34|||
30748878|NCT00442559|58759030|FG000|Overall Study|Protocol Violation|1|||
30748879|NCT00442559|58759031|FG001|Overall Study|Protocol Violation|1|||
30748880|NCT00442559|58759030|FG000|Overall Study|Withdrawal by Subject|1|||
30748881|NCT00442559|58759031|FG001|Overall Study|Withdrawal by Subject|0|||
30748882|NCT00441701|58759053|FG000|Overall Study|Adverse Event|3|||
30748883|NCT00441701|58759054|FG001|Overall Study|Adverse Event|2|||
30807286|NCT02711956|58825005|FG007|Overall Study|PSA progression with clinical progression|0|||
30807287|NCT02711956|58825006|FG008|Overall Study|PSA progression with clinical progression|0|||
30807288|NCT02711956|58825007|FG009|Overall Study|PSA progression with clinical progression|0|||
30748884|NCT00441701|58759055|FG002|Overall Study|Adverse Event|1|||
30748885|NCT00441701|58759056|FG003|Overall Study|Adverse Event|0|||
30807289|NCT02711956|58825008|FG010|Overall Study|PSA progression with clinical progression|0|||
30807290|NCT02711956|58825009|FG011|Overall Study|PSA progression with clinical progression|0|||
30908865|NCT01909791|58943705|FG002|Overall Study|Lost to Follow-up|10|||
30908866|NCT01909791|58943703|FG000|Overall Study|Missed Visit|2|||
30807291|NCT02711956|58825010|FG012|Overall Study|PSA progression with clinical progression|1|||
30807292|NCT02711956|58825011|FG013|Overall Study|PSA progression with clinical progression|1|||
30807293|NCT02711956|58825012|FG014|Overall Study|PSA progression with clinical progression|0|||
30807294|NCT02711956|58824998|FG000|Overall Study|PSA progression with radiographic progression|0|||
30807295|NCT02711956|58824999|FG001|Overall Study|PSA progression with radiographic progression|1|||
30807296|NCT02711956|58825000|FG002|Overall Study|PSA progression with radiographic progression|0|||
30807297|NCT02711956|58825001|FG003|Overall Study|PSA progression with radiographic progression|0|||
30807298|NCT02711956|58825002|FG004|Overall Study|PSA progression with radiographic progression|0|||
30807299|NCT02711956|58825003|FG005|Overall Study|PSA progression with radiographic progression|2|||
30807300|NCT02711956|58825004|FG006|Overall Study|PSA progression with radiographic progression|2|||
30807301|NCT02711956|58825005|FG007|Overall Study|PSA progression with radiographic progression|1|||
30807302|NCT02711956|58825006|FG008|Overall Study|PSA progression with radiographic progression|0|||
30807303|NCT02711956|58825007|FG009|Overall Study|PSA progression with radiographic progression|1|||
30807304|NCT02711956|58825008|FG010|Overall Study|PSA progression with radiographic progression|0|||
30807305|NCT02711956|58825009|FG011|Overall Study|PSA progression with radiographic progression|1|||
30807306|NCT02711956|58825010|FG012|Overall Study|PSA progression with radiographic progression|2|||
30807307|NCT02711956|58825011|FG013|Overall Study|PSA progression with radiographic progression|3|||
30807308|NCT02711956|58825012|FG014|Overall Study|PSA progression with radiographic progression|3|||
30807309|NCT04149353|58825053|FG000|Overall Study|Study terminated|1|||
30807310|NCT02711800|58825058|FG000|Overall Study|Lost to Follow-up|1|||
30807311|NCT02711800|58825058|FG000|Overall Study|Withdrawal by Subject|1|||
30807312|NCT03031496|58825062|FG000|Period 1|Adverse Event|2|||
30807313|NCT03031496|58825063|FG001|Period 1|Adverse Event|0|||
30807314|NCT03031496|58825062|FG000|Period 1|Withdrawal by Subject|0|||
30807315|NCT03031496|58825063|FG001|Period 1|Withdrawal by Subject|2|||
30908867|NCT01909791|58943704|FG001|Overall Study|Missed Visit|0|||
30908868|NCT01909791|58943705|FG002|Overall Study|Missed Visit|1|||
30908869|NCT02202499|58943721|FG000|Overall Study|Cancer diagnosis|0|||
30908870|NCT02202499|58943722|FG001|Overall Study|Cancer diagnosis|0|||
30807316|NCT02659020|58825076|FG000|Overall Study|Adverse Event|0|||
30807317|NCT02659020|58825077|FG001|Overall Study|Adverse Event|0|||
30807318|NCT02659020|58825078|FG002|Overall Study|Adverse Event|0|||
30807319|NCT02659020|58825079|FG003|Overall Study|Adverse Event|2|||
30807320|NCT02659020|58825080|FG004|Overall Study|Adverse Event|0|||
30807321|NCT02659020|58825081|FG005|Overall Study|Adverse Event|0|||
30807322|NCT02659020|58825082|FG006|Overall Study|Adverse Event|2|||
30807323|NCT02659020|58825076|FG000|Overall Study|Lost to Follow-up|1|||
30807324|NCT02659020|58825077|FG001|Overall Study|Lost to Follow-up|2|||
30807325|NCT02659020|58825078|FG002|Overall Study|Lost to Follow-up|1|||
30807326|NCT02659020|58825079|FG003|Overall Study|Lost to Follow-up|6|||
30807327|NCT02659020|58825080|FG004|Overall Study|Lost to Follow-up|1|||
30807328|NCT02659020|58825081|FG005|Overall Study|Lost to Follow-up|5|||
30807329|NCT02659020|58825082|FG006|Overall Study|Lost to Follow-up|0|||
30807330|NCT02659020|58825076|FG000|Overall Study|Physician Decision|0|||
30807331|NCT02659020|58825077|FG001|Overall Study|Physician Decision|0|||
30807332|NCT02659020|58825078|FG002|Overall Study|Physician Decision|0|||
30807333|NCT02659020|58825079|FG003|Overall Study|Physician Decision|1|||
30807334|NCT02659020|58825080|FG004|Overall Study|Physician Decision|1|||
30807335|NCT02659020|58825081|FG005|Overall Study|Physician Decision|0|||
30807336|NCT02659020|58825082|FG006|Overall Study|Physician Decision|1|||
30807337|NCT02659020|58825076|FG000|Overall Study|Withdrawal by Subject|2|||
30807338|NCT02659020|58825077|FG001|Overall Study|Withdrawal by Subject|1|||
30807339|NCT02659020|58825078|FG002|Overall Study|Withdrawal by Subject|0|||
30807340|NCT02659020|58825079|FG003|Overall Study|Withdrawal by Subject|3|||
30807341|NCT02659020|58825080|FG004|Overall Study|Withdrawal by Subject|3|||
30807342|NCT02659020|58825081|FG005|Overall Study|Withdrawal by Subject|6|||
30622448|NCT00934102|58634164|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
30622449|NCT00934102|58634165|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
30622450|NCT00970281|58634184|FG000|Overall Study|Lack of Efficacy|1|||
30622451|NCT00970281|58634185|FG001|Overall Study|Lack of Efficacy|14|||
30622452|NCT00970281|58634184|FG000|Overall Study|Withdrawal by Subject|0|||
30622453|NCT00970281|58634185|FG001|Overall Study|Withdrawal by Subject|1|||
30622454|NCT00970281|58634184|FG000|Overall Study|Physician Decision|1|||
30622455|NCT00970281|58634185|FG001|Overall Study|Physician Decision|1|||
30622456|NCT00976209|58634193|FG000|Treatment Period 1|Protocol Violation|1|||
30622457|NCT00976209|58634194|FG001|Treatment Period 1|Protocol Violation|0|||
30622458|NCT00976209|58634193|FG000|Treatment Period 1|Lost to Follow-up|2|||
30622459|NCT00976209|58634194|FG001|Treatment Period 1|Lost to Follow-up|0|||
30622460|NCT00976209|58634193|FG000|Treatment Period 1|Other|0|||
30622461|NCT00976209|58634194|FG001|Treatment Period 1|Other|1|||
30622462|NCT00976209|58634193|FG000|Wash-out Period|Adverse Event|1|||
30622463|NCT00976209|58634194|FG001|Wash-out Period|Adverse Event|2|||
30622464|NCT00976209|58634193|FG000|Wash-out Period|Lost to Follow-up|1|||
30622465|NCT00976209|58634194|FG001|Wash-out Period|Lost to Follow-up|0|||
30807343|NCT02659020|58825082|FG006|Overall Study|Withdrawal by Subject|3|||
30807344|NCT02659020|58825076|FG000|Overall Study|Progressive Disease|0|||
30807345|NCT02659020|58825077|FG001|Overall Study|Progressive Disease|0|||
30807346|NCT02659020|58825078|FG002|Overall Study|Progressive Disease|0|||
30807347|NCT02659020|58825079|FG003|Overall Study|Progressive Disease|4|||
30807348|NCT02659020|58825080|FG004|Overall Study|Progressive Disease|1|||
30807349|NCT02659020|58825081|FG005|Overall Study|Progressive Disease|0|||
30807350|NCT02659020|58825082|FG006|Overall Study|Progressive Disease|2|||
30807351|NCT03482011|58825107|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
30807352|NCT03482011|58825108|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
30807353|NCT03482011|58825109|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
30807354|NCT03482011|58825110|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
30807355|NCT03482011|58825111|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
30807356|NCT03482011|58825112|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
30807357|NCT03482011|58825113|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
30807358|NCT03482011|58825114|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
30807359|NCT03482011|58825107|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
30807360|NCT03482011|58825108|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
30807361|NCT03482011|58825109|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30807362|NCT03482011|58825110|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30807363|NCT03482011|58825111|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30807364|NCT03482011|58825112|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30807365|NCT03482011|58825113|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30807366|NCT03482011|58825114|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30807367|NCT03482011|58825107|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
30807368|NCT03482011|58825108|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
30807369|NCT03482011|58825109|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
30807370|NCT03482011|58825110|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
30807371|NCT03482011|58825111|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
30807372|NCT03482011|58825112|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
30807373|NCT03482011|58825113|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
30807374|NCT03482011|58825114|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
30807375|NCT03482011|58825107|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
30807376|NCT03482011|58825108|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
30807377|NCT03482011|58825109|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
30807378|NCT03482011|58825110|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
30807379|NCT03482011|58825111|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
30807380|NCT03482011|58825112|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
30807381|NCT03482011|58825113|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
30807382|NCT03482011|58825114|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
30807383|NCT03482011|58825107|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
30807384|NCT03482011|58825108|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
30807385|NCT03482011|58825109|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30807386|NCT03482011|58825110|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30908871|NCT02202499|58943723|FG002|Overall Study|Cancer diagnosis|1|||
30908872|NCT02202499|58943721|FG000|Overall Study|Moved from area|0|||
30908873|NCT02202499|58943722|FG001|Overall Study|Moved from area|0|||
30908874|NCT02202499|58943723|FG002|Overall Study|Moved from area|1|||
30908875|NCT02202499|58943721|FG000|Overall Study|Declined before randomization|1|||
30908876|NCT02202499|58943722|FG001|Overall Study|Declined before randomization|0|||
30908877|NCT02202499|58943723|FG002|Overall Study|Declined before randomization|0|||
30908878|NCT02202499|58943721|FG000|Overall Study|Auto accident|1|||
30908879|NCT02202499|58943722|FG001|Overall Study|Auto accident|0|||
30908880|NCT02202499|58943723|FG002|Overall Study|Auto accident|0|||
30748886|NCT00441701|58759057|FG004|Overall Study|Adverse Event|2|||
30748887|NCT00441701|58759058|FG005|Overall Study|Adverse Event|2|||
30748888|NCT00441701|58759059|FG006|Overall Study|Adverse Event|0|||
30748889|NCT00441701|58759060|FG007|Overall Study|Adverse Event|0|||
30748890|NCT00441701|58759061|FG008|Overall Study|Adverse Event|0|||
30748891|NCT00441701|58759062|FG009|Overall Study|Adverse Event|0|||
30748892|NCT00441701|58759053|FG000|Overall Study|Lack of Efficacy|2|||
30748893|NCT00441701|58759054|FG001|Overall Study|Lack of Efficacy|0|||
30807387|NCT03482011|58825111|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30807388|NCT03482011|58825112|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30807389|NCT03482011|58825113|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30807390|NCT03482011|58825114|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30807391|NCT03482011|58825107|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
30908881|NCT02202109|58943738|FG000|Overall Study|Lost to Follow-up|88|||
30908882|NCT02202109|58943739|FG001|Overall Study|Lost to Follow-up|87|||
30748894|NCT00441701|58759055|FG002|Overall Study|Lack of Efficacy|2|||
30908883|NCT02202109|58943738|FG000|Overall Study|Withdrawal by Subject|2|||
30908884|NCT02202109|58943739|FG001|Overall Study|Withdrawal by Subject|0|||
30748895|NCT00441701|58759056|FG003|Overall Study|Lack of Efficacy|2|||
30748896|NCT00441701|58759057|FG004|Overall Study|Lack of Efficacy|0|||
30908885|NCT02227849|58943745|FG000|Overall Study|Adverse Event|4|||
30807392|NCT03482011|58825108|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
30807393|NCT03482011|58825109|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
30807394|NCT03482011|58825110|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
30807395|NCT03482011|58825111|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
30807396|NCT03482011|58825112|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
30807397|NCT03482011|58825113|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
30807398|NCT03482011|58825114|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
30807399|NCT03482011|58825107|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
30807400|NCT03482011|58825108|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
30807401|NCT03482011|58825109|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
30807402|NCT03482011|58825110|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
30807403|NCT03482011|58825111|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
30807404|NCT03482011|58825112|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
30807405|NCT03482011|58825113|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
30908886|NCT02227849|58943745|FG000|Overall Study|Physician Decision|1|||
30908887|NCT02227849|58943745|FG000|Overall Study|Withdrawal by Subject|3|||
30908888|NCT01927497|58943751|FG000|Overall Study|Death|0|||
30908889|NCT01927497|58943752|FG001|Overall Study|Death|1|||
30807406|NCT03482011|58825114|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
30807407|NCT03482011|58825107|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30807408|NCT03482011|58825108|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30807409|NCT03482011|58825109|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30807410|NCT03482011|58825110|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30807411|NCT03482011|58825111|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
30807412|NCT03482011|58825112|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30807413|NCT03482011|58825113|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30908890|NCT01927497|58943751|FG000|Overall Study|Protocol Violation|2|||
30908891|NCT01927497|58943752|FG001|Overall Study|Protocol Violation|0|||
30908892|NCT02169271|58943760|FG000|Overall Study|Protocol Violation|1|||
30908893|NCT02169271|58943761|FG001|Overall Study|Protocol Violation|2|||
30908894|NCT02202031|58943769|FG000|Overall Study|Lost to Follow-up|1|||
30908895|NCT02202031|58943770|FG001|Overall Study|Lost to Follow-up|0|||
30908896|NCT02202031|58943769|FG000|Overall Study|Too Busy|1|||
30908897|NCT02202031|58943770|FG001|Overall Study|Too Busy|3|||
30908898|NCT02202031|58943769|FG000|Overall Study|Illness/Medical Reason|0|||
30908899|NCT02202031|58943770|FG001|Overall Study|Illness/Medical Reason|2|||
30908900|NCT02202031|58943769|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
30908901|NCT02202031|58943770|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
30908902|NCT01644188|58943778|FG000|Overall Study|Adverse Event|44|||
30908903|NCT01644188|58943779|FG001|Overall Study|Adverse Event|20|||
30748897|NCT00441701|58759058|FG005|Overall Study|Lack of Efficacy|1|||
30748898|NCT00441701|58759059|FG006|Overall Study|Lack of Efficacy|0|||
30807414|NCT03482011|58825114|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
30807415|NCT03482011|58825107|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
30908904|NCT01644188|58943778|FG000|Overall Study|Poor compliance to protocol|26|||
30908905|NCT01644188|58943779|FG001|Overall Study|Poor compliance to protocol|14|||
30908906|NCT01644188|58943778|FG000|Overall Study|Physician Decision|1|||
30748899|NCT00441701|58759060|FG007|Overall Study|Lack of Efficacy|0|||
30748900|NCT00441701|58759061|FG008|Overall Study|Lack of Efficacy|0|||
30748901|NCT00441701|58759062|FG009|Overall Study|Lack of Efficacy|0|||
30748902|NCT00441701|58759053|FG000|Overall Study|Withdrawal by Subject|0|||
30748903|NCT00441701|58759054|FG001|Overall Study|Withdrawal by Subject|2|||
30748904|NCT00441701|58759055|FG002|Overall Study|Withdrawal by Subject|1|||
30748905|NCT00441701|58759056|FG003|Overall Study|Withdrawal by Subject|1|||
30748906|NCT00441701|58759057|FG004|Overall Study|Withdrawal by Subject|0|||
30748907|NCT00441701|58759058|FG005|Overall Study|Withdrawal by Subject|0|||
30748908|NCT00441701|58759059|FG006|Overall Study|Withdrawal by Subject|0|||
30748909|NCT00441701|58759060|FG007|Overall Study|Withdrawal by Subject|0|||
30748910|NCT00441701|58759061|FG008|Overall Study|Withdrawal by Subject|0|||
30748911|NCT00441701|58759062|FG009|Overall Study|Withdrawal by Subject|0|||
30748912|NCT00441545|58759080|FG000|First Intervention|Adverse Event|6|||
30748913|NCT00441545|58759081|FG001|First Intervention|Adverse Event|5|||
30748914|NCT00441545|58759080|FG000|First Intervention|Protocol Violation|2|||
30748915|NCT00441545|58759081|FG001|First Intervention|Protocol Violation|2|||
30748916|NCT00441545|58759080|FG000|First Intervention|Withdrawal by Subject|3|||
30748917|NCT00441545|58759081|FG001|First Intervention|Withdrawal by Subject|3|||
30748918|NCT00441545|58759080|FG000|First Intervention|Kidney transplant|1|||
30807416|NCT03482011|58825108|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
30807417|NCT03482011|58825109|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
30807418|NCT03482011|58825110|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
30908907|NCT01644188|58943779|FG001|Overall Study|Physician Decision|3|||
30908908|NCT01644188|58943778|FG000|Overall Study|Participant moved|7|||
30748919|NCT00441545|58759081|FG001|First Intervention|Kidney transplant|1|||
30807419|NCT03482011|58825111|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
30807420|NCT03482011|58825112|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
30807421|NCT03482011|58825113|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
30807422|NCT03482011|58825114|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
30807423|NCT03482011|58825107|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30807424|NCT03482011|58825108|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30807425|NCT03482011|58825109|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30807426|NCT03482011|58825110|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
30807427|NCT03482011|58825111|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
30807428|NCT03482011|58825112|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
30807429|NCT03482011|58825113|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
30807430|NCT03482011|58825114|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
30807431|NCT03482011|58825107|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
30807432|NCT03482011|58825108|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
30807433|NCT03482011|58825109|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
30807434|NCT03482011|58825110|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
30807435|NCT03482011|58825111|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
30807436|NCT03482011|58825112|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
30807437|NCT03482011|58825113|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
30807438|NCT03482011|58825114|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
30807439|NCT03482011|58825107|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
30807440|NCT03482011|58825108|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
30807441|NCT03482011|58825109|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
30807442|NCT03482011|58825110|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
30807443|NCT03482011|58825111|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
30807444|NCT03482011|58825112|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
30807445|NCT03482011|58825113|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
30748920|NCT00441545|58759080|FG000|First Intervention|Lack of Efficacy|2|||
30807446|NCT03482011|58825114|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
30807447|NCT03482011|58825107|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
30807448|NCT03482011|58825108|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
30807449|NCT03482011|58825109|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
30807450|NCT03482011|58825110|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
30807451|NCT03482011|58825111|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
30807452|NCT03482011|58825112|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
30807453|NCT03482011|58825113|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
30807454|NCT03482011|58825114|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
30807455|NCT03482011|58825107|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
30807456|NCT03482011|58825108|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
30807457|NCT03482011|58825109|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
30807458|NCT03482011|58825110|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
30807459|NCT03482011|58825111|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
30807460|NCT03482011|58825112|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
30748921|NCT00441545|58759081|FG001|First Intervention|Lack of Efficacy|0|||
30748922|NCT00441545|58759080|FG000|First Intervention|Subject exceeded safety criteria|0|||
30748923|NCT00441545|58759081|FG001|First Intervention|Subject exceeded safety criteria|1|||
30748924|NCT00441545|58759080|FG000|First Intervention|Subject met an exclusionary criteria|1|||
30748925|NCT00441545|58759081|FG001|First Intervention|Subject met an exclusionary criteria|0|||
30748926|NCT00441545|58759080|FG000|First Intervention|Extended hospitalization|1|||
30748927|NCT00441545|58759081|FG001|First Intervention|Extended hospitalization|0|||
30807461|NCT03482011|58825113|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
30807462|NCT03482011|58825114|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
30807463|NCT03482011|58825107|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
30807464|NCT03482011|58825108|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
30807465|NCT03482011|58825109|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
30807466|NCT03482011|58825110|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
30807467|NCT03482011|58825111|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
30807468|NCT03482011|58825112|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
30807469|NCT03482011|58825113|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
30807470|NCT03482011|58825114|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
30807471|NCT03481309|58825145|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
30807472|NCT03481309|58825146|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
30807473|NCT03481309|58825147|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
30807474|NCT03481309|58825148|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
30807475|NCT03481309|58825149|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
30807476|NCT03481309|58825150|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
30807477|NCT03480841|58825158|FG000|Overall Study|Lost to Follow-up|2|||
30807478|NCT02709538|58825165|FG000|Overall Study|Adverse Event|13|||
30807479|NCT02709538|58825166|FG001|Overall Study|Adverse Event|2|||
30807480|NCT02709538|58825167|FG002|Overall Study|Adverse Event|3|||
30807481|NCT02709538|58825165|FG000|Overall Study|Lack of Efficacy|1|||
30807482|NCT02709538|58825166|FG001|Overall Study|Lack of Efficacy|0|||
30807483|NCT02709538|58825167|FG002|Overall Study|Lack of Efficacy|0|||
30807484|NCT02709538|58825165|FG000|Overall Study|Lost to Follow-up|24|||
30807485|NCT02709538|58825166|FG001|Overall Study|Lost to Follow-up|8|||
30807486|NCT02709538|58825167|FG002|Overall Study|Lost to Follow-up|4|||
30807487|NCT02709538|58825165|FG000|Overall Study|Physician Decision|1|||
30807488|NCT02709538|58825166|FG001|Overall Study|Physician Decision|0|||
30807489|NCT02709538|58825167|FG002|Overall Study|Physician Decision|0|||
30807490|NCT02709538|58825165|FG000|Overall Study|Withdrawal by Subject|40|||
30807491|NCT02709538|58825166|FG001|Overall Study|Withdrawal by Subject|7|||
30807492|NCT02709538|58825167|FG002|Overall Study|Withdrawal by Subject|4|||
30807493|NCT02709538|58825165|FG000|Overall Study|Non-compliance with study procedures|5|||
30807494|NCT02709538|58825166|FG001|Overall Study|Non-compliance with study procedures|0|||
30807495|NCT02709538|58825167|FG002|Overall Study|Non-compliance with study procedures|0|||
30807496|NCT02709538|58825165|FG000|Overall Study|Non-compliance with study drug|2|||
30807497|NCT02709538|58825166|FG001|Overall Study|Non-compliance with study drug|0|||
30807498|NCT02709538|58825167|FG002|Overall Study|Non-compliance with study drug|0|||
30807499|NCT02709538|58825165|FG000|Overall Study|Protocol deviation|10|||
30807500|NCT02709538|58825166|FG001|Overall Study|Protocol deviation|4|||
30807501|NCT02709538|58825167|FG002|Overall Study|Protocol deviation|4|||
30807502|NCT02709538|58825165|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
30807503|NCT02709538|58825166|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
30807504|NCT02709538|58825167|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
30748928|NCT00441545|58759080|FG000|First Intervention|Site error|1|||
30748929|NCT00441545|58759081|FG001|First Intervention|Site error|0|||
30748930|NCT00441545|58759080|FG000|First Intervention|Sponsor's request|1|||
30748931|NCT00441545|58759081|FG001|First Intervention|Sponsor's request|0|||
30748932|NCT00441545|58759080|FG000|Second Intervention|Adverse Event|5|||
30748933|NCT00441545|58759081|FG001|Second Intervention|Adverse Event|2|||
30748934|NCT00441545|58759080|FG000|Second Intervention|Protocol Violation|4|||
30748935|NCT00441545|58759081|FG001|Second Intervention|Protocol Violation|1|||
30748936|NCT00441545|58759080|FG000|Second Intervention|Withdrawal by Subject|1|||
30748937|NCT00441545|58759081|FG001|Second Intervention|Withdrawal by Subject|1|||
30748938|NCT00441545|58759080|FG000|Second Intervention|Kidney Transplant|1|||
30748939|NCT00441545|58759081|FG001|Second Intervention|Kidney Transplant|1|||
30748940|NCT00441545|58759080|FG000|Second Intervention|Lack of Efficacy|0|||
30748941|NCT00441545|58759081|FG001|Second Intervention|Lack of Efficacy|1|||
30748942|NCT00441545|58759080|FG000|Second Intervention|Subject exceeded safety criteria|1|||
30748943|NCT00441545|58759081|FG001|Second Intervention|Subject exceeded safety criteria|0|||
30748944|NCT00441545|58759080|FG000|Second Intervention|Subject moved|0|||
30748945|NCT00441545|58759081|FG001|Second Intervention|Subject moved|1|||
30748946|NCT00436553|58759090|FG000|Overall Study|Adverse Event|4|||
30748947|NCT00436553|58759091|FG001|Overall Study|Adverse Event|3|||
30748948|NCT00436553|58759092|FG002|Overall Study|Adverse Event|4|||
30748949|NCT00436553|58759090|FG000|Overall Study|Death|3|||
30748950|NCT00436553|58759091|FG001|Overall Study|Death|1|||
30748951|NCT00436553|58759092|FG002|Overall Study|Death|3|||
30748952|NCT00436553|58759090|FG000|Overall Study|Lost to Follow-up|0|||
30748953|NCT00436553|58759091|FG001|Overall Study|Lost to Follow-up|2|||
30748954|NCT00436553|58759092|FG002|Overall Study|Lost to Follow-up|0|||
30807505|NCT02709538|58825165|FG000|Overall Study|Other|16|||
30622466|NCT00976209|58634193|FG000|Wash-out Period|Protocol Violation|1|||
30748955|NCT00436553|58759090|FG000|Overall Study|Protocol Violation|1|||
30748956|NCT00436553|58759091|FG001|Overall Study|Protocol Violation|0|||
30807506|NCT02709538|58825166|FG001|Overall Study|Other|7|||
30807507|NCT02709538|58825167|FG002|Overall Study|Other|5|||
30807508|NCT03789318|58825180|FG000|Overall Study|Adverse Event|0|||
30807509|NCT03789318|58825181|FG001|Overall Study|Adverse Event|0|||
30807510|NCT03789318|58825182|FG002|Overall Study|Adverse Event|1|||
30807511|NCT03789318|58825183|FG003|Overall Study|Adverse Event|1|||
30807512|NCT03789318|58825184|FG004|Overall Study|Adverse Event|0|||
30807513|NCT03789318|58825180|FG000|Overall Study|Lost to Follow-up|0|||
30807514|NCT03789318|58825181|FG001|Overall Study|Lost to Follow-up|0|||
30807515|NCT03789318|58825182|FG002|Overall Study|Lost to Follow-up|1|||
30807516|NCT03789318|58825183|FG003|Overall Study|Lost to Follow-up|0|||
30807517|NCT03789318|58825184|FG004|Overall Study|Lost to Follow-up|0|||
30807518|NCT03789318|58825180|FG000|Overall Study|Withdrawal by Subject|0|||
30807519|NCT03789318|58825181|FG001|Overall Study|Withdrawal by Subject|0|||
30807520|NCT03789318|58825182|FG002|Overall Study|Withdrawal by Subject|1|||
30807521|NCT03789318|58825183|FG003|Overall Study|Withdrawal by Subject|0|||
30807522|NCT03789318|58825184|FG004|Overall Study|Withdrawal by Subject|0|||
30807523|NCT00511134|58825202|FG000|Overall Study|Withdrawal by Subject|0|||
30807524|NCT00511134|58825203|FG001|Overall Study|Withdrawal by Subject|2|||
30807525|NCT01372384|58825209|FG000|Overall Study|Progression of disease|3|||
30807526|NCT03115476|58825216|FG000|LP0084-1369|Death|1|||
30807527|NCT03115476|58825217|FG001|LP0084-1369|Death|0|||
30807528|NCT03115476|58825218|FG002|LP0084-1369|Death|2|||
30807529|NCT03115476|58825216|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
30807530|NCT03115476|58825217|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
30807531|NCT03115476|58825218|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
30807532|NCT03480763|58825228|FG000|Overall Study|Withdrawal by Subject|18|||
30807533|NCT03480763|58825229|FG001|Overall Study|Withdrawal by Subject|10|||
30807534|NCT03480763|58825228|FG000|Overall Study|Lost to Follow-up|4|||
30807535|NCT03480763|58825229|FG001|Overall Study|Lost to Follow-up|7|||
30807536|NCT03480763|58825228|FG000|Overall Study|non-study pneumococcal vaccine|1|||
30807537|NCT03480763|58825229|FG001|Overall Study|non-study pneumococcal vaccine|0|||
30807538|NCT03480763|58825228|FG000|Overall Study|oncological treatment|0|||
30807539|NCT03480763|58825229|FG001|Overall Study|oncological treatment|2|||
30807540|NCT03480763|58825228|FG000|Overall Study|pain with vaccination|1|||
30807541|NCT03480763|58825229|FG001|Overall Study|pain with vaccination|0|||
30807542|NCT03123120|58825243|FG000|Overall Study|Lost to Follow-up|0|||
30807543|NCT03123120|58825244|FG001|Overall Study|Lost to Follow-up|1|||
30807544|NCT03123120|58825243|FG000|Overall Study|Withdrawal by Subject|0|||
30807545|NCT03123120|58825244|FG001|Overall Study|Withdrawal by Subject|1|||
30807546|NCT01319994|58825254|FG000|Overall Study|Protocol Violation|7|||
30807547|NCT01319994|58825255|FG001|Overall Study|Protocol Violation|6|||
30807548|NCT03453151|58825265|FG000|Overall Study|Withdrawal by Subject|1|||
30807549|NCT03453151|58825265|FG000|Overall Study|Physician Decision|3|||
30908909|NCT01644188|58943779|FG001|Overall Study|Participant moved|2|||
30908910|NCT01644188|58943778|FG000|Overall Study|Related to auto-injector administration|2|||
30908911|NCT01644188|58943779|FG001|Overall Study|Related to auto-injector administration|2|||
30908912|NCT01644188|58943778|FG000|Overall Study|Consent withdrawn by participant|14|||
30748957|NCT00436553|58759092|FG002|Overall Study|Protocol Violation|0|||
30748958|NCT00436553|58759090|FG000|Overall Study|Withdrawal by Subject|5|||
30748959|NCT00436553|58759091|FG001|Overall Study|Withdrawal by Subject|6|||
30748960|NCT00436553|58759092|FG002|Overall Study|Withdrawal by Subject|3|||
30748961|NCT00441467|58759100|FG000|Overall Study|Adverse Event|6|||
30748962|NCT00441467|58759100|FG000|Overall Study|Withdrawal by Subject|3|||
30748963|NCT00441467|58759100|FG000|Overall Study|Progressive disease|9|||
30748964|NCT00436163|58759104|FG000|Overall Study|Lost to Follow-up|2|||
30748965|NCT00436163|58759104|FG000|Overall Study|Adverse Event|1|||
30807550|NCT02887248|58825269|FG000|Overall Study|Withdrawal by Subject|1|||
30807551|NCT02887248|58825269|FG000|Overall Study|Adverse Event|1|||
30807552|NCT02887248|58825269|FG000|Overall Study|Progressive Disease|1|||
30807553|NCT03452527|58825275|FG000|Overall Study|Withdrawal by Subject|1|||
30807554|NCT03452527|58825276|FG001|Overall Study|Withdrawal by Subject|1|||
30807555|NCT03452527|58825275|FG000|Overall Study|Study Terminated|2|||
30807556|NCT03452527|58825276|FG001|Overall Study|Study Terminated|3|||
30807557|NCT03028142|58825282|FG000|Overall Study|Adverse Event|1|||
30807558|NCT03028142|58825283|FG001|Overall Study|Adverse Event|1|||
30807559|NCT03028142|58825284|FG002|Overall Study|Adverse Event|0|||
30748966|NCT00006604|58759116|FG000|Overall Study|Met study objective - no further FU|1|||
30748967|NCT00006604|58759117|FG001|Overall Study|Met study objective - no further FU|0|||
30807560|NCT03028142|58825285|FG003|Overall Study|Adverse Event|0|||
30807561|NCT03028142|58825286|FG004|Overall Study|Adverse Event|0|||
30807562|NCT03028142|58825287|FG005|Overall Study|Adverse Event|1|||
30807563|NCT03028142|58825282|FG000|Overall Study|Withdrawal by Subject|0|||
30807564|NCT03028142|58825283|FG001|Overall Study|Withdrawal by Subject|0|||
30807565|NCT03028142|58825284|FG002|Overall Study|Withdrawal by Subject|0|||
30807566|NCT03028142|58825285|FG003|Overall Study|Withdrawal by Subject|0|||
30807567|NCT03028142|58825286|FG004|Overall Study|Withdrawal by Subject|1|||
30807568|NCT03028142|58825287|FG005|Overall Study|Withdrawal by Subject|0|||
30807569|NCT02708524|58825300|FG000|Overall Study|Adverse Event|0|||
30807570|NCT02708524|58825301|FG001|Overall Study|Adverse Event|1|||
30807571|NCT02708524|58825302|FG002|Overall Study|Adverse Event|0|||
30807572|NCT02708524|58825303|FG003|Overall Study|Adverse Event|0|||
30807573|NCT02708524|58825300|FG000|Overall Study|Lens Discomfort|1|||
30908913|NCT01644188|58943779|FG001|Overall Study|Consent withdrawn by participant|7|||
30908914|NCT01644188|58943778|FG000|Overall Study|Selection criteria finally not met|2|||
30908915|NCT01644188|58943779|FG001|Overall Study|Selection criteria finally not met|0|||
30908916|NCT01644188|58943778|FG000|Overall Study|Lost to Follow-up|1|||
30908917|NCT01644188|58943779|FG001|Overall Study|Lost to Follow-up|0|||
30807574|NCT02708524|58825301|FG001|Overall Study|Lens Discomfort|0|||
30807575|NCT02708524|58825302|FG002|Overall Study|Lens Discomfort|1|||
30807576|NCT02708524|58825303|FG003|Overall Study|Lens Discomfort|0|||
30807577|NCT02708524|58825300|FG000|Overall Study|Lost to Follow-up|1|||
30807578|NCT02708524|58825301|FG001|Overall Study|Lost to Follow-up|1|||
30807579|NCT02708524|58825302|FG002|Overall Study|Lost to Follow-up|1|||
30807580|NCT02708524|58825303|FG003|Overall Study|Lost to Follow-up|0|||
30807581|NCT02708524|58825300|FG000|Overall Study|Protocol Violation|0|||
30807582|NCT02708524|58825301|FG001|Overall Study|Protocol Violation|1|||
30807583|NCT02708524|58825302|FG002|Overall Study|Protocol Violation|0|||
30807584|NCT02708524|58825303|FG003|Overall Study|Protocol Violation|0|||
30807585|NCT02708524|58825300|FG000|Overall Study|Withdrawal by Subject|1|||
30807586|NCT02708524|58825301|FG001|Overall Study|Withdrawal by Subject|1|||
30807587|NCT02708524|58825302|FG002|Overall Study|Withdrawal by Subject|0|||
30908918|NCT01644188|58943778|FG000|Overall Study|Death|4|||
30908919|NCT01644188|58943779|FG001|Overall Study|Death|3|||
30807588|NCT02708524|58825303|FG003|Overall Study|Withdrawal by Subject|0|||
30807589|NCT02708524|58825300|FG000|Overall Study|Dispensed incorrect study lens|0|||
30807590|NCT02708524|58825301|FG001|Overall Study|Dispensed incorrect study lens|1|||
30807591|NCT02708524|58825302|FG002|Overall Study|Dispensed incorrect study lens|1|||
30807592|NCT02708524|58825303|FG003|Overall Study|Dispensed incorrect study lens|0|||
30807593|NCT02708524|58825300|FG000|Overall Study|Did not wear lens at final visit|0|||
30807594|NCT02708524|58825301|FG001|Overall Study|Did not wear lens at final visit|1|||
30807595|NCT02708524|58825302|FG002|Overall Study|Did not wear lens at final visit|0|||
30807596|NCT02708524|58825303|FG003|Overall Study|Did not wear lens at final visit|0|||
30807597|NCT02708524|58825300|FG000|Overall Study|Subject lost study lens|1|||
30807598|NCT02708524|58825301|FG001|Overall Study|Subject lost study lens|0|||
30807599|NCT02708524|58825302|FG002|Overall Study|Subject lost study lens|0|||
30807600|NCT02708524|58825303|FG003|Overall Study|Subject lost study lens|0|||
30807601|NCT03418675|58825315|FG000|Overall Study|Lost to Follow-up|13|||
30807602|NCT03418675|58825316|FG001|Overall Study|Lost to Follow-up|10|||
30807603|NCT03418675|58825315|FG000|Overall Study|Adverse Event|2|||
30807604|NCT03418675|58825316|FG001|Overall Study|Adverse Event|0|||
30807605|NCT03417505|58825333|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
30807606|NCT03417505|58825334|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
30807607|NCT02953639|58825343|FG000|Overall Study|Adverse Event|2|||
30807608|NCT02953639|58825344|FG001|Overall Study|Adverse Event|0|||
30807609|NCT02953639|58825345|FG002|Overall Study|Adverse Event|1|||
30807610|NCT02953639|58825343|FG000|Overall Study|Lost to Follow-up|8|||
30807611|NCT02953639|58825344|FG001|Overall Study|Lost to Follow-up|4|||
30807612|NCT02953639|58825345|FG002|Overall Study|Lost to Follow-up|3|||
30807613|NCT02953639|58825343|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30807614|NCT02953639|58825344|FG001|Overall Study|Non-Compliance With Study Drug|2|||
30807615|NCT02953639|58825345|FG002|Overall Study|Non-Compliance With Study Drug|1|||
30807616|NCT02953639|58825343|FG000|Overall Study|Multiple Reasons|1|||
30807617|NCT02953639|58825344|FG001|Overall Study|Multiple Reasons|0|||
30908920|NCT01644188|58943778|FG000|Overall Study|Last visit outside protocol visit window|14|||
30908921|NCT01644188|58943779|FG001|Overall Study|Last visit outside protocol visit window|16|||
30908922|NCT01644188|58943778|FG000|Overall Study|Site closure|1|||
30908923|NCT01644188|58943779|FG001|Overall Study|Site closure|1|||
30908924|NCT01644188|58943778|FG000|Overall Study|Other than specified above|6|||
30908925|NCT01644188|58943779|FG001|Overall Study|Other than specified above|7|||
30908926|NCT02201953|58943787|FG000|Overall Study|Randomized but Never Treated|1|||
30908927|NCT02201953|58943788|FG001|Overall Study|Randomized but Never Treated|5|||
30908928|NCT02201953|58943787|FG000|Overall Study|Lack of Efficacy|9|||
30807618|NCT02953639|58825345|FG002|Overall Study|Multiple Reasons|1|||
30807619|NCT02953639|58825343|FG000|Overall Study|Physician Decision|1|||
30807620|NCT02953639|58825344|FG001|Overall Study|Physician Decision|0|||
30807621|NCT02953639|58825345|FG002|Overall Study|Physician Decision|0|||
30807622|NCT02953639|58825343|FG000|Overall Study|Withdrawal by Subject|7|||
30807623|NCT02953639|58825344|FG001|Overall Study|Withdrawal by Subject|8|||
30807624|NCT02953639|58825345|FG002|Overall Study|Withdrawal by Subject|10|||
30807625|NCT02953639|58825343|FG000|Overall Study|Completed or Discontinued information is missing|1|||
30908929|NCT02201953|58943788|FG001|Overall Study|Lack of Efficacy|30|||
30908930|NCT02201953|58943787|FG000|Overall Study|Lost to Follow-up|8|||
30908931|NCT02201953|58943788|FG001|Overall Study|Lost to Follow-up|8|||
30807626|NCT02953639|58825344|FG001|Overall Study|Completed or Discontinued information is missing|0|||
30807627|NCT02953639|58825345|FG002|Overall Study|Completed or Discontinued information is missing|0|||
30807628|NCT04147715|58825367|FG000|Overall Study|Adverse Event|0|||
30908932|NCT02201953|58943787|FG000|Overall Study|Withdrew Consent|2|||
30908933|NCT02201953|58943788|FG001|Overall Study|Withdrew Consent|5|||
30807629|NCT04147715|58825368|FG001|Overall Study|Adverse Event|0|||
30807630|NCT04147715|58825369|FG002|Overall Study|Adverse Event|0|||
30807631|NCT04147715|58825370|FG003|Overall Study|Adverse Event|0|||
30807632|NCT04147715|58825371|FG004|Overall Study|Adverse Event|0|||
30807633|NCT04147715|58825372|FG005|Overall Study|Adverse Event|0|||
30807634|NCT04147715|58825373|FG006|Overall Study|Adverse Event|0|||
30807635|NCT04147715|58825374|FG007|Overall Study|Adverse Event|2|||
30807636|NCT04147715|58825375|FG008|Overall Study|Adverse Event|1|||
30807637|NCT04147715|58825376|FG009|Overall Study|Adverse Event|0|||
30807638|NCT04147715|58825377|FG010|Overall Study|Adverse Event|0|||
30807639|NCT04147715|58825378|FG011|Overall Study|Adverse Event|0|||
30807640|NCT02452554|58825465|FG000|Overall Study|Death|2|||
30807641|NCT02452554|58825466|FG001|Overall Study|Death|1|||
30807642|NCT02452554|58825467|FG002|Overall Study|Death|0|||
30807643|NCT02452554|58825468|FG003|Overall Study|Death|0|||
30807644|NCT02452554|58825469|FG004|Overall Study|Death|0|||
30807645|NCT02452554|58825470|FG005|Overall Study|Death|0|||
30807646|NCT02452554|58825465|FG000|Overall Study|Lack of Efficacy|13|||
30807647|NCT02452554|58825466|FG001|Overall Study|Lack of Efficacy|14|||
30807648|NCT02452554|58825467|FG002|Overall Study|Lack of Efficacy|9|||
30807649|NCT02452554|58825468|FG003|Overall Study|Lack of Efficacy|1|||
30807650|NCT02452554|58825469|FG004|Overall Study|Lack of Efficacy|5|||
30807651|NCT02452554|58825470|FG005|Overall Study|Lack of Efficacy|8|||
30807652|NCT02452554|58825465|FG000|Overall Study|Physician Decision|0|||
30908934|NCT02201953|58943787|FG000|Overall Study|Adverse Event|0|||
30908935|NCT02201953|58943788|FG001|Overall Study|Adverse Event|5|||
30908936|NCT02201953|58943787|FG000|Overall Study|Death|0|||
30908937|NCT02201953|58943788|FG001|Overall Study|Death|3|||
30908938|NCT02271854|58943794|FG000|Overall Study|Withdrawal by Subject|2|||
30908939|NCT02271854|58943794|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
30908940|NCT02271854|58943794|FG000|Overall Study|Lost to Follow-up|1|||
30908941|NCT02296892|58943802|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
30908942|NCT02296892|58943803|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
30908943|NCT02296892|58943804|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
30908944|NCT02296892|58943802|FG000|Overall Study|Lost to Follow-up|5|||
30908945|NCT02296892|58943803|FG001|Overall Study|Lost to Follow-up|0|||
30908946|NCT02296892|58943804|FG002|Overall Study|Lost to Follow-up|1|||
30908947|NCT02270684|58943814|FG000|Overall Study|Lost to Follow-up|0|||
30908948|NCT02270684|58943815|FG001|Overall Study|Lost to Follow-up|3|||
30908949|NCT02270684|58943814|FG000|Overall Study|Study terminated|1|||
30908950|NCT02270684|58943815|FG001|Overall Study|Study terminated|0|||
30908951|NCT02168803|58943824|FG000|Overall Study|Lost to Follow-up|1|||
30908952|NCT02168803|58943825|FG001|Overall Study|Lost to Follow-up|0|||
30908953|NCT02168803|58943826|FG002|Overall Study|Lost to Follow-up|1|||
30908954|NCT02168803|58943824|FG000|Overall Study|Withdrawal by Subject|1|||
30908955|NCT02168803|58943825|FG001|Overall Study|Withdrawal by Subject|1|||
30908956|NCT02168803|58943826|FG002|Overall Study|Withdrawal by Subject|2|||
30908957|NCT02168803|58943824|FG000|Overall Study|Physician Decision|0|||
30908958|NCT02168803|58943825|FG001|Overall Study|Physician Decision|1|||
30908959|NCT02168803|58943826|FG002|Overall Study|Physician Decision|0|||
30908960|NCT02168803|58943824|FG000|Overall Study|Adverse Event|0|||
30908961|NCT02168803|58943825|FG001|Overall Study|Adverse Event|1|||
30908962|NCT02168803|58943826|FG002|Overall Study|Adverse Event|1|||
30908963|NCT02168803|58943824|FG000|Overall Study|Death|0|||
30908964|NCT02168803|58943825|FG001|Overall Study|Death|0|||
30908965|NCT02168803|58943826|FG002|Overall Study|Death|1|||
30908966|NCT02168803|58943824|FG000|Overall Study|Sponsor Decision|0|||
30908967|NCT02168803|58943825|FG001|Overall Study|Sponsor Decision|0|||
30908968|NCT02168803|58943826|FG002|Overall Study|Sponsor Decision|1|||
30908969|NCT02201329|58943841|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
30807653|NCT02452554|58825466|FG001|Overall Study|Physician Decision|1|||
30807654|NCT02452554|58825467|FG002|Overall Study|Physician Decision|0|||
30807655|NCT02452554|58825468|FG003|Overall Study|Physician Decision|0|||
30807656|NCT02452554|58825469|FG004|Overall Study|Physician Decision|0|||
30807657|NCT02452554|58825470|FG005|Overall Study|Physician Decision|0|||
30807658|NCT02452554|58825465|FG000|Overall Study|Withdrawal by Subject|1|||
30908970|NCT02201329|58943841|FG000|Overall Study|Withdrawal by Subject|2|||
30908971|NCT01927419|58943847|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
30908972|NCT01927419|58943848|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
30908973|NCT01927419|58943847|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
30908974|NCT01927419|58943848|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
30908975|NCT01927419|58943847|FG000|Treatment Period|Disease progression|17|||
30908976|NCT01927419|58943848|FG001|Treatment Period|Disease progression|20|||
30908977|NCT01927419|58943847|FG000|Treatment Period|Study drug toxicity|48|||
30908978|NCT01927419|58943848|FG001|Treatment Period|Study drug toxicity|10|||
30908979|NCT01927419|58943847|FG000|Treatment Period|Death|0|||
30908980|NCT01927419|58943848|FG001|Treatment Period|Death|1|||
30908981|NCT01927419|58943847|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
30908982|NCT01927419|58943848|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
30807659|NCT02452554|58825466|FG001|Overall Study|Withdrawal by Subject|0|||
30807660|NCT02452554|58825467|FG002|Overall Study|Withdrawal by Subject|2|||
30807661|NCT02452554|58825468|FG003|Overall Study|Withdrawal by Subject|0|||
30807662|NCT02452554|58825469|FG004|Overall Study|Withdrawal by Subject|0|||
30807663|NCT02452554|58825470|FG005|Overall Study|Withdrawal by Subject|1|||
30807664|NCT02452554|58825465|FG000|Overall Study|Ineligible|0|||
30807665|NCT02452554|58825466|FG001|Overall Study|Ineligible|1|||
30807666|NCT02452554|58825467|FG002|Overall Study|Ineligible|0|||
30807667|NCT02452554|58825468|FG003|Overall Study|Ineligible|0|||
30807668|NCT02452554|58825469|FG004|Overall Study|Ineligible|0|||
30807669|NCT02452554|58825470|FG005|Overall Study|Ineligible|0|||
30807670|NCT02452554|58825465|FG000|Overall Study|Never Received Treatment|1|||
30807671|NCT02452554|58825466|FG001|Overall Study|Never Received Treatment|0|||
30807672|NCT02452554|58825467|FG002|Overall Study|Never Received Treatment|0|||
30807673|NCT02452554|58825468|FG003|Overall Study|Never Received Treatment|0|||
30807674|NCT02452554|58825469|FG004|Overall Study|Never Received Treatment|0|||
30807675|NCT02452554|58825470|FG005|Overall Study|Never Received Treatment|0|||
30807676|NCT04009577|58825489|FG000|Core Study|Adverse Event|1|||
30807677|NCT04009577|58825490|FG001|Core Study|Adverse Event|0|||
30807678|NCT04009577|58825491|FG002|Core Study|Adverse Event|2|||
30807679|NCT04009577|58825492|FG003|Core Study|Adverse Event|4|||
30807680|NCT04009577|58825489|FG000|Core Study|Withdrawal by Subject|0|||
30807681|NCT04009577|58825490|FG001|Core Study|Withdrawal by Subject|0|||
30807682|NCT04009577|58825491|FG002|Core Study|Withdrawal by Subject|2|||
30807683|NCT04009577|58825492|FG003|Core Study|Withdrawal by Subject|0|||
30807684|NCT04009577|58825489|FG000|Core Study|Other|0|||
30807685|NCT04009577|58825490|FG001|Core Study|Other|0|||
30807686|NCT04009577|58825491|FG002|Core Study|Other|0|||
30807687|NCT04009577|58825492|FG003|Core Study|Other|1|||
30807688|NCT04009577|58825489|FG000|Extension Phase|Adverse Event|0|||
30807689|NCT04009577|58825490|FG001|Extension Phase|Adverse Event|0|||
30807690|NCT04009577|58825491|FG002|Extension Phase|Adverse Event|0|||
30807691|NCT04009577|58825492|FG003|Extension Phase|Adverse Event|1|||
30807692|NCT04009577|58825489|FG000|Extension Phase|Inadequate therapeutic effect|0|||
30807693|NCT04009577|58825490|FG001|Extension Phase|Inadequate therapeutic effect|0|||
30807694|NCT04009577|58825491|FG002|Extension Phase|Inadequate therapeutic effect|1|||
30807695|NCT04009577|58825492|FG003|Extension Phase|Inadequate therapeutic effect|0|||
30807696|NCT04009577|58825489|FG000|Extension Phase|Withdrawal by Subject|0|||
30807697|NCT04009577|58825490|FG001|Extension Phase|Withdrawal by Subject|0|||
30807698|NCT04009577|58825491|FG002|Extension Phase|Withdrawal by Subject|1|||
30807699|NCT04009577|58825492|FG003|Extension Phase|Withdrawal by Subject|0|||
30807700|NCT04009577|58825489|FG000|Extension Phase|Not Treated|0|||
30807701|NCT04009577|58825490|FG001|Extension Phase|Not Treated|0|||
30807702|NCT04009577|58825491|FG002|Extension Phase|Not Treated|2|||
30807703|NCT04009577|58825492|FG003|Extension Phase|Not Treated|0|||
30807704|NCT04146467|58825520|FG000|Overall Study|Adverse Event|0|||
30807705|NCT04146467|58825521|FG001|Overall Study|Adverse Event|1|||
30807706|NCT04146467|58825520|FG000|Overall Study|Lost to Follow-up|0|||
30807707|NCT04146467|58825521|FG001|Overall Study|Lost to Follow-up|2|||
30807708|NCT02705716|58825532|FG000|Overall Study|Adverse Event|0|||
30807709|NCT02705716|58825533|FG001|Overall Study|Adverse Event|1|||
30908983|NCT01927419|58943847|FG000|Treatment Period|Participant request to discontinue|12|||
30622467|NCT00976209|58634194|FG001|Wash-out Period|Protocol Violation|0|||
30622468|NCT00976209|58634193|FG000|Wash-out Period|Other|1|||
30807710|NCT02705716|58825532|FG000|Overall Study|Protocol Violation|3|||
30807711|NCT02705716|58825533|FG001|Overall Study|Protocol Violation|0|||
30807712|NCT02705716|58825532|FG000|Overall Study|Withdrawal of Consent|1|||
30807713|NCT02705716|58825533|FG001|Overall Study|Withdrawal of Consent|1|||
30807714|NCT04138043|58825541|FG000|Overall Study|Withdrawal by Subject|0|||
30807715|NCT04138043|58825542|FG001|Overall Study|Withdrawal by Subject|1|||
30807716|NCT03443713|58825561|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
30908984|NCT01927419|58943848|FG001|Treatment Period|Participant request to discontinue|4|||
30908985|NCT01927419|58943847|FG000|Treatment Period|Withdrawal by Subject|1|||
30807717|NCT03443713|58825562|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
30807718|NCT03443713|58825563|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
30807719|NCT04133519|58825577|FG000|Overall Study|Withdrawal by Subject|5|||
30807720|NCT04133519|58825578|FG001|Overall Study|Withdrawal by Subject|4|||
30807721|NCT04133519|58825577|FG000|Overall Study|Protocol Violation|0|||
30807722|NCT04133519|58825578|FG001|Overall Study|Protocol Violation|1|||
30807723|NCT04133519|58825577|FG000|Overall Study|Never started treatment|1|||
30807724|NCT04133519|58825578|FG001|Overall Study|Never started treatment|1|||
30807725|NCT04007159|58825584|FG000|Induction Phase|(missed study visits)|16|||
30807726|NCT04007159|58825584|FG000|Induction Phase|Withdrawal by Subject|4|||
30807727|NCT04007159|58825584|FG000|Induction Phase|Adverse Event|2|||
30807728|NCT04007159|58825584|FG000|Challenge Phase|missed study visits|3|||
30807729|NCT03119688|58825595|FG000|Overall Study|Adverse Event|4|||
30807730|NCT03389893|58825614|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
30807731|NCT03389893|58825615|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
30807732|NCT03389893|58825616|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
30807733|NCT03389893|58825617|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
30807734|NCT03389893|58825614|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
30807735|NCT03389893|58825615|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
30807736|NCT03389893|58825616|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
30807737|NCT03389893|58825617|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
30807738|NCT03389893|58825614|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
30807739|NCT03389893|58825615|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
30807740|NCT03389893|58825616|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
30807741|NCT03389893|58825617|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
30807742|NCT03389893|58825614|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
30807743|NCT03389893|58825615|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
30807744|NCT03389893|58825616|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
30807745|NCT03389893|58825617|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
30807746|NCT04128293|58825627|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
30807747|NCT04128293|58825628|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
30807748|NCT04128293|58825629|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
30807749|NCT04128293|58825630|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
30807750|NCT00787176|58825649|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
30807751|NCT00787176|58825650|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
30807752|NCT00787176|58825651|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
30807753|NCT00787176|58825652|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
30807754|NCT03691571|58825665|FG000|Overall Study|Withdrawal by Subject|9|||
30807755|NCT03691571|58825666|FG001|Overall Study|Withdrawal by Subject|2|||
30807756|NCT03113916|58825675|FG000|Overall Study|Withdrawal by Subject|9|||
30807757|NCT03113916|58825676|FG001|Overall Study|Withdrawal by Subject|7|||
30807758|NCT03113916|58825675|FG000|Overall Study|Pregnancy|1|||
30807759|NCT03113916|58825676|FG001|Overall Study|Pregnancy|3|||
30807760|NCT03113916|58825675|FG000|Overall Study|Lost to Follow-up|1|||
30807761|NCT03113916|58825676|FG001|Overall Study|Lost to Follow-up|2|||
30807762|NCT02925494|58825691|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
30807763|NCT02925494|58825692|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
30908986|NCT01927419|58943848|FG001|Treatment Period|Withdrawal by Subject|1|||
30908987|NCT01927419|58943847|FG000|Treatment Period|Maximum Clinical Benefit|6|||
30807764|NCT02925494|58825693|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
30807765|NCT02925494|58825694|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
30807766|NCT02925494|58825691|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
30807767|NCT02925494|58825692|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
30807768|NCT02925494|58825693|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
30908988|NCT01927419|58943848|FG001|Treatment Period|Maximum Clinical Benefit|2|||
30908989|NCT01927419|58943847|FG000|Treatment Period|Other reasons|3|||
30908990|NCT01927419|58943848|FG001|Treatment Period|Other reasons|4|||
30908991|NCT01927419|58943847|FG000|Treatment Period|Not Reported|1|||
30908992|NCT01927419|58943848|FG001|Treatment Period|Not Reported|1|||
30807769|NCT02925494|58825694|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
30807770|NCT02925494|58825691|FG000|Post-Treatment Follow-Up Period|Other|1|||
30807771|NCT02925494|58825692|FG001|Post-Treatment Follow-Up Period|Other|4|||
30807772|NCT02925494|58825693|FG002|Post-Treatment Follow-Up Period|Other|3|||
30807773|NCT02925494|58825694|FG003|Post-Treatment Follow-Up Period|Other|6|||
30807774|NCT02925494|58825691|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
30807775|NCT02925494|58825692|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
30807776|NCT02925494|58825693|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
30807777|NCT02925494|58825694|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
30807778|NCT02925494|58825691|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
30807779|NCT02925494|58825692|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
30807780|NCT02925494|58825693|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
30807781|NCT02925494|58825694|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
30807782|NCT02925494|58825691|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
30807783|NCT02925494|58825692|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
30807784|NCT02925494|58825693|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
30807785|NCT02925494|58825694|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
30807786|NCT02925494|58825691|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
30807787|NCT02925494|58825692|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
30807788|NCT02925494|58825693|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
30807789|NCT02925494|58825694|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
30807790|NCT04006145|58825707|FG000|Overall Study|Lost to Follow-up|0|||
30807791|NCT04006145|58825708|FG001|Overall Study|Lost to Follow-up|1|||
30807792|NCT04006145|58825707|FG000|Overall Study|Other|1|||
30807793|NCT04006145|58825708|FG001|Overall Study|Other|2|||
30908993|NCT02168491|58943854|FG000|Overall Study|Withdrawal by Subject|1|||
30908994|NCT02225743|58943858|FG000|Overall Study|Withdrawal by Subject|18|||
30908995|NCT01721746|58943864|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
30908996|NCT01721746|58943865|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
30908997|NCT01721746|58943864|FG000|Pre-Treatment|Withdrawal by Subject|1|||
30908998|NCT01721746|58943865|FG001|Pre-Treatment|Withdrawal by Subject|16|||
30908999|NCT01721746|58943864|FG000|Pre-Treatment|Poor/Non-compliance|1|||
30909000|NCT01721746|58943865|FG001|Pre-Treatment|Poor/Non-compliance|0|||
30807794|NCT03386773|58825716|FG000|Overall Study|Lost to Follow-up|24|||
30807795|NCT03386773|58825717|FG001|Overall Study|Lost to Follow-up|33|||
30807796|NCT03386773|58825716|FG000|Overall Study|Withdrawal by Subject|3|||
30807797|NCT03386773|58825717|FG001|Overall Study|Withdrawal by Subject|2|||
30807798|NCT04126343|58825729|FG000|Overall Study|Adverse Event|0|||
30807799|NCT04126343|58825730|FG001|Overall Study|Adverse Event|0|||
30807800|NCT04126343|58825731|FG002|Overall Study|Adverse Event|0|||
30909001|NCT01721746|58943864|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
30909002|NCT01721746|58943865|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
30909003|NCT01721746|58943864|FG000|Treatment|Disease Progression|192|||
30807801|NCT04126343|58825732|FG003|Overall Study|Adverse Event|0|||
30807802|NCT04126343|58825733|FG004|Overall Study|Adverse Event|0|||
30807803|NCT04126343|58825734|FG005|Overall Study|Adverse Event|1|||
30807804|NCT04126343|58825729|FG000|Overall Study|Withdrawal by Subject|0|||
30807805|NCT04126343|58825730|FG001|Overall Study|Withdrawal by Subject|0|||
30807806|NCT04126343|58825731|FG002|Overall Study|Withdrawal by Subject|0|||
30807807|NCT04126343|58825732|FG003|Overall Study|Withdrawal by Subject|1|||
30807808|NCT04126343|58825733|FG004|Overall Study|Withdrawal by Subject|0|||
30807809|NCT04126343|58825734|FG005|Overall Study|Withdrawal by Subject|0|||
30807810|NCT04126343|58825729|FG000|Overall Study|Related to COVID-19 pandemic|3|||
30807811|NCT04126343|58825730|FG001|Overall Study|Related to COVID-19 pandemic|4|||
30807812|NCT04126343|58825731|FG002|Overall Study|Related to COVID-19 pandemic|3|||
30807813|NCT04126343|58825732|FG003|Overall Study|Related to COVID-19 pandemic|3|||
30807814|NCT04126343|58825733|FG004|Overall Study|Related to COVID-19 pandemic|3|||
30807815|NCT04126343|58825734|FG005|Overall Study|Related to COVID-19 pandemic|3|||
30807816|NCT02952313|58825749|FG000|Primary Endpoint|Lost to Follow-up|4|||
30807817|NCT02952313|58825749|FG000|Primary Endpoint|Withdrawal by Subject|1|||
30807818|NCT02952313|58825749|FG000|Primary Endpoint|Lack of Efficacy|1|||
30807819|NCT02952313|58825749|FG000|Primary Endpoint|Missed visit|1|||
30807820|NCT02952313|58825749|FG000|Long-term Follow-up|Lost to Follow-up|12|||
30807821|NCT02952313|58825749|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
30807822|NCT02952313|58825749|FG000|Long-term Follow-up|Lack of Efficacy|6|||
30807823|NCT02952313|58825749|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
30807824|NCT02952313|58825749|FG000|Long-term Follow-up|Physician Decision|1|||
30807825|NCT02952313|58825749|FG000|Long-term Follow-up|Death|1|||
30807826|NCT03119610|58825756|FG000|Overall Study|Adverse Event|1|||
30807827|NCT03119610|58825757|FG001|Overall Study|Adverse Event|0|||
30807828|NCT03119610|58825756|FG000|Overall Study|Lost to Follow-up|0|||
30807829|NCT03119610|58825757|FG001|Overall Study|Lost to Follow-up|1|||
30807830|NCT04005755|58825763|FG000|Overall Study|Adverse Event|6|||
30909004|NCT01721746|58943865|FG001|Treatment|Disease Progression|74|||
30909005|NCT01721746|58943864|FG000|Treatment|Study Drug Toxicity|19|||
30622469|NCT00976209|58634194|FG001|Wash-out Period|Other|0|||
30622470|NCT00976209|58634193|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30807831|NCT04005755|58825763|FG000|Overall Study|Physician Decision|3|||
30807832|NCT04005755|58825763|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
30807833|NCT04005755|58825763|FG000|Overall Study|Withdrawal by Subject|3|||
30807834|NCT04005755|58825763|FG000|Overall Study|Lost to Follow-up|1|||
30807835|NCT03442777|58825770|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
30807836|NCT03442777|58825771|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
30807837|NCT03442777|58825772|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
30807838|NCT03401749|58825781|FG000|Overall Study|Lost to Follow-up|20|||
30807839|NCT03401749|58825782|FG001|Overall Study|Lost to Follow-up|16|||
30807840|NCT03401749|58825783|FG002|Overall Study|Lost to Follow-up|26|||
30807841|NCT03029624|58825791|FG000|Overall Study|Adverse Event|1|||
30807842|NCT03029624|58825791|FG000|Overall Study|Withdrawal by Subject|1|||
30807843|NCT03029624|58825791|FG000|Overall Study|Lack of Efficacy|1|||
30807844|NCT03029624|58825791|FG000|Overall Study|MRI need|2|||
30807845|NCT02952001|58825799|FG000|Overall Study|Adverse Event|3|||
30807846|NCT02952001|58825800|FG001|Overall Study|Adverse Event|0|||
30807847|NCT02952001|58825799|FG000|Overall Study|Prohibited therapy|10|||
30807848|NCT02952001|58825800|FG001|Overall Study|Prohibited therapy|3|||
30622471|NCT00976209|58634194|FG001|Treatment Period 2|Withdrawal by Subject|1|||
30622472|NCT00976209|58634193|FG000|Treatment Period 2|Lost to Follow-up|0|||
30622473|NCT00976209|58634194|FG001|Treatment Period 2|Lost to Follow-up|1|||
30622474|NCT00925990|58634201|FG000|Overall Study|Adverse Event|1|||
30622475|NCT00925990|58634202|FG001|Overall Study|Adverse Event|3|||
30622476|NCT00925990|58634201|FG000|Overall Study|Withdrawal by Subject|2|||
30622477|NCT00925990|58634202|FG001|Overall Study|Withdrawal by Subject|2|||
30622478|NCT00925990|58634201|FG000|Overall Study|Lost to Follow-up|1|||
30807849|NCT02952001|58825799|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
30622479|NCT00925990|58634202|FG001|Overall Study|Lost to Follow-up|3|||
30748968|NCT00006604|58759118|FG002|Overall Study|Met study objective - no further FU|0|||
30748969|NCT00006604|58759119|FG003|Overall Study|Met study objective - no further FU|0|||
30748970|NCT00006604|58759120|FG004|Overall Study|Met study objective - no further FU|0|||
30748971|NCT00006604|58759121|FG005|Overall Study|Met study objective - no further FU|0|||
30748972|NCT00006604|58759122|FG006|Overall Study|Met study objective - no further FU|0|||
30748973|NCT00006604|58759123|FG007|Overall Study|Met study objective - no further FU|0|||
30748974|NCT00006604|58759124|FG008|Overall Study|Met study objective - no further FU|0|||
30748975|NCT00006604|58759125|FG009|Overall Study|Met study objective - no further FU|0|||
30748976|NCT00006604|58759126|FG010|Overall Study|Met study objective - no further FU|0|||
30807850|NCT02952001|58825800|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
30807851|NCT04123067|58825809|FG000|Overall Study|Lost to Follow-up|0|||
30807852|NCT04123067|58825810|FG001|Overall Study|Lost to Follow-up|1|||
30807853|NCT04117607|58825819|FG000|Overall Study|Early Termination|0|||
30807854|NCT04117607|58825820|FG001|Overall Study|Early Termination|1|||
30807855|NCT04117607|58825821|FG002|Overall Study|Early Termination|0|||
30807856|NCT04117607|58825822|FG003|Overall Study|Early Termination|0|||
30807857|NCT04117607|58825823|FG004|Overall Study|Early Termination|0|||
30807858|NCT04117607|58825824|FG005|Overall Study|Early Termination|0|||
30807859|NCT04117607|58825825|FG006|Overall Study|Early Termination|1|||
30807860|NCT04117607|58825826|FG007|Overall Study|Early Termination|0|||
30807861|NCT04117607|58825827|FG008|Overall Study|Early Termination|0|||
30807862|NCT04117607|58825828|FG009|Overall Study|Early Termination|0|||
30807863|NCT04117607|58825829|FG010|Overall Study|Early Termination|0|||
30807864|NCT04117607|58825830|FG011|Overall Study|Early Termination|0|||
30807865|NCT04117607|58825831|FG012|Overall Study|Early Termination|0|||
30807866|NCT04117607|58825832|FG013|Overall Study|Early Termination|0|||
30807867|NCT04112303|58825848|FG000|Overall Study|Death|1|||
30807868|NCT03998189|58825854|FG000|Overall Study|Lack of Efficacy|0|||
30807869|NCT03998189|58825855|FG001|Overall Study|Lack of Efficacy|1|||
30807870|NCT04099277|58825861|FG000|Overall Study|Physician Decision|1|||
30807871|NCT04099277|58825861|FG000|Overall Study|Withdrawal by Subject|1|||
30807872|NCT03990389|58825867|FG000|Overall Study|Lost to Follow-up|3|||
30807873|NCT03990389|58825868|FG001|Overall Study|Lost to Follow-up|0|||
30807874|NCT03988907|58825876|FG000|Overall Study|Unable to complete visit|0|||
30807875|NCT03988907|58825877|FG001|Overall Study|Unable to complete visit|1|||
30807876|NCT03987191|58825891|FG000|Overall Study|COVID-19 related research disruption|0|||
30807877|NCT03987191|58825892|FG001|Overall Study|COVID-19 related research disruption|2|||
30807878|NCT04098809|58825900|FG000|Overall Study|Withdrawal by Subject|1|||
30807879|NCT04098809|58825901|FG001|Overall Study|Withdrawal by Subject|3|||
30807880|NCT04098809|58825900|FG000|Overall Study|Physician Decision|2|||
30807881|NCT04098809|58825901|FG001|Overall Study|Physician Decision|1|||
30807882|NCT03122184|58825909|FG000|Overall Study|Lost to Follow-up|4|||
30807883|NCT03122184|58825910|FG001|Overall Study|Lost to Follow-up|6|||
30807884|NCT03122184|58825909|FG000|Overall Study|Withdrawal by Subject|3|||
30807885|NCT03122184|58825910|FG001|Overall Study|Withdrawal by Subject|0|||
30807886|NCT03122184|58825909|FG000|Overall Study|Terminated due to cognitive problem|1|||
30807887|NCT03122184|58825910|FG001|Overall Study|Terminated due to cognitive problem|0|||
30807888|NCT04091087|58825935|FG000|Overall Study|Not treated|1|||
30807889|NCT04091087|58825936|FG001|Overall Study|Not treated|0|||
30807890|NCT04091087|58825935|FG000|Overall Study|Adverse Event|4|||
30807891|NCT04091087|58825936|FG001|Overall Study|Adverse Event|4|||
30807892|NCT04091087|58825935|FG000|Overall Study|Protocol Violation|0|||
30807893|NCT04091087|58825936|FG001|Overall Study|Protocol Violation|1|||
30807894|NCT04091087|58825935|FG000|Overall Study|Withdrawal by Subject|5|||
30807895|NCT04091087|58825936|FG001|Overall Study|Withdrawal by Subject|2|||
30807896|NCT03400033|58825954|FG000|Overall Study|Withdrawal by Subject|1|||
30807897|NCT03400033|58825955|FG001|Overall Study|Withdrawal by Subject|2|||
30807898|NCT04089761|58825970|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
30807899|NCT04089761|58825970|FG000|"Run In Phase"|Lost to Follow-up|1|||
30807900|NCT04089761|58825970|FG000|"Treatment Phase"|No evaluable data|5|||
30807901|NCT04089761|58825970|FG000|"Treatment Phase"|Lost to Follow-up|1|||
30807902|NCT03118518|58825976|FG000|Overall Study|Early Exit after treatment|2|||
30807903|NCT03118518|58825977|FG001|Overall Study|Early Exit after treatment|8|||
30807904|NCT03118518|58825976|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
30807905|NCT03118518|58825977|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
30807906|NCT03984305|58825985|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
30807907|NCT03984305|58825986|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
30807908|NCT03984305|58825985|FG000|Overall Study|Withdrawal by Subject|3|||
30807909|NCT03984305|58825986|FG001|Overall Study|Withdrawal by Subject|3|||
30807910|NCT03984305|58825985|FG000|Overall Study|Lost to Follow-up|1|||
30909006|NCT01721746|58943865|FG001|Treatment|Study Drug Toxicity|11|||
30909007|NCT01721746|58943864|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
30909008|NCT01721746|58943865|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
30909009|NCT01721746|58943864|FG000|Treatment|Participant request to discontinue Study treatment|26|||
30909010|NCT01721746|58943865|FG001|Treatment|Participant request to discontinue Study treatment|7|||
30909011|NCT01721746|58943864|FG000|Treatment|Participant withdrew consent|4|||
30909012|NCT01721746|58943865|FG001|Treatment|Participant withdrew consent|2|||
30909013|NCT01721746|58943864|FG000|Treatment|Maximum Clinical Benefit|9|||
30807911|NCT03984305|58825986|FG001|Overall Study|Lost to Follow-up|0|||
30807912|NCT03397771|58825994|FG000|Overall Study|2 erroneously randomized, never treated|3|||
30909014|NCT01721746|58943865|FG001|Treatment|Maximum Clinical Benefit|3|||
30909015|NCT01721746|58943864|FG000|Treatment|Poor/Non-compliance|2|||
30909016|NCT01721746|58943865|FG001|Treatment|Poor/Non-compliance|0|||
30807913|NCT03397771|58825995|FG001|Overall Study|2 erroneously randomized, never treated|1|||
30807914|NCT03397771|58825994|FG000|Overall Study|Withdrawal by Subject|1|||
30807915|NCT03397771|58825995|FG001|Overall Study|Withdrawal by Subject|3|||
30807916|NCT03397771|58825994|FG000|Overall Study|Protocol Violation|2|||
30807917|NCT03397771|58825995|FG001|Overall Study|Protocol Violation|2|||
30807918|NCT03397771|58825994|FG000|Overall Study|Adverse Event|2|||
30807919|NCT03397771|58825995|FG001|Overall Study|Adverse Event|1|||
30807920|NCT02876835|58826003|FG000|Treatment Period (51.1 Month)|Other|1|||
30807921|NCT02876835|58826004|FG001|Treatment Period (51.1 Month)|Other|0|||
30807922|NCT02876835|58826003|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
30807923|NCT02876835|58826004|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
30807924|NCT02876835|58826003|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
30807925|NCT02876835|58826004|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
30807926|NCT02876835|58826003|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
30807927|NCT02876835|58826004|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
30807928|NCT04086641|58826013|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
30807929|NCT04086641|58826014|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
30807930|NCT03503318|58826023|FG000|Overall Study|Death|1|||
30807931|NCT03503318|58826024|FG001|Overall Study|Death|0|||
30807932|NCT03503318|58826025|FG002|Overall Study|Death|4|||
30807933|NCT03503318|58826023|FG000|Overall Study|Adverse Event|3|||
30807934|NCT03503318|58826024|FG001|Overall Study|Adverse Event|4|||
30807935|NCT03503318|58826025|FG002|Overall Study|Adverse Event|2|||
30807936|NCT03503318|58826023|FG000|Overall Study|Withdrawal by Subject|12|||
30807937|NCT03503318|58826024|FG001|Overall Study|Withdrawal by Subject|17|||
30807938|NCT03503318|58826025|FG002|Overall Study|Withdrawal by Subject|16|||
30807939|NCT03503318|58826023|FG000|Overall Study|Protocol Violation|5|||
30807940|NCT03503318|58826024|FG001|Overall Study|Protocol Violation|0|||
30807941|NCT03503318|58826025|FG002|Overall Study|Protocol Violation|3|||
30807942|NCT03503318|58826023|FG000|Overall Study|Lost to Follow-up|17|||
30807943|NCT03503318|58826024|FG001|Overall Study|Lost to Follow-up|15|||
30807944|NCT03503318|58826025|FG002|Overall Study|Lost to Follow-up|12|||
30807945|NCT03503318|58826023|FG000|Overall Study|Other than specified|1|||
30807946|NCT03503318|58826024|FG001|Overall Study|Other than specified|3|||
30807947|NCT03503318|58826025|FG002|Overall Study|Other than specified|3|||
30807948|NCT03396913|58826035|FG000|Overall Study|Lost to Follow-up|0|||
30807949|NCT03396913|58826036|FG001|Overall Study|Lost to Follow-up|6|||
30807950|NCT03982433|58826042|FG000|Overall Study|Lost to Follow-up|1|||
30807951|NCT03396835|58826046|FG000|Overall Study|Withdrawn prior to completion|1|||
30807952|NCT03396835|58826046|FG000|Overall Study|Did not meet criteria for data analysis|1|||
30807956|NCT04084769|58826058|FG000|Overall Study|Protocol Violation|1|||
30807957|NCT04084769|58826059|FG001|Overall Study|Protocol Violation|3|||
30807958|NCT04084769|58826060|FG002|Overall Study|Protocol Violation|0|||
30807959|NCT04084769|58826061|FG003|Overall Study|Protocol Violation|1|||
30807960|NCT04084769|58826058|FG000|Overall Study|Withdrawal by Subject|0|||
30807961|NCT04084769|58826059|FG001|Overall Study|Withdrawal by Subject|1|||
30807962|NCT04084769|58826060|FG002|Overall Study|Withdrawal by Subject|0|||
30807963|NCT04084769|58826061|FG003|Overall Study|Withdrawal by Subject|0|||
30807964|NCT04084769|58826058|FG000|Overall Study|Withdrawal by parent/guardian|1|||
30909017|NCT01721746|58943864|FG000|Treatment|Participant no longer met Study criteria|4|||
30909018|NCT01721746|58943865|FG001|Treatment|Participant no longer met Study criteria|0|||
30909019|NCT01721746|58943864|FG000|Treatment|Other reasons|6|||
30909020|NCT01721746|58943865|FG001|Treatment|Other reasons|2|||
30909021|NCT02225665|58943874|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
30909022|NCT02225665|58943875|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
30909023|NCT02225665|58943874|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
30909024|NCT02225665|58943875|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
30909025|NCT01721200|58943883|FG000|Overall Study|Lost to Follow-up|3|||
30909026|NCT01721200|58943884|FG001|Overall Study|Lost to Follow-up|5|||
30909027|NCT02225587|58943897|FG000|Overall Study|Adverse Event|5|||
30909028|NCT02225587|58943898|FG001|Overall Study|Adverse Event|5|||
30909029|NCT02225587|58943897|FG000|Overall Study|Lost to Follow-up|5|||
30909030|NCT02225587|58943898|FG001|Overall Study|Lost to Follow-up|5|||
30909031|NCT02225587|58943897|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30909032|NCT02225587|58943898|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30909033|NCT02225587|58943897|FG000|Overall Study|Physician Decision|2|||
30909034|NCT02225587|58943898|FG001|Overall Study|Physician Decision|0|||
30807965|NCT04084769|58826059|FG001|Overall Study|Withdrawal by parent/guardian|0|||
30807966|NCT04084769|58826060|FG002|Overall Study|Withdrawal by parent/guardian|0|||
30909035|NCT02225587|58943897|FG000|Overall Study|Protocol Violation|1|||
30909036|NCT02225587|58943898|FG001|Overall Study|Protocol Violation|0|||
30909037|NCT02225587|58943897|FG000|Overall Study|Participant Moved|1|||
30807967|NCT04084769|58826061|FG003|Overall Study|Withdrawal by parent/guardian|1|||
30909038|NCT02225587|58943898|FG001|Overall Study|Participant Moved|0|||
30909039|NCT02225587|58943897|FG000|Overall Study|Withdrawal by Subject|13|||
30807968|NCT04084769|58826058|FG000|Overall Study|Lost to Follow-up|2|||
30807969|NCT04084769|58826059|FG001|Overall Study|Lost to Follow-up|0|||
30807970|NCT04084769|58826060|FG002|Overall Study|Lost to Follow-up|0|||
30909040|NCT02225587|58943898|FG001|Overall Study|Withdrawal by Subject|28|||
30909041|NCT02296424|58943906|FG000|Part 1|New therapy for study indication|0|||
30909042|NCT02296424|58943907|FG001|Part 1|New therapy for study indication|1|||
30909043|NCT02296424|58943908|FG002|Part 1|New therapy for study indication|0|||
30909044|NCT02296424|58943909|FG003|Part 1|New therapy for study indication|0|||
30909045|NCT02296424|58943906|FG000|Part 1|Protocol Violation|0|||
30909046|NCT02296424|58943907|FG001|Part 1|Protocol Violation|1|||
30909047|NCT02296424|58943908|FG002|Part 1|Protocol Violation|0|||
30909048|NCT02296424|58943909|FG003|Part 1|Protocol Violation|0|||
30909049|NCT02296424|58943906|FG000|Part 1|Withdrawal by Subject|0|||
30909050|NCT02296424|58943907|FG001|Part 1|Withdrawal by Subject|2|||
30909051|NCT02296424|58943908|FG002|Part 1|Withdrawal by Subject|0|||
30909052|NCT02296424|58943909|FG003|Part 1|Withdrawal by Subject|0|||
30909053|NCT02296424|58943906|FG000|Part 1|Study terminated by sponsor|0|||
30909054|NCT02296424|58943907|FG001|Part 1|Study terminated by sponsor|1|||
30909055|NCT02296424|58943908|FG002|Part 1|Study terminated by sponsor|0|||
30909056|NCT02296424|58943909|FG003|Part 1|Study terminated by sponsor|0|||
30909057|NCT02296424|58943906|FG000|Part 1|Adverse Event|2|||
30909058|NCT02296424|58943907|FG001|Part 1|Adverse Event|11|||
30909059|NCT02296424|58943908|FG002|Part 1|Adverse Event|0|||
30909060|NCT02296424|58943909|FG003|Part 1|Adverse Event|0|||
30909061|NCT02296424|58943906|FG000|Part 1|Lack of Efficacy|5|||
30909062|NCT02296424|58943907|FG001|Part 1|Lack of Efficacy|17|||
30909063|NCT02296424|58943908|FG002|Part 1|Lack of Efficacy|0|||
30909064|NCT02296424|58943909|FG003|Part 1|Lack of Efficacy|0|||
30909065|NCT02296424|58943906|FG000|Part 1|16 directly started part II|16|||
30909066|NCT02296424|58943907|FG001|Part 1|16 directly started part II|0|||
30909067|NCT02296424|58943908|FG002|Part 1|16 directly started part II|0|||
30909068|NCT02296424|58943909|FG003|Part 1|16 directly started part II|0|||
30807971|NCT04084769|58826061|FG003|Overall Study|Lost to Follow-up|0|||
30807972|NCT03121950|58826078|FG000|Overall Study|Withdrawal by Subject|11|||
30807973|NCT03121950|58826079|FG001|Overall Study|Withdrawal by Subject|2|||
30807974|NCT03395353|58826087|FG000|Overall Study|Adverse Event|20|||
30807975|NCT03395353|58826087|FG000|Overall Study|Protocol Violation|1|||
30807976|NCT03395353|58826087|FG000|Overall Study|Lack of Efficacy|3|||
30807977|NCT03395353|58826087|FG000|Overall Study|Withdrawal by Subject|24|||
30807978|NCT03395353|58826087|FG000|Overall Study|Discontinued visit|1|||
30807979|NCT03395353|58826087|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
30807980|NCT03395353|58826087|FG000|Overall Study|Physician Decision|4|||
30807981|NCT03395353|58826087|FG000|Overall Study|Early termination of overall study|33|||
30807982|NCT04082663|58826095|FG000|Overall Study|Adverse Event|6|||
30807983|NCT04082663|58826095|FG000|Overall Study|Lost to Follow-up|1|||
30807984|NCT03682367|58826101|FG000|Overall Study|Protocol Violation|2|||
30807985|NCT03682367|58826102|FG001|Overall Study|Protocol Violation|1|||
30807986|NCT03682367|58826101|FG000|Overall Study|Closed Study Early|0|||
30807987|NCT03682367|58826102|FG001|Overall Study|Closed Study Early|3|||
30807988|NCT03681353|58826108|FG000|Overall Study|Lost to Follow-up|2|||
30807989|NCT03681353|58826108|FG000|Overall Study|Withdrawal by Subject|3|||
30807990|NCT03681353|58826108|FG000|Overall Study|withdrawn by PI|2|||
30807991|NCT03394885|58826112|FG000|Overall Study|Adverse Event|4|||
30807992|NCT03394885|58826112|FG000|Overall Study|Lack of Efficacy|1|||
30807993|NCT03394885|58826112|FG000|Overall Study|Physician Decision|1|||
30807994|NCT03394885|58826112|FG000|Overall Study|Withdrawal by Subject|8|||
30807995|NCT03394885|58826112|FG000|Overall Study|Alternative Therapy|1|||
30807996|NCT02877927|58826118|FG000|Overall Study|Adverse Event|1|||
30807997|NCT02877927|58826119|FG001|Overall Study|Adverse Event|0|||
30807998|NCT02877927|58826118|FG000|Overall Study|Lost to Follow-up|37|||
30807999|NCT02877927|58826119|FG001|Overall Study|Lost to Follow-up|38|||
30808000|NCT02877927|58826118|FG000|Overall Study|Withdrawal by Subject|11|||
30808001|NCT02877927|58826119|FG001|Overall Study|Withdrawal by Subject|12|||
30808002|NCT02877927|58826118|FG000|Overall Study|Physician Decision|0|||
30808003|NCT02877927|58826119|FG001|Overall Study|Physician Decision|1|||
30808004|NCT02877927|58826118|FG000|Overall Study|Missed EOT/PTE Visit|5|||
30909069|NCT02296424|58943906|FG000|Part 2|Lack of Efficacy|0|||
30909070|NCT02296424|58943907|FG001|Part 2|Lack of Efficacy|0|||
30909071|NCT02296424|58943908|FG002|Part 2|Lack of Efficacy|1|||
30909072|NCT02296424|58943909|FG003|Part 2|Lack of Efficacy|0|||
30909073|NCT02296424|58943906|FG000|Part 2|Adverse Event|0|||
30909074|NCT02296424|58943907|FG001|Part 2|Adverse Event|0|||
30808005|NCT02877927|58826119|FG001|Overall Study|Missed EOT/PTE Visit|6|||
30808006|NCT02706886|58826134|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
30808007|NCT02706886|58826135|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
30808008|NCT02706886|58826136|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
30808009|NCT02706886|58826137|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
30808010|NCT02706886|58826138|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
30808011|NCT02706886|58826139|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
30808012|NCT02706886|58826140|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
30909075|NCT02296424|58943908|FG002|Part 2|Adverse Event|1|||
30909076|NCT02296424|58943909|FG003|Part 2|Adverse Event|0|||
30909077|NCT02296424|58943906|FG000|Part 2|Lost to Follow-up|0|||
30808013|NCT02706886|58826141|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
30808014|NCT02706886|58826142|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
30808015|NCT04069715|58826196|FG000|Overall Study|Lost to Follow-up|1|||
30808016|NCT04069715|58826197|FG001|Overall Study|Lost to Follow-up|1|||
30808017|NCT04069715|58826196|FG000|Overall Study|Physician Decision|1|||
30808018|NCT04069715|58826197|FG001|Overall Study|Physician Decision|1|||
30808019|NCT04069715|58826196|FG000|Overall Study|Withdrawal by Subject|3|||
30808020|NCT04069715|58826197|FG001|Overall Study|Withdrawal by Subject|3|||
30808021|NCT03681119|58826205|FG000|Overall Study|No specific reason|4|||
30808022|NCT03681119|58826206|FG001|Overall Study|No specific reason|0|||
30808023|NCT03681119|58826205|FG000|Overall Study|Sickness|2|||
30808024|NCT03681119|58826206|FG001|Overall Study|Sickness|0|||
30808025|NCT03111108|58826212|FG000|Overall Study|Death|0|||
30808026|NCT03111108|58826213|FG001|Overall Study|Death|1|||
30808027|NCT03111108|58826212|FG000|Overall Study|Withdrawal by Subject|1|||
30808028|NCT03111108|58826213|FG001|Overall Study|Withdrawal by Subject|0|||
30808029|NCT03677375|58826219|FG000|Overall Study|Incomplete procedure|8|||
30808030|NCT03677375|58826219|FG000|Overall Study|Adverse Event|3|||
30808031|NCT03677375|58826219|FG000|Overall Study|Physician Decision|1|||
30808032|NCT00702520|58826225|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
30808033|NCT00702520|58826226|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
30808034|NCT00702520|58826227|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
30808035|NCT00702520|58826228|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
30808036|NCT00702520|58826225|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
30808037|NCT00702520|58826226|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
30808038|NCT00702520|58826227|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
30808039|NCT00702520|58826228|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
30808040|NCT00702520|58826225|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
30808041|NCT00702520|58826226|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
30808042|NCT00702520|58826227|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
30808043|NCT00702520|58826228|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
30808044|NCT04067141|58826238|FG000|First Intervention|Withdrawal by Subject|0|||
30808045|NCT04067141|58826239|FG001|First Intervention|Withdrawal by Subject|1|||
30808046|NCT04067141|58826238|FG000|Second Intervention|Adverse Event|0|||
30808047|NCT04067141|58826239|FG001|Second Intervention|Adverse Event|2|||
30808048|NCT02876601|58826249|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
30808049|NCT02876601|58826250|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
30808050|NCT02876601|58826251|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
30808051|NCT02876601|58826252|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
30808052|NCT04054193|58826297|FG000|Cycle 1|Physician Decision|1|||
30808053|NCT04054193|58826297|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
30808054|NCT04054193|58826297|FG000|Cycle 1|Allocated but not treated|3|||
30808055|NCT04054193|58826297|FG000|Cycles 2-3|Physician Decision|2|||
30808056|NCT04054193|58826297|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
30808057|NCT04054193|58826297|FG000|Cycles 2-3|Various reasons|17|||
30808058|NCT03394027|58826305|FG000|Overall Study|Ineligible|3|||
30808059|NCT03394027|58826306|FG001|Overall Study|Ineligible|1|||
30808060|NCT03394027|58826307|FG002|Overall Study|Ineligible|3|||
30909078|NCT02296424|58943907|FG001|Part 2|Lost to Follow-up|0|||
30909079|NCT02296424|58943908|FG002|Part 2|Lost to Follow-up|1|||
30909080|NCT02296424|58943909|FG003|Part 2|Lost to Follow-up|0|||
30909081|NCT02296190|58943923|FG000|Overall Study|Lost to Follow-up|0|||
30909082|NCT02296190|58943924|FG001|Overall Study|Lost to Follow-up|0|||
30909083|NCT02296190|58943925|FG002|Overall Study|Lost to Follow-up|0|||
30909084|NCT02296190|58943926|FG003|Overall Study|Lost to Follow-up|0|||
30909085|NCT02296190|58943927|FG004|Overall Study|Lost to Follow-up|1|||
30909086|NCT02296190|58943928|FG005|Overall Study|Lost to Follow-up|0|||
30909087|NCT02296190|58943923|FG000|Overall Study|Failure to induce PSVT|6|||
30909088|NCT02296190|58943924|FG001|Overall Study|Failure to induce PSVT|10|||
30909089|NCT02296190|58943925|FG002|Overall Study|Failure to induce PSVT|5|||
30909090|NCT02296190|58943926|FG003|Overall Study|Failure to induce PSVT|13|||
30808061|NCT03394027|58826305|FG000|Overall Study|Participant declined to participate before treatment started|0|||
30808062|NCT03394027|58826306|FG001|Overall Study|Participant declined to participate before treatment started|0|||
30808063|NCT03394027|58826307|FG002|Overall Study|Participant declined to participate before treatment started|1|||
30808064|NCT03136107|58826333|FG000|Overall Study|Other (Not specified)|1|||
30808065|NCT02916056|58826341|FG000|Overall Study|Adverse Event|6|||
30909091|NCT02296190|58943927|FG004|Overall Study|Failure to induce PSVT|8|||
30808066|NCT02916056|58826341|FG000|Overall Study|Lost to Follow-up|1|||
30808067|NCT02916056|58826341|FG000|Overall Study|Other|12|||
30808068|NCT02916056|58826341|FG000|Overall Study|Protocol Violation|1|||
30909092|NCT02296190|58943928|FG005|Overall Study|Failure to induce PSVT|0|||
30909093|NCT02296190|58943923|FG000|Overall Study|Physician Decision|1|||
30909094|NCT02296190|58943924|FG001|Overall Study|Physician Decision|1|||
30909095|NCT02296190|58943925|FG002|Overall Study|Physician Decision|0|||
30909096|NCT02296190|58943926|FG003|Overall Study|Physician Decision|1|||
30909097|NCT02296190|58943927|FG004|Overall Study|Physician Decision|2|||
30909098|NCT02296190|58943928|FG005|Overall Study|Physician Decision|0|||
30909099|NCT02296190|58943923|FG000|Overall Study|Withdrawal by Subject|0|||
30909100|NCT02296190|58943924|FG001|Overall Study|Withdrawal by Subject|1|||
30909101|NCT02296190|58943925|FG002|Overall Study|Withdrawal by Subject|0|||
30909102|NCT02296190|58943926|FG003|Overall Study|Withdrawal by Subject|0|||
30909103|NCT02296190|58943927|FG004|Overall Study|Withdrawal by Subject|0|||
30909104|NCT02296190|58943928|FG005|Overall Study|Withdrawal by Subject|0|||
30909105|NCT02296190|58943923|FG000|Overall Study|PSVT < 5 minutes|5|||
30909106|NCT02296190|58943924|FG001|Overall Study|PSVT < 5 minutes|6|||
30909107|NCT02296190|58943925|FG002|Overall Study|PSVT < 5 minutes|6|||
30909108|NCT02296190|58943926|FG003|Overall Study|PSVT < 5 minutes|6|||
30909109|NCT02296190|58943927|FG004|Overall Study|PSVT < 5 minutes|5|||
30909110|NCT02296190|58943928|FG005|Overall Study|PSVT < 5 minutes|0|||
30909111|NCT02296190|58943923|FG000|Overall Study|Patient was given Propofol|0|||
30909112|NCT02296190|58943924|FG001|Overall Study|Patient was given Propofol|1|||
30909113|NCT02296190|58943925|FG002|Overall Study|Patient was given Propofol|0|||
30909114|NCT02296190|58943926|FG003|Overall Study|Patient was given Propofol|1|||
30909115|NCT02296190|58943927|FG004|Overall Study|Patient was given Propofol|0|||
30909116|NCT02296190|58943928|FG005|Overall Study|Patient was given Propofol|0|||
30909117|NCT02296190|58943923|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
30909118|NCT02296190|58943924|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
30909119|NCT02296190|58943925|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
30909120|NCT02296190|58943926|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
30909121|NCT02296190|58943927|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
30909122|NCT02296190|58943928|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
30909123|NCT02296190|58943923|FG000|Overall Study|Blood pressure <100 after sedation|0|||
30909124|NCT02296190|58943924|FG001|Overall Study|Blood pressure <100 after sedation|0|||
30909125|NCT02296190|58943925|FG002|Overall Study|Blood pressure <100 after sedation|0|||
30909126|NCT02296190|58943926|FG003|Overall Study|Blood pressure <100 after sedation|1|||
30909127|NCT02296190|58943927|FG004|Overall Study|Blood pressure <100 after sedation|0|||
30909128|NCT02296190|58943928|FG005|Overall Study|Blood pressure <100 after sedation|0|||
30909129|NCT02296190|58943923|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
30909130|NCT02296190|58943924|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
30909131|NCT02296190|58943925|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
30909132|NCT02296190|58943926|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
30909133|NCT02296190|58943927|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
30909134|NCT02296190|58943928|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
30909135|NCT02296190|58943923|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
30909136|NCT02296190|58943924|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
30909137|NCT02296190|58943925|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
30909138|NCT02296190|58943926|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
30909139|NCT02296190|58943927|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
30909140|NCT02296190|58943928|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
30909141|NCT02296190|58943923|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
30909142|NCT02296190|58943924|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
30909143|NCT02296190|58943925|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
30909144|NCT02296190|58943926|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
30808069|NCT02916056|58826341|FG000|Overall Study|Withdrawal by Subject|8|||
30808070|NCT02916056|58826341|FG000|Overall Study|Study Terminated by Sponsor|269|||
30808071|NCT04854642|58826345|FG000|Overall Study|Adverse Event|1|||
30808072|NCT04854642|58826346|FG001|Overall Study|Adverse Event|2|||
30808073|NCT04854642|58826345|FG000|Overall Study|Withdrawal by Subject|0|||
30808074|NCT04854642|58826346|FG001|Overall Study|Withdrawal by Subject|1|||
30808075|NCT03689712|58826356|FG000|Overall Study|Adverse Event|1|||
30808076|NCT03689712|58826357|FG001|Overall Study|Adverse Event|0|||
30808077|NCT03689712|58826356|FG000|Overall Study|Death|20|||
30808078|NCT03689712|58826357|FG001|Overall Study|Death|10|||
30808079|NCT03689712|58826356|FG000|Overall Study|Lost to Follow-up|6|||
30808080|NCT03689712|58826357|FG001|Overall Study|Lost to Follow-up|6|||
30909145|NCT02296190|58943927|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
30909146|NCT02296190|58943928|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
30909147|NCT02296190|58943923|FG000|Overall Study|Lab result not available in time|1|||
30909148|NCT02296190|58943924|FG001|Overall Study|Lab result not available in time|0|||
30909149|NCT02296190|58943925|FG002|Overall Study|Lab result not available in time|0|||
30808081|NCT03689712|58826356|FG000|Overall Study|Other|1|||
30808082|NCT03689712|58826357|FG001|Overall Study|Other|0|||
30808083|NCT03689712|58826356|FG000|Overall Study|Patient Non-Compliance|0|||
30808084|NCT03689712|58826357|FG001|Overall Study|Patient Non-Compliance|1|||
30808085|NCT03689712|58826356|FG000|Overall Study|Withdrawal by Subject|20|||
30808086|NCT03689712|58826357|FG001|Overall Study|Withdrawal by Subject|4|||
30808087|NCT03689712|58826356|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
30808088|NCT03689712|58826357|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
30808089|NCT03689712|58826356|FG000|Overall Study|Randomized but not Treated|13|||
30808090|NCT03689712|58826357|FG001|Overall Study|Randomized but not Treated|7|||
30808091|NCT03689712|58826356|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
30808092|NCT03689712|58826357|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
30808093|NCT03384745|58826369|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
30808094|NCT03384745|58826370|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
30808095|NCT03384745|58826371|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
30808096|NCT03384745|58826372|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
30808097|NCT03384745|58826373|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
30808098|NCT03384745|58826374|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
30808099|NCT03384745|58826369|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
30808100|NCT03384745|58826370|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
30808101|NCT03384745|58826371|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
30808102|NCT03384745|58826372|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
30808103|NCT03384745|58826373|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
30808104|NCT03384745|58826374|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
30808105|NCT03384745|58826369|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
30808106|NCT03384745|58826370|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
30808107|NCT03384745|58826371|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
30909150|NCT02296190|58943926|FG003|Overall Study|Lab result not available in time|0|||
30909151|NCT02296190|58943927|FG004|Overall Study|Lab result not available in time|0|||
30909152|NCT02296190|58943928|FG005|Overall Study|Lab result not available in time|0|||
30909153|NCT02296112|58943941|FG000|Overall Study|Disease progression|7|||
30748977|NCT00006604|58759127|FG011|Overall Study|Met study objective - no further FU|0|||
30748978|NCT00006604|58759128|FG012|Overall Study|Met study objective - no further FU|0|||
30748979|NCT00006604|58759129|FG013|Overall Study|Met study objective - no further FU|0|||
30748980|NCT00006604|58759130|FG014|Overall Study|Met study objective - no further FU|1|||
30748981|NCT00006604|58759131|FG015|Overall Study|Met study objective - no further FU|1|||
30748982|NCT00006604|58759132|FG016|Overall Study|Met study objective - no further FU|0|||
30748983|NCT00006604|58759116|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
30748984|NCT00006604|58759117|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
30748985|NCT00006604|58759118|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
30748986|NCT00006604|58759119|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
30748987|NCT00006604|58759120|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
30748988|NCT00006604|58759121|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
30748989|NCT00006604|58759122|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
30748990|NCT00006604|58759123|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
30748991|NCT00006604|58759124|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
30748992|NCT00006604|58759125|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
30748993|NCT00006604|58759126|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
30748994|NCT00006604|58759127|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
30748995|NCT00006604|58759128|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
30748996|NCT00006604|58759129|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
30748997|NCT00006604|58759130|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
30748998|NCT00006604|58759131|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
30748999|NCT00006604|58759132|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
30749000|NCT00006604|58759116|FG000|Overall Study|Death|0|||
30749001|NCT00006604|58759117|FG001|Overall Study|Death|0|||
30749002|NCT00006604|58759118|FG002|Overall Study|Death|0|||
30808108|NCT03384745|58826372|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
30749003|NCT00006604|58759119|FG003|Overall Study|Death|0|||
30749004|NCT00006604|58759120|FG004|Overall Study|Death|0|||
30749005|NCT00006604|58759121|FG005|Overall Study|Death|0|||
30749006|NCT00006604|58759122|FG006|Overall Study|Death|0|||
30749007|NCT00006604|58759123|FG007|Overall Study|Death|0|||
30749008|NCT00006604|58759124|FG008|Overall Study|Death|0|||
30749009|NCT00006604|58759125|FG009|Overall Study|Death|1|||
30749010|NCT00006604|58759126|FG010|Overall Study|Death|1|||
30749011|NCT00006604|58759127|FG011|Overall Study|Death|1|||
30749012|NCT00006604|58759128|FG012|Overall Study|Death|0|||
30749013|NCT00006604|58759129|FG013|Overall Study|Death|0|||
30808109|NCT03384745|58826373|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
30808110|NCT03384745|58826374|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
30808111|NCT03384745|58826369|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
30808112|NCT03384745|58826370|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
30808113|NCT03384745|58826371|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
30808114|NCT03384745|58826372|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
30808115|NCT03384745|58826373|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
30808116|NCT03384745|58826374|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
30808117|NCT03384745|58826369|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
30808118|NCT03384745|58826370|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
30808119|NCT03384745|58826371|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
30808120|NCT03384745|58826372|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
30808121|NCT03384745|58826373|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
30808122|NCT03384745|58826374|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
30808123|NCT03384745|58826369|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
30808124|NCT03384745|58826370|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
30808125|NCT03384745|58826371|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
30808126|NCT03384745|58826372|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
30808127|NCT03384745|58826373|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
30808128|NCT03384745|58826374|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
30808129|NCT03384745|58826369|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
30808130|NCT03384745|58826370|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
30808131|NCT03384745|58826371|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
30808132|NCT03384745|58826372|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
30808133|NCT03384745|58826373|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
30808134|NCT03384745|58826374|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
30808135|NCT03384745|58826369|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
30808136|NCT03384745|58826370|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
30808137|NCT03384745|58826371|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
30808138|NCT03384745|58826372|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
30808139|NCT03384745|58826373|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
30808140|NCT03384745|58826374|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
30808141|NCT03384745|58826369|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
30808142|NCT03384745|58826370|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
30808143|NCT03384745|58826371|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
30808144|NCT03384745|58826372|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
30808145|NCT03384745|58826373|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
30808146|NCT03384745|58826374|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
30808147|NCT03384745|58826369|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
30808148|NCT03384745|58826370|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
30808149|NCT03384745|58826371|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
30808150|NCT03384745|58826372|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
30808151|NCT03384745|58826373|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
30808152|NCT03384745|58826374|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
30808153|NCT03384745|58826369|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
30808154|NCT03384745|58826370|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
30808155|NCT03384745|58826371|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
30808156|NCT03384745|58826372|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
30808157|NCT03384745|58826373|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
30808158|NCT03384745|58826374|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
30808159|NCT03383887|58826394|FG000|Overall Study|Lost to Follow-up|0|||
30808160|NCT03383887|58826395|FG001|Overall Study|Lost to Follow-up|1|||
30808161|NCT03379753|58826403|FG000|Overall Study|Withdrawal by Subject|2|||
30808162|NCT03379753|58826404|FG001|Overall Study|Withdrawal by Subject|1|||
30808163|NCT03379753|58826403|FG000|Overall Study|not having correct procedure|1|||
30808164|NCT03379753|58826404|FG001|Overall Study|not having correct procedure|2|||
30808165|NCT03379753|58826403|FG000|Overall Study|No primary outcome|12|||
30808166|NCT03379753|58826404|FG001|Overall Study|No primary outcome|22|||
30808167|NCT03379675|58826413|FG000|Overall Study|Lost to Follow-up|0|||
30808168|NCT03379675|58826414|FG001|Overall Study|Lost to Follow-up|1|||
30808169|NCT03379675|58826415|FG002|Overall Study|Lost to Follow-up|0|||
30808170|NCT03379675|58826413|FG000|Overall Study|Adverse Event|2|||
30808171|NCT03379675|58826414|FG001|Overall Study|Adverse Event|0|||
30808172|NCT03379675|58826415|FG002|Overall Study|Adverse Event|0|||
30808173|NCT03379675|58826413|FG000|Overall Study|Withdrawal by Subject|2|||
30808174|NCT03379675|58826414|FG001|Overall Study|Withdrawal by Subject|1|||
30808175|NCT03379675|58826415|FG002|Overall Study|Withdrawal by Subject|2|||
30808176|NCT02930889|58826423|FG000|Overall Study|Lost to Follow-up|2|||
30808177|NCT02930889|58826423|FG000|Overall Study|Withdrawal by Subject|6|||
30808178|NCT02930889|58826423|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
30808179|NCT02875977|58826429|FG000|Overall Study|Lost to Follow-up|42|||
30808180|NCT02875977|58826430|FG001|Overall Study|Lost to Follow-up|29|||
30808181|NCT02703532|58826449|FG000|Overall Study|Withdrawal by Subject|0|||
30808182|NCT02703532|58826450|FG001|Overall Study|Withdrawal by Subject|1|||
30808183|NCT02703532|58826451|FG002|Overall Study|Withdrawal by Subject|0|||
30808184|NCT02703532|58826452|FG003|Overall Study|Withdrawal by Subject|1|||
30808185|NCT02703532|58826449|FG000|Overall Study|Lost to Follow-up|2|||
30808186|NCT02703532|58826450|FG001|Overall Study|Lost to Follow-up|0|||
30808187|NCT02703532|58826451|FG002|Overall Study|Lost to Follow-up|2|||
30808188|NCT02703532|58826452|FG003|Overall Study|Lost to Follow-up|0|||
30909154|NCT02296112|58943941|FG000|Overall Study|Toxicity|1|||
30909155|NCT02296112|58943941|FG000|Overall Study|Began an alternate therapy|1|||
30909156|NCT02295644|58943954|FG000|Overall Study|Did not meet inclusion criterion|0|||
30909157|NCT02295644|58943955|FG001|Overall Study|Did not meet inclusion criterion|0|||
30909158|NCT02295644|58943956|FG002|Overall Study|Did not meet inclusion criterion|1|||
30909159|NCT02295644|58943957|FG003|Overall Study|Did not meet inclusion criterion|2|||
30909160|NCT02269670|58943967|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
30909161|NCT02225353|58943974|FG000|Overall Study|Lost to Follow-up|0|||
30909162|NCT02225353|58943975|FG001|Overall Study|Lost to Follow-up|1|||
30909163|NCT02225353|58943976|FG002|Overall Study|Lost to Follow-up|3|||
30909164|NCT02225353|58943974|FG000|Overall Study|Protocol Violation|4|||
30909165|NCT02225353|58943975|FG001|Overall Study|Protocol Violation|5|||
30909166|NCT02225353|58943976|FG002|Overall Study|Protocol Violation|12|||
30909167|NCT01641926|58943991|FG000|Overall Study|Adverse Event|5|||
30909168|NCT01641926|58943992|FG001|Overall Study|Adverse Event|2|||
30909169|NCT01641926|58943993|FG002|Overall Study|Adverse Event|3|||
30909170|NCT01641926|58943994|FG003|Overall Study|Adverse Event|1|||
30909171|NCT01641926|58943991|FG000|Overall Study|Lost to Follow-up|2|||
30909172|NCT01641926|58943992|FG001|Overall Study|Lost to Follow-up|2|||
30909173|NCT01641926|58943993|FG002|Overall Study|Lost to Follow-up|1|||
30909174|NCT01641926|58943994|FG003|Overall Study|Lost to Follow-up|0|||
30909175|NCT01641926|58943991|FG000|Overall Study|Physician Decision|6|||
30808189|NCT02930343|58826485|FG000|Overall Study|Lost to Follow-up|9|||
30808190|NCT02930343|58826486|FG001|Overall Study|Lost to Follow-up|7|||
30808191|NCT02703454|58826494|FG000|Overall Study|Not treated|1|||
30808192|NCT02703454|58826495|FG001|Overall Study|Not treated|3|||
30808193|NCT02703454|58826494|FG000|Overall Study|Withdrawal by Subject|4|||
30808194|NCT02703454|58826495|FG001|Overall Study|Withdrawal by Subject|3|||
30808195|NCT02703454|58826494|FG000|Overall Study|Lost to Follow-up|1|||
30808196|NCT02703454|58826495|FG001|Overall Study|Lost to Follow-up|2|||
30808197|NCT02703454|58826494|FG000|Overall Study|Study discontinuation|5|||
30808198|NCT02703454|58826495|FG001|Overall Study|Study discontinuation|8|||
30909176|NCT01641926|58943992|FG001|Overall Study|Physician Decision|5|||
30808199|NCT03103542|58826501|FG000|Overall Study|Physician Decision|2|||
30808200|NCT03103542|58826501|FG000|Overall Study|Adverse Event|2|||
30808201|NCT03103542|58826501|FG000|Overall Study|Other|2|||
30909177|NCT01641926|58943993|FG002|Overall Study|Physician Decision|0|||
30909178|NCT01641926|58943994|FG003|Overall Study|Physician Decision|1|||
30808202|NCT03103542|58826501|FG000|Overall Study|Withdrawal by Subject|1|||
30808203|NCT03376321|58826528|FG000|Overall Study|Other|5|||
30808204|NCT03376321|58826529|FG001|Overall Study|Other|1|||
30808205|NCT03376321|58826528|FG000|Overall Study|Withdrawal by Subject|8|||
30622480|NCT00925990|58634201|FG000|Overall Study|Physician Decision|1|||
30749014|NCT00006604|58759130|FG014|Overall Study|Death|0|||
30749015|NCT00006604|58759131|FG015|Overall Study|Death|0|||
30749016|NCT00006604|58759132|FG016|Overall Study|Death|0|||
30749017|NCT00006604|58759116|FG000|Overall Study|Severe debilitation, unable to continue|0|||
30749018|NCT00006604|58759117|FG001|Overall Study|Severe debilitation, unable to continue|0|||
30749019|NCT00006604|58759118|FG002|Overall Study|Severe debilitation, unable to continue|0|||
30749020|NCT00006604|58759119|FG003|Overall Study|Severe debilitation, unable to continue|0|||
30622481|NCT00925990|58634202|FG001|Overall Study|Physician Decision|1|||
30749021|NCT00006604|58759120|FG004|Overall Study|Severe debilitation, unable to continue|0|||
30749022|NCT00006604|58759121|FG005|Overall Study|Severe debilitation, unable to continue|0|||
30749023|NCT00006604|58759122|FG006|Overall Study|Severe debilitation, unable to continue|3|||
30749024|NCT00006604|58759123|FG007|Overall Study|Severe debilitation, unable to continue|0|||
30808206|NCT03376321|58826529|FG001|Overall Study|Withdrawal by Subject|14|||
30808207|NCT03376321|58826528|FG000|Overall Study|Lost to Follow-up|1|||
30808208|NCT03376321|58826529|FG001|Overall Study|Lost to Follow-up|7|||
30808209|NCT03376321|58826528|FG000|Overall Study|Death|4|||
30808210|NCT03376321|58826529|FG001|Overall Study|Death|0|||
30808211|NCT03376321|58826528|FG000|Overall Study|Randomized, not treated|5|||
30808212|NCT03376321|58826529|FG001|Overall Study|Randomized, not treated|3|||
30808213|NCT03374995|58826537|FG000|Overall Study|Withdrawal by Subject|0|||
30808214|NCT03374995|58826538|FG001|Overall Study|Withdrawal by Subject|1|||
30808215|NCT02828982|58826544|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
30808216|NCT02828982|58826545|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
30808217|NCT03133767|58826555|FG000|Overall Study|Lost to Follow-up|38|||
30808218|NCT03133767|58826556|FG001|Overall Study|Lost to Follow-up|24|||
30808219|NCT03133767|58826555|FG000|Overall Study|Protocol Violation|0|||
30808220|NCT03133767|58826556|FG001|Overall Study|Protocol Violation|1|||
30808221|NCT03391765|58826566|FG000|Overall Study|Adverse Event|2|||
30808222|NCT03391765|58826567|FG001|Overall Study|Adverse Event|0|||
30808223|NCT03391765|58826568|FG002|Overall Study|Adverse Event|0|||
30808224|NCT03391765|58826569|FG003|Overall Study|Adverse Event|2|||
30808225|NCT03391765|58826566|FG000|Overall Study|Withdrew consent|5|||
30808226|NCT03391765|58826567|FG001|Overall Study|Withdrew consent|7|||
30808227|NCT03391765|58826568|FG002|Overall Study|Withdrew consent|2|||
30808228|NCT03391765|58826569|FG003|Overall Study|Withdrew consent|5|||
30808229|NCT03391765|58826566|FG000|Overall Study|Other, not specified|44|||
30808230|NCT03391765|58826567|FG001|Overall Study|Other, not specified|38|||
30808231|NCT03391765|58826568|FG002|Overall Study|Other, not specified|21|||
30808232|NCT03391765|58826569|FG003|Overall Study|Other, not specified|16|||
30808233|NCT02802228|58826581|FG000|Overall Study|Withdrawal by Subject|2|||
30808234|NCT02802228|58826582|FG001|Overall Study|Withdrawal by Subject|0|||
30808235|NCT02802228|58826581|FG000|Overall Study|Lost to Follow-up|1|||
30808236|NCT02802228|58826582|FG001|Overall Study|Lost to Follow-up|0|||
30808237|NCT02802228|58826581|FG000|Overall Study|Adverse Event|1|||
30808238|NCT02802228|58826582|FG001|Overall Study|Adverse Event|0|||
30808239|NCT02802228|58826581|FG000|Overall Study|Physician Decision|1|||
30808240|NCT02802228|58826582|FG001|Overall Study|Physician Decision|0|||
30808241|NCT03130257|58826591|FG000|Overall Study|Withdrawal by Subject|1|||
30808242|NCT03130257|58826592|FG001|Overall Study|Withdrawal by Subject|0|||
30808243|NCT03130257|58826593|FG002|Overall Study|Withdrawal by Subject|2|||
30808244|NCT03674177|58826605|FG000|Overall Study|Lost to Follow-up|2|||
30808245|NCT03674177|58826606|FG001|Overall Study|Lost to Follow-up|1|||
30808246|NCT03674177|58826607|FG002|Overall Study|Lost to Follow-up|0|||
30808247|NCT03674177|58826608|FG003|Overall Study|Lost to Follow-up|2|||
30808248|NCT03354637|58826634|FG000|Double-blind Period|Protocol Violation|2|||
30808249|NCT03354637|58826635|FG001|Double-blind Period|Protocol Violation|0|||
30808250|NCT03354637|58826636|FG002|Double-blind Period|Protocol Violation|0|||
30808251|NCT03354637|58826634|FG000|Double-blind Period|Adverse Event|1|||
30808252|NCT03354637|58826635|FG001|Double-blind Period|Adverse Event|2|||
30808253|NCT03354637|58826636|FG002|Double-blind Period|Adverse Event|0|||
30808254|NCT03354637|58826634|FG000|Double-blind Period|Lost to Follow-up|3|||
30749025|NCT00006604|58759124|FG008|Overall Study|Severe debilitation, unable to continue|0|||
30749026|NCT00006604|58759125|FG009|Overall Study|Severe debilitation, unable to continue|5|||
30749027|NCT00006604|58759126|FG010|Overall Study|Severe debilitation, unable to continue|0|||
30749028|NCT00006604|58759127|FG011|Overall Study|Severe debilitation, unable to continue|2|||
30749029|NCT00006604|58759128|FG012|Overall Study|Severe debilitation, unable to continue|1|||
30749030|NCT00006604|58759129|FG013|Overall Study|Severe debilitation, unable to continue|0|||
30749031|NCT00006604|58759130|FG014|Overall Study|Severe debilitation, unable to continue|2|||
30749032|NCT00006604|58759131|FG015|Overall Study|Severe debilitation, unable to continue|0|||
30749033|NCT00006604|58759132|FG016|Overall Study|Severe debilitation, unable to continue|0|||
30749034|NCT00006604|58759116|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
30749035|NCT00006604|58759117|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
30749036|NCT00006604|58759118|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
30749037|NCT00006604|58759119|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
30749038|NCT00006604|58759120|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
30749039|NCT00006604|58759121|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
30749040|NCT00006604|58759122|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
30749041|NCT00006604|58759123|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
30808255|NCT03354637|58826635|FG001|Double-blind Period|Lost to Follow-up|4|||
30808256|NCT03354637|58826636|FG002|Double-blind Period|Lost to Follow-up|3|||
30808257|NCT03354637|58826634|FG000|Double-blind Period|Withdrawal by Subject|10|||
30808258|NCT03354637|58826635|FG001|Double-blind Period|Withdrawal by Subject|6|||
30808259|NCT03354637|58826636|FG002|Double-blind Period|Withdrawal by Subject|4|||
30808260|NCT03354637|58826634|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
30808261|NCT03354637|58826635|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
30808262|NCT03354637|58826636|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
30808263|NCT03354637|58826634|FG000|Open Label Extension|Adverse Event|0|||
30808264|NCT03354637|58826635|FG001|Open Label Extension|Adverse Event|0|||
30808265|NCT03354637|58826636|FG002|Open Label Extension|Adverse Event|1|||
30808266|NCT03354637|58826634|FG000|Open Label Extension|Lost to Follow-up|0|||
30808267|NCT03354637|58826635|FG001|Open Label Extension|Lost to Follow-up|0|||
30808268|NCT03354637|58826636|FG002|Open Label Extension|Lost to Follow-up|2|||
30808269|NCT03354637|58826634|FG000|Open Label Extension|Withdrawal by Subject|0|||
30808270|NCT03354637|58826635|FG001|Open Label Extension|Withdrawal by Subject|0|||
30808271|NCT03354637|58826636|FG002|Open Label Extension|Withdrawal by Subject|5|||
30808272|NCT03354637|58826634|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
30808273|NCT03354637|58826635|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
30909179|NCT01641926|58943991|FG000|Overall Study|Protocol Violation|1|||
30909180|NCT01641926|58943992|FG001|Overall Study|Protocol Violation|0|||
30909181|NCT01641926|58943993|FG002|Overall Study|Protocol Violation|0|||
30909182|NCT01641926|58943994|FG003|Overall Study|Protocol Violation|1|||
30909183|NCT01641926|58943991|FG000|Overall Study|Withdrawal by Subject|13|||
30909184|NCT01641926|58943992|FG001|Overall Study|Withdrawal by Subject|5|||
30909185|NCT01641926|58943993|FG002|Overall Study|Withdrawal by Subject|6|||
30909186|NCT01641926|58943994|FG003|Overall Study|Withdrawal by Subject|1|||
30909187|NCT01641926|58943991|FG000|Overall Study|Not Treated|1|||
30909188|NCT01641926|58943992|FG001|Overall Study|Not Treated|1|||
30909189|NCT01641926|58943993|FG002|Overall Study|Not Treated|1|||
30909190|NCT01641926|58943994|FG003|Overall Study|Not Treated|0|||
30909191|NCT02295020|58944006|FG000|Overall Study|Adverse Event|0|||
30909192|NCT02295020|58944007|FG001|Overall Study|Adverse Event|1|||
30909193|NCT02295020|58944006|FG000|Overall Study|Withdrawal by Subject|3|||
30909194|NCT02295020|58944007|FG001|Overall Study|Withdrawal by Subject|2|||
30749042|NCT00006604|58759124|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
30749043|NCT00006604|58759125|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
30749044|NCT00006604|58759126|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
30749045|NCT00006604|58759127|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
30749046|NCT00006604|58759128|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
30749047|NCT00006604|58759129|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
30749048|NCT00006604|58759130|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
30749049|NCT00006604|58759131|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
30749050|NCT00006604|58759132|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
30749051|NCT00006604|58759116|FG000|Overall Study|Site closing|0|||
30749052|NCT00006604|58759117|FG001|Overall Study|Site closing|0|||
30749053|NCT00006604|58759118|FG002|Overall Study|Site closing|1|||
30749054|NCT00006604|58759119|FG003|Overall Study|Site closing|1|||
30749055|NCT00006604|58759120|FG004|Overall Study|Site closing|0|||
30808274|NCT03354637|58826636|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
30808275|NCT03354637|58826634|FG000|Open Label Extension|Subject Noncompliance|0|||
30808276|NCT03354637|58826635|FG001|Open Label Extension|Subject Noncompliance|0|||
30808277|NCT03354637|58826636|FG002|Open Label Extension|Subject Noncompliance|1|||
30808278|NCT03354637|58826634|FG000|Open Label Extension|Lack of Efficacy|0|||
30909195|NCT02200939|58944021|FG000|Overall Study|Participant withdrew consent|0|||
30909196|NCT02200939|58944022|FG001|Overall Study|Participant withdrew consent|1|||
30749056|NCT00006604|58759121|FG005|Overall Study|Site closing|0|||
30749057|NCT00006604|58759122|FG006|Overall Study|Site closing|0|||
30909197|NCT02200939|58944021|FG000|Overall Study|Lost to Follow-up|2|||
30909198|NCT02200939|58944022|FG001|Overall Study|Lost to Follow-up|9|||
30808279|NCT03354637|58826635|FG001|Open Label Extension|Lack of Efficacy|0|||
30808280|NCT03354637|58826636|FG002|Open Label Extension|Lack of Efficacy|1|||
30808281|NCT03354637|58826634|FG000|Open Label Extension|Physician Decision|0|||
30808282|NCT03354637|58826635|FG001|Open Label Extension|Physician Decision|0|||
30808283|NCT03354637|58826636|FG002|Open Label Extension|Physician Decision|1|||
30808284|NCT04053023|58826647|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
30808285|NCT04053023|58826648|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
30808286|NCT03352453|58826660|FG000|Overall Study|Miscellaneous Reasons|1|||
30808287|NCT03352453|58826661|FG001|Overall Study|Miscellaneous Reasons|2|||
30808288|NCT03352453|58826660|FG000|Overall Study|Lack of Efficacy|1|||
30808289|NCT03352453|58826661|FG001|Overall Study|Lack of Efficacy|0|||
30808290|NCT03352453|58826660|FG000|Overall Study|Withdrawal by Subject|8|||
30909199|NCT02200939|58944021|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
30909200|NCT02200939|58944022|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
30909201|NCT02294786|58944034|FG000|Overall Study|Withdrawal by Subject|0|||
30909202|NCT02294786|58944035|FG001|Overall Study|Withdrawal by Subject|1|||
30909203|NCT02294786|58944034|FG000|Overall Study|Physician Decision|6|||
30909204|NCT02294786|58944035|FG001|Overall Study|Physician Decision|7|||
30909205|NCT02294786|58944034|FG000|Overall Study|Lost to Follow-up|1|||
30909206|NCT02294786|58944035|FG001|Overall Study|Lost to Follow-up|2|||
30909207|NCT02294786|58944034|FG000|Overall Study|Protocol Violation|1|||
30909208|NCT02294786|58944035|FG001|Overall Study|Protocol Violation|0|||
30909209|NCT02294786|58944034|FG000|Overall Study|Adverse Event|1|||
30909210|NCT02294786|58944035|FG001|Overall Study|Adverse Event|1|||
30909211|NCT02294786|58944034|FG000|Overall Study|Death|2|||
30909212|NCT02294786|58944035|FG001|Overall Study|Death|3|||
30948481|NCT01976741|58994456|FG003|Overall Study|Withdrawal by Subject|1|||
30749058|NCT00006604|58759123|FG007|Overall Study|Site closing|1|||
30749059|NCT00006604|58759124|FG008|Overall Study|Site closing|0|||
30749060|NCT00006604|58759125|FG009|Overall Study|Site closing|0|||
30749061|NCT00006604|58759126|FG010|Overall Study|Site closing|0|||
30749062|NCT00006604|58759127|FG011|Overall Study|Site closing|1|||
30808291|NCT03352453|58826661|FG001|Overall Study|Withdrawal by Subject|14|||
30808292|NCT03352453|58826660|FG000|Overall Study|Study Terminated by Sponsor|2|||
30808293|NCT03352453|58826661|FG001|Overall Study|Study Terminated by Sponsor|1|||
30808294|NCT03352453|58826660|FG000|Overall Study|Protocol Deviation|1|||
30808295|NCT03352453|58826661|FG001|Overall Study|Protocol Deviation|0|||
30808296|NCT03352453|58826660|FG000|Overall Study|Lost to Follow-up|7|||
30749063|NCT00006604|58759128|FG012|Overall Study|Site closing|1|||
30749064|NCT00006604|58759129|FG013|Overall Study|Site closing|1|||
30749065|NCT00006604|58759130|FG014|Overall Study|Site closing|0|||
30749066|NCT00006604|58759131|FG015|Overall Study|Site closing|0|||
30749067|NCT00006604|58759132|FG016|Overall Study|Site closing|1|||
30749068|NCT00006604|58759116|FG000|Overall Study|Withdrawal by Subject|1|||
30749069|NCT00006604|58759117|FG001|Overall Study|Withdrawal by Subject|0|||
30749070|NCT00006604|58759118|FG002|Overall Study|Withdrawal by Subject|2|||
30749071|NCT00006604|58759119|FG003|Overall Study|Withdrawal by Subject|0|||
30749072|NCT00006604|58759120|FG004|Overall Study|Withdrawal by Subject|1|||
30749073|NCT00006604|58759121|FG005|Overall Study|Withdrawal by Subject|2|||
30749074|NCT00006604|58759122|FG006|Overall Study|Withdrawal by Subject|2|||
30749075|NCT00006604|58759123|FG007|Overall Study|Withdrawal by Subject|0|||
30749076|NCT00006604|58759124|FG008|Overall Study|Withdrawal by Subject|1|||
30749077|NCT00006604|58759125|FG009|Overall Study|Withdrawal by Subject|3|||
30808297|NCT03352453|58826661|FG001|Overall Study|Lost to Follow-up|6|||
30808298|NCT03352453|58826660|FG000|Overall Study|Adverse Event|2|||
30808299|NCT03352453|58826661|FG001|Overall Study|Adverse Event|9|||
30808300|NCT03128931|58826667|FG000|Overall Study|Physician Decision|1|||
30808301|NCT03128931|58826667|FG000|Overall Study|Equipment Issues|3|||
30808302|NCT03107052|58826674|FG000|Overall Study|Adverse Event|6|||
30808303|NCT03107052|58826675|FG001|Overall Study|Adverse Event|1|||
30808304|NCT03107052|58826676|FG002|Overall Study|Adverse Event|2|||
30808305|NCT03107052|58826674|FG000|Overall Study|Withdrawal by Subject|9|||
30808306|NCT03107052|58826675|FG001|Overall Study|Withdrawal by Subject|5|||
30808307|NCT03107052|58826676|FG002|Overall Study|Withdrawal by Subject|8|||
30808308|NCT03107052|58826674|FG000|Overall Study|Protocol Violation|6|||
30749078|NCT00006604|58759126|FG010|Overall Study|Withdrawal by Subject|2|||
30749079|NCT00006604|58759127|FG011|Overall Study|Withdrawal by Subject|0|||
30749080|NCT00006604|58759128|FG012|Overall Study|Withdrawal by Subject|1|||
30948482|NCT01976741|58994457|FG004|Overall Study|Withdrawal by Subject|0|||
30948483|NCT01976741|58994458|FG005|Overall Study|Withdrawal by Subject|0|||
30948484|NCT01976741|58994459|FG006|Overall Study|Withdrawal by Subject|1|||
30808309|NCT03107052|58826675|FG001|Overall Study|Protocol Violation|0|||
30909213|NCT02269124|58944044|FG000|Overall Study|Lost to Follow-up|1|||
30909214|NCT02269124|58944045|FG001|Overall Study|Lost to Follow-up|0|||
30909215|NCT02269124|58944044|FG000|Overall Study|Withdrawal by Subject|0|||
30909216|NCT02269124|58944045|FG001|Overall Study|Withdrawal by Subject|2|||
30808310|NCT03107052|58826676|FG002|Overall Study|Protocol Violation|3|||
30808311|NCT03107052|58826674|FG000|Overall Study|Lost to Follow-up|4|||
30808312|NCT03107052|58826675|FG001|Overall Study|Lost to Follow-up|0|||
30808313|NCT03107052|58826676|FG002|Overall Study|Lost to Follow-up|1|||
30808314|NCT03107052|58826674|FG000|Overall Study|Lack of Efficacy|23|||
30808315|NCT03107052|58826675|FG001|Overall Study|Lack of Efficacy|7|||
30808316|NCT03107052|58826676|FG002|Overall Study|Lack of Efficacy|4|||
30909217|NCT01927341|58944057|FG000|Phase 1b|Lost to Follow-up|1|||
30909218|NCT01927341|58944058|FG001|Phase 1b|Lost to Follow-up|0|||
30808317|NCT03107052|58826674|FG000|Overall Study|Other than specified|4|||
30808318|NCT03107052|58826675|FG001|Overall Study|Other than specified|2|||
30808319|NCT03107052|58826676|FG002|Overall Study|Other than specified|0|||
30808320|NCT03107052|58826674|FG000|Overall Study|Study terminated due to futility|67|||
30808321|NCT03107052|58826675|FG001|Overall Study|Study terminated due to futility|31|||
30808322|NCT03107052|58826676|FG002|Overall Study|Study terminated due to futility|23|||
30808323|NCT04050371|58826686|FG000|Overall Study|Withdrawal by Subject|1|||
30808324|NCT04050371|58826687|FG001|Overall Study|Withdrawal by Subject|0|||
30808325|NCT04447287|58826696|FG000|Period 1: Run-in Period|Adverse Event|3|||
30808326|NCT04447287|58826697|FG001|Period 1: Run-in Period|Adverse Event|0|||
30808327|NCT04447287|58826698|FG002|Period 1: Run-in Period|Adverse Event|0|||
30808328|NCT04447287|58826696|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
30808329|NCT04447287|58826697|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
30808330|NCT04447287|58826698|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
30808331|NCT04447287|58826696|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
30808332|NCT04447287|58826697|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
30808333|NCT04447287|58826698|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
30808334|NCT01879319|58826719|FG000|Overall Study|Withdrawal by Subject|1|||
30808335|NCT01879319|58826720|FG001|Overall Study|Withdrawal by Subject|0|||
30808336|NCT01879319|58826719|FG000|Overall Study|Lost to Follow-up|1|||
30808337|NCT01879319|58826720|FG001|Overall Study|Lost to Follow-up|5|||
30808338|NCT03102918|58826728|FG000|Overall Study|Protocol Violation|1|||
30808339|NCT03102918|58826729|FG001|Overall Study|Protocol Violation|0|||
30808340|NCT03128307|58826735|FG000|Overall Study|Lost to Follow-up|29|||
30808341|NCT03128307|58826735|FG000|Overall Study|Withdrawal by Subject|5|||
30808342|NCT03102762|58826741|FG000|Overall Study|Lost to Follow-up|1|||
30808343|NCT03102762|58826742|FG001|Overall Study|Lost to Follow-up|0|||
30909219|NCT01927341|58944059|FG002|Phase 1b|Lost to Follow-up|0|||
30622482|NCT00925990|58634201|FG000|Overall Study|moved out of state, missed medication|0|||
30749081|NCT00006604|58759129|FG013|Overall Study|Withdrawal by Subject|2|||
30749082|NCT00006604|58759130|FG014|Overall Study|Withdrawal by Subject|1|||
30749083|NCT00006604|58759131|FG015|Overall Study|Withdrawal by Subject|0|||
30749084|NCT00006604|58759132|FG016|Overall Study|Withdrawal by Subject|1|||
30749085|NCT00006604|58759116|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
30749086|NCT00006604|58759117|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
30749087|NCT00006604|58759118|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
30749088|NCT00006604|58759119|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
30749089|NCT00006604|58759120|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
30749090|NCT00006604|58759121|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
30749091|NCT00006604|58759122|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
30749092|NCT00006604|58759123|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
30749093|NCT00006604|58759124|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
30749094|NCT00006604|58759125|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
30749095|NCT00006604|58759126|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
30749096|NCT00006604|58759127|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
30749097|NCT00006604|58759128|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
30749098|NCT00006604|58759129|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
30749099|NCT00006604|58759130|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
30749100|NCT00006604|58759131|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
30749101|NCT00006604|58759132|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
30749102|NCT00006604|58759116|FG000|Overall Study|Lost to Follow-up|0|||
30749103|NCT00006604|58759117|FG001|Overall Study|Lost to Follow-up|0|||
30749104|NCT00006604|58759118|FG002|Overall Study|Lost to Follow-up|0|||
30749105|NCT00006604|58759119|FG003|Overall Study|Lost to Follow-up|0|||
30749106|NCT00006604|58759120|FG004|Overall Study|Lost to Follow-up|0|||
30808344|NCT01346475|58826755|FG000|First Intervention|Lost to Follow-up|4|||
30909220|NCT01927341|58944060|FG003|Phase 1b|Lost to Follow-up|0|||
30808345|NCT01346475|58826756|FG001|First Intervention|Lost to Follow-up|3|||
30808346|NCT01338636|58826762|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
30808347|NCT00322218|58826768|FG000|Overall Study|Death|3|||
30808348|NCT00322218|58826769|FG001|Overall Study|Death|6|||
30808349|NCT02873754|58826775|FG000|Overall Study|Lost to Follow-up|5|||
30808350|NCT02873754|58826775|FG000|Overall Study|Couldn't complete study procedures|1|||
30808351|NCT03287414|58826781|FG000|Treatment Epoch|Adverse Event|0|||
30808352|NCT03287414|58826782|FG001|Treatment Epoch|Adverse Event|1|||
30808353|NCT03287414|58826781|FG000|Treatment Epoch|Study terminated by sponsor|2|||
30808354|NCT03287414|58826782|FG001|Treatment Epoch|Study terminated by sponsor|2|||
30909221|NCT01927341|58944061|FG004|Phase 1b|Lost to Follow-up|0|||
30909222|NCT01927341|58944057|FG000|Phase 1b|Death|2|||
30909223|NCT01927341|58944058|FG001|Phase 1b|Death|0|||
30909224|NCT01927341|58944059|FG002|Phase 1b|Death|0|||
30909225|NCT01927341|58944060|FG003|Phase 1b|Death|0|||
30909226|NCT01927341|58944061|FG004|Phase 1b|Death|0|||
30909227|NCT01927341|58944057|FG000|Phase 1b|Follow-up completed|7|||
30909228|NCT01927341|58944058|FG001|Phase 1b|Follow-up completed|0|||
30909229|NCT01927341|58944059|FG002|Phase 1b|Follow-up completed|0|||
30909230|NCT01927341|58944060|FG003|Phase 1b|Follow-up completed|0|||
30909231|NCT01927341|58944061|FG004|Phase 1b|Follow-up completed|0|||
30909232|NCT01927341|58944057|FG000|Phase 2|Lost to Follow-up|0|||
30909233|NCT01927341|58944058|FG001|Phase 2|Lost to Follow-up|1|||
30909234|NCT01927341|58944059|FG002|Phase 2|Lost to Follow-up|0|||
30909235|NCT01927341|58944060|FG003|Phase 2|Lost to Follow-up|0|||
30909236|NCT01927341|58944061|FG004|Phase 2|Lost to Follow-up|0|||
30909237|NCT01927341|58944057|FG000|Phase 2|Participant withdrew consent|0|||
30909238|NCT01927341|58944058|FG001|Phase 2|Participant withdrew consent|2|||
30909239|NCT01927341|58944059|FG002|Phase 2|Participant withdrew consent|1|||
30909240|NCT01927341|58944060|FG003|Phase 2|Participant withdrew consent|2|||
30909241|NCT01927341|58944061|FG004|Phase 2|Participant withdrew consent|3|||
30909242|NCT01927341|58944057|FG000|Phase 2|Death|0|||
30909243|NCT01927341|58944058|FG001|Phase 2|Death|4|||
30909244|NCT01927341|58944059|FG002|Phase 2|Death|0|||
30909245|NCT01927341|58944060|FG003|Phase 2|Death|3|||
30909246|NCT01927341|58944061|FG004|Phase 2|Death|2|||
30909247|NCT01927341|58944057|FG000|Phase 2|New cancer therapy|0|||
30909248|NCT01927341|58944058|FG001|Phase 2|New cancer therapy|1|||
30749107|NCT00006604|58759121|FG005|Overall Study|Lost to Follow-up|0|||
30749108|NCT00006604|58759122|FG006|Overall Study|Lost to Follow-up|0|||
30749109|NCT00006604|58759123|FG007|Overall Study|Lost to Follow-up|1|||
30808355|NCT03287414|58826781|FG000|Treatment Epoch|Subject/Guardian decision|4|||
30808356|NCT03287414|58826782|FG001|Treatment Epoch|Subject/Guardian decision|0|||
30808357|NCT03287414|58826781|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
30808358|NCT03287414|58826782|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
30808359|NCT03287414|58826781|FG000|Treatment Epoch|Withdrawal by Subject|1|||
30808360|NCT03287414|58826782|FG001|Treatment Epoch|Withdrawal by Subject|0|||
30808361|NCT03287414|58826781|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
30808362|NCT03287414|58826782|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
30808363|NCT03287414|58826781|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
30808364|NCT03287414|58826782|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
30808365|NCT03101592|58826812|FG000|Overall Study|participant files could not be located|111|||
30808366|NCT03101592|58826813|FG001|Overall Study|participant files could not be located|170|||
30808367|NCT03101592|58826814|FG002|Overall Study|participant files could not be located|118|||
30808368|NCT04046939|58826832|FG000|Primary Assessment Period|Adverse Event|1|||
30808369|NCT04046939|58826833|FG001|Primary Assessment Period|Adverse Event|0|||
30808370|NCT04046939|58826834|FG002|Primary Assessment Period|Adverse Event|0|||
30808371|NCT04046939|58826835|FG003|Primary Assessment Period|Adverse Event|0|||
30749110|NCT00006604|58759124|FG008|Overall Study|Lost to Follow-up|0|||
30749111|NCT00006604|58759125|FG009|Overall Study|Lost to Follow-up|2|||
30749112|NCT00006604|58759126|FG010|Overall Study|Lost to Follow-up|0|||
30749113|NCT00006604|58759127|FG011|Overall Study|Lost to Follow-up|0|||
30749114|NCT00006604|58759128|FG012|Overall Study|Lost to Follow-up|0|||
30749115|NCT00006604|58759129|FG013|Overall Study|Lost to Follow-up|0|||
30808372|NCT04046939|58826832|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
30808373|NCT04046939|58826833|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
30808374|NCT04046939|58826834|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
30808375|NCT04046939|58826835|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
30808376|NCT04046939|58826832|FG000|Primary Assessment Period|Physician Decision|0|||
30909249|NCT01927341|58944059|FG002|Phase 2|New cancer therapy|0|||
30909250|NCT01927341|58944060|FG003|Phase 2|New cancer therapy|4|||
30909251|NCT01927341|58944061|FG004|Phase 2|New cancer therapy|1|||
30909252|NCT01927341|58944057|FG000|Phase 2|Disease progression|0|||
30909253|NCT01927341|58944058|FG001|Phase 2|Disease progression|1|||
30909254|NCT01927341|58944059|FG002|Phase 2|Disease progression|1|||
30749116|NCT00006604|58759130|FG014|Overall Study|Lost to Follow-up|0|||
30749117|NCT00006604|58759131|FG015|Overall Study|Lost to Follow-up|1|||
30909255|NCT01927341|58944060|FG003|Phase 2|Disease progression|1|||
30909256|NCT01927341|58944061|FG004|Phase 2|Disease progression|0|||
30808377|NCT04046939|58826833|FG001|Primary Assessment Period|Physician Decision|0|||
30808378|NCT04046939|58826834|FG002|Primary Assessment Period|Physician Decision|1|||
30808379|NCT04046939|58826835|FG003|Primary Assessment Period|Physician Decision|0|||
30808380|NCT04046939|58826832|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
30808381|NCT04046939|58826833|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
30808382|NCT04046939|58826834|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
30808383|NCT04046939|58826835|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
30808384|NCT04042103|58826851|FG000|Overall Study|Lost to Follow-up|1|||
30808385|NCT04042103|58826851|FG000|Overall Study|Withdrawal by Subject|1|||
30808386|NCT02955797|58826859|FG000|Overall Study|Protocol Violation|1|||
30808387|NCT02955797|58826860|FG001|Overall Study|Protocol Violation|0|||
30808388|NCT02955797|58826861|FG002|Overall Study|Protocol Violation|0|||
30808389|NCT02955797|58826862|FG003|Overall Study|Protocol Violation|1|||
30808390|NCT02955797|58826859|FG000|Overall Study|Withdrawal by Subject|2|||
30808391|NCT02955797|58826860|FG001|Overall Study|Withdrawal by Subject|2|||
30808392|NCT02955797|58826861|FG002|Overall Study|Withdrawal by Subject|0|||
30808393|NCT02955797|58826862|FG003|Overall Study|Withdrawal by Subject|1|||
30808394|NCT02955797|58826859|FG000|Overall Study|Lost to Follow-up|0|||
30808395|NCT02955797|58826860|FG001|Overall Study|Lost to Follow-up|1|||
30808396|NCT02955797|58826861|FG002|Overall Study|Lost to Follow-up|0|||
30808397|NCT02955797|58826862|FG003|Overall Study|Lost to Follow-up|0|||
30808398|NCT03101514|58826875|FG000|Overall Study|Withdrawal by Subject|4|||
30808399|NCT03101514|58826875|FG000|Overall Study|Protocol Violation|2|||
30808400|NCT03101514|58826875|FG000|Overall Study|patient's information was incomplete|1|||
30808401|NCT02702518|58826881|FG000|Overall Study|Lost to Follow-up|3|||
30808402|NCT02702518|58826882|FG001|Overall Study|Lost to Follow-up|4|||
30808403|NCT04039503|58826892|FG000|Overall Study|Adverse Event|3|||
30808404|NCT04039503|58826893|FG001|Overall Study|Adverse Event|0|||
30808405|NCT04039503|58826894|FG002|Overall Study|Adverse Event|2|||
30808406|NCT04039503|58826895|FG003|Overall Study|Adverse Event|0|||
30808407|NCT04039503|58826892|FG000|Overall Study|Lost to Follow-up|0|||
30808408|NCT04039503|58826893|FG001|Overall Study|Lost to Follow-up|0|||
30808409|NCT04039503|58826894|FG002|Overall Study|Lost to Follow-up|1|||
30808410|NCT04039503|58826895|FG003|Overall Study|Lost to Follow-up|0|||
30808411|NCT04039503|58826892|FG000|Overall Study|Protocol Violation|0|||
30808412|NCT04039503|58826893|FG001|Overall Study|Protocol Violation|1|||
30808413|NCT04039503|58826894|FG002|Overall Study|Protocol Violation|2|||
30808414|NCT04039503|58826895|FG003|Overall Study|Protocol Violation|1|||
30808415|NCT04039503|58826892|FG000|Overall Study|Withdrawal by Subject|4|||
30808416|NCT04039503|58826893|FG001|Overall Study|Withdrawal by Subject|3|||
30808417|NCT04039503|58826894|FG002|Overall Study|Withdrawal by Subject|5|||
30808418|NCT04039503|58826895|FG003|Overall Study|Withdrawal by Subject|2|||
30808419|NCT03131895|58826932|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
30808420|NCT03131895|58826933|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
30808421|NCT03131895|58826934|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
30808422|NCT03131895|58826935|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
30808423|NCT03131895|58826932|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
30808424|NCT03131895|58826933|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
30808425|NCT03131895|58826934|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
30808426|NCT03131895|58826935|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
30808427|NCT03131895|58826932|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
30909257|NCT01927341|58944057|FG000|Phase 2|Follow-up completed|0|||
30909258|NCT01927341|58944058|FG001|Phase 2|Follow-up completed|6|||
30909259|NCT01927341|58944059|FG002|Phase 2|Follow-up completed|3|||
30909260|NCT01927341|58944060|FG003|Phase 2|Follow-up completed|5|||
30909261|NCT01927341|58944061|FG004|Phase 2|Follow-up completed|2|||
30909262|NCT02294474|58944079|FG000|Overall Study|Adverse Event|7|||
30909263|NCT02294474|58944080|FG001|Overall Study|Adverse Event|7|||
30909264|NCT02294474|58944079|FG000|Overall Study|Lack of Efficacy|2|||
30909265|NCT02294474|58944080|FG001|Overall Study|Lack of Efficacy|1|||
30909266|NCT02294474|58944079|FG000|Overall Study|Protocol Violation|4|||
30909267|NCT02294474|58944080|FG001|Overall Study|Protocol Violation|2|||
30749118|NCT00006604|58759132|FG016|Overall Study|Lost to Follow-up|3|||
30749119|NCT00006604|58759116|FG000|Overall Study|Other Reason|0|||
30749120|NCT00006604|58759117|FG001|Overall Study|Other Reason|0|||
30749121|NCT00006604|58759118|FG002|Overall Study|Other Reason|0|||
30749122|NCT00006604|58759119|FG003|Overall Study|Other Reason|0|||
30749123|NCT00006604|58759120|FG004|Overall Study|Other Reason|0|||
30749124|NCT00006604|58759121|FG005|Overall Study|Other Reason|1|||
30749125|NCT00006604|58759122|FG006|Overall Study|Other Reason|0|||
30749126|NCT00006604|58759123|FG007|Overall Study|Other Reason|0|||
30749127|NCT00006604|58759124|FG008|Overall Study|Other Reason|0|||
30749128|NCT00006604|58759125|FG009|Overall Study|Other Reason|1|||
30749129|NCT00006604|58759126|FG010|Overall Study|Other Reason|0|||
30749130|NCT00006604|58759127|FG011|Overall Study|Other Reason|0|||
30749131|NCT00006604|58759128|FG012|Overall Study|Other Reason|0|||
30749132|NCT00006604|58759129|FG013|Overall Study|Other Reason|0|||
30808428|NCT03131895|58826933|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
30808429|NCT03131895|58826934|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
30808430|NCT03131895|58826935|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
30808431|NCT03131895|58826932|FG000|Washout Period (at Least 5 Days)|Other|0|||
30808432|NCT03131895|58826933|FG001|Washout Period (at Least 5 Days)|Other|0|||
30808433|NCT03131895|58826934|FG002|Washout Period (at Least 5 Days)|Other|2|||
30808434|NCT03131895|58826935|FG003|Washout Period (at Least 5 Days)|Other|0|||
30808435|NCT03131895|58826932|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
30808436|NCT03131895|58826933|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
30808437|NCT03131895|58826934|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
30808438|NCT03131895|58826935|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
30909268|NCT02294474|58944079|FG000|Overall Study|Other than specified above|12|||
30909269|NCT02294474|58944080|FG001|Overall Study|Other than specified above|12|||
30808439|NCT03131895|58826932|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
30808440|NCT03131895|58826933|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
30808441|NCT03131895|58826934|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
30808442|NCT03131895|58826935|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
30909270|NCT02168101|58944090|FG000|Overall Study|Death|2|||
30909271|NCT02168101|58944091|FG001|Overall Study|Death|2|||
30909272|NCT02168101|58944092|FG002|Overall Study|Death|1|||
30808443|NCT04039919|58826950|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30808444|NCT04039919|58826951|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30808445|NCT04039919|58826952|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30808446|NCT04039919|58826953|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30808447|NCT04039919|58826954|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30808448|NCT04039919|58826950|FG000|Treatment Period 1|Sponsor's decision|0|||
30808449|NCT04039919|58826951|FG001|Treatment Period 1|Sponsor's decision|0|||
30808450|NCT04039919|58826952|FG002|Treatment Period 1|Sponsor's decision|0|||
30808451|NCT04039919|58826953|FG003|Treatment Period 1|Sponsor's decision|0|||
30808452|NCT04039919|58826954|FG004|Treatment Period 1|Sponsor's decision|16|||
30808453|NCT04039919|58826950|FG000|Treatment Period 5|Withdrawal by Subject|1|||
30808454|NCT04039919|58826951|FG001|Treatment Period 5|Withdrawal by Subject|0|||
30808455|NCT04039919|58826952|FG002|Treatment Period 5|Withdrawal by Subject|0|||
30808456|NCT04039919|58826953|FG003|Treatment Period 5|Withdrawal by Subject|0|||
30808457|NCT04039919|58826954|FG004|Treatment Period 5|Withdrawal by Subject|0|||
30808458|NCT04035473|58826990|FG000|Screening/Baseline|Death|0|||
30808459|NCT04035473|58826991|FG001|Screening/Baseline|Death|1|||
30808460|NCT04035473|58826990|FG000|Screening/Baseline|Adverse Event|0|||
30808461|NCT04035473|58826991|FG001|Screening/Baseline|Adverse Event|1|||
30808462|NCT04035473|58826990|FG000|Follow-up Period|Adverse Event|2|||
30808463|NCT04035473|58826991|FG001|Follow-up Period|Adverse Event|0|||
30808464|NCT04032977|58826999|FG000|Overall Study|Withdrawal by Subject|6|||
30808465|NCT04032977|58827000|FG001|Overall Study|Withdrawal by Subject|1|||
30808466|NCT04032977|58826999|FG000|Overall Study|Lost to Follow-up|2|||
30808467|NCT04032977|58827000|FG001|Overall Study|Lost to Follow-up|7|||
30808468|NCT04032977|58826999|FG000|Overall Study|Pregnancy|1|||
30808469|NCT04032977|58827000|FG001|Overall Study|Pregnancy|0|||
30808470|NCT04030247|58827006|FG000|Overall Study|Withdrawal by Subject|4|||
30808471|NCT04030247|58827006|FG000|Overall Study|Lost to Follow-up|13|||
30808472|NCT02915978|58827013|FG000|Overall Study|Adverse Event|2|||
30808473|NCT02915978|58827014|FG001|Overall Study|Adverse Event|1|||
30808474|NCT02915978|58827015|FG002|Overall Study|Adverse Event|0|||
30808475|NCT02701192|58827023|FG000|Overall Study|Protocol Violation|2|||
30808476|NCT02701192|58827023|FG000|Overall Study|Lost to Follow-up|4|||
30808477|NCT03101358|58827031|FG000|Overall Study|Non-compliance with study schedule|1|||
30808478|NCT03101358|58827032|FG001|Overall Study|Non-compliance with study schedule|0|||
30808479|NCT03101358|58827033|FG002|Overall Study|Non-compliance with study schedule|0|||
30808480|NCT03101358|58827034|FG003|Overall Study|Non-compliance with study schedule|1|||
30808481|NCT03101358|58827031|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
30808482|NCT03101358|58827032|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
30808483|NCT03101358|58827033|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
30808484|NCT03101358|58827034|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
30808485|NCT03101358|58827031|FG000|Overall Study|Physician Decision|1|||
30808486|NCT03101358|58827032|FG001|Overall Study|Physician Decision|0|||
30808487|NCT03101358|58827033|FG002|Overall Study|Physician Decision|0|||
30909273|NCT01956123|58944103|FG000|COS Cycle 2|Protocol Violation|8|||
30808488|NCT03101358|58827034|FG003|Overall Study|Physician Decision|3|||
30808489|NCT03101358|58827031|FG000|Overall Study|Adverse Event|0|||
30808490|NCT03101358|58827032|FG001|Overall Study|Adverse Event|0|||
30808491|NCT03101358|58827033|FG002|Overall Study|Adverse Event|1|||
30808492|NCT03101358|58827034|FG003|Overall Study|Adverse Event|0|||
30808493|NCT03101358|58827031|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
30808494|NCT03101358|58827032|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
30808495|NCT03101358|58827033|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
30808496|NCT03101358|58827034|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
30808497|NCT03101358|58827031|FG000|Overall Study|Lost to Follow-up|1|||
30808498|NCT03101358|58827032|FG001|Overall Study|Lost to Follow-up|0|||
30808499|NCT03101358|58827033|FG002|Overall Study|Lost to Follow-up|0|||
30808500|NCT03101358|58827034|FG003|Overall Study|Lost to Follow-up|1|||
30808501|NCT03657095|58827047|FG000|Overall Study|Withdrawal by Subject|1|||
30808502|NCT03657095|58827048|FG001|Overall Study|Withdrawal by Subject|1|||
30808503|NCT03657095|58827047|FG000|Overall Study|Adverse Event|0|||
30808504|NCT03657095|58827048|FG001|Overall Study|Adverse Event|3|||
30808505|NCT03657095|58827047|FG000|Overall Study|Study Terminated by Sponsor|58|||
30808506|NCT03657095|58827048|FG001|Overall Study|Study Terminated by Sponsor|49|||
30808507|NCT03100344|58827058|FG000|Overall Study|Adverse Event|0|||
30808508|NCT03100344|58827059|FG001|Overall Study|Adverse Event|3|||
30808509|NCT03100344|58827060|FG002|Overall Study|Adverse Event|2|||
30808510|NCT03100344|58827061|FG003|Overall Study|Adverse Event|3|||
30808511|NCT03100344|58827058|FG000|Overall Study|Lack of Efficacy|2|||
30808512|NCT03100344|58827059|FG001|Overall Study|Lack of Efficacy|0|||
30808513|NCT03100344|58827060|FG002|Overall Study|Lack of Efficacy|0|||
30808514|NCT03100344|58827061|FG003|Overall Study|Lack of Efficacy|0|||
30808515|NCT03100344|58827058|FG000|Overall Study|Protocol Violation|1|||
30808516|NCT03100344|58827059|FG001|Overall Study|Protocol Violation|0|||
30808517|NCT03100344|58827060|FG002|Overall Study|Protocol Violation|0|||
30808518|NCT03100344|58827061|FG003|Overall Study|Protocol Violation|0|||
30808519|NCT03100344|58827058|FG000|Overall Study|Withdrawal by Subject|10|||
30808520|NCT03100344|58827059|FG001|Overall Study|Withdrawal by Subject|7|||
30808521|NCT03100344|58827060|FG002|Overall Study|Withdrawal by Subject|4|||
30808522|NCT03100344|58827061|FG003|Overall Study|Withdrawal by Subject|8|||
30808523|NCT03100344|58827058|FG000|Overall Study|Lost to Follow-up|1|||
30808524|NCT03100344|58827059|FG001|Overall Study|Lost to Follow-up|1|||
30808525|NCT03100344|58827060|FG002|Overall Study|Lost to Follow-up|1|||
30749133|NCT00006604|58759130|FG014|Overall Study|Other Reason|0|||
30749134|NCT00006604|58759131|FG015|Overall Study|Other Reason|0|||
30749135|NCT00006604|58759132|FG016|Overall Study|Other Reason|0|||
30749136|NCT00006478|58759155|FG000|Overall Study|Vaccine could not be produced|1|||
30749137|NCT00006478|58759155|FG000|Overall Study|Physician Decision|6|||
30749138|NCT00436007|58759162|FG000|Overall Study|Withdrawal by Subject|5|||
30749139|NCT00436007|58759163|FG001|Overall Study|Withdrawal by Subject|3|||
30749140|NCT00436007|58759164|FG002|Overall Study|Withdrawal by Subject|4|||
30749141|NCT00436007|58759162|FG000|Overall Study|Lost to Follow-up|14|||
30749142|NCT00436007|58759163|FG001|Overall Study|Lost to Follow-up|10|||
30749143|NCT00436007|58759164|FG002|Overall Study|Lost to Follow-up|13|||
30749144|NCT00436007|58759162|FG000|Overall Study|Physician Decision|0|||
30749145|NCT00436007|58759163|FG001|Overall Study|Physician Decision|0|||
30749146|NCT00436007|58759164|FG002|Overall Study|Physician Decision|2|||
30749147|NCT00436007|58759162|FG000|Overall Study|Death|0|||
30749148|NCT00436007|58759163|FG001|Overall Study|Death|1|||
30749149|NCT00436007|58759164|FG002|Overall Study|Death|3|||
30749150|NCT00436007|58759162|FG000|Overall Study|Other|0|||
30749151|NCT00436007|58759163|FG001|Overall Study|Other|0|||
30749152|NCT00436007|58759164|FG002|Overall Study|Other|1|||
30749153|NCT00435461|58759180|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
30749154|NCT00435461|58759181|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
30749155|NCT00435461|58759182|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
30749156|NCT00435461|58759180|FG000|Overall Study|Protocol Violation|6|||
30749157|NCT00435461|58759181|FG001|Overall Study|Protocol Violation|9|||
30749158|NCT00435461|58759182|FG002|Overall Study|Protocol Violation|10|||
30808526|NCT03100344|58827061|FG003|Overall Study|Lost to Follow-up|1|||
30749159|NCT00435461|58759180|FG000|Overall Study|Participant randomized(inadequate score)|1|||
30749160|NCT00435461|58759181|FG001|Overall Study|Participant randomized(inadequate score)|0|||
30808527|NCT02951533|58827074|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
30808528|NCT02951533|58827075|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
30808529|NCT02951533|58827076|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
30808530|NCT02951533|58827074|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
30808531|NCT02951533|58827075|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
30808532|NCT02951533|58827076|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
30808533|NCT02951533|58827074|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
30808534|NCT02951533|58827075|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
30808535|NCT02951533|58827076|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
30909274|NCT01956123|58944104|FG001|COS Cycle 2|Protocol Violation|3|||
30909275|NCT01956123|58944105|FG002|COS Cycle 2|Protocol Violation|0|||
30909276|NCT01956123|58944106|FG003|COS Cycle 2|Protocol Violation|0|||
30909277|NCT01956123|58944103|FG000|COS Cycle 2|Adverse Event|3|||
30909278|NCT01956123|58944104|FG001|COS Cycle 2|Adverse Event|4|||
30909279|NCT01956123|58944105|FG002|COS Cycle 2|Adverse Event|0|||
30749161|NCT00435461|58759182|FG002|Overall Study|Participant randomized(inadequate score)|0|||
30808536|NCT02951533|58827074|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
30808537|NCT02951533|58827075|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
30808538|NCT02951533|58827076|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
30808539|NCT02951533|58827074|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
30808540|NCT02951533|58827075|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
30808541|NCT02951533|58827076|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
30808542|NCT02951533|58827074|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
30808543|NCT02951533|58827075|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
30808544|NCT02951533|58827076|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
30808545|NCT02951533|58827074|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
30808546|NCT02951533|58827075|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
30808547|NCT02951533|58827076|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
30808548|NCT02951533|58827074|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
30808549|NCT02951533|58827075|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
30808550|NCT02951533|58827076|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
30808551|NCT02951533|58827074|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
30808552|NCT02951533|58827075|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
30808553|NCT02951533|58827076|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
30808554|NCT02951533|58827074|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
30808555|NCT02951533|58827075|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
30808556|NCT02951533|58827076|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
30808557|NCT02951533|58827074|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
30808558|NCT02951533|58827075|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
30808559|NCT02951533|58827076|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
30808560|NCT02700412|58827093|FG000|Overall Study|Adverse Event|6|||
30808561|NCT02700412|58827093|FG000|Overall Study|Death|1|||
30808562|NCT02700412|58827093|FG000|Overall Study|Lack of Efficacy|19|||
30808563|NCT02700412|58827093|FG000|Overall Study|Protocol Violation|5|||
30808564|NCT02700412|58827093|FG000|Overall Study|Withdrawal by Subject|2|||
30808565|NCT03665441|58827099|FG000|Overall Study|survival follow up ongoing|23|||
30808566|NCT03665441|58827100|FG001|Overall Study|survival follow up ongoing|0|||
30808567|NCT03665441|58827099|FG000|Overall Study|Patients ongoing on treatment|9|||
30808568|NCT03665441|58827100|FG001|Overall Study|Patients ongoing on treatment|6|||
30808569|NCT03665441|58827099|FG000|Overall Study|Randomized but not treated|7|||
30808570|NCT03665441|58827100|FG001|Overall Study|Randomized but not treated|11|||
30808571|NCT02699866|58827106|FG000|Overall Study|Withdrawal by Subject|3|||
30808572|NCT02699866|58827106|FG000|Overall Study|Physician Decision|2|||
30808573|NCT02699866|58827106|FG000|Overall Study|Adverse Event|3|||
30808574|NCT03663569|58827110|FG000|Overall Study|Discontinuation of study|11|||
30909280|NCT01956123|58944106|FG003|COS Cycle 2|Adverse Event|0|||
30909281|NCT01956123|58944103|FG000|COS Cycle 2|Personal Reasons|2|||
30749162|NCT00435461|58759180|FG000|Overall Study|Compliance less than 80 percent|1|||
30749163|NCT00435461|58759181|FG001|Overall Study|Compliance less than 80 percent|0|||
30749164|NCT00435461|58759182|FG002|Overall Study|Compliance less than 80 percent|0|||
30749165|NCT00435461|58759180|FG000|Overall Study|In error, two study medications switched|1|||
30749166|NCT00435461|58759181|FG001|Overall Study|In error, two study medications switched|0|||
30749167|NCT00435461|58759182|FG002|Overall Study|In error, two study medications switched|0|||
30749168|NCT00435461|58759180|FG000|Overall Study|Lack of Efficacy|2|||
30749169|NCT00435461|58759181|FG001|Overall Study|Lack of Efficacy|1|||
30749170|NCT00435461|58759182|FG002|Overall Study|Lack of Efficacy|0|||
30749171|NCT00435461|58759180|FG000|Overall Study|Withdrawal by Subject|1|||
30749172|NCT00435461|58759181|FG001|Overall Study|Withdrawal by Subject|0|||
30749173|NCT00435461|58759182|FG002|Overall Study|Withdrawal by Subject|2|||
30749174|NCT00435461|58759180|FG000|Overall Study|Randomized in error|1|||
30749175|NCT00435461|58759181|FG001|Overall Study|Randomized in error|0|||
30808575|NCT03663569|58827110|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
30808576|NCT03663569|58827110|FG000|Overall Study|Deceased patient|6|||
30808577|NCT03663569|58827110|FG000|Overall Study|Lost to Follow-up|18|||
30808578|NCT03663569|58827110|FG000|Overall Study|Withdrawal of consent|5|||
30808579|NCT03663569|58827110|FG000|Overall Study|Patient's request|11|||
30808580|NCT03663569|58827110|FG000|Overall Study|Adverse Event|4|||
30808581|NCT03663569|58827110|FG000|Overall Study|Not come to second visit|3|||
30808582|NCT03663569|58827110|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
30808583|NCT03663569|58827110|FG000|Overall Study|Serious adverse event|1|||
30808584|NCT03596762|58827119|FG000|Overall Study|Protocol Violation|0|||
30808585|NCT03596762|58827120|FG001|Overall Study|Protocol Violation|0|||
30808586|NCT03596762|58827121|FG002|Overall Study|Protocol Violation|0|||
30808587|NCT03596762|58827122|FG003|Overall Study|Protocol Violation|0|||
30909282|NCT01956123|58944104|FG001|COS Cycle 2|Personal Reasons|0|||
30909283|NCT01956123|58944105|FG002|COS Cycle 2|Personal Reasons|0|||
30909284|NCT01956123|58944106|FG003|COS Cycle 2|Personal Reasons|0|||
30909285|NCT01956123|58944103|FG000|COS Cycle 2|Withdrawal by Subject|1|||
30909286|NCT01956123|58944104|FG001|COS Cycle 2|Withdrawal by Subject|0|||
30909287|NCT01956123|58944105|FG002|COS Cycle 2|Withdrawal by Subject|0|||
30909288|NCT01956123|58944106|FG003|COS Cycle 2|Withdrawal by Subject|0|||
30909289|NCT01956123|58944103|FG000|COS Cycle 3|Protocol Violation|0|||
30909290|NCT01956123|58944104|FG001|COS Cycle 3|Protocol Violation|0|||
30909291|NCT01956123|58944105|FG002|COS Cycle 3|Protocol Violation|2|||
30909292|NCT01956123|58944106|FG003|COS Cycle 3|Protocol Violation|1|||
30749176|NCT00435461|58759182|FG002|Overall Study|Randomized in error|0|||
30749177|NCT00435461|58759180|FG000|Overall Study|Participant could not tolerate symptoms|0|||
30749178|NCT00435461|58759181|FG001|Overall Study|Participant could not tolerate symptoms|0|||
30749179|NCT00435461|58759182|FG002|Overall Study|Participant could not tolerate symptoms|1|||
30749180|NCT00435461|58759180|FG000|Overall Study|Participant could not swallow capsule|0|||
30749181|NCT00435461|58759181|FG001|Overall Study|Participant could not swallow capsule|0|||
30749182|NCT00435461|58759182|FG002|Overall Study|Participant could not swallow capsule|1|||
30749183|NCT00435461|58759180|FG000|Overall Study|Pregnancy|2|||
30749184|NCT00435461|58759181|FG001|Overall Study|Pregnancy|0|||
30749185|NCT00435461|58759182|FG002|Overall Study|Pregnancy|0|||
30749186|NCT00435461|58759180|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
30749187|NCT00435461|58759181|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
30749188|NCT00435461|58759182|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
30749189|NCT00435461|58759180|FG000|Overall Study|Participant ended study one day early|1|||
30749190|NCT00435461|58759181|FG001|Overall Study|Participant ended study one day early|0|||
30749191|NCT00435461|58759182|FG002|Overall Study|Participant ended study one day early|0|||
30749192|NCT00435461|58759180|FG000|Overall Study|Noncompliance with study requirements|1|||
30749193|NCT00435461|58759181|FG001|Overall Study|Noncompliance with study requirements|1|||
30749194|NCT00435461|58759182|FG002|Overall Study|Noncompliance with study requirements|1|||
30749195|NCT00435461|58759180|FG000|Overall Study|Adverse Event|1|||
30749196|NCT00435461|58759181|FG001|Overall Study|Adverse Event|2|||
30749197|NCT00435461|58759182|FG002|Overall Study|Adverse Event|6|||
30749198|NCT00435461|58759180|FG000|Overall Study|Non-Compliance of diary|2|||
30749199|NCT00435461|58759181|FG001|Overall Study|Non-Compliance of diary|0|||
30749200|NCT00435461|58759182|FG002|Overall Study|Non-Compliance of diary|1|||
30749201|NCT00435461|58759180|FG000|Overall Study|Lost to Follow-up|1|||
30808588|NCT03596762|58827123|FG004|Overall Study|Protocol Violation|1|||
30808589|NCT03596762|58827119|FG000|Overall Study|Adverse Event|2|||
30808590|NCT03596762|58827120|FG001|Overall Study|Adverse Event|0|||
30909293|NCT01956123|58944103|FG000|COS Cycle 3|Adverse Event|0|||
30909294|NCT01956123|58944104|FG001|COS Cycle 3|Adverse Event|0|||
30909295|NCT01956123|58944105|FG002|COS Cycle 3|Adverse Event|3|||
30909296|NCT01956123|58944106|FG003|COS Cycle 3|Adverse Event|0|||
30909297|NCT01956123|58944103|FG000|COS Cycle 3|Personal Reasons|0|||
30808591|NCT03596762|58827121|FG002|Overall Study|Adverse Event|1|||
30808592|NCT03596762|58827122|FG003|Overall Study|Adverse Event|0|||
30808593|NCT03596762|58827123|FG004|Overall Study|Adverse Event|5|||
30808594|NCT03596762|58827119|FG000|Overall Study|Withdrawal by Subject|2|||
30808595|NCT03596762|58827120|FG001|Overall Study|Withdrawal by Subject|1|||
30808596|NCT03596762|58827121|FG002|Overall Study|Withdrawal by Subject|0|||
30808597|NCT03596762|58827122|FG003|Overall Study|Withdrawal by Subject|1|||
30808598|NCT03596762|58827123|FG004|Overall Study|Withdrawal by Subject|1|||
30808599|NCT03663179|58827141|FG000|Overall Study|Withdrawal by Subject|2|||
30808600|NCT03663179|58827142|FG001|Overall Study|Withdrawal by Subject|0|||
30808601|NCT03663179|58827141|FG000|Overall Study|Lost to Follow-up|1|||
30808602|NCT03663179|58827142|FG001|Overall Study|Lost to Follow-up|1|||
30808603|NCT03663179|58827141|FG000|Overall Study|Revealed exclusionary condition|1|||
30808604|NCT03663179|58827142|FG001|Overall Study|Revealed exclusionary condition|0|||
30808605|NCT03662789|58827150|FG000|Overall Study|Lost to Follow-up|1|||
30808606|NCT03662789|58827151|FG001|Overall Study|Lost to Follow-up|2|||
30808607|NCT03662789|58827150|FG000|Overall Study|Could not perform treadmill test|4|||
30808608|NCT03662789|58827151|FG001|Overall Study|Could not perform treadmill test|4|||
30808609|NCT03662789|58827150|FG000|Overall Study|Death|0|||
30808610|NCT03662789|58827151|FG001|Overall Study|Death|1|||
30808611|NCT03658889|58827159|FG000|Overall Study|Protocol Violation|2|||
30808612|NCT03658889|58827160|FG001|Overall Study|Protocol Violation|0|||
30808613|NCT03655691|58827168|FG000|Overall Study|Adverse Event|0|||
30808614|NCT03655691|58827169|FG001|Overall Study|Adverse Event|0|||
30808615|NCT03655691|58827170|FG002|Overall Study|Adverse Event|1|||
30808616|NCT03655691|58827168|FG000|Overall Study|Lost to Follow-up|1|||
30808617|NCT03655691|58827169|FG001|Overall Study|Lost to Follow-up|1|||
30808618|NCT03655691|58827170|FG002|Overall Study|Lost to Follow-up|2|||
30808619|NCT03655691|58827168|FG000|Overall Study|Protocol Violation|0|||
30808620|NCT03655691|58827169|FG001|Overall Study|Protocol Violation|1|||
30808621|NCT03655691|58827170|FG002|Overall Study|Protocol Violation|0|||
30808622|NCT03655691|58827168|FG000|Overall Study|Withdrawal by Subject|1|||
30808623|NCT03655691|58827169|FG001|Overall Study|Withdrawal by Subject|1|||
30808624|NCT03655691|58827170|FG002|Overall Study|Withdrawal by Subject|0|||
30808625|NCT03658811|58827178|FG000|Overall Study|Lost to Follow-up|3|||
30808626|NCT03631355|58827188|FG000|Overall Study|Lost to Follow-up|1|||
30808627|NCT03631355|58827189|FG001|Overall Study|Lost to Follow-up|2|||
30808628|NCT03629249|58827198|FG000|Overall Study|Study terminated by sponsor|197|||
30808629|NCT03629249|58827199|FG001|Overall Study|Study terminated by sponsor|197|||
30808630|NCT03629249|58827200|FG002|Overall Study|Study terminated by sponsor|194|||
30749202|NCT00435461|58759181|FG001|Overall Study|Lost to Follow-up|1|||
30749203|NCT00435461|58759182|FG002|Overall Study|Lost to Follow-up|2|||
30749204|NCT00434759|58759192|FG000|Overall Study|Lack of Efficacy|5|||
30749205|NCT00434759|58759193|FG001|Overall Study|Lack of Efficacy|4|||
30749206|NCT00434759|58759192|FG000|Overall Study|Withdrawal by Subject|17|||
30749207|NCT00434759|58759193|FG001|Overall Study|Withdrawal by Subject|1|||
30749208|NCT00434759|58759192|FG000|Overall Study|family affairs|2|||
30749209|NCT00434759|58759193|FG001|Overall Study|family affairs|0|||
30749210|NCT00440999|58759203|FG000|Overall Study|Adverse Event|0|||
30749211|NCT00440999|58759204|FG001|Overall Study|Adverse Event|2|||
30749212|NCT00440999|58759203|FG000|Overall Study|Lack of Efficacy|6|||
30749213|NCT00440999|58759204|FG001|Overall Study|Lack of Efficacy|7|||
30749214|NCT00440999|58759203|FG000|Overall Study|Lost to Follow-up|19|||
30749215|NCT00440999|58759204|FG001|Overall Study|Lost to Follow-up|12|||
30749216|NCT00440999|58759203|FG000|Overall Study|Protocol Violation|1|||
30749217|NCT00440999|58759204|FG001|Overall Study|Protocol Violation|0|||
30749218|NCT00440999|58759203|FG000|Overall Study|Withdrawal by Subject|2|||
30749219|NCT00440999|58759204|FG001|Overall Study|Withdrawal by Subject|5|||
30749220|NCT00440999|58759203|FG000|Overall Study|Subjets missed the visit|1|||
30749221|NCT00440999|58759204|FG001|Overall Study|Subjets missed the visit|0|||
30749222|NCT00440999|58759203|FG000|Overall Study|Mixed infection at entry|1|||
30749223|NCT00440999|58759204|FG001|Overall Study|Mixed infection at entry|0|||
30808631|NCT03629249|58827198|FG000|Overall Study|Protocol deviation|0|||
30808632|NCT03629249|58827199|FG001|Overall Study|Protocol deviation|2|||
30808633|NCT03629249|58827200|FG002|Overall Study|Protocol deviation|5|||
30749224|NCT00440999|58759203|FG000|Overall Study|P. falciparum malaria|5|||
30749225|NCT00440999|58759204|FG001|Overall Study|P. falciparum malaria|14|||
30749226|NCT00440999|58759203|FG000|Overall Study|Subj left hosp without inform staff|0|||
30749227|NCT00440999|58759204|FG001|Overall Study|Subj left hosp without inform staff|1|||
30749228|NCT00434213|58759212|FG000|Overall Study|Adverse Event|12|||
30808634|NCT03629249|58827198|FG000|Overall Study|Subject decision|1|||
30808635|NCT03629249|58827199|FG001|Overall Study|Subject decision|1|||
30808636|NCT03629249|58827200|FG002|Overall Study|Subject decision|3|||
30808637|NCT03629249|58827198|FG000|Overall Study|Adverse Event|1|||
30909298|NCT01956123|58944104|FG001|COS Cycle 3|Personal Reasons|0|||
30909299|NCT01956123|58944105|FG002|COS Cycle 3|Personal Reasons|1|||
30909300|NCT01956123|58944106|FG003|COS Cycle 3|Personal Reasons|0|||
30909301|NCT01956123|58944103|FG000|COS Cycle 3|Withdrawal by Subject|0|||
30909302|NCT01956123|58944104|FG001|COS Cycle 3|Withdrawal by Subject|0|||
30909303|NCT01956123|58944105|FG002|COS Cycle 3|Withdrawal by Subject|0|||
30909304|NCT01956123|58944106|FG003|COS Cycle 3|Withdrawal by Subject|1|||
30909305|NCT02298179|58944129|FG000|Overall Study|Lost to Follow-up|0|||
30909306|NCT02298179|58944130|FG001|Overall Study|Lost to Follow-up|0|||
30909307|NCT02298179|58944131|FG002|Overall Study|Lost to Follow-up|1|||
30909308|NCT02298179|58944132|FG003|Overall Study|Lost to Follow-up|0|||
30909309|NCT02298179|58944133|FG004|Overall Study|Lost to Follow-up|0|||
30909310|NCT02298179|58944134|FG005|Overall Study|Lost to Follow-up|0|||
30909311|NCT02298179|58944135|FG006|Overall Study|Lost to Follow-up|0|||
30909312|NCT02298179|58944136|FG007|Overall Study|Lost to Follow-up|1|||
30808638|NCT03629249|58827199|FG001|Overall Study|Adverse Event|1|||
30808639|NCT03629249|58827200|FG002|Overall Study|Adverse Event|0|||
30808640|NCT03629249|58827198|FG000|Overall Study|Death|1|||
30808641|NCT03629249|58827199|FG001|Overall Study|Death|0|||
30808642|NCT03629249|58827200|FG002|Overall Study|Death|0|||
30808643|NCT03629249|58827198|FG000|Overall Study|Physician Decision|1|||
30808644|NCT03629249|58827199|FG001|Overall Study|Physician Decision|0|||
30808645|NCT03629249|58827200|FG002|Overall Study|Physician Decision|0|||
30808646|NCT03628781|58827210|FG000|Overall Study|Lost to Follow-up|16|||
30808647|NCT03628781|58827211|FG001|Overall Study|Lost to Follow-up|8|||
30808648|NCT03628781|58827210|FG000|Overall Study|Withdrawal by Subject|16|||
30808649|NCT03628781|58827211|FG001|Overall Study|Withdrawal by Subject|1|||
30808650|NCT03371251|58827223|FG000|Overall Study|Withdrawal by Subject|1|||
30808651|NCT03371251|58827224|FG001|Overall Study|Withdrawal by Subject|0|||
30808652|NCT03371251|58827225|FG002|Overall Study|Withdrawal by Subject|1|||
30909313|NCT02298179|58944137|FG008|Overall Study|Lost to Follow-up|0|||
30909314|NCT02298179|58944138|FG009|Overall Study|Lost to Follow-up|0|||
30909315|NCT02298179|58944139|FG010|Overall Study|Lost to Follow-up|0|||
30909316|NCT02298179|58944140|FG011|Overall Study|Lost to Follow-up|0|||
30909317|NCT02298023|58944169|FG000|Overall Study|Withdrawal by Subject|1|||
30909318|NCT02298023|58944170|FG001|Overall Study|Withdrawal by Subject|0|||
30909319|NCT02298023|58944171|FG002|Overall Study|Withdrawal by Subject|0|||
30909320|NCT02296931|58944184|FG000|Overall Study|Protocol Violation|0|||
30909321|NCT02296931|58944185|FG001|Overall Study|Protocol Violation|2|||
30909322|NCT02166697|58944191|FG000|Overall Study|Protocol Violation|347|||
30909323|NCT01909479|58944197|FG000|From Baseline to Week 26|Adverse Event|3|||
30909324|NCT01909479|58944198|FG001|From Baseline to Week 26|Adverse Event|2|||
30909325|NCT01909479|58944197|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
30909326|NCT01909479|58944198|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
30909327|NCT01909479|58944197|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
30749229|NCT00434213|58759212|FG000|Overall Study|Lack of Efficacy|9|||
30749230|NCT00434213|58759212|FG000|Overall Study|Lost to Follow-up|14|||
30749231|NCT00434213|58759212|FG000|Overall Study|Withdrawal by Subject|7|||
30749232|NCT00434213|58759212|FG000|Overall Study|Protocol Violation|3|||
30749233|NCT00434213|58759212|FG000|Overall Study|Unable to comply with study visit window|2|||
30749234|NCT00434213|58759212|FG000|Overall Study|Application site reaction|1|||
30749235|NCT00434213|58759212|FG000|Overall Study|Non-compliant to study schedule|1|||
30749236|NCT00006184|58759218|FG000|Overall Study|Death|1|||
30749237|NCT00006184|58759219|FG001|Overall Study|Death|0|||
30749238|NCT00434057|58759225|FG000|Overall Study|Withdrawal by Subject|1|||
30749239|NCT00433199|58759231|FG000|Double-Blind Period|Adverse Event|0|||
30749240|NCT00433199|58759232|FG001|Double-Blind Period|Adverse Event|25|||
30749241|NCT00433199|58759231|FG000|Double-Blind Period|Lack of Efficacy|0|||
30749242|NCT00433199|58759232|FG001|Double-Blind Period|Lack of Efficacy|2|||
30749243|NCT00433199|58759231|FG000|Double-Blind Period|Lost to Follow-up|2|||
30749244|NCT00433199|58759232|FG001|Double-Blind Period|Lost to Follow-up|5|||
30808653|NCT03371251|58827226|FG003|Overall Study|Withdrawal by Subject|0|||
30909328|NCT01909479|58944198|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
30909329|NCT01909479|58944197|FG000|26 - 52 Weeks|Adverse Event|0|||
30909330|NCT01909479|58944198|FG001|26 - 52 Weeks|Adverse Event|1|||
30909331|NCT01909479|58944197|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
30909332|NCT01909479|58944198|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
30909333|NCT01909479|58944197|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
30808654|NCT03371251|58827227|FG004|Overall Study|Withdrawal by Subject|2|||
30808655|NCT03371251|58827228|FG005|Overall Study|Withdrawal by Subject|2|||
30808656|NCT03371251|58827223|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
30808657|NCT03371251|58827224|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
30808658|NCT03371251|58827225|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
30808659|NCT03371251|58827226|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
30808660|NCT03371251|58827227|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
30808661|NCT03371251|58827228|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
30808662|NCT03371251|58827223|FG000|Overall Study|Adverse Event|0|||
30808663|NCT03371251|58827224|FG001|Overall Study|Adverse Event|0|||
30808664|NCT03371251|58827225|FG002|Overall Study|Adverse Event|0|||
30622483|NCT00925990|58634202|FG001|Overall Study|moved out of state, missed medication|2|||
30622484|NCT01131078|58634211|FG000|Overall Study|Adverse Event|22|||
30622485|NCT01131078|58634212|FG001|Overall Study|Adverse Event|12|||
30622486|NCT01131078|58634213|FG002|Overall Study|Adverse Event|17|||
30622487|NCT01131078|58634211|FG000|Overall Study|Progressive Disease|58|||
30622488|NCT01131078|58634212|FG001|Overall Study|Progressive Disease|77|||
30622489|NCT01131078|58634213|FG002|Overall Study|Progressive Disease|71|||
30622490|NCT01131078|58634211|FG000|Overall Study|Protocol Violation|1|||
30622491|NCT01131078|58634212|FG001|Overall Study|Protocol Violation|0|||
30622492|NCT01131078|58634213|FG002|Overall Study|Protocol Violation|0|||
30622493|NCT01131078|58634211|FG000|Overall Study|Lost to Follow-up|1|||
30622494|NCT01131078|58634212|FG001|Overall Study|Lost to Follow-up|1|||
30749245|NCT00433199|58759231|FG000|Double-Blind Period|Withdrawal by Subject|8|||
30749246|NCT00433199|58759232|FG001|Double-Blind Period|Withdrawal by Subject|19|||
30808665|NCT03371251|58827226|FG003|Overall Study|Adverse Event|0|||
30808666|NCT03371251|58827227|FG004|Overall Study|Adverse Event|1|||
30808667|NCT03371251|58827228|FG005|Overall Study|Adverse Event|0|||
30808668|NCT03371251|58827223|FG000|Overall Study|Decision by Sponsor|0|||
30808669|NCT03371251|58827224|FG001|Overall Study|Decision by Sponsor|0|||
30808670|NCT03371251|58827225|FG002|Overall Study|Decision by Sponsor|0|||
30808671|NCT03371251|58827226|FG003|Overall Study|Decision by Sponsor|0|||
30808672|NCT03371251|58827227|FG004|Overall Study|Decision by Sponsor|2|||
30808673|NCT03371251|58827228|FG005|Overall Study|Decision by Sponsor|0|||
30808674|NCT03370471|58827247|FG000|Overall Study|Withdrawal by Subject|6|||
30808675|NCT03370471|58827248|FG001|Overall Study|Withdrawal by Subject|1|||
30808676|NCT03370471|58827247|FG000|Overall Study|Unable to access veins for blood draw|0|||
30808677|NCT03370471|58827248|FG001|Overall Study|Unable to access veins for blood draw|1|||
30808678|NCT03370471|58827247|FG000|Overall Study|Screen fail|1|||
30808679|NCT03370471|58827248|FG001|Overall Study|Screen fail|0|||
30808680|NCT03349645|58827256|FG000|Overall Study|Sponsor Terminated Study|75|||
30808681|NCT03349645|58827256|FG000|Overall Study|Withdrawal by Subject|4|||
30808682|NCT03349645|58827256|FG000|Overall Study|Protocol Violation|1|||
30808683|NCT03349645|58827256|FG000|Overall Study|Other|2|||
30808684|NCT03349333|58827260|FG000|Overall Study|Progression of Disease|36|||
30808685|NCT03349333|58827260|FG000|Overall Study|Adverse Event|11|||
30808686|NCT03349333|58827260|FG000|Overall Study|Other|6|||
30808687|NCT03349333|58827260|FG000|Overall Study|Withdrawal by Subject|5|||
30808688|NCT03349333|58827260|FG000|Overall Study|Conditions interfere with participation|2|||
30808689|NCT03349333|58827260|FG000|Overall Study|Physician Decision|2|||
30808690|NCT03349333|58827260|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
30808691|NCT03349333|58827260|FG000|Overall Study|Patients in treatment less than 24 month|8|||
30808692|NCT03349099|58827266|FG000|Overall Study|Physician Decision|3|||
30808693|NCT03349099|58827267|FG001|Overall Study|Physician Decision|4|||
30808694|NCT03349099|58827266|FG000|Overall Study|Stone migrated from the kidney|1|||
30749247|NCT00433199|58759231|FG000|Double-Blind Period|Protocol Violation|1|||
30749248|NCT00433199|58759232|FG001|Double-Blind Period|Protocol Violation|10|||
30749249|NCT00433199|58759231|FG000|Double-Blind Period|Administrative|1|||
30749250|NCT00433199|58759232|FG001|Double-Blind Period|Administrative|5|||
30749251|NCT00433199|58759231|FG000|Open-Label Period|Adverse Event|0|||
30749252|NCT00433199|58759232|FG001|Open-Label Period|Adverse Event|19|||
30808695|NCT03349099|58827267|FG001|Overall Study|Stone migrated from the kidney|0|||
30808696|NCT03348163|58827275|FG000|Overall Study|Withdrawal by Subject|2|||
30808697|NCT03348163|58827276|FG001|Overall Study|Withdrawal by Subject|0|||
30808698|NCT03347695|58827284|FG000|Overall Study|Death|0|||
30622495|NCT01131078|58634213|FG002|Overall Study|Lost to Follow-up|1|||
30622496|NCT01131078|58634211|FG000|Overall Study|Withdrawal by Subject|2|||
30749253|NCT00433199|58759231|FG000|Open-Label Period|Lack of Efficacy|0|||
30808699|NCT03347695|58827285|FG001|Overall Study|Death|4|||
30622497|NCT01131078|58634212|FG001|Overall Study|Withdrawal by Subject|4|||
30622498|NCT01131078|58634213|FG002|Overall Study|Withdrawal by Subject|3|||
30749254|NCT00433199|58759232|FG001|Open-Label Period|Lack of Efficacy|2|||
30808700|NCT03347695|58827284|FG000|Overall Study|Lost to Follow-up|0|||
30622499|NCT01131078|58634211|FG000|Overall Study|Non-compliance|3|||
30808701|NCT03347695|58827285|FG001|Overall Study|Lost to Follow-up|1|||
30808702|NCT02892019|58827295|FG000|Overall Study|randomized but not treated|0|||
30808703|NCT02892019|58827296|FG001|Overall Study|randomized but not treated|1|||
30808704|NCT02892019|58827295|FG000|Overall Study|Withdrawal by Subject|0|||
30808705|NCT02892019|58827296|FG001|Overall Study|Withdrawal by Subject|1|||
30808706|NCT02892019|58827295|FG000|Overall Study|Adverse Event|1|||
30808707|NCT02892019|58827296|FG001|Overall Study|Adverse Event|1|||
30808708|NCT03365791|58827302|FG000|Overall Study|Adverse Event|5|||
30808709|NCT03365791|58827302|FG000|Overall Study|Death|1|||
30808710|NCT03365791|58827302|FG000|Overall Study|Lost to Follow-up|1|||
30808711|NCT03365791|58827302|FG000|Overall Study|Physician Decision|9|||
30808712|NCT03365791|58827302|FG000|Overall Study|Progressive disease|51|||
30808713|NCT03365791|58827302|FG000|Overall Study|Subject/guardian decision|5|||
30808714|NCT03365011|58827309|FG000|Overall Study|Withdrawal by Subject|1|||
30808715|NCT03365011|58827310|FG001|Overall Study|Withdrawal by Subject|2|||
30808716|NCT03627767|58827319|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
30808717|NCT03627767|58827320|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
30808718|NCT03627767|58827321|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
30808719|NCT03627767|58827322|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
30808720|NCT03627767|58827323|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
30808721|NCT03627767|58827319|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
30808722|NCT03627767|58827320|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
30808723|NCT03627767|58827321|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
30808724|NCT03627767|58827322|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
30808725|NCT03627767|58827323|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
30808726|NCT03627767|58827319|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
30808727|NCT03627767|58827320|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
30909334|NCT01909479|58944198|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
30909335|NCT01909479|58944197|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
30909336|NCT01909479|58944198|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
30909337|NCT01909479|58944197|FG000|52 Weeks to End of Study|Adverse Event|2|||
30909338|NCT01909479|58944198|FG001|52 Weeks to End of Study|Adverse Event|1|||
30909339|NCT01909479|58944197|FG000|52 Weeks to End of Study|Death|0|||
30909340|NCT01909479|58944198|FG001|52 Weeks to End of Study|Death|1|||
30909341|NCT01909479|58944197|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
30909342|NCT01909479|58944198|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
30909343|NCT01909479|58944197|FG000|52 Weeks to End of Study|Protocol Violation|1|||
30909344|NCT01909479|58944198|FG001|52 Weeks to End of Study|Protocol Violation|0|||
30909345|NCT01909479|58944197|FG000|52 Weeks to End of Study|Progressive disease|1|||
30622500|NCT01131078|58634212|FG001|Overall Study|Non-compliance|0|||
30622501|NCT01131078|58634213|FG002|Overall Study|Non-compliance|0|||
30622502|NCT01131078|58634211|FG000|Overall Study|Physician Decision|10|||
30909346|NCT01909479|58944198|FG001|52 Weeks to End of Study|Progressive disease|1|||
30909347|NCT01909479|58944197|FG000|52 Weeks to End of Study|Personal reasons|2|||
30909348|NCT01909479|58944198|FG001|52 Weeks to End of Study|Personal reasons|1|||
30909349|NCT01909479|58944197|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
30909350|NCT01909479|58944198|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
30909351|NCT01909479|58944197|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
30909352|NCT01909479|58944198|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
30909353|NCT01909479|58944197|FG000|52 Weeks to End of Study|Lack of contact|1|||
30909354|NCT01909479|58944198|FG001|52 Weeks to End of Study|Lack of contact|0|||
30909355|NCT01909479|58944197|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
30909356|NCT01909479|58944198|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
30909357|NCT01909479|58944197|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
30622503|NCT01131078|58634212|FG001|Overall Study|Physician Decision|6|||
30749255|NCT00433199|58759231|FG000|Open-Label Period|Lost to Follow-up|0|||
30749256|NCT00433199|58759232|FG001|Open-Label Period|Lost to Follow-up|3|||
30749257|NCT00433199|58759231|FG000|Open-Label Period|Withdrawal by Subject|0|||
30749258|NCT00433199|58759232|FG001|Open-Label Period|Withdrawal by Subject|7|||
30749259|NCT00433199|58759231|FG000|Open-Label Period|Protocol Violation|0|||
30749260|NCT00433199|58759232|FG001|Open-Label Period|Protocol Violation|2|||
30749261|NCT00433199|58759231|FG000|Open-Label Period|Administrative|0|||
30808728|NCT03627767|58827321|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
30808729|NCT03627767|58827322|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
30808730|NCT03627767|58827323|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
30909358|NCT01909479|58944198|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
30909359|NCT01955733|58944211|FG000|Period 1|Lost to Follow-up|1|||
30909360|NCT01955733|58944212|FG001|Period 1|Lost to Follow-up|0|||
30749262|NCT00433199|58759232|FG001|Open-Label Period|Administrative|1|||
30808731|NCT03627767|58827319|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
30808732|NCT03627767|58827320|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
30808733|NCT03627767|58827321|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
30808734|NCT03627767|58827322|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
30808735|NCT03627767|58827323|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
30808736|NCT03627767|58827319|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
30808737|NCT03627767|58827320|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
30808738|NCT03627767|58827321|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
30808739|NCT03627767|58827322|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
30808740|NCT03627767|58827323|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
30808741|NCT03627767|58827319|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
30808742|NCT03627767|58827320|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
30808743|NCT03627767|58827321|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
30808744|NCT03627767|58827322|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
30808745|NCT03627767|58827323|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
30808746|NCT03627767|58827319|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
30808747|NCT03627767|58827320|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
30808748|NCT03627767|58827321|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
30808749|NCT03627767|58827322|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
30909361|NCT01955733|58944213|FG002|Period 1|Lost to Follow-up|0|||
30909362|NCT01955733|58944211|FG000|Period 2|Adverse Event|1|||
30909363|NCT01955733|58944212|FG001|Period 2|Adverse Event|0|||
30749263|NCT00006046|58759248|FG000|Overall Study|Adverse Event|3|||
30749264|NCT00006046|58759249|FG001|Overall Study|Adverse Event|0|||
30749265|NCT00006046|58759250|FG002|Overall Study|Adverse Event|0|||
30749266|NCT00006046|58759251|FG003|Overall Study|Adverse Event|0|||
30749267|NCT00006046|58759252|FG004|Overall Study|Adverse Event|0|||
30749268|NCT00006046|58759248|FG000|Overall Study|Disease Progression|2|||
30749269|NCT00006046|58759249|FG001|Overall Study|Disease Progression|0|||
30749270|NCT00006046|58759250|FG002|Overall Study|Disease Progression|0|||
30749271|NCT00006046|58759251|FG003|Overall Study|Disease Progression|0|||
30749272|NCT00006046|58759252|FG004|Overall Study|Disease Progression|0|||
30749273|NCT00005908|58759264|FG000|Overall Study|Withdrawal by Subject|1|||
30749274|NCT00005908|58759265|FG001|Overall Study|Withdrawal by Subject|0|||
30749275|NCT00432965|58759276|FG000|Overall Study|Lost to Follow-up|22|||
30808750|NCT03627767|58827323|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
30808751|NCT03627767|58827319|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
30808752|NCT03627767|58827320|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
30808753|NCT03627767|58827321|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
30808754|NCT03627767|58827322|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
30808755|NCT03627767|58827323|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
30808756|NCT03627767|58827319|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
30909364|NCT01955733|58944213|FG002|Period 2|Adverse Event|0|||
30909365|NCT01955733|58944211|FG000|Period 2|Physician Decision|0|||
30909366|NCT01955733|58944212|FG001|Period 2|Physician Decision|0|||
30909367|NCT01955733|58944213|FG002|Period 2|Physician Decision|1|||
30909368|NCT01955733|58944211|FG000|Period 2|Withdrawal by Subject|1|||
30909369|NCT01955733|58944212|FG001|Period 2|Withdrawal by Subject|3|||
30909370|NCT01955733|58944213|FG002|Period 2|Withdrawal by Subject|2|||
30909371|NCT01955733|58944211|FG000|Period 2|Study terminated by sponsor|8|||
30909372|NCT01955733|58944212|FG001|Period 2|Study terminated by sponsor|14|||
30909373|NCT01955733|58944213|FG002|Period 2|Study terminated by sponsor|16|||
30909374|NCT01955733|58944211|FG000|Period 2|Lost to Follow-up|2|||
30909375|NCT01955733|58944212|FG001|Period 2|Lost to Follow-up|0|||
30909376|NCT01955733|58944213|FG002|Period 2|Lost to Follow-up|0|||
30808757|NCT03627767|58827320|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
30808758|NCT03627767|58827321|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
30909377|NCT01955733|58944211|FG000|Period 2|Other not defined above|0|||
30909378|NCT01955733|58944212|FG001|Period 2|Other not defined above|2|||
30909379|NCT01955733|58944213|FG002|Period 2|Other not defined above|2|||
30909380|NCT02197897|58944221|FG000|Overall Study|not eligible|1|||
30909381|NCT02223793|58944228|FG000|Overall Study|Lost to Follow-up|10|||
30909382|NCT02223793|58944229|FG001|Overall Study|Lost to Follow-up|1|||
30909383|NCT02223793|58944230|FG002|Overall Study|Lost to Follow-up|2|||
30749276|NCT00432965|58759277|FG001|Overall Study|Lost to Follow-up|19|||
30749277|NCT00432965|58759276|FG000|Overall Study|Withdrawal by Subject|13|||
30909384|NCT02223793|58944228|FG000|Overall Study|Withdrawal by Subject|3|||
30749278|NCT00432965|58759277|FG001|Overall Study|Withdrawal by Subject|13|||
30749279|NCT00432965|58759276|FG000|Overall Study|Physician Decision|14|||
30749280|NCT00432965|58759277|FG001|Overall Study|Physician Decision|13|||
30749281|NCT00432965|58759276|FG000|Overall Study|Lack of Efficacy|8|||
30808759|NCT03627767|58827322|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
30808760|NCT03627767|58827323|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
30808761|NCT03627767|58827319|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
30808762|NCT03627767|58827320|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
30808763|NCT03627767|58827321|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
30808764|NCT03627767|58827322|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
30808765|NCT03627767|58827323|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
30808766|NCT03627767|58827319|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
30808767|NCT03627767|58827320|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
30808768|NCT03627767|58827321|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
30808769|NCT03627767|58827322|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
30808770|NCT03627767|58827323|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
30808771|NCT03627767|58827319|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
30808772|NCT03627767|58827320|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
30808773|NCT03627767|58827321|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
30808774|NCT03627767|58827322|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
30808775|NCT03627767|58827323|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
30808776|NCT03627767|58827319|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
30808777|NCT03627767|58827320|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
30808778|NCT03627767|58827321|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
30808779|NCT03627767|58827322|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
30808780|NCT03627767|58827323|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
30808781|NCT03627767|58827319|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
30808782|NCT03627767|58827320|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
30808783|NCT03627767|58827321|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
30808784|NCT03627767|58827322|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
30808785|NCT03627767|58827323|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
30808786|NCT03627767|58827319|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
30808787|NCT03627767|58827320|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
30808788|NCT03627767|58827321|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
30808789|NCT03627767|58827322|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
30808790|NCT03627767|58827323|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
30808791|NCT03627767|58827319|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
30808792|NCT03627767|58827320|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
30909385|NCT02223793|58944229|FG001|Overall Study|Withdrawal by Subject|2|||
30808793|NCT03627767|58827321|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
30808794|NCT03627767|58827322|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
30808795|NCT03627767|58827323|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
30808796|NCT03627767|58827319|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
30808797|NCT03627767|58827320|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
30808798|NCT03627767|58827321|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
30808799|NCT03627767|58827322|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
30808800|NCT03627767|58827323|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
30808801|NCT03627767|58827319|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
30808802|NCT03627767|58827320|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
30808803|NCT03627767|58827321|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
30808804|NCT03627767|58827322|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
30808805|NCT03627767|58827323|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
30808806|NCT03627767|58827319|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
30808807|NCT03627767|58827320|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
30749282|NCT00432965|58759277|FG001|Overall Study|Lack of Efficacy|13|||
30749283|NCT00432965|58759276|FG000|Overall Study|Non-compliance|7|||
30749284|NCT00432965|58759277|FG001|Overall Study|Non-compliance|0|||
30749285|NCT00432965|58759276|FG000|Overall Study|Adverse Event|22|||
30749286|NCT00432965|58759277|FG001|Overall Study|Adverse Event|19|||
30749287|NCT00432965|58759276|FG000|Overall Study|Death|3|||
30749288|NCT00432965|58759277|FG001|Overall Study|Death|4|||
30749289|NCT00432965|58759276|FG000|Overall Study|Exclusionary Methods|1|||
30749290|NCT00432965|58759277|FG001|Overall Study|Exclusionary Methods|2|||
30749291|NCT00432965|58759276|FG000|Overall Study|Incomplete Data|4|||
30749292|NCT00432965|58759277|FG001|Overall Study|Incomplete Data|3|||
30749293|NCT00440297|58759285|FG000|Overall Study|Adverse Event|8|||
30749294|NCT00440297|58759286|FG001|Overall Study|Adverse Event|5|||
30749295|NCT00440297|58759285|FG000|Overall Study|Lost to Follow-up|1|||
30749296|NCT00440297|58759286|FG001|Overall Study|Lost to Follow-up|0|||
30749297|NCT00440297|58759285|FG000|Overall Study|Physician Decision|1|||
30749298|NCT00440297|58759286|FG001|Overall Study|Physician Decision|0|||
30808808|NCT03627767|58827321|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
30808809|NCT03627767|58827322|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
30808810|NCT03627767|58827323|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
30808811|NCT03627767|58827319|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
30808812|NCT03627767|58827320|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
30808813|NCT03627767|58827321|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
30808814|NCT03627767|58827322|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
30808815|NCT03627767|58827323|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
30808816|NCT03627065|58827334|FG000|Overall Study|Study Terminated by sponsor|1|||
30808817|NCT03627065|58827334|FG000|Overall Study|Withdrawal by Subject|2|||
30808818|NCT02142738|58827340|FG000|Overall Study|Adverse Event|13|||
30808819|NCT02142738|58827341|FG001|Overall Study|Adverse Event|9|||
30808820|NCT02142738|58827340|FG000|Overall Study|Death|92|||
30808821|NCT02142738|58827341|FG001|Overall Study|Death|112|||
30808822|NCT02142738|58827340|FG000|Overall Study|Lost to Follow-up|0|||
30808823|NCT02142738|58827341|FG001|Overall Study|Lost to Follow-up|3|||
30808824|NCT02142738|58827340|FG000|Overall Study|Withdrawal by Subject|6|||
30808825|NCT02142738|58827341|FG001|Overall Study|Withdrawal by Subject|7|||
30808826|NCT02142738|58827340|FG000|Overall Study|Follow up ended by sponsor|43|||
30808827|NCT02142738|58827341|FG001|Overall Study|Follow up ended by sponsor|20|||
30808828|NCT03617861|58827352|FG000|Second Intervention (1 Day)|Adverse Event|0|||
30808829|NCT03617861|58827353|FG001|Second Intervention (1 Day)|Adverse Event|0|||
30808830|NCT03617861|58827354|FG002|Second Intervention (1 Day)|Adverse Event|1|||
30808831|NCT03617861|58827355|FG003|Second Intervention (1 Day)|Adverse Event|0|||
30808832|NCT03614975|58827367|FG000|Overall Study|Physician Decision|7|||
30808833|NCT03614975|58827368|FG001|Overall Study|Physician Decision|5|||
30808834|NCT03614975|58827367|FG000|Overall Study|Withdrawal by Subject|2|||
30808835|NCT03614975|58827368|FG001|Overall Study|Withdrawal by Subject|2|||
30808836|NCT03614975|58827367|FG000|Overall Study|Specimens not in lab batch shipment|1|||
30808837|NCT03614975|58827368|FG001|Overall Study|Specimens not in lab batch shipment|1|||
30808838|NCT03613649|58827386|FG000|Second Treatment|Lost to Follow-up|0|||
30808839|NCT03613649|58827387|FG001|Second Treatment|Lost to Follow-up|0|||
30808840|NCT03613649|58827388|FG002|Second Treatment|Lost to Follow-up|1|||
30808841|NCT03613649|58827389|FG003|Second Treatment|Lost to Follow-up|0|||
30808842|NCT03613649|58827390|FG004|Second Treatment|Lost to Follow-up|0|||
30808843|NCT03613649|58827391|FG005|Second Treatment|Lost to Follow-up|0|||
30808844|NCT03613649|58827392|FG006|Second Treatment|Lost to Follow-up|0|||
30808845|NCT03613649|58827393|FG007|Second Treatment|Lost to Follow-up|0|||
30808846|NCT03613649|58827394|FG008|Second Treatment|Lost to Follow-up|0|||
30808847|NCT03613649|58827395|FG009|Second Treatment|Lost to Follow-up|0|||
30808848|NCT03613649|58827396|FG010|Second Treatment|Lost to Follow-up|0|||
30808849|NCT03613649|58827397|FG011|Second Treatment|Lost to Follow-up|0|||
30808850|NCT03613649|58827386|FG000|Second Treatment|Withdrawal by Subject|0|||
30808851|NCT03613649|58827387|FG001|Second Treatment|Withdrawal by Subject|0|||
30749299|NCT00440297|58759285|FG000|Overall Study|Protocol Violation|11|||
30749300|NCT00440297|58759286|FG001|Overall Study|Protocol Violation|7|||
30749301|NCT00440297|58759285|FG000|Overall Study|Withdrawal by Subject|1|||
30749302|NCT00440297|58759286|FG001|Overall Study|Withdrawal by Subject|6|||
30808852|NCT03613649|58827388|FG002|Second Treatment|Withdrawal by Subject|0|||
30808853|NCT03613649|58827389|FG003|Second Treatment|Withdrawal by Subject|0|||
30808854|NCT03613649|58827390|FG004|Second Treatment|Withdrawal by Subject|1|||
30808855|NCT03613649|58827391|FG005|Second Treatment|Withdrawal by Subject|0|||
30808856|NCT03613649|58827392|FG006|Second Treatment|Withdrawal by Subject|0|||
30808857|NCT03613649|58827393|FG007|Second Treatment|Withdrawal by Subject|0|||
30808858|NCT03613649|58827394|FG008|Second Treatment|Withdrawal by Subject|0|||
30808859|NCT03613649|58827395|FG009|Second Treatment|Withdrawal by Subject|0|||
30808860|NCT03613649|58827396|FG010|Second Treatment|Withdrawal by Subject|0|||
30808861|NCT03613649|58827397|FG011|Second Treatment|Withdrawal by Subject|0|||
30808862|NCT03613649|58827386|FG000|Third Treatment|Lost to Follow-up|0|||
30808863|NCT03613649|58827387|FG001|Third Treatment|Lost to Follow-up|0|||
30808864|NCT03613649|58827388|FG002|Third Treatment|Lost to Follow-up|0|||
30808865|NCT03613649|58827389|FG003|Third Treatment|Lost to Follow-up|0|||
30808866|NCT03613649|58827390|FG004|Third Treatment|Lost to Follow-up|1|||
30808867|NCT03613649|58827391|FG005|Third Treatment|Lost to Follow-up|0|||
30808868|NCT03613649|58827392|FG006|Third Treatment|Lost to Follow-up|0|||
30808869|NCT03613649|58827393|FG007|Third Treatment|Lost to Follow-up|0|||
30808870|NCT03613649|58827394|FG008|Third Treatment|Lost to Follow-up|0|||
30808871|NCT03613649|58827395|FG009|Third Treatment|Lost to Follow-up|0|||
30808872|NCT03613649|58827396|FG010|Third Treatment|Lost to Follow-up|0|||
30808873|NCT03613649|58827397|FG011|Third Treatment|Lost to Follow-up|1|||
30808874|NCT03613649|58827386|FG000|Third Treatment|Protocol Violation|0|||
30808875|NCT03613649|58827387|FG001|Third Treatment|Protocol Violation|0|||
30808876|NCT03613649|58827388|FG002|Third Treatment|Protocol Violation|0|||
30808877|NCT03613649|58827389|FG003|Third Treatment|Protocol Violation|0|||
30808878|NCT03613649|58827390|FG004|Third Treatment|Protocol Violation|0|||
30808879|NCT03613649|58827391|FG005|Third Treatment|Protocol Violation|0|||
30808880|NCT03613649|58827392|FG006|Third Treatment|Protocol Violation|1|||
30808881|NCT03613649|58827393|FG007|Third Treatment|Protocol Violation|0|||
30808882|NCT03613649|58827394|FG008|Third Treatment|Protocol Violation|0|||
30808883|NCT03613649|58827395|FG009|Third Treatment|Protocol Violation|0|||
30808884|NCT03613649|58827396|FG010|Third Treatment|Protocol Violation|0|||
30808885|NCT03613649|58827397|FG011|Third Treatment|Protocol Violation|1|||
30808886|NCT03613649|58827386|FG000|Fourth Treatment|Protocol Violation|1|||
30808887|NCT03613649|58827387|FG001|Fourth Treatment|Protocol Violation|0|||
30808888|NCT03613649|58827388|FG002|Fourth Treatment|Protocol Violation|0|||
30808889|NCT03613649|58827389|FG003|Fourth Treatment|Protocol Violation|0|||
30808890|NCT03613649|58827390|FG004|Fourth Treatment|Protocol Violation|1|||
30808891|NCT03613649|58827391|FG005|Fourth Treatment|Protocol Violation|0|||
30808892|NCT03613649|58827392|FG006|Fourth Treatment|Protocol Violation|0|||
30808893|NCT03613649|58827393|FG007|Fourth Treatment|Protocol Violation|0|||
30808894|NCT03613649|58827394|FG008|Fourth Treatment|Protocol Violation|0|||
30808895|NCT03613649|58827395|FG009|Fourth Treatment|Protocol Violation|0|||
30808896|NCT03613649|58827396|FG010|Fourth Treatment|Protocol Violation|0|||
30808897|NCT03613649|58827397|FG011|Fourth Treatment|Protocol Violation|0|||
30808898|NCT03613649|58827386|FG000|Fourth Treatment|Physician Decision|0|||
30808899|NCT03613649|58827387|FG001|Fourth Treatment|Physician Decision|0|||
30808900|NCT03613649|58827388|FG002|Fourth Treatment|Physician Decision|0|||
30808901|NCT03613649|58827389|FG003|Fourth Treatment|Physician Decision|0|||
30808902|NCT03613649|58827390|FG004|Fourth Treatment|Physician Decision|0|||
30808903|NCT03613649|58827391|FG005|Fourth Treatment|Physician Decision|0|||
30808904|NCT03613649|58827392|FG006|Fourth Treatment|Physician Decision|1|||
30808905|NCT03613649|58827393|FG007|Fourth Treatment|Physician Decision|0|||
30808906|NCT03613649|58827394|FG008|Fourth Treatment|Physician Decision|0|||
30808907|NCT03613649|58827395|FG009|Fourth Treatment|Physician Decision|0|||
30808908|NCT03613649|58827396|FG010|Fourth Treatment|Physician Decision|0|||
30808909|NCT03613649|58827397|FG011|Fourth Treatment|Physician Decision|0|||
30808910|NCT03096288|58827419|FG000|Overall Study|Withdrawal by Subject|0|||
30808911|NCT03096288|58827420|FG001|Overall Study|Withdrawal by Subject|1|||
30808912|NCT03096288|58827421|FG002|Overall Study|Withdrawal by Subject|0|||
30808913|NCT03096288|58827422|FG003|Overall Study|Withdrawal by Subject|1|||
30808914|NCT03611075|58827441|FG000|Overall Study|Physician Decision|0|||
30808915|NCT03611075|58827442|FG001|Overall Study|Physician Decision|1|||
30808916|NCT03611075|58827443|FG002|Overall Study|Physician Decision|1|||
30808917|NCT03611075|58827444|FG003|Overall Study|Physician Decision|0|||
30808918|NCT03611075|58827445|FG004|Overall Study|Physician Decision|0|||
30808919|NCT03611075|58827446|FG005|Overall Study|Physician Decision|0|||
30808920|NCT03611075|58827447|FG006|Overall Study|Physician Decision|0|||
30808921|NCT03611075|58827448|FG007|Overall Study|Physician Decision|0|||
30808922|NCT03611075|58827449|FG008|Overall Study|Physician Decision|0|||
30808923|NCT03611075|58827441|FG000|Overall Study|Lost to Follow-up|1|||
30808924|NCT03611075|58827442|FG001|Overall Study|Lost to Follow-up|0|||
30808925|NCT03611075|58827443|FG002|Overall Study|Lost to Follow-up|0|||
30808926|NCT03611075|58827444|FG003|Overall Study|Lost to Follow-up|2|||
30808927|NCT03611075|58827445|FG004|Overall Study|Lost to Follow-up|0|||
30808928|NCT03611075|58827446|FG005|Overall Study|Lost to Follow-up|0|||
30808929|NCT03611075|58827447|FG006|Overall Study|Lost to Follow-up|0|||
30808930|NCT03611075|58827448|FG007|Overall Study|Lost to Follow-up|0|||
30808931|NCT03611075|58827449|FG008|Overall Study|Lost to Follow-up|0|||
30808932|NCT03611075|58827441|FG000|Overall Study|Withdrawal by Subject|0|||
30808933|NCT03611075|58827442|FG001|Overall Study|Withdrawal by Subject|1|||
30909386|NCT02223793|58944230|FG002|Overall Study|Withdrawal by Subject|3|||
30909387|NCT02223793|58944228|FG000|Overall Study|Moved/studycenter unable to participate|4|||
30909388|NCT02223793|58944229|FG001|Overall Study|Moved/studycenter unable to participate|6|||
30909389|NCT02223793|58944230|FG002|Overall Study|Moved/studycenter unable to participate|8|||
30909390|NCT01926015|58944240|FG000|Overall Study|Withdrawal by parent/guardian|0|||
30909391|NCT01926015|58944241|FG001|Overall Study|Withdrawal by parent/guardian|1|||
30909392|NCT01926015|58944240|FG000|Overall Study|Randomized not treated|2|||
30909393|NCT01926015|58944241|FG001|Overall Study|Randomized not treated|0|||
30909394|NCT02223715|58944247|FG000|Overall Study|Death|31|||
30808934|NCT03611075|58827443|FG002|Overall Study|Withdrawal by Subject|1|||
30808935|NCT03611075|58827444|FG003|Overall Study|Withdrawal by Subject|1|||
30909395|NCT02223715|58944247|FG000|Overall Study|Lost to Follow-up|73|||
30909396|NCT02196259|58944257|FG000|Overall Study|Researcher choice|0|||
30909397|NCT02196259|58944258|FG001|Overall Study|Researcher choice|0|||
30909398|NCT02196259|58944259|FG002|Overall Study|Researcher choice|1|||
30909399|NCT02196259|58944257|FG000|Overall Study|Partial data analysis|0|||
30909400|NCT02196259|58944258|FG001|Overall Study|Partial data analysis|3|||
30909401|NCT02196259|58944259|FG002|Overall Study|Partial data analysis|0|||
30909402|NCT02294396|58944270|FG000|Overall Study|Adverse Event|26|||
30909403|NCT02294396|58944271|FG001|Overall Study|Adverse Event|25|||
30909404|NCT02294396|58944272|FG002|Overall Study|Adverse Event|21|||
30909405|NCT02294396|58944273|FG003|Overall Study|Adverse Event|24|||
30909406|NCT02294396|58944270|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
30909407|NCT02294396|58944271|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
30808936|NCT03611075|58827445|FG004|Overall Study|Withdrawal by Subject|0|||
30808937|NCT03611075|58827446|FG005|Overall Study|Withdrawal by Subject|0|||
30808938|NCT03611075|58827447|FG006|Overall Study|Withdrawal by Subject|1|||
30808939|NCT03611075|58827448|FG007|Overall Study|Withdrawal by Subject|0|||
30808940|NCT03611075|58827449|FG008|Overall Study|Withdrawal by Subject|0|||
30808941|NCT03611075|58827441|FG000|Overall Study|Reason unknown|0|||
30808942|NCT03611075|58827442|FG001|Overall Study|Reason unknown|0|||
30808943|NCT03611075|58827443|FG002|Overall Study|Reason unknown|0|||
30808944|NCT03611075|58827444|FG003|Overall Study|Reason unknown|1|||
30808945|NCT03611075|58827445|FG004|Overall Study|Reason unknown|0|||
30808946|NCT03611075|58827446|FG005|Overall Study|Reason unknown|0|||
30808947|NCT03611075|58827447|FG006|Overall Study|Reason unknown|1|||
30808948|NCT03611075|58827448|FG007|Overall Study|Reason unknown|0|||
30808949|NCT03611075|58827449|FG008|Overall Study|Reason unknown|0|||
30808950|NCT03095508|58827494|FG000|Overall Study|Adverse Event|0|||
30808951|NCT03095508|58827495|FG001|Overall Study|Adverse Event|1|||
30808952|NCT03607487|58827505|FG000|Overall Study|Withdrawal by Subject|2|||
30808953|NCT03607487|58827506|FG001|Overall Study|Withdrawal by Subject|0|||
30808954|NCT03607487|58827507|FG002|Overall Study|Withdrawal by Subject|0|||
30808955|NCT03607487|58827508|FG003|Overall Study|Withdrawal by Subject|1|||
30808956|NCT03605693|58827522|FG000|Overall Study|Lost to Follow-up|4|||
30808957|NCT03605693|58827523|FG001|Overall Study|Lost to Follow-up|0|||
30808958|NCT03605693|58827522|FG000|Overall Study|Physician Decision|1|||
30808959|NCT03605693|58827523|FG001|Overall Study|Physician Decision|0|||
30808960|NCT03605303|58827529|FG000|Period 1|Study Terminated|2|||
30808961|NCT03605303|58827530|FG001|Period 1|Study Terminated|1|||
30808962|NCT03604523|58827538|FG000|Overall Study|Physician Decision|1|||
30808963|NCT03604523|58827539|FG001|Overall Study|Physician Decision|0|||
30808964|NCT03602339|58827545|FG000|Overall Study|Withdrawal by Subject|9|||
30808965|NCT03602339|58827545|FG000|Overall Study|Physician Decision|2|||
30808966|NCT03602339|58827545|FG000|Overall Study|Other reason|4|||
30808967|NCT03653429|58827554|FG000|Overall Study|Physician Decision|4|||
30808968|NCT03653429|58827555|FG001|Overall Study|Physician Decision|10|||
30808969|NCT03601715|58827564|FG000|Second Intervention|Lost to Follow-up|1|||
30808970|NCT03601715|58827565|FG001|Second Intervention|Lost to Follow-up|1|||
30808971|NCT03601715|58827566|FG002|Second Intervention|Lost to Follow-up|0|||
30808972|NCT03594227|58827578|FG000|Overall Study|Adverse Event|2|||
30909408|NCT02294396|58944272|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
30909409|NCT02294396|58944273|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
30909410|NCT02294396|58944270|FG000|Overall Study|Withdrawal by Subject|8|||
30909411|NCT02294396|58944271|FG001|Overall Study|Withdrawal by Subject|6|||
30808973|NCT03594227|58827579|FG001|Overall Study|Adverse Event|1|||
30808974|NCT03594227|58827580|FG002|Overall Study|Adverse Event|0|||
30808975|NCT03594227|58827581|FG003|Overall Study|Adverse Event|2|||
30808976|NCT03594227|58827578|FG000|Overall Study|Lost to Follow-up|1|||
30808977|NCT03594227|58827579|FG001|Overall Study|Lost to Follow-up|1|||
30808978|NCT03594227|58827580|FG002|Overall Study|Lost to Follow-up|1|||
30808979|NCT03594227|58827581|FG003|Overall Study|Lost to Follow-up|0|||
30808980|NCT03594227|58827578|FG000|Overall Study|Withdrawal by Subject|1|||
30808981|NCT03594227|58827579|FG001|Overall Study|Withdrawal by Subject|1|||
30808982|NCT03594227|58827580|FG002|Overall Study|Withdrawal by Subject|1|||
30808983|NCT03594227|58827581|FG003|Overall Study|Withdrawal by Subject|1|||
30808984|NCT03594227|58827578|FG000|Overall Study|Pregnancy|0|||
30808985|NCT03594227|58827579|FG001|Overall Study|Pregnancy|1|||
30808986|NCT03594227|58827580|FG002|Overall Study|Pregnancy|0|||
30808987|NCT03594227|58827581|FG003|Overall Study|Pregnancy|0|||
30808988|NCT03594227|58827578|FG000|Overall Study|Sponsor Decision|0|||
30808989|NCT03594227|58827579|FG001|Overall Study|Sponsor Decision|0|||
30808990|NCT03594227|58827580|FG002|Overall Study|Sponsor Decision|0|||
30808991|NCT03594227|58827581|FG003|Overall Study|Sponsor Decision|1|||
30808992|NCT03594227|58827578|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
30808993|NCT03594227|58827579|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
30808994|NCT03594227|58827580|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
30808995|NCT03594227|58827581|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
30808996|NCT03098550|58827605|FG000|Overall Study|Disease Progression|30|||
30808997|NCT03098550|58827606|FG001|Overall Study|Disease Progression|19|||
30808998|NCT03098550|58827607|FG002|Overall Study|Disease Progression|41|||
30622504|NCT01131078|58634213|FG002|Overall Study|Physician Decision|8|||
30749303|NCT00440297|58759285|FG000|Overall Study|Randomized by mistake|1|||
30749304|NCT00440297|58759286|FG001|Overall Study|Randomized by mistake|0|||
30749305|NCT00432809|58759295|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
30749306|NCT00432809|58759296|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
30749307|NCT00432809|58759297|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
30749308|NCT00432809|58759295|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
30749309|NCT00432809|58759296|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
30808999|NCT03098550|58827605|FG000|Overall Study|Study Drug Toxicity|2|||
30809000|NCT03098550|58827606|FG001|Overall Study|Study Drug Toxicity|1|||
30809001|NCT03098550|58827607|FG002|Overall Study|Study Drug Toxicity|0|||
30809002|NCT03098550|58827605|FG000|Overall Study|Death|1|||
30809003|NCT03098550|58827606|FG001|Overall Study|Death|0|||
30809004|NCT03098550|58827607|FG002|Overall Study|Death|0|||
30809005|NCT03098550|58827605|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
30809006|NCT03098550|58827606|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
30809007|NCT03098550|58827607|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
30809008|NCT03098550|58827605|FG000|Overall Study|Administrative reason by sponsor|0|||
30809009|NCT03098550|58827606|FG001|Overall Study|Administrative reason by sponsor|0|||
30809010|NCT03098550|58827607|FG002|Overall Study|Administrative reason by sponsor|1|||
30809011|NCT03098550|58827605|FG000|Overall Study|Other reasons|2|||
30809012|NCT03098550|58827606|FG001|Overall Study|Other reasons|0|||
30809013|NCT03098550|58827607|FG002|Overall Study|Other reasons|0|||
30809014|NCT03095118|58827619|FG000|Overall Study|Adverse Event|1|||
30809015|NCT03095118|58827619|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
30809016|NCT03594071|58827623|FG000|Overall Study|Re-operation|3|||
30809017|NCT03594071|58827623|FG000|Overall Study|Missed visit|2|||
30809018|NCT02696902|58827630|FG000|Overall Study|Lost to Follow-up|0|||
30809019|NCT02696902|58827631|FG001|Overall Study|Lost to Follow-up|1|||
30809020|NCT02696902|58827632|FG002|Overall Study|Lost to Follow-up|1|||
30622505|NCT01131078|58634211|FG000|Overall Study|Death|4|||
30749310|NCT00432809|58759297|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
30809021|NCT02696902|58827630|FG000|Overall Study|Withdrawal by Subject|0|||
30809022|NCT02696902|58827631|FG001|Overall Study|Withdrawal by Subject|0|||
30809023|NCT02696902|58827632|FG002|Overall Study|Withdrawal by Subject|1|||
30809024|NCT02696902|58827630|FG000|Overall Study|Death|19|||
30809025|NCT02696902|58827631|FG001|Overall Study|Death|3|||
30809026|NCT02696902|58827632|FG002|Overall Study|Death|24|||
30809027|NCT02696902|58827630|FG000|Overall Study|Participant not fit post-randomization|0|||
30809028|NCT02696902|58827631|FG001|Overall Study|Participant not fit post-randomization|0|||
30809029|NCT02696902|58827632|FG002|Overall Study|Participant not fit post-randomization|1|||
30809030|NCT02696902|58827630|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
30909412|NCT02294396|58944272|FG002|Overall Study|Withdrawal by Subject|6|||
30909413|NCT02294396|58944273|FG003|Overall Study|Withdrawal by Subject|8|||
30909414|NCT02294396|58944270|FG000|Overall Study|Lost to Follow-up|0|||
30909415|NCT02294396|58944271|FG001|Overall Study|Lost to Follow-up|0|||
30909416|NCT02294396|58944272|FG002|Overall Study|Lost to Follow-up|1|||
30909417|NCT02294396|58944273|FG003|Overall Study|Lost to Follow-up|1|||
30909418|NCT02294396|58944270|FG000|Overall Study|Protocol Deviation|3|||
30909419|NCT02294396|58944271|FG001|Overall Study|Protocol Deviation|2|||
30909420|NCT02294396|58944272|FG002|Overall Study|Protocol Deviation|2|||
30909421|NCT02294396|58944273|FG003|Overall Study|Protocol Deviation|1|||
30909422|NCT02294396|58944270|FG000|Overall Study|Miscellaneous|2|||
30909423|NCT02294396|58944271|FG001|Overall Study|Miscellaneous|0|||
30622506|NCT01131078|58634212|FG001|Overall Study|Death|0|||
30622507|NCT01131078|58634213|FG002|Overall Study|Death|2|||
30749311|NCT00431951|58759309|FG000|Overall Study|Inability to follow study procedures|1|||
30749312|NCT00431951|58759310|FG001|Overall Study|Inability to follow study procedures|0|||
30749313|NCT00431951|58759311|FG002|Overall Study|Inability to follow study procedures|1|||
30749314|NCT00431951|58759312|FG003|Overall Study|Inability to follow study procedures|2|||
30749315|NCT00431951|58759309|FG000|Overall Study|Lost to Follow-up|0|||
30749316|NCT00431951|58759310|FG001|Overall Study|Lost to Follow-up|1|||
30749317|NCT00431951|58759311|FG002|Overall Study|Lost to Follow-up|0|||
30749318|NCT00431951|58759312|FG003|Overall Study|Lost to Follow-up|0|||
30749319|NCT00431951|58759309|FG000|Overall Study|Withdrawal by Subject|0|||
30749320|NCT00431951|58759310|FG001|Overall Study|Withdrawal by Subject|1|||
30749321|NCT00431951|58759311|FG002|Overall Study|Withdrawal by Subject|0|||
30749322|NCT00431951|58759312|FG003|Overall Study|Withdrawal by Subject|0|||
30749323|NCT00431951|58759309|FG000|Overall Study|Adverse Event|0|||
30749324|NCT00431951|58759310|FG001|Overall Study|Adverse Event|0|||
30749325|NCT00431951|58759311|FG002|Overall Study|Adverse Event|1|||
30749326|NCT00431951|58759312|FG003|Overall Study|Adverse Event|0|||
30749327|NCT00004978|58759328|FG000|Overall Study|Death|107|||
30749328|NCT00004978|58759329|FG001|Overall Study|Death|116|||
30749329|NCT00004978|58759328|FG000|Overall Study|Lost to Follow-up|101|||
30749330|NCT00004978|58759329|FG001|Overall Study|Lost to Follow-up|108|||
30749331|NCT00004978|58759328|FG000|Overall Study|Withdrawal by Subject|17|||
30749332|NCT00004978|58759329|FG001|Overall Study|Withdrawal by Subject|26|||
30749333|NCT00004978|58759328|FG000|Overall Study|site closure - not in analysis cohort|19|||
30749334|NCT00004978|58759329|FG001|Overall Study|site closure - not in analysis cohort|20|||
30749335|NCT00430937|58759337|FG000|Overall Study|Adverse Event|3|||
30749336|NCT00430937|58759338|FG001|Overall Study|Adverse Event|8|||
30749337|NCT00430937|58759337|FG000|Overall Study|Death|0|||
30749338|NCT00430937|58759338|FG001|Overall Study|Death|1|||
30749339|NCT00430937|58759337|FG000|Overall Study|Lost to Follow-up|6|||
30749340|NCT00430937|58759338|FG001|Overall Study|Lost to Follow-up|6|||
30749341|NCT00430937|58759337|FG000|Overall Study|Withdrawal by Subject|5|||
30749342|NCT00430937|58759338|FG001|Overall Study|Withdrawal by Subject|2|||
30749343|NCT00430937|58759337|FG000|Overall Study|Protocol Violation|3|||
30749344|NCT00430937|58759338|FG001|Overall Study|Protocol Violation|2|||
30749345|NCT00430937|58759337|FG000|Overall Study|Lack of Efficacy|6|||
30749346|NCT00430937|58759338|FG001|Overall Study|Lack of Efficacy|5|||
30749347|NCT00430937|58759337|FG000|Overall Study|Inappropriate enrollment|2|||
30749348|NCT00430937|58759338|FG001|Overall Study|Inappropriate enrollment|1|||
30749349|NCT00430937|58759337|FG000|Overall Study|Administrative reasons|1|||
30749350|NCT00430937|58759338|FG001|Overall Study|Administrative reasons|0|||
30809031|NCT02696902|58827631|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
30809032|NCT02696902|58827632|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
30909424|NCT02294396|58944272|FG002|Overall Study|Miscellaneous|5|||
30622508|NCT01131078|58634211|FG000|Overall Study|Other|0|||
30749351|NCT00430937|58759337|FG000|Overall Study|Protocol discontinuation criteria met|1|||
30749352|NCT00430937|58759338|FG001|Overall Study|Protocol discontinuation criteria met|2|||
30749353|NCT00430937|58759337|FG000|Overall Study|Unable to classify|0|||
30749354|NCT00430937|58759338|FG001|Overall Study|Unable to classify|1|||
30749355|NCT00004888|58759346|FG000|Overall Study|Adverse Event|5|||
30749356|NCT00004888|58759347|FG001|Overall Study|Adverse Event|10|||
30749357|NCT00004888|58759346|FG000|Overall Study|Withdrawal by Subject|0|||
30749358|NCT00004888|58759347|FG001|Overall Study|Withdrawal by Subject|3|||
30749359|NCT00004888|58759346|FG000|Overall Study|Physician Decision|1|||
30749360|NCT00004888|58759347|FG001|Overall Study|Physician Decision|1|||
30809033|NCT02696902|58827630|FG000|Overall Study|Principal investigator's decision|1|||
30909425|NCT02294396|58944273|FG003|Overall Study|Miscellaneous|2|||
30909426|NCT01721044|58944286|FG000|Treatment Period|Adverse Event|7|||
30809034|NCT02696902|58827631|FG001|Overall Study|Principal investigator's decision|0|||
30749361|NCT00004888|58759346|FG000|Overall Study|Progressive Disease|4|||
30749362|NCT00004888|58759347|FG001|Overall Study|Progressive Disease|9|||
30749363|NCT00004888|58759346|FG000|Overall Study|Death without progressive disease|0|||
30749364|NCT00004888|58759347|FG001|Overall Study|Death without progressive disease|1|||
30749365|NCT00004888|58759346|FG000|Overall Study|Toxic death|1|||
30749366|NCT00004888|58759347|FG001|Overall Study|Toxic death|0|||
30809035|NCT02696902|58827632|FG002|Overall Study|Principal investigator's decision|0|||
30809036|NCT02696902|58827630|FG000|Overall Study|Sponsor's decision|1|||
30809037|NCT02696902|58827631|FG001|Overall Study|Sponsor's decision|0|||
30809038|NCT02696902|58827632|FG002|Overall Study|Sponsor's decision|0|||
30809039|NCT02696902|58827630|FG000|Overall Study|Transferred to other hospital|1|||
30809040|NCT02696902|58827631|FG001|Overall Study|Transferred to other hospital|0|||
30809041|NCT02696902|58827632|FG002|Overall Study|Transferred to other hospital|0|||
30809042|NCT02694562|58827642|FG000|Overall Study|Death|8|||
30809043|NCT02694562|58827642|FG000|Overall Study|Protocol Violation|4|||
30809044|NCT02694562|58827642|FG000|Overall Study|Lost to Follow-up|3|||
30809045|NCT02694562|58827642|FG000|Overall Study|Screen Failure|2|||
30809046|NCT02694562|58827642|FG000|Overall Study|Physician Decision|1|||
30809047|NCT02874534|58827648|FG000|Overall Study|Withdrawal by Subject|5|||
30809048|NCT02874534|58827649|FG001|Overall Study|Withdrawal by Subject|8|||
30809049|NCT02874534|58827648|FG000|Overall Study|Lost to Follow-up|2|||
30809050|NCT02874534|58827649|FG001|Overall Study|Lost to Follow-up|2|||
30809051|NCT02874534|58827648|FG000|Overall Study|Ongoing in study|1|||
30809052|NCT02874534|58827649|FG001|Overall Study|Ongoing in study|1|||
30809053|NCT03097614|58827655|FG000|Overall Study|Adverse Event|3|||
30809054|NCT03364309|58827662|FG000|Induction Period|Adverse Event|4|||
30809055|NCT03364309|58827663|FG001|Induction Period|Adverse Event|0|||
30809056|NCT03364309|58827664|FG002|Induction Period|Adverse Event|1|||
30809057|NCT03364309|58827665|FG003|Induction Period|Adverse Event|0|||
30809058|NCT03364309|58827666|FG004|Induction Period|Adverse Event|0|||
30809059|NCT03364309|58827667|FG005|Induction Period|Adverse Event|0|||
30809060|NCT03364309|58827668|FG006|Induction Period|Adverse Event|0|||
30809061|NCT03364309|58827669|FG007|Induction Period|Adverse Event|0|||
30809062|NCT03364309|58827670|FG008|Induction Period|Adverse Event|0|||
30809063|NCT03364309|58827671|FG009|Induction Period|Adverse Event|0|||
30809064|NCT03364309|58827672|FG010|Induction Period|Adverse Event|0|||
30809065|NCT03364309|58827673|FG011|Induction Period|Adverse Event|0|||
30809066|NCT03364309|58827674|FG012|Induction Period|Adverse Event|0|||
30809067|NCT03364309|58827675|FG013|Induction Period|Adverse Event|0|||
30809068|NCT03364309|58827676|FG014|Induction Period|Adverse Event|0|||
30809069|NCT03364309|58827677|FG015|Induction Period|Adverse Event|0|||
30749367|NCT00004732|58759355|FG000|Overall Study|Withdrawal by Subject|36|||
30809070|NCT03364309|58827678|FG016|Induction Period|Adverse Event|0|||
30809071|NCT03364309|58827679|FG017|Induction Period|Adverse Event|0|||
30749368|NCT00004732|58759356|FG001|Overall Study|Withdrawal by Subject|64|||
30749369|NCT00004732|58759355|FG000|Overall Study|Lost to Follow-up|33|||
30749370|NCT00004732|58759356|FG001|Overall Study|Lost to Follow-up|47|||
30749371|NCT00430781|58759367|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
30749372|NCT00430781|58759368|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
30749373|NCT00430781|58759369|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
30749374|NCT00430781|58759367|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
30749375|NCT00430781|58759368|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
30749376|NCT00430781|58759369|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
30749377|NCT00430781|58759367|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
30749378|NCT00430781|58759368|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
30749379|NCT00430781|58759369|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
30749380|NCT00430781|58759367|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
30809072|NCT03364309|58827680|FG018|Induction Period|Adverse Event|0|||
30809073|NCT03364309|58827662|FG000|Induction Period|Withdrawal by Subject|1|||
30809074|NCT03364309|58827663|FG001|Induction Period|Withdrawal by Subject|3|||
30809075|NCT03364309|58827664|FG002|Induction Period|Withdrawal by Subject|0|||
30809076|NCT03364309|58827665|FG003|Induction Period|Withdrawal by Subject|0|||
30749381|NCT00430781|58759368|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
30749382|NCT00430781|58759369|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
30749383|NCT00430781|58759367|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
30809077|NCT03364309|58827666|FG004|Induction Period|Withdrawal by Subject|0|||
30809078|NCT03364309|58827667|FG005|Induction Period|Withdrawal by Subject|0|||
30809079|NCT03364309|58827668|FG006|Induction Period|Withdrawal by Subject|0|||
30809080|NCT03364309|58827669|FG007|Induction Period|Withdrawal by Subject|0|||
30809081|NCT03364309|58827670|FG008|Induction Period|Withdrawal by Subject|0|||
30809082|NCT03364309|58827671|FG009|Induction Period|Withdrawal by Subject|0|||
30809083|NCT03364309|58827672|FG010|Induction Period|Withdrawal by Subject|0|||
30809084|NCT03364309|58827673|FG011|Induction Period|Withdrawal by Subject|0|||
30809085|NCT03364309|58827674|FG012|Induction Period|Withdrawal by Subject|0|||
30809086|NCT03364309|58827675|FG013|Induction Period|Withdrawal by Subject|0|||
30809087|NCT03364309|58827676|FG014|Induction Period|Withdrawal by Subject|0|||
30809088|NCT03364309|58827677|FG015|Induction Period|Withdrawal by Subject|0|||
30809089|NCT03364309|58827678|FG016|Induction Period|Withdrawal by Subject|0|||
30809090|NCT03364309|58827679|FG017|Induction Period|Withdrawal by Subject|0|||
30809091|NCT03364309|58827680|FG018|Induction Period|Withdrawal by Subject|0|||
30809092|NCT03364309|58827662|FG000|Induction Period|Lost to Follow-up|1|||
30809093|NCT03364309|58827663|FG001|Induction Period|Lost to Follow-up|0|||
30809094|NCT03364309|58827664|FG002|Induction Period|Lost to Follow-up|0|||
30809095|NCT03364309|58827665|FG003|Induction Period|Lost to Follow-up|0|||
30809096|NCT03364309|58827666|FG004|Induction Period|Lost to Follow-up|0|||
30809097|NCT03364309|58827667|FG005|Induction Period|Lost to Follow-up|0|||
30809098|NCT03364309|58827668|FG006|Induction Period|Lost to Follow-up|0|||
30809099|NCT03364309|58827669|FG007|Induction Period|Lost to Follow-up|0|||
30809100|NCT03364309|58827670|FG008|Induction Period|Lost to Follow-up|0|||
30809101|NCT03364309|58827671|FG009|Induction Period|Lost to Follow-up|0|||
30809102|NCT03364309|58827672|FG010|Induction Period|Lost to Follow-up|0|||
30809103|NCT03364309|58827673|FG011|Induction Period|Lost to Follow-up|0|||
30809104|NCT03364309|58827674|FG012|Induction Period|Lost to Follow-up|0|||
30809105|NCT03364309|58827675|FG013|Induction Period|Lost to Follow-up|0|||
30809106|NCT03364309|58827676|FG014|Induction Period|Lost to Follow-up|0|||
30809107|NCT03364309|58827677|FG015|Induction Period|Lost to Follow-up|0|||
30809108|NCT03364309|58827678|FG016|Induction Period|Lost to Follow-up|0|||
30809109|NCT03364309|58827679|FG017|Induction Period|Lost to Follow-up|0|||
30809110|NCT03364309|58827680|FG018|Induction Period|Lost to Follow-up|0|||
30809111|NCT03364309|58827662|FG000|Induction Period|Physician Decision|0|||
30749384|NCT00430781|58759368|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
30749385|NCT00430781|58759369|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
30809112|NCT03364309|58827663|FG001|Induction Period|Physician Decision|1|||
30809113|NCT03364309|58827664|FG002|Induction Period|Physician Decision|0|||
30809114|NCT03364309|58827665|FG003|Induction Period|Physician Decision|0|||
30809115|NCT03364309|58827666|FG004|Induction Period|Physician Decision|0|||
30809116|NCT03364309|58827667|FG005|Induction Period|Physician Decision|0|||
30809117|NCT03364309|58827668|FG006|Induction Period|Physician Decision|0|||
30809118|NCT03364309|58827669|FG007|Induction Period|Physician Decision|0|||
30809119|NCT03364309|58827670|FG008|Induction Period|Physician Decision|0|||
30809120|NCT03364309|58827671|FG009|Induction Period|Physician Decision|0|||
30809121|NCT03364309|58827672|FG010|Induction Period|Physician Decision|0|||
30809122|NCT03364309|58827673|FG011|Induction Period|Physician Decision|0|||
30809123|NCT03364309|58827674|FG012|Induction Period|Physician Decision|0|||
30809124|NCT03364309|58827675|FG013|Induction Period|Physician Decision|0|||
30809125|NCT03364309|58827676|FG014|Induction Period|Physician Decision|0|||
30909427|NCT01721044|58944287|FG001|Treatment Period|Adverse Event|7|||
30749386|NCT00430781|58759367|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
30749387|NCT00430781|58759368|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
30749388|NCT00430781|58759369|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
30749389|NCT00430781|58759367|FG000|Interim Analysis; 11 February 2008|Death|0|||
30749390|NCT00430781|58759368|FG001|Interim Analysis; 11 February 2008|Death|1|||
30749391|NCT00430781|58759369|FG002|Interim Analysis; 11 February 2008|Death|0|||
30749392|NCT00430781|58759367|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
30749393|NCT00430781|58759368|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
30749394|NCT00430781|58759369|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
30749395|NCT00430781|58759367|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
30809126|NCT03364309|58827677|FG015|Induction Period|Physician Decision|0|||
30809127|NCT03364309|58827678|FG016|Induction Period|Physician Decision|0|||
30809128|NCT03364309|58827679|FG017|Induction Period|Physician Decision|0|||
30809129|NCT03364309|58827680|FG018|Induction Period|Physician Decision|0|||
30909428|NCT01721044|58944288|FG002|Treatment Period|Adverse Event|10|||
30809130|NCT03364309|58827662|FG000|Maintenance Period|Withdrawal by Subject|0|||
30809131|NCT03364309|58827663|FG001|Maintenance Period|Withdrawal by Subject|0|||
30809132|NCT03364309|58827664|FG002|Maintenance Period|Withdrawal by Subject|0|||
30809133|NCT03364309|58827665|FG003|Maintenance Period|Withdrawal by Subject|1|||
30809134|NCT03364309|58827666|FG004|Maintenance Period|Withdrawal by Subject|3|||
30909429|NCT01721044|58944286|FG000|Treatment Period|Death|0|||
30809135|NCT03364309|58827667|FG005|Maintenance Period|Withdrawal by Subject|1|||
30809136|NCT03364309|58827668|FG006|Maintenance Period|Withdrawal by Subject|3|||
30809137|NCT03364309|58827669|FG007|Maintenance Period|Withdrawal by Subject|0|||
30809138|NCT03364309|58827670|FG008|Maintenance Period|Withdrawal by Subject|1|||
30809139|NCT03364309|58827671|FG009|Maintenance Period|Withdrawal by Subject|1|||
30809140|NCT03364309|58827672|FG010|Maintenance Period|Withdrawal by Subject|2|||
30809141|NCT03364309|58827673|FG011|Maintenance Period|Withdrawal by Subject|0|||
30809142|NCT03364309|58827674|FG012|Maintenance Period|Withdrawal by Subject|0|||
30809143|NCT03364309|58827675|FG013|Maintenance Period|Withdrawal by Subject|0|||
30809144|NCT03364309|58827676|FG014|Maintenance Period|Withdrawal by Subject|0|||
30809145|NCT03364309|58827677|FG015|Maintenance Period|Withdrawal by Subject|0|||
30809146|NCT03364309|58827678|FG016|Maintenance Period|Withdrawal by Subject|0|||
30809147|NCT03364309|58827679|FG017|Maintenance Period|Withdrawal by Subject|0|||
30809148|NCT03364309|58827680|FG018|Maintenance Period|Withdrawal by Subject|0|||
30909430|NCT01721044|58944287|FG001|Treatment Period|Death|0|||
30909431|NCT01721044|58944288|FG002|Treatment Period|Death|1|||
30909432|NCT01721044|58944286|FG000|Treatment Period|Lack of Efficacy|16|||
30909433|NCT01721044|58944287|FG001|Treatment Period|Lack of Efficacy|4|||
30909434|NCT01721044|58944288|FG002|Treatment Period|Lack of Efficacy|4|||
30909435|NCT01721044|58944286|FG000|Treatment Period|Lost to Follow-up|0|||
30909436|NCT01721044|58944287|FG001|Treatment Period|Lost to Follow-up|0|||
30909437|NCT01721044|58944288|FG002|Treatment Period|Lost to Follow-up|1|||
30909438|NCT01721044|58944286|FG000|Treatment Period|Physician Decision|1|||
30909439|NCT01721044|58944287|FG001|Treatment Period|Physician Decision|0|||
30809149|NCT03364309|58827662|FG000|Maintenance Period|Adverse Event|0|||
30809150|NCT03364309|58827663|FG001|Maintenance Period|Adverse Event|0|||
30809151|NCT03364309|58827664|FG002|Maintenance Period|Adverse Event|0|||
30809152|NCT03364309|58827665|FG003|Maintenance Period|Adverse Event|0|||
30809153|NCT03364309|58827666|FG004|Maintenance Period|Adverse Event|2|||
30809154|NCT03364309|58827667|FG005|Maintenance Period|Adverse Event|0|||
30809155|NCT03364309|58827668|FG006|Maintenance Period|Adverse Event|3|||
30809156|NCT03364309|58827669|FG007|Maintenance Period|Adverse Event|0|||
30809157|NCT03364309|58827670|FG008|Maintenance Period|Adverse Event|1|||
30809158|NCT03364309|58827671|FG009|Maintenance Period|Adverse Event|0|||
30809159|NCT03364309|58827672|FG010|Maintenance Period|Adverse Event|2|||
30809160|NCT03364309|58827673|FG011|Maintenance Period|Adverse Event|0|||
30809161|NCT03364309|58827674|FG012|Maintenance Period|Adverse Event|0|||
30909440|NCT01721044|58944288|FG002|Treatment Period|Physician Decision|2|||
30909441|NCT01721044|58944286|FG000|Treatment Period|Protocol Violation|1|||
30909442|NCT01721044|58944287|FG001|Treatment Period|Protocol Violation|0|||
30909443|NCT01721044|58944288|FG002|Treatment Period|Protocol Violation|0|||
30749396|NCT00430781|58759368|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
30749397|NCT00430781|58759369|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
30749398|NCT00430781|58759367|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
30749399|NCT00430781|58759368|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
30749400|NCT00430781|58759369|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
30749401|NCT00430781|58759367|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
30749402|NCT00430781|58759368|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
30749403|NCT00430781|58759369|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
30749404|NCT00430781|58759367|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
30749405|NCT00430781|58759368|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
30749406|NCT00430781|58759369|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
30749407|NCT00430781|58759367|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
30749408|NCT00430781|58759368|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
30749409|NCT00430781|58759369|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
30749410|NCT00430781|58759367|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
30749411|NCT00430781|58759368|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
30749412|NCT00430781|58759369|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
30749413|NCT00430781|58759367|FG000|Final Analysis; 31 July 2008|Other|0|||
30749414|NCT00430781|58759368|FG001|Final Analysis; 31 July 2008|Other|1|||
30749415|NCT00430781|58759369|FG002|Final Analysis; 31 July 2008|Other|0|||
30749416|NCT00430781|58759367|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
30809162|NCT03364309|58827675|FG013|Maintenance Period|Adverse Event|0|||
30809163|NCT03364309|58827676|FG014|Maintenance Period|Adverse Event|0|||
30809164|NCT03364309|58827677|FG015|Maintenance Period|Adverse Event|0|||
30809165|NCT03364309|58827678|FG016|Maintenance Period|Adverse Event|0|||
30809166|NCT03364309|58827679|FG017|Maintenance Period|Adverse Event|0|||
30809167|NCT03364309|58827680|FG018|Maintenance Period|Adverse Event|0|||
30749417|NCT00430781|58759368|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
30809168|NCT03364309|58827662|FG000|Maintenance Period|Relapsed|0|||
30909444|NCT01721044|58944286|FG000|Treatment Period|Withdrawal by Subject|7|||
30909445|NCT01721044|58944287|FG001|Treatment Period|Withdrawal by Subject|6|||
30909446|NCT01721044|58944288|FG002|Treatment Period|Withdrawal by Subject|1|||
30909447|NCT02164981|58944310|FG000|Started|Withdrawal by Subject|2|||
30909448|NCT02164981|58944311|FG001|Started|Withdrawal by Subject|1|||
30909449|NCT02164981|58944312|FG002|Started|Withdrawal by Subject|0|||
30809169|NCT03364309|58827663|FG001|Maintenance Period|Relapsed|0|||
30809170|NCT03364309|58827664|FG002|Maintenance Period|Relapsed|0|||
30809171|NCT03364309|58827665|FG003|Maintenance Period|Relapsed|43|||
30809172|NCT03364309|58827666|FG004|Maintenance Period|Relapsed|7|||
30809173|NCT03364309|58827667|FG005|Maintenance Period|Relapsed|45|||
30809174|NCT03364309|58827668|FG006|Maintenance Period|Relapsed|10|||
30809175|NCT03364309|58827669|FG007|Maintenance Period|Relapsed|2|||
30809176|NCT03364309|58827670|FG008|Maintenance Period|Relapsed|0|||
30809177|NCT03364309|58827671|FG009|Maintenance Period|Relapsed|0|||
30809178|NCT03364309|58827672|FG010|Maintenance Period|Relapsed|0|||
30809179|NCT03364309|58827673|FG011|Maintenance Period|Relapsed|0|||
30809180|NCT03364309|58827674|FG012|Maintenance Period|Relapsed|0|||
30909450|NCT02164981|58944310|FG000|Started|Protocol Violation|2|||
30909451|NCT02164981|58944311|FG001|Started|Protocol Violation|0|||
30909452|NCT02164981|58944312|FG002|Started|Protocol Violation|0|||
30909453|NCT02164981|58944310|FG000|Started|Adverse Event|1|||
30749418|NCT00430781|58759369|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
30749419|NCT00430781|58759367|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
30809181|NCT03364309|58827675|FG013|Maintenance Period|Relapsed|0|||
30809182|NCT03364309|58827676|FG014|Maintenance Period|Relapsed|0|||
30809183|NCT03364309|58827677|FG015|Maintenance Period|Relapsed|0|||
30809184|NCT03364309|58827678|FG016|Maintenance Period|Relapsed|0|||
30809185|NCT03364309|58827679|FG017|Maintenance Period|Relapsed|0|||
30809186|NCT03364309|58827680|FG018|Maintenance Period|Relapsed|0|||
30809187|NCT03364309|58827662|FG000|Maintenance Period|Lack of Efficacy|0|||
30809188|NCT03364309|58827663|FG001|Maintenance Period|Lack of Efficacy|0|||
30809189|NCT03364309|58827664|FG002|Maintenance Period|Lack of Efficacy|0|||
30809190|NCT03364309|58827665|FG003|Maintenance Period|Lack of Efficacy|0|||
30809191|NCT03364309|58827666|FG004|Maintenance Period|Lack of Efficacy|0|||
30809192|NCT03364309|58827667|FG005|Maintenance Period|Lack of Efficacy|0|||
30809193|NCT03364309|58827668|FG006|Maintenance Period|Lack of Efficacy|0|||
30809194|NCT03364309|58827669|FG007|Maintenance Period|Lack of Efficacy|0|||
30809195|NCT03364309|58827670|FG008|Maintenance Period|Lack of Efficacy|1|||
30809196|NCT03364309|58827671|FG009|Maintenance Period|Lack of Efficacy|3|||
30809197|NCT03364309|58827672|FG010|Maintenance Period|Lack of Efficacy|2|||
30809198|NCT03364309|58827673|FG011|Maintenance Period|Lack of Efficacy|0|||
30809199|NCT03364309|58827674|FG012|Maintenance Period|Lack of Efficacy|0|||
30809200|NCT03364309|58827675|FG013|Maintenance Period|Lack of Efficacy|0|||
30809201|NCT03364309|58827676|FG014|Maintenance Period|Lack of Efficacy|0|||
30809202|NCT03364309|58827677|FG015|Maintenance Period|Lack of Efficacy|0|||
30809203|NCT03364309|58827678|FG016|Maintenance Period|Lack of Efficacy|0|||
30809204|NCT03364309|58827679|FG017|Maintenance Period|Lack of Efficacy|0|||
30809205|NCT03364309|58827680|FG018|Maintenance Period|Lack of Efficacy|0|||
30809206|NCT03364309|58827662|FG000|Maintenance Period|Death|0|||
30809207|NCT03364309|58827663|FG001|Maintenance Period|Death|0|||
30809208|NCT03364309|58827664|FG002|Maintenance Period|Death|0|||
30809209|NCT03364309|58827665|FG003|Maintenance Period|Death|0|||
30809210|NCT03364309|58827666|FG004|Maintenance Period|Death|0|||
30809211|NCT03364309|58827667|FG005|Maintenance Period|Death|0|||
30809212|NCT03364309|58827668|FG006|Maintenance Period|Death|0|||
30909454|NCT02164981|58944311|FG001|Started|Adverse Event|2|||
30749420|NCT00430781|58759368|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
30749421|NCT00430781|58759369|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
30749422|NCT00430781|58759367|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
30749423|NCT00430781|58759368|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
30749424|NCT00430781|58759369|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
30749425|NCT00430781|58759367|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
30749426|NCT00430781|58759368|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
30749427|NCT00430781|58759369|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
30749428|NCT00430781|58759367|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
30749429|NCT00430781|58759368|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
30749430|NCT00430781|58759369|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
30749431|NCT00430781|58759367|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
30809213|NCT03364309|58827669|FG007|Maintenance Period|Death|0|||
30809214|NCT03364309|58827670|FG008|Maintenance Period|Death|1|||
30809215|NCT03364309|58827671|FG009|Maintenance Period|Death|0|||
30809216|NCT03364309|58827672|FG010|Maintenance Period|Death|0|||
30809217|NCT03364309|58827673|FG011|Maintenance Period|Death|0|||
30809218|NCT03364309|58827674|FG012|Maintenance Period|Death|0|||
30809219|NCT03364309|58827675|FG013|Maintenance Period|Death|0|||
30809220|NCT03364309|58827676|FG014|Maintenance Period|Death|0|||
30809221|NCT03364309|58827677|FG015|Maintenance Period|Death|0|||
30749432|NCT00430781|58759368|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
30809222|NCT03364309|58827678|FG016|Maintenance Period|Death|0|||
30809223|NCT03364309|58827679|FG017|Maintenance Period|Death|0|||
30809224|NCT03364309|58827680|FG018|Maintenance Period|Death|0|||
30809225|NCT03364309|58827662|FG000|Maintenance Period|Lost to Follow-up|0|||
30909455|NCT02164981|58944312|FG002|Started|Adverse Event|0|||
30809226|NCT03364309|58827663|FG001|Maintenance Period|Lost to Follow-up|0|||
30809227|NCT03364309|58827664|FG002|Maintenance Period|Lost to Follow-up|0|||
30809228|NCT03364309|58827665|FG003|Maintenance Period|Lost to Follow-up|0|||
30809229|NCT03364309|58827666|FG004|Maintenance Period|Lost to Follow-up|0|||
30809230|NCT03364309|58827667|FG005|Maintenance Period|Lost to Follow-up|0|||
30809231|NCT03364309|58827668|FG006|Maintenance Period|Lost to Follow-up|0|||
30809232|NCT03364309|58827669|FG007|Maintenance Period|Lost to Follow-up|0|||
30809233|NCT03364309|58827670|FG008|Maintenance Period|Lost to Follow-up|1|||
30809234|NCT03364309|58827671|FG009|Maintenance Period|Lost to Follow-up|0|||
30809235|NCT03364309|58827672|FG010|Maintenance Period|Lost to Follow-up|0|||
30809236|NCT03364309|58827673|FG011|Maintenance Period|Lost to Follow-up|0|||
30809237|NCT03364309|58827674|FG012|Maintenance Period|Lost to Follow-up|0|||
30809238|NCT03364309|58827675|FG013|Maintenance Period|Lost to Follow-up|0|||
30809239|NCT03364309|58827676|FG014|Maintenance Period|Lost to Follow-up|0|||
30809240|NCT03364309|58827677|FG015|Maintenance Period|Lost to Follow-up|0|||
30809241|NCT03364309|58827678|FG016|Maintenance Period|Lost to Follow-up|0|||
30809242|NCT03364309|58827679|FG017|Maintenance Period|Lost to Follow-up|0|||
30809243|NCT03364309|58827680|FG018|Maintenance Period|Lost to Follow-up|0|||
30809244|NCT03364309|58827662|FG000|Maintenance Period|Miscellaneous|0|||
30809245|NCT03364309|58827663|FG001|Maintenance Period|Miscellaneous|0|||
30809246|NCT03364309|58827664|FG002|Maintenance Period|Miscellaneous|0|||
30809247|NCT03364309|58827665|FG003|Maintenance Period|Miscellaneous|0|||
30809248|NCT03364309|58827666|FG004|Maintenance Period|Miscellaneous|0|||
30809249|NCT03364309|58827667|FG005|Maintenance Period|Miscellaneous|0|||
30809250|NCT03364309|58827668|FG006|Maintenance Period|Miscellaneous|0|||
30809251|NCT03364309|58827669|FG007|Maintenance Period|Miscellaneous|0|||
30809252|NCT03364309|58827670|FG008|Maintenance Period|Miscellaneous|1|||
30809253|NCT03364309|58827671|FG009|Maintenance Period|Miscellaneous|0|||
30809254|NCT03364309|58827672|FG010|Maintenance Period|Miscellaneous|0|||
30809255|NCT03364309|58827673|FG011|Maintenance Period|Miscellaneous|0|||
30809256|NCT03364309|58827674|FG012|Maintenance Period|Miscellaneous|0|||
30809257|NCT03364309|58827675|FG013|Maintenance Period|Miscellaneous|0|||
30809258|NCT03364309|58827676|FG014|Maintenance Period|Miscellaneous|0|||
30809259|NCT03364309|58827677|FG015|Maintenance Period|Miscellaneous|0|||
30749433|NCT00430781|58759369|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
30749434|NCT00430781|58759367|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
30749435|NCT00430781|58759368|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
30809260|NCT03364309|58827678|FG016|Maintenance Period|Miscellaneous|0|||
30809261|NCT03364309|58827679|FG017|Maintenance Period|Miscellaneous|0|||
30809262|NCT03364309|58827680|FG018|Maintenance Period|Miscellaneous|0|||
30809263|NCT03364309|58827662|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809264|NCT03364309|58827663|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809265|NCT03364309|58827664|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809266|NCT03364309|58827665|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809267|NCT03364309|58827666|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809268|NCT03364309|58827667|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809269|NCT03364309|58827668|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809270|NCT03364309|58827669|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809271|NCT03364309|58827670|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30909456|NCT02164981|58944310|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
30749436|NCT00430781|58759369|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
30809272|NCT03364309|58827671|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809273|NCT03364309|58827672|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809274|NCT03364309|58827673|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809275|NCT03364309|58827674|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809276|NCT03364309|58827675|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
30809277|NCT03364309|58827676|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
30809278|NCT03364309|58827677|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
30809279|NCT03364309|58827678|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809280|NCT03364309|58827679|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809281|NCT03364309|58827680|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
30809282|NCT03364309|58827662|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
30749437|NCT00429299|58759383|FG000|Overall Study|Disease Progression|1|||
30749438|NCT00429299|58759384|FG001|Overall Study|Disease Progression|1|||
30749439|NCT00429299|58759385|FG002|Overall Study|Disease Progression|0|||
30749440|NCT00429299|58759383|FG000|Overall Study|Adverse Event|2|||
30749441|NCT00429299|58759384|FG001|Overall Study|Adverse Event|5|||
30749442|NCT00429299|58759385|FG002|Overall Study|Adverse Event|1|||
30749443|NCT00429299|58759383|FG000|Overall Study|Protocol Violation|1|||
30809283|NCT03364309|58827663|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809284|NCT03364309|58827664|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809285|NCT03364309|58827665|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809286|NCT03364309|58827666|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809287|NCT03364309|58827667|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809288|NCT03364309|58827668|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809289|NCT03364309|58827669|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809290|NCT03364309|58827670|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809291|NCT03364309|58827671|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
30909457|NCT02164981|58944311|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
30909458|NCT02164981|58944312|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
30909459|NCT02164981|58944310|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
30909460|NCT02164981|58944311|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
30909461|NCT02164981|58944312|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
30909462|NCT02164981|58944310|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
30909463|NCT02164981|58944311|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
30909464|NCT02164981|58944312|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
30909465|NCT02195869|58944333|FG000|Overall Study|cGVHD Progression|5|||
30909466|NCT02195869|58944333|FG000|Overall Study|Malignancy Progression/relapse|2|||
30909467|NCT02195869|58944333|FG000|Overall Study|Adverse Event|15|||
30909468|NCT02195869|58944333|FG000|Overall Study|Withdrawal by Subject|7|||
30809292|NCT03364309|58827672|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809293|NCT03364309|58827673|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809294|NCT03364309|58827674|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809295|NCT03364309|58827675|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809296|NCT03364309|58827676|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
30809297|NCT03364309|58827677|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809298|NCT03364309|58827678|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809299|NCT03364309|58827679|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809300|NCT03364309|58827680|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
30809301|NCT03364309|58827662|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
30809302|NCT03364309|58827663|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
30809303|NCT03364309|58827664|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
30809304|NCT03364309|58827665|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
30809305|NCT03364309|58827666|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
30809306|NCT03364309|58827667|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
30809307|NCT03364309|58827668|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
30809308|NCT03364309|58827669|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
30809309|NCT03364309|58827670|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
30809310|NCT03364309|58827671|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
30809311|NCT03364309|58827672|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
30809312|NCT03364309|58827673|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
30809313|NCT03364309|58827674|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
30809314|NCT03364309|58827675|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
30809315|NCT03364309|58827676|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
30809316|NCT03364309|58827677|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
30809317|NCT03364309|58827678|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
30809318|NCT03364309|58827679|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
30809319|NCT03364309|58827680|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
30809320|NCT03364309|58827662|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809321|NCT03364309|58827663|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809322|NCT03364309|58827664|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809323|NCT03364309|58827665|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809324|NCT03364309|58827666|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809325|NCT03364309|58827667|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809326|NCT03364309|58827668|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809327|NCT03364309|58827669|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809328|NCT03364309|58827670|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809329|NCT03364309|58827671|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809330|NCT03364309|58827672|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809331|NCT03364309|58827673|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809332|NCT03364309|58827674|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809333|NCT03364309|58827675|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809334|NCT03364309|58827676|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30909469|NCT02195869|58944333|FG000|Overall Study|Physician Decision|4|||
30909470|NCT02195869|58944333|FG000|Overall Study|Study Terminated by Sponsor|7|||
30909471|NCT02195869|58944333|FG000|Overall Study|Noncompliance with study drug|2|||
30909472|NCT01908699|58944342|FG000|Overall Study|Adverse Event|8|||
30909473|NCT01908699|58944343|FG001|Overall Study|Adverse Event|12|||
30909474|NCT01908699|58944342|FG000|Overall Study|Lack of Efficacy|2|||
30909475|NCT01908699|58944343|FG001|Overall Study|Lack of Efficacy|2|||
30909476|NCT01908699|58944342|FG000|Overall Study|Lost to Follow-up|2|||
30909477|NCT01908699|58944343|FG001|Overall Study|Lost to Follow-up|4|||
30909478|NCT01908699|58944342|FG000|Overall Study|Physician Decision|8|||
30909479|NCT01908699|58944343|FG001|Overall Study|Physician Decision|8|||
30909480|NCT01908699|58944342|FG000|Overall Study|Withdrawal by Subject|15|||
30909481|NCT01908699|58944343|FG001|Overall Study|Withdrawal by Subject|10|||
30909482|NCT01908699|58944342|FG000|Overall Study|Pregnancy|0|||
30909483|NCT01908699|58944343|FG001|Overall Study|Pregnancy|1|||
30909484|NCT01908699|58944342|FG000|Overall Study|Randomized in Error|1|||
30909485|NCT01908699|58944343|FG001|Overall Study|Randomized in Error|0|||
30909486|NCT01908699|58944342|FG000|Overall Study|Death|9|||
30909487|NCT01908699|58944343|FG001|Overall Study|Death|12|||
30909488|NCT01908699|58944342|FG000|Overall Study|Progressive Disease|30|||
30909489|NCT01908699|58944343|FG001|Overall Study|Progressive Disease|29|||
30909490|NCT01599637|58944352|FG000|Overall Study|administrative problems|0|||
30909491|NCT01599637|58944353|FG001|Overall Study|administrative problems|2|||
30909492|NCT01599637|58944354|FG002|Overall Study|administrative problems|0|||
30909493|NCT01599637|58944352|FG000|Overall Study|Adverse Event|1|||
30909494|NCT01599637|58944353|FG001|Overall Study|Adverse Event|0|||
30909495|NCT01599637|58944354|FG002|Overall Study|Adverse Event|0|||
30909496|NCT02264639|58944369|FG000|Overall Study|Death (after completing single-dose phase)|1|||
30909497|NCT02264639|58944370|FG001|Overall Study|Death (after completing single-dose phase)|0|||
30809335|NCT03364309|58827677|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
30809336|NCT03364309|58827678|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
30809337|NCT03364309|58827679|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
30809338|NCT03364309|58827680|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
30809339|NCT03364309|58827662|FG000|Post-Treatment Followup Period|Adverse Event|0|||
30809340|NCT03364309|58827663|FG001|Post-Treatment Followup Period|Adverse Event|0|||
30809341|NCT03364309|58827664|FG002|Post-Treatment Followup Period|Adverse Event|0|||
30809342|NCT03364309|58827665|FG003|Post-Treatment Followup Period|Adverse Event|0|||
30809343|NCT03364309|58827666|FG004|Post-Treatment Followup Period|Adverse Event|0|||
30809344|NCT03364309|58827667|FG005|Post-Treatment Followup Period|Adverse Event|0|||
30809345|NCT03364309|58827668|FG006|Post-Treatment Followup Period|Adverse Event|0|||
30809346|NCT03364309|58827669|FG007|Post-Treatment Followup Period|Adverse Event|0|||
30809347|NCT03364309|58827670|FG008|Post-Treatment Followup Period|Adverse Event|0|||
30809348|NCT03364309|58827671|FG009|Post-Treatment Followup Period|Adverse Event|0|||
30809349|NCT03364309|58827672|FG010|Post-Treatment Followup Period|Adverse Event|0|||
30809350|NCT03364309|58827673|FG011|Post-Treatment Followup Period|Adverse Event|0|||
30809351|NCT03364309|58827674|FG012|Post-Treatment Followup Period|Adverse Event|0|||
30809352|NCT03364309|58827675|FG013|Post-Treatment Followup Period|Adverse Event|0|||
30809353|NCT03364309|58827676|FG014|Post-Treatment Followup Period|Adverse Event|0|||
30809354|NCT03364309|58827677|FG015|Post-Treatment Followup Period|Adverse Event|0|||
30809355|NCT03364309|58827678|FG016|Post-Treatment Followup Period|Adverse Event|2|||
30809356|NCT03364309|58827679|FG017|Post-Treatment Followup Period|Adverse Event|6|||
30809357|NCT03364309|58827680|FG018|Post-Treatment Followup Period|Adverse Event|1|||
30809358|NCT03364309|58827662|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809359|NCT03364309|58827663|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809360|NCT03364309|58827664|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809361|NCT03364309|58827665|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809362|NCT03364309|58827666|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809363|NCT03364309|58827667|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809364|NCT03364309|58827668|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
30909498|NCT02264639|58944371|FG002|Overall Study|Death (after completing single-dose phase)|0|||
30909499|NCT02264639|58944372|FG003|Overall Study|Death (after completing single-dose phase)|0|||
30909500|NCT02264639|58944373|FG004|Overall Study|Death (after completing single-dose phase)|0|||
30909501|NCT02264639|58944369|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
30909502|NCT02264639|58944370|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
30909503|NCT02264639|58944371|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
30809365|NCT03364309|58827669|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809366|NCT03364309|58827670|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809367|NCT03364309|58827671|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809368|NCT03364309|58827672|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809369|NCT03364309|58827673|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809370|NCT03364309|58827674|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809371|NCT03364309|58827675|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809372|NCT03364309|58827676|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809373|NCT03364309|58827677|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809374|NCT03364309|58827678|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809375|NCT03364309|58827679|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
30809376|NCT03364309|58827680|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
30809377|NCT03364309|58827662|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
30809378|NCT03364309|58827663|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
30809379|NCT03364309|58827664|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
30809380|NCT03364309|58827665|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
30909504|NCT02264639|58944372|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
30909505|NCT02264639|58944373|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
30909506|NCT02264639|58944369|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
30909507|NCT02264639|58944370|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
30909508|NCT02264639|58944371|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
30909509|NCT02264639|58944372|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
30909510|NCT02264639|58944373|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
30909511|NCT02264639|58944369|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
30909512|NCT02264639|58944370|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
30909513|NCT02264639|58944371|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
30909514|NCT02264639|58944372|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
30909515|NCT02264639|58944373|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
30909516|NCT01363011|58944390|FG000|Main Study|Adverse Event|2|||
30909517|NCT01363011|58944391|FG001|Main Study|Adverse Event|3|||
30909518|NCT01363011|58944390|FG000|Main Study|Investigator's Discretion|1|||
30909519|NCT01363011|58944391|FG001|Main Study|Investigator's Discretion|1|||
30909520|NCT01363011|58944390|FG000|Main Study|Withdrew Consent|1|||
30909521|NCT01363011|58944391|FG001|Main Study|Withdrew Consent|4|||
30909522|NCT01363011|58944390|FG000|Main Study|Protocol Violation|0|||
30909523|NCT01363011|58944391|FG001|Main Study|Protocol Violation|1|||
30909524|NCT01363011|58944390|FG000|Extension Phase|Adverse Event|1|||
30909525|NCT01363011|58944391|FG001|Extension Phase|Adverse Event|1|||
30809381|NCT03364309|58827666|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
30809382|NCT03364309|58827667|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
30809383|NCT03364309|58827668|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
30809384|NCT03364309|58827669|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
30809385|NCT03364309|58827670|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
30809386|NCT03364309|58827671|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
30809387|NCT03364309|58827672|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
30809388|NCT03364309|58827673|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
30809389|NCT03364309|58827674|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
30809390|NCT03364309|58827675|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
30809391|NCT03364309|58827676|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
30809392|NCT03364309|58827677|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
30809393|NCT03364309|58827678|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
30809394|NCT03364309|58827679|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
30809395|NCT03364309|58827680|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
30809396|NCT03334903|58827706|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
30809397|NCT03334903|58827707|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
30809398|NCT03334903|58827706|FG000|Overall Study|Protocol Violation|1|||
30809399|NCT03334903|58827707|FG001|Overall Study|Protocol Violation|3|||
30809400|NCT03334903|58827706|FG000|Overall Study|Surgery postponed|1|||
30909526|NCT01363011|58944390|FG000|Extension Phase|Lack of Efficacy|0|||
30909527|NCT01363011|58944391|FG001|Extension Phase|Lack of Efficacy|1|||
30909528|NCT01363011|58944390|FG000|Extension Phase|Investigator's Discretion|2|||
30809401|NCT03334903|58827707|FG001|Overall Study|Surgery postponed|0|||
30809402|NCT03334903|58827706|FG000|Overall Study|Adverse Event|1|||
30809403|NCT03334903|58827707|FG001|Overall Study|Adverse Event|1|||
30809404|NCT03334903|58827706|FG000|Overall Study|Withdrawal by Subject|0|||
30809405|NCT03334903|58827707|FG001|Overall Study|Withdrawal by Subject|1|||
30909529|NCT01363011|58944391|FG001|Extension Phase|Investigator's Discretion|2|||
30909530|NCT01363011|58944390|FG000|Extension Phase|Withdrew Consent|0|||
30809406|NCT01353664|58827713|FG000|Overall Study|Other|3|||
30809407|NCT01353664|58827713|FG000|Overall Study|Disease Progression|16|||
30809408|NCT02694328|58827719|FG000|Overall Study|Adverse Event|27|||
30809409|NCT02694328|58827720|FG001|Overall Study|Adverse Event|33|||
30809410|NCT02694328|58827719|FG000|Overall Study|Withdrawal by Subject|27|||
30809411|NCT02694328|58827720|FG001|Overall Study|Withdrawal by Subject|23|||
30809412|NCT02694328|58827719|FG000|Overall Study|Lost to Follow-up|26|||
30809413|NCT02694328|58827720|FG001|Overall Study|Lost to Follow-up|22|||
30809414|NCT02694328|58827719|FG000|Overall Study|Noncompliant with study drug|11|||
30809415|NCT02694328|58827720|FG001|Overall Study|Noncompliant with study drug|8|||
30809416|NCT02694328|58827719|FG000|Overall Study|Incarceration|1|||
30809417|NCT02694328|58827720|FG001|Overall Study|Incarceration|1|||
30809418|NCT02694328|58827719|FG000|Overall Study|Lack of Efficacy|1|||
30809419|NCT02694328|58827720|FG001|Overall Study|Lack of Efficacy|2|||
30809420|NCT02694328|58827719|FG000|Overall Study|Pregnancy|1|||
30809421|NCT02694328|58827720|FG001|Overall Study|Pregnancy|1|||
30809422|NCT02694328|58827719|FG000|Overall Study|Protocol Violation|6|||
30809423|NCT02694328|58827720|FG001|Overall Study|Protocol Violation|5|||
30809424|NCT02694328|58827719|FG000|Overall Study|Abnormal Laboratory Value|0|||
30809425|NCT02694328|58827720|FG001|Overall Study|Abnormal Laboratory Value|3|||
30809426|NCT03334747|58827735|FG000|Treatment Phase|Technical problems|0|||
30809427|NCT03334747|58827736|FG001|Treatment Phase|Technical problems|0|||
30809428|NCT03334747|58827737|FG002|Treatment Phase|Technical problems|0|||
30809429|NCT03334747|58827738|FG003|Treatment Phase|Technical problems|0|||
30809430|NCT03334747|58827739|FG004|Treatment Phase|Technical problems|1|||
30809431|NCT03334747|58827740|FG005|Treatment Phase|Technical problems|0|||
30809432|NCT03334747|58827741|FG006|Treatment Phase|Technical problems|0|||
30809433|NCT03334747|58827742|FG007|Treatment Phase|Technical problems|0|||
30809434|NCT03334747|58827743|FG008|Treatment Phase|Technical problems|0|||
30809435|NCT03334747|58827735|FG000|Treatment Phase|Subject/guardian decision|1|||
30809436|NCT03334747|58827736|FG001|Treatment Phase|Subject/guardian decision|0|||
30809437|NCT03334747|58827737|FG002|Treatment Phase|Subject/guardian decision|0|||
30749444|NCT00429299|58759384|FG001|Overall Study|Protocol Violation|0|||
30749445|NCT00429299|58759385|FG002|Overall Study|Protocol Violation|0|||
30749446|NCT00429299|58759383|FG000|Overall Study|Withdrawal by Subject|0|||
30749447|NCT00429299|58759384|FG001|Overall Study|Withdrawal by Subject|1|||
30749448|NCT00429299|58759385|FG002|Overall Study|Withdrawal by Subject|3|||
30749449|NCT00428597|58759395|FG000|Overall Study|Randomized but not treated|3|||
30749450|NCT00428597|58759396|FG001|Overall Study|Randomized but not treated|3|||
30749451|NCT00428597|58759395|FG000|Overall Study|Objective Progression or Relapse|19|||
30749452|NCT00428597|58759396|FG001|Overall Study|Objective Progression or Relapse|47|||
30749453|NCT00428597|58759395|FG000|Overall Study|Study Terminated by Sponsor|41|||
30749454|NCT00428597|58759396|FG001|Overall Study|Study Terminated by Sponsor|16|||
30749455|NCT00428597|58759395|FG000|Overall Study|Adverse Event|15|||
30749456|NCT00428597|58759396|FG001|Overall Study|Adverse Event|7|||
30749457|NCT00428597|58759395|FG000|Overall Study|Global Deterioration of Health Status|1|||
30749458|NCT00428597|58759396|FG001|Overall Study|Global Deterioration of Health Status|5|||
30749459|NCT00428597|58759395|FG000|Overall Study|Protocol Violation|2|||
30749460|NCT00428597|58759396|FG001|Overall Study|Protocol Violation|1|||
30749461|NCT00428597|58759395|FG000|Overall Study|Withdrawal by Subject|2|||
30749462|NCT00428597|58759396|FG001|Overall Study|Withdrawal by Subject|1|||
30749463|NCT00428597|58759395|FG000|Overall Study|Other|1|||
30749464|NCT00428597|58759396|FG001|Overall Study|Other|1|||
30749465|NCT00428597|58759395|FG000|Overall Study|Lost to Follow-up|0|||
30749466|NCT00428597|58759396|FG001|Overall Study|Lost to Follow-up|1|||
30749467|NCT00428597|58759395|FG000|Overall Study|Pregnancy|1|||
30749468|NCT00428597|58759396|FG001|Overall Study|Pregnancy|0|||
30749469|NCT00428597|58759395|FG000|Overall Study|Death|1|||
30749470|NCT00428597|58759396|FG001|Overall Study|Death|3|||
30809438|NCT03334747|58827738|FG003|Treatment Phase|Subject/guardian decision|0|||
30809439|NCT03334747|58827739|FG004|Treatment Phase|Subject/guardian decision|0|||
30809440|NCT03334747|58827740|FG005|Treatment Phase|Subject/guardian decision|1|||
30809441|NCT03334747|58827741|FG006|Treatment Phase|Subject/guardian decision|0|||
30749471|NCT00428441|58759402|FG000|Overall Study|Lost to Follow-up|1|||
30809442|NCT03334747|58827742|FG007|Treatment Phase|Subject/guardian decision|0|||
30809443|NCT03334747|58827743|FG008|Treatment Phase|Subject/guardian decision|0|||
30809444|NCT03334747|58827735|FG000|Follow-Up Phase|Subject/guardian decision|0|||
30749472|NCT00144339|58759408|FG000|Overall Study|Adverse Event|746|||
30749473|NCT00144339|58759409|FG001|Overall Study|Adverse Event|627|||
30749474|NCT00144339|58759408|FG000|Overall Study|Protocol Violation|75|||
30809445|NCT03334747|58827736|FG001|Follow-Up Phase|Subject/guardian decision|0|||
30809446|NCT03334747|58827737|FG002|Follow-Up Phase|Subject/guardian decision|0|||
30809447|NCT03334747|58827738|FG003|Follow-Up Phase|Subject/guardian decision|0|||
30809448|NCT03334747|58827739|FG004|Follow-Up Phase|Subject/guardian decision|0|||
30809449|NCT03334747|58827740|FG005|Follow-Up Phase|Subject/guardian decision|0|||
30809450|NCT03334747|58827741|FG006|Follow-Up Phase|Subject/guardian decision|1|||
30809451|NCT03334747|58827742|FG007|Follow-Up Phase|Subject/guardian decision|0|||
30809452|NCT03334747|58827743|FG008|Follow-Up Phase|Subject/guardian decision|1|||
30809453|NCT03346759|58827765|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
30809454|NCT03346759|58827766|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
30809455|NCT03346759|58827765|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
30809456|NCT03346759|58827766|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
30809457|NCT03346759|58827765|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
30809458|NCT03346759|58827766|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
30809459|NCT03361423|58827775|FG000|Overall Study|Withdrawal by Subject|4|||
30809460|NCT03361423|58827776|FG001|Overall Study|Withdrawal by Subject|3|||
30809461|NCT03361423|58827775|FG000|Overall Study|Did not treat|19|||
30809462|NCT03361423|58827776|FG001|Overall Study|Did not treat|18|||
30809463|NCT03361423|58827775|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
30809464|NCT03361423|58827776|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
30809465|NCT03361423|58827775|FG000|Overall Study|Missing data|4|||
30809466|NCT03361423|58827776|FG001|Overall Study|Missing data|1|||
30809467|NCT02693002|58827784|FG000|Overall Study|Withdrawal by Subject|1|||
30809468|NCT02693002|58827785|FG001|Overall Study|Withdrawal by Subject|0|||
30809469|NCT03093870|58827794|FG000|Overall Study|Withdrawal by Subject|2|||
30809470|NCT03093870|58827795|FG001|Overall Study|Withdrawal by Subject|6|||
30909531|NCT01363011|58944391|FG001|Extension Phase|Withdrew Consent|1|||
30749475|NCT00144339|58759409|FG001|Overall Study|Protocol Violation|48|||
30749476|NCT00144339|58759408|FG000|Overall Study|Withdrawal by Subject|403|||
30749477|NCT00144339|58759409|FG001|Overall Study|Withdrawal by Subject|300|||
30809471|NCT03093870|58827796|FG002|Overall Study|Withdrawal by Subject|5|||
30809472|NCT03093870|58827794|FG000|Overall Study|Death|1|||
30809473|NCT03093870|58827795|FG001|Overall Study|Death|35|||
30809474|NCT03093870|58827796|FG002|Overall Study|Death|35|||
30809475|NCT03093870|58827794|FG000|Overall Study|Radiographic disease progression|10|||
30809476|NCT03093870|58827795|FG001|Overall Study|Radiographic disease progression|0|||
30809477|NCT03093870|58827796|FG002|Overall Study|Radiographic disease progression|0|||
30809478|NCT03093870|58827794|FG000|Overall Study|Clinical disease progression|1|||
30809479|NCT03093870|58827795|FG001|Overall Study|Clinical disease progression|0|||
30809480|NCT03093870|58827796|FG002|Overall Study|Clinical disease progression|0|||
30809481|NCT03093870|58827794|FG000|Overall Study|Physician Decision|2|||
30809482|NCT03093870|58827795|FG001|Overall Study|Physician Decision|0|||
30809483|NCT03093870|58827796|FG002|Overall Study|Physician Decision|0|||
30809484|NCT03093870|58827794|FG000|Overall Study|Adverse Event|7|||
30809485|NCT03093870|58827795|FG001|Overall Study|Adverse Event|0|||
30809486|NCT03093870|58827796|FG002|Overall Study|Adverse Event|0|||
30809487|NCT03093870|58827794|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
30809488|NCT03093870|58827795|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
30809489|NCT03093870|58827796|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
30809490|NCT03093870|58827794|FG000|Overall Study|Lost to Follow-up|0|||
30809491|NCT03093870|58827795|FG001|Overall Study|Lost to Follow-up|0|||
30749478|NCT00144339|58759408|FG000|Overall Study|Lost to Follow-up|76|||
30749479|NCT00144339|58759409|FG001|Overall Study|Lost to Follow-up|64|||
30749480|NCT00144339|58759408|FG000|Overall Study|Other|58|||
30749481|NCT00144339|58759409|FG001|Overall Study|Other|60|||
30749482|NCT00144027|58759417|FG000|Overall Study|Lost to Follow-up|1|||
30749483|NCT00144027|58759418|FG001|Overall Study|Lost to Follow-up|3|||
30749484|NCT00144027|58759417|FG000|Overall Study|Withdrawal by Subject|2|||
30749485|NCT00144027|58759418|FG001|Overall Study|Withdrawal by Subject|2|||
30749486|NCT00144027|58759417|FG000|Overall Study|did not complete baseline assessment|0|||
30749487|NCT00144027|58759418|FG001|Overall Study|did not complete baseline assessment|6|||
30749488|NCT00127803|58759428|FG000|Overall Study|Adverse Event|2|||
30749489|NCT00127803|58759429|FG001|Overall Study|Adverse Event|0|||
30749490|NCT00127803|58759430|FG002|Overall Study|Adverse Event|0|||
30749491|NCT00127803|58759431|FG003|Overall Study|Adverse Event|0|||
30749492|NCT00127803|58759428|FG000|Overall Study|Withdrawal by Subject|1|||
30809492|NCT03093870|58827796|FG002|Overall Study|Lost to Follow-up|1|||
30809493|NCT03346057|58827819|FG000|Overall Study|Death|1|||
30809494|NCT03346057|58827820|FG001|Overall Study|Death|2|||
30809495|NCT03346057|58827821|FG002|Overall Study|Death|0|||
30809496|NCT03346057|58827822|FG003|Overall Study|Death|0|||
30809497|NCT03346057|58827819|FG000|Overall Study|Lost to Follow-up|0|||
30909532|NCT01363011|58944390|FG000|Extension Phase|Lost to Follow-up|0|||
30749493|NCT00127803|58759429|FG001|Overall Study|Withdrawal by Subject|0|||
30749494|NCT00127803|58759430|FG002|Overall Study|Withdrawal by Subject|0|||
30749495|NCT00127803|58759431|FG003|Overall Study|Withdrawal by Subject|0|||
30749496|NCT00127803|58759428|FG000|Overall Study|Lost to Follow-up|0|||
30809498|NCT03346057|58827820|FG001|Overall Study|Lost to Follow-up|2|||
30809499|NCT03346057|58827821|FG002|Overall Study|Lost to Follow-up|1|||
30809500|NCT03346057|58827822|FG003|Overall Study|Lost to Follow-up|0|||
30809501|NCT03346057|58827819|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
30809502|NCT03346057|58827820|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
30809503|NCT03346057|58827821|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
30809504|NCT03346057|58827822|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
30809505|NCT03346057|58827819|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
30809506|NCT03346057|58827820|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
30809507|NCT03346057|58827821|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
30809508|NCT03346057|58827822|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
30809509|NCT03346057|58827819|FG000|Overall Study|Physician Decision|3|||
30809510|NCT03346057|58827820|FG001|Overall Study|Physician Decision|2|||
30809511|NCT03346057|58827821|FG002|Overall Study|Physician Decision|0|||
30809512|NCT03346057|58827822|FG003|Overall Study|Physician Decision|2|||
30809513|NCT03346057|58827819|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
30809514|NCT03346057|58827820|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
30809515|NCT03346057|58827821|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
30809516|NCT03346057|58827822|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
30909533|NCT01363011|58944391|FG001|Extension Phase|Lost to Follow-up|2|||
30909534|NCT01363011|58944390|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
30909535|NCT01363011|58944391|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
30749497|NCT00127803|58759429|FG001|Overall Study|Lost to Follow-up|0|||
30749498|NCT00127803|58759430|FG002|Overall Study|Lost to Follow-up|0|||
30749499|NCT00127803|58759431|FG003|Overall Study|Lost to Follow-up|1|||
30749500|NCT00127413|58759445|FG000|Overall Study|Lost to Follow-up|6|||
30749501|NCT00127413|58759446|FG001|Overall Study|Lost to Follow-up|4|||
30749502|NCT00127413|58759447|FG002|Overall Study|Lost to Follow-up|8|||
30749503|NCT00127413|58759448|FG003|Overall Study|Lost to Follow-up|2|||
30749504|NCT00143403|58759460|FG000|Overall Study|Adverse Event|3|||
30749505|NCT00143403|58759461|FG001|Overall Study|Adverse Event|8|||
30749506|NCT00143403|58759460|FG000|Overall Study|Death|1|||
30749507|NCT00143403|58759461|FG001|Overall Study|Death|0|||
30749508|NCT00143403|58759460|FG000|Overall Study|Withdrawal by Subject|3|||
30749509|NCT00143403|58759461|FG001|Overall Study|Withdrawal by Subject|12|||
30749510|NCT00143403|58759460|FG000|Overall Study|Relapse|15|||
30749511|NCT00143403|58759461|FG001|Overall Study|Relapse|7|||
30749512|NCT00143403|58759460|FG000|Overall Study|Protocol Violation|2|||
30749513|NCT00143403|58759461|FG001|Overall Study|Protocol Violation|2|||
30749514|NCT00143403|58759460|FG000|Overall Study|specified by site|4|||
30749515|NCT00143403|58759461|FG001|Overall Study|specified by site|9|||
30749516|NCT00143403|58759460|FG000|Overall Study|Randomized Not Treated|7|||
30749517|NCT00143403|58759461|FG001|Overall Study|Randomized Not Treated|8|||
30749518|NCT00220701|58759469|FG000|Overall Study|Lost to Follow-up|5|||
30749519|NCT00220701|58759470|FG001|Overall Study|Lost to Follow-up|4|||
30749520|NCT00127101|58759482|FG000|Base Protocol|Adverse Event|0|||
30749521|NCT00127101|58759483|FG001|Base Protocol|Adverse Event|2|||
30749522|NCT00127101|58759484|FG002|Base Protocol|Adverse Event|1|||
30749523|NCT00127101|58759485|FG003|Base Protocol|Adverse Event|0|||
30749524|NCT00127101|58759486|FG004|Base Protocol|Adverse Event|0|||
30749525|NCT00127101|58759487|FG005|Base Protocol|Adverse Event|0|||
30749526|NCT00127101|58759482|FG000|Base Protocol|Lack of Efficacy|1|||
30749527|NCT00127101|58759483|FG001|Base Protocol|Lack of Efficacy|0|||
30749528|NCT00127101|58759484|FG002|Base Protocol|Lack of Efficacy|0|||
30749529|NCT00127101|58759485|FG003|Base Protocol|Lack of Efficacy|0|||
30749530|NCT00127101|58759486|FG004|Base Protocol|Lack of Efficacy|2|||
30749531|NCT00127101|58759487|FG005|Base Protocol|Lack of Efficacy|0|||
30749532|NCT00127101|58759482|FG000|Base Protocol|Withdrawal by Subject|1|||
30749533|NCT00127101|58759483|FG001|Base Protocol|Withdrawal by Subject|2|||
30749534|NCT00127101|58759484|FG002|Base Protocol|Withdrawal by Subject|1|||
30749535|NCT00127101|58759485|FG003|Base Protocol|Withdrawal by Subject|0|||
30749536|NCT00127101|58759486|FG004|Base Protocol|Withdrawal by Subject|0|||
30749537|NCT00127101|58759487|FG005|Base Protocol|Withdrawal by Subject|1|||
30749538|NCT00127101|58759482|FG000|Continuation Phase|Adverse Event|0|||
30809517|NCT03346057|58827819|FG000|Overall Study|Withdrawal by Subject|1|||
30809518|NCT03346057|58827820|FG001|Overall Study|Withdrawal by Subject|0|||
30749539|NCT00127101|58759483|FG001|Continuation Phase|Adverse Event|0|||
30749540|NCT00127101|58759484|FG002|Continuation Phase|Adverse Event|0|||
30749541|NCT00127101|58759485|FG003|Continuation Phase|Adverse Event|0|||
30749542|NCT00127101|58759486|FG004|Continuation Phase|Adverse Event|1|||
30749543|NCT00127101|58759487|FG005|Continuation Phase|Adverse Event|1|||
30749544|NCT00127101|58759482|FG000|Continuation Phase|Lack of Efficacy|0|||
30749545|NCT00127101|58759483|FG001|Continuation Phase|Lack of Efficacy|0|||
30749546|NCT00127101|58759484|FG002|Continuation Phase|Lack of Efficacy|0|||
30749547|NCT00127101|58759485|FG003|Continuation Phase|Lack of Efficacy|0|||
30809519|NCT03346057|58827821|FG002|Overall Study|Withdrawal by Subject|0|||
30809520|NCT03346057|58827822|FG003|Overall Study|Withdrawal by Subject|0|||
30809521|NCT03345979|58827834|FG000|Overall Study|Withdrawal by Subject|20|||
30809522|NCT03345979|58827835|FG001|Overall Study|Withdrawal by Subject|31|||
30809523|NCT03345979|58827834|FG000|Overall Study|Adverse Event|10|||
30809524|NCT03345979|58827835|FG001|Overall Study|Adverse Event|11|||
30809525|NCT03345979|58827834|FG000|Overall Study|Lost to Follow-up|8|||
30809526|NCT03345979|58827835|FG001|Overall Study|Lost to Follow-up|9|||
30809527|NCT03345979|58827834|FG000|Overall Study|Lack of Efficacy|4|||
30809528|NCT03345979|58827835|FG001|Overall Study|Lack of Efficacy|2|||
30809529|NCT03345979|58827834|FG000|Overall Study|Protocol Violation|1|||
30809530|NCT03345979|58827835|FG001|Overall Study|Protocol Violation|3|||
30809531|NCT03345979|58827834|FG000|Overall Study|Physician Decision|0|||
30809532|NCT03345979|58827835|FG001|Overall Study|Physician Decision|2|||
30809533|NCT02696434|58827843|FG000|Overall Study|Adverse Event|3|||
30809534|NCT02696434|58827844|FG001|Overall Study|Adverse Event|1|||
30809535|NCT02696434|58827843|FG000|Overall Study|Lost to Follow-up|5|||
30809536|NCT02696434|58827844|FG001|Overall Study|Lost to Follow-up|4|||
30809537|NCT02696434|58827843|FG000|Overall Study|Withdrawal by Subject|14|||
30809538|NCT02696434|58827844|FG001|Overall Study|Withdrawal by Subject|12|||
30809539|NCT02696434|58827843|FG000|Overall Study|Physician Decision|0|||
30622509|NCT01131078|58634212|FG001|Overall Study|Other|1|||
30809540|NCT02696434|58827844|FG001|Overall Study|Physician Decision|1|||
30809541|NCT03345901|58827850|FG000|Overall Study|The study was terminated|18|||
30809542|NCT02950831|58827855|FG000|Overall Study|Lost to Follow-up|1|||
30809543|NCT02950831|58827855|FG000|Overall Study|Withdrawal by Subject|3|||
30809544|NCT02950831|58827855|FG000|Overall Study|stimulation trail failure|5|||
30809545|NCT03593915|58827865|FG000|Overall Study|Adverse Event|0|||
30809546|NCT03593915|58827866|FG001|Overall Study|Adverse Event|0|||
30809547|NCT03593915|58827867|FG002|Overall Study|Adverse Event|0|||
30809548|NCT03593915|58827868|FG003|Overall Study|Adverse Event|1|||
30809549|NCT03593915|58827869|FG004|Overall Study|Adverse Event|0|||
30809550|NCT03593915|58827870|FG005|Overall Study|Adverse Event|0|||
30749548|NCT00127101|58759486|FG004|Continuation Phase|Lack of Efficacy|0|||
30749549|NCT00127101|58759487|FG005|Continuation Phase|Lack of Efficacy|1|||
30749550|NCT00127101|58759482|FG000|Continuation Phase|Withdrawal by Subject|0|||
30749551|NCT00127101|58759483|FG001|Continuation Phase|Withdrawal by Subject|0|||
30809551|NCT03593915|58827865|FG000|Overall Study|Physician Decision|0|||
30809552|NCT03593915|58827866|FG001|Overall Study|Physician Decision|0|||
30809553|NCT03593915|58827867|FG002|Overall Study|Physician Decision|0|||
30809554|NCT03593915|58827868|FG003|Overall Study|Physician Decision|0|||
30809555|NCT03593915|58827869|FG004|Overall Study|Physician Decision|0|||
30809556|NCT03593915|58827870|FG005|Overall Study|Physician Decision|1|||
30809557|NCT03593681|58827884|FG000|Overall Study|Inadequate sample collected|12|||
30809558|NCT03593681|58827884|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
30809559|NCT03593681|58827884|FG000|Overall Study|Protocol Violation|3|||
30809560|NCT03593681|58827884|FG000|Overall Study|Withdrawal by Subject|3|||
30809561|NCT03593681|58827884|FG000|Overall Study|Procedure not attempted|3|||
30809562|NCT03593681|58827884|FG000|Overall Study|Adverse Event|2|||
30809563|NCT03593681|58827884|FG000|Overall Study|Physician Decision|1|||
30809564|NCT03592745|58827907|FG000|Overall Study|Adverse Event|0|||
30809565|NCT03592745|58827908|FG001|Overall Study|Adverse Event|2|||
30809566|NCT03592745|58827907|FG000|Overall Study|Lost to Follow-up|2|||
30809567|NCT03592745|58827908|FG001|Overall Study|Lost to Follow-up|0|||
30809568|NCT03592745|58827907|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
30809569|NCT03592745|58827908|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
30809570|NCT03592277|58827916|FG000|Overall Study|Withdrawal by Subject|6|||
30809571|NCT03592277|58827917|FG001|Overall Study|Withdrawal by Subject|8|||
30809572|NCT03401112|58827928|FG000|Overall Study|Adverse Event|1|||
30809573|NCT03401112|58827929|FG001|Overall Study|Adverse Event|2|||
30809574|NCT03401112|58827930|FG002|Overall Study|Adverse Event|3|||
30809575|NCT03401112|58827931|FG003|Overall Study|Adverse Event|2|||
30809576|NCT03401112|58827932|FG004|Overall Study|Adverse Event|0|||
30809577|NCT03401112|58827928|FG000|Overall Study|Lost to Follow-up|1|||
30749552|NCT00127101|58759484|FG002|Continuation Phase|Withdrawal by Subject|1|||
30749553|NCT00127101|58759485|FG003|Continuation Phase|Withdrawal by Subject|0|||
30749554|NCT00127101|58759486|FG004|Continuation Phase|Withdrawal by Subject|2|||
30749555|NCT00127101|58759487|FG005|Continuation Phase|Withdrawal by Subject|1|||
30749556|NCT00126555|58759501|FG000|Overall Study|Withdrawal by Subject|1|||
30809578|NCT03401112|58827929|FG001|Overall Study|Lost to Follow-up|0|||
30809579|NCT03401112|58827930|FG002|Overall Study|Lost to Follow-up|0|||
30809580|NCT03401112|58827931|FG003|Overall Study|Lost to Follow-up|0|||
30809581|NCT03401112|58827932|FG004|Overall Study|Lost to Follow-up|0|||
30809582|NCT03401112|58827928|FG000|Overall Study|Noncompliance|1|||
30809583|NCT03401112|58827929|FG001|Overall Study|Noncompliance|2|||
30809584|NCT03401112|58827930|FG002|Overall Study|Noncompliance|3|||
30809585|NCT03401112|58827931|FG003|Overall Study|Noncompliance|0|||
30809586|NCT03401112|58827932|FG004|Overall Study|Noncompliance|0|||
30809587|NCT03401112|58827928|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
30809588|NCT03401112|58827929|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
30809589|NCT03401112|58827930|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
30809590|NCT03401112|58827931|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
30809591|NCT03401112|58827932|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
30809592|NCT03401112|58827928|FG000|Overall Study|Withdrawal by Subject|0|||
30809593|NCT03401112|58827929|FG001|Overall Study|Withdrawal by Subject|3|||
30809594|NCT03401112|58827930|FG002|Overall Study|Withdrawal by Subject|2|||
30809595|NCT03401112|58827931|FG003|Overall Study|Withdrawal by Subject|1|||
30809596|NCT03401112|58827932|FG004|Overall Study|Withdrawal by Subject|0|||
30809597|NCT03401112|58827928|FG000|Overall Study|Physician Decision|0|||
30809598|NCT03401112|58827929|FG001|Overall Study|Physician Decision|0|||
30809599|NCT03401112|58827930|FG002|Overall Study|Physician Decision|0|||
30809600|NCT03401112|58827931|FG003|Overall Study|Physician Decision|2|||
30809601|NCT03401112|58827932|FG004|Overall Study|Physician Decision|0|||
30809602|NCT03401112|58827928|FG000|Overall Study|Study was Terminated by Sponsor|0|||
30809603|NCT03401112|58827929|FG001|Overall Study|Study was Terminated by Sponsor|0|||
30809604|NCT03401112|58827930|FG002|Overall Study|Study was Terminated by Sponsor|0|||
30809605|NCT03401112|58827931|FG003|Overall Study|Study was Terminated by Sponsor|1|||
30809606|NCT03401112|58827932|FG004|Overall Study|Study was Terminated by Sponsor|0|||
30809607|NCT03401112|58827928|FG000|Overall Study|Day 1 Assessment not Done|1|||
30809608|NCT03401112|58827929|FG001|Overall Study|Day 1 Assessment not Done|0|||
30809609|NCT03401112|58827930|FG002|Overall Study|Day 1 Assessment not Done|0|||
30809610|NCT03401112|58827931|FG003|Overall Study|Day 1 Assessment not Done|0|||
30809611|NCT03401112|58827932|FG004|Overall Study|Day 1 Assessment not Done|0|||
30809612|NCT03401112|58827928|FG000|Overall Study|Not Dosed|0|||
30809613|NCT03401112|58827929|FG001|Overall Study|Not Dosed|0|||
30809614|NCT03401112|58827930|FG002|Overall Study|Not Dosed|1|||
30809615|NCT03401112|58827931|FG003|Overall Study|Not Dosed|0|||
30809616|NCT03401112|58827932|FG004|Overall Study|Not Dosed|0|||
30809617|NCT03401112|58827928|FG000|Overall Study|Missed Clinical Visit|0|||
30809618|NCT03401112|58827929|FG001|Overall Study|Missed Clinical Visit|0|||
30809619|NCT03401112|58827930|FG002|Overall Study|Missed Clinical Visit|1|||
30809620|NCT03401112|58827931|FG003|Overall Study|Missed Clinical Visit|0|||
30809621|NCT03401112|58827932|FG004|Overall Study|Missed Clinical Visit|0|||
30809622|NCT03401112|58827928|FG000|Overall Study|Missed Doses|0|||
30809623|NCT03401112|58827929|FG001|Overall Study|Missed Doses|0|||
30809624|NCT03401112|58827930|FG002|Overall Study|Missed Doses|1|||
30809625|NCT03401112|58827931|FG003|Overall Study|Missed Doses|0|||
30809626|NCT03401112|58827932|FG004|Overall Study|Missed Doses|0|||
30809627|NCT02697916|58827961|FG000|Overall Study|Death|357|||
30809628|NCT02697916|58827962|FG001|Overall Study|Death|315|||
30809629|NCT02697916|58827961|FG000|Overall Study|Withdrawal by Subject|221|||
30809630|NCT02697916|58827962|FG001|Overall Study|Withdrawal by Subject|393|||
30809631|NCT03650387|58827968|FG000|Overall Study|Withdrawal by Subject|13|||
30809632|NCT03650387|58827968|FG000|Overall Study|Lost to Follow-up|12|||
30809633|NCT03650387|58827968|FG000|Overall Study|Adverse Event (Not related)|1|||
30809634|NCT03650387|58827968|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
30809635|NCT03359473|58827994|FG000|Overall Study|Adverse Event|0|||
30809636|NCT03359473|58827995|FG001|Overall Study|Adverse Event|2|||
30809637|NCT03359473|58827996|FG002|Overall Study|Adverse Event|5|||
30809638|NCT03359473|58827997|FG003|Overall Study|Adverse Event|3|||
30809639|NCT03359473|58827994|FG000|Overall Study|Lost to Follow-up|0|||
30809640|NCT03359473|58827995|FG001|Overall Study|Lost to Follow-up|1|||
30809641|NCT03359473|58827996|FG002|Overall Study|Lost to Follow-up|0|||
30809642|NCT03359473|58827997|FG003|Overall Study|Lost to Follow-up|0|||
30809643|NCT03359473|58827994|FG000|Overall Study|Physician Decision|0|||
30809644|NCT03359473|58827995|FG001|Overall Study|Physician Decision|1|||
30809645|NCT03359473|58827996|FG002|Overall Study|Physician Decision|0|||
30809646|NCT03359473|58827997|FG003|Overall Study|Physician Decision|1|||
30809647|NCT03359473|58827994|FG000|Overall Study|Withdrawal by Subject|1|||
30809648|NCT03359473|58827995|FG001|Overall Study|Withdrawal by Subject|2|||
30809649|NCT03359473|58827996|FG002|Overall Study|Withdrawal by Subject|1|||
30809650|NCT03359473|58827997|FG003|Overall Study|Withdrawal by Subject|0|||
30809651|NCT03359473|58827994|FG000|Overall Study|Protocol-defined stopping criteria|1|||
30809652|NCT03359473|58827995|FG001|Overall Study|Protocol-defined stopping criteria|0|||
30809653|NCT03359473|58827996|FG002|Overall Study|Protocol-defined stopping criteria|0|||
30809654|NCT03359473|58827997|FG003|Overall Study|Protocol-defined stopping criteria|1|||
30809655|NCT03589469|58828010|FG000|Overall Study|Withdrawal by Subject|8|||
30809656|NCT03589469|58828010|FG000|Overall Study|Physician Decision|20|||
30809657|NCT03589469|58828010|FG000|Overall Study|Death|97|||
30809658|NCT03589469|58828010|FG000|Overall Study|Lost to Follow-up|8|||
30809659|NCT03589469|58828010|FG000|Overall Study|Miscellaneous|1|||
30809660|NCT03359395|58828016|FG000|First Intervention A / B|Withdrawal by Subject|1|||
30809661|NCT03359395|58828017|FG001|First Intervention A / B|Withdrawal by Subject|0|||
30809662|NCT03359395|58828016|FG000|First Intervention A / B|Lost to Follow-up|2|||
30809663|NCT03359395|58828017|FG001|First Intervention A / B|Lost to Follow-up|3|||
30809664|NCT03359395|58828016|FG000|Second Intervention B/A|Exclusion criteria|0|||
30809665|NCT03359395|58828017|FG001|Second Intervention B/A|Exclusion criteria|1|||
30809666|NCT03359395|58828016|FG000|Second Intervention B/A|Lost to Follow-up|3|||
30809667|NCT03359395|58828017|FG001|Second Intervention B/A|Lost to Follow-up|2|||
30809668|NCT03586427|58828028|FG000|Overall Study|Lost to Follow-up|0|||
30809669|NCT03586427|58828029|FG001|Overall Study|Lost to Follow-up|3|||
30809670|NCT03586427|58828030|FG002|Overall Study|Lost to Follow-up|1|||
30809671|NCT03586427|58828031|FG003|Overall Study|Lost to Follow-up|3|||
30809672|NCT03586427|58828032|FG004|Overall Study|Lost to Follow-up|3|||
30809673|NCT03586427|58828028|FG000|Overall Study|Withdrawal by Subject|0|||
30809674|NCT03586427|58828029|FG001|Overall Study|Withdrawal by Subject|1|||
30809675|NCT03586427|58828030|FG002|Overall Study|Withdrawal by Subject|2|||
30809676|NCT03586427|58828031|FG003|Overall Study|Withdrawal by Subject|1|||
30809677|NCT03586427|58828032|FG004|Overall Study|Withdrawal by Subject|1|||
30909536|NCT02263547|58944397|FG000|Overall Study|Adverse Event|1|||
30909537|NCT02263547|58944397|FG000|Overall Study|Lost to Follow-up|2|||
30909538|NCT01925703|58944401|FG000|Overall Study|Physician Decision|1|||
30909539|NCT01925703|58944401|FG000|Overall Study|Lost to Follow-up|2|||
30909540|NCT01925703|58944401|FG000|Overall Study|Discharge prior to full iron repletion|1|||
30909541|NCT02195011|58944407|FG000|Overall Study|Adverse Event|4|||
30909542|NCT02195011|58944408|FG001|Overall Study|Adverse Event|0|||
30909543|NCT02195011|58944407|FG000|Overall Study|Progressive Disease|18|||
30909544|NCT02195011|58944408|FG001|Overall Study|Progressive Disease|1|||
30909545|NCT02195011|58944407|FG000|Overall Study|Withdrawal by Subject|3|||
30909546|NCT02195011|58944408|FG001|Overall Study|Withdrawal by Subject|0|||
30909547|NCT01617681|58944418|FG000|Period 1 Double Blind|Adverse Event|2|||
30809678|NCT03586427|58828028|FG000|Overall Study|Adverse Event|0|||
30809679|NCT03586427|58828029|FG001|Overall Study|Adverse Event|0|||
30809680|NCT03586427|58828030|FG002|Overall Study|Adverse Event|1|||
30809681|NCT03586427|58828031|FG003|Overall Study|Adverse Event|0|||
30809682|NCT03586427|58828032|FG004|Overall Study|Adverse Event|0|||
30809683|NCT03586427|58828028|FG000|Overall Study|Protocol Violation|0|||
30809684|NCT03586427|58828029|FG001|Overall Study|Protocol Violation|0|||
30809685|NCT03586427|58828030|FG002|Overall Study|Protocol Violation|1|||
30909548|NCT01617681|58944419|FG001|Period 1 Double Blind|Adverse Event|0|||
30909549|NCT01617681|58944420|FG002|Period 1 Double Blind|Adverse Event|0|||
30909550|NCT01617681|58944421|FG003|Period 1 Double Blind|Adverse Event|2|||
30809686|NCT03586427|58828031|FG003|Overall Study|Protocol Violation|0|||
30809687|NCT03586427|58828032|FG004|Overall Study|Protocol Violation|1|||
30809688|NCT03586427|58828028|FG000|Overall Study|Noncompliance with study drug|0|||
30909551|NCT01617681|58944422|FG004|Period 1 Double Blind|Adverse Event|0|||
30909552|NCT01617681|58944418|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
30909553|NCT01617681|58944419|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
30909554|NCT01617681|58944420|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
30909555|NCT01617681|58944421|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
30909556|NCT01617681|58944422|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
30909557|NCT01617681|58944418|FG000|Period 2 Open Label|Adverse Event|0|||
30909558|NCT01617681|58944419|FG001|Period 2 Open Label|Adverse Event|0|||
30909559|NCT01617681|58944420|FG002|Period 2 Open Label|Adverse Event|0|||
30909560|NCT01617681|58944421|FG003|Period 2 Open Label|Adverse Event|0|||
30909561|NCT01617681|58944422|FG004|Period 2 Open Label|Adverse Event|3|||
30909562|NCT01617681|58944418|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
30909563|NCT01617681|58944419|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
30749557|NCT00126555|58759501|FG000|Overall Study|Adverse Event|2|||
30749558|NCT00126555|58759501|FG000|Overall Study|Progressive Disease|3|||
30749559|NCT00004228|58759524|FG000|Overall Study|Adverse Event|0|||
30749560|NCT00004228|58759525|FG001|Overall Study|Adverse Event|1|||
30749561|NCT00004228|58759526|FG002|Overall Study|Adverse Event|0|||
30809689|NCT03586427|58828029|FG001|Overall Study|Noncompliance with study drug|0|||
30809690|NCT03586427|58828030|FG002|Overall Study|Noncompliance with study drug|1|||
30809691|NCT03586427|58828031|FG003|Overall Study|Noncompliance with study drug|0|||
30809692|NCT03586427|58828032|FG004|Overall Study|Noncompliance with study drug|0|||
30809693|NCT03648983|58828049|FG000|Overall Study|Study was terminated due to PI departure|95|||
30809694|NCT02695420|58828058|FG000|Overall Study|Death|0|||
30809695|NCT02695420|58828059|FG001|Overall Study|Death|1|||
30809696|NCT02695420|58828060|FG002|Overall Study|Death|0|||
30809697|NCT02695420|58828061|FG003|Overall Study|Death|0|||
30809698|NCT03358147|58828079|FG000|Overall Study|Withdrawal by Subject|13|||
30749562|NCT00004228|58759527|FG003|Overall Study|Adverse Event|0|||
30749563|NCT00004228|58759528|FG004|Overall Study|Adverse Event|1|||
30749564|NCT00004228|58759529|FG005|Overall Study|Adverse Event|0|||
30809699|NCT03358147|58828080|FG001|Overall Study|Withdrawal by Subject|19|||
30809700|NCT03358147|58828081|FG002|Overall Study|Withdrawal by Subject|16|||
30809701|NCT03358147|58828082|FG003|Overall Study|Withdrawal by Subject|10|||
30809702|NCT03358147|58828083|FG004|Overall Study|Withdrawal by Subject|5|||
30809703|NCT03358147|58828079|FG000|Overall Study|Adverse Event|3|||
30809704|NCT03358147|58828080|FG001|Overall Study|Adverse Event|9|||
30809705|NCT03358147|58828081|FG002|Overall Study|Adverse Event|7|||
30809706|NCT03358147|58828082|FG003|Overall Study|Adverse Event|5|||
30809707|NCT03358147|58828083|FG004|Overall Study|Adverse Event|2|||
30809708|NCT03358147|58828079|FG000|Overall Study|Lost to Follow-up|4|||
30809709|NCT03358147|58828080|FG001|Overall Study|Lost to Follow-up|3|||
30809710|NCT03358147|58828081|FG002|Overall Study|Lost to Follow-up|7|||
30809711|NCT03358147|58828082|FG003|Overall Study|Lost to Follow-up|6|||
30809712|NCT03358147|58828083|FG004|Overall Study|Lost to Follow-up|4|||
30809713|NCT03358147|58828079|FG000|Overall Study|Major Protocol Deviation|11|||
30809714|NCT03358147|58828080|FG001|Overall Study|Major Protocol Deviation|3|||
30809715|NCT03358147|58828081|FG002|Overall Study|Major Protocol Deviation|2|||
30809716|NCT03358147|58828082|FG003|Overall Study|Major Protocol Deviation|3|||
30809717|NCT03358147|58828083|FG004|Overall Study|Major Protocol Deviation|1|||
30749565|NCT00004228|58759530|FG006|Overall Study|Adverse Event|0|||
30749566|NCT00004228|58759524|FG000|Overall Study|Death|0|||
30749567|NCT00004228|58759525|FG001|Overall Study|Death|1|||
30749568|NCT00004228|58759526|FG002|Overall Study|Death|2|||
30749569|NCT00004228|58759527|FG003|Overall Study|Death|0|||
30749570|NCT00004228|58759528|FG004|Overall Study|Death|1|||
30749571|NCT00004228|58759529|FG005|Overall Study|Death|0|||
30749572|NCT00004228|58759530|FG006|Overall Study|Death|0|||
30749573|NCT00004228|58759524|FG000|Overall Study|Lack of Efficacy|1|||
30749574|NCT00004228|58759525|FG001|Overall Study|Lack of Efficacy|6|||
30749575|NCT00004228|58759526|FG002|Overall Study|Lack of Efficacy|5|||
30909564|NCT01617681|58944420|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
30909565|NCT01617681|58944421|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
30909566|NCT01617681|58944422|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
30909567|NCT02263079|58944434|FG000|Overall Study|Physician Decision|1|||
30909568|NCT02263079|58944435|FG001|Overall Study|Physician Decision|0|||
30909569|NCT02263079|58944436|FG002|Overall Study|Physician Decision|0|||
30909570|NCT02263079|58944434|FG000|Overall Study|Withdrawal by Subject|2|||
30909571|NCT02263079|58944435|FG001|Overall Study|Withdrawal by Subject|8|||
30749576|NCT00004228|58759527|FG003|Overall Study|Lack of Efficacy|3|||
30749577|NCT00004228|58759528|FG004|Overall Study|Lack of Efficacy|9|||
30749578|NCT00004228|58759529|FG005|Overall Study|Lack of Efficacy|8|||
30749579|NCT00004228|58759530|FG006|Overall Study|Lack of Efficacy|4|||
30749580|NCT00004228|58759524|FG000|Overall Study|Lost to Follow-up|0|||
30749581|NCT00004228|58759525|FG001|Overall Study|Lost to Follow-up|0|||
30749582|NCT00004228|58759526|FG002|Overall Study|Lost to Follow-up|1|||
30749583|NCT00004228|58759527|FG003|Overall Study|Lost to Follow-up|0|||
30809718|NCT03358147|58828079|FG000|Overall Study|Protocol specified criteria|2|||
30809719|NCT03358147|58828080|FG001|Overall Study|Protocol specified criteria|3|||
30809720|NCT03358147|58828081|FG002|Overall Study|Protocol specified criteria|0|||
30809721|NCT03358147|58828082|FG003|Overall Study|Protocol specified criteria|3|||
30809722|NCT03358147|58828083|FG004|Overall Study|Protocol specified criteria|1|||
30809723|NCT03358147|58828079|FG000|Overall Study|Physician Decision|1|||
30809724|NCT03358147|58828080|FG001|Overall Study|Physician Decision|0|||
30809725|NCT03358147|58828081|FG002|Overall Study|Physician Decision|1|||
30809726|NCT03358147|58828082|FG003|Overall Study|Physician Decision|6|||
30809727|NCT03358147|58828083|FG004|Overall Study|Physician Decision|1|||
30809728|NCT03358147|58828079|FG000|Overall Study|Administrative reasons|0|||
30809729|NCT03358147|58828080|FG001|Overall Study|Administrative reasons|1|||
30809730|NCT03358147|58828081|FG002|Overall Study|Administrative reasons|0|||
30809731|NCT03358147|58828082|FG003|Overall Study|Administrative reasons|3|||
30749584|NCT00004228|58759528|FG004|Overall Study|Lost to Follow-up|0|||
30749585|NCT00004228|58759529|FG005|Overall Study|Lost to Follow-up|0|||
30749586|NCT00004228|58759530|FG006|Overall Study|Lost to Follow-up|0|||
30749587|NCT00004228|58759524|FG000|Overall Study|Physician Decision|1|||
30749588|NCT00004228|58759525|FG001|Overall Study|Physician Decision|0|||
30749589|NCT00004228|58759526|FG002|Overall Study|Physician Decision|3|||
30749590|NCT00004228|58759527|FG003|Overall Study|Physician Decision|2|||
30749591|NCT00004228|58759528|FG004|Overall Study|Physician Decision|1|||
30749592|NCT00004228|58759529|FG005|Overall Study|Physician Decision|1|||
30749593|NCT00004228|58759530|FG006|Overall Study|Physician Decision|1|||
30749594|NCT00004228|58759524|FG000|Overall Study|Protocol Violation|0|||
30749595|NCT00004228|58759525|FG001|Overall Study|Protocol Violation|5|||
30749596|NCT00004228|58759526|FG002|Overall Study|Protocol Violation|2|||
30749597|NCT00004228|58759527|FG003|Overall Study|Protocol Violation|1|||
30749598|NCT00004228|58759528|FG004|Overall Study|Protocol Violation|1|||
30749599|NCT00004228|58759529|FG005|Overall Study|Protocol Violation|2|||
30749600|NCT00004228|58759530|FG006|Overall Study|Protocol Violation|0|||
30749601|NCT00004228|58759524|FG000|Overall Study|Withdrawal by Subject|3|||
30749602|NCT00004228|58759525|FG001|Overall Study|Withdrawal by Subject|0|||
30749603|NCT00004228|58759526|FG002|Overall Study|Withdrawal by Subject|1|||
30749604|NCT00004228|58759527|FG003|Overall Study|Withdrawal by Subject|0|||
30749605|NCT00004228|58759528|FG004|Overall Study|Withdrawal by Subject|2|||
30749606|NCT00004228|58759529|FG005|Overall Study|Withdrawal by Subject|1|||
30809732|NCT03358147|58828083|FG004|Overall Study|Administrative reasons|0|||
30749607|NCT00004228|58759530|FG006|Overall Study|Withdrawal by Subject|2|||
30749608|NCT00004228|58759524|FG000|Overall Study|Other|0|||
30749609|NCT00004228|58759525|FG001|Overall Study|Other|0|||
30749610|NCT00004228|58759526|FG002|Overall Study|Other|1|||
30749611|NCT00004228|58759527|FG003|Overall Study|Other|0|||
30749612|NCT00004228|58759528|FG004|Overall Study|Other|0|||
30749613|NCT00004228|58759529|FG005|Overall Study|Other|0|||
30809733|NCT03358147|58828079|FG000|Overall Study|Lack of Efficacy|0|||
30809734|NCT03358147|58828080|FG001|Overall Study|Lack of Efficacy|1|||
30749614|NCT00004228|58759530|FG006|Overall Study|Other|0|||
30749615|NCT00004228|58759524|FG000|Overall Study|ineligible|4|||
30749616|NCT00004228|58759525|FG001|Overall Study|ineligible|2|||
30749617|NCT00004228|58759526|FG002|Overall Study|ineligible|4|||
30749618|NCT00004228|58759527|FG003|Overall Study|ineligible|1|||
30749619|NCT00004228|58759528|FG004|Overall Study|ineligible|1|||
30749620|NCT00004228|58759529|FG005|Overall Study|ineligible|2|||
30749621|NCT00004228|58759530|FG006|Overall Study|ineligible|5|||
30749622|NCT00003526|58759547|FG000|Overall Study|Not evaluable|6|||
30749623|NCT00195260|58759553|FG000|Part 1: Dose Escalation|Adverse Event|0|||
30749624|NCT00195260|58759554|FG001|Part 1: Dose Escalation|Adverse Event|1|||
30749625|NCT00195260|58759555|FG002|Part 1: Dose Escalation|Adverse Event|0|||
30749626|NCT00195260|58759556|FG003|Part 1: Dose Escalation|Adverse Event|1|||
30749627|NCT00195260|58759557|FG004|Part 1: Dose Escalation|Adverse Event|1|||
30749628|NCT00195260|58759558|FG005|Part 1: Dose Escalation|Adverse Event|0|||
30749629|NCT00195260|58759559|FG006|Part 1: Dose Escalation|Adverse Event|3|||
30749630|NCT00195260|58759560|FG007|Part 1: Dose Escalation|Adverse Event|0|||
30749631|NCT00195260|58759561|FG008|Part 1: Dose Escalation|Adverse Event|0|||
30749632|NCT00195260|58759562|FG009|Part 1: Dose Escalation|Adverse Event|0|||
30809735|NCT03358147|58828081|FG002|Overall Study|Lack of Efficacy|1|||
30809736|NCT03358147|58828082|FG003|Overall Study|Lack of Efficacy|0|||
30809737|NCT03358147|58828083|FG004|Overall Study|Lack of Efficacy|0|||
30809738|NCT03093402|58828099|FG000|Overall Study|Lost to Follow-up|1|||
30809739|NCT03093402|58828100|FG001|Overall Study|Lost to Follow-up|0|||
30809740|NCT03093402|58828101|FG002|Overall Study|Lost to Follow-up|0|||
30809741|NCT03093402|58828102|FG003|Overall Study|Lost to Follow-up|0|||
30809742|NCT03093402|58828099|FG000|Overall Study|Withdrawal by Subject|3|||
30809743|NCT03093402|58828100|FG001|Overall Study|Withdrawal by Subject|3|||
30809744|NCT03093402|58828101|FG002|Overall Study|Withdrawal by Subject|0|||
30809745|NCT03093402|58828102|FG003|Overall Study|Withdrawal by Subject|1|||
30809746|NCT03093402|58828099|FG000|Overall Study|Withdrew prior to dosing|2|||
30809747|NCT03093402|58828100|FG001|Overall Study|Withdrew prior to dosing|1|||
30809748|NCT03093402|58828101|FG002|Overall Study|Withdrew prior to dosing|2|||
30809749|NCT03093402|58828102|FG003|Overall Study|Withdrew prior to dosing|3|||
30809750|NCT03093402|58828099|FG000|Overall Study|Ineligible for study|1|||
30809751|NCT03093402|58828100|FG001|Overall Study|Ineligible for study|0|||
30809752|NCT03093402|58828101|FG002|Overall Study|Ineligible for study|0|||
30809753|NCT03093402|58828102|FG003|Overall Study|Ineligible for study|0|||
30809754|NCT03093402|58828099|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
30809755|NCT03093402|58828100|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
30809756|NCT03093402|58828101|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
30809757|NCT03093402|58828102|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
30809758|NCT03585959|58828112|FG000|Overall Study|Physician Decision|1|||
30809759|NCT03585959|58828112|FG000|Overall Study|Unsuccessful Procedure|2|||
30809760|NCT03584789|58828121|FG000|Overall Study|refused EHR permission|19|||
30809761|NCT03584789|58828122|FG001|Overall Study|refused EHR permission|28|||
30809762|NCT03584789|58828123|FG002|Overall Study|refused EHR permission|23|||
30809763|NCT03584789|58828121|FG000|Overall Study|patients tied to a provider who retired|0|||
30809764|NCT03584789|58828122|FG001|Overall Study|patients tied to a provider who retired|0|||
30809765|NCT03584789|58828123|FG002|Overall Study|patients tied to a provider who retired|3|||
30809766|NCT03343639|58828133|FG000|Overall Study|Withdrawal by Subject|10|||
30809767|NCT03343639|58828134|FG001|Overall Study|Withdrawal by Subject|6|||
30809768|NCT03343639|58828133|FG000|Overall Study|Lost to Follow-up|4|||
30809769|NCT03343639|58828134|FG001|Overall Study|Lost to Follow-up|5|||
30809770|NCT03343639|58828133|FG000|Overall Study|Protocol Violation|0|||
30809771|NCT03343639|58828134|FG001|Overall Study|Protocol Violation|1|||
30809772|NCT03647267|58828142|FG000|Overall Study|Lost to Follow-up|1|||
30809773|NCT03647267|58828143|FG001|Overall Study|Lost to Follow-up|0|||
30809774|NCT03356977|58828151|FG000|Overall Study|Lost to Follow-up|3|||
30809775|NCT03356977|58828151|FG000|Overall Study|Withdrawal by parent/guardian|2|||
30809776|NCT02690974|58828155|FG000|Overall Study|Adverse Event|16|||
30809777|NCT02690974|58828155|FG000|Overall Study|Death|9|||
30809778|NCT02690974|58828155|FG000|Overall Study|Subject/guardian decision|4|||
30909572|NCT02263079|58944436|FG002|Overall Study|Withdrawal by Subject|0|||
30909573|NCT02295995|58944446|FG000|Overall Study|Lost to Follow-up|5|||
30909574|NCT02295995|58944447|FG001|Overall Study|Lost to Follow-up|1|||
30909575|NCT02294981|58944454|FG000|Overall Study|Lost to Follow-up|1|||
30909576|NCT02262377|58944460|FG000|Overall Study|Lost to Follow-up|5|||
30909577|NCT02262377|58944461|FG001|Overall Study|Lost to Follow-up|6|||
30909578|NCT02262377|58944460|FG000|Overall Study|Found ineligible after enrollment|3|||
30909579|NCT02262377|58944461|FG001|Overall Study|Found ineligible after enrollment|0|||
30909580|NCT02262377|58944460|FG000|Overall Study|Withdrawal by Subject|4|||
30909581|NCT02262377|58944461|FG001|Overall Study|Withdrawal by Subject|0|||
30909582|NCT02260817|58944470|FG000|Overall Study|Lost to Follow-up|0|||
30909583|NCT02260817|58944471|FG001|Overall Study|Lost to Follow-up|14|||
30909584|NCT02260817|58944470|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
30909585|NCT02260817|58944471|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
30909586|NCT02260817|58944470|FG000|Overall Study|Observation, no biopsy|0|||
30909587|NCT02260817|58944471|FG001|Overall Study|Observation, no biopsy|1|||
30909588|NCT02260817|58944470|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
30909589|NCT02260817|58944471|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
30909590|NCT02260817|58944470|FG000|Overall Study|Protocol Violation|0|||
30809779|NCT02690974|58828155|FG000|Overall Study|Lost to Follow-up|3|||
30809780|NCT02690974|58828155|FG000|Overall Study|Withdrawal of Informed Consent|3|||
30809781|NCT02690974|58828155|FG000|Overall Study|Physician Decision|2|||
30809782|NCT02690974|58828155|FG000|Overall Study|Non-compliance with study treatment|1|||
30809783|NCT02690974|58828155|FG000|Overall Study|Protocol-defined stopping criteria|1|||
30809784|NCT02690974|58828155|FG000|Overall Study|Protocol Deviation|1|||
30809785|NCT03093324|58828161|FG000|Overall Study|Adverse Event|4|||
30809786|NCT03093324|58828162|FG001|Overall Study|Adverse Event|15|||
30909591|NCT02260817|58944471|FG001|Overall Study|Protocol Violation|14|||
30909592|NCT01642589|58944479|FG000|Overall Study|Withdrawal by Subject|1|||
30909593|NCT01642589|58944480|FG001|Overall Study|Withdrawal by Subject|1|||
30909594|NCT02268812|58944490|FG000|Overall Study|Adverse Event|8|||
30622510|NCT01131078|58634213|FG002|Overall Study|Other|0|||
30622511|NCT01167582|58634225|FG000|Overall Study|Lost to Follow-up|0|||
30809787|NCT03093324|58828161|FG000|Overall Study|Lost to Follow-up|1|||
30809788|NCT03093324|58828162|FG001|Overall Study|Lost to Follow-up|0|||
30809789|NCT03093324|58828161|FG000|Overall Study|Protocol Deviation|2|||
30809790|NCT03093324|58828162|FG001|Overall Study|Protocol Deviation|2|||
30809791|NCT03093324|58828161|FG000|Overall Study|Withdrawal by Subject|2|||
30809792|NCT03093324|58828162|FG001|Overall Study|Withdrawal by Subject|2|||
30809793|NCT03584009|58828170|FG000|Overall Study|Death|25|||
30809794|NCT03584009|58828171|FG001|Overall Study|Death|18|||
30809795|NCT03584009|58828170|FG000|Overall Study|Lost to Follow-up|0|||
30809796|NCT03584009|58828171|FG001|Overall Study|Lost to Follow-up|1|||
30809797|NCT03584009|58828170|FG000|Overall Study|Physician Decision|1|||
30809798|NCT03584009|58828171|FG001|Overall Study|Physician Decision|1|||
30809799|NCT03584009|58828170|FG000|Overall Study|Study Terminated by Sponsor|22|||
30809800|NCT03584009|58828171|FG001|Overall Study|Study Terminated by Sponsor|30|||
30809801|NCT03584009|58828170|FG000|Overall Study|Withdrawal by Subject|3|||
30809802|NCT03584009|58828171|FG001|Overall Study|Withdrawal by Subject|2|||
30809803|NCT04167462|58828182|FG000|Overall Study|Other reasons|3|||
30809804|NCT04167462|58828183|FG001|Overall Study|Other reasons|2|||
30809805|NCT04167462|58828182|FG000|Overall Study|Withdrawal by Subject|6|||
30809806|NCT04167462|58828183|FG001|Overall Study|Withdrawal by Subject|7|||
30809807|NCT04167462|58828182|FG000|Overall Study|Adverse Event|4|||
30809808|NCT04167462|58828183|FG001|Overall Study|Adverse Event|0|||
30809809|NCT04167462|58828182|FG000|Overall Study|Pregnancy|1|||
30809810|NCT04167462|58828183|FG001|Overall Study|Pregnancy|0|||
30809811|NCT04167462|58828182|FG000|Overall Study|Lack of Efficacy|0|||
30809812|NCT04167462|58828183|FG001|Overall Study|Lack of Efficacy|1|||
30809813|NCT03583385|58828190|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30809814|NCT03583385|58828191|FG001|Treatment Period 1|Withdrawal by Subject|1|||
30809815|NCT03583385|58828190|FG000|Treatment Period 2|Adverse Event|1|||
30809816|NCT03583385|58828191|FG001|Treatment Period 2|Adverse Event|0|||
30809817|NCT04350372|58828197|FG000|Overall Study|Death|1|||
30809818|NCT02949973|58828201|FG000|Overall Study|Physician Decision|1|||
30809819|NCT02948959|58828207|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
30809820|NCT02948959|58828208|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
30809821|NCT02948959|58828207|FG000|52 Weeks Treatment Period|Adverse Event|2|||
30809822|NCT02948959|58828208|FG001|52 Weeks Treatment Period|Adverse Event|5|||
30809823|NCT02948959|58828207|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
30809824|NCT02948959|58828208|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
30809825|NCT02948959|58828207|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
30809826|NCT02948959|58828208|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
30809827|NCT02948959|58828207|FG000|52 Weeks Treatment Period|Randomized by error|0|||
30809828|NCT02948959|58828208|FG001|52 Weeks Treatment Period|Randomized by error|5|||
30809829|NCT02948959|58828207|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
30809830|NCT02948959|58828208|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
30809831|NCT02948959|58828207|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
30809832|NCT02948959|58828208|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
30809833|NCT02948959|58828207|FG000|52 Weeks Treatment Period|Change of residence location|0|||
30809834|NCT02948959|58828208|FG001|52 Weeks Treatment Period|Change of residence location|1|||
30809835|NCT02948959|58828207|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
30809836|NCT02948959|58828208|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
30809837|NCT02948959|58828207|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
30809838|NCT02948959|58828208|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
30809839|NCT02948959|58828207|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
30809840|NCT02948959|58828208|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
30809841|NCT02948959|58828207|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
30809842|NCT02948959|58828208|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
30809843|NCT02948959|58828207|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
30809844|NCT02948959|58828208|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
30809845|NCT02948959|58828207|FG000|12 Weeks Follow-up Period|Study site closure|1|||
30809846|NCT02948959|58828208|FG001|12 Weeks Follow-up Period|Study site closure|0|||
30809847|NCT03582215|58828230|FG000|Overall Study|Adverse Event|1|||
30809848|NCT03582215|58828231|FG001|Overall Study|Adverse Event|0|||
30809849|NCT03582215|58828232|FG002|Overall Study|Adverse Event|0|||
30909595|NCT02268812|58944491|FG001|Overall Study|Adverse Event|26|||
30909596|NCT02268812|58944492|FG002|Overall Study|Adverse Event|7|||
30809850|NCT03582215|58828233|FG003|Overall Study|Adverse Event|0|||
30809851|NCT03582215|58828234|FG004|Overall Study|Adverse Event|0|||
30809852|NCT03582215|58828235|FG005|Overall Study|Adverse Event|0|||
30809853|NCT03582215|58828236|FG006|Overall Study|Adverse Event|2|||
30809854|NCT03582215|58828237|FG007|Overall Study|Adverse Event|2|||
30809855|NCT03089580|58828266|FG000|Overall Study|Lost to Follow-up|2|||
30809856|NCT03645395|58828276|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
30809857|NCT03645395|58828277|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
30809858|NCT03645395|58828278|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
30809859|NCT03645395|58828279|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
30809860|NCT03645395|58828276|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
30809861|NCT03645395|58828277|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
30809862|NCT03645395|58828278|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
30809863|NCT03645395|58828279|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
30809864|NCT03645395|58828276|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
30809865|NCT03645395|58828277|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
30809866|NCT03645395|58828278|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
30809867|NCT03645395|58828279|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
30809868|NCT03645395|58828276|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
30809869|NCT03645395|58828277|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
30809870|NCT03645395|58828278|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
30809871|NCT03645395|58828279|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
30809872|NCT03342469|58828292|FG000|Overall Study|Withdrawal by Subject|0|||
30622512|NCT01167582|58634226|FG001|Overall Study|Lost to Follow-up|1|||
30622513|NCT01167426|58634232|FG000|Overall Study|Lost to Follow-up|6|||
30809873|NCT03342469|58828293|FG001|Overall Study|Withdrawal by Subject|1|||
30809874|NCT03342469|58828294|FG002|Overall Study|Withdrawal by Subject|0|||
30809875|NCT03342469|58828295|FG003|Overall Study|Withdrawal by Subject|0|||
30809876|NCT03581825|58828306|FG000|Period 1|Lens Discomfort|1|||
30809877|NCT03581825|58828307|FG001|Period 1|Lens Discomfort|0|||
30809878|NCT03581825|58828306|FG000|Period 2|Unsatisfactory Vision to Test|0|||
30809879|NCT03581825|58828307|FG001|Period 2|Unsatisfactory Vision to Test|1|||
30809880|NCT03342001|58828313|FG000|Overall Study|Adverse Event|1|||
30809881|NCT03342001|58828313|FG000|Overall Study|Lost to Follow-up|1|||
30809882|NCT03341923|58828317|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
30809883|NCT03341923|58828318|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
30809884|NCT03579719|58828326|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
30809885|NCT03341533|58828332|FG000|Overall Study|Withdrawal by Subject|1|||
30809886|NCT03341533|58828333|FG001|Overall Study|Withdrawal by Subject|1|||
30809887|NCT03341533|58828332|FG000|Overall Study|Not eligible after randomization|2|||
30809888|NCT03341533|58828333|FG001|Overall Study|Not eligible after randomization|1|||
30809889|NCT02688088|58828339|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
30809890|NCT02688088|58828340|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
30809891|NCT02688088|58828341|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
30809892|NCT02688088|58828342|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
30809893|NCT02688088|58828343|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
30809894|NCT02688088|58828339|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
30909597|NCT02268812|58944493|FG003|Overall Study|Adverse Event|10|||
30909598|NCT02268812|58944490|FG000|Overall Study|Protocol deviation|0|||
30809895|NCT02688088|58828340|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
30809896|NCT02688088|58828341|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
30809897|NCT02688088|58828342|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
30809898|NCT02688088|58828343|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
30809899|NCT02688088|58828339|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
30809900|NCT02688088|58828340|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
30809901|NCT02688088|58828341|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
30809902|NCT02688088|58828342|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
30809903|NCT02688088|58828343|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
30809904|NCT02688088|58828339|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
30809905|NCT02688088|58828340|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
30809906|NCT02688088|58828341|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
30809907|NCT02688088|58828342|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
30809908|NCT02688088|58828343|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
30809909|NCT02688088|58828339|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
30909599|NCT02268812|58944491|FG001|Overall Study|Protocol deviation|0|||
30909600|NCT02268812|58944492|FG002|Overall Study|Protocol deviation|1|||
30809910|NCT02688088|58828340|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
30809911|NCT02688088|58828341|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
30809912|NCT02688088|58828342|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
30809913|NCT02688088|58828343|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
30809914|NCT02688088|58828339|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
30809915|NCT02688088|58828340|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
30809916|NCT02688088|58828341|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
30809917|NCT02688088|58828342|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
30809918|NCT02688088|58828343|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
30809919|NCT02688088|58828339|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
30809920|NCT02688088|58828340|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
30809921|NCT02688088|58828341|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
30809922|NCT02688088|58828342|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
30809923|NCT02688088|58828343|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
30809924|NCT02688088|58828339|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
30809925|NCT02688088|58828340|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
30809926|NCT02688088|58828341|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
30809927|NCT02688088|58828342|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
30809928|NCT02688088|58828343|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
30809929|NCT02688088|58828339|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
30809930|NCT02688088|58828340|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
30809931|NCT02688088|58828341|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
30809932|NCT02688088|58828342|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
30809933|NCT02688088|58828343|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
30809934|NCT03641651|58828368|FG000|Overall Study|organizational issues at one study site|1|||
30809935|NCT03341299|58828372|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
30809936|NCT03341299|58828373|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
30809937|NCT03341299|58828374|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
30809938|NCT03341299|58828375|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
30809939|NCT02949271|58828389|FG000|Overall Study|Lack of Efficacy|5|||
30809940|NCT02949271|58828390|FG001|Overall Study|Lack of Efficacy|4|||
30809941|NCT02949271|58828389|FG000|Overall Study|Lost to Follow-up|3|||
30809942|NCT02949271|58828390|FG001|Overall Study|Lost to Follow-up|6|||
30809943|NCT02949271|58828389|FG000|Overall Study|Physician Decision|5|||
30809944|NCT02949271|58828390|FG001|Overall Study|Physician Decision|5|||
30809945|NCT02949271|58828389|FG000|Overall Study|Protocol Violation|6|||
30809946|NCT02949271|58828390|FG001|Overall Study|Protocol Violation|3|||
30809947|NCT02949271|58828389|FG000|Overall Study|Withdrawal by Subject|1|||
30809948|NCT02949271|58828390|FG001|Overall Study|Withdrawal by Subject|0|||
30809949|NCT02949271|58828389|FG000|Overall Study|Delivered prior to intervention|7|||
30809950|NCT02949271|58828390|FG001|Overall Study|Delivered prior to intervention|9|||
30809951|NCT02949271|58828389|FG000|Overall Study|Outside the window for cervical dilation|2|||
30809952|NCT02949271|58828390|FG001|Overall Study|Outside the window for cervical dilation|3|||
30809953|NCT03640559|58828398|FG000|Overall Study|Physician Decision|1|||
30809954|NCT03640559|58828399|FG001|Overall Study|Physician Decision|1|||
30809955|NCT03640559|58828398|FG000|Overall Study|Withdrawal by Subject|1|||
30809956|NCT03640559|58828399|FG001|Overall Study|Withdrawal by Subject|0|||
30809957|NCT03339583|58828407|FG000|First Intervention (14 Days)|Adverse Event|1|||
30809958|NCT03339583|58828408|FG001|First Intervention (14 Days)|Adverse Event|0|||
30809959|NCT03339583|58828407|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
30809960|NCT03339583|58828408|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
30809961|NCT03339583|58828407|FG000|Second Intervention (14 Days)|Adverse Event|0|||
30809962|NCT03339583|58828408|FG001|Second Intervention (14 Days)|Adverse Event|1|||
30809963|NCT03339583|58828407|FG000|Follow-up (14 Days)|Physician Decision|6|||
30809964|NCT03339583|58828408|FG001|Follow-up (14 Days)|Physician Decision|3|||
30809965|NCT03639779|58828416|FG000|Overall Study|Lost to Follow-up|1|||
30809966|NCT03575975|58828425|FG000|Overall Study|Lost to Follow-up|1|||
30809967|NCT03575975|58828426|FG001|Overall Study|Lost to Follow-up|0|||
30809968|NCT03575975|58828427|FG002|Overall Study|Lost to Follow-up|0|||
30809969|NCT03636893|58828435|FG000|Overall Study|Death|0|||
30809970|NCT03636893|58828436|FG001|Overall Study|Death|1|||
30809971|NCT03636893|58828435|FG000|Overall Study|Protocol Violation|0|||
30809972|NCT03636893|58828436|FG001|Overall Study|Protocol Violation|3|||
30809973|NCT03636893|58828435|FG000|Overall Study|Withdrawal by Subject|1|||
30809974|NCT03636893|58828436|FG001|Overall Study|Withdrawal by Subject|2|||
30809975|NCT03636893|58828435|FG000|Overall Study|Refusal to surgery|4|||
30809976|NCT03636893|58828436|FG001|Overall Study|Refusal to surgery|3|||
30909601|NCT02268812|58944493|FG003|Overall Study|Protocol deviation|0|||
30909602|NCT02268812|58944490|FG000|Overall Study|Withdrawal by Subject|0|||
30909603|NCT02268812|58944491|FG001|Overall Study|Withdrawal by Subject|1|||
30909604|NCT02268812|58944492|FG002|Overall Study|Withdrawal by Subject|0|||
30909605|NCT02268812|58944493|FG003|Overall Study|Withdrawal by Subject|0|||
30909606|NCT02268812|58944490|FG000|Overall Study|Physician Decision|3|||
30909607|NCT02268812|58944491|FG001|Overall Study|Physician Decision|1|||
30909608|NCT02268812|58944492|FG002|Overall Study|Physician Decision|0|||
30909609|NCT02268812|58944493|FG003|Overall Study|Physician Decision|1|||
30909610|NCT02268812|58944490|FG000|Overall Study|Other|5|||
30909611|NCT02268812|58944491|FG001|Overall Study|Other|4|||
30909612|NCT02268812|58944492|FG002|Overall Study|Other|1|||
30909613|NCT02268812|58944493|FG003|Overall Study|Other|3|||
30909614|NCT01954251|58944505|FG000|Overall Study|Adverse Event|5|||
30622514|NCT01167426|58634232|FG000|Overall Study|Protocol Violation|1|||
30622515|NCT01167426|58634232|FG000|Overall Study|Withdrawal by Subject|2|||
30622516|NCT01167426|58634232|FG000|Overall Study|Sponsor Decision|1|||
30809977|NCT03636893|58828435|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
30809978|NCT03636893|58828436|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
30809979|NCT03636893|58828435|FG000|Overall Study|Adverse Event|1|||
30809980|NCT03636893|58828436|FG001|Overall Study|Adverse Event|1|||
30809981|NCT01353586|58828444|FG000|Overall Study|Procedure terminated prior to ablation|3|||
30809982|NCT01353586|58828445|FG001|Overall Study|Procedure terminated prior to ablation|0|||
30809983|NCT01353586|58828444|FG000|Overall Study|Never had insertion of study catheter|4|||
30809984|NCT01353586|58828445|FG001|Overall Study|Never had insertion of study catheter|1|||
30622517|NCT00922636|58634242|FG000|Overall Study|Adverse Event|3|||
30749633|NCT00195260|58759563|FG010|Part 1: Dose Escalation|Adverse Event|0|||
30809985|NCT01353586|58828444|FG000|Overall Study|Neurological exam not done|0|||
30809986|NCT01353586|58828445|FG001|Overall Study|Neurological exam not done|1|||
30809987|NCT03091920|58828457|FG000|Overall Study|Adverse Event|0|||
30809988|NCT03091920|58828458|FG001|Overall Study|Adverse Event|1|||
30809989|NCT03091920|58828459|FG002|Overall Study|Adverse Event|0|||
30809990|NCT03338569|58828475|FG000|Overall Study|Physician Decision|8|||
30809991|NCT03338569|58828476|FG001|Overall Study|Physician Decision|3|||
30809992|NCT03338569|58828475|FG000|Overall Study|Withdrawal by Subject|0|||
30809993|NCT03338569|58828476|FG001|Overall Study|Withdrawal by Subject|1|||
30809994|NCT03338569|58828475|FG000|Overall Study|Lost to Follow-up|0|||
30809995|NCT03338569|58828476|FG001|Overall Study|Lost to Follow-up|1|||
30809996|NCT03338023|58828484|FG000|Overall Study|Withdrawal by Subject|3|||
30809997|NCT03338023|58828485|FG001|Overall Study|Withdrawal by Subject|4|||
30809998|NCT03338023|58828484|FG000|Overall Study|Protocol Violation|3|||
30809999|NCT03338023|58828485|FG001|Overall Study|Protocol Violation|3|||
30810000|NCT03338023|58828484|FG000|Overall Study|Lost to Follow-up|2|||
30810001|NCT03338023|58828485|FG001|Overall Study|Lost to Follow-up|1|||
30749634|NCT00195260|58759553|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30749635|NCT00195260|58759554|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30749636|NCT00195260|58759555|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30749637|NCT00195260|58759556|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30749638|NCT00195260|58759557|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
30749639|NCT00195260|58759558|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30749640|NCT00195260|58759559|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30749641|NCT00195260|58759560|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
30749642|NCT00195260|58759561|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30749643|NCT00195260|58759562|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30749644|NCT00195260|58759563|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
30749645|NCT00195260|58759553|FG000|Part 1: Dose Escalation|Death|0|||
30749646|NCT00195260|58759554|FG001|Part 1: Dose Escalation|Death|0|||
30749647|NCT00195260|58759555|FG002|Part 1: Dose Escalation|Death|0|||
30749648|NCT00195260|58759556|FG003|Part 1: Dose Escalation|Death|0|||
30749649|NCT00195260|58759557|FG004|Part 1: Dose Escalation|Death|0|||
30749650|NCT00195260|58759558|FG005|Part 1: Dose Escalation|Death|0|||
30749651|NCT00195260|58759559|FG006|Part 1: Dose Escalation|Death|0|||
30749652|NCT00195260|58759560|FG007|Part 1: Dose Escalation|Death|1|||
30749653|NCT00195260|58759561|FG008|Part 1: Dose Escalation|Death|0|||
30749654|NCT00195260|58759562|FG009|Part 1: Dose Escalation|Death|0|||
30749655|NCT00195260|58759563|FG010|Part 1: Dose Escalation|Death|0|||
30749656|NCT00195260|58759553|FG000|Part 1: Dose Escalation|Disease Progression|3|||
30749657|NCT00195260|58759554|FG001|Part 1: Dose Escalation|Disease Progression|2|||
30810002|NCT03338023|58828484|FG000|Overall Study|Physician Decision|1|||
30810003|NCT03338023|58828485|FG001|Overall Study|Physician Decision|2|||
30810004|NCT03337477|58828493|FG000|Overall Study|not categorized into the listed ones|11|||
30810005|NCT03337477|58828494|FG001|Overall Study|not categorized into the listed ones|9|||
30810006|NCT03337477|58828493|FG000|Overall Study|Withdrawal by Subject|0|||
30810007|NCT03337477|58828494|FG001|Overall Study|Withdrawal by Subject|1|||
30909615|NCT01954251|58944506|FG001|Overall Study|Adverse Event|7|||
30909616|NCT01954251|58944505|FG000|Overall Study|Lost to Follow-up|6|||
30909617|NCT01954251|58944506|FG001|Overall Study|Lost to Follow-up|6|||
30749658|NCT00195260|58759555|FG002|Part 1: Dose Escalation|Disease Progression|5|||
30810008|NCT03337477|58828493|FG000|Overall Study|Death|0|||
30810009|NCT03337477|58828494|FG001|Overall Study|Death|1|||
30909618|NCT01954251|58944505|FG000|Overall Study|Withdrawal by Subject|2|||
30622518|NCT00922636|58634243|FG001|Overall Study|Adverse Event|3|||
30622519|NCT00922636|58634244|FG002|Overall Study|Adverse Event|2|||
30622520|NCT00922636|58634245|FG003|Overall Study|Adverse Event|3|||
30622521|NCT00922636|58634246|FG004|Overall Study|Adverse Event|2|||
30622522|NCT00922636|58634242|FG000|Overall Study|Lack of Efficacy|1|||
30622523|NCT00922636|58634243|FG001|Overall Study|Lack of Efficacy|7|||
30622524|NCT00922636|58634244|FG002|Overall Study|Lack of Efficacy|3|||
30622525|NCT00922636|58634245|FG003|Overall Study|Lack of Efficacy|2|||
30622526|NCT00922636|58634246|FG004|Overall Study|Lack of Efficacy|4|||
30622527|NCT00922636|58634242|FG000|Overall Study|Sponsor Decision|0|||
30622528|NCT00922636|58634243|FG001|Overall Study|Sponsor Decision|0|||
30622529|NCT00922636|58634244|FG002|Overall Study|Sponsor Decision|2|||
30622530|NCT00922636|58634245|FG003|Overall Study|Sponsor Decision|0|||
30622531|NCT00922636|58634246|FG004|Overall Study|Sponsor Decision|0|||
30622532|NCT00922636|58634242|FG000|Overall Study|Withdrawal by Subject|0|||
30622533|NCT00922636|58634243|FG001|Overall Study|Withdrawal by Subject|0|||
30749659|NCT00195260|58759556|FG003|Part 1: Dose Escalation|Disease Progression|6|||
30749660|NCT00195260|58759557|FG004|Part 1: Dose Escalation|Disease Progression|4|||
30749661|NCT00195260|58759558|FG005|Part 1: Dose Escalation|Disease Progression|6|||
30749662|NCT00195260|58759559|FG006|Part 1: Dose Escalation|Disease Progression|7|||
30909619|NCT01954251|58944506|FG001|Overall Study|Withdrawal by Subject|6|||
30749663|NCT00195260|58759560|FG007|Part 1: Dose Escalation|Disease Progression|4|||
30749664|NCT00195260|58759561|FG008|Part 1: Dose Escalation|Disease Progression|0|||
30810010|NCT03337477|58828493|FG000|Overall Study|Lost to Follow-up|0|||
30810011|NCT03337477|58828494|FG001|Overall Study|Lost to Follow-up|2|||
30810012|NCT02687542|58828507|FG000|Overall Study|Medication error without associated AEs|0|||
30810013|NCT02687542|58828508|FG001|Overall Study|Medication error without associated AEs|0|||
30810014|NCT02687542|58828509|FG002|Overall Study|Medication error without associated AEs|0|||
30810015|NCT02687542|58828510|FG003|Overall Study|Medication error without associated AEs|0|||
30810016|NCT02687542|58828511|FG004|Overall Study|Medication error without associated AEs|1|||
30810017|NCT02687542|58828507|FG000|Overall Study|Lost to Follow-up|0|||
30749665|NCT00195260|58759562|FG009|Part 1: Dose Escalation|Disease Progression|0|||
30749666|NCT00195260|58759563|FG010|Part 1: Dose Escalation|Disease Progression|0|||
30749667|NCT00195260|58759553|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
30749668|NCT00195260|58759554|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
30749669|NCT00195260|58759555|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
30749670|NCT00195260|58759556|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
30749671|NCT00195260|58759557|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
30749672|NCT00195260|58759558|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
30749673|NCT00195260|58759559|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
30749674|NCT00195260|58759560|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
30749675|NCT00195260|58759561|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
30749676|NCT00195260|58759562|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
30749677|NCT00195260|58759563|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
30749678|NCT00195260|58759553|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
30749679|NCT00195260|58759554|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
30749680|NCT00195260|58759555|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
30749681|NCT00195260|58759556|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
30749682|NCT00195260|58759557|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
30749683|NCT00195260|58759558|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
30749684|NCT00195260|58759559|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
30749685|NCT00195260|58759560|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
30749686|NCT00195260|58759561|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
30749687|NCT00195260|58759562|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
30749688|NCT00195260|58759563|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
30749689|NCT00195260|58759553|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
30749690|NCT00195260|58759554|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
30749691|NCT00195260|58759555|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
30749692|NCT00195260|58759556|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
30810018|NCT02687542|58828508|FG001|Overall Study|Lost to Follow-up|0|||
30810019|NCT02687542|58828509|FG002|Overall Study|Lost to Follow-up|0|||
30810020|NCT02687542|58828510|FG003|Overall Study|Lost to Follow-up|0|||
30622534|NCT00922636|58634244|FG002|Overall Study|Withdrawal by Subject|5|||
30622535|NCT00922636|58634245|FG003|Overall Study|Withdrawal by Subject|2|||
30622536|NCT00922636|58634246|FG004|Overall Study|Withdrawal by Subject|4|||
30622537|NCT00922636|58634242|FG000|Overall Study|Protocol Violation|0|||
30622538|NCT00922636|58634243|FG001|Overall Study|Protocol Violation|0|||
30749693|NCT00195260|58759557|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
30749694|NCT00195260|58759558|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
30749695|NCT00195260|58759559|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
30810021|NCT02687542|58828511|FG004|Overall Study|Lost to Follow-up|1|||
30810022|NCT02687542|58828507|FG000|Overall Study|Protocol Violation|0|||
30810023|NCT02687542|58828508|FG001|Overall Study|Protocol Violation|1|||
30810024|NCT02687542|58828509|FG002|Overall Study|Protocol Violation|0|||
30810025|NCT02687542|58828510|FG003|Overall Study|Protocol Violation|0|||
30810026|NCT02687542|58828511|FG004|Overall Study|Protocol Violation|0|||
30810027|NCT02687542|58828507|FG000|Overall Study|Other|5|||
30810028|NCT02687542|58828508|FG001|Overall Study|Other|9|||
30810029|NCT02687542|58828509|FG002|Overall Study|Other|10|||
30810030|NCT02687542|58828510|FG003|Overall Study|Other|6|||
30810031|NCT02687542|58828511|FG004|Overall Study|Other|5|||
30810032|NCT02687542|58828507|FG000|Overall Study|Adverse Event|3|||
30810033|NCT02687542|58828508|FG001|Overall Study|Adverse Event|1|||
30810034|NCT02687542|58828509|FG002|Overall Study|Adverse Event|3|||
30810035|NCT02687542|58828510|FG003|Overall Study|Adverse Event|2|||
30810036|NCT02687542|58828511|FG004|Overall Study|Adverse Event|9|||
30810037|NCT02687542|58828507|FG000|Overall Study|Withdrawal by Subject|0|||
30810038|NCT02687542|58828508|FG001|Overall Study|Withdrawal by Subject|1|||
30810039|NCT02687542|58828509|FG002|Overall Study|Withdrawal by Subject|1|||
30810040|NCT02687542|58828510|FG003|Overall Study|Withdrawal by Subject|2|||
30810041|NCT02687542|58828511|FG004|Overall Study|Withdrawal by Subject|4|||
30810042|NCT03336619|58828525|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
30810043|NCT03336619|58828526|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
30810044|NCT03336619|58828525|FG000|Overall Study|Withdrawal by Subject|17|||
30810045|NCT03336619|58828526|FG001|Overall Study|Withdrawal by Subject|16|||
30810046|NCT03336619|58828525|FG000|Overall Study|Adverse Event|2|||
30810047|NCT03336619|58828526|FG001|Overall Study|Adverse Event|5|||
30810048|NCT03336619|58828525|FG000|Overall Study|Physician Decision|3|||
30810049|NCT03336619|58828526|FG001|Overall Study|Physician Decision|0|||
30810050|NCT01353508|58828548|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
30810051|NCT01353508|58828549|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
30810052|NCT01353508|58828550|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
30810053|NCT01353508|58828551|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
30810054|NCT01353508|58828548|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
30810055|NCT01353508|58828549|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
30909620|NCT01644617|58944516|FG000|Overall Study|Withdrawal by Subject|3|||
30909621|NCT01644617|58944517|FG001|Overall Study|Withdrawal by Subject|4|||
30909622|NCT01644617|58944518|FG002|Overall Study|Withdrawal by Subject|1|||
30909623|NCT01644617|58944516|FG000|Overall Study|Lost to Follow-up|0|||
30909624|NCT01644617|58944517|FG001|Overall Study|Lost to Follow-up|1|||
30909625|NCT01644617|58944518|FG002|Overall Study|Lost to Follow-up|0|||
30749696|NCT00195260|58759560|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
30749697|NCT00195260|58759561|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
30749698|NCT00195260|58759562|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
30749699|NCT00195260|58759563|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
30749700|NCT00195260|58759553|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
30749701|NCT00195260|58759554|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
30749702|NCT00195260|58759555|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
30749703|NCT00195260|58759556|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
30810056|NCT01353508|58828550|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
30810057|NCT01353508|58828551|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
30810058|NCT03636269|58828563|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
30810059|NCT03636269|58828564|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
30810060|NCT03636269|58828565|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
30810061|NCT03636269|58828563|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
30909626|NCT01644617|58944516|FG000|Overall Study|Adverse Event|3|||
30909627|NCT01644617|58944517|FG001|Overall Study|Adverse Event|0|||
30909628|NCT01644617|58944518|FG002|Overall Study|Adverse Event|6|||
30909629|NCT02294318|58944528|FG000|Overall Study|Worsening of drinking|3|||
30810062|NCT03636269|58828564|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
30810063|NCT03636269|58828565|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
30810064|NCT03636269|58828563|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
30810065|NCT03636269|58828564|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
30810066|NCT03636269|58828565|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
30810067|NCT03636269|58828563|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
30810068|NCT03636269|58828564|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
30810069|NCT03636269|58828565|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
30810070|NCT03636269|58828563|FG000|Period 1: Double-blind Phase|Other|6|||
30810071|NCT03636269|58828564|FG001|Period 1: Double-blind Phase|Other|3|||
30810072|NCT03636269|58828565|FG002|Period 1: Double-blind Phase|Other|0|||
30810073|NCT03636269|58828563|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
30810074|NCT03636269|58828564|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
30810075|NCT03636269|58828565|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
30810076|NCT03636269|58828563|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
30810077|NCT03636269|58828564|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
30810078|NCT03636269|58828565|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
30810079|NCT03636269|58828563|FG000|Period 2: Open-label Phase|Adverse Event|0|||
30810080|NCT03636269|58828564|FG001|Period 2: Open-label Phase|Adverse Event|0|||
30810081|NCT03636269|58828565|FG002|Period 2: Open-label Phase|Adverse Event|21|||
30810082|NCT03636269|58828563|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
30810083|NCT03636269|58828564|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
30810084|NCT03636269|58828565|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
30810085|NCT03636269|58828563|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
30810086|NCT03636269|58828564|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
30810087|NCT03636269|58828565|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
30810088|NCT03636269|58828563|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
30810089|NCT03636269|58828564|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
30810090|NCT03636269|58828565|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
30810091|NCT03636269|58828563|FG000|Period 2: Open-label Phase|Administrative|0|||
30810092|NCT03636269|58828564|FG001|Period 2: Open-label Phase|Administrative|0|||
30810093|NCT03636269|58828565|FG002|Period 2: Open-label Phase|Administrative|36|||
30810094|NCT03636269|58828563|FG000|Period 2: Open-label Phase|Other|0|||
30810095|NCT03636269|58828564|FG001|Period 2: Open-label Phase|Other|0|||
30810096|NCT03636269|58828565|FG002|Period 2: Open-label Phase|Other|9|||
30810097|NCT03636269|58828563|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
30810098|NCT03636269|58828564|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
30810099|NCT03636269|58828565|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
30810100|NCT02685202|58828574|FG000|Overall Study|Lost to Follow-up|9|||
30810101|NCT03087786|58828580|FG000|Overall Study|Withdrawal by Subject|2|||
30810102|NCT03087786|58828581|FG001|Overall Study|Withdrawal by Subject|0|||
30810103|NCT03635957|58828587|FG000|Run-In Period|Lost to Follow-up|1|||
30810104|NCT03635957|58828587|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
30810105|NCT01353274|58828592|FG000|Overall Study|No case report form (CRF) collected|28|||
30810106|NCT02690194|58828599|FG000|Overall Study|Withdrawal by Subject|1|||
30810107|NCT02690194|58828600|FG001|Overall Study|Withdrawal by Subject|4|||
30810108|NCT02690194|58828601|FG002|Overall Study|Withdrawal by Subject|0|||
30810109|NCT02684344|58828611|FG000|Overall Study|Withdrawal by Subject|0|||
30810110|NCT02684344|58828612|FG001|Overall Study|Withdrawal by Subject|1|||
30909630|NCT02294318|58944529|FG001|Overall Study|Worsening of drinking|0|||
30909631|NCT02294318|58944528|FG000|Overall Study|Not exposed to intervention|0|||
30909632|NCT02294318|58944529|FG001|Overall Study|Not exposed to intervention|2|||
30909633|NCT02293499|58944538|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
30810111|NCT02683876|58828620|FG000|Overall Study|samples damaged during shipping|2|||
30810112|NCT02683876|58828621|FG001|Overall Study|samples damaged during shipping|0|||
30810113|NCT03974100|58828631|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
30810114|NCT03974100|58828632|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
30810115|NCT03974100|58828633|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
30810116|NCT03974100|58828634|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
30810117|NCT03974100|58828635|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
30810118|NCT03974100|58828631|FG000|TP1 - Day 1 to Week 52|Death|1|||
30810119|NCT03974100|58828632|FG001|TP1 - Day 1 to Week 52|Death|0|||
30810120|NCT03974100|58828633|FG002|TP1 - Day 1 to Week 52|Death|0|||
30810121|NCT03974100|58828634|FG003|TP1 - Day 1 to Week 52|Death|0|||
30810122|NCT03974100|58828635|FG004|TP1 - Day 1 to Week 52|Death|0|||
30810123|NCT03974100|58828631|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
30810124|NCT03974100|58828632|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
30810125|NCT03974100|58828633|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
30810126|NCT03974100|58828634|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
30810127|NCT03974100|58828635|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
30948485|NCT01976741|58994460|FG007|Overall Study|Withdrawal by Subject|4|||
30810128|NCT03974100|58828631|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
30810129|NCT03974100|58828632|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
30810130|NCT03974100|58828633|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
30810131|NCT03974100|58828634|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
30810132|NCT03974100|58828635|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
30810133|NCT03974100|58828631|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
30810134|NCT03974100|58828632|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
30810135|NCT03974100|58828633|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
30810136|NCT03974100|58828634|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
30810137|NCT03974100|58828635|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
30810138|NCT03974100|58828631|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
30810139|NCT03974100|58828632|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
30810140|NCT03974100|58828633|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
30810141|NCT03974100|58828634|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
30810142|NCT03974100|58828635|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
30810143|NCT03974100|58828631|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
30810144|NCT03974100|58828632|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
30810145|NCT03974100|58828633|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
30810146|NCT03974100|58828634|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
30810147|NCT03974100|58828635|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
30810148|NCT02689804|58828649|FG000|Overall Study|Withdrawal by Subject|2|||
30810149|NCT02689804|58828650|FG001|Overall Study|Withdrawal by Subject|0|||
30810150|NCT02946931|58828659|FG000|Overall Study|Did not require collection of CRFs|588|||
30810151|NCT02946931|58828659|FG000|Overall Study|Other than listed|37|||
30810152|NCT02946931|58828659|FG000|Overall Study|Discharge from hospital|118|||
30810153|NCT02946931|58828659|FG000|Overall Study|Adverse Event|81|||
30810154|NCT02946931|58828659|FG000|Overall Study|CRFs not valid|1|||
30810155|NCT02946931|58828659|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
30810156|NCT02689492|58828663|FG000|Overall Study|Lost to Follow-up|61|||
30810157|NCT02689492|58828663|FG000|Overall Study|Withdrawal by Subject|11|||
30810158|NCT02689492|58828663|FG000|Overall Study|Death|9|||
30810159|NCT02689492|58828663|FG000|Overall Study|Physician Decision|2|||
30810160|NCT02689492|58828663|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
30810161|NCT02689492|58828663|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
30810162|NCT02689492|58828663|FG000|Overall Study|Other than listed|1|||
30810163|NCT01374568|58828681|FG000|Overall Study|Lab unable to analyze BTM|0|||
30909634|NCT02293499|58944539|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
30909635|NCT02293499|58944540|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
30909636|NCT02293499|58944538|FG000|Intervention - Camp|Withdrawal by Subject|3|||
30909637|NCT02293499|58944539|FG001|Intervention - Camp|Withdrawal by Subject|6|||
30909638|NCT02293499|58944540|FG002|Intervention - Camp|Withdrawal by Subject|2|||
30909639|NCT02293499|58944538|FG000|Intervention - Camp|these are those not showing up at camp|24|||
30909640|NCT02293499|58944539|FG001|Intervention - Camp|these are those not showing up at camp|28|||
30909641|NCT02293499|58944540|FG002|Intervention - Camp|these are those not showing up at camp|4|||
30810164|NCT01374568|58828682|FG001|Overall Study|Lab unable to analyze BTM|2|||
30810165|NCT02682784|58828692|FG000|Overall Study|Withdrawal by Subject|0|||
30810166|NCT02682784|58828693|FG001|Overall Study|Withdrawal by Subject|2|||
30810167|NCT02682784|58828694|FG002|Overall Study|Withdrawal by Subject|1|||
30909642|NCT02293499|58944538|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
30909643|NCT02293499|58944539|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
30909644|NCT02293499|58944540|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
30909645|NCT02293499|58944538|FG000|3 Month Follow Up|Lost to Follow-up|14|||
30909646|NCT02293499|58944539|FG001|3 Month Follow Up|Lost to Follow-up|15|||
30909647|NCT02293499|58944540|FG002|3 Month Follow Up|Lost to Follow-up|6|||
30909648|NCT02293499|58944538|FG000|6 Month Follow Up|Lost to Follow-up|17|||
30909649|NCT02293499|58944539|FG001|6 Month Follow Up|Lost to Follow-up|27|||
30909650|NCT02293499|58944540|FG002|6 Month Follow Up|Lost to Follow-up|6|||
30909651|NCT02293499|58944538|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
30909652|NCT02293499|58944539|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
30909653|NCT02293499|58944540|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
30909654|NCT02293499|58944538|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
30909655|NCT02293499|58944539|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
30810168|NCT02682784|58828695|FG003|Overall Study|Withdrawal by Subject|2|||
30810169|NCT02682784|58828692|FG000|Overall Study|Physician Decision|1|||
30810170|NCT02682784|58828693|FG001|Overall Study|Physician Decision|0|||
30810171|NCT02682784|58828694|FG002|Overall Study|Physician Decision|1|||
30810172|NCT02682784|58828695|FG003|Overall Study|Physician Decision|1|||
30810173|NCT03387852|58828709|FG000|Overall Study|Adverse event (AE)|3|||
30810174|NCT03387852|58828710|FG001|Overall Study|Adverse event (AE)|0|||
30909656|NCT02293499|58944540|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
30909657|NCT02293499|58944538|FG000|9 Month Follow Up|Lost to Follow-up|24|||
30909658|NCT02293499|58944539|FG001|9 Month Follow Up|Lost to Follow-up|28|||
30909659|NCT02293499|58944540|FG002|9 Month Follow Up|Lost to Follow-up|4|||
30810175|NCT03387852|58828711|FG002|Overall Study|Adverse event (AE)|2|||
30810176|NCT03387852|58828712|FG003|Overall Study|Adverse event (AE)|0|||
30810177|NCT03387852|58828709|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
30810178|NCT03387852|58828710|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
30810179|NCT03387852|58828711|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
30810180|NCT03387852|58828712|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
30810181|NCT03387852|58828709|FG000|Overall Study|Withdrawal by participant|1|||
30810182|NCT03387852|58828710|FG001|Overall Study|Withdrawal by participant|1|||
30810183|NCT03387852|58828711|FG002|Overall Study|Withdrawal by participant|3|||
30810184|NCT03387852|58828712|FG003|Overall Study|Withdrawal by participant|2|||
30810185|NCT03387852|58828709|FG000|Overall Study|Other- Unspecified|1|||
30810186|NCT03387852|58828710|FG001|Overall Study|Other- Unspecified|1|||
30810187|NCT03387852|58828711|FG002|Overall Study|Other- Unspecified|2|||
30810188|NCT03387852|58828712|FG003|Overall Study|Other- Unspecified|1|||
30810189|NCT03387852|58828709|FG000|Overall Study|Poor compliance to protocol|0|||
30810190|NCT03387852|58828710|FG001|Overall Study|Poor compliance to protocol|0|||
30810191|NCT03387852|58828711|FG002|Overall Study|Poor compliance to protocol|0|||
30810192|NCT03387852|58828712|FG003|Overall Study|Poor compliance to protocol|1|||
30810193|NCT03387852|58828709|FG000|Overall Study|Randomized and not treated|0|||
30810194|NCT03387852|58828710|FG001|Overall Study|Randomized and not treated|0|||
30810195|NCT03387852|58828711|FG002|Overall Study|Randomized and not treated|0|||
30810196|NCT03387852|58828712|FG003|Overall Study|Randomized and not treated|1|||
30810197|NCT02679274|58828725|FG000|Overall Study|Withdrawal by Subject|1|||
30810198|NCT02679274|58828726|FG001|Overall Study|Withdrawal by Subject|0|||
30810199|NCT04969861|58828734|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
30810200|NCT04969861|58828735|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
30909660|NCT02293499|58944538|FG000|12 Month Follow Up|Lost to Follow-up|26|||
30909661|NCT02293499|58944539|FG001|12 Month Follow Up|Lost to Follow-up|25|||
30909662|NCT02293499|58944540|FG002|12 Month Follow Up|Lost to Follow-up|6|||
30909663|NCT02293499|58944538|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
30909664|NCT02293499|58944539|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
30909665|NCT02293499|58944540|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
30909666|NCT02293499|58944538|FG000|15 Month Follow Up|Lost to Follow-up|22|||
30909667|NCT02293499|58944539|FG001|15 Month Follow Up|Lost to Follow-up|22|||
30909668|NCT02293499|58944540|FG002|15 Month Follow Up|Lost to Follow-up|7|||
30909669|NCT02257385|58944551|FG000|Overall Study|Adverse Event|12|||
30909670|NCT02257385|58944552|FG001|Overall Study|Adverse Event|8|||
30909671|NCT02257385|58944551|FG000|Overall Study|Lack of Efficacy|1|||
30909672|NCT02257385|58944552|FG001|Overall Study|Lack of Efficacy|2|||
30909673|NCT02257385|58944551|FG000|Overall Study|Protocol Violation|5|||
30909674|NCT02257385|58944552|FG001|Overall Study|Protocol Violation|7|||
30909675|NCT02257385|58944551|FG000|Overall Study|Lost to Follow-up|0|||
30909676|NCT02257385|58944552|FG001|Overall Study|Lost to Follow-up|1|||
30909677|NCT02257385|58944551|FG000|Overall Study|Withdrawal by Subject|4|||
30909678|NCT02257385|58944552|FG001|Overall Study|Withdrawal by Subject|4|||
30909679|NCT01629667|58944561|FG000|Overall Study|Lost to Follow-up|0|||
30909680|NCT01629667|58944562|FG001|Overall Study|Lost to Follow-up|1|||
30909681|NCT01629667|58944563|FG002|Overall Study|Lost to Follow-up|1|||
30909682|NCT01629667|58944561|FG000|Overall Study|Withdrawal by Subject|31|||
30810201|NCT02678416|58828743|FG000|Part 1|Withdrawal by Subject|1|||
30909683|NCT01629667|58944562|FG001|Overall Study|Withdrawal by Subject|20|||
30909684|NCT01629667|58944563|FG002|Overall Study|Withdrawal by Subject|28|||
30909685|NCT01629667|58944561|FG000|Overall Study|Death|1|||
30909686|NCT01629667|58944562|FG001|Overall Study|Death|5|||
30909687|NCT01629667|58944563|FG002|Overall Study|Death|3|||
30909688|NCT01629667|58944561|FG000|Overall Study|Randomized, not treated|2|||
30909689|NCT01629667|58944562|FG001|Overall Study|Randomized, not treated|1|||
30909690|NCT01629667|58944563|FG002|Overall Study|Randomized, not treated|0|||
30909691|NCT01629667|58944561|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
30909692|NCT01629667|58944562|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
30909693|NCT01629667|58944563|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
30909694|NCT01629667|58944561|FG000|Overall Study|Requiring lung transplant|2|||
30810202|NCT02678416|58828743|FG000|Part 2|Adverse Event|2|||
30810203|NCT02678416|58828743|FG000|Part 2|Withdrawal by Subject|1|||
30810204|NCT02680834|58828763|FG000|Overall Study|Physician Decision|5|||
30810205|NCT02680834|58828764|FG001|Overall Study|Physician Decision|2|||
30909695|NCT01629667|58944562|FG001|Overall Study|Requiring lung transplant|1|||
30909696|NCT01629667|58944563|FG002|Overall Study|Requiring lung transplant|3|||
30909697|NCT01629667|58944561|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
30909698|NCT01629667|58944562|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
30909699|NCT01629667|58944563|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
30909700|NCT01629667|58944561|FG000|Overall Study|Started other medicine|1|||
30909701|NCT01629667|58944562|FG001|Overall Study|Started other medicine|0|||
30622539|NCT00922636|58634244|FG002|Overall Study|Protocol Violation|2|||
30810206|NCT02680834|58828763|FG000|Overall Study|Withdrawal by Subject|6|||
30810207|NCT02680834|58828764|FG001|Overall Study|Withdrawal by Subject|0|||
30810208|NCT02680834|58828763|FG000|Overall Study|Lost to Follow-up|0|||
30810209|NCT02680834|58828764|FG001|Overall Study|Lost to Follow-up|1|||
30810210|NCT03343704|58828772|FG000|Overall Study|Refused to complete follow up|0|||
30810211|NCT03343704|58828773|FG001|Overall Study|Refused to complete follow up|1|||
30810212|NCT03343704|58828772|FG000|Overall Study|Death|0|||
30810213|NCT03343704|58828773|FG001|Overall Study|Death|1|||
30810214|NCT03343704|58828772|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
30810215|NCT03343704|58828773|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
30810216|NCT02680756|58828783|FG000|Overall Study|Adverse Event|10|||
30810217|NCT02680756|58828784|FG001|Overall Study|Adverse Event|2|||
30810218|NCT02680756|58828783|FG000|Overall Study|Lost to Follow-up|7|||
30810219|NCT02680756|58828784|FG001|Overall Study|Lost to Follow-up|6|||
30810220|NCT02680756|58828783|FG000|Overall Study|Withdrawal by Subject|5|||
30810221|NCT02680756|58828784|FG001|Overall Study|Withdrawal by Subject|5|||
30810222|NCT02680756|58828783|FG000|Overall Study|Physician Decision|4|||
30810223|NCT02680756|58828784|FG001|Overall Study|Physician Decision|1|||
30810224|NCT02680756|58828783|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
30810225|NCT02680756|58828784|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
30810226|NCT02680756|58828783|FG000|Overall Study|Blood transfusion for any reason|0|||
30810227|NCT02680756|58828784|FG001|Overall Study|Blood transfusion for any reason|1|||
30810228|NCT02680756|58828783|FG000|Overall Study|Death|1|||
30810229|NCT02680756|58828784|FG001|Overall Study|Death|0|||
30810230|NCT02680756|58828783|FG000|Overall Study|Protocol Violation|1|||
30810231|NCT02680756|58828784|FG001|Overall Study|Protocol Violation|0|||
30810232|NCT02680756|58828783|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
30810233|NCT02680756|58828784|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
30810234|NCT02680756|58828783|FG000|Overall Study|None of above or not recorded|3|||
30810235|NCT02680756|58828784|FG001|Overall Study|None of above or not recorded|2|||
30810236|NCT03086460|58828790|FG000|Study Participants|Lost to Follow-up|2|||
30810237|NCT03086460|58828790|FG000|Study Participants|Protocol Violation|1|||
30810238|NCT03086460|58828790|FG000|Study Participants|Withdrawal by Subject|6|||
30810239|NCT03086460|58828790|FG000|Treatment A|Lost to Follow-up|1|||
30810240|NCT03086460|58828790|FG000|Treatment A|Protocol Violation|1|||
30810241|NCT03086460|58828790|FG000|Treatment A|Withdrawal by Subject|2|||
30810242|NCT03086460|58828790|FG000|Treatment C|Withdrawal by Subject|2|||
30810243|NCT03086460|58828790|FG000|Treatment E|Lost to Follow-up|1|||
30810244|NCT03086460|58828790|FG000|Treatment E|Withdrawal by Subject|3|||
30810245|NCT02677714|58828816|FG000|Overall Study|Withdrawal by Subject|2|||
30909702|NCT01629667|58944563|FG002|Overall Study|Started other medicine|1|||
30909703|NCT01629667|58944561|FG000|Overall Study|Site error in safety follow-up|0|||
30909704|NCT01629667|58944562|FG001|Overall Study|Site error in safety follow-up|0|||
30909705|NCT01629667|58944563|FG002|Overall Study|Site error in safety follow-up|1|||
30909706|NCT01629667|58944561|FG000|Overall Study|Enrolled in another clinical study|0|||
30909707|NCT01629667|58944562|FG001|Overall Study|Enrolled in another clinical study|1|||
30749704|NCT00195260|58759557|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
30749705|NCT00195260|58759558|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
30749706|NCT00195260|58759559|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
30749707|NCT00195260|58759560|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
30749708|NCT00195260|58759561|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
30749709|NCT00195260|58759562|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
30749710|NCT00195260|58759563|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
30749711|NCT00195260|58759553|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
30749712|NCT00195260|58759554|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
30749713|NCT00195260|58759555|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
30749714|NCT00195260|58759556|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
30749715|NCT00195260|58759557|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
30749716|NCT00195260|58759558|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
30749717|NCT00195260|58759559|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
30749718|NCT00195260|58759560|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
30749719|NCT00195260|58759561|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
30749720|NCT00195260|58759562|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
30749721|NCT00195260|58759563|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
30749722|NCT00031486|58759593|FG000|Overall Study|Adverse Event|1|||
30749723|NCT00031486|58759594|FG001|Overall Study|Adverse Event|0|||
30749724|NCT00031486|58759593|FG000|Overall Study|Lost to Follow-up|0|||
30749725|NCT00031486|58759594|FG001|Overall Study|Lost to Follow-up|1|||
30810246|NCT02677714|58828817|FG001|Overall Study|Withdrawal by Subject|0|||
30810247|NCT02677324|58828823|FG000|Overall Study|Disease Progression|6|||
30909708|NCT01629667|58944563|FG002|Overall Study|Enrolled in another clinical study|0|||
30909709|NCT01629667|58944561|FG000|Overall Study|Code break|1|||
30810248|NCT02677324|58828823|FG000|Overall Study|Inability to Swallow pills|1|||
30810249|NCT02677324|58828823|FG000|Overall Study|Non-compliance|1|||
30810250|NCT02677324|58828823|FG000|Overall Study|Lack of Efficacy|1|||
30810251|NCT02677324|58828823|FG000|Overall Study|Medical insurance coverage|1|||
30810252|NCT02677324|58828823|FG000|Overall Study|Adverse Event|1|||
30810253|NCT02677324|58828823|FG000|Overall Study|IgM Myeloma diagnosis|1|||
30810254|NCT01971008|58828831|FG000|Overall Study|Protocol Violation|2|||
30810255|NCT01971008|58828832|FG001|Overall Study|Protocol Violation|1|||
30810256|NCT01374178|58828841|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
30810257|NCT01374178|58828842|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
30810258|NCT01374178|58828841|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
30810259|NCT01374178|58828842|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
30810260|NCT03025542|58828850|FG000|Overall Study|Adverse Event|0|||
30810261|NCT03025542|58828851|FG001|Overall Study|Adverse Event|2|||
30810262|NCT03025542|58828850|FG000|Overall Study|Lost to Follow-up|1|||
30810263|NCT03025542|58828851|FG001|Overall Study|Lost to Follow-up|0|||
30810264|NCT03025542|58828850|FG000|Overall Study|Withdrawal by Subject|1|||
30810265|NCT03025542|58828851|FG001|Overall Study|Withdrawal by Subject|0|||
30810266|NCT03022370|58828865|FG000|Overall Study|Death|6|||
30810267|NCT03022370|58828866|FG001|Overall Study|Death|12|||
30810268|NCT03022370|58828865|FG000|Overall Study|Lost to Follow-up|174|||
30810269|NCT03022370|58828866|FG001|Overall Study|Lost to Follow-up|109|||
30810270|NCT03021668|58828878|FG000|Overall Study|Physician Decision|0|||
30810271|NCT03021668|58828879|FG001|Overall Study|Physician Decision|1|||
30810272|NCT03020888|58828885|FG000|Overall Study|Physician Decision|4|||
30810273|NCT03020888|58828885|FG000|Overall Study|Withdrawal by Subject|6|||
30810274|NCT03020888|58828885|FG000|Overall Study|Insurance coverage|2|||
30810275|NCT03020888|58828885|FG000|Overall Study|Lost to Follow-up|1|||
30810276|NCT02250300|58828893|FG000|Expansion Phase|Death|6|||
30810277|NCT02250300|58828894|FG001|Expansion Phase|Death|7|||
30622540|NCT00922636|58634245|FG003|Overall Study|Protocol Violation|2|||
30622541|NCT00922636|58634246|FG004|Overall Study|Protocol Violation|0|||
30810278|NCT02250300|58828895|FG002|Expansion Phase|Death|0|||
30810279|NCT02250300|58828896|FG003|Expansion Phase|Death|0|||
30810280|NCT03020966|58828909|FG000|Overall Study|Withdrawal by Subject|2|||
30810281|NCT03020966|58828910|FG001|Overall Study|Withdrawal by Subject|0|||
30810282|NCT03020576|58828918|FG000|Overall Study|Withdrawal by Subject|1|||
30810283|NCT03020576|58828919|FG001|Overall Study|Withdrawal by Subject|2|||
30810284|NCT03017612|58828925|FG000|Overall Study|Adverse Event|2|||
30810285|NCT03635099|58828937|FG000|Period 1|Adverse Event|1|||
30810286|NCT03635099|58828938|FG001|Period 1|Adverse Event|0|||
30810287|NCT03635099|58828939|FG002|Period 1|Adverse Event|0|||
30810288|NCT03635099|58828940|FG003|Period 1|Adverse Event|1|||
30810289|NCT03635099|58828941|FG004|Period 1|Adverse Event|0|||
30810290|NCT03635099|58828942|FG005|Period 1|Adverse Event|0|||
30810291|NCT03635099|58828943|FG006|Period 1|Adverse Event|0|||
30810292|NCT03635099|58828944|FG007|Period 1|Adverse Event|0|||
30810293|NCT03635099|58828937|FG000|Period 1|Protocol Violation|0|||
30810294|NCT03635099|58828938|FG001|Period 1|Protocol Violation|0|||
30810295|NCT03635099|58828939|FG002|Period 1|Protocol Violation|1|||
30810296|NCT03635099|58828940|FG003|Period 1|Protocol Violation|0|||
30810297|NCT03635099|58828941|FG004|Period 1|Protocol Violation|0|||
30810298|NCT03635099|58828942|FG005|Period 1|Protocol Violation|0|||
30810299|NCT03635099|58828943|FG006|Period 1|Protocol Violation|0|||
30810300|NCT03635099|58828944|FG007|Period 1|Protocol Violation|0|||
30810301|NCT03635099|58828937|FG000|Period 1|Lost to Follow-up|0|||
30909710|NCT01629667|58944562|FG001|Overall Study|Code break|0|||
30909711|NCT01629667|58944563|FG002|Overall Study|Code break|0|||
30810302|NCT03635099|58828938|FG001|Period 1|Lost to Follow-up|0|||
30810303|NCT03635099|58828939|FG002|Period 1|Lost to Follow-up|1|||
30810304|NCT03635099|58828940|FG003|Period 1|Lost to Follow-up|2|||
30810305|NCT03635099|58828941|FG004|Period 1|Lost to Follow-up|1|||
30810306|NCT03635099|58828942|FG005|Period 1|Lost to Follow-up|0|||
30810307|NCT03635099|58828943|FG006|Period 1|Lost to Follow-up|1|||
30810308|NCT03635099|58828944|FG007|Period 1|Lost to Follow-up|2|||
30810309|NCT03635099|58828937|FG000|Period 1|Withdrawal by Subject|3|||
30810310|NCT03635099|58828938|FG001|Period 1|Withdrawal by Subject|3|||
30909712|NCT01645280|58944578|FG000|Overall Study|Death|0|||
30810311|NCT03635099|58828939|FG002|Period 1|Withdrawal by Subject|5|||
30810312|NCT03635099|58828940|FG003|Period 1|Withdrawal by Subject|2|||
30622542|NCT00922636|58634242|FG000|Overall Study|Entry Criteria Not Met|0|||
30622543|NCT00922636|58634243|FG001|Overall Study|Entry Criteria Not Met|0|||
30810313|NCT03635099|58828941|FG004|Period 1|Withdrawal by Subject|2|||
30810314|NCT03635099|58828942|FG005|Period 1|Withdrawal by Subject|0|||
30810315|NCT03635099|58828943|FG006|Period 1|Withdrawal by Subject|3|||
30810316|NCT03635099|58828944|FG007|Period 1|Withdrawal by Subject|0|||
30810317|NCT03635099|58828937|FG000|Period 1|History of suicidal ideation|0|||
30909713|NCT01645280|58944579|FG001|Overall Study|Death|1|||
30810318|NCT03635099|58828938|FG001|Period 1|History of suicidal ideation|0|||
30810319|NCT03635099|58828939|FG002|Period 1|History of suicidal ideation|1|||
30810320|NCT03635099|58828940|FG003|Period 1|History of suicidal ideation|0|||
30810321|NCT03635099|58828941|FG004|Period 1|History of suicidal ideation|0|||
30810322|NCT03635099|58828942|FG005|Period 1|History of suicidal ideation|0|||
30810323|NCT03635099|58828943|FG006|Period 1|History of suicidal ideation|0|||
30810324|NCT03635099|58828944|FG007|Period 1|History of suicidal ideation|0|||
30810325|NCT03635099|58828937|FG000|Period 1|pursue other treatment options|0|||
30810326|NCT03635099|58828938|FG001|Period 1|pursue other treatment options|0|||
30810327|NCT03635099|58828939|FG002|Period 1|pursue other treatment options|0|||
30810328|NCT03635099|58828940|FG003|Period 1|pursue other treatment options|0|||
30909714|NCT01645280|58944580|FG002|Overall Study|Death|0|||
30909715|NCT01645280|58944581|FG003|Overall Study|Death|0|||
30909716|NCT01645280|58944582|FG004|Overall Study|Death|0|||
30909717|NCT01645280|58944578|FG000|Overall Study|Withdrawal by Subject|4|||
30909718|NCT01645280|58944579|FG001|Overall Study|Withdrawal by Subject|0|||
30909719|NCT01645280|58944580|FG002|Overall Study|Withdrawal by Subject|2|||
30909720|NCT01645280|58944581|FG003|Overall Study|Withdrawal by Subject|4|||
30909721|NCT01645280|58944582|FG004|Overall Study|Withdrawal by Subject|5|||
30909722|NCT01645280|58944578|FG000|Overall Study|Lost to Follow-up|0|||
30909723|NCT01645280|58944579|FG001|Overall Study|Lost to Follow-up|0|||
30909724|NCT01645280|58944580|FG002|Overall Study|Lost to Follow-up|0|||
30749726|NCT00031486|58759593|FG000|Overall Study|Withdrawal by Subject|3|||
30749727|NCT00031486|58759594|FG001|Overall Study|Withdrawal by Subject|2|||
30749728|NCT00031486|58759593|FG000|Overall Study|Death|0|||
30749729|NCT00031486|58759594|FG001|Overall Study|Death|3|||
30749730|NCT00031486|58759593|FG000|Overall Study|Non-compliant|0|||
30749731|NCT00031486|58759594|FG001|Overall Study|Non-compliant|4|||
30749732|NCT00031486|58759593|FG000|Overall Study|Did not meet eligibility requirement|2|||
30749733|NCT00031486|58759594|FG001|Overall Study|Did not meet eligibility requirement|1|||
30749734|NCT00031486|58759593|FG000|Overall Study|Other|1|||
30749735|NCT00031486|58759594|FG001|Overall Study|Other|1|||
30749736|NCT00003508|58759602|FG000|Overall Study|Not evaluable|5|||
30749737|NCT00003472|58759606|FG000|Overall Study|Not evaluable|3|||
30749738|NCT00003298|58759610|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
30749739|NCT00003298|58759610|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
30749740|NCT00003298|58759610|FG000|Surgery|Unresectable at surgery|3|||
30749741|NCT00003298|58759610|FG000|Surgery|Progression before surgery|2|||
30749742|NCT00003298|58759610|FG000|Surgery|Unevaluable and off study|2|||
30749743|NCT00003298|58759610|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
30749744|NCT00003298|58759610|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
30749745|NCT00003298|58759610|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
30749746|NCT00003298|58759610|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
30749747|NCT00003298|58759610|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
30749748|NCT00003298|58759610|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
30749749|NCT00003298|58759610|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
30749750|NCT00003298|58759610|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
30749751|NCT00003298|58759610|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
30749752|NCT00003298|58759610|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
30749753|NCT00002842|58759615|FG000|Overall Study|ineligible for surgical resection|27|||
30749754|NCT00143247|58759619|FG000|Overall Study|Death|8|||
30749755|NCT00143247|58759619|FG000|Overall Study|Adverse Event|19|||
30749756|NCT00143247|58759619|FG000|Overall Study|Lack of Efficacy|3|||
30810329|NCT03635099|58828941|FG004|Period 1|pursue other treatment options|0|||
30810330|NCT03635099|58828942|FG005|Period 1|pursue other treatment options|1|||
30909725|NCT01645280|58944581|FG003|Overall Study|Lost to Follow-up|2|||
30810331|NCT03635099|58828943|FG006|Period 1|pursue other treatment options|0|||
30909726|NCT01645280|58944582|FG004|Overall Study|Lost to Follow-up|1|||
30909727|NCT01645280|58944578|FG000|Overall Study|Other|1|||
30909728|NCT01645280|58944579|FG001|Overall Study|Other|1|||
30909729|NCT01645280|58944580|FG002|Overall Study|Other|2|||
30909730|NCT01645280|58944581|FG003|Overall Study|Other|0|||
30909731|NCT01645280|58944582|FG004|Overall Study|Other|0|||
30909732|NCT01645280|58944578|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
30909733|NCT01645280|58944579|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
30909734|NCT01645280|58944580|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
30909735|NCT01645280|58944581|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
30909736|NCT01645280|58944582|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
30909737|NCT02256917|58944595|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
30909738|NCT02256917|58944595|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
30909739|NCT02256917|58944595|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
30810332|NCT03635099|58828944|FG007|Period 1|pursue other treatment options|0|||
30810333|NCT03635099|58828937|FG000|Not Eligible for Period 2|Pregnancy|0|||
30810334|NCT03635099|58828938|FG001|Not Eligible for Period 2|Pregnancy|0|||
30810335|NCT03635099|58828939|FG002|Not Eligible for Period 2|Pregnancy|0|||
30810336|NCT03635099|58828940|FG003|Not Eligible for Period 2|Pregnancy|1|||
30810337|NCT03635099|58828941|FG004|Not Eligible for Period 2|Pregnancy|0|||
30810338|NCT03635099|58828942|FG005|Not Eligible for Period 2|Pregnancy|0|||
30810339|NCT03635099|58828943|FG006|Not Eligible for Period 2|Pregnancy|0|||
30810340|NCT03635099|58828944|FG007|Not Eligible for Period 2|Pregnancy|0|||
30810341|NCT03635099|58828937|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
30810342|NCT03635099|58828938|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
30810343|NCT03635099|58828939|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
30810344|NCT03635099|58828940|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
30810345|NCT03635099|58828941|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
30810346|NCT03635099|58828942|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
30810347|NCT03635099|58828943|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
30810348|NCT03635099|58828944|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
30810349|NCT03635099|58828937|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
30810350|NCT03635099|58828938|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
30810351|NCT03635099|58828939|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
30810352|NCT03635099|58828940|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
30810353|NCT03635099|58828941|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
30810354|NCT03635099|58828942|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
30810355|NCT03635099|58828943|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
30810356|NCT03635099|58828944|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
30810357|NCT03635099|58828937|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
30810358|NCT03635099|58828938|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
30810359|NCT03635099|58828939|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
30810360|NCT03635099|58828940|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
30810361|NCT03635099|58828941|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
30810362|NCT03635099|58828942|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
30810363|NCT03635099|58828943|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
30810364|NCT03635099|58828944|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
30810365|NCT03635099|58828937|FG000|Period 2|Adverse Event|0|||
30810366|NCT03635099|58828938|FG001|Period 2|Adverse Event|0|||
30810367|NCT03635099|58828939|FG002|Period 2|Adverse Event|1|||
30810368|NCT03635099|58828940|FG003|Period 2|Adverse Event|0|||
30810369|NCT03635099|58828941|FG004|Period 2|Adverse Event|1|||
30810370|NCT03635099|58828942|FG005|Period 2|Adverse Event|0|||
30810371|NCT03635099|58828943|FG006|Period 2|Adverse Event|0|||
30810372|NCT03635099|58828944|FG007|Period 2|Adverse Event|0|||
30810373|NCT03635099|58828937|FG000|Period 2|Lost to Follow-up|0|||
30810374|NCT03635099|58828938|FG001|Period 2|Lost to Follow-up|0|||
30810375|NCT03635099|58828939|FG002|Period 2|Lost to Follow-up|1|||
30810376|NCT03635099|58828940|FG003|Period 2|Lost to Follow-up|0|||
30810377|NCT03635099|58828941|FG004|Period 2|Lost to Follow-up|4|||
30810378|NCT03635099|58828942|FG005|Period 2|Lost to Follow-up|0|||
30810379|NCT03635099|58828943|FG006|Period 2|Lost to Follow-up|0|||
30810380|NCT03635099|58828944|FG007|Period 2|Lost to Follow-up|0|||
30909740|NCT02256917|58944595|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
30810381|NCT03635099|58828937|FG000|Period 2|Withdrawal by Subject|0|||
30810382|NCT03635099|58828938|FG001|Period 2|Withdrawal by Subject|0|||
30810383|NCT03635099|58828939|FG002|Period 2|Withdrawal by Subject|7|||
30810384|NCT03635099|58828940|FG003|Period 2|Withdrawal by Subject|4|||
30810385|NCT03635099|58828941|FG004|Period 2|Withdrawal by Subject|7|||
30810386|NCT03635099|58828942|FG005|Period 2|Withdrawal by Subject|0|||
30909741|NCT02256917|58944595|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
30810387|NCT03635099|58828943|FG006|Period 2|Withdrawal by Subject|0|||
30810388|NCT03635099|58828944|FG007|Period 2|Withdrawal by Subject|0|||
30810389|NCT02108652|58828970|FG000|Overall Study|Death|226|||
30810390|NCT02108652|58828970|FG000|Overall Study|Lost to Follow-up|2|||
30810391|NCT02108652|58828970|FG000|Overall Study|Withdrawal by Subject|8|||
30810392|NCT02108652|58828970|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74|||
30810393|NCT03634085|58828976|FG000|Overall Study|Adverse Event|1|||
30810394|NCT03634085|58828977|FG001|Overall Study|Adverse Event|0|||
30810395|NCT03634085|58828976|FG000|Overall Study|Withdrawal by Subject|0|||
30810396|NCT03634085|58828977|FG001|Overall Study|Withdrawal by Subject|2|||
30810397|NCT02676778|58828993|FG000|Overall Study|Disease Progression|7|||
30810398|NCT02676778|58828994|FG001|Overall Study|Disease Progression|3|||
30810399|NCT02676778|58828995|FG002|Overall Study|Disease Progression|1|||
30810400|NCT02676778|58828993|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
30810401|NCT02676778|58828994|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
30810402|NCT02676778|58828995|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
30810403|NCT02676778|58828993|FG000|Overall Study|Withdrawal by Subject|3|||
30810404|NCT02676778|58828994|FG001|Overall Study|Withdrawal by Subject|2|||
30810405|NCT02676778|58828995|FG002|Overall Study|Withdrawal by Subject|0|||
30810406|NCT02676778|58828993|FG000|Overall Study|Other|4|||
30810407|NCT02676778|58828994|FG001|Overall Study|Other|3|||
30810408|NCT02676778|58828995|FG002|Overall Study|Other|0|||
30810409|NCT02676778|58828993|FG000|Overall Study|Adverse Event|2|||
30810410|NCT02676778|58828994|FG001|Overall Study|Adverse Event|3|||
30810411|NCT02676778|58828995|FG002|Overall Study|Adverse Event|0|||
30810412|NCT02946385|58829010|FG000|Overall Study|Lost to Follow-up|0|||
30810413|NCT02946385|58829011|FG001|Overall Study|Lost to Follow-up|0|||
30810414|NCT02946385|58829012|FG002|Overall Study|Lost to Follow-up|3|||
30810415|NCT02946385|58829013|FG003|Overall Study|Lost to Follow-up|0|||
30810416|NCT02946385|58829014|FG004|Overall Study|Lost to Follow-up|2|||
30810417|NCT02946385|58829015|FG005|Overall Study|Lost to Follow-up|1|||
30810418|NCT02694718|58829035|FG000|Overall Study|Death|1|||
30810419|NCT02694718|58829035|FG000|Overall Study|Withdrawal by Subject|1|||
30810420|NCT02944513|58829041|FG000|Overall Study|Withdrawal by Subject|4|||
30810421|NCT02944513|58829042|FG001|Overall Study|Withdrawal by Subject|1|||
30810422|NCT03018938|58829057|FG000|Overall Study|Death|0|||
30810423|NCT03018938|58829058|FG001|Overall Study|Death|1|||
30810424|NCT03018938|58829057|FG000|Overall Study|Lost to Follow-up|21|||
30810425|NCT03018938|58829058|FG001|Overall Study|Lost to Follow-up|32|||
30810426|NCT03018938|58829057|FG000|Overall Study|Withdrawal by Subject|38|||
30810427|NCT03018938|58829058|FG001|Overall Study|Withdrawal by Subject|45|||
30810428|NCT03018938|58829057|FG000|Overall Study|Physician Decision|3|||
30810429|NCT03018938|58829058|FG001|Overall Study|Physician Decision|2|||
30810430|NCT03018938|58829057|FG000|Overall Study|Sponsor Decision|0|||
30810431|NCT03018938|58829058|FG001|Overall Study|Sponsor Decision|1|||
30810432|NCT03018938|58829057|FG000|Overall Study|Screen failure-After randomization|4|||
30810433|NCT03018938|58829058|FG001|Overall Study|Screen failure-After randomization|2|||
30810434|NCT03018938|58829057|FG000|Overall Study|Not recorded|0|||
30810435|NCT03018938|58829058|FG001|Overall Study|Not recorded|2|||
30810436|NCT02943577|58829066|FG000|Overall Study|Protocol Violation|0|||
30810437|NCT02943577|58829067|FG001|Overall Study|Protocol Violation|1|||
30810438|NCT02943577|58829066|FG000|Overall Study|Adverse Event|3|||
30810439|NCT02943577|58829067|FG001|Overall Study|Adverse Event|2|||
30810440|NCT02943577|58829066|FG000|Overall Study|Lost to Follow-up|0|||
30810441|NCT02943577|58829067|FG001|Overall Study|Lost to Follow-up|1|||
30810442|NCT02943577|58829066|FG000|Overall Study|Withdrawal by Subject|1|||
30909742|NCT01629589|58944608|FG000|Overall Study|Protocol Violation|4|||
30909743|NCT01629589|58944609|FG001|Overall Study|Protocol Violation|2|||
30749757|NCT00143247|58759619|FG000|Overall Study|Withdrawal by Subject|55|||
30749758|NCT00143247|58759619|FG000|Overall Study|Study terminated by sponsor|31|||
30749759|NCT00143247|58759619|FG000|Overall Study|Protocol Violation|15|||
30749760|NCT00143247|58759619|FG000|Overall Study|Lost to Follow-up|12|||
30749761|NCT00143247|58759619|FG000|Overall Study|following inaccurate lab adverse event|1|||
30749762|NCT00143247|58759619|FG000|Overall Study|Other|12|||
30810443|NCT02943577|58829067|FG001|Overall Study|Withdrawal by Subject|1|||
30810444|NCT02943577|58829066|FG000|Overall Study|Pregnancy|1|||
30810445|NCT02943577|58829067|FG001|Overall Study|Pregnancy|0|||
30810446|NCT03016598|58829075|FG000|Overall Study|Lost to Follow-up|0|||
30810447|NCT03016598|58829076|FG001|Overall Study|Lost to Follow-up|2|||
30810448|NCT03017846|58829082|FG000|Overall Study|Lost to Follow-up|3|||
30749763|NCT00125853|58759623|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
30749764|NCT00125853|58759624|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
30749765|NCT00219141|58759633|FG000|Overall Study|Adverse Event|4|||
30749766|NCT00219141|58759634|FG001|Overall Study|Adverse Event|10|||
30749767|NCT00219141|58759635|FG002|Overall Study|Adverse Event|5|||
30749768|NCT00219141|58759633|FG000|Overall Study|Lack of Efficacy|3|||
30810449|NCT03017846|58829082|FG000|Overall Study|Adverse Event|2|||
30810450|NCT03014180|58829088|FG000|Overall Study|Protocol Violation|2|||
30810451|NCT03011840|58829098|FG000|Overall Study|Not received PIL in post PIL phase|0|||
30810452|NCT03011840|58829099|FG001|Overall Study|Not received PIL in post PIL phase|21|||
30810453|NCT02942485|58829107|FG000|Overall Study|Lost to Follow-up|1|||
30810454|NCT02942485|58829108|FG001|Overall Study|Lost to Follow-up|0|||
30810455|NCT02942407|58829116|FG000|Overall Study|Lost to Follow-up|3|||
30810456|NCT02942407|58829117|FG001|Overall Study|Lost to Follow-up|2|||
30810457|NCT02942407|58829116|FG000|Overall Study|Withdrawal by Subject|7|||
30810458|NCT02942407|58829117|FG001|Overall Study|Withdrawal by Subject|9|||
30810459|NCT02942407|58829116|FG000|Overall Study|Death|16|||
30810460|NCT02942407|58829117|FG001|Overall Study|Death|13|||
30810461|NCT03009344|58829131|FG000|Overall Study|Lack of Efficacy|5|||
30810462|NCT03009344|58829131|FG000|Overall Study|Withdrawal by Subject|1|||
30810463|NCT03009344|58829131|FG000|Overall Study|Adverse Event|1|||
30810464|NCT03322423|58829135|FG000|Period 1|Subject no longer eligible|0|||
30810465|NCT03322423|58829136|FG001|Period 1|Subject no longer eligible|1|||
30810466|NCT03322423|58829135|FG000|Period 1|Withdrawal by Subject|0|||
30810467|NCT03322423|58829136|FG001|Period 1|Withdrawal by Subject|1|||
30810468|NCT03322423|58829135|FG000|Period 1|Incorrect Lens Dispensed|1|||
30810469|NCT03322423|58829136|FG001|Period 1|Incorrect Lens Dispensed|0|||
30810470|NCT03322423|58829135|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
30810471|NCT03322423|58829136|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
30810472|NCT03322423|58829135|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
30810473|NCT03322423|58829136|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
30810474|NCT03322423|58829135|FG000|Period 2|Protocol Violation|1|||
30810475|NCT03322423|58829136|FG001|Period 2|Protocol Violation|0|||
30810476|NCT03322423|58829135|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
30810477|NCT03322423|58829136|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
30810478|NCT03007472|58829142|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
30810479|NCT03007472|58829142|FG000|Overall Study|Death|2|||
30810480|NCT03007472|58829142|FG000|Overall Study|Loss to Follow Up|1|||
30810481|NCT03321721|58829149|FG000|Overall Study|Lost to Follow-up|4|||
30810482|NCT03321721|58829150|FG001|Overall Study|Lost to Follow-up|8|||
30810483|NCT03321721|58829151|FG002|Overall Study|Lost to Follow-up|11|||
30810484|NCT03015116|58829163|FG000|Overall Study|Lost to Follow-up|3|||
30810485|NCT03015116|58829164|FG001|Overall Study|Lost to Follow-up|0|||
30810486|NCT03015116|58829165|FG002|Overall Study|Lost to Follow-up|2|||
30810487|NCT03015116|58829163|FG000|Overall Study|Withdrawal by Subject|3|||
30810488|NCT03015116|58829164|FG001|Overall Study|Withdrawal by Subject|1|||
30749769|NCT00219141|58759634|FG001|Overall Study|Lack of Efficacy|2|||
30810489|NCT03015116|58829165|FG002|Overall Study|Withdrawal by Subject|0|||
30810490|NCT03015116|58829163|FG000|Overall Study|Subject has New Medical Status|1|||
30909744|NCT01629589|58944608|FG000|Overall Study|Lost to Follow-up|2|||
30909745|NCT01629589|58944609|FG001|Overall Study|Lost to Follow-up|1|||
30909746|NCT01629589|58944608|FG000|Overall Study|Withdrawal by Subject|2|||
30909747|NCT01629589|58944609|FG001|Overall Study|Withdrawal by Subject|3|||
30909748|NCT01629589|58944608|FG000|Overall Study|Did not receive study vaccine|0|||
30909749|NCT01629589|58944609|FG001|Overall Study|Did not receive study vaccine|1|||
30810491|NCT03015116|58829164|FG001|Overall Study|Subject has New Medical Status|0|||
30810492|NCT03015116|58829165|FG002|Overall Study|Subject has New Medical Status|0|||
30810493|NCT03015116|58829163|FG000|Overall Study|Physician Decision|0|||
30810494|NCT03015116|58829164|FG001|Overall Study|Physician Decision|1|||
30810495|NCT03015116|58829165|FG002|Overall Study|Physician Decision|0|||
30909750|NCT02256839|58944617|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
30909751|NCT02256839|58944618|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
30909752|NCT02220907|58944624|FG000|Overall Study|Adverse Event|7|||
30909753|NCT02220907|58944624|FG000|Overall Study|Physician Decision|1|||
30909754|NCT02220907|58944624|FG000|Overall Study|Withdrawal by Subject|2|||
30909755|NCT02220907|58944624|FG000|Overall Study|Conflict with the stopping criteria|1|||
30909756|NCT02255981|58944628|FG000|Overall Study|Lost to Follow-up|3|||
30749770|NCT00219141|58759635|FG002|Overall Study|Lack of Efficacy|0|||
30749771|NCT00219141|58759633|FG000|Overall Study|Administrative problems|0|||
30810496|NCT03006458|58829175|FG000|First Intervention|Unsatisfied Vision|0|||
30810497|NCT03006458|58829176|FG001|First Intervention|Unsatisfied Vision|3|||
30810498|NCT03320941|58829187|FG000|Overall Study|subject/guardian decision|0|||
30810499|NCT03320941|58829188|FG001|Overall Study|subject/guardian decision|0|||
30810500|NCT03320941|58829189|FG002|Overall Study|subject/guardian decision|0|||
30909757|NCT02255981|58944628|FG000|Overall Study|Withdrawal by Subject|1|||
30909758|NCT01601873|58944640|FG000|Overall Study|Lost to Follow-up|2|||
30749772|NCT00219141|58759634|FG001|Overall Study|Administrative problems|1|||
30749773|NCT00219141|58759635|FG002|Overall Study|Administrative problems|0|||
30749774|NCT00219141|58759633|FG000|Overall Study|Lost to Follow-up|2|||
30749775|NCT00219141|58759634|FG001|Overall Study|Lost to Follow-up|4|||
30749776|NCT00219141|58759635|FG002|Overall Study|Lost to Follow-up|1|||
30749777|NCT00219141|58759633|FG000|Overall Study|Protocol Violation|3|||
30749778|NCT00219141|58759634|FG001|Overall Study|Protocol Violation|1|||
30749779|NCT00219141|58759635|FG002|Overall Study|Protocol Violation|1|||
30749780|NCT00219141|58759633|FG000|Overall Study|Withdrawal by Subject|1|||
30749781|NCT00219141|58759634|FG001|Overall Study|Withdrawal by Subject|3|||
30749782|NCT00219141|58759635|FG002|Overall Study|Withdrawal by Subject|5|||
30749783|NCT00219141|58759633|FG000|Overall Study|Condition no longer requires study drug|1|||
30749784|NCT00219141|58759634|FG001|Overall Study|Condition no longer requires study drug|0|||
30810501|NCT03320941|58829190|FG003|Overall Study|subject/guardian decision|1|||
30909759|NCT01601873|58944641|FG001|Overall Study|Lost to Follow-up|3|||
30909760|NCT02194933|58944649|FG000|Overall Study|Lost to Follow-up|1|||
30909761|NCT02194933|58944650|FG001|Overall Study|Lost to Follow-up|2|||
30749785|NCT00219141|58759635|FG002|Overall Study|Condition no longer requires study drug|0|||
30749786|NCT00142935|58759646|FG000|Overall Study|Other reason|1|||
30749787|NCT00142935|58759647|FG001|Overall Study|Other reason|1|||
30749788|NCT00142935|58759648|FG002|Overall Study|Other reason|1|||
30749789|NCT00142935|58759646|FG000|Overall Study|Lost to Follow-up|2|||
30810502|NCT03320941|58829191|FG004|Overall Study|subject/guardian decision|0|||
30810503|NCT03005288|58829205|FG000|Overall Study|Withdrawal by Subject|7|||
30810504|NCT03005288|58829206|FG001|Overall Study|Withdrawal by Subject|5|||
30810505|NCT03005288|58829205|FG000|Overall Study|Lost to Follow-up|0|||
30909762|NCT02194933|58944649|FG000|Overall Study|Participant met withdrawal criteria|1|||
30909763|NCT02194933|58944650|FG001|Overall Study|Participant met withdrawal criteria|3|||
30810506|NCT03005288|58829206|FG001|Overall Study|Lost to Follow-up|1|||
30810507|NCT03005288|58829205|FG000|Overall Study|Adverse Event|5|||
30810508|NCT03005288|58829206|FG001|Overall Study|Adverse Event|0|||
30810509|NCT03005288|58829205|FG000|Overall Study|Protocol deviation|0|||
30810510|NCT03005288|58829206|FG001|Overall Study|Protocol deviation|1|||
30810511|NCT03005288|58829205|FG000|Overall Study|Physician Decision|0|||
30810512|NCT03005288|58829206|FG001|Overall Study|Physician Decision|1|||
30810513|NCT03003494|58829212|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
30810514|NCT03559699|58829216|FG000|Overall Study|Withdrawal by Subject|6|||
30810515|NCT03559699|58829216|FG000|Overall Study|Lost to Follow-up|1|||
30810516|NCT03085758|58829223|FG000|Overall Study|Death|26|||
30810517|NCT03085758|58829224|FG001|Overall Study|Death|24|||
30810518|NCT03085758|58829225|FG002|Overall Study|Death|53|||
30810519|NCT03085758|58829223|FG000|Overall Study|Lost to Follow-up|1|||
30810520|NCT03085758|58829224|FG001|Overall Study|Lost to Follow-up|1|||
30810521|NCT03085758|58829225|FG002|Overall Study|Lost to Follow-up|1|||
30810522|NCT03085758|58829223|FG000|Overall Study|Withdrawal by Subject|2|||
30810523|NCT03085758|58829224|FG001|Overall Study|Withdrawal by Subject|2|||
30810524|NCT03085758|58829225|FG002|Overall Study|Withdrawal by Subject|1|||
30810525|NCT03085758|58829223|FG000|Overall Study|Refusal to recall it up to day 90|0|||
30810526|NCT03085758|58829224|FG001|Overall Study|Refusal to recall it up to day 90|0|||
30810527|NCT03085758|58829225|FG002|Overall Study|Refusal to recall it up to day 90|1|||
30810528|NCT03085758|58829223|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
30810529|NCT03085758|58829224|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
30810530|NCT03085758|58829225|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
30810531|NCT03935880|58829249|FG000|Overall Study|Lost to Follow-up|0|||
30810532|NCT03935880|58829250|FG001|Overall Study|Lost to Follow-up|1|||
30810533|NCT03315793|58829258|FG000|Overall Study|Adverse Event|4|||
30810534|NCT03315793|58829259|FG001|Overall Study|Adverse Event|2|||
30810535|NCT03315793|58829258|FG000|Overall Study|Protocol Deviation|1|||
30810536|NCT03315793|58829259|FG001|Overall Study|Protocol Deviation|0|||
30810537|NCT03315793|58829258|FG000|Overall Study|Difficult for regular visit|0|||
30810538|NCT03315793|58829259|FG001|Overall Study|Difficult for regular visit|1|||
30810539|NCT02676466|58829275|FG000|Overall Study|Death|0|||
30810540|NCT02676466|58829276|FG001|Overall Study|Death|2|||
30810541|NCT02676466|58829277|FG002|Overall Study|Death|1|||
30810542|NCT02676466|58829278|FG003|Overall Study|Death|0|||
30810543|NCT02676466|58829279|FG004|Overall Study|Death|0|||
30810544|NCT02676466|58829280|FG005|Overall Study|Death|0|||
30810545|NCT02676466|58829281|FG006|Overall Study|Death|0|||
30810546|NCT02676466|58829282|FG007|Overall Study|Death|0|||
30810547|NCT02676466|58829275|FG000|Overall Study|Withdrawal by Subject|4|||
30810548|NCT02676466|58829276|FG001|Overall Study|Withdrawal by Subject|3|||
30810549|NCT02676466|58829277|FG002|Overall Study|Withdrawal by Subject|1|||
30810550|NCT02676466|58829278|FG003|Overall Study|Withdrawal by Subject|0|||
30810551|NCT02676466|58829279|FG004|Overall Study|Withdrawal by Subject|3|||
30810552|NCT02676466|58829280|FG005|Overall Study|Withdrawal by Subject|1|||
30810553|NCT02676466|58829281|FG006|Overall Study|Withdrawal by Subject|1|||
30810554|NCT02676466|58829282|FG007|Overall Study|Withdrawal by Subject|1|||
30810555|NCT03314857|58829304|FG000|Overall Study|Death|4|||
30810556|NCT03314857|58829304|FG000|Overall Study|Physician Decision|1|||
30810557|NCT03633695|58829310|FG000|Overall Study|Lost to Follow-up|4|||
30810558|NCT03633695|58829311|FG001|Overall Study|Lost to Follow-up|5|||
30810559|NCT03633695|58829310|FG000|Overall Study|Discontinued|8|||
30810560|NCT03633695|58829311|FG001|Overall Study|Discontinued|4|||
30810561|NCT03314233|58829333|FG000|Overall Study|No longer eligible at time of delivery|1|||
30810562|NCT02675998|58829341|FG000|8-Week Treatment Period|Adverse Event|6|||
30810563|NCT02675998|58829342|FG001|8-Week Treatment Period|Adverse Event|5|||
30810564|NCT02675998|58829343|FG002|8-Week Treatment Period|Adverse Event|6|||
30810565|NCT02675998|58829344|FG003|8-Week Treatment Period|Adverse Event|0|||
30810566|NCT02675998|58829341|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
30810567|NCT02675998|58829342|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
30810568|NCT02675998|58829343|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
30810569|NCT02675998|58829344|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
30810570|NCT02675998|58829341|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
30810571|NCT02675998|58829342|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
30810572|NCT02675998|58829343|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
30810573|NCT02675998|58829344|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
30810574|NCT02675998|58829341|FG000|8-Week Treatment Period|Physician Decision|1|||
30810575|NCT02675998|58829342|FG001|8-Week Treatment Period|Physician Decision|0|||
30810576|NCT02675998|58829343|FG002|8-Week Treatment Period|Physician Decision|2|||
30810577|NCT02675998|58829344|FG003|8-Week Treatment Period|Physician Decision|0|||
30810578|NCT02675998|58829341|FG000|8-Week Treatment Period|GI side Effects|1|||
30810579|NCT02675998|58829342|FG001|8-Week Treatment Period|GI side Effects|4|||
30810580|NCT02675998|58829343|FG002|8-Week Treatment Period|GI side Effects|2|||
30810581|NCT02675998|58829344|FG003|8-Week Treatment Period|GI side Effects|0|||
30810582|NCT02675998|58829341|FG000|8-Week Treatment Period|Protocol Violation|1|||
30810583|NCT02675998|58829342|FG001|8-Week Treatment Period|Protocol Violation|1|||
30810584|NCT02675998|58829343|FG002|8-Week Treatment Period|Protocol Violation|1|||
30810585|NCT02675998|58829344|FG003|8-Week Treatment Period|Protocol Violation|0|||
30810586|NCT02675998|58829341|FG000|8-Week Treatment Period|Other|3|||
30810587|NCT02675998|58829342|FG001|8-Week Treatment Period|Other|1|||
30810588|NCT02675998|58829343|FG002|8-Week Treatment Period|Other|2|||
30810589|NCT02675998|58829344|FG003|8-Week Treatment Period|Other|0|||
30810590|NCT02675998|58829341|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
30810591|NCT02675998|58829342|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
30810592|NCT02675998|58829343|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
30810593|NCT02675998|58829344|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
30810594|NCT02675998|58829341|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
30810595|NCT02675998|58829342|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
30810596|NCT02675998|58829343|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
30810597|NCT02675998|58829344|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
30810598|NCT02675998|58829341|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
30909764|NCT02194933|58944649|FG000|Overall Study|Withdrawal by Subject|0|||
30909765|NCT02194933|58944650|FG001|Overall Study|Withdrawal by Subject|2|||
30810599|NCT02675998|58829342|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
30810600|NCT02675998|58829343|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
30810601|NCT02675998|58829344|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
30810602|NCT02675998|58829341|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
30909766|NCT02194933|58944649|FG000|Overall Study|Lack of Efficacy|1|||
30909767|NCT02194933|58944650|FG001|Overall Study|Lack of Efficacy|2|||
30909768|NCT01644890|58944660|FG000|Overall Study|Adverse Event|7|||
30909769|NCT01644890|58944661|FG001|Overall Study|Adverse Event|20|||
30622544|NCT00922636|58634244|FG002|Overall Study|Entry Criteria Not Met|1|||
30622545|NCT00922636|58634245|FG003|Overall Study|Entry Criteria Not Met|1|||
30622546|NCT00922636|58634246|FG004|Overall Study|Entry Criteria Not Met|0|||
30622547|NCT00922636|58634242|FG000|Overall Study|Parent/Caregiver Decision|2|||
30622548|NCT00922636|58634243|FG001|Overall Study|Parent/Caregiver Decision|4|||
30810603|NCT02675998|58829342|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
30909770|NCT01644890|58944660|FG000|Overall Study|Death|1|||
30909771|NCT01644890|58944661|FG001|Overall Study|Death|3|||
30909772|NCT01644890|58944660|FG000|Overall Study|Physician Decision|3|||
30909773|NCT01644890|58944661|FG001|Overall Study|Physician Decision|9|||
30909774|NCT01644890|58944660|FG000|Overall Study|Protocol Violation|6|||
30810604|NCT02675998|58829343|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
30810605|NCT02675998|58829344|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
30810606|NCT02675998|58829341|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
30810607|NCT02675998|58829342|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
30810608|NCT02675998|58829343|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
30810609|NCT02675998|58829344|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
30810610|NCT02674204|58829360|FG000|Overall Study|Adverse Event|1|||
30810611|NCT02674204|58829361|FG001|Overall Study|Adverse Event|0|||
30810612|NCT02941627|58829367|FG000|Overall Study|Death|1|||
30810613|NCT02941627|58829367|FG000|Overall Study|Surgical failure|1|||
30810614|NCT02941627|58829367|FG000|Overall Study|cholesteatoma prevented implantation|1|||
30810615|NCT03521934|58829379|FG000|Overall Study|Death|65|||
30810616|NCT03521934|58829380|FG001|Overall Study|Death|73|||
30810617|NCT03521934|58829379|FG000|Overall Study|Withdrawal by Subject|18|||
30810618|NCT03521934|58829380|FG001|Overall Study|Withdrawal by Subject|23|||
30810619|NCT03521934|58829379|FG000|Overall Study|Site Terminated by Sponsor|39|||
30810620|NCT03521934|58829380|FG001|Overall Study|Site Terminated by Sponsor|35|||
30810621|NCT03521934|58829379|FG000|Overall Study|Study Terminated by Sponsor|483|||
30810622|NCT03521934|58829380|FG001|Overall Study|Study Terminated by Sponsor|477|||
30810623|NCT03521934|58829379|FG000|Overall Study|Reason not Specified|3|||
30810624|NCT03521934|58829380|FG001|Overall Study|Reason not Specified|6|||
30810625|NCT03434353|58829391|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
30909775|NCT01644890|58944661|FG001|Overall Study|Protocol Violation|7|||
30909776|NCT01644890|58944660|FG000|Overall Study|Withdrawal by Subject|19|||
30909777|NCT01644890|58944661|FG001|Overall Study|Withdrawal by Subject|27|||
30909778|NCT01644890|58944660|FG000|Overall Study|Progression Disease|160|||
30622549|NCT00922636|58634244|FG002|Overall Study|Parent/Caregiver Decision|3|||
30810626|NCT03434353|58829392|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
30810627|NCT03434353|58829393|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
30810628|NCT03434353|58829394|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
30810629|NCT03434353|58829395|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
30810630|NCT03434353|58829391|FG000|Overall Study|Withdrew consent|1|||
30810631|NCT03434353|58829392|FG001|Overall Study|Withdrew consent|0|||
30909779|NCT01644890|58944661|FG001|Overall Study|Progression Disease|131|||
30909780|NCT01644890|58944660|FG000|Overall Study|Clinical Progression|6|||
30622550|NCT00922636|58634245|FG003|Overall Study|Parent/Caregiver Decision|5|||
30810632|NCT03434353|58829393|FG002|Overall Study|Withdrew consent|3|||
30810633|NCT03434353|58829394|FG003|Overall Study|Withdrew consent|0|||
30810634|NCT03434353|58829395|FG004|Overall Study|Withdrew consent|0|||
30810635|NCT03434353|58829391|FG000|Overall Study|Adverse Event|1|||
30810636|NCT03434353|58829392|FG001|Overall Study|Adverse Event|0|||
30810637|NCT03434353|58829393|FG002|Overall Study|Adverse Event|0|||
30810638|NCT03434353|58829394|FG003|Overall Study|Adverse Event|0|||
30810639|NCT03434353|58829395|FG004|Overall Study|Adverse Event|1|||
30810640|NCT03434353|58829391|FG000|Overall Study|Lost to Follow-up|2|||
30810641|NCT03434353|58829392|FG001|Overall Study|Lost to Follow-up|0|||
30810642|NCT03434353|58829393|FG002|Overall Study|Lost to Follow-up|0|||
30810643|NCT03434353|58829394|FG003|Overall Study|Lost to Follow-up|0|||
30810644|NCT03434353|58829395|FG004|Overall Study|Lost to Follow-up|0|||
30810645|NCT02914184|58829411|FG000|Overall Study|Lost to Follow-up|7|||
30810646|NCT02914184|58829412|FG001|Overall Study|Lost to Follow-up|10|||
30810647|NCT02914184|58829413|FG002|Overall Study|Lost to Follow-up|8|||
30810648|NCT02914184|58829414|FG003|Overall Study|Lost to Follow-up|7|||
30810649|NCT02914184|58829411|FG000|Overall Study|Withdrawal by Subject|4|||
30810650|NCT02914184|58829412|FG001|Overall Study|Withdrawal by Subject|2|||
30810651|NCT02914184|58829413|FG002|Overall Study|Withdrawal by Subject|7|||
30810652|NCT02914184|58829414|FG003|Overall Study|Withdrawal by Subject|3|||
30810653|NCT02914184|58829411|FG000|Overall Study|Other|1|||
30810654|NCT02914184|58829412|FG001|Overall Study|Other|0|||
30810655|NCT02914184|58829413|FG002|Overall Study|Other|0|||
30810656|NCT02914184|58829414|FG003|Overall Study|Other|0|||
30810657|NCT02914184|58829411|FG000|Overall Study|Migrated/moved from the study area|2|||
30810658|NCT02914184|58829412|FG001|Overall Study|Migrated/moved from the study area|1|||
30909781|NCT01644890|58944661|FG001|Overall Study|Clinical Progression|6|||
30909782|NCT01644890|58944660|FG000|Overall Study|> 28 days since last dose of study drug|6|||
30810659|NCT02914184|58829413|FG002|Overall Study|Migrated/moved from the study area|2|||
30810660|NCT02914184|58829414|FG003|Overall Study|Migrated/moved from the study area|1|||
30810661|NCT03633227|58829428|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
30810662|NCT03633227|58829429|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
30810663|NCT03633227|58829428|FG000|Double Blind (DB), up to Week 48|Death|2|||
30810664|NCT03633227|58829429|FG001|Double Blind (DB), up to Week 48|Death|1|||
30810665|NCT03633227|58829428|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
30909783|NCT01644890|58944661|FG001|Overall Study|> 28 days since last dose of study drug|3|||
30909784|NCT01644890|58944660|FG000|Overall Study|Other|8|||
30909785|NCT01644890|58944661|FG001|Overall Study|Other|9|||
30909786|NCT01628965|58944667|FG000|Overall Study|Adverse Event|30|||
30909787|NCT01628965|58944667|FG000|Overall Study|Lack of Efficacy|7|||
30909788|NCT01628965|58944667|FG000|Overall Study|Withdrawal by Subject|3|||
30909789|NCT01628965|58944667|FG000|Overall Study|Lost to Follow-up|1|||
30909790|NCT01628965|58944667|FG000|Overall Study|Discontinuation criteria|8|||
30909791|NCT01644734|58944671|FG000|Overall Study|Adverse Event|4|||
30909792|NCT01644734|58944671|FG000|Overall Study|Lost to Follow-up|17|||
30909793|NCT01644734|58944671|FG000|Overall Study|Reasons other than stated above|7|||
30909794|NCT01644734|58944671|FG000|Overall Study|Missing documentation|238|||
30909795|NCT02255279|58944677|FG000|Overall Study|Lost to Follow-up|2|||
30909796|NCT02255279|58944678|FG001|Overall Study|Lost to Follow-up|2|||
30909797|NCT02255279|58944677|FG000|Overall Study|Protocol Violation|0|||
30909798|NCT02255279|58944678|FG001|Overall Study|Protocol Violation|1|||
30909799|NCT02255279|58944677|FG000|Overall Study|Withdrawal by Subject|3|||
30909800|NCT02255279|58944678|FG001|Overall Study|Withdrawal by Subject|6|||
30909801|NCT01643798|58944698|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
30909802|NCT01643798|58944699|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
30909803|NCT02194699|58944712|FG000|Randomised|Did not receive treatment|1|||
30909804|NCT02194699|58944713|FG001|Randomised|Did not receive treatment|5|||
30909805|NCT02194699|58944712|FG000|Randomised|Without potential for 52 weeks of IP|5|||
30909806|NCT02194699|58944713|FG001|Randomised|Without potential for 52 weeks of IP|5|||
30909807|NCT02194699|58944712|FG000|Randomised|Duplicate patient|2|||
30909808|NCT02194699|58944713|FG001|Randomised|Duplicate patient|1|||
30810666|NCT03633227|58829429|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
30810667|NCT03633227|58829428|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
30810668|NCT03633227|58829429|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
30810669|NCT03633227|58829428|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
30810670|NCT03633227|58829429|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
30810671|NCT03633227|58829428|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
30909809|NCT02194699|58944712|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
30909810|NCT02194699|58944713|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
30810672|NCT03633227|58829429|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
30810673|NCT03633227|58829428|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
30810674|NCT03633227|58829429|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
30810675|NCT03633227|58829428|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
30810676|NCT03633227|58829429|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
30810677|NCT03633227|58829428|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
30810678|NCT03633227|58829429|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
30810679|NCT03633227|58829428|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
30810680|NCT03633227|58829429|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
30810681|NCT03633227|58829428|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
30810682|NCT03633227|58829429|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
30810683|NCT03633227|58829428|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
30909811|NCT02194699|58944712|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
30909812|NCT02194699|58944713|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
30909813|NCT02194699|58944712|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
30909814|NCT02194699|58944713|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
30909815|NCT02194699|58944712|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
30909816|NCT02194699|58944713|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
30909817|NCT02194699|58944712|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
30909818|NCT02194699|58944713|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
30909819|NCT02194699|58944712|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
30909820|NCT02194699|58944713|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
30810684|NCT03633227|58829429|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
30810685|NCT02913326|58829442|FG000|Overall Study|Reason not listed|0|||
30810686|NCT02913326|58829443|FG001|Overall Study|Reason not listed|1|||
30810687|NCT02913326|58829442|FG000|Overall Study|Lost to Follow-up|0|||
30810688|NCT02913326|58829443|FG001|Overall Study|Lost to Follow-up|1|||
30810689|NCT02913326|58829442|FG000|Overall Study|Adverse Event|1|||
30810690|NCT02913326|58829443|FG001|Overall Study|Adverse Event|0|||
30810691|NCT02912468|58829451|FG000|Overall Study|Adverse Event|3|||
30810692|NCT02912468|58829452|FG001|Overall Study|Adverse Event|2|||
30810693|NCT02912468|58829451|FG000|Overall Study|Withdrawal by Subject|6|||
30810694|NCT02912468|58829452|FG001|Overall Study|Withdrawal by Subject|2|||
30810695|NCT02912468|58829451|FG000|Overall Study|Randomized and not treated|0|||
30810696|NCT02912468|58829452|FG001|Overall Study|Randomized and not treated|1|||
30810697|NCT04438499|58829459|FG000|Overall Study|Lack of Efficacy|2|||
30810698|NCT00002874|58829465|FG000|Overall Study|Withdrawal by Subject|1|||
30810699|NCT00002874|58829466|FG001|Overall Study|Withdrawal by Subject|1|||
30810700|NCT00002874|58829465|FG000|Overall Study|Protocol Violation|44|||
30810701|NCT00002874|58829466|FG001|Overall Study|Protocol Violation|34|||
30810702|NCT03001076|58829474|FG000|Overall Study|Withdrawal by patient|2|||
30810703|NCT03001076|58829475|FG001|Overall Study|Withdrawal by patient|0|||
30810704|NCT03001076|58829474|FG000|Overall Study|Other|1|||
30749790|NCT00142935|58759647|FG001|Overall Study|Lost to Follow-up|5|||
30749791|NCT00142935|58759648|FG002|Overall Study|Lost to Follow-up|5|||
30749792|NCT00142935|58759646|FG000|Overall Study|Death|0|||
30749793|NCT00142935|58759647|FG001|Overall Study|Death|2|||
30749794|NCT00142935|58759648|FG002|Overall Study|Death|1|||
30749795|NCT00233948|58759662|FG000|Overall Study|Adverse Event|1|||
30749796|NCT00233948|58759663|FG001|Overall Study|Adverse Event|0|||
30749797|NCT00233948|58759664|FG002|Overall Study|Adverse Event|0|||
30749798|NCT00233948|58759665|FG003|Overall Study|Adverse Event|0|||
30749799|NCT00233948|58759666|FG004|Overall Study|Adverse Event|0|||
30749800|NCT00233948|58759667|FG005|Overall Study|Adverse Event|0|||
30810705|NCT03001076|58829475|FG001|Overall Study|Other|0|||
30810706|NCT03001076|58829474|FG000|Overall Study|Adverse Event|3|||
30810707|NCT03001076|58829475|FG001|Overall Study|Adverse Event|3|||
30810708|NCT03001076|58829474|FG000|Overall Study|Sponsor decision|1|||
30810709|NCT03001076|58829475|FG001|Overall Study|Sponsor decision|0|||
30810710|NCT03001076|58829474|FG000|Overall Study|Lost to Follow-up|0|||
30810711|NCT03001076|58829475|FG001|Overall Study|Lost to Follow-up|2|||
30810712|NCT03555305|58829481|FG000|Period 1|Physician Decision|0|||
30810713|NCT03555305|58829482|FG001|Period 1|Physician Decision|1|||
30810714|NCT03555305|58829481|FG000|Period 1|Adverse Event|0|||
30810715|NCT03555305|58829482|FG001|Period 1|Adverse Event|1|||
30810716|NCT03553823|58829490|FG000|Overall Study|Physician Decision|0|||
30810717|NCT03553823|58829491|FG001|Overall Study|Physician Decision|1|||
30810718|NCT03000686|58829499|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
30810719|NCT03000686|58829500|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
30810720|NCT03000686|58829501|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
30810721|NCT03000686|58829502|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
30810722|NCT02493660|58829520|FG000|Overall Study|Physician Decision|0|||
30810723|NCT02493660|58829521|FG001|Overall Study|Physician Decision|1|||
30810724|NCT02493660|58829520|FG000|Overall Study|Adverse Event|4|||
30810725|NCT02493660|58829521|FG001|Overall Study|Adverse Event|2|||
30810726|NCT02493660|58829520|FG000|Overall Study|Withdrawal by Subject|2|||
30810727|NCT02493660|58829521|FG001|Overall Study|Withdrawal by Subject|3|||
30810728|NCT02493660|58829520|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
30810729|NCT02493660|58829521|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
30810730|NCT02493660|58829520|FG000|Overall Study|Protocol Violation|0|||
30810731|NCT02493660|58829521|FG001|Overall Study|Protocol Violation|1|||
30810732|NCT02493660|58829520|FG000|Overall Study|Death|0|||
30810733|NCT02493660|58829521|FG001|Overall Study|Death|1|||
30810734|NCT02493660|58829520|FG000|Overall Study|Lost to Follow-up|2|||
30810735|NCT02493660|58829521|FG001|Overall Study|Lost to Follow-up|4|||
30810736|NCT03552029|58829531|FG000|Overall Study|Death|3|||
30810737|NCT03552029|58829532|FG001|Overall Study|Death|0|||
30810738|NCT03552029|58829531|FG000|Overall Study|Adverse Event|1|||
30810739|NCT03552029|58829532|FG001|Overall Study|Adverse Event|0|||
30810740|NCT03552029|58829531|FG000|Overall Study|Lack of Efficacy|0|||
30810741|NCT03552029|58829532|FG001|Overall Study|Lack of Efficacy|2|||
30909821|NCT02293538|58944729|FG000|Overall Study|Adverse Event|0|||
30909822|NCT02293538|58944730|FG001|Overall Study|Adverse Event|1|||
30909823|NCT02293538|58944729|FG000|Overall Study|Lost to Follow-up|1|||
30810742|NCT03552029|58829531|FG000|Overall Study|Physician Decision|0|||
30810743|NCT03552029|58829532|FG001|Overall Study|Physician Decision|1|||
30909824|NCT02293538|58944730|FG001|Overall Study|Lost to Follow-up|0|||
30909825|NCT02293538|58944729|FG000|Overall Study|Withdrawal by Subject|0|||
30810744|NCT03552029|58829531|FG000|Overall Study|Study terminated by Sponsor|0|||
30810745|NCT03552029|58829532|FG001|Overall Study|Study terminated by Sponsor|1|||
30810746|NCT03552029|58829531|FG000|Overall Study|Other|0|||
30810747|NCT03552029|58829532|FG001|Overall Study|Other|2|||
30810748|NCT03521141|58829541|FG000|Overall Study|Death|1|||
30810749|NCT03521141|58829542|FG001|Overall Study|Death|0|||
30810750|NCT03521141|58829543|FG002|Overall Study|Death|1|||
30810751|NCT02997176|58829555|FG000|Overall Study|Adverse Event|0|||
30810752|NCT02997176|58829556|FG001|Overall Study|Adverse Event|0|||
30810753|NCT02997176|58829557|FG002|Overall Study|Adverse Event|0|||
30810754|NCT02997176|58829558|FG003|Overall Study|Adverse Event|8|||
30810755|NCT02997176|58829555|FG000|Overall Study|Progressive Disease|1|||
30909826|NCT02293538|58944730|FG001|Overall Study|Withdrawal by Subject|1|||
30909827|NCT02194621|58944740|FG000|Overall Study|6 withdrew prior to randomization|2|||
30909828|NCT02194621|58944741|FG001|Overall Study|6 withdrew prior to randomization|2|||
30909829|NCT02194621|58944742|FG002|Overall Study|6 withdrew prior to randomization|2|||
30909830|NCT02194621|58944740|FG000|Overall Study|Withdrawal by Subject|4|||
30909831|NCT02194621|58944741|FG001|Overall Study|Withdrawal by Subject|4|||
30909832|NCT02194621|58944742|FG002|Overall Study|Withdrawal by Subject|7|||
30810756|NCT02997176|58829556|FG001|Overall Study|Progressive Disease|0|||
30909833|NCT02220205|58944752|FG000|Overall Study|Withdrawal by Subject|1|||
30810757|NCT02997176|58829557|FG002|Overall Study|Progressive Disease|1|||
30810758|NCT02997176|58829558|FG003|Overall Study|Progressive Disease|1|||
30810759|NCT02997176|58829555|FG000|Overall Study|Death|0|||
30810760|NCT02997176|58829556|FG001|Overall Study|Death|0|||
30810761|NCT02997176|58829557|FG002|Overall Study|Death|1|||
30810762|NCT02997176|58829558|FG003|Overall Study|Death|1|||
30810763|NCT02997176|58829555|FG000|Overall Study|Withdrawal by Subject|0|||
30810764|NCT02997176|58829556|FG001|Overall Study|Withdrawal by Subject|2|||
30810765|NCT02997176|58829557|FG002|Overall Study|Withdrawal by Subject|0|||
30810766|NCT02997176|58829558|FG003|Overall Study|Withdrawal by Subject|1|||
30810767|NCT03000452|58829568|FG000|Treatment Period|Death|1|||
30810768|NCT03000452|58829568|FG000|Treatment Period|Progressive Disease (PD)|14|||
30810769|NCT03000452|58829568|FG000|Treatment Period|Physician Decision|1|||
30810770|NCT03000452|58829568|FG000|Treatment Period|Miscellaneous|2|||
30909834|NCT02220205|58944753|FG001|Overall Study|Withdrawal by Subject|0|||
30909835|NCT02266706|58944768|FG000|Overall Study|Withdrawal by Subject|0|||
30810771|NCT03000452|58829568|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
30810772|NCT03000452|58829568|FG000|Follow-Up Period|Death|3|||
30810773|NCT03000452|58829568|FG000|Follow-Up Period|Withdrawal by Subject|3|||
30810774|NCT01373164|58829577|FG000|Overall Study|Lost to Follow-up|0|||
30810775|NCT01373164|58829578|FG001|Overall Study|Lost to Follow-up|0|||
30810776|NCT01373164|58829579|FG002|Overall Study|Lost to Follow-up|1|||
30810777|NCT01373164|58829580|FG003|Overall Study|Lost to Follow-up|2|||
30810778|NCT01373164|58829581|FG004|Overall Study|Lost to Follow-up|0|||
30810779|NCT01373164|58829577|FG000|Overall Study|Withdrawal by Subject|0|||
30810780|NCT01373164|58829578|FG001|Overall Study|Withdrawal by Subject|1|||
30810781|NCT01373164|58829579|FG002|Overall Study|Withdrawal by Subject|0|||
30810782|NCT01373164|58829580|FG003|Overall Study|Withdrawal by Subject|10|||
30810783|NCT01373164|58829581|FG004|Overall Study|Withdrawal by Subject|2|||
30810784|NCT02999984|58829596|FG000|Overall Study|Treatment Failure|1|||
30810785|NCT03550313|58829603|FG000|Overall Study|Adverse Event|0|||
30810786|NCT03550313|58829604|FG001|Overall Study|Adverse Event|1|||
30810787|NCT03550313|58829605|FG002|Overall Study|Adverse Event|0|||
30810788|NCT03550313|58829603|FG000|Overall Study|Lost to Follow-up|5|||
30810789|NCT03550313|58829604|FG001|Overall Study|Lost to Follow-up|7|||
30810790|NCT03550313|58829605|FG002|Overall Study|Lost to Follow-up|12|||
30810791|NCT03550313|58829603|FG000|Overall Study|Study terminated by sponsor|44|||
30810792|NCT03550313|58829604|FG001|Overall Study|Study terminated by sponsor|37|||
30909836|NCT02266706|58944769|FG001|Overall Study|Withdrawal by Subject|1|||
30909837|NCT02266706|58944770|FG002|Overall Study|Withdrawal by Subject|1|||
30909838|NCT02266706|58944771|FG003|Overall Study|Withdrawal by Subject|0|||
30909839|NCT02266706|58944772|FG004|Overall Study|Withdrawal by Subject|0|||
30909840|NCT02266706|58944773|FG005|Overall Study|Withdrawal by Subject|1|||
30909841|NCT02266706|58944774|FG006|Overall Study|Withdrawal by Subject|0|||
30909842|NCT02266706|58944775|FG007|Overall Study|Withdrawal by Subject|0|||
30909843|NCT02266706|58944776|FG008|Overall Study|Withdrawal by Subject|0|||
30909844|NCT02266706|58944768|FG000|Overall Study|Screen failure|0|||
30909845|NCT02266706|58944769|FG001|Overall Study|Screen failure|0|||
30909846|NCT02266706|58944770|FG002|Overall Study|Screen failure|0|||
30909847|NCT02266706|58944771|FG003|Overall Study|Screen failure|0|||
30909848|NCT02266706|58944772|FG004|Overall Study|Screen failure|0|||
30909849|NCT02266706|58944773|FG005|Overall Study|Screen failure|1|||
30909850|NCT02266706|58944774|FG006|Overall Study|Screen failure|1|||
30909851|NCT02266706|58944775|FG007|Overall Study|Screen failure|0|||
30909852|NCT02266706|58944776|FG008|Overall Study|Screen failure|0|||
30909853|NCT02266706|58944768|FG000|Overall Study|Enrollment in another study|0|||
30909854|NCT02266706|58944769|FG001|Overall Study|Enrollment in another study|0|||
30909855|NCT02266706|58944770|FG002|Overall Study|Enrollment in another study|0|||
30909856|NCT02266706|58944771|FG003|Overall Study|Enrollment in another study|1|||
30909857|NCT02266706|58944772|FG004|Overall Study|Enrollment in another study|0|||
30909858|NCT02266706|58944773|FG005|Overall Study|Enrollment in another study|0|||
30909859|NCT02266706|58944774|FG006|Overall Study|Enrollment in another study|0|||
30749801|NCT00233480|58759684|FG000|Overall Study|Underwent status II heart transplant|0|||
30749802|NCT00233480|58759685|FG001|Overall Study|Underwent status II heart transplant|1|||
30749803|NCT03801928|58759699|FG000|Overall Study|Adverse Event|1|||
30749804|NCT03801928|58759700|FG001|Overall Study|Adverse Event|0|||
30749805|NCT03801928|58759701|FG002|Overall Study|Adverse Event|1|||
30749806|NCT03801928|58759702|FG003|Overall Study|Adverse Event|2|||
30749807|NCT03801928|58759703|FG004|Overall Study|Adverse Event|0|||
30749808|NCT03801928|58759704|FG005|Overall Study|Adverse Event|2|||
30749809|NCT03801928|58759699|FG000|Overall Study|Lack of Efficacy|0|||
30749810|NCT03801928|58759700|FG001|Overall Study|Lack of Efficacy|0|||
30749811|NCT03801928|58759701|FG002|Overall Study|Lack of Efficacy|1|||
30749812|NCT03801928|58759702|FG003|Overall Study|Lack of Efficacy|0|||
30749813|NCT03801928|58759703|FG004|Overall Study|Lack of Efficacy|0|||
30749814|NCT03801928|58759704|FG005|Overall Study|Lack of Efficacy|0|||
30749815|NCT03801928|58759699|FG000|Overall Study|Lost to Follow-up|5|||
30749816|NCT03801928|58759700|FG001|Overall Study|Lost to Follow-up|1|||
30749817|NCT03801928|58759701|FG002|Overall Study|Lost to Follow-up|1|||
30810793|NCT03550313|58829605|FG002|Overall Study|Study terminated by sponsor|48|||
30810794|NCT03550313|58829603|FG000|Overall Study|No longer met eligibility criteria|3|||
30810795|NCT03550313|58829604|FG001|Overall Study|No longer met eligibility criteria|5|||
30810796|NCT03550313|58829605|FG002|Overall Study|No longer met eligibility criteria|6|||
30810797|NCT03550313|58829603|FG000|Overall Study|Withdrawal by parent/guardian|20|||
30810798|NCT03550313|58829604|FG001|Overall Study|Withdrawal by parent/guardian|18|||
30810799|NCT03550313|58829605|FG002|Overall Study|Withdrawal by parent/guardian|26|||
30909860|NCT02266706|58944775|FG007|Overall Study|Enrollment in another study|0|||
30749818|NCT03801928|58759702|FG003|Overall Study|Lost to Follow-up|4|||
30909861|NCT02266706|58944776|FG008|Overall Study|Enrollment in another study|0|||
30909862|NCT02293460|58944796|FG000|Overall Study|Protocol Violation|1|||
30810800|NCT03550313|58829603|FG000|Overall Study|Other|4|||
30810801|NCT03550313|58829604|FG001|Overall Study|Other|2|||
30810802|NCT03550313|58829605|FG002|Overall Study|Other|2|||
30810803|NCT03550313|58829603|FG000|Overall Study|Randomized but not vaccinated|3|||
30810804|NCT03550313|58829604|FG001|Overall Study|Randomized but not vaccinated|23|||
30810805|NCT03550313|58829605|FG002|Overall Study|Randomized but not vaccinated|2|||
30810806|NCT03550313|58829603|FG000|Overall Study|Sites terminated due to quality issues|18|||
30810807|NCT03550313|58829604|FG001|Overall Study|Sites terminated due to quality issues|17|||
30810808|NCT03550313|58829605|FG002|Overall Study|Sites terminated due to quality issues|18|||
30810809|NCT03312907|58829617|FG000|Overall Study|Adverse Event|1|||
30810810|NCT03312907|58829618|FG001|Overall Study|Adverse Event|6|||
30810811|NCT03312907|58829619|FG002|Overall Study|Adverse Event|1|||
30810812|NCT03312907|58829617|FG000|Overall Study|Protocol Violation|2|||
30810813|NCT03312907|58829618|FG001|Overall Study|Protocol Violation|3|||
30810814|NCT03312907|58829619|FG002|Overall Study|Protocol Violation|4|||
30810815|NCT03312907|58829617|FG000|Overall Study|Lost to Follow-up|2|||
30810816|NCT03312907|58829618|FG001|Overall Study|Lost to Follow-up|3|||
30810817|NCT03312907|58829619|FG002|Overall Study|Lost to Follow-up|2|||
30810818|NCT03312907|58829617|FG000|Overall Study|Physician Decision|3|||
30810819|NCT03312907|58829618|FG001|Overall Study|Physician Decision|4|||
30810820|NCT03312907|58829619|FG002|Overall Study|Physician Decision|2|||
30810821|NCT03312907|58829617|FG000|Overall Study|Withdrawal by Subject|9|||
30810822|NCT03312907|58829618|FG001|Overall Study|Withdrawal by Subject|14|||
30810823|NCT03312907|58829619|FG002|Overall Study|Withdrawal by Subject|10|||
30810824|NCT02999672|58829629|FG000|Overall Study|Death|0|||
30810825|NCT02999672|58829630|FG001|Overall Study|Death|1|||
30810826|NCT02999672|58829629|FG000|Overall Study|Study Terminated by Sponsor|0|||
30810827|NCT02999672|58829630|FG001|Overall Study|Study Terminated by Sponsor|1|||
30810828|NCT02999672|58829629|FG000|Overall Study|Progressive Disease|9|||
30810829|NCT02999672|58829630|FG001|Overall Study|Progressive Disease|5|||
30810830|NCT02999672|58829629|FG000|Overall Study|Adverse Event|4|||
30810831|NCT02999672|58829630|FG001|Overall Study|Adverse Event|0|||
30810832|NCT01911676|58829640|FG000|Period 1 of Study|Withdrawal by Subject|4|||
30749819|NCT03801928|58759703|FG004|Overall Study|Lost to Follow-up|4|||
30749820|NCT03801928|58759704|FG005|Overall Study|Lost to Follow-up|2|||
30749821|NCT03801928|58759699|FG000|Overall Study|Withdrawal by Subject|0|||
30749822|NCT03801928|58759700|FG001|Overall Study|Withdrawal by Subject|0|||
30749823|NCT03801928|58759701|FG002|Overall Study|Withdrawal by Subject|2|||
30749824|NCT03801928|58759702|FG003|Overall Study|Withdrawal by Subject|1|||
30749825|NCT03801928|58759703|FG004|Overall Study|Withdrawal by Subject|0|||
30749826|NCT03801928|58759704|FG005|Overall Study|Withdrawal by Subject|0|||
30749827|NCT03801928|58759699|FG000|Overall Study|Other|0|||
30749828|NCT03801928|58759700|FG001|Overall Study|Other|2|||
30749829|NCT03801928|58759701|FG002|Overall Study|Other|0|||
30749830|NCT03801928|58759702|FG003|Overall Study|Other|1|||
30749831|NCT03801928|58759703|FG004|Overall Study|Other|0|||
30749832|NCT03801928|58759704|FG005|Overall Study|Other|1|||
30749833|NCT00263588|58759723|FG000|Overall Study|Death|54|||
30749834|NCT00263588|58759724|FG001|Overall Study|Death|90|||
30749835|NCT00263588|58759723|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
30749836|NCT00263588|58759724|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
30810833|NCT01911676|58829641|FG001|Period 1 of Study|Withdrawal by Subject|2|||
30810834|NCT01911676|58829642|FG002|Period 1 of Study|Withdrawal by Subject|1|||
30810835|NCT01911676|58829643|FG003|Period 1 of Study|Withdrawal by Subject|2|||
30810836|NCT01911676|58829640|FG000|Period 1 of Study|Physician Decision|2|||
30810837|NCT01911676|58829641|FG001|Period 1 of Study|Physician Decision|0|||
30810838|NCT01911676|58829642|FG002|Period 1 of Study|Physician Decision|0|||
30810839|NCT01911676|58829643|FG003|Period 1 of Study|Physician Decision|1|||
30810840|NCT01911676|58829640|FG000|Period 2 of Study|Physician Decision|2|||
30810841|NCT01911676|58829641|FG001|Period 2 of Study|Physician Decision|0|||
30810842|NCT01911676|58829642|FG002|Period 2 of Study|Physician Decision|0|||
30810843|NCT01911676|58829643|FG003|Period 2 of Study|Physician Decision|1|||
30810844|NCT01911676|58829640|FG000|Period 2 of Study|Lost to Follow-up|0|||
30749837|NCT00263588|58759723|FG000|Overall Study|Lost to Follow-up|7|||
30810845|NCT01911676|58829641|FG001|Period 2 of Study|Lost to Follow-up|0|||
30810846|NCT01911676|58829642|FG002|Period 2 of Study|Lost to Follow-up|0|||
30909863|NCT02293460|58944796|FG000|Overall Study|Lack of Efficacy|2|||
30909864|NCT02293460|58944796|FG000|Overall Study|Adverse Event|2|||
30909865|NCT02293460|58944796|FG000|Overall Study|Withdrawal by Subject|1|||
30909866|NCT02266004|58944800|FG000|Overall Study|unrelated adverse event|1|||
30909867|NCT02266004|58944800|FG000|Overall Study|Physician Decision|1|||
30909868|NCT02292719|58944810|FG000|Overall Study|Withdrawal by Subject|0|||
30909869|NCT02292719|58944811|FG001|Overall Study|Withdrawal by Subject|0|||
30909870|NCT02292719|58944812|FG002|Overall Study|Withdrawal by Subject|0|||
30909871|NCT02292719|58944813|FG003|Overall Study|Withdrawal by Subject|1|||
30909872|NCT02292719|58944814|FG004|Overall Study|Withdrawal by Subject|1|||
30909873|NCT02292719|58944815|FG005|Overall Study|Withdrawal by Subject|0|||
30909874|NCT02292719|58944810|FG000|Overall Study|Subject enrolled in new study.|0|||
30909875|NCT02292719|58944811|FG001|Overall Study|Subject enrolled in new study.|0|||
30909876|NCT02292719|58944812|FG002|Overall Study|Subject enrolled in new study.|1|||
30909877|NCT02292719|58944813|FG003|Overall Study|Subject enrolled in new study.|0|||
30909878|NCT02292719|58944814|FG004|Overall Study|Subject enrolled in new study.|0|||
30909879|NCT02292719|58944815|FG005|Overall Study|Subject enrolled in new study.|0|||
30909880|NCT02291861|58944833|FG000|Overall Study|Adverse Event|2|||
30909881|NCT02291861|58944834|FG001|Overall Study|Adverse Event|4|||
30909882|NCT02291861|58944835|FG002|Overall Study|Adverse Event|1|||
30909883|NCT02291861|58944836|FG003|Overall Study|Adverse Event|2|||
30909884|NCT02291861|58944833|FG000|Overall Study|Death|0|||
30909885|NCT02291861|58944834|FG001|Overall Study|Death|0|||
30909886|NCT02291861|58944835|FG002|Overall Study|Death|1|||
30909887|NCT02291861|58944836|FG003|Overall Study|Death|1|||
30909888|NCT02291861|58944833|FG000|Overall Study|Protocol Violation|1|||
30909889|NCT02291861|58944834|FG001|Overall Study|Protocol Violation|0|||
30909890|NCT02291861|58944835|FG002|Overall Study|Protocol Violation|0|||
30909891|NCT02291861|58944836|FG003|Overall Study|Protocol Violation|1|||
30909892|NCT02291861|58944833|FG000|Overall Study|Withdrawal by Subject|1|||
30909893|NCT02291861|58944834|FG001|Overall Study|Withdrawal by Subject|2|||
30909894|NCT02291861|58944835|FG002|Overall Study|Withdrawal by Subject|1|||
30909895|NCT02291861|58944836|FG003|Overall Study|Withdrawal by Subject|4|||
30909896|NCT02291861|58944833|FG000|Overall Study|Noncompliance|1|||
30909897|NCT02291861|58944834|FG001|Overall Study|Noncompliance|1|||
30909898|NCT02291861|58944835|FG002|Overall Study|Noncompliance|2|||
30909899|NCT02291861|58944836|FG003|Overall Study|Noncompliance|1|||
30909900|NCT02291861|58944833|FG000|Overall Study|Lost to Follow-up|2|||
30909901|NCT02291861|58944834|FG001|Overall Study|Lost to Follow-up|1|||
30909902|NCT02291861|58944835|FG002|Overall Study|Lost to Follow-up|4|||
30909903|NCT02291861|58944836|FG003|Overall Study|Lost to Follow-up|0|||
30909904|NCT02291861|58944833|FG000|Overall Study|Other|0|||
30909905|NCT02291861|58944834|FG001|Overall Study|Other|0|||
30909906|NCT02291861|58944835|FG002|Overall Study|Other|0|||
30909907|NCT02291861|58944836|FG003|Overall Study|Other|1|||
30909908|NCT02291549|58944848|FG000|Overall Study|Lost to Follow-up|1|||
30749838|NCT00263588|58759724|FG001|Overall Study|Lost to Follow-up|10|||
30749839|NCT00263588|58759723|FG000|Overall Study|Withdrawal by Subject|3|||
30749840|NCT00263588|58759724|FG001|Overall Study|Withdrawal by Subject|4|||
30909909|NCT02291549|58944849|FG001|Overall Study|Lost to Follow-up|0|||
30909910|NCT02291549|58944848|FG000|Overall Study|Withdrawal by Subject|0|||
30909911|NCT02291549|58944849|FG001|Overall Study|Withdrawal by Subject|1|||
30749841|NCT00263588|58759723|FG000|Overall Study|Protocol Violation|0|||
30749842|NCT00263588|58759724|FG001|Overall Study|Protocol Violation|1|||
30749843|NCT00263588|58759723|FG000|Overall Study|Investigator decision|7|||
30749844|NCT00263588|58759724|FG001|Overall Study|Investigator decision|15|||
30749845|NCT00263588|58759723|FG000|Overall Study|Sponsor terminated study|0|||
30749846|NCT00263588|58759724|FG001|Overall Study|Sponsor terminated study|1|||
30749847|NCT00213135|58759734|FG000|Overall Study|Adverse Event|9|||
30909912|NCT02264990|58944859|FG000|Overall Study|Death|255|||
30909913|NCT02264990|58944860|FG001|Overall Study|Death|250|||
30909914|NCT02264990|58944859|FG000|Overall Study|Withdrawal by Subject|4|||
30909915|NCT02264990|58944860|FG001|Overall Study|Withdrawal by Subject|5|||
30909916|NCT02264990|58944859|FG000|Overall Study|Lost to Follow-up|1|||
30909917|NCT02264990|58944860|FG001|Overall Study|Lost to Follow-up|3|||
30909918|NCT02264990|58944859|FG000|Overall Study|Other|0|||
30909919|NCT02264990|58944860|FG001|Overall Study|Other|1|||
30909920|NCT02291237|58944869|FG000|Overall Study|Study Terminated by Sponsor|72|||
30909921|NCT02291237|58944870|FG001|Overall Study|Study Terminated by Sponsor|67|||
30909922|NCT02291237|58944869|FG000|Overall Study|Adverse Event|1|||
30909923|NCT02291237|58944870|FG001|Overall Study|Adverse Event|3|||
30909924|NCT02291237|58944869|FG000|Overall Study|Investigator's Discretion|0|||
30909925|NCT02291237|58944870|FG001|Overall Study|Investigator's Discretion|3|||
30909926|NCT02291237|58944869|FG000|Overall Study|Withdrew Consent|11|||
30909927|NCT02291237|58944870|FG001|Overall Study|Withdrew Consent|11|||
30909928|NCT02291237|58944869|FG000|Overall Study|Lost to Follow-up|0|||
30909929|NCT02291237|58944870|FG001|Overall Study|Lost to Follow-up|2|||
30810847|NCT01911676|58829643|FG003|Period 2 of Study|Lost to Follow-up|1|||
30810848|NCT03573323|58829660|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
30810849|NCT03573323|58829661|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
30810850|NCT03573323|58829660|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
30810851|NCT03573323|58829661|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
30810852|NCT03573323|58829660|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
30810853|NCT03573323|58829661|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
30810854|NCT03573323|58829660|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
30810855|NCT03573323|58829661|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
30810856|NCT03573323|58829660|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
30810857|NCT03573323|58829661|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
30810858|NCT03573323|58829660|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
30810859|NCT03573323|58829661|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
30810860|NCT03573323|58829660|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
30810861|NCT03573323|58829661|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
30810862|NCT03573323|58829660|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
30810863|NCT03573323|58829661|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
30810864|NCT03573323|58829660|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
30810865|NCT03573323|58829661|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
30810866|NCT03573323|58829660|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
30810867|NCT03573323|58829661|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
30810868|NCT03573323|58829660|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
30810869|NCT03573323|58829661|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
30810870|NCT03573323|58829660|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
30810871|NCT03573323|58829661|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
30810872|NCT03573323|58829660|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
30810873|NCT03573323|58829661|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
30810874|NCT03573323|58829660|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
30810875|NCT03573323|58829661|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
30810876|NCT03573323|58829660|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
30810877|NCT03573323|58829661|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
30810878|NCT03573323|58829660|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
30810879|NCT03573323|58829661|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
30810880|NCT03573323|58829660|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
30810881|NCT03573323|58829661|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
30810882|NCT03573323|58829660|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
30810883|NCT03573323|58829661|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
30810884|NCT03573323|58829660|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
30810885|NCT03573323|58829661|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
30810886|NCT03306043|58829687|FG000|Overall Study|Adverse Event|1|||
30810887|NCT03306043|58829687|FG000|Overall Study|Lost to Follow-up|1|||
30810888|NCT03306043|58829687|FG000|Overall Study|Withdrawal by Subject|2|||
30810889|NCT01069172|58829691|FG000|Overall Study|Withdrawal by Subject|1|||
30810890|NCT01069172|58829692|FG001|Overall Study|Withdrawal by Subject|0|||
30810891|NCT02911688|58829701|FG000|Washout|Lost to Follow-up|1|||
30810892|NCT02911688|58829702|FG001|Washout|Lost to Follow-up|1|||
30810893|NCT02911688|58829701|FG000|Washout|Withdrawal by Subject|0|||
30909930|NCT02291237|58944869|FG000|Overall Study|Subject Required Prohibited Medication|2|||
30909931|NCT02291237|58944870|FG001|Overall Study|Subject Required Prohibited Medication|0|||
30909932|NCT02292446|58944876|FG000|Overall Study|Adverse Event|12|||
30909933|NCT02292446|58944876|FG000|Overall Study|Death|1|||
30810894|NCT02911688|58829702|FG001|Washout|Withdrawal by Subject|1|||
30810895|NCT02670928|58829712|FG000|Overall Study|Adverse Event|3|||
30810896|NCT02670928|58829713|FG001|Overall Study|Adverse Event|1|||
30810897|NCT02670928|58829712|FG000|Overall Study|Withdrawal by Subject|4|||
30810898|NCT02670928|58829713|FG001|Overall Study|Withdrawal by Subject|0|||
30810899|NCT02670928|58829712|FG000|Overall Study|Lost to Follow-up|1|||
30810900|NCT02670928|58829713|FG001|Overall Study|Lost to Follow-up|0|||
30810901|NCT02670928|58829712|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
30810902|NCT02670928|58829713|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
30810903|NCT03305809|58829723|FG000|Overall Study|Adverse Event|2|||
30810904|NCT03305809|58829724|FG001|Overall Study|Adverse Event|2|||
30810905|NCT03305809|58829725|FG002|Overall Study|Adverse Event|6|||
30810906|NCT03305809|58829726|FG003|Overall Study|Adverse Event|6|||
30810907|NCT03305809|58829723|FG000|Overall Study|Death|0|||
30810908|NCT03305809|58829724|FG001|Overall Study|Death|0|||
30810909|NCT03305809|58829725|FG002|Overall Study|Death|1|||
30810910|NCT03305809|58829726|FG003|Overall Study|Death|1|||
30810911|NCT03305809|58829723|FG000|Overall Study|Lost to Follow-up|1|||
30810912|NCT03305809|58829724|FG001|Overall Study|Lost to Follow-up|2|||
30810913|NCT03305809|58829725|FG002|Overall Study|Lost to Follow-up|0|||
30810914|NCT03305809|58829726|FG003|Overall Study|Lost to Follow-up|0|||
30810915|NCT03305809|58829723|FG000|Overall Study|Sponsor Decision|1|||
30810916|NCT03305809|58829724|FG001|Overall Study|Sponsor Decision|0|||
30810917|NCT03305809|58829725|FG002|Overall Study|Sponsor Decision|1|||
30810918|NCT03305809|58829726|FG003|Overall Study|Sponsor Decision|8|||
30810919|NCT03305809|58829723|FG000|Overall Study|Physician Decision|0|||
30810920|NCT03305809|58829724|FG001|Overall Study|Physician Decision|0|||
30810921|NCT03305809|58829725|FG002|Overall Study|Physician Decision|2|||
30810922|NCT03305809|58829726|FG003|Overall Study|Physician Decision|4|||
30810923|NCT03305809|58829723|FG000|Overall Study|Progressive Disease|0|||
30810924|NCT03305809|58829724|FG001|Overall Study|Progressive Disease|0|||
30810925|NCT03305809|58829725|FG002|Overall Study|Progressive Disease|1|||
30810926|NCT03305809|58829726|FG003|Overall Study|Progressive Disease|0|||
30810927|NCT03305809|58829723|FG000|Overall Study|Protocol Violation|1|||
30810928|NCT03305809|58829724|FG001|Overall Study|Protocol Violation|0|||
30810929|NCT03305809|58829725|FG002|Overall Study|Protocol Violation|2|||
30810930|NCT03305809|58829726|FG003|Overall Study|Protocol Violation|3|||
30810931|NCT03305809|58829723|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
30909934|NCT02292446|58944876|FG000|Overall Study|Disease progression|2|||
30909935|NCT02292446|58944876|FG000|Overall Study|Subject/guardian decision|2|||
30909936|NCT02292446|58944876|FG000|Overall Study|Withdrawal by Subject|3|||
30909937|NCT02290925|58944885|FG000|First Period of Three Months|Lost to Follow-up|2|||
30909938|NCT02290925|58944886|FG001|First Period of Three Months|Lost to Follow-up|1|||
30909939|NCT02290925|58944885|FG000|First Period of Three Months|Death|1|||
30909940|NCT02290925|58944886|FG001|First Period of Three Months|Death|0|||
30909941|NCT02290925|58944885|FG000|First Period of Three Months|Insulin Started|1|||
30909942|NCT02290925|58944886|FG001|First Period of Three Months|Insulin Started|1|||
30909943|NCT02290925|58944885|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
30909944|NCT02290925|58944886|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
30909945|NCT02290925|58944885|FG000|Second Period of 3 Months|insulin started|0|||
30909946|NCT02290925|58944886|FG001|Second Period of 3 Months|insulin started|1|||
30909947|NCT02290691|58944896|FG000|Overall Study|Noncompliance|0|||
30909948|NCT02290691|58944897|FG001|Overall Study|Noncompliance|1|||
30909949|NCT02290691|58944896|FG000|Overall Study|Withdrawal by Subject|1|||
30909950|NCT02290691|58944897|FG001|Overall Study|Withdrawal by Subject|1|||
30909951|NCT02290691|58944896|FG000|Overall Study|Lost to Follow-up|7|||
30909952|NCT02290691|58944897|FG001|Overall Study|Lost to Follow-up|7|||
30810932|NCT03305809|58829724|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
30810933|NCT03305809|58829725|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
30810934|NCT03305809|58829726|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
30810935|NCT03305809|58829723|FG000|Overall Study|Withdrawal by Subject|2|||
30810936|NCT03305809|58829724|FG001|Overall Study|Withdrawal by Subject|4|||
30909953|NCT02292212|58944903|FG000|ViE Phase|Withdrawal by Subject|1|||
30909954|NCT02292212|58944903|FG000|ViE Phase|Protocol Violation|2|||
30909955|NCT02291510|58944918|FG000|Overall Study|Adverse Event|0|||
30909956|NCT02291510|58944919|FG001|Overall Study|Adverse Event|0|||
30909957|NCT02291510|58944920|FG002|Overall Study|Adverse Event|0|||
30810937|NCT03305809|58829725|FG002|Overall Study|Withdrawal by Subject|5|||
30810938|NCT03305809|58829726|FG003|Overall Study|Withdrawal by Subject|2|||
30810939|NCT03305809|58829723|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
30810940|NCT03305809|58829724|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
30810941|NCT03305809|58829725|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
30810942|NCT03305809|58829726|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
30909958|NCT02291510|58944921|FG003|Overall Study|Adverse Event|1|||
30909959|NCT02290223|58944933|FG000|6 Months|Lost to Follow-up|9|||
30909960|NCT02290223|58944934|FG001|6 Months|Lost to Follow-up|6|||
30909961|NCT02290223|58944933|FG000|6 Months|Withdrawal by Subject|5|||
30810943|NCT02994056|58829739|FG000|Overall Study|Death|8|||
30810944|NCT02994056|58829739|FG000|Overall Study|Withdrew Consent|1|||
30810945|NCT03548051|58829758|FG000|Overall Study|Death|1|||
30810946|NCT03548051|58829759|FG001|Overall Study|Death|1|||
30810947|NCT03548051|58829758|FG000|Overall Study|Withdrawal by Subject|1|||
30810948|NCT03548051|58829759|FG001|Overall Study|Withdrawal by Subject|0|||
30810949|NCT03305731|58829765|FG000|Overall Study|Protocol Violation|1|||
30810950|NCT03305575|58829771|FG000|Overall Study|Physician Decision|1|||
30810951|NCT03305575|58829772|FG001|Overall Study|Physician Decision|0|||
30810952|NCT02993822|58829782|FG000|Overall Study|Lack of Efficacy|1|||
30810953|NCT02993822|58829783|FG001|Overall Study|Lack of Efficacy|1|||
30810954|NCT02993822|58829784|FG002|Overall Study|Lack of Efficacy|0|||
30810955|NCT02993822|58829785|FG003|Overall Study|Lack of Efficacy|0|||
30810956|NCT02993822|58829782|FG000|Overall Study|Protocol Violation|1|||
30810957|NCT02993822|58829783|FG001|Overall Study|Protocol Violation|0|||
30810958|NCT02993822|58829784|FG002|Overall Study|Protocol Violation|0|||
30810959|NCT02993822|58829785|FG003|Overall Study|Protocol Violation|0|||
30810960|NCT02993822|58829782|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
30810961|NCT02993822|58829783|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
30810962|NCT02993822|58829784|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
30810963|NCT02993822|58829785|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
30810964|NCT02993822|58829782|FG000|Overall Study|Adverse Event|3|||
30810965|NCT02993822|58829783|FG001|Overall Study|Adverse Event|1|||
30810966|NCT02993822|58829784|FG002|Overall Study|Adverse Event|7|||
30810967|NCT02993822|58829785|FG003|Overall Study|Adverse Event|0|||
30810968|NCT02993822|58829782|FG000|Overall Study|Withdrawal by Subject|4|||
30810969|NCT02993822|58829783|FG001|Overall Study|Withdrawal by Subject|2|||
30810970|NCT02993822|58829784|FG002|Overall Study|Withdrawal by Subject|2|||
30810971|NCT02993822|58829785|FG003|Overall Study|Withdrawal by Subject|3|||
30810972|NCT02993822|58829782|FG000|Overall Study|Lost to Follow-up|1|||
30810973|NCT02993822|58829783|FG001|Overall Study|Lost to Follow-up|0|||
30810974|NCT02993822|58829784|FG002|Overall Study|Lost to Follow-up|1|||
30810975|NCT02993822|58829785|FG003|Overall Study|Lost to Follow-up|0|||
30810976|NCT01068860|58829805|FG000|Overall Study|Withdrawal by Subject|0|||
30810977|NCT01068860|58829806|FG001|Overall Study|Withdrawal by Subject|0|||
30810978|NCT01068860|58829807|FG002|Overall Study|Withdrawal by Subject|0|||
30810979|NCT01068860|58829808|FG003|Overall Study|Withdrawal by Subject|0|||
30810980|NCT01068860|58829809|FG004|Overall Study|Withdrawal by Subject|0|||
30909962|NCT02290223|58944934|FG001|6 Months|Withdrawal by Subject|0|||
30749848|NCT00213135|58759735|FG001|Overall Study|Adverse Event|5|||
30749849|NCT00213135|58759736|FG002|Overall Study|Adverse Event|5|||
30749850|NCT00213135|58759734|FG000|Overall Study|Lost to Follow-up|11|||
30749851|NCT00213135|58759735|FG001|Overall Study|Lost to Follow-up|8|||
30749852|NCT00213135|58759736|FG002|Overall Study|Lost to Follow-up|4|||
30749853|NCT00213135|58759734|FG000|Overall Study|Protocol Violation|4|||
30749854|NCT00213135|58759735|FG001|Overall Study|Protocol Violation|4|||
30749855|NCT00213135|58759736|FG002|Overall Study|Protocol Violation|10|||
30749856|NCT00213135|58759734|FG000|Overall Study|Death|1|||
30749857|NCT00213135|58759735|FG001|Overall Study|Death|1|||
30810981|NCT01068860|58829810|FG005|Overall Study|Withdrawal by Subject|2|||
30810982|NCT01068860|58829811|FG006|Overall Study|Withdrawal by Subject|0|||
30810983|NCT01068860|58829812|FG007|Overall Study|Withdrawal by Subject|0|||
30810984|NCT01068860|58829813|FG008|Overall Study|Withdrawal by Subject|0|||
30810985|NCT01068860|58829814|FG009|Overall Study|Withdrawal by Subject|3|||
30810986|NCT01068860|58829805|FG000|Overall Study|Administrative problems; misrandomized|0|||
30810987|NCT01068860|58829806|FG001|Overall Study|Administrative problems; misrandomized|0|||
30749858|NCT00213135|58759736|FG002|Overall Study|Death|2|||
30810988|NCT01068860|58829807|FG002|Overall Study|Administrative problems; misrandomized|0|||
30810989|NCT01068860|58829808|FG003|Overall Study|Administrative problems; misrandomized|1|||
30810990|NCT01068860|58829809|FG004|Overall Study|Administrative problems; misrandomized|0|||
30810991|NCT01068860|58829810|FG005|Overall Study|Administrative problems; misrandomized|0|||
30810992|NCT01068860|58829811|FG006|Overall Study|Administrative problems; misrandomized|0|||
30810993|NCT01068860|58829812|FG007|Overall Study|Administrative problems; misrandomized|0|||
30810994|NCT01068860|58829813|FG008|Overall Study|Administrative problems; misrandomized|0|||
30810995|NCT01068860|58829814|FG009|Overall Study|Administrative problems; misrandomized|1|||
30810996|NCT01068860|58829805|FG000|Overall Study|Lost to Follow-up|0|||
30810997|NCT01068860|58829806|FG001|Overall Study|Lost to Follow-up|1|||
30810998|NCT01068860|58829807|FG002|Overall Study|Lost to Follow-up|0|||
30810999|NCT01068860|58829808|FG003|Overall Study|Lost to Follow-up|0|||
30811000|NCT01068860|58829809|FG004|Overall Study|Lost to Follow-up|0|||
30811001|NCT01068860|58829810|FG005|Overall Study|Lost to Follow-up|0|||
30811002|NCT01068860|58829811|FG006|Overall Study|Lost to Follow-up|0|||
30811003|NCT01068860|58829812|FG007|Overall Study|Lost to Follow-up|0|||
30811004|NCT01068860|58829813|FG008|Overall Study|Lost to Follow-up|0|||
30811005|NCT01068860|58829814|FG009|Overall Study|Lost to Follow-up|0|||
30811006|NCT02989610|58829836|FG000|Overall Study|Withdrawal/Other reasons|39|||
30811007|NCT01372774|58829842|FG000|Overall Study|Withdrawal prior to treatment|4|||
30811008|NCT01372774|58829843|FG001|Overall Study|Withdrawal prior to treatment|5|||
30811009|NCT02670538|58829854|FG000|Overall Study|Withdrawal of Consent|8|||
30811010|NCT02670538|58829855|FG001|Overall Study|Withdrawal of Consent|6|||
30811011|NCT02670538|58829856|FG002|Overall Study|Withdrawal of Consent|5|||
30811012|NCT02670538|58829854|FG000|Overall Study|Lost to Follow-up|8|||
30811013|NCT02670538|58829855|FG001|Overall Study|Lost to Follow-up|12|||
30811014|NCT02670538|58829856|FG002|Overall Study|Lost to Follow-up|7|||
30811015|NCT02670538|58829854|FG000|Overall Study|Adverse Event|5|||
30811016|NCT02670538|58829855|FG001|Overall Study|Adverse Event|5|||
30811017|NCT02670538|58829856|FG002|Overall Study|Adverse Event|11|||
30811018|NCT02670538|58829854|FG000|Overall Study|Lack of Efficacy|7|||
30811019|NCT02670538|58829855|FG001|Overall Study|Lack of Efficacy|1|||
30811020|NCT02670538|58829856|FG002|Overall Study|Lack of Efficacy|2|||
30811021|NCT02670538|58829854|FG000|Overall Study|Protocol Violation|3|||
30811022|NCT02670538|58829855|FG001|Overall Study|Protocol Violation|4|||
30811023|NCT02670538|58829856|FG002|Overall Study|Protocol Violation|1|||
30811024|NCT02670538|58829854|FG000|Overall Study|Noncompliance with Study Drug|1|||
30811025|NCT02670538|58829855|FG001|Overall Study|Noncompliance with Study Drug|3|||
30811026|NCT02670538|58829856|FG002|Overall Study|Noncompliance with Study Drug|2|||
30811027|NCT02670538|58829854|FG000|Overall Study|Other Miscellaneous Reasons|0|||
30811028|NCT02670538|58829855|FG001|Overall Study|Other Miscellaneous Reasons|1|||
30811029|NCT02670538|58829856|FG002|Overall Study|Other Miscellaneous Reasons|2|||
30811030|NCT03547583|58829867|FG000|Overall Study|Adverse Event|16|||
30811031|NCT03547583|58829868|FG001|Overall Study|Adverse Event|11|||
30811032|NCT03547583|58829869|FG002|Overall Study|Adverse Event|10|||
30811033|NCT03547583|58829867|FG000|Overall Study|Death|11|||
30811034|NCT03547583|58829868|FG001|Overall Study|Death|7|||
30811035|NCT03547583|58829869|FG002|Overall Study|Death|4|||
30811036|NCT03547583|58829867|FG000|Overall Study|Lost to Follow-up|1|||
30811037|NCT03547583|58829868|FG001|Overall Study|Lost to Follow-up|0|||
30811038|NCT03547583|58829869|FG002|Overall Study|Lost to Follow-up|0|||
30811039|NCT03547583|58829867|FG000|Overall Study|Non-compliance with study drug|0|||
30811040|NCT03547583|58829868|FG001|Overall Study|Non-compliance with study drug|0|||
30811041|NCT03547583|58829869|FG002|Overall Study|Non-compliance with study drug|1|||
30811042|NCT03547583|58829867|FG000|Overall Study|Physician Decision|1|||
30749859|NCT00213135|58759734|FG000|Overall Study|Disease progression|4|||
30749860|NCT00213135|58759735|FG001|Overall Study|Disease progression|5|||
30749861|NCT00213135|58759736|FG002|Overall Study|Disease progression|21|||
30749862|NCT00213135|58759734|FG000|Overall Study|Other|21|||
30749863|NCT00213135|58759735|FG001|Overall Study|Other|12|||
30749864|NCT00213135|58759736|FG002|Overall Study|Other|15|||
30749865|NCT00077974|58759744|FG000|Overall Study|Adverse Event|22|||
30749866|NCT00077974|58759744|FG000|Overall Study|Protocol Violation|1|||
30749867|NCT00077974|58759744|FG000|Overall Study|Withdrawal by Subject|3|||
30749868|NCT00077974|58759744|FG000|Overall Study|Lack of Efficacy|76|||
30749869|NCT00077974|58759744|FG000|Overall Study|Decision of Sponsor|2|||
30749870|NCT00124917|58759748|FG000|Overall Study|Physician Decision|3|||
30749871|NCT00141921|58759753|FG000|Overall Study|Remain on Study|28|||
30811043|NCT03547583|58829868|FG001|Overall Study|Physician Decision|0|||
30811044|NCT03547583|58829869|FG002|Overall Study|Physician Decision|3|||
30749872|NCT00141921|58759753|FG000|Overall Study|Withdrawal by Subject|42|||
30811045|NCT03547583|58829867|FG000|Overall Study|Protocol Violation|2|||
30811046|NCT03547583|58829868|FG001|Overall Study|Protocol Violation|1|||
30811047|NCT03547583|58829869|FG002|Overall Study|Protocol Violation|1|||
30811048|NCT03547583|58829867|FG000|Overall Study|Withdrawal by Subject|12|||
30811049|NCT03547583|58829868|FG001|Overall Study|Withdrawal by Subject|19|||
30811050|NCT03547583|58829869|FG002|Overall Study|Withdrawal by Subject|10|||
30811051|NCT03547583|58829867|FG000|Overall Study|Other|2|||
30811052|NCT03547583|58829868|FG001|Overall Study|Other|2|||
30811053|NCT03547583|58829869|FG002|Overall Study|Other|3|||
30811054|NCT02670382|58829880|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
30811055|NCT02670382|58829881|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
30811056|NCT02991482|58829891|FG000|Overall Study|Disease progression|56|||
30749873|NCT00141921|58759753|FG000|Overall Study|Lost to Follow-up|19|||
30749874|NCT00141921|58759753|FG000|Overall Study|Noncompliance|17|||
30749875|NCT00141921|58759753|FG000|Overall Study|Disease Progression|7|||
30749876|NCT00141921|58759753|FG000|Overall Study|Protocol Deviation|7|||
30749877|NCT00141921|58759753|FG000|Overall Study|Adverse Event|5|||
30749878|NCT00141921|58759753|FG000|Overall Study|Administrative Decision|2|||
30749879|NCT00141921|58759753|FG000|Overall Study|Pregnancy|4|||
30749880|NCT00141921|58759753|FG000|Overall Study|Ineligibility Determined|2|||
30749881|NCT00141921|58759753|FG000|Overall Study|Other|8|||
30749882|NCT00029146|58759759|FG000|Overall Study|Lost to Follow-up|2|||
30749883|NCT00029146|58759760|FG001|Overall Study|Lost to Follow-up|1|||
30749884|NCT00026494|58759770|FG000|Overall Study|Withdrawal by Subject|1|||
30749885|NCT00026494|58759771|FG001|Overall Study|Withdrawal by Subject|0|||
30749886|NCT00026494|58759772|FG002|Overall Study|Withdrawal by Subject|1|||
30811057|NCT02991482|58829892|FG001|Overall Study|Disease progression|47|||
30811058|NCT02991482|58829891|FG000|Overall Study|Death|4|||
30811059|NCT02991482|58829892|FG001|Overall Study|Death|4|||
30811060|NCT02991482|58829891|FG000|Overall Study|Adverse Event|1|||
30811061|NCT02991482|58829892|FG001|Overall Study|Adverse Event|6|||
30811062|NCT02991482|58829891|FG000|Overall Study|Patient decision|1|||
30811063|NCT02991482|58829892|FG001|Overall Study|Patient decision|1|||
30811064|NCT02991482|58829891|FG000|Overall Study|Physician Decision|0|||
30811065|NCT02991482|58829892|FG001|Overall Study|Physician Decision|6|||
30811066|NCT02991482|58829891|FG000|Overall Study|Clinical deterioration|1|||
30811067|NCT02991482|58829892|FG001|Overall Study|Clinical deterioration|0|||
30811068|NCT02991482|58829891|FG000|Overall Study|Patient feeling too unwell|1|||
30811069|NCT02991482|58829892|FG001|Overall Study|Patient feeling too unwell|0|||
30811070|NCT02991482|58829891|FG000|Overall Study|Worsening of performance status|0|||
30811071|NCT02991482|58829892|FG001|Overall Study|Worsening of performance status|1|||
30811072|NCT02991482|58829891|FG000|Overall Study|Death prior to study drug initiation|1|||
30811073|NCT02991482|58829892|FG001|Overall Study|Death prior to study drug initiation|0|||
30811074|NCT02991482|58829891|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
30811075|NCT02991482|58829892|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
30811076|NCT02674750|58829901|FG000|Overall Study|Death|4|||
30811077|NCT02674750|58829902|FG001|Overall Study|Death|5|||
30811078|NCT02674750|58829903|FG002|Overall Study|Death|8|||
30811079|NCT02674750|58829901|FG000|Overall Study|Lost to Follow-up|0|||
30811080|NCT02674750|58829902|FG001|Overall Study|Lost to Follow-up|8|||
30811081|NCT02674750|58829903|FG002|Overall Study|Lost to Follow-up|0|||
30811082|NCT02674750|58829901|FG000|Overall Study|Lack of Efficacy|1|||
30811083|NCT02674750|58829902|FG001|Overall Study|Lack of Efficacy|17|||
30811084|NCT02674750|58829903|FG002|Overall Study|Lack of Efficacy|3|||
30909963|NCT02290223|58944933|FG000|6 Months|deceased (not related to study)|2|||
30811085|NCT02674750|58829901|FG000|Overall Study|Withdrawal by Subject|0|||
30811086|NCT02674750|58829902|FG001|Overall Study|Withdrawal by Subject|7|||
30811087|NCT02674750|58829903|FG002|Overall Study|Withdrawal by Subject|1|||
30811088|NCT02674750|58829901|FG000|Overall Study|Other|0|||
30811089|NCT02674750|58829902|FG001|Overall Study|Other|8|||
30811090|NCT02674750|58829903|FG002|Overall Study|Other|0|||
30811091|NCT02987972|58829932|FG000|Overall Study|Adverse Event|1|||
30811092|NCT02987972|58829933|FG001|Overall Study|Adverse Event|1|||
30811093|NCT02987972|58829934|FG002|Overall Study|Adverse Event|0|||
30811094|NCT02987972|58829932|FG000|Overall Study|Death|1|||
30811095|NCT02987972|58829933|FG001|Overall Study|Death|0|||
30811096|NCT02987972|58829934|FG002|Overall Study|Death|0|||
30811097|NCT02987972|58829932|FG000|Overall Study|Lack of Efficacy|9|||
30811098|NCT02987972|58829933|FG001|Overall Study|Lack of Efficacy|12|||
30811099|NCT02987972|58829934|FG002|Overall Study|Lack of Efficacy|12|||
30811100|NCT02987972|58829932|FG000|Overall Study|Lost to Follow-up|7|||
30749887|NCT00026494|58759773|FG003|Overall Study|Withdrawal by Subject|0|||
30749888|NCT00026494|58759770|FG000|Overall Study|Patient non-compliance|1|||
30811101|NCT02987972|58829933|FG001|Overall Study|Lost to Follow-up|8|||
30811102|NCT02987972|58829934|FG002|Overall Study|Lost to Follow-up|4|||
30811103|NCT02987972|58829932|FG000|Overall Study|Physician Decision|1|||
30811104|NCT02987972|58829933|FG001|Overall Study|Physician Decision|6|||
30811105|NCT02987972|58829934|FG002|Overall Study|Physician Decision|0|||
30811106|NCT02987972|58829932|FG000|Overall Study|Protocol Violation|2|||
30811107|NCT02987972|58829933|FG001|Overall Study|Protocol Violation|1|||
30811108|NCT02987972|58829934|FG002|Overall Study|Protocol Violation|5|||
30811109|NCT02987972|58829932|FG000|Overall Study|Withdrawal by Subject|22|||
30811110|NCT02987972|58829933|FG001|Overall Study|Withdrawal by Subject|17|||
30811111|NCT02987972|58829934|FG002|Overall Study|Withdrawal by Subject|21|||
30811112|NCT03305419|58829950|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
30811113|NCT03305419|58829951|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
30811114|NCT03305419|58829952|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
30811115|NCT03305419|58829953|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
30811116|NCT03305419|58829954|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
30811117|NCT03305419|58829955|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
30811118|NCT03305419|58829956|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
30811119|NCT03305419|58829957|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
30811120|NCT03305419|58829950|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
30811121|NCT03305419|58829951|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
30811122|NCT03305419|58829952|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
30811123|NCT03305419|58829953|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
30811124|NCT03305419|58829954|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
30811125|NCT03305419|58829955|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
30811126|NCT03305419|58829956|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
30811127|NCT03305419|58829957|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
30811128|NCT03305419|58829950|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
30811129|NCT03305419|58829951|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
30811130|NCT03305419|58829952|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
30811131|NCT03305419|58829953|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
30811132|NCT03305419|58829954|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
30811133|NCT03305419|58829955|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
30811134|NCT03305419|58829956|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
30811135|NCT03305419|58829957|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
30811136|NCT03305419|58829950|FG000|Part B (14 Days)|Adverse Event|0|||
30811137|NCT03305419|58829951|FG001|Part B (14 Days)|Adverse Event|0|||
30811138|NCT03305419|58829952|FG002|Part B (14 Days)|Adverse Event|0|||
30811139|NCT03305419|58829953|FG003|Part B (14 Days)|Adverse Event|0|||
30811140|NCT03305419|58829954|FG004|Part B (14 Days)|Adverse Event|1|||
30811141|NCT03305419|58829955|FG005|Part B (14 Days)|Adverse Event|2|||
30811142|NCT03305419|58829956|FG006|Part B (14 Days)|Adverse Event|4|||
30811143|NCT03305419|58829957|FG007|Part B (14 Days)|Adverse Event|0|||
30811144|NCT03305419|58829950|FG000|Part B (14 Days)|Physician Decision|0|||
30811145|NCT03305419|58829951|FG001|Part B (14 Days)|Physician Decision|0|||
30811146|NCT03305419|58829952|FG002|Part B (14 Days)|Physician Decision|0|||
30811147|NCT03305419|58829953|FG003|Part B (14 Days)|Physician Decision|0|||
30811148|NCT03305419|58829954|FG004|Part B (14 Days)|Physician Decision|2|||
30811149|NCT03305419|58829955|FG005|Part B (14 Days)|Physician Decision|8|||
30811150|NCT03305419|58829956|FG006|Part B (14 Days)|Physician Decision|1|||
30811151|NCT03305419|58829957|FG007|Part B (14 Days)|Physician Decision|0|||
30811152|NCT01372618|58829980|FG000|Overall Study|PI Died. Study Terminated|9|||
30811153|NCT03304873|58829986|FG000|Overall Study|Lost to Follow-up|1|||
30811154|NCT03304873|58829987|FG001|Overall Study|Lost to Follow-up|8|||
30811155|NCT02669758|58829993|FG000|Overall Study|Withdrawal by Subject|43|||
30811156|NCT02669758|58829993|FG000|Overall Study|Lost to Follow-up|19|||
30811157|NCT02669758|58829993|FG000|Overall Study|Adverse Event|16|||
30811158|NCT02669758|58829993|FG000|Overall Study|Non-Compliance with Study Drug|8|||
30811159|NCT02669758|58829993|FG000|Overall Study|Lack of Efficacy|5|||
30811160|NCT02669758|58829993|FG000|Overall Study|Pregnancy|1|||
30811161|NCT02669758|58829993|FG000|Overall Study|Study noncompliance|1|||
30811162|NCT02669758|58829993|FG000|Overall Study|Protocol Violation|1|||
30811163|NCT02987660|58829999|FG000|Overall Study|Study terminated by sponsor|10|||
30811164|NCT02987660|58830000|FG001|Overall Study|Study terminated by sponsor|10|||
30811165|NCT04528069|58830006|FG000|Overall Study|Adverse Event|1|||
30811166|NCT04528069|58830006|FG000|Overall Study|Lost to Follow-up|1|||
30811167|NCT04528069|58830006|FG000|Overall Study|Patient Unable to Come|1|||
30811168|NCT04528069|58830006|FG000|Overall Study|Patient Unable to Attend|1|||
30811169|NCT03303469|58830022|FG000|Overall Study|Lost to Follow-up|2|||
30811170|NCT02990000|58830028|FG000|Overall Study|Failed to provide data beyond baseline|36|||
30811171|NCT02990000|58830029|FG001|Overall Study|Failed to provide data beyond baseline|34|||
30811172|NCT01068626|58830037|FG000|Overall Study|Adverse Event|3|||
30811173|NCT01068626|58830038|FG001|Overall Study|Adverse Event|0|||
30811174|NCT01068626|58830037|FG000|Overall Study|Withdrawal by Subject|0|||
30811175|NCT01068626|58830038|FG001|Overall Study|Withdrawal by Subject|2|||
30811176|NCT02921750|58830046|FG000|Overall Study|Adverse Event|1|||
30811177|NCT02921750|58830047|FG001|Overall Study|Adverse Event|2|||
30811178|NCT02921750|58830046|FG000|Overall Study|Withdrawal by Subject|1|||
30811179|NCT02921750|58830047|FG001|Overall Study|Withdrawal by Subject|1|||
30811180|NCT02921750|58830046|FG000|Overall Study|Lost to Follow-up|3|||
30811181|NCT02921750|58830047|FG001|Overall Study|Lost to Follow-up|3|||
30811182|NCT02921750|58830046|FG000|Overall Study|Wound healed|3|||
30811183|NCT02921750|58830047|FG001|Overall Study|Wound healed|3|||
30811184|NCT02921750|58830046|FG000|Overall Study|Serious Adverse Event|1|||
30811185|NCT02921750|58830047|FG001|Overall Study|Serious Adverse Event|2|||
30811186|NCT02920970|58830056|FG000|First Intervention|Protocol Violation|0|||
30811187|NCT02920970|58830057|FG001|First Intervention|Protocol Violation|1|||
30811188|NCT02920970|58830056|FG000|First Intervention|Adverse Event|0|||
30811189|NCT02920970|58830057|FG001|First Intervention|Adverse Event|1|||
30811190|NCT02920970|58830056|FG000|Second Intervention|Poor Lens Fit|1|||
30811191|NCT02920970|58830057|FG001|Second Intervention|Poor Lens Fit|0|||
30811192|NCT01068158|58830067|FG000|Overall Study|Withdrawal by Subject|1|||
30811193|NCT01068158|58830068|FG001|Overall Study|Withdrawal by Subject|2|||
30811194|NCT01068158|58830067|FG000|Overall Study|Lost to Follow-up|7|||
30811195|NCT01068158|58830068|FG001|Overall Study|Lost to Follow-up|0|||
30811196|NCT01068158|58830067|FG000|Overall Study|Protocol Violation|0|||
30811197|NCT01068158|58830068|FG001|Overall Study|Protocol Violation|2|||
30811198|NCT03303079|58830077|FG000|Overall Study|Adverse Event|0|||
30811199|NCT03303079|58830078|FG001|Overall Study|Adverse Event|1|||
30811200|NCT03303079|58830079|FG002|Overall Study|Adverse Event|3|||
30811201|NCT03303079|58830077|FG000|Overall Study|Protocol Violation|5|||
30811202|NCT03303079|58830078|FG001|Overall Study|Protocol Violation|4|||
30811203|NCT03303079|58830079|FG002|Overall Study|Protocol Violation|7|||
30811204|NCT03303079|58830077|FG000|Overall Study|Withdrawal by Subject|2|||
30811205|NCT03303079|58830078|FG001|Overall Study|Withdrawal by Subject|4|||
30811206|NCT03303079|58830079|FG002|Overall Study|Withdrawal by Subject|2|||
30811207|NCT03303079|58830077|FG000|Overall Study|Other than specified|0|||
30811208|NCT03303079|58830078|FG001|Overall Study|Other than specified|2|||
30811209|NCT03303079|58830079|FG002|Overall Study|Other than specified|0|||
30811210|NCT01067846|58830089|FG000|Overall Study|Lost to Follow-up|17|||
30811211|NCT01067846|58830090|FG001|Overall Study|Lost to Follow-up|19|||
30811212|NCT01067846|58830089|FG000|Overall Study|Withdrawal by Subject|1|||
30811213|NCT01067846|58830090|FG001|Overall Study|Withdrawal by Subject|0|||
30811214|NCT01067846|58830089|FG000|Overall Study|participation in other tx study|1|||
30811215|NCT01067846|58830090|FG001|Overall Study|participation in other tx study|0|||
30811216|NCT03311659|58830096|FG000|Overall Study|Protocol Violation|1|||
30811217|NCT03874234|58830113|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811218|NCT03874234|58830114|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811219|NCT03874234|58830115|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811220|NCT03874234|58830116|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
30811221|NCT03874234|58830117|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811222|NCT03874234|58830118|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811223|NCT03874234|58830119|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811224|NCT03874234|58830120|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811225|NCT03874234|58830121|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811226|NCT03874234|58830122|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811227|NCT03874234|58830123|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811228|NCT03874234|58830124|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811229|NCT03874234|58830125|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
30811230|NCT03874234|58830113|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
30811231|NCT03874234|58830114|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811232|NCT03874234|58830115|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811233|NCT03874234|58830116|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811234|NCT03874234|58830117|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811235|NCT03874234|58830118|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811236|NCT03874234|58830119|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811237|NCT03874234|58830120|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811238|NCT03874234|58830121|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811239|NCT03874234|58830122|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811240|NCT03874234|58830123|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811241|NCT03874234|58830124|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811242|NCT03874234|58830125|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
30811243|NCT03874234|58830113|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30811244|NCT03874234|58830114|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30811245|NCT03874234|58830115|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30811246|NCT03874234|58830116|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
30811247|NCT03874234|58830117|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30909964|NCT02290223|58944934|FG001|6 Months|deceased (not related to study)|0|||
30909965|NCT02290223|58944933|FG000|12 Months|Lost to Follow-up|16|||
30811248|NCT03874234|58830118|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30811249|NCT03874234|58830119|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30811250|NCT03874234|58830120|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30811251|NCT03874234|58830121|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30909966|NCT02290223|58944934|FG001|12 Months|Lost to Follow-up|10|||
30909967|NCT02290223|58944933|FG000|12 Months|Refusal|0|||
30811252|NCT03874234|58830122|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30811253|NCT03874234|58830123|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30811254|NCT03874234|58830124|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30811255|NCT03874234|58830125|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
30811256|NCT03874234|58830113|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811257|NCT03874234|58830114|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811258|NCT03874234|58830115|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811259|NCT03874234|58830116|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811260|NCT03874234|58830117|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
30811261|NCT03874234|58830118|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811262|NCT03874234|58830119|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811263|NCT03874234|58830120|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811264|NCT03874234|58830121|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811265|NCT03874234|58830122|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811266|NCT03874234|58830123|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811267|NCT03874234|58830124|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811268|NCT03874234|58830125|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
30811269|NCT03874234|58830113|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30811270|NCT03874234|58830114|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30811271|NCT03874234|58830115|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30811272|NCT03874234|58830116|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30811273|NCT03874234|58830117|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30811274|NCT03874234|58830118|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30909968|NCT02290223|58944934|FG001|12 Months|Refusal|1|||
30909969|NCT02289833|58944942|FG000|Overall Study|Study discontinuation|0|||
30909970|NCT02289833|58944943|FG001|Overall Study|Study discontinuation|1|||
30749889|NCT00026494|58759771|FG001|Overall Study|Patient non-compliance|0|||
30749890|NCT00026494|58759772|FG002|Overall Study|Patient non-compliance|0|||
30811275|NCT03874234|58830119|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30811276|NCT03874234|58830120|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
30811277|NCT03874234|58830121|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30811278|NCT03874234|58830122|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30811279|NCT03874234|58830123|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30811280|NCT03874234|58830124|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30811281|NCT03874234|58830125|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
30811282|NCT03874234|58830113|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
30811283|NCT03874234|58830114|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
30811284|NCT03874234|58830115|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
30811285|NCT03874234|58830116|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
30811286|NCT03874234|58830117|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
30811287|NCT03874234|58830118|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
30811288|NCT03874234|58830119|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
30811289|NCT03874234|58830120|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
30811290|NCT03874234|58830121|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
30811291|NCT03874234|58830122|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
30811292|NCT03874234|58830123|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
30811293|NCT03874234|58830124|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
30811294|NCT03874234|58830125|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
30811295|NCT03874234|58830113|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30811296|NCT03874234|58830114|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30811297|NCT03874234|58830115|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30811298|NCT03874234|58830116|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30811299|NCT03874234|58830117|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30811300|NCT03874234|58830118|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30811301|NCT03874234|58830119|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
30811302|NCT03874234|58830120|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30811303|NCT03874234|58830121|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30811304|NCT03874234|58830122|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30811305|NCT03874234|58830123|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30749891|NCT00026494|58759773|FG003|Overall Study|Patient non-compliance|0|||
30749892|NCT00026494|58759770|FG000|Overall Study|Patient not treated|0|||
30909971|NCT02289833|58944942|FG000|Overall Study|Lost to Follow-up|4|||
30909972|NCT02289833|58944943|FG001|Overall Study|Lost to Follow-up|0|||
30749893|NCT00026494|58759771|FG001|Overall Study|Patient not treated|0|||
30749894|NCT00026494|58759772|FG002|Overall Study|Patient not treated|2|||
30749895|NCT00026494|58759773|FG003|Overall Study|Patient not treated|0|||
30749896|NCT00026494|58759770|FG000|Overall Study|Clinical progression|0|||
30811306|NCT03874234|58830124|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30811307|NCT03874234|58830125|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
30811308|NCT03874234|58830113|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811309|NCT03874234|58830114|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811310|NCT03874234|58830115|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811311|NCT03874234|58830116|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811312|NCT03874234|58830117|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
30811313|NCT03874234|58830118|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811314|NCT03874234|58830119|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811315|NCT03874234|58830120|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811316|NCT03874234|58830121|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811317|NCT03874234|58830122|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811318|NCT03874234|58830123|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811319|NCT03874234|58830124|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811320|NCT03874234|58830125|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
30811321|NCT02985398|58830161|FG000|Overall Study|Adverse Event|1|||
30811322|NCT02985398|58830161|FG000|Overall Study|Lost to Follow-up|4|||
30811323|NCT02985398|58830161|FG000|Overall Study|Withdrawal by Subject|8|||
30811324|NCT02985398|58830161|FG000|Overall Study|Study Burden|9|||
30811325|NCT03310723|58830167|FG000|Overall Study|Withdrawal by Subject|0|||
30811326|NCT03310723|58830168|FG001|Overall Study|Withdrawal by Subject|1|||
30811327|NCT03310723|58830167|FG000|Overall Study|Protocol Violation|0|||
30811328|NCT03310723|58830168|FG001|Overall Study|Protocol Violation|2|||
30749897|NCT00026494|58759771|FG001|Overall Study|Clinical progression|0|||
30749898|NCT00026494|58759772|FG002|Overall Study|Clinical progression|3|||
30811329|NCT02663674|58830176|FG000|Overall Study|Lost to Follow-up|5|||
30811330|NCT02663674|58830177|FG001|Overall Study|Lost to Follow-up|4|||
30811331|NCT02663674|58830176|FG000|Overall Study|Withdrawal by Subject|1|||
30811332|NCT02663674|58830177|FG001|Overall Study|Withdrawal by Subject|4|||
30909973|NCT02289833|58944942|FG000|Overall Study|Death|23|||
30909974|NCT02289833|58944943|FG001|Overall Study|Death|16|||
30811333|NCT02663674|58830176|FG000|Overall Study|Physician Decision|1|||
30811334|NCT02663674|58830177|FG001|Overall Study|Physician Decision|1|||
30811335|NCT02663674|58830176|FG000|Overall Study|Other Event (Health Related)|0|||
30811336|NCT02663674|58830177|FG001|Overall Study|Other Event (Health Related)|1|||
30811337|NCT02908880|58830183|FG000|Overall Study|Lost to Follow-up|4|||
30811338|NCT02908880|58830183|FG000|Overall Study|Explantation of the device|1|||
30811339|NCT02908880|58830183|FG000|Overall Study|Withdrawal by Subject|17|||
30811340|NCT02908880|58830183|FG000|Overall Study|Death|5|||
30811341|NCT03310411|58830187|FG000|Period 1|Adverse Event|0|||
30811342|NCT03310411|58830188|FG001|Period 1|Adverse Event|0|||
30909975|NCT01702558|58944956|FG000|Overall Study|Withdrawal by Subject|0|||
30909976|NCT01702558|58944957|FG001|Overall Study|Withdrawal by Subject|0|||
30749899|NCT00026494|58759773|FG003|Overall Study|Clinical progression|0|||
30749900|NCT00023764|58759783|FG000|Overall Study|Other|1|||
30749901|NCT00023764|58759783|FG000|Overall Study|Adverse Event|4|||
30749902|NCT00023764|58759783|FG000|Overall Study|Withdrawal by Subject|1|||
30749903|NCT00023764|58759783|FG000|Overall Study|Progression of disease|6|||
30749904|NCT00023764|58759783|FG000|Overall Study|patient received other treatment|1|||
30749905|NCT00023764|58759783|FG000|Overall Study|delay in obtaining staging images|1|||
30811343|NCT03310411|58830189|FG002|Period 1|Adverse Event|0|||
30811344|NCT03310411|58830190|FG003|Period 1|Adverse Event|1|||
30811345|NCT03301831|58830208|FG000|Overall Study|Lost to Follow-up|5|||
30811346|NCT03301831|58830209|FG001|Overall Study|Lost to Follow-up|3|||
30811347|NCT03301831|58830208|FG000|Overall Study|Protocol Violation|4|||
30811348|NCT03301831|58830209|FG001|Overall Study|Protocol Violation|0|||
30811349|NCT03301831|58830208|FG000|Overall Study|Withdrawal by Subject|11|||
30811350|NCT03301831|58830209|FG001|Overall Study|Withdrawal by Subject|0|||
30811351|NCT02909504|58830215|FG000|Overall Study|Adverse Event|2|||
30811352|NCT02909504|58830215|FG000|Overall Study|Lack of Efficacy|3|||
30811353|NCT02909504|58830215|FG000|Overall Study|Withdrawal by Subject|4|||
30811354|NCT02909504|58830215|FG000|Overall Study|Pregnancy|1|||
30909977|NCT01702558|58944958|FG002|Overall Study|Withdrawal by Subject|0|||
30909978|NCT01702558|58944959|FG003|Overall Study|Withdrawal by Subject|12|||
30811355|NCT02909504|58830215|FG000|Overall Study|Subject moved|1|||
30811356|NCT02909504|58830215|FG000|Overall Study|Lost to Follow-up|1|||
30811357|NCT02199691|58830224|FG000|Overall Study|Protocol Violation|3|||
30811358|NCT02199691|58830225|FG001|Overall Study|Protocol Violation|3|||
30811359|NCT02199691|58830226|FG002|Overall Study|Protocol Violation|6|||
30811360|NCT02199691|58830227|FG003|Overall Study|Protocol Violation|7|||
30811361|NCT02199691|58830224|FG000|Overall Study|Withdrawal by Subject|5|||
30811362|NCT02199691|58830225|FG001|Overall Study|Withdrawal by Subject|3|||
30811363|NCT02199691|58830226|FG002|Overall Study|Withdrawal by Subject|12|||
30811364|NCT02199691|58830227|FG003|Overall Study|Withdrawal by Subject|13|||
30811365|NCT02199691|58830224|FG000|Overall Study|Lost to Follow-up|2|||
30811366|NCT02199691|58830225|FG001|Overall Study|Lost to Follow-up|1|||
30811367|NCT02199691|58830226|FG002|Overall Study|Lost to Follow-up|9|||
30811368|NCT02199691|58830227|FG003|Overall Study|Lost to Follow-up|10|||
30811369|NCT03299881|58830241|FG000|Overall Study|Study Termination|17|||
30811370|NCT03299881|58830242|FG001|Overall Study|Study Termination|13|||
30811371|NCT03299101|58830248|FG000|Overall Study|Lost to Follow-up|1|||
30811372|NCT03299101|58830248|FG000|Overall Study|Withdrawal by Subject|5|||
30811373|NCT03299101|58830248|FG000|Overall Study|Surgery was changed|3|||
30811374|NCT03299101|58830248|FG000|Overall Study|Not enough time to complete prehab|1|||
30811375|NCT02663128|58830254|FG000|Period 2|Physician Decision|0|||
30811376|NCT02663128|58830255|FG001|Period 2|Physician Decision|0|||
30811377|NCT02663128|58830256|FG002|Period 2|Physician Decision|0|||
30811378|NCT02663128|58830257|FG003|Period 2|Physician Decision|0|||
30811379|NCT02663128|58830258|FG004|Period 2|Physician Decision|1|||
30811380|NCT02663128|58830259|FG005|Period 2|Physician Decision|0|||
30811381|NCT03298867|58830270|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
30811382|NCT03298867|58830271|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
30811383|NCT03298867|58830270|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
30811384|NCT03298867|58830271|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
30811385|NCT03298867|58830270|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
30811386|NCT03298867|58830271|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
30811387|NCT03298867|58830270|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
30811388|NCT03298867|58830271|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
30811389|NCT03298867|58830270|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
30811390|NCT03298867|58830271|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
30811391|NCT03298867|58830270|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
30811392|NCT03298867|58830271|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
30811393|NCT03298867|58830270|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
30811394|NCT03298867|58830271|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
30811395|NCT03298867|58830270|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
30811396|NCT03298867|58830271|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
30811397|NCT03298867|58830270|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
30811398|NCT03298867|58830271|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
30811399|NCT02906930|58830281|FG000|Overall Study|Withdrawal by Subject|0|||
30811400|NCT02906930|58830282|FG001|Overall Study|Withdrawal by Subject|5|||
30811401|NCT02906930|58830283|FG002|Overall Study|Withdrawal by Subject|5|||
30811402|NCT02906930|58830284|FG003|Overall Study|Withdrawal by Subject|4|||
30811403|NCT02906930|58830281|FG000|Overall Study|Lost to Follow-up|5|||
30811404|NCT02906930|58830282|FG001|Overall Study|Lost to Follow-up|7|||
30811405|NCT02906930|58830283|FG002|Overall Study|Lost to Follow-up|5|||
30811406|NCT02906930|58830284|FG003|Overall Study|Lost to Follow-up|2|||
30811407|NCT02906930|58830281|FG000|Overall Study|Death|0|||
30811408|NCT02906930|58830282|FG001|Overall Study|Death|0|||
30909979|NCT01702558|58944960|FG004|Overall Study|Withdrawal by Subject|4|||
30909980|NCT01702558|58944956|FG000|Overall Study|Lost to Follow-up|0|||
30811409|NCT02906930|58830283|FG002|Overall Study|Death|1|||
30811410|NCT02906930|58830284|FG003|Overall Study|Death|0|||
30811411|NCT02906930|58830281|FG000|Overall Study|Other|1|||
30811412|NCT02906930|58830282|FG001|Overall Study|Other|2|||
30811413|NCT02906930|58830283|FG002|Overall Study|Other|1|||
30811414|NCT02906930|58830284|FG003|Overall Study|Other|2|||
30811415|NCT02983604|58830298|FG000|Overall Study|Enrolled but not Treated|0|||
30811416|NCT02983604|58830299|FG001|Overall Study|Enrolled but not Treated|0|||
30909981|NCT01702558|58944957|FG001|Overall Study|Lost to Follow-up|0|||
30909982|NCT01702558|58944958|FG002|Overall Study|Lost to Follow-up|0|||
30909983|NCT01702558|58944959|FG003|Overall Study|Lost to Follow-up|3|||
30909984|NCT01702558|58944960|FG004|Overall Study|Lost to Follow-up|0|||
30909985|NCT01702558|58944956|FG000|Overall Study|Death|4|||
30909986|NCT01702558|58944957|FG001|Overall Study|Death|3|||
30909987|NCT01702558|58944958|FG002|Overall Study|Death|3|||
30909988|NCT01702558|58944959|FG003|Overall Study|Death|16|||
30909989|NCT01702558|58944960|FG004|Overall Study|Death|20|||
30909990|NCT01702558|58944956|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
30909991|NCT01702558|58944957|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
30909992|NCT01702558|58944958|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
30909993|NCT01702558|58944959|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
30909994|NCT01702558|58944960|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
30909995|NCT01702558|58944956|FG000|Overall Study|Study Terminated by Sponsor|0|||
30909996|NCT01702558|58944957|FG001|Overall Study|Study Terminated by Sponsor|1|||
30909997|NCT01702558|58944958|FG002|Overall Study|Study Terminated by Sponsor|0|||
30909998|NCT01702558|58944959|FG003|Overall Study|Study Terminated by Sponsor|0|||
30909999|NCT01702558|58944960|FG004|Overall Study|Study Terminated by Sponsor|1|||
30910000|NCT01702558|58944956|FG000|Overall Study|Other|0|||
30910001|NCT01702558|58944957|FG001|Overall Study|Other|0|||
30910002|NCT01702558|58944958|FG002|Overall Study|Other|0|||
30910003|NCT01702558|58944959|FG003|Overall Study|Other|16|||
30910004|NCT01702558|58944960|FG004|Overall Study|Other|17|||
30910005|NCT02287883|58944975|FG000|Overall Study|Death|8|||
30910006|NCT02287883|58944976|FG001|Overall Study|Death|7|||
30910007|NCT02287883|58944975|FG000|Overall Study|No longer eligible|222|||
30910008|NCT02287883|58944976|FG001|Overall Study|No longer eligible|182|||
30910009|NCT02287883|58944975|FG000|Overall Study|Non-response to survey|229|||
30910010|NCT02287883|58944976|FG001|Overall Study|Non-response to survey|237|||
30910011|NCT01743040|58944982|FG000|Overall Study|Death|1|||
30910012|NCT01743040|58944982|FG000|Overall Study|Lost to Follow-up|66|||
30910013|NCT01743040|58944982|FG000|Overall Study|Physician Decision|40|||
30910014|NCT01743040|58944982|FG000|Overall Study|Protocol Violation|1|||
30910015|NCT01743040|58944982|FG000|Overall Study|Withdrawal by Subject|121|||
30910016|NCT02194465|58944993|FG000|Overall Study|Adverse Event|6|||
30910017|NCT02194465|58944994|FG001|Overall Study|Adverse Event|1|||
30910018|NCT02194465|58944995|FG002|Overall Study|Adverse Event|4|||
30910019|NCT02194465|58944996|FG003|Overall Study|Adverse Event|4|||
30910020|NCT02194465|58944997|FG004|Overall Study|Adverse Event|4|||
30910021|NCT02194465|58944998|FG005|Overall Study|Adverse Event|2|||
30910022|NCT02194465|58944999|FG006|Overall Study|Adverse Event|0|||
30910023|NCT02194465|58944993|FG000|Overall Study|Lost to Follow-up|0|||
30910024|NCT02194465|58944994|FG001|Overall Study|Lost to Follow-up|0|||
30910025|NCT02194465|58944995|FG002|Overall Study|Lost to Follow-up|0|||
30910026|NCT02194465|58944996|FG003|Overall Study|Lost to Follow-up|1|||
30910027|NCT02194465|58944997|FG004|Overall Study|Lost to Follow-up|0|||
30910028|NCT02194465|58944998|FG005|Overall Study|Lost to Follow-up|1|||
30910029|NCT02194465|58944999|FG006|Overall Study|Lost to Follow-up|0|||
30910030|NCT02194465|58944993|FG000|Overall Study|Physician Decision|1|||
30910031|NCT02194465|58944994|FG001|Overall Study|Physician Decision|0|||
30910032|NCT02194465|58944995|FG002|Overall Study|Physician Decision|0|||
30910033|NCT02194465|58944996|FG003|Overall Study|Physician Decision|0|||
30910034|NCT02194465|58944997|FG004|Overall Study|Physician Decision|0|||
30910035|NCT02194465|58944998|FG005|Overall Study|Physician Decision|0|||
30910036|NCT02194465|58944999|FG006|Overall Study|Physician Decision|0|||
30910037|NCT02194465|58944993|FG000|Overall Study|Protocol Violation|1|||
30910038|NCT02194465|58944994|FG001|Overall Study|Protocol Violation|1|||
30910039|NCT02194465|58944995|FG002|Overall Study|Protocol Violation|2|||
30910040|NCT02194465|58944996|FG003|Overall Study|Protocol Violation|1|||
30910041|NCT02194465|58944997|FG004|Overall Study|Protocol Violation|1|||
30910042|NCT02194465|58944998|FG005|Overall Study|Protocol Violation|0|||
30910043|NCT02194465|58944999|FG006|Overall Study|Protocol Violation|0|||
30910044|NCT02194465|58944993|FG000|Overall Study|Withdrawal by Subject|1|||
30910045|NCT02194465|58944994|FG001|Overall Study|Withdrawal by Subject|3|||
30910046|NCT02194465|58944995|FG002|Overall Study|Withdrawal by Subject|1|||
30910047|NCT02194465|58944996|FG003|Overall Study|Withdrawal by Subject|2|||
30910048|NCT02194465|58944997|FG004|Overall Study|Withdrawal by Subject|2|||
30910049|NCT02194465|58944998|FG005|Overall Study|Withdrawal by Subject|1|||
30910050|NCT02194465|58944999|FG006|Overall Study|Withdrawal by Subject|2|||
30910051|NCT02194465|58944993|FG000|Overall Study|Discontinued follow-up period|0|||
30910052|NCT02194465|58944994|FG001|Overall Study|Discontinued follow-up period|2|||
30910053|NCT02194465|58944995|FG002|Overall Study|Discontinued follow-up period|1|||
30910054|NCT02194465|58944996|FG003|Overall Study|Discontinued follow-up period|0|||
30910055|NCT02194465|58944997|FG004|Overall Study|Discontinued follow-up period|2|||
30910056|NCT02194465|58944998|FG005|Overall Study|Discontinued follow-up period|0|||
30910057|NCT02194465|58944999|FG006|Overall Study|Discontinued follow-up period|0|||
30910058|NCT02287025|58945021|FG000|Overall Study|Not treated|2|||
30910059|NCT02287025|58945022|FG001|Overall Study|Not treated|0|||
30910060|NCT02287025|58945021|FG000|Overall Study|Progression of disease|3|||
30910061|NCT02287025|58945022|FG001|Overall Study|Progression of disease|2|||
30910062|NCT02287025|58945021|FG000|Overall Study|Adverse Event|2|||
30910063|NCT02287025|58945022|FG001|Overall Study|Adverse Event|4|||
30910064|NCT02287025|58945021|FG000|Overall Study|Withdrawal by Subject|2|||
30910065|NCT02287025|58945022|FG001|Overall Study|Withdrawal by Subject|2|||
30910066|NCT02287025|58945021|FG000|Overall Study|Screening failed|1|||
30910067|NCT02287025|58945022|FG001|Overall Study|Screening failed|1|||
30910068|NCT01720264|58945026|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
30910069|NCT01720264|58945026|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
30910070|NCT01720264|58945026|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
30910071|NCT01702246|58945030|FG000|Overall Study|Lost to Follow-up|2|||
30910072|NCT01702246|58945030|FG000|Overall Study|Withdrawal by Subject|2|||
30910073|NCT01702246|58945030|FG000|Overall Study|Physician Decision|1|||
30910074|NCT01631227|58945039|FG000|Overall Study|withdrawn consent|27|||
30910075|NCT01631227|58945040|FG001|Overall Study|withdrawn consent|21|||
30910076|NCT01631227|58945039|FG000|Overall Study|Adverse Event|1|||
30910077|NCT01631227|58945040|FG001|Overall Study|Adverse Event|0|||
30910078|NCT01631227|58945039|FG000|Overall Study|administrative|2|||
30910079|NCT01631227|58945040|FG001|Overall Study|administrative|1|||
30910080|NCT01719172|58945046|FG000|Overall Study|Lost to Follow-up|1|||
30910081|NCT01719172|58945046|FG000|Overall Study|Death|1|||
30910082|NCT02286947|58945050|FG000|Overall Study|Withdrawal by Subject|2|||
30910083|NCT02286713|58945058|FG000|One Week Follow-Up|Death|1|||
30910084|NCT02286713|58945059|FG001|One Week Follow-Up|Death|0|||
30910085|NCT02286713|58945058|FG000|One Week Follow-Up|Lost to Follow-up|17|||
30910086|NCT02286713|58945059|FG001|One Week Follow-Up|Lost to Follow-up|21|||
30910087|NCT02286713|58945058|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
30910088|NCT02286713|58945059|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
30910089|NCT02286713|58945058|FG000|Three Month Follow-Up|Death|1|||
30910090|NCT02286713|58945059|FG001|Three Month Follow-Up|Death|1|||
30910091|NCT02286713|58945058|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
30910092|NCT02286713|58945059|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
30910093|NCT02286713|58945058|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
30910094|NCT02286713|58945059|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
30910095|NCT02286713|58945058|FG000|Six Month Follow-Up|Death|2|||
30910096|NCT02286713|58945059|FG001|Six Month Follow-Up|Death|0|||
30910097|NCT02286713|58945058|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
30910098|NCT02286713|58945059|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
30910099|NCT02285855|58945067|FG000|Overall Study|Withdrawal by Subject|2|||
30910100|NCT02285855|58945068|FG001|Overall Study|Withdrawal by Subject|1|||
30910101|NCT02285777|58945076|FG000|Overall Study|Withdrawal by Subject|1|||
30910102|NCT02285777|58945077|FG001|Overall Study|Withdrawal by Subject|1|||
30910103|NCT02285777|58945076|FG000|Overall Study|Lost to Follow-up|4|||
30910104|NCT02285777|58945077|FG001|Overall Study|Lost to Follow-up|2|||
30910105|NCT02285153|58945085|FG000|Overall Study|Adverse Event|1|||
30910106|NCT02285153|58945086|FG001|Overall Study|Adverse Event|0|||
30910107|NCT02284373|58945095|FG000|Overall Study|Withdrawal by Subject|0|||
30910108|NCT02284373|58945096|FG001|Overall Study|Withdrawal by Subject|1|||
30910109|NCT02284373|58945097|FG002|Overall Study|Withdrawal by Subject|0|||
30910110|NCT02284373|58945095|FG000|Overall Study|Other|0|||
30910111|NCT02284373|58945096|FG001|Overall Study|Other|1|||
30910112|NCT02284373|58945097|FG002|Overall Study|Other|0|||
30910113|NCT02284373|58945095|FG000|Overall Study|Lost to Follow-up|0|||
30910114|NCT02284373|58945096|FG001|Overall Study|Lost to Follow-up|1|||
30910115|NCT02284373|58945097|FG002|Overall Study|Lost to Follow-up|0|||
30910116|NCT01632241|58945107|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
30910117|NCT01632241|58945108|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
30910118|NCT01632241|58945107|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
30910119|NCT01632241|58945108|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
30910120|NCT01632241|58945107|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
30749906|NCT00189488|58759790|FG000|Overall Study|Ineligibility determined|1|||
30749907|NCT00189488|58759791|FG001|Overall Study|Ineligibility determined|0|||
30910121|NCT01632241|58945108|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
30910122|NCT01632241|58945107|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
30910123|NCT01632241|58945108|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
30910124|NCT01632241|58945107|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
30910125|NCT01632241|58945108|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
30910126|NCT01632241|58945107|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
30910127|NCT01632241|58945108|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
30910128|NCT01632241|58945107|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
30910129|NCT01632241|58945108|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
30910130|NCT01632241|58945107|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
30910131|NCT01632241|58945108|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
30910132|NCT01632241|58945107|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
30910133|NCT01632241|58945108|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
30910134|NCT01632241|58945107|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
30910135|NCT01632241|58945108|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
30910136|NCT01632241|58945107|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
30910137|NCT01632241|58945108|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
30910138|NCT01632241|58945107|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
30910139|NCT01632241|58945108|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
30910140|NCT01632241|58945107|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
30910141|NCT01632241|58945108|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
30910142|NCT01632241|58945107|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
30910143|NCT01632241|58945108|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
30910144|NCT02263508|58945123|FG000|Overall Study|Withdrawal by Subject|1|||
30910145|NCT02263508|58945124|FG001|Overall Study|Withdrawal by Subject|23|||
30910146|NCT02263508|58945125|FG002|Overall Study|Withdrawal by Subject|17|||
30910147|NCT02263508|58945123|FG000|Overall Study|Sponsor Decision|12|||
30910148|NCT02263508|58945124|FG001|Overall Study|Sponsor Decision|165|||
30910149|NCT02263508|58945125|FG002|Overall Study|Sponsor Decision|182|||
30910150|NCT02263508|58945123|FG000|Overall Study|Lost to Follow-up|2|||
30910151|NCT02263508|58945124|FG001|Overall Study|Lost to Follow-up|7|||
30910152|NCT02263508|58945125|FG002|Overall Study|Lost to Follow-up|7|||
30910153|NCT02263508|58945123|FG000|Overall Study|Death|6|||
30910154|NCT02263508|58945124|FG001|Overall Study|Death|151|||
30910155|NCT02263508|58945125|FG002|Overall Study|Death|140|||
30910156|NCT02291432|58945136|FG000|Overall Study|Withdrawal by Subject|2|||
30910157|NCT02290340|58945144|FG000|Overall Study|Lost to Follow-up|0|||
30910158|NCT02290340|58945145|FG001|Overall Study|Lost to Follow-up|0|||
30910159|NCT02290340|58945146|FG002|Overall Study|Lost to Follow-up|0|||
30910160|NCT02290340|58945147|FG003|Overall Study|Lost to Follow-up|1|||
30910161|NCT02290340|58945144|FG000|Overall Study|Withdrawal by Subject|1|||
30910162|NCT02290340|58945145|FG001|Overall Study|Withdrawal by Subject|0|||
30910163|NCT02290340|58945146|FG002|Overall Study|Withdrawal by Subject|0|||
30910164|NCT02290340|58945147|FG003|Overall Study|Withdrawal by Subject|0|||
30910165|NCT02290340|58945144|FG000|Overall Study|Other|1|||
30910166|NCT02290340|58945145|FG001|Overall Study|Other|0|||
30910167|NCT02290340|58945146|FG002|Overall Study|Other|0|||
30910168|NCT02290340|58945147|FG003|Overall Study|Other|1|||
30910169|NCT02290028|58945160|FG000|Overall Study|Death|217|||
30910170|NCT02290028|58945160|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
30910171|NCT02290028|58945160|FG000|Overall Study|No longer under care of study physician|76|||
30910172|NCT02290028|58945160|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
30910173|NCT02290028|58945160|FG000|Overall Study|Withdrawal by Subject|52|||
30910174|NCT02290028|58945160|FG000|Overall Study|Study site closure|44|||
30910175|NCT02290028|58945160|FG000|Overall Study|Lost to Follow-up|34|||
30910176|NCT02290028|58945160|FG000|Overall Study|Miscellaneous|10|||
30910177|NCT02290028|58945160|FG000|Overall Study|Transition to EP PASSION|1295|||
30910178|NCT02290028|58945160|FG000|Overall Study|Planned study completion at 12 months|257|||
30910179|NCT01741792|58945170|FG000|Overall Study|Death|6|||
30910180|NCT01741792|58945171|FG001|Overall Study|Death|1|||
30910181|NCT01741792|58945172|FG002|Overall Study|Death|12|||
30910182|NCT02289950|58945188|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
30910183|NCT02289950|58945189|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
30910184|NCT02289950|58945188|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
30910185|NCT02289950|58945189|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
30910186|NCT02289950|58945188|FG000|Overall Study|Lost to Follow-up|1|||
30910187|NCT02289950|58945189|FG001|Overall Study|Lost to Follow-up|0|||
30910188|NCT02289950|58945188|FG000|Overall Study|Physician Decision|9|||
30910189|NCT02289950|58945189|FG001|Overall Study|Physician Decision|3|||
30910190|NCT02289950|58945188|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
30910191|NCT02289950|58945189|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
30910192|NCT02289950|58945188|FG000|Overall Study|Withdrawal by Subject|1|||
30910193|NCT02289950|58945189|FG001|Overall Study|Withdrawal by Subject|3|||
30910194|NCT02289950|58945188|FG000|Overall Study|Test article held for greater than 28 days|0|||
30910195|NCT02289950|58945189|FG001|Overall Study|Test article held for greater than 28 days|1|||
30910196|NCT02289950|58945188|FG000|Overall Study|Adverse Event|11|||
30910197|NCT02289950|58945189|FG001|Overall Study|Adverse Event|3|||
30910198|NCT02289950|58945188|FG000|Overall Study|Death|1|||
30910199|NCT02289950|58945189|FG001|Overall Study|Death|1|||
30910200|NCT02289950|58945188|FG000|Overall Study|Other|5|||
30910201|NCT02289950|58945189|FG001|Overall Study|Other|2|||
30910202|NCT02289950|58945188|FG000|Overall Study|Not Treated|2|||
30910203|NCT02289950|58945189|FG001|Overall Study|Not Treated|1|||
30910204|NCT01741012|58945195|FG000|Overall Study|Lost to Follow-up|1|||
30910205|NCT01741012|58945195|FG000|Overall Study|Withdrawal by Subject|2|||
30910206|NCT02288312|58945203|FG000|Overall Study|Pregnancy|1|||
30910207|NCT02288312|58945204|FG001|Overall Study|Pregnancy|0|||
30910208|NCT02288312|58945205|FG002|Overall Study|Pregnancy|0|||
30910209|NCT01740388|58945215|FG000|Overall Study|Withdrawal by Subject|1|||
30910210|NCT01740388|58945216|FG001|Overall Study|Withdrawal by Subject|2|||
30910211|NCT01740388|58945215|FG000|Overall Study|Lost to Follow-up|2|||
30910212|NCT01740388|58945216|FG001|Overall Study|Lost to Follow-up|0|||
30910213|NCT01740388|58945215|FG000|Overall Study|Physician Decision|2|||
30910214|NCT01740388|58945216|FG001|Overall Study|Physician Decision|6|||
30910215|NCT01740388|58945215|FG000|Overall Study|Subjects missing data, completed|41|||
30910216|NCT01740388|58945216|FG001|Overall Study|Subjects missing data, completed|36|||
30910217|NCT01740154|58945222|FG000|Overall Study|Adverse Event|1|||
30910218|NCT02287922|58945230|FG000|Overall Study|Adverse Event|1|||
30910219|NCT02287922|58945231|FG001|Overall Study|Adverse Event|1|||
30910220|NCT02287922|58945232|FG002|Overall Study|Adverse Event|3|||
30910221|NCT02287922|58945233|FG003|Overall Study|Adverse Event|4|||
30910222|NCT02287922|58945230|FG000|Overall Study|Withdrawal by Subject|1|||
30910223|NCT02287922|58945231|FG001|Overall Study|Withdrawal by Subject|1|||
30910224|NCT02287922|58945232|FG002|Overall Study|Withdrawal by Subject|1|||
30910225|NCT02287922|58945233|FG003|Overall Study|Withdrawal by Subject|2|||
30910226|NCT02287922|58945230|FG000|Overall Study|Lost to Follow-up|0|||
30910227|NCT02287922|58945231|FG001|Overall Study|Lost to Follow-up|0|||
30910228|NCT02287922|58945232|FG002|Overall Study|Lost to Follow-up|1|||
30910229|NCT02287922|58945233|FG003|Overall Study|Lost to Follow-up|0|||
30910230|NCT02287922|58945230|FG000|Overall Study|Sponsor's decision|0|||
30910231|NCT02287922|58945231|FG001|Overall Study|Sponsor's decision|0|||
30910232|NCT02287922|58945232|FG002|Overall Study|Sponsor's decision|0|||
30910233|NCT02287922|58945233|FG003|Overall Study|Sponsor's decision|1|||
30910234|NCT02287922|58945230|FG000|Overall Study|Other|1|||
30910235|NCT02287922|58945231|FG001|Overall Study|Other|0|||
30910236|NCT02287922|58945232|FG002|Overall Study|Other|2|||
30910237|NCT02287922|58945233|FG003|Overall Study|Other|0|||
30910238|NCT02287610|58945244|FG000|Overall Study|Lost to Follow-up|3|||
30910239|NCT02287610|58945244|FG000|Overall Study|Withdrawal by Subject|8|||
30910240|NCT02287610|58945244|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
30910241|NCT02262728|58945250|FG000|Follow-up Phase (3 Years)|Death|0|||
30910242|NCT02262728|58945251|FG001|Follow-up Phase (3 Years)|Death|1|||
30910243|NCT02262728|58945250|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
30910244|NCT02262728|58945251|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
30910245|NCT02262728|58945250|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
30910246|NCT02262728|58945251|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
30910247|NCT02262260|58945259|FG000|Overall Study|Adverse Event|4|||
30910248|NCT02262260|58945260|FG001|Overall Study|Adverse Event|1|||
30910249|NCT02262260|58945259|FG000|Overall Study|Withdrawal of consent|4|||
30910250|NCT02262260|58945260|FG001|Overall Study|Withdrawal of consent|2|||
30910251|NCT02262260|58945259|FG000|Overall Study|Lost to Follow-up|1|||
30910252|NCT02262260|58945260|FG001|Overall Study|Lost to Follow-up|2|||
30910253|NCT02262260|58945259|FG000|Overall Study|Protocol deviation|2|||
30910254|NCT02262260|58945260|FG001|Overall Study|Protocol deviation|5|||
30910255|NCT02285270|58945266|FG000|Overall Study|Lost to Follow-up|1|||
30910256|NCT02285270|58945266|FG000|Overall Study|Physician Decision|3|||
30910257|NCT02285270|58945266|FG000|Overall Study|Determined to be ineligible|1|||
30910258|NCT01717768|58945280|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
30910259|NCT01717768|58945281|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
30910260|NCT01717768|58945282|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
30910261|NCT01717768|58945283|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
30910262|NCT01717768|58945284|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
30910263|NCT01717768|58945285|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
30910264|NCT01717768|58945286|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
30910265|NCT01717768|58945287|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
30910266|NCT01717768|58945288|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
30910267|NCT01717768|58945289|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
30910268|NCT01717768|58945290|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
30910269|NCT01717768|58945291|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
30910270|NCT01717768|58945280|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
30910271|NCT01717768|58945281|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
30910272|NCT01717768|58945282|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
30910273|NCT01717768|58945283|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
30910274|NCT01717768|58945284|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
30910275|NCT01717768|58945285|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
30910276|NCT01717768|58945286|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
30910277|NCT01717768|58945287|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
30749908|NCT00189488|58759790|FG000|Overall Study|Protocol deviation|2|||
30910278|NCT01717768|58945288|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
30910279|NCT01717768|58945289|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
30910280|NCT01717768|58945290|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
30910281|NCT01717768|58945291|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
30910282|NCT01717768|58945280|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
30910283|NCT01717768|58945281|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
30910284|NCT01717768|58945282|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
30910285|NCT01717768|58945283|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
30910286|NCT01717768|58945284|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
30910287|NCT01717768|58945285|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
30910288|NCT01717768|58945286|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
30910289|NCT01717768|58945287|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
30910290|NCT01717768|58945288|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
30910291|NCT01717768|58945289|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
30910292|NCT01717768|58945290|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
30910293|NCT01717768|58945291|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
30910294|NCT01717768|58945280|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
30910295|NCT01717768|58945281|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
30910296|NCT01717768|58945282|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
30910297|NCT01717768|58945283|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
30910298|NCT01717768|58945284|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
30910299|NCT01717768|58945285|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
30910300|NCT01717768|58945286|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
30910301|NCT01717768|58945287|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
30910302|NCT01717768|58945288|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
30910303|NCT01717768|58945289|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
30910304|NCT01717768|58945290|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
30910305|NCT01717768|58945291|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
30910306|NCT02260934|58945319|FG000|Overall Study|Lost to Follow-up|2|||
30910307|NCT02260934|58945320|FG001|Overall Study|Lost to Follow-up|1|||
30910308|NCT02260934|58945319|FG000|Overall Study|Withdrawal by Subject|0|||
30910309|NCT02260934|58945320|FG001|Overall Study|Withdrawal by Subject|2|||
30910310|NCT02260934|58945319|FG000|Overall Study|Participant Relocated|1|||
30910311|NCT02260934|58945320|FG001|Overall Study|Participant Relocated|0|||
30910312|NCT02260934|58945319|FG000|Overall Study|Site error|0|||
30910313|NCT02260934|58945320|FG001|Overall Study|Site error|1|||
30910314|NCT02260388|58945337|FG000|Overall Study|Lost to Follow-up|2|||
30811417|NCT02983604|58830300|FG002|Overall Study|Enrolled but not Treated|1|||
30811418|NCT02983604|58830301|FG003|Overall Study|Enrolled but not Treated|0|||
30811419|NCT02662582|58830313|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
30811420|NCT02662582|58830314|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
30811421|NCT02662582|58830313|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
30811422|NCT02662582|58830314|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
30910315|NCT02260388|58945338|FG001|Overall Study|Lost to Follow-up|8|||
30910316|NCT02260388|58945339|FG002|Overall Study|Lost to Follow-up|3|||
30811423|NCT02662582|58830313|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
30811424|NCT02662582|58830314|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
30811425|NCT02662582|58830313|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
30811426|NCT02662582|58830314|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
30811427|NCT02908100|58830324|FG000|Overall Study|Adverse Event|7|||
30811428|NCT02908100|58830325|FG001|Overall Study|Adverse Event|6|||
30811429|NCT02908100|58830326|FG002|Overall Study|Adverse Event|9|||
30811430|NCT02908100|58830324|FG000|Overall Study|Death|2|||
30811431|NCT02908100|58830325|FG001|Overall Study|Death|0|||
30811432|NCT02908100|58830326|FG002|Overall Study|Death|0|||
30811433|NCT02908100|58830324|FG000|Overall Study|Lack of Efficacy|2|||
30811434|NCT02908100|58830325|FG001|Overall Study|Lack of Efficacy|3|||
30811435|NCT02908100|58830326|FG002|Overall Study|Lack of Efficacy|3|||
30811436|NCT02908100|58830324|FG000|Overall Study|Lost to Follow-up|0|||
30811437|NCT02908100|58830325|FG001|Overall Study|Lost to Follow-up|1|||
30811438|NCT02908100|58830326|FG002|Overall Study|Lost to Follow-up|2|||
30811439|NCT02908100|58830324|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30811440|NCT02908100|58830325|FG001|Overall Study|Non-Compliance With Study Drug|1|||
30811441|NCT02908100|58830326|FG002|Overall Study|Non-Compliance With Study Drug|2|||
30811442|NCT02908100|58830324|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
30749909|NCT00189488|58759791|FG001|Overall Study|Protocol deviation|1|||
30749910|NCT00189488|58759790|FG000|Overall Study|Adverse Event|2|||
30749911|NCT00189488|58759791|FG001|Overall Study|Adverse Event|1|||
30749912|NCT00189488|58759790|FG000|Overall Study|Withdrawal by Subject|2|||
30749913|NCT00189488|58759791|FG001|Overall Study|Withdrawal by Subject|6|||
30749914|NCT00189488|58759790|FG000|Overall Study|Disease progression|2|||
30749915|NCT00189488|58759791|FG001|Overall Study|Disease progression|4|||
30749916|NCT00189488|58759790|FG000|Overall Study|Administrative Decision|0|||
30749917|NCT00189488|58759791|FG001|Overall Study|Administrative Decision|2|||
30749918|NCT00189488|58759790|FG000|Overall Study|Death|5|||
30811443|NCT02908100|58830325|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
30811444|NCT02908100|58830326|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
30811445|NCT02908100|58830324|FG000|Overall Study|Physician Decision|0|||
30811446|NCT02908100|58830325|FG001|Overall Study|Physician Decision|1|||
30811447|NCT02908100|58830326|FG002|Overall Study|Physician Decision|0|||
30910317|NCT02260388|58945340|FG003|Overall Study|Lost to Follow-up|4|||
30811448|NCT02908100|58830324|FG000|Overall Study|Pregnancy|1|||
30811449|NCT02908100|58830325|FG001|Overall Study|Pregnancy|2|||
30811450|NCT02908100|58830326|FG002|Overall Study|Pregnancy|0|||
30811451|NCT02908100|58830324|FG000|Overall Study|Withdrawal by Subject|8|||
30811452|NCT02908100|58830325|FG001|Overall Study|Withdrawal by Subject|7|||
30811453|NCT02908100|58830326|FG002|Overall Study|Withdrawal by Subject|5|||
30811454|NCT02908100|58830324|FG000|Overall Study|Randomised in Error|1|||
30910318|NCT02260154|58945350|FG000|Overall Study|Screening failure|2|||
30910319|NCT02284178|58945357|FG000|Overall Study|Met exclusion criteria|49|||
30910320|NCT02284178|58945358|FG001|Overall Study|Met exclusion criteria|54|||
30910321|NCT01643408|58945364|FG000|Overall Study|Adverse Event|12|||
30811455|NCT02908100|58830325|FG001|Overall Study|Randomised in Error|0|||
30811456|NCT02908100|58830326|FG002|Overall Study|Randomised in Error|0|||
30811457|NCT02982590|58830350|FG000|Overall Study|Lost to Follow-up|0|||
30811458|NCT02982590|58830351|FG001|Overall Study|Lost to Follow-up|1|||
30811459|NCT02982590|58830350|FG000|Overall Study|Death|4|||
30811460|NCT02982590|58830351|FG001|Overall Study|Death|0|||
30811461|NCT03310021|58830377|FG000|Overall Study|Withdrawal by Subject|0|||
30811462|NCT03310021|58830378|FG001|Overall Study|Withdrawal by Subject|0|||
30811463|NCT03310021|58830379|FG002|Overall Study|Withdrawal by Subject|0|||
30811464|NCT03310021|58830380|FG003|Overall Study|Withdrawal by Subject|0|||
30910322|NCT01643408|58945364|FG000|Overall Study|Other|2|||
30811465|NCT03310021|58830381|FG004|Overall Study|Withdrawal by Subject|0|||
30811466|NCT03310021|58830382|FG005|Overall Study|Withdrawal by Subject|0|||
30811467|NCT03310021|58830383|FG006|Overall Study|Withdrawal by Subject|1|||
30811468|NCT03310021|58830384|FG007|Overall Study|Withdrawal by Subject|0|||
30811469|NCT03310021|58830385|FG008|Overall Study|Withdrawal by Subject|0|||
30811470|NCT03310021|58830386|FG009|Overall Study|Withdrawal by Subject|0|||
30811471|NCT03310021|58830387|FG010|Overall Study|Withdrawal by Subject|0|||
30811472|NCT03310021|58830388|FG011|Overall Study|Withdrawal by Subject|0|||
30811473|NCT03310021|58830389|FG012|Overall Study|Withdrawal by Subject|0|||
30811474|NCT03310021|58830390|FG013|Overall Study|Withdrawal by Subject|0|||
30811475|NCT03310021|58830391|FG014|Overall Study|Withdrawal by Subject|0|||
30811476|NCT03310021|58830392|FG015|Overall Study|Withdrawal by Subject|0|||
30811477|NCT03310021|58830393|FG016|Overall Study|Withdrawal by Subject|0|||
30811478|NCT03310021|58830394|FG017|Overall Study|Withdrawal by Subject|0|||
30811479|NCT03310021|58830395|FG018|Overall Study|Withdrawal by Subject|0|||
30811480|NCT03310021|58830396|FG019|Overall Study|Withdrawal by Subject|0|||
30811481|NCT03310021|58830377|FG000|Overall Study|Lost to Follow-up|0|||
30811482|NCT03310021|58830378|FG001|Overall Study|Lost to Follow-up|0|||
30811483|NCT03310021|58830379|FG002|Overall Study|Lost to Follow-up|0|||
30811484|NCT03310021|58830380|FG003|Overall Study|Lost to Follow-up|0|||
30811485|NCT03310021|58830381|FG004|Overall Study|Lost to Follow-up|0|||
30811486|NCT03310021|58830382|FG005|Overall Study|Lost to Follow-up|0|||
30811487|NCT03310021|58830383|FG006|Overall Study|Lost to Follow-up|0|||
30811488|NCT03310021|58830384|FG007|Overall Study|Lost to Follow-up|0|||
30811489|NCT03310021|58830385|FG008|Overall Study|Lost to Follow-up|0|||
30811490|NCT03310021|58830386|FG009|Overall Study|Lost to Follow-up|0|||
30811491|NCT03310021|58830387|FG010|Overall Study|Lost to Follow-up|1|||
30811492|NCT03310021|58830388|FG011|Overall Study|Lost to Follow-up|0|||
30811493|NCT03310021|58830389|FG012|Overall Study|Lost to Follow-up|0|||
30811494|NCT03310021|58830390|FG013|Overall Study|Lost to Follow-up|0|||
30910323|NCT02283788|58945372|FG000|Overall Study|Adverse Event|1|||
30811495|NCT03310021|58830391|FG014|Overall Study|Lost to Follow-up|0|||
30811496|NCT03310021|58830392|FG015|Overall Study|Lost to Follow-up|0|||
30811497|NCT03310021|58830393|FG016|Overall Study|Lost to Follow-up|0|||
30811498|NCT03310021|58830394|FG017|Overall Study|Lost to Follow-up|0|||
30811499|NCT03310021|58830395|FG018|Overall Study|Lost to Follow-up|0|||
30811500|NCT03310021|58830396|FG019|Overall Study|Lost to Follow-up|0|||
30811501|NCT03333109|58830441|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
30910324|NCT02283788|58945373|FG001|Overall Study|Adverse Event|3|||
30910325|NCT02283788|58945374|FG002|Overall Study|Adverse Event|5|||
30910326|NCT02283788|58945375|FG003|Overall Study|Adverse Event|1|||
30910327|NCT02283788|58945372|FG000|Overall Study|Withdrawal by Subject|0|||
30910328|NCT02283788|58945373|FG001|Overall Study|Withdrawal by Subject|1|||
30910329|NCT02283788|58945374|FG002|Overall Study|Withdrawal by Subject|0|||
30910330|NCT02283788|58945375|FG003|Overall Study|Withdrawal by Subject|1|||
30910331|NCT01739764|58945388|FG000|Overall Study|Adverse Event|0|||
30910332|NCT01739764|58945389|FG001|Overall Study|Adverse Event|3|||
30910333|NCT01739764|58945390|FG002|Overall Study|Adverse Event|4|||
30910334|NCT01739764|58945388|FG000|Overall Study|Death|4|||
30910335|NCT01739764|58945389|FG001|Overall Study|Death|6|||
30910336|NCT01739764|58945390|FG002|Overall Study|Death|38|||
30910337|NCT01739764|58945388|FG000|Overall Study|Lost to Follow-up|0|||
30910338|NCT01739764|58945389|FG001|Overall Study|Lost to Follow-up|0|||
30910339|NCT01739764|58945390|FG002|Overall Study|Lost to Follow-up|5|||
30910340|NCT01739764|58945388|FG000|Overall Study|Non-Compliance|0|||
30910341|NCT01739764|58945389|FG001|Overall Study|Non-Compliance|0|||
30910342|NCT01739764|58945390|FG002|Overall Study|Non-Compliance|1|||
30910343|NCT01739764|58945388|FG000|Overall Study|Multiple Reasons|3|||
30910344|NCT01739764|58945389|FG001|Overall Study|Multiple Reasons|2|||
30910345|NCT01739764|58945390|FG002|Overall Study|Multiple Reasons|3|||
30910346|NCT01739764|58945388|FG000|Overall Study|Physician Decision|2|||
30910347|NCT01739764|58945389|FG001|Overall Study|Physician Decision|2|||
30910348|NCT01739764|58945390|FG002|Overall Study|Physician Decision|4|||
30910349|NCT01739764|58945388|FG000|Overall Study|Progressive Disease|3|||
30910350|NCT01739764|58945389|FG001|Overall Study|Progressive Disease|5|||
30910351|NCT01739764|58945390|FG002|Overall Study|Progressive Disease|16|||
30910352|NCT01739764|58945388|FG000|Overall Study|Protocol Violation|0|||
30910353|NCT01739764|58945389|FG001|Overall Study|Protocol Violation|0|||
30910354|NCT01739764|58945390|FG002|Overall Study|Protocol Violation|2|||
30910355|NCT01739764|58945388|FG000|Overall Study|Study Terminated by Sponsor|8|||
30910356|NCT01739764|58945389|FG001|Overall Study|Study Terminated by Sponsor|13|||
30910357|NCT01739764|58945390|FG002|Overall Study|Study Terminated by Sponsor|26|||
30910358|NCT01739764|58945388|FG000|Overall Study|Withdrawal by Subject|6|||
30910359|NCT01739764|58945389|FG001|Overall Study|Withdrawal by Subject|5|||
30910360|NCT01739764|58945390|FG002|Overall Study|Withdrawal by Subject|27|||
30910361|NCT01700530|58945401|FG000|Overall Study|Withdrawal by Subject|0|||
30910362|NCT01700530|58945402|FG001|Overall Study|Withdrawal by Subject|3|||
30910363|NCT01700530|58945403|FG002|Overall Study|Withdrawal by Subject|1|||
30910364|NCT01700140|58945414|FG000|Overall Study|Use of rescue drugs|3|||
30910365|NCT01700140|58945415|FG001|Overall Study|Use of rescue drugs|3|||
30910366|NCT01700140|58945416|FG002|Overall Study|Use of rescue drugs|1|||
30910367|NCT01700140|58945414|FG000|Overall Study|Discontinuation of radiotherapy|1|||
30910368|NCT01700140|58945415|FG001|Overall Study|Discontinuation of radiotherapy|0|||
30910369|NCT01700140|58945416|FG002|Overall Study|Discontinuation of radiotherapy|0|||
30910370|NCT01700140|58945414|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
30910371|NCT01700140|58945415|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
30910372|NCT01700140|58945416|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
30910373|NCT01700140|58945414|FG000|Overall Study|Aggravation of symptoms|1|||
30910374|NCT01700140|58945415|FG001|Overall Study|Aggravation of symptoms|0|||
30910375|NCT01700140|58945416|FG002|Overall Study|Aggravation of symptoms|0|||
30910376|NCT01700140|58945414|FG000|Overall Study|Adverse Event|0|||
30910377|NCT01700140|58945415|FG001|Overall Study|Adverse Event|1|||
30910378|NCT01700140|58945416|FG002|Overall Study|Adverse Event|0|||
30910379|NCT01700140|58945414|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
30910380|NCT01700140|58945415|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
30910381|NCT01700140|58945416|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
30910382|NCT01717456|58945429|FG000|End of Treatment|Physician Decision|0|||
30910383|NCT01717456|58945430|FG001|End of Treatment|Physician Decision|1|||
30749919|NCT00189488|58759791|FG001|Overall Study|Death|8|||
30910384|NCT01717456|58945429|FG000|End of Treatment|Lost to Follow-up|0|||
30910385|NCT01717456|58945430|FG001|End of Treatment|Lost to Follow-up|1|||
30910386|NCT01717456|58945429|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
30910387|NCT01717456|58945430|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
30910388|NCT01699750|58945439|FG000|Overall Study|Withdrew Consent|0|||
30910389|NCT01699750|58945440|FG001|Overall Study|Withdrew Consent|1|||
30910390|NCT01699750|58945439|FG000|Overall Study|Other|0|||
30749920|NCT00189488|58759790|FG000|Overall Study|Other|1|||
30749921|NCT00189488|58759791|FG001|Overall Study|Other|0|||
30749922|NCT00233402|58759800|FG000|Overall Study|No pathology data|12|||
30749923|NCT00233402|58759801|FG001|Overall Study|No pathology data|9|||
30749924|NCT00233402|58759800|FG000|Overall Study|No Ta/T1|89|||
30749925|NCT00233402|58759801|FG001|Overall Study|No Ta/T1|94|||
30749926|NCT00233402|58759800|FG000|Overall Study|Lost to follow up etc|3|||
30910391|NCT01699750|58945440|FG001|Overall Study|Other|2|||
30811502|NCT03333109|58830442|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
30811503|NCT03333109|58830443|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
30811504|NCT03333109|58830441|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
30811505|NCT03333109|58830442|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
30811506|NCT03333109|58830443|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
30811507|NCT03333109|58830441|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
30811508|NCT03333109|58830442|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
30811509|NCT03333109|58830443|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
30811510|NCT03333109|58830441|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
30811511|NCT03333109|58830442|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
30811512|NCT03333109|58830443|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
30811513|NCT03333109|58830441|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
30811514|NCT03333109|58830442|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
30811515|NCT03333109|58830443|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
30811516|NCT03333109|58830441|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
30811517|NCT03333109|58830442|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
30811518|NCT03333109|58830443|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
30811519|NCT03333109|58830441|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
30811520|NCT03333109|58830442|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
30811521|NCT03333109|58830443|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
30811522|NCT03333109|58830441|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
30811523|NCT03333109|58830442|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
30811524|NCT03333109|58830443|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
30811525|NCT02940223|58830453|FG000|Overall Study|Failed Requirement|2|||
30811526|NCT02940223|58830454|FG001|Overall Study|Failed Requirement|0|||
30811527|NCT03295201|58830462|FG000|Overall Study|Lost to Follow-up|1|||
30811528|NCT03295201|58830463|FG001|Overall Study|Lost to Follow-up|1|||
30811529|NCT03295201|58830462|FG000|Overall Study|Hospital admission|0|||
30811530|NCT03295201|58830463|FG001|Overall Study|Hospital admission|1|||
30811531|NCT03293485|58830469|FG000|Overall Study|Death|1|||
30811532|NCT03293485|58830469|FG000|Overall Study|Screen Failure|2|||
30811533|NCT03293485|58830469|FG000|Overall Study|Withdrawal by Subject|2|||
30811534|NCT03309943|58830477|FG000|Overall Study|Withdrawal by Subject|0|||
30811535|NCT03309943|58830478|FG001|Overall Study|Withdrawal by Subject|1|||
30811536|NCT03309943|58830477|FG000|Overall Study|Inappropriate behavior towards staff|0|||
30811537|NCT03309943|58830478|FG001|Overall Study|Inappropriate behavior towards staff|1|||
30811538|NCT01732627|58830486|FG000|Overall Study|Withdrawal by Subject|1|||
30811539|NCT01732627|58830487|FG001|Overall Study|Withdrawal by Subject|0|||
30811540|NCT03307837|58830499|FG000|Overall Study|Withdrawal by Subject|0|||
30811541|NCT03307837|58830500|FG001|Overall Study|Withdrawal by Subject|0|||
30811542|NCT03307837|58830501|FG002|Overall Study|Withdrawal by Subject|1|||
30811543|NCT03307837|58830502|FG003|Overall Study|Withdrawal by Subject|0|||
30811544|NCT03307837|58830503|FG004|Overall Study|Withdrawal by Subject|0|||
30811545|NCT03307837|58830504|FG005|Overall Study|Withdrawal by Subject|1|||
30811546|NCT03307837|58830499|FG000|Overall Study|Lost to Follow-up|1|||
30811547|NCT03307837|58830500|FG001|Overall Study|Lost to Follow-up|1|||
30811548|NCT03307837|58830501|FG002|Overall Study|Lost to Follow-up|0|||
30811549|NCT03307837|58830502|FG003|Overall Study|Lost to Follow-up|0|||
30811550|NCT03307837|58830503|FG004|Overall Study|Lost to Follow-up|0|||
30811551|NCT03307837|58830504|FG005|Overall Study|Lost to Follow-up|1|||
30811552|NCT03331315|58830525|FG000|Overall Study|Physician Decision|18|||
30811553|NCT03331315|58830526|FG001|Overall Study|Physician Decision|14|||
30811554|NCT03329989|58830534|FG000|Overall Study|Withdrawal by Subject|9|||
30811555|NCT03329989|58830534|FG000|Overall Study|Lost to Follow-up|8|||
30811556|NCT03329989|58830534|FG000|Overall Study|Adverse Event|5|||
30811557|NCT03329989|58830534|FG000|Overall Study|Protocol Violation|1|||
30811558|NCT03287869|58830540|FG000|Overall Study|Adverse Event|14|||
30749927|NCT00233402|58759801|FG001|Overall Study|Lost to follow up etc|21|||
30749928|NCT00233324|58759813|FG000|Main Study|Death|68|||
30749929|NCT00233324|58759814|FG001|Main Study|Death|60|||
30749930|NCT00233324|58759815|FG002|Main Study|Death|62|||
30749931|NCT00233324|58759816|FG003|Main Study|Death|47|||
30749932|NCT00233324|58759813|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
30749933|NCT00233324|58759814|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
30749934|NCT00233324|58759815|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
30749935|NCT00233324|58759816|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
30749936|NCT00233324|58759813|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
30749937|NCT00233324|58759814|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
30749938|NCT00233324|58759815|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
30749939|NCT00233324|58759816|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
30749940|NCT00023452|58759835|FG000|Overall Study|Ineligible for Study|163|||
30749941|NCT00023452|58759836|FG001|Overall Study|Ineligible for Study|159|||
30811559|NCT03287869|58830541|FG001|Overall Study|Adverse Event|12|||
30811560|NCT03287869|58830540|FG000|Overall Study|Lack of Efficacy|1|||
30811561|NCT03287869|58830541|FG001|Overall Study|Lack of Efficacy|0|||
30811562|NCT03287869|58830540|FG000|Overall Study|Lost to Follow-up|13|||
30622551|NCT00922636|58634246|FG004|Overall Study|Parent/Caregiver Decision|2|||
30622552|NCT00922636|58634242|FG000|Overall Study|Lost to Follow-up|1|||
30749942|NCT00023452|58759835|FG000|Overall Study|Out of Window|129|||
30811563|NCT03287869|58830541|FG001|Overall Study|Lost to Follow-up|19|||
30811564|NCT03287869|58830540|FG000|Overall Study|Non-Compliance With Study Drug|5|||
30811565|NCT03287869|58830541|FG001|Overall Study|Non-Compliance With Study Drug|9|||
30811566|NCT03287869|58830540|FG000|Overall Study|Progressive Disease|1|||
30811567|NCT03287869|58830541|FG001|Overall Study|Progressive Disease|0|||
30811568|NCT03287869|58830540|FG000|Overall Study|Protocol Deviation|2|||
30811569|NCT03287869|58830541|FG001|Overall Study|Protocol Deviation|1|||
30811570|NCT03287869|58830540|FG000|Overall Study|Withdrawal by Subject|36|||
30811571|NCT03287869|58830541|FG001|Overall Study|Withdrawal by Subject|43|||
30811572|NCT03287869|58830540|FG000|Overall Study|Early Closure of the Site|0|||
30811573|NCT03287869|58830541|FG001|Overall Study|Early Closure of the Site|1|||
30811574|NCT03287869|58830540|FG000|Overall Study|Physician Decision|5|||
30811575|NCT03287869|58830541|FG001|Overall Study|Physician Decision|5|||
30811576|NCT03287869|58830540|FG000|Overall Study|Reason not Specified|6|||
30811577|NCT03287869|58830541|FG001|Overall Study|Reason not Specified|3|||
30811578|NCT02661490|58830552|FG000|Overall Study|Lost to Follow-up|0|||
30811579|NCT02661490|58830553|FG001|Overall Study|Lost to Follow-up|1|||
30811580|NCT02661490|58830554|FG002|Overall Study|Lost to Follow-up|0|||
30811581|NCT02661490|58830555|FG003|Overall Study|Lost to Follow-up|0|||
30811582|NCT02661490|58830556|FG004|Overall Study|Lost to Follow-up|2|||
30811583|NCT02661490|58830552|FG000|Overall Study|Withdrawal by Subject|2|||
30811584|NCT02661490|58830553|FG001|Overall Study|Withdrawal by Subject|0|||
30811585|NCT02661490|58830554|FG002|Overall Study|Withdrawal by Subject|2|||
30811586|NCT02661490|58830555|FG003|Overall Study|Withdrawal by Subject|0|||
30811587|NCT02661490|58830556|FG004|Overall Study|Withdrawal by Subject|0|||
30811588|NCT02661490|58830552|FG000|Overall Study|Death|1|||
30811589|NCT02661490|58830553|FG001|Overall Study|Death|1|||
30811590|NCT02661490|58830554|FG002|Overall Study|Death|0|||
30811591|NCT02661490|58830555|FG003|Overall Study|Death|1|||
30811592|NCT02661490|58830556|FG004|Overall Study|Death|0|||
30811593|NCT02661490|58830552|FG000|Overall Study|Reason not Specified|0|||
30811594|NCT02661490|58830553|FG001|Overall Study|Reason not Specified|0|||
30811595|NCT02661490|58830554|FG002|Overall Study|Reason not Specified|0|||
30811596|NCT02661490|58830555|FG003|Overall Study|Reason not Specified|0|||
30811597|NCT02661490|58830556|FG004|Overall Study|Reason not Specified|1|||
30811598|NCT03287791|58830571|FG000|Overall Study|Insufficient Therapeutic Response|0|||
30811599|NCT03287791|58830572|FG001|Overall Study|Insufficient Therapeutic Response|0|||
30811600|NCT03287791|58830573|FG002|Overall Study|Insufficient Therapeutic Response|1|||
30811601|NCT03287791|58830571|FG000|Overall Study|Adverse Event|0|||
30811602|NCT03287791|58830572|FG001|Overall Study|Adverse Event|4|||
30811603|NCT03287791|58830573|FG002|Overall Study|Adverse Event|3|||
30811604|NCT03287791|58830571|FG000|Overall Study|Withdrawal by Subject|12|||
30811605|NCT03287791|58830572|FG001|Overall Study|Withdrawal by Subject|12|||
30811606|NCT03287791|58830573|FG002|Overall Study|Withdrawal by Subject|17|||
30811607|NCT03287791|58830571|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
30811608|NCT03287791|58830572|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
30811609|NCT03287791|58830573|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
30811610|NCT03287791|58830571|FG000|Overall Study|Lost to Follow-up|8|||
30811611|NCT03287791|58830572|FG001|Overall Study|Lost to Follow-up|14|||
30811612|NCT03287791|58830573|FG002|Overall Study|Lost to Follow-up|11|||
30910392|NCT01716754|58945454|FG000|Overall Study|Death|0|||
30749943|NCT00023452|58759836|FG001|Overall Study|Out of Window|69|||
30749944|NCT00023452|58759835|FG000|Overall Study|Death|2|||
30749945|NCT00023452|58759836|FG001|Overall Study|Death|0|||
30749946|NCT00023452|58759835|FG000|Overall Study|Withdrawal by Subject|66|||
30749947|NCT00023452|58759836|FG001|Overall Study|Withdrawal by Subject|54|||
30749948|NCT00023452|58759835|FG000|Overall Study|Adverse Event|139|||
30749949|NCT00023452|58759836|FG001|Overall Study|Adverse Event|196|||
30749950|NCT00023452|58759835|FG000|Overall Study|Lost to Follow-up|293|||
30749951|NCT00023452|58759836|FG001|Overall Study|Lost to Follow-up|60|||
30749952|NCT00023452|58759835|FG000|Overall Study|Physician Decision|49|||
30749953|NCT00023452|58759836|FG001|Overall Study|Physician Decision|21|||
30811613|NCT03287791|58830571|FG000|Overall Study|Protocol Violation|7|||
30811614|NCT03287791|58830572|FG001|Overall Study|Protocol Violation|2|||
30811615|NCT03287791|58830573|FG002|Overall Study|Protocol Violation|1|||
30749954|NCT00023452|58759835|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
30811616|NCT03287791|58830571|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
30811617|NCT03287791|58830572|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
30910393|NCT01716754|58945455|FG001|Overall Study|Death|0|||
30910394|NCT01716754|58945456|FG002|Overall Study|Death|0|||
30749955|NCT00023452|58759836|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
30811618|NCT03287791|58830573|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
30811619|NCT03287791|58830571|FG000|Overall Study|Too much time between 2 visits|0|||
30811620|NCT03287791|58830572|FG001|Overall Study|Too much time between 2 visits|1|||
30811621|NCT03287791|58830573|FG002|Overall Study|Too much time between 2 visits|0|||
30811622|NCT03287791|58830571|FG000|Overall Study|Non-compliance|0|||
30811623|NCT03287791|58830572|FG001|Overall Study|Non-compliance|1|||
30811624|NCT03287791|58830573|FG002|Overall Study|Non-compliance|0|||
30811625|NCT03287791|58830571|FG000|Overall Study|Did not meet inclusion criteria|1|||
30811626|NCT03287791|58830572|FG001|Overall Study|Did not meet inclusion criteria|0|||
30811627|NCT03287791|58830573|FG002|Overall Study|Did not meet inclusion criteria|0|||
30811628|NCT03287635|58830581|FG000|Overall Study|Lost to Follow-up|5|||
30811629|NCT03287635|58830581|FG000|Overall Study|Withdrawal by Subject|1|||
30811630|NCT03287635|58830581|FG000|Overall Study|Physician Decision|1|||
30811631|NCT03287089|58830587|FG000|Overall Study|Lost to Follow-up|0|||
30811632|NCT03287089|58830588|FG001|Overall Study|Lost to Follow-up|2|||
30811633|NCT03287089|58830587|FG000|Overall Study|Physician Decision|0|||
30811634|NCT03287089|58830588|FG001|Overall Study|Physician Decision|2|||
30811635|NCT03287089|58830587|FG000|Overall Study|Withdrawal by Subject|0|||
30811636|NCT03287089|58830588|FG001|Overall Study|Withdrawal by Subject|2|||
30811637|NCT03286543|58830596|FG000|Consented|Screen failure before randomization|2|||
30811638|NCT03286543|58830597|FG001|Consented|Screen failure before randomization|0|||
30811639|NCT03286543|58830598|FG002|Consented|Screen failure before randomization|0|||
30811640|NCT03286543|58830596|FG000|Consented|Screen failure before enrollment|4|||
30811641|NCT03286543|58830597|FG001|Consented|Screen failure before enrollment|0|||
30811642|NCT03286543|58830598|FG002|Consented|Screen failure before enrollment|0|||
30811643|NCT03286543|58830596|FG000|Consented|TKA cancelled after enrollment|1|||
30811644|NCT03286543|58830597|FG001|Consented|TKA cancelled after enrollment|0|||
30811645|NCT03286543|58830598|FG002|Consented|TKA cancelled after enrollment|0|||
30811646|NCT03286543|58830596|FG000|Consented|Withdrawn from study|12|||
30811647|NCT03286543|58830597|FG001|Consented|Withdrawn from study|0|||
30811648|NCT03286543|58830598|FG002|Consented|Withdrawn from study|0|||
30811649|NCT03286543|58830596|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
30811650|NCT03286543|58830597|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
30811651|NCT03286543|58830598|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
30811652|NCT03286543|58830596|FG000|Study Enrollment|Withdrawn from study|0|||
30910395|NCT01716754|58945457|FG003|Overall Study|Death|1|||
30910396|NCT01716754|58945454|FG000|Overall Study|Protocol deviation|0|||
30910397|NCT01716754|58945455|FG001|Overall Study|Protocol deviation|2|||
30910398|NCT01716754|58945456|FG002|Overall Study|Protocol deviation|7|||
30910399|NCT01716754|58945457|FG003|Overall Study|Protocol deviation|2|||
30910400|NCT01716754|58945454|FG000|Overall Study|Non-compliance with study treatment|0|||
30910401|NCT01716754|58945455|FG001|Overall Study|Non-compliance with study treatment|0|||
30910402|NCT01716754|58945456|FG002|Overall Study|Non-compliance with study treatment|1|||
30910403|NCT01716754|58945457|FG003|Overall Study|Non-compliance with study treatment|0|||
30910404|NCT01716754|58945454|FG000|Overall Study|Physician Decision|1|||
30910405|NCT01716754|58945455|FG001|Overall Study|Physician Decision|0|||
30910406|NCT01716754|58945456|FG002|Overall Study|Physician Decision|0|||
30910407|NCT01716754|58945457|FG003|Overall Study|Physician Decision|0|||
30910408|NCT01716754|58945454|FG000|Overall Study|Lost to Follow-up|1|||
30910409|NCT01716754|58945455|FG001|Overall Study|Lost to Follow-up|0|||
30910410|NCT01716754|58945456|FG002|Overall Study|Lost to Follow-up|0|||
30910411|NCT01716754|58945457|FG003|Overall Study|Lost to Follow-up|1|||
30910412|NCT01716754|58945454|FG000|Overall Study|Adverse Event|4|||
30910413|NCT01716754|58945455|FG001|Overall Study|Adverse Event|2|||
30910414|NCT01716754|58945456|FG002|Overall Study|Adverse Event|2|||
30910415|NCT01716754|58945457|FG003|Overall Study|Adverse Event|1|||
30910416|NCT01716754|58945454|FG000|Overall Study|Withdrawal by Subject|5|||
30910417|NCT01716754|58945455|FG001|Overall Study|Withdrawal by Subject|0|||
30910418|NCT01716754|58945456|FG002|Overall Study|Withdrawal by Subject|4|||
30910419|NCT01716754|58945457|FG003|Overall Study|Withdrawal by Subject|3|||
30622553|NCT00922636|58634243|FG001|Overall Study|Lost to Follow-up|2|||
30910420|NCT01698814|58945468|FG000|Overall Study|Adverse Event|0|||
30910421|NCT01698814|58945469|FG001|Overall Study|Adverse Event|2|||
30910422|NCT01698814|58945468|FG000|Overall Study|Lost to Follow-up|0|||
30811653|NCT03286543|58830597|FG001|Study Enrollment|Withdrawn from study|6|||
30910423|NCT01698814|58945469|FG001|Overall Study|Lost to Follow-up|1|||
30910424|NCT01698814|58945468|FG000|Overall Study|Pregnancy|1|||
30910425|NCT01698814|58945469|FG001|Overall Study|Pregnancy|0|||
30910426|NCT01698814|58945468|FG000|Overall Study|Randomized in error|1|||
30622554|NCT00922636|58634244|FG002|Overall Study|Lost to Follow-up|2|||
30622555|NCT00922636|58634245|FG003|Overall Study|Lost to Follow-up|2|||
30811654|NCT03286543|58830598|FG002|Study Enrollment|Withdrawn from study|6|||
30811655|NCT03306433|58830604|FG000|Overall Study|Lost to Follow-up|3|||
30811656|NCT03306433|58830604|FG000|Overall Study|Patient did not have teeth extracted|1|||
30811657|NCT03306433|58830604|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
30811658|NCT02940691|58830612|FG000|Overall Study|Lost to Follow-up|5|||
30910427|NCT01698814|58945469|FG001|Overall Study|Randomized in error|0|||
30910428|NCT01738984|58945477|FG000|Overall Study|Pregnancy|4|||
30910429|NCT01738984|58945478|FG001|Overall Study|Pregnancy|0|||
30910430|NCT01738984|58945477|FG000|Overall Study|Withdrawal by Subject|1|||
30910431|NCT01738984|58945478|FG001|Overall Study|Withdrawal by Subject|0|||
30910432|NCT01738984|58945477|FG000|Overall Study|Lost to Follow-up|59|||
30910433|NCT01738984|58945478|FG001|Overall Study|Lost to Follow-up|39|||
30910434|NCT01738594|58945487|FG000|Registration and Treatment Start|Adverse Event|0|||
30910435|NCT01738594|58945488|FG001|Registration and Treatment Start|Adverse Event|1|||
30910436|NCT01738594|58945489|FG002|Registration and Treatment Start|Adverse Event|0|||
30910437|NCT01738594|58945490|FG003|Registration and Treatment Start|Adverse Event|0|||
30910438|NCT01738594|58945491|FG004|Registration and Treatment Start|Adverse Event|0|||
30910439|NCT01738594|58945492|FG005|Registration and Treatment Start|Adverse Event|0|||
30910440|NCT01738594|58945493|FG006|Registration and Treatment Start|Adverse Event|0|||
30910441|NCT01738594|58945494|FG007|Registration and Treatment Start|Adverse Event|0|||
30910442|NCT01738594|58945487|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
30910443|NCT01738594|58945488|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
30910444|NCT01738594|58945489|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
30910445|NCT01738594|58945490|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
30910446|NCT01738594|58945491|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
30910447|NCT01738594|58945492|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
30910448|NCT01738594|58945493|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
30910449|NCT01738594|58945494|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
30910450|NCT01738594|58945487|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
30811659|NCT02940691|58830612|FG000|Overall Study|Incarceration|1|||
30811660|NCT03306277|58830650|FG000|Overall Study|Death|1|||
30811661|NCT03306277|58830650|FG000|Overall Study|Adverse Event|1|||
30811662|NCT03306277|58830650|FG000|Overall Study|Withdrawal by Subject|1|||
30811663|NCT03130959|58830664|FG000|Overall Study|Disease progression|19|||
30811664|NCT03130959|58830665|FG001|Overall Study|Disease progression|7|||
30811665|NCT03130959|58830666|FG002|Overall Study|Disease progression|12|||
30811666|NCT03130959|58830667|FG003|Overall Study|Disease progression|7|||
30811667|NCT03130959|58830668|FG004|Overall Study|Disease progression|12|||
30910451|NCT01738594|58945488|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
30910452|NCT01738594|58945489|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
30749956|NCT00023452|58759835|FG000|Overall Study|Pregnant|53|||
30749957|NCT00023452|58759836|FG001|Overall Study|Pregnant|20|||
30749958|NCT00023452|58759835|FG000|Overall Study|Other|204|||
30749959|NCT00023452|58759836|FG001|Overall Study|Other|69|||
30749960|NCT00022672|58759848|FG000|Main Phase: 24 Months|Adverse Event|6|||
30749961|NCT00022672|58759849|FG001|Main Phase: 24 Months|Adverse Event|0|||
30749962|NCT00022672|58759848|FG000|Main Phase: 24 Months|Death|0|||
30749963|NCT00022672|58759849|FG001|Main Phase: 24 Months|Death|3|||
30749964|NCT00022672|58759848|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
30749965|NCT00022672|58759849|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
30749966|NCT00022672|58759848|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
30749967|NCT00022672|58759849|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
30749968|NCT00022672|58759848|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
30811668|NCT03130959|58830669|FG005|Overall Study|Disease progression|3|||
30811669|NCT03130959|58830670|FG006|Overall Study|Disease progression|6|||
30811670|NCT03130959|58830671|FG007|Overall Study|Disease progression|3|||
30811671|NCT03130959|58830672|FG008|Overall Study|Disease progression|15|||
30811672|NCT03130959|58830673|FG009|Overall Study|Disease progression|8|||
30811673|NCT03130959|58830664|FG000|Overall Study|Study drug toxicity|2|||
30811674|NCT03130959|58830665|FG001|Overall Study|Study drug toxicity|2|||
30811675|NCT03130959|58830666|FG002|Overall Study|Study drug toxicity|1|||
30811676|NCT03130959|58830667|FG003|Overall Study|Study drug toxicity|2|||
30811677|NCT03130959|58830668|FG004|Overall Study|Study drug toxicity|1|||
30811678|NCT03130959|58830669|FG005|Overall Study|Study drug toxicity|1|||
30811679|NCT03130959|58830670|FG006|Overall Study|Study drug toxicity|3|||
30811680|NCT03130959|58830671|FG007|Overall Study|Study drug toxicity|0|||
30811681|NCT03130959|58830672|FG008|Overall Study|Study drug toxicity|3|||
30811682|NCT03130959|58830673|FG009|Overall Study|Study drug toxicity|3|||
30811683|NCT03130959|58830664|FG000|Overall Study|Other reasons|0|||
30811684|NCT03130959|58830665|FG001|Overall Study|Other reasons|0|||
30811685|NCT03130959|58830666|FG002|Overall Study|Other reasons|0|||
30811686|NCT03130959|58830667|FG003|Overall Study|Other reasons|0|||
30811687|NCT03130959|58830668|FG004|Overall Study|Other reasons|0|||
30811688|NCT03130959|58830669|FG005|Overall Study|Other reasons|1|||
30811689|NCT03130959|58830670|FG006|Overall Study|Other reasons|1|||
30811690|NCT03130959|58830671|FG007|Overall Study|Other reasons|0|||
30811691|NCT03130959|58830672|FG008|Overall Study|Other reasons|0|||
30811692|NCT03130959|58830673|FG009|Overall Study|Other reasons|0|||
30811693|NCT03130959|58830664|FG000|Overall Study|Subject request to discontinue therapy|0|||
30811694|NCT03130959|58830665|FG001|Overall Study|Subject request to discontinue therapy|0|||
30811695|NCT03130959|58830666|FG002|Overall Study|Subject request to discontinue therapy|1|||
30811696|NCT03130959|58830667|FG003|Overall Study|Subject request to discontinue therapy|1|||
30811697|NCT03130959|58830668|FG004|Overall Study|Subject request to discontinue therapy|0|||
30811698|NCT03130959|58830669|FG005|Overall Study|Subject request to discontinue therapy|0|||
30811699|NCT03130959|58830670|FG006|Overall Study|Subject request to discontinue therapy|1|||
30811700|NCT03130959|58830671|FG007|Overall Study|Subject request to discontinue therapy|1|||
30811701|NCT03130959|58830672|FG008|Overall Study|Subject request to discontinue therapy|0|||
30811702|NCT03130959|58830673|FG009|Overall Study|Subject request to discontinue therapy|0|||
30811703|NCT03130959|58830664|FG000|Overall Study|Not reported|0|||
30811704|NCT03130959|58830665|FG001|Overall Study|Not reported|0|||
30749969|NCT00022672|58759849|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
30749970|NCT00022672|58759848|FG000|Main Phase: 24 Months|Refused Treatment|3|||
30749971|NCT00022672|58759849|FG001|Main Phase: 24 Months|Refused Treatment|4|||
30749972|NCT00022672|58759848|FG000|Main Phase: 24 Months|Failure to Return|1|||
30749973|NCT00022672|58759849|FG001|Main Phase: 24 Months|Failure to Return|1|||
30749974|NCT00022672|58759848|FG000|Main Phase: 24 Months|Other|1|||
30749975|NCT00022672|58759849|FG001|Main Phase: 24 Months|Other|0|||
30749976|NCT00022672|58759848|FG000|Extension Phase|Adverse Event|1|||
30749977|NCT00022672|58759849|FG001|Extension Phase|Adverse Event|3|||
30749978|NCT00022672|58759848|FG000|Extension Phase|Death|0|||
30749979|NCT00022672|58759849|FG001|Extension Phase|Death|1|||
30749980|NCT00022672|58759848|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
30749981|NCT00022672|58759849|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
30749982|NCT00022672|58759848|FG000|Extension Phase|Refused Treatment|0|||
30749983|NCT00022672|58759849|FG001|Extension Phase|Refused Treatment|2|||
30749984|NCT00022672|58759848|FG000|Extension Phase|Other|1|||
30749985|NCT00022672|58759849|FG001|Extension Phase|Other|1|||
30811705|NCT03130959|58830666|FG002|Overall Study|Not reported|0|||
30811706|NCT03130959|58830667|FG003|Overall Study|Not reported|1|||
30811707|NCT03130959|58830668|FG004|Overall Study|Not reported|0|||
30749986|NCT00076804|58759858|FG000|Overall Study|Death|9|||
30811708|NCT03130959|58830669|FG005|Overall Study|Not reported|1|||
30811709|NCT03130959|58830670|FG006|Overall Study|Not reported|0|||
30811710|NCT03130959|58830671|FG007|Overall Study|Not reported|0|||
30811711|NCT03130959|58830672|FG008|Overall Study|Not reported|0|||
30811712|NCT03130959|58830673|FG009|Overall Study|Not reported|1|||
30811713|NCT03130959|58830664|FG000|Overall Study|Adverse Event unrelated to drug|0|||
30811714|NCT03130959|58830665|FG001|Overall Study|Adverse Event unrelated to drug|0|||
30811715|NCT03130959|58830666|FG002|Overall Study|Adverse Event unrelated to drug|1|||
30811716|NCT03130959|58830667|FG003|Overall Study|Adverse Event unrelated to drug|1|||
30811717|NCT03130959|58830668|FG004|Overall Study|Adverse Event unrelated to drug|1|||
30811718|NCT03130959|58830669|FG005|Overall Study|Adverse Event unrelated to drug|0|||
30811719|NCT03130959|58830670|FG006|Overall Study|Adverse Event unrelated to drug|1|||
30811720|NCT03130959|58830671|FG007|Overall Study|Adverse Event unrelated to drug|0|||
30811721|NCT03130959|58830672|FG008|Overall Study|Adverse Event unrelated to drug|1|||
30811722|NCT03130959|58830673|FG009|Overall Study|Adverse Event unrelated to drug|1|||
30811723|NCT03130959|58830664|FG000|Overall Study|Participant withdrew consent|0|||
30811724|NCT03130959|58830665|FG001|Overall Study|Participant withdrew consent|1|||
30811725|NCT03130959|58830666|FG002|Overall Study|Participant withdrew consent|0|||
30811726|NCT03130959|58830667|FG003|Overall Study|Participant withdrew consent|2|||
30811727|NCT03130959|58830668|FG004|Overall Study|Participant withdrew consent|1|||
30811728|NCT03130959|58830669|FG005|Overall Study|Participant withdrew consent|0|||
30811729|NCT03130959|58830670|FG006|Overall Study|Participant withdrew consent|0|||
30811730|NCT03130959|58830671|FG007|Overall Study|Participant withdrew consent|0|||
30811731|NCT03130959|58830672|FG008|Overall Study|Participant withdrew consent|0|||
30811732|NCT03130959|58830673|FG009|Overall Study|Participant withdrew consent|2|||
30811733|NCT03130959|58830664|FG000|Overall Study|Administrative reason by sponsor|1|||
30811734|NCT03130959|58830665|FG001|Overall Study|Administrative reason by sponsor|0|||
30811735|NCT03130959|58830666|FG002|Overall Study|Administrative reason by sponsor|1|||
30811736|NCT03130959|58830667|FG003|Overall Study|Administrative reason by sponsor|0|||
30811737|NCT03130959|58830668|FG004|Overall Study|Administrative reason by sponsor|0|||
30811738|NCT03130959|58830669|FG005|Overall Study|Administrative reason by sponsor|0|||
30811739|NCT03130959|58830670|FG006|Overall Study|Administrative reason by sponsor|0|||
30811740|NCT03130959|58830671|FG007|Overall Study|Administrative reason by sponsor|0|||
30811741|NCT03130959|58830672|FG008|Overall Study|Administrative reason by sponsor|0|||
30811742|NCT03130959|58830673|FG009|Overall Study|Administrative reason by sponsor|0|||
30811743|NCT03130959|58830664|FG000|Overall Study|Lost to Follow-up|1|||
30811744|NCT03130959|58830665|FG001|Overall Study|Lost to Follow-up|0|||
30749987|NCT00076804|58759859|FG001|Overall Study|Death|20|||
30749988|NCT00076804|58759858|FG000|Overall Study|Lost to Follow-up|9|||
30811745|NCT03130959|58830666|FG002|Overall Study|Lost to Follow-up|0|||
30811746|NCT03130959|58830667|FG003|Overall Study|Lost to Follow-up|0|||
30811747|NCT03130959|58830668|FG004|Overall Study|Lost to Follow-up|0|||
30811748|NCT03130959|58830669|FG005|Overall Study|Lost to Follow-up|0|||
30811749|NCT03130959|58830670|FG006|Overall Study|Lost to Follow-up|0|||
30811750|NCT03130959|58830671|FG007|Overall Study|Lost to Follow-up|0|||
30811751|NCT03130959|58830672|FG008|Overall Study|Lost to Follow-up|0|||
30811752|NCT03130959|58830673|FG009|Overall Study|Lost to Follow-up|0|||
30749989|NCT00076804|58759859|FG001|Overall Study|Lost to Follow-up|9|||
30749990|NCT00076804|58759858|FG000|Overall Study|Withdrawal by Subject|10|||
30749991|NCT00076804|58759859|FG001|Overall Study|Withdrawal by Subject|8|||
30749992|NCT00076804|58759858|FG000|Overall Study|Early study Closure|32|||
30749993|NCT00076804|58759859|FG001|Overall Study|Early study Closure|32|||
30749994|NCT00141453|58759867|FG000|Overall Study|Protocol Violation|6|||
30749995|NCT00141453|58759868|FG001|Overall Study|Protocol Violation|5|||
30749996|NCT00076570|58759876|FG000|Overall Study|Drug intolerance|8|||
30749997|NCT00076570|58759877|FG001|Overall Study|Drug intolerance|8|||
30749998|NCT00124449|58759885|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
30749999|NCT00124449|58759886|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
30750000|NCT00124449|58759885|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
30811753|NCT03124407|58830712|FG000|Overall Study|Lost to Follow-up|1|||
30811754|NCT03124407|58830713|FG001|Overall Study|Lost to Follow-up|0|||
30811755|NCT03124407|58830714|FG002|Overall Study|Lost to Follow-up|0|||
30811756|NCT03124407|58830715|FG003|Overall Study|Lost to Follow-up|0|||
30811757|NCT03124407|58830712|FG000|Overall Study|Adverse Event|0|||
30811758|NCT03124407|58830713|FG001|Overall Study|Adverse Event|0|||
30811759|NCT03124407|58830714|FG002|Overall Study|Adverse Event|1|||
30811760|NCT03124407|58830715|FG003|Overall Study|Adverse Event|0|||
30811761|NCT02929407|58830729|FG000|Overall Study|Adverse Event|1|||
30811762|NCT03123939|58830733|FG000|Overall Study|Lack of Efficacy|6|||
30811763|NCT03123939|58830733|FG000|Overall Study|Death|5|||
30811764|NCT03123939|58830733|FG000|Overall Study|Physician Decision|2|||
30811765|NCT03123939|58830733|FG000|Overall Study|Subject/guardian decision|2|||
30811766|NCT03123939|58830733|FG000|Overall Study|Lost to Follow-up|1|||
30811767|NCT03123939|58830733|FG000|Overall Study|New therapy for study indication|1|||
30811768|NCT03123939|58830733|FG000|Overall Study|Protocol deviation|1|||
30811769|NCT03123939|58830733|FG000|Overall Study|Progressive disease|18|||
30811770|NCT03123939|58830733|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
30811771|NCT03123939|58830733|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
30811772|NCT03123861|58830748|FG000|Overall Study|Protocol Violation|1|||
30811773|NCT03123861|58830749|FG001|Overall Study|Protocol Violation|1|||
30811774|NCT03123861|58830748|FG000|Overall Study|Withdrawal by Subject|2|||
30811775|NCT03123861|58830749|FG001|Overall Study|Withdrawal by Subject|2|||
30811776|NCT03123471|58830757|FG000|Placebo-controlled Phase|Adverse Event|3|||
30811777|NCT03123471|58830758|FG001|Placebo-controlled Phase|Adverse Event|8|||
30811778|NCT03123471|58830757|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
30811779|NCT03123471|58830758|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
30811780|NCT03123471|58830757|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
30811781|NCT03123471|58830758|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
30811782|NCT03123471|58830757|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
30811783|NCT03123471|58830758|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
30811784|NCT03123471|58830757|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
30750001|NCT00124449|58759886|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
30750002|NCT00124449|58759885|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
30750003|NCT00124449|58759886|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
30750004|NCT00124449|58759885|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
30750005|NCT00124449|58759886|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
30750006|NCT00124449|58759885|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
30750007|NCT00124449|58759886|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
30750008|NCT00124449|58759885|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
30750009|NCT00124449|58759886|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
30750010|NCT00124449|58759885|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
30750011|NCT00124449|58759886|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
30750012|NCT00124449|58759885|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
30750013|NCT00124449|58759886|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
30750014|NCT00124449|58759885|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
30750015|NCT00124449|58759886|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
30750016|NCT00124449|58759885|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
30750017|NCT00124449|58759886|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
30750018|NCT00124449|58759885|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
30750019|NCT00124449|58759886|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
30750020|NCT00124449|58759885|FG000|18-Month Untreated Observation Period|Relocated|1|||
30750021|NCT00124449|58759886|FG001|18-Month Untreated Observation Period|Relocated|0|||
30750022|NCT00076336|58759895|FG000|Overall Study|Death|13|||
30750023|NCT00076336|58759896|FG001|Overall Study|Death|17|||
30750024|NCT00076336|58759895|FG000|Overall Study|Adverse Event|4|||
30750025|NCT00076336|58759896|FG001|Overall Study|Adverse Event|4|||
30750026|NCT00076336|58759895|FG000|Overall Study|Lost to Follow-up|4|||
30750027|NCT00076336|58759896|FG001|Overall Study|Lost to Follow-up|4|||
30750028|NCT00076336|58759895|FG000|Overall Study|Non-Compliance|2|||
30750029|NCT00076336|58759896|FG001|Overall Study|Non-Compliance|0|||
30750030|NCT00076336|58759895|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
30750031|NCT00076336|58759896|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
30750032|NCT00076336|58759895|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
30811785|NCT03123471|58830758|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
30811786|NCT03123471|58830757|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
30811787|NCT03123471|58830758|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
30811788|NCT03123471|58830757|FG000|Placebo-controlled Phase|Miscellaneous|0|||
30811789|NCT03123471|58830758|FG001|Placebo-controlled Phase|Miscellaneous|1|||
30811790|NCT03123471|58830757|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
30811791|NCT03123471|58830758|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
30811792|NCT03123471|58830757|FG000|Apremilast Extension Phase|Adverse Event|1|||
30811793|NCT03123471|58830758|FG001|Apremilast Extension Phase|Adverse Event|5|||
30811794|NCT03123471|58830757|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
30811795|NCT03123471|58830758|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
30811796|NCT03123471|58830757|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
30811797|NCT03123471|58830758|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
30811798|NCT02661178|58830785|FG000|Part 1|Protocol Violation|1|||
30811799|NCT02661178|58830786|FG001|Part 1|Protocol Violation|0|||
30811800|NCT02661178|58830787|FG002|Part 1|Protocol Violation|0|||
30811801|NCT02661178|58830788|FG003|Part 1|Protocol Violation|0|||
30811802|NCT02661178|58830789|FG004|Part 1|Protocol Violation|0|||
30811803|NCT02661178|58830790|FG005|Part 1|Protocol Violation|0|||
30910453|NCT01738594|58945490|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
30910454|NCT01738594|58945491|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
30910455|NCT01738594|58945492|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
30910456|NCT01738594|58945493|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
30910457|NCT01738594|58945494|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
30910458|NCT01738594|58945487|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
30910459|NCT01738594|58945488|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
30910460|NCT01738594|58945489|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
30910461|NCT01738594|58945490|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
30910462|NCT01738594|58945491|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
30910463|NCT01738594|58945492|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
30910464|NCT01738594|58945493|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
30910465|NCT01738594|58945494|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
30910466|NCT01738594|58945487|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
30811804|NCT02661178|58830791|FG006|Part 1|Protocol Violation|0|||
30811805|NCT02661178|58830792|FG007|Part 1|Protocol Violation|0|||
30811806|NCT02661178|58830793|FG008|Part 1|Protocol Violation|0|||
30811807|NCT02661178|58830794|FG009|Part 1|Protocol Violation|0|||
30811808|NCT02661178|58830795|FG010|Part 1|Protocol Violation|0|||
30811809|NCT02661178|58830796|FG011|Part 1|Protocol Violation|0|||
30811810|NCT02661178|58830797|FG012|Part 1|Protocol Violation|0|||
30811811|NCT02661178|58830798|FG013|Part 1|Protocol Violation|0|||
30811812|NCT02661178|58830799|FG014|Part 1|Protocol Violation|0|||
30811813|NCT02660944|58830851|FG000|Overall Study|Adverse Event|3|||
30811814|NCT02660944|58830852|FG001|Overall Study|Adverse Event|4|||
30811815|NCT02660944|58830851|FG000|Overall Study|Physician Decision|3|||
30811816|NCT02660944|58830852|FG001|Overall Study|Physician Decision|1|||
30811817|NCT02660944|58830851|FG000|Overall Study|Withdrawal by Subject|5|||
30811818|NCT02660944|58830852|FG001|Overall Study|Withdrawal by Subject|3|||
30811819|NCT02660944|58830851|FG000|Overall Study|Lost to Follow-up|4|||
30811820|NCT02660944|58830852|FG001|Overall Study|Lost to Follow-up|1|||
30811821|NCT02660944|58830851|FG000|Overall Study|Subject schedule|0|||
30910467|NCT01738594|58945488|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
30910468|NCT01738594|58945489|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
30910469|NCT01738594|58945490|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
30910470|NCT01738594|58945491|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
30910471|NCT01738594|58945492|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
30910472|NCT01738594|58945493|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
30910473|NCT01738594|58945494|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
30811822|NCT02660944|58830852|FG001|Overall Study|Subject schedule|1|||
30811823|NCT02660944|58830851|FG000|Overall Study|Exclusion criteria met|2|||
30811824|NCT02660944|58830852|FG001|Overall Study|Exclusion criteria met|0|||
30811825|NCT02975336|58830862|FG000|DBPC (52 Weeks)|Adverse Event|16|||
30811826|NCT02975336|58830863|FG001|DBPC (52 Weeks)|Adverse Event|17|||
30811827|NCT02975336|58830864|FG002|DBPC (52 Weeks)|Adverse Event|13|||
30811828|NCT02975336|58830865|FG003|DBPC (52 Weeks)|Adverse Event|18|||
30811829|NCT02975336|58830866|FG004|DBPC (52 Weeks)|Adverse Event|0|||
30811830|NCT02975336|58830867|FG005|DBPC (52 Weeks)|Adverse Event|0|||
30811831|NCT02975336|58830868|FG006|DBPC (52 Weeks)|Adverse Event|0|||
30811832|NCT02975336|58830869|FG007|DBPC (52 Weeks)|Adverse Event|0|||
30811833|NCT02975336|58830862|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
30910474|NCT01738594|58945487|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
30910475|NCT01738594|58945488|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
30910476|NCT01738594|58945489|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
30910477|NCT01738594|58945490|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
30910478|NCT01738594|58945491|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
30910479|NCT01738594|58945492|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
30910480|NCT01738594|58945493|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
30910481|NCT01738594|58945494|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
30910482|NCT01738594|58945487|FG000|Follow up for 1 Year|Death|0|||
30910483|NCT01738594|58945488|FG001|Follow up for 1 Year|Death|0|||
30811834|NCT02975336|58830863|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
30811835|NCT02975336|58830864|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
30811836|NCT02975336|58830865|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
30811837|NCT02975336|58830866|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
30811838|NCT02975336|58830867|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
30811839|NCT02975336|58830868|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
30811840|NCT02975336|58830869|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
30811841|NCT02975336|58830862|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
30811842|NCT02975336|58830863|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
30811843|NCT02975336|58830864|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
30811844|NCT02975336|58830865|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
30811845|NCT02975336|58830866|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
30811846|NCT02975336|58830867|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
30811847|NCT02975336|58830868|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
30811848|NCT02975336|58830869|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
30811849|NCT02975336|58830862|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
30910484|NCT01738594|58945489|FG002|Follow up for 1 Year|Death|0|||
30811850|NCT02975336|58830863|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
30811851|NCT02975336|58830864|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
30811852|NCT02975336|58830865|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
30811853|NCT02975336|58830866|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
30811854|NCT02975336|58830867|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
30811855|NCT02975336|58830868|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
30811856|NCT02975336|58830869|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
30811857|NCT02975336|58830862|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
30811858|NCT02975336|58830863|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
30910485|NCT01738594|58945490|FG003|Follow up for 1 Year|Death|0|||
30910486|NCT01738594|58945491|FG004|Follow up for 1 Year|Death|0|||
30910487|NCT01738594|58945492|FG005|Follow up for 1 Year|Death|1|||
30750033|NCT00076336|58759896|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
30750034|NCT00076336|58759895|FG000|Overall Study|Liver Transplantation|3|||
30750035|NCT00076336|58759896|FG001|Overall Study|Liver Transplantation|3|||
30750036|NCT00076336|58759895|FG000|Overall Study|Virologic Breakthrough|14|||
30910488|NCT01738594|58945493|FG006|Follow up for 1 Year|Death|0|||
30910489|NCT01738594|58945494|FG007|Follow up for 1 Year|Death|0|||
30910490|NCT01738594|58945487|FG000|Follow up for 1 Year|Other|0|||
30910491|NCT01738594|58945488|FG001|Follow up for 1 Year|Other|0|||
30910492|NCT01738594|58945489|FG002|Follow up for 1 Year|Other|0|||
30910493|NCT01738594|58945490|FG003|Follow up for 1 Year|Other|0|||
30910494|NCT01738594|58945491|FG004|Follow up for 1 Year|Other|0|||
30910495|NCT01738594|58945492|FG005|Follow up for 1 Year|Other|2|||
30910496|NCT01738594|58945493|FG006|Follow up for 1 Year|Other|0|||
30910497|NCT01738594|58945494|FG007|Follow up for 1 Year|Other|0|||
30910498|NCT01738438|58945504|FG000|Overall Study|Disease Progression|32|||
30910499|NCT01738438|58945504|FG000|Overall Study|Adverse Event|3|||
30910500|NCT01716520|58945508|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
30910501|NCT01716520|58945509|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
30910502|NCT01716520|58945510|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
30910503|NCT01716520|58945511|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
30910504|NCT01716520|58945512|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
30910505|NCT01716520|58945513|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
30750037|NCT00076336|58759896|FG001|Overall Study|Virologic Breakthrough|16|||
30750038|NCT00076336|58759895|FG000|Overall Study|Treatment failure|4|||
30750039|NCT00076336|58759896|FG001|Overall Study|Treatment failure|5|||
30750040|NCT00185588|58759906|FG000|Overall Study|Adverse Event|3|||
30750041|NCT00185588|58759907|FG001|Overall Study|Adverse Event|1|||
30750042|NCT00185588|58759908|FG002|Overall Study|Adverse Event|4|||
30750043|NCT00185588|58759909|FG003|Overall Study|Adverse Event|2|||
30750044|NCT00185588|58759906|FG000|Overall Study|Lost to Follow-up|0|||
30750045|NCT00185588|58759907|FG001|Overall Study|Lost to Follow-up|0|||
30750046|NCT00185588|58759908|FG002|Overall Study|Lost to Follow-up|1|||
30811859|NCT02975336|58830864|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
30811860|NCT02975336|58830865|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
30910506|NCT01716520|58945508|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
30910507|NCT01716520|58945509|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
30910508|NCT01716520|58945510|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
30910509|NCT01716520|58945511|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
30910510|NCT01716520|58945512|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
30910511|NCT01716520|58945513|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
30910512|NCT01716520|58945508|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30750047|NCT00185588|58759909|FG003|Overall Study|Lost to Follow-up|2|||
30750048|NCT00185588|58759906|FG000|Overall Study|Withdrawal by Subject|0|||
30750049|NCT00185588|58759907|FG001|Overall Study|Withdrawal by Subject|1|||
30750050|NCT00185588|58759908|FG002|Overall Study|Withdrawal by Subject|0|||
30750051|NCT00185588|58759909|FG003|Overall Study|Withdrawal by Subject|0|||
30750052|NCT00185588|58759906|FG000|Overall Study|Physician Decision|0|||
30750053|NCT00185588|58759907|FG001|Overall Study|Physician Decision|0|||
30750054|NCT00185588|58759908|FG002|Overall Study|Physician Decision|1|||
30750055|NCT00185588|58759909|FG003|Overall Study|Physician Decision|0|||
30750056|NCT00232544|58759921|FG000|Overall Study|Lost to Follow-up|20|||
30811861|NCT02975336|58830866|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
30811862|NCT02975336|58830867|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
30811863|NCT02975336|58830868|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
30811864|NCT02975336|58830869|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
30811865|NCT02975336|58830862|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
30811866|NCT02975336|58830863|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
30811867|NCT02975336|58830864|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
30811868|NCT02975336|58830865|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
30811869|NCT02975336|58830866|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
30811870|NCT02975336|58830867|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
30811871|NCT02975336|58830868|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
30811872|NCT02975336|58830869|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
30811873|NCT02975336|58830862|FG000|LTE (104 Weeks)|Adverse Event|0|||
30811874|NCT02975336|58830863|FG001|LTE (104 Weeks)|Adverse Event|0|||
30811875|NCT02975336|58830864|FG002|LTE (104 Weeks)|Adverse Event|0|||
30811876|NCT02975336|58830865|FG003|LTE (104 Weeks)|Adverse Event|0|||
30811877|NCT02975336|58830866|FG004|LTE (104 Weeks)|Adverse Event|7|||
30811878|NCT02975336|58830867|FG005|LTE (104 Weeks)|Adverse Event|4|||
30811879|NCT02975336|58830868|FG006|LTE (104 Weeks)|Adverse Event|2|||
30811880|NCT02975336|58830869|FG007|LTE (104 Weeks)|Adverse Event|0|||
30811881|NCT02975336|58830862|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
30811882|NCT02975336|58830863|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
30811883|NCT02975336|58830864|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
30811884|NCT02975336|58830865|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
30811885|NCT02975336|58830866|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
30811886|NCT02975336|58830867|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
30811887|NCT02975336|58830868|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
30811888|NCT02975336|58830869|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
30811889|NCT02975336|58830862|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
30811890|NCT02975336|58830863|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
30811891|NCT02975336|58830864|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
30811892|NCT02975336|58830865|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
30811893|NCT02975336|58830866|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
30811894|NCT02975336|58830867|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
30811895|NCT02975336|58830868|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
30811896|NCT02975336|58830869|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
30811897|NCT02975336|58830862|FG000|LTE (104 Weeks)|Other|0|||
30811898|NCT02975336|58830863|FG001|LTE (104 Weeks)|Other|0|||
30811899|NCT02975336|58830864|FG002|LTE (104 Weeks)|Other|0|||
30811900|NCT02975336|58830865|FG003|LTE (104 Weeks)|Other|0|||
30811901|NCT02975336|58830866|FG004|LTE (104 Weeks)|Other|55|||
30811902|NCT02975336|58830867|FG005|LTE (104 Weeks)|Other|63|||
30811903|NCT02975336|58830868|FG006|LTE (104 Weeks)|Other|76|||
30811904|NCT02975336|58830869|FG007|LTE (104 Weeks)|Other|72|||
30811905|NCT03124563|58830885|FG000|Overall Study|Lost to Follow-up|1|||
30811906|NCT03124563|58830886|FG001|Overall Study|Lost to Follow-up|1|||
30811907|NCT03124563|58830885|FG000|Overall Study|Withdrawal by Subject|1|||
30811908|NCT03124563|58830886|FG001|Overall Study|Withdrawal by Subject|1|||
30811909|NCT03079869|58830894|FG000|Overall Study|Adverse Event|6|||
30811910|NCT03079869|58830895|FG001|Overall Study|Adverse Event|8|||
30811911|NCT03079869|58830894|FG000|Overall Study|Withdrawal by Subject|4|||
30811912|NCT03079869|58830895|FG001|Overall Study|Withdrawal by Subject|1|||
30811913|NCT03079869|58830894|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
30811914|NCT03079869|58830895|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
30811915|NCT03085914|58830908|FG000|Overall Study|Death|6|||
30811916|NCT03085914|58830909|FG001|Overall Study|Death|6|||
30811917|NCT03085914|58830910|FG002|Overall Study|Death|4|||
30811918|NCT03085914|58830911|FG003|Overall Study|Death|1|||
30811919|NCT03085914|58830912|FG004|Overall Study|Death|5|||
30811920|NCT03085914|58830913|FG005|Overall Study|Death|2|||
30811921|NCT03085914|58830914|FG006|Overall Study|Death|2|||
30811922|NCT03085914|58830908|FG000|Overall Study|Withdrawal by Subject|1|||
30811923|NCT03085914|58830909|FG001|Overall Study|Withdrawal by Subject|1|||
30811924|NCT03085914|58830910|FG002|Overall Study|Withdrawal by Subject|2|||
30811925|NCT03085914|58830911|FG003|Overall Study|Withdrawal by Subject|2|||
30811926|NCT03085914|58830912|FG004|Overall Study|Withdrawal by Subject|2|||
30811927|NCT03085914|58830913|FG005|Overall Study|Withdrawal by Subject|0|||
30811928|NCT03085914|58830914|FG006|Overall Study|Withdrawal by Subject|1|||
30811929|NCT03085914|58830908|FG000|Overall Study|Lost to Follow-up|0|||
30811930|NCT03085914|58830909|FG001|Overall Study|Lost to Follow-up|0|||
30811931|NCT03085914|58830910|FG002|Overall Study|Lost to Follow-up|1|||
30811932|NCT03085914|58830911|FG003|Overall Study|Lost to Follow-up|0|||
30811933|NCT03085914|58830912|FG004|Overall Study|Lost to Follow-up|0|||
30811934|NCT03085914|58830913|FG005|Overall Study|Lost to Follow-up|1|||
30811935|NCT03085914|58830914|FG006|Overall Study|Lost to Follow-up|1|||
30811936|NCT03085914|58830908|FG000|Overall Study|Reason was not specified,|2|||
30811937|NCT03085914|58830909|FG001|Overall Study|Reason was not specified,|2|||
30811938|NCT03085914|58830910|FG002|Overall Study|Reason was not specified,|2|||
30811939|NCT03085914|58830911|FG003|Overall Study|Reason was not specified,|3|||
30811940|NCT03085914|58830912|FG004|Overall Study|Reason was not specified,|3|||
30811941|NCT03085914|58830913|FG005|Overall Study|Reason was not specified,|3|||
30811942|NCT03085914|58830914|FG006|Overall Study|Reason was not specified,|6|||
30811943|NCT03085914|58830908|FG000|Overall Study|Progressive Disease|0|||
30811944|NCT03085914|58830909|FG001|Overall Study|Progressive Disease|0|||
30811945|NCT03085914|58830910|FG002|Overall Study|Progressive Disease|2|||
30811946|NCT03085914|58830911|FG003|Overall Study|Progressive Disease|2|||
30811947|NCT03085914|58830912|FG004|Overall Study|Progressive Disease|1|||
30811948|NCT03085914|58830913|FG005|Overall Study|Progressive Disease|1|||
30811949|NCT03085914|58830914|FG006|Overall Study|Progressive Disease|1|||
30910513|NCT01716520|58945509|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
30910514|NCT01716520|58945510|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30910515|NCT01716520|58945511|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30910516|NCT01716520|58945512|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30910517|NCT01716520|58945513|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30910518|NCT01716520|58945508|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
30910519|NCT01716520|58945509|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
30910520|NCT01716520|58945510|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
30910521|NCT01716520|58945511|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
30910522|NCT01716520|58945512|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
30910523|NCT01716520|58945513|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
30910524|NCT01716520|58945508|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
30910525|NCT01716520|58945509|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
30811950|NCT03085914|58830908|FG000|Overall Study|Study Terminated by the Sponsor|0|||
30811951|NCT03085914|58830909|FG001|Overall Study|Study Terminated by the Sponsor|0|||
30811952|NCT03085914|58830910|FG002|Overall Study|Study Terminated by the Sponsor|0|||
30811953|NCT03085914|58830911|FG003|Overall Study|Study Terminated by the Sponsor|1|||
30811954|NCT03085914|58830912|FG004|Overall Study|Study Terminated by the Sponsor|2|||
30811955|NCT03085914|58830913|FG005|Overall Study|Study Terminated by the Sponsor|1|||
30811956|NCT03085914|58830914|FG006|Overall Study|Study Terminated by the Sponsor|0|||
30811957|NCT03078582|58830942|FG000|Overall Study|Adverse Event|0|||
30811958|NCT03078582|58830943|FG001|Overall Study|Adverse Event|8|||
30811959|NCT03077724|58830951|FG000|Overall Study|Lost to Follow-up|5|||
30811960|NCT03077724|58830952|FG001|Overall Study|Lost to Follow-up|1|||
30811961|NCT03077724|58830951|FG000|Overall Study|Withdrawal by Subject|3|||
30811962|NCT03077724|58830952|FG001|Overall Study|Withdrawal by Subject|1|||
30811963|NCT00979212|58830960|FG000|Overall Study|Protocol Violation|1|||
30910526|NCT01716520|58945510|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
30910527|NCT01716520|58945511|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
30811964|NCT00979212|58830961|FG001|Overall Study|Protocol Violation|8|||
30811965|NCT00979212|58830960|FG000|Overall Study|No protocol therapy received|1|||
30811966|NCT00979212|58830961|FG001|Overall Study|No protocol therapy received|0|||
30811967|NCT03080454|58830967|FG000|Baseline|Adverse Event|2|||
30811968|NCT03080454|58830967|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
30811969|NCT03080454|58830967|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
30811970|NCT02981342|58830991|FG000|Overall Study|Adverse Event|0|||
30811971|NCT02981342|58830992|FG001|Overall Study|Adverse Event|0|||
30811972|NCT02981342|58830993|FG002|Overall Study|Adverse Event|0|||
30811973|NCT02981342|58830994|FG003|Overall Study|Adverse Event|1|||
30811974|NCT02981342|58830991|FG000|Overall Study|Death|0|||
30811975|NCT02981342|58830992|FG001|Overall Study|Death|9|||
30811976|NCT02981342|58830993|FG002|Overall Study|Death|9|||
30811977|NCT02981342|58830994|FG003|Overall Study|Death|4|||
30811978|NCT02981342|58830991|FG000|Overall Study|Withdrawal by Subject|0|||
30811979|NCT02981342|58830992|FG001|Overall Study|Withdrawal by Subject|0|||
30811980|NCT02981342|58830993|FG002|Overall Study|Withdrawal by Subject|3|||
30811981|NCT02981342|58830994|FG003|Overall Study|Withdrawal by Subject|1|||
30811982|NCT02981342|58830991|FG000|Overall Study|Study closed by sponsor|0|||
30811983|NCT02981342|58830992|FG001|Overall Study|Study closed by sponsor|0|||
30811984|NCT02981342|58830993|FG002|Overall Study|Study closed by sponsor|1|||
30811985|NCT02981342|58830994|FG003|Overall Study|Study closed by sponsor|1|||
30811986|NCT02981342|58830991|FG000|Overall Study|Randomized, Never Treated|0|||
30811987|NCT02981342|58830992|FG001|Overall Study|Randomized, Never Treated|1|||
30811988|NCT02981342|58830993|FG002|Overall Study|Randomized, Never Treated|0|||
30811989|NCT02981342|58830994|FG003|Overall Study|Randomized, Never Treated|7|||
30910528|NCT01716520|58945512|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
30910529|NCT01716520|58945513|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
30910530|NCT01716520|58945508|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
30910531|NCT01716520|58945509|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
30910532|NCT01716520|58945510|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
30910533|NCT01716520|58945511|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
30811990|NCT02981342|58830991|FG000|Overall Study|Lost to Follow-up|0|||
30910534|NCT01716520|58945512|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
30910535|NCT01716520|58945513|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
30910536|NCT01716520|58945508|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
30910537|NCT01716520|58945509|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
30811991|NCT02981342|58830992|FG001|Overall Study|Lost to Follow-up|1|||
30811992|NCT02981342|58830993|FG002|Overall Study|Lost to Follow-up|0|||
30811993|NCT02981342|58830994|FG003|Overall Study|Lost to Follow-up|0|||
30811994|NCT02794246|58831006|FG000|Overall Study|Withdrawal by Subject|2|||
30811995|NCT02794246|58831006|FG000|Overall Study|Physician Decision|4|||
30811996|NCT03428100|58831014|FG000|Overall Study|Adverse Event|1|||
30910538|NCT01716520|58945510|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
30910539|NCT01716520|58945511|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
30910540|NCT01716520|58945512|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
30910541|NCT01716520|58945513|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
30910542|NCT01716520|58945508|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
30622556|NCT00922636|58634246|FG004|Overall Study|Lost to Follow-up|4|||
30811997|NCT03428100|58831015|FG001|Overall Study|Adverse Event|0|||
30811998|NCT03428100|58831016|FG002|Overall Study|Adverse Event|3|||
30811999|NCT03428100|58831017|FG003|Overall Study|Adverse Event|1|||
30812000|NCT03428100|58831014|FG000|Overall Study|Lack of Efficacy|16|||
30812001|NCT03428100|58831015|FG001|Overall Study|Lack of Efficacy|10|||
30622557|NCT01175135|58634267|FG000|Overall Study|Adverse Event|2|||
30812002|NCT03428100|58831016|FG002|Overall Study|Lack of Efficacy|7|||
30812003|NCT03428100|58831017|FG003|Overall Study|Lack of Efficacy|6|||
30812004|NCT03428100|58831014|FG000|Overall Study|Protocol Deviation|0|||
30812005|NCT03428100|58831015|FG001|Overall Study|Protocol Deviation|2|||
30812006|NCT03428100|58831016|FG002|Overall Study|Protocol Deviation|2|||
30812007|NCT03428100|58831017|FG003|Overall Study|Protocol Deviation|0|||
30812008|NCT03428100|58831014|FG000|Overall Study|Withdrawal by Subject|4|||
30812009|NCT03428100|58831015|FG001|Overall Study|Withdrawal by Subject|0|||
30812010|NCT03428100|58831016|FG002|Overall Study|Withdrawal by Subject|0|||
30812011|NCT03428100|58831017|FG003|Overall Study|Withdrawal by Subject|0|||
30812012|NCT03428100|58831014|FG000|Overall Study|Physician Decision|0|||
30812013|NCT03428100|58831015|FG001|Overall Study|Physician Decision|1|||
30622558|NCT01175135|58634268|FG001|Overall Study|Adverse Event|5|||
30622559|NCT01175135|58634269|FG002|Overall Study|Adverse Event|3|||
30812014|NCT03428100|58831016|FG002|Overall Study|Physician Decision|0|||
30812015|NCT03428100|58831017|FG003|Overall Study|Physician Decision|0|||
30910543|NCT01716520|58945509|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
30910544|NCT01716520|58945510|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
30812016|NCT02980874|58831039|FG000|Overall Study|Adverse Event|2|||
30812017|NCT02980874|58831040|FG001|Overall Study|Adverse Event|7|||
30812018|NCT02980874|58831039|FG000|Overall Study|Withdrawal by Subject|7|||
30812019|NCT02980874|58831040|FG001|Overall Study|Withdrawal by Subject|2|||
30812020|NCT02980874|58831039|FG000|Overall Study|Lost to Follow-up|5|||
30812021|NCT02980874|58831040|FG001|Overall Study|Lost to Follow-up|5|||
30812022|NCT02980874|58831039|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
30812023|NCT02980874|58831040|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
30812024|NCT02980874|58831039|FG000|Overall Study|Unknown study completion status|1|||
30812025|NCT02980874|58831040|FG001|Overall Study|Unknown study completion status|0|||
30812026|NCT01066052|58831048|FG000|Overall Study|Enrolled But Not Treated|3|||
30812027|NCT01066052|58831049|FG001|Overall Study|Enrolled But Not Treated|0|||
30812028|NCT03077646|58831057|FG000|Overall Study|Lost to Follow-up|29|||
30812029|NCT03077646|58831058|FG001|Overall Study|Lost to Follow-up|30|||
30812030|NCT03077646|58831059|FG002|Overall Study|Lost to Follow-up|31|||
30910545|NCT01716520|58945511|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
30910546|NCT01716520|58945512|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
30910547|NCT01716520|58945513|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
30910548|NCT01716520|58945508|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
30910549|NCT01716520|58945509|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
30910550|NCT01716520|58945510|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
30910551|NCT01716520|58945511|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
30910552|NCT01716520|58945512|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
30910553|NCT01716520|58945513|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
30910554|NCT01716520|58945508|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
30910555|NCT01716520|58945509|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
30910556|NCT01716520|58945510|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
30750057|NCT00232544|58759922|FG001|Overall Study|Lost to Follow-up|15|||
30812031|NCT02892149|58831069|FG000|Overall Study|Death|262|||
30812032|NCT02892149|58831070|FG001|Overall Study|Death|278|||
30812033|NCT02892149|58831069|FG000|Overall Study|Withdrawal by Subject|53|||
30812034|NCT02892149|58831070|FG001|Overall Study|Withdrawal by Subject|47|||
30812035|NCT02892149|58831069|FG000|Overall Study|Lost to Follow-up|37|||
30812036|NCT02892149|58831070|FG001|Overall Study|Lost to Follow-up|31|||
30812037|NCT04187092|58831078|FG000|Overall Study|Lost to Follow-up|1|||
30812038|NCT04187092|58831079|FG001|Overall Study|Lost to Follow-up|1|||
30812039|NCT04187092|58831078|FG000|Overall Study|Withdrawal by Subject|1|||
30812040|NCT04187092|58831079|FG001|Overall Study|Withdrawal by Subject|1|||
30910557|NCT01716520|58945511|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
30750058|NCT00231842|58759928|FG000|Overall Study|Withdrawal by Subject|3|||
30750059|NCT00231842|58759928|FG000|Overall Study|Did not complete the last 3 cycle|8|||
30750060|NCT00076102|58759933|FG000|Overall Study|Clinical progression|1|||
30750061|NCT00076102|58759933|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
30750062|NCT00076102|58759933|FG000|Overall Study|plexiform neurofibroma surgery|1|||
30750063|NCT00076102|58759933|FG000|Overall Study|refusal of further therapy|2|||
30750064|NCT00231062|58759947|FG000|Overall Study|Physician Decision|6|||
30750065|NCT00184028|58759951|FG000|Overall Study|Death|1|||
30750066|NCT00184028|58759951|FG000|Overall Study|Lack of Efficacy|4|||
30750067|NCT00184028|58759951|FG000|Overall Study|Adverse Event|2|||
30750068|NCT00184028|58759951|FG000|Overall Study|Withdrawal by Subject|1|||
30750069|NCT00184028|58759951|FG000|Overall Study|Non-compliance|2|||
30750070|NCT00183872|58759956|FG000|Overall Study|Death|3|||
30750071|NCT00183872|58759956|FG000|Overall Study|Adverse Event|9|||
30750072|NCT00183872|58759956|FG000|Overall Study|Withdrawal by Subject|2|||
30750073|NCT00183872|58759956|FG000|Overall Study|Drug delayed more than 28 days|2|||
30750074|NCT03815175|58759960|FG000|Overall Study|Subject Lost to Follow-up|6|||
30750075|NCT03815175|58759960|FG000|Overall Study|Subject Withdrew Consent|48|||
30750076|NCT03815175|58759960|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
30750077|NCT03815175|58759960|FG000|Overall Study|Death|86|||
30750078|NCT03815175|58759960|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
30750079|NCT03815175|58759960|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
30750080|NCT03815175|58759960|FG000|Overall Study|Other Status Change Reason|1|||
30750081|NCT03815175|58759960|FG000|Overall Study|Missed Visit|12|||
30750082|NCT00262028|58759973|FG000|Overall Study|Withdrawal by Subject|6|||
30750083|NCT00262028|58759974|FG001|Overall Study|Withdrawal by Subject|3|||
30812041|NCT04187092|58831078|FG000|Overall Study|Adverse Event|0|||
30812042|NCT04187092|58831079|FG001|Overall Study|Adverse Event|1|||
30812043|NCT02896127|58831087|FG000|COMPLETED WEEK 52|Adverse Event|9|||
30812044|NCT02896127|58831088|FG001|COMPLETED WEEK 52|Adverse Event|2|||
30812045|NCT02896127|58831087|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
30812046|NCT02896127|58831088|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
30812047|NCT02896127|58831087|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
30812048|NCT02896127|58831088|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
30812049|NCT02896127|58831087|FG000|COMPLETED WEEK 52|Physician Decision|1|||
30812050|NCT02896127|58831088|FG001|COMPLETED WEEK 52|Physician Decision|1|||
30812051|NCT02896127|58831087|FG000|COMPLETED WEEK 52|Pregnancy|2|||
30812052|NCT02896127|58831088|FG001|COMPLETED WEEK 52|Pregnancy|0|||
30812053|NCT02896127|58831087|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
30812054|NCT02896127|58831088|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
30812055|NCT02896127|58831087|FG000|COMPLETED WEEK 52|Technical problems|1|||
30812056|NCT02896127|58831088|FG001|COMPLETED WEEK 52|Technical problems|0|||
30812057|NCT02896127|58831087|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
30812058|NCT02896127|58831088|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
30812059|NCT02896127|58831087|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
30812060|NCT02896127|58831088|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
30812061|NCT02896127|58831087|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
30812062|NCT02896127|58831088|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
30812063|NCT02896127|58831087|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
30812064|NCT02896127|58831088|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
30910558|NCT01716520|58945512|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
30910559|NCT01716520|58945513|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
30910560|NCT01716520|58945508|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
30910561|NCT01716520|58945509|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
30910562|NCT01716520|58945510|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
30910563|NCT01716520|58945511|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
30910564|NCT01716520|58945512|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
30910565|NCT01716520|58945513|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
30812065|NCT02896127|58831087|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
30812066|NCT02896127|58831088|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
30812067|NCT03546647|58831094|FG000|Overall Study|Adverse Event|1|||
30812068|NCT03546647|58831095|FG001|Overall Study|Adverse Event|0|||
30812069|NCT03077412|58831104|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
30812070|NCT03077412|58831105|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
30812071|NCT03077412|58831106|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
30812072|NCT03077412|58831104|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
30812073|NCT03077412|58831105|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
30812074|NCT03077412|58831106|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
30812075|NCT03077412|58831104|FG000|Overall Study|Adverse Event|1|||
30812076|NCT03077412|58831105|FG001|Overall Study|Adverse Event|2|||
30812077|NCT03077412|58831106|FG002|Overall Study|Adverse Event|2|||
30812078|NCT03077412|58831104|FG000|Overall Study|Investigator's Discretion|0|||
30812079|NCT03077412|58831105|FG001|Overall Study|Investigator's Discretion|1|||
30812080|NCT03077412|58831106|FG002|Overall Study|Investigator's Discretion|1|||
30812081|NCT03077412|58831104|FG000|Overall Study|Withdrew Consent|0|||
30812082|NCT03077412|58831105|FG001|Overall Study|Withdrew Consent|2|||
30812083|NCT03077412|58831106|FG002|Overall Study|Withdrew Consent|0|||
30812084|NCT03544229|58831118|FG000|Overall Study|Adverse Event|1|||
30812085|NCT03544229|58831119|FG001|Overall Study|Adverse Event|0|||
30812086|NCT03544229|58831120|FG002|Overall Study|Adverse Event|1|||
30812087|NCT03544229|58831121|FG003|Overall Study|Adverse Event|0|||
30812088|NCT03544229|58831118|FG000|Overall Study|Protocol Deviation|0|||
30812089|NCT03544229|58831119|FG001|Overall Study|Protocol Deviation|0|||
30910566|NCT01716520|58945508|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
30910567|NCT01716520|58945509|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
30910568|NCT01716520|58945510|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
30910569|NCT01716520|58945511|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
30910570|NCT01716520|58945512|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
30910571|NCT01716520|58945513|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
30910572|NCT01716520|58945508|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
30910573|NCT01716520|58945509|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
30812090|NCT03544229|58831120|FG002|Overall Study|Protocol Deviation|1|||
30910574|NCT01716520|58945510|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
30910575|NCT01716520|58945511|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
30812091|NCT03544229|58831121|FG003|Overall Study|Protocol Deviation|0|||
30910576|NCT01716520|58945512|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
30812092|NCT03544229|58831118|FG000|Overall Study|Lost to Follow-up|3|||
30812093|NCT03544229|58831119|FG001|Overall Study|Lost to Follow-up|0|||
30812094|NCT03544229|58831120|FG002|Overall Study|Lost to Follow-up|0|||
30812095|NCT03544229|58831121|FG003|Overall Study|Lost to Follow-up|2|||
30812096|NCT03544229|58831118|FG000|Overall Study|Voluntary Withdrawal|2|||
30812097|NCT03544229|58831119|FG001|Overall Study|Voluntary Withdrawal|1|||
30812098|NCT03544229|58831120|FG002|Overall Study|Voluntary Withdrawal|3|||
30812099|NCT03544229|58831121|FG003|Overall Study|Voluntary Withdrawal|0|||
30812100|NCT03544229|58831118|FG000|Overall Study|Lack of Efficacy|0|||
30812101|NCT03544229|58831119|FG001|Overall Study|Lack of Efficacy|1|||
30812102|NCT03544229|58831120|FG002|Overall Study|Lack of Efficacy|0|||
30812103|NCT03544229|58831121|FG003|Overall Study|Lack of Efficacy|0|||
30812104|NCT03078816|58831131|FG000|Overall Study|Withdrawal by Subject|1|||
30812105|NCT03510455|58831135|FG000|Overall Study|Physician Decision|1|||
30812106|NCT03509675|58831143|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
30812107|NCT03509675|58831144|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
30812108|NCT03509675|58831143|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
30812109|NCT03509675|58831144|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
30910577|NCT01716520|58945513|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
30910578|NCT01716520|58945508|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30910579|NCT01716520|58945509|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30910580|NCT01716520|58945510|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30910581|NCT01716520|58945511|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30910582|NCT01716520|58945512|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30910583|NCT01716520|58945513|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
30910584|NCT01716520|58945508|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
30812110|NCT03509675|58831143|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
30812111|NCT03509675|58831144|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
30812112|NCT03509675|58831143|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
30812113|NCT03509675|58831144|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
30812114|NCT03509207|58831150|FG000|Overall Study|Death|2|||
30812115|NCT03543137|58831154|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
30812116|NCT03543137|58831155|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
30812117|NCT03543137|58831154|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
30812118|NCT03543137|58831155|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
30812119|NCT03543137|58831154|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
30812120|NCT03543137|58831155|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
30812121|NCT02895347|58831165|FG000|Overall Study|Withdrawal by Subject|3|||
30812122|NCT02895347|58831166|FG001|Overall Study|Withdrawal by Subject|1|||
30812123|NCT03539549|58831173|FG000|Overall Study|Adverse Event|12|||
30910585|NCT01716520|58945509|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
30910586|NCT01716520|58945510|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
30910587|NCT01716520|58945511|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
30750084|NCT00262028|58759975|FG002|Overall Study|Withdrawal by Subject|6|||
30750085|NCT00262028|58759976|FG003|Overall Study|Withdrawal by Subject|5|||
30750086|NCT00262028|58759977|FG004|Overall Study|Withdrawal by Subject|2|||
30750087|NCT00262028|58759978|FG005|Overall Study|Withdrawal by Subject|3|||
30750088|NCT00262028|58759979|FG006|Overall Study|Withdrawal by Subject|5|||
30750089|NCT00262028|58759980|FG007|Overall Study|Withdrawal by Subject|7|||
30750090|NCT00262028|58759981|FG008|Overall Study|Withdrawal by Subject|2|||
30750091|NCT00262028|58759973|FG000|Overall Study|Lost to Follow-up|7|||
30750092|NCT00262028|58759974|FG001|Overall Study|Lost to Follow-up|7|||
30750093|NCT00262028|58759975|FG002|Overall Study|Lost to Follow-up|5|||
30750094|NCT00262028|58759976|FG003|Overall Study|Lost to Follow-up|5|||
30750095|NCT00262028|58759977|FG004|Overall Study|Lost to Follow-up|4|||
30750096|NCT00262028|58759978|FG005|Overall Study|Lost to Follow-up|3|||
30750097|NCT00262028|58759979|FG006|Overall Study|Lost to Follow-up|3|||
30750098|NCT00262028|58759980|FG007|Overall Study|Lost to Follow-up|5|||
30750099|NCT00262028|58759981|FG008|Overall Study|Lost to Follow-up|6|||
30750100|NCT00262028|58759973|FG000|Overall Study|Administrative Reason|11|||
30812124|NCT03539549|58831173|FG000|Overall Study|Lost to Follow-up|1|||
30812125|NCT03539549|58831173|FG000|Overall Study|Death|2|||
30812126|NCT03539549|58831173|FG000|Overall Study|Progressive Disease|1|||
30812127|NCT03539549|58831173|FG000|Overall Study|Reason not Specified|1|||
30812128|NCT03506477|58831179|FG000|Overall Study|Withdrawal by Subject|1|||
30812129|NCT03506477|58831180|FG001|Overall Study|Withdrawal by Subject|0|||
30812130|NCT03073980|58831189|FG000|Overall Study|Lost to Follow-up|10|||
30812131|NCT03073980|58831190|FG001|Overall Study|Lost to Follow-up|2|||
30812132|NCT03073980|58831191|FG002|Overall Study|Lost to Follow-up|9|||
30812133|NCT03073980|58831189|FG000|Overall Study|No post-procedure data|0|||
30812134|NCT03073980|58831190|FG001|Overall Study|No post-procedure data|0|||
30812135|NCT03073980|58831191|FG002|Overall Study|No post-procedure data|2|||
30812136|NCT03930186|58831203|FG000|Weeks 0 to 16|Adverse Event|6|||
30812137|NCT03930186|58831203|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
30812138|NCT03930186|58831203|FG000|Weeks 16 to 32|Adverse Event|1|||
30812139|NCT03930186|58831203|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
30812140|NCT03504917|58831209|FG000|Blinded Treatment Period|Protocol Violation|1|||
30812141|NCT03504917|58831210|FG001|Blinded Treatment Period|Protocol Violation|0|||
30812142|NCT03504917|58831209|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
30812143|NCT03504917|58831210|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
30812144|NCT03504917|58831209|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
30812145|NCT03504917|58831210|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
30812146|NCT03504917|58831209|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
30812147|NCT03504917|58831210|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
30812148|NCT03504917|58831209|FG000|Blinded Treatment Period|Adverse Event|4|||
30812149|NCT03504917|58831210|FG001|Blinded Treatment Period|Adverse Event|4|||
30812150|NCT03504917|58831209|FG000|Blinded Treatment Period|Physician Decision|1|||
30812151|NCT03504917|58831210|FG001|Blinded Treatment Period|Physician Decision|0|||
30812152|NCT03504917|58831209|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
30812153|NCT03504917|58831210|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
30812154|NCT03504917|58831209|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
30812155|NCT03504917|58831210|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
30812156|NCT03504917|58831209|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
30812157|NCT03504917|58831210|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
30910588|NCT01716520|58945512|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
30910589|NCT01716520|58945513|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
30910590|NCT01698268|58945523|FG000|Overall Study|Physician Decision|2|||
30910591|NCT01698268|58945524|FG001|Overall Study|Physician Decision|1|||
30910592|NCT01697956|58945532|FG000|Overall Study|Protocol Violation|1|||
30910593|NCT01697956|58945533|FG001|Overall Study|Protocol Violation|1|||
30622560|NCT01175135|58634270|FG003|Overall Study|Adverse Event|4|||
30622561|NCT01175135|58634267|FG000|Overall Study|Death|1|||
30750101|NCT00262028|58759974|FG001|Overall Study|Administrative Reason|14|||
30750102|NCT00262028|58759975|FG002|Overall Study|Administrative Reason|9|||
30750103|NCT00262028|58759976|FG003|Overall Study|Administrative Reason|12|||
30750104|NCT00262028|58759977|FG004|Overall Study|Administrative Reason|6|||
30750105|NCT00262028|58759978|FG005|Overall Study|Administrative Reason|7|||
30750106|NCT00262028|58759979|FG006|Overall Study|Administrative Reason|4|||
30750107|NCT00262028|58759980|FG007|Overall Study|Administrative Reason|6|||
30750108|NCT00262028|58759981|FG008|Overall Study|Administrative Reason|10|||
30750109|NCT00262028|58759973|FG000|Overall Study|Protocol Violation|0|||
30750110|NCT00262028|58759974|FG001|Overall Study|Protocol Violation|0|||
30750111|NCT00262028|58759975|FG002|Overall Study|Protocol Violation|0|||
30750112|NCT00262028|58759976|FG003|Overall Study|Protocol Violation|1|||
30750113|NCT00262028|58759977|FG004|Overall Study|Protocol Violation|0|||
30750114|NCT00262028|58759978|FG005|Overall Study|Protocol Violation|0|||
30750115|NCT00262028|58759979|FG006|Overall Study|Protocol Violation|0|||
30750116|NCT00262028|58759980|FG007|Overall Study|Protocol Violation|0|||
30750117|NCT00262028|58759981|FG008|Overall Study|Protocol Violation|0|||
30750118|NCT00262028|58759973|FG000|Overall Study|Unable to classify|0|||
30750119|NCT00262028|58759974|FG001|Overall Study|Unable to classify|3|||
30750120|NCT00262028|58759975|FG002|Overall Study|Unable to classify|0|||
30750121|NCT00262028|58759976|FG003|Overall Study|Unable to classify|0|||
30750122|NCT00262028|58759977|FG004|Overall Study|Unable to classify|0|||
30750123|NCT00262028|58759978|FG005|Overall Study|Unable to classify|0|||
30750124|NCT00262028|58759979|FG006|Overall Study|Unable to classify|0|||
30750125|NCT00262028|58759980|FG007|Overall Study|Unable to classify|0|||
30750126|NCT00262028|58759981|FG008|Overall Study|Unable to classify|1|||
30750127|NCT00183248|58760025|FG000|Overall Study|Lost to Follow-up|0|||
30750128|NCT00183248|58760026|FG001|Overall Study|Lost to Follow-up|1|||
30750129|NCT00183248|58760025|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
30750130|NCT00183248|58760026|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
30750131|NCT00183170|58760034|FG000|First Intervention|Did not complete study|1|||
30750132|NCT00183170|58760035|FG001|First Intervention|Did not complete study|0|||
30750133|NCT00183170|58760034|FG000|First Intervention|Did not meet targeted BrAC|1|||
30750134|NCT00183170|58760035|FG001|First Intervention|Did not meet targeted BrAC|0|||
30750135|NCT00183170|58760034|FG000|Washout 1 Week|Did not complete study|6|||
30812158|NCT03504917|58831209|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
30812159|NCT03504917|58831210|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
30812160|NCT03504917|58831209|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
30812161|NCT03504917|58831210|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
30812162|NCT03504917|58831209|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
30812163|NCT03504917|58831210|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
30812164|NCT03504917|58831209|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
30812165|NCT03504917|58831210|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
30812166|NCT03504917|58831209|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
30812167|NCT03504917|58831210|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
30812168|NCT03504917|58831209|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
30812169|NCT03504917|58831210|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
30812170|NCT03504917|58831209|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
30812171|NCT03504917|58831210|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
30812172|NCT03536663|58831222|FG000|Endexo|Protocol Violation|1|||
30812173|NCT03565211|58831231|FG000|Overall Study|Withdrawal by Subject|2|||
30812174|NCT03565211|58831231|FG000|Overall Study|Lost to Follow-up|1|||
30812175|NCT03565211|58831231|FG000|Overall Study|Adverse Event|44|||
30812176|NCT03565211|58831231|FG000|Overall Study|Personal issues|1|||
30812177|NCT03531905|58831238|FG000|Overall Study|Withdrawal by Subject|3|||
30812178|NCT03531905|58831239|FG001|Overall Study|Withdrawal by Subject|3|||
30812179|NCT03531905|58831240|FG002|Overall Study|Withdrawal by Subject|2|||
30812180|NCT03531905|58831238|FG000|Overall Study|Lost to Follow-up|2|||
30812181|NCT03531905|58831239|FG001|Overall Study|Lost to Follow-up|2|||
30812182|NCT03531905|58831240|FG002|Overall Study|Lost to Follow-up|1|||
30812183|NCT03531905|58831238|FG000|Overall Study|Participant was out of town|1|||
30812184|NCT03531905|58831239|FG001|Overall Study|Participant was out of town|0|||
30812185|NCT03531905|58831240|FG002|Overall Study|Participant was out of town|0|||
30812186|NCT03531905|58831238|FG000|Overall Study|Could not speak with the participant|1|||
30812187|NCT03531905|58831239|FG001|Overall Study|Could not speak with the participant|0|||
30812188|NCT03531905|58831240|FG002|Overall Study|Could not speak with the participant|0|||
30812189|NCT03531827|58831250|FG000|Overall Study|Adverse Event|2|||
30910594|NCT01697800|58945547|FG000|Overall Study|Death|0|||
30910595|NCT01697800|58945548|FG001|Overall Study|Death|1|||
30812190|NCT03531827|58831251|FG001|Overall Study|Adverse Event|0|||
30812191|NCT03531827|58831250|FG000|Overall Study|Progressive disease|1|||
30812192|NCT03531827|58831251|FG001|Overall Study|Progressive disease|0|||
30812193|NCT03530345|58831280|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
30812194|NCT03530345|58831281|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
30812195|NCT03530345|58831280|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
30812196|NCT03530345|58831281|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
30812197|NCT03530345|58831280|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
30910596|NCT01644500|58945557|FG000|Overall Study|Adverse Event|6|||
30910597|NCT01644500|58945558|FG001|Overall Study|Adverse Event|1|||
30910598|NCT01644500|58945559|FG002|Overall Study|Adverse Event|2|||
30910599|NCT01644500|58945557|FG000|Overall Study|Death|0|||
30910600|NCT01644500|58945558|FG001|Overall Study|Death|1|||
30910601|NCT01644500|58945559|FG002|Overall Study|Death|0|||
30910602|NCT01644500|58945557|FG000|Overall Study|Lost to Follow-up|3|||
30910603|NCT01644500|58945558|FG001|Overall Study|Lost to Follow-up|8|||
30910604|NCT01644500|58945559|FG002|Overall Study|Lost to Follow-up|0|||
30910605|NCT01644500|58945557|FG000|Overall Study|Protocol Violation|1|||
30910606|NCT01644500|58945558|FG001|Overall Study|Protocol Violation|1|||
30910607|NCT01644500|58945559|FG002|Overall Study|Protocol Violation|0|||
30910608|NCT01644500|58945557|FG000|Overall Study|Withdrawal by Subject|11|||
30910609|NCT01644500|58945558|FG001|Overall Study|Withdrawal by Subject|12|||
30910610|NCT01644500|58945559|FG002|Overall Study|Withdrawal by Subject|12|||
30910611|NCT01644500|58945557|FG000|Overall Study|Physician Decision|1|||
30910612|NCT01644500|58945558|FG001|Overall Study|Physician Decision|1|||
30812198|NCT03530345|58831281|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
30812199|NCT03530345|58831280|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
30812200|NCT03530345|58831281|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
30812201|NCT03500159|58831295|FG000|Overall Study|Study Terminated|2|||
30812202|NCT03500159|58831296|FG001|Overall Study|Study Terminated|1|||
30910613|NCT01644500|58945559|FG002|Overall Study|Physician Decision|1|||
30910614|NCT01604824|58945571|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
30812203|NCT03785340|58831304|FG000|Overall Study|Lost to Follow-up|2|||
30812204|NCT03785340|58831305|FG001|Overall Study|Lost to Follow-up|0|||
30812205|NCT03785340|58831304|FG000|Overall Study|Adverse Event|1|||
30812206|NCT03785340|58831305|FG001|Overall Study|Adverse Event|0|||
30812207|NCT03499067|58831311|FG000|First Intervention|Physician Decision|2|||
30812208|NCT03499067|58831312|FG001|First Intervention|Physician Decision|1|||
30812209|NCT03499067|58831311|FG000|First Intervention|Withdrawal by Subject|3|||
30812210|NCT03499067|58831312|FG001|First Intervention|Withdrawal by Subject|6|||
30812211|NCT03562481|58831320|FG000|First Intervention|Lost to Follow-up|1|||
30812212|NCT03562481|58831321|FG001|First Intervention|Lost to Follow-up|0|||
30812213|NCT03529409|58831347|FG000|Randomized|Lost to Follow-up|0|||
30812214|NCT03529409|58831348|FG001|Randomized|Lost to Follow-up|0|||
30812215|NCT03529409|58831349|FG002|Randomized|Lost to Follow-up|4|||
30910615|NCT01604824|58945572|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
30910616|NCT01604824|58945573|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
30910617|NCT01604824|58945574|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
30910618|NCT01604824|58945575|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
30910619|NCT01604824|58945576|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
30910620|NCT01604824|58945571|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
30910621|NCT01604824|58945572|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
30910622|NCT01604824|58945573|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
30910623|NCT01604824|58945574|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
30910624|NCT01604824|58945575|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
30910625|NCT01604824|58945576|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
30910626|NCT01716052|58945590|FG000|Overall Study|Withdrawal of funding|1|||
30910627|NCT01716052|58945591|FG001|Overall Study|Withdrawal of funding|1|||
30910628|NCT01641692|58945597|FG000|Treatment Period 1|Adverse Event|1|||
30910629|NCT01641692|58945598|FG001|Treatment Period 1|Adverse Event|0|||
30910630|NCT01641692|58945599|FG002|Treatment Period 1|Adverse Event|0|||
30910631|NCT01641692|58945600|FG003|Treatment Period 1|Adverse Event|0|||
30910632|NCT01641692|58945601|FG004|Treatment Period 1|Adverse Event|0|||
30910633|NCT01641692|58945602|FG005|Treatment Period 1|Adverse Event|0|||
30910634|NCT01641692|58945603|FG006|Treatment Period 1|Adverse Event|0|||
30910635|NCT01641692|58945604|FG007|Treatment Period 1|Adverse Event|0|||
30910636|NCT01641692|58945597|FG000|Treatment Period 1|Lack of Efficacy|0|||
30910637|NCT01641692|58945598|FG001|Treatment Period 1|Lack of Efficacy|0|||
30910638|NCT01641692|58945599|FG002|Treatment Period 1|Lack of Efficacy|0|||
30910639|NCT01641692|58945600|FG003|Treatment Period 1|Lack of Efficacy|0|||
30910640|NCT01641692|58945601|FG004|Treatment Period 1|Lack of Efficacy|0|||
30910641|NCT01641692|58945602|FG005|Treatment Period 1|Lack of Efficacy|0|||
30910642|NCT01641692|58945603|FG006|Treatment Period 1|Lack of Efficacy|0|||
30910643|NCT01641692|58945604|FG007|Treatment Period 1|Lack of Efficacy|1|||
30910644|NCT01641692|58945597|FG000|Treatment Period 1|Protocol Violation|1|||
30910645|NCT01641692|58945598|FG001|Treatment Period 1|Protocol Violation|0|||
30910646|NCT01641692|58945599|FG002|Treatment Period 1|Protocol Violation|0|||
30910647|NCT01641692|58945600|FG003|Treatment Period 1|Protocol Violation|0|||
30910648|NCT01641692|58945601|FG004|Treatment Period 1|Protocol Violation|2|||
30910649|NCT01641692|58945602|FG005|Treatment Period 1|Protocol Violation|0|||
30910650|NCT01641692|58945603|FG006|Treatment Period 1|Protocol Violation|0|||
30910651|NCT01641692|58945604|FG007|Treatment Period 1|Protocol Violation|0|||
30910652|NCT01641692|58945597|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
30910653|NCT01641692|58945598|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
30910654|NCT01641692|58945599|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
30910655|NCT01641692|58945600|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
30910656|NCT01641692|58945601|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
30812216|NCT03529409|58831347|FG000|Randomized|Excluded|0|||
30812217|NCT03529409|58831348|FG001|Randomized|Excluded|0|||
30812218|NCT03529409|58831349|FG002|Randomized|Excluded|1|||
30910657|NCT01641692|58945602|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
30910658|NCT01641692|58945603|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
30812219|NCT03529409|58831347|FG000|Post-treatment Assessment|Death|1|||
30812220|NCT03529409|58831348|FG001|Post-treatment Assessment|Death|0|||
30812221|NCT03529409|58831349|FG002|Post-treatment Assessment|Death|0|||
30812222|NCT03529409|58831347|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
30812223|NCT03529409|58831348|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
30812224|NCT03529409|58831349|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
30812225|NCT03529409|58831347|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
30812226|NCT03529409|58831348|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
30812227|NCT03529409|58831349|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
30812228|NCT03529409|58831347|FG000|Follow-up Assessment|Death|1|||
30812229|NCT03529409|58831348|FG001|Follow-up Assessment|Death|0|||
30812230|NCT03529409|58831349|FG002|Follow-up Assessment|Death|0|||
30812231|NCT03529409|58831347|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
30812232|NCT03529409|58831348|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
30812233|NCT03529409|58831349|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
30750136|NCT00183170|58760035|FG001|Washout 1 Week|Did not complete study|8|||
30812234|NCT03498287|58831358|FG000|Overall Study|Withdrawal by Subject|3|||
30812235|NCT03498287|58831359|FG001|Overall Study|Withdrawal by Subject|0|||
30812236|NCT03498287|58831358|FG000|Overall Study|Protocol Violation|0|||
30812237|NCT03498287|58831359|FG001|Overall Study|Protocol Violation|4|||
30812238|NCT03498287|58831358|FG000|Overall Study|Adverse Event|0|||
30812239|NCT03498287|58831359|FG001|Overall Study|Adverse Event|1|||
30812240|NCT03497429|58831367|FG000|Overall Study|Progressive disease|3|||
30812241|NCT03497429|58831368|FG001|Overall Study|Progressive disease|4|||
30812242|NCT03497429|58831367|FG000|Overall Study|Adverse Event|0|||
30812243|NCT03497429|58831368|FG001|Overall Study|Adverse Event|2|||
30812244|NCT03497039|58831376|FG000|Overall Study|Withdrawal by Subject|1|||
30812245|NCT03497039|58831377|FG001|Overall Study|Withdrawal by Subject|0|||
30812246|NCT03497039|58831376|FG000|Overall Study|Protocol Violation|0|||
30812247|NCT03497039|58831377|FG001|Overall Study|Protocol Violation|1|||
30622562|NCT01175135|58634268|FG001|Overall Study|Death|0|||
30750137|NCT00183170|58760034|FG000|Second Intervention|Did not complete study|1|||
30750138|NCT00183170|58760035|FG001|Second Intervention|Did not complete study|0|||
30750139|NCT00183170|58760034|FG000|Second Intervention|Did not meet targeted BrAC|0|||
30750140|NCT00183170|58760035|FG001|Second Intervention|Did not meet targeted BrAC|2|||
30750141|NCT00230282|58760041|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
30750142|NCT00230282|58760041|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
30750143|NCT00230282|58760041|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
30750144|NCT00230282|58760041|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
30750145|NCT00261950|58760045|FG000|Overall Study|Lost to Follow-up|2|||
30750146|NCT00261950|58760045|FG000|Overall Study|Death|6|||
30750147|NCT00261950|58760045|FG000|Overall Study|Withdrawal by Subject|5|||
30750148|NCT00261950|58760045|FG000|Overall Study|Other|1|||
30750149|NCT00261950|58760045|FG000|Overall Study|Physician Decision|1|||
30750150|NCT00261950|58760045|FG000|Overall Study|Protocol specified Criteria|11|||
30750151|NCT00230048|58760051|FG000|Overall Study|Lost to Follow-up|13|||
30750152|NCT00230048|58760052|FG001|Overall Study|Lost to Follow-up|18|||
30750153|NCT00229658|58760062|FG000|Overall Study|Administrative|2|||
30750154|NCT00229658|58760063|FG001|Overall Study|Administrative|1|||
30750155|NCT00229658|58760062|FG000|Overall Study|Investigator decision|13|||
30812248|NCT03495869|58831396|FG000|Overall Study|Lost to Follow-up|4|||
30812249|NCT03495869|58831397|FG001|Overall Study|Lost to Follow-up|17|||
30812250|NCT03495869|58831398|FG002|Overall Study|Lost to Follow-up|8|||
30812251|NCT03495869|58831399|FG003|Overall Study|Lost to Follow-up|14|||
30812252|NCT03495869|58831396|FG000|Overall Study|Withdrawal by Subject|0|||
30812253|NCT03495869|58831397|FG001|Overall Study|Withdrawal by Subject|3|||
30812254|NCT03495869|58831398|FG002|Overall Study|Withdrawal by Subject|0|||
30812255|NCT03495869|58831399|FG003|Overall Study|Withdrawal by Subject|3|||
30812256|NCT03495869|58831396|FG000|Overall Study|Dropped from study|0|||
30812257|NCT03495869|58831397|FG001|Overall Study|Dropped from study|7|||
30812258|NCT03495869|58831398|FG002|Overall Study|Dropped from study|2|||
30812259|NCT03495869|58831399|FG003|Overall Study|Dropped from study|4|||
30812260|NCT03071094|58831420|FG000|Overall Study|Death|1|||
30812261|NCT03071094|58831421|FG001|Overall Study|Death|1|||
30812262|NCT03071094|58831420|FG000|Overall Study|Adverse Event|1|||
30812263|NCT03071094|58831421|FG001|Overall Study|Adverse Event|0|||
30812264|NCT03559517|58831430|FG000|Overall Study|Withdrawal by Subject|1|||
30812265|NCT03559517|58831431|FG001|Overall Study|Withdrawal by Subject|0|||
30812266|NCT03559517|58831432|FG002|Overall Study|Withdrawal by Subject|0|||
30812267|NCT02509494|58831449|FG000|Overall Study|Lost to Follow-up|8|||
30812268|NCT02509494|58831450|FG001|Overall Study|Lost to Follow-up|47|||
30812269|NCT02509494|58831451|FG002|Overall Study|Lost to Follow-up|19|||
30812270|NCT02509494|58831452|FG003|Overall Study|Lost to Follow-up|6|||
30812271|NCT02509494|58831453|FG004|Overall Study|Lost to Follow-up|3|||
30812272|NCT02509494|58831454|FG005|Overall Study|Lost to Follow-up|3|||
30812273|NCT02509494|58831455|FG006|Overall Study|Lost to Follow-up|1|||
30812274|NCT02509494|58831456|FG007|Overall Study|Lost to Follow-up|3|||
30812275|NCT02509494|58831457|FG008|Overall Study|Lost to Follow-up|1|||
30812276|NCT02509494|58831449|FG000|Overall Study|Physician Decision|2|||
30812277|NCT02509494|58831450|FG001|Overall Study|Physician Decision|1|||
30812278|NCT02509494|58831451|FG002|Overall Study|Physician Decision|0|||
30750156|NCT00229658|58760063|FG001|Overall Study|Investigator decision|10|||
30812279|NCT02509494|58831452|FG003|Overall Study|Physician Decision|0|||
30812280|NCT02509494|58831453|FG004|Overall Study|Physician Decision|0|||
30812281|NCT02509494|58831454|FG005|Overall Study|Physician Decision|0|||
30812282|NCT02509494|58831455|FG006|Overall Study|Physician Decision|0|||
30812283|NCT02509494|58831456|FG007|Overall Study|Physician Decision|0|||
30910659|NCT01641692|58945604|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
30910660|NCT01641692|58945597|FG000|Treatment Period 1|Lost to Follow-up|0|||
30910661|NCT01641692|58945598|FG001|Treatment Period 1|Lost to Follow-up|0|||
30750157|NCT00229658|58760062|FG000|Overall Study|Other|80|||
30750158|NCT00229658|58760063|FG001|Overall Study|Other|60|||
30750159|NCT00229658|58760062|FG000|Overall Study|Lost to Follow-up|82|||
30750160|NCT00229658|58760063|FG001|Overall Study|Lost to Follow-up|55|||
30750161|NCT00229658|58760062|FG000|Overall Study|Serious Adverse Event|2|||
30750162|NCT00229658|58760063|FG001|Overall Study|Serious Adverse Event|2|||
30750163|NCT00229658|58760062|FG000|Overall Study|Withdrawal of consent|46|||
30750164|NCT00229658|58760063|FG001|Overall Study|Withdrawal of consent|39|||
30750165|NCT00182078|58760071|FG000|Overall Study|Withdrawal by Subject|1|||
30750166|NCT00182078|58760072|FG001|Overall Study|Withdrawal by Subject|0|||
30750167|NCT00181844|58760078|FG000|Signed Consent|Withdrawal by Subject|5|||
30750168|NCT00181844|58760078|FG000|Signed Consent|Did not meet entrance criteria|7|||
30910662|NCT01641692|58945599|FG002|Treatment Period 1|Lost to Follow-up|1|||
30910663|NCT01641692|58945600|FG003|Treatment Period 1|Lost to Follow-up|0|||
30910664|NCT01641692|58945601|FG004|Treatment Period 1|Lost to Follow-up|0|||
30910665|NCT01641692|58945602|FG005|Treatment Period 1|Lost to Follow-up|0|||
30910666|NCT01641692|58945603|FG006|Treatment Period 1|Lost to Follow-up|0|||
30910667|NCT01641692|58945604|FG007|Treatment Period 1|Lost to Follow-up|0|||
30910668|NCT01641692|58945597|FG000|Treatment Period 1|Physician Decision|0|||
30750169|NCT00181844|58760078|FG000|Exposed to Study Medication|Adverse Event|10|||
30812284|NCT02509494|58831457|FG008|Overall Study|Physician Decision|0|||
30812285|NCT02509494|58831449|FG000|Overall Study|Withdrawal by Subject|4|||
30812286|NCT02509494|58831450|FG001|Overall Study|Withdrawal by Subject|17|||
30812287|NCT02509494|58831451|FG002|Overall Study|Withdrawal by Subject|7|||
30812288|NCT02509494|58831452|FG003|Overall Study|Withdrawal by Subject|5|||
30812289|NCT02509494|58831453|FG004|Overall Study|Withdrawal by Subject|0|||
30812290|NCT02509494|58831454|FG005|Overall Study|Withdrawal by Subject|6|||
30812291|NCT02509494|58831455|FG006|Overall Study|Withdrawal by Subject|1|||
30812292|NCT02509494|58831456|FG007|Overall Study|Withdrawal by Subject|2|||
30812293|NCT02509494|58831457|FG008|Overall Study|Withdrawal by Subject|1|||
30812294|NCT02509494|58831449|FG000|Overall Study|Death|0|||
30812295|NCT02509494|58831450|FG001|Overall Study|Death|1|||
30812296|NCT02509494|58831451|FG002|Overall Study|Death|0|||
30812297|NCT02509494|58831452|FG003|Overall Study|Death|0|||
30812298|NCT02509494|58831453|FG004|Overall Study|Death|1|||
30812299|NCT02509494|58831454|FG005|Overall Study|Death|0|||
30812300|NCT02509494|58831455|FG006|Overall Study|Death|0|||
30812301|NCT02509494|58831456|FG007|Overall Study|Death|1|||
30812302|NCT02509494|58831457|FG008|Overall Study|Death|0|||
30812303|NCT02509494|58831449|FG000|Overall Study|Other|0|||
30812304|NCT02509494|58831450|FG001|Overall Study|Other|4|||
30812305|NCT02509494|58831451|FG002|Overall Study|Other|5|||
30812306|NCT02509494|58831452|FG003|Overall Study|Other|0|||
30812307|NCT02509494|58831453|FG004|Overall Study|Other|0|||
30812308|NCT02509494|58831454|FG005|Overall Study|Other|0|||
30812309|NCT02509494|58831455|FG006|Overall Study|Other|0|||
30812310|NCT02509494|58831456|FG007|Overall Study|Other|0|||
30812311|NCT02509494|58831457|FG008|Overall Study|Other|0|||
30812312|NCT02509494|58831449|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30812313|NCT02509494|58831450|FG001|Overall Study|Non-Compliance With Study Drug|11|||
30812314|NCT02509494|58831451|FG002|Overall Study|Non-Compliance With Study Drug|7|||
30812315|NCT02509494|58831452|FG003|Overall Study|Non-Compliance With Study Drug|0|||
30812316|NCT02509494|58831453|FG004|Overall Study|Non-Compliance With Study Drug|1|||
30812317|NCT02509494|58831454|FG005|Overall Study|Non-Compliance With Study Drug|2|||
30812318|NCT02509494|58831455|FG006|Overall Study|Non-Compliance With Study Drug|1|||
30812319|NCT02509494|58831456|FG007|Overall Study|Non-Compliance With Study Drug|1|||
30812320|NCT02509494|58831457|FG008|Overall Study|Non-Compliance With Study Drug|0|||
30812321|NCT03493451|58831494|FG000|Overall Study|Death|11|||
30812322|NCT03493451|58831495|FG001|Overall Study|Death|26|||
30812323|NCT03493451|58831496|FG002|Overall Study|Death|3|||
30812324|NCT03493451|58831494|FG000|Overall Study|Lost to Follow-up|1|||
30812325|NCT03493451|58831495|FG001|Overall Study|Lost to Follow-up|4|||
30812326|NCT03493451|58831496|FG002|Overall Study|Lost to Follow-up|1|||
30812327|NCT03493451|58831494|FG000|Overall Study|Withdrawal by Subject|1|||
30812328|NCT03493451|58831495|FG001|Overall Study|Withdrawal by Subject|1|||
30812329|NCT03493451|58831496|FG002|Overall Study|Withdrawal by Subject|2|||
30812330|NCT03493451|58831494|FG000|Overall Study|Progressive Disease|1|||
30812331|NCT03493451|58831495|FG001|Overall Study|Progressive Disease|0|||
30812332|NCT03493451|58831496|FG002|Overall Study|Progressive Disease|0|||
30812333|NCT03493451|58831494|FG000|Overall Study|Transferred to long term extension study|8|||
30812334|NCT03493451|58831495|FG001|Overall Study|Transferred to long term extension study|13|||
30812335|NCT03493451|58831496|FG002|Overall Study|Transferred to long term extension study|5|||
30812336|NCT03492281|58831507|FG000|Overall Study|Withdrawal by Subject|21|||
30812337|NCT03492281|58831508|FG001|Overall Study|Withdrawal by Subject|14|||
30812338|NCT03492281|58831509|FG002|Overall Study|Withdrawal by Subject|13|||
30812339|NCT03492281|58831507|FG000|Overall Study|Lost to Follow-up|14|||
30812340|NCT03492281|58831508|FG001|Overall Study|Lost to Follow-up|15|||
30812341|NCT03492281|58831509|FG002|Overall Study|Lost to Follow-up|10|||
30910669|NCT01641692|58945598|FG001|Treatment Period 1|Physician Decision|0|||
30910670|NCT01641692|58945599|FG002|Treatment Period 1|Physician Decision|0|||
30910671|NCT01641692|58945600|FG003|Treatment Period 1|Physician Decision|0|||
30910672|NCT01641692|58945601|FG004|Treatment Period 1|Physician Decision|1|||
30910673|NCT01641692|58945602|FG005|Treatment Period 1|Physician Decision|0|||
30910674|NCT01641692|58945603|FG006|Treatment Period 1|Physician Decision|0|||
30910675|NCT01641692|58945604|FG007|Treatment Period 1|Physician Decision|0|||
30910676|NCT01641692|58945597|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30910677|NCT01641692|58945598|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30910678|NCT01641692|58945599|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30910679|NCT01641692|58945600|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30910680|NCT01641692|58945601|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30910681|NCT01641692|58945602|FG005|Treatment Period 1|Withdrawal by Subject|2|||
30910682|NCT01641692|58945603|FG006|Treatment Period 1|Withdrawal by Subject|0|||
30910683|NCT01641692|58945604|FG007|Treatment Period 1|Withdrawal by Subject|1|||
30910684|NCT01641692|58945597|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
30910685|NCT01641692|58945598|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
30622563|NCT01175135|58634269|FG002|Overall Study|Death|0|||
30812342|NCT03492281|58831507|FG000|Overall Study|Adverse Event|6|||
30812343|NCT03492281|58831508|FG001|Overall Study|Adverse Event|8|||
30812344|NCT03492281|58831509|FG002|Overall Study|Adverse Event|13|||
30812345|NCT03492281|58831507|FG000|Overall Study|Lack of Efficacy|3|||
30812346|NCT03492281|58831508|FG001|Overall Study|Lack of Efficacy|0|||
30812347|NCT03492281|58831509|FG002|Overall Study|Lack of Efficacy|1|||
30812348|NCT03492281|58831507|FG000|Overall Study|Physician Decision|1|||
30812349|NCT03492281|58831508|FG001|Overall Study|Physician Decision|0|||
30812350|NCT03492281|58831509|FG002|Overall Study|Physician Decision|3|||
30812351|NCT03492281|58831507|FG000|Overall Study|Protocol Violation|0|||
30812352|NCT03492281|58831508|FG001|Overall Study|Protocol Violation|2|||
30812353|NCT03492281|58831509|FG002|Overall Study|Protocol Violation|1|||
30812354|NCT03492281|58831507|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
30812355|NCT03492281|58831508|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
30812356|NCT03492281|58831509|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
30812357|NCT03492281|58831507|FG000|Overall Study|Death|0|||
30812358|NCT03492281|58831508|FG001|Overall Study|Death|0|||
30812359|NCT03492281|58831509|FG002|Overall Study|Death|1|||
30812360|NCT03492281|58831507|FG000|Overall Study|Captured as Other in Database|8|||
30812361|NCT03492281|58831508|FG001|Overall Study|Captured as Other in Database|6|||
30812362|NCT03492281|58831509|FG002|Overall Study|Captured as Other in Database|3|||
30812363|NCT03070782|58831526|FG000|Overall Study|Adverse Event|3|||
30812364|NCT03070782|58831527|FG001|Overall Study|Adverse Event|0|||
30812365|NCT03070782|58831528|FG002|Overall Study|Adverse Event|3|||
30812366|NCT03070782|58831529|FG003|Overall Study|Adverse Event|1|||
30622564|NCT01175135|58634270|FG003|Overall Study|Death|0|||
30910686|NCT01641692|58945599|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
30910687|NCT01641692|58945600|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
30910688|NCT01641692|58945601|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
30812367|NCT03070782|58831530|FG004|Overall Study|Adverse Event|6|||
30812368|NCT03070782|58831531|FG005|Overall Study|Adverse Event|2|||
30812369|NCT03070782|58831526|FG000|Overall Study|Withdrawal by Subject|2|||
30812370|NCT03070782|58831527|FG001|Overall Study|Withdrawal by Subject|1|||
30812371|NCT03070782|58831528|FG002|Overall Study|Withdrawal by Subject|1|||
30812372|NCT03070782|58831529|FG003|Overall Study|Withdrawal by Subject|0|||
30812373|NCT03070782|58831530|FG004|Overall Study|Withdrawal by Subject|4|||
30812374|NCT03070782|58831531|FG005|Overall Study|Withdrawal by Subject|3|||
30812375|NCT03070782|58831526|FG000|Overall Study|Reason Not Specified|2|||
30812376|NCT03070782|58831527|FG001|Overall Study|Reason Not Specified|0|||
30812377|NCT03070782|58831528|FG002|Overall Study|Reason Not Specified|0|||
30812378|NCT03070782|58831529|FG003|Overall Study|Reason Not Specified|1|||
30812379|NCT03070782|58831530|FG004|Overall Study|Reason Not Specified|2|||
30812380|NCT03070782|58831531|FG005|Overall Study|Reason Not Specified|1|||
30812381|NCT03070782|58831526|FG000|Overall Study|Ineligibility|0|||
30812382|NCT03070782|58831527|FG001|Overall Study|Ineligibility|0|||
30812383|NCT03070782|58831528|FG002|Overall Study|Ineligibility|0|||
30812384|NCT03070782|58831529|FG003|Overall Study|Ineligibility|1|||
30812385|NCT03070782|58831530|FG004|Overall Study|Ineligibility|0|||
30812386|NCT03070782|58831531|FG005|Overall Study|Ineligibility|1|||
30812387|NCT03070782|58831526|FG000|Overall Study|Pregnancy|0|||
30812388|NCT03070782|58831527|FG001|Overall Study|Pregnancy|0|||
30812389|NCT03070782|58831528|FG002|Overall Study|Pregnancy|0|||
30812390|NCT03070782|58831529|FG003|Overall Study|Pregnancy|1|||
30812391|NCT03070782|58831530|FG004|Overall Study|Pregnancy|0|||
30812392|NCT03070782|58831531|FG005|Overall Study|Pregnancy|0|||
30812393|NCT03070782|58831526|FG000|Overall Study|Investigator Judgement|0|||
30812394|NCT03070782|58831527|FG001|Overall Study|Investigator Judgement|0|||
30812395|NCT03070782|58831528|FG002|Overall Study|Investigator Judgement|0|||
30812396|NCT03070782|58831529|FG003|Overall Study|Investigator Judgement|1|||
30812397|NCT03070782|58831530|FG004|Overall Study|Investigator Judgement|0|||
30812398|NCT03070782|58831531|FG005|Overall Study|Investigator Judgement|0|||
30812399|NCT03525119|58831567|FG000|Overall Study|Adverse Event|0|||
30812400|NCT03525119|58831568|FG001|Overall Study|Adverse Event|1|||
30812401|NCT03525119|58831569|FG002|Overall Study|Adverse Event|0|||
30812402|NCT03525119|58831567|FG000|Overall Study|Lost to Follow-up|32|||
30812403|NCT03525119|58831568|FG001|Overall Study|Lost to Follow-up|33|||
30812404|NCT03525119|58831569|FG002|Overall Study|Lost to Follow-up|37|||
30812405|NCT03525119|58831567|FG000|Overall Study|Withdrawal by Subject|5|||
30812406|NCT03525119|58831568|FG001|Overall Study|Withdrawal by Subject|4|||
30812407|NCT03525119|58831569|FG002|Overall Study|Withdrawal by Subject|2|||
30812408|NCT03525119|58831567|FG000|Overall Study|Reason not Specified|2|||
30812409|NCT03525119|58831568|FG001|Overall Study|Reason not Specified|1|||
30910689|NCT01641692|58945602|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
30910690|NCT01641692|58945603|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
30910691|NCT01641692|58945604|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
30910692|NCT01641692|58945597|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
30750170|NCT00181844|58760078|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
30750171|NCT00181844|58760078|FG000|Exposed to Study Medication|Non-compliance|2|||
30750172|NCT00181844|58760078|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
30750173|NCT00181844|58760078|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
30750174|NCT00181766|58760082|FG000|Overall Study|Lost to Follow-up|6|||
30750175|NCT00181766|58760082|FG000|Overall Study|Adverse Event|4|||
30750176|NCT00181766|58760082|FG000|Overall Study|non-compliance|2|||
30750177|NCT00180674|58760086|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
30750178|NCT00180674|58760086|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
30750179|NCT00076024|58760097|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
30750180|NCT00076024|58760098|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
30750181|NCT00076024|58760099|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
30750182|NCT00076024|58760100|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
30750183|NCT00076024|58760097|FG000|Phase 1, Lead-in|Adverse Event|1|||
30750184|NCT00076024|58760098|FG001|Phase 1, Lead-in|Adverse Event|0|||
30750185|NCT00076024|58760099|FG002|Phase 1, Lead-in|Adverse Event|0|||
30750186|NCT00076024|58760100|FG003|Phase 1, Lead-in|Adverse Event|0|||
30750187|NCT00076024|58760097|FG000|Phase 1, Lead-in|Clinical progression|1|||
30750188|NCT00076024|58760098|FG001|Phase 1, Lead-in|Clinical progression|0|||
30750189|NCT00076024|58760099|FG002|Phase 1, Lead-in|Clinical progression|0|||
30750190|NCT00076024|58760100|FG003|Phase 1, Lead-in|Clinical progression|0|||
30812410|NCT03525119|58831569|FG002|Overall Study|Reason not Specified|2|||
30812411|NCT03525119|58831567|FG000|Overall Study|Randomized but not Vaccinated|1|||
30812412|NCT03525119|58831568|FG001|Overall Study|Randomized but not Vaccinated|0|||
30812413|NCT03525119|58831569|FG002|Overall Study|Randomized but not Vaccinated|2|||
30812414|NCT03558503|58831577|FG000|Overall Study|Adverse Event|1|||
30812415|NCT03558503|58831577|FG000|Overall Study|Death|1|||
30812416|NCT03558503|58831577|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
30812417|NCT03489863|58831583|FG000|Overall Study|Withdrawal by Subject|0|||
30812418|NCT03489863|58831584|FG001|Overall Study|Withdrawal by Subject|1|||
30812419|NCT03489551|58831590|FG000|Overall Study|Withdrawal by Subject|2|||
30812420|NCT03557801|58831597|FG000|Overall Study|Protocol Violation|1|||
30812421|NCT03557801|58831598|FG001|Overall Study|Protocol Violation|0|||
30812422|NCT03557801|58831599|FG002|Overall Study|Protocol Violation|0|||
30812423|NCT03557801|58831597|FG000|Overall Study|Withdrawal by Subject|1|||
30812424|NCT03557801|58831598|FG001|Overall Study|Withdrawal by Subject|0|||
30812425|NCT03557801|58831599|FG002|Overall Study|Withdrawal by Subject|3|||
30910693|NCT01641692|58945598|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
30910694|NCT01641692|58945599|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
30812426|NCT03557801|58831597|FG000|Overall Study|Lost to Follow-up|0|||
30812427|NCT03557801|58831598|FG001|Overall Study|Lost to Follow-up|1|||
30812428|NCT03557801|58831599|FG002|Overall Study|Lost to Follow-up|0|||
30812429|NCT04210180|58831607|FG000|Overall Study|Withdrawal by Subject|2|||
30812430|NCT03523871|58831611|FG000|Overall Study|Death|1|||
30812431|NCT03523715|58831617|FG000|Overall Study|Lost to Follow-up|11|||
30812432|NCT03523715|58831618|FG001|Overall Study|Lost to Follow-up|14|||
30812433|NCT03523715|58831617|FG000|Overall Study|Did not meet inclusion criteria|1|||
30812434|NCT03523715|58831618|FG001|Overall Study|Did not meet inclusion criteria|0|||
30812435|NCT03523715|58831617|FG000|Overall Study|Internally inconsistent reporting|0|||
30812436|NCT03523715|58831618|FG001|Overall Study|Internally inconsistent reporting|2|||
30812437|NCT03980730|58831626|FG000|Overall Study|Study Terminated by Sponsor|0|||
30812438|NCT03980730|58831627|FG001|Overall Study|Study Terminated by Sponsor|3|||
30812439|NCT03980730|58831626|FG000|Overall Study|Adverse Event|2|||
30812440|NCT03980730|58831627|FG001|Overall Study|Adverse Event|0|||
30812441|NCT03980730|58831626|FG000|Overall Study|Sponsor Request|0|||
30812442|NCT03980730|58831627|FG001|Overall Study|Sponsor Request|1|||
30812443|NCT03523091|58831635|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
30812444|NCT03523091|58831636|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
30812445|NCT03523091|58831635|FG000|Overall Study|Withdrawal by Subject|0|||
30812446|NCT03523091|58831636|FG001|Overall Study|Withdrawal by Subject|3|||
30812447|NCT03523091|58831635|FG000|Overall Study|Increase Botox dose|0|||
30812448|NCT03523091|58831636|FG001|Overall Study|Increase Botox dose|1|||
30812449|NCT03438383|58831657|FG000|Overall Study|Protocol Violation|9|||
30812450|NCT03438383|58831658|FG001|Overall Study|Protocol Violation|3|||
30812451|NCT03478787|58831666|FG000|Overall Study|Adverse Event|5|||
30812452|NCT03478787|58831667|FG001|Overall Study|Adverse Event|1|||
30812453|NCT03478787|58831666|FG000|Overall Study|Protocol Violation|3|||
30812454|NCT03478787|58831667|FG001|Overall Study|Protocol Violation|0|||
30812455|NCT03478787|58831666|FG000|Overall Study|Lack of Efficacy|7|||
30812456|NCT03478787|58831667|FG001|Overall Study|Lack of Efficacy|1|||
30812457|NCT03478787|58831666|FG000|Overall Study|Lost to Follow-up|9|||
30812458|NCT03478787|58831667|FG001|Overall Study|Lost to Follow-up|5|||
30812459|NCT03478787|58831666|FG000|Overall Study|Withdrawal by Subject|2|||
30812460|NCT03478787|58831667|FG001|Overall Study|Withdrawal by Subject|6|||
30812461|NCT03478787|58831666|FG000|Overall Study|Other, Not Specified|3|||
30812462|NCT03478787|58831667|FG001|Overall Study|Other, Not Specified|0|||
30812463|NCT03488927|58831676|FG000|Overall Study|Withdrawal by Subject|44|||
30910695|NCT01641692|58945600|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
30910696|NCT01641692|58945601|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
30812464|NCT03488927|58831677|FG001|Overall Study|Withdrawal by Subject|118|||
30812465|NCT03488927|58831678|FG002|Overall Study|Withdrawal by Subject|217|||
30812466|NCT03488225|58831686|FG000|Overall Study|Off Protocol Therapy|2|||
30812467|NCT03488225|58831686|FG000|Overall Study|Stem Cell Transplant|2|||
30812468|NCT03437447|58831693|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30812469|NCT03437447|58831694|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30812470|NCT03437447|58831695|FG002|Treatment Period 1|Withdrawal by Subject|1|||
30812471|NCT03487445|58831718|FG000|Randomization|Not treated for administrative reasons|1|||
30812472|NCT03487445|58831719|FG001|Randomization|Not treated for administrative reasons|0|||
30812473|NCT02109172|58831725|FG000|Overall Study|Withdrawal by Subject|1|||
30812474|NCT02109172|58831726|FG001|Overall Study|Withdrawal by Subject|0|||
30812475|NCT02109172|58831727|FG002|Overall Study|Withdrawal by Subject|0|||
30812476|NCT02109172|58831728|FG003|Overall Study|Withdrawal by Subject|1|||
30812477|NCT02109172|58831729|FG004|Overall Study|Withdrawal by Subject|0|||
30812478|NCT02109172|58831730|FG005|Overall Study|Withdrawal by Subject|0|||
30812479|NCT02109172|58831725|FG000|Overall Study|Adverse Event|0|||
30812480|NCT02109172|58831726|FG001|Overall Study|Adverse Event|0|||
30812481|NCT02109172|58831727|FG002|Overall Study|Adverse Event|1|||
30812482|NCT02109172|58831728|FG003|Overall Study|Adverse Event|0|||
30812483|NCT02109172|58831729|FG004|Overall Study|Adverse Event|0|||
30812484|NCT02109172|58831730|FG005|Overall Study|Adverse Event|1|||
30812485|NCT02109172|58831725|FG000|Overall Study|Death|0|||
30812486|NCT02109172|58831726|FG001|Overall Study|Death|0|||
30812487|NCT02109172|58831727|FG002|Overall Study|Death|0|||
30910697|NCT01641692|58945602|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
30812488|NCT02109172|58831728|FG003|Overall Study|Death|0|||
30812489|NCT02109172|58831729|FG004|Overall Study|Death|1|||
30812490|NCT02109172|58831730|FG005|Overall Study|Death|0|||
30812491|NCT02974868|58831741|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
30812492|NCT02974868|58831742|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
30812493|NCT02974868|58831743|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
30812494|NCT02974868|58831744|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
30812495|NCT02974868|58831741|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
30812496|NCT02974868|58831742|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
30910698|NCT01641692|58945603|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
30910699|NCT01641692|58945604|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
30910700|NCT01641692|58945597|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
30910701|NCT01641692|58945598|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
30910702|NCT01641692|58945599|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
30910703|NCT01641692|58945600|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
30910704|NCT01641692|58945601|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
30910705|NCT01641692|58945602|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
30750191|NCT00076024|58760097|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
30750192|NCT00076024|58760098|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
30750193|NCT00076024|58760099|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
30750194|NCT00076024|58760100|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
30750195|NCT00076024|58760097|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
30750196|NCT00076024|58760098|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
30750197|NCT00076024|58760099|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
30750198|NCT00076024|58760100|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
30750199|NCT00076024|58760097|FG000|Phase 2, Double-blind|Adverse Event|0|||
30750200|NCT00076024|58760098|FG001|Phase 2, Double-blind|Adverse Event|25|||
30750201|NCT00076024|58760099|FG002|Phase 2, Double-blind|Adverse Event|6|||
30750202|NCT00076024|58760100|FG003|Phase 2, Double-blind|Adverse Event|0|||
30750203|NCT00076024|58760097|FG000|Phase 2, Double-blind|Un-specified|0|||
30750204|NCT00076024|58760098|FG001|Phase 2, Double-blind|Un-specified|14|||
30750205|NCT00076024|58760099|FG002|Phase 2, Double-blind|Un-specified|6|||
30750206|NCT00076024|58760100|FG003|Phase 2, Double-blind|Un-specified|0|||
30750207|NCT00076024|58760097|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
30750208|NCT00076024|58760098|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
30812497|NCT02974868|58831743|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
30812498|NCT02974868|58831744|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
30812499|NCT02974868|58831741|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
30812500|NCT02974868|58831742|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
30812501|NCT02974868|58831743|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
30812502|NCT02974868|58831744|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
30812503|NCT02974868|58831741|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
30812504|NCT02974868|58831742|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
30812505|NCT02974868|58831743|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
30812506|NCT02974868|58831744|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
30910706|NCT01641692|58945603|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
30812507|NCT03486899|58831789|FG000|Overall Study|Lost to Follow-up|4|||
30812508|NCT03486899|58831790|FG001|Overall Study|Lost to Follow-up|1|||
30812509|NCT03486899|58831791|FG002|Overall Study|Lost to Follow-up|4|||
30812510|NCT03486899|58831792|FG003|Overall Study|Lost to Follow-up|3|||
30812511|NCT03486899|58831789|FG000|Overall Study|Death|1|||
30812512|NCT03486899|58831790|FG001|Overall Study|Death|0|||
30812513|NCT03486899|58831791|FG002|Overall Study|Death|0|||
30812514|NCT03486899|58831792|FG003|Overall Study|Death|1|||
30812515|NCT03486899|58831789|FG000|Overall Study|Adverse Event|0|||
30812516|NCT03486899|58831790|FG001|Overall Study|Adverse Event|2|||
30812517|NCT03486899|58831791|FG002|Overall Study|Adverse Event|0|||
30812518|NCT03486899|58831792|FG003|Overall Study|Adverse Event|2|||
30812519|NCT03486899|58831789|FG000|Overall Study|Withdrawal by Subject|3|||
30812520|NCT03486899|58831790|FG001|Overall Study|Withdrawal by Subject|7|||
30812521|NCT03486899|58831791|FG002|Overall Study|Withdrawal by Subject|4|||
30812522|NCT03486899|58831792|FG003|Overall Study|Withdrawal by Subject|3|||
30812523|NCT03486899|58831789|FG000|Overall Study|Other Reasons|0|||
30812524|NCT03486899|58831790|FG001|Overall Study|Other Reasons|1|||
30812525|NCT03486899|58831791|FG002|Overall Study|Other Reasons|0|||
30812526|NCT03486899|58831792|FG003|Overall Study|Other Reasons|1|||
30812527|NCT02918552|58831804|FG000|Overall Study|Failed Pharmacokinetics|1|||
30812528|NCT02918552|58831805|FG001|Overall Study|Failed Pharmacokinetics|0|||
30812529|NCT02918552|58831804|FG000|Overall Study|Withdrawal by Subject|0|||
30812530|NCT02918552|58831805|FG001|Overall Study|Withdrawal by Subject|1|||
30812531|NCT02918552|58831804|FG000|Overall Study|Lost to Follow-up|0|||
30812532|NCT02918552|58831805|FG001|Overall Study|Lost to Follow-up|1|||
30812533|NCT03485495|58831813|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
30812534|NCT03485495|58831814|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
30812535|NCT01065818|58831820|FG000|Overall Study|Withdrawal by Subject|1|||
30812536|NCT01065818|58831820|FG000|Overall Study|Not a candidate for surgery|1|||
30910707|NCT01641692|58945604|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
30910708|NCT01641692|58945597|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
30910709|NCT01641692|58945598|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
30910710|NCT01641692|58945599|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
30910711|NCT01641692|58945600|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
30622565|NCT01175135|58634267|FG000|Overall Study|Lack of Efficacy|4|||
30812537|NCT03483623|58831824|FG000|Overall Study|43 complete sets achieved|1|||
30812538|NCT02318277|58831836|FG000|Overall Study|Physician Decision|0|||
30812539|NCT02318277|58831837|FG001|Overall Study|Physician Decision|0|||
30812540|NCT02318277|58831838|FG002|Overall Study|Physician Decision|0|||
30812541|NCT02318277|58831839|FG003|Overall Study|Physician Decision|0|||
30812542|NCT02318277|58831840|FG004|Overall Study|Physician Decision|0|||
30910712|NCT01641692|58945601|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
30910713|NCT01641692|58945602|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
30910714|NCT01641692|58945603|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
30750209|NCT00076024|58760099|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
30750210|NCT00076024|58760100|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
30750211|NCT00076024|58760097|FG000|Phase 2, Open-label|Adverse Event|0|||
30750212|NCT00076024|58760098|FG001|Phase 2, Open-label|Adverse Event|0|||
30750213|NCT00076024|58760099|FG002|Phase 2, Open-label|Adverse Event|0|||
30750214|NCT00076024|58760100|FG003|Phase 2, Open-label|Adverse Event|2|||
30750215|NCT00076024|58760097|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
30750216|NCT00076024|58760098|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
30622566|NCT01175135|58634268|FG001|Overall Study|Lack of Efficacy|5|||
30622567|NCT01175135|58634269|FG002|Overall Study|Lack of Efficacy|0|||
30750217|NCT00076024|58760099|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
30750218|NCT00076024|58760100|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
30750219|NCT00076024|58760097|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
30750220|NCT00076024|58760098|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
30750221|NCT00076024|58760099|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
30750222|NCT00076024|58760100|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
30750223|NCT00076024|58760097|FG000|Phase 2, Open-label|Other|0|||
30750224|NCT00076024|58760098|FG001|Phase 2, Open-label|Other|0|||
30750225|NCT00076024|58760099|FG002|Phase 2, Open-label|Other|0|||
30750226|NCT00076024|58760100|FG003|Phase 2, Open-label|Other|2|||
30750227|NCT00075478|58760111|FG000|Overall Study|not eligible|1|||
30750228|NCT00075478|58760112|FG001|Overall Study|not eligible|0|||
30750229|NCT00075478|58760111|FG000|Overall Study|Physician Decision|0|||
30750230|NCT00075478|58760112|FG001|Overall Study|Physician Decision|1|||
30750231|NCT00175916|58760118|FG000|Overall Study|Death|19|||
30750232|NCT00175916|58760118|FG000|Overall Study|Adverse Event|81|||
30750233|NCT00175916|58760118|FG000|Overall Study|Lack of Efficacy|354|||
30750234|NCT00175916|58760118|FG000|Overall Study|Lost to Follow-up|17|||
30750235|NCT00175916|58760118|FG000|Overall Study|Subject Choice|98|||
30750236|NCT00175916|58760118|FG000|Overall Study|Lack of compliance|8|||
30910715|NCT01641692|58945604|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
30910716|NCT01641692|58945597|FG000|Treatment Period 2|Lack of Efficacy|1|||
30812543|NCT02318277|58831841|FG005|Overall Study|Physician Decision|0|||
30812544|NCT02318277|58831842|FG006|Overall Study|Physician Decision|0|||
30812545|NCT02318277|58831843|FG007|Overall Study|Physician Decision|1|||
30812546|NCT02318277|58831836|FG000|Overall Study|Other|0|||
30812547|NCT02318277|58831837|FG001|Overall Study|Other|0|||
30812548|NCT02318277|58831838|FG002|Overall Study|Other|0|||
30812549|NCT02318277|58831839|FG003|Overall Study|Other|0|||
30812550|NCT02318277|58831840|FG004|Overall Study|Other|0|||
30812551|NCT02318277|58831841|FG005|Overall Study|Other|0|||
30812552|NCT02318277|58831842|FG006|Overall Study|Other|1|||
30812553|NCT02318277|58831843|FG007|Overall Study|Other|0|||
30812554|NCT02318277|58831836|FG000|Overall Study|Withdrawal by Subject|0|||
30812555|NCT02318277|58831837|FG001|Overall Study|Withdrawal by Subject|0|||
30812556|NCT02318277|58831838|FG002|Overall Study|Withdrawal by Subject|1|||
30812557|NCT02318277|58831839|FG003|Overall Study|Withdrawal by Subject|0|||
30812558|NCT02318277|58831840|FG004|Overall Study|Withdrawal by Subject|1|||
30812559|NCT02318277|58831841|FG005|Overall Study|Withdrawal by Subject|1|||
30812560|NCT02318277|58831842|FG006|Overall Study|Withdrawal by Subject|6|||
30812561|NCT02318277|58831843|FG007|Overall Study|Withdrawal by Subject|14|||
30812562|NCT02318277|58831836|FG000|Overall Study|Participant trial terminated by sponsor|0|||
30812563|NCT02318277|58831837|FG001|Overall Study|Participant trial terminated by sponsor|0|||
30812564|NCT02318277|58831838|FG002|Overall Study|Participant trial terminated by sponsor|1|||
30812565|NCT02318277|58831839|FG003|Overall Study|Participant trial terminated by sponsor|0|||
30812566|NCT02318277|58831840|FG004|Overall Study|Participant trial terminated by sponsor|1|||
30812567|NCT02318277|58831841|FG005|Overall Study|Participant trial terminated by sponsor|2|||
30812568|NCT02318277|58831842|FG006|Overall Study|Participant trial terminated by sponsor|5|||
30812569|NCT02318277|58831843|FG007|Overall Study|Participant trial terminated by sponsor|16|||
30812570|NCT02318277|58831836|FG000|Overall Study|Lost to Follow-up|1|||
30910717|NCT01641692|58945598|FG001|Treatment Period 2|Lack of Efficacy|0|||
30910718|NCT01641692|58945599|FG002|Treatment Period 2|Lack of Efficacy|0|||
30910719|NCT01641692|58945600|FG003|Treatment Period 2|Lack of Efficacy|0|||
30910720|NCT01641692|58945601|FG004|Treatment Period 2|Lack of Efficacy|0|||
30910721|NCT01641692|58945602|FG005|Treatment Period 2|Lack of Efficacy|0|||
30910722|NCT01641692|58945603|FG006|Treatment Period 2|Lack of Efficacy|0|||
30910723|NCT01641692|58945604|FG007|Treatment Period 2|Lack of Efficacy|0|||
30910724|NCT01641692|58945597|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
30910725|NCT01641692|58945598|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30910726|NCT01641692|58945599|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30910727|NCT01641692|58945600|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30910728|NCT01641692|58945601|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30910729|NCT01641692|58945602|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30910730|NCT01641692|58945603|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30910731|NCT01641692|58945604|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30910732|NCT01641692|58945597|FG000|Treatment Period 2|Lost to Follow-up|0|||
30910733|NCT01641692|58945598|FG001|Treatment Period 2|Lost to Follow-up|0|||
30910734|NCT01641692|58945599|FG002|Treatment Period 2|Lost to Follow-up|0|||
30910735|NCT01641692|58945600|FG003|Treatment Period 2|Lost to Follow-up|0|||
30910736|NCT01641692|58945601|FG004|Treatment Period 2|Lost to Follow-up|0|||
30910737|NCT01641692|58945602|FG005|Treatment Period 2|Lost to Follow-up|1|||
30910738|NCT01641692|58945603|FG006|Treatment Period 2|Lost to Follow-up|0|||
30910739|NCT01641692|58945604|FG007|Treatment Period 2|Lost to Follow-up|0|||
30910740|NCT01641692|58945597|FG000|Treatment Period 2|Withdrawal by Subject|1|||
30910741|NCT01641692|58945598|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30910742|NCT01641692|58945599|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30910743|NCT01641692|58945600|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30910744|NCT01641692|58945601|FG004|Treatment Period 2|Withdrawal by Subject|0|||
30910745|NCT01641692|58945602|FG005|Treatment Period 2|Withdrawal by Subject|1|||
30910746|NCT01641692|58945603|FG006|Treatment Period 2|Withdrawal by Subject|0|||
30910747|NCT01641692|58945604|FG007|Treatment Period 2|Withdrawal by Subject|1|||
30910748|NCT01641692|58945597|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
30910749|NCT01641692|58945598|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
30910750|NCT01641692|58945599|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
30910751|NCT01641692|58945600|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
30910752|NCT01641692|58945601|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
30812571|NCT02318277|58831837|FG001|Overall Study|Lost to Follow-up|0|||
30812572|NCT02318277|58831838|FG002|Overall Study|Lost to Follow-up|1|||
30812573|NCT02318277|58831839|FG003|Overall Study|Lost to Follow-up|0|||
30812574|NCT02318277|58831840|FG004|Overall Study|Lost to Follow-up|0|||
30812575|NCT02318277|58831841|FG005|Overall Study|Lost to Follow-up|0|||
30812576|NCT02318277|58831842|FG006|Overall Study|Lost to Follow-up|3|||
30812577|NCT02318277|58831843|FG007|Overall Study|Lost to Follow-up|4|||
30812578|NCT02318277|58831836|FG000|Overall Study|Death|5|||
30812579|NCT02318277|58831837|FG001|Overall Study|Death|3|||
30812580|NCT02318277|58831838|FG002|Overall Study|Death|1|||
30812581|NCT02318277|58831839|FG003|Overall Study|Death|4|||
30812582|NCT02318277|58831840|FG004|Overall Study|Death|6|||
30812583|NCT02318277|58831841|FG005|Overall Study|Death|5|||
30812584|NCT02318277|58831842|FG006|Overall Study|Death|34|||
30812585|NCT02318277|58831843|FG007|Overall Study|Death|58|||
30812586|NCT02318277|58831836|FG000|Overall Study|Transitioned to Hospice|0|||
30812587|NCT02318277|58831837|FG001|Overall Study|Transitioned to Hospice|0|||
30812588|NCT02318277|58831838|FG002|Overall Study|Transitioned to Hospice|0|||
30812589|NCT02318277|58831839|FG003|Overall Study|Transitioned to Hospice|0|||
30812590|NCT02318277|58831840|FG004|Overall Study|Transitioned to Hospice|0|||
30812591|NCT02318277|58831841|FG005|Overall Study|Transitioned to Hospice|1|||
30812592|NCT02318277|58831842|FG006|Overall Study|Transitioned to Hospice|0|||
30812593|NCT02318277|58831843|FG007|Overall Study|Transitioned to Hospice|0|||
30812594|NCT01063868|58831888|FG000|Overall Study|Adverse Event|9|||
30812595|NCT01063868|58831889|FG001|Overall Study|Adverse Event|7|||
30812596|NCT01063868|58831888|FG000|Overall Study|Withdrawal by Subject|3|||
30812597|NCT01063868|58831889|FG001|Overall Study|Withdrawal by Subject|1|||
30812598|NCT01063868|58831888|FG000|Overall Study|Study Terminated By Sponsor|23|||
30812599|NCT01063868|58831889|FG001|Overall Study|Study Terminated By Sponsor|4|||
30812600|NCT02974088|58831897|FG000|Overall Study|Lost to Follow-up|0|||
30812601|NCT02974088|58831898|FG001|Overall Study|Lost to Follow-up|2|||
30812602|NCT02974088|58831897|FG000|Overall Study|Adverse Event|0|||
30812603|NCT02974088|58831898|FG001|Overall Study|Adverse Event|1|||
30812604|NCT02385045|58831904|FG000|Overall Study|Endoscopy could not be completed|4|||
30812605|NCT02974010|58831912|FG000|Overall Study|Lost to Follow-up|3|||
30812606|NCT02974010|58831913|FG001|Overall Study|Lost to Follow-up|1|||
30812607|NCT02974010|58831914|FG002|Overall Study|Lost to Follow-up|0|||
30812608|NCT02974010|58831915|FG003|Overall Study|Lost to Follow-up|0|||
30812609|NCT02974010|58831912|FG000|Overall Study|Withdrawal by Subject|2|||
30812610|NCT02974010|58831913|FG001|Overall Study|Withdrawal by Subject|1|||
30812611|NCT02974010|58831914|FG002|Overall Study|Withdrawal by Subject|0|||
30812612|NCT02974010|58831915|FG003|Overall Study|Withdrawal by Subject|0|||
30812613|NCT02974010|58831912|FG000|Overall Study|Adverse Event|0|||
30812614|NCT02974010|58831913|FG001|Overall Study|Adverse Event|1|||
30812615|NCT02974010|58831914|FG002|Overall Study|Adverse Event|0|||
30812616|NCT02974010|58831915|FG003|Overall Study|Adverse Event|0|||
30750237|NCT00175916|58760118|FG000|Overall Study|Patient cannot record seizures|1|||
30750238|NCT00175916|58760118|FG000|Overall Study|Sponsor decision|17|||
30750239|NCT00175916|58760118|FG000|Overall Study|Vigabatrin intake|1|||
30750240|NCT00175916|58760118|FG000|Overall Study|Suicidal behaviour|1|||
30750241|NCT00175916|58760118|FG000|Overall Study|Withdrawal by Subject|1|||
30750242|NCT00175916|58760118|FG000|Overall Study|Seizure - free|4|||
30750243|NCT00175916|58760118|FG000|Overall Study|Administrative reason|1|||
30750244|NCT00175916|58760118|FG000|Overall Study|Pregnancy|1|||
30750245|NCT00175916|58760118|FG000|Overall Study|Patient's request|2|||
30750246|NCT00175916|58760118|FG000|Overall Study|Treating physiciant's choice|1|||
30750247|NCT00175916|58760118|FG000|Overall Study|Moved overseas|1|||
30812617|NCT02974010|58831912|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
30812618|NCT02974010|58831913|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
30812619|NCT02974010|58831914|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
30812620|NCT02974010|58831915|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
30812621|NCT02974010|58831912|FG000|Overall Study|Lack of Efficacy|0|||
30812622|NCT02974010|58831913|FG001|Overall Study|Lack of Efficacy|0|||
30812623|NCT02974010|58831914|FG002|Overall Study|Lack of Efficacy|1|||
30910753|NCT01641692|58945602|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
30622568|NCT01175135|58634270|FG003|Overall Study|Lack of Efficacy|5|||
30750248|NCT00175916|58760118|FG000|Overall Study|Loss of job and economic burden|1|||
30750249|NCT00175916|58760118|FG000|Overall Study|Site was closed|9|||
30750250|NCT00175916|58760118|FG000|Overall Study|Patient went to prison|1|||
30750251|NCT00075400|58760123|FG000|Overall Study|Ineligible: wrong primary|1|||
30812624|NCT02974010|58831915|FG003|Overall Study|Lack of Efficacy|0|||
30812625|NCT02030938|58831925|FG000|Overall Study|Lost to Follow-up|4|||
30812626|NCT02030938|58831925|FG000|Overall Study|Withdrawal by Subject|1|||
30812627|NCT03122535|58831933|FG000|Overall Study|Lost to Follow-up|68|||
30812628|NCT03122535|58831934|FG001|Overall Study|Lost to Follow-up|68|||
30812629|NCT03122535|58831933|FG000|Overall Study|Physician Decision|3|||
30812630|NCT03122535|58831934|FG001|Overall Study|Physician Decision|3|||
30812631|NCT03122535|58831933|FG000|Overall Study|Withdrawal by Subject|2|||
30812632|NCT03122535|58831934|FG001|Overall Study|Withdrawal by Subject|2|||
30812633|NCT01061606|58831940|FG000|Overall Study|Adverse Event|1|||
30812634|NCT01061606|58831940|FG000|Overall Study|Death|1|||
30812635|NCT01061606|58831940|FG000|Overall Study|Disease Progression|4|||
30812636|NCT01061606|58831940|FG000|Overall Study|alternative therapy|2|||
30812637|NCT03122457|58831944|FG000|Overall Study|Withdrawal by Subject|6|||
30750252|NCT00075400|58760123|FG000|Overall Study|Never treated|2|||
30812638|NCT03482453|58831960|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
30812639|NCT03482453|58831961|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
30812640|NCT03482453|58831962|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
30812641|NCT03482453|58831963|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
30812642|NCT03482453|58831964|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
30812643|NCT03482453|58831965|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
30812644|NCT03482453|58831966|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
30812645|NCT03482453|58831967|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
30812646|NCT03482453|58831968|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
30812647|NCT03482453|58831969|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
30910754|NCT01641692|58945603|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
30910755|NCT01641692|58945604|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
30910756|NCT01641692|58945597|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
30812648|NCT03482453|58831970|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
30812649|NCT03482453|58831971|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
30812650|NCT03480425|58832007|FG000|Overall Study|Force transducer technical failure|1|||
30812651|NCT03472547|58832011|FG000|Overall Study|Withdrawal by Subject|30|||
30812652|NCT00799396|58832015|FG000|Clopidogrel Treatment|Adverse Event|6|||
30812653|NCT00799396|58832015|FG000|Clopidogrel Treatment|Physician Decision|5|||
30812654|NCT00799396|58832015|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
30812655|NCT00799396|58832015|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
30812656|NCT00799396|58832015|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
30812657|NCT03469349|58832021|FG000|Overall Study|Withdrawal by Subject|1|||
30812658|NCT03469349|58832022|FG001|Overall Study|Withdrawal by Subject|3|||
30812659|NCT03469349|58832021|FG000|Overall Study|Progressive Disease|0|||
30812660|NCT03469349|58832022|FG001|Overall Study|Progressive Disease|1|||
30812661|NCT03469349|58832021|FG000|Overall Study|Lost to Follow-up|2|||
30812662|NCT03469349|58832022|FG001|Overall Study|Lost to Follow-up|2|||
30812663|NCT03469349|58832021|FG000|Overall Study|Adverse Event|2|||
30812664|NCT03469349|58832022|FG001|Overall Study|Adverse Event|4|||
30812665|NCT03467945|58832032|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30812666|NCT03467945|58832033|FG001|Treatment Period 2|Withdrawal by Subject|1|||
30812667|NCT03467945|58832034|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30812668|NCT03467945|58832035|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30812669|NCT03467945|58832032|FG000|Treatment Period 3|Withdrawal by Subject|1|||
30812670|NCT03467945|58832033|FG001|Treatment Period 3|Withdrawal by Subject|0|||
30812671|NCT03467945|58832034|FG002|Treatment Period 3|Withdrawal by Subject|2|||
30812672|NCT03467945|58832035|FG003|Treatment Period 3|Withdrawal by Subject|1|||
30812673|NCT00069238|58832046|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
30812674|NCT00069238|58832047|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
30812675|NCT00069238|58832048|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
30812676|NCT00069238|58832046|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
30812677|NCT00069238|58832047|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
30812678|NCT00069238|58832048|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
30812679|NCT00069238|58832046|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
30812680|NCT00069238|58832047|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
30812681|NCT00069238|58832048|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
30910757|NCT01641692|58945598|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
30910758|NCT01641692|58945599|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
30622569|NCT01175135|58634267|FG000|Overall Study|Lost to Follow-up|1|||
30622570|NCT01175135|58634268|FG001|Overall Study|Lost to Follow-up|2|||
30750253|NCT00228566|58760132|FG000|Overall Study|Adverse Event|31|||
30750254|NCT00228566|58760132|FG000|Overall Study|Lack of Efficacy|14|||
30750255|NCT00228566|58760132|FG000|Overall Study|Lost to Follow-up|16|||
30750256|NCT00228566|58760132|FG000|Overall Study|Physician Decision|5|||
30750257|NCT00228566|58760132|FG000|Overall Study|Withdrawal by Subject|4|||
30750258|NCT00228566|58760132|FG000|Overall Study|Miscellaneous|1|||
30750259|NCT00074152|58760138|FG000|Overall Study|Death|21|||
30750260|NCT00074152|58760139|FG001|Overall Study|Death|9|||
30750261|NCT00074152|58760138|FG000|Overall Study|Lack of Efficacy|34|||
30750262|NCT00074152|58760139|FG001|Overall Study|Lack of Efficacy|24|||
30750263|NCT00261846|58760155|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
30750264|NCT00261846|58760156|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
30812682|NCT03435497|58832055|FG000|Overall Study|Lost to Follow-up|1|||
30622571|NCT01175135|58634269|FG002|Overall Study|Lost to Follow-up|0|||
30750265|NCT00261846|58760157|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
30812683|NCT03435497|58832056|FG001|Overall Study|Lost to Follow-up|0|||
30812684|NCT03435497|58832055|FG000|Overall Study|Death|1|||
30812685|NCT03435497|58832056|FG001|Overall Study|Death|0|||
30812686|NCT03435497|58832055|FG000|Overall Study|Withdrawal by Subject|0|||
30812687|NCT03435497|58832056|FG001|Overall Study|Withdrawal by Subject|4|||
30812688|NCT03435497|58832055|FG000|Overall Study|Wrong survey administered|0|||
30812689|NCT03435497|58832056|FG001|Overall Study|Wrong survey administered|2|||
30812690|NCT03073200|58832065|FG000|Double Blind Treatment Period|Protocol Violation|1|||
30812691|NCT03073200|58832066|FG001|Double Blind Treatment Period|Protocol Violation|0|||
30812692|NCT03073200|58832067|FG002|Double Blind Treatment Period|Protocol Violation|0|||
30812693|NCT03073200|58832068|FG003|Double Blind Treatment Period|Protocol Violation|0|||
30812694|NCT03073200|58832069|FG004|Double Blind Treatment Period|Protocol Violation|0|||
30812695|NCT03073200|58832070|FG005|Double Blind Treatment Period|Protocol Violation|0|||
30812696|NCT03073200|58832071|FG006|Double Blind Treatment Period|Protocol Violation|0|||
30812697|NCT03073200|58832072|FG007|Double Blind Treatment Period|Protocol Violation|0|||
30812698|NCT03073200|58832073|FG008|Double Blind Treatment Period|Protocol Violation|0|||
30812699|NCT03073200|58832074|FG009|Double Blind Treatment Period|Protocol Violation|0|||
30812700|NCT03073200|58832075|FG010|Double Blind Treatment Period|Protocol Violation|0|||
30812701|NCT03073200|58832076|FG011|Double Blind Treatment Period|Protocol Violation|0|||
30812702|NCT03073200|58832077|FG012|Double Blind Treatment Period|Protocol Violation|0|||
30750266|NCT00261846|58760158|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
30812703|NCT03073200|58832078|FG013|Double Blind Treatment Period|Protocol Violation|0|||
30812704|NCT03073200|58832079|FG014|Double Blind Treatment Period|Protocol Violation|0|||
30812705|NCT03073200|58832065|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812706|NCT03073200|58832066|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
30812707|NCT03073200|58832067|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812708|NCT03073200|58832068|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812709|NCT03073200|58832069|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812710|NCT03073200|58832070|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812711|NCT03073200|58832071|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812712|NCT03073200|58832072|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812713|NCT03073200|58832073|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812714|NCT03073200|58832074|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812715|NCT03073200|58832075|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812716|NCT03073200|58832076|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812717|NCT03073200|58832077|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812718|NCT03073200|58832078|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812719|NCT03073200|58832079|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
30812720|NCT03073200|58832065|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
30812721|NCT03073200|58832066|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812722|NCT03073200|58832067|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812723|NCT03073200|58832068|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812724|NCT03073200|58832069|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812725|NCT03073200|58832070|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812726|NCT03073200|58832071|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812727|NCT03073200|58832072|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
30750267|NCT00261846|58760159|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
30750268|NCT00261846|58760160|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
30750269|NCT00261846|58760161|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
30750270|NCT00261846|58760162|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
30750271|NCT00261846|58760163|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
30750272|NCT00261846|58760164|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
30750273|NCT00261846|58760165|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
30750274|NCT00261846|58760166|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
30750275|NCT00261846|58760155|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
30750276|NCT00261846|58760156|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
30750277|NCT00261846|58760157|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
30750278|NCT00261846|58760158|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
30750279|NCT00261846|58760159|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
30750280|NCT00261846|58760160|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
30750281|NCT00261846|58760161|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
30750282|NCT00261846|58760162|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
30750283|NCT00261846|58760163|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
30750284|NCT00261846|58760164|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
30750285|NCT00261846|58760165|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
30750286|NCT00261846|58760166|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
30750287|NCT00261846|58760155|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
30750288|NCT00261846|58760156|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
30750289|NCT00261846|58760157|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
30750290|NCT00261846|58760158|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
30750291|NCT00261846|58760159|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
30812728|NCT03073200|58832073|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812729|NCT03073200|58832074|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812730|NCT03073200|58832075|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812731|NCT03073200|58832076|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812732|NCT03073200|58832077|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812733|NCT03073200|58832078|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812734|NCT03073200|58832079|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
30812735|NCT03073200|58832065|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812736|NCT03073200|58832066|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812737|NCT03073200|58832067|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812738|NCT03073200|58832068|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
30812739|NCT03073200|58832069|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
30812740|NCT03073200|58832070|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812741|NCT03073200|58832071|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812742|NCT03073200|58832072|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812743|NCT03073200|58832073|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812744|NCT03073200|58832074|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812745|NCT03073200|58832075|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812746|NCT03073200|58832076|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812747|NCT03073200|58832077|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812748|NCT03073200|58832078|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812749|NCT03073200|58832079|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
30812750|NCT03073200|58832065|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
30812751|NCT03073200|58832066|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
30812752|NCT03073200|58832067|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
30812753|NCT03073200|58832068|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
30812754|NCT03073200|58832069|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
30812755|NCT03073200|58832070|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
30812756|NCT03073200|58832071|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
30812757|NCT03073200|58832072|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
30812758|NCT03073200|58832073|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
30812759|NCT03073200|58832074|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
30812760|NCT03073200|58832075|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
30812761|NCT03073200|58832076|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
30812762|NCT03073200|58832077|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
30812763|NCT03073200|58832078|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
30812764|NCT03073200|58832079|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
30812765|NCT03073200|58832065|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812766|NCT03073200|58832066|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812767|NCT03073200|58832067|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812768|NCT03073200|58832068|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812769|NCT03073200|58832069|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
30812770|NCT03073200|58832070|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812771|NCT03073200|58832071|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812772|NCT03073200|58832072|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812773|NCT03073200|58832073|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812774|NCT03073200|58832074|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812775|NCT03073200|58832075|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812776|NCT03073200|58832076|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812777|NCT03073200|58832077|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812778|NCT03073200|58832078|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812779|NCT03073200|58832079|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
30812780|NCT03073200|58832065|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812781|NCT03073200|58832066|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812782|NCT03073200|58832067|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812783|NCT03073200|58832068|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
30812784|NCT03073200|58832069|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
30812785|NCT03073200|58832070|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812786|NCT03073200|58832071|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812787|NCT03073200|58832072|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812788|NCT03073200|58832073|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812789|NCT03073200|58832074|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812790|NCT03073200|58832075|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812791|NCT03073200|58832076|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812792|NCT03073200|58832077|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812793|NCT03073200|58832078|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30910759|NCT01641692|58945600|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
30910760|NCT01641692|58945601|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
30812794|NCT03073200|58832079|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
30812795|NCT03073200|58832065|FG000|Extension Period|Lost to Follow-up|0|||
30812796|NCT03073200|58832066|FG001|Extension Period|Lost to Follow-up|0|||
30812797|NCT03073200|58832067|FG002|Extension Period|Lost to Follow-up|0|||
30812798|NCT03073200|58832068|FG003|Extension Period|Lost to Follow-up|0|||
30812799|NCT03073200|58832069|FG004|Extension Period|Lost to Follow-up|0|||
30812800|NCT03073200|58832070|FG005|Extension Period|Lost to Follow-up|0|||
30812801|NCT03073200|58832071|FG006|Extension Period|Lost to Follow-up|1|||
30812802|NCT03073200|58832072|FG007|Extension Period|Lost to Follow-up|1|||
30812803|NCT03073200|58832073|FG008|Extension Period|Lost to Follow-up|0|||
30812804|NCT03073200|58832074|FG009|Extension Period|Lost to Follow-up|0|||
30812805|NCT03073200|58832075|FG010|Extension Period|Lost to Follow-up|0|||
30812806|NCT03073200|58832076|FG011|Extension Period|Lost to Follow-up|0|||
30812807|NCT03073200|58832077|FG012|Extension Period|Lost to Follow-up|0|||
30812808|NCT03073200|58832078|FG013|Extension Period|Lost to Follow-up|0|||
30812809|NCT03073200|58832079|FG014|Extension Period|Lost to Follow-up|0|||
30812810|NCT03073200|58832065|FG000|Extension Period|Sponsor Decision|0|||
30812811|NCT03073200|58832066|FG001|Extension Period|Sponsor Decision|0|||
30812812|NCT03073200|58832067|FG002|Extension Period|Sponsor Decision|0|||
30812813|NCT03073200|58832068|FG003|Extension Period|Sponsor Decision|0|||
30812814|NCT03073200|58832069|FG004|Extension Period|Sponsor Decision|0|||
30812815|NCT03073200|58832070|FG005|Extension Period|Sponsor Decision|0|||
30812816|NCT03073200|58832071|FG006|Extension Period|Sponsor Decision|0|||
30812817|NCT03073200|58832072|FG007|Extension Period|Sponsor Decision|0|||
30812818|NCT03073200|58832073|FG008|Extension Period|Sponsor Decision|1|||
30812819|NCT03073200|58832074|FG009|Extension Period|Sponsor Decision|0|||
30812820|NCT03073200|58832075|FG010|Extension Period|Sponsor Decision|0|||
30812821|NCT03073200|58832076|FG011|Extension Period|Sponsor Decision|0|||
30812822|NCT03073200|58832077|FG012|Extension Period|Sponsor Decision|0|||
30812823|NCT03073200|58832078|FG013|Extension Period|Sponsor Decision|0|||
30812824|NCT03073200|58832079|FG014|Extension Period|Sponsor Decision|0|||
30812825|NCT03073200|58832065|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
30812826|NCT03073200|58832066|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
30812827|NCT03073200|58832067|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
30812828|NCT03073200|58832068|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
30812829|NCT03073200|58832069|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
30812830|NCT03073200|58832070|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
30812831|NCT03073200|58832071|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
30812832|NCT03073200|58832072|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
30812833|NCT03073200|58832073|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
30812834|NCT03073200|58832074|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
30812835|NCT03073200|58832075|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
30812836|NCT03073200|58832076|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
30812837|NCT03073200|58832077|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
30812838|NCT03073200|58832078|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
30812839|NCT03073200|58832079|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
30812840|NCT03073200|58832065|FG000|Extension Period|Withdrawal by Subject|0|||
30812841|NCT03073200|58832066|FG001|Extension Period|Withdrawal by Subject|0|||
30812842|NCT03073200|58832067|FG002|Extension Period|Withdrawal by Subject|0|||
30812843|NCT03073200|58832068|FG003|Extension Period|Withdrawal by Subject|0|||
30812844|NCT03073200|58832069|FG004|Extension Period|Withdrawal by Subject|0|||
30812845|NCT03073200|58832070|FG005|Extension Period|Withdrawal by Subject|0|||
30812846|NCT03073200|58832071|FG006|Extension Period|Withdrawal by Subject|1|||
30812847|NCT03073200|58832072|FG007|Extension Period|Withdrawal by Subject|2|||
30812848|NCT03073200|58832073|FG008|Extension Period|Withdrawal by Subject|0|||
30910761|NCT01641692|58945602|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
30812849|NCT03073200|58832074|FG009|Extension Period|Withdrawal by Subject|0|||
30812850|NCT03073200|58832075|FG010|Extension Period|Withdrawal by Subject|0|||
30812851|NCT03073200|58832076|FG011|Extension Period|Withdrawal by Subject|0|||
30812852|NCT03073200|58832077|FG012|Extension Period|Withdrawal by Subject|0|||
30812853|NCT03073200|58832078|FG013|Extension Period|Withdrawal by Subject|0|||
30812854|NCT03073200|58832079|FG014|Extension Period|Withdrawal by Subject|0|||
30812855|NCT03073200|58832065|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812856|NCT03073200|58832066|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812857|NCT03073200|58832067|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812858|NCT03073200|58832068|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
30910762|NCT01641692|58945603|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
30910763|NCT01641692|58945604|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
30910764|NCT01641692|58945597|FG000|Treatment Period 3|Adverse Event|0|||
30910765|NCT01641692|58945598|FG001|Treatment Period 3|Adverse Event|0|||
30910766|NCT01641692|58945599|FG002|Treatment Period 3|Adverse Event|0|||
30910767|NCT01641692|58945600|FG003|Treatment Period 3|Adverse Event|0|||
30910768|NCT01641692|58945601|FG004|Treatment Period 3|Adverse Event|0|||
30910769|NCT01641692|58945602|FG005|Treatment Period 3|Adverse Event|0|||
30910770|NCT01641692|58945603|FG006|Treatment Period 3|Adverse Event|1|||
30910771|NCT01641692|58945604|FG007|Treatment Period 3|Adverse Event|0|||
30910772|NCT01641692|58945597|FG000|Treatment Period 3|Protocol Violation|0|||
30910773|NCT01641692|58945598|FG001|Treatment Period 3|Protocol Violation|0|||
30910774|NCT01641692|58945599|FG002|Treatment Period 3|Protocol Violation|1|||
30910775|NCT01641692|58945600|FG003|Treatment Period 3|Protocol Violation|0|||
30910776|NCT01641692|58945601|FG004|Treatment Period 3|Protocol Violation|0|||
30910777|NCT01641692|58945602|FG005|Treatment Period 3|Protocol Violation|0|||
30910778|NCT01641692|58945603|FG006|Treatment Period 3|Protocol Violation|0|||
30910779|NCT01641692|58945604|FG007|Treatment Period 3|Protocol Violation|0|||
30910780|NCT01641692|58945597|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30910781|NCT01641692|58945598|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30910782|NCT01641692|58945599|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30910783|NCT01641692|58945600|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30910784|NCT01641692|58945601|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30910785|NCT01641692|58945602|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30910786|NCT01641692|58945603|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
30910787|NCT01641692|58945604|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30910788|NCT01641692|58945597|FG000|Treatment Period 3|Lost to Follow-up|0|||
30910789|NCT01641692|58945598|FG001|Treatment Period 3|Lost to Follow-up|1|||
30910790|NCT01641692|58945599|FG002|Treatment Period 3|Lost to Follow-up|0|||
30910791|NCT01641692|58945600|FG003|Treatment Period 3|Lost to Follow-up|0|||
30750292|NCT00261846|58760160|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
30750293|NCT00261846|58760161|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
30750294|NCT00261846|58760162|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
30750295|NCT00261846|58760163|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
30750296|NCT00261846|58760164|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
30812859|NCT03073200|58832069|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812860|NCT03073200|58832070|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812861|NCT03073200|58832071|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812862|NCT03073200|58832072|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812863|NCT03073200|58832073|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812864|NCT03073200|58832074|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812865|NCT03073200|58832075|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812866|NCT03073200|58832076|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
30812867|NCT03073200|58832077|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812868|NCT03073200|58832078|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812869|NCT03073200|58832079|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
30812870|NCT03073200|58832065|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30910792|NCT01641692|58945601|FG004|Treatment Period 3|Lost to Follow-up|0|||
30910793|NCT01641692|58945602|FG005|Treatment Period 3|Lost to Follow-up|0|||
30750297|NCT00261846|58760165|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
30750298|NCT00261846|58760166|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
30750299|NCT00261846|58760155|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
30750300|NCT00261846|58760156|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
30750301|NCT00261846|58760157|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
30750302|NCT00261846|58760158|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
30750303|NCT00261846|58760159|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
30910794|NCT01641692|58945603|FG006|Treatment Period 3|Lost to Follow-up|0|||
30910795|NCT01641692|58945604|FG007|Treatment Period 3|Lost to Follow-up|0|||
30910796|NCT01641692|58945597|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
30910797|NCT01641692|58945598|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
30910798|NCT01641692|58945599|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
30910799|NCT01641692|58945600|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
30750304|NCT00261846|58760160|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
30750305|NCT00261846|58760161|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
30812871|NCT03073200|58832066|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812872|NCT03073200|58832067|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812873|NCT03073200|58832068|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812874|NCT03073200|58832069|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812875|NCT03073200|58832070|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812876|NCT03073200|58832071|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812877|NCT03073200|58832072|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812878|NCT03073200|58832073|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812879|NCT03073200|58832074|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812880|NCT03073200|58832075|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812881|NCT03073200|58832076|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
30812882|NCT03073200|58832077|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812883|NCT03073200|58832078|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812884|NCT03073200|58832079|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
30812885|NCT03073200|58832065|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812886|NCT03073200|58832066|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812887|NCT03073200|58832067|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812888|NCT03073200|58832068|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812889|NCT03073200|58832069|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812890|NCT03073200|58832070|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812891|NCT03073200|58832071|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812892|NCT03073200|58832072|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30910800|NCT01641692|58945601|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
30910801|NCT01641692|58945602|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
30910802|NCT01641692|58945603|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
30910803|NCT01641692|58945604|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
30812893|NCT03073200|58832073|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812894|NCT03073200|58832074|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812895|NCT03073200|58832075|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
30812896|NCT03073200|58832076|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
30812897|NCT03073200|58832077|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812898|NCT03073200|58832078|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812899|NCT03073200|58832079|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30812900|NCT03073200|58832065|FG000|Randomized Withdrawal Period|Adverse Event|0|||
30812901|NCT03073200|58832066|FG001|Randomized Withdrawal Period|Adverse Event|0|||
30812902|NCT03073200|58832067|FG002|Randomized Withdrawal Period|Adverse Event|0|||
30812903|NCT03073200|58832068|FG003|Randomized Withdrawal Period|Adverse Event|0|||
30812904|NCT03073200|58832069|FG004|Randomized Withdrawal Period|Adverse Event|0|||
30812905|NCT03073200|58832070|FG005|Randomized Withdrawal Period|Adverse Event|0|||
30812906|NCT03073200|58832071|FG006|Randomized Withdrawal Period|Adverse Event|0|||
30812907|NCT03073200|58832072|FG007|Randomized Withdrawal Period|Adverse Event|0|||
30812908|NCT03073200|58832073|FG008|Randomized Withdrawal Period|Adverse Event|0|||
30812909|NCT03073200|58832074|FG009|Randomized Withdrawal Period|Adverse Event|0|||
30812910|NCT03073200|58832075|FG010|Randomized Withdrawal Period|Adverse Event|1|||
30812911|NCT03073200|58832076|FG011|Randomized Withdrawal Period|Adverse Event|0|||
30812912|NCT03073200|58832077|FG012|Randomized Withdrawal Period|Adverse Event|0|||
30812913|NCT03073200|58832078|FG013|Randomized Withdrawal Period|Adverse Event|0|||
30812914|NCT03073200|58832079|FG014|Randomized Withdrawal Period|Adverse Event|0|||
30812915|NCT03073200|58832065|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812916|NCT03073200|58832066|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812917|NCT03073200|58832067|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812918|NCT03073200|58832068|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812919|NCT03073200|58832069|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
30910804|NCT01641692|58945597|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
30812920|NCT03073200|58832070|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812921|NCT03073200|58832071|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812922|NCT03073200|58832072|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812923|NCT03073200|58832073|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812924|NCT03073200|58832074|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
30622572|NCT01175135|58634270|FG003|Overall Study|Lost to Follow-up|0|||
30812925|NCT03073200|58832075|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812926|NCT03073200|58832076|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812927|NCT03073200|58832077|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812928|NCT03073200|58832078|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
30812929|NCT03073200|58832079|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
30812930|NCT03073200|58832065|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812931|NCT03073200|58832066|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812932|NCT03073200|58832067|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812933|NCT03073200|58832068|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812934|NCT03073200|58832069|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812935|NCT03073200|58832070|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812936|NCT03073200|58832071|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812937|NCT03073200|58832072|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812938|NCT03073200|58832073|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812939|NCT03073200|58832074|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812940|NCT03073200|58832075|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812941|NCT03073200|58832076|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812942|NCT03073200|58832077|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812943|NCT03073200|58832078|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
30812944|NCT03073200|58832079|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30812945|NCT03073200|58832065|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812946|NCT03073200|58832066|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812947|NCT03073200|58832067|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812948|NCT03073200|58832068|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812949|NCT03073200|58832069|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812950|NCT03073200|58832070|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812951|NCT03073200|58832071|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812952|NCT03073200|58832072|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812953|NCT03073200|58832073|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812954|NCT03073200|58832074|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812955|NCT03073200|58832075|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812956|NCT03073200|58832076|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812957|NCT03073200|58832077|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812958|NCT03073200|58832078|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
30812959|NCT03073200|58832079|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
30812960|NCT03073200|58832065|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812961|NCT03073200|58832066|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812962|NCT03073200|58832067|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812963|NCT03073200|58832068|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812964|NCT03073200|58832069|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812965|NCT03073200|58832070|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812966|NCT03073200|58832071|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812967|NCT03073200|58832072|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812968|NCT03073200|58832073|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812969|NCT03073200|58832074|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812970|NCT03073200|58832075|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812971|NCT03073200|58832076|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812972|NCT03073200|58832077|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812973|NCT03073200|58832078|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
30812974|NCT03073200|58832079|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30812975|NCT03073200|58832065|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812976|NCT03073200|58832066|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812977|NCT03073200|58832067|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812978|NCT03073200|58832068|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812979|NCT03073200|58832069|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812980|NCT03073200|58832070|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812981|NCT03073200|58832071|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812982|NCT03073200|58832072|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812983|NCT03073200|58832073|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812984|NCT03073200|58832074|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812985|NCT03073200|58832075|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812986|NCT03073200|58832076|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812987|NCT03073200|58832077|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812988|NCT03073200|58832078|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
30812989|NCT03073200|58832079|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
30812990|NCT03073200|58832065|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30812991|NCT03073200|58832066|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30812992|NCT03073200|58832067|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30812993|NCT03073200|58832068|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30812994|NCT03073200|58832069|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30812995|NCT03073200|58832070|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30812996|NCT03073200|58832071|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30812997|NCT03073200|58832072|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30812998|NCT03073200|58832073|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30812999|NCT03073200|58832074|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30813000|NCT03073200|58832075|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30813001|NCT03073200|58832076|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30813002|NCT03073200|58832077|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30813003|NCT03073200|58832078|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
30813004|NCT03073200|58832079|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
30813005|NCT03073200|58832065|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813006|NCT03073200|58832066|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813007|NCT03073200|58832067|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813008|NCT03073200|58832068|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813009|NCT03073200|58832069|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813010|NCT03073200|58832070|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813011|NCT03073200|58832071|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813012|NCT03073200|58832072|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813013|NCT03073200|58832073|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813014|NCT03073200|58832074|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813015|NCT03073200|58832075|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813016|NCT03073200|58832076|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813017|NCT03073200|58832077|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813018|NCT03073200|58832078|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
30813019|NCT03073200|58832079|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30813020|NCT03073200|58832065|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813021|NCT03073200|58832066|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813022|NCT03073200|58832067|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813023|NCT03073200|58832068|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813024|NCT03073200|58832069|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813025|NCT03073200|58832070|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813026|NCT03073200|58832071|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813027|NCT03073200|58832072|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813028|NCT03073200|58832073|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813029|NCT03073200|58832074|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813030|NCT03073200|58832075|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813031|NCT03073200|58832076|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813032|NCT03073200|58832077|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813033|NCT03073200|58832078|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
30813034|NCT03073200|58832079|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
30813035|NCT03290781|58832108|FG000|Overall Study|Adverse Event|5|||
30813036|NCT03290781|58832109|FG001|Overall Study|Adverse Event|7|||
30813037|NCT03290781|58832110|FG002|Overall Study|Adverse Event|4|||
30813038|NCT03290781|58832111|FG003|Overall Study|Adverse Event|1|||
30813039|NCT03290781|58832112|FG004|Overall Study|Adverse Event|0|||
30813040|NCT03290781|58832113|FG005|Overall Study|Adverse Event|0|||
30813041|NCT03290781|58832114|FG006|Overall Study|Adverse Event|0|||
30813042|NCT03290781|58832108|FG000|Overall Study|Death|0|||
30813043|NCT03290781|58832109|FG001|Overall Study|Death|0|||
30813044|NCT03290781|58832110|FG002|Overall Study|Death|1|||
30813045|NCT03290781|58832111|FG003|Overall Study|Death|0|||
30813046|NCT03290781|58832112|FG004|Overall Study|Death|1|||
30813047|NCT03290781|58832113|FG005|Overall Study|Death|0|||
30813048|NCT03290781|58832114|FG006|Overall Study|Death|0|||
30813049|NCT03290781|58832108|FG000|Overall Study|Withdrawal by Subject|6|||
30813050|NCT03290781|58832109|FG001|Overall Study|Withdrawal by Subject|5|||
30813051|NCT03290781|58832110|FG002|Overall Study|Withdrawal by Subject|9|||
30813052|NCT03290781|58832111|FG003|Overall Study|Withdrawal by Subject|10|||
30813053|NCT03290781|58832112|FG004|Overall Study|Withdrawal by Subject|1|||
30813054|NCT03290781|58832113|FG005|Overall Study|Withdrawal by Subject|2|||
30813055|NCT03290781|58832114|FG006|Overall Study|Withdrawal by Subject|0|||
30813056|NCT03290781|58832108|FG000|Overall Study|Physician Decision|0|||
30813057|NCT03290781|58832109|FG001|Overall Study|Physician Decision|1|||
30813058|NCT03290781|58832110|FG002|Overall Study|Physician Decision|0|||
30813059|NCT03290781|58832111|FG003|Overall Study|Physician Decision|0|||
30813060|NCT03290781|58832112|FG004|Overall Study|Physician Decision|0|||
30813061|NCT03290781|58832113|FG005|Overall Study|Physician Decision|0|||
30813062|NCT03290781|58832114|FG006|Overall Study|Physician Decision|0|||
30813063|NCT03290781|58832108|FG000|Overall Study|Site Terminated by Sponsor|1|||
30813064|NCT03290781|58832109|FG001|Overall Study|Site Terminated by Sponsor|0|||
30813065|NCT03290781|58832110|FG002|Overall Study|Site Terminated by Sponsor|2|||
30813066|NCT03290781|58832111|FG003|Overall Study|Site Terminated by Sponsor|1|||
30813067|NCT03290781|58832112|FG004|Overall Study|Site Terminated by Sponsor|0|||
30813068|NCT03290781|58832113|FG005|Overall Study|Site Terminated by Sponsor|0|||
30813069|NCT03290781|58832114|FG006|Overall Study|Site Terminated by Sponsor|0|||
30813070|NCT03290781|58832108|FG000|Overall Study|Lost to Follow-up|0|||
30813071|NCT03290781|58832109|FG001|Overall Study|Lost to Follow-up|0|||
30813072|NCT03290781|58832110|FG002|Overall Study|Lost to Follow-up|0|||
30813073|NCT03290781|58832111|FG003|Overall Study|Lost to Follow-up|1|||
30813074|NCT03290781|58832112|FG004|Overall Study|Lost to Follow-up|0|||
30813075|NCT03290781|58832113|FG005|Overall Study|Lost to Follow-up|0|||
30813076|NCT03290781|58832114|FG006|Overall Study|Lost to Follow-up|0|||
30813077|NCT03290781|58832108|FG000|Overall Study|Protocol Deviation|2|||
30813078|NCT03290781|58832109|FG001|Overall Study|Protocol Deviation|0|||
30813079|NCT03290781|58832110|FG002|Overall Study|Protocol Deviation|0|||
30813080|NCT03290781|58832111|FG003|Overall Study|Protocol Deviation|1|||
30813081|NCT03290781|58832112|FG004|Overall Study|Protocol Deviation|0|||
30813082|NCT03290781|58832113|FG005|Overall Study|Protocol Deviation|0|||
30813083|NCT03290781|58832114|FG006|Overall Study|Protocol Deviation|0|||
30813084|NCT03290781|58832108|FG000|Overall Study|Disease Relapse|32|||
30813085|NCT03290781|58832109|FG001|Overall Study|Disease Relapse|5|||
30813086|NCT03290781|58832110|FG002|Overall Study|Disease Relapse|38|||
30813087|NCT03290781|58832111|FG003|Overall Study|Disease Relapse|7|||
30813088|NCT03290781|58832112|FG004|Overall Study|Disease Relapse|3|||
30910805|NCT01641692|58945598|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
30910806|NCT01641692|58945599|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
30910807|NCT01641692|58945600|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
30910808|NCT01641692|58945601|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
30750306|NCT00261846|58760162|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
30813089|NCT03290781|58832113|FG005|Overall Study|Disease Relapse|1|||
30813090|NCT03290781|58832114|FG006|Overall Study|Disease Relapse|4|||
30813091|NCT03290781|58832108|FG000|Overall Study|Other|3|||
30813092|NCT03290781|58832109|FG001|Overall Study|Other|0|||
30813093|NCT03290781|58832110|FG002|Overall Study|Other|2|||
30813094|NCT03290781|58832111|FG003|Overall Study|Other|2|||
30813095|NCT03290781|58832112|FG004|Overall Study|Other|0|||
30813096|NCT03290781|58832113|FG005|Overall Study|Other|0|||
30813097|NCT03290781|58832114|FG006|Overall Study|Other|0|||
30813098|NCT03466073|58832143|FG000|Overall Study|Death|1|||
30813099|NCT03466073|58832144|FG001|Overall Study|Death|0|||
30813100|NCT03466073|58832145|FG002|Overall Study|Death|0|||
30813101|NCT03466073|58832146|FG003|Overall Study|Death|0|||
30750307|NCT00261846|58760163|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
30750308|NCT00261846|58760164|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
30750309|NCT00261846|58760165|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
30750310|NCT00261846|58760166|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
30750311|NCT00261846|58760155|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
30750312|NCT00261846|58760156|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
30750313|NCT00261846|58760157|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
30750314|NCT00261846|58760158|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
30750315|NCT00261846|58760159|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
30813102|NCT03466073|58832147|FG004|Overall Study|Death|0|||
30813103|NCT03466073|58832148|FG005|Overall Study|Death|1|||
30813104|NCT03412019|58832171|FG000|Overall Study|Withdrawal by Subject|1|||
30813105|NCT03412019|58832172|FG001|Overall Study|Withdrawal by Subject|1|||
30813106|NCT03070002|58832178|FG000|Follow up for 2 Years|Death|1|||
30813107|NCT02918318|58832186|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
30813108|NCT02918318|58832187|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
30813109|NCT02918318|58832188|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
30813110|NCT02918318|58832189|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
30750316|NCT00261846|58760160|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
30813111|NCT02918318|58832190|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
30910809|NCT01641692|58945602|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
30910810|NCT01641692|58945603|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
30910811|NCT01641692|58945604|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
30910812|NCT01682512|58945626|FG000|Overall Study|Adverse Event|6|||
30910813|NCT01682512|58945627|FG001|Overall Study|Adverse Event|5|||
30910814|NCT01682512|58945628|FG002|Overall Study|Adverse Event|2|||
30813112|NCT02918318|58832186|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
30813113|NCT02918318|58832187|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
30813114|NCT02918318|58832188|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
30813115|NCT02918318|58832189|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
30813116|NCT02918318|58832190|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
30813117|NCT02918318|58832186|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
30813118|NCT02918318|58832187|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
30813119|NCT02918318|58832188|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
30813120|NCT02918318|58832189|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
30813121|NCT02918318|58832190|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
30813122|NCT02918318|58832186|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
30813123|NCT02918318|58832187|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
30813124|NCT02918318|58832188|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
30813125|NCT02918318|58832189|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
30813126|NCT02918318|58832190|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
30813127|NCT02918318|58832186|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
30813128|NCT02918318|58832187|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
30813129|NCT02918318|58832188|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
30813130|NCT02918318|58832189|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
30813131|NCT02918318|58832190|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
30813132|NCT02918318|58832186|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
30813133|NCT02918318|58832187|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
30813134|NCT02918318|58832188|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
30813135|NCT02918318|58832189|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
30813136|NCT02918318|58832190|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
30813137|NCT02918318|58832186|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
30813138|NCT02918318|58832187|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
30813139|NCT02918318|58832188|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
30813140|NCT02918318|58832189|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
30813141|NCT02918318|58832190|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
30813142|NCT02918318|58832186|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
30813143|NCT02918318|58832187|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
30813144|NCT02918318|58832188|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
30813145|NCT02918318|58832189|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
30813146|NCT02918318|58832190|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
30813147|NCT02918318|58832186|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
30813148|NCT02918318|58832187|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
30813149|NCT02918318|58832188|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
30813150|NCT02918318|58832189|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
30813151|NCT02918318|58832190|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
30813152|NCT02918318|58832186|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
30813153|NCT02918318|58832187|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
30813154|NCT02918318|58832188|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
30813155|NCT02918318|58832189|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
30813156|NCT02918318|58832190|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
30813157|NCT02918318|58832186|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
30813158|NCT02918318|58832187|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
30813159|NCT02918318|58832188|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
30813160|NCT02918318|58832189|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
30813161|NCT02918318|58832190|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
30813162|NCT02918318|58832186|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
30813163|NCT02918318|58832187|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
30813164|NCT02918318|58832188|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
30813165|NCT02918318|58832189|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
30813166|NCT02918318|58832190|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
30813167|NCT03411863|58832235|FG000|Overall Study|Withdrawal by Subject|3|||
30813168|NCT03411863|58832236|FG001|Overall Study|Withdrawal by Subject|1|||
30813169|NCT03411863|58832235|FG000|Overall Study|Physician Decision|0|||
30910815|NCT01682512|58945626|FG000|Overall Study|Withdrawal by Subject|2|||
30813170|NCT03411863|58832236|FG001|Overall Study|Physician Decision|1|||
30813171|NCT01065350|58832245|FG000|Overall Study|Received incorrect drug allocation|0|||
30813172|NCT01065350|58832246|FG001|Overall Study|Received incorrect drug allocation|1|||
30813173|NCT03434249|58832254|FG000|Overall Study|Adverse Event|1|||
30813174|NCT03434249|58832255|FG001|Overall Study|Adverse Event|0|||
30813175|NCT03434249|58832254|FG000|Overall Study|Lost to Follow-up|0|||
30813176|NCT03434249|58832255|FG001|Overall Study|Lost to Follow-up|1|||
30813177|NCT03434249|58832254|FG000|Overall Study|Non-compliance of family|2|||
30813178|NCT03434249|58832255|FG001|Overall Study|Non-compliance of family|1|||
30813179|NCT03434249|58832254|FG000|Overall Study|Difficulties in completing daily diary|2|||
30813180|NCT03434249|58832255|FG001|Overall Study|Difficulties in completing daily diary|1|||
30813181|NCT03114969|58832270|FG000|Overall Study|Lost to Follow-up|0|||
30813182|NCT03114969|58832271|FG001|Overall Study|Lost to Follow-up|0|||
30813183|NCT03114969|58832272|FG002|Overall Study|Lost to Follow-up|3|||
30813184|NCT03114969|58832273|FG003|Overall Study|Lost to Follow-up|2|||
30813185|NCT03114969|58832274|FG004|Overall Study|Lost to Follow-up|0|||
30813186|NCT03114969|58832275|FG005|Overall Study|Lost to Follow-up|0|||
30813187|NCT03114969|58832276|FG006|Overall Study|Lost to Follow-up|0|||
30813188|NCT03114969|58832277|FG007|Overall Study|Lost to Follow-up|0|||
30813189|NCT03114969|58832278|FG008|Overall Study|Lost to Follow-up|0|||
30813190|NCT03114969|58832270|FG000|Overall Study|Adverse Event|0|||
30813191|NCT03114969|58832271|FG001|Overall Study|Adverse Event|0|||
30813192|NCT03114969|58832272|FG002|Overall Study|Adverse Event|1|||
30813193|NCT03114969|58832273|FG003|Overall Study|Adverse Event|0|||
30813194|NCT03114969|58832274|FG004|Overall Study|Adverse Event|0|||
30813195|NCT03114969|58832275|FG005|Overall Study|Adverse Event|1|||
30813196|NCT03114969|58832276|FG006|Overall Study|Adverse Event|1|||
30813197|NCT03114969|58832277|FG007|Overall Study|Adverse Event|0|||
30813198|NCT03114969|58832278|FG008|Overall Study|Adverse Event|2|||
30813199|NCT02046096|58832307|FG000|Overall Study|Death|28|||
30813200|NCT02046096|58832308|FG001|Overall Study|Death|45|||
30813201|NCT02046096|58832307|FG000|Overall Study|Lost to Follow-up|9|||
30813202|NCT02046096|58832308|FG001|Overall Study|Lost to Follow-up|20|||
30813203|NCT02046096|58832307|FG000|Overall Study|Withdrawal by Subject|5|||
30813204|NCT02046096|58832308|FG001|Overall Study|Withdrawal by Subject|17|||
30813205|NCT02046096|58832307|FG000|Overall Study|Other endpoint|2|||
30813206|NCT02046096|58832308|FG001|Overall Study|Other endpoint|19|||
30813207|NCT03463577|58832322|FG000|Overall Study|Lost to Follow-up|238|||
30813208|NCT03463577|58832323|FG001|Overall Study|Lost to Follow-up|435|||
30813209|NCT03463577|58832324|FG002|Overall Study|Lost to Follow-up|0|||
30813210|NCT03463577|58832325|FG003|Overall Study|Lost to Follow-up|0|||
30813211|NCT03463577|58832326|FG004|Overall Study|Lost to Follow-up|0|||
30813212|NCT03463577|58832327|FG005|Overall Study|Lost to Follow-up|0|||
30813213|NCT03463577|58832322|FG000|Overall Study|With unknown pregnancy outcome|0|||
30813214|NCT03463577|58832323|FG001|Overall Study|With unknown pregnancy outcome|5|||
30813215|NCT03463577|58832324|FG002|Overall Study|With unknown pregnancy outcome|0|||
30813216|NCT03463577|58832325|FG003|Overall Study|With unknown pregnancy outcome|0|||
30813217|NCT03463577|58832326|FG004|Overall Study|With unknown pregnancy outcome|0|||
30813218|NCT03463577|58832327|FG005|Overall Study|With unknown pregnancy outcome|0|||
30813219|NCT03463577|58832322|FG000|Overall Study|Maternal death|2|||
30813220|NCT03463577|58832323|FG001|Overall Study|Maternal death|0|||
30813221|NCT03463577|58832324|FG002|Overall Study|Maternal death|0|||
30813222|NCT03463577|58832325|FG003|Overall Study|Maternal death|0|||
30813223|NCT03463577|58832326|FG004|Overall Study|Maternal death|0|||
30813224|NCT03463577|58832327|FG005|Overall Study|Maternal death|0|||
30813225|NCT03463577|58832322|FG000|Overall Study|Neonatal death|0|||
30813226|NCT03463577|58832323|FG001|Overall Study|Neonatal death|0|||
30813227|NCT03463577|58832324|FG002|Overall Study|Neonatal death|0|||
30813228|NCT03463577|58832325|FG003|Overall Study|Neonatal death|15|||
30813229|NCT03463577|58832326|FG004|Overall Study|Neonatal death|17|||
30813230|NCT03463577|58832327|FG005|Overall Study|Neonatal death|0|||
30813231|NCT03122145|58832343|FG000|Overall Study|Concurrent respiratory disease|3|||
30813232|NCT03122145|58832344|FG001|Overall Study|Concurrent respiratory disease|0|||
30813233|NCT03114657|58832352|FG000|Overall Study|Adverse Event|9|||
30813234|NCT03114657|58832353|FG001|Overall Study|Adverse Event|6|||
30813235|NCT03114657|58832352|FG000|Overall Study|Death|4|||
30813236|NCT03114657|58832353|FG001|Overall Study|Death|0|||
30813237|NCT03114657|58832352|FG000|Overall Study|Multiple Reasons|1|||
30813238|NCT03114657|58832353|FG001|Overall Study|Multiple Reasons|2|||
30813239|NCT03114657|58832352|FG000|Overall Study|Physician Decision|2|||
30813240|NCT03114657|58832353|FG001|Overall Study|Physician Decision|2|||
30813241|NCT03114657|58832352|FG000|Overall Study|Study Terminated By Sponsor|355|||
30813242|NCT03114657|58832353|FG001|Overall Study|Study Terminated By Sponsor|374|||
30813243|NCT03114657|58832352|FG000|Overall Study|Symptomatic Deterioration|0|||
30813244|NCT03114657|58832353|FG001|Overall Study|Symptomatic Deterioration|1|||
30813245|NCT03114657|58832352|FG000|Overall Study|Withdrawal by Subject|28|||
30813246|NCT03114657|58832353|FG001|Overall Study|Withdrawal by Subject|22|||
30813247|NCT02926950|58832362|FG000|Overall Study|Adverse Event|4|||
30813248|NCT02926950|58832363|FG001|Overall Study|Adverse Event|6|||
30813249|NCT02926950|58832362|FG000|Overall Study|At the participant's own request|21|||
30813250|NCT02926950|58832363|FG001|Overall Study|At the participant's own request|25|||
30813251|NCT02926950|58832362|FG000|Overall Study|Reason not Specified|17|||
30813252|NCT02926950|58832363|FG001|Overall Study|Reason not Specified|9|||
30813253|NCT02926950|58832362|FG000|Overall Study|Lost to Follow-up|7|||
30813254|NCT02926950|58832363|FG001|Overall Study|Lost to Follow-up|8|||
30813255|NCT03410693|58832372|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
30813256|NCT03410693|58832373|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
30813257|NCT03410693|58832372|FG000|Overall Study|Disc trt: Lost to follow up|0|||
30813258|NCT03410693|58832373|FG001|Overall Study|Disc trt: Lost to follow up|1|||
30813259|NCT03410693|58832372|FG000|Overall Study|Disc trt: radiological progression|58|||
30813260|NCT03410693|58832373|FG001|Overall Study|Disc trt: radiological progression|50|||
30813261|NCT03410693|58832372|FG000|Overall Study|Disc trt: Other|1|||
30813262|NCT03410693|58832373|FG001|Overall Study|Disc trt: Other|0|||
30813263|NCT03410693|58832372|FG000|Overall Study|Study drug never administered|1|||
30813264|NCT03410693|58832373|FG001|Overall Study|Study drug never administered|6|||
30813265|NCT03410693|58832372|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
30813266|NCT03410693|58832373|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
30813267|NCT03410693|58832372|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
30813268|NCT03410693|58832373|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
30813269|NCT03410693|58832372|FG000|Overall Study|Disc trt: Physician decision|0|||
30813270|NCT03410693|58832373|FG001|Overall Study|Disc trt: Physician decision|5|||
30813271|NCT03410693|58832372|FG000|Overall Study|Disc trt: clinical progression|1|||
30813272|NCT03410693|58832373|FG001|Overall Study|Disc trt: clinical progression|5|||
30813273|NCT03410693|58832372|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
30813274|NCT03410693|58832373|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
30813275|NCT01064414|58832388|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
30813276|NCT01064414|58832389|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
30813277|NCT01064414|58832390|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
30813278|NCT01064414|58832388|FG000|Core Period: Baseline to Week 26|Death|0|||
30813279|NCT01064414|58832389|FG001|Core Period: Baseline to Week 26|Death|1|||
30813280|NCT01064414|58832390|FG002|Core Period: Baseline to Week 26|Death|0|||
30813281|NCT01064414|58832388|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
30813282|NCT01064414|58832389|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
30813283|NCT01064414|58832390|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
30813284|NCT01064414|58832388|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
30813285|NCT01064414|58832389|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
30813286|NCT01064414|58832390|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
30813287|NCT01064414|58832388|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
30813288|NCT01064414|58832389|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
30813289|NCT01064414|58832390|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
30813290|NCT01064414|58832388|FG000|Core Period: Baseline to Week 26|Other|4|||
30813291|NCT01064414|58832389|FG001|Core Period: Baseline to Week 26|Other|7|||
30813292|NCT01064414|58832390|FG002|Core Period: Baseline to Week 26|Other|2|||
30813293|NCT01064414|58832388|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
30813294|NCT01064414|58832389|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
30813295|NCT01064414|58832390|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
30813296|NCT01064414|58832388|FG000|Extension Period: Week 26 to Week 52|Death|0|||
30813297|NCT01064414|58832389|FG001|Extension Period: Week 26 to Week 52|Death|1|||
30813298|NCT01064414|58832390|FG002|Extension Period: Week 26 to Week 52|Death|0|||
30813299|NCT01064414|58832388|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
30813300|NCT01064414|58832389|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
30813301|NCT01064414|58832390|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
30813302|NCT01064414|58832388|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
30813303|NCT01064414|58832389|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
30813304|NCT01064414|58832390|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
30813305|NCT01064414|58832388|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
30813306|NCT01064414|58832389|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
30813307|NCT01064414|58832390|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
30813308|NCT01064414|58832388|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
30813309|NCT01064414|58832389|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
30813310|NCT01064414|58832390|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
30813311|NCT01064414|58832388|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
30813312|NCT01064414|58832389|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
30813313|NCT01064414|58832390|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
30813314|NCT01064414|58832388|FG000|Extension Period: Week 26 to Week 52|Other|5|||
30813315|NCT01064414|58832389|FG001|Extension Period: Week 26 to Week 52|Other|2|||
30813316|NCT01064414|58832390|FG002|Extension Period: Week 26 to Week 52|Other|1|||
30813317|NCT03433703|58832401|FG000|Overall Study|Study terminated by Sponsor|2|||
30813318|NCT03463031|58832411|FG000|Overall Study|Withdrawal by Subject|4|||
30813319|NCT03463031|58832412|FG001|Overall Study|Withdrawal by Subject|2|||
30813320|NCT03463031|58832411|FG000|Overall Study|Investigator/Sponsor Decision|0|||
30813321|NCT03463031|58832412|FG001|Overall Study|Investigator/Sponsor Decision|1|||
30813322|NCT03463031|58832411|FG000|Overall Study|Lost to Follow-up|1|||
30813323|NCT03463031|58832412|FG001|Overall Study|Lost to Follow-up|1|||
30910816|NCT01682512|58945627|FG001|Overall Study|Withdrawal by Subject|6|||
30910817|NCT01682512|58945628|FG002|Overall Study|Withdrawal by Subject|3|||
30910818|NCT01682512|58945626|FG000|Overall Study|Physician Decision|0|||
30910819|NCT01682512|58945627|FG001|Overall Study|Physician Decision|2|||
30910820|NCT01682512|58945628|FG002|Overall Study|Physician Decision|0|||
30910821|NCT01682512|58945626|FG000|Overall Study|Study terminated by sponsor|46|||
30910822|NCT01682512|58945627|FG001|Overall Study|Study terminated by sponsor|43|||
30910823|NCT01682512|58945628|FG002|Overall Study|Study terminated by sponsor|0|||
30910824|NCT01682512|58945626|FG000|Overall Study|Lost to Follow-up|3|||
30910825|NCT01682512|58945627|FG001|Overall Study|Lost to Follow-up|0|||
30910826|NCT01682512|58945628|FG002|Overall Study|Lost to Follow-up|2|||
30910827|NCT01682512|58945626|FG000|Overall Study|Protocol Violation|2|||
30910828|NCT01682512|58945627|FG001|Overall Study|Protocol Violation|3|||
30910829|NCT01682512|58945628|FG002|Overall Study|Protocol Violation|2|||
30910830|NCT01682512|58945626|FG000|Overall Study|Primary lack of efficacy|10|||
30910831|NCT01682512|58945627|FG001|Overall Study|Primary lack of efficacy|7|||
30910832|NCT01682512|58945628|FG002|Overall Study|Primary lack of efficacy|7|||
30910833|NCT01682512|58945626|FG000|Overall Study|Secondary lack of efficacy|1|||
30910834|NCT01682512|58945627|FG001|Overall Study|Secondary lack of efficacy|1|||
30910835|NCT01682512|58945628|FG002|Overall Study|Secondary lack of efficacy|0|||
30910836|NCT01682512|58945626|FG000|Overall Study|Other than stated above|2|||
30910837|NCT01682512|58945627|FG001|Overall Study|Other than stated above|4|||
30910838|NCT01682512|58945628|FG002|Overall Study|Other than stated above|2|||
30813324|NCT03463031|58832411|FG000|Overall Study|Adverse Event|4|||
30813325|NCT03463031|58832412|FG001|Overall Study|Adverse Event|1|||
30813326|NCT03463031|58832411|FG000|Overall Study|Use of prohibited medication by subject|1|||
30813327|NCT03463031|58832412|FG001|Overall Study|Use of prohibited medication by subject|0|||
30813328|NCT03462641|58832420|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
30910839|NCT02256488|58945640|FG000|Overall Study|Lost to Follow-up|6|||
30750317|NCT00261846|58760161|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
30750318|NCT00261846|58760162|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
30750319|NCT00261846|58760163|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
30750320|NCT00261846|58760164|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
30910840|NCT02256488|58945641|FG001|Overall Study|Lost to Follow-up|6|||
30910841|NCT02256488|58945642|FG002|Overall Study|Lost to Follow-up|9|||
30750321|NCT00261846|58760165|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
30750322|NCT00261846|58760166|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
30750323|NCT00261846|58760155|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
30910842|NCT02256488|58945643|FG003|Overall Study|Lost to Follow-up|3|||
30910843|NCT02256488|58945640|FG000|Overall Study|OTHER|1|||
30910844|NCT02256488|58945641|FG001|Overall Study|OTHER|0|||
30910845|NCT02256488|58945642|FG002|Overall Study|OTHER|1|||
30910846|NCT02256488|58945643|FG003|Overall Study|OTHER|1|||
30622573|NCT01175135|58634267|FG000|Overall Study|Protocol Violation|1|||
30750324|NCT00261846|58760156|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
30750325|NCT00261846|58760157|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
30750326|NCT00261846|58760158|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
30750327|NCT00261846|58760159|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
30750328|NCT00261846|58760160|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
30910847|NCT02256488|58945640|FG000|Overall Study|Withdrawal by Subject|1|||
30910848|NCT02256488|58945641|FG001|Overall Study|Withdrawal by Subject|0|||
30910849|NCT02256488|58945642|FG002|Overall Study|Withdrawal by Subject|0|||
30910850|NCT02256488|58945643|FG003|Overall Study|Withdrawal by Subject|2|||
30622574|NCT01175135|58634268|FG001|Overall Study|Protocol Violation|1|||
30622575|NCT01175135|58634269|FG002|Overall Study|Protocol Violation|0|||
30622576|NCT01175135|58634270|FG003|Overall Study|Protocol Violation|0|||
30622577|NCT01175135|58634267|FG000|Overall Study|Withdrawal by Subject|4|||
30622578|NCT01175135|58634268|FG001|Overall Study|Withdrawal by Subject|8|||
30622579|NCT01175135|58634269|FG002|Overall Study|Withdrawal by Subject|5|||
30622580|NCT01175135|58634270|FG003|Overall Study|Withdrawal by Subject|5|||
30622581|NCT01175135|58634267|FG000|Overall Study|Other|3|||
30622582|NCT01175135|58634268|FG001|Overall Study|Other|1|||
30750329|NCT00261846|58760161|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
30750330|NCT00261846|58760162|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
30910851|NCT01715896|58945656|FG000|Overall Study|Lost to Follow-up|0|||
30910852|NCT01715896|58945657|FG001|Overall Study|Lost to Follow-up|2|||
30750331|NCT00261846|58760163|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
30750332|NCT00261846|58760164|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
30750333|NCT00261846|58760165|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
30750334|NCT00261846|58760166|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
30750335|NCT00261846|58760155|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
30750336|NCT00261846|58760156|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
30750337|NCT00261846|58760157|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
30750338|NCT00261846|58760158|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
30750339|NCT00261846|58760159|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
30750340|NCT00261846|58760160|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
30750341|NCT00261846|58760161|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
30750342|NCT00261846|58760162|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
30750343|NCT00261846|58760163|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
30750344|NCT00261846|58760164|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
30750345|NCT00261846|58760165|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
30750346|NCT00261846|58760166|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
30813329|NCT03462641|58832421|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
30813330|NCT03462641|58832420|FG000|Visit 2|Withdrawal by Subject|0|||
30813331|NCT03462641|58832421|FG001|Visit 2|Withdrawal by Subject|1|||
30813332|NCT02974634|58832431|FG000|Overall Study|Advanced disease|12|||
30813333|NCT02974634|58832432|FG001|Overall Study|Advanced disease|3|||
30813334|NCT02974634|58832431|FG000|Overall Study|Noncompliance|3|||
30813335|NCT02974634|58832432|FG001|Overall Study|Noncompliance|7|||
30813336|NCT02974634|58832431|FG000|Overall Study|intervention technology related issues|5|||
30813337|NCT02974634|58832432|FG001|Overall Study|intervention technology related issues|0|||
30813338|NCT02974634|58832431|FG000|Overall Study|Death|8|||
30813339|NCT02974634|58832432|FG001|Overall Study|Death|11|||
30813340|NCT01060670|58832441|FG000|Run In|screen failure|0|||
30813341|NCT01060670|58832442|FG001|Run In|screen failure|238|||
30813342|NCT02971670|58832454|FG000|Overall Study|Withdrawal by Subject|4|||
30813343|NCT02971670|58832455|FG001|Overall Study|Withdrawal by Subject|1|||
30813344|NCT02971670|58832456|FG002|Overall Study|Withdrawal by Subject|1|||
30813345|NCT02971670|58832457|FG003|Overall Study|Withdrawal by Subject|2|||
30813346|NCT02971202|58832470|FG000|Overall Study|Pregnancy|1|||
30813347|NCT02971202|58832471|FG001|Overall Study|Pregnancy|0|||
30813348|NCT02971202|58832472|FG002|Overall Study|Pregnancy|0|||
30910853|NCT01715896|58945656|FG000|Overall Study|Withdrawal by Subject|1|||
30910854|NCT01715896|58945657|FG001|Overall Study|Withdrawal by Subject|4|||
30910855|NCT01715896|58945656|FG000|Overall Study|Other|2|||
30910856|NCT01715896|58945657|FG001|Overall Study|Other|5|||
30910857|NCT02255552|58945666|FG000|Overall Study|Participants enrolled into another study|0|||
30910858|NCT02255552|58945667|FG001|Overall Study|Participants enrolled into another study|11|||
30910859|NCT02255552|58945666|FG000|Overall Study|Withdrawal by Subject|1|||
30910860|NCT02255552|58945667|FG001|Overall Study|Withdrawal by Subject|4|||
30910861|NCT01714726|58945675|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
30910862|NCT01714726|58945676|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
30910863|NCT01714726|58945677|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
30910864|NCT01714726|58945678|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
30910865|NCT01714726|58945675|FG000|Double-Blinded Induction Period|Adverse Event|0|||
30910866|NCT01714726|58945676|FG001|Double-Blinded Induction Period|Adverse Event|1|||
30910867|NCT01714726|58945677|FG002|Double-Blinded Induction Period|Adverse Event|0|||
30910868|NCT01714726|58945678|FG003|Double-Blinded Induction Period|Adverse Event|0|||
30910869|NCT01714726|58945675|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
30750347|NCT00169442|58760211|FG000|Overall Study|Withdrawal by Subject|0|||
30750348|NCT00169442|58760212|FG001|Overall Study|Withdrawal by Subject|0|||
30750349|NCT00169442|58760213|FG002|Overall Study|Withdrawal by Subject|1|||
30750350|NCT00169442|58760214|FG003|Overall Study|Withdrawal by Subject|0|||
30750351|NCT00169442|58760215|FG004|Overall Study|Withdrawal by Subject|0|||
30750352|NCT00169442|58760216|FG005|Overall Study|Withdrawal by Subject|0|||
30750353|NCT00169442|58760211|FG000|Overall Study|Migrated/moved from study area|0|||
30750354|NCT00169442|58760212|FG001|Overall Study|Migrated/moved from study area|0|||
30813349|NCT02971202|58832470|FG000|Overall Study|screen fail after consent|1|||
30813350|NCT02971202|58832471|FG001|Overall Study|screen fail after consent|0|||
30910870|NCT01714726|58945676|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
30750355|NCT00169442|58760213|FG002|Overall Study|Migrated/moved from study area|0|||
30750356|NCT00169442|58760214|FG003|Overall Study|Migrated/moved from study area|0|||
30750357|NCT00169442|58760215|FG004|Overall Study|Migrated/moved from study area|0|||
30813351|NCT02971202|58832472|FG002|Overall Study|screen fail after consent|1|||
30813352|NCT02926638|58832482|FG000|Overall Study|Progression|2|||
30813353|NCT02926638|58832483|FG001|Overall Study|Progression|5|||
30813354|NCT02926638|58832482|FG000|Overall Study|Ineligible|1|||
30813355|NCT02926638|58832483|FG001|Overall Study|Ineligible|0|||
30813356|NCT02926638|58832482|FG000|Overall Study|Not protocol specified|1|||
30813357|NCT02926638|58832483|FG001|Overall Study|Not protocol specified|0|||
30813358|NCT02903030|58832491|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
30813359|NCT02903030|58832492|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
30813360|NCT02969408|58832501|FG000|Overall Study|Adverse Event|2|||
30813361|NCT02969408|58832501|FG000|Overall Study|Withdrawal by Subject|8|||
30813362|NCT02969408|58832501|FG000|Overall Study|Lost to Follow-up|4|||
30813363|NCT02969408|58832501|FG000|Overall Study|Protocol Violation|1|||
30813364|NCT02969408|58832501|FG000|Overall Study|Other than specified|1|||
30813365|NCT03462563|58832507|FG000|Overall Study|Death|1|||
30813366|NCT03462563|58832508|FG001|Overall Study|Death|1|||
30813367|NCT03462563|58832507|FG000|Overall Study|Termination of study|2|||
30813368|NCT03462563|58832508|FG001|Overall Study|Termination of study|1|||
30813369|NCT03462563|58832507|FG000|Overall Study|Adverse Event|1|||
30813370|NCT03462563|58832508|FG001|Overall Study|Adverse Event|3|||
30813371|NCT03462563|58832507|FG000|Overall Study|Unspecified reason|10|||
30813372|NCT03462563|58832508|FG001|Overall Study|Unspecified reason|12|||
30813373|NCT03462563|58832507|FG000|Overall Study|Physician Decision|1|||
30813374|NCT03462563|58832508|FG001|Overall Study|Physician Decision|0|||
30813375|NCT01060124|58832514|FG000|Overall Study|Other|16|||
30813376|NCT01060124|58832514|FG000|Overall Study|Adverse Event|14|||
30813377|NCT01060124|58832514|FG000|Overall Study|Withdrawal by Subject|7|||
30813378|NCT03461003|58832520|FG000|Overall Study|Lost to Follow-up|2|||
30813379|NCT03461003|58832521|FG001|Overall Study|Lost to Follow-up|2|||
30813380|NCT03461003|58832520|FG000|Overall Study|Withdrawal by Subject|3|||
30813381|NCT03461003|58832521|FG001|Overall Study|Withdrawal by Subject|1|||
30813382|NCT02904902|58832527|FG000|Overall Study|Withdrawal by Subject|1|||
30813383|NCT04425720|58832533|FG000|Overall Study|Withdrawal by Subject|0|||
30813384|NCT04425720|58832534|FG001|Overall Study|Withdrawal by Subject|20|||
30813385|NCT02904512|58832543|FG000|Overall Study|Withdrawal by Subject|1|||
30813386|NCT02904512|58832544|FG001|Overall Study|Withdrawal by Subject|0|||
30813387|NCT02904512|58832543|FG000|Overall Study|Transferred to ICU|1|||
30813388|NCT02904512|58832544|FG001|Overall Study|Transferred to ICU|0|||
30813389|NCT02904512|58832543|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
30813390|NCT02904512|58832544|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
30813391|NCT02904200|58832550|FG000|Overall Study|Withdrawal by Subject|1|||
30813392|NCT02904200|58832551|FG001|Overall Study|Withdrawal by Subject|0|||
30813393|NCT03432533|58832557|FG000|Overall Study|Lost to Follow-up|1|||
30750358|NCT00169442|58760216|FG005|Overall Study|Migrated/moved from study area|2|||
30813394|NCT03432533|58832558|FG001|Overall Study|Lost to Follow-up|2|||
30813395|NCT03432533|58832557|FG000|Overall Study|Withdrawal by Subject|14|||
30813396|NCT03432533|58832558|FG001|Overall Study|Withdrawal by Subject|9|||
30813397|NCT02901548|58832564|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
30813398|NCT02903966|58832570|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
30813399|NCT02903966|58832571|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
30813400|NCT02903966|58832570|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
30910871|NCT01714726|58945677|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
30910872|NCT01714726|58945678|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
30910873|NCT01714726|58945675|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
30750359|NCT00169442|58760211|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
30750360|NCT00169442|58760212|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
30750361|NCT00169442|58760213|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
30750362|NCT00169442|58760214|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
30750363|NCT00169442|58760215|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
30813401|NCT02903966|58832571|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
30813402|NCT02903966|58832570|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
30813403|NCT02903966|58832571|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
30813404|NCT03457727|58832587|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
30813405|NCT03457727|58832588|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
30813406|NCT03457727|58832589|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
30813407|NCT03457727|58832590|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
30750364|NCT00169442|58760216|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
30750365|NCT00169442|58760211|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
30750366|NCT00169442|58760212|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
30813408|NCT03431441|58832622|FG000|Overall Study|Withdrawal by Subject|2|||
30813409|NCT03431441|58832622|FG000|Overall Study|Adverse Event|2|||
30813410|NCT03431441|58832622|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
30813411|NCT03457103|58832628|FG000|Overall Study|illness/hospitalization|4|||
30813412|NCT03457103|58832629|FG001|Overall Study|illness/hospitalization|2|||
30813413|NCT03457103|58832628|FG000|Overall Study|Lost to Follow-up|2|||
30813414|NCT03457103|58832629|FG001|Overall Study|Lost to Follow-up|1|||
30813415|NCT03457103|58832628|FG000|Overall Study|Withdrawal by Subject|1|||
30813416|NCT03457103|58832629|FG001|Overall Study|Withdrawal by Subject|2|||
30813417|NCT03457103|58832628|FG000|Overall Study|financial/ insurance issues|1|||
30813418|NCT03457103|58832629|FG001|Overall Study|financial/ insurance issues|1|||
30813419|NCT03455543|58832637|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
30813420|NCT03455543|58832638|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
30813421|NCT03455543|58832639|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
30813422|NCT03455543|58832637|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
30813423|NCT03455543|58832638|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
30813424|NCT03455543|58832639|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
30813425|NCT03455543|58832637|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
30813426|NCT03455543|58832638|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
30813427|NCT03455543|58832639|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
30813428|NCT03455543|58832637|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
30813429|NCT03455543|58832638|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
30813430|NCT03455543|58832639|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
30813431|NCT03455543|58832637|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
30813432|NCT03455543|58832638|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
30813433|NCT03455543|58832639|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
30813434|NCT03455543|58832637|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
30813435|NCT03455543|58832638|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
30813436|NCT03455543|58832639|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
30813437|NCT03455543|58832637|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
30813438|NCT03455543|58832638|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
30813439|NCT03455543|58832639|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
30813440|NCT03455543|58832637|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
30813441|NCT03455543|58832638|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
30813442|NCT03455543|58832639|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
30813443|NCT03455543|58832637|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
30813444|NCT03455543|58832638|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
30813445|NCT03455543|58832639|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
30813446|NCT03068754|58832649|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
30813447|NCT03068754|58832650|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
30813448|NCT03068754|58832651|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
30813449|NCT03068754|58832652|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
30813450|NCT03068754|58832649|FG000|Randomized Treatment Period (RTP)|Death|2|||
30813451|NCT03068754|58832650|FG001|Randomized Treatment Period (RTP)|Death|2|||
30813452|NCT03068754|58832651|FG002|Randomized Treatment Period (RTP)|Death|0|||
30813453|NCT03068754|58832652|FG003|Randomized Treatment Period (RTP)|Death|0|||
30813454|NCT03068754|58832649|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
30813455|NCT03068754|58832650|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
30813456|NCT03068754|58832651|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
30813457|NCT03068754|58832652|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
30813458|NCT03068754|58832649|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
30813459|NCT03068754|58832650|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
30813460|NCT03068754|58832651|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
30910874|NCT01714726|58945676|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
30910875|NCT01714726|58945677|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
30910876|NCT01714726|58945678|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
30910877|NCT01714726|58945675|FG000|Open-Label Period|Other|0|||
30910878|NCT01714726|58945676|FG001|Open-Label Period|Other|0|||
30910879|NCT01714726|58945677|FG002|Open-Label Period|Other|1|||
30910880|NCT01714726|58945678|FG003|Open-Label Period|Other|3|||
30910881|NCT01714726|58945675|FG000|Open-Label Period|Adverse Event|0|||
30910882|NCT01714726|58945676|FG001|Open-Label Period|Adverse Event|0|||
30910883|NCT01714726|58945677|FG002|Open-Label Period|Adverse Event|1|||
30910884|NCT01714726|58945678|FG003|Open-Label Period|Adverse Event|0|||
30910885|NCT01714726|58945675|FG000|Open-Label Period|Withdrawal by Subject|0|||
30910886|NCT01714726|58945676|FG001|Open-Label Period|Withdrawal by Subject|0|||
30910887|NCT01714726|58945677|FG002|Open-Label Period|Withdrawal by Subject|9|||
30910888|NCT01714726|58945678|FG003|Open-Label Period|Withdrawal by Subject|19|||
30910889|NCT01714726|58945675|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
30910890|NCT01714726|58945676|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
30910891|NCT01714726|58945677|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
30910892|NCT01714726|58945678|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
30910893|NCT01714726|58945675|FG000|Open-Label Period|Lost to Follow-up|0|||
30910894|NCT01714726|58945676|FG001|Open-Label Period|Lost to Follow-up|0|||
30910895|NCT01714726|58945677|FG002|Open-Label Period|Lost to Follow-up|3|||
30910896|NCT01714726|58945678|FG003|Open-Label Period|Lost to Follow-up|4|||
30910897|NCT02255474|58945691|FG000|Overall Study|Lost to Follow-up|1|||
30910898|NCT02255474|58945692|FG001|Overall Study|Lost to Follow-up|1|||
30910899|NCT02255474|58945693|FG002|Overall Study|Lost to Follow-up|3|||
30910900|NCT02255474|58945691|FG000|Overall Study|Withdrawal by Subject|1|||
30910901|NCT02255474|58945692|FG001|Overall Study|Withdrawal by Subject|1|||
30910902|NCT02255474|58945693|FG002|Overall Study|Withdrawal by Subject|0|||
30910903|NCT02254772|58945702|FG000|Overall Study|Ineligible|1|||
30910904|NCT02254772|58945702|FG000|Overall Study|Withdrawal by Subject|1|||
30813461|NCT03068754|58832652|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
30813462|NCT03068754|58832649|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
30813463|NCT03068754|58832650|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
30813464|NCT03068754|58832651|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
30813465|NCT03068754|58832652|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
30813466|NCT03068754|58832649|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
30813467|NCT03068754|58832650|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
30813468|NCT03068754|58832651|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
30813469|NCT03068754|58832652|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
30813470|NCT03068754|58832649|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
30813471|NCT03068754|58832650|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
30843596|NCT02101853|58869617|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
30910905|NCT02254460|58945706|FG000|Overall Study|Adverse Event|1|||
30910906|NCT02254460|58945707|FG001|Overall Study|Adverse Event|0|||
30910907|NCT01682044|58945713|FG000|Overall Study|Death|1|||
30910908|NCT01682044|58945713|FG000|Overall Study|Progression|3|||
30910909|NCT01696942|58945719|FG000|Overall Study|Withdrawal by Subject|1|||
30910910|NCT01696942|58945720|FG001|Overall Study|Withdrawal by Subject|0|||
30910911|NCT01696942|58945719|FG000|Overall Study|Protocol Violation|1|||
30843597|NCT02101853|58869612|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
30843598|NCT02101853|58869613|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
30843599|NCT02101853|58869614|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
30910912|NCT01696942|58945720|FG001|Overall Study|Protocol Violation|2|||
30843600|NCT02101853|58869615|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
30813472|NCT03068754|58832651|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
30813473|NCT03068754|58832652|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
30813474|NCT03068754|58832649|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
30813475|NCT03068754|58832650|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
30813476|NCT03068754|58832651|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
30813477|NCT03068754|58832652|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
30813478|NCT03068754|58832649|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
30813479|NCT03068754|58832650|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
30813480|NCT03068754|58832651|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
30813481|NCT03068754|58832652|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
30813482|NCT03068754|58832649|FG000|Open Label Extension Period (OLE)|Death|0|||
30813483|NCT03068754|58832650|FG001|Open Label Extension Period (OLE)|Death|0|||
30813484|NCT03068754|58832651|FG002|Open Label Extension Period (OLE)|Death|0|||
30813485|NCT03068754|58832652|FG003|Open Label Extension Period (OLE)|Death|1|||
30813486|NCT03068754|58832649|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
30813487|NCT03068754|58832650|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
30813488|NCT03068754|58832651|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
30813489|NCT03068754|58832652|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
30813490|NCT03068754|58832649|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
30813491|NCT03068754|58832650|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
30813492|NCT03068754|58832651|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
30813493|NCT03068754|58832652|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
30813494|NCT03068754|58832649|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
30813495|NCT03068754|58832650|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
30813496|NCT03068754|58832651|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
30813497|NCT03068754|58832652|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
30813498|NCT03068754|58832649|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
30813499|NCT03068754|58832650|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
30813500|NCT03068754|58832651|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
30813501|NCT03068754|58832652|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
30813502|NCT02965820|58832662|FG000|Period 2, Second 30 Days|Adverse Event|1|||
30813503|NCT02965820|58832663|FG001|Period 2, Second 30 Days|Adverse Event|1|||
30813504|NCT03430895|58832669|FG000|Overall Study|Not Treated|2|||
30813505|NCT03452189|58832673|FG000|First Intervention (3 Months)|Adverse Event|1|||
30813506|NCT03452189|58832674|FG001|First Intervention (3 Months)|Adverse Event|0|||
30813507|NCT03452189|58832673|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
30813508|NCT03452189|58832674|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
30813509|NCT03451721|58832680|FG000|Overall Study|Death|1|||
30813510|NCT00603954|58832686|FG000|Overall Study|Protocol Violation|1|||
30813511|NCT00603954|58832687|FG001|Overall Study|Protocol Violation|2|||
30813512|NCT03427619|58832694|FG000|Overall Study|Physician Decision|3|||
30813513|NCT03427619|58832694|FG000|Overall Study|Withdrawal by Subject|4|||
30813514|NCT03427619|58832694|FG000|Overall Study|Lost to Follow-up|5|||
30813515|NCT03427619|58832694|FG000|Overall Study|Administrative|4|||
30813516|NCT03427619|58832694|FG000|Overall Study|Other|2|||
30813517|NCT03427619|58832694|FG000|Overall Study|Unknown or Missing Completion Status|48|||
30813518|NCT03407729|58832700|FG000|Overall Study|Lost to Follow-up|2|||
30813519|NCT03407729|58832701|FG001|Overall Study|Lost to Follow-up|0|||
30813520|NCT03407729|58832700|FG000|Overall Study|Unable to schedule|0|||
30813521|NCT03407729|58832701|FG001|Overall Study|Unable to schedule|3|||
30813522|NCT02435433|58832712|FG000|Overall Study|Withdrawal by Subject|2|||
30813523|NCT02435433|58832713|FG001|Overall Study|Withdrawal by Subject|3|||
30813524|NCT02435433|58832714|FG002|Overall Study|Withdrawal by Subject|1|||
30813525|NCT02435433|58832715|FG003|Overall Study|Withdrawal by Subject|0|||
30813526|NCT02435433|58832716|FG004|Overall Study|Withdrawal by Subject|0|||
30813527|NCT02435433|58832712|FG000|Overall Study|Lost to Follow-up|2|||
30813528|NCT02435433|58832713|FG001|Overall Study|Lost to Follow-up|2|||
30813529|NCT02435433|58832714|FG002|Overall Study|Lost to Follow-up|4|||
30813530|NCT02435433|58832715|FG003|Overall Study|Lost to Follow-up|1|||
30813531|NCT02435433|58832716|FG004|Overall Study|Lost to Follow-up|0|||
30813532|NCT03120351|58832729|FG000|Overall Study|Physician Decision|1|||
30813533|NCT03120351|58832730|FG001|Overall Study|Physician Decision|1|||
30813534|NCT02354703|58832740|FG000|Overall Study|Withdrawal by Subject|1|||
30813535|NCT02354703|58832741|FG001|Overall Study|Withdrawal by Subject|1|||
30813536|NCT02354703|58832742|FG002|Overall Study|Withdrawal by Subject|1|||
30813537|NCT02354703|58832743|FG003|Overall Study|Withdrawal by Subject|1|||
30813538|NCT02354703|58832740|FG000|Overall Study|Lost to Follow-up|2|||
30813539|NCT02354703|58832741|FG001|Overall Study|Lost to Follow-up|7|||
30813540|NCT02354703|58832742|FG002|Overall Study|Lost to Follow-up|9|||
30813541|NCT02354703|58832743|FG003|Overall Study|Lost to Follow-up|2|||
30813542|NCT02354703|58832740|FG000|Overall Study|Adverse Event|0|||
30813543|NCT02354703|58832741|FG001|Overall Study|Adverse Event|0|||
30813544|NCT02354703|58832742|FG002|Overall Study|Adverse Event|1|||
30813545|NCT02354703|58832743|FG003|Overall Study|Adverse Event|0|||
30813546|NCT00384111|58832759|FG000|Overall Study|Disease Progression|3|||
30813547|NCT00384111|58832759|FG000|Overall Study|Adverse Event|1|||
30813548|NCT00384111|58832759|FG000|Overall Study|Investigator Decision|3|||
30813549|NCT00384111|58832759|FG000|Overall Study|Study Terminated by the Sponsor|19|||
30813550|NCT03113409|58832763|FG000|Overall Study|Withdrawal by Subject|5|||
30813551|NCT03113409|58832764|FG001|Overall Study|Withdrawal by Subject|0|||
30813552|NCT03113409|58832765|FG002|Overall Study|Withdrawal by Subject|0|||
30813553|NCT01319877|58832771|FG000|Overall Study|Lost to Follow-up|100|||
30813554|NCT01319877|58832772|FG001|Overall Study|Lost to Follow-up|37|||
30813555|NCT01319877|58832771|FG000|Overall Study|Physician Decision|2|||
30813556|NCT01319877|58832772|FG001|Overall Study|Physician Decision|0|||
30813557|NCT01319877|58832771|FG000|Overall Study|Disease Progression|2|||
30813558|NCT01319877|58832772|FG001|Overall Study|Disease Progression|2|||
30813559|NCT01319877|58832771|FG000|Overall Study|Withdrawal by Subject|0|||
30813560|NCT01319877|58832772|FG001|Overall Study|Withdrawal by Subject|1|||
30813561|NCT01319877|58832771|FG000|Overall Study|Reason Not Specified|4|||
30813562|NCT01319877|58832772|FG001|Overall Study|Reason Not Specified|5|||
30813563|NCT03427073|58832785|FG000|Overall Study|Disease Progression|1|||
30813564|NCT03427073|58832786|FG001|Overall Study|Disease Progression|1|||
30813565|NCT03427073|58832787|FG002|Overall Study|Disease Progression|1|||
30813566|NCT03427073|58832788|FG003|Overall Study|Disease Progression|3|||
30813567|NCT03427073|58832789|FG004|Overall Study|Disease Progression|3|||
30813568|NCT03427073|58832790|FG005|Overall Study|Disease Progression|4|||
30813569|NCT03427073|58832791|FG006|Overall Study|Disease Progression|2|||
30813570|NCT03427073|58832792|FG007|Overall Study|Disease Progression|3|||
30813571|NCT03427073|58832785|FG000|Overall Study|Physician Decision|0|||
30813572|NCT03427073|58832786|FG001|Overall Study|Physician Decision|0|||
30813573|NCT03427073|58832787|FG002|Overall Study|Physician Decision|0|||
30813574|NCT03427073|58832788|FG003|Overall Study|Physician Decision|0|||
30813575|NCT03427073|58832789|FG004|Overall Study|Physician Decision|0|||
30813576|NCT03427073|58832790|FG005|Overall Study|Physician Decision|0|||
30813577|NCT03427073|58832791|FG006|Overall Study|Physician Decision|1|||
30813578|NCT03427073|58832792|FG007|Overall Study|Physician Decision|1|||
30813579|NCT03066804|58832812|FG000|Overall Study|Physician Decision|0|||
30813580|NCT03066804|58832813|FG001|Overall Study|Physician Decision|4|||
30813581|NCT03066804|58832812|FG000|Overall Study|Death|23|||
30813582|NCT03066804|58832813|FG001|Overall Study|Death|17|||
30813583|NCT03066804|58832812|FG000|Overall Study|Withdrawal by Subject|19|||
30813584|NCT03066804|58832813|FG001|Overall Study|Withdrawal by Subject|25|||
30813585|NCT03066804|58832812|FG000|Overall Study|Lost to Follow-up|2|||
30813586|NCT03066804|58832813|FG001|Overall Study|Lost to Follow-up|0|||
30813587|NCT03066804|58832812|FG000|Overall Study|Adverse Event|2|||
30813588|NCT03066804|58832813|FG001|Overall Study|Adverse Event|3|||
30813589|NCT03066804|58832812|FG000|Overall Study|Technical problems|5|||
30813590|NCT03066804|58832813|FG001|Overall Study|Technical problems|1|||
30813591|NCT02954237|58832820|FG000|Overall Study|Withdrawal by Subject|25|||
30813592|NCT02954237|58832820|FG000|Overall Study|Missed visit|16|||
30813593|NCT02954237|58832820|FG000|Overall Study|Death|2|||
30813594|NCT04250337|58832826|FG000|Overall Study|Adverse Event|0|||
30813595|NCT04250337|58832827|FG001|Overall Study|Adverse Event|3|||
30813596|NCT04250337|58832826|FG000|Overall Study|Lack of Efficacy|1|||
30813597|NCT04250337|58832827|FG001|Overall Study|Lack of Efficacy|3|||
30813598|NCT04250337|58832826|FG000|Overall Study|Physician Decision|1|||
30813599|NCT04250337|58832827|FG001|Overall Study|Physician Decision|0|||
30813600|NCT04250337|58832826|FG000|Overall Study|Protocol Deviation|2|||
30813601|NCT04250337|58832827|FG001|Overall Study|Protocol Deviation|2|||
30813602|NCT04250337|58832826|FG000|Overall Study|Withdrawal by Subject|4|||
30813603|NCT04250337|58832827|FG001|Overall Study|Withdrawal by Subject|3|||
30813604|NCT03118947|58832834|FG000|Overall Study|Adverse Event|7|||
30813605|NCT03118947|58832834|FG000|Overall Study|Death|3|||
30813606|NCT03118947|58832834|FG000|Overall Study|Lack of Efficacy|4|||
30813607|NCT03118947|58832834|FG000|Overall Study|Non-compliance with study drug|1|||
30813608|NCT03118947|58832834|FG000|Overall Study|Protocol Violation|2|||
30813609|NCT03118947|58832834|FG000|Overall Study|Withdrawal by Subject|3|||
30813610|NCT03118947|58832834|FG000|Overall Study|Withdrawal by caregiver|3|||
30813611|NCT03118947|58832834|FG000|Overall Study|Change in patient's living situation|4|||
30813612|NCT03118947|58832834|FG000|Overall Study|Lost to Follow-up|2|||
30813613|NCT03953079|58832841|FG000|Core Study|Withdrawal by Subject|1|||
30813614|NCT03953079|58832842|FG001|Core Study|Withdrawal by Subject|2|||
30813615|NCT03953079|58832843|FG002|Core Study|Withdrawal by Subject|1|||
30813616|NCT03953079|58832841|FG000|Core Study|COVID-19|0|||
30813617|NCT03953079|58832842|FG001|Core Study|COVID-19|1|||
30813618|NCT03953079|58832843|FG002|Core Study|COVID-19|0|||
30813619|NCT03953079|58832841|FG000|Core Study|Difficulties leaving the house|0|||
30813620|NCT03953079|58832842|FG001|Core Study|Difficulties leaving the house|1|||
30813621|NCT03953079|58832843|FG002|Core Study|Difficulties leaving the house|0|||
30813622|NCT03953079|58832841|FG000|Extension Study|Withdrawal by Subject|1|||
30813623|NCT03953079|58832842|FG001|Extension Study|Withdrawal by Subject|0|||
30813624|NCT03953079|58832843|FG002|Extension Study|Withdrawal by Subject|0|||
30813625|NCT03953079|58832841|FG000|Extension Study|Received Rescue Treatment|5|||
30813626|NCT03953079|58832842|FG001|Extension Study|Received Rescue Treatment|6|||
30813627|NCT03953079|58832843|FG002|Extension Study|Received Rescue Treatment|5|||
30813628|NCT03885999|58832856|FG000|Overall Study|Adverse Event|1|||
30813629|NCT03108027|58832870|FG000|Period 1|Subject/Guardian Decision|0|||
30813630|NCT03108027|58832871|FG001|Period 1|Subject/Guardian Decision|0|||
30813631|NCT03108027|58832872|FG002|Period 1|Subject/Guardian Decision|0|||
30813632|NCT03108027|58832873|FG003|Period 1|Subject/Guardian Decision|2|||
30813633|NCT03108027|58832874|FG004|Period 1|Subject/Guardian Decision|0|||
30813634|NCT03108027|58832875|FG005|Period 1|Subject/Guardian Decision|0|||
30813635|NCT03108027|58832870|FG000|Period 3|Adverse Event|0|||
30813636|NCT03108027|58832871|FG001|Period 3|Adverse Event|1|||
30813637|NCT03108027|58832872|FG002|Period 3|Adverse Event|0|||
30813638|NCT03108027|58832873|FG003|Period 3|Adverse Event|0|||
30813639|NCT03108027|58832874|FG004|Period 3|Adverse Event|0|||
30813640|NCT03108027|58832875|FG005|Period 3|Adverse Event|0|||
30813641|NCT03107715|58832891|FG000|Overall Study|did not deliver at the home hospital|4|||
30813642|NCT03107715|58832892|FG001|Overall Study|did not deliver at the home hospital|6|||
30813643|NCT03107715|58832891|FG000|Overall Study|infant stillborn|0|||
30813644|NCT03107715|58832892|FG001|Overall Study|infant stillborn|1|||
30813645|NCT03567057|58832901|FG000|Overall Study|Adverse Event|56|||
30813646|NCT03567057|58832902|FG001|Overall Study|Adverse Event|53|||
30813647|NCT03567057|58832903|FG002|Overall Study|Adverse Event|28|||
30813648|NCT03567057|58832901|FG000|Overall Study|Withdrawal by Subject|22|||
30813649|NCT03567057|58832902|FG001|Overall Study|Withdrawal by Subject|24|||
30813650|NCT03567057|58832903|FG002|Overall Study|Withdrawal by Subject|13|||
30813651|NCT03567057|58832901|FG000|Overall Study|Lost to Follow-up|3|||
30813652|NCT03567057|58832902|FG001|Overall Study|Lost to Follow-up|5|||
30813653|NCT03567057|58832903|FG002|Overall Study|Lost to Follow-up|2|||
30813654|NCT03567057|58832901|FG000|Overall Study|COVID-19 pandemic|4|||
30813655|NCT03567057|58832902|FG001|Overall Study|COVID-19 pandemic|3|||
30813656|NCT03567057|58832903|FG002|Overall Study|COVID-19 pandemic|0|||
30750367|NCT00169442|58760213|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
30750368|NCT00169442|58760214|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
30750369|NCT00169442|58760215|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
30750370|NCT00169442|58760216|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
30750371|NCT00261716|58760234|FG000|Overall Study|Withdrawal by Subject|6|||
30750372|NCT00261716|58760235|FG001|Overall Study|Withdrawal by Subject|8|||
30750373|NCT00261716|58760234|FG000|Overall Study|Lost to Follow-up|0|||
30750374|NCT00261716|58760235|FG001|Overall Study|Lost to Follow-up|2|||
30750375|NCT03809104|58760245|FG000|Overall Study|Withdrawal by Subject|3|||
30750376|NCT00203502|58760249|FG000|Overall Study|Death|1|||
30750377|NCT03799198|58760255|FG000|Overall Study|Lost to Follow-up|4|||
30750378|NCT03799198|58760256|FG001|Overall Study|Lost to Follow-up|8|||
30750379|NCT03799198|58760255|FG000|Overall Study|Death|0|||
30750380|NCT03799198|58760256|FG001|Overall Study|Death|1|||
30750381|NCT00232596|58760264|FG000|6-Week Titration Phase|Adverse Event|6|||
30750382|NCT00232596|58760265|FG001|6-Week Titration Phase|Adverse Event|19|||
30750383|NCT00232596|58760264|FG000|6-Week Titration Phase|Failed to Return|2|||
30750384|NCT00232596|58760265|FG001|6-Week Titration Phase|Failed to Return|1|||
30750385|NCT00232596|58760264|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
30750386|NCT00232596|58760265|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
30750387|NCT00232596|58760264|FG000|6-Week Titration Phase|Protocol Violation|1|||
30750388|NCT00232596|58760265|FG001|6-Week Titration Phase|Protocol Violation|3|||
30750389|NCT00232596|58760264|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
30750390|NCT00232596|58760265|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
30750391|NCT00232596|58760264|FG000|6-Week Titration Phase|Other|3|||
30750392|NCT00232596|58760265|FG001|6-Week Titration Phase|Other|3|||
30750393|NCT00232596|58760264|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
30750394|NCT00232596|58760265|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
30750395|NCT00232596|58760264|FG000|12-Week Maintenance Phase|Adverse Event|7|||
30813657|NCT03567057|58832901|FG000|Overall Study|Non-compliance with study drug|4|||
30813658|NCT03567057|58832902|FG001|Overall Study|Non-compliance with study drug|2|||
30813659|NCT03567057|58832903|FG002|Overall Study|Non-compliance with study drug|0|||
30813660|NCT03567057|58832901|FG000|Overall Study|Lack of Efficacy|3|||
30813661|NCT03567057|58832902|FG001|Overall Study|Lack of Efficacy|0|||
30813662|NCT03567057|58832903|FG002|Overall Study|Lack of Efficacy|1|||
30813663|NCT03567057|58832901|FG000|Overall Study|Death|1|||
30750396|NCT00232596|58760265|FG001|12-Week Maintenance Phase|Adverse Event|22|||
30750397|NCT00232596|58760264|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
30750398|NCT00232596|58760265|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
30813664|NCT03567057|58832902|FG001|Overall Study|Death|0|||
30813665|NCT03567057|58832903|FG002|Overall Study|Death|0|||
30813666|NCT03567057|58832901|FG000|Overall Study|Physician Decision|1|||
30813667|NCT03567057|58832902|FG001|Overall Study|Physician Decision|0|||
30910913|NCT01696942|58945719|FG000|Overall Study|screen failure|0|||
30910914|NCT01696942|58945720|FG001|Overall Study|screen failure|1|||
30750399|NCT00232596|58760264|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
30750400|NCT00232596|58760265|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
30750401|NCT00232596|58760264|FG000|12-Week Maintenance Phase|Other|1|||
30813668|NCT03567057|58832903|FG002|Overall Study|Physician Decision|0|||
30813669|NCT03567057|58832901|FG000|Overall Study|Unstable medical condition|1|||
30813670|NCT03567057|58832902|FG001|Overall Study|Unstable medical condition|0|||
30813671|NCT03567057|58832903|FG002|Overall Study|Unstable medical condition|0|||
30813672|NCT03567057|58832901|FG000|Overall Study|Medical history event|0|||
30813673|NCT03567057|58832902|FG001|Overall Study|Medical history event|0|||
30813674|NCT03567057|58832903|FG002|Overall Study|Medical history event|1|||
30813675|NCT03567057|58832901|FG000|Overall Study|Other|0|||
30813676|NCT03567057|58832902|FG001|Overall Study|Other|0|||
30813677|NCT03567057|58832903|FG002|Overall Study|Other|1|||
30813678|NCT04388787|58832911|FG000|Blinded Period|Patient could not follow instructions|1|||
30813679|NCT04388787|58832911|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
30813680|NCT03057600|58832923|FG000|Overall Study|Adverse Event|0|||
30813681|NCT03057600|58832924|FG001|Overall Study|Adverse Event|0|||
30813682|NCT03057600|58832925|FG002|Overall Study|Adverse Event|4|||
30813683|NCT03057600|58832926|FG003|Overall Study|Adverse Event|0|||
30813684|NCT03057600|58832923|FG000|Overall Study|Radiologic Disease Progression|8|||
30813685|NCT03057600|58832924|FG001|Overall Study|Radiologic Disease Progression|7|||
30813686|NCT03057600|58832925|FG002|Overall Study|Radiologic Disease Progression|13|||
30813687|NCT03057600|58832926|FG003|Overall Study|Radiologic Disease Progression|10|||
30813688|NCT03057600|58832923|FG000|Overall Study|Symptomatic Deterioration|0|||
30813689|NCT03057600|58832924|FG001|Overall Study|Symptomatic Deterioration|1|||
30813690|NCT03057600|58832925|FG002|Overall Study|Symptomatic Deterioration|1|||
30813691|NCT03057600|58832926|FG003|Overall Study|Symptomatic Deterioration|0|||
30813692|NCT03057600|58832923|FG000|Overall Study|Investigator Decision|0|||
30813693|NCT03057600|58832924|FG001|Overall Study|Investigator Decision|0|||
30813694|NCT03057600|58832925|FG002|Overall Study|Investigator Decision|1|||
30813695|NCT03057600|58832926|FG003|Overall Study|Investigator Decision|0|||
30813696|NCT03057600|58832923|FG000|Overall Study|Study Termination by Sponsor|0|||
30813697|NCT03057600|58832924|FG001|Overall Study|Study Termination by Sponsor|0|||
30813698|NCT03057600|58832925|FG002|Overall Study|Study Termination by Sponsor|0|||
30813699|NCT03057600|58832926|FG003|Overall Study|Study Termination by Sponsor|2|||
30813700|NCT03057600|58832923|FG000|Overall Study|Withdrawal by Subject|0|||
30813701|NCT03057600|58832924|FG001|Overall Study|Withdrawal by Subject|1|||
30813702|NCT03057600|58832925|FG002|Overall Study|Withdrawal by Subject|0|||
30813703|NCT03057600|58832926|FG003|Overall Study|Withdrawal by Subject|0|||
30813704|NCT03057600|58832923|FG000|Overall Study|Other, Not Specified|1|||
30813705|NCT03057600|58832924|FG001|Overall Study|Other, Not Specified|1|||
30813706|NCT03057600|58832925|FG002|Overall Study|Other, Not Specified|1|||
30813707|NCT03057600|58832926|FG003|Overall Study|Other, Not Specified|1|||
30813708|NCT03371823|58832956|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
30813709|NCT03371823|58832957|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
30750402|NCT00232596|58760265|FG001|12-Week Maintenance Phase|Other|3|||
30750403|NCT00073918|58760283|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
30750404|NCT00073918|58760283|FG000|Overall Study|Rapid disease progression|2|||
30750405|NCT00073918|58760283|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
30750406|NCT00231894|58760289|FG000|Overall Study|Withdrawal by Subject|1|||
30750407|NCT00231894|58760290|FG001|Overall Study|Withdrawal by Subject|1|||
30750408|NCT00203424|58760302|FG000|Treatment Period|Withdrawal by Subject|4|||
30750409|NCT00203424|58760302|FG000|Treatment Period|Adverse Event|5|||
30750410|NCT00203424|58760302|FG000|Treatment Period|progressive disease|2|||
30750411|NCT00203424|58760302|FG000|Follow-up Period|Withdrawal by Subject|1|||
30750412|NCT00203424|58760302|FG000|Follow-up Period|progressive disease|4|||
30750413|NCT00203424|58760302|FG000|Follow-up Period|Lost to Follow-up|1|||
30750414|NCT00203268|58760306|FG000|Early Treatment|only treated one headache|2|||
30813710|NCT02966301|58832972|FG000|Overall Study|Death|2|||
30813711|NCT02966301|58832972|FG000|Overall Study|Withdrawal by Subject|1|||
30813712|NCT03107091|58832976|FG000|Overall Study|Physician Decision|1|||
30813713|NCT03065400|58832990|FG000|Overall Study|Adverse Event|1|||
30813714|NCT03065400|58832990|FG000|Overall Study|Physician Decision|3|||
30813715|NCT03065400|58832990|FG000|Overall Study|Withdrawal by Subject|1|||
30813716|NCT03065400|58832990|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
30813717|NCT03085095|58832996|FG000|Overall Study|Adverse Event|23|||
30813718|NCT03085095|58832997|FG001|Overall Study|Adverse Event|8|||
30750415|NCT00203268|58760306|FG000|Early Treatment|Lost to Follow-up|1|||
30750416|NCT00203268|58760306|FG000|Early Treatment|Withdrawal by Subject|1|||
30813719|NCT03085095|58832996|FG000|Overall Study|Protocol Violation|0|||
30813720|NCT03085095|58832997|FG001|Overall Study|Protocol Violation|1|||
30813721|NCT03085095|58832996|FG000|Overall Study|Lost to Follow-up|2|||
30813722|NCT03085095|58832997|FG001|Overall Study|Lost to Follow-up|1|||
30813723|NCT03085095|58832996|FG000|Overall Study|Withdrawal by Subject|17|||
30813724|NCT03085095|58832997|FG001|Overall Study|Withdrawal by Subject|6|||
30813725|NCT03085095|58832996|FG000|Overall Study|Physician Decision|9|||
30813726|NCT03085095|58832997|FG001|Overall Study|Physician Decision|3|||
30813727|NCT03085095|58832996|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
30813728|NCT03085095|58832997|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
30813729|NCT03085095|58832996|FG000|Overall Study|Did not Receive Study Drug|2|||
30813730|NCT03085095|58832997|FG001|Overall Study|Did not Receive Study Drug|2|||
30813731|NCT03085095|58832996|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
30813732|NCT03085095|58832997|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
30813733|NCT04097301|58833006|FG000|Overall Study|Death|1|||
30813734|NCT04097301|58833006|FG000|Overall Study|Withdrawal by Subject|1|||
30813735|NCT04097301|58833006|FG000|Overall Study|Screening Failure|5|||
30813736|NCT02649855|58833015|FG000|Overall Study|Refused further treatment|2|||
30813737|NCT02649855|58833016|FG001|Overall Study|Refused further treatment|1|||
30813738|NCT02649855|58833017|FG002|Overall Study|Refused further treatment|1|||
30813739|NCT02649855|58833015|FG000|Overall Study|Withdrew consent|0|||
30910915|NCT01640366|58945726|FG000|Overall Study|Withdrawal by Subject|1|||
30910916|NCT01640366|58945726|FG000|Overall Study|Protocol Violation|16|||
30910917|NCT01640366|58945726|FG000|Overall Study|Lost to Follow-up|5|||
30910918|NCT01640288|58945734|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
30910919|NCT01640288|58945735|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
30750417|NCT00168818|58760315|FG000|Overall Study|Adverse Event|23|||
30813740|NCT02649855|58833016|FG001|Overall Study|Withdrew consent|1|||
30813741|NCT02649855|58833017|FG002|Overall Study|Withdrew consent|0|||
30813742|NCT02649855|58833015|FG000|Overall Study|Switched to alternative treatment|0|||
30813743|NCT02649855|58833016|FG001|Overall Study|Switched to alternative treatment|1|||
30813744|NCT02649855|58833017|FG002|Overall Study|Switched to alternative treatment|1|||
30813745|NCT02649855|58833015|FG000|Overall Study|Principal investigator discretion|0|||
30813746|NCT02649855|58833016|FG001|Overall Study|Principal investigator discretion|1|||
30813747|NCT02649855|58833017|FG002|Overall Study|Principal investigator discretion|1|||
30813748|NCT02649855|58833015|FG000|Overall Study|No treatment, per protocol|1|||
30813749|NCT02649855|58833016|FG001|Overall Study|No treatment, per protocol|0|||
30813750|NCT02649855|58833017|FG002|Overall Study|No treatment, per protocol|0|||
30813751|NCT02649855|58833015|FG000|Overall Study|Initiate new treatment|1|||
30813752|NCT02649855|58833016|FG001|Overall Study|Initiate new treatment|0|||
30813753|NCT02649855|58833017|FG002|Overall Study|Initiate new treatment|0|||
30750418|NCT00168818|58760316|FG001|Overall Study|Adverse Event|29|||
30750419|NCT00168818|58760317|FG002|Overall Study|Adverse Event|31|||
30750420|NCT00168818|58760315|FG000|Overall Study|Protocol Violation|16|||
30750421|NCT00168818|58760316|FG001|Overall Study|Protocol Violation|11|||
30750422|NCT00168818|58760317|FG002|Overall Study|Protocol Violation|11|||
30750423|NCT00168818|58760315|FG000|Overall Study|Lost to Follow-up|13|||
30750424|NCT00168818|58760316|FG001|Overall Study|Lost to Follow-up|4|||
30750425|NCT00168818|58760317|FG002|Overall Study|Lost to Follow-up|15|||
30750426|NCT00168818|58760315|FG000|Overall Study|Withdrawal by Subject|43|||
30750427|NCT00168818|58760316|FG001|Overall Study|Withdrawal by Subject|41|||
30750428|NCT00168818|58760317|FG002|Overall Study|Withdrawal by Subject|37|||
30750429|NCT00168818|58760315|FG000|Overall Study|Other|22|||
30750430|NCT00168818|58760316|FG001|Overall Study|Other|24|||
30750431|NCT00168818|58760317|FG002|Overall Study|Other|30|||
30750432|NCT00168818|58760315|FG000|Treatment|Adverse Event|77|||
30750433|NCT00168818|58760316|FG001|Treatment|Adverse Event|89|||
30750434|NCT00168818|58760317|FG002|Treatment|Adverse Event|68|||
30750435|NCT00168818|58760315|FG000|Treatment|Protocol Violation|8|||
30750436|NCT00168818|58760316|FG001|Treatment|Protocol Violation|11|||
30750437|NCT00168818|58760317|FG002|Treatment|Protocol Violation|11|||
30750438|NCT00168818|58760315|FG000|Treatment|Lost to Follow-up|0|||
30750439|NCT00168818|58760316|FG001|Treatment|Lost to Follow-up|2|||
30813754|NCT02276547|58833025|FG000|Overall Study|Death|2|||
30813755|NCT02276547|58833025|FG000|Overall Study|Explant|2|||
30813756|NCT02966834|58833035|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
30910920|NCT01640288|58945734|FG000|Overall Study|Screen Failure|20|||
30910921|NCT01640288|58945735|FG001|Overall Study|Screen Failure|18|||
30910922|NCT01640288|58945734|FG000|Overall Study|Withdrawn by PI|5|||
30750440|NCT00168818|58760317|FG002|Treatment|Lost to Follow-up|1|||
30750441|NCT00168818|58760315|FG000|Treatment|Withdrawal by Subject|25|||
30750442|NCT00168818|58760316|FG001|Treatment|Withdrawal by Subject|20|||
30813757|NCT02966834|58833036|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
30813758|NCT02966834|58833037|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
30813759|NCT02966834|58833038|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
30813760|NCT02966834|58833039|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
30813761|NCT02966834|58833040|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
30813762|NCT02966834|58833035|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
30813763|NCT02966834|58833036|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
30813764|NCT02966834|58833037|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
30813765|NCT02966834|58833038|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
30813766|NCT02966834|58833039|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
30813767|NCT02966834|58833040|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
30813768|NCT02966834|58833035|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
30813769|NCT02966834|58833036|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
30813770|NCT02966834|58833037|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
30813771|NCT02966834|58833038|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
30813772|NCT02966834|58833039|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
30813773|NCT02966834|58833040|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
30813774|NCT02966834|58833035|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
30813775|NCT02966834|58833036|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
30813776|NCT02966834|58833037|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
30813777|NCT02966834|58833038|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
30813778|NCT02966834|58833039|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
30813779|NCT02966834|58833040|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
30813780|NCT02966834|58833035|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
30813781|NCT02966834|58833036|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
30813782|NCT02966834|58833037|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
30813783|NCT02966834|58833038|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
30813784|NCT02966834|58833039|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
30813785|NCT02966834|58833040|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
30813786|NCT02966834|58833035|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
30813787|NCT02966834|58833036|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
30813788|NCT02966834|58833037|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
30813789|NCT02966834|58833038|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
30813790|NCT02966834|58833039|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
30813791|NCT02966834|58833040|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
30813792|NCT03106077|58833089|FG000|Overall Study|Screen Failure|94|||
30813793|NCT03106077|58833090|FG001|Overall Study|Screen Failure|0|||
30813794|NCT03105297|58833095|FG000|Baseline Phase (Day 1)|Other|21|||
30813795|NCT03105297|58833095|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
30813796|NCT03105297|58833095|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
30813797|NCT03426995|58833125|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813798|NCT03426995|58833126|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813799|NCT03426995|58833127|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
30813800|NCT03426995|58833128|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813801|NCT03426995|58833129|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813802|NCT03426995|58833130|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813803|NCT03426995|58833131|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813804|NCT03426995|58833132|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813805|NCT03426995|58833133|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813806|NCT03426995|58833134|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813807|NCT03426995|58833135|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813808|NCT03426995|58833136|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813809|NCT03426995|58833137|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813810|NCT03426995|58833138|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813811|NCT03426995|58833139|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813812|NCT03426995|58833140|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813813|NCT03426995|58833141|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813814|NCT03426995|58833142|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813815|NCT03426995|58833143|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
30813816|NCT03426995|58833125|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813817|NCT03426995|58833126|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813818|NCT03426995|58833127|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813819|NCT03426995|58833128|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813820|NCT03426995|58833129|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813821|NCT03426995|58833130|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
30813822|NCT03426995|58833131|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30910923|NCT01640288|58945735|FG001|Overall Study|Withdrawn by PI|0|||
30910924|NCT01640288|58945734|FG000|Overall Study|Withdrawal by Subject|1|||
30910925|NCT01640288|58945735|FG001|Overall Study|Withdrawal by Subject|0|||
30910926|NCT01639040|58945744|FG000|Overall Study|Adverse Event|1|||
30910927|NCT01639040|58945745|FG001|Overall Study|Adverse Event|0|||
30910928|NCT01640054|58945754|FG000|Overall Study|Study-specific disc criteria|1|||
30910929|NCT01640054|58945754|FG000|Overall Study|Lack of Efficacy|3|||
30910930|NCT01640054|58945754|FG000|Overall Study|Adverse Event|2|||
30910931|NCT01600586|58945760|FG000|Overall Study|Physician Decision|3|||
30910932|NCT01600586|58945761|FG001|Overall Study|Physician Decision|3|||
30910933|NCT01639742|58945774|FG000|Overall Study|Study Ongoing|17|||
30910934|NCT01639742|58945774|FG000|Overall Study|Lost to Follow-up|1|||
30910935|NCT02164513|58945781|FG000|Overall Study|Adverse Event|162|||
30910936|NCT02164513|58945782|FG001|Overall Study|Adverse Event|180|||
30910937|NCT02164513|58945783|FG002|Overall Study|Adverse Event|111|||
30910938|NCT02164513|58945781|FG000|Overall Study|Other: Study Closed or terminated|5|||
30910939|NCT02164513|58945782|FG001|Overall Study|Other: Study Closed or terminated|2|||
30910940|NCT02164513|58945783|FG002|Overall Study|Other: Study Closed or terminated|4|||
30910941|NCT02164513|58945781|FG000|Overall Study|Lost to Follow-up|30|||
30910942|NCT02164513|58945782|FG001|Overall Study|Lost to Follow-up|36|||
30910943|NCT02164513|58945783|FG002|Overall Study|Lost to Follow-up|22|||
30910944|NCT02164513|58945781|FG000|Overall Study|Physician Decision|47|||
30910945|NCT02164513|58945782|FG001|Overall Study|Physician Decision|57|||
30910946|NCT02164513|58945783|FG002|Overall Study|Physician Decision|28|||
30910947|NCT02164513|58945781|FG000|Overall Study|Withdrawal by Subject|192|||
30910948|NCT02164513|58945782|FG001|Overall Study|Withdrawal by Subject|261|||
30750443|NCT00168818|58760317|FG002|Treatment|Withdrawal by Subject|22|||
30750444|NCT00168818|58760315|FG000|Treatment|Other|23|||
30750445|NCT00168818|58760316|FG001|Treatment|Other|29|||
30750446|NCT00168818|58760317|FG002|Treatment|Other|31|||
30750447|NCT00260832|58760327|FG000|Overall Study|Adverse Event|26|||
30750448|NCT00260832|58760328|FG001|Overall Study|Adverse Event|19|||
30750449|NCT00260832|58760327|FG000|Overall Study|Progression|116|||
30750450|NCT00260832|58760328|FG001|Overall Study|Progression|96|||
30750451|NCT00260832|58760327|FG000|Overall Study|Withdrawal by Subject|15|||
30750452|NCT00260832|58760328|FG001|Overall Study|Withdrawal by Subject|17|||
30750453|NCT00260832|58760327|FG000|Overall Study|Physician Decision|15|||
30750454|NCT00260832|58760328|FG001|Overall Study|Physician Decision|9|||
30750455|NCT00260832|58760327|FG000|Overall Study|Death|43|||
30750456|NCT00260832|58760328|FG001|Overall Study|Death|62|||
30750457|NCT00260832|58760327|FG000|Overall Study|Other|10|||
30750458|NCT00260832|58760328|FG001|Overall Study|Other|7|||
30750459|NCT00260832|58760327|FG000|Overall Study|Protocol Violation|3|||
30750460|NCT00260832|58760328|FG001|Overall Study|Protocol Violation|1|||
30750461|NCT00168038|58760334|FG000|Overall Study|Adverse Event|1|||
30750462|NCT00168038|58760334|FG000|Overall Study|Therapy failure|1|||
30750463|NCT00167414|58760338|FG000|Overall Study|Death|10|||
30750464|NCT00166712|58760344|FG000|Overall Study|Death|0|||
30750465|NCT00166712|58760345|FG001|Overall Study|Death|1|||
30750466|NCT00166712|58760344|FG000|Overall Study|Adverse Event|1|||
30750467|NCT00166712|58760345|FG001|Overall Study|Adverse Event|0|||
30750468|NCT00166712|58760344|FG000|Overall Study|Withdrawal by Subject|1|||
30750469|NCT00166712|58760345|FG001|Overall Study|Withdrawal by Subject|2|||
30750470|NCT00166712|58760344|FG000|Overall Study|Physician Decision|0|||
30750471|NCT00166712|58760345|FG001|Overall Study|Physician Decision|2|||
30750472|NCT00073528|58760357|FG000|Overall Study|Death|488|||
30750473|NCT00073528|58760358|FG001|Overall Study|Death|473|||
30750474|NCT00073528|58760357|FG000|Overall Study|Lost to Follow-up|52|||
30750475|NCT00073528|58760358|FG001|Overall Study|Lost to Follow-up|45|||
30750476|NCT00073528|58760357|FG000|Overall Study|Withdrawal by Subject|50|||
30750477|NCT00073528|58760358|FG001|Overall Study|Withdrawal by Subject|45|||
30750478|NCT00073528|58760357|FG000|Overall Study|Study terminated by Sponsor|10|||
30750479|NCT00073528|58760358|FG001|Overall Study|Study terminated by Sponsor|29|||
30750480|NCT00073528|58760357|FG000|Overall Study|Other|18|||
30750481|NCT00073528|58760358|FG001|Overall Study|Other|19|||
30750482|NCT00073528|58760357|FG000|Overall Study|Other|9|||
30750483|NCT00073528|58760358|FG001|Overall Study|Other|12|||
30750484|NCT00073528|58760357|FG000|Overall Study|Protocol Violation|3|||
30750485|NCT00073528|58760358|FG001|Overall Study|Protocol Violation|5|||
30750486|NCT03801148|58760368|FG000|Period 1 (2 Days)|Adverse Event|1|||
30750487|NCT03801148|58760369|FG001|Period 1 (2 Days)|Adverse Event|1|||
30750488|NCT03801148|58760370|FG002|Period 1 (2 Days)|Adverse Event|0|||
30910949|NCT02164513|58945783|FG002|Overall Study|Withdrawal by Subject|130|||
30813823|NCT03426995|58833132|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813824|NCT03426995|58833133|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813825|NCT03426995|58833134|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813826|NCT03426995|58833135|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813827|NCT03426995|58833136|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813828|NCT03426995|58833137|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813829|NCT03426995|58833138|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813830|NCT03426995|58833139|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813831|NCT03426995|58833140|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813832|NCT03426995|58833141|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813833|NCT03426995|58833142|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813834|NCT03426995|58833143|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
30813835|NCT03426995|58833125|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813836|NCT03426995|58833126|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813837|NCT03426995|58833127|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813838|NCT03426995|58833128|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813839|NCT03426995|58833129|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
30813840|NCT03426995|58833130|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
30813841|NCT03426995|58833131|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813842|NCT03426995|58833132|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813843|NCT03426995|58833133|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813844|NCT03426995|58833134|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813845|NCT03426995|58833135|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813846|NCT03426995|58833136|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813847|NCT03426995|58833137|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813848|NCT03426995|58833138|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813849|NCT03426995|58833139|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813850|NCT03426995|58833140|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813851|NCT03426995|58833141|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813852|NCT03426995|58833142|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813853|NCT03426995|58833143|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
30813854|NCT03426995|58833125|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813855|NCT03426995|58833126|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813856|NCT03426995|58833127|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813857|NCT03426995|58833128|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813858|NCT03426995|58833129|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813859|NCT03426995|58833130|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813860|NCT03426995|58833131|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813861|NCT03426995|58833132|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813862|NCT03426995|58833133|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813863|NCT03426995|58833134|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813864|NCT03426995|58833135|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
30813865|NCT03426995|58833136|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813866|NCT03426995|58833137|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813867|NCT03426995|58833138|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813868|NCT03426995|58833139|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813869|NCT03426995|58833140|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813870|NCT03426995|58833141|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813871|NCT03426995|58833142|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813872|NCT03426995|58833143|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
30813873|NCT03426995|58833125|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813874|NCT03426995|58833126|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813875|NCT03426995|58833127|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813876|NCT03426995|58833128|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813877|NCT03426995|58833129|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813878|NCT03426995|58833130|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813879|NCT03426995|58833131|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813880|NCT03426995|58833132|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
30813881|NCT03426995|58833133|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813882|NCT03426995|58833134|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813883|NCT03426995|58833135|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813884|NCT03426995|58833136|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813885|NCT03426995|58833137|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813886|NCT03426995|58833138|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813887|NCT03426995|58833139|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813888|NCT03426995|58833140|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813889|NCT03426995|58833141|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813890|NCT03426995|58833142|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813891|NCT03426995|58833143|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
30813892|NCT03426995|58833125|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813893|NCT03426995|58833126|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813894|NCT03426995|58833127|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813895|NCT03426995|58833128|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813896|NCT03426995|58833129|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813897|NCT03426995|58833130|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813898|NCT03426995|58833131|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813899|NCT03426995|58833132|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813900|NCT03426995|58833133|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813901|NCT03426995|58833134|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813902|NCT03426995|58833135|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813903|NCT03426995|58833136|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813904|NCT03426995|58833137|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813905|NCT03426995|58833138|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813906|NCT03426995|58833139|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
30813907|NCT03426995|58833140|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
30813908|NCT03426995|58833141|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813909|NCT03426995|58833142|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813910|NCT03426995|58833143|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
30813911|NCT03426995|58833125|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813912|NCT03426995|58833126|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813913|NCT03426995|58833127|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813914|NCT03426995|58833128|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813915|NCT03426995|58833129|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813916|NCT03426995|58833130|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813917|NCT03426995|58833131|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813918|NCT03426995|58833132|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813919|NCT03426995|58833133|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813920|NCT03426995|58833134|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813921|NCT03426995|58833135|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813922|NCT03426995|58833136|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813923|NCT03426995|58833137|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813924|NCT03426995|58833138|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813925|NCT03426995|58833139|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
30813926|NCT03426995|58833140|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
30813927|NCT03426995|58833141|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813928|NCT03426995|58833142|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813929|NCT03426995|58833143|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
30813930|NCT03424265|58833192|FG000|Overall Study|screening failure|1|||
30813931|NCT03424265|58833193|FG001|Overall Study|screening failure|0|||
30813932|NCT03424265|58833192|FG000|Overall Study|Withdrawal by Subject|0|||
30813933|NCT03424265|58833193|FG001|Overall Study|Withdrawal by Subject|2|||
30813934|NCT03322566|58833202|FG000|Overall Study|Death|34|||
30813935|NCT03322566|58833203|FG001|Overall Study|Death|35|||
30813936|NCT03322566|58833204|FG002|Overall Study|Death|23|||
30813937|NCT03322566|58833202|FG000|Overall Study|Physician Decision|6|||
30813938|NCT03322566|58833203|FG001|Overall Study|Physician Decision|7|||
30813939|NCT03322566|58833204|FG002|Overall Study|Physician Decision|2|||
30813940|NCT03322566|58833202|FG000|Overall Study|Withdrawal by Subject|4|||
30813941|NCT03322566|58833203|FG001|Overall Study|Withdrawal by Subject|3|||
30813942|NCT03322566|58833204|FG002|Overall Study|Withdrawal by Subject|6|||
30813943|NCT03322566|58833202|FG000|Overall Study|Lost to Follow-up|0|||
30813944|NCT03322566|58833203|FG001|Overall Study|Lost to Follow-up|0|||
30813945|NCT03322566|58833204|FG002|Overall Study|Lost to Follow-up|1|||
30813946|NCT03322566|58833202|FG000|Overall Study|Study terminated by sponsor|1|||
30813947|NCT03322566|58833203|FG001|Overall Study|Study terminated by sponsor|0|||
30813948|NCT03322566|58833204|FG002|Overall Study|Study terminated by sponsor|1|||
30813949|NCT02969018|58833220|FG000|Overall Study|Adverse Event|2|||
30813950|NCT02969018|58833221|FG001|Overall Study|Adverse Event|4|||
30813951|NCT02969018|58833222|FG002|Overall Study|Adverse Event|1|||
30813952|NCT02969018|58833223|FG003|Overall Study|Adverse Event|2|||
30813953|NCT02969018|58833224|FG004|Overall Study|Adverse Event|0|||
30813954|NCT02969018|58833225|FG005|Overall Study|Adverse Event|1|||
30910950|NCT02164513|58945781|FG000|Overall Study|Other: Reason not provided by site|1|||
30910951|NCT02164513|58945782|FG001|Overall Study|Other: Reason not provided by site|0|||
30910952|NCT02164513|58945783|FG002|Overall Study|Other: Reason not provided by site|0|||
30910953|NCT02218489|58945803|FG000|Overall Study|Withdrawal by Subject|4|||
30813955|NCT02969018|58833226|FG006|Overall Study|Adverse Event|2|||
30813956|NCT02969018|58833227|FG007|Overall Study|Adverse Event|0|||
30813957|NCT02969018|58833220|FG000|Overall Study|Lack of Efficacy|0|||
30813958|NCT02969018|58833221|FG001|Overall Study|Lack of Efficacy|1|||
30813959|NCT02969018|58833222|FG002|Overall Study|Lack of Efficacy|0|||
30813960|NCT02969018|58833223|FG003|Overall Study|Lack of Efficacy|0|||
30813961|NCT02969018|58833224|FG004|Overall Study|Lack of Efficacy|1|||
30813962|NCT02969018|58833225|FG005|Overall Study|Lack of Efficacy|1|||
30813963|NCT02969018|58833226|FG006|Overall Study|Lack of Efficacy|1|||
30813964|NCT02969018|58833227|FG007|Overall Study|Lack of Efficacy|1|||
30813965|NCT02969018|58833220|FG000|Overall Study|Lost to Follow-up|1|||
30813966|NCT02969018|58833221|FG001|Overall Study|Lost to Follow-up|2|||
30813967|NCT02969018|58833222|FG002|Overall Study|Lost to Follow-up|2|||
30813968|NCT02969018|58833223|FG003|Overall Study|Lost to Follow-up|0|||
30813969|NCT02969018|58833224|FG004|Overall Study|Lost to Follow-up|1|||
30813970|NCT02969018|58833225|FG005|Overall Study|Lost to Follow-up|1|||
30813971|NCT02969018|58833226|FG006|Overall Study|Lost to Follow-up|0|||
30813972|NCT02969018|58833227|FG007|Overall Study|Lost to Follow-up|1|||
30813973|NCT02969018|58833220|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
30813974|NCT02969018|58833221|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
30813975|NCT02969018|58833222|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
30813976|NCT02969018|58833223|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
30813977|NCT02969018|58833224|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
30813978|NCT02969018|58833225|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
30813979|NCT02969018|58833226|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
30910954|NCT02218489|58945804|FG001|Overall Study|Withdrawal by Subject|3|||
30813980|NCT02969018|58833227|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
30813981|NCT02969018|58833220|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30813982|NCT02969018|58833221|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30813983|NCT02969018|58833222|FG002|Overall Study|Non-Compliance With Study Drug|0|||
30813984|NCT02969018|58833223|FG003|Overall Study|Non-Compliance With Study Drug|0|||
30813985|NCT02969018|58833224|FG004|Overall Study|Non-Compliance With Study Drug|0|||
30813986|NCT02969018|58833225|FG005|Overall Study|Non-Compliance With Study Drug|0|||
30813987|NCT02969018|58833226|FG006|Overall Study|Non-Compliance With Study Drug|0|||
30813988|NCT02969018|58833227|FG007|Overall Study|Non-Compliance With Study Drug|0|||
30813989|NCT02969018|58833220|FG000|Overall Study|Other|0|||
30813990|NCT02969018|58833221|FG001|Overall Study|Other|0|||
30813991|NCT02969018|58833222|FG002|Overall Study|Other|0|||
30813992|NCT02969018|58833223|FG003|Overall Study|Other|1|||
30813993|NCT02969018|58833224|FG004|Overall Study|Other|0|||
30813994|NCT02969018|58833225|FG005|Overall Study|Other|0|||
30813995|NCT02969018|58833226|FG006|Overall Study|Other|0|||
30910955|NCT02218489|58945803|FG000|Overall Study|Lost to Follow-up|1|||
30910956|NCT02218489|58945804|FG001|Overall Study|Lost to Follow-up|0|||
30910957|NCT02192905|58945811|FG000|Overall Study|Lost to Follow-up|1|||
30910958|NCT01713946|58945819|FG000|Overall Study|Death|0|||
30910959|NCT01713946|58945820|FG001|Overall Study|Death|2|||
30910960|NCT01713946|58945821|FG002|Overall Study|Death|2|||
30910961|NCT01713946|58945819|FG000|Overall Study|Adverse Event|19|||
30910962|NCT01713946|58945820|FG001|Overall Study|Adverse Event|14|||
30910963|NCT01713946|58945821|FG002|Overall Study|Adverse Event|13|||
30910964|NCT01713946|58945819|FG000|Overall Study|Withdrawal by Subject|12|||
30910965|NCT01713946|58945820|FG001|Overall Study|Withdrawal by Subject|12|||
30910966|NCT01713946|58945821|FG002|Overall Study|Withdrawal by Subject|8|||
30910967|NCT01713946|58945819|FG000|Overall Study|Lack of Efficacy|8|||
30813996|NCT02969018|58833227|FG007|Overall Study|Other|2|||
30813997|NCT02969018|58833220|FG000|Overall Study|Pregnancy|0|||
30813998|NCT02969018|58833221|FG001|Overall Study|Pregnancy|0|||
30813999|NCT02969018|58833222|FG002|Overall Study|Pregnancy|0|||
30814000|NCT02969018|58833223|FG003|Overall Study|Pregnancy|0|||
30910968|NCT01713946|58945820|FG001|Overall Study|Lack of Efficacy|8|||
30910969|NCT01713946|58945821|FG002|Overall Study|Lack of Efficacy|14|||
30910970|NCT01713946|58945819|FG000|Overall Study|Protocol Violation|2|||
30910971|NCT01713946|58945820|FG001|Overall Study|Protocol Violation|4|||
30910972|NCT01713946|58945821|FG002|Overall Study|Protocol Violation|1|||
30910973|NCT01713946|58945819|FG000|Overall Study|Lost to Follow-up|0|||
30814001|NCT02969018|58833224|FG004|Overall Study|Pregnancy|0|||
30814002|NCT02969018|58833225|FG005|Overall Study|Pregnancy|1|||
30814003|NCT02969018|58833226|FG006|Overall Study|Pregnancy|0|||
30910974|NCT01713946|58945820|FG001|Overall Study|Lost to Follow-up|0|||
30910975|NCT01713946|58945821|FG002|Overall Study|Lost to Follow-up|1|||
30814004|NCT02969018|58833227|FG007|Overall Study|Pregnancy|0|||
30814005|NCT02969018|58833220|FG000|Overall Study|Protocol Violation|0|||
30814006|NCT02969018|58833221|FG001|Overall Study|Protocol Violation|0|||
30814007|NCT02969018|58833222|FG002|Overall Study|Protocol Violation|1|||
30814008|NCT02969018|58833223|FG003|Overall Study|Protocol Violation|1|||
30814009|NCT02969018|58833224|FG004|Overall Study|Protocol Violation|0|||
30814010|NCT02969018|58833225|FG005|Overall Study|Protocol Violation|0|||
30814011|NCT02969018|58833226|FG006|Overall Study|Protocol Violation|0|||
30814012|NCT02969018|58833227|FG007|Overall Study|Protocol Violation|0|||
30814013|NCT02969018|58833220|FG000|Overall Study|Withdrawal by Subject|0|||
30814014|NCT02969018|58833221|FG001|Overall Study|Withdrawal by Subject|1|||
30814015|NCT02969018|58833222|FG002|Overall Study|Withdrawal by Subject|2|||
30814016|NCT02969018|58833223|FG003|Overall Study|Withdrawal by Subject|1|||
30814017|NCT02969018|58833224|FG004|Overall Study|Withdrawal by Subject|0|||
30814018|NCT02969018|58833225|FG005|Overall Study|Withdrawal by Subject|4|||
30814019|NCT02969018|58833226|FG006|Overall Study|Withdrawal by Subject|4|||
30814020|NCT02969018|58833227|FG007|Overall Study|Withdrawal by Subject|3|||
30814021|NCT01319721|58833250|FG000|Overall Study|Lost to Follow-up|1|||
30814022|NCT01319721|58833251|FG001|Overall Study|Lost to Follow-up|6|||
30814023|NCT02905032|58833260|FG000|Overall Study|Withdrawal by Subject|2|||
30814024|NCT02905032|58833261|FG001|Overall Study|Withdrawal by Subject|0|||
30814025|NCT02905032|58833262|FG002|Overall Study|Withdrawal by Subject|0|||
30814026|NCT02905032|58833260|FG000|Overall Study|Protocol Violation|6|||
30814027|NCT02905032|58833261|FG001|Overall Study|Protocol Violation|12|||
30814028|NCT02905032|58833262|FG002|Overall Study|Protocol Violation|0|||
30814029|NCT03259425|58833269|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
30814030|NCT03101241|58833275|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
30814031|NCT03101241|58833276|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
30814032|NCT03101241|58833275|FG000|Overall Study|Participant withdrew consent|3|||
30814033|NCT03101241|58833276|FG001|Overall Study|Participant withdrew consent|1|||
30814034|NCT03101241|58833275|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
30814035|NCT03101241|58833276|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
30814036|NCT03101241|58833275|FG000|Overall Study|Lost to Follow-up|2|||
30814037|NCT03101241|58833276|FG001|Overall Study|Lost to Follow-up|0|||
30814038|NCT03101241|58833275|FG000|Overall Study|Lack of Efficacy|0|||
30814039|NCT03101241|58833276|FG001|Overall Study|Lack of Efficacy|1|||
30814040|NCT03101241|58833275|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
30814041|NCT03101241|58833276|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
30814042|NCT03061188|58833286|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
30814043|NCT03061188|58833287|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
30814044|NCT03061188|58833288|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
30814045|NCT03061188|58833289|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
30814046|NCT03061188|58833286|FG000|On Follow-up for 3 Years|Death|0|||
30814047|NCT03061188|58833287|FG001|On Follow-up for 3 Years|Death|3|||
30814048|NCT03061188|58833288|FG002|On Follow-up for 3 Years|Death|5|||
30814049|NCT03061188|58833289|FG003|On Follow-up for 3 Years|Death|2|||
30814050|NCT03061188|58833286|FG000|On Follow-up for 3 Years|Still in follow-up|0|||
30814051|NCT03061188|58833287|FG001|On Follow-up for 3 Years|Still in follow-up|0|||
30814052|NCT03061188|58833288|FG002|On Follow-up for 3 Years|Still in follow-up|0|||
30814053|NCT03061188|58833289|FG003|On Follow-up for 3 Years|Still in follow-up|3|||
30814054|NCT03449147|58833307|FG000|52-week Treatment Period|Death|0|||
30814055|NCT03449147|58833308|FG001|52-week Treatment Period|Death|1|||
30814056|NCT03449147|58833309|FG002|52-week Treatment Period|Death|0|||
30814057|NCT03449147|58833307|FG000|52-week Treatment Period|Lost to Follow-up|6|||
30814058|NCT03449147|58833308|FG001|52-week Treatment Period|Lost to Follow-up|2|||
30814059|NCT03449147|58833309|FG002|52-week Treatment Period|Lost to Follow-up|5|||
30814060|NCT03449147|58833307|FG000|52-week Treatment Period|Other|0|||
30814061|NCT03449147|58833308|FG001|52-week Treatment Period|Other|1|||
30814062|NCT03449147|58833309|FG002|52-week Treatment Period|Other|2|||
30814063|NCT03449147|58833307|FG000|52-week Treatment Period|Physician Decision|1|||
30814064|NCT03449147|58833308|FG001|52-week Treatment Period|Physician Decision|0|||
30814065|NCT03449147|58833309|FG002|52-week Treatment Period|Physician Decision|3|||
30814066|NCT03449147|58833307|FG000|52-week Treatment Period|Screen Failure|1|||
30814067|NCT03449147|58833308|FG001|52-week Treatment Period|Screen Failure|2|||
30750489|NCT03801148|58760371|FG003|Period 1 (2 Days)|Adverse Event|0|||
30750490|NCT03801148|58760368|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
30750491|NCT03801148|58760369|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
30750492|NCT03801148|58760370|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
30750493|NCT03801148|58760371|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
30750494|NCT03801148|58760368|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
30750495|NCT03801148|58760369|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
30750496|NCT03801148|58760370|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
30750497|NCT03801148|58760371|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
30814068|NCT03449147|58833309|FG002|52-week Treatment Period|Screen Failure|0|||
30814069|NCT03449147|58833307|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
30814070|NCT03449147|58833308|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
30814071|NCT03449147|58833309|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
30814072|NCT03449147|58833307|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
30814073|NCT03449147|58833308|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
30814074|NCT03449147|58833309|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
30814075|NCT03449147|58833307|FG000|12-Week Off-Treatment Durability Period|Other|0|||
30814076|NCT03449147|58833308|FG001|12-Week Off-Treatment Durability Period|Other|1|||
30814077|NCT03449147|58833309|FG002|12-Week Off-Treatment Durability Period|Other|0|||
30814078|NCT03423173|58833325|FG000|Overall Study|Randomized but not vaccinated|1|||
30814079|NCT03423173|58833326|FG001|Overall Study|Randomized but not vaccinated|0|||
30814080|NCT03423173|58833327|FG002|Overall Study|Randomized but not vaccinated|2|||
30814081|NCT03423173|58833328|FG003|Overall Study|Randomized but not vaccinated|1|||
30814082|NCT03423173|58833325|FG000|Overall Study|Adverse Event|1|||
30814083|NCT03423173|58833326|FG001|Overall Study|Adverse Event|1|||
30814084|NCT03423173|58833327|FG002|Overall Study|Adverse Event|1|||
30814085|NCT03423173|58833328|FG003|Overall Study|Adverse Event|1|||
30814086|NCT03423173|58833325|FG000|Overall Study|Lost to Follow-up|10|||
30814087|NCT03423173|58833326|FG001|Overall Study|Lost to Follow-up|19|||
30814088|NCT03423173|58833327|FG002|Overall Study|Lost to Follow-up|17|||
30814089|NCT03423173|58833328|FG003|Overall Study|Lost to Follow-up|22|||
30814090|NCT03423173|58833325|FG000|Overall Study|Withdrawal of consent|4|||
30814091|NCT03423173|58833326|FG001|Overall Study|Withdrawal of consent|10|||
30814092|NCT03423173|58833327|FG002|Overall Study|Withdrawal of consent|4|||
30814093|NCT03423173|58833328|FG003|Overall Study|Withdrawal of consent|5|||
30814094|NCT03423173|58833325|FG000|Overall Study|Death|1|||
30814095|NCT03423173|58833326|FG001|Overall Study|Death|0|||
30814096|NCT03423173|58833327|FG002|Overall Study|Death|0|||
30814097|NCT03423173|58833328|FG003|Overall Study|Death|0|||
30814098|NCT03423173|58833325|FG000|Overall Study|Reason not Specified|2|||
30814099|NCT03423173|58833326|FG001|Overall Study|Reason not Specified|5|||
30814100|NCT03423173|58833327|FG002|Overall Study|Reason not Specified|3|||
30814101|NCT03423173|58833328|FG003|Overall Study|Reason not Specified|1|||
30814102|NCT03447821|58833341|FG000|Overall Study|Withdrawal by Subject|1|||
30814103|NCT03447821|58833342|FG001|Overall Study|Withdrawal by Subject|1|||
30814104|NCT03447821|58833343|FG002|Overall Study|Withdrawal by Subject|0|||
30814105|NCT03447821|58833341|FG000|Overall Study|Lost to Follow-up|0|||
30814106|NCT03447821|58833342|FG001|Overall Study|Lost to Follow-up|0|||
30910976|NCT01713946|58945819|FG000|Overall Study|Administrative problems|1|||
30910977|NCT01713946|58945820|FG001|Overall Study|Administrative problems|0|||
30910978|NCT01713946|58945821|FG002|Overall Study|Administrative problems|0|||
30910979|NCT01713946|58945819|FG000|Overall Study|Did not continue in Ext|0|||
30910980|NCT01713946|58945820|FG001|Overall Study|Did not continue in Ext|3|||
30910981|NCT01713946|58945821|FG002|Overall Study|Did not continue in Ext|0|||
30910982|NCT01713946|58945819|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
30622583|NCT01175135|58634269|FG002|Overall Study|Other|3|||
30814107|NCT03447821|58833343|FG002|Overall Study|Lost to Follow-up|1|||
30814108|NCT03447353|58833357|FG000|Overall Study|Failure at Screening Visit|2|||
30814109|NCT03447353|58833357|FG000|Overall Study|Lost to Follow-up|4|||
30814110|NCT03447353|58833357|FG000|Overall Study|Scheduling Conflicts|3|||
30814111|NCT03447353|58833357|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
30814112|NCT03446885|58833367|FG000|Overall Study|Lost to Follow-up|1|||
30814113|NCT03446885|58833368|FG001|Overall Study|Lost to Follow-up|0|||
30814114|NCT03446885|58833367|FG000|Overall Study|Did not complete entire visit|1|||
30814115|NCT03446885|58833368|FG001|Overall Study|Did not complete entire visit|0|||
30814116|NCT00710970|58833376|FG000|Overall Study|Never took drug|3|||
30814117|NCT03421379|58833382|FG000|Period 1|Withdrawal by Subject|0|||
30814118|NCT03421379|58833383|FG001|Period 1|Withdrawal by Subject|1|||
30814119|NCT03421379|58833382|FG000|Period 1|Physician Decision|1|||
30814120|NCT03421379|58833383|FG001|Period 1|Physician Decision|1|||
30814121|NCT03421379|58833382|FG000|Period 1|Did not receive treatment|1|||
30910983|NCT01713946|58945820|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
30910984|NCT01713946|58945821|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
30814122|NCT03421379|58833383|FG001|Period 1|Did not receive treatment|2|||
30814123|NCT02900378|58833391|FG000|Randomization (Visit 2)|Adverse Event|14|||
30814124|NCT02900378|58833392|FG001|Randomization (Visit 2)|Adverse Event|11|||
30814125|NCT02900378|58833391|FG000|Randomization (Visit 2)|Death|1|||
30814126|NCT02900378|58833392|FG001|Randomization (Visit 2)|Death|4|||
30814127|NCT02900378|58833391|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
30814128|NCT02900378|58833392|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
30814129|NCT02900378|58833391|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
30814130|NCT02900378|58833392|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
30910985|NCT01713946|58945819|FG000|Overall Study|Patients never switched to everolimus|0|||
30910986|NCT01713946|58945820|FG001|Overall Study|Patients never switched to everolimus|0|||
30814131|NCT02900378|58833391|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
30814132|NCT02900378|58833392|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
30814133|NCT02900378|58833391|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
30814134|NCT02900378|58833392|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
30814135|NCT02900378|58833391|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
30814136|NCT02900378|58833392|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
30814137|NCT03058692|58833400|FG000|Overall Study|Lost to Follow-up|2|||
30814138|NCT03058692|58833401|FG001|Overall Study|Lost to Follow-up|1|||
30814139|NCT03058692|58833400|FG000|Overall Study|Withdrawal by Subject|1|||
30814140|NCT03058692|58833401|FG001|Overall Study|Withdrawal by Subject|1|||
30814141|NCT02964338|58833411|FG000|Overall Study|Sponsor terminated study for futility|12|||
30814142|NCT02964338|58833412|FG001|Overall Study|Sponsor terminated study for futility|15|||
30814143|NCT02964338|58833413|FG002|Overall Study|Sponsor terminated study for futility|14|||
30814144|NCT02964338|58833411|FG000|Overall Study|Lack of Efficacy|0|||
30814145|NCT02964338|58833412|FG001|Overall Study|Lack of Efficacy|3|||
30814146|NCT02964338|58833413|FG002|Overall Study|Lack of Efficacy|0|||
30814147|NCT02964338|58833411|FG000|Overall Study|Lost to Follow-up|1|||
30814148|NCT02964338|58833412|FG001|Overall Study|Lost to Follow-up|0|||
30814149|NCT02964338|58833413|FG002|Overall Study|Lost to Follow-up|3|||
30814150|NCT02964338|58833411|FG000|Overall Study|Protocol Violation|0|||
30814151|NCT02964338|58833412|FG001|Overall Study|Protocol Violation|1|||
30814152|NCT02964338|58833413|FG002|Overall Study|Protocol Violation|0|||
30814153|NCT02964338|58833411|FG000|Overall Study|Withdrawal by Subject|1|||
30814154|NCT02964338|58833412|FG001|Overall Study|Withdrawal by Subject|3|||
30814155|NCT02964338|58833413|FG002|Overall Study|Withdrawal by Subject|1|||
30814156|NCT02964338|58833411|FG000|Overall Study|Adverse Event|2|||
30814157|NCT02964338|58833412|FG001|Overall Study|Adverse Event|1|||
30622584|NCT01175135|58634270|FG003|Overall Study|Other|0|||
30814158|NCT02964338|58833413|FG002|Overall Study|Adverse Event|1|||
30814159|NCT02964338|58833411|FG000|Overall Study|Non-compliant with e-diary|0|||
30814160|NCT02964338|58833412|FG001|Overall Study|Non-compliant with e-diary|1|||
30814161|NCT02964338|58833413|FG002|Overall Study|Non-compliant with e-diary|0|||
30814162|NCT02964338|58833411|FG000|Overall Study|Did not meet criteria|1|||
30814163|NCT02964338|58833412|FG001|Overall Study|Did not meet criteria|0|||
30814164|NCT02964338|58833413|FG002|Overall Study|Did not meet criteria|0|||
30814165|NCT03056352|58833421|FG000|Overall Study|Lost to Follow-up|1|||
30814166|NCT02898662|58833427|FG000|Overall Study|Adverse Event|1|||
30814167|NCT02898662|58833428|FG001|Overall Study|Adverse Event|0|||
30814168|NCT02898662|58833427|FG000|Overall Study|Loss of asthma control|23|||
30814169|NCT02898662|58833428|FG001|Overall Study|Loss of asthma control|24|||
30814170|NCT02898662|58833427|FG000|Overall Study|Withdrawal by Subject|4|||
30814171|NCT02898662|58833428|FG001|Overall Study|Withdrawal by Subject|1|||
30814172|NCT02898662|58833427|FG000|Overall Study|Technical issue|0|||
30814173|NCT02898662|58833428|FG001|Overall Study|Technical issue|1|||
30910987|NCT01713946|58945821|FG002|Overall Study|Patients never switched to everolimus|5|||
30910988|NCT02163499|58945847|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
30910989|NCT02163499|58945847|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
30910990|NCT02163499|58945847|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
30910991|NCT02163499|58945847|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
30910992|NCT02163499|58945847|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
30910993|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
30910994|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
30910995|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
30910996|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
30814174|NCT02898662|58833427|FG000|Overall Study|Randomized in error|0|||
30814175|NCT02898662|58833428|FG001|Overall Study|Randomized in error|1|||
30910997|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
30910998|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
30910999|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
30911000|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
30911001|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
30911002|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Death|8|||
30911003|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
30911004|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
30911005|NCT02163499|58945847|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
30911006|NCT02163187|58945857|FG000|Overall Study|Device removed|1|||
30911007|NCT02163187|58945858|FG001|Overall Study|Device removed|0|||
30911008|NCT02163187|58945857|FG000|Overall Study|Progressive disease|1|||
30911009|NCT02163187|58945858|FG001|Overall Study|Progressive disease|0|||
30911010|NCT02191579|58945866|FG000|Treatment 1|Multiple Reasons Specified|27|||
30911011|NCT02191579|58945867|FG001|Treatment 1|Multiple Reasons Specified|58|||
30911012|NCT02191579|58945866|FG000|Treatment 2|Multiple Reasons Specified|0|||
30911013|NCT02191579|58945867|FG001|Treatment 2|Multiple Reasons Specified|25|||
30911014|NCT01363700|58945876|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
30911015|NCT01363700|58945877|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
30911016|NCT01363700|58945878|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
30911017|NCT01363700|58945879|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
30911018|NCT01363700|58945880|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
30911019|NCT01637402|58945891|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
30911020|NCT01637402|58945892|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
30814176|NCT02898662|58833427|FG000|Overall Study|Subject decision|1|||
30814177|NCT02898662|58833428|FG001|Overall Study|Subject decision|0|||
30814178|NCT02898662|58833427|FG000|Overall Study|Other|0|||
30911021|NCT01637402|58945891|FG000|Standard Dose Regimen|Adverse Event|1|||
30911022|NCT01637402|58945892|FG001|Standard Dose Regimen|Adverse Event|0|||
30911023|NCT01637402|58945891|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
30911024|NCT01637402|58945892|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
30911025|NCT01637402|58945891|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
30911026|NCT01637402|58945892|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
30911027|NCT01637402|58945891|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
30911028|NCT01637402|58945892|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
30911029|NCT01637402|58945891|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
30911030|NCT01637402|58945892|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
30814179|NCT02898662|58833428|FG001|Overall Study|Other|1|||
30814180|NCT03055338|58833437|FG000|Overall Study|Lost to Follow-up|9|||
30814181|NCT03055338|58833438|FG001|Overall Study|Lost to Follow-up|2|||
30814182|NCT03055338|58833439|FG002|Overall Study|Lost to Follow-up|3|||
30911031|NCT02217475|58945920|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
30911032|NCT02217475|58945921|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
30814183|NCT03055338|58833437|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
30814184|NCT03055338|58833438|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
30814185|NCT03055338|58833439|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
30814186|NCT03055338|58833437|FG000|Overall Study|Physician Decision|0|||
30814187|NCT03055338|58833438|FG001|Overall Study|Physician Decision|0|||
30814188|NCT03055338|58833439|FG002|Overall Study|Physician Decision|2|||
30814189|NCT03055338|58833437|FG000|Overall Study|Withdrawal by Subject|9|||
30814190|NCT03055338|58833438|FG001|Overall Study|Withdrawal by Subject|8|||
30814191|NCT03055338|58833439|FG002|Overall Study|Withdrawal by Subject|7|||
30814192|NCT03913130|58833447|FG000|Overall Study|Sponsor Decision|1|||
30814193|NCT03419741|58833453|FG000|Overall Study|Adverse Event|1|||
30814194|NCT03419741|58833454|FG001|Overall Study|Adverse Event|0|||
30814195|NCT03419741|58833453|FG000|Overall Study|Withdrawal by Subject|1|||
30814196|NCT03419741|58833454|FG001|Overall Study|Withdrawal by Subject|2|||
30814197|NCT02896400|58833476|FG000|1 Month Follow-up|Lost to Follow-up|7|||
30814198|NCT02896400|58833477|FG001|1 Month Follow-up|Lost to Follow-up|7|||
30814199|NCT02896400|58833478|FG002|1 Month Follow-up|Lost to Follow-up|5|||
30814200|NCT02896400|58833479|FG003|1 Month Follow-up|Lost to Follow-up|8|||
30814201|NCT02896400|58833480|FG004|1 Month Follow-up|Lost to Follow-up|9|||
30814202|NCT02896400|58833481|FG005|1 Month Follow-up|Lost to Follow-up|6|||
30814203|NCT02896400|58833482|FG006|1 Month Follow-up|Lost to Follow-up|5|||
30814204|NCT02896400|58833483|FG007|1 Month Follow-up|Lost to Follow-up|6|||
30814205|NCT02896400|58833484|FG008|1 Month Follow-up|Lost to Follow-up|4|||
30814206|NCT02896400|58833485|FG009|1 Month Follow-up|Lost to Follow-up|7|||
30814207|NCT02896400|58833486|FG010|1 Month Follow-up|Lost to Follow-up|5|||
30814208|NCT02896400|58833487|FG011|1 Month Follow-up|Lost to Follow-up|5|||
30814209|NCT02896400|58833488|FG012|1 Month Follow-up|Lost to Follow-up|3|||
30814210|NCT02896400|58833489|FG013|1 Month Follow-up|Lost to Follow-up|4|||
30814211|NCT02896400|58833490|FG014|1 Month Follow-up|Lost to Follow-up|1|||
30814212|NCT02896400|58833491|FG015|1 Month Follow-up|Lost to Follow-up|2|||
30814213|NCT02896400|58833476|FG000|1 Month Follow-up|Death|0|||
30814214|NCT02896400|58833477|FG001|1 Month Follow-up|Death|0|||
30814215|NCT02896400|58833478|FG002|1 Month Follow-up|Death|0|||
30814216|NCT02896400|58833479|FG003|1 Month Follow-up|Death|0|||
30814217|NCT02896400|58833480|FG004|1 Month Follow-up|Death|0|||
30814218|NCT02896400|58833481|FG005|1 Month Follow-up|Death|0|||
30814219|NCT02896400|58833482|FG006|1 Month Follow-up|Death|0|||
30911033|NCT02217475|58945922|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
30814220|NCT02896400|58833483|FG007|1 Month Follow-up|Death|0|||
30814221|NCT02896400|58833484|FG008|1 Month Follow-up|Death|0|||
30814222|NCT02896400|58833485|FG009|1 Month Follow-up|Death|0|||
30814223|NCT02896400|58833486|FG010|1 Month Follow-up|Death|0|||
30814224|NCT02896400|58833487|FG011|1 Month Follow-up|Death|0|||
30814225|NCT02896400|58833488|FG012|1 Month Follow-up|Death|0|||
30911034|NCT02217475|58945920|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
30814226|NCT02896400|58833489|FG013|1 Month Follow-up|Death|0|||
30814227|NCT02896400|58833490|FG014|1 Month Follow-up|Death|0|||
30814228|NCT02896400|58833491|FG015|1 Month Follow-up|Death|1|||
30814229|NCT02896400|58833476|FG000|3 Month Follow-up|Lost to Follow-up|6|||
30814230|NCT02896400|58833477|FG001|3 Month Follow-up|Lost to Follow-up|3|||
30814231|NCT02896400|58833478|FG002|3 Month Follow-up|Lost to Follow-up|6|||
30911035|NCT02217475|58945921|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
30911036|NCT02217475|58945922|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
30911037|NCT02217475|58945920|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
30911038|NCT02217475|58945921|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
30814232|NCT02896400|58833479|FG003|3 Month Follow-up|Lost to Follow-up|11|||
30814233|NCT02896400|58833480|FG004|3 Month Follow-up|Lost to Follow-up|12|||
30814234|NCT02896400|58833481|FG005|3 Month Follow-up|Lost to Follow-up|6|||
30814235|NCT02896400|58833482|FG006|3 Month Follow-up|Lost to Follow-up|4|||
30814236|NCT02896400|58833483|FG007|3 Month Follow-up|Lost to Follow-up|3|||
30814237|NCT02896400|58833484|FG008|3 Month Follow-up|Lost to Follow-up|6|||
30814238|NCT02896400|58833485|FG009|3 Month Follow-up|Lost to Follow-up|5|||
30814239|NCT02896400|58833486|FG010|3 Month Follow-up|Lost to Follow-up|6|||
30814240|NCT02896400|58833487|FG011|3 Month Follow-up|Lost to Follow-up|6|||
30814241|NCT02896400|58833488|FG012|3 Month Follow-up|Lost to Follow-up|3|||
30814242|NCT02896400|58833489|FG013|3 Month Follow-up|Lost to Follow-up|5|||
30814243|NCT02896400|58833490|FG014|3 Month Follow-up|Lost to Follow-up|3|||
30814244|NCT02896400|58833491|FG015|3 Month Follow-up|Lost to Follow-up|2|||
30814245|NCT02896400|58833476|FG000|3 Month Follow-up|Death|0|||
30814246|NCT02896400|58833477|FG001|3 Month Follow-up|Death|0|||
30814247|NCT02896400|58833478|FG002|3 Month Follow-up|Death|0|||
30814248|NCT02896400|58833479|FG003|3 Month Follow-up|Death|0|||
30750498|NCT03801148|58760368|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
30750499|NCT03801148|58760369|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
30750500|NCT03801148|58760370|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
30750501|NCT03801148|58760371|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
30750502|NCT00072280|58760383|FG000|Treatment|Found ineligible|1|||
30750503|NCT00072280|58760384|FG001|Treatment|Found ineligible|2|||
30750504|NCT00072280|58760383|FG000|Follow-up|Early termination of study|2|||
30750505|NCT00072280|58760384|FG001|Follow-up|Early termination of study|2|||
30750506|NCT00071812|58760393|FG000|24-Week Double-Blind Period|Adverse Event|2|||
30750507|NCT00071812|58760394|FG001|24-Week Double-Blind Period|Adverse Event|3|||
30814249|NCT02896400|58833480|FG004|3 Month Follow-up|Death|0|||
30814250|NCT02896400|58833481|FG005|3 Month Follow-up|Death|0|||
30814251|NCT02896400|58833482|FG006|3 Month Follow-up|Death|0|||
30814252|NCT02896400|58833483|FG007|3 Month Follow-up|Death|0|||
30814253|NCT02896400|58833484|FG008|3 Month Follow-up|Death|0|||
30911039|NCT02217475|58945922|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
30911040|NCT02217475|58945920|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
30750508|NCT00071812|58760395|FG002|24-Week Double-Blind Period|Adverse Event|4|||
30814254|NCT02896400|58833485|FG009|3 Month Follow-up|Death|0|||
30814255|NCT02896400|58833486|FG010|3 Month Follow-up|Death|0|||
30911041|NCT02217475|58945921|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
30911042|NCT02217475|58945922|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
30911043|NCT02217475|58945920|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
30814256|NCT02896400|58833487|FG011|3 Month Follow-up|Death|0|||
30814257|NCT02896400|58833488|FG012|3 Month Follow-up|Death|0|||
30814258|NCT02896400|58833489|FG013|3 Month Follow-up|Death|1|||
30814259|NCT02896400|58833490|FG014|3 Month Follow-up|Death|1|||
30814260|NCT02896400|58833491|FG015|3 Month Follow-up|Death|0|||
30911044|NCT02217475|58945921|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
30750509|NCT00071812|58760396|FG003|24-Week Double-Blind Period|Adverse Event|4|||
30814261|NCT02896400|58833476|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
30814262|NCT02896400|58833477|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
30814263|NCT02896400|58833478|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
30814264|NCT02896400|58833479|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
30814265|NCT02896400|58833480|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
30814266|NCT02896400|58833481|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
30814267|NCT02896400|58833482|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
30814268|NCT02896400|58833483|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
30814269|NCT02896400|58833484|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
30814270|NCT02896400|58833485|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
30814271|NCT02896400|58833486|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
30814272|NCT02896400|58833487|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
30814273|NCT02896400|58833488|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
30814274|NCT02896400|58833489|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
30814275|NCT02896400|58833490|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
30814276|NCT02896400|58833491|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
30814277|NCT02896400|58833476|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
30814278|NCT02896400|58833477|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
30814279|NCT02896400|58833478|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
30814280|NCT02896400|58833479|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
30814281|NCT02896400|58833480|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
30814282|NCT02896400|58833481|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
30911045|NCT02217475|58945922|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
30911046|NCT02217475|58945920|FG000|Discontinued After Period 1|Adverse Event|1|||
30911047|NCT02217475|58945921|FG001|Discontinued After Period 1|Adverse Event|2|||
30911048|NCT02217475|58945922|FG002|Discontinued After Period 1|Adverse Event|0|||
30911049|NCT02217475|58945920|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
30911050|NCT02217475|58945921|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
30911051|NCT02217475|58945922|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
30911052|NCT02217475|58945920|FG000|Discontinued After Period 1|Physician Decision|0|||
30814283|NCT02896400|58833482|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
30814284|NCT02896400|58833483|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
30814285|NCT02896400|58833484|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
30814286|NCT02896400|58833485|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
30814287|NCT02896400|58833486|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
30814288|NCT02896400|58833487|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
30814289|NCT02896400|58833488|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
30814290|NCT02896400|58833489|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
30814291|NCT02896400|58833490|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
30814292|NCT02896400|58833491|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
30814293|NCT03405935|58833517|FG000|Overall Study|Adverse Event|3|||
30814294|NCT03405935|58833517|FG000|Overall Study|Death|2|||
30911053|NCT02217475|58945921|FG001|Discontinued After Period 1|Physician Decision|0|||
30814295|NCT03405935|58833517|FG000|Overall Study|Withdrawal by Subject|1|||
30814296|NCT03405935|58833517|FG000|Overall Study|Lost to Follow-up|2|||
30814297|NCT03055260|58833523|FG000|Overall Study|Withdrawal by Subject|1|||
30814298|NCT03055260|58833524|FG001|Overall Study|Withdrawal by Subject|0|||
30911054|NCT02217475|58945922|FG002|Discontinued After Period 1|Physician Decision|1|||
30911055|NCT02217475|58945920|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
30911056|NCT02217475|58945921|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
30911057|NCT02217475|58945922|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
30911058|NCT02217475|58945920|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
30911059|NCT02217475|58945921|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
30814299|NCT03404843|58833532|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
30814300|NCT03404843|58833533|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
30814301|NCT03444155|58833557|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
30814302|NCT03444155|58833558|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
30814303|NCT02898116|58833564|FG000|Overall Study|Adverse Event|1|||
30814304|NCT02898116|58833564|FG000|Overall Study|Progressive disease|1|||
30814305|NCT03658304|58833568|FG000|Overall Study|participants still on follow up|8|||
30814306|NCT03422159|58833574|FG000|Overall Study|Exclusion due to terminal disease|2|||
30814307|NCT03422159|58833575|FG001|Overall Study|Exclusion due to terminal disease|1|||
30814308|NCT03403751|58833585|FG000|Overall Study|Death|5|||
30814309|NCT03403751|58833586|FG001|Overall Study|Death|6|||
30814310|NCT03403751|58833585|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
30814311|NCT03403751|58833586|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
30814312|NCT02297412|58833596|FG000|Overall Study|Canceled|1|||
30814313|NCT02297412|58833597|FG001|Overall Study|Canceled|1|||
30814314|NCT03418727|58833606|FG000|Overall Study|Adverse Event|1|||
30814315|NCT03418727|58833607|FG001|Overall Study|Adverse Event|2|||
30814316|NCT03418727|58833608|FG002|Overall Study|Adverse Event|0|||
30814317|NCT03418727|58833606|FG000|Overall Study|Withdrawal by Subject|0|||
30814318|NCT03418727|58833607|FG001|Overall Study|Withdrawal by Subject|0|||
30814319|NCT03418727|58833608|FG002|Overall Study|Withdrawal by Subject|2|||
30814320|NCT03418571|58833618|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
30814321|NCT03418571|58833619|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
30814322|NCT03402893|58833625|FG000|Overall Study|Withdrawal by Subject|1|||
30814323|NCT03442985|58833633|FG000|Overall Study|Sponsor Request|55|||
30814324|NCT03442985|58833634|FG001|Overall Study|Sponsor Request|60|||
30814325|NCT03442985|58833635|FG002|Overall Study|Sponsor Request|54|||
30814326|NCT03442985|58833633|FG000|Overall Study|Lost to Follow-up|5|||
30814327|NCT03442985|58833634|FG001|Overall Study|Lost to Follow-up|2|||
30814328|NCT03442985|58833635|FG002|Overall Study|Lost to Follow-up|7|||
30814329|NCT03442985|58833633|FG000|Overall Study|Withdrawal by Subject|2|||
30814330|NCT03442985|58833634|FG001|Overall Study|Withdrawal by Subject|3|||
30911060|NCT02217475|58945922|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
30814331|NCT03442985|58833635|FG002|Overall Study|Withdrawal by Subject|4|||
30814332|NCT03442985|58833633|FG000|Overall Study|Adverse Event|0|||
30814333|NCT03442985|58833634|FG001|Overall Study|Adverse Event|1|||
30814334|NCT03442985|58833635|FG002|Overall Study|Adverse Event|0|||
30814335|NCT01318122|58833647|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30814336|NCT01318122|58833648|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30814337|NCT01318122|58833649|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
30911061|NCT02217475|58945920|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
30911062|NCT02217475|58945921|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
30911063|NCT02217475|58945922|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
30911064|NCT02217475|58945920|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
30911065|NCT02217475|58945921|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
30911066|NCT02217475|58945922|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
30911067|NCT02217475|58945920|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
30911068|NCT02217475|58945921|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
30911069|NCT02217475|58945922|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
30911070|NCT02191267|58945942|FG000|Overall Study|Withdrawal by Subject|1|||
30911071|NCT02191267|58945943|FG001|Overall Study|Withdrawal by Subject|0|||
30911072|NCT02191267|58945944|FG002|Overall Study|Withdrawal by Subject|0|||
30911073|NCT02189941|58945952|FG000|Overall Study|Non-compliance|0|||
30911074|NCT02189941|58945953|FG001|Overall Study|Non-compliance|0|||
30911075|NCT02189941|58945954|FG002|Overall Study|Non-compliance|1|||
30911076|NCT02216773|58945964|FG000|Overall Study|Disease progression|4|||
30911077|NCT02216773|58945965|FG001|Overall Study|Disease progression|2|||
30911078|NCT02216773|58945964|FG000|Overall Study|Insufficient FLRV|4|||
30911079|NCT02216773|58945965|FG001|Overall Study|Insufficient FLRV|0|||
30911080|NCT02216773|58945964|FG000|Overall Study|Abandoned|4|||
30911081|NCT02216773|58945965|FG001|Overall Study|Abandoned|3|||
30911082|NCT01601132|58945971|FG000|Overall Study|Patient withdrew consent|1|||
30911083|NCT01601132|58945971|FG000|Overall Study|Protocol deviation|1|||
30911084|NCT02162719|58945980|FG000|Overall Study|Death|41|||
30911085|NCT02162719|58945981|FG001|Overall Study|Death|46|||
30911086|NCT02162719|58945980|FG000|Overall Study|Lost to Follow-up|1|||
30814338|NCT01318122|58833650|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
30814339|NCT01318122|58833647|FG000|Enrolled - Long-Term Extension Study|Other|1|||
30814340|NCT01318122|58833648|FG001|Enrolled - Long-Term Extension Study|Other|0|||
30814341|NCT01318122|58833649|FG002|Enrolled - Long-Term Extension Study|Other|0|||
30814342|NCT01318122|58833650|FG003|Enrolled - Long-Term Extension Study|Other|0|||
30814343|NCT01318122|58833647|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
30814344|NCT01318122|58833648|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
30814345|NCT01318122|58833649|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
30814346|NCT01318122|58833650|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
30814347|NCT01318122|58833647|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
30814348|NCT01318122|58833648|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
30814349|NCT01318122|58833649|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
30814350|NCT01318122|58833650|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
30814351|NCT01318122|58833647|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
30814352|NCT01318122|58833648|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
30814353|NCT01318122|58833649|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
30814354|NCT01318122|58833650|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
30814355|NCT01318122|58833647|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
30814356|NCT01318122|58833648|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
30814357|NCT01318122|58833649|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
30814358|NCT01318122|58833650|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
30814359|NCT02954159|58833658|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
30911087|NCT02162719|58945981|FG001|Overall Study|Lost to Follow-up|3|||
30911088|NCT02162719|58945980|FG000|Overall Study|Disease Progression|2|||
30911089|NCT02162719|58945981|FG001|Overall Study|Disease Progression|1|||
30911090|NCT02162719|58945980|FG000|Overall Study|Withdrawal by Subject|8|||
30911091|NCT02162719|58945981|FG001|Overall Study|Withdrawal by Subject|2|||
30911092|NCT02162719|58945980|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
30814360|NCT02954159|58833659|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
30814361|NCT02954159|58833658|FG000|Overall Study|Withdrawal by Subject|0|||
30814362|NCT02954159|58833659|FG001|Overall Study|Withdrawal by Subject|1|||
30814363|NCT03442829|58833667|FG000|Overall Study|Scheduling clash|3|||
30814364|NCT03442829|58833668|FG001|Overall Study|Scheduling clash|1|||
30814365|NCT03442829|58833667|FG000|Overall Study|Illness unrelated to study|1|||
30814366|NCT03442829|58833668|FG001|Overall Study|Illness unrelated to study|1|||
30814367|NCT03442595|58833676|FG000|Overall Study|Lost to Follow-up|94|||
30814368|NCT03442595|58833677|FG001|Overall Study|Lost to Follow-up|0|||
30814369|NCT03440411|58833686|FG000|Overall Study|Adverse Event|0|||
30814370|NCT03440411|58833687|FG001|Overall Study|Adverse Event|0|||
30814371|NCT03440411|58833688|FG002|Overall Study|Adverse Event|1|||
30814372|NCT03440411|58833689|FG003|Overall Study|Adverse Event|0|||
30814373|NCT03440411|58833686|FG000|Overall Study|PD|2|||
30814374|NCT03440411|58833687|FG001|Overall Study|PD|1|||
30814375|NCT03440411|58833688|FG002|Overall Study|PD|1|||
30814376|NCT03440411|58833689|FG003|Overall Study|PD|1|||
30814377|NCT03440411|58833686|FG000|Overall Study|Withdrawal by Subject|1|||
30814378|NCT03440411|58833687|FG001|Overall Study|Withdrawal by Subject|0|||
30814379|NCT03440411|58833688|FG002|Overall Study|Withdrawal by Subject|0|||
30814380|NCT03440411|58833689|FG003|Overall Study|Withdrawal by Subject|0|||
30814381|NCT03440411|58833686|FG000|Overall Study|Closed study by sponsor|0|||
30814382|NCT03440411|58833687|FG001|Overall Study|Closed study by sponsor|0|||
30814383|NCT03440411|58833688|FG002|Overall Study|Closed study by sponsor|0|||
30814384|NCT03440411|58833689|FG003|Overall Study|Closed study by sponsor|1|||
30814385|NCT03438539|58833710|FG000|Overall Study|Lost to Follow-up|8|||
30814386|NCT03438539|58833711|FG001|Overall Study|Lost to Follow-up|4|||
30814387|NCT03438539|58833712|FG002|Overall Study|Lost to Follow-up|10|||
30814388|NCT03438539|58833713|FG003|Overall Study|Lost to Follow-up|9|||
30814389|NCT03438539|58833714|FG004|Overall Study|Lost to Follow-up|3|||
30814390|NCT03438539|58833715|FG005|Overall Study|Lost to Follow-up|8|||
30814391|NCT03400787|58833731|FG000|Overall Study|Lost to Follow-up|1|||
30814392|NCT03400787|58833732|FG001|Overall Study|Lost to Follow-up|0|||
30814393|NCT03400787|58833731|FG000|Overall Study|Death|1|||
30814394|NCT03400787|58833732|FG001|Overall Study|Death|0|||
30814395|NCT03400787|58833731|FG000|Overall Study|Protocol Violation|0|||
30814396|NCT03400787|58833732|FG001|Overall Study|Protocol Violation|2|||
30814397|NCT03400787|58833731|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
30911093|NCT02162719|58945981|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
30911094|NCT02161549|58945989|FG000|Overall Study|Physician Decision|6|||
30814398|NCT03400787|58833732|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
30814399|NCT03417245|58833740|FG000|Overall Study|Adverse Event|1|||
30814400|NCT03417245|58833741|FG001|Overall Study|Adverse Event|0|||
30814401|NCT03417245|58833740|FG000|Overall Study|Protocol Violation|1|||
30814402|NCT03417245|58833741|FG001|Overall Study|Protocol Violation|0|||
30750510|NCT00071812|58760393|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
30750511|NCT00071812|58760394|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
30750512|NCT00071812|58760395|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
30814403|NCT03417245|58833740|FG000|Overall Study|Withdrawal by Subject|1|||
30814404|NCT03417245|58833741|FG001|Overall Study|Withdrawal by Subject|1|||
30814405|NCT03389555|58833749|FG000|Overall Study|Protocol Violation|1|||
30814406|NCT03389555|58833750|FG001|Overall Study|Protocol Violation|3|||
30814407|NCT03389555|58833749|FG000|Overall Study|Death|1|||
30814408|NCT03389555|58833750|FG001|Overall Study|Death|0|||
30814409|NCT03395639|58833758|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
30911095|NCT02161549|58945990|FG001|Overall Study|Physician Decision|2|||
30911096|NCT02189863|58945996|FG000|First 2 Weeks|Motion Sickness|4|||
30911097|NCT02189863|58945997|FG001|First 2 Weeks|Motion Sickness|2|||
30750513|NCT00071812|58760396|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
30750514|NCT00071812|58760393|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
30750515|NCT00071812|58760394|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
30750516|NCT00071812|58760395|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
30750517|NCT00071812|58760396|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
30750518|NCT00071812|58760393|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
30750519|NCT00071812|58760394|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
30750520|NCT00071812|58760395|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
30814410|NCT03395639|58833759|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
30814411|NCT03395639|58833760|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
30814412|NCT03395639|58833758|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
30814413|NCT03395639|58833759|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
30814414|NCT03395639|58833760|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
30814415|NCT03395639|58833758|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
30814416|NCT03395639|58833759|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
30911098|NCT02189473|58946008|FG000|Overall Study|Death|22|||
30911099|NCT02189473|58946009|FG001|Overall Study|Death|23|||
30814417|NCT03395639|58833760|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
30814418|NCT03395639|58833758|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
30814419|NCT03395639|58833759|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
30814420|NCT03395639|58833760|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
30814421|NCT03395639|58833758|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
30814422|NCT03395639|58833759|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
30814423|NCT03395639|58833760|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
30814424|NCT03353922|58833767|FG000|Overall Study|Withdrawal by Subject|1|||
30814425|NCT03353922|58833768|FG001|Overall Study|Withdrawal by Subject|0|||
30814426|NCT03353922|58833769|FG002|Overall Study|Withdrawal by Subject|1|||
30814427|NCT03353922|58833770|FG003|Overall Study|Withdrawal by Subject|1|||
30814428|NCT03353922|58833771|FG004|Overall Study|Withdrawal by Subject|0|||
30814429|NCT03353922|58833772|FG005|Overall Study|Withdrawal by Subject|0|||
30911100|NCT02189473|58946008|FG000|Overall Study|Lost to Follow-up|1|||
30911101|NCT02189473|58946009|FG001|Overall Study|Lost to Follow-up|2|||
30750521|NCT00071812|58760396|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
30814430|NCT03353922|58833767|FG000|Overall Study|Adverse Event|0|||
30814431|NCT03353922|58833768|FG001|Overall Study|Adverse Event|1|||
30814432|NCT03353922|58833769|FG002|Overall Study|Adverse Event|0|||
30814433|NCT03353922|58833770|FG003|Overall Study|Adverse Event|0|||
30814434|NCT03353922|58833771|FG004|Overall Study|Adverse Event|0|||
30814435|NCT03353922|58833772|FG005|Overall Study|Adverse Event|0|||
30814436|NCT03395405|58833785|FG000|Overall Study|Death|0|||
30814437|NCT03395405|58833786|FG001|Overall Study|Death|2|||
30814438|NCT03395405|58833785|FG000|Overall Study|Lost to Follow-up|0|||
30814439|NCT03395405|58833786|FG001|Overall Study|Lost to Follow-up|1|||
30814440|NCT03395405|58833785|FG000|Overall Study|Protocol Violation|0|||
30814441|NCT03395405|58833786|FG001|Overall Study|Protocol Violation|1|||
30814442|NCT03395405|58833785|FG000|Overall Study|Withdrawal by Subject|3|||
30814443|NCT03395405|58833786|FG001|Overall Study|Withdrawal by Subject|1|||
30814444|NCT03395405|58833785|FG000|Overall Study|COVID-19 Pandemic|1|||
30814445|NCT03395405|58833786|FG001|Overall Study|COVID-19 Pandemic|0|||
30814446|NCT03387683|58833794|FG000|Overall Study|In receipt of disallowed medication|1|||
30814447|NCT03387683|58833795|FG001|Overall Study|In receipt of disallowed medication|0|||
30814448|NCT03387683|58833794|FG000|Overall Study|Did not receive treatment|1|||
30814449|NCT03387683|58833795|FG001|Overall Study|Did not receive treatment|0|||
30814450|NCT03387059|58833803|FG000|Overall Study|Study termination|5|||
30814451|NCT03387059|58833804|FG001|Overall Study|Study termination|4|||
30814452|NCT02942004|58833813|FG000|Overall Study|Withdrawal by Subject|0|||
30814453|NCT02942004|58833814|FG001|Overall Study|Withdrawal by Subject|2|||
30814454|NCT02942004|58833815|FG002|Overall Study|Withdrawal by Subject|3|||
30814455|NCT02942004|58833813|FG000|Overall Study|Lost to Follow-up|1|||
30814456|NCT02942004|58833814|FG001|Overall Study|Lost to Follow-up|1|||
30814457|NCT02942004|58833815|FG002|Overall Study|Lost to Follow-up|2|||
30814458|NCT02942004|58833813|FG000|Overall Study|Randomized but not dosed|3|||
30814459|NCT02942004|58833814|FG001|Overall Study|Randomized but not dosed|9|||
30814460|NCT02942004|58833815|FG002|Overall Study|Randomized but not dosed|4|||
30814461|NCT03394391|58833825|FG000|Overall Study|Lost to Follow-up|1|||
30814462|NCT03394391|58833826|FG001|Overall Study|Lost to Follow-up|2|||
30814463|NCT03386435|58833834|FG000|Overall Study|Protocol Violation|5|||
30814464|NCT03386435|58833835|FG001|Overall Study|Protocol Violation|7|||
30814465|NCT02726880|58833843|FG000|Overall Study|Withdrawal by Subject|2|||
30814466|NCT02726880|58833844|FG001|Overall Study|Withdrawal by Subject|0|||
30814467|NCT02726880|58833843|FG000|Overall Study|Lost to Follow-up|1|||
30814468|NCT02726880|58833844|FG001|Overall Study|Lost to Follow-up|3|||
30814469|NCT03275389|58833861|FG000|Overall Study|Lost to Follow-up|10|||
30814470|NCT03275389|58833862|FG001|Overall Study|Lost to Follow-up|10|||
30814471|NCT03275389|58833863|FG002|Overall Study|Lost to Follow-up|19|||
30814472|NCT03275389|58833864|FG003|Overall Study|Lost to Follow-up|12|||
30814473|NCT03275389|58833865|FG004|Overall Study|Lost to Follow-up|11|||
30814474|NCT03275389|58833866|FG005|Overall Study|Lost to Follow-up|12|||
30814475|NCT03275389|58833867|FG006|Overall Study|Lost to Follow-up|21|||
30814476|NCT03275389|58833868|FG007|Overall Study|Lost to Follow-up|15|||
30814477|NCT03275389|58833869|FG008|Overall Study|Lost to Follow-up|12|||
30814478|NCT03275389|58833870|FG009|Overall Study|Lost to Follow-up|14|||
30814479|NCT03275389|58833861|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
30750522|NCT00071812|58760393|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
30750523|NCT00071812|58760394|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
30750524|NCT00071812|58760395|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
30750525|NCT00071812|58760396|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
30750526|NCT00071812|58760393|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
30750527|NCT00071812|58760394|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
30814480|NCT03275389|58833862|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
30814481|NCT03275389|58833863|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
30814482|NCT03275389|58833864|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
30814483|NCT03275389|58833865|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
30814484|NCT03275389|58833866|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
30814485|NCT03275389|58833867|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
30814486|NCT03275389|58833868|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
30814487|NCT03275389|58833869|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
30814488|NCT03275389|58833870|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
30814489|NCT03275389|58833861|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
30814490|NCT03275389|58833862|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
30814491|NCT03275389|58833863|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
30814492|NCT03275389|58833864|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
30814493|NCT03275389|58833865|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
30814494|NCT03275389|58833866|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
30814495|NCT03275389|58833867|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
30814496|NCT03275389|58833868|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
30814497|NCT03275389|58833869|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
30814498|NCT03275389|58833870|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
30814499|NCT03275389|58833861|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30814500|NCT03275389|58833862|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
30814501|NCT03275389|58833863|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30814502|NCT03275389|58833864|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
30814503|NCT03275389|58833865|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30814504|NCT03275389|58833866|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30814505|NCT03275389|58833867|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
30814506|NCT03275389|58833868|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30814507|NCT03275389|58833869|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30814508|NCT03275389|58833870|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30814509|NCT03275389|58833861|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
30814510|NCT03275389|58833862|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
30814511|NCT03275389|58833863|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
30814512|NCT03275389|58833864|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
30814513|NCT03275389|58833865|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
30814514|NCT03275389|58833866|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
30814515|NCT03275389|58833867|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
30814516|NCT03275389|58833868|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
30814517|NCT03275389|58833869|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
30814518|NCT03275389|58833870|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
30814519|NCT03275389|58833861|FG000|Overall Study|Other|0|||
30814520|NCT03275389|58833862|FG001|Overall Study|Other|4|||
30814521|NCT03275389|58833863|FG002|Overall Study|Other|3|||
30814522|NCT03275389|58833864|FG003|Overall Study|Other|2|||
30814523|NCT03275389|58833865|FG004|Overall Study|Other|2|||
30814524|NCT03275389|58833866|FG005|Overall Study|Other|2|||
30814525|NCT03275389|58833867|FG006|Overall Study|Other|0|||
30814526|NCT03275389|58833868|FG007|Overall Study|Other|0|||
30814527|NCT03275389|58833869|FG008|Overall Study|Other|1|||
30814528|NCT03275389|58833870|FG009|Overall Study|Other|0|||
30814529|NCT03414983|58833894|FG000|Pre-Treatment|Other reasons|1|||
30814530|NCT03414983|58833895|FG001|Pre-Treatment|Other reasons|0|||
30814531|NCT03414983|58833894|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
30814532|NCT03414983|58833895|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
30814533|NCT03414983|58833894|FG000|Pre-Treatment|Participant withdrew consent|1|||
30814534|NCT03414983|58833895|FG001|Pre-Treatment|Participant withdrew consent|3|||
30814535|NCT03414983|58833894|FG000|Treatment|Participant withdrew consent|4|||
30814536|NCT03414983|58833895|FG001|Treatment|Participant withdrew consent|3|||
30814537|NCT03414983|58833894|FG000|Treatment|Participant request to discontinue study treatment|8|||
30814538|NCT03414983|58833895|FG001|Treatment|Participant request to discontinue study treatment|10|||
30814539|NCT03414983|58833894|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
30814540|NCT03414983|58833895|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
30814541|NCT03414983|58833894|FG000|Treatment|Death|0|||
30814542|NCT03414983|58833895|FG001|Treatment|Death|2|||
30814543|NCT03414983|58833894|FG000|Treatment|Study Drug Toxicity|11|||
30814544|NCT03414983|58833895|FG001|Treatment|Study Drug Toxicity|4|||
30814545|NCT03414983|58833894|FG000|Treatment|Disease Progression|72|||
30814546|NCT03414983|58833895|FG001|Treatment|Disease Progression|27|||
30814547|NCT03414983|58833894|FG000|Treatment|Not reported|1|||
30814548|NCT03414983|58833895|FG001|Treatment|Not reported|0|||
30814549|NCT03414983|58833894|FG000|Treatment|Other reasons|3|||
30814550|NCT03414983|58833895|FG001|Treatment|Other reasons|2|||
30814551|NCT03414983|58833894|FG000|Treatment|Completed treatment as per protocol|8|||
30814552|NCT03414983|58833895|FG001|Treatment|Completed treatment as per protocol|0|||
30814553|NCT03414983|58833894|FG000|Treatment|Poor/non-compliance|2|||
30814554|NCT03414983|58833895|FG001|Treatment|Poor/non-compliance|0|||
30814555|NCT03414983|58833894|FG000|Treatment|Maximum clinical benefit|5|||
30814556|NCT03414983|58833895|FG001|Treatment|Maximum clinical benefit|9|||
30814557|NCT03414983|58833894|FG000|Treatment|Lost to Follow-up|0|||
30814558|NCT03414983|58833895|FG001|Treatment|Lost to Follow-up|1|||
30814559|NCT03414359|58833903|FG000|Overall Study|Lack of Efficacy|1|||
30814560|NCT03414359|58833904|FG001|Overall Study|Lack of Efficacy|1|||
30814561|NCT03414359|58833903|FG000|Overall Study|Protocol Violation|0|||
30814562|NCT03414359|58833904|FG001|Overall Study|Protocol Violation|1|||
30814563|NCT03285295|58833915|FG000|Alinity s HBsAg|Protocol Violation|11|||
30814564|NCT03285295|58833916|FG001|Alinity s HBsAg|Protocol Violation|0|||
30814565|NCT03285295|58833917|FG002|Alinity s HBsAg|Protocol Violation|0|||
30814566|NCT03285295|58833918|FG003|Alinity s HBsAg|Protocol Violation|0|||
30814567|NCT03285295|58833919|FG004|Alinity s HBsAg|Protocol Violation|0|||
30814568|NCT03285295|58833915|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
30814569|NCT03285295|58833916|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
30814570|NCT03285295|58833917|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
30814571|NCT03285295|58833918|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
30814572|NCT03285295|58833919|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
30814573|NCT03285295|58833915|FG000|Alinity s HBsAg|No Results Generated|74|||
30814574|NCT03285295|58833916|FG001|Alinity s HBsAg|No Results Generated|6|||
30814575|NCT03285295|58833917|FG002|Alinity s HBsAg|No Results Generated|0|||
30814576|NCT03285295|58833918|FG003|Alinity s HBsAg|No Results Generated|0|||
30814577|NCT03285295|58833919|FG004|Alinity s HBsAg|No Results Generated|0|||
30814578|NCT03285295|58833915|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
30814579|NCT03285295|58833916|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
30814580|NCT03285295|58833917|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
30814581|NCT03285295|58833918|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
30814582|NCT03285295|58833919|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
30814583|NCT03285295|58833915|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
30814584|NCT03285295|58833916|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
30814585|NCT03285295|58833917|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
30814586|NCT03285295|58833918|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
30814587|NCT03285295|58833919|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
30814588|NCT03285295|58833915|FG000|Alinity s HTLV I/II|No Results Generated|70|||
30814589|NCT03285295|58833916|FG001|Alinity s HTLV I/II|No Results Generated|0|||
30814590|NCT03285295|58833917|FG002|Alinity s HTLV I/II|No Results Generated|0|||
30814591|NCT03285295|58833918|FG003|Alinity s HTLV I/II|No Results Generated|0|||
30814592|NCT03285295|58833919|FG004|Alinity s HTLV I/II|No Results Generated|0|||
30814593|NCT03285295|58833915|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
30814594|NCT03285295|58833916|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
30814595|NCT03285295|58833917|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
30814596|NCT03285295|58833918|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
30814597|NCT03285295|58833919|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
30814598|NCT03285295|58833915|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
30814599|NCT03285295|58833916|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
30814600|NCT03285295|58833917|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
30814601|NCT03285295|58833918|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
30814602|NCT03285295|58833919|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
30814603|NCT03285295|58833915|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
30814604|NCT03285295|58833916|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
30814605|NCT03285295|58833917|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
30814606|NCT03285295|58833918|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
30814607|NCT03285295|58833919|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
30814608|NCT03285295|58833915|FG000|Alinity s Anti-HCV|No Results Generated|71|||
30814609|NCT03285295|58833916|FG001|Alinity s Anti-HCV|No Results Generated|0|||
30814610|NCT03285295|58833917|FG002|Alinity s Anti-HCV|No Results Generated|0|||
30814611|NCT03285295|58833918|FG003|Alinity s Anti-HCV|No Results Generated|0|||
30814612|NCT03285295|58833919|FG004|Alinity s Anti-HCV|No Results Generated|0|||
30814613|NCT03285295|58833915|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
30814614|NCT03285295|58833916|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
30814615|NCT03285295|58833917|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
30814616|NCT03285295|58833918|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
30814617|NCT03285295|58833919|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
30814618|NCT03285295|58833915|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
30911102|NCT02188849|58946017|FG000|Overall Study|Lost to Follow-up|3|||
30622585|NCT01175135|58634267|FG000|Overall Study|Randomized But Not Treated|0|||
30622586|NCT01175135|58634268|FG001|Overall Study|Randomized But Not Treated|0|||
30814619|NCT03285295|58833916|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
30814620|NCT03285295|58833917|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
30814621|NCT03285295|58833918|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
30814622|NCT03285295|58833919|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
30911103|NCT02188849|58946018|FG001|Overall Study|Lost to Follow-up|8|||
30911104|NCT01636076|58946026|FG000|Overall Study|Terminated by sponsor|1|||
30814623|NCT03285295|58833915|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
30814624|NCT03285295|58833916|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
30814625|NCT03285295|58833917|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
30814626|NCT03285295|58833918|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
30814627|NCT03285295|58833919|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
30814628|NCT03285295|58833915|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
30814629|NCT03285295|58833916|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
30814630|NCT03285295|58833917|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
30814631|NCT03285295|58833918|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
30814632|NCT03285295|58833919|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
30814633|NCT03285295|58833915|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
30814634|NCT03285295|58833916|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
30814635|NCT03285295|58833917|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
30814636|NCT03285295|58833918|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
30814637|NCT03285295|58833919|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
30814638|NCT03285295|58833915|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
30814639|NCT03285295|58833916|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
30814640|NCT03285295|58833917|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
30814641|NCT03285295|58833918|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
30814642|NCT03285295|58833919|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
30814643|NCT03285295|58833915|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
30814644|NCT03285295|58833916|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
30814645|NCT03285295|58833917|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
30814646|NCT03285295|58833918|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
30814647|NCT03285295|58833919|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
30814648|NCT03285295|58833915|FG000|Alinity s Anti-HBc|No Results Generated|70|||
30814649|NCT03285295|58833916|FG001|Alinity s Anti-HBc|No Results Generated|0|||
30814650|NCT03285295|58833917|FG002|Alinity s Anti-HBc|No Results Generated|0|||
30814651|NCT03285295|58833918|FG003|Alinity s Anti-HBc|No Results Generated|0|||
30814652|NCT03285295|58833919|FG004|Alinity s Anti-HBc|No Results Generated|0|||
30814653|NCT03285295|58833915|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
30814654|NCT03285295|58833916|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
30814655|NCT03285295|58833917|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
30814656|NCT03285295|58833918|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
30814657|NCT03285295|58833919|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
30814658|NCT03285295|58833915|FG000|Alinity s Chagas|Protocol Violation|76|||
30814659|NCT03285295|58833916|FG001|Alinity s Chagas|Protocol Violation|0|||
30814660|NCT03285295|58833917|FG002|Alinity s Chagas|Protocol Violation|0|||
30814661|NCT03285295|58833918|FG003|Alinity s Chagas|Protocol Violation|0|||
30814662|NCT03285295|58833919|FG004|Alinity s Chagas|Protocol Violation|0|||
30814663|NCT03285295|58833915|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
30814664|NCT03285295|58833916|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
30814665|NCT03285295|58833917|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
30814666|NCT03285295|58833918|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
30814667|NCT03285295|58833919|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
30814668|NCT03285295|58833915|FG000|Alinity s Chagas|No Results Generated|105|||
30814669|NCT03285295|58833916|FG001|Alinity s Chagas|No Results Generated|0|||
30814670|NCT03285295|58833917|FG002|Alinity s Chagas|No Results Generated|0|||
30814671|NCT03285295|58833918|FG003|Alinity s Chagas|No Results Generated|0|||
30814672|NCT03285295|58833919|FG004|Alinity s Chagas|No Results Generated|0|||
30814673|NCT03285295|58833915|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
30814674|NCT03285295|58833916|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
30814675|NCT03285295|58833917|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
30814676|NCT03285295|58833918|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
30814677|NCT03285295|58833919|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
30814678|NCT02583048|58833951|FG000|Overall Study|Withdrawal by Subject|0|||
30814679|NCT02583048|58833952|FG001|Overall Study|Withdrawal by Subject|1|||
30814680|NCT02583048|58833953|FG002|Overall Study|Withdrawal by Subject|0|||
30814681|NCT02583048|58833951|FG000|Overall Study|Failed to meet eligibility criterion|0|||
30814682|NCT02583048|58833952|FG001|Overall Study|Failed to meet eligibility criterion|0|||
30814683|NCT02583048|58833953|FG002|Overall Study|Failed to meet eligibility criterion|1|||
30814684|NCT02939599|58833966|FG000|Overall Study|Adverse Event|1|||
30814685|NCT02939599|58833967|FG001|Overall Study|Adverse Event|0|||
30814686|NCT02939599|58833966|FG000|Overall Study|Study Terminated By Sponsor|2|||
30814687|NCT02939599|58833967|FG001|Overall Study|Study Terminated By Sponsor|2|||
30814688|NCT01318512|58833974|FG000|Maintenance Period (6 Months)|Death|2|||
30814689|NCT01318512|58833974|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
30814690|NCT03274687|58833995|FG000|Overall Study|Protocol Violation|1|||
30814691|NCT03274687|58833996|FG001|Overall Study|Protocol Violation|1|||
30814692|NCT04651218|58834002|FG000|Overall Study|Withdrawal by Subject|0|||
30911105|NCT01636076|58946027|FG001|Overall Study|Terminated by sponsor|1|||
30911106|NCT01636076|58946026|FG000|Overall Study|Lack of Efficacy|0|||
30750528|NCT00071812|58760395|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
30750529|NCT00071812|58760396|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
30750530|NCT00071812|58760393|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
30750531|NCT00071812|58760394|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
30750532|NCT00071812|58760395|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
30750533|NCT00071812|58760396|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
30750534|NCT00071812|58760393|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
30750535|NCT00071812|58760394|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
30750536|NCT00071812|58760395|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
30750537|NCT00071812|58760396|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
30750538|NCT00071812|58760393|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
30750539|NCT00071812|58760394|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
30750540|NCT00071812|58760395|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
30750541|NCT00071812|58760396|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
30750542|NCT00071812|58760393|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
30750543|NCT00071812|58760394|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
30750544|NCT00071812|58760395|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
30750545|NCT00071812|58760396|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
30750546|NCT00071110|58760410|FG000|Overall Study|Protocol Violation|0|||
30750547|NCT00071110|58760411|FG001|Overall Study|Protocol Violation|4|||
30750548|NCT00071032|58760419|FG000|Overall Study|Lost to Follow-up|1|||
30750549|NCT00071032|58760420|FG001|Overall Study|Lost to Follow-up|1|||
30750550|NCT00071032|58760419|FG000|Overall Study|Withdrawal by Subject|8|||
30750551|NCT00071032|58760420|FG001|Overall Study|Withdrawal by Subject|6|||
30750552|NCT00071032|58760419|FG000|Overall Study|Missing Primary Outcome|0|||
30750553|NCT00071032|58760420|FG001|Overall Study|Missing Primary Outcome|1|||
30750554|NCT00259610|58760431|FG000|Overall Study|Withdrawal by Subject|33|||
30750555|NCT00259610|58760432|FG001|Overall Study|Withdrawal by Subject|25|||
30750556|NCT00259610|58760433|FG002|Overall Study|Withdrawal by Subject|29|||
30750557|NCT00259610|58760434|FG003|Overall Study|Withdrawal by Subject|19|||
30750558|NCT00259610|58760431|FG000|Overall Study|Lost to Follow-up|19|||
30750559|NCT00259610|58760432|FG001|Overall Study|Lost to Follow-up|8|||
30750560|NCT00259610|58760433|FG002|Overall Study|Lost to Follow-up|18|||
30750561|NCT00259610|58760434|FG003|Overall Study|Lost to Follow-up|15|||
30750562|NCT00259610|58760431|FG000|Overall Study|Physician Decision|6|||
30750563|NCT00259610|58760432|FG001|Overall Study|Physician Decision|4|||
30750564|NCT00259610|58760433|FG002|Overall Study|Physician Decision|7|||
30750565|NCT00259610|58760434|FG003|Overall Study|Physician Decision|2|||
30750566|NCT00259610|58760431|FG000|Overall Study|Death|1|||
30750567|NCT00259610|58760432|FG001|Overall Study|Death|1|||
30750568|NCT00259610|58760433|FG002|Overall Study|Death|2|||
30750569|NCT00259610|58760434|FG003|Overall Study|Death|0|||
30750570|NCT00259610|58760431|FG000|Overall Study|non medical reason|6|||
30750571|NCT00259610|58760432|FG001|Overall Study|non medical reason|2|||
30750572|NCT00259610|58760433|FG002|Overall Study|non medical reason|10|||
30750573|NCT00259610|58760434|FG003|Overall Study|non medical reason|3|||
30750574|NCT00259610|58760431|FG000|Overall Study|Adverse Event|3|||
30750575|NCT00259610|58760432|FG001|Overall Study|Adverse Event|4|||
30750576|NCT00259610|58760433|FG002|Overall Study|Adverse Event|5|||
30750577|NCT00259610|58760434|FG003|Overall Study|Adverse Event|2|||
30750578|NCT00259610|58760431|FG000|Overall Study|Serious Adverse Event|8|||
30750579|NCT00259610|58760432|FG001|Overall Study|Serious Adverse Event|2|||
30750580|NCT00259610|58760433|FG002|Overall Study|Serious Adverse Event|2|||
30750581|NCT00259610|58760434|FG003|Overall Study|Serious Adverse Event|2|||
30750582|NCT00165776|58760448|FG000|Overall Study|Lack of Efficacy|0|||
30750583|NCT00165776|58760449|FG001|Overall Study|Lack of Efficacy|0|||
30750584|NCT00165776|58760450|FG002|Overall Study|Lack of Efficacy|0|||
30750585|NCT00165776|58760451|FG003|Overall Study|Lack of Efficacy|1|||
30750586|NCT00165776|58760448|FG000|Overall Study|Withdrawal by Subject|4|||
30750587|NCT00165776|58760449|FG001|Overall Study|Withdrawal by Subject|1|||
30750588|NCT00165776|58760450|FG002|Overall Study|Withdrawal by Subject|2|||
30750589|NCT00165776|58760451|FG003|Overall Study|Withdrawal by Subject|0|||
30750590|NCT00165776|58760448|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
30750591|NCT00165776|58760449|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
30750592|NCT00165776|58760450|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
30750593|NCT00165776|58760451|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
30814693|NCT04651218|58834003|FG001|Overall Study|Withdrawal by Subject|2|||
30814694|NCT03274453|58834013|FG000|Overall Study|Lost to Follow-up|2|||
30814695|NCT03274453|58834014|FG001|Overall Study|Lost to Follow-up|5|||
30814696|NCT03274453|58834015|FG002|Overall Study|Lost to Follow-up|4|||
30814697|NCT03274453|58834016|FG003|Overall Study|Lost to Follow-up|1|||
30814698|NCT03274453|58834013|FG000|Overall Study|Physician Decision|2|||
30814699|NCT03274453|58834014|FG001|Overall Study|Physician Decision|0|||
30814700|NCT03274453|58834015|FG002|Overall Study|Physician Decision|0|||
30814701|NCT03274453|58834016|FG003|Overall Study|Physician Decision|3|||
30814702|NCT03274453|58834013|FG000|Overall Study|Surgery Cancelled|0|||
30814703|NCT03274453|58834014|FG001|Overall Study|Surgery Cancelled|1|||
30814704|NCT03274453|58834015|FG002|Overall Study|Surgery Cancelled|0|||
30814705|NCT03274453|58834016|FG003|Overall Study|Surgery Cancelled|0|||
30814706|NCT03273907|58834026|FG000|Overall Study|Death|1|||
30814707|NCT03273907|58834026|FG000|Overall Study|Lost to Follow-up|4|||
30814708|NCT03273907|58834026|FG000|Overall Study|Withdrawal by Subject|2|||
30814709|NCT03273907|58834026|FG000|Overall Study|COVID 19|2|||
30814710|NCT00659646|58834048|FG000|Overall Study|Protocol Violation|12|||
30814711|NCT00659646|58834049|FG001|Overall Study|Protocol Violation|8|||
30814712|NCT00659646|58834048|FG000|Overall Study|Adverse Event|1|||
30750594|NCT00165698|58760463|FG000|Overall Study|Adverse Event|2|||
30750595|NCT00165698|58760464|FG001|Overall Study|Adverse Event|10|||
30750596|NCT00165698|58760463|FG000|Overall Study|Lost to Follow-up|2|||
30750597|NCT00165698|58760464|FG001|Overall Study|Lost to Follow-up|2|||
30750598|NCT00165698|58760463|FG000|Overall Study|Withdrawal by Subject|2|||
30750599|NCT00165698|58760464|FG001|Overall Study|Withdrawal by Subject|1|||
30750600|NCT00165698|58760463|FG000|Overall Study|Protocol Violation|1|||
30750601|NCT00165698|58760464|FG001|Overall Study|Protocol Violation|0|||
30750602|NCT00165698|58760463|FG000|Overall Study|Not Taken/Lost the medicine|1|||
30750603|NCT00165698|58760464|FG001|Overall Study|Not Taken/Lost the medicine|2|||
30750604|NCT00225758|58760470|FG000|Overall Study|Adverse Event|4|||
30750605|NCT00259298|58760476|FG000|Overall Study|Withdrawal by Subject|1|||
30750606|NCT00259298|58760476|FG000|Overall Study|Physician Decision|2|||
30750607|NCT03789292|58760486|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
30750608|NCT03789292|58760487|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
30750609|NCT03789292|58760488|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
30750610|NCT03789292|58760486|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
30750611|NCT03789292|58760487|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
30750612|NCT03789292|58760488|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
30750613|NCT03789292|58760486|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
30750614|NCT03789292|58760487|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
30750615|NCT03789292|58760488|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
30750616|NCT03789292|58760486|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
30750617|NCT03789292|58760487|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
30750618|NCT03789292|58760488|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
30750619|NCT03789292|58760486|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
30750620|NCT03789292|58760487|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
30750621|NCT03789292|58760488|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
30814713|NCT00659646|58834049|FG001|Overall Study|Adverse Event|0|||
30814714|NCT00659646|58834048|FG000|Overall Study|Lost to Follow-up|1|||
30814715|NCT00659646|58834049|FG001|Overall Study|Lost to Follow-up|0|||
30814716|NCT00659646|58834048|FG000|Overall Study|protocol noncompliance after randomized|1|||
30814717|NCT00659646|58834049|FG001|Overall Study|protocol noncompliance after randomized|0|||
30814718|NCT02236572|58834057|FG000|Overall Study|Withdrawal by Subject|1|||
30814719|NCT02236572|58834057|FG000|Overall Study|Protocol Violation|1|||
30814720|NCT02236572|58834057|FG000|Overall Study|Lost to Follow-up|1|||
30814721|NCT03054870|58834061|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
30814722|NCT03054870|58834061|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
30814723|NCT03414047|58834080|FG000|Overall Study|Adverse Event|0|||
30814724|NCT03414047|58834081|FG001|Overall Study|Adverse Event|0|||
30814725|NCT03414047|58834082|FG002|Overall Study|Adverse Event|1|||
30814726|NCT03414047|58834083|FG003|Overall Study|Adverse Event|1|||
30814727|NCT03414047|58834080|FG000|Overall Study|Physician Decision|1|||
30814728|NCT03414047|58834081|FG001|Overall Study|Physician Decision|0|||
30814729|NCT03414047|58834082|FG002|Overall Study|Physician Decision|0|||
30750622|NCT03789292|58760486|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
30814730|NCT03414047|58834083|FG003|Overall Study|Physician Decision|1|||
30814731|NCT03414047|58834080|FG000|Overall Study|Withdrawal by Subject|1|||
30814732|NCT03414047|58834081|FG001|Overall Study|Withdrawal by Subject|0|||
30814733|NCT03414047|58834082|FG002|Overall Study|Withdrawal by Subject|2|||
30814734|NCT03414047|58834083|FG003|Overall Study|Withdrawal by Subject|0|||
30814735|NCT03351335|58834097|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
30814736|NCT03351335|58834098|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
30814737|NCT03351335|58834099|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
30814738|NCT03055806|58834111|FG000|Overall Study|Adverse Event|0|||
30814739|NCT03055806|58834112|FG001|Overall Study|Adverse Event|0|||
30814740|NCT03055806|58834113|FG002|Overall Study|Adverse Event|1|||
30814741|NCT03055806|58834114|FG003|Overall Study|Adverse Event|1|||
30814742|NCT03055806|58834111|FG000|Overall Study|Lost to Follow-up|0|||
30814743|NCT03055806|58834112|FG001|Overall Study|Lost to Follow-up|3|||
30814744|NCT03055806|58834113|FG002|Overall Study|Lost to Follow-up|6|||
30814745|NCT03055806|58834114|FG003|Overall Study|Lost to Follow-up|7|||
30814746|NCT03055806|58834111|FG000|Overall Study|Physician Decision|1|||
30814747|NCT03055806|58834112|FG001|Overall Study|Physician Decision|0|||
30814748|NCT03055806|58834113|FG002|Overall Study|Physician Decision|0|||
30814749|NCT03055806|58834114|FG003|Overall Study|Physician Decision|1|||
30814750|NCT03055806|58834111|FG000|Overall Study|Protocol Violation|1|||
30814751|NCT03055806|58834112|FG001|Overall Study|Protocol Violation|0|||
30814752|NCT03055806|58834113|FG002|Overall Study|Protocol Violation|0|||
30814753|NCT03055806|58834114|FG003|Overall Study|Protocol Violation|0|||
30814754|NCT03055806|58834111|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
30814755|NCT03055806|58834112|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
30814756|NCT03055806|58834113|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
30814757|NCT03055806|58834114|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
30814758|NCT03055806|58834111|FG000|Overall Study|Withdrawal of consent to continue study|2|||
30814759|NCT03055806|58834112|FG001|Overall Study|Withdrawal of consent to continue study|3|||
30814760|NCT03055806|58834113|FG002|Overall Study|Withdrawal of consent to continue study|4|||
30814761|NCT03055806|58834114|FG003|Overall Study|Withdrawal of consent to continue study|6|||
30814762|NCT03055806|58834111|FG000|Overall Study|Partner not willing to try intercourse|1|||
30814763|NCT03055806|58834112|FG001|Overall Study|Partner not willing to try intercourse|0|||
30814764|NCT03055806|58834113|FG002|Overall Study|Partner not willing to try intercourse|0|||
30814765|NCT03055806|58834114|FG003|Overall Study|Partner not willing to try intercourse|0|||
30814766|NCT04620798|58834126|FG000|Overall Study|Lost to Follow-up|126|||
30814767|NCT04620798|58834127|FG001|Overall Study|Lost to Follow-up|138|||
30814768|NCT03052764|58834135|FG000|Double-Blind Treatment Period|Adverse Event|2|||
30814769|NCT03052764|58834136|FG001|Double-Blind Treatment Period|Adverse Event|0|||
30814770|NCT03052764|58834135|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
30814771|NCT03052764|58834136|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
30814772|NCT03052764|58834135|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
30814773|NCT03052764|58834136|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
30814774|NCT03052764|58834135|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
30814775|NCT03052764|58834136|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
30814776|NCT03052764|58834135|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
30814777|NCT03052764|58834136|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
30814778|NCT02951819|58834146|FG000|Overall Study|Death|9|||
30814779|NCT02951819|58834147|FG001|Overall Study|Death|7|||
30814780|NCT02951819|58834146|FG000|Overall Study|Withdrawal by Subject|3|||
30814781|NCT02951819|58834147|FG001|Overall Study|Withdrawal by Subject|0|||
30814782|NCT02951819|58834146|FG000|Overall Study|Adverse Event|1|||
30814783|NCT02951819|58834147|FG001|Overall Study|Adverse Event|0|||
30814784|NCT02951819|58834146|FG000|Overall Study|Lack of Efficacy|4|||
30814785|NCT02951819|58834147|FG001|Overall Study|Lack of Efficacy|0|||
30814786|NCT02951819|58834146|FG000|Overall Study|Lost to Follow-up|1|||
30814787|NCT02951819|58834147|FG001|Overall Study|Lost to Follow-up|0|||
30814788|NCT02951819|58834146|FG000|Overall Study|Progressive Disease|1|||
30814789|NCT02951819|58834147|FG001|Overall Study|Progressive Disease|0|||
30814790|NCT02951819|58834146|FG000|Overall Study|Other|9|||
30814791|NCT02951819|58834147|FG001|Overall Study|Other|0|||
30814792|NCT03383783|58834153|FG000|Overall Study|Withdrawal by Subject|2|||
30814793|NCT03334721|58834171|FG000|Overall Study|Withdrawal by Subject|1|||
30814794|NCT03334721|58834172|FG001|Overall Study|Withdrawal by Subject|0|||
30814795|NCT03334721|58834171|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
30622587|NCT01175135|58634269|FG002|Overall Study|Randomized But Not Treated|1|||
30814796|NCT03334721|58834172|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
30814797|NCT03515551|58834185|FG000|Overall Study|Death|4|||
30814798|NCT03515551|58834186|FG001|Overall Study|Death|1|||
30814799|NCT03515551|58834187|FG002|Overall Study|Death|2|||
30814800|NCT03515551|58834188|FG003|Overall Study|Death|2|||
30814801|NCT03515551|58834189|FG004|Overall Study|Death|2|||
30814802|NCT03515551|58834190|FG005|Overall Study|Death|4|||
30814803|NCT03515551|58834191|FG006|Overall Study|Death|1|||
30814804|NCT03515551|58834185|FG000|Overall Study|Lost to Follow-up|0|||
30814805|NCT03515551|58834186|FG001|Overall Study|Lost to Follow-up|0|||
30814806|NCT03515551|58834187|FG002|Overall Study|Lost to Follow-up|1|||
30814807|NCT03515551|58834188|FG003|Overall Study|Lost to Follow-up|0|||
30814808|NCT03515551|58834189|FG004|Overall Study|Lost to Follow-up|0|||
30814809|NCT03515551|58834190|FG005|Overall Study|Lost to Follow-up|0|||
30814810|NCT03515551|58834191|FG006|Overall Study|Lost to Follow-up|0|||
30814811|NCT03515551|58834185|FG000|Overall Study|Withdrawal by Subject|0|||
30814812|NCT03515551|58834186|FG001|Overall Study|Withdrawal by Subject|1|||
30814813|NCT03515551|58834187|FG002|Overall Study|Withdrawal by Subject|0|||
30814814|NCT03515551|58834188|FG003|Overall Study|Withdrawal by Subject|0|||
30814815|NCT03515551|58834189|FG004|Overall Study|Withdrawal by Subject|0|||
30814816|NCT03515551|58834190|FG005|Overall Study|Withdrawal by Subject|0|||
30814817|NCT03515551|58834191|FG006|Overall Study|Withdrawal by Subject|1|||
30814818|NCT03515551|58834185|FG000|Overall Study|Study ended by sponsor|0|||
30814819|NCT03515551|58834186|FG001|Overall Study|Study ended by sponsor|0|||
30814820|NCT03515551|58834187|FG002|Overall Study|Study ended by sponsor|2|||
30814821|NCT03515551|58834188|FG003|Overall Study|Study ended by sponsor|1|||
30814822|NCT03515551|58834189|FG004|Overall Study|Study ended by sponsor|3|||
30814823|NCT03515551|58834190|FG005|Overall Study|Study ended by sponsor|0|||
30814824|NCT03515551|58834191|FG006|Overall Study|Study ended by sponsor|3|||
30814825|NCT03515551|58834185|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
30814826|NCT03515551|58834186|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
30814827|NCT03515551|58834187|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
30814828|NCT03515551|58834188|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
30814829|NCT03515551|58834189|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
30814830|NCT03515551|58834190|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
30814831|NCT03515551|58834191|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
30814832|NCT03380429|58834217|FG000|Overall Study|Physician Decision|0|||
30814833|NCT03380429|58834218|FG001|Overall Study|Physician Decision|1|||
30814834|NCT03380429|58834219|FG002|Overall Study|Physician Decision|0|||
30814835|NCT03380429|58834220|FG003|Overall Study|Physician Decision|1|||
30814836|NCT03380429|58834221|FG004|Overall Study|Physician Decision|1|||
30814837|NCT03380429|58834217|FG000|Overall Study|Withdrawal by Subject|3|||
30814838|NCT03380429|58834218|FG001|Overall Study|Withdrawal by Subject|3|||
30814839|NCT03380429|58834219|FG002|Overall Study|Withdrawal by Subject|5|||
30814840|NCT03380429|58834220|FG003|Overall Study|Withdrawal by Subject|2|||
30814841|NCT03380429|58834221|FG004|Overall Study|Withdrawal by Subject|1|||
30814842|NCT03380429|58834217|FG000|Overall Study|Lost to Follow-up|0|||
30814843|NCT03380429|58834218|FG001|Overall Study|Lost to Follow-up|2|||
30814844|NCT03380429|58834219|FG002|Overall Study|Lost to Follow-up|4|||
30814845|NCT03380429|58834220|FG003|Overall Study|Lost to Follow-up|3|||
30814846|NCT03380429|58834221|FG004|Overall Study|Lost to Follow-up|1|||
30814847|NCT03380429|58834217|FG000|Overall Study|Protocol Violation|1|||
30814848|NCT03380429|58834218|FG001|Overall Study|Protocol Violation|0|||
30814849|NCT03380429|58834219|FG002|Overall Study|Protocol Violation|1|||
30814850|NCT03380429|58834220|FG003|Overall Study|Protocol Violation|0|||
30814851|NCT03380429|58834221|FG004|Overall Study|Protocol Violation|1|||
30814852|NCT03380429|58834217|FG000|Overall Study|Lack of Efficacy|0|||
30814853|NCT03380429|58834218|FG001|Overall Study|Lack of Efficacy|0|||
30814854|NCT03380429|58834219|FG002|Overall Study|Lack of Efficacy|0|||
30814855|NCT03380429|58834220|FG003|Overall Study|Lack of Efficacy|2|||
30814856|NCT03380429|58834221|FG004|Overall Study|Lack of Efficacy|1|||
30814857|NCT03380429|58834217|FG000|Overall Study|Adverse Event|1|||
30814858|NCT03380429|58834218|FG001|Overall Study|Adverse Event|1|||
30814859|NCT03380429|58834219|FG002|Overall Study|Adverse Event|1|||
30814860|NCT03380429|58834220|FG003|Overall Study|Adverse Event|2|||
30814861|NCT03380429|58834221|FG004|Overall Study|Adverse Event|0|||
30911107|NCT01636076|58946027|FG001|Overall Study|Lack of Efficacy|1|||
30911108|NCT01636076|58946026|FG000|Overall Study|Lost to Follow-up|1|||
30911109|NCT01636076|58946027|FG001|Overall Study|Lost to Follow-up|0|||
30814862|NCT03280615|58834240|FG000|Overall Study|Lost to Follow-up|1|||
30814863|NCT03280615|58834241|FG001|Overall Study|Lost to Follow-up|2|||
30814864|NCT03280615|58834240|FG000|Overall Study|Adverse Event|1|||
30814865|NCT03280615|58834241|FG001|Overall Study|Adverse Event|1|||
30814866|NCT03280615|58834240|FG000|Overall Study|Withdrawal by Subject|2|||
30814867|NCT03280615|58834241|FG001|Overall Study|Withdrawal by Subject|2|||
30814868|NCT03280537|58834249|FG000|Overall Study|Withdrawal by Subject|2|||
30814869|NCT03280537|58834250|FG001|Overall Study|Withdrawal by Subject|4|||
30814870|NCT03280381|58834258|FG000|Overall Study|Physician Decision|0|||
30814871|NCT03280381|58834259|FG001|Overall Study|Physician Decision|2|||
30814872|NCT03270085|58834268|FG000|Overall Study|Withdrawal by Subject|1|||
30814873|NCT03270085|58834269|FG001|Overall Study|Withdrawal by Subject|0|||
30814874|NCT03267511|58834279|FG000|Overall Study|Lost to Follow-up|0|||
30814875|NCT03267511|58834280|FG001|Overall Study|Lost to Follow-up|0|||
30814876|NCT03267511|58834281|FG002|Overall Study|Lost to Follow-up|0|||
30814877|NCT03267511|58834282|FG003|Overall Study|Lost to Follow-up|1|||
30814878|NCT03379259|58834309|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
30814879|NCT03379259|58834310|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
30814880|NCT03379259|58834311|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
30911110|NCT01636076|58946026|FG000|Overall Study|Physician Decision|1|||
30911111|NCT01636076|58946027|FG001|Overall Study|Physician Decision|1|||
30911112|NCT01636076|58946026|FG000|Overall Study|Non-compliance with study treatment|1|||
30911113|NCT01636076|58946027|FG001|Overall Study|Non-compliance with study treatment|1|||
30911114|NCT01636076|58946026|FG000|Overall Study|Adverse Event|6|||
30911115|NCT01636076|58946027|FG001|Overall Study|Adverse Event|11|||
30911116|NCT01636076|58946026|FG000|Overall Study|Withdrawal by Subject|7|||
30911117|NCT01636076|58946027|FG001|Overall Study|Withdrawal by Subject|10|||
30911118|NCT01635998|58946042|FG000|Overall Study|Death|1|||
30911119|NCT01635998|58946043|FG001|Overall Study|Death|1|||
30911120|NCT01635998|58946042|FG000|Overall Study|Lost to Follow-up|2|||
30911121|NCT01635998|58946043|FG001|Overall Study|Lost to Follow-up|1|||
30911122|NCT01635998|58946042|FG000|Overall Study|Withdrawal by Subject|1|||
30911123|NCT01635998|58946043|FG001|Overall Study|Withdrawal by Subject|5|||
30911124|NCT01635920|58946051|FG000|Overall Study|Adverse Event|1|||
30911125|NCT01635920|58946052|FG001|Overall Study|Adverse Event|0|||
30911126|NCT01635920|58946051|FG000|Overall Study|Lost to Follow-up|0|||
30911127|NCT01635920|58946052|FG001|Overall Study|Lost to Follow-up|1|||
30911128|NCT01635920|58946051|FG000|Overall Study|Subject decision|2|||
30911129|NCT01635920|58946052|FG001|Overall Study|Subject decision|0|||
30750623|NCT03789292|58760487|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
30750624|NCT03789292|58760488|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
30750625|NCT03789292|58760486|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
30750626|NCT03789292|58760487|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
30814881|NCT03379259|58834312|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
30750627|NCT03789292|58760488|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
30814882|NCT03379259|58834313|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
30814883|NCT03379259|58834314|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
30814884|NCT03379259|58834309|FG000|Overall Study|Death|0|||
30750628|NCT03789292|58760486|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
30750629|NCT03789292|58760487|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
30750630|NCT03789292|58760488|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
30750631|NCT03789292|58760486|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
30750632|NCT03789292|58760487|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
30750633|NCT03789292|58760488|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
30750634|NCT03789292|58760486|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
30750635|NCT03789292|58760487|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
30750636|NCT03789292|58760488|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
30750637|NCT03789292|58760486|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
30750638|NCT03789292|58760487|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
30750639|NCT03789292|58760488|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
30750640|NCT03789292|58760486|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
30750641|NCT03789292|58760487|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
30750642|NCT03789292|58760488|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
30750643|NCT03789292|58760486|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
30750644|NCT03789292|58760487|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
30750645|NCT03789292|58760488|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
30750646|NCT03781336|58760504|FG000|Overall Study|Withdrawal by Subject|2|||
30750647|NCT03781336|58760505|FG001|Overall Study|Withdrawal by Subject|2|||
30750648|NCT03780400|58760511|FG000|Overall Study|Lost to Follow-up|5|||
30750649|NCT03780400|58760511|FG000|Overall Study|Withdrawal by Subject|2|||
30750650|NCT03780244|58760517|FG000|Overall Study|Lost to Follow-up|1|||
30750651|NCT03780244|58760518|FG001|Overall Study|Lost to Follow-up|0|||
30750652|NCT03785548|58760526|FG000|Overall Study|age > 80|1|||
30750653|NCT03785548|58760527|FG001|Overall Study|age > 80|0|||
30814885|NCT03379259|58834310|FG001|Overall Study|Death|1|||
30911130|NCT02160145|58946069|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
30911131|NCT02160145|58946070|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
30911132|NCT02160145|58946071|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
30814886|NCT03379259|58834311|FG002|Overall Study|Death|2|||
30814887|NCT03379259|58834312|FG003|Overall Study|Death|1|||
30814888|NCT03379259|58834313|FG004|Overall Study|Death|4|||
30911133|NCT02160145|58946069|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
30948486|NCT01976741|58994461|FG008|Overall Study|Withdrawal by Subject|0|||
30814889|NCT03379259|58834314|FG005|Overall Study|Death|2|||
30814890|NCT03379259|58834309|FG000|Overall Study|Withdrawal by Subject|0|||
30814891|NCT03379259|58834310|FG001|Overall Study|Withdrawal by Subject|0|||
30911134|NCT02160145|58946070|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
30814892|NCT03379259|58834311|FG002|Overall Study|Withdrawal by Subject|1|||
30814893|NCT03379259|58834312|FG003|Overall Study|Withdrawal by Subject|0|||
30814894|NCT03379259|58834313|FG004|Overall Study|Withdrawal by Subject|2|||
30814895|NCT03379259|58834314|FG005|Overall Study|Withdrawal by Subject|0|||
30814896|NCT03379259|58834309|FG000|Overall Study|Study terminated by sponsor|0|||
30814897|NCT03379259|58834310|FG001|Overall Study|Study terminated by sponsor|0|||
30814898|NCT03379259|58834311|FG002|Overall Study|Study terminated by sponsor|0|||
30814899|NCT03379259|58834312|FG003|Overall Study|Study terminated by sponsor|1|||
30814900|NCT03379259|58834313|FG004|Overall Study|Study terminated by sponsor|1|||
30814901|NCT03379259|58834314|FG005|Overall Study|Study terminated by sponsor|4|||
30911135|NCT02160145|58946071|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
30911136|NCT02160145|58946069|FG000|Randomized Double-blind Period|Subject decision|0|||
30911137|NCT02160145|58946070|FG001|Randomized Double-blind Period|Subject decision|21|||
30911138|NCT02160145|58946071|FG002|Randomized Double-blind Period|Subject decision|20|||
30911139|NCT02160145|58946069|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
30814902|NCT03379259|58834309|FG000|Overall Study|Disease progression|0|||
30814903|NCT03379259|58834310|FG001|Overall Study|Disease progression|0|||
30814904|NCT03379259|58834311|FG002|Overall Study|Disease progression|0|||
30814905|NCT03379259|58834312|FG003|Overall Study|Disease progression|1|||
30814906|NCT03379259|58834313|FG004|Overall Study|Disease progression|0|||
30814907|NCT03379259|58834314|FG005|Overall Study|Disease progression|1|||
30911140|NCT02160145|58946070|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
30814908|NCT03379259|58834309|FG000|Overall Study|Lost to Follow-up|0|||
30814909|NCT03379259|58834310|FG001|Overall Study|Lost to Follow-up|0|||
30814910|NCT03379259|58834311|FG002|Overall Study|Lost to Follow-up|0|||
30814911|NCT03379259|58834312|FG003|Overall Study|Lost to Follow-up|0|||
30814912|NCT03379259|58834313|FG004|Overall Study|Lost to Follow-up|1|||
30814913|NCT03379259|58834314|FG005|Overall Study|Lost to Follow-up|0|||
30814914|NCT03379259|58834309|FG000|Overall Study|Deteriorating condition|0|||
30814915|NCT03379259|58834310|FG001|Overall Study|Deteriorating condition|0|||
30814916|NCT03379259|58834311|FG002|Overall Study|Deteriorating condition|0|||
30814917|NCT03379259|58834312|FG003|Overall Study|Deteriorating condition|0|||
30814918|NCT03379259|58834313|FG004|Overall Study|Deteriorating condition|1|||
30814919|NCT03379259|58834314|FG005|Overall Study|Deteriorating condition|0|||
30814920|NCT03328897|58834334|FG000|Randomized-treatment Epoch|Adverse Event|4|||
30814921|NCT03328897|58834335|FG001|Randomized-treatment Epoch|Adverse Event|1|||
30814922|NCT03328897|58834336|FG002|Randomized-treatment Epoch|Adverse Event|1|||
30814923|NCT03328897|58834334|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
30814924|NCT03328897|58834335|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
30814925|NCT03328897|58834336|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
30814926|NCT03328897|58834334|FG000|Randomized-treatment Epoch|Pregnancy|3|||
30814927|NCT03328897|58834335|FG001|Randomized-treatment Epoch|Pregnancy|0|||
30814928|NCT03328897|58834336|FG002|Randomized-treatment Epoch|Pregnancy|0|||
30814929|NCT03328897|58834334|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
30814930|NCT03328897|58834335|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
30814931|NCT03328897|58834336|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
30814932|NCT03328897|58834334|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
30814933|NCT03328897|58834335|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
30814934|NCT03328897|58834336|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
30814935|NCT03328897|58834334|FG000|Follow-up Epoch|Adverse Event|4|||
30814936|NCT03328897|58834335|FG001|Follow-up Epoch|Adverse Event|0|||
30814937|NCT03328897|58834336|FG002|Follow-up Epoch|Adverse Event|1|||
30814938|NCT03328897|58834334|FG000|Follow-up Epoch|Lack of Efficacy|1|||
30814939|NCT03328897|58834335|FG001|Follow-up Epoch|Lack of Efficacy|1|||
30814940|NCT03328897|58834336|FG002|Follow-up Epoch|Lack of Efficacy|1|||
30814941|NCT03328897|58834334|FG000|Follow-up Epoch|Lost to Follow-up|0|||
30814942|NCT03328897|58834335|FG001|Follow-up Epoch|Lost to Follow-up|1|||
30814943|NCT03328897|58834336|FG002|Follow-up Epoch|Lost to Follow-up|0|||
30814944|NCT03328897|58834334|FG000|Follow-up Epoch|Pregnancy|1|||
30814945|NCT03328897|58834335|FG001|Follow-up Epoch|Pregnancy|0|||
30814946|NCT03328897|58834336|FG002|Follow-up Epoch|Pregnancy|0|||
30814947|NCT03328897|58834334|FG000|Follow-up Epoch|Patient/guardian decision|2|||
30814948|NCT03328897|58834335|FG001|Follow-up Epoch|Patient/guardian decision|1|||
30814949|NCT03328897|58834336|FG002|Follow-up Epoch|Patient/guardian decision|0|||
30814950|NCT03266107|58834344|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
30814951|NCT03266107|58834344|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
30814952|NCT03266107|58834344|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
30814953|NCT03266107|58834344|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
30814954|NCT03378635|58834353|FG000|Overall Study|Adverse Event|1|||
30814955|NCT03378635|58834354|FG001|Overall Study|Adverse Event|0|||
30814956|NCT03378635|58834355|FG002|Overall Study|Adverse Event|0|||
30814957|NCT03378635|58834353|FG000|Overall Study|Withdrawal by Subject|1|||
30814958|NCT03378635|58834354|FG001|Overall Study|Withdrawal by Subject|0|||
30814959|NCT03378635|58834355|FG002|Overall Study|Withdrawal by Subject|0|||
30814960|NCT03326869|58834366|FG000|Overall Study|Study data has been lost to natural disa|1|||
30814961|NCT03326869|58834367|FG001|Overall Study|Study data has been lost to natural disa|1|||
30814962|NCT03334409|58834379|FG000|Overall Study|Did not meet inclusion criteria|1|||
30814963|NCT03334409|58834380|FG001|Overall Study|Did not meet inclusion criteria|0|||
30814964|NCT02891915|58834388|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
30814965|NCT02891915|58834389|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
30814966|NCT02891915|58834388|FG000|Overall Study|Withdrawal by Subject|3|||
30814967|NCT02891915|58834389|FG001|Overall Study|Withdrawal by Subject|3|||
30814968|NCT02891915|58834388|FG000|Overall Study|Became Ineligible After Enrollment|2|||
30814969|NCT02891915|58834389|FG001|Overall Study|Became Ineligible After Enrollment|1|||
30814970|NCT02891915|58834388|FG000|Overall Study|Lost to Follow-up|1|||
30814971|NCT02891915|58834389|FG001|Overall Study|Lost to Follow-up|4|||
30814972|NCT02891915|58834388|FG000|Overall Study|Physician Decision|1|||
30814973|NCT02891915|58834389|FG001|Overall Study|Physician Decision|0|||
30814974|NCT02891681|58834398|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
30814975|NCT02891681|58834399|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
30814976|NCT02891681|58834400|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
30814977|NCT02891681|58834398|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
30814978|NCT02891681|58834399|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
30814979|NCT02891681|58834400|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
30814980|NCT02891681|58834398|FG000|Overall Study|Taken off study after first imaging appointment|1|||
30814981|NCT02891681|58834399|FG001|Overall Study|Taken off study after first imaging appointment|0|||
30814982|NCT02891681|58834400|FG002|Overall Study|Taken off study after first imaging appointment|0|||
30814983|NCT04671342|58834408|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
30814984|NCT04671342|58834408|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
30814985|NCT04671342|58834408|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
30814986|NCT04671342|58834408|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
30814987|NCT04671342|58834408|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
30814988|NCT04671342|58834408|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
30814989|NCT03046446|58834412|FG000|Overall Study|Lack of Efficacy|7|||
30814990|NCT03046446|58834412|FG000|Overall Study|Adverse Event|6|||
30814991|NCT03046446|58834412|FG000|Overall Study|Lost to Follow-up|3|||
30814992|NCT03046446|58834412|FG000|Overall Study|Withdrawal by Subject|14|||
30814993|NCT03046446|58834412|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
30814994|NCT03046446|58834412|FG000|Overall Study|Disease Progression (see caveats)|25|||
30814995|NCT03046446|58834412|FG000|Overall Study|Non OA related knee surgery|1|||
30814996|NCT03051217|58834419|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
30814997|NCT03051217|58834420|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30814998|NCT03051217|58834421|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
30814999|NCT03051217|58834422|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30815000|NCT03051217|58834423|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30815001|NCT03051217|58834424|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30815002|NCT03051217|58834425|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
30815003|NCT03051217|58834419|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
30911141|NCT02160145|58946071|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
30750654|NCT03785548|58760526|FG000|Overall Study|no Postop queries|1|||
30750655|NCT03785548|58760527|FG001|Overall Study|no Postop queries|0|||
30750656|NCT00141297|58760535|FG000|Overall Study|Adverse Event|0|||
30750657|NCT00141297|58760536|FG001|Overall Study|Adverse Event|0|||
30750658|NCT00141297|58760537|FG002|Overall Study|Adverse Event|1|||
30750659|NCT00141297|58760538|FG003|Overall Study|Adverse Event|0|||
30750660|NCT00141297|58760539|FG004|Overall Study|Adverse Event|1|||
30750661|NCT00141297|58760540|FG005|Overall Study|Adverse Event|1|||
30750662|NCT00141297|58760541|FG006|Overall Study|Adverse Event|0|||
30750663|NCT00141297|58760542|FG007|Overall Study|Adverse Event|1|||
30750664|NCT00141297|58760543|FG008|Overall Study|Adverse Event|1|||
30750665|NCT00141297|58760544|FG009|Overall Study|Adverse Event|0|||
30750666|NCT00141297|58760535|FG000|Overall Study|Death|1|||
30750667|NCT00141297|58760536|FG001|Overall Study|Death|0|||
30750668|NCT00141297|58760537|FG002|Overall Study|Death|0|||
30750669|NCT00141297|58760538|FG003|Overall Study|Death|0|||
30750670|NCT00141297|58760539|FG004|Overall Study|Death|0|||
30750671|NCT00141297|58760540|FG005|Overall Study|Death|0|||
30750672|NCT00141297|58760541|FG006|Overall Study|Death|0|||
30750673|NCT00141297|58760542|FG007|Overall Study|Death|0|||
30750674|NCT00141297|58760543|FG008|Overall Study|Death|1|||
30815004|NCT03051217|58834420|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
30815005|NCT03051217|58834421|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
30815006|NCT03051217|58834422|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
30815007|NCT03051217|58834423|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
30815008|NCT03051217|58834424|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
30815009|NCT03051217|58834425|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
30815010|NCT03051217|58834419|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
30815011|NCT03051217|58834420|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
30815012|NCT03051217|58834421|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
30815013|NCT03051217|58834422|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30815014|NCT03051217|58834423|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30815015|NCT03051217|58834424|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30815016|NCT03051217|58834425|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
30815017|NCT03051217|58834419|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
30815018|NCT03051217|58834420|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
30815019|NCT03051217|58834421|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
30815020|NCT03051217|58834422|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
30815021|NCT03051217|58834423|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
30815022|NCT03051217|58834424|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
30815023|NCT03051217|58834425|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
30815024|NCT03051217|58834419|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
30815025|NCT03051217|58834420|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
30815026|NCT03051217|58834421|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
30911142|NCT02160145|58946069|FG000|Randomized Double-blind Period|Physician Decision|0|||
30815027|NCT03051217|58834422|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
30815028|NCT03051217|58834423|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
30815029|NCT03051217|58834424|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
30815030|NCT03051217|58834425|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
30911143|NCT02160145|58946070|FG001|Randomized Double-blind Period|Physician Decision|7|||
30911144|NCT02160145|58946071|FG002|Randomized Double-blind Period|Physician Decision|5|||
30911145|NCT01696396|58946082|FG000|Overall Study|Withdrawal by Subject|19|||
30911146|NCT01696396|58946083|FG001|Overall Study|Withdrawal by Subject|5|||
30911147|NCT01696396|58946084|FG002|Overall Study|Withdrawal by Subject|19|||
30911148|NCT01696396|58946085|FG003|Overall Study|Withdrawal by Subject|11|||
30911149|NCT01696396|58946082|FG000|Overall Study|Decision by Sponsor|3|||
30911150|NCT01696396|58946083|FG001|Overall Study|Decision by Sponsor|1|||
30911151|NCT01696396|58946084|FG002|Overall Study|Decision by Sponsor|2|||
30911152|NCT01696396|58946085|FG003|Overall Study|Decision by Sponsor|2|||
30911153|NCT01696396|58946082|FG000|Overall Study|Lost to Follow-up|9|||
30911154|NCT01696396|58946083|FG001|Overall Study|Lost to Follow-up|1|||
30911155|NCT01696396|58946084|FG002|Overall Study|Lost to Follow-up|4|||
30911156|NCT01696396|58946085|FG003|Overall Study|Lost to Follow-up|1|||
30911157|NCT01696396|58946082|FG000|Overall Study|Death|0|||
30815031|NCT03051217|58834419|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
30815032|NCT03051217|58834420|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
30815033|NCT03051217|58834421|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
30815034|NCT03051217|58834422|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
30815035|NCT03051217|58834423|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
30815036|NCT03051217|58834424|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
30815037|NCT03051217|58834425|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
30815038|NCT03051217|58834419|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
30815039|NCT03051217|58834420|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
30815040|NCT03051217|58834421|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
30815041|NCT03051217|58834422|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
30815042|NCT03051217|58834423|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
30815043|NCT03051217|58834424|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
30815044|NCT03051217|58834425|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
30815045|NCT03051217|58834419|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
30815046|NCT03051217|58834420|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
30815047|NCT03051217|58834421|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
30815048|NCT03051217|58834422|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
30815049|NCT03051217|58834423|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
30815050|NCT03051217|58834424|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
30911158|NCT01696396|58946083|FG001|Overall Study|Death|0|||
30911159|NCT01696396|58946084|FG002|Overall Study|Death|1|||
30911160|NCT01696396|58946085|FG003|Overall Study|Death|0|||
30911161|NCT02216071|58946101|FG000|Overall Study|Withdrawal by Subject|7|||
30911162|NCT02216071|58946102|FG001|Overall Study|Withdrawal by Subject|2|||
30911163|NCT02216071|58946101|FG000|Overall Study|Lost to Follow-up|3|||
30911164|NCT02216071|58946102|FG001|Overall Study|Lost to Follow-up|3|||
30815051|NCT03051217|58834425|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
30815052|NCT03046056|58834451|FG000|Overall Study|Non-responder at Week 10|6|||
30815053|NCT03046056|58834452|FG001|Overall Study|Non-responder at Week 10|6|||
30815054|NCT03046056|58834453|FG002|Overall Study|Non-responder at Week 10|4|||
30815055|NCT03046056|58834451|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
30815056|NCT03046056|58834452|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
30815057|NCT03046056|58834453|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
30815058|NCT03046056|58834451|FG000|Overall Study|Adverse Event|1|||
30815059|NCT03046056|58834452|FG001|Overall Study|Adverse Event|5|||
30815060|NCT03046056|58834453|FG002|Overall Study|Adverse Event|0|||
30815061|NCT03046056|58834451|FG000|Overall Study|Non-compliance With Study Drug|0|||
30815062|NCT03046056|58834452|FG001|Overall Study|Non-compliance With Study Drug|0|||
30815063|NCT03046056|58834453|FG002|Overall Study|Non-compliance With Study Drug|2|||
30815064|NCT03046056|58834451|FG000|Overall Study|Protocol Violation|1|||
30815065|NCT03046056|58834452|FG001|Overall Study|Protocol Violation|1|||
30815066|NCT03046056|58834453|FG002|Overall Study|Protocol Violation|0|||
30815067|NCT03046056|58834451|FG000|Overall Study|Investigator's Discretion|0|||
30815068|NCT03046056|58834452|FG001|Overall Study|Investigator's Discretion|1|||
30815069|NCT03046056|58834453|FG002|Overall Study|Investigator's Discretion|0|||
30815070|NCT03046056|58834451|FG000|Overall Study|Withdrew Consent|1|||
30815071|NCT03046056|58834452|FG001|Overall Study|Withdrew Consent|0|||
30815072|NCT03046056|58834453|FG002|Overall Study|Withdrew Consent|0|||
30815073|NCT02849587|58834464|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
30815074|NCT02849587|58834465|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
30815075|NCT02849587|58834466|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
30815076|NCT02849587|58834464|FG000|Overall Study|Withdrawal by Subject|0|||
30815077|NCT02849587|58834465|FG001|Overall Study|Withdrawal by Subject|1|||
30815078|NCT02849587|58834466|FG002|Overall Study|Withdrawal by Subject|0|||
30815079|NCT03347279|58834480|FG000|Overall Study|Withdrawal by Subject|8|||
30815080|NCT03347279|58834481|FG001|Overall Study|Withdrawal by Subject|15|||
30815081|NCT03347279|58834480|FG000|Overall Study|Death|0|||
30815082|NCT03347279|58834481|FG001|Overall Study|Death|2|||
30815083|NCT03347279|58834480|FG000|Overall Study|Lost to Follow-up|5|||
30815084|NCT03347279|58834481|FG001|Overall Study|Lost to Follow-up|2|||
30815085|NCT03347279|58834480|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
30815086|NCT03347279|58834481|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
30815087|NCT03262441|58834487|FG000|Overall Study|Withdrawal by Subject|1|||
30815088|NCT04580394|58834491|FG000|First Intervention|Incorrectly Randomized|1|||
30815089|NCT04580394|58834491|FG000|First Intervention|Physician Decision|1|||
30815090|NCT04580394|58834491|FG000|First Intervention|Lost to Follow-up|1|||
30815091|NCT04580394|58834491|FG000|Washout (One Week)|Withdrawal by Subject|1|||
30815092|NCT04580394|58834491|FG000|Washout (One Week)|Adverse Event|1|||
30815093|NCT04580394|58834491|FG000|Washout (One Week)|Withdrawal by Subject|2|||
30815094|NCT04580394|58834491|FG000|Third Intervention|Adverse Event|1|||
30815095|NCT04580394|58834491|FG000|Third Intervention|Withdrawal by Subject|1|||
30815096|NCT04580394|58834491|FG000|Washout (One Week)|Withdrawal by Subject|2|||
30815097|NCT02781727|58834503|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
30815098|NCT02781727|58834504|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
30815099|NCT02781727|58834503|FG000|Treatment Period|Withdrawal by Subject|1|||
30815100|NCT02781727|58834504|FG001|Treatment Period|Withdrawal by Subject|0|||
30815101|NCT02781727|58834503|FG000|Treatment Period|Lost to Follow-up|0|||
30815102|NCT02781727|58834504|FG001|Treatment Period|Lost to Follow-up|1|||
30815103|NCT01343082|58834510|FG000|The run-in Period|Not meeting criteria|3|||
30815104|NCT01343082|58834511|FG001|The run-in Period|Not meeting criteria|4|||
30815105|NCT01343082|58834512|FG002|The run-in Period|Not meeting criteria|5|||
30815106|NCT01343082|58834510|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
30815107|NCT01343082|58834511|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
30815108|NCT01343082|58834512|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
30815109|NCT01343082|58834510|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
30815110|NCT01343082|58834511|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
30815111|NCT01343082|58834512|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
30815112|NCT01343082|58834510|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
30815113|NCT01343082|58834511|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
30815114|NCT01343082|58834512|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
30815115|NCT01343082|58834510|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
30815116|NCT01343082|58834511|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
30815117|NCT01343082|58834512|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
30815118|NCT03374189|58834518|FG000|Overall Study|Lost to Follow-up|1|||
30815119|NCT03374189|58834519|FG001|Overall Study|Lost to Follow-up|0|||
30815120|NCT03261037|58834529|FG000|Overall Study|Withdrawal by Subject|2|||
30815121|NCT03261037|58834530|FG001|Overall Study|Withdrawal by Subject|13|||
30815122|NCT03261037|58834531|FG002|Overall Study|Withdrawal by Subject|0|||
30815123|NCT03261037|58834532|FG003|Overall Study|Withdrawal by Subject|18|||
30815124|NCT03261037|58834529|FG000|Overall Study|Non-compliance with study procedures|0|||
30815125|NCT03261037|58834530|FG001|Overall Study|Non-compliance with study procedures|2|||
30815126|NCT03261037|58834531|FG002|Overall Study|Non-compliance with study procedures|0|||
30815127|NCT03261037|58834532|FG003|Overall Study|Non-compliance with study procedures|6|||
30815128|NCT03261037|58834529|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
30815129|NCT03261037|58834530|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
30815130|NCT03261037|58834531|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
30815131|NCT03261037|58834532|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
30815132|NCT03261037|58834529|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
30815133|NCT03261037|58834530|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
30815134|NCT03261037|58834531|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
30815135|NCT03261037|58834532|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
30815136|NCT03261037|58834529|FG000|Overall Study|Diagnosed but protocol deviation|1|||
30815137|NCT03261037|58834530|FG001|Overall Study|Diagnosed but protocol deviation|0|||
30815138|NCT03261037|58834531|FG002|Overall Study|Diagnosed but protocol deviation|0|||
30815139|NCT03261037|58834532|FG003|Overall Study|Diagnosed but protocol deviation|0|||
30815140|NCT03261037|58834529|FG000|Overall Study|Participant did not want to continue the study|0|||
30815141|NCT03261037|58834530|FG001|Overall Study|Participant did not want to continue the study|1|||
30815142|NCT03261037|58834531|FG002|Overall Study|Participant did not want to continue the study|0|||
30815143|NCT03261037|58834532|FG003|Overall Study|Participant did not want to continue the study|0|||
30815144|NCT03261037|58834529|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
30815145|NCT03261037|58834530|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
30815146|NCT03261037|58834531|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
30815147|NCT03261037|58834532|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
30815148|NCT03261037|58834529|FG000|Overall Study|Participant presented clinical improvement|0|||
30815149|NCT03261037|58834530|FG001|Overall Study|Participant presented clinical improvement|2|||
30815150|NCT03261037|58834531|FG002|Overall Study|Participant presented clinical improvement|0|||
30815151|NCT03261037|58834532|FG003|Overall Study|Participant presented clinical improvement|0|||
30815152|NCT03261037|58834529|FG000|Overall Study|Technical difficulties|0|||
30815153|NCT03261037|58834530|FG001|Overall Study|Technical difficulties|0|||
30815154|NCT03261037|58834531|FG002|Overall Study|Technical difficulties|0|||
30815155|NCT03261037|58834532|FG003|Overall Study|Technical difficulties|1|||
30815156|NCT03261037|58834529|FG000|Overall Study|Equipment failed to work|0|||
30815157|NCT03261037|58834530|FG001|Overall Study|Equipment failed to work|0|||
30815158|NCT03261037|58834531|FG002|Overall Study|Equipment failed to work|0|||
30815159|NCT03261037|58834532|FG003|Overall Study|Equipment failed to work|1|||
30815160|NCT03261037|58834529|FG000|Overall Study|End of study for participant and no follow up|0|||
30815161|NCT03261037|58834530|FG001|Overall Study|End of study for participant and no follow up|0|||
30815162|NCT03261037|58834531|FG002|Overall Study|End of study for participant and no follow up|0|||
30815163|NCT03261037|58834532|FG003|Overall Study|End of study for participant and no follow up|1|||
30815164|NCT03261037|58834529|FG000|Overall Study|Participant was too weak to continue in study|1|||
30815165|NCT03261037|58834530|FG001|Overall Study|Participant was too weak to continue in study|0|||
30815166|NCT03261037|58834531|FG002|Overall Study|Participant was too weak to continue in study|0|||
30815167|NCT03261037|58834532|FG003|Overall Study|Participant was too weak to continue in study|0|||
30815168|NCT03372551|58834543|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
30815169|NCT03372551|58834544|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
30815170|NCT03326323|58834557|FG000|Overall Study|Unable to receive ANH protocol|3|||
30815171|NCT03259789|58834568|FG000|Overall Study|Adverse Event|3|||
30815172|NCT03259789|58834569|FG001|Overall Study|Adverse Event|2|||
30815173|NCT03259789|58834570|FG002|Overall Study|Adverse Event|1|||
30815174|NCT03259789|58834568|FG000|Overall Study|Withdrawal by Subject|9|||
30815175|NCT03259789|58834569|FG001|Overall Study|Withdrawal by Subject|5|||
30815176|NCT03259789|58834570|FG002|Overall Study|Withdrawal by Subject|1|||
30815177|NCT03259789|58834568|FG000|Overall Study|Lost to Follow-up|5|||
30815178|NCT03259789|58834569|FG001|Overall Study|Lost to Follow-up|9|||
30815179|NCT03259789|58834570|FG002|Overall Study|Lost to Follow-up|4|||
30815180|NCT03259789|58834568|FG000|Overall Study|Physician Decision|0|||
30815181|NCT03259789|58834569|FG001|Overall Study|Physician Decision|1|||
30815182|NCT03259789|58834570|FG002|Overall Study|Physician Decision|0|||
30815183|NCT03259555|58834581|FG000|Overall Study|Adverse Event|6|||
30815184|NCT03259555|58834582|FG001|Overall Study|Adverse Event|4|||
30815185|NCT03259555|58834581|FG000|Overall Study|Lack of Efficacy|6|||
30815186|NCT03259555|58834582|FG001|Overall Study|Lack of Efficacy|4|||
30815187|NCT03259555|58834581|FG000|Overall Study|Lost to Follow-up|0|||
30815188|NCT03259555|58834582|FG001|Overall Study|Lost to Follow-up|2|||
30815189|NCT03259555|58834581|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30815190|NCT03259555|58834582|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30911165|NCT02216071|58946101|FG000|Overall Study|Protocol Violation|3|||
30815191|NCT03259555|58834581|FG000|Overall Study|Progressive Disease|0|||
30815192|NCT03259555|58834582|FG001|Overall Study|Progressive Disease|2|||
30815193|NCT03259555|58834581|FG000|Overall Study|Withdrawal by Subject|19|||
30815194|NCT03259555|58834582|FG001|Overall Study|Withdrawal by Subject|16|||
30815195|NCT03259555|58834581|FG000|Overall Study|Physician Decision|1|||
30815196|NCT03259555|58834582|FG001|Overall Study|Physician Decision|2|||
30815197|NCT03259555|58834581|FG000|Overall Study|Other|1|||
30815198|NCT03259555|58834582|FG001|Overall Study|Other|0|||
30815199|NCT03259087|58834593|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
30815200|NCT03259087|58834594|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
30815201|NCT03259087|58834595|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
30815202|NCT03259087|58834596|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
30815203|NCT03259087|58834597|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
30815204|NCT03259087|58834593|FG000|Period 2 of Part 2|Adverse Event|0|||
30815205|NCT03259087|58834594|FG001|Period 2 of Part 2|Adverse Event|0|||
30815206|NCT03259087|58834595|FG002|Period 2 of Part 2|Adverse Event|0|||
30815207|NCT03259087|58834596|FG003|Period 2 of Part 2|Adverse Event|0|||
30815208|NCT03259087|58834597|FG004|Period 2 of Part 2|Adverse Event|1|||
30815209|NCT03257995|58834619|FG000|Overall Study|Adverse Event|0|||
30815210|NCT03257995|58834620|FG001|Overall Study|Adverse Event|1|||
30815211|NCT03257995|58834621|FG002|Overall Study|Adverse Event|0|||
30815212|NCT03257995|58834622|FG003|Overall Study|Adverse Event|0|||
30815213|NCT03257995|58834623|FG004|Overall Study|Adverse Event|0|||
30815214|NCT03257995|58834624|FG005|Overall Study|Adverse Event|0|||
30815215|NCT03257995|58834619|FG000|Overall Study|Protocol deviation|0|||
30815216|NCT03257995|58834620|FG001|Overall Study|Protocol deviation|0|||
30815217|NCT03257995|58834621|FG002|Overall Study|Protocol deviation|0|||
30815218|NCT03257995|58834622|FG003|Overall Study|Protocol deviation|0|||
30815219|NCT03257995|58834623|FG004|Overall Study|Protocol deviation|0|||
30815220|NCT03257995|58834624|FG005|Overall Study|Protocol deviation|2|||
30815221|NCT03049488|58834642|FG000|Overall Study|Lost to Follow-up|1|||
30815222|NCT03049488|58834643|FG001|Overall Study|Lost to Follow-up|1|||
30815223|NCT03049488|58834644|FG002|Overall Study|Lost to Follow-up|0|||
30815224|NCT03049488|58834645|FG003|Overall Study|Lost to Follow-up|0|||
30815225|NCT03049488|58834646|FG004|Overall Study|Lost to Follow-up|0|||
30815226|NCT03049488|58834647|FG005|Overall Study|Lost to Follow-up|0|||
30815227|NCT03049488|58834642|FG000|Overall Study|Moved from Area|1|||
30815228|NCT03049488|58834643|FG001|Overall Study|Moved from Area|0|||
30815229|NCT03049488|58834644|FG002|Overall Study|Moved from Area|0|||
30815230|NCT03049488|58834645|FG003|Overall Study|Moved from Area|1|||
30815231|NCT03049488|58834646|FG004|Overall Study|Moved from Area|1|||
30815232|NCT03049488|58834647|FG005|Overall Study|Moved from Area|0|||
30815233|NCT03049488|58834642|FG000|Overall Study|Physician Decision|0|||
30815234|NCT03049488|58834643|FG001|Overall Study|Physician Decision|1|||
30815235|NCT03049488|58834644|FG002|Overall Study|Physician Decision|0|||
30815236|NCT03049488|58834645|FG003|Overall Study|Physician Decision|0|||
30815237|NCT03049488|58834646|FG004|Overall Study|Physician Decision|0|||
30815238|NCT03049488|58834647|FG005|Overall Study|Physician Decision|0|||
30815239|NCT03049488|58834642|FG000|Overall Study|Withdrawal by Subject|0|||
30815240|NCT03049488|58834643|FG001|Overall Study|Withdrawal by Subject|0|||
30815241|NCT03049488|58834644|FG002|Overall Study|Withdrawal by Subject|0|||
30815242|NCT03049488|58834645|FG003|Overall Study|Withdrawal by Subject|1|||
30815243|NCT03049488|58834646|FG004|Overall Study|Withdrawal by Subject|1|||
30815244|NCT03049488|58834647|FG005|Overall Study|Withdrawal by Subject|0|||
30815245|NCT03257371|58834662|FG000|Overall Study|Lost to Follow-up|1|||
30815246|NCT03242863|58834666|FG000|Study Week 1|Withdrawal by Subject|0|||
30815247|NCT03242863|58834667|FG001|Study Week 1|Withdrawal by Subject|1|||
30815248|NCT03242863|58834668|FG002|Study Week 1|Withdrawal by Subject|0|||
30815249|NCT03242863|58834669|FG003|Study Week 1|Withdrawal by Subject|0|||
30815250|NCT03242863|58834670|FG004|Study Week 1|Withdrawal by Subject|3|||
30815251|NCT03242863|58834671|FG005|Study Week 1|Withdrawal by Subject|0|||
30815252|NCT03044106|58834679|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
30815253|NCT03044106|58834680|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
30815254|NCT03043560|58834706|FG000|Overall Study|Discontinued Intervention|1|||
30815255|NCT03043560|58834707|FG001|Overall Study|Discontinued Intervention|2|||
30815256|NCT03043560|58834706|FG000|Overall Study|Lost to Follow-up|0|||
30815257|NCT03043560|58834707|FG001|Overall Study|Lost to Follow-up|1|||
30815258|NCT03255733|58834733|FG000|Overall Study|Lost to Follow-up|4|||
30815259|NCT03255655|58834739|FG000|Overall Study|Lost to Follow-up|7|||
30815260|NCT03255655|58834740|FG001|Overall Study|Lost to Follow-up|4|||
30815261|NCT02899988|58834750|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
30815262|NCT02899988|58834751|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
30815263|NCT02899988|58834752|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30815264|NCT02899988|58834753|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30815265|NCT02899988|58834754|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30815266|NCT02899988|58834755|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30815267|NCT02899988|58834756|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30815268|NCT02899988|58834757|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30815269|NCT02899988|58834758|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30815270|NCT02899988|58834759|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30815271|NCT02899988|58834760|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30815272|NCT02899988|58834750|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
30815273|NCT02899988|58834751|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
30815274|NCT02899988|58834752|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
30815275|NCT02899988|58834753|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
30815276|NCT02899988|58834754|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
30815277|NCT02899988|58834755|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
30815278|NCT02899988|58834756|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
30815279|NCT02899988|58834757|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
30815280|NCT02899988|58834758|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
30815281|NCT02899988|58834759|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
30815282|NCT02899988|58834760|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
30815283|NCT02899988|58834750|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
30815284|NCT02899988|58834751|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
30815285|NCT02899988|58834752|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
30815286|NCT02899988|58834753|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
30815287|NCT02899988|58834754|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
30815288|NCT02899988|58834755|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
30815289|NCT02899988|58834756|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
30815290|NCT02899988|58834757|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
30815291|NCT02899988|58834758|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
30815292|NCT02899988|58834759|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
30815293|NCT02899988|58834760|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
30815294|NCT02899988|58834750|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
30815295|NCT02899988|58834751|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
30815296|NCT02899988|58834752|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
30815297|NCT02899988|58834753|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
30815298|NCT02899988|58834754|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
30815299|NCT02899988|58834755|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
30815300|NCT02899988|58834756|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
30815301|NCT02899988|58834757|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
30815302|NCT02899988|58834758|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
30815303|NCT02899988|58834759|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
30815304|NCT02899988|58834760|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
30815305|NCT02899988|58834750|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
30815306|NCT02899988|58834751|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
30815307|NCT02899988|58834752|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
30815308|NCT02899988|58834753|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
30815309|NCT02899988|58834754|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
30815310|NCT02899988|58834755|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
30815311|NCT02899988|58834756|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
30815312|NCT02899988|58834757|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
30815313|NCT02899988|58834758|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
30815314|NCT02899988|58834759|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
30815315|NCT02899988|58834760|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
30815316|NCT02899988|58834750|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
30815317|NCT02899988|58834751|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
30815318|NCT02899988|58834752|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
30815319|NCT02899988|58834753|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
30815320|NCT02899988|58834754|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
30815321|NCT02899988|58834755|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
30750675|NCT00141297|58760544|FG009|Overall Study|Death|0|||
30750676|NCT00141297|58760535|FG000|Overall Study|Withdrawal by Subject|0|||
30750677|NCT00141297|58760536|FG001|Overall Study|Withdrawal by Subject|0|||
30750678|NCT00141297|58760537|FG002|Overall Study|Withdrawal by Subject|0|||
30750679|NCT00141297|58760538|FG003|Overall Study|Withdrawal by Subject|0|||
30750680|NCT00141297|58760539|FG004|Overall Study|Withdrawal by Subject|0|||
30750681|NCT00141297|58760540|FG005|Overall Study|Withdrawal by Subject|0|||
30815322|NCT02899988|58834756|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
30815323|NCT02899988|58834757|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
30815324|NCT02899988|58834758|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
30750682|NCT00141297|58760541|FG006|Overall Study|Withdrawal by Subject|0|||
30750683|NCT00141297|58760542|FG007|Overall Study|Withdrawal by Subject|0|||
30622588|NCT01175135|58634270|FG003|Overall Study|Randomized But Not Treated|0|||
30622589|NCT00922480|58634282|FG000|Main Study|Protocol Violation|3|||
30622590|NCT00922480|58634283|FG001|Main Study|Protocol Violation|6|||
30622591|NCT00922480|58634282|FG000|Main Study|Adverse Event|6|||
30750684|NCT00141297|58760543|FG008|Overall Study|Withdrawal by Subject|1|||
30750685|NCT00141297|58760544|FG009|Overall Study|Withdrawal by Subject|0|||
30750686|NCT00141297|58760535|FG000|Overall Study|Other|0|||
30750687|NCT00141297|58760536|FG001|Overall Study|Other|0|||
30750688|NCT00141297|58760537|FG002|Overall Study|Other|0|||
30750689|NCT00141297|58760538|FG003|Overall Study|Other|1|||
30750690|NCT00141297|58760539|FG004|Overall Study|Other|5|||
30750691|NCT00141297|58760540|FG005|Overall Study|Other|0|||
30750692|NCT00141297|58760541|FG006|Overall Study|Other|0|||
30750693|NCT00141297|58760542|FG007|Overall Study|Other|0|||
30750694|NCT00141297|58760543|FG008|Overall Study|Other|2|||
30750695|NCT00141297|58760544|FG009|Overall Study|Other|0|||
30750696|NCT00141297|58760535|FG000|Overall Study|Progressive Disease|2|||
30750697|NCT00141297|58760536|FG001|Overall Study|Progressive Disease|3|||
30750698|NCT00141297|58760537|FG002|Overall Study|Progressive Disease|6|||
30750699|NCT00141297|58760538|FG003|Overall Study|Progressive Disease|2|||
30750700|NCT00141297|58760539|FG004|Overall Study|Progressive Disease|15|||
30750701|NCT00141297|58760540|FG005|Overall Study|Progressive Disease|2|||
30750702|NCT00141297|58760541|FG006|Overall Study|Progressive Disease|3|||
30750703|NCT00141297|58760542|FG007|Overall Study|Progressive Disease|3|||
30750704|NCT00141297|58760543|FG008|Overall Study|Progressive Disease|15|||
30750705|NCT00141297|58760544|FG009|Overall Study|Progressive Disease|6|||
30750706|NCT00141297|58760535|FG000|Overall Study|Transitioned|0|||
30750707|NCT00141297|58760536|FG001|Overall Study|Transitioned|0|||
30750708|NCT00141297|58760537|FG002|Overall Study|Transitioned|0|||
30750709|NCT00141297|58760538|FG003|Overall Study|Transitioned|0|||
30750710|NCT00141297|58760539|FG004|Overall Study|Transitioned|1|||
30750711|NCT00141297|58760540|FG005|Overall Study|Transitioned|0|||
30750712|NCT00141297|58760541|FG006|Overall Study|Transitioned|0|||
30750713|NCT00141297|58760542|FG007|Overall Study|Transitioned|0|||
30750714|NCT00141297|58760543|FG008|Overall Study|Transitioned|0|||
30750715|NCT00141297|58760544|FG009|Overall Study|Transitioned|0|||
30750716|NCT00141219|58760579|FG000|Overall Study|Protocol violations|5|||
30750717|NCT00141219|58760580|FG001|Overall Study|Protocol violations|4|||
30750718|NCT00141219|58760579|FG000|Overall Study|Adverse Event|8|||
30750719|NCT00141219|58760580|FG001|Overall Study|Adverse Event|6|||
30815325|NCT02899988|58834759|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
30815326|NCT02899988|58834760|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
30815327|NCT02939131|58834794|FG000|Overall Study|Unable to get to clinic|6|||
30815328|NCT02939131|58834795|FG001|Overall Study|Unable to get to clinic|4|||
30815329|NCT02939131|58834794|FG000|Overall Study|Lost to Follow-up|2|||
30815330|NCT02939131|58834795|FG001|Overall Study|Lost to Follow-up|4|||
30815331|NCT02939131|58834794|FG000|Overall Study|severe debilitation|1|||
30815332|NCT02939131|58834795|FG001|Overall Study|severe debilitation|0|||
30815333|NCT02939131|58834794|FG000|Overall Study|Other|0|||
30815334|NCT02939131|58834795|FG001|Overall Study|Other|1|||
30815335|NCT02939131|58834794|FG000|Overall Study|not willing to adhere to protocol|2|||
30815336|NCT02939131|58834795|FG001|Overall Study|not willing to adhere to protocol|0|||
30815337|NCT03345407|58834809|FG000|Overall Study|Withdrawal by Subject|11|||
30815338|NCT03345407|58834810|FG001|Overall Study|Withdrawal by Subject|1|||
30815339|NCT03345407|58834811|FG002|Overall Study|Withdrawal by Subject|5|||
30815340|NCT03345407|58834812|FG003|Overall Study|Withdrawal by Subject|6|||
30815341|NCT03345407|58834813|FG004|Overall Study|Withdrawal by Subject|3|||
30815342|NCT03345407|58834814|FG005|Overall Study|Withdrawal by Subject|6|||
30815343|NCT03345407|58834815|FG006|Overall Study|Withdrawal by Subject|16|||
30815344|NCT03345407|58834809|FG000|Overall Study|Physician Decision|3|||
30815345|NCT03345407|58834810|FG001|Overall Study|Physician Decision|1|||
30815346|NCT03345407|58834811|FG002|Overall Study|Physician Decision|0|||
30815347|NCT03345407|58834812|FG003|Overall Study|Physician Decision|0|||
30815348|NCT03345407|58834813|FG004|Overall Study|Physician Decision|1|||
30815349|NCT03345407|58834814|FG005|Overall Study|Physician Decision|2|||
30815350|NCT03345407|58834815|FG006|Overall Study|Physician Decision|3|||
30815351|NCT03345407|58834809|FG000|Overall Study|Lost to Follow-up|2|||
30815352|NCT03345407|58834810|FG001|Overall Study|Lost to Follow-up|0|||
30815353|NCT03345407|58834811|FG002|Overall Study|Lost to Follow-up|1|||
30815354|NCT03345407|58834812|FG003|Overall Study|Lost to Follow-up|0|||
30815355|NCT03345407|58834813|FG004|Overall Study|Lost to Follow-up|1|||
30815356|NCT03345407|58834814|FG005|Overall Study|Lost to Follow-up|2|||
30815357|NCT03345407|58834815|FG006|Overall Study|Lost to Follow-up|3|||
30815358|NCT03345407|58834809|FG000|Overall Study|Protocol-defined stopping criteria|9|||
30815359|NCT03345407|58834810|FG001|Overall Study|Protocol-defined stopping criteria|0|||
30815360|NCT03345407|58834811|FG002|Overall Study|Protocol-defined stopping criteria|0|||
30815361|NCT03345407|58834812|FG003|Overall Study|Protocol-defined stopping criteria|0|||
30815362|NCT03345407|58834813|FG004|Overall Study|Protocol-defined stopping criteria|2|||
30815363|NCT03345407|58834814|FG005|Overall Study|Protocol-defined stopping criteria|1|||
30815364|NCT03345407|58834815|FG006|Overall Study|Protocol-defined stopping criteria|1|||
30815365|NCT03345407|58834809|FG000|Overall Study|Protocol Violation|2|||
30815366|NCT03345407|58834810|FG001|Overall Study|Protocol Violation|0|||
30815367|NCT03345407|58834811|FG002|Overall Study|Protocol Violation|0|||
30815368|NCT03345407|58834812|FG003|Overall Study|Protocol Violation|0|||
30815369|NCT03345407|58834813|FG004|Overall Study|Protocol Violation|1|||
30815370|NCT03345407|58834814|FG005|Overall Study|Protocol Violation|0|||
30815371|NCT03345407|58834815|FG006|Overall Study|Protocol Violation|3|||
30815372|NCT03345407|58834809|FG000|Overall Study|Lack of Efficacy|1|||
30815373|NCT03345407|58834810|FG001|Overall Study|Lack of Efficacy|1|||
30750720|NCT00141219|58760579|FG000|Overall Study|Lack of Efficacy|5|||
30750721|NCT00141219|58760580|FG001|Overall Study|Lack of Efficacy|4|||
30815374|NCT03345407|58834811|FG002|Overall Study|Lack of Efficacy|1|||
30815375|NCT03345407|58834812|FG003|Overall Study|Lack of Efficacy|1|||
30815376|NCT03345407|58834813|FG004|Overall Study|Lack of Efficacy|1|||
30815377|NCT03345407|58834814|FG005|Overall Study|Lack of Efficacy|0|||
30815378|NCT03345407|58834815|FG006|Overall Study|Lack of Efficacy|3|||
30815379|NCT03345407|58834809|FG000|Overall Study|Adverse Event|4|||
30815380|NCT03345407|58834810|FG001|Overall Study|Adverse Event|0|||
30750722|NCT00141219|58760579|FG000|Overall Study|Withdrawal by Subject|6|||
30750723|NCT00141219|58760580|FG001|Overall Study|Withdrawal by Subject|2|||
30750724|NCT00162266|58760589|FG000|Double-Blind Period|Adverse Event|5|||
30750725|NCT00162266|58760590|FG001|Double-Blind Period|Adverse Event|9|||
30750726|NCT00162266|58760591|FG002|Double-Blind Period|Adverse Event|11|||
30750727|NCT00162266|58760592|FG003|Double-Blind Period|Adverse Event|0|||
30750728|NCT00162266|58760589|FG000|Double-Blind Period|Death|0|||
30750729|NCT00162266|58760590|FG001|Double-Blind Period|Death|1|||
30750730|NCT00162266|58760591|FG002|Double-Blind Period|Death|0|||
30815381|NCT03345407|58834811|FG002|Overall Study|Adverse Event|5|||
30815382|NCT03345407|58834812|FG003|Overall Study|Adverse Event|4|||
30815383|NCT03345407|58834813|FG004|Overall Study|Adverse Event|6|||
30815384|NCT03345407|58834814|FG005|Overall Study|Adverse Event|5|||
30815385|NCT03345407|58834815|FG006|Overall Study|Adverse Event|16|||
30815386|NCT03255187|58834839|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
30750731|NCT00162266|58760592|FG003|Double-Blind Period|Death|0|||
30750732|NCT00162266|58760589|FG000|Double-Blind Period|Lost to Follow-up|1|||
30750733|NCT00162266|58760590|FG001|Double-Blind Period|Lost to Follow-up|2|||
30815387|NCT03255187|58834840|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
30815388|NCT03255187|58834839|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
30815389|NCT03255187|58834840|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
30815390|NCT02929329|58834848|FG000|Overall Study|Withdrawal by Subject|24|||
30815391|NCT02929329|58834849|FG001|Overall Study|Withdrawal by Subject|21|||
30815392|NCT02929329|58834848|FG000|Overall Study|Lost to Follow-up|26|||
30815393|NCT02929329|58834849|FG001|Overall Study|Lost to Follow-up|20|||
30815394|NCT02929329|58834848|FG000|Overall Study|Death|1054|||
30815395|NCT02929329|58834849|FG001|Overall Study|Death|1051|||
30815396|NCT03240133|58834862|FG000|Overall Study|Withdrawal by Subject|0|||
30815397|NCT03240133|58834863|FG001|Overall Study|Withdrawal by Subject|1|||
30815398|NCT03240133|58834864|FG002|Overall Study|Withdrawal by Subject|0|||
30815399|NCT03240133|58834862|FG000|Overall Study|Adverse Event|1|||
30815400|NCT03240133|58834863|FG001|Overall Study|Adverse Event|1|||
30815401|NCT03240133|58834864|FG002|Overall Study|Adverse Event|0|||
30815402|NCT03240133|58834862|FG000|Overall Study|Rash|1|||
30815403|NCT03240133|58834863|FG001|Overall Study|Rash|0|||
30911166|NCT02216071|58946102|FG001|Overall Study|Protocol Violation|5|||
30911167|NCT02216071|58946101|FG000|Overall Study|Other|2|||
30911168|NCT02216071|58946102|FG001|Overall Study|Other|2|||
30911169|NCT01681576|58946110|FG000|Period 1|Adverse Event|1|||
30911170|NCT01681576|58946111|FG001|Period 1|Adverse Event|0|||
30911171|NCT01681576|58946110|FG000|Period 1|Protocol Deviation|1|||
30750734|NCT00162266|58760591|FG002|Double-Blind Period|Lost to Follow-up|0|||
30815404|NCT03240133|58834864|FG002|Overall Study|Rash|0|||
30815405|NCT03240133|58834862|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
30815406|NCT03240133|58834863|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
30815407|NCT03240133|58834864|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
30815408|NCT03240133|58834862|FG000|Overall Study|Intercurrent illness.|0|||
30815409|NCT03240133|58834863|FG001|Overall Study|Intercurrent illness.|1|||
30815410|NCT03240133|58834864|FG002|Overall Study|Intercurrent illness.|0|||
30815411|NCT03240133|58834862|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
30815412|NCT03240133|58834863|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
30815413|NCT03240133|58834864|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
30815414|NCT03372083|58834888|FG000|Overall Study|Adverse Event|3|||
30815415|NCT03372083|58834888|FG000|Overall Study|Physician Decision|1|||
30815416|NCT03372083|58834888|FG000|Overall Study|Withdrawal by Subject|1|||
30815417|NCT03044886|58834895|FG000|Overall Study|Lost to Follow-up|15|||
30815418|NCT03044886|58834896|FG001|Overall Study|Lost to Follow-up|10|||
30815419|NCT03044886|58834897|FG002|Overall Study|Lost to Follow-up|12|||
30815420|NCT02961764|58834907|FG000|Overall Study|Protocol Violation|0|||
30815421|NCT02961764|58834908|FG001|Overall Study|Protocol Violation|1|||
30815422|NCT02961764|58834907|FG000|Overall Study|Death|2|||
30815423|NCT02961764|58834908|FG001|Overall Study|Death|0|||
30911172|NCT01681576|58946111|FG001|Period 1|Protocol Deviation|0|||
30911173|NCT01681576|58946110|FG000|Period 2|subject/guardian decision|3|||
30750735|NCT00162266|58760592|FG003|Double-Blind Period|Lost to Follow-up|0|||
30750736|NCT00162266|58760589|FG000|Double-Blind Period|Other Reason|1|||
30750737|NCT00162266|58760590|FG001|Double-Blind Period|Other Reason|0|||
30750738|NCT00162266|58760591|FG002|Double-Blind Period|Other Reason|1|||
30750739|NCT00162266|58760592|FG003|Double-Blind Period|Other Reason|0|||
30750740|NCT00162266|58760589|FG000|Double-Blind Period|Lack of Efficacy|13|||
30750741|NCT00162266|58760590|FG001|Double-Blind Period|Lack of Efficacy|17|||
30750742|NCT00162266|58760591|FG002|Double-Blind Period|Lack of Efficacy|30|||
30750743|NCT00162266|58760592|FG003|Double-Blind Period|Lack of Efficacy|0|||
30750744|NCT00162266|58760589|FG000|Double-Blind Period|Withdrawal by Subject|5|||
30750745|NCT00162266|58760590|FG001|Double-Blind Period|Withdrawal by Subject|2|||
30750746|NCT00162266|58760591|FG002|Double-Blind Period|Withdrawal by Subject|6|||
30750747|NCT00162266|58760592|FG003|Double-Blind Period|Withdrawal by Subject|0|||
30750748|NCT00162266|58760589|FG000|Open-Label Period|Death|0|||
30750749|NCT00162266|58760590|FG001|Open-Label Period|Death|0|||
30750750|NCT00162266|58760591|FG002|Open-Label Period|Death|0|||
30750751|NCT00162266|58760592|FG003|Open-Label Period|Death|7|||
30750752|NCT00162266|58760589|FG000|Open-Label Period|Adverse Event|0|||
30750753|NCT00162266|58760590|FG001|Open-Label Period|Adverse Event|0|||
30750754|NCT00162266|58760591|FG002|Open-Label Period|Adverse Event|0|||
30750755|NCT00162266|58760592|FG003|Open-Label Period|Adverse Event|46|||
30750756|NCT00162266|58760589|FG000|Open-Label Period|Lack of Efficacy|0|||
30750757|NCT00162266|58760590|FG001|Open-Label Period|Lack of Efficacy|0|||
30750758|NCT00162266|58760591|FG002|Open-Label Period|Lack of Efficacy|0|||
30750759|NCT00162266|58760592|FG003|Open-Label Period|Lack of Efficacy|26|||
30750760|NCT00162266|58760589|FG000|Open-Label Period|Lost to Follow-up|0|||
30911174|NCT01681576|58946111|FG001|Period 2|subject/guardian decision|1|||
30750761|NCT00162266|58760590|FG001|Open-Label Period|Lost to Follow-up|0|||
30815424|NCT02961764|58834907|FG000|Overall Study|Lost to Follow-up|35|||
30815425|NCT02961764|58834908|FG001|Overall Study|Lost to Follow-up|24|||
30815426|NCT02961764|58834907|FG000|Overall Study|Withdrawal by Subject|2|||
30815427|NCT02961764|58834908|FG001|Overall Study|Withdrawal by Subject|0|||
30911175|NCT01681576|58946110|FG000|Period 2|Non-compliance with study treatment|1|||
30750762|NCT00162266|58760591|FG002|Open-Label Period|Lost to Follow-up|0|||
30815428|NCT03371459|58834914|FG000|Washout|Lost to Follow-up|0|||
30815429|NCT03371459|58834915|FG001|Washout|Lost to Follow-up|1|||
30815430|NCT02961920|58834923|FG000|Overall Study|did not achive stydy protocol schedule|1|||
30815431|NCT02961920|58834924|FG001|Overall Study|did not achive stydy protocol schedule|1|||
30815432|NCT03371381|58834930|FG000|Overall Study|Death|5|||
30815433|NCT03371381|58834930|FG000|Overall Study|Study terminated by sponsor|3|||
30815434|NCT03371381|58834930|FG000|Overall Study|Other|4|||
30815435|NCT03044730|58834934|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
30815436|NCT03044730|58834934|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
30815437|NCT03044730|58834934|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
30815438|NCT03044730|58834934|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
30815439|NCT03044730|58834934|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
30815440|NCT03044730|58834934|FG000|Cycles 4 and Beyond|Adverse Event|1|||
30815441|NCT03044730|58834934|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
30815442|NCT03044730|58834934|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
30815443|NCT03044730|58834934|FG000|On Follow-up for 2 Years|Death|17|||
30815444|NCT02961374|58834939|FG000|Overall Study|Adverse Event|4|||
30815445|NCT02951429|58834945|FG000|Overall Study|Adverse Event|3|||
30911176|NCT01681576|58946111|FG001|Period 2|Non-compliance with study treatment|0|||
30911177|NCT02188459|58946121|FG000|Overall Study|Lost to Follow-up|3|||
30911178|NCT02188459|58946122|FG001|Overall Study|Lost to Follow-up|4|||
30911179|NCT02188459|58946121|FG000|Overall Study|Early Termination|0|||
30911180|NCT02188459|58946122|FG001|Overall Study|Early Termination|3|||
30911181|NCT02214121|58946144|FG000|Part A|Patient decision|2|||
30911182|NCT02214121|58946145|FG001|Part A|Patient decision|0|||
30911183|NCT02214121|58946146|FG002|Part A|Patient decision|0|||
30911184|NCT02214121|58946144|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
30911185|NCT02214121|58946145|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
30911186|NCT02214121|58946146|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
30911187|NCT02214121|58946144|FG000|Part A|Other|1|||
30911188|NCT02214121|58946145|FG001|Part A|Other|0|||
30911189|NCT02214121|58946146|FG002|Part A|Other|0|||
30911190|NCT02214121|58946144|FG000|Part B|Patient decision|0|||
30911191|NCT02214121|58946145|FG001|Part B|Patient decision|1|||
30911192|NCT02214121|58946146|FG002|Part B|Patient decision|0|||
30911193|NCT02214121|58946144|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
30911194|NCT02214121|58946145|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
30911195|NCT02214121|58946146|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
30911196|NCT02214121|58946144|FG000|Part B|Lost to Follow-up|0|||
30911197|NCT02214121|58946145|FG001|Part B|Lost to Follow-up|0|||
30750763|NCT00162266|58760592|FG003|Open-Label Period|Lost to Follow-up|3|||
30750764|NCT00162266|58760589|FG000|Open-Label Period|Withdrawal by Subject|0|||
30815446|NCT02951429|58834946|FG001|Overall Study|Adverse Event|7|||
30815447|NCT02951429|58834945|FG000|Overall Study|Death|28|||
30750765|NCT00162266|58760590|FG001|Open-Label Period|Withdrawal by Subject|0|||
30815448|NCT02951429|58834946|FG001|Overall Study|Death|36|||
30815449|NCT02951429|58834945|FG000|Overall Study|Lack of Efficacy|0|||
30815450|NCT02951429|58834946|FG001|Overall Study|Lack of Efficacy|1|||
30815451|NCT02951429|58834945|FG000|Overall Study|Lost to Follow-up|0|||
30815452|NCT02951429|58834946|FG001|Overall Study|Lost to Follow-up|1|||
30815453|NCT02951429|58834945|FG000|Overall Study|Lung Transplantation|9|||
30815454|NCT02951429|58834946|FG001|Overall Study|Lung Transplantation|6|||
30815455|NCT02951429|58834945|FG000|Overall Study|Other|1|||
30815456|NCT02951429|58834946|FG001|Overall Study|Other|3|||
30815457|NCT02951429|58834945|FG000|Overall Study|Progressive Disease|1|||
30815458|NCT02951429|58834946|FG001|Overall Study|Progressive Disease|1|||
30815459|NCT02951429|58834945|FG000|Overall Study|Withdrawal by Subject|7|||
30815460|NCT02951429|58834946|FG001|Overall Study|Withdrawal by Subject|11|||
30815461|NCT02951429|58834945|FG000|Overall Study|Participant ongoing in the study|23|||
30750766|NCT00162266|58760591|FG002|Open-Label Period|Withdrawal by Subject|0|||
30750767|NCT00162266|58760592|FG003|Open-Label Period|Withdrawal by Subject|31|||
30750768|NCT00162266|58760589|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
30750769|NCT00162266|58760590|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
30911198|NCT02214121|58946146|FG002|Part B|Lost to Follow-up|1|||
30911199|NCT01681186|58946174|FG000|Washout Period From Second Intervention|Adverse Event|0|||
30911200|NCT01681186|58946175|FG001|Washout Period From Second Intervention|Adverse Event|0|||
30911201|NCT01681186|58946176|FG002|Washout Period From Second Intervention|Adverse Event|0|||
30911202|NCT01681186|58946177|FG003|Washout Period From Second Intervention|Adverse Event|0|||
30911203|NCT01681186|58946178|FG004|Washout Period From Second Intervention|Adverse Event|0|||
30911204|NCT01681186|58946179|FG005|Washout Period From Second Intervention|Adverse Event|0|||
30911205|NCT01681186|58946180|FG006|Washout Period From Second Intervention|Adverse Event|1|||
30750770|NCT00162266|58760591|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
30815462|NCT02951429|58834946|FG001|Overall Study|Participant ongoing in the study|17|||
30815463|NCT03343067|58834959|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
30815464|NCT03343067|58834960|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
30911206|NCT01681186|58946181|FG007|Washout Period From Second Intervention|Adverse Event|0|||
30750771|NCT00162266|58760592|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
30750772|NCT00162266|58760589|FG000|Open-Label Period|Other Reasons|0|||
30750773|NCT00162266|58760590|FG001|Open-Label Period|Other Reasons|0|||
30750774|NCT00162266|58760591|FG002|Open-Label Period|Other Reasons|0|||
30750775|NCT00162266|58760592|FG003|Open-Label Period|Other Reasons|15|||
30815465|NCT03343067|58834961|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
30815466|NCT03103503|58834969|FG000|Overall Study|Death|64|||
30815467|NCT03103503|58834969|FG000|Overall Study|Physician Decision|57|||
30815468|NCT03103503|58834969|FG000|Overall Study|Withdrawal by Subject|10|||
30815469|NCT03103503|58834969|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
30815470|NCT03103503|58834969|FG000|Overall Study|Lost to Follow-up|3|||
30815471|NCT03103503|58834969|FG000|Overall Study|Study Closure|757|||
30815472|NCT02961218|58834975|FG000|Overall Study|Lost to Follow-up|0|||
30815473|NCT02961218|58834976|FG001|Overall Study|Lost to Follow-up|2|||
30815474|NCT02961218|58834975|FG000|Overall Study|Physician Decision|0|||
30815475|NCT02961218|58834976|FG001|Overall Study|Physician Decision|2|||
30815476|NCT02961218|58834975|FG000|Overall Study|Subject/Guardian Decision|3|||
30815477|NCT02961218|58834976|FG001|Overall Study|Subject/Guardian Decision|1|||
30815478|NCT02949947|58834986|FG000|Overall Study|Non Compliance|0|||
30815479|NCT02949947|58834987|FG001|Overall Study|Non Compliance|1|||
30815480|NCT02949947|58834986|FG000|Overall Study|Insurance change|1|||
30815481|NCT02949947|58834987|FG001|Overall Study|Insurance change|0|||
30815482|NCT03341507|58834993|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
30815483|NCT01345058|58834999|FG000|Overall Study|Withdrawal by Subject|1|||
30815484|NCT01345058|58835000|FG001|Overall Study|Withdrawal by Subject|0|||
30815485|NCT01345058|58834999|FG000|Overall Study|Participant Reported Increase in Events|1|||
30815486|NCT01345058|58835000|FG001|Overall Study|Participant Reported Increase in Events|0|||
30815487|NCT01345058|58834999|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
30815488|NCT01345058|58835000|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
30815489|NCT01345058|58834999|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
30815490|NCT01345058|58835000|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
30815491|NCT01345058|58834999|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
30815492|NCT01345058|58835000|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
30815493|NCT01345292|58835009|FG000|Overall Study|Withdrawal by Subject|2|||
30815494|NCT01345292|58835010|FG001|Overall Study|Withdrawal by Subject|0|||
30815495|NCT01345292|58835011|FG002|Overall Study|Withdrawal by Subject|1|||
30815496|NCT03340961|58835023|FG000|Overall Study|Adverse Event|1|||
30815497|NCT03340961|58835024|FG001|Overall Study|Adverse Event|3|||
30750776|NCT00225212|58760644|FG000|Overall Study|Disease progression|2|||
30750777|NCT00225212|58760644|FG000|Overall Study|Death|1|||
30750778|NCT00225212|58760644|FG000|Overall Study|Adverse Event|2|||
30750779|NCT00225212|58760644|FG000|Overall Study|Intercurrent illness|1|||
30750780|NCT00162032|58760650|FG000|Overall Study|Lost to Follow-up|4|||
30750781|NCT00162032|58760651|FG001|Overall Study|Lost to Follow-up|2|||
30750782|NCT00162032|58760650|FG000|Overall Study|Reason not specified|1|||
30750783|NCT00162032|58760651|FG001|Overall Study|Reason not specified|0|||
30750784|NCT00258674|58760665|FG000|Overall Study|Death|32|||
30750785|NCT00258674|58760666|FG001|Overall Study|Death|53|||
30750786|NCT00258674|58760667|FG002|Overall Study|Death|34|||
30750787|NCT00258440|58760678|FG000|Overall Study|Withdrawal by Subject|0|||
30750788|NCT00258440|58760679|FG001|Overall Study|Withdrawal by Subject|0|||
30750789|NCT00258440|58760680|FG002|Overall Study|Withdrawal by Subject|1|||
30750790|NCT00224120|58760690|FG000|Overall Study|Adverse Event|10|||
30750791|NCT00224120|58760691|FG001|Overall Study|Adverse Event|4|||
30815498|NCT03340961|58835025|FG002|Overall Study|Adverse Event|2|||
30815499|NCT03340961|58835026|FG003|Overall Study|Adverse Event|4|||
30750792|NCT00224120|58760690|FG000|Overall Study|Protocol Violation|1|||
30750793|NCT00224120|58760691|FG001|Overall Study|Protocol Violation|0|||
30750794|NCT00224120|58760690|FG000|Overall Study|Withdrawal by Subject|5|||
30750795|NCT00224120|58760691|FG001|Overall Study|Withdrawal by Subject|10|||
30815500|NCT03340961|58835023|FG000|Overall Study|Lost to Follow-up|0|||
30815501|NCT03340961|58835024|FG001|Overall Study|Lost to Follow-up|1|||
30750796|NCT00224120|58760690|FG000|Overall Study|Lack of Efficacy|0|||
30815502|NCT03340961|58835025|FG002|Overall Study|Lost to Follow-up|0|||
30815503|NCT03340961|58835026|FG003|Overall Study|Lost to Follow-up|1|||
30815504|NCT03340961|58835023|FG000|Overall Study|Withdrawal by Subject|3|||
30815505|NCT03340961|58835024|FG001|Overall Study|Withdrawal by Subject|2|||
30815506|NCT03340961|58835025|FG002|Overall Study|Withdrawal by Subject|4|||
30815507|NCT03340961|58835026|FG003|Overall Study|Withdrawal by Subject|7|||
30815508|NCT03340961|58835023|FG000|Overall Study|Use of prohibited treatment|0|||
30815509|NCT03340961|58835024|FG001|Overall Study|Use of prohibited treatment|3|||
30815510|NCT03340961|58835025|FG002|Overall Study|Use of prohibited treatment|2|||
30815511|NCT03340961|58835026|FG003|Overall Study|Use of prohibited treatment|4|||
30815512|NCT03340961|58835023|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
30622592|NCT00922480|58634283|FG001|Main Study|Adverse Event|7|||
30750797|NCT00224120|58760691|FG001|Overall Study|Lack of Efficacy|2|||
30750798|NCT00224120|58760690|FG000|Overall Study|Lost to Follow-up|2|||
30750799|NCT00224120|58760691|FG001|Overall Study|Lost to Follow-up|3|||
30750800|NCT00224120|58760690|FG000|Overall Study|Other|4|||
30750801|NCT00224120|58760691|FG001|Overall Study|Other|5|||
30750802|NCT00257660|58760699|FG000|Overall Study|Lack of Efficacy|5|||
30750803|NCT00257660|58760700|FG001|Overall Study|Lack of Efficacy|23|||
30750804|NCT00257660|58760699|FG000|Overall Study|Withdrawal by Subject|2|||
30750805|NCT00257660|58760700|FG001|Overall Study|Withdrawal by Subject|0|||
30750806|NCT00257660|58760699|FG000|Overall Study|Lost to Follow-up|1|||
30750807|NCT00257660|58760700|FG001|Overall Study|Lost to Follow-up|0|||
30750808|NCT00257660|58760699|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
30750809|NCT00257660|58760700|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
30750810|NCT00257660|58760699|FG000|Overall Study|No longer wanted to do blood draws|1|||
30750811|NCT00257660|58760700|FG001|Overall Study|No longer wanted to do blood draws|0|||
30750812|NCT00224042|58760708|FG000|Overall Study|Adverse Event|2|||
30750813|NCT00224042|58760709|FG001|Overall Study|Adverse Event|1|||
30750814|NCT00224042|58760708|FG000|Overall Study|Protocol Violation|0|||
30750815|NCT00224042|58760709|FG001|Overall Study|Protocol Violation|1|||
30750816|NCT00224042|58760708|FG000|Overall Study|Physician Decision|0|||
30750817|NCT00224042|58760709|FG001|Overall Study|Physician Decision|1|||
30750818|NCT00224042|58760708|FG000|Overall Study|Did not meet lab incusion criteria|2|||
30750819|NCT00224042|58760709|FG001|Overall Study|Did not meet lab incusion criteria|3|||
30750820|NCT00224042|58760708|FG000|Overall Study|Other|2|||
30750821|NCT00224042|58760709|FG001|Overall Study|Other|0|||
30750822|NCT00160706|58760715|FG000|Overall Study|Adverse Event|53|||
30750823|NCT00160706|58760715|FG000|Overall Study|Adverse Event and Other Reason|105|||
30750824|NCT00160706|58760715|FG000|Overall Study|Protocol Violation|3|||
30750825|NCT00160706|58760715|FG000|Overall Study|Withdrawal by Subject|41|||
30750826|NCT00160706|58760715|FG000|Overall Study|Withdrawal by Subject and Other|12|||
30750827|NCT00160706|58760715|FG000|Overall Study|Physician Decision|10|||
30750828|NCT00160706|58760715|FG000|Overall Study|Physician Decision and Other|3|||
30750829|NCT00160706|58760715|FG000|Overall Study|Lost to Follow-up|4|||
30815513|NCT03340961|58835024|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
30622593|NCT00922480|58634282|FG000|Main Study|Lack of Efficacy|3|||
30622594|NCT00922480|58634283|FG001|Main Study|Lack of Efficacy|0|||
30750830|NCT00160706|58760715|FG000|Overall Study|Lost to Follow-up and Other|1|||
30750831|NCT00160706|58760715|FG000|Overall Study|Lack of Efficacy|42|||
30750832|NCT00160706|58760715|FG000|Overall Study|Lack of Efficacy and Other|1|||
30750833|NCT00160706|58760715|FG000|Overall Study|Other Reason|11|||
30750834|NCT00257192|58760721|FG000|Overall Study|Adverse Event|21|||
30815514|NCT03340961|58835025|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
30815515|NCT03340961|58835026|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
30815516|NCT03340961|58835023|FG000|Overall Study|Subject developed an exclusion criterion|0|||
30815517|NCT03340961|58835024|FG001|Overall Study|Subject developed an exclusion criterion|1|||
30815518|NCT03340961|58835025|FG002|Overall Study|Subject developed an exclusion criterion|0|||
30815519|NCT03340961|58835026|FG003|Overall Study|Subject developed an exclusion criterion|0|||
30815520|NCT03340961|58835023|FG000|Overall Study|Protocol Violation|1|||
30911207|NCT01681186|58946174|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
30911208|NCT01681186|58946175|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
30911209|NCT01681186|58946176|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
30911210|NCT01681186|58946177|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
30911211|NCT01681186|58946178|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
30911212|NCT01681186|58946179|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
30911213|NCT01681186|58946180|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
30911214|NCT01681186|58946181|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
30911215|NCT01681186|58946174|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
30911216|NCT01681186|58946175|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
30911217|NCT01681186|58946176|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
30911218|NCT01681186|58946177|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
30622595|NCT00922480|58634282|FG000|Main Study|Withdrawal by Subject|20|||
30622596|NCT00922480|58634283|FG001|Main Study|Withdrawal by Subject|15|||
30815521|NCT03340961|58835024|FG001|Overall Study|Protocol Violation|0|||
30815522|NCT03340961|58835025|FG002|Overall Study|Protocol Violation|1|||
30815523|NCT03340961|58835026|FG003|Overall Study|Protocol Violation|0|||
30815524|NCT03340961|58835023|FG000|Overall Study|Adverse Event|1|||
30815525|NCT03340961|58835024|FG001|Overall Study|Adverse Event|1|||
30815526|NCT03340961|58835025|FG002|Overall Study|Adverse Event|0|||
30815527|NCT03340961|58835026|FG003|Overall Study|Adverse Event|0|||
30815528|NCT03340961|58835023|FG000|Overall Study|Lack of Efficacy|0|||
30815529|NCT03340961|58835024|FG001|Overall Study|Lack of Efficacy|0|||
30815530|NCT03340961|58835025|FG002|Overall Study|Lack of Efficacy|0|||
30815531|NCT03340961|58835026|FG003|Overall Study|Lack of Efficacy|1|||
30815532|NCT03340025|58835038|FG000|Overall Study|Lost to Follow-up|2|||
30815533|NCT03340025|58835039|FG001|Overall Study|Lost to Follow-up|2|||
30815534|NCT03339713|58835047|FG000|Overall Study|Lost to Follow-up|2|||
30815535|NCT03339713|58835048|FG001|Overall Study|Lost to Follow-up|1|||
30815536|NCT03339713|58835047|FG000|Overall Study|Protocol Violation|1|||
30815537|NCT03339713|58835048|FG001|Overall Study|Protocol Violation|0|||
30815538|NCT03339713|58835047|FG000|Overall Study|Withdrawal by Subject|1|||
30815539|NCT03339713|58835048|FG001|Overall Study|Withdrawal by Subject|1|||
30815540|NCT03254485|58835060|FG000|Overall Study|Adverse Event|3|||
30815541|NCT03254485|58835061|FG001|Overall Study|Adverse Event|0|||
30815542|NCT03254485|58835062|FG002|Overall Study|Adverse Event|0|||
30815543|NCT03254485|58835063|FG003|Overall Study|Adverse Event|6|||
30815544|NCT03254485|58835060|FG000|Overall Study|Protocol Violation|6|||
30815545|NCT03254485|58835061|FG001|Overall Study|Protocol Violation|0|||
30815546|NCT03254485|58835062|FG002|Overall Study|Protocol Violation|0|||
30815547|NCT03254485|58835063|FG003|Overall Study|Protocol Violation|2|||
30815548|NCT03254485|58835060|FG000|Overall Study|Withdrawal by Subject|1|||
30815549|NCT03254485|58835061|FG001|Overall Study|Withdrawal by Subject|0|||
30815550|NCT03254485|58835062|FG002|Overall Study|Withdrawal by Subject|0|||
30815551|NCT03254485|58835063|FG003|Overall Study|Withdrawal by Subject|4|||
30815552|NCT03254485|58835060|FG000|Overall Study|Death|0|||
30815553|NCT03254485|58835061|FG001|Overall Study|Death|0|||
30815554|NCT03254485|58835062|FG002|Overall Study|Death|0|||
30815555|NCT03254485|58835063|FG003|Overall Study|Death|1|||
30815556|NCT03254485|58835060|FG000|Overall Study|Lost to Follow-up|1|||
30815557|NCT03254485|58835061|FG001|Overall Study|Lost to Follow-up|0|||
30815558|NCT03254485|58835062|FG002|Overall Study|Lost to Follow-up|0|||
30815559|NCT03254485|58835063|FG003|Overall Study|Lost to Follow-up|0|||
30815560|NCT03254485|58835060|FG000|Overall Study|Other|1|||
30815561|NCT03254485|58835061|FG001|Overall Study|Other|0|||
30815562|NCT03254485|58835062|FG002|Overall Study|Other|0|||
30815563|NCT03254485|58835063|FG003|Overall Study|Other|2|||
30815564|NCT03339401|58835086|FG000|Overall Study|Death|2|||
30815565|NCT03339401|58835087|FG001|Overall Study|Death|1|||
30815566|NCT03339401|58835086|FG000|Overall Study|Withdrawal by Subject|2|||
30815567|NCT03339401|58835087|FG001|Overall Study|Withdrawal by Subject|0|||
30815568|NCT03339401|58835086|FG000|Overall Study|Study terminated|4|||
30622597|NCT00922480|58634282|FG000|Main Study|Lost to Follow-up|5|||
30622598|NCT00922480|58634283|FG001|Main Study|Lost to Follow-up|0|||
30815569|NCT03339401|58835087|FG001|Overall Study|Study terminated|3|||
30815570|NCT03339401|58835086|FG000|Overall Study|Investigator Decision|1|||
30622599|NCT00922480|58634282|FG000|Main Study|Physician Decision|0|||
30815571|NCT03339401|58835087|FG001|Overall Study|Investigator Decision|0|||
30815572|NCT03370289|58835093|FG000|Overall Study|Screen Failure|1|||
30815573|NCT03370289|58835093|FG000|Overall Study|Sample Size Sufficient|4|||
30815574|NCT01344824|58835097|FG000|Overall Study|Adverse Event|15|||
30815575|NCT01344824|58835097|FG000|Overall Study|Withdrawal by Subject|6|||
30815576|NCT01344824|58835097|FG000|Overall Study|Other complicating disease|1|||
30815577|NCT01344824|58835097|FG000|Overall Study|Progression|15|||
30815578|NCT03339245|58835104|FG000|Overall Study|Adverse Event|1|||
30815579|NCT03339245|58835105|FG001|Overall Study|Adverse Event|1|||
30815580|NCT03339245|58835104|FG000|Overall Study|Withdrawal by Subject|1|||
30815581|NCT03339245|58835105|FG001|Overall Study|Withdrawal by Subject|0|||
30815582|NCT03044574|58835113|FG000|Overall Study|Lost to Follow-up|37|||
30815583|NCT03044574|58835114|FG001|Overall Study|Lost to Follow-up|45|||
30815584|NCT02959892|58835122|FG000|Overall Study|PET tracer synthesis failure|1|||
30815585|NCT02959892|58835123|FG001|Overall Study|PET tracer synthesis failure|0|||
30815586|NCT02959892|58835122|FG000|Overall Study|Study termination|0|||
30815587|NCT02959892|58835123|FG001|Overall Study|Study termination|1|||
30622600|NCT00922480|58634283|FG001|Main Study|Physician Decision|1|||
30622601|NCT00922480|58634282|FG000|Extension Study|Protocol Violation|3|||
30815588|NCT03252145|58835131|FG000|Overall Study|Withdrawal by Subject|1|||
30815589|NCT03252145|58835132|FG001|Overall Study|Withdrawal by Subject|0|||
30815590|NCT03252145|58835131|FG000|Overall Study|Complicating Disease|1|||
30815591|NCT03252145|58835132|FG001|Overall Study|Complicating Disease|2|||
30815592|NCT02959814|58835138|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
30815593|NCT02959814|58835138|FG000|Overall Study|Excluded based on anatomical criteria|2|||
30815594|NCT02959814|58835138|FG000|Overall Study|Protocol Violation|7|||
30815595|NCT02959814|58835138|FG000|Overall Study|FFR not measured|2|||
30815596|NCT02959814|58835138|FG000|Overall Study|In-procedure QFR not computed|6|||
30815597|NCT02959814|58835138|FG000|Overall Study|Excluded by FFR core-lab|24|||
30622602|NCT00922480|58634283|FG001|Extension Study|Protocol Violation|0|||
30622603|NCT00922480|58634282|FG000|Extension Study|Adverse Event|1|||
30622604|NCT00922480|58634283|FG001|Extension Study|Adverse Event|1|||
30622605|NCT00922480|58634282|FG000|Extension Study|Withdrawal by Subject|1|||
30622606|NCT00922480|58634283|FG001|Extension Study|Withdrawal by Subject|1|||
30622607|NCT00922480|58634282|FG000|Extension Study|Others|0|||
30622608|NCT00922480|58634283|FG001|Extension Study|Others|1|||
30622609|NCT00973479|58634293|FG000|Overall Study|Lost to Follow-up|0|||
30622610|NCT00973479|58634294|FG001|Overall Study|Lost to Follow-up|3|||
30622611|NCT00973479|58634293|FG000|Overall Study|Death|2|||
30622612|NCT00973479|58634294|FG001|Overall Study|Death|2|||
30622613|NCT00973479|58634293|FG000|Overall Study|Withdrawal by Subject|15|||
30622614|NCT00973479|58634294|FG001|Overall Study|Withdrawal by Subject|16|||
30622615|NCT00973479|58634293|FG000|Overall Study|Lack of Efficacy|5|||
30622616|NCT00973479|58634294|FG001|Overall Study|Lack of Efficacy|7|||
30622617|NCT00973479|58634293|FG000|Overall Study|Adverse Event|12|||
30622618|NCT00973479|58634294|FG001|Overall Study|Adverse Event|32|||
30622619|NCT00973479|58634293|FG000|Overall Study|Protocol Violation|2|||
30815598|NCT03666624|58835145|FG000|Overall Study|participant grieving over recent death of parent|1|||
30815599|NCT03666624|58835146|FG001|Overall Study|participant grieving over recent death of parent|0|||
30815600|NCT03368807|58835152|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
30911219|NCT01681186|58946178|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
30622620|NCT00973479|58634294|FG001|Overall Study|Protocol Violation|2|||
30622621|NCT00973479|58634293|FG000|Overall Study|Other|1|||
30622622|NCT00973479|58634294|FG001|Overall Study|Other|7|||
30622623|NCT01174043|58634302|FG000|Overall Study|Disease progression|5|||
30622624|NCT01174043|58634302|FG000|Overall Study|Adverse Event|3|||
30622625|NCT01174043|58634302|FG000|Overall Study|Death|1|||
30622626|NCT01174043|58634302|FG000|Overall Study|Withdrawal by Subject|2|||
30622627|NCT01173653|58634308|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
30750835|NCT00257192|58760722|FG001|Overall Study|Adverse Event|10|||
30750836|NCT00257192|58760721|FG000|Overall Study|Laboratory abnormality|1|||
30750837|NCT00257192|58760722|FG001|Overall Study|Laboratory abnormality|1|||
30750838|NCT00257192|58760721|FG000|Overall Study|Lost to Follow-up|3|||
30750839|NCT00257192|58760722|FG001|Overall Study|Lost to Follow-up|3|||
30750840|NCT00257192|58760721|FG000|Overall Study|Insufficient clinical response|18|||
30750841|NCT00257192|58760722|FG001|Overall Study|Insufficient clinical response|18|||
30750842|NCT00257192|58760721|FG000|Overall Study|Withdrawal by Subject|14|||
30750843|NCT00257192|58760722|FG001|Overall Study|Withdrawal by Subject|2|||
30750844|NCT00257192|58760721|FG000|Overall Study|Randomized but not treated|0|||
30750845|NCT00257192|58760722|FG001|Overall Study|Randomized but not treated|1|||
30750846|NCT00257192|58760721|FG000|Overall Study|Study terminated by sponsor|1|||
30750847|NCT00257192|58760722|FG001|Overall Study|Study terminated by sponsor|0|||
30750848|NCT00257192|58760721|FG000|Overall Study|Miscellaneous|0|||
30750849|NCT00257192|58760722|FG001|Overall Study|Miscellaneous|4|||
30750850|NCT00256724|58760730|FG000|Overall Study|Physician Decision|2|||
30750851|NCT00256724|58760731|FG001|Overall Study|Physician Decision|5|||
30750852|NCT00256724|58760730|FG000|Overall Study|Protocol Violation|3|||
30750853|NCT00256724|58760731|FG001|Overall Study|Protocol Violation|3|||
30750854|NCT00157820|58760740|FG000|Randomized|Physician Decision|4|||
30911220|NCT01681186|58946179|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
30911221|NCT01681186|58946180|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
30911222|NCT01681186|58946181|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
30911223|NCT01681186|58946174|FG000|Fourth Intervention|Protocol Violation|0|||
30911224|NCT01681186|58946175|FG001|Fourth Intervention|Protocol Violation|0|||
30911225|NCT01681186|58946176|FG002|Fourth Intervention|Protocol Violation|0|||
30911226|NCT01681186|58946177|FG003|Fourth Intervention|Protocol Violation|0|||
30911227|NCT01681186|58946178|FG004|Fourth Intervention|Protocol Violation|0|||
30911228|NCT01681186|58946179|FG005|Fourth Intervention|Protocol Violation|0|||
30911229|NCT01681186|58946180|FG006|Fourth Intervention|Protocol Violation|0|||
30911230|NCT01681186|58946181|FG007|Fourth Intervention|Protocol Violation|1|||
30911231|NCT03597464|58946213|FG000|Overall Study|Withdrawal by Subject|4|||
30622628|NCT01173653|58634309|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
30622629|NCT01172873|58634317|FG000|Overall Study|Withdrawal by Subject|3|||
30750855|NCT00157820|58760741|FG001|Randomized|Physician Decision|2|||
30750856|NCT00157820|58760742|FG002|Randomized|Physician Decision|3|||
30750857|NCT00157820|58760740|FG000|Randomized|Withdrawal by Subject|1|||
30750858|NCT00157820|58760741|FG001|Randomized|Withdrawal by Subject|2|||
30750859|NCT00157820|58760742|FG002|Randomized|Withdrawal by Subject|3|||
30750860|NCT00157820|58760740|FG000|Randomized|Protocol Violation|2|||
30750861|NCT00157820|58760741|FG001|Randomized|Protocol Violation|1|||
30750862|NCT00157820|58760742|FG002|Randomized|Protocol Violation|2|||
30815601|NCT03368807|58835152|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
30815602|NCT03368807|58835152|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
30911232|NCT03597464|58946214|FG001|Overall Study|Withdrawal by Subject|5|||
30911233|NCT03597464|58946213|FG000|Overall Study|Lost to Follow-up|3|||
30911234|NCT03597464|58946214|FG001|Overall Study|Lost to Follow-up|1|||
30911235|NCT03597464|58946213|FG000|Overall Study|Pregnancy|3|||
30911236|NCT03597464|58946214|FG001|Overall Study|Pregnancy|1|||
30911237|NCT03597464|58946213|FG000|Overall Study|Lack of Efficacy|2|||
30911238|NCT03597464|58946214|FG001|Overall Study|Lack of Efficacy|0|||
30911239|NCT03597464|58946213|FG000|Overall Study|Physician Decision|2|||
30911240|NCT03597464|58946214|FG001|Overall Study|Physician Decision|2|||
30911241|NCT03597464|58946213|FG000|Overall Study|Protocol Violation|1|||
30911242|NCT03597464|58946214|FG001|Overall Study|Protocol Violation|1|||
30911243|NCT03597464|58946213|FG000|Overall Study|Adverse Event|0|||
30911244|NCT03597464|58946214|FG001|Overall Study|Adverse Event|2|||
30815603|NCT03368807|58835152|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
30911245|NCT03597464|58946213|FG000|Overall Study|Death|0|||
30911246|NCT03597464|58946214|FG001|Overall Study|Death|3|||
30911247|NCT01695772|58946222|FG000|Overall Study|Withdrawal by Subject|18|||
30911248|NCT01695772|58946222|FG000|Overall Study|Progressive Disease|8|||
30911249|NCT01695772|58946222|FG000|Overall Study|Investigator Decision|5|||
30911250|NCT01695772|58946222|FG000|Overall Study|Lost to Follow-up|4|||
30911251|NCT01695772|58946222|FG000|Overall Study|Protocol Violation|2|||
30911252|NCT01695772|58946222|FG000|Overall Study|Unspecified Reason|1|||
30911253|NCT02159521|58946226|FG000|Overall Study|Enrolled but not treated|3|||
30911254|NCT02159521|58946226|FG000|Overall Study|Withdrawal by Subject|7|||
30911255|NCT02159521|58946226|FG000|Overall Study|Lost to Follow-up|6|||
30911256|NCT02159521|58946226|FG000|Overall Study|Death|1|||
30815604|NCT03338855|58835160|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
30911257|NCT02159521|58946226|FG000|Overall Study|Other than specified|1|||
30911258|NCT01636934|58946232|FG000|Overall Study|Withdrawal by Subject|3|||
30815605|NCT03338855|58835161|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
30815606|NCT03367793|58835173|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
30815607|NCT03367793|58835174|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
30815608|NCT03367793|58835175|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
30815609|NCT03367793|58835176|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
30815610|NCT03367793|58835177|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
30815611|NCT03367793|58835178|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
30911259|NCT01636934|58946233|FG001|Overall Study|Withdrawal by Subject|2|||
30911260|NCT01636934|58946232|FG000|Overall Study|Chemo cancel|1|||
30911261|NCT01636934|58946233|FG001|Overall Study|Chemo cancel|0|||
30622630|NCT01172873|58634318|FG001|Overall Study|Withdrawal by Subject|2|||
30622631|NCT00925600|58634330|FG000|Overall Study|Withdrawal by Subject|16|||
30750863|NCT00157820|58760740|FG000|1st 8 Month|Death|7|||
30815612|NCT01347307|58835200|FG000|Overall Study|Death|0|||
30815613|NCT01347307|58835201|FG001|Overall Study|Death|4|||
30815614|NCT01347307|58835200|FG000|Overall Study|Physician Decision|0|||
30815615|NCT01347307|58835201|FG001|Overall Study|Physician Decision|1|||
30911262|NCT01636934|58946232|FG000|Overall Study|Too ill to continue|1|||
30911263|NCT01636934|58946233|FG001|Overall Study|Too ill to continue|0|||
30911264|NCT01636934|58946232|FG000|Overall Study|Never started study medication|1|||
30911265|NCT01636934|58946233|FG001|Overall Study|Never started study medication|1|||
30911266|NCT01712854|58946239|FG000|Overall Study|Physician Decision|1|||
30911267|NCT01693120|58946243|FG000|Enrollment|Lost to Follow-up|1|||
30911268|NCT01693120|58946243|FG000|Enrollment|Withdrawal by Subject|10|||
30815616|NCT03247543|58835258|FG000|Overall Study|Adverse Event|3|||
30815617|NCT03247543|58835259|FG001|Overall Study|Adverse Event|6|||
30815618|NCT03247543|58835260|FG002|Overall Study|Adverse Event|4|||
30815619|NCT03247543|58835258|FG000|Overall Study|Lost to Follow-up|10|||
30815620|NCT03247543|58835259|FG001|Overall Study|Lost to Follow-up|7|||
30815621|NCT03247543|58835260|FG002|Overall Study|Lost to Follow-up|8|||
30815622|NCT03247543|58835258|FG000|Overall Study|Consent withdrawn by caregiver|2|||
30911269|NCT01693120|58946243|FG000|Enrollment|Protocol Violation|46|||
30750864|NCT00157820|58760741|FG001|1st 8 Month|Death|8|||
30750865|NCT00157820|58760742|FG002|1st 8 Month|Death|3|||
30750866|NCT00157820|58760740|FG000|1st 8 Month|Lost to Follow-up|1|||
30750867|NCT00157820|58760741|FG001|1st 8 Month|Lost to Follow-up|2|||
30750868|NCT00157820|58760742|FG002|1st 8 Month|Lost to Follow-up|1|||
30750869|NCT00157820|58760740|FG000|1st 8 Month|Premature cross-over|0|||
30750870|NCT00157820|58760741|FG001|1st 8 Month|Premature cross-over|2|||
30750871|NCT00157820|58760742|FG002|1st 8 Month|Premature cross-over|2|||
30750872|NCT00157820|58760740|FG000|2nd 8 Months|Death|3|||
30750873|NCT00157820|58760741|FG001|2nd 8 Months|Death|1|||
30750874|NCT00157820|58760742|FG002|2nd 8 Months|Death|3|||
30750875|NCT00157820|58760740|FG000|2nd 8 Months|Lost to Follow-up|1|||
30750876|NCT00157820|58760741|FG001|2nd 8 Months|Lost to Follow-up|5|||
30750877|NCT00157820|58760742|FG002|2nd 8 Months|Lost to Follow-up|2|||
30750878|NCT00157820|58760740|FG000|2nd 8 Months|Premature cross-over|1|||
30750879|NCT00157820|58760741|FG001|2nd 8 Months|Premature cross-over|7|||
30750880|NCT00157820|58760742|FG002|2nd 8 Months|Premature cross-over|9|||
30750881|NCT00223808|58760754|FG000|Overall Study|<5 hrs therapy before discharge|3|||
30750882|NCT00223808|58760755|FG001|Overall Study|<5 hrs therapy before discharge|5|||
30750883|NCT00223808|58760756|FG002|Overall Study|<5 hrs therapy before discharge|5|||
30750884|NCT00154310|58760766|FG000|Overall Study|Adverse Event|19|||
30750885|NCT00154310|58760767|FG001|Overall Study|Adverse Event|9|||
30750886|NCT00154310|58760766|FG000|Overall Study|Lack of Efficacy|5|||
30750887|NCT00154310|58760767|FG001|Overall Study|Lack of Efficacy|4|||
30750888|NCT00154310|58760766|FG000|Overall Study|Protocol Violation|4|||
30750889|NCT00154310|58760767|FG001|Overall Study|Protocol Violation|2|||
30750890|NCT00154310|58760766|FG000|Overall Study|Withdrawal by Subject|9|||
30750891|NCT00154310|58760767|FG001|Overall Study|Withdrawal by Subject|3|||
30750892|NCT00154310|58760766|FG000|Overall Study|Lost to Follow-up|0|||
30750893|NCT00154310|58760767|FG001|Overall Study|Lost to Follow-up|8|||
30750894|NCT00154310|58760766|FG000|Overall Study|Administrative problems|0|||
30750895|NCT00154310|58760767|FG001|Overall Study|Administrative problems|1|||
30750896|NCT00154310|58760766|FG000|Overall Study|Death|0|||
30750897|NCT00154310|58760767|FG001|Overall Study|Death|1|||
30750898|NCT03771664|58760775|FG000|Overall Study|Adverse Event|1|||
30750899|NCT03771664|58760776|FG001|Overall Study|Adverse Event|0|||
30750900|NCT03771664|58760775|FG000|Overall Study|Lost to Follow-up|1|||
30750901|NCT03771664|58760776|FG001|Overall Study|Lost to Follow-up|0|||
30750902|NCT03771664|58760775|FG000|Overall Study|Withdrawal by Participant|1|||
30750903|NCT03771664|58760776|FG001|Overall Study|Withdrawal by Participant|4|||
30750904|NCT03771664|58760775|FG000|Overall Study|Randomized but not Treated|0|||
30750905|NCT03771664|58760776|FG001|Overall Study|Randomized but not Treated|1|||
30750906|NCT03771352|58760782|FG000|Overall Study|Screen failure|2|||
30750907|NCT03771352|58760782|FG000|Overall Study|Withdrawal by Subject|2|||
30750908|NCT03770728|58760790|FG000|Overall Study|Adverse Event|1|||
30750909|NCT03770728|58760791|FG001|Overall Study|Adverse Event|0|||
30750910|NCT03770728|58760792|FG002|Overall Study|Adverse Event|1|||
30750911|NCT03770728|58760793|FG003|Overall Study|Adverse Event|0|||
30750912|NCT03770728|58760790|FG000|Overall Study|Poor compliance to protocol|0|||
30750913|NCT03770728|58760791|FG001|Overall Study|Poor compliance to protocol|0|||
30750914|NCT03770728|58760792|FG002|Overall Study|Poor compliance to protocol|1|||
30750915|NCT03770728|58760793|FG003|Overall Study|Poor compliance to protocol|0|||
30750916|NCT03770728|58760790|FG000|Overall Study|Withdrawal by Subject|13|||
30750917|NCT03770728|58760791|FG001|Overall Study|Withdrawal by Subject|8|||
30815623|NCT03247543|58835259|FG001|Overall Study|Consent withdrawn by caregiver|2|||
30750918|NCT03770728|58760792|FG002|Overall Study|Withdrawal by Subject|9|||
30750919|NCT03770728|58760793|FG003|Overall Study|Withdrawal by Subject|13|||
30750920|NCT03770728|58760790|FG000|Overall Study|Other than specified|24|||
30750921|NCT03770728|58760791|FG001|Overall Study|Other than specified|23|||
30750922|NCT03770728|58760792|FG002|Overall Study|Other than specified|21|||
30911270|NCT01693120|58946243|FG000|Enrollment|Physician Decision|3|||
30622632|NCT00925600|58634331|FG001|Overall Study|Withdrawal by Subject|14|||
30622633|NCT00925600|58634330|FG000|Overall Study|Death|4|||
30622634|NCT00925600|58634331|FG001|Overall Study|Death|3|||
30622635|NCT00925600|58634330|FG000|Overall Study|Lost to Follow-up|2|||
30622636|NCT00925600|58634331|FG001|Overall Study|Lost to Follow-up|2|||
30750923|NCT03770728|58760793|FG003|Overall Study|Other than specified|22|||
30750924|NCT03769090|58760808|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
30911271|NCT01693120|58946243|FG000|Enrollment|Adverse Event|1|||
30911272|NCT01693120|58946243|FG000|Enrollment|Study closed|8|||
30750925|NCT03769090|58760809|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
30750926|NCT03769090|58760810|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
30750927|NCT03769090|58760808|FG000|Overall Study|Withdrawal by Subject|52|||
30750928|NCT03769090|58760809|FG001|Overall Study|Withdrawal by Subject|62|||
30750929|NCT03769090|58760810|FG002|Overall Study|Withdrawal by Subject|74|||
30750930|NCT03769090|58760808|FG000|Overall Study|Death|4|||
30750931|NCT03769090|58760809|FG001|Overall Study|Death|2|||
30750932|NCT03769090|58760810|FG002|Overall Study|Death|2|||
30750933|NCT03769090|58760808|FG000|Overall Study|Adverse Event|7|||
30622637|NCT00925600|58634330|FG000|Overall Study|Disease Progression|1|||
30750934|NCT03769090|58760809|FG001|Overall Study|Adverse Event|7|||
30750935|NCT03769090|58760810|FG002|Overall Study|Adverse Event|8|||
30750936|NCT03769090|58760808|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
30750937|NCT03769090|58760809|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
30750938|NCT03769090|58760810|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
30750939|NCT03769090|58760808|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
30750940|NCT03769090|58760809|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
30750941|NCT03769090|58760810|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
30750942|NCT03769090|58760808|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
30750943|NCT03769090|58760809|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
30750944|NCT03769090|58760810|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
30750945|NCT03769090|58760808|FG000|Overall Study|Protocol Violation|5|||
30750946|NCT03769090|58760809|FG001|Overall Study|Protocol Violation|6|||
30750947|NCT03769090|58760810|FG002|Overall Study|Protocol Violation|8|||
30750948|NCT03769090|58760808|FG000|Overall Study|Pregnancy|1|||
30750949|NCT03769090|58760809|FG001|Overall Study|Pregnancy|0|||
30750950|NCT03769090|58760810|FG002|Overall Study|Pregnancy|3|||
30750951|NCT03769090|58760808|FG000|Overall Study|Lost to Follow-up|19|||
30750952|NCT03769090|58760809|FG001|Overall Study|Lost to Follow-up|25|||
30750953|NCT03769090|58760810|FG002|Overall Study|Lost to Follow-up|21|||
30750954|NCT03769090|58760808|FG000|Overall Study|Condition under investigation worsened|2|||
30750955|NCT03769090|58760809|FG001|Overall Study|Condition under investigation worsened|0|||
30750956|NCT03769090|58760810|FG002|Overall Study|Condition under investigation worsened|1|||
30750957|NCT03769090|58760808|FG000|Overall Study|Lack of Efficacy|1|||
30750958|NCT03769090|58760809|FG001|Overall Study|Lack of Efficacy|2|||
30750959|NCT03769090|58760810|FG002|Overall Study|Lack of Efficacy|2|||
30750960|NCT03769090|58760808|FG000|Overall Study|Other reasons|8|||
30750961|NCT03769090|58760809|FG001|Overall Study|Other reasons|12|||
30750962|NCT03769090|58760810|FG002|Overall Study|Other reasons|15|||
30750963|NCT03559270|58760834|FG000|Overall Study|Adverse Event|6|||
30750964|NCT03559270|58760835|FG001|Overall Study|Adverse Event|5|||
30750965|NCT03559270|58760836|FG002|Overall Study|Adverse Event|3|||
30750966|NCT03559270|58760837|FG003|Overall Study|Adverse Event|0|||
30750967|NCT03559270|58760834|FG000|Overall Study|Lack of Efficacy|34|||
30750968|NCT03559270|58760835|FG001|Overall Study|Lack of Efficacy|52|||
30750969|NCT03559270|58760836|FG002|Overall Study|Lack of Efficacy|37|||
30750970|NCT03559270|58760837|FG003|Overall Study|Lack of Efficacy|2|||
30750971|NCT03559270|58760834|FG000|Overall Study|Death|0|||
30750972|NCT03559270|58760835|FG001|Overall Study|Death|2|||
30750973|NCT03559270|58760836|FG002|Overall Study|Death|0|||
30750974|NCT03559270|58760837|FG003|Overall Study|Death|0|||
30750975|NCT03559270|58760834|FG000|Overall Study|Lost to Follow-up|16|||
30750976|NCT03559270|58760835|FG001|Overall Study|Lost to Follow-up|4|||
30750977|NCT03559270|58760836|FG002|Overall Study|Lost to Follow-up|12|||
30750978|NCT03559270|58760837|FG003|Overall Study|Lost to Follow-up|3|||
30750979|NCT03559270|58760834|FG000|Overall Study|Sponsor Decision|38|||
30750980|NCT03559270|58760835|FG001|Overall Study|Sponsor Decision|31|||
30750981|NCT03559270|58760836|FG002|Overall Study|Sponsor Decision|35|||
30750982|NCT03559270|58760837|FG003|Overall Study|Sponsor Decision|18|||
30750983|NCT03559270|58760834|FG000|Overall Study|Withdrawal by Subject|19|||
30750984|NCT03559270|58760835|FG001|Overall Study|Withdrawal by Subject|21|||
30750985|NCT03559270|58760836|FG002|Overall Study|Withdrawal by Subject|18|||
30750986|NCT03559270|58760837|FG003|Overall Study|Withdrawal by Subject|7|||
30750987|NCT03559270|58760834|FG000|Overall Study|Physician Decision|3|||
30750988|NCT03559270|58760835|FG001|Overall Study|Physician Decision|2|||
30750989|NCT03559270|58760836|FG002|Overall Study|Physician Decision|1|||
30750990|NCT03559270|58760837|FG003|Overall Study|Physician Decision|0|||
30750991|NCT03559270|58760834|FG000|Overall Study|Pregnancy|0|||
30750992|NCT03559270|58760835|FG001|Overall Study|Pregnancy|1|||
30815624|NCT03247543|58835260|FG002|Overall Study|Consent withdrawn by caregiver|9|||
30750993|NCT03559270|58760836|FG002|Overall Study|Pregnancy|0|||
30750994|NCT03559270|58760837|FG003|Overall Study|Pregnancy|0|||
30750995|NCT03559270|58760834|FG000|Overall Study|Protocol Violation|1|||
30750996|NCT03559270|58760835|FG001|Overall Study|Protocol Violation|0|||
30750997|NCT03559270|58760836|FG002|Overall Study|Protocol Violation|2|||
30750998|NCT03559270|58760837|FG003|Overall Study|Protocol Violation|0|||
30750999|NCT02685826|58760892|FG000|Overall Study|Adverse Event|2|||
30911273|NCT01693120|58946243|FG000|Enrollment|Other|1|||
30911274|NCT01693120|58946243|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
30911275|NCT01693120|58946243|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
30911276|NCT01693120|58946243|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
30911277|NCT01693120|58946243|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
30911278|NCT01693120|58946243|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
30911279|NCT02159365|58946247|FG000|Overall Study|Disease Progression|23|||
30911280|NCT02159365|58946247|FG000|Overall Study|Other reasons|11|||
30911281|NCT02159365|58946247|FG000|Overall Study|Administrative reason by Sponsor|9|||
30911282|NCT02159365|58946247|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
30911283|NCT02159365|58946247|FG000|Overall Study|Study drug toxicity|7|||
30911284|NCT02159365|58946247|FG000|Overall Study|Maximum clinical benefit|3|||
30911285|NCT02159365|58946247|FG000|Overall Study|Subject request to discontinue treatment|3|||
30751000|NCT02685826|58760893|FG001|Overall Study|Adverse Event|0|||
30911286|NCT02159365|58946247|FG000|Overall Study|Subject withdrew consent|3|||
30911287|NCT02159365|58946247|FG000|Overall Study|Death|1|||
30911288|NCT02159365|58946247|FG000|Overall Study|Lost to Follow-up|1|||
30911289|NCT01712074|58946254|FG000|Placebo Run-in Period|Adverse Event|2|||
30911290|NCT01712074|58946255|FG001|Placebo Run-in Period|Adverse Event|0|||
30911291|NCT01712074|58946256|FG002|Placebo Run-in Period|Adverse Event|0|||
30911292|NCT01712074|58946254|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
30911293|NCT01712074|58946255|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
30911294|NCT01712074|58946256|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
30911295|NCT01712074|58946254|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
30911296|NCT01712074|58946255|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
30911297|NCT01712074|58946256|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
30911298|NCT01712074|58946254|FG000|Placebo Run-in Period|Other|1|||
30911299|NCT01712074|58946255|FG001|Placebo Run-in Period|Other|0|||
30911300|NCT01712074|58946256|FG002|Placebo Run-in Period|Other|0|||
30911301|NCT01712074|58946254|FG000|Placebo Run-in Period|No longer willing to participate|1|||
30911302|NCT01712074|58946255|FG001|Placebo Run-in Period|No longer willing to participate|0|||
30911303|NCT01712074|58946256|FG002|Placebo Run-in Period|No longer willing to participate|0|||
30911304|NCT01712074|58946254|FG000|Double Blind Period|Adverse Event|0|||
30911305|NCT01712074|58946255|FG001|Double Blind Period|Adverse Event|2|||
30911306|NCT01712074|58946256|FG002|Double Blind Period|Adverse Event|1|||
30911307|NCT01712074|58946254|FG000|Double Blind Period|No longer willing to participate|0|||
30911308|NCT01712074|58946255|FG001|Double Blind Period|No longer willing to participate|2|||
30911309|NCT01712074|58946256|FG002|Double Blind Period|No longer willing to participate|4|||
30911310|NCT01712074|58946254|FG000|Double Blind Period|Death|0|||
30911311|NCT01712074|58946255|FG001|Double Blind Period|Death|1|||
30911312|NCT01712074|58946256|FG002|Double Blind Period|Death|0|||
30911313|NCT01712074|58946254|FG000|Double Blind Period|Lost to Follow-up|0|||
30911314|NCT01712074|58946255|FG001|Double Blind Period|Lost to Follow-up|2|||
30911315|NCT01712074|58946256|FG002|Double Blind Period|Lost to Follow-up|1|||
30751001|NCT02685826|58760894|FG002|Overall Study|Adverse Event|1|||
30911316|NCT01712074|58946254|FG000|Double Blind Period|Other|0|||
30911317|NCT01712074|58946255|FG001|Double Blind Period|Other|4|||
30911318|NCT01712074|58946256|FG002|Double Blind Period|Other|1|||
30911319|NCT01712074|58946254|FG000|Double Blind Period|Protocol Violation|0|||
30911320|NCT01712074|58946255|FG001|Double Blind Period|Protocol Violation|0|||
30911321|NCT01712074|58946256|FG002|Double Blind Period|Protocol Violation|1|||
30911322|NCT01712074|58946254|FG000|Double Blind Period|No longer met eligibility criteria|0|||
30911323|NCT01712074|58946255|FG001|Double Blind Period|No longer met eligibility criteria|3|||
30911324|NCT01712074|58946256|FG002|Double Blind Period|No longer met eligibility criteria|0|||
30911325|NCT01711216|58946271|FG000|Overall Study|Adverse Event|4|||
30911326|NCT01711216|58946271|FG000|Overall Study|Pregnancy|56|||
30911327|NCT01711216|58946271|FG000|Overall Study|Withdrawal by Subject|6|||
30911328|NCT01711216|58946271|FG000|Overall Study|Lost to Follow-up|46|||
30911329|NCT01711216|58946271|FG000|Overall Study|variety of other minor reasons|83|||
30911330|NCT01711216|58946271|FG000|Overall Study|no reason specified|22|||
30911331|NCT01692730|58946281|FG000|Overall Study|Lost to Follow-up|225|||
30911332|NCT01692730|58946282|FG001|Overall Study|Lost to Follow-up|227|||
30911333|NCT01691794|58946291|FG000|Overall Study|Poor/Non-Compliance|1|||
30911334|NCT01691794|58946292|FG001|Overall Study|Poor/Non-Compliance|4|||
30911335|NCT01691794|58946293|FG002|Overall Study|Poor/Non-Compliance|1|||
30911336|NCT01691794|58946291|FG000|Overall Study|Death|0|||
30911337|NCT01691794|58946292|FG001|Overall Study|Death|0|||
30911338|NCT01691794|58946293|FG002|Overall Study|Death|1|||
30911339|NCT01691794|58946291|FG000|Overall Study|Lack of Efficacy|0|||
30911340|NCT01691794|58946292|FG001|Overall Study|Lack of Efficacy|7|||
30911341|NCT01691794|58946293|FG002|Overall Study|Lack of Efficacy|1|||
30911342|NCT01691794|58946291|FG000|Overall Study|Participant request to discontinue|0|||
30911343|NCT01691794|58946292|FG001|Overall Study|Participant request to discontinue|1|||
30911344|NCT01691794|58946293|FG002|Overall Study|Participant request to discontinue|0|||
30911345|NCT01691794|58946291|FG000|Overall Study|Adverse Event|0|||
30911346|NCT01691794|58946292|FG001|Overall Study|Adverse Event|1|||
30911347|NCT01691794|58946293|FG002|Overall Study|Adverse Event|1|||
30911348|NCT01691794|58946291|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
30911349|NCT01691794|58946292|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
30911350|NCT01691794|58946293|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
30911351|NCT01691794|58946291|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
30911352|NCT01691794|58946292|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
30911353|NCT01691794|58946293|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
30911354|NCT01710514|58946303|FG000|Overall Study|Adverse Event|6|||
30911355|NCT01710514|58946304|FG001|Overall Study|Adverse Event|7|||
30911356|NCT01710514|58946303|FG000|Overall Study|Withdrawal by Subject|1|||
30911357|NCT01710514|58946304|FG001|Overall Study|Withdrawal by Subject|0|||
30911358|NCT01592344|58946315|FG000|Overall Study|Adverse Event|1|||
30911359|NCT01592344|58946316|FG001|Overall Study|Adverse Event|1|||
30911360|NCT01592344|58946315|FG000|Overall Study|Lack of Efficacy|1|||
30911361|NCT01592344|58946316|FG001|Overall Study|Lack of Efficacy|0|||
30911362|NCT01592344|58946315|FG000|Overall Study|not available at primary outcome visit|2|||
30911363|NCT01592344|58946316|FG001|Overall Study|not available at primary outcome visit|4|||
30911364|NCT01636778|58946322|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
30911365|NCT01636778|58946323|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
30911366|NCT01636778|58946324|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
30911367|NCT01636778|58946322|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
30911368|NCT01636778|58946323|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
30911369|NCT01636778|58946324|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
30911370|NCT01636778|58946322|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
30911371|NCT01636778|58946323|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
30911372|NCT01636778|58946324|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
30911373|NCT01636778|58946322|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
30911374|NCT01636778|58946323|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
30911375|NCT01636778|58946324|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
30911376|NCT01636778|58946322|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
30911377|NCT01636778|58946323|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
30911378|NCT01636778|58946324|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
30911379|NCT01636778|58946322|FG000|Follow-up Period After Part 2|Other|0|||
30911380|NCT01636778|58946323|FG001|Follow-up Period After Part 2|Other|0|||
30911381|NCT01636778|58946324|FG002|Follow-up Period After Part 2|Other|1|||
30911382|NCT01636778|58946322|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
30911383|NCT01636778|58946323|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
30911384|NCT01636778|58946324|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
30911385|NCT01636778|58946322|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
30911386|NCT01636778|58946323|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
30911387|NCT01636778|58946324|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
30911388|NCT02159053|58946335|FG000|Overall Study|Death|2|||
30911389|NCT02159053|58946336|FG001|Overall Study|Death|0|||
30911390|NCT02159053|58946337|FG002|Overall Study|Death|1|||
30911391|NCT02159053|58946335|FG000|Overall Study|Physician Decision|0|||
30911392|NCT02159053|58946336|FG001|Overall Study|Physician Decision|1|||
30911393|NCT02159053|58946337|FG002|Overall Study|Physician Decision|1|||
30911394|NCT02159053|58946335|FG000|Overall Study|Lack of Efficacy|3|||
30911395|NCT02159053|58946336|FG001|Overall Study|Lack of Efficacy|4|||
30911396|NCT02159053|58946337|FG002|Overall Study|Lack of Efficacy|7|||
30911397|NCT02159053|58946335|FG000|Overall Study|Adverse Event|7|||
30911398|NCT02159053|58946336|FG001|Overall Study|Adverse Event|6|||
30911399|NCT02159053|58946337|FG002|Overall Study|Adverse Event|5|||
30911400|NCT02159053|58946335|FG000|Overall Study|Participants/guardian decision|8|||
30911401|NCT02159053|58946336|FG001|Overall Study|Participants/guardian decision|10|||
30911402|NCT02159053|58946337|FG002|Overall Study|Participants/guardian decision|6|||
30911403|NCT02158975|58946347|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
30911404|NCT02158663|58946354|FG000|Overall Study|Withdrawal by Subject|5|||
30911405|NCT02158663|58946355|FG001|Overall Study|Withdrawal by Subject|4|||
30911406|NCT02158039|58946363|FG000|Overall Study|Withdrawal by Subject|1|||
30911407|NCT02158039|58946363|FG000|Overall Study|Screen Failure|9|||
30911408|NCT01635764|58946381|FG000|Overall Study|Adverse Event|46|||
30911409|NCT01635764|58946381|FG000|Overall Study|Lack of Efficacy|76|||
30911410|NCT01635764|58946381|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
30911411|NCT01635764|58946381|FG000|Overall Study|Protocol Deviation|1|||
30911412|NCT01635764|58946381|FG000|Overall Study|Withdrew Consent|67|||
30911413|NCT01635764|58946381|FG000|Overall Study|Lost to Follow-up|53|||
30911414|NCT01635764|58946381|FG000|Overall Study|Other|28|||
30911415|NCT03432260|58946397|FG000|Overall Study|Lost to Follow-up|1|||
30911416|NCT03432260|58946398|FG001|Overall Study|Lost to Follow-up|1|||
30911417|NCT03432260|58946399|FG002|Overall Study|Lost to Follow-up|0|||
30911418|NCT03432260|58946400|FG003|Overall Study|Lost to Follow-up|0|||
30911419|NCT03432260|58946401|FG004|Overall Study|Lost to Follow-up|1|||
30911420|NCT01634360|58946415|FG000|Overall Study|Adverse Event|10|||
30911421|NCT01634360|58946416|FG001|Overall Study|Adverse Event|34|||
30911422|NCT01634360|58946415|FG000|Overall Study|subject withdrew consent|13|||
30911423|NCT01634360|58946416|FG001|Overall Study|subject withdrew consent|23|||
30911424|NCT01634360|58946415|FG000|Overall Study|Protocol Violation|1|||
30911425|NCT01634360|58946416|FG001|Overall Study|Protocol Violation|1|||
30911426|NCT01634360|58946415|FG000|Overall Study|Lack of Efficacy|4|||
30911427|NCT01634360|58946416|FG001|Overall Study|Lack of Efficacy|14|||
30911428|NCT01634360|58946415|FG000|Overall Study|Other|3|||
30911429|NCT01634360|58946416|FG001|Overall Study|Other|20|||
30911430|NCT01634360|58946415|FG000|Overall Study|Study termination by sponsor|18|||
30911431|NCT01634360|58946416|FG001|Overall Study|Study termination by sponsor|44|||
30911432|NCT01635218|58946433|FG000|Overall Study|Lost to Follow-up|3|||
30911433|NCT01635218|58946434|FG001|Overall Study|Lost to Follow-up|7|||
30911434|NCT01635218|58946435|FG002|Overall Study|Lost to Follow-up|6|||
30911435|NCT02049866|58946443|FG000|Overall Study|Withdrawal by Subject|1|||
30911436|NCT04274894|58946447|FG000|Overall Study|Adverse Event|7|||
30911437|NCT04274894|58946447|FG000|Overall Study|Withdrew consent|5|||
30911438|NCT04274894|58946447|FG000|Overall Study|Lost to Follow-up|9|||
30911439|NCT04274894|58946447|FG000|Overall Study|COVID-19 infection|1|||
30911440|NCT04274894|58946447|FG000|Overall Study|Other, not specified|20|||
30911441|NCT02213263|58946453|FG000|Overall Study|Insufficient clinical response|4|||
30911442|NCT02213263|58946454|FG001|Overall Study|Insufficient clinical response|3|||
30911443|NCT02213263|58946453|FG000|Overall Study|Lost to Follow-up|0|||
30911444|NCT02213263|58946454|FG001|Overall Study|Lost to Follow-up|1|||
30911445|NCT02213263|58946453|FG000|Overall Study|No longer willing to participate|3|||
30911446|NCT02213263|58946454|FG001|Overall Study|No longer willing to participate|4|||
30911447|NCT02213263|58946453|FG000|Overall Study|Progressive disease|20|||
30911448|NCT02213263|58946454|FG001|Overall Study|Progressive disease|14|||
30911449|NCT02213263|58946453|FG000|Overall Study|Protocol Violation|0|||
30911450|NCT02213263|58946454|FG001|Overall Study|Protocol Violation|1|||
30911451|NCT02213263|58946453|FG000|Overall Study|Adverse Event|1|||
30911452|NCT02213263|58946454|FG001|Overall Study|Adverse Event|3|||
30911453|NCT02211313|58946462|FG000|Overall Study|Treatment Failure|5|||
30911454|NCT02211313|58946463|FG001|Overall Study|Treatment Failure|2|||
30911455|NCT02211313|58946462|FG000|Overall Study|No Follow up Questionnaires|1|||
30751002|NCT02685826|58760892|FG000|Overall Study|Progressive Disease|2|||
30751003|NCT02685826|58760893|FG001|Overall Study|Progressive Disease|1|||
30751004|NCT02685826|58760894|FG002|Overall Study|Progressive Disease|0|||
30751005|NCT02685826|58760892|FG000|Overall Study|Withdrawal by Subject|2|||
30751006|NCT02685826|58760893|FG001|Overall Study|Withdrawal by Subject|0|||
30751007|NCT02685826|58760894|FG002|Overall Study|Withdrawal by Subject|0|||
30751008|NCT02685826|58760892|FG000|Overall Study|Full Clinical Hold by FDA|19|||
30751009|NCT02685826|58760893|FG001|Overall Study|Full Clinical Hold by FDA|9|||
30911456|NCT02211313|58946463|FG001|Overall Study|No Follow up Questionnaires|1|||
30911457|NCT02210689|58946472|FG000|Overall Study|Withdrawal by Subject|7|||
30911458|NCT02210689|58946473|FG001|Overall Study|Withdrawal by Subject|4|||
30911459|NCT02210689|58946474|FG002|Overall Study|Withdrawal by Subject|2|||
30622638|NCT00925600|58634331|FG001|Overall Study|Disease Progression|3|||
30911460|NCT02210689|58946472|FG000|Overall Study|Adverse Event|0|||
30911461|NCT02210689|58946473|FG001|Overall Study|Adverse Event|1|||
30911462|NCT02210689|58946474|FG002|Overall Study|Adverse Event|0|||
30911463|NCT02210689|58946472|FG000|Overall Study|Protocol Violation|1|||
30911464|NCT02210689|58946473|FG001|Overall Study|Protocol Violation|0|||
30911465|NCT02210689|58946474|FG002|Overall Study|Protocol Violation|0|||
30815625|NCT03247543|58835258|FG000|Overall Study|Withdrawal by Subject|0|||
30815626|NCT03247543|58835259|FG001|Overall Study|Withdrawal by Subject|0|||
30815627|NCT03247543|58835260|FG002|Overall Study|Withdrawal by Subject|1|||
30815628|NCT03247543|58835258|FG000|Overall Study|Failure to Follow study procedures|1|||
30815629|NCT03247543|58835259|FG001|Overall Study|Failure to Follow study procedures|3|||
30815630|NCT03247543|58835260|FG002|Overall Study|Failure to Follow study procedures|1|||
30815631|NCT03247543|58835258|FG000|Overall Study|Lack of Efficacy|1|||
30815632|NCT03247543|58835259|FG001|Overall Study|Lack of Efficacy|0|||
30815633|NCT03247543|58835260|FG002|Overall Study|Lack of Efficacy|0|||
30815634|NCT03247543|58835258|FG000|Overall Study|Non-compliance with study visits|0|||
30815635|NCT03247543|58835259|FG001|Overall Study|Non-compliance with study visits|1|||
30815636|NCT03247543|58835260|FG002|Overall Study|Non-compliance with study visits|0|||
30815637|NCT01347073|58835270|FG000|Overall Study|Adverse Event|1|||
30815638|NCT01347073|58835270|FG000|Overall Study|Liver Transplant|1|||
30815639|NCT01315236|58835282|FG000|Double-blind Phase|Death|1|||
30815640|NCT01315236|58835283|FG001|Double-blind Phase|Death|0|||
30911466|NCT02210689|58946472|FG000|Overall Study|Lost to Follow-up|11|||
30815641|NCT01315236|58835282|FG000|Double-blind Phase|Adverse Event|1|||
30815642|NCT01315236|58835283|FG001|Double-blind Phase|Adverse Event|0|||
30815643|NCT01315236|58835282|FG000|Double-blind Phase|Withdrawal of Consent|1|||
30815644|NCT01315236|58835283|FG001|Double-blind Phase|Withdrawal of Consent|0|||
30815645|NCT01315236|58835282|FG000|Double-blind Phase|Lost to Follow-up|1|||
30815646|NCT01315236|58835283|FG001|Double-blind Phase|Lost to Follow-up|0|||
30815647|NCT01315236|58835282|FG000|Open-label Phase|Death|1|||
30815648|NCT01315236|58835283|FG001|Open-label Phase|Death|0|||
30815649|NCT01315236|58835282|FG000|Open-label Phase|Adverse Event|0|||
30815650|NCT01315236|58835283|FG001|Open-label Phase|Adverse Event|1|||
30815651|NCT01315236|58835282|FG000|Open-label Phase|Other|0|||
30815652|NCT01315236|58835283|FG001|Open-label Phase|Other|1|||
30815653|NCT01315236|58835282|FG000|12-Month Follow-up Period|Death|0|||
30815654|NCT01315236|58835283|FG001|12-Month Follow-up Period|Death|1|||
30815655|NCT01315236|58835282|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
30815656|NCT01315236|58835283|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
30815657|NCT03232567|58835295|FG000|Overall Study|Withdrawal by Subject|0|||
30815658|NCT03232567|58835296|FG001|Overall Study|Withdrawal by Subject|1|||
30815659|NCT03232567|58835297|FG002|Overall Study|Withdrawal by Subject|0|||
30815660|NCT03232567|58835298|FG003|Overall Study|Withdrawal by Subject|0|||
30815661|NCT01348490|58835319|FG000|Overall Study|Death|1|||
30815662|NCT01348490|58835319|FG000|Overall Study|Adverse Event|3|||
30815663|NCT01348490|58835319|FG000|Overall Study|Consent withdrawn|7|||
30815664|NCT01348490|58835319|FG000|Overall Study|Disease progression|3|||
30815665|NCT01348490|58835319|FG000|Overall Study|Lost to Follow-up|1|||
30815666|NCT01348490|58835319|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
30815667|NCT01348490|58835319|FG000|Overall Study|Other Unspecified|8|||
30815668|NCT03040674|58835340|FG000|Overall Study|Lost to Follow-up|225|||
30815669|NCT03040674|58835340|FG000|Overall Study|Death|23|||
30815670|NCT03232333|58835345|FG000|Overall Study|Infection or Osteomyelitis|9|||
30815671|NCT03232333|58835345|FG000|Overall Study|Lost to Follow-up|4|||
30815672|NCT03232333|58835345|FG000|Overall Study|Withdrawal by Subject|2|||
30815673|NCT03364049|58835353|FG000|Overall Study|Death|6|||
30815674|NCT03364049|58835354|FG001|Overall Study|Death|4|||
30815675|NCT03364049|58835355|FG002|Overall Study|Death|5|||
30815676|NCT03364049|58835356|FG003|Overall Study|Death|14|||
30815677|NCT03364049|58835353|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
30815678|NCT03364049|58835354|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
30815679|NCT03364049|58835355|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
30815680|NCT03364049|58835356|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
30815681|NCT03364049|58835353|FG000|Overall Study|Withdrawal by Subject|0|||
30815682|NCT03364049|58835354|FG001|Overall Study|Withdrawal by Subject|1|||
30815683|NCT03364049|58835355|FG002|Overall Study|Withdrawal by Subject|1|||
30815684|NCT03364049|58835356|FG003|Overall Study|Withdrawal by Subject|1|||
30815685|NCT03238963|58835368|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
30911467|NCT02210689|58946473|FG001|Overall Study|Lost to Follow-up|9|||
30911468|NCT02210689|58946474|FG002|Overall Study|Lost to Follow-up|5|||
30815686|NCT03238963|58835369|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
30815687|NCT03238963|58835368|FG000|Overall Study|Withdrawal by Subject|1|||
30911469|NCT02210689|58946472|FG000|Overall Study|Pregnancy|0|||
30911470|NCT02210689|58946473|FG001|Overall Study|Pregnancy|1|||
30911471|NCT02210689|58946474|FG002|Overall Study|Pregnancy|0|||
30911472|NCT02210689|58946472|FG000|Overall Study|Lack of Efficacy|0|||
30911473|NCT02210689|58946473|FG001|Overall Study|Lack of Efficacy|1|||
30911474|NCT02210689|58946474|FG002|Overall Study|Lack of Efficacy|5|||
30911475|NCT02210689|58946472|FG000|Overall Study|Prohibited medication|2|||
30911476|NCT02210689|58946473|FG001|Overall Study|Prohibited medication|8|||
30911477|NCT02210689|58946474|FG002|Overall Study|Prohibited medication|1|||
30911478|NCT02210689|58946472|FG000|Overall Study|Negative Nugent score at baseline|6|||
30911479|NCT02210689|58946473|FG001|Overall Study|Negative Nugent score at baseline|2|||
30911480|NCT02210689|58946474|FG002|Overall Study|Negative Nugent score at baseline|2|||
30751010|NCT02685826|58760894|FG002|Overall Study|Full Clinical Hold by FDA|20|||
30751011|NCT00114777|58760905|FG000|Randomization to Month 36|Death|10|||
30751012|NCT00114777|58760906|FG001|Randomization to Month 36|Death|4|||
30751013|NCT00114777|58760907|FG002|Randomization to Month 36|Death|3|||
30751014|NCT00114777|58760905|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
30751015|NCT00114777|58760906|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
30751016|NCT00114777|58760907|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
30622639|NCT00925600|58634330|FG000|Overall Study|Administrative Decision|1|||
30622640|NCT00925600|58634331|FG001|Overall Study|Administrative Decision|1|||
30751017|NCT00114777|58760905|FG000|Randomization to Month 36|Lack of Efficacy|19|||
30751018|NCT00114777|58760906|FG001|Randomization to Month 36|Lack of Efficacy|15|||
30751019|NCT00114777|58760907|FG002|Randomization to Month 36|Lack of Efficacy|17|||
30751020|NCT00114777|58760905|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
30751021|NCT00114777|58760906|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
30751022|NCT00114777|58760907|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
30751023|NCT00114777|58760905|FG000|Randomization to Month 36|Adverse Event|34|||
30751024|NCT00114777|58760906|FG001|Randomization to Month 36|Adverse Event|35|||
30751025|NCT00114777|58760907|FG002|Randomization to Month 36|Adverse Event|44|||
30751026|NCT00114777|58760905|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
30751027|NCT00114777|58760906|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
30751028|NCT00114777|58760907|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
30751029|NCT00114777|58760905|FG000|Randomization to Month 36|Other|9|||
30751030|NCT00114777|58760906|FG001|Randomization to Month 36|Other|3|||
30751031|NCT00114777|58760907|FG002|Randomization to Month 36|Other|12|||
30751032|NCT00114777|58760905|FG000|Long-Term Extension to Month 84|Death|8|||
30751033|NCT00114777|58760906|FG001|Long-Term Extension to Month 84|Death|13|||
30751034|NCT00114777|58760907|FG002|Long-Term Extension to Month 84|Death|7|||
30751035|NCT00114777|58760905|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
30751036|NCT00114777|58760906|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
30751037|NCT00114777|58760907|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
30751038|NCT00114777|58760905|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
30751039|NCT00114777|58760906|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
30751040|NCT00114777|58760907|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
30751041|NCT00114777|58760905|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
30751042|NCT00114777|58760906|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
30751043|NCT00114777|58760907|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
30751044|NCT00114777|58760905|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
30751045|NCT00114777|58760906|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
30751046|NCT00114777|58760907|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
30751047|NCT00114777|58760905|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
30751048|NCT00114777|58760906|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
30751049|NCT00114777|58760907|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
30751050|NCT00114777|58760905|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
30815688|NCT03238963|58835369|FG001|Overall Study|Withdrawal by Subject|1|||
30815689|NCT03238963|58835368|FG000|Overall Study|Lost to Follow-up|1|||
30815690|NCT03238963|58835369|FG001|Overall Study|Lost to Follow-up|0|||
30815691|NCT03238963|58835368|FG000|Overall Study|Protocol Violation|1|||
30815692|NCT03238963|58835369|FG001|Overall Study|Protocol Violation|1|||
30815693|NCT03238963|58835368|FG000|Overall Study|Adverse Event|1|||
30815694|NCT03238963|58835369|FG001|Overall Study|Adverse Event|0|||
30815695|NCT03337139|58835377|FG000|Phase I|Withdrawal by Subject|10|||
30815696|NCT03337139|58835378|FG001|Phase I|Withdrawal by Subject|0|||
30815697|NCT03042312|58835386|FG000|Overall Study|Administrative Reason|1|||
30815698|NCT03042312|58835387|FG001|Overall Study|Administrative Reason|1|||
30815699|NCT03042312|58835386|FG000|Overall Study|Adverse Event|0|||
30815700|NCT03042312|58835387|FG001|Overall Study|Adverse Event|1|||
30815701|NCT03042312|58835386|FG000|Overall Study|Lost to Follow-up|1|||
30815702|NCT03042312|58835387|FG001|Overall Study|Lost to Follow-up|3|||
30815703|NCT03042312|58835386|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
30815704|NCT03042312|58835387|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
30815705|NCT03042312|58835386|FG000|Overall Study|Withdrawal by Subject|4|||
30815706|NCT03042312|58835387|FG001|Overall Study|Withdrawal by Subject|5|||
30815707|NCT03360071|58835395|FG000|Overall Study|Lost to Follow-up|1|||
30751051|NCT00114777|58760906|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
30751052|NCT00114777|58760907|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
30751053|NCT00114777|58760905|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
30751054|NCT00114777|58760906|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
30751055|NCT00114777|58760907|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
30751056|NCT00114777|58760905|FG000|Long-Term Extension to Month 84|Other|2|||
30751057|NCT00114777|58760906|FG001|Long-Term Extension to Month 84|Other|0|||
30751058|NCT00114777|58760907|FG002|Long-Term Extension to Month 84|Other|2|||
30751059|NCT00139737|58760916|FG000|Overall Study|Withdrawal by Subject|190|||
30751060|NCT00139737|58760916|FG000|Overall Study|Adverse Event|58|||
30751061|NCT00139737|58760916|FG000|Overall Study|Lack of Efficacy|40|||
30751062|NCT00139737|58760916|FG000|Overall Study|Lost to Follow-up|8|||
30751063|NCT00139737|58760916|FG000|Overall Study|Death|3|||
30751064|NCT00139737|58760916|FG000|Overall Study|Laboratory Abnormality|2|||
30751065|NCT00139737|58760916|FG000|Overall Study|Protocol Violation|18|||
30751066|NCT00139737|58760916|FG000|Overall Study|Withdrew During Screening Phase|8|||
30751067|NCT00139737|58760916|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
30751068|NCT00139737|58760916|FG000|Overall Study|Screened, Not Treated|13|||
30751069|NCT00122187|58760922|FG000|Overall Study|Withdrew because of resource limitations|2|||
30751070|NCT00122187|58760923|FG001|Overall Study|Withdrew because of resource limitations|2|||
30751071|NCT00139659|58760933|FG000|Overall Study|Adverse Event|12|||
30751072|NCT00139659|58760934|FG001|Overall Study|Adverse Event|1|||
30751073|NCT00139659|58760933|FG000|Overall Study|Lack of Efficacy|1|||
30751074|NCT00139659|58760934|FG001|Overall Study|Lack of Efficacy|1|||
30751075|NCT00139659|58760933|FG000|Overall Study|Lost to Follow-up|7|||
30751076|NCT00139659|58760934|FG001|Overall Study|Lost to Follow-up|3|||
30751077|NCT00139659|58760933|FG000|Overall Study|Reason not Specified|6|||
30751078|NCT00139659|58760934|FG001|Overall Study|Reason not Specified|3|||
30815708|NCT03360071|58835396|FG001|Overall Study|Lost to Follow-up|0|||
30815709|NCT02949011|58835405|FG000|Overall Study|Adverse Event|6|||
30815710|NCT02949011|58835406|FG001|Overall Study|Adverse Event|7|||
30751079|NCT00139659|58760933|FG000|Overall Study|Withdrawal by Subject|14|||
30751080|NCT00139659|58760934|FG001|Overall Study|Withdrawal by Subject|10|||
30751081|NCT00137631|58760946|FG000|Overall Study|Lost to Follow-up|37|||
30815711|NCT02949011|58835407|FG002|Overall Study|Adverse Event|3|||
30815712|NCT02949011|58835405|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
30911481|NCT02210689|58946472|FG000|Overall Study|Other|25|||
30815713|NCT02949011|58835406|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
30815714|NCT02949011|58835407|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
30815715|NCT02949011|58835405|FG000|Overall Study|Protocol Deviation|5|||
30815716|NCT02949011|58835406|FG001|Overall Study|Protocol Deviation|3|||
30815717|NCT02949011|58835407|FG002|Overall Study|Protocol Deviation|3|||
30815718|NCT02949011|58835405|FG000|Overall Study|Lack of Efficacy|0|||
30815719|NCT02949011|58835406|FG001|Overall Study|Lack of Efficacy|2|||
30815720|NCT02949011|58835407|FG002|Overall Study|Lack of Efficacy|0|||
30815721|NCT02949011|58835405|FG000|Overall Study|Withdrawal by Subject|13|||
30815722|NCT02949011|58835406|FG001|Overall Study|Withdrawal by Subject|13|||
30815723|NCT02949011|58835407|FG002|Overall Study|Withdrawal by Subject|21|||
30815724|NCT02949011|58835405|FG000|Overall Study|Lost to Follow-up|7|||
30815725|NCT02949011|58835406|FG001|Overall Study|Lost to Follow-up|5|||
30815726|NCT02949011|58835407|FG002|Overall Study|Lost to Follow-up|5|||
30815727|NCT02949011|58835405|FG000|Overall Study|Death|0|||
30815728|NCT02949011|58835406|FG001|Overall Study|Death|0|||
30815729|NCT02949011|58835407|FG002|Overall Study|Death|1|||
30815730|NCT02949011|58835405|FG000|Overall Study|Miscellaneous|2|||
30815731|NCT02949011|58835406|FG001|Overall Study|Miscellaneous|4|||
30815732|NCT02949011|58835407|FG002|Overall Study|Miscellaneous|6|||
30911482|NCT02210689|58946473|FG001|Overall Study|Other|21|||
30911483|NCT02210689|58946474|FG002|Overall Study|Other|8|||
30911484|NCT02209597|58946482|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
30911485|NCT02209597|58946482|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
30911486|NCT02209597|58946482|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
30911487|NCT02209597|58946482|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
30911488|NCT02188303|58946511|FG000|Overall Study|Adverse Event|0|||
30911489|NCT02188303|58946512|FG001|Overall Study|Adverse Event|0|||
30911490|NCT02188303|58946513|FG002|Overall Study|Adverse Event|0|||
30911491|NCT02188303|58946514|FG003|Overall Study|Adverse Event|0|||
30911492|NCT02188303|58946515|FG004|Overall Study|Adverse Event|0|||
30815733|NCT03357731|58835419|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
30815734|NCT03357731|58835420|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
30815735|NCT03357731|58835421|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
30815736|NCT03357731|58835422|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
30815737|NCT03357731|58835423|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
30815738|NCT03357731|58835424|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
30815739|NCT03357731|58835419|FG000|Overall Study|Acute bradycardia and hypotension|0|||
30815740|NCT03357731|58835420|FG001|Overall Study|Acute bradycardia and hypotension|0|||
30815741|NCT03357731|58835421|FG002|Overall Study|Acute bradycardia and hypotension|0|||
30815742|NCT03357731|58835422|FG003|Overall Study|Acute bradycardia and hypotension|1|||
30815743|NCT03357731|58835423|FG004|Overall Study|Acute bradycardia and hypotension|0|||
30815744|NCT03357731|58835424|FG005|Overall Study|Acute bradycardia and hypotension|0|||
30815745|NCT03357731|58835419|FG000|Overall Study|Adverse Event|0|||
30815746|NCT03357731|58835420|FG001|Overall Study|Adverse Event|0|||
30815747|NCT03357731|58835421|FG002|Overall Study|Adverse Event|0|||
30815748|NCT03357731|58835422|FG003|Overall Study|Adverse Event|0|||
30815749|NCT03357731|58835423|FG004|Overall Study|Adverse Event|0|||
30815750|NCT03357731|58835424|FG005|Overall Study|Adverse Event|1|||
30815751|NCT03357731|58835419|FG000|Overall Study|Hypotension|0|||
30815752|NCT03357731|58835420|FG001|Overall Study|Hypotension|0|||
30815753|NCT03357731|58835421|FG002|Overall Study|Hypotension|1|||
30815754|NCT03357731|58835422|FG003|Overall Study|Hypotension|1|||
30815755|NCT03357731|58835423|FG004|Overall Study|Hypotension|0|||
30815756|NCT03357731|58835424|FG005|Overall Study|Hypotension|0|||
30815757|NCT03357731|58835419|FG000|Overall Study|Lost to Follow-up|0|||
30815758|NCT03357731|58835420|FG001|Overall Study|Lost to Follow-up|0|||
30815759|NCT03357731|58835421|FG002|Overall Study|Lost to Follow-up|0|||
30815760|NCT03357731|58835422|FG003|Overall Study|Lost to Follow-up|1|||
30815761|NCT03357731|58835423|FG004|Overall Study|Lost to Follow-up|0|||
30815762|NCT03357731|58835424|FG005|Overall Study|Lost to Follow-up|0|||
30815763|NCT03357341|58835434|FG000|Overall Study|Withdrawal by Subject|3|||
30815764|NCT03357341|58835435|FG001|Overall Study|Withdrawal by Subject|6|||
30911493|NCT02188303|58946516|FG005|Overall Study|Adverse Event|2|||
30911494|NCT02188303|58946517|FG006|Overall Study|Adverse Event|0|||
30815765|NCT03357341|58835434|FG000|Overall Study|Lost to Follow-up|4|||
30815766|NCT03357341|58835435|FG001|Overall Study|Lost to Follow-up|5|||
30911495|NCT02188303|58946518|FG007|Overall Study|Adverse Event|2|||
30911496|NCT02188303|58946511|FG000|Overall Study|Dose Termination Criteria Met|0|||
30911497|NCT02188303|58946512|FG001|Overall Study|Dose Termination Criteria Met|0|||
30815767|NCT03357341|58835434|FG000|Overall Study|Death|0|||
30815768|NCT03357341|58835435|FG001|Overall Study|Death|1|||
30815769|NCT03039738|58835444|FG000|Overall Study|Incomplete data sets|54|||
30815770|NCT03039738|58835445|FG001|Overall Study|Incomplete data sets|0|||
30815771|NCT03036852|58835466|FG000|Overall Study|Death|2|||
30815772|NCT03036852|58835466|FG000|Overall Study|Lack of Efficacy|2|||
30815773|NCT03036852|58835466|FG000|Overall Study|Adverse Event|1|||
30815774|NCT03036852|58835466|FG000|Overall Study|Lost to Follow-up|1|||
30815775|NCT02945657|58835477|FG000|Overall Study|Adverse Event|1|||
30815776|NCT02945657|58835477|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
30815777|NCT02948777|58835482|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
30751082|NCT00137631|58760947|FG001|Overall Study|Lost to Follow-up|41|||
30815778|NCT03324581|58835490|FG000|Overall Study|Adverse Event|18|||
30815779|NCT03324581|58835491|FG001|Overall Study|Adverse Event|11|||
30815780|NCT03324581|58835492|FG002|Overall Study|Adverse Event|7|||
30815781|NCT03324581|58835490|FG000|Overall Study|Lack of Efficacy|0|||
30815782|NCT03324581|58835491|FG001|Overall Study|Lack of Efficacy|1|||
30815783|NCT03324581|58835492|FG002|Overall Study|Lack of Efficacy|0|||
30815784|NCT03324581|58835490|FG000|Overall Study|Lost to Follow-up|5|||
30815785|NCT03324581|58835491|FG001|Overall Study|Lost to Follow-up|3|||
30815786|NCT03324581|58835492|FG002|Overall Study|Lost to Follow-up|6|||
30815787|NCT03324581|58835490|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
30815788|NCT03324581|58835491|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
30815789|NCT03324581|58835492|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
30815790|NCT03324581|58835490|FG000|Overall Study|Physician Decision|0|||
30815791|NCT03324581|58835491|FG001|Overall Study|Physician Decision|1|||
30815792|NCT03324581|58835492|FG002|Overall Study|Physician Decision|2|||
30815793|NCT03324581|58835490|FG000|Overall Study|Protocol Deviation|8|||
30622641|NCT00925600|58634330|FG000|Overall Study|Noncompliance|2|||
30622642|NCT00925600|58634331|FG001|Overall Study|Noncompliance|0|||
30751083|NCT00114231|58760955|FG000|Overall Study|No consent|2|||
30751084|NCT00114231|58760956|FG001|Overall Study|No consent|0|||
30751085|NCT00114231|58760955|FG000|Overall Study|QARC requirement not met|1|||
30751086|NCT00114231|58760956|FG001|Overall Study|QARC requirement not met|0|||
30751087|NCT00114231|58760955|FG000|Overall Study|Suspected metastatic disease|1|||
30751088|NCT00114231|58760956|FG001|Overall Study|Suspected metastatic disease|0|||
30751089|NCT00114231|58760955|FG000|Overall Study|No adenocarcinoma|1|||
30751090|NCT00114231|58760956|FG001|Overall Study|No adenocarcinoma|0|||
30751091|NCT00114231|58760955|FG000|Overall Study|Low creatinine clearance|0|||
30751092|NCT00114231|58760956|FG001|Overall Study|Low creatinine clearance|1|||
30751093|NCT00114231|58760955|FG000|Overall Study|Tumor size > 4cm|1|||
30751094|NCT00114231|58760956|FG001|Overall Study|Tumor size > 4cm|0|||
30751095|NCT00114231|58760955|FG000|Overall Study|Tumor fixed on digital exam|0|||
30751096|NCT00114231|58760956|FG001|Overall Study|Tumor fixed on digital exam|1|||
30751097|NCT00114231|58760955|FG000|Overall Study|No Absolute Neutrophil Count|2|||
30751098|NCT00114231|58760956|FG001|Overall Study|No Absolute Neutrophil Count|0|||
30751099|NCT00114231|58760955|FG000|Overall Study|Biopsy done after registration|1|||
30751100|NCT00114231|58760956|FG001|Overall Study|Biopsy done after registration|0|||
30751101|NCT00113919|58760961|FG000|Overall Study|Physician Decision|8|||
30751102|NCT00113919|58760961|FG000|Overall Study|Death|6|||
30751103|NCT00113841|58760967|FG000|Overall Study|Disease progression|0|||
30751104|NCT00113841|58760968|FG001|Overall Study|Disease progression|2|||
30751105|NCT00113841|58760967|FG000|Overall Study|Non-compliant|1|||
30751106|NCT00113841|58760968|FG001|Overall Study|Non-compliant|0|||
30751107|NCT00113607|58760976|FG000|Overall Study|Adverse Event|40|||
30751108|NCT00113607|58760977|FG001|Overall Study|Adverse Event|71|||
30751109|NCT00113607|58760976|FG000|Overall Study|Death|8|||
30751110|NCT00113607|58760977|FG001|Overall Study|Death|8|||
30751111|NCT00113607|58760976|FG000|Overall Study|Withdrawal by Subject|50|||
30751112|NCT00113607|58760977|FG001|Overall Study|Withdrawal by Subject|58|||
30751113|NCT00113607|58760976|FG000|Overall Study|Lost to Follow-up|0|||
30751114|NCT00113607|58760977|FG001|Overall Study|Lost to Follow-up|2|||
30751115|NCT00113607|58760976|FG000|Overall Study|Disease Progression|180|||
30751116|NCT00113607|58760977|FG001|Overall Study|Disease Progression|142|||
30751117|NCT00113607|58760976|FG000|Overall Study|Complete Response (Confirmed)|14|||
30751118|NCT00113607|58760977|FG001|Overall Study|Complete Response (Confirmed)|24|||
30751119|NCT00113607|58760976|FG000|Overall Study|Other|43|||
30751120|NCT00113607|58760977|FG001|Overall Study|Other|32|||
30751121|NCT00113529|58760984|FG000|Overall Study|Adverse Event|4|||
30751122|NCT00113529|58760984|FG000|Overall Study|Lack of Efficacy|20|||
30815794|NCT03324581|58835491|FG001|Overall Study|Protocol Deviation|9|||
30815795|NCT03324581|58835492|FG002|Overall Study|Protocol Deviation|4|||
30815796|NCT03324581|58835490|FG000|Overall Study|Withdrawal by Subject|6|||
30751123|NCT00113529|58760984|FG000|Overall Study|Decision of sponsor|6|||
30751124|NCT00113529|58760984|FG000|Overall Study|Withdrawal by Subject|4|||
30751125|NCT00134901|58760990|FG000|Overall Study|Lost to Follow-up|5|||
30751126|NCT00134901|58760991|FG001|Overall Study|Lost to Follow-up|5|||
30751127|NCT00134901|58760990|FG000|Overall Study|discontinued intervention|12|||
30815797|NCT03324581|58835491|FG001|Overall Study|Withdrawal by Subject|8|||
30751128|NCT00134901|58760991|FG001|Overall Study|discontinued intervention|10|||
30751129|NCT00122109|58761001|FG000|Overall Study|Did not meet criteria|6|||
30815798|NCT03324581|58835492|FG002|Overall Study|Withdrawal by Subject|6|||
30815799|NCT03324581|58835490|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
30815800|NCT03324581|58835491|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
30911498|NCT02188303|58946513|FG002|Overall Study|Dose Termination Criteria Met|0|||
30911499|NCT02188303|58946514|FG003|Overall Study|Dose Termination Criteria Met|0|||
30911500|NCT02188303|58946515|FG004|Overall Study|Dose Termination Criteria Met|0|||
30911501|NCT02188303|58946516|FG005|Overall Study|Dose Termination Criteria Met|0|||
30911502|NCT02188303|58946517|FG006|Overall Study|Dose Termination Criteria Met|2|||
30911503|NCT02188303|58946518|FG007|Overall Study|Dose Termination Criteria Met|4|||
30911504|NCT04867382|58946554|FG000|Overall Study|Did not complete the survey|2|||
30911505|NCT04867382|58946555|FG001|Overall Study|Did not complete the survey|1|||
30911506|NCT02187055|58946564|FG000|Overall Study|Lack of Efficacy|10|||
30911507|NCT02187055|58946565|FG001|Overall Study|Lack of Efficacy|3|||
30815801|NCT03324581|58835492|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
30815802|NCT02943473|58835500|FG000|Overall Study|enrolled but not dosed|1|||
30815803|NCT02943473|58835500|FG000|Overall Study|screen failure|1|||
30815804|NCT02943473|58835500|FG000|Overall Study|Physician Decision|4|||
30815805|NCT03320369|58835504|FG000|Overall Study|Adverse Event|1|||
30815806|NCT03320369|58835504|FG000|Overall Study|Withdrawal by Subject|2|||
30815807|NCT02650895|58835514|FG000|Overall Study|Withdrawal by Subject|0|||
30815808|NCT02650895|58835515|FG001|Overall Study|Withdrawal by Subject|1|||
30815809|NCT02650895|58835516|FG002|Overall Study|Withdrawal by Subject|0|||
30815810|NCT02650895|58835517|FG003|Overall Study|Withdrawal by Subject|0|||
30815811|NCT02650895|58835518|FG004|Overall Study|Withdrawal by Subject|0|||
30815812|NCT02650895|58835519|FG005|Overall Study|Withdrawal by Subject|0|||
30815813|NCT03320057|58835538|FG000|Overall Study|Lost to Follow-up|4|||
30815814|NCT03320057|58835539|FG001|Overall Study|Lost to Follow-up|17|||
30815815|NCT03320057|58835538|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
30815816|NCT03320057|58835539|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
30751130|NCT00122109|58761002|FG001|Overall Study|Did not meet criteria|7|||
30751131|NCT00113373|58761011|FG000|Overall Study|Ineligible: wrong primary|1|||
30751132|NCT00113373|58761011|FG000|Overall Study|Ineligible: second primary|1|||
30751133|NCT00113373|58761011|FG000|Overall Study|Never Treated|1|||
30815817|NCT03316547|58835547|FG000|Overall Study|Death|3|||
30815818|NCT03316547|58835548|FG001|Overall Study|Death|1|||
30911508|NCT02187055|58946566|FG002|Overall Study|Lack of Efficacy|7|||
30911509|NCT02187055|58946564|FG000|Overall Study|Lost to Follow-up|2|||
30751134|NCT00113295|58761022|FG000|Overall Study|Adverse Event|4|||
30751135|NCT00113295|58761023|FG001|Overall Study|Adverse Event|1|||
30751136|NCT00113295|58761022|FG000|Overall Study|Unrelated Medical Illness|1|||
30751137|NCT00113295|58761023|FG001|Overall Study|Unrelated Medical Illness|0|||
30751138|NCT00112905|58761031|FG000|Overall Study|Adverse Event|4|||
30751139|NCT00112905|58761031|FG000|Overall Study|Death|1|||
30751140|NCT00112905|58761031|FG000|Overall Study|Ineligibility|5|||
30751141|NCT00112905|58761031|FG000|Overall Study|Alternative treatment|1|||
30751142|NCT00112905|58761031|FG000|Overall Study|performance status was deteiorating|1|||
30751143|NCT00427895|58761039|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
30751144|NCT00427895|58761040|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
30751145|NCT00427895|58761041|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
30751146|NCT00427895|58761042|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
30751147|NCT00427895|58761043|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
30751148|NCT00427895|58761044|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
30751149|NCT00427895|58761045|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
30751150|NCT00427895|58761046|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
30751151|NCT00427895|58761039|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
30751152|NCT00427895|58761040|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
30751153|NCT00427895|58761041|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
30751154|NCT00427895|58761042|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
30751155|NCT00427895|58761043|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
30751156|NCT00427895|58761044|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
30751157|NCT00427895|58761045|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
30751158|NCT00427895|58761046|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
30751159|NCT00427895|58761039|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
30751160|NCT00427895|58761040|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
30815819|NCT03316547|58835547|FG000|Overall Study|Lost to Follow-up|6|||
30815820|NCT03316547|58835548|FG001|Overall Study|Lost to Follow-up|6|||
30815821|NCT03316547|58835547|FG000|Overall Study|Withdrawal by Subject|3|||
30815822|NCT03316547|58835548|FG001|Overall Study|Withdrawal by Subject|2|||
30751161|NCT00427895|58761041|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
30751162|NCT00427895|58761042|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
30751163|NCT00427895|58761043|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
30751164|NCT00427895|58761044|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
30751165|NCT00427895|58761045|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
30751166|NCT00427895|58761046|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
30751167|NCT00427895|58761039|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
30751168|NCT00427895|58761040|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
30751169|NCT00427895|58761041|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
30751170|NCT00427895|58761042|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
30751171|NCT00427895|58761043|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
30751172|NCT00427895|58761044|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
30751173|NCT00427895|58761045|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
30751174|NCT00427895|58761046|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
30751175|NCT00427895|58761039|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
30751176|NCT00427895|58761040|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
30751177|NCT00427895|58761041|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
30751178|NCT00427895|58761042|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
30751179|NCT00427895|58761043|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
30751180|NCT00427895|58761044|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
30751181|NCT00427895|58761045|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
30751182|NCT00427895|58761046|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
30751183|NCT00427895|58761039|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
30751184|NCT00427895|58761040|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
30751185|NCT00427895|58761041|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
30815823|NCT03316547|58835547|FG000|Overall Study|Transfer to another hospital|6|||
30815824|NCT03316547|58835548|FG001|Overall Study|Transfer to another hospital|4|||
30751186|NCT00427895|58761042|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
30751187|NCT00427895|58761043|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
30751188|NCT00427895|58761044|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
30751189|NCT00427895|58761045|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
30815831|NCT03315689|58835588|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
30815832|NCT03315689|58835589|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
30815833|NCT03315689|58835588|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
30815834|NCT03315689|58835589|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
30815835|NCT03315689|58835588|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
30815836|NCT03315689|58835589|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
30815837|NCT03314519|58835599|FG000|Overall Study|Protocol Violation|3|||
30815838|NCT03314519|58835600|FG001|Overall Study|Protocol Violation|2|||
30815839|NCT03313037|58835612|FG000|Overall Study|Protocol Violation|4|||
30815840|NCT03313037|58835613|FG001|Overall Study|Protocol Violation|1|||
30815841|NCT03313037|58835612|FG000|Overall Study|Other|1|||
30815842|NCT03313037|58835613|FG001|Overall Study|Other|1|||
30815843|NCT03313037|58835612|FG000|Overall Study|Withdrawal by Subject|4|||
30815844|NCT03313037|58835613|FG001|Overall Study|Withdrawal by Subject|3|||
30911510|NCT02187055|58946565|FG001|Overall Study|Lost to Follow-up|7|||
30911511|NCT02187055|58946566|FG002|Overall Study|Lost to Follow-up|3|||
30911512|NCT02187055|58946564|FG000|Overall Study|No longer meets eligibility criteria|0|||
30622643|NCT00925600|58634330|FG000|Overall Study|Ineligibility Determined|2|||
30622644|NCT00925600|58634331|FG001|Overall Study|Ineligibility Determined|0|||
30622645|NCT00925600|58634330|FG000|Overall Study|Protocol Deviation|0|||
30622646|NCT00925600|58634331|FG001|Overall Study|Protocol Deviation|1|||
30622647|NCT00925600|58634330|FG000|Overall Study|Requirement for Alternative Therapy|0|||
30622648|NCT00925600|58634331|FG001|Overall Study|Requirement for Alternative Therapy|1|||
30622649|NCT00925600|58634330|FG000|Overall Study|Other|3|||
30622650|NCT00925600|58634331|FG001|Overall Study|Other|1|||
30622651|NCT00925600|58634330|FG000|Overall Study|Adverse Event|1|||
30622652|NCT00925600|58634331|FG001|Overall Study|Adverse Event|2|||
30622653|NCT00968253|58634344|FG000|Overall Study|Death|0|||
30911513|NCT02187055|58946565|FG001|Overall Study|No longer meets eligibility criteria|2|||
30911514|NCT02187055|58946566|FG002|Overall Study|No longer meets eligibility criteria|0|||
30622654|NCT00968253|58634345|FG001|Overall Study|Death|0|||
30622655|NCT00968253|58634346|FG002|Overall Study|Death|2|||
30622656|NCT00968253|58634344|FG000|Overall Study|Withdrawal by Subject|0|||
30815845|NCT03313037|58835612|FG000|Overall Study|No longer meets eligibility criteria|1|||
30815846|NCT03313037|58835613|FG001|Overall Study|No longer meets eligibility criteria|7|||
30815847|NCT03313037|58835612|FG000|Overall Study|Lost to Follow-up|9|||
30815848|NCT03313037|58835613|FG001|Overall Study|Lost to Follow-up|8|||
30815849|NCT03313037|58835612|FG000|Overall Study|Randomized but not treated|1|||
30622657|NCT00968253|58634345|FG001|Overall Study|Withdrawal by Subject|0|||
30622658|NCT00968253|58634346|FG002|Overall Study|Withdrawal by Subject|1|||
30622659|NCT00968253|58634344|FG000|Overall Study|Disease Progression|0|||
30622660|NCT00968253|58634345|FG001|Overall Study|Disease Progression|3|||
30622661|NCT00968253|58634346|FG002|Overall Study|Disease Progression|3|||
30622662|NCT00968253|58634344|FG000|Overall Study|Adverse Event|0|||
30622663|NCT00968253|58634345|FG001|Overall Study|Adverse Event|0|||
30622664|NCT00968253|58634346|FG002|Overall Study|Adverse Event|1|||
30815850|NCT03313037|58835613|FG001|Overall Study|Randomized but not treated|0|||
30815851|NCT02420795|58835622|FG000|Overall Study|Withdrawal by Subject|1|||
30815852|NCT02420795|58835623|FG001|Overall Study|Withdrawal by Subject|0|||
30815853|NCT02420795|58835624|FG002|Overall Study|Withdrawal by Subject|0|||
30815854|NCT02420795|58835622|FG000|Overall Study|Adverse Event|1|||
30815855|NCT02420795|58835623|FG001|Overall Study|Adverse Event|0|||
30815856|NCT02420795|58835624|FG002|Overall Study|Adverse Event|0|||
30911515|NCT02187055|58946564|FG000|Overall Study|No longer willing to participate|6|||
30815857|NCT02420795|58835622|FG000|Overall Study|Progressive disease|2|||
30815858|NCT02420795|58835623|FG001|Overall Study|Progressive disease|2|||
30815859|NCT02420795|58835624|FG002|Overall Study|Progressive disease|4|||
30815860|NCT02420795|58835622|FG000|Overall Study|Death|0|||
30815861|NCT02420795|58835623|FG001|Overall Study|Death|0|||
30815862|NCT02420795|58835624|FG002|Overall Study|Death|1|||
30815863|NCT03334175|58835636|FG000|Overall Study|Lost to Follow-up|0|||
30815864|NCT03334175|58835637|FG001|Overall Study|Lost to Follow-up|1|||
30815865|NCT02942771|58835648|FG000|Overall Study|Adverse Event|1|||
30815866|NCT02942771|58835649|FG001|Overall Study|Adverse Event|0|||
30815867|NCT02942771|58835650|FG002|Overall Study|Adverse Event|0|||
30815868|NCT02942771|58835651|FG003|Overall Study|Adverse Event|0|||
30815869|NCT02942771|58835652|FG004|Overall Study|Adverse Event|2|||
30815870|NCT02942771|58835648|FG000|Overall Study|Lost to Follow-up|1|||
30815871|NCT02942771|58835649|FG001|Overall Study|Lost to Follow-up|0|||
30815872|NCT02942771|58835650|FG002|Overall Study|Lost to Follow-up|0|||
30815873|NCT02942771|58835651|FG003|Overall Study|Lost to Follow-up|0|||
30815874|NCT02942771|58835652|FG004|Overall Study|Lost to Follow-up|0|||
30815875|NCT02942771|58835648|FG000|Overall Study|Withdrawal by Subject|1|||
30815876|NCT02942771|58835649|FG001|Overall Study|Withdrawal by Subject|0|||
30815877|NCT02942771|58835650|FG002|Overall Study|Withdrawal by Subject|0|||
30815878|NCT02942771|58835651|FG003|Overall Study|Withdrawal by Subject|0|||
30815879|NCT02942771|58835652|FG004|Overall Study|Withdrawal by Subject|2|||
30815880|NCT03036150|58835666|FG000|Overall Study|Withdrawal by Subject|8|||
30815881|NCT03036150|58835667|FG001|Overall Study|Withdrawal by Subject|3|||
30815882|NCT03036150|58835666|FG000|Overall Study|Lost to Follow-up|2|||
30815883|NCT03036150|58835667|FG001|Overall Study|Lost to Follow-up|2|||
30815884|NCT03332771|58835677|FG000|Overall Study|Adverse Event|6|||
30815885|NCT03332771|58835678|FG001|Overall Study|Adverse Event|4|||
30815886|NCT03332771|58835679|FG002|Overall Study|Adverse Event|1|||
30815887|NCT03332771|58835680|FG003|Overall Study|Adverse Event|3|||
30815888|NCT03332771|58835677|FG000|Overall Study|Poor Compliance to Protocol|0|||
30911516|NCT02187055|58946565|FG001|Overall Study|No longer willing to participate|8|||
30911517|NCT02187055|58946566|FG002|Overall Study|No longer willing to participate|10|||
30911518|NCT02187055|58946564|FG000|Overall Study|Other|5|||
30911519|NCT02187055|58946565|FG001|Overall Study|Other|6|||
30622665|NCT00964743|58634355|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
30622666|NCT00925522|58634359|FG000|Overall Study|study closed -- business decision|20|||
30911520|NCT02187055|58946566|FG002|Overall Study|Other|3|||
30622667|NCT01130532|58634366|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
30622668|NCT01130532|58634367|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
30815889|NCT03332771|58835678|FG001|Overall Study|Poor Compliance to Protocol|1|||
30815890|NCT03332771|58835679|FG002|Overall Study|Poor Compliance to Protocol|0|||
30815891|NCT03332771|58835680|FG003|Overall Study|Poor Compliance to Protocol|1|||
30815892|NCT03332771|58835677|FG000|Overall Study|Lost to Follow-up|2|||
30911521|NCT02187055|58946564|FG000|Overall Study|Protocol Violation|9|||
30815893|NCT03332771|58835678|FG001|Overall Study|Lost to Follow-up|2|||
30815894|NCT03332771|58835679|FG002|Overall Study|Lost to Follow-up|1|||
30815895|NCT03332771|58835680|FG003|Overall Study|Lost to Follow-up|2|||
30815896|NCT03332771|58835677|FG000|Overall Study|At the Participant's own request|20|||
30815897|NCT03332771|58835678|FG001|Overall Study|At the Participant's own request|26|||
30815898|NCT03332771|58835679|FG002|Overall Study|At the Participant's own request|14|||
30815899|NCT03332771|58835680|FG003|Overall Study|At the Participant's own request|23|||
30911522|NCT02187055|58946565|FG001|Overall Study|Protocol Violation|9|||
30815900|NCT03332771|58835677|FG000|Overall Study|Reason Not Specified|6|||
30815901|NCT03332771|58835678|FG001|Overall Study|Reason Not Specified|18|||
30911523|NCT02187055|58946566|FG002|Overall Study|Protocol Violation|4|||
30911524|NCT02187055|58946564|FG000|Overall Study|Pregnancy|3|||
30911525|NCT02187055|58946565|FG001|Overall Study|Pregnancy|1|||
30911526|NCT02187055|58946566|FG002|Overall Study|Pregnancy|0|||
30911527|NCT02187055|58946564|FG000|Overall Study|Withdrawal by Subject|11|||
30911528|NCT02187055|58946565|FG001|Overall Study|Withdrawal by Subject|11|||
30911529|NCT02187055|58946566|FG002|Overall Study|Withdrawal by Subject|11|||
30911530|NCT02187055|58946564|FG000|Overall Study|Adverse Event|21|||
30911531|NCT02187055|58946565|FG001|Overall Study|Adverse Event|26|||
30911532|NCT02187055|58946566|FG002|Overall Study|Adverse Event|36|||
30911533|NCT02187055|58946564|FG000|Overall Study|Death|2|||
30815902|NCT03332771|58835679|FG002|Overall Study|Reason Not Specified|16|||
30815903|NCT03332771|58835680|FG003|Overall Study|Reason Not Specified|19|||
30815904|NCT03310775|58835692|FG000|Overall Study|Lost to Follow-up|2|||
30815905|NCT03310775|58835693|FG001|Overall Study|Lost to Follow-up|3|||
30815906|NCT03310775|58835692|FG000|Overall Study|aggravation of depression|0|||
30815907|NCT03310775|58835693|FG001|Overall Study|aggravation of depression|1|||
30815908|NCT03330119|58835705|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
30815909|NCT03330119|58835706|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
30815910|NCT03040986|58835714|FG000|Overall Study|Hospice|1|||
30815911|NCT03040986|58835715|FG001|Overall Study|Hospice|0|||
30815912|NCT03040986|58835714|FG000|Overall Study|Adverse Event|2|||
30815913|NCT03040986|58835715|FG001|Overall Study|Adverse Event|1|||
30815914|NCT03040986|58835714|FG000|Overall Study|Disease progression on study|3|||
30815915|NCT03040986|58835715|FG001|Overall Study|Disease progression on study|1|||
30815916|NCT03039192|58835725|FG000|Overall Study|Lost to Follow-up|4|||
30815917|NCT03039192|58835726|FG001|Overall Study|Lost to Follow-up|4|||
30911534|NCT02187055|58946565|FG001|Overall Study|Death|0|||
30911535|NCT02187055|58946566|FG002|Overall Study|Death|0|||
30815918|NCT03039192|58835725|FG000|Overall Study|Adverse event, serious fatal|0|||
30815919|NCT03039192|58835726|FG001|Overall Study|Adverse event, serious fatal|1|||
30815920|NCT03039192|58835725|FG000|Overall Study|Adverse event, non-fatal|0|||
30815921|NCT03039192|58835726|FG001|Overall Study|Adverse event, non-fatal|2|||
30815922|NCT03039192|58835725|FG000|Overall Study|Withdrawal by Subject|6|||
30815923|NCT03039192|58835726|FG001|Overall Study|Withdrawal by Subject|9|||
30815924|NCT03039192|58835725|FG000|Overall Study|Discontinued from treatment phase|19|||
30815925|NCT03039192|58835726|FG001|Overall Study|Discontinued from treatment phase|12|||
30815926|NCT03039192|58835725|FG000|Overall Study|Other|3|||
30815927|NCT03039192|58835726|FG001|Overall Study|Other|2|||
30911536|NCT02246660|58946606|FG000|Overall Study|Withdrawal by Subject|0|||
30911537|NCT02246660|58946607|FG001|Overall Study|Withdrawal by Subject|1|||
30911538|NCT02246660|58946608|FG002|Overall Study|Withdrawal by Subject|0|||
30911539|NCT02246660|58946606|FG000|Overall Study|Death|0|||
30911540|NCT02246660|58946607|FG001|Overall Study|Death|0|||
30911541|NCT02246660|58946608|FG002|Overall Study|Death|1|||
30622669|NCT01130532|58634368|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
30751190|NCT00427895|58761046|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
30751191|NCT00427895|58761039|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
30751192|NCT00427895|58761040|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
30751193|NCT00427895|58761041|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
30751194|NCT00427895|58761042|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
30751195|NCT00427895|58761043|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
30751196|NCT00427895|58761044|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
30751197|NCT00427895|58761045|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
30751198|NCT00427895|58761046|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
30751199|NCT00427895|58761039|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
30751200|NCT00427895|58761040|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
30751201|NCT00427895|58761041|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
30751202|NCT00427895|58761042|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
30751203|NCT00427895|58761043|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
30751204|NCT00427895|58761044|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
30751205|NCT00427895|58761045|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
30751206|NCT00427895|58761046|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
30751207|NCT00427895|58761039|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
30815928|NCT03698279|58835738|FG000|Overall Study|Withdrawal by parent/guardian|1|||
30815929|NCT03698279|58835739|FG001|Overall Study|Withdrawal by parent/guardian|1|||
30815930|NCT03698279|58835740|FG002|Overall Study|Withdrawal by parent/guardian|1|||
30815931|NCT03698279|58835741|FG003|Overall Study|Withdrawal by parent/guardian|1|||
30815932|NCT03698279|58835742|FG004|Overall Study|Withdrawal by parent/guardian|0|||
30815933|NCT03698279|58835743|FG005|Overall Study|Withdrawal by parent/guardian|0|||
30815934|NCT03698279|58835738|FG000|Overall Study|Protocol deviation|1|||
30815935|NCT03698279|58835739|FG001|Overall Study|Protocol deviation|0|||
30815936|NCT03698279|58835740|FG002|Overall Study|Protocol deviation|1|||
30815937|NCT03698279|58835741|FG003|Overall Study|Protocol deviation|0|||
30815938|NCT03698279|58835742|FG004|Overall Study|Protocol deviation|0|||
30815939|NCT03698279|58835743|FG005|Overall Study|Protocol deviation|0|||
30815940|NCT03698279|58835738|FG000|Overall Study|Withdrawal by Subject|0|||
30815941|NCT03698279|58835739|FG001|Overall Study|Withdrawal by Subject|0|||
30815942|NCT03698279|58835740|FG002|Overall Study|Withdrawal by Subject|1|||
30815943|NCT03698279|58835741|FG003|Overall Study|Withdrawal by Subject|0|||
30815944|NCT03698279|58835742|FG004|Overall Study|Withdrawal by Subject|0|||
30815945|NCT03698279|58835743|FG005|Overall Study|Withdrawal by Subject|0|||
30815946|NCT03698279|58835738|FG000|Overall Study|Lost to Follow-up|3|||
30815947|NCT03698279|58835739|FG001|Overall Study|Lost to Follow-up|1|||
30815948|NCT03698279|58835740|FG002|Overall Study|Lost to Follow-up|4|||
30815949|NCT03698279|58835741|FG003|Overall Study|Lost to Follow-up|5|||
30815950|NCT03698279|58835742|FG004|Overall Study|Lost to Follow-up|0|||
30815951|NCT03698279|58835743|FG005|Overall Study|Lost to Follow-up|0|||
30815952|NCT01529034|58835762|FG000|Overall Study|Discontinued prior to study treatment|14|||
30815953|NCT01529034|58835762|FG000|Overall Study|Site closure|62|||
30815954|NCT01529034|58835762|FG000|Overall Study|Study termination|29|||
30815955|NCT01529034|58835762|FG000|Overall Study|Withdrawal by Subject|25|||
30815956|NCT01529034|58835762|FG000|Overall Study|No treated SCs within protocol window|13|||
30815957|NCT01529034|58835762|FG000|Overall Study|Noncompliance|8|||
30815958|NCT01529034|58835762|FG000|Overall Study|Caregiver no longer available|7|||
30815959|NCT01529034|58835762|FG000|Overall Study|Adverse Event|4|||
30815960|NCT01529034|58835762|FG000|Overall Study|Protocol Violation|4|||
30815961|NCT01529034|58835762|FG000|Overall Study|Lack of Efficacy|4|||
30815962|NCT01529034|58835762|FG000|Overall Study|Investigator no longer available|2|||
30815963|NCT01529034|58835762|FG000|Overall Study|Study drug not available|2|||
30815964|NCT03036072|58835769|FG000|Overall Study|Death|0|||
30815965|NCT03036072|58835770|FG001|Overall Study|Death|1|||
30815966|NCT03036072|58835769|FG000|Overall Study|Withdrawal by Subject|0|||
30815967|NCT03036072|58835770|FG001|Overall Study|Withdrawal by Subject|1|||
30815968|NCT03036072|58835769|FG000|Overall Study|Physician Decision|0|||
30815969|NCT03036072|58835770|FG001|Overall Study|Physician Decision|1|||
30815970|NCT03038880|58835779|FG000|Overall Study|Death|1|||
30815971|NCT03038880|58835780|FG001|Overall Study|Death|2|||
30815972|NCT03038880|58835781|FG002|Overall Study|Death|0|||
30815973|NCT03038880|58835779|FG000|Overall Study|Physician Decision|2|||
30815974|NCT03038880|58835780|FG001|Overall Study|Physician Decision|1|||
30815975|NCT03038880|58835781|FG002|Overall Study|Physician Decision|0|||
30815976|NCT03035916|58835792|FG000|Overall Study|Puncture failed|0|||
30815977|NCT03035916|58835793|FG001|Overall Study|Puncture failed|2|||
30815978|NCT03035916|58835794|FG002|Overall Study|Puncture failed|0|||
30815979|NCT01702571|58835804|FG000|Overall Study|Death|1067|||
30815980|NCT01702571|58835805|FG001|Overall Study|Death|76|||
30815981|NCT01702571|58835804|FG000|Overall Study|Lost to Follow-up|144|||
30815982|NCT01702571|58835805|FG001|Overall Study|Lost to Follow-up|10|||
30815983|NCT01702571|58835804|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
30815984|NCT01702571|58835805|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
30815985|NCT01702571|58835804|FG000|Overall Study|Investigator Decision|5|||
30815986|NCT01702571|58835805|FG001|Overall Study|Investigator Decision|0|||
30815987|NCT01702571|58835804|FG000|Overall Study|Not Classifiable|1|||
30815988|NCT01702571|58835805|FG001|Overall Study|Not Classifiable|0|||
30815989|NCT01702571|58835804|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
30815990|NCT01702571|58835805|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
30815991|NCT01702571|58835804|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
30815992|NCT01702571|58835805|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
30815993|NCT01702571|58835804|FG000|Overall Study|Progressive Disease|3|||
30815994|NCT01702571|58835805|FG001|Overall Study|Progressive Disease|0|||
30815995|NCT01702571|58835804|FG000|Overall Study|Protocol Violation|2|||
30815996|NCT01702571|58835805|FG001|Overall Study|Protocol Violation|0|||
30815997|NCT01702571|58835804|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
30815998|NCT01702571|58835805|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
30815999|NCT01702571|58835804|FG000|Overall Study|Termination By Sponsor|4|||
30816000|NCT01702571|58835805|FG001|Overall Study|Termination By Sponsor|0|||
30816001|NCT01702571|58835804|FG000|Overall Study|Withdrawal by Subject|177|||
30816002|NCT01702571|58835805|FG001|Overall Study|Withdrawal by Subject|29|||
30816003|NCT03231943|58835828|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
30816004|NCT03231943|58835829|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
30816005|NCT03231943|58835830|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
30816006|NCT03231943|58835831|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
30816007|NCT03231943|58835832|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
30816008|NCT03231943|58835833|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
30816009|NCT03231943|58835834|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
30816010|NCT03231943|58835835|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
30816011|NCT03231943|58835836|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
30816012|NCT03231943|58835837|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
30816013|NCT03231943|58835838|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
30816014|NCT03231943|58835839|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
30816015|NCT03231943|58835840|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
30816016|NCT03231943|58835828|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30751208|NCT00427895|58761040|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
30751209|NCT00427895|58761041|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
30751210|NCT00427895|58761042|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
30751211|NCT00427895|58761043|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
30751212|NCT00427895|58761044|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
30751213|NCT00427895|58761045|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
30751214|NCT00427895|58761046|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
30751215|NCT00427895|58761039|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
30751216|NCT00427895|58761040|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
30751217|NCT00427895|58761041|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
30751218|NCT00427895|58761042|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
30751219|NCT00427895|58761043|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
30751220|NCT00427895|58761044|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
30816017|NCT03231943|58835829|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
30816018|NCT03231943|58835830|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30816019|NCT03231943|58835831|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30816020|NCT03231943|58835832|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30816021|NCT03231943|58835833|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30816022|NCT03231943|58835834|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30816023|NCT03231943|58835835|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30816024|NCT03231943|58835836|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30816025|NCT03231943|58835837|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30751221|NCT00427895|58761045|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
30751222|NCT00427895|58761046|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
30751223|NCT00427895|58761039|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
30751224|NCT00427895|58761040|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
30751225|NCT00427895|58761041|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
30751226|NCT00427895|58761042|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
30816026|NCT03231943|58835838|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30816027|NCT03231943|58835839|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30816028|NCT03231943|58835840|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
30816029|NCT03231943|58835828|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
30816030|NCT03231943|58835829|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816031|NCT03231943|58835830|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816032|NCT03231943|58835831|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816033|NCT03231943|58835832|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816034|NCT03231943|58835833|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816035|NCT03231943|58835834|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816036|NCT03231943|58835835|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816037|NCT03231943|58835836|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816038|NCT03231943|58835837|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816039|NCT03231943|58835838|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816040|NCT03231943|58835839|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816041|NCT03231943|58835840|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
30816042|NCT03231943|58835828|FG000|Part 2|Adverse Event|0|||
30816043|NCT03231943|58835829|FG001|Part 2|Adverse Event|0|||
30816044|NCT03231943|58835830|FG002|Part 2|Adverse Event|0|||
30816045|NCT03231943|58835831|FG003|Part 2|Adverse Event|0|||
30816046|NCT03231943|58835832|FG004|Part 2|Adverse Event|0|||
30816047|NCT03231943|58835833|FG005|Part 2|Adverse Event|0|||
30816048|NCT03231943|58835834|FG006|Part 2|Adverse Event|0|||
30816049|NCT03231943|58835835|FG007|Part 2|Adverse Event|0|||
30816050|NCT03231943|58835836|FG008|Part 2|Adverse Event|0|||
30816051|NCT03231943|58835837|FG009|Part 2|Adverse Event|0|||
30816052|NCT03231943|58835838|FG010|Part 2|Adverse Event|1|||
30816053|NCT03231943|58835839|FG011|Part 2|Adverse Event|0|||
30816054|NCT03231943|58835840|FG012|Part 2|Adverse Event|0|||
30816055|NCT03231943|58835828|FG000|Part 2|Withdrawal by Subject|0|||
30816056|NCT03231943|58835829|FG001|Part 2|Withdrawal by Subject|0|||
30816057|NCT03231943|58835830|FG002|Part 2|Withdrawal by Subject|0|||
30816058|NCT03231943|58835831|FG003|Part 2|Withdrawal by Subject|0|||
30816059|NCT03231943|58835832|FG004|Part 2|Withdrawal by Subject|0|||
30816060|NCT03231943|58835833|FG005|Part 2|Withdrawal by Subject|0|||
30816061|NCT03231943|58835834|FG006|Part 2|Withdrawal by Subject|0|||
30816062|NCT03231943|58835835|FG007|Part 2|Withdrawal by Subject|0|||
30816063|NCT03231943|58835836|FG008|Part 2|Withdrawal by Subject|0|||
30816064|NCT03231943|58835837|FG009|Part 2|Withdrawal by Subject|0|||
30816065|NCT03231943|58835838|FG010|Part 2|Withdrawal by Subject|0|||
30816066|NCT03231943|58835839|FG011|Part 2|Withdrawal by Subject|1|||
30816067|NCT03231943|58835840|FG012|Part 2|Withdrawal by Subject|0|||
30816068|NCT01578239|58835872|FG000|Treatment Period|Progressive Disease|19|||
30816069|NCT01578239|58835873|FG001|Treatment Period|Progressive Disease|64|||
30816070|NCT01578239|58835872|FG000|Treatment Period|Physician Decision|17|||
30816071|NCT01578239|58835873|FG001|Treatment Period|Physician Decision|17|||
30816072|NCT01578239|58835872|FG000|Treatment Period|Adverse Event|13|||
30816073|NCT01578239|58835873|FG001|Treatment Period|Adverse Event|10|||
30816074|NCT01578239|58835872|FG000|Treatment Period|Non-compliance|2|||
30816075|NCT01578239|58835873|FG001|Treatment Period|Non-compliance|0|||
30816076|NCT01578239|58835872|FG000|Treatment Period|Withdrawal by Subject|10|||
30816077|NCT01578239|58835873|FG001|Treatment Period|Withdrawal by Subject|9|||
30816078|NCT01578239|58835872|FG000|Treatment Period|Other|6|||
30816079|NCT01578239|58835873|FG001|Treatment Period|Other|1|||
30816080|NCT01578239|58835872|FG000|Long-term Follow-Up Period|Death|69|||
30816081|NCT01578239|58835873|FG001|Long-term Follow-Up Period|Death|64|||
30816082|NCT01578239|58835872|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
30816083|NCT01578239|58835873|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
30816084|NCT01578239|58835872|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
30816085|NCT01578239|58835873|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
30816086|NCT01578239|58835872|FG000|Long-term Follow-Up Period|Other|2|||
30816087|NCT01578239|58835873|FG001|Long-term Follow-Up Period|Other|2|||
30816088|NCT03231709|58835881|FG000|Treatment Period 1|Reason not Specified|0|||
30816089|NCT03231709|58835882|FG001|Treatment Period 1|Reason not Specified|1|||
30816090|NCT03231709|58835881|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
30816091|NCT03231709|58835882|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
30816092|NCT03241927|58835892|FG000|Overall Study|study terminated|1|||
30911542|NCT02246582|58946616|FG000|Overall Study|Withdrawal by Subject|3|||
30911543|NCT02246582|58946617|FG001|Overall Study|Withdrawal by Subject|4|||
30911544|NCT02137369|58946623|FG000|Overall Study|Withdrawal by Subject|3|||
30911545|NCT02137369|58946624|FG001|Overall Study|Withdrawal by Subject|2|||
30911546|NCT02137369|58946623|FG000|Overall Study|Adverse Event|2|||
30911547|NCT02137369|58946624|FG001|Overall Study|Adverse Event|0|||
30622670|NCT01130532|58634369|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
30622671|NCT01130532|58634366|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
30622672|NCT01130532|58634367|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
30622673|NCT01130532|58634368|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
30622674|NCT01130532|58634369|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
30622675|NCT01130532|58634366|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
30622676|NCT01130532|58634367|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
30751227|NCT00427895|58761043|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
30751228|NCT00427895|58761044|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
30751229|NCT00427895|58761045|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
30751230|NCT00427895|58761046|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
30751231|NCT00427895|58761039|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
30751232|NCT00427895|58761040|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
30751233|NCT00427895|58761041|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
30751234|NCT00427895|58761042|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
30751235|NCT00427895|58761043|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
30751236|NCT00427895|58761044|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
30751237|NCT00427895|58761045|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
30751238|NCT00427895|58761046|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
30816093|NCT03241927|58835893|FG001|Overall Study|study terminated|0|||
30816094|NCT03329885|58835905|FG000|Overall Study|Sponsor discontinued the study early|0|||
30816095|NCT03329885|58835906|FG001|Overall Study|Sponsor discontinued the study early|0|||
30911548|NCT02137369|58946623|FG000|Overall Study|Lost to Follow-up|1|||
30911549|NCT02137369|58946624|FG001|Overall Study|Lost to Follow-up|0|||
30911550|NCT02137369|58946623|FG000|Overall Study|Moved away|2|||
30911551|NCT02137369|58946624|FG001|Overall Study|Moved away|0|||
30911552|NCT02155309|58946633|FG000|Overall Study|Protocol Violation|0|||
30911553|NCT02155309|58946634|FG001|Overall Study|Protocol Violation|0|||
30911554|NCT02155309|58946635|FG002|Overall Study|Protocol Violation|1|||
30911555|NCT02186821|58946642|FG000|Overall Study|Adverse Event|9|||
30911556|NCT02186821|58946642|FG000|Overall Study|Death|2|||
30911557|NCT02186821|58946642|FG000|Overall Study|Disease progression|32|||
30911558|NCT02186821|58946642|FG000|Overall Study|Protocol Violation|1|||
30911559|NCT02186821|58946642|FG000|Overall Study|Physician Decision|1|||
30911560|NCT02186821|58946642|FG000|Overall Study|Study terminated by sponsor|2|||
30911561|NCT01710358|58946649|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
30911562|NCT01710358|58946650|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
30911563|NCT01710358|58946651|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
30911564|NCT01710358|58946649|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
30911565|NCT01710358|58946650|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
30911566|NCT01710358|58946651|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
30911567|NCT01710358|58946649|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
30911568|NCT01710358|58946650|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
30911569|NCT01710358|58946651|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
30911570|NCT01710358|58946649|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
30911571|NCT01710358|58946650|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
30911572|NCT01710358|58946651|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
30911573|NCT01710358|58946649|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
30911574|NCT01710358|58946650|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
30911575|NCT01710358|58946651|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
30911576|NCT01710358|58946649|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
30911577|NCT01710358|58946650|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
30911578|NCT01710358|58946651|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
30911579|NCT01710358|58946649|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
30911580|NCT01710358|58946650|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
30911581|NCT01710358|58946651|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
30911582|NCT01710358|58946649|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
30911583|NCT01710358|58946650|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
30911584|NCT01710358|58946651|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
30911585|NCT01710358|58946649|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
30911586|NCT01710358|58946650|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
30911587|NCT01710358|58946651|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
30911588|NCT01710358|58946649|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
30911589|NCT01710358|58946650|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
30911590|NCT01710358|58946651|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
30911591|NCT01710358|58946649|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
30911592|NCT01710358|58946650|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
30911593|NCT01710358|58946651|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
30911594|NCT01710358|58946649|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
30911595|NCT01710358|58946650|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
30911596|NCT01710358|58946651|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
30911597|NCT01710358|58946649|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
30911598|NCT01710358|58946650|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
30911599|NCT01710358|58946651|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
30911600|NCT01710358|58946649|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
30911601|NCT01710358|58946650|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
30911602|NCT01710358|58946651|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
30911603|NCT01710358|58946649|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
30911604|NCT01710358|58946650|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
30911605|NCT01710358|58946651|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
30911606|NCT01710358|58946649|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
30911607|NCT01710358|58946650|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
30911608|NCT01710358|58946651|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
30911609|NCT01710358|58946649|FG000|Rescue Period|Adverse Event|0|||
30911610|NCT01710358|58946650|FG001|Rescue Period|Adverse Event|15|||
30911611|NCT01710358|58946651|FG002|Rescue Period|Adverse Event|0|||
30911612|NCT01710358|58946649|FG000|Rescue Period|Death|0|||
30911613|NCT01710358|58946650|FG001|Rescue Period|Death|1|||
30911614|NCT01710358|58946651|FG002|Rescue Period|Death|0|||
30911615|NCT01710358|58946649|FG000|Rescue Period|Lack of Efficacy|0|||
30911616|NCT01710358|58946650|FG001|Rescue Period|Lack of Efficacy|7|||
30911617|NCT01710358|58946651|FG002|Rescue Period|Lack of Efficacy|0|||
30911618|NCT01710358|58946649|FG000|Rescue Period|Withdrawal by Subject|0|||
30911619|NCT01710358|58946650|FG001|Rescue Period|Withdrawal by Subject|8|||
30911620|NCT01710358|58946651|FG002|Rescue Period|Withdrawal by Subject|0|||
30911621|NCT01633112|58946675|FG000|Overall Study|Lack of Efficacy|1|||
30911622|NCT01633112|58946676|FG001|Overall Study|Lack of Efficacy|6|||
30911623|NCT01633112|58946677|FG002|Overall Study|Lack of Efficacy|13|||
30911624|NCT01633112|58946675|FG000|Overall Study|Abnormal laboratory value(s)|3|||
30911625|NCT01633112|58946676|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30911626|NCT01633112|58946677|FG002|Overall Study|Abnormal laboratory value(s)|0|||
30911627|NCT01633112|58946675|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30911628|NCT01633112|58946676|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30911629|NCT01633112|58946677|FG002|Overall Study|Abnormal test procedure result(s)|0|||
30911630|NCT01633112|58946675|FG000|Overall Study|Administrative problems|1|||
30911631|NCT01633112|58946676|FG001|Overall Study|Administrative problems|2|||
30911632|NCT01633112|58946677|FG002|Overall Study|Administrative problems|5|||
30911633|NCT01633112|58946675|FG000|Overall Study|Adverse Event|16|||
30911634|NCT01633112|58946676|FG001|Overall Study|Adverse Event|18|||
30911635|NCT01633112|58946677|FG002|Overall Study|Adverse Event|20|||
30911636|NCT01633112|58946675|FG000|Overall Study|Lost to Follow-up|7|||
30911637|NCT01633112|58946676|FG001|Overall Study|Lost to Follow-up|19|||
30911638|NCT01633112|58946677|FG002|Overall Study|Lost to Follow-up|6|||
30911639|NCT01633112|58946675|FG000|Overall Study|Protocol Violation|4|||
30911640|NCT01633112|58946676|FG001|Overall Study|Protocol Violation|0|||
30911641|NCT01633112|58946677|FG002|Overall Study|Protocol Violation|2|||
30911642|NCT01633112|58946675|FG000|Overall Study|Subject no longer requires study drug|0|||
30911643|NCT01633112|58946676|FG001|Overall Study|Subject no longer requires study drug|0|||
30911644|NCT01633112|58946677|FG002|Overall Study|Subject no longer requires study drug|1|||
30911645|NCT01633112|58946675|FG000|Overall Study|Withdrawal by Subject|20|||
30911646|NCT01633112|58946676|FG001|Overall Study|Withdrawal by Subject|12|||
30911647|NCT01633112|58946677|FG002|Overall Study|Withdrawal by Subject|41|||
30911648|NCT01633112|58946675|FG000|Overall Study|missing Study Completion CRF|1|||
30911649|NCT01633112|58946676|FG001|Overall Study|missing Study Completion CRF|1|||
30911650|NCT01633112|58946677|FG002|Overall Study|missing Study Completion CRF|4|||
30911651|NCT01691482|58946686|FG000|Treatment Period 2|Adverse Event|0|||
30751239|NCT00427895|58761039|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
30751240|NCT00427895|58761040|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
30751241|NCT00427895|58761041|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
30751242|NCT00427895|58761042|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
30751243|NCT00427895|58761043|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
30751244|NCT00427895|58761044|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
30751245|NCT00427895|58761045|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
30751246|NCT00427895|58761046|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
30751247|NCT00427895|58761039|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
30751248|NCT00427895|58761040|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
30751249|NCT00427895|58761041|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
30751250|NCT00427895|58761042|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
30751251|NCT00427895|58761043|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
30751252|NCT00427895|58761044|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
30751253|NCT00427895|58761045|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
30751254|NCT00427895|58761046|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
30751255|NCT00427895|58761039|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
30751256|NCT00427895|58761040|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
30751257|NCT00427895|58761041|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
30751258|NCT00427895|58761042|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
30751259|NCT00427895|58761043|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
30751260|NCT00427895|58761044|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
30751261|NCT00427895|58761045|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
30751262|NCT00427895|58761046|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
30751263|NCT00427895|58761039|FG000|Vax 1/Year 1 Follow-up|Death|1|||
30751264|NCT00427895|58761040|FG001|Vax 1/Year 1 Follow-up|Death|0|||
30751265|NCT00427895|58761041|FG002|Vax 1/Year 1 Follow-up|Death|0|||
30751266|NCT00427895|58761042|FG003|Vax 1/Year 1 Follow-up|Death|0|||
30751267|NCT00427895|58761043|FG004|Vax 1/Year 1 Follow-up|Death|0|||
30911652|NCT01691482|58946687|FG001|Treatment Period 2|Adverse Event|1|||
30911653|NCT01691482|58946686|FG000|Treatment Period 2|Protocol Violation|1|||
30911654|NCT01691482|58946687|FG001|Treatment Period 2|Protocol Violation|1|||
30622677|NCT01130532|58634368|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
30751268|NCT00427895|58761044|FG005|Vax 1/Year 1 Follow-up|Death|0|||
30751269|NCT00427895|58761045|FG006|Vax 1/Year 1 Follow-up|Death|0|||
30911655|NCT02246114|58946696|FG000|Overall Study|miscarriage|1|||
30751270|NCT00427895|58761046|FG007|Vax 1/Year 1 Follow-up|Death|0|||
30622678|NCT01130532|58634369|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
30622679|NCT01130532|58634366|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
30622680|NCT01130532|58634367|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
30622681|NCT01130532|58634368|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
30622682|NCT01130532|58634369|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
30622683|NCT01130532|58634366|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
30622684|NCT01130532|58634367|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
30622685|NCT01130532|58634368|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
30622686|NCT01130532|58634369|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
30622687|NCT01130532|58634366|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
30622688|NCT01130532|58634367|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
30622689|NCT01130532|58634368|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
30622690|NCT01130532|58634369|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
30622691|NCT01130532|58634366|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
30622692|NCT01130532|58634367|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
30622693|NCT01130532|58634368|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
30622694|NCT01130532|58634369|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
30622695|NCT01130532|58634366|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
30622696|NCT01130532|58634367|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
30622697|NCT01130532|58634368|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
30622698|NCT01130532|58634369|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
30622699|NCT01130532|58634366|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
30622700|NCT01130532|58634367|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
30622701|NCT01130532|58634368|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
30622702|NCT01130532|58634369|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
30622703|NCT01130532|58634366|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
30622704|NCT01130532|58634367|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
30622705|NCT01130532|58634368|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
30622706|NCT01130532|58634369|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
30622707|NCT01130532|58634366|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
30816096|NCT03329885|58835907|FG002|Overall Study|Sponsor discontinued the study early|0|||
30816097|NCT03329885|58835908|FG003|Overall Study|Sponsor discontinued the study early|0|||
30816098|NCT03329885|58835909|FG004|Overall Study|Sponsor discontinued the study early|0|||
30816099|NCT03329885|58835910|FG005|Overall Study|Sponsor discontinued the study early|0|||
30816100|NCT03329885|58835911|FG006|Overall Study|Sponsor discontinued the study early|1|||
30816101|NCT03329885|58835912|FG007|Overall Study|Sponsor discontinued the study early|1|||
30911656|NCT02246114|58946697|FG001|Overall Study|miscarriage|0|||
30911657|NCT01710046|58946705|FG000|Overall Study|Lost to Follow-up|1|||
30911658|NCT01710046|58946706|FG001|Overall Study|Lost to Follow-up|0|||
30911659|NCT02154529|58946716|FG000|Overall Study|Death|1|||
30911660|NCT02154529|58946717|FG001|Overall Study|Death|1|||
30816102|NCT03329885|58835913|FG008|Overall Study|Sponsor discontinued the study early|0|||
30816103|NCT02941523|58835935|FG000|Monotherapy|Withdrawal by Subject|0|||
30816104|NCT02941523|58835936|FG001|Monotherapy|Withdrawal by Subject|1|||
30816105|NCT02941523|58835935|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
30816106|NCT02941523|58835936|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
30816107|NCT02941523|58835935|FG000|Carboplatin Combination Therapy|Death|1|||
30816108|NCT02941523|58835936|FG001|Carboplatin Combination Therapy|Death|2|||
30816109|NCT02941523|58835935|FG000|Carboplatin Combination Therapy|Disease progression|2|||
30816110|NCT02941523|58835936|FG001|Carboplatin Combination Therapy|Disease progression|0|||
30816111|NCT02941523|58835935|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
30816112|NCT02941523|58835936|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
30816113|NCT02938585|58835954|FG000|Overall Study|Withdrawal by parent or guardian|0|||
30816114|NCT02938585|58835955|FG001|Overall Study|Withdrawal by parent or guardian|1|||
30816115|NCT02938585|58835956|FG002|Overall Study|Withdrawal by parent or guardian|0|||
30816116|NCT02938585|58835957|FG003|Overall Study|Withdrawal by parent or guardian|0|||
30816117|NCT02938585|58835954|FG000|Overall Study|Withdrawal by Subject|0|||
30816118|NCT02938585|58835955|FG001|Overall Study|Withdrawal by Subject|0|||
30816119|NCT02938585|58835956|FG002|Overall Study|Withdrawal by Subject|0|||
30816120|NCT02938585|58835957|FG003|Overall Study|Withdrawal by Subject|5|||
30816121|NCT03229759|58835981|FG000|Overall Study|Screen Failure|30|||
30816122|NCT03228433|58835993|FG000|Overall Study|Lost to Follow-up|1|||
30816123|NCT03228433|58835994|FG001|Overall Study|Lost to Follow-up|0|||
30816124|NCT03228433|58835995|FG002|Overall Study|Lost to Follow-up|0|||
30911661|NCT02154529|58946718|FG002|Overall Study|Death|5|||
30911662|NCT02154529|58946719|FG003|Overall Study|Death|1|||
30816125|NCT03228433|58835996|FG003|Overall Study|Lost to Follow-up|0|||
30816126|NCT03228433|58835997|FG004|Overall Study|Lost to Follow-up|0|||
30816127|NCT03228433|58835998|FG005|Overall Study|Lost to Follow-up|0|||
30816128|NCT03228433|58835993|FG000|Overall Study|Positive alcohol test|0|||
30911663|NCT02154529|58946716|FG000|Overall Study|Termination of study by sponsor|2|||
30622708|NCT01130532|58634367|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
30622709|NCT01130532|58634368|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
30816129|NCT03228433|58835994|FG001|Overall Study|Positive alcohol test|0|||
30816130|NCT03228433|58835995|FG002|Overall Study|Positive alcohol test|0|||
30816131|NCT03228433|58835996|FG003|Overall Study|Positive alcohol test|1|||
30816132|NCT03228433|58835997|FG004|Overall Study|Positive alcohol test|0|||
30816133|NCT03228433|58835998|FG005|Overall Study|Positive alcohol test|0|||
30816134|NCT01496118|58836028|FG000|Overall Study|Disease progression|3|||
30816135|NCT01496118|58836029|FG001|Overall Study|Disease progression|2|||
30816136|NCT01496118|58836030|FG002|Overall Study|Disease progression|3|||
30816137|NCT01496118|58836031|FG003|Overall Study|Disease progression|1|||
30816138|NCT01496118|58836032|FG004|Overall Study|Disease progression|2|||
30816139|NCT01496118|58836033|FG005|Overall Study|Disease progression|2|||
30816140|NCT01496118|58836034|FG006|Overall Study|Disease progression|14|||
30816141|NCT01496118|58836035|FG007|Overall Study|Disease progression|10|||
30816142|NCT01496118|58836028|FG000|Overall Study|Physician Decision|0|||
30816143|NCT01496118|58836029|FG001|Overall Study|Physician Decision|0|||
30816144|NCT01496118|58836030|FG002|Overall Study|Physician Decision|0|||
30816145|NCT01496118|58836031|FG003|Overall Study|Physician Decision|0|||
30816146|NCT01496118|58836032|FG004|Overall Study|Physician Decision|1|||
30816147|NCT01496118|58836033|FG005|Overall Study|Physician Decision|0|||
30816148|NCT01496118|58836034|FG006|Overall Study|Physician Decision|3|||
30816149|NCT01496118|58836035|FG007|Overall Study|Physician Decision|6|||
30816150|NCT01496118|58836028|FG000|Overall Study|Adverse Event|1|||
30816151|NCT01496118|58836029|FG001|Overall Study|Adverse Event|1|||
30816152|NCT01496118|58836030|FG002|Overall Study|Adverse Event|0|||
30816153|NCT01496118|58836031|FG003|Overall Study|Adverse Event|0|||
30911664|NCT02154529|58946717|FG001|Overall Study|Termination of study by sponsor|2|||
30911665|NCT02154529|58946718|FG002|Overall Study|Termination of study by sponsor|3|||
30911666|NCT02154529|58946719|FG003|Overall Study|Termination of study by sponsor|1|||
30911667|NCT02154529|58946716|FG000|Overall Study|Lost to Follow-up|1|||
30911668|NCT02154529|58946717|FG001|Overall Study|Lost to Follow-up|0|||
30911669|NCT02154529|58946718|FG002|Overall Study|Lost to Follow-up|0|||
30911670|NCT02154529|58946719|FG003|Overall Study|Lost to Follow-up|0|||
30911671|NCT01954017|58946734|FG000|Overall Study|Adverse Event|0|||
30911672|NCT01954017|58946735|FG001|Overall Study|Adverse Event|0|||
30911673|NCT01954017|58946736|FG002|Overall Study|Adverse Event|1|||
30911674|NCT01954017|58946734|FG000|Overall Study|Death|2|||
30911675|NCT01954017|58946735|FG001|Overall Study|Death|1|||
30911676|NCT01954017|58946736|FG002|Overall Study|Death|1|||
30911677|NCT01954017|58946734|FG000|Overall Study|Withdrawal by Subject|0|||
30911678|NCT01954017|58946735|FG001|Overall Study|Withdrawal by Subject|1|||
30816154|NCT01496118|58836032|FG004|Overall Study|Adverse Event|0|||
30816155|NCT01496118|58836033|FG005|Overall Study|Adverse Event|0|||
30816156|NCT01496118|58836034|FG006|Overall Study|Adverse Event|6|||
30816157|NCT01496118|58836035|FG007|Overall Study|Adverse Event|10|||
30816158|NCT01496118|58836028|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
30816159|NCT01496118|58836029|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
30816160|NCT01496118|58836030|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
30816161|NCT01496118|58836031|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
30816162|NCT01496118|58836032|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
30816163|NCT01496118|58836033|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
30816164|NCT01496118|58836034|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
30816165|NCT01496118|58836035|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
30816166|NCT01496118|58836028|FG000|Overall Study|Death|0|||
30816167|NCT01496118|58836029|FG001|Overall Study|Death|0|||
30911679|NCT01954017|58946736|FG002|Overall Study|Withdrawal by Subject|0|||
30911680|NCT01954017|58946734|FG000|Overall Study|Protocol Violation|0|||
30911681|NCT01954017|58946735|FG001|Overall Study|Protocol Violation|3|||
30911682|NCT01954017|58946736|FG002|Overall Study|Protocol Violation|2|||
30816168|NCT01496118|58836030|FG002|Overall Study|Death|0|||
30816169|NCT01496118|58836031|FG003|Overall Study|Death|0|||
30816170|NCT01496118|58836032|FG004|Overall Study|Death|0|||
30816171|NCT01496118|58836033|FG005|Overall Study|Death|0|||
30816172|NCT01496118|58836034|FG006|Overall Study|Death|1|||
30816173|NCT01496118|58836035|FG007|Overall Study|Death|1|||
30816174|NCT01496118|58836028|FG000|Overall Study|Withdrawal by Subject|0|||
30911683|NCT01954017|58946734|FG000|Overall Study|Necrotizing enterocolitis|1|||
30816175|NCT01496118|58836029|FG001|Overall Study|Withdrawal by Subject|0|||
30816176|NCT01496118|58836030|FG002|Overall Study|Withdrawal by Subject|0|||
30816177|NCT01496118|58836031|FG003|Overall Study|Withdrawal by Subject|2|||
30816178|NCT01496118|58836032|FG004|Overall Study|Withdrawal by Subject|0|||
30816179|NCT01496118|58836033|FG005|Overall Study|Withdrawal by Subject|1|||
30816180|NCT01496118|58836034|FG006|Overall Study|Withdrawal by Subject|6|||
30911684|NCT01954017|58946735|FG001|Overall Study|Necrotizing enterocolitis|0|||
30816181|NCT01496118|58836035|FG007|Overall Study|Withdrawal by Subject|3|||
30816182|NCT02936869|58836055|FG000|Overall Study|Lost to Follow-up|1|||
30816183|NCT02936869|58836056|FG001|Overall Study|Lost to Follow-up|3|||
30816184|NCT02936869|58836055|FG000|Overall Study|Death|0|||
30816185|NCT02936869|58836056|FG001|Overall Study|Death|1|||
30816186|NCT02936869|58836055|FG000|Overall Study|Legal Case|0|||
30816187|NCT02936869|58836056|FG001|Overall Study|Legal Case|1|||
30816188|NCT02936869|58836055|FG000|Overall Study|Protocol Violation|1|||
30816189|NCT02936869|58836056|FG001|Overall Study|Protocol Violation|0|||
30816190|NCT03309605|58836071|FG000|Overall Study|Adverse Event|0|||
30816191|NCT03309605|58836072|FG001|Overall Study|Adverse Event|0|||
30816192|NCT03309605|58836073|FG002|Overall Study|Adverse Event|0|||
30816193|NCT03309605|58836074|FG003|Overall Study|Adverse Event|1|||
30816194|NCT03309605|58836075|FG004|Overall Study|Adverse Event|0|||
30816195|NCT03309605|58836076|FG005|Overall Study|Adverse Event|0|||
30816196|NCT03309605|58836077|FG006|Overall Study|Adverse Event|2|||
30816197|NCT03309605|58836078|FG007|Overall Study|Adverse Event|1|||
30816198|NCT03309605|58836071|FG000|Overall Study|Withdrawal by Subject|0|||
30816199|NCT03309605|58836072|FG001|Overall Study|Withdrawal by Subject|0|||
30816200|NCT03309605|58836073|FG002|Overall Study|Withdrawal by Subject|0|||
30751271|NCT00427895|58761039|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
30751272|NCT00427895|58761040|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
30751273|NCT00427895|58761041|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
30751274|NCT00427895|58761042|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
30751275|NCT00427895|58761043|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
30751276|NCT00427895|58761044|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
30751277|NCT00427895|58761045|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
30816201|NCT03309605|58836074|FG003|Overall Study|Withdrawal by Subject|0|||
30816202|NCT03309605|58836075|FG004|Overall Study|Withdrawal by Subject|1|||
30816203|NCT03309605|58836076|FG005|Overall Study|Withdrawal by Subject|0|||
30816204|NCT03309605|58836077|FG006|Overall Study|Withdrawal by Subject|1|||
30816205|NCT03309605|58836078|FG007|Overall Study|Withdrawal by Subject|1|||
30816206|NCT02936635|58836094|FG000|Overall Study|Adverse Event|43|||
30816207|NCT02936635|58836095|FG001|Overall Study|Adverse Event|25|||
30816208|NCT02936635|58836094|FG000|Overall Study|Progressive Disease|10|||
30816209|NCT02936635|58836095|FG001|Overall Study|Progressive Disease|18|||
30816210|NCT02936635|58836094|FG000|Overall Study|Sponsor Discretion|10|||
30816211|NCT02936635|58836095|FG001|Overall Study|Sponsor Discretion|16|||
30816212|NCT02936635|58836094|FG000|Overall Study|Death|9|||
30816213|NCT02936635|58836095|FG001|Overall Study|Death|15|||
30816214|NCT02936635|58836094|FG000|Overall Study|Withdrawal by Subject|8|||
30816215|NCT02936635|58836095|FG001|Overall Study|Withdrawal by Subject|15|||
30816216|NCT02936635|58836094|FG000|Overall Study|Physician Decision|2|||
30816217|NCT02936635|58836095|FG001|Overall Study|Physician Decision|9|||
30816218|NCT02936635|58836094|FG000|Overall Study|Lost to Follow-up|1|||
30816219|NCT02936635|58836095|FG001|Overall Study|Lost to Follow-up|2|||
30751278|NCT00427895|58761046|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
30751279|NCT00427895|58761039|FG000|Vax 1/Year 1 Follow-up|Other|0|||
30751280|NCT00427895|58761040|FG001|Vax 1/Year 1 Follow-up|Other|0|||
30751281|NCT00427895|58761041|FG002|Vax 1/Year 1 Follow-up|Other|0|||
30751282|NCT00427895|58761042|FG003|Vax 1/Year 1 Follow-up|Other|2|||
30751283|NCT00427895|58761043|FG004|Vax 1/Year 1 Follow-up|Other|0|||
30751284|NCT00427895|58761044|FG005|Vax 1/Year 1 Follow-up|Other|0|||
30751285|NCT00427895|58761045|FG006|Vax 1/Year 1 Follow-up|Other|0|||
30751286|NCT00427895|58761046|FG007|Vax 1/Year 1 Follow-up|Other|0|||
30816220|NCT02936635|58836094|FG000|Overall Study|Protocol Violation|1|||
30816221|NCT02936635|58836095|FG001|Overall Study|Protocol Violation|0|||
30622710|NCT01130532|58634369|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
30751287|NCT00427895|58761039|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
30816222|NCT02936635|58836094|FG000|Overall Study|Lack of effect/Entry into other study|31|||
30816223|NCT02936635|58836095|FG001|Overall Study|Lack of effect/Entry into other study|65|||
30816224|NCT03227029|58836104|FG000|Overall Study|Child Wheezed (no treatment)|0|||
30751288|NCT00427895|58761040|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
30816225|NCT03227029|58836105|FG001|Overall Study|Child Wheezed (no treatment)|1|||
30816226|NCT03227029|58836106|FG002|Overall Study|Child Wheezed (no treatment)|0|||
30816227|NCT03227029|58836104|FG000|Overall Study|No post RSV season visit due to COVID|3|||
30816228|NCT03227029|58836105|FG001|Overall Study|No post RSV season visit due to COVID|3|||
30816229|NCT03227029|58836106|FG002|Overall Study|No post RSV season visit due to COVID|2|||
30816230|NCT03227029|58836104|FG000|Overall Study|Not able to get to clinic|0|||
30816231|NCT03227029|58836105|FG001|Overall Study|Not able to get to clinic|0|||
30816232|NCT03227029|58836106|FG002|Overall Study|Not able to get to clinic|1|||
30816233|NCT03227029|58836104|FG000|Overall Study|Withdrawal by Subject|1|||
30816234|NCT03227029|58836105|FG001|Overall Study|Withdrawal by Subject|0|||
30816235|NCT03227029|58836106|FG002|Overall Study|Withdrawal by Subject|0|||
30816236|NCT03227029|58836104|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
30816237|NCT03227029|58836105|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
30816238|NCT03227029|58836106|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
30816239|NCT03329573|58836118|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
30816240|NCT03329573|58836119|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
30816241|NCT03329573|58836120|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
30816242|NCT03329573|58836121|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
30816243|NCT03329573|58836118|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
30816244|NCT03329573|58836119|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
30816245|NCT03329573|58836120|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30816246|NCT03329573|58836121|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
30816247|NCT03329573|58836118|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
30816248|NCT03329573|58836119|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
30816249|NCT03329573|58836120|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
30816250|NCT03329573|58836121|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
30816251|NCT03329573|58836118|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
30816252|NCT03329573|58836119|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
30816253|NCT03329573|58836120|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
30816254|NCT03329573|58836121|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
30816255|NCT03308825|58836152|FG000|Overall Study|Lost to Follow-up|2|||
30816256|NCT03308825|58836153|FG001|Overall Study|Lost to Follow-up|2|||
30816257|NCT03308825|58836154|FG002|Overall Study|Lost to Follow-up|1|||
30816258|NCT03308825|58836155|FG003|Overall Study|Lost to Follow-up|0|||
30816259|NCT03308825|58836152|FG000|Overall Study|Protocol Violation|0|||
30816260|NCT03308825|58836153|FG001|Overall Study|Protocol Violation|2|||
30816261|NCT03308825|58836154|FG002|Overall Study|Protocol Violation|0|||
30816262|NCT03308825|58836155|FG003|Overall Study|Protocol Violation|0|||
30816263|NCT03328325|58836169|FG000|Overall Study|Lost to Follow-up|4|||
30816264|NCT03328325|58836169|FG000|Overall Study|Physician Decision|1|||
30816265|NCT03328325|58836169|FG000|Overall Study|Withdrawal by Subject|3|||
30816266|NCT03328325|58836169|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
30816267|NCT03305081|58836179|FG000|Overall Study|Lost to Follow-up|10|||
30816268|NCT03305081|58836180|FG001|Overall Study|Lost to Follow-up|15|||
30816269|NCT03325673|58836198|FG000|Overall Study|Adverse Event|4|||
30816270|NCT03325673|58836199|FG001|Overall Study|Adverse Event|0|||
30816271|NCT03223909|58836208|FG000|Overall Study|Protocol Violation|48|||
30816272|NCT03223909|58836209|FG001|Overall Study|Protocol Violation|45|||
30816273|NCT03223909|58836210|FG002|Overall Study|Protocol Violation|16|||
30816274|NCT03733925|58836218|FG000|Overall Study|Lost to Follow-up|1|||
30816275|NCT03733925|58836218|FG000|Overall Study|Withdrawal by Subject|2|||
30911685|NCT01954017|58946736|FG002|Overall Study|Necrotizing enterocolitis|1|||
30911686|NCT01954017|58946734|FG000|Overall Study|Enteral intake stopped >7 days|0|||
30911687|NCT01954017|58946735|FG001|Overall Study|Enteral intake stopped >7 days|1|||
30911688|NCT01954017|58946736|FG002|Overall Study|Enteral intake stopped >7 days|1|||
30911689|NCT01954017|58946734|FG000|Overall Study|All other reasons|2|||
30911690|NCT01954017|58946735|FG001|Overall Study|All other reasons|2|||
30911691|NCT01954017|58946736|FG002|Overall Study|All other reasons|7|||
30911692|NCT02154139|58946770|FG000|Overall Study|Injection not administered|2|||
30911693|NCT02154139|58946770|FG000|Overall Study|Other|2|||
30911694|NCT02154139|58946770|FG000|Overall Study|Investigator transferred|3|||
30911695|NCT02245568|58946774|FG000|Overall Study|Study terminated by Sponsor|346|||
30622711|NCT00972777|58634383|FG000|Overall Study|Adverse Event|3|||
30622712|NCT00972777|58634384|FG001|Overall Study|Adverse Event|2|||
30751289|NCT00427895|58761041|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
30751290|NCT00427895|58761042|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
30751291|NCT00427895|58761043|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
30751292|NCT00427895|58761044|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
30751293|NCT00427895|58761045|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
30751294|NCT00427895|58761046|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
30751295|NCT00425945|58761087|FG000|Overall Study|Concern about Supplement|2|||
30751296|NCT00425945|58761088|FG001|Overall Study|Concern about Supplement|0|||
30751297|NCT00425945|58761087|FG000|Overall Study|Inconvenience|0|||
30816276|NCT03733925|58836218|FG000|Overall Study|Adverse Event|2|||
30816277|NCT03733925|58836218|FG000|Overall Study|Non-Compliance with Study Drug|1|||
30911696|NCT02245568|58946774|FG000|Overall Study|Adverse Event|144|||
30816278|NCT03649711|58836225|FG000|Overall Study|Adverse Event|0|||
30816279|NCT03649711|58836226|FG001|Overall Study|Adverse Event|1|||
30816280|NCT03649711|58836227|FG002|Overall Study|Adverse Event|0|||
30816281|NCT03649711|58836225|FG000|Overall Study|Kidney Transplant|1|||
30816282|NCT03649711|58836226|FG001|Overall Study|Kidney Transplant|0|||
30816283|NCT03649711|58836227|FG002|Overall Study|Kidney Transplant|0|||
30816284|NCT03303521|58836237|FG000|Overall Study|Withdrawal by Subject|2|||
30816285|NCT03303521|58836238|FG001|Overall Study|Withdrawal by Subject|0|||
30816286|NCT03303521|58836237|FG000|Overall Study|Death|1|||
30816287|NCT03303521|58836238|FG001|Overall Study|Death|0|||
30816288|NCT03303521|58836237|FG000|Overall Study|Kidney transplantation|0|||
30816289|NCT03303521|58836238|FG001|Overall Study|Kidney transplantation|1|||
30816290|NCT03303521|58836237|FG000|Overall Study|Investigational product discontinuation|0|||
30816291|NCT03303521|58836238|FG001|Overall Study|Investigational product discontinuation|1|||
30816292|NCT03303521|58836237|FG000|Overall Study|Transferred to non-study dialysis center|1|||
30911697|NCT02245568|58946774|FG000|Overall Study|Lack of Efficacy|98|||
30911698|NCT02245568|58946774|FG000|Overall Study|Withdrawal by Caregiver|85|||
30911699|NCT02245568|58946774|FG000|Overall Study|Withdrawal by Subject|77|||
30911700|NCT02245568|58946774|FG000|Overall Study|Withdrawal by Legal Representative|31|||
30911701|NCT02245568|58946774|FG000|Overall Study|Missing (Site closure)|16|||
30911702|NCT02245568|58946774|FG000|Overall Study|Physician Decision|14|||
30911703|NCT02245568|58946774|FG000|Overall Study|Non-compliance with study drug|11|||
30911704|NCT02245568|58946774|FG000|Overall Study|Death|9|||
30911705|NCT02245568|58946774|FG000|Overall Study|Blue staining|6|||
30911706|NCT02245568|58946774|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
30911707|NCT02245568|58946774|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
30911708|NCT02245568|58946774|FG000|Overall Study|Lost to Follow-up|5|||
30911709|NCT02154061|58946780|FG000|Overall Study|Pregnancy|1|||
30911710|NCT02154061|58946781|FG001|Overall Study|Pregnancy|0|||
30911711|NCT02154061|58946780|FG000|Overall Study|enrolled but not vaccinated|1|||
30911712|NCT02154061|58946781|FG001|Overall Study|enrolled but not vaccinated|0|||
30911713|NCT01907217|58946789|FG000|Overall Study|Withdrawal by Subject|0|||
30911714|NCT01907217|58946790|FG001|Overall Study|Withdrawal by Subject|2|||
30911715|NCT01953783|58946798|FG000|Overall Study|Progressive disease|2|||
30911716|NCT02134015|58946804|FG000|Overall Study|Protocol Violation|0|||
30751298|NCT00425945|58761088|FG001|Overall Study|Inconvenience|2|||
30751299|NCT00425945|58761087|FG000|Overall Study|Lost to Follow-up|0|||
30751300|NCT00425945|58761088|FG001|Overall Study|Lost to Follow-up|2|||
30751301|NCT00425945|58761087|FG000|Overall Study|Began hypertension medication|1|||
30751302|NCT00425945|58761088|FG001|Overall Study|Began hypertension medication|0|||
30751303|NCT00425945|58761087|FG000|Overall Study|Began cancer treatments|1|||
30751304|NCT00425945|58761088|FG001|Overall Study|Began cancer treatments|0|||
30751305|NCT00425945|58761087|FG000|Overall Study|Moved from area|0|||
30751306|NCT00425945|58761088|FG001|Overall Study|Moved from area|1|||
30751307|NCT00416195|58761098|FG000|Overall Study|Adverse Event|1|||
30751308|NCT00416195|58761099|FG001|Overall Study|Adverse Event|2|||
30751309|NCT00416195|58761098|FG000|Overall Study|Protocol Violation|1|||
30751310|NCT00416195|58761099|FG001|Overall Study|Protocol Violation|1|||
30751311|NCT00416195|58761098|FG000|Overall Study|Other|0|||
30751312|NCT00416195|58761099|FG001|Overall Study|Other|1|||
30751313|NCT00121641|58761109|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
30751314|NCT00121641|58761110|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
30751315|NCT00121641|58761111|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
30751316|NCT00121641|58761112|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
30751317|NCT00121641|58761113|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
30751318|NCT00121641|58761109|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
30751319|NCT00121641|58761110|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
30911717|NCT02134015|58946805|FG001|Overall Study|Protocol Violation|1|||
30911718|NCT02134015|58946804|FG000|Overall Study|Death|2|||
30816293|NCT03303521|58836238|FG001|Overall Study|Transferred to non-study dialysis center|0|||
30911719|NCT02134015|58946805|FG001|Overall Study|Death|1|||
30911720|NCT02134015|58946804|FG000|Overall Study|Reason not provided|1|||
30911721|NCT02134015|58946805|FG001|Overall Study|Reason not provided|2|||
30911722|NCT02134015|58946804|FG000|Overall Study|Clinical progression|14|||
30911723|NCT02134015|58946805|FG001|Overall Study|Clinical progression|7|||
30911724|NCT02134015|58946804|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
30911725|NCT02134015|58946805|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
30911726|NCT02134015|58946804|FG000|Overall Study|Study terminated by sponsor|2|||
30911727|NCT02134015|58946805|FG001|Overall Study|Study terminated by sponsor|3|||
30911728|NCT02134015|58946804|FG000|Overall Study|Adverse Event|9|||
30911729|NCT02134015|58946805|FG001|Overall Study|Adverse Event|10|||
30911730|NCT02134015|58946804|FG000|Overall Study|Withdrawal by Subject|3|||
30911731|NCT02134015|58946805|FG001|Overall Study|Withdrawal by Subject|7|||
30911732|NCT01924845|58946811|FG000|Overall Study|Adverse Event|3|||
30816294|NCT03303521|58836237|FG000|Overall Study|Non-comliance to study protocol|0|||
30816295|NCT03303521|58836238|FG001|Overall Study|Non-comliance to study protocol|1|||
30816296|NCT03303521|58836237|FG000|Overall Study|Adverse Event|1|||
30816297|NCT03303521|58836238|FG001|Overall Study|Adverse Event|0|||
30816298|NCT03214081|58836244|FG000|Overall Study|Case Report Forms Uncollected|9|||
30816299|NCT03214081|58836244|FG000|Overall Study|Protocol Deviation|54|||
30816300|NCT02888171|58836250|FG000|Overall Study|Lost to Follow-up|2|||
30816301|NCT02888171|58836251|FG001|Overall Study|Lost to Follow-up|1|||
30816302|NCT02888171|58836250|FG000|Overall Study|Withdrawal by Subject|3|||
30816303|NCT02888171|58836251|FG001|Overall Study|Withdrawal by Subject|2|||
30816304|NCT02888171|58836250|FG000|Overall Study|Adverse Event|0|||
30816305|NCT02888171|58836251|FG001|Overall Study|Adverse Event|1|||
30816306|NCT02932891|58836257|FG000|Overall Study|Lost to Follow-up|2|||
30816307|NCT02932891|58836257|FG000|Overall Study|HPA Suppress|2|||
30816308|NCT03302975|58836261|FG000|Overall Study|Lost to Follow-up|4|||
30911733|NCT01924845|58946811|FG000|Overall Study|Withdrawal by Subject|2|||
30911734|NCT01924845|58946811|FG000|Overall Study|Protocol Violation|1|||
30911735|NCT01630135|58946817|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
30911736|NCT01630135|58946818|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
30911737|NCT01691248|58946826|FG000|Overall Study|Protocol Violation|43|||
30911738|NCT01691248|58946827|FG001|Overall Study|Protocol Violation|27|||
30911739|NCT01691248|58946826|FG000|Overall Study|Adverse Event|24|||
30911740|NCT01691248|58946827|FG001|Overall Study|Adverse Event|22|||
30911741|NCT01691248|58946826|FG000|Overall Study|Withdrawal by Subject|20|||
30911742|NCT01691248|58946827|FG001|Overall Study|Withdrawal by Subject|18|||
30911743|NCT01691248|58946826|FG000|Overall Study|Confirmed CDAD|14|||
30911744|NCT01691248|58946827|FG001|Overall Study|Confirmed CDAD|31|||
30911745|NCT01691248|58946826|FG000|Overall Study|Lost to Follow-up|2|||
30816309|NCT03212521|58836265|FG000|Overall Study|Adverse Event|1|||
30911746|NCT01691248|58946827|FG001|Overall Study|Lost to Follow-up|5|||
30911747|NCT01691248|58946826|FG000|Overall Study|Reason not provided|4|||
30751320|NCT00121641|58761111|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
30751321|NCT00121641|58761112|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
30751322|NCT00121641|58761113|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
30751323|NCT00121641|58761109|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
30751324|NCT00121641|58761110|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
30751325|NCT00121641|58761111|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
30751326|NCT00121641|58761112|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
30751327|NCT00121641|58761113|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
30751328|NCT00121641|58761109|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
30816310|NCT03212521|58836265|FG000|Overall Study|Lost to Follow-up|4|||
30816311|NCT03212521|58836265|FG000|Overall Study|Withdrawal by Subject|1|||
30816312|NCT03212521|58836265|FG000|Overall Study|Other|1|||
30816313|NCT03212365|58836271|FG000|Overall Study|Discharged prior to Xa level|12|||
30911748|NCT01691248|58946827|FG001|Overall Study|Reason not provided|4|||
30911749|NCT01691248|58946826|FG000|Overall Study|Not Treated|4|||
30911750|NCT01691248|58946827|FG001|Overall Study|Not Treated|7|||
30911751|NCT01924767|58946838|FG000|Overall Study|Adverse Event|1|||
30816314|NCT03212365|58836272|FG001|Overall Study|Discharged prior to Xa level|8|||
30816315|NCT03212365|58836271|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
30816316|NCT03212365|58836272|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
30816317|NCT03212365|58836271|FG000|Overall Study|Refused study medication|3|||
30816318|NCT03212365|58836272|FG001|Overall Study|Refused study medication|0|||
30816319|NCT03212365|58836271|FG000|Overall Study|Initiated heparin infusion on floor|1|||
30816320|NCT03212365|58836272|FG001|Overall Study|Initiated heparin infusion on floor|1|||
30816321|NCT03212365|58836271|FG000|Overall Study|Unexpected return to OR|1|||
30751329|NCT00121641|58761110|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
30751330|NCT00121641|58761111|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
30751331|NCT00121641|58761112|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
30751332|NCT00121641|58761113|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
30751333|NCT00121641|58761109|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
30751334|NCT00121641|58761110|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
30751335|NCT00121641|58761111|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
30751336|NCT00121641|58761112|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
30751337|NCT00121641|58761113|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
30751338|NCT00121641|58761109|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
30751339|NCT00121641|58761110|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
30751340|NCT00121641|58761111|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
30751341|NCT00121641|58761112|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
30751342|NCT00121641|58761113|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
30751343|NCT00121641|58761109|FG000|24-week Short-term Treatment Period|Other Reason|1|||
30751344|NCT00121641|58761110|FG001|24-week Short-term Treatment Period|Other Reason|0|||
30751345|NCT00121641|58761111|FG002|24-week Short-term Treatment Period|Other Reason|0|||
30751346|NCT00121641|58761112|FG003|24-week Short-term Treatment Period|Other Reason|0|||
30751347|NCT00121641|58761113|FG004|24-week Short-term Treatment Period|Other Reason|0|||
30751348|NCT00121641|58761109|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
30751349|NCT00121641|58761110|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
30751350|NCT00121641|58761111|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
30751351|NCT00121641|58761112|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
30751352|NCT00121641|58761113|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
30816322|NCT03212365|58836272|FG001|Overall Study|Unexpected return to OR|1|||
30816323|NCT03212365|58836271|FG000|Overall Study|Medication distribution error|1|||
30816324|NCT03212365|58836272|FG001|Overall Study|Medication distribution error|0|||
30816325|NCT03212365|58836271|FG000|Overall Study|Required epidural placement|1|||
30751353|NCT00121641|58761109|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
30751354|NCT00121641|58761110|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
30751355|NCT00121641|58761111|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
30751356|NCT00121641|58761112|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
30751357|NCT00121641|58761113|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
30751358|NCT00121641|58761109|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
30751359|NCT00121641|58761110|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
30751360|NCT00121641|58761111|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
30751361|NCT00121641|58761112|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
30751362|NCT00121641|58761113|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
30751363|NCT00121641|58761109|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
30751364|NCT00121641|58761110|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
30751365|NCT00121641|58761111|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
30751366|NCT00121641|58761112|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
30751367|NCT00121641|58761113|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
30751368|NCT00121641|58761109|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
30751369|NCT00121641|58761110|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
30816326|NCT03212365|58836272|FG001|Overall Study|Required epidural placement|0|||
30816327|NCT03212365|58836271|FG000|Overall Study|Withdrawal by Subject|0|||
30816328|NCT03212365|58836272|FG001|Overall Study|Withdrawal by Subject|1|||
30816329|NCT03212365|58836271|FG000|Overall Study|developed acute renal failure|0|||
30816330|NCT03212365|58836272|FG001|Overall Study|developed acute renal failure|1|||
30816331|NCT03273257|58836280|FG000|Overall Study|Death|0|||
30816332|NCT03273257|58836281|FG001|Overall Study|Death|1|||
30816333|NCT03273257|58836280|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
30816334|NCT03273257|58836281|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
30816335|NCT03273257|58836280|FG000|Overall Study|Study terminated|3|||
30816336|NCT03273257|58836281|FG001|Overall Study|Study terminated|2|||
30816337|NCT04316741|58836289|FG000|Baseline Enrollment|Lost to Follow-up|1|||
30816338|NCT04316741|58836290|FG001|Baseline Enrollment|Lost to Follow-up|1|||
30816339|NCT04316741|58836289|FG000|Immediate Post-Test|Lost to Follow-up|5|||
30816340|NCT04316741|58836290|FG001|Immediate Post-Test|Lost to Follow-up|1|||
30816341|NCT04316741|58836289|FG000|1-month Post-test|Lost to Follow-up|7|||
30816342|NCT04316741|58836290|FG001|1-month Post-test|Lost to Follow-up|2|||
30816343|NCT04316741|58836289|FG000|3-month Follow-up|Lost to Follow-up|10|||
30816344|NCT04316741|58836290|FG001|3-month Follow-up|Lost to Follow-up|2|||
30816345|NCT03271307|58836300|FG000|Overall Study|Lost to Follow-up|0|||
30816346|NCT03271307|58836301|FG001|Overall Study|Lost to Follow-up|0|||
30816347|NCT03271307|58836302|FG002|Overall Study|Lost to Follow-up|0|||
30816348|NCT03271307|58836303|FG003|Overall Study|Lost to Follow-up|28|||
30816349|NCT03271307|58836304|FG004|Overall Study|Lost to Follow-up|91|||
30816350|NCT03271151|58836321|FG000|Overall Study|Lost to Follow-up|1|||
30816351|NCT03271151|58836322|FG001|Overall Study|Lost to Follow-up|3|||
30816352|NCT03271151|58836321|FG000|Overall Study|Withdrawal by Subject|1|||
30911752|NCT01924767|58946839|FG001|Overall Study|Adverse Event|0|||
30816353|NCT03271151|58836322|FG001|Overall Study|Withdrawal by Subject|0|||
30816354|NCT03245723|58836330|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
30816355|NCT03245723|58836331|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
30816356|NCT03245723|58836330|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
30816357|NCT03245723|58836331|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
30816358|NCT03245723|58836330|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
30816359|NCT03245723|58836331|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
30816360|NCT03245723|58836330|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
30911753|NCT01924767|58946840|FG002|Overall Study|Adverse Event|1|||
30911754|NCT01924767|58946841|FG003|Overall Study|Adverse Event|0|||
30911755|NCT01924767|58946842|FG004|Overall Study|Adverse Event|0|||
30911756|NCT01691092|58946859|FG000|Overall Study|Lost to Follow-up|10|||
30911757|NCT01691092|58946859|FG000|Overall Study|Physician Decision|4|||
30911758|NCT01691092|58946859|FG000|Overall Study|Withdrawal by Subject|3|||
30911759|NCT01691092|58946859|FG000|Overall Study|non-compliance|3|||
30911760|NCT01691092|58946859|FG000|Overall Study|used for different study|2|||
30911761|NCT01691092|58946859|FG000|Overall Study|screen fail|19|||
30911762|NCT02133001|58946865|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
30911763|NCT02133001|58946866|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
30911764|NCT02133001|58946865|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
30816361|NCT03245723|58836331|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
30816362|NCT03301649|58836340|FG000|Overall Study|Need alternate therapy due to live lice|17|||
30816363|NCT03301649|58836341|FG001|Overall Study|Need alternate therapy due to live lice|25|||
30816364|NCT03301649|58836342|FG002|Overall Study|Need alternate therapy due to live lice|81|||
30816365|NCT03301649|58836340|FG000|Overall Study|Lost to Follow-up|11|||
30816366|NCT03301649|58836341|FG001|Overall Study|Lost to Follow-up|11|||
30816367|NCT03301649|58836342|FG002|Overall Study|Lost to Follow-up|3|||
30816368|NCT03301649|58836340|FG000|Overall Study|Protocol Violation|0|||
30911765|NCT02133001|58946866|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
30911766|NCT02133001|58946865|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
30911767|NCT02133001|58946866|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
30911768|NCT02133001|58946865|FG000|Double Blind (Day 1-25)|Other|2|||
30911769|NCT02133001|58946866|FG001|Double Blind (Day 1-25)|Other|2|||
30911770|NCT02133001|58946865|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
30911771|NCT02133001|58946866|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
30911772|NCT02133001|58946865|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
30911773|NCT02133001|58946866|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
30911774|NCT02133001|58946865|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
30911775|NCT02133001|58946866|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
30911776|NCT02133001|58946865|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
30911777|NCT02133001|58946866|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
30816369|NCT03301649|58836341|FG001|Overall Study|Protocol Violation|1|||
30816370|NCT03301649|58836342|FG002|Overall Study|Protocol Violation|1|||
30816371|NCT03301649|58836340|FG000|Overall Study|Withdrawal by Subject|10|||
30816372|NCT03301649|58836341|FG001|Overall Study|Withdrawal by Subject|4|||
30816373|NCT03301649|58836342|FG002|Overall Study|Withdrawal by Subject|0|||
30816374|NCT03301649|58836340|FG000|Overall Study|Other than specified|5|||
30816375|NCT03301649|58836341|FG001|Overall Study|Other than specified|3|||
30816376|NCT03301649|58836342|FG002|Overall Study|Other than specified|0|||
30816377|NCT03222973|58836352|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
30816378|NCT03222973|58836353|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
30816379|NCT03222973|58836354|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
30816380|NCT03222973|58836355|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
30816381|NCT03222973|58836352|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
30816382|NCT03222973|58836353|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
30816383|NCT03222973|58836354|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
30816384|NCT03222973|58836355|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
30816385|NCT03222973|58836352|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
30816386|NCT03222973|58836353|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
30816387|NCT03222973|58836354|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
30816388|NCT03222973|58836355|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
30816389|NCT03222973|58836352|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
30816390|NCT03222973|58836353|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
30816391|NCT03222973|58836354|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
30816392|NCT03222973|58836355|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
30816393|NCT03222973|58836352|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
30911778|NCT01709578|58946877|FG000|Overall Study|Rescued and entered in long term safety|63|||
30911779|NCT01709578|58946878|FG001|Overall Study|Rescued and entered in long term safety|25|||
30911780|NCT01709578|58946879|FG002|Overall Study|Rescued and entered in long term safety|26|||
30911781|NCT01709578|58946877|FG000|Overall Study|Adverse Event|9|||
30911782|NCT01709578|58946878|FG001|Overall Study|Adverse Event|18|||
30816394|NCT03222973|58836353|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
30816395|NCT03222973|58836354|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
30816396|NCT03222973|58836355|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
30911783|NCT01709578|58946879|FG002|Overall Study|Adverse Event|17|||
30816397|NCT03222973|58836352|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
30816398|NCT03222973|58836353|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
30816399|NCT03222973|58836354|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
30816400|NCT03222973|58836355|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
30816401|NCT03222973|58836352|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
30911784|NCT01709578|58946877|FG000|Overall Study|Lack of Efficacy|5|||
30911785|NCT01709578|58946878|FG001|Overall Study|Lack of Efficacy|4|||
30911786|NCT01709578|58946879|FG002|Overall Study|Lack of Efficacy|2|||
30911787|NCT01709578|58946877|FG000|Overall Study|Poor compliance to protocol|1|||
30816402|NCT03222973|58836353|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
30816403|NCT03222973|58836354|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
30816404|NCT03222973|58836355|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
30816405|NCT03222973|58836352|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
30816406|NCT03222973|58836353|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
30816407|NCT03222973|58836354|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
30816408|NCT03222973|58836355|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
30816409|NCT03222973|58836352|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
30816410|NCT03222973|58836353|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
30816411|NCT03222973|58836354|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
30816412|NCT03222973|58836355|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
30816413|NCT03222973|58836352|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
30816414|NCT03222973|58836353|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
30816415|NCT03222973|58836354|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
30816416|NCT03222973|58836355|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
30816417|NCT03222973|58836352|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
30816418|NCT03222973|58836353|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
30816419|NCT03222973|58836354|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
30816420|NCT03222973|58836355|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
30816421|NCT03222973|58836352|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
30816422|NCT03222973|58836353|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
30816423|NCT03222973|58836354|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
30816424|NCT03222973|58836355|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
30816425|NCT01144416|58836367|FG000|Intervention Period|Adverse Event|5|||
30816426|NCT01144416|58836368|FG001|Intervention Period|Adverse Event|6|||
30816427|NCT01144416|58836367|FG000|Intervention Period|Insufficient ovarian response|11|||
30816428|NCT01144416|58836368|FG001|Intervention Period|Insufficient ovarian response|17|||
30816429|NCT01144416|58836367|FG000|Intervention Period|Risk of OHSS|0|||
30816430|NCT01144416|58836368|FG001|Intervention Period|Risk of OHSS|1|||
30816431|NCT01144416|58836367|FG000|Intervention Period|Too high ovarian response|4|||
30816432|NCT01144416|58836368|FG001|Intervention Period|Too high ovarian response|2|||
30816433|NCT01144416|58836367|FG000|Intervention Period|No/too few/bad oocytes|7|||
30816434|NCT01144416|58836368|FG001|Intervention Period|No/too few/bad oocytes|5|||
30816435|NCT01144416|58836367|FG000|Intervention Period|No or abnormal fertilization|25|||
30816436|NCT01144416|58836368|FG001|Intervention Period|No or abnormal fertilization|10|||
30816437|NCT01144416|58836367|FG000|Intervention Period|No/too few/bad quality embryos|3|||
30816438|NCT01144416|58836368|FG001|Intervention Period|No/too few/bad quality embryos|3|||
30816439|NCT01144416|58836367|FG000|Intervention Period|Other|7|||
30816440|NCT01144416|58836368|FG001|Intervention Period|Other|5|||
30816441|NCT00335777|58836378|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
30816442|NCT00335777|58836378|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
30911788|NCT01709578|58946878|FG001|Overall Study|Poor compliance to protocol|2|||
30911789|NCT01709578|58946879|FG002|Overall Study|Poor compliance to protocol|1|||
30751370|NCT00121641|58761111|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
30751371|NCT00121641|58761112|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
30751372|NCT00121641|58761113|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
30751373|NCT00121641|58761109|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
30751374|NCT00121641|58761110|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
30751375|NCT00121641|58761111|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
30751376|NCT00121641|58761112|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
30751377|NCT00121641|58761113|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
30751378|NCT00121641|58761109|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
30751379|NCT00121641|58761110|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
30751380|NCT00121641|58761111|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
30751381|NCT00121641|58761112|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
30751382|NCT00121641|58761113|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
30816443|NCT00335777|58836378|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
30816444|NCT00335777|58836378|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
30816445|NCT00335777|58836378|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
30911790|NCT01709578|58946877|FG000|Overall Study|Other, not related to safety or efficacy|2|||
30911791|NCT01709578|58946878|FG001|Overall Study|Other, not related to safety or efficacy|7|||
30911792|NCT01709578|58946879|FG002|Overall Study|Other, not related to safety or efficacy|5|||
30911793|NCT02132767|58946889|FG000|Overall Study|Death|3|||
30911794|NCT02132767|58946890|FG001|Overall Study|Death|2|||
30911795|NCT02132767|58946889|FG000|Overall Study|Withdrawal by Subject|10|||
30911796|NCT02132767|58946890|FG001|Overall Study|Withdrawal by Subject|9|||
30911797|NCT02132767|58946889|FG000|Overall Study|Lost to Follow-up|4|||
30911798|NCT02132767|58946890|FG001|Overall Study|Lost to Follow-up|4|||
30911799|NCT02153905|58946898|FG000|Overall Study|Death|1|||
30911800|NCT02153905|58946899|FG001|Overall Study|Death|0|||
30911801|NCT02153827|58946907|FG000|Overall Study|Lost to Follow-up|3|||
30911802|NCT02153827|58946908|FG001|Overall Study|Lost to Follow-up|9|||
30911803|NCT02153359|58946914|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
30911804|NCT02153359|58946915|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
30911805|NCT01691014|58946928|FG000|Overall Study|Premature Termination|1|||
30911806|NCT01691014|58946929|FG001|Overall Study|Premature Termination|6|||
30911807|NCT01691014|58946930|FG002|Overall Study|Premature Termination|0|||
30911808|NCT01691014|58946931|FG003|Overall Study|Premature Termination|3|||
30911809|NCT01691014|58946928|FG000|Overall Study|Other|0|||
30911810|NCT01691014|58946929|FG001|Overall Study|Other|0|||
30816446|NCT01140048|58836383|FG000|Overall Study|Physician Decision|1|||
30911811|NCT01691014|58946930|FG002|Overall Study|Other|2|||
30911812|NCT01691014|58946931|FG003|Overall Study|Other|0|||
30911813|NCT01691014|58946928|FG000|Overall Study|Withdrawal by Subject|0|||
30911814|NCT01691014|58946929|FG001|Overall Study|Withdrawal by Subject|1|||
30911815|NCT01691014|58946930|FG002|Overall Study|Withdrawal by Subject|1|||
30911816|NCT01691014|58946931|FG003|Overall Study|Withdrawal by Subject|1|||
30911817|NCT01691014|58946928|FG000|Overall Study|Adverse Event|0|||
30911818|NCT01691014|58946929|FG001|Overall Study|Adverse Event|5|||
30911819|NCT01691014|58946930|FG002|Overall Study|Adverse Event|1|||
30911820|NCT01691014|58946931|FG003|Overall Study|Adverse Event|1|||
30911821|NCT01691014|58946928|FG000|Overall Study|Lack of Efficacy|2|||
30911822|NCT01691014|58946929|FG001|Overall Study|Lack of Efficacy|3|||
30911823|NCT01691014|58946930|FG002|Overall Study|Lack of Efficacy|7|||
30911824|NCT01691014|58946931|FG003|Overall Study|Lack of Efficacy|0|||
30911825|NCT02245412|58946944|FG000|Treatment Period|Death|1|||
30911826|NCT02245412|58946945|FG001|Treatment Period|Death|1|||
30911827|NCT02245412|58946946|FG002|Treatment Period|Death|0|||
30911828|NCT02245412|58946944|FG000|Treatment Period|Physician Decision|1|||
30911829|NCT02245412|58946945|FG001|Treatment Period|Physician Decision|1|||
30911830|NCT02245412|58946946|FG002|Treatment Period|Physician Decision|0|||
30911831|NCT02245412|58946944|FG000|Treatment Period|Withdrawal by Subject|2|||
30911832|NCT02245412|58946945|FG001|Treatment Period|Withdrawal by Subject|1|||
30911833|NCT02245412|58946946|FG002|Treatment Period|Withdrawal by Subject|0|||
30911834|NCT02245412|58946944|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
30751383|NCT00121641|58761109|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
30751384|NCT00121641|58761110|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
30751385|NCT00121641|58761111|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
30751386|NCT00121641|58761112|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
30751387|NCT00121641|58761113|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
30751388|NCT00121641|58761109|FG000|48-month Short Term + Long Term Period|Death|0|||
30911835|NCT02245412|58946945|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
30911836|NCT02245412|58946946|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
30911837|NCT02245412|58946944|FG000|Follow-Up Period|Death|4|||
30911838|NCT02245412|58946945|FG001|Follow-Up Period|Death|2|||
30751389|NCT00121641|58761110|FG001|48-month Short Term + Long Term Period|Death|0|||
30751390|NCT00121641|58761111|FG002|48-month Short Term + Long Term Period|Death|0|||
30751391|NCT00121641|58761112|FG003|48-month Short Term + Long Term Period|Death|1|||
30751392|NCT00121641|58761113|FG004|48-month Short Term + Long Term Period|Death|0|||
30816447|NCT01140048|58836383|FG000|Overall Study|Withdrawal by Subject|13|||
30816448|NCT01140048|58836383|FG000|Overall Study|Lost to Follow-up|31|||
30816449|NCT02889809|58836389|FG000|Overall Study|Withdrawal by Subject|30|||
30911839|NCT02245412|58946946|FG002|Follow-Up Period|Death|1|||
30911840|NCT02245412|58946944|FG000|Follow-Up Period|Physician Decision|1|||
30911841|NCT02245412|58946945|FG001|Follow-Up Period|Physician Decision|0|||
30911842|NCT02245412|58946946|FG002|Follow-Up Period|Physician Decision|0|||
30911843|NCT02245412|58946944|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
30911844|NCT02245412|58946945|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
30911845|NCT02245412|58946946|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
30911846|NCT02244944|58946954|FG000|Overall Study|Withdrawal by Subject|1|||
30911847|NCT02244944|58946954|FG000|Overall Study|Study Terminated|1|||
30911848|NCT01689532|58946960|FG000|Overall Study|Adverse Event|9|||
30911849|NCT01689532|58946961|FG001|Overall Study|Adverse Event|5|||
30911850|NCT01689532|58946960|FG000|Overall Study|Lack of Efficacy|2|||
30911851|NCT01689532|58946961|FG001|Overall Study|Lack of Efficacy|2|||
30911852|NCT01689532|58946960|FG000|Overall Study|Withdrawal by Subject|1|||
30911853|NCT01689532|58946961|FG001|Overall Study|Withdrawal by Subject|2|||
30911854|NCT01689532|58946960|FG000|Overall Study|Physician Decision|2|||
30911855|NCT01689532|58946961|FG001|Overall Study|Physician Decision|0|||
30911856|NCT01924689|58946973|FG000|Overall Study|Death|0|||
30911857|NCT01924689|58946974|FG001|Overall Study|Death|1|||
30911858|NCT01924689|58946975|FG002|Overall Study|Death|0|||
30911859|NCT01924689|58946976|FG003|Overall Study|Death|1|||
30911860|NCT01924689|58946977|FG004|Overall Study|Death|0|||
30911861|NCT01924689|58946978|FG005|Overall Study|Death|0|||
30911862|NCT01924689|58946973|FG000|Overall Study|Disease progression|0|||
30911863|NCT01924689|58946974|FG001|Overall Study|Disease progression|0|||
30911864|NCT01924689|58946975|FG002|Overall Study|Disease progression|2|||
30911865|NCT01924689|58946976|FG003|Overall Study|Disease progression|0|||
30911866|NCT01924689|58946977|FG004|Overall Study|Disease progression|3|||
30911867|NCT01924689|58946978|FG005|Overall Study|Disease progression|2|||
30911868|NCT01924689|58946973|FG000|Overall Study|New therapy or study|3|||
30911869|NCT01924689|58946974|FG001|Overall Study|New therapy or study|2|||
30911870|NCT01924689|58946975|FG002|Overall Study|New therapy or study|1|||
30911871|NCT01924689|58946976|FG003|Overall Study|New therapy or study|4|||
30911872|NCT01924689|58946977|FG004|Overall Study|New therapy or study|2|||
30911873|NCT01924689|58946978|FG005|Overall Study|New therapy or study|0|||
30911874|NCT01924689|58946973|FG000|Overall Study|Withdrawal of consent|0|||
30911875|NCT01924689|58946974|FG001|Overall Study|Withdrawal of consent|0|||
30911876|NCT01924689|58946975|FG002|Overall Study|Withdrawal of consent|1|||
30911877|NCT01924689|58946976|FG003|Overall Study|Withdrawal of consent|1|||
30911878|NCT01924689|58946977|FG004|Overall Study|Withdrawal of consent|0|||
30911879|NCT01924689|58946978|FG005|Overall Study|Withdrawal of consent|0|||
30911880|NCT01924689|58946973|FG000|Overall Study|Other|0|||
30911881|NCT01924689|58946974|FG001|Overall Study|Other|0|||
30911882|NCT01924689|58946975|FG002|Overall Study|Other|0|||
30911883|NCT01924689|58946976|FG003|Overall Study|Other|0|||
30911884|NCT01924689|58946977|FG004|Overall Study|Other|1|||
30911885|NCT01924689|58946978|FG005|Overall Study|Other|0|||
30911886|NCT01591330|58946996|FG000|Period 1|Adverse Event|1|||
30911887|NCT01591330|58946997|FG001|Period 1|Adverse Event|0|||
30911888|NCT01591330|58946998|FG002|Period 1|Adverse Event|0|||
30911889|NCT01591330|58946999|FG003|Period 1|Adverse Event|0|||
30911890|NCT01591330|58946996|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
30911891|NCT01591330|58946997|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
30911892|NCT01591330|58946998|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
30911893|NCT01591330|58946999|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
30911894|NCT01591330|58946996|FG000|Period 2|Adverse Event|1|||
30911895|NCT01591330|58946997|FG001|Period 2|Adverse Event|0|||
30816450|NCT02889809|58836390|FG001|Overall Study|Withdrawal by Subject|21|||
30816451|NCT02889809|58836389|FG000|Overall Study|Lost to Follow-up|1|||
30816452|NCT02889809|58836390|FG001|Overall Study|Lost to Follow-up|1|||
30816453|NCT02889809|58836389|FG000|Overall Study|Site Closed|12|||
30816454|NCT02889809|58836390|FG001|Overall Study|Site Closed|11|||
30911896|NCT01591330|58946998|FG002|Period 2|Adverse Event|0|||
30911897|NCT01591330|58946999|FG003|Period 2|Adverse Event|0|||
30911898|NCT01591096|58947009|FG000|Overall Study|Adverse Event|1|||
30911899|NCT01953003|58947015|FG000|Overall Study|Not treated|0|||
30911900|NCT01953003|58947016|FG001|Overall Study|Not treated|1|||
30911901|NCT01953003|58947015|FG000|Overall Study|Progressive disease|35|||
30816455|NCT00972738|58836403|FG000|Overall Study|Adverse Event|7|||
30816456|NCT00972738|58836404|FG001|Overall Study|Adverse Event|1|||
30911902|NCT01953003|58947016|FG001|Overall Study|Progressive disease|45|||
30911903|NCT01953003|58947015|FG000|Overall Study|Related Adverse events|7|||
30911904|NCT01953003|58947016|FG001|Overall Study|Related Adverse events|2|||
30911905|NCT01953003|58947015|FG000|Overall Study|Non-related adverse events|0|||
30911906|NCT01953003|58947016|FG001|Overall Study|Non-related adverse events|2|||
30911907|NCT01953003|58947015|FG000|Overall Study|Protocol Violation|0|||
30911908|NCT01953003|58947016|FG001|Overall Study|Protocol Violation|1|||
30816457|NCT00972738|58836405|FG002|Overall Study|Adverse Event|8|||
30816458|NCT00972738|58836403|FG000|Overall Study|Protocol Violation|2|||
30816459|NCT00972738|58836404|FG001|Overall Study|Protocol Violation|1|||
30816460|NCT00972738|58836405|FG002|Overall Study|Protocol Violation|3|||
30816461|NCT00972738|58836403|FG000|Overall Study|Lost to Follow-up|1|||
30816462|NCT00972738|58836404|FG001|Overall Study|Lost to Follow-up|0|||
30816463|NCT00972738|58836405|FG002|Overall Study|Lost to Follow-up|1|||
30816464|NCT00972738|58836403|FG000|Overall Study|Lack of Efficacy|5|||
30816465|NCT00972738|58836404|FG001|Overall Study|Lack of Efficacy|1|||
30816466|NCT00972738|58836405|FG002|Overall Study|Lack of Efficacy|11|||
30816467|NCT00972738|58836403|FG000|Overall Study|Withdrawal by Subject|5|||
30816468|NCT00972738|58836404|FG001|Overall Study|Withdrawal by Subject|1|||
30816469|NCT00972738|58836405|FG002|Overall Study|Withdrawal by Subject|4|||
30816470|NCT00972738|58836403|FG000|Overall Study|Moved|0|||
30816471|NCT00972738|58836404|FG001|Overall Study|Moved|0|||
30816472|NCT00972738|58836405|FG002|Overall Study|Moved|1|||
30816473|NCT00972738|58836403|FG000|Overall Study|Other|1|||
30816474|NCT00972738|58836404|FG001|Overall Study|Other|2|||
30816475|NCT00972738|58836405|FG002|Overall Study|Other|1|||
30816476|NCT03243305|58836413|FG000|Overall Study|Lost to Follow-up|250|||
30816477|NCT03243305|58836413|FG000|Overall Study|Withdrawal by Subject|170|||
30816478|NCT03243305|58836413|FG000|Overall Study|Pregnancy|104|||
30816479|NCT03243305|58836413|FG000|Overall Study|Non-Compliance with Study Drug|38|||
30816480|NCT03243305|58836413|FG000|Overall Study|Adverse Event|23|||
30816481|NCT03243305|58836413|FG000|Overall Study|No sexually active|26|||
30816482|NCT03243305|58836413|FG000|Overall Study|Physician Decision|22|||
30816483|NCT03243305|58836413|FG000|Overall Study|Protocol Violation|22|||
30816484|NCT03243305|58836413|FG000|Overall Study|Study method no longer primary method|12|||
30816485|NCT03243305|58836413|FG000|Overall Study|Study Terminated by Sponsor|1|||
30816486|NCT03243305|58836413|FG000|Overall Study|Early terminations|267|||
30816487|NCT03222583|58836419|FG000|Overall Study|Withdrawal by Subject|3|||
30816488|NCT03222583|58836420|FG001|Overall Study|Withdrawal by Subject|3|||
30816489|NCT03222583|58836419|FG000|Overall Study|Lost to Follow-up|1|||
30816490|NCT03222583|58836420|FG001|Overall Study|Lost to Follow-up|0|||
30816491|NCT03222583|58836419|FG000|Overall Study|Other|1|||
30816492|NCT03222583|58836420|FG001|Overall Study|Other|3|||
30816493|NCT03295721|58836429|FG000|Overall Study|Adverse Event|1|||
30816494|NCT03295721|58836430|FG001|Overall Study|Adverse Event|0|||
30816495|NCT03295721|58836431|FG002|Overall Study|Adverse Event|0|||
30816496|NCT03295721|58836429|FG000|Overall Study|Lost to Follow-up|1|||
30816497|NCT03295721|58836430|FG001|Overall Study|Lost to Follow-up|1|||
30816498|NCT03295721|58836431|FG002|Overall Study|Lost to Follow-up|1|||
30911909|NCT01953003|58947015|FG000|Overall Study|Withdrawal by Subject|14|||
30911910|NCT01953003|58947016|FG001|Overall Study|Withdrawal by Subject|4|||
30911911|NCT01952691|58947022|FG000|Overall Study|Lost to Follow-up|2|||
30911912|NCT01709500|58947028|FG000|Overall Study|Randomized but not treated|0|||
30911913|NCT01709500|58947029|FG001|Overall Study|Randomized but not treated|1|||
30911914|NCT01709500|58947028|FG000|Overall Study|Adverse Event|5|||
30911915|NCT01709500|58947029|FG001|Overall Study|Adverse Event|1|||
30911916|NCT01709500|58947028|FG000|Overall Study|Poor compliance to protocol|2|||
30911917|NCT01709500|58947029|FG001|Overall Study|Poor compliance to protocol|1|||
30816499|NCT03295721|58836429|FG000|Overall Study|Withdrawal by Subject|1|||
30816500|NCT03295721|58836430|FG001|Overall Study|Withdrawal by Subject|0|||
30816501|NCT03295721|58836431|FG002|Overall Study|Withdrawal by Subject|1|||
30816502|NCT03295721|58836429|FG000|Overall Study|Death|0|||
30816503|NCT03295721|58836430|FG001|Overall Study|Death|0|||
30816504|NCT03295721|58836431|FG002|Overall Study|Death|1|||
30816505|NCT00803790|58836442|FG000|Period 1|Adverse Event|0|||
30816506|NCT00803790|58836443|FG001|Period 1|Adverse Event|1|||
30816507|NCT00803790|58836444|FG002|Period 1|Adverse Event|0|||
30911918|NCT01709500|58947028|FG000|Overall Study|Other|3|||
30911919|NCT01709500|58947029|FG001|Overall Study|Other|1|||
30911920|NCT01709500|58947028|FG000|Overall Study|Related to IMP administration|1|||
30911921|NCT01709500|58947029|FG001|Overall Study|Related to IMP administration|0|||
30911922|NCT01709500|58947028|FG000|Overall Study|Treatment ongoing|156|||
30911923|NCT01709500|58947029|FG001|Overall Study|Treatment ongoing|78|||
30911924|NCT01599806|58947037|FG000|Overall Study|Lost to Follow-up|20|||
30816508|NCT00803790|58836445|FG003|Period 1|Adverse Event|0|||
30816509|NCT00803790|58836442|FG000|Period 1|Lost to Follow-up|1|||
30911925|NCT01599806|58947038|FG001|Overall Study|Lost to Follow-up|20|||
30911926|NCT01599806|58947037|FG000|Overall Study|Withdrawal by Subject|12|||
30816510|NCT00803790|58836443|FG001|Period 1|Lost to Follow-up|2|||
30816511|NCT00803790|58836444|FG002|Period 1|Lost to Follow-up|0|||
30816512|NCT00803790|58836445|FG003|Period 1|Lost to Follow-up|0|||
30816513|NCT00803790|58836442|FG000|Period 1|Withdrawal by Subject|8|||
30816514|NCT00803790|58836443|FG001|Period 1|Withdrawal by Subject|6|||
30816515|NCT00803790|58836444|FG002|Period 1|Withdrawal by Subject|0|||
30816516|NCT00803790|58836445|FG003|Period 1|Withdrawal by Subject|0|||
30816517|NCT00803790|58836442|FG000|Period 1|positive drug screen or personal reasons|0|||
30816518|NCT00803790|58836443|FG001|Period 1|positive drug screen or personal reasons|3|||
30816519|NCT00803790|58836444|FG002|Period 1|positive drug screen or personal reasons|0|||
30816520|NCT00803790|58836445|FG003|Period 1|positive drug screen or personal reasons|4|||
30816521|NCT00803790|58836442|FG000|Period 1|Protocol Violation|0|||
30816522|NCT00803790|58836443|FG001|Period 1|Protocol Violation|0|||
30816523|NCT00803790|58836444|FG002|Period 1|Protocol Violation|1|||
30751393|NCT00121641|58761109|FG000|48-month Short Term + Long Term Period|Missing|0|||
30751394|NCT00121641|58761110|FG001|48-month Short Term + Long Term Period|Missing|0|||
30751395|NCT00121641|58761111|FG002|48-month Short Term + Long Term Period|Missing|1|||
30751396|NCT00121641|58761112|FG003|48-month Short Term + Long Term Period|Missing|0|||
30751397|NCT00121641|58761113|FG004|48-month Short Term + Long Term Period|Missing|0|||
30751398|NCT00121641|58761109|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
30816524|NCT00803790|58836445|FG003|Period 1|Protocol Violation|0|||
30816525|NCT00803790|58836442|FG000|Period 2|Adverse Event|0|||
30816526|NCT00803790|58836443|FG001|Period 2|Adverse Event|0|||
30816527|NCT00803790|58836444|FG002|Period 2|Adverse Event|1|||
30816528|NCT00803790|58836445|FG003|Period 2|Adverse Event|1|||
30816529|NCT00803790|58836442|FG000|Period 2|Withdrawal by Subject|1|||
30816530|NCT00803790|58836443|FG001|Period 2|Withdrawal by Subject|0|||
30816531|NCT00803790|58836444|FG002|Period 2|Withdrawal by Subject|0|||
30751399|NCT00121641|58761110|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
30751400|NCT00121641|58761111|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
30751401|NCT00121641|58761112|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
30751402|NCT00121641|58761113|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
30816532|NCT00803790|58836445|FG003|Period 2|Withdrawal by Subject|0|||
30816533|NCT00803790|58836442|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
30751403|NCT00425555|58761129|FG000|Overall Study|Withdrawal by Subject|11|||
30816534|NCT00803790|58836443|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
30816535|NCT00803790|58836444|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
30816536|NCT00803790|58836445|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
30816537|NCT00250458|58836493|FG000|Overall Study|Lost to Follow-up|4|||
30911927|NCT01599806|58947038|FG001|Overall Study|Withdrawal by Subject|12|||
30911928|NCT01599806|58947037|FG000|Overall Study|Other Eligibility criteria|11|||
30911929|NCT01599806|58947038|FG001|Overall Study|Other Eligibility criteria|9|||
30911930|NCT01599325|58947044|FG000|Primary Parent Phase|Adverse Event|5|||
30911931|NCT01599325|58947044|FG000|Primary Parent Phase|Disease Progression|7|||
30911932|NCT01599325|58947044|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
30911933|NCT01599325|58947044|FG000|Primary Parent Phase|Death|13|||
30911934|NCT01599325|58947044|FG000|Primary Parent Phase|Protocol Violation|1|||
30911935|NCT01599325|58947044|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
30911936|NCT01599325|58947044|FG000|Primary Parent Phase|Other|2|||
30911937|NCT01599325|58947044|FG000|Extension Phase|Study Closure|1|||
30911938|NCT01599325|58947044|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
30911939|NCT01599325|58947044|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
30911940|NCT01599325|58947044|FG000|Extension Phase|Disease Progression|1|||
30911941|NCT01599325|58947044|FG000|Extension Phase|Withdrawal by Subject|8|||
30911942|NCT01924299|58947051|FG000|Period 2|Withdrawal by Subject|1|||
30911943|NCT01924299|58947052|FG001|Period 2|Withdrawal by Subject|0|||
30911944|NCT01924299|58947051|FG000|Period 2|Adverse Event|0|||
30911945|NCT01924299|58947052|FG001|Period 2|Adverse Event|1|||
30816538|NCT00250458|58836494|FG001|Overall Study|Lost to Follow-up|2|||
30816539|NCT00250458|58836493|FG000|Overall Study|Protocol Violation|0|||
30816540|NCT00250458|58836494|FG001|Overall Study|Protocol Violation|1|||
30816541|NCT00250458|58836493|FG000|Overall Study|Withdrawal by Subject|4|||
30816542|NCT00250458|58836494|FG001|Overall Study|Withdrawal by Subject|2|||
30816543|NCT00250458|58836493|FG000|Overall Study|Lack of Migraine Attack|20|||
30816544|NCT00250458|58836494|FG001|Overall Study|Lack of Migraine Attack|9|||
30816545|NCT00250458|58836493|FG000|Overall Study|Qualifying migraine but did not treat|3|||
30816546|NCT00250458|58836494|FG001|Overall Study|Qualifying migraine but did not treat|3|||
30816547|NCT00250458|58836493|FG000|Overall Study|Other|1|||
30816548|NCT00250458|58836494|FG001|Overall Study|Other|0|||
30816549|NCT01667133|58836512|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
30816550|NCT01667133|58836513|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
30816551|NCT01667133|58836514|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
30816552|NCT01667133|58836515|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
30816553|NCT01667133|58836516|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
30816554|NCT01667133|58836517|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
30816555|NCT01667133|58836518|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
30816556|NCT01667133|58836519|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
30816557|NCT01667133|58836520|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
30816558|NCT01667133|58836521|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
30816559|NCT01667133|58836522|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
30816560|NCT01667133|58836523|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
30816561|NCT01667133|58836512|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
30816562|NCT01667133|58836513|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
30816563|NCT01667133|58836514|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
30816564|NCT01667133|58836515|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
30816565|NCT01667133|58836516|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
30816566|NCT01667133|58836517|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
30816567|NCT01667133|58836518|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
30816568|NCT01667133|58836519|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
30816569|NCT01667133|58836520|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
30816570|NCT01667133|58836521|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
30816571|NCT01667133|58836522|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
30816572|NCT01667133|58836523|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
30816573|NCT01667133|58836512|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
30816574|NCT01667133|58836513|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
30816575|NCT01667133|58836514|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
30911946|NCT02182999|58947066|FG000|Overall Study|Adverse Event|4|||
30911947|NCT02182999|58947067|FG001|Overall Study|Adverse Event|3|||
30911948|NCT02182999|58947066|FG000|Overall Study|Physician Decision|1|||
30911949|NCT02182999|58947067|FG001|Overall Study|Physician Decision|0|||
30911950|NCT02243696|58947073|FG000|Overall Study|Death|282|||
30911951|NCT02243696|58947073|FG000|Overall Study|Withdrawal by Subject|79|||
30911952|NCT02243696|58947073|FG000|Overall Study|Lost to Follow-up|57|||
30911953|NCT02243696|58947073|FG000|Overall Study|Subject No Longer has Study System|42|||
30911954|NCT02243696|58947073|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
30911955|NCT02243696|58947073|FG000|Overall Study|Study Terminated for EP PASSION|961|||
30622713|NCT00972777|58634383|FG000|Overall Study|Lost to Follow-up|0|||
30816576|NCT01667133|58836515|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
30816577|NCT01667133|58836516|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
30816578|NCT01667133|58836517|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
30816579|NCT01667133|58836518|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
30816580|NCT01667133|58836519|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
30816581|NCT01667133|58836520|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
30816582|NCT01667133|58836521|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
30816583|NCT01667133|58836522|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
30816584|NCT01667133|58836523|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
30816585|NCT01667133|58836512|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
30816586|NCT01667133|58836513|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
30816587|NCT01667133|58836514|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
30816588|NCT01667133|58836515|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
30816589|NCT01667133|58836516|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
30816590|NCT01667133|58836517|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
30816591|NCT01667133|58836518|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
30816592|NCT01667133|58836519|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
30816593|NCT01667133|58836520|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
30816594|NCT01667133|58836521|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
30816595|NCT01667133|58836522|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
30816596|NCT01667133|58836523|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
30816597|NCT01667133|58836512|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
30816598|NCT01667133|58836513|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
30816599|NCT01667133|58836514|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
30816600|NCT01667133|58836515|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
30816601|NCT01667133|58836516|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
30816602|NCT01667133|58836517|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
30816603|NCT01667133|58836518|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
30816604|NCT01667133|58836519|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
30816605|NCT01667133|58836520|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
30911956|NCT01598311|58947079|FG000|Overall Study|Physician Decision|4|||
30911957|NCT01598311|58947080|FG001|Overall Study|Physician Decision|5|||
30911958|NCT01598311|58947079|FG000|Overall Study|Adverse Event|9|||
30911959|NCT01598311|58947080|FG001|Overall Study|Adverse Event|13|||
30911960|NCT01598311|58947079|FG000|Overall Study|Lost to Follow-up|7|||
30911961|NCT01598311|58947080|FG001|Overall Study|Lost to Follow-up|12|||
30911962|NCT01598311|58947079|FG000|Overall Study|Withdrawal by Subject|9|||
30911963|NCT01598311|58947080|FG001|Overall Study|Withdrawal by Subject|13|||
30911964|NCT01598311|58947079|FG000|Overall Study|No reason provided.|0|||
30911965|NCT01598311|58947080|FG001|Overall Study|No reason provided.|5|||
30911966|NCT01598311|58947079|FG000|Overall Study|Randomized but never treated|8|||
30816606|NCT01667133|58836521|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
30816607|NCT01667133|58836522|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
30816608|NCT01667133|58836523|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
30816609|NCT01667133|58836512|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
30816610|NCT01667133|58836513|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
30816611|NCT01667133|58836514|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
30816612|NCT01667133|58836515|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
30911967|NCT01598311|58947080|FG001|Overall Study|Randomized but never treated|5|||
30911968|NCT01598311|58947079|FG000|Overall Study|Treated but no confirmed CDAD|9|||
30911969|NCT01598311|58947080|FG001|Overall Study|Treated but no confirmed CDAD|8|||
30911970|NCT01598311|58947079|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
30622714|NCT00972777|58634384|FG001|Overall Study|Lost to Follow-up|4|||
30816613|NCT01667133|58836516|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
30816614|NCT01667133|58836517|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
30816615|NCT01667133|58836518|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
30911971|NCT01598311|58947080|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
30911972|NCT02182843|58947086|FG000|Overall Study|Withdrawal by Subject|7|||
30911973|NCT02182843|58947086|FG000|Overall Study|Lost to Follow-up|2|||
30911974|NCT02182843|58947086|FG000|Overall Study|Adverse Event|1|||
30911975|NCT02208050|58947092|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
30816616|NCT01667133|58836519|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
30816617|NCT01667133|58836520|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
30816618|NCT01667133|58836521|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
30816619|NCT01667133|58836522|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
30816620|NCT01667133|58836523|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
30816621|NCT01667133|58836512|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
30816622|NCT01667133|58836513|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
30816623|NCT01667133|58836514|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
30816624|NCT01667133|58836515|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
30816625|NCT01667133|58836516|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
30816626|NCT01667133|58836517|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
30816627|NCT01667133|58836518|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
30816628|NCT01667133|58836519|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
30816629|NCT01667133|58836520|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
30816630|NCT01667133|58836521|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
30816631|NCT01667133|58836522|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
30816632|NCT01667133|58836523|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
30816633|NCT01667133|58836512|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
30816634|NCT01667133|58836513|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
30816635|NCT01667133|58836514|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
30816636|NCT01667133|58836515|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
30816637|NCT01667133|58836516|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
30816638|NCT01667133|58836517|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
30816639|NCT01667133|58836518|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
30816640|NCT01667133|58836519|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
30816641|NCT01667133|58836520|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
30816642|NCT01667133|58836521|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
30816643|NCT01667133|58836522|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
30816644|NCT01667133|58836523|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
30816645|NCT01667133|58836512|FG000|Phase 2: Dose-expansion|Death|0|||
30911976|NCT02208050|58947093|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
30911977|NCT02978222|58947115|FG000|Overall Study|Withdrawal by Subject|2|||
30911978|NCT02978222|58947116|FG001|Overall Study|Withdrawal by Subject|2|||
30622715|NCT00972777|58634383|FG000|Overall Study|Withdrawal by Subject|4|||
30751404|NCT00425555|58761130|FG001|Overall Study|Withdrawal by Subject|8|||
30751405|NCT00425555|58761129|FG000|Overall Study|Lost to Follow-up|0|||
30751406|NCT00425555|58761130|FG001|Overall Study|Lost to Follow-up|1|||
30751407|NCT00425555|58761129|FG000|Overall Study|Administrative problems|3|||
30751408|NCT00425555|58761130|FG001|Overall Study|Administrative problems|0|||
30751409|NCT00425555|58761129|FG000|Overall Study|Death|1|||
30751410|NCT00425555|58761130|FG001|Overall Study|Death|2|||
30751411|NCT00425555|58761129|FG000|Overall Study|New cancer therapy|2|||
30751412|NCT00425555|58761130|FG001|Overall Study|New cancer therapy|1|||
30816646|NCT01667133|58836513|FG001|Phase 2: Dose-expansion|Death|0|||
30816647|NCT01667133|58836514|FG002|Phase 2: Dose-expansion|Death|0|||
30816648|NCT01667133|58836515|FG003|Phase 2: Dose-expansion|Death|0|||
30816649|NCT01667133|58836516|FG004|Phase 2: Dose-expansion|Death|0|||
30911979|NCT02978222|58947115|FG000|Overall Study|Physician Decision|2|||
30751413|NCT00425555|58761129|FG000|Overall Study|Disease progression|36|||
30816650|NCT01667133|58836517|FG005|Phase 2: Dose-expansion|Death|0|||
30816651|NCT01667133|58836518|FG006|Phase 2: Dose-expansion|Death|0|||
30816652|NCT01667133|58836519|FG007|Phase 2: Dose-expansion|Death|0|||
30816653|NCT01667133|58836520|FG008|Phase 2: Dose-expansion|Death|0|||
30816654|NCT01667133|58836521|FG009|Phase 2: Dose-expansion|Death|1|||
30816655|NCT01667133|58836522|FG010|Phase 2: Dose-expansion|Death|0|||
30816656|NCT01667133|58836523|FG011|Phase 2: Dose-expansion|Death|0|||
30816657|NCT01667133|58836512|FG000|Phase 2: Dose-expansion|Other|0|||
30911980|NCT02978222|58947116|FG001|Overall Study|Physician Decision|0|||
30751414|NCT00425555|58761130|FG001|Overall Study|Disease progression|33|||
30751415|NCT00425555|58761129|FG000|Overall Study|Adverse Event|25|||
30751416|NCT00425555|58761130|FG001|Overall Study|Adverse Event|15|||
30751417|NCT00425555|58761129|FG000|Overall Study|Protocol Violation|1|||
30751418|NCT00425555|58761130|FG001|Overall Study|Protocol Violation|0|||
30751419|NCT00424775|58761139|FG000|Overall Study|Adverse Event|2|||
30751420|NCT00424775|58761140|FG001|Overall Study|Adverse Event|0|||
30751421|NCT00424775|58761139|FG000|Overall Study|Lack of Efficacy|1|||
30751422|NCT00424775|58761140|FG001|Overall Study|Lack of Efficacy|0|||
30751423|NCT00121485|58761146|FG000|Overall Study|Not implanted|1|||
30751424|NCT00121485|58761147|FG001|Overall Study|Not implanted|5|||
30751425|NCT00121485|58761146|FG000|Overall Study|Crossover|0|||
30751426|NCT00121485|58761147|FG001|Overall Study|Crossover|2|||
30751427|NCT01763866|58761178|FG000|Overall Study|Withdrawal by Subject|2|||
30751428|NCT01763866|58761179|FG001|Overall Study|Withdrawal by Subject|1|||
30751429|NCT01763866|58761180|FG002|Overall Study|Withdrawal by Subject|4|||
30751430|NCT01763866|58761181|FG003|Overall Study|Withdrawal by Subject|0|||
30751431|NCT01763866|58761182|FG004|Overall Study|Withdrawal by Subject|0|||
30751432|NCT01763866|58761183|FG005|Overall Study|Withdrawal by Subject|3|||
30751433|NCT01763866|58761184|FG006|Overall Study|Withdrawal by Subject|4|||
30751434|NCT01763866|58761185|FG007|Overall Study|Withdrawal by Subject|0|||
30751435|NCT01763866|58761186|FG008|Overall Study|Withdrawal by Subject|1|||
30751436|NCT01763866|58761187|FG009|Overall Study|Withdrawal by Subject|1|||
30751437|NCT01763866|58761188|FG010|Overall Study|Withdrawal by Subject|2|||
30751438|NCT01763866|58761189|FG011|Overall Study|Withdrawal by Subject|2|||
30751439|NCT01763866|58761190|FG012|Overall Study|Withdrawal by Subject|2|||
30751440|NCT01763866|58761191|FG013|Overall Study|Withdrawal by Subject|0|||
30751441|NCT01763866|58761192|FG014|Overall Study|Withdrawal by Subject|6|||
30751442|NCT01763866|58761193|FG015|Overall Study|Withdrawal by Subject|3|||
30751443|NCT01763866|58761194|FG016|Overall Study|Withdrawal by Subject|0|||
30751444|NCT01763866|58761195|FG017|Overall Study|Withdrawal by Subject|1|||
30751445|NCT01763866|58761196|FG018|Overall Study|Withdrawal by Subject|1|||
30751446|NCT01763866|58761197|FG019|Overall Study|Withdrawal by Subject|1|||
30751447|NCT01763866|58761198|FG020|Overall Study|Withdrawal by Subject|2|||
30751448|NCT01763866|58761199|FG021|Overall Study|Withdrawal by Subject|1|||
30751449|NCT01763866|58761200|FG022|Overall Study|Withdrawal by Subject|2|||
30751450|NCT01763866|58761201|FG023|Overall Study|Withdrawal by Subject|1|||
30751451|NCT01763866|58761178|FG000|Overall Study|Decision by sponsor|0|||
30751452|NCT01763866|58761179|FG001|Overall Study|Decision by sponsor|0|||
30751453|NCT01763866|58761180|FG002|Overall Study|Decision by sponsor|1|||
30751454|NCT01763866|58761181|FG003|Overall Study|Decision by sponsor|0|||
30751455|NCT01763866|58761182|FG004|Overall Study|Decision by sponsor|2|||
30751456|NCT01763866|58761183|FG005|Overall Study|Decision by sponsor|0|||
30751457|NCT01763866|58761184|FG006|Overall Study|Decision by sponsor|2|||
30751458|NCT01763866|58761185|FG007|Overall Study|Decision by sponsor|0|||
30751459|NCT01763866|58761186|FG008|Overall Study|Decision by sponsor|2|||
30751460|NCT01763866|58761187|FG009|Overall Study|Decision by sponsor|0|||
30751461|NCT01763866|58761188|FG010|Overall Study|Decision by sponsor|6|||
30751462|NCT01763866|58761189|FG011|Overall Study|Decision by sponsor|0|||
30751463|NCT01763866|58761190|FG012|Overall Study|Decision by sponsor|1|||
30751464|NCT01763866|58761191|FG013|Overall Study|Decision by sponsor|0|||
30751465|NCT01763866|58761192|FG014|Overall Study|Decision by sponsor|5|||
30751466|NCT01763866|58761193|FG015|Overall Study|Decision by sponsor|0|||
30816658|NCT01667133|58836513|FG001|Phase 2: Dose-expansion|Other|0|||
30751467|NCT01763866|58761194|FG016|Overall Study|Decision by sponsor|0|||
30751468|NCT01763866|58761195|FG017|Overall Study|Decision by sponsor|0|||
30751469|NCT01763866|58761196|FG018|Overall Study|Decision by sponsor|4|||
30751470|NCT01763866|58761197|FG019|Overall Study|Decision by sponsor|0|||
30751471|NCT01763866|58761198|FG020|Overall Study|Decision by sponsor|2|||
30751472|NCT01763866|58761199|FG021|Overall Study|Decision by sponsor|0|||
30751473|NCT01763866|58761200|FG022|Overall Study|Decision by sponsor|1|||
30816659|NCT01667133|58836514|FG002|Phase 2: Dose-expansion|Other|0|||
30816660|NCT01667133|58836515|FG003|Phase 2: Dose-expansion|Other|0|||
30816661|NCT01667133|58836516|FG004|Phase 2: Dose-expansion|Other|0|||
30751474|NCT01763866|58761201|FG023|Overall Study|Decision by sponsor|0|||
30751475|NCT01763866|58761178|FG000|Overall Study|Lost to Follow-up|0|||
30751476|NCT01763866|58761179|FG001|Overall Study|Lost to Follow-up|0|||
30751477|NCT01763866|58761180|FG002|Overall Study|Lost to Follow-up|0|||
30751478|NCT01763866|58761181|FG003|Overall Study|Lost to Follow-up|0|||
30816662|NCT01667133|58836517|FG005|Phase 2: Dose-expansion|Other|0|||
30751479|NCT01763866|58761182|FG004|Overall Study|Lost to Follow-up|0|||
30816663|NCT01667133|58836518|FG006|Phase 2: Dose-expansion|Other|0|||
30816664|NCT01667133|58836519|FG007|Phase 2: Dose-expansion|Other|0|||
30816665|NCT01667133|58836520|FG008|Phase 2: Dose-expansion|Other|0|||
30816666|NCT01667133|58836521|FG009|Phase 2: Dose-expansion|Other|0|||
30816667|NCT01667133|58836522|FG010|Phase 2: Dose-expansion|Other|0|||
30816668|NCT01667133|58836523|FG011|Phase 2: Dose-expansion|Other|1|||
30816669|NCT01181778|58836584|FG000|Overall Study|Physician Decision|48|||
30816670|NCT00092118|58836592|FG000|Overall Study|Adverse Event|35|||
30816671|NCT00092118|58836593|FG001|Overall Study|Adverse Event|32|||
30816672|NCT00092118|58836592|FG000|Overall Study|Lack of Efficacy|12|||
30816673|NCT00092118|58836593|FG001|Overall Study|Lack of Efficacy|14|||
30911981|NCT02978222|58947115|FG000|Overall Study|Adverse Event|0|||
30911982|NCT02978222|58947116|FG001|Overall Study|Adverse Event|1|||
30911983|NCT02978222|58947115|FG000|Overall Study|Death|1|||
30911984|NCT02978222|58947116|FG001|Overall Study|Death|0|||
30911985|NCT02978222|58947115|FG000|Overall Study|Disease Progression|32|||
30911986|NCT02978222|58947116|FG001|Overall Study|Disease Progression|32|||
30911987|NCT02978222|58947115|FG000|Overall Study|Early Study Termination|24|||
30911988|NCT02978222|58947116|FG001|Overall Study|Early Study Termination|21|||
30911989|NCT02181673|58947124|FG000|Up to Week 24|Adverse Event|2|||
30911990|NCT02181673|58947125|FG001|Up to Week 24|Adverse Event|0|||
30911991|NCT02181673|58947126|FG002|Up to Week 24|Adverse Event|3|||
30816674|NCT00092118|58836592|FG000|Overall Study|Lost to Follow-up|4|||
30816675|NCT00092118|58836593|FG001|Overall Study|Lost to Follow-up|3|||
30816676|NCT00092118|58836592|FG000|Overall Study|Protocol Violation|23|||
30816677|NCT00092118|58836593|FG001|Overall Study|Protocol Violation|25|||
30816678|NCT00092118|58836592|FG000|Overall Study|Withdrawal by Subject|4|||
30816679|NCT00092118|58836593|FG001|Overall Study|Withdrawal by Subject|10|||
30816680|NCT00092118|58836592|FG000|Overall Study|Other|6|||
30816681|NCT00092118|58836593|FG001|Overall Study|Other|5|||
30911992|NCT02181673|58947124|FG000|Up to Week 24|Death|1|||
30911993|NCT02181673|58947125|FG001|Up to Week 24|Death|0|||
30816682|NCT03261947|58836604|FG000|Overall Study|Death|10|||
30816683|NCT03261947|58836605|FG001|Overall Study|Death|13|||
30911994|NCT02181673|58947126|FG002|Up to Week 24|Death|0|||
30816684|NCT03261947|58836606|FG002|Overall Study|Death|17|||
30816685|NCT03261947|58836607|FG003|Overall Study|Death|12|||
30816686|NCT03261947|58836608|FG004|Overall Study|Death|8|||
30816687|NCT03261947|58836604|FG000|Overall Study|Lost to Follow-up|0|||
30911995|NCT02181673|58947124|FG000|Up to Week 24|Lack of Efficacy|1|||
30816688|NCT03261947|58836605|FG001|Overall Study|Lost to Follow-up|0|||
30816689|NCT03261947|58836606|FG002|Overall Study|Lost to Follow-up|2|||
30816690|NCT03261947|58836607|FG003|Overall Study|Lost to Follow-up|1|||
30816691|NCT03261947|58836608|FG004|Overall Study|Lost to Follow-up|0|||
30816692|NCT03261947|58836604|FG000|Overall Study|Withdrawal by Subject|0|||
30816693|NCT03261947|58836605|FG001|Overall Study|Withdrawal by Subject|0|||
30816694|NCT03261947|58836606|FG002|Overall Study|Withdrawal by Subject|3|||
30816695|NCT03261947|58836607|FG003|Overall Study|Withdrawal by Subject|0|||
30816696|NCT03261947|58836608|FG004|Overall Study|Withdrawal by Subject|1|||
30816697|NCT03261947|58836604|FG000|Overall Study|Site Terminated by Sponsor|0|||
30816698|NCT03261947|58836605|FG001|Overall Study|Site Terminated by Sponsor|0|||
30816699|NCT03261947|58836606|FG002|Overall Study|Site Terminated by Sponsor|4|||
30816700|NCT03261947|58836607|FG003|Overall Study|Site Terminated by Sponsor|7|||
30911996|NCT02181673|58947125|FG001|Up to Week 24|Lack of Efficacy|0|||
30911997|NCT02181673|58947126|FG002|Up to Week 24|Lack of Efficacy|0|||
30911998|NCT02181673|58947124|FG000|Up to Week 24|Lost to Follow-up|1|||
30911999|NCT02181673|58947125|FG001|Up to Week 24|Lost to Follow-up|0|||
30912000|NCT02181673|58947126|FG002|Up to Week 24|Lost to Follow-up|0|||
30912001|NCT02181673|58947124|FG000|Up to Week 24|Physician Decision|0|||
30912002|NCT02181673|58947125|FG001|Up to Week 24|Physician Decision|0|||
30912003|NCT02181673|58947126|FG002|Up to Week 24|Physician Decision|3|||
30912004|NCT02181673|58947124|FG000|Up to Week 24|Withdrawal by Subject|10|||
30912005|NCT02181673|58947125|FG001|Up to Week 24|Withdrawal by Subject|0|||
30912006|NCT02181673|58947126|FG002|Up to Week 24|Withdrawal by Subject|1|||
30912007|NCT02181673|58947124|FG000|Up to Week 24|Other|2|||
30912008|NCT02181673|58947125|FG001|Up to Week 24|Other|0|||
30912009|NCT02181673|58947126|FG002|Up to Week 24|Other|3|||
30912010|NCT02181673|58947124|FG000|Up to Week 24|Randomized not Treated|0|||
30912011|NCT02181673|58947125|FG001|Up to Week 24|Randomized not Treated|0|||
30912012|NCT02181673|58947126|FG002|Up to Week 24|Randomized not Treated|1|||
30912013|NCT02181673|58947124|FG000|Week 24-Week 60|Adverse Event|0|||
30912014|NCT02181673|58947125|FG001|Week 24-Week 60|Adverse Event|4|||
30912015|NCT02181673|58947126|FG002|Week 24-Week 60|Adverse Event|10|||
30912016|NCT02181673|58947124|FG000|Week 24-Week 60|Other|0|||
30912017|NCT02181673|58947125|FG001|Week 24-Week 60|Other|2|||
30912018|NCT02181673|58947126|FG002|Week 24-Week 60|Other|1|||
30912019|NCT02181673|58947124|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
30912020|NCT02181673|58947125|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
30912021|NCT02181673|58947126|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
30912022|NCT02181673|58947124|FG000|Week 24-Week 60|Pregnancy|0|||
30912023|NCT02181673|58947125|FG001|Week 24-Week 60|Pregnancy|0|||
30912024|NCT02181673|58947126|FG002|Week 24-Week 60|Pregnancy|1|||
30912025|NCT02181673|58947124|FG000|Week 24-Week 60|Lack of Efficacy|0|||
30912026|NCT02181673|58947125|FG001|Week 24-Week 60|Lack of Efficacy|0|||
30912027|NCT02181673|58947126|FG002|Week 24-Week 60|Lack of Efficacy|1|||
30912028|NCT02181673|58947124|FG000|Week 24-Week 60|Lost to Follow-up|0|||
30912029|NCT02181673|58947125|FG001|Week 24-Week 60|Lost to Follow-up|0|||
30912030|NCT02181673|58947126|FG002|Week 24-Week 60|Lost to Follow-up|1|||
30912031|NCT02181673|58947124|FG000|Week 24-Week 60|Physician Decision|0|||
30912032|NCT02181673|58947125|FG001|Week 24-Week 60|Physician Decision|0|||
30912033|NCT02181673|58947126|FG002|Week 24-Week 60|Physician Decision|1|||
30912034|NCT02131129|58947135|FG000|Overall Study|Withdrawal by Subject|1|||
30912035|NCT02131129|58947136|FG001|Overall Study|Withdrawal by Subject|0|||
30912036|NCT02152345|58947144|FG000|Overall Study|Case Cancellations|2|||
30912037|NCT02152345|58947145|FG001|Overall Study|Case Cancellations|4|||
30912038|NCT02152345|58947144|FG000|Overall Study|Withdrawal by Subject|2|||
30912039|NCT02152345|58947145|FG001|Overall Study|Withdrawal by Subject|1|||
30912040|NCT02180659|58947153|FG000|Overall Study|Adverse Event|1|||
30912041|NCT02180659|58947154|FG001|Overall Study|Adverse Event|0|||
30912042|NCT02180659|58947153|FG000|Overall Study|Lost to Follow-up|4|||
30912043|NCT02180659|58947154|FG001|Overall Study|Lost to Follow-up|2|||
30912044|NCT02180659|58947153|FG000|Overall Study|Subject incarcerated during conduct|1|||
30912045|NCT02180659|58947154|FG001|Overall Study|Subject incarcerated during conduct|0|||
30912046|NCT02180659|58947153|FG000|Overall Study|Withdrawal by Subject|0|||
30912047|NCT02180659|58947154|FG001|Overall Study|Withdrawal by Subject|2|||
30912048|NCT02180659|58947153|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
30912049|NCT02180659|58947154|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
30912050|NCT02130427|58947160|FG000|Overall Study|Imaging results not interpretable|30|||
30912051|NCT02207816|58947167|FG000|Overall Study|Serious Adverse Event|0|||
30912052|NCT02207816|58947168|FG001|Overall Study|Serious Adverse Event|5|||
30912053|NCT02207816|58947169|FG002|Overall Study|Serious Adverse Event|2|||
30912054|NCT02207816|58947167|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
30816701|NCT03261947|58836608|FG004|Overall Study|Site Terminated by Sponsor|5|||
30816702|NCT03261947|58836604|FG000|Overall Study|Reason not Specified|2|||
30912055|NCT02207816|58947168|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
30912056|NCT02207816|58947169|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
30912057|NCT02207816|58947167|FG000|Overall Study|Withdrawal by Subject|4|||
30912058|NCT02207816|58947168|FG001|Overall Study|Withdrawal by Subject|9|||
30816703|NCT03261947|58836605|FG001|Overall Study|Reason not Specified|0|||
30912059|NCT02207816|58947169|FG002|Overall Study|Withdrawal by Subject|7|||
30912060|NCT02207816|58947167|FG000|Overall Study|Migrated/Moved From Study Area|41|||
30816704|NCT03261947|58836606|FG002|Overall Study|Reason not Specified|4|||
30816705|NCT03261947|58836607|FG003|Overall Study|Reason not Specified|1|||
30816706|NCT03261947|58836608|FG004|Overall Study|Reason not Specified|3|||
30816707|NCT03034044|58836624|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
30816708|NCT03098979|58836643|FG000|Overall Study|Adverse Event|1|||
30816709|NCT03098979|58836644|FG001|Overall Study|Adverse Event|0|||
30816710|NCT03098979|58836645|FG002|Overall Study|Adverse Event|1|||
30816711|NCT03098979|58836646|FG003|Overall Study|Adverse Event|4|||
30816712|NCT03098979|58836647|FG004|Overall Study|Adverse Event|6|||
30816713|NCT03098979|58836648|FG005|Overall Study|Adverse Event|1|||
30816714|NCT03098979|58836643|FG000|Overall Study|Withdrawal by Subject|2|||
30816715|NCT03098979|58836644|FG001|Overall Study|Withdrawal by Subject|1|||
30816716|NCT03098979|58836645|FG002|Overall Study|Withdrawal by Subject|1|||
30816717|NCT03098979|58836646|FG003|Overall Study|Withdrawal by Subject|1|||
30816718|NCT03098979|58836647|FG004|Overall Study|Withdrawal by Subject|2|||
30816719|NCT03098979|58836648|FG005|Overall Study|Withdrawal by Subject|1|||
30816720|NCT03098979|58836643|FG000|Overall Study|Death|1|||
30816721|NCT03098979|58836644|FG001|Overall Study|Death|0|||
30816722|NCT03098979|58836645|FG002|Overall Study|Death|2|||
30816723|NCT03098979|58836646|FG003|Overall Study|Death|0|||
30816724|NCT03098979|58836647|FG004|Overall Study|Death|1|||
30816725|NCT03098979|58836648|FG005|Overall Study|Death|0|||
30816726|NCT03098979|58836643|FG000|Overall Study|Physician Decision|2|||
30816727|NCT03098979|58836644|FG001|Overall Study|Physician Decision|1|||
30816728|NCT03098979|58836645|FG002|Overall Study|Physician Decision|0|||
30816729|NCT03098979|58836646|FG003|Overall Study|Physician Decision|0|||
30816730|NCT03098979|58836647|FG004|Overall Study|Physician Decision|0|||
30816731|NCT03098979|58836648|FG005|Overall Study|Physician Decision|0|||
30816732|NCT03098979|58836643|FG000|Overall Study|Non-compliance|0|||
30816733|NCT03098979|58836644|FG001|Overall Study|Non-compliance|0|||
30816734|NCT03098979|58836645|FG002|Overall Study|Non-compliance|0|||
30816735|NCT03098979|58836646|FG003|Overall Study|Non-compliance|0|||
30912061|NCT02207816|58947168|FG001|Overall Study|Migrated/Moved From Study Area|60|||
30912062|NCT02207816|58947169|FG002|Overall Study|Migrated/Moved From Study Area|51|||
30912063|NCT02207816|58947167|FG000|Overall Study|Lost to Follow-up|3|||
30816736|NCT03098979|58836647|FG004|Overall Study|Non-compliance|0|||
30816737|NCT03098979|58836648|FG005|Overall Study|Non-compliance|1|||
30816738|NCT03098979|58836643|FG000|Overall Study|Protocol Violation|0|||
30816739|NCT03098979|58836644|FG001|Overall Study|Protocol Violation|0|||
30816740|NCT03098979|58836645|FG002|Overall Study|Protocol Violation|0|||
30816741|NCT03098979|58836646|FG003|Overall Study|Protocol Violation|0|||
30816742|NCT03098979|58836647|FG004|Overall Study|Protocol Violation|0|||
30816743|NCT03098979|58836648|FG005|Overall Study|Protocol Violation|1|||
30816744|NCT03261167|58836664|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
30816745|NCT03261167|58836665|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
30816746|NCT03261167|58836664|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
30816747|NCT03261167|58836665|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
30816748|NCT03261167|58836664|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
30816749|NCT03261167|58836665|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
30816750|NCT03261167|58836664|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
30816751|NCT03261167|58836665|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
30816752|NCT03261167|58836664|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
30816753|NCT03261167|58836665|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
30816754|NCT03294941|58836679|FG000|Overall Study|Withdrawal by Subject|0|||
30816755|NCT03294941|58836680|FG001|Overall Study|Withdrawal by Subject|2|||
30816756|NCT03098433|58836687|FG000|Overall Study|Withdrawal by Subject|10|||
30816757|NCT03294317|58836692|FG000|Overall Study|Physician Decision|1|||
30816758|NCT03294317|58836692|FG000|Overall Study|Withdrawal by Subject|6|||
30816759|NCT03294317|58836692|FG000|Overall Study|Lost to Follow-up|1|||
30816760|NCT03294317|58836692|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
30816761|NCT03294317|58836692|FG000|Overall Study|Failed HB lead implant|8|||
30816762|NCT03294317|58836692|FG000|Overall Study|Received CRT instead|1|||
30816763|NCT03294317|58836692|FG000|Overall Study|Exited after lead revision|2|||
30816764|NCT03292913|58836698|FG000|Overall Study|Death|9|||
30816765|NCT03292913|58836699|FG001|Overall Study|Death|3|||
30816766|NCT03292913|58836698|FG000|Overall Study|Lost to Follow-up|49|||
30816767|NCT03292913|58836699|FG001|Overall Study|Lost to Follow-up|49|||
30816768|NCT03292913|58836698|FG000|Overall Study|Withdrawal by Subject|2|||
30816769|NCT03292913|58836699|FG001|Overall Study|Withdrawal by Subject|0|||
30816770|NCT03292913|58836698|FG000|Overall Study|Clinic closed due to COVID|22|||
30816771|NCT03292913|58836699|FG001|Overall Study|Clinic closed due to COVID|36|||
30816772|NCT03291587|58836711|FG000|Overall Study|Lost to Follow-up|62|||
30816773|NCT03291587|58836712|FG001|Overall Study|Lost to Follow-up|43|||
30816774|NCT03291587|58836711|FG000|Overall Study|Refused to Answer|5|||
30816775|NCT03291587|58836712|FG001|Overall Study|Refused to Answer|2|||
30816776|NCT03291587|58836711|FG000|Overall Study|Death|2|||
30816777|NCT03291587|58836712|FG001|Overall Study|Death|4|||
30816778|NCT03291587|58836711|FG000|Overall Study|Not interested in participating|8|||
30816779|NCT03291587|58836712|FG001|Overall Study|Not interested in participating|6|||
30816780|NCT03291587|58836711|FG000|Overall Study|Too busy to participate|4|||
30816781|NCT03291587|58836712|FG001|Overall Study|Too busy to participate|2|||
30816782|NCT03210961|58836743|FG000|Overall Study|Adverse Event|0|||
30816783|NCT03210961|58836744|FG001|Overall Study|Adverse Event|0|||
30816784|NCT03210961|58836745|FG002|Overall Study|Adverse Event|0|||
30816785|NCT03210961|58836746|FG003|Overall Study|Adverse Event|0|||
30816786|NCT03210961|58836747|FG004|Overall Study|Adverse Event|0|||
30816787|NCT03210961|58836748|FG005|Overall Study|Adverse Event|0|||
30816788|NCT03210961|58836749|FG006|Overall Study|Adverse Event|0|||
30816789|NCT03210961|58836750|FG007|Overall Study|Adverse Event|0|||
30816790|NCT03210961|58836751|FG008|Overall Study|Adverse Event|0|||
30816791|NCT03210961|58836752|FG009|Overall Study|Adverse Event|0|||
30816792|NCT03210961|58836753|FG010|Overall Study|Adverse Event|0|||
30816793|NCT03210961|58836754|FG011|Overall Study|Adverse Event|0|||
30816794|NCT03210961|58836755|FG012|Overall Study|Adverse Event|0|||
30816795|NCT03210961|58836756|FG013|Overall Study|Adverse Event|1|||
30912064|NCT02207816|58947168|FG001|Overall Study|Lost to Follow-up|9|||
30816796|NCT03210961|58836757|FG014|Overall Study|Adverse Event|0|||
30816797|NCT03210961|58836743|FG000|Overall Study|Lost to Follow-up|0|||
30816798|NCT03210961|58836744|FG001|Overall Study|Lost to Follow-up|0|||
30912065|NCT02207816|58947169|FG002|Overall Study|Lost to Follow-up|1|||
30912066|NCT02207816|58947167|FG000|Overall Study|Other|1|||
30912067|NCT02207816|58947168|FG001|Overall Study|Other|2|||
30912068|NCT02207816|58947169|FG002|Overall Study|Other|4|||
30912069|NCT02241512|58947182|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
30912070|NCT02241512|58947183|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
30912071|NCT02205476|58947191|FG000|Overall Study|Study termination by Sponsor|7|||
30912072|NCT02205476|58947192|FG001|Overall Study|Study termination by Sponsor|3|||
30912073|NCT01709110|58947206|FG000|Overall Study|Adverse Event|56|||
30912074|NCT01709110|58947207|FG001|Overall Study|Adverse Event|48|||
30912075|NCT01709110|58947206|FG000|Overall Study|Death|14|||
30912076|NCT01709110|58947207|FG001|Overall Study|Death|6|||
30751480|NCT01763866|58761183|FG005|Overall Study|Lost to Follow-up|0|||
30751481|NCT01763866|58761184|FG006|Overall Study|Lost to Follow-up|1|||
30751482|NCT01763866|58761185|FG007|Overall Study|Lost to Follow-up|0|||
30751483|NCT01763866|58761186|FG008|Overall Study|Lost to Follow-up|0|||
30751484|NCT01763866|58761187|FG009|Overall Study|Lost to Follow-up|0|||
30751485|NCT01763866|58761188|FG010|Overall Study|Lost to Follow-up|0|||
30751486|NCT01763866|58761189|FG011|Overall Study|Lost to Follow-up|0|||
30751487|NCT01763866|58761190|FG012|Overall Study|Lost to Follow-up|1|||
30751488|NCT01763866|58761191|FG013|Overall Study|Lost to Follow-up|0|||
30751489|NCT01763866|58761192|FG014|Overall Study|Lost to Follow-up|1|||
30751490|NCT01763866|58761193|FG015|Overall Study|Lost to Follow-up|0|||
30751491|NCT01763866|58761194|FG016|Overall Study|Lost to Follow-up|0|||
30751492|NCT01763866|58761195|FG017|Overall Study|Lost to Follow-up|0|||
30816799|NCT03210961|58836745|FG002|Overall Study|Lost to Follow-up|0|||
30816800|NCT03210961|58836746|FG003|Overall Study|Lost to Follow-up|0|||
30816801|NCT03210961|58836747|FG004|Overall Study|Lost to Follow-up|0|||
30816802|NCT03210961|58836748|FG005|Overall Study|Lost to Follow-up|0|||
30816803|NCT03210961|58836749|FG006|Overall Study|Lost to Follow-up|0|||
30816804|NCT03210961|58836750|FG007|Overall Study|Lost to Follow-up|0|||
30751493|NCT01763866|58761196|FG018|Overall Study|Lost to Follow-up|1|||
30816805|NCT03210961|58836751|FG008|Overall Study|Lost to Follow-up|0|||
30816806|NCT03210961|58836752|FG009|Overall Study|Lost to Follow-up|0|||
30816807|NCT03210961|58836753|FG010|Overall Study|Lost to Follow-up|0|||
30816808|NCT03210961|58836754|FG011|Overall Study|Lost to Follow-up|0|||
30912077|NCT01709110|58947206|FG000|Overall Study|Lost to Follow-up|7|||
30912078|NCT01709110|58947207|FG001|Overall Study|Lost to Follow-up|5|||
30912079|NCT01709110|58947206|FG000|Overall Study|Protocol Violation|4|||
30912080|NCT01709110|58947207|FG001|Overall Study|Protocol Violation|6|||
30912081|NCT01709110|58947206|FG000|Overall Study|Withdrawal by Subject|96|||
30912082|NCT01709110|58947207|FG001|Overall Study|Withdrawal by Subject|89|||
30912083|NCT01709110|58947206|FG000|Overall Study|Physician Decision|4|||
30912084|NCT01709110|58947207|FG001|Overall Study|Physician Decision|10|||
30912085|NCT01709110|58947206|FG000|Overall Study|Sponsor Decision|2|||
30912086|NCT01709110|58947207|FG001|Overall Study|Sponsor Decision|2|||
30912087|NCT01709110|58947206|FG000|Overall Study|Lack of Efficacy|1|||
30912088|NCT01709110|58947207|FG001|Overall Study|Lack of Efficacy|1|||
30912089|NCT01709110|58947206|FG000|Overall Study|Caregiver Decision|1|||
30912090|NCT01709110|58947207|FG001|Overall Study|Caregiver Decision|1|||
30912091|NCT02240108|58947215|FG000|Overall Study|Other than specified|8|||
30912092|NCT02240108|58947216|FG001|Overall Study|Other than specified|6|||
30912093|NCT02240108|58947215|FG000|Overall Study|Adverse Event|1|||
30912094|NCT02240108|58947216|FG001|Overall Study|Adverse Event|9|||
30912095|NCT02240108|58947215|FG000|Overall Study|Pregnancy|1|||
30912096|NCT02240108|58947216|FG001|Overall Study|Pregnancy|0|||
30912097|NCT02240108|58947215|FG000|Overall Study|Withdrawal by Subject|4|||
30912098|NCT02240108|58947216|FG001|Overall Study|Withdrawal by Subject|9|||
30912099|NCT02240108|58947215|FG000|Overall Study|StudyTerminated by Sponsor|0|||
30816809|NCT03210961|58836755|FG012|Overall Study|Lost to Follow-up|0|||
30816810|NCT03210961|58836756|FG013|Overall Study|Lost to Follow-up|0|||
30816811|NCT03210961|58836757|FG014|Overall Study|Lost to Follow-up|1|||
30816812|NCT03210961|58836743|FG000|Overall Study|Withdrawal by Subject|0|||
30816813|NCT03210961|58836744|FG001|Overall Study|Withdrawal by Subject|0|||
30622716|NCT00972777|58634384|FG001|Overall Study|Withdrawal by Subject|5|||
30622717|NCT00972777|58634383|FG000|Overall Study|Physician Decision|4|||
30622718|NCT00972777|58634384|FG001|Overall Study|Physician Decision|0|||
30622719|NCT00972777|58634383|FG000|Overall Study|Protocol Violation|0|||
30622720|NCT00972777|58634384|FG001|Overall Study|Protocol Violation|2|||
30622721|NCT00972777|58634383|FG000|Overall Study|Screening Failure|2|||
30622722|NCT00972777|58634384|FG001|Overall Study|Screening Failure|1|||
30622723|NCT00972777|58634383|FG000|Overall Study|Missed visit|1|||
30751494|NCT01763866|58761197|FG019|Overall Study|Lost to Follow-up|1|||
30751495|NCT01763866|58761198|FG020|Overall Study|Lost to Follow-up|0|||
30751496|NCT01763866|58761199|FG021|Overall Study|Lost to Follow-up|0|||
30751497|NCT01763866|58761200|FG022|Overall Study|Lost to Follow-up|0|||
30751498|NCT01763866|58761201|FG023|Overall Study|Lost to Follow-up|1|||
30751499|NCT01763866|58761178|FG000|Overall Study|Death|0|||
30751500|NCT01763866|58761179|FG001|Overall Study|Death|0|||
30751501|NCT01763866|58761180|FG002|Overall Study|Death|0|||
30751502|NCT01763866|58761181|FG003|Overall Study|Death|0|||
30751503|NCT01763866|58761182|FG004|Overall Study|Death|0|||
30751504|NCT01763866|58761183|FG005|Overall Study|Death|0|||
30816814|NCT03210961|58836745|FG002|Overall Study|Withdrawal by Subject|0|||
30622724|NCT00972777|58634384|FG001|Overall Study|Missed visit|0|||
30622725|NCT00918736|58634390|FG000|Overall Study|Withdrawal by Subject|4|||
30751505|NCT01763866|58761184|FG006|Overall Study|Death|0|||
30751506|NCT01763866|58761185|FG007|Overall Study|Death|0|||
30751507|NCT01763866|58761186|FG008|Overall Study|Death|0|||
30751508|NCT01763866|58761187|FG009|Overall Study|Death|0|||
30816815|NCT03210961|58836746|FG003|Overall Study|Withdrawal by Subject|0|||
30912100|NCT02240108|58947216|FG001|Overall Study|StudyTerminated by Sponsor|1|||
30912101|NCT02239640|58947222|FG000|Overall Study|Withdrawal by Subject|3|||
30912102|NCT02239640|58947222|FG000|Overall Study|Lost to Follow-up|72|||
30912103|NCT02239640|58947222|FG000|Overall Study|Death|142|||
30912104|NCT01590628|58947234|FG000|Overall Study|Death|2|||
30622726|NCT01172639|58634399|FG000|Overall Study|Death|1|||
30622727|NCT01172639|58634400|FG001|Overall Study|Death|1|||
30622728|NCT01172639|58634401|FG002|Overall Study|Death|0|||
30622729|NCT01172639|58634402|FG003|Overall Study|Death|0|||
30622730|NCT01172639|58634403|FG004|Overall Study|Death|0|||
30622731|NCT01172639|58634399|FG000|Overall Study|Lost to Follow-up|9|||
30622732|NCT01172639|58634400|FG001|Overall Study|Lost to Follow-up|7|||
30622733|NCT01172639|58634401|FG002|Overall Study|Lost to Follow-up|11|||
30622734|NCT01172639|58634402|FG003|Overall Study|Lost to Follow-up|6|||
30622735|NCT01172639|58634403|FG004|Overall Study|Lost to Follow-up|6|||
30622736|NCT01172639|58634399|FG000|Overall Study|Withdrawal by Subject|3|||
30622737|NCT01172639|58634400|FG001|Overall Study|Withdrawal by Subject|3|||
30622738|NCT01172639|58634401|FG002|Overall Study|Withdrawal by Subject|5|||
30622739|NCT01172639|58634402|FG003|Overall Study|Withdrawal by Subject|5|||
30622740|NCT01172639|58634403|FG004|Overall Study|Withdrawal by Subject|0|||
30622741|NCT01144182|58634417|FG000|Overall Study|Death|5|||
30622742|NCT01144182|58634418|FG001|Overall Study|Death|6|||
30622743|NCT01144182|58634417|FG000|Overall Study|Withdrawal by Subject|3|||
30622744|NCT01144182|58634418|FG001|Overall Study|Withdrawal by Subject|6|||
30751509|NCT01763866|58761188|FG010|Overall Study|Death|0|||
30751510|NCT01763866|58761189|FG011|Overall Study|Death|0|||
30751511|NCT01763866|58761190|FG012|Overall Study|Death|0|||
30751512|NCT01763866|58761191|FG013|Overall Study|Death|0|||
30751513|NCT01763866|58761192|FG014|Overall Study|Death|0|||
30751514|NCT01763866|58761193|FG015|Overall Study|Death|0|||
30751515|NCT01763866|58761194|FG016|Overall Study|Death|1|||
30751516|NCT01763866|58761195|FG017|Overall Study|Death|0|||
30751517|NCT01763866|58761196|FG018|Overall Study|Death|0|||
30751518|NCT01763866|58761197|FG019|Overall Study|Death|0|||
30751519|NCT01763866|58761198|FG020|Overall Study|Death|0|||
30751520|NCT01763866|58761199|FG021|Overall Study|Death|0|||
30751521|NCT01763866|58761200|FG022|Overall Study|Death|0|||
30751522|NCT01763866|58761201|FG023|Overall Study|Death|0|||
30751523|NCT00132873|58761251|FG000|Overall Study|Adverse Event|3|||
30751524|NCT00132873|58761251|FG000|Overall Study|Lost to Follow-up|1|||
30751525|NCT00132873|58761251|FG000|Overall Study|Lack of Efficacy|1|||
30751526|NCT00132873|58761251|FG000|Overall Study|Withdrawal by Subject|3|||
30751527|NCT00132873|58761251|FG000|Overall Study|Planned Pregnancy|1|||
30751528|NCT00120627|58761257|FG000|Overall Study|Withdrawal by Subject|5|||
30751529|NCT00120627|58761258|FG001|Overall Study|Withdrawal by Subject|5|||
30751530|NCT03762616|58761273|FG000|Overall Study|Protocol Violation|2|||
30751531|NCT04246996|58761281|FG000|Overall Study|Physician Decision|1|||
30751532|NCT04246996|58761282|FG001|Overall Study|Physician Decision|1|||
30751533|NCT04246996|58761281|FG000|Overall Study|Did not meet eligibility criteria|1|||
30751534|NCT04246996|58761282|FG001|Overall Study|Did not meet eligibility criteria|4|||
30912105|NCT01590628|58947235|FG001|Overall Study|Death|0|||
30912106|NCT02130193|58947247|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
30912107|NCT02130193|58947248|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
30912108|NCT02130193|58947249|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
30912109|NCT02130193|58947247|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
30912110|NCT02130193|58947248|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
30912111|NCT02130193|58947249|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
30912112|NCT02130193|58947247|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
30912113|NCT02130193|58947248|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
30912114|NCT02130193|58947249|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
30912115|NCT02130193|58947247|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
30912116|NCT02130193|58947248|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
30912117|NCT02130193|58947249|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
30912118|NCT01590082|58947260|FG000|Overall Study|Withdrawal by Subject|1|||
30912119|NCT01590082|58947261|FG001|Overall Study|Withdrawal by Subject|0|||
30912120|NCT01590082|58947260|FG000|Overall Study|Ineligible|1|||
30912121|NCT01590082|58947261|FG001|Overall Study|Ineligible|0|||
30912122|NCT01631474|58947272|FG000|Overall Study|Lost to Follow-up|8|||
30912123|NCT01631474|58947273|FG001|Overall Study|Lost to Follow-up|5|||
30912124|NCT01631474|58947274|FG002|Overall Study|Lost to Follow-up|7|||
30622745|NCT01144182|58634417|FG000|Overall Study|Lost to Follow-up|9|||
30751535|NCT00424463|58761291|FG000|Overall Study|Adverse Event|2|||
30751536|NCT00424463|58761292|FG001|Overall Study|Adverse Event|3|||
30912125|NCT01631474|58947275|FG003|Overall Study|Lost to Follow-up|5|||
30912126|NCT01631474|58947276|FG004|Overall Study|Lost to Follow-up|5|||
30622746|NCT01144182|58634418|FG001|Overall Study|Lost to Follow-up|9|||
30622747|NCT01225562|58634428|FG000|Overall Study|Withdrawal by Subject|52|||
30751537|NCT00424463|58761293|FG002|Overall Study|Adverse Event|2|||
30751538|NCT00424463|58761291|FG000|Overall Study|Physician Decision|0|||
30622748|NCT01225562|58634429|FG001|Overall Study|Withdrawal by Subject|50|||
30622749|NCT01225562|58634430|FG002|Overall Study|Withdrawal by Subject|52|||
30622750|NCT01225562|58634428|FG000|Overall Study|Lost to Follow-up|3|||
30751539|NCT00424463|58761292|FG001|Overall Study|Physician Decision|2|||
30912127|NCT01631474|58947272|FG000|Overall Study|Withdrawal by Subject|4|||
30912128|NCT01631474|58947273|FG001|Overall Study|Withdrawal by Subject|4|||
30912129|NCT01631474|58947274|FG002|Overall Study|Withdrawal by Subject|2|||
30912130|NCT01631474|58947275|FG003|Overall Study|Withdrawal by Subject|6|||
30912131|NCT01631474|58947276|FG004|Overall Study|Withdrawal by Subject|5|||
30912132|NCT01631474|58947272|FG000|Overall Study|Lack of Efficacy|2|||
30912133|NCT01631474|58947273|FG001|Overall Study|Lack of Efficacy|2|||
30912134|NCT01631474|58947274|FG002|Overall Study|Lack of Efficacy|0|||
30912135|NCT01631474|58947275|FG003|Overall Study|Lack of Efficacy|0|||
30912136|NCT01631474|58947276|FG004|Overall Study|Lack of Efficacy|2|||
30912137|NCT01631474|58947272|FG000|Overall Study|Noncompliance with Study Drug|0|||
30912138|NCT01631474|58947273|FG001|Overall Study|Noncompliance with Study Drug|0|||
30912139|NCT01631474|58947274|FG002|Overall Study|Noncompliance with Study Drug|0|||
30912140|NCT01631474|58947275|FG003|Overall Study|Noncompliance with Study Drug|0|||
30912141|NCT01631474|58947276|FG004|Overall Study|Noncompliance with Study Drug|1|||
30912142|NCT01631474|58947272|FG000|Overall Study|Adverse Event|0|||
30912143|NCT01631474|58947273|FG001|Overall Study|Adverse Event|1|||
30912144|NCT01631474|58947274|FG002|Overall Study|Adverse Event|0|||
30912145|NCT01631474|58947275|FG003|Overall Study|Adverse Event|0|||
30912146|NCT01631474|58947276|FG004|Overall Study|Adverse Event|0|||
30912147|NCT02203916|58947291|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
30912148|NCT02203916|58947292|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
30912149|NCT02203916|58947293|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
30912150|NCT02203916|58947291|FG000|Overall Study|Major Protocol Deviation|1|||
30912151|NCT02203916|58947292|FG001|Overall Study|Major Protocol Deviation|1|||
30912152|NCT02203916|58947293|FG002|Overall Study|Major Protocol Deviation|0|||
30912153|NCT02203916|58947291|FG000|Overall Study|Lost to Follow-up|0|||
30912154|NCT02203916|58947292|FG001|Overall Study|Lost to Follow-up|1|||
30912155|NCT02203916|58947293|FG002|Overall Study|Lost to Follow-up|0|||
30751540|NCT00424463|58761293|FG002|Overall Study|Physician Decision|2|||
30751541|NCT00424463|58761291|FG000|Overall Study|Withdrawal by Subject|4|||
30816816|NCT03210961|58836747|FG004|Overall Study|Withdrawal by Subject|0|||
30816817|NCT03210961|58836748|FG005|Overall Study|Withdrawal by Subject|0|||
30816818|NCT03210961|58836749|FG006|Overall Study|Withdrawal by Subject|0|||
30816819|NCT03210961|58836750|FG007|Overall Study|Withdrawal by Subject|0|||
30816820|NCT03210961|58836751|FG008|Overall Study|Withdrawal by Subject|0|||
30816821|NCT03210961|58836752|FG009|Overall Study|Withdrawal by Subject|0|||
30816822|NCT03210961|58836753|FG010|Overall Study|Withdrawal by Subject|0|||
30816823|NCT03210961|58836754|FG011|Overall Study|Withdrawal by Subject|0|||
30816824|NCT03210961|58836755|FG012|Overall Study|Withdrawal by Subject|0|||
30816825|NCT03210961|58836756|FG013|Overall Study|Withdrawal by Subject|0|||
30816826|NCT03210961|58836757|FG014|Overall Study|Withdrawal by Subject|1|||
30816827|NCT03210961|58836743|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816828|NCT03210961|58836744|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816829|NCT03210961|58836745|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
30912156|NCT02203916|58947291|FG000|Overall Study|Voluntary Withdrawal|3|||
30751542|NCT00424463|58761292|FG001|Overall Study|Withdrawal by Subject|2|||
30751543|NCT00424463|58761293|FG002|Overall Study|Withdrawal by Subject|5|||
30751544|NCT00424463|58761291|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
30751545|NCT00424463|58761292|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
30751546|NCT00424463|58761293|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
30751547|NCT00424463|58761291|FG000|Overall Study|Patient's convenience|0|||
30751548|NCT00424463|58761292|FG001|Overall Study|Patient's convenience|0|||
30751549|NCT00424463|58761293|FG002|Overall Study|Patient's convenience|1|||
30751550|NCT00424385|58761301|FG000|Cohort 0|Withdrawal by Subject|5|||
30751551|NCT00424385|58761301|FG000|Cohort 0|Physician Decision|1|||
30751552|NCT00424385|58761301|FG000|Cohort 1|Withdrawal by Subject|1|||
30751553|NCT00423917|58761307|FG000|Overall Study|Cancel|2|||
30751554|NCT00423917|58761307|FG000|Overall Study|Ineligible|1|||
30751555|NCT00845026|58761313|FG000|Study Period III|Adverse Event|23|||
30816830|NCT03210961|58836746|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816831|NCT03210961|58836747|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816832|NCT03210961|58836748|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
30912157|NCT02203916|58947292|FG001|Overall Study|Voluntary Withdrawal|3|||
30912158|NCT02203916|58947293|FG002|Overall Study|Voluntary Withdrawal|8|||
30751556|NCT00845026|58761314|FG001|Study Period III|Adverse Event|19|||
30912159|NCT02203916|58947291|FG000|Overall Study|Lack of Efficacy|3|||
30816833|NCT03210961|58836749|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816834|NCT03210961|58836750|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816835|NCT03210961|58836751|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816836|NCT03210961|58836752|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816837|NCT03210961|58836753|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816838|NCT03210961|58836754|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816839|NCT03210961|58836755|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816840|NCT03210961|58836756|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
30816841|NCT03210961|58836757|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
30816842|NCT03210961|58836743|FG000|Overall Study|Other|0|||
30816843|NCT03210961|58836744|FG001|Overall Study|Other|0|||
30816844|NCT03210961|58836745|FG002|Overall Study|Other|0|||
30816845|NCT03210961|58836746|FG003|Overall Study|Other|1|||
30816846|NCT03210961|58836747|FG004|Overall Study|Other|0|||
30816847|NCT03210961|58836748|FG005|Overall Study|Other|0|||
30816848|NCT03210961|58836749|FG006|Overall Study|Other|1|||
30816849|NCT03210961|58836750|FG007|Overall Study|Other|0|||
30816850|NCT03210961|58836751|FG008|Overall Study|Other|0|||
30816851|NCT03210961|58836752|FG009|Overall Study|Other|0|||
30816852|NCT03210961|58836753|FG010|Overall Study|Other|1|||
30816853|NCT03210961|58836754|FG011|Overall Study|Other|0|||
30816854|NCT03210961|58836755|FG012|Overall Study|Other|2|||
30816855|NCT03210961|58836756|FG013|Overall Study|Other|2|||
30816856|NCT03210961|58836757|FG014|Overall Study|Other|0|||
30816857|NCT03242759|58836810|FG000|Overall Study|Adverse Event|5|||
30912160|NCT02203916|58947292|FG001|Overall Study|Lack of Efficacy|0|||
30912161|NCT02203916|58947293|FG002|Overall Study|Lack of Efficacy|0|||
30912162|NCT02203916|58947291|FG000|Overall Study|Reason Not Specified|0|||
30912163|NCT02203916|58947292|FG001|Overall Study|Reason Not Specified|2|||
30912164|NCT02203916|58947293|FG002|Overall Study|Reason Not Specified|1|||
30912165|NCT02179177|58947317|FG000|Overall Study|Lost to Follow-up|1|||
30912166|NCT02179177|58947318|FG001|Overall Study|Lost to Follow-up|1|||
30912167|NCT02179177|58947317|FG000|Overall Study|Withdrawal by Subject|1|||
30622751|NCT01225562|58634429|FG001|Overall Study|Lost to Follow-up|6|||
30622752|NCT01225562|58634430|FG002|Overall Study|Lost to Follow-up|1|||
30622753|NCT00925288|58634440|FG000|Overall Study|Lost to Follow-up|9|||
30751557|NCT00845026|58761313|FG000|Study Period III|Perceived lack of efficacy|27|||
30751558|NCT00845026|58761314|FG001|Study Period III|Perceived lack of efficacy|15|||
30751559|NCT00845026|58761313|FG000|Study Period III|Withdrawal by Subject|19|||
30751560|NCT00845026|58761314|FG001|Study Period III|Withdrawal by Subject|15|||
30751561|NCT00845026|58761313|FG000|Study Period III|Entry Criteria not met|8|||
30751562|NCT00845026|58761314|FG001|Study Period III|Entry Criteria not met|11|||
30751563|NCT00845026|58761313|FG000|Study Period III|Lost to Follow-up|4|||
30751564|NCT00845026|58761314|FG001|Study Period III|Lost to Follow-up|5|||
30751565|NCT00845026|58761313|FG000|Study Period III|Protocol Violation|8|||
30751566|NCT00845026|58761314|FG001|Study Period III|Protocol Violation|1|||
30751567|NCT00845026|58761313|FG000|Study Period III|Scheduled conflict|3|||
30751568|NCT00845026|58761314|FG001|Study Period III|Scheduled conflict|1|||
30751569|NCT00845026|58761313|FG000|Study Period III|Subject is moving or has moved|2|||
30751570|NCT00845026|58761314|FG001|Study Period III|Subject is moving or has moved|4|||
30751571|NCT00845026|58761313|FG000|Study Period III|Transportation issues|1|||
30751572|NCT00845026|58761314|FG001|Study Period III|Transportation issues|1|||
30751573|NCT00845026|58761313|FG000|Study Period IV|Adverse Event|4|||
30751574|NCT00845026|58761314|FG001|Study Period IV|Adverse Event|0|||
30751575|NCT00845026|58761313|FG000|Study Period IV|Perceived lack of efficacy|2|||
30751576|NCT00845026|58761314|FG001|Study Period IV|Perceived lack of efficacy|1|||
30751577|NCT00845026|58761313|FG000|Study Period IV|Protocol Violation|3|||
30751578|NCT00845026|58761314|FG001|Study Period IV|Protocol Violation|1|||
30816858|NCT03242759|58836811|FG001|Overall Study|Adverse Event|1|||
30816859|NCT03242759|58836810|FG000|Overall Study|Withdrawal by Subject|4|||
30816860|NCT03242759|58836811|FG001|Overall Study|Withdrawal by Subject|3|||
30816861|NCT03242759|58836810|FG000|Overall Study|Lost to Follow-up|3|||
30816862|NCT03242759|58836811|FG001|Overall Study|Lost to Follow-up|1|||
30816863|NCT03242759|58836810|FG000|Overall Study|Administrative problems|1|||
30816864|NCT03242759|58836811|FG001|Overall Study|Administrative problems|1|||
30622754|NCT00925288|58634441|FG001|Overall Study|Lost to Follow-up|7|||
30751579|NCT00845026|58761313|FG000|Study Period IV|Lost to Follow-up|1|||
30751580|NCT00845026|58761314|FG001|Study Period IV|Lost to Follow-up|0|||
30751581|NCT00845026|58761313|FG000|Study Period IV|Withdrawal by Subject|4|||
30751582|NCT00845026|58761314|FG001|Study Period IV|Withdrawal by Subject|1|||
30751583|NCT00845026|58761313|FG000|Study Period IV|Entry Criteria Not Met|1|||
30751584|NCT00845026|58761314|FG001|Study Period IV|Entry Criteria Not Met|0|||
30751585|NCT00845026|58761313|FG000|Study Period IV|Subject is moving or has moved|0|||
30816865|NCT03242759|58836810|FG000|Overall Study|Death|22|||
30816866|NCT03242759|58836811|FG001|Overall Study|Death|0|||
30816867|NCT03242759|58836810|FG000|Overall Study|Change visit schedule|0|||
30912168|NCT02179177|58947318|FG001|Overall Study|Withdrawal by Subject|1|||
30622755|NCT01143714|58634451|FG000|Overall Study|Adverse Event|4|||
30622756|NCT01143714|58634452|FG001|Overall Study|Adverse Event|2|||
30622757|NCT01143714|58634451|FG000|Overall Study|Withdrawal by Subject|1|||
30622758|NCT01143714|58634452|FG001|Overall Study|Withdrawal by Subject|0|||
30622759|NCT01143714|58634451|FG000|Overall Study|Subject non-compliance|0|||
30622760|NCT01143714|58634452|FG001|Overall Study|Subject non-compliance|1|||
30622761|NCT01143714|58634451|FG000|Overall Study|wound closed = deemed healed|1|||
30622762|NCT01143714|58634452|FG001|Overall Study|wound closed = deemed healed|0|||
30622763|NCT01143714|58634451|FG000|Overall Study|wound size increased|1|||
30622764|NCT01143714|58634452|FG001|Overall Study|wound size increased|0|||
30622765|NCT00972543|58634473|FG000|Overall Study|Adverse Event|1|||
30622766|NCT00972543|58634474|FG001|Overall Study|Adverse Event|0|||
30622767|NCT00972543|58634473|FG000|Overall Study|Early study termination by sponsor|4|||
30622768|NCT00972543|58634474|FG001|Overall Study|Early study termination by sponsor|1|||
30622769|NCT00925132|58634480|FG000|Overall Study|Withdrawal by Subject|2|||
30622770|NCT00925132|58634481|FG001|Overall Study|Withdrawal by Subject|0|||
30622771|NCT00925132|58634482|FG002|Overall Study|Withdrawal by Subject|0|||
30622772|NCT00925132|58634483|FG003|Overall Study|Withdrawal by Subject|0|||
30622773|NCT00925132|58634484|FG004|Overall Study|Withdrawal by Subject|1|||
30622774|NCT00925132|58634480|FG000|Overall Study|Removed due to disease progression|0|||
30622775|NCT00925132|58634481|FG001|Overall Study|Removed due to disease progression|0|||
30622776|NCT00925132|58634482|FG002|Overall Study|Removed due to disease progression|0|||
30622777|NCT00925132|58634483|FG003|Overall Study|Removed due to disease progression|0|||
30816868|NCT03242759|58836811|FG001|Overall Study|Change visit schedule|1|||
30622778|NCT00925132|58634484|FG004|Overall Study|Removed due to disease progression|4|||
30622779|NCT01143402|58634493|FG000|Overall Study|Rapid clinical decline|1|||
30622780|NCT01143402|58634494|FG001|Overall Study|Rapid clinical decline|1|||
30622781|NCT01143402|58634495|FG002|Overall Study|Rapid clinical decline|0|||
30622782|NCT01143402|58634493|FG000|Overall Study|Not Treated|0|||
30622783|NCT01143402|58634494|FG001|Overall Study|Not Treated|0|||
30622784|NCT01143402|58634495|FG002|Overall Study|Not Treated|1|||
30622785|NCT01171625|58634502|FG000|Overall Study|On-Protocol|67|||
30622786|NCT01171625|58634502|FG000|Overall Study|Death|38|||
30622787|NCT01171625|58634502|FG000|Overall Study|Withdrawal by Subject|31|||
30622788|NCT01171625|58634502|FG000|Overall Study|Explanted|10|||
30622789|NCT01171625|58634502|FG000|Overall Study|Lost to Follow-up|5|||
30622790|NCT01171625|58634502|FG000|Overall Study|Patient received valve-in-valve|3|||
30622791|NCT01171625|58634502|FG000|Overall Study|Other|1|||
30622792|NCT01171625|58634502|FG000|Overall Study|Consented but did not receive device|25|||
30622793|NCT00924898|58634514|FG000|Overall Study|Withdrawal by Subject|2|||
30622794|NCT01167192|58634523|FG000|Overall Study|Adverse Event|1|||
30622795|NCT01167192|58634523|FG000|Overall Study|Death|1|||
30622796|NCT01167192|58634523|FG000|Overall Study|Withdrawal by Subject|1|||
30622797|NCT01167192|58634523|FG000|Overall Study|Insurance denial|1|||
30622798|NCT01166958|58634529|FG000|Overall Study|Withdrawal by Subject|1|||
30622799|NCT01166958|58634530|FG001|Overall Study|Withdrawal by Subject|0|||
30622800|NCT01170221|58634538|FG000|Overall Study|Lost to Follow-up|22|||
30622801|NCT01170221|58634539|FG001|Overall Study|Lost to Follow-up|21|||
30622802|NCT01170221|58634538|FG000|Overall Study|Withdrawal by Subject|9|||
30622803|NCT01170221|58634539|FG001|Overall Study|Withdrawal by Subject|7|||
30622804|NCT01170221|58634538|FG000|Overall Study|Subject completed only screening and LFU|1|||
30816869|NCT03097029|58836817|FG000|Overall Study|Withdrawal by Subject|1|||
30816870|NCT03257813|58836823|FG000|Overall Study|Protocol Violation|6|||
30622805|NCT01170221|58634539|FG001|Overall Study|Subject completed only screening and LFU|0|||
30622806|NCT01170221|58634538|FG000|Overall Study|Randomized but not treated|1|||
30622807|NCT01170221|58634539|FG001|Overall Study|Randomized but not treated|0|||
30622808|NCT01166646|58634547|FG000|Overall Study|Protocol Violation|0|||
30622809|NCT01166646|58634548|FG001|Overall Study|Protocol Violation|1|||
30622810|NCT01166646|58634547|FG000|Overall Study|Adverse Event|1|||
30622811|NCT01166646|58634548|FG001|Overall Study|Adverse Event|0|||
30622812|NCT01129284|58634557|FG000|Overall Study|Adverse Event|2|||
30816871|NCT03257813|58836824|FG001|Overall Study|Protocol Violation|3|||
30816872|NCT03210259|58836835|FG000|12-Week Run-in Period|Adverse Event|1|||
30816873|NCT03210259|58836836|FG001|12-Week Run-in Period|Adverse Event|0|||
30816874|NCT03210259|58836837|FG002|12-Week Run-in Period|Adverse Event|0|||
30816875|NCT03210259|58836835|FG000|12-Week Run-in Period|Death|1|||
30816876|NCT03210259|58836836|FG001|12-Week Run-in Period|Death|0|||
30816877|NCT03210259|58836837|FG002|12-Week Run-in Period|Death|0|||
30816878|NCT03210259|58836835|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
30816879|NCT03210259|58836836|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
30816880|NCT03210259|58836837|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
30816881|NCT03210259|58836835|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
30816882|NCT03210259|58836836|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
30816883|NCT03210259|58836837|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
30622813|NCT01129284|58634558|FG001|Overall Study|Adverse Event|0|||
30622814|NCT01129284|58634559|FG002|Overall Study|Adverse Event|1|||
30622815|NCT01166568|58634570|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
30622816|NCT01166568|58634571|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
30912169|NCT02239328|58947324|FG000|Overall Study|Benign disease noted at time of surgery|6|||
30912170|NCT02239328|58947324|FG000|Overall Study|Equipment or website malfunction|2|||
30912171|NCT02129803|58947330|FG000|Overall Study|Protocol Violation|4|||
30912172|NCT02129803|58947331|FG001|Overall Study|Protocol Violation|0|||
30912173|NCT02129803|58947330|FG000|Overall Study|Physician Decision|0|||
30622817|NCT01166568|58634572|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
30622818|NCT01166568|58634570|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
30622819|NCT01166568|58634571|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
30622820|NCT01166568|58634572|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
30912174|NCT02129803|58947331|FG001|Overall Study|Physician Decision|1|||
30912175|NCT02129803|58947330|FG000|Overall Study|Difficulty sleeping|1|||
30912176|NCT02129803|58947331|FG001|Overall Study|Difficulty sleeping|0|||
30912177|NCT02129803|58947330|FG000|Overall Study|Morning headache|0|||
30912178|NCT02129803|58947331|FG001|Overall Study|Morning headache|1|||
30912179|NCT02129803|58947330|FG000|Overall Study|Withdrawal by Subject|1|||
30912180|NCT02129803|58947331|FG001|Overall Study|Withdrawal by Subject|1|||
30751586|NCT00845026|58761314|FG001|Study Period IV|Subject is moving or has moved|1|||
30751587|NCT00845026|58761313|FG000|Study Period IV|Scheduling conflict|1|||
30816884|NCT03210259|58836835|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
30816885|NCT03210259|58836836|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
30751588|NCT00845026|58761314|FG001|Study Period IV|Scheduling conflict|0|||
30751589|NCT00691678|58761322|FG000|Overall Study|Adverse Event|5|||
30751590|NCT00691678|58761322|FG000|Overall Study|life events, pain|11|||
30751591|NCT00423605|58761326|FG000|Overall Study|Adverse Event|129|||
30751592|NCT00423605|58761326|FG000|Overall Study|Withdrawal by Subject|36|||
30751593|NCT00423605|58761326|FG000|Overall Study|Lost to Follow-up|15|||
30751594|NCT00423605|58761326|FG000|Overall Study|Lack of Efficacy|38|||
30751595|NCT00423605|58761326|FG000|Overall Study|Sponsor Decision|3|||
30751596|NCT00423605|58761326|FG000|Overall Study|Physician Decision|8|||
30751597|NCT00423605|58761326|FG000|Overall Study|Protocol Violation|7|||
30751598|NCT00423605|58761326|FG000|Overall Study|Not one of the pre-specified options|5|||
30751599|NCT00003838|58761333|FG000|Overall Study|Death|0|||
30751600|NCT00003838|58761334|FG001|Overall Study|Death|12|||
30751601|NCT00003838|58761335|FG002|Overall Study|Death|7|||
30751602|NCT00003838|58761333|FG000|Overall Study|Lost to Follow-up|0|||
30751603|NCT00003838|58761334|FG001|Overall Study|Lost to Follow-up|1|||
30751604|NCT00003838|58761335|FG002|Overall Study|Lost to Follow-up|1|||
30751605|NCT00003838|58761333|FG000|Overall Study|Disease Progression|0|||
30751606|NCT00003838|58761334|FG001|Overall Study|Disease Progression|12|||
30751607|NCT00003838|58761335|FG002|Overall Study|Disease Progression|0|||
30751608|NCT00423449|58761342|FG000|Overall Study|Clinical Adverse Event|1|||
30751609|NCT00423449|58761343|FG001|Overall Study|Clinical Adverse Event|0|||
30751610|NCT00423449|58761344|FG002|Overall Study|Clinical Adverse Event|1|||
30816886|NCT03210259|58836837|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
30816887|NCT03210259|58836835|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
30816888|NCT03210259|58836836|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
30751611|NCT00423449|58761345|FG003|Overall Study|Clinical Adverse Event|8|||
30751612|NCT00423449|58761346|FG004|Overall Study|Clinical Adverse Event|2|||
30751613|NCT00423449|58761342|FG000|Overall Study|Death|1|||
30751614|NCT00423449|58761343|FG001|Overall Study|Death|0|||
30751615|NCT00423449|58761344|FG002|Overall Study|Death|2|||
30751616|NCT00423449|58761345|FG003|Overall Study|Death|1|||
30751617|NCT00423449|58761346|FG004|Overall Study|Death|1|||
30751618|NCT00423449|58761342|FG000|Overall Study|Progressive Disease|1|||
30816889|NCT03210259|58836837|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
30816890|NCT03210259|58836835|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
30912181|NCT02239094|58947337|FG000|Overall Study|Withdrawal by Subject|1|||
30912182|NCT02239094|58947337|FG000|Overall Study|Remitted before started|1|||
30912183|NCT02129647|58947341|FG000|Overall Study|Adverse Event|2|||
30816891|NCT03210259|58836836|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
30816892|NCT03210259|58836837|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
30816893|NCT03210259|58836835|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
30816894|NCT03210259|58836836|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
30816895|NCT03210259|58836837|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
30816896|NCT03210259|58836835|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
30912184|NCT02129647|58947341|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
30912185|NCT02238626|58947349|FG000|Overall Study|Adverse Event|3|||
30912186|NCT02238626|58947350|FG001|Overall Study|Adverse Event|5|||
30912187|NCT02238626|58947351|FG002|Overall Study|Adverse Event|0|||
30912188|NCT02238626|58947352|FG003|Overall Study|Adverse Event|3|||
30912189|NCT02238626|58947349|FG000|Overall Study|Lost to Follow-up|2|||
30912190|NCT02238626|58947350|FG001|Overall Study|Lost to Follow-up|4|||
30912191|NCT02238626|58947351|FG002|Overall Study|Lost to Follow-up|2|||
30912192|NCT02238626|58947352|FG003|Overall Study|Lost to Follow-up|2|||
30912193|NCT02238626|58947349|FG000|Overall Study|Withdrawal by Subject|0|||
30912194|NCT02238626|58947350|FG001|Overall Study|Withdrawal by Subject|3|||
30912195|NCT02238626|58947351|FG002|Overall Study|Withdrawal by Subject|0|||
30912196|NCT02238626|58947352|FG003|Overall Study|Withdrawal by Subject|1|||
30912197|NCT02238626|58947349|FG000|Overall Study|Death|0|||
30912198|NCT02238626|58947350|FG001|Overall Study|Death|0|||
30912199|NCT02238626|58947351|FG002|Overall Study|Death|1|||
30912200|NCT02238626|58947352|FG003|Overall Study|Death|1|||
30912201|NCT02238626|58947349|FG000|Overall Study|Other|0|||
30912202|NCT02238626|58947350|FG001|Overall Study|Other|2|||
30912203|NCT02238626|58947351|FG002|Overall Study|Other|0|||
30912204|NCT02238626|58947352|FG003|Overall Study|Other|0|||
30912205|NCT02151643|58947378|FG000|Overall Study|Adverse Event|2|||
30912206|NCT02151643|58947379|FG001|Overall Study|Adverse Event|0|||
30912207|NCT02151643|58947380|FG002|Overall Study|Adverse Event|1|||
30912208|NCT02151643|58947381|FG003|Overall Study|Adverse Event|4|||
30912209|NCT02151643|58947382|FG004|Overall Study|Adverse Event|0|||
30912210|NCT02151643|58947378|FG000|Overall Study|Withdrawal by Subject|0|||
30912211|NCT02151643|58947379|FG001|Overall Study|Withdrawal by Subject|1|||
30622821|NCT01166568|58634570|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
30622822|NCT01166568|58634571|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
30622823|NCT01166568|58634572|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
30622824|NCT01166178|58634580|FG000|Overall Study|Withdrawal by Subject|1|||
30622825|NCT01166178|58634581|FG001|Overall Study|Withdrawal by Subject|0|||
30816897|NCT03210259|58836836|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
30816898|NCT03210259|58836837|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
30816899|NCT03210259|58836835|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
30912212|NCT02151643|58947380|FG002|Overall Study|Withdrawal by Subject|1|||
30912213|NCT02151643|58947381|FG003|Overall Study|Withdrawal by Subject|1|||
30912214|NCT02151643|58947382|FG004|Overall Study|Withdrawal by Subject|1|||
30912215|NCT02151643|58947378|FG000|Overall Study|Hyperphosphataemia|1|||
30912216|NCT02151643|58947379|FG001|Overall Study|Hyperphosphataemia|0|||
30912217|NCT02151643|58947380|FG002|Overall Study|Hyperphosphataemia|0|||
30912218|NCT02151643|58947381|FG003|Overall Study|Hyperphosphataemia|0|||
30912219|NCT02151643|58947382|FG004|Overall Study|Hyperphosphataemia|1|||
30622826|NCT01166178|58634580|FG000|Overall Study|Study was terminated|20|||
30622827|NCT01166178|58634581|FG001|Overall Study|Study was terminated|8|||
30622828|NCT00924820|58634587|FG000|Overall Study|Death|2|||
30622829|NCT00924820|58634587|FG000|Overall Study|Ineligible, Screen Failure|5|||
30622830|NCT01225172|58634593|FG000|Overall Study|Subject decision to stop|1|||
30622831|NCT01225172|58634594|FG001|Overall Study|Subject decision to stop|0|||
30751619|NCT00423449|58761343|FG001|Overall Study|Progressive Disease|3|||
30751620|NCT00423449|58761344|FG002|Overall Study|Progressive Disease|8|||
30751621|NCT00423449|58761345|FG003|Overall Study|Progressive Disease|11|||
30751622|NCT00423449|58761346|FG004|Overall Study|Progressive Disease|4|||
30751623|NCT00423449|58761342|FG000|Overall Study|Laboratory Adverse Event|0|||
30751624|NCT00423449|58761343|FG001|Overall Study|Laboratory Adverse Event|1|||
30751625|NCT00423449|58761344|FG002|Overall Study|Laboratory Adverse Event|2|||
30751626|NCT00423449|58761345|FG003|Overall Study|Laboratory Adverse Event|0|||
30751627|NCT00423449|58761346|FG004|Overall Study|Laboratory Adverse Event|0|||
30751628|NCT00423449|58761342|FG000|Overall Study|Other|0|||
30751629|NCT00423449|58761343|FG001|Overall Study|Other|0|||
30751630|NCT00423449|58761344|FG002|Overall Study|Other|0|||
30751631|NCT00423449|58761345|FG003|Overall Study|Other|1|||
30751632|NCT00423449|58761346|FG004|Overall Study|Other|0|||
30751633|NCT00423449|58761342|FG000|Overall Study|Protocol Violation|0|||
30751634|NCT00423449|58761343|FG001|Overall Study|Protocol Violation|0|||
30751635|NCT00423449|58761344|FG002|Overall Study|Protocol Violation|2|||
30751636|NCT00423449|58761345|FG003|Overall Study|Protocol Violation|1|||
30751637|NCT00423449|58761346|FG004|Overall Study|Protocol Violation|0|||
30751638|NCT00423293|58761359|FG000|Overall Study|Ineligible / No protocol treatment|11|||
30816900|NCT03210259|58836836|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
30816901|NCT03210259|58836837|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
30816902|NCT03210259|58836835|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
30816903|NCT03210259|58836836|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
30816904|NCT03210259|58836837|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
30816905|NCT03257657|58836846|FG000|Overall Study|Lost to Follow-up|0|||
30816906|NCT03257657|58836847|FG001|Overall Study|Lost to Follow-up|3|||
30816907|NCT03257657|58836846|FG000|Overall Study|Withdrawn|0|||
30816908|NCT03257657|58836847|FG001|Overall Study|Withdrawn|1|||
30816909|NCT03257657|58836846|FG000|Overall Study|Noted not eligible right after enrolled|0|||
30816910|NCT03257657|58836847|FG001|Overall Study|Noted not eligible right after enrolled|1|||
30816911|NCT02496611|58836856|FG000|Overall Study|Lost to Follow-up|2|||
30816912|NCT02496611|58836857|FG001|Overall Study|Lost to Follow-up|1|||
30816913|NCT02496611|58836856|FG000|Overall Study|Withdrawal by Subject|5|||
30816914|NCT02496611|58836857|FG001|Overall Study|Withdrawal by Subject|2|||
30816915|NCT03237481|58836867|FG000|Overall Study|Lost to Follow-up|1|||
30816916|NCT03237481|58836868|FG001|Overall Study|Lost to Follow-up|0|||
30816917|NCT03237481|58836869|FG002|Overall Study|Lost to Follow-up|0|||
30816918|NCT03237481|58836867|FG000|Overall Study|Protocol Violation|1|||
30816919|NCT03237481|58836868|FG001|Overall Study|Protocol Violation|0|||
30816920|NCT03237481|58836869|FG002|Overall Study|Protocol Violation|0|||
30816921|NCT03237481|58836867|FG000|Overall Study|Withdrawal by Subject|3|||
30816922|NCT03237481|58836868|FG001|Overall Study|Withdrawal by Subject|2|||
30816923|NCT03237481|58836869|FG002|Overall Study|Withdrawal by Subject|1|||
30816924|NCT03222349|58836877|FG000|Overall Study|Treatment B not done|5|||
30816925|NCT03222349|58836878|FG001|Overall Study|Treatment B not done|0|||
30816926|NCT03222349|58836877|FG000|Overall Study|Lost to Follow-up|1|||
30816927|NCT03222349|58836878|FG001|Overall Study|Lost to Follow-up|2|||
30816928|NCT03222349|58836877|FG000|Overall Study|Withdrawal by Subject|1|||
30816929|NCT03222349|58836878|FG001|Overall Study|Withdrawal by Subject|0|||
30816930|NCT03222349|58836877|FG000|Overall Study|Treatment A not done|0|||
30816931|NCT03222349|58836878|FG001|Overall Study|Treatment A not done|5|||
30816932|NCT03222349|58836877|FG000|Overall Study|Study terminated by sponsor|1|||
30816933|NCT03222349|58836878|FG001|Overall Study|Study terminated by sponsor|0|||
30816934|NCT02927925|58836891|FG000|Overall Study|Death|16|||
30816935|NCT02927925|58836891|FG000|Overall Study|Physician Decision|1|||
30816936|NCT02927925|58836891|FG000|Overall Study|Withdrawal by Subject|11|||
30816937|NCT02927925|58836891|FG000|Overall Study|Other|3|||
30816938|NCT02927925|58836891|FG000|Overall Study|Disease progression at clinical cutoff|1|||
30816939|NCT03208933|58836895|FG000|Overall Study|Death|3|||
30816940|NCT03208933|58836895|FG000|Overall Study|Withdrawal by Subject|3|||
30816941|NCT03208933|58836895|FG000|Overall Study|Adverse Event|1|||
30816942|NCT03208933|58836895|FG000|Overall Study|Lost to Follow-up|2|||
30816943|NCT03208933|58836895|FG000|Overall Study|Physician Decision|3|||
30816944|NCT03208933|58836895|FG000|Overall Study|Protocol Violation|1|||
30816945|NCT02499120|58836901|FG000|Overall Study|Death|45|||
30816946|NCT02499120|58836902|FG001|Overall Study|Death|42|||
30816947|NCT02499120|58836901|FG000|Overall Study|Lost to Follow-up|1|||
30816948|NCT02499120|58836902|FG001|Overall Study|Lost to Follow-up|2|||
30816949|NCT02499120|58836901|FG000|Overall Study|Participant refused further follow-up|1|||
30816950|NCT02499120|58836902|FG001|Overall Study|Participant refused further follow-up|0|||
30816951|NCT02499120|58836901|FG000|Overall Study|Withdrawal by Subject|2|||
30816952|NCT02499120|58836902|FG001|Overall Study|Withdrawal by Subject|5|||
30816953|NCT02499120|58836901|FG000|Overall Study|Other|1|||
30816954|NCT02499120|58836902|FG001|Overall Study|Other|0|||
30816955|NCT02499120|58836901|FG000|Overall Study|Ongoing on study|15|||
30816956|NCT02499120|58836902|FG001|Overall Study|Ongoing on study|11|||
30816957|NCT03207763|58836910|FG000|Overall Study|Lost to Follow-up|1|||
30816958|NCT03207763|58836911|FG001|Overall Study|Lost to Follow-up|0|||
30816959|NCT04766034|58836930|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
30816960|NCT04766034|58836931|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
30816961|NCT04766034|58836932|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
30816962|NCT04766034|58836933|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
30816963|NCT04766034|58836934|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
30816964|NCT04766034|58836930|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
30816965|NCT04766034|58836931|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
30816966|NCT04766034|58836932|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
30816967|NCT04766034|58836933|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
30816968|NCT04766034|58836934|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
30816969|NCT04766034|58836930|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
30816970|NCT04766034|58836931|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
30816971|NCT04766034|58836932|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
30816972|NCT04766034|58836933|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
30816973|NCT04766034|58836934|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
30816974|NCT04766034|58836930|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
30816975|NCT04766034|58836931|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
30816976|NCT04766034|58836932|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
30816977|NCT04766034|58836933|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
30816978|NCT04766034|58836934|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
30816979|NCT03237013|58836949|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
30816980|NCT03237013|58836950|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
30816981|NCT03237013|58836951|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
30816982|NCT03236779|58836961|FG000|Overall Study|Lost to Follow-up|13|||
30816983|NCT03236779|58836962|FG001|Overall Study|Lost to Follow-up|21|||
30816984|NCT03096483|58836970|FG000|Overall Study|Withdrawal by site|1|||
30816985|NCT02932579|58836976|FG000|Overall Study|Withdrawal by Subject|4|||
30816986|NCT02932579|58836977|FG001|Overall Study|Withdrawal by Subject|1|||
30816987|NCT03207451|58836987|FG000|Overall Study|scheduling conflict|1|||
30816988|NCT03207451|58836988|FG001|Overall Study|scheduling conflict|0|||
30816989|NCT03207451|58836989|FG002|Overall Study|scheduling conflict|2|||
30816990|NCT03207451|58836990|FG003|Overall Study|scheduling conflict|2|||
30816991|NCT03207451|58836987|FG000|Overall Study|Adverse Event|0|||
30816992|NCT03207451|58836988|FG001|Overall Study|Adverse Event|0|||
30816993|NCT03207451|58836989|FG002|Overall Study|Adverse Event|0|||
30816994|NCT03207451|58836990|FG003|Overall Study|Adverse Event|1|||
30816995|NCT03350503|58837017|FG000|Overall Study|Adverse Event|5|||
30816996|NCT03350503|58837017|FG000|Overall Study|Withdrawal by Subject|5|||
30912220|NCT02151643|58947378|FG000|Overall Study|High Ferritin levels|3|||
30912221|NCT02151643|58947379|FG001|Overall Study|High Ferritin levels|3|||
30816997|NCT03350503|58837017|FG000|Overall Study|Continuation impossible due to move|4|||
30816998|NCT03350503|58837017|FG000|Overall Study|Physician Decision|3|||
30816999|NCT03288779|58837040|FG000|Overall Study|Withdrawal by Subject|3|||
30817000|NCT03206749|58837047|FG000|Overall Study|Withdrawal of consent|5|||
30817001|NCT03206749|58837048|FG001|Overall Study|Withdrawal of consent|3|||
30817002|NCT03206749|58837049|FG002|Overall Study|Withdrawal of consent|6|||
30817003|NCT03206749|58837047|FG000|Overall Study|Lost to Follow-up|0|||
30817004|NCT03206749|58837048|FG001|Overall Study|Lost to Follow-up|0|||
30817005|NCT03206749|58837049|FG002|Overall Study|Lost to Follow-up|1|||
30817006|NCT03255941|58837069|FG000|Overall Study|Not eligible or refused injection|37|||
30817007|NCT03255941|58837070|FG001|Overall Study|Not eligible or refused injection|44|||
30817008|NCT03255941|58837071|FG002|Overall Study|Not eligible or refused injection|5|||
30817009|NCT03255941|58837072|FG003|Overall Study|Not eligible or refused injection|6|||
30817010|NCT03255941|58837069|FG000|Overall Study|Did not complete exit interview|1|||
30817011|NCT03255941|58837070|FG001|Overall Study|Did not complete exit interview|2|||
30817012|NCT03255941|58837071|FG002|Overall Study|Did not complete exit interview|0|||
30817013|NCT03255941|58837072|FG003|Overall Study|Did not complete exit interview|0|||
30817014|NCT03255629|58837094|FG000|Overall Study|Adverse Event|1|||
30817015|NCT03255629|58837095|FG001|Overall Study|Adverse Event|0|||
30817016|NCT03255629|58837094|FG000|Overall Study|did not experience hypoglycemia|2|||
30817017|NCT03255629|58837095|FG001|Overall Study|did not experience hypoglycemia|1|||
30817018|NCT03031938|58837104|FG000|Overall Study|Death|1|||
30817019|NCT03031938|58837105|FG001|Overall Study|Death|0|||
30817020|NCT01137773|58837113|FG000|Overall Study|Death|3|||
30817021|NCT01137773|58837114|FG001|Overall Study|Death|3|||
30817022|NCT01137773|58837113|FG000|Overall Study|Lost to Follow-up|6|||
30817023|NCT01137773|58837114|FG001|Overall Study|Lost to Follow-up|0|||
30817024|NCT03094611|58837122|FG000|Overall Study|Lack of Efficacy|1|||
30817025|NCT03094611|58837122|FG000|Overall Study|Stem Cell Transplant|1|||
30817026|NCT04105725|58837146|FG000|Primary Intervention|Lost to Follow-up|0|||
30817027|NCT04105725|58837147|FG001|Primary Intervention|Lost to Follow-up|2|||
30817028|NCT04105725|58837146|FG000|Primary Intervention|Withdrawal by Subject|0|||
30817029|NCT04105725|58837147|FG001|Primary Intervention|Withdrawal by Subject|1|||
30817030|NCT04066023|58837156|FG000|Overall Study|Adverse Event|0|||
30912222|NCT02151643|58947380|FG002|Overall Study|High Ferritin levels|2|||
30912223|NCT02151643|58947381|FG003|Overall Study|High Ferritin levels|2|||
30912224|NCT02151643|58947382|FG004|Overall Study|High Ferritin levels|1|||
30912225|NCT02203838|58947398|FG000|Overall Study|Lack of Efficacy|7|||
30912226|NCT02203838|58947399|FG001|Overall Study|Lack of Efficacy|0|||
30912227|NCT02203838|58947400|FG002|Overall Study|Lack of Efficacy|1|||
30912228|NCT02203838|58947401|FG003|Overall Study|Lack of Efficacy|1|||
30912229|NCT02203838|58947398|FG000|Overall Study|Adverse Event|46|||
30912230|NCT02203838|58947399|FG001|Overall Study|Adverse Event|6|||
30912231|NCT02203838|58947400|FG002|Overall Study|Adverse Event|3|||
30912232|NCT02203838|58947401|FG003|Overall Study|Adverse Event|2|||
30912233|NCT02203838|58947398|FG000|Overall Study|Lost to Follow-up|39|||
30912234|NCT02203838|58947399|FG001|Overall Study|Lost to Follow-up|3|||
30912235|NCT02203838|58947400|FG002|Overall Study|Lost to Follow-up|2|||
30912236|NCT02203838|58947401|FG003|Overall Study|Lost to Follow-up|1|||
30912237|NCT02203838|58947398|FG000|Overall Study|Protocol Violation|7|||
30622832|NCT01225172|58634593|FG000|Overall Study|Subject request to discontinue treatment|3|||
30622833|NCT01225172|58634594|FG001|Overall Study|Subject request to discontinue treatment|1|||
30622834|NCT01225172|58634593|FG000|Overall Study|Subject no longer meets study criteria|1|||
30622835|NCT01225172|58634594|FG001|Overall Study|Subject no longer meets study criteria|0|||
30622836|NCT01225172|58634593|FG000|Overall Study|Withdrawal by Subject|1|||
30622837|NCT01225172|58634594|FG001|Overall Study|Withdrawal by Subject|0|||
30622838|NCT01143324|58634600|FG000|Overall Study|Lost to Follow-up|11|||
30751639|NCT00423137|58761367|FG000|Overall Study|Lost to Follow-up|0|||
30751640|NCT00423137|58761368|FG001|Overall Study|Lost to Follow-up|0|||
30751641|NCT00423137|58761369|FG002|Overall Study|Lost to Follow-up|1|||
30751642|NCT00423137|58761370|FG003|Overall Study|Lost to Follow-up|0|||
30751643|NCT00423137|58761367|FG000|Overall Study|Protocol Violation|0|||
30751644|NCT00423137|58761368|FG001|Overall Study|Protocol Violation|0|||
30751645|NCT00423137|58761369|FG002|Overall Study|Protocol Violation|0|||
30751646|NCT00423137|58761370|FG003|Overall Study|Protocol Violation|1|||
30751647|NCT00423137|58761367|FG000|Overall Study|Adverse Event Study disease worse|1|||
30751648|NCT00423137|58761368|FG001|Overall Study|Adverse Event Study disease worse|0|||
30817031|NCT04066023|58837157|FG001|Overall Study|Adverse Event|0|||
30817032|NCT04066023|58837158|FG002|Overall Study|Adverse Event|1|||
30751649|NCT00423137|58761369|FG002|Overall Study|Adverse Event Study disease worse|3|||
30751650|NCT00423137|58761370|FG003|Overall Study|Adverse Event Study disease worse|1|||
30817033|NCT04066023|58837156|FG000|Overall Study|Sponsor decision|3|||
30817034|NCT04066023|58837157|FG001|Overall Study|Sponsor decision|6|||
30817035|NCT04066023|58837158|FG002|Overall Study|Sponsor decision|2|||
30817036|NCT04066023|58837156|FG000|Overall Study|Physician Decision|0|||
30817037|NCT04066023|58837157|FG001|Overall Study|Physician Decision|0|||
30912238|NCT02203838|58947399|FG001|Overall Study|Protocol Violation|3|||
30912239|NCT02203838|58947400|FG002|Overall Study|Protocol Violation|0|||
30912240|NCT02203838|58947401|FG003|Overall Study|Protocol Violation|0|||
30912241|NCT02203838|58947398|FG000|Overall Study|Withdrawal by Subject|83|||
30912242|NCT02203838|58947399|FG001|Overall Study|Withdrawal by Subject|10|||
30622839|NCT01143324|58634600|FG000|Overall Study|Withdrawal by Subject|4|||
30622840|NCT01143324|58634600|FG000|Overall Study|Explant of the device|4|||
30622841|NCT01224782|58634604|FG000|Overall Study|Lost to Follow-up|177|||
30622842|NCT01224782|58634604|FG000|Overall Study|Withdrawal by Subject|16|||
30622843|NCT01224782|58634604|FG000|Overall Study|Death|14|||
30622844|NCT01224782|58634604|FG000|Overall Study|Improvement|13|||
30622845|NCT01224782|58634604|FG000|Overall Study|Adverse Event|12|||
30622846|NCT01224782|58634604|FG000|Overall Study|Adverse Reaction|11|||
30622847|NCT01224782|58634604|FG000|Overall Study|Noncompliance|10|||
30622848|NCT01224782|58634604|FG000|Overall Study|Other|4|||
30622849|NCT01224782|58634604|FG000|Overall Study|Start of Dialysis|3|||
30622850|NCT01224782|58634604|FG000|Overall Study|Change of Treatment|1|||
30622851|NCT01224782|58634604|FG000|Overall Study|Financial Reasons|1|||
30622852|NCT01224782|58634604|FG000|Overall Study|Deterioration|1|||
30622853|NCT01224782|58634604|FG000|Overall Study|Transplantation|1|||
30622854|NCT01224158|58634610|FG000|Overall Study|Withdrawal by Subject|1|||
30622855|NCT01224158|58634611|FG001|Overall Study|Withdrawal by Subject|0|||
30751651|NCT00423137|58761367|FG000|Overall Study|Adverse Event Other|0|||
30751652|NCT00423137|58761368|FG001|Overall Study|Adverse Event Other|0|||
30751653|NCT00423137|58761369|FG002|Overall Study|Adverse Event Other|2|||
30817038|NCT04066023|58837158|FG002|Overall Study|Physician Decision|1|||
30817039|NCT04066023|58837156|FG000|Overall Study|Lost to Follow-up|0|||
30817040|NCT04066023|58837157|FG001|Overall Study|Lost to Follow-up|1|||
30817041|NCT04066023|58837158|FG002|Overall Study|Lost to Follow-up|1|||
30817042|NCT04066023|58837156|FG000|Overall Study|Noncompliance|0|||
30817043|NCT04066023|58837157|FG001|Overall Study|Noncompliance|1|||
30817044|NCT04066023|58837158|FG002|Overall Study|Noncompliance|1|||
30817045|NCT03106987|58837170|FG000|Overall Study|Death|37|||
30817046|NCT03106987|58837171|FG001|Overall Study|Death|22|||
30817047|NCT03106987|58837172|FG002|Overall Study|Death|12|||
30817048|NCT03106987|58837173|FG003|Overall Study|Death|8|||
30817049|NCT03106987|58837170|FG000|Overall Study|Lost to Follow-up|2|||
30817050|NCT03106987|58837171|FG001|Overall Study|Lost to Follow-up|0|||
30817051|NCT03106987|58837172|FG002|Overall Study|Lost to Follow-up|2|||
30817052|NCT03106987|58837173|FG003|Overall Study|Lost to Follow-up|2|||
30817053|NCT03106987|58837170|FG000|Overall Study|Withdrawal by Subject|5|||
30751654|NCT00423137|58761370|FG003|Overall Study|Adverse Event Other|0|||
30751655|NCT00422903|58761385|FG000|Overall Study|Disease Progression|3|||
30751656|NCT00422903|58761386|FG001|Overall Study|Disease Progression|1|||
30751657|NCT00422903|58761385|FG000|Overall Study|Adverse Event|0|||
30751658|NCT00422903|58761386|FG001|Overall Study|Adverse Event|2|||
30751659|NCT00422903|58761385|FG000|Overall Study|Informed Consent Withdrawn|1|||
30751660|NCT00422903|58761386|FG001|Overall Study|Informed Consent Withdrawn|2|||
30751661|NCT00422669|58761395|FG000|Overall Study|The study was terminated early.|98|||
30751662|NCT00422669|58761396|FG001|Overall Study|The study was terminated early.|100|||
30751663|NCT00422669|58761397|FG002|Overall Study|The study was terminated early.|7|||
30751664|NCT00422591|58761403|FG000|Overall Study|Physician Decision|4|||
30751665|NCT00422591|58761403|FG000|Overall Study|Withdrawal by Subject|2|||
30751666|NCT00422513|58761409|FG000|Overall Study|Lack of Efficacy|4|||
30751667|NCT00422513|58761410|FG001|Overall Study|Lack of Efficacy|5|||
30751668|NCT00422513|58761409|FG000|Overall Study|Protocol Violation|23|||
30751669|NCT00422513|58761410|FG001|Overall Study|Protocol Violation|7|||
30751670|NCT00422513|58761409|FG000|Overall Study|Refused Treatment|4|||
30751671|NCT00422513|58761410|FG001|Overall Study|Refused Treatment|2|||
30751672|NCT00422513|58761409|FG000|Overall Study|Withdrawal by Subject|2|||
30751673|NCT00422513|58761410|FG001|Overall Study|Withdrawal by Subject|1|||
30751674|NCT00422513|58761409|FG000|Overall Study|early termination of the study|67|||
30751675|NCT00422513|58761410|FG001|Overall Study|early termination of the study|80|||
30751676|NCT00422513|58761409|FG000|Overall Study|Adverse Event|4|||
30751677|NCT00422513|58761410|FG001|Overall Study|Adverse Event|4|||
30751678|NCT00422513|58761409|FG000|Overall Study|Death|3|||
30817054|NCT03106987|58837171|FG001|Overall Study|Withdrawal by Subject|1|||
30912243|NCT02203838|58947400|FG002|Overall Study|Withdrawal by Subject|8|||
30622856|NCT01129128|58634620|FG000|Overall Study|Lost to Follow-up|2|||
30622857|NCT01129128|58634621|FG001|Overall Study|Lost to Follow-up|2|||
30751679|NCT00422513|58761410|FG001|Overall Study|Death|7|||
30751680|NCT00202878|58761418|FG000|Overall Study|Death|964|||
30751681|NCT00202878|58761419|FG001|Overall Study|Death|968|||
30751682|NCT00202878|58761418|FG000|Overall Study|Only Vital Status Known|357|||
30751683|NCT00202878|58761419|FG001|Overall Study|Only Vital Status Known|356|||
30751684|NCT00202878|58761418|FG000|Overall Study|Lost to Follow-up|44|||
30751685|NCT00202878|58761419|FG001|Overall Study|Lost to Follow-up|49|||
30751686|NCT00202878|58761418|FG000|Overall Study|Site Closure|39|||
30751687|NCT00202878|58761419|FG001|Overall Study|Site Closure|36|||
30751688|NCT00202878|58761418|FG000|Overall Study|Withdrawal by Subject|795|||
30817055|NCT03106987|58837172|FG002|Overall Study|Withdrawal by Subject|4|||
30817056|NCT03106987|58837173|FG003|Overall Study|Withdrawal by Subject|1|||
30622858|NCT01129128|58634622|FG002|Overall Study|Lost to Follow-up|1|||
30817057|NCT02932267|58837183|FG000|Overall Study|Withdrawal by Subject|3|||
30912244|NCT02203838|58947401|FG003|Overall Study|Withdrawal by Subject|11|||
30817058|NCT02932267|58837183|FG000|Overall Study|Lost to Follow-up|4|||
30817059|NCT02932267|58837183|FG000|Overall Study|Pregnancy|1|||
30817060|NCT03217591|58837190|FG000|Overall Study|Adverse Event|1|||
30817061|NCT03217591|58837191|FG001|Overall Study|Adverse Event|2|||
30817062|NCT03217591|58837192|FG002|Overall Study|Adverse Event|6|||
30817063|NCT03217591|58837190|FG000|Overall Study|Withdrawal by Subject|0|||
30817064|NCT03217591|58837191|FG001|Overall Study|Withdrawal by Subject|1|||
30817065|NCT03217591|58837192|FG002|Overall Study|Withdrawal by Subject|3|||
30817066|NCT03217591|58837190|FG000|Overall Study|Lost to Follow-up|1|||
30817067|NCT03217591|58837191|FG001|Overall Study|Lost to Follow-up|0|||
30817068|NCT03217591|58837192|FG002|Overall Study|Lost to Follow-up|0|||
30817069|NCT03217591|58837190|FG000|Overall Study|Protocol Violation|1|||
30817070|NCT03217591|58837191|FG001|Overall Study|Protocol Violation|0|||
30817071|NCT03217591|58837192|FG002|Overall Study|Protocol Violation|1|||
30817072|NCT03031782|58837201|FG000|Treatment Period 1|Lack of Efficacy|3|||
30817073|NCT03031782|58837202|FG001|Treatment Period 1|Lack of Efficacy|0|||
30817074|NCT03031782|58837203|FG002|Treatment Period 1|Lack of Efficacy|0|||
30817075|NCT03031782|58837204|FG003|Treatment Period 1|Lack of Efficacy|0|||
30817076|NCT03031782|58837205|FG004|Treatment Period 1|Lack of Efficacy|0|||
30817077|NCT03031782|58837201|FG000|Treatment Period 2|Physician Decision|0|||
30817078|NCT03031782|58837202|FG001|Treatment Period 2|Physician Decision|1|||
30817079|NCT03031782|58837203|FG002|Treatment Period 2|Physician Decision|0|||
30912245|NCT02203838|58947398|FG000|Overall Study|Physician Decision|27|||
30817080|NCT03031782|58837204|FG003|Treatment Period 2|Physician Decision|0|||
30817081|NCT03031782|58837205|FG004|Treatment Period 2|Physician Decision|3|||
30817082|NCT03031782|58837201|FG000|Treatment Period 2|Lack of Efficacy|0|||
30817083|NCT03031782|58837202|FG001|Treatment Period 2|Lack of Efficacy|1|||
30817084|NCT03031782|58837203|FG002|Treatment Period 2|Lack of Efficacy|0|||
30817085|NCT03031782|58837204|FG003|Treatment Period 2|Lack of Efficacy|0|||
30817086|NCT03031782|58837205|FG004|Treatment Period 2|Lack of Efficacy|1|||
30817087|NCT03031782|58837201|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30817088|NCT03031782|58837202|FG001|Treatment Period 2|Withdrawal by Subject|3|||
30817089|NCT03031782|58837203|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30817090|NCT03031782|58837204|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30817091|NCT03031782|58837205|FG004|Treatment Period 2|Withdrawal by Subject|1|||
30817092|NCT03031782|58837201|FG000|Treatment Period 2|Adverse Event|0|||
30817093|NCT03031782|58837202|FG001|Treatment Period 2|Adverse Event|1|||
30817094|NCT03031782|58837203|FG002|Treatment Period 2|Adverse Event|2|||
30817095|NCT03031782|58837204|FG003|Treatment Period 2|Adverse Event|0|||
30817096|NCT03031782|58837205|FG004|Treatment Period 2|Adverse Event|0|||
30817097|NCT03031782|58837201|FG000|Treatment Period 3|Withdrawal by Subject|0|||
30817098|NCT03031782|58837202|FG001|Treatment Period 3|Withdrawal by Subject|0|||
30817099|NCT03031782|58837203|FG002|Treatment Period 3|Withdrawal by Subject|0|||
30817100|NCT03031782|58837204|FG003|Treatment Period 3|Withdrawal by Subject|1|||
30817101|NCT03031782|58837205|FG004|Treatment Period 3|Withdrawal by Subject|0|||
30817102|NCT03216265|58837222|FG000|Overall Study|Adverse Event|2|||
30817103|NCT03216265|58837223|FG001|Overall Study|Adverse Event|0|||
30817104|NCT03216265|58837224|FG002|Overall Study|Adverse Event|2|||
30817105|NCT03216265|58837222|FG000|Overall Study|Lost to Follow-up|0|||
30912246|NCT02203838|58947399|FG001|Overall Study|Physician Decision|0|||
30912247|NCT02203838|58947400|FG002|Overall Study|Physician Decision|2|||
30912248|NCT02203838|58947401|FG003|Overall Study|Physician Decision|3|||
30912249|NCT02203838|58947398|FG000|Overall Study|Other|1|||
30912250|NCT02203838|58947399|FG001|Overall Study|Other|0|||
30912251|NCT02203838|58947400|FG002|Overall Study|Other|0|||
30912252|NCT02203838|58947401|FG003|Overall Study|Other|0|||
30912253|NCT02178787|58947413|FG000|Overall Study|Lost to Follow-up|1|||
30912254|NCT02178787|58947414|FG001|Overall Study|Lost to Follow-up|0|||
30912255|NCT02178787|58947413|FG000|Overall Study|Withdrawal by Subject|0|||
30912256|NCT02178787|58947414|FG001|Overall Study|Withdrawal by Subject|2|||
30912257|NCT02178787|58947413|FG000|Overall Study|No TCD window|3|||
30912258|NCT02178787|58947414|FG001|Overall Study|No TCD window|7|||
30912259|NCT02178787|58947413|FG000|Overall Study|Physician Decision|1|||
30912260|NCT02178787|58947414|FG001|Overall Study|Physician Decision|0|||
30817106|NCT03216265|58837223|FG001|Overall Study|Lost to Follow-up|1|||
30817107|NCT03216265|58837224|FG002|Overall Study|Lost to Follow-up|0|||
30817108|NCT03216265|58837222|FG000|Overall Study|Withdrawal by Subject|0|||
30817109|NCT03216265|58837223|FG001|Overall Study|Withdrawal by Subject|0|||
30817110|NCT03216265|58837224|FG002|Overall Study|Withdrawal by Subject|1|||
30817111|NCT04486950|58837246|FG000|Overall Study|Lost to Follow-up|0|||
30817112|NCT04486950|58837247|FG001|Overall Study|Lost to Follow-up|0|||
30817113|NCT04486950|58837248|FG002|Overall Study|Lost to Follow-up|0|||
30817114|NCT04486950|58837249|FG003|Overall Study|Lost to Follow-up|0|||
30817115|NCT04486950|58837250|FG004|Overall Study|Lost to Follow-up|0|||
30912261|NCT02178709|58947422|FG000|Overall Study|Adverse Event|5|||
30912262|NCT02178709|58947422|FG000|Overall Study|Death|2|||
30912263|NCT02178709|58947422|FG000|Overall Study|Withdrawal by Subject|2|||
30817116|NCT04486950|58837251|FG005|Overall Study|Lost to Follow-up|1|||
30817117|NCT04486950|58837252|FG006|Overall Study|Lost to Follow-up|0|||
30817118|NCT04693416|58837274|FG000|Overall Study|Lost to Follow-up|13|||
30817119|NCT04693416|58837275|FG001|Overall Study|Lost to Follow-up|0|||
30817120|NCT00265941|58837283|FG000|Overall Study|Protocol Violation|22|||
30817121|NCT00265941|58837284|FG001|Overall Study|Protocol Violation|25|||
30817122|NCT00265941|58837283|FG000|Overall Study|Lost to Follow-up|1|||
30817123|NCT00265941|58837284|FG001|Overall Study|Lost to Follow-up|1|||
30817124|NCT03882957|58837298|FG000|Overall Study|Did not complete all three arms|1|||
30817125|NCT03201211|58837310|FG000|Overall Study|Adverse Event|1|||
30817126|NCT03201211|58837311|FG001|Overall Study|Adverse Event|0|||
30817127|NCT03201211|58837312|FG002|Overall Study|Adverse Event|0|||
30817128|NCT03201211|58837310|FG000|Overall Study|Protocol Violation|1|||
30622859|NCT01129128|58634620|FG000|Overall Study|Protocol Violation|0|||
30622860|NCT01129128|58634621|FG001|Overall Study|Protocol Violation|1|||
30622861|NCT01129128|58634622|FG002|Overall Study|Protocol Violation|0|||
30622862|NCT01129128|58634620|FG000|Overall Study|Withdrawal by Subject|0|||
30622863|NCT01129128|58634621|FG001|Overall Study|Withdrawal by Subject|1|||
30622864|NCT01129128|58634622|FG002|Overall Study|Withdrawal by Subject|3|||
30622865|NCT01129128|58634620|FG000|Overall Study|Physician Decision|1|||
30622866|NCT01129128|58634621|FG001|Overall Study|Physician Decision|0|||
30622867|NCT01129128|58634622|FG002|Overall Study|Physician Decision|0|||
30622868|NCT01222520|58634632|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
30622869|NCT01222520|58634633|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
30622870|NCT01222520|58634632|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
30622871|NCT01222520|58634633|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
30622872|NCT01222520|58634632|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
30622873|NCT01222520|58634633|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
30622874|NCT01222520|58634632|FG000|Double-blind Period|Adverse Event|0|||
30622875|NCT01222520|58634633|FG001|Double-blind Period|Adverse Event|1|||
30622876|NCT01222520|58634632|FG000|Double-blind Period|Lack of Efficacy|0|||
30622877|NCT01222520|58634633|FG001|Double-blind Period|Lack of Efficacy|1|||
30622878|NCT01222520|58634632|FG000|Double-blind Period|Study medication stolen|1|||
30622879|NCT01222520|58634633|FG001|Double-blind Period|Study medication stolen|0|||
30622880|NCT01221350|58634641|FG000|Overall Study|Discontinued intervention (GERD)|1|||
30817129|NCT03201211|58837311|FG001|Overall Study|Protocol Violation|0|||
30817130|NCT03201211|58837312|FG002|Overall Study|Protocol Violation|0|||
30817131|NCT03201211|58837310|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
30817132|NCT03201211|58837311|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
30622881|NCT01221350|58634642|FG001|Overall Study|Discontinued intervention (GERD)|0|||
30622882|NCT01221350|58634641|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
30622883|NCT01221350|58634642|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
30622884|NCT01221350|58634641|FG000|Overall Study|Withdrawal by Subject|4|||
30622885|NCT01221350|58634642|FG001|Overall Study|Withdrawal by Subject|2|||
30622886|NCT01221272|58634650|FG000|Period 1|Adverse Event|2|||
30622887|NCT01221272|58634651|FG001|Period 1|Adverse Event|0|||
30622888|NCT01221272|58634650|FG000|Period 1|Consent Withdrawal|0|||
30622889|NCT01221272|58634651|FG001|Period 1|Consent Withdrawal|1|||
30622890|NCT01221272|58634650|FG000|Period 1|Significant Dosing Noncompliance|0|||
30622891|NCT01221272|58634651|FG001|Period 1|Significant Dosing Noncompliance|1|||
30751689|NCT00202878|58761419|FG001|Overall Study|Withdrawal by Subject|808|||
30751690|NCT00414011|58761425|FG000|Overall Study|Physician Decision|3|||
30751691|NCT00414011|58761425|FG000|Overall Study|Withdrawal by Subject|2|||
30751692|NCT00231816|58761432|FG000|Overall Study|Adverse Event|1|||
30751693|NCT00231816|58761433|FG001|Overall Study|Adverse Event|0|||
30751694|NCT00231816|58761432|FG000|Overall Study|Lost to Follow-up|8|||
30751695|NCT00231816|58761433|FG001|Overall Study|Lost to Follow-up|5|||
30751696|NCT00231816|58761432|FG000|Overall Study|Protocol Violation|2|||
30751697|NCT00231816|58761433|FG001|Overall Study|Protocol Violation|3|||
30817133|NCT03201211|58837312|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
30912264|NCT02178709|58947422|FG000|Overall Study|Physician Decision|2|||
30912265|NCT02178709|58947422|FG000|Overall Study|Disease Progression|5|||
30622892|NCT01221272|58634650|FG000|Period 2|Adverse Event|0|||
30622893|NCT01221272|58634651|FG001|Period 2|Adverse Event|2|||
30751698|NCT00231816|58761432|FG000|Overall Study|Withdrawal by Subject|3|||
30751699|NCT00231816|58761433|FG001|Overall Study|Withdrawal by Subject|3|||
30817134|NCT03201211|58837310|FG000|Overall Study|OTHER unknown reasons|0|||
30622894|NCT01220414|58634662|FG000|Overall Study|Withdrawal by Subject|1|||
30817135|NCT03201211|58837311|FG001|Overall Study|OTHER unknown reasons|1|||
30622895|NCT01220414|58634663|FG001|Overall Study|Withdrawal by Subject|0|||
30622896|NCT01220414|58634664|FG002|Overall Study|Withdrawal by Subject|0|||
30751700|NCT00231816|58761432|FG000|Overall Study|Other|2|||
30817136|NCT03201211|58837312|FG002|Overall Study|OTHER unknown reasons|0|||
30751701|NCT00231816|58761433|FG001|Overall Study|Other|1|||
30817137|NCT04633837|58837322|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
30622897|NCT01220414|58634665|FG003|Overall Study|Withdrawal by Subject|1|||
30622898|NCT01128894|58634674|FG000|Overall Study|Adverse Event|31|||
30622899|NCT01128894|58634675|FG001|Overall Study|Adverse Event|41|||
30817138|NCT04633837|58837323|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
30817139|NCT03029832|58837331|FG000|Overall Study|Safety Follow-Up Completed|2|||
30817140|NCT03029832|58837332|FG001|Overall Study|Safety Follow-Up Completed|0|||
30817141|NCT03029832|58837331|FG000|Overall Study|Death due to Disease Progression|1|||
30817142|NCT03029832|58837332|FG001|Overall Study|Death due to Disease Progression|0|||
30817143|NCT03029832|58837331|FG000|Overall Study|Study Terminated By Sponsor|1|||
30817144|NCT03029832|58837332|FG001|Overall Study|Study Terminated By Sponsor|1|||
30817145|NCT03089697|58837340|FG000|Overall Study|Adverse Event|1|||
30817146|NCT03089697|58837341|FG001|Overall Study|Adverse Event|2|||
30817147|NCT03089697|58837340|FG000|Overall Study|Withdrawal by Subject|1|||
30817148|NCT03089697|58837341|FG001|Overall Study|Withdrawal by Subject|0|||
30817149|NCT03199963|58837349|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
30817150|NCT03199963|58837350|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
30817151|NCT03199963|58837349|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
30622900|NCT01128894|58634674|FG000|Overall Study|Protocol Violation|2|||
30751702|NCT00260208|58761442|FG000|Overall Study|Subject withdrew consent|11|||
30817152|NCT03199963|58837350|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
30817153|NCT03199963|58837349|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
30817154|NCT03199963|58837350|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
30817155|NCT03199963|58837349|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
30817156|NCT03199963|58837350|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
30817157|NCT03199963|58837349|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
30817158|NCT03199963|58837350|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
30817159|NCT03199963|58837349|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
30817160|NCT03199963|58837350|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
30817161|NCT03257631|58837366|FG000|Overall Study|Death|8|||
30817162|NCT03257631|58837367|FG001|Overall Study|Death|5|||
30817163|NCT03257631|58837368|FG002|Overall Study|Death|13|||
30817164|NCT03257631|58837369|FG003|Overall Study|Death|5|||
30817165|NCT03257631|58837366|FG000|Overall Study|Progressive Disease|0|||
30751703|NCT00260208|58761443|FG001|Overall Study|Subject withdrew consent|7|||
30751704|NCT00260208|58761442|FG000|Overall Study|Lost to Follow-up|6|||
30751705|NCT00260208|58761443|FG001|Overall Study|Lost to Follow-up|1|||
30751706|NCT00260208|58761442|FG000|Overall Study|Death|12|||
30751707|NCT00260208|58761443|FG001|Overall Study|Death|10|||
30751708|NCT00260208|58761442|FG000|Overall Study|Missing|18|||
30751709|NCT00260208|58761443|FG001|Overall Study|Missing|16|||
30751710|NCT00202644|58761451|FG000|Overall Study|Adverse Event|12|||
30622901|NCT01128894|58634675|FG001|Overall Study|Protocol Violation|1|||
30622902|NCT01128894|58634674|FG000|Overall Study|Noncompliance|4|||
30751711|NCT00202644|58761452|FG001|Overall Study|Adverse Event|13|||
30751712|NCT00202644|58761451|FG000|Overall Study|Withdrawal by Subject|8|||
30751713|NCT00202644|58761452|FG001|Overall Study|Withdrawal by Subject|6|||
30751714|NCT00202644|58761451|FG000|Overall Study|Lack of Efficacy|6|||
30751715|NCT00202644|58761452|FG001|Overall Study|Lack of Efficacy|6|||
30751716|NCT00202644|58761451|FG000|Overall Study|Lost to Follow-up|0|||
30751717|NCT00202644|58761452|FG001|Overall Study|Lost to Follow-up|1|||
30751718|NCT00202644|58761451|FG000|Overall Study|Other|9|||
30751719|NCT00202644|58761452|FG001|Overall Study|Other|1|||
30751720|NCT01235962|58761462|FG000|Overall Study|Withdrawal by Subject|20|||
30751721|NCT01235962|58761463|FG001|Overall Study|Withdrawal by Subject|19|||
30751722|NCT01235962|58761464|FG002|Overall Study|Withdrawal by Subject|62|||
30751723|NCT01235962|58761465|FG003|Overall Study|Withdrawal by Subject|49|||
30751724|NCT01235962|58761462|FG000|Overall Study|Lost to Follow-up|21|||
30751725|NCT01235962|58761463|FG001|Overall Study|Lost to Follow-up|16|||
30817166|NCT03257631|58837367|FG001|Overall Study|Progressive Disease|0|||
30751726|NCT01235962|58761464|FG002|Overall Study|Lost to Follow-up|47|||
30751727|NCT01235962|58761465|FG003|Overall Study|Lost to Follow-up|32|||
30817167|NCT03257631|58837368|FG002|Overall Study|Progressive Disease|1|||
30817168|NCT03257631|58837369|FG003|Overall Study|Progressive Disease|0|||
30912266|NCT02238080|58947426|FG000|Overall Study|Death|13|||
30817169|NCT03257631|58837366|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30817170|NCT03257631|58837367|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
30817171|NCT03257631|58837368|FG002|Overall Study|Withdrawal by Parent/Guardian|4|||
30817172|NCT03257631|58837369|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
30817173|NCT03257631|58837366|FG000|Overall Study|Lost to Follow-up|0|||
30817174|NCT03257631|58837367|FG001|Overall Study|Lost to Follow-up|0|||
30817175|NCT03257631|58837368|FG002|Overall Study|Lost to Follow-up|1|||
30817176|NCT03257631|58837369|FG003|Overall Study|Lost to Follow-up|0|||
30817177|NCT03257631|58837366|FG000|Overall Study|Still on Study|3|||
30817178|NCT03257631|58837367|FG001|Overall Study|Still on Study|2|||
30817179|NCT03257631|58837368|FG002|Overall Study|Still on Study|4|||
30817180|NCT03257631|58837369|FG003|Overall Study|Still on Study|4|||
30817181|NCT03883581|58837379|FG000|Overall Study|Withdrawal by Subject|4|||
30817182|NCT03029208|58837385|FG000|Overall Study|Withdrawal by Subject|2|||
30817183|NCT03029208|58837386|FG001|Overall Study|Withdrawal by Subject|3|||
30817184|NCT03029208|58837385|FG000|Overall Study|Lost to Follow-up|0|||
30817185|NCT03029208|58837386|FG001|Overall Study|Lost to Follow-up|1|||
30817186|NCT03198715|58837406|FG000|Overall Study|Death|0|||
30817187|NCT03198715|58837407|FG001|Overall Study|Death|0|||
30817188|NCT03198715|58837408|FG002|Overall Study|Death|1|||
30817189|NCT03198715|58837409|FG003|Overall Study|Death|0|||
30817190|NCT03198715|58837410|FG004|Overall Study|Death|2|||
30817191|NCT03198715|58837406|FG000|Overall Study|Other|0|||
30817192|NCT03198715|58837407|FG001|Overall Study|Other|1|||
30817193|NCT03198715|58837408|FG002|Overall Study|Other|1|||
30817194|NCT03198715|58837409|FG003|Overall Study|Other|0|||
30817195|NCT03198715|58837410|FG004|Overall Study|Other|0|||
30817196|NCT03197935|58837433|FG000|Overall Study|Death due to any cause|9|||
30817197|NCT03197935|58837434|FG001|Overall Study|Death due to any cause|7|||
30817198|NCT03197935|58837433|FG000|Overall Study|Lost to Follow-up|0|||
30817199|NCT03197935|58837434|FG001|Overall Study|Lost to Follow-up|3|||
30817200|NCT03197935|58837433|FG000|Overall Study|Physician Decision|0|||
30817201|NCT03197935|58837434|FG001|Overall Study|Physician Decision|1|||
30817202|NCT03197935|58837433|FG000|Overall Study|Withdrawal by Subject|11|||
30817203|NCT03197935|58837434|FG001|Overall Study|Withdrawal by Subject|7|||
30817204|NCT03197935|58837433|FG000|Overall Study|On-Going in Study|147|||
30817205|NCT03197935|58837434|FG001|Overall Study|On-Going in Study|146|||
30817206|NCT03197935|58837433|FG000|Overall Study|Did not receive any study treatment|1|||
30817207|NCT03197935|58837434|FG001|Overall Study|Did not receive any study treatment|1|||
30817208|NCT03088917|58837441|FG000|Overall Study|In care/cured elsewhere|15|||
30817209|NCT03088917|58837441|FG000|Overall Study|Refuse re-evaluation|13|||
30817210|NCT03088917|58837441|FG000|Overall Study|Contact not established|13|||
30817211|NCT03088917|58837441|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
30817212|NCT03088917|58837441|FG000|Overall Study|Moved outside study region|50|||
30817213|NCT03087513|58837447|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
30817214|NCT02917629|58837462|FG000|Overall Study|Withdrawal by Subject|0|||
30817215|NCT02917629|58837463|FG001|Overall Study|Withdrawal by Subject|1|||
30817216|NCT02927847|58837472|FG000|Overall Study|Lost to Follow-up|1|||
30817217|NCT02927847|58837473|FG001|Overall Study|Lost to Follow-up|0|||
30817218|NCT02927847|58837472|FG000|Overall Study|Withdrawal by Subject|4|||
30817219|NCT02927847|58837473|FG001|Overall Study|Withdrawal by Subject|2|||
30817220|NCT02927847|58837472|FG000|Overall Study|PI withdrawn due to missed visits|1|||
30817221|NCT02927847|58837473|FG001|Overall Study|PI withdrawn due to missed visits|1|||
30912267|NCT02238080|58947426|FG000|Overall Study|Treatment interrupted|6|||
30912268|NCT02238080|58947426|FG000|Overall Study|Withdrawal by Subject|2|||
30912269|NCT02238080|58947426|FG000|Overall Study|Other|4|||
30912270|NCT02150863|58947433|FG000|Overall Study|Lost to Follow-up|0|||
30912271|NCT02150863|58947434|FG001|Overall Study|Lost to Follow-up|1|||
30912272|NCT02150863|58947435|FG002|Overall Study|Lost to Follow-up|0|||
30622903|NCT01128894|58634675|FG001|Overall Study|Noncompliance|5|||
30817222|NCT02960438|58837483|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
30817223|NCT02960438|58837484|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
30817224|NCT02960438|58837485|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
30817225|NCT02960438|58837486|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
30817226|NCT02960438|58837483|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
30817227|NCT02960438|58837484|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
30817228|NCT02960438|58837485|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
30817229|NCT02960438|58837486|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
30817230|NCT02960438|58837483|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
30817231|NCT02960438|58837484|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
30817232|NCT02960438|58837485|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
30817233|NCT02960438|58837486|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
30817234|NCT02960438|58837483|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
30912273|NCT02178553|58947445|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
30817235|NCT02960438|58837484|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
30817236|NCT02960438|58837485|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
30817237|NCT02960438|58837486|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
30817238|NCT02960438|58837483|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
30912274|NCT02178553|58947446|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
30912275|NCT02178553|58947445|FG000|Overall Study|Physician Decision|0|||
30912276|NCT02178553|58947446|FG001|Overall Study|Physician Decision|4|||
30912277|NCT02178553|58947445|FG000|Overall Study|Technical problem with injection|1|||
30912278|NCT02178553|58947446|FG001|Overall Study|Technical problem with injection|3|||
30912279|NCT01627327|58947454|FG000|Overall Study|Adverse Event|6|||
30912280|NCT01627327|58947455|FG001|Overall Study|Adverse Event|12|||
30912281|NCT01627327|58947454|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
30912282|NCT01627327|58947455|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
30912283|NCT01627327|58947454|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
30912284|NCT01627327|58947455|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
30912285|NCT01627327|58947454|FG000|Overall Study|Protocol Violation|4|||
30912286|NCT01627327|58947455|FG001|Overall Study|Protocol Violation|10|||
30817239|NCT02960438|58837484|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
30817240|NCT02960438|58837485|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
30817241|NCT02960438|58837486|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
30817242|NCT02960438|58837483|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
30817243|NCT02960438|58837484|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
30817244|NCT02960438|58837485|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
30817245|NCT02960438|58837486|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
30817246|NCT02960438|58837483|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
30817247|NCT02960438|58837484|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
30817248|NCT02960438|58837485|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
30817249|NCT02960438|58837486|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
30817250|NCT02960438|58837483|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
30817251|NCT02960438|58837484|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
30817252|NCT02960438|58837485|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
30817253|NCT02960438|58837486|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
30817254|NCT02960438|58837483|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
30817255|NCT02960438|58837484|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
30817256|NCT02960438|58837485|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
30817257|NCT02960438|58837486|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
30817258|NCT02960438|58837483|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
30817259|NCT02960438|58837484|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
30817260|NCT02960438|58837485|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
30817261|NCT02960438|58837486|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
30817262|NCT02960438|58837483|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
30817263|NCT02960438|58837484|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
30817264|NCT02960438|58837485|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
30912287|NCT01627327|58947454|FG000|Overall Study|Lost to Follow-up|1|||
30912288|NCT01627327|58947455|FG001|Overall Study|Lost to Follow-up|3|||
30912289|NCT01627327|58947454|FG000|Overall Study|Physician Decision|1|||
30912290|NCT01627327|58947455|FG001|Overall Study|Physician Decision|0|||
30912291|NCT01627327|58947454|FG000|Overall Study|Withdrawal by Subject|3|||
30751728|NCT01235962|58761462|FG000|Overall Study|Physician Decision|5|||
30751729|NCT01235962|58761463|FG001|Overall Study|Physician Decision|0|||
30751730|NCT01235962|58761464|FG002|Overall Study|Physician Decision|9|||
30751731|NCT01235962|58761465|FG003|Overall Study|Physician Decision|5|||
30751732|NCT00259740|58761485|FG000|Overall Study|Physician Decision|1|||
30751733|NCT00259740|58761486|FG001|Overall Study|Physician Decision|1|||
30751734|NCT00259740|58761485|FG000|Overall Study|Adverse Event|0|||
30751735|NCT00259740|58761486|FG001|Overall Study|Adverse Event|2|||
30751736|NCT00259740|58761485|FG000|Overall Study|Withdrawal by Subject|2|||
30751737|NCT00259740|58761486|FG001|Overall Study|Withdrawal by Subject|6|||
30751738|NCT00259740|58761485|FG000|Overall Study|Death|1|||
30751739|NCT00259740|58761486|FG001|Overall Study|Death|1|||
30751740|NCT00259740|58761485|FG000|Overall Study|Disease progression|19|||
30751741|NCT00259740|58761486|FG001|Overall Study|Disease progression|36|||
30751742|NCT00259740|58761485|FG000|Overall Study|Ongoing|17|||
30751743|NCT00259740|58761486|FG001|Overall Study|Ongoing|3|||
30751744|NCT00259740|58761485|FG000|Overall Study|Other|3|||
30751745|NCT00259740|58761486|FG001|Overall Study|Other|0|||
30751746|NCT00259740|58761485|FG000|Overall Study|Requirement for alternative therapy|0|||
30751747|NCT00259740|58761486|FG001|Overall Study|Requirement for alternative therapy|4|||
30751748|NCT00201006|58761495|FG000|Overall Study|Withdrawal by Subject|7|||
30751749|NCT00201006|58761496|FG001|Overall Study|Withdrawal by Subject|2|||
30751750|NCT00201006|58761497|FG002|Overall Study|Withdrawal by Subject|3|||
30817265|NCT02960438|58837486|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
30817266|NCT02960438|58837483|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
30817267|NCT02960438|58837484|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
30912292|NCT01627327|58947455|FG001|Overall Study|Withdrawal by Subject|3|||
30912293|NCT01627249|58947464|FG000|Overall Study|Death|3|||
30912294|NCT01627249|58947465|FG001|Overall Study|Death|5|||
30912295|NCT01627249|58947466|FG002|Overall Study|Death|3|||
30912296|NCT01627249|58947464|FG000|Overall Study|Withdrawal by Subject|12|||
30912297|NCT01627249|58947465|FG001|Overall Study|Withdrawal by Subject|6|||
30912298|NCT01627249|58947466|FG002|Overall Study|Withdrawal by Subject|9|||
30912299|NCT01627249|58947464|FG000|Overall Study|Missed Visit|1|||
30912300|NCT01627249|58947465|FG001|Overall Study|Missed Visit|1|||
30912301|NCT01627249|58947466|FG002|Overall Study|Missed Visit|0|||
30912302|NCT01688830|58947495|FG000|Overall Study|Lost to Follow-up|0|||
30912303|NCT01688830|58947496|FG001|Overall Study|Lost to Follow-up|0|||
30912304|NCT01688830|58947497|FG002|Overall Study|Lost to Follow-up|0|||
30912305|NCT01688830|58947498|FG003|Overall Study|Lost to Follow-up|0|||
30912306|NCT01688830|58947499|FG004|Overall Study|Lost to Follow-up|0|||
30912307|NCT01688830|58947500|FG005|Overall Study|Lost to Follow-up|0|||
30912308|NCT01688830|58947501|FG006|Overall Study|Lost to Follow-up|0|||
30912309|NCT01688830|58947502|FG007|Overall Study|Lost to Follow-up|0|||
30912310|NCT01688830|58947503|FG008|Overall Study|Lost to Follow-up|0|||
30912311|NCT01688830|58947504|FG009|Overall Study|Lost to Follow-up|0|||
30912312|NCT01688830|58947505|FG010|Overall Study|Lost to Follow-up|1|||
30912313|NCT01688830|58947506|FG011|Overall Study|Lost to Follow-up|0|||
30912314|NCT01688830|58947507|FG012|Overall Study|Lost to Follow-up|0|||
30912315|NCT01688830|58947508|FG013|Overall Study|Lost to Follow-up|0|||
30912316|NCT01688830|58947509|FG014|Overall Study|Lost to Follow-up|0|||
30912317|NCT01688830|58947510|FG015|Overall Study|Lost to Follow-up|0|||
30912318|NCT01688830|58947511|FG016|Overall Study|Lost to Follow-up|0|||
30912319|NCT01688830|58947512|FG017|Overall Study|Lost to Follow-up|0|||
30912320|NCT01688830|58947513|FG018|Overall Study|Lost to Follow-up|0|||
30912321|NCT01688830|58947514|FG019|Overall Study|Lost to Follow-up|0|||
30912322|NCT01688830|58947515|FG020|Overall Study|Lost to Follow-up|0|||
30912323|NCT02178475|58947599|FG000|Overall Study|Withdrawal by Subject|7|||
30912324|NCT02178475|58947599|FG000|Overall Study|Lost to Follow-up|10|||
30912325|NCT02178475|58947599|FG000|Overall Study|Death|13|||
30912326|NCT02178475|58947599|FG000|Overall Study|Protocol-specified Criteria|99|||
30912327|NCT01569022|58947603|FG000|First Intervention|Lost to Follow-up|2|||
30912328|NCT01569022|58947604|FG001|First Intervention|Lost to Follow-up|1|||
30912329|NCT01569022|58947603|FG000|Second Intervention|Lost to Follow-up|2|||
30912330|NCT01569022|58947604|FG001|Second Intervention|Lost to Follow-up|2|||
30912331|NCT01629823|58947615|FG000|Trial Period|Missed visit|11|||
30912332|NCT01629823|58947616|FG001|Trial Period|Missed visit|9|||
30912333|NCT01629823|58947617|FG002|Trial Period|Missed visit|8|||
30912334|NCT01629823|58947615|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
30912335|NCT01629823|58947616|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
30912336|NCT01629823|58947617|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
30912337|NCT01629823|58947615|FG000|Trial Period|Pregnancy|1|||
30912338|NCT01629823|58947616|FG001|Trial Period|Pregnancy|0|||
30912339|NCT01629823|58947617|FG002|Trial Period|Pregnancy|0|||
30912340|NCT01629823|58947615|FG000|Trial Period|Adverse Event|0|||
30912341|NCT01629823|58947616|FG001|Trial Period|Adverse Event|1|||
30912342|NCT01629823|58947617|FG002|Trial Period|Adverse Event|0|||
30912343|NCT01629823|58947615|FG000|Trial Period|Out-of-window visit|0|||
30912344|NCT01629823|58947616|FG001|Trial Period|Out-of-window visit|2|||
30912345|NCT01629823|58947617|FG002|Trial Period|Out-of-window visit|0|||
30912346|NCT01629823|58947615|FG000|Trial Period|Failed to hold medication|0|||
30912347|NCT01629823|58947616|FG001|Trial Period|Failed to hold medication|0|||
30622904|NCT01128894|58634674|FG000|Overall Study|Lost to Follow-up|8|||
30817268|NCT02960438|58837485|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
30817269|NCT02960438|58837486|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
30817270|NCT02957942|58837506|FG000|Overall Study|Withdrawal by Subject|0|||
30817271|NCT02957942|58837507|FG001|Overall Study|Withdrawal by Subject|1|||
30817272|NCT02957942|58837506|FG000|Overall Study|Practicing experiment protocol|0|||
30912348|NCT01629823|58947617|FG002|Trial Period|Failed to hold medication|1|||
30817273|NCT02957942|58837507|FG001|Overall Study|Practicing experiment protocol|6|||
30817274|NCT02959970|58837515|FG000|Overall Study|Adverse Event|1|||
30817275|NCT02959970|58837516|FG001|Overall Study|Adverse Event|0|||
30912349|NCT01629823|58947615|FG000|Washout Period|Safety|2|||
30912350|NCT01629823|58947616|FG001|Washout Period|Safety|5|||
30912351|NCT01629823|58947617|FG002|Washout Period|Safety|0|||
30912352|NCT01629823|58947615|FG000|Washout Period|Pregnancy|1|||
30912353|NCT01629823|58947616|FG001|Washout Period|Pregnancy|0|||
30912354|NCT01629823|58947617|FG002|Washout Period|Pregnancy|0|||
30912355|NCT01629823|58947615|FG000|Washout Period|Protocol Violation|0|||
30912356|NCT01629823|58947616|FG001|Washout Period|Protocol Violation|1|||
30912357|NCT01629823|58947617|FG002|Washout Period|Protocol Violation|0|||
30912358|NCT01688050|58947625|FG000|Overall Study|Death|7|||
30912359|NCT01688050|58947625|FG000|Overall Study|Conversion to open repair|1|||
30817276|NCT02959970|58837515|FG000|Overall Study|Withdrawal by Subject|0|||
30817277|NCT02959970|58837516|FG001|Overall Study|Withdrawal by Subject|2|||
30817278|NCT02959970|58837515|FG000|Overall Study|Lost to Follow-up|1|||
30817279|NCT02959970|58837516|FG001|Overall Study|Lost to Follow-up|5|||
30817280|NCT05300763|58837549|FG000|Overall Study|Adverse Event|0|||
30817281|NCT05300763|58837550|FG001|Overall Study|Adverse Event|1|||
30817282|NCT05300763|58837549|FG000|Overall Study|Major Protocol Deviation|1|||
30817283|NCT05300763|58837550|FG001|Overall Study|Major Protocol Deviation|0|||
30817284|NCT05300763|58837549|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
30817285|NCT05300763|58837550|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
30817286|NCT02925312|58837558|FG000|Overall Study|Lost to Follow-up|25|||
30817287|NCT02925312|58837559|FG001|Overall Study|Lost to Follow-up|0|||
30817288|NCT02925312|58837558|FG000|Overall Study|Adverse Event|2|||
30817289|NCT02925312|58837559|FG001|Overall Study|Adverse Event|0|||
30817290|NCT03196297|58837574|FG000|Main Period|Withdrawal by Subject|4|||
30817291|NCT03196297|58837574|FG000|Extension Period|Withdrawal by Subject|1|||
30817292|NCT03196297|58837574|FG000|Extension Period|Lack of Efficacy|2|||
30817293|NCT03192475|58837599|FG000|Overall Study|Death|0|||
30817294|NCT03192475|58837600|FG001|Overall Study|Death|1|||
30817295|NCT03192475|58837599|FG000|Overall Study|Lost to Follow-up|13|||
30817296|NCT03192475|58837600|FG001|Overall Study|Lost to Follow-up|8|||
30817297|NCT03189745|58837609|FG000|Overall Study|Conflict in work schedule of participant|1|||
30817298|NCT03189745|58837610|FG001|Overall Study|Conflict in work schedule of participant|1|||
30817299|NCT03188263|58837618|FG000|Overall Study|Withdrawal by Subject|3|||
30817300|NCT03188263|58837619|FG001|Overall Study|Withdrawal by Subject|0|||
30817301|NCT03188263|58837618|FG000|Overall Study|Physician Decision|1|||
30817302|NCT03188263|58837619|FG001|Overall Study|Physician Decision|0|||
30817303|NCT03188185|58837627|FG000|Stage 1|Adverse Event|4|||
30817304|NCT03188185|58837628|FG001|Stage 1|Adverse Event|12|||
30817305|NCT03188185|58837629|FG002|Stage 1|Adverse Event|0|||
30817306|NCT03188185|58837630|FG003|Stage 1|Adverse Event|0|||
30817307|NCT03188185|58837627|FG000|Stage 1|Lack of Efficacy|0|||
30817308|NCT03188185|58837628|FG001|Stage 1|Lack of Efficacy|2|||
30817309|NCT03188185|58837629|FG002|Stage 1|Lack of Efficacy|0|||
30817310|NCT03188185|58837630|FG003|Stage 1|Lack of Efficacy|0|||
30817311|NCT03188185|58837627|FG000|Stage 1|Lost to Follow-up|6|||
30817312|NCT03188185|58837628|FG001|Stage 1|Lost to Follow-up|1|||
30817313|NCT03188185|58837629|FG002|Stage 1|Lost to Follow-up|0|||
30817314|NCT03188185|58837630|FG003|Stage 1|Lost to Follow-up|0|||
30817315|NCT03188185|58837627|FG000|Stage 1|Withdrawal by Subject|9|||
30817316|NCT03188185|58837628|FG001|Stage 1|Withdrawal by Subject|0|||
30817317|NCT03188185|58837629|FG002|Stage 1|Withdrawal by Subject|0|||
30817318|NCT03188185|58837630|FG003|Stage 1|Withdrawal by Subject|0|||
30817319|NCT03188185|58837627|FG000|Stage 1|Identified as a professional patient|0|||
30817320|NCT03188185|58837628|FG001|Stage 1|Identified as a professional patient|1|||
30817321|NCT03188185|58837629|FG002|Stage 1|Identified as a professional patient|0|||
30817322|NCT03188185|58837630|FG003|Stage 1|Identified as a professional patient|0|||
30817323|NCT03188185|58837627|FG000|Stage 2|Adverse Event|0|||
30817324|NCT03188185|58837628|FG001|Stage 2|Adverse Event|0|||
30817325|NCT03188185|58837629|FG002|Stage 2|Adverse Event|2|||
30817326|NCT03188185|58837630|FG003|Stage 2|Adverse Event|4|||
30817327|NCT03188185|58837627|FG000|Stage 2|Lack of Efficacy|0|||
30817328|NCT03188185|58837628|FG001|Stage 2|Lack of Efficacy|0|||
30817329|NCT03188185|58837629|FG002|Stage 2|Lack of Efficacy|3|||
30817330|NCT03188185|58837630|FG003|Stage 2|Lack of Efficacy|0|||
30817331|NCT03188185|58837627|FG000|Stage 2|Lost to Follow-up|0|||
30817332|NCT03188185|58837628|FG001|Stage 2|Lost to Follow-up|0|||
30817333|NCT03188185|58837629|FG002|Stage 2|Lost to Follow-up|1|||
30817334|NCT03188185|58837630|FG003|Stage 2|Lost to Follow-up|0|||
30817335|NCT03188185|58837627|FG000|Stage 2|Physician Decision|0|||
30817336|NCT03188185|58837628|FG001|Stage 2|Physician Decision|0|||
30622905|NCT01128894|58634675|FG001|Overall Study|Lost to Follow-up|8|||
30817337|NCT03188185|58837629|FG002|Stage 2|Physician Decision|0|||
30817338|NCT03188185|58837630|FG003|Stage 2|Physician Decision|1|||
30817339|NCT03188185|58837627|FG000|Stage 2|Withdrawal by Subject|0|||
30817340|NCT03188185|58837628|FG001|Stage 2|Withdrawal by Subject|0|||
30817341|NCT03188185|58837629|FG002|Stage 2|Withdrawal by Subject|3|||
30817342|NCT03188185|58837630|FG003|Stage 2|Withdrawal by Subject|1|||
30817343|NCT03186781|58837646|FG000|Overall Study|Lost to Follow-up|0|||
30817344|NCT03186781|58837647|FG001|Overall Study|Lost to Follow-up|0|||
30817345|NCT03186781|58837648|FG002|Overall Study|Lost to Follow-up|1|||
30817346|NCT03186781|58837649|FG003|Overall Study|Lost to Follow-up|0|||
30622906|NCT01128894|58634674|FG000|Overall Study|Withdrawal by Subject|10|||
30622907|NCT01128894|58634675|FG001|Overall Study|Withdrawal by Subject|12|||
30817347|NCT03186781|58837650|FG004|Overall Study|Lost to Follow-up|1|||
30817348|NCT03186781|58837651|FG005|Overall Study|Lost to Follow-up|0|||
30817349|NCT03186781|58837646|FG000|Overall Study|Moved from Area|0|||
30817350|NCT03186781|58837647|FG001|Overall Study|Moved from Area|0|||
30817351|NCT03186781|58837648|FG002|Overall Study|Moved from Area|0|||
30817352|NCT03186781|58837649|FG003|Overall Study|Moved from Area|0|||
30817353|NCT03186781|58837650|FG004|Overall Study|Moved from Area|1|||
30622908|NCT01128894|58634674|FG000|Overall Study|Physician Decision|2|||
30622909|NCT01128894|58634675|FG001|Overall Study|Physician Decision|1|||
30622910|NCT01128894|58634674|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
30622911|NCT01128894|58634675|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
30622912|NCT01220180|58634684|FG000|Overall Study|Lost to Follow-up|76|||
30622913|NCT01220180|58634684|FG000|Overall Study|Other|72|||
30622914|NCT01220180|58634684|FG000|Overall Study|Adverse Event|35|||
30622915|NCT01220180|58634684|FG000|Overall Study|Lack of Efficacy|22|||
30622916|NCT01220180|58634684|FG000|Overall Study|Death|1|||
30622917|NCT01220180|58634684|FG000|Overall Study|Randomized but not treated|1|||
30622918|NCT01220024|58634690|FG000|Overall Study|Lost to Follow-up|1|||
30622919|NCT01220024|58634691|FG001|Overall Study|Lost to Follow-up|1|||
30622920|NCT01128738|58634699|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
30622921|NCT01128738|58634700|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
30622922|NCT01128738|58634699|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
30622923|NCT01128738|58634700|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
30622924|NCT01128738|58634699|FG000|Second TP|Lost to Follow-up|0|||
30622925|NCT01128738|58634700|FG001|Second TP|Lost to Follow-up|1|||
30622926|NCT01128738|58634699|FG000|Second TP|Withdrawal by Subject|0|||
30622927|NCT01128738|58634700|FG001|Second TP|Withdrawal by Subject|2|||
30817354|NCT03186781|58837651|FG005|Overall Study|Moved from Area|0|||
30817355|NCT03186781|58837646|FG000|Overall Study|Withdrawal by Subject|0|||
30817356|NCT03186781|58837647|FG001|Overall Study|Withdrawal by Subject|0|||
30817357|NCT03186781|58837648|FG002|Overall Study|Withdrawal by Subject|0|||
30817358|NCT03186781|58837649|FG003|Overall Study|Withdrawal by Subject|0|||
30817359|NCT03186781|58837650|FG004|Overall Study|Withdrawal by Subject|1|||
30817360|NCT03186781|58837651|FG005|Overall Study|Withdrawal by Subject|0|||
30817361|NCT03184987|58837678|FG000|Overall Study|Withdrawal by Subject|0|||
30817362|NCT03184987|58837679|FG001|Overall Study|Withdrawal by Subject|1|||
30817363|NCT03184987|58837680|FG002|Overall Study|Withdrawal by Subject|2|||
30817364|NCT03184987|58837678|FG000|Overall Study|Physician Decision|0|||
30817365|NCT03184987|58837679|FG001|Overall Study|Physician Decision|0|||
30817366|NCT03184987|58837680|FG002|Overall Study|Physician Decision|1|||
30817367|NCT03184987|58837678|FG000|Overall Study|Adverse Event|1|||
30817368|NCT03184987|58837679|FG001|Overall Study|Adverse Event|0|||
30817369|NCT03184987|58837680|FG002|Overall Study|Adverse Event|1|||
30817370|NCT03184519|58837688|FG000|Overall Study|Lost to Follow-up|6|||
30817371|NCT03184519|58837688|FG000|Overall Study|Physician Decision|21|||
30817372|NCT03184441|58837692|FG000|Overall Study|Withdrawal by Subject|1|||
30817373|NCT03026166|58837701|FG000|Overall Study|Death|22|||
30817374|NCT03026166|58837702|FG001|Overall Study|Death|7|||
30817375|NCT03026166|58837701|FG000|Overall Study|Physician Decision|2|||
30817376|NCT03026166|58837702|FG001|Overall Study|Physician Decision|0|||
30817377|NCT03026166|58837701|FG000|Overall Study|Withdrawal by Subject|1|||
30817378|NCT03026166|58837702|FG001|Overall Study|Withdrawal by Subject|2|||
30817379|NCT03026166|58837701|FG000|Overall Study|Lost to Follow-up|1|||
30817380|NCT03026166|58837702|FG001|Overall Study|Lost to Follow-up|0|||
30817381|NCT03026166|58837701|FG000|Overall Study|Study Terminated by Sponsor|3|||
30817382|NCT03026166|58837702|FG001|Overall Study|Study Terminated by Sponsor|3|||
30817383|NCT03026166|58837701|FG000|Overall Study|Other|1|||
30817384|NCT03026166|58837702|FG001|Overall Study|Other|0|||
30817385|NCT03026088|58837708|FG000|Overall Study|Study termination|20|||
30817386|NCT03181789|58837716|FG000|Overall Study|Withdrawal by Subject|0|||
30817387|NCT03181789|58837717|FG001|Overall Study|Withdrawal by Subject|1|||
30817388|NCT03181789|58837718|FG002|Overall Study|Withdrawal by Subject|1|||
30817389|NCT03181789|58837719|FG003|Overall Study|Withdrawal by Subject|0|||
30817390|NCT03181789|58837716|FG000|Overall Study|Lost to Follow-up|7|||
30817391|NCT03181789|58837717|FG001|Overall Study|Lost to Follow-up|1|||
30817392|NCT03181789|58837718|FG002|Overall Study|Lost to Follow-up|0|||
30817393|NCT03181789|58837719|FG003|Overall Study|Lost to Follow-up|0|||
30817394|NCT03181789|58837716|FG000|Overall Study|Participant unable to adhere to visit|0|||
30817395|NCT03181789|58837717|FG001|Overall Study|Participant unable to adhere to visit|1|||
30817396|NCT03181789|58837718|FG002|Overall Study|Participant unable to adhere to visit|0|||
30622928|NCT01143090|58634707|FG000|Overall Study|Lack of Efficacy|2|||
30622929|NCT01143090|58634707|FG000|Overall Study|Adverse Event|17|||
30622930|NCT01143090|58634707|FG000|Overall Study|Lost to Follow-up|9|||
30622931|NCT01143090|58634707|FG000|Overall Study|Protocol Violation|2|||
30817397|NCT03181789|58837719|FG003|Overall Study|Participant unable to adhere to visit|0|||
30817398|NCT03024606|58837731|FG000|Overall Study|Withdrawal by Subject|9|||
30817399|NCT03024606|58837732|FG001|Overall Study|Withdrawal by Subject|10|||
30817400|NCT03180619|58837741|FG000|Overall Study|Withdrew Consent|5|||
30817401|NCT03180619|58837742|FG001|Overall Study|Withdrew Consent|0|||
30817402|NCT03180619|58837743|FG002|Overall Study|Withdrew Consent|2|||
30912360|NCT01688050|58947625|FG000|Overall Study|Lost to Follow-up|13|||
30622932|NCT01143090|58634707|FG000|Overall Study|Withdrawal by Subject|18|||
30622933|NCT01143090|58634707|FG000|Overall Study|Non-compliance with study drug|1|||
30817403|NCT03180619|58837741|FG000|Overall Study|Death|2|||
30817404|NCT03180619|58837742|FG001|Overall Study|Death|1|||
30817405|NCT03180619|58837743|FG002|Overall Study|Death|2|||
30912361|NCT01688050|58947625|FG000|Overall Study|Withdrawal by Subject|10|||
30912362|NCT01604278|58947631|FG000|Overall Study|Lack of Efficacy|0|||
30912363|NCT01604278|58947632|FG001|Overall Study|Lack of Efficacy|1|||
30912364|NCT01604278|58947631|FG000|Overall Study|Lost to Follow-up|1|||
30912365|NCT01604278|58947632|FG001|Overall Study|Lost to Follow-up|0|||
30912366|NCT01604278|58947631|FG000|Overall Study|Administrative problems|2|||
30912367|NCT01604278|58947632|FG001|Overall Study|Administrative problems|1|||
30912368|NCT01604278|58947631|FG000|Overall Study|Withdrawal by Subject|3|||
30912369|NCT01604278|58947632|FG001|Overall Study|Withdrawal by Subject|3|||
30912370|NCT01604278|58947631|FG000|Overall Study|Adverse Event|3|||
30912371|NCT01604278|58947632|FG001|Overall Study|Adverse Event|5|||
30912372|NCT01604278|58947631|FG000|Overall Study|Protocol Deviation|5|||
30912373|NCT01604278|58947632|FG001|Overall Study|Protocol Deviation|3|||
30912374|NCT01687270|58947638|FG000|Overall Study|Lack of Efficacy|11|||
30912375|NCT01687270|58947638|FG000|Overall Study|Lost to Follow-up|1|||
30912376|NCT01589770|58947644|FG000|Overall Study|EGFR <60ml/min|6|||
30912377|NCT01589770|58947645|FG001|Overall Study|EGFR <60ml/min|4|||
30912378|NCT01589770|58947644|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
30912379|NCT01589770|58947645|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
30912380|NCT01588990|58947651|FG000|Phase A|Withdrawal by Subject|5|||
30622934|NCT01143090|58634707|FG000|Overall Study|Failure to meet eligibility criteria|1|||
30622935|NCT01143090|58634707|FG000|Overall Study|Administrative|1|||
30622936|NCT01165554|58634711|FG000|Overall Study|Withdrawal by Subject|23|||
30622937|NCT01218308|58634720|FG000|Overall Study|Adverse Event|1|||
30622938|NCT01218308|58634721|FG001|Overall Study|Adverse Event|2|||
30622939|NCT01218308|58634720|FG000|Overall Study|Protocol Violation|0|||
30622940|NCT01218308|58634721|FG001|Overall Study|Protocol Violation|2|||
30622941|NCT01218308|58634720|FG000|Overall Study|Withdrawal by Subject|61|||
30622942|NCT01218308|58634721|FG001|Overall Study|Withdrawal by Subject|64|||
30622943|NCT01218308|58634720|FG000|Overall Study|Lost to Follow-up|27|||
30622944|NCT01218308|58634721|FG001|Overall Study|Lost to Follow-up|31|||
30622945|NCT01218308|58634720|FG000|Overall Study|Other|14|||
30622946|NCT01218308|58634721|FG001|Overall Study|Other|21|||
30622947|NCT01165320|58634729|FG000|Overall Study|Clinical adverse experience|2|||
30622948|NCT01165320|58634730|FG001|Overall Study|Clinical adverse experience|1|||
30622949|NCT01165320|58634731|FG002|Overall Study|Clinical adverse experience|0|||
30622950|NCT01165320|58634729|FG000|Overall Study|Laboratory adverse experience|1|||
30622951|NCT01165320|58634730|FG001|Overall Study|Laboratory adverse experience|0|||
30622952|NCT01165320|58634731|FG002|Overall Study|Laboratory adverse experience|0|||
30622953|NCT01165320|58634729|FG000|Overall Study|Lack of Efficacy|0|||
30622954|NCT01165320|58634730|FG001|Overall Study|Lack of Efficacy|2|||
30622955|NCT01165320|58634731|FG002|Overall Study|Lack of Efficacy|0|||
30622956|NCT01165320|58634729|FG000|Overall Study|Reason unknown|0|||
30751751|NCT00201006|58761495|FG000|Overall Study|Adverse Event|1|||
30751752|NCT00201006|58761496|FG001|Overall Study|Adverse Event|0|||
30751753|NCT00201006|58761497|FG002|Overall Study|Adverse Event|1|||
30751754|NCT00200850|58761508|FG000|Overall Study|relocation|1|||
30751755|NCT00200850|58761509|FG001|Overall Study|relocation|0|||
30751756|NCT00200850|58761510|FG002|Overall Study|relocation|1|||
30751757|NCT00200850|58761508|FG000|Overall Study|too busy|1|||
30751758|NCT00200850|58761509|FG001|Overall Study|too busy|0|||
30751759|NCT00200850|58761510|FG002|Overall Study|too busy|0|||
30751760|NCT00200850|58761508|FG000|Overall Study|Pregnancy|0|||
30751761|NCT00200850|58761509|FG001|Overall Study|Pregnancy|0|||
30751762|NCT00200850|58761510|FG002|Overall Study|Pregnancy|1|||
30751763|NCT00200850|58761508|FG000|Overall Study|Poor adherence|0|||
30751764|NCT00200850|58761509|FG001|Overall Study|Poor adherence|0|||
30751765|NCT00200850|58761510|FG002|Overall Study|Poor adherence|1|||
30751766|NCT00200850|58761508|FG000|Overall Study|optic neuritis|0|||
30751767|NCT00200850|58761509|FG001|Overall Study|optic neuritis|0|||
30751768|NCT00200850|58761510|FG002|Overall Study|optic neuritis|1|||
30751769|NCT00200850|58761508|FG000|Overall Study|Adverse Event|1|||
30751770|NCT00200850|58761509|FG001|Overall Study|Adverse Event|1|||
30751771|NCT00200850|58761510|FG002|Overall Study|Adverse Event|2|||
30751772|NCT03812224|58761520|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
30751773|NCT03812224|58761521|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
30751774|NCT03812224|58761520|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
30751775|NCT03812224|58761521|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
30817406|NCT03180619|58837741|FG000|Overall Study|Adverse Event|2|||
30912381|NCT01588990|58947651|FG000|Phase A|Physician Decision|11|||
30622957|NCT01165320|58634730|FG001|Overall Study|Reason unknown|1|||
30751776|NCT03812224|58761520|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
30622958|NCT01165320|58634731|FG002|Overall Study|Reason unknown|0|||
30817407|NCT03180619|58837742|FG001|Overall Study|Adverse Event|0|||
30622959|NCT01217606|58634739|FG000|Initial Treatment Phase|Other Reasons|0|||
30622960|NCT01217606|58634740|FG001|Initial Treatment Phase|Other Reasons|2|||
30622961|NCT01217606|58634739|FG000|Initial Treatment Phase|Protocol Violation|3|||
30622962|NCT01217606|58634740|FG001|Initial Treatment Phase|Protocol Violation|2|||
30622963|NCT01217606|58634739|FG000|Initial Treatment Phase|Personal Reasons|0|||
30622964|NCT01217606|58634740|FG001|Initial Treatment Phase|Personal Reasons|2|||
30622965|NCT01217606|58634739|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
30622966|NCT01217606|58634740|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
30622967|NCT01217606|58634739|FG000|Initial Treatment Phase|Adverse Event|10|||
30622968|NCT01217606|58634740|FG001|Initial Treatment Phase|Adverse Event|6|||
30751777|NCT03812224|58761521|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
30751778|NCT03812224|58761520|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
30751779|NCT03812224|58761521|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
30751780|NCT00231114|58761530|FG000|Randomized|Withdrawal by Subject|6|||
30817408|NCT03180619|58837743|FG002|Overall Study|Adverse Event|1|||
30817409|NCT03180619|58837741|FG000|Overall Study|Investigator's discretion|2|||
30817410|NCT03180619|58837742|FG001|Overall Study|Investigator's discretion|0|||
30817411|NCT03180619|58837743|FG002|Overall Study|Investigator's discretion|1|||
30751781|NCT00231114|58761531|FG001|Randomized|Withdrawal by Subject|3|||
30912382|NCT01588990|58947651|FG000|Phase A|Other|14|||
30751782|NCT00231114|58761530|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
30751783|NCT00231114|58761531|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
30751784|NCT00231114|58761530|FG000|Post-Treatment Period|Lost to Follow-up|6|||
30912383|NCT01588990|58947651|FG000|Phase A|Lost to Follow-up|1|||
30912384|NCT01588990|58947651|FG000|Phase A|Death|5|||
30912385|NCT01588990|58947651|FG000|Phase A|Adverse Event|28|||
30912386|NCT01588990|58947651|FG000|Phase A|Still on therapy at end of study|6|||
30912387|NCT01588990|58947651|FG000|Phase B|Adverse Event|2|||
30912388|NCT01588990|58947651|FG000|Phase B|Still on therapy at end of study|5|||
30751785|NCT00231114|58761531|FG001|Post-Treatment Period|Lost to Follow-up|1|||
30751786|NCT00231114|58761530|FG000|Post-Treatment Period|Physician Decision|1|||
30751787|NCT00231114|58761531|FG001|Post-Treatment Period|Physician Decision|0|||
30751788|NCT00231114|58761530|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
30751789|NCT00231114|58761531|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
30751790|NCT03543046|58761541|FG000|Overall Study|Adverse Event|1|||
30751791|NCT03543046|58761542|FG001|Overall Study|Adverse Event|1|||
30751792|NCT03543046|58761541|FG000|Overall Study|Physician Decision|1|||
30751793|NCT03543046|58761542|FG001|Overall Study|Physician Decision|1|||
30751794|NCT03543046|58761541|FG000|Overall Study|Protocol Violation|1|||
30751795|NCT03543046|58761542|FG001|Overall Study|Protocol Violation|0|||
30751796|NCT00259272|58761561|FG000|Overall Study|Adverse Event|2|||
30751797|NCT00259272|58761562|FG001|Overall Study|Adverse Event|1|||
30751798|NCT00259272|58761563|FG002|Overall Study|Adverse Event|0|||
30751799|NCT00259272|58761564|FG003|Overall Study|Adverse Event|3|||
30751800|NCT00259272|58761561|FG000|Overall Study|Lack of Efficacy|5|||
30751801|NCT00259272|58761562|FG001|Overall Study|Lack of Efficacy|1|||
30751802|NCT00259272|58761563|FG002|Overall Study|Lack of Efficacy|2|||
30751803|NCT00259272|58761564|FG003|Overall Study|Lack of Efficacy|6|||
30751804|NCT00259272|58761561|FG000|Overall Study|Physician Decision|1|||
30751805|NCT00259272|58761562|FG001|Overall Study|Physician Decision|2|||
30751806|NCT00259272|58761563|FG002|Overall Study|Physician Decision|1|||
30751807|NCT00259272|58761564|FG003|Overall Study|Physician Decision|3|||
30751808|NCT00259272|58761561|FG000|Overall Study|Protocol Violation|2|||
30751809|NCT00259272|58761562|FG001|Overall Study|Protocol Violation|0|||
30751810|NCT00259272|58761563|FG002|Overall Study|Protocol Violation|0|||
30751811|NCT00259272|58761564|FG003|Overall Study|Protocol Violation|1|||
30751812|NCT00259272|58761561|FG000|Overall Study|Sponsor Decision|0|||
30751813|NCT00259272|58761562|FG001|Overall Study|Sponsor Decision|1|||
30751814|NCT00259272|58761563|FG002|Overall Study|Sponsor Decision|0|||
30751815|NCT00259272|58761564|FG003|Overall Study|Sponsor Decision|0|||
30751816|NCT00259272|58761561|FG000|Overall Study|Withdrawal by Subject|4|||
30751817|NCT00259272|58761562|FG001|Overall Study|Withdrawal by Subject|2|||
30751818|NCT00259272|58761563|FG002|Overall Study|Withdrawal by Subject|2|||
30751819|NCT00259272|58761564|FG003|Overall Study|Withdrawal by Subject|7|||
30751820|NCT00259272|58761561|FG000|Overall Study|Lost to Follow-up|1|||
30912389|NCT01588990|58947651|FG000|Phase B|Withdrawal by Subject|3|||
30622969|NCT01217606|58634739|FG000|9-Month Masked Extension|Adverse Event|3|||
30622970|NCT01217606|58634740|FG001|9-Month Masked Extension|Adverse Event|6|||
30751821|NCT00259272|58761562|FG001|Overall Study|Lost to Follow-up|0|||
30751822|NCT00259272|58761563|FG002|Overall Study|Lost to Follow-up|0|||
30751823|NCT00259272|58761564|FG003|Overall Study|Lost to Follow-up|1|||
30751824|NCT00421889|58761597|FG000|Overall Study|Adverse Event|1|||
30751825|NCT00421889|58761598|FG001|Overall Study|Adverse Event|0|||
30751826|NCT00421889|58761599|FG002|Overall Study|Adverse Event|1|||
30751827|NCT00421889|58761600|FG003|Overall Study|Adverse Event|1|||
30751828|NCT00421889|58761601|FG004|Overall Study|Adverse Event|1|||
30751829|NCT00421889|58761602|FG005|Overall Study|Adverse Event|4|||
30817412|NCT02915874|58837760|FG000|Overall Study|Lost to Follow-up|5|||
30817413|NCT02915874|58837761|FG001|Overall Study|Lost to Follow-up|4|||
30817414|NCT02915874|58837760|FG000|Overall Study|Withdrawal by Subject|1|||
30817415|NCT02915874|58837761|FG001|Overall Study|Withdrawal by Subject|1|||
30817416|NCT02915874|58837760|FG000|Overall Study|Started New Anxiety Medication|0|||
30817417|NCT02915874|58837761|FG001|Overall Study|Started New Anxiety Medication|1|||
30817418|NCT03022578|58837767|FG000|Overall Study|Adverse Event|1|||
30817419|NCT03022578|58837767|FG000|Overall Study|Lack of Efficacy|2|||
30817420|NCT03022578|58837767|FG000|Overall Study|Withdrawal by Subject|1|||
30817421|NCT03022422|58837777|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
30817422|NCT03022422|58837778|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
30817423|NCT03022422|58837779|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
30817424|NCT03022422|58837780|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
30817425|NCT03022422|58837781|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
30817426|NCT03022422|58837782|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
30817427|NCT03023826|58837798|FG000|Period 1|Withdrawal by Subject|0|||
30817428|NCT03023826|58837799|FG001|Period 1|Withdrawal by Subject|0|||
30817429|NCT03023826|58837800|FG002|Period 1|Withdrawal by Subject|0|||
30817430|NCT03023826|58837801|FG003|Period 1|Withdrawal by Subject|0|||
30817431|NCT03023826|58837802|FG004|Period 1|Withdrawal by Subject|1|||
30817432|NCT03023826|58837803|FG005|Period 1|Withdrawal by Subject|0|||
30817433|NCT03166735|58837816|FG000|Overall Study|Not Treated|1|||
30817434|NCT03166735|58837817|FG001|Overall Study|Not Treated|0|||
30817435|NCT03166735|58837818|FG002|Overall Study|Not Treated|0|||
30817436|NCT03166735|58837819|FG003|Overall Study|Not Treated|0|||
30817437|NCT03166735|58837820|FG004|Overall Study|Not Treated|0|||
30817438|NCT03166735|58837816|FG000|Overall Study|follow-up not completed as planned|0|||
30817439|NCT03166735|58837817|FG001|Overall Study|follow-up not completed as planned|1|||
30817440|NCT03166735|58837818|FG002|Overall Study|follow-up not completed as planned|1|||
30817441|NCT03166735|58837819|FG003|Overall Study|follow-up not completed as planned|0|||
30817442|NCT03166735|58837820|FG004|Overall Study|follow-up not completed as planned|1|||
30817443|NCT03166735|58837816|FG000|Overall Study|Withdrawal by Subject|0|||
30817444|NCT03166735|58837817|FG001|Overall Study|Withdrawal by Subject|0|||
30817445|NCT03166735|58837818|FG002|Overall Study|Withdrawal by Subject|1|||
30817446|NCT03166735|58837819|FG003|Overall Study|Withdrawal by Subject|1|||
30817447|NCT03166735|58837820|FG004|Overall Study|Withdrawal by Subject|2|||
30817448|NCT03166735|58837816|FG000|Overall Study|Lost to Follow-up|0|||
30817449|NCT03166735|58837817|FG001|Overall Study|Lost to Follow-up|2|||
30817450|NCT03166735|58837818|FG002|Overall Study|Lost to Follow-up|1|||
30817451|NCT03166735|58837819|FG003|Overall Study|Lost to Follow-up|0|||
30817452|NCT03166735|58837820|FG004|Overall Study|Lost to Follow-up|1|||
30817453|NCT03165955|58837833|FG000|Treatment|Withdrawal by Subject|3|||
30817454|NCT03165955|58837833|FG000|Treatment|Death|1|||
30817455|NCT03165955|58837833|FG000|Treatment|Adverse Event|1|||
30817456|NCT03165955|58837833|FG000|Treatment|Progressive disease|3|||
30817457|NCT03055494|58837839|FG000|Overall Study|Lost to Follow-up|6|||
30817458|NCT03055494|58837840|FG001|Overall Study|Lost to Follow-up|0|||
30817459|NCT03055494|58837839|FG000|Overall Study|Physician Decision|2|||
30817460|NCT03055494|58837840|FG001|Overall Study|Physician Decision|0|||
30817461|NCT03055494|58837839|FG000|Overall Study|Withdrawal by Subject|1|||
30912390|NCT01588990|58947651|FG000|Phase B|Physician Decision|4|||
30912391|NCT01588990|58947651|FG000|Phase B|Other|2|||
30817462|NCT03055494|58837840|FG001|Overall Study|Withdrawal by Subject|0|||
30817463|NCT03055494|58837839|FG000|Overall Study|Adverse Event|0|||
30817464|NCT03055494|58837840|FG001|Overall Study|Adverse Event|1|||
30817465|NCT03055494|58837839|FG000|Overall Study|Non-compliance with study treatment|1|||
30817466|NCT03055494|58837840|FG001|Overall Study|Non-compliance with study treatment|0|||
30817467|NCT02914548|58837850|FG000|Overall Study|Adverse Event|15|||
30817468|NCT02914548|58837851|FG001|Overall Study|Adverse Event|7|||
30817469|NCT02914548|58837852|FG002|Overall Study|Adverse Event|15|||
30817470|NCT02914548|58837850|FG000|Overall Study|Physician Decision|2|||
30817471|NCT02914548|58837851|FG001|Overall Study|Physician Decision|2|||
30817472|NCT02914548|58837852|FG002|Overall Study|Physician Decision|0|||
30817473|NCT02914548|58837850|FG000|Overall Study|Protocol Violation|1|||
30817474|NCT02914548|58837851|FG001|Overall Study|Protocol Violation|0|||
30817475|NCT02914548|58837852|FG002|Overall Study|Protocol Violation|0|||
30817476|NCT02914548|58837850|FG000|Overall Study|Withdrawal by Subject|3|||
30817477|NCT02914548|58837851|FG001|Overall Study|Withdrawal by Subject|4|||
30817478|NCT02914548|58837852|FG002|Overall Study|Withdrawal by Subject|4|||
30817479|NCT02914548|58837850|FG000|Overall Study|>40% of body surface area|0|||
30817480|NCT02914548|58837851|FG001|Overall Study|>40% of body surface area|1|||
30817481|NCT02914548|58837852|FG002|Overall Study|>40% of body surface area|1|||
30912392|NCT02176525|58947667|FG000|Overall Study|Adverse Event|0|||
30817482|NCT03165721|58837868|FG000|Overall Study|Refused further treatment|3|||
30817483|NCT03165721|58837869|FG001|Overall Study|Refused further treatment|0|||
30817484|NCT03165721|58837870|FG002|Overall Study|Refused further treatment|0|||
30817485|NCT03165721|58837868|FG000|Overall Study|Physician Decision|1|||
30912393|NCT02176525|58947668|FG001|Overall Study|Adverse Event|0|||
30912394|NCT02176525|58947669|FG002|Overall Study|Adverse Event|0|||
30817486|NCT03165721|58837869|FG001|Overall Study|Physician Decision|0|||
30817487|NCT03165721|58837870|FG002|Overall Study|Physician Decision|0|||
30817488|NCT02187198|58837886|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
30817489|NCT02187198|58837887|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
30817490|NCT02187198|58837886|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
30817491|NCT02187198|58837887|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
30817492|NCT02642029|58837893|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
30817493|NCT02642029|58837894|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
30817494|NCT02642029|58837895|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
30912395|NCT02176525|58947670|FG003|Overall Study|Adverse Event|1|||
30912396|NCT02176525|58947671|FG004|Overall Study|Adverse Event|1|||
30817495|NCT02642029|58837896|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
30817496|NCT02642029|58837897|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
30817497|NCT02642029|58837898|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
30817498|NCT02642029|58837893|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
30912397|NCT02176525|58947672|FG005|Overall Study|Adverse Event|0|||
30912398|NCT02176525|58947673|FG006|Overall Study|Adverse Event|1|||
30912399|NCT02176525|58947674|FG007|Overall Study|Adverse Event|0|||
30622971|NCT01217606|58634739|FG000|9-Month Masked Extension|Other Reasons|4|||
30751830|NCT00421889|58761603|FG006|Overall Study|Adverse Event|1|||
30751831|NCT00421889|58761604|FG007|Overall Study|Adverse Event|0|||
30751832|NCT00421889|58761605|FG008|Overall Study|Adverse Event|2|||
30751833|NCT00421889|58761597|FG000|Overall Study|Withdrawal by Subject|1|||
30751834|NCT00421889|58761598|FG001|Overall Study|Withdrawal by Subject|3|||
30751835|NCT00421889|58761599|FG002|Overall Study|Withdrawal by Subject|0|||
30751836|NCT00421889|58761600|FG003|Overall Study|Withdrawal by Subject|0|||
30751837|NCT00421889|58761601|FG004|Overall Study|Withdrawal by Subject|2|||
30751838|NCT00421889|58761602|FG005|Overall Study|Withdrawal by Subject|0|||
30751839|NCT00421889|58761603|FG006|Overall Study|Withdrawal by Subject|0|||
30751840|NCT00421889|58761604|FG007|Overall Study|Withdrawal by Subject|0|||
30751841|NCT00421889|58761605|FG008|Overall Study|Withdrawal by Subject|0|||
30751842|NCT00421889|58761597|FG000|Overall Study|Death|0|||
30751843|NCT00421889|58761598|FG001|Overall Study|Death|0|||
30751844|NCT00421889|58761599|FG002|Overall Study|Death|0|||
30751845|NCT00421889|58761600|FG003|Overall Study|Death|0|||
30751846|NCT00421889|58761601|FG004|Overall Study|Death|1|||
30751847|NCT00421889|58761602|FG005|Overall Study|Death|1|||
30751848|NCT00421889|58761603|FG006|Overall Study|Death|0|||
30751849|NCT00421889|58761604|FG007|Overall Study|Death|0|||
30751850|NCT00421889|58761605|FG008|Overall Study|Death|0|||
30751851|NCT00421889|58761597|FG000|Overall Study|Progressive disease|3|||
30751852|NCT00421889|58761598|FG001|Overall Study|Progressive disease|2|||
30751853|NCT00421889|58761599|FG002|Overall Study|Progressive disease|2|||
30751854|NCT00421889|58761600|FG003|Overall Study|Progressive disease|3|||
30751855|NCT00421889|58761601|FG004|Overall Study|Progressive disease|2|||
30751856|NCT00421889|58761602|FG005|Overall Study|Progressive disease|21|||
30751857|NCT00421889|58761603|FG006|Overall Study|Progressive disease|3|||
30751858|NCT00421889|58761604|FG007|Overall Study|Progressive disease|1|||
30751859|NCT00421889|58761605|FG008|Overall Study|Progressive disease|5|||
30751860|NCT00421889|58761597|FG000|Overall Study|Patient/Investigator request|0|||
30751861|NCT00421889|58761598|FG001|Overall Study|Patient/Investigator request|0|||
30751862|NCT00421889|58761599|FG002|Overall Study|Patient/Investigator request|0|||
30751863|NCT00421889|58761600|FG003|Overall Study|Patient/Investigator request|0|||
30751864|NCT00421889|58761601|FG004|Overall Study|Patient/Investigator request|0|||
30751865|NCT00421889|58761602|FG005|Overall Study|Patient/Investigator request|9|||
30751866|NCT00421889|58761603|FG006|Overall Study|Patient/Investigator request|0|||
30751867|NCT00421889|58761604|FG007|Overall Study|Patient/Investigator request|1|||
30751868|NCT00421889|58761605|FG008|Overall Study|Patient/Investigator request|3|||
30751869|NCT00421889|58761597|FG000|Overall Study|Lost to Follow-up|0|||
30751870|NCT00421889|58761598|FG001|Overall Study|Lost to Follow-up|0|||
30751871|NCT00421889|58761599|FG002|Overall Study|Lost to Follow-up|0|||
30751872|NCT00421889|58761600|FG003|Overall Study|Lost to Follow-up|0|||
30751873|NCT00421889|58761601|FG004|Overall Study|Lost to Follow-up|0|||
30751874|NCT00421889|58761602|FG005|Overall Study|Lost to Follow-up|0|||
30912400|NCT02176525|58947667|FG000|Overall Study|not treated|1|||
30912401|NCT02176525|58947668|FG001|Overall Study|not treated|0|||
30912402|NCT02176525|58947669|FG002|Overall Study|not treated|0|||
30622972|NCT01217606|58634740|FG001|9-Month Masked Extension|Other Reasons|4|||
30751875|NCT00421889|58761603|FG006|Overall Study|Lost to Follow-up|0|||
30751876|NCT00421889|58761604|FG007|Overall Study|Lost to Follow-up|0|||
30751877|NCT00421889|58761605|FG008|Overall Study|Lost to Follow-up|1|||
30751878|NCT00421733|58761632|FG000|Overall Study|Adverse Event|4|||
30751879|NCT00421733|58761633|FG001|Overall Study|Adverse Event|9|||
30751880|NCT00421733|58761634|FG002|Overall Study|Adverse Event|2|||
30751881|NCT00421733|58761632|FG000|Overall Study|Lost to Follow-up|1|||
30751882|NCT00421733|58761633|FG001|Overall Study|Lost to Follow-up|2|||
30751883|NCT00421733|58761634|FG002|Overall Study|Lost to Follow-up|4|||
30622973|NCT01217606|58634739|FG000|9-Month Masked Extension|Personal Reasons|2|||
30622974|NCT01217606|58634740|FG001|9-Month Masked Extension|Personal Reasons|1|||
30622975|NCT01217606|58634739|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
30622976|NCT01217606|58634740|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
30622977|NCT01217606|58634739|FG000|9-Month Masked Extension|Pregnancy|1|||
30622978|NCT01217606|58634740|FG001|9-Month Masked Extension|Pregnancy|0|||
30622979|NCT01217606|58634739|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
30622980|NCT01217606|58634740|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
30622981|NCT01128114|58634746|FG000|Overall Study|Treatment Withdrawn|6|||
30622982|NCT01128114|58634746|FG000|Overall Study|Screening Failed|2|||
30622983|NCT01217060|58634750|FG000|Overall Study|Withdrawal by Subject|1|||
30622984|NCT01216202|58634756|FG000|Overall Study|Withdrawal by Subject|8|||
30622985|NCT01216202|58634757|FG001|Overall Study|Withdrawal by Subject|0|||
30622986|NCT01216202|58634756|FG000|Overall Study|Death|0|||
30622987|NCT01216202|58634757|FG001|Overall Study|Death|2|||
30622988|NCT01216202|58634756|FG000|Overall Study|Lost to Follow-up|14|||
30622989|NCT01216202|58634757|FG001|Overall Study|Lost to Follow-up|0|||
30622990|NCT04816669|58634769|FG000|Part 1|Adverse Event|1|||
30622991|NCT04816669|58634770|FG001|Part 1|Adverse Event|1|||
30622992|NCT04816669|58634771|FG002|Part 1|Adverse Event|0|||
30622993|NCT04816669|58634772|FG003|Part 1|Adverse Event|0|||
30622994|NCT04816669|58634769|FG000|Part 1|Lost to Follow-up|2|||
30622995|NCT04816669|58634770|FG001|Part 1|Lost to Follow-up|2|||
30622996|NCT04816669|58634771|FG002|Part 1|Lost to Follow-up|0|||
30622997|NCT04816669|58634772|FG003|Part 1|Lost to Follow-up|0|||
30622998|NCT04816669|58634769|FG000|Part 1|Protocol Violation|0|||
30622999|NCT04816669|58634770|FG001|Part 1|Protocol Violation|1|||
30623000|NCT04816669|58634771|FG002|Part 1|Protocol Violation|0|||
30623001|NCT04816669|58634772|FG003|Part 1|Protocol Violation|0|||
30623002|NCT04816669|58634769|FG000|Part 1|Withdrawal by Subject|1|||
30623003|NCT04816669|58634770|FG001|Part 1|Withdrawal by Subject|2|||
30623004|NCT04816669|58634771|FG002|Part 1|Withdrawal by Subject|0|||
30623005|NCT04816669|58634772|FG003|Part 1|Withdrawal by Subject|0|||
30623006|NCT04816669|58634769|FG000|Part 2|Other|0|||
30623007|NCT04816669|58634770|FG001|Part 2|Other|0|||
30623008|NCT04816669|58634771|FG002|Part 2|Other|1|||
30623009|NCT04816669|58634772|FG003|Part 2|Other|0|||
30623010|NCT04816669|58634769|FG000|Part 2|Withdrawal by Subject|0|||
30623011|NCT04816669|58634770|FG001|Part 2|Withdrawal by Subject|0|||
30623012|NCT04816669|58634771|FG002|Part 2|Withdrawal by Subject|0|||
30623013|NCT04816669|58634772|FG003|Part 2|Withdrawal by Subject|1|||
30623014|NCT04816669|58634769|FG000|Part 2|Lost to Follow-up|0|||
30623015|NCT04816669|58634770|FG001|Part 2|Lost to Follow-up|0|||
30623016|NCT04816669|58634771|FG002|Part 2|Lost to Follow-up|1|||
30623017|NCT04816669|58634772|FG003|Part 2|Lost to Follow-up|0|||
30623018|NCT01165242|58634789|FG000|Overall Study|Unreachable Subjects|1|||
30751884|NCT00421733|58761632|FG000|Overall Study|Withdrawal by Subject|1|||
30751885|NCT00421733|58761633|FG001|Overall Study|Withdrawal by Subject|2|||
30751886|NCT00421733|58761634|FG002|Overall Study|Withdrawal by Subject|7|||
30751887|NCT00421733|58761632|FG000|Overall Study|Death|0|||
30751888|NCT00421733|58761633|FG001|Overall Study|Death|3|||
30751889|NCT00421733|58761634|FG002|Overall Study|Death|0|||
30751890|NCT00421733|58761632|FG000|Overall Study|Required dialysis|1|||
30751891|NCT00421733|58761633|FG001|Overall Study|Required dialysis|0|||
30751892|NCT00421733|58761634|FG002|Overall Study|Required dialysis|0|||
30751893|NCT00421733|58761632|FG000|Overall Study|Administrative|2|||
30751894|NCT00421733|58761633|FG001|Overall Study|Administrative|0|||
30751895|NCT00421733|58761634|FG002|Overall Study|Administrative|0|||
30751896|NCT00421733|58761632|FG000|Overall Study|Did not satisfy entry criteria|1|||
30751897|NCT00421733|58761633|FG001|Overall Study|Did not satisfy entry criteria|3|||
30751898|NCT00421733|58761634|FG002|Overall Study|Did not satisfy entry criteria|2|||
30751899|NCT00421733|58761632|FG000|Overall Study|Sponsor request|1|||
30751900|NCT00421733|58761633|FG001|Overall Study|Sponsor request|0|||
30751901|NCT00421733|58761634|FG002|Overall Study|Sponsor request|3|||
30751902|NCT00421733|58761632|FG000|Overall Study|Protocol deviation|4|||
30751903|NCT00421733|58761633|FG001|Overall Study|Protocol deviation|7|||
30623019|NCT01165242|58634790|FG001|Overall Study|Unreachable Subjects|0|||
30623020|NCT01165242|58634791|FG002|Overall Study|Unreachable Subjects|0|||
30623021|NCT01165242|58634789|FG000|Overall Study|Incarcerated Subjects|0|||
30623022|NCT01165242|58634790|FG001|Overall Study|Incarcerated Subjects|1|||
30751904|NCT00421733|58761634|FG002|Overall Study|Protocol deviation|2|||
30751905|NCT00421343|58761646|FG000|Overall Study|Death|1|||
30912403|NCT02176525|58947670|FG003|Overall Study|not treated|0|||
30623023|NCT01165242|58634791|FG002|Overall Study|Incarcerated Subjects|0|||
30623024|NCT01165242|58634789|FG000|Overall Study|Visit 2 Declined by Subject|0|||
30623025|NCT01165242|58634790|FG001|Overall Study|Visit 2 Declined by Subject|0|||
30623026|NCT01165242|58634791|FG002|Overall Study|Visit 2 Declined by Subject|1|||
30751906|NCT00421343|58761646|FG000|Overall Study|Withdrawal by Subject|2|||
30751907|NCT00421343|58761646|FG000|Overall Study|Lost to Follow-up|3|||
30751908|NCT00230178|58761653|FG000|Overall Study|Adverse Event|1|||
30751909|NCT00230178|58761654|FG001|Overall Study|Adverse Event|5|||
30623027|NCT01165242|58634789|FG000|Overall Study|Withdrawal by Subject|0|||
30623028|NCT01165242|58634790|FG001|Overall Study|Withdrawal by Subject|2|||
30623029|NCT01165242|58634791|FG002|Overall Study|Withdrawal by Subject|2|||
30623030|NCT01165242|58634789|FG000|Overall Study|Extended Holiday|0|||
30623031|NCT01165242|58634790|FG001|Overall Study|Extended Holiday|0|||
30623032|NCT01165242|58634791|FG002|Overall Study|Extended Holiday|1|||
30623033|NCT01165242|58634789|FG000|Overall Study|Lost to Follow-up|9|||
30623034|NCT01165242|58634790|FG001|Overall Study|Lost to Follow-up|7|||
30623035|NCT01165242|58634791|FG002|Overall Study|Lost to Follow-up|10|||
30623036|NCT01170065|58634804|FG000|Overall Study|Adverse Event|17|||
30623037|NCT01170065|58634805|FG001|Overall Study|Adverse Event|50|||
30623038|NCT01170065|58634806|FG002|Overall Study|Adverse Event|10|||
30623039|NCT01170065|58634804|FG000|Overall Study|Lost to Follow-up|1|||
30817499|NCT02642029|58837894|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
30817500|NCT02642029|58837895|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
30817501|NCT02642029|58837896|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
30817502|NCT02642029|58837897|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
30817503|NCT02642029|58837898|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
30912404|NCT02176525|58947671|FG004|Overall Study|not treated|0|||
30912405|NCT02176525|58947672|FG005|Overall Study|not treated|1|||
30912406|NCT02176525|58947673|FG006|Overall Study|not treated|0|||
30912407|NCT02176525|58947674|FG007|Overall Study|not treated|0|||
30912408|NCT02127931|58947700|FG000|Overall Study|Glitch in Game|1|||
30817504|NCT02642029|58837893|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
30817505|NCT02642029|58837894|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
30817506|NCT02642029|58837895|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
30817507|NCT02642029|58837896|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
30817508|NCT02642029|58837897|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
30817509|NCT02642029|58837898|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
30817510|NCT02642029|58837893|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
30817511|NCT02642029|58837894|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
30817512|NCT02642029|58837895|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
30817513|NCT02642029|58837896|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
30817514|NCT02642029|58837897|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
30817515|NCT02642029|58837898|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
30817516|NCT02642029|58837893|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
30817517|NCT02642029|58837894|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
30817518|NCT02642029|58837895|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
30817519|NCT02642029|58837896|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
30817520|NCT02642029|58837897|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
30817521|NCT02642029|58837898|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
30817522|NCT02642029|58837893|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
30817523|NCT02642029|58837894|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
30817524|NCT02642029|58837895|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
30817525|NCT02642029|58837896|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
30817526|NCT02642029|58837897|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
30817527|NCT02642029|58837898|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
30817528|NCT03178669|58837911|FG000|Overall Study|Adverse Event|4|||
30817529|NCT03178669|58837912|FG001|Overall Study|Adverse Event|1|||
30817530|NCT03178669|58837913|FG002|Overall Study|Adverse Event|4|||
30912409|NCT02127307|58947705|FG000|Overall Study|Protocol Violation|36|||
30912410|NCT02127307|58947705|FG000|Overall Study|Lost to Follow-up|2|||
30623040|NCT01170065|58634805|FG001|Overall Study|Lost to Follow-up|4|||
30623041|NCT01170065|58634806|FG002|Overall Study|Lost to Follow-up|1|||
30623042|NCT01170065|58634804|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
30623043|NCT01170065|58634805|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
30817531|NCT03178669|58837914|FG003|Overall Study|Adverse Event|2|||
30817532|NCT03178669|58837915|FG004|Overall Study|Adverse Event|2|||
30817533|NCT03178669|58837911|FG000|Overall Study|Lack of Efficacy|0|||
30817534|NCT03178669|58837912|FG001|Overall Study|Lack of Efficacy|0|||
30817535|NCT03178669|58837913|FG002|Overall Study|Lack of Efficacy|2|||
30817536|NCT03178669|58837914|FG003|Overall Study|Lack of Efficacy|0|||
30817537|NCT03178669|58837915|FG004|Overall Study|Lack of Efficacy|1|||
30817538|NCT03178669|58837911|FG000|Overall Study|Physician Decision|0|||
30817539|NCT03178669|58837912|FG001|Overall Study|Physician Decision|0|||
30817540|NCT03178669|58837913|FG002|Overall Study|Physician Decision|0|||
30817541|NCT03178669|58837914|FG003|Overall Study|Physician Decision|0|||
30817542|NCT03178669|58837915|FG004|Overall Study|Physician Decision|1|||
30817543|NCT03178669|58837911|FG000|Overall Study|Withdrawal by Subject|1|||
30817544|NCT03178669|58837912|FG001|Overall Study|Withdrawal by Subject|0|||
30817545|NCT03178669|58837913|FG002|Overall Study|Withdrawal by Subject|1|||
30817546|NCT03178669|58837914|FG003|Overall Study|Withdrawal by Subject|1|||
30817547|NCT03178669|58837915|FG004|Overall Study|Withdrawal by Subject|0|||
30817548|NCT03178669|58837911|FG000|Overall Study|Lost to Follow-up|0|||
30817549|NCT03178669|58837912|FG001|Overall Study|Lost to Follow-up|0|||
30817550|NCT03178669|58837913|FG002|Overall Study|Lost to Follow-up|0|||
30817551|NCT03178669|58837914|FG003|Overall Study|Lost to Follow-up|1|||
30912411|NCT02127307|58947705|FG000|Overall Study|Death|101|||
30912412|NCT02127307|58947705|FG000|Overall Study|Other than specified above|169|||
30912413|NCT02126839|58947711|FG000|Overall Study|Adverse Event|0|||
30912414|NCT02126839|58947712|FG001|Overall Study|Adverse Event|1|||
30817552|NCT03178669|58837915|FG004|Overall Study|Lost to Follow-up|0|||
30817553|NCT03178201|58837927|FG000|Overall Study|Off study|5|||
30817554|NCT03021642|58837931|FG000|Washout Period (21 Days)|Adverse Event|1|||
30817555|NCT03021642|58837932|FG001|Washout Period (21 Days)|Adverse Event|1|||
30817556|NCT03021564|58837940|FG000|Overall Study|Death|84|||
30817557|NCT03021564|58837941|FG001|Overall Study|Death|466|||
30817558|NCT03021564|58837940|FG000|Overall Study|Lost to Follow-up|0|||
30817559|NCT03021564|58837941|FG001|Overall Study|Lost to Follow-up|2|||
30817560|NCT03023046|58837951|FG000|Overall Study|Withdrawal by Subject|1|||
30817561|NCT03019458|58837959|FG000|Overall Study|Death|0|||
30817562|NCT03019458|58837960|FG001|Overall Study|Death|1|||
30817563|NCT02923830|58837970|FG000|Overall Study|Physician Decision|13|||
30817564|NCT02923830|58837971|FG001|Overall Study|Physician Decision|15|||
30817565|NCT03021018|58837980|FG000|Overall Study|Adverse Event|1|||
30817566|NCT03021018|58837981|FG001|Overall Study|Adverse Event|0|||
30817567|NCT03021018|58837982|FG002|Overall Study|Adverse Event|0|||
30817568|NCT03021018|58837980|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
30817569|NCT03021018|58837981|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
30817570|NCT03021018|58837982|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
30817571|NCT02509507|58837999|FG000|Overall Study|Death|21|||
30817572|NCT02509507|58838000|FG001|Overall Study|Death|3|||
30817573|NCT02509507|58838001|FG002|Overall Study|Death|22|||
30817574|NCT02509507|58838002|FG003|Overall Study|Death|13|||
30817575|NCT02509507|58838003|FG004|Overall Study|Death|6|||
30817576|NCT02509507|58838004|FG005|Overall Study|Death|9|||
30817577|NCT02509507|58838005|FG006|Overall Study|Death|4|||
30817578|NCT02509507|58838006|FG007|Overall Study|Death|3|||
30817579|NCT02509507|58838007|FG008|Overall Study|Death|7|||
30817580|NCT02509507|58837999|FG000|Overall Study|Lost to Follow-up|0|||
30817581|NCT02509507|58838000|FG001|Overall Study|Lost to Follow-up|1|||
30817582|NCT02509507|58838001|FG002|Overall Study|Lost to Follow-up|0|||
30817583|NCT02509507|58838002|FG003|Overall Study|Lost to Follow-up|0|||
30817584|NCT02509507|58838003|FG004|Overall Study|Lost to Follow-up|0|||
30912415|NCT02126839|58947711|FG000|Overall Study|Withdrawal by Subject|1|||
30912416|NCT02126839|58947712|FG001|Overall Study|Withdrawal by Subject|0|||
30817585|NCT02509507|58838004|FG005|Overall Study|Lost to Follow-up|1|||
30817586|NCT02509507|58838005|FG006|Overall Study|Lost to Follow-up|0|||
30817587|NCT02509507|58838006|FG007|Overall Study|Lost to Follow-up|0|||
30817588|NCT02509507|58838007|FG008|Overall Study|Lost to Follow-up|0|||
30817589|NCT02509507|58837999|FG000|Overall Study|Withdrawal by Subject|2|||
30817590|NCT02509507|58838000|FG001|Overall Study|Withdrawal by Subject|0|||
30817591|NCT02509507|58838001|FG002|Overall Study|Withdrawal by Subject|1|||
30817592|NCT02509507|58838002|FG003|Overall Study|Withdrawal by Subject|4|||
30817593|NCT02509507|58838003|FG004|Overall Study|Withdrawal by Subject|0|||
30817594|NCT02509507|58838004|FG005|Overall Study|Withdrawal by Subject|3|||
30817595|NCT02509507|58838005|FG006|Overall Study|Withdrawal by Subject|3|||
30817596|NCT02509507|58838006|FG007|Overall Study|Withdrawal by Subject|0|||
30817597|NCT02509507|58838007|FG008|Overall Study|Withdrawal by Subject|0|||
30817598|NCT02509507|58837999|FG000|Overall Study|Continuing Study|0|||
30912417|NCT02126839|58947711|FG000|Overall Study|Withdrawal by parent/guardian|1|||
30817599|NCT02509507|58838000|FG001|Overall Study|Continuing Study|1|||
30817600|NCT02509507|58838001|FG002|Overall Study|Continuing Study|1|||
30817601|NCT02509507|58838002|FG003|Overall Study|Continuing Study|5|||
30817602|NCT02509507|58838003|FG004|Overall Study|Continuing Study|4|||
30817603|NCT02509507|58838004|FG005|Overall Study|Continuing Study|5|||
30817604|NCT02509507|58838005|FG006|Overall Study|Continuing Study|3|||
30817605|NCT02509507|58838006|FG007|Overall Study|Continuing Study|2|||
30817606|NCT02509507|58838007|FG008|Overall Study|Continuing Study|3|||
30817607|NCT03176407|58838032|FG000|Overall Study|Protocol Violation|1|||
30817608|NCT03176407|58838032|FG000|Overall Study|human failure|1|||
30817609|NCT03176407|58838032|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
30817610|NCT03175549|58838040|FG000|Overall Study|Lost to Follow-up|2|||
30817611|NCT03175549|58838041|FG001|Overall Study|Lost to Follow-up|2|||
30817612|NCT03175549|58838040|FG000|Overall Study|Medication non-compliance|2|||
30817613|NCT03175549|58838041|FG001|Overall Study|Medication non-compliance|2|||
30817614|NCT03174925|58838049|FG000|Overall Study|Elastographic images not retrievable|2|||
30817615|NCT03174925|58838049|FG000|Overall Study|Elastography image not interpretable|1|||
30817616|NCT02924688|58838059|FG000|Overall Study|Adverse Event|9|||
30817617|NCT02924688|58838060|FG001|Overall Study|Adverse Event|3|||
30817618|NCT02924688|58838061|FG002|Overall Study|Adverse Event|2|||
30817619|NCT02924688|58838062|FG003|Overall Study|Adverse Event|2|||
30817620|NCT02924688|58838063|FG004|Overall Study|Adverse Event|3|||
30817621|NCT02924688|58838064|FG005|Overall Study|Adverse Event|2|||
30817622|NCT02924688|58838059|FG000|Overall Study|Lack of Efficacy|2|||
30817623|NCT02924688|58838060|FG001|Overall Study|Lack of Efficacy|3|||
30817624|NCT02924688|58838061|FG002|Overall Study|Lack of Efficacy|4|||
30817625|NCT02924688|58838062|FG003|Overall Study|Lack of Efficacy|2|||
30817626|NCT02924688|58838063|FG004|Overall Study|Lack of Efficacy|1|||
30817627|NCT02924688|58838064|FG005|Overall Study|Lack of Efficacy|1|||
30817628|NCT02924688|58838059|FG000|Overall Study|Protocol Violation|3|||
30817629|NCT02924688|58838060|FG001|Overall Study|Protocol Violation|7|||
30817630|NCT02924688|58838061|FG002|Overall Study|Protocol Violation|5|||
30817631|NCT02924688|58838062|FG003|Overall Study|Protocol Violation|6|||
30817632|NCT02924688|58838063|FG004|Overall Study|Protocol Violation|2|||
30817633|NCT02924688|58838064|FG005|Overall Study|Protocol Violation|2|||
30817634|NCT02924688|58838059|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
30817635|NCT02924688|58838060|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
30817636|NCT02924688|58838061|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
30817637|NCT02924688|58838062|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
30817638|NCT02924688|58838063|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
30817639|NCT02924688|58838064|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
30817640|NCT02924688|58838059|FG000|Overall Study|Lost to Follow-up|2|||
30912418|NCT02126839|58947712|FG001|Overall Study|Withdrawal by parent/guardian|0|||
30912419|NCT02126839|58947711|FG000|Overall Study|Protocol Violation|2|||
30912420|NCT02126839|58947712|FG001|Overall Study|Protocol Violation|3|||
30912421|NCT02126839|58947711|FG000|Overall Study|Sponsor request|0|||
30912422|NCT02126839|58947712|FG001|Overall Study|Sponsor request|1|||
30912423|NCT02126839|58947711|FG000|Overall Study|Lost to Follow-up|1|||
30912424|NCT02126839|58947712|FG001|Overall Study|Lost to Follow-up|4|||
30912425|NCT02126839|58947711|FG000|Overall Study|Other|5|||
30912426|NCT02126839|58947712|FG001|Overall Study|Other|5|||
30912427|NCT02125279|58947718|FG000|Overall Study|Lack of Efficacy|2|||
30817641|NCT02924688|58838060|FG001|Overall Study|Lost to Follow-up|4|||
30817642|NCT02924688|58838061|FG002|Overall Study|Lost to Follow-up|2|||
30817643|NCT02924688|58838062|FG003|Overall Study|Lost to Follow-up|4|||
30817644|NCT02924688|58838063|FG004|Overall Study|Lost to Follow-up|2|||
30817645|NCT02924688|58838064|FG005|Overall Study|Lost to Follow-up|4|||
30817646|NCT02924688|58838059|FG000|Overall Study|Physician Decision|2|||
30817647|NCT02924688|58838060|FG001|Overall Study|Physician Decision|1|||
30817648|NCT02924688|58838061|FG002|Overall Study|Physician Decision|0|||
30817649|NCT02924688|58838062|FG003|Overall Study|Physician Decision|1|||
30817650|NCT02924688|58838063|FG004|Overall Study|Physician Decision|1|||
30817651|NCT02924688|58838064|FG005|Overall Study|Physician Decision|1|||
30817652|NCT02924688|58838059|FG000|Overall Study|Withdrawal by Subject|14|||
30912428|NCT02125279|58947718|FG000|Overall Study|Withdrawal by Subject|6|||
30912429|NCT02125279|58947718|FG000|Overall Study|Protocol Violation|1|||
30912430|NCT02125279|58947718|FG000|Overall Study|Lost to Follow-up|4|||
30817653|NCT02924688|58838060|FG001|Overall Study|Withdrawal by Subject|13|||
30912431|NCT02124811|58947726|FG000|Overall Study|Early termination|2|||
30912432|NCT02124811|58947727|FG001|Overall Study|Early termination|2|||
30817654|NCT02924688|58838061|FG002|Overall Study|Withdrawal by Subject|9|||
30817655|NCT02924688|58838062|FG003|Overall Study|Withdrawal by Subject|12|||
30817656|NCT02924688|58838063|FG004|Overall Study|Withdrawal by Subject|13|||
30817657|NCT02924688|58838064|FG005|Overall Study|Withdrawal by Subject|14|||
30817658|NCT03011892|58838087|FG000|Double Blind (DB) Period|Adverse Event|0|||
30817659|NCT03011892|58838088|FG001|Double Blind (DB) Period|Adverse Event|1|||
30817660|NCT03011892|58838089|FG002|Double Blind (DB) Period|Adverse Event|1|||
30912433|NCT02124811|58947726|FG000|Overall Study|Withdrawal by Subject|1|||
30817661|NCT03011892|58838090|FG003|Double Blind (DB) Period|Adverse Event|0|||
30817662|NCT03011892|58838091|FG004|Double Blind (DB) Period|Adverse Event|0|||
30817663|NCT03011892|58838092|FG005|Double Blind (DB) Period|Adverse Event|0|||
30817664|NCT03011892|58838093|FG006|Double Blind (DB) Period|Adverse Event|0|||
30817665|NCT03011892|58838094|FG007|Double Blind (DB) Period|Adverse Event|0|||
30817666|NCT03011892|58838095|FG008|Double Blind (DB) Period|Adverse Event|0|||
30817667|NCT03011892|58838096|FG009|Double Blind (DB) Period|Adverse Event|0|||
30817668|NCT03011892|58838097|FG010|Double Blind (DB) Period|Adverse Event|0|||
30817669|NCT03011892|58838098|FG011|Double Blind (DB) Period|Adverse Event|0|||
30817670|NCT03011892|58838087|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
30817671|NCT03011892|58838088|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
30817672|NCT03011892|58838089|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
30817673|NCT03011892|58838090|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
30817674|NCT03011892|58838091|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
30817675|NCT03011892|58838092|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
30817676|NCT03011892|58838093|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
30817677|NCT03011892|58838094|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
30817678|NCT03011892|58838095|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
30817679|NCT03011892|58838096|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
30817680|NCT03011892|58838097|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
30817681|NCT03011892|58838098|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
30817682|NCT03011892|58838087|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
30817683|NCT03011892|58838088|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
30817684|NCT03011892|58838089|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
30817685|NCT03011892|58838090|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
30817686|NCT03011892|58838091|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
30817687|NCT03011892|58838092|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
30817688|NCT03011892|58838093|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
30817689|NCT03011892|58838094|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
30817690|NCT03011892|58838095|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
30817691|NCT03011892|58838096|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
30817692|NCT03011892|58838097|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
30817693|NCT03011892|58838098|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
30817694|NCT03011892|58838087|FG000|Double Blind (DB) Period|Other|1|||
30817695|NCT03011892|58838088|FG001|Double Blind (DB) Period|Other|1|||
30817696|NCT03011892|58838089|FG002|Double Blind (DB) Period|Other|1|||
30817697|NCT03011892|58838090|FG003|Double Blind (DB) Period|Other|0|||
30817698|NCT03011892|58838091|FG004|Double Blind (DB) Period|Other|1|||
30817699|NCT03011892|58838092|FG005|Double Blind (DB) Period|Other|0|||
30817700|NCT03011892|58838093|FG006|Double Blind (DB) Period|Other|0|||
30817701|NCT03011892|58838094|FG007|Double Blind (DB) Period|Other|0|||
30817702|NCT03011892|58838095|FG008|Double Blind (DB) Period|Other|0|||
30817703|NCT03011892|58838096|FG009|Double Blind (DB) Period|Other|0|||
30817704|NCT03011892|58838097|FG010|Double Blind (DB) Period|Other|0|||
30817705|NCT03011892|58838098|FG011|Double Blind (DB) Period|Other|0|||
30817706|NCT03011892|58838087|FG000|Double Blind (DB) Period|Physician Decision|1|||
30817707|NCT03011892|58838088|FG001|Double Blind (DB) Period|Physician Decision|0|||
30817708|NCT03011892|58838089|FG002|Double Blind (DB) Period|Physician Decision|1|||
30912434|NCT02124811|58947727|FG001|Overall Study|Withdrawal by Subject|0|||
30912435|NCT02148445|58947735|FG000|Overall Study|Death|1|||
30817709|NCT03011892|58838090|FG003|Double Blind (DB) Period|Physician Decision|0|||
30817710|NCT03011892|58838091|FG004|Double Blind (DB) Period|Physician Decision|0|||
30817711|NCT03011892|58838092|FG005|Double Blind (DB) Period|Physician Decision|0|||
30817712|NCT03011892|58838093|FG006|Double Blind (DB) Period|Physician Decision|0|||
30817713|NCT03011892|58838094|FG007|Double Blind (DB) Period|Physician Decision|0|||
30817714|NCT03011892|58838095|FG008|Double Blind (DB) Period|Physician Decision|0|||
30817715|NCT03011892|58838096|FG009|Double Blind (DB) Period|Physician Decision|0|||
30817716|NCT03011892|58838097|FG010|Double Blind (DB) Period|Physician Decision|0|||
30817717|NCT03011892|58838098|FG011|Double Blind (DB) Period|Physician Decision|0|||
30817718|NCT03011892|58838087|FG000|Double Blind (DB) Period|Pregnancy|0|||
30912436|NCT02148445|58947736|FG001|Overall Study|Death|3|||
30912437|NCT02148211|58947744|FG000|Overall Study|Lost to Follow-up|352|||
30817719|NCT03011892|58838088|FG001|Double Blind (DB) Period|Pregnancy|0|||
30817720|NCT03011892|58838089|FG002|Double Blind (DB) Period|Pregnancy|0|||
30817721|NCT03011892|58838090|FG003|Double Blind (DB) Period|Pregnancy|0|||
30817722|NCT03011892|58838091|FG004|Double Blind (DB) Period|Pregnancy|1|||
30817723|NCT03011892|58838092|FG005|Double Blind (DB) Period|Pregnancy|0|||
30817724|NCT03011892|58838093|FG006|Double Blind (DB) Period|Pregnancy|0|||
30817725|NCT03011892|58838094|FG007|Double Blind (DB) Period|Pregnancy|0|||
30817726|NCT03011892|58838095|FG008|Double Blind (DB) Period|Pregnancy|0|||
30817727|NCT03011892|58838096|FG009|Double Blind (DB) Period|Pregnancy|0|||
30817728|NCT03011892|58838097|FG010|Double Blind (DB) Period|Pregnancy|0|||
30817729|NCT03011892|58838098|FG011|Double Blind (DB) Period|Pregnancy|0|||
30912438|NCT02147587|58947750|FG000|Overall Study|Adverse Event|9|||
30623044|NCT01170065|58634806|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
30817730|NCT03011892|58838087|FG000|Double Blind (DB) Period|Protocol Violation|1|||
30817731|NCT03011892|58838088|FG001|Double Blind (DB) Period|Protocol Violation|0|||
30817732|NCT03011892|58838089|FG002|Double Blind (DB) Period|Protocol Violation|0|||
30817733|NCT03011892|58838090|FG003|Double Blind (DB) Period|Protocol Violation|0|||
30817734|NCT03011892|58838091|FG004|Double Blind (DB) Period|Protocol Violation|0|||
30817735|NCT03011892|58838092|FG005|Double Blind (DB) Period|Protocol Violation|0|||
30817736|NCT03011892|58838093|FG006|Double Blind (DB) Period|Protocol Violation|0|||
30817737|NCT03011892|58838094|FG007|Double Blind (DB) Period|Protocol Violation|0|||
30817738|NCT03011892|58838095|FG008|Double Blind (DB) Period|Protocol Violation|0|||
30817739|NCT03011892|58838096|FG009|Double Blind (DB) Period|Protocol Violation|0|||
30817740|NCT03011892|58838097|FG010|Double Blind (DB) Period|Protocol Violation|0|||
30817741|NCT03011892|58838098|FG011|Double Blind (DB) Period|Protocol Violation|0|||
30817742|NCT03011892|58838087|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
30817743|NCT03011892|58838088|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
30817744|NCT03011892|58838089|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
30817745|NCT03011892|58838090|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
30817746|NCT03011892|58838091|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
30817747|NCT03011892|58838092|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
30817748|NCT03011892|58838093|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
30817749|NCT03011892|58838094|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
30817750|NCT03011892|58838095|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
30817751|NCT03011892|58838096|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
30817752|NCT03011892|58838097|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
30817753|NCT03011892|58838098|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
30817754|NCT03011892|58838087|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
30817755|NCT03011892|58838088|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
30817756|NCT03011892|58838089|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
30817757|NCT03011892|58838090|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
30817758|NCT03011892|58838091|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
30817759|NCT03011892|58838092|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
30817760|NCT03011892|58838093|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
30817761|NCT03011892|58838094|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
30817762|NCT03011892|58838095|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
30817763|NCT03011892|58838096|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
30817764|NCT03011892|58838097|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
30817765|NCT03011892|58838098|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
30817766|NCT03011892|58838087|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
30817767|NCT03011892|58838088|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
30817768|NCT03011892|58838089|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
30817769|NCT03011892|58838090|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
30817770|NCT03011892|58838091|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
30817771|NCT03011892|58838092|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
30817772|NCT03011892|58838093|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
30817773|NCT03011892|58838094|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
30817774|NCT03011892|58838095|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
30817775|NCT03011892|58838096|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
30817776|NCT03011892|58838097|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
30817777|NCT03011892|58838098|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
30817778|NCT03011892|58838087|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
30817779|NCT03011892|58838088|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
30817780|NCT03011892|58838089|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
30817781|NCT03011892|58838090|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
30817782|NCT03011892|58838091|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
30817783|NCT03011892|58838092|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
30817784|NCT03011892|58838093|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
30817785|NCT03011892|58838094|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
30817786|NCT03011892|58838095|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
30817787|NCT03011892|58838096|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
30817788|NCT03011892|58838097|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
30817789|NCT03011892|58838098|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
30817790|NCT03011892|58838087|FG000|Open Label (OL) Period|Reason not specified|0|||
30817791|NCT03011892|58838088|FG001|Open Label (OL) Period|Reason not specified|0|||
30817792|NCT03011892|58838089|FG002|Open Label (OL) Period|Reason not specified|0|||
30817793|NCT03011892|58838090|FG003|Open Label (OL) Period|Reason not specified|0|||
30817794|NCT03011892|58838091|FG004|Open Label (OL) Period|Reason not specified|0|||
30817795|NCT03011892|58838092|FG005|Open Label (OL) Period|Reason not specified|0|||
30817796|NCT03011892|58838093|FG006|Open Label (OL) Period|Reason not specified|0|||
30817797|NCT03011892|58838094|FG007|Open Label (OL) Period|Reason not specified|1|||
30817798|NCT03011892|58838095|FG008|Open Label (OL) Period|Reason not specified|0|||
30817799|NCT03011892|58838096|FG009|Open Label (OL) Period|Reason not specified|0|||
30817800|NCT03011892|58838097|FG010|Open Label (OL) Period|Reason not specified|0|||
30817801|NCT03011892|58838098|FG011|Open Label (OL) Period|Reason not specified|0|||
30817802|NCT03017742|58838125|FG000|Overall Study|Protocol Violation|36|||
30817803|NCT03017742|58838125|FG000|Overall Study|Withdrawal by Subject|37|||
30817804|NCT03012828|58838135|FG000|Overall Study|Lost to Follow-up|1|||
30817805|NCT03012828|58838136|FG001|Overall Study|Lost to Follow-up|0|||
30817806|NCT03012828|58838137|FG002|Overall Study|Lost to Follow-up|1|||
30817807|NCT03012828|58838138|FG003|Overall Study|Lost to Follow-up|0|||
30817808|NCT03012828|58838139|FG004|Overall Study|Lost to Follow-up|1|||
30817809|NCT03012828|58838140|FG005|Overall Study|Lost to Follow-up|0|||
30912439|NCT02147587|58947751|FG001|Overall Study|Adverse Event|4|||
30912440|NCT02147587|58947750|FG000|Overall Study|Lack of Efficacy|2|||
30817810|NCT03012828|58838135|FG000|Overall Study|Withdrawal by Subject|0|||
30817811|NCT03012828|58838136|FG001|Overall Study|Withdrawal by Subject|0|||
30817812|NCT03012828|58838137|FG002|Overall Study|Withdrawal by Subject|1|||
30817813|NCT03012828|58838138|FG003|Overall Study|Withdrawal by Subject|0|||
30817814|NCT03012828|58838139|FG004|Overall Study|Withdrawal by Subject|0|||
30817815|NCT03012828|58838140|FG005|Overall Study|Withdrawal by Subject|1|||
30817816|NCT03012828|58838135|FG000|Overall Study|Non-compliance with protocol|0|||
30817817|NCT03012828|58838136|FG001|Overall Study|Non-compliance with protocol|0|||
30817818|NCT03012828|58838137|FG002|Overall Study|Non-compliance with protocol|0|||
30817819|NCT03012828|58838138|FG003|Overall Study|Non-compliance with protocol|0|||
30817820|NCT03012828|58838139|FG004|Overall Study|Non-compliance with protocol|1|||
30817821|NCT03012828|58838140|FG005|Overall Study|Non-compliance with protocol|0|||
30817822|NCT03012828|58838135|FG000|Overall Study|Delay to last visit would delay DBL|0|||
30817823|NCT03012828|58838136|FG001|Overall Study|Delay to last visit would delay DBL|0|||
30817824|NCT03012828|58838137|FG002|Overall Study|Delay to last visit would delay DBL|0|||
30817825|NCT03012828|58838138|FG003|Overall Study|Delay to last visit would delay DBL|0|||
30817826|NCT03012828|58838139|FG004|Overall Study|Delay to last visit would delay DBL|0|||
30817827|NCT03012828|58838140|FG005|Overall Study|Delay to last visit would delay DBL|1|||
30817828|NCT03010254|58838158|FG000|Overall Study|Adverse Event|0|||
30817829|NCT03010254|58838159|FG001|Overall Study|Adverse Event|1|||
30912441|NCT02147587|58947751|FG001|Overall Study|Lack of Efficacy|1|||
30912442|NCT02147353|58947759|FG000|Overall Study|Lost to Follow-up|2|||
30912443|NCT02147353|58947760|FG001|Overall Study|Lost to Follow-up|0|||
30912444|NCT02147353|58947759|FG000|Overall Study|unable to make visits|4|||
30912445|NCT02147353|58947760|FG001|Overall Study|unable to make visits|0|||
30912446|NCT02147353|58947759|FG000|Overall Study|medication noncompliance|3|||
30912447|NCT02147353|58947760|FG001|Overall Study|medication noncompliance|0|||
30912448|NCT02147197|58947769|FG000|Overall Study|Adverse Event|1|||
30912449|NCT02147197|58947770|FG001|Overall Study|Adverse Event|0|||
30817830|NCT03010254|58838158|FG000|Overall Study|Lost to Follow-up|4|||
30817831|NCT03010254|58838159|FG001|Overall Study|Lost to Follow-up|0|||
30817832|NCT03010254|58838158|FG000|Overall Study|Withdrawal by Subject|1|||
30912450|NCT02147197|58947771|FG002|Overall Study|Adverse Event|0|||
30912451|NCT02147197|58947769|FG000|Overall Study|Withdrawal of Consent|4|||
30912452|NCT02147197|58947770|FG001|Overall Study|Withdrawal of Consent|3|||
30912453|NCT02147197|58947771|FG002|Overall Study|Withdrawal of Consent|2|||
30817833|NCT03010254|58838159|FG001|Overall Study|Withdrawal by Subject|1|||
30817834|NCT03010254|58838158|FG000|Overall Study|Other|2|||
30912454|NCT02147197|58947769|FG000|Overall Study|Lost to Follow-up|2|||
30751910|NCT00230178|58761655|FG002|Overall Study|Adverse Event|2|||
30751911|NCT00230178|58761653|FG000|Overall Study|Withdrawal by Subject|0|||
30817835|NCT03010254|58838159|FG001|Overall Study|Other|3|||
30817836|NCT03008460|58838174|FG000|Overall Study|Protocol deviation|0|||
30817837|NCT03008460|58838175|FG001|Overall Study|Protocol deviation|2|||
30817838|NCT03008460|58838174|FG000|Overall Study|Study drug not dispensed|0|||
30817839|NCT03008460|58838175|FG001|Overall Study|Study drug not dispensed|1|||
30817840|NCT03008460|58838174|FG000|Overall Study|Adverse Event|0|||
30817841|NCT03008460|58838175|FG001|Overall Study|Adverse Event|1|||
30817842|NCT03008460|58838174|FG000|Overall Study|Withdrawal by Subject|5|||
30817843|NCT03008460|58838175|FG001|Overall Study|Withdrawal by Subject|6|||
30817844|NCT03008460|58838174|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
30817845|NCT03008460|58838175|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
30817846|NCT03008460|58838174|FG000|Overall Study|End of study visit outside permitted time window|0|||
30817847|NCT03008460|58838175|FG001|Overall Study|End of study visit outside permitted time window|1|||
30817848|NCT03008460|58838174|FG000|Overall Study|Lost to Follow-up|1|||
30817849|NCT03008460|58838175|FG001|Overall Study|Lost to Follow-up|3|||
30817850|NCT02914236|58838181|FG000|Overall Study|Lost to Follow-up|1|||
30817851|NCT03003390|58838187|FG000|Overall Study|Physician Decision|2|||
30817852|NCT03003390|58838188|FG001|Overall Study|Physician Decision|0|||
30817853|NCT03003390|58838187|FG000|Overall Study|Parent refused intervention|2|||
30817854|NCT03003390|58838188|FG001|Overall Study|Parent refused intervention|0|||
30912455|NCT02147197|58947770|FG001|Overall Study|Lost to Follow-up|3|||
30912456|NCT02147197|58947771|FG002|Overall Study|Lost to Follow-up|1|||
30912457|NCT02147197|58947769|FG000|Overall Study|Protocol Violation|1|||
30912458|NCT02147197|58947770|FG001|Overall Study|Protocol Violation|0|||
30912459|NCT02147197|58947771|FG002|Overall Study|Protocol Violation|3|||
30912460|NCT02147197|58947769|FG000|Overall Study|Other Miscellaneous Reasons|1|||
30817855|NCT03003000|58838202|FG000|Overall Study|Adverse Event|1|||
30817856|NCT03003000|58838203|FG001|Overall Study|Adverse Event|2|||
30817857|NCT03003000|58838204|FG002|Overall Study|Adverse Event|3|||
30817858|NCT03003000|58838202|FG000|Overall Study|Lack of Efficacy|1|||
30817859|NCT03003000|58838203|FG001|Overall Study|Lack of Efficacy|0|||
30817860|NCT03003000|58838204|FG002|Overall Study|Lack of Efficacy|0|||
30817861|NCT03003000|58838202|FG000|Overall Study|Non-compliant with protocol|0|||
30817862|NCT03003000|58838203|FG001|Overall Study|Non-compliant with protocol|1|||
30817863|NCT03003000|58838204|FG002|Overall Study|Non-compliant with protocol|1|||
30817864|NCT03003000|58838202|FG000|Overall Study|Refused to continue medication|2|||
30817865|NCT03003000|58838203|FG001|Overall Study|Refused to continue medication|0|||
30817866|NCT03003000|58838204|FG002|Overall Study|Refused to continue medication|0|||
30817867|NCT03003000|58838202|FG000|Overall Study|Other than listed|1|||
30751912|NCT00230178|58761654|FG001|Overall Study|Withdrawal by Subject|0|||
30817868|NCT03003000|58838203|FG001|Overall Study|Other than listed|1|||
30817869|NCT03003000|58838204|FG002|Overall Study|Other than listed|1|||
30912461|NCT02147197|58947770|FG001|Overall Study|Other Miscellaneous Reasons|0|||
30912462|NCT02147197|58947771|FG002|Overall Study|Other Miscellaneous Reasons|3|||
30751913|NCT00230178|58761655|FG002|Overall Study|Withdrawal by Subject|1|||
30751914|NCT00230178|58761653|FG000|Overall Study|Various other reasons|3|||
30751915|NCT00230178|58761654|FG001|Overall Study|Various other reasons|2|||
30751916|NCT00230178|58761655|FG002|Overall Study|Various other reasons|4|||
30751917|NCT00413777|58761665|FG000|Fixed-dose Period|Lost to Follow-up|1|||
30751918|NCT00413777|58761666|FG001|Fixed-dose Period|Lost to Follow-up|1|||
30751919|NCT00413777|58761665|FG000|Fixed-dose Period|Adverse Event|2|||
30817870|NCT03002610|58838215|FG000|Overall Study|Withdrawal by Subject|6|||
30817871|NCT03002610|58838216|FG001|Overall Study|Withdrawal by Subject|25|||
30817872|NCT03002610|58838217|FG002|Overall Study|Withdrawal by Subject|13|||
30817873|NCT03005106|58838225|FG000|Overall Study|Lost to Follow-up|16|||
30817874|NCT03005106|58838225|FG000|Overall Study|Adverse Event|1|||
30817875|NCT03005106|58838225|FG000|Overall Study|Physician Decision|1|||
30817876|NCT03005106|58838225|FG000|Overall Study|Death|2|||
30912463|NCT02176291|58947781|FG000|Overall Study|Death|1|||
30817877|NCT01004861|58838242|FG000|Overall Study|Disease progression|3|||
30912464|NCT02176291|58947782|FG001|Overall Study|Death|0|||
30817878|NCT01004861|58838243|FG001|Overall Study|Disease progression|4|||
30817879|NCT01004861|58838244|FG002|Overall Study|Disease progression|5|||
30817880|NCT01004861|58838245|FG003|Overall Study|Disease progression|4|||
30817881|NCT01004861|58838246|FG004|Overall Study|Disease progression|4|||
30817882|NCT01004861|58838247|FG005|Overall Study|Disease progression|4|||
30817883|NCT01004861|58838248|FG006|Overall Study|Disease progression|5|||
30817884|NCT01004861|58838249|FG007|Overall Study|Disease progression|1|||
30817885|NCT01004861|58838250|FG008|Overall Study|Disease progression|4|||
30817886|NCT01004861|58838251|FG009|Overall Study|Disease progression|7|||
30817887|NCT01004861|58838252|FG010|Overall Study|Disease progression|6|||
30817888|NCT01004861|58838253|FG011|Overall Study|Disease progression|3|||
30817889|NCT01004861|58838254|FG012|Overall Study|Disease progression|8|||
30817890|NCT01004861|58838242|FG000|Overall Study|Physician Decision|0|||
30817891|NCT01004861|58838243|FG001|Overall Study|Physician Decision|2|||
30817892|NCT01004861|58838244|FG002|Overall Study|Physician Decision|1|||
30817893|NCT01004861|58838245|FG003|Overall Study|Physician Decision|1|||
30912465|NCT02176291|58947781|FG000|Overall Study|non compliance with protocol|2|||
30817894|NCT01004861|58838246|FG004|Overall Study|Physician Decision|1|||
30912466|NCT02176291|58947782|FG001|Overall Study|non compliance with protocol|0|||
30817895|NCT01004861|58838247|FG005|Overall Study|Physician Decision|0|||
30817896|NCT01004861|58838248|FG006|Overall Study|Physician Decision|0|||
30817897|NCT01004861|58838249|FG007|Overall Study|Physician Decision|1|||
30817898|NCT01004861|58838250|FG008|Overall Study|Physician Decision|0|||
30817899|NCT01004861|58838251|FG009|Overall Study|Physician Decision|0|||
30817900|NCT01004861|58838252|FG010|Overall Study|Physician Decision|0|||
30817901|NCT01004861|58838253|FG011|Overall Study|Physician Decision|0|||
30817902|NCT01004861|58838254|FG012|Overall Study|Physician Decision|3|||
30817903|NCT01004861|58838242|FG000|Overall Study|Adverse Event|0|||
30817904|NCT01004861|58838243|FG001|Overall Study|Adverse Event|0|||
30817905|NCT01004861|58838244|FG002|Overall Study|Adverse Event|0|||
30817906|NCT01004861|58838245|FG003|Overall Study|Adverse Event|1|||
30817907|NCT01004861|58838246|FG004|Overall Study|Adverse Event|0|||
30817908|NCT01004861|58838247|FG005|Overall Study|Adverse Event|2|||
30817909|NCT01004861|58838248|FG006|Overall Study|Adverse Event|1|||
30817910|NCT01004861|58838249|FG007|Overall Study|Adverse Event|1|||
30817911|NCT01004861|58838250|FG008|Overall Study|Adverse Event|13|||
30817912|NCT01004861|58838251|FG009|Overall Study|Adverse Event|1|||
30817913|NCT01004861|58838252|FG010|Overall Study|Adverse Event|1|||
30817914|NCT01004861|58838253|FG011|Overall Study|Adverse Event|0|||
30817915|NCT01004861|58838254|FG012|Overall Study|Adverse Event|2|||
30817916|NCT01004861|58838242|FG000|Overall Study|Protocol Violation|0|||
30817917|NCT01004861|58838243|FG001|Overall Study|Protocol Violation|0|||
30817918|NCT01004861|58838244|FG002|Overall Study|Protocol Violation|0|||
30817919|NCT01004861|58838245|FG003|Overall Study|Protocol Violation|0|||
30817920|NCT01004861|58838246|FG004|Overall Study|Protocol Violation|1|||
30817921|NCT01004861|58838247|FG005|Overall Study|Protocol Violation|0|||
30817922|NCT01004861|58838248|FG006|Overall Study|Protocol Violation|0|||
30817923|NCT01004861|58838249|FG007|Overall Study|Protocol Violation|0|||
30817924|NCT01004861|58838250|FG008|Overall Study|Protocol Violation|0|||
30817925|NCT01004861|58838251|FG009|Overall Study|Protocol Violation|0|||
30751920|NCT00413777|58761666|FG001|Fixed-dose Period|Adverse Event|1|||
30817926|NCT01004861|58838252|FG010|Overall Study|Protocol Violation|0|||
30817927|NCT01004861|58838253|FG011|Overall Study|Protocol Violation|0|||
30817928|NCT01004861|58838254|FG012|Overall Study|Protocol Violation|0|||
30817929|NCT01004861|58838242|FG000|Overall Study|Lost to Follow-up|0|||
30817930|NCT01004861|58838243|FG001|Overall Study|Lost to Follow-up|0|||
30817931|NCT01004861|58838244|FG002|Overall Study|Lost to Follow-up|0|||
30817932|NCT01004861|58838245|FG003|Overall Study|Lost to Follow-up|0|||
30817933|NCT01004861|58838246|FG004|Overall Study|Lost to Follow-up|0|||
30817934|NCT01004861|58838247|FG005|Overall Study|Lost to Follow-up|0|||
30817935|NCT01004861|58838248|FG006|Overall Study|Lost to Follow-up|0|||
30817936|NCT01004861|58838249|FG007|Overall Study|Lost to Follow-up|1|||
30751921|NCT00413777|58761665|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
30751922|NCT00413777|58761666|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
30751923|NCT00413777|58761665|FG000|Fixed-dose Period|Withdrew Consent|0|||
30751924|NCT00413777|58761666|FG001|Fixed-dose Period|Withdrew Consent|1|||
30751925|NCT00197028|58761674|FG000|Overall Study|Adverse Event|2|||
30751926|NCT00197028|58761675|FG001|Overall Study|Adverse Event|2|||
30751927|NCT00197028|58761674|FG000|Overall Study|Protocol Violation|2|||
30751928|NCT00197028|58761675|FG001|Overall Study|Protocol Violation|1|||
30751929|NCT00197028|58761674|FG000|Overall Study|Withdrawal by Subject|8|||
30751930|NCT00197028|58761675|FG001|Overall Study|Withdrawal by Subject|12|||
30751931|NCT00197028|58761674|FG000|Overall Study|Lost to Follow-up|1|||
30751932|NCT00197028|58761675|FG001|Overall Study|Lost to Follow-up|0|||
30751933|NCT00197028|58761674|FG000|Overall Study|Other|3|||
30751934|NCT00197028|58761675|FG001|Overall Study|Other|6|||
30751935|NCT00420641|58761684|FG000|Overall Study|Adverse Event|3|||
30751936|NCT00420641|58761685|FG001|Overall Study|Adverse Event|25|||
30751937|NCT00420641|58761686|FG002|Overall Study|Adverse Event|10|||
30751938|NCT00420641|58761684|FG000|Overall Study|Lost to Follow-up|2|||
30751939|NCT00420641|58761685|FG001|Overall Study|Lost to Follow-up|4|||
30751940|NCT00420641|58761686|FG002|Overall Study|Lost to Follow-up|2|||
30751941|NCT00420641|58761684|FG000|Overall Study|Protocol Violation|8|||
30751942|NCT00420641|58761685|FG001|Overall Study|Protocol Violation|8|||
30751943|NCT00420641|58761686|FG002|Overall Study|Protocol Violation|7|||
30751944|NCT00420641|58761684|FG000|Overall Study|Withdrawal by Subject|15|||
30751945|NCT00420641|58761685|FG001|Overall Study|Withdrawal by Subject|21|||
30751946|NCT00420641|58761686|FG002|Overall Study|Withdrawal by Subject|14|||
30751947|NCT00420641|58761684|FG000|Overall Study|Lack of Efficacy|6|||
30751948|NCT00420641|58761685|FG001|Overall Study|Lack of Efficacy|5|||
30751949|NCT00420641|58761686|FG002|Overall Study|Lack of Efficacy|4|||
30751950|NCT00420641|58761684|FG000|Overall Study|Non-compliance|7|||
30751951|NCT00420641|58761685|FG001|Overall Study|Non-compliance|5|||
30751952|NCT00420641|58761686|FG002|Overall Study|Non-compliance|4|||
30751953|NCT00420641|58761684|FG000|Overall Study|Other|4|||
30751954|NCT00420641|58761685|FG001|Overall Study|Other|4|||
30751955|NCT00420641|58761686|FG002|Overall Study|Other|3|||
30751956|NCT00257556|58761696|FG000|Overall Study|Adverse Event|1|||
30751957|NCT00257556|58761697|FG001|Overall Study|Adverse Event|4|||
30817937|NCT01004861|58838250|FG008|Overall Study|Lost to Follow-up|3|||
30751958|NCT00257556|58761696|FG000|Overall Study|Physician Decision|6|||
30817938|NCT01004861|58838251|FG009|Overall Study|Lost to Follow-up|0|||
30817939|NCT01004861|58838252|FG010|Overall Study|Lost to Follow-up|0|||
30817940|NCT01004861|58838253|FG011|Overall Study|Lost to Follow-up|1|||
30751959|NCT00257556|58761697|FG001|Overall Study|Physician Decision|0|||
30817941|NCT01004861|58838254|FG012|Overall Study|Lost to Follow-up|0|||
30912467|NCT02176291|58947781|FG000|Overall Study|Withdrawal by Subject|2|||
30912468|NCT02176291|58947782|FG001|Overall Study|Withdrawal by Subject|0|||
30817942|NCT01004861|58838242|FG000|Overall Study|Non-compliance|0|||
30817943|NCT01004861|58838243|FG001|Overall Study|Non-compliance|0|||
30817944|NCT01004861|58838244|FG002|Overall Study|Non-compliance|0|||
30817945|NCT01004861|58838245|FG003|Overall Study|Non-compliance|0|||
30817946|NCT01004861|58838246|FG004|Overall Study|Non-compliance|0|||
30817947|NCT01004861|58838247|FG005|Overall Study|Non-compliance|0|||
30817948|NCT01004861|58838248|FG006|Overall Study|Non-compliance|0|||
30817949|NCT01004861|58838249|FG007|Overall Study|Non-compliance|0|||
30817950|NCT01004861|58838250|FG008|Overall Study|Non-compliance|5|||
30817951|NCT01004861|58838251|FG009|Overall Study|Non-compliance|0|||
30912469|NCT02175745|58947788|FG000|Overall Study|Not Eligible|1|||
30817952|NCT01004861|58838252|FG010|Overall Study|Non-compliance|0|||
30817953|NCT01004861|58838253|FG011|Overall Study|Non-compliance|0|||
30817954|NCT01004861|58838254|FG012|Overall Study|Non-compliance|1|||
30817955|NCT01004861|58838242|FG000|Overall Study|Other|0|||
30817956|NCT01004861|58838243|FG001|Overall Study|Other|0|||
30817957|NCT01004861|58838244|FG002|Overall Study|Other|0|||
30817958|NCT01004861|58838245|FG003|Overall Study|Other|0|||
30817959|NCT01004861|58838246|FG004|Overall Study|Other|0|||
30817960|NCT01004861|58838247|FG005|Overall Study|Other|0|||
30817961|NCT01004861|58838248|FG006|Overall Study|Other|0|||
30817962|NCT01004861|58838249|FG007|Overall Study|Other|0|||
30817963|NCT01004861|58838250|FG008|Overall Study|Other|0|||
30912470|NCT02175277|58947792|FG000|Overall Study|Protocol-specified Criteria|1|||
30912471|NCT02124265|58947796|FG000|Overall Study|Adverse Event|1|||
30912472|NCT02146105|58947800|FG000|Overall Study|Adverse Event|1|||
30912473|NCT02146105|58947800|FG000|Overall Study|Withdrawal by Subject|5|||
30751960|NCT00257556|58761696|FG000|Overall Study|Did not meet hCG criterion|3|||
30817964|NCT01004861|58838251|FG009|Overall Study|Other|2|||
30817965|NCT01004861|58838252|FG010|Overall Study|Other|1|||
30817966|NCT01004861|58838253|FG011|Overall Study|Other|2|||
30817967|NCT01004861|58838254|FG012|Overall Study|Other|3|||
30817968|NCT01004861|58838242|FG000|Overall Study|Patient decision|0|||
30817969|NCT01004861|58838243|FG001|Overall Study|Patient decision|0|||
30912474|NCT02175199|58947806|FG000|Overall Study|Withdrawal by Subject|1|||
30912475|NCT02175199|58947807|FG001|Overall Study|Withdrawal by Subject|5|||
30751961|NCT00257556|58761697|FG001|Overall Study|Did not meet hCG criterion|0|||
30751962|NCT00257556|58761696|FG000|Overall Study|other reason|4|||
30751963|NCT00257556|58761697|FG001|Overall Study|other reason|6|||
30751964|NCT00228384|58761705|FG000|Overall Study|Death|9|||
30751965|NCT00228384|58761706|FG001|Overall Study|Death|3|||
30751966|NCT00228384|58761705|FG000|Overall Study|Lost to Follow-up|6|||
30751967|NCT00228384|58761706|FG001|Overall Study|Lost to Follow-up|10|||
30751968|NCT00228384|58761705|FG000|Overall Study|Surgical Intervention (bypass)|5|||
30751969|NCT00228384|58761706|FG001|Overall Study|Surgical Intervention (bypass)|5|||
30751970|NCT00228384|58761705|FG000|Overall Study|Withdrawal by Subject|9|||
30751971|NCT00228384|58761706|FG001|Overall Study|Withdrawal by Subject|10|||
30751972|NCT00228384|58761705|FG000|Overall Study|Physician Decision|0|||
30751973|NCT00228384|58761706|FG001|Overall Study|Physician Decision|1|||
30751974|NCT00257166|58761714|FG000|Overall Study|Adverse Event|18|||
30751975|NCT00257166|58761715|FG001|Overall Study|Adverse Event|13|||
30751976|NCT00257166|58761714|FG000|Overall Study|Laboratory abnormality|1|||
30751977|NCT00257166|58761715|FG001|Overall Study|Laboratory abnormality|0|||
30751978|NCT00257166|58761714|FG000|Overall Study|Lost to Follow-up|8|||
30751979|NCT00257166|58761715|FG001|Overall Study|Lost to Follow-up|1|||
30751980|NCT00257166|58761714|FG000|Overall Study|Withdrawal by Subject|9|||
30751981|NCT00257166|58761715|FG001|Overall Study|Withdrawal by Subject|2|||
30751982|NCT00257166|58761714|FG000|Overall Study|Other|16|||
30751983|NCT00257166|58761715|FG001|Overall Study|Other|21|||
30751984|NCT00257166|58761714|FG000|Overall Study|Randomized, but not treated|1|||
30751985|NCT00257166|58761715|FG001|Overall Study|Randomized, but not treated|0|||
30817970|NCT01004861|58838244|FG002|Overall Study|Patient decision|0|||
30912476|NCT02175199|58947806|FG000|Overall Study|Randomized in Error|1|||
30912477|NCT02175199|58947807|FG001|Overall Study|Randomized in Error|0|||
30760676|NCT02899299|58769151|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189|||
30760677|NCT02899195|58769157|FG000|Concurrent Durvalumab|Adverse Event|4|||
30760678|NCT02899195|58769157|FG000|Concurrent Durvalumab|Physician Decision|1|||
30760679|NCT02899195|58769157|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
30817971|NCT01004861|58838245|FG003|Overall Study|Patient decision|0|||
30760680|NCT02899195|58769157|FG000|Concurrent Durvalumab|Progressive Disease|5|||
30760681|NCT02899195|58769157|FG000|Maintenance Durvalumab|Adverse Event|1|||
30817972|NCT01004861|58838246|FG004|Overall Study|Patient decision|1|||
30817973|NCT01004861|58838247|FG005|Overall Study|Patient decision|0|||
30817974|NCT01004861|58838248|FG006|Overall Study|Patient decision|1|||
30817975|NCT01004861|58838249|FG007|Overall Study|Patient decision|0|||
30817976|NCT01004861|58838250|FG008|Overall Study|Patient decision|7|||
30817977|NCT01004861|58838251|FG009|Overall Study|Patient decision|1|||
30912478|NCT02175199|58947806|FG000|Overall Study|Sponsor Decision|1|||
30817978|NCT01004861|58838252|FG010|Overall Study|Patient decision|1|||
30817979|NCT01004861|58838253|FG011|Overall Study|Patient decision|2|||
30817980|NCT01004861|58838254|FG012|Overall Study|Patient decision|3|||
30817981|NCT01004861|58838242|FG000|Overall Study|Transitioned to Phase 4 study|0|||
30817982|NCT01004861|58838243|FG001|Overall Study|Transitioned to Phase 4 study|0|||
30817983|NCT01004861|58838244|FG002|Overall Study|Transitioned to Phase 4 study|0|||
30817984|NCT01004861|58838245|FG003|Overall Study|Transitioned to Phase 4 study|0|||
30912479|NCT02175199|58947807|FG001|Overall Study|Sponsor Decision|0|||
30912480|NCT02123797|58947816|FG000|Baseline Intervention|Death|9|||
30912481|NCT02123797|58947817|FG001|Baseline Intervention|Death|16|||
30912482|NCT02123797|58947818|FG002|Baseline Intervention|Death|0|||
30912483|NCT02123797|58947819|FG003|Baseline Intervention|Death|0|||
30912484|NCT02123797|58947820|FG004|Baseline Intervention|Death|0|||
30912485|NCT02123797|58947816|FG000|Baseline Intervention|Withdrawal by Subject|2|||
30912486|NCT02123797|58947817|FG001|Baseline Intervention|Withdrawal by Subject|8|||
30912487|NCT02123797|58947818|FG002|Baseline Intervention|Withdrawal by Subject|0|||
30912488|NCT02123797|58947819|FG003|Baseline Intervention|Withdrawal by Subject|0|||
30912489|NCT02123797|58947820|FG004|Baseline Intervention|Withdrawal by Subject|0|||
30912490|NCT02123797|58947816|FG000|Baseline Intervention|Relocation|2|||
30912491|NCT02123797|58947817|FG001|Baseline Intervention|Relocation|0|||
30912492|NCT02123797|58947818|FG002|Baseline Intervention|Relocation|0|||
30912493|NCT02123797|58947819|FG003|Baseline Intervention|Relocation|0|||
30912494|NCT02123797|58947820|FG004|Baseline Intervention|Relocation|0|||
30912495|NCT02123797|58947816|FG000|Baseline Intervention|Out of window for initial survey|6|||
30912496|NCT02123797|58947817|FG001|Baseline Intervention|Out of window for initial survey|13|||
30912497|NCT02123797|58947818|FG002|Baseline Intervention|Out of window for initial survey|0|||
30912498|NCT02123797|58947819|FG003|Baseline Intervention|Out of window for initial survey|0|||
30912499|NCT02123797|58947820|FG004|Baseline Intervention|Out of window for initial survey|0|||
30912500|NCT02123797|58947816|FG000|Baseline Intervention|Lost to Follow-up|0|||
30912501|NCT02123797|58947817|FG001|Baseline Intervention|Lost to Follow-up|5|||
30912502|NCT02123797|58947818|FG002|Baseline Intervention|Lost to Follow-up|0|||
30912503|NCT02123797|58947819|FG003|Baseline Intervention|Lost to Follow-up|0|||
30912504|NCT02123797|58947820|FG004|Baseline Intervention|Lost to Follow-up|0|||
30912505|NCT02123797|58947816|FG000|Baseline Intervention|Other Disease|3|||
30912506|NCT02123797|58947817|FG001|Baseline Intervention|Other Disease|0|||
30912507|NCT02123797|58947818|FG002|Baseline Intervention|Other Disease|0|||
30912508|NCT02123797|58947819|FG003|Baseline Intervention|Other Disease|0|||
30912509|NCT02123797|58947820|FG004|Baseline Intervention|Other Disease|0|||
30912510|NCT02123797|58947816|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
30912511|NCT02123797|58947817|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
30912512|NCT02123797|58947818|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
30912513|NCT02123797|58947819|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
30912514|NCT02123797|58947820|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
30912515|NCT02123797|58947816|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
30912516|NCT02123797|58947817|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
30912517|NCT02123797|58947818|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
30912518|NCT02123797|58947819|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
30912519|NCT02123797|58947820|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
30912520|NCT02123797|58947816|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
30912521|NCT02123797|58947817|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
30912522|NCT02123797|58947818|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
30912523|NCT02123797|58947819|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
30912524|NCT02123797|58947820|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
30751986|NCT00227370|58761723|FG000|Overall Study|Withdrawal by Subject|1|||
30751987|NCT00227370|58761724|FG001|Overall Study|Withdrawal by Subject|2|||
30751988|NCT00227370|58761723|FG000|Overall Study|Death|3|||
30751989|NCT00227370|58761724|FG001|Overall Study|Death|4|||
30751990|NCT00227370|58761723|FG000|Overall Study|Adverse Event|6|||
30751991|NCT00227370|58761724|FG001|Overall Study|Adverse Event|11|||
30751992|NCT00227370|58761723|FG000|Overall Study|Physician Decision|9|||
30817985|NCT01004861|58838246|FG004|Overall Study|Transitioned to Phase 4 study|0|||
30912525|NCT02123797|58947816|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
30912526|NCT02123797|58947817|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
30912527|NCT02123797|58947818|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
30912528|NCT02123797|58947819|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
30912529|NCT02123797|58947820|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
30623045|NCT01170065|58634804|FG000|Overall Study|Reason other than specified|3|||
30817986|NCT01004861|58838247|FG005|Overall Study|Transitioned to Phase 4 study|0|||
30751993|NCT00227370|58761724|FG001|Overall Study|Physician Decision|6|||
30751994|NCT00227370|58761723|FG000|Overall Study|Other reasons|2|||
30817987|NCT01004861|58838248|FG006|Overall Study|Transitioned to Phase 4 study|0|||
30751995|NCT00227370|58761724|FG001|Overall Study|Other reasons|1|||
30751996|NCT00191100|58761732|FG000|Overall Study|Adverse Event|18|||
30912530|NCT02123797|58947816|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
30912531|NCT02123797|58947817|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
30912532|NCT02123797|58947818|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
30912533|NCT02123797|58947819|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
30912534|NCT02123797|58947820|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
30912535|NCT02123797|58947816|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
30912536|NCT02123797|58947817|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
30912537|NCT02123797|58947818|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
30912538|NCT02123797|58947819|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
30912539|NCT02123797|58947820|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
30817988|NCT01004861|58838249|FG007|Overall Study|Transitioned to Phase 4 study|0|||
30817989|NCT01004861|58838250|FG008|Overall Study|Transitioned to Phase 4 study|2|||
30817990|NCT01004861|58838251|FG009|Overall Study|Transitioned to Phase 4 study|0|||
30817991|NCT01004861|58838252|FG010|Overall Study|Transitioned to Phase 4 study|0|||
30817992|NCT01004861|58838253|FG011|Overall Study|Transitioned to Phase 4 study|0|||
30817993|NCT01004861|58838254|FG012|Overall Study|Transitioned to Phase 4 study|0|||
30817994|NCT01004861|58838242|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30817995|NCT01004861|58838243|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30817996|NCT01004861|58838244|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30817997|NCT01004861|58838245|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30817998|NCT01004861|58838246|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30817999|NCT01004861|58838247|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30818000|NCT01004861|58838248|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30818001|NCT01004861|58838249|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30912540|NCT02123797|58947816|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
30912541|NCT02123797|58947817|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
30912542|NCT02123797|58947818|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
30912543|NCT02123797|58947819|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
30912544|NCT02123797|58947820|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
30912545|NCT02123797|58947816|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
30912546|NCT02123797|58947817|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
30751997|NCT00191100|58761733|FG001|Overall Study|Adverse Event|1|||
30751998|NCT00191100|58761732|FG000|Overall Study|Lost to Follow-up|2|||
30751999|NCT00191100|58761733|FG001|Overall Study|Lost to Follow-up|0|||
30752000|NCT00191100|58761732|FG000|Overall Study|Patient Moved|0|||
30752001|NCT00191100|58761733|FG001|Overall Study|Patient Moved|1|||
30752002|NCT00191100|58761732|FG000|Overall Study|Withdrawal by Subject|9|||
30752003|NCT00191100|58761733|FG001|Overall Study|Withdrawal by Subject|3|||
30752004|NCT00191100|58761732|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
30752005|NCT00191100|58761733|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
30752006|NCT00191100|58761732|FG000|Overall Study|Clinical Relapse|2|||
30752007|NCT00191100|58761733|FG001|Overall Study|Clinical Relapse|1|||
30818002|NCT01004861|58838250|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
30818003|NCT01004861|58838251|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30818004|NCT01004861|58838252|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30818005|NCT01004861|58838253|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30818006|NCT01004861|58838254|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
30818007|NCT01004861|58838242|FG000|Overall Study|Patient withdrew|0|||
30818008|NCT01004861|58838243|FG001|Overall Study|Patient withdrew|0|||
30818009|NCT01004861|58838244|FG002|Overall Study|Patient withdrew|0|||
30818010|NCT01004861|58838245|FG003|Overall Study|Patient withdrew|0|||
30818011|NCT01004861|58838246|FG004|Overall Study|Patient withdrew|0|||
30818012|NCT01004861|58838247|FG005|Overall Study|Patient withdrew|0|||
30818013|NCT01004861|58838248|FG006|Overall Study|Patient withdrew|0|||
30818014|NCT01004861|58838249|FG007|Overall Study|Patient withdrew|0|||
30818015|NCT01004861|58838250|FG008|Overall Study|Patient withdrew|1|||
30818016|NCT01004861|58838251|FG009|Overall Study|Patient withdrew|0|||
30818017|NCT01004861|58838252|FG010|Overall Study|Patient withdrew|0|||
30818018|NCT01004861|58838253|FG011|Overall Study|Patient withdrew|0|||
30818019|NCT01004861|58838254|FG012|Overall Study|Patient withdrew|0|||
30818020|NCT01004861|58838242|FG000|Overall Study|Surgical resection|0|||
30818021|NCT01004861|58838243|FG001|Overall Study|Surgical resection|0|||
30818022|NCT01004861|58838244|FG002|Overall Study|Surgical resection|0|||
30818023|NCT01004861|58838245|FG003|Overall Study|Surgical resection|0|||
30818024|NCT01004861|58838246|FG004|Overall Study|Surgical resection|0|||
30818025|NCT01004861|58838247|FG005|Overall Study|Surgical resection|0|||
30818026|NCT01004861|58838248|FG006|Overall Study|Surgical resection|0|||
30818027|NCT01004861|58838249|FG007|Overall Study|Surgical resection|0|||
30818028|NCT01004861|58838250|FG008|Overall Study|Surgical resection|1|||
30818029|NCT01004861|58838251|FG009|Overall Study|Surgical resection|0|||
30818030|NCT01004861|58838252|FG010|Overall Study|Surgical resection|0|||
30623046|NCT01170065|58634805|FG001|Overall Study|Reason other than specified|8|||
30623047|NCT01170065|58634806|FG002|Overall Study|Reason other than specified|3|||
30623048|NCT01170065|58634804|FG000|Overall Study|Ongoing after planned observation time|5|||
30623049|NCT01170065|58634805|FG001|Overall Study|Ongoing after planned observation time|26|||
30623050|NCT01170065|58634806|FG002|Overall Study|Ongoing after planned observation time|10|||
30623051|NCT00966693|58634818|FG000|Overall Study|Adverse Event|0|||
30623052|NCT00966693|58634819|FG001|Overall Study|Adverse Event|0|||
30818031|NCT01004861|58838253|FG011|Overall Study|Surgical resection|0|||
30818032|NCT01004861|58838254|FG012|Overall Study|Surgical resection|0|||
30818033|NCT01004861|58838242|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30752008|NCT00191100|58761732|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
30818034|NCT01004861|58838243|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30818035|NCT01004861|58838244|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30818036|NCT01004861|58838245|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30818037|NCT01004861|58838246|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30818038|NCT01004861|58838247|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30818039|NCT01004861|58838248|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30818040|NCT01004861|58838249|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30818041|NCT01004861|58838250|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
30818042|NCT01004861|58838251|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30818043|NCT01004861|58838252|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30818044|NCT01004861|58838253|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30752009|NCT00191100|58761733|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
30818045|NCT01004861|58838254|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
30818046|NCT01004861|58838242|FG000|Overall Study|Study termination by Sponsor|0|||
30818047|NCT01004861|58838243|FG001|Overall Study|Study termination by Sponsor|0|||
30818048|NCT01004861|58838244|FG002|Overall Study|Study termination by Sponsor|0|||
30818049|NCT01004861|58838245|FG003|Overall Study|Study termination by Sponsor|0|||
30818050|NCT01004861|58838246|FG004|Overall Study|Study termination by Sponsor|0|||
30818051|NCT01004861|58838247|FG005|Overall Study|Study termination by Sponsor|0|||
30818052|NCT01004861|58838248|FG006|Overall Study|Study termination by Sponsor|0|||
30818053|NCT01004861|58838249|FG007|Overall Study|Study termination by Sponsor|0|||
30818054|NCT01004861|58838250|FG008|Overall Study|Study termination by Sponsor|1|||
30818055|NCT01004861|58838251|FG009|Overall Study|Study termination by Sponsor|0|||
30818056|NCT01004861|58838252|FG010|Overall Study|Study termination by Sponsor|0|||
30818057|NCT01004861|58838253|FG011|Overall Study|Study termination by Sponsor|0|||
30818058|NCT01004861|58838254|FG012|Overall Study|Study termination by Sponsor|0|||
30818059|NCT03254459|58838301|FG000|Overall Study|Adverse Event|7|||
30818060|NCT03254459|58838302|FG001|Overall Study|Adverse Event|20|||
30818061|NCT03254459|58838301|FG000|Overall Study|Withdrawal by Subject Consent|3|||
30818062|NCT03254459|58838302|FG001|Overall Study|Withdrawal by Subject Consent|1|||
30818063|NCT03254459|58838301|FG000|Overall Study|Lost to Follow-up|0|||
30818064|NCT03254459|58838302|FG001|Overall Study|Lost to Follow-up|1|||
30818065|NCT03254459|58838301|FG000|Overall Study|Miscellaneous|0|||
30818066|NCT03254459|58838302|FG001|Overall Study|Miscellaneous|1|||
30818067|NCT02736617|58838308|FG000|Treatment|Adverse Event|1|||
30818068|NCT02736617|58838308|FG000|Treatment|Lack of Efficacy|1|||
30752010|NCT00191100|58761732|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
30752011|NCT00191100|58761733|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
30752012|NCT00191100|58761732|FG000|Overall Study|Physician Decision|3|||
30752013|NCT00191100|58761733|FG001|Overall Study|Physician Decision|1|||
30752014|NCT00191100|58761732|FG000|Overall Study|Death from Study Drug Toxicity|2|||
30752015|NCT00191100|58761733|FG001|Overall Study|Death from Study Drug Toxicity|0|||
30752016|NCT00191100|58761732|FG000|Overall Study|Protocol Violation|1|||
30752017|NCT00191100|58761733|FG001|Overall Study|Protocol Violation|1|||
30752018|NCT00191100|58761732|FG000|Overall Study|Death from Other Cause|1|||
30752019|NCT00191100|58761733|FG001|Overall Study|Death from Other Cause|0|||
30752020|NCT00191100|58761732|FG000|Overall Study|Reason Not Specified|0|||
30752021|NCT00191100|58761733|FG001|Overall Study|Reason Not Specified|1|||
30752022|NCT00189540|58761741|FG000|Overall Study|Withdrawal by Subject|3|||
30818069|NCT02736617|58838308|FG000|Treatment|Withdrawal by Subject|1|||
30818070|NCT02736617|58838308|FG000|Maintenance|Lack of Efficacy|4|||
30818071|NCT02736617|58838308|FG000|Maintenance|Physician Decision|1|||
30623053|NCT00966693|58634820|FG002|Overall Study|Adverse Event|1|||
30752023|NCT00189540|58761742|FG001|Overall Study|Withdrawal by Subject|0|||
30752024|NCT00189540|58761741|FG000|Overall Study|Death|4|||
30752025|NCT00189540|58761742|FG001|Overall Study|Death|1|||
30818072|NCT03251963|58838315|FG000|Overall Study|inappropriate Xa level timing|6|||
30818073|NCT03251963|58838316|FG001|Overall Study|inappropriate Xa level timing|3|||
30818074|NCT03251963|58838315|FG000|Overall Study|no peak Xa level drawn|2|||
30818075|NCT03251963|58838316|FG001|Overall Study|no peak Xa level drawn|0|||
30818076|NCT03251963|58838315|FG000|Overall Study|bled prior to Xa level|1|||
30818077|NCT03251963|58838316|FG001|Overall Study|bled prior to Xa level|2|||
30818078|NCT03287219|58838324|FG000|Overall Study|Protocol Violation|0|||
30818079|NCT03287219|58838325|FG001|Overall Study|Protocol Violation|2|||
30818080|NCT03286751|58838364|FG000|Washout Period 1|Withdrawal by Subject|0|||
30818081|NCT03286751|58838365|FG001|Washout Period 1|Withdrawal by Subject|0|||
30818082|NCT03286751|58838366|FG002|Washout Period 1|Withdrawal by Subject|0|||
30912547|NCT02123797|58947818|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
30912548|NCT02123797|58947819|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
30912549|NCT02123797|58947820|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
30912550|NCT02123797|58947816|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
30912551|NCT02123797|58947817|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
30912552|NCT02123797|58947818|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
30912553|NCT02123797|58947819|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
30912554|NCT02123797|58947820|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
30912555|NCT02175121|58947845|FG000|Overall Study|Lack of Efficacy|1|||
30912556|NCT02175121|58947846|FG001|Overall Study|Lack of Efficacy|0|||
30912557|NCT02175121|58947847|FG002|Overall Study|Lack of Efficacy|0|||
30912558|NCT02175121|58947848|FG003|Overall Study|Lack of Efficacy|0|||
30912559|NCT02175121|58947849|FG004|Overall Study|Lack of Efficacy|0|||
30912560|NCT02175121|58947845|FG000|Overall Study|Lost to Follow-up|0|||
30912561|NCT02175121|58947846|FG001|Overall Study|Lost to Follow-up|1|||
30912562|NCT02175121|58947847|FG002|Overall Study|Lost to Follow-up|0|||
30912563|NCT02175121|58947848|FG003|Overall Study|Lost to Follow-up|1|||
30912564|NCT02175121|58947849|FG004|Overall Study|Lost to Follow-up|0|||
30912565|NCT02175121|58947845|FG000|Overall Study|Personal emergency|0|||
30818083|NCT03286751|58838367|FG003|Washout Period 1|Withdrawal by Subject|0|||
30818084|NCT03286751|58838368|FG004|Washout Period 1|Withdrawal by Subject|1|||
30818085|NCT03286751|58838369|FG005|Washout Period 1|Withdrawal by Subject|0|||
30818086|NCT03286751|58838364|FG000|Washout Period 2|Personal Reasons|0|||
30818087|NCT03286751|58838365|FG001|Washout Period 2|Personal Reasons|1|||
30818088|NCT03286751|58838366|FG002|Washout Period 2|Personal Reasons|0|||
30818089|NCT03286751|58838367|FG003|Washout Period 2|Personal Reasons|0|||
30818090|NCT03286751|58838368|FG004|Washout Period 2|Personal Reasons|0|||
30818091|NCT03286751|58838369|FG005|Washout Period 2|Personal Reasons|0|||
30818092|NCT03286751|58838364|FG000|Washout Period 5|Adverse Event|0|||
30818093|NCT03286751|58838365|FG001|Washout Period 5|Adverse Event|0|||
30818094|NCT03286751|58838366|FG002|Washout Period 5|Adverse Event|0|||
30818095|NCT03286751|58838367|FG003|Washout Period 5|Adverse Event|0|||
30818096|NCT03286751|58838368|FG004|Washout Period 5|Adverse Event|1|||
30818097|NCT03286751|58838369|FG005|Washout Period 5|Adverse Event|0|||
30623054|NCT00966693|58634821|FG003|Overall Study|Adverse Event|2|||
30818098|NCT03249935|58838383|FG000|Overall Study|Discharged from facility early|36|||
30818099|NCT03249935|58838383|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
30818100|NCT03249935|58838383|FG000|Overall Study|Protocol Violation|5|||
30912566|NCT02175121|58947846|FG001|Overall Study|Personal emergency|0|||
30912567|NCT02175121|58947847|FG002|Overall Study|Personal emergency|0|||
30818101|NCT03285113|58838389|FG000|Overall Study|Unable to implant leads|2|||
30818102|NCT03000348|58838399|FG000|Overall Study|Adverse Event|1|||
30818103|NCT03000348|58838400|FG001|Overall Study|Adverse Event|1|||
30818104|NCT03000348|58838401|FG002|Overall Study|Adverse Event|1|||
30912568|NCT02175121|58947848|FG003|Overall Study|Personal emergency|0|||
30912569|NCT02175121|58947849|FG004|Overall Study|Personal emergency|1|||
30912570|NCT02175121|58947845|FG000|Overall Study|Schedule conflict|0|||
30818105|NCT03000348|58838402|FG003|Overall Study|Adverse Event|1|||
30818106|NCT03000348|58838403|FG004|Overall Study|Adverse Event|1|||
30818107|NCT03000348|58838404|FG005|Overall Study|Adverse Event|1|||
30818108|NCT03000348|58838399|FG000|Overall Study|Lost to Follow-up|0|||
30818109|NCT03000348|58838400|FG001|Overall Study|Lost to Follow-up|0|||
30818110|NCT03000348|58838401|FG002|Overall Study|Lost to Follow-up|1|||
30818111|NCT03000348|58838402|FG003|Overall Study|Lost to Follow-up|0|||
30818112|NCT03000348|58838403|FG004|Overall Study|Lost to Follow-up|0|||
30818113|NCT03000348|58838404|FG005|Overall Study|Lost to Follow-up|0|||
30818114|NCT03000348|58838399|FG000|Overall Study|Withdrawal by Subject|0|||
30818115|NCT03000348|58838400|FG001|Overall Study|Withdrawal by Subject|1|||
30818116|NCT03000348|58838401|FG002|Overall Study|Withdrawal by Subject|0|||
30818117|NCT03000348|58838402|FG003|Overall Study|Withdrawal by Subject|0|||
30818118|NCT03000348|58838403|FG004|Overall Study|Withdrawal by Subject|0|||
30818119|NCT03000348|58838404|FG005|Overall Study|Withdrawal by Subject|0|||
30818120|NCT03000348|58838399|FG000|Overall Study|Consent|0|||
30818121|NCT03000348|58838400|FG001|Overall Study|Consent|0|||
30818122|NCT03000348|58838401|FG002|Overall Study|Consent|0|||
30912571|NCT02175121|58947846|FG001|Overall Study|Schedule conflict|0|||
30912572|NCT02175121|58947847|FG002|Overall Study|Schedule conflict|1|||
30912573|NCT02175121|58947848|FG003|Overall Study|Schedule conflict|0|||
30912574|NCT02175121|58947849|FG004|Overall Study|Schedule conflict|0|||
30752026|NCT00257010|58761748|FG000|Overall Study|Lack of Efficacy|11|||
30752027|NCT00257010|58761748|FG000|Overall Study|Lost to Follow-up|53|||
30752028|NCT00257010|58761748|FG000|Overall Study|Withdrawal by Subject|34|||
30752029|NCT00257010|58761748|FG000|Overall Study|Adverse Event|10|||
30752030|NCT00257010|58761748|FG000|Overall Study|various|11|||
30752031|NCT00257010|58761748|FG000|Overall Study|no headache reported|9|||
30752032|NCT00256854|58761758|FG000|Overall Study|Withdrawal by Subject|2|||
30752033|NCT00256854|58761759|FG001|Overall Study|Withdrawal by Subject|3|||
30752034|NCT00256854|58761760|FG002|Overall Study|Withdrawal by Subject|0|||
30752035|NCT00256854|58761761|FG003|Overall Study|Withdrawal by Subject|0|||
30752036|NCT00256854|58761762|FG004|Overall Study|Withdrawal by Subject|0|||
30752037|NCT00256854|58761763|FG005|Overall Study|Withdrawal by Subject|0|||
30752038|NCT00256854|58761758|FG000|Overall Study|Lack of Efficacy|1|||
30752039|NCT00256854|58761759|FG001|Overall Study|Lack of Efficacy|0|||
30752040|NCT00256854|58761760|FG002|Overall Study|Lack of Efficacy|0|||
30752041|NCT00256854|58761761|FG003|Overall Study|Lack of Efficacy|0|||
30752042|NCT00256854|58761762|FG004|Overall Study|Lack of Efficacy|0|||
30752043|NCT00256854|58761763|FG005|Overall Study|Lack of Efficacy|0|||
30752044|NCT00256854|58761758|FG000|Overall Study|Protocol Violation|0|||
30752045|NCT00256854|58761759|FG001|Overall Study|Protocol Violation|1|||
30752046|NCT00256854|58761760|FG002|Overall Study|Protocol Violation|1|||
30752047|NCT00256854|58761761|FG003|Overall Study|Protocol Violation|1|||
30752048|NCT00256854|58761762|FG004|Overall Study|Protocol Violation|0|||
30752049|NCT00256854|58761763|FG005|Overall Study|Protocol Violation|0|||
30752050|NCT00256854|58761758|FG000|Overall Study|Adverse Event|0|||
30752051|NCT00256854|58761759|FG001|Overall Study|Adverse Event|0|||
30752052|NCT00256854|58761760|FG002|Overall Study|Adverse Event|2|||
30752053|NCT00256854|58761761|FG003|Overall Study|Adverse Event|2|||
30752054|NCT00256854|58761762|FG004|Overall Study|Adverse Event|0|||
30752055|NCT00256854|58761763|FG005|Overall Study|Adverse Event|1|||
30752056|NCT00256854|58761758|FG000|Overall Study|Not compliant with the study drug|0|||
30752057|NCT00256854|58761759|FG001|Overall Study|Not compliant with the study drug|0|||
30752058|NCT00256854|58761760|FG002|Overall Study|Not compliant with the study drug|0|||
30752059|NCT00256854|58761761|FG003|Overall Study|Not compliant with the study drug|0|||
30752060|NCT00256854|58761762|FG004|Overall Study|Not compliant with the study drug|1|||
30752061|NCT00256854|58761763|FG005|Overall Study|Not compliant with the study drug|0|||
30752062|NCT00189462|58761780|FG000|Overall Study|Lack of Efficacy|5|||
30752063|NCT00189462|58761781|FG001|Overall Study|Lack of Efficacy|1|||
30752064|NCT00189462|58761780|FG000|Overall Study|Lost to Follow-up|18|||
30752065|NCT00189462|58761781|FG001|Overall Study|Lost to Follow-up|20|||
30752066|NCT00256698|58761789|FG000|Overall Study|Withdrawal by Subject|7|||
30752067|NCT00256698|58761790|FG001|Overall Study|Withdrawal by Subject|7|||
30752068|NCT00256698|58761789|FG000|Overall Study|Adverse Event|13|||
30818123|NCT03000348|58838402|FG003|Overall Study|Consent|0|||
30818124|NCT03000348|58838403|FG004|Overall Study|Consent|1|||
30818125|NCT03000348|58838404|FG005|Overall Study|Consent|0|||
30912575|NCT02175121|58947845|FG000|Overall Study|Time issues|0|||
30752069|NCT00256698|58761790|FG001|Overall Study|Adverse Event|6|||
30752070|NCT00256698|58761789|FG000|Overall Study|Protocol Violation|6|||
30818126|NCT03000348|58838399|FG000|Overall Study|Failure to expectorate sputum|1|||
30818127|NCT03000348|58838400|FG001|Overall Study|Failure to expectorate sputum|0|||
30818128|NCT03000348|58838401|FG002|Overall Study|Failure to expectorate sputum|1|||
30818129|NCT03000348|58838402|FG003|Overall Study|Failure to expectorate sputum|0|||
30818130|NCT03000348|58838403|FG004|Overall Study|Failure to expectorate sputum|1|||
30912576|NCT02175121|58947846|FG001|Overall Study|Time issues|0|||
30912577|NCT02175121|58947847|FG002|Overall Study|Time issues|1|||
30912578|NCT02175121|58947848|FG003|Overall Study|Time issues|0|||
30912579|NCT02175121|58947849|FG004|Overall Study|Time issues|0|||
30912580|NCT01568866|58947867|FG000|Overall Study|Disease Progression|208|||
30912581|NCT01568866|58947868|FG001|Overall Study|Disease Progression|183|||
30912582|NCT01568866|58947867|FG000|Overall Study|Adverse Event|94|||
30912583|NCT01568866|58947868|FG001|Overall Study|Adverse Event|96|||
30912584|NCT01568866|58947867|FG000|Overall Study|Patient Request|55|||
30912585|NCT01568866|58947868|FG001|Overall Study|Patient Request|71|||
30912586|NCT01568866|58947867|FG000|Overall Study|Physician Decision|40|||
30912587|NCT01568866|58947868|FG001|Overall Study|Physician Decision|32|||
30912588|NCT01568866|58947867|FG000|Overall Study|Withdrawal by Subject|19|||
30912589|NCT01568866|58947868|FG001|Overall Study|Withdrawal by Subject|11|||
30818131|NCT03000348|58838404|FG005|Overall Study|Failure to expectorate sputum|0|||
30818132|NCT03000348|58838399|FG000|Overall Study|No gram negative|1|||
30818133|NCT03000348|58838400|FG001|Overall Study|No gram negative|2|||
30818134|NCT03000348|58838401|FG002|Overall Study|No gram negative|1|||
30818135|NCT03000348|58838402|FG003|Overall Study|No gram negative|1|||
30818136|NCT03000348|58838403|FG004|Overall Study|No gram negative|1|||
30623055|NCT00966693|58634818|FG000|Overall Study|Death|0|||
30818137|NCT03000348|58838404|FG005|Overall Study|No gram negative|1|||
30818138|NCT03000348|58838399|FG000|Overall Study|Patient had no transport|0|||
30818139|NCT03000348|58838400|FG001|Overall Study|Patient had no transport|0|||
30818140|NCT03000348|58838401|FG002|Overall Study|Patient had no transport|0|||
30818141|NCT03000348|58838402|FG003|Overall Study|Patient had no transport|1|||
30818142|NCT03000348|58838403|FG004|Overall Study|Patient had no transport|0|||
30818143|NCT03000348|58838404|FG005|Overall Study|Patient had no transport|0|||
30818144|NCT03000348|58838399|FG000|Overall Study|Dosing|0|||
30818145|NCT03000348|58838400|FG001|Overall Study|Dosing|0|||
30818146|NCT03000348|58838401|FG002|Overall Study|Dosing|0|||
30818147|NCT03000348|58838402|FG003|Overall Study|Dosing|0|||
30818148|NCT03000348|58838403|FG004|Overall Study|Dosing|1|||
30818149|NCT03000348|58838404|FG005|Overall Study|Dosing|0|||
30818150|NCT03283709|58838423|FG000|Overall Study|trial terminated|0|||
30818151|NCT03283709|58838424|FG001|Overall Study|trial terminated|1|||
30818152|NCT03247673|58838433|FG000|Overall Study|Withdrawal by Subject|1|||
30818153|NCT03247673|58838434|FG001|Overall Study|Withdrawal by Subject|0|||
30818154|NCT03247673|58838435|FG002|Overall Study|Withdrawal by Subject|3|||
30818155|NCT03247673|58838433|FG000|Overall Study|Lost to Follow-up|0|||
30818156|NCT03247673|58838434|FG001|Overall Study|Lost to Follow-up|0|||
30818157|NCT03247673|58838435|FG002|Overall Study|Lost to Follow-up|1|||
30818158|NCT03247517|58838446|FG000|Overall Study|Adverse Event|0|||
30818159|NCT03247517|58838447|FG001|Overall Study|Adverse Event|4|||
30818160|NCT03247517|58838448|FG002|Overall Study|Adverse Event|2|||
30818161|NCT03247517|58838446|FG000|Overall Study|Lost to Follow-up|2|||
30818162|NCT03247517|58838447|FG001|Overall Study|Lost to Follow-up|6|||
30818163|NCT03247517|58838448|FG002|Overall Study|Lost to Follow-up|4|||
30818164|NCT03247517|58838446|FG000|Overall Study|Consent withdrawn by caregiver|1|||
30818165|NCT03247517|58838447|FG001|Overall Study|Consent withdrawn by caregiver|4|||
30818166|NCT03247517|58838448|FG002|Overall Study|Consent withdrawn by caregiver|7|||
30818167|NCT03247517|58838446|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
30818168|NCT03247517|58838447|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
30818169|NCT03247517|58838448|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
30818170|NCT03247517|58838446|FG000|Overall Study|Protocol Violation|0|||
30912590|NCT01568866|58947867|FG000|Overall Study|Death|10|||
30912591|NCT01568866|58947868|FG001|Overall Study|Death|18|||
30912592|NCT01568866|58947867|FG000|Overall Study|Protocol Non-compliance|2|||
30912593|NCT01568866|58947868|FG001|Overall Study|Protocol Non-compliance|4|||
30818171|NCT03247517|58838447|FG001|Overall Study|Protocol Violation|2|||
30818172|NCT03247517|58838448|FG002|Overall Study|Protocol Violation|0|||
30818173|NCT03247517|58838446|FG000|Overall Study|Multiple reasons|3|||
30818174|NCT03247517|58838447|FG001|Overall Study|Multiple reasons|1|||
30818175|NCT03247517|58838448|FG002|Overall Study|Multiple reasons|0|||
30818176|NCT03283553|58838458|FG000|Patient Participant Flow|Death|5|||
30818177|NCT03283553|58838459|FG001|Patient Participant Flow|Death|10|||
30912594|NCT01568866|58947867|FG000|Overall Study|Lost to Follow-up|1|||
30818178|NCT03283553|58838458|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
30818179|NCT03283553|58838459|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
30818180|NCT03283553|58838458|FG000|Patient Participant Flow|Lost to Follow-up|1|||
30818181|NCT03283553|58838459|FG001|Patient Participant Flow|Lost to Follow-up|1|||
30818182|NCT03283553|58838458|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
30818183|NCT03283553|58838459|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
30818184|NCT03283553|58838458|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
30818185|NCT03283553|58838459|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
30818186|NCT03283553|58838458|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
30818187|NCT03283553|58838459|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
30818188|NCT03283319|58838473|FG000|Overall Study|Lost to Follow-up|5|||
30818189|NCT03283319|58838474|FG001|Overall Study|Lost to Follow-up|4|||
30818190|NCT03283319|58838475|FG002|Overall Study|Lost to Follow-up|5|||
30818191|NCT03283319|58838476|FG003|Overall Study|Lost to Follow-up|5|||
30818192|NCT03283319|58838477|FG004|Overall Study|Lost to Follow-up|4|||
30818193|NCT03283319|58838478|FG005|Overall Study|Lost to Follow-up|3|||
30818194|NCT03283319|58838473|FG000|Overall Study|Withdrawal by Subject|2|||
30818195|NCT03283319|58838474|FG001|Overall Study|Withdrawal by Subject|2|||
30818196|NCT03283319|58838475|FG002|Overall Study|Withdrawal by Subject|2|||
30818197|NCT03283319|58838476|FG003|Overall Study|Withdrawal by Subject|1|||
30818198|NCT03283319|58838477|FG004|Overall Study|Withdrawal by Subject|0|||
30818199|NCT03283319|58838478|FG005|Overall Study|Withdrawal by Subject|1|||
30818200|NCT03283319|58838473|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
30818201|NCT03283319|58838474|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
30818202|NCT03283319|58838475|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
30818203|NCT03283319|58838476|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
30818204|NCT03283319|58838477|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
30818205|NCT03283319|58838478|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
30818206|NCT03282227|58838492|FG000|Overall Study|Exposure Goals Achieved|60|||
30818207|NCT03282227|58838492|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
30818208|NCT03282227|58838492|FG000|Overall Study|Adverse Event|15|||
30818209|NCT03282227|58838492|FG000|Overall Study|Lost to Follow-up|21|||
30818210|NCT03282227|58838492|FG000|Overall Study|Withdrawal by Subject|20|||
30818211|NCT03282227|58838492|FG000|Overall Study|Lack of Efficacy|12|||
30818212|NCT03282227|58838492|FG000|Overall Study|Sponsor decision|3|||
30818213|NCT03282227|58838492|FG000|Overall Study|Physician Decision|2|||
30818214|NCT03282227|58838492|FG000|Overall Study|Pregnancy|2|||
30818215|NCT03282227|58838492|FG000|Overall Study|Other|1|||
30818216|NCT03240575|58838500|FG000|Overall Study|Adverse Event|0|||
30818217|NCT03240575|58838501|FG001|Overall Study|Adverse Event|2|||
30818218|NCT03240575|58838502|FG002|Overall Study|Adverse Event|0|||
30818219|NCT03240575|58838503|FG003|Overall Study|Adverse Event|1|||
30818220|NCT03240575|58838500|FG000|Overall Study|Withdrawal by Subject|2|||
30818221|NCT03240575|58838501|FG001|Overall Study|Withdrawal by Subject|11|||
30818222|NCT03240575|58838502|FG002|Overall Study|Withdrawal by Subject|0|||
30818223|NCT03240575|58838503|FG003|Overall Study|Withdrawal by Subject|1|||
30818224|NCT03240575|58838500|FG000|Overall Study|Other|0|||
30818225|NCT03240575|58838501|FG001|Overall Study|Other|1|||
30818226|NCT03240575|58838502|FG002|Overall Study|Other|0|||
30818227|NCT03240575|58838503|FG003|Overall Study|Other|0|||
30818228|NCT03385265|58838515|FG000|Overall Study|Withdrawal by Subject|5|||
30818229|NCT03385265|58838516|FG001|Overall Study|Withdrawal by Subject|2|||
30818230|NCT03385265|58838517|FG002|Overall Study|Withdrawal by Subject|5|||
30818231|NCT03385265|58838518|FG003|Overall Study|Withdrawal by Subject|2|||
30818232|NCT03280121|58838530|FG000|Overall Study|Physician Decision|1|||
30818233|NCT03280121|58838530|FG000|Overall Study|Lost to Follow-up|1|||
30818234|NCT03280121|58838530|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
30818235|NCT03233009|58838534|FG000|Overall Study|Lost to Follow-up|1|||
30818236|NCT04034225|58838549|FG000|Overall Study|Death|3|||
30818237|NCT04034225|58838549|FG000|Overall Study|Withdrawal by Subject|2|||
30818238|NCT04034225|58838549|FG000|Overall Study|Study termination by Sponsor|18|||
30818239|NCT04034225|58838549|FG000|Overall Study|Physician Decision|1|||
30818240|NCT04034225|58838549|FG000|Overall Study|Lack of Efficacy|1|||
30818241|NCT02999178|58838557|FG000|Overall Study|Adverse Event|85|||
30818242|NCT02999178|58838558|FG001|Overall Study|Adverse Event|62|||
30818243|NCT02999178|58838557|FG000|Overall Study|Protocol Violation|1|||
30818244|NCT02999178|58838558|FG001|Overall Study|Protocol Violation|2|||
30818245|NCT02999178|58838557|FG000|Overall Study|Lost to Follow-up|0|||
30818246|NCT02999178|58838558|FG001|Overall Study|Lost to Follow-up|2|||
30818247|NCT02999178|58838557|FG000|Overall Study|Withdrawal by Subject|21|||
30912595|NCT01568866|58947868|FG001|Overall Study|Lost to Follow-up|0|||
30912596|NCT01568866|58947867|FG000|Overall Study|Randomized but Not Dosed|9|||
30912597|NCT01568866|58947868|FG001|Overall Study|Randomized but Not Dosed|1|||
30912598|NCT01568320|58947874|FG000|Overall Study|Death|20|||
30912599|NCT01568320|58947874|FG000|Overall Study|Lost to Follow-up|9|||
30912600|NCT01568320|58947874|FG000|Overall Study|Withdrawal by Subject|10|||
30912601|NCT01568320|58947874|FG000|Overall Study|Conversion to open repair|1|||
30912602|NCT01568320|58947874|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
30912603|NCT01567852|58947880|FG000|Overall Study|Withdrawal by Subject|3|||
30912604|NCT01567852|58947881|FG001|Overall Study|Withdrawal by Subject|6|||
30818248|NCT02999178|58838558|FG001|Overall Study|Withdrawal by Subject|21|||
30818249|NCT02999178|58838557|FG000|Overall Study|Other reason not defined above|7|||
30818250|NCT02999178|58838558|FG001|Overall Study|Other reason not defined above|13|||
30818251|NCT02959190|58838570|FG000|Open Label|Adverse Event|5|||
30912605|NCT01567852|58947880|FG000|Overall Study|ECT discontinued|1|||
30912606|NCT01567852|58947881|FG001|Overall Study|ECT discontinued|1|||
30912607|NCT01588366|58947892|FG000|Overall Study|Adverse Event|0|||
30912608|NCT01588366|58947893|FG001|Overall Study|Adverse Event|1|||
30912609|NCT01588366|58947894|FG002|Overall Study|Adverse Event|0|||
30912610|NCT01588366|58947895|FG003|Overall Study|Adverse Event|1|||
30818252|NCT02959190|58838571|FG001|Open Label|Adverse Event|7|||
30912611|NCT01588366|58947896|FG004|Overall Study|Adverse Event|0|||
30912612|NCT01588366|58947897|FG005|Overall Study|Adverse Event|2|||
30912613|NCT01686958|58947913|FG000|Overall Study|Withdrawal by Subject|1|||
30912614|NCT01686568|58947920|FG000|Main Study|Withdrawal by Subject|1|||
30912615|NCT01686568|58947921|FG001|Main Study|Withdrawal by Subject|3|||
30912616|NCT01686568|58947920|FG000|Main Study|Noncompliance with protocol|0|||
30912617|NCT01686568|58947921|FG001|Main Study|Noncompliance with protocol|1|||
30912618|NCT01686568|58947920|FG000|Main Study|Liver enzymes above range of exclusion|1|||
30912619|NCT01686568|58947921|FG001|Main Study|Liver enzymes above range of exclusion|0|||
30912620|NCT01686568|58947920|FG000|Sub-Study|Not consented for sub-study|2|||
30912621|NCT01686568|58947921|FG001|Sub-Study|Not consented for sub-study|2|||
30912622|NCT01567462|58947929|FG000|Overall Study|Withdrawal by Subject|4|||
30912623|NCT01567462|58947930|FG001|Overall Study|Withdrawal by Subject|7|||
30912624|NCT01587898|58947940|FG000|Overall Study|Adverse Event|1|||
30912625|NCT01587898|58947941|FG001|Overall Study|Adverse Event|1|||
30912626|NCT01587898|58947942|FG002|Overall Study|Adverse Event|0|||
30912627|NCT01587898|58947943|FG003|Overall Study|Adverse Event|0|||
30912628|NCT01587898|58947940|FG000|Overall Study|Protocol Violation|0|||
30912629|NCT01587898|58947941|FG001|Overall Study|Protocol Violation|2|||
30912630|NCT01587898|58947942|FG002|Overall Study|Protocol Violation|1|||
30912631|NCT01587898|58947943|FG003|Overall Study|Protocol Violation|1|||
30912632|NCT01587898|58947940|FG000|Overall Study|Lost to Follow-up|0|||
30912633|NCT01587898|58947941|FG001|Overall Study|Lost to Follow-up|0|||
30912634|NCT01587898|58947942|FG002|Overall Study|Lost to Follow-up|0|||
30912635|NCT01587898|58947943|FG003|Overall Study|Lost to Follow-up|1|||
30912636|NCT01587898|58947940|FG000|Overall Study|Withdrawal by Subject|2|||
30912637|NCT01587898|58947941|FG001|Overall Study|Withdrawal by Subject|1|||
30912638|NCT01587898|58947942|FG002|Overall Study|Withdrawal by Subject|0|||
30912639|NCT01587898|58947943|FG003|Overall Study|Withdrawal by Subject|0|||
30912640|NCT01587898|58947940|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
30912641|NCT01587898|58947941|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
30912642|NCT01587898|58947942|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
30912643|NCT01587898|58947943|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
30752071|NCT00256698|58761790|FG001|Overall Study|Protocol Violation|5|||
30752072|NCT00256698|58761789|FG000|Overall Study|Lost to Follow-up|1|||
30752073|NCT00256698|58761790|FG001|Overall Study|Lost to Follow-up|3|||
30752074|NCT00256698|58761789|FG000|Overall Study|disease progression|97|||
30752075|NCT00256698|58761790|FG001|Overall Study|disease progression|105|||
30752076|NCT00256698|58761789|FG000|Overall Study|still ongoing at data cut-off|41|||
30752077|NCT00256698|58761790|FG001|Overall Study|still ongoing at data cut-off|46|||
30752078|NCT00256698|58761789|FG000|Overall Study|withdrawn due to osteoporosis|1|||
30752079|NCT00256698|58761790|FG001|Overall Study|withdrawn due to osteoporosis|0|||
30752080|NCT00256698|58761789|FG000|Overall Study|Prematurely Discontinued|1|||
30818253|NCT02959190|58838572|FG002|Open Label|Adverse Event|3|||
30912644|NCT01567306|58947962|FG000|Overall Study|Protocol Violation|2|||
30912645|NCT01567306|58947963|FG001|Overall Study|Protocol Violation|2|||
30912646|NCT01567306|58947964|FG002|Overall Study|Protocol Violation|0|||
30912647|NCT01567306|58947965|FG003|Overall Study|Protocol Violation|3|||
30912648|NCT01567306|58947966|FG004|Overall Study|Protocol Violation|1|||
30912649|NCT01567306|58947967|FG005|Overall Study|Protocol Violation|1|||
30912650|NCT01567306|58947962|FG000|Overall Study|Change site living|1|||
30752081|NCT00256698|58761790|FG001|Overall Study|Prematurely Discontinued|0|||
30752082|NCT00189306|58761796|FG000|Treatment Period|Withdrawal by Subject|2|||
30752083|NCT00189306|58761796|FG000|Treatment Period|Adverse Event|2|||
30912651|NCT01567306|58947963|FG001|Overall Study|Change site living|0|||
30912652|NCT01567306|58947964|FG002|Overall Study|Change site living|0|||
30912653|NCT01567306|58947965|FG003|Overall Study|Change site living|0|||
30912654|NCT01567306|58947966|FG004|Overall Study|Change site living|0|||
30912655|NCT01567306|58947967|FG005|Overall Study|Change site living|0|||
30912656|NCT01567306|58947962|FG000|Overall Study|Adverse Event|0|||
30912657|NCT01567306|58947963|FG001|Overall Study|Adverse Event|0|||
30912658|NCT01567306|58947964|FG002|Overall Study|Adverse Event|0|||
30912659|NCT01567306|58947965|FG003|Overall Study|Adverse Event|2|||
30912660|NCT01567306|58947966|FG004|Overall Study|Adverse Event|4|||
30912661|NCT01567306|58947967|FG005|Overall Study|Adverse Event|1|||
30912662|NCT01567306|58947962|FG000|Overall Study|Lost to Follow-up|0|||
30912663|NCT01567306|58947963|FG001|Overall Study|Lost to Follow-up|0|||
30912664|NCT01567306|58947964|FG002|Overall Study|Lost to Follow-up|0|||
30912665|NCT01567306|58947965|FG003|Overall Study|Lost to Follow-up|0|||
30912666|NCT01567306|58947966|FG004|Overall Study|Lost to Follow-up|2|||
30912667|NCT01567306|58947967|FG005|Overall Study|Lost to Follow-up|0|||
30912668|NCT01567306|58947962|FG000|Overall Study|Withdrawal by Subject|0|||
30912669|NCT01567306|58947963|FG001|Overall Study|Withdrawal by Subject|0|||
30912670|NCT01567306|58947964|FG002|Overall Study|Withdrawal by Subject|0|||
30912671|NCT01567306|58947965|FG003|Overall Study|Withdrawal by Subject|0|||
30912672|NCT01567306|58947966|FG004|Overall Study|Withdrawal by Subject|0|||
30912673|NCT01567306|58947967|FG005|Overall Study|Withdrawal by Subject|1|||
30818254|NCT02959190|58838573|FG003|Open Label|Adverse Event|4|||
30818255|NCT02959190|58838570|FG000|Open Label|Pregnancy|0|||
30818256|NCT02959190|58838571|FG001|Open Label|Pregnancy|1|||
30818257|NCT02959190|58838572|FG002|Open Label|Pregnancy|0|||
30818258|NCT02959190|58838573|FG003|Open Label|Pregnancy|0|||
30818259|NCT02959190|58838570|FG000|Open Label|Withdrawal by Subject|2|||
30912674|NCT01587274|58947984|FG000|Overall Study|Lost to Follow-up|4|||
30912675|NCT01587274|58947985|FG001|Overall Study|Lost to Follow-up|5|||
30912676|NCT01587274|58947986|FG002|Overall Study|Lost to Follow-up|3|||
30912677|NCT01587118|58947994|FG000|Overall Study|Adverse Event|3|||
30912678|NCT01587118|58947994|FG000|Overall Study|Lost to Follow-up|2|||
30912679|NCT01587118|58947994|FG000|Overall Study|Relocation|1|||
30912680|NCT01587118|58947994|FG000|Overall Study|nonresponse|1|||
30912681|NCT01905657|58948001|FG000|Overall Study|Adverse Event|23|||
30912682|NCT01905657|58948002|FG001|Overall Study|Adverse Event|17|||
30912683|NCT01905657|58948003|FG002|Overall Study|Adverse Event|18|||
30912684|NCT01905657|58948001|FG000|Overall Study|Clinical Progression|103|||
30912685|NCT01905657|58948002|FG001|Overall Study|Clinical Progression|78|||
30912686|NCT01905657|58948003|FG002|Overall Study|Clinical Progression|59|||
30912687|NCT01905657|58948001|FG000|Overall Study|Death|40|||
30752084|NCT00189306|58761796|FG000|Treatment Period|Protocol Violation|1|||
30752085|NCT00189306|58761796|FG000|Posttreatment Period|Death|1|||
30752086|NCT00189306|58761796|FG000|Posttreatment Period|Withdrawal by Subject|2|||
30752087|NCT00189306|58761796|FG000|Posttreatment Period|Noncompliance|1|||
30752088|NCT00189306|58761796|FG000|Posttreatment Period|Target lesion excised|1|||
30752089|NCT00189306|58761796|FG000|Posttreatment Period|Protocol Violation|1|||
30752090|NCT00189306|58761796|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
30818260|NCT02959190|58838571|FG001|Open Label|Withdrawal by Subject|8|||
30912688|NCT01905657|58948002|FG001|Overall Study|Death|43|||
30912689|NCT01905657|58948003|FG002|Overall Study|Death|47|||
30912690|NCT01905657|58948001|FG000|Overall Study|Excluded Medication|13|||
30752091|NCT00189306|58761796|FG000|Posttreatment Period|Local skin reaction/sign|1|||
30912691|NCT01905657|58948002|FG001|Overall Study|Excluded Medication|16|||
30912692|NCT01905657|58948003|FG002|Overall Study|Excluded Medication|9|||
30912693|NCT01905657|58948001|FG000|Overall Study|Lost to Follow-up|1|||
30912694|NCT01905657|58948002|FG001|Overall Study|Lost to Follow-up|2|||
30912695|NCT01905657|58948003|FG002|Overall Study|Lost to Follow-up|1|||
30912696|NCT01905657|58948001|FG000|Overall Study|Physician Decision|5|||
30912697|NCT01905657|58948002|FG001|Overall Study|Physician Decision|8|||
30912698|NCT01905657|58948003|FG002|Overall Study|Physician Decision|12|||
30912699|NCT01905657|58948001|FG000|Overall Study|Protocol Violation|2|||
30912700|NCT01905657|58948002|FG001|Overall Study|Protocol Violation|1|||
30912701|NCT01905657|58948003|FG002|Overall Study|Protocol Violation|1|||
30912702|NCT01905657|58948001|FG000|Overall Study|Screen Failure|0|||
30818261|NCT02959190|58838572|FG002|Open Label|Withdrawal by Subject|0|||
30818262|NCT02959190|58838573|FG003|Open Label|Withdrawal by Subject|0|||
30818263|NCT02959190|58838570|FG000|Open Label|Physician Decision|0|||
30818264|NCT02959190|58838571|FG001|Open Label|Physician Decision|0|||
30818265|NCT02959190|58838572|FG002|Open Label|Physician Decision|1|||
30818266|NCT02959190|58838573|FG003|Open Label|Physician Decision|0|||
30818267|NCT02959190|58838570|FG000|Open Label|Protocol Violation|0|||
30818268|NCT02959190|58838571|FG001|Open Label|Protocol Violation|0|||
30818269|NCT02959190|58838572|FG002|Open Label|Protocol Violation|0|||
30818270|NCT02959190|58838573|FG003|Open Label|Protocol Violation|2|||
30818271|NCT02959190|58838570|FG000|Post Treatment Follow Up|Adverse Event|1|||
30818272|NCT02959190|58838571|FG001|Post Treatment Follow Up|Adverse Event|1|||
30818273|NCT02959190|58838572|FG002|Post Treatment Follow Up|Adverse Event|0|||
30818274|NCT02959190|58838573|FG003|Post Treatment Follow Up|Adverse Event|0|||
30818275|NCT02959190|58838570|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
30818276|NCT02959190|58838571|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
30818277|NCT02959190|58838572|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
30818278|NCT02959190|58838573|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
30818279|NCT01344356|58838594|FG000|Overall Study|Physician Decision|0|||
30818280|NCT01344356|58838595|FG001|Overall Study|Physician Decision|3|||
30818281|NCT01344356|58838594|FG000|Overall Study|Lost to Follow-up|0|||
30818282|NCT01344356|58838595|FG001|Overall Study|Lost to Follow-up|6|||
30818283|NCT02956460|58838621|FG000|Lens 1|Lost to Follow-up|1|||
30818284|NCT02956460|58838622|FG001|Lens 1|Lost to Follow-up|0|||
30818285|NCT02999100|58838634|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
30818286|NCT02999100|58838635|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
30818287|NCT02999100|58838636|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
30818288|NCT02999100|58838637|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
30818289|NCT02999100|58838638|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
30818290|NCT02999100|58838639|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
30818291|NCT02999100|58838634|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
30818292|NCT02999100|58838635|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
30818293|NCT02999100|58838636|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
30818294|NCT02999100|58838637|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
30818295|NCT02999100|58838638|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
30818296|NCT02999100|58838639|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
30818297|NCT02999100|58838634|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
30752092|NCT00189306|58761796|FG000|Long-Term Follow-up|Adverse Event|2|||
30752093|NCT00189306|58761796|FG000|Long-Term Follow-up|Death|4|||
30752094|NCT00189306|58761796|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
30752095|NCT00189306|58761796|FG000|Long-Term Follow-up|Intercurrent disease|2|||
30752096|NCT00189306|58761796|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
30752097|NCT00189306|58761796|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
30752098|NCT00187278|58761802|FG000|Overall Study|Protocol Violation|10|||
30752099|NCT00187278|58761803|FG001|Overall Study|Protocol Violation|13|||
30752100|NCT00256308|58761811|FG000|Overall Study|Death|2|||
30752101|NCT00255840|58761817|FG000|Overall Study|Lost to Follow-up|10|||
30752102|NCT00255840|58761818|FG001|Overall Study|Lost to Follow-up|14|||
30752103|NCT00255840|58761817|FG000|Overall Study|Discontinued intervention|53|||
30752104|NCT00255840|58761818|FG001|Overall Study|Discontinued intervention|56|||
30752105|NCT00224874|58761828|FG000|Overall Study|Withdrawal by Subject|0|||
30752106|NCT00224874|58761829|FG001|Overall Study|Withdrawal by Subject|0|||
30752107|NCT00224874|58761830|FG002|Overall Study|Withdrawal by Subject|1|||
30752108|NCT00224874|58761831|FG003|Overall Study|Withdrawal by Subject|0|||
30752109|NCT00186186|58761841|FG000|Overall Study|Lack of Efficacy|3|||
30752110|NCT00186186|58761841|FG000|Overall Study|Withdrawal by Subject|3|||
30818298|NCT02999100|58838635|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
30818299|NCT02999100|58838636|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
30818300|NCT02999100|58838637|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
30818301|NCT02999100|58838638|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
30818302|NCT02999100|58838639|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
30912703|NCT01905657|58948002|FG001|Overall Study|Screen Failure|1|||
30912704|NCT01905657|58948003|FG002|Overall Study|Screen Failure|0|||
30752111|NCT00186186|58761841|FG000|Overall Study|Not reported as to reason|2|||
30818303|NCT02749370|58838661|FG000|Overall Study|Withdrawal by Subject|11|||
30818304|NCT02749370|58838661|FG000|Overall Study|Lost to Follow-up|3|||
30912705|NCT01905657|58948001|FG000|Overall Study|Withdrawal by Subject|15|||
30912706|NCT01905657|58948002|FG001|Overall Study|Withdrawal by Subject|21|||
30818305|NCT03607994|58838667|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
30818306|NCT03607994|58838668|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
30912707|NCT01905657|58948003|FG002|Overall Study|Withdrawal by Subject|53|||
30912708|NCT01905657|58948001|FG000|Overall Study|Sponsor Decision|1|||
30912709|NCT01905657|58948002|FG001|Overall Study|Sponsor Decision|0|||
30912710|NCT01905657|58948003|FG002|Overall Study|Sponsor Decision|0|||
30912711|NCT02202980|58948028|FG000|Overall Study|Lack of Efficacy|1|||
30912712|NCT02202980|58948029|FG001|Overall Study|Lack of Efficacy|0|||
30912713|NCT02202980|58948030|FG002|Overall Study|Lack of Efficacy|7|||
30912714|NCT02202980|58948031|FG003|Overall Study|Lack of Efficacy|0|||
30912715|NCT02202980|58948032|FG004|Overall Study|Lack of Efficacy|3|||
30912716|NCT02202980|58948033|FG005|Overall Study|Lack of Efficacy|1|||
30912717|NCT02202980|58948034|FG006|Overall Study|Lack of Efficacy|11|||
30912718|NCT02202980|58948035|FG007|Overall Study|Lack of Efficacy|2|||
30623056|NCT00966693|58634819|FG001|Overall Study|Death|0|||
30623057|NCT00966693|58634820|FG002|Overall Study|Death|1|||
30623058|NCT00966693|58634821|FG003|Overall Study|Death|0|||
30623059|NCT00966693|58634818|FG000|Overall Study|Withdrawal by Subject|1|||
30623060|NCT00966693|58634819|FG001|Overall Study|Withdrawal by Subject|0|||
30623061|NCT00966693|58634820|FG002|Overall Study|Withdrawal by Subject|0|||
30623062|NCT00966693|58634821|FG003|Overall Study|Withdrawal by Subject|5|||
30623063|NCT00966693|58634818|FG000|Overall Study|Disease Progression|0|||
30623064|NCT00966693|58634819|FG001|Overall Study|Disease Progression|0|||
30623065|NCT00966693|58634820|FG002|Overall Study|Disease Progression|1|||
30623066|NCT00966693|58634821|FG003|Overall Study|Disease Progression|16|||
30623067|NCT01215968|58634833|FG000|Overall Study|Adverse Event|0|||
30623068|NCT01215968|58634834|FG001|Overall Study|Adverse Event|2|||
30752112|NCT00185640|58761846|FG000|Overall Study|Not Eligible|4|||
30752113|NCT00185640|58761846|FG000|Overall Study|Withdrawal by Subject|3|||
30752114|NCT00185640|58761846|FG000|Overall Study|Death|138|||
30912719|NCT02202980|58948036|FG008|Overall Study|Lack of Efficacy|2|||
30912720|NCT02202980|58948037|FG009|Overall Study|Lack of Efficacy|0|||
30912721|NCT02202980|58948038|FG010|Overall Study|Lack of Efficacy|0|||
30912722|NCT02202980|58948039|FG011|Overall Study|Lack of Efficacy|3|||
30912723|NCT02202980|58948040|FG012|Overall Study|Lack of Efficacy|10|||
30912724|NCT02202980|58948041|FG013|Overall Study|Lack of Efficacy|0|||
30912725|NCT02202980|58948028|FG000|Overall Study|Protocol Violation|0|||
30912726|NCT02202980|58948029|FG001|Overall Study|Protocol Violation|0|||
30912727|NCT02202980|58948030|FG002|Overall Study|Protocol Violation|0|||
30912728|NCT02202980|58948031|FG003|Overall Study|Protocol Violation|3|||
30912729|NCT02202980|58948032|FG004|Overall Study|Protocol Violation|3|||
30912730|NCT02202980|58948033|FG005|Overall Study|Protocol Violation|0|||
30912731|NCT02202980|58948034|FG006|Overall Study|Protocol Violation|0|||
30912732|NCT02202980|58948035|FG007|Overall Study|Protocol Violation|0|||
30912733|NCT02202980|58948036|FG008|Overall Study|Protocol Violation|0|||
30912734|NCT02202980|58948037|FG009|Overall Study|Protocol Violation|0|||
30912735|NCT02202980|58948038|FG010|Overall Study|Protocol Violation|0|||
30912736|NCT02202980|58948039|FG011|Overall Study|Protocol Violation|0|||
30912737|NCT02202980|58948040|FG012|Overall Study|Protocol Violation|0|||
30912738|NCT02202980|58948041|FG013|Overall Study|Protocol Violation|0|||
30912739|NCT02202980|58948028|FG000|Overall Study|Lost to Follow-up|0|||
30752115|NCT03760666|58761853|FG000|Overall Study|Adverse Event|2|||
30752116|NCT03760666|58761854|FG001|Overall Study|Adverse Event|4|||
30752117|NCT03760666|58761855|FG002|Overall Study|Adverse Event|1|||
30752118|NCT03760666|58761853|FG000|Overall Study|AML Disease Progression|3|||
30752119|NCT03760666|58761854|FG001|Overall Study|AML Disease Progression|3|||
30752120|NCT03760666|58761855|FG002|Overall Study|AML Disease Progression|0|||
30912740|NCT02202980|58948029|FG001|Overall Study|Lost to Follow-up|1|||
30912741|NCT02202980|58948030|FG002|Overall Study|Lost to Follow-up|1|||
30912742|NCT02202980|58948031|FG003|Overall Study|Lost to Follow-up|1|||
30912743|NCT02202980|58948032|FG004|Overall Study|Lost to Follow-up|0|||
30912744|NCT02202980|58948033|FG005|Overall Study|Lost to Follow-up|0|||
30912745|NCT02202980|58948034|FG006|Overall Study|Lost to Follow-up|0|||
30623069|NCT01215968|58634833|FG000|Overall Study|Protocol Violation|2|||
30623070|NCT01215968|58634834|FG001|Overall Study|Protocol Violation|4|||
30912746|NCT02202980|58948035|FG007|Overall Study|Lost to Follow-up|1|||
30623071|NCT01215968|58634833|FG000|Overall Study|Not received study drug|0|||
30912747|NCT02202980|58948036|FG008|Overall Study|Lost to Follow-up|1|||
30912748|NCT02202980|58948037|FG009|Overall Study|Lost to Follow-up|0|||
30912749|NCT02202980|58948038|FG010|Overall Study|Lost to Follow-up|0|||
30912750|NCT02202980|58948039|FG011|Overall Study|Lost to Follow-up|0|||
30912751|NCT02202980|58948040|FG012|Overall Study|Lost to Follow-up|1|||
30912752|NCT02202980|58948041|FG013|Overall Study|Lost to Follow-up|0|||
30912753|NCT02202980|58948028|FG000|Overall Study|Withdrew Consent|0|||
30912754|NCT02202980|58948029|FG001|Overall Study|Withdrew Consent|1|||
30818307|NCT02996682|58838676|FG000|Overall Study|Death|0|||
30818308|NCT02996682|58838677|FG001|Overall Study|Death|3|||
30818309|NCT02873702|58838685|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
30818310|NCT02873702|58838686|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
30818311|NCT02873702|58838687|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
30818312|NCT02873702|58838688|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
30818313|NCT02873702|58838685|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
30818314|NCT02873702|58838686|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
30818315|NCT02873702|58838687|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
30818316|NCT02873702|58838688|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
30818317|NCT02873702|58838685|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
30818318|NCT02873702|58838686|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
30818319|NCT02873702|58838687|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
30818320|NCT02873702|58838688|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
30818321|NCT02873702|58838685|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
30818322|NCT02873702|58838686|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
30818323|NCT02873702|58838687|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
30818324|NCT02873702|58838688|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
30818325|NCT02873702|58838685|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
30818326|NCT02873702|58838686|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
30818327|NCT02873702|58838687|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
30818328|NCT02873702|58838688|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
30912755|NCT02202980|58948030|FG002|Overall Study|Withdrew Consent|2|||
30912756|NCT02202980|58948031|FG003|Overall Study|Withdrew Consent|0|||
30912757|NCT02202980|58948032|FG004|Overall Study|Withdrew Consent|0|||
30912758|NCT02202980|58948033|FG005|Overall Study|Withdrew Consent|0|||
30912759|NCT02202980|58948034|FG006|Overall Study|Withdrew Consent|0|||
30912760|NCT02202980|58948035|FG007|Overall Study|Withdrew Consent|0|||
30912761|NCT02202980|58948036|FG008|Overall Study|Withdrew Consent|1|||
30912762|NCT02202980|58948037|FG009|Overall Study|Withdrew Consent|0|||
30912763|NCT02202980|58948038|FG010|Overall Study|Withdrew Consent|0|||
30912764|NCT02202980|58948039|FG011|Overall Study|Withdrew Consent|0|||
30912765|NCT02202980|58948040|FG012|Overall Study|Withdrew Consent|0|||
30912766|NCT02202980|58948041|FG013|Overall Study|Withdrew Consent|0|||
30912767|NCT01952145|58948073|FG000|Overall Study|Protocol Violation|2|||
30912768|NCT01952145|58948074|FG001|Overall Study|Protocol Violation|1|||
30912769|NCT01952145|58948073|FG000|Overall Study|Death|0|||
30912770|NCT01952145|58948074|FG001|Overall Study|Death|1|||
30912771|NCT01952145|58948073|FG000|Overall Study|Adverse Event|9|||
30912772|NCT01952145|58948074|FG001|Overall Study|Adverse Event|0|||
30912773|NCT01952145|58948073|FG000|Overall Study|Withdrawal Criteria|16|||
30912774|NCT01952145|58948074|FG001|Overall Study|Withdrawal Criteria|11|||
30912775|NCT01952145|58948073|FG000|Overall Study|Unclassified|1|||
30912776|NCT01952145|58948074|FG001|Overall Study|Unclassified|1|||
30912777|NCT01923363|58948080|FG000|Overall Study|Protocol Violation|1|||
30818329|NCT02911116|58838700|FG000|Overall Study|Insufficient Therapeutic Response|1|||
30818330|NCT02911116|58838701|FG001|Overall Study|Insufficient Therapeutic Response|0|||
30818331|NCT02911116|58838700|FG000|Overall Study|Lost to Follow-up|0|||
30818332|NCT02911116|58838701|FG001|Overall Study|Lost to Follow-up|1|||
30818333|NCT02998554|58838709|FG000|Overall Study|Adverse Event|8|||
30818334|NCT02998554|58838710|FG001|Overall Study|Adverse Event|3|||
30818335|NCT02998554|58838709|FG000|Overall Study|Protocol deviation|1|||
30818336|NCT02998554|58838710|FG001|Overall Study|Protocol deviation|0|||
30818337|NCT02998554|58838709|FG000|Overall Study|Withdrawal by Subject|2|||
30818338|NCT02998554|58838710|FG001|Overall Study|Withdrawal by Subject|6|||
30818339|NCT02998554|58838709|FG000|Overall Study|Lost to Follow-up|0|||
30818340|NCT02998554|58838710|FG001|Overall Study|Lost to Follow-up|1|||
30818341|NCT02998554|58838709|FG000|Overall Study|Lack of Efficacy|0|||
30818342|NCT02998554|58838710|FG001|Overall Study|Lack of Efficacy|1|||
30818343|NCT02996448|58838718|FG000|Overall Study|Study terminated due to adverse effects|3|||
30818344|NCT02995980|58838723|FG000|Overall Study|Lost to Follow-up|14|||
30912778|NCT01905267|58948086|FG000|Overall Study|Physician Decision|2|||
30912779|NCT01905267|58948087|FG001|Overall Study|Physician Decision|2|||
30818345|NCT02872142|58838728|FG000|Overall Study|Adverse Event|2|||
30818346|NCT02872142|58838728|FG000|Overall Study|Death|1|||
30818347|NCT02872142|58838728|FG000|Overall Study|Participant Decision|3|||
30818348|NCT02994654|58838732|FG000|Overall Study|Lost to Follow-up|1|||
30818349|NCT02870972|58838742|FG000|Overall Study|Adverse Event|1|||
30818350|NCT02870972|58838743|FG001|Overall Study|Adverse Event|0|||
30912780|NCT01923285|58948095|FG000|Overall Study|Withdrawal by Subject|7|||
30912781|NCT01923285|58948096|FG001|Overall Study|Withdrawal by Subject|6|||
30912782|NCT01904721|58948109|FG000|Overall Study|Other Reasons|0|||
30752121|NCT03760666|58761853|FG000|Overall Study|Physician Decision|0|||
30752122|NCT03760666|58761854|FG001|Overall Study|Physician Decision|3|||
30752123|NCT03760666|58761855|FG002|Overall Study|Physician Decision|0|||
30752124|NCT03760666|58761853|FG000|Overall Study|Withdrawal by Subject|0|||
30752125|NCT03760666|58761854|FG001|Overall Study|Withdrawal by Subject|1|||
30752126|NCT03760666|58761855|FG002|Overall Study|Withdrawal by Subject|0|||
30752127|NCT03760510|58761868|FG000|Overall Study|Not ventilated for 24 hours|105|||
30752128|NCT03760510|58761869|FG001|Overall Study|Not ventilated for 24 hours|97|||
30752129|NCT00224484|58761878|FG000|Overall Study|Serious Adverse Event|1|||
30818351|NCT02870972|58838744|FG002|Overall Study|Adverse Event|0|||
30818352|NCT02870972|58838745|FG003|Overall Study|Adverse Event|0|||
30818353|NCT02870972|58838746|FG004|Overall Study|Adverse Event|0|||
30818354|NCT03214367|58838766|FG000|Lead-in Period|Withdrawal by Subject|50|||
30818355|NCT03214367|58838767|FG001|Lead-in Period|Withdrawal by Subject|0|||
30818356|NCT03214367|58838768|FG002|Lead-in Period|Withdrawal by Subject|0|||
30818357|NCT03214367|58838769|FG003|Lead-in Period|Withdrawal by Subject|0|||
30752130|NCT00224484|58761879|FG001|Overall Study|Serious Adverse Event|1|||
30752131|NCT00224484|58761880|FG002|Overall Study|Serious Adverse Event|0|||
30752132|NCT00224484|58761878|FG000|Overall Study|Non-Serious Adverse Event|5|||
30752133|NCT00224484|58761879|FG001|Overall Study|Non-Serious Adverse Event|7|||
30752134|NCT00224484|58761880|FG002|Overall Study|Non-Serious Adverse Event|3|||
30752135|NCT00224484|58761878|FG000|Overall Study|Protocol Violation|2|||
30752136|NCT00224484|58761879|FG001|Overall Study|Protocol Violation|2|||
30752137|NCT00224484|58761880|FG002|Overall Study|Protocol Violation|0|||
30752138|NCT00224484|58761878|FG000|Overall Study|Withdrawal by Subject|49|||
30818358|NCT03214367|58838770|FG004|Lead-in Period|Withdrawal by Subject|2|||
30818359|NCT03214367|58838771|FG005|Lead-in Period|Withdrawal by Subject|0|||
30818360|NCT03214367|58838772|FG006|Lead-in Period|Withdrawal by Subject|0|||
30818361|NCT03214367|58838773|FG007|Lead-in Period|Withdrawal by Subject|0|||
30912783|NCT01904721|58948110|FG001|Overall Study|Other Reasons|0|||
30818362|NCT03214367|58838766|FG000|Lead-in Period|Adverse Event|3|||
30912784|NCT01904721|58948111|FG002|Overall Study|Other Reasons|1|||
30912785|NCT01904721|58948112|FG003|Overall Study|Other Reasons|1|||
30912786|NCT01904721|58948113|FG004|Overall Study|Other Reasons|2|||
30752139|NCT00224484|58761879|FG001|Overall Study|Withdrawal by Subject|18|||
30752140|NCT00224484|58761880|FG002|Overall Study|Withdrawal by Subject|16|||
30752141|NCT00224484|58761878|FG000|Overall Study|Migrated/moved from study area|18|||
30752142|NCT00224484|58761879|FG001|Overall Study|Migrated/moved from study area|5|||
30752143|NCT00224484|58761880|FG002|Overall Study|Migrated/moved from study area|5|||
30818363|NCT03214367|58838767|FG001|Lead-in Period|Adverse Event|0|||
30818364|NCT03214367|58838768|FG002|Lead-in Period|Adverse Event|0|||
30818365|NCT03214367|58838769|FG003|Lead-in Period|Adverse Event|0|||
30818366|NCT03214367|58838770|FG004|Lead-in Period|Adverse Event|0|||
30818367|NCT03214367|58838771|FG005|Lead-in Period|Adverse Event|0|||
30912787|NCT01904721|58948114|FG005|Overall Study|Other Reasons|2|||
30912788|NCT01904721|58948115|FG006|Overall Study|Other Reasons|2|||
30818368|NCT03214367|58838772|FG006|Lead-in Period|Adverse Event|0|||
30818369|NCT03214367|58838773|FG007|Lead-in Period|Adverse Event|0|||
30912789|NCT01904721|58948109|FG000|Overall Study|Personal Reasons|0|||
30912790|NCT01904721|58948110|FG001|Overall Study|Personal Reasons|0|||
30912791|NCT01904721|58948111|FG002|Overall Study|Personal Reasons|0|||
30912792|NCT01904721|58948112|FG003|Overall Study|Personal Reasons|0|||
30818370|NCT03214367|58838766|FG000|Lead-in Period|Lost to Follow-up|12|||
30818371|NCT03214367|58838767|FG001|Lead-in Period|Lost to Follow-up|0|||
30818372|NCT03214367|58838768|FG002|Lead-in Period|Lost to Follow-up|0|||
30818373|NCT03214367|58838769|FG003|Lead-in Period|Lost to Follow-up|0|||
30818374|NCT03214367|58838770|FG004|Lead-in Period|Lost to Follow-up|0|||
30818375|NCT03214367|58838771|FG005|Lead-in Period|Lost to Follow-up|0|||
30912793|NCT01904721|58948113|FG004|Overall Study|Personal Reasons|2|||
30912794|NCT01904721|58948114|FG005|Overall Study|Personal Reasons|3|||
30912795|NCT01904721|58948115|FG006|Overall Study|Personal Reasons|3|||
30912796|NCT01904721|58948109|FG000|Overall Study|Lost to Follow-up|0|||
30912797|NCT01904721|58948110|FG001|Overall Study|Lost to Follow-up|0|||
30912798|NCT01904721|58948111|FG002|Overall Study|Lost to Follow-up|0|||
30912799|NCT01904721|58948112|FG003|Overall Study|Lost to Follow-up|0|||
30912800|NCT01904721|58948113|FG004|Overall Study|Lost to Follow-up|1|||
30912801|NCT01904721|58948114|FG005|Overall Study|Lost to Follow-up|3|||
30912802|NCT01904721|58948115|FG006|Overall Study|Lost to Follow-up|1|||
30912803|NCT01904721|58948109|FG000|Overall Study|Lack of Efficacy|0|||
30912804|NCT01904721|58948110|FG001|Overall Study|Lack of Efficacy|0|||
30912805|NCT01904721|58948111|FG002|Overall Study|Lack of Efficacy|0|||
30912806|NCT01904721|58948112|FG003|Overall Study|Lack of Efficacy|0|||
30912807|NCT01904721|58948113|FG004|Overall Study|Lack of Efficacy|0|||
30912808|NCT01904721|58948114|FG005|Overall Study|Lack of Efficacy|0|||
30912809|NCT01904721|58948115|FG006|Overall Study|Lack of Efficacy|1|||
30818376|NCT03214367|58838772|FG006|Lead-in Period|Lost to Follow-up|0|||
30818377|NCT03214367|58838773|FG007|Lead-in Period|Lost to Follow-up|0|||
30912810|NCT01904721|58948109|FG000|Overall Study|Adverse Event|0|||
30912811|NCT01904721|58948110|FG001|Overall Study|Adverse Event|0|||
30912812|NCT01904721|58948111|FG002|Overall Study|Adverse Event|0|||
30912813|NCT01904721|58948112|FG003|Overall Study|Adverse Event|0|||
30818378|NCT03214367|58838766|FG000|Lead-in Period|Sponsor Decision|11|||
30818379|NCT03214367|58838767|FG001|Lead-in Period|Sponsor Decision|0|||
30818380|NCT03214367|58838768|FG002|Lead-in Period|Sponsor Decision|0|||
30912814|NCT01904721|58948113|FG004|Overall Study|Adverse Event|3|||
30912815|NCT01904721|58948114|FG005|Overall Study|Adverse Event|1|||
30912816|NCT01904721|58948115|FG006|Overall Study|Adverse Event|0|||
30912817|NCT01904019|58948127|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
30912818|NCT01904019|58948127|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
30912819|NCT01904019|58948127|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
30912820|NCT01904019|58948127|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
30912821|NCT01904019|58948127|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
30912822|NCT01904019|58948127|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
30912823|NCT01922895|58948133|FG000|Overall Study|Death|0|||
30912824|NCT01922895|58948134|FG001|Overall Study|Death|1|||
30912825|NCT01922895|58948133|FG000|Overall Study|Withdrawal by Subject|1|||
30912826|NCT01922895|58948134|FG001|Overall Study|Withdrawal by Subject|2|||
30912827|NCT01922895|58948133|FG000|Overall Study|Lost to Follow-up|5|||
30912828|NCT01922895|58948134|FG001|Overall Study|Lost to Follow-up|11|||
30912829|NCT01922739|58948142|FG000|Titration/Adjustment Period|Adverse Event|3|||
30912830|NCT01922739|58948142|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
30912831|NCT01922739|58948142|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
30912832|NCT01922739|58948142|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
30912833|NCT01922739|58948142|FG000|Open-label Treatment Period|Adverse Event|6|||
30912834|NCT01922739|58948142|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
30912835|NCT01922739|58948142|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
30912836|NCT01922739|58948142|FG000|Open-label Treatment Period|Protocol Violation|5|||
30912837|NCT01922739|58948142|FG000|Open-label Treatment Period|Pregnancy|1|||
30912838|NCT01922739|58948142|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
30912839|NCT01922739|58948142|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
30912840|NCT01922739|58948142|FG000|Open-label Treatment Period|Physician Decision|1|||
30912841|NCT01922739|58948142|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
30912842|NCT02236988|58948162|FG000|Overall Study|Lost to Follow-up|0|||
30912843|NCT02236988|58948163|FG001|Overall Study|Lost to Follow-up|0|||
30912844|NCT02236988|58948164|FG002|Overall Study|Lost to Follow-up|0|||
30912845|NCT02236988|58948165|FG003|Overall Study|Lost to Follow-up|1|||
30912846|NCT02236988|58948162|FG000|Overall Study|Unable to Comply with Study Visits|0|||
30912847|NCT02236988|58948163|FG001|Overall Study|Unable to Comply with Study Visits|0|||
30912848|NCT02236988|58948164|FG002|Overall Study|Unable to Comply with Study Visits|0|||
30912849|NCT02236988|58948165|FG003|Overall Study|Unable to Comply with Study Visits|2|||
30912850|NCT02236598|58948218|FG000|Overall Study|Adverse Event|0|||
30912851|NCT02236598|58948219|FG001|Overall Study|Adverse Event|1|||
30912852|NCT02236598|58948218|FG000|Overall Study|Withdrawal by Subject|0|||
30912853|NCT02236598|58948219|FG001|Overall Study|Withdrawal by Subject|1|||
30912854|NCT01922349|58948229|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
30912855|NCT01922349|58948230|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
30912856|NCT01922349|58948231|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
30912857|NCT01922349|58948232|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
30912858|NCT02236520|58948270|FG000|Overall Study|Physician Decision|0|||
30912859|NCT02236520|58948271|FG001|Overall Study|Physician Decision|5|||
30912860|NCT02236520|58948272|FG002|Overall Study|Physician Decision|0|||
30912861|NCT02236520|58948273|FG003|Overall Study|Physician Decision|0|||
30912862|NCT02236520|58948270|FG000|Overall Study|Withdrawal by Subject|1|||
30912863|NCT02236520|58948271|FG001|Overall Study|Withdrawal by Subject|0|||
30912864|NCT02236520|58948272|FG002|Overall Study|Withdrawal by Subject|0|||
30818381|NCT03214367|58838769|FG003|Lead-in Period|Sponsor Decision|0|||
30818382|NCT03214367|58838770|FG004|Lead-in Period|Sponsor Decision|0|||
30818383|NCT03214367|58838771|FG005|Lead-in Period|Sponsor Decision|0|||
30818384|NCT03214367|58838772|FG006|Lead-in Period|Sponsor Decision|0|||
30818385|NCT03214367|58838773|FG007|Lead-in Period|Sponsor Decision|0|||
30818386|NCT03214367|58838766|FG000|Lead-in Period|Physician Decision|12|||
30818387|NCT03214367|58838767|FG001|Lead-in Period|Physician Decision|0|||
30818388|NCT03214367|58838768|FG002|Lead-in Period|Physician Decision|0|||
30818389|NCT03214367|58838769|FG003|Lead-in Period|Physician Decision|0|||
30818390|NCT03214367|58838770|FG004|Lead-in Period|Physician Decision|0|||
30818391|NCT03214367|58838771|FG005|Lead-in Period|Physician Decision|0|||
30818392|NCT03214367|58838772|FG006|Lead-in Period|Physician Decision|0|||
30912865|NCT02236520|58948273|FG003|Overall Study|Withdrawal by Subject|1|||
30912866|NCT02236520|58948270|FG000|Overall Study|Pregnancy|1|||
30818393|NCT03214367|58838773|FG007|Lead-in Period|Physician Decision|0|||
30818394|NCT03214367|58838766|FG000|Lead-in Period|Protocol Violation|5|||
30912867|NCT02236520|58948271|FG001|Overall Study|Pregnancy|0|||
30912868|NCT02236520|58948272|FG002|Overall Study|Pregnancy|0|||
30912869|NCT02236520|58948273|FG003|Overall Study|Pregnancy|0|||
30912870|NCT01922271|58948285|FG000|WASHOUT Period|Withdrawal by Subject|1|||
30912871|NCT01922271|58948286|FG001|WASHOUT Period|Withdrawal by Subject|0|||
30912872|NCT02236130|58948294|FG000|Overall Study|Lost to Follow-up|7|||
30912873|NCT02236130|58948295|FG001|Overall Study|Lost to Follow-up|12|||
30912874|NCT02233946|58948303|FG000|Baseline|Withdrawal by Subject|2|||
30912875|NCT02233946|58948304|FG001|Baseline|Withdrawal by Subject|0|||
30912876|NCT02233946|58948303|FG000|3-months Follow-up|Lost to Follow-up|53|||
30912877|NCT02233946|58948304|FG001|3-months Follow-up|Lost to Follow-up|29|||
30912878|NCT02233946|58948303|FG000|6-months Follow-up|Lost to Follow-up|21|||
30912879|NCT02233946|58948304|FG001|6-months Follow-up|Lost to Follow-up|2|||
30912880|NCT02233946|58948303|FG000|9-month Follow-up|Lost to Follow-up|20|||
30912881|NCT02233946|58948304|FG001|9-month Follow-up|Lost to Follow-up|11|||
30912882|NCT02233946|58948303|FG000|12-month Follow-up|Lost to Follow-up|28|||
30912883|NCT02233946|58948304|FG001|12-month Follow-up|Lost to Follow-up|11|||
30912884|NCT02232698|58948312|FG000|Overall Study|Pregnancy|1|||
30912885|NCT02232698|58948313|FG001|Overall Study|Pregnancy|1|||
30912886|NCT02232698|58948312|FG000|Overall Study|Met exclusion criteria|1|||
30912887|NCT02232698|58948313|FG001|Overall Study|Met exclusion criteria|1|||
30912888|NCT02232698|58948312|FG000|Overall Study|Had device-associated symptoms|7|||
30912889|NCT02232698|58948313|FG001|Overall Study|Had device-associated symptoms|0|||
30912890|NCT02232698|58948312|FG000|Overall Study|Non-compliance with study device|1|||
30912891|NCT02232698|58948313|FG001|Overall Study|Non-compliance with study device|4|||
30912892|NCT02232698|58948312|FG000|Overall Study|Allocated to control group|0|||
30912893|NCT02232698|58948313|FG001|Overall Study|Allocated to control group|3|||
30912894|NCT02232698|58948312|FG000|Overall Study|Withdrawal by Subject|0|||
30912895|NCT02232698|58948313|FG001|Overall Study|Withdrawal by Subject|11|||
30912896|NCT01632878|58948321|FG000|Screening|Physician Decision|268|||
30912897|NCT01632878|58948321|FG000|Treatment|Lost to Follow-up|41|||
30912898|NCT01632878|58948321|FG000|Treatment|Withdrawal by Subject|36|||
30912899|NCT01632878|58948321|FG000|Treatment|Physician Decision|34|||
30912900|NCT01632878|58948321|FG000|Treatment|missing information|4|||
30912901|NCT01632878|58948321|FG000|Treatment|no information on study completion|43|||
30912902|NCT01632800|58948325|FG000|Overall Study|Subject did not fit in apparatus|1|||
30912903|NCT01641809|58948333|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
30912904|NCT01641809|58948334|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
30912905|NCT01641809|58948335|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
30912906|NCT01641809|58948336|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
30912907|NCT01641809|58948333|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
30912908|NCT01641809|58948334|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
30912909|NCT01641809|58948335|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
30752144|NCT00224484|58761878|FG000|Overall Study|Lost to Follow-up|66|||
30912910|NCT01641809|58948336|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
30752145|NCT00224484|58761879|FG001|Overall Study|Lost to Follow-up|28|||
30752146|NCT00224484|58761880|FG002|Overall Study|Lost to Follow-up|36|||
30752147|NCT00224484|58761878|FG000|Overall Study|Reason not specified|5|||
30752148|NCT00224484|58761879|FG001|Overall Study|Reason not specified|4|||
30752149|NCT00224484|58761880|FG002|Overall Study|Reason not specified|2|||
30752150|NCT00254982|58761893|FG000|Overall Study|Other|2|||
30752151|NCT00254982|58761894|FG001|Overall Study|Other|1|||
30752152|NCT00254982|58761893|FG000|Overall Study|Lack of Efficacy|5|||
30752153|NCT00254982|58761894|FG001|Overall Study|Lack of Efficacy|3|||
30752154|NCT00254982|58761893|FG000|Overall Study|Lost to Follow-up|5|||
30752155|NCT00254982|58761894|FG001|Overall Study|Lost to Follow-up|3|||
30752156|NCT00254982|58761893|FG000|Overall Study|Adverse Event|18|||
30752157|NCT00254982|58761894|FG001|Overall Study|Adverse Event|16|||
30752158|NCT00254982|58761893|FG000|Overall Study|Withdrawal by Subject|1|||
30752159|NCT00254982|58761894|FG001|Overall Study|Withdrawal by Subject|1|||
30752160|NCT00254982|58761893|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
30752161|NCT00254982|58761894|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
30752162|NCT00254982|58761893|FG000|Overall Study|Protocol deviation|1|||
30752163|NCT00254982|58761894|FG001|Overall Study|Protocol deviation|1|||
30752164|NCT00254982|58761893|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
30752165|NCT00254982|58761894|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
30752166|NCT00254982|58761893|FG000|Overall Study|Malignancy|0|||
30752167|NCT00254982|58761894|FG001|Overall Study|Malignancy|2|||
30752168|NCT00254982|58761893|FG000|Overall Study|Opportunistic infection|1|||
30752169|NCT00254982|58761894|FG001|Overall Study|Opportunistic infection|0|||
30752170|NCT00254982|58761893|FG000|Overall Study|Abnormal liver function tests|2|||
30752171|NCT00254982|58761894|FG001|Overall Study|Abnormal liver function tests|1|||
30752172|NCT03759340|58761900|FG000|Overall Study|Adverse Event|2|||
30752173|NCT03759340|58761900|FG000|Overall Study|Lost to Follow-up|1|||
30752174|NCT03759340|58761900|FG000|Overall Study|Withdrawal by Subject|15|||
30752175|NCT03759340|58761900|FG000|Overall Study|Study Terminated by Sponsor|38|||
30752176|NCT00224016|58761906|FG000|Titration Period|Withdrawal by Subject|0|||
30752177|NCT00224016|58761907|FG001|Titration Period|Withdrawal by Subject|1|||
30912911|NCT01641809|58948333|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
30912912|NCT01641809|58948334|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
30912913|NCT01641809|58948335|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
30912914|NCT01641809|58948336|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
30818395|NCT03214367|58838767|FG001|Lead-in Period|Protocol Violation|0|||
30818396|NCT03214367|58838768|FG002|Lead-in Period|Protocol Violation|0|||
30818397|NCT03214367|58838769|FG003|Lead-in Period|Protocol Violation|0|||
30818398|NCT03214367|58838770|FG004|Lead-in Period|Protocol Violation|0|||
30818399|NCT03214367|58838771|FG005|Lead-in Period|Protocol Violation|0|||
30818400|NCT03214367|58838772|FG006|Lead-in Period|Protocol Violation|0|||
30818401|NCT03214367|58838773|FG007|Lead-in Period|Protocol Violation|0|||
30818402|NCT03214367|58838766|FG000|Lead-in Period|Treatment Interruption|1|||
30818403|NCT03214367|58838767|FG001|Lead-in Period|Treatment Interruption|0|||
30818404|NCT03214367|58838768|FG002|Lead-in Period|Treatment Interruption|0|||
30818405|NCT03214367|58838769|FG003|Lead-in Period|Treatment Interruption|0|||
30818406|NCT03214367|58838770|FG004|Lead-in Period|Treatment Interruption|0|||
30818407|NCT03214367|58838771|FG005|Lead-in Period|Treatment Interruption|0|||
30818408|NCT03214367|58838772|FG006|Lead-in Period|Treatment Interruption|0|||
30818409|NCT03214367|58838773|FG007|Lead-in Period|Treatment Interruption|0|||
30818410|NCT03214367|58838766|FG000|Treatment Period|Adverse Event|0|||
30818411|NCT03214367|58838767|FG001|Treatment Period|Adverse Event|1|||
30818412|NCT03214367|58838768|FG002|Treatment Period|Adverse Event|4|||
30818413|NCT03214367|58838769|FG003|Treatment Period|Adverse Event|2|||
30818414|NCT03214367|58838770|FG004|Treatment Period|Adverse Event|0|||
30818415|NCT03214367|58838771|FG005|Treatment Period|Adverse Event|0|||
30818416|NCT03214367|58838772|FG006|Treatment Period|Adverse Event|0|||
30818417|NCT03214367|58838773|FG007|Treatment Period|Adverse Event|0|||
30818418|NCT03214367|58838766|FG000|Treatment Period|Death|0|||
30818419|NCT03214367|58838767|FG001|Treatment Period|Death|1|||
30818420|NCT03214367|58838768|FG002|Treatment Period|Death|1|||
30818421|NCT03214367|58838769|FG003|Treatment Period|Death|1|||
30818422|NCT03214367|58838770|FG004|Treatment Period|Death|0|||
30818423|NCT03214367|58838771|FG005|Treatment Period|Death|0|||
30818424|NCT03214367|58838772|FG006|Treatment Period|Death|0|||
30818425|NCT03214367|58838773|FG007|Treatment Period|Death|0|||
30818426|NCT03214367|58838766|FG000|Treatment Period|Lost to Follow-up|0|||
30818427|NCT03214367|58838767|FG001|Treatment Period|Lost to Follow-up|5|||
30818428|NCT03214367|58838768|FG002|Treatment Period|Lost to Follow-up|3|||
30818429|NCT03214367|58838769|FG003|Treatment Period|Lost to Follow-up|2|||
30818430|NCT03214367|58838770|FG004|Treatment Period|Lost to Follow-up|0|||
30818431|NCT03214367|58838771|FG005|Treatment Period|Lost to Follow-up|2|||
30818432|NCT03214367|58838772|FG006|Treatment Period|Lost to Follow-up|1|||
30818433|NCT03214367|58838773|FG007|Treatment Period|Lost to Follow-up|0|||
30818434|NCT03214367|58838766|FG000|Treatment Period|Sponsor Decision|0|||
30818435|NCT03214367|58838767|FG001|Treatment Period|Sponsor Decision|3|||
30818436|NCT03214367|58838768|FG002|Treatment Period|Sponsor Decision|0|||
30818437|NCT03214367|58838769|FG003|Treatment Period|Sponsor Decision|0|||
30818438|NCT03214367|58838770|FG004|Treatment Period|Sponsor Decision|0|||
30818439|NCT03214367|58838771|FG005|Treatment Period|Sponsor Decision|0|||
30818440|NCT03214367|58838772|FG006|Treatment Period|Sponsor Decision|0|||
30818441|NCT03214367|58838773|FG007|Treatment Period|Sponsor Decision|0|||
30818442|NCT03214367|58838766|FG000|Treatment Period|Physician Decision|0|||
30818443|NCT03214367|58838767|FG001|Treatment Period|Physician Decision|1|||
30818444|NCT03214367|58838768|FG002|Treatment Period|Physician Decision|2|||
30818445|NCT03214367|58838769|FG003|Treatment Period|Physician Decision|0|||
30818446|NCT03214367|58838770|FG004|Treatment Period|Physician Decision|0|||
30912915|NCT01641809|58948333|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
30912916|NCT01641809|58948334|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
30912917|NCT01641809|58948335|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
30912918|NCT01641809|58948336|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
30912919|NCT01641809|58948333|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
30912920|NCT01641809|58948334|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
30912921|NCT01641809|58948335|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
30912922|NCT01641809|58948336|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
30912923|NCT01641809|58948333|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
30912924|NCT01641809|58948334|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
30912925|NCT01641809|58948335|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
30912926|NCT01641809|58948336|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
30912927|NCT01641809|58948333|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
30912928|NCT01641809|58948334|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
30912929|NCT01641809|58948335|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
30912930|NCT01641809|58948336|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
30818447|NCT03214367|58838771|FG005|Treatment Period|Physician Decision|0|||
30818448|NCT03214367|58838772|FG006|Treatment Period|Physician Decision|0|||
30818449|NCT03214367|58838773|FG007|Treatment Period|Physician Decision|0|||
30818450|NCT03214367|58838766|FG000|Treatment Period|Protocol Violation|0|||
30818451|NCT03214367|58838767|FG001|Treatment Period|Protocol Violation|3|||
30818452|NCT03214367|58838768|FG002|Treatment Period|Protocol Violation|0|||
30818453|NCT03214367|58838769|FG003|Treatment Period|Protocol Violation|0|||
30912931|NCT01641809|58948333|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
30912932|NCT01641809|58948334|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
30912933|NCT01641809|58948335|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
30912934|NCT01641809|58948336|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
30912935|NCT01641809|58948333|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
30912936|NCT01641809|58948334|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
30912937|NCT01641809|58948335|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
30912938|NCT01641809|58948336|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
30818454|NCT03214367|58838770|FG004|Treatment Period|Protocol Violation|0|||
30818455|NCT03214367|58838771|FG005|Treatment Period|Protocol Violation|0|||
30818456|NCT03214367|58838772|FG006|Treatment Period|Protocol Violation|0|||
30818457|NCT03214367|58838773|FG007|Treatment Period|Protocol Violation|0|||
30818458|NCT03214367|58838766|FG000|Treatment Period|Withdrawal by Subject|0|||
30818459|NCT03214367|58838767|FG001|Treatment Period|Withdrawal by Subject|20|||
30818460|NCT03214367|58838768|FG002|Treatment Period|Withdrawal by Subject|23|||
30818461|NCT03214367|58838769|FG003|Treatment Period|Withdrawal by Subject|14|||
30818462|NCT03214367|58838770|FG004|Treatment Period|Withdrawal by Subject|0|||
30818463|NCT03214367|58838771|FG005|Treatment Period|Withdrawal by Subject|1|||
30912939|NCT01641809|58948333|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
30912940|NCT01641809|58948334|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
30912941|NCT01641809|58948335|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
30912942|NCT01641809|58948336|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
30912943|NCT01641809|58948333|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
30912944|NCT01641809|58948334|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
30912945|NCT01641809|58948335|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
30912946|NCT01641809|58948336|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
30912947|NCT01641809|58948333|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
30912948|NCT01641809|58948334|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
30912949|NCT01641809|58948335|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
30912950|NCT01641809|58948336|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
30912951|NCT01641809|58948333|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
30912952|NCT01641809|58948334|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
30818464|NCT03214367|58838772|FG006|Treatment Period|Withdrawal by Subject|1|||
30818465|NCT03214367|58838773|FG007|Treatment Period|Withdrawal by Subject|1|||
30818466|NCT02994108|58838789|FG000|Intervention Messages|Withdrawal by Subject|2|||
30818467|NCT02994108|58838790|FG001|Intervention Messages|Withdrawal by Subject|0|||
30818468|NCT02994108|58838789|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
30818469|NCT02994108|58838790|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
30818470|NCT02994108|58838789|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
30818471|NCT02994108|58838790|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
30818472|NCT02994108|58838789|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
30818473|NCT02994108|58838790|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
30818474|NCT03231371|58838797|FG000|Overall Study|Withdrawal by Subject|1|||
30818475|NCT03231371|58838797|FG000|Overall Study|chose or were ineligible to have MRI|12|||
30818476|NCT02870348|58838801|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
30818477|NCT03239873|58838807|FG000|Overall Study|Lost to Follow-up|15|||
30818478|NCT03239873|58838808|FG001|Overall Study|Lost to Follow-up|16|||
30818479|NCT03239873|58838807|FG000|Overall Study|Physician Decision|1|||
30912953|NCT01641809|58948335|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
30912954|NCT01641809|58948336|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
30818480|NCT03239873|58838808|FG001|Overall Study|Physician Decision|0|||
30818481|NCT03239873|58838807|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
30818482|NCT03239873|58838808|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
30818483|NCT03239873|58838807|FG000|Overall Study|Withdrawal by Subject|2|||
30818484|NCT03239873|58838808|FG001|Overall Study|Withdrawal by Subject|0|||
30818485|NCT03239873|58838807|FG000|Overall Study|Contraindication to study medication|1|||
30912955|NCT01641809|58948333|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
30912956|NCT01641809|58948334|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
30752178|NCT00224016|58761906|FG000|Titration Period|Lost to Follow-up|1|||
30752179|NCT00224016|58761907|FG001|Titration Period|Lost to Follow-up|0|||
30752180|NCT00224016|58761906|FG000|Maintenance Period|Withdrawal by Subject|2|||
30752181|NCT00224016|58761907|FG001|Maintenance Period|Withdrawal by Subject|0|||
30752182|NCT00224016|58761906|FG000|Maintenance Period|Lost to Follow-up|0|||
30752183|NCT00224016|58761907|FG001|Maintenance Period|Lost to Follow-up|1|||
30752184|NCT03757234|58761918|FG000|Overall Study|Adverse Event|0|||
30752185|NCT03757234|58761919|FG001|Overall Study|Adverse Event|0|||
30752186|NCT03757234|58761920|FG002|Overall Study|Adverse Event|0|||
30752187|NCT03757234|58761921|FG003|Overall Study|Adverse Event|0|||
30752188|NCT03757234|58761922|FG004|Overall Study|Adverse Event|1|||
30818486|NCT03239873|58838808|FG001|Overall Study|Contraindication to study medication|0|||
30818487|NCT03239873|58838807|FG000|Overall Study|Protocol Violation|1|||
30818488|NCT03239873|58838808|FG001|Overall Study|Protocol Violation|0|||
30818489|NCT03213509|58838816|FG000|Overall Study|Did not consent for verbal autopsy|4|||
30818490|NCT03213509|58838817|FG001|Overall Study|Did not consent for verbal autopsy|5|||
30818491|NCT03239483|58838826|FG000|Overall Study|Lost to Follow-up|1|||
30818492|NCT03239483|58838827|FG001|Overall Study|Lost to Follow-up|0|||
30818493|NCT03239483|58838826|FG000|Overall Study|Withdrawal by Subject|1|||
30818494|NCT03239483|58838827|FG001|Overall Study|Withdrawal by Subject|0|||
30818495|NCT02868554|58838836|FG000|Overall Study|Lost to Follow-up|3|||
30818496|NCT02868554|58838837|FG001|Overall Study|Lost to Follow-up|0|||
30818497|NCT02868554|58838838|FG002|Overall Study|Lost to Follow-up|1|||
30818498|NCT01068912|58838849|FG000|Overall Study|Adverse Event|2|||
30818499|NCT01068912|58838850|FG001|Overall Study|Adverse Event|3|||
30818500|NCT01068912|58838851|FG002|Overall Study|Adverse Event|2|||
30818501|NCT01068912|58838849|FG000|Overall Study|Withdrawal by Subject|5|||
30818502|NCT01068912|58838850|FG001|Overall Study|Withdrawal by Subject|6|||
30818503|NCT01068912|58838851|FG002|Overall Study|Withdrawal by Subject|6|||
30818504|NCT01068912|58838849|FG000|Overall Study|Lost to Follow-up|3|||
30818505|NCT01068912|58838850|FG001|Overall Study|Lost to Follow-up|7|||
30818506|NCT01068912|58838851|FG002|Overall Study|Lost to Follow-up|3|||
30818507|NCT01068912|58838849|FG000|Overall Study|Protocol Violation|0|||
30818508|NCT01068912|58838850|FG001|Overall Study|Protocol Violation|2|||
30912957|NCT01641809|58948335|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
30912958|NCT01641809|58948336|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
30912959|NCT01641809|58948333|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
30912960|NCT01641809|58948334|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
30912961|NCT01641809|58948335|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
30912962|NCT01641809|58948336|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
30912963|NCT01641809|58948333|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
30912964|NCT01641809|58948334|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
30912965|NCT01641809|58948335|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
30752189|NCT03757234|58761918|FG000|Overall Study|Lost to Follow-up|1|||
30752190|NCT03757234|58761919|FG001|Overall Study|Lost to Follow-up|0|||
30818509|NCT01068912|58838851|FG002|Overall Study|Protocol Violation|0|||
30818510|NCT01068912|58838849|FG000|Overall Study|aggravation influenza|1|||
30818511|NCT01068912|58838850|FG001|Overall Study|aggravation influenza|1|||
30818512|NCT01068912|58838851|FG002|Overall Study|aggravation influenza|1|||
30818513|NCT01068912|58838849|FG000|Overall Study|other underlying illness|0|||
30818514|NCT01068912|58838850|FG001|Overall Study|other underlying illness|3|||
30818515|NCT01068912|58838851|FG002|Overall Study|other underlying illness|3|||
30818516|NCT03229109|58838863|FG000|Overall Study|Withdrawal by Subject|0|||
30818517|NCT03229109|58838864|FG001|Overall Study|Withdrawal by Subject|0|||
30818518|NCT03229109|58838865|FG002|Overall Study|Withdrawal by Subject|0|||
30818519|NCT03229109|58838866|FG003|Overall Study|Withdrawal by Subject|1|||
30818520|NCT03212261|58838876|FG000|Overall Study|Became ineligible d/t tech|2|||
30818521|NCT03212261|58838876|FG000|Overall Study|Tech Trouble- No first study visit|1|||
30818522|NCT03212261|58838876|FG000|Overall Study|Lost to Follow-up|7|||
30818523|NCT03212261|58838876|FG000|Overall Study|Family Emergency|1|||
30818524|NCT03212261|58838876|FG000|Overall Study|Too busy/ No time|5|||
30818525|NCT02993250|58838883|FG000|Overall Study|Lost to Follow-up|0|||
30818526|NCT02993250|58838884|FG001|Overall Study|Lost to Follow-up|1|||
30818527|NCT02989194|58838893|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
30818528|NCT02989194|58838894|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
30818529|NCT02989194|58838895|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
30912966|NCT01641809|58948336|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
30912967|NCT01641809|58948333|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
30912968|NCT01641809|58948334|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
30912969|NCT01641809|58948335|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
30752191|NCT03757234|58761920|FG002|Overall Study|Lost to Follow-up|0|||
30752192|NCT03757234|58761921|FG003|Overall Study|Lost to Follow-up|0|||
30752193|NCT03757234|58761922|FG004|Overall Study|Lost to Follow-up|1|||
30752194|NCT03757234|58761918|FG000|Overall Study|Withdrawal by Subject|1|||
30752195|NCT03757234|58761919|FG001|Overall Study|Withdrawal by Subject|1|||
30752196|NCT03757234|58761920|FG002|Overall Study|Withdrawal by Subject|0|||
30818530|NCT02989194|58838893|FG000|Overall Study|Lost to Follow-up|0|||
30818531|NCT02989194|58838894|FG001|Overall Study|Lost to Follow-up|1|||
30818532|NCT02989194|58838895|FG002|Overall Study|Lost to Follow-up|0|||
30818533|NCT02989194|58838893|FG000|Overall Study|Withdrawal by Subject|0|||
30818534|NCT02989194|58838894|FG001|Overall Study|Withdrawal by Subject|1|||
30818535|NCT02989194|58838895|FG002|Overall Study|Withdrawal by Subject|0|||
30818536|NCT02990910|58838916|FG000|Overall Study|Lack of Efficacy|6|||
30752197|NCT03757234|58761921|FG003|Overall Study|Withdrawal by Subject|1|||
30752198|NCT03757234|58761922|FG004|Overall Study|Withdrawal by Subject|2|||
30818537|NCT02990910|58838917|FG001|Overall Study|Lack of Efficacy|10|||
30818538|NCT03227861|58838923|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
30818539|NCT03227861|58838923|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
30818540|NCT03227861|58838923|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
30818541|NCT03227861|58838923|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
30818542|NCT03227861|58838923|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
30818543|NCT03227861|58838923|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
30818544|NCT03227861|58838923|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
30818545|NCT03227861|58838923|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
30818546|NCT03227861|58838923|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
30818547|NCT03227861|58838923|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
30818548|NCT01336712|58838929|FG000|Overall Study|Death|2|||
30818549|NCT01336712|58838929|FG000|Overall Study|Lack of Efficacy|1|||
30818550|NCT03208127|58838933|FG000|Overall Study|Death|1|||
30818551|NCT02865122|58838940|FG000|Overall Study|Adverse Event|1|||
30818552|NCT02865122|58838941|FG001|Overall Study|Adverse Event|0|||
30818553|NCT02865122|58838942|FG002|Overall Study|Adverse Event|0|||
30818554|NCT02864498|58838953|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
30818555|NCT02864498|58838954|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
30818556|NCT02864498|58838955|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
30818557|NCT02864498|58838953|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
30818558|NCT02864498|58838954|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
30818559|NCT02864498|58838955|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
30818560|NCT02864498|58838953|FG000|Overall Study|Investigator Discretion|0|||
30818561|NCT02864498|58838954|FG001|Overall Study|Investigator Discretion|2|||
30818562|NCT02864498|58838955|FG002|Overall Study|Investigator Discretion|1|||
30818563|NCT02864498|58838953|FG000|Overall Study|Lost to Follow-up|8|||
30818564|NCT02864498|58838954|FG001|Overall Study|Lost to Follow-up|6|||
30818565|NCT02864498|58838955|FG002|Overall Study|Lost to Follow-up|3|||
30818566|NCT02864498|58838953|FG000|Overall Study|Lack of Efficacy|5|||
30818567|NCT02864498|58838954|FG001|Overall Study|Lack of Efficacy|3|||
30818568|NCT02864498|58838955|FG002|Overall Study|Lack of Efficacy|3|||
30818569|NCT02864498|58838953|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
30818570|NCT02864498|58838954|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
30818571|NCT02864498|58838955|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
30818572|NCT02864498|58838953|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
30818573|NCT02864498|58838954|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
30818574|NCT02864498|58838955|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
30818575|NCT02864498|58838953|FG000|Overall Study|Subject moved out of the country.|0|||
30818576|NCT02864498|58838954|FG001|Overall Study|Subject moved out of the country.|0|||
30818577|NCT02864498|58838955|FG002|Overall Study|Subject moved out of the country.|1|||
30818578|NCT03238781|58838966|FG000|Overall Study|Adverse Event|1|||
30818579|NCT03238781|58838967|FG001|Overall Study|Adverse Event|1|||
30818580|NCT03238781|58838968|FG002|Overall Study|Adverse Event|2|||
30818581|NCT03238781|58838966|FG000|Overall Study|Lost to Follow-up|2|||
30818582|NCT03238781|58838967|FG001|Overall Study|Lost to Follow-up|1|||
30818583|NCT03238781|58838968|FG002|Overall Study|Lost to Follow-up|2|||
30818584|NCT03238781|58838966|FG000|Overall Study|Withdrawal by Subject|23|||
30818585|NCT03238781|58838967|FG001|Overall Study|Withdrawal by Subject|14|||
30818586|NCT03238781|58838968|FG002|Overall Study|Withdrawal by Subject|16|||
30818587|NCT03238781|58838966|FG000|Overall Study|Decision by sponsor|0|||
30818588|NCT03238781|58838967|FG001|Overall Study|Decision by sponsor|1|||
30818589|NCT03238781|58838968|FG002|Overall Study|Decision by sponsor|0|||
30818590|NCT02097121|58838979|FG000|Overall Study|Other, not specified|4|||
30818591|NCT02097121|58838980|FG001|Overall Study|Other, not specified|2|||
30818592|NCT02097121|58838981|FG002|Overall Study|Other, not specified|3|||
30818593|NCT02097121|58838979|FG000|Overall Study|Lack of Efficacy|2|||
30818594|NCT02097121|58838980|FG001|Overall Study|Lack of Efficacy|1|||
30818595|NCT02097121|58838981|FG002|Overall Study|Lack of Efficacy|3|||
30818596|NCT02097121|58838979|FG000|Overall Study|Withdrawal by Subject|0|||
30818597|NCT02097121|58838980|FG001|Overall Study|Withdrawal by Subject|1|||
30818598|NCT02097121|58838981|FG002|Overall Study|Withdrawal by Subject|2|||
30818599|NCT02097121|58838979|FG000|Overall Study|Adverse Event|0|||
30818600|NCT02097121|58838980|FG001|Overall Study|Adverse Event|1|||
30818601|NCT02097121|58838981|FG002|Overall Study|Adverse Event|0|||
30818602|NCT02097121|58838979|FG000|Overall Study|Lost to Follow-up|1|||
30818603|NCT02097121|58838980|FG001|Overall Study|Lost to Follow-up|1|||
30818604|NCT02097121|58838981|FG002|Overall Study|Lost to Follow-up|2|||
30818605|NCT02747420|58839010|FG000|Overall Study|Lost to Follow-up|4|||
30818606|NCT02747420|58839011|FG001|Overall Study|Lost to Follow-up|2|||
30818607|NCT02747420|58839010|FG000|Overall Study|Withdrawal by Subject|3|||
30818608|NCT02747420|58839011|FG001|Overall Study|Withdrawal by Subject|2|||
30818609|NCT03238001|58839017|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
30818610|NCT03238001|58839017|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
30818611|NCT03238001|58839017|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
30818612|NCT03238001|58839017|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
30818613|NCT03238001|58839017|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
30818614|NCT03238001|58839017|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
30818615|NCT03238001|58839017|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
30818616|NCT03238001|58839017|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
30818617|NCT02747108|58839031|FG000|Overall Study|Death|2|||
30818618|NCT02747108|58839032|FG001|Overall Study|Death|2|||
30818619|NCT02747108|58839031|FG000|Overall Study|Withdrawal by Subject|1|||
30818620|NCT02747108|58839032|FG001|Overall Study|Withdrawal by Subject|0|||
30818621|NCT02747108|58839031|FG000|Overall Study|Protocol Violation|2|||
30818622|NCT02747108|58839032|FG001|Overall Study|Protocol Violation|0|||
30818623|NCT03226769|58839060|FG000|Overall Study|Withdrawal by Subject|0|||
30818624|NCT03226769|58839061|FG001|Overall Study|Withdrawal by Subject|1|||
30818625|NCT02864342|58839069|FG000|Overall Study|Eligibility Criteria Deviation|2|||
30818626|NCT02864342|58839070|FG001|Overall Study|Eligibility Criteria Deviation|3|||
30818627|NCT02864342|58839069|FG000|Overall Study|Withdrawal by Subject|4|||
30818628|NCT02864342|58839070|FG001|Overall Study|Withdrawal by Subject|2|||
30818629|NCT02864342|58839069|FG000|Overall Study|Device Technology Issue|6|||
30818630|NCT02864342|58839070|FG001|Overall Study|Device Technology Issue|7|||
30818631|NCT02864342|58839069|FG000|Overall Study|Death|0|||
30818632|NCT02864342|58839070|FG001|Overall Study|Death|1|||
30818633|NCT02864342|58839069|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
30818634|NCT02864342|58839070|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
30818635|NCT02864342|58839069|FG000|Overall Study|Lost to Follow-up|1|||
30818636|NCT02864342|58839070|FG001|Overall Study|Lost to Follow-up|5|||
30818637|NCT02864342|58839069|FG000|Overall Study|Lost Device|1|||
30818638|NCT02864342|58839070|FG001|Overall Study|Lost Device|0|||
30818639|NCT02864342|58839069|FG000|Overall Study|Adverse Event|1|||
30818640|NCT02864342|58839070|FG001|Overall Study|Adverse Event|0|||
30818641|NCT03237065|58839079|FG000|Overall Study|Adverse Event|0|||
30818642|NCT03237065|58839080|FG001|Overall Study|Adverse Event|2|||
30818643|NCT03237065|58839079|FG000|Overall Study|Protocol Violation|0|||
30818644|NCT03237065|58839080|FG001|Overall Study|Protocol Violation|1|||
30818645|NCT03237065|58839079|FG000|Overall Study|Withdrawal by Subject|3|||
30818646|NCT03237065|58839080|FG001|Overall Study|Withdrawal by Subject|0|||
30818647|NCT03237065|58839079|FG000|Overall Study|Lost to Follow-up|1|||
30818648|NCT03237065|58839080|FG001|Overall Study|Lost to Follow-up|0|||
30818649|NCT03237065|58839079|FG000|Overall Study|Unable to obtain venous access|0|||
30818650|NCT03237065|58839080|FG001|Overall Study|Unable to obtain venous access|1|||
30818651|NCT03171415|58839091|FG000|Overall Study|Lost to Follow-up|0|||
30818652|NCT03171415|58839092|FG001|Overall Study|Lost to Follow-up|0|||
30818653|NCT03171415|58839093|FG002|Overall Study|Lost to Follow-up|0|||
30818654|NCT03171415|58839094|FG003|Overall Study|Lost to Follow-up|0|||
30818655|NCT03171415|58839095|FG004|Overall Study|Lost to Follow-up|2|||
30818656|NCT03829241|58839120|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
30818657|NCT03829241|58839121|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
30818658|NCT03829241|58839120|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
30912970|NCT01641809|58948336|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
30818659|NCT03829241|58839121|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
30818660|NCT03829241|58839120|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
30818661|NCT03829241|58839121|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
30818662|NCT03829241|58839120|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
30818663|NCT03829241|58839121|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
30818664|NCT03829241|58839120|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
30818665|NCT03829241|58839121|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
30818666|NCT03829241|58839120|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
30818667|NCT03829241|58839121|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
30818668|NCT03829241|58839120|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
30818669|NCT03829241|58839121|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
30818670|NCT03829241|58839120|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
30818671|NCT03829241|58839121|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
30818672|NCT03829241|58839120|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
30818673|NCT03829241|58839121|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
30818674|NCT03829241|58839120|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
30818675|NCT03829241|58839121|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
30818676|NCT03829241|58839120|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
30818677|NCT03829241|58839121|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
30818678|NCT03829241|58839120|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
30818679|NCT03829241|58839121|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
30818680|NCT03829241|58839120|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
30818681|NCT03829241|58839121|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
30818682|NCT03829241|58839120|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
30818683|NCT03829241|58839121|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
30818684|NCT03164551|58839133|FG000|Overall Study|Imaging discontinued prior completion|8|||
30818685|NCT03164551|58839134|FG001|Overall Study|Imaging discontinued prior completion|0|||
30818686|NCT03164551|58839133|FG000|Overall Study|Participant was non-compliant|1|||
30818687|NCT03164551|58839134|FG001|Overall Study|Participant was non-compliant|0|||
30818688|NCT03164551|58839133|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
30818689|NCT03164551|58839134|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
30818690|NCT03164551|58839133|FG000|Overall Study|Other|8|||
30818691|NCT03164551|58839134|FG001|Overall Study|Other|2|||
30818692|NCT02863328|58839142|FG000|Overall Study|Lost to Follow-up|4|||
30818693|NCT02863328|58839143|FG001|Overall Study|Lost to Follow-up|10|||
30818694|NCT02863328|58839142|FG000|Overall Study|Withdrawal by Subject|7|||
30818695|NCT02863328|58839143|FG001|Overall Study|Withdrawal by Subject|12|||
30818696|NCT02863328|58839142|FG000|Overall Study|Died|0|||
30818697|NCT02863328|58839143|FG001|Overall Study|Died|1|||
30818698|NCT03040141|58839152|FG000|Overall Study|Death|1|||
30818699|NCT03040141|58839153|FG001|Overall Study|Death|2|||
30818700|NCT03040141|58839154|FG002|Overall Study|Death|3|||
30818701|NCT03040141|58839152|FG000|Overall Study|Withdrawal by Subject|3|||
30818702|NCT03040141|58839153|FG001|Overall Study|Withdrawal by Subject|1|||
30818703|NCT03040141|58839154|FG002|Overall Study|Withdrawal by Subject|1|||
30818704|NCT03040141|58839152|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
30818705|NCT03040141|58839153|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
30818706|NCT03040141|58839154|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
30818707|NCT03040141|58839152|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
30818708|NCT03040141|58839153|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
30818709|NCT03040141|58839154|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
30818710|NCT02937701|58839168|FG000|Day 1 to Week 22|Adverse Event|11|||
30818711|NCT02937701|58839169|FG001|Day 1 to Week 22|Adverse Event|14|||
30818712|NCT02937701|58839170|FG002|Day 1 to Week 22|Adverse Event|0|||
30818713|NCT02937701|58839171|FG003|Day 1 to Week 22|Adverse Event|0|||
30818714|NCT02937701|58839172|FG004|Day 1 to Week 22|Adverse Event|0|||
30818715|NCT02937701|58839168|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
30818716|NCT02937701|58839169|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
30818717|NCT02937701|58839170|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
30818718|NCT02937701|58839171|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
30912971|NCT01641809|58948333|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
30912972|NCT01641809|58948334|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
30912973|NCT01641809|58948335|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
30912974|NCT01641809|58948336|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
30912975|NCT01632566|58948359|FG000|Overall Study|Withdrawal by Subject|0|||
30912976|NCT01632566|58948360|FG001|Overall Study|Withdrawal by Subject|1|||
30912977|NCT01632566|58948361|FG002|Overall Study|Withdrawal by Subject|0|||
30818719|NCT02937701|58839172|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
30818720|NCT02937701|58839168|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
30818721|NCT02937701|58839169|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
30818722|NCT02937701|58839170|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
30818723|NCT02937701|58839171|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
30912978|NCT01632566|58948362|FG003|Overall Study|Withdrawal by Subject|0|||
30912979|NCT01632566|58948363|FG004|Overall Study|Withdrawal by Subject|0|||
30818724|NCT02937701|58839172|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
30818725|NCT02937701|58839168|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
30818726|NCT02937701|58839169|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
30818727|NCT02937701|58839170|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
30818728|NCT02937701|58839171|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
30818729|NCT02937701|58839172|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
30818730|NCT02937701|58839168|FG000|Day 1 to Week 22|Death|1|||
30818731|NCT02937701|58839169|FG001|Day 1 to Week 22|Death|1|||
30818732|NCT02937701|58839170|FG002|Day 1 to Week 22|Death|0|||
30818733|NCT02937701|58839171|FG003|Day 1 to Week 22|Death|0|||
30818734|NCT02937701|58839172|FG004|Day 1 to Week 22|Death|0|||
30818735|NCT02937701|58839168|FG000|Day 1 to Week 22|Protocol Violation|1|||
30818736|NCT02937701|58839169|FG001|Day 1 to Week 22|Protocol Violation|1|||
30818737|NCT02937701|58839170|FG002|Day 1 to Week 22|Protocol Violation|0|||
30818738|NCT02937701|58839171|FG003|Day 1 to Week 22|Protocol Violation|0|||
30818739|NCT02937701|58839172|FG004|Day 1 to Week 22|Protocol Violation|0|||
30818740|NCT02937701|58839168|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
30818741|NCT02937701|58839169|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
30818742|NCT02937701|58839170|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
30912980|NCT01632566|58948359|FG000|Overall Study|Sponsor Decision|0|||
30912981|NCT01632566|58948360|FG001|Overall Study|Sponsor Decision|2|||
30818743|NCT02937701|58839171|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
30818744|NCT02937701|58839172|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
30818745|NCT02937701|58839168|FG000|Day 1 to Week 22|Physician Decision|2|||
30818746|NCT02937701|58839169|FG001|Day 1 to Week 22|Physician Decision|0|||
30818747|NCT02937701|58839170|FG002|Day 1 to Week 22|Physician Decision|0|||
30818748|NCT02937701|58839171|FG003|Day 1 to Week 22|Physician Decision|0|||
30912982|NCT01632566|58948361|FG002|Overall Study|Sponsor Decision|9|||
30818749|NCT02937701|58839172|FG004|Day 1 to Week 22|Physician Decision|0|||
30912983|NCT01632566|58948362|FG003|Overall Study|Sponsor Decision|2|||
30912984|NCT01632566|58948363|FG004|Overall Study|Sponsor Decision|2|||
30818750|NCT02937701|58839168|FG000|Day 1 to Week 22|Other|1|||
30818751|NCT02937701|58839169|FG001|Day 1 to Week 22|Other|0|||
30818752|NCT02937701|58839170|FG002|Day 1 to Week 22|Other|0|||
30818753|NCT02937701|58839171|FG003|Day 1 to Week 22|Other|0|||
30912985|NCT02254304|58948381|FG000|Overall Study|Adverse Event|2|||
30818754|NCT02937701|58839172|FG004|Day 1 to Week 22|Other|0|||
30818755|NCT02937701|58839168|FG000|Week 22 to Week 50|Adverse Event|0|||
30818756|NCT02937701|58839169|FG001|Week 22 to Week 50|Adverse Event|0|||
30818757|NCT02937701|58839170|FG002|Week 22 to Week 50|Adverse Event|10|||
30818758|NCT02937701|58839171|FG003|Week 22 to Week 50|Adverse Event|3|||
30818759|NCT02937701|58839172|FG004|Week 22 to Week 50|Adverse Event|3|||
30818760|NCT02937701|58839168|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
30912986|NCT02254304|58948382|FG001|Overall Study|Adverse Event|1|||
30912987|NCT02254304|58948381|FG000|Overall Study|Lost to Follow-up|2|||
30912988|NCT02254304|58948382|FG001|Overall Study|Lost to Follow-up|2|||
30912989|NCT02254304|58948381|FG000|Overall Study|Protocol Violation|1|||
30912990|NCT02254304|58948382|FG001|Overall Study|Protocol Violation|0|||
30912991|NCT02254304|58948381|FG000|Overall Study|Withdrawal by Subject|3|||
30912992|NCT02254304|58948382|FG001|Overall Study|Withdrawal by Subject|0|||
30912993|NCT02254304|58948381|FG000|Overall Study|Injection site pain and Injection fear|1|||
30912994|NCT02254304|58948382|FG001|Overall Study|Injection site pain and Injection fear|0|||
30912995|NCT02254304|58948381|FG000|Overall Study|Personal causes|4|||
30912996|NCT02254304|58948382|FG001|Overall Study|Personal causes|1|||
30912997|NCT02254304|58948381|FG000|Overall Study|Personal decision|1|||
30912998|NCT02254304|58948382|FG001|Overall Study|Personal decision|0|||
30912999|NCT02174731|58948392|FG000|Overall Study|Participant decision|67|||
30913000|NCT02174731|58948393|FG001|Overall Study|Participant decision|64|||
30913001|NCT02174731|58948392|FG000|Overall Study|Incorrect enrolment before randomization|0|||
30913002|NCT02174731|58948393|FG001|Overall Study|Incorrect enrolment before randomization|1|||
30913003|NCT02174731|58948392|FG000|Overall Study|Missing|2|||
30913004|NCT02174731|58948393|FG001|Overall Study|Missing|0|||
30913005|NCT01922037|58948401|FG000|Overall Study|Withdrawal by Subject|2|||
30913006|NCT01922037|58948402|FG001|Overall Study|Withdrawal by Subject|44|||
30913007|NCT01922037|58948401|FG000|Overall Study|Adverse Event|1|||
30913008|NCT01922037|58948402|FG001|Overall Study|Adverse Event|7|||
30913009|NCT01922037|58948401|FG000|Overall Study|Death|0|||
30913010|NCT01922037|58948402|FG001|Overall Study|Death|5|||
30913011|NCT01922037|58948401|FG000|Overall Study|Pregnancy|0|||
30913012|NCT01922037|58948402|FG001|Overall Study|Pregnancy|2|||
30913013|NCT01922037|58948401|FG000|Overall Study|Participant non-compliance|4|||
30913014|NCT01922037|58948402|FG001|Overall Study|Participant non-compliance|46|||
30913015|NCT01922037|58948401|FG000|Overall Study|Investigator/Sponsor decision|1|||
30913016|NCT01922037|58948402|FG001|Overall Study|Investigator/Sponsor decision|4|||
30913017|NCT01922037|58948401|FG000|Overall Study|Other unspecified|2|||
30913018|NCT01922037|58948402|FG001|Overall Study|Other unspecified|66|||
30913019|NCT02282813|58948413|FG000|Overall Study|Withdrawal by Subject|4|||
30913020|NCT02282813|58948414|FG001|Overall Study|Withdrawal by Subject|5|||
30913021|NCT02282813|58948415|FG002|Overall Study|Withdrawal by Subject|0|||
30752199|NCT03757234|58761918|FG000|Overall Study|Other|1|||
30752200|NCT03757234|58761919|FG001|Overall Study|Other|1|||
30752201|NCT03757234|58761920|FG002|Overall Study|Other|0|||
30752202|NCT03757234|58761921|FG003|Overall Study|Other|0|||
30752203|NCT03757234|58761922|FG004|Overall Study|Other|0|||
30752204|NCT00223080|58761936|FG000|Overall Study|Withdrawal by Subject|253|||
30752205|NCT00223080|58761937|FG001|Overall Study|Withdrawal by Subject|232|||
30752206|NCT00223080|58761936|FG000|Overall Study|Required contraindicated med|0|||
30752207|NCT00223080|58761937|FG001|Overall Study|Required contraindicated med|1|||
30752208|NCT00223080|58761936|FG000|Overall Study|Non-compliant|7|||
30818761|NCT02937701|58839169|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
30913022|NCT02282813|58948413|FG000|Overall Study|Adverse Event|3|||
30913023|NCT02282813|58948414|FG001|Overall Study|Adverse Event|10|||
30913024|NCT02282813|58948415|FG002|Overall Study|Adverse Event|1|||
30913025|NCT02282813|58948413|FG000|Overall Study|Subject non-compliance|1|||
30913026|NCT02282813|58948414|FG001|Overall Study|Subject non-compliance|4|||
30913027|NCT02282813|58948415|FG002|Overall Study|Subject non-compliance|0|||
30913028|NCT02282813|58948413|FG000|Overall Study|Physician Decision|0|||
30913029|NCT02282813|58948414|FG001|Overall Study|Physician Decision|3|||
30913030|NCT02282813|58948415|FG002|Overall Study|Physician Decision|1|||
30913031|NCT02282813|58948413|FG000|Overall Study|Lost to Follow-up|2|||
30752209|NCT00223080|58761937|FG001|Overall Study|Non-compliant|7|||
30752210|NCT00223080|58761936|FG000|Overall Study|Moved from study area|37|||
30752211|NCT00223080|58761937|FG001|Overall Study|Moved from study area|47|||
30913032|NCT02282813|58948414|FG001|Overall Study|Lost to Follow-up|0|||
30913033|NCT02282813|58948415|FG002|Overall Study|Lost to Follow-up|1|||
30818762|NCT02937701|58839170|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
30818763|NCT02937701|58839171|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
30818764|NCT02937701|58839172|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
30818765|NCT02937701|58839168|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
30818766|NCT02937701|58839169|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
30818767|NCT02937701|58839170|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
30818768|NCT02937701|58839171|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
30818769|NCT02937701|58839172|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
30818770|NCT02937701|58839168|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
30818771|NCT02937701|58839169|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
30818772|NCT02937701|58839170|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
30818773|NCT02937701|58839171|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
30818774|NCT02937701|58839172|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
30818775|NCT02937701|58839168|FG000|Week 22 to Week 50|Physician Decision|0|||
30818776|NCT02937701|58839169|FG001|Week 22 to Week 50|Physician Decision|0|||
30818777|NCT02937701|58839170|FG002|Week 22 to Week 50|Physician Decision|2|||
30818778|NCT02937701|58839171|FG003|Week 22 to Week 50|Physician Decision|0|||
30818779|NCT02937701|58839172|FG004|Week 22 to Week 50|Physician Decision|1|||
30818780|NCT02937701|58839168|FG000|Week 22 to Week 50|Other|0|||
30818781|NCT02937701|58839169|FG001|Week 22 to Week 50|Other|0|||
30818782|NCT02937701|58839170|FG002|Week 22 to Week 50|Other|0|||
30913034|NCT02282813|58948413|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
30913035|NCT02282813|58948414|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
30913036|NCT02282813|58948415|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
30913037|NCT02282813|58948413|FG000|Overall Study|Lack of Efficacy|1|||
30913038|NCT02282813|58948414|FG001|Overall Study|Lack of Efficacy|0|||
30913039|NCT02282813|58948415|FG002|Overall Study|Lack of Efficacy|0|||
30913040|NCT02282813|58948413|FG000|Overall Study|Administrative reasons|0|||
30913041|NCT02282813|58948414|FG001|Overall Study|Administrative reasons|1|||
30913042|NCT02282813|58948415|FG002|Overall Study|Administrative reasons|0|||
30913043|NCT01903863|58948427|FG000|Overall Study|Physician Decision|2|||
30913044|NCT01903863|58948428|FG001|Overall Study|Physician Decision|0|||
30913045|NCT02123251|58948436|FG000|Overall Study|Death|1|||
30913046|NCT02123251|58948437|FG001|Overall Study|Death|1|||
30913047|NCT02123251|58948436|FG000|Overall Study|Withdrawal by Subject|0|||
30913048|NCT02123251|58948437|FG001|Overall Study|Withdrawal by Subject|3|||
30913049|NCT02123251|58948436|FG000|Overall Study|Lost Medicaid eligibility|29|||
30913050|NCT02123251|58948437|FG001|Overall Study|Lost Medicaid eligibility|22|||
30913051|NCT02123251|58948436|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
30913052|NCT02123251|58948437|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
30818783|NCT02937701|58839171|FG003|Week 22 to Week 50|Other|0|||
30818784|NCT02937701|58839172|FG004|Week 22 to Week 50|Other|1|||
30818785|NCT03169153|58839184|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
30818786|NCT03169153|58839185|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
30818787|NCT03169153|58839184|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
30818788|NCT03169153|58839185|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
30818789|NCT03169153|58839184|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
30818790|NCT03169153|58839185|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
30818791|NCT03169153|58839184|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
30818792|NCT03169153|58839185|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
30818793|NCT03168919|58839191|FG000|Overall Study|Withdrawal by Subject|2|||
30818794|NCT03205163|58839201|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
30818795|NCT03205163|58839202|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
30818796|NCT01759537|58839217|FG000|Overall Study|Death|1|||
30818797|NCT01759537|58839218|FG001|Overall Study|Death|1|||
30818798|NCT01759537|58839217|FG000|Overall Study|Pregnancy|1|||
30818799|NCT01759537|58839218|FG001|Overall Study|Pregnancy|1|||
30913053|NCT01902303|58948446|FG000|Overall Study|Adverse Event|0|||
30913054|NCT01902303|58948447|FG001|Overall Study|Adverse Event|1|||
30913055|NCT01902303|58948446|FG000|Overall Study|Lost to Follow-up|0|||
30913056|NCT01902303|58948447|FG001|Overall Study|Lost to Follow-up|1|||
30913057|NCT01902303|58948446|FG000|Overall Study|Protocol Violation|2|||
30818800|NCT01759537|58839217|FG000|Overall Study|Lost to Follow-up|9|||
30818801|NCT01759537|58839218|FG001|Overall Study|Lost to Follow-up|9|||
30818802|NCT01759537|58839217|FG000|Overall Study|Accident involving jaw fracture|1|||
30818803|NCT01759537|58839218|FG001|Overall Study|Accident involving jaw fracture|1|||
30818804|NCT01759537|58839217|FG000|Overall Study|Subcrestal implant too coronal|1|||
30818805|NCT01759537|58839218|FG001|Overall Study|Subcrestal implant too coronal|1|||
30818806|NCT03204539|58839226|FG000|Overall Study|Loss of funding|0|||
30913058|NCT01902303|58948447|FG001|Overall Study|Protocol Violation|2|||
30818807|NCT03204539|58839227|FG001|Overall Study|Loss of funding|1|||
30818808|NCT03502681|58839244|FG000|Overall Study|Adverse Event|1|||
30818809|NCT03502681|58839245|FG001|Overall Study|Adverse Event|1|||
30818810|NCT03502681|58839244|FG000|Overall Study|Disease Progression|2|||
30818811|NCT03502681|58839245|FG001|Overall Study|Disease Progression|1|||
30818812|NCT02860130|58839252|FG000|Overall Study|Adverse Event|2|||
30818813|NCT02860130|58839253|FG001|Overall Study|Adverse Event|3|||
30818814|NCT02860130|58839252|FG000|Overall Study|Protocol Violation|1|||
30818815|NCT02860130|58839253|FG001|Overall Study|Protocol Violation|1|||
30818816|NCT02860130|58839252|FG000|Overall Study|Withdrawal by Subject|0|||
30818817|NCT02860130|58839253|FG001|Overall Study|Withdrawal by Subject|2|||
30818818|NCT02860130|58839252|FG000|Overall Study|Physician Decision|2|||
30818819|NCT02860130|58839253|FG001|Overall Study|Physician Decision|2|||
30818820|NCT02860130|58839252|FG000|Overall Study|Other|2|||
30818821|NCT02860130|58839253|FG001|Overall Study|Other|1|||
30818822|NCT00788671|58839259|FG000|Overall Study|Death|2|||
30818823|NCT00788671|58839259|FG000|Overall Study|Unable to biopsy|1|||
30818824|NCT00788671|58839259|FG000|Overall Study|Withdrawal by Subject|4|||
30818825|NCT00788671|58839259|FG000|Overall Study|IUD expulsed|1|||
30818826|NCT00788671|58839259|FG000|Overall Study|Lost to follow up|2|||
30818827|NCT02986854|58839266|FG000|Overall Study|Withdrawal by Subject|0|||
30818828|NCT02986854|58839267|FG001|Overall Study|Withdrawal by Subject|1|||
30818829|NCT02986854|58839268|FG002|Overall Study|Withdrawal by Subject|1|||
30818830|NCT02986854|58839266|FG000|Overall Study|Lost to Follow-up|3|||
30818831|NCT02986854|58839267|FG001|Overall Study|Lost to Follow-up|11|||
30818832|NCT02986854|58839268|FG002|Overall Study|Lost to Follow-up|2|||
30818833|NCT02887183|58839278|FG000|Overall Study|Adverse Event|44|||
30818834|NCT02887183|58839278|FG000|Overall Study|Death|30|||
30818835|NCT02887183|58839278|FG000|Overall Study|Pregnancy|1|||
30818836|NCT02887183|58839278|FG000|Overall Study|Protocol Violation|6|||
30818837|NCT02887183|58839278|FG000|Overall Study|Technical Problems|2|||
30818838|NCT02887183|58839278|FG000|Overall Study|Lost to Follow-up|13|||
30818839|NCT02887183|58839278|FG000|Overall Study|Physician Decision|10|||
30818840|NCT02887183|58839278|FG000|Overall Study|Withdrawal by Subject|35|||
30818841|NCT03167359|58839282|FG000|Overall Study|Physician Decision|1|||
30818842|NCT03167359|58839282|FG000|Overall Study|Lost to Follow-up|1|||
30818843|NCT01068600|58839288|FG000|Overall Study|Withdrawal by Subject|5|||
30818844|NCT01068600|58839289|FG001|Overall Study|Withdrawal by Subject|6|||
30818845|NCT01068600|58839288|FG000|Overall Study|Adverse Event|3|||
30818846|NCT01068600|58839289|FG001|Overall Study|Adverse Event|3|||
30818847|NCT01068600|58839288|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30818848|NCT01068600|58839289|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30818849|NCT01068600|58839288|FG000|Overall Study|Lost to Follow-up|1|||
30818850|NCT01068600|58839289|FG001|Overall Study|Lost to Follow-up|2|||
30818851|NCT01068600|58839288|FG000|Overall Study|Protocol deviation|1|||
30818852|NCT01068600|58839289|FG001|Overall Study|Protocol deviation|1|||
30818853|NCT01068600|58839288|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30818854|NCT01068600|58839289|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
30818855|NCT01068600|58839288|FG000|Overall Study|Administrative problems|0|||
30818856|NCT01068600|58839289|FG001|Overall Study|Administrative problems|1|||
30818857|NCT01067976|58839295|FG000|Overall Study|Study drug never administered|20|||
30818858|NCT01067976|58839295|FG000|Overall Study|Study prematurely discontinued|2|||
30818859|NCT02858492|58839317|FG000|Overall Study|Withdrawal by Subject|0|||
30818860|NCT02858492|58839318|FG001|Overall Study|Withdrawal by Subject|1|||
30818861|NCT02858492|58839319|FG002|Overall Study|Withdrawal by Subject|0|||
30818862|NCT02858492|58839320|FG003|Overall Study|Withdrawal by Subject|1|||
30818863|NCT02858492|58839317|FG000|Overall Study|Adverse Event|0|||
30818864|NCT02858492|58839318|FG001|Overall Study|Adverse Event|0|||
30818865|NCT02858492|58839319|FG002|Overall Study|Adverse Event|0|||
30913059|NCT01902303|58948446|FG000|Overall Study|subject lost investigational product|0|||
30913060|NCT01902303|58948447|FG001|Overall Study|subject lost investigational product|1|||
30913061|NCT01902303|58948446|FG000|Overall Study|Did not develop a cold sore|21|||
30913062|NCT01902303|58948447|FG001|Overall Study|Did not develop a cold sore|19|||
30913063|NCT02122783|58948457|FG000|Overall Study|Adverse Event|0|||
30818866|NCT02858492|58839320|FG003|Overall Study|Adverse Event|3|||
30818867|NCT02858492|58839317|FG000|Overall Study|Lack of Efficacy|0|||
30818868|NCT02858492|58839318|FG001|Overall Study|Lack of Efficacy|0|||
30818869|NCT02858492|58839319|FG002|Overall Study|Lack of Efficacy|0|||
30818870|NCT02858492|58839320|FG003|Overall Study|Lack of Efficacy|1|||
30818871|NCT02858492|58839317|FG000|Overall Study|Protocol defined stopping criteria|0|||
30818872|NCT02858492|58839318|FG001|Overall Study|Protocol defined stopping criteria|0|||
30818873|NCT02858492|58839319|FG002|Overall Study|Protocol defined stopping criteria|0|||
30818874|NCT02858492|58839320|FG003|Overall Study|Protocol defined stopping criteria|1|||
30818875|NCT01067508|58839334|FG000|Overall Study|Physician Decision|0|||
30818876|NCT01067508|58839335|FG001|Overall Study|Physician Decision|1|||
30818877|NCT01067508|58839334|FG000|Overall Study|Withdrawal by Subject|0|||
30818878|NCT01067508|58839335|FG001|Overall Study|Withdrawal by Subject|1|||
30818879|NCT01067352|58839344|FG000|Overall Study|Withdrawal by Subject|1|||
30818880|NCT01067352|58839345|FG001|Overall Study|Withdrawal by Subject|2|||
30818881|NCT01067352|58839346|FG002|Overall Study|Withdrawal by Subject|1|||
30818882|NCT01067352|58839344|FG000|Overall Study|Physician Decision|0|||
30818883|NCT01067352|58839345|FG001|Overall Study|Physician Decision|1|||
30818884|NCT01067352|58839346|FG002|Overall Study|Physician Decision|0|||
30818885|NCT02986074|58839354|FG000|First Trial Period|Adverse Event|1|||
30818886|NCT02986074|58839355|FG001|First Trial Period|Adverse Event|0|||
30818887|NCT02986074|58839356|FG002|First Trial Period|Adverse Event|0|||
30818888|NCT02986074|58839357|FG003|First Trial Period|Adverse Event|0|||
30818889|NCT02986074|58839354|FG000|Follow up Period|system explant|0|||
30818890|NCT02986074|58839355|FG001|Follow up Period|system explant|0|||
30818891|NCT02986074|58839356|FG002|Follow up Period|system explant|1|||
30818892|NCT02986074|58839357|FG003|Follow up Period|system explant|2|||
30818893|NCT02986074|58839354|FG000|Follow up Period|Physician Decision|0|||
30818894|NCT02986074|58839355|FG001|Follow up Period|Physician Decision|0|||
30818895|NCT02986074|58839356|FG002|Follow up Period|Physician Decision|0|||
30818896|NCT02986074|58839357|FG003|Follow up Period|Physician Decision|1|||
30818897|NCT02920242|58839365|FG000|Overall Study|Withdrawal by Subject|1|||
30818898|NCT02920242|58839366|FG001|Overall Study|Withdrawal by Subject|0|||
30818899|NCT02920242|58839367|FG002|Overall Study|Withdrawal by Subject|1|||
30818900|NCT02920242|58839365|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
30818901|NCT02920242|58839366|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
30818902|NCT02920242|58839367|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
30818903|NCT02985996|58839380|FG000|Overall Study|Withdrawal by Subject|0|||
30818904|NCT02985996|58839381|FG001|Overall Study|Withdrawal by Subject|0|||
30818905|NCT02985996|58839382|FG002|Overall Study|Withdrawal by Subject|1|||
30818906|NCT02985996|58839383|FG003|Overall Study|Withdrawal by Subject|0|||
30818907|NCT02985996|58839384|FG004|Overall Study|Withdrawal by Subject|0|||
30818908|NCT02985996|58839380|FG000|Overall Study|Protocol Violation|0|||
30818909|NCT02985996|58839381|FG001|Overall Study|Protocol Violation|1|||
30818910|NCT02985996|58839382|FG002|Overall Study|Protocol Violation|0|||
30818911|NCT02985996|58839383|FG003|Overall Study|Protocol Violation|0|||
30818912|NCT02985996|58839384|FG004|Overall Study|Protocol Violation|0|||
30818913|NCT03225833|58839406|FG000|Overall Study|Adverse Event|0|||
30818914|NCT03225833|58839407|FG001|Overall Study|Adverse Event|1|||
30818915|NCT03225833|58839408|FG002|Overall Study|Adverse Event|2|||
30818916|NCT03225833|58839409|FG003|Overall Study|Adverse Event|0|||
30818917|NCT03225833|58839410|FG004|Overall Study|Adverse Event|0|||
30818918|NCT03225833|58839411|FG005|Overall Study|Adverse Event|2|||
30818919|NCT03225833|58839406|FG000|Overall Study|Withdrawal by Subject|1|||
30818920|NCT03225833|58839407|FG001|Overall Study|Withdrawal by Subject|0|||
30818921|NCT03225833|58839408|FG002|Overall Study|Withdrawal by Subject|0|||
30818922|NCT03225833|58839409|FG003|Overall Study|Withdrawal by Subject|0|||
30818923|NCT03225833|58839410|FG004|Overall Study|Withdrawal by Subject|1|||
30818924|NCT03225833|58839411|FG005|Overall Study|Withdrawal by Subject|0|||
30818925|NCT03225833|58839406|FG000|Overall Study|Termination of Study by Sponsor|4|||
30818926|NCT03225833|58839407|FG001|Overall Study|Termination of Study by Sponsor|0|||
30818927|NCT03225833|58839408|FG002|Overall Study|Termination of Study by Sponsor|0|||
30818928|NCT03225833|58839409|FG003|Overall Study|Termination of Study by Sponsor|0|||
30818929|NCT03225833|58839410|FG004|Overall Study|Termination of Study by Sponsor|0|||
30818930|NCT03225833|58839411|FG005|Overall Study|Termination of Study by Sponsor|7|||
30818931|NCT03225833|58839406|FG000|Overall Study|Sponsor Decision|0|||
30818932|NCT03225833|58839407|FG001|Overall Study|Sponsor Decision|0|||
30818933|NCT03225833|58839408|FG002|Overall Study|Sponsor Decision|0|||
30818934|NCT03225833|58839409|FG003|Overall Study|Sponsor Decision|0|||
30818935|NCT03225833|58839410|FG004|Overall Study|Sponsor Decision|0|||
30818936|NCT03225833|58839411|FG005|Overall Study|Sponsor Decision|1|||
30818937|NCT03203447|58839432|FG000|Overall Study|Withdrawal by Subject|2|||
30818938|NCT03203447|58839433|FG001|Overall Study|Withdrawal by Subject|1|||
30818939|NCT03203447|58839432|FG000|Overall Study|Lost to Follow-up|1|||
30818940|NCT03203447|58839433|FG001|Overall Study|Lost to Follow-up|10|||
30818941|NCT03203447|58839432|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
30818942|NCT03203447|58839433|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
30818943|NCT02858726|58839443|FG000|Overall Study|Adverse Event|4|||
30818944|NCT02858726|58839444|FG001|Overall Study|Adverse Event|4|||
30818945|NCT02858726|58839445|FG002|Overall Study|Adverse Event|9|||
30818946|NCT02858726|58839446|FG003|Overall Study|Adverse Event|1|||
30818947|NCT02858726|58839443|FG000|Overall Study|Physician Decision|0|||
30818948|NCT02858726|58839444|FG001|Overall Study|Physician Decision|0|||
30818949|NCT02858726|58839445|FG002|Overall Study|Physician Decision|1|||
30818950|NCT02858726|58839446|FG003|Overall Study|Physician Decision|0|||
30818951|NCT02858726|58839443|FG000|Overall Study|Protocol Violation|0|||
30818952|NCT02858726|58839444|FG001|Overall Study|Protocol Violation|0|||
30623072|NCT01215968|58634834|FG001|Overall Study|Not received study drug|1|||
30623073|NCT00963807|58634843|FG000|Overall Study|Physician Decision|2|||
30623074|NCT00963807|58634843|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
30623075|NCT00963807|58634843|FG000|Overall Study|Disease progression|15|||
30623076|NCT01142466|58634851|FG000|Overall Study|Adverse Event|2|||
30623077|NCT01142466|58634852|FG001|Overall Study|Adverse Event|1|||
30623078|NCT01142466|58634851|FG000|Overall Study|Withdrawal by Subject|1|||
30623079|NCT01142466|58634852|FG001|Overall Study|Withdrawal by Subject|1|||
30752212|NCT00223080|58761936|FG000|Overall Study|Lost to Follow-up|259|||
30752213|NCT00223080|58761937|FG001|Overall Study|Lost to Follow-up|284|||
30752214|NCT00223080|58761936|FG000|Overall Study|Death|85|||
30752215|NCT00223080|58761937|FG001|Overall Study|Death|74|||
30752216|NCT00223080|58761936|FG000|Overall Study|Other|14|||
30752217|NCT00223080|58761937|FG001|Overall Study|Other|11|||
30752218|NCT00223080|58761936|FG000|Overall Study|Reason not provided|141|||
30752219|NCT00223080|58761937|FG001|Overall Study|Reason not provided|140|||
30752220|NCT00223080|58761936|FG000|Overall Study|Adverse Event|0|||
30752221|NCT00223080|58761937|FG001|Overall Study|Adverse Event|1|||
30752222|NCT00220740|58761945|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
30752223|NCT00220740|58761946|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
30752224|NCT00220740|58761945|FG000|Efficacy Period|Adverse Event|1|||
30752225|NCT00220740|58761946|FG001|Efficacy Period|Adverse Event|1|||
30752226|NCT00220740|58761945|FG000|Efficacy Period|Withdrawal by Subject|1|||
30752227|NCT00220740|58761946|FG001|Efficacy Period|Withdrawal by Subject|0|||
30752228|NCT00220740|58761945|FG000|Efficacy Period|Protocol Violation|1|||
30752229|NCT00220740|58761946|FG001|Efficacy Period|Protocol Violation|0|||
30752230|NCT00220740|58761945|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
30752231|NCT00220740|58761946|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
30752232|NCT00184002|58761954|FG000|Overall Study|Adverse Event|9|||
30752233|NCT00184002|58761954|FG000|Overall Study|Death|3|||
30752234|NCT00184002|58761954|FG000|Overall Study|Physician Decision|1|||
30752235|NCT00184002|58761954|FG000|Overall Study|Withdrawal by Subject|4|||
30752236|NCT00165672|58761960|FG000|Overall Study|Adverse Event|0|||
30752237|NCT00165672|58761961|FG001|Overall Study|Adverse Event|1|||
30752238|NCT00180414|58761969|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
30752239|NCT00180414|58761970|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
30752240|NCT00174252|58761976|FG000|Overall Study|Protocol Violation|2|||
30752241|NCT00169104|58761984|FG000|Overall Study|Withdrawal by Subject|2|||
30752242|NCT00169104|58761985|FG001|Overall Study|Withdrawal by Subject|0|||
30752243|NCT00169104|58761984|FG000|Overall Study|Protocol Violation|0|||
30752244|NCT00169104|58761985|FG001|Overall Study|Protocol Violation|1|||
30752245|NCT00169104|58761984|FG000|Overall Study|Physician Decision|0|||
30752246|NCT00169104|58761985|FG001|Overall Study|Physician Decision|1|||
30752247|NCT00163020|58761994|FG000|Overall Study|Lost to Follow-up|0|||
30752248|NCT00163020|58761995|FG001|Overall Study|Lost to Follow-up|2|||
30752249|NCT00252720|58762005|FG000|Overall Study|Withdrawal by Subject|95|||
30752250|NCT00252720|58762006|FG001|Overall Study|Withdrawal by Subject|97|||
30752251|NCT00252720|58762005|FG000|Overall Study|Death|7|||
30752252|NCT00252720|58762006|FG001|Overall Study|Death|8|||
30752253|NCT00252720|58762005|FG000|Overall Study|Moving|23|||
30752254|NCT00252720|58762006|FG001|Overall Study|Moving|42|||
30752255|NCT00252720|58762005|FG000|Overall Study|Mainly patients lost to follow-up|7|||
30752256|NCT00252720|58762006|FG001|Overall Study|Mainly patients lost to follow-up|18|||
30752257|NCT00167778|58762012|FG000|Overall Study|Withdrawal by Subject|1|||
30752258|NCT00167310|58762019|FG000|Overall Study|Protocol Violation|5|||
30752259|NCT00167310|58762020|FG001|Overall Study|Protocol Violation|3|||
30752260|NCT00167310|58762019|FG000|Overall Study|Withdrawal by Subject|3|||
30752261|NCT00167310|58762020|FG001|Overall Study|Withdrawal by Subject|7|||
30752262|NCT03754582|58762026|FG000|Treatment Phase|Adverse Event|0|||
30752263|NCT03754582|58762027|FG001|Treatment Phase|Adverse Event|1|||
30818953|NCT02858726|58839445|FG002|Overall Study|Protocol Violation|0|||
30913064|NCT02122783|58948458|FG001|Overall Study|Adverse Event|1|||
30913065|NCT01921257|58948467|FG000|Overall Study|Adverse Event|1|||
30913066|NCT01921257|58948467|FG000|Overall Study|Protocol Violation|1|||
30913067|NCT01921257|58948467|FG000|Overall Study|Withdrawal by Subject|1|||
30913068|NCT02121847|58948472|FG000|Overall Study|Administrative Reasons|1|||
30913069|NCT02121847|58948472|FG000|Overall Study|Adverse Event|2|||
30913070|NCT01921179|58948478|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
30913071|NCT01921179|58948479|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
30913072|NCT01921179|58948478|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
30913073|NCT01921179|58948479|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
30913074|NCT01587040|58948490|FG000|Overall Study|Protocol Violation|0|||
30818954|NCT02858726|58839446|FG003|Overall Study|Protocol Violation|1|||
30818955|NCT02858726|58839443|FG000|Overall Study|Study Terminated by Sponsor|0|||
30818956|NCT02858726|58839444|FG001|Overall Study|Study Terminated by Sponsor|0|||
30818957|NCT02858726|58839445|FG002|Overall Study|Study Terminated by Sponsor|0|||
30818958|NCT02858726|58839446|FG003|Overall Study|Study Terminated by Sponsor|1|||
30818959|NCT02858726|58839443|FG000|Overall Study|Withdrawal by Subject|1|||
30818960|NCT02858726|58839444|FG001|Overall Study|Withdrawal by Subject|2|||
30818961|NCT02858726|58839445|FG002|Overall Study|Withdrawal by Subject|1|||
30818962|NCT02858726|58839446|FG003|Overall Study|Withdrawal by Subject|0|||
30818963|NCT02858726|58839443|FG000|Overall Study|Noncompliance|0|||
30818964|NCT02858726|58839444|FG001|Overall Study|Noncompliance|1|||
30818965|NCT02858726|58839445|FG002|Overall Study|Noncompliance|0|||
30818966|NCT02858726|58839446|FG003|Overall Study|Noncompliance|0|||
30818967|NCT03203291|58839460|FG000|Overall Study|Withdrawal by Subject|1|||
30818968|NCT01068678|58839466|FG000|Overall Study|Lack of Efficacy|3|||
30818969|NCT01068678|58839467|FG001|Overall Study|Lack of Efficacy|2|||
30818970|NCT01068678|58839466|FG000|Overall Study|Protocol Violation|5|||
30818971|NCT01068678|58839467|FG001|Overall Study|Protocol Violation|1|||
30818972|NCT01068678|58839466|FG000|Overall Study|Withdrawal criteria|12|||
30818973|NCT01068678|58839467|FG001|Overall Study|Withdrawal criteria|6|||
30818974|NCT01068678|58839466|FG000|Overall Study|Unclassified|18|||
30818975|NCT01068678|58839467|FG001|Overall Study|Unclassified|15|||
30818976|NCT03202511|58839473|FG000|Overall Study|Withdrawal by Subject|1|||
30818977|NCT03202511|58839474|FG001|Overall Study|Withdrawal by Subject|0|||
30818978|NCT02919696|58839495|FG000|Overall Study|Adverse Event|1|||
30818979|NCT02919696|58839496|FG001|Overall Study|Adverse Event|2|||
30818980|NCT02919696|58839495|FG000|Overall Study|Withdrawal by Subject|2|||
30818981|NCT02919696|58839496|FG001|Overall Study|Withdrawal by Subject|1|||
30818982|NCT02919696|58839495|FG000|Overall Study|Sponsor Decision|1|||
30818983|NCT02919696|58839496|FG001|Overall Study|Sponsor Decision|1|||
30818984|NCT02919696|58839495|FG000|Overall Study|Never Treated|0|||
30818985|NCT02919696|58839496|FG001|Overall Study|Never Treated|1|||
30818986|NCT02935673|58839511|FG000|Overall Study|Adverse Event|0|||
30818987|NCT02935673|58839512|FG001|Overall Study|Adverse Event|1|||
30818988|NCT02935673|58839513|FG002|Overall Study|Adverse Event|0|||
30818989|NCT02935673|58839511|FG000|Overall Study|Withdrawal by Subject|1|||
30818990|NCT02935673|58839512|FG001|Overall Study|Withdrawal by Subject|2|||
30818991|NCT02935673|58839513|FG002|Overall Study|Withdrawal by Subject|0|||
30818992|NCT03201809|58839525|FG000|Overall Study|Lost to Follow-up|2|||
30818993|NCT03201809|58839526|FG001|Overall Study|Lost to Follow-up|0|||
30818994|NCT02985450|58839537|FG000|Overall Study|Lost to Follow-up|7|||
30818995|NCT02908464|58839546|FG000|Overall Study|Withdrawal by Subject|2|||
30818996|NCT02908464|58839547|FG001|Overall Study|Withdrawal by Subject|1|||
30818997|NCT02908464|58839546|FG000|Overall Study|Found ineligible after randomization|0|||
30818998|NCT02908464|58839547|FG001|Overall Study|Found ineligible after randomization|2|||
30818999|NCT02907216|58839556|FG000|Overall Study|No benefit to be obtained by continuing|0|||
30819000|NCT02907216|58839557|FG001|Overall Study|No benefit to be obtained by continuing|1|||
30819001|NCT02907216|58839556|FG000|Overall Study|Withdrawal by Subject|1|||
30819002|NCT02907216|58839557|FG001|Overall Study|Withdrawal by Subject|0|||
30819003|NCT02984982|58839565|FG000|Overall Study|Adverse Event|2|||
30819004|NCT02984982|58839566|FG001|Overall Study|Adverse Event|5|||
30819005|NCT02984982|58839565|FG000|Overall Study|Poor Compliance to Protocol|4|||
30819006|NCT02984982|58839566|FG001|Overall Study|Poor Compliance to Protocol|4|||
30913075|NCT01587040|58948491|FG001|Overall Study|Protocol Violation|0|||
30913076|NCT01587040|58948492|FG002|Overall Study|Protocol Violation|1|||
30913077|NCT01587040|58948493|FG003|Overall Study|Protocol Violation|0|||
30913078|NCT01587040|58948490|FG000|Overall Study|Adverse Event|0|||
30913079|NCT01587040|58948491|FG001|Overall Study|Adverse Event|1|||
30913080|NCT01587040|58948492|FG002|Overall Study|Adverse Event|10|||
30819007|NCT02984982|58839565|FG000|Overall Study|Withdrawal by Subject|2|||
30819008|NCT02984982|58839566|FG001|Overall Study|Withdrawal by Subject|0|||
30819009|NCT02984982|58839565|FG000|Overall Study|Randomized but not treated|0|||
30819010|NCT02984982|58839566|FG001|Overall Study|Randomized but not treated|1|||
30819011|NCT02981472|58839575|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
30819012|NCT02981472|58839576|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
30819013|NCT02981472|58839575|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
30819014|NCT02981472|58839576|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30819015|NCT02981472|58839575|FG000|Treatment Period|Adverse Event|6|||
30819016|NCT02981472|58839576|FG001|Treatment Period|Adverse Event|1|||
30819017|NCT02981472|58839575|FG000|Treatment Period|Participant withdrew consent|1|||
30819018|NCT02981472|58839576|FG001|Treatment Period|Participant withdrew consent|0|||
30819019|NCT02981472|58839575|FG000|Treatment Period|Lost to Follow-up|0|||
30819020|NCT02981472|58839576|FG001|Treatment Period|Lost to Follow-up|1|||
30819021|NCT02982720|58839588|FG000|Overall Study|Adverse Event|3|||
30819022|NCT02982720|58839588|FG000|Overall Study|Death|1|||
30819023|NCT00849667|58839595|FG000|Overall Study|Withdrawal by Subject|16|||
30819024|NCT00849667|58839596|FG001|Overall Study|Withdrawal by Subject|33|||
30819025|NCT00849667|58839597|FG002|Overall Study|Withdrawal by Subject|35|||
30819026|NCT00849667|58839595|FG000|Overall Study|Lost to Follow-up|8|||
30819027|NCT00849667|58839596|FG001|Overall Study|Lost to Follow-up|8|||
30819028|NCT00849667|58839597|FG002|Overall Study|Lost to Follow-up|8|||
30819029|NCT00849667|58839595|FG000|Overall Study|Adverse Event|1|||
30819030|NCT00849667|58839596|FG001|Overall Study|Adverse Event|2|||
30819031|NCT00849667|58839597|FG002|Overall Study|Adverse Event|0|||
30819032|NCT00849667|58839595|FG000|Overall Study|Other|18|||
30819033|NCT00849667|58839596|FG001|Overall Study|Other|19|||
30819034|NCT00849667|58839597|FG002|Overall Study|Other|18|||
30819035|NCT00849667|58839595|FG000|Overall Study|Progressive disease|119|||
30819036|NCT00849667|58839596|FG001|Overall Study|Progressive disease|100|||
30819037|NCT00849667|58839597|FG002|Overall Study|Progressive disease|112|||
30819038|NCT00849667|58839595|FG000|Overall Study|Sponsor decision|208|||
30819039|NCT00849667|58839596|FG001|Overall Study|Sponsor decision|204|||
30819040|NCT00849667|58839597|FG002|Overall Study|Sponsor decision|190|||
30819041|NCT00849667|58839595|FG000|Overall Study|Investigator discretion|0|||
30819042|NCT00849667|58839596|FG001|Overall Study|Investigator discretion|0|||
30819043|NCT00849667|58839597|FG002|Overall Study|Investigator discretion|1|||
30819044|NCT03201419|58839616|FG000|Overall Study|Adverse Event|3|||
30819045|NCT03201419|58839617|FG001|Overall Study|Adverse Event|1|||
30819046|NCT03201419|58839618|FG002|Overall Study|Adverse Event|0|||
30819047|NCT03201419|58839619|FG003|Overall Study|Adverse Event|0|||
30819048|NCT03201419|58839620|FG004|Overall Study|Adverse Event|1|||
30819049|NCT03201419|58839621|FG005|Overall Study|Adverse Event|1|||
30819050|NCT03201419|58839622|FG006|Overall Study|Adverse Event|5|||
30819051|NCT03201419|58839623|FG007|Overall Study|Adverse Event|0|||
30819052|NCT03201419|58839624|FG008|Overall Study|Adverse Event|0|||
30819053|NCT03201419|58839616|FG000|Overall Study|Lost to Follow-up|1|||
30819054|NCT03201419|58839617|FG001|Overall Study|Lost to Follow-up|0|||
30819055|NCT03201419|58839618|FG002|Overall Study|Lost to Follow-up|0|||
30819056|NCT03201419|58839619|FG003|Overall Study|Lost to Follow-up|0|||
30819057|NCT03201419|58839620|FG004|Overall Study|Lost to Follow-up|0|||
30819058|NCT03201419|58839621|FG005|Overall Study|Lost to Follow-up|0|||
30819059|NCT03201419|58839622|FG006|Overall Study|Lost to Follow-up|0|||
30819060|NCT03201419|58839623|FG007|Overall Study|Lost to Follow-up|0|||
30819061|NCT03201419|58839624|FG008|Overall Study|Lost to Follow-up|0|||
30819062|NCT03201419|58839616|FG000|Overall Study|Protocol Deviation|0|||
30819063|NCT03201419|58839617|FG001|Overall Study|Protocol Deviation|0|||
30819064|NCT03201419|58839618|FG002|Overall Study|Protocol Deviation|0|||
30819065|NCT03201419|58839619|FG003|Overall Study|Protocol Deviation|0|||
30819066|NCT03201419|58839620|FG004|Overall Study|Protocol Deviation|0|||
30819067|NCT03201419|58839621|FG005|Overall Study|Protocol Deviation|0|||
30819068|NCT03201419|58839622|FG006|Overall Study|Protocol Deviation|1|||
30819069|NCT03201419|58839623|FG007|Overall Study|Protocol Deviation|0|||
30819070|NCT03201419|58839624|FG008|Overall Study|Protocol Deviation|0|||
30819071|NCT03201419|58839616|FG000|Overall Study|Withdrawal by Subject|4|||
30819072|NCT03201419|58839617|FG001|Overall Study|Withdrawal by Subject|2|||
30913081|NCT01587040|58948493|FG003|Overall Study|Adverse Event|0|||
30819073|NCT03201419|58839618|FG002|Overall Study|Withdrawal by Subject|1|||
30819074|NCT03201419|58839619|FG003|Overall Study|Withdrawal by Subject|0|||
30819075|NCT03201419|58839620|FG004|Overall Study|Withdrawal by Subject|0|||
30819076|NCT03201419|58839621|FG005|Overall Study|Withdrawal by Subject|0|||
30819077|NCT03201419|58839622|FG006|Overall Study|Withdrawal by Subject|0|||
30819078|NCT03201419|58839623|FG007|Overall Study|Withdrawal by Subject|1|||
30819079|NCT03201419|58839624|FG008|Overall Study|Withdrawal by Subject|2|||
30819080|NCT03201419|58839616|FG000|Overall Study|Other|0|||
30819081|NCT03201419|58839617|FG001|Overall Study|Other|0|||
30819082|NCT03201419|58839618|FG002|Overall Study|Other|1|||
30819083|NCT03201419|58839619|FG003|Overall Study|Other|0|||
30913082|NCT01587040|58948490|FG000|Overall Study|Disease progression|12|||
30819084|NCT03201419|58839620|FG004|Overall Study|Other|0|||
30819085|NCT03201419|58839621|FG005|Overall Study|Other|0|||
30819086|NCT03201419|58839622|FG006|Overall Study|Other|0|||
30819087|NCT03201419|58839623|FG007|Overall Study|Other|0|||
30819088|NCT03201419|58839624|FG008|Overall Study|Other|0|||
30819089|NCT01764633|58839660|FG000|Overall Study|Withdrawal by Subject|105|||
30819090|NCT01764633|58839661|FG001|Overall Study|Withdrawal by Subject|88|||
30819091|NCT01764633|58839660|FG000|Overall Study|Lost to Follow-up|13|||
30819092|NCT01764633|58839661|FG001|Overall Study|Lost to Follow-up|5|||
30819093|NCT02924389|58839669|FG000|Overall Study|Lost to Follow-up|1|||
30819094|NCT02924389|58839670|FG001|Overall Study|Lost to Follow-up|0|||
30819095|NCT02924389|58839669|FG000|Overall Study|Physician Decision|2|||
30819096|NCT02924389|58839670|FG001|Overall Study|Physician Decision|0|||
30819097|NCT02924389|58839669|FG000|Overall Study|Withdrawal by Subject|3|||
30819098|NCT02924389|58839670|FG001|Overall Study|Withdrawal by Subject|0|||
30819099|NCT02924389|58839669|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
30819100|NCT02924389|58839670|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
30819101|NCT03235349|58839677|FG000|Overall Study|Adverse Event|1|||
30819102|NCT03235349|58839677|FG000|Overall Study|Other|1|||
30819103|NCT03235115|58839681|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
30819104|NCT03235115|58839682|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
30819105|NCT03235115|58839683|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
30819106|NCT03235115|58839684|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
30819107|NCT03235115|58839685|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
30819108|NCT03235115|58839686|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
30819109|NCT02923531|58839694|FG000|Overall Study|Adverse Event|4|||
30819110|NCT02923531|58839694|FG000|Overall Study|Clinical Deterioration|1|||
30819111|NCT02923531|58839694|FG000|Overall Study|Disease Progression|3|||
30819112|NCT02923531|58839694|FG000|Overall Study|Study Termination|1|||
30819113|NCT02934503|58839699|FG000|Overall Study|progression of disease|3|||
30819114|NCT02934503|58839699|FG000|Overall Study|Withdrawal by Subject|1|||
30819115|NCT02937545|58839705|FG000|Overall Study|Withdrawal by Subject|1|||
30819116|NCT02937545|58839706|FG001|Overall Study|Withdrawal by Subject|2|||
30819117|NCT02937545|58839707|FG002|Overall Study|Withdrawal by Subject|6|||
30819118|NCT02937545|58839708|FG003|Overall Study|Withdrawal by Subject|7|||
30819119|NCT02937545|58839705|FG000|Overall Study|Lost to Follow-up|1|||
30819120|NCT02937545|58839706|FG001|Overall Study|Lost to Follow-up|0|||
30819121|NCT02937545|58839707|FG002|Overall Study|Lost to Follow-up|0|||
30819122|NCT02937545|58839708|FG003|Overall Study|Lost to Follow-up|0|||
30819123|NCT03199391|58839719|FG000|Overall Study|Death|1|||
30819124|NCT03199391|58839719|FG000|Overall Study|Lost to Follow-up|3|||
30819125|NCT03199391|58839719|FG000|Overall Study|Adverse Event|2|||
30819126|NCT03199391|58839719|FG000|Overall Study|Withdrawal by Subject|10|||
30819127|NCT03198767|58839730|FG000|Overall Study|Protocol Violation|0|||
30819128|NCT03198767|58839731|FG001|Overall Study|Protocol Violation|0|||
30819129|NCT03198767|58839732|FG002|Overall Study|Protocol Violation|0|||
30819130|NCT03198767|58839733|FG003|Overall Study|Protocol Violation|6|||
30819131|NCT03198767|58839734|FG004|Overall Study|Protocol Violation|0|||
30819132|NCT03198767|58839735|FG005|Overall Study|Protocol Violation|0|||
30819133|NCT03198767|58839736|FG006|Overall Study|Protocol Violation|0|||
30819134|NCT03162055|58839753|FG000|Overall Study|Adverse Event|6|||
30819135|NCT03162055|58839754|FG001|Overall Study|Adverse Event|5|||
30819136|NCT03162055|58839753|FG000|Overall Study|Death|3|||
30819137|NCT03162055|58839754|FG001|Overall Study|Death|3|||
30819138|NCT03162055|58839753|FG000|Overall Study|Lost to Follow-up|0|||
30819139|NCT03162055|58839754|FG001|Overall Study|Lost to Follow-up|1|||
30819140|NCT03162055|58839753|FG000|Overall Study|Study-specific withdrawal criteria|22|||
30913083|NCT01587040|58948491|FG001|Overall Study|Disease progression|1|||
30913084|NCT01587040|58948492|FG002|Overall Study|Disease progression|15|||
30913085|NCT01587040|58948493|FG003|Overall Study|Disease progression|3|||
30913086|NCT01587040|58948490|FG000|Overall Study|Other than specified|5|||
30913087|NCT01587040|58948491|FG001|Overall Study|Other than specified|1|||
30913088|NCT01587040|58948492|FG002|Overall Study|Other than specified|11|||
30913089|NCT01587040|58948493|FG003|Overall Study|Other than specified|1|||
30752264|NCT03754582|58762028|FG002|Treatment Phase|Adverse Event|0|||
30752265|NCT03754582|58762026|FG000|Follow-up Phase|Other|0|||
30752266|NCT03754582|58762027|FG001|Follow-up Phase|Other|0|||
30752267|NCT03754582|58762028|FG002|Follow-up Phase|Other|1|||
30752268|NCT00161616|58762046|FG000|Overall Study|Withdrawal by Subject|6|||
30752269|NCT00161616|58762047|FG001|Overall Study|Withdrawal by Subject|5|||
30752270|NCT00161616|58762046|FG000|Overall Study|Physician Decision|1|||
30752271|NCT00161616|58762047|FG001|Overall Study|Physician Decision|0|||
30819141|NCT03162055|58839754|FG001|Overall Study|Study-specific withdrawal criteria|14|||
30913090|NCT02144701|58948505|FG000|Overall Study|development of relapse, GVHD or death|9|||
30819142|NCT03162055|58839753|FG000|Overall Study|Withdrawal by Subject|17|||
30819143|NCT03162055|58839754|FG001|Overall Study|Withdrawal by Subject|2|||
30819144|NCT03162055|58839753|FG000|Overall Study|Did not receive treatment|2|||
30819145|NCT03162055|58839754|FG001|Overall Study|Did not receive treatment|0|||
30819146|NCT03162055|58839753|FG000|Overall Study|Incorrect randomization|4|||
30752272|NCT00161616|58762046|FG000|Overall Study|Death|1|||
30752273|NCT00161616|58762047|FG001|Overall Study|Death|1|||
30819147|NCT03162055|58839754|FG001|Overall Study|Incorrect randomization|3|||
30819148|NCT03162055|58839753|FG000|Overall Study|Other|8|||
30819149|NCT03162055|58839754|FG001|Overall Study|Other|15|||
30819150|NCT02927145|58839767|FG000|Initial Recruitment|Withdrawal by Subject|0|||
30819151|NCT02927145|58839768|FG001|Initial Recruitment|Withdrawal by Subject|1|||
30819152|NCT02927145|58839769|FG002|Initial Recruitment|Withdrawal by Subject|1|||
30819153|NCT02927145|58839770|FG003|Initial Recruitment|Withdrawal by Subject|4|||
30819154|NCT02927145|58839771|FG004|Initial Recruitment|Withdrawal by Subject|1|||
30819155|NCT02927145|58839772|FG005|Initial Recruitment|Withdrawal by Subject|1|||
30819156|NCT02927145|58839773|FG006|Initial Recruitment|Withdrawal by Subject|0|||
30819157|NCT02927145|58839774|FG007|Initial Recruitment|Withdrawal by Subject|0|||
30819158|NCT02927145|58839775|FG008|Initial Recruitment|Withdrawal by Subject|2|||
30819159|NCT02927145|58839767|FG000|Initial Recruitment|Adverse Event|0|||
30819160|NCT02927145|58839768|FG001|Initial Recruitment|Adverse Event|0|||
30819161|NCT02927145|58839769|FG002|Initial Recruitment|Adverse Event|0|||
30819162|NCT02927145|58839770|FG003|Initial Recruitment|Adverse Event|0|||
30819163|NCT02927145|58839771|FG004|Initial Recruitment|Adverse Event|2|||
30819164|NCT02927145|58839772|FG005|Initial Recruitment|Adverse Event|0|||
30819165|NCT02927145|58839773|FG006|Initial Recruitment|Adverse Event|0|||
30819166|NCT02927145|58839774|FG007|Initial Recruitment|Adverse Event|0|||
30819167|NCT02927145|58839775|FG008|Initial Recruitment|Adverse Event|0|||
30819168|NCT02927145|58839767|FG000|Invitation for Additional Challenge|Pregnancy|0|||
30819169|NCT02927145|58839768|FG001|Invitation for Additional Challenge|Pregnancy|0|||
30819170|NCT02927145|58839769|FG002|Invitation for Additional Challenge|Pregnancy|0|||
30819171|NCT02927145|58839770|FG003|Invitation for Additional Challenge|Pregnancy|0|||
30819172|NCT02927145|58839771|FG004|Invitation for Additional Challenge|Pregnancy|0|||
30819173|NCT02927145|58839772|FG005|Invitation for Additional Challenge|Pregnancy|0|||
30819174|NCT02927145|58839773|FG006|Invitation for Additional Challenge|Pregnancy|1|||
30819175|NCT02927145|58839774|FG007|Invitation for Additional Challenge|Pregnancy|0|||
30819176|NCT02927145|58839775|FG008|Invitation for Additional Challenge|Pregnancy|0|||
30819177|NCT03688919|58839798|FG000|Overall Study|Lost to Follow-up|2|||
30819178|NCT03688919|58839799|FG001|Overall Study|Lost to Follow-up|1|||
30819179|NCT03688919|58839798|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
30819180|NCT03688919|58839799|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
30819181|NCT02888119|58839822|FG000|Overall Study|Lost to Follow-up|5|||
30819182|NCT02888119|58839823|FG001|Overall Study|Lost to Follow-up|4|||
30819183|NCT02888119|58839824|FG002|Overall Study|Lost to Follow-up|0|||
30843601|NCT02101853|58869616|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
30843602|NCT02101853|58869617|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
30843603|NCT02101853|58869612|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
30843604|NCT02101853|58869613|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
30913091|NCT02144701|58948506|FG001|Overall Study|development of relapse, GVHD or death|3|||
30913092|NCT01921101|58948514|FG000|Overall Study|Death|16|||
30913093|NCT01921101|58948515|FG001|Overall Study|Death|6|||
30843605|NCT02101853|58869614|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
30843606|NCT02101853|58869615|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
30843607|NCT02101853|58869616|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
30843608|NCT02101853|58869617|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
30843609|NCT02101853|58869612|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
30843610|NCT02101853|58869613|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
30843611|NCT02101853|58869614|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
30843612|NCT02101853|58869615|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
30913094|NCT01586806|58948524|FG000|Overall Study|Protocol Violation|0|||
30913095|NCT01586806|58948525|FG001|Overall Study|Protocol Violation|1|||
30913096|NCT01586806|58948526|FG002|Overall Study|Protocol Violation|0|||
30913097|NCT01586806|58948524|FG000|Overall Study|Withdrawal by Subject|1|||
30913098|NCT01586806|58948525|FG001|Overall Study|Withdrawal by Subject|0|||
30913099|NCT01586806|58948526|FG002|Overall Study|Withdrawal by Subject|0|||
30843613|NCT02101853|58869616|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
30843614|NCT02101853|58869617|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
30843615|NCT02101853|58869612|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
30843616|NCT02101853|58869613|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
30843617|NCT02101853|58869614|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
30843618|NCT02101853|58869615|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
30843619|NCT02101853|58869616|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
30843620|NCT02101853|58869617|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
30843621|NCT02101853|58869612|FG000|Blinatumomab Salvage Therapy|Death|0|||
30843622|NCT02101853|58869613|FG001|Blinatumomab Salvage Therapy|Death|0|||
30913100|NCT01586806|58948524|FG000|Overall Study|Lost to Follow-up|2|||
30913101|NCT01586806|58948525|FG001|Overall Study|Lost to Follow-up|3|||
30913102|NCT01586806|58948526|FG002|Overall Study|Lost to Follow-up|2|||
30623080|NCT01215734|58634860|FG000|Overall Study|Death|0|||
30819184|NCT03197129|58839833|FG000|Overall Study|did not answer the VPT: shyness|4|||
30819185|NCT03197129|58839834|FG001|Overall Study|did not answer the VPT: shyness|5|||
30819186|NCT03196973|58839843|FG000|Overall Study|Adverse Event|1|||
30819187|NCT03196973|58839844|FG001|Overall Study|Adverse Event|1|||
30819188|NCT03196973|58839845|FG002|Overall Study|Adverse Event|2|||
30819189|NCT03196973|58839843|FG000|Overall Study|Lack of Efficacy|2|||
30819190|NCT03196973|58839844|FG001|Overall Study|Lack of Efficacy|6|||
30819191|NCT03196973|58839845|FG002|Overall Study|Lack of Efficacy|1|||
30819192|NCT03196973|58839843|FG000|Overall Study|Lost to Follow-up|4|||
30819193|NCT03196973|58839844|FG001|Overall Study|Lost to Follow-up|3|||
30819194|NCT03196973|58839845|FG002|Overall Study|Lost to Follow-up|2|||
30819195|NCT03196973|58839843|FG000|Overall Study|Consent withdrawn|2|||
30819196|NCT03196973|58839844|FG001|Overall Study|Consent withdrawn|1|||
30819197|NCT03196973|58839845|FG002|Overall Study|Consent withdrawn|0|||
30819198|NCT03196973|58839843|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
30819199|NCT03196973|58839844|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
30819200|NCT03196973|58839845|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
30819201|NCT03196505|58839855|FG000|Overall Study|Physician Decision|26|||
30819202|NCT03196505|58839856|FG001|Overall Study|Physician Decision|26|||
30819203|NCT03196349|58839865|FG000|Overall Study|Did not receive study drug|0|||
30819204|NCT03196349|58839866|FG001|Overall Study|Did not receive study drug|1|||
30819205|NCT03196349|58839867|FG002|Overall Study|Did not receive study drug|2|||
30819206|NCT03196349|58839865|FG000|Overall Study|No data entered|2|||
30819207|NCT03196349|58839866|FG001|Overall Study|No data entered|4|||
30819208|NCT03196349|58839867|FG002|Overall Study|No data entered|0|||
30819209|NCT03196349|58839865|FG000|Overall Study|Study Terminated early|15|||
30819210|NCT03196349|58839866|FG001|Overall Study|Study Terminated early|9|||
30819211|NCT03196349|58839867|FG002|Overall Study|Study Terminated early|11|||
30819212|NCT02886715|58839878|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30819213|NCT02886715|58839879|FG001|Overall Study|Non-Compliance With Study Drug|2|||
30819214|NCT02886715|58839880|FG002|Overall Study|Non-Compliance With Study Drug|0|||
30819215|NCT02886715|58839878|FG000|Overall Study|Adverse Event|4|||
30819216|NCT02886715|58839879|FG001|Overall Study|Adverse Event|2|||
30819217|NCT02886715|58839880|FG002|Overall Study|Adverse Event|0|||
30819218|NCT02886715|58839878|FG000|Overall Study|Lack of Efficacy|0|||
30819219|NCT02886715|58839879|FG001|Overall Study|Lack of Efficacy|2|||
30819220|NCT02886715|58839880|FG002|Overall Study|Lack of Efficacy|1|||
30819221|NCT02886715|58839878|FG000|Overall Study|Lost to Follow-up|29|||
30913103|NCT02144077|58948536|FG000|Overall Study|Withdrawal by Subject|3|||
30913104|NCT02144077|58948537|FG001|Overall Study|Withdrawal by Subject|3|||
30913105|NCT02144077|58948536|FG000|Overall Study|Adverse Event|2|||
30819222|NCT02886715|58839879|FG001|Overall Study|Lost to Follow-up|26|||
30819223|NCT02886715|58839880|FG002|Overall Study|Lost to Follow-up|10|||
30819224|NCT02886715|58839878|FG000|Overall Study|Pregnancy|1|||
30819225|NCT02886715|58839879|FG001|Overall Study|Pregnancy|1|||
30819226|NCT02886715|58839880|FG002|Overall Study|Pregnancy|1|||
30819227|NCT02886715|58839878|FG000|Overall Study|Protocol Violation|3|||
30819228|NCT02886715|58839879|FG001|Overall Study|Protocol Violation|2|||
30819229|NCT02886715|58839880|FG002|Overall Study|Protocol Violation|1|||
30819230|NCT02886715|58839878|FG000|Overall Study|Withdrawal by Subject|20|||
30819231|NCT02886715|58839879|FG001|Overall Study|Withdrawal by Subject|18|||
30819232|NCT02886715|58839880|FG002|Overall Study|Withdrawal by Subject|5|||
30819233|NCT02886715|58839878|FG000|Overall Study|missing|7|||
30819234|NCT02886715|58839879|FG001|Overall Study|missing|2|||
30819235|NCT02886715|58839880|FG002|Overall Study|missing|2|||
30819236|NCT03085797|58839890|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
30819237|NCT03085797|58839891|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
30819238|NCT03085797|58839890|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
30819239|NCT03085797|58839891|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
30819240|NCT03085797|58839890|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
30819241|NCT03085797|58839891|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
30819242|NCT03157531|58839899|FG000|Overall Study|Death|2|||
30913106|NCT02144077|58948537|FG001|Overall Study|Adverse Event|3|||
30913107|NCT02144077|58948536|FG000|Overall Study|Lost to Follow-up|2|||
30913108|NCT02144077|58948537|FG001|Overall Study|Lost to Follow-up|2|||
30913109|NCT02144077|58948536|FG000|Overall Study|Protocol Violation|1|||
30819243|NCT03157531|58839899|FG000|Overall Study|Lost to Follow-up|4|||
30819244|NCT03159091|58839905|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
30819245|NCT03159091|58839906|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
30819246|NCT03159091|58839905|FG000|Overall Study|Patient has taken no dose of study drug|0|||
30819247|NCT03159091|58839906|FG001|Overall Study|Patient has taken no dose of study drug|1|||
30819248|NCT03196193|58839914|FG000|Overall Study|Adverse Event|1|||
30819249|NCT03196193|58839915|FG001|Overall Study|Adverse Event|0|||
30819250|NCT03196193|58839914|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
30913110|NCT02144077|58948537|FG001|Overall Study|Protocol Violation|2|||
30913111|NCT02144077|58948536|FG000|Overall Study|Death|0|||
30819251|NCT03196193|58839915|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
30819252|NCT03621761|58839924|FG000|Overall Study|Lost to Follow-up|1|||
30819253|NCT03621761|58839925|FG001|Overall Study|Lost to Follow-up|1|||
30819254|NCT03621761|58839926|FG002|Overall Study|Lost to Follow-up|2|||
30819255|NCT03621761|58839924|FG000|Overall Study|Withdrawal by Subject|2|||
30819256|NCT03621761|58839925|FG001|Overall Study|Withdrawal by Subject|1|||
30819257|NCT03621761|58839926|FG002|Overall Study|Withdrawal by Subject|1|||
30819258|NCT03621761|58839924|FG000|Overall Study|Became Ineligible|0|||
30819259|NCT03621761|58839925|FG001|Overall Study|Became Ineligible|2|||
30819260|NCT03621761|58839926|FG002|Overall Study|Became Ineligible|0|||
30819261|NCT03221387|58839934|FG000|Overall Study|Lost to Follow-up|1|||
30819262|NCT03221387|58839934|FG000|Overall Study|Lung transplant|1|||
30819263|NCT03318861|58839943|FG000|Overall Study|Death|1|||
30819264|NCT03318861|58839944|FG001|Overall Study|Death|2|||
30819265|NCT03318861|58839945|FG002|Overall Study|Death|2|||
30819266|NCT03318861|58839946|FG003|Overall Study|Death|1|||
30819267|NCT03318861|58839947|FG004|Overall Study|Death|1|||
30819268|NCT03318861|58839943|FG000|Overall Study|Still on Study|2|||
30819269|NCT03318861|58839944|FG001|Overall Study|Still on Study|1|||
30819270|NCT03318861|58839945|FG002|Overall Study|Still on Study|1|||
30819271|NCT03318861|58839946|FG003|Overall Study|Still on Study|2|||
30819272|NCT03318861|58839947|FG004|Overall Study|Still on Study|1|||
30819273|NCT03318861|58839943|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
30819274|NCT03318861|58839944|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
30819275|NCT03318861|58839945|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
30819276|NCT03318861|58839946|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
30819277|NCT03318861|58839947|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
30819278|NCT03084315|58839961|FG000|Overall Study|Lost to Follow-up|8|||
30819279|NCT03084315|58839962|FG001|Overall Study|Lost to Follow-up|7|||
30819280|NCT03084315|58839961|FG000|Overall Study|Withdrawal by Subject|2|||
30819281|NCT03084315|58839962|FG001|Overall Study|Withdrawal by Subject|2|||
30819282|NCT03187301|58839968|FG000|Titration Period|Adverse Event|0|||
30819283|NCT03187301|58839969|FG001|Titration Period|Adverse Event|0|||
30819284|NCT03187301|58839970|FG002|Titration Period|Adverse Event|0|||
30819285|NCT03187301|58839971|FG003|Titration Period|Adverse Event|0|||
30819286|NCT03187301|58839972|FG004|Titration Period|Adverse Event|0|||
30819287|NCT03187301|58839973|FG005|Titration Period|Adverse Event|0|||
30819288|NCT03187301|58839974|FG006|Titration Period|Adverse Event|5|||
30819289|NCT03187301|58839968|FG000|Titration Period|Withdrawal by Subject|0|||
30819290|NCT03187301|58839969|FG001|Titration Period|Withdrawal by Subject|0|||
30819291|NCT03187301|58839970|FG002|Titration Period|Withdrawal by Subject|0|||
30819292|NCT03187301|58839971|FG003|Titration Period|Withdrawal by Subject|0|||
30819293|NCT03187301|58839972|FG004|Titration Period|Withdrawal by Subject|0|||
30819294|NCT03187301|58839973|FG005|Titration Period|Withdrawal by Subject|0|||
30819295|NCT03187301|58839974|FG006|Titration Period|Withdrawal by Subject|1|||
30819296|NCT03187301|58839968|FG000|Titration Period|Exclusion Criteria Met|0|||
30819297|NCT03187301|58839969|FG001|Titration Period|Exclusion Criteria Met|0|||
30819298|NCT03187301|58839970|FG002|Titration Period|Exclusion Criteria Met|0|||
30819299|NCT03187301|58839971|FG003|Titration Period|Exclusion Criteria Met|0|||
30819300|NCT03187301|58839972|FG004|Titration Period|Exclusion Criteria Met|0|||
30819301|NCT03187301|58839973|FG005|Titration Period|Exclusion Criteria Met|0|||
30819302|NCT03187301|58839974|FG006|Titration Period|Exclusion Criteria Met|1|||
30819303|NCT03187301|58839968|FG000|Pre-Intervention|Withdrawal by Subject|1|||
30819304|NCT03187301|58839969|FG001|Pre-Intervention|Withdrawal by Subject|0|||
30819305|NCT03187301|58839970|FG002|Pre-Intervention|Withdrawal by Subject|0|||
30819306|NCT03187301|58839971|FG003|Pre-Intervention|Withdrawal by Subject|0|||
30819307|NCT03187301|58839972|FG004|Pre-Intervention|Withdrawal by Subject|0|||
30819308|NCT03187301|58839973|FG005|Pre-Intervention|Withdrawal by Subject|0|||
30819309|NCT03187301|58839974|FG006|Pre-Intervention|Withdrawal by Subject|0|||
30819310|NCT02946047|58839999|FG000|Overall Study|Adverse Event|1|||
30819311|NCT02946047|58840000|FG001|Overall Study|Adverse Event|0|||
30819312|NCT02946047|58840001|FG002|Overall Study|Adverse Event|0|||
30913112|NCT02144077|58948537|FG001|Overall Study|Death|1|||
30913113|NCT02144077|58948536|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
30913114|NCT02144077|58948537|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
30913115|NCT02172625|58948545|FG000|Overall Study|Adverse Event|0|||
30913116|NCT02172625|58948546|FG001|Overall Study|Adverse Event|1|||
30913117|NCT02172625|58948545|FG000|Overall Study|Pregnancy|0|||
30819313|NCT02946047|58840002|FG003|Overall Study|Adverse Event|0|||
30819314|NCT03077919|58840014|FG000|Overall Study|Lost to Follow-up|4|||
30819315|NCT03077919|58840015|FG001|Overall Study|Lost to Follow-up|1|||
30819316|NCT03220217|58840024|FG000|Overall Study|Withdrawal by Subject|0|||
30819317|NCT03220217|58840025|FG001|Overall Study|Withdrawal by Subject|1|||
30819318|NCT03220217|58840026|FG002|Overall Study|Withdrawal by Subject|0|||
30819319|NCT03220217|58840024|FG000|Overall Study|Subject Missed Procedure|0|||
30913118|NCT02172625|58948546|FG001|Overall Study|Pregnancy|1|||
30913119|NCT02172625|58948545|FG000|Overall Study|car accident|0|||
30819320|NCT03220217|58840025|FG001|Overall Study|Subject Missed Procedure|0|||
30819321|NCT03220217|58840026|FG002|Overall Study|Subject Missed Procedure|1|||
30819322|NCT03192137|58840057|FG000|Overall Study|Adverse Event|10|||
30819323|NCT03192137|58840058|FG001|Overall Study|Adverse Event|11|||
30819324|NCT03192137|58840057|FG000|Overall Study|Physician Decision|1|||
30819325|NCT03192137|58840058|FG001|Overall Study|Physician Decision|0|||
30819326|NCT03192137|58840057|FG000|Overall Study|Lack of Efficacy|20|||
30819327|NCT03192137|58840058|FG001|Overall Study|Lack of Efficacy|37|||
30819328|NCT03192137|58840057|FG000|Overall Study|Withdrawal by Subject|3|||
30819329|NCT03192137|58840058|FG001|Overall Study|Withdrawal by Subject|3|||
30819330|NCT03192137|58840057|FG000|Overall Study|Protocol Violation|4|||
30819331|NCT03192137|58840058|FG001|Overall Study|Protocol Violation|3|||
30819332|NCT03192137|58840057|FG000|Overall Study|Surgery Cancelled|4|||
30819333|NCT03192137|58840058|FG001|Overall Study|Surgery Cancelled|1|||
30819334|NCT03192137|58840057|FG000|Overall Study|Other - Various Administrative Reasons|8|||
30819335|NCT03192137|58840058|FG001|Overall Study|Other - Various Administrative Reasons|3|||
30819336|NCT03881059|58840078|FG000|Treatment Period - Part A|Adverse Event|1|||
30819337|NCT03881059|58840079|FG001|Treatment Period - Part A|Adverse Event|3|||
30819338|NCT03881059|58840080|FG002|Treatment Period - Part A|Adverse Event|4|||
30819339|NCT03881059|58840078|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
30819340|NCT03881059|58840079|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
30819341|NCT03881059|58840080|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
30819342|NCT03881059|58840078|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
30819343|NCT03881059|58840079|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
30819344|NCT03881059|58840080|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
30819345|NCT03881059|58840078|FG000|Treatment Period - Part A|Other reasons|2|||
30819346|NCT03881059|58840079|FG001|Treatment Period - Part A|Other reasons|1|||
30819347|NCT03881059|58840080|FG002|Treatment Period - Part A|Other reasons|0|||
30819348|NCT03881059|58840078|FG000|Treatment Period - Part B|Adverse Event|0|||
30819349|NCT03881059|58840079|FG001|Treatment Period - Part B|Adverse Event|0|||
30819350|NCT03881059|58840080|FG002|Treatment Period - Part B|Adverse Event|3|||
30819351|NCT03881059|58840078|FG000|Treatment Period - Part B|Death|0|||
30819352|NCT03881059|58840079|FG001|Treatment Period - Part B|Death|1|||
30819353|NCT03881059|58840080|FG002|Treatment Period - Part B|Death|1|||
30819354|NCT03881059|58840078|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
30819355|NCT03881059|58840079|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
30819356|NCT03881059|58840080|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
30819357|NCT03881059|58840078|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
30819358|NCT03881059|58840079|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
30819359|NCT03881059|58840080|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
30819360|NCT03881059|58840078|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
30819361|NCT03881059|58840079|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
30819362|NCT03881059|58840080|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
30819363|NCT03881059|58840078|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
30819364|NCT03881059|58840079|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
30819365|NCT03881059|58840080|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
30819366|NCT03881059|58840078|FG000|Treatment Period - Part B|Other reasons|4|||
30819367|NCT03881059|58840079|FG001|Treatment Period - Part B|Other reasons|3|||
30819368|NCT03881059|58840080|FG002|Treatment Period - Part B|Other reasons|3|||
30819369|NCT02861534|58840095|FG000|Overall Study|Death|541|||
30819370|NCT02861534|58840096|FG001|Overall Study|Death|552|||
30819371|NCT02861534|58840095|FG000|Overall Study|Lost to Follow-up|14|||
30819372|NCT02861534|58840096|FG001|Overall Study|Lost to Follow-up|14|||
30819373|NCT02861534|58840095|FG000|Overall Study|Site Terminated by Sponsor|4|||
30819374|NCT02861534|58840096|FG001|Overall Study|Site Terminated by Sponsor|3|||
30819375|NCT02861534|58840095|FG000|Overall Study|Withdrawal by Subject|15|||
30819376|NCT02861534|58840096|FG001|Overall Study|Withdrawal by Subject|18|||
30819377|NCT03083847|58840137|FG000|Main|Physician Decision|0|||
30819378|NCT03083847|58840138|FG001|Main|Physician Decision|0|||
30819379|NCT03083847|58840139|FG002|Main|Physician Decision|0|||
30819380|NCT03083847|58840140|FG003|Main|Physician Decision|0|||
30819381|NCT03083847|58840141|FG004|Main|Physician Decision|0|||
30819382|NCT03083847|58840142|FG005|Main|Physician Decision|1|||
30819383|NCT03083847|58840143|FG006|Main|Physician Decision|0|||
30819384|NCT03083847|58840144|FG007|Main|Physician Decision|0|||
30819385|NCT03083847|58840145|FG008|Main|Physician Decision|0|||
30819386|NCT03083847|58840146|FG009|Main|Physician Decision|0|||
30819387|NCT03083847|58840137|FG000|Main|Pregnancy|0|||
30819388|NCT03083847|58840138|FG001|Main|Pregnancy|0|||
30819389|NCT03083847|58840139|FG002|Main|Pregnancy|0|||
30819390|NCT03083847|58840140|FG003|Main|Pregnancy|0|||
30819391|NCT03083847|58840141|FG004|Main|Pregnancy|0|||
30819392|NCT03083847|58840142|FG005|Main|Pregnancy|0|||
30819393|NCT03083847|58840143|FG006|Main|Pregnancy|0|||
30819394|NCT03083847|58840144|FG007|Main|Pregnancy|1|||
30819395|NCT03083847|58840145|FG008|Main|Pregnancy|0|||
30819396|NCT03083847|58840146|FG009|Main|Pregnancy|0|||
30819397|NCT03083847|58840137|FG000|Main|Adverse Event|0|||
30819398|NCT03083847|58840138|FG001|Main|Adverse Event|0|||
30819399|NCT03083847|58840139|FG002|Main|Adverse Event|0|||
30819400|NCT03083847|58840140|FG003|Main|Adverse Event|0|||
30819401|NCT03083847|58840141|FG004|Main|Adverse Event|0|||
30819402|NCT03083847|58840142|FG005|Main|Adverse Event|0|||
30819403|NCT03083847|58840143|FG006|Main|Adverse Event|0|||
30819404|NCT03083847|58840144|FG007|Main|Adverse Event|2|||
30819405|NCT03083847|58840145|FG008|Main|Adverse Event|0|||
30819406|NCT03083847|58840146|FG009|Main|Adverse Event|0|||
30819407|NCT03083847|58840137|FG000|Main|Withdrawal by Subject|0|||
30819408|NCT03083847|58840138|FG001|Main|Withdrawal by Subject|0|||
30819409|NCT03083847|58840139|FG002|Main|Withdrawal by Subject|0|||
30819410|NCT03083847|58840140|FG003|Main|Withdrawal by Subject|0|||
30819411|NCT03083847|58840141|FG004|Main|Withdrawal by Subject|0|||
30819412|NCT03083847|58840142|FG005|Main|Withdrawal by Subject|0|||
30819413|NCT03083847|58840143|FG006|Main|Withdrawal by Subject|1|||
30819414|NCT03083847|58840144|FG007|Main|Withdrawal by Subject|1|||
30819415|NCT03083847|58840145|FG008|Main|Withdrawal by Subject|0|||
30819416|NCT03083847|58840146|FG009|Main|Withdrawal by Subject|0|||
30819417|NCT03082677|58840174|FG000|Overall Study|Not Treated|2|||
30819418|NCT02858180|58840189|FG000|Overall Study|Lost to Follow-up|0|||
30819419|NCT02858180|58840190|FG001|Overall Study|Lost to Follow-up|2|||
30819420|NCT03082599|58840198|FG000|Overall Study|Lost to Follow-up|1|||
30819421|NCT03082599|58840199|FG001|Overall Study|Lost to Follow-up|0|||
30819422|NCT01346501|58840207|FG000|Overall Study|Initiated Other Biological Agents|3|||
30819423|NCT01346501|58840208|FG001|Overall Study|Initiated Other Biological Agents|1|||
30752274|NCT00161616|58762046|FG000|Overall Study|Lost to Follow-up|17|||
30752275|NCT00161616|58762047|FG001|Overall Study|Lost to Follow-up|13|||
30752276|NCT00161616|58762046|FG000|Overall Study|Protocol deviation|1|||
30819424|NCT01346501|58840207|FG000|Overall Study|Other|8|||
30819425|NCT01346501|58840208|FG001|Overall Study|Other|12|||
30819426|NCT03160885|58840218|FG000|Initial Treatment Period|Not dosed|2|||
30819427|NCT03160885|58840219|FG001|Initial Treatment Period|Not dosed|0|||
30819428|NCT03160885|58840220|FG002|Initial Treatment Period|Not dosed|0|||
30819429|NCT03160885|58840221|FG003|Initial Treatment Period|Not dosed|0|||
30819430|NCT03160885|58840222|FG004|Initial Treatment Period|Not dosed|0|||
30819431|NCT03160885|58840223|FG005|Initial Treatment Period|Not dosed|0|||
30819432|NCT03160885|58840224|FG006|Initial Treatment Period|Not dosed|0|||
30819433|NCT03160885|58840218|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
30819434|NCT03160885|58840219|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
30819435|NCT03160885|58840220|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
30819436|NCT03160885|58840221|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
30819437|NCT03160885|58840222|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
30819438|NCT03160885|58840223|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
30819439|NCT03160885|58840224|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
30819440|NCT03160885|58840218|FG000|Open-label Treatment|Not dosed|0|||
30819441|NCT03160885|58840219|FG001|Open-label Treatment|Not dosed|0|||
30819442|NCT03160885|58840220|FG002|Open-label Treatment|Not dosed|0|||
30819443|NCT03160885|58840221|FG003|Open-label Treatment|Not dosed|0|||
30913120|NCT02172625|58948546|FG001|Overall Study|car accident|1|||
30752277|NCT00161616|58762047|FG001|Overall Study|Protocol deviation|0|||
30752278|NCT00252564|58762055|FG000|Overall Study|Adverse Event|17|||
30752279|NCT00252564|58762056|FG001|Overall Study|Adverse Event|13|||
30752280|NCT00252564|58762055|FG000|Overall Study|Unrelated Complication|2|||
30752281|NCT00252564|58762056|FG001|Overall Study|Unrelated Complication|1|||
30752282|NCT00252564|58762055|FG000|Overall Study|Disease Progression|14|||
30752283|NCT00252564|58762056|FG001|Overall Study|Disease Progression|20|||
30752284|NCT00252564|58762055|FG000|Overall Study|Death|0|||
30752285|NCT00252564|58762056|FG001|Overall Study|Death|3|||
30752286|NCT00252564|58762055|FG000|Overall Study|Physician Decision|1|||
30819444|NCT03160885|58840222|FG004|Open-label Treatment|Not dosed|0|||
30819445|NCT03160885|58840223|FG005|Open-label Treatment|Not dosed|0|||
30819446|NCT03160885|58840224|FG006|Open-label Treatment|Not dosed|2|||
30819447|NCT03160885|58840218|FG000|Open-label Treatment|Discontinued IMP|0|||
30819448|NCT03160885|58840219|FG001|Open-label Treatment|Discontinued IMP|0|||
30819449|NCT03160885|58840220|FG002|Open-label Treatment|Discontinued IMP|0|||
30819450|NCT03160885|58840221|FG003|Open-label Treatment|Discontinued IMP|0|||
30819451|NCT03160885|58840222|FG004|Open-label Treatment|Discontinued IMP|0|||
30819452|NCT03160885|58840223|FG005|Open-label Treatment|Discontinued IMP|0|||
30819453|NCT03160885|58840224|FG006|Open-label Treatment|Discontinued IMP|131|||
30819454|NCT03160885|58840218|FG000|Open-label Treatment|Completed Week 50|0|||
30819455|NCT03160885|58840219|FG001|Open-label Treatment|Completed Week 50|0|||
30819456|NCT03160885|58840220|FG002|Open-label Treatment|Completed Week 50|0|||
30819457|NCT03160885|58840221|FG003|Open-label Treatment|Completed Week 50|0|||
30819458|NCT03160885|58840222|FG004|Open-label Treatment|Completed Week 50|0|||
30819459|NCT03160885|58840223|FG005|Open-label Treatment|Completed Week 50|0|||
30819460|NCT03160885|58840224|FG006|Open-label Treatment|Completed Week 50|4|||
30819461|NCT03160885|58840218|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
30819462|NCT03160885|58840219|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
30819463|NCT03160885|58840220|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
30819464|NCT03160885|58840221|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
30819465|NCT03160885|58840222|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
30819466|NCT03160885|58840223|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
30819467|NCT03160885|58840224|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
30819468|NCT03160885|58840218|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
30819469|NCT03160885|58840219|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
30819470|NCT03160885|58840220|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
30819471|NCT03160885|58840221|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
30819472|NCT03160885|58840222|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
30819473|NCT03160885|58840223|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
30819474|NCT03160885|58840224|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
30819475|NCT03160885|58840218|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
30819476|NCT03160885|58840219|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
30819477|NCT03160885|58840220|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
30819478|NCT03160885|58840221|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
30819479|NCT03160885|58840222|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
30819480|NCT03160885|58840223|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
30819481|NCT03160885|58840224|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
30819482|NCT03160885|58840218|FG000|Maintenance Treatment Period|Completed Week 50|0|||
30819483|NCT03160885|58840219|FG001|Maintenance Treatment Period|Completed Week 50|0|||
30819484|NCT03160885|58840220|FG002|Maintenance Treatment Period|Completed Week 50|1|||
30819485|NCT03160885|58840221|FG003|Maintenance Treatment Period|Completed Week 50|0|||
30819486|NCT03160885|58840222|FG004|Maintenance Treatment Period|Completed Week 50|0|||
30819487|NCT03160885|58840223|FG005|Maintenance Treatment Period|Completed Week 50|0|||
30819488|NCT03160885|58840224|FG006|Maintenance Treatment Period|Completed Week 50|0|||
30819489|NCT03181451|58840244|FG000|Overall Study|Adverse Event|0|||
30819490|NCT03181451|58840245|FG001|Overall Study|Adverse Event|1|||
30819491|NCT03181451|58840246|FG002|Overall Study|Adverse Event|0|||
30819492|NCT03181451|58840244|FG000|Overall Study|Withdrawal by Subject|0|||
30819493|NCT03181451|58840245|FG001|Overall Study|Withdrawal by Subject|1|||
30819494|NCT03181451|58840246|FG002|Overall Study|Withdrawal by Subject|0|||
30819495|NCT00406783|58840258|FG000|Overall Study|Adverse Event|4|||
30819496|NCT00406783|58840259|FG001|Overall Study|Adverse Event|4|||
30819497|NCT00406783|58840258|FG000|Overall Study|Treatment Failure|2|||
30819498|NCT00406783|58840259|FG001|Overall Study|Treatment Failure|3|||
30819499|NCT00406783|58840258|FG000|Overall Study|Lost to Follow-up|3|||
30819500|NCT00406783|58840259|FG001|Overall Study|Lost to Follow-up|0|||
30819501|NCT00406783|58840258|FG000|Overall Study|Withdrawal by Subject|1|||
30819502|NCT00406783|58840259|FG001|Overall Study|Withdrawal by Subject|4|||
30819503|NCT00406783|58840258|FG000|Overall Study|Protocol Violation|4|||
30819504|NCT00406783|58840259|FG001|Overall Study|Protocol Violation|4|||
30819505|NCT03179891|58840265|FG000|First Intervention|Withdrawal by Subject|1|||
30819506|NCT03179891|58840266|FG001|First Intervention|Withdrawal by Subject|1|||
30819507|NCT03179891|58840265|FG000|First Intervention|Unspecified reason|1|||
30819508|NCT03179891|58840266|FG001|First Intervention|Unspecified reason|0|||
30819509|NCT03179891|58840265|FG000|First Intervention|Protocol Violation|0|||
30819510|NCT03179891|58840266|FG001|First Intervention|Protocol Violation|1|||
30819511|NCT02973815|58840277|FG000|Post Intervention|Death|1|||
30819512|NCT02973815|58840278|FG001|Post Intervention|Death|0|||
30819513|NCT02973815|58840277|FG000|Post Intervention|Lost to Follow-up|7|||
30819514|NCT02973815|58840278|FG001|Post Intervention|Lost to Follow-up|24|||
30819515|NCT02973815|58840277|FG000|Follow-up|Lost to Follow-up|2|||
30819516|NCT02973815|58840278|FG001|Follow-up|Lost to Follow-up|0|||
30819517|NCT03160573|58840288|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
30819518|NCT03160573|58840289|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
30819519|NCT03160573|58840290|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
30819520|NCT03160573|58840291|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
30819521|NCT02736227|58840304|FG000|Overall Study|Withdrawal by Subject|0|||
30819522|NCT02736227|58840305|FG001|Overall Study|Withdrawal by Subject|0|||
30819523|NCT02736227|58840306|FG002|Overall Study|Withdrawal by Subject|1|||
30819524|NCT02736227|58840304|FG000|Overall Study|Physician Decision|0|||
30819525|NCT02736227|58840305|FG001|Overall Study|Physician Decision|0|||
30819526|NCT02736227|58840306|FG002|Overall Study|Physician Decision|5|||
30819527|NCT02736227|58840304|FG000|Overall Study|Non Compliant|0|||
30819528|NCT02736227|58840305|FG001|Overall Study|Non Compliant|0|||
30819529|NCT02736227|58840306|FG002|Overall Study|Non Compliant|2|||
30819530|NCT03176459|58840315|FG000|Overall Study|Lost to Follow-up|5|||
30819531|NCT03176459|58840316|FG001|Overall Study|Lost to Follow-up|7|||
30819532|NCT03155269|58840324|FG000|Overall Study|Withdrawal by Subject|4|||
30819533|NCT03155269|58840325|FG001|Overall Study|Withdrawal by Subject|5|||
30819534|NCT03155269|58840324|FG000|Overall Study|Lost to Follow-up|1|||
30819535|NCT03155269|58840325|FG001|Overall Study|Lost to Follow-up|2|||
30819536|NCT02906670|58840341|FG000|Cohort 1, QW|Radiological Progression|1|||
30819537|NCT02906670|58840342|FG001|Cohort 1, QW|Radiological Progression|0|||
30819538|NCT02906670|58840343|FG002|Cohort 1, QW|Radiological Progression|0|||
30819539|NCT02906670|58840344|FG003|Cohort 1, QW|Radiological Progression|0|||
30819540|NCT02906670|58840345|FG004|Cohort 1, QW|Radiological Progression|0|||
30819541|NCT02906670|58840346|FG005|Cohort 1, QW|Radiological Progression|0|||
30819542|NCT02906670|58840347|FG006|Cohort 1, QW|Radiological Progression|0|||
30819543|NCT02906670|58840348|FG007|Cohort 1, QW|Radiological Progression|0|||
30819544|NCT02906670|58840349|FG008|Cohort 1, QW|Radiological Progression|0|||
30819545|NCT02906670|58840350|FG009|Cohort 1, QW|Radiological Progression|0|||
30819546|NCT02906670|58840341|FG000|Cohort 2, QW|Radiological Progression|0|||
30819547|NCT02906670|58840342|FG001|Cohort 2, QW|Radiological Progression|1|||
30819548|NCT02906670|58840343|FG002|Cohort 2, QW|Radiological Progression|0|||
30819549|NCT02906670|58840344|FG003|Cohort 2, QW|Radiological Progression|0|||
30819550|NCT02906670|58840345|FG004|Cohort 2, QW|Radiological Progression|0|||
30819551|NCT02906670|58840346|FG005|Cohort 2, QW|Radiological Progression|0|||
30819552|NCT02906670|58840347|FG006|Cohort 2, QW|Radiological Progression|0|||
30819553|NCT02906670|58840348|FG007|Cohort 2, QW|Radiological Progression|0|||
30819554|NCT02906670|58840349|FG008|Cohort 2, QW|Radiological Progression|0|||
30819555|NCT02906670|58840350|FG009|Cohort 2, QW|Radiological Progression|0|||
30819556|NCT02906670|58840341|FG000|Cohort 3, QW|Radiological Progression|0|||
30819557|NCT02906670|58840342|FG001|Cohort 3, QW|Radiological Progression|0|||
30819558|NCT02906670|58840343|FG002|Cohort 3, QW|Radiological Progression|2|||
30819559|NCT02906670|58840344|FG003|Cohort 3, QW|Radiological Progression|0|||
30819560|NCT02906670|58840345|FG004|Cohort 3, QW|Radiological Progression|0|||
30819561|NCT02906670|58840346|FG005|Cohort 3, QW|Radiological Progression|0|||
30819562|NCT02906670|58840347|FG006|Cohort 3, QW|Radiological Progression|0|||
30913121|NCT02143843|58948556|FG000|Overall Study|Adverse Event|8|||
30913122|NCT02143843|58948556|FG000|Overall Study|Lack of Efficacy|2|||
30913123|NCT02143843|58948556|FG000|Overall Study|Withdrawal by Subject|2|||
30819563|NCT02906670|58840348|FG007|Cohort 3, QW|Radiological Progression|0|||
30819564|NCT02906670|58840349|FG008|Cohort 3, QW|Radiological Progression|0|||
30819565|NCT02906670|58840350|FG009|Cohort 3, QW|Radiological Progression|0|||
30819566|NCT02906670|58840341|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
30819567|NCT02906670|58840342|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
30819568|NCT02906670|58840343|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
30819569|NCT02906670|58840344|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
30819570|NCT02906670|58840345|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
30819571|NCT02906670|58840346|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
30819572|NCT02906670|58840347|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
30819573|NCT02906670|58840348|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
30819574|NCT02906670|58840349|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
30819575|NCT02906670|58840350|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
30819576|NCT02906670|58840341|FG000|Cohort 4, Q2W|Radiological Progression|0|||
30819577|NCT02906670|58840342|FG001|Cohort 4, Q2W|Radiological Progression|0|||
30819578|NCT02906670|58840343|FG002|Cohort 4, Q2W|Radiological Progression|0|||
30819579|NCT02906670|58840344|FG003|Cohort 4, Q2W|Radiological Progression|0|||
30819580|NCT02906670|58840345|FG004|Cohort 4, Q2W|Radiological Progression|0|||
30819581|NCT02906670|58840346|FG005|Cohort 4, Q2W|Radiological Progression|1|||
30819582|NCT02906670|58840347|FG006|Cohort 4, Q2W|Radiological Progression|0|||
30819583|NCT02906670|58840348|FG007|Cohort 4, Q2W|Radiological Progression|0|||
30819584|NCT02906670|58840349|FG008|Cohort 4, Q2W|Radiological Progression|0|||
30819585|NCT02906670|58840350|FG009|Cohort 4, Q2W|Radiological Progression|0|||
30819586|NCT02906670|58840341|FG000|Cohort 4, Q2W|Clinical Progression|0|||
30819587|NCT02906670|58840342|FG001|Cohort 4, Q2W|Clinical Progression|0|||
30819588|NCT02906670|58840343|FG002|Cohort 4, Q2W|Clinical Progression|0|||
30819589|NCT02906670|58840344|FG003|Cohort 4, Q2W|Clinical Progression|0|||
30819590|NCT02906670|58840345|FG004|Cohort 4, Q2W|Clinical Progression|0|||
30819591|NCT02906670|58840346|FG005|Cohort 4, Q2W|Clinical Progression|2|||
30819592|NCT02906670|58840347|FG006|Cohort 4, Q2W|Clinical Progression|0|||
30819593|NCT02906670|58840348|FG007|Cohort 4, Q2W|Clinical Progression|0|||
30819594|NCT02906670|58840349|FG008|Cohort 4, Q2W|Clinical Progression|0|||
30819595|NCT02906670|58840350|FG009|Cohort 4, Q2W|Clinical Progression|0|||
30819596|NCT02906670|58840341|FG000|Cohort 5, Q2W|Radiological Progression|0|||
30819597|NCT02906670|58840342|FG001|Cohort 5, Q2W|Radiological Progression|0|||
30819598|NCT02906670|58840343|FG002|Cohort 5, Q2W|Radiological Progression|0|||
30819599|NCT02906670|58840344|FG003|Cohort 5, Q2W|Radiological Progression|0|||
30819600|NCT02906670|58840345|FG004|Cohort 5, Q2W|Radiological Progression|0|||
30819601|NCT02906670|58840346|FG005|Cohort 5, Q2W|Radiological Progression|0|||
30819602|NCT02906670|58840347|FG006|Cohort 5, Q2W|Radiological Progression|4|||
30819603|NCT02906670|58840348|FG007|Cohort 5, Q2W|Radiological Progression|0|||
30819604|NCT02906670|58840349|FG008|Cohort 5, Q2W|Radiological Progression|0|||
30819605|NCT02906670|58840350|FG009|Cohort 5, Q2W|Radiological Progression|0|||
30819606|NCT02906670|58840341|FG000|Cohort 5, Q2W|Clinical Progression|0|||
30819607|NCT02906670|58840342|FG001|Cohort 5, Q2W|Clinical Progression|0|||
30819608|NCT02906670|58840343|FG002|Cohort 5, Q2W|Clinical Progression|0|||
30819609|NCT02906670|58840344|FG003|Cohort 5, Q2W|Clinical Progression|0|||
30819610|NCT02906670|58840345|FG004|Cohort 5, Q2W|Clinical Progression|0|||
30819611|NCT02906670|58840346|FG005|Cohort 5, Q2W|Clinical Progression|0|||
30819612|NCT02906670|58840347|FG006|Cohort 5, Q2W|Clinical Progression|1|||
30819613|NCT02906670|58840348|FG007|Cohort 5, Q2W|Clinical Progression|0|||
30819614|NCT02906670|58840349|FG008|Cohort 5, Q2W|Clinical Progression|0|||
30819615|NCT02906670|58840350|FG009|Cohort 5, Q2W|Clinical Progression|0|||
30819616|NCT02906670|58840341|FG000|Cohort 5, Q2W|Adverse Event|0|||
30819617|NCT02906670|58840342|FG001|Cohort 5, Q2W|Adverse Event|0|||
30819618|NCT02906670|58840343|FG002|Cohort 5, Q2W|Adverse Event|0|||
30819619|NCT02906670|58840344|FG003|Cohort 5, Q2W|Adverse Event|0|||
30819620|NCT02906670|58840345|FG004|Cohort 5, Q2W|Adverse Event|0|||
30819621|NCT02906670|58840346|FG005|Cohort 5, Q2W|Adverse Event|0|||
30819622|NCT02906670|58840347|FG006|Cohort 5, Q2W|Adverse Event|1|||
30819623|NCT02906670|58840348|FG007|Cohort 5, Q2W|Adverse Event|0|||
30819624|NCT02906670|58840349|FG008|Cohort 5, Q2W|Adverse Event|0|||
30819625|NCT02906670|58840350|FG009|Cohort 5, Q2W|Adverse Event|0|||
30819626|NCT02906670|58840341|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
30819627|NCT02906670|58840342|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
30819628|NCT02906670|58840343|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
30819629|NCT02906670|58840344|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
30819630|NCT02906670|58840345|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
30819631|NCT02906670|58840346|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
30819632|NCT02906670|58840347|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
30819633|NCT02906670|58840348|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
30819634|NCT02906670|58840349|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
30819635|NCT02906670|58840350|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
30819636|NCT02906670|58840341|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
30819637|NCT02906670|58840342|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
30819638|NCT02906670|58840343|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
30819639|NCT02906670|58840344|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
30819640|NCT02906670|58840345|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
30819641|NCT02906670|58840346|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
30819642|NCT02906670|58840347|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
30819643|NCT02906670|58840348|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
30819644|NCT02906670|58840349|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
30819645|NCT02906670|58840350|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
30819646|NCT02906670|58840341|FG000|Cohort 5P, Q2W|Adverse Event|0|||
30819647|NCT02906670|58840342|FG001|Cohort 5P, Q2W|Adverse Event|0|||
30819648|NCT02906670|58840343|FG002|Cohort 5P, Q2W|Adverse Event|0|||
30819649|NCT02906670|58840344|FG003|Cohort 5P, Q2W|Adverse Event|0|||
30819650|NCT02906670|58840345|FG004|Cohort 5P, Q2W|Adverse Event|0|||
30819651|NCT02906670|58840346|FG005|Cohort 5P, Q2W|Adverse Event|0|||
30819652|NCT02906670|58840347|FG006|Cohort 5P, Q2W|Adverse Event|0|||
30819653|NCT02906670|58840348|FG007|Cohort 5P, Q2W|Adverse Event|1|||
30819654|NCT02906670|58840349|FG008|Cohort 5P, Q2W|Adverse Event|0|||
30819655|NCT02906670|58840350|FG009|Cohort 5P, Q2W|Adverse Event|0|||
30819656|NCT02906670|58840341|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
30819657|NCT02906670|58840342|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
30819658|NCT02906670|58840343|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
30819659|NCT02906670|58840344|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
30819660|NCT02906670|58840345|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
30819661|NCT02906670|58840346|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
30819662|NCT02906670|58840347|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
30819663|NCT02906670|58840348|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
30819664|NCT02906670|58840349|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
30819665|NCT02906670|58840350|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
30819666|NCT02906670|58840341|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
30819667|NCT02906670|58840342|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
30819668|NCT02906670|58840343|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
30819669|NCT02906670|58840344|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
30819670|NCT02906670|58840345|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
30819671|NCT02906670|58840346|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
30819672|NCT02906670|58840347|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
30819673|NCT02906670|58840348|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
30819674|NCT02906670|58840349|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
30819675|NCT02906670|58840350|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
30819676|NCT02906670|58840341|FG000|Cohort 4P, QW|Radiological Progression|0|||
30819677|NCT02906670|58840342|FG001|Cohort 4P, QW|Radiological Progression|0|||
30819678|NCT02906670|58840343|FG002|Cohort 4P, QW|Radiological Progression|0|||
30819679|NCT02906670|58840344|FG003|Cohort 4P, QW|Radiological Progression|3|||
30819680|NCT02906670|58840345|FG004|Cohort 4P, QW|Radiological Progression|0|||
30819681|NCT02906670|58840346|FG005|Cohort 4P, QW|Radiological Progression|0|||
30819682|NCT02906670|58840347|FG006|Cohort 4P, QW|Radiological Progression|0|||
30819683|NCT02906670|58840348|FG007|Cohort 4P, QW|Radiological Progression|0|||
30819684|NCT02906670|58840349|FG008|Cohort 4P, QW|Radiological Progression|0|||
30819685|NCT02906670|58840350|FG009|Cohort 4P, QW|Radiological Progression|0|||
30819686|NCT02906670|58840341|FG000|Cohort 7P, Q2W|Adverse Event|0|||
30819687|NCT02906670|58840342|FG001|Cohort 7P, Q2W|Adverse Event|0|||
30819688|NCT02906670|58840343|FG002|Cohort 7P, Q2W|Adverse Event|0|||
30819689|NCT02906670|58840344|FG003|Cohort 7P, Q2W|Adverse Event|0|||
30819690|NCT02906670|58840345|FG004|Cohort 7P, Q2W|Adverse Event|0|||
30819691|NCT02906670|58840346|FG005|Cohort 7P, Q2W|Adverse Event|0|||
30819692|NCT02906670|58840347|FG006|Cohort 7P, Q2W|Adverse Event|0|||
30819693|NCT02906670|58840348|FG007|Cohort 7P, Q2W|Adverse Event|0|||
30819694|NCT02906670|58840349|FG008|Cohort 7P, Q2W|Adverse Event|0|||
30819695|NCT02906670|58840350|FG009|Cohort 7P, Q2W|Adverse Event|1|||
30819696|NCT02906670|58840341|FG000|Cohort 7P, Q2W|Physician Decision|0|||
30819697|NCT02906670|58840342|FG001|Cohort 7P, Q2W|Physician Decision|0|||
30819698|NCT02906670|58840343|FG002|Cohort 7P, Q2W|Physician Decision|0|||
30819699|NCT02906670|58840344|FG003|Cohort 7P, Q2W|Physician Decision|0|||
30819700|NCT02906670|58840345|FG004|Cohort 7P, Q2W|Physician Decision|0|||
30819701|NCT02906670|58840346|FG005|Cohort 7P, Q2W|Physician Decision|0|||
30819702|NCT02906670|58840347|FG006|Cohort 7P, Q2W|Physician Decision|0|||
30819703|NCT02906670|58840348|FG007|Cohort 7P, Q2W|Physician Decision|0|||
30819704|NCT02906670|58840349|FG008|Cohort 7P, Q2W|Physician Decision|0|||
30819705|NCT02906670|58840350|FG009|Cohort 7P, Q2W|Physician Decision|1|||
30819706|NCT02906670|58840341|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
30819707|NCT02906670|58840342|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
30819708|NCT02906670|58840343|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
30819709|NCT02906670|58840344|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
30819710|NCT02906670|58840345|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
30819711|NCT02906670|58840346|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
30819712|NCT02906670|58840347|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
30819713|NCT02906670|58840348|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
30819714|NCT02906670|58840349|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
30819715|NCT02906670|58840350|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
30819716|NCT02906670|58840341|FG000|Cohort 5P, QW|Radiological Progression|0|||
30819717|NCT02906670|58840342|FG001|Cohort 5P, QW|Radiological Progression|0|||
30819718|NCT02906670|58840343|FG002|Cohort 5P, QW|Radiological Progression|0|||
30913124|NCT02121535|58948562|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
30819719|NCT02906670|58840344|FG003|Cohort 5P, QW|Radiological Progression|0|||
30819720|NCT02906670|58840345|FG004|Cohort 5P, QW|Radiological Progression|3|||
30819721|NCT02906670|58840346|FG005|Cohort 5P, QW|Radiological Progression|0|||
30819722|NCT02906670|58840347|FG006|Cohort 5P, QW|Radiological Progression|0|||
30913125|NCT02121535|58948563|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
30819723|NCT02906670|58840348|FG007|Cohort 5P, QW|Radiological Progression|0|||
30819724|NCT02906670|58840349|FG008|Cohort 5P, QW|Radiological Progression|0|||
30913126|NCT02121535|58948562|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
30913127|NCT02121535|58948563|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
30913128|NCT01586338|58948570|FG000|Overall Study|Adverse Event|3|||
30913129|NCT01586338|58948570|FG000|Overall Study|Lost to Follow-up|1|||
30913130|NCT01586338|58948570|FG000|Overall Study|Withdrawal by participant|3|||
30913131|NCT01586338|58948570|FG000|Overall Study|Other|1|||
30819725|NCT02906670|58840350|FG009|Cohort 5P, QW|Radiological Progression|0|||
30819726|NCT02906358|58840402|FG000|Overall Study|Withdrawal by Subject|10|||
30819727|NCT02906358|58840403|FG001|Overall Study|Withdrawal by Subject|7|||
30819728|NCT02906358|58840402|FG000|Overall Study|Lost to Follow-up|12|||
30819729|NCT02906358|58840403|FG001|Overall Study|Lost to Follow-up|15|||
30819730|NCT02186834|58840409|FG000|Dose Escalation|Death|0|||
30819731|NCT02186834|58840410|FG001|Dose Escalation|Death|0|||
30819732|NCT02186834|58840411|FG002|Dose Escalation|Death|0|||
30819733|NCT02186834|58840412|FG003|Dose Escalation|Death|1|||
30819734|NCT02186834|58840413|FG004|Dose Escalation|Death|0|||
30819735|NCT02186834|58840414|FG005|Dose Escalation|Death|0|||
30819736|NCT02186834|58840409|FG000|Treatment at RP2D|Died prior to treatment|0|||
30819737|NCT02186834|58840410|FG001|Treatment at RP2D|Died prior to treatment|0|||
30819738|NCT02186834|58840411|FG002|Treatment at RP2D|Died prior to treatment|0|||
30913132|NCT02143141|58948576|FG000|Overall Study|pain scores at 24 hours not collected|1|||
30752287|NCT00252564|58762056|FG001|Overall Study|Physician Decision|0|||
30752288|NCT00252564|58762055|FG000|Overall Study|Lost to Follow-up|1|||
30752289|NCT00252564|58762056|FG001|Overall Study|Lost to Follow-up|0|||
30752290|NCT00252564|58762055|FG000|Overall Study|Patient Request|4|||
30752291|NCT00252564|58762056|FG001|Overall Study|Patient Request|5|||
30752292|NCT00252564|58762055|FG000|Overall Study|Withdrawal by Subject|0|||
30752293|NCT00252564|58762056|FG001|Overall Study|Withdrawal by Subject|2|||
30752294|NCT00166296|58762064|FG000|Overall Study|Withdrawal by Subject|1|||
30752295|NCT00166296|58762065|FG001|Overall Study|Withdrawal by Subject|3|||
30752296|NCT00166296|58762064|FG000|Overall Study|Adverse Event|2|||
30752297|NCT00166296|58762065|FG001|Overall Study|Adverse Event|4|||
30752298|NCT00166296|58762064|FG000|Overall Study|Lost to Follow-up|4|||
30752299|NCT00166296|58762065|FG001|Overall Study|Lost to Follow-up|2|||
30752300|NCT00252174|58762074|FG000|Overall Study|Withdrawal by Subject|0|||
30752301|NCT00252174|58762075|FG001|Overall Study|Withdrawal by Subject|1|||
30752302|NCT00252174|58762076|FG002|Overall Study|Withdrawal by Subject|0|||
30752303|NCT00165984|58762084|FG000|Overall Study|Death|15|||
30752312|NCT00160524|58762100|FG000|Overall Study|Adverse Event|119|||
30752313|NCT00160524|58762100|FG000|Overall Study|Adverse Event and Other|94|||
30819739|NCT02186834|58840412|FG003|Treatment at RP2D|Died prior to treatment|0|||
30819740|NCT02186834|58840413|FG004|Treatment at RP2D|Died prior to treatment|0|||
30913133|NCT02143141|58948577|FG001|Overall Study|pain scores at 24 hours not collected|0|||
30819741|NCT02186834|58840414|FG005|Treatment at RP2D|Died prior to treatment|1|||
30819742|NCT03144687|58840425|FG000|Overall Study|Death|0|||
30819743|NCT03144687|58840426|FG001|Overall Study|Death|2|||
30819744|NCT03144687|58840425|FG000|Overall Study|Lost to Follow-up|0|||
30819745|NCT03144687|58840426|FG001|Overall Study|Lost to Follow-up|1|||
30819746|NCT03144687|58840425|FG000|Overall Study|Physician Decision|0|||
30819747|NCT03144687|58840426|FG001|Overall Study|Physician Decision|1|||
30819748|NCT03144687|58840425|FG000|Overall Study|Withdrawal by Subject|1|||
30819749|NCT03144687|58840426|FG001|Overall Study|Withdrawal by Subject|3|||
30819750|NCT03144687|58840425|FG000|Overall Study|Not Reported|2|||
30819751|NCT03144687|58840426|FG001|Overall Study|Not Reported|0|||
30819752|NCT03080961|58840436|FG000|Overall Study|Withdrawal by Subject|3|||
30819753|NCT02905266|58840460|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
30819754|NCT02905266|58840461|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
30819755|NCT02905266|58840460|FG000|Treatment Phase Part 1|Disease Progression|6|||
30819756|NCT02905266|58840461|FG001|Treatment Phase Part 1|Disease Progression|7|||
30819757|NCT02905266|58840460|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
30819758|NCT02905266|58840461|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
30819759|NCT02905266|58840460|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
30819760|NCT02905266|58840461|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
30819761|NCT02905266|58840460|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
30819762|NCT02905266|58840461|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
30819763|NCT02905266|58840460|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
30819764|NCT02905266|58840461|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
30819765|NCT02905266|58840460|FG000|Transition From Part 1 to Part 2|Death|0|||
30819766|NCT02905266|58840461|FG001|Transition From Part 1 to Part 2|Death|1|||
30819767|NCT02905266|58840460|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
30819768|NCT02905266|58840461|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
30819769|NCT02905266|58840460|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
30819770|NCT02905266|58840461|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
30913134|NCT02171065|58948586|FG000|Overall Study|Withdrawal by Subject|1|||
30819771|NCT02905266|58840460|FG000|Maintenance Phase Part 2|Disease Progression|9|||
30819772|NCT02905266|58840461|FG001|Maintenance Phase Part 2|Disease Progression|2|||
30819773|NCT02905266|58840460|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
30819774|NCT02905266|58840461|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
30819775|NCT02905266|58840460|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
30819776|NCT02905266|58840461|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
30819777|NCT02982018|58840469|FG000|Overall Study|Incorrect Lens Dispensed|1|||
30819778|NCT02982018|58840470|FG001|Overall Study|Incorrect Lens Dispensed|0|||
30819779|NCT02982018|58840469|FG000|Overall Study|Protocol Violation|1|||
30819780|NCT02982018|58840470|FG001|Overall Study|Protocol Violation|1|||
30819781|NCT02982018|58840469|FG000|Overall Study|Adverse Event|1|||
30819782|NCT02982018|58840470|FG001|Overall Study|Adverse Event|1|||
30819783|NCT02982018|58840469|FG000|Overall Study|Lens Discomfort|2|||
30819784|NCT02982018|58840470|FG001|Overall Study|Lens Discomfort|0|||
30819785|NCT02982018|58840469|FG000|Overall Study|Withdrawal by Subject|0|||
30819786|NCT02982018|58840470|FG001|Overall Study|Withdrawal by Subject|1|||
30819787|NCT03080493|58840478|FG000|Overall Study|Did not provide NRS pain results|1|||
30819788|NCT03080493|58840479|FG001|Overall Study|Did not provide NRS pain results|0|||
30752314|NCT00160524|58762100|FG000|Overall Study|Protocol Violation|16|||
30752315|NCT00160524|58762100|FG000|Overall Study|Protocol Violation and Other|2|||
30752316|NCT00160524|58762100|FG000|Overall Study|Withdrawal by Subject|141|||
30752317|NCT00160524|58762100|FG000|Overall Study|Withdrawal by Subject and Other|17|||
30752318|NCT00160524|58762100|FG000|Overall Study|Physician Decision|27|||
30752319|NCT00160524|58762100|FG000|Overall Study|Physician Decision and Other|6|||
30752320|NCT00160524|58762100|FG000|Overall Study|Lost to Follow-up|13|||
30752321|NCT00160524|58762100|FG000|Overall Study|Lost to Follow-up and Other|1|||
30752322|NCT00160524|58762100|FG000|Overall Study|Lack of Efficacy|21|||
30819789|NCT03080493|58840478|FG000|Overall Study|Adverse Event|0|||
30819790|NCT03080493|58840479|FG001|Overall Study|Adverse Event|1|||
30819791|NCT03080493|58840478|FG000|Overall Study|Randomization error (parity group)|0|||
30819792|NCT03080493|58840479|FG001|Overall Study|Randomization error (parity group)|1|||
30819793|NCT01339910|58840487|FG000|Overall Study|Withdrawal by Subject|1|||
30819794|NCT01339910|58840488|FG001|Overall Study|Withdrawal by Subject|0|||
30819795|NCT01339910|58840487|FG000|Overall Study|Physician Decision|1|||
30819796|NCT01339910|58840488|FG001|Overall Study|Physician Decision|0|||
30819797|NCT01339910|58840487|FG000|Overall Study|Disease relapse|1|||
30819798|NCT01339910|58840488|FG001|Overall Study|Disease relapse|4|||
30819799|NCT02981082|58840496|FG000|Overall Study|Withdrawal by Subject|2|||
30819800|NCT02981082|58840497|FG001|Overall Study|Withdrawal by Subject|0|||
30819801|NCT02981082|58840496|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
30819802|NCT02981082|58840497|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
30819803|NCT02981082|58840496|FG000|Overall Study|Adverse Event|0|||
30819804|NCT02981082|58840497|FG001|Overall Study|Adverse Event|1|||
30819805|NCT01066104|58840505|FG000|Overall Study|Adverse Event|1|||
30819806|NCT01066104|58840506|FG001|Overall Study|Adverse Event|1|||
30819807|NCT01066104|58840505|FG000|Overall Study|Protocol Violation|1|||
30819808|NCT01066104|58840506|FG001|Overall Study|Protocol Violation|0|||
30819809|NCT02736968|58840517|FG000|Overall Study|Lost to Follow-up|0|||
30819810|NCT02736968|58840518|FG001|Overall Study|Lost to Follow-up|0|||
30819811|NCT02736968|58840519|FG002|Overall Study|Lost to Follow-up|0|||
30819812|NCT02736968|58840520|FG003|Overall Study|Lost to Follow-up|0|||
30819813|NCT02736968|58840521|FG004|Overall Study|Lost to Follow-up|0|||
30819814|NCT02736968|58840522|FG005|Overall Study|Lost to Follow-up|0|||
30819815|NCT02736968|58840523|FG006|Overall Study|Lost to Follow-up|5|||
30819816|NCT02736968|58840524|FG007|Overall Study|Lost to Follow-up|2|||
30819817|NCT02736968|58840517|FG000|Overall Study|COVID-19 Pandemic|0|||
30819818|NCT02736968|58840518|FG001|Overall Study|COVID-19 Pandemic|0|||
30819819|NCT02736968|58840519|FG002|Overall Study|COVID-19 Pandemic|0|||
30819820|NCT02736968|58840520|FG003|Overall Study|COVID-19 Pandemic|0|||
30819821|NCT02736968|58840521|FG004|Overall Study|COVID-19 Pandemic|0|||
30819822|NCT02736968|58840522|FG005|Overall Study|COVID-19 Pandemic|0|||
30819823|NCT02736968|58840523|FG006|Overall Study|COVID-19 Pandemic|2|||
30819824|NCT02736968|58840524|FG007|Overall Study|COVID-19 Pandemic|0|||
30819825|NCT02736968|58840517|FG000|Overall Study|Withdrawal by Subject|0|||
30819826|NCT02736968|58840518|FG001|Overall Study|Withdrawal by Subject|0|||
30819827|NCT02736968|58840519|FG002|Overall Study|Withdrawal by Subject|0|||
30913135|NCT02171065|58948587|FG001|Overall Study|Withdrawal by Subject|0|||
30819828|NCT02736968|58840520|FG003|Overall Study|Withdrawal by Subject|0|||
30819829|NCT02736968|58840521|FG004|Overall Study|Withdrawal by Subject|0|||
30819830|NCT02736968|58840522|FG005|Overall Study|Withdrawal by Subject|0|||
30819831|NCT02736968|58840523|FG006|Overall Study|Withdrawal by Subject|1|||
30819832|NCT02736968|58840524|FG007|Overall Study|Withdrawal by Subject|0|||
30819833|NCT02980224|58840537|FG000|Overall Study|Adverse Event|4|||
30913136|NCT02171065|58948588|FG002|Overall Study|Withdrawal by Subject|0|||
30819834|NCT02980224|58840538|FG001|Overall Study|Adverse Event|1|||
30819835|NCT02980224|58840537|FG000|Overall Study|Withdrawal by Subject|0|||
30819836|NCT02980224|58840538|FG001|Overall Study|Withdrawal by Subject|2|||
30819837|NCT02591615|58840548|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
30819838|NCT02591615|58840549|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
30913137|NCT02171065|58948586|FG000|Overall Study|Lost to Follow-up|0|||
30819839|NCT02591615|58840550|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
30819840|NCT02591615|58840551|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
30819841|NCT02591615|58840548|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
30819842|NCT02591615|58840549|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
30913138|NCT02171065|58948587|FG001|Overall Study|Lost to Follow-up|0|||
30913139|NCT02171065|58948588|FG002|Overall Study|Lost to Follow-up|1|||
30819843|NCT02591615|58840550|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
30819844|NCT02591615|58840551|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
30913140|NCT01566604|58948600|FG000|Overall Study|Patient's inability to use the device|1|||
30752323|NCT00160524|58762100|FG000|Overall Study|Lack of Efficacy and Other|1|||
30752324|NCT00160524|58762100|FG000|Overall Study|Other|20|||
30819845|NCT02591615|58840548|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
30819846|NCT02591615|58840549|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
30819847|NCT02591615|58840550|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
30819848|NCT02591615|58840551|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
30819849|NCT02591615|58840548|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
30819850|NCT02591615|58840549|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
30752325|NCT00159822|58762104|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
30752326|NCT00159822|58762104|FG000|Voriconazole Treatment Period|Adverse Event|9|||
30752327|NCT00159822|58762104|FG000|Voriconazole Treatment Period|Death|4|||
30752328|NCT00159822|58762104|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
30752329|NCT00159822|58762104|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
30752330|NCT00159822|58762104|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
30752331|NCT00159822|58762104|FG000|Post-treatment Follow-up Period|Death|1|||
30752332|NCT00159822|58762104|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
30752333|NCT00159822|58762104|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
30752334|NCT00158262|58762110|FG000|Overall Study|Lost to Follow-up|1|||
30752335|NCT00158262|58762111|FG001|Overall Study|Lost to Follow-up|1|||
30752336|NCT00157950|58762119|FG000|Overall Study|Death|1|||
30752337|NCT00157950|58762120|FG001|Overall Study|Death|0|||
30752338|NCT03745768|58762128|FG000|Overall Study|discontinued study|2|||
30752339|NCT03745768|58762129|FG001|Overall Study|discontinued study|0|||
30752340|NCT03745222|58762138|FG000|Overall Study|Withdrawal by Subject|0|||
30752341|NCT03745222|58762139|FG001|Overall Study|Withdrawal by Subject|1|||
30819851|NCT02591615|58840550|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
30819852|NCT02591615|58840551|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
30819853|NCT02591615|58840548|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
30913141|NCT01566604|58948601|FG001|Overall Study|Patient's inability to use the device|0|||
30913142|NCT01566604|58948600|FG000|Overall Study|Administrative problems|1|||
30913143|NCT01566604|58948601|FG001|Overall Study|Administrative problems|0|||
30913144|NCT01566604|58948600|FG000|Overall Study|Lack of Efficacy|1|||
30913145|NCT01566604|58948601|FG001|Overall Study|Lack of Efficacy|2|||
30819854|NCT02591615|58840549|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
30819855|NCT02591615|58840550|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
30819856|NCT02591615|58840551|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
30819857|NCT02591615|58840548|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
30913146|NCT01566604|58948600|FG000|Overall Study|Protocol deviation|2|||
30819858|NCT02591615|58840549|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
30819859|NCT02591615|58840550|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
30819860|NCT02591615|58840551|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
30819861|NCT02591615|58840548|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
30819862|NCT02591615|58840549|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
30819863|NCT02591615|58840550|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
30819864|NCT02591615|58840551|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
30913147|NCT01566604|58948601|FG001|Overall Study|Protocol deviation|0|||
30913148|NCT01566604|58948600|FG000|Overall Study|Abnormal laboratory value|2|||
30913149|NCT01566604|58948601|FG001|Overall Study|Abnormal laboratory value|0|||
30913150|NCT01566604|58948600|FG000|Overall Study|Death|4|||
30913151|NCT01566604|58948601|FG001|Overall Study|Death|1|||
30913152|NCT01566604|58948600|FG000|Overall Study|Adverse Event|4|||
30913153|NCT01566604|58948601|FG001|Overall Study|Adverse Event|2|||
30913154|NCT01566604|58948600|FG000|Overall Study|Withdrawal by Subject|9|||
30913155|NCT01566604|58948601|FG001|Overall Study|Withdrawal by Subject|6|||
30913156|NCT01684930|58948609|FG000|Overall Study|Withdrawal by Subject|3|||
30913157|NCT01684930|58948610|FG001|Overall Study|Withdrawal by Subject|1|||
30752342|NCT03745222|58762140|FG002|Overall Study|Withdrawal by Subject|0|||
30752343|NCT03743038|58762148|FG000|Overall Study|Physician Decision|1|||
30819865|NCT02591615|58840548|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
30819866|NCT02591615|58840549|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
30913158|NCT01566214|58948618|FG000|Overall Study|Lost to Follow-up|3|||
30913159|NCT01566214|58948619|FG001|Overall Study|Lost to Follow-up|0|||
30752344|NCT00153816|58762160|FG000|Overall Study|Death|6|||
30819867|NCT02591615|58840550|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
30819868|NCT02591615|58840551|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
30913160|NCT02253992|58948628|FG000|Overall Study|Study drug toxicity|1|||
30913161|NCT02253992|58948629|FG001|Overall Study|Study drug toxicity|0|||
30913162|NCT02253992|58948630|FG002|Overall Study|Study drug toxicity|10|||
30913163|NCT02253992|58948628|FG000|Overall Study|Disease progression|4|||
30752345|NCT00153816|58762161|FG001|Overall Study|Death|5|||
30913164|NCT02253992|58948629|FG001|Overall Study|Disease progression|3|||
30913165|NCT02253992|58948630|FG002|Overall Study|Disease progression|98|||
30819869|NCT02591615|58840548|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
30819870|NCT02591615|58840549|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
30819871|NCT02591615|58840550|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
30819872|NCT02591615|58840551|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
30819873|NCT02591615|58840548|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
30819874|NCT02591615|58840549|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
30819875|NCT02591615|58840550|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
30819876|NCT02591615|58840551|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
30819877|NCT02591615|58840548|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
30819878|NCT02591615|58840549|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
30819879|NCT02591615|58840550|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
30819880|NCT02591615|58840551|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
30819881|NCT02591615|58840548|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
30819882|NCT02591615|58840549|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
30819883|NCT02591615|58840550|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
30819884|NCT02591615|58840551|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
30819885|NCT02591615|58840548|FG000|Maintenance MK-3475|Adverse Event|0|||
30819886|NCT02591615|58840549|FG001|Maintenance MK-3475|Adverse Event|3|||
30819887|NCT02591615|58840550|FG002|Maintenance MK-3475|Adverse Event|1|||
30819888|NCT02591615|58840551|FG003|Maintenance MK-3475|Adverse Event|2|||
30819889|NCT02591615|58840548|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
30819890|NCT02591615|58840549|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
30819891|NCT02591615|58840550|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
30819892|NCT02591615|58840551|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
30819893|NCT02591615|58840548|FG000|Maintenance MK-3475|Death|0|||
30819894|NCT02591615|58840549|FG001|Maintenance MK-3475|Death|1|||
30819895|NCT02591615|58840550|FG002|Maintenance MK-3475|Death|1|||
30819896|NCT02591615|58840551|FG003|Maintenance MK-3475|Death|0|||
30819897|NCT02591615|58840548|FG000|Maintenance MK-3475|Physician discretion|0|||
30752346|NCT00153816|58762162|FG002|Overall Study|Death|4|||
30752347|NCT00153816|58762163|FG003|Overall Study|Death|6|||
30752348|NCT00153816|58762164|FG004|Overall Study|Death|0|||
30752349|NCT00153816|58762165|FG005|Overall Study|Death|2|||
30752350|NCT00153816|58762160|FG000|Overall Study|Lost to Follow-up|7|||
30752351|NCT00153816|58762161|FG001|Overall Study|Lost to Follow-up|8|||
30752352|NCT00153816|58762162|FG002|Overall Study|Lost to Follow-up|5|||
30752353|NCT00153816|58762163|FG003|Overall Study|Lost to Follow-up|8|||
30752354|NCT00153816|58762164|FG004|Overall Study|Lost to Follow-up|7|||
30752355|NCT00153816|58762165|FG005|Overall Study|Lost to Follow-up|9|||
30752356|NCT00153816|58762160|FG000|Overall Study|Withdrawal by Subject|9|||
30752357|NCT00153816|58762161|FG001|Overall Study|Withdrawal by Subject|9|||
30752358|NCT00153816|58762162|FG002|Overall Study|Withdrawal by Subject|9|||
30752359|NCT00153816|58762163|FG003|Overall Study|Withdrawal by Subject|4|||
30752360|NCT00153816|58762164|FG004|Overall Study|Withdrawal by Subject|1|||
30752361|NCT00153816|58762165|FG005|Overall Study|Withdrawal by Subject|5|||
30819898|NCT02591615|58840549|FG001|Maintenance MK-3475|Physician discretion|0|||
30819899|NCT02591615|58840550|FG002|Maintenance MK-3475|Physician discretion|1|||
30819900|NCT02591615|58840551|FG003|Maintenance MK-3475|Physician discretion|0|||
30819901|NCT02591615|58840548|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
30819902|NCT02591615|58840549|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
30819903|NCT02591615|58840550|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
30819904|NCT02591615|58840551|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
30819905|NCT02591615|58840548|FG000|Maintenance MK-3475|In active treatment|2|||
30819906|NCT02591615|58840549|FG001|Maintenance MK-3475|In active treatment|0|||
30819907|NCT02591615|58840550|FG002|Maintenance MK-3475|In active treatment|0|||
30819908|NCT02591615|58840551|FG003|Maintenance MK-3475|In active treatment|1|||
30819909|NCT03077607|58840566|FG000|Period 1 (15 Days)|Adverse Event|1|||
30752362|NCT00153816|58762160|FG000|Overall Study|Follow-up exam not done|8|||
30752363|NCT00153816|58762161|FG001|Overall Study|Follow-up exam not done|7|||
30752364|NCT00153816|58762162|FG002|Overall Study|Follow-up exam not done|11|||
30752365|NCT00153816|58762163|FG003|Overall Study|Follow-up exam not done|10|||
30752366|NCT00153816|58762164|FG004|Overall Study|Follow-up exam not done|8|||
30752367|NCT00153816|58762165|FG005|Overall Study|Follow-up exam not done|9|||
30752368|NCT00153816|58762160|FG000|Overall Study|Follow-up exam done, histology missing|2|||
30752369|NCT00153816|58762161|FG001|Overall Study|Follow-up exam done, histology missing|3|||
30752370|NCT00153816|58762162|FG002|Overall Study|Follow-up exam done, histology missing|3|||
30752371|NCT00153816|58762163|FG003|Overall Study|Follow-up exam done, histology missing|3|||
30819910|NCT03077607|58840567|FG001|Period 1 (15 Days)|Adverse Event|0|||
30819911|NCT03077607|58840566|FG000|Period 1 (15 Days)|Death|1|||
30819912|NCT03077607|58840567|FG001|Period 1 (15 Days)|Death|0|||
30819913|NCT03077607|58840566|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
30819914|NCT03077607|58840567|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
30819915|NCT03077607|58840566|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
30819916|NCT03077607|58840567|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
30819917|NCT02977572|58840586|FG000|Overall Study|Exclusion criterion|2|||
30819918|NCT02977572|58840587|FG001|Overall Study|Exclusion criterion|2|||
30819919|NCT02746874|58840599|FG000|Overall Study|Withdrawal by Subject|0|||
30819920|NCT02746874|58840600|FG001|Overall Study|Withdrawal by Subject|1|||
30819921|NCT02746874|58840599|FG000|Overall Study|Surgery Date Changed|0|||
30819922|NCT02746874|58840600|FG001|Overall Study|Surgery Date Changed|2|||
30819923|NCT03217175|58840606|FG000|Overall Study|Physician Decision|4|||
30819924|NCT03217175|58840607|FG001|Overall Study|Physician Decision|1|||
30819925|NCT01062126|58840613|FG000|Overall Study|Death|209|||
30819926|NCT01062126|58840613|FG000|Overall Study|All Withdrawals|324|||
30819927|NCT02522429|58840617|FG000|Overall Study|Lost to Follow-up|8|||
30819928|NCT02522429|58840617|FG000|Overall Study|Adverse Event|2|||
30819929|NCT02522429|58840617|FG000|Overall Study|Death|1|||
30819930|NCT02522429|58840617|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
30819931|NCT02974140|58840621|FG000|Overall Study|Adverse Event|2|||
30819932|NCT02974140|58840621|FG000|Overall Study|Lost to Follow-up|1|||
30819933|NCT02974140|58840621|FG000|Overall Study|Study Terminated by Sponsor|36|||
30752372|NCT00153816|58762164|FG004|Overall Study|Follow-up exam done, histology missing|1|||
30752373|NCT00153816|58762165|FG005|Overall Study|Follow-up exam done, histology missing|2|||
30752374|NCT00151476|58762182|FG000|FAP Identified Subjects|Protocol Violation|0|||
30752375|NCT00151476|58762183|FG001|FAP Identified Subjects|Protocol Violation|1|||
30752376|NCT00151476|58762182|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
30819934|NCT02974842|58840628|FG000|Overall Study|Withdrawal by Subject|4|||
30819935|NCT02974842|58840628|FG000|Overall Study|Screen failures|4|||
30819936|NCT03172481|58840634|FG000|Double-blind|Withdrawal by Subject|1|||
30819937|NCT03172481|58840635|FG001|Double-blind|Withdrawal by Subject|0|||
30913166|NCT02253992|58948628|FG000|Overall Study|Withdrawal by Subject|0|||
30913167|NCT02253992|58948629|FG001|Overall Study|Withdrawal by Subject|0|||
30913168|NCT02253992|58948630|FG002|Overall Study|Withdrawal by Subject|3|||
30913169|NCT02253992|58948628|FG000|Overall Study|Adverse Event|0|||
30913170|NCT02253992|58948629|FG001|Overall Study|Adverse Event|0|||
30913171|NCT02253992|58948630|FG002|Overall Study|Adverse Event|8|||
30913172|NCT02253992|58948628|FG000|Overall Study|Death|0|||
30913173|NCT02253992|58948629|FG001|Overall Study|Death|0|||
30913174|NCT02253992|58948630|FG002|Overall Study|Death|1|||
30913175|NCT02253992|58948628|FG000|Overall Study|Subject discontinued study drug|1|||
30913176|NCT02253992|58948629|FG001|Overall Study|Subject discontinued study drug|0|||
30913177|NCT02253992|58948630|FG002|Overall Study|Subject discontinued study drug|1|||
30913178|NCT02253992|58948628|FG000|Overall Study|Completed treatment as per protocol|0|||
30913179|NCT02253992|58948629|FG001|Overall Study|Completed treatment as per protocol|1|||
30913180|NCT02253992|58948630|FG002|Overall Study|Completed treatment as per protocol|22|||
30913181|NCT02253992|58948628|FG000|Overall Study|Other|0|||
30913182|NCT02253992|58948629|FG001|Overall Study|Other|0|||
30913183|NCT02253992|58948630|FG002|Overall Study|Other|1|||
30819938|NCT02855450|58840643|FG000|Overall Study|Adverse Event|1|||
30819939|NCT02855450|58840644|FG001|Overall Study|Adverse Event|0|||
30913184|NCT02252588|58948654|FG000|Overall Study|Withdrawal by Subject|4|||
30913185|NCT02252588|58948655|FG001|Overall Study|Withdrawal by Subject|0|||
30913186|NCT01585558|58948664|FG000|Overall Study|Withdrawal by Subject|4|||
30913187|NCT01585558|58948665|FG001|Overall Study|Withdrawal by Subject|5|||
30913188|NCT01585558|58948666|FG002|Overall Study|Withdrawal by Subject|8|||
30913189|NCT01585558|58948664|FG000|Overall Study|Lost to Follow-up|2|||
30913190|NCT01585558|58948665|FG001|Overall Study|Lost to Follow-up|0|||
30913191|NCT01585558|58948666|FG002|Overall Study|Lost to Follow-up|3|||
30913192|NCT01585558|58948664|FG000|Overall Study|Adverse Event|3|||
30913193|NCT01585558|58948665|FG001|Overall Study|Adverse Event|4|||
30913194|NCT01585558|58948666|FG002|Overall Study|Adverse Event|1|||
30913195|NCT01585558|58948664|FG000|Overall Study|Protocol Violation|4|||
30913196|NCT01585558|58948665|FG001|Overall Study|Protocol Violation|3|||
30913197|NCT01585558|58948666|FG002|Overall Study|Protocol Violation|2|||
30913198|NCT01585558|58948664|FG000|Overall Study|Lack of Efficacy|0|||
30913199|NCT01585558|58948665|FG001|Overall Study|Lack of Efficacy|0|||
30913200|NCT01585558|58948666|FG002|Overall Study|Lack of Efficacy|1|||
30913201|NCT01565980|58948676|FG000|Overall Study|Death|1|||
30913202|NCT01565980|58948677|FG001|Overall Study|Death|0|||
30913203|NCT01565980|58948676|FG000|Overall Study|Lost to Follow-up|1|||
30913204|NCT01565980|58948677|FG001|Overall Study|Lost to Follow-up|0|||
30913205|NCT01565980|58948676|FG000|Overall Study|health complications|1|||
30913206|NCT01565980|58948677|FG001|Overall Study|health complications|1|||
30819940|NCT02855450|58840643|FG000|Overall Study|Lost to Follow-up|4|||
30819941|NCT02855450|58840644|FG001|Overall Study|Lost to Follow-up|0|||
30819942|NCT03172325|58840652|FG000|Overall Study|Adverse Event|2|||
30819943|NCT03172325|58840653|FG001|Overall Study|Adverse Event|3|||
30819944|NCT03172325|58840652|FG000|Overall Study|Positive PPD|1|||
30913207|NCT01565980|58948676|FG000|Overall Study|stopped medical treatment|1|||
30623081|NCT01215734|58634861|FG001|Overall Study|Death|1|||
30819945|NCT03172325|58840653|FG001|Overall Study|Positive PPD|0|||
30913208|NCT01565980|58948677|FG001|Overall Study|stopped medical treatment|0|||
30623082|NCT01169987|58634867|FG000|Overall Study|Withdrawal by Subject|3|||
30819946|NCT03172325|58840652|FG000|Overall Study|Poor Compliance|1|||
30913209|NCT01565980|58948676|FG000|Overall Study|Withdrawal by Subject|0|||
30913210|NCT01565980|58948677|FG001|Overall Study|Withdrawal by Subject|3|||
30913211|NCT01585246|58948692|FG000|Overall Study|Lost to Follow-up|0|||
30819947|NCT03172325|58840653|FG001|Overall Study|Poor Compliance|1|||
30913212|NCT01585246|58948693|FG001|Overall Study|Lost to Follow-up|0|||
30913213|NCT01585246|58948694|FG002|Overall Study|Lost to Follow-up|2|||
30819948|NCT03085017|58840661|FG000|Overall Study|Death|0|||
30819949|NCT03085017|58840662|FG001|Overall Study|Death|3|||
30819950|NCT03215771|58840668|FG000|Overall Study|Withdrawal by Subject|2|||
30819951|NCT03215771|58840668|FG000|Overall Study|Physician Decision|1|||
30819952|NCT02745392|58840677|FG000|Overall Study|Lost to Follow-up|0|||
30819953|NCT02745392|58840678|FG001|Overall Study|Lost to Follow-up|1|||
30819954|NCT02745392|58840679|FG002|Overall Study|Lost to Follow-up|0|||
30913214|NCT01585246|58948695|FG003|Overall Study|Lost to Follow-up|1|||
30913215|NCT01585246|58948696|FG004|Overall Study|Lost to Follow-up|0|||
30913216|NCT01585246|58948692|FG000|Overall Study|Protocol Violation|0|||
30913217|NCT01585246|58948693|FG001|Overall Study|Protocol Violation|0|||
30913218|NCT01585246|58948694|FG002|Overall Study|Protocol Violation|0|||
30913219|NCT01585246|58948695|FG003|Overall Study|Protocol Violation|0|||
30913220|NCT01585246|58948696|FG004|Overall Study|Protocol Violation|1|||
30913221|NCT01585246|58948692|FG000|Overall Study|Withdrawal by Subject|0|||
30913222|NCT01585246|58948693|FG001|Overall Study|Withdrawal by Subject|0|||
30913223|NCT01585246|58948694|FG002|Overall Study|Withdrawal by Subject|1|||
30913224|NCT01585246|58948695|FG003|Overall Study|Withdrawal by Subject|2|||
30913225|NCT01585246|58948696|FG004|Overall Study|Withdrawal by Subject|1|||
30913226|NCT01585246|58948692|FG000|Overall Study|Other|0|||
30819955|NCT02745392|58840680|FG003|Overall Study|Lost to Follow-up|0|||
30913227|NCT01585246|58948693|FG001|Overall Study|Other|1|||
30913228|NCT01585246|58948694|FG002|Overall Study|Other|1|||
30913229|NCT01585246|58948695|FG003|Overall Study|Other|1|||
30913230|NCT01585246|58948696|FG004|Overall Study|Other|0|||
30913231|NCT01585168|58948713|FG000|Overall Study|Lost to Follow-up|3|||
30913232|NCT01585168|58948714|FG001|Overall Study|Lost to Follow-up|1|||
30913233|NCT01585168|58948715|FG002|Overall Study|Lost to Follow-up|1|||
30913234|NCT01585168|58948716|FG003|Overall Study|Lost to Follow-up|1|||
30819956|NCT03076515|58840692|FG000|Overall Study|DMC decision based on interim analysis|25|||
30819957|NCT03076515|58840693|FG001|Overall Study|DMC decision based on interim analysis|29|||
30819958|NCT03170609|58840706|FG000|Overall Study|Death|0|||
30819959|NCT03170609|58840707|FG001|Overall Study|Death|0|||
30819960|NCT03170609|58840708|FG002|Overall Study|Death|1|||
30819961|NCT03170609|58840709|FG003|Overall Study|Death|0|||
30819962|NCT03170609|58840710|FG004|Overall Study|Death|0|||
30819963|NCT03170609|58840711|FG005|Overall Study|Death|0|||
30819964|NCT03170609|58840712|FG006|Overall Study|Death|0|||
30819965|NCT03170609|58840706|FG000|Overall Study|Withdrawal by Subject|1|||
30913235|NCT02232074|58948726|FG000|Overall Study|Withdrawal by Subject|5|||
30819966|NCT03170609|58840707|FG001|Overall Study|Withdrawal by Subject|2|||
30819967|NCT03170609|58840708|FG002|Overall Study|Withdrawal by Subject|0|||
30913236|NCT02232074|58948727|FG001|Overall Study|Withdrawal by Subject|3|||
30819968|NCT03170609|58840709|FG003|Overall Study|Withdrawal by Subject|0|||
30819969|NCT03170609|58840710|FG004|Overall Study|Withdrawal by Subject|0|||
30819970|NCT03170609|58840711|FG005|Overall Study|Withdrawal by Subject|0|||
30819971|NCT03170609|58840712|FG006|Overall Study|Withdrawal by Subject|1|||
30819972|NCT03170609|58840706|FG000|Overall Study|Lost to Follow-up|1|||
30819973|NCT03170609|58840707|FG001|Overall Study|Lost to Follow-up|0|||
30819974|NCT03170609|58840708|FG002|Overall Study|Lost to Follow-up|5|||
30819975|NCT03170609|58840709|FG003|Overall Study|Lost to Follow-up|2|||
30819976|NCT03170609|58840710|FG004|Overall Study|Lost to Follow-up|1|||
30819977|NCT03170609|58840711|FG005|Overall Study|Lost to Follow-up|1|||
30819978|NCT03170609|58840712|FG006|Overall Study|Lost to Follow-up|0|||
30819979|NCT03170609|58840706|FG000|Overall Study|Other|1|||
30819980|NCT03170609|58840707|FG001|Overall Study|Other|0|||
30819981|NCT03170609|58840708|FG002|Overall Study|Other|0|||
30819982|NCT03170609|58840709|FG003|Overall Study|Other|0|||
30819983|NCT03170609|58840710|FG004|Overall Study|Other|0|||
30819984|NCT03170609|58840711|FG005|Overall Study|Other|1|||
30819985|NCT03170609|58840712|FG006|Overall Study|Other|0|||
30819986|NCT01141712|58840728|FG000|Overall Study|Disease progression|3|||
30819987|NCT03219333|58840738|FG000|Overall Study|Withdrawal by Subject|8|||
30819988|NCT03219333|58840739|FG001|Overall Study|Withdrawal by Subject|3|||
30819989|NCT03219333|58840738|FG000|Overall Study|Lost to Follow-up|1|||
30819990|NCT03219333|58840739|FG001|Overall Study|Lost to Follow-up|0|||
30819991|NCT03219333|58840738|FG000|Overall Study|Death|94|||
30819992|NCT03219333|58840739|FG001|Overall Study|Death|44|||
30819993|NCT03219333|58840738|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
30819994|NCT03219333|58840739|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
30819995|NCT03168867|58840747|FG000|Overall Study|Withdrawal by Subject|1|||
30819996|NCT03168867|58840748|FG001|Overall Study|Withdrawal by Subject|5|||
30819997|NCT01064622|58840757|FG000|Randomized Phase II|Withdrawal by Subject|2|||
30819998|NCT01064622|58840758|FG001|Randomized Phase II|Withdrawal by Subject|2|||
30819999|NCT01064622|58840757|FG000|Randomized Phase II|Protocol Violation|0|||
30820000|NCT01064622|58840758|FG001|Randomized Phase II|Protocol Violation|1|||
30820001|NCT04163718|58840767|FG000|Overall Study|Study terminated|12|||
30820002|NCT01063764|58840771|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
30820003|NCT01063764|58840771|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
30820004|NCT01063764|58840771|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
30820005|NCT01063764|58840771|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
30820006|NCT01063764|58840771|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
30820007|NCT01063764|58840771|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
30913237|NCT02232074|58948726|FG000|Overall Study|No legal concerns at baseline|36|||
30820008|NCT01063764|58840771|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
30820009|NCT03075891|58840781|FG000|Overall Study|Withdrawal by Subject|3|||
30820010|NCT03075891|58840782|FG001|Overall Study|Withdrawal by Subject|6|||
30820011|NCT03075891|58840781|FG000|Overall Study|Lost to Follow-up|1|||
30820012|NCT03075891|58840782|FG001|Overall Study|Lost to Follow-up|0|||
30820013|NCT03075891|58840781|FG000|Overall Study|Pregnancy|3|||
30820014|NCT03075891|58840782|FG001|Overall Study|Pregnancy|1|||
30820015|NCT03075891|58840781|FG000|Overall Study|visits not performed (no time)|1|||
30820016|NCT03075891|58840782|FG001|Overall Study|visits not performed (no time)|0|||
30820017|NCT03075891|58840781|FG000|Overall Study|Drug abuse relapse issue|0|||
30820018|NCT03075891|58840782|FG001|Overall Study|Drug abuse relapse issue|1|||
30820019|NCT03075891|58840781|FG000|Overall Study|Participant requiring study withdrawal|0|||
30820020|NCT03075891|58840782|FG001|Overall Study|Participant requiring study withdrawal|1|||
30820021|NCT03075891|58840781|FG000|Overall Study|Adverse event, non-fatal|1|||
30820022|NCT03075891|58840782|FG001|Overall Study|Adverse event, non-fatal|4|||
30820023|NCT02013167|58840792|FG000|Overall Study|Withdrawal by Subject|15|||
30820024|NCT02013167|58840793|FG001|Overall Study|Withdrawal by Subject|14|||
30820025|NCT02013167|58840792|FG000|Overall Study|Sponsor Decision|1|||
30820026|NCT02013167|58840793|FG001|Overall Study|Sponsor Decision|3|||
30820027|NCT02013167|58840792|FG000|Overall Study|Lost to Follow-up|0|||
30820028|NCT02013167|58840793|FG001|Overall Study|Lost to Follow-up|1|||
30820029|NCT02013167|58840792|FG000|Overall Study|Death|85|||
30820030|NCT02013167|58840793|FG001|Overall Study|Death|160|||
30820031|NCT01063062|58840802|FG000|Overall Study|Patient withdrew consent|0|||
30820032|NCT01063062|58840803|FG001|Overall Study|Patient withdrew consent|1|||
30820033|NCT01063062|58840802|FG000|Overall Study|Adverse Event|2|||
30820034|NCT01063062|58840803|FG001|Overall Study|Adverse Event|4|||
30820035|NCT01063062|58840802|FG000|Overall Study|Protocol Violation|5|||
30820036|NCT01063062|58840803|FG001|Overall Study|Protocol Violation|4|||
30820037|NCT01063062|58840802|FG000|Overall Study|Investigator's request|1|||
30820038|NCT01063062|58840803|FG001|Overall Study|Investigator's request|0|||
30820039|NCT01063062|58840802|FG000|Overall Study|Lost to Follow-up|0|||
30820040|NCT01063062|58840803|FG001|Overall Study|Lost to Follow-up|2|||
30820041|NCT01063062|58840802|FG000|Overall Study|Miscellaneous reason|0|||
30820042|NCT01063062|58840803|FG001|Overall Study|Miscellaneous reason|1|||
30820043|NCT02973048|58840812|FG000|Overall Study|Epidural catheter insertion failure|1|||
30820044|NCT02973048|58840813|FG001|Overall Study|Epidural catheter insertion failure|0|||
30820045|NCT02973048|58840812|FG000|Overall Study|Withdrawal by Subject|0|||
30820046|NCT02973048|58840813|FG001|Overall Study|Withdrawal by Subject|3|||
30820047|NCT02932943|58840821|FG000|Overall Study|Lost to Follow-up|0|||
30820048|NCT02932943|58840822|FG001|Overall Study|Lost to Follow-up|2|||
30820049|NCT02932943|58840821|FG000|Overall Study|Adverse Event|2|||
30820050|NCT02932943|58840822|FG001|Overall Study|Adverse Event|2|||
30820051|NCT02932943|58840821|FG000|Overall Study|Withdrawal by Subject|3|||
30820052|NCT02932943|58840822|FG001|Overall Study|Withdrawal by Subject|3|||
30820053|NCT02972658|58840847|FG000|Overall Study|Adverse Event|0|||
30820054|NCT02972658|58840848|FG001|Overall Study|Adverse Event|3|||
30820055|NCT02972658|58840849|FG002|Overall Study|Adverse Event|0|||
30820056|NCT02972658|58840850|FG003|Overall Study|Adverse Event|2|||
30752377|NCT00151476|58762183|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
30752378|NCT00151476|58762182|FG000|FAP Analyzed Subjects|Other study participation|0|||
30820057|NCT02972658|58840847|FG000|Overall Study|Other-determined by Investigator|1|||
30752379|NCT00151476|58762183|FG001|FAP Analyzed Subjects|Other study participation|1|||
30752380|NCT00149994|58762192|FG000|Overall Study|Administrative problems:|1|||
30752381|NCT00149994|58762193|FG001|Overall Study|Administrative problems:|0|||
30752382|NCT00149994|58762192|FG000|Overall Study|Protocol Violation|0|||
30752383|NCT00149994|58762193|FG001|Overall Study|Protocol Violation|1|||
30752384|NCT00149214|58762201|FG000|Overall Study|Adverse Event|12|||
30752385|NCT00149214|58762202|FG001|Overall Study|Adverse Event|9|||
30752386|NCT00149214|58762201|FG000|Overall Study|Withdrawal by Subject|4|||
30752387|NCT00149214|58762202|FG001|Overall Study|Withdrawal by Subject|1|||
30752388|NCT00149214|58762201|FG000|Overall Study|Physician Decision|3|||
30752389|NCT00149214|58762202|FG001|Overall Study|Physician Decision|3|||
30752390|NCT00149214|58762201|FG000|Overall Study|Sponsor Decision|0|||
30752391|NCT00149214|58762202|FG001|Overall Study|Sponsor Decision|1|||
30752392|NCT00149214|58762201|FG000|Overall Study|Progressive Disease|7|||
30752393|NCT00149214|58762202|FG001|Overall Study|Progressive Disease|3|||
30752394|NCT00114972|58762219|FG000|Overall Study|Withdrawal by Subject|40|||
30752395|NCT00114972|58762220|FG001|Overall Study|Withdrawal by Subject|7|||
30752396|NCT00114972|58762219|FG000|Overall Study|Lost to Follow-up|8|||
30752397|NCT00114972|58762220|FG001|Overall Study|Lost to Follow-up|5|||
30752398|NCT00129402|58762228|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
30752399|NCT00129402|58762229|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
30752400|NCT00129402|58762230|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
30752401|NCT00129402|58762231|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
30752402|NCT00129402|58762232|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
30752403|NCT00129402|58762233|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
30752404|NCT00129402|58762234|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
30752405|NCT00129402|58762228|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
30752406|NCT00129402|58762229|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
30752407|NCT00129402|58762230|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
30752408|NCT00129402|58762231|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
30752409|NCT00129402|58762232|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
30752410|NCT00129402|58762233|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
30752411|NCT00129402|58762234|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
30752412|NCT00129402|58762228|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
30752413|NCT00129402|58762229|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
30752414|NCT00129402|58762230|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
30752415|NCT00129402|58762231|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
30752416|NCT00129402|58762232|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
30752417|NCT00129402|58762233|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
30752418|NCT00129402|58762234|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
30752419|NCT00129402|58762228|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
30752420|NCT00129402|58762229|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
30752421|NCT00129402|58762230|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
30752422|NCT00129402|58762231|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
30752423|NCT00129402|58762232|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
30752424|NCT00129402|58762233|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
30752425|NCT00129402|58762234|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
30752426|NCT00129402|58762228|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
30752427|NCT00129402|58762229|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
30752428|NCT00129402|58762230|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
30820058|NCT02972658|58840848|FG001|Overall Study|Other-determined by Investigator|1|||
30752429|NCT00129402|58762231|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
30752430|NCT00129402|58762232|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
30752431|NCT00129402|58762233|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
30752432|NCT00129402|58762234|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
30820059|NCT02972658|58840849|FG002|Overall Study|Other-determined by Investigator|0|||
30820060|NCT02972658|58840850|FG003|Overall Study|Other-determined by Investigator|0|||
30820061|NCT02972658|58840847|FG000|Overall Study|Death|0|||
30820062|NCT02972658|58840848|FG001|Overall Study|Death|0|||
30820063|NCT02972658|58840849|FG002|Overall Study|Death|0|||
30820064|NCT02972658|58840850|FG003|Overall Study|Death|1|||
30820065|NCT02972658|58840847|FG000|Overall Study|Lost to Follow-up|0|||
30820066|NCT02972658|58840848|FG001|Overall Study|Lost to Follow-up|1|||
30820067|NCT02972658|58840849|FG002|Overall Study|Lost to Follow-up|1|||
30820068|NCT02972658|58840850|FG003|Overall Study|Lost to Follow-up|2|||
30820069|NCT02972658|58840847|FG000|Overall Study|Progressive Disease|0|||
30820070|NCT02972658|58840848|FG001|Overall Study|Progressive Disease|1|||
30820071|NCT02972658|58840849|FG002|Overall Study|Progressive Disease|0|||
30820072|NCT02972658|58840850|FG003|Overall Study|Progressive Disease|1|||
30820073|NCT02972658|58840847|FG000|Overall Study|Withdrawal by Subject|4|||
30820074|NCT02972658|58840848|FG001|Overall Study|Withdrawal by Subject|4|||
30820075|NCT02972658|58840849|FG002|Overall Study|Withdrawal by Subject|1|||
30820076|NCT02972658|58840850|FG003|Overall Study|Withdrawal by Subject|6|||
30820077|NCT02972658|58840847|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
30820078|NCT02972658|58840848|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
30820079|NCT02972658|58840849|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
30820080|NCT02972658|58840850|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
30820081|NCT02972658|58840847|FG000|Overall Study|Sponsor Decision|70|||
30820082|NCT02972658|58840848|FG001|Overall Study|Sponsor Decision|127|||
30820083|NCT02972658|58840849|FG002|Overall Study|Sponsor Decision|72|||
30820084|NCT02972658|58840850|FG003|Overall Study|Sponsor Decision|119|||
30820085|NCT02853032|58840862|FG000|Overall Study|Adverse Event|4|||
30820086|NCT02853032|58840863|FG001|Overall Study|Adverse Event|0|||
30820087|NCT02853032|58840862|FG000|Overall Study|Withdrawal by Subject|3|||
30820088|NCT02853032|58840863|FG001|Overall Study|Withdrawal by Subject|1|||
30820089|NCT02853032|58840862|FG000|Overall Study|Requested to withdraw from all treatment|2|||
30820090|NCT02853032|58840863|FG001|Overall Study|Requested to withdraw from all treatment|2|||
30820091|NCT02232087|58840871|FG000|Overall Study|Withdrawal by Subject|2|||
30820092|NCT02232087|58840872|FG001|Overall Study|Withdrawal by Subject|0|||
30820093|NCT02232087|58840873|FG002|Overall Study|Withdrawal by Subject|0|||
30820094|NCT02232087|58840874|FG003|Overall Study|Withdrawal by Subject|0|||
30820095|NCT02232087|58840875|FG004|Overall Study|Withdrawal by Subject|0|||
30820096|NCT02232087|58840876|FG005|Overall Study|Withdrawal by Subject|1|||
30820097|NCT02232087|58840871|FG000|Overall Study|poor inhalation technique|0|||
30820098|NCT02232087|58840872|FG001|Overall Study|poor inhalation technique|1|||
30820099|NCT02232087|58840873|FG002|Overall Study|poor inhalation technique|0|||
30820100|NCT02232087|58840874|FG003|Overall Study|poor inhalation technique|0|||
30820101|NCT02232087|58840875|FG004|Overall Study|poor inhalation technique|0|||
30820102|NCT02232087|58840876|FG005|Overall Study|poor inhalation technique|2|||
30820103|NCT02232087|58840871|FG000|Overall Study|protocol stop criteria|0|||
30820104|NCT02232087|58840872|FG001|Overall Study|protocol stop criteria|1|||
30820105|NCT02232087|58840873|FG002|Overall Study|protocol stop criteria|0|||
30820106|NCT02232087|58840874|FG003|Overall Study|protocol stop criteria|1|||
30820107|NCT02232087|58840875|FG004|Overall Study|protocol stop criteria|0|||
30820108|NCT02232087|58840876|FG005|Overall Study|protocol stop criteria|0|||
30820109|NCT02232087|58840871|FG000|Overall Study|Adverse Event|0|||
30820110|NCT02232087|58840872|FG001|Overall Study|Adverse Event|0|||
30820111|NCT02232087|58840873|FG002|Overall Study|Adverse Event|0|||
30820112|NCT02232087|58840874|FG003|Overall Study|Adverse Event|0|||
30820113|NCT02232087|58840875|FG004|Overall Study|Adverse Event|1|||
30820114|NCT02232087|58840876|FG005|Overall Study|Adverse Event|0|||
30820115|NCT03168425|58840897|FG000|Overall Study|Lost to Follow-up|5|||
30820116|NCT03168425|58840898|FG001|Overall Study|Lost to Follow-up|8|||
30820117|NCT03168425|58840897|FG000|Overall Study|unable to confirm post op opioids|2|||
30820118|NCT03168425|58840898|FG001|Overall Study|unable to confirm post op opioids|3|||
30820119|NCT00004445|58840905|FG000|Overall Study|Physician Decision|2|||
30820120|NCT00004445|58840905|FG000|Overall Study|Withdrawal by Subject|1|||
30820121|NCT02972502|58840915|FG000|Overall Study|Lost to Follow-up|3|||
30820122|NCT02972502|58840916|FG001|Overall Study|Lost to Follow-up|1|||
30820123|NCT02972502|58840915|FG000|Overall Study|Withdrawal by Subject|1|||
30820124|NCT02972502|58840916|FG001|Overall Study|Withdrawal by Subject|1|||
30820125|NCT02971800|58840922|FG000|Overall Study|Protocol Violation|1|||
30820126|NCT02971800|58840922|FG000|Overall Study|Withdrawal by Subject|1|||
30820127|NCT02971800|58840922|FG000|Overall Study|Exclusion criteria prior intervention|1|||
30820128|NCT02971800|58840922|FG000|Overall Study|Number evaluable participant already reached|4|||
30820129|NCT03163667|58840928|FG000|Overall Study|Death|15|||
30820130|NCT03163667|58840929|FG001|Overall Study|Death|27|||
30820131|NCT03163667|58840928|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
30820132|NCT03163667|58840929|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
30820133|NCT03167411|58840937|FG000|Overall Study|Adverse Event|0|||
30820134|NCT03167411|58840938|FG001|Overall Study|Adverse Event|1|||
30820135|NCT01952847|58840948|FG000|Overall Study|Ineligible|1|||
30820136|NCT01952847|58840949|FG001|Overall Study|Ineligible|0|||
30820137|NCT01952847|58840950|FG002|Overall Study|Ineligible|0|||
30820138|NCT01952847|58840951|FG003|Overall Study|Ineligible|0|||
30820139|NCT01952847|58840948|FG000|Overall Study|Lack of Insurance Coverage|0|||
30820140|NCT01952847|58840949|FG001|Overall Study|Lack of Insurance Coverage|1|||
30820141|NCT01952847|58840950|FG002|Overall Study|Lack of Insurance Coverage|0|||
30820142|NCT01952847|58840951|FG003|Overall Study|Lack of Insurance Coverage|0|||
30820143|NCT01952847|58840948|FG000|Overall Study|Withdrawal by Subject|1|||
30820144|NCT01952847|58840949|FG001|Overall Study|Withdrawal by Subject|1|||
30752433|NCT00129402|58762228|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
30752434|NCT00129402|58762229|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
30752435|NCT00129402|58762230|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
30752436|NCT00129402|58762231|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
30752437|NCT00129402|58762232|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
30752438|NCT00129402|58762233|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
30752439|NCT00129402|58762234|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
30752440|NCT00129402|58762228|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
30752441|NCT00129402|58762229|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
30752442|NCT00129402|58762230|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
30752443|NCT00129402|58762231|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
30752444|NCT00129402|58762232|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
30820145|NCT01952847|58840950|FG002|Overall Study|Withdrawal by Subject|0|||
30820146|NCT01952847|58840951|FG003|Overall Study|Withdrawal by Subject|1|||
30820147|NCT01560585|58840963|FG000|Overall Study|Physician Decision|3|||
30752445|NCT00129402|58762233|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
30752446|NCT00129402|58762234|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
30752447|NCT00129402|58762228|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
30820148|NCT03075501|58840970|FG000|Overall Study|Scheduling difficulties|15|||
30820149|NCT03075501|58840971|FG001|Overall Study|Scheduling difficulties|9|||
30820150|NCT02317991|58840978|FG000|Overall Study|Adverse Event|12|||
30820151|NCT02317991|58840978|FG000|Overall Study|Death|4|||
30820152|NCT02317991|58840978|FG000|Overall Study|Withdrawal by Subject|8|||
30820153|NCT02317991|58840978|FG000|Overall Study|Progressive Disease|41|||
30820154|NCT03075267|58840985|FG000|Overall Study|Protocol Violation|1|||
30820155|NCT03075267|58840986|FG001|Overall Study|Protocol Violation|0|||
30820156|NCT03075267|58840987|FG002|Overall Study|Protocol Violation|0|||
30820157|NCT03074331|58840995|FG000|Overall Study|Enrolled but Not Treated|1|||
30820158|NCT03074331|58840995|FG000|Overall Study|Lost to Follow-up|5|||
30820159|NCT03074331|58840995|FG000|Overall Study|Withdrew Consent|1|||
30820160|NCT02260193|58841002|FG000|Overall Study|Lack of Efficacy|0|||
30820161|NCT02260193|58841003|FG001|Overall Study|Lack of Efficacy|1|||
30820162|NCT02260193|58841004|FG002|Overall Study|Lack of Efficacy|6|||
30820163|NCT02260193|58841002|FG000|Overall Study|Adverse Event|3|||
30820164|NCT02260193|58841003|FG001|Overall Study|Adverse Event|4|||
30820165|NCT02260193|58841004|FG002|Overall Study|Adverse Event|1|||
30820166|NCT02260193|58841002|FG000|Overall Study|Protocol Violation|0|||
30820167|NCT02260193|58841003|FG001|Overall Study|Protocol Violation|4|||
30820168|NCT02260193|58841004|FG002|Overall Study|Protocol Violation|0|||
30820169|NCT02260193|58841002|FG000|Overall Study|Withdrawal by Subject|3|||
30820170|NCT02260193|58841003|FG001|Overall Study|Withdrawal by Subject|0|||
30820171|NCT02260193|58841004|FG002|Overall Study|Withdrawal by Subject|2|||
30820172|NCT02260193|58841002|FG000|Overall Study|Kidney Transplantation|0|||
30820173|NCT02260193|58841003|FG001|Overall Study|Kidney Transplantation|0|||
30820174|NCT02260193|58841004|FG002|Overall Study|Kidney Transplantation|1|||
30820175|NCT02849678|58841014|FG000|Overall Study|Protocol Violation|3|||
30820176|NCT02849678|58841015|FG001|Overall Study|Protocol Violation|6|||
30820177|NCT01596257|58841023|FG000|Overall Study|Inadequate Collection|23|||
30820178|NCT01596257|58841024|FG001|Overall Study|Inadequate Collection|19|||
30820179|NCT04577781|58841034|FG000|Overall Study|Adverse Event|2|||
30913238|NCT02232074|58948727|FG001|Overall Study|No legal concerns at baseline|41|||
30913239|NCT02232074|58948726|FG000|Overall Study|deemed ineligible|0|||
30913240|NCT02232074|58948727|FG001|Overall Study|deemed ineligible|1|||
30913241|NCT02142283|58948741|FG000|Overall Study|Death|20|||
30913242|NCT02142283|58948742|FG001|Overall Study|Death|18|||
30913243|NCT02142283|58948741|FG000|Overall Study|Withdrawal by Subject|1|||
30913244|NCT02142283|58948742|FG001|Overall Study|Withdrawal by Subject|3|||
30913245|NCT02231918|58948751|FG000|Overall Study|Withdrawal by Subject|0|||
30913246|NCT02231918|58948752|FG001|Overall Study|Withdrawal by Subject|1|||
30913247|NCT02231918|58948753|FG002|Overall Study|Withdrawal by Subject|0|||
30913248|NCT02231918|58948751|FG000|Overall Study|Adverse Event|0|||
30913249|NCT02231918|58948752|FG001|Overall Study|Adverse Event|0|||
30913250|NCT02231918|58948753|FG002|Overall Study|Adverse Event|1|||
30913251|NCT02199314|58948761|FG000|Overall Study|Withdrawal by Subject|6|||
30913252|NCT02199314|58948761|FG000|Overall Study|Physician Decision|10|||
30913253|NCT02199080|58948765|FG000|Overall Study|Protocol Violation|12|||
30913254|NCT02251652|58948771|FG000|Overall Study|Withdrawal by Subject|1|||
30913255|NCT02197520|58948777|FG000|Period 1|Withdrawal by Subject|1|||
30913256|NCT02197520|58948778|FG001|Period 1|Withdrawal by Subject|0|||
30913257|NCT02197520|58948777|FG000|Period 2|Adverse Event|0|||
30913258|NCT02197520|58948778|FG001|Period 2|Adverse Event|2|||
30820180|NCT04577781|58841035|FG001|Overall Study|Adverse Event|2|||
30820181|NCT04577781|58841034|FG000|Overall Study|Physician Decision|1|||
30913259|NCT02197520|58948777|FG000|Period 2|Withdrawal by Subject|1|||
30913260|NCT02197520|58948778|FG001|Period 2|Withdrawal by Subject|0|||
30820182|NCT04577781|58841035|FG001|Overall Study|Physician Decision|0|||
30820183|NCT02737826|58841042|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
30820184|NCT02737826|58841043|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
30913261|NCT02230904|58948788|FG000|Overall Study|Safety follow up could not take place|0|||
30913262|NCT02230904|58948789|FG001|Overall Study|Safety follow up could not take place|1|||
30820185|NCT02737826|58841044|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
30913263|NCT02230670|58948799|FG000|Overall Study|Adverse Event|1|||
30913264|NCT02230670|58948800|FG001|Overall Study|Adverse Event|2|||
30913265|NCT02230670|58948799|FG000|Overall Study|Withdrawal by Subject|2|||
30913266|NCT02230670|58948800|FG001|Overall Study|Withdrawal by Subject|2|||
30913267|NCT02230670|58948799|FG000|Overall Study|Physician Decision|0|||
30913268|NCT02230670|58948800|FG001|Overall Study|Physician Decision|1|||
30913269|NCT02230670|58948799|FG000|Overall Study|Protocol Violation|0|||
30913270|NCT02230670|58948800|FG001|Overall Study|Protocol Violation|1|||
30820186|NCT03070431|58841071|FG000|Overall Study|Withdrawal by Subject|2|||
30820187|NCT03070431|58841071|FG000|Overall Study|Lost to Follow-up|2|||
30820188|NCT01071395|58841082|FG000|Overall Study|Withdrawal by Subject|2|||
30820189|NCT01071395|58841083|FG001|Overall Study|Withdrawal by Subject|1|||
30820190|NCT01071395|58841082|FG000|Overall Study|Adverse Event|3|||
30820191|NCT01071395|58841083|FG001|Overall Study|Adverse Event|1|||
30820192|NCT02970942|58841093|FG000|Overall Study|Death|0|||
30820193|NCT02970942|58841094|FG001|Overall Study|Death|1|||
30820194|NCT02970942|58841095|FG002|Overall Study|Death|0|||
30820195|NCT02970942|58841096|FG003|Overall Study|Death|0|||
30820196|NCT02970942|58841093|FG000|Overall Study|Lost to Follow-up|1|||
30820197|NCT02970942|58841094|FG001|Overall Study|Lost to Follow-up|0|||
30820198|NCT02970942|58841095|FG002|Overall Study|Lost to Follow-up|2|||
30820199|NCT02970942|58841096|FG003|Overall Study|Lost to Follow-up|1|||
30913271|NCT02230670|58948799|FG000|Overall Study|Progression to Child-Pugh C|1|||
30913272|NCT02230670|58948800|FG001|Overall Study|Progression to Child-Pugh C|2|||
30913273|NCT02197130|58948809|FG000|Overall Study|Adverse Event|13|||
30913274|NCT02197130|58948810|FG001|Overall Study|Adverse Event|4|||
30913275|NCT02197130|58948811|FG002|Overall Study|Adverse Event|23|||
30913276|NCT02197130|58948809|FG000|Overall Study|Death|0|||
30913277|NCT02197130|58948810|FG001|Overall Study|Death|1|||
30913278|NCT02197130|58948811|FG002|Overall Study|Death|0|||
30913279|NCT02197130|58948809|FG000|Overall Study|Lost to Follow-up|2|||
30913280|NCT02197130|58948810|FG001|Overall Study|Lost to Follow-up|0|||
30913281|NCT02197130|58948811|FG002|Overall Study|Lost to Follow-up|1|||
30820200|NCT02970942|58841093|FG000|Overall Study|Withdrawal by Subject|3|||
30820201|NCT02970942|58841094|FG001|Overall Study|Withdrawal by Subject|5|||
30820202|NCT02970942|58841095|FG002|Overall Study|Withdrawal by Subject|3|||
30820203|NCT02970942|58841096|FG003|Overall Study|Withdrawal by Subject|2|||
30820204|NCT03073005|58841110|FG000|Overall Study|Death|6|||
30820205|NCT03073005|58841111|FG001|Overall Study|Death|0|||
30820206|NCT03073005|58841112|FG002|Overall Study|Death|7|||
30820207|NCT03073005|58841113|FG003|Overall Study|Death|0|||
30820208|NCT03073005|58841110|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
30820209|NCT03073005|58841111|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
30820210|NCT03073005|58841112|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
30820211|NCT03073005|58841113|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
30820212|NCT03073005|58841110|FG000|Overall Study|Lost to Follow-up|2|||
30820213|NCT03073005|58841111|FG001|Overall Study|Lost to Follow-up|2|||
30820214|NCT03073005|58841112|FG002|Overall Study|Lost to Follow-up|1|||
30820215|NCT03073005|58841113|FG003|Overall Study|Lost to Follow-up|2|||
30820216|NCT03073005|58841110|FG000|Overall Study|Withdrawal by Subject|0|||
30820217|NCT03073005|58841111|FG001|Overall Study|Withdrawal by Subject|4|||
30913282|NCT02197130|58948809|FG000|Overall Study|Does not meet entrance criteria|0|||
30913283|NCT02197130|58948810|FG001|Overall Study|Does not meet entrance criteria|0|||
30820218|NCT03073005|58841112|FG002|Overall Study|Withdrawal by Subject|4|||
30820219|NCT03073005|58841113|FG003|Overall Study|Withdrawal by Subject|4|||
30820220|NCT02849171|58841126|FG000|Overall Study|Withdrawal by Subject|1|||
30820221|NCT02849171|58841126|FG000|Overall Study|Not treated|1|||
30820222|NCT02848664|58841139|FG000|Overall Study|Withdrawal by Subject|2|||
30820223|NCT02848664|58841139|FG000|Overall Study|Adverse Event|1|||
30820224|NCT02848664|58841139|FG000|Overall Study|no assistance for device training|1|||
30913284|NCT02197130|58948811|FG002|Overall Study|Does not meet entrance criteria|1|||
30913285|NCT02197130|58948809|FG000|Overall Study|Withdrawal by Subject|0|||
30820225|NCT02969382|58841149|FG000|Overall Study|Adverse Event|8|||
30820226|NCT02969382|58841150|FG001|Overall Study|Adverse Event|10|||
30820227|NCT02969382|58841149|FG000|Overall Study|Lack of Efficacy|4|||
30820228|NCT02969382|58841150|FG001|Overall Study|Lack of Efficacy|5|||
30820229|NCT02969382|58841149|FG000|Overall Study|Death|0|||
30820230|NCT02969382|58841150|FG001|Overall Study|Death|1|||
30820231|NCT02969382|58841149|FG000|Overall Study|PROTOCOL DEVIATION|0|||
30820232|NCT02969382|58841150|FG001|Overall Study|PROTOCOL DEVIATION|1|||
30913286|NCT02197130|58948810|FG001|Overall Study|Withdrawal by Subject|3|||
30913287|NCT02197130|58948811|FG002|Overall Study|Withdrawal by Subject|4|||
30913288|NCT02197130|58948809|FG000|Overall Study|Other|1|||
30913289|NCT02197130|58948810|FG001|Overall Study|Other|0|||
30913290|NCT02197130|58948811|FG002|Overall Study|Other|3|||
30913291|NCT02196506|58948821|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
30913292|NCT02196506|58948822|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
30752448|NCT00129402|58762229|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
30752449|NCT00129402|58762230|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
30752450|NCT00129402|58762231|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
30752451|NCT00129402|58762232|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
30752452|NCT00129402|58762233|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
30752453|NCT00129402|58762234|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
30752454|NCT00129402|58762228|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
30752455|NCT00129402|58762229|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
30752456|NCT00129402|58762230|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
30752457|NCT00129402|58762231|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
30752458|NCT00129402|58762232|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
30752459|NCT00129402|58762233|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
30752460|NCT00129402|58762234|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
30752461|NCT00129402|58762228|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
30752462|NCT00129402|58762229|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
30752463|NCT00129402|58762230|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
30752464|NCT00129402|58762231|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
30752465|NCT00129402|58762232|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
30752466|NCT00129402|58762233|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
30752467|NCT00129402|58762234|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
30752468|NCT00129402|58762228|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
30752469|NCT00129402|58762229|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
30820233|NCT02969382|58841149|FG000|Overall Study|Withdrawal by Subject|14|||
30820234|NCT02969382|58841150|FG001|Overall Study|Withdrawal by Subject|9|||
30913293|NCT02196506|58948823|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
30913294|NCT02196506|58948824|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
30820235|NCT01989104|58841161|FG000|Overall Study|Withdrawal by Subject|3|||
30820236|NCT01989104|58841162|FG001|Overall Study|Withdrawal by Subject|0|||
30820237|NCT01989104|58841163|FG002|Overall Study|Withdrawal by Subject|0|||
30820238|NCT01989104|58841164|FG003|Overall Study|Withdrawal by Subject|0|||
30820239|NCT01989104|58841165|FG004|Overall Study|Withdrawal by Subject|0|||
30820240|NCT02903238|58841177|FG000|Overall Study|Lost to Follow-up|4|||
30820241|NCT02847260|58841182|FG000|Overall Study|Adverse Event|3|||
30820242|NCT02847260|58841182|FG000|Overall Study|Withdrawal by Subject|2|||
30820243|NCT02847260|58841182|FG000|Overall Study|Clinical Deterioration|1|||
30820244|NCT02847260|58841182|FG000|Overall Study|Physician Decision|1|||
30820245|NCT02968563|58841188|FG000|Overall Study|Adverse Event|0|||
30913295|NCT02196506|58948821|FG000|Phase A|Withdrawal by Subject|34|||
30913296|NCT02196506|58948822|FG001|Phase A|Withdrawal by Subject|0|||
30913297|NCT02196506|58948823|FG002|Phase A|Withdrawal by Subject|0|||
30820246|NCT02968563|58841189|FG001|Overall Study|Adverse Event|6|||
30820247|NCT02968563|58841188|FG000|Overall Study|Death|1|||
30820248|NCT02968563|58841189|FG001|Overall Study|Death|1|||
30820249|NCT02968563|58841188|FG000|Overall Study|Lost to Follow-up|0|||
30820250|NCT02968563|58841189|FG001|Overall Study|Lost to Follow-up|1|||
30820251|NCT02904096|58841197|FG000|Overall Study|Adverse Event|1|||
30820252|NCT02904096|58841198|FG001|Overall Study|Adverse Event|0|||
30820253|NCT02904096|58841197|FG000|Overall Study|Withdrawal by Subject|4|||
30820254|NCT02904096|58841198|FG001|Overall Study|Withdrawal by Subject|3|||
30820255|NCT02904096|58841197|FG000|Overall Study|Lost to Follow-up|10|||
30820256|NCT02904096|58841198|FG001|Overall Study|Lost to Follow-up|17|||
30820257|NCT02904096|58841197|FG000|Overall Study|Non-compliant|3|||
30820258|NCT02904096|58841198|FG001|Overall Study|Non-compliant|1|||
30820259|NCT02904096|58841197|FG000|Overall Study|Sponsor instructed|1|||
30820260|NCT02904096|58841198|FG001|Overall Study|Sponsor instructed|0|||
30820261|NCT03161405|58841208|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
30913298|NCT02196506|58948824|FG003|Phase A|Withdrawal by Subject|0|||
30820262|NCT01813929|58841217|FG000|Overall Study|Withdrawal by Subject|0|||
30820263|NCT01813929|58841218|FG001|Overall Study|Withdrawal by Subject|1|||
30820264|NCT02901054|58841228|FG000|Overall Study|Physician Decision|1|||
30820265|NCT02901054|58841228|FG000|Overall Study|Withdrawal by Subject|3|||
30913299|NCT02196506|58948821|FG000|Phase A|Adverse Event|22|||
30820266|NCT03068715|58841234|FG000|Overall Study|No longer met inclusion criteria|1|||
30820267|NCT03068715|58841235|FG001|Overall Study|No longer met inclusion criteria|0|||
30820268|NCT02966340|58841243|FG000|Overall Study|Adverse Event|0|||
30820269|NCT02966340|58841244|FG001|Overall Study|Adverse Event|1|||
30820270|NCT02966340|58841243|FG000|Overall Study|Lost to Follow-up|0|||
30820271|NCT02966340|58841244|FG001|Overall Study|Lost to Follow-up|1|||
30820272|NCT02966340|58841243|FG000|Overall Study|Withdrawal by Subject|1|||
30820273|NCT02966340|58841244|FG001|Overall Study|Withdrawal by Subject|0|||
30820274|NCT02966340|58841243|FG000|Overall Study|data acquisition error|1|||
30820275|NCT02966340|58841244|FG001|Overall Study|data acquisition error|0|||
30820276|NCT02966340|58841243|FG000|Overall Study|startle non-responder|1|||
30820277|NCT02966340|58841244|FG001|Overall Study|startle non-responder|1|||
30820278|NCT03067311|58841252|FG000|Overall Study|Lost to Follow-up|1|||
30820279|NCT03067311|58841253|FG001|Overall Study|Lost to Follow-up|1|||
30820280|NCT03067311|58841252|FG000|Overall Study|Moved away|1|||
30820281|NCT03067311|58841253|FG001|Overall Study|Moved away|1|||
30820282|NCT04380519|58841262|FG000|Overall Study|Withdrawal by Subject|4|||
30913300|NCT02196506|58948822|FG001|Phase A|Adverse Event|0|||
30913301|NCT02196506|58948823|FG002|Phase A|Adverse Event|0|||
30913302|NCT02196506|58948824|FG003|Phase A|Adverse Event|0|||
30913303|NCT02196506|58948821|FG000|Phase A|Lost to Follow-up|9|||
30913304|NCT02196506|58948822|FG001|Phase A|Lost to Follow-up|0|||
30913305|NCT02196506|58948823|FG002|Phase A|Lost to Follow-up|0|||
30913306|NCT02196506|58948824|FG003|Phase A|Lost to Follow-up|0|||
30913307|NCT02196506|58948821|FG000|Phase A|Protocol deviation|12|||
30913308|NCT02196506|58948822|FG001|Phase A|Protocol deviation|0|||
30913309|NCT02196506|58948823|FG002|Phase A|Protocol deviation|0|||
30913310|NCT02196506|58948824|FG003|Phase A|Protocol deviation|0|||
30913311|NCT02196506|58948821|FG000|Phase A|Participant withdrawn by investigator|10|||
30913312|NCT02196506|58948822|FG001|Phase A|Participant withdrawn by investigator|0|||
30913313|NCT02196506|58948823|FG002|Phase A|Participant withdrawn by investigator|0|||
30913314|NCT02196506|58948824|FG003|Phase A|Participant withdrawn by investigator|0|||
30752470|NCT00129402|58762230|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
30752471|NCT00129402|58762231|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
30752472|NCT00129402|58762232|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
30752473|NCT00129402|58762233|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
30752474|NCT00129402|58762234|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
30752475|NCT00129402|58762228|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
30752476|NCT00129402|58762229|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
30752477|NCT00129402|58762230|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
30752478|NCT00129402|58762231|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
30752479|NCT00129402|58762232|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
30752480|NCT00129402|58762233|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
30752481|NCT00129402|58762234|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
30752482|NCT00129402|58762228|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
30820283|NCT04380519|58841263|FG001|Overall Study|Withdrawal by Subject|0|||
30820284|NCT04380519|58841264|FG002|Overall Study|Withdrawal by Subject|1|||
30913315|NCT02196506|58948821|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
30820285|NCT04380519|58841262|FG000|Overall Study|Death|14|||
30820286|NCT04380519|58841263|FG001|Overall Study|Death|9|||
30820287|NCT04380519|58841264|FG002|Overall Study|Death|6|||
30913316|NCT02196506|58948822|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
30913317|NCT02196506|58948823|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
30913318|NCT02196506|58948824|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
30752483|NCT00129402|58762229|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
30752484|NCT00129402|58762230|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
30752485|NCT00129402|58762231|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
30752486|NCT00129402|58762232|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
30752487|NCT00129402|58762233|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
30752488|NCT00129402|58762234|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
30752489|NCT03739528|58762244|FG000|Overall Study|Not treated|8|||
30752490|NCT03739528|58762245|FG001|Overall Study|Not treated|12|||
30752491|NCT03739528|58762244|FG000|Overall Study|Treatment and study discontinued|6|||
30752492|NCT03739528|58762245|FG001|Overall Study|Treatment and study discontinued|2|||
30752493|NCT03739528|58762244|FG000|Overall Study|Treatment discontinued + study completed|1|||
30752494|NCT03739528|58762245|FG001|Overall Study|Treatment discontinued + study completed|3|||
30752495|NCT00114738|58762254|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
30913319|NCT02196506|58948821|FG000|Phase B|Lack of Efficacy|0|||
30913320|NCT02196506|58948822|FG001|Phase B|Lack of Efficacy|1|||
30752496|NCT00114738|58762255|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
30752497|NCT00114738|58762256|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
30820288|NCT04380519|58841262|FG000|Overall Study|Adverse Event|0|||
30820289|NCT04380519|58841263|FG001|Overall Study|Adverse Event|1|||
30820290|NCT04380519|58841264|FG002|Overall Study|Adverse Event|0|||
30913321|NCT02196506|58948823|FG002|Phase B|Lack of Efficacy|2|||
30752498|NCT00114738|58762254|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
30752499|NCT00114738|58762255|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
30752500|NCT00114738|58762256|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
30752501|NCT00114738|58762254|FG000|Screening for Randomization|Neuropathy|17|||
30913322|NCT02196506|58948824|FG003|Phase B|Lack of Efficacy|0|||
30752502|NCT00114738|58762255|FG001|Screening for Randomization|Neuropathy|0|||
30752503|NCT00114738|58762256|FG002|Screening for Randomization|Neuropathy|0|||
30752504|NCT00114738|58762254|FG000|Screening for Randomization|Progressive disease|2|||
30913323|NCT02196506|58948821|FG000|Phase B|Withdrawal by Participant|0|||
30752505|NCT00114738|58762255|FG001|Screening for Randomization|Progressive disease|0|||
30752506|NCT00114738|58762256|FG002|Screening for Randomization|Progressive disease|0|||
30752507|NCT00114738|58762254|FG000|Screening for Randomization|CNS Hemorrhage|1|||
30752508|NCT00114738|58762255|FG001|Screening for Randomization|CNS Hemorrhage|0|||
30752509|NCT00114738|58762256|FG002|Screening for Randomization|CNS Hemorrhage|0|||
30752510|NCT00114738|58762254|FG000|Screening for Randomization|Other|1|||
30752511|NCT00114738|58762255|FG001|Screening for Randomization|Other|0|||
30752512|NCT00114738|58762256|FG002|Screening for Randomization|Other|0|||
30752513|NCT00148122|58762263|FG000|Overall Study|Withdrawal by Subject|2|||
30752514|NCT00147498|58762271|FG000|Overall Study|Adverse Event|1|||
30820291|NCT04380519|58841262|FG000|Overall Study|relatives' decision|0|||
30820292|NCT04380519|58841263|FG001|Overall Study|relatives' decision|1|||
30820293|NCT04380519|58841264|FG002|Overall Study|relatives' decision|0|||
30820294|NCT02847182|58841274|FG000|Overall Study|Withdrawal by Subject|0|||
30820295|NCT02847182|58841275|FG001|Overall Study|Withdrawal by Subject|1|||
30820296|NCT02846558|58841291|FG000|Overall Study|Adverse Event|1|||
30820297|NCT02846558|58841292|FG001|Overall Study|Adverse Event|0|||
30913324|NCT02196506|58948822|FG001|Phase B|Withdrawal by Participant|8|||
30913325|NCT02196506|58948823|FG002|Phase B|Withdrawal by Participant|1|||
30913326|NCT02196506|58948824|FG003|Phase B|Withdrawal by Participant|0|||
30913327|NCT02196506|58948821|FG000|Phase B|Adverse Event|0|||
30913328|NCT02196506|58948822|FG001|Phase B|Adverse Event|4|||
30913329|NCT02196506|58948823|FG002|Phase B|Adverse Event|1|||
30913330|NCT02196506|58948824|FG003|Phase B|Adverse Event|0|||
30913331|NCT02196506|58948821|FG000|Phase B|Lost to Follow-up|0|||
30913332|NCT02196506|58948822|FG001|Phase B|Lost to Follow-up|2|||
30752515|NCT00147498|58762272|FG001|Overall Study|Adverse Event|6|||
30820298|NCT02846558|58841293|FG002|Overall Study|Adverse Event|0|||
30820299|NCT02846558|58841294|FG003|Overall Study|Adverse Event|0|||
30820300|NCT02846558|58841291|FG000|Overall Study|Withdrawal by Subject|5|||
30752516|NCT00147498|58762273|FG002|Overall Study|Adverse Event|7|||
30752517|NCT00147498|58762274|FG003|Overall Study|Adverse Event|3|||
30752518|NCT00147498|58762271|FG000|Overall Study|Lack of Efficacy|1|||
30752519|NCT00147498|58762272|FG001|Overall Study|Lack of Efficacy|1|||
30752520|NCT00147498|58762273|FG002|Overall Study|Lack of Efficacy|1|||
30820301|NCT02846558|58841292|FG001|Overall Study|Withdrawal by Subject|4|||
30820302|NCT02846558|58841293|FG002|Overall Study|Withdrawal by Subject|2|||
30820303|NCT02846558|58841294|FG003|Overall Study|Withdrawal by Subject|2|||
30820304|NCT02846558|58841291|FG000|Overall Study|Lost to Follow-up|2|||
30752521|NCT00147498|58762274|FG003|Overall Study|Lack of Efficacy|8|||
30752522|NCT00147498|58762271|FG000|Overall Study|Laboratory abnormality|0|||
30752523|NCT00147498|58762272|FG001|Overall Study|Laboratory abnormality|0|||
30913333|NCT02196506|58948823|FG002|Phase B|Lost to Follow-up|1|||
30913334|NCT02196506|58948824|FG003|Phase B|Lost to Follow-up|0|||
30820305|NCT02846558|58841292|FG001|Overall Study|Lost to Follow-up|0|||
30820306|NCT02846558|58841293|FG002|Overall Study|Lost to Follow-up|0|||
30752524|NCT00147498|58762273|FG002|Overall Study|Laboratory abnormality|2|||
30752525|NCT00147498|58762274|FG003|Overall Study|Laboratory abnormality|0|||
30752526|NCT00147498|58762271|FG000|Overall Study|Participant defaulted|0|||
30752527|NCT00147498|58762272|FG001|Overall Study|Participant defaulted|1|||
30752528|NCT00147498|58762273|FG002|Overall Study|Participant defaulted|4|||
30752529|NCT00147498|58762274|FG003|Overall Study|Participant defaulted|3|||
30820307|NCT02846558|58841294|FG003|Overall Study|Lost to Follow-up|0|||
30820308|NCT04362813|58841313|FG000|Overall Study|Death|12|||
30820309|NCT04362813|58841314|FG001|Overall Study|Death|16|||
30820310|NCT04362813|58841313|FG000|Overall Study|Withdrawal by Subject|3|||
30820311|NCT04362813|58841314|FG001|Overall Study|Withdrawal by Subject|1|||
30752530|NCT00147498|58762271|FG000|Overall Study|Other|1|||
30752531|NCT00147498|58762272|FG001|Overall Study|Other|1|||
30752532|NCT00147498|58762273|FG002|Overall Study|Other|3|||
30752533|NCT00147498|58762274|FG003|Overall Study|Other|3|||
30752534|NCT00113568|58762284|FG000|Overall Study|Adverse Event|97|||
30752535|NCT00113568|58762284|FG000|Overall Study|Death|1|||
30752536|NCT00113568|58762284|FG000|Overall Study|Lack of Efficacy|30|||
30913335|NCT02196506|58948821|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
30913336|NCT02196506|58948822|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
30913337|NCT02196506|58948823|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
30913338|NCT02196506|58948824|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
30913339|NCT02196506|58948821|FG000|Phase A+|Withdrawal by Participant|0|||
30913340|NCT02196506|58948822|FG001|Phase A+|Withdrawal by Participant|0|||
30913341|NCT02196506|58948823|FG002|Phase A+|Withdrawal by Participant|0|||
30913342|NCT02196506|58948824|FG003|Phase A+|Withdrawal by Participant|5|||
30913343|NCT02196506|58948821|FG000|Phase A+|Adverse Event|0|||
30913344|NCT02196506|58948822|FG001|Phase A+|Adverse Event|0|||
30913345|NCT02196506|58948823|FG002|Phase A+|Adverse Event|0|||
30913346|NCT02196506|58948824|FG003|Phase A+|Adverse Event|1|||
30913347|NCT02196506|58948821|FG000|Phase A+|Lost to Follow-up|0|||
30913348|NCT02196506|58948822|FG001|Phase A+|Lost to Follow-up|0|||
30913349|NCT02196506|58948823|FG002|Phase A+|Lost to Follow-up|0|||
30913350|NCT02196506|58948824|FG003|Phase A+|Lost to Follow-up|6|||
30913351|NCT02196506|58948821|FG000|Phase A+|Participant withdrawn by investigator|0|||
30913352|NCT02196506|58948822|FG001|Phase A+|Participant withdrawn by investigator|0|||
30913353|NCT02196506|58948823|FG002|Phase A+|Participant withdrawn by investigator|0|||
30913354|NCT02196506|58948824|FG003|Phase A+|Participant withdrawn by investigator|1|||
30913355|NCT02228720|58948830|FG000|Open Label - Day 30|Lost to Follow-up|1|||
30913356|NCT02228564|58948834|FG000|Overall Study|Withdrawal by Subject|10|||
30913357|NCT02228564|58948834|FG000|Overall Study|Death|11|||
30913358|NCT02228564|58948834|FG000|Overall Study|Physician Decision|5|||
30820312|NCT04362813|58841313|FG000|Overall Study|Protocol Violation|0|||
30820313|NCT04362813|58841314|FG001|Overall Study|Protocol Violation|3|||
30820314|NCT04362813|58841313|FG000|Overall Study|Lost to Follow-up|1|||
30820315|NCT04362813|58841314|FG001|Overall Study|Lost to Follow-up|1|||
30820316|NCT04362813|58841313|FG000|Overall Study|Enrolled but did not receive treatment|2|||
30820317|NCT04362813|58841314|FG001|Overall Study|Enrolled but did not receive treatment|4|||
30820318|NCT02966028|58841323|FG000|Overall Study|Adverse Event|7|||
30820319|NCT02966028|58841324|FG001|Overall Study|Adverse Event|13|||
30820320|NCT02966028|58841325|FG002|Overall Study|Adverse Event|10|||
30820321|NCT02966028|58841323|FG000|Overall Study|Physician Decision|1|||
30820322|NCT02966028|58841324|FG001|Overall Study|Physician Decision|0|||
30820323|NCT02966028|58841325|FG002|Overall Study|Physician Decision|2|||
30820324|NCT02966028|58841323|FG000|Overall Study|Withdrawal by Subject|7|||
30820325|NCT02966028|58841324|FG001|Overall Study|Withdrawal by Subject|5|||
30820326|NCT02966028|58841325|FG002|Overall Study|Withdrawal by Subject|5|||
30820327|NCT02966028|58841323|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
30820328|NCT02966028|58841324|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
30820329|NCT02966028|58841325|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
30820330|NCT02925741|58841339|FG000|Overall Study|Withdrawal by Subject|11|||
30820331|NCT02925741|58841340|FG001|Overall Study|Withdrawal by Subject|0|||
30820332|NCT02964312|58841349|FG000|Overall Study|Lost to Follow-up|28|||
30820333|NCT02964312|58841349|FG000|Overall Study|Withdrawal by Subject|11|||
30820334|NCT02964312|58841349|FG000|Overall Study|Lack of Efficacy|10|||
30820335|NCT02964312|58841349|FG000|Overall Study|Did not consent to long-term FU|14|||
30820336|NCT02964312|58841349|FG000|Overall Study|Death|1|||
30820337|NCT02899962|58841373|FG000|Open-label Phase|Adverse Event|2|||
30913359|NCT02228564|58948834|FG000|Overall Study|Lost to Follow-up|17|||
30913360|NCT02228564|58948834|FG000|Overall Study|Other|6|||
30913361|NCT01640951|58948846|FG000|Overall Study|Adverse Event|8|||
30820338|NCT02899962|58841374|FG001|Open-label Phase|Adverse Event|0|||
30913362|NCT01640951|58948847|FG001|Overall Study|Adverse Event|3|||
30820339|NCT02899962|58841375|FG002|Open-label Phase|Adverse Event|0|||
30820340|NCT02899962|58841373|FG000|Open-label Phase|Lost to Follow-up|9|||
30820341|NCT02899962|58841374|FG001|Open-label Phase|Lost to Follow-up|0|||
30820342|NCT02899962|58841375|FG002|Open-label Phase|Lost to Follow-up|0|||
30820343|NCT02899962|58841373|FG000|Open-label Phase|Other reasons|9|||
30820344|NCT02899962|58841374|FG001|Open-label Phase|Other reasons|0|||
30913363|NCT01640951|58948848|FG002|Overall Study|Adverse Event|10|||
30913364|NCT01640951|58948849|FG003|Overall Study|Adverse Event|6|||
30913365|NCT01640951|58948850|FG004|Overall Study|Adverse Event|1|||
30752537|NCT00113568|58762284|FG000|Overall Study|Lost to Follow-up|156|||
30752538|NCT00113568|58762284|FG000|Overall Study|Protocol Violation|32|||
30752539|NCT00113568|58762284|FG000|Overall Study|Withdrawal by Subject|117|||
30752540|NCT00113568|58762284|FG000|Overall Study|Other|112|||
30752541|NCT00113490|58762290|FG000|Overall Study|Withdrawal by Subject|1|||
30752542|NCT00113490|58762291|FG001|Overall Study|Withdrawal by Subject|3|||
30913366|NCT01640951|58948851|FG005|Overall Study|Adverse Event|11|||
30913367|NCT01640951|58948852|FG006|Overall Study|Adverse Event|1|||
30913368|NCT01640951|58948853|FG007|Overall Study|Adverse Event|3|||
30913369|NCT01640951|58948846|FG000|Overall Study|Lack of Efficacy|20|||
30913370|NCT01640951|58948847|FG001|Overall Study|Lack of Efficacy|1|||
30913371|NCT01640951|58948848|FG002|Overall Study|Lack of Efficacy|7|||
30913372|NCT01640951|58948849|FG003|Overall Study|Lack of Efficacy|14|||
30913373|NCT01640951|58948850|FG004|Overall Study|Lack of Efficacy|0|||
30913374|NCT01640951|58948851|FG005|Overall Study|Lack of Efficacy|6|||
30913375|NCT01640951|58948852|FG006|Overall Study|Lack of Efficacy|5|||
30913376|NCT01640951|58948853|FG007|Overall Study|Lack of Efficacy|6|||
30913377|NCT01640951|58948846|FG000|Overall Study|Lost to Follow-up|1|||
30913378|NCT01640951|58948847|FG001|Overall Study|Lost to Follow-up|0|||
30913379|NCT01640951|58948848|FG002|Overall Study|Lost to Follow-up|6|||
30913380|NCT01640951|58948849|FG003|Overall Study|Lost to Follow-up|2|||
30913381|NCT01640951|58948850|FG004|Overall Study|Lost to Follow-up|2|||
30913382|NCT01640951|58948851|FG005|Overall Study|Lost to Follow-up|3|||
30913383|NCT01640951|58948852|FG006|Overall Study|Lost to Follow-up|1|||
30913384|NCT01640951|58948853|FG007|Overall Study|Lost to Follow-up|1|||
30913385|NCT01640951|58948846|FG000|Overall Study|Non-compliance with study treatment|0|||
30913386|NCT01640951|58948847|FG001|Overall Study|Non-compliance with study treatment|0|||
30913387|NCT01640951|58948848|FG002|Overall Study|Non-compliance with study treatment|1|||
30913388|NCT01640951|58948849|FG003|Overall Study|Non-compliance with study treatment|1|||
30913389|NCT01640951|58948850|FG004|Overall Study|Non-compliance with study treatment|1|||
30913390|NCT01640951|58948851|FG005|Overall Study|Non-compliance with study treatment|4|||
30913391|NCT01640951|58948852|FG006|Overall Study|Non-compliance with study treatment|1|||
30913392|NCT01640951|58948853|FG007|Overall Study|Non-compliance with study treatment|0|||
30913393|NCT01640951|58948846|FG000|Overall Study|Physician Decision|2|||
30913394|NCT01640951|58948847|FG001|Overall Study|Physician Decision|5|||
30913395|NCT01640951|58948848|FG002|Overall Study|Physician Decision|2|||
30913396|NCT01640951|58948849|FG003|Overall Study|Physician Decision|2|||
30913397|NCT01640951|58948850|FG004|Overall Study|Physician Decision|2|||
30913398|NCT01640951|58948851|FG005|Overall Study|Physician Decision|3|||
30913399|NCT01640951|58948852|FG006|Overall Study|Physician Decision|3|||
30913400|NCT01640951|58948853|FG007|Overall Study|Physician Decision|0|||
30913401|NCT01640951|58948846|FG000|Overall Study|Pregnancy|3|||
30752543|NCT00113490|58762290|FG000|Overall Study|Lost to Follow-up|1|||
30820345|NCT02899962|58841375|FG002|Open-label Phase|Other reasons|0|||
30820346|NCT02899962|58841373|FG000|Open-label Phase|Withdrawal by Subject|7|||
30820347|NCT02899962|58841374|FG001|Open-label Phase|Withdrawal by Subject|0|||
30820348|NCT02899962|58841375|FG002|Open-label Phase|Withdrawal by Subject|0|||
30820349|NCT02899962|58841373|FG000|Maintenance Phase|Adverse Event|0|||
30820350|NCT02899962|58841374|FG001|Maintenance Phase|Adverse Event|2|||
30820351|NCT02899962|58841375|FG002|Maintenance Phase|Adverse Event|1|||
30820352|NCT02899962|58841373|FG000|Maintenance Phase|Death|0|||
30820353|NCT02899962|58841374|FG001|Maintenance Phase|Death|0|||
30820354|NCT02899962|58841375|FG002|Maintenance Phase|Death|1|||
30820355|NCT02899962|58841373|FG000|Maintenance Phase|Lack of Efficacy|0|||
30913402|NCT01640951|58948847|FG001|Overall Study|Pregnancy|0|||
30913403|NCT01640951|58948848|FG002|Overall Study|Pregnancy|0|||
30820356|NCT02899962|58841374|FG001|Maintenance Phase|Lack of Efficacy|20|||
30752544|NCT00113490|58762291|FG001|Overall Study|Lost to Follow-up|0|||
30820357|NCT02899962|58841375|FG002|Maintenance Phase|Lack of Efficacy|16|||
30913404|NCT01640951|58948849|FG003|Overall Study|Pregnancy|4|||
30913405|NCT01640951|58948850|FG004|Overall Study|Pregnancy|0|||
30913406|NCT01640951|58948851|FG005|Overall Study|Pregnancy|0|||
30752545|NCT00146640|58762299|FG000|Overall Study|Adverse Event|12|||
30820358|NCT02899962|58841373|FG000|Maintenance Phase|Lost to Follow-up|0|||
30913407|NCT01640951|58948852|FG006|Overall Study|Pregnancy|2|||
30913408|NCT01640951|58948853|FG007|Overall Study|Pregnancy|0|||
30820359|NCT02899962|58841374|FG001|Maintenance Phase|Lost to Follow-up|12|||
30820360|NCT02899962|58841375|FG002|Maintenance Phase|Lost to Follow-up|14|||
30820361|NCT02899962|58841373|FG000|Maintenance Phase|Other reasons|0|||
30820362|NCT02899962|58841374|FG001|Maintenance Phase|Other reasons|9|||
30820363|NCT02899962|58841375|FG002|Maintenance Phase|Other reasons|13|||
30820364|NCT02899962|58841373|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
30820365|NCT02899962|58841374|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
30820366|NCT02899962|58841375|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
30820367|NCT02899962|58841373|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
30820368|NCT02899962|58841374|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
30820369|NCT02899962|58841375|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
30820370|NCT02899962|58841373|FG000|Maintenance Phase|Withdrawal by Subject|0|||
30820371|NCT02899962|58841374|FG001|Maintenance Phase|Withdrawal by Subject|30|||
30820372|NCT02899962|58841375|FG002|Maintenance Phase|Withdrawal by Subject|36|||
30820373|NCT02899728|58841384|FG000|Overall Study|Withdrawal by Subject|1|||
30820374|NCT02899728|58841385|FG001|Overall Study|Withdrawal by Subject|1|||
30820375|NCT02899338|58841393|FG000|Overall Study|Adverse Event|1|||
30820376|NCT02899338|58841394|FG001|Overall Study|Adverse Event|2|||
30913409|NCT01640951|58948846|FG000|Overall Study|Protocol Deviation|0|||
30913410|NCT01640951|58948847|FG001|Overall Study|Protocol Deviation|1|||
30913411|NCT01640951|58948848|FG002|Overall Study|Protocol Deviation|2|||
30913412|NCT01640951|58948849|FG003|Overall Study|Protocol Deviation|1|||
30913413|NCT01640951|58948850|FG004|Overall Study|Protocol Deviation|0|||
30913414|NCT01640951|58948851|FG005|Overall Study|Protocol Deviation|1|||
30913415|NCT01640951|58948852|FG006|Overall Study|Protocol Deviation|0|||
30913416|NCT01640951|58948853|FG007|Overall Study|Protocol Deviation|0|||
30752546|NCT00146640|58762300|FG001|Overall Study|Adverse Event|10|||
30752547|NCT00146640|58762299|FG000|Overall Study|Medical Reasons|3|||
30752548|NCT00146640|58762300|FG001|Overall Study|Medical Reasons|0|||
30752549|NCT00146640|58762299|FG000|Overall Study|Non-Medical Reasons|8|||
30752550|NCT00146640|58762300|FG001|Overall Study|Non-Medical Reasons|4|||
30752551|NCT03737110|58762317|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
30752552|NCT03737110|58762318|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
30752553|NCT03737110|58762319|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
30752554|NCT03737110|58762317|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
30752555|NCT03737110|58762318|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
30752556|NCT03737110|58762319|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
30752557|NCT03737110|58762317|FG000|Run-in (RI) Period|Adverse Event|4|||
30820377|NCT02899338|58841393|FG000|Overall Study|Withdrawal by Subject|2|||
30820378|NCT02899338|58841394|FG001|Overall Study|Withdrawal by Subject|0|||
30752558|NCT03737110|58762318|FG001|Run-in (RI) Period|Adverse Event|0|||
30752559|NCT03737110|58762319|FG002|Run-in (RI) Period|Adverse Event|0|||
30820379|NCT03066609|58841403|FG000|INDUCTION|Pregnancy|0|||
30820380|NCT03066609|58841404|FG001|INDUCTION|Pregnancy|0|||
30820381|NCT03066609|58841405|FG002|INDUCTION|Pregnancy|1|||
30820382|NCT03066609|58841406|FG003|INDUCTION|Pregnancy|0|||
30913417|NCT01640951|58948846|FG000|Overall Study|Subject/Guardian decision|12|||
30913418|NCT01640951|58948847|FG001|Overall Study|Subject/Guardian decision|4|||
30913419|NCT01640951|58948848|FG002|Overall Study|Subject/Guardian decision|13|||
30820383|NCT03066609|58841403|FG000|INDUCTION|Lack of Efficacy|0|||
30820384|NCT03066609|58841404|FG001|INDUCTION|Lack of Efficacy|0|||
30820385|NCT03066609|58841405|FG002|INDUCTION|Lack of Efficacy|1|||
30820386|NCT03066609|58841406|FG003|INDUCTION|Lack of Efficacy|0|||
30820387|NCT03066609|58841403|FG000|INDUCTION|Adverse Event|2|||
30820388|NCT03066609|58841404|FG001|INDUCTION|Adverse Event|2|||
30820389|NCT03066609|58841405|FG002|INDUCTION|Adverse Event|0|||
30820390|NCT03066609|58841406|FG003|INDUCTION|Adverse Event|0|||
30820391|NCT03066609|58841403|FG000|MAINTENANCE|Adverse Event|0|||
30820392|NCT03066609|58841404|FG001|MAINTENANCE|Adverse Event|0|||
30820393|NCT03066609|58841405|FG002|MAINTENANCE|Adverse Event|0|||
30820394|NCT03066609|58841406|FG003|MAINTENANCE|Adverse Event|1|||
30820395|NCT03066609|58841403|FG000|MAINTENANCE|Withdrawal by Subject|4|||
30820396|NCT03066609|58841404|FG001|MAINTENANCE|Withdrawal by Subject|2|||
30820397|NCT03066609|58841405|FG002|MAINTENANCE|Withdrawal by Subject|1|||
30913420|NCT01640951|58948849|FG003|Overall Study|Subject/Guardian decision|15|||
30913421|NCT01640951|58948850|FG004|Overall Study|Subject/Guardian decision|7|||
30820398|NCT03066609|58841406|FG003|MAINTENANCE|Withdrawal by Subject|1|||
30820399|NCT03066609|58841403|FG000|MAINTENANCE|Lost to Follow-up|0|||
30820400|NCT03066609|58841404|FG001|MAINTENANCE|Lost to Follow-up|1|||
30820401|NCT03066609|58841405|FG002|MAINTENANCE|Lost to Follow-up|1|||
30820402|NCT03066609|58841406|FG003|MAINTENANCE|Lost to Follow-up|0|||
30820403|NCT03066609|58841403|FG000|MAINTENANCE|Pregnancy|1|||
30820404|NCT03066609|58841404|FG001|MAINTENANCE|Pregnancy|0|||
30820405|NCT03066609|58841405|FG002|MAINTENANCE|Pregnancy|0|||
30820406|NCT03066609|58841406|FG003|MAINTENANCE|Pregnancy|0|||
30820407|NCT03066609|58841403|FG000|MAINTENANCE|Lack of Efficacy|2|||
30820408|NCT03066609|58841404|FG001|MAINTENANCE|Lack of Efficacy|1|||
30820409|NCT03066609|58841405|FG002|MAINTENANCE|Lack of Efficacy|0|||
30820410|NCT03066609|58841406|FG003|MAINTENANCE|Lack of Efficacy|1|||
30820411|NCT03066609|58841403|FG000|OVERALL STUDY|Adverse Event|2|||
30820412|NCT03066609|58841404|FG001|OVERALL STUDY|Adverse Event|2|||
30820413|NCT03066609|58841405|FG002|OVERALL STUDY|Adverse Event|0|||
30820414|NCT03066609|58841406|FG003|OVERALL STUDY|Adverse Event|1|||
30820415|NCT03066609|58841403|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
30820416|NCT03066609|58841404|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
30820417|NCT03066609|58841405|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
30913422|NCT01640951|58948851|FG005|Overall Study|Subject/Guardian decision|19|||
30913423|NCT01640951|58948852|FG006|Overall Study|Subject/Guardian decision|5|||
30752560|NCT03737110|58762317|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
30752561|NCT03737110|58762318|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
30913424|NCT01640951|58948853|FG007|Overall Study|Subject/Guardian decision|4|||
30913425|NCT01640951|58948846|FG000|Overall Study|Death|0|||
30913426|NCT01640951|58948847|FG001|Overall Study|Death|1|||
30913427|NCT01640951|58948848|FG002|Overall Study|Death|1|||
30913428|NCT01640951|58948849|FG003|Overall Study|Death|0|||
30913429|NCT01640951|58948850|FG004|Overall Study|Death|0|||
30752562|NCT03737110|58762319|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
30752563|NCT03737110|58762317|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
30752564|NCT03737110|58762318|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
30752565|NCT03737110|58762319|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
30752566|NCT00146328|58762340|FG000|Overall Study|Adverse Event|39|||
30752567|NCT00146328|58762341|FG001|Overall Study|Adverse Event|48|||
30752568|NCT00146328|58762342|FG002|Overall Study|Adverse Event|79|||
30752569|NCT00146328|58762340|FG000|Overall Study|Protocol Violation|11|||
30752570|NCT00146328|58762341|FG001|Overall Study|Protocol Violation|6|||
30820418|NCT03066609|58841406|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
30913430|NCT01640951|58948851|FG005|Overall Study|Death|0|||
30752571|NCT00146328|58762342|FG002|Overall Study|Protocol Violation|12|||
30820419|NCT03066609|58841403|FG000|OVERALL STUDY|Lost to Follow-up|1|||
30820420|NCT03066609|58841404|FG001|OVERALL STUDY|Lost to Follow-up|1|||
30913431|NCT01640951|58948852|FG006|Overall Study|Death|0|||
30913432|NCT01640951|58948853|FG007|Overall Study|Death|2|||
30752572|NCT00146328|58762340|FG000|Overall Study|Lost to Follow-up|7|||
30820421|NCT03066609|58841405|FG002|OVERALL STUDY|Lost to Follow-up|1|||
30820422|NCT03066609|58841406|FG003|OVERALL STUDY|Lost to Follow-up|1|||
30820423|NCT03066609|58841403|FG000|OVERALL STUDY|Pregnancy|1|||
30913433|NCT02228096|58948875|FG000|Overall Study|Study terminated by Sponsor|24|||
30913434|NCT02228096|58948875|FG000|Overall Study|Lack of Efficacy|18|||
30820424|NCT03066609|58841404|FG001|OVERALL STUDY|Pregnancy|0|||
30820425|NCT03066609|58841405|FG002|OVERALL STUDY|Pregnancy|1|||
30820426|NCT03066609|58841406|FG003|OVERALL STUDY|Pregnancy|0|||
30820427|NCT03066609|58841403|FG000|OVERALL STUDY|Lack of Efficacy|2|||
30913435|NCT02228096|58948875|FG000|Overall Study|Death|12|||
30913436|NCT02228096|58948875|FG000|Overall Study|Physician Decision|3|||
30913437|NCT02228096|58948875|FG000|Overall Study|Subject/guardian decision|2|||
30913438|NCT02228096|58948875|FG000|Overall Study|New therapy for study indication|1|||
30913439|NCT02228096|58948875|FG000|Overall Study|Enrolled, not infused|11|||
30913440|NCT01640873|58948895|FG000|Overall Study|Protocol Violation|2|||
30913441|NCT01640873|58948896|FG001|Overall Study|Protocol Violation|1|||
30913442|NCT01683994|58948907|FG000|Overall Study|Withdrawal by Subject|1|||
30913443|NCT01683994|58948908|FG001|Overall Study|Withdrawal by Subject|0|||
30913444|NCT01683994|58948909|FG002|Overall Study|Withdrawal by Subject|0|||
30913445|NCT01683994|58948910|FG003|Overall Study|Withdrawal by Subject|1|||
30752573|NCT00146328|58762341|FG001|Overall Study|Lost to Follow-up|4|||
30752574|NCT00146328|58762342|FG002|Overall Study|Lost to Follow-up|7|||
30752575|NCT00146328|58762340|FG000|Overall Study|Withdrawal by Subject|16|||
30752576|NCT00146328|58762341|FG001|Overall Study|Withdrawal by Subject|16|||
30752577|NCT00146328|58762342|FG002|Overall Study|Withdrawal by Subject|22|||
30820428|NCT03066609|58841404|FG001|OVERALL STUDY|Lack of Efficacy|1|||
30820429|NCT03066609|58841405|FG002|OVERALL STUDY|Lack of Efficacy|1|||
30752578|NCT00146328|58762340|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
30752579|NCT00146328|58762341|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
30752580|NCT00146328|58762342|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
30752581|NCT00146328|58762340|FG000|Overall Study|Trial ended/site closed|8|||
30752582|NCT00146328|58762341|FG001|Overall Study|Trial ended/site closed|2|||
30752583|NCT00146328|58762342|FG002|Overall Study|Trial ended/site closed|19|||
30752584|NCT00146328|58762340|FG000|Overall Study|Patient decision to end|0|||
30820430|NCT03066609|58841406|FG003|OVERALL STUDY|Lack of Efficacy|1|||
30820431|NCT03066609|58841403|FG000|OVERALL STUDY|discontinued follow up|0|||
30820432|NCT03066609|58841404|FG001|OVERALL STUDY|discontinued follow up|2|||
30820433|NCT03066609|58841405|FG002|OVERALL STUDY|discontinued follow up|0|||
30820434|NCT03066609|58841406|FG003|OVERALL STUDY|discontinued follow up|0|||
30820435|NCT02964234|58841423|FG000|Overall Study|Lost to Follow-up|22|||
30820436|NCT02964234|58841424|FG001|Overall Study|Lost to Follow-up|13|||
30820437|NCT01345188|58841430|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
30820438|NCT01345188|58841430|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
30820439|NCT03852459|58841439|FG000|Overall Study|Adverse Event|2|||
30820440|NCT03852459|58841440|FG001|Overall Study|Adverse Event|2|||
30820441|NCT03852459|58841439|FG000|Overall Study|Withdrawal by Subject|1|||
30820442|NCT03852459|58841440|FG001|Overall Study|Withdrawal by Subject|1|||
30820443|NCT02896296|58841446|FG000|Overall Study|Adverse Event|1|||
30820444|NCT02896296|58841446|FG000|Overall Study|Lost to Follow-up|19|||
30820445|NCT02896296|58841446|FG000|Overall Study|Pregnancy|1|||
30820446|NCT02896296|58841446|FG000|Overall Study|Physician Decision|2|||
30820447|NCT02896296|58841446|FG000|Overall Study|Withdrawal by Subject|10|||
30820448|NCT02896296|58841446|FG000|Overall Study|Site closing|7|||
30820449|NCT02896296|58841446|FG000|Overall Study|Incarceration|1|||
30820450|NCT02896296|58841446|FG000|Overall Study|Relocation|1|||
30820451|NCT03740919|58841453|FG000|Lead-in Period|Lost to Follow-up|1|||
30820452|NCT03740919|58841454|FG001|Lead-in Period|Lost to Follow-up|0|||
30820453|NCT03740919|58841455|FG002|Lead-in Period|Lost to Follow-up|0|||
30820454|NCT03740919|58841456|FG003|Lead-in Period|Lost to Follow-up|0|||
30820455|NCT03740919|58841453|FG000|Lead-in Period|Physician Decision|2|||
30820456|NCT03740919|58841454|FG001|Lead-in Period|Physician Decision|0|||
30820457|NCT03740919|58841455|FG002|Lead-in Period|Physician Decision|0|||
30820458|NCT03740919|58841456|FG003|Lead-in Period|Physician Decision|0|||
30820459|NCT03740919|58841453|FG000|Lead-in Period|Protocol Violation|1|||
30820460|NCT03740919|58841454|FG001|Lead-in Period|Protocol Violation|0|||
30820461|NCT03740919|58841455|FG002|Lead-in Period|Protocol Violation|0|||
30820462|NCT03740919|58841456|FG003|Lead-in Period|Protocol Violation|0|||
30820463|NCT03740919|58841453|FG000|Lead-in Period|Withdrawal by Subject|10|||
30820464|NCT03740919|58841454|FG001|Lead-in Period|Withdrawal by Subject|0|||
30820465|NCT03740919|58841455|FG002|Lead-in Period|Withdrawal by Subject|0|||
30820466|NCT03740919|58841456|FG003|Lead-in Period|Withdrawal by Subject|0|||
30820467|NCT03740919|58841453|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
30913446|NCT01683994|58948911|FG004|Overall Study|Withdrawal by Subject|0|||
30913447|NCT01683994|58948907|FG000|Overall Study|Intercurrent illness|0|||
30913448|NCT01683994|58948908|FG001|Overall Study|Intercurrent illness|0|||
30752585|NCT00146328|58762341|FG001|Overall Study|Patient decision to end|1|||
30752586|NCT00146328|58762342|FG002|Overall Study|Patient decision to end|6|||
30752587|NCT00146328|58762340|FG000|Overall Study|Enroll into other trial|2|||
30820468|NCT03740919|58841454|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
30820469|NCT03740919|58841455|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
30913449|NCT01683994|58948909|FG002|Overall Study|Intercurrent illness|0|||
30820470|NCT03740919|58841456|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
30820471|NCT03740919|58841453|FG000|Lead-in Period|Study Task Too Burdensome|1|||
30820472|NCT03740919|58841454|FG001|Lead-in Period|Study Task Too Burdensome|0|||
30820473|NCT03740919|58841455|FG002|Lead-in Period|Study Task Too Burdensome|0|||
30913450|NCT01683994|58948910|FG003|Overall Study|Intercurrent illness|2|||
30913451|NCT01683994|58948911|FG004|Overall Study|Intercurrent illness|1|||
30820474|NCT03740919|58841456|FG003|Lead-in Period|Study Task Too Burdensome|0|||
30820475|NCT03740919|58841453|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
30820476|NCT03740919|58841454|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
30820477|NCT03740919|58841455|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
30820478|NCT03740919|58841456|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
30820479|NCT03740919|58841453|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
30820480|NCT03740919|58841454|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
30913452|NCT02247440|58948929|FG000|Overall Study|Withdrawal by Subject|1|||
30913453|NCT02247440|58948929|FG000|Overall Study|Lack of Efficacy|3|||
30913454|NCT01683838|58948935|FG000|Overall Study|Adverse Event|12|||
30913455|NCT01683838|58948936|FG001|Overall Study|Adverse Event|2|||
30820481|NCT03740919|58841455|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
30820482|NCT03740919|58841456|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
30820483|NCT03740919|58841453|FG000|Treatment Period|Adverse Event|0|||
30820484|NCT03740919|58841454|FG001|Treatment Period|Adverse Event|0|||
30820485|NCT03740919|58841455|FG002|Treatment Period|Adverse Event|2|||
30820486|NCT03740919|58841456|FG003|Treatment Period|Adverse Event|0|||
30820487|NCT03740919|58841453|FG000|Treatment Period|Protocol Violation|0|||
30820488|NCT03740919|58841454|FG001|Treatment Period|Protocol Violation|1|||
30820489|NCT03740919|58841455|FG002|Treatment Period|Protocol Violation|0|||
30820490|NCT03740919|58841456|FG003|Treatment Period|Protocol Violation|0|||
30820491|NCT03740919|58841453|FG000|Treatment Period|Withdrawal by Subject|0|||
30820492|NCT03740919|58841454|FG001|Treatment Period|Withdrawal by Subject|7|||
30820493|NCT03740919|58841455|FG002|Treatment Period|Withdrawal by Subject|6|||
30820494|NCT03740919|58841456|FG003|Treatment Period|Withdrawal by Subject|2|||
30820495|NCT03740919|58841453|FG000|Treatment Period|Terminated by Sponsor|0|||
30820496|NCT03740919|58841454|FG001|Treatment Period|Terminated by Sponsor|1|||
30820497|NCT03740919|58841455|FG002|Treatment Period|Terminated by Sponsor|0|||
30820498|NCT03740919|58841456|FG003|Treatment Period|Terminated by Sponsor|0|||
30820499|NCT03740919|58841453|FG000|Treatment Period|Issue with Insulin Pump|0|||
30820500|NCT03740919|58841454|FG001|Treatment Period|Issue with Insulin Pump|1|||
30820501|NCT03740919|58841455|FG002|Treatment Period|Issue with Insulin Pump|0|||
30820502|NCT03740919|58841456|FG003|Treatment Period|Issue with Insulin Pump|0|||
30820503|NCT03740919|58841453|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
30820504|NCT03740919|58841454|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
30820505|NCT03740919|58841455|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
30820506|NCT03740919|58841456|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
30820507|NCT03740919|58841453|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
30820508|NCT03740919|58841454|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
30820509|NCT03740919|58841455|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
30820510|NCT03740919|58841456|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
30820511|NCT03740919|58841453|FG000|Treatment Period|Not Completing Diary|0|||
30820512|NCT03740919|58841454|FG001|Treatment Period|Not Completing Diary|0|||
30820513|NCT03740919|58841455|FG002|Treatment Period|Not Completing Diary|1|||
30820514|NCT03740919|58841456|FG003|Treatment Period|Not Completing Diary|0|||
30913456|NCT01683838|58948935|FG000|Overall Study|Protocol Violation|3|||
30913457|NCT01683838|58948936|FG001|Overall Study|Protocol Violation|1|||
30820515|NCT03740919|58841453|FG000|Treatment Period|Insulin Painful to Participant|0|||
30820516|NCT03740919|58841454|FG001|Treatment Period|Insulin Painful to Participant|0|||
30820517|NCT03740919|58841455|FG002|Treatment Period|Insulin Painful to Participant|1|||
30820518|NCT03740919|58841456|FG003|Treatment Period|Insulin Painful to Participant|0|||
30820519|NCT01335685|58841471|FG000|Overall Study|Study Terminated by Sponsor|2|||
30820520|NCT01335685|58841472|FG001|Overall Study|Study Terminated by Sponsor|1|||
30820521|NCT01335685|58841473|FG002|Overall Study|Study Terminated by Sponsor|1|||
30820522|NCT01335685|58841474|FG003|Overall Study|Study Terminated by Sponsor|10|||
30820523|NCT01335685|58841475|FG004|Overall Study|Study Terminated by Sponsor|0|||
30820524|NCT01335685|58841476|FG005|Overall Study|Study Terminated by Sponsor|4|||
30820525|NCT01335685|58841477|FG006|Overall Study|Study Terminated by Sponsor|2|||
30913458|NCT01683838|58948935|FG000|Overall Study|Withdrawal by Subject|6|||
30913459|NCT01683838|58948936|FG001|Overall Study|Withdrawal by Subject|5|||
30913460|NCT01683838|58948935|FG000|Overall Study|Lost to Follow-up|1|||
30913461|NCT01683838|58948936|FG001|Overall Study|Lost to Follow-up|1|||
30913462|NCT01683838|58948935|FG000|Overall Study|Other|4|||
30913463|NCT01683838|58948936|FG001|Overall Study|Other|3|||
30820526|NCT01335685|58841478|FG007|Overall Study|Study Terminated by Sponsor|3|||
30820527|NCT01335685|58841471|FG000|Overall Study|Withdrawal by Subject|1|||
30820528|NCT01335685|58841472|FG001|Overall Study|Withdrawal by Subject|0|||
30820529|NCT01335685|58841473|FG002|Overall Study|Withdrawal by Subject|0|||
30820530|NCT01335685|58841474|FG003|Overall Study|Withdrawal by Subject|1|||
30820531|NCT01335685|58841475|FG004|Overall Study|Withdrawal by Subject|0|||
30820532|NCT01335685|58841476|FG005|Overall Study|Withdrawal by Subject|0|||
30820533|NCT01335685|58841477|FG006|Overall Study|Withdrawal by Subject|0|||
30820534|NCT01335685|58841478|FG007|Overall Study|Withdrawal by Subject|0|||
30820535|NCT01335685|58841471|FG000|Overall Study|Reason not Specified|0|||
30820536|NCT01335685|58841472|FG001|Overall Study|Reason not Specified|0|||
30820537|NCT01335685|58841473|FG002|Overall Study|Reason not Specified|1|||
30820538|NCT01335685|58841474|FG003|Overall Study|Reason not Specified|0|||
30820539|NCT01335685|58841475|FG004|Overall Study|Reason not Specified|0|||
30820540|NCT01335685|58841476|FG005|Overall Study|Reason not Specified|1|||
30820541|NCT01335685|58841477|FG006|Overall Study|Reason not Specified|0|||
30820542|NCT01335685|58841478|FG007|Overall Study|Reason not Specified|0|||
30913464|NCT01683604|58948942|FG000|Overall Study|Adverse Event|2|||
30913465|NCT01683604|58948942|FG000|Overall Study|Lack of Efficacy|1|||
30913466|NCT01683604|58948942|FG000|Overall Study|Other|2|||
30913467|NCT02196038|58948953|FG000|Overall Study|Death|16|||
30913468|NCT02196038|58948954|FG001|Overall Study|Death|21|||
30913469|NCT02196038|58948953|FG000|Overall Study|Withdrawal by Subject|0|||
30913470|NCT02196038|58948954|FG001|Overall Study|Withdrawal by Subject|1|||
30913471|NCT02196038|58948953|FG000|Overall Study|Lost to Follow-up|1|||
30820543|NCT02926209|58841501|FG000|Study Cohort|Poor Bowel Preparation|1|||
30820544|NCT02926209|58841502|FG001|Study Cohort|Poor Bowel Preparation|0|||
30820545|NCT03066999|58841511|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
30820546|NCT03066999|58841512|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
30820547|NCT02963922|58841526|FG000|Overall Study|Adverse Event|15|||
30820548|NCT02963922|58841527|FG001|Overall Study|Adverse Event|6|||
30820549|NCT02963922|58841526|FG000|Overall Study|Protocol deviation|6|||
30820550|NCT02963922|58841527|FG001|Overall Study|Protocol deviation|6|||
30820551|NCT02963922|58841526|FG000|Overall Study|Lack of Efficacy|1|||
30820552|NCT02963922|58841527|FG001|Overall Study|Lack of Efficacy|1|||
30820553|NCT02963922|58841526|FG000|Overall Study|Lost to Follow-up|2|||
30820554|NCT02963922|58841527|FG001|Overall Study|Lost to Follow-up|3|||
30820555|NCT02963922|58841526|FG000|Overall Study|Other|8|||
30820556|NCT02963922|58841527|FG001|Overall Study|Other|14|||
30820557|NCT02881567|58841533|FG000|Overall Study|Adverse Event|1|||
30820558|NCT02881567|58841533|FG000|Overall Study|Lost to Follow-up|3|||
30820559|NCT02881567|58841533|FG000|Overall Study|Consent withdrawn|1|||
30820560|NCT02881567|58841533|FG000|Overall Study|Investigator decision|1|||
30820561|NCT02881567|58841533|FG000|Overall Study|Study terminated by sponsor|9|||
30820562|NCT02881567|58841533|FG000|Overall Study|Reason not Specified|3|||
30820563|NCT02962674|58841537|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
30820564|NCT02962908|58841547|FG000|Overall Study|Lost to Follow-up|0|||
30820565|NCT02962908|58841548|FG001|Overall Study|Lost to Follow-up|3|||
30820566|NCT02962908|58841549|FG002|Overall Study|Lost to Follow-up|0|||
30820567|NCT02962908|58841550|FG003|Overall Study|Lost to Follow-up|1|||
30820568|NCT02962908|58841547|FG000|Overall Study|Withdrawal by Subject|0|||
30820569|NCT02962908|58841548|FG001|Overall Study|Withdrawal by Subject|3|||
30820570|NCT02962908|58841549|FG002|Overall Study|Withdrawal by Subject|0|||
30820571|NCT02962908|58841550|FG003|Overall Study|Withdrawal by Subject|2|||
30820572|NCT02962908|58841547|FG000|Overall Study|Protocol Violation|0|||
30820573|NCT02962908|58841548|FG001|Overall Study|Protocol Violation|1|||
30820574|NCT02962908|58841549|FG002|Overall Study|Protocol Violation|0|||
30820575|NCT02962908|58841550|FG003|Overall Study|Protocol Violation|0|||
30820576|NCT02962908|58841547|FG000|Overall Study|Physician Decision|0|||
30820577|NCT02962908|58841548|FG001|Overall Study|Physician Decision|1|||
30820578|NCT02962908|58841549|FG002|Overall Study|Physician Decision|0|||
30820579|NCT02962908|58841550|FG003|Overall Study|Physician Decision|0|||
30820580|NCT02962284|58841568|FG000|Overall Study|Death|2|||
30820581|NCT02962284|58841569|FG001|Overall Study|Death|0|||
30820582|NCT02962284|58841568|FG000|Overall Study|Progressive disease|2|||
30820583|NCT02962284|58841569|FG001|Overall Study|Progressive disease|3|||
30820584|NCT02962284|58841568|FG000|Overall Study|Withdrawal by Subject|1|||
30820585|NCT02962284|58841569|FG001|Overall Study|Withdrawal by Subject|0|||
30820586|NCT01344876|58841577|FG000|Overall Study|Adverse Event|0|||
30820587|NCT01344876|58841578|FG001|Overall Study|Adverse Event|0|||
30820588|NCT01344876|58841579|FG002|Overall Study|Adverse Event|0|||
30913472|NCT02196038|58948954|FG001|Overall Study|Lost to Follow-up|0|||
30913473|NCT02141659|58948966|FG000|Overall Study|Major Protocol Deviation|0|||
30913474|NCT02141659|58948967|FG001|Overall Study|Major Protocol Deviation|1|||
30913475|NCT02141659|58948968|FG002|Overall Study|Major Protocol Deviation|0|||
30913476|NCT02141659|58948969|FG003|Overall Study|Major Protocol Deviation|0|||
30913477|NCT02141659|58948970|FG004|Overall Study|Major Protocol Deviation|0|||
30820589|NCT01344876|58841580|FG003|Overall Study|Adverse Event|0|||
30820590|NCT01344876|58841581|FG004|Overall Study|Adverse Event|1|||
30820591|NCT01344876|58841577|FG000|Overall Study|Withdrawal by Subject|0|||
30820592|NCT01344876|58841578|FG001|Overall Study|Withdrawal by Subject|0|||
30820593|NCT01344876|58841579|FG002|Overall Study|Withdrawal by Subject|1|||
30820594|NCT01344876|58841580|FG003|Overall Study|Withdrawal by Subject|0|||
30820595|NCT01344876|58841581|FG004|Overall Study|Withdrawal by Subject|0|||
30820596|NCT01344876|58841577|FG000|Overall Study|Definite progression of primary disease|1|||
30820597|NCT01344876|58841578|FG001|Overall Study|Definite progression of primary disease|0|||
30820598|NCT01344876|58841579|FG002|Overall Study|Definite progression of primary disease|0|||
30820599|NCT01344876|58841580|FG003|Overall Study|Definite progression of primary disease|3|||
30820600|NCT01344876|58841581|FG004|Overall Study|Definite progression of primary disease|0|||
30820601|NCT02846324|58841598|FG000|Overall Study|Other|1|||
30820602|NCT02846324|58841599|FG001|Overall Study|Other|0|||
30820603|NCT02846324|58841600|FG002|Overall Study|Other|0|||
30820604|NCT02846324|58841601|FG003|Overall Study|Other|0|||
30820605|NCT02846324|58841598|FG000|Overall Study|Withdrawal by Subject|1|||
30820606|NCT02846324|58841599|FG001|Overall Study|Withdrawal by Subject|0|||
30820607|NCT02846324|58841600|FG002|Overall Study|Withdrawal by Subject|4|||
30820608|NCT02846324|58841601|FG003|Overall Study|Withdrawal by Subject|0|||
30820609|NCT03161093|58841626|FG000|Overall Study|Protocol Violation|11|||
30820610|NCT03161093|58841627|FG001|Overall Study|Protocol Violation|14|||
30820611|NCT03161093|58841628|FG002|Overall Study|Protocol Violation|6|||
30820612|NCT03161093|58841629|FG003|Overall Study|Protocol Violation|13|||
30820613|NCT03161093|58841630|FG004|Overall Study|Protocol Violation|1|||
30820614|NCT03161093|58841631|FG005|Overall Study|Protocol Violation|0|||
30820615|NCT03161093|58841626|FG000|Overall Study|Adverse Event|5|||
30820616|NCT03161093|58841627|FG001|Overall Study|Adverse Event|21|||
30820617|NCT03161093|58841628|FG002|Overall Study|Adverse Event|16|||
30820618|NCT03161093|58841629|FG003|Overall Study|Adverse Event|35|||
30820619|NCT03161093|58841630|FG004|Overall Study|Adverse Event|2|||
30820620|NCT03161093|58841631|FG005|Overall Study|Adverse Event|1|||
30820621|NCT03161093|58841626|FG000|Overall Study|Lack of Efficacy|9|||
30913478|NCT02141659|58948971|FG005|Overall Study|Major Protocol Deviation|0|||
30913479|NCT02141659|58948966|FG000|Overall Study|Lack of Efficacy|0|||
30913480|NCT02141659|58948967|FG001|Overall Study|Lack of Efficacy|0|||
30820622|NCT03161093|58841627|FG001|Overall Study|Lack of Efficacy|13|||
30820623|NCT03161093|58841628|FG002|Overall Study|Lack of Efficacy|9|||
30820624|NCT03161093|58841629|FG003|Overall Study|Lack of Efficacy|24|||
30820625|NCT03161093|58841630|FG004|Overall Study|Lack of Efficacy|4|||
30820626|NCT03161093|58841631|FG005|Overall Study|Lack of Efficacy|1|||
30820627|NCT03161093|58841626|FG000|Overall Study|Physician Decision|0|||
30820628|NCT03161093|58841627|FG001|Overall Study|Physician Decision|1|||
30820629|NCT03161093|58841628|FG002|Overall Study|Physician Decision|0|||
30820630|NCT03161093|58841629|FG003|Overall Study|Physician Decision|2|||
30820631|NCT03161093|58841630|FG004|Overall Study|Physician Decision|17|||
30752588|NCT00146328|58762341|FG001|Overall Study|Enroll into other trial|4|||
30752589|NCT00146328|58762342|FG002|Overall Study|Enroll into other trial|2|||
30752590|NCT00146328|58762340|FG000|Overall Study|Death|0|||
30752591|NCT00146328|58762341|FG001|Overall Study|Death|1|||
30752592|NCT00146328|58762342|FG002|Overall Study|Death|1|||
30752593|NCT00146328|58762340|FG000|Overall Study|Moved|2|||
30752594|NCT00146328|58762341|FG001|Overall Study|Moved|0|||
30752595|NCT00146328|58762342|FG002|Overall Study|Moved|0|||
30752596|NCT00146328|58762340|FG000|Overall Study|Interaction with other medication|2|||
30752597|NCT00146328|58762341|FG001|Overall Study|Interaction with other medication|0|||
30752598|NCT00146328|58762342|FG002|Overall Study|Interaction with other medication|1|||
30752599|NCT03733444|58762353|FG000|Overall Study|Adverse Event|8|||
30820632|NCT03161093|58841631|FG005|Overall Study|Physician Decision|15|||
30820633|NCT03161093|58841626|FG000|Overall Study|Withdrawal by Subject|24|||
30820634|NCT03161093|58841627|FG001|Overall Study|Withdrawal by Subject|73|||
30820635|NCT03161093|58841628|FG002|Overall Study|Withdrawal by Subject|44|||
30820636|NCT03161093|58841629|FG003|Overall Study|Withdrawal by Subject|97|||
30820637|NCT03161093|58841630|FG004|Overall Study|Withdrawal by Subject|11|||
30752600|NCT03733444|58762354|FG001|Overall Study|Adverse Event|10|||
30820638|NCT03161093|58841631|FG005|Overall Study|Withdrawal by Subject|10|||
30820639|NCT03161093|58841626|FG000|Overall Study|Lost to Follow-up|3|||
30820640|NCT03161093|58841627|FG001|Overall Study|Lost to Follow-up|12|||
30752601|NCT03733444|58762355|FG002|Overall Study|Adverse Event|5|||
30913481|NCT02141659|58948968|FG002|Overall Study|Lack of Efficacy|0|||
30913482|NCT02141659|58948969|FG003|Overall Study|Lack of Efficacy|0|||
30820641|NCT03161093|58841628|FG002|Overall Study|Lost to Follow-up|4|||
30820642|NCT03161093|58841629|FG003|Overall Study|Lost to Follow-up|7|||
30820643|NCT03161093|58841630|FG004|Overall Study|Lost to Follow-up|8|||
30820644|NCT03161093|58841631|FG005|Overall Study|Lost to Follow-up|13|||
30820645|NCT03161093|58841626|FG000|Overall Study|Death|3|||
30820646|NCT03161093|58841627|FG001|Overall Study|Death|9|||
30820647|NCT03161093|58841628|FG002|Overall Study|Death|7|||
30820648|NCT03161093|58841629|FG003|Overall Study|Death|9|||
30820649|NCT03161093|58841630|FG004|Overall Study|Death|0|||
30820650|NCT03161093|58841631|FG005|Overall Study|Death|0|||
30820651|NCT03161093|58841626|FG000|Overall Study|Unknown - Not reported|0|||
30820652|NCT03161093|58841627|FG001|Overall Study|Unknown - Not reported|1|||
30820653|NCT03161093|58841628|FG002|Overall Study|Unknown - Not reported|0|||
30820654|NCT03161093|58841629|FG003|Overall Study|Unknown - Not reported|0|||
30820655|NCT03161093|58841630|FG004|Overall Study|Unknown - Not reported|0|||
30820656|NCT03161093|58841631|FG005|Overall Study|Unknown - Not reported|1|||
30820657|NCT02847650|58841652|FG000|Overall Study|Adverse Event|2|||
30820658|NCT02847650|58841653|FG001|Overall Study|Adverse Event|4|||
30820659|NCT02847650|58841652|FG000|Overall Study|Lost to Follow-up|1|||
30820660|NCT02847650|58841653|FG001|Overall Study|Lost to Follow-up|0|||
30820661|NCT02847650|58841652|FG000|Overall Study|Protocol Violation|0|||
30820662|NCT02847650|58841653|FG001|Overall Study|Protocol Violation|1|||
30820663|NCT02847650|58841652|FG000|Overall Study|Withdrawal by Subject|1|||
30820664|NCT02847650|58841653|FG001|Overall Study|Withdrawal by Subject|1|||
30820665|NCT02847494|58841661|FG000|Overall Study|Lost to Follow-up|8|||
30820666|NCT02847494|58841662|FG001|Overall Study|Lost to Follow-up|5|||
30820667|NCT02554253|58841670|FG000|Overall Study|ineligible after enrollment|1|||
30820668|NCT02554253|58841671|FG001|Overall Study|ineligible after enrollment|0|||
30820669|NCT02554253|58841670|FG000|Overall Study|converted to transcatheter procedure|0|||
30820670|NCT02554253|58841671|FG001|Overall Study|converted to transcatheter procedure|1|||
30820671|NCT02554253|58841670|FG000|Overall Study|received both drugs|0|||
30820672|NCT02554253|58841671|FG001|Overall Study|received both drugs|1|||
30820673|NCT03157583|58841678|FG000|Overall Study|Other (did not meet study criteria)|1|||
30820674|NCT02842736|58841696|FG000|Overall Study|Lost to Follow-up|13|||
30820675|NCT02842736|58841696|FG000|Overall Study|Intervention for menstrual bleeding|17|||
30820676|NCT02842736|58841696|FG000|Overall Study|Withdrawal by Subject|4|||
30752602|NCT03733444|58762353|FG000|Overall Study|Death|20|||
30752603|NCT03733444|58762354|FG001|Overall Study|Death|19|||
30752604|NCT03733444|58762355|FG002|Overall Study|Death|11|||
30752605|NCT03733444|58762353|FG000|Overall Study|Lost to Follow-up|3|||
30752606|NCT03733444|58762354|FG001|Overall Study|Lost to Follow-up|0|||
30752607|NCT03733444|58762355|FG002|Overall Study|Lost to Follow-up|1|||
30752608|NCT03733444|58762353|FG000|Overall Study|Lack of Efficacy|0|||
30752609|NCT03733444|58762354|FG001|Overall Study|Lack of Efficacy|1|||
30752610|NCT03733444|58762355|FG002|Overall Study|Lack of Efficacy|1|||
30752611|NCT03733444|58762353|FG000|Overall Study|Physician Decision|2|||
30752612|NCT03733444|58762354|FG001|Overall Study|Physician Decision|1|||
30752613|NCT03733444|58762355|FG002|Overall Study|Physician Decision|0|||
30752614|NCT03733444|58762353|FG000|Overall Study|Protocol Violation|2|||
30752615|NCT03733444|58762354|FG001|Overall Study|Protocol Violation|1|||
30752616|NCT03733444|58762355|FG002|Overall Study|Protocol Violation|0|||
30752617|NCT03733444|58762353|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
30752618|NCT03733444|58762354|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
30752619|NCT03733444|58762355|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
30752620|NCT03733444|58762353|FG000|Overall Study|Study Terminated by Sponsor|203|||
30752621|NCT03733444|58762354|FG001|Overall Study|Study Terminated by Sponsor|209|||
30752622|NCT03733444|58762355|FG002|Overall Study|Study Terminated by Sponsor|221|||
30752623|NCT03733444|58762353|FG000|Overall Study|Withdrawal by Subject|19|||
30752624|NCT03733444|58762354|FG001|Overall Study|Withdrawal by Subject|18|||
30752625|NCT03733444|58762355|FG002|Overall Study|Withdrawal by Subject|16|||
30752626|NCT03733444|58762353|FG000|Overall Study|Miscellaneous|1|||
30752627|NCT03733444|58762354|FG001|Overall Study|Miscellaneous|0|||
30752628|NCT03733444|58762355|FG002|Overall Study|Miscellaneous|1|||
30752629|NCT03733444|58762353|FG000|Overall Study|Not Treated|1|||
30752630|NCT03733444|58762354|FG001|Overall Study|Not Treated|2|||
30752631|NCT03733444|58762355|FG002|Overall Study|Not Treated|1|||
30820677|NCT02842736|58841696|FG000|Overall Study|Pregnancy|3|||
30820678|NCT02842736|58841696|FG000|Overall Study|Hysterectomy for fibroids|2|||
30820679|NCT02842736|58841696|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
30820680|NCT02842736|58841696|FG000|Overall Study|IUD: Mirena|1|||
30820681|NCT01307033|58841702|FG000|8-week Double-blind Period|Adverse Event|2|||
30820682|NCT01307033|58841703|FG001|8-week Double-blind Period|Adverse Event|0|||
30820683|NCT01307033|58841704|FG002|8-week Double-blind Period|Adverse Event|0|||
30820684|NCT01307033|58841705|FG003|8-week Double-blind Period|Adverse Event|0|||
30820685|NCT01307033|58841702|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
30820686|NCT01307033|58841703|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
30820687|NCT01307033|58841704|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
30820688|NCT01307033|58841705|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
30820689|NCT01307033|58841702|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
30913483|NCT02141659|58948970|FG004|Overall Study|Lack of Efficacy|0|||
30913484|NCT02141659|58948971|FG005|Overall Study|Lack of Efficacy|1|||
30913485|NCT02141659|58948966|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
30913486|NCT02141659|58948967|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
30913487|NCT02141659|58948968|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
30913488|NCT02141659|58948969|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
30913489|NCT02141659|58948970|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
30913490|NCT02141659|58948971|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
30820690|NCT01307033|58841703|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
30820691|NCT01307033|58841704|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
30820692|NCT01307033|58841705|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
30820693|NCT01307033|58841702|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
30820694|NCT01307033|58841703|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
30820695|NCT01307033|58841704|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
30820696|NCT01307033|58841705|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
30623083|NCT01169987|58634867|FG000|Overall Study|Lost to Follow-up|24|||
30820697|NCT01307033|58841702|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
30820698|NCT01307033|58841703|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
30820699|NCT01307033|58841704|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
30820700|NCT01307033|58841705|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
30820701|NCT01307033|58841702|FG000|44-week Open-label Extension|Adverse Event|0|||
30913491|NCT01640249|58948992|FG000|Period 1|Withdrawal by Subject|1|||
30913492|NCT01640249|58948993|FG001|Period 1|Withdrawal by Subject|0|||
30820702|NCT01307033|58841703|FG001|44-week Open-label Extension|Adverse Event|0|||
30820703|NCT01307033|58841704|FG002|44-week Open-label Extension|Adverse Event|2|||
30820704|NCT01307033|58841705|FG003|44-week Open-label Extension|Adverse Event|1|||
30820705|NCT01307033|58841702|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
30820706|NCT01307033|58841703|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
30913493|NCT01640249|58948994|FG002|Period 1|Withdrawal by Subject|0|||
30913494|NCT01640249|58948995|FG003|Period 1|Withdrawal by Subject|0|||
30913495|NCT01640249|58948996|FG004|Period 1|Withdrawal by Subject|0|||
30913496|NCT01640249|58948997|FG005|Period 1|Withdrawal by Subject|1|||
30913497|NCT01640249|58948998|FG006|Period 1|Withdrawal by Subject|0|||
30913498|NCT02121301|58949020|FG000|Overall Study|Protocol Violation|1|||
30913499|NCT02121301|58949021|FG001|Overall Study|Protocol Violation|4|||
30820707|NCT01307033|58841704|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
30820708|NCT01307033|58841705|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
30820709|NCT01307033|58841702|FG000|44-week Open-label Extension|Physician Decision|0|||
30820710|NCT01307033|58841703|FG001|44-week Open-label Extension|Physician Decision|0|||
30820711|NCT01307033|58841704|FG002|44-week Open-label Extension|Physician Decision|1|||
30820712|NCT01307033|58841705|FG003|44-week Open-label Extension|Physician Decision|0|||
30820713|NCT01307033|58841702|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
30820714|NCT01307033|58841703|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
30820715|NCT01307033|58841704|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
30820716|NCT01307033|58841705|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
30820717|NCT01307033|58841702|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
30820718|NCT01307033|58841703|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
30913500|NCT02121301|58949022|FG002|Overall Study|Protocol Violation|1|||
30913501|NCT02227862|58949032|FG000|Overall Study|Protocol Violation|7|||
30913502|NCT02227862|58949033|FG001|Overall Study|Protocol Violation|9|||
30913503|NCT02227862|58949032|FG000|Overall Study|Other|0|||
30913504|NCT02227862|58949033|FG001|Overall Study|Other|2|||
30623084|NCT01169987|58634867|FG000|Overall Study|Other|4|||
30820719|NCT01307033|58841704|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
30820720|NCT01307033|58841705|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
30820721|NCT01307033|58841702|FG000|44-week Open-label Extension|Death|0|||
30820722|NCT01307033|58841703|FG001|44-week Open-label Extension|Death|0|||
30820723|NCT01307033|58841704|FG002|44-week Open-label Extension|Death|0|||
30820724|NCT01307033|58841705|FG003|44-week Open-label Extension|Death|1|||
30820725|NCT02844920|58841717|FG000|Overall Study|Lost to Follow-up|2|||
30820726|NCT03158311|58841724|FG000|Overall Study|Subject/Guardian Decision|10|||
30820727|NCT03158311|58841725|FG001|Overall Study|Subject/Guardian Decision|6|||
30820728|NCT03158311|58841726|FG002|Overall Study|Subject/Guardian Decision|11|||
30820729|NCT03158311|58841724|FG000|Overall Study|Adverse Event|5|||
30820730|NCT03158311|58841725|FG001|Overall Study|Adverse Event|3|||
30820731|NCT03158311|58841726|FG002|Overall Study|Adverse Event|3|||
30820732|NCT03158311|58841724|FG000|Overall Study|Techinical Problems|3|||
30820733|NCT03158311|58841725|FG001|Overall Study|Techinical Problems|1|||
30820734|NCT03158311|58841726|FG002|Overall Study|Techinical Problems|5|||
30820735|NCT03158311|58841724|FG000|Overall Study|Physician Decision|2|||
30820736|NCT03158311|58841725|FG001|Overall Study|Physician Decision|3|||
30820737|NCT03158311|58841726|FG002|Overall Study|Physician Decision|7|||
30820738|NCT03158311|58841724|FG000|Overall Study|Lost to Follow-up|1|||
30820739|NCT03158311|58841725|FG001|Overall Study|Lost to Follow-up|1|||
30820740|NCT03158311|58841726|FG002|Overall Study|Lost to Follow-up|1|||
30820741|NCT03158311|58841724|FG000|Overall Study|Sponsor decision|1|||
30820742|NCT03158311|58841725|FG001|Overall Study|Sponsor decision|0|||
30820743|NCT03158311|58841726|FG002|Overall Study|Sponsor decision|0|||
30820744|NCT03158311|58841724|FG000|Overall Study|Pregnancy|0|||
30820745|NCT03158311|58841725|FG001|Overall Study|Pregnancy|2|||
30820746|NCT03158311|58841726|FG002|Overall Study|Pregnancy|0|||
30820747|NCT03158311|58841724|FG000|Overall Study|Randomized in error|0|||
30820748|NCT03158311|58841725|FG001|Overall Study|Randomized in error|0|||
30820749|NCT03158311|58841726|FG002|Overall Study|Randomized in error|1|||
30820750|NCT01336621|58841738|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
30623085|NCT01215422|58634881|FG000|Overall Study|Relocation|1|||
30623086|NCT01215422|58634882|FG001|Overall Study|Relocation|0|||
30623087|NCT01215422|58634883|FG002|Overall Study|Relocation|0|||
30820751|NCT01336621|58841738|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
30820752|NCT01336621|58841738|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
30820753|NCT01336621|58841738|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
30820754|NCT01336621|58841738|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
30820755|NCT01336621|58841738|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
30820756|NCT01336621|58841738|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
30820757|NCT01336621|58841738|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
30820758|NCT01336621|58841738|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
30820759|NCT01336621|58841738|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
30820760|NCT01336621|58841738|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
30820761|NCT01336621|58841738|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
30820762|NCT01336621|58841738|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
30820763|NCT01336621|58841738|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
30820764|NCT00383435|58841750|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
30820765|NCT00383435|58841751|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
30820766|NCT00383435|58841752|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
30820767|NCT00383435|58841753|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
30820768|NCT00383435|58841754|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
30820769|NCT00383435|58841750|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
30820770|NCT00383435|58841751|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
30820771|NCT00383435|58841752|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
30820772|NCT00383435|58841753|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
30820773|NCT00383435|58841754|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
30820774|NCT00383435|58841750|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
30820775|NCT00383435|58841751|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
30820776|NCT00383435|58841752|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
30820777|NCT00383435|58841753|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
30623088|NCT01215422|58634884|FG003|Overall Study|Relocation|0|||
30623089|NCT01215422|58634881|FG000|Overall Study|Failed intubations|0|||
30820778|NCT00383435|58841754|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
30820779|NCT00383435|58841750|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
30820780|NCT00383435|58841751|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
30820781|NCT00383435|58841752|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
30820782|NCT00383435|58841753|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
30820783|NCT00383435|58841754|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
30820784|NCT00383435|58841750|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
30820785|NCT00383435|58841751|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
30820786|NCT00383435|58841752|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
30820787|NCT00383435|58841753|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
30820788|NCT00383435|58841754|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
30820789|NCT00383435|58841750|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
30820790|NCT00383435|58841751|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
30820791|NCT00383435|58841752|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
30820792|NCT00383435|58841753|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
30820793|NCT00383435|58841754|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
30820794|NCT00383435|58841750|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
30820795|NCT00383435|58841751|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
30820796|NCT00383435|58841752|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
30820797|NCT00383435|58841753|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
30820798|NCT00383435|58841754|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
30820799|NCT00383435|58841750|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
30820800|NCT00383435|58841751|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
30820801|NCT00383435|58841752|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
30820802|NCT00383435|58841753|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
30820803|NCT00383435|58841754|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
30820804|NCT00383435|58841750|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
30820805|NCT00383435|58841751|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
30820806|NCT00383435|58841752|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
30820807|NCT00383435|58841753|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
30820808|NCT00383435|58841754|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
30820809|NCT00383435|58841750|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
30820810|NCT00383435|58841751|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
30820811|NCT00383435|58841752|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
30820812|NCT00383435|58841753|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
30820813|NCT00383435|58841754|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
30820814|NCT00383435|58841750|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
30820815|NCT00383435|58841751|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
30820816|NCT00383435|58841752|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
30820817|NCT00383435|58841753|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
30820818|NCT00383435|58841754|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
30820819|NCT00383435|58841750|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
30820820|NCT00383435|58841751|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
30820821|NCT00383435|58841752|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
30820822|NCT00383435|58841753|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
30820823|NCT00383435|58841754|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
30820824|NCT00383435|58841750|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
30820825|NCT00383435|58841751|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
30820826|NCT00383435|58841752|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
30820827|NCT00383435|58841753|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
30820828|NCT00383435|58841754|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
30820829|NCT00383435|58841750|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
30913505|NCT02227862|58949032|FG000|Overall Study|Adverse Event|4|||
30913506|NCT02227862|58949033|FG001|Overall Study|Adverse Event|3|||
30913507|NCT02227862|58949032|FG000|Overall Study|Withdrawal by Subject|7|||
30913508|NCT02227862|58949033|FG001|Overall Study|Withdrawal by Subject|6|||
30913509|NCT02227862|58949032|FG000|Overall Study|Lost to Follow-up|1|||
30913510|NCT02227862|58949033|FG001|Overall Study|Lost to Follow-up|2|||
30913511|NCT02120833|58949041|FG000|Overall Study|Adverse Event|1|||
30913512|NCT02120833|58949042|FG001|Overall Study|Adverse Event|0|||
30913513|NCT02120833|58949041|FG000|Overall Study|Withdrawal by Subject|2|||
30913514|NCT02120833|58949042|FG001|Overall Study|Withdrawal by Subject|0|||
30623090|NCT01215422|58634882|FG001|Overall Study|Failed intubations|0|||
30913515|NCT02120833|58949041|FG000|Overall Study|Lost to Follow-up|1|||
30913516|NCT02120833|58949042|FG001|Overall Study|Lost to Follow-up|1|||
30913517|NCT02170207|58949048|FG000|Overall Study|Case report forms unavailable|5|||
30913518|NCT02227784|58949056|FG000|Double-Blind Phase|Adverse Event|3|||
30913519|NCT02227784|58949057|FG001|Double-Blind Phase|Adverse Event|2|||
30913520|NCT02227784|58949058|FG002|Double-Blind Phase|Adverse Event|1|||
30913521|NCT02227784|58949059|FG003|Double-Blind Phase|Adverse Event|3|||
30913522|NCT02227784|58949060|FG004|Double-Blind Phase|Adverse Event|0|||
30913523|NCT02227784|58949056|FG000|Double-Blind Phase|Physician Decision|1|||
30913524|NCT02227784|58949057|FG001|Double-Blind Phase|Physician Decision|0|||
30913525|NCT02227784|58949058|FG002|Double-Blind Phase|Physician Decision|0|||
30913526|NCT02227784|58949059|FG003|Double-Blind Phase|Physician Decision|1|||
30913527|NCT02227784|58949060|FG004|Double-Blind Phase|Physician Decision|0|||
30913528|NCT02227784|58949056|FG000|Double-Blind Phase|Protocol Violation|0|||
30913529|NCT02227784|58949057|FG001|Double-Blind Phase|Protocol Violation|0|||
30913530|NCT02227784|58949058|FG002|Double-Blind Phase|Protocol Violation|1|||
30913531|NCT02227784|58949059|FG003|Double-Blind Phase|Protocol Violation|1|||
30913532|NCT02227784|58949060|FG004|Double-Blind Phase|Protocol Violation|0|||
30913533|NCT02227784|58949056|FG000|Double-Blind Phase|Sponsor Decision|34|||
30913534|NCT02227784|58949057|FG001|Double-Blind Phase|Sponsor Decision|15|||
30913535|NCT02227784|58949058|FG002|Double-Blind Phase|Sponsor Decision|14|||
30913536|NCT02227784|58949059|FG003|Double-Blind Phase|Sponsor Decision|32|||
30913537|NCT02227784|58949060|FG004|Double-Blind Phase|Sponsor Decision|0|||
30913538|NCT02227784|58949056|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
30913539|NCT02227784|58949057|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
30913540|NCT02227784|58949058|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
30913541|NCT02227784|58949059|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
30913542|NCT02227784|58949060|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
30913543|NCT02227784|58949056|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
30913544|NCT02227784|58949057|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
30913545|NCT02227784|58949058|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
30913546|NCT02227784|58949059|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
30913547|NCT02227784|58949060|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
30913548|NCT02227784|58949056|FG000|Open-Label Extension Phase (OLE)|Death|0|||
30913549|NCT02227784|58949057|FG001|Open-Label Extension Phase (OLE)|Death|0|||
30913550|NCT02227784|58949058|FG002|Open-Label Extension Phase (OLE)|Death|0|||
30913551|NCT02227784|58949059|FG003|Open-Label Extension Phase (OLE)|Death|0|||
30913552|NCT02227784|58949060|FG004|Open-Label Extension Phase (OLE)|Death|1|||
30913553|NCT02227784|58949056|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
30913554|NCT02227784|58949057|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
30913555|NCT02227784|58949058|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
30913556|NCT02227784|58949059|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
30913557|NCT02227784|58949060|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
30913558|NCT02227784|58949056|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
30913559|NCT02227784|58949057|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
30913560|NCT02227784|58949058|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
30913561|NCT02227784|58949059|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
30913562|NCT02227784|58949060|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
30913563|NCT01565668|58949075|FG000|Overall Study|Death|2|||
30913564|NCT01565668|58949076|FG001|Overall Study|Death|1|||
30913565|NCT01565668|58949075|FG000|Overall Study|Lack of Efficacy|4|||
30913566|NCT01565668|58949076|FG001|Overall Study|Lack of Efficacy|2|||
30913567|NCT01565668|58949075|FG000|Overall Study|Participant went on Hospice Care|1|||
30913568|NCT01565668|58949076|FG001|Overall Study|Participant went on Hospice Care|0|||
30913569|NCT01565668|58949075|FG000|Overall Study|Adverse Event|6|||
30913570|NCT01565668|58949076|FG001|Overall Study|Adverse Event|1|||
30913571|NCT01565668|58949075|FG000|Overall Study|Randomized, but never received drug|0|||
30913572|NCT01565668|58949076|FG001|Overall Study|Randomized, but never received drug|2|||
30913573|NCT01565668|58949075|FG000|Overall Study|Progressive disease|13|||
30913574|NCT01565668|58949076|FG001|Overall Study|Progressive disease|14|||
30913575|NCT01565668|58949075|FG000|Overall Study|Withdrawal by Subject|1|||
30913576|NCT01565668|58949076|FG001|Overall Study|Withdrawal by Subject|3|||
30913577|NCT01565668|58949075|FG000|Overall Study|HSCT Transplant|11|||
30752632|NCT03731182|58762375|FG000|Overall Study|Lost to Follow-up|2|||
30913578|NCT01565668|58949076|FG001|Overall Study|HSCT Transplant|15|||
30913579|NCT01683058|58949082|FG000|Overall Study|Lost to Follow-up|9|||
30913580|NCT01683058|58949082|FG000|Overall Study|Adverse Event|6|||
30913581|NCT01683058|58949082|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
30913582|NCT01683058|58949082|FG000|Overall Study|Withdrawal by Subject|7|||
30913583|NCT01683058|58949082|FG000|Overall Study|Lack of Efficacy|2|||
30913584|NCT01626859|58949090|FG000|Overall Study|Adverse Event|1|||
30913585|NCT01626859|58949091|FG001|Overall Study|Adverse Event|3|||
30913586|NCT01626859|58949092|FG002|Overall Study|Adverse Event|2|||
30913587|NCT01626859|58949090|FG000|Overall Study|Physician Decision|0|||
30820830|NCT00383435|58841751|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
30820831|NCT00383435|58841752|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
30820832|NCT00383435|58841753|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
30820833|NCT00383435|58841754|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
30820834|NCT00383435|58841750|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
30820835|NCT00383435|58841751|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
30820836|NCT00383435|58841752|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
30820837|NCT00383435|58841753|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
30820838|NCT00383435|58841754|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
30820839|NCT00383435|58841750|FG000|26-Week Treatment Safety Extension|Administrative|1|||
30820840|NCT00383435|58841751|FG001|26-Week Treatment Safety Extension|Administrative|1|||
30820841|NCT00383435|58841752|FG002|26-Week Treatment Safety Extension|Administrative|0|||
30820842|NCT00383435|58841753|FG003|26-Week Treatment Safety Extension|Administrative|1|||
30820843|NCT00383435|58841754|FG004|26-Week Treatment Safety Extension|Administrative|0|||
30820844|NCT03157037|58841766|FG000|Overall Study|Death|1|||
30820845|NCT00381485|58841788|FG000|Open-Label Run-In Period|Adverse Event|9|||
30820846|NCT00381485|58841789|FG001|Open-Label Run-In Period|Adverse Event|0|||
30820847|NCT00381485|58841790|FG002|Open-Label Run-In Period|Adverse Event|0|||
30820848|NCT00381485|58841791|FG003|Open-Label Run-In Period|Adverse Event|0|||
30820849|NCT00381485|58841788|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
30820850|NCT00381485|58841789|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
30820851|NCT00381485|58841790|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
30820852|NCT00381485|58841791|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
30820853|NCT00381485|58841788|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
30820854|NCT00381485|58841789|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
30820855|NCT00381485|58841790|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
30820856|NCT00381485|58841791|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
30820857|NCT00381485|58841788|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
30820858|NCT00381485|58841789|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
30820859|NCT00381485|58841790|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
30820860|NCT00381485|58841791|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
30913588|NCT01626859|58949091|FG001|Overall Study|Physician Decision|1|||
30752633|NCT03731182|58762376|FG001|Overall Study|Lost to Follow-up|0|||
30752634|NCT03731182|58762375|FG000|Overall Study|Physician Decision|1|||
30752635|NCT03731182|58762376|FG001|Overall Study|Physician Decision|0|||
30752636|NCT03731182|58762375|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
30752637|NCT03731182|58762376|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
30752638|NCT03730012|58762385|FG000|Overall Study|Adverse Event|0|||
30752639|NCT03730012|58762386|FG001|Overall Study|Adverse Event|1|||
30752640|NCT03730012|58762385|FG000|Overall Study|Lack of Efficacy|1|||
30752641|NCT03730012|58762386|FG001|Overall Study|Lack of Efficacy|5|||
30752642|NCT03730012|58762385|FG000|Overall Study|Withdrawal by Subject|0|||
30752643|NCT03730012|58762386|FG001|Overall Study|Withdrawal by Subject|1|||
30752644|NCT03730012|58762385|FG000|Overall Study|Miscellaneous|2|||
30752645|NCT03730012|58762386|FG001|Overall Study|Miscellaneous|1|||
30752646|NCT03728140|58762397|FG000|Overall Study|Abnormal embryo transfer operation|10|||
30752647|NCT03728140|58762398|FG001|Overall Study|Abnormal embryo transfer operation|7|||
30752648|NCT03725722|58762423|FG000|Overall Study|Lack of Efficacy|2|||
30752649|NCT03725722|58762424|FG001|Overall Study|Lack of Efficacy|1|||
30820861|NCT00381485|58841788|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
30820862|NCT00381485|58841789|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
30820863|NCT00381485|58841790|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
30820864|NCT00381485|58841791|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
30820865|NCT00381485|58841788|FG000|Open-Label Run-In Period|Treatment failure|1|||
30820866|NCT00381485|58841789|FG001|Open-Label Run-In Period|Treatment failure|0|||
30820867|NCT00381485|58841790|FG002|Open-Label Run-In Period|Treatment failure|0|||
30820868|NCT00381485|58841791|FG003|Open-Label Run-In Period|Treatment failure|0|||
30820869|NCT00381485|58841788|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30820870|NCT00381485|58841789|FG001|Double-Blind Treatment Period|Adverse Event|2|||
30820871|NCT00381485|58841790|FG002|Double-Blind Treatment Period|Adverse Event|2|||
30820872|NCT00381485|58841791|FG003|Double-Blind Treatment Period|Adverse Event|5|||
30820873|NCT00381485|58841788|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
30820874|NCT00381485|58841789|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
30820875|NCT00381485|58841790|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
30820876|NCT00381485|58841791|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
30820877|NCT00381485|58841788|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
30820878|NCT00381485|58841789|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
30820879|NCT00381485|58841790|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
30820880|NCT00381485|58841791|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
30820881|NCT00381485|58841788|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
30820882|NCT00381485|58841789|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
30820883|NCT00381485|58841790|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
30820884|NCT00381485|58841791|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
30820885|NCT00381485|58841788|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
30820886|NCT00381485|58841789|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
30820887|NCT00381485|58841790|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
30623091|NCT01215422|58634883|FG002|Overall Study|Failed intubations|3|||
30623092|NCT01215422|58634884|FG003|Overall Study|Failed intubations|8|||
30820888|NCT00381485|58841791|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
30820889|NCT00381485|58841788|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
30820890|NCT00381485|58841789|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
30820891|NCT00381485|58841790|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
30820892|NCT00381485|58841791|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
30820893|NCT00381485|58841788|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
30820894|NCT00381485|58841789|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
30820895|NCT00381485|58841790|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
30820896|NCT00381485|58841791|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
30820897|NCT00381485|58841788|FG000|Double-Blind Treatment Period|Administrative|0|||
30820898|NCT00381485|58841789|FG001|Double-Blind Treatment Period|Administrative|1|||
30820899|NCT00381485|58841790|FG002|Double-Blind Treatment Period|Administrative|0|||
30820900|NCT00381485|58841791|FG003|Double-Blind Treatment Period|Administrative|1|||
30820901|NCT02840474|58841802|FG000|Overall Study|Lost to Follow-up|1|||
30820902|NCT02840474|58841803|FG001|Overall Study|Lost to Follow-up|0|||
30820903|NCT03155945|58841811|FG000|Overall Study|Lost to Follow-up|0|||
30820904|NCT03155945|58841812|FG001|Overall Study|Lost to Follow-up|1|||
30820905|NCT03155945|58841811|FG000|Overall Study|Withdrawal by Subject|0|||
30820906|NCT03155945|58841812|FG001|Overall Study|Withdrawal by Subject|1|||
30820907|NCT03155945|58841811|FG000|Overall Study|Other Reason|0|||
30820908|NCT03155945|58841812|FG001|Overall Study|Other Reason|1|||
30820909|NCT03160703|58841822|FG000|Overall Study|Withdrawal by Subject|0|||
30820910|NCT03160703|58841823|FG001|Overall Study|Withdrawal by Subject|0|||
30820911|NCT03160703|58841824|FG002|Overall Study|Withdrawal by Subject|0|||
30820912|NCT03160703|58841825|FG003|Overall Study|Withdrawal by Subject|1|||
30820913|NCT03159611|58841837|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
30820914|NCT03159611|58841838|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
30820915|NCT03159611|58841837|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
30913589|NCT01626859|58949092|FG002|Overall Study|Physician Decision|0|||
30913590|NCT01626859|58949090|FG000|Overall Study|Withdrawal by Subject|1|||
30623093|NCT01215422|58634881|FG000|Overall Study|Did not complete all intubations|7|||
30820916|NCT03159611|58841838|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
30820917|NCT03159611|58841837|FG000|Overall Study|Protocol Violation|7|||
30820918|NCT03159611|58841838|FG001|Overall Study|Protocol Violation|4|||
30820919|NCT03159611|58841837|FG000|Overall Study|Adverse Event|1|||
30820920|NCT03159611|58841838|FG001|Overall Study|Adverse Event|0|||
30913591|NCT01626859|58949091|FG001|Overall Study|Withdrawal by Subject|4|||
30913592|NCT01626859|58949092|FG002|Overall Study|Withdrawal by Subject|2|||
30913593|NCT02193776|58949104|FG000|Overall Study|Consent withdrawn|1|||
30913594|NCT02193776|58949105|FG001|Overall Study|Consent withdrawn|0|||
30913595|NCT02193776|58949106|FG002|Overall Study|Consent withdrawn|0|||
30913596|NCT02193776|58949107|FG003|Overall Study|Consent withdrawn|0|||
30913597|NCT02193776|58949104|FG000|Overall Study|Failure to comply with protocol|0|||
30913598|NCT02193776|58949105|FG001|Overall Study|Failure to comply with protocol|1|||
30913599|NCT02193776|58949106|FG002|Overall Study|Failure to comply with protocol|0|||
30913600|NCT02193776|58949107|FG003|Overall Study|Failure to comply with protocol|0|||
30913601|NCT02193776|58949104|FG000|Overall Study|Investigator/Sponsor decision|1|||
30913602|NCT02193776|58949105|FG001|Overall Study|Investigator/Sponsor decision|1|||
30820921|NCT03159611|58841837|FG000|Overall Study|Withdrawal by Subject|1|||
30820922|NCT03159611|58841838|FG001|Overall Study|Withdrawal by Subject|1|||
30820923|NCT03159611|58841837|FG000|Overall Study|Non-compliance with protocol requirement|3|||
30820924|NCT03159611|58841838|FG001|Overall Study|Non-compliance with protocol requirement|2|||
30820925|NCT03159611|58841837|FG000|Overall Study|Inability to perform procedures|1|||
30820926|NCT03159611|58841838|FG001|Overall Study|Inability to perform procedures|0|||
30820927|NCT03159455|58841850|FG000|Overall Study|Adverse Event|0|||
30820928|NCT03159455|58841851|FG001|Overall Study|Adverse Event|0|||
30820929|NCT03159455|58841852|FG002|Overall Study|Adverse Event|0|||
30820930|NCT03159455|58841853|FG003|Overall Study|Adverse Event|0|||
30820931|NCT03159455|58841854|FG004|Overall Study|Adverse Event|0|||
30820932|NCT03159455|58841855|FG005|Overall Study|Adverse Event|1|||
30820933|NCT02838134|58841875|FG000|Overall Study|Lost to Follow-up|1|||
30820934|NCT02838134|58841876|FG001|Overall Study|Lost to Follow-up|2|||
30820935|NCT02838134|58841875|FG000|Overall Study|logistic problems|1|||
30820936|NCT02838134|58841876|FG001|Overall Study|logistic problems|1|||
30820937|NCT03150589|58841884|FG000|Overall Study|Withdrawal by Subject|16|||
30820938|NCT03150589|58841885|FG001|Overall Study|Withdrawal by Subject|9|||
30820939|NCT03150589|58841884|FG000|Overall Study|Adverse Event|7|||
30820940|NCT03150589|58841885|FG001|Overall Study|Adverse Event|6|||
30820941|NCT03150589|58841884|FG000|Overall Study|Protocol Violation|4|||
30820942|NCT03150589|58841885|FG001|Overall Study|Protocol Violation|3|||
30820943|NCT03150589|58841884|FG000|Overall Study|Lost to Follow-up|3|||
30820944|NCT03150589|58841885|FG001|Overall Study|Lost to Follow-up|3|||
30820945|NCT03150589|58841884|FG000|Overall Study|Death|2|||
30820946|NCT03150589|58841885|FG001|Overall Study|Death|3|||
30820947|NCT03150589|58841884|FG000|Overall Study|IP non-compliance and other reasons|12|||
30820948|NCT03150589|58841885|FG001|Overall Study|IP non-compliance and other reasons|3|||
30820949|NCT02835092|58841894|FG000|Overall Study|Withdrawal by Subject|3|||
30820950|NCT02835092|58841895|FG001|Overall Study|Withdrawal by Subject|6|||
30820951|NCT02835092|58841896|FG002|Overall Study|Withdrawal by Subject|3|||
30820952|NCT02835092|58841894|FG000|Overall Study|Lost to Follow-up|0|||
30820953|NCT02835092|58841895|FG001|Overall Study|Lost to Follow-up|2|||
30820954|NCT02835092|58841896|FG002|Overall Study|Lost to Follow-up|0|||
30913603|NCT02193776|58949106|FG002|Overall Study|Investigator/Sponsor decision|0|||
30913604|NCT02193776|58949107|FG003|Overall Study|Investigator/Sponsor decision|0|||
30913605|NCT02193776|58949104|FG000|Overall Study|Death|1|||
30820955|NCT03145207|58841904|FG000|Overall Study|volunteer started taking allergy shots|1|||
30820956|NCT03145207|58841904|FG000|Overall Study|baseline blood pressure high|1|||
30820957|NCT02836652|58841921|FG000|Overall Study|Death|3|||
30820958|NCT02836652|58841922|FG001|Overall Study|Death|3|||
30820959|NCT02836652|58841921|FG000|Overall Study|Transplant/Explant|3|||
30820960|NCT02836652|58841922|FG001|Overall Study|Transplant/Explant|4|||
30820961|NCT02836652|58841921|FG000|Overall Study|Withdrawn|9|||
30820962|NCT02836652|58841922|FG001|Overall Study|Withdrawn|9|||
30913606|NCT02193776|58949105|FG001|Overall Study|Death|0|||
30820963|NCT02836652|58841921|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
30820964|NCT02836652|58841922|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
30820965|NCT02836496|58841930|FG000|Overall Study|Adverse Event|2|||
30820966|NCT02836496|58841931|FG001|Overall Study|Adverse Event|1|||
30820967|NCT02836496|58841930|FG000|Overall Study|Withdrawal by Subject|0|||
30820968|NCT02836496|58841931|FG001|Overall Study|Withdrawal by Subject|1|||
30820969|NCT04213807|58841940|FG000|Overall Study|Physician Decision|0|||
30820970|NCT04213807|58841941|FG001|Overall Study|Physician Decision|0|||
30820971|NCT04213807|58841942|FG002|Overall Study|Physician Decision|1|||
30820972|NCT00577577|58841961|FG000|Overall Study|Adverse Event|3|||
30820973|NCT00577577|58841962|FG001|Overall Study|Adverse Event|2|||
30820974|NCT00577577|58841961|FG000|Overall Study|Lost to Follow-up|1|||
30820975|NCT00577577|58841962|FG001|Overall Study|Lost to Follow-up|0|||
30820976|NCT00577577|58841961|FG000|Overall Study|Protocol Violation|0|||
30820977|NCT00577577|58841962|FG001|Overall Study|Protocol Violation|3|||
30820978|NCT00577577|58841961|FG000|Overall Study|Transportation|1|||
30820979|NCT00577577|58841962|FG001|Overall Study|Transportation|0|||
30820980|NCT02833844|58841970|FG000|Double-Blind Period|Withdrawal by Subject|2|||
30913607|NCT02193776|58949106|FG002|Overall Study|Death|0|||
30913608|NCT02193776|58949107|FG003|Overall Study|Death|0|||
30913609|NCT02193776|58949104|FG000|Overall Study|Adverse event/Specific toxicity|5|||
30913610|NCT02193776|58949105|FG001|Overall Study|Adverse event/Specific toxicity|5|||
30913611|NCT02193776|58949106|FG002|Overall Study|Adverse event/Specific toxicity|2|||
30913612|NCT02193776|58949107|FG003|Overall Study|Adverse event/Specific toxicity|2|||
30913613|NCT02170064|58949120|FG000|Overall Study|Withdrawal by Subject|5|||
30913614|NCT02170064|58949121|FG001|Overall Study|Withdrawal by Subject|1|||
30913615|NCT02170064|58949122|FG002|Overall Study|Withdrawal by Subject|1|||
30913616|NCT02170064|58949120|FG000|Overall Study|Physician Decision|1|||
30913617|NCT02170064|58949121|FG001|Overall Study|Physician Decision|1|||
30913618|NCT02170064|58949122|FG002|Overall Study|Physician Decision|0|||
30913619|NCT02169830|58949133|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
30913620|NCT02169830|58949134|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
30913621|NCT02169830|58949135|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
30913622|NCT02169830|58949133|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
30913623|NCT02169830|58949134|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
30913624|NCT02169830|58949135|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
30913625|NCT02169830|58949133|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
30752650|NCT03725722|58762425|FG002|Overall Study|Lack of Efficacy|2|||
30752651|NCT03725722|58762426|FG003|Overall Study|Lack of Efficacy|0|||
30752652|NCT03725722|58762427|FG004|Overall Study|Lack of Efficacy|2|||
30752653|NCT03725722|58762423|FG000|Overall Study|Adverse Event|2|||
30752654|NCT03725722|58762424|FG001|Overall Study|Adverse Event|2|||
30752655|NCT03725722|58762425|FG002|Overall Study|Adverse Event|1|||
30752656|NCT03725722|58762426|FG003|Overall Study|Adverse Event|0|||
30752657|NCT03725722|58762427|FG004|Overall Study|Adverse Event|6|||
30752658|NCT03725722|58762423|FG000|Overall Study|Withdrawal by Subject|4|||
30752659|NCT03725722|58762424|FG001|Overall Study|Withdrawal by Subject|1|||
30820981|NCT02833844|58841971|FG001|Double-Blind Period|Withdrawal by Subject|3|||
30820982|NCT02833844|58841970|FG000|Double-Blind Period|Protocol Violation|0|||
30913626|NCT02169830|58949134|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
30820983|NCT02833844|58841971|FG001|Double-Blind Period|Protocol Violation|4|||
30752660|NCT03725722|58762425|FG002|Overall Study|Withdrawal by Subject|0|||
30913627|NCT02169830|58949135|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
30913628|NCT02169830|58949133|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
30913629|NCT02169830|58949134|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
30913630|NCT02169830|58949135|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
30913631|NCT02169830|58949133|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
30913632|NCT02169830|58949134|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
30913633|NCT02169830|58949135|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
30913634|NCT02169674|58949145|FG000|Overall Study|Withdrawal by Subject|2|||
30913635|NCT02169674|58949146|FG001|Overall Study|Withdrawal by Subject|1|||
30913636|NCT02169674|58949145|FG000|Overall Study|Seroprotected|30|||
30913637|NCT02169674|58949146|FG001|Overall Study|Seroprotected|76|||
30913638|NCT02169674|58949145|FG000|Overall Study|Lost to Follow-up|0|||
30913639|NCT02169674|58949146|FG001|Overall Study|Lost to Follow-up|1|||
30913640|NCT02169284|58949154|FG000|Overall Study|Physician Decision|0|||
30913641|NCT02169284|58949155|FG001|Overall Study|Physician Decision|1|||
30913642|NCT02119819|58949169|FG000|Overall Study|Adverse Event|3|||
30913643|NCT02119819|58949170|FG001|Overall Study|Adverse Event|1|||
30913644|NCT02119819|58949171|FG002|Overall Study|Adverse Event|2|||
30913645|NCT02119819|58949172|FG003|Overall Study|Adverse Event|3|||
30913646|NCT02119819|58949173|FG004|Overall Study|Adverse Event|0|||
30913647|NCT02119819|58949174|FG005|Overall Study|Adverse Event|1|||
30913648|NCT02119819|58949169|FG000|Overall Study|Lack of Efficacy|0|||
30913649|NCT02119819|58949170|FG001|Overall Study|Lack of Efficacy|0|||
30913650|NCT02119819|58949171|FG002|Overall Study|Lack of Efficacy|0|||
30913651|NCT02119819|58949172|FG003|Overall Study|Lack of Efficacy|0|||
30913652|NCT02119819|58949173|FG004|Overall Study|Lack of Efficacy|0|||
30913653|NCT02119819|58949174|FG005|Overall Study|Lack of Efficacy|1|||
30913654|NCT02119819|58949169|FG000|Overall Study|Lost to Follow-up|0|||
30913655|NCT02119819|58949170|FG001|Overall Study|Lost to Follow-up|0|||
30623094|NCT01215422|58634882|FG001|Overall Study|Did not complete all intubations|0|||
30820984|NCT02833844|58841970|FG000|Open-Label Period|Death|0|||
30820985|NCT02833844|58841971|FG001|Open-Label Period|Death|2|||
30820986|NCT02833844|58841970|FG000|Open-Label Period|Lost to Follow-up|1|||
30820987|NCT02833844|58841971|FG001|Open-Label Period|Lost to Follow-up|0|||
30820988|NCT02833844|58841970|FG000|Open-Label Period|Withdrawal by Subject|1|||
30820989|NCT02833844|58841971|FG001|Open-Label Period|Withdrawal by Subject|0|||
30820990|NCT01341782|58841981|FG000|Overall Study|Adverse Event|1|||
30820991|NCT01341782|58841982|FG001|Overall Study|Adverse Event|1|||
30820992|NCT01341782|58841981|FG000|Overall Study|Withdrawal by Subject|6|||
30820993|NCT01341782|58841982|FG001|Overall Study|Withdrawal by Subject|5|||
30820994|NCT01341782|58841981|FG000|Overall Study|Missed 3 consecutive doses|0|||
30820995|NCT01341782|58841982|FG001|Overall Study|Missed 3 consecutive doses|4|||
30820996|NCT01341782|58841981|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
30820997|NCT01341782|58841982|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
30820998|NCT01341782|58841981|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
30820999|NCT01341782|58841982|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
30821000|NCT01341782|58841981|FG000|Overall Study|Other|5|||
30821001|NCT01341782|58841982|FG001|Overall Study|Other|0|||
30821002|NCT01341470|58841994|FG000|Overall Study|Sponsor decision|0|||
30821003|NCT01341470|58841995|FG001|Overall Study|Sponsor decision|0|||
30821004|NCT01341470|58841996|FG002|Overall Study|Sponsor decision|1|||
30821005|NCT01341470|58841997|FG003|Overall Study|Sponsor decision|1|||
30821006|NCT01341470|58841998|FG004|Overall Study|Sponsor decision|0|||
30821007|NCT01341470|58841999|FG005|Overall Study|Sponsor decision|1|||
30821008|NCT03143101|58842018|FG000|Overall Study|Withdrawal by Subject|0|||
30821009|NCT03143101|58842019|FG001|Overall Study|Withdrawal by Subject|1|||
30821010|NCT03143101|58842020|FG002|Overall Study|Withdrawal by Subject|0|||
30821011|NCT03143101|58842018|FG000|Overall Study|Lost to Follow-up|2|||
30821012|NCT03143101|58842019|FG001|Overall Study|Lost to Follow-up|2|||
30821013|NCT03143101|58842020|FG002|Overall Study|Lost to Follow-up|0|||
30821014|NCT00871351|58842031|FG000|Overall Study|Withdrawal by Subject|1|||
30821015|NCT00871351|58842032|FG001|Overall Study|Withdrawal by Subject|0|||
30821016|NCT00871351|58842033|FG002|Overall Study|Withdrawal by Subject|0|||
30821017|NCT00871351|58842031|FG000|Overall Study|Adverse Event|3|||
30913656|NCT02119819|58949171|FG002|Overall Study|Lost to Follow-up|1|||
30913657|NCT02119819|58949172|FG003|Overall Study|Lost to Follow-up|2|||
30913658|NCT02119819|58949173|FG004|Overall Study|Lost to Follow-up|1|||
30913659|NCT02119819|58949174|FG005|Overall Study|Lost to Follow-up|2|||
30623095|NCT01215422|58634883|FG002|Overall Study|Did not complete all intubations|0|||
30821018|NCT00871351|58842032|FG001|Overall Study|Adverse Event|1|||
30821019|NCT00871351|58842033|FG002|Overall Study|Adverse Event|0|||
30821020|NCT02745080|58842043|FG000|Overall Study|Adverse Event|13|||
30821021|NCT02745080|58842044|FG001|Overall Study|Adverse Event|21|||
30821022|NCT02745080|58842043|FG000|Overall Study|Lack of Efficacy|11|||
30821023|NCT02745080|58842044|FG001|Overall Study|Lack of Efficacy|23|||
30913660|NCT02119819|58949169|FG000|Overall Study|Physician Decision|1|||
30913661|NCT02119819|58949170|FG001|Overall Study|Physician Decision|1|||
30913662|NCT02119819|58949171|FG002|Overall Study|Physician Decision|0|||
30821024|NCT02745080|58842043|FG000|Overall Study|Lost to Follow-up|3|||
30821025|NCT02745080|58842044|FG001|Overall Study|Lost to Follow-up|3|||
30821026|NCT02745080|58842043|FG000|Overall Study|Physician Decision|3|||
30821027|NCT02745080|58842044|FG001|Overall Study|Physician Decision|0|||
30821028|NCT02745080|58842043|FG000|Overall Study|Protocol Violation|3|||
30821029|NCT02745080|58842044|FG001|Overall Study|Protocol Violation|1|||
30821030|NCT02745080|58842043|FG000|Overall Study|Withdrawal by Subject|22|||
30821031|NCT02745080|58842044|FG001|Overall Study|Withdrawal by Subject|41|||
30821032|NCT00521599|58842054|FG000|Overall Study|Adverse Event|5|||
30821033|NCT00521599|58842055|FG001|Overall Study|Adverse Event|7|||
30821034|NCT00521599|58842056|FG002|Overall Study|Adverse Event|6|||
30821035|NCT00521599|58842054|FG000|Overall Study|Treatment Failure|8|||
30821036|NCT00521599|58842055|FG001|Overall Study|Treatment Failure|9|||
30821037|NCT00521599|58842056|FG002|Overall Study|Treatment Failure|22|||
30821038|NCT00521599|58842054|FG000|Overall Study|Lost to Follow-up|2|||
30821039|NCT00521599|58842055|FG001|Overall Study|Lost to Follow-up|1|||
30821040|NCT00521599|58842056|FG002|Overall Study|Lost to Follow-up|2|||
30821041|NCT00521599|58842054|FG000|Overall Study|Withdrawal by Subject|3|||
30821042|NCT00521599|58842055|FG001|Overall Study|Withdrawal by Subject|5|||
30821043|NCT00521599|58842056|FG002|Overall Study|Withdrawal by Subject|1|||
30821044|NCT00521599|58842054|FG000|Overall Study|Withdrawal by subject treatment related|3|||
30821045|NCT00521599|58842055|FG001|Overall Study|Withdrawal by subject treatment related|1|||
30913663|NCT02119819|58949172|FG003|Overall Study|Physician Decision|0|||
30913664|NCT02119819|58949173|FG004|Overall Study|Physician Decision|0|||
30913665|NCT02119819|58949174|FG005|Overall Study|Physician Decision|1|||
30821046|NCT00521599|58842056|FG002|Overall Study|Withdrawal by subject treatment related|2|||
30821047|NCT00521599|58842054|FG000|Overall Study|Protocol Violation|2|||
30821048|NCT00521599|58842055|FG001|Overall Study|Protocol Violation|4|||
30821049|NCT00521599|58842056|FG002|Overall Study|Protocol Violation|2|||
30821050|NCT00521599|58842054|FG000|Overall Study|Did not meet protocol eligibility|2|||
30821051|NCT00521599|58842055|FG001|Overall Study|Did not meet protocol eligibility|2|||
30821052|NCT00521599|58842056|FG002|Overall Study|Did not meet protocol eligibility|1|||
30821053|NCT00442897|58842067|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
30913666|NCT02119819|58949169|FG000|Overall Study|Withdrawal by Subject|5|||
30752661|NCT03725722|58762426|FG003|Overall Study|Withdrawal by Subject|4|||
30752662|NCT03725722|58762427|FG004|Overall Study|Withdrawal by Subject|4|||
30752663|NCT03725722|58762423|FG000|Overall Study|Lost to Follow-up|3|||
30752664|NCT03725722|58762424|FG001|Overall Study|Lost to Follow-up|1|||
30752665|NCT03725722|58762425|FG002|Overall Study|Lost to Follow-up|2|||
30752666|NCT03725722|58762426|FG003|Overall Study|Lost to Follow-up|2|||
30752667|NCT03725722|58762427|FG004|Overall Study|Lost to Follow-up|1|||
30752668|NCT03725722|58762423|FG000|Overall Study|Personal reasons|0|||
30752669|NCT03725722|58762424|FG001|Overall Study|Personal reasons|0|||
30752670|NCT03725722|58762425|FG002|Overall Study|Personal reasons|1|||
30752671|NCT03725722|58762426|FG003|Overall Study|Personal reasons|0|||
30752672|NCT03725722|58762427|FG004|Overall Study|Personal reasons|1|||
30752673|NCT03725722|58762423|FG000|Overall Study|COVID-19 situation|0|||
30752674|NCT03725722|58762424|FG001|Overall Study|COVID-19 situation|1|||
30821054|NCT00442897|58842068|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
30821055|NCT00442897|58842067|FG000|Base Study (12 Week Follow-up)|Death|0|||
30821056|NCT00442897|58842068|FG001|Base Study (12 Week Follow-up)|Death|1|||
30821057|NCT00442897|58842067|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
30821058|NCT00442897|58842068|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
30821059|NCT00442897|58842067|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
30913667|NCT02119819|58949170|FG001|Overall Study|Withdrawal by Subject|3|||
30913668|NCT02119819|58949171|FG002|Overall Study|Withdrawal by Subject|0|||
30913669|NCT02119819|58949172|FG003|Overall Study|Withdrawal by Subject|0|||
30913670|NCT02119819|58949173|FG004|Overall Study|Withdrawal by Subject|6|||
30913671|NCT02119819|58949174|FG005|Overall Study|Withdrawal by Subject|10|||
30913672|NCT02119819|58949169|FG000|Overall Study|Jury Duty|0|||
30913673|NCT02119819|58949170|FG001|Overall Study|Jury Duty|0|||
30913674|NCT02119819|58949171|FG002|Overall Study|Jury Duty|1|||
30913675|NCT02119819|58949172|FG003|Overall Study|Jury Duty|0|||
30913676|NCT02119819|58949173|FG004|Overall Study|Jury Duty|0|||
30821060|NCT00442897|58842068|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
30821061|NCT00442897|58842067|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
30821062|NCT00442897|58842068|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
30821063|NCT00442897|58842067|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
30821064|NCT00442897|58842068|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
30821065|NCT00442897|58842067|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
30821066|NCT00442897|58842068|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
30821067|NCT00442897|58842067|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
30821068|NCT00442897|58842068|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
30821069|NCT02834390|58842076|FG000|Induction Phase|Progressive disease|0|||
30821070|NCT02834390|58842077|FG001|Induction Phase|Progressive disease|1|||
30821071|NCT02834390|58842076|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
30821072|NCT02834390|58842077|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
30821073|NCT02834390|58842076|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
30821074|NCT02834390|58842077|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
30821075|NCT02834390|58842076|FG000|Consolidation Phase|Physician Decision|1|||
30821076|NCT02834390|58842077|FG001|Consolidation Phase|Physician Decision|1|||
30913677|NCT02119819|58949174|FG005|Overall Study|Jury Duty|0|||
30821077|NCT03141151|58842085|FG000|Overall Study|Lost to Follow-up|3|||
30821078|NCT03141151|58842086|FG001|Overall Study|Lost to Follow-up|2|||
30913678|NCT02119819|58949169|FG000|Overall Study|Protocol Violation|0|||
30913679|NCT02119819|58949170|FG001|Overall Study|Protocol Violation|0|||
30913680|NCT02119819|58949171|FG002|Overall Study|Protocol Violation|0|||
30913681|NCT02119819|58949172|FG003|Overall Study|Protocol Violation|1|||
30913682|NCT02119819|58949173|FG004|Overall Study|Protocol Violation|0|||
30913683|NCT02119819|58949174|FG005|Overall Study|Protocol Violation|0|||
30913684|NCT02119819|58949169|FG000|Overall Study|Left the city to get a job|0|||
30913685|NCT02119819|58949170|FG001|Overall Study|Left the city to get a job|0|||
30913686|NCT02119819|58949171|FG002|Overall Study|Left the city to get a job|0|||
30913687|NCT02119819|58949172|FG003|Overall Study|Left the city to get a job|1|||
30913688|NCT02119819|58949173|FG004|Overall Study|Left the city to get a job|0|||
30913689|NCT02119819|58949174|FG005|Overall Study|Left the city to get a job|0|||
30913690|NCT02168816|58949190|FG000|Overall Study|Lost to Follow-up|2|||
30913691|NCT02168816|58949191|FG001|Overall Study|Lost to Follow-up|2|||
30913692|NCT01584232|58949199|FG000|Overall Study|Adverse Event|3|||
30913693|NCT01584232|58949200|FG001|Overall Study|Adverse Event|1|||
30913694|NCT01584232|58949199|FG000|Overall Study|Withdrawal by Subject|2|||
30913695|NCT01584232|58949200|FG001|Overall Study|Withdrawal by Subject|1|||
30913696|NCT01584232|58949199|FG000|Overall Study|Physician Decision|2|||
30913697|NCT01584232|58949200|FG001|Overall Study|Physician Decision|1|||
30913698|NCT01584232|58949199|FG000|Overall Study|Lost to Follow-up|1|||
30913699|NCT01584232|58949200|FG001|Overall Study|Lost to Follow-up|0|||
30913700|NCT01639703|58949206|FG000|Overall Study|Withdrawal by Subject|5|||
30913701|NCT01639703|58949206|FG000|Overall Study|Other reason|7|||
30913702|NCT02119663|58949224|FG000|Overall Study|Disease progression|26|||
30913703|NCT02119663|58949225|FG001|Overall Study|Disease progression|27|||
30913704|NCT02119663|58949224|FG000|Overall Study|Adverse Event|5|||
30913705|NCT02119663|58949225|FG001|Overall Study|Adverse Event|5|||
30913706|NCT02119663|58949224|FG000|Overall Study|Death|3|||
30913707|NCT02119663|58949225|FG001|Overall Study|Death|2|||
30913708|NCT02119663|58949224|FG000|Overall Study|Physician Decision|1|||
30913709|NCT02119663|58949225|FG001|Overall Study|Physician Decision|2|||
30913710|NCT02119663|58949224|FG000|Overall Study|Other unspecified|2|||
30913711|NCT02119663|58949225|FG001|Overall Study|Other unspecified|0|||
30913712|NCT02119663|58949224|FG000|Overall Study|Subject decision|0|||
30913713|NCT02119663|58949225|FG001|Overall Study|Subject decision|1|||
30913714|NCT02119663|58949224|FG000|Overall Study|Study Terminated by the Sponsor|3|||
30913715|NCT02119663|58949225|FG001|Overall Study|Study Terminated by the Sponsor|4|||
30913716|NCT01639469|58949233|FG000|Overall Study|Death|4|||
30913717|NCT01639469|58949234|FG001|Overall Study|Death|2|||
30913718|NCT01639469|58949233|FG000|Overall Study|Lost to Follow-up|1|||
30913719|NCT01639469|58949234|FG001|Overall Study|Lost to Follow-up|1|||
30913720|NCT02193074|58949242|FG000|Overall Study|Withdrawal by Subject|1|||
30913721|NCT02193074|58949243|FG001|Overall Study|Withdrawal by Subject|2|||
30913722|NCT02193074|58949242|FG000|Overall Study|Adverse Event|16|||
30913723|NCT02193074|58949243|FG001|Overall Study|Adverse Event|13|||
30913724|NCT02192606|58949251|FG000|Overall Study|surgery type was changed|1|||
30913725|NCT02192606|58949252|FG001|Overall Study|surgery type was changed|1|||
30913726|NCT02192606|58949251|FG000|Overall Study|Physician Decision|1|||
30913727|NCT02192606|58949252|FG001|Overall Study|Physician Decision|2|||
30913728|NCT02192606|58949251|FG000|Overall Study|3D equipment rep unable to join|0|||
30913729|NCT02192606|58949252|FG001|Overall Study|3D equipment rep unable to join|1|||
30913730|NCT01628107|58949258|FG000|Overall Study|Withdrawal by Subject|17|||
30913731|NCT01628107|58949258|FG000|Overall Study|Lost to Follow-up|4|||
30913732|NCT01628107|58949258|FG000|Overall Study|Adverse Event|33|||
30913733|NCT01628107|58949258|FG000|Overall Study|Physician Decision|2|||
30913734|NCT01628107|58949258|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
30913735|NCT01628107|58949258|FG000|Overall Study|Non-compliant with Study Procedures|10|||
30913736|NCT01628107|58949258|FG000|Overall Study|Not Treated|8|||
30913737|NCT01628107|58949258|FG000|Overall Study|Sponsor Decision|11|||
30913738|NCT01628107|58949258|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
30913739|NCT01628107|58949258|FG000|Overall Study|Relocated|8|||
30913740|NCT01628107|58949258|FG000|Overall Study|Kidney Transplant|9|||
30913741|NCT01628107|58949258|FG000|Overall Study|Use of Standard of Care|9|||
30913742|NCT01583530|58949268|FG000|Overall Study|Adverse Event|0|||
30913743|NCT01583530|58949269|FG001|Overall Study|Adverse Event|0|||
30913744|NCT01583530|58949270|FG002|Overall Study|Adverse Event|0|||
30913745|NCT01583530|58949271|FG003|Overall Study|Adverse Event|0|||
30913746|NCT01583530|58949272|FG004|Overall Study|Adverse Event|0|||
30913747|NCT01583530|58949273|FG005|Overall Study|Adverse Event|1|||
30913748|NCT01583530|58949268|FG000|Overall Study|Withdrawal by Subject|0|||
30913749|NCT01583530|58949269|FG001|Overall Study|Withdrawal by Subject|3|||
30913750|NCT01583530|58949270|FG002|Overall Study|Withdrawal by Subject|0|||
30913751|NCT01583530|58949271|FG003|Overall Study|Withdrawal by Subject|1|||
30913752|NCT01583530|58949272|FG004|Overall Study|Withdrawal by Subject|1|||
30913753|NCT01583530|58949273|FG005|Overall Study|Withdrawal by Subject|2|||
30913754|NCT01583530|58949268|FG000|Overall Study|Lost to Follow-up|0|||
30913755|NCT01583530|58949269|FG001|Overall Study|Lost to Follow-up|0|||
30913756|NCT01583530|58949270|FG002|Overall Study|Lost to Follow-up|0|||
30913757|NCT01583530|58949271|FG003|Overall Study|Lost to Follow-up|0|||
30821079|NCT03141151|58842085|FG000|Overall Study|Withdrawal by Subject|3|||
30913758|NCT01583530|58949272|FG004|Overall Study|Lost to Follow-up|3|||
30913759|NCT01583530|58949273|FG005|Overall Study|Lost to Follow-up|0|||
30913760|NCT01583530|58949268|FG000|Overall Study|Lack of compliance|0|||
30913761|NCT01583530|58949269|FG001|Overall Study|Lack of compliance|0|||
30913762|NCT01583530|58949270|FG002|Overall Study|Lack of compliance|0|||
30913763|NCT01583530|58949271|FG003|Overall Study|Lack of compliance|0|||
30913764|NCT01583530|58949272|FG004|Overall Study|Lack of compliance|1|||
30913765|NCT01583530|58949273|FG005|Overall Study|Lack of compliance|0|||
30821080|NCT03141151|58842086|FG001|Overall Study|Withdrawal by Subject|2|||
30821081|NCT01358708|58842094|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
30821082|NCT01358708|58842095|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
30821083|NCT01358708|58842094|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
30821084|NCT01358708|58842095|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
30821085|NCT01356602|58842108|FG000|Overall Study|Protocol Deviation|0|||
30821086|NCT01356602|58842109|FG001|Overall Study|Protocol Deviation|1|||
30821087|NCT01356602|58842110|FG002|Overall Study|Protocol Deviation|1|||
30821088|NCT01356602|58842108|FG000|Overall Study|Administrative Problems|1|||
30821089|NCT01356602|58842109|FG001|Overall Study|Administrative Problems|4|||
30821090|NCT01356602|58842110|FG002|Overall Study|Administrative Problems|5|||
30821091|NCT01356602|58842108|FG000|Overall Study|Lost to Follow-up|4|||
30821092|NCT01356602|58842109|FG001|Overall Study|Lost to Follow-up|5|||
30821093|NCT01356602|58842110|FG002|Overall Study|Lost to Follow-up|6|||
30821094|NCT01356602|58842108|FG000|Overall Study|Withdrawal by Subject|4|||
30821095|NCT01356602|58842109|FG001|Overall Study|Withdrawal by Subject|3|||
30821096|NCT01356602|58842110|FG002|Overall Study|Withdrawal by Subject|7|||
30821097|NCT01356602|58842108|FG000|Overall Study|Lack of Efficacy|0|||
30821098|NCT01356602|58842109|FG001|Overall Study|Lack of Efficacy|1|||
30821099|NCT01356602|58842110|FG002|Overall Study|Lack of Efficacy|4|||
30821100|NCT01356602|58842108|FG000|Overall Study|Adverse Event|0|||
30821101|NCT01356602|58842109|FG001|Overall Study|Adverse Event|1|||
30821102|NCT01356602|58842110|FG002|Overall Study|Adverse Event|1|||
30821103|NCT02830880|58842118|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
30821104|NCT02830880|58842118|FG000|Overall Study|Death|1|||
30821105|NCT02830880|58842118|FG000|Overall Study|Physician Decision|1|||
30821106|NCT03141307|58842124|FG000|In-Hospital|Withdrawal by Subject|0|||
30821107|NCT03141307|58842125|FG001|In-Hospital|Withdrawal by Subject|2|||
30821108|NCT03141307|58842124|FG000|In-Hospital|Protocol Violation|4|||
30821109|NCT03141307|58842125|FG001|In-Hospital|Protocol Violation|0|||
30821110|NCT03141307|58842124|FG000|Follow-Up|Lost to Follow-up|97|||
30821111|NCT03141307|58842125|FG001|Follow-Up|Lost to Follow-up|54|||
30821112|NCT02825420|58842133|FG000|Overall Study|Death|30|||
30821113|NCT02825420|58842134|FG001|Overall Study|Death|12|||
30821114|NCT02825420|58842133|FG000|Overall Study|Progressive disease|6|||
30821115|NCT02825420|58842134|FG001|Overall Study|Progressive disease|1|||
30821116|NCT02825420|58842133|FG000|Overall Study|Lost to Follow-up|2|||
30821117|NCT02825420|58842134|FG001|Overall Study|Lost to Follow-up|2|||
30821118|NCT02825420|58842133|FG000|Overall Study|Withdrawal by Subject|1|||
30913766|NCT01639001|58949292|FG000|Overall Study|Refused further follow-up|9|||
30913767|NCT01639001|58949293|FG001|Overall Study|Refused further follow-up|12|||
30913768|NCT01639001|58949292|FG000|Overall Study|Lost to Follow-up|3|||
30913769|NCT01639001|58949293|FG001|Overall Study|Lost to Follow-up|0|||
30913770|NCT01639001|58949292|FG000|Overall Study|Death|62|||
30913771|NCT01639001|58949293|FG001|Overall Study|Death|61|||
30821119|NCT02825420|58842134|FG001|Overall Study|Withdrawal by Subject|1|||
30821120|NCT02825420|58842133|FG000|Overall Study|Protocol amendment not signed|1|||
30821121|NCT02825420|58842134|FG001|Overall Study|Protocol amendment not signed|1|||
30821122|NCT02825420|58842133|FG000|Overall Study|Physician Decision|1|||
30821123|NCT02825420|58842134|FG001|Overall Study|Physician Decision|0|||
30821124|NCT02825420|58842133|FG000|Overall Study|Did not receive PLD|2|||
30821125|NCT02825420|58842134|FG001|Overall Study|Did not receive PLD|0|||
30821126|NCT02829944|58842147|FG000|Overall Study|Physician Decision|0|||
30821127|NCT02829944|58842148|FG001|Overall Study|Physician Decision|1|||
30821128|NCT02829944|58842147|FG000|Overall Study|Screen Failure|2|||
30821129|NCT02829944|58842148|FG001|Overall Study|Screen Failure|2|||
30821130|NCT02829944|58842147|FG000|Overall Study|Inadequate Neuraxial Block|1|||
30821131|NCT02829944|58842148|FG001|Overall Study|Inadequate Neuraxial Block|1|||
30821132|NCT02829944|58842147|FG000|Overall Study|Withdrawal by Subject|2|||
30821133|NCT02829944|58842148|FG001|Overall Study|Withdrawal by Subject|1|||
30821134|NCT02829944|58842147|FG000|Overall Study|Catheter Displacement|1|||
30821135|NCT02829944|58842148|FG001|Overall Study|Catheter Displacement|0|||
30821136|NCT02829944|58842147|FG000|Overall Study|Catheter broke|0|||
30821137|NCT02829944|58842148|FG001|Overall Study|Catheter broke|1|||
30913772|NCT01639001|58949292|FG000|Overall Study|Randomized but not treated|0|||
30913773|NCT01639001|58949293|FG001|Overall Study|Randomized but not treated|2|||
30913774|NCT01639001|58949292|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
30913775|NCT01639001|58949293|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
30913776|NCT02224664|58949301|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
30913777|NCT02224664|58949302|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
30913778|NCT02224664|58949303|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
30913779|NCT02224664|58949304|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
30752675|NCT03725722|58762425|FG002|Overall Study|COVID-19 situation|0|||
30752676|NCT03725722|58762426|FG003|Overall Study|COVID-19 situation|0|||
30752677|NCT03725722|58762427|FG004|Overall Study|COVID-19 situation|0|||
30752678|NCT02966314|58762441|FG000|Overall Study|Lost to Follow-up|1|||
30752679|NCT02966314|58762442|FG001|Overall Study|Lost to Follow-up|0|||
30752680|NCT03723070|58762448|FG000|Overall Study|Lost to Follow-up|2|||
30752681|NCT03723070|58762448|FG000|Overall Study|Physician Decision|1|||
30752682|NCT03723070|58762448|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
30752683|NCT03722524|58762456|FG000|Overall Study|Protocol Violation|86|||
30752684|NCT03722524|58762456|FG000|Overall Study|Adverse Event|7|||
30752685|NCT03722524|58762456|FG000|Overall Study|Lost to Follow-up|1|||
30752686|NCT03722524|58762456|FG000|Overall Study|Reason is not stated|1|||
30752687|NCT03722524|58762456|FG000|Overall Study|Physician Decision|1|||
30821138|NCT02829944|58842147|FG000|Overall Study|Staff unavailable|0|||
30821139|NCT02829944|58842148|FG001|Overall Study|Staff unavailable|1|||
30821140|NCT02824562|58842156|FG000|Overall Study|Lost to Follow-up|3|||
30821141|NCT02824562|58842157|FG001|Overall Study|Lost to Follow-up|4|||
30821142|NCT02824562|58842156|FG000|Overall Study|Death|0|||
30821143|NCT02824562|58842157|FG001|Overall Study|Death|1|||
30821144|NCT02744066|58842165|FG000|Overall Study|Withdrawal by parent|0|||
30821145|NCT02744066|58842166|FG001|Overall Study|Withdrawal by parent|1|||
30821146|NCT02744066|58842165|FG000|Overall Study|Discharged from NICU prior to completion|0|||
30821147|NCT02744066|58842166|FG001|Overall Study|Discharged from NICU prior to completion|4|||
30821148|NCT01338818|58842174|FG000|Overall Study|Adverse Event|8|||
30821149|NCT01338818|58842174|FG000|Overall Study|Lack of Efficacy|5|||
30752688|NCT03722524|58762456|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
30821150|NCT01338818|58842174|FG000|Overall Study|no longer require study drug|1|||
30913780|NCT02224664|58949305|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
30913781|NCT02224664|58949301|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
30913782|NCT02224664|58949302|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
30913783|NCT02224664|58949303|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
30821151|NCT01338818|58842174|FG000|Overall Study|Withdrawal by Subject|11|||
30821152|NCT01338818|58842174|FG000|Overall Study|Lost to Follow-up|4|||
30821153|NCT01338818|58842174|FG000|Overall Study|Administrative problems|3|||
30821154|NCT01338818|58842174|FG000|Overall Study|Protocol Deviation|4|||
30821155|NCT02823470|58842180|FG000|Overall Study|Adverse Event|1|||
30821156|NCT02823470|58842181|FG001|Overall Study|Adverse Event|0|||
30821157|NCT02823470|58842180|FG000|Overall Study|Study terminated by sponsor|8|||
30821158|NCT02823470|58842181|FG001|Overall Study|Study terminated by sponsor|15|||
30913784|NCT02224664|58949304|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
30821159|NCT01371656|58842192|FG000|Overall Study|Death|7|||
30821160|NCT01371656|58842193|FG001|Overall Study|Death|4|||
30821161|NCT01371656|58842192|FG000|Overall Study|Physician Decision|46|||
30821162|NCT01371656|58842193|FG001|Overall Study|Physician Decision|7|||
30821163|NCT01371656|58842192|FG000|Overall Study|Withdrawal by Subject|7|||
30821164|NCT01371656|58842193|FG001|Overall Study|Withdrawal by Subject|0|||
30821165|NCT01371656|58842192|FG000|Overall Study|Ineligible|4|||
30821166|NCT01371656|58842193|FG001|Overall Study|Ineligible|3|||
30821167|NCT01354106|58842199|FG000|Overall Study|Withdrawal by Subject|2|||
30821168|NCT01354028|58842205|FG000|Overall Study|Physician Decision|0|||
30821169|NCT01354028|58842206|FG001|Overall Study|Physician Decision|2|||
30913785|NCT02224664|58949305|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
30913786|NCT02224664|58949301|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
30913787|NCT02224664|58949302|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
30821170|NCT01354028|58842205|FG000|Overall Study|Discharged before study start|2|||
30821171|NCT01354028|58842206|FG001|Overall Study|Discharged before study start|2|||
30821172|NCT01354028|58842205|FG000|Overall Study|No quiet alert state|0|||
30821173|NCT01354028|58842206|FG001|Overall Study|No quiet alert state|1|||
30821174|NCT01354964|58842220|FG000|Overall Study|Lost to Follow-up|2|||
30821175|NCT01354964|58842221|FG001|Overall Study|Lost to Follow-up|0|||
30821176|NCT01354964|58842220|FG000|Overall Study|IV access issues|1|||
30821177|NCT01354964|58842221|FG001|Overall Study|IV access issues|1|||
30821178|NCT01354964|58842220|FG000|Overall Study|Physician Decision|1|||
30821179|NCT01354964|58842221|FG001|Overall Study|Physician Decision|0|||
30821180|NCT01354496|58842231|FG000|Period 1|Adverse Event|0|||
30821181|NCT01354496|58842232|FG001|Period 1|Adverse Event|0|||
30821182|NCT01354496|58842233|FG002|Period 1|Adverse Event|1|||
30821183|NCT01354496|58842234|FG003|Period 1|Adverse Event|0|||
30821184|NCT01354496|58842235|FG004|Period 1|Adverse Event|0|||
30821185|NCT01354496|58842236|FG005|Period 1|Adverse Event|0|||
30913788|NCT02224664|58949303|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
30821186|NCT01354496|58842231|FG000|Period 1|Physician Decision|0|||
30821187|NCT01354496|58842232|FG001|Period 1|Physician Decision|0|||
30821188|NCT01354496|58842233|FG002|Period 1|Physician Decision|1|||
30821189|NCT01354496|58842234|FG003|Period 1|Physician Decision|0|||
30821190|NCT01354496|58842235|FG004|Period 1|Physician Decision|0|||
30821191|NCT01354496|58842236|FG005|Period 1|Physician Decision|0|||
30821192|NCT01354496|58842231|FG000|Period 2|Adverse Event|0|||
30821193|NCT01354496|58842232|FG001|Period 2|Adverse Event|0|||
30821194|NCT01354496|58842233|FG002|Period 2|Adverse Event|0|||
30913789|NCT02224664|58949304|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
30913790|NCT02224664|58949305|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
30913791|NCT02168270|58949321|FG000|Overall Study|Lack of Efficacy|4|||
30913792|NCT02167256|58949327|FG000|Overall Study|Adverse Event|13|||
30913793|NCT02167256|58949328|FG001|Overall Study|Adverse Event|6|||
30913794|NCT02167256|58949327|FG000|Overall Study|Withdrawal by Subject|4|||
30913795|NCT02167256|58949328|FG001|Overall Study|Withdrawal by Subject|4|||
30913796|NCT02167256|58949327|FG000|Overall Study|non-compliance|3|||
30913797|NCT02167256|58949328|FG001|Overall Study|non-compliance|0|||
30913798|NCT02167256|58949327|FG000|Overall Study|Study partner unable to participate|1|||
30913799|NCT02167256|58949328|FG001|Overall Study|Study partner unable to participate|0|||
30913800|NCT02191046|58949336|FG000|Overall Study|low compliance|5|||
30821195|NCT01354496|58842234|FG003|Period 2|Adverse Event|1|||
30913801|NCT02191046|58949337|FG001|Overall Study|low compliance|1|||
30913802|NCT02166476|58949345|FG000|Overall Study|Withdrawal by Subject|5|||
30913803|NCT02166476|58949346|FG001|Overall Study|Withdrawal by Subject|7|||
30913804|NCT02166476|58949345|FG000|Overall Study|Adverse Event|3|||
30821196|NCT01354496|58842235|FG004|Period 2|Adverse Event|0|||
30821197|NCT01354496|58842236|FG005|Period 2|Adverse Event|0|||
30821198|NCT01354496|58842231|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
30821199|NCT01354496|58842232|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
30821200|NCT01354496|58842233|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
30821201|NCT01354496|58842234|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
30821202|NCT01354496|58842235|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
30821203|NCT01354496|58842236|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
30821204|NCT02822222|58842259|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
30821205|NCT02822222|58842260|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
30821206|NCT02821910|58842272|FG000|Overall Study|Withdrawal by Subject|0|||
30821207|NCT02821910|58842273|FG001|Overall Study|Withdrawal by Subject|0|||
30821208|NCT02821910|58842274|FG002|Overall Study|Withdrawal by Subject|1|||
30821209|NCT02821910|58842275|FG003|Overall Study|Withdrawal by Subject|0|||
30821210|NCT02821910|58842276|FG004|Overall Study|Withdrawal by Subject|0|||
30821211|NCT02821910|58842277|FG005|Overall Study|Withdrawal by Subject|1|||
30821212|NCT02821910|58842272|FG000|Overall Study|Other than specified|1|||
30821213|NCT02821910|58842273|FG001|Overall Study|Other than specified|0|||
30821214|NCT02821910|58842274|FG002|Overall Study|Other than specified|1|||
30821215|NCT02821910|58842275|FG003|Overall Study|Other than specified|0|||
30821216|NCT02821910|58842276|FG004|Overall Study|Other than specified|0|||
30821217|NCT02821910|58842277|FG005|Overall Study|Other than specified|0|||
30821218|NCT02817776|58842291|FG000|Overall Study|Excluded|33|||
30821219|NCT02817776|58842291|FG000|Overall Study|Lost to Follow-up|20|||
30821220|NCT02817776|58842291|FG000|Overall Study|Withdrawal by Subject|33|||
30821221|NCT02817776|58842291|FG000|Overall Study|Death|2|||
30821222|NCT03138655|58842303|FG000|Overall Study|Adverse Event|2|||
30821223|NCT03138655|58842304|FG001|Overall Study|Adverse Event|1|||
30821224|NCT03138655|58842305|FG002|Overall Study|Adverse Event|2|||
30821225|NCT03138655|58842306|FG003|Overall Study|Adverse Event|1|||
30821226|NCT03138655|58842307|FG004|Overall Study|Adverse Event|1|||
30821227|NCT03138655|58842308|FG005|Overall Study|Adverse Event|4|||
30821228|NCT03138655|58842309|FG006|Overall Study|Adverse Event|2|||
30821229|NCT03138655|58842310|FG007|Overall Study|Adverse Event|2|||
30821230|NCT03138655|58842303|FG000|Overall Study|Withdrawal by Subject|0|||
30821231|NCT03138655|58842304|FG001|Overall Study|Withdrawal by Subject|1|||
30821232|NCT03138655|58842305|FG002|Overall Study|Withdrawal by Subject|0|||
30821233|NCT03138655|58842306|FG003|Overall Study|Withdrawal by Subject|0|||
30821234|NCT03138655|58842307|FG004|Overall Study|Withdrawal by Subject|0|||
30821235|NCT03138655|58842308|FG005|Overall Study|Withdrawal by Subject|0|||
30913805|NCT02166476|58949346|FG001|Overall Study|Adverse Event|3|||
30913806|NCT02166476|58949345|FG000|Overall Study|Lost to Follow-up|5|||
30913807|NCT02166476|58949346|FG001|Overall Study|Lost to Follow-up|10|||
30821236|NCT03138655|58842309|FG006|Overall Study|Withdrawal by Subject|1|||
30913808|NCT02166476|58949345|FG000|Overall Study|Physician Decision|1|||
30913809|NCT02166476|58949346|FG001|Overall Study|Physician Decision|0|||
30913810|NCT02166476|58949345|FG000|Overall Study|Unable to Come for Visit|0|||
30821237|NCT03138655|58842310|FG007|Overall Study|Withdrawal by Subject|0|||
30821238|NCT03138655|58842303|FG000|Overall Study|Reason not Specified|1|||
30821239|NCT03138655|58842304|FG001|Overall Study|Reason not Specified|0|||
30821240|NCT03138655|58842305|FG002|Overall Study|Reason not Specified|0|||
30821241|NCT03138655|58842306|FG003|Overall Study|Reason not Specified|2|||
30821242|NCT03138655|58842307|FG004|Overall Study|Reason not Specified|1|||
30821243|NCT03138655|58842308|FG005|Overall Study|Reason not Specified|1|||
30821244|NCT03138655|58842309|FG006|Overall Study|Reason not Specified|0|||
30821245|NCT03138655|58842310|FG007|Overall Study|Reason not Specified|0|||
30821246|NCT02820038|58842336|FG000|Overall Study|Lost to Follow-up|7|||
30821247|NCT02820038|58842337|FG001|Overall Study|Lost to Follow-up|11|||
30821248|NCT02820038|58842338|FG002|Overall Study|Lost to Follow-up|2|||
30821249|NCT02820038|58842339|FG003|Overall Study|Lost to Follow-up|9|||
30821250|NCT02820038|58842336|FG000|Overall Study|Withdrawal by Subject|3|||
30821251|NCT02820038|58842337|FG001|Overall Study|Withdrawal by Subject|14|||
30821252|NCT02820038|58842338|FG002|Overall Study|Withdrawal by Subject|3|||
30821253|NCT02820038|58842339|FG003|Overall Study|Withdrawal by Subject|13|||
30821254|NCT02819804|58842350|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
30821255|NCT02819726|58842357|FG000|Part A (All Participants)|Lost to Follow-up|0|||
30821256|NCT02819726|58842358|FG001|Part A (All Participants)|Lost to Follow-up|1|||
30821257|NCT02819726|58842359|FG002|Part A (All Participants)|Lost to Follow-up|0|||
30821258|NCT02819726|58842360|FG003|Part A (All Participants)|Lost to Follow-up|0|||
30821259|NCT02819726|58842357|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
30821260|NCT02819726|58842358|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
30821261|NCT02819726|58842359|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
30821262|NCT02819726|58842360|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
30821263|NCT02819726|58842357|FG000|Part A (All Participants)|Protocol non-compliance|3|||
30821264|NCT02819726|58842358|FG001|Part A (All Participants)|Protocol non-compliance|4|||
30913811|NCT02166476|58949346|FG001|Overall Study|Unable to Come for Visit|3|||
30752689|NCT03722446|58762462|FG000|Overall Study|Protocol Violation|15|||
30752690|NCT03722446|58762463|FG001|Overall Study|Protocol Violation|2|||
30752691|NCT00146172|58762477|FG000|Overall Study|Adverse Event|0|||
30752692|NCT00146172|58762478|FG001|Overall Study|Adverse Event|0|||
30752693|NCT00146172|58762479|FG002|Overall Study|Adverse Event|1|||
30752694|NCT00146172|58762480|FG003|Overall Study|Adverse Event|1|||
30752695|NCT00146172|58762481|FG004|Overall Study|Adverse Event|0|||
30752696|NCT00146172|58762482|FG005|Overall Study|Adverse Event|2|||
30752697|NCT00146172|58762483|FG006|Overall Study|Adverse Event|3|||
30752698|NCT00146172|58762484|FG007|Overall Study|Adverse Event|10|||
30752699|NCT00146172|58762477|FG000|Overall Study|Lost to Follow-up|0|||
30752700|NCT00146172|58762478|FG001|Overall Study|Lost to Follow-up|0|||
30752701|NCT00146172|58762479|FG002|Overall Study|Lost to Follow-up|0|||
30752702|NCT00146172|58762480|FG003|Overall Study|Lost to Follow-up|0|||
30752703|NCT00146172|58762481|FG004|Overall Study|Lost to Follow-up|0|||
30752704|NCT00146172|58762482|FG005|Overall Study|Lost to Follow-up|0|||
30752705|NCT00146172|58762483|FG006|Overall Study|Lost to Follow-up|0|||
30752706|NCT00146172|58762484|FG007|Overall Study|Lost to Follow-up|1|||
30752707|NCT00146172|58762477|FG000|Overall Study|Disease Progression|2|||
30752708|NCT00146172|58762478|FG001|Overall Study|Disease Progression|4|||
30752709|NCT00146172|58762479|FG002|Overall Study|Disease Progression|2|||
30752710|NCT00146172|58762480|FG003|Overall Study|Disease Progression|5|||
30752711|NCT00146172|58762481|FG004|Overall Study|Disease Progression|2|||
30752712|NCT00146172|58762482|FG005|Overall Study|Disease Progression|2|||
30752713|NCT00146172|58762483|FG006|Overall Study|Disease Progression|1|||
30752714|NCT00146172|58762484|FG007|Overall Study|Disease Progression|22|||
30752715|NCT00146172|58762477|FG000|Overall Study|Death|0|||
30752716|NCT00146172|58762478|FG001|Overall Study|Death|0|||
30752717|NCT00146172|58762479|FG002|Overall Study|Death|0|||
30752718|NCT00146172|58762480|FG003|Overall Study|Death|0|||
30752719|NCT00146172|58762481|FG004|Overall Study|Death|0|||
30752720|NCT00146172|58762482|FG005|Overall Study|Death|0|||
30752721|NCT00146172|58762483|FG006|Overall Study|Death|1|||
30752722|NCT00146172|58762484|FG007|Overall Study|Death|0|||
30752723|NCT00146172|58762477|FG000|Overall Study|Physician Decision|0|||
30752724|NCT00146172|58762478|FG001|Overall Study|Physician Decision|0|||
30752725|NCT00146172|58762479|FG002|Overall Study|Physician Decision|0|||
30752726|NCT00146172|58762480|FG003|Overall Study|Physician Decision|0|||
30752727|NCT00146172|58762481|FG004|Overall Study|Physician Decision|0|||
30752728|NCT00146172|58762482|FG005|Overall Study|Physician Decision|0|||
30752729|NCT00146172|58762483|FG006|Overall Study|Physician Decision|0|||
30752730|NCT00146172|58762484|FG007|Overall Study|Physician Decision|1|||
30752731|NCT00146172|58762477|FG000|Overall Study|Withdrawal by Subject|0|||
30752732|NCT00146172|58762478|FG001|Overall Study|Withdrawal by Subject|0|||
30752733|NCT00146172|58762479|FG002|Overall Study|Withdrawal by Subject|0|||
30752734|NCT00146172|58762480|FG003|Overall Study|Withdrawal by Subject|0|||
30821265|NCT02819726|58842359|FG002|Part A (All Participants)|Protocol non-compliance|5|||
30821266|NCT02819726|58842360|FG003|Part A (All Participants)|Protocol non-compliance|0|||
30821267|NCT02819726|58842357|FG000|Part B (All Participants)|Lost to Follow-up|1|||
30821268|NCT02819726|58842358|FG001|Part B (All Participants)|Lost to Follow-up|1|||
30821269|NCT02819726|58842359|FG002|Part B (All Participants)|Lost to Follow-up|2|||
30821270|NCT02819726|58842360|FG003|Part B (All Participants)|Lost to Follow-up|2|||
30821271|NCT02819726|58842357|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
30821272|NCT02819726|58842358|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
30821273|NCT02819726|58842359|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
30821274|NCT02819726|58842360|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
30821275|NCT02819726|58842357|FG000|Part B (All Participants)|Protocol non-compliance|0|||
30821276|NCT02819726|58842358|FG001|Part B (All Participants)|Protocol non-compliance|0|||
30821277|NCT02819726|58842359|FG002|Part B (All Participants)|Protocol non-compliance|1|||
30821278|NCT02819726|58842360|FG003|Part B (All Participants)|Protocol non-compliance|0|||
30821279|NCT02816138|58842368|FG000|Overall Study|Adverse Event|1|||
30821280|NCT02815670|58842372|FG000|Overall Study|Prematurely discontinued of the trial|1|||
30821281|NCT02809976|58842376|FG000|Overall Study|Lost to Follow-up|1|||
30821282|NCT02809976|58842376|FG000|Overall Study|Withdrawal by Subject|1|||
30821283|NCT02880865|58842382|FG000|Overall Study|Adverse Event|1|||
30821284|NCT02880865|58842383|FG001|Overall Study|Adverse Event|0|||
30821285|NCT02880865|58842382|FG000|Overall Study|Withdrawal by Subject|0|||
30821286|NCT02880865|58842383|FG001|Overall Study|Withdrawal by Subject|2|||
30821287|NCT02880865|58842382|FG000|Overall Study|Physician Decision|0|||
30821288|NCT02880865|58842383|FG001|Overall Study|Physician Decision|1|||
30821289|NCT01854385|58842410|FG000|Pre-Treatment|Withdrawal by Subject|4|||
30821290|NCT01854385|58842410|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
30821291|NCT01854385|58842410|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
30821292|NCT01854385|58842410|FG000|Pre-Treatment|Unable to come for study visits|1|||
30821293|NCT01854385|58842410|FG000|Treatment|Lost to Follow-up|1|||
30821294|NCT02809118|58842417|FG000|Overall Study|Withdrawal by Subject|0|||
30821295|NCT02809118|58842418|FG001|Overall Study|Withdrawal by Subject|1|||
30821296|NCT02809118|58842419|FG002|Overall Study|Withdrawal by Subject|1|||
30821297|NCT03604159|58842429|FG000|Overall Study|Lost to Follow-up|6|||
30821298|NCT03604159|58842430|FG001|Overall Study|Lost to Follow-up|7|||
30821299|NCT02808338|58842436|FG000|Screening|Screen Failure|10|||
30821300|NCT02808338|58842436|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
30821301|NCT02808338|58842436|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
30821302|NCT02807948|58842447|FG000|Overall Study|Physician Decision|1|||
30821303|NCT02807948|58842448|FG001|Overall Study|Physician Decision|0|||
30821304|NCT02879383|58842457|FG000|First 24 Weeks|Physician Decision|0|||
30821305|NCT02879383|58842458|FG001|First 24 Weeks|Physician Decision|1|||
30821306|NCT02879383|58842459|FG002|First 24 Weeks|Physician Decision|0|||
30821307|NCT02879383|58842460|FG003|First 24 Weeks|Physician Decision|0|||
30821308|NCT02049710|58842474|FG000|Overall Study|Lost to Follow-up|319|||
30821309|NCT02049710|58842475|FG001|Overall Study|Lost to Follow-up|324|||
30821310|NCT02806232|58842503|FG000|Overall Study|Lost to Follow-up|1|||
30821311|NCT02806232|58842504|FG001|Overall Study|Lost to Follow-up|2|||
30821312|NCT02806232|58842505|FG002|Overall Study|Lost to Follow-up|1|||
30821313|NCT02806232|58842506|FG003|Overall Study|Lost to Follow-up|0|||
30821314|NCT02806232|58842507|FG004|Overall Study|Lost to Follow-up|0|||
30821315|NCT02806232|58842508|FG005|Overall Study|Lost to Follow-up|1|||
30821316|NCT02806232|58842509|FG006|Overall Study|Lost to Follow-up|0|||
30821317|NCT02806232|58842510|FG007|Overall Study|Lost to Follow-up|0|||
30821318|NCT02806232|58842511|FG008|Overall Study|Lost to Follow-up|0|||
30821319|NCT02806232|58842503|FG000|Overall Study|Withdrawal by Subject|0|||
30821320|NCT02806232|58842504|FG001|Overall Study|Withdrawal by Subject|2|||
30821321|NCT02806232|58842505|FG002|Overall Study|Withdrawal by Subject|0|||
30821322|NCT02806232|58842506|FG003|Overall Study|Withdrawal by Subject|0|||
30821323|NCT02806232|58842507|FG004|Overall Study|Withdrawal by Subject|2|||
30821324|NCT02806232|58842508|FG005|Overall Study|Withdrawal by Subject|1|||
30821325|NCT02806232|58842509|FG006|Overall Study|Withdrawal by Subject|0|||
30821326|NCT02806232|58842510|FG007|Overall Study|Withdrawal by Subject|0|||
30821327|NCT02806232|58842511|FG008|Overall Study|Withdrawal by Subject|0|||
30821328|NCT02807402|58842531|FG000|Overall Study|Failure to Return|1|||
30821329|NCT02807402|58842531|FG000|Overall Study|Death|3|||
30821330|NCT02807402|58842531|FG000|Overall Study|Other|2|||
30821331|NCT00392327|58842551|FG000|Overall Study|Death|1|||
30821332|NCT00392327|58842552|FG001|Overall Study|Death|0|||
30821333|NCT00392327|58842553|FG002|Overall Study|Death|1|||
30821334|NCT00392327|58842554|FG003|Overall Study|Death|0|||
30821335|NCT00392327|58842555|FG004|Overall Study|Death|0|||
30821336|NCT00392327|58842556|FG005|Overall Study|Death|0|||
30821337|NCT00392327|58842557|FG006|Overall Study|Death|0|||
30821338|NCT00392327|58842558|FG007|Overall Study|Death|0|||
30821339|NCT00392327|58842551|FG000|Overall Study|Lack of Efficacy|8|||
30821340|NCT00392327|58842552|FG001|Overall Study|Lack of Efficacy|8|||
30821341|NCT00392327|58842553|FG002|Overall Study|Lack of Efficacy|9|||
30821342|NCT00392327|58842554|FG003|Overall Study|Lack of Efficacy|6|||
30821343|NCT00392327|58842555|FG004|Overall Study|Lack of Efficacy|3|||
30821344|NCT00392327|58842556|FG005|Overall Study|Lack of Efficacy|3|||
30821345|NCT00392327|58842557|FG006|Overall Study|Lack of Efficacy|3|||
30821346|NCT00392327|58842558|FG007|Overall Study|Lack of Efficacy|3|||
30821347|NCT00392327|58842551|FG000|Overall Study|Physician Decision|3|||
30821348|NCT00392327|58842552|FG001|Overall Study|Physician Decision|5|||
30821349|NCT00392327|58842553|FG002|Overall Study|Physician Decision|2|||
30821350|NCT00392327|58842554|FG003|Overall Study|Physician Decision|2|||
30821351|NCT00392327|58842555|FG004|Overall Study|Physician Decision|0|||
30821352|NCT00392327|58842556|FG005|Overall Study|Physician Decision|1|||
30821353|NCT00392327|58842557|FG006|Overall Study|Physician Decision|5|||
30821354|NCT00392327|58842558|FG007|Overall Study|Physician Decision|3|||
30821355|NCT00392327|58842551|FG000|Overall Study|Protocol Violation|0|||
30821356|NCT00392327|58842552|FG001|Overall Study|Protocol Violation|0|||
30821357|NCT00392327|58842553|FG002|Overall Study|Protocol Violation|1|||
30821358|NCT00392327|58842554|FG003|Overall Study|Protocol Violation|0|||
30821359|NCT00392327|58842555|FG004|Overall Study|Protocol Violation|0|||
30821360|NCT00392327|58842556|FG005|Overall Study|Protocol Violation|0|||
30821361|NCT00392327|58842557|FG006|Overall Study|Protocol Violation|0|||
30821362|NCT00392327|58842558|FG007|Overall Study|Protocol Violation|0|||
30821363|NCT00392327|58842551|FG000|Overall Study|Withdrawal by Subject|3|||
30821364|NCT00392327|58842552|FG001|Overall Study|Withdrawal by Subject|2|||
30821365|NCT00392327|58842553|FG002|Overall Study|Withdrawal by Subject|4|||
30821366|NCT00392327|58842554|FG003|Overall Study|Withdrawal by Subject|6|||
30913812|NCT02224274|58949357|FG000|Overall Study|Death|1|||
30913813|NCT02224274|58949358|FG001|Overall Study|Death|0|||
30913814|NCT02189252|58949372|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
30821367|NCT00392327|58842555|FG004|Overall Study|Withdrawal by Subject|0|||
30821368|NCT00392327|58842556|FG005|Overall Study|Withdrawal by Subject|1|||
30821369|NCT00392327|58842557|FG006|Overall Study|Withdrawal by Subject|1|||
30821370|NCT00392327|58842558|FG007|Overall Study|Withdrawal by Subject|5|||
30821371|NCT00392327|58842551|FG000|Overall Study|Ineligible|0|||
30821372|NCT00392327|58842552|FG001|Overall Study|Ineligible|4|||
30821373|NCT00392327|58842553|FG002|Overall Study|Ineligible|3|||
30821374|NCT00392327|58842554|FG003|Overall Study|Ineligible|2|||
30821375|NCT00392327|58842555|FG004|Overall Study|Ineligible|0|||
30821376|NCT00392327|58842556|FG005|Overall Study|Ineligible|0|||
30821377|NCT00392327|58842557|FG006|Overall Study|Ineligible|0|||
30821378|NCT00392327|58842558|FG007|Overall Study|Ineligible|0|||
30821379|NCT02960490|58842578|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
30821380|NCT02960490|58842579|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
30821381|NCT02960490|58842580|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
30821382|NCT02960490|58842581|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
30821383|NCT02960490|58842582|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
30821384|NCT02960490|58842583|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
30821385|NCT02960490|58842584|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
30821386|NCT02960490|58842585|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
30821387|NCT02960490|58842586|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
30821388|NCT02960490|58842587|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
30821389|NCT02960490|58842578|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
30821390|NCT02960490|58842579|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
30821391|NCT02960490|58842580|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
30821392|NCT02960490|58842581|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
30821393|NCT02960490|58842582|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
30821394|NCT02960490|58842583|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
30821395|NCT02960490|58842584|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
30821396|NCT02960490|58842585|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
30821397|NCT02960490|58842586|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
30821398|NCT02960490|58842587|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
30821399|NCT02960490|58842578|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
30821400|NCT02960490|58842579|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
30821401|NCT02960490|58842580|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
30821402|NCT02960490|58842581|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
30821403|NCT02960490|58842582|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
30821404|NCT02960490|58842583|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
30821405|NCT02960490|58842584|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
30821406|NCT02960490|58842585|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
30821407|NCT02960490|58842586|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
30821408|NCT02960490|58842587|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
30821409|NCT02960490|58842578|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
30821410|NCT02960490|58842579|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
30821411|NCT02960490|58842580|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
30821412|NCT02960490|58842581|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
30821413|NCT02960490|58842582|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
30821414|NCT02960490|58842583|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
30821415|NCT02960490|58842584|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
30821416|NCT02960490|58842585|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
30821417|NCT02960490|58842586|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
30821418|NCT02960490|58842587|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
30821419|NCT02960490|58842578|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
30821420|NCT02960490|58842579|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
30821421|NCT02960490|58842580|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
30821422|NCT02960490|58842581|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
30821423|NCT02960490|58842582|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
30821424|NCT02960490|58842583|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
30623096|NCT01215422|58634884|FG003|Overall Study|Did not complete all intubations|0|||
30623097|NCT00972153|58634909|FG000|Overall Study|Equipment malfunction during case|0|||
30623098|NCT00972153|58634910|FG001|Overall Study|Equipment malfunction during case|1|||
30623099|NCT00972153|58634911|FG002|Overall Study|Equipment malfunction during case|0|||
30623100|NCT00971997|58634919|FG000|Overall Study|Adverse Event|2|||
30623101|NCT00971997|58634919|FG000|Overall Study|Death|1|||
30623102|NCT00971997|58634919|FG000|Overall Study|Protocol Violation|4|||
30623103|NCT00971997|58634919|FG000|Overall Study|Withdrawal by Subject|5|||
30623104|NCT00971997|58634919|FG000|Overall Study|Physician Decision|7|||
30623105|NCT01127646|58634928|FG000|Overall Study|Entry Criteria Not Met|1|||
30623106|NCT01127646|58634929|FG001|Overall Study|Entry Criteria Not Met|0|||
30623107|NCT01127646|58634928|FG000|Overall Study|Protocol Violation|0|||
30623108|NCT01127646|58634929|FG001|Overall Study|Protocol Violation|1|||
30623109|NCT01215188|58634940|FG000|Overall Study|Lost to Follow-up|22|||
30623110|NCT01215188|58634941|FG001|Overall Study|Lost to Follow-up|22|||
30623111|NCT01215188|58634942|FG002|Overall Study|Lost to Follow-up|16|||
30623112|NCT01215188|58634940|FG000|Overall Study|Adverse Event|1|||
30623113|NCT01215188|58634941|FG001|Overall Study|Adverse Event|1|||
30623114|NCT01215188|58634942|FG002|Overall Study|Adverse Event|3|||
30623115|NCT01215188|58634940|FG000|Overall Study|Physician Decision|2|||
30623116|NCT01215188|58634941|FG001|Overall Study|Physician Decision|1|||
30623117|NCT01215188|58634942|FG002|Overall Study|Physician Decision|0|||
30623118|NCT01215188|58634940|FG000|Overall Study|Lack of Efficacy|0|||
30623119|NCT01215188|58634941|FG001|Overall Study|Lack of Efficacy|0|||
30623120|NCT01215188|58634942|FG002|Overall Study|Lack of Efficacy|1|||
30623121|NCT01215188|58634940|FG000|Overall Study|Protocol Violation|1|||
30623122|NCT01215188|58634941|FG001|Overall Study|Protocol Violation|1|||
30623123|NCT01215188|58634942|FG002|Overall Study|Protocol Violation|1|||
30623124|NCT01215188|58634940|FG000|Overall Study|Withdrawal by Subject|32|||
30623125|NCT01215188|58634941|FG001|Overall Study|Withdrawal by Subject|34|||
30623126|NCT01215188|58634942|FG002|Overall Study|Withdrawal by Subject|31|||
30623127|NCT01215032|58634950|FG000|Overall Study|Adverse Event|3|||
30913815|NCT02189252|58949373|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
30913816|NCT02189252|58949374|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
30913817|NCT02189252|58949375|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
30913818|NCT02189252|58949372|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
30913819|NCT02189252|58949373|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
30913820|NCT02189252|58949374|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
30913821|NCT02189252|58949375|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
30913822|NCT01583374|58949389|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
30913823|NCT01583374|58949390|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
30752735|NCT00146172|58762481|FG004|Overall Study|Withdrawal by Subject|0|||
30821425|NCT02960490|58842584|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
30821426|NCT02960490|58842585|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
30821427|NCT02960490|58842586|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
30821428|NCT02960490|58842587|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
30913824|NCT01583374|58949391|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
30913825|NCT01583374|58949392|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30913826|NCT01583374|58949393|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30913827|NCT01583374|58949394|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30913828|NCT01583374|58949395|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30913829|NCT01583374|58949396|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30913830|NCT01583374|58949397|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30913831|NCT01583374|58949389|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
30913832|NCT01583374|58949390|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
30913833|NCT01583374|58949391|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
30821429|NCT02960490|58842578|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
30821430|NCT02960490|58842579|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
30752736|NCT00146172|58762482|FG005|Overall Study|Withdrawal by Subject|1|||
30752737|NCT00146172|58762483|FG006|Overall Study|Withdrawal by Subject|1|||
30752738|NCT00146172|58762484|FG007|Overall Study|Withdrawal by Subject|4|||
30752739|NCT00146172|58762477|FG000|Overall Study|Symptomatic Deterioration|1|||
30752740|NCT00146172|58762478|FG001|Overall Study|Symptomatic Deterioration|0|||
30752741|NCT00146172|58762479|FG002|Overall Study|Symptomatic Deterioration|1|||
30752742|NCT00146172|58762480|FG003|Overall Study|Symptomatic Deterioration|0|||
30752743|NCT00146172|58762481|FG004|Overall Study|Symptomatic Deterioration|1|||
30752744|NCT00146172|58762482|FG005|Overall Study|Symptomatic Deterioration|2|||
30752745|NCT00146172|58762483|FG006|Overall Study|Symptomatic Deterioration|0|||
30752746|NCT00146172|58762484|FG007|Overall Study|Symptomatic Deterioration|2|||
30752747|NCT00145626|58762512|FG000|Overall Study|Did not have NK infusions|2|||
30752748|NCT00145626|58762512|FG000|Overall Study|Turned 2 years old before treatment|1|||
30623128|NCT01215032|58634950|FG000|Overall Study|Lack of Efficacy|17|||
30623129|NCT00962247|58634956|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
30752749|NCT00145626|58762512|FG000|Overall Study|Death|1|||
30752750|NCT00145626|58762512|FG000|Overall Study|Withdrawal by Subject|1|||
30752751|NCT00153062|58762536|FG000|Overall Study|Death|360|||
30821431|NCT02960490|58842580|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
30821432|NCT02960490|58842581|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
30821433|NCT02960490|58842582|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
30821434|NCT02960490|58842583|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
30821435|NCT02960490|58842584|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
30821436|NCT02960490|58842585|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
30821437|NCT02960490|58842586|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
30821438|NCT02960490|58842587|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
30821439|NCT02960490|58842578|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
30821440|NCT02960490|58842579|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
30821441|NCT02960490|58842580|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
30821442|NCT02960490|58842581|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
30821443|NCT02960490|58842582|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
30821444|NCT02960490|58842583|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
30821445|NCT02960490|58842584|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
30821446|NCT02960490|58842585|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
30821447|NCT02960490|58842586|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
30821448|NCT02960490|58842587|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
30821449|NCT02960490|58842578|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
30821450|NCT02960490|58842579|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
30821451|NCT02960490|58842580|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
30821452|NCT02960490|58842581|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
30821453|NCT02960490|58842582|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
30821454|NCT02960490|58842583|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
30821455|NCT02960490|58842584|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
30821456|NCT02960490|58842585|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
30821457|NCT02960490|58842586|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
30821458|NCT02960490|58842587|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
30821459|NCT02960490|58842578|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
30821460|NCT02960490|58842579|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
30821461|NCT02960490|58842580|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
30821462|NCT02960490|58842581|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
30821463|NCT02960490|58842582|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
30821464|NCT02960490|58842583|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
30821465|NCT02960490|58842584|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
30821466|NCT02960490|58842585|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
30821467|NCT02960490|58842586|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
30821468|NCT02960490|58842587|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
30821469|NCT02960490|58842578|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
30821470|NCT02960490|58842579|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
30821471|NCT02960490|58842580|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
30821472|NCT02960490|58842581|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
30821473|NCT02960490|58842582|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
30821474|NCT02960490|58842583|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
30821475|NCT02960490|58842584|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
30821476|NCT02960490|58842585|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
30821477|NCT02960490|58842586|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
30821478|NCT02960490|58842587|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
30821479|NCT02960490|58842578|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
30821480|NCT02960490|58842579|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
30752752|NCT00153062|58762537|FG001|Overall Study|Death|352|||
30752753|NCT00153062|58762538|FG002|Overall Study|Death|369|||
30752754|NCT00153062|58762539|FG003|Overall Study|Death|365|||
30752755|NCT00153062|58762536|FG000|Overall Study|Withdrawal by Subject|14|||
30752756|NCT00153062|58762537|FG001|Overall Study|Withdrawal by Subject|30|||
30752757|NCT00153062|58762538|FG002|Overall Study|Withdrawal by Subject|27|||
30752758|NCT00153062|58762539|FG003|Overall Study|Withdrawal by Subject|28|||
30752759|NCT00153062|58762536|FG000|Overall Study|Lost to Follow-up|12|||
30752760|NCT00153062|58762537|FG001|Overall Study|Lost to Follow-up|20|||
30752761|NCT00153062|58762538|FG002|Overall Study|Lost to Follow-up|15|||
30752762|NCT00153062|58762539|FG003|Overall Study|Lost to Follow-up|16|||
30752763|NCT00153062|58762536|FG000|Overall Study|Adverse Event|0|||
30752764|NCT00153062|58762537|FG001|Overall Study|Adverse Event|1|||
30752765|NCT00153062|58762538|FG002|Overall Study|Adverse Event|1|||
30752766|NCT00153062|58762539|FG003|Overall Study|Adverse Event|0|||
30752767|NCT00153062|58762536|FG000|Overall Study|Protocol Violation|0|||
30752768|NCT00153062|58762537|FG001|Overall Study|Protocol Violation|2|||
30752769|NCT00153062|58762538|FG002|Overall Study|Protocol Violation|1|||
30821481|NCT02960490|58842580|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
30821482|NCT02960490|58842581|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
30821483|NCT02960490|58842582|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
30821484|NCT02960490|58842583|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
30821485|NCT02960490|58842584|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
30821486|NCT02960490|58842585|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
30821487|NCT02960490|58842586|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
30821488|NCT02960490|58842587|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
30821489|NCT02960490|58842578|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
30821490|NCT02960490|58842579|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
30821491|NCT02960490|58842580|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
30821492|NCT02960490|58842581|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
30821493|NCT02960490|58842582|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
30821494|NCT02960490|58842583|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
30821495|NCT02960490|58842584|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
30821496|NCT02960490|58842585|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
30821497|NCT02960490|58842586|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
30821498|NCT02960490|58842587|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
30821499|NCT02804750|58842611|FG000|Period 1|Adverse Event|0|||
30821500|NCT02804750|58842612|FG001|Period 1|Adverse Event|2|||
30821501|NCT02804750|58842611|FG000|Period 1|Withdrawal by Subject|0|||
30821502|NCT02804750|58842612|FG001|Period 1|Withdrawal by Subject|1|||
30821503|NCT02804750|58842611|FG000|Period 2|Adverse Event|1|||
30821504|NCT02804750|58842612|FG001|Period 2|Adverse Event|0|||
30913834|NCT01583374|58949392|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30913835|NCT01583374|58949393|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30913836|NCT01583374|58949394|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30752770|NCT00153062|58762539|FG003|Overall Study|Protocol Violation|1|||
30752771|NCT00153062|58762536|FG000|Overall Study|No disposition data available|1|||
30752772|NCT00153062|58762537|FG001|Overall Study|No disposition data available|1|||
30752773|NCT00153062|58762538|FG002|Overall Study|No disposition data available|1|||
30752774|NCT00153062|58762539|FG003|Overall Study|No disposition data available|1|||
30752775|NCT00153062|58762536|FG000|Overall Study|Other|0|||
30752776|NCT00153062|58762537|FG001|Overall Study|Other|0|||
30752777|NCT00153062|58762538|FG002|Overall Study|Other|1|||
30752778|NCT00153062|58762539|FG003|Overall Study|Other|0|||
30752779|NCT00145470|58762551|FG000|Overall Study|Adverse Event|19|||
30752780|NCT00145470|58762552|FG001|Overall Study|Adverse Event|25|||
30752781|NCT00145470|58762551|FG000|Overall Study|Lack of Efficacy|27|||
30752782|NCT00145470|58762552|FG001|Overall Study|Lack of Efficacy|13|||
30752783|NCT00145470|58762551|FG000|Overall Study|Withdrawal by Subject|36|||
30752784|NCT00145470|58762552|FG001|Overall Study|Withdrawal by Subject|34|||
30752785|NCT00145470|58762551|FG000|Overall Study|Lost to Follow-up|21|||
30752786|NCT00145470|58762552|FG001|Overall Study|Lost to Follow-up|17|||
30752787|NCT00145470|58762551|FG000|Overall Study|Reason Not Reported|9|||
30752788|NCT00145470|58762552|FG001|Overall Study|Reason Not Reported|9|||
30752789|NCT00152516|58762558|FG000|Overall Study|Adverse Event|18|||
30752790|NCT00152516|58762558|FG000|Overall Study|Lack and Loss of Efficacy|30|||
30752791|NCT00152516|58762558|FG000|Overall Study|Lost to Follow-up|5|||
30821505|NCT02804750|58842611|FG000|Period 3|Adverse Event|0|||
30821506|NCT02804750|58842612|FG001|Period 3|Adverse Event|2|||
30821507|NCT02804750|58842611|FG000|Period 4|Adverse Event|0|||
30821508|NCT02804750|58842612|FG001|Period 4|Adverse Event|5|||
30821509|NCT02959866|58842620|FG000|Overall Study|Withdrawal by Subject|1|||
30821510|NCT02748512|58842627|FG000|Overall Study|Lost to Follow-up|1|||
30821511|NCT02748512|58842628|FG001|Overall Study|Lost to Follow-up|1|||
30821512|NCT02748356|58842634|FG000|Overall Study|Withdrawal by Subject|1|||
30821513|NCT03439657|58842640|FG000|Overall Study|Adverse Event|2|||
30821514|NCT03439657|58842641|FG001|Overall Study|Adverse Event|3|||
30821515|NCT03439657|58842640|FG000|Overall Study|Lost to Follow-up|1|||
30821516|NCT03439657|58842641|FG001|Overall Study|Lost to Follow-up|0|||
30821517|NCT03439657|58842640|FG000|Overall Study|Protocol Violation|1|||
30821518|NCT03439657|58842641|FG001|Overall Study|Protocol Violation|1|||
30821519|NCT03439657|58842640|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
30821520|NCT03439657|58842641|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
30821521|NCT02803580|58842649|FG000|Overall Study|Death|13|||
30821522|NCT02803580|58842649|FG000|Overall Study|Lost to Follow-up|19|||
30821523|NCT02803580|58842649|FG000|Overall Study|Withdrawal by Subject|3|||
30821524|NCT02803580|58842649|FG000|Overall Study|Inclusion in clinical trial|1|||
30821525|NCT02878213|58842653|FG000|Overall Study|Withdrawal by Subject|2|||
30821526|NCT02878213|58842653|FG000|Overall Study|Adverse Event|1|||
30821527|NCT02802878|58842660|FG000|Overall Study|Withdrawal by Subject|3|||
30821528|NCT02802878|58842661|FG001|Overall Study|Withdrawal by Subject|3|||
30821529|NCT02802878|58842660|FG000|Overall Study|Protocol Violation|1|||
30821530|NCT02802878|58842661|FG001|Overall Study|Protocol Violation|0|||
30821531|NCT02801396|58842667|FG000|Period 1|Withdrawal by Subject|0|||
30821532|NCT02801396|58842668|FG001|Period 1|Withdrawal by Subject|0|||
30821533|NCT02801396|58842669|FG002|Period 1|Withdrawal by Subject|0|||
30821534|NCT02801396|58842670|FG003|Period 1|Withdrawal by Subject|0|||
30821535|NCT02801396|58842671|FG004|Period 1|Withdrawal by Subject|1|||
30821536|NCT02801396|58842672|FG005|Period 1|Withdrawal by Subject|0|||
30821537|NCT02800928|58842680|FG000|Overall Study|Withdrawal by Subject|1|||
30821538|NCT02800928|58842681|FG001|Overall Study|Withdrawal by Subject|1|||
30821539|NCT02800928|58842680|FG000|Overall Study|Protocol Violation|1|||
30821540|NCT02800928|58842681|FG001|Overall Study|Protocol Violation|1|||
30821541|NCT03148691|58842690|FG000|Overall Study|Protocol Violation|1|||
30821542|NCT03148691|58842691|FG001|Overall Study|Protocol Violation|2|||
30821543|NCT03148691|58842692|FG002|Overall Study|Protocol Violation|7|||
30821544|NCT03148691|58842690|FG000|Overall Study|Lost to Follow-up|0|||
30821545|NCT03148691|58842691|FG001|Overall Study|Lost to Follow-up|0|||
30752792|NCT00152516|58762558|FG000|Overall Study|Withdrawal by Subject|8|||
30752793|NCT00152516|58762558|FG000|Overall Study|Protocol Violation|3|||
30752794|NCT00152516|58762558|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
30752795|NCT00152516|58762558|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
30821546|NCT03148691|58842692|FG002|Overall Study|Lost to Follow-up|1|||
30821547|NCT03148691|58842690|FG000|Overall Study|Other|1|||
30821548|NCT03148691|58842691|FG001|Overall Study|Other|0|||
30821549|NCT03148691|58842692|FG002|Overall Study|Other|0|||
30821550|NCT03148691|58842690|FG000|Overall Study|Withdrawal by Subject|1|||
30821551|NCT03148691|58842691|FG001|Overall Study|Withdrawal by Subject|0|||
30821552|NCT03148691|58842692|FG002|Overall Study|Withdrawal by Subject|0|||
30821553|NCT03148067|58842700|FG000|Overall Study|Lost to Follow-up|3|||
30821554|NCT03148067|58842700|FG000|Overall Study|Death|1|||
30821555|NCT03146741|58842714|FG000|Overall Study|Txp with non-HCV+ heart|4|||
30821556|NCT03146741|58842714|FG000|Overall Study|Listeted for MOT|2|||
30821557|NCT03146741|58842714|FG000|Overall Study|Physician Decision|2|||
30821558|NCT03146741|58842714|FG000|Overall Study|Awaiting txp|2|||
30821559|NCT03150719|58842720|FG000|Overall Study|Adverse Event|0|||
30821560|NCT03150719|58842721|FG001|Overall Study|Adverse Event|1|||
30821561|NCT03150719|58842720|FG000|Overall Study|Death|0|||
30821562|NCT03150719|58842721|FG001|Overall Study|Death|1|||
30821563|NCT03150719|58842720|FG000|Overall Study|Other|1|||
30821564|NCT03150719|58842721|FG001|Overall Study|Other|0|||
30821565|NCT04039217|58842727|FG000|Overall Study|Lost to Follow-up|1|||
30752796|NCT00152516|58762558|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
30752797|NCT00152516|58762558|FG000|Overall Study|Other: Non-Compliance|2|||
30752798|NCT00152516|58762558|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
30752799|NCT00152516|58762558|FG000|Overall Study|Other: Moved Out Of State|1|||
30752800|NCT00152516|58762558|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
30752801|NCT00152516|58762558|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
30821566|NCT00982111|58842737|FG000|Overall Study|Adverse Event|1|||
30821567|NCT00982111|58842738|FG001|Overall Study|Adverse Event|1|||
30821568|NCT00982111|58842737|FG000|Overall Study|Progressive Disease|46|||
30821569|NCT00982111|58842738|FG001|Overall Study|Progressive Disease|39|||
30821570|NCT00982111|58842737|FG000|Overall Study|Lost to Follow-up|9|||
30821571|NCT00982111|58842738|FG001|Overall Study|Lost to Follow-up|6|||
30821572|NCT00982111|58842737|FG000|Overall Study|New Anti-Cancer Therapy|5|||
30821573|NCT00982111|58842738|FG001|Overall Study|New Anti-Cancer Therapy|5|||
30821574|NCT00982111|58842737|FG000|Overall Study|Medical Decision|1|||
30821575|NCT00982111|58842738|FG001|Overall Study|Medical Decision|0|||
30821576|NCT00982111|58842737|FG000|Overall Study|Withdrawal by Subject|17|||
30821577|NCT00982111|58842738|FG001|Overall Study|Withdrawal by Subject|19|||
30821578|NCT00982111|58842737|FG000|Overall Study|Global Study End|0|||
30913837|NCT01583374|58949395|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30913838|NCT01583374|58949396|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30913839|NCT01583374|58949397|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30913840|NCT01583374|58949389|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
30913841|NCT01583374|58949390|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
30913842|NCT01583374|58949391|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30913843|NCT01583374|58949392|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30913844|NCT01583374|58949393|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30913845|NCT01583374|58949394|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30752802|NCT00145158|58762564|FG000|Overall Study|premature withdrawal|2|||
30821579|NCT00982111|58842738|FG001|Overall Study|Global Study End|1|||
30821580|NCT00982111|58842737|FG000|Overall Study|Sponsor's Decision|0|||
30821581|NCT00982111|58842738|FG001|Overall Study|Sponsor's Decision|1|||
30821582|NCT02957682|58842747|FG000|Overall Study|Adverse Event|64|||
30821583|NCT02957682|58842748|FG001|Overall Study|Adverse Event|67|||
30821584|NCT02957682|58842747|FG000|Overall Study|Poor Compliance to Protocol|30|||
30821585|NCT02957682|58842748|FG001|Overall Study|Poor Compliance to Protocol|26|||
30821586|NCT02957682|58842747|FG000|Overall Study|Physician Decision|4|||
30821587|NCT02957682|58842748|FG001|Overall Study|Physician Decision|4|||
30821588|NCT02957682|58842747|FG000|Overall Study|Study Terminated by Sponsor|4|||
30821589|NCT02957682|58842748|FG001|Overall Study|Study Terminated by Sponsor|3|||
30821590|NCT02957682|58842747|FG000|Overall Study|Subject Moved|10|||
30821591|NCT02957682|58842748|FG001|Overall Study|Subject Moved|16|||
30821592|NCT02957682|58842747|FG000|Overall Study|Withdrawal by Subject|64|||
30821593|NCT02957682|58842748|FG001|Overall Study|Withdrawal by Subject|33|||
30821594|NCT02957682|58842747|FG000|Overall Study|Related to IMP Administration|3|||
30821595|NCT02957682|58842748|FG001|Overall Study|Related to IMP Administration|6|||
30821596|NCT02957682|58842747|FG000|Overall Study|Non-disclosed|16|||
30821597|NCT02957682|58842748|FG001|Overall Study|Non-disclosed|12|||
30821598|NCT02957682|58842747|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
30821599|NCT02957682|58842748|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
30821600|NCT03057951|58842756|FG000|Overall Study|Adverse Event|553|||
30821601|NCT03057951|58842757|FG001|Overall Study|Adverse Event|575|||
30821602|NCT03057951|58842756|FG000|Overall Study|Protocol Violation|30|||
30821603|NCT03057951|58842757|FG001|Overall Study|Protocol Violation|24|||
30821604|NCT03057951|58842756|FG000|Overall Study|Lost to Follow-up|6|||
30821605|NCT03057951|58842757|FG001|Overall Study|Lost to Follow-up|16|||
30821606|NCT03057951|58842756|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
30821607|NCT03057951|58842757|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
30821608|NCT03057951|58842756|FG000|Overall Study|Study drug stopped, reason missing|6|||
30821609|NCT03057951|58842757|FG001|Overall Study|Study drug stopped, reason missing|1|||
30821610|NCT03057951|58842756|FG000|Overall Study|Medical advice|6|||
30821611|NCT03057951|58842757|FG001|Overall Study|Medical advice|2|||
30913846|NCT01583374|58949395|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30913847|NCT01583374|58949396|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30752803|NCT00145158|58762565|FG001|Overall Study|premature withdrawal|3|||
30752804|NCT00150800|58762572|FG000|Overall Study|Adverse Event|89|||
30752805|NCT00150800|58762572|FG000|Overall Study|Death|18|||
30752806|NCT00150800|58762572|FG000|Overall Study|Lack of Efficacy|166|||
30752807|NCT00150800|58762572|FG000|Overall Study|Lost to Follow-up|58|||
30752808|NCT00150800|58762572|FG000|Overall Study|Subject's choice|90|||
30752809|NCT00150800|58762572|FG000|Overall Study|No compliance|18|||
30752810|NCT00150800|58762572|FG000|Overall Study|IP misshandling|1|||
30752811|NCT00150800|58762572|FG000|Overall Study|Site closure|24|||
30752812|NCT00150800|58762572|FG000|Overall Study|Protocol non-adherence|2|||
30752813|NCT00150800|58762572|FG000|Overall Study|Nobody to accompany patient|1|||
30752814|NCT00150800|58762572|FG000|Overall Study|Distance too long for patient|1|||
30752815|NCT00150800|58762572|FG000|Overall Study|Neurosurgery|2|||
30752816|NCT00150800|58762572|FG000|Overall Study|BRV monotherapy|1|||
30752817|NCT00150800|58762572|FG000|Overall Study|Visit refusal|3|||
30821612|NCT03057951|58842756|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
30821613|NCT03057951|58842757|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
30821614|NCT03057951|58842756|FG000|Overall Study|Investigator decision|2|||
30821615|NCT03057951|58842757|FG001|Overall Study|Investigator decision|0|||
30821616|NCT03057951|58842756|FG000|Overall Study|Patient decision|5|||
30821617|NCT03057951|58842757|FG001|Overall Study|Patient decision|2|||
30821618|NCT03057951|58842756|FG000|Overall Study|Not attending study visits|3|||
30821619|NCT03057951|58842757|FG001|Overall Study|Not attending study visits|0|||
30752818|NCT00150800|58762572|FG000|Overall Study|Sponsor's request|2|||
30821620|NCT03057951|58842756|FG000|Overall Study|Patient moved away|3|||
30821621|NCT03057951|58842757|FG001|Overall Study|Patient moved away|4|||
30821622|NCT03057951|58842756|FG000|Overall Study|Other reason than stated above|23|||
30821623|NCT03057951|58842757|FG001|Overall Study|Other reason than stated above|29|||
30821624|NCT03057951|58842756|FG000|Overall Study|Not treated|2|||
30821625|NCT03057951|58842757|FG001|Overall Study|Not treated|1|||
30821626|NCT03146663|58842765|FG000|Overall Study|Did not receive study treatment|1|||
30821627|NCT03146663|58842766|FG001|Overall Study|Did not receive study treatment|1|||
30821628|NCT02956278|58842776|FG000|Overall Study|Withdrawal by Subject|6|||
30821629|NCT02956278|58842777|FG001|Overall Study|Withdrawal by Subject|2|||
30821630|NCT02956278|58842778|FG002|Overall Study|Withdrawal by Subject|0|||
30821631|NCT02957136|58842788|FG000|Overall Study|Withdrawal by Subject|2|||
30821632|NCT02957136|58842789|FG001|Overall Study|Withdrawal by Subject|1|||
30821633|NCT03150485|58842795|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
30821634|NCT03150485|58842796|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
30821635|NCT03150485|58842797|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
30821636|NCT03150485|58842798|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
30821637|NCT03150485|58842799|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
30821638|NCT03150485|58842800|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
30821639|NCT03134911|58842807|FG000|Overall Study|Screen failure|31|||
30821640|NCT03134911|58842807|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
30821641|NCT03134599|58842826|FG000|Week 1|Lost to Follow-up|0|||
30821642|NCT03134599|58842827|FG001|Week 1|Lost to Follow-up|0|||
30821643|NCT03134599|58842828|FG002|Week 1|Lost to Follow-up|0|||
30821644|NCT03134599|58842829|FG003|Week 1|Lost to Follow-up|0|||
30821645|NCT03134599|58842830|FG004|Week 1|Lost to Follow-up|1|||
30821646|NCT03134599|58842831|FG005|Week 1|Lost to Follow-up|0|||
30821647|NCT03134599|58842826|FG000|Week 2|Lost to Follow-up|1|||
30821648|NCT03134599|58842827|FG001|Week 2|Lost to Follow-up|0|||
30821649|NCT03134599|58842828|FG002|Week 2|Lost to Follow-up|0|||
30821650|NCT03134599|58842829|FG003|Week 2|Lost to Follow-up|1|||
30821651|NCT03134599|58842830|FG004|Week 2|Lost to Follow-up|1|||
30821652|NCT03134599|58842831|FG005|Week 2|Lost to Follow-up|0|||
30821653|NCT03134599|58842826|FG000|Week 3|Lost to Follow-up|0|||
30821654|NCT03134599|58842827|FG001|Week 3|Lost to Follow-up|0|||
30821655|NCT03134599|58842828|FG002|Week 3|Lost to Follow-up|0|||
30821656|NCT03134599|58842829|FG003|Week 3|Lost to Follow-up|1|||
30821657|NCT03134599|58842830|FG004|Week 3|Lost to Follow-up|0|||
30821658|NCT03134599|58842831|FG005|Week 3|Lost to Follow-up|1|||
30821659|NCT03153137|58842841|FG000|Overall Study|Lost to Follow-up|1|||
30821660|NCT03153137|58842842|FG001|Overall Study|Lost to Follow-up|0|||
30821661|NCT03153137|58842841|FG000|Overall Study|Withdrawal by Subject|2|||
30821662|NCT03153137|58842842|FG001|Overall Study|Withdrawal by Subject|1|||
30821663|NCT03153137|58842841|FG000|Overall Study|Physician Decision|0|||
30821664|NCT03153137|58842842|FG001|Overall Study|Physician Decision|3|||
30821665|NCT03136861|58842855|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
30821666|NCT03136861|58842856|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
30821667|NCT03136861|58842857|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
30821668|NCT03136861|58842858|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
30821669|NCT03136861|58842859|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
30821670|NCT03136861|58842860|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
30821671|NCT03136861|58842861|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
30821672|NCT03136861|58842855|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
30752819|NCT00150800|58762572|FG000|Overall Study|Generalized Epilepsy|1|||
30752820|NCT00150800|58762572|FG000|Overall Study|Moved from area/country|8|||
30752821|NCT00150800|58762572|FG000|Overall Study|PI retiring|2|||
30752822|NCT00150800|58762572|FG000|Overall Study|PI leaving site|2|||
30752823|NCT00150800|58762572|FG000|Overall Study|Patient insurance|1|||
30752824|NCT00150800|58762572|FG000|Overall Study|Surgical intervention|4|||
30752825|NCT00150800|58762572|FG000|Overall Study|Pregnancy planned|1|||
30752826|NCT00150800|58762572|FG000|Overall Study|PI discontinuation request|1|||
30752827|NCT00144300|58762579|FG000|Overall Study|Adverse Event|18|||
30752828|NCT00144300|58762580|FG001|Overall Study|Adverse Event|16|||
30752829|NCT00144300|58762579|FG000|Overall Study|Protocol Violation|1|||
30752830|NCT00144300|58762580|FG001|Overall Study|Protocol Violation|3|||
30752831|NCT00144300|58762579|FG000|Overall Study|Lost to Follow-up|3|||
30752832|NCT00144300|58762580|FG001|Overall Study|Lost to Follow-up|0|||
30752833|NCT00144300|58762579|FG000|Overall Study|Withdrawal by Subject|6|||
30752834|NCT00144300|58762580|FG001|Overall Study|Withdrawal by Subject|6|||
30752835|NCT00144300|58762579|FG000|Overall Study|Other reason (not specified)|1|||
30752836|NCT00144300|58762580|FG001|Overall Study|Other reason (not specified)|3|||
30752837|NCT00149630|58762588|FG000|Overall Study|Incarceration|2|||
30752838|NCT00149630|58762589|FG001|Overall Study|Incarceration|0|||
30752839|NCT00149630|58762588|FG000|Overall Study|Treatment Programs|4|||
30752840|NCT00149630|58762589|FG001|Overall Study|Treatment Programs|5|||
30752841|NCT00149630|58762588|FG000|Overall Study|Adverse Event|2|||
30821673|NCT03136861|58842856|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
30821674|NCT03136861|58842857|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
30821675|NCT03136861|58842858|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
30821676|NCT03136861|58842859|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
30821677|NCT03136861|58842860|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
30821678|NCT03136861|58842861|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
30821679|NCT03136861|58842855|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
30821680|NCT03136861|58842856|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
30821681|NCT03136861|58842857|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
30821682|NCT03136861|58842858|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
30821683|NCT03136861|58842859|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
30821684|NCT03136861|58842860|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
30821685|NCT03136861|58842861|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
30821686|NCT03136861|58842855|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
30821687|NCT03136861|58842856|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
30821688|NCT03136861|58842857|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
30821689|NCT03136861|58842858|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
30821690|NCT03136861|58842859|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
30821691|NCT03136861|58842860|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
30821692|NCT03136861|58842861|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
30913848|NCT01583374|58949397|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30752842|NCT00149630|58762589|FG001|Overall Study|Adverse Event|0|||
30752843|NCT00127842|58762599|FG000|Overall Study|Adverse Event|15|||
30752844|NCT00127842|58762599|FG000|Overall Study|Withdrawal by Subject|3|||
30752845|NCT00127842|58762599|FG000|Overall Study|Lost to Follow-up|1|||
30752846|NCT00127842|58762599|FG000|Overall Study|Lack of Efficacy|12|||
30752847|NCT00127842|58762599|FG000|Overall Study|Noncompliance|2|||
30752848|NCT00127842|58762599|FG000|Overall Study|Protocol Violation|1|||
30752849|NCT00127842|58762599|FG000|Overall Study|Other|5|||
30752850|NCT03720652|58762605|FG000|Overall Study|Withdrawal by Subject|2|||
30752851|NCT03720652|58762606|FG001|Overall Study|Withdrawal by Subject|7|||
30752852|NCT03720652|58762605|FG000|Overall Study|Lost to Follow-up|0|||
30752853|NCT03720652|58762606|FG001|Overall Study|Lost to Follow-up|4|||
30752854|NCT00112866|58762616|FG000|Overall Study|Protocol Violation|1|||
30752855|NCT00112866|58762617|FG001|Overall Study|Protocol Violation|0|||
30752856|NCT00112866|58762616|FG000|Overall Study|did not start treatment post-op|1|||
30752857|NCT00112866|58762617|FG001|Overall Study|did not start treatment post-op|2|||
30752858|NCT00127608|58762631|FG000|Overall Study|VZV DNA negative|1|||
30821693|NCT03136861|58842855|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
30821694|NCT03136861|58842856|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
30821695|NCT03136861|58842857|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
30821696|NCT03136861|58842858|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
30821697|NCT03136861|58842859|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
30821698|NCT03136861|58842860|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
30821699|NCT03136861|58842861|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
30821700|NCT03136861|58842855|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
30752859|NCT00149396|58762635|FG000|Overall Study|Death|15|||
30752860|NCT00149396|58762635|FG000|Overall Study|Withdrawal by Subject|1|||
30821701|NCT03136861|58842856|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
30752861|NCT00149396|58762635|FG000|Overall Study|Subject noncompliance|2|||
30752862|NCT00149396|58762635|FG000|Overall Study|other treatment|5|||
30752863|NCT00223496|58762646|FG000|Overall Study|screen failure|9|||
30752864|NCT00223496|58762646|FG000|Overall Study|Lost to Follow-up|4|||
30752865|NCT00223496|58762646|FG000|Overall Study|Lack of Efficacy|6|||
30752866|NCT00223496|58762646|FG000|Overall Study|Withdrawal by Subject|1|||
30821702|NCT03136861|58842857|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
30752867|NCT00223496|58762646|FG000|Overall Study|Physician Decision|2|||
30752868|NCT00255944|58762652|FG000|Overall Study|Lost to Follow-up|797|||
30752869|NCT00255944|58762653|FG001|Overall Study|Lost to Follow-up|834|||
30752870|NCT00143598|58762661|FG000|Overall Study|Lost to Follow-up|23|||
30752871|NCT00143598|58762662|FG001|Overall Study|Lost to Follow-up|21|||
30752872|NCT00143598|58762661|FG000|Overall Study|Withdrawal by Subject|33|||
30752873|NCT00143598|58762662|FG001|Overall Study|Withdrawal by Subject|37|||
30752874|NCT00143598|58762661|FG000|Overall Study|Death|36|||
30821703|NCT03136861|58842858|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
30821704|NCT03136861|58842859|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
30821705|NCT03136861|58842860|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
30821706|NCT03136861|58842861|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
30821707|NCT03136861|58842855|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
30821708|NCT03136861|58842856|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
30821709|NCT03136861|58842857|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
30821710|NCT03136861|58842858|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
30821711|NCT03136861|58842859|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
30821712|NCT03136861|58842860|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
30821713|NCT03136861|58842861|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
30821714|NCT03136861|58842855|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
30821715|NCT03136861|58842856|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
30821716|NCT03136861|58842857|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
30821717|NCT03136861|58842858|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
30821718|NCT03136861|58842859|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
30821719|NCT03136861|58842860|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
30821720|NCT03136861|58842861|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
30821721|NCT03316950|58842889|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
30821722|NCT03316950|58842890|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
30752875|NCT00143598|58762662|FG001|Overall Study|Death|36|||
30752876|NCT00126672|58762668|FG000|Overall Study|Adverse Event|4|||
30752877|NCT00126672|58762668|FG000|Overall Study|Lost to Follow-up|4|||
30752878|NCT00145574|58762675|FG000|Double Blind|Adverse Event|0|||
30752879|NCT00145574|58762676|FG001|Double Blind|Adverse Event|3|||
30821723|NCT03316950|58842891|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
30821724|NCT03316950|58842892|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
30821725|NCT03316950|58842889|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
30821726|NCT03316950|58842890|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
30821727|NCT03316950|58842891|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
30821728|NCT03316950|58842892|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
30821729|NCT03316950|58842889|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
30821730|NCT03316950|58842890|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
30821731|NCT03316950|58842891|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
30821732|NCT03316950|58842892|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
30821733|NCT03139279|58842906|FG000|Overall Study|Physician Decision|2|||
30821734|NCT03139279|58842907|FG001|Overall Study|Physician Decision|0|||
30752880|NCT00145574|58762677|FG002|Double Blind|Adverse Event|1|||
30752881|NCT00145574|58762675|FG000|Double Blind|Withdrawal by Subject|1|||
30752882|NCT00145574|58762676|FG001|Double Blind|Withdrawal by Subject|1|||
30752883|NCT00145574|58762677|FG002|Double Blind|Withdrawal by Subject|1|||
30821735|NCT03139279|58842906|FG000|Overall Study|Protocol Violation|5|||
30821736|NCT03139279|58842907|FG001|Overall Study|Protocol Violation|4|||
30821737|NCT03139279|58842906|FG000|Overall Study|Withdrawal by Subject|0|||
30752884|NCT00145574|58762675|FG000|Double Blind|required restricted medicine|0|||
30752885|NCT00145574|58762676|FG001|Double Blind|required restricted medicine|1|||
30752886|NCT00145574|58762677|FG002|Double Blind|required restricted medicine|0|||
30752887|NCT00145574|58762675|FG000|Open Label Long-term Extension|Adverse Event|0|||
30752888|NCT00145574|58762676|FG001|Open Label Long-term Extension|Adverse Event|0|||
30752889|NCT00145574|58762677|FG002|Open Label Long-term Extension|Adverse Event|5|||
30752890|NCT00145574|58762675|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
30752891|NCT00145574|58762676|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
30752892|NCT00145574|58762677|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
30752893|NCT00145574|58762675|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
30752894|NCT00145574|58762676|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
30752895|NCT00145574|58762677|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
30752896|NCT00145574|58762675|FG000|Open Label Long-term Extension|required restricted medicine|0|||
30752897|NCT00145574|58762676|FG001|Open Label Long-term Extension|required restricted medicine|0|||
30821738|NCT03139279|58842907|FG001|Overall Study|Withdrawal by Subject|2|||
30821739|NCT01370642|58842916|FG000|Overall Study|Adverse Event|2|||
30821740|NCT01370642|58842917|FG001|Overall Study|Adverse Event|1|||
30821741|NCT01370642|58842918|FG002|Overall Study|Adverse Event|1|||
30821742|NCT01370642|58842916|FG000|Overall Study|Detectable HCV RNA|0|||
30821743|NCT01370642|58842917|FG001|Overall Study|Detectable HCV RNA|0|||
30821744|NCT01370642|58842918|FG002|Overall Study|Detectable HCV RNA|22|||
30752898|NCT00145574|58762677|FG002|Open Label Long-term Extension|required restricted medicine|1|||
30821745|NCT01370642|58842916|FG000|Overall Study|Lost to Follow-up|0|||
30821746|NCT01370642|58842917|FG001|Overall Study|Lost to Follow-up|0|||
30821747|NCT01370642|58842918|FG002|Overall Study|Lost to Follow-up|1|||
30821748|NCT01370642|58842916|FG000|Overall Study|Physician Decision|4|||
30821749|NCT01370642|58842917|FG001|Overall Study|Physician Decision|1|||
30821750|NCT01370642|58842918|FG002|Overall Study|Physician Decision|2|||
30821751|NCT01370642|58842916|FG000|Overall Study|Withdrawal by Subject|2|||
30821752|NCT01370642|58842917|FG001|Overall Study|Withdrawal by Subject|4|||
30821753|NCT01370642|58842918|FG002|Overall Study|Withdrawal by Subject|3|||
30821754|NCT02873208|58842926|FG000|Overall Study|Withdrawal by Subject|36|||
30821755|NCT02873208|58842926|FG000|Overall Study|Lost to Follow-up|22|||
30821756|NCT02873208|58842926|FG000|Overall Study|Adverse Event|15|||
30821757|NCT02873208|58842926|FG000|Overall Study|Non-compliance with study drug|12|||
30821758|NCT02873208|58842926|FG000|Overall Study|Protocol Violation|8|||
30821759|NCT02873208|58842926|FG000|Overall Study|Pregnancy|2|||
30821760|NCT02873208|58842926|FG000|Overall Study|Incarceration|1|||
30821761|NCT02873208|58842926|FG000|Overall Study|Lack of Efficacy|1|||
30821762|NCT02873208|58842926|FG000|Overall Study|Physician Decision|1|||
30821763|NCT03138967|58842932|FG000|Overall Study|Death|0|||
30821764|NCT03138967|58842933|FG001|Overall Study|Death|1|||
30821765|NCT03138967|58842932|FG000|Overall Study|Physician Decision|1|||
30821766|NCT03138967|58842933|FG001|Overall Study|Physician Decision|3|||
30821767|NCT01547117|58842943|FG000|Overall Study|Physician Decision|0|||
30821768|NCT01547117|58842944|FG001|Overall Study|Physician Decision|1|||
30821769|NCT01547117|58842945|FG002|Overall Study|Physician Decision|1|||
30752899|NCT00145496|58762692|FG000|Overall Study|Adverse Event|42|||
30752900|NCT00145496|58762693|FG001|Overall Study|Adverse Event|30|||
30752901|NCT00145496|58762692|FG000|Overall Study|Lack of Efficacy|12|||
30752902|NCT00145496|58762693|FG001|Overall Study|Lack of Efficacy|7|||
30821770|NCT01547117|58842946|FG003|Overall Study|Physician Decision|3|||
30752903|NCT00145496|58762692|FG000|Overall Study|Withdrawal by Subject|32|||
30752904|NCT00145496|58762693|FG001|Overall Study|Withdrawal by Subject|26|||
30752905|NCT00145496|58762692|FG000|Overall Study|Lost to Follow-up|12|||
30752906|NCT00145496|58762693|FG001|Overall Study|Lost to Follow-up|5|||
30752907|NCT00145496|58762692|FG000|Overall Study|Other|25|||
30752908|NCT00145496|58762693|FG001|Overall Study|Other|13|||
30752909|NCT00255164|58762702|FG000|Overall Study|Adverse Event|10|||
30752910|NCT00255164|58762703|FG001|Overall Study|Adverse Event|6|||
30752911|NCT00255164|58762704|FG002|Overall Study|Adverse Event|9|||
30752912|NCT00255164|58762702|FG000|Overall Study|Lost to Follow-up|4|||
30821771|NCT01547117|58842943|FG000|Overall Study|Withdrawal by Subject|1|||
30821772|NCT01547117|58842944|FG001|Overall Study|Withdrawal by Subject|2|||
30821773|NCT01547117|58842945|FG002|Overall Study|Withdrawal by Subject|1|||
30821774|NCT01547117|58842946|FG003|Overall Study|Withdrawal by Subject|2|||
30821775|NCT03136159|58842974|FG000|Overall Study|chorioamnionitis|2|||
30913849|NCT01583374|58949389|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
30913850|NCT01583374|58949390|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
30913851|NCT01583374|58949391|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
30821776|NCT03136159|58842975|FG001|Overall Study|chorioamnionitis|0|||
30821777|NCT03136159|58842974|FG000|Overall Study|vertical skin incision|1|||
30821778|NCT03136159|58842975|FG001|Overall Study|vertical skin incision|0|||
30752913|NCT00255164|58762703|FG001|Overall Study|Lost to Follow-up|3|||
30752914|NCT00255164|58762704|FG002|Overall Study|Lost to Follow-up|4|||
30821779|NCT03136159|58842974|FG000|Overall Study|additional dressing|1|||
30821780|NCT03136159|58842975|FG001|Overall Study|additional dressing|0|||
30821781|NCT03136159|58842974|FG000|Overall Study|never got dressing placed|1|||
30913852|NCT01583374|58949392|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30821782|NCT03136159|58842975|FG001|Overall Study|never got dressing placed|0|||
30821783|NCT01986933|58842986|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
30752915|NCT00255164|58762702|FG000|Overall Study|Withdrawal by Subject|18|||
30752916|NCT00255164|58762703|FG001|Overall Study|Withdrawal by Subject|17|||
30752917|NCT00255164|58762704|FG002|Overall Study|Withdrawal by Subject|8|||
30821784|NCT01986933|58842987|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
30821785|NCT01986933|58842988|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
30821786|NCT01986933|58842989|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
30821787|NCT01986933|58842990|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
30821788|NCT01986933|58842986|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
30821789|NCT01986933|58842987|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
30821790|NCT01986933|58842988|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
30821791|NCT01986933|58842989|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
30821792|NCT01986933|58842990|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
30821793|NCT01986933|58842986|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
30821794|NCT01986933|58842987|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
30821795|NCT01986933|58842988|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
30821796|NCT01986933|58842989|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
30821797|NCT01986933|58842990|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
30821798|NCT01986933|58842986|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
30821799|NCT01986933|58842987|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
30821800|NCT01986933|58842988|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
30821801|NCT01986933|58842989|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
30821802|NCT01986933|58842990|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
30821803|NCT01986933|58842986|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
30821804|NCT01986933|58842987|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
30821805|NCT01986933|58842988|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
30821806|NCT01986933|58842989|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
30821807|NCT01986933|58842990|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
30821808|NCT01986933|58842986|FG000|Active-to-active (Part B)|Adverse Event|0|||
30821809|NCT01986933|58842987|FG001|Active-to-active (Part B)|Adverse Event|2|||
30821810|NCT01986933|58842988|FG002|Active-to-active (Part B)|Adverse Event|0|||
30821811|NCT01986933|58842989|FG003|Active-to-active (Part B)|Adverse Event|1|||
30821812|NCT01986933|58842990|FG004|Active-to-active (Part B)|Adverse Event|3|||
30821813|NCT01986933|58842986|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
30821814|NCT01986933|58842987|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
30821815|NCT01986933|58842988|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
30821816|NCT01986933|58842989|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
30821817|NCT01986933|58842990|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
30821818|NCT01986933|58842986|FG000|Active-to-active (Part B)|Pregnancy|0|||
30821819|NCT01986933|58842987|FG001|Active-to-active (Part B)|Pregnancy|0|||
30821820|NCT01986933|58842988|FG002|Active-to-active (Part B)|Pregnancy|0|||
30821821|NCT01986933|58842989|FG003|Active-to-active (Part B)|Pregnancy|0|||
30821822|NCT01986933|58842990|FG004|Active-to-active (Part B)|Pregnancy|1|||
30821823|NCT01986933|58842986|FG000|Active-to-active (Part B)|Physician Decision|0|||
30821824|NCT01986933|58842987|FG001|Active-to-active (Part B)|Physician Decision|0|||
30821825|NCT01986933|58842988|FG002|Active-to-active (Part B)|Physician Decision|1|||
30821826|NCT01986933|58842989|FG003|Active-to-active (Part B)|Physician Decision|1|||
30821827|NCT01986933|58842990|FG004|Active-to-active (Part B)|Physician Decision|0|||
30821828|NCT01986933|58842986|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
30821829|NCT01986933|58842987|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
30913853|NCT01583374|58949393|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30913854|NCT01583374|58949394|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30913855|NCT01583374|58949395|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30821830|NCT01986933|58842988|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
30821831|NCT01986933|58842989|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
30821832|NCT01986933|58842990|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
30821833|NCT01986933|58842986|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
30821834|NCT01986933|58842987|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
30821835|NCT01986933|58842988|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
30821836|NCT01986933|58842989|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
30821837|NCT01986933|58842990|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
30821838|NCT01986933|58842986|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
30821839|NCT01986933|58842987|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
30913856|NCT01583374|58949396|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30752918|NCT00255164|58762702|FG000|Overall Study|Noncompliance|0|||
30821840|NCT01986933|58842988|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
30821841|NCT01986933|58842989|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
30821842|NCT01986933|58842990|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
30821843|NCT01986933|58842986|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
30821844|NCT01986933|58842987|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
30821845|NCT01986933|58842988|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
30821846|NCT01986933|58842989|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
30821847|NCT01986933|58842990|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
30821848|NCT01986933|58842986|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
30821849|NCT01986933|58842987|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
30821850|NCT01986933|58842988|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
30821851|NCT01986933|58842989|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
30821852|NCT01986933|58842990|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
30821853|NCT01986933|58842986|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
30821854|NCT01986933|58842987|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
30821855|NCT01986933|58842988|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
30821856|NCT01986933|58842989|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
30821857|NCT01986933|58842990|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
30821858|NCT01986933|58842986|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
30821859|NCT01986933|58842987|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
30913857|NCT01583374|58949397|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30752919|NCT00255164|58762703|FG001|Overall Study|Noncompliance|1|||
30752920|NCT00255164|58762704|FG002|Overall Study|Noncompliance|2|||
30752921|NCT00255164|58762702|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
30752922|NCT00255164|58762703|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
30752923|NCT00255164|58762704|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
30752924|NCT00255164|58762702|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
30752925|NCT00255164|58762703|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
30752926|NCT00255164|58762704|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
30752927|NCT00255164|58762702|FG000|Overall Study|Possible Barrett's Esophagus|1|||
30752928|NCT00255164|58762703|FG001|Overall Study|Possible Barrett's Esophagus|3|||
30752929|NCT00255164|58762704|FG002|Overall Study|Possible Barrett's Esophagus|8|||
30752930|NCT00255164|58762702|FG000|Overall Study|Esophageal Stricture|0|||
30752931|NCT00255164|58762703|FG001|Overall Study|Esophageal Stricture|0|||
30752932|NCT00255164|58762704|FG002|Overall Study|Esophageal Stricture|1|||
30752933|NCT00255164|58762702|FG000|Overall Study|Therapeutic Failure|11|||
30752934|NCT00255164|58762703|FG001|Overall Study|Therapeutic Failure|2|||
30752935|NCT00255164|58762704|FG002|Overall Study|Therapeutic Failure|3|||
30752936|NCT00126594|58762714|FG000|Overall Study|Ineligible|2|||
30752937|NCT00126594|58762715|FG001|Overall Study|Ineligible|0|||
30752938|NCT00126594|58762714|FG000|Overall Study|Withdrawal by Subject|0|||
30752939|NCT00126594|58762715|FG001|Overall Study|Withdrawal by Subject|4|||
30752940|NCT00126594|58762714|FG000|Overall Study|Physician Decision|1|||
30752941|NCT00126594|58762715|FG001|Overall Study|Physician Decision|3|||
30752942|NCT00126594|58762714|FG000|Overall Study|Adverse Event|7|||
30752943|NCT00126594|58762715|FG001|Overall Study|Adverse Event|5|||
30752944|NCT00126594|58762714|FG000|Overall Study|Non-compliance|0|||
30752945|NCT00126594|58762715|FG001|Overall Study|Non-compliance|1|||
30752946|NCT00126594|58762714|FG000|Overall Study|Disease Progression|29|||
30752947|NCT00126594|58762715|FG001|Overall Study|Disease Progression|24|||
30752948|NCT00126438|58762724|FG000|Overall Study|Withdrawal due to adverse event|1|||
30752949|NCT00126438|58762725|FG001|Overall Study|Withdrawal due to adverse event|0|||
30752950|NCT00126438|58762724|FG000|Overall Study|Lost to Follow-up|22|||
30752951|NCT00126438|58762725|FG001|Overall Study|Lost to Follow-up|0|||
30752952|NCT00126438|58762724|FG000|Overall Study|Protocol Violation|8|||
30821860|NCT01986933|58842988|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
30821861|NCT01986933|58842989|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
30821862|NCT01986933|58842990|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
30821863|NCT01986933|58842986|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
30821864|NCT01986933|58842987|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
30821865|NCT01986933|58842988|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
30821866|NCT01986933|58842989|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
30821867|NCT01986933|58842990|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
30821868|NCT00394355|58843034|FG000|Overall Study|Adverse Event|10|||
30821869|NCT00394355|58843035|FG001|Overall Study|Adverse Event|6|||
30821870|NCT00394355|58843036|FG002|Overall Study|Adverse Event|7|||
30821871|NCT00394355|58843037|FG003|Overall Study|Adverse Event|8|||
30821872|NCT00394355|58843034|FG000|Overall Study|Did not meet protocol eligibility|1|||
30821873|NCT00394355|58843035|FG001|Overall Study|Did not meet protocol eligibility|5|||
30821874|NCT00394355|58843036|FG002|Overall Study|Did not meet protocol eligibility|4|||
30821875|NCT00394355|58843037|FG003|Overall Study|Did not meet protocol eligibility|2|||
30821876|NCT00394355|58843034|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
30821877|NCT00394355|58843035|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
30821878|NCT00394355|58843036|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
30821879|NCT00394355|58843037|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
30821880|NCT00394355|58843034|FG000|Overall Study|Subject withdrawal - related to drug|1|||
30821881|NCT00394355|58843035|FG001|Overall Study|Subject withdrawal - related to drug|0|||
30821882|NCT00394355|58843036|FG002|Overall Study|Subject withdrawal - related to drug|0|||
30821883|NCT00394355|58843037|FG003|Overall Study|Subject withdrawal - related to drug|0|||
30821884|NCT00394355|58843034|FG000|Overall Study|Lost to Follow-up|7|||
30821885|NCT00394355|58843035|FG001|Overall Study|Lost to Follow-up|5|||
30821886|NCT00394355|58843036|FG002|Overall Study|Lost to Follow-up|4|||
30821887|NCT00394355|58843037|FG003|Overall Study|Lost to Follow-up|3|||
30821888|NCT00394355|58843034|FG000|Overall Study|Noncompliance with protocol|4|||
30821889|NCT00394355|58843035|FG001|Overall Study|Noncompliance with protocol|3|||
30821890|NCT00394355|58843036|FG002|Overall Study|Noncompliance with protocol|10|||
30821891|NCT00394355|58843037|FG003|Overall Study|Noncompliance with protocol|8|||
30821892|NCT00394355|58843034|FG000|Overall Study|Administrative|0|||
30821893|NCT00394355|58843035|FG001|Overall Study|Administrative|1|||
30821894|NCT00394355|58843036|FG002|Overall Study|Administrative|1|||
30821895|NCT00394355|58843037|FG003|Overall Study|Administrative|1|||
30821896|NCT00394355|58843034|FG000|Overall Study|Lack of Efficacy|0|||
30821897|NCT00394355|58843035|FG001|Overall Study|Lack of Efficacy|0|||
30821898|NCT00394355|58843036|FG002|Overall Study|Lack of Efficacy|2|||
30821899|NCT00394355|58843037|FG003|Overall Study|Lack of Efficacy|3|||
30821900|NCT02797808|58843049|FG000|Overall Study|Withdrawal by Subject|1|||
30821901|NCT02797808|58843050|FG001|Overall Study|Withdrawal by Subject|1|||
30821902|NCT02797808|58843049|FG000|Overall Study|Physician Decision|6|||
30821903|NCT02797808|58843050|FG001|Overall Study|Physician Decision|2|||
30821904|NCT02796560|58843058|FG000|Overall Study|Adverse Event|2|||
30821905|NCT02796560|58843059|FG001|Overall Study|Adverse Event|0|||
30821906|NCT02796560|58843058|FG000|Overall Study|Withdrawal by Subject|2|||
30913858|NCT01583374|58949389|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
30913859|NCT01583374|58949390|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
30913860|NCT01583374|58949391|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
30821907|NCT02796560|58843059|FG001|Overall Study|Withdrawal by Subject|2|||
30821908|NCT00344487|58843065|FG000|Overall Study|immunologic failure|1|||
30821909|NCT02871492|58843074|FG000|Overall Study|Lost to Follow-up|6|||
30821910|NCT02871492|58843075|FG001|Overall Study|Lost to Follow-up|3|||
30821911|NCT02871492|58843076|FG002|Overall Study|Lost to Follow-up|5|||
30821912|NCT02871492|58843074|FG000|Overall Study|Withdrawal by Subject|0|||
30821913|NCT02871492|58843075|FG001|Overall Study|Withdrawal by Subject|0|||
30821914|NCT02871492|58843076|FG002|Overall Study|Withdrawal by Subject|1|||
30821915|NCT03143855|58843086|FG000|Overall Study|Withdrawal by Subject|4|||
30821916|NCT03143855|58843087|FG001|Overall Study|Withdrawal by Subject|3|||
30821917|NCT03143855|58843086|FG000|Overall Study|Protocol Violation|1|||
30821918|NCT03143855|58843087|FG001|Overall Study|Protocol Violation|0|||
30821919|NCT03143855|58843086|FG000|Overall Study|Participant experienced withdrawal|0|||
30821920|NCT03143855|58843087|FG001|Overall Study|Participant experienced withdrawal|1|||
30821921|NCT02878603|58843095|FG000|Overall Study|Lost to Follow-up|4|||
30821922|NCT02878603|58843096|FG001|Overall Study|Lost to Follow-up|1|||
30821923|NCT02878603|58843095|FG000|Overall Study|Withdrawal by Subject|1|||
30821924|NCT02878603|58843096|FG001|Overall Study|Withdrawal by Subject|1|||
30821925|NCT02878603|58843095|FG000|Overall Study|Death|1|||
30821926|NCT02878603|58843096|FG001|Overall Study|Death|0|||
30821927|NCT02878603|58843095|FG000|Overall Study|Physician Decision|0|||
30821928|NCT02878603|58843096|FG001|Overall Study|Physician Decision|3|||
30821929|NCT01370408|58843102|FG000|Overall Study|treatment failure|9|||
30821930|NCT03294109|58843108|FG000|Overall Study|Withdrawal by Subject|6|||
30821931|NCT03294109|58843109|FG001|Overall Study|Withdrawal by Subject|5|||
30821932|NCT03132805|58843128|FG000|Overall Study|Lost to Follow-up|142|||
30821933|NCT03132805|58843129|FG001|Overall Study|Lost to Follow-up|141|||
30821934|NCT03132805|58843130|FG002|Overall Study|Lost to Follow-up|113|||
30821935|NCT02793128|58843138|FG000|Overall Study|Death|4|||
30821936|NCT02793128|58843138|FG000|Overall Study|Withdrawal by Subject|2|||
30821937|NCT02793128|58843138|FG000|Overall Study|Physician Decision|1|||
30821938|NCT02793128|58843138|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
30821939|NCT02793128|58843138|FG000|Overall Study|Patient elected nephroureterectomy|1|||
30821940|NCT03142451|58843152|FG000|Overall Study|Adverse Event|5|||
30821941|NCT03142451|58843153|FG001|Overall Study|Adverse Event|2|||
30821942|NCT03142451|58843152|FG000|Overall Study|Lost to Follow-up|25|||
30821943|NCT03142451|58843153|FG001|Overall Study|Lost to Follow-up|8|||
30821944|NCT03142451|58843152|FG000|Overall Study|Participant request|24|||
30821945|NCT03142451|58843153|FG001|Overall Study|Participant request|12|||
30821946|NCT03142451|58843152|FG000|Overall Study|Protocol Violation|3|||
30821947|NCT03142451|58843153|FG001|Overall Study|Protocol Violation|1|||
30821948|NCT03142451|58843152|FG000|Overall Study|Other|1|||
30821949|NCT03142451|58843153|FG001|Overall Study|Other|1|||
30821950|NCT03141905|58843161|FG000|Overall Study|Death|3|||
30821951|NCT03141905|58843162|FG001|Overall Study|Death|2|||
30821952|NCT03141905|58843161|FG000|Overall Study|Withdrawal by Subject|1|||
30821953|NCT03141905|58843162|FG001|Overall Study|Withdrawal by Subject|0|||
30821954|NCT03141905|58843161|FG000|Overall Study|Lost to Follow-up|3|||
30821955|NCT03141905|58843162|FG001|Overall Study|Lost to Follow-up|7|||
30821956|NCT03141905|58843161|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
30821957|NCT03141905|58843162|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
30821958|NCT01370018|58843169|FG000|Overall Study|Did not meet criteria for analysis|1|||
30821959|NCT04034355|58843175|FG000|Overall Study|Study terminated by Sponsor|10|||
30821960|NCT04034355|58843176|FG001|Overall Study|Study terminated by Sponsor|17|||
30821961|NCT04034355|58843175|FG000|Overall Study|Withdrawal by Subject|12|||
30821962|NCT04034355|58843176|FG001|Overall Study|Withdrawal by Subject|11|||
30821963|NCT04034355|58843175|FG000|Overall Study|Site terminated by Sponsor|4|||
30821964|NCT04034355|58843176|FG001|Overall Study|Site terminated by Sponsor|5|||
30821965|NCT04034355|58843175|FG000|Overall Study|Adverse Event|2|||
30821966|NCT04034355|58843176|FG001|Overall Study|Adverse Event|0|||
30821967|NCT04034355|58843175|FG000|Overall Study|Death|1|||
30821968|NCT04034355|58843176|FG001|Overall Study|Death|1|||
30821969|NCT04034355|58843175|FG000|Overall Study|Not reported|2|||
30821970|NCT04034355|58843176|FG001|Overall Study|Not reported|0|||
30821971|NCT04034355|58843175|FG000|Overall Study|Lost to Follow-up|1|||
30821972|NCT04034355|58843176|FG001|Overall Study|Lost to Follow-up|0|||
30821973|NCT04034355|58843175|FG000|Overall Study|Physician Decision|1|||
30821974|NCT04034355|58843176|FG001|Overall Study|Physician Decision|0|||
30821975|NCT04034355|58843175|FG000|Overall Study|Protocol Violation|0|||
30821976|NCT04034355|58843176|FG001|Overall Study|Protocol Violation|1|||
30821977|NCT04034355|58843175|FG000|Overall Study|Progressive disease|1|||
30821978|NCT04034355|58843176|FG001|Overall Study|Progressive disease|0|||
30821979|NCT01336764|58843193|FG000|Overall Study|Withdrawal by Subject|5|||
30821980|NCT01336764|58843194|FG001|Overall Study|Withdrawal by Subject|5|||
30821981|NCT01336608|58843203|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
30821982|NCT01336608|58843204|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30821983|NCT01336608|58843205|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30821984|NCT01336608|58843206|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30821985|NCT01336608|58843203|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
30821986|NCT01336608|58843204|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30821987|NCT01336608|58843205|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30821988|NCT01336608|58843206|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30821989|NCT01336608|58843203|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
30821990|NCT01336608|58843204|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
30821991|NCT01336608|58843205|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
30821992|NCT01336608|58843206|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
30821993|NCT01336608|58843203|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
30821994|NCT01336608|58843204|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
30821995|NCT01336608|58843205|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
30821996|NCT01336608|58843206|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
30821997|NCT01336608|58843203|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
30821998|NCT01336608|58843204|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30821999|NCT01336608|58843205|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30822000|NCT01336608|58843206|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30822001|NCT01336608|58843203|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
30822002|NCT01336608|58843204|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
30822003|NCT01336608|58843205|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
30822004|NCT01336608|58843206|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
30822005|NCT01336608|58843203|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
30822006|NCT01336608|58843204|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
30822007|NCT01336608|58843205|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
30822008|NCT01336608|58843206|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
30822009|NCT01336608|58843203|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
30822010|NCT01336608|58843204|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
30822011|NCT01336608|58843205|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
30913861|NCT01583374|58949392|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
30913862|NCT01583374|58949393|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
30913863|NCT01583374|58949394|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
30913864|NCT01583374|58949395|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
30913865|NCT01583374|58949396|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
30913866|NCT01583374|58949397|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
30913867|NCT01583374|58949389|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30913868|NCT01583374|58949390|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30913869|NCT01583374|58949391|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
30913870|NCT01583374|58949392|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30913871|NCT01583374|58949393|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30913872|NCT01583374|58949394|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30913873|NCT01583374|58949395|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30913874|NCT01583374|58949396|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30913875|NCT01583374|58949397|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30913876|NCT01583374|58949389|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
30913877|NCT01583374|58949390|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
30913878|NCT01583374|58949391|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
30913879|NCT01583374|58949392|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
30913880|NCT01583374|58949393|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
30913881|NCT01583374|58949394|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
30913882|NCT01583374|58949395|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
30913883|NCT01583374|58949396|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
30913884|NCT01583374|58949397|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
30913885|NCT01583374|58949389|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
30913886|NCT01583374|58949390|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
30752953|NCT00126438|58762725|FG001|Overall Study|Protocol Violation|8|||
30752954|NCT00126438|58762724|FG000|Overall Study|Withdrawal by Subject|3|||
30752955|NCT00126438|58762725|FG001|Overall Study|Withdrawal by Subject|2|||
30752956|NCT00142584|58762733|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
30752957|NCT00142584|58762734|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
30752958|NCT00142584|58762733|FG000|Overall Study|Withdrawal by Subject|30|||
30752959|NCT00142584|58762734|FG001|Overall Study|Withdrawal by Subject|16|||
30752960|NCT00142584|58762733|FG000|Overall Study|Lost to Follow-up|22|||
30752961|NCT00142584|58762734|FG001|Overall Study|Lost to Follow-up|12|||
30752962|NCT00142584|58762733|FG000|Overall Study|Adverse Event|14|||
30752963|NCT00142584|58762734|FG001|Overall Study|Adverse Event|5|||
30752964|NCT00142584|58762733|FG000|Overall Study|Protocol Violation|4|||
30752965|NCT00142584|58762734|FG001|Overall Study|Protocol Violation|7|||
30752966|NCT00142584|58762733|FG000|Overall Study|Treatment Failure|2|||
30752967|NCT00142584|58762734|FG001|Overall Study|Treatment Failure|0|||
30752968|NCT00126126|58762744|FG000|Overall Study|Lost to Follow-up|0|||
30752969|NCT00126126|58762745|FG001|Overall Study|Lost to Follow-up|2|||
30752970|NCT00125268|58762753|FG000|Overall Study|Withdrawal by Subject|1|||
30752971|NCT00125268|58762754|FG001|Overall Study|Withdrawal by Subject|1|||
30822012|NCT01336608|58843206|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
30822013|NCT01336608|58843203|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
30822014|NCT01336608|58843204|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
30822015|NCT01336608|58843205|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
30822016|NCT01336608|58843206|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
30822017|NCT01336608|58843203|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
30822018|NCT01336608|58843204|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
30822019|NCT01336608|58843205|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
30822020|NCT01336608|58843206|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
30822021|NCT01336608|58843203|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30822022|NCT01336608|58843204|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
30822023|NCT01336608|58843205|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30822024|NCT01336608|58843206|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30822025|NCT01336608|58843203|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
30822026|NCT01336608|58843204|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
30822027|NCT01336608|58843205|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
30822028|NCT01336608|58843206|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
30822029|NCT01336608|58843203|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
30822030|NCT01336608|58843204|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
30822031|NCT01336608|58843205|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
30822032|NCT01336608|58843206|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
30822033|NCT01346371|58843225|FG000|Overall Study|Lost to Follow-up|2|||
30822034|NCT01346371|58843226|FG001|Overall Study|Lost to Follow-up|0|||
30822035|NCT03644849|58843244|FG000|Overall Study|Lost to Follow-up|1|||
30822036|NCT03644849|58843245|FG001|Overall Study|Lost to Follow-up|3|||
30822037|NCT03131479|58843256|FG000|Overall Study|Adverse Event|0|||
30822038|NCT03131479|58843257|FG001|Overall Study|Adverse Event|0|||
30822039|NCT03131479|58843258|FG002|Overall Study|Adverse Event|1|||
30822040|NCT03131479|58843259|FG003|Overall Study|Adverse Event|1|||
30822041|NCT03131479|58843260|FG004|Overall Study|Adverse Event|0|||
30822042|NCT03131479|58843256|FG000|Overall Study|Subject/Guardian Decision|0|||
30822043|NCT03131479|58843257|FG001|Overall Study|Subject/Guardian Decision|0|||
30822044|NCT03131479|58843258|FG002|Overall Study|Subject/Guardian Decision|0|||
30822045|NCT03131479|58843259|FG003|Overall Study|Subject/Guardian Decision|1|||
30822046|NCT03131479|58843260|FG004|Overall Study|Subject/Guardian Decision|0|||
30822047|NCT03602885|58843274|FG000|Overall Study|Lost to Follow-up|3|||
30822048|NCT03602885|58843275|FG001|Overall Study|Lost to Follow-up|0|||
30822049|NCT02880761|58843283|FG000|Overall Study|Death|6|||
30822050|NCT02880761|58843284|FG001|Overall Study|Death|8|||
30822051|NCT02880761|58843283|FG000|Overall Study|Withdrawal by Subject|3|||
30822052|NCT02880761|58843284|FG001|Overall Study|Withdrawal by Subject|6|||
30822053|NCT02880761|58843283|FG000|Overall Study|Protocol Violation|4|||
30822054|NCT02880761|58843284|FG001|Overall Study|Protocol Violation|3|||
30822055|NCT02880761|58843283|FG000|Overall Study|Lost to Follow-up|3|||
30822056|NCT02880761|58843284|FG001|Overall Study|Lost to Follow-up|4|||
30822057|NCT02930941|58843292|FG000|Overall Study|Lost to Follow-up|1|||
30822058|NCT02930941|58843293|FG001|Overall Study|Lost to Follow-up|2|||
30822059|NCT03137537|58843305|FG000|Overall Study|Adverse Event|0|||
30822060|NCT03137537|58843306|FG001|Overall Study|Adverse Event|1|||
30822061|NCT03137459|58843314|FG000|2-month Assessment|Withdrawal by Subject|13|||
30822062|NCT03137459|58843315|FG001|2-month Assessment|Withdrawal by Subject|3|||
30822063|NCT03137459|58843314|FG000|2-month Assessment|Unable to reach|42|||
30822064|NCT03137459|58843315|FG001|2-month Assessment|Unable to reach|32|||
30822065|NCT03137459|58843314|FG000|2-month Assessment|Refused assessment|7|||
30822066|NCT03137459|58843315|FG001|2-month Assessment|Refused assessment|5|||
30822067|NCT03137459|58843314|FG000|2-month Assessment|Acutely ill|6|||
30822068|NCT03137459|58843315|FG001|2-month Assessment|Acutely ill|2|||
30822069|NCT03137459|58843314|FG000|4-month Assessment|Death|4|||
30822070|NCT03137459|58843315|FG001|4-month Assessment|Death|2|||
30822071|NCT03137459|58843314|FG000|4-month Assessment|Withdrawal by Subject|4|||
30822072|NCT03137459|58843315|FG001|4-month Assessment|Withdrawal by Subject|2|||
30822073|NCT03137459|58843314|FG000|4-month Assessment|Unable to reach|44|||
30822074|NCT03137459|58843315|FG001|4-month Assessment|Unable to reach|29|||
30822075|NCT03137459|58843314|FG000|4-month Assessment|Refused assessment|24|||
30822076|NCT03137459|58843315|FG001|4-month Assessment|Refused assessment|10|||
30822077|NCT03137459|58843314|FG000|4-month Assessment|Acutely ill|2|||
30822078|NCT03137459|58843315|FG001|4-month Assessment|Acutely ill|3|||
30822079|NCT03137459|58843314|FG000|6-months|Lost to Follow-up|14|||
30822080|NCT03137459|58843315|FG001|6-months|Lost to Follow-up|11|||
30822081|NCT03137459|58843314|FG000|6-months|Death|0|||
30822082|NCT03137459|58843315|FG001|6-months|Death|2|||
30822083|NCT03137459|58843314|FG000|6-months|Refused assessment|6|||
30822084|NCT03137459|58843315|FG001|6-months|Refused assessment|3|||
30913887|NCT01583374|58949391|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
30822085|NCT03137459|58843314|FG000|6-months|Acutely ill|1|||
30822086|NCT03137459|58843315|FG001|6-months|Acutely ill|1|||
30822087|NCT03131713|58843324|FG000|Overall Study|Lost to Follow-up|5|||
30822088|NCT03131713|58843325|FG001|Overall Study|Lost to Follow-up|0|||
30822089|NCT02930005|58843333|FG000|Overall Study|Lost to Follow-up|1|||
30822090|NCT02930005|58843334|FG001|Overall Study|Lost to Follow-up|5|||
30822091|NCT03637491|58843344|FG000|Overall Study|Death|9|||
30822092|NCT03637491|58843345|FG001|Overall Study|Death|9|||
30822093|NCT03637491|58843346|FG002|Overall Study|Death|5|||
30822094|NCT03637491|58843347|FG003|Overall Study|Death|3|||
30822095|NCT03637491|58843344|FG000|Overall Study|Lost to Follow-up|0|||
30822096|NCT03637491|58843345|FG001|Overall Study|Lost to Follow-up|1|||
30822097|NCT03637491|58843346|FG002|Overall Study|Lost to Follow-up|0|||
30822098|NCT03637491|58843347|FG003|Overall Study|Lost to Follow-up|1|||
30822099|NCT03637491|58843344|FG000|Overall Study|Study Terminated By Sponsor|0|||
30822100|NCT03637491|58843345|FG001|Overall Study|Study Terminated By Sponsor|2|||
30822101|NCT03637491|58843346|FG002|Overall Study|Study Terminated By Sponsor|1|||
30822102|NCT03637491|58843347|FG003|Overall Study|Study Terminated By Sponsor|0|||
30822103|NCT03637491|58843344|FG000|Overall Study|Withdrawal by Subject|1|||
30822104|NCT03637491|58843345|FG001|Overall Study|Withdrawal by Subject|0|||
30822105|NCT03637491|58843346|FG002|Overall Study|Withdrawal by Subject|1|||
30822106|NCT03637491|58843347|FG003|Overall Study|Withdrawal by Subject|2|||
30822107|NCT03334539|58843381|FG000|Overall Study|Adverse Event|3|||
30822108|NCT03334539|58843382|FG001|Overall Study|Adverse Event|5|||
30822109|NCT03334539|58843383|FG002|Overall Study|Adverse Event|0|||
30822110|NCT03334539|58843381|FG000|Overall Study|Withdrawal by Subject|0|||
30822111|NCT03334539|58843382|FG001|Overall Study|Withdrawal by Subject|1|||
30822112|NCT03334539|58843383|FG002|Overall Study|Withdrawal by Subject|1|||
30822113|NCT03334539|58843381|FG000|Overall Study|Administrative Reasons|1|||
30623130|NCT00962247|58634956|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
30623131|NCT00918580|58634962|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
30623132|NCT00918580|58634962|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
30752972|NCT00125190|58762760|FG000|Overall Study|Subject/Parent Decision|7|||
30752973|NCT00125190|58762760|FG000|Overall Study|Non-compliance|2|||
30752974|NCT00125190|58762760|FG000|Overall Study|Adverse Event|1|||
30752975|NCT00125190|58762760|FG000|Overall Study|Other|1|||
30752976|NCT00125190|58762760|FG000|Overall Study|Lost to Follow-up|4|||
30752977|NCT00141726|58762765|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
30752978|NCT00111228|58762772|FG000|Overall Study|Withdrawal by Subject|5|||
30752979|NCT00111228|58762773|FG001|Overall Study|Withdrawal by Subject|1|||
30752980|NCT00111228|58762774|FG002|Overall Study|Withdrawal by Subject|0|||
30752981|NCT00110994|58762784|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
30752982|NCT00110994|58762785|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
30752983|NCT00110994|58762784|FG000|Double-blind (DB) Treatment|Death|1|||
30752984|NCT00110994|58762785|FG001|Double-blind (DB) Treatment|Death|0|||
30752985|NCT00110994|58762784|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
30752986|NCT00110994|58762785|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
30822114|NCT03334539|58843382|FG001|Overall Study|Administrative Reasons|0|||
30822115|NCT03334539|58843383|FG002|Overall Study|Administrative Reasons|0|||
30822116|NCT03334539|58843381|FG000|Overall Study|Hypertension Not Controlled|0|||
30752987|NCT00110994|58762784|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
30822117|NCT03334539|58843382|FG001|Overall Study|Hypertension Not Controlled|1|||
30822118|NCT03334539|58843383|FG002|Overall Study|Hypertension Not Controlled|0|||
30822119|NCT03137303|58843398|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
30913888|NCT01583374|58949392|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
30913889|NCT01583374|58949393|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
30752988|NCT00110994|58762785|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
30752989|NCT00110994|58762784|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
30822120|NCT03137303|58843399|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
30822121|NCT03137303|58843398|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
30822122|NCT03137303|58843399|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
30822123|NCT03137303|58843398|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
30822124|NCT03137303|58843399|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
30822125|NCT03137303|58843398|FG000|T3: 9-month Follow-up|Death|1|||
30822126|NCT03137303|58843399|FG001|T3: 9-month Follow-up|Death|0|||
30822127|NCT03137303|58843398|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
30822128|NCT03137303|58843399|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
30752990|NCT00110994|58762785|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
30822129|NCT03137303|58843398|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
30822130|NCT03137303|58843399|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
30822131|NCT03137303|58843398|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
30822132|NCT03137303|58843399|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
30822133|NCT03296553|58843407|FG000|Overall Study|Withdrawal by Subject|1|||
30822134|NCT03296553|58843408|FG001|Overall Study|Withdrawal by Subject|1|||
30822135|NCT03296553|58843407|FG000|Overall Study|Death|1|||
30822136|NCT03296553|58843408|FG001|Overall Study|Death|0|||
30822137|NCT03131167|58843427|FG000|Overall Study|Other (Unspecified)|0|||
30822138|NCT03131167|58843428|FG001|Overall Study|Other (Unspecified)|0|||
30822139|NCT03131167|58843429|FG002|Overall Study|Other (Unspecified)|0|||
30822140|NCT03131167|58843430|FG003|Overall Study|Other (Unspecified)|0|||
30822141|NCT03131167|58843431|FG004|Overall Study|Other (Unspecified)|0|||
30822142|NCT03131167|58843432|FG005|Overall Study|Other (Unspecified)|1|||
30822143|NCT03131167|58843433|FG006|Overall Study|Other (Unspecified)|0|||
30822144|NCT03131167|58843434|FG007|Overall Study|Other (Unspecified)|0|||
30752991|NCT00110994|58762784|FG000|Double-blind (DB) Treatment|other reasons|2|||
30822145|NCT03131167|58843435|FG008|Overall Study|Other (Unspecified)|0|||
30822146|NCT03131167|58843436|FG009|Overall Study|Other (Unspecified)|0|||
30822147|NCT03131167|58843437|FG010|Overall Study|Other (Unspecified)|0|||
30822148|NCT03131167|58843438|FG011|Overall Study|Other (Unspecified)|0|||
30822149|NCT03131167|58843439|FG012|Overall Study|Other (Unspecified)|0|||
30822150|NCT03060447|58843470|FG000|Overall Study|Withdrawal by Subject|2|||
30822151|NCT03060447|58843471|FG001|Overall Study|Withdrawal by Subject|0|||
30822152|NCT01712789|58843483|FG000|Overall Study|Lack of Efficacy|2|||
30822153|NCT01712789|58843483|FG000|Overall Study|Lost to Follow-up|1|||
30822154|NCT01712789|58843483|FG000|Overall Study|Progressive Disease|504|||
30822155|NCT01712789|58843483|FG000|Overall Study|Death|57|||
30822156|NCT01712789|58843483|FG000|Overall Study|Adverse Event|52|||
30822157|NCT01712789|58843483|FG000|Overall Study|Miscellaneous|31|||
30822158|NCT01712789|58843483|FG000|Overall Study|Withdrawal by Subject|21|||
30822159|NCT01712789|58843483|FG000|Overall Study|Transition to Commercial Treatment|8|||
30822160|NCT01712789|58843483|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
30822161|NCT02978781|58843490|FG000|Part A|Adverse Event|1|||
30822162|NCT02978781|58843491|FG001|Part A|Adverse Event|1|||
30822163|NCT02978781|58843492|FG002|Part A|Adverse Event|0|||
30822164|NCT02978781|58843493|FG003|Part A|Adverse Event|0|||
30822165|NCT02978781|58843494|FG004|Part A|Adverse Event|0|||
30752992|NCT00110994|58762785|FG001|Double-blind (DB) Treatment|other reasons|3|||
30752993|NCT00110994|58762784|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
30752994|NCT00110994|58762785|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
30752995|NCT00110994|58762784|FG000|Active Follow-up|Other reasons|0|||
30752996|NCT00110994|58762785|FG001|Active Follow-up|Other reasons|2|||
30752997|NCT00110994|58762784|FG000|Long Term Follow-up|Death|19|||
30752998|NCT00110994|58762785|FG001|Long Term Follow-up|Death|17|||
30752999|NCT00144170|58762793|FG000|Overall Study|Adverse Event|84|||
30753000|NCT00144170|58762794|FG001|Overall Study|Adverse Event|41|||
30753001|NCT00144170|58762793|FG000|Overall Study|Protocol Violation|23|||
30753002|NCT00144170|58762794|FG001|Overall Study|Protocol Violation|16|||
30753003|NCT00144170|58762793|FG000|Overall Study|Lost to Follow-up|5|||
30753004|NCT00144170|58762794|FG001|Overall Study|Lost to Follow-up|10|||
30822166|NCT02978781|58843490|FG000|Part A|Withdrawal by Subject|0|||
30822167|NCT02978781|58843491|FG001|Part A|Withdrawal by Subject|1|||
30822168|NCT02978781|58843492|FG002|Part A|Withdrawal by Subject|0|||
30822169|NCT02978781|58843493|FG003|Part A|Withdrawal by Subject|0|||
30822170|NCT02978781|58843494|FG004|Part A|Withdrawal by Subject|0|||
30822171|NCT02978781|58843490|FG000|Part B|Withdrawal by Subject|0|||
30753005|NCT00144170|58762793|FG000|Overall Study|Withdrawal by Subject|29|||
30753006|NCT00144170|58762794|FG001|Overall Study|Withdrawal by Subject|13|||
30753007|NCT00144170|58762793|FG000|Overall Study|Other reason not defined above|211|||
30753008|NCT00144170|58762794|FG001|Overall Study|Other reason not defined above|316|||
30822172|NCT02978781|58843491|FG001|Part B|Withdrawal by Subject|0|||
30822173|NCT02978781|58843492|FG002|Part B|Withdrawal by Subject|0|||
30822174|NCT02978781|58843493|FG003|Part B|Withdrawal by Subject|1|||
30822175|NCT02978781|58843494|FG004|Part B|Withdrawal by Subject|0|||
30822176|NCT02978781|58843490|FG000|Part C|Adverse Event|0|||
30822177|NCT02978781|58843491|FG001|Part C|Adverse Event|0|||
30822178|NCT02978781|58843492|FG002|Part C|Adverse Event|0|||
30822179|NCT02978781|58843493|FG003|Part C|Adverse Event|0|||
30822180|NCT02978781|58843494|FG004|Part C|Adverse Event|2|||
30822181|NCT02978781|58843490|FG000|Part C|Withdrawal by Subject|0|||
30822182|NCT02978781|58843491|FG001|Part C|Withdrawal by Subject|0|||
30822183|NCT02978781|58843492|FG002|Part C|Withdrawal by Subject|0|||
30822184|NCT02978781|58843493|FG003|Part C|Withdrawal by Subject|0|||
30822185|NCT02978781|58843494|FG004|Part C|Withdrawal by Subject|1|||
30822186|NCT02978781|58843490|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
30822187|NCT02978781|58843491|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
30822188|NCT02978781|58843492|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
30822189|NCT02978781|58843493|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
30822190|NCT02978781|58843494|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
30822191|NCT03074318|58843524|FG000|Overall Study|Adverse Event|0|||
30822192|NCT03074318|58843525|FG001|Overall Study|Adverse Event|1|||
30822193|NCT03074318|58843526|FG002|Overall Study|Adverse Event|1|||
30822194|NCT03074318|58843527|FG003|Overall Study|Adverse Event|1|||
30822195|NCT03074318|58843524|FG000|Overall Study|Death|1|||
30822196|NCT03074318|58843525|FG001|Overall Study|Death|0|||
30822197|NCT03074318|58843526|FG002|Overall Study|Death|0|||
30822198|NCT03074318|58843527|FG003|Overall Study|Death|0|||
30822199|NCT03074318|58843524|FG000|Overall Study|Withdrawal by Subject|1|||
30913890|NCT01583374|58949394|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
30913891|NCT01583374|58949395|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
30913892|NCT01583374|58949396|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
30913893|NCT01583374|58949397|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
30913894|NCT01583374|58949389|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
30913895|NCT01583374|58949390|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
30913896|NCT01583374|58949391|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
30913897|NCT01583374|58949392|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
30913898|NCT01583374|58949393|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
30913899|NCT01583374|58949394|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
30913900|NCT01583374|58949395|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
30913901|NCT01583374|58949396|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
30913902|NCT01583374|58949397|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
30913903|NCT01583374|58949389|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
30913904|NCT01583374|58949390|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
30913905|NCT01583374|58949391|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
30913906|NCT01583374|58949392|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
30822200|NCT03074318|58843525|FG001|Overall Study|Withdrawal by Subject|2|||
30822201|NCT03074318|58843526|FG002|Overall Study|Withdrawal by Subject|2|||
30913907|NCT01583374|58949393|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
30913908|NCT01583374|58949394|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
30913909|NCT01583374|58949395|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
30913910|NCT01583374|58949396|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
30913911|NCT01583374|58949397|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
30913912|NCT01583374|58949389|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
30913913|NCT01583374|58949390|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
30913914|NCT01583374|58949391|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
30913915|NCT01583374|58949392|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
30913916|NCT01583374|58949393|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
30913917|NCT01583374|58949394|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
30913918|NCT01583374|58949395|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
30913919|NCT01583374|58949396|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
30913920|NCT01583374|58949397|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
30913921|NCT01583374|58949389|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
30913922|NCT01583374|58949390|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
30913923|NCT01583374|58949391|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
30913924|NCT01583374|58949392|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
30822202|NCT03074318|58843527|FG003|Overall Study|Withdrawal by Subject|4|||
30913925|NCT01583374|58949393|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
30913926|NCT01583374|58949394|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
30822203|NCT03074318|58843524|FG000|Overall Study|Trial Closure|2|||
30822204|NCT03074318|58843525|FG001|Overall Study|Trial Closure|2|||
30822205|NCT03074318|58843526|FG002|Overall Study|Trial Closure|3|||
30822206|NCT03074318|58843527|FG003|Overall Study|Trial Closure|11|||
30822207|NCT03135119|58843548|FG000|Overall Study|Lost to Follow-up|2|||
30913927|NCT01583374|58949395|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
30913928|NCT01583374|58949396|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
30913929|NCT01583374|58949397|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
30822208|NCT03135119|58843549|FG001|Overall Study|Lost to Follow-up|0|||
30822209|NCT03135119|58843548|FG000|Overall Study|Physician Decision|1|||
30822210|NCT03135119|58843549|FG001|Overall Study|Physician Decision|1|||
30822211|NCT03135119|58843548|FG000|Overall Study|COVID-19 Shutdown|2|||
30822212|NCT03135119|58843549|FG001|Overall Study|COVID-19 Shutdown|2|||
30822213|NCT01369784|58843555|FG000|Overall Study|Protocol Violation|12|||
30822214|NCT03353675|58843559|FG000|Overall Study|Adverse Event|4|||
30822215|NCT03137069|58843569|FG000|Overall Study|Withdrawal by Subject|1|||
30822216|NCT03137069|58843570|FG001|Overall Study|Withdrawal by Subject|2|||
30822217|NCT03137069|58843571|FG002|Overall Study|Withdrawal by Subject|2|||
30753009|NCT00255086|58762802|FG000|Overall Study|Adverse Event|1|||
30753010|NCT00255086|58762803|FG001|Overall Study|Adverse Event|1|||
30753011|NCT00255086|58762802|FG000|Overall Study|Protocol Violation|1|||
30753012|NCT00255086|58762803|FG001|Overall Study|Protocol Violation|1|||
30753013|NCT00110214|58762812|FG000|Overall Study|Never started treatment|21|||
30753014|NCT00110214|58762813|FG001|Overall Study|Never started treatment|20|||
30753015|NCT00110214|58762812|FG000|Overall Study|Disease progression or death|260|||
30753016|NCT00110214|58762813|FG001|Overall Study|Disease progression or death|151|||
30753017|NCT00110214|58762812|FG000|Overall Study|Adverse Event|115|||
30822218|NCT03137069|58843572|FG003|Overall Study|Withdrawal by Subject|2|||
30822219|NCT03137069|58843573|FG004|Overall Study|Withdrawal by Subject|0|||
30822220|NCT03137069|58843574|FG005|Overall Study|Withdrawal by Subject|0|||
30822221|NCT03137069|58843569|FG000|Overall Study|Adverse Event|0|||
30753018|NCT00110214|58762813|FG001|Overall Study|Adverse Event|192|||
30753019|NCT00110214|58762812|FG000|Overall Study|Refused further treatment|52|||
30753020|NCT00110214|58762813|FG001|Overall Study|Refused further treatment|65|||
30753021|NCT00110214|58762812|FG000|Overall Study|Other (not specified)|61|||
30822222|NCT03137069|58843570|FG001|Overall Study|Adverse Event|3|||
30822223|NCT03137069|58843571|FG002|Overall Study|Adverse Event|1|||
30822224|NCT03137069|58843572|FG003|Overall Study|Adverse Event|1|||
30822225|NCT03137069|58843573|FG004|Overall Study|Adverse Event|0|||
30822226|NCT03137069|58843574|FG005|Overall Study|Adverse Event|1|||
30822227|NCT03137069|58843569|FG000|Overall Study|Protocol Violation|0|||
30822228|NCT03137069|58843570|FG001|Overall Study|Protocol Violation|1|||
30822229|NCT03137069|58843571|FG002|Overall Study|Protocol Violation|0|||
30822230|NCT03137069|58843572|FG003|Overall Study|Protocol Violation|1|||
30822231|NCT03137069|58843573|FG004|Overall Study|Protocol Violation|1|||
30822232|NCT03137069|58843574|FG005|Overall Study|Protocol Violation|1|||
30822233|NCT03137069|58843569|FG000|Overall Study|Physician Decision|0|||
30822234|NCT03137069|58843570|FG001|Overall Study|Physician Decision|0|||
30822235|NCT03137069|58843571|FG002|Overall Study|Physician Decision|0|||
30822236|NCT03137069|58843572|FG003|Overall Study|Physician Decision|1|||
30822237|NCT03137069|58843573|FG004|Overall Study|Physician Decision|0|||
30822238|NCT03137069|58843574|FG005|Overall Study|Physician Decision|0|||
30822239|NCT03137069|58843569|FG000|Overall Study|Study Terminated by Sponsor|0|||
30822240|NCT03137069|58843570|FG001|Overall Study|Study Terminated by Sponsor|0|||
30822241|NCT03137069|58843571|FG002|Overall Study|Study Terminated by Sponsor|0|||
30822242|NCT03137069|58843572|FG003|Overall Study|Study Terminated by Sponsor|0|||
30822243|NCT03137069|58843573|FG004|Overall Study|Study Terminated by Sponsor|1|||
30822244|NCT03137069|58843574|FG005|Overall Study|Study Terminated by Sponsor|0|||
30822245|NCT03137069|58843569|FG000|Overall Study|Data Entry Error|0|||
30822246|NCT03137069|58843570|FG001|Overall Study|Data Entry Error|0|||
30822247|NCT03137069|58843571|FG002|Overall Study|Data Entry Error|0|||
30822248|NCT03137069|58843572|FG003|Overall Study|Data Entry Error|1|||
30822249|NCT03137069|58843573|FG004|Overall Study|Data Entry Error|0|||
30822250|NCT03137069|58843574|FG005|Overall Study|Data Entry Error|0|||
30822251|NCT02792504|58843592|FG000|Overall Study|Lost to Follow-up|24|||
30822252|NCT02792504|58843592|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
30913930|NCT01583374|58949389|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
30623133|NCT00918580|58634962|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
30822253|NCT03124459|58843602|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
30822254|NCT03124459|58843603|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
30822255|NCT03124459|58843604|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
30822256|NCT03124459|58843605|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
30822257|NCT03124459|58843606|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
30822258|NCT03124459|58843607|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
30822259|NCT03124459|58843602|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
30822260|NCT03124459|58843603|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
30822261|NCT03124459|58843604|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
30822262|NCT03124459|58843605|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
30822263|NCT03124459|58843606|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
30822264|NCT03124459|58843607|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
30822265|NCT03124459|58843602|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
30822266|NCT03124459|58843603|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
30822267|NCT03124459|58843604|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
30822268|NCT03124459|58843605|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
30822269|NCT03124459|58843606|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
30822270|NCT03124459|58843607|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
30822271|NCT03124459|58843602|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
30822272|NCT03124459|58843603|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
30822273|NCT03124459|58843604|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
30822274|NCT03124459|58843605|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
30822275|NCT03124459|58843606|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
30822276|NCT03124459|58843607|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
30822277|NCT03124459|58843602|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
30822278|NCT03124459|58843603|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
30822279|NCT03124459|58843604|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
30822280|NCT03124459|58843605|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
30822281|NCT03124459|58843606|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
30822282|NCT03124459|58843607|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
30822283|NCT03124459|58843602|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
30822284|NCT03124459|58843603|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
30822285|NCT03124459|58843604|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
30822286|NCT03124459|58843605|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
30822287|NCT03124459|58843606|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
30822288|NCT03124459|58843607|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
30822289|NCT03134183|58843622|FG000|Overall Study|Withdrawal by Subject|1|||
30913931|NCT01583374|58949390|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
30913932|NCT01583374|58949391|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
30822290|NCT03134183|58843623|FG001|Overall Study|Withdrawal by Subject|1|||
30822291|NCT03136367|58843632|FG000|T1 Consultation|discontinued mistakenly included|2|||
30822292|NCT03136367|58843633|FG001|T1 Consultation|discontinued mistakenly included|6|||
30822293|NCT03136367|58843634|FG002|T1 Consultation|discontinued mistakenly included|1|||
30822294|NCT03136367|58843632|FG000|T1 Consultation|Discontinued other|0|||
30822295|NCT03136367|58843633|FG001|T1 Consultation|Discontinued other|1|||
30822296|NCT03136367|58843634|FG002|T1 Consultation|Discontinued other|0|||
30822297|NCT03136367|58843632|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
30822298|NCT03136367|58843633|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
30822299|NCT03136367|58843634|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
30822300|NCT03136367|58843632|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
30822301|NCT03136367|58843633|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
30822302|NCT03136367|58843634|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
30822303|NCT03136367|58843632|FG000|T2 Post-consultation|Discontinued other|0|||
30822304|NCT03136367|58843633|FG001|T2 Post-consultation|Discontinued other|2|||
30822305|NCT03136367|58843634|FG002|T2 Post-consultation|Discontinued other|6|||
30822306|NCT03136367|58843632|FG000|T2 Post-consultation|Discontinued transferred care|0|||
30822307|NCT03136367|58843633|FG001|T2 Post-consultation|Discontinued transferred care|0|||
30822308|NCT03136367|58843634|FG002|T2 Post-consultation|Discontinued transferred care|3|||
30913933|NCT01583374|58949392|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
30913934|NCT01583374|58949393|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
30913935|NCT01583374|58949394|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
30913936|NCT01583374|58949395|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
30753022|NCT00110214|58762813|FG001|Overall Study|Other (not specified)|75|||
30753023|NCT00124020|58762821|FG000|Overall Study|Death|67|||
30753024|NCT00124020|58762822|FG001|Overall Study|Death|71|||
30753025|NCT00124020|58762821|FG000|Overall Study|Withdrawal by Subject|13|||
30753026|NCT00124020|58762822|FG001|Overall Study|Withdrawal by Subject|11|||
30753027|NCT00124020|58762821|FG000|Overall Study|Lost to Follow-up|5|||
30753028|NCT00124020|58762822|FG001|Overall Study|Lost to Follow-up|8|||
30753029|NCT00124020|58762821|FG000|Overall Study|Other|1|||
30753030|NCT00124020|58762822|FG001|Overall Study|Other|1|||
30753031|NCT00124020|58762821|FG000|Overall Study|Transfer to another hospital|2|||
30753032|NCT00124020|58762822|FG001|Overall Study|Transfer to another hospital|0|||
30753033|NCT00215540|58762831|FG000|Overall Study|Withdrew from study medication|1|||
30753034|NCT00215540|58762832|FG001|Overall Study|Withdrew from study medication|0|||
30753035|NCT00215540|58762833|FG002|Overall Study|Withdrew from study medication|0|||
30753036|NCT00143390|58762843|FG000|Overall Study|Death|2|||
30753037|NCT00143390|58762844|FG001|Overall Study|Death|0|||
30753038|NCT00143390|58762843|FG000|Overall Study|Not meeting entry criteria|2|||
30753039|NCT00143390|58762844|FG001|Overall Study|Not meeting entry criteria|5|||
30822309|NCT03136367|58843632|FG000|T2 Post-consultation|Discontinued lost contact|0|||
30822310|NCT03136367|58843633|FG001|T2 Post-consultation|Discontinued lost contact|1|||
30822311|NCT03136367|58843634|FG002|T2 Post-consultation|Discontinued lost contact|0|||
30822312|NCT03136367|58843632|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
30822313|NCT03136367|58843633|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
30822314|NCT03136367|58843634|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
30822315|NCT03136367|58843632|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
30822316|NCT03136367|58843633|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
30822317|NCT03136367|58843634|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
30822318|NCT03136367|58843632|FG000|T3 1 Week After Surgery|other discontinued|2|||
30822319|NCT03136367|58843633|FG001|T3 1 Week After Surgery|other discontinued|4|||
30822320|NCT03136367|58843634|FG002|T3 1 Week After Surgery|other discontinued|3|||
30822321|NCT03136367|58843632|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
30822322|NCT03136367|58843633|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
30822323|NCT03136367|58843634|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
30822324|NCT03136367|58843632|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
30822325|NCT03136367|58843633|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
30822326|NCT03136367|58843634|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
30822327|NCT03136367|58843632|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
30822328|NCT03136367|58843633|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
30822329|NCT03136367|58843634|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
30822330|NCT03136367|58843632|FG000|T4 12 Weeks After Surgery|Death|0|||
30822331|NCT03136367|58843633|FG001|T4 12 Weeks After Surgery|Death|1|||
30822332|NCT03136367|58843634|FG002|T4 12 Weeks After Surgery|Death|3|||
30822333|NCT03136367|58843632|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
30822334|NCT03136367|58843633|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
30822335|NCT03136367|58843634|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
30822336|NCT03136367|58843632|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
30822337|NCT03136367|58843633|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
30822338|NCT03136367|58843634|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
30822339|NCT03136367|58843632|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
30822340|NCT03136367|58843633|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
30822341|NCT03136367|58843634|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
30822342|NCT03136367|58843632|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
30822343|NCT03136367|58843633|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
30822344|NCT03136367|58843634|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
30822345|NCT03136367|58843632|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
30822346|NCT03136367|58843633|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
30822347|NCT03136367|58843634|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
30822348|NCT03136367|58843632|FG000|T5 1 Year After Surgery|Death|0|||
30822349|NCT03136367|58843633|FG001|T5 1 Year After Surgery|Death|0|||
30822350|NCT03136367|58843634|FG002|T5 1 Year After Surgery|Death|1|||
30822351|NCT03136367|58843632|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
30822352|NCT03136367|58843633|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
30822353|NCT03136367|58843634|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
30822354|NCT03136367|58843632|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
30822355|NCT03136367|58843633|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
30822356|NCT03136367|58843634|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
30822357|NCT03136367|58843632|FG000|T5 1 Year After Surgery|study ended before due|31|||
30822358|NCT03136367|58843633|FG001|T5 1 Year After Surgery|study ended before due|103|||
30822359|NCT03136367|58843634|FG002|T5 1 Year After Surgery|study ended before due|110|||
30822360|NCT03136367|58843632|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
30822361|NCT03136367|58843633|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
30822362|NCT03136367|58843634|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
30822363|NCT03124381|58843647|FG000|Overall Study|Lost to Follow-up|1|||
30822364|NCT03124381|58843648|FG001|Overall Study|Lost to Follow-up|1|||
30822365|NCT03124381|58843647|FG000|Overall Study|Withdrawal by Subject|6|||
30822366|NCT03124381|58843648|FG001|Overall Study|Withdrawal by Subject|3|||
30822367|NCT03124381|58843647|FG000|Overall Study|Protocol Violation|0|||
30822368|NCT03124381|58843648|FG001|Overall Study|Protocol Violation|1|||
30913937|NCT01583374|58949396|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
30913938|NCT01583374|58949397|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
30913939|NCT01583374|58949389|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
30822369|NCT03124381|58843647|FG000|Overall Study|Adverse Event|1|||
30822370|NCT03124381|58843648|FG001|Overall Study|Adverse Event|1|||
30822371|NCT03124381|58843647|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
30822372|NCT03124381|58843648|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
30822373|NCT03133793|58843658|FG000|Overall Study|Withdrawal by Subject|0|||
30822374|NCT03133793|58843659|FG001|Overall Study|Withdrawal by Subject|4|||
30822375|NCT03133793|58843660|FG002|Overall Study|Withdrawal by Subject|2|||
30822376|NCT03133793|58843661|FG003|Overall Study|Withdrawal by Subject|4|||
30822377|NCT03133793|58843658|FG000|Overall Study|Lost to Follow-up|1|||
30822378|NCT03133793|58843659|FG001|Overall Study|Lost to Follow-up|0|||
30822379|NCT03133793|58843660|FG002|Overall Study|Lost to Follow-up|2|||
30822380|NCT03133793|58843661|FG003|Overall Study|Lost to Follow-up|0|||
30822381|NCT03133793|58843658|FG000|Overall Study|Death|0|||
30822382|NCT03133793|58843659|FG001|Overall Study|Death|0|||
30822383|NCT03133793|58843660|FG002|Overall Study|Death|0|||
30822384|NCT03133793|58843661|FG003|Overall Study|Death|1|||
30822385|NCT02747238|58843677|FG000|Overall Study|Lack of Efficacy|0|||
30822386|NCT02747238|58843678|FG001|Overall Study|Lack of Efficacy|1|||
30822387|NCT02747238|58843677|FG000|Overall Study|Data lost|3|||
30822388|NCT02747238|58843678|FG001|Overall Study|Data lost|5|||
30822389|NCT03133481|58843686|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
30913940|NCT01583374|58949390|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
30913941|NCT01583374|58949391|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
30913942|NCT01583374|58949392|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
30913943|NCT01583374|58949393|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
30913944|NCT01583374|58949394|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
30913945|NCT01583374|58949395|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
30913946|NCT01583374|58949396|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
30913947|NCT01583374|58949397|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
30913948|NCT01583374|58949389|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
30913949|NCT01583374|58949390|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
30913950|NCT01583374|58949391|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
30913951|NCT01583374|58949392|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
30913952|NCT01583374|58949393|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
30913953|NCT01583374|58949394|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
30913954|NCT01583374|58949395|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
30913955|NCT01583374|58949396|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
30913956|NCT01583374|58949397|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
30913957|NCT01583374|58949389|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
30913958|NCT01583374|58949390|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
30913959|NCT01583374|58949391|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
30913960|NCT01583374|58949392|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
30822390|NCT03133481|58843687|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
30822391|NCT02864316|58843695|FG000|Overall Study|Progressive Disease|2|||
30822392|NCT02864316|58843696|FG001|Overall Study|Progressive Disease|1|||
30822393|NCT02864316|58843695|FG000|Overall Study|Adverse Event|0|||
30822394|NCT02864316|58843696|FG001|Overall Study|Adverse Event|1|||
30822395|NCT02862600|58843702|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
30822396|NCT02862600|58843702|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
30822397|NCT02862600|58843702|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
30822398|NCT02862600|58843702|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
30822399|NCT02864082|58843710|FG000|Overall Study|Adverse Event|1|||
30822400|NCT02864082|58843711|FG001|Overall Study|Adverse Event|1|||
30822401|NCT02864082|58843710|FG000|Overall Study|Lost to Follow-up|0|||
30822402|NCT02864082|58843711|FG001|Overall Study|Lost to Follow-up|1|||
30822403|NCT02864082|58843710|FG000|Overall Study|Withdrawal by Subject|2|||
30822404|NCT02864082|58843711|FG001|Overall Study|Withdrawal by Subject|2|||
30822405|NCT02792192|58843735|FG000|Overall Study|Death|1|||
30822406|NCT02792192|58843736|FG001|Overall Study|Death|0|||
30822407|NCT02792192|58843737|FG002|Overall Study|Death|0|||
30822408|NCT02792192|58843738|FG003|Overall Study|Death|0|||
30822409|NCT02792192|58843735|FG000|Overall Study|Informed Consent Withdrawn|4|||
30822410|NCT02792192|58843736|FG001|Overall Study|Informed Consent Withdrawn|0|||
30822411|NCT02792192|58843737|FG002|Overall Study|Informed Consent Withdrawn|0|||
30822412|NCT02792192|58843738|FG003|Overall Study|Informed Consent Withdrawn|0|||
30822413|NCT02792192|58843735|FG000|Overall Study|Physician Decision|1|||
30913961|NCT01583374|58949393|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
30913962|NCT01583374|58949394|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
30913963|NCT01583374|58949395|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
30913964|NCT01583374|58949396|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
30753040|NCT00143390|58762843|FG000|Overall Study|Withdrawal by Subject|4|||
30753041|NCT00143390|58762844|FG001|Overall Study|Withdrawal by Subject|4|||
30753042|NCT00143390|58762843|FG000|Overall Study|Progressive disease|119|||
30753043|NCT00143390|58762844|FG001|Overall Study|Progressive disease|115|||
30913965|NCT01583374|58949397|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
30913966|NCT01583374|58949389|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
30913967|NCT01583374|58949390|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
30913968|NCT01583374|58949391|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
30913969|NCT01583374|58949392|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
30913970|NCT01583374|58949393|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
30913971|NCT01583374|58949394|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
30913972|NCT01583374|58949395|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
30913973|NCT01583374|58949396|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
30913974|NCT01583374|58949397|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
30913975|NCT01583374|58949389|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
30913976|NCT01583374|58949390|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
30913977|NCT01583374|58949391|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
30753044|NCT00143390|58762843|FG000|Overall Study|Protocol Violation|2|||
30753045|NCT00143390|58762844|FG001|Overall Study|Protocol Violation|0|||
30753046|NCT00143390|58762843|FG000|Overall Study|Study termination|10|||
30753047|NCT00143390|58762844|FG001|Overall Study|Study termination|15|||
30753048|NCT00143390|58762843|FG000|Overall Study|Adverse Event|9|||
30822414|NCT02792192|58843736|FG001|Overall Study|Physician Decision|0|||
30822415|NCT02792192|58843737|FG002|Overall Study|Physician Decision|0|||
30822416|NCT02792192|58843738|FG003|Overall Study|Physician Decision|0|||
30822417|NCT02792192|58843735|FG000|Overall Study|Progressive Disease|0|||
30822418|NCT02792192|58843736|FG001|Overall Study|Progressive Disease|1|||
30822419|NCT02792192|58843737|FG002|Overall Study|Progressive Disease|0|||
30753049|NCT00143390|58762844|FG001|Overall Study|Adverse Event|8|||
30753050|NCT00143390|58762843|FG000|Overall Study|Other|1|||
30753051|NCT00143390|58762844|FG001|Overall Study|Other|2|||
30753052|NCT00141102|58762852|FG000|Overall Study|Adverse Event|233|||
30753053|NCT00141102|58762853|FG001|Overall Study|Adverse Event|305|||
30753054|NCT00141102|58762852|FG000|Overall Study|Laboratory Abnormality|9|||
30753055|NCT00141102|58762853|FG001|Overall Study|Laboratory Abnormality|33|||
30753056|NCT00141102|58762852|FG000|Overall Study|Lack of Efficacy|21|||
30753057|NCT00141102|58762853|FG001|Overall Study|Lack of Efficacy|26|||
30753058|NCT00141102|58762852|FG000|Overall Study|Lost to Follow-up|29|||
30753059|NCT00141102|58762853|FG001|Overall Study|Lost to Follow-up|32|||
30753060|NCT00141102|58762852|FG000|Overall Study|Other|87|||
30753061|NCT00141102|58762853|FG001|Overall Study|Other|76|||
30753062|NCT00141102|58762852|FG000|Overall Study|Withdrawal by Subject|112|||
30753063|NCT00141102|58762853|FG001|Overall Study|Withdrawal by Subject|142|||
30822420|NCT02792192|58843738|FG003|Overall Study|Progressive Disease|0|||
30822421|NCT02792192|58843735|FG000|Overall Study|Study Terminated By Sponsor|6|||
30822422|NCT02792192|58843736|FG001|Overall Study|Study Terminated By Sponsor|10|||
30822423|NCT02792192|58843737|FG002|Overall Study|Study Terminated By Sponsor|0|||
30822424|NCT02792192|58843738|FG003|Overall Study|Study Terminated By Sponsor|0|||
30913978|NCT01583374|58949392|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
30753064|NCT00141102|58762852|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
30753065|NCT00141102|58762853|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
30753066|NCT00141102|58762852|FG000|Overall Study|Death|2|||
30753067|NCT00141102|58762853|FG001|Overall Study|Death|2|||
30753068|NCT00255008|58762864|FG000|Overall Study|Adverse Event|1|||
30753069|NCT00255008|58762865|FG001|Overall Study|Adverse Event|1|||
30753070|NCT00255008|58762866|FG002|Overall Study|Adverse Event|2|||
30753071|NCT00255008|58762867|FG003|Overall Study|Adverse Event|0|||
30822425|NCT02964507|58843757|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
30822426|NCT02964507|58843758|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
30822427|NCT02964507|58843759|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
30822428|NCT02964507|58843760|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
30822429|NCT02964507|58843761|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
30822430|NCT02964507|58843762|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
30822431|NCT02964507|58843763|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
30822432|NCT02964507|58843764|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
30822433|NCT02964507|58843757|FG000|Overall Study|Study terminated by Sponsor|9|||
30822434|NCT02964507|58843758|FG001|Overall Study|Study terminated by Sponsor|1|||
30822435|NCT02964507|58843759|FG002|Overall Study|Study terminated by Sponsor|9|||
30822436|NCT02964507|58843760|FG003|Overall Study|Study terminated by Sponsor|3|||
30822437|NCT02964507|58843761|FG004|Overall Study|Study terminated by Sponsor|3|||
30822438|NCT02964507|58843762|FG005|Overall Study|Study terminated by Sponsor|2|||
30822439|NCT02964507|58843763|FG006|Overall Study|Study terminated by Sponsor|0|||
30822440|NCT02964507|58843764|FG007|Overall Study|Study terminated by Sponsor|0|||
30822441|NCT02964507|58843757|FG000|Overall Study|Other|3|||
30822442|NCT02964507|58843758|FG001|Overall Study|Other|0|||
30822443|NCT02964507|58843759|FG002|Overall Study|Other|0|||
30822444|NCT02964507|58843760|FG003|Overall Study|Other|0|||
30822445|NCT02964507|58843761|FG004|Overall Study|Other|1|||
30913979|NCT01583374|58949393|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
30913980|NCT01583374|58949394|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
30913981|NCT01583374|58949395|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
30913982|NCT01583374|58949396|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
30822446|NCT02964507|58843762|FG005|Overall Study|Other|0|||
30822447|NCT02964507|58843763|FG006|Overall Study|Other|0|||
30913983|NCT01583374|58949397|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
30913984|NCT01583374|58949389|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
30913985|NCT01583374|58949390|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
30913986|NCT01583374|58949391|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
30913987|NCT01583374|58949392|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
30913988|NCT01583374|58949393|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
30913989|NCT01583374|58949394|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
30913990|NCT01583374|58949395|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
30913991|NCT01583374|58949396|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
30913992|NCT01583374|58949397|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
30913993|NCT01583296|58949418|FG000|Overall Study|Withdrawal by Subject|11|||
30913994|NCT01583296|58949419|FG001|Overall Study|Withdrawal by Subject|10|||
30913995|NCT02222714|58949430|FG000|Overall Study|Death|0|||
30913996|NCT02222714|58949431|FG001|Overall Study|Death|2|||
30913997|NCT02222714|58949432|FG002|Overall Study|Death|3|||
30913998|NCT02222714|58949433|FG003|Overall Study|Death|4|||
30913999|NCT02222714|58949434|FG004|Overall Study|Death|6|||
30914000|NCT02222714|58949430|FG000|Overall Study|Withdrawal by Subject|0|||
30914001|NCT02222714|58949431|FG001|Overall Study|Withdrawal by Subject|0|||
30914002|NCT02222714|58949432|FG002|Overall Study|Withdrawal by Subject|1|||
30914003|NCT02222714|58949433|FG003|Overall Study|Withdrawal by Subject|0|||
30914004|NCT02222714|58949434|FG004|Overall Study|Withdrawal by Subject|1|||
30914005|NCT02164916|58949451|FG000|Overall Study|Adverse Event|3|||
30914006|NCT02164916|58949452|FG001|Overall Study|Adverse Event|8|||
30822448|NCT02964507|58843764|FG007|Overall Study|Other|0|||
30822449|NCT02964507|58843757|FG000|Overall Study|Death|11|||
30822450|NCT02964507|58843758|FG001|Overall Study|Death|9|||
30822451|NCT02964507|58843759|FG002|Overall Study|Death|12|||
30822452|NCT02964507|58843760|FG003|Overall Study|Death|2|||
30822453|NCT02964507|58843761|FG004|Overall Study|Death|10|||
30914007|NCT02164916|58949451|FG000|Overall Study|Death|1|||
30914008|NCT02164916|58949452|FG001|Overall Study|Death|1|||
30914009|NCT02164916|58949451|FG000|Overall Study|Refusal unrelated to adverse event|3|||
30914010|NCT02164916|58949452|FG001|Overall Study|Refusal unrelated to adverse event|7|||
30914011|NCT02164916|58949451|FG000|Overall Study|Progression|37|||
30914012|NCT02164916|58949452|FG001|Overall Study|Progression|26|||
30914013|NCT02164916|58949451|FG000|Overall Study|Not protocol specified|5|||
30914014|NCT02164916|58949452|FG001|Overall Study|Not protocol specified|1|||
30914015|NCT02164916|58949451|FG000|Overall Study|Reason under review|1|||
30914016|NCT02164916|58949452|FG001|Overall Study|Reason under review|6|||
30822454|NCT02964507|58843762|FG005|Overall Study|Death|5|||
30822455|NCT02964507|58843763|FG006|Overall Study|Death|0|||
30822456|NCT02964507|58843764|FG007|Overall Study|Death|0|||
30822457|NCT02964507|58843757|FG000|Overall Study|Withdrawal by Subject|1|||
30822458|NCT02964507|58843758|FG001|Overall Study|Withdrawal by Subject|0|||
30822459|NCT02964507|58843759|FG002|Overall Study|Withdrawal by Subject|1|||
30822460|NCT02964507|58843760|FG003|Overall Study|Withdrawal by Subject|1|||
30822461|NCT02964507|58843761|FG004|Overall Study|Withdrawal by Subject|0|||
30822462|NCT02964507|58843762|FG005|Overall Study|Withdrawal by Subject|1|||
30822463|NCT02964507|58843763|FG006|Overall Study|Withdrawal by Subject|0|||
30822464|NCT02964507|58843764|FG007|Overall Study|Withdrawal by Subject|0|||
30822465|NCT02964507|58843757|FG000|Overall Study|Physician Decision|2|||
30822466|NCT02964507|58843758|FG001|Overall Study|Physician Decision|0|||
30822467|NCT02964507|58843759|FG002|Overall Study|Physician Decision|3|||
30822468|NCT02964507|58843760|FG003|Overall Study|Physician Decision|0|||
30822469|NCT02964507|58843761|FG004|Overall Study|Physician Decision|1|||
30822470|NCT02964507|58843762|FG005|Overall Study|Physician Decision|0|||
30822471|NCT02964507|58843763|FG006|Overall Study|Physician Decision|0|||
30822472|NCT02964507|58843764|FG007|Overall Study|Physician Decision|0|||
30822473|NCT03170869|58843783|FG000|Overall Study|Protocol Violation|5|||
30822474|NCT03170869|58843783|FG000|Overall Study|Early study termination|3|||
30822475|NCT02440464|58843790|FG000|Overall Study|Withdrawal by Subject|3|||
30822476|NCT02440464|58843791|FG001|Overall Study|Withdrawal by Subject|2|||
30822477|NCT03103321|58843802|FG000|Overall Study|Protocol Violation|1|||
30822478|NCT03103321|58843803|FG001|Overall Study|Protocol Violation|1|||
30822479|NCT03103321|58843804|FG002|Overall Study|Protocol Violation|1|||
30822480|NCT03103321|58843805|FG003|Overall Study|Protocol Violation|0|||
30822481|NCT03131453|58843818|FG000|Overall Study|Study terminated by Sponsor|424|||
30822482|NCT03131453|58843819|FG001|Overall Study|Study terminated by Sponsor|222|||
30822483|NCT03131453|58843820|FG002|Overall Study|Study terminated by Sponsor|438|||
30822484|NCT03131453|58843818|FG000|Overall Study|Withdrawal by Subject|18|||
30822485|NCT03131453|58843819|FG001|Overall Study|Withdrawal by Subject|7|||
30822486|NCT03131453|58843820|FG002|Overall Study|Withdrawal by Subject|13|||
30822487|NCT03131453|58843818|FG000|Overall Study|Adverse Event|10|||
30822488|NCT03131453|58843819|FG001|Overall Study|Adverse Event|3|||
30822489|NCT03131453|58843820|FG002|Overall Study|Adverse Event|3|||
30822490|NCT03131453|58843818|FG000|Overall Study|Lost to Follow-up|1|||
30822491|NCT03131453|58843819|FG001|Overall Study|Lost to Follow-up|0|||
30822492|NCT03131453|58843820|FG002|Overall Study|Lost to Follow-up|1|||
30822493|NCT03131453|58843818|FG000|Overall Study|Physician Decision|1|||
30822494|NCT03131453|58843819|FG001|Overall Study|Physician Decision|0|||
30822495|NCT03131453|58843820|FG002|Overall Study|Physician Decision|1|||
30822496|NCT03131453|58843818|FG000|Overall Study|Non-compliance with study treatment|1|||
30822497|NCT03131453|58843819|FG001|Overall Study|Non-compliance with study treatment|0|||
30822498|NCT03131453|58843820|FG002|Overall Study|Non-compliance with study treatment|0|||
30822499|NCT03131453|58843818|FG000|Overall Study|Technical problems|1|||
30822500|NCT03131453|58843819|FG001|Overall Study|Technical problems|0|||
30822501|NCT03131453|58843820|FG002|Overall Study|Technical problems|0|||
30822502|NCT03131453|58843818|FG000|Overall Study|Protocol deviation|0|||
30822503|NCT03131453|58843819|FG001|Overall Study|Protocol deviation|1|||
30822504|NCT03131453|58843820|FG002|Overall Study|Protocol deviation|0|||
30822505|NCT02942277|58843848|FG000|Year 1|Withdrawal by Subject|0|||
30822506|NCT02942277|58843849|FG001|Year 1|Withdrawal by Subject|0|||
30822507|NCT02942277|58843850|FG002|Year 1|Withdrawal by Subject|0|||
30822508|NCT02942277|58843851|FG003|Year 1|Withdrawal by Subject|0|||
30822509|NCT02942277|58843852|FG004|Year 1|Withdrawal by Subject|1|||
30822510|NCT02942277|58843853|FG005|Year 1|Withdrawal by Subject|3|||
30822511|NCT02942277|58843854|FG006|Year 1|Withdrawal by Subject|0|||
30822512|NCT02942277|58843855|FG007|Year 1|Withdrawal by Subject|1|||
30822513|NCT02942277|58843856|FG008|Year 1|Withdrawal by Subject|0|||
30822514|NCT02942277|58843857|FG009|Year 1|Withdrawal by Subject|0|||
30914017|NCT02164916|58949451|FG000|Overall Study|Not eligible|2|||
30822515|NCT02942277|58843858|FG010|Year 1|Withdrawal by Subject|3|||
30822516|NCT02942277|58843848|FG000|Year 1|Travel|0|||
30822517|NCT02942277|58843849|FG001|Year 1|Travel|1|||
30822518|NCT02942277|58843850|FG002|Year 1|Travel|0|||
30822519|NCT02942277|58843851|FG003|Year 1|Travel|0|||
30914018|NCT02164916|58949452|FG001|Overall Study|Not eligible|5|||
30914019|NCT02222558|58949463|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
30822520|NCT02942277|58843852|FG004|Year 1|Travel|4|||
30822521|NCT02942277|58843853|FG005|Year 1|Travel|5|||
30822522|NCT02942277|58843854|FG006|Year 1|Travel|0|||
30822523|NCT02942277|58843855|FG007|Year 1|Travel|0|||
30822524|NCT02942277|58843856|FG008|Year 1|Travel|0|||
30822525|NCT02942277|58843857|FG009|Year 1|Travel|0|||
30822526|NCT02942277|58843858|FG010|Year 1|Travel|8|||
30822527|NCT02942277|58843848|FG000|Year 1|Joined Army|0|||
30822528|NCT02942277|58843849|FG001|Year 1|Joined Army|1|||
30822529|NCT02942277|58843850|FG002|Year 1|Joined Army|0|||
30914020|NCT02222558|58949464|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
30914021|NCT02222558|58949465|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
30914022|NCT02222558|58949466|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
30914023|NCT02222558|58949467|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
30914024|NCT02222558|58949468|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
30914025|NCT02222558|58949463|FG000|Period 3|Withdrawal by Subject|0|||
30914026|NCT02222558|58949464|FG001|Period 3|Withdrawal by Subject|0|||
30914027|NCT02222558|58949465|FG002|Period 3|Withdrawal by Subject|0|||
30914028|NCT02222558|58949466|FG003|Period 3|Withdrawal by Subject|0|||
30914029|NCT02222558|58949467|FG004|Period 3|Withdrawal by Subject|0|||
30914030|NCT02222558|58949468|FG005|Period 3|Withdrawal by Subject|1|||
30914031|NCT02188784|58949484|FG000|Overall Study|Death|3|||
30914032|NCT02188784|58949485|FG001|Overall Study|Death|1|||
30914033|NCT02188784|58949484|FG000|Overall Study|Lost to Follow-up|1|||
30914034|NCT02188784|58949485|FG001|Overall Study|Lost to Follow-up|0|||
30914035|NCT02188784|58949484|FG000|Overall Study|Withdrawal by Subject|3|||
30914036|NCT02188784|58949485|FG001|Overall Study|Withdrawal by Subject|9|||
30914037|NCT02188784|58949484|FG000|Overall Study|Physician Decision|2|||
30822530|NCT02942277|58843851|FG003|Year 1|Joined Army|0|||
30822531|NCT02942277|58843852|FG004|Year 1|Joined Army|0|||
30822532|NCT02942277|58843853|FG005|Year 1|Joined Army|0|||
30822533|NCT02942277|58843854|FG006|Year 1|Joined Army|0|||
30822534|NCT02942277|58843855|FG007|Year 1|Joined Army|0|||
30822535|NCT02942277|58843856|FG008|Year 1|Joined Army|0|||
30822536|NCT02942277|58843857|FG009|Year 1|Joined Army|0|||
30822537|NCT02942277|58843858|FG010|Year 1|Joined Army|0|||
30822538|NCT02942277|58843848|FG000|Year 1|Subject met withdrawal criteria|0|||
30822539|NCT02942277|58843849|FG001|Year 1|Subject met withdrawal criteria|0|||
30822540|NCT02942277|58843850|FG002|Year 1|Subject met withdrawal criteria|0|||
30822541|NCT02942277|58843851|FG003|Year 1|Subject met withdrawal criteria|1|||
30822542|NCT02942277|58843852|FG004|Year 1|Subject met withdrawal criteria|0|||
30822543|NCT02942277|58843853|FG005|Year 1|Subject met withdrawal criteria|0|||
30822544|NCT02942277|58843854|FG006|Year 1|Subject met withdrawal criteria|0|||
30822545|NCT02942277|58843855|FG007|Year 1|Subject met withdrawal criteria|0|||
30822546|NCT02942277|58843856|FG008|Year 1|Subject met withdrawal criteria|0|||
30822547|NCT02942277|58843857|FG009|Year 1|Subject met withdrawal criteria|0|||
30822548|NCT02942277|58843858|FG010|Year 1|Subject met withdrawal criteria|0|||
30822549|NCT02942277|58843848|FG000|Year 1|Lost to Follow-up|0|||
30822550|NCT02942277|58843849|FG001|Year 1|Lost to Follow-up|0|||
30822551|NCT02942277|58843850|FG002|Year 1|Lost to Follow-up|0|||
30822552|NCT02942277|58843851|FG003|Year 1|Lost to Follow-up|0|||
30822553|NCT02942277|58843852|FG004|Year 1|Lost to Follow-up|1|||
30822554|NCT02942277|58843853|FG005|Year 1|Lost to Follow-up|0|||
30822555|NCT02942277|58843854|FG006|Year 1|Lost to Follow-up|0|||
30822556|NCT02942277|58843855|FG007|Year 1|Lost to Follow-up|0|||
30822557|NCT02942277|58843856|FG008|Year 1|Lost to Follow-up|0|||
30822558|NCT02942277|58843857|FG009|Year 1|Lost to Follow-up|0|||
30822559|NCT02942277|58843858|FG010|Year 1|Lost to Follow-up|2|||
30822560|NCT02942277|58843848|FG000|Year 1|Protocol Violation|0|||
30822561|NCT02942277|58843849|FG001|Year 1|Protocol Violation|0|||
30822562|NCT02942277|58843850|FG002|Year 1|Protocol Violation|0|||
30822563|NCT02942277|58843851|FG003|Year 1|Protocol Violation|0|||
30822564|NCT02942277|58843852|FG004|Year 1|Protocol Violation|1|||
30822565|NCT02942277|58843853|FG005|Year 1|Protocol Violation|1|||
30822566|NCT02942277|58843854|FG006|Year 1|Protocol Violation|0|||
30822567|NCT02942277|58843855|FG007|Year 1|Protocol Violation|0|||
30822568|NCT02942277|58843856|FG008|Year 1|Protocol Violation|0|||
30822569|NCT02942277|58843857|FG009|Year 1|Protocol Violation|0|||
30822570|NCT02942277|58843858|FG010|Year 1|Protocol Violation|2|||
30822571|NCT02942277|58843848|FG000|Year 1|Pregnancy|0|||
30822572|NCT02942277|58843849|FG001|Year 1|Pregnancy|0|||
30822573|NCT02942277|58843850|FG002|Year 1|Pregnancy|0|||
30822574|NCT02942277|58843851|FG003|Year 1|Pregnancy|0|||
30822575|NCT02942277|58843852|FG004|Year 1|Pregnancy|0|||
30822576|NCT02942277|58843853|FG005|Year 1|Pregnancy|1|||
30914038|NCT02188784|58949485|FG001|Overall Study|Physician Decision|3|||
30914039|NCT02222246|58949508|FG000|Overall Study|No Emergency Department Visits|27|||
30914040|NCT02222246|58949509|FG001|Overall Study|No Emergency Department Visits|26|||
30822577|NCT02942277|58843854|FG006|Year 1|Pregnancy|0|||
30822578|NCT02942277|58843855|FG007|Year 1|Pregnancy|0|||
30822579|NCT02942277|58843856|FG008|Year 1|Pregnancy|0|||
30822580|NCT02942277|58843857|FG009|Year 1|Pregnancy|0|||
30822581|NCT02942277|58843858|FG010|Year 1|Pregnancy|0|||
30822582|NCT02942277|58843848|FG000|Year 2|Lost to Follow-up|0|||
30822583|NCT02942277|58843849|FG001|Year 2|Lost to Follow-up|0|||
30822584|NCT02942277|58843850|FG002|Year 2|Lost to Follow-up|0|||
30822585|NCT02942277|58843851|FG003|Year 2|Lost to Follow-up|0|||
30822586|NCT02942277|58843852|FG004|Year 2|Lost to Follow-up|2|||
30822587|NCT02942277|58843853|FG005|Year 2|Lost to Follow-up|1|||
30822588|NCT02942277|58843854|FG006|Year 2|Lost to Follow-up|0|||
30822589|NCT02942277|58843855|FG007|Year 2|Lost to Follow-up|0|||
30822590|NCT02942277|58843856|FG008|Year 2|Lost to Follow-up|0|||
30822591|NCT02942277|58843857|FG009|Year 2|Lost to Follow-up|0|||
30822592|NCT02942277|58843858|FG010|Year 2|Lost to Follow-up|0|||
30822593|NCT02942277|58843848|FG000|Year 2|Did not rescreen|0|||
30822594|NCT02942277|58843849|FG001|Year 2|Did not rescreen|0|||
30822595|NCT02942277|58843850|FG002|Year 2|Did not rescreen|1|||
30822596|NCT02942277|58843851|FG003|Year 2|Did not rescreen|1|||
30822597|NCT02942277|58843852|FG004|Year 2|Did not rescreen|9|||
30822598|NCT02942277|58843853|FG005|Year 2|Did not rescreen|6|||
30822599|NCT02942277|58843854|FG006|Year 2|Did not rescreen|0|||
30822600|NCT02942277|58843855|FG007|Year 2|Did not rescreen|1|||
30822601|NCT02942277|58843856|FG008|Year 2|Did not rescreen|0|||
30822602|NCT02942277|58843857|FG009|Year 2|Did not rescreen|0|||
30822603|NCT02942277|58843858|FG010|Year 2|Did not rescreen|21|||
30822604|NCT02942277|58843848|FG000|Year 2|Met withdrawal criteria|0|||
30822605|NCT02942277|58843849|FG001|Year 2|Met withdrawal criteria|0|||
30822606|NCT02942277|58843850|FG002|Year 2|Met withdrawal criteria|0|||
30822607|NCT02942277|58843851|FG003|Year 2|Met withdrawal criteria|0|||
30822608|NCT02942277|58843852|FG004|Year 2|Met withdrawal criteria|1|||
30822609|NCT02942277|58843853|FG005|Year 2|Met withdrawal criteria|2|||
30822610|NCT02942277|58843854|FG006|Year 2|Met withdrawal criteria|0|||
30822611|NCT02942277|58843855|FG007|Year 2|Met withdrawal criteria|0|||
30822612|NCT02942277|58843856|FG008|Year 2|Met withdrawal criteria|0|||
30822613|NCT02942277|58843857|FG009|Year 2|Met withdrawal criteria|0|||
30822614|NCT02942277|58843858|FG010|Year 2|Met withdrawal criteria|1|||
30822615|NCT02942277|58843848|FG000|Year 2|Travel|0|||
30822616|NCT02942277|58843849|FG001|Year 2|Travel|1|||
30822617|NCT02942277|58843850|FG002|Year 2|Travel|0|||
30822618|NCT02942277|58843851|FG003|Year 2|Travel|0|||
30822619|NCT02942277|58843852|FG004|Year 2|Travel|0|||
30822620|NCT02942277|58843853|FG005|Year 2|Travel|1|||
30822621|NCT02942277|58843854|FG006|Year 2|Travel|0|||
30822622|NCT02942277|58843855|FG007|Year 2|Travel|0|||
30822623|NCT02942277|58843856|FG008|Year 2|Travel|0|||
30822624|NCT02942277|58843857|FG009|Year 2|Travel|1|||
30822625|NCT02942277|58843858|FG010|Year 2|Travel|3|||
30822626|NCT02942277|58843848|FG000|Year 2|Non-compliant|0|||
30822627|NCT02942277|58843849|FG001|Year 2|Non-compliant|0|||
30822628|NCT02942277|58843850|FG002|Year 2|Non-compliant|0|||
30822629|NCT02942277|58843851|FG003|Year 2|Non-compliant|0|||
30822630|NCT02942277|58843852|FG004|Year 2|Non-compliant|1|||
30822631|NCT02942277|58843853|FG005|Year 2|Non-compliant|1|||
30822632|NCT02942277|58843854|FG006|Year 2|Non-compliant|0|||
30822633|NCT02942277|58843855|FG007|Year 2|Non-compliant|0|||
30822634|NCT02942277|58843856|FG008|Year 2|Non-compliant|0|||
30822635|NCT02942277|58843857|FG009|Year 2|Non-compliant|0|||
30822636|NCT02942277|58843858|FG010|Year 2|Non-compliant|0|||
30822637|NCT02942277|58843848|FG000|Year 2|Withdrawal by Subject|0|||
30822638|NCT02942277|58843849|FG001|Year 2|Withdrawal by Subject|0|||
30822639|NCT02942277|58843850|FG002|Year 2|Withdrawal by Subject|0|||
30822640|NCT02942277|58843851|FG003|Year 2|Withdrawal by Subject|0|||
30822641|NCT02942277|58843852|FG004|Year 2|Withdrawal by Subject|0|||
30822642|NCT02942277|58843853|FG005|Year 2|Withdrawal by Subject|0|||
30822643|NCT02942277|58843854|FG006|Year 2|Withdrawal by Subject|1|||
30822644|NCT02942277|58843855|FG007|Year 2|Withdrawal by Subject|0|||
30822645|NCT02942277|58843856|FG008|Year 2|Withdrawal by Subject|0|||
30822646|NCT02942277|58843857|FG009|Year 2|Withdrawal by Subject|0|||
30822647|NCT02942277|58843858|FG010|Year 2|Withdrawal by Subject|0|||
30822648|NCT02859324|58843909|FG000|Overall Study|Death|4|||
30822649|NCT02859324|58843910|FG001|Overall Study|Death|6|||
30822650|NCT02859324|58843911|FG002|Overall Study|Death|5|||
30822651|NCT02859324|58843909|FG000|Overall Study|Other reasons|3|||
30822652|NCT02859324|58843910|FG001|Overall Study|Other reasons|3|||
30822653|NCT02859324|58843911|FG002|Overall Study|Other reasons|0|||
30822654|NCT02143063|58843922|FG000|Overall Study|Lost to Follow-up|16|||
30822655|NCT02143063|58843923|FG001|Overall Study|Lost to Follow-up|28|||
30822656|NCT02143063|58843924|FG002|Overall Study|Lost to Follow-up|29|||
30822657|NCT02143063|58843922|FG000|Overall Study|Withdrawal by Subject|0|||
30822658|NCT02143063|58843923|FG001|Overall Study|Withdrawal by Subject|1|||
30822659|NCT02143063|58843924|FG002|Overall Study|Withdrawal by Subject|0|||
30822660|NCT02143063|58843922|FG000|Overall Study|Death|0|||
30822661|NCT02143063|58843923|FG001|Overall Study|Death|1|||
30822662|NCT02143063|58843924|FG002|Overall Study|Death|1|||
30822663|NCT02859246|58843932|FG000|Overall Study|Screen fails|3|||
30822664|NCT02859246|58843932|FG000|Overall Study|Adverse Event|1|||
30822665|NCT02859246|58843932|FG000|Overall Study|Withdrawal by Subject|1|||
30822666|NCT01083433|58843955|FG000|Overall Study|Lost to Follow-up|2|||
30822667|NCT01083433|58843956|FG001|Overall Study|Lost to Follow-up|1|||
30822668|NCT01083433|58843957|FG002|Overall Study|Lost to Follow-up|1|||
30822669|NCT01083433|58843955|FG000|Overall Study|Withdrawal by Subject|0|||
30822670|NCT01083433|58843956|FG001|Overall Study|Withdrawal by Subject|5|||
30822671|NCT01083433|58843957|FG002|Overall Study|Withdrawal by Subject|3|||
30822672|NCT01083433|58843955|FG000|Overall Study|Pregnancy|0|||
30822673|NCT01083433|58843956|FG001|Overall Study|Pregnancy|0|||
30822674|NCT01083433|58843957|FG002|Overall Study|Pregnancy|1|||
30822675|NCT02791490|58843971|FG000|Overall Study|Lost to Follow-up|1|||
30822676|NCT02791490|58843972|FG001|Overall Study|Lost to Follow-up|2|||
30822677|NCT02791490|58843971|FG000|Overall Study|Withdrawal by Subject|2|||
30822678|NCT02791490|58843972|FG001|Overall Study|Withdrawal by Subject|6|||
30822679|NCT02507973|58843987|FG000|Overall Study|Adverse Event|1|||
30822680|NCT02425644|58843995|FG000|Overall Study|Lost to Follow-up|2|||
30822681|NCT02425644|58843996|FG001|Overall Study|Lost to Follow-up|3|||
30822682|NCT02425644|58843995|FG000|Overall Study|Withdrawal by Subject|41|||
30822683|NCT02425644|58843996|FG001|Overall Study|Withdrawal by Subject|36|||
30822684|NCT02425644|58843995|FG000|Overall Study|Lack of Efficacy|3|||
30822685|NCT02425644|58843996|FG001|Overall Study|Lack of Efficacy|10|||
30822686|NCT02425644|58843995|FG000|Overall Study|Adverse Event|13|||
30822687|NCT02425644|58843996|FG001|Overall Study|Adverse Event|3|||
30822688|NCT02425644|58843995|FG000|Overall Study|Death|0|||
30822689|NCT02425644|58843996|FG001|Overall Study|Death|2|||
30822690|NCT02425644|58843995|FG000|Overall Study|Other|18|||
30822691|NCT02425644|58843996|FG001|Overall Study|Other|17|||
30822692|NCT02861664|58844008|FG000|Overall Study|Withdrawal of Consent|0|||
30822693|NCT02861664|58844009|FG001|Overall Study|Withdrawal of Consent|1|||
30822694|NCT01307787|58844017|FG000|Overall Study|Withdrawal by Subject|2|||
30822695|NCT01307787|58844018|FG001|Overall Study|Withdrawal by Subject|0|||
30822696|NCT03284853|58844031|FG000|Overall Study|Adverse Event|40|||
30822697|NCT03284853|58844032|FG001|Overall Study|Adverse Event|4|||
30822698|NCT03284853|58844031|FG000|Overall Study|Withdrawal by Subject|5|||
30822699|NCT03284853|58844032|FG001|Overall Study|Withdrawal by Subject|1|||
30822700|NCT03284853|58844031|FG000|Overall Study|Lost to Follow-up|1|||
30822701|NCT03284853|58844032|FG001|Overall Study|Lost to Follow-up|0|||
30822702|NCT03284853|58844031|FG000|Overall Study|Lack of Efficacy|1|||
30822703|NCT03284853|58844032|FG001|Overall Study|Lack of Efficacy|0|||
30822704|NCT03284853|58844031|FG000|Overall Study|Disallowed Concurrent Medication|1|||
30822705|NCT03284853|58844032|FG001|Overall Study|Disallowed Concurrent Medication|1|||
30822706|NCT03284853|58844031|FG000|Overall Study|Protocol Violation|3|||
30822707|NCT03284853|58844032|FG001|Overall Study|Protocol Violation|3|||
30822708|NCT03284853|58844031|FG000|Overall Study|Death|0|||
30822709|NCT03284853|58844032|FG001|Overall Study|Death|1|||
30822710|NCT03284853|58844031|FG000|Overall Study|Other - Reason not reported in CSR|4|||
30822711|NCT03284853|58844032|FG001|Overall Study|Other - Reason not reported in CSR|3|||
30822712|NCT03055221|58844038|FG000|Overall Study|Adverse Event|2|||
30822713|NCT03055221|58844038|FG000|Overall Study|Withdrawal by Subject|4|||
30822714|NCT03055221|58844038|FG000|Overall Study|Death|6|||
30822715|NCT03055221|58844038|FG000|Overall Study|Physician Decision|1|||
30822716|NCT03055221|58844038|FG000|Overall Study|Study terminated by Sponsor|3|||
30822717|NCT04497415|58844064|FG000|Overall Study|Lost to Follow-up|43|||
30822718|NCT04497415|58844065|FG001|Overall Study|Lost to Follow-up|27|||
30822719|NCT03125941|58844073|FG000|Overall Study|did not receive intervention|1|||
30822720|NCT03125941|58844074|FG001|Overall Study|did not receive intervention|2|||
30822721|NCT02774889|58844082|FG000|Overall Study|Lost to Follow-up|2|||
30822722|NCT02774889|58844083|FG001|Overall Study|Lost to Follow-up|1|||
30822723|NCT03125629|58844091|FG000|Overall Study|Withdrawal by Subject|2|||
30822724|NCT03125629|58844091|FG000|Overall Study|Equipment malfunction|1|||
30822725|NCT03125395|58844103|FG000|Overall Study|Adverse Event|2|||
30822726|NCT03125395|58844103|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
30822727|NCT03125395|58844103|FG000|Overall Study|Physician Decision|2|||
30822728|NCT03125395|58844103|FG000|Overall Study|Commercial drug is available|5|||
30822729|NCT00261807|58844117|FG000|Overall Study|Lost to Follow-up|2|||
30822730|NCT00261807|58844117|FG000|Overall Study|Adverse Event|2|||
30822731|NCT00261807|58844117|FG000|Overall Study|Death|1|||
30822732|NCT00261807|58844117|FG000|Overall Study|Protocol Violation|2|||
30822733|NCT02820753|58844124|FG000|2 Month|Withdrawal by Subject|3|||
30822734|NCT02820753|58844125|FG001|2 Month|Withdrawal by Subject|3|||
30822735|NCT02820753|58844124|FG000|2 Month|Lost to Follow-up|24|||
30822736|NCT02820753|58844125|FG001|2 Month|Lost to Follow-up|26|||
30822737|NCT02820753|58844124|FG000|2 Month|Stopped per NIH Hold|51|||
30822738|NCT02820753|58844125|FG001|2 Month|Stopped per NIH Hold|13|||
30822739|NCT02820753|58844124|FG000|6 Month|Withdrawal by Subject|2|||
30822740|NCT02820753|58844125|FG001|6 Month|Withdrawal by Subject|2|||
30822741|NCT02820753|58844124|FG000|6 Month|Lost to Follow-up|20|||
30822742|NCT02820753|58844125|FG001|6 Month|Lost to Follow-up|27|||
30822743|NCT02820753|58844124|FG000|6 Month|Stopped per NIH Hold|81|||
30822744|NCT02820753|58844125|FG001|6 Month|Stopped per NIH Hold|81|||
30822745|NCT02820753|58844124|FG000|6 Month|Death|0|||
30822746|NCT02820753|58844125|FG001|6 Month|Death|1|||
30914041|NCT02222246|58949508|FG000|Overall Study|Physician Decision|0|||
30822747|NCT02861586|58844139|FG000|Overall Study|Withdrawal by Subject|1|||
30822748|NCT02861586|58844140|FG001|Overall Study|Withdrawal by Subject|2|||
30822749|NCT02861586|58844141|FG002|Overall Study|Withdrawal by Subject|0|||
30822750|NCT02861586|58844142|FG003|Overall Study|Withdrawal by Subject|0|||
30822751|NCT02861586|58844143|FG004|Overall Study|Withdrawal by Subject|0|||
30822752|NCT02861586|58844144|FG005|Overall Study|Withdrawal by Subject|1|||
30822753|NCT02861586|58844145|FG006|Overall Study|Withdrawal by Subject|1|||
30822754|NCT02861586|58844146|FG007|Overall Study|Withdrawal by Subject|0|||
30822755|NCT02861586|58844139|FG000|Overall Study|Lost to Follow-up|3|||
30822756|NCT02861586|58844140|FG001|Overall Study|Lost to Follow-up|1|||
30822757|NCT02861586|58844141|FG002|Overall Study|Lost to Follow-up|1|||
30822758|NCT02861586|58844142|FG003|Overall Study|Lost to Follow-up|0|||
30822759|NCT02861586|58844143|FG004|Overall Study|Lost to Follow-up|0|||
30822760|NCT02861586|58844144|FG005|Overall Study|Lost to Follow-up|3|||
30822761|NCT02861586|58844145|FG006|Overall Study|Lost to Follow-up|0|||
30822762|NCT02861586|58844146|FG007|Overall Study|Lost to Follow-up|0|||
30822763|NCT02861586|58844139|FG000|Overall Study|Adverse Event|0|||
30822764|NCT02861586|58844140|FG001|Overall Study|Adverse Event|0|||
30822765|NCT02861586|58844141|FG002|Overall Study|Adverse Event|0|||
30822766|NCT02861586|58844142|FG003|Overall Study|Adverse Event|0|||
30822767|NCT02861586|58844143|FG004|Overall Study|Adverse Event|0|||
30822768|NCT02861586|58844144|FG005|Overall Study|Adverse Event|1|||
30822769|NCT02861586|58844145|FG006|Overall Study|Adverse Event|0|||
30822770|NCT02861586|58844146|FG007|Overall Study|Adverse Event|0|||
30822771|NCT03120949|58844182|FG000|Overall Study|randomized in error|1|||
30822772|NCT03120949|58844183|FG001|Overall Study|randomized in error|0|||
30822773|NCT03120949|58844182|FG000|Overall Study|Death|13|||
30822774|NCT03120949|58844183|FG001|Overall Study|Death|13|||
30822775|NCT03120949|58844182|FG000|Overall Study|Lost to Follow-up|23|||
30822776|NCT03120949|58844183|FG001|Overall Study|Lost to Follow-up|13|||
30822777|NCT03120949|58844182|FG000|Overall Study|Withdrawal by Subject|139|||
30822778|NCT03120949|58844183|FG001|Overall Study|Withdrawal by Subject|124|||
30822779|NCT03120949|58844182|FG000|Overall Study|Covid-19|43|||
30822780|NCT03120949|58844183|FG001|Overall Study|Covid-19|34|||
30822781|NCT03120949|58844182|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
30822782|NCT03120949|58844183|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
30822783|NCT03120949|58844182|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
30822784|NCT03120949|58844183|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
30822785|NCT03120949|58844182|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
30822786|NCT03120949|58844183|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
30822787|NCT03120949|58844182|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
30914042|NCT02222246|58949509|FG001|Overall Study|Physician Decision|1|||
30914043|NCT02188160|58949519|FG000|Overall Study|Adverse Event|1|||
30822788|NCT03120949|58844183|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
30822789|NCT03120949|58844182|FG000|Overall Study|Site was closed|2|||
30822790|NCT03120949|58844183|FG001|Overall Study|Site was closed|3|||
30822791|NCT03120949|58844182|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
30822792|NCT03120949|58844183|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
30822793|NCT03120949|58844182|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
30822794|NCT03120949|58844183|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
30822795|NCT03120949|58844182|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
30822796|NCT03120949|58844183|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
30822797|NCT03120949|58844182|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
30822798|NCT03120949|58844183|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
30822799|NCT03120949|58844182|FG000|Overall Study|Other: Adverse Event|0|||
30822800|NCT03120949|58844183|FG001|Overall Study|Other: Adverse Event|1|||
30822801|NCT03120949|58844182|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
30914044|NCT02188160|58949520|FG001|Overall Study|Adverse Event|0|||
30914045|NCT02188160|58949519|FG000|Overall Study|Use of an excluded medication|0|||
30914046|NCT02188160|58949520|FG001|Overall Study|Use of an excluded medication|1|||
30914047|NCT02220998|58949528|FG000|Overall Study|Randomized but Never Treated|1|||
30753072|NCT00255008|58762864|FG000|Overall Study|Lost to Follow-up|1|||
30753073|NCT00255008|58762865|FG001|Overall Study|Lost to Follow-up|0|||
30753074|NCT00255008|58762866|FG002|Overall Study|Lost to Follow-up|1|||
30753075|NCT00255008|58762867|FG003|Overall Study|Lost to Follow-up|2|||
30753076|NCT00255008|58762864|FG000|Overall Study|Did not meet viral reduction criteria|4|||
30753077|NCT00255008|58762865|FG001|Overall Study|Did not meet viral reduction criteria|5|||
30753078|NCT00255008|58762866|FG002|Overall Study|Did not meet viral reduction criteria|0|||
30753079|NCT00255008|58762867|FG003|Overall Study|Did not meet viral reduction criteria|1|||
30753080|NCT00255008|58762864|FG000|Overall Study|Withdrew consent|0|||
30753081|NCT00255008|58762865|FG001|Overall Study|Withdrew consent|0|||
30753082|NCT00255008|58762866|FG002|Overall Study|Withdrew consent|2|||
30753083|NCT00255008|58762867|FG003|Overall Study|Withdrew consent|0|||
30753084|NCT00255008|58762864|FG000|Overall Study|Sponsor request|18|||
30753085|NCT00255008|58762865|FG001|Overall Study|Sponsor request|3|||
30753086|NCT00255008|58762866|FG002|Overall Study|Sponsor request|8|||
30822802|NCT03120949|58844183|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
30822803|NCT03120949|58844182|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
30822804|NCT03120949|58844183|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
30822805|NCT03120949|58844182|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
30822806|NCT03120949|58844183|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
30822807|NCT03120949|58844182|FG000|Overall Study|Personal Reasons|0|||
30822808|NCT03120949|58844183|FG001|Overall Study|Personal Reasons|1|||
30822809|NCT03120949|58844182|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
30822810|NCT03120949|58844183|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
30822811|NCT03120949|58844182|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
30822812|NCT03120949|58844183|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
30822813|NCT03120949|58844182|FG000|Overall Study|Compliance With Medication|0|||
30822814|NCT03120949|58844183|FG001|Overall Study|Compliance With Medication|1|||
30822815|NCT03120949|58844182|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
30822816|NCT03120949|58844183|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
30822817|NCT03120949|58844182|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
30822818|NCT03120949|58844183|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
30822819|NCT03120949|58844182|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
30822820|NCT03120949|58844183|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
30822821|NCT03124537|58844202|FG000|Overall Study|Lost to Follow-up|3|||
30822822|NCT03124537|58844203|FG001|Overall Study|Lost to Follow-up|5|||
30822823|NCT03124537|58844202|FG000|Overall Study|App Crash, Incomplete Data|7|||
30822824|NCT03124537|58844203|FG001|Overall Study|App Crash, Incomplete Data|8|||
30822825|NCT03118297|58844211|FG000|Overall Study|Lost to Follow-up|0|||
30822826|NCT03118297|58844212|FG001|Overall Study|Lost to Follow-up|2|||
30822827|NCT03117361|58844218|FG000|Overall Study|Progressive disease|5|||
30822828|NCT03117361|58844218|FG000|Overall Study|Death|1|||
30822829|NCT03117361|58844218|FG000|Overall Study|Physician Decision|2|||
30822830|NCT03117361|58844218|FG000|Overall Study|On study treatment at the end of study|1|||
30822831|NCT03117361|58844218|FG000|Overall Study|Treatment-related adverse event|1|||
30822832|NCT01368614|58844222|FG000|Screening Period|Screen Failure|58|||
30822833|NCT01368614|58844223|FG001|Screening Period|Screen Failure|0|||
30822834|NCT01368614|58844224|FG002|Screening Period|Screen Failure|0|||
30822835|NCT01368614|58844225|FG003|Screening Period|Screen Failure|0|||
30822836|NCT01368614|58844222|FG000|Study Period|Withdrawal by Subject|0|||
30822837|NCT01368614|58844223|FG001|Study Period|Withdrawal by Subject|1|||
30822838|NCT01368614|58844224|FG002|Study Period|Withdrawal by Subject|1|||
30822839|NCT01368614|58844225|FG003|Study Period|Withdrawal by Subject|3|||
30822840|NCT01368614|58844222|FG000|Study Period|Lost to Follow-up|0|||
30822841|NCT01368614|58844223|FG001|Study Period|Lost to Follow-up|0|||
30822842|NCT01368614|58844224|FG002|Study Period|Lost to Follow-up|1|||
30822843|NCT01368614|58844225|FG003|Study Period|Lost to Follow-up|0|||
30822844|NCT03053427|58844235|FG000|Overall Study|Adverse Event|4|||
30822845|NCT03053427|58844236|FG001|Overall Study|Adverse Event|4|||
30822846|NCT03053427|58844235|FG000|Overall Study|Lack of Efficacy|1|||
30822847|NCT03053427|58844236|FG001|Overall Study|Lack of Efficacy|3|||
30822848|NCT03053427|58844235|FG000|Overall Study|Lost to Follow-up|2|||
30822849|NCT03053427|58844236|FG001|Overall Study|Lost to Follow-up|2|||
30822850|NCT03053427|58844235|FG000|Overall Study|Worsening of the target disease|0|||
30822851|NCT03053427|58844236|FG001|Overall Study|Worsening of the target disease|1|||
30822852|NCT03053427|58844235|FG000|Overall Study|Protocol Deviation|3|||
30822853|NCT03053427|58844236|FG001|Overall Study|Protocol Deviation|3|||
30822854|NCT03053427|58844235|FG000|Overall Study|Withdrawal by Subject|3|||
30822855|NCT03053427|58844236|FG001|Overall Study|Withdrawal by Subject|2|||
30822856|NCT03053427|58844235|FG000|Overall Study|Miscellaneous|0|||
30822857|NCT03053427|58844236|FG001|Overall Study|Miscellaneous|1|||
30822858|NCT03052959|58844253|FG000|Overall Study|Lost to Follow-up|4|||
30822859|NCT03052959|58844254|FG001|Overall Study|Lost to Follow-up|5|||
30822860|NCT03120013|58844261|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
30822861|NCT03120013|58844262|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
30822862|NCT01845649|58844270|FG000|Overall Study|Adverse Event|7|||
30753087|NCT00255008|58762867|FG003|Overall Study|Sponsor request|17|||
30914048|NCT02220998|58949529|FG001|Overall Study|Randomized but Never Treated|2|||
30753088|NCT00255008|58762864|FG000|Overall Study|Adverse lab experience|1|||
30753089|NCT00255008|58762865|FG001|Overall Study|Adverse lab experience|0|||
30753090|NCT00255008|58762866|FG002|Overall Study|Adverse lab experience|0|||
30753091|NCT00255008|58762867|FG003|Overall Study|Adverse lab experience|0|||
30753092|NCT00255008|58762864|FG000|Overall Study|Other|7|||
30753093|NCT00255008|58762865|FG001|Overall Study|Other|0|||
30753094|NCT00255008|58762866|FG002|Overall Study|Other|3|||
30753095|NCT00255008|58762867|FG003|Overall Study|Other|2|||
30753096|NCT03714022|58762879|FG000|Overall Study|Adverse Event|1|||
30822863|NCT01845649|58844271|FG001|Overall Study|Adverse Event|10|||
30822864|NCT01845649|58844270|FG000|Overall Study|Lack of Efficacy|1|||
30822865|NCT01845649|58844271|FG001|Overall Study|Lack of Efficacy|1|||
30822866|NCT01845649|58844270|FG000|Overall Study|Lost to Follow-up|2|||
30822867|NCT01845649|58844271|FG001|Overall Study|Lost to Follow-up|2|||
30822868|NCT01845649|58844270|FG000|Overall Study|Withdrew Consent|12|||
30822869|NCT01845649|58844271|FG001|Overall Study|Withdrew Consent|4|||
30822870|NCT01845649|58844270|FG000|Overall Study|Protocol Deviation|7|||
30822871|NCT01845649|58844271|FG001|Overall Study|Protocol Deviation|4|||
30822872|NCT01845649|58844270|FG000|Overall Study|Reason not Specified|2|||
30822873|NCT01845649|58844271|FG001|Overall Study|Reason not Specified|1|||
30822874|NCT01345929|58844279|FG000|Overall Study|Withdrawal by Subject|9|||
30822875|NCT01345929|58844280|FG001|Overall Study|Withdrawal by Subject|8|||
30822876|NCT01345929|58844279|FG000|Overall Study|Lost to Follow-up|9|||
30822877|NCT01345929|58844280|FG001|Overall Study|Lost to Follow-up|9|||
30822878|NCT01345929|58844279|FG000|Overall Study|Adverse Event|0|||
30822879|NCT01345929|58844280|FG001|Overall Study|Adverse Event|1|||
30822880|NCT01345929|58844279|FG000|Overall Study|Didn't meet eligibility criteria|2|||
30822881|NCT01345929|58844280|FG001|Overall Study|Didn't meet eligibility criteria|0|||
30822882|NCT01345929|58844279|FG000|Overall Study|40,000 CFU/ML|1|||
30822883|NCT01345929|58844280|FG001|Overall Study|40,000 CFU/ML|0|||
30822884|NCT01345929|58844279|FG000|Overall Study|Patient withdrawal|0|||
30822885|NCT01345929|58844280|FG001|Overall Study|Patient withdrawal|1|||
30822886|NCT01343901|58844286|FG000|Overall Study|Death|85|||
30822887|NCT01343901|58844286|FG000|Overall Study|Physician Decision|4|||
30822888|NCT01343901|58844286|FG000|Overall Study|Lost to Follow-up|12|||
30822889|NCT01343901|58844286|FG000|Overall Study|Management by another medical team|11|||
30822890|NCT01343901|58844286|FG000|Overall Study|Participant decision|1|||
30822891|NCT03053271|58844290|FG000|Overall Study|Did not meet randomization criteria|3|||
30822892|NCT03053271|58844290|FG000|Overall Study|Withdrawal by Subject|1|||
30822893|NCT01343823|58844298|FG000|Overall Study|Study Terminated|1|||
30822894|NCT01343823|58844299|FG001|Overall Study|Study Terminated|0|||
30822895|NCT01343823|58844300|FG002|Overall Study|Study Terminated|0|||
30822896|NCT01343823|58844301|FG003|Overall Study|Study Terminated|1|||
30822897|NCT01343823|58844298|FG000|Overall Study|Withdrawal by Subject|1|||
30822898|NCT01343823|58844299|FG001|Overall Study|Withdrawal by Subject|0|||
30822899|NCT01343823|58844300|FG002|Overall Study|Withdrawal by Subject|0|||
30822900|NCT01343823|58844301|FG003|Overall Study|Withdrawal by Subject|0|||
30822901|NCT01318083|58844314|FG000|Overall Study|Adverse Event|4|||
30822902|NCT01318083|58844315|FG001|Overall Study|Adverse Event|1|||
30822903|NCT01318083|58844316|FG002|Overall Study|Adverse Event|2|||
30822904|NCT01318083|58844314|FG000|Overall Study|Withdrawal by Subject|1|||
30822905|NCT01318083|58844315|FG001|Overall Study|Withdrawal by Subject|0|||
30822906|NCT01318083|58844316|FG002|Overall Study|Withdrawal by Subject|2|||
30822907|NCT01318083|58844314|FG000|Overall Study|Lack of Efficacy|0|||
30822908|NCT01318083|58844315|FG001|Overall Study|Lack of Efficacy|0|||
30822909|NCT01318083|58844316|FG002|Overall Study|Lack of Efficacy|1|||
30822910|NCT01318083|58844314|FG000|Overall Study|Treatment Complications|1|||
30822911|NCT01318083|58844315|FG001|Overall Study|Treatment Complications|0|||
30822912|NCT01318083|58844316|FG002|Overall Study|Treatment Complications|0|||
30914049|NCT02220998|58949528|FG000|Overall Study|Death|2|||
30753097|NCT03714022|58762880|FG001|Overall Study|Adverse Event|0|||
30753098|NCT03714022|58762879|FG000|Overall Study|Consent withdrawal|0|||
30753099|NCT03714022|58762880|FG001|Overall Study|Consent withdrawal|1|||
30753100|NCT03714022|58762879|FG000|Overall Study|Lost to Follow-up|3|||
30753101|NCT03714022|58762880|FG001|Overall Study|Lost to Follow-up|2|||
30753102|NCT00143312|58762886|FG000|Overall Study|Death|11|||
30753103|NCT00143312|58762886|FG000|Overall Study|Adverse Event|2|||
30753104|NCT00143312|58762886|FG000|Overall Study|Lost to Follow-up|1|||
30753105|NCT00143312|58762886|FG000|Overall Study|Other|1|||
30753106|NCT00143312|58762886|FG000|Overall Study|Withdrawal by Subject|1|||
30753107|NCT00254540|58762892|FG000|Overall Study|Adverse Event|6|||
30753108|NCT00254540|58762893|FG001|Overall Study|Adverse Event|7|||
30753109|NCT00254540|58762892|FG000|Overall Study|Lack of Efficacy|13|||
30753110|NCT00254540|58762893|FG001|Overall Study|Lack of Efficacy|13|||
30753111|NCT00254540|58762892|FG000|Overall Study|Death|0|||
30753112|NCT00254540|58762893|FG001|Overall Study|Death|1|||
30753113|NCT00254540|58762892|FG000|Overall Study|Laboratory Test Abnormality|0|||
30753114|NCT00254540|58762893|FG001|Overall Study|Laboratory Test Abnormality|1|||
30822913|NCT01318083|58844314|FG000|Overall Study|Lack of Study Medication Compliance|0|||
30822914|NCT01318083|58844315|FG001|Overall Study|Lack of Study Medication Compliance|1|||
30822915|NCT01318083|58844316|FG002|Overall Study|Lack of Study Medication Compliance|0|||
30822916|NCT01376323|58844329|FG000|Overall Study|Adverse Event|1|||
30914050|NCT02220998|58949529|FG001|Overall Study|Death|0|||
30822917|NCT01376323|58844330|FG001|Overall Study|Adverse Event|0|||
30822918|NCT01376323|58844331|FG002|Overall Study|Adverse Event|0|||
30822919|NCT01376323|58844332|FG003|Overall Study|Adverse Event|2|||
30822920|NCT01376323|58844333|FG004|Overall Study|Adverse Event|0|||
30753115|NCT00139776|58762902|FG000|Period I|Did not enter Period II|575|||
30753116|NCT00139776|58762903|FG001|Period I|Did not enter Period II|0|||
30753117|NCT00139776|58762904|FG002|Period I|Did not enter Period II|0|||
30753118|NCT00139776|58762905|FG003|Period I|Did not enter Period II|0|||
30753119|NCT00139776|58762902|FG000|Period II|Not Randomized into Period III|0|||
30753120|NCT00139776|58762903|FG001|Period II|Not Randomized into Period III|322|||
30822921|NCT01376323|58844329|FG000|Overall Study|Lost to Follow-up|0|||
30822922|NCT01376323|58844330|FG001|Overall Study|Lost to Follow-up|0|||
30822923|NCT01376323|58844331|FG002|Overall Study|Lost to Follow-up|0|||
30822924|NCT01376323|58844332|FG003|Overall Study|Lost to Follow-up|2|||
30822925|NCT01376323|58844333|FG004|Overall Study|Lost to Follow-up|0|||
30822926|NCT01376323|58844329|FG000|Overall Study|Physician Decision|1|||
30822927|NCT01376323|58844330|FG001|Overall Study|Physician Decision|0|||
30822928|NCT01376323|58844331|FG002|Overall Study|Physician Decision|2|||
30822929|NCT01376323|58844332|FG003|Overall Study|Physician Decision|1|||
30914051|NCT02220998|58949528|FG000|Overall Study|Lack of Efficacy|0|||
30914052|NCT02220998|58949529|FG001|Overall Study|Lack of Efficacy|5|||
30822930|NCT01376323|58844333|FG004|Overall Study|Physician Decision|1|||
30822931|NCT01376323|58844329|FG000|Overall Study|Withdrawal by Subject|0|||
30822932|NCT01376323|58844330|FG001|Overall Study|Withdrawal by Subject|1|||
30822933|NCT01376323|58844331|FG002|Overall Study|Withdrawal by Subject|1|||
30822934|NCT01376323|58844332|FG003|Overall Study|Withdrawal by Subject|0|||
30822935|NCT01376323|58844333|FG004|Overall Study|Withdrawal by Subject|0|||
30822936|NCT03725293|58844370|FG000|Overall Study|Physician Decision|9|||
30822937|NCT03725293|58844371|FG001|Overall Study|Physician Decision|6|||
30822938|NCT03725293|58844370|FG000|Overall Study|alternative vascular access needs|1|||
30822939|NCT03725293|58844371|FG001|Overall Study|alternative vascular access needs|2|||
30822940|NCT03725293|58844370|FG000|Overall Study|venous anatomy screen failures|2|||
30914053|NCT02220998|58949528|FG000|Overall Study|Lost to Follow-up|4|||
30914054|NCT02220998|58949529|FG001|Overall Study|Lost to Follow-up|4|||
30914055|NCT02220920|58949537|FG000|Overall Study|Adverse Event|1|||
30914056|NCT02220920|58949538|FG001|Overall Study|Adverse Event|0|||
30914057|NCT02220920|58949537|FG000|Overall Study|Lack of Efficacy|0|||
30914058|NCT02220920|58949538|FG001|Overall Study|Lack of Efficacy|1|||
30914059|NCT02220920|58949537|FG000|Overall Study|Withdrawal by Subject|1|||
30914060|NCT02220920|58949538|FG001|Overall Study|Withdrawal by Subject|0|||
30914061|NCT02220920|58949537|FG000|Overall Study|Conflict with the stopping criteria|1|||
30914062|NCT02220920|58949538|FG001|Overall Study|Conflict with the stopping criteria|2|||
30914063|NCT03966053|58949544|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
30914064|NCT01634555|58949557|FG000|Overall Study|Adverse Event|3|||
30914065|NCT01634555|58949557|FG000|Overall Study|Physician Decision|1|||
30914066|NCT01634243|58949564|FG000|Overall Study|Adverse Event|5|||
30914067|NCT01634243|58949565|FG001|Overall Study|Adverse Event|5|||
30914068|NCT01634243|58949564|FG000|Overall Study|Lack of Efficacy|1|||
30914069|NCT01634243|58949565|FG001|Overall Study|Lack of Efficacy|0|||
30914070|NCT01542034|58949582|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
30914071|NCT01542034|58949583|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
30914072|NCT01542034|58949582|FG000|Overall Study|Administrative decision|0|||
30914073|NCT01542034|58949583|FG001|Overall Study|Administrative decision|3|||
30914074|NCT01542034|58949582|FG000|Overall Study|Subject Noncompliance|1|||
30914075|NCT01542034|58949583|FG001|Overall Study|Subject Noncompliance|0|||
30914076|NCT01542034|58949582|FG000|Overall Study|Adverse Event|2|||
30914077|NCT01542034|58949583|FG001|Overall Study|Adverse Event|2|||
30914078|NCT01542034|58949582|FG000|Overall Study|Lost to Follow-up|7|||
30914079|NCT01542034|58949583|FG001|Overall Study|Lost to Follow-up|6|||
30914080|NCT01564732|58949591|FG000|Overall Study|Early termination by the study sponsor|6|||
30914081|NCT01564732|58949592|FG001|Overall Study|Early termination by the study sponsor|5|||
30914082|NCT01541644|58949598|FG000|Overall Study|Withdrawal by Subject|3|||
30753121|NCT00139776|58762904|FG002|Period II|Not Randomized into Period III|0|||
30753122|NCT00139776|58762905|FG003|Period II|Not Randomized into Period III|0|||
30753123|NCT00139776|58762902|FG000|Period III|Adverse Event|0|||
30753124|NCT00139776|58762903|FG001|Period III|Adverse Event|0|||
30753125|NCT00139776|58762904|FG002|Period III|Adverse Event|22|||
30753126|NCT00139776|58762905|FG003|Period III|Adverse Event|23|||
30753127|NCT00139776|58762902|FG000|Period III|Other|0|||
30753128|NCT00139776|58762903|FG001|Period III|Other|0|||
30914083|NCT01582282|58949605|FG000|Overall Study|Adverse Event|1|||
30914084|NCT01582282|58949606|FG001|Overall Study|Adverse Event|1|||
30914085|NCT01582282|58949607|FG002|Overall Study|Adverse Event|0|||
30914086|NCT01582282|58949605|FG000|Overall Study|Lost to Follow-up|1|||
30914087|NCT01582282|58949606|FG001|Overall Study|Lost to Follow-up|0|||
30914088|NCT01582282|58949607|FG002|Overall Study|Lost to Follow-up|0|||
30914089|NCT01582282|58949605|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
30753129|NCT00139776|58762904|FG002|Period III|Other|23|||
30753130|NCT00139776|58762905|FG003|Period III|Other|34|||
30822941|NCT03725293|58844371|FG001|Overall Study|venous anatomy screen failures|1|||
30753131|NCT00139776|58762902|FG000|Period III|Lack of Efficacy|0|||
30822942|NCT01368536|58844380|FG000|Overall Study|Adverse Event|5|||
30914090|NCT01582282|58949606|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
30914091|NCT01582282|58949607|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
30914092|NCT01599650|58949618|FG000|Overall Study|Administrative issue|1|||
30914093|NCT01599650|58949619|FG001|Overall Study|Administrative issue|0|||
30914094|NCT01599650|58949620|FG002|Overall Study|Administrative issue|1|||
30914095|NCT01599650|58949618|FG000|Overall Study|Physician Decision|2|||
30914096|NCT01599650|58949619|FG001|Overall Study|Physician Decision|0|||
30914097|NCT01599650|58949620|FG002|Overall Study|Physician Decision|7|||
30914098|NCT01599650|58949618|FG000|Overall Study|Protocol Violation|0|||
30914099|NCT01599650|58949619|FG001|Overall Study|Protocol Violation|3|||
30914100|NCT01599650|58949620|FG002|Overall Study|Protocol Violation|0|||
30914101|NCT01599650|58949618|FG000|Overall Study|Death|2|||
30914102|NCT01599650|58949619|FG001|Overall Study|Death|1|||
30914103|NCT01599650|58949620|FG002|Overall Study|Death|2|||
30914104|NCT01599650|58949618|FG000|Overall Study|Lost to Follow-up|3|||
30914105|NCT01599650|58949619|FG001|Overall Study|Lost to Follow-up|3|||
30914106|NCT01599650|58949620|FG002|Overall Study|Lost to Follow-up|3|||
30822943|NCT01368536|58844381|FG001|Overall Study|Adverse Event|6|||
30822944|NCT01368536|58844382|FG002|Overall Study|Adverse Event|8|||
30822945|NCT01368536|58844380|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30822946|NCT01368536|58844381|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30822947|NCT01368536|58844382|FG002|Overall Study|Abnormal laboratory value(s)|2|||
30822948|NCT01368536|58844380|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30822949|NCT01368536|58844381|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30822950|NCT01368536|58844382|FG002|Overall Study|Abnormal test procedure result(s)|1|||
30822951|NCT01368536|58844380|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
30822952|NCT01368536|58844381|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30822953|NCT01368536|58844382|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
30822954|NCT01368536|58844380|FG000|Overall Study|No longer required study medication|0|||
30822955|NCT01368536|58844381|FG001|Overall Study|No longer required study medication|0|||
30822956|NCT01368536|58844382|FG002|Overall Study|No longer required study medication|1|||
30822957|NCT01368536|58844380|FG000|Overall Study|Withdrawal by Subject|2|||
30822958|NCT01368536|58844381|FG001|Overall Study|Withdrawal by Subject|5|||
30822959|NCT01368536|58844382|FG002|Overall Study|Withdrawal by Subject|4|||
30822960|NCT01368536|58844380|FG000|Overall Study|Lost to Follow-up|3|||
30822961|NCT01368536|58844381|FG001|Overall Study|Lost to Follow-up|3|||
30822962|NCT01368536|58844382|FG002|Overall Study|Lost to Follow-up|5|||
30822963|NCT01368536|58844380|FG000|Overall Study|Administrative problems|34|||
30822964|NCT01368536|58844381|FG001|Overall Study|Administrative problems|39|||
30822965|NCT01368536|58844382|FG002|Overall Study|Administrative problems|35|||
30822966|NCT01368536|58844380|FG000|Overall Study|Protocol deviation|0|||
30822967|NCT01368536|58844381|FG001|Overall Study|Protocol deviation|3|||
30822968|NCT01368536|58844382|FG002|Overall Study|Protocol deviation|1|||
30822969|NCT03051165|58844391|FG000|Overall Study|Withdrawal by Subject|1|||
30822970|NCT03051165|58844391|FG000|Overall Study|Early termination of study|12|||
30914107|NCT01599650|58949618|FG000|Overall Study|Withdrawal by Subject|11|||
30914108|NCT01599650|58949619|FG001|Overall Study|Withdrawal by Subject|11|||
30753132|NCT00139776|58762903|FG001|Period III|Lack of Efficacy|0|||
30753133|NCT00139776|58762904|FG002|Period III|Lack of Efficacy|10|||
30753134|NCT00139776|58762905|FG003|Period III|Lack of Efficacy|24|||
30753135|NCT00139776|58762902|FG000|Period III|Lost to Follow-up|0|||
30753136|NCT00139776|58762903|FG001|Period III|Lost to Follow-up|0|||
30753137|NCT00139776|58762904|FG002|Period III|Lost to Follow-up|5|||
30753138|NCT00139776|58762905|FG003|Period III|Lost to Follow-up|4|||
30753139|NCT00139776|58762902|FG000|Period III|Withdrawal by Subject|0|||
30753140|NCT00139776|58762903|FG001|Period III|Withdrawal by Subject|0|||
30753141|NCT00139776|58762904|FG002|Period III|Withdrawal by Subject|16|||
30753142|NCT00139776|58762905|FG003|Period III|Withdrawal by Subject|21|||
30753143|NCT00413699|58762914|FG000|Initial Period|Death|25|||
30753144|NCT00413699|58762915|FG001|Initial Period|Death|30|||
30753145|NCT00413699|58762916|FG002|Initial Period|Death|0|||
30753146|NCT00413699|58762914|FG000|Initial Period|Lack of Efficacy|59|||
30753147|NCT00413699|58762915|FG001|Initial Period|Lack of Efficacy|115|||
30753148|NCT00413699|58762916|FG002|Initial Period|Lack of Efficacy|0|||
30753149|NCT00413699|58762914|FG000|Initial Period|Lost to Follow-up|31|||
30753150|NCT00413699|58762915|FG001|Initial Period|Lost to Follow-up|101|||
30753151|NCT00413699|58762916|FG002|Initial Period|Lost to Follow-up|0|||
30914109|NCT01599650|58949620|FG002|Overall Study|Withdrawal by Subject|10|||
30914110|NCT01599650|58949618|FG000|Overall Study|Adverse Event|3|||
30914111|NCT01599650|58949619|FG001|Overall Study|Adverse Event|8|||
30753152|NCT00413699|58762914|FG000|Initial Period|Protocol Violation|38|||
30822971|NCT01319929|58844397|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
30822972|NCT01319929|58844398|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
30914112|NCT01599650|58949620|FG002|Overall Study|Adverse Event|4|||
30753153|NCT00413699|58762915|FG001|Initial Period|Protocol Violation|89|||
30753154|NCT00413699|58762916|FG002|Initial Period|Protocol Violation|0|||
30822973|NCT01319929|58844397|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
30914113|NCT01541254|58949630|FG000|Overall Study|Withdrawal by Subject|1|||
30914114|NCT01541254|58949630|FG000|Overall Study|excluded - metal allergy|1|||
30914115|NCT01541254|58949630|FG000|Overall Study|enrolled after study closed|1|||
30914116|NCT01541254|58949630|FG000|Overall Study|GI bleed prior to procedure|1|||
30914117|NCT01541254|58949630|FG000|Overall Study|stent not required|1|||
30914118|NCT01541254|58949630|FG000|Overall Study|alternate stent used|1|||
30914119|NCT02163902|58949636|FG000|Overall Study|Subject's Request|3|||
30914120|NCT02163902|58949637|FG001|Overall Study|Subject's Request|4|||
30914121|NCT02163902|58949636|FG000|Overall Study|Lost to Follow-up|6|||
30914122|NCT02163902|58949637|FG001|Overall Study|Lost to Follow-up|7|||
30914123|NCT02163902|58949636|FG000|Overall Study|Administrative Decision|2|||
30914124|NCT02163902|58949637|FG001|Overall Study|Administrative Decision|2|||
30914125|NCT01630616|58949649|FG000|Overall Study|Adverse Event|0|||
30914126|NCT01630616|58949650|FG001|Overall Study|Adverse Event|0|||
30914127|NCT01630616|58949651|FG002|Overall Study|Adverse Event|0|||
30914128|NCT01630616|58949652|FG003|Overall Study|Adverse Event|1|||
30914129|NCT01630616|58949653|FG004|Overall Study|Adverse Event|0|||
30914130|NCT01630616|58949654|FG005|Overall Study|Adverse Event|0|||
30914131|NCT01630616|58949649|FG000|Overall Study|Withdrawal by Subject|0|||
30914132|NCT01630616|58949650|FG001|Overall Study|Withdrawal by Subject|0|||
30914133|NCT01630616|58949651|FG002|Overall Study|Withdrawal by Subject|0|||
30914134|NCT01630616|58949652|FG003|Overall Study|Withdrawal by Subject|2|||
30914135|NCT01630616|58949653|FG004|Overall Study|Withdrawal by Subject|0|||
30914136|NCT01630616|58949654|FG005|Overall Study|Withdrawal by Subject|0|||
30914137|NCT03774875|58949673|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
30914138|NCT03774875|58949674|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
30914139|NCT03774875|58949673|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
30914140|NCT03774875|58949674|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
30914141|NCT03774875|58949673|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
30822974|NCT01319929|58844398|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
30822975|NCT01319929|58844397|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
30822976|NCT01319929|58844398|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
30822977|NCT01319929|58844397|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
30914142|NCT03774875|58949674|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
30914143|NCT03774875|58949673|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
30914144|NCT03774875|58949674|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
30914145|NCT03774875|58949673|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
30914146|NCT03774875|58949674|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
30914147|NCT03774875|58949673|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
30914148|NCT03774875|58949674|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
30914149|NCT03774875|58949673|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
30914150|NCT03774875|58949674|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
30914151|NCT03774875|58949673|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
30914152|NCT03774875|58949674|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
30914153|NCT03774875|58949673|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
30914154|NCT03774875|58949674|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
30914155|NCT03774875|58949673|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
30914156|NCT03774875|58949674|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
30914157|NCT03774875|58949673|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
30914158|NCT03774875|58949674|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
30914159|NCT03774875|58949673|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
30914160|NCT03774875|58949674|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
30914161|NCT03774875|58949673|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
30914162|NCT03774875|58949674|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
30914163|NCT02220764|58949687|FG000|Overall Study|Lost to Follow-up|3|||
30914164|NCT02220764|58949688|FG001|Overall Study|Lost to Follow-up|1|||
30822978|NCT01319929|58844398|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
30822979|NCT01319929|58844397|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
30822980|NCT01319929|58844398|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
30822981|NCT03110185|58844407|FG000|Overall Study|Death|0|||
30914165|NCT02220764|58949687|FG000|Overall Study|Death|1|||
30914166|NCT02220764|58949688|FG001|Overall Study|Death|0|||
30914167|NCT01563172|58949694|FG000|Overall Study|Adverse Event|5|||
30914168|NCT01563172|58949694|FG000|Overall Study|Lost to Follow-up|2|||
30914169|NCT01563172|58949694|FG000|Overall Study|Other (Protocol deviation)|5|||
30914170|NCT01563172|58949694|FG000|Overall Study|Other (Not specified)|1|||
30914171|NCT02161718|58949711|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
30914172|NCT02161718|58949712|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
30914173|NCT02161718|58949713|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
30914174|NCT02161718|58949711|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
30822982|NCT03110185|58844408|FG001|Overall Study|Death|1|||
30822983|NCT03110185|58844407|FG000|Overall Study|Withdrawal by Subject|2|||
30822984|NCT03110185|58844408|FG001|Overall Study|Withdrawal by Subject|7|||
30822985|NCT03110185|58844407|FG000|Overall Study|Time Constraints|0|||
30822986|NCT03110185|58844408|FG001|Overall Study|Time Constraints|6|||
30822987|NCT03110185|58844407|FG000|Overall Study|Conflict with care|5|||
30822988|NCT03110185|58844408|FG001|Overall Study|Conflict with care|12|||
30822989|NCT03110185|58844407|FG000|Overall Study|Protocol Violation|1|||
30822990|NCT03110185|58844408|FG001|Overall Study|Protocol Violation|4|||
30822991|NCT03110185|58844407|FG000|Overall Study|MRI Incompatible|2|||
30822992|NCT03110185|58844408|FG001|Overall Study|MRI Incompatible|0|||
30822993|NCT03110185|58844407|FG000|Overall Study|Patient Refusal|0|||
30822994|NCT03110185|58844408|FG001|Overall Study|Patient Refusal|1|||
30822995|NCT02858076|58844419|FG000|Overall Study|Death|6|||
30822996|NCT02858076|58844420|FG001|Overall Study|Death|3|||
30822997|NCT02858076|58844419|FG000|Overall Study|Withdrawal by Subject|1|||
30822998|NCT02858076|58844420|FG001|Overall Study|Withdrawal by Subject|5|||
30822999|NCT02858076|58844419|FG000|Overall Study|Lost to Follow-up|2|||
30823000|NCT02858076|58844420|FG001|Overall Study|Lost to Follow-up|7|||
30823001|NCT02858076|58844419|FG000|Overall Study|Completed Out of Window|1|||
30823002|NCT02858076|58844420|FG001|Overall Study|Completed Out of Window|3|||
30823003|NCT04594759|58844428|FG000|Overall Study|Lost to Follow-up|3|||
30823004|NCT02856282|58844432|FG000|Overall Study|Withdrawal by Subject|1|||
30823005|NCT03833817|58844438|FG000|Overall Study|Withdrawal by Subject|3|||
30823006|NCT03833817|58844439|FG001|Overall Study|Withdrawal by Subject|3|||
30823007|NCT03833817|58844438|FG000|Overall Study|Lost to Follow-up|3|||
30823008|NCT03833817|58844439|FG001|Overall Study|Lost to Follow-up|3|||
30823009|NCT03119701|58844447|FG000|6-day Dosing|Death|4|||
30823010|NCT03119701|58844448|FG001|6-day Dosing|Death|1|||
30914175|NCT02161718|58949712|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
30914176|NCT02161718|58949713|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
30914177|NCT02161718|58949711|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
30914178|NCT02161718|58949712|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
30914179|NCT02161718|58949713|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
30914180|NCT02161718|58949711|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
30823011|NCT03119701|58844447|FG000|6-day Dosing|Adverse Event|3|||
30823012|NCT03119701|58844448|FG001|6-day Dosing|Adverse Event|0|||
30914181|NCT02161718|58949712|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
30914182|NCT02161718|58949713|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
30914183|NCT02161718|58949711|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
30914184|NCT02161718|58949712|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
30914185|NCT02161718|58949713|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
30914186|NCT02161718|58949711|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
30914187|NCT02161718|58949712|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
30823013|NCT03119701|58844447|FG000|6-day Dosing|Physician Decision|0|||
30823014|NCT03119701|58844448|FG001|6-day Dosing|Physician Decision|1|||
30823015|NCT03119701|58844447|FG000|6-day Dosing|Withdrawal by Subject|0|||
30823016|NCT03119701|58844448|FG001|6-day Dosing|Withdrawal by Subject|1|||
30823017|NCT03119701|58844447|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
30823018|NCT03119701|58844448|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
30823019|NCT02679781|58844462|FG000|Overall Study|Lost to Follow-up|1|||
30823020|NCT02679781|58844463|FG001|Overall Study|Lost to Follow-up|2|||
30823021|NCT02679781|58844462|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
30823022|NCT02679781|58844463|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
30823023|NCT02624869|58844472|FG000|Overall Study|Lost to Follow-up|0|||
30823024|NCT02624869|58844473|FG001|Overall Study|Lost to Follow-up|0|||
30823025|NCT02624869|58844474|FG002|Overall Study|Lost to Follow-up|1|||
30823026|NCT02624869|58844472|FG000|Overall Study|Withdrawal by Subject|1|||
30823027|NCT02624869|58844473|FG001|Overall Study|Withdrawal by Subject|3|||
30823028|NCT02624869|58844474|FG002|Overall Study|Withdrawal by Subject|1|||
30914188|NCT02161718|58949713|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
30914189|NCT02161718|58949711|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
30914190|NCT02161718|58949712|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
30914191|NCT02161718|58949713|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
30823029|NCT03110029|58844494|FG000|Overall Study|Withdrawal by Subject|1|||
30823030|NCT03110029|58844495|FG001|Overall Study|Withdrawal by Subject|1|||
30823031|NCT02747004|58844504|FG000|Overall Study|Withdrawal by Subject|8|||
30914192|NCT02161718|58949711|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
30914193|NCT02161718|58949712|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
30823032|NCT02747004|58844505|FG001|Overall Study|Withdrawal by Subject|5|||
30823033|NCT02747004|58844506|FG002|Overall Study|Withdrawal by Subject|4|||
30823034|NCT02747004|58844504|FG000|Overall Study|Lost to Follow-up|1|||
30823035|NCT02747004|58844505|FG001|Overall Study|Lost to Follow-up|2|||
30823036|NCT02747004|58844506|FG002|Overall Study|Lost to Follow-up|2|||
30823037|NCT02747004|58844504|FG000|Overall Study|on study treatment/follow-up|48|||
30823038|NCT02747004|58844505|FG001|Overall Study|on study treatment/follow-up|42|||
30823039|NCT02747004|58844506|FG002|Overall Study|on study treatment/follow-up|41|||
30823040|NCT04207749|58844516|FG000|Overall Study|Lost to Follow-up|0|||
30823041|NCT04207749|58844517|FG001|Overall Study|Lost to Follow-up|2|||
30823042|NCT04207749|58844516|FG000|Overall Study|Protocol Violation|0|||
30823043|NCT04207749|58844517|FG001|Overall Study|Protocol Violation|1|||
30823044|NCT04207749|58844516|FG000|Overall Study|Withdrawal by Subject|3|||
30823045|NCT04207749|58844517|FG001|Overall Study|Withdrawal by Subject|0|||
30823046|NCT04207749|58844516|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
30823047|NCT04207749|58844517|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
30823048|NCT03043365|58844528|FG000|Weeks 0 to Week 8|Adverse Event|1|||
30823049|NCT03043365|58844529|FG001|Weeks 0 to Week 8|Adverse Event|3|||
30823050|NCT03043365|58844528|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
30823051|NCT03043365|58844529|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
30823052|NCT03043365|58844528|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
30823053|NCT03043365|58844529|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
30823054|NCT03108157|58844539|FG000|Overall Study|Protocol Violation|15|||
30823055|NCT03108157|58844540|FG001|Overall Study|Protocol Violation|4|||
30823056|NCT04421131|58844547|FG000|Overall Study|Lost to Follow-up|1|||
30823057|NCT04421131|58844547|FG000|Overall Study|Protocol Violation|2|||
30823058|NCT04421131|58844547|FG000|Overall Study|App crashed|5|||
30823059|NCT04167345|58844556|FG000|Overall Study|Other|1|||
30823060|NCT04167345|58844557|FG001|Overall Study|Other|1|||
30823061|NCT04167345|58844558|FG002|Overall Study|Other|0|||
30823062|NCT04167345|58844559|FG003|Overall Study|Other|0|||
30823063|NCT04167345|58844560|FG004|Overall Study|Other|0|||
30823064|NCT02854800|58844579|FG000|Overall Study|Protocol Violation|16|||
30823065|NCT02854800|58844580|FG001|Overall Study|Protocol Violation|11|||
30823066|NCT02854800|58844581|FG002|Overall Study|Protocol Violation|3|||
30823067|NCT02854800|58844579|FG000|Overall Study|Withdrawal by Subject|4|||
30823068|NCT02854800|58844580|FG001|Overall Study|Withdrawal by Subject|2|||
30823069|NCT02854800|58844581|FG002|Overall Study|Withdrawal by Subject|3|||
30823070|NCT02931539|58844594|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
30823071|NCT02931539|58844595|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
30823072|NCT02931539|58844596|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
30823073|NCT02931539|58844594|FG000|Period 1: Treatment Phase|Adverse Event|5|||
30823074|NCT02931539|58844595|FG001|Period 1: Treatment Phase|Adverse Event|1|||
30823075|NCT02931539|58844596|FG002|Period 1: Treatment Phase|Adverse Event|0|||
30823076|NCT02931539|58844594|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
30823077|NCT02931539|58844595|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
30823078|NCT02931539|58844596|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
30823079|NCT02931539|58844594|FG000|Period 1: Treatment Phase|Death|8|||
30823080|NCT02931539|58844595|FG001|Period 1: Treatment Phase|Death|24|||
30823081|NCT02931539|58844596|FG002|Period 1: Treatment Phase|Death|0|||
30823082|NCT02931539|58844594|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
30823083|NCT02931539|58844595|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
30823084|NCT02931539|58844596|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
30823085|NCT02931539|58844594|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
30823086|NCT02931539|58844595|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
30823087|NCT02931539|58844596|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
30823088|NCT02931539|58844594|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
30823089|NCT02931539|58844595|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
30823090|NCT02931539|58844596|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
30823091|NCT02931539|58844594|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
30823092|NCT02931539|58844595|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
30823093|NCT02931539|58844596|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
30823094|NCT04042077|58844613|FG000|Overall Study|Adverse Event|0|||
30823095|NCT04042077|58844614|FG001|Overall Study|Adverse Event|1|||
30823096|NCT04042077|58844613|FG000|Overall Study|Death|2|||
30623134|NCT00918580|58634962|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
30623135|NCT00918580|58634962|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
30623136|NCT00918580|58634962|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
30823097|NCT04042077|58844614|FG001|Overall Study|Death|1|||
30823098|NCT04042077|58844613|FG000|Overall Study|Physician Decision|2|||
30823099|NCT04042077|58844614|FG001|Overall Study|Physician Decision|0|||
30823100|NCT04042077|58844613|FG000|Overall Study|Withdrawal by Subject|3|||
30823101|NCT04042077|58844614|FG001|Overall Study|Withdrawal by Subject|2|||
30823102|NCT04042077|58844613|FG000|Overall Study|Lack of Efficacy|0|||
30823103|NCT04042077|58844614|FG001|Overall Study|Lack of Efficacy|1|||
30823104|NCT02853318|58844635|FG000|Overall Study|Withdrawal by Subject|1|||
30823105|NCT03113071|58844645|FG000|Overall Study|Withdrawal by Subject|1|||
30823106|NCT03113071|58844646|FG001|Overall Study|Withdrawal by Subject|0|||
30823107|NCT03050307|58844654|FG000|Overall Study|Adverse Event|4|||
30823108|NCT03050307|58844655|FG001|Overall Study|Adverse Event|2|||
30823109|NCT03050307|58844654|FG000|Overall Study|Significant Protocol Deviation|0|||
30823110|NCT03050307|58844655|FG001|Overall Study|Significant Protocol Deviation|1|||
30823111|NCT03050307|58844654|FG000|Overall Study|Lost to Follow-up|0|||
30823112|NCT03050307|58844655|FG001|Overall Study|Lost to Follow-up|1|||
30823113|NCT03050307|58844654|FG000|Overall Study|Voluntary Withdrawal|3|||
30823114|NCT03050307|58844655|FG001|Overall Study|Voluntary Withdrawal|4|||
30823115|NCT03050307|58844654|FG000|Overall Study|Reason not Specified|1|||
30823116|NCT03050307|58844655|FG001|Overall Study|Reason not Specified|1|||
30823117|NCT03118765|58844681|FG000|Overall Study|Withdrawal by Subject|0|||
30823118|NCT03118765|58844682|FG001|Overall Study|Withdrawal by Subject|0|||
30823119|NCT03118765|58844683|FG002|Overall Study|Withdrawal by Subject|1|||
30823120|NCT03118765|58844684|FG003|Overall Study|Withdrawal by Subject|0|||
30823121|NCT03118765|58844685|FG004|Overall Study|Withdrawal by Subject|0|||
30823122|NCT03118765|58844681|FG000|Overall Study|Adverse Event|1|||
30823123|NCT03118765|58844682|FG001|Overall Study|Adverse Event|1|||
30823124|NCT03118765|58844683|FG002|Overall Study|Adverse Event|1|||
30823125|NCT03118765|58844684|FG003|Overall Study|Adverse Event|1|||
30823126|NCT03118765|58844685|FG004|Overall Study|Adverse Event|1|||
30914194|NCT02161718|58949713|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
30914195|NCT02161718|58949711|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
30914196|NCT02161718|58949712|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
30914197|NCT02161718|58949713|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
30914198|NCT02161718|58949711|FG000|Post- Randomization Period|Lost to Follow-up|0|||
30914199|NCT02161718|58949712|FG001|Post- Randomization Period|Lost to Follow-up|9|||
30914200|NCT02161718|58949713|FG002|Post- Randomization Period|Lost to Follow-up|15|||
30914201|NCT02161718|58949711|FG000|Post- Randomization Period|Adverse Event|0|||
30914202|NCT02161718|58949712|FG001|Post- Randomization Period|Adverse Event|9|||
30914203|NCT02161718|58949713|FG002|Post- Randomization Period|Adverse Event|10|||
30914204|NCT02161718|58949711|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
30914205|NCT02161718|58949712|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
30914206|NCT02161718|58949713|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
30914207|NCT02161718|58949711|FG000|Post- Randomization Period|Physician Decision|0|||
30914208|NCT02161718|58949712|FG001|Post- Randomization Period|Physician Decision|2|||
30914209|NCT02161718|58949713|FG002|Post- Randomization Period|Physician Decision|4|||
30914210|NCT02161718|58949711|FG000|Post- Randomization Period|Protocol Violation|0|||
30914211|NCT02161718|58949712|FG001|Post- Randomization Period|Protocol Violation|2|||
30914212|NCT02161718|58949713|FG002|Post- Randomization Period|Protocol Violation|3|||
30914213|NCT02161718|58949711|FG000|Post- Randomization Period|Lack of Efficacy|0|||
30914214|NCT02161718|58949712|FG001|Post- Randomization Period|Lack of Efficacy|0|||
30914215|NCT02161718|58949713|FG002|Post- Randomization Period|Lack of Efficacy|1|||
30914216|NCT02161718|58949711|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
30914217|NCT02161718|58949712|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
30914218|NCT02161718|58949713|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
30914219|NCT02161718|58949711|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
30914220|NCT02161718|58949712|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
30914221|NCT02161718|58949713|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
30914222|NCT02161718|58949711|FG000|Post- Randomization Period|Relocation|0|||
30914223|NCT02161718|58949712|FG001|Post- Randomization Period|Relocation|3|||
30914224|NCT02161718|58949713|FG002|Post- Randomization Period|Relocation|0|||
30914225|NCT02219048|58949722|FG000|Overall Study|Adverse Event|2|||
30914226|NCT02219048|58949723|FG001|Overall Study|Adverse Event|5|||
30914227|NCT02219048|58949722|FG000|Overall Study|No longer meets eligibility criteria|1|||
30914228|NCT02219048|58949723|FG001|Overall Study|No longer meets eligibility criteria|0|||
30914229|NCT02219048|58949722|FG000|Overall Study|Study terminated by sponsor|16|||
30914230|NCT02219048|58949723|FG001|Overall Study|Study terminated by sponsor|15|||
30914231|NCT02219048|58949722|FG000|Overall Study|Withdrawal by Subject|2|||
30753155|NCT00413699|58762914|FG000|Initial Period|Pregnancy|10|||
30753156|NCT00413699|58762915|FG001|Initial Period|Pregnancy|8|||
30753157|NCT00413699|58762916|FG002|Initial Period|Pregnancy|0|||
30753158|NCT00413699|58762914|FG000|Initial Period|Did not meet entrance criteria|2|||
30753159|NCT00413699|58762915|FG001|Initial Period|Did not meet entrance criteria|2|||
30753160|NCT00413699|58762916|FG002|Initial Period|Did not meet entrance criteria|0|||
30753161|NCT00413699|58762914|FG000|Initial Period|Medication error without adverse event|0|||
30753162|NCT00413699|58762915|FG001|Initial Period|Medication error without adverse event|1|||
30753163|NCT00413699|58762916|FG002|Initial Period|Medication error without adverse event|0|||
30753164|NCT00413699|58762914|FG000|Initial Period|Study terminated by Sponsor|0|||
30753165|NCT00413699|58762915|FG001|Initial Period|Study terminated by Sponsor|1|||
30753166|NCT00413699|58762916|FG002|Initial Period|Study terminated by Sponsor|0|||
30753167|NCT00413699|58762914|FG000|Initial Period|Other|67|||
30753168|NCT00413699|58762915|FG001|Initial Period|Other|211|||
30753169|NCT00413699|58762916|FG002|Initial Period|Other|0|||
30914232|NCT02219048|58949723|FG001|Overall Study|Withdrawal by Subject|0|||
30914233|NCT02219048|58949722|FG000|Overall Study|Other|0|||
30914234|NCT02219048|58949723|FG001|Overall Study|Other|1|||
30914235|NCT02218736|58949731|FG000|Overall Study|Withdrawal by Subject|10|||
30914236|NCT02218736|58949732|FG001|Overall Study|Withdrawal by Subject|9|||
30914237|NCT02218736|58949731|FG000|Overall Study|Protocol Violation|2|||
30914238|NCT02218736|58949732|FG001|Overall Study|Protocol Violation|0|||
30914239|NCT01540474|58949742|FG000|Vaccination Period|Lost to Follow-up|0|||
30914240|NCT01540474|58949743|FG001|Vaccination Period|Lost to Follow-up|1|||
30914241|NCT01540474|58949744|FG002|Vaccination Period|Lost to Follow-up|0|||
30914242|NCT01540474|58949745|FG003|Vaccination Period|Lost to Follow-up|0|||
30914243|NCT01580488|58949756|FG000|Overall Study|Withdrawal by Subject|1|||
30914244|NCT01580020|58949772|FG000|Overall Study|Lack of Efficacy|0|||
30914245|NCT01580020|58949773|FG001|Overall Study|Lack of Efficacy|5|||
30914246|NCT01580020|58949774|FG002|Overall Study|Lack of Efficacy|0|||
30914247|NCT01580020|58949775|FG003|Overall Study|Lack of Efficacy|1|||
30914248|NCT01580020|58949772|FG000|Overall Study|Withdrawal by Subject|0|||
30914249|NCT01580020|58949773|FG001|Overall Study|Withdrawal by Subject|1|||
30914250|NCT01580020|58949774|FG002|Overall Study|Withdrawal by Subject|1|||
30914251|NCT01580020|58949775|FG003|Overall Study|Withdrawal by Subject|0|||
30914252|NCT01580020|58949772|FG000|Overall Study|Adverse Event|1|||
30914253|NCT01580020|58949773|FG001|Overall Study|Adverse Event|1|||
30914254|NCT01580020|58949774|FG002|Overall Study|Adverse Event|1|||
30914255|NCT01580020|58949775|FG003|Overall Study|Adverse Event|1|||
30914256|NCT01580020|58949772|FG000|Overall Study|Administrative Problems|0|||
30823127|NCT03118765|58844681|FG000|Overall Study|Non compliance with Study Procedures|0|||
30823128|NCT03118765|58844682|FG001|Overall Study|Non compliance with Study Procedures|0|||
30823129|NCT03118765|58844683|FG002|Overall Study|Non compliance with Study Procedures|0|||
30823130|NCT03118765|58844684|FG003|Overall Study|Non compliance with Study Procedures|1|||
30823131|NCT03118765|58844685|FG004|Overall Study|Non compliance with Study Procedures|0|||
30823132|NCT03118765|58844681|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
30823133|NCT03118765|58844682|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
30823134|NCT03118765|58844683|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
30823135|NCT03118765|58844684|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
30823136|NCT03118765|58844685|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
30823137|NCT03118765|58844681|FG000|Overall Study|COPD Exacerbation|1|||
30823138|NCT03118765|58844682|FG001|Overall Study|COPD Exacerbation|0|||
30823139|NCT03118765|58844683|FG002|Overall Study|COPD Exacerbation|0|||
30823140|NCT03118765|58844684|FG003|Overall Study|COPD Exacerbation|1|||
30823141|NCT03118765|58844685|FG004|Overall Study|COPD Exacerbation|0|||
30823142|NCT03118765|58844681|FG000|Overall Study|Lost to Follow-up|1|||
30823143|NCT03118765|58844682|FG001|Overall Study|Lost to Follow-up|0|||
30823144|NCT03118765|58844683|FG002|Overall Study|Lost to Follow-up|1|||
30823145|NCT03118765|58844684|FG003|Overall Study|Lost to Follow-up|0|||
30823146|NCT03118765|58844685|FG004|Overall Study|Lost to Follow-up|0|||
30823147|NCT03118765|58844681|FG000|Overall Study|Sponsor Decision|1|||
30823148|NCT03118765|58844682|FG001|Overall Study|Sponsor Decision|0|||
30823149|NCT03118765|58844683|FG002|Overall Study|Sponsor Decision|1|||
30823150|NCT03118765|58844684|FG003|Overall Study|Sponsor Decision|0|||
30823151|NCT03118765|58844685|FG004|Overall Study|Sponsor Decision|1|||
30823152|NCT05222880|58844700|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
30823153|NCT05222880|58844700|FG000|Overall Study|Withdrew Consent during Study|1|||
30823154|NCT05222880|58844700|FG000|Overall Study|COVID-19 Related|1|||
30823155|NCT04810962|58844717|FG000|Overall Study|Adverse Event|0|||
30823156|NCT04810962|58844718|FG001|Overall Study|Adverse Event|1|||
30823157|NCT04810962|58844717|FG000|Overall Study|Lost to Follow-up|2|||
30823158|NCT04810962|58844718|FG001|Overall Study|Lost to Follow-up|1|||
30823159|NCT04810962|58844717|FG000|Overall Study|Physician Decision|1|||
30823160|NCT04810962|58844718|FG001|Overall Study|Physician Decision|0|||
30823161|NCT04810962|58844717|FG000|Overall Study|Withdrawal by Subject|1|||
30823162|NCT04810962|58844718|FG001|Overall Study|Withdrawal by Subject|3|||
30823163|NCT04810962|58844717|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
30823164|NCT04810962|58844718|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
30823165|NCT04606134|58844751|FG000|Overall Study|Adverse Event|0|||
30823166|NCT04606134|58844752|FG001|Overall Study|Adverse Event|1|||
30823167|NCT04426825|58844758|FG000|Overall Study|Continuing on study|6|||
30914257|NCT01580020|58949773|FG001|Overall Study|Administrative Problems|0|||
30914258|NCT01580020|58949774|FG002|Overall Study|Administrative Problems|1|||
30914259|NCT01580020|58949775|FG003|Overall Study|Administrative Problems|0|||
30914260|NCT01580020|58949772|FG000|Overall Study|Lost to Follow-up|0|||
30914261|NCT01580020|58949773|FG001|Overall Study|Lost to Follow-up|0|||
30823168|NCT04426825|58844758|FG000|Overall Study|Death|17|||
30823169|NCT04399538|58844767|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
30823170|NCT04399538|58844768|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
30823171|NCT04399538|58844769|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
30823172|NCT04399538|58844770|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
30823173|NCT04399538|58844771|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
30823174|NCT04399538|58844767|FG000|Double-Blind Treatment|Adverse Event|0|||
30823175|NCT04399538|58844768|FG001|Double-Blind Treatment|Adverse Event|0|||
30823176|NCT04399538|58844769|FG002|Double-Blind Treatment|Adverse Event|0|||
30823177|NCT04399538|58844770|FG003|Double-Blind Treatment|Adverse Event|0|||
30823178|NCT04399538|58844771|FG004|Double-Blind Treatment|Adverse Event|1|||
30823179|NCT04399538|58844767|FG000|Follow-Up|Adverse Event|0|||
30823180|NCT04399538|58844768|FG001|Follow-Up|Adverse Event|0|||
30823181|NCT04399538|58844769|FG002|Follow-Up|Adverse Event|0|||
30823182|NCT04399538|58844770|FG003|Follow-Up|Adverse Event|0|||
30823183|NCT04399538|58844771|FG004|Follow-Up|Adverse Event|1|||
30823184|NCT04399538|58844767|FG000|Follow-Up|Withdrawal by Subject|0|||
30823185|NCT04399538|58844768|FG001|Follow-Up|Withdrawal by Subject|0|||
30823186|NCT04399538|58844769|FG002|Follow-Up|Withdrawal by Subject|0|||
30823187|NCT04399538|58844770|FG003|Follow-Up|Withdrawal by Subject|2|||
30823188|NCT04399538|58844771|FG004|Follow-Up|Withdrawal by Subject|0|||
30823189|NCT03875235|58844789|FG000|Overall Study|Ongoing study treatment|63|||
30823190|NCT03875235|58844790|FG001|Overall Study|Ongoing study treatment|20|||
30823191|NCT03875235|58844789|FG000|Overall Study|Off treatment|77|||
30823192|NCT03875235|58844790|FG001|Overall Study|Off treatment|91|||
30823193|NCT03875235|58844789|FG000|Overall Study|Withdrawal by Subject|3|||
30823194|NCT03875235|58844790|FG001|Overall Study|Withdrawal by Subject|10|||
30823195|NCT03875235|58844789|FG000|Overall Study|Death|198|||
30823196|NCT03875235|58844790|FG001|Overall Study|Death|223|||
30823197|NCT03094832|58844826|FG000|Overall Study|Lost to Follow-up|0|||
30823198|NCT03094832|58844827|FG001|Overall Study|Lost to Follow-up|0|||
30823199|NCT03094832|58844828|FG002|Overall Study|Lost to Follow-up|0|||
30823200|NCT03094832|58844829|FG003|Overall Study|Lost to Follow-up|1|||
30823201|NCT03094832|58844830|FG004|Overall Study|Lost to Follow-up|1|||
30823202|NCT03094832|58844826|FG000|Overall Study|Death|1|||
30823203|NCT03094832|58844827|FG001|Overall Study|Death|0|||
30823204|NCT03094832|58844828|FG002|Overall Study|Death|0|||
30823205|NCT03094832|58844829|FG003|Overall Study|Death|0|||
30823206|NCT03094832|58844830|FG004|Overall Study|Death|0|||
30823207|NCT03094832|58844826|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
30823208|NCT03094832|58844827|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
30823209|NCT03094832|58844828|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
30823210|NCT03094832|58844829|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
30823211|NCT03094832|58844830|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
30823212|NCT03094832|58844826|FG000|Overall Study|Other|13|||
30823213|NCT03094832|58844827|FG001|Overall Study|Other|20|||
30823214|NCT03094832|58844828|FG002|Overall Study|Other|1|||
30823215|NCT03094832|58844829|FG003|Overall Study|Other|7|||
30823216|NCT03094832|58844830|FG004|Overall Study|Other|1|||
30823217|NCT03036579|58844844|FG000|2 Years|Lost to Follow-up|1|||
30823218|NCT03036579|58844845|FG001|2 Years|Lost to Follow-up|0|||
30823219|NCT03036579|58844844|FG000|3 Years|Lost to Follow-up|0|||
30823220|NCT03036579|58844845|FG001|3 Years|Lost to Follow-up|1|||
30823221|NCT02867761|58844853|FG000|Overall Study|Participant withdrawn by investigator|0|||
30823222|NCT02867761|58844854|FG001|Overall Study|Participant withdrawn by investigator|1|||
30823223|NCT02867761|58844853|FG000|Overall Study|Lost to Follow-up|25|||
30823224|NCT02867761|58844854|FG001|Overall Study|Lost to Follow-up|18|||
30823225|NCT02867761|58844853|FG000|Overall Study|Unable to complete protocol|3|||
30823226|NCT02867761|58844854|FG001|Overall Study|Unable to complete protocol|7|||
30823227|NCT02719990|58844869|FG000|Overall Study|Physician Decision|2|||
30823228|NCT02719990|58844869|FG000|Overall Study|Withdrawal by Subject|2|||
30823229|NCT02719990|58844869|FG000|Overall Study|Study Terminated By Sponsor|32|||
30823230|NCT02494583|58844876|FG000|Overall Study|Death|224|||
30823231|NCT02494583|58844877|FG001|Overall Study|Death|214|||
30823232|NCT02494583|58844878|FG002|Overall Study|Death|225|||
30823233|NCT02494583|58844876|FG000|Overall Study|Lost to Follow-up|1|||
30823234|NCT02494583|58844877|FG001|Overall Study|Lost to Follow-up|0|||
30823235|NCT02494583|58844878|FG002|Overall Study|Lost to Follow-up|0|||
30823236|NCT02494583|58844876|FG000|Overall Study|Protocol Violation|1|||
30823237|NCT02494583|58844877|FG001|Overall Study|Protocol Violation|2|||
30823238|NCT02494583|58844878|FG002|Overall Study|Protocol Violation|0|||
30823239|NCT02494583|58844876|FG000|Overall Study|Screen Failure|0|||
30823240|NCT02494583|58844877|FG001|Overall Study|Screen Failure|1|||
30823241|NCT02494583|58844878|FG002|Overall Study|Screen Failure|0|||
30823242|NCT02494583|58844876|FG000|Overall Study|Transferred to Extension Study|15|||
30823243|NCT02494583|58844877|FG001|Overall Study|Transferred to Extension Study|15|||
30823244|NCT02494583|58844878|FG002|Overall Study|Transferred to Extension Study|6|||
30823245|NCT02494583|58844876|FG000|Overall Study|Did Not Continue on Extension Study|8|||
30823246|NCT02494583|58844877|FG001|Overall Study|Did Not Continue on Extension Study|10|||
30823247|NCT02494583|58844878|FG002|Overall Study|Did Not Continue on Extension Study|4|||
30823248|NCT02494583|58844876|FG000|Overall Study|Withdrawal by Subject|7|||
30823249|NCT02494583|58844877|FG001|Overall Study|Withdrawal by Subject|15|||
30823250|NCT02494583|58844878|FG002|Overall Study|Withdrawal by Subject|15|||
30823251|NCT02322814|58844893|FG000|Overall Study|Death|7|||
30823252|NCT02322814|58844894|FG001|Overall Study|Death|29|||
30823253|NCT02322814|58844895|FG002|Overall Study|Death|32|||
30823254|NCT02322814|58844896|FG003|Overall Study|Death|23|||
30914262|NCT01580020|58949774|FG002|Overall Study|Lost to Follow-up|1|||
30914263|NCT01580020|58949775|FG003|Overall Study|Lost to Follow-up|0|||
30914264|NCT01579474|58949791|FG000|Overall Study|Adverse Event|1|||
30823255|NCT02322814|58844897|FG004|Overall Study|Death|14|||
30823256|NCT02322814|58844893|FG000|Overall Study|Lost to Follow-up|1|||
30823257|NCT02322814|58844894|FG001|Overall Study|Lost to Follow-up|3|||
30823258|NCT02322814|58844895|FG002|Overall Study|Lost to Follow-up|3|||
30823259|NCT02322814|58844896|FG003|Overall Study|Lost to Follow-up|1|||
30823260|NCT02322814|58844897|FG004|Overall Study|Lost to Follow-up|0|||
30823261|NCT02322814|58844893|FG000|Overall Study|Various Reasons|2|||
30823262|NCT02322814|58844894|FG001|Overall Study|Various Reasons|0|||
30823263|NCT02322814|58844895|FG002|Overall Study|Various Reasons|1|||
30823264|NCT02322814|58844896|FG003|Overall Study|Various Reasons|1|||
30823265|NCT02322814|58844897|FG004|Overall Study|Various Reasons|0|||
30823266|NCT02322814|58844893|FG000|Overall Study|Progressive Disease|0|||
30823267|NCT02322814|58844894|FG001|Overall Study|Progressive Disease|0|||
30823268|NCT02322814|58844895|FG002|Overall Study|Progressive Disease|0|||
30823269|NCT02322814|58844896|FG003|Overall Study|Progressive Disease|1|||
30823270|NCT02322814|58844897|FG004|Overall Study|Progressive Disease|1|||
30914265|NCT01579474|58949792|FG001|Overall Study|Adverse Event|13|||
30914266|NCT01579474|58949793|FG002|Overall Study|Adverse Event|2|||
30914267|NCT01579474|58949794|FG003|Overall Study|Adverse Event|0|||
30914268|NCT01579474|58949795|FG004|Overall Study|Adverse Event|0|||
30914269|NCT01579474|58949796|FG005|Overall Study|Adverse Event|1|||
30914270|NCT01579474|58949791|FG000|Overall Study|Lack of Efficacy|1|||
30914271|NCT01579474|58949792|FG001|Overall Study|Lack of Efficacy|0|||
30914272|NCT01579474|58949793|FG002|Overall Study|Lack of Efficacy|0|||
30914273|NCT01579474|58949794|FG003|Overall Study|Lack of Efficacy|0|||
30914274|NCT01579474|58949795|FG004|Overall Study|Lack of Efficacy|1|||
30914275|NCT01579474|58949796|FG005|Overall Study|Lack of Efficacy|0|||
30914276|NCT01579474|58949791|FG000|Overall Study|Withdrawal by Subject|1|||
30914277|NCT01579474|58949792|FG001|Overall Study|Withdrawal by Subject|0|||
30914278|NCT01579474|58949793|FG002|Overall Study|Withdrawal by Subject|0|||
30914279|NCT01579474|58949794|FG003|Overall Study|Withdrawal by Subject|0|||
30914280|NCT01579474|58949795|FG004|Overall Study|Withdrawal by Subject|0|||
30914281|NCT01579474|58949796|FG005|Overall Study|Withdrawal by Subject|0|||
30914282|NCT01579318|58949809|FG000|Overall Study|Disease Progression|1|||
30914283|NCT01562782|58949815|FG000|Overall Study|Withdrawal by Subject|3|||
30914284|NCT01562782|58949816|FG001|Overall Study|Withdrawal by Subject|3|||
30753170|NCT00413699|58762914|FG000|Initial Period|Adverse event related to study drug|178|||
30753171|NCT00413699|58762915|FG001|Initial Period|Adverse event related to study drug|527|||
30753172|NCT00413699|58762916|FG002|Initial Period|Adverse event related to study drug|0|||
30753173|NCT00413699|58762914|FG000|Initial Period|Adverse event not related to study drug|113|||
30753174|NCT00413699|58762915|FG001|Initial Period|Adverse event not related to study drug|248|||
30753175|NCT00413699|58762916|FG002|Initial Period|Adverse event not related to study drug|0|||
30753176|NCT00413699|58762914|FG000|Initial Period|Missing end of study page|0|||
30753177|NCT00413699|58762915|FG001|Initial Period|Missing end of study page|4|||
30753178|NCT00413699|58762916|FG002|Initial Period|Missing end of study page|0|||
30753179|NCT00413699|58762914|FG000|Initial Period|No longer willing to participate|116|||
30753180|NCT00413699|58762915|FG001|Initial Period|No longer willing to participate|368|||
30753181|NCT00413699|58762916|FG002|Initial Period|No longer willing to participate|0|||
30753182|NCT00413699|58762914|FG000|Extension Period|No Longer Willing to Participate|0|||
30753183|NCT00413699|58762915|FG001|Extension Period|No Longer Willing to Participate|0|||
30753184|NCT00413699|58762916|FG002|Extension Period|No Longer Willing to Participate|2|||
30753185|NCT00413699|58762914|FG000|Extension Period|Protocol Violation|0|||
30753186|NCT00413699|58762915|FG001|Extension Period|Protocol Violation|0|||
30823271|NCT02322814|58844893|FG000|Overall Study|Protocol Violation|1|||
30823272|NCT02322814|58844894|FG001|Overall Study|Protocol Violation|0|||
30823273|NCT02322814|58844895|FG002|Overall Study|Protocol Violation|0|||
30823274|NCT02322814|58844896|FG003|Overall Study|Protocol Violation|0|||
30753187|NCT00413699|58762916|FG002|Extension Period|Protocol Violation|1|||
30753188|NCT00413699|58762914|FG000|Extension Period|Adverse Event|0|||
30823275|NCT02322814|58844897|FG004|Overall Study|Protocol Violation|0|||
30823276|NCT02322814|58844893|FG000|Overall Study|Study Terminated by Sponsor|0|||
30914285|NCT01562782|58949815|FG000|Overall Study|screen failure|1|||
30914286|NCT01562782|58949816|FG001|Overall Study|screen failure|2|||
30914287|NCT01579006|58949822|FG000|Overall Study|Lack of Efficacy|10|||
30914288|NCT01579006|58949822|FG000|Overall Study|Adverse Event|13|||
30914289|NCT01579006|58949822|FG000|Overall Study|Withdrawal by Subject|5|||
30914290|NCT01579006|58949822|FG000|Overall Study|Non-compliance|3|||
30914291|NCT01579006|58949822|FG000|Overall Study|Due to participant's health fund|1|||
30914292|NCT01579006|58949822|FG000|Overall Study|Scheduled surgery|1|||
30914293|NCT01578850|58949828|FG000|Period 1|Insufficient Clinical Response|1|||
30914294|NCT01578850|58949829|FG001|Period 1|Insufficient Clinical Response|0|||
30914295|NCT01578850|58949830|FG002|Period 1|Insufficient Clinical Response|0|||
30914296|NCT01578850|58949828|FG000|Period 1|Adverse Event|11|||
30914297|NCT01578850|58949829|FG001|Period 1|Adverse Event|0|||
30914298|NCT01578850|58949830|FG002|Period 1|Adverse Event|0|||
30914299|NCT01578850|58949828|FG000|Period 1|Death|1|||
30914300|NCT01578850|58949829|FG001|Period 1|Death|0|||
30914301|NCT01578850|58949830|FG002|Period 1|Death|0|||
30914302|NCT01578850|58949828|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
30914303|NCT01578850|58949829|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
30914304|NCT01578850|58949830|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
30823277|NCT02322814|58844894|FG001|Overall Study|Study Terminated by Sponsor|7|||
30823278|NCT02322814|58844895|FG002|Overall Study|Study Terminated by Sponsor|9|||
30823279|NCT02322814|58844896|FG003|Overall Study|Study Terminated by Sponsor|5|||
30823280|NCT02322814|58844897|FG004|Overall Study|Study Terminated by Sponsor|13|||
30823281|NCT02322814|58844893|FG000|Overall Study|Withdrawal by Subject|5|||
30823282|NCT02322814|58844894|FG001|Overall Study|Withdrawal by Subject|4|||
30823283|NCT02322814|58844895|FG002|Overall Study|Withdrawal by Subject|2|||
30823284|NCT02322814|58844896|FG003|Overall Study|Withdrawal by Subject|1|||
30823285|NCT02322814|58844897|FG004|Overall Study|Withdrawal by Subject|3|||
30823286|NCT01333033|58844919|FG000|Overall Study|Ineligible|0|||
30823287|NCT01333033|58844920|FG001|Overall Study|Ineligible|0|||
30823288|NCT01333033|58844921|FG002|Overall Study|Ineligible|0|||
30823289|NCT01333033|58844922|FG003|Overall Study|Ineligible|0|||
30823290|NCT01333033|58844923|FG004|Overall Study|Ineligible|6|||
30823291|NCT01333033|58844924|FG005|Overall Study|Ineligible|8|||
30823292|NCT01333033|58844919|FG000|Overall Study|Withdrawal by Subject|0|||
30914305|NCT01578850|58949828|FG000|Period 1|Withdrawal by Subject|9|||
30914306|NCT01578850|58949829|FG001|Period 1|Withdrawal by Subject|0|||
30914307|NCT01578850|58949830|FG002|Period 1|Withdrawal by Subject|0|||
30914308|NCT01578850|58949828|FG000|Period 1|Study Terminated by Sponsor|3|||
30914309|NCT01578850|58949829|FG001|Period 1|Study Terminated by Sponsor|0|||
30823293|NCT01333033|58844920|FG001|Overall Study|Withdrawal by Subject|0|||
30823294|NCT01333033|58844921|FG002|Overall Study|Withdrawal by Subject|0|||
30823295|NCT01333033|58844922|FG003|Overall Study|Withdrawal by Subject|0|||
30914310|NCT01578850|58949830|FG002|Period 1|Study Terminated by Sponsor|0|||
30914311|NCT01578850|58949828|FG000|Period 2|Insufficient Clinical Response|0|||
30914312|NCT01578850|58949829|FG001|Period 2|Insufficient Clinical Response|1|||
30914313|NCT01578850|58949830|FG002|Period 2|Insufficient Clinical Response|0|||
30753189|NCT00413699|58762915|FG001|Extension Period|Adverse Event|0|||
30753190|NCT00413699|58762916|FG002|Extension Period|Adverse Event|2|||
30753191|NCT03713320|58762944|FG000|Randomized Period|Adverse Event|1|||
30753192|NCT03713320|58762945|FG001|Randomized Period|Adverse Event|5|||
30753193|NCT03713320|58762946|FG002|Randomized Period|Adverse Event|0|||
30753194|NCT03713320|58762944|FG000|Randomized Period|Physician Decision|1|||
30753195|NCT03713320|58762945|FG001|Randomized Period|Physician Decision|1|||
30753196|NCT03713320|58762946|FG002|Randomized Period|Physician Decision|0|||
30753197|NCT03713320|58762944|FG000|Randomized Period|Withdrawal by Subject|4|||
30753198|NCT03713320|58762945|FG001|Randomized Period|Withdrawal by Subject|0|||
30753199|NCT03713320|58762946|FG002|Randomized Period|Withdrawal by Subject|0|||
30753200|NCT03713320|58762944|FG000|Randomized Period|Participant decision|3|||
30753201|NCT03713320|58762945|FG001|Randomized Period|Participant decision|1|||
30753202|NCT03713320|58762946|FG002|Randomized Period|Participant decision|0|||
30753203|NCT03713320|58762944|FG000|Randomized Period|Study terminated by sponsor|6|||
30753204|NCT03713320|58762945|FG001|Randomized Period|Study terminated by sponsor|3|||
30753205|NCT03713320|58762946|FG002|Randomized Period|Study terminated by sponsor|0|||
30753206|NCT03713320|58762944|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
30823296|NCT01333033|58844923|FG004|Overall Study|Withdrawal by Subject|4|||
30823297|NCT01333033|58844924|FG005|Overall Study|Withdrawal by Subject|2|||
30914314|NCT01578850|58949828|FG000|Period 2|Adverse Event|0|||
30823298|NCT01333033|58844919|FG000|Overall Study|PET inevaluable|0|||
30823299|NCT01333033|58844920|FG001|Overall Study|PET inevaluable|0|||
30823300|NCT01333033|58844921|FG002|Overall Study|PET inevaluable|0|||
30753207|NCT03713320|58762945|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
30823301|NCT01333033|58844922|FG003|Overall Study|PET inevaluable|0|||
30914315|NCT01578850|58949829|FG001|Period 2|Adverse Event|3|||
30914316|NCT01578850|58949830|FG002|Period 2|Adverse Event|6|||
30914317|NCT01578850|58949828|FG000|Period 2|Lost to Follow-up|0|||
30914318|NCT01578850|58949829|FG001|Period 2|Lost to Follow-up|1|||
30914319|NCT01578850|58949830|FG002|Period 2|Lost to Follow-up|2|||
30914320|NCT01578850|58949828|FG000|Period 2|Withdrawal by Subject|0|||
30753208|NCT03713320|58762946|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
30753209|NCT03713320|58762944|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
30823302|NCT01333033|58844923|FG004|Overall Study|PET inevaluable|2|||
30823303|NCT01333033|58844924|FG005|Overall Study|PET inevaluable|4|||
30823304|NCT01333033|58844919|FG000|Overall Study|Adverse Event|0|||
30823305|NCT01333033|58844920|FG001|Overall Study|Adverse Event|0|||
30823306|NCT01333033|58844921|FG002|Overall Study|Adverse Event|0|||
30823307|NCT01333033|58844922|FG003|Overall Study|Adverse Event|0|||
30914321|NCT01578850|58949829|FG001|Period 2|Withdrawal by Subject|2|||
30914322|NCT01578850|58949830|FG002|Period 2|Withdrawal by Subject|2|||
30914323|NCT01578850|58949828|FG000|Period 2|Study Terminated by Sponsor|0|||
30914324|NCT01578850|58949829|FG001|Period 2|Study Terminated by Sponsor|5|||
30914325|NCT01578850|58949830|FG002|Period 2|Study Terminated by Sponsor|4|||
30914326|NCT01578850|58949828|FG000|Period 2|Unspecified Reasons|0|||
30914327|NCT01578850|58949829|FG001|Period 2|Unspecified Reasons|1|||
30914328|NCT01578850|58949830|FG002|Period 2|Unspecified Reasons|0|||
30823308|NCT01333033|58844923|FG004|Overall Study|Adverse Event|2|||
30823309|NCT01333033|58844924|FG005|Overall Study|Adverse Event|1|||
30823310|NCT01333033|58844919|FG000|Overall Study|Progression|0|||
30823311|NCT01333033|58844920|FG001|Overall Study|Progression|0|||
30823312|NCT01333033|58844921|FG002|Overall Study|Progression|0|||
30823313|NCT01333033|58844922|FG003|Overall Study|Progression|0|||
30823314|NCT01333033|58844923|FG004|Overall Study|Progression|0|||
30823315|NCT01333033|58844924|FG005|Overall Study|Progression|1|||
30823316|NCT01333033|58844919|FG000|Overall Study|MD Decision|0|||
30823317|NCT01333033|58844920|FG001|Overall Study|MD Decision|0|||
30823318|NCT01333033|58844921|FG002|Overall Study|MD Decision|0|||
30823319|NCT01333033|58844922|FG003|Overall Study|MD Decision|0|||
30823320|NCT01333033|58844923|FG004|Overall Study|MD Decision|0|||
30823321|NCT01333033|58844924|FG005|Overall Study|MD Decision|2|||
30823322|NCT01192776|58844946|FG000|Overall Study|Death|8|||
30823323|NCT01192776|58844947|FG001|Overall Study|Death|15|||
30823324|NCT01192776|58844948|FG002|Overall Study|Death|18|||
30823325|NCT01192776|58844949|FG003|Overall Study|Death|15|||
30823326|NCT01192776|58844946|FG000|Overall Study|Lost to Follow-up|3|||
30823327|NCT01192776|58844947|FG001|Overall Study|Lost to Follow-up|6|||
30823328|NCT01192776|58844948|FG002|Overall Study|Lost to Follow-up|3|||
30823329|NCT01192776|58844949|FG003|Overall Study|Lost to Follow-up|5|||
30823330|NCT01367834|58844982|FG000|Overall Study|Withdrawal by Subject|2|||
30823331|NCT01367834|58844983|FG001|Overall Study|Withdrawal by Subject|2|||
30823332|NCT01367834|58844982|FG000|Overall Study|Study was ended.|0|||
30914329|NCT01539538|58949840|FG000|Overall Study|Adverse Event|13|||
30914330|NCT01539538|58949841|FG001|Overall Study|Adverse Event|18|||
30914331|NCT01539538|58949840|FG000|Overall Study|Lack of Efficacy|13|||
30914332|NCT01539538|58949841|FG001|Overall Study|Lack of Efficacy|16|||
30753210|NCT03713320|58762945|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
30753211|NCT03713320|58762946|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
30753212|NCT03712930|58762953|FG000|Overall Study|Death|7|||
30753213|NCT03712930|58762953|FG000|Overall Study|Physician Decision|1|||
30753214|NCT03712930|58762953|FG000|Overall Study|Study Terminated by Sponsor|3|||
30753215|NCT03712930|58762953|FG000|Overall Study|Progressive Disease|2|||
30753216|NCT00420407|58762959|FG000|Overall Study|Lost to Follow-up|0|||
30753217|NCT00420407|58762960|FG001|Overall Study|Lost to Follow-up|3|||
30753218|NCT00420407|58762959|FG000|Overall Study|Physician Decision|2|||
30753219|NCT00420407|58762960|FG001|Overall Study|Physician Decision|1|||
30753220|NCT00420407|58762959|FG000|Overall Study|subject identified as detainee|1|||
30753221|NCT00420407|58762960|FG001|Overall Study|subject identified as detainee|0|||
30753222|NCT00420407|58762959|FG000|Overall Study|subject identified as Jehovah's witness|1|||
30753223|NCT00420407|58762960|FG001|Overall Study|subject identified as Jehovah's witness|0|||
30753224|NCT00420407|58762959|FG000|Overall Study|Withdrawal by Subject|0|||
30753225|NCT00420407|58762960|FG001|Overall Study|Withdrawal by Subject|2|||
30753226|NCT00420095|58762969|FG000|Overall Study|Adverse Event|1|||
30753227|NCT00420095|58762970|FG001|Overall Study|Adverse Event|0|||
30753228|NCT00420095|58762969|FG000|Overall Study|Protocol Violation|1|||
30753229|NCT00420095|58762970|FG001|Overall Study|Protocol Violation|1|||
30753230|NCT00420095|58762969|FG000|Overall Study|Lost to Follow-up|1|||
30823333|NCT01367834|58844983|FG001|Overall Study|Study was ended.|1|||
30823334|NCT03106753|58844991|FG000|Overall Study|Withdrawal by Subject|0|||
30823335|NCT03106753|58844992|FG001|Overall Study|Withdrawal by Subject|1|||
30823336|NCT03045081|58845002|FG000|Overall Study|Withdrawal by Subject|6|||
30823337|NCT03045081|58845003|FG001|Overall Study|Withdrawal by Subject|11|||
30914333|NCT01539538|58949840|FG000|Overall Study|Withdrawal by Subject|2|||
30914334|NCT01539538|58949841|FG001|Overall Study|Withdrawal by Subject|3|||
30753231|NCT00420095|58762970|FG001|Overall Study|Lost to Follow-up|0|||
30753232|NCT00419393|58762976|FG000|Overall Study|Adverse Event|5|||
30753233|NCT00419393|58762976|FG000|Overall Study|Protocol Violation|5|||
30753234|NCT00419393|58762976|FG000|Overall Study|Withdrawal by Subject|7|||
30823338|NCT03107377|58845011|FG000|Overall Study|Adverse Event|3|||
30823339|NCT03107377|58845012|FG001|Overall Study|Adverse Event|3|||
30823340|NCT03107377|58845011|FG000|Overall Study|Protocol Violation|9|||
30823341|NCT03107377|58845012|FG001|Overall Study|Protocol Violation|12|||
30823342|NCT03107377|58845011|FG000|Overall Study|Physician Decision|3|||
30753235|NCT00419393|58762976|FG000|Overall Study|Other: Sponsor request|3|||
30753236|NCT00419393|58762976|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
30753237|NCT00419393|58762976|FG000|Overall Study|Other: Site closure|1|||
30753238|NCT00419393|58762976|FG000|Overall Study|Other: Other health problems|1|||
30753239|NCT00419393|58762976|FG000|Overall Study|Other: Investigator decision|1|||
30753240|NCT00419159|58762982|FG000|Overall Study|Adverse Event|7|||
30753241|NCT00419159|58762983|FG001|Overall Study|Adverse Event|15|||
30753242|NCT00419159|58762982|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30753243|NCT00419159|58762983|FG001|Overall Study|Abnormal laboratory value(s)|2|||
30753244|NCT00419159|58762982|FG000|Overall Study|Subject's no longer requires study drug|0|||
30753245|NCT00419159|58762983|FG001|Overall Study|Subject's no longer requires study drug|1|||
30753246|NCT00419159|58762982|FG000|Overall Study|Protocol Violation|1|||
30753247|NCT00419159|58762983|FG001|Overall Study|Protocol Violation|0|||
30753248|NCT00419159|58762982|FG000|Overall Study|Withdrawal by Subject|10|||
30753249|NCT00419159|58762983|FG001|Overall Study|Withdrawal by Subject|3|||
30753250|NCT00419159|58762982|FG000|Overall Study|Lost to Follow-up|0|||
30753251|NCT00419159|58762983|FG001|Overall Study|Lost to Follow-up|1|||
30753252|NCT00419159|58762982|FG000|Overall Study|Death|2|||
30753253|NCT00419159|58762983|FG001|Overall Study|Death|2|||
30753254|NCT00419159|58762982|FG000|Overall Study|Disease progression|79|||
30753255|NCT00419159|58762983|FG001|Overall Study|Disease progression|76|||
30753256|NCT03717064|58762997|FG000|Period 2|Adverse Event|1|||
30753257|NCT03716050|58763009|FG000|Overall Study|Lost to Follow-up|0|||
30753258|NCT03716050|58763010|FG001|Overall Study|Lost to Follow-up|0|||
30753259|NCT03716050|58763011|FG002|Overall Study|Lost to Follow-up|1|||
30753260|NCT03716050|58763012|FG003|Overall Study|Lost to Follow-up|0|||
30753261|NCT03716050|58763013|FG004|Overall Study|Lost to Follow-up|0|||
30753262|NCT03716050|58763014|FG005|Overall Study|Lost to Follow-up|0|||
30753263|NCT03716050|58763015|FG006|Overall Study|Lost to Follow-up|0|||
30753264|NCT03716050|58763016|FG007|Overall Study|Lost to Follow-up|0|||
30753265|NCT03716050|58763009|FG000|Overall Study|Physician Decision|0|||
30753266|NCT03716050|58763010|FG001|Overall Study|Physician Decision|0|||
30753267|NCT03716050|58763011|FG002|Overall Study|Physician Decision|0|||
30753268|NCT03716050|58763012|FG003|Overall Study|Physician Decision|1|||
30753269|NCT03716050|58763013|FG004|Overall Study|Physician Decision|0|||
30753270|NCT03716050|58763014|FG005|Overall Study|Physician Decision|0|||
30753271|NCT03716050|58763015|FG006|Overall Study|Physician Decision|0|||
30753272|NCT03716050|58763016|FG007|Overall Study|Physician Decision|0|||
30753273|NCT03716050|58763009|FG000|Overall Study|Protocol Violation|0|||
30753274|NCT03716050|58763010|FG001|Overall Study|Protocol Violation|0|||
30753275|NCT03716050|58763011|FG002|Overall Study|Protocol Violation|0|||
30753276|NCT03716050|58763012|FG003|Overall Study|Protocol Violation|1|||
30753277|NCT03716050|58763013|FG004|Overall Study|Protocol Violation|0|||
30753278|NCT03716050|58763014|FG005|Overall Study|Protocol Violation|0|||
30753279|NCT03716050|58763015|FG006|Overall Study|Protocol Violation|0|||
30753280|NCT03716050|58763016|FG007|Overall Study|Protocol Violation|2|||
30753281|NCT00413231|58763033|FG000|0 to 30-day Post Treatment|Death|5|||
30753282|NCT00413231|58763033|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
30753283|NCT00413231|58763033|FG000|30-day to 365-day Post Treatment|Death|13|||
30753284|NCT00413231|58763033|FG000|365-day to 60-month Post Treatment|Death|36|||
30753285|NCT00413231|58763033|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
30753286|NCT00413231|58763033|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
30753287|NCT00413231|58763033|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
30753288|NCT00413153|58763053|FG000|Overall Study|Withdrawal by Subject|1|||
30753289|NCT00413153|58763054|FG001|Overall Study|Withdrawal by Subject|1|||
30753290|NCT00413153|58763053|FG000|Overall Study|Adverse Event|1|||
30753291|NCT00413153|58763054|FG001|Overall Study|Adverse Event|0|||
30753292|NCT00412607|58763060|FG000|Overall Study|Withdrawal by Subject|9|||
30753293|NCT00412607|58763060|FG000|Overall Study|Lost to Follow-up|19|||
30753294|NCT00412607|58763060|FG000|Overall Study|Death|61|||
30753295|NCT00412607|58763060|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
30753296|NCT00419003|58763069|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
30753297|NCT00419003|58763070|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
30753298|NCT00419003|58763069|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
30753299|NCT00419003|58763070|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
30753300|NCT00418691|58763082|FG000|Overall Study|Lost to Follow-up|1|||
30753301|NCT00418691|58763083|FG001|Overall Study|Lost to Follow-up|2|||
30753302|NCT00418691|58763084|FG002|Overall Study|Lost to Follow-up|3|||
30753303|NCT00418691|58763082|FG000|Overall Study|Started new medication voiding entry|0|||
30753304|NCT00418691|58763083|FG001|Overall Study|Started new medication voiding entry|0|||
30753305|NCT00418691|58763084|FG002|Overall Study|Started new medication voiding entry|1|||
30753306|NCT00418691|58763082|FG000|Overall Study|Progressive Disease|1|||
30823343|NCT03107377|58845012|FG001|Overall Study|Physician Decision|6|||
30753307|NCT00418691|58763083|FG001|Overall Study|Progressive Disease|0|||
30753308|NCT00418691|58763084|FG002|Overall Study|Progressive Disease|1|||
30753309|NCT00412373|58763094|FG000|Overall Study|Adverse Event|8|||
30823344|NCT03107377|58845011|FG000|Overall Study|Pregnancy|7|||
30823345|NCT03107377|58845012|FG001|Overall Study|Pregnancy|7|||
30823346|NCT03107377|58845011|FG000|Overall Study|Withdrawal by Subject|16|||
30823347|NCT03107377|58845012|FG001|Overall Study|Withdrawal by Subject|22|||
30823348|NCT03107377|58845011|FG000|Overall Study|Lost to Follow-up|37|||
30823349|NCT03107377|58845012|FG001|Overall Study|Lost to Follow-up|34|||
30823350|NCT03107377|58845011|FG000|Overall Study|Other reason not specified|16|||
30823351|NCT03107377|58845012|FG001|Overall Study|Other reason not specified|15|||
30823352|NCT02545283|58845020|FG000|Overall Study|Lost to Follow-up|2|||
30823353|NCT02545283|58845021|FG001|Overall Study|Lost to Follow-up|4|||
30823354|NCT02545283|58845020|FG000|Overall Study|Withdrawal by Subject|5|||
30823355|NCT02545283|58845021|FG001|Overall Study|Withdrawal by Subject|9|||
30823356|NCT02545283|58845020|FG000|Overall Study|Death|109|||
30823357|NCT02545283|58845021|FG001|Overall Study|Death|211|||
30823358|NCT02545283|58845020|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
30823359|NCT02545283|58845021|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
30823360|NCT02545283|58845020|FG000|Overall Study|Study Terminated By Sponsor|33|||
30823361|NCT02545283|58845021|FG001|Overall Study|Study Terminated By Sponsor|71|||
30823362|NCT03282565|58845032|FG000|Overall Study|COVID-19 Research Shutdown|0|||
30823363|NCT03282565|58845033|FG001|Overall Study|COVID-19 Research Shutdown|2|||
30823364|NCT03282565|58845034|FG002|Overall Study|COVID-19 Research Shutdown|2|||
30823365|NCT02875613|58845042|FG000|Overall Study|Withdrawal by Subject|1|||
30823366|NCT02815267|58845052|FG000|Double-Blind Phase|Adverse Event|0|||
30823367|NCT02815267|58845053|FG001|Double-Blind Phase|Adverse Event|3|||
30823368|NCT02815267|58845052|FG000|Double-Blind Phase|Lost to Follow-up|17|||
30823369|NCT02815267|58845053|FG001|Double-Blind Phase|Lost to Follow-up|9|||
30823370|NCT02815267|58845052|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
30823371|NCT02815267|58845053|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
30823372|NCT02815267|58845052|FG000|Double-Blind Phase|Protocol Violation|3|||
30823373|NCT02815267|58845053|FG001|Double-Blind Phase|Protocol Violation|2|||
30823374|NCT02815267|58845052|FG000|Double-Blind Phase|Site withdrawal|1|||
30823375|NCT02815267|58845053|FG001|Double-Blind Phase|Site withdrawal|6|||
30823376|NCT02815267|58845052|FG000|Double-Blind Phase|Received a disallowed medication|1|||
30823377|NCT02815267|58845053|FG001|Double-Blind Phase|Received a disallowed medication|1|||
30823378|NCT02815267|58845052|FG000|Open-Label Phase|Adverse Event|1|||
30823379|NCT02815267|58845053|FG001|Open-Label Phase|Adverse Event|1|||
30823380|NCT02815267|58845052|FG000|Open-Label Phase|Lost to Follow-up|23|||
30823381|NCT02815267|58845053|FG001|Open-Label Phase|Lost to Follow-up|9|||
30823382|NCT02815267|58845052|FG000|Open-Label Phase|Withdrawal by Subject|24|||
30823383|NCT02815267|58845053|FG001|Open-Label Phase|Withdrawal by Subject|13|||
30823384|NCT02815267|58845052|FG000|Open-Label Phase|Protocol Violation|0|||
30823385|NCT02815267|58845053|FG001|Open-Label Phase|Protocol Violation|1|||
30823386|NCT02815267|58845052|FG000|Open-Label Phase|Administrative|21|||
30823387|NCT02815267|58845053|FG001|Open-Label Phase|Administrative|12|||
30823388|NCT02815267|58845052|FG000|Open-Label Phase|Other|2|||
30823389|NCT02815267|58845053|FG001|Open-Label Phase|Other|5|||
30823390|NCT02930837|58845063|FG000|Overall Study|Adverse Event|6|||
30823391|NCT02930837|58845063|FG000|Overall Study|Lost to Follow-up|5|||
30823392|NCT02930837|58845063|FG000|Overall Study|Withdrawal by Subject|1|||
30823393|NCT01343277|58845069|FG000|Overall Study|Other|3|||
30823394|NCT01343277|58845070|FG001|Overall Study|Other|3|||
30823395|NCT01343277|58845069|FG000|Overall Study|Withdrawal by Subject|18|||
30823396|NCT01343277|58845070|FG001|Overall Study|Withdrawal by Subject|13|||
30823397|NCT01343277|58845069|FG000|Overall Study|Physician Decision|1|||
30823398|NCT01343277|58845070|FG001|Overall Study|Physician Decision|2|||
30823399|NCT01343277|58845069|FG000|Overall Study|Death|10|||
30823400|NCT01343277|58845070|FG001|Overall Study|Death|1|||
30823401|NCT01343277|58845069|FG000|Overall Study|Adverse Event|67|||
30823402|NCT01343277|58845070|FG001|Overall Study|Adverse Event|13|||
30823403|NCT01343277|58845069|FG000|Overall Study|Disease progression|270|||
30823404|NCT01343277|58845070|FG001|Overall Study|Disease progression|138|||
30823405|NCT01343277|58845069|FG000|Overall Study|Randomized not treated|6|||
30823406|NCT01343277|58845070|FG001|Overall Study|Randomized not treated|21|||
30823407|NCT01343277|58845069|FG000|Overall Study|Treatment ongoing|8|||
30823408|NCT01343277|58845070|FG001|Overall Study|Treatment ongoing|2|||
30823409|NCT01343277|58845069|FG000|Overall Study|Subsequent anticancer therapy|1|||
30914335|NCT01539538|58949840|FG000|Overall Study|PCA no longer required or PCA problem|3|||
30823410|NCT01343277|58845070|FG001|Overall Study|Subsequent anticancer therapy|0|||
30823411|NCT03135899|58845084|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
30823412|NCT03135899|58845085|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
30823413|NCT03135899|58845086|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
30823414|NCT03135899|58845087|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
30823415|NCT03135899|58845088|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
30823416|NCT03135899|58845089|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
30823417|NCT03135899|58845090|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
30823418|NCT03135899|58845091|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
30823419|NCT03135899|58845084|FG000|Overall Study|Withdrawal by Subject|0|||
30823420|NCT03135899|58845085|FG001|Overall Study|Withdrawal by Subject|0|||
30823421|NCT03135899|58845086|FG002|Overall Study|Withdrawal by Subject|0|||
30823422|NCT03135899|58845087|FG003|Overall Study|Withdrawal by Subject|0|||
30823423|NCT03135899|58845088|FG004|Overall Study|Withdrawal by Subject|0|||
30914336|NCT01539538|58949841|FG001|Overall Study|PCA no longer required or PCA problem|7|||
30914337|NCT01562548|58949851|FG000|Overall Study|Lost to Follow-up|0|||
30914338|NCT01562548|58949852|FG001|Overall Study|Lost to Follow-up|0|||
30914339|NCT01562548|58949853|FG002|Overall Study|Lost to Follow-up|1|||
30914340|NCT01562548|58949854|FG003|Overall Study|Lost to Follow-up|0|||
30914341|NCT01562314|58949868|FG000|Overall Study|Adverse Event|10|||
30914342|NCT01562314|58949869|FG001|Overall Study|Adverse Event|5|||
30914343|NCT01562314|58949868|FG000|Overall Study|Met Withdrawal Criteria|3|||
30914344|NCT01562314|58949869|FG001|Overall Study|Met Withdrawal Criteria|2|||
30914345|NCT01562314|58949868|FG000|Overall Study|Withdrawal by Subject|0|||
30914346|NCT01562314|58949869|FG001|Overall Study|Withdrawal by Subject|1|||
30914347|NCT01539226|58949877|FG000|Overall Study|Withdrawal by Subject|24|||
30914348|NCT01539226|58949878|FG001|Overall Study|Withdrawal by Subject|54|||
30914349|NCT01539226|58949877|FG000|Overall Study|Lost to Follow-up|20|||
30914350|NCT01539226|58949878|FG001|Overall Study|Lost to Follow-up|54|||
30914351|NCT01539226|58949877|FG000|Overall Study|Death|1|||
30914352|NCT01539226|58949878|FG001|Overall Study|Death|2|||
30914353|NCT01539226|58949877|FG000|Overall Study|Adverse Event|2|||
30914354|NCT01539226|58949878|FG001|Overall Study|Adverse Event|0|||
30914355|NCT01539226|58949877|FG000|Overall Study|Pregnancy|13|||
30914356|NCT01539226|58949878|FG001|Overall Study|Pregnancy|29|||
30914357|NCT01539226|58949877|FG000|Overall Study|inappropriate enrollment|0|||
30914358|NCT01539226|58949878|FG001|Overall Study|inappropriate enrollment|1|||
30914359|NCT01539226|58949877|FG000|Overall Study|Multiple Reasons|3|||
30914360|NCT01539226|58949878|FG001|Overall Study|Multiple Reasons|1|||
30914361|NCT01539226|58949877|FG000|Overall Study|not HIV seroconversion-related|93|||
30914362|NCT01539226|58949878|FG001|Overall Study|not HIV seroconversion-related|176|||
30823424|NCT03135899|58845089|FG005|Overall Study|Withdrawal by Subject|2|||
30823425|NCT03135899|58845090|FG006|Overall Study|Withdrawal by Subject|0|||
30823426|NCT03135899|58845091|FG007|Overall Study|Withdrawal by Subject|0|||
30823427|NCT02487979|58845105|FG000|Overall Study|Physician Decision|2|||
30823428|NCT02487979|58845105|FG000|Overall Study|Withdrawal by Subject|2|||
30823429|NCT02487979|58845105|FG000|Overall Study|Progressive Disease|17|||
30823430|NCT03103087|58845116|FG000|Overall Study|Did not receive any study drug|1|||
30823431|NCT03103087|58845117|FG001|Overall Study|Did not receive any study drug|0|||
30823432|NCT03103087|58845118|FG002|Overall Study|Did not receive any study drug|0|||
30823433|NCT03103087|58845116|FG000|Overall Study|Protocol Violation|1|||
30823434|NCT03103087|58845117|FG001|Overall Study|Protocol Violation|2|||
30823435|NCT03103087|58845118|FG002|Overall Study|Protocol Violation|1|||
30823436|NCT03103087|58845116|FG000|Overall Study|Lack of Efficacy|2|||
30823437|NCT03103087|58845117|FG001|Overall Study|Lack of Efficacy|1|||
30823438|NCT03103087|58845118|FG002|Overall Study|Lack of Efficacy|1|||
30823439|NCT03103087|58845116|FG000|Overall Study|Pregnancy|0|||
30823440|NCT03103087|58845117|FG001|Overall Study|Pregnancy|0|||
30914363|NCT01539226|58949877|FG000|Overall Study|HIV seroconversion-related|55|||
30914364|NCT01539226|58949878|FG001|Overall Study|HIV seroconversion-related|80|||
30914365|NCT01539226|58949877|FG000|Overall Study|Non-compliance|6|||
30914366|NCT01539226|58949878|FG001|Overall Study|Non-compliance|8|||
30914367|NCT01577758|58949884|FG000|Dose Escalation Phase|Adverse Event|0|||
30914368|NCT01577758|58949885|FG001|Dose Escalation Phase|Adverse Event|0|||
30914369|NCT01577758|58949886|FG002|Dose Escalation Phase|Adverse Event|0|||
30914370|NCT01577758|58949887|FG003|Dose Escalation Phase|Adverse Event|0|||
30914371|NCT01577758|58949888|FG004|Dose Escalation Phase|Adverse Event|0|||
30914372|NCT01577758|58949889|FG005|Dose Escalation Phase|Adverse Event|2|||
30914373|NCT01577758|58949890|FG006|Dose Escalation Phase|Adverse Event|1|||
30914374|NCT01577758|58949891|FG007|Dose Escalation Phase|Adverse Event|0|||
30914375|NCT01577758|58949884|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
30914376|NCT01577758|58949885|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
30914377|NCT01577758|58949886|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
30914378|NCT01577758|58949887|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
30823441|NCT03103087|58845118|FG002|Overall Study|Pregnancy|1|||
30823442|NCT03103087|58845116|FG000|Overall Study|Adverse Event|2|||
30823443|NCT03103087|58845117|FG001|Overall Study|Adverse Event|15|||
30823444|NCT03103087|58845118|FG002|Overall Study|Adverse Event|6|||
30914379|NCT01577758|58949888|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
30914380|NCT01577758|58949889|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
30914381|NCT01577758|58949890|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
30823445|NCT03103087|58845116|FG000|Overall Study|Withdrawal by Subject|13|||
30914382|NCT01577758|58949891|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
30914383|NCT01577758|58949884|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
30914384|NCT01577758|58949885|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
30914385|NCT01577758|58949886|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
30914386|NCT01577758|58949887|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
30914387|NCT01577758|58949888|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
30914388|NCT01577758|58949889|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
30914389|NCT01577758|58949890|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
30914390|NCT01577758|58949891|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
30623137|NCT00918580|58634962|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
30823446|NCT03103087|58845117|FG001|Overall Study|Withdrawal by Subject|6|||
30823447|NCT03103087|58845118|FG002|Overall Study|Withdrawal by Subject|6|||
30823448|NCT03103087|58845116|FG000|Overall Study|Lost to Follow-up|4|||
30823449|NCT03103087|58845117|FG001|Overall Study|Lost to Follow-up|2|||
30823450|NCT03103087|58845118|FG002|Overall Study|Lost to Follow-up|7|||
30823451|NCT03103087|58845116|FG000|Overall Study|Other reason not reported|1|||
30823452|NCT03103087|58845117|FG001|Overall Study|Other reason not reported|3|||
30823453|NCT03103087|58845118|FG002|Overall Study|Other reason not reported|5|||
30823454|NCT03131999|58845130|FG000|Overall Study|Withdrawal by Subject|0|||
30823455|NCT03131999|58845131|FG001|Overall Study|Withdrawal by Subject|1|||
30823456|NCT02263885|58845146|FG000|Overall Study|Withdrawal by Subject|7|||
30823457|NCT02263885|58845146|FG000|Overall Study|Alternative Treatment|3|||
30823458|NCT02000219|58845151|FG000|14-Week Study Period|Physician Decision|1|||
30823459|NCT02000219|58845151|FG000|14-Week Study Period|Adverse Event|1|||
30823460|NCT02000219|58845151|FG000|14-Week Study Period|Underwent transplantation|1|||
30823461|NCT02000219|58845151|FG000|Continuation Period|Withdrawal by Subject|1|||
30823462|NCT02000219|58845151|FG000|Continuation Period|Had liver transplant|2|||
30823463|NCT02000219|58845151|FG000|Continuation Period|Non-compliance with study drug|2|||
30823464|NCT03101371|58845157|FG000|Overall Study|Physician Decision|0|||
30823465|NCT03101371|58845158|FG001|Overall Study|Physician Decision|1|||
30823466|NCT03101371|58845157|FG000|Overall Study|Lost to Follow-up|1|||
30823467|NCT03101371|58845158|FG001|Overall Study|Lost to Follow-up|4|||
30823468|NCT03101371|58845157|FG000|Overall Study|Did not meet eligibility criteria|2|||
30823469|NCT03101371|58845158|FG001|Overall Study|Did not meet eligibility criteria|1|||
30823470|NCT02850276|58845164|FG000|Overall Study|screen failure|43|||
30823471|NCT02850276|58845164|FG000|Overall Study|Withdrawal by Subject|14|||
30823472|NCT02850276|58845164|FG000|Overall Study|Physician Decision|2|||
30823473|NCT02850276|58845164|FG000|Overall Study|Lost to Follow-up|2|||
30823474|NCT02783768|58845169|FG000|Overall Study|Lost to Follow-up|1|||
30823475|NCT02783768|58845170|FG001|Overall Study|Lost to Follow-up|0|||
30823476|NCT03131687|58845182|FG000|Overall Study|Adverse Event|0|||
30823477|NCT03131687|58845183|FG001|Overall Study|Adverse Event|1|||
30823478|NCT03131687|58845184|FG002|Overall Study|Adverse Event|0|||
30823479|NCT03131687|58845185|FG003|Overall Study|Adverse Event|1|||
30823480|NCT03131687|58845186|FG004|Overall Study|Adverse Event|2|||
30823481|NCT03131687|58845187|FG005|Overall Study|Adverse Event|2|||
30823482|NCT03131687|58845182|FG000|Overall Study|Death|1|||
30823483|NCT03131687|58845183|FG001|Overall Study|Death|0|||
30823484|NCT03131687|58845184|FG002|Overall Study|Death|0|||
30823485|NCT03131687|58845185|FG003|Overall Study|Death|0|||
30823486|NCT03131687|58845186|FG004|Overall Study|Death|0|||
30823487|NCT03131687|58845187|FG005|Overall Study|Death|0|||
30823488|NCT03131687|58845182|FG000|Overall Study|Withdrawal by Subject|3|||
30823489|NCT03131687|58845183|FG001|Overall Study|Withdrawal by Subject|3|||
30823490|NCT03131687|58845184|FG002|Overall Study|Withdrawal by Subject|3|||
30823491|NCT03131687|58845185|FG003|Overall Study|Withdrawal by Subject|1|||
30823492|NCT03131687|58845186|FG004|Overall Study|Withdrawal by Subject|2|||
30823493|NCT03131687|58845187|FG005|Overall Study|Withdrawal by Subject|1|||
30823494|NCT03131687|58845182|FG000|Overall Study|Lost to Follow-up|1|||
30823495|NCT03131687|58845183|FG001|Overall Study|Lost to Follow-up|4|||
30823496|NCT03131687|58845184|FG002|Overall Study|Lost to Follow-up|0|||
30823497|NCT03131687|58845185|FG003|Overall Study|Lost to Follow-up|1|||
30823498|NCT03131687|58845186|FG004|Overall Study|Lost to Follow-up|4|||
30823499|NCT03131687|58845187|FG005|Overall Study|Lost to Follow-up|2|||
30823500|NCT03131687|58845182|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
30823501|NCT03131687|58845183|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
30823502|NCT03131687|58845184|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
30823503|NCT03131687|58845185|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
30823504|NCT03131687|58845186|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
30914391|NCT01577758|58949884|FG000|Dose Escalation Phase|Progression Disease|2|||
30914392|NCT01577758|58949885|FG001|Dose Escalation Phase|Progression Disease|2|||
30823505|NCT03131687|58845187|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
30823506|NCT03131687|58845182|FG000|Overall Study|Principle Investigator Decision|0|||
30823507|NCT03131687|58845183|FG001|Overall Study|Principle Investigator Decision|1|||
30823508|NCT03131687|58845184|FG002|Overall Study|Principle Investigator Decision|0|||
30823509|NCT03131687|58845185|FG003|Overall Study|Principle Investigator Decision|0|||
30823510|NCT03131687|58845186|FG004|Overall Study|Principle Investigator Decision|0|||
30823511|NCT03131687|58845187|FG005|Overall Study|Principle Investigator Decision|0|||
30823512|NCT03131687|58845182|FG000|Overall Study|Inadvertent Enrollment|0|||
30823513|NCT03131687|58845183|FG001|Overall Study|Inadvertent Enrollment|0|||
30823514|NCT03131687|58845184|FG002|Overall Study|Inadvertent Enrollment|0|||
30823515|NCT03131687|58845185|FG003|Overall Study|Inadvertent Enrollment|1|||
30823516|NCT03131687|58845186|FG004|Overall Study|Inadvertent Enrollment|0|||
30823517|NCT03131687|58845187|FG005|Overall Study|Inadvertent Enrollment|0|||
30823518|NCT03101293|58845216|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
30823519|NCT03101293|58845217|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
30823520|NCT02850978|58845223|FG000|Overall Study|Uncollectable CRF|27|||
30823521|NCT02850978|58845223|FG000|Overall Study|No visit since the first visit|35|||
30823522|NCT02850978|58845223|FG000|Overall Study|Adverse Event|81|||
30823523|NCT02850978|58845223|FG000|Overall Study|Lack of Efficacy|40|||
30823524|NCT02850978|58845223|FG000|Overall Study|Improvement in condition|34|||
30823525|NCT02850978|58845223|FG000|Overall Study|Lost to Follow-up|121|||
30823526|NCT02850978|58845223|FG000|Overall Study|Reason not listed|88|||
30823527|NCT03135431|58845229|FG000|Overall Study|Study Surgeon not available|2|||
30823528|NCT03135431|58845230|FG001|Overall Study|Study Surgeon not available|0|||
30823529|NCT04534517|58845252|FG000|Overall Study|Adverse Event|1|||
30823530|NCT04534517|58845252|FG000|Overall Study|Withdrawal by Subject|1|||
30823531|NCT04534517|58845252|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
30823532|NCT04534517|58845252|FG000|Overall Study|COVID-19 Related|1|||
30823533|NCT02831257|58845256|FG000|Overall Study|Lack of Efficacy|3|||
30823534|NCT02831257|58845256|FG000|Overall Study|Adverse Event|2|||
30823535|NCT02831257|58845256|FG000|Overall Study|Physician Decision|1|||
30823536|NCT02831257|58845256|FG000|Overall Study|Withdrawal by Subject|6|||
30823537|NCT03100825|58845260|FG000|Overall Study|Participant/Guardian Decision|7|||
30823538|NCT03100825|58845260|FG000|Overall Study|Physician Decision|1|||
30823539|NCT02250534|58845267|FG000|Overall Study|Lost to Follow-up|18|||
30823540|NCT02250534|58845268|FG001|Overall Study|Lost to Follow-up|28|||
30823541|NCT02250534|58845269|FG002|Overall Study|Lost to Follow-up|33|||
30823542|NCT02250534|58845267|FG000|Overall Study|Personal reasons|7|||
30823543|NCT02250534|58845268|FG001|Overall Study|Personal reasons|8|||
30823544|NCT02250534|58845269|FG002|Overall Study|Personal reasons|14|||
30823545|NCT02250534|58845267|FG000|Overall Study|Adverse Event|6|||
30823546|NCT02250534|58845268|FG001|Overall Study|Adverse Event|3|||
30823547|NCT02250534|58845269|FG002|Overall Study|Adverse Event|8|||
30823548|NCT02250534|58845267|FG000|Overall Study|incarcerated|2|||
30823549|NCT02250534|58845268|FG001|Overall Study|incarcerated|1|||
30823550|NCT02250534|58845269|FG002|Overall Study|incarcerated|2|||
30823551|NCT02250534|58845267|FG000|Overall Study|Withdrawal by Subject|0|||
30823552|NCT02250534|58845268|FG001|Overall Study|Withdrawal by Subject|1|||
30823553|NCT02250534|58845269|FG002|Overall Study|Withdrawal by Subject|2|||
30823554|NCT02250534|58845267|FG000|Overall Study|Death|0|||
30823555|NCT02250534|58845268|FG001|Overall Study|Death|1|||
30823556|NCT02250534|58845269|FG002|Overall Study|Death|1|||
30823557|NCT02250534|58845267|FG000|Overall Study|Physician Decision|1|||
30823558|NCT02250534|58845268|FG001|Overall Study|Physician Decision|3|||
30823559|NCT02250534|58845269|FG002|Overall Study|Physician Decision|1|||
30823560|NCT02250534|58845267|FG000|Overall Study|Protocol Violation|1|||
30823561|NCT02250534|58845268|FG001|Overall Study|Protocol Violation|0|||
30823562|NCT02250534|58845269|FG002|Overall Study|Protocol Violation|1|||
30823563|NCT02250534|58845267|FG000|Overall Study|Reason unknown|1|||
30823564|NCT02250534|58845268|FG001|Overall Study|Reason unknown|0|||
30823565|NCT02250534|58845269|FG002|Overall Study|Reason unknown|0|||
30823566|NCT02848326|58845283|FG000|Treatment Period|Adverse Event|5|||
30823567|NCT02848326|58845284|FG001|Treatment Period|Adverse Event|4|||
30823568|NCT02848326|58845285|FG002|Treatment Period|Adverse Event|11|||
30823569|NCT02848326|58845286|FG003|Treatment Period|Adverse Event|6|||
30823570|NCT02848326|58845287|FG004|Treatment Period|Adverse Event|5|||
30823571|NCT02848326|58845288|FG005|Treatment Period|Adverse Event|7|||
30823572|NCT02848326|58845283|FG000|Treatment Period|Withdrawal of Consent|20|||
30823573|NCT02848326|58845284|FG001|Treatment Period|Withdrawal of Consent|6|||
30823574|NCT02848326|58845285|FG002|Treatment Period|Withdrawal of Consent|9|||
30823575|NCT02848326|58845286|FG003|Treatment Period|Withdrawal of Consent|6|||
30823576|NCT02848326|58845287|FG004|Treatment Period|Withdrawal of Consent|9|||
30823577|NCT02848326|58845288|FG005|Treatment Period|Withdrawal of Consent|6|||
30823578|NCT02848326|58845283|FG000|Treatment Period|Lost to Follow-up|5|||
30823579|NCT02848326|58845284|FG001|Treatment Period|Lost to Follow-up|1|||
30823580|NCT02848326|58845285|FG002|Treatment Period|Lost to Follow-up|11|||
30823581|NCT02848326|58845286|FG003|Treatment Period|Lost to Follow-up|7|||
30823582|NCT02848326|58845287|FG004|Treatment Period|Lost to Follow-up|2|||
30823583|NCT02848326|58845288|FG005|Treatment Period|Lost to Follow-up|3|||
30823584|NCT02848326|58845283|FG000|Treatment Period|Pregnancy|0|||
30823585|NCT02848326|58845284|FG001|Treatment Period|Pregnancy|0|||
30823586|NCT02848326|58845285|FG002|Treatment Period|Pregnancy|1|||
30823587|NCT02848326|58845286|FG003|Treatment Period|Pregnancy|1|||
30823588|NCT02848326|58845287|FG004|Treatment Period|Pregnancy|0|||
30823589|NCT02848326|58845288|FG005|Treatment Period|Pregnancy|1|||
30823590|NCT02848326|58845283|FG000|Treatment Period|Protocol Violation|4|||
30823591|NCT02848326|58845284|FG001|Treatment Period|Protocol Violation|3|||
30823592|NCT02848326|58845285|FG002|Treatment Period|Protocol Violation|4|||
30823593|NCT02848326|58845286|FG003|Treatment Period|Protocol Violation|2|||
30823594|NCT02848326|58845287|FG004|Treatment Period|Protocol Violation|3|||
30823595|NCT02848326|58845288|FG005|Treatment Period|Protocol Violation|3|||
30823596|NCT02848326|58845283|FG000|Treatment Period|Non-compliance with Study Drug|4|||
30823597|NCT02848326|58845284|FG001|Treatment Period|Non-compliance with Study Drug|0|||
30823598|NCT02848326|58845285|FG002|Treatment Period|Non-compliance with Study Drug|0|||
30823599|NCT02848326|58845286|FG003|Treatment Period|Non-compliance with Study Drug|1|||
30823600|NCT02848326|58845287|FG004|Treatment Period|Non-compliance with Study Drug|0|||
30823601|NCT02848326|58845288|FG005|Treatment Period|Non-compliance with Study Drug|0|||
30823602|NCT02848326|58845283|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
30823603|NCT02848326|58845284|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
30823604|NCT02848326|58845285|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
30823605|NCT02848326|58845286|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
30823606|NCT02848326|58845287|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
30823607|NCT02848326|58845288|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
30823608|NCT02848326|58845283|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
30823609|NCT02848326|58845284|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
30823610|NCT02848326|58845285|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
30823611|NCT02848326|58845286|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
30823612|NCT02848326|58845287|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
30823613|NCT02848326|58845288|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
30823614|NCT03128723|58845302|FG000|Overall Study|Withdrawal by Subject|2|||
30823615|NCT03128411|58845306|FG000|Treatment Phase|Adverse Event|21|||
30823616|NCT03128411|58845306|FG000|Treatment Phase|Physician Decision|1|||
30823617|NCT03128411|58845306|FG000|Treatment Phase|Other|2|||
30823618|NCT03128411|58845306|FG000|Long Term Follow-up Phase|Death|2|||
30823619|NCT02847858|58845312|FG000|Overall Study|Lost to Follow-up|401|||
30823620|NCT02847858|58845313|FG001|Overall Study|Lost to Follow-up|269|||
30823621|NCT03124199|58845324|FG000|Overall Study|Lost to Follow-up|4|||
30823622|NCT04465916|58845330|FG000|Overall Study|Withdrawal by Subject|0|||
30823623|NCT04465916|58845331|FG001|Overall Study|Withdrawal by Subject|1|||
30753310|NCT00412373|58763095|FG001|Overall Study|Adverse Event|13|||
30753311|NCT00412373|58763094|FG000|Overall Study|Lack of Efficacy|16|||
30753312|NCT00412373|58763095|FG001|Overall Study|Lack of Efficacy|22|||
30753313|NCT00412373|58763094|FG000|Overall Study|Lost to Follow-up|7|||
30753314|NCT00412373|58763095|FG001|Overall Study|Lost to Follow-up|13|||
30753315|NCT00412373|58763094|FG000|Overall Study|Withdrawal by Subject|8|||
30753316|NCT00412373|58763095|FG001|Overall Study|Withdrawal by Subject|27|||
30753317|NCT00412373|58763094|FG000|Overall Study|Other|2|||
30753318|NCT00412373|58763095|FG001|Overall Study|Other|2|||
30753319|NCT00418379|58763104|FG000|Year 1|Adverse Event|9|||
30753320|NCT00418379|58763105|FG001|Year 1|Adverse Event|15|||
30753321|NCT00418379|58763106|FG002|Year 1|Adverse Event|3|||
30753322|NCT00418379|58763104|FG000|Year 1|Withdrawal by Subject|7|||
30753323|NCT00418379|58763105|FG001|Year 1|Withdrawal by Subject|8|||
30753324|NCT00418379|58763106|FG002|Year 1|Withdrawal by Subject|5|||
30753325|NCT00418379|58763104|FG000|Year 1|Any other reason not above-mentioned|2|||
30753326|NCT00418379|58763105|FG001|Year 1|Any other reason not above-mentioned|5|||
30753327|NCT00418379|58763106|FG002|Year 1|Any other reason not above-mentioned|7|||
30753328|NCT00418379|58763104|FG000|Year 2|Adverse Event|5|||
30753329|NCT00418379|58763105|FG001|Year 2|Adverse Event|2|||
30753330|NCT00418379|58763106|FG002|Year 2|Adverse Event|1|||
30753331|NCT00418379|58763104|FG000|Year 2|Withdrawal by Subject|1|||
30753332|NCT00418379|58763105|FG001|Year 2|Withdrawal by Subject|1|||
30753333|NCT00418379|58763106|FG002|Year 2|Withdrawal by Subject|3|||
30753334|NCT00418379|58763104|FG000|Year 2|Any other reason not above-mentioned|2|||
30753335|NCT00418379|58763105|FG001|Year 2|Any other reason not above-mentioned|1|||
30753336|NCT00418379|58763106|FG002|Year 2|Any other reason not above-mentioned|6|||
30753337|NCT00418379|58763104|FG000|Year 3|Withdrawal by Subject|1|||
30753338|NCT00418379|58763105|FG001|Year 3|Withdrawal by Subject|1|||
30823624|NCT05090852|58845337|FG000|Overall Study|Physician Decision|5|||
30823625|NCT00075816|58845352|FG000|Overall Study|Did not undergo transplantation|14|||
30823626|NCT00075816|58845353|FG001|Overall Study|Did not undergo transplantation|11|||
30823627|NCT00109772|58845367|FG000|Double-blind Treatment|Adverse Event|14|||
30823628|NCT00109772|58845368|FG001|Double-blind Treatment|Adverse Event|5|||
30753339|NCT00418379|58763106|FG002|Year 3|Withdrawal by Subject|2|||
30823629|NCT00109772|58845367|FG000|Double-blind Treatment|Lack of Efficacy|1|||
30823630|NCT00109772|58845368|FG001|Double-blind Treatment|Lack of Efficacy|0|||
30823631|NCT00109772|58845367|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
30823632|NCT00109772|58845368|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
30823633|NCT00109772|58845367|FG000|Double-blind Treatment|Lost to Follow-up|2|||
30823634|NCT00109772|58845368|FG001|Double-blind Treatment|Lost to Follow-up|3|||
30823635|NCT00109772|58845367|FG000|Double-blind Treatment|Protocol Violation|0|||
30823636|NCT00109772|58845368|FG001|Double-blind Treatment|Protocol Violation|1|||
30823637|NCT00109772|58845367|FG000|Double-blind Treatment|Other|0|||
30823638|NCT00109772|58845368|FG001|Double-blind Treatment|Other|4|||
30823639|NCT00109772|58845367|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
30823640|NCT00109772|58845368|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
30823641|NCT00109772|58845367|FG000|Open-label Extension|Adverse Event|10|||
30823642|NCT00109772|58845368|FG001|Open-label Extension|Adverse Event|19|||
30823643|NCT00109772|58845367|FG000|Open-label Extension|Lack of Efficacy|19|||
30823644|NCT00109772|58845368|FG001|Open-label Extension|Lack of Efficacy|11|||
30823645|NCT00109772|58845367|FG000|Open-label Extension|Withdrawal by Subject|9|||
30823646|NCT00109772|58845368|FG001|Open-label Extension|Withdrawal by Subject|6|||
30823647|NCT00109772|58845367|FG000|Open-label Extension|Lost to Follow-up|1|||
30823648|NCT00109772|58845368|FG001|Open-label Extension|Lost to Follow-up|0|||
30823649|NCT00109772|58845367|FG000|Open-label Extension|Death|0|||
30823650|NCT00109772|58845368|FG001|Open-label Extension|Death|1|||
30823651|NCT00109772|58845367|FG000|Open-label Extension|Protocol Violation|2|||
30823652|NCT00109772|58845368|FG001|Open-label Extension|Protocol Violation|2|||
30823653|NCT00109772|58845367|FG000|Open-label Extension|Other|4|||
30823654|NCT00109772|58845368|FG001|Open-label Extension|Other|10|||
30823655|NCT02783066|58845374|FG000|Overall Study|Withdrawal by Subject|13|||
30823656|NCT01371305|58845385|FG000|Overall Study|Adverse Event|0|||
30823657|NCT01371305|58845386|FG001|Overall Study|Adverse Event|0|||
30823658|NCT01371305|58845387|FG002|Overall Study|Adverse Event|0|||
30823659|NCT01371305|58845388|FG003|Overall Study|Adverse Event|2|||
30823660|NCT01371305|58845389|FG004|Overall Study|Adverse Event|1|||
30823661|NCT01371305|58845390|FG005|Overall Study|Adverse Event|0|||
30823662|NCT01371305|58845385|FG000|Overall Study|Study terminated by sponsor|0|||
30823663|NCT01371305|58845386|FG001|Overall Study|Study terminated by sponsor|0|||
30823664|NCT01371305|58845387|FG002|Overall Study|Study terminated by sponsor|0|||
30823665|NCT01371305|58845388|FG003|Overall Study|Study terminated by sponsor|0|||
30823666|NCT01371305|58845389|FG004|Overall Study|Study terminated by sponsor|3|||
30823667|NCT01371305|58845390|FG005|Overall Study|Study terminated by sponsor|1|||
30823668|NCT01371305|58845385|FG000|Overall Study|Subject request|0|||
30823669|NCT01371305|58845386|FG001|Overall Study|Subject request|0|||
30823670|NCT01371305|58845387|FG002|Overall Study|Subject request|0|||
30823671|NCT01371305|58845388|FG003|Overall Study|Subject request|0|||
30823672|NCT01371305|58845389|FG004|Overall Study|Subject request|0|||
30823673|NCT01371305|58845390|FG005|Overall Study|Subject request|1|||
30823674|NCT00109928|58845405|FG000|Overall Study|Adverse Event|2|||
30823675|NCT00109928|58845405|FG000|Overall Study|Progression|6|||
30823676|NCT00109928|58845405|FG000|Overall Study|Death|2|||
30823677|NCT00109928|58845405|FG000|Overall Study|not protocol specified|2|||
30823678|NCT00109928|58845405|FG000|Overall Study|not eligible|1|||
30823679|NCT00109850|58845410|FG000|Overall Study|Adverse Event|1|||
30823680|NCT00109850|58845410|FG000|Overall Study|Death|2|||
30823681|NCT00109850|58845410|FG000|Overall Study|Ineligible|1|||
30823682|NCT01342926|58845418|FG000|Overall Study|Adverse Event|5|||
30823683|NCT01342926|58845419|FG001|Overall Study|Adverse Event|8|||
30823684|NCT01342926|58845420|FG002|Overall Study|Adverse Event|10|||
30823685|NCT01342926|58845421|FG003|Overall Study|Adverse Event|7|||
30823686|NCT01342926|58845418|FG000|Overall Study|Lost to Follow-up|0|||
30823687|NCT01342926|58845419|FG001|Overall Study|Lost to Follow-up|1|||
30823688|NCT01342926|58845420|FG002|Overall Study|Lost to Follow-up|1|||
30823689|NCT01342926|58845421|FG003|Overall Study|Lost to Follow-up|0|||
30823690|NCT01342926|58845418|FG000|Overall Study|Investigator Discretion|2|||
30823691|NCT01342926|58845419|FG001|Overall Study|Investigator Discretion|2|||
30823692|NCT01342926|58845420|FG002|Overall Study|Investigator Discretion|0|||
30623138|NCT00920686|58634972|FG000|Overall Study|Lost to Follow-up|2|||
30623139|NCT00920686|58634973|FG001|Overall Study|Lost to Follow-up|3|||
30823693|NCT01342926|58845421|FG003|Overall Study|Investigator Discretion|0|||
30823694|NCT01342926|58845418|FG000|Overall Study|Withdrawal by Subject|2|||
30823695|NCT01342926|58845419|FG001|Overall Study|Withdrawal by Subject|4|||
30823696|NCT01342926|58845420|FG002|Overall Study|Withdrawal by Subject|3|||
30823697|NCT01342926|58845421|FG003|Overall Study|Withdrawal by Subject|5|||
30823698|NCT01810016|58845434|FG000|Overall Study|Progressive disease|1|||
30823699|NCT01810016|58845435|FG001|Overall Study|Progressive disease|1|||
30823700|NCT01810016|58845436|FG002|Overall Study|Progressive disease|0|||
30823701|NCT01810016|58845434|FG000|Overall Study|Death|0|||
30823702|NCT01810016|58845435|FG001|Overall Study|Death|0|||
30823703|NCT01810016|58845436|FG002|Overall Study|Death|1|||
30623140|NCT00920686|58634974|FG002|Overall Study|Lost to Follow-up|1|||
30823704|NCT02843178|58845448|FG000|Overall Study|Lost to Follow-up|8|||
30823705|NCT02843178|58845449|FG001|Overall Study|Lost to Follow-up|8|||
30823706|NCT02843178|58845450|FG002|Overall Study|Lost to Follow-up|6|||
30823707|NCT02843178|58845451|FG003|Overall Study|Lost to Follow-up|3|||
30823708|NCT02843178|58845448|FG000|Overall Study|Withdrawal by Subject|0|||
30823709|NCT02843178|58845449|FG001|Overall Study|Withdrawal by Subject|0|||
30823710|NCT02843178|58845450|FG002|Overall Study|Withdrawal by Subject|1|||
30823711|NCT02843178|58845451|FG003|Overall Study|Withdrawal by Subject|1|||
30823712|NCT01722266|58845465|FG000|Overall Study|Withdrawal by Subject|1|||
30823713|NCT01722266|58845466|FG001|Overall Study|Withdrawal by Subject|2|||
30823714|NCT01722266|58845467|FG002|Overall Study|Withdrawal by Subject|0|||
30823715|NCT01722266|58845468|FG003|Overall Study|Withdrawal by Subject|0|||
30823716|NCT01722266|58845465|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
30823717|NCT01722266|58845466|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
30823718|NCT01722266|58845467|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
30823719|NCT01722266|58845468|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
30823720|NCT01722266|58845465|FG000|Overall Study|Dropped out due to Nausea|0|||
30823721|NCT01722266|58845466|FG001|Overall Study|Dropped out due to Nausea|0|||
30823722|NCT01722266|58845467|FG002|Overall Study|Dropped out due to Nausea|2|||
30823723|NCT01722266|58845468|FG003|Overall Study|Dropped out due to Nausea|0|||
30823724|NCT03123185|58845492|FG000|Overall Study|Withdrawal by Subject|0|||
30823725|NCT03123185|58845493|FG001|Overall Study|Withdrawal by Subject|0|||
30823726|NCT03123185|58845494|FG002|Overall Study|Withdrawal by Subject|0|||
30823727|NCT03123185|58845495|FG003|Overall Study|Withdrawal by Subject|0|||
30823728|NCT03123185|58845496|FG004|Overall Study|Withdrawal by Subject|0|||
30823729|NCT03123185|58845497|FG005|Overall Study|Withdrawal by Subject|0|||
30823730|NCT03123185|58845498|FG006|Overall Study|Withdrawal by Subject|0|||
30823731|NCT03123185|58845499|FG007|Overall Study|Withdrawal by Subject|0|||
30823732|NCT03123185|58845500|FG008|Overall Study|Withdrawal by Subject|0|||
30823733|NCT03123185|58845501|FG009|Overall Study|Withdrawal by Subject|0|||
30823734|NCT03123185|58845502|FG010|Overall Study|Withdrawal by Subject|0|||
30823735|NCT03123185|58845503|FG011|Overall Study|Withdrawal by Subject|0|||
30823736|NCT03123185|58845504|FG012|Overall Study|Withdrawal by Subject|1|||
30823737|NCT03123185|58845505|FG013|Overall Study|Withdrawal by Subject|0|||
30823738|NCT02842866|58845564|FG000|Overall Study|Serious Adverse Event|0|||
30823739|NCT02842866|58845565|FG001|Overall Study|Serious Adverse Event|1|||
30823740|NCT02842866|58845564|FG000|Overall Study|Protocol Violation|4|||
30823741|NCT02842866|58845565|FG001|Overall Study|Protocol Violation|2|||
30823742|NCT02842866|58845564|FG000|Overall Study|Lost to Follow-up|2|||
30823743|NCT02842866|58845565|FG001|Overall Study|Lost to Follow-up|0|||
30823744|NCT02842866|58845564|FG000|Overall Study|Withdrawal by Subject|1|||
30823745|NCT02842866|58845565|FG001|Overall Study|Withdrawal by Subject|0|||
30823746|NCT01316913|58845575|FG000|Overall Study|Adverse Event|17|||
30823747|NCT01316913|58845576|FG001|Overall Study|Adverse Event|20|||
30823748|NCT01316913|58845577|FG002|Overall Study|Adverse Event|15|||
30823749|NCT01316913|58845578|FG003|Overall Study|Adverse Event|11|||
30823750|NCT01316913|58845575|FG000|Overall Study|Lack of Efficacy|22|||
30823751|NCT01316913|58845576|FG001|Overall Study|Lack of Efficacy|12|||
30823752|NCT01316913|58845577|FG002|Overall Study|Lack of Efficacy|9|||
30823753|NCT01316913|58845578|FG003|Overall Study|Lack of Efficacy|13|||
30823754|NCT01316913|58845575|FG000|Overall Study|Protocol Violation|1|||
30823755|NCT01316913|58845576|FG001|Overall Study|Protocol Violation|4|||
30823756|NCT01316913|58845577|FG002|Overall Study|Protocol Violation|4|||
30823757|NCT01316913|58845578|FG003|Overall Study|Protocol Violation|1|||
30823758|NCT01316913|58845575|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
30823759|NCT01316913|58845576|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
30823760|NCT01316913|58845577|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
30823761|NCT01316913|58845578|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
30823762|NCT01316913|58845575|FG000|Overall Study|Lost to Follow-up|0|||
30823763|NCT01316913|58845576|FG001|Overall Study|Lost to Follow-up|1|||
30823764|NCT01316913|58845577|FG002|Overall Study|Lost to Follow-up|0|||
30823765|NCT01316913|58845578|FG003|Overall Study|Lost to Follow-up|2|||
30823766|NCT01316913|58845575|FG000|Overall Study|Withdrawal by Subject|10|||
30823767|NCT01316913|58845576|FG001|Overall Study|Withdrawal by Subject|9|||
30623141|NCT00920686|58634972|FG000|Overall Study|Study drug dosing criteria not met|17|||
30623142|NCT00920686|58634973|FG001|Overall Study|Study drug dosing criteria not met|19|||
30823768|NCT01316913|58845577|FG002|Overall Study|Withdrawal by Subject|10|||
30823769|NCT01316913|58845578|FG003|Overall Study|Withdrawal by Subject|6|||
30823770|NCT02875067|58845589|FG000|Overall Study|Withdrawal by Subject|1|||
30823771|NCT02875067|58845589|FG000|Overall Study|Withdrawal by Termination of Study|5|||
30823772|NCT02781506|58845593|FG000|Overall Study|Adverse Event|5|||
30623143|NCT00920686|58634974|FG002|Overall Study|Study drug dosing criteria not met|12|||
30823773|NCT03132753|58845599|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
30823774|NCT03132753|58845600|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
30823775|NCT03132753|58845599|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
30823776|NCT03132753|58845600|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
30823777|NCT01468454|58845606|FG000|Overall Study|Did not have surgery after PET|9|||
30823778|NCT03067077|58845611|FG000|Overall Study|Did not receive surgery|4|||
30823779|NCT03067077|58845612|FG001|Overall Study|Did not receive surgery|5|||
30823780|NCT03067077|58845611|FG000|Overall Study|Lost to Follow-up|3|||
30823781|NCT03067077|58845612|FG001|Overall Study|Lost to Follow-up|2|||
30823782|NCT03096847|58845621|FG000|Overall Study|Other|2|||
30823783|NCT03096847|58845622|FG001|Overall Study|Other|1|||
30823784|NCT03096847|58845623|FG002|Overall Study|Other|2|||
30914393|NCT01577758|58949886|FG002|Dose Escalation Phase|Progression Disease|1|||
30914394|NCT01577758|58949887|FG003|Dose Escalation Phase|Progression Disease|2|||
30914395|NCT01577758|58949888|FG004|Dose Escalation Phase|Progression Disease|5|||
30914396|NCT01577758|58949889|FG005|Dose Escalation Phase|Progression Disease|0|||
30914397|NCT01577758|58949890|FG006|Dose Escalation Phase|Progression Disease|0|||
30914398|NCT01577758|58949891|FG007|Dose Escalation Phase|Progression Disease|0|||
30914399|NCT01577758|58949884|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
30914400|NCT01577758|58949885|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
30914401|NCT01577758|58949886|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
30914402|NCT01577758|58949887|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
30914403|NCT01577758|58949888|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
30914404|NCT01577758|58949889|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
30914405|NCT01577758|58949890|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
30914406|NCT01577758|58949891|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
30914407|NCT01577758|58949884|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
30914408|NCT01577758|58949885|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
30914409|NCT01577758|58949886|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
30914410|NCT01577758|58949887|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
30914411|NCT01577758|58949888|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
30914412|NCT01577758|58949889|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
30914413|NCT01577758|58949890|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
30914414|NCT01577758|58949891|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
30914415|NCT01577758|58949884|FG000|mCRC Expansion Phase|Progression Disease|0|||
30914416|NCT01577758|58949885|FG001|mCRC Expansion Phase|Progression Disease|0|||
30914417|NCT01577758|58949886|FG002|mCRC Expansion Phase|Progression Disease|0|||
30914418|NCT01577758|58949887|FG003|mCRC Expansion Phase|Progression Disease|0|||
30914419|NCT01577758|58949888|FG004|mCRC Expansion Phase|Progression Disease|0|||
30914420|NCT01577758|58949889|FG005|mCRC Expansion Phase|Progression Disease|0|||
30914421|NCT01577758|58949890|FG006|mCRC Expansion Phase|Progression Disease|0|||
30914422|NCT01577758|58949891|FG007|mCRC Expansion Phase|Progression Disease|19|||
30914423|NCT01537432|58949913|FG000|Overall Study|Lost to Follow-up|3|||
30823785|NCT03096847|58845621|FG000|Overall Study|Lost to Follow-up|1|||
30823786|NCT03096847|58845622|FG001|Overall Study|Lost to Follow-up|0|||
30823787|NCT03096847|58845623|FG002|Overall Study|Lost to Follow-up|1|||
30823788|NCT03096847|58845621|FG000|Overall Study|Death|6|||
30823789|NCT03096847|58845622|FG001|Overall Study|Death|0|||
30823790|NCT03096847|58845623|FG002|Overall Study|Death|2|||
30823791|NCT03096847|58845621|FG000|Overall Study|Protocol Violation|3|||
30823792|NCT03096847|58845622|FG001|Overall Study|Protocol Violation|0|||
30823793|NCT03096847|58845623|FG002|Overall Study|Protocol Violation|6|||
30823794|NCT03096847|58845621|FG000|Overall Study|Physician Decision|12|||
30823795|NCT03096847|58845622|FG001|Overall Study|Physician Decision|2|||
30823796|NCT03096847|58845623|FG002|Overall Study|Physician Decision|8|||
30823797|NCT03096847|58845621|FG000|Overall Study|Withdrawal by Subject|24|||
30823798|NCT03096847|58845622|FG001|Overall Study|Withdrawal by Subject|1|||
30823799|NCT03096847|58845623|FG002|Overall Study|Withdrawal by Subject|12|||
30914424|NCT01537432|58949914|FG001|Overall Study|Lost to Follow-up|1|||
30914425|NCT01537432|58949913|FG000|Overall Study|Withdrawal by Subject|0|||
30914426|NCT01537432|58949914|FG001|Overall Study|Withdrawal by Subject|1|||
30914427|NCT01537432|58949913|FG000|Overall Study|Administrative problems|1|||
30914428|NCT01537432|58949914|FG001|Overall Study|Administrative problems|0|||
30914429|NCT01537432|58949913|FG000|Overall Study|Adverse Event|1|||
30914430|NCT01537432|58949914|FG001|Overall Study|Adverse Event|0|||
30914431|NCT01537432|58949913|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30914432|NCT01537432|58949914|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30623144|NCT01214720|58634988|FG000|Overall Study|Alive and still on treatment|34|||
30823800|NCT03096847|58845621|FG000|Overall Study|Adverse Event|72|||
30914433|NCT01537198|58949920|FG000|Overall Study|RSV infection|2|||
30914434|NCT01537198|58949920|FG000|Overall Study|Adverse Event|4|||
30914435|NCT01537198|58949920|FG000|Overall Study|No Further Visits to the Clinic|37|||
30914436|NCT01537198|58949920|FG000|Overall Study|Other|111|||
30914437|NCT01537120|58949924|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
30823801|NCT03096847|58845622|FG001|Overall Study|Adverse Event|6|||
30823802|NCT03096847|58845623|FG002|Overall Study|Adverse Event|28|||
30823803|NCT03096847|58845621|FG000|Overall Study|Progressive disease|97|||
30823804|NCT03096847|58845622|FG001|Overall Study|Progressive disease|10|||
30823805|NCT03096847|58845623|FG002|Overall Study|Progressive disease|78|||
30823806|NCT03096847|58845621|FG000|Overall Study|Non-compliance with study medication|1|||
30823807|NCT03096847|58845622|FG001|Overall Study|Non-compliance with study medication|0|||
30823808|NCT03096847|58845623|FG002|Overall Study|Non-compliance with study medication|0|||
30823809|NCT03096847|58845621|FG000|Overall Study|New therapy for study indication|1|||
30823810|NCT03096847|58845622|FG001|Overall Study|New therapy for study indication|0|||
30823811|NCT03096847|58845623|FG002|Overall Study|New therapy for study indication|1|||
30823812|NCT01365182|58845642|FG000|Overall Study|Withdrawal by Subject|10|||
30823813|NCT01365182|58845643|FG001|Overall Study|Withdrawal by Subject|13|||
30823814|NCT01365182|58845644|FG002|Overall Study|Withdrawal by Subject|12|||
30823815|NCT03128099|58845662|FG000|Overall Study|High dose task was too long|0|||
30823816|NCT03128099|58845663|FG001|Overall Study|High dose task was too long|4|||
30823817|NCT03128099|58845664|FG002|Overall Study|High dose task was too long|0|||
30823818|NCT03128099|58845662|FG000|Overall Study|Participant got a full time job.|1|||
30823819|NCT03128099|58845663|FG001|Overall Study|Participant got a full time job.|0|||
30823820|NCT03128099|58845664|FG002|Overall Study|Participant got a full time job.|0|||
30914438|NCT01537120|58949924|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
30914439|NCT01537042|58949932|FG000|Overall Study|Adverse Event|0|||
30914440|NCT01537042|58949933|FG001|Overall Study|Adverse Event|2|||
30914441|NCT01537042|58949932|FG000|Overall Study|Lack of Efficacy|0|||
30914442|NCT01537042|58949933|FG001|Overall Study|Lack of Efficacy|1|||
30914443|NCT01537042|58949932|FG000|Overall Study|Protocol Violation|0|||
30914444|NCT01537042|58949933|FG001|Overall Study|Protocol Violation|1|||
30914445|NCT01537042|58949932|FG000|Overall Study|Other|0|||
30914446|NCT01537042|58949933|FG001|Overall Study|Other|1|||
30914447|NCT01536574|58949954|FG000|Overall Study|Adverse Event|4|||
30914448|NCT01536574|58949955|FG001|Overall Study|Adverse Event|5|||
30914449|NCT01536574|58949954|FG000|Overall Study|Withdrawal by Subject|1|||
30914450|NCT01536574|58949955|FG001|Overall Study|Withdrawal by Subject|2|||
30914451|NCT01536574|58949954|FG000|Overall Study|Lack of Efficacy|1|||
30914452|NCT01536574|58949955|FG001|Overall Study|Lack of Efficacy|0|||
30914453|NCT01536418|58949963|FG000|Overall Study|Protocol Violation|2|||
30914454|NCT01536418|58949964|FG001|Overall Study|Protocol Violation|3|||
30914455|NCT01536418|58949963|FG000|Overall Study|Physician Decision|1|||
30914456|NCT01536418|58949964|FG001|Overall Study|Physician Decision|3|||
30914457|NCT01536418|58949963|FG000|Overall Study|Study closed/terminated|41|||
30914458|NCT01536418|58949964|FG001|Overall Study|Study closed/terminated|37|||
30914459|NCT01536418|58949963|FG000|Overall Study|Lack of Efficacy|10|||
30823821|NCT03128099|58845662|FG000|Overall Study|Became homeless and lost contact|1|||
30823822|NCT03128099|58845663|FG001|Overall Study|Became homeless and lost contact|0|||
30823823|NCT03128099|58845664|FG002|Overall Study|Became homeless and lost contact|0|||
30823824|NCT03128099|58845662|FG000|Overall Study|Did not complete all the assessments|0|||
30823825|NCT03128099|58845663|FG001|Overall Study|Did not complete all the assessments|0|||
30823826|NCT03128099|58845664|FG002|Overall Study|Did not complete all the assessments|1|||
30823827|NCT02886494|58845672|FG000|Overall Study|Adverse Event|1|||
30823828|NCT02886494|58845673|FG001|Overall Study|Adverse Event|0|||
30823829|NCT02886494|58845672|FG000|Overall Study|Withdrawal by Subject|12|||
30823830|NCT02886494|58845673|FG001|Overall Study|Withdrawal by Subject|3|||
30823831|NCT02886494|58845672|FG000|Overall Study|Protocol Violation|4|||
30823832|NCT02886494|58845673|FG001|Overall Study|Protocol Violation|1|||
30823833|NCT02846532|58845685|FG000|Overall Study|Lost to Follow-up|0|||
30823834|NCT02846532|58845686|FG001|Overall Study|Lost to Follow-up|1|||
30823835|NCT02846532|58845687|FG002|Overall Study|Lost to Follow-up|1|||
30823836|NCT02846532|58845685|FG000|Overall Study|Withdrawal by Subject|1|||
30823837|NCT02846532|58845686|FG001|Overall Study|Withdrawal by Subject|2|||
30823838|NCT02846532|58845687|FG002|Overall Study|Withdrawal by Subject|0|||
30914460|NCT01536418|58949964|FG001|Overall Study|Lack of Efficacy|16|||
30914461|NCT01536418|58949963|FG000|Overall Study|Adverse Event|9|||
30914462|NCT01536418|58949964|FG001|Overall Study|Adverse Event|4|||
30914463|NCT01536418|58949963|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
30914464|NCT01536418|58949964|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
30914465|NCT01536418|58949963|FG000|Overall Study|Withdrawal by Subject|5|||
30823839|NCT00842348|58845706|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
30914466|NCT01536418|58949964|FG001|Overall Study|Withdrawal by Subject|3|||
30914467|NCT01576042|58949973|FG000|Overall Study|Physician Decision|2|||
30914468|NCT01576042|58949974|FG001|Overall Study|Physician Decision|0|||
30914469|NCT01561300|58949980|FG000|Run in on Placebo|Adverse Event|1|||
30914470|NCT01561300|58949981|FG001|Run in on Placebo|Adverse Event|0|||
30914471|NCT01536262|58949991|FG000|Overall Study|Adverse Event|6|||
30914472|NCT01536262|58949992|FG001|Overall Study|Adverse Event|1|||
30823840|NCT00842348|58845707|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
30823841|NCT00842348|58845706|FG000|Study 729|Disease progression/death|19|||
30914473|NCT01536262|58949993|FG002|Overall Study|Adverse Event|2|||
30914474|NCT01536262|58949991|FG000|Overall Study|Withdrawal by Subject|1|||
30914475|NCT01536262|58949992|FG001|Overall Study|Withdrawal by Subject|1|||
30914476|NCT01536262|58949993|FG002|Overall Study|Withdrawal by Subject|0|||
30914477|NCT01536262|58949991|FG000|Overall Study|Other than stated above|1|||
30914478|NCT01536262|58949992|FG001|Overall Study|Other than stated above|0|||
30914479|NCT01536262|58949993|FG002|Overall Study|Other than stated above|0|||
30914480|NCT01560988|58950002|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
30914481|NCT01560988|58950003|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
30914482|NCT01560988|58950002|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
30823842|NCT00842348|58845707|FG001|Study 729|Disease progression/death|30|||
30823843|NCT00842348|58845706|FG000|Study 729|Adverse Event|1|||
30823844|NCT00842348|58845707|FG001|Study 729|Adverse Event|1|||
30823845|NCT00842348|58845706|FG000|Study 729|Protocol Violation|1|||
30914483|NCT01560988|58950003|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
30914484|NCT01560988|58950002|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
30914485|NCT01560988|58950003|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
30914486|NCT01535638|58950014|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
30914487|NCT01535638|58950015|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
30914488|NCT01535638|58950016|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
30914489|NCT01535638|58950017|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
30914490|NCT01535638|58950018|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
30914491|NCT01535638|58950019|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
30914492|NCT01535638|58950014|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
30914493|NCT01535638|58950015|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
30914494|NCT01535638|58950016|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
30914495|NCT01535638|58950017|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
30914496|NCT01535638|58950018|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
30914497|NCT01535638|58950019|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
30914498|NCT01535560|58950030|FG000|Overall Study|Adverse Event|12|||
30914499|NCT01535560|58950031|FG001|Overall Study|Adverse Event|7|||
30914500|NCT01535560|58950030|FG000|Overall Study|Lost to Follow-up|1|||
30914501|NCT01535560|58950031|FG001|Overall Study|Lost to Follow-up|3|||
30914502|NCT01535560|58950030|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
30914503|NCT01535560|58950031|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
30823846|NCT00842348|58845707|FG001|Study 729|Protocol Violation|1|||
30823847|NCT00842348|58845706|FG000|Study 729|Withdrawal by Subject|2|||
30823848|NCT00842348|58845707|FG001|Study 729|Withdrawal by Subject|4|||
30823849|NCT00842348|58845706|FG000|Study 729|Due to Sponsor stopping the study|1|||
30823850|NCT00842348|58845707|FG001|Study 729|Due to Sponsor stopping the study|1|||
30823851|NCT00842348|58845706|FG000|Study 729|Due to non-availability of IP|0|||
30823852|NCT00842348|58845707|FG001|Study 729|Due to non-availability of IP|1|||
30823853|NCT00842348|58845706|FG000|Study 729|Sponsor's decision|1|||
30823854|NCT00842348|58845707|FG001|Study 729|Sponsor's decision|0|||
30823855|NCT00842348|58845706|FG000|Study 729|Surgical resection|1|||
30823856|NCT00842348|58845707|FG001|Study 729|Surgical resection|0|||
30823857|NCT03095599|58845719|FG000|Overall Study|Withdrawal by Subject|1|||
30823858|NCT03095599|58845720|FG001|Overall Study|Withdrawal by Subject|0|||
30823859|NCT03095599|58845719|FG000|Overall Study|Lost to Follow-up|1|||
30823860|NCT03095599|58845720|FG001|Overall Study|Lost to Follow-up|0|||
30823861|NCT03095599|58845719|FG000|Overall Study|Withdrawal prior to vaccination|1|||
30823862|NCT03095599|58845720|FG001|Overall Study|Withdrawal prior to vaccination|0|||
30823863|NCT03095521|58845730|FG000|Overall Study|Withdrawal by Subject|0|||
30823864|NCT03095521|58845731|FG001|Overall Study|Withdrawal by Subject|1|||
30623145|NCT01214720|58634989|FG001|Overall Study|Alive and still on treatment|18|||
30753340|NCT00418379|58763104|FG000|Year 3|Any other reason not above-mentioned|2|||
30753341|NCT00418379|58763105|FG001|Year 3|Any other reason not above-mentioned|1|||
30753342|NCT00418379|58763106|FG002|Year 3|Any other reason not above-mentioned|1|||
30753343|NCT00418379|58763104|FG000|Year 4|Adverse Event|0|||
30753344|NCT00418379|58763105|FG001|Year 4|Adverse Event|1|||
30753345|NCT00418379|58763106|FG002|Year 4|Adverse Event|0|||
30753346|NCT00418379|58763104|FG000|Year 4|Withdrawal by Subject|2|||
30753347|NCT00418379|58763105|FG001|Year 4|Withdrawal by Subject|3|||
30753348|NCT00418379|58763106|FG002|Year 4|Withdrawal by Subject|2|||
30753349|NCT00418379|58763104|FG000|Year 4|Any other reason not above-mentioned|1|||
30753350|NCT00418379|58763105|FG001|Year 4|Any other reason not above-mentioned|1|||
30753351|NCT00418379|58763106|FG002|Year 4|Any other reason not above-mentioned|0|||
30753352|NCT00418379|58763104|FG000|Year 5|Adverse Event|0|||
30753353|NCT00418379|58763105|FG001|Year 5|Adverse Event|1|||
30753354|NCT00418379|58763106|FG002|Year 5|Adverse Event|0|||
30753355|NCT00418379|58763104|FG000|Year 5|Any other reason not above-mentioned|2|||
30823865|NCT03095521|58845730|FG000|Overall Study|Lost to Follow-up|0|||
30914504|NCT01535560|58950030|FG000|Overall Study|Treatment Failure|21|||
30914505|NCT01535560|58950031|FG001|Overall Study|Treatment Failure|83|||
30914506|NCT01535560|58950030|FG000|Overall Study|Other|0|||
30914507|NCT01535560|58950031|FG001|Overall Study|Other|1|||
30823866|NCT03095521|58845731|FG001|Overall Study|Lost to Follow-up|1|||
30823867|NCT03033875|58845740|FG000|Overall Study|Withdrawal by Subject|5|||
30914508|NCT01535560|58950030|FG000|Overall Study|Randomized in Error|0|||
30914509|NCT01535560|58950031|FG001|Overall Study|Randomized in Error|1|||
30914510|NCT01575028|58950039|FG000|Overall Study|Physician Decision|0|||
30914511|NCT01575028|58950040|FG001|Overall Study|Physician Decision|1|||
30914512|NCT01574716|58950056|FG000|Part 1|Death|3|||
30914513|NCT01574716|58950057|FG001|Part 1|Death|1|||
30914514|NCT01574716|58950058|FG002|Part 1|Death|8|||
30914515|NCT01574716|58950059|FG003|Part 1|Death|0|||
30823868|NCT03033875|58845741|FG001|Overall Study|Withdrawal by Subject|9|||
30914516|NCT01574716|58950060|FG004|Part 1|Death|0|||
30914517|NCT01574716|58950056|FG000|Part 1|Discontinuation of study by sponsor|0|||
30914518|NCT01574716|58950057|FG001|Part 1|Discontinuation of study by sponsor|0|||
30823869|NCT03033875|58845742|FG002|Overall Study|Withdrawal by Subject|4|||
30823870|NCT03033875|58845740|FG000|Overall Study|Other|14|||
30823871|NCT03033875|58845741|FG001|Overall Study|Other|15|||
30823872|NCT03033875|58845742|FG002|Overall Study|Other|8|||
30823873|NCT01968785|58845760|FG000|Overall Study|Withdrawal by Subject|1|||
30823874|NCT01968785|58845761|FG001|Overall Study|Withdrawal by Subject|0|||
30823875|NCT03095287|58845767|FG000|Overall Study|Treatment Failure|1|||
30823876|NCT03095287|58845767|FG000|Overall Study|Adverse Event|1|||
30823877|NCT02839746|58845785|FG000|Overall Study|Not met selection criteria|12|||
30823878|NCT00033293|58845791|FG000|Overall Study|Death|0|||
30823879|NCT00033293|58845792|FG001|Overall Study|Death|1|||
30823880|NCT00033293|58845791|FG000|Overall Study|Lack of Efficacy|5|||
30823881|NCT00033293|58845792|FG001|Overall Study|Lack of Efficacy|8|||
30823882|NCT00033293|58845791|FG000|Overall Study|Lost to Follow-up|0|||
30823883|NCT00033293|58845792|FG001|Overall Study|Lost to Follow-up|1|||
30823884|NCT00033293|58845791|FG000|Overall Study|Physician Decision|3|||
30823885|NCT00033293|58845792|FG001|Overall Study|Physician Decision|1|||
30823886|NCT00033293|58845791|FG000|Overall Study|Withdrawal by Subject|1|||
30823887|NCT00033293|58845792|FG001|Overall Study|Withdrawal by Subject|0|||
30823888|NCT00033293|58845791|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
30823889|NCT00033293|58845792|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
30823890|NCT00033293|58845791|FG000|Overall Study|Treatment refused|0|||
30823891|NCT00033293|58845792|FG001|Overall Study|Treatment refused|6|||
30823892|NCT02039674|58845814|FG000|Overall Study|Adverse Event|0|||
30823893|NCT02039674|58845815|FG001|Overall Study|Adverse Event|0|||
30823894|NCT02039674|58845816|FG002|Overall Study|Adverse Event|0|||
30823895|NCT02039674|58845817|FG003|Overall Study|Adverse Event|1|||
30823896|NCT02039674|58845818|FG004|Overall Study|Adverse Event|0|||
30823897|NCT02039674|58845819|FG005|Overall Study|Adverse Event|0|||
30823898|NCT02039674|58845820|FG006|Overall Study|Adverse Event|0|||
30823899|NCT02039674|58845821|FG007|Overall Study|Adverse Event|0|||
30823900|NCT02039674|58845822|FG008|Overall Study|Adverse Event|2|||
30823901|NCT02039674|58845823|FG009|Overall Study|Adverse Event|1|||
30823902|NCT02039674|58845824|FG010|Overall Study|Adverse Event|0|||
30823903|NCT02039674|58845825|FG011|Overall Study|Adverse Event|2|||
30823904|NCT02039674|58845826|FG012|Overall Study|Adverse Event|3|||
30823905|NCT02039674|58845827|FG013|Overall Study|Adverse Event|1|||
30823906|NCT02039674|58845814|FG000|Overall Study|Death|2|||
30823907|NCT02039674|58845815|FG001|Overall Study|Death|0|||
30823908|NCT02039674|58845816|FG002|Overall Study|Death|2|||
30823909|NCT02039674|58845817|FG003|Overall Study|Death|3|||
30823910|NCT02039674|58845818|FG004|Overall Study|Death|0|||
30823911|NCT02039674|58845819|FG005|Overall Study|Death|0|||
30823912|NCT02039674|58845820|FG006|Overall Study|Death|1|||
30823913|NCT02039674|58845821|FG007|Overall Study|Death|0|||
30823914|NCT02039674|58845822|FG008|Overall Study|Death|2|||
30823915|NCT02039674|58845823|FG009|Overall Study|Death|0|||
30914519|NCT01574716|58950058|FG002|Part 1|Discontinuation of study by sponsor|1|||
30914520|NCT01574716|58950059|FG003|Part 1|Discontinuation of study by sponsor|0|||
30914521|NCT01574716|58950060|FG004|Part 1|Discontinuation of study by sponsor|0|||
30914522|NCT01574716|58950056|FG000|Part 1|Withdrawal by Subject|0|||
30914523|NCT01574716|58950057|FG001|Part 1|Withdrawal by Subject|2|||
30914524|NCT01574716|58950058|FG002|Part 1|Withdrawal by Subject|0|||
30914525|NCT01574716|58950059|FG003|Part 1|Withdrawal by Subject|0|||
30914526|NCT01574716|58950060|FG004|Part 1|Withdrawal by Subject|0|||
30914527|NCT01574716|58950056|FG000|Part 1|Lost to Follow-up|0|||
30914528|NCT01574716|58950057|FG001|Part 1|Lost to Follow-up|1|||
30914529|NCT01574716|58950058|FG002|Part 1|Lost to Follow-up|0|||
30823916|NCT02039674|58845824|FG010|Overall Study|Death|1|||
30823917|NCT02039674|58845825|FG011|Overall Study|Death|3|||
30823918|NCT02039674|58845826|FG012|Overall Study|Death|2|||
30823919|NCT02039674|58845827|FG013|Overall Study|Death|8|||
30823920|NCT02039674|58845814|FG000|Overall Study|Excluded Medication|1|||
30823921|NCT02039674|58845815|FG001|Overall Study|Excluded Medication|1|||
30823922|NCT02039674|58845816|FG002|Overall Study|Excluded Medication|0|||
30823923|NCT02039674|58845817|FG003|Overall Study|Excluded Medication|1|||
30914530|NCT01574716|58950059|FG003|Part 1|Lost to Follow-up|0|||
30914531|NCT01574716|58950060|FG004|Part 1|Lost to Follow-up|0|||
30914532|NCT01574716|58950056|FG000|Part 2|Progressive disease|0|||
30914533|NCT01574716|58950057|FG001|Part 2|Progressive disease|0|||
30823924|NCT02039674|58845818|FG004|Overall Study|Excluded Medication|0|||
30823925|NCT02039674|58845819|FG005|Overall Study|Excluded Medication|1|||
30823926|NCT02039674|58845820|FG006|Overall Study|Excluded Medication|0|||
30823927|NCT02039674|58845821|FG007|Overall Study|Excluded Medication|0|||
30823928|NCT02039674|58845822|FG008|Overall Study|Excluded Medication|2|||
30823929|NCT02039674|58845823|FG009|Overall Study|Excluded Medication|3|||
30823930|NCT02039674|58845824|FG010|Overall Study|Excluded Medication|5|||
30823931|NCT02039674|58845825|FG011|Overall Study|Excluded Medication|6|||
30823932|NCT02039674|58845826|FG012|Overall Study|Excluded Medication|8|||
30823933|NCT02039674|58845827|FG013|Overall Study|Excluded Medication|3|||
30823934|NCT02039674|58845814|FG000|Overall Study|Lost to Follow-up|0|||
30823935|NCT02039674|58845815|FG001|Overall Study|Lost to Follow-up|0|||
30823936|NCT02039674|58845816|FG002|Overall Study|Lost to Follow-up|0|||
30823937|NCT02039674|58845817|FG003|Overall Study|Lost to Follow-up|0|||
30823938|NCT02039674|58845818|FG004|Overall Study|Lost to Follow-up|1|||
30823939|NCT02039674|58845819|FG005|Overall Study|Lost to Follow-up|1|||
30823940|NCT02039674|58845820|FG006|Overall Study|Lost to Follow-up|0|||
30823941|NCT02039674|58845821|FG007|Overall Study|Lost to Follow-up|0|||
30823942|NCT02039674|58845822|FG008|Overall Study|Lost to Follow-up|0|||
30823943|NCT02039674|58845823|FG009|Overall Study|Lost to Follow-up|0|||
30823944|NCT02039674|58845824|FG010|Overall Study|Lost to Follow-up|0|||
30823945|NCT02039674|58845825|FG011|Overall Study|Lost to Follow-up|2|||
30823946|NCT02039674|58845826|FG012|Overall Study|Lost to Follow-up|2|||
30823947|NCT02039674|58845827|FG013|Overall Study|Lost to Follow-up|1|||
30823948|NCT02039674|58845814|FG000|Overall Study|Physician Decision|0|||
30823949|NCT02039674|58845815|FG001|Overall Study|Physician Decision|0|||
30823950|NCT02039674|58845816|FG002|Overall Study|Physician Decision|0|||
30823951|NCT02039674|58845817|FG003|Overall Study|Physician Decision|0|||
30823952|NCT02039674|58845818|FG004|Overall Study|Physician Decision|0|||
30823953|NCT02039674|58845819|FG005|Overall Study|Physician Decision|0|||
30823954|NCT02039674|58845820|FG006|Overall Study|Physician Decision|0|||
30823955|NCT02039674|58845821|FG007|Overall Study|Physician Decision|0|||
30823956|NCT02039674|58845822|FG008|Overall Study|Physician Decision|0|||
30823957|NCT02039674|58845823|FG009|Overall Study|Physician Decision|0|||
30823958|NCT02039674|58845824|FG010|Overall Study|Physician Decision|0|||
30823959|NCT02039674|58845825|FG011|Overall Study|Physician Decision|1|||
30823960|NCT02039674|58845826|FG012|Overall Study|Physician Decision|1|||
30823961|NCT02039674|58845827|FG013|Overall Study|Physician Decision|0|||
30823962|NCT02039674|58845814|FG000|Overall Study|Progressive Disease|8|||
30823963|NCT02039674|58845815|FG001|Overall Study|Progressive Disease|8|||
30823964|NCT02039674|58845816|FG002|Overall Study|Progressive Disease|6|||
30823965|NCT02039674|58845817|FG003|Overall Study|Progressive Disease|7|||
30823966|NCT02039674|58845818|FG004|Overall Study|Progressive Disease|9|||
30823967|NCT02039674|58845819|FG005|Overall Study|Progressive Disease|10|||
30823968|NCT02039674|58845820|FG006|Overall Study|Progressive Disease|1|||
30823969|NCT02039674|58845821|FG007|Overall Study|Progressive Disease|3|||
30823970|NCT02039674|58845822|FG008|Overall Study|Progressive Disease|6|||
30823971|NCT02039674|58845823|FG009|Overall Study|Progressive Disease|4|||
30823972|NCT02039674|58845824|FG010|Overall Study|Progressive Disease|0|||
30823973|NCT02039674|58845825|FG011|Overall Study|Progressive Disease|34|||
30823974|NCT02039674|58845826|FG012|Overall Study|Progressive Disease|34|||
30823975|NCT02039674|58845827|FG013|Overall Study|Progressive Disease|18|||
30823976|NCT02039674|58845814|FG000|Overall Study|Withdrawal by Subject|1|||
30823977|NCT02039674|58845815|FG001|Overall Study|Withdrawal by Subject|2|||
30823978|NCT02039674|58845816|FG002|Overall Study|Withdrawal by Subject|3|||
30823979|NCT02039674|58845817|FG003|Overall Study|Withdrawal by Subject|0|||
30823980|NCT02039674|58845818|FG004|Overall Study|Withdrawal by Subject|1|||
30823981|NCT02039674|58845819|FG005|Overall Study|Withdrawal by Subject|0|||
30823982|NCT02039674|58845820|FG006|Overall Study|Withdrawal by Subject|0|||
30823983|NCT02039674|58845821|FG007|Overall Study|Withdrawal by Subject|0|||
30823984|NCT02039674|58845822|FG008|Overall Study|Withdrawal by Subject|0|||
30823985|NCT02039674|58845823|FG009|Overall Study|Withdrawal by Subject|1|||
30823986|NCT02039674|58845824|FG010|Overall Study|Withdrawal by Subject|1|||
30914534|NCT01574716|58950058|FG002|Part 2|Progressive disease|0|||
30914535|NCT01574716|58950059|FG003|Part 2|Progressive disease|1|||
30914536|NCT01574716|58950060|FG004|Part 2|Progressive disease|0|||
30823987|NCT02039674|58845825|FG011|Overall Study|Withdrawal by Subject|4|||
30823988|NCT02039674|58845826|FG012|Overall Study|Withdrawal by Subject|6|||
30914537|NCT01574716|58950056|FG000|Part 2|Death|0|||
30914538|NCT01574716|58950057|FG001|Part 2|Death|0|||
30914539|NCT01574716|58950058|FG002|Part 2|Death|0|||
30914540|NCT01574716|58950059|FG003|Part 2|Death|76|||
30823989|NCT02039674|58845827|FG013|Overall Study|Withdrawal by Subject|2|||
30823990|NCT02039674|58845814|FG000|Overall Study|Clinical Progression|0|||
30823991|NCT02039674|58845815|FG001|Overall Study|Clinical Progression|0|||
30823992|NCT02039674|58845816|FG002|Overall Study|Clinical Progression|0|||
30823993|NCT02039674|58845817|FG003|Overall Study|Clinical Progression|0|||
30823994|NCT02039674|58845818|FG004|Overall Study|Clinical Progression|0|||
30823995|NCT02039674|58845819|FG005|Overall Study|Clinical Progression|0|||
30914541|NCT01574716|58950060|FG004|Part 2|Death|35|||
30823996|NCT02039674|58845820|FG006|Overall Study|Clinical Progression|1|||
30823997|NCT02039674|58845821|FG007|Overall Study|Clinical Progression|0|||
30823998|NCT02039674|58845822|FG008|Overall Study|Clinical Progression|0|||
30823999|NCT02039674|58845823|FG009|Overall Study|Clinical Progression|0|||
30824000|NCT02039674|58845824|FG010|Overall Study|Clinical Progression|0|||
30824001|NCT02039674|58845825|FG011|Overall Study|Clinical Progression|0|||
30824002|NCT02039674|58845826|FG012|Overall Study|Clinical Progression|1|||
30824003|NCT02039674|58845827|FG013|Overall Study|Clinical Progression|0|||
30824004|NCT02039674|58845814|FG000|Overall Study|Sponsor Decision|1|||
30824005|NCT02039674|58845815|FG001|Overall Study|Sponsor Decision|1|||
30824006|NCT02039674|58845816|FG002|Overall Study|Sponsor Decision|1|||
30824007|NCT02039674|58845817|FG003|Overall Study|Sponsor Decision|1|||
30824008|NCT02039674|58845818|FG004|Overall Study|Sponsor Decision|1|||
30824009|NCT02039674|58845819|FG005|Overall Study|Sponsor Decision|0|||
30824010|NCT02039674|58845820|FG006|Overall Study|Sponsor Decision|0|||
30824011|NCT02039674|58845821|FG007|Overall Study|Sponsor Decision|0|||
30824012|NCT02039674|58845822|FG008|Overall Study|Sponsor Decision|0|||
30824013|NCT02039674|58845823|FG009|Overall Study|Sponsor Decision|3|||
30824014|NCT02039674|58845824|FG010|Overall Study|Sponsor Decision|0|||
30824015|NCT02039674|58845825|FG011|Overall Study|Sponsor Decision|8|||
30824016|NCT02039674|58845826|FG012|Overall Study|Sponsor Decision|5|||
30824017|NCT02039674|58845827|FG013|Overall Study|Sponsor Decision|0|||
30824018|NCT02039674|58845814|FG000|Overall Study|Other|0|||
30824019|NCT02039674|58845815|FG001|Overall Study|Other|0|||
30824020|NCT02039674|58845816|FG002|Overall Study|Other|0|||
30824021|NCT02039674|58845817|FG003|Overall Study|Other|0|||
30824022|NCT02039674|58845818|FG004|Overall Study|Other|0|||
30824023|NCT02039674|58845819|FG005|Overall Study|Other|0|||
30824024|NCT02039674|58845820|FG006|Overall Study|Other|0|||
30824025|NCT02039674|58845821|FG007|Overall Study|Other|0|||
30824026|NCT02039674|58845822|FG008|Overall Study|Other|0|||
30824027|NCT02039674|58845823|FG009|Overall Study|Other|0|||
30824028|NCT02039674|58845824|FG010|Overall Study|Other|0|||
30824029|NCT02039674|58845825|FG011|Overall Study|Other|0|||
30824030|NCT02039674|58845826|FG012|Overall Study|Other|1|||
30824031|NCT02039674|58845827|FG013|Overall Study|Other|0|||
30824032|NCT03126227|58845867|FG000|Overall Study|Adverse Event|43|||
30824033|NCT03126227|58845868|FG001|Overall Study|Adverse Event|4|||
30824034|NCT03126227|58845867|FG000|Overall Study|Death|0|||
30824035|NCT03126227|58845868|FG001|Overall Study|Death|1|||
30824036|NCT03126227|58845867|FG000|Overall Study|Lost to Follow-up|0|||
30824037|NCT03126227|58845868|FG001|Overall Study|Lost to Follow-up|1|||
30824038|NCT03126227|58845867|FG000|Overall Study|Physician Decision|2|||
30824039|NCT03126227|58845868|FG001|Overall Study|Physician Decision|0|||
30824040|NCT03126227|58845867|FG000|Overall Study|Protocol Violation|1|||
30824041|NCT03126227|58845868|FG001|Overall Study|Protocol Violation|0|||
30824042|NCT03126227|58845867|FG000|Overall Study|Withdrawal by Subject|19|||
30824043|NCT03126227|58845868|FG001|Overall Study|Withdrawal by Subject|3|||
30824044|NCT03126227|58845867|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
30824045|NCT03126227|58845868|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
30824046|NCT03126227|58845867|FG000|Overall Study|Lack of dosing compliance|2|||
30824047|NCT03126227|58845868|FG001|Overall Study|Lack of dosing compliance|0|||
30824048|NCT03126227|58845867|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
30824049|NCT03126227|58845868|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
30824050|NCT03126227|58845867|FG000|Overall Study|Scheduling conflict|1|||
30824051|NCT03126227|58845868|FG001|Overall Study|Scheduling conflict|0|||
30824052|NCT03099187|58845876|FG000|Double-blind Treatment|Adverse Event|19|||
30824053|NCT03099187|58845877|FG001|Double-blind Treatment|Adverse Event|1|||
30824054|NCT03099187|58845878|FG002|Double-blind Treatment|Adverse Event|0|||
30824055|NCT03099187|58845879|FG003|Double-blind Treatment|Adverse Event|0|||
30824056|NCT03099187|58845876|FG000|Double-blind Treatment|Death|1|||
30824057|NCT03099187|58845877|FG001|Double-blind Treatment|Death|3|||
30824058|NCT03099187|58845878|FG002|Double-blind Treatment|Death|0|||
30824059|NCT03099187|58845879|FG003|Double-blind Treatment|Death|0|||
30824060|NCT03099187|58845876|FG000|Double-blind Treatment|Lack of Efficacy|1|||
30824061|NCT03099187|58845877|FG001|Double-blind Treatment|Lack of Efficacy|0|||
30824062|NCT03099187|58845878|FG002|Double-blind Treatment|Lack of Efficacy|0|||
30824063|NCT03099187|58845879|FG003|Double-blind Treatment|Lack of Efficacy|0|||
30824064|NCT03099187|58845876|FG000|Double-blind Treatment|Physician Decision|2|||
30824065|NCT03099187|58845877|FG001|Double-blind Treatment|Physician Decision|1|||
30824066|NCT03099187|58845878|FG002|Double-blind Treatment|Physician Decision|0|||
30824067|NCT03099187|58845879|FG003|Double-blind Treatment|Physician Decision|0|||
30824068|NCT03099187|58845876|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
30824069|NCT03099187|58845877|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
30824070|NCT03099187|58845878|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
30824071|NCT03099187|58845879|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
30824072|NCT03099187|58845876|FG000|Double-blind Treatment|Lung transplantation|0|||
30824073|NCT03099187|58845877|FG001|Double-blind Treatment|Lung transplantation|1|||
30824074|NCT03099187|58845878|FG002|Double-blind Treatment|Lung transplantation|0|||
30824075|NCT03099187|58845879|FG003|Double-blind Treatment|Lung transplantation|0|||
30824076|NCT03099187|58845876|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
30824077|NCT03099187|58845877|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
30824078|NCT03099187|58845878|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
30824079|NCT03099187|58845879|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
30824080|NCT03099187|58845876|FG000|Double-blind Treatment|Disease progression|0|||
30824081|NCT03099187|58845877|FG001|Double-blind Treatment|Disease progression|1|||
30824082|NCT03099187|58845878|FG002|Double-blind Treatment|Disease progression|0|||
30824083|NCT03099187|58845879|FG003|Double-blind Treatment|Disease progression|0|||
30824084|NCT03099187|58845876|FG000|Double-blind Treatment|Randomization error|0|||
30824085|NCT03099187|58845877|FG001|Double-blind Treatment|Randomization error|2|||
30824086|NCT03099187|58845878|FG002|Double-blind Treatment|Randomization error|0|||
30824087|NCT03099187|58845879|FG003|Double-blind Treatment|Randomization error|0|||
30824088|NCT03099187|58845876|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
30824089|NCT03099187|58845877|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
30824090|NCT03099187|58845878|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
30824091|NCT03099187|58845879|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
30824092|NCT03099187|58845876|FG000|12-month Safety Follow-up|Adverse Event|0|||
30824093|NCT03099187|58845877|FG001|12-month Safety Follow-up|Adverse Event|0|||
30824094|NCT03099187|58845878|FG002|12-month Safety Follow-up|Adverse Event|5|||
30824095|NCT03099187|58845879|FG003|12-month Safety Follow-up|Adverse Event|12|||
30824096|NCT03099187|58845876|FG000|12-month Safety Follow-up|Death|0|||
30824097|NCT03099187|58845877|FG001|12-month Safety Follow-up|Death|0|||
30824098|NCT03099187|58845878|FG002|12-month Safety Follow-up|Death|7|||
30824099|NCT03099187|58845879|FG003|12-month Safety Follow-up|Death|9|||
30824100|NCT03099187|58845876|FG000|12-month Safety Follow-up|Lung transplantation|0|||
30824101|NCT03099187|58845877|FG001|12-month Safety Follow-up|Lung transplantation|0|||
30824102|NCT03099187|58845878|FG002|12-month Safety Follow-up|Lung transplantation|2|||
30824103|NCT03099187|58845879|FG003|12-month Safety Follow-up|Lung transplantation|1|||
30824104|NCT03099187|58845876|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
30824105|NCT03099187|58845877|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
30824106|NCT03099187|58845878|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
30824107|NCT03099187|58845879|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
30824108|NCT03099187|58845876|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
30824109|NCT03099187|58845877|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
30824110|NCT03099187|58845878|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
30824111|NCT03099187|58845879|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
30824112|NCT03099187|58845876|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
30824113|NCT03099187|58845877|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
30824114|NCT03099187|58845878|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
30824115|NCT03099187|58845879|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
30824116|NCT03099187|58845876|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
30914542|NCT01574716|58950056|FG000|Part 2|Discontinuation of study by sponsor|0|||
30914543|NCT01574716|58950057|FG001|Part 2|Discontinuation of study by sponsor|0|||
30824117|NCT03099187|58845877|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
30824118|NCT03099187|58845878|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
30824119|NCT03099187|58845879|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
30824120|NCT04535453|58845901|FG000|Overall Study|Death|0|||
30914544|NCT01574716|58950058|FG002|Part 2|Discontinuation of study by sponsor|0|||
30914545|NCT01574716|58950059|FG003|Part 2|Discontinuation of study by sponsor|51|||
30914546|NCT01574716|58950060|FG004|Part 2|Discontinuation of study by sponsor|31|||
30914547|NCT01574716|58950056|FG000|Part 2|Withdrawal by Subject|0|||
30914548|NCT01574716|58950057|FG001|Part 2|Withdrawal by Subject|0|||
30914549|NCT01574716|58950058|FG002|Part 2|Withdrawal by Subject|0|||
30914550|NCT01574716|58950059|FG003|Part 2|Withdrawal by Subject|5|||
30914551|NCT01574716|58950060|FG004|Part 2|Withdrawal by Subject|4|||
30914552|NCT01574716|58950056|FG000|Part 2|Brain metastases|0|||
30914553|NCT01574716|58950057|FG001|Part 2|Brain metastases|0|||
30914554|NCT01574716|58950058|FG002|Part 2|Brain metastases|0|||
30914555|NCT01574716|58950059|FG003|Part 2|Brain metastases|1|||
30914556|NCT01574716|58950060|FG004|Part 2|Brain metastases|0|||
30914557|NCT01574716|58950056|FG000|Part 2|Lost to Follow-up|0|||
30914558|NCT01574716|58950057|FG001|Part 2|Lost to Follow-up|0|||
30824121|NCT04535453|58845902|FG001|Overall Study|Death|1|||
30824122|NCT04535453|58845903|FG002|Overall Study|Death|0|||
30824123|NCT04535453|58845904|FG003|Overall Study|Death|0|||
30914559|NCT01574716|58950058|FG002|Part 2|Lost to Follow-up|0|||
30914560|NCT01574716|58950059|FG003|Part 2|Lost to Follow-up|3|||
30914561|NCT01574716|58950060|FG004|Part 2|Lost to Follow-up|0|||
30914562|NCT02161562|58950071|FG000|Overall Study|Withdrawal by Subject|5|||
30914563|NCT02161562|58950072|FG001|Overall Study|Withdrawal by Subject|8|||
30914564|NCT02161562|58950071|FG000|Overall Study|Protocol Violation|9|||
30914565|NCT02161562|58950072|FG001|Overall Study|Protocol Violation|4|||
30914566|NCT02161562|58950071|FG000|Overall Study|Pregnancy|1|||
30914567|NCT02161562|58950072|FG001|Overall Study|Pregnancy|2|||
30914568|NCT02161562|58950071|FG000|Overall Study|Lost to Follow-up|3|||
30914569|NCT02161562|58950072|FG001|Overall Study|Lost to Follow-up|1|||
30914570|NCT02161562|58950071|FG000|Overall Study|Lack of Efficacy|4|||
30914571|NCT02161562|58950072|FG001|Overall Study|Lack of Efficacy|1|||
30914572|NCT02161562|58950071|FG000|Overall Study|Adverse Event|1|||
30914573|NCT02161562|58950072|FG001|Overall Study|Adverse Event|1|||
30914574|NCT02161562|58950071|FG000|Overall Study|Participant moved back to home country|1|||
30914575|NCT02161562|58950072|FG001|Overall Study|Participant moved back to home country|0|||
30914576|NCT02161562|58950071|FG000|Overall Study|Withdrew due to being out of the country|1|||
30914577|NCT02161562|58950072|FG001|Overall Study|Withdrew due to being out of the country|0|||
30914578|NCT02161562|58950071|FG000|Overall Study|Participant moved out of province|1|||
30914579|NCT02161562|58950072|FG001|Overall Study|Participant moved out of province|0|||
30914580|NCT01559116|58950091|FG000|Overall Study|Adverse Event|10|||
30914581|NCT01559116|58950091|FG000|Overall Study|Lack of Efficacy|1|||
30914582|NCT01559116|58950091|FG000|Overall Study|Lost to Follow-up|1|||
30914583|NCT01559116|58950091|FG000|Overall Study|Protocol Violation|1|||
30914584|NCT01559116|58950091|FG000|Overall Study|Withdrawal by Subject|4|||
30914585|NCT01559116|58950091|FG000|Overall Study|other than stated above|9|||
30914586|NCT01574326|58950110|FG000|Overall Study|Randomized but not treated|0|||
30914587|NCT01574326|58950111|FG001|Overall Study|Randomized but not treated|1|||
30914588|NCT01574326|58950110|FG000|Overall Study|Withdrawal by Participant|2|||
30914589|NCT01574326|58950111|FG001|Overall Study|Withdrawal by Participant|4|||
30914590|NCT01574326|58950110|FG000|Overall Study|Physician Decision|5|||
30914591|NCT01574326|58950111|FG001|Overall Study|Physician Decision|3|||
30914592|NCT01574326|58950110|FG000|Overall Study|Adverse Event|1|||
30914593|NCT01574326|58950111|FG001|Overall Study|Adverse Event|3|||
30914594|NCT01574326|58950110|FG000|Overall Study|Other: Mainly kidney transplant|8|||
30914595|NCT01574326|58950111|FG001|Overall Study|Other: Mainly kidney transplant|8|||
30914596|NCT01574248|58950124|FG000|Overall Study|Withdrawal by Subject|2|||
30914597|NCT01574248|58950125|FG001|Overall Study|Withdrawal by Subject|0|||
30914598|NCT01574248|58950124|FG000|Overall Study|Missing primary endpoint data|1|||
30914599|NCT01574248|58950125|FG001|Overall Study|Missing primary endpoint data|0|||
30914600|NCT01573624|58950131|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
30914601|NCT01573624|58950132|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
30914602|NCT01573624|58950133|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
30914603|NCT01573624|58950134|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
30914604|NCT01573624|58950135|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
30914605|NCT01573624|58950136|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
30824124|NCT04535453|58845905|FG004|Overall Study|Death|0|||
30824125|NCT04535453|58845906|FG005|Overall Study|Death|0|||
30824126|NCT04535453|58845907|FG006|Overall Study|Death|0|||
30824127|NCT04535453|58845908|FG007|Overall Study|Death|0|||
30824128|NCT04535453|58845909|FG008|Overall Study|Death|0|||
30824129|NCT04535453|58845910|FG009|Overall Study|Death|0|||
30824130|NCT04535453|58845911|FG010|Overall Study|Death|0|||
30824131|NCT04535453|58845912|FG011|Overall Study|Death|0|||
30824132|NCT04535453|58845901|FG000|Overall Study|Lost to Follow-up|1|||
30824133|NCT04535453|58845902|FG001|Overall Study|Lost to Follow-up|1|||
30824134|NCT04535453|58845903|FG002|Overall Study|Lost to Follow-up|1|||
30824135|NCT04535453|58845904|FG003|Overall Study|Lost to Follow-up|0|||
30824136|NCT04535453|58845905|FG004|Overall Study|Lost to Follow-up|3|||
30824137|NCT04535453|58845906|FG005|Overall Study|Lost to Follow-up|1|||
30824138|NCT04535453|58845907|FG006|Overall Study|Lost to Follow-up|0|||
30824139|NCT04535453|58845908|FG007|Overall Study|Lost to Follow-up|0|||
30824140|NCT04535453|58845909|FG008|Overall Study|Lost to Follow-up|1|||
30824141|NCT04535453|58845910|FG009|Overall Study|Lost to Follow-up|1|||
30824142|NCT04535453|58845911|FG010|Overall Study|Lost to Follow-up|0|||
30824143|NCT04535453|58845912|FG011|Overall Study|Lost to Follow-up|0|||
30824144|NCT04535453|58845901|FG000|Overall Study|Physician Decision|0|||
30824145|NCT04535453|58845902|FG001|Overall Study|Physician Decision|0|||
30824146|NCT04535453|58845903|FG002|Overall Study|Physician Decision|0|||
30824147|NCT04535453|58845904|FG003|Overall Study|Physician Decision|1|||
30824148|NCT04535453|58845905|FG004|Overall Study|Physician Decision|0|||
30824149|NCT04535453|58845906|FG005|Overall Study|Physician Decision|0|||
30824150|NCT04535453|58845907|FG006|Overall Study|Physician Decision|0|||
30824151|NCT04535453|58845908|FG007|Overall Study|Physician Decision|0|||
30824152|NCT04535453|58845909|FG008|Overall Study|Physician Decision|0|||
30824153|NCT04535453|58845910|FG009|Overall Study|Physician Decision|0|||
30824154|NCT04535453|58845911|FG010|Overall Study|Physician Decision|0|||
30914606|NCT01573624|58950137|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
30914607|NCT01573624|58950131|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
30914608|NCT01573624|58950132|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
30914609|NCT01573624|58950133|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
30914610|NCT01573624|58950134|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
30914611|NCT01573624|58950135|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
30914612|NCT01573624|58950136|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
30914613|NCT01573624|58950137|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
30914614|NCT01573624|58950131|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
30914615|NCT01573624|58950132|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
30914616|NCT01573624|58950133|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
30914617|NCT01573624|58950134|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
30914618|NCT01573624|58950135|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
30914619|NCT01573624|58950136|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
30914620|NCT01573624|58950137|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
30914621|NCT01573624|58950131|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
30914622|NCT01573624|58950132|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30914623|NCT01573624|58950133|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
30914624|NCT01573624|58950134|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30914625|NCT01573624|58950135|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30914626|NCT01573624|58950136|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
30914627|NCT01573624|58950137|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30914628|NCT01573624|58950131|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
30914629|NCT01573624|58950132|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
30914630|NCT01573624|58950133|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
30914631|NCT01573624|58950134|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
30914632|NCT01573624|58950135|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
30914633|NCT01573624|58950136|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
30914634|NCT01573624|58950137|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
30914635|NCT01573624|58950131|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
30914636|NCT01573624|58950132|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
30914637|NCT01573624|58950133|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
30914638|NCT01573624|58950134|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
30914639|NCT01573624|58950135|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
30914640|NCT01573624|58950136|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
30914641|NCT01573624|58950137|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
30914642|NCT01573624|58950131|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
30914643|NCT01573624|58950132|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
30914644|NCT01573624|58950133|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
30914645|NCT01573624|58950134|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
30914646|NCT01573624|58950135|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
30914647|NCT01573624|58950136|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
30914648|NCT01573624|58950137|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
30914649|NCT01573624|58950131|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
30914650|NCT01573624|58950132|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
30914651|NCT01573624|58950133|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
30914652|NCT01573624|58950134|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
30914653|NCT01573624|58950135|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
30914654|NCT01573624|58950136|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
30914655|NCT01573624|58950137|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
30914656|NCT01573624|58950131|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
30914657|NCT01573624|58950132|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
30914658|NCT01573624|58950133|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
30914659|NCT01573624|58950134|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
30914660|NCT01573624|58950135|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
30914661|NCT01573624|58950136|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
30914662|NCT01573624|58950137|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
30914663|NCT01573624|58950131|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
30914664|NCT01573624|58950132|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
30914665|NCT01573624|58950133|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
30914666|NCT01573624|58950134|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
30914667|NCT01573624|58950135|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
30914668|NCT01573624|58950136|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
30914669|NCT01573624|58950137|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
30914670|NCT01573624|58950131|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
30914671|NCT01573624|58950132|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
30914672|NCT01573624|58950133|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
30914673|NCT01573624|58950134|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
30914674|NCT01573624|58950135|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
30914675|NCT01573624|58950136|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
30914676|NCT01573624|58950137|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
30914677|NCT01573624|58950131|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
30914678|NCT01573624|58950132|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
30914679|NCT01573624|58950133|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
30914680|NCT01573624|58950134|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
30914681|NCT01573624|58950135|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
30914682|NCT01573624|58950136|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
30914683|NCT01573624|58950137|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
30914684|NCT01573624|58950131|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
30914685|NCT01573624|58950132|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
30914686|NCT01573624|58950133|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
30914687|NCT01573624|58950134|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
30914688|NCT01573624|58950135|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
30824155|NCT04535453|58845912|FG011|Overall Study|Physician Decision|0|||
30824156|NCT04535453|58845901|FG000|Overall Study|Withdrawal by Subject|3|||
30824157|NCT04535453|58845902|FG001|Overall Study|Withdrawal by Subject|6|||
30824158|NCT04535453|58845903|FG002|Overall Study|Withdrawal by Subject|3|||
30824159|NCT04535453|58845904|FG003|Overall Study|Withdrawal by Subject|3|||
30824160|NCT04535453|58845905|FG004|Overall Study|Withdrawal by Subject|2|||
30824161|NCT04535453|58845906|FG005|Overall Study|Withdrawal by Subject|1|||
30824162|NCT04535453|58845907|FG006|Overall Study|Withdrawal by Subject|1|||
30824163|NCT04535453|58845908|FG007|Overall Study|Withdrawal by Subject|1|||
30824164|NCT04535453|58845909|FG008|Overall Study|Withdrawal by Subject|1|||
30824165|NCT04535453|58845910|FG009|Overall Study|Withdrawal by Subject|1|||
30824166|NCT04535453|58845911|FG010|Overall Study|Withdrawal by Subject|0|||
30824167|NCT04535453|58845912|FG011|Overall Study|Withdrawal by Subject|1|||
30824168|NCT04535453|58845901|FG000|Overall Study|Other|0|||
30824169|NCT04535453|58845902|FG001|Overall Study|Other|0|||
30824170|NCT04535453|58845903|FG002|Overall Study|Other|1|||
30824171|NCT04535453|58845904|FG003|Overall Study|Other|0|||
30824172|NCT04535453|58845905|FG004|Overall Study|Other|1|||
30824173|NCT04535453|58845906|FG005|Overall Study|Other|0|||
30824174|NCT04535453|58845907|FG006|Overall Study|Other|1|||
30824175|NCT04535453|58845908|FG007|Overall Study|Other|1|||
30914689|NCT01573624|58950136|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
30914690|NCT01573624|58950137|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
30914691|NCT01573624|58950131|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
30914692|NCT01573624|58950132|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
30824176|NCT04535453|58845909|FG008|Overall Study|Other|1|||
30824177|NCT04535453|58845910|FG009|Overall Study|Other|0|||
30824178|NCT04535453|58845911|FG010|Overall Study|Other|0|||
30824179|NCT04535453|58845912|FG011|Overall Study|Other|0|||
30824180|NCT04463069|58845955|FG000|Overall Study|Withdrawal by Subject|2|||
30824181|NCT04463069|58845956|FG001|Overall Study|Withdrawal by Subject|10|||
30824182|NCT04463069|58845955|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
30824183|NCT04463069|58845956|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
30824184|NCT03521687|58845962|FG000|Overall Study|Adverse Event|4|||
30914693|NCT01573624|58950133|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
30824185|NCT03521687|58845962|FG000|Overall Study|Physician Decision|1|||
30824186|NCT03125915|58845970|FG000|1 Month Follow up|Lost to Follow-up|3|||
30824187|NCT03125915|58845971|FG001|1 Month Follow up|Lost to Follow-up|3|||
30824188|NCT03125915|58845972|FG002|1 Month Follow up|Lost to Follow-up|2|||
30824189|NCT03125915|58845973|FG003|1 Month Follow up|Lost to Follow-up|3|||
30824190|NCT03125915|58845970|FG000|3 Month Follow-up|Lost to Follow-up|6|||
30824191|NCT03125915|58845971|FG001|3 Month Follow-up|Lost to Follow-up|4|||
30824192|NCT03125915|58845972|FG002|3 Month Follow-up|Lost to Follow-up|4|||
30824193|NCT03125915|58845973|FG003|3 Month Follow-up|Lost to Follow-up|2|||
30824194|NCT03125915|58845970|FG000|6 Month Follow-up|Lost to Follow-up|7|||
30753356|NCT00418379|58763105|FG001|Year 5|Any other reason not above-mentioned|4|||
30753357|NCT00418379|58763106|FG002|Year 5|Any other reason not above-mentioned|3|||
30753358|NCT00418145|58763114|FG000|Overall Study|study terminated|6|||
30753359|NCT00417989|58763122|FG000|Overall Study|Withdrawal by Subject|13|||
30753360|NCT00417989|58763123|FG001|Overall Study|Withdrawal by Subject|13|||
30753361|NCT00417989|58763122|FG000|Overall Study|Lost to Follow-up|1|||
30753362|NCT00417989|58763123|FG001|Overall Study|Lost to Follow-up|6|||
30753363|NCT00417989|58763122|FG000|Overall Study|Protocol Violation|1|||
30753364|NCT00417989|58763123|FG001|Overall Study|Protocol Violation|0|||
30753365|NCT00417989|58763122|FG000|Overall Study|Death|0|||
30753366|NCT00417989|58763123|FG001|Overall Study|Death|1|||
30753367|NCT00417989|58763122|FG000|Overall Study|Physician Decision|5|||
30753368|NCT00417989|58763123|FG001|Overall Study|Physician Decision|2|||
30753369|NCT00412217|58763133|FG000|Overall Study|Insufficient Data Available|8|||
30753370|NCT00412217|58763134|FG001|Overall Study|Insufficient Data Available|3|||
30753371|NCT00412217|58763133|FG000|Overall Study|Death|5|||
30753372|NCT00412217|58763134|FG001|Overall Study|Death|4|||
30753373|NCT00412217|58763133|FG000|Overall Study|Disease Progression|2|||
30753374|NCT00412217|58763134|FG001|Overall Study|Disease Progression|3|||
30753375|NCT00412217|58763133|FG000|Overall Study|Investigator Decision|1|||
30753376|NCT00412217|58763134|FG001|Overall Study|Investigator Decision|0|||
30753377|NCT00412217|58763133|FG000|Overall Study|Withdrawal by Subject|2|||
30753378|NCT00412217|58763134|FG001|Overall Study|Withdrawal by Subject|0|||
30753379|NCT00412217|58763133|FG000|Overall Study|Lost to Follow-up|1|||
30753380|NCT00412217|58763134|FG001|Overall Study|Lost to Follow-up|4|||
30753381|NCT00412217|58763133|FG000|Overall Study|Study Terminated by Sponsor|26|||
30753382|NCT00412217|58763134|FG001|Overall Study|Study Terminated by Sponsor|33|||
30753383|NCT00412217|58763133|FG000|Overall Study|Other|1|||
30753384|NCT00412217|58763134|FG001|Overall Study|Other|1|||
30753385|NCT05000164|58763140|FG000|Overall Study|Adverse Event|1|||
30753386|NCT05000164|58763140|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
30753387|NCT05000164|58763140|FG000|Overall Study|Lens Discomfort|3|||
30753388|NCT05000164|58763140|FG000|Overall Study|Withdrew Consent during Study|2|||
30753389|NCT05000164|58763140|FG000|Overall Study|Subject Withdrawn by PI|2|||
30753390|NCT05000164|58763140|FG000|Overall Study|Other Fractured Test Article|1|||
30753391|NCT00123474|58763148|FG000|Randomized to Treatment|Randomized, never treated|1|||
30753392|NCT00123474|58763149|FG001|Randomized to Treatment|Randomized, never treated|4|||
30753393|NCT00123474|58763150|FG002|Randomized to Treatment|Randomized, never treated|2|||
30753394|NCT00123474|58763151|FG003|Randomized to Treatment|Randomized, never treated|1|||
30753395|NCT00123474|58763148|FG000|As Treated at Study Closure|not reported when site closed|1|||
30753396|NCT00123474|58763149|FG001|As Treated at Study Closure|not reported when site closed|0|||
30753397|NCT00123474|58763150|FG002|As Treated at Study Closure|not reported when site closed|1|||
30753398|NCT00123474|58763151|FG003|As Treated at Study Closure|not reported when site closed|0|||
30753399|NCT00123474|58763148|FG000|As Treated at Study Closure|Adverse Event|10|||
30753400|NCT00123474|58763149|FG001|As Treated at Study Closure|Adverse Event|4|||
30753401|NCT00123474|58763150|FG002|As Treated at Study Closure|Adverse Event|10|||
30753402|NCT00123474|58763151|FG003|As Treated at Study Closure|Adverse Event|8|||
30753403|NCT00123474|58763148|FG000|As Treated at Study Closure|Disease Progression|35|||
30753404|NCT00123474|58763149|FG001|As Treated at Study Closure|Disease Progression|42|||
30753405|NCT00123474|58763150|FG002|As Treated at Study Closure|Disease Progression|29|||
30753406|NCT00123474|58763151|FG003|As Treated at Study Closure|Disease Progression|27|||
30753407|NCT00123474|58763148|FG000|As Treated at Study Closure|Investigator Request|12|||
30753408|NCT00123474|58763149|FG001|As Treated at Study Closure|Investigator Request|6|||
30753409|NCT00123474|58763150|FG002|As Treated at Study Closure|Investigator Request|7|||
30753410|NCT00123474|58763151|FG003|As Treated at Study Closure|Investigator Request|5|||
30753411|NCT00123474|58763148|FG000|As Treated at Study Closure|non-specified|54|||
30753412|NCT00123474|58763149|FG001|As Treated at Study Closure|non-specified|47|||
30753413|NCT00123474|58763150|FG002|As Treated at Study Closure|non-specified|57|||
30753414|NCT00123474|58763151|FG003|As Treated at Study Closure|non-specified|60|||
30753415|NCT00123474|58763148|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
30753416|NCT00123474|58763149|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
30753417|NCT00123474|58763150|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
30753418|NCT00123474|58763151|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
30753419|NCT00123474|58763148|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
30753420|NCT00123474|58763149|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
30753421|NCT00123474|58763150|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
30753422|NCT00123474|58763151|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
30753423|NCT00142298|58763192|FG000|Overall Study|Adverse Event|10|||
30753424|NCT00142298|58763193|FG001|Overall Study|Adverse Event|10|||
30753425|NCT00142298|58763194|FG002|Overall Study|Adverse Event|1|||
30753426|NCT00142298|58763195|FG003|Overall Study|Adverse Event|5|||
30753427|NCT00142298|58763196|FG004|Overall Study|Adverse Event|2|||
30753428|NCT00142298|58763197|FG005|Overall Study|Adverse Event|2|||
30753429|NCT00142298|58763198|FG006|Overall Study|Adverse Event|0|||
30753430|NCT00142298|58763199|FG007|Overall Study|Adverse Event|0|||
30824195|NCT03125915|58845971|FG001|6 Month Follow-up|Lost to Follow-up|3|||
30623146|NCT01214720|58634988|FG000|Overall Study|Alive and in follow-up|45|||
30623147|NCT01214720|58634989|FG001|Overall Study|Alive and in follow-up|48|||
30623148|NCT01214720|58634988|FG000|Overall Study|Lost to Follow-up|6|||
30623149|NCT01214720|58634989|FG001|Overall Study|Lost to Follow-up|2|||
30623150|NCT01142232|58635000|FG000|Overall Study|Adverse Event|1|||
30623151|NCT01142232|58635001|FG001|Overall Study|Adverse Event|2|||
30623152|NCT01142232|58635002|FG002|Overall Study|Adverse Event|1|||
30753431|NCT00142298|58763200|FG008|Overall Study|Adverse Event|0|||
30753432|NCT00142298|58763201|FG009|Overall Study|Adverse Event|0|||
30753433|NCT00142298|58763192|FG000|Overall Study|Clinical disease progression|1|||
30753434|NCT00142298|58763193|FG001|Overall Study|Clinical disease progression|0|||
30824196|NCT03125915|58845972|FG002|6 Month Follow-up|Lost to Follow-up|6|||
30824197|NCT03125915|58845973|FG003|6 Month Follow-up|Lost to Follow-up|3|||
30824198|NCT03122171|58845983|FG000|Overall Study|Withdrawal by Subject|1|||
30824199|NCT01427725|58845987|FG000|Overall Study|Lost to Follow-up|17|||
30824200|NCT01427725|58845987|FG000|Overall Study|Protocol Violation|1|||
30824201|NCT01427725|58845987|FG000|Overall Study|Drug not administered|1|||
30824202|NCT01427725|58845987|FG000|Overall Study|Failure to visit|7|||
30824203|NCT01427725|58845987|FG000|Overall Study|Adverse Event|46|||
30824204|NCT01427725|58845987|FG000|Overall Study|Failure to visit after administration|40|||
30824205|NCT01427725|58845987|FG000|Overall Study|Patient's rejection|27|||
30824206|NCT01427725|58845987|FG000|Overall Study|Transfer to a different hospital|17|||
30824207|NCT01427725|58845987|FG000|Overall Study|Lack of Efficacy|8|||
30824208|NCT01427725|58845987|FG000|Overall Study|Death|7|||
30824209|NCT01427725|58845987|FG000|Overall Study|Symptom improvement|6|||
30824210|NCT01427725|58845987|FG000|Overall Study|AE and Patient's rejection|5|||
30824211|NCT01427725|58845987|FG000|Overall Study|Physician Decision|5|||
30824212|NCT01427725|58845987|FG000|Overall Study|Exacerbation of underlying disease|5|||
30824213|NCT01427725|58845987|FG000|Overall Study|Oral feeding difficulty|5|||
30824214|NCT01427725|58845987|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
30824215|NCT01427725|58845987|FG000|Overall Study|Forgetting prescription|1|||
30824216|NCT01427725|58845987|FG000|Overall Study|Other|2|||
30824217|NCT02839200|58845998|FG000|Overall Study|Withdrawal by Subject|2|||
30824218|NCT02839200|58845999|FG001|Overall Study|Withdrawal by Subject|0|||
30824219|NCT02839200|58846000|FG002|Overall Study|Withdrawal by Subject|1|||
30824220|NCT02839200|58846001|FG003|Overall Study|Withdrawal by Subject|0|||
30824221|NCT02839200|58846002|FG004|Overall Study|Withdrawal by Subject|0|||
30824222|NCT02839200|58846003|FG005|Overall Study|Withdrawal by Subject|1|||
30824223|NCT02839200|58845998|FG000|Overall Study|Lost to Follow-up|2|||
30824224|NCT02839200|58845999|FG001|Overall Study|Lost to Follow-up|0|||
30824225|NCT02839200|58846000|FG002|Overall Study|Lost to Follow-up|0|||
30824226|NCT02839200|58846001|FG003|Overall Study|Lost to Follow-up|0|||
30824227|NCT02839200|58846002|FG004|Overall Study|Lost to Follow-up|1|||
30824228|NCT02839200|58846003|FG005|Overall Study|Lost to Follow-up|0|||
30824229|NCT02839200|58845998|FG000|Overall Study|Adverse Event|0|||
30824230|NCT02839200|58845999|FG001|Overall Study|Adverse Event|0|||
30824231|NCT02839200|58846000|FG002|Overall Study|Adverse Event|0|||
30824232|NCT02839200|58846001|FG003|Overall Study|Adverse Event|0|||
30824233|NCT02839200|58846002|FG004|Overall Study|Adverse Event|1|||
30824234|NCT02839200|58846003|FG005|Overall Study|Adverse Event|0|||
30914694|NCT01573624|58950134|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
30753435|NCT00142298|58763194|FG002|Overall Study|Clinical disease progression|0|||
30753436|NCT00142298|58763195|FG003|Overall Study|Clinical disease progression|0|||
30753437|NCT00142298|58763196|FG004|Overall Study|Clinical disease progression|0|||
30753438|NCT00142298|58763197|FG005|Overall Study|Clinical disease progression|0|||
30753439|NCT00142298|58763198|FG006|Overall Study|Clinical disease progression|0|||
30753440|NCT00142298|58763199|FG007|Overall Study|Clinical disease progression|0|||
30824235|NCT02839200|58845998|FG000|Overall Study|Randomized in error|0|||
30824236|NCT02839200|58845999|FG001|Overall Study|Randomized in error|1|||
30623153|NCT01142232|58635003|FG003|Overall Study|Adverse Event|0|||
30623154|NCT01142232|58635004|FG004|Overall Study|Adverse Event|4|||
30824237|NCT02839200|58846000|FG002|Overall Study|Randomized in error|0|||
30824238|NCT02839200|58846001|FG003|Overall Study|Randomized in error|0|||
30824239|NCT02839200|58846002|FG004|Overall Study|Randomized in error|0|||
30824240|NCT02839200|58846003|FG005|Overall Study|Randomized in error|0|||
30824241|NCT03118739|58846019|FG000|Overall Study|Physician Decision|0|||
30824242|NCT03118739|58846020|FG001|Overall Study|Physician Decision|1|||
30623155|NCT01142232|58635000|FG000|Overall Study|Death|0|||
30824243|NCT03118739|58846019|FG000|Overall Study|Withdrawal by Subject|5|||
30824244|NCT03118739|58846020|FG001|Overall Study|Withdrawal by Subject|3|||
30824245|NCT03118739|58846019|FG000|Overall Study|Lost to Follow-up|2|||
30623156|NCT01142232|58635001|FG001|Overall Study|Death|0|||
30623157|NCT01142232|58635002|FG002|Overall Study|Death|0|||
30623158|NCT01142232|58635003|FG003|Overall Study|Death|0|||
30753441|NCT00142298|58763200|FG008|Overall Study|Clinical disease progression|0|||
30753442|NCT00142298|58763201|FG009|Overall Study|Clinical disease progression|0|||
30753443|NCT00142298|58763192|FG000|Overall Study|Death|1|||
30753444|NCT00142298|58763193|FG001|Overall Study|Death|1|||
30753445|NCT00142298|58763194|FG002|Overall Study|Death|1|||
30753446|NCT00142298|58763195|FG003|Overall Study|Death|0|||
30753447|NCT00142298|58763196|FG004|Overall Study|Death|0|||
30753448|NCT00142298|58763197|FG005|Overall Study|Death|6|||
30753449|NCT00142298|58763198|FG006|Overall Study|Death|0|||
30824246|NCT03118739|58846020|FG001|Overall Study|Lost to Follow-up|0|||
30824247|NCT03094195|58846029|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
30824248|NCT03094195|58846030|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
30824249|NCT03094195|58846031|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
30824250|NCT03094195|58846032|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
30824251|NCT03094195|58846033|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
30824252|NCT03094195|58846034|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
30824253|NCT03094195|58846035|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
30824254|NCT03094195|58846036|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
30824255|NCT03094195|58846029|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
30824256|NCT03094195|58846030|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
30824257|NCT03094195|58846031|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
30824258|NCT03094195|58846032|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
30824259|NCT03094195|58846033|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
30824260|NCT03094195|58846034|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
30824261|NCT03094195|58846035|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
30824262|NCT03094195|58846036|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
30753450|NCT00142298|58763199|FG007|Overall Study|Death|0|||
30824263|NCT03094195|58846029|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
30824264|NCT03094195|58846030|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
30824265|NCT03094195|58846031|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
30824266|NCT03094195|58846032|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
30824267|NCT03094195|58846033|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
30824268|NCT03094195|58846034|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
30824269|NCT03094195|58846035|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
30824270|NCT03094195|58846036|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
30824271|NCT03094195|58846029|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
30824272|NCT03094195|58846030|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
30824273|NCT03094195|58846031|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
30824274|NCT03094195|58846032|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
30824275|NCT03094195|58846033|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
30824276|NCT03094195|58846034|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
30824277|NCT03094195|58846035|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
30824278|NCT03094195|58846036|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
30824279|NCT02835690|58846057|FG000|Overall Study|Death|12|||
30824280|NCT02835690|58846058|FG001|Overall Study|Death|11|||
30824281|NCT02835690|58846059|FG002|Overall Study|Death|13|||
30824282|NCT02835690|58846057|FG000|Overall Study|Transferred to Extension Study|2|||
30824283|NCT02835690|58846058|FG001|Overall Study|Transferred to Extension Study|2|||
30824284|NCT02835690|58846059|FG002|Overall Study|Transferred to Extension Study|1|||
30824285|NCT02835690|58846057|FG000|Overall Study|Did Not Continue on Extension Study|0|||
30824286|NCT02835690|58846058|FG001|Overall Study|Did Not Continue on Extension Study|0|||
30824287|NCT02835690|58846059|FG002|Overall Study|Did Not Continue on Extension Study|1|||
30824288|NCT02835690|58846057|FG000|Overall Study|Not Treated|0|||
30824289|NCT02835690|58846058|FG001|Overall Study|Not Treated|2|||
30824290|NCT02835690|58846059|FG002|Overall Study|Not Treated|0|||
30824291|NCT02837952|58846070|FG000|Overall Study|Adverse Event|0|||
30824292|NCT02837952|58846071|FG001|Overall Study|Adverse Event|1|||
30753451|NCT00142298|58763200|FG008|Overall Study|Death|0|||
30824293|NCT02837952|58846070|FG000|Overall Study|Withdrawal by Subject|4|||
30824294|NCT02837952|58846071|FG001|Overall Study|Withdrawal by Subject|5|||
30824295|NCT02837952|58846070|FG000|Overall Study|Medication Error|1|||
30824296|NCT02837952|58846071|FG001|Overall Study|Medication Error|0|||
30824297|NCT02832167|58846077|FG000|Treatment Period 1|Disease progression|90|||
30824298|NCT02832167|58846077|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
30824299|NCT02832167|58846077|FG000|Treatment Period 1|Death|2|||
30824300|NCT02832167|58846077|FG000|Treatment Period 1|Study Drug Toxicity|6|||
30824301|NCT02832167|58846077|FG000|Treatment Period 1|Participant request to discontinue|9|||
30824302|NCT02832167|58846077|FG000|Treatment Period 1|No longer meet study criteria|1|||
30824303|NCT02832167|58846077|FG000|Treatment Period 1|Participant withdrew consent|3|||
30824304|NCT02832167|58846077|FG000|Treatment Period 1|Other reasons|6|||
30824305|NCT02832167|58846077|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
30824306|NCT02832167|58846077|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
30824307|NCT02832167|58846077|FG000|Transition From Period 1 to Period 2|Death|2|||
30824308|NCT02832167|58846077|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
30824309|NCT02832167|58846077|FG000|Treatment Period 2|Disease progression|69|||
30824310|NCT02832167|58846077|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
30824311|NCT02832167|58846077|FG000|Treatment Period 2|Maximum clinical benefit|1|||
30824312|NCT02832167|58846077|FG000|Treatment Period 2|Study Drug Toxicity|5|||
30824313|NCT02832167|58846077|FG000|Treatment Period 2|Participant request to discontinue|2|||
30824314|NCT02832167|58846077|FG000|Treatment Period 2|Participant withdrew consent|3|||
30824315|NCT02832167|58846077|FG000|Treatment Period 2|Other reasons|3|||
30824316|NCT02674529|58846083|FG000|Overall Study|Lost to Follow-up|1|||
30824317|NCT02674529|58846084|FG001|Overall Study|Lost to Follow-up|2|||
30824318|NCT02674529|58846083|FG000|Overall Study|Withdrawal by Subject|2|||
30824319|NCT02674529|58846084|FG001|Overall Study|Withdrawal by Subject|1|||
30824320|NCT02674529|58846083|FG000|Overall Study|Physician Decision|0|||
30824321|NCT02674529|58846084|FG001|Overall Study|Physician Decision|1|||
30824322|NCT02674529|58846083|FG000|Overall Study|Protocol Violation|0|||
30824323|NCT02674529|58846084|FG001|Overall Study|Protocol Violation|1|||
30824324|NCT02626949|58846095|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
30824325|NCT02626949|58846096|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
30824326|NCT02626949|58846095|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
30824327|NCT02626949|58846096|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
30824328|NCT02626949|58846095|FG000|Enrolled|Lost to Follow-up|7|||
30824329|NCT02626949|58846096|FG001|Enrolled|Lost to Follow-up|6|||
30824330|NCT02626949|58846095|FG000|Enrolled|Withdrawal by Subject|3|||
30824331|NCT02626949|58846096|FG001|Enrolled|Withdrawal by Subject|2|||
30824332|NCT03116399|58846104|FG000|Overall Study|Death|8|||
30824333|NCT03116399|58846105|FG001|Overall Study|Death|3|||
30824334|NCT03116399|58846104|FG000|Overall Study|Lost to Follow-up|7|||
30824335|NCT03116399|58846105|FG001|Overall Study|Lost to Follow-up|11|||
30824336|NCT03116399|58846104|FG000|Overall Study|Investigator Decision|1|||
30824337|NCT03116399|58846105|FG001|Overall Study|Investigator Decision|1|||
30824338|NCT03116399|58846104|FG000|Overall Study|Withdrawal by Subject|24|||
30824339|NCT03116399|58846105|FG001|Overall Study|Withdrawal by Subject|9|||
30824340|NCT03097861|58846114|FG000|Overall Study|Adverse Event|3|||
30753452|NCT00142298|58763201|FG009|Overall Study|Death|0|||
30753453|NCT00142298|58763192|FG000|Overall Study|Lack of Efficacy|44|||
30753454|NCT00142298|58763193|FG001|Overall Study|Lack of Efficacy|62|||
30753455|NCT00142298|58763194|FG002|Overall Study|Lack of Efficacy|9|||
30753456|NCT00142298|58763195|FG003|Overall Study|Lack of Efficacy|12|||
30753457|NCT00142298|58763196|FG004|Overall Study|Lack of Efficacy|1|||
30753458|NCT00142298|58763197|FG005|Overall Study|Lack of Efficacy|0|||
30753459|NCT00142298|58763198|FG006|Overall Study|Lack of Efficacy|0|||
30753460|NCT00142298|58763199|FG007|Overall Study|Lack of Efficacy|1|||
30753461|NCT00142298|58763200|FG008|Overall Study|Lack of Efficacy|0|||
30753462|NCT00142298|58763201|FG009|Overall Study|Lack of Efficacy|0|||
30753463|NCT00142298|58763192|FG000|Overall Study|Non-compliance|15|||
30753464|NCT00142298|58763193|FG001|Overall Study|Non-compliance|13|||
30753465|NCT00142298|58763194|FG002|Overall Study|Non-compliance|0|||
30753466|NCT00142298|58763195|FG003|Overall Study|Non-compliance|6|||
30824341|NCT03097861|58846115|FG001|Overall Study|Adverse Event|8|||
30824342|NCT03097861|58846116|FG002|Overall Study|Adverse Event|4|||
30824343|NCT03097861|58846114|FG000|Overall Study|Investigator Decision|0|||
30824344|NCT03097861|58846115|FG001|Overall Study|Investigator Decision|1|||
30824345|NCT03097861|58846116|FG002|Overall Study|Investigator Decision|0|||
30824346|NCT03097861|58846114|FG000|Overall Study|Lost to Follow-up|0|||
30824347|NCT03097861|58846115|FG001|Overall Study|Lost to Follow-up|7|||
30753467|NCT00142298|58763196|FG004|Overall Study|Non-compliance|1|||
30753468|NCT00142298|58763197|FG005|Overall Study|Non-compliance|0|||
30824348|NCT03097861|58846116|FG002|Overall Study|Lost to Follow-up|1|||
30824349|NCT03097861|58846114|FG000|Overall Study|Withdrawal by Subject|1|||
30753469|NCT00142298|58763198|FG006|Overall Study|Non-compliance|0|||
30753470|NCT00142298|58763199|FG007|Overall Study|Non-compliance|3|||
30824350|NCT03097861|58846115|FG001|Overall Study|Withdrawal by Subject|5|||
30824351|NCT03097861|58846116|FG002|Overall Study|Withdrawal by Subject|3|||
30824352|NCT03097861|58846114|FG000|Overall Study|Reason not provided|3|||
30824353|NCT03097861|58846115|FG001|Overall Study|Reason not provided|1|||
30824354|NCT03097861|58846116|FG002|Overall Study|Reason not provided|1|||
30824355|NCT03910673|58846131|FG000|Overall Study|Adverse Event|0|||
30824356|NCT03910673|58846132|FG001|Overall Study|Adverse Event|0|||
30824357|NCT03910673|58846133|FG002|Overall Study|Adverse Event|0|||
30824358|NCT03910673|58846134|FG003|Overall Study|Adverse Event|2|||
30824359|NCT03910673|58846135|FG004|Overall Study|Adverse Event|0|||
30824360|NCT01816139|58846141|FG000|Overall Study|Adverse Event|6|||
30824361|NCT01816139|58846142|FG001|Overall Study|Adverse Event|8|||
30824362|NCT01816139|58846141|FG000|Overall Study|Lack of Efficacy|1|||
30824363|NCT01816139|58846142|FG001|Overall Study|Lack of Efficacy|2|||
30824364|NCT01816139|58846141|FG000|Overall Study|Lost to Follow-up|5|||
30824365|NCT01816139|58846142|FG001|Overall Study|Lost to Follow-up|3|||
30824366|NCT01816139|58846141|FG000|Overall Study|Withdrew Consent|6|||
30824367|NCT01816139|58846142|FG001|Overall Study|Withdrew Consent|4|||
30824368|NCT01816139|58846141|FG000|Overall Study|Protocol Violation|6|||
30824369|NCT01816139|58846142|FG001|Overall Study|Protocol Violation|3|||
30824370|NCT01816139|58846141|FG000|Overall Study|Reason not Specified|4|||
30824371|NCT01816139|58846142|FG001|Overall Study|Reason not Specified|2|||
30824372|NCT02833350|58846185|FG000|Overall Study|Adverse Event|0|||
30824373|NCT02833350|58846186|FG001|Overall Study|Adverse Event|3|||
30824374|NCT02833350|58846187|FG002|Overall Study|Adverse Event|4|||
30824375|NCT02833350|58846188|FG003|Overall Study|Adverse Event|4|||
30824376|NCT02833350|58846189|FG004|Overall Study|Adverse Event|1|||
30824377|NCT02833350|58846190|FG005|Overall Study|Adverse Event|0|||
30824378|NCT02833350|58846191|FG006|Overall Study|Adverse Event|1|||
30824379|NCT02833350|58846185|FG000|Overall Study|Death|0|||
30824380|NCT02833350|58846186|FG001|Overall Study|Death|0|||
30824381|NCT02833350|58846187|FG002|Overall Study|Death|1|||
30914695|NCT01573624|58950135|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
30914696|NCT01573624|58950136|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
30914697|NCT01573624|58950137|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
30914698|NCT01573624|58950131|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
30914699|NCT01573624|58950132|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
30914700|NCT01573624|58950133|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
30914701|NCT01573624|58950134|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
30914702|NCT01573624|58950135|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
30914703|NCT01573624|58950136|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
30623159|NCT01142232|58635004|FG004|Overall Study|Death|1|||
30623160|NCT01142232|58635000|FG000|Overall Study|Disease Progression|2|||
30623161|NCT01142232|58635001|FG001|Overall Study|Disease Progression|0|||
30623162|NCT01142232|58635002|FG002|Overall Study|Disease Progression|1|||
30623163|NCT01142232|58635003|FG003|Overall Study|Disease Progression|2|||
30623164|NCT01142232|58635004|FG004|Overall Study|Disease Progression|12|||
30623165|NCT01142232|58635000|FG000|Overall Study|Withdrawal by Subject|0|||
30623166|NCT01142232|58635001|FG001|Overall Study|Withdrawal by Subject|0|||
30623167|NCT01142232|58635002|FG002|Overall Study|Withdrawal by Subject|0|||
30623168|NCT01142232|58635003|FG003|Overall Study|Withdrawal by Subject|1|||
30623169|NCT01142232|58635004|FG004|Overall Study|Withdrawal by Subject|3|||
30623170|NCT01142232|58635000|FG000|Overall Study|Physician Decision|0|||
30753471|NCT00142298|58763200|FG008|Overall Study|Non-compliance|3|||
30753472|NCT00142298|58763201|FG009|Overall Study|Non-compliance|0|||
30753473|NCT00142298|58763192|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
30753474|NCT00142298|58763193|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
30824382|NCT02833350|58846188|FG003|Overall Study|Death|0|||
30824383|NCT02833350|58846189|FG004|Overall Study|Death|0|||
30753475|NCT00142298|58763194|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
30753476|NCT00142298|58763195|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
30753477|NCT00142298|58763196|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
30753478|NCT00142298|58763197|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
30753479|NCT00142298|58763198|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
30753480|NCT00142298|58763199|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
30753481|NCT00142298|58763200|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
30753482|NCT00142298|58763201|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
30753483|NCT00142298|58763192|FG000|Overall Study|Pregnancy|4|||
30753484|NCT00142298|58763193|FG001|Overall Study|Pregnancy|4|||
30824384|NCT02833350|58846190|FG005|Overall Study|Death|0|||
30824385|NCT02833350|58846191|FG006|Overall Study|Death|0|||
30824386|NCT02833350|58846185|FG000|Overall Study|Lack of Efficacy|0|||
30824387|NCT02833350|58846186|FG001|Overall Study|Lack of Efficacy|2|||
30824388|NCT02833350|58846187|FG002|Overall Study|Lack of Efficacy|1|||
30824389|NCT02833350|58846188|FG003|Overall Study|Lack of Efficacy|4|||
30824390|NCT02833350|58846189|FG004|Overall Study|Lack of Efficacy|0|||
30824391|NCT02833350|58846190|FG005|Overall Study|Lack of Efficacy|1|||
30753485|NCT00142298|58763194|FG002|Overall Study|Pregnancy|2|||
30753486|NCT00142298|58763195|FG003|Overall Study|Pregnancy|3|||
30824392|NCT02833350|58846191|FG006|Overall Study|Lack of Efficacy|1|||
30824393|NCT02833350|58846185|FG000|Overall Study|Lost to Follow-up|0|||
30824394|NCT02833350|58846186|FG001|Overall Study|Lost to Follow-up|1|||
30824395|NCT02833350|58846187|FG002|Overall Study|Lost to Follow-up|0|||
30824396|NCT02833350|58846188|FG003|Overall Study|Lost to Follow-up|0|||
30824397|NCT02833350|58846189|FG004|Overall Study|Lost to Follow-up|0|||
30824398|NCT02833350|58846190|FG005|Overall Study|Lost to Follow-up|0|||
30824399|NCT02833350|58846191|FG006|Overall Study|Lost to Follow-up|1|||
30824400|NCT02833350|58846185|FG000|Overall Study|Withdrawal by Subject|3|||
30824401|NCT02833350|58846186|FG001|Overall Study|Withdrawal by Subject|3|||
30824402|NCT02833350|58846187|FG002|Overall Study|Withdrawal by Subject|2|||
30824403|NCT02833350|58846188|FG003|Overall Study|Withdrawal by Subject|0|||
30824404|NCT02833350|58846189|FG004|Overall Study|Withdrawal by Subject|2|||
30824405|NCT02833350|58846190|FG005|Overall Study|Withdrawal by Subject|0|||
30824406|NCT02833350|58846191|FG006|Overall Study|Withdrawal by Subject|2|||
30824407|NCT01343043|58846214|FG000|Overall Study|Disease progression before treatment|1|||
30623171|NCT01142232|58635001|FG001|Overall Study|Physician Decision|1|||
30623172|NCT01142232|58635002|FG002|Overall Study|Physician Decision|0|||
30623173|NCT01142232|58635003|FG003|Overall Study|Physician Decision|2|||
30623174|NCT01142232|58635004|FG004|Overall Study|Physician Decision|10|||
30623175|NCT01142232|58635000|FG000|Overall Study|Alternative Therapy|0|||
30824408|NCT01343043|58846215|FG001|Overall Study|Disease progression before treatment|0|||
30824409|NCT01343043|58846216|FG002|Overall Study|Disease progression before treatment|0|||
30824410|NCT01343043|58846217|FG003|Overall Study|Disease progression before treatment|0|||
30824411|NCT01343043|58846214|FG000|Overall Study|Withdrawal by Subject|1|||
30824412|NCT01343043|58846215|FG001|Overall Study|Withdrawal by Subject|0|||
30824413|NCT01343043|58846216|FG002|Overall Study|Withdrawal by Subject|0|||
30824414|NCT01343043|58846217|FG003|Overall Study|Withdrawal by Subject|0|||
30824415|NCT01343043|58846214|FG000|Overall Study|Death|1|||
30824416|NCT01343043|58846215|FG001|Overall Study|Death|1|||
30824417|NCT01343043|58846216|FG002|Overall Study|Death|0|||
30824418|NCT01343043|58846217|FG003|Overall Study|Death|1|||
30824419|NCT03548987|58846232|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
30824420|NCT03548987|58846233|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
30824421|NCT03548987|58846232|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
30824422|NCT03548987|58846233|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
30824423|NCT03548987|58846232|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
30824424|NCT03548987|58846233|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
30824425|NCT03548987|58846232|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
30824426|NCT03548987|58846233|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
30824427|NCT03548987|58846232|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
30824428|NCT03548987|58846233|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
30824429|NCT03548987|58846232|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
30824430|NCT03548987|58846233|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
30824431|NCT03548987|58846232|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
30824432|NCT03548987|58846233|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
30824433|NCT03548987|58846232|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
30824434|NCT03548987|58846233|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
30824435|NCT03548987|58846232|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
30824436|NCT03548987|58846233|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
30914704|NCT01573624|58950137|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
30914705|NCT01573624|58950131|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
30914706|NCT01573624|58950132|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
30914707|NCT01573624|58950133|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
30914708|NCT01573624|58950134|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
30914709|NCT01573624|58950135|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
30914710|NCT01573624|58950136|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
30914711|NCT01573624|58950137|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
30914712|NCT01573624|58950131|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
30914713|NCT01573624|58950132|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
30914714|NCT01573624|58950133|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
30914715|NCT01573624|58950134|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
30914716|NCT01573624|58950135|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
30914717|NCT01573624|58950136|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
30914718|NCT01573624|58950137|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
30914719|NCT01573624|58950131|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
30914720|NCT01573624|58950132|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
30914721|NCT01573624|58950133|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
30914722|NCT01573624|58950134|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
30914723|NCT01573624|58950135|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
30914724|NCT01573624|58950136|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
30914725|NCT01573624|58950137|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
30914726|NCT01573624|58950131|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
30914727|NCT01573624|58950132|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
30914728|NCT01573624|58950133|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
30914729|NCT01573624|58950134|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
30914730|NCT01573624|58950135|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
30914731|NCT01573624|58950136|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
30914732|NCT01573624|58950137|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
30914733|NCT01573624|58950131|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
30914734|NCT01573624|58950132|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
30914735|NCT01573624|58950133|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
30914736|NCT01573624|58950134|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
30914737|NCT01573624|58950135|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
30914738|NCT01573624|58950136|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
30824437|NCT03548987|58846232|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
30824438|NCT03548987|58846233|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
30824439|NCT03548987|58846232|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
30824440|NCT03548987|58846233|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
30824441|NCT03548987|58846232|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
30824442|NCT03548987|58846233|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
30824443|NCT03548987|58846232|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
30824444|NCT03548987|58846233|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
30824445|NCT03548987|58846232|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
30824446|NCT03548987|58846233|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
30824447|NCT01358760|58846243|FG000|Overall Study|Adverse Event|3|||
30824448|NCT01358760|58846244|FG001|Overall Study|Adverse Event|4|||
30824449|NCT01358760|58846245|FG002|Overall Study|Adverse Event|3|||
30824450|NCT01358760|58846243|FG000|Overall Study|Lost to Follow-up|1|||
30824451|NCT01358760|58846244|FG001|Overall Study|Lost to Follow-up|1|||
30824452|NCT01358760|58846245|FG002|Overall Study|Lost to Follow-up|3|||
30824453|NCT01358760|58846243|FG000|Overall Study|Withdrawal by Subject|5|||
30824454|NCT01358760|58846244|FG001|Overall Study|Withdrawal by Subject|3|||
30824455|NCT01358760|58846245|FG002|Overall Study|Withdrawal by Subject|2|||
30824456|NCT01358760|58846243|FG000|Overall Study|Physician Decision|1|||
30824457|NCT01358760|58846244|FG001|Overall Study|Physician Decision|0|||
30914739|NCT01573624|58950137|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
30914740|NCT01573624|58950131|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
30914741|NCT01573624|58950132|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
30914742|NCT01573624|58950133|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
30914743|NCT01573624|58950134|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
30914744|NCT01573624|58950135|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
30914745|NCT01573624|58950136|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
30914746|NCT01573624|58950137|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
30914747|NCT01573624|58950131|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
30914748|NCT01573624|58950132|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
30914749|NCT01573624|58950133|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
30914750|NCT01573624|58950134|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
30914751|NCT01573624|58950135|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
30914752|NCT01573624|58950136|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
30914753|NCT01573624|58950137|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
30914754|NCT01573624|58950131|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
30914755|NCT01573624|58950132|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30914756|NCT01573624|58950133|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30914757|NCT01573624|58950134|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30914758|NCT01573624|58950135|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
30914759|NCT01573624|58950136|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
30914760|NCT01573624|58950137|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
30914761|NCT01573624|58950131|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
30824458|NCT01358760|58846245|FG002|Overall Study|Physician Decision|1|||
30824459|NCT01358760|58846243|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
30824460|NCT01358760|58846244|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
30824461|NCT01358760|58846245|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
30824462|NCT01341990|58846255|FG000|Overall Study|Adverse Event|0|||
30753487|NCT00142298|58763196|FG004|Overall Study|Pregnancy|0|||
30753488|NCT00142298|58763197|FG005|Overall Study|Pregnancy|0|||
30753489|NCT00142298|58763198|FG006|Overall Study|Pregnancy|0|||
30753490|NCT00142298|58763199|FG007|Overall Study|Pregnancy|0|||
30753491|NCT00142298|58763200|FG008|Overall Study|Pregnancy|1|||
30753492|NCT00142298|58763201|FG009|Overall Study|Pregnancy|0|||
30753493|NCT00142298|58763192|FG000|Overall Study|Virologic breakthrough|19|||
30753494|NCT00142298|58763193|FG001|Overall Study|Virologic breakthrough|23|||
30753495|NCT00142298|58763194|FG002|Overall Study|Virologic breakthrough|9|||
30753496|NCT00142298|58763195|FG003|Overall Study|Virologic breakthrough|7|||
30753497|NCT00142298|58763196|FG004|Overall Study|Virologic breakthrough|2|||
30753498|NCT00142298|58763197|FG005|Overall Study|Virologic breakthrough|3|||
30753499|NCT00142298|58763198|FG006|Overall Study|Virologic breakthrough|3|||
30753500|NCT00142298|58763199|FG007|Overall Study|Virologic breakthrough|0|||
30753501|NCT00142298|58763200|FG008|Overall Study|Virologic breakthrough|0|||
30753502|NCT00142298|58763201|FG009|Overall Study|Virologic breakthrough|0|||
30753503|NCT00142298|58763192|FG000|Overall Study|Other- not specified|0|||
30753504|NCT00142298|58763193|FG001|Overall Study|Other- not specified|3|||
30824463|NCT01341990|58846256|FG001|Overall Study|Adverse Event|1|||
30824464|NCT01341990|58846255|FG000|Overall Study|Torn Study Lens|1|||
30824465|NCT01341990|58846256|FG001|Overall Study|Torn Study Lens|0|||
30824466|NCT01341990|58846255|FG000|Overall Study|Withdrawal by Subject|2|||
30824467|NCT01341990|58846256|FG001|Overall Study|Withdrawal by Subject|0|||
30824468|NCT03048747|58846262|FG000|Overall Study|Adverse Event|2|||
30824469|NCT03048747|58846262|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
30824470|NCT03048747|58846262|FG000|Overall Study|Physician Decision|1|||
30914762|NCT01573624|58950132|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
30914763|NCT01573624|58950133|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
30914764|NCT01573624|58950134|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
30914765|NCT01573624|58950135|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
30914766|NCT01573624|58950136|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
30914767|NCT01573624|58950137|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
30914768|NCT01573624|58950131|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
30753505|NCT00142298|58763194|FG002|Overall Study|Other- not specified|0|||
30753506|NCT00142298|58763195|FG003|Overall Study|Other- not specified|1|||
30753507|NCT00142298|58763196|FG004|Overall Study|Other- not specified|0|||
30753508|NCT00142298|58763197|FG005|Overall Study|Other- not specified|0|||
30753509|NCT00142298|58763198|FG006|Overall Study|Other- not specified|0|||
30753510|NCT00142298|58763199|FG007|Overall Study|Other- not specified|0|||
30753511|NCT00142298|58763200|FG008|Overall Study|Other- not specified|0|||
30824471|NCT01991067|58846324|FG000|Overall Study|Lost to Follow-up|6|||
30824472|NCT01991067|58846325|FG001|Overall Study|Lost to Follow-up|5|||
30824473|NCT01709331|58846331|FG000|Overall Study|Adverse Event|1|||
30824474|NCT03255083|58846339|FG000|Overall Study|Clinical progression|1|||
30824475|NCT03255083|58846340|FG001|Overall Study|Clinical progression|0|||
30824476|NCT03255083|58846341|FG002|Overall Study|Clinical progression|0|||
30824477|NCT03255083|58846342|FG003|Overall Study|Clinical progression|0|||
30824478|NCT03255083|58846339|FG000|Overall Study|Adverse Event|0|||
30824479|NCT03255083|58846340|FG001|Overall Study|Adverse Event|1|||
30824480|NCT03255083|58846341|FG002|Overall Study|Adverse Event|0|||
30824481|NCT03255083|58846342|FG003|Overall Study|Adverse Event|0|||
30824482|NCT03255083|58846339|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
30824483|NCT03255083|58846340|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
30824484|NCT03255083|58846341|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
30824485|NCT03255083|58846342|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
30824486|NCT03255083|58846339|FG000|Overall Study|Withdrawal by Subject|1|||
30824487|NCT03255083|58846340|FG001|Overall Study|Withdrawal by Subject|1|||
30824488|NCT03255083|58846341|FG002|Overall Study|Withdrawal by Subject|1|||
30824489|NCT03255083|58846342|FG003|Overall Study|Withdrawal by Subject|0|||
30824490|NCT04552587|58846358|FG000|Overall Study|Lost to Follow-up|4|||
30824491|NCT01316055|58846374|FG000|Overall Study|Lost to Follow-up|1|||
30824492|NCT01316055|58846375|FG001|Overall Study|Lost to Follow-up|0|||
30824493|NCT01316055|58846376|FG002|Overall Study|Lost to Follow-up|0|||
30824494|NCT01340976|58846393|FG000|Overall Study|Physician Decision|2|||
30824495|NCT01340976|58846394|FG001|Overall Study|Physician Decision|0|||
30824496|NCT01340976|58846395|FG002|Overall Study|Physician Decision|1|||
30824497|NCT01340976|58846396|FG003|Overall Study|Physician Decision|1|||
30824498|NCT01340976|58846397|FG004|Overall Study|Physician Decision|1|||
30824499|NCT01340976|58846398|FG005|Overall Study|Physician Decision|0|||
30824500|NCT01340976|58846393|FG000|Overall Study|Death|0|||
30824501|NCT01340976|58846394|FG001|Overall Study|Death|1|||
30824502|NCT01340976|58846395|FG002|Overall Study|Death|0|||
30824503|NCT01340976|58846396|FG003|Overall Study|Death|0|||
30824504|NCT01340976|58846397|FG004|Overall Study|Death|0|||
30824505|NCT01340976|58846398|FG005|Overall Study|Death|0|||
30824506|NCT01340976|58846393|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
30824507|NCT01340976|58846394|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
30824508|NCT01340976|58846395|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
30824509|NCT01340976|58846396|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
30824510|NCT01340976|58846397|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
30914769|NCT01573624|58950132|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
30914770|NCT01573624|58950133|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
30914771|NCT01573624|58950134|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
30914772|NCT01573624|58950135|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
30753512|NCT00142298|58763201|FG009|Overall Study|Other- not specified|0|||
30824511|NCT01340976|58846398|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
30824512|NCT01340976|58846393|FG000|Overall Study|Withdrawal by Subject|0|||
30824513|NCT01340976|58846394|FG001|Overall Study|Withdrawal by Subject|0|||
30824514|NCT01340976|58846395|FG002|Overall Study|Withdrawal by Subject|0|||
30824515|NCT01340976|58846396|FG003|Overall Study|Withdrawal by Subject|1|||
30824516|NCT01340976|58846397|FG004|Overall Study|Withdrawal by Subject|1|||
30824517|NCT01340976|58846398|FG005|Overall Study|Withdrawal by Subject|0|||
30824518|NCT01340976|58846393|FG000|Overall Study|Other anemia treatment|1|||
30824519|NCT01340976|58846394|FG001|Overall Study|Other anemia treatment|0|||
30824520|NCT01340976|58846395|FG002|Overall Study|Other anemia treatment|2|||
30824521|NCT01340976|58846396|FG003|Overall Study|Other anemia treatment|1|||
30824522|NCT01340976|58846397|FG004|Overall Study|Other anemia treatment|0|||
30824523|NCT01340976|58846398|FG005|Overall Study|Other anemia treatment|1|||
30914773|NCT01573624|58950136|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
30914774|NCT01573624|58950137|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
30753513|NCT00142298|58763192|FG000|Overall Study|Lost to Follow-up|0|||
30753514|NCT00142298|58763193|FG001|Overall Study|Lost to Follow-up|0|||
30753515|NCT00142298|58763194|FG002|Overall Study|Lost to Follow-up|0|||
30753516|NCT00142298|58763195|FG003|Overall Study|Lost to Follow-up|0|||
30753517|NCT00142298|58763196|FG004|Overall Study|Lost to Follow-up|0|||
30753518|NCT00142298|58763197|FG005|Overall Study|Lost to Follow-up|0|||
30753519|NCT00142298|58763198|FG006|Overall Study|Lost to Follow-up|2|||
30753520|NCT00142298|58763199|FG007|Overall Study|Lost to Follow-up|0|||
30753521|NCT00142298|58763200|FG008|Overall Study|Lost to Follow-up|0|||
30753522|NCT00142298|58763201|FG009|Overall Study|Lost to Follow-up|0|||
30753523|NCT00142298|58763192|FG000|Overall Study|Treatment Failure|0|||
30753524|NCT00142298|58763193|FG001|Overall Study|Treatment Failure|0|||
30753525|NCT00142298|58763194|FG002|Overall Study|Treatment Failure|0|||
30753526|NCT00142298|58763195|FG003|Overall Study|Treatment Failure|0|||
30753527|NCT00142298|58763196|FG004|Overall Study|Treatment Failure|0|||
30753528|NCT00142298|58763197|FG005|Overall Study|Treatment Failure|2|||
30753529|NCT00142298|58763198|FG006|Overall Study|Treatment Failure|2|||
30753530|NCT00142298|58763199|FG007|Overall Study|Treatment Failure|0|||
30753531|NCT00142298|58763200|FG008|Overall Study|Treatment Failure|0|||
30753532|NCT00142298|58763201|FG009|Overall Study|Treatment Failure|0|||
30753533|NCT03709654|58763225|FG000|Overall Study|Lost to Follow-up|1|||
30753534|NCT03709654|58763226|FG001|Overall Study|Lost to Follow-up|1|||
30753535|NCT03709654|58763225|FG000|Overall Study|Withdrawal by Subject|1|||
30753536|NCT03709654|58763226|FG001|Overall Study|Withdrawal by Subject|1|||
30753537|NCT03709654|58763225|FG000|Overall Study|Adverse Event|1|||
30753538|NCT03709654|58763226|FG001|Overall Study|Adverse Event|0|||
30753539|NCT00412061|58763234|FG000|Double Blind Phase|Disease Progression|101|||
30753540|NCT00412061|58763235|FG001|Double Blind Phase|Disease Progression|154|||
30753541|NCT00412061|58763234|FG000|Double Blind Phase|Adverse Event|61|||
30914775|NCT01573624|58950131|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
30914776|NCT01573624|58950132|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
30914777|NCT01573624|58950133|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
30914778|NCT01573624|58950134|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
30914779|NCT01573624|58950135|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
30914780|NCT01573624|58950136|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
30824524|NCT01340976|58846393|FG000|Overall Study|Adverse Event|0|||
30824525|NCT01340976|58846394|FG001|Overall Study|Adverse Event|1|||
30824526|NCT01340976|58846395|FG002|Overall Study|Adverse Event|0|||
30824527|NCT01340976|58846396|FG003|Overall Study|Adverse Event|0|||
30824528|NCT01340976|58846397|FG004|Overall Study|Adverse Event|0|||
30824529|NCT01340976|58846398|FG005|Overall Study|Adverse Event|0|||
30824530|NCT01680016|58846420|FG000|Overall Study|Adverse Event|0|||
30824531|NCT01680016|58846421|FG001|Overall Study|Adverse Event|0|||
30824532|NCT01680016|58846422|FG002|Overall Study|Adverse Event|1|||
30824533|NCT01680016|58846423|FG003|Overall Study|Adverse Event|4|||
30824534|NCT01680016|58846420|FG000|Overall Study|The Subject went out of The Trial|1|||
30824535|NCT01680016|58846421|FG001|Overall Study|The Subject went out of The Trial|0|||
30824536|NCT01680016|58846422|FG002|Overall Study|The Subject went out of The Trial|3|||
30824537|NCT01680016|58846423|FG003|Overall Study|The Subject went out of The Trial|0|||
30824538|NCT01680016|58846420|FG000|Overall Study|Protocol Violation|0|||
30824539|NCT01680016|58846421|FG001|Overall Study|Protocol Violation|1|||
30824540|NCT01680016|58846422|FG002|Overall Study|Protocol Violation|0|||
30824541|NCT01680016|58846423|FG003|Overall Study|Protocol Violation|0|||
30824542|NCT01680016|58846420|FG000|Overall Study|Withdrawal by Subject|5|||
30824543|NCT01680016|58846421|FG001|Overall Study|Withdrawal by Subject|7|||
30824544|NCT01680016|58846422|FG002|Overall Study|Withdrawal by Subject|1|||
30824545|NCT01680016|58846423|FG003|Overall Study|Withdrawal by Subject|1|||
30824546|NCT01340898|58846448|FG000|Primary Phase|Serious Adverse Events|0|||
30824547|NCT01340898|58846449|FG001|Primary Phase|Serious Adverse Events|0|||
30824548|NCT01340898|58846450|FG002|Primary Phase|Serious Adverse Events|1|||
30824549|NCT01340898|58846448|FG000|Primary Phase|Withdrawal by Subject|8|||
30824550|NCT01340898|58846449|FG001|Primary Phase|Withdrawal by Subject|7|||
30824551|NCT01340898|58846450|FG002|Primary Phase|Withdrawal by Subject|5|||
30824552|NCT01340898|58846448|FG000|Primary Phase|Migrated/moved from study area|4|||
30824553|NCT01340898|58846449|FG001|Primary Phase|Migrated/moved from study area|1|||
30824554|NCT01340898|58846450|FG002|Primary Phase|Migrated/moved from study area|0|||
30824555|NCT01340898|58846448|FG000|Primary Phase|Lost to Follow-up|4|||
30824556|NCT01340898|58846449|FG001|Primary Phase|Lost to Follow-up|1|||
30824557|NCT01340898|58846450|FG002|Primary Phase|Lost to Follow-up|0|||
30824558|NCT01340898|58846448|FG000|Booster Phase|Withdrawal by Subject|3|||
30824559|NCT01340898|58846449|FG001|Booster Phase|Withdrawal by Subject|0|||
30824560|NCT01340898|58846450|FG002|Booster Phase|Withdrawal by Subject|4|||
30824561|NCT01340898|58846448|FG000|Booster Phase|Migrated/moved from study area|3|||
30824562|NCT01340898|58846449|FG001|Booster Phase|Migrated/moved from study area|0|||
30824563|NCT01340898|58846450|FG002|Booster Phase|Migrated/moved from study area|0|||
30824564|NCT01340898|58846448|FG000|Booster Phase|Lost to Follow-up|4|||
30824565|NCT01340898|58846449|FG001|Booster Phase|Lost to Follow-up|2|||
30824566|NCT01340898|58846450|FG002|Booster Phase|Lost to Follow-up|3|||
30824567|NCT02744898|58846471|FG000|Overall Study|Progressive Disease|2|||
30824568|NCT02744898|58846471|FG000|Overall Study|Physician Decision|1|||
30824569|NCT02744898|58846471|FG000|Overall Study|Toxicity|1|||
30824570|NCT03097315|58846475|FG000|Overall Study|Withdrawal by Subject|1|||
30824571|NCT03039699|58846481|FG000|Overall Study|Incorrect inclusion|5|||
30824572|NCT03039699|58846482|FG001|Overall Study|Incorrect inclusion|4|||
30824573|NCT03039699|58846481|FG000|Overall Study|Lack of data to assess study endpoint|5|||
30824574|NCT03039699|58846482|FG001|Overall Study|Lack of data to assess study endpoint|3|||
30824575|NCT03039699|58846481|FG000|Overall Study|Bacterial infection|12|||
30824576|NCT03039699|58846482|FG001|Overall Study|Bacterial infection|28|||
30824577|NCT02833974|58846490|FG000|Overall Study|Lost to Follow-up|1|||
30824578|NCT02833974|58846491|FG001|Overall Study|Lost to Follow-up|0|||
30824579|NCT02833974|58846490|FG000|Overall Study|Adverse Event|0|||
30623176|NCT01142232|58635001|FG001|Overall Study|Alternative Therapy|1|||
30623177|NCT01142232|58635002|FG002|Overall Study|Alternative Therapy|1|||
30753542|NCT00412061|58763235|FG001|Double Blind Phase|Adverse Event|16|||
30753543|NCT00412061|58763234|FG000|Double Blind Phase|Final Primary Analysis|26|||
30753544|NCT00412061|58763235|FG001|Double Blind Phase|Final Primary Analysis|14|||
30753545|NCT00412061|58763234|FG000|Double Blind Phase|Withdrawal by Subject|18|||
30753546|NCT00412061|58763235|FG001|Double Blind Phase|Withdrawal by Subject|20|||
30753547|NCT00412061|58763234|FG000|Double Blind Phase|Death|6|||
30753548|NCT00412061|58763235|FG001|Double Blind Phase|Death|3|||
30753549|NCT00412061|58763234|FG000|Double Blind Phase|Protocol Violation|3|||
30753550|NCT00412061|58763235|FG001|Double Blind Phase|Protocol Violation|4|||
30753551|NCT00412061|58763234|FG000|Double Blind Phase|New Cander Therapy|1|||
30914781|NCT01573624|58950137|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
30914782|NCT01573624|58950131|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
30914783|NCT01573624|58950132|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
30914784|NCT01573624|58950133|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
30914785|NCT01573624|58950134|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
30914786|NCT01573624|58950135|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
30914787|NCT01573624|58950136|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
30914788|NCT01573624|58950137|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
30914789|NCT01557946|58950161|FG000|Overall Study|Adverse Event|3|||
30914790|NCT01557946|58950162|FG001|Overall Study|Adverse Event|0|||
30914791|NCT01534078|58950167|FG000|Overall Study|Death|1|||
30914792|NCT01534078|58950167|FG000|Overall Study|Withdrawal by Subject|1|||
30914793|NCT02185040|58950176|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
30914794|NCT02185040|58950177|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
30914795|NCT02185040|58950178|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
30914796|NCT02185040|58950179|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
30824580|NCT02833974|58846491|FG001|Overall Study|Adverse Event|3|||
30824581|NCT03093415|58846500|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
30824582|NCT03093415|58846501|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
30824583|NCT03093415|58846502|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
30824584|NCT03093415|58846500|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
30824585|NCT03093415|58846501|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
30824586|NCT03093415|58846502|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
30824587|NCT03093415|58846500|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
30824588|NCT03093415|58846501|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
30824589|NCT03093415|58846502|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
30824590|NCT03093415|58846500|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
30824591|NCT03093415|58846501|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
30824592|NCT03093415|58846502|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
30824593|NCT03093415|58846500|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
30824594|NCT03093415|58846501|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
30824595|NCT03093415|58846502|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
30824596|NCT03093415|58846500|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
30824597|NCT03093415|58846501|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
30824598|NCT03093415|58846502|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
30824599|NCT03093415|58846500|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
30824600|NCT03093415|58846501|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
30824601|NCT03093415|58846502|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
30824602|NCT03093415|58846500|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
30824603|NCT03093415|58846501|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
30914797|NCT02185040|58950180|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
30914798|NCT02185040|58950181|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
30914799|NCT02185040|58950182|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
30914800|NCT02185040|58950176|FG000|Part 1 Treatment Phase|Adverse Event|1|||
30914801|NCT02185040|58950177|FG001|Part 1 Treatment Phase|Adverse Event|0|||
30914802|NCT02185040|58950178|FG002|Part 1 Treatment Phase|Adverse Event|0|||
30914803|NCT02185040|58950179|FG003|Part 1 Treatment Phase|Adverse Event|2|||
30914804|NCT02185040|58950180|FG004|Part 1 Treatment Phase|Adverse Event|3|||
30914805|NCT02185040|58950181|FG005|Part 1 Treatment Phase|Adverse Event|0|||
30914806|NCT02185040|58950182|FG006|Part 1 Treatment Phase|Adverse Event|0|||
30914807|NCT02185040|58950176|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
30914808|NCT02185040|58950177|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
30914809|NCT02185040|58950178|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
30914810|NCT02185040|58950179|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
30914811|NCT02185040|58950180|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
30914812|NCT02185040|58950181|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
30914813|NCT02185040|58950182|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
30914814|NCT02185040|58950176|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
30914815|NCT02185040|58950177|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
30914816|NCT02185040|58950178|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
30914817|NCT02185040|58950179|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
30914818|NCT02185040|58950180|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
30914819|NCT02185040|58950181|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
30623178|NCT01142232|58635003|FG003|Overall Study|Alternative Therapy|0|||
30914820|NCT02185040|58950182|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
30914821|NCT02185040|58950176|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
30824604|NCT03093415|58846502|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
30824605|NCT03093415|58846500|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
30824606|NCT03093415|58846501|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
30824607|NCT03093415|58846502|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
30824608|NCT03093415|58846500|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
30914822|NCT02185040|58950177|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
30914823|NCT02185040|58950178|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
30914824|NCT02185040|58950179|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
30914825|NCT02185040|58950180|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
30824609|NCT03093415|58846501|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
30824610|NCT03093415|58846502|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
30824611|NCT03093415|58846500|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
30824612|NCT03093415|58846501|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
30824613|NCT03093415|58846502|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
30824614|NCT01358526|58846512|FG000|Open-label Titration Period|Adverse Event|95|||
30824615|NCT01358526|58846513|FG001|Open-label Titration Period|Adverse Event|0|||
30824616|NCT01358526|58846514|FG002|Open-label Titration Period|Adverse Event|0|||
30824617|NCT01358526|58846512|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
30824618|NCT01358526|58846513|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
30824619|NCT01358526|58846514|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
30824620|NCT01358526|58846512|FG000|Open-label Titration Period|Lost to Follow-up|25|||
30824621|NCT01358526|58846513|FG001|Open-label Titration Period|Lost to Follow-up|0|||
30824622|NCT01358526|58846514|FG002|Open-label Titration Period|Lost to Follow-up|0|||
30824623|NCT01358526|58846512|FG000|Open-label Titration Period|Lack of Efficacy|107|||
30824624|NCT01358526|58846513|FG001|Open-label Titration Period|Lack of Efficacy|0|||
30824625|NCT01358526|58846514|FG002|Open-label Titration Period|Lack of Efficacy|0|||
30824626|NCT01358526|58846512|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
30914826|NCT02185040|58950181|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
30914827|NCT02185040|58950182|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
30914828|NCT02185040|58950176|FG000|Active Treatment Extension Phase|Adverse Event|0|||
30914829|NCT02185040|58950177|FG001|Active Treatment Extension Phase|Adverse Event|0|||
30914830|NCT02185040|58950178|FG002|Active Treatment Extension Phase|Adverse Event|0|||
30914831|NCT02185040|58950179|FG003|Active Treatment Extension Phase|Adverse Event|0|||
30914832|NCT02185040|58950180|FG004|Active Treatment Extension Phase|Adverse Event|0|||
30914833|NCT02185040|58950181|FG005|Active Treatment Extension Phase|Adverse Event|1|||
30914834|NCT02185040|58950182|FG006|Active Treatment Extension Phase|Adverse Event|4|||
30914835|NCT02185040|58950176|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
30914836|NCT02185040|58950177|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
30914837|NCT02185040|58950178|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
30914838|NCT02185040|58950179|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
30914839|NCT02185040|58950180|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
30914840|NCT02185040|58950181|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
30914841|NCT02185040|58950182|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
30914842|NCT02185040|58950176|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
30914843|NCT02185040|58950177|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
30914844|NCT02185040|58950178|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
30914845|NCT02185040|58950179|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
30914846|NCT02185040|58950180|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
30914847|NCT02185040|58950181|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
30914848|NCT02185040|58950182|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
30914849|NCT02161406|58950204|FG000|Overall Study|Death|2|||
30914850|NCT02161406|58950205|FG001|Overall Study|Death|1|||
30914851|NCT02161406|58950204|FG000|Overall Study|Lost to Follow-up|2|||
30914852|NCT02161406|58950205|FG001|Overall Study|Lost to Follow-up|1|||
30914853|NCT02161406|58950204|FG000|Overall Study|Withdrawal by Subject|2|||
30914854|NCT02161406|58950205|FG001|Overall Study|Withdrawal by Subject|4|||
30914855|NCT02161406|58950204|FG000|Overall Study|investigator withdrew subject|3|||
30914856|NCT02161406|58950205|FG001|Overall Study|investigator withdrew subject|1|||
30914857|NCT02161406|58950204|FG000|Overall Study|Lack of Efficacy|1|||
30824627|NCT01358526|58846513|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
30824628|NCT01358526|58846514|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
30914858|NCT02161406|58950205|FG001|Overall Study|Lack of Efficacy|1|||
30914859|NCT02161406|58950204|FG000|Overall Study|relocation|0|||
30914860|NCT02161406|58950205|FG001|Overall Study|relocation|1|||
30914861|NCT02161016|58950211|FG000|Overall Study|withdrawn by IRB|1|||
30914862|NCT01573000|58950217|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
30914863|NCT01573000|58950218|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
30914864|NCT01573000|58950217|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
30914865|NCT01573000|58950218|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
30914866|NCT01573000|58950217|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
30914867|NCT01573000|58950218|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
30914868|NCT01573000|58950217|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
30914869|NCT01573000|58950218|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
30824629|NCT01358526|58846512|FG000|Open-label Titration Period|Administrative|8|||
30824630|NCT01358526|58846513|FG001|Open-label Titration Period|Administrative|0|||
30824631|NCT01358526|58846514|FG002|Open-label Titration Period|Administrative|0|||
30824632|NCT01358526|58846512|FG000|Open-label Titration Period|Did not qualify|178|||
30824633|NCT01358526|58846513|FG001|Open-label Titration Period|Did not qualify|0|||
30824634|NCT01358526|58846514|FG002|Open-label Titration Period|Did not qualify|0|||
30824635|NCT01358526|58846512|FG000|Double-blind Phase|Adverse Event|0|||
30824636|NCT01358526|58846513|FG001|Double-blind Phase|Adverse Event|24|||
30824637|NCT01358526|58846514|FG002|Double-blind Phase|Adverse Event|23|||
30824638|NCT01358526|58846512|FG000|Double-blind Phase|Withdrawal by Subject|0|||
30824639|NCT01358526|58846513|FG001|Double-blind Phase|Withdrawal by Subject|10|||
30824640|NCT01358526|58846514|FG002|Double-blind Phase|Withdrawal by Subject|8|||
30824641|NCT01358526|58846512|FG000|Double-blind Phase|Lost to Follow-up|0|||
30824642|NCT01358526|58846513|FG001|Double-blind Phase|Lost to Follow-up|4|||
30824643|NCT01358526|58846514|FG002|Double-blind Phase|Lost to Follow-up|1|||
30824644|NCT01358526|58846512|FG000|Double-blind Phase|Lack of Efficacy|0|||
30824645|NCT01358526|58846513|FG001|Double-blind Phase|Lack of Efficacy|31|||
30824646|NCT01358526|58846514|FG002|Double-blind Phase|Lack of Efficacy|73|||
30824647|NCT01358526|58846512|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
30824648|NCT01358526|58846513|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
30824649|NCT01358526|58846514|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
30824650|NCT01358526|58846512|FG000|Double-blind Phase|Administrative|0|||
30914870|NCT01573000|58950217|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
30914871|NCT01573000|58950218|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
30914872|NCT01573000|58950217|FG000|Crossover Phase|Lack of Efficacy|0|||
30914873|NCT01573000|58950218|FG001|Crossover Phase|Lack of Efficacy|13|||
30914874|NCT01573000|58950217|FG000|Crossover Phase|Lost to Follow-up|0|||
30914875|NCT01573000|58950218|FG001|Crossover Phase|Lost to Follow-up|2|||
30914876|NCT01573000|58950217|FG000|Crossover Phase|Death|0|||
30914877|NCT01573000|58950218|FG001|Crossover Phase|Death|3|||
30914878|NCT01573000|58950217|FG000|Long-Term Follow-Up|Death|3|||
30914879|NCT01573000|58950218|FG001|Long-Term Follow-Up|Death|0|||
30914880|NCT01573000|58950217|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
30914881|NCT01573000|58950218|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
30914882|NCT01572922|58950228|FG000|Overall Study|Adverse Event|1|||
30914883|NCT01572922|58950228|FG000|Overall Study|Protocol Violation|1|||
30914884|NCT01572922|58950228|FG000|Overall Study|Death|1|||
30914885|NCT01572844|58950237|FG000|Overall Study|Physician Decision|1|||
30914886|NCT01572844|58950238|FG001|Overall Study|Physician Decision|1|||
30914887|NCT01557400|58950247|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
30914888|NCT01557400|58950247|FG000|Overall Study|Adverse Event|3|||
30914889|NCT01557400|58950247|FG000|Overall Study|Lost to Follow-up|5|||
30914890|NCT01557400|58950247|FG000|Overall Study|Withdrawal by Subject|9|||
30914891|NCT01533922|58950251|FG000|Overall Study|Adverse Event|5|||
30914892|NCT01533922|58950252|FG001|Overall Study|Adverse Event|8|||
30914893|NCT01533922|58950253|FG002|Overall Study|Adverse Event|6|||
30914894|NCT01533922|58950254|FG003|Overall Study|Adverse Event|3|||
30914895|NCT01533922|58950255|FG004|Overall Study|Adverse Event|4|||
30914896|NCT01533922|58950251|FG000|Overall Study|Lack of Efficacy|0|||
30914897|NCT01533922|58950252|FG001|Overall Study|Lack of Efficacy|0|||
30914898|NCT01533922|58950253|FG002|Overall Study|Lack of Efficacy|1|||
30914899|NCT01533922|58950254|FG003|Overall Study|Lack of Efficacy|0|||
30914900|NCT01533922|58950255|FG004|Overall Study|Lack of Efficacy|0|||
30914901|NCT01533922|58950251|FG000|Overall Study|Protocol Violation|0|||
30914902|NCT01533922|58950252|FG001|Overall Study|Protocol Violation|3|||
30914903|NCT01533922|58950253|FG002|Overall Study|Protocol Violation|0|||
30914904|NCT01533922|58950254|FG003|Overall Study|Protocol Violation|0|||
30914905|NCT01533922|58950255|FG004|Overall Study|Protocol Violation|1|||
30914906|NCT01533922|58950251|FG000|Overall Study|Withdrawal by Subject|3|||
30914907|NCT01533922|58950252|FG001|Overall Study|Withdrawal by Subject|1|||
30914908|NCT01533922|58950253|FG002|Overall Study|Withdrawal by Subject|2|||
30914909|NCT01533922|58950254|FG003|Overall Study|Withdrawal by Subject|2|||
30914910|NCT01533922|58950255|FG004|Overall Study|Withdrawal by Subject|1|||
30914911|NCT01533922|58950251|FG000|Overall Study|Other reason not defined above|2|||
30824651|NCT01358526|58846513|FG001|Double-blind Phase|Administrative|6|||
30824652|NCT01358526|58846514|FG002|Double-blind Phase|Administrative|10|||
30824653|NCT02830776|58846521|FG000|Overall Study|Lost to Follow-up|1|||
30914912|NCT01533922|58950252|FG001|Overall Study|Other reason not defined above|0|||
30914913|NCT01533922|58950253|FG002|Overall Study|Other reason not defined above|1|||
30753552|NCT00412061|58763235|FG001|Double Blind Phase|New Cander Therapy|1|||
30753553|NCT00412061|58763234|FG000|Double Blind Phase|Lost to Follow-up|0|||
30753554|NCT00412061|58763235|FG001|Double Blind Phase|Lost to Follow-up|1|||
30753555|NCT00412061|58763234|FG000|Open Label Phase|Disease Progression|0|||
30753556|NCT00412061|58763235|FG001|Open Label Phase|Disease Progression|86|||
30753557|NCT00412061|58763234|FG000|Open Label Phase|Adverse Event|0|||
30753558|NCT00412061|58763235|FG001|Open Label Phase|Adverse Event|46|||
30753559|NCT00412061|58763234|FG000|Open Label Phase|Withdrawal by Subject|0|||
30753560|NCT00412061|58763235|FG001|Open Label Phase|Withdrawal by Subject|15|||
30753561|NCT00412061|58763234|FG000|Open Label Phase|Administrative Problems|0|||
30753562|NCT00412061|58763235|FG001|Open Label Phase|Administrative Problems|13|||
30753563|NCT00412061|58763234|FG000|Open Label Phase|Death|0|||
30753564|NCT00412061|58763235|FG001|Open Label Phase|Death|7|||
30753565|NCT00412061|58763234|FG000|Open Label Phase|Lost to Follow-up|0|||
30753566|NCT00412061|58763235|FG001|Open Label Phase|Lost to Follow-up|2|||
30753567|NCT00412061|58763234|FG000|Open Label Phase|New Cancer Therapy|0|||
30753568|NCT00412061|58763235|FG001|Open Label Phase|New Cancer Therapy|1|||
30753569|NCT00411671|58763253|FG000|Overall Study|Adverse Event|15|||
30753570|NCT00411671|58763253|FG000|Overall Study|Death|2|||
30753571|NCT00411671|58763253|FG000|Overall Study|Lost to Follow-up|3|||
30753572|NCT03835481|58763262|FG000|Double-blind Period|Other not stated below|0|||
30753573|NCT03835481|58763263|FG001|Double-blind Period|Other not stated below|0|||
30753574|NCT03835481|58763264|FG002|Double-blind Period|Other not stated below|0|||
30753575|NCT03835481|58763265|FG003|Double-blind Period|Other not stated below|1|||
30753576|NCT03835481|58763266|FG004|Double-blind Period|Other not stated below|1|||
30753577|NCT03835481|58763262|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
30753578|NCT03835481|58763263|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
30753579|NCT03835481|58763264|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
30753580|NCT03835481|58763265|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
30753581|NCT03835481|58763266|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
30753582|NCT03835481|58763262|FG000|Double-blind Period|Withdrawal by Subject|0|||
30753583|NCT03835481|58763263|FG001|Double-blind Period|Withdrawal by Subject|0|||
30753584|NCT03835481|58763264|FG002|Double-blind Period|Withdrawal by Subject|1|||
30753585|NCT03835481|58763265|FG003|Double-blind Period|Withdrawal by Subject|0|||
30753586|NCT03835481|58763266|FG004|Double-blind Period|Withdrawal by Subject|5|||
30753587|NCT03835481|58763262|FG000|Double-blind Period|Lost to Follow-up|0|||
30753588|NCT03835481|58763263|FG001|Double-blind Period|Lost to Follow-up|0|||
30753589|NCT03835481|58763264|FG002|Double-blind Period|Lost to Follow-up|0|||
30753590|NCT03835481|58763265|FG003|Double-blind Period|Lost to Follow-up|1|||
30753591|NCT03835481|58763266|FG004|Double-blind Period|Lost to Follow-up|0|||
30753592|NCT03835481|58763262|FG000|Double-blind Period|Protocol Violation|0|||
30753593|NCT03835481|58763263|FG001|Double-blind Period|Protocol Violation|2|||
30753594|NCT03835481|58763264|FG002|Double-blind Period|Protocol Violation|0|||
30753595|NCT03835481|58763265|FG003|Double-blind Period|Protocol Violation|1|||
30753596|NCT03835481|58763266|FG004|Double-blind Period|Protocol Violation|0|||
30753597|NCT03835481|58763262|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
30753598|NCT03835481|58763263|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
30753599|NCT03835481|58763264|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
30753600|NCT03835481|58763265|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
30753601|NCT03835481|58763266|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
30753602|NCT03835481|58763262|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
30753603|NCT03835481|58763263|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
30753604|NCT03835481|58763264|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
30753605|NCT03835481|58763265|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
30753606|NCT03835481|58763266|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
30753607|NCT03835481|58763262|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
30753608|NCT03835481|58763263|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
30753609|NCT03835481|58763264|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
30753610|NCT03835481|58763265|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
30753611|NCT03835481|58763266|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
30753612|NCT03835481|58763262|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
30753613|NCT03835481|58763263|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
30753614|NCT03835481|58763264|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
30824654|NCT03039621|58846528|FG000|Overall Study|Violation of inclusion criteria|3|||
30824655|NCT03039621|58846529|FG001|Overall Study|Violation of inclusion criteria|2|||
30824656|NCT03039621|58846528|FG000|Overall Study|Non-compliance with protocol requirement|4|||
30824657|NCT03039621|58846529|FG001|Overall Study|Non-compliance with protocol requirement|5|||
30824658|NCT03039621|58846528|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
30914914|NCT01533922|58950254|FG003|Overall Study|Other reason not defined above|0|||
30824659|NCT03039621|58846529|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
30824660|NCT03039621|58846528|FG000|Overall Study|Violation of non-inclusion criteria|1|||
30824661|NCT03039621|58846529|FG001|Overall Study|Violation of non-inclusion criteria|2|||
30914915|NCT01533922|58950255|FG004|Overall Study|Other reason not defined above|0|||
30914916|NCT01533688|58950270|FG000|Overall Study|Withdrawal by Subject|5|||
30914917|NCT01533688|58950271|FG001|Overall Study|Withdrawal by Subject|4|||
30914918|NCT01533688|58950272|FG002|Overall Study|Withdrawal by Subject|3|||
30914919|NCT01533688|58950270|FG000|Overall Study|Medically unstable|1|||
30914920|NCT01533688|58950271|FG001|Overall Study|Medically unstable|3|||
30914921|NCT01533688|58950272|FG002|Overall Study|Medically unstable|3|||
30914922|NCT01533688|58950270|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
30914923|NCT01533688|58950271|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
30914924|NCT01533688|58950272|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
30914925|NCT01532986|58950284|FG000|Overall Study|Death|9|||
30914926|NCT01532986|58950285|FG001|Overall Study|Death|9|||
30914927|NCT01532986|58950284|FG000|Overall Study|Withdrawal by Subject|7|||
30914928|NCT01532986|58950285|FG001|Overall Study|Withdrawal by Subject|10|||
30914929|NCT01532986|58950284|FG000|Overall Study|Physician Decision|7|||
30914930|NCT01532986|58950285|FG001|Overall Study|Physician Decision|5|||
30914931|NCT01532908|58950294|FG000|Overall Study|Not Transplanted|1|||
30914932|NCT01532908|58950295|FG001|Overall Study|Not Transplanted|0|||
30914933|NCT02160782|58950301|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
30914934|NCT02160782|58950302|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
30914935|NCT02160782|58950303|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
30914936|NCT02160782|58950304|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
30914937|NCT02160782|58950305|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
30914938|NCT02160782|58950301|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
30914939|NCT02160782|58950302|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
30914940|NCT02160782|58950303|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
30914941|NCT02160782|58950304|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
30914942|NCT02160782|58950305|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
30914943|NCT02160782|58950301|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
30914944|NCT02160782|58950302|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
30914945|NCT02160782|58950303|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
30914946|NCT02160782|58950304|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
30914947|NCT02160782|58950305|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
30914948|NCT02160782|58950301|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
30914949|NCT02160782|58950302|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
30914950|NCT02160782|58950303|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
30914951|NCT02160782|58950304|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
30914952|NCT02160782|58950305|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
30914953|NCT02160782|58950301|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
30914954|NCT02160782|58950302|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
30914955|NCT02160782|58950303|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
30753615|NCT03835481|58763265|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
30753616|NCT03835481|58763266|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
30753617|NCT03835481|58763262|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
30753618|NCT03835481|58763263|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
30753619|NCT03835481|58763264|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
30753620|NCT03835481|58763265|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
30753621|NCT03835481|58763266|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
30824662|NCT03041181|58846537|FG000|Overall Study|Disease Progression|1|||
30824663|NCT03041181|58846538|FG001|Overall Study|Disease Progression|2|||
30824664|NCT02828436|58846544|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
30824665|NCT02828436|58846545|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
30824666|NCT02828436|58846544|FG000|Period 1|Lost to Follow-up|0|||
30824667|NCT02828436|58846545|FG001|Period 1|Lost to Follow-up|1|||
30824668|NCT02828436|58846544|FG000|Period 2|Withdrawal by Subject|4|||
30824669|NCT02828436|58846545|FG001|Period 2|Withdrawal by Subject|0|||
30824670|NCT02828436|58846544|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
30824671|NCT02828436|58846545|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
30824672|NCT02828436|58846544|FG000|Period 2|Lost to Follow-up|1|||
30824673|NCT02828436|58846545|FG001|Period 2|Lost to Follow-up|0|||
30824674|NCT02828124|58846559|FG000|Overall Study|Disease Progression|1|||
30824675|NCT02828124|58846560|FG001|Overall Study|Disease Progression|2|||
30824676|NCT02828124|58846561|FG002|Overall Study|Disease Progression|1|||
30914956|NCT02160782|58950304|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
30914957|NCT02160782|58950305|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
30914958|NCT02160782|58950301|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
30914959|NCT02160782|58950302|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
30914960|NCT02160782|58950303|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
30914961|NCT02160782|58950304|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
30914962|NCT02160782|58950305|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
30914963|NCT02160782|58950301|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
30914964|NCT02160782|58950302|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
30914965|NCT02160782|58950303|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
30824677|NCT02828124|58846562|FG003|Overall Study|Disease Progression|4|||
30824678|NCT02828124|58846559|FG000|Overall Study|AE Unrelated to Study Drug|0|||
30824679|NCT02828124|58846560|FG001|Overall Study|AE Unrelated to Study Drug|0|||
30824680|NCT02828124|58846561|FG002|Overall Study|AE Unrelated to Study Drug|0|||
30824681|NCT02828124|58846562|FG003|Overall Study|AE Unrelated to Study Drug|1|||
30824682|NCT02828124|58846559|FG000|Overall Study|Subject Withdrew Consent|0|||
30914966|NCT02160782|58950304|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
30914967|NCT02160782|58950305|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
30914968|NCT02160626|58950332|FG000|Overall Study|Adverse Event|1|||
30914969|NCT02160626|58950333|FG001|Overall Study|Adverse Event|0|||
30914970|NCT02160626|58950334|FG002|Overall Study|Adverse Event|0|||
30914971|NCT02160626|58950332|FG000|Overall Study|Schedule not conducive to study visits|0|||
30914972|NCT02160626|58950333|FG001|Overall Study|Schedule not conducive to study visits|0|||
30914973|NCT02160626|58950334|FG002|Overall Study|Schedule not conducive to study visits|1|||
30914974|NCT02160626|58950332|FG000|Overall Study|Withdrawal by Subject|0|||
30914975|NCT02160626|58950333|FG001|Overall Study|Withdrawal by Subject|1|||
30914976|NCT02160626|58950334|FG002|Overall Study|Withdrawal by Subject|0|||
30914977|NCT02160314|58950346|FG000|Overall Study|Adverse Event|0|||
30914978|NCT02160314|58950347|FG001|Overall Study|Adverse Event|6|||
30914979|NCT02160314|58950346|FG000|Overall Study|Protocol Violation|0|||
30914980|NCT02160314|58950347|FG001|Overall Study|Protocol Violation|4|||
30914981|NCT02160314|58950346|FG000|Overall Study|Withdrawal by Subject|1|||
30914982|NCT02160314|58950347|FG001|Overall Study|Withdrawal by Subject|2|||
30914983|NCT02160314|58950346|FG000|Overall Study|Lost to Follow-up|0|||
30914984|NCT02160314|58950347|FG001|Overall Study|Lost to Follow-up|1|||
30914985|NCT02160002|58950355|FG000|Overall Study|Withdrawal by Subject|2|||
30914986|NCT02160002|58950356|FG001|Overall Study|Withdrawal by Subject|1|||
30914987|NCT02218268|58950362|FG000|24 Hour Washout|Physician Decision|11|||
30914988|NCT02218268|58950363|FG001|24 Hour Washout|Physician Decision|9|||
30914989|NCT02217878|58950371|FG000|Overall Study|required morphine due to chest pain|1|||
30914990|NCT02217878|58950372|FG001|Overall Study|required morphine due to chest pain|2|||
30914991|NCT02217878|58950371|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
30914992|NCT02217878|58950372|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
30623179|NCT01142232|58635004|FG004|Overall Study|Alternative Therapy|1|||
30623180|NCT01142232|58635000|FG000|Overall Study|Off Trt for other complicating disease|0|||
30623181|NCT01142232|58635001|FG001|Overall Study|Off Trt for other complicating disease|0|||
30623182|NCT01142232|58635002|FG002|Overall Study|Off Trt for other complicating disease|0|||
30623183|NCT01142232|58635003|FG003|Overall Study|Off Trt for other complicating disease|0|||
30623184|NCT01142232|58635004|FG004|Overall Study|Off Trt for other complicating disease|1|||
30623185|NCT01142232|58635000|FG000|Overall Study|Noncompliance|0|||
30623186|NCT01142232|58635001|FG001|Overall Study|Noncompliance|0|||
30623187|NCT01142232|58635002|FG002|Overall Study|Noncompliance|0|||
30623188|NCT01142232|58635003|FG003|Overall Study|Noncompliance|0|||
30623189|NCT01142232|58635004|FG004|Overall Study|Noncompliance|2|||
30623190|NCT01140906|58635020|FG000|Overall Study|Adverse Event|7|||
30623191|NCT01140906|58635021|FG001|Overall Study|Adverse Event|10|||
30623192|NCT01140906|58635022|FG002|Overall Study|Adverse Event|17|||
30623193|NCT01140906|58635023|FG003|Overall Study|Adverse Event|7|||
30824683|NCT02828124|58846560|FG001|Overall Study|Subject Withdrew Consent|0|||
30824684|NCT02828124|58846561|FG002|Overall Study|Subject Withdrew Consent|0|||
30623194|NCT01140906|58635020|FG000|Overall Study|Lack of Efficacy|6|||
30623195|NCT01140906|58635021|FG001|Overall Study|Lack of Efficacy|8|||
30623196|NCT01140906|58635022|FG002|Overall Study|Lack of Efficacy|2|||
30623197|NCT01140906|58635023|FG003|Overall Study|Lack of Efficacy|1|||
30623198|NCT01140906|58635020|FG000|Overall Study|Non-compliance|0|||
30623199|NCT01140906|58635021|FG001|Overall Study|Non-compliance|1|||
30623200|NCT01140906|58635022|FG002|Overall Study|Non-compliance|0|||
30824685|NCT02828124|58846562|FG003|Overall Study|Subject Withdrew Consent|1|||
30824686|NCT02829996|58846577|FG000|Overall Study|Withdrawal by Subject|1|||
30824687|NCT02829996|58846578|FG001|Overall Study|Withdrawal by Subject|0|||
30824688|NCT02829996|58846579|FG002|Overall Study|Withdrawal by Subject|0|||
30824689|NCT02829996|58846580|FG003|Overall Study|Withdrawal by Subject|0|||
30824690|NCT02829996|58846581|FG004|Overall Study|Withdrawal by Subject|0|||
30623201|NCT01140906|58635023|FG003|Overall Study|Non-compliance|1|||
30623202|NCT01140906|58635020|FG000|Overall Study|Protocol Violation|5|||
30824691|NCT02827500|58846595|FG000|Overall Study|Death|7|||
30824692|NCT02827500|58846596|FG001|Overall Study|Death|3|||
30824693|NCT02827500|58846595|FG000|Overall Study|Lost to Follow-up|1|||
30824694|NCT02827500|58846596|FG001|Overall Study|Lost to Follow-up|1|||
30824695|NCT02827500|58846595|FG000|Overall Study|Withdrawal by Subject|3|||
30824696|NCT02827500|58846596|FG001|Overall Study|Withdrawal by Subject|1|||
30623203|NCT01140906|58635021|FG001|Overall Study|Protocol Violation|3|||
30623204|NCT01140906|58635022|FG002|Overall Study|Protocol Violation|2|||
30623205|NCT01140906|58635023|FG003|Overall Study|Protocol Violation|1|||
30623206|NCT01140906|58635020|FG000|Overall Study|Withdrawal of consent|6|||
30623207|NCT01140906|58635021|FG001|Overall Study|Withdrawal of consent|6|||
30623208|NCT01140906|58635022|FG002|Overall Study|Withdrawal of consent|2|||
30623209|NCT01140906|58635023|FG003|Overall Study|Withdrawal of consent|2|||
30623210|NCT01140906|58635020|FG000|Overall Study|Lost to Follow-up|1|||
30623211|NCT01140906|58635021|FG001|Overall Study|Lost to Follow-up|1|||
30623212|NCT01140906|58635022|FG002|Overall Study|Lost to Follow-up|0|||
30623213|NCT01140906|58635023|FG003|Overall Study|Lost to Follow-up|2|||
30623214|NCT01140906|58635020|FG000|Overall Study|Administrative or other reason|0|||
30623215|NCT01140906|58635021|FG001|Overall Study|Administrative or other reason|5|||
30824697|NCT02827500|58846595|FG000|Overall Study|Missing primary endpoint data|3|||
30824698|NCT02827500|58846596|FG001|Overall Study|Missing primary endpoint data|1|||
30753622|NCT03835481|58763262|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
30824699|NCT02827500|58846595|FG000|Overall Study|Other|5|||
30824700|NCT02827500|58846596|FG001|Overall Study|Other|1|||
30824701|NCT02826798|58846607|FG000|Overall Study|Withdrawal by Subject|0|||
30914993|NCT02217566|58950378|FG000|Overall Study|Lost to Follow-up|2|||
30753623|NCT03835481|58763263|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
30753624|NCT03835481|58763264|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
30753625|NCT03835481|58763265|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
30914994|NCT02217566|58950378|FG000|Overall Study|Death|3|||
30914995|NCT02217566|58950378|FG000|Overall Study|Early study termination|6|||
30914996|NCT02217410|58950385|FG000|Overall Study|Graft Loss|0|||
30914997|NCT02217410|58950386|FG001|Overall Study|Graft Loss|0|||
30914998|NCT02217410|58950387|FG002|Overall Study|Graft Loss|2|||
30914999|NCT02217410|58950385|FG000|Overall Study|Withdrawal by Subject|0|||
30915000|NCT02217410|58950386|FG001|Overall Study|Withdrawal by Subject|0|||
30915001|NCT02217410|58950387|FG002|Overall Study|Withdrawal by Subject|2|||
30915002|NCT02217410|58950385|FG000|Overall Study|Lost to Follow-up|0|||
30915003|NCT02217410|58950386|FG001|Overall Study|Lost to Follow-up|0|||
30915004|NCT02217410|58950387|FG002|Overall Study|Lost to Follow-up|1|||
30915005|NCT02217410|58950385|FG000|Overall Study|Lack of Efficacy|0|||
30915006|NCT02217410|58950386|FG001|Overall Study|Lack of Efficacy|1|||
30915007|NCT02217410|58950387|FG002|Overall Study|Lack of Efficacy|0|||
30915008|NCT02217410|58950385|FG000|Overall Study|Physician Decision|1|||
30915009|NCT02217410|58950386|FG001|Overall Study|Physician Decision|3|||
30915010|NCT02217410|58950387|FG002|Overall Study|Physician Decision|0|||
30915011|NCT02217332|58950400|FG000|Overall Study|Adverse Event|3|||
30915012|NCT02217332|58950400|FG000|Overall Study|Dose interruption >1 month|1|||
30915013|NCT02217332|58950400|FG000|Overall Study|Protocol Violation (eligibility)|1|||
30915014|NCT02217332|58950400|FG000|Overall Study|Withdrawal by Subject|1|||
30915015|NCT02217332|58950400|FG000|Overall Study|Lost to Follow-up|1|||
30753626|NCT03835481|58763266|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
30753627|NCT03709576|58763313|FG000|Overall Study|progression prior to enrollment|1|||
30753628|NCT00122460|58763320|FG000|Overall Study|investigational study phase ongoing|7|||
30753629|NCT00122460|58763321|FG001|Overall Study|investigational study phase ongoing|1|||
30753630|NCT00137436|58763327|FG000|Overall Study|Adverse Event|13|||
30753631|NCT00137436|58763327|FG000|Overall Study|Death|2|||
30824702|NCT02826798|58846608|FG001|Overall Study|Withdrawal by Subject|1|||
30824703|NCT02826798|58846609|FG002|Overall Study|Withdrawal by Subject|0|||
30915016|NCT02184572|58950406|FG000|Overall Study|Lost to Follow-up|29|||
30915017|NCT02184572|58950407|FG001|Overall Study|Lost to Follow-up|21|||
30915018|NCT02184572|58950406|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
30915019|NCT02184572|58950407|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
30915020|NCT02184572|58950406|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
30623216|NCT01140906|58635022|FG002|Overall Study|Administrative or other reason|3|||
30623217|NCT01140906|58635023|FG003|Overall Study|Administrative or other reason|2|||
30623218|NCT00962091|58635040|FG000|Overall Study|Withdrawal by Subject|1|||
30623219|NCT00962091|58635041|FG001|Overall Study|Withdrawal by Subject|2|||
30623220|NCT00962091|58635042|FG002|Overall Study|Withdrawal by Subject|1|||
30623221|NCT00962091|58635043|FG003|Overall Study|Withdrawal by Subject|1|||
30623222|NCT00962091|58635044|FG004|Overall Study|Withdrawal by Subject|0|||
30824704|NCT02826798|58846610|FG003|Overall Study|Withdrawal by Subject|1|||
30915021|NCT02184572|58950407|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
30915022|NCT02184572|58950406|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
30915023|NCT02184572|58950407|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
30915024|NCT02184572|58950406|FG000|Overall Study|Traveling Outside The Country|1|||
30915025|NCT02184572|58950407|FG001|Overall Study|Traveling Outside The Country|0|||
30915026|NCT02184572|58950406|FG000|Overall Study|Withdrawal by Subject|14|||
30915027|NCT02184572|58950407|FG001|Overall Study|Withdrawal by Subject|9|||
30915028|NCT02181842|58950415|FG000|Overall Study|Case Report Forms Uncollected|2|||
30915029|NCT01632020|58950421|FG000|Overall Study|Withdrawal by Subject|1|||
30915030|NCT01632020|58950422|FG001|Overall Study|Withdrawal by Subject|0|||
30915031|NCT01632020|58950421|FG000|Overall Study|Adverse Event|1|||
30915032|NCT01632020|58950422|FG001|Overall Study|Adverse Event|0|||
30915033|NCT02181296|58950430|FG000|Overall Study|Lost to Follow-up|7|||
30915034|NCT02181296|58950431|FG001|Overall Study|Lost to Follow-up|6|||
30915035|NCT02215616|58950441|FG000|Overall Study|Sponsor requested to stop study drug|0|||
30915036|NCT02215616|58950442|FG001|Overall Study|Sponsor requested to stop study drug|0|||
30915037|NCT02215616|58950443|FG002|Overall Study|Sponsor requested to stop study drug|1|||
30915038|NCT02215616|58950444|FG003|Overall Study|Sponsor requested to stop study drug|4|||
30915039|NCT02215616|58950441|FG000|Overall Study|Death|1|||
30915040|NCT02215616|58950442|FG001|Overall Study|Death|0|||
30915041|NCT02215616|58950443|FG002|Overall Study|Death|0|||
30915042|NCT02215616|58950444|FG003|Overall Study|Death|0|||
30915043|NCT02215616|58950441|FG000|Overall Study|Adverse Event|7|||
30915044|NCT02215616|58950442|FG001|Overall Study|Adverse Event|4|||
30915045|NCT02215616|58950443|FG002|Overall Study|Adverse Event|9|||
30824705|NCT02826798|58846611|FG004|Overall Study|Withdrawal by Subject|0|||
30824706|NCT02829138|58846625|FG000|Overall Study|Withdrawal by Subject|1|||
30824707|NCT02829138|58846626|FG001|Overall Study|Withdrawal by Subject|0|||
30824708|NCT02825550|58846632|FG000|Overall Study|Physician Decision|1|||
30824709|NCT02744040|58846641|FG000|Overall Study|Withdrawal by Subject|3|||
30824710|NCT02744040|58846642|FG001|Overall Study|Withdrawal by Subject|2|||
30824711|NCT02744040|58846643|FG002|Overall Study|Withdrawal by Subject|2|||
30824712|NCT02744040|58846641|FG000|Overall Study|Physician Decision|0|||
30824713|NCT02744040|58846642|FG001|Overall Study|Physician Decision|8|||
30824714|NCT02744040|58846643|FG002|Overall Study|Physician Decision|13|||
30824715|NCT02744040|58846641|FG000|Overall Study|Lost to Follow-up|3|||
30824716|NCT02744040|58846642|FG001|Overall Study|Lost to Follow-up|1|||
30824717|NCT02744040|58846643|FG002|Overall Study|Lost to Follow-up|7|||
30824718|NCT02743962|58846653|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
30824719|NCT02743962|58846654|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
30824720|NCT03094416|58846663|FG000|Run-in|Screening failure|8|||
30824721|NCT03094416|58846663|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
30824722|NCT03094416|58846663|FG000|Run-in|Withdrawal by Subject|3|||
30824723|NCT03094416|58846663|FG000|Treatment Period|Withdrawal by Subject|2|||
30824724|NCT03041025|58846671|FG000|Overall Study|Adverse Event|0|||
30824725|NCT03041025|58846672|FG001|Overall Study|Adverse Event|0|||
30824726|NCT03041025|58846673|FG002|Overall Study|Adverse Event|1|||
30824727|NCT03041025|58846671|FG000|Overall Study|Lost to Follow-up|1|||
30824728|NCT03041025|58846672|FG001|Overall Study|Lost to Follow-up|0|||
30824729|NCT03041025|58846673|FG002|Overall Study|Lost to Follow-up|0|||
30824730|NCT03041025|58846671|FG000|Overall Study|Withdrawal by Subject|0|||
30824731|NCT03041025|58846672|FG001|Overall Study|Withdrawal by Subject|0|||
30824732|NCT03041025|58846673|FG002|Overall Study|Withdrawal by Subject|1|||
30824733|NCT01338870|58846690|FG000|Overall Study|Lost to Follow-up|0|||
30824734|NCT01338870|58846691|FG001|Overall Study|Lost to Follow-up|0|||
30824735|NCT01338870|58846692|FG002|Overall Study|Lost to Follow-up|1|||
30824736|NCT01338870|58846693|FG003|Overall Study|Lost to Follow-up|0|||
30824737|NCT01338870|58846694|FG004|Overall Study|Lost to Follow-up|1|||
30915046|NCT02215616|58950444|FG003|Overall Study|Adverse Event|2|||
30824738|NCT01338870|58846695|FG005|Overall Study|Lost to Follow-up|0|||
30824739|NCT01338870|58846690|FG000|Overall Study|Withdrawal by Subject|2|||
30824740|NCT01338870|58846691|FG001|Overall Study|Withdrawal by Subject|3|||
30824741|NCT01338870|58846692|FG002|Overall Study|Withdrawal by Subject|4|||
30824742|NCT01338870|58846693|FG003|Overall Study|Withdrawal by Subject|0|||
30824743|NCT01338870|58846694|FG004|Overall Study|Withdrawal by Subject|0|||
30824744|NCT01338870|58846695|FG005|Overall Study|Withdrawal by Subject|2|||
30824745|NCT01338870|58846690|FG000|Overall Study|Other|3|||
30915047|NCT02215616|58950441|FG000|Overall Study|Withdrawal by Subject|1|||
30915048|NCT02215616|58950442|FG001|Overall Study|Withdrawal by Subject|8|||
30915049|NCT02215616|58950443|FG002|Overall Study|Withdrawal by Subject|2|||
30915050|NCT02215616|58950444|FG003|Overall Study|Withdrawal by Subject|5|||
30824746|NCT01338870|58846691|FG001|Overall Study|Other|3|||
30824747|NCT01338870|58846692|FG002|Overall Study|Other|3|||
30824748|NCT01338870|58846693|FG003|Overall Study|Other|2|||
30824749|NCT01338870|58846694|FG004|Overall Study|Other|0|||
30824750|NCT01338870|58846695|FG005|Overall Study|Other|2|||
30824751|NCT01338870|58846690|FG000|Overall Study|Protocol Violation|0|||
30824752|NCT01338870|58846691|FG001|Overall Study|Protocol Violation|2|||
30824753|NCT01338870|58846692|FG002|Overall Study|Protocol Violation|2|||
30824754|NCT01338870|58846693|FG003|Overall Study|Protocol Violation|2|||
30824755|NCT01338870|58846694|FG004|Overall Study|Protocol Violation|1|||
30824756|NCT01338870|58846695|FG005|Overall Study|Protocol Violation|1|||
30824757|NCT01338870|58846690|FG000|Overall Study|Adverse Event|4|||
30824758|NCT01338870|58846691|FG001|Overall Study|Adverse Event|4|||
30824759|NCT01338870|58846692|FG002|Overall Study|Adverse Event|1|||
30824760|NCT01338870|58846693|FG003|Overall Study|Adverse Event|5|||
30824761|NCT01338870|58846694|FG004|Overall Study|Adverse Event|4|||
30824762|NCT01338870|58846695|FG005|Overall Study|Adverse Event|1|||
30824763|NCT02824224|58846711|FG000|Overall Study|Discontinued, IUS expulsion|0|||
30824764|NCT02824224|58846712|FG001|Overall Study|Discontinued, IUS expulsion|1|||
30824765|NCT02824224|58846711|FG000|Overall Study|Did not show up for allocation visit|2|||
30824766|NCT02824224|58846712|FG001|Overall Study|Did not show up for allocation visit|0|||
30824767|NCT01338792|58846718|FG000|Overall Study|Adverse Event|2|||
30824768|NCT01338792|58846718|FG000|Overall Study|Death|1|||
30824769|NCT01338792|58846718|FG000|Overall Study|Withdrawal by Subject|1|||
30824770|NCT01314105|58846724|FG000|Overall Study|Progressive Disease|6|||
30824771|NCT01314105|58846725|FG001|Overall Study|Progressive Disease|10|||
30824772|NCT01314105|58846724|FG000|Overall Study|Refused to continue taking medication|0|||
30824773|NCT01314105|58846725|FG001|Overall Study|Refused to continue taking medication|1|||
30824774|NCT01314105|58846724|FG000|Overall Study|Other Adverse Event|1|||
30824775|NCT01314105|58846725|FG001|Overall Study|Other Adverse Event|1|||
30824776|NCT03040713|58846733|FG000|Overall Study|Positive amyloid scan|3|||
30824777|NCT01966471|58846739|FG000|Overall Study|Death|44|||
30824778|NCT01966471|58846740|FG001|Overall Study|Death|56|||
30824779|NCT01966471|58846739|FG000|Overall Study|Lost to Follow-up|46|||
30824780|NCT01966471|58846740|FG001|Overall Study|Lost to Follow-up|39|||
30824781|NCT01966471|58846739|FG000|Overall Study|Various reasons|4|||
30824782|NCT01966471|58846740|FG001|Overall Study|Various reasons|4|||
30824783|NCT01966471|58846739|FG000|Overall Study|Physician Decision|7|||
30824784|NCT01966471|58846740|FG001|Overall Study|Physician Decision|5|||
30824785|NCT01966471|58846739|FG000|Overall Study|Study Terminated By Sponsor|758|||
30915051|NCT02215616|58950441|FG000|Overall Study|Non-compliance|0|||
30824786|NCT01966471|58846740|FG001|Overall Study|Study Terminated By Sponsor|773|||
30824787|NCT01966471|58846739|FG000|Overall Study|Withdrawal by Subject|59|||
30915052|NCT02215616|58950442|FG001|Overall Study|Non-compliance|2|||
30915053|NCT02215616|58950443|FG002|Overall Study|Non-compliance|1|||
30915054|NCT02215616|58950444|FG003|Overall Study|Non-compliance|0|||
30915055|NCT02215616|58950441|FG000|Overall Study|Protocol Violation|0|||
30915056|NCT02215616|58950442|FG001|Overall Study|Protocol Violation|2|||
30915057|NCT02215616|58950443|FG002|Overall Study|Protocol Violation|0|||
30915058|NCT02215616|58950444|FG003|Overall Study|Protocol Violation|0|||
30915059|NCT02215616|58950441|FG000|Overall Study|Lost to Follow-up|1|||
30915060|NCT02215616|58950442|FG001|Overall Study|Lost to Follow-up|1|||
30915061|NCT02215616|58950443|FG002|Overall Study|Lost to Follow-up|0|||
30915062|NCT02215616|58950444|FG003|Overall Study|Lost to Follow-up|1|||
30915063|NCT02215616|58950441|FG000|Overall Study|Other than specified|1|||
30915064|NCT02215616|58950442|FG001|Overall Study|Other than specified|0|||
30915065|NCT02215616|58950443|FG002|Overall Study|Other than specified|1|||
30915066|NCT02215616|58950444|FG003|Overall Study|Other than specified|1|||
30915067|NCT02213666|58950454|FG000|Overall Study|Withdrawal by Subject|1|||
30915068|NCT02213510|58950460|FG000|Overall Study|Death|0|||
30915069|NCT02213510|58950461|FG001|Overall Study|Death|1|||
30915070|NCT02213510|58950460|FG000|Overall Study|Lost to Follow-up|1|||
30824788|NCT01966471|58846740|FG001|Overall Study|Withdrawal by Subject|51|||
30824789|NCT03227471|58846769|FG000|Overall Study|Withdrawal by Subject|0|||
30824790|NCT03227471|58846770|FG001|Overall Study|Withdrawal by Subject|0|||
30824791|NCT03227471|58846771|FG002|Overall Study|Withdrawal by Subject|0|||
30824792|NCT03227471|58846772|FG003|Overall Study|Withdrawal by Subject|0|||
30824793|NCT03227471|58846773|FG004|Overall Study|Withdrawal by Subject|1|||
30824794|NCT03227471|58846774|FG005|Overall Study|Withdrawal by Subject|0|||
30824795|NCT03227471|58846775|FG006|Overall Study|Withdrawal by Subject|0|||
30824796|NCT03227471|58846776|FG007|Overall Study|Withdrawal by Subject|0|||
30824797|NCT03227471|58846777|FG008|Overall Study|Withdrawal by Subject|0|||
30824798|NCT03227471|58846778|FG009|Overall Study|Withdrawal by Subject|0|||
30915071|NCT02213510|58950461|FG001|Overall Study|Lost to Follow-up|0|||
30915072|NCT02158442|58950469|FG000|Overall Study|Withdrawal by Subject|1|||
30915073|NCT02158442|58950470|FG001|Overall Study|Withdrawal by Subject|0|||
30824799|NCT03227471|58846779|FG010|Overall Study|Withdrawal by Subject|0|||
30915074|NCT02158442|58950469|FG000|Overall Study|Perfusion staff not available|1|||
30915075|NCT02158442|58950470|FG001|Overall Study|Perfusion staff not available|0|||
30915076|NCT02158364|58950476|FG000|Overall Study|Case report forms uncollected|10|||
30915077|NCT02158364|58950476|FG000|Overall Study|Protocol Deviation|50|||
30915078|NCT02180672|58950482|FG000|Overall Study|Lost to Follow-up|5|||
30915079|NCT02180672|58950483|FG001|Overall Study|Lost to Follow-up|7|||
30915080|NCT02213198|58950491|FG000|Baseline|No show for intake|7|||
30915081|NCT02213198|58950492|FG001|Baseline|No show for intake|9|||
30915082|NCT02213198|58950491|FG000|Baseline|Withdrawal by Subject|34|||
30915083|NCT02213198|58950492|FG001|Baseline|Withdrawal by Subject|11|||
30915084|NCT02213198|58950491|FG000|Baseline|transferred out of clinic|7|||
30915085|NCT02213198|58950492|FG001|Baseline|transferred out of clinic|9|||
30915086|NCT02213198|58950491|FG000|Baseline|Lost to Follow-up|40|||
30915087|NCT02213198|58950492|FG001|Baseline|Lost to Follow-up|21|||
30915088|NCT02213198|58950491|FG000|Baseline|incarcerated,violent|0|||
30915089|NCT02213198|58950492|FG001|Baseline|incarcerated,violent|1|||
30915090|NCT02213198|58950491|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
30915091|NCT02213198|58950492|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
30915092|NCT02213198|58950491|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
30915093|NCT02213198|58950492|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
30915094|NCT02213198|58950491|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
30915095|NCT02213198|58950492|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
30915096|NCT02213198|58950491|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
30915097|NCT02213198|58950492|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
30915098|NCT02213198|58950491|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
30915099|NCT02213198|58950492|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
30915100|NCT02213198|58950491|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
30915101|NCT02213198|58950492|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
30915102|NCT02157506|58950503|FG000|Overall Study|Adverse Event|0|||
30915103|NCT02157506|58950504|FG001|Overall Study|Adverse Event|1|||
30915104|NCT02157506|58950505|FG002|Overall Study|Adverse Event|0|||
30915105|NCT02157506|58950506|FG003|Overall Study|Adverse Event|0|||
30915106|NCT02157506|58950507|FG004|Overall Study|Adverse Event|0|||
30824800|NCT03227471|58846780|FG011|Overall Study|Withdrawal by Subject|0|||
30824801|NCT03227471|58846781|FG012|Overall Study|Withdrawal by Subject|1|||
30824802|NCT03227471|58846782|FG013|Overall Study|Withdrawal by Subject|0|||
30824803|NCT03227471|58846783|FG014|Overall Study|Withdrawal by Subject|0|||
30824804|NCT03227471|58846769|FG000|Overall Study|Randomized, Never Dosed|0|||
30824805|NCT03227471|58846770|FG001|Overall Study|Randomized, Never Dosed|0|||
30824806|NCT03227471|58846771|FG002|Overall Study|Randomized, Never Dosed|0|||
30824807|NCT03227471|58846772|FG003|Overall Study|Randomized, Never Dosed|0|||
30915107|NCT02157506|58950503|FG000|Overall Study|Lost to Follow-up|0|||
30915108|NCT02157506|58950504|FG001|Overall Study|Lost to Follow-up|0|||
30915109|NCT02157506|58950505|FG002|Overall Study|Lost to Follow-up|1|||
30915110|NCT02157506|58950506|FG003|Overall Study|Lost to Follow-up|0|||
30915111|NCT02157506|58950507|FG004|Overall Study|Lost to Follow-up|0|||
30915112|NCT01920711|58950521|FG000|Overall Study|Death|347|||
30915113|NCT01920711|58950522|FG001|Overall Study|Death|356|||
30915114|NCT01920711|58950521|FG000|Overall Study|Lost to Follow-up|13|||
30915115|NCT01920711|58950522|FG001|Overall Study|Lost to Follow-up|14|||
30915116|NCT01920711|58950521|FG000|Overall Study|Withdrawal by Subject|4|||
30915117|NCT01920711|58950522|FG001|Overall Study|Withdrawal by Subject|3|||
30915118|NCT02180438|58950529|FG000|Overall Study|Lost to Follow-up|1|||
30915119|NCT02179190|58950533|FG000|Enrollment|Exit Prior to Device Attempt|11|||
30915120|NCT02179190|58950533|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
30915121|NCT02179190|58950533|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
30915122|NCT02179190|58950533|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
30915123|NCT02179190|58950533|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
30915124|NCT02179190|58950533|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
30915125|NCT02157116|58950537|FG000|Overall Study|Withdrawal by Subject|4|||
30915126|NCT02157116|58950537|FG000|Overall Study|Physician Decision|3|||
30915127|NCT02157116|58950537|FG000|Overall Study|Failed Screening|2|||
30915128|NCT01920555|58950546|FG000|Overall Study|Physician Decision|1|||
30915129|NCT01920555|58950547|FG001|Overall Study|Physician Decision|2|||
30915130|NCT01920555|58950548|FG002|Overall Study|Physician Decision|1|||
30915131|NCT01920555|58950549|FG003|Overall Study|Physician Decision|2|||
30915132|NCT01920555|58950550|FG004|Overall Study|Physician Decision|0|||
30824808|NCT03227471|58846773|FG004|Overall Study|Randomized, Never Dosed|0|||
30824809|NCT03227471|58846774|FG005|Overall Study|Randomized, Never Dosed|0|||
30915133|NCT01920555|58950546|FG000|Overall Study|Lack of Efficacy|2|||
30915134|NCT01920555|58950547|FG001|Overall Study|Lack of Efficacy|0|||
30753632|NCT00137436|58763327|FG000|Overall Study|Lack of Efficacy|17|||
30753633|NCT00137436|58763327|FG000|Overall Study|Withdrawal by Subject|6|||
30753634|NCT00137436|58763327|FG000|Overall Study|Other|5|||
30753635|NCT03834623|58763333|FG000|Overall Study|Progression|0|||
30915135|NCT01920555|58950548|FG002|Overall Study|Lack of Efficacy|0|||
30915136|NCT01920555|58950549|FG003|Overall Study|Lack of Efficacy|0|||
30915137|NCT01920555|58950550|FG004|Overall Study|Lack of Efficacy|0|||
30915138|NCT01920555|58950546|FG000|Overall Study|Travel Difficulties|1|||
30915139|NCT01920555|58950547|FG001|Overall Study|Travel Difficulties|1|||
30915140|NCT01920555|58950548|FG002|Overall Study|Travel Difficulties|0|||
30915141|NCT01920555|58950549|FG003|Overall Study|Travel Difficulties|0|||
30915142|NCT01920555|58950550|FG004|Overall Study|Travel Difficulties|1|||
30915143|NCT01920555|58950546|FG000|Overall Study|Lost to Follow-up|0|||
30915144|NCT01920555|58950547|FG001|Overall Study|Lost to Follow-up|1|||
30915145|NCT01920555|58950548|FG002|Overall Study|Lost to Follow-up|0|||
30915146|NCT01920555|58950549|FG003|Overall Study|Lost to Follow-up|1|||
30915147|NCT01920555|58950550|FG004|Overall Study|Lost to Follow-up|0|||
30915148|NCT02156804|58950562|FG000|Overall Study|Withdrawal by Subject|1|||
30915149|NCT02156492|58950569|FG000|Period 1|No Reason Given|0|||
30915150|NCT02156492|58950570|FG001|Period 1|No Reason Given|1|||
30915151|NCT02156492|58950571|FG002|Period 1|No Reason Given|0|||
30915152|NCT02156492|58950569|FG000|Period 3|Adverse Event|0|||
30915153|NCT02156492|58950570|FG001|Period 3|Adverse Event|1|||
30915154|NCT02156492|58950571|FG002|Period 3|Adverse Event|0|||
30824810|NCT03227471|58846775|FG006|Overall Study|Randomized, Never Dosed|0|||
30824811|NCT03227471|58846776|FG007|Overall Study|Randomized, Never Dosed|0|||
30824812|NCT03227471|58846777|FG008|Overall Study|Randomized, Never Dosed|0|||
30824813|NCT03227471|58846778|FG009|Overall Study|Randomized, Never Dosed|0|||
30824814|NCT03227471|58846779|FG010|Overall Study|Randomized, Never Dosed|0|||
30824815|NCT03227471|58846780|FG011|Overall Study|Randomized, Never Dosed|0|||
30824816|NCT03227471|58846781|FG012|Overall Study|Randomized, Never Dosed|0|||
30824817|NCT03227471|58846782|FG013|Overall Study|Randomized, Never Dosed|0|||
30824818|NCT03227471|58846783|FG014|Overall Study|Randomized, Never Dosed|1|||
30915155|NCT01920477|58950591|FG000|Overall Study|Adverse Event|0|||
30915156|NCT01920477|58950592|FG001|Overall Study|Adverse Event|1|||
30915157|NCT01920477|58950591|FG000|Overall Study|Lack of Efficacy|1|||
30915158|NCT01920477|58950592|FG001|Overall Study|Lack of Efficacy|0|||
30915159|NCT01920477|58950591|FG000|Overall Study|Study closed/terminated|14|||
30915160|NCT01920477|58950592|FG001|Overall Study|Study closed/terminated|15|||
30915161|NCT01920477|58950591|FG000|Overall Study|Withdrawal by Subject|0|||
30915162|NCT01920477|58950592|FG001|Overall Study|Withdrawal by Subject|1|||
30915163|NCT02213042|58950601|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
30915164|NCT02213042|58950602|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
30915165|NCT02213042|58950603|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
30915166|NCT02213042|58950601|FG000|Overall Study|Adverse Event|2|||
30824819|NCT01354314|58846848|FG000|Overall Study|Lost to Follow-up|1|||
30824820|NCT01354314|58846849|FG001|Overall Study|Lost to Follow-up|0|||
30824821|NCT01354314|58846850|FG002|Overall Study|Lost to Follow-up|1|||
30824822|NCT01354314|58846851|FG003|Overall Study|Lost to Follow-up|1|||
30824823|NCT01354314|58846848|FG000|Overall Study|Withdrawal by Subject|0|||
30824824|NCT01354314|58846849|FG001|Overall Study|Withdrawal by Subject|0|||
30915167|NCT02213042|58950602|FG001|Overall Study|Adverse Event|1|||
30915168|NCT02213042|58950603|FG002|Overall Study|Adverse Event|0|||
30915169|NCT02213042|58950601|FG000|Overall Study|Withdrawal by Subject|0|||
30915170|NCT02213042|58950602|FG001|Overall Study|Withdrawal by Subject|1|||
30915171|NCT02213042|58950603|FG002|Overall Study|Withdrawal by Subject|1|||
30915172|NCT02213042|58950601|FG000|Overall Study|Protocol Violation|1|||
30915173|NCT02213042|58950602|FG001|Overall Study|Protocol Violation|0|||
30915174|NCT02213042|58950603|FG002|Overall Study|Protocol Violation|0|||
30915175|NCT02213042|58950601|FG000|Overall Study|Investigator discretion|0|||
30915176|NCT02213042|58950602|FG001|Overall Study|Investigator discretion|0|||
30824825|NCT01354314|58846850|FG002|Overall Study|Withdrawal by Subject|1|||
30824826|NCT01354314|58846851|FG003|Overall Study|Withdrawal by Subject|0|||
30824827|NCT01354314|58846848|FG000|Overall Study|Adverse Event|0|||
30824828|NCT01354314|58846849|FG001|Overall Study|Adverse Event|0|||
30915177|NCT02213042|58950603|FG002|Overall Study|Investigator discretion|1|||
30915178|NCT02212730|58950615|FG000|Overall Study|Tumor not of the required cell histology|1|||
30915179|NCT02212730|58950616|FG001|Overall Study|Tumor not of the required cell histology|0|||
30915180|NCT02212730|58950615|FG000|Overall Study|Withdrawal by Subject|1|||
30915181|NCT02212730|58950616|FG001|Overall Study|Withdrawal by Subject|0|||
30824829|NCT01354314|58846850|FG002|Overall Study|Adverse Event|0|||
30824830|NCT01354314|58846851|FG003|Overall Study|Adverse Event|1|||
30915182|NCT02212730|58950615|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
30915183|NCT02212730|58950616|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
30824831|NCT01354314|58846848|FG000|Overall Study|Protocol Violation|1|||
30824832|NCT01354314|58846849|FG001|Overall Study|Protocol Violation|1|||
30824833|NCT01354314|58846850|FG002|Overall Study|Protocol Violation|0|||
30915184|NCT02178956|58950626|FG000|Overall Study|Lost to Follow-up|4|||
30915185|NCT02178956|58950627|FG001|Overall Study|Lost to Follow-up|4|||
30915186|NCT02178956|58950626|FG000|Overall Study|Sponsor terminated study|49|||
30915187|NCT02178956|58950627|FG001|Overall Study|Sponsor terminated study|58|||
30915188|NCT02178956|58950626|FG000|Overall Study|Withdrawal by Subject|15|||
30915189|NCT02178956|58950627|FG001|Overall Study|Withdrawal by Subject|11|||
30915190|NCT02178956|58950626|FG000|Overall Study|Various Reasons|3|||
30915191|NCT02178956|58950627|FG001|Overall Study|Various Reasons|5|||
30915192|NCT02211638|58950637|FG000|Overall Study|Case Report Forms Uncollected|291|||
30915193|NCT02211638|58950637|FG000|Overall Study|Protocol Violation|692|||
30915194|NCT02178566|58950643|FG000|Overall Study|patient did not complete due to noncompliance|0|||
30915195|NCT02178566|58950644|FG001|Overall Study|patient did not complete due to noncompliance|1|||
30915196|NCT02211014|58950652|FG000|Overall Study|Adverse Event|0|||
30915197|NCT02211014|58950653|FG001|Overall Study|Adverse Event|2|||
30915198|NCT02211014|58950652|FG000|Overall Study|Physician Decision|1|||
30915199|NCT02211014|58950653|FG001|Overall Study|Physician Decision|2|||
30915200|NCT02211014|58950652|FG000|Overall Study|Started another cancer therapy|1|||
30915201|NCT02211014|58950653|FG001|Overall Study|Started another cancer therapy|0|||
30915202|NCT02211014|58950652|FG000|Overall Study|Withdrawal by Subject|0|||
30915203|NCT02211014|58950653|FG001|Overall Study|Withdrawal by Subject|1|||
30915204|NCT02211014|58950652|FG000|Overall Study|In agreement with patient, no benefit|0|||
30915205|NCT02211014|58950653|FG001|Overall Study|In agreement with patient, no benefit|1|||
30915206|NCT01631864|58950677|FG000|Overall Study|Withdrawal by Subject|0|||
30915207|NCT01631864|58950678|FG001|Overall Study|Withdrawal by Subject|1|||
30915208|NCT01631864|58950677|FG000|Overall Study|Adverse Event|2|||
30915209|NCT01631864|58950678|FG001|Overall Study|Adverse Event|3|||
30915210|NCT02210780|58950686|FG000|Overall Study|Adverse Event|0|||
30915211|NCT02210780|58950687|FG001|Overall Study|Adverse Event|5|||
30915212|NCT02210780|58950686|FG000|Overall Study|Lost to Follow-up|2|||
30915213|NCT02210780|58950687|FG001|Overall Study|Lost to Follow-up|1|||
30915214|NCT02210780|58950686|FG000|Overall Study|Withdrawal by Subject|1|||
30915215|NCT02210780|58950687|FG001|Overall Study|Withdrawal by Subject|1|||
30915216|NCT02210780|58950686|FG000|Overall Study|Physician Decision|1|||
30915217|NCT02210780|58950687|FG001|Overall Study|Physician Decision|0|||
30915218|NCT02210780|58950686|FG000|Overall Study|Protocol Violation|1|||
30915219|NCT02210780|58950687|FG001|Overall Study|Protocol Violation|0|||
30915220|NCT02210780|58950686|FG000|Overall Study|Other than specified above|0|||
30915221|NCT02210780|58950687|FG001|Overall Study|Other than specified above|1|||
30915222|NCT01557244|58950698|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
30915223|NCT01557244|58950699|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
30915224|NCT01557244|58950700|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
30915225|NCT01557244|58950701|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
30915226|NCT01557244|58950702|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
30915227|NCT01557244|58950703|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
30915228|NCT01557244|58950704|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
30915229|NCT01557244|58950698|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
30915230|NCT01557244|58950699|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
30915231|NCT01557244|58950700|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
30915232|NCT01557244|58950701|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
30915233|NCT01557244|58950702|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
30915234|NCT01557244|58950703|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
30915235|NCT01557244|58950704|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
30915236|NCT01557244|58950698|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
30915237|NCT01557244|58950699|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
30915238|NCT01557244|58950700|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
30915239|NCT01557244|58950701|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
30753636|NCT03834623|58763334|FG001|Overall Study|Progression|1|||
30753637|NCT00410813|58763342|FG000|Overall Study|Adverse Event|6|||
30753638|NCT00410813|58763343|FG001|Overall Study|Adverse Event|11|||
30753639|NCT00410813|58763342|FG000|Overall Study|Progression|32|||
30753640|NCT00410813|58763343|FG001|Overall Study|Progression|21|||
30753641|NCT00410813|58763342|FG000|Overall Study|Not protocol specified|3|||
30753642|NCT00410813|58763343|FG001|Overall Study|Not protocol specified|4|||
30753643|NCT00410813|58763342|FG000|Overall Study|Ineligible|2|||
30753644|NCT00410813|58763343|FG001|Overall Study|Ineligible|4|||
30753645|NCT00410813|58763342|FG000|Overall Study|Death|0|||
30753646|NCT00410813|58763343|FG001|Overall Study|Death|2|||
30753647|NCT00405821|58763374|FG000|Overall Study|Death|5|||
30753648|NCT00405821|58763375|FG001|Overall Study|Death|7|||
30753649|NCT00405821|58763374|FG000|Overall Study|Lost to Follow-up|7|||
30753650|NCT00405821|58763375|FG001|Overall Study|Lost to Follow-up|7|||
30753651|NCT00405821|58763374|FG000|Overall Study|Protocol Violation|1|||
30915240|NCT01557244|58950702|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
30915241|NCT01557244|58950703|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
30915242|NCT01557244|58950704|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
30915243|NCT01557244|58950698|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
30915244|NCT01557244|58950699|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
30915245|NCT01557244|58950700|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
30915246|NCT01557244|58950701|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
30915247|NCT01557244|58950702|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
30915248|NCT01557244|58950703|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
30915249|NCT01557244|58950704|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
30915250|NCT01557244|58950698|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
30915251|NCT01557244|58950699|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
30915252|NCT01557244|58950700|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
30915253|NCT01557244|58950701|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
30915254|NCT01557244|58950702|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
30915255|NCT01557244|58950703|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
30915256|NCT01557244|58950704|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
30915257|NCT01557244|58950698|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
30915258|NCT01557244|58950699|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
30915259|NCT01557244|58950700|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
30915260|NCT01557244|58950701|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
30915261|NCT01557244|58950702|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
30915262|NCT01557244|58950703|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
30915263|NCT01557244|58950704|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
30915264|NCT01557244|58950698|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
30915265|NCT01557244|58950699|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
30915266|NCT01557244|58950700|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
30915267|NCT01557244|58950701|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
30915268|NCT01557244|58950702|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
30915269|NCT01557244|58950703|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
30915270|NCT01557244|58950704|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
30915271|NCT01557244|58950698|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
30915272|NCT01557244|58950699|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
30915273|NCT01557244|58950700|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
30915274|NCT01557244|58950701|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
30915275|NCT01557244|58950702|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
30915276|NCT01557244|58950703|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
30915277|NCT01557244|58950704|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
30915278|NCT01557244|58950698|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
30915279|NCT01557244|58950699|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
30915280|NCT01557244|58950700|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
30915281|NCT01557244|58950701|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
30915282|NCT01557244|58950702|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
30915283|NCT01557244|58950703|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
30915284|NCT01557244|58950704|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
30915285|NCT01557244|58950698|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
30915286|NCT01557244|58950699|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
30915287|NCT01557244|58950700|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
30915288|NCT01557244|58950701|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
30915289|NCT01557244|58950702|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
30915290|NCT01557244|58950703|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
30915291|NCT01557244|58950704|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
30915292|NCT01557244|58950698|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
30915293|NCT01557244|58950699|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
30915294|NCT01557244|58950700|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
30915295|NCT01557244|58950701|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
30915296|NCT01557244|58950702|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
30915297|NCT01557244|58950703|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
30915298|NCT01557244|58950704|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
30915299|NCT01557244|58950698|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
30915300|NCT01557244|58950699|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
30915301|NCT01557244|58950700|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
30915302|NCT01557244|58950701|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
30915303|NCT01557244|58950702|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
30915304|NCT01557244|58950703|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
30915305|NCT01557244|58950704|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
30915306|NCT02155712|58950734|FG000|Primary Objective|Death|3|||
30915307|NCT02155712|58950735|FG001|Primary Objective|Death|0|||
30915308|NCT02155712|58950734|FG000|Primary Objective|Lost to Follow-up|22|||
30915309|NCT02155712|58950735|FG001|Primary Objective|Lost to Follow-up|0|||
30915310|NCT02155712|58950734|FG000|Primary Objective|No 2-Year Forms but not Terminated|13|||
30915311|NCT02155712|58950735|FG001|Primary Objective|No 2-Year Forms but not Terminated|0|||
30915312|NCT02155712|58950734|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1|||
30915313|NCT02155712|58950735|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0|||
30915314|NCT02155712|58950734|FG000|Primary Objective|Withdrawal by Subject|21|||
30915315|NCT02155712|58950735|FG001|Primary Objective|Withdrawal by Subject|0|||
30915316|NCT02177942|58950743|FG000|Overall Study|Adverse Event|1|||
30915317|NCT02177942|58950744|FG001|Overall Study|Adverse Event|0|||
30915318|NCT02177942|58950743|FG000|Overall Study|Lost to Follow-up|1|||
30915319|NCT02177942|58950744|FG001|Overall Study|Lost to Follow-up|1|||
30915320|NCT02177942|58950743|FG000|Overall Study|Protocol Violation|4|||
30915321|NCT02177942|58950744|FG001|Overall Study|Protocol Violation|6|||
30824834|NCT01354314|58846851|FG003|Overall Study|Protocol Violation|0|||
30824835|NCT01354314|58846848|FG000|Overall Study|Less than 90% Adherence|4|||
30824836|NCT01354314|58846849|FG001|Overall Study|Less than 90% Adherence|2|||
30824837|NCT01354314|58846850|FG002|Overall Study|Less than 90% Adherence|6|||
30824838|NCT01354314|58846851|FG003|Overall Study|Less than 90% Adherence|4|||
30824839|NCT03194321|58846863|FG000|Overall Study|Withdrawal by Subject|1|||
30824840|NCT03194321|58846863|FG000|Overall Study|Lost to Follow-up|1|||
30824841|NCT03194321|58846863|FG000|Overall Study|Travel for Follow-up|1|||
30824842|NCT01354938|58846867|FG000|Overall Study|Lost to Follow-up|1|||
30824843|NCT03092791|58846890|FG000|Overall Study|Lost to Follow-up|0|||
30824844|NCT03092791|58846891|FG001|Overall Study|Lost to Follow-up|0|||
30824845|NCT03092791|58846892|FG002|Overall Study|Lost to Follow-up|0|||
30824846|NCT03092791|58846893|FG003|Overall Study|Lost to Follow-up|0|||
30824847|NCT03092791|58846894|FG004|Overall Study|Lost to Follow-up|0|||
30824848|NCT03092791|58846895|FG005|Overall Study|Lost to Follow-up|0|||
30824849|NCT03092791|58846896|FG006|Overall Study|Lost to Follow-up|1|||
30824850|NCT03092791|58846897|FG007|Overall Study|Lost to Follow-up|0|||
30824851|NCT03092791|58846890|FG000|Overall Study|Withdrawal of Consent|0|||
30824852|NCT03092791|58846891|FG001|Overall Study|Withdrawal of Consent|0|||
30824853|NCT03092791|58846892|FG002|Overall Study|Withdrawal of Consent|0|||
30824854|NCT03092791|58846893|FG003|Overall Study|Withdrawal of Consent|0|||
30824855|NCT03092791|58846894|FG004|Overall Study|Withdrawal of Consent|4|||
30824856|NCT03092791|58846895|FG005|Overall Study|Withdrawal of Consent|12|||
30824857|NCT03092791|58846896|FG006|Overall Study|Withdrawal of Consent|6|||
30824858|NCT03092791|58846897|FG007|Overall Study|Withdrawal of Consent|4|||
30824859|NCT03092791|58846890|FG000|Overall Study|Study Termination|0|||
30824860|NCT03092791|58846891|FG001|Overall Study|Study Termination|0|||
30824861|NCT03092791|58846892|FG002|Overall Study|Study Termination|0|||
30824862|NCT03092791|58846893|FG003|Overall Study|Study Termination|0|||
30824863|NCT03092791|58846894|FG004|Overall Study|Study Termination|55|||
30824864|NCT03092791|58846895|FG005|Overall Study|Study Termination|46|||
30824865|NCT03092791|58846896|FG006|Overall Study|Study Termination|53|||
30824866|NCT03092791|58846897|FG007|Overall Study|Study Termination|55|||
30824867|NCT03092791|58846890|FG000|Overall Study|Death|0|||
30824868|NCT03092791|58846891|FG001|Overall Study|Death|0|||
30824869|NCT03092791|58846892|FG002|Overall Study|Death|0|||
30824870|NCT03092791|58846893|FG003|Overall Study|Death|0|||
30824871|NCT03092791|58846894|FG004|Overall Study|Death|0|||
30824872|NCT03092791|58846895|FG005|Overall Study|Death|1|||
30824873|NCT03092791|58846896|FG006|Overall Study|Death|0|||
30824874|NCT03092791|58846897|FG007|Overall Study|Death|1|||
30824875|NCT03092791|58846890|FG000|Overall Study|Reason Not Specified|0|||
30824876|NCT03092791|58846891|FG001|Overall Study|Reason Not Specified|0|||
30824877|NCT03092791|58846892|FG002|Overall Study|Reason Not Specified|0|||
30824878|NCT03092791|58846893|FG003|Overall Study|Reason Not Specified|0|||
30824879|NCT03092791|58846894|FG004|Overall Study|Reason Not Specified|1|||
30824880|NCT03092791|58846895|FG005|Overall Study|Reason Not Specified|1|||
30824881|NCT03092791|58846896|FG006|Overall Study|Reason Not Specified|0|||
30824882|NCT03092791|58846897|FG007|Overall Study|Reason Not Specified|0|||
30824883|NCT04283461|58846925|FG000|Overall Study|Enrolled in separate trial|0|||
30824884|NCT04283461|58846926|FG001|Overall Study|Enrolled in separate trial|0|||
30824885|NCT04283461|58846927|FG002|Overall Study|Enrolled in separate trial|8|||
30824886|NCT04283461|58846928|FG003|Overall Study|Enrolled in separate trial|13|||
30824887|NCT04283461|58846929|FG004|Overall Study|Enrolled in separate trial|12|||
30824888|NCT04283461|58846930|FG005|Overall Study|Enrolled in separate trial|0|||
30824889|NCT04283461|58846931|FG006|Overall Study|Enrolled in separate trial|0|||
30824890|NCT04283461|58846932|FG007|Overall Study|Enrolled in separate trial|8|||
30824891|NCT04283461|58846933|FG008|Overall Study|Enrolled in separate trial|0|||
30824892|NCT04283461|58846934|FG009|Overall Study|Enrolled in separate trial|0|||
30824893|NCT04283461|58846935|FG010|Overall Study|Enrolled in separate trial|0|||
30824894|NCT04283461|58846936|FG011|Overall Study|Enrolled in separate trial|7|||
30824895|NCT04283461|58846937|FG012|Overall Study|Enrolled in separate trial|0|||
30824896|NCT02505425|58846968|FG000|Overall Study|Lost to Follow-up|41|||
30824897|NCT02505425|58846969|FG001|Overall Study|Lost to Follow-up|61|||
30915322|NCT02177942|58950743|FG000|Overall Study|Withdrawal by Subject|71|||
30915323|NCT02177942|58950744|FG001|Overall Study|Withdrawal by Subject|81|||
30915324|NCT02155322|58950754|FG000|Overall Study|Adverse Event|1|||
30915325|NCT02155322|58950754|FG000|Overall Study|Physician Decision|1|||
30915326|NCT02155322|58950754|FG000|Overall Study|Relapse/Recurrence|8|||
30915327|NCT02155322|58950754|FG000|Overall Study|Withdrawal by Subject|4|||
30915328|NCT02210000|58950760|FG000|Overall Study|Study Terminated|11|||
30915329|NCT02210000|58950761|FG001|Overall Study|Study Terminated|12|||
30915330|NCT02210000|58950760|FG000|Overall Study|Withdrawal by Subject|7|||
30915331|NCT02210000|58950761|FG001|Overall Study|Withdrawal by Subject|1|||
30915332|NCT02210000|58950760|FG000|Overall Study|Adverse Event|1|||
30915333|NCT02210000|58950761|FG001|Overall Study|Adverse Event|5|||
30915334|NCT02210000|58950760|FG000|Overall Study|Lost to Follow-up|0|||
30915335|NCT02210000|58950761|FG001|Overall Study|Lost to Follow-up|2|||
30915336|NCT02210000|58950760|FG000|Overall Study|Physician Decision|0|||
30915337|NCT02210000|58950761|FG001|Overall Study|Physician Decision|1|||
30915338|NCT01531894|58950767|FG000|Overall Study|Physician Decision|8|||
30915339|NCT01531894|58950767|FG000|Overall Study|Death|1|||
30915340|NCT02209766|58950775|FG000|Overall Study|Withdrawal by Subject|0|||
30915341|NCT02209766|58950776|FG001|Overall Study|Withdrawal by Subject|0|||
30915342|NCT02209766|58950777|FG002|Overall Study|Withdrawal by Subject|0|||
30915343|NCT02209766|58950778|FG003|Overall Study|Withdrawal by Subject|1|||
30915344|NCT02209766|58950779|FG004|Overall Study|Withdrawal by Subject|0|||
30915345|NCT02209454|58950789|FG000|Second Period|Adverse Event|1|||
30915346|NCT02209454|58950790|FG001|Second Period|Adverse Event|0|||
30915347|NCT01571596|58950799|FG000|Overall Study|Adverse Event|2|||
30915348|NCT01571596|58950800|FG001|Overall Study|Adverse Event|0|||
30915349|NCT01571596|58950801|FG002|Overall Study|Adverse Event|0|||
30915350|NCT01571596|58950799|FG000|Overall Study|Study Terminated by the Sponsor|0|||
30915351|NCT01571596|58950800|FG001|Overall Study|Study Terminated by the Sponsor|1|||
30915352|NCT01571596|58950801|FG002|Overall Study|Study Terminated by the Sponsor|1|||
30753652|NCT00405821|58763375|FG001|Overall Study|Protocol Violation|0|||
30915353|NCT01557166|58950813|FG000|Overall Study|Adverse Event|20|||
30915354|NCT01557166|58950814|FG001|Overall Study|Adverse Event|6|||
30915355|NCT01557166|58950813|FG000|Overall Study|Lack of Efficacy|2|||
30915356|NCT01557166|58950814|FG001|Overall Study|Lack of Efficacy|1|||
30915357|NCT01557166|58950813|FG000|Overall Study|Protocol Violation|8|||
30915358|NCT01557166|58950814|FG001|Overall Study|Protocol Violation|5|||
30915359|NCT01557166|58950813|FG000|Overall Study|Withdrawn consent|12|||
30915360|NCT01557166|58950814|FG001|Overall Study|Withdrawn consent|20|||
30915361|NCT01557166|58950813|FG000|Overall Study|Target dose not tolerated|1|||
30915362|NCT01557166|58950814|FG001|Overall Study|Target dose not tolerated|0|||
30915363|NCT01557166|58950813|FG000|Overall Study|Psychiatric disorder|1|||
30915364|NCT01557166|58950814|FG001|Overall Study|Psychiatric disorder|0|||
30915365|NCT01557166|58950813|FG000|Overall Study|Unclassified|2|||
30915366|NCT01557166|58950814|FG001|Overall Study|Unclassified|5|||
30753653|NCT00405821|58763374|FG000|Overall Study|initiated ART|9|||
30753654|NCT00405821|58763375|FG001|Overall Study|initiated ART|8|||
30753655|NCT01446016|58763381|FG000|Overall Study|Lost to Follow-up|3|||
30753656|NCT01446016|58763381|FG000|Overall Study|Withdrawal by Subject|1|||
30753657|NCT01446016|58763381|FG000|Overall Study|Toxicity|3|||
30753658|NCT00137046|58763387|FG000|Overall Study|Death|2|||
30753659|NCT00137046|58763388|FG001|Overall Study|Death|1|||
30753660|NCT00137046|58763387|FG000|Overall Study|Adverse Event|16|||
30824898|NCT02505425|58846970|FG002|Overall Study|Lost to Follow-up|31|||
30824899|NCT02505425|58846971|FG003|Overall Study|Lost to Follow-up|19|||
30824900|NCT02505425|58846968|FG000|Overall Study|Withdrawal by Subject|39|||
30753661|NCT00137046|58763388|FG001|Overall Study|Adverse Event|5|||
30753662|NCT00137046|58763387|FG000|Overall Study|Laboratory Abnormality|2|||
30753663|NCT00137046|58763388|FG001|Overall Study|Laboratory Abnormality|0|||
30753664|NCT00137046|58763387|FG000|Overall Study|Lack of Efficacy|13|||
30753665|NCT00137046|58763388|FG001|Overall Study|Lack of Efficacy|1|||
30753666|NCT00137046|58763387|FG000|Overall Study|Lost to Follow-up|8|||
30753667|NCT00137046|58763388|FG001|Overall Study|Lost to Follow-up|24|||
30753668|NCT00137046|58763387|FG000|Overall Study|Other|23|||
30824901|NCT02505425|58846969|FG001|Overall Study|Withdrawal by Subject|9|||
30824902|NCT02505425|58846970|FG002|Overall Study|Withdrawal by Subject|19|||
30824903|NCT02505425|58846971|FG003|Overall Study|Withdrawal by Subject|7|||
30824904|NCT02505425|58846968|FG000|Overall Study|Death|8|||
30824905|NCT02505425|58846969|FG001|Overall Study|Death|12|||
30824906|NCT02505425|58846970|FG002|Overall Study|Death|0|||
30824907|NCT02505425|58846971|FG003|Overall Study|Death|0|||
30824908|NCT03089047|58846983|FG000|Overall Study|Lost to Follow-up|1|||
30824909|NCT03089047|58846984|FG001|Overall Study|Lost to Follow-up|0|||
30824910|NCT01371006|58846992|FG000|Overall Study|Adverse Event|1|||
30824911|NCT01371006|58846993|FG001|Overall Study|Adverse Event|0|||
30753669|NCT00137046|58763388|FG001|Overall Study|Other|19|||
30824912|NCT01371552|58847028|FG000|Part 1, First 3 Days|Inconvenience|0|||
30824913|NCT01371552|58847029|FG001|Part 1, First 3 Days|Inconvenience|0|||
30753670|NCT00137046|58763387|FG000|Overall Study|Withdrawal by Subject|33|||
30824914|NCT01371552|58847030|FG002|Part 1, First 3 Days|Inconvenience|1|||
30753671|NCT00137046|58763388|FG001|Overall Study|Withdrawal by Subject|42|||
30753672|NCT00137046|58763387|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
30753673|NCT00137046|58763388|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
30753674|NCT00137046|58763387|FG000|Overall Study|Withdrew prior to study treatment|1|||
30753675|NCT00137046|58763388|FG001|Overall Study|Withdrew prior to study treatment|1|||
30915367|NCT01556932|58950820|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
30915368|NCT01556932|58950821|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
30915369|NCT02177786|58950830|FG000|Overall Study|Withdrew Consent|2|||
30915370|NCT02177786|58950831|FG001|Overall Study|Withdrew Consent|6|||
30915371|NCT02177786|58950832|FG002|Overall Study|Withdrew Consent|9|||
30915372|NCT02177786|58950833|FG003|Overall Study|Withdrew Consent|5|||
30915373|NCT02177786|58950830|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
30915374|NCT02177786|58950831|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
30915375|NCT02177786|58950832|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
30915376|NCT02177786|58950833|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
30915377|NCT02177786|58950830|FG000|Overall Study|Adverse Event|1|||
30915378|NCT02177786|58950831|FG001|Overall Study|Adverse Event|1|||
30915379|NCT02177786|58950832|FG002|Overall Study|Adverse Event|2|||
30915380|NCT02177786|58950833|FG003|Overall Study|Adverse Event|3|||
30915381|NCT02177786|58950830|FG000|Overall Study|Death|1|||
30915382|NCT02177786|58950831|FG001|Overall Study|Death|1|||
30915383|NCT02177786|58950832|FG002|Overall Study|Death|1|||
30915384|NCT02177786|58950833|FG003|Overall Study|Death|1|||
30915385|NCT02177786|58950830|FG000|Overall Study|Lost to Follow-up|0|||
30915386|NCT02177786|58950831|FG001|Overall Study|Lost to Follow-up|0|||
30915387|NCT02177786|58950832|FG002|Overall Study|Lost to Follow-up|2|||
30915388|NCT02177786|58950833|FG003|Overall Study|Lost to Follow-up|2|||
30915389|NCT02177786|58950830|FG000|Overall Study|Non-Compliance with Study Drug|0|||
30915390|NCT02177786|58950831|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30915391|NCT02177786|58950832|FG002|Overall Study|Non-Compliance with Study Drug|0|||
30915392|NCT02177786|58950833|FG003|Overall Study|Non-Compliance with Study Drug|1|||
30915393|NCT02177786|58950830|FG000|Overall Study|Protocol Violation|0|||
30915394|NCT02177786|58950831|FG001|Overall Study|Protocol Violation|0|||
30915395|NCT02177786|58950832|FG002|Overall Study|Protocol Violation|2|||
30915396|NCT02177786|58950833|FG003|Overall Study|Protocol Violation|0|||
30915397|NCT02177786|58950830|FG000|Overall Study|Progressive Disease|0|||
30915398|NCT02177786|58950831|FG001|Overall Study|Progressive Disease|1|||
30915399|NCT02177786|58950832|FG002|Overall Study|Progressive Disease|0|||
30915400|NCT02177786|58950833|FG003|Overall Study|Progressive Disease|0|||
30915401|NCT02177786|58950830|FG000|Overall Study|Missing study completion status|0|||
30915402|NCT02177786|58950831|FG001|Overall Study|Missing study completion status|1|||
30915403|NCT02177786|58950832|FG002|Overall Study|Missing study completion status|0|||
30915404|NCT02177786|58950833|FG003|Overall Study|Missing study completion status|0|||
30915405|NCT01555762|58950843|FG000|Overall Study|No information on Bevacizumab intake|11|||
30915406|NCT01555762|58950843|FG000|Overall Study|Missing start date of infusion|8|||
30915407|NCT01555762|58950843|FG000|Overall Study|75 years old or more ticked No|1|||
30915408|NCT01555762|58950843|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
30915409|NCT01555762|58950843|FG000|Overall Study|Death linked to progression of disease|165|||
30915410|NCT01555762|58950843|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
30915411|NCT01555762|58950843|FG000|Overall Study|Investigator's decision|10|||
30915412|NCT01555762|58950843|FG000|Overall Study|Participant not wishing to continue|5|||
30915413|NCT01555762|58950843|FG000|Overall Study|Missing data|1|||
30915414|NCT01555762|58950843|FG000|Overall Study|Death linked to an adverse event|14|||
30915415|NCT02153918|58950847|FG000|Overall Study|Refused further treatment|1|||
30915416|NCT02176928|58950853|FG000|Overall Study|Lost to Follow-up|2|||
30915417|NCT02176928|58950854|FG001|Overall Study|Lost to Follow-up|4|||
30915418|NCT01628510|58950862|FG000|Overall Study|Withdrawal by Subject|0|||
30915419|NCT01628510|58950863|FG001|Overall Study|Withdrawal by Subject|4|||
30915420|NCT01628510|58950862|FG000|Overall Study|Death|3|||
30915421|NCT01628510|58950863|FG001|Overall Study|Death|1|||
30915422|NCT01571362|58950871|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
30915423|NCT01571362|58950872|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
30915424|NCT01571362|58950873|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
30915425|NCT01571362|58950871|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
30915426|NCT01571362|58950872|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
30753676|NCT00122382|58763400|FG000|Double-Blind Study|Adverse Event|9|||
30915427|NCT01571362|58950873|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
30915428|NCT01571362|58950871|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
30915429|NCT01571362|58950872|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
30915430|NCT01571362|58950873|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
30915431|NCT01571362|58950871|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
30915432|NCT01571362|58950872|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
30915433|NCT01571362|58950873|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
30915434|NCT01571362|58950871|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
30915435|NCT01571362|58950872|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
30915436|NCT01571362|58950873|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
30915437|NCT01571362|58950871|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
30824915|NCT01371552|58847031|FG003|Part 1, First 3 Days|Inconvenience|0|||
30824916|NCT01371552|58847032|FG004|Part 1, First 3 Days|Inconvenience|0|||
30824917|NCT01371552|58847033|FG005|Part 1, First 3 Days|Inconvenience|0|||
30824918|NCT02819310|58847042|FG000|Overall Study|Withdrawal by Subject|37|||
30824919|NCT02819310|58847042|FG000|Overall Study|Lost to Follow-up|16|||
30824920|NCT02819310|58847042|FG000|Overall Study|Adverse Event|13|||
30824921|NCT02819310|58847042|FG000|Overall Study|Lack of Efficacy|5|||
30824922|NCT02819310|58847042|FG000|Overall Study|Physician Decision|8|||
30824923|NCT02819310|58847042|FG000|Overall Study|Protocol Violation|30|||
30824924|NCT03087643|58847048|FG000|Overall Study|Withdrawal by Subject|2|||
30824925|NCT03087643|58847049|FG001|Overall Study|Withdrawal by Subject|4|||
30824926|NCT03087643|58847048|FG000|Overall Study|Death|2|||
30824927|NCT03087643|58847049|FG001|Overall Study|Death|2|||
30824928|NCT02821962|58847057|FG000|Overall Study|Lost to Follow-up|2|||
30824929|NCT02821962|58847058|FG001|Overall Study|Lost to Follow-up|0|||
30824930|NCT03092479|58847066|FG000|Overall Study|Lost to Follow-up|3|||
30824931|NCT03092479|58847067|FG001|Overall Study|Lost to Follow-up|2|||
30824932|NCT03092479|58847066|FG000|Overall Study|Withdrawal by Subject|4|||
30824933|NCT03092479|58847067|FG001|Overall Study|Withdrawal by Subject|0|||
30824934|NCT03086551|58847075|FG000|First Intervention|Failure to meet inclusion criterion|1|||
30824935|NCT03086551|58847076|FG001|First Intervention|Failure to meet inclusion criterion|0|||
30915438|NCT01571362|58950872|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
30915439|NCT01571362|58950873|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
30915440|NCT01571362|58950871|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30915441|NCT01571362|58950872|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
30915442|NCT01571362|58950873|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
30915443|NCT01571362|58950871|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
30915444|NCT01571362|58950872|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
30915445|NCT01571362|58950873|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
30753677|NCT00122382|58763401|FG001|Double-Blind Study|Adverse Event|11|||
30753678|NCT00122382|58763402|FG002|Double-Blind Study|Adverse Event|0|||
30753679|NCT00122382|58763400|FG000|Double-Blind Study|Death|2|||
30753680|NCT00122382|58763401|FG001|Double-Blind Study|Death|2|||
30753681|NCT00122382|58763402|FG002|Double-Blind Study|Death|0|||
30753682|NCT00122382|58763400|FG000|Double-Blind Study|Lack of Efficacy|0|||
30753683|NCT00122382|58763401|FG001|Double-Blind Study|Lack of Efficacy|8|||
30753684|NCT00122382|58763402|FG002|Double-Blind Study|Lack of Efficacy|0|||
30753685|NCT00122382|58763400|FG000|Double-Blind Study|Lost to Follow-up|2|||
30753686|NCT00122382|58763401|FG001|Double-Blind Study|Lost to Follow-up|1|||
30753687|NCT00122382|58763402|FG002|Double-Blind Study|Lost to Follow-up|0|||
30753688|NCT00122382|58763400|FG000|Double-Blind Study|Pregnancy|2|||
30753689|NCT00122382|58763401|FG001|Double-Blind Study|Pregnancy|0|||
30824936|NCT03086551|58847075|FG000|First Intervention|Lost to Follow-up|0|||
30753690|NCT00122382|58763402|FG002|Double-Blind Study|Pregnancy|0|||
30753691|NCT00122382|58763400|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
30824937|NCT03086551|58847076|FG001|First Intervention|Lost to Follow-up|1|||
30824938|NCT03086551|58847075|FG000|Washout|Lost to Follow-up|1|||
30824939|NCT03086551|58847076|FG001|Washout|Lost to Follow-up|2|||
30824940|NCT03086551|58847075|FG000|Washout|Withdrawal by Subject|2|||
30824941|NCT03086551|58847076|FG001|Washout|Withdrawal by Subject|1|||
30824942|NCT03265249|58847084|FG000|Overall Study|Withdrawal by Subject|0|||
30824943|NCT03265249|58847085|FG001|Overall Study|Withdrawal by Subject|1|||
30824944|NCT02951767|58847091|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54|||
30824945|NCT02951767|58847091|FG000|Overall Study|Withdrawal by Subject|5|||
30824946|NCT02951767|58847091|FG000|Overall Study|Death|59|||
30824947|NCT02951767|58847091|FG000|Overall Study|Lost to Follow-up|1|||
30824948|NCT03093181|58847098|FG000|Overall Study|Withdrawal by Subject|2|||
30824949|NCT03093181|58847099|FG001|Overall Study|Withdrawal by Subject|1|||
30915446|NCT01571362|58950871|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30915447|NCT01571362|58950872|FG001|Double-Blind Treatment Period|Adverse Event|9|||
30915448|NCT01571362|58950873|FG002|Double-Blind Treatment Period|Adverse Event|14|||
30824950|NCT03093181|58847100|FG002|Overall Study|Withdrawal by Subject|2|||
30824951|NCT03093181|58847098|FG000|Overall Study|Other (Not specified)|1|||
30915449|NCT01571362|58950871|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
30915450|NCT01571362|58950872|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
30915451|NCT01571362|58950873|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
30824952|NCT03093181|58847099|FG001|Overall Study|Other (Not specified)|0|||
30824953|NCT03093181|58847100|FG002|Overall Study|Other (Not specified)|0|||
30824954|NCT03093181|58847098|FG000|Overall Study|Adverse Event|0|||
30824955|NCT03093181|58847099|FG001|Overall Study|Adverse Event|1|||
30824956|NCT03093181|58847100|FG002|Overall Study|Adverse Event|0|||
30824957|NCT03093181|58847098|FG000|Overall Study|Other (Protocol violation)|0|||
30824958|NCT03093181|58847099|FG001|Overall Study|Other (Protocol violation)|0|||
30824959|NCT03093181|58847100|FG002|Overall Study|Other (Protocol violation)|1|||
30824960|NCT03091777|58847111|FG000|Overall Study|Pregnancy|2|||
30824961|NCT03091777|58847112|FG001|Overall Study|Pregnancy|1|||
30824962|NCT03091777|58847113|FG002|Overall Study|Pregnancy|0|||
30824963|NCT03091777|58847111|FG000|Overall Study|Adverse Event|2|||
30824964|NCT03091777|58847112|FG001|Overall Study|Adverse Event|1|||
30824965|NCT03091777|58847113|FG002|Overall Study|Adverse Event|4|||
30824966|NCT03091777|58847111|FG000|Overall Study|Withdrawal by Subject|4|||
30824967|NCT03091777|58847112|FG001|Overall Study|Withdrawal by Subject|2|||
30824968|NCT03091777|58847113|FG002|Overall Study|Withdrawal by Subject|6|||
30824969|NCT03091777|58847111|FG000|Overall Study|Protocol Violation|2|||
30824970|NCT03091777|58847112|FG001|Overall Study|Protocol Violation|1|||
30824971|NCT03091777|58847113|FG002|Overall Study|Protocol Violation|1|||
30824972|NCT03091777|58847111|FG000|Overall Study|Lost to Follow-up|12|||
30824973|NCT03091777|58847112|FG001|Overall Study|Lost to Follow-up|14|||
30824974|NCT03091777|58847113|FG002|Overall Study|Lost to Follow-up|7|||
30824975|NCT03091777|58847111|FG000|Overall Study|Lack of Efficacy|0|||
30824976|NCT03091777|58847112|FG001|Overall Study|Lack of Efficacy|0|||
30824977|NCT03091777|58847113|FG002|Overall Study|Lack of Efficacy|5|||
30824978|NCT03091777|58847111|FG000|Overall Study|Noncompliance with study drug|2|||
30824979|NCT03091777|58847112|FG001|Overall Study|Noncompliance with study drug|3|||
30824980|NCT03091777|58847113|FG002|Overall Study|Noncompliance with study drug|1|||
30824981|NCT03091777|58847111|FG000|Overall Study|Physician Decision|1|||
30824982|NCT03091777|58847112|FG001|Overall Study|Physician Decision|0|||
30824983|NCT03091777|58847113|FG002|Overall Study|Physician Decision|1|||
30824984|NCT03091777|58847111|FG000|Overall Study|Abnormal Laboratory Value|7|||
30824985|NCT03091777|58847112|FG001|Overall Study|Abnormal Laboratory Value|11|||
30824986|NCT03091777|58847113|FG002|Overall Study|Abnormal Laboratory Value|12|||
30824987|NCT02818998|58847124|FG000|Overall Study|Adverse Event|3|||
30824988|NCT02818998|58847125|FG001|Overall Study|Adverse Event|2|||
30824989|NCT02818998|58847126|FG002|Overall Study|Adverse Event|1|||
30824990|NCT02818998|58847124|FG000|Overall Study|Lost to Follow-up|4|||
30824991|NCT02818998|58847125|FG001|Overall Study|Lost to Follow-up|1|||
30824992|NCT02818998|58847126|FG002|Overall Study|Lost to Follow-up|2|||
30824993|NCT02818998|58847124|FG000|Overall Study|Withdrawal by sponsor|0|||
30824994|NCT02818998|58847125|FG001|Overall Study|Withdrawal by sponsor|1|||
30824995|NCT02818998|58847126|FG002|Overall Study|Withdrawal by sponsor|1|||
30824996|NCT02818998|58847124|FG000|Overall Study|Death|3|||
30915452|NCT01571362|58950871|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
30824997|NCT02818998|58847125|FG001|Overall Study|Death|6|||
30824998|NCT02818998|58847126|FG002|Overall Study|Death|8|||
30824999|NCT02818998|58847124|FG000|Overall Study|Withdrawal by Subject|7|||
30825000|NCT02818998|58847125|FG001|Overall Study|Withdrawal by Subject|6|||
30825001|NCT02818998|58847126|FG002|Overall Study|Withdrawal by Subject|6|||
30825002|NCT02818998|58847124|FG000|Overall Study|Physician Decision|1|||
30825003|NCT02818998|58847125|FG001|Overall Study|Physician Decision|0|||
30825004|NCT02818998|58847126|FG002|Overall Study|Physician Decision|0|||
30825005|NCT02821416|58847136|FG000|Overall Study|Adverse Event|0|||
30825006|NCT02821416|58847137|FG001|Overall Study|Adverse Event|1|||
30825007|NCT02821416|58847136|FG000|Overall Study|Withdrawal by Subject|2|||
30825008|NCT02821416|58847137|FG001|Overall Study|Withdrawal by Subject|0|||
30825009|NCT02821416|58847136|FG000|Overall Study|Lost to Follow-up|1|||
30825010|NCT02821416|58847137|FG001|Overall Study|Lost to Follow-up|0|||
30825011|NCT03108521|58847146|FG000|Overall Study|Lost to Follow-up|3|||
30825012|NCT03108521|58847147|FG001|Overall Study|Lost to Follow-up|0|||
30825013|NCT03108521|58847146|FG000|Overall Study|Lack of Efficacy|2|||
30825014|NCT03108521|58847147|FG001|Overall Study|Lack of Efficacy|0|||
30825015|NCT03108521|58847146|FG000|Overall Study|Physician Decision|4|||
30825016|NCT03108521|58847147|FG001|Overall Study|Physician Decision|0|||
30825017|NCT03108521|58847146|FG000|Overall Study|Adverse Event|3|||
30825018|NCT03108521|58847147|FG001|Overall Study|Adverse Event|0|||
30825019|NCT02817828|58847170|FG000|Overall Study|Lost to Follow-up|41|||
30825020|NCT02817828|58847170|FG000|Overall Study|Adverse event not related to bleeding|104|||
30825021|NCT02817828|58847170|FG000|Overall Study|Adverse event related to bleeding|53|||
30825022|NCT02817828|58847170|FG000|Overall Study|Protocol Violation|11|||
30825023|NCT02817828|58847170|FG000|Overall Study|Pregnancy|7|||
30825024|NCT02817828|58847170|FG000|Overall Study|Pregnancy wish|15|||
30825025|NCT02817828|58847170|FG000|Overall Study|Withdrawal by Subject|78|||
30825026|NCT02817828|58847170|FG000|Overall Study|Other|26|||
30825027|NCT02817906|58847181|FG000|Overall Study|Adverse Event|3|||
30825028|NCT02817906|58847182|FG001|Overall Study|Adverse Event|0|||
30825029|NCT02817906|58847181|FG000|Overall Study|Lack of Efficacy|1|||
30825030|NCT02817906|58847182|FG001|Overall Study|Lack of Efficacy|0|||
30825031|NCT02817906|58847181|FG000|Overall Study|Protocol Violation|1|||
30825032|NCT02817906|58847182|FG001|Overall Study|Protocol Violation|1|||
30825033|NCT02817906|58847181|FG000|Overall Study|Study Terminated by Sponsor|2|||
30825034|NCT02817906|58847182|FG001|Overall Study|Study Terminated by Sponsor|2|||
30825035|NCT02817906|58847181|FG000|Overall Study|Withdrawal by Subject|7|||
30825036|NCT02817906|58847182|FG001|Overall Study|Withdrawal by Subject|0|||
30825037|NCT02817906|58847181|FG000|Overall Study|Other|2|||
30825038|NCT02817906|58847182|FG001|Overall Study|Other|2|||
30915453|NCT01571362|58950872|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
30915454|NCT01571362|58950873|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
30915455|NCT01571362|58950871|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
30915456|NCT01571362|58950872|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
30915457|NCT01571362|58950873|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
30915458|NCT01571284|58950881|FG000|Overall Study|Participant's decision|84|||
30915459|NCT01571284|58950881|FG000|Overall Study|Lost to Follow-up|3|||
30915460|NCT01571284|58950881|FG000|Overall Study|Enrolled but not treated|2|||
30915461|NCT01571284|58950881|FG000|Overall Study|Other than specified above|80|||
30915462|NCT02137772|58950887|FG000|Overall Study|Adverse Event|6|||
30915463|NCT02137772|58950888|FG001|Overall Study|Adverse Event|3|||
30915464|NCT02137772|58950887|FG000|Overall Study|Death|71|||
30915465|NCT02137772|58950888|FG001|Overall Study|Death|44|||
30915466|NCT02137772|58950887|FG000|Overall Study|Lost to Follow-up|8|||
30915467|NCT02137772|58950888|FG001|Overall Study|Lost to Follow-up|4|||
30915468|NCT02137772|58950887|FG000|Overall Study|Physician Decision|15|||
30915469|NCT02137772|58950888|FG001|Overall Study|Physician Decision|5|||
30915470|NCT02137772|58950887|FG000|Overall Study|Withdrawal by Subject|28|||
30915471|NCT02137772|58950888|FG001|Overall Study|Withdrawal by Subject|17|||
30915472|NCT02137772|58950887|FG000|Overall Study|Non-compliance with study drug|1|||
30915473|NCT02137772|58950888|FG001|Overall Study|Non-compliance with study drug|0|||
30915474|NCT02137772|58950887|FG000|Overall Study|Not treated|3|||
30915475|NCT02137772|58950888|FG001|Overall Study|Not treated|2|||
30915476|NCT01555138|58950896|FG000|Overall Study|Death|0|||
30915477|NCT01555138|58950897|FG001|Overall Study|Death|1|||
30915478|NCT01555138|58950896|FG000|Overall Study|Lost to Follow-up|1|||
30915479|NCT01555138|58950897|FG001|Overall Study|Lost to Follow-up|0|||
30915480|NCT01555138|58950896|FG000|Overall Study|Abnormal Lab reults|1|||
30915481|NCT01555138|58950897|FG001|Overall Study|Abnormal Lab reults|3|||
30915482|NCT01555138|58950896|FG000|Overall Study|Lack of Efficacy|2|||
30825039|NCT02817594|58847193|FG000|Overall Study|Withdrawal by Subject|1|||
30825040|NCT02817594|58847193|FG000|Overall Study|Other|1|||
30825041|NCT02817594|58847193|FG000|Overall Study|Did Not Receive Treatment|1|||
30825042|NCT02813694|58847203|FG000|Overall Study|Physician Decision|0|||
30825043|NCT02813694|58847204|FG001|Overall Study|Physician Decision|1|||
30825044|NCT02813694|58847203|FG000|Overall Study|Withdrawal by Subject|10|||
30825045|NCT02813694|58847204|FG001|Overall Study|Withdrawal by Subject|9|||
30825046|NCT02813694|58847203|FG000|Overall Study|Lost to Follow-up|1|||
30915483|NCT01555138|58950897|FG001|Overall Study|Lack of Efficacy|2|||
30915484|NCT01555138|58950896|FG000|Overall Study|Protocol Violation|5|||
30915485|NCT01555138|58950897|FG001|Overall Study|Protocol Violation|3|||
30915486|NCT01555138|58950896|FG000|Overall Study|Administrative problems|8|||
30915487|NCT01555138|58950897|FG001|Overall Study|Administrative problems|0|||
30915488|NCT01555138|58950896|FG000|Overall Study|Withdrawal by Subject|16|||
30915489|NCT01555138|58950897|FG001|Overall Study|Withdrawal by Subject|15|||
30915490|NCT01555138|58950896|FG000|Overall Study|Adverse Event|14|||
30915491|NCT01555138|58950897|FG001|Overall Study|Adverse Event|14|||
30915492|NCT02137226|58950905|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
30915493|NCT02137226|58950906|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
30915494|NCT02137226|58950907|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
30915495|NCT02137226|58950908|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
30915496|NCT02137226|58950909|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
30915497|NCT02137226|58950905|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
30915498|NCT02137226|58950906|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
30915499|NCT02137226|58950907|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
30915500|NCT02137226|58950908|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
30915501|NCT02137226|58950909|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
30915502|NCT02137226|58950905|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
30915503|NCT02137226|58950906|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
30915504|NCT02137226|58950907|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
30915505|NCT02137226|58950908|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
30915506|NCT02137226|58950909|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
30915507|NCT02137226|58950905|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
30915508|NCT02137226|58950906|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
30915509|NCT02137226|58950907|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
30915510|NCT02137226|58950908|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
30915511|NCT02137226|58950909|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
30915512|NCT02137226|58950905|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
30915513|NCT02137226|58950906|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
30915514|NCT02137226|58950907|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
30915515|NCT02137226|58950908|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
30915516|NCT02137226|58950909|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
30623223|NCT00962091|58635045|FG005|Overall Study|Withdrawal by Subject|1|||
30623224|NCT00962091|58635046|FG006|Overall Study|Withdrawal by Subject|0|||
30623225|NCT00962091|58635040|FG000|Overall Study|Adverse Event|0|||
30753692|NCT00122382|58763401|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
30753693|NCT00122382|58763402|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
30753694|NCT00122382|58763400|FG000|Double-Blind Study|Withdrawal of Consent|7|||
30753695|NCT00122382|58763401|FG001|Double-Blind Study|Withdrawal of Consent|3|||
30753696|NCT00122382|58763402|FG002|Double-Blind Study|Withdrawal of Consent|0|||
30753697|NCT00122382|58763400|FG000|Double-Blind Study|Protocol Violation|1|||
30753698|NCT00122382|58763401|FG001|Double-Blind Study|Protocol Violation|0|||
30753699|NCT00122382|58763402|FG002|Double-Blind Study|Protocol Violation|0|||
30753700|NCT00122382|58763400|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
30825047|NCT02813694|58847204|FG001|Overall Study|Lost to Follow-up|1|||
30825048|NCT02813694|58847203|FG000|Overall Study|Death|3|||
30825049|NCT02813694|58847204|FG001|Overall Study|Death|3|||
30825050|NCT02813694|58847203|FG000|Overall Study|Randomized- did not receive study drug|2|||
30825051|NCT02813694|58847204|FG001|Overall Study|Randomized- did not receive study drug|0|||
30825052|NCT02813694|58847203|FG000|Overall Study|Patient hospitalized|1|||
30825053|NCT02813694|58847204|FG001|Overall Study|Patient hospitalized|0|||
30825054|NCT03103919|58847212|FG000|Overall Study|Adverse Event|2|||
30825055|NCT03103919|58847213|FG001|Overall Study|Adverse Event|2|||
30825056|NCT02810964|58847223|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
30825057|NCT02810964|58847224|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
30825058|NCT02810964|58847223|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
30825059|NCT02810964|58847224|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
30825060|NCT02810964|58847223|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
30915517|NCT02137226|58950905|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
30915518|NCT02137226|58950906|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
30915519|NCT02137226|58950907|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
30915520|NCT02137226|58950908|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
30915521|NCT02137226|58950909|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
30623226|NCT00962091|58635041|FG001|Overall Study|Adverse Event|0|||
30753701|NCT00122382|58763401|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
30825061|NCT02810964|58847224|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
30825062|NCT02810964|58847223|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
30915522|NCT02137226|58950905|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
30915523|NCT02137226|58950906|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
30915524|NCT02137226|58950907|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
30915525|NCT02137226|58950908|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
30915526|NCT02137226|58950909|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
30915527|NCT02137226|58950905|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
30915528|NCT02137226|58950906|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
30915529|NCT02137226|58950907|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
30915530|NCT02137226|58950908|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
30915531|NCT02137226|58950909|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
30915532|NCT02137226|58950905|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
30915533|NCT02137226|58950906|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
30915534|NCT02137226|58950907|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
30915535|NCT02137226|58950908|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
30915536|NCT02137226|58950909|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
30915537|NCT02137226|58950905|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
30915538|NCT02137226|58950906|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
30915539|NCT02137226|58950907|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
30915540|NCT02137226|58950908|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
30915541|NCT02137226|58950909|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
30915542|NCT02137226|58950905|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
30915543|NCT02137226|58950906|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
30915544|NCT02137226|58950907|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
30915545|NCT02137226|58950908|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
30915546|NCT02137226|58950909|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
30915547|NCT02137226|58950905|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
30915548|NCT02137226|58950906|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
30915549|NCT02137226|58950907|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
30915550|NCT02137226|58950908|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
30915551|NCT02137226|58950909|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
30915552|NCT01530334|58950917|FG000|Overall Study|Adverse Event|3|||
30915553|NCT01530334|58950917|FG000|Overall Study|unknown reason|1|||
30915554|NCT01530334|58950917|FG000|Overall Study|Progressive disease|47|||
30915555|NCT01570192|58950923|FG000|Overall Study|no qualifying organism|6|||
30915556|NCT01570192|58950924|FG001|Overall Study|no qualifying organism|12|||
30915557|NCT01570192|58950923|FG000|Overall Study|changed to palliative care|1|||
30915558|NCT01570192|58950924|FG001|Overall Study|changed to palliative care|0|||
30915559|NCT01570192|58950923|FG000|Overall Study|Physician Decision|0|||
30915560|NCT01570192|58950924|FG001|Overall Study|Physician Decision|1|||
30915561|NCT02136914|58950937|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
30915562|NCT02136914|58950938|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
30915563|NCT02136914|58950937|FG000|Overall Study|Withdrawal by Subject|3|||
30915564|NCT02136914|58950938|FG001|Overall Study|Withdrawal by Subject|10|||
30915565|NCT02136914|58950937|FG000|Overall Study|Subject Unwilling to Proceed|7|||
30915566|NCT02136914|58950938|FG001|Overall Study|Subject Unwilling to Proceed|2|||
30915567|NCT02136914|58950937|FG000|Overall Study|Lost to Follow-up|1|||
30915568|NCT02136914|58950938|FG001|Overall Study|Lost to Follow-up|1|||
30825063|NCT02810964|58847224|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
30825064|NCT03103763|58847233|FG000|Overall Study|Death|15|||
30825065|NCT03103763|58847234|FG001|Overall Study|Death|5|||
30825066|NCT03103763|58847235|FG002|Overall Study|Death|5|||
30825067|NCT03103763|58847233|FG000|Overall Study|Withdrawal by Subject|0|||
30825068|NCT03103763|58847234|FG001|Overall Study|Withdrawal by Subject|3|||
30825069|NCT03103763|58847235|FG002|Overall Study|Withdrawal by Subject|2|||
30825070|NCT03101267|58847259|FG000|Primary Study Period|Withdrawal by Subject|1|||
30825071|NCT03101267|58847260|FG001|Primary Study Period|Withdrawal by Subject|2|||
30825072|NCT03101267|58847261|FG002|Primary Study Period|Withdrawal by Subject|3|||
30825073|NCT03101267|58847259|FG000|Primary Study Period|Miscellaneous|2|||
30825074|NCT03101267|58847260|FG001|Primary Study Period|Miscellaneous|0|||
30825075|NCT03101267|58847261|FG002|Primary Study Period|Miscellaneous|0|||
30915569|NCT02136914|58950937|FG000|Overall Study|Did Not Receive Study Drug|2|||
30915570|NCT02136914|58950938|FG001|Overall Study|Did Not Receive Study Drug|0|||
30915571|NCT02136914|58950937|FG000|Overall Study|Lack of Efficacy|1|||
30915572|NCT02136914|58950938|FG001|Overall Study|Lack of Efficacy|0|||
30915573|NCT02136914|58950937|FG000|Overall Study|Death|0|||
30915574|NCT02136914|58950938|FG001|Overall Study|Death|1|||
30825076|NCT02810418|58847276|FG000|Arm A Dose Escalation|Adverse Event|2|||
30915575|NCT01530256|58950944|FG000|Overall Study|Death|2|||
30825077|NCT02810418|58847277|FG001|Arm A Dose Escalation|Adverse Event|1|||
30825078|NCT02810418|58847278|FG002|Arm A Dose Escalation|Adverse Event|0|||
30825079|NCT02810418|58847279|FG003|Arm A Dose Escalation|Adverse Event|0|||
30825080|NCT02810418|58847280|FG004|Arm A Dose Escalation|Adverse Event|0|||
30825081|NCT02810418|58847281|FG005|Arm A Dose Escalation|Adverse Event|0|||
30825082|NCT02810418|58847282|FG006|Arm A Dose Escalation|Adverse Event|0|||
30825083|NCT02810418|58847276|FG000|Dose Expansion|Adverse Event|0|||
30825084|NCT02810418|58847277|FG001|Dose Expansion|Adverse Event|1|||
30915576|NCT01554904|58950948|FG000|Overall Study|Withdrawal by Subject|3|||
30915577|NCT01554904|58950948|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
30915578|NCT01529632|58950954|FG000|Overall Study|Administrative problem|2|||
30915579|NCT01529632|58950955|FG001|Overall Study|Administrative problem|1|||
30915580|NCT01529632|58950954|FG000|Overall Study|Protocol Violation|0|||
30915581|NCT01529632|58950955|FG001|Overall Study|Protocol Violation|1|||
30915582|NCT01529632|58950954|FG000|Overall Study|Adverse Event|1|||
30915583|NCT01529632|58950955|FG001|Overall Study|Adverse Event|1|||
30915584|NCT01554514|58950961|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
30915585|NCT01554514|58950961|FG000|Overall Study|Physician Decision|1|||
30915586|NCT01553188|58950969|FG000|Overall Study|Patient choice|1|||
30915587|NCT01553188|58950970|FG001|Overall Study|Patient choice|0|||
30915588|NCT01553188|58950971|FG002|Overall Study|Patient choice|0|||
30915589|NCT01553188|58950972|FG003|Overall Study|Patient choice|0|||
30915590|NCT01553188|58950969|FG000|Overall Study|Intercurrent illness and adverse event|0|||
30915591|NCT01553188|58950970|FG001|Overall Study|Intercurrent illness and adverse event|1|||
30915592|NCT01553188|58950971|FG002|Overall Study|Intercurrent illness and adverse event|2|||
30915593|NCT01553188|58950972|FG003|Overall Study|Intercurrent illness and adverse event|0|||
30915594|NCT02175758|58950991|FG000|Treatment Phase|Lost to Follow-up|0|||
30915595|NCT02175758|58950992|FG001|Treatment Phase|Lost to Follow-up|1|||
30915596|NCT02175758|58950993|FG002|Treatment Phase|Lost to Follow-up|0|||
30915597|NCT02175758|58950994|FG003|Treatment Phase|Lost to Follow-up|0|||
30915598|NCT02175758|58950995|FG004|Treatment Phase|Lost to Follow-up|0|||
30915599|NCT02175758|58950996|FG005|Treatment Phase|Lost to Follow-up|0|||
30915600|NCT02175758|58950991|FG000|Treatment Phase|Adverse Event|0|||
30915601|NCT02175758|58950992|FG001|Treatment Phase|Adverse Event|0|||
30915602|NCT02175758|58950993|FG002|Treatment Phase|Adverse Event|0|||
30915603|NCT02175758|58950994|FG003|Treatment Phase|Adverse Event|0|||
30915604|NCT02175758|58950995|FG004|Treatment Phase|Adverse Event|1|||
30915605|NCT02175758|58950996|FG005|Treatment Phase|Adverse Event|0|||
30915606|NCT01529008|58951038|FG000|Bone Marrow Harvesting|Physician Decision|1|||
30915607|NCT01529008|58951039|FG001|Bone Marrow Harvesting|Physician Decision|1|||
30915608|NCT01529008|58951038|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
30915609|NCT01529008|58951039|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
30915610|NCT01529008|58951038|FG000|Treatment|Adverse Event|6|||
30915611|NCT01529008|58951039|FG001|Treatment|Adverse Event|0|||
30915612|NCT01529008|58951038|FG000|Treatment|Other|3|||
30825085|NCT02810418|58847278|FG002|Dose Expansion|Adverse Event|1|||
30825086|NCT02810418|58847279|FG003|Dose Expansion|Adverse Event|0|||
30825087|NCT02810418|58847280|FG004|Dose Expansion|Adverse Event|0|||
30825088|NCT02810418|58847281|FG005|Dose Expansion|Adverse Event|0|||
30825089|NCT02810418|58847282|FG006|Dose Expansion|Adverse Event|0|||
30825090|NCT02810418|58847276|FG000|Dose Expansion|Physician Decision|0|||
30825091|NCT02810418|58847277|FG001|Dose Expansion|Physician Decision|0|||
30825092|NCT02810418|58847278|FG002|Dose Expansion|Physician Decision|2|||
30825093|NCT02810418|58847279|FG003|Dose Expansion|Physician Decision|0|||
30825094|NCT02810418|58847280|FG004|Dose Expansion|Physician Decision|0|||
30825095|NCT02810418|58847281|FG005|Dose Expansion|Physician Decision|0|||
30825096|NCT02810418|58847282|FG006|Dose Expansion|Physician Decision|0|||
30825097|NCT02810418|58847276|FG000|Arm B Dose Escalation|Adverse Event|0|||
30825098|NCT02810418|58847277|FG001|Arm B Dose Escalation|Adverse Event|0|||
30915613|NCT01529008|58951039|FG001|Treatment|Other|1|||
30915614|NCT01529008|58951038|FG000|Efficacy Analysis|Protocol Violation|2|||
30915615|NCT01529008|58951039|FG001|Efficacy Analysis|Protocol Violation|0|||
30915616|NCT01529008|58951038|FG000|Efficacy Analysis|Physician Decision|0|||
30915617|NCT01529008|58951039|FG001|Efficacy Analysis|Physician Decision|1|||
30915618|NCT01529008|58951038|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
30915619|NCT01529008|58951039|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
30825099|NCT02810418|58847278|FG002|Arm B Dose Escalation|Adverse Event|0|||
30825100|NCT02810418|58847279|FG003|Arm B Dose Escalation|Adverse Event|0|||
30825101|NCT02810418|58847280|FG004|Arm B Dose Escalation|Adverse Event|1|||
30825102|NCT02810418|58847281|FG005|Arm B Dose Escalation|Adverse Event|2|||
30825103|NCT02810418|58847282|FG006|Arm B Dose Escalation|Adverse Event|0|||
30915620|NCT01599104|58951048|FG000|Overall Study|Withdrawal by Subject|1|||
30915621|NCT01599104|58951049|FG001|Overall Study|Withdrawal by Subject|1|||
30915622|NCT01599104|58951050|FG002|Overall Study|Withdrawal by Subject|2|||
30915623|NCT01599104|58951048|FG000|Overall Study|Technical Problems|1|||
30915624|NCT01599104|58951049|FG001|Overall Study|Technical Problems|0|||
30915625|NCT01599104|58951050|FG002|Overall Study|Technical Problems|0|||
30825104|NCT02810340|58847348|FG000|Overall Study|Withdrawal by Subject|1|||
30825105|NCT02810340|58847349|FG001|Overall Study|Withdrawal by Subject|0|||
30825106|NCT02810340|58847350|FG002|Overall Study|Withdrawal by Subject|0|||
30825107|NCT02810340|58847348|FG000|Overall Study|Incarceration|0|||
30825108|NCT02810340|58847349|FG001|Overall Study|Incarceration|1|||
30825109|NCT02810340|58847350|FG002|Overall Study|Incarceration|0|||
30825110|NCT02810340|58847348|FG000|Overall Study|Lost to Follow-up|0|||
30825111|NCT02810340|58847349|FG001|Overall Study|Lost to Follow-up|0|||
30825112|NCT02810340|58847350|FG002|Overall Study|Lost to Follow-up|1|||
30825113|NCT02817516|58847362|FG000|Overall Study|Other|0|||
30825114|NCT02817516|58847363|FG001|Overall Study|Other|0|||
30825115|NCT02817516|58847364|FG002|Overall Study|Other|1|||
30825116|NCT02817516|58847365|FG003|Overall Study|Other|0|||
30825117|NCT02928029|58847380|FG000|Overall Study|Withdrawal by Subject|0|||
30825118|NCT02928029|58847381|FG001|Overall Study|Withdrawal by Subject|1|||
30825119|NCT02928029|58847380|FG000|Overall Study|Radiological progression|1|||
30825120|NCT02928029|58847381|FG001|Overall Study|Radiological progression|0|||
30825121|NCT02928029|58847380|FG000|Overall Study|Clinical progression|1|||
30825122|NCT02928029|58847381|FG001|Overall Study|Clinical progression|2|||
30825123|NCT02928029|58847380|FG000|Overall Study|AE not related to clinical progression|1|||
30825124|NCT02928029|58847381|FG001|Overall Study|AE not related to clinical progression|1|||
30825125|NCT02806986|58847387|FG000|Treatment Stage 1|Adverse Event|1|||
30825126|NCT02806986|58847387|FG000|Treatment Stage 2|Adverse Event|3|||
30825127|NCT02806986|58847387|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
30825128|NCT03095651|58847403|FG000|Overall Study|Lost to Follow-up|1|||
30825129|NCT03095651|58847404|FG001|Overall Study|Lost to Follow-up|1|||
30825130|NCT03095651|58847405|FG002|Overall Study|Lost to Follow-up|0|||
30825131|NCT03095651|58847406|FG003|Overall Study|Lost to Follow-up|1|||
30825132|NCT03095651|58847407|FG004|Overall Study|Lost to Follow-up|0|||
30825133|NCT03095651|58847408|FG005|Overall Study|Lost to Follow-up|0|||
30825134|NCT03095651|58847409|FG006|Overall Study|Lost to Follow-up|0|||
30825135|NCT03095651|58847410|FG007|Overall Study|Lost to Follow-up|0|||
30825136|NCT03095651|58847403|FG000|Overall Study|Withdrawal by Subject|0|||
30825137|NCT03095651|58847404|FG001|Overall Study|Withdrawal by Subject|0|||
30825138|NCT03095651|58847405|FG002|Overall Study|Withdrawal by Subject|0|||
30825139|NCT03095651|58847406|FG003|Overall Study|Withdrawal by Subject|0|||
30825140|NCT03095651|58847407|FG004|Overall Study|Withdrawal by Subject|0|||
30825141|NCT03095651|58847408|FG005|Overall Study|Withdrawal by Subject|1|||
30825142|NCT03095651|58847409|FG006|Overall Study|Withdrawal by Subject|0|||
30825143|NCT03095651|58847410|FG007|Overall Study|Withdrawal by Subject|0|||
30825144|NCT02808312|58847433|FG000|Overall Study|Enrolled but Never Treated|0|||
30825145|NCT02808312|58847434|FG001|Overall Study|Enrolled but Never Treated|0|||
30825146|NCT02808312|58847435|FG002|Overall Study|Enrolled but Never Treated|1|||
30825147|NCT02808312|58847436|FG003|Overall Study|Enrolled but Never Treated|0|||
30825148|NCT02808312|58847437|FG004|Overall Study|Enrolled but Never Treated|0|||
30825149|NCT03099161|58847457|FG000|Overall Study|Adverse Event|0|||
30825150|NCT03099161|58847458|FG001|Overall Study|Adverse Event|0|||
30825151|NCT03099161|58847459|FG002|Overall Study|Adverse Event|2|||
30825152|NCT03099161|58847457|FG000|Overall Study|Physician Decision|2|||
30825153|NCT03099161|58847458|FG001|Overall Study|Physician Decision|0|||
30825154|NCT03099161|58847459|FG002|Overall Study|Physician Decision|0|||
30825155|NCT03099161|58847457|FG000|Overall Study|Progressive Disease|1|||
30825156|NCT03099161|58847458|FG001|Overall Study|Progressive Disease|4|||
30825157|NCT03099161|58847459|FG002|Overall Study|Progressive Disease|1|||
30825158|NCT03095027|58847467|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
30825159|NCT03095027|58847468|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
30825160|NCT04227197|58847476|FG000|Randomization|Protocol Violation|1|||
30825161|NCT04227197|58847477|FG001|Randomization|Protocol Violation|0|||
30825162|NCT04227197|58847476|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
30825163|NCT04227197|58847477|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
30825164|NCT04227197|58847476|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
30825165|NCT04227197|58847477|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
30825166|NCT04227197|58847476|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
30825167|NCT04227197|58847477|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
30825168|NCT04227197|58847476|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
30825169|NCT04227197|58847477|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
30825170|NCT04227197|58847476|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
30825171|NCT04227197|58847477|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
30825172|NCT04227197|58847476|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
30825173|NCT04227197|58847477|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
30915626|NCT01599104|58951048|FG000|Overall Study|Physician Decision|3|||
30915627|NCT01599104|58951049|FG001|Overall Study|Physician Decision|2|||
30915628|NCT01599104|58951050|FG002|Overall Study|Physician Decision|2|||
30915629|NCT01599104|58951048|FG000|Overall Study|Non-compliance with study treatment|0|||
30915630|NCT01599104|58951049|FG001|Overall Study|Non-compliance with study treatment|1|||
30915631|NCT01599104|58951050|FG002|Overall Study|Non-compliance with study treatment|0|||
30915632|NCT01599104|58951048|FG000|Overall Study|Lack of Efficacy|4|||
30915633|NCT01599104|58951049|FG001|Overall Study|Lack of Efficacy|4|||
30915634|NCT01599104|58951050|FG002|Overall Study|Lack of Efficacy|10|||
30915635|NCT01599104|58951048|FG000|Overall Study|Adverse Event|7|||
30915636|NCT01599104|58951049|FG001|Overall Study|Adverse Event|6|||
30915637|NCT01599104|58951050|FG002|Overall Study|Adverse Event|12|||
30915638|NCT01569568|58951060|FG000|Overall Study|Physician Decision|0|||
30915639|NCT01569568|58951061|FG001|Overall Study|Physician Decision|2|||
30915640|NCT02136680|58951069|FG000|Overall Study|No Longer Interested|1|||
30915641|NCT02136680|58951070|FG001|Overall Study|No Longer Interested|1|||
30825174|NCT03080935|58847488|FG000|Overall Study|Death|34|||
30825175|NCT03080935|58847489|FG001|Overall Study|Death|50|||
30825176|NCT03080935|58847488|FG000|Overall Study|Lost to Follow-up|5|||
30825177|NCT03080935|58847489|FG001|Overall Study|Lost to Follow-up|4|||
30825178|NCT03080935|58847488|FG000|Overall Study|Withdrawal by Subject|11|||
30825179|NCT03080935|58847489|FG001|Overall Study|Withdrawal by Subject|15|||
30825180|NCT02921789|58847501|FG000|Overall Study|Adverse Event|0|||
30825181|NCT02921789|58847502|FG001|Overall Study|Adverse Event|1|||
30825182|NCT02921789|58847501|FG000|Overall Study|Lost to Follow-up|1|||
30825183|NCT02921789|58847502|FG001|Overall Study|Lost to Follow-up|0|||
30825184|NCT02921789|58847501|FG000|Overall Study|Protocol Deviation|2|||
30825185|NCT02921789|58847502|FG001|Overall Study|Protocol Deviation|0|||
30825186|NCT02921789|58847501|FG000|Overall Study|Withdrawal by Subject|2|||
30825187|NCT02921789|58847502|FG001|Overall Study|Withdrawal by Subject|1|||
30825188|NCT02921789|58847501|FG000|Overall Study|Miscellaneous|3|||
30825189|NCT02921789|58847502|FG001|Overall Study|Miscellaneous|2|||
30825190|NCT02564900|58847523|FG000|Dose Escalation|Progressive disease per RECIST|2|||
30825191|NCT02564900|58847524|FG001|Dose Escalation|Progressive disease per RECIST|3|||
30825192|NCT02564900|58847525|FG002|Dose Escalation|Progressive disease per RECIST|3|||
30825193|NCT02564900|58847526|FG003|Dose Escalation|Progressive disease per RECIST|3|||
30825194|NCT02564900|58847527|FG004|Dose Escalation|Progressive disease per RECIST|3|||
30825195|NCT02564900|58847528|FG005|Dose Escalation|Progressive disease per RECIST|1|||
30825196|NCT02564900|58847529|FG006|Dose Escalation|Progressive disease per RECIST|0|||
30825197|NCT02564900|58847530|FG007|Dose Escalation|Progressive disease per RECIST|0|||
30825198|NCT02564900|58847531|FG008|Dose Escalation|Progressive disease per RECIST|0|||
30825199|NCT02564900|58847532|FG009|Dose Escalation|Progressive disease per RECIST|0|||
30825200|NCT02564900|58847533|FG010|Dose Escalation|Progressive disease per RECIST|0|||
30825201|NCT02564900|58847534|FG011|Dose Escalation|Progressive disease per RECIST|0|||
30825202|NCT02564900|58847535|FG012|Dose Escalation|Progressive disease per RECIST|0|||
30825203|NCT02564900|58847536|FG013|Dose Escalation|Progressive disease per RECIST|0|||
30825204|NCT02564900|58847537|FG014|Dose Escalation|Progressive disease per RECIST|0|||
30825205|NCT02564900|58847523|FG000|Dose Escalation|Ongoing|1|||
30825206|NCT02564900|58847524|FG001|Dose Escalation|Ongoing|0|||
30825207|NCT02564900|58847525|FG002|Dose Escalation|Ongoing|0|||
30825208|NCT02564900|58847526|FG003|Dose Escalation|Ongoing|2|||
30825209|NCT02564900|58847527|FG004|Dose Escalation|Ongoing|2|||
30825210|NCT02564900|58847528|FG005|Dose Escalation|Ongoing|2|||
30825211|NCT02564900|58847529|FG006|Dose Escalation|Ongoing|0|||
30825212|NCT02564900|58847530|FG007|Dose Escalation|Ongoing|0|||
30825213|NCT02564900|58847531|FG008|Dose Escalation|Ongoing|0|||
30825214|NCT02564900|58847532|FG009|Dose Escalation|Ongoing|0|||
30825215|NCT02564900|58847533|FG010|Dose Escalation|Ongoing|0|||
30825216|NCT02564900|58847534|FG011|Dose Escalation|Ongoing|0|||
30825217|NCT02564900|58847535|FG012|Dose Escalation|Ongoing|0|||
30825218|NCT02564900|58847536|FG013|Dose Escalation|Ongoing|0|||
30825219|NCT02564900|58847537|FG014|Dose Escalation|Ongoing|0|||
30825220|NCT02564900|58847523|FG000|Dose Escalation|Adverse Event|0|||
30915642|NCT02136680|58951069|FG000|Overall Study|No longer receiving care at clinic|3|||
30825221|NCT02564900|58847524|FG001|Dose Escalation|Adverse Event|0|||
30825222|NCT02564900|58847525|FG002|Dose Escalation|Adverse Event|0|||
30825223|NCT02564900|58847526|FG003|Dose Escalation|Adverse Event|1|||
30915643|NCT02136680|58951070|FG001|Overall Study|No longer receiving care at clinic|5|||
30825224|NCT02564900|58847527|FG004|Dose Escalation|Adverse Event|1|||
30915644|NCT02136680|58951069|FG000|Overall Study|Moved away|5|||
30825225|NCT02564900|58847528|FG005|Dose Escalation|Adverse Event|3|||
30825226|NCT02564900|58847529|FG006|Dose Escalation|Adverse Event|0|||
30915645|NCT02136680|58951070|FG001|Overall Study|Moved away|4|||
30825227|NCT02564900|58847530|FG007|Dose Escalation|Adverse Event|0|||
30915646|NCT02136680|58951069|FG000|Overall Study|Unable to schedule|17|||
30915647|NCT02136680|58951070|FG001|Overall Study|Unable to schedule|16|||
30915648|NCT02136680|58951069|FG000|Overall Study|Study ended before interview due|6|||
30915649|NCT02136680|58951070|FG001|Overall Study|Study ended before interview due|3|||
30915650|NCT01552954|58951078|FG000|Overall Study|Adverse Event|1|||
30915651|NCT01552954|58951079|FG001|Overall Study|Adverse Event|2|||
30915652|NCT01552954|58951078|FG000|Overall Study|Lost to Follow-up|1|||
30915653|NCT01552954|58951079|FG001|Overall Study|Lost to Follow-up|1|||
30915654|NCT01552954|58951078|FG000|Overall Study|Withdrawal by Subject|1|||
30915655|NCT01552954|58951079|FG001|Overall Study|Withdrawal by Subject|1|||
30915656|NCT01552954|58951078|FG000|Overall Study|Protocol Violation|1|||
30915657|NCT01552954|58951079|FG001|Overall Study|Protocol Violation|2|||
30915658|NCT01552954|58951078|FG000|Overall Study|diagnosed DM|1|||
30915659|NCT01552954|58951079|FG001|Overall Study|diagnosed DM|0|||
30915660|NCT02175368|58951085|FG000|Overall Study|Lost to Follow-up|1|||
30915661|NCT01518244|58951089|FG000|Overall Study|Adverse Event|3|||
30915662|NCT01552408|58951095|FG000|Overall Study|Lost to Follow-up|2|||
30915663|NCT01552408|58951096|FG001|Overall Study|Lost to Follow-up|0|||
30915664|NCT01552408|58951095|FG000|Overall Study|Relocation|0|||
30915665|NCT01552408|58951096|FG001|Overall Study|Relocation|1|||
30915666|NCT01552408|58951095|FG000|Overall Study|Withdrawal by Subject|2|||
30915667|NCT01552408|58951096|FG001|Overall Study|Withdrawal by Subject|1|||
30915668|NCT01528696|58951105|FG000|Overall Study|See detailed description|18|||
30915669|NCT01528696|58951106|FG001|Overall Study|See detailed description|19|||
30915670|NCT02174276|58951116|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
30915671|NCT02174276|58951117|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
30915672|NCT02174276|58951118|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
30915673|NCT02174276|58951119|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
30915674|NCT02174276|58951116|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
30915675|NCT02174276|58951117|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
30915676|NCT02174276|58951118|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
30915677|NCT02174276|58951119|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
30915678|NCT02174276|58951116|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
30825228|NCT02564900|58847531|FG008|Dose Escalation|Adverse Event|0|||
30825229|NCT02564900|58847532|FG009|Dose Escalation|Adverse Event|0|||
30825230|NCT02564900|58847533|FG010|Dose Escalation|Adverse Event|0|||
30825231|NCT02564900|58847534|FG011|Dose Escalation|Adverse Event|0|||
30825232|NCT02564900|58847535|FG012|Dose Escalation|Adverse Event|0|||
30825233|NCT02564900|58847536|FG013|Dose Escalation|Adverse Event|0|||
30825234|NCT02564900|58847537|FG014|Dose Escalation|Adverse Event|0|||
30825235|NCT02564900|58847523|FG000|Dose Expansion|Progressive disease per RECIST|0|||
30825236|NCT02564900|58847524|FG001|Dose Expansion|Progressive disease per RECIST|0|||
30825237|NCT02564900|58847525|FG002|Dose Expansion|Progressive disease per RECIST|0|||
30825238|NCT02564900|58847526|FG003|Dose Expansion|Progressive disease per RECIST|0|||
30825239|NCT02564900|58847527|FG004|Dose Expansion|Progressive disease per RECIST|0|||
30825240|NCT02564900|58847528|FG005|Dose Expansion|Progressive disease per RECIST|0|||
30825241|NCT02564900|58847529|FG006|Dose Expansion|Progressive disease per RECIST|19|||
30825242|NCT02564900|58847530|FG007|Dose Expansion|Progressive disease per RECIST|17|||
30825243|NCT02564900|58847531|FG008|Dose Expansion|Progressive disease per RECIST|8|||
30825244|NCT02564900|58847532|FG009|Dose Expansion|Progressive disease per RECIST|16|||
30825245|NCT02564900|58847533|FG010|Dose Expansion|Progressive disease per RECIST|13|||
30825246|NCT02564900|58847534|FG011|Dose Expansion|Progressive disease per RECIST|19|||
30825247|NCT02564900|58847535|FG012|Dose Expansion|Progressive disease per RECIST|10|||
30825248|NCT02564900|58847536|FG013|Dose Expansion|Progressive disease per RECIST|13|||
30825249|NCT02564900|58847537|FG014|Dose Expansion|Progressive disease per RECIST|11|||
30825250|NCT02564900|58847523|FG000|Dose Expansion|Clinical progression|0|||
30825251|NCT02564900|58847524|FG001|Dose Expansion|Clinical progression|0|||
30825252|NCT02564900|58847525|FG002|Dose Expansion|Clinical progression|0|||
30825253|NCT02564900|58847526|FG003|Dose Expansion|Clinical progression|0|||
30825254|NCT02564900|58847527|FG004|Dose Expansion|Clinical progression|0|||
30825255|NCT02564900|58847528|FG005|Dose Expansion|Clinical progression|0|||
30915679|NCT02174276|58951117|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
30915680|NCT02174276|58951118|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
30915681|NCT02174276|58951119|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
30915682|NCT02174276|58951116|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
30915683|NCT02174276|58951117|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
30915684|NCT02174276|58951118|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
30915685|NCT02174276|58951119|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
30915686|NCT02174276|58951116|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
30915687|NCT02174276|58951117|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
30915688|NCT02174276|58951118|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
30915689|NCT02174276|58951119|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
30915690|NCT02174276|58951116|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
30915691|NCT02174276|58951117|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
30915692|NCT02174276|58951118|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
30915693|NCT02174276|58951119|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
30915694|NCT01528072|58951129|FG000|Overall Study|Withdrawal by Subject|5|||
30915695|NCT01528072|58951129|FG000|Overall Study|Physician Decision|1|||
30915696|NCT01528072|58951129|FG000|Overall Study|Determined not eligible by AEAC|1|||
30915697|NCT01528072|58951129|FG000|Overall Study|Missed Visit|2|||
30915698|NCT01528072|58951129|FG000|Overall Study|Lost to Follow-up|5|||
30915699|NCT01528072|58951129|FG000|Overall Study|Explanted|2|||
30915700|NCT01528072|58951129|FG000|Overall Study|Site Closure|4|||
30915701|NCT01528072|58951129|FG000|Overall Study|Death|2|||
30915702|NCT01528072|58951129|FG000|Overall Study|Early Termination of Study|52|||
30915703|NCT01527682|58951133|FG000|Overall Study|Protocol Violation|8|||
30915704|NCT01527370|58951137|FG000|Overall Study|Withdrawal by Subject|4|||
30915705|NCT01527370|58951137|FG000|Overall Study|Physician Decision|1|||
30915706|NCT01527370|58951137|FG000|Overall Study|Death|1|||
30915707|NCT01527292|58951143|FG000|Overall Study|Physician Decision|0|||
30915708|NCT01527292|58951144|FG001|Overall Study|Physician Decision|3|||
30915709|NCT01516216|58951152|FG000|Overall Study|Adverse Event|2|||
30915710|NCT01516216|58951153|FG001|Overall Study|Adverse Event|4|||
30915711|NCT01516216|58951152|FG000|Overall Study|Disease Progression|38|||
30915712|NCT01516216|58951153|FG001|Overall Study|Disease Progression|34|||
30915713|NCT01516216|58951152|FG000|Overall Study|Withdrawal by Subject|9|||
30915714|NCT01516216|58951153|FG001|Overall Study|Withdrawal by Subject|11|||
30915715|NCT01516216|58951152|FG000|Overall Study|Potentially Curative Resection|6|||
30915716|NCT01516216|58951153|FG001|Overall Study|Potentially Curative Resection|12|||
30915717|NCT01516216|58951152|FG000|Overall Study|Nonadherence|2|||
30915718|NCT01516216|58951153|FG001|Overall Study|Nonadherence|3|||
30915719|NCT01516216|58951152|FG000|Overall Study|Physician Decision|6|||
30915720|NCT01516216|58951153|FG001|Overall Study|Physician Decision|3|||
30915721|NCT01516216|58951152|FG000|Overall Study|Prolonged Treatment Delay|5|||
30915722|NCT01516216|58951153|FG001|Overall Study|Prolonged Treatment Delay|1|||
30915723|NCT01516216|58951152|FG000|Overall Study|Intercurrent Illness|1|||
30915724|NCT01516216|58951153|FG001|Overall Study|Intercurrent Illness|0|||
30915725|NCT01516216|58951152|FG000|Overall Study|Death|1|||
30915726|NCT01516216|58951153|FG001|Overall Study|Death|1|||
30915727|NCT01950819|58951163|FG000|Overall Study|Graft Loss|35|||
30915728|NCT01950819|58951164|FG001|Overall Study|Graft Loss|30|||
30915729|NCT01950819|58951163|FG000|Overall Study|Death|29|||
30915730|NCT01950819|58951164|FG001|Overall Study|Death|34|||
30915731|NCT01950819|58951163|FG000|Overall Study|Subject / Gardian decision|54|||
30915732|NCT01950819|58951164|FG001|Overall Study|Subject / Gardian decision|51|||
30915733|NCT01950819|58951163|FG000|Overall Study|technical problems|2|||
30915734|NCT01950819|58951164|FG001|Overall Study|technical problems|0|||
30915735|NCT01950819|58951163|FG000|Overall Study|Pregnancy|0|||
30915736|NCT01950819|58951164|FG001|Overall Study|Pregnancy|2|||
30915737|NCT01950819|58951163|FG000|Overall Study|Lost to Follow-up|9|||
30915738|NCT01950819|58951164|FG001|Overall Study|Lost to Follow-up|17|||
30915739|NCT01514422|58951170|FG000|Overall Study|Lost to Follow-up|1|||
30915740|NCT01513330|58951174|FG000|SenSura Mio First,|Adverse Event|2|||
30915741|NCT01513330|58951175|FG001|SenSura Mio First,|Adverse Event|0|||
30915742|NCT01513330|58951174|FG000|SenSura Mio First,|Lack of Efficacy|0|||
30915743|NCT01513330|58951175|FG001|SenSura Mio First,|Lack of Efficacy|1|||
30915744|NCT01513330|58951174|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
30915745|NCT01513330|58951175|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
30915746|NCT01513330|58951174|FG000|SenSura Mio First,|Other|1|||
30623227|NCT00962091|58635042|FG002|Overall Study|Adverse Event|0|||
30915747|NCT01513330|58951175|FG001|SenSura Mio First,|Other|0|||
30915748|NCT01513330|58951174|FG000|Standard Care First,|Lack of Efficacy|2|||
30915749|NCT01513330|58951175|FG001|Standard Care First,|Lack of Efficacy|2|||
30915750|NCT01513330|58951174|FG000|Standard Care First,|Withdrawal by Subject|1|||
30915751|NCT01513330|58951175|FG001|Standard Care First,|Withdrawal by Subject|2|||
30915752|NCT01513330|58951174|FG000|Standard Care First,|Other|1|||
30915753|NCT01513330|58951175|FG001|Standard Care First,|Other|0|||
30915754|NCT01524796|58951181|FG000|Overall Study|Adverse Event|13|||
30915755|NCT01524796|58951181|FG000|Overall Study|Lack of Efficacy|3|||
30915756|NCT01524796|58951181|FG000|Overall Study|Lost to Follow-up|1|||
30915757|NCT01524796|58951181|FG000|Overall Study|The price|1|||
30915758|NCT01524796|58951181|FG000|Overall Study|Withdrawal by Subject|4|||
30915759|NCT01524796|58951181|FG000|Overall Study|Move|1|||
30915760|NCT01524796|58951181|FG000|Overall Study|Deterioration of pains|1|||
30915761|NCT01524796|58951181|FG000|Overall Study|Gall stone surgery|1|||
30915762|NCT01524796|58951181|FG000|Overall Study|Nervous about confidentiality|1|||
30915763|NCT01524796|58951181|FG000|Overall Study|Switch to carbamazapine|1|||
30915764|NCT01524796|58951181|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
30915765|NCT01547728|58951185|FG000|Overall Study|Change in procedure and equipment|1|||
30915766|NCT01547728|58951185|FG000|Overall Study|Drug not ready for subject|1|||
30915767|NCT01547728|58951185|FG000|Overall Study|Screen failure|39|||
30915768|NCT01523392|58951191|FG000|Treatment Period 1|Withdrawal by Subject|2|||
30915769|NCT01523392|58951192|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30915770|NCT01523392|58951191|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
30915771|NCT01523392|58951192|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
30915772|NCT01523392|58951191|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
30915773|NCT01523392|58951192|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
30915774|NCT01512160|58951204|FG000|Overall Study|Lost to Follow-up|1|||
30915775|NCT01512160|58951205|FG001|Overall Study|Lost to Follow-up|0|||
30915776|NCT01512160|58951206|FG002|Overall Study|Lost to Follow-up|0|||
30915777|NCT01512160|58951207|FG003|Overall Study|Lost to Follow-up|0|||
30915778|NCT01512160|58951204|FG000|Overall Study|Withdrawal by Subject|1|||
30915779|NCT01512160|58951205|FG001|Overall Study|Withdrawal by Subject|0|||
30915780|NCT01512160|58951206|FG002|Overall Study|Withdrawal by Subject|0|||
30915781|NCT01512160|58951207|FG003|Overall Study|Withdrawal by Subject|1|||
30915782|NCT01546168|58951220|FG000|Overall Study|Lost to Follow-up|1|||
30915783|NCT01546168|58951221|FG001|Overall Study|Lost to Follow-up|0|||
30915784|NCT01546168|58951220|FG000|Overall Study|Withdrawal by Subject|1|||
30915785|NCT01546168|58951221|FG001|Overall Study|Withdrawal by Subject|0|||
30915786|NCT01546168|58951220|FG000|Overall Study|ineligible after signing consent|2|||
30915787|NCT01546168|58951221|FG001|Overall Study|ineligible after signing consent|0|||
30915788|NCT01901289|58951227|FG000|Overall Study|Death|32|||
30915789|NCT01901289|58951227|FG000|Overall Study|Lost to Follow-up|16|||
30915790|NCT01901289|58951227|FG000|Overall Study|Withdrawal by Subject|35|||
30915791|NCT01901289|58951227|FG000|Overall Study|Other type of endpoint met|2|||
30915792|NCT01950741|58951231|FG000|Overall Study|Lost to Follow-up|1|||
30915793|NCT01950741|58951231|FG000|Overall Study|Death|1|||
30915794|NCT01950741|58951231|FG000|Overall Study|Withdrawal by Subject|1|||
30915795|NCT01950273|58951237|FG000|Overall Study|Protocol Violation|1|||
30915796|NCT01950273|58951238|FG001|Overall Study|Protocol Violation|0|||
30915797|NCT01950273|58951237|FG000|Overall Study|Withdrawal by Subject|2|||
30915798|NCT01950273|58951238|FG001|Overall Study|Withdrawal by Subject|0|||
30915799|NCT01950273|58951237|FG000|Overall Study|Other not defined above|1|||
30915800|NCT01950273|58951238|FG001|Overall Study|Other not defined above|0|||
30915801|NCT01919307|58951244|FG000|Overall Study|Withdrawal by Subject|9|||
30915802|NCT01919229|58951251|FG000|Overall Study|Subject/guardian decision|0|||
30915803|NCT01919229|58951252|FG001|Overall Study|Subject/guardian decision|0|||
30623228|NCT00962091|58635043|FG003|Overall Study|Adverse Event|0|||
30825256|NCT02564900|58847529|FG006|Dose Expansion|Clinical progression|5|||
30825257|NCT02564900|58847530|FG007|Dose Expansion|Clinical progression|12|||
30825258|NCT02564900|58847531|FG008|Dose Expansion|Clinical progression|0|||
30825259|NCT02564900|58847532|FG009|Dose Expansion|Clinical progression|3|||
30825260|NCT02564900|58847533|FG010|Dose Expansion|Clinical progression|2|||
30825261|NCT02564900|58847534|FG011|Dose Expansion|Clinical progression|0|||
30825262|NCT02564900|58847535|FG012|Dose Expansion|Clinical progression|1|||
30825263|NCT02564900|58847536|FG013|Dose Expansion|Clinical progression|3|||
30825264|NCT02564900|58847537|FG014|Dose Expansion|Clinical progression|1|||
30825265|NCT02564900|58847523|FG000|Dose Expansion|Adverse Event|0|||
30825266|NCT02564900|58847524|FG001|Dose Expansion|Adverse Event|0|||
30825267|NCT02564900|58847525|FG002|Dose Expansion|Adverse Event|0|||
30825268|NCT02564900|58847526|FG003|Dose Expansion|Adverse Event|0|||
30825269|NCT02564900|58847527|FG004|Dose Expansion|Adverse Event|0|||
30825270|NCT02564900|58847528|FG005|Dose Expansion|Adverse Event|0|||
30825271|NCT02564900|58847529|FG006|Dose Expansion|Adverse Event|9|||
30915804|NCT01919229|58951253|FG002|Overall Study|Subject/guardian decision|1|||
30915805|NCT01901055|58951263|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
30915806|NCT01901055|58951264|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
30915807|NCT01901055|58951263|FG000|Randomization But Not Titrated|Physician Decision|0|||
30915808|NCT01901055|58951264|FG001|Randomization But Not Titrated|Physician Decision|1|||
30915809|NCT01901055|58951263|FG000|Started Protocol to Week 6|Physician Decision|2|||
30825272|NCT02564900|58847530|FG007|Dose Expansion|Adverse Event|22|||
30825273|NCT02564900|58847531|FG008|Dose Expansion|Adverse Event|0|||
30825274|NCT02564900|58847532|FG009|Dose Expansion|Adverse Event|11|||
30825275|NCT02564900|58847533|FG010|Dose Expansion|Adverse Event|0|||
30623229|NCT00962091|58635044|FG004|Overall Study|Adverse Event|0|||
30915810|NCT01901055|58951264|FG001|Started Protocol to Week 6|Physician Decision|1|||
30915811|NCT01901055|58951263|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
30825276|NCT02564900|58847534|FG011|Dose Expansion|Adverse Event|5|||
30825277|NCT02564900|58847535|FG012|Dose Expansion|Adverse Event|2|||
30825278|NCT02564900|58847536|FG013|Dose Expansion|Adverse Event|2|||
30825279|NCT02564900|58847537|FG014|Dose Expansion|Adverse Event|1|||
30825280|NCT02564900|58847523|FG000|Dose Expansion|Ongoing|0|||
30915812|NCT01901055|58951264|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
30915813|NCT01901055|58951263|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
30915814|NCT01901055|58951264|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
30915815|NCT01901055|58951263|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
30915816|NCT01901055|58951264|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
30915817|NCT01901055|58951263|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
30915818|NCT01901055|58951264|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
30915819|NCT01901055|58951263|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
30915820|NCT01901055|58951264|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
30915821|NCT01901055|58951263|FG000|Week 24|Withdrawal by Subject|13|||
30915822|NCT01901055|58951264|FG001|Week 24|Withdrawal by Subject|19|||
30915823|NCT01901055|58951263|FG000|Week 24|Physician Decision|1|||
30915824|NCT01901055|58951264|FG001|Week 24|Physician Decision|0|||
30915825|NCT01901055|58951263|FG000|Week 36|Withdrawal by Subject|0|||
30915826|NCT01901055|58951264|FG001|Week 36|Withdrawal by Subject|5|||
30915827|NCT01511536|58951276|FG000|Phase 1|Other|0|||
30915828|NCT01511536|58951277|FG001|Phase 1|Other|1|||
30915829|NCT01511536|58951278|FG002|Phase 1|Other|0|||
30915830|NCT01511536|58951276|FG000|Phase 2|Other|0|||
30915831|NCT01511536|58951277|FG001|Phase 2|Other|0|||
30915832|NCT01511536|58951278|FG002|Phase 2|Other|9|||
30915833|NCT01890759|58951288|FG000|Overall Study|Protocol Violation|0|||
30915834|NCT01890759|58951289|FG001|Overall Study|Protocol Violation|2|||
30915835|NCT01890759|58951288|FG000|Overall Study|Lost to Follow-up|0|||
30915836|NCT01890759|58951289|FG001|Overall Study|Lost to Follow-up|2|||
30915837|NCT01890759|58951288|FG000|Overall Study|Withdrawal by Subject|2|||
30915838|NCT01890759|58951289|FG001|Overall Study|Withdrawal by Subject|8|||
30915839|NCT01900899|58951297|FG000|Overall Study|Withdrawal by Subject|7|||
30915840|NCT01900899|58951298|FG001|Overall Study|Withdrawal by Subject|1|||
30915841|NCT01900899|58951297|FG000|Overall Study|Migrated from study area|2|||
30915842|NCT01900899|58951298|FG001|Overall Study|Migrated from study area|0|||
30915843|NCT01510912|58951304|FG000|Overall Study|Adverse Event|99|||
30825281|NCT02564900|58847524|FG001|Dose Expansion|Ongoing|0|||
30825282|NCT02564900|58847525|FG002|Dose Expansion|Ongoing|0|||
30825283|NCT02564900|58847526|FG003|Dose Expansion|Ongoing|0|||
30825284|NCT02564900|58847527|FG004|Dose Expansion|Ongoing|0|||
30825285|NCT02564900|58847528|FG005|Dose Expansion|Ongoing|0|||
30825286|NCT02564900|58847529|FG006|Dose Expansion|Ongoing|9|||
30825287|NCT02564900|58847530|FG007|Dose Expansion|Ongoing|10|||
30825288|NCT02564900|58847531|FG008|Dose Expansion|Ongoing|11|||
30825289|NCT02564900|58847532|FG009|Dose Expansion|Ongoing|3|||
30825290|NCT02564900|58847533|FG010|Dose Expansion|Ongoing|0|||
30825291|NCT02564900|58847534|FG011|Dose Expansion|Ongoing|0|||
30825292|NCT02564900|58847535|FG012|Dose Expansion|Ongoing|4|||
30825293|NCT02564900|58847536|FG013|Dose Expansion|Ongoing|0|||
30825294|NCT02564900|58847537|FG014|Dose Expansion|Ongoing|6|||
30825295|NCT02564900|58847523|FG000|Dose Expansion|Death|0|||
30825296|NCT02564900|58847524|FG001|Dose Expansion|Death|0|||
30825297|NCT02564900|58847525|FG002|Dose Expansion|Death|0|||
30915844|NCT01510912|58951304|FG000|Overall Study|Lack of Efficacy|12|||
30915845|NCT01510912|58951304|FG000|Overall Study|Non-compliance with trial drug|23|||
30915846|NCT01510912|58951304|FG000|Overall Study|Withdrawal by Subject|49|||
30825298|NCT02564900|58847526|FG003|Dose Expansion|Death|0|||
30825299|NCT02564900|58847527|FG004|Dose Expansion|Death|0|||
30915847|NCT01510912|58951304|FG000|Overall Study|Physician Decision|1|||
30825300|NCT02564900|58847528|FG005|Dose Expansion|Death|0|||
30825301|NCT02564900|58847529|FG006|Dose Expansion|Death|1|||
30825302|NCT02564900|58847530|FG007|Dose Expansion|Death|0|||
30825303|NCT02564900|58847531|FG008|Dose Expansion|Death|0|||
30915848|NCT01510912|58951304|FG000|Overall Study|Protocol Violation|27|||
30915849|NCT01510912|58951304|FG000|Overall Study|Lost to Follow-up|26|||
30915850|NCT01510912|58951304|FG000|Overall Study|Other, including joint replacement|5|||
30915851|NCT01510756|58951308|FG000|Overall Study|Death|1|||
30915852|NCT01510756|58951308|FG000|Overall Study|Lack of Efficacy|2|||
30915853|NCT01510756|58951308|FG000|Overall Study|Physician Decision|1|||
30915854|NCT01522456|58951312|FG000|Overall Study|Adverse Event|2|||
30915855|NCT01522456|58951312|FG000|Overall Study|Lost to Follow-up|2|||
30915856|NCT01522456|58951312|FG000|Overall Study|Withdrawal by Subject|2|||
30915857|NCT01522456|58951312|FG000|Overall Study|Pregnancy|1|||
30915858|NCT01522456|58951312|FG000|Overall Study|Tolerability Assessment|1|||
30915859|NCT01545934|58951325|FG000|Overall Study|Withdrawal by Subject|4|||
30915860|NCT01545934|58951326|FG001|Overall Study|Withdrawal by Subject|3|||
30915861|NCT01545934|58951325|FG000|Overall Study|Lost to Follow-up|1|||
30915862|NCT01545934|58951326|FG001|Overall Study|Lost to Follow-up|0|||
30915863|NCT01521364|58951333|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
30915864|NCT01521364|58951333|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
30915865|NCT01545388|58951347|FG000|Overall Study|Adverse Event|2|||
30915866|NCT01545388|58951348|FG001|Overall Study|Adverse Event|4|||
30915867|NCT01545388|58951349|FG002|Overall Study|Adverse Event|1|||
30915868|NCT01545388|58951347|FG000|Overall Study|Lack of Efficacy|3|||
30915869|NCT01545388|58951348|FG001|Overall Study|Lack of Efficacy|2|||
30915870|NCT01545388|58951349|FG002|Overall Study|Lack of Efficacy|5|||
30915871|NCT01545388|58951347|FG000|Overall Study|Participant moved or relocated|1|||
30915872|NCT01545388|58951348|FG001|Overall Study|Participant moved or relocated|0|||
30915873|NCT01545388|58951349|FG002|Overall Study|Participant moved or relocated|0|||
30915874|NCT01545388|58951347|FG000|Overall Study|Withdrawal by Subject|1|||
30915875|NCT01545388|58951348|FG001|Overall Study|Withdrawal by Subject|4|||
30915876|NCT01545388|58951349|FG002|Overall Study|Withdrawal by Subject|2|||
30915877|NCT01545388|58951347|FG000|Overall Study|Other|1|||
30915878|NCT01545388|58951348|FG001|Overall Study|Other|1|||
30915879|NCT01545388|58951349|FG002|Overall Study|Other|0|||
30915880|NCT01545076|58951357|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
30915881|NCT01545076|58951358|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
30915882|NCT01545076|58951359|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
30915883|NCT01545076|58951360|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
30915884|NCT01545076|58951361|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
30915885|NCT01545076|58951357|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
30915886|NCT01545076|58951358|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
30915887|NCT01545076|58951359|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
30915888|NCT01545076|58951360|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
30915889|NCT01545076|58951361|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
30825304|NCT02564900|58847532|FG009|Dose Expansion|Death|0|||
30825305|NCT02564900|58847533|FG010|Dose Expansion|Death|1|||
30825306|NCT02564900|58847534|FG011|Dose Expansion|Death|0|||
30825307|NCT02564900|58847535|FG012|Dose Expansion|Death|1|||
30825308|NCT02564900|58847536|FG013|Dose Expansion|Death|1|||
30825309|NCT02564900|58847537|FG014|Dose Expansion|Death|0|||
30825310|NCT02564900|58847523|FG000|Dose Expansion|Withdrawal by Subject|0|||
30825311|NCT02564900|58847524|FG001|Dose Expansion|Withdrawal by Subject|0|||
30825312|NCT02564900|58847525|FG002|Dose Expansion|Withdrawal by Subject|0|||
30825313|NCT02564900|58847526|FG003|Dose Expansion|Withdrawal by Subject|0|||
30825314|NCT02564900|58847527|FG004|Dose Expansion|Withdrawal by Subject|0|||
30825315|NCT02564900|58847528|FG005|Dose Expansion|Withdrawal by Subject|0|||
30825316|NCT02564900|58847529|FG006|Dose Expansion|Withdrawal by Subject|4|||
30825317|NCT02564900|58847530|FG007|Dose Expansion|Withdrawal by Subject|0|||
30825318|NCT02564900|58847531|FG008|Dose Expansion|Withdrawal by Subject|0|||
30825319|NCT02564900|58847532|FG009|Dose Expansion|Withdrawal by Subject|0|||
30825320|NCT02564900|58847533|FG010|Dose Expansion|Withdrawal by Subject|1|||
30825321|NCT02564900|58847534|FG011|Dose Expansion|Withdrawal by Subject|0|||
30825322|NCT02564900|58847535|FG012|Dose Expansion|Withdrawal by Subject|0|||
30825323|NCT02564900|58847536|FG013|Dose Expansion|Withdrawal by Subject|1|||
30825324|NCT02564900|58847537|FG014|Dose Expansion|Withdrawal by Subject|1|||
30825325|NCT02564900|58847523|FG000|Dose Expansion|Other|0|||
30825326|NCT02564900|58847524|FG001|Dose Expansion|Other|0|||
30825327|NCT02564900|58847525|FG002|Dose Expansion|Other|0|||
30825328|NCT02564900|58847526|FG003|Dose Expansion|Other|0|||
30825329|NCT02564900|58847527|FG004|Dose Expansion|Other|0|||
30915890|NCT01545076|58951357|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
30915891|NCT01545076|58951358|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
30915892|NCT01545076|58951359|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
30623230|NCT00962091|58635045|FG005|Overall Study|Adverse Event|0|||
30825330|NCT02564900|58847528|FG005|Dose Expansion|Other|0|||
30825331|NCT02564900|58847529|FG006|Dose Expansion|Other|1|||
30825332|NCT02564900|58847530|FG007|Dose Expansion|Other|0|||
30825333|NCT02564900|58847531|FG008|Dose Expansion|Other|1|||
30825334|NCT02564900|58847532|FG009|Dose Expansion|Other|0|||
30915893|NCT01545076|58951360|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
30915894|NCT01545076|58951361|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
30915895|NCT01545076|58951357|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
30915896|NCT01545076|58951358|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
30915897|NCT01545076|58951359|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
30915898|NCT01545076|58951360|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
30915899|NCT01545076|58951361|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
30915900|NCT01545076|58951357|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
30915901|NCT01545076|58951358|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
30825335|NCT02564900|58847533|FG010|Dose Expansion|Other|0|||
30825336|NCT02564900|58847534|FG011|Dose Expansion|Other|0|||
30825337|NCT02564900|58847535|FG012|Dose Expansion|Other|0|||
30915902|NCT01545076|58951359|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
30915903|NCT01545076|58951360|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
30915904|NCT01545076|58951361|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
30915905|NCT01545076|58951357|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
30915906|NCT01545076|58951358|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
30915907|NCT01545076|58951359|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
30915908|NCT01545076|58951360|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
30915909|NCT01545076|58951361|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
30915910|NCT01545076|58951357|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
30915911|NCT01545076|58951358|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
30915912|NCT01545076|58951359|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
30915913|NCT01545076|58951360|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
30915914|NCT01545076|58951361|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
30915915|NCT01545076|58951357|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
30915916|NCT01545076|58951358|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
30915917|NCT01545076|58951359|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
30915918|NCT01545076|58951360|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
30915919|NCT01545076|58951361|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
30915920|NCT01545076|58951357|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
30915921|NCT01545076|58951358|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
30915922|NCT01545076|58951359|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
30915923|NCT01545076|58951360|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
30915924|NCT01545076|58951361|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
30915925|NCT01544920|58951376|FG000|Overall Study|Adverse Event|0|||
30915926|NCT01544920|58951377|FG001|Overall Study|Adverse Event|3|||
30915927|NCT01544920|58951376|FG000|Overall Study|Death|0|||
30915928|NCT01544920|58951377|FG001|Overall Study|Death|1|||
30915929|NCT01544920|58951376|FG000|Overall Study|Lost to Follow-up|11|||
30915930|NCT01544920|58951377|FG001|Overall Study|Lost to Follow-up|12|||
30915931|NCT01544920|58951376|FG000|Overall Study|Protocol Violation|0|||
30825338|NCT02564900|58847536|FG013|Dose Expansion|Other|0|||
30825339|NCT02564900|58847537|FG014|Dose Expansion|Other|1|||
30915932|NCT01544920|58951377|FG001|Overall Study|Protocol Violation|2|||
30915933|NCT01544920|58951376|FG000|Overall Study|Physician Decision|4|||
30915934|NCT01544920|58951377|FG001|Overall Study|Physician Decision|1|||
30915935|NCT01544920|58951376|FG000|Overall Study|Withdrawal by Subject|4|||
30915936|NCT01544920|58951377|FG001|Overall Study|Withdrawal by Subject|4|||
30915937|NCT01509664|58951387|FG000|Overall Study|Lost to Follow-up|15|||
30915938|NCT01509664|58951388|FG001|Overall Study|Lost to Follow-up|21|||
30915939|NCT01543828|58951396|FG000|Treatment 2|Lost to Follow-up|1|||
30915940|NCT01543828|58951397|FG001|Treatment 2|Lost to Follow-up|0|||
30915941|NCT01520506|58951405|FG000|Overall Study|Missed Visit|4|||
30825340|NCT02564900|58847523|FG000|Dose Expansion|Did not receive treatment|0|||
30825341|NCT02564900|58847524|FG001|Dose Expansion|Did not receive treatment|0|||
30825342|NCT02564900|58847525|FG002|Dose Expansion|Did not receive treatment|0|||
30825343|NCT02564900|58847526|FG003|Dose Expansion|Did not receive treatment|0|||
30825344|NCT02564900|58847527|FG004|Dose Expansion|Did not receive treatment|0|||
30825345|NCT02564900|58847528|FG005|Dose Expansion|Did not receive treatment|0|||
30825346|NCT02564900|58847529|FG006|Dose Expansion|Did not receive treatment|1|||
30825347|NCT02564900|58847530|FG007|Dose Expansion|Did not receive treatment|1|||
30825348|NCT02564900|58847531|FG008|Dose Expansion|Did not receive treatment|0|||
30825349|NCT02564900|58847532|FG009|Dose Expansion|Did not receive treatment|0|||
30825350|NCT02564900|58847533|FG010|Dose Expansion|Did not receive treatment|0|||
30825351|NCT02564900|58847534|FG011|Dose Expansion|Did not receive treatment|0|||
30825352|NCT02564900|58847535|FG012|Dose Expansion|Did not receive treatment|0|||
30915942|NCT01520506|58951405|FG000|Overall Study|Lost to Follow-up|1|||
30915943|NCT01520506|58951405|FG000|Overall Study|Withdrawal by Subject|1|||
30915944|NCT01519960|58951412|FG000|Overall Study|Withdrawal from the study|26|||
30915945|NCT01519960|58951413|FG001|Overall Study|Withdrawal from the study|22|||
30915946|NCT01519960|58951414|FG002|Overall Study|Withdrawal from the study|5|||
30915947|NCT01543204|58951430|FG000|Overall Study|Non-compliance|1|||
30825353|NCT02564900|58847536|FG013|Dose Expansion|Did not receive treatment|0|||
30825354|NCT02564900|58847537|FG014|Dose Expansion|Did not receive treatment|1|||
30825355|NCT03364673|58847587|FG000|Overall Study|Withdrawal by Subject|2|||
30825356|NCT03364673|58847587|FG000|Overall Study|Injury unrelated to study|3|||
30825357|NCT03097289|58847591|FG000|Overall Study|Adverse Event|1|||
30825358|NCT03097289|58847591|FG000|Overall Study|Equipment failure|2|||
30825359|NCT03097289|58847591|FG000|Overall Study|Collected platelet product unusable|3|||
30825360|NCT02419742|58847613|FG000|Overall Study|Adverse Event|2|||
30915948|NCT01543204|58951430|FG000|Overall Study|Adverse Event|1|||
30915949|NCT01543204|58951430|FG000|Overall Study|Withdrawal by Subject|4|||
30915950|NCT01543204|58951430|FG000|Overall Study|Requirement for Alternative Therapy|1|||
30915951|NCT01543204|58951430|FG000|Overall Study|Lost to Follow-up|1|||
30825361|NCT02419742|58847614|FG001|Overall Study|Adverse Event|0|||
30915952|NCT01488994|58951440|FG000|Overall Study|Withdrawal by Subject|0|||
30915953|NCT01488994|58951441|FG001|Overall Study|Withdrawal by Subject|1|||
30915954|NCT01508650|58951454|FG000|Overall Study|Lost to Follow-up|0|||
30915955|NCT01508650|58951455|FG001|Overall Study|Lost to Follow-up|3|||
30915956|NCT01488448|58951463|FG000|Overall Study|Withdrawal by Subject|3|||
30915957|NCT01488448|58951464|FG001|Overall Study|Withdrawal by Subject|1|||
30915958|NCT01488448|58951463|FG000|Overall Study|Adverse Event|9|||
30915959|NCT01488448|58951464|FG001|Overall Study|Adverse Event|4|||
30915960|NCT01488448|58951463|FG000|Overall Study|Physician Decision|4|||
30915961|NCT01488448|58951464|FG001|Overall Study|Physician Decision|9|||
30915962|NCT01488448|58951463|FG000|Overall Study|Protocol Violation|4|||
30915963|NCT01488448|58951464|FG001|Overall Study|Protocol Violation|3|||
30915964|NCT01518946|58951474|FG000|Open-label Phase|Other|4|||
30915965|NCT01518946|58951475|FG001|Open-label Phase|Other|0|||
30915966|NCT01518946|58951476|FG002|Open-label Phase|Other|0|||
30915967|NCT01518946|58951474|FG000|Randomized Phase (First Intervention)|Other|0|||
30915968|NCT01518946|58951475|FG001|Randomized Phase (First Intervention)|Other|1|||
30915969|NCT01518946|58951476|FG002|Randomized Phase (First Intervention)|Other|0|||
30915970|NCT01488370|58951486|FG000|Overall Study|Protocol Violation|0|||
30915971|NCT01488370|58951487|FG001|Overall Study|Protocol Violation|1|||
30915972|NCT01488370|58951488|FG002|Overall Study|Protocol Violation|1|||
30915973|NCT01518322|58951496|FG000|Overall Study|FeNO measurement was missing|13|||
30915974|NCT01507246|58951507|FG000|Overall Study|Required different surgical procedures|2|||
30915975|NCT01507246|58951508|FG001|Overall Study|Required different surgical procedures|1|||
30915976|NCT01507090|58951517|FG000|Overall Study|incomplete dataset|18|||
30915977|NCT01464346|58951531|FG000|Overall Study|Withdrawal by Subject|0|||
30915978|NCT01464346|58951532|FG001|Overall Study|Withdrawal by Subject|0|||
30915979|NCT01464346|58951533|FG002|Overall Study|Withdrawal by Subject|1|||
30915980|NCT01487200|58951560|FG000|Overall Study|Withdrawal by Subject|0|||
30915981|NCT01487200|58951561|FG001|Overall Study|Withdrawal by Subject|1|||
30915982|NCT01487200|58951562|FG002|Overall Study|Withdrawal by Subject|0|||
30623231|NCT00962091|58635046|FG006|Overall Study|Adverse Event|1|||
30825362|NCT02419742|58847613|FG000|Overall Study|Disease Progression|0|||
30825363|NCT02419742|58847614|FG001|Overall Study|Disease Progression|1|||
30825364|NCT02419742|58847613|FG000|Overall Study|Withdrew Consent|2|||
30825365|NCT02419742|58847614|FG001|Overall Study|Withdrew Consent|1|||
30825366|NCT02419742|58847613|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
30825367|NCT02419742|58847614|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
30825368|NCT02898077|58847622|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
30825369|NCT02898077|58847623|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
30825370|NCT02898077|58847622|FG000|Overall Study|Lost to Follow-up|4|||
30825371|NCT02898077|58847623|FG001|Overall Study|Lost to Follow-up|3|||
30825372|NCT02898077|58847622|FG000|Overall Study|Physician Decision|0|||
30825373|NCT02898077|58847623|FG001|Overall Study|Physician Decision|2|||
30825374|NCT02898077|58847622|FG000|Overall Study|Sponsor Decision|32|||
30825375|NCT02898077|58847623|FG001|Overall Study|Sponsor Decision|13|||
30825376|NCT02898077|58847622|FG000|Overall Study|Withdrawal by Subject|6|||
30825377|NCT02898077|58847623|FG001|Overall Study|Withdrawal by Subject|3|||
30825378|NCT02898077|58847622|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
30825379|NCT02898077|58847623|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
30825380|NCT02898077|58847622|FG000|Overall Study|Ended extension period|3|||
30915983|NCT01487200|58951563|FG003|Overall Study|Withdrawal by Subject|0|||
30915984|NCT01463878|58951576|FG000|Overall Study|no longer met criteria for tube feed|2|||
30915985|NCT01463878|58951577|FG001|Overall Study|no longer met criteria for tube feed|2|||
30915986|NCT01505608|58951585|FG000|Phase I|Lack of Efficacy|0|||
30915987|NCT01505608|58951586|FG001|Phase I|Lack of Efficacy|4|||
30915988|NCT01505608|58951585|FG000|Phase I|Adverse Event|0|||
30915989|NCT01505608|58951586|FG001|Phase I|Adverse Event|1|||
30915990|NCT01505608|58951585|FG000|Phase I|Withdrawal by Subject|0|||
30915991|NCT01505608|58951586|FG001|Phase I|Withdrawal by Subject|1|||
30915992|NCT01505608|58951585|FG000|Phase II|Lack of Efficacy|2|||
30915993|NCT01505608|58951586|FG001|Phase II|Lack of Efficacy|1|||
30623232|NCT01163916|58635073|FG000|Overall Study|Withdrawal by Subject|2|||
30825381|NCT02898077|58847623|FG001|Overall Study|Ended extension period|0|||
30825382|NCT03097133|58847631|FG000|Overall Study|Lost to Follow-up|3|||
30825383|NCT03097133|58847632|FG001|Overall Study|Lost to Follow-up|2|||
30825384|NCT03097133|58847631|FG000|Overall Study|Withdrawal by Subject|2|||
30825385|NCT03097133|58847632|FG001|Overall Study|Withdrawal by Subject|5|||
30915994|NCT01505608|58951585|FG000|Phase II|Protocol Violation|0|||
30915995|NCT01505608|58951586|FG001|Phase II|Protocol Violation|1|||
30915996|NCT01486966|58951597|FG000|Overall Study|Adverse Event|0|||
30915997|NCT01486966|58951598|FG001|Overall Study|Adverse Event|1|||
30915998|NCT01486966|58951597|FG000|Overall Study|Withdrawal by Subject|0|||
30915999|NCT01486966|58951598|FG001|Overall Study|Withdrawal by Subject|1|||
30916000|NCT01900665|58951606|FG000|Placebo Controlled Period|Death|9|||
30916001|NCT01900665|58951607|FG001|Placebo Controlled Period|Death|16|||
30916002|NCT01900665|58951606|FG000|Placebo Controlled Period|Adverse Event|48|||
30916003|NCT01900665|58951607|FG001|Placebo Controlled Period|Adverse Event|39|||
30916004|NCT01900665|58951606|FG000|Placebo Controlled Period|Protocol Violation|1|||
30916005|NCT01900665|58951607|FG001|Placebo Controlled Period|Protocol Violation|7|||
30916006|NCT01900665|58951606|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
30916007|NCT01900665|58951607|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
30916008|NCT01900665|58951606|FG000|Placebo Controlled Period|Physician Decision|11|||
30916009|NCT01900665|58951607|FG001|Placebo Controlled Period|Physician Decision|7|||
30916010|NCT01900665|58951606|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
30916011|NCT01900665|58951607|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
30916012|NCT01900665|58951606|FG000|Placebo Controlled Period|Caregiver Decision|33|||
30916013|NCT01900665|58951607|FG001|Placebo Controlled Period|Caregiver Decision|41|||
30916014|NCT01900665|58951606|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
30916015|NCT01900665|58951607|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
30916016|NCT01900665|58951606|FG000|Open Label Period|Adverse Event|16|||
30916017|NCT01900665|58951607|FG001|Open Label Period|Adverse Event|20|||
30916018|NCT01900665|58951606|FG000|Open Label Period|Death|5|||
30916019|NCT01900665|58951607|FG001|Open Label Period|Death|6|||
30916020|NCT01900665|58951606|FG000|Open Label Period|Lost to Follow-up|1|||
30916021|NCT01900665|58951607|FG001|Open Label Period|Lost to Follow-up|1|||
30916022|NCT01900665|58951606|FG000|Open Label Period|Parent/Caregiver Decision|33|||
30916023|NCT01900665|58951607|FG001|Open Label Period|Parent/Caregiver Decision|34|||
30916024|NCT01900665|58951606|FG000|Open Label Period|Physician Decision|4|||
30916025|NCT01900665|58951607|FG001|Open Label Period|Physician Decision|4|||
30916026|NCT01900665|58951606|FG000|Open Label Period|Protocol Violation|0|||
30916027|NCT01900665|58951607|FG001|Open Label Period|Protocol Violation|1|||
30916028|NCT01900665|58951606|FG000|Open Label Period|Sponsor Decision|802|||
30916029|NCT01900665|58951607|FG001|Open Label Period|Sponsor Decision|765|||
30916030|NCT01900665|58951606|FG000|Open Label Period|Withdrawal by Subject|20|||
30916031|NCT01900665|58951607|FG001|Open Label Period|Withdrawal by Subject|28|||
30916032|NCT01900431|58951618|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
30916033|NCT01900431|58951619|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
30916034|NCT01900431|58951620|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
30916035|NCT01900431|58951618|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
30916036|NCT01900431|58951619|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
30825386|NCT03097133|58847631|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
30825387|NCT03097133|58847632|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
30825388|NCT03097133|58847631|FG000|Overall Study|Other|3|||
30825389|NCT03097133|58847632|FG001|Overall Study|Other|2|||
30825390|NCT03097133|58847631|FG000|Overall Study|Adverse Event|1|||
30825391|NCT03097133|58847632|FG001|Overall Study|Adverse Event|0|||
30825392|NCT03889639|58847646|FG000|Overall Study|Withdrawal by Subject|0|||
30825393|NCT03889639|58847647|FG001|Overall Study|Withdrawal by Subject|0|||
30825394|NCT03889639|58847648|FG002|Overall Study|Withdrawal by Subject|0|||
30825395|NCT03889639|58847649|FG003|Overall Study|Withdrawal by Subject|0|||
30825396|NCT03889639|58847650|FG004|Overall Study|Withdrawal by Subject|0|||
30825397|NCT03889639|58847651|FG005|Overall Study|Withdrawal by Subject|0|||
30825398|NCT03889639|58847652|FG006|Overall Study|Withdrawal by Subject|0|||
30825399|NCT03889639|58847653|FG007|Overall Study|Withdrawal by Subject|1|||
30825400|NCT03265145|58847676|FG000|Overall Study|Protocol Violation|2|||
30825401|NCT03265145|58847677|FG001|Overall Study|Protocol Violation|0|||
30825402|NCT03265145|58847676|FG000|Overall Study|Adverse Event|1|||
30916037|NCT01900431|58951620|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
30916038|NCT01900431|58951618|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
30916039|NCT01900431|58951619|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
30916040|NCT01900431|58951620|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
30916041|NCT01900431|58951618|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
30825403|NCT03265145|58847677|FG001|Overall Study|Adverse Event|0|||
30825404|NCT03265145|58847676|FG000|Overall Study|Withdrawal by Subject|23|||
30825405|NCT03265145|58847677|FG001|Overall Study|Withdrawal by Subject|19|||
30916042|NCT01900431|58951619|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
30916043|NCT01900431|58951620|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
30916044|NCT01900431|58951618|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
30916045|NCT01900431|58951619|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
30916046|NCT01900431|58951620|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
30916047|NCT01900431|58951618|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
30916048|NCT01900431|58951619|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
30916049|NCT01900431|58951620|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
30916050|NCT01900431|58951618|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
30916051|NCT01900431|58951619|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
30916052|NCT01900431|58951620|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
30916053|NCT01900431|58951618|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
30916054|NCT01900431|58951619|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
30916055|NCT01900431|58951620|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
30916056|NCT01900431|58951618|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
30916057|NCT01900431|58951619|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
30916058|NCT01900431|58951620|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
30916059|NCT01948791|58951628|FG000|Overall Study|Adverse Event|12|||
30916060|NCT01948791|58951628|FG000|Overall Study|Lack of Efficacy|3|||
30916061|NCT01948791|58951628|FG000|Overall Study|Protocol Violation|2|||
30916062|NCT01948791|58951628|FG000|Overall Study|Withdrawal by Subject|5|||
30916063|NCT01948791|58951628|FG000|Overall Study|Lost to Follow-up|6|||
30916064|NCT01948791|58951628|FG000|Overall Study|Management issues|1|||
30916065|NCT01948791|58951628|FG000|Overall Study|Others|7|||
30916066|NCT01948791|58951628|FG000|Overall Study|Screening failure|35|||
30916067|NCT01899729|58951637|FG000|Overall Study|Adverse Event|1|||
30916068|NCT01899729|58951638|FG001|Overall Study|Adverse Event|0|||
30916069|NCT01899729|58951639|FG002|Overall Study|Adverse Event|0|||
30916070|NCT01899729|58951640|FG003|Overall Study|Adverse Event|0|||
30916071|NCT01899729|58951641|FG004|Overall Study|Adverse Event|1|||
30916072|NCT01899729|58951637|FG000|Overall Study|Withdrawal by Subject|1|||
30916073|NCT01899729|58951638|FG001|Overall Study|Withdrawal by Subject|2|||
30916074|NCT01899729|58951639|FG002|Overall Study|Withdrawal by Subject|0|||
30916075|NCT01899729|58951640|FG003|Overall Study|Withdrawal by Subject|0|||
30916076|NCT01899729|58951641|FG004|Overall Study|Withdrawal by Subject|0|||
30916077|NCT01899729|58951637|FG000|Overall Study|Lack of Efficacy|0|||
30916078|NCT01899729|58951638|FG001|Overall Study|Lack of Efficacy|0|||
30916079|NCT01899729|58951639|FG002|Overall Study|Lack of Efficacy|2|||
30916080|NCT01899729|58951640|FG003|Overall Study|Lack of Efficacy|0|||
30916081|NCT01899729|58951641|FG004|Overall Study|Lack of Efficacy|1|||
30916082|NCT01898091|58951655|FG000|Overall Study|Lost to Follow-up|1|||
30916083|NCT01898091|58951656|FG001|Overall Study|Lost to Follow-up|1|||
30916084|NCT01898091|58951655|FG000|Overall Study|Withdrawal by Subject|1|||
30916085|NCT01898091|58951656|FG001|Overall Study|Withdrawal by Subject|5|||
30916086|NCT01947855|58951665|FG000|Overall Study|Withdrawal by Subject|1|||
30825406|NCT03265145|58847676|FG000|Overall Study|Death|12|||
30825407|NCT03265145|58847677|FG001|Overall Study|Death|12|||
30825408|NCT03265145|58847676|FG000|Overall Study|Lost to Follow-up|13|||
30825409|NCT03265145|58847677|FG001|Overall Study|Lost to Follow-up|9|||
30825410|NCT03265145|58847676|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
30825411|NCT03265145|58847677|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
30825412|NCT03265145|58847676|FG000|Overall Study|Switched back to previous medication|1|||
30825413|NCT03265145|58847677|FG001|Overall Study|Switched back to previous medication|0|||
30825414|NCT03265145|58847676|FG000|Overall Study|Did not want to take medication|1|||
30825415|NCT03265145|58847677|FG001|Overall Study|Did not want to take medication|0|||
30825416|NCT03265145|58847676|FG000|Overall Study|Subject could not afford medication|0|||
30825417|NCT03265145|58847677|FG001|Overall Study|Subject could not afford medication|1|||
30825418|NCT03265145|58847676|FG000|Overall Study|Site closed|2|||
30825419|NCT03265145|58847677|FG001|Overall Study|Site closed|3|||
30825420|NCT03265145|58847676|FG000|Overall Study|Incorrectly randomized|16|||
30825421|NCT03265145|58847677|FG001|Overall Study|Incorrectly randomized|6|||
30825422|NCT03265145|58847676|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
30825423|NCT03265145|58847677|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
30825424|NCT03265145|58847676|FG000|Overall Study|Physician Decision|0|||
30916087|NCT01947855|58951666|FG001|Overall Study|Withdrawal by Subject|0|||
30916088|NCT01947855|58951667|FG002|Overall Study|Withdrawal by Subject|0|||
30916089|NCT01888965|58951675|FG000|Overall Study|Adverse Event|5|||
30916090|NCT01888965|58951675|FG000|Overall Study|Lack of Efficacy|4|||
30916091|NCT01888497|58951679|FG000|Washout Period 1|Withdrawal by Subject|0|||
30916092|NCT01888497|58951680|FG001|Washout Period 1|Withdrawal by Subject|0|||
30825425|NCT03265145|58847677|FG001|Overall Study|Physician Decision|3|||
30825426|NCT03265145|58847676|FG000|Overall Study|Subject transferred to another facility|0|||
30825427|NCT03265145|58847677|FG001|Overall Study|Subject transferred to another facility|1|||
30825428|NCT05674344|58847688|FG000|Overall Study|Screen Fail|21|||
30825429|NCT05674344|58847688|FG000|Overall Study|Incomplete study procedures|3|||
30825438|NCT04424641|58847763|FG000|Overall Study|Death|1|||
30825439|NCT04424641|58847764|FG001|Overall Study|Death|2|||
30825440|NCT04424641|58847765|FG002|Overall Study|Death|3|||
30825441|NCT04424641|58847766|FG003|Overall Study|Death|0|||
30825442|NCT04424641|58847767|FG004|Overall Study|Death|3|||
30825443|NCT04424641|58847768|FG005|Overall Study|Death|0|||
30825444|NCT04424641|58847769|FG006|Overall Study|Death|1|||
30825445|NCT04424641|58847770|FG007|Overall Study|Death|2|||
30825446|NCT04424641|58847763|FG000|Overall Study|Sponsor decision|0|||
30825447|NCT04424641|58847764|FG001|Overall Study|Sponsor decision|2|||
30825448|NCT04424641|58847765|FG002|Overall Study|Sponsor decision|3|||
30825449|NCT04424641|58847766|FG003|Overall Study|Sponsor decision|7|||
30825450|NCT04424641|58847767|FG004|Overall Study|Sponsor decision|2|||
30825451|NCT04424641|58847768|FG005|Overall Study|Sponsor decision|2|||
30825452|NCT04424641|58847769|FG006|Overall Study|Sponsor decision|3|||
30825453|NCT04424641|58847770|FG007|Overall Study|Sponsor decision|4|||
30825454|NCT04424641|58847763|FG000|Overall Study|Withdrawal by Subject|0|||
30825455|NCT04424641|58847764|FG001|Overall Study|Withdrawal by Subject|0|||
30825456|NCT04424641|58847765|FG002|Overall Study|Withdrawal by Subject|0|||
30825457|NCT04424641|58847766|FG003|Overall Study|Withdrawal by Subject|0|||
30825458|NCT04424641|58847767|FG004|Overall Study|Withdrawal by Subject|1|||
30825459|NCT04424641|58847768|FG005|Overall Study|Withdrawal by Subject|0|||
30825460|NCT04424641|58847769|FG006|Overall Study|Withdrawal by Subject|0|||
30825461|NCT04424641|58847770|FG007|Overall Study|Withdrawal by Subject|0|||
30825462|NCT04424641|58847763|FG000|Overall Study|Other|0|||
30825463|NCT04424641|58847764|FG001|Overall Study|Other|0|||
30825464|NCT04424641|58847765|FG002|Overall Study|Other|1|||
30825465|NCT04424641|58847766|FG003|Overall Study|Other|0|||
30825466|NCT04424641|58847767|FG004|Overall Study|Other|0|||
30825467|NCT04424641|58847768|FG005|Overall Study|Other|0|||
30825468|NCT04424641|58847769|FG006|Overall Study|Other|0|||
30825469|NCT04424641|58847770|FG007|Overall Study|Other|0|||
30825470|NCT04276090|58847799|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
30825471|NCT04276090|58847800|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
30825472|NCT04105842|58847810|FG000|Overall Study|Withdrawal by Subject|2|||
30825473|NCT04088734|58847817|FG000|Overall Study|Other, Not Specified|5|||
30825474|NCT03868787|58847840|FG000|Overall Study|Withdrawal by Subject|2|||
30825475|NCT03868787|58847841|FG001|Overall Study|Withdrawal by Subject|1|||
30825476|NCT03457701|58847872|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
30825477|NCT03457701|58847873|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
30825478|NCT03457701|58847872|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
30825479|NCT03457701|58847873|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
30825480|NCT03317405|58847949|FG000|Overall Study|Withdrawal by Subject|1|||
30825481|NCT03317405|58847950|FG001|Overall Study|Withdrawal by Subject|0|||
30825482|NCT03317405|58847951|FG002|Overall Study|Withdrawal by Subject|0|||
30825483|NCT03317405|58847949|FG000|Overall Study|Physician Decision|0|||
30825484|NCT03317405|58847950|FG001|Overall Study|Physician Decision|0|||
30916093|NCT01888497|58951681|FG002|Washout Period 1|Withdrawal by Subject|1|||
30916094|NCT01888497|58951682|FG003|Washout Period 1|Withdrawal by Subject|1|||
30916095|NCT01888497|58951679|FG000|Washout Period 2|Adverse Event|0|||
30916096|NCT01888497|58951680|FG001|Washout Period 2|Adverse Event|0|||
30825485|NCT03317405|58847951|FG002|Overall Study|Physician Decision|1|||
30825486|NCT03317405|58847949|FG000|Overall Study|Surgery Rescheduled|0|||
30825487|NCT03317405|58847950|FG001|Overall Study|Surgery Rescheduled|1|||
30825488|NCT03317405|58847951|FG002|Overall Study|Surgery Rescheduled|0|||
30825489|NCT02694978|58848026|FG000|Overall Study|Adverse Event|10|||
30825490|NCT02694978|58848027|FG001|Overall Study|Adverse Event|9|||
30825491|NCT02694978|58848026|FG000|Overall Study|Withdrawal by Subject|22|||
30825492|NCT02694978|58848027|FG001|Overall Study|Withdrawal by Subject|19|||
30825493|NCT02694978|58848026|FG000|Overall Study|Lost to Follow-up|14|||
30916097|NCT01888497|58951681|FG002|Washout Period 2|Adverse Event|0|||
30825494|NCT02694978|58848027|FG001|Overall Study|Lost to Follow-up|17|||
30916098|NCT01888497|58951682|FG003|Washout Period 2|Adverse Event|1|||
30916099|NCT01888497|58951679|FG000|Washout Period 2|Withdrawal by Subject|0|||
30916100|NCT01888497|58951680|FG001|Washout Period 2|Withdrawal by Subject|0|||
30916101|NCT01888497|58951681|FG002|Washout Period 2|Withdrawal by Subject|0|||
30916102|NCT01888497|58951682|FG003|Washout Period 2|Withdrawal by Subject|1|||
30916103|NCT01505530|58951695|FG000|Overall Study|Progressive Disease|19|||
30916104|NCT01505530|58951696|FG001|Overall Study|Progressive Disease|17|||
30916105|NCT01505530|58951697|FG002|Overall Study|Progressive Disease|18|||
30916106|NCT01505530|58951695|FG000|Overall Study|Adverse Event|1|||
30916107|NCT01505530|58951696|FG001|Overall Study|Adverse Event|1|||
30916108|NCT01505530|58951697|FG002|Overall Study|Adverse Event|0|||
30916109|NCT01505530|58951695|FG000|Overall Study|Withdrawal by Subject|7|||
30916110|NCT01505530|58951696|FG001|Overall Study|Withdrawal by Subject|8|||
30916111|NCT01505530|58951697|FG002|Overall Study|Withdrawal by Subject|6|||
30916112|NCT01505530|58951695|FG000|Overall Study|Physician Decision|6|||
30916113|NCT01505530|58951696|FG001|Overall Study|Physician Decision|2|||
30623233|NCT01163916|58635074|FG001|Overall Study|Withdrawal by Subject|0|||
30825495|NCT02694978|58848026|FG000|Overall Study|Death|4|||
30825496|NCT02694978|58848027|FG001|Overall Study|Death|1|||
30825497|NCT02694978|58848026|FG000|Overall Study|Other-Decision of Participant|6|||
30825498|NCT02694978|58848027|FG001|Overall Study|Other-Decision of Participant|1|||
30825499|NCT02694978|58848026|FG000|Overall Study|Other-Investigator's decision|1|||
30825500|NCT02694978|58848027|FG001|Overall Study|Other-Investigator's decision|0|||
30825501|NCT02694978|58848026|FG000|Overall Study|Other-Unable to be reached|0|||
30825502|NCT02694978|58848027|FG001|Overall Study|Other-Unable to be reached|1|||
30825503|NCT02694978|58848026|FG000|Overall Study|Other-Protocol noncompliant|2|||
30825504|NCT02694978|58848027|FG001|Overall Study|Other-Protocol noncompliant|1|||
30825505|NCT02694978|58848026|FG000|Overall Study|Other-Personal reasons|3|||
30825506|NCT02694978|58848027|FG001|Overall Study|Other-Personal reasons|3|||
30825507|NCT02694978|58848026|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
30825508|NCT02694978|58848027|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
30825509|NCT02563002|58848035|FG000|Overall Study|Death|62|||
30825510|NCT02563002|58848036|FG001|Overall Study|Death|75|||
30825511|NCT02563002|58848035|FG000|Overall Study|Lost to Follow-up|1|||
30825512|NCT02563002|58848036|FG001|Overall Study|Lost to Follow-up|0|||
30825513|NCT02563002|58848035|FG000|Overall Study|Withdrawal by Subject|0|||
30825514|NCT02563002|58848036|FG001|Overall Study|Withdrawal by Subject|9|||
30825515|NCT02563002|58848035|FG000|Overall Study|Ongoing|90|||
30825516|NCT02563002|58848036|FG001|Overall Study|Ongoing|70|||
30825517|NCT02454933|58848047|FG000|Overall Study|Progressive disease|7|||
30825518|NCT02454933|58848048|FG001|Overall Study|Progressive disease|5|||
30825519|NCT02454933|58848047|FG000|Overall Study|Adverse Event|1|||
30825520|NCT02454933|58848048|FG001|Overall Study|Adverse Event|1|||
30825521|NCT02454933|58848047|FG000|Overall Study|Withdrawal by Subject|0|||
30825522|NCT02454933|58848048|FG001|Overall Study|Withdrawal by Subject|2|||
30825523|NCT02430480|58848053|FG000|Overall Study|Death|1|||
30825524|NCT02430480|58848053|FG000|Overall Study|Anesthesia concerns|1|||
30825525|NCT02430480|58848053|FG000|Overall Study|Progressed on treatment|1|||
30825526|NCT01967888|58848067|FG000|Overall Study|Lost to Follow-up|6|||
30825527|NCT01967888|58848068|FG001|Overall Study|Lost to Follow-up|4|||
30825528|NCT01967888|58848067|FG000|Overall Study|Withdrawal by Subject|1|||
30825529|NCT01967888|58848068|FG001|Overall Study|Withdrawal by Subject|1|||
30825530|NCT01967888|58848067|FG000|Overall Study|Did Not Have Transplant|1|||
30825531|NCT01967888|58848068|FG001|Overall Study|Did Not Have Transplant|0|||
30753702|NCT00122382|58763402|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
30753703|NCT00122382|58763400|FG000|Double-Blind Study|Randomized but not treated|0|||
30753704|NCT00122382|58763401|FG001|Double-Blind Study|Randomized but not treated|2|||
30753705|NCT00122382|58763402|FG002|Double-Blind Study|Randomized but not treated|0|||
30753706|NCT00122382|58763400|FG000|Open-Label Study|Adverse Event|0|||
30753707|NCT00122382|58763401|FG001|Open-Label Study|Adverse Event|0|||
30753708|NCT00122382|58763402|FG002|Open-Label Study|Adverse Event|11|||
30753709|NCT00122382|58763400|FG000|Open-Label Study|Death|0|||
30753710|NCT00122382|58763401|FG001|Open-Label Study|Death|0|||
30825532|NCT01967888|58848067|FG000|Overall Study|Research visit not done, data recorded|1|||
30825533|NCT01967888|58848068|FG001|Overall Study|Research visit not done, data recorded|0|||
30825534|NCT01967888|58848067|FG000|Overall Study|Subject excluded after randomization|1|||
30825535|NCT01967888|58848068|FG001|Overall Study|Subject excluded after randomization|0|||
30825536|NCT01967888|58848067|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
30825537|NCT01967888|58848068|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
30825538|NCT01967888|58848067|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
30916114|NCT01505530|58951697|FG002|Overall Study|Physician Decision|5|||
30916115|NCT01505530|58951695|FG000|Overall Study|Sponsor Decision|1|||
30916116|NCT01505530|58951696|FG001|Overall Study|Sponsor Decision|8|||
30753711|NCT00122382|58763402|FG002|Open-Label Study|Death|2|||
30753712|NCT00122382|58763400|FG000|Open-Label Study|Lack of Efficacy|0|||
30916117|NCT01505530|58951697|FG002|Overall Study|Sponsor Decision|7|||
30916118|NCT01505530|58951695|FG000|Overall Study|Death|7|||
30916119|NCT01505530|58951696|FG001|Overall Study|Death|6|||
30916120|NCT01505530|58951697|FG002|Overall Study|Death|5|||
30916121|NCT01505530|58951695|FG000|Overall Study|entry criteria not met|0|||
30916122|NCT01505530|58951696|FG001|Overall Study|entry criteria not met|1|||
30916123|NCT01505530|58951697|FG002|Overall Study|entry criteria not met|0|||
30916124|NCT01485796|58951705|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
30916125|NCT01485796|58951705|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
30916126|NCT01485796|58951705|FG000|Period 2: Epoch 2|Adverse Event|3|||
30916127|NCT01485796|58951705|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
30916128|NCT01485796|58951705|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
30916129|NCT01485796|58951705|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
30916130|NCT01485796|58951705|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
30916131|NCT01485796|58951705|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
30916132|NCT01505374|58951713|FG000|Overall Study|Lost to Follow-up|1|||
30916133|NCT01505374|58951714|FG001|Overall Study|Lost to Follow-up|0|||
30916134|NCT01897233|58951721|FG000|Part B (24 Weeks)|Adverse Event|1|||
30916135|NCT01897233|58951721|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
30916136|NCT01897233|58951721|FG000|Part B (24 Weeks)|Physician Decision|1|||
30916137|NCT01887717|58951731|FG000|Overall Study|Withdrawal by Subject|1|||
30916138|NCT01887717|58951732|FG001|Overall Study|Withdrawal by Subject|7|||
30916139|NCT01887717|58951731|FG000|Overall Study|Physician Decision|0|||
30916140|NCT01887717|58951732|FG001|Overall Study|Physician Decision|2|||
30916141|NCT01887717|58951731|FG000|Overall Study|Administrative reasons|5|||
30916142|NCT01887717|58951732|FG001|Overall Study|Administrative reasons|2|||
30916143|NCT01886781|58951740|FG000|Overall Study|Protocol Violation|5|||
30916144|NCT01886781|58951741|FG001|Overall Study|Protocol Violation|0|||
30916145|NCT01886781|58951740|FG000|Overall Study|Adverse Event|1|||
30916146|NCT01886781|58951741|FG001|Overall Study|Adverse Event|0|||
30916147|NCT01886781|58951740|FG000|Overall Study|Lost to Follow-up|5|||
30916148|NCT01886781|58951741|FG001|Overall Study|Lost to Follow-up|0|||
30916149|NCT01886781|58951740|FG000|Overall Study|Withdrawal by Subject|2|||
30916150|NCT01886781|58951741|FG001|Overall Study|Withdrawal by Subject|1|||
30916151|NCT01886781|58951740|FG000|Overall Study|Worsening of symptoms|1|||
30916152|NCT01886781|58951741|FG001|Overall Study|Worsening of symptoms|1|||
30916153|NCT01463098|58951761|FG000|Part A (11 Days)|Participant Choice|2|||
30916154|NCT01463098|58951762|FG001|Part A (11 Days)|Participant Choice|0|||
30916155|NCT01463098|58951763|FG002|Part A (11 Days)|Participant Choice|0|||
30916156|NCT01463098|58951764|FG003|Part A (11 Days)|Participant Choice|0|||
30916157|NCT01463098|58951765|FG004|Part A (11 Days)|Participant Choice|0|||
30916158|NCT01463098|58951766|FG005|Part A (11 Days)|Participant Choice|0|||
30916159|NCT01463098|58951767|FG006|Part A (11 Days)|Participant Choice|0|||
30916160|NCT01463098|58951768|FG007|Part A (11 Days)|Participant Choice|0|||
30916161|NCT01463098|58951769|FG008|Part A (11 Days)|Participant Choice|1|||
30916162|NCT01463098|58951770|FG009|Part A (11 Days)|Participant Choice|0|||
30825539|NCT01967888|58848068|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
30825540|NCT01864018|58848076|FG000|Overall Study|Ineligible|3|||
30825541|NCT01864018|58848077|FG001|Overall Study|Ineligible|1|||
30825542|NCT01796197|58848088|FG000|Overall Study|Lost to Follow-up|1|||
30825543|NCT01796197|58848088|FG000|Overall Study|Lack of Efficacy|1|||
30825544|NCT01205048|58848094|FG000|Overall Study|Withdrawal by Subject|14|||
30825545|NCT01205048|58848094|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
30825546|NCT01205048|58848094|FG000|Overall Study|Lost to Follow-up|4|||
30825547|NCT01205048|58848094|FG000|Overall Study|Other|2|||
30825548|NCT01052779|58848102|FG000|Overall Study|Adverse Event|1|||
30825549|NCT01052779|58848103|FG001|Overall Study|Adverse Event|4|||
30825550|NCT01052779|58848102|FG000|Overall Study|Withdrawal by Subject|1|||
30825551|NCT01052779|58848103|FG001|Overall Study|Withdrawal by Subject|2|||
30825552|NCT01052779|58848102|FG000|Overall Study|Other-Protocol Violation|1|||
30825553|NCT01052779|58848103|FG001|Overall Study|Other-Protocol Violation|1|||
30825554|NCT01052779|58848102|FG000|Overall Study|Other-Surgery|0|||
30916163|NCT01463098|58951771|FG010|Part A (11 Days)|Participant Choice|0|||
30916164|NCT01463098|58951772|FG011|Part A (11 Days)|Participant Choice|0|||
30916165|NCT01463098|58951773|FG012|Part A (11 Days)|Participant Choice|0|||
30916166|NCT01463098|58951774|FG013|Part A (11 Days)|Participant Choice|0|||
30916167|NCT01463098|58951761|FG000|Part A (11 Days)|Lost to Follow-up|0|||
30916168|NCT01463098|58951762|FG001|Part A (11 Days)|Lost to Follow-up|0|||
30825555|NCT01052779|58848103|FG001|Overall Study|Other-Surgery|2|||
30825556|NCT01052779|58848102|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
30825557|NCT01052779|58848103|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
30825558|NCT00591370|58848113|FG000|Overall Study|Not Treated|2|||
30916169|NCT01463098|58951763|FG002|Part A (11 Days)|Lost to Follow-up|0|||
30916170|NCT01463098|58951764|FG003|Part A (11 Days)|Lost to Follow-up|0|||
30916171|NCT01463098|58951765|FG004|Part A (11 Days)|Lost to Follow-up|1|||
30916172|NCT01463098|58951766|FG005|Part A (11 Days)|Lost to Follow-up|0|||
30916173|NCT01463098|58951767|FG006|Part A (11 Days)|Lost to Follow-up|0|||
30916174|NCT01463098|58951768|FG007|Part A (11 Days)|Lost to Follow-up|0|||
30916175|NCT01463098|58951769|FG008|Part A (11 Days)|Lost to Follow-up|0|||
30916176|NCT01463098|58951770|FG009|Part A (11 Days)|Lost to Follow-up|0|||
30916177|NCT01463098|58951771|FG010|Part A (11 Days)|Lost to Follow-up|0|||
30916178|NCT01463098|58951772|FG011|Part A (11 Days)|Lost to Follow-up|0|||
30916179|NCT01463098|58951773|FG012|Part A (11 Days)|Lost to Follow-up|0|||
30916180|NCT01463098|58951774|FG013|Part A (11 Days)|Lost to Follow-up|0|||
30916181|NCT01463098|58951761|FG000|Part B (11 Days)|Participant Choice|0|||
30916182|NCT01463098|58951762|FG001|Part B (11 Days)|Participant Choice|0|||
30916183|NCT01463098|58951763|FG002|Part B (11 Days)|Participant Choice|0|||
30916184|NCT01463098|58951764|FG003|Part B (11 Days)|Participant Choice|0|||
30916185|NCT01463098|58951765|FG004|Part B (11 Days)|Participant Choice|0|||
30916186|NCT01463098|58951766|FG005|Part B (11 Days)|Participant Choice|0|||
30916187|NCT01463098|58951767|FG006|Part B (11 Days)|Participant Choice|0|||
30916188|NCT01463098|58951768|FG007|Part B (11 Days)|Participant Choice|0|||
30916189|NCT01463098|58951769|FG008|Part B (11 Days)|Participant Choice|0|||
30916190|NCT01463098|58951770|FG009|Part B (11 Days)|Participant Choice|0|||
30916191|NCT01463098|58951771|FG010|Part B (11 Days)|Participant Choice|0|||
30916192|NCT01463098|58951772|FG011|Part B (11 Days)|Participant Choice|1|||
30916193|NCT01463098|58951773|FG012|Part B (11 Days)|Participant Choice|0|||
30916194|NCT01463098|58951774|FG013|Part B (11 Days)|Participant Choice|0|||
30916195|NCT01626079|58951826|FG000|Overall Study|Death|117|||
30916196|NCT01626079|58951827|FG001|Overall Study|Death|153|||
30916197|NCT01626079|58951828|FG002|Overall Study|Death|39|||
30916198|NCT01626079|58951826|FG000|Overall Study|Withdrawal by Subject|15|||
30916199|NCT01626079|58951827|FG001|Overall Study|Withdrawal by Subject|39|||
30916200|NCT01626079|58951828|FG002|Overall Study|Withdrawal by Subject|5|||
30916201|NCT01626079|58951826|FG000|Overall Study|Lost to Follow-up|5|||
30916202|NCT01626079|58951827|FG001|Overall Study|Lost to Follow-up|4|||
30916203|NCT01626079|58951828|FG002|Overall Study|Lost to Follow-up|2|||
30916204|NCT01626079|58951826|FG000|Overall Study|Missed Visits|13|||
30916205|NCT01626079|58951827|FG001|Overall Study|Missed Visits|5|||
30916206|NCT01626079|58951828|FG002|Overall Study|Missed Visits|6|||
30916207|NCT01462942|58951844|FG000|Overall Study|Adverse Event|7|||
30916208|NCT01462942|58951845|FG001|Overall Study|Adverse Event|12|||
30916209|NCT01462942|58951846|FG002|Overall Study|Adverse Event|10|||
30916210|NCT01462942|58951847|FG003|Overall Study|Adverse Event|11|||
30916211|NCT01462942|58951848|FG004|Overall Study|Adverse Event|11|||
30916212|NCT01462942|58951844|FG000|Overall Study|Other, including COPD exacerbation|3|||
30916213|NCT01462942|58951845|FG001|Overall Study|Other, including COPD exacerbation|5|||
30916214|NCT01462942|58951846|FG002|Overall Study|Other, including COPD exacerbation|2|||
30916215|NCT01462942|58951847|FG003|Overall Study|Other, including COPD exacerbation|8|||
30916216|NCT01462942|58951848|FG004|Overall Study|Other, including COPD exacerbation|5|||
30916217|NCT01462942|58951844|FG000|Overall Study|Withdrawal by Subject|14|||
30916218|NCT01462942|58951845|FG001|Overall Study|Withdrawal by Subject|10|||
30916219|NCT01462942|58951846|FG002|Overall Study|Withdrawal by Subject|14|||
30916220|NCT01462942|58951847|FG003|Overall Study|Withdrawal by Subject|16|||
30916221|NCT01462942|58951848|FG004|Overall Study|Withdrawal by Subject|19|||
30916222|NCT01462942|58951844|FG000|Overall Study|Lack of Efficacy|6|||
30916223|NCT01462942|58951845|FG001|Overall Study|Lack of Efficacy|0|||
30916224|NCT01462942|58951846|FG002|Overall Study|Lack of Efficacy|4|||
30916225|NCT01462942|58951847|FG003|Overall Study|Lack of Efficacy|5|||
30916226|NCT01462942|58951848|FG004|Overall Study|Lack of Efficacy|3|||
30916227|NCT01462942|58951844|FG000|Overall Study|Lost to Follow-up|0|||
30916228|NCT01462942|58951845|FG001|Overall Study|Lost to Follow-up|1|||
30916229|NCT01462942|58951846|FG002|Overall Study|Lost to Follow-up|1|||
30916230|NCT01462942|58951847|FG003|Overall Study|Lost to Follow-up|1|||
30916231|NCT01462942|58951848|FG004|Overall Study|Lost to Follow-up|1|||
30916232|NCT01462942|58951844|FG000|Overall Study|Protocol Violation|4|||
30916233|NCT01462942|58951845|FG001|Overall Study|Protocol Violation|6|||
30916234|NCT01462942|58951846|FG002|Overall Study|Protocol Violation|9|||
30916235|NCT01462942|58951847|FG003|Overall Study|Protocol Violation|9|||
30916236|NCT01462942|58951848|FG004|Overall Study|Protocol Violation|6|||
30916237|NCT01462630|58951860|FG000|Overall Study|Did not initiate therapy|3|||
30916238|NCT01462630|58951860|FG000|Overall Study|Death|1|||
30916239|NCT01462630|58951860|FG000|Overall Study|Protocol Violation|2|||
30916240|NCT01462630|58951860|FG000|Overall Study|Adverse Event|1|||
30916241|NCT01504204|58951866|FG000|Overall Study|Lost to Follow-up|1|||
30916242|NCT01504204|58951867|FG001|Overall Study|Lost to Follow-up|1|||
30916243|NCT01485640|58951873|FG000|Overall Study|Adverse Event|10|||
30916244|NCT01485640|58951873|FG000|Overall Study|Lack of Efficacy|2|||
30916245|NCT01485640|58951873|FG000|Overall Study|Protocol Violation|1|||
30916246|NCT01485640|58951873|FG000|Overall Study|Withdrawal by Subject|14|||
30916247|NCT01485640|58951873|FG000|Overall Study|Terminated by Sponsor|95|||
30916248|NCT02118961|58951879|FG000|Overall Study|Withdrawal by Subject|1|||
30916249|NCT02118961|58951880|FG001|Overall Study|Withdrawal by Subject|0|||
30916250|NCT02140645|58951892|FG000|Overall Study|Not linked|5489|||
30916251|NCT02140645|58951893|FG001|Overall Study|Not linked|61654|||
30916252|NCT02140645|58951894|FG002|Overall Study|Not linked|4236|||
30916253|NCT02140645|58951895|FG003|Overall Study|Not linked|13833|||
30916254|NCT02140645|58951896|FG004|Overall Study|Not linked|3286|||
30916255|NCT02140645|58951897|FG005|Overall Study|Not linked|70896|||
30916256|NCT02140567|58951906|FG000|Overall Study|Problems with recording equipment|6|||
30916257|NCT02140411|58951911|FG000|Overall Study|Adverse Event|1|||
30916258|NCT02139943|58951918|FG000|Overall Study|Adverse Event|0|||
30916259|NCT02139943|58951919|FG001|Overall Study|Adverse Event|1|||
30916260|NCT02139943|58951920|FG002|Overall Study|Adverse Event|2|||
30916261|NCT02139943|58951918|FG000|Overall Study|Lost to Follow-up|3|||
30916262|NCT02139943|58951919|FG001|Overall Study|Lost to Follow-up|2|||
30916263|NCT02139943|58951920|FG002|Overall Study|Lost to Follow-up|2|||
30916264|NCT02139943|58951918|FG000|Overall Study|Withdrawal by Subject|4|||
30916265|NCT02139943|58951919|FG001|Overall Study|Withdrawal by Subject|3|||
30916266|NCT02139943|58951920|FG002|Overall Study|Withdrawal by Subject|0|||
30916267|NCT02139943|58951918|FG000|Overall Study|Other|0|||
30916268|NCT02139943|58951919|FG001|Overall Study|Other|0|||
30916269|NCT02139943|58951920|FG002|Overall Study|Other|1|||
30916270|NCT02139943|58951918|FG000|Overall Study|Participant wishes to discontinue|2|||
30916271|NCT02139943|58951919|FG001|Overall Study|Participant wishes to discontinue|0|||
30916272|NCT02139943|58951920|FG002|Overall Study|Participant wishes to discontinue|0|||
30916273|NCT02139943|58951918|FG000|Overall Study|Participant in Poor Compliance|1|||
30916274|NCT02139943|58951919|FG001|Overall Study|Participant in Poor Compliance|0|||
30916275|NCT02139943|58951920|FG002|Overall Study|Participant in Poor Compliance|1|||
30916276|NCT02139943|58951918|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
30916277|NCT02139943|58951919|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
30916278|NCT02139943|58951920|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
30916279|NCT01485172|58951934|FG000|Overall Study|Adverse Event|2|||
30916280|NCT01485172|58951935|FG001|Overall Study|Adverse Event|1|||
30916281|NCT01485172|58951936|FG002|Overall Study|Adverse Event|2|||
30916282|NCT01485172|58951937|FG003|Overall Study|Adverse Event|2|||
30916283|NCT01485172|58951938|FG004|Overall Study|Adverse Event|1|||
30916284|NCT01485172|58951939|FG005|Overall Study|Adverse Event|2|||
30916285|NCT01485172|58951934|FG000|Overall Study|Lack of Efficacy|2|||
30916286|NCT01485172|58951935|FG001|Overall Study|Lack of Efficacy|0|||
30916287|NCT01485172|58951936|FG002|Overall Study|Lack of Efficacy|0|||
30916288|NCT01485172|58951937|FG003|Overall Study|Lack of Efficacy|0|||
30916289|NCT01485172|58951938|FG004|Overall Study|Lack of Efficacy|0|||
30916290|NCT01485172|58951939|FG005|Overall Study|Lack of Efficacy|0|||
30916291|NCT01485172|58951934|FG000|Overall Study|Protocol Violation|0|||
30916292|NCT01485172|58951935|FG001|Overall Study|Protocol Violation|0|||
30916293|NCT01485172|58951936|FG002|Overall Study|Protocol Violation|4|||
30916294|NCT01485172|58951937|FG003|Overall Study|Protocol Violation|5|||
30916295|NCT01485172|58951938|FG004|Overall Study|Protocol Violation|1|||
30916296|NCT01485172|58951939|FG005|Overall Study|Protocol Violation|0|||
30916297|NCT01485172|58951934|FG000|Overall Study|Protocol defined stopping criteria|1|||
30916298|NCT01485172|58951935|FG001|Overall Study|Protocol defined stopping criteria|0|||
30916299|NCT01485172|58951936|FG002|Overall Study|Protocol defined stopping criteria|0|||
30916300|NCT01485172|58951937|FG003|Overall Study|Protocol defined stopping criteria|0|||
30916301|NCT01485172|58951938|FG004|Overall Study|Protocol defined stopping criteria|1|||
30916302|NCT01485172|58951939|FG005|Overall Study|Protocol defined stopping criteria|0|||
30916303|NCT01485172|58951934|FG000|Overall Study|Lost to Follow-up|0|||
30916304|NCT01485172|58951935|FG001|Overall Study|Lost to Follow-up|0|||
30916305|NCT01485172|58951936|FG002|Overall Study|Lost to Follow-up|1|||
30916306|NCT01485172|58951937|FG003|Overall Study|Lost to Follow-up|0|||
30916307|NCT01485172|58951938|FG004|Overall Study|Lost to Follow-up|0|||
30916308|NCT01485172|58951939|FG005|Overall Study|Lost to Follow-up|1|||
30916309|NCT01485172|58951934|FG000|Overall Study|Physician Decision|0|||
30916310|NCT01485172|58951935|FG001|Overall Study|Physician Decision|0|||
30916311|NCT01485172|58951936|FG002|Overall Study|Physician Decision|0|||
30916312|NCT01485172|58951937|FG003|Overall Study|Physician Decision|0|||
30916313|NCT01485172|58951938|FG004|Overall Study|Physician Decision|1|||
30916314|NCT01485172|58951939|FG005|Overall Study|Physician Decision|0|||
30916315|NCT01485172|58951934|FG000|Overall Study|Withdrawal by Subject|2|||
30916316|NCT01485172|58951935|FG001|Overall Study|Withdrawal by Subject|0|||
30916317|NCT01485172|58951936|FG002|Overall Study|Withdrawal by Subject|0|||
30916318|NCT01485172|58951937|FG003|Overall Study|Withdrawal by Subject|1|||
30916319|NCT01485172|58951938|FG004|Overall Study|Withdrawal by Subject|1|||
30916320|NCT01485172|58951939|FG005|Overall Study|Withdrawal by Subject|1|||
30916321|NCT02105701|58951957|FG000|Overall Study|Lost to Follow-up|1|||
30916322|NCT02105701|58951958|FG001|Overall Study|Lost to Follow-up|0|||
30916323|NCT02105701|58951959|FG002|Overall Study|Lost to Follow-up|2|||
30916324|NCT02105701|58951960|FG003|Overall Study|Lost to Follow-up|1|||
30916325|NCT02105701|58951957|FG000|Overall Study|Protocol Violation|0|||
30916326|NCT02105701|58951958|FG001|Overall Study|Protocol Violation|0|||
30916327|NCT02105701|58951959|FG002|Overall Study|Protocol Violation|1|||
30916328|NCT02105701|58951960|FG003|Overall Study|Protocol Violation|0|||
30916329|NCT02105701|58951957|FG000|Overall Study|Withdrawal by Subject|2|||
30916330|NCT02105701|58951958|FG001|Overall Study|Withdrawal by Subject|1|||
30916331|NCT02105701|58951959|FG002|Overall Study|Withdrawal by Subject|0|||
30916332|NCT02105701|58951960|FG003|Overall Study|Withdrawal by Subject|1|||
30916333|NCT02105701|58951957|FG000|Overall Study|Death|1|||
30916334|NCT02105701|58951958|FG001|Overall Study|Death|0|||
30916335|NCT02105701|58951959|FG002|Overall Study|Death|0|||
30825559|NCT00389610|58848119|FG000|Overall Study|Disease Progression|0|||
30825560|NCT00389610|58848120|FG001|Overall Study|Disease Progression|19|||
30825561|NCT00389610|58848119|FG000|Overall Study|Death|0|||
30916336|NCT02105701|58951960|FG003|Overall Study|Death|0|||
30916337|NCT01502956|58951972|FG000|Overall Study|Death|0|||
30916338|NCT01502956|58951973|FG001|Overall Study|Death|2|||
30916339|NCT01502956|58951972|FG000|Overall Study|Lost to Follow-up|14|||
30916340|NCT01502956|58951973|FG001|Overall Study|Lost to Follow-up|11|||
30916341|NCT01502956|58951972|FG000|Overall Study|Physician Decision|2|||
30916342|NCT01502956|58951973|FG001|Overall Study|Physician Decision|3|||
30916343|NCT01502956|58951972|FG000|Overall Study|Withdrawal by Subject|8|||
30916344|NCT01502956|58951973|FG001|Overall Study|Withdrawal by Subject|10|||
30916345|NCT01502644|58951982|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
30916346|NCT01502644|58951983|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
30916347|NCT01502644|58951984|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
30916348|NCT01502644|58951985|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
30916349|NCT01502644|58951982|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
30916350|NCT01502644|58951983|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
30753713|NCT00122382|58763401|FG001|Open-Label Study|Lack of Efficacy|0|||
30753714|NCT00122382|58763402|FG002|Open-Label Study|Lack of Efficacy|3|||
30753715|NCT00122382|58763400|FG000|Open-Label Study|Lost to Follow-up|0|||
30753716|NCT00122382|58763401|FG001|Open-Label Study|Lost to Follow-up|0|||
30753717|NCT00122382|58763402|FG002|Open-Label Study|Lost to Follow-up|3|||
30753718|NCT00122382|58763400|FG000|Open-Label Study|Pregnancy|0|||
30753719|NCT00122382|58763401|FG001|Open-Label Study|Pregnancy|0|||
30753720|NCT00122382|58763402|FG002|Open-Label Study|Pregnancy|2|||
30753721|NCT00122382|58763400|FG000|Open-Label Study|Poor/Non-Compliance|0|||
30753722|NCT00122382|58763401|FG001|Open-Label Study|Poor/Non-Compliance|0|||
30825562|NCT00389610|58848120|FG001|Overall Study|Death|1|||
30825563|NCT00389610|58848119|FG000|Overall Study|Physician Decision|0|||
30825564|NCT00389610|58848120|FG001|Overall Study|Physician Decision|1|||
30825565|NCT00389610|58848119|FG000|Overall Study|Withdrawal by Subject|0|||
30825566|NCT00389610|58848120|FG001|Overall Study|Withdrawal by Subject|1|||
30825567|NCT03064763|58848126|FG000|Overall Study|Lost to Follow-up|1|||
30825568|NCT03064763|58848126|FG000|Overall Study|Death|8|||
30825569|NCT02782676|58848130|FG000|Overall Study|Lost to Follow-up|0|||
30825570|NCT02782676|58848131|FG001|Overall Study|Lost to Follow-up|1|||
30825571|NCT02471339|58848139|FG000|Overall Study|Did not provide follow-up data|2|||
30825572|NCT02471339|58848140|FG001|Overall Study|Did not provide follow-up data|0|||
30825573|NCT00107978|58848148|FG000|Overall Study|Adverse Event|1|||
30825574|NCT00107978|58848149|FG001|Overall Study|Adverse Event|5|||
30825575|NCT00107978|58848148|FG000|Overall Study|Death|3|||
30825576|NCT00107978|58848149|FG001|Overall Study|Death|3|||
30825577|NCT00107978|58848148|FG000|Overall Study|Lost to Follow-up|20|||
30825578|NCT00107978|58848149|FG001|Overall Study|Lost to Follow-up|28|||
30753723|NCT00122382|58763402|FG002|Open-Label Study|Poor/Non-Compliance|1|||
30753724|NCT00122382|58763400|FG000|Open-Label Study|Withdrawal of Consent|0|||
30753725|NCT00122382|58763401|FG001|Open-Label Study|Withdrawal of Consent|0|||
30753726|NCT00122382|58763402|FG002|Open-Label Study|Withdrawal of Consent|4|||
30825579|NCT00107978|58848148|FG000|Overall Study|Withdrawal by Subject|4|||
30825580|NCT00107978|58848149|FG001|Overall Study|Withdrawal by Subject|9|||
30825581|NCT00107978|58848148|FG000|Overall Study|Protocol Violation|0|||
30825582|NCT00107978|58848149|FG001|Overall Study|Protocol Violation|1|||
30825583|NCT00107978|58848148|FG000|Overall Study|Other|5|||
30825584|NCT00107978|58848149|FG001|Overall Study|Other|4|||
30825585|NCT02781818|58848158|FG000|Overall Study|Lost to Follow-up|4|||
30825586|NCT02781818|58848159|FG001|Overall Study|Lost to Follow-up|2|||
30825587|NCT02781818|58848160|FG002|Overall Study|Lost to Follow-up|1|||
30825588|NCT02927873|58848174|FG000|Overall Study|Lost to Follow-up|0|||
30825589|NCT02927873|58848175|FG001|Overall Study|Lost to Follow-up|1|||
30825590|NCT02927873|58848176|FG002|Overall Study|Lost to Follow-up|0|||
30825591|NCT02927873|58848177|FG003|Overall Study|Lost to Follow-up|0|||
30825592|NCT02927873|58848178|FG004|Overall Study|Lost to Follow-up|0|||
30916351|NCT01502644|58951984|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
30916352|NCT01502644|58951985|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
30916353|NCT01502644|58951982|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
30916354|NCT01502644|58951983|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
30916355|NCT01502644|58951984|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
30916356|NCT01502644|58951985|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
30916357|NCT01502644|58951982|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
30916358|NCT01502644|58951983|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
30916359|NCT01502644|58951984|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
30916360|NCT01502644|58951985|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
30916361|NCT01502644|58951982|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
30916362|NCT01502644|58951983|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
30916363|NCT01502644|58951984|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
30916364|NCT01502644|58951985|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
30916365|NCT01462318|58951995|FG000|Main Study / TP-DI Study|Other|2|||
30916366|NCT01462318|58951996|FG001|Main Study / TP-DI Study|Other|0|||
30916367|NCT01462318|58951997|FG002|Main Study / TP-DI Study|Other|0|||
30916368|NCT01462318|58951995|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
30916369|NCT01462318|58951996|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
30916370|NCT01462318|58951997|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
30916371|NCT01462318|58951995|FG000|Main Study / TP-DI Study|Adverse Event|4|||
30916372|NCT01462318|58951996|FG001|Main Study / TP-DI Study|Adverse Event|0|||
30825593|NCT02927873|58848179|FG005|Overall Study|Lost to Follow-up|0|||
30825594|NCT02927873|58848174|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
30916373|NCT01462318|58951997|FG002|Main Study / TP-DI Study|Adverse Event|0|||
30916374|NCT01462318|58951995|FG000|Extension Phase|Lost to Follow-up|0|||
30916375|NCT01462318|58951996|FG001|Extension Phase|Lost to Follow-up|0|||
30916376|NCT01462318|58951997|FG002|Extension Phase|Lost to Follow-up|1|||
30916377|NCT01462318|58951995|FG000|Extension Phase|Other|0|||
30916378|NCT01462318|58951996|FG001|Extension Phase|Other|0|||
30916379|NCT01462318|58951997|FG002|Extension Phase|Other|1|||
30825595|NCT02927873|58848175|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
30825596|NCT02927873|58848176|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
30825597|NCT02927873|58848177|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
30825598|NCT02927873|58848178|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
30916380|NCT01462318|58951995|FG000|Extension Phase|Disease Progression|0|||
30916381|NCT01462318|58951996|FG001|Extension Phase|Disease Progression|0|||
30916382|NCT01462318|58951997|FG002|Extension Phase|Disease Progression|1|||
30916383|NCT01462318|58951995|FG000|Extension Phase|Withdrawal by Subject|0|||
30916384|NCT01462318|58951996|FG001|Extension Phase|Withdrawal by Subject|0|||
30916385|NCT01462318|58951997|FG002|Extension Phase|Withdrawal by Subject|15|||
30916386|NCT01462318|58951995|FG000|Extension Phase|Investigator Decision|0|||
30753727|NCT01028716|58763420|FG000|Overall Study|Physician Decision|1|||
30753728|NCT00106704|58763427|FG000|Overall Study|Adverse Event|10|||
30753729|NCT00106704|58763428|FG001|Overall Study|Adverse Event|7|||
30753730|NCT00106704|58763427|FG000|Overall Study|Death|2|||
30753731|NCT00106704|58763428|FG001|Overall Study|Death|1|||
30753732|NCT00106704|58763427|FG000|Overall Study|Lack of Efficacy|67|||
30753733|NCT00106704|58763428|FG001|Overall Study|Lack of Efficacy|69|||
30753734|NCT00106704|58763427|FG000|Overall Study|Lost to Follow-up|7|||
30753735|NCT00106704|58763428|FG001|Overall Study|Lost to Follow-up|3|||
30753736|NCT00106704|58763427|FG000|Overall Study|Pregnancy|1|||
30753737|NCT00106704|58763428|FG001|Overall Study|Pregnancy|0|||
30753738|NCT00106704|58763427|FG000|Overall Study|Protocol Violation|4|||
30753739|NCT00106704|58763428|FG001|Overall Study|Protocol Violation|7|||
30825599|NCT02927873|58848179|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
30825600|NCT02927873|58848174|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30825601|NCT02927873|58848175|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30825602|NCT02927873|58848176|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30825603|NCT02927873|58848177|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30825604|NCT02927873|58848178|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30825605|NCT02927873|58848179|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
30916387|NCT01462318|58951996|FG001|Extension Phase|Investigator Decision|0|||
30916388|NCT01462318|58951997|FG002|Extension Phase|Investigator Decision|5|||
30916389|NCT01462318|58951995|FG000|Extension Phase|Adverse Event|0|||
30825606|NCT02927873|58848174|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
30825607|NCT02927873|58848175|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
30916390|NCT01462318|58951996|FG001|Extension Phase|Adverse Event|0|||
30916391|NCT01462318|58951997|FG002|Extension Phase|Adverse Event|22|||
30753740|NCT00106704|58763427|FG000|Overall Study|Withdrawal by Subject|14|||
30753741|NCT00106704|58763428|FG001|Overall Study|Withdrawal by Subject|21|||
30753742|NCT00106704|58763427|FG000|Overall Study|Patient moved|1|||
30916392|NCT01485094|58952005|FG000|Overall Study|Adverse Event|1|||
30916393|NCT01485094|58952006|FG001|Overall Study|Adverse Event|1|||
30916394|NCT01485094|58952007|FG002|Overall Study|Adverse Event|1|||
30916395|NCT01485094|58952005|FG000|Overall Study|Lost to Follow-up|1|||
30916396|NCT01485094|58952006|FG001|Overall Study|Lost to Follow-up|0|||
30916397|NCT01485094|58952007|FG002|Overall Study|Lost to Follow-up|0|||
30916398|NCT01485094|58952005|FG000|Overall Study|Withdrawal by Subject|1|||
30916399|NCT01485094|58952006|FG001|Overall Study|Withdrawal by Subject|1|||
30916400|NCT01485094|58952007|FG002|Overall Study|Withdrawal by Subject|0|||
30916401|NCT01484938|58952015|FG000|Overall Study|Adverse Event|2|||
30916402|NCT01484938|58952015|FG000|Overall Study|Lost to Follow-up|1|||
30916403|NCT01484938|58952015|FG000|Overall Study|Noncompliance|1|||
30916404|NCT01502410|58952023|FG000|Overall Study|Adverse Event|1|||
30916405|NCT01502410|58952024|FG001|Overall Study|Adverse Event|2|||
30916406|NCT01502410|58952025|FG002|Overall Study|Adverse Event|0|||
30916407|NCT01502410|58952026|FG003|Overall Study|Adverse Event|0|||
30916408|NCT01502410|58952023|FG000|Overall Study|Lack of Efficacy|7|||
30916409|NCT01502410|58952024|FG001|Overall Study|Lack of Efficacy|7|||
30916410|NCT01502410|58952025|FG002|Overall Study|Lack of Efficacy|0|||
30916411|NCT01502410|58952026|FG003|Overall Study|Lack of Efficacy|0|||
30916412|NCT01502410|58952023|FG000|Overall Study|Physician Decision|0|||
30916413|NCT01502410|58952024|FG001|Overall Study|Physician Decision|1|||
30916414|NCT01502410|58952025|FG002|Overall Study|Physician Decision|0|||
30916415|NCT01502410|58952026|FG003|Overall Study|Physician Decision|0|||
30916416|NCT01502410|58952023|FG000|Overall Study|Withdrawal by Subject|2|||
30916417|NCT01502410|58952024|FG001|Overall Study|Withdrawal by Subject|0|||
30916418|NCT01502410|58952025|FG002|Overall Study|Withdrawal by Subject|0|||
30916419|NCT01502410|58952026|FG003|Overall Study|Withdrawal by Subject|0|||
30916420|NCT01462162|58952035|FG000|Overall Study|Adverse Event|5|||
30916421|NCT01462162|58952035|FG000|Overall Study|Lack of Efficacy|4|||
30916422|NCT01462162|58952035|FG000|Overall Study|Abnormal laboratory parameters|1|||
30916423|NCT01462162|58952035|FG000|Overall Study|Other|2|||
30916424|NCT01483924|58952045|FG000|Overall Study|Withdrawal by Subject|2|||
30916425|NCT01483924|58952046|FG001|Overall Study|Withdrawal by Subject|0|||
30916426|NCT01483924|58952047|FG002|Overall Study|Withdrawal by Subject|0|||
30916427|NCT01483924|58952048|FG003|Overall Study|Withdrawal by Subject|1|||
30916428|NCT01483924|58952049|FG004|Overall Study|Withdrawal by Subject|1|||
30916429|NCT01483924|58952045|FG000|Overall Study|Adverse Event|0|||
30916430|NCT01483924|58952046|FG001|Overall Study|Adverse Event|0|||
30916431|NCT01483924|58952047|FG002|Overall Study|Adverse Event|1|||
30916432|NCT01483924|58952048|FG003|Overall Study|Adverse Event|1|||
30916433|NCT01483924|58952049|FG004|Overall Study|Adverse Event|0|||
30916434|NCT01483924|58952045|FG000|Overall Study|Non-compliance|0|||
30916435|NCT01483924|58952046|FG001|Overall Study|Non-compliance|0|||
30916436|NCT01483924|58952047|FG002|Overall Study|Non-compliance|0|||
30916437|NCT01483924|58952048|FG003|Overall Study|Non-compliance|1|||
30916438|NCT01483924|58952049|FG004|Overall Study|Non-compliance|1|||
30916439|NCT01483924|58952045|FG000|Overall Study|Sponsor concern over ECG result|0|||
30916440|NCT01483924|58952046|FG001|Overall Study|Sponsor concern over ECG result|0|||
30916441|NCT01483924|58952047|FG002|Overall Study|Sponsor concern over ECG result|0|||
30916442|NCT01483924|58952048|FG003|Overall Study|Sponsor concern over ECG result|1|||
30916443|NCT01483924|58952049|FG004|Overall Study|Sponsor concern over ECG result|0|||
30916444|NCT01462084|58952070|FG000|Overall Study|Withdrawal by Subject|1|||
30916445|NCT01462084|58952071|FG001|Overall Study|Withdrawal by Subject|0|||
30916446|NCT01462084|58952070|FG000|Overall Study|Protocol Violation|1|||
30916447|NCT01462084|58952071|FG001|Overall Study|Protocol Violation|1|||
30916448|NCT02134028|58952086|FG000|Overall Study|Lack of Efficacy|1|||
30916449|NCT02134028|58952087|FG001|Overall Study|Lack of Efficacy|0|||
30916450|NCT02134028|58952088|FG002|Overall Study|Lack of Efficacy|3|||
30916451|NCT02134028|58952089|FG003|Overall Study|Lack of Efficacy|2|||
30753743|NCT00106704|58763428|FG001|Overall Study|Patient moved|0|||
30753744|NCT00106704|58763427|FG000|Overall Study|Site terminated|0|||
30753745|NCT00106704|58763428|FG001|Overall Study|Site terminated|1|||
30753746|NCT00106704|58763427|FG000|Overall Study|Planned major surgery|1|||
30753747|NCT00106704|58763428|FG001|Overall Study|Planned major surgery|0|||
30753748|NCT00106704|58763427|FG000|Overall Study|Patient Received Glycemic Medication|22|||
30753749|NCT00106704|58763428|FG001|Overall Study|Patient Received Glycemic Medication|41|||
30753750|NCT00106704|58763427|FG000|Overall Study|Unable to re-enter US|1|||
30753751|NCT00106704|58763428|FG001|Overall Study|Unable to re-enter US|0|||
30753752|NCT00106704|58763427|FG000|Overall Study|Laboratory test|1|||
30753753|NCT00106704|58763428|FG001|Overall Study|Laboratory test|1|||
30753754|NCT00105066|58763436|FG000|Overall Study|Adverse Event|2|||
30753755|NCT00105066|58763437|FG001|Overall Study|Adverse Event|5|||
30916452|NCT02134028|58952090|FG004|Overall Study|Lack of Efficacy|1|||
30916453|NCT02134028|58952091|FG005|Overall Study|Lack of Efficacy|2|||
30916454|NCT02134028|58952092|FG006|Overall Study|Lack of Efficacy|1|||
30916455|NCT02134028|58952093|FG007|Overall Study|Lack of Efficacy|0|||
30916456|NCT02134028|58952086|FG000|Overall Study|Poor compliance to protocol|1|||
30916457|NCT02134028|58952087|FG001|Overall Study|Poor compliance to protocol|1|||
30916458|NCT02134028|58952088|FG002|Overall Study|Poor compliance to protocol|3|||
30916459|NCT02134028|58952089|FG003|Overall Study|Poor compliance to protocol|7|||
30916460|NCT02134028|58952090|FG004|Overall Study|Poor compliance to protocol|1|||
30916461|NCT02134028|58952091|FG005|Overall Study|Poor compliance to protocol|1|||
30916462|NCT02134028|58952092|FG006|Overall Study|Poor compliance to protocol|0|||
30916463|NCT02134028|58952093|FG007|Overall Study|Poor compliance to protocol|0|||
30916464|NCT02134028|58952086|FG000|Overall Study|Other unspecified|4|||
30916465|NCT02134028|58952087|FG001|Overall Study|Other unspecified|22|||
30916466|NCT02134028|58952088|FG002|Overall Study|Other unspecified|33|||
30916467|NCT02134028|58952089|FG003|Overall Study|Other unspecified|64|||
30916468|NCT02134028|58952090|FG004|Overall Study|Other unspecified|8|||
30916469|NCT02134028|58952091|FG005|Overall Study|Other unspecified|6|||
30916470|NCT02134028|58952092|FG006|Overall Study|Other unspecified|2|||
30916471|NCT02134028|58952093|FG007|Overall Study|Other unspecified|1|||
30916472|NCT02134028|58952086|FG000|Overall Study|Adverse Event|3|||
30916473|NCT02134028|58952087|FG001|Overall Study|Adverse Event|19|||
30916474|NCT02134028|58952088|FG002|Overall Study|Adverse Event|13|||
30916475|NCT02134028|58952089|FG003|Overall Study|Adverse Event|32|||
30916476|NCT02134028|58952090|FG004|Overall Study|Adverse Event|4|||
30916477|NCT02134028|58952091|FG005|Overall Study|Adverse Event|5|||
30916478|NCT02134028|58952092|FG006|Overall Study|Adverse Event|1|||
30916479|NCT02134028|58952093|FG007|Overall Study|Adverse Event|2|||
30916480|NCT02172950|58952115|FG000|Overall Study|Physician Decision|3|||
30916481|NCT02172950|58952116|FG001|Overall Study|Physician Decision|3|||
30916482|NCT02172950|58952115|FG000|Overall Study|Lack of Efficacy|1|||
30916483|NCT02172950|58952116|FG001|Overall Study|Lack of Efficacy|0|||
30916484|NCT02172950|58952115|FG000|Overall Study|Adverse Event|4|||
30916485|NCT02172950|58952116|FG001|Overall Study|Adverse Event|1|||
30916486|NCT02172950|58952115|FG000|Overall Study|Withdrawal by Subject|10|||
30916487|NCT02172950|58952116|FG001|Overall Study|Withdrawal by Subject|0|||
30825608|NCT02927873|58848176|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
30825609|NCT02927873|58848177|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
30825610|NCT02927873|58848178|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
30825611|NCT02927873|58848179|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
30825612|NCT02927873|58848174|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
30825613|NCT02927873|58848175|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
30825614|NCT02927873|58848176|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
30825615|NCT02927873|58848177|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
30825616|NCT02927873|58848178|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
30825617|NCT02927873|58848179|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
30825618|NCT02927873|58848174|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
30825619|NCT02927873|58848175|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
30825620|NCT02927873|58848176|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
30825621|NCT02927873|58848177|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
30825622|NCT02927873|58848178|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
30825623|NCT02927873|58848179|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
30825624|NCT01220999|58848198|FG000|Overall Study|Progressive disease|0|||
30825625|NCT01220999|58848199|FG001|Overall Study|Progressive disease|0|||
30825626|NCT01220999|58848200|FG002|Overall Study|Progressive disease|1|||
30825627|NCT01220999|58848201|FG003|Overall Study|Progressive disease|0|||
30825628|NCT01220999|58848202|FG004|Overall Study|Progressive disease|0|||
30825629|NCT00142415|58848220|FG000|Overall Study|Physician Decision|0|||
30825630|NCT00142415|58848221|FG001|Overall Study|Physician Decision|0|||
30825631|NCT00142415|58848222|FG002|Overall Study|Physician Decision|0|||
30825632|NCT00142415|58848223|FG003|Overall Study|Physician Decision|0|||
30916488|NCT02172950|58952115|FG000|Overall Study|Protocol Violation|1|||
30916489|NCT02172950|58952116|FG001|Overall Study|Protocol Violation|0|||
30916490|NCT02172950|58952115|FG000|Overall Study|Lost to Follow-up|1|||
30916491|NCT02172950|58952116|FG001|Overall Study|Lost to Follow-up|0|||
30916492|NCT02172950|58952115|FG000|Overall Study|Death|1|||
30916493|NCT02172950|58952116|FG001|Overall Study|Death|0|||
30916494|NCT02172950|58952115|FG000|Overall Study|Patient traveling|1|||
30825633|NCT00142415|58848224|FG004|Overall Study|Physician Decision|1|||
30916495|NCT02172950|58952116|FG001|Overall Study|Patient traveling|0|||
30916496|NCT02172950|58952115|FG000|Overall Study|Patient went to other country|1|||
30916497|NCT02172950|58952116|FG001|Overall Study|Patient went to other country|0|||
30916498|NCT02172950|58952115|FG000|Overall Study|Patient relocated overseas|1|||
30916499|NCT02172950|58952116|FG001|Overall Study|Patient relocated overseas|1|||
30916500|NCT02172950|58952115|FG000|Overall Study|Patient moving|1|||
30916501|NCT02172950|58952116|FG001|Overall Study|Patient moving|0|||
30916502|NCT02151266|58952126|FG000|Overall Study|Lost to Follow-up|1|||
30916503|NCT02151266|58952127|FG001|Overall Study|Lost to Follow-up|4|||
30916504|NCT02151266|58952128|FG002|Overall Study|Lost to Follow-up|1|||
30916505|NCT02151266|58952126|FG000|Overall Study|Did NOT receive intervention|3|||
30916506|NCT02151266|58952127|FG001|Overall Study|Did NOT receive intervention|6|||
30916507|NCT02151266|58952128|FG002|Overall Study|Did NOT receive intervention|2|||
30916508|NCT02151266|58952126|FG000|Overall Study|Not able to exercise|4|||
30916509|NCT02151266|58952127|FG001|Overall Study|Not able to exercise|5|||
30916510|NCT02151266|58952128|FG002|Overall Study|Not able to exercise|4|||
30916511|NCT02151110|58952144|FG000|Overall Study|Withdrawal by Subject|0|||
30916512|NCT02151110|58952145|FG001|Overall Study|Withdrawal by Subject|0|||
30916513|NCT02151110|58952146|FG002|Overall Study|Withdrawal by Subject|0|||
30916514|NCT02151110|58952147|FG003|Overall Study|Withdrawal by Subject|0|||
30916515|NCT02151110|58952148|FG004|Overall Study|Withdrawal by Subject|0|||
30916516|NCT02151110|58952149|FG005|Overall Study|Withdrawal by Subject|0|||
30825634|NCT00142415|58848225|FG005|Overall Study|Physician Decision|2|||
30825635|NCT02781584|58848267|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
30825636|NCT02781584|58848268|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
30825637|NCT02781584|58848269|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
30825638|NCT02781584|58848270|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
30825639|NCT02781584|58848271|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
30825640|NCT02781584|58848272|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
30825641|NCT02781584|58848273|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
30825642|NCT02781584|58848274|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
30825643|NCT02781584|58848275|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
30825644|NCT02781584|58848276|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
30825645|NCT02781584|58848277|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
30825646|NCT02781584|58848278|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
30825647|NCT02781584|58848279|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
30825648|NCT02781584|58848267|FG000|Pre-treatment Phase|Adverse Event|0|||
30825649|NCT02781584|58848268|FG001|Pre-treatment Phase|Adverse Event|0|||
30825650|NCT02781584|58848269|FG002|Pre-treatment Phase|Adverse Event|0|||
30825651|NCT02781584|58848270|FG003|Pre-treatment Phase|Adverse Event|0|||
30825652|NCT02781584|58848271|FG004|Pre-treatment Phase|Adverse Event|0|||
30825653|NCT02781584|58848272|FG005|Pre-treatment Phase|Adverse Event|0|||
30825654|NCT02781584|58848273|FG006|Pre-treatment Phase|Adverse Event|0|||
30825655|NCT02781584|58848274|FG007|Pre-treatment Phase|Adverse Event|0|||
30825656|NCT02781584|58848275|FG008|Pre-treatment Phase|Adverse Event|0|||
30825657|NCT02781584|58848276|FG009|Pre-treatment Phase|Adverse Event|0|||
30825658|NCT02781584|58848277|FG010|Pre-treatment Phase|Adverse Event|0|||
30825659|NCT02781584|58848278|FG011|Pre-treatment Phase|Adverse Event|1|||
30825660|NCT02781584|58848279|FG012|Pre-treatment Phase|Adverse Event|0|||
30825661|NCT02781584|58848267|FG000|Treatment Phase|Withdrew Consent|0|||
30825662|NCT02781584|58848268|FG001|Treatment Phase|Withdrew Consent|0|||
30916517|NCT02151110|58952150|FG006|Overall Study|Withdrawal by Subject|0|||
30916518|NCT02151110|58952151|FG007|Overall Study|Withdrawal by Subject|1|||
30916519|NCT02151110|58952144|FG000|Overall Study|Lost to Follow-up|0|||
30916520|NCT02151110|58952145|FG001|Overall Study|Lost to Follow-up|0|||
30916521|NCT02151110|58952146|FG002|Overall Study|Lost to Follow-up|0|||
30916522|NCT02151110|58952147|FG003|Overall Study|Lost to Follow-up|0|||
30753756|NCT00104520|58763445|FG000|Overall Study|Unrelated adverse event|34|||
30753757|NCT00104520|58763446|FG001|Overall Study|Unrelated adverse event|47|||
30753758|NCT00104520|58763445|FG000|Overall Study|Study drug intolerance|0|||
30753759|NCT00104520|58763446|FG001|Overall Study|Study drug intolerance|1|||
30753760|NCT00104520|58763445|FG000|Overall Study|Related adverse event|13|||
30753761|NCT00104520|58763446|FG001|Overall Study|Related adverse event|15|||
30753762|NCT00104520|58763445|FG000|Overall Study|Lost to Follow-up|1|||
30753763|NCT00104520|58763446|FG001|Overall Study|Lost to Follow-up|0|||
30753764|NCT00104520|58763445|FG000|Overall Study|Noncompliance|0|||
30753765|NCT00104520|58763446|FG001|Overall Study|Noncompliance|2|||
30753766|NCT00104520|58763445|FG000|Overall Study|Personal/administrative|1|||
30916523|NCT02151110|58952148|FG004|Overall Study|Lost to Follow-up|0|||
30916524|NCT02151110|58952149|FG005|Overall Study|Lost to Follow-up|0|||
30825663|NCT02781584|58848269|FG002|Treatment Phase|Withdrew Consent|0|||
30825664|NCT02781584|58848270|FG003|Treatment Phase|Withdrew Consent|0|||
30825665|NCT02781584|58848271|FG004|Treatment Phase|Withdrew Consent|0|||
30916525|NCT02151110|58952150|FG006|Overall Study|Lost to Follow-up|0|||
30753767|NCT00104520|58763446|FG001|Overall Study|Personal/administrative|1|||
30825666|NCT02781584|58848272|FG005|Treatment Phase|Withdrew Consent|1|||
30825667|NCT02781584|58848273|FG006|Treatment Phase|Withdrew Consent|0|||
30825668|NCT02781584|58848274|FG007|Treatment Phase|Withdrew Consent|0|||
30825669|NCT02781584|58848275|FG008|Treatment Phase|Withdrew Consent|0|||
30916526|NCT02151110|58952151|FG007|Overall Study|Lost to Follow-up|2|||
30753768|NCT00104520|58763445|FG000|Overall Study|Other|1|||
30753769|NCT00104520|58763446|FG001|Overall Study|Other|5|||
30916527|NCT02132312|58952178|FG000|Overall Study|Adverse Event|2|||
30916528|NCT02132312|58952179|FG001|Overall Study|Adverse Event|0|||
30916529|NCT02132312|58952178|FG000|Overall Study|Physician Decision|1|||
30916530|NCT02132312|58952179|FG001|Overall Study|Physician Decision|1|||
30916531|NCT02132312|58952178|FG000|Overall Study|Protocol Violation|0|||
30916532|NCT02132312|58952179|FG001|Overall Study|Protocol Violation|1|||
30916533|NCT02132312|58952178|FG000|Overall Study|Withdrawal by Subject|1|||
30916534|NCT02132312|58952179|FG001|Overall Study|Withdrawal by Subject|0|||
30916535|NCT02132312|58952178|FG000|Overall Study|Lost to Follow-up|2|||
30916536|NCT02132312|58952179|FG001|Overall Study|Lost to Follow-up|1|||
30916537|NCT02131766|58952185|FG000|Overall Study|Withdrawal by Subject|4|||
30916538|NCT02150954|58952194|FG000|Overall Study|Protocol Violation|1|||
30916539|NCT02150954|58952195|FG001|Overall Study|Protocol Violation|0|||
30916540|NCT02131532|58952201|FG000|Overall Study|Withdrawal by Subject|1|||
30916541|NCT02131532|58952201|FG000|Overall Study|Physician Decision|1|||
30916542|NCT02131532|58952201|FG000|Overall Study|Other health conditions|2|||
30916543|NCT02170688|58952215|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
30916544|NCT02170688|58952216|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
30916545|NCT02170688|58952217|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
30916546|NCT02170688|58952218|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
30916547|NCT02170688|58952219|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
30916548|NCT02170688|58952215|FG000|Overall Study|Full dose not received|0|||
30916549|NCT02170688|58952216|FG001|Overall Study|Full dose not received|1|||
30916550|NCT02170688|58952217|FG002|Overall Study|Full dose not received|0|||
30916551|NCT02170688|58952218|FG003|Overall Study|Full dose not received|0|||
30916552|NCT02170688|58952219|FG004|Overall Study|Full dose not received|0|||
30916553|NCT02170688|58952215|FG000|Overall Study|Physician Decision|0|||
30916554|NCT02170688|58952216|FG001|Overall Study|Physician Decision|0|||
30916555|NCT02170688|58952217|FG002|Overall Study|Physician Decision|1|||
30916556|NCT02170688|58952218|FG003|Overall Study|Physician Decision|0|||
30916557|NCT02170688|58952219|FG004|Overall Study|Physician Decision|0|||
30916558|NCT02170298|58952233|FG000|Overall Study|Withdrawal by Subject|0|||
30916559|NCT02170298|58952234|FG001|Overall Study|Withdrawal by Subject|1|||
30916560|NCT02170298|58952233|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
30916561|NCT02170298|58952234|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
30916562|NCT02131064|58952242|FG000|Overall Study|Death|5|||
30916563|NCT02131064|58952243|FG001|Overall Study|Death|6|||
30916564|NCT02131064|58952242|FG000|Overall Study|Lost to Follow-up|4|||
30916565|NCT02131064|58952243|FG001|Overall Study|Lost to Follow-up|8|||
30916566|NCT02131064|58952242|FG000|Overall Study|Withdrawal by Subject|14|||
30916567|NCT02131064|58952243|FG001|Overall Study|Withdrawal by Subject|18|||
30916568|NCT02131064|58952242|FG000|Overall Study|Other|2|||
30825670|NCT02781584|58848276|FG009|Treatment Phase|Withdrew Consent|0|||
30825671|NCT02781584|58848277|FG010|Treatment Phase|Withdrew Consent|1|||
30916569|NCT02131064|58952243|FG001|Overall Study|Other|2|||
30916570|NCT02130986|58952252|FG000|Overall Study|Withdrawal by Subject|4|||
30916571|NCT02130986|58952253|FG001|Overall Study|Withdrawal by Subject|4|||
30916572|NCT02130986|58952252|FG000|Overall Study|Lost to Follow-up|151|||
30916573|NCT02130986|58952253|FG001|Overall Study|Lost to Follow-up|160|||
30916574|NCT02130284|58952261|FG000|Overall Study|Withdrawal by Subject|3|||
30916575|NCT02130284|58952261|FG000|Overall Study|Subject Withdrew Consent|1|||
30916576|NCT02130284|58952261|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
30916577|NCT02130284|58952261|FG000|Overall Study|Subject was screened as backup for study|3|||
30916578|NCT02130284|58952261|FG000|Overall Study|Screen Failure|1|||
30916579|NCT02147288|58952267|FG000|Overall Study|post-operative hematoma|1|||
30916580|NCT02147288|58952268|FG001|Overall Study|post-operative hematoma|1|||
30916581|NCT02147288|58952269|FG002|Overall Study|post-operative hematoma|0|||
30825672|NCT02781584|58848278|FG011|Treatment Phase|Withdrew Consent|2|||
30825673|NCT02781584|58848279|FG012|Treatment Phase|Withdrew Consent|0|||
30825674|NCT02781584|58848267|FG000|Treatment Phase|Adverse Event|0|||
30825675|NCT02781584|58848268|FG001|Treatment Phase|Adverse Event|0|||
30825676|NCT02781584|58848269|FG002|Treatment Phase|Adverse Event|0|||
30825677|NCT02781584|58848270|FG003|Treatment Phase|Adverse Event|0|||
30916582|NCT02147288|58952270|FG003|Overall Study|post-operative hematoma|0|||
30916583|NCT02147288|58952271|FG004|Overall Study|post-operative hematoma|0|||
30916584|NCT02147288|58952272|FG005|Overall Study|post-operative hematoma|0|||
30916585|NCT02147288|58952273|FG006|Overall Study|post-operative hematoma|0|||
30916586|NCT02147288|58952274|FG007|Overall Study|post-operative hematoma|0|||
30916587|NCT02147288|58952275|FG008|Overall Study|post-operative hematoma|0|||
30916588|NCT02147288|58952276|FG009|Overall Study|post-operative hematoma|0|||
30916589|NCT02147288|58952267|FG000|Overall Study|complications from concurrent hernia rep|0|||
30916590|NCT02147288|58952268|FG001|Overall Study|complications from concurrent hernia rep|1|||
30916591|NCT02147288|58952269|FG002|Overall Study|complications from concurrent hernia rep|0|||
30825678|NCT02781584|58848271|FG004|Treatment Phase|Adverse Event|0|||
30916592|NCT02147288|58952270|FG003|Overall Study|complications from concurrent hernia rep|0|||
30825679|NCT02781584|58848272|FG005|Treatment Phase|Adverse Event|0|||
30825680|NCT02781584|58848273|FG006|Treatment Phase|Adverse Event|0|||
30825681|NCT02781584|58848274|FG007|Treatment Phase|Adverse Event|1|||
30825682|NCT02781584|58848275|FG008|Treatment Phase|Adverse Event|0|||
30916593|NCT02147288|58952271|FG004|Overall Study|complications from concurrent hernia rep|0|||
30916594|NCT02147288|58952272|FG005|Overall Study|complications from concurrent hernia rep|0|||
30916595|NCT02147288|58952273|FG006|Overall Study|complications from concurrent hernia rep|0|||
30916596|NCT02147288|58952274|FG007|Overall Study|complications from concurrent hernia rep|0|||
30916597|NCT02147288|58952275|FG008|Overall Study|complications from concurrent hernia rep|0|||
30916598|NCT02147288|58952276|FG009|Overall Study|complications from concurrent hernia rep|0|||
30916599|NCT02147132|58952282|FG000|Overall Study|Lost to Follow-up|1|||
30916600|NCT02147132|58952283|FG001|Overall Study|Lost to Follow-up|0|||
30916601|NCT02147132|58952284|FG002|Overall Study|Lost to Follow-up|0|||
30916602|NCT02147132|58952285|FG003|Overall Study|Lost to Follow-up|0|||
30825683|NCT02781584|58848276|FG009|Treatment Phase|Adverse Event|0|||
30825684|NCT02781584|58848277|FG010|Treatment Phase|Adverse Event|0|||
30825685|NCT02781584|58848278|FG011|Treatment Phase|Adverse Event|0|||
30825686|NCT02781584|58848279|FG012|Treatment Phase|Adverse Event|0|||
30825687|NCT02776670|58848309|FG000|Overall Study|Adverse Event|0|||
30825688|NCT02776670|58848310|FG001|Overall Study|Adverse Event|2|||
30825689|NCT02776670|58848309|FG000|Overall Study|Protocol Violation|0|||
30825690|NCT02776670|58848310|FG001|Overall Study|Protocol Violation|2|||
30825691|NCT02776670|58848309|FG000|Overall Study|Withdrawal by Subject|0|||
30825692|NCT02776670|58848310|FG001|Overall Study|Withdrawal by Subject|1|||
30825693|NCT02776670|58848309|FG000|Overall Study|Other - Reason not given|0|||
30825694|NCT02776670|58848310|FG001|Overall Study|Other - Reason not given|1|||
30825695|NCT01307423|58848319|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
30825696|NCT01307423|58848320|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
30825697|NCT01307423|58848321|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
30825698|NCT01307423|58848322|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30825699|NCT01307423|58848323|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30825700|NCT01307423|58848324|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30825701|NCT01307423|58848325|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30825702|NCT01307423|58848326|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30825703|NCT01307423|58848327|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30825704|NCT01307423|58848319|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
30825705|NCT01307423|58848320|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
30825706|NCT01307423|58848321|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
30825707|NCT01307423|58848322|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30825708|NCT01307423|58848323|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30825709|NCT01307423|58848324|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30825710|NCT01307423|58848325|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30825711|NCT01307423|58848326|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30916603|NCT02146430|58952299|FG000|Overall Study|Protocol Violation|5|||
30916604|NCT02146430|58952300|FG001|Overall Study|Protocol Violation|4|||
30916605|NCT02146430|58952301|FG002|Overall Study|Protocol Violation|8|||
30916606|NCT02146430|58952302|FG003|Overall Study|Protocol Violation|6|||
30916607|NCT02146430|58952299|FG000|Overall Study|Lack of Efficacy|13|||
30916608|NCT02146430|58952300|FG001|Overall Study|Lack of Efficacy|11|||
30916609|NCT02146430|58952301|FG002|Overall Study|Lack of Efficacy|8|||
30916610|NCT02146430|58952302|FG003|Overall Study|Lack of Efficacy|5|||
30916611|NCT02146430|58952299|FG000|Overall Study|Adverse Event|20|||
30916612|NCT02146430|58952300|FG001|Overall Study|Adverse Event|40|||
30916613|NCT02146430|58952301|FG002|Overall Study|Adverse Event|32|||
30916614|NCT02146430|58952302|FG003|Overall Study|Adverse Event|49|||
30916615|NCT02146430|58952299|FG000|Overall Study|Reason missing or not reported|2|||
30916616|NCT02146430|58952300|FG001|Overall Study|Reason missing or not reported|3|||
30916617|NCT02146430|58952301|FG002|Overall Study|Reason missing or not reported|4|||
30916618|NCT02146430|58952302|FG003|Overall Study|Reason missing or not reported|5|||
30916619|NCT02146430|58952299|FG000|Overall Study|Withdrawal by Subject|27|||
30753770|NCT00135330|58763455|FG000|Overall Study|Adverse Event|2|||
30753771|NCT00135330|58763456|FG001|Overall Study|Adverse Event|5|||
30753772|NCT00135330|58763457|FG002|Overall Study|Adverse Event|1|||
30753773|NCT00135330|58763455|FG000|Overall Study|Lost to Follow-up|0|||
30753774|NCT00135330|58763456|FG001|Overall Study|Lost to Follow-up|2|||
30753775|NCT00135330|58763457|FG002|Overall Study|Lost to Follow-up|3|||
30753776|NCT00135330|58763455|FG000|Overall Study|Physician Decision|1|||
30753777|NCT00135330|58763456|FG001|Overall Study|Physician Decision|1|||
30753778|NCT00135330|58763457|FG002|Overall Study|Physician Decision|0|||
30753779|NCT00135330|58763455|FG000|Overall Study|Protocol Violation|4|||
30753780|NCT00135330|58763456|FG001|Overall Study|Protocol Violation|3|||
30753781|NCT00135330|58763457|FG002|Overall Study|Protocol Violation|3|||
30753782|NCT00135330|58763455|FG000|Overall Study|Patient Decision|5|||
30916620|NCT02146430|58952300|FG001|Overall Study|Withdrawal by Subject|29|||
30916621|NCT02146430|58952301|FG002|Overall Study|Withdrawal by Subject|30|||
30916622|NCT02146430|58952302|FG003|Overall Study|Withdrawal by Subject|34|||
30916623|NCT02129192|58952318|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
30916624|NCT02129192|58952319|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
30916625|NCT02105948|58952332|FG000|Overall Study|Adverse Event|10|||
30916626|NCT02105948|58952333|FG001|Overall Study|Adverse Event|7|||
30916627|NCT02105948|58952334|FG002|Overall Study|Adverse Event|11|||
30916628|NCT02105948|58952335|FG003|Overall Study|Adverse Event|11|||
30916629|NCT02105948|58952332|FG000|Overall Study|Lack of Efficacy|0|||
30916630|NCT02105948|58952333|FG001|Overall Study|Lack of Efficacy|1|||
30916631|NCT02105948|58952334|FG002|Overall Study|Lack of Efficacy|3|||
30916632|NCT02105948|58952335|FG003|Overall Study|Lack of Efficacy|2|||
30916633|NCT02105948|58952332|FG000|Overall Study|Lost to Follow-up|0|||
30916634|NCT02105948|58952333|FG001|Overall Study|Lost to Follow-up|0|||
30916635|NCT02105948|58952334|FG002|Overall Study|Lost to Follow-up|2|||
30916636|NCT02105948|58952335|FG003|Overall Study|Lost to Follow-up|1|||
30916637|NCT02105948|58952332|FG000|Overall Study|Physician Decision|2|||
30916638|NCT02105948|58952333|FG001|Overall Study|Physician Decision|2|||
30916639|NCT02105948|58952334|FG002|Overall Study|Physician Decision|2|||
30916640|NCT02105948|58952335|FG003|Overall Study|Physician Decision|2|||
30916641|NCT02105948|58952332|FG000|Overall Study|Withdrawal by Subject|15|||
30916642|NCT02105948|58952333|FG001|Overall Study|Withdrawal by Subject|10|||
30916643|NCT02105948|58952334|FG002|Overall Study|Withdrawal by Subject|10|||
30916644|NCT02105948|58952335|FG003|Overall Study|Withdrawal by Subject|11|||
30916645|NCT02128724|58952350|FG000|Overall Study|Death|1|||
30916646|NCT02128724|58952351|FG001|Overall Study|Death|0|||
30916647|NCT02128724|58952352|FG002|Overall Study|Death|0|||
30916648|NCT02128724|58952353|FG003|Overall Study|Death|0|||
30916649|NCT02128724|58952350|FG000|Overall Study|Adverse Event|0|||
30916650|NCT02128724|58952351|FG001|Overall Study|Adverse Event|1|||
30916651|NCT02128724|58952352|FG002|Overall Study|Adverse Event|0|||
30916652|NCT02128724|58952353|FG003|Overall Study|Adverse Event|0|||
30916653|NCT02128724|58952350|FG000|Overall Study|Physician Decision|0|||
30916654|NCT02128724|58952351|FG001|Overall Study|Physician Decision|0|||
30916655|NCT02128724|58952352|FG002|Overall Study|Physician Decision|0|||
30916656|NCT02128724|58952353|FG003|Overall Study|Physician Decision|2|||
30916657|NCT02128724|58952350|FG000|Overall Study|Withdrawal by Subject|0|||
30916658|NCT02128724|58952351|FG001|Overall Study|Withdrawal by Subject|0|||
30916659|NCT02128724|58952352|FG002|Overall Study|Withdrawal by Subject|0|||
30916660|NCT02128724|58952353|FG003|Overall Study|Withdrawal by Subject|1|||
30916661|NCT02128490|58952367|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
30916662|NCT02128490|58952368|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
30916663|NCT02128490|58952369|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
30916664|NCT02128490|58952370|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
30916665|NCT02128490|58952371|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
30916666|NCT02128490|58952367|FG000|Overall Study|Major Protocol Deviation|1|||
30916667|NCT02128490|58952368|FG001|Overall Study|Major Protocol Deviation|2|||
30916668|NCT02128490|58952369|FG002|Overall Study|Major Protocol Deviation|0|||
30916669|NCT02128490|58952370|FG003|Overall Study|Major Protocol Deviation|2|||
30916670|NCT02128490|58952371|FG004|Overall Study|Major Protocol Deviation|2|||
30916671|NCT02128490|58952367|FG000|Overall Study|Lost to Follow-up|0|||
30916672|NCT02128490|58952368|FG001|Overall Study|Lost to Follow-up|0|||
30916673|NCT02128490|58952369|FG002|Overall Study|Lost to Follow-up|1|||
30753783|NCT00135330|58763456|FG001|Overall Study|Patient Decision|1|||
30753784|NCT00135330|58763457|FG002|Overall Study|Patient Decision|4|||
30753785|NCT00135330|58763455|FG000|Overall Study|Sponsor Decision|0|||
30753786|NCT00135330|58763456|FG001|Overall Study|Sponsor Decision|1|||
30753787|NCT00135330|58763457|FG002|Overall Study|Sponsor Decision|0|||
30916674|NCT02128490|58952370|FG003|Overall Study|Lost to Follow-up|1|||
30916675|NCT02128490|58952371|FG004|Overall Study|Lost to Follow-up|1|||
30916676|NCT02128490|58952367|FG000|Overall Study|Voluntary Withdrawal|3|||
30916677|NCT02128490|58952368|FG001|Overall Study|Voluntary Withdrawal|3|||
30916678|NCT02128490|58952369|FG002|Overall Study|Voluntary Withdrawal|1|||
30916679|NCT02128490|58952370|FG003|Overall Study|Voluntary Withdrawal|1|||
30753788|NCT00134784|58763469|FG000|Overall Study|Withdrawal by Subject|2|||
30916680|NCT02128490|58952371|FG004|Overall Study|Voluntary Withdrawal|2|||
30916681|NCT02128490|58952367|FG000|Overall Study|Lack of Efficacy|0|||
30916682|NCT02128490|58952368|FG001|Overall Study|Lack of Efficacy|1|||
30916683|NCT02128490|58952369|FG002|Overall Study|Lack of Efficacy|0|||
30753789|NCT00134784|58763470|FG001|Overall Study|Withdrawal by Subject|2|||
30916684|NCT02128490|58952370|FG003|Overall Study|Lack of Efficacy|0|||
30916685|NCT02128490|58952371|FG004|Overall Study|Lack of Efficacy|0|||
30916686|NCT02128490|58952367|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
30916687|NCT02128490|58952368|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
30753790|NCT00134784|58763471|FG002|Overall Study|Withdrawal by Subject|2|||
30916688|NCT02128490|58952369|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
30916689|NCT02128490|58952370|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
30916690|NCT02128490|58952371|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
30916691|NCT02128490|58952367|FG000|Overall Study|Other Miscellaneous Reasons|0|||
30916692|NCT02128490|58952368|FG001|Overall Study|Other Miscellaneous Reasons|0|||
30916693|NCT02128490|58952369|FG002|Overall Study|Other Miscellaneous Reasons|2|||
30916694|NCT02128490|58952370|FG003|Overall Study|Other Miscellaneous Reasons|1|||
30916695|NCT02128490|58952371|FG004|Overall Study|Other Miscellaneous Reasons|1|||
30916696|NCT02146352|58952383|FG000|Overall Study|Death|1|||
30916697|NCT02146352|58952383|FG000|Overall Study|Patient entered hospice care|1|||
30916698|NCT02146274|58952387|FG000|Overall Study|Protocol Violation|73|||
30916699|NCT02105636|58952396|FG000|Pre-Treatment|Disease Progression|1|||
30916700|NCT02105636|58952397|FG001|Pre-Treatment|Disease Progression|0|||
30916701|NCT02105636|58952396|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
30916702|NCT02105636|58952397|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
30916703|NCT02105636|58952396|FG000|Pre-Treatment|Participant withdrew consent|0|||
30916704|NCT02105636|58952397|FG001|Pre-Treatment|Participant withdrew consent|6|||
30916705|NCT02105636|58952396|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
30916706|NCT02105636|58952397|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
30916707|NCT02105636|58952396|FG000|Treatment|Study Drug Toxicity|14|||
30916708|NCT02105636|58952397|FG001|Treatment|Study Drug Toxicity|10|||
30916709|NCT02105636|58952396|FG000|Treatment|Adverse event unrelated to study drug|19|||
30916710|NCT02105636|58952397|FG001|Treatment|Adverse event unrelated to study drug|3|||
30916711|NCT02105636|58952396|FG000|Treatment|Participant request to discontinue study treatment|8|||
30916712|NCT02105636|58952397|FG001|Treatment|Participant request to discontinue study treatment|6|||
30916713|NCT02105636|58952396|FG000|Treatment|Participant withdrew consent|5|||
30916714|NCT02105636|58952397|FG001|Treatment|Participant withdrew consent|1|||
30916715|NCT02105636|58952396|FG000|Treatment|Lost to Follow-up|1|||
30916716|NCT02105636|58952397|FG001|Treatment|Lost to Follow-up|0|||
30916717|NCT02105636|58952396|FG000|Treatment|Maximum Clinical Benefit|1|||
30916718|NCT02105636|58952397|FG001|Treatment|Maximum Clinical Benefit|3|||
30916719|NCT02105636|58952396|FG000|Treatment|Poor/Non-compliance|0|||
30916720|NCT02105636|58952397|FG001|Treatment|Poor/Non-compliance|1|||
30916721|NCT02105636|58952396|FG000|Treatment|Participant no longer meets study criteria|1|||
30916722|NCT02105636|58952397|FG001|Treatment|Participant no longer meets study criteria|0|||
30916723|NCT02105636|58952396|FG000|Treatment|Other reasons|1|||
30916724|NCT02105636|58952397|FG001|Treatment|Other reasons|0|||
30916725|NCT02105636|58952396|FG000|Treatment|Disease Progression|185|||
30916726|NCT02105636|58952397|FG001|Treatment|Disease Progression|87|||
30916727|NCT01626872|58952406|FG000|Overall Study|Physician Decision|13|||
30916728|NCT01626872|58952407|FG001|Overall Study|Physician Decision|9|||
30916729|NCT01626872|58952408|FG002|Overall Study|Physician Decision|6|||
30916730|NCT01626872|58952406|FG000|Overall Study|Withdrawal by Subject|19|||
30916731|NCT01626872|58952407|FG001|Overall Study|Withdrawal by Subject|27|||
30916732|NCT01626872|58952408|FG002|Overall Study|Withdrawal by Subject|8|||
30916733|NCT01626872|58952406|FG000|Overall Study|Adverse Event (including Death)|20|||
30916734|NCT01626872|58952407|FG001|Overall Study|Adverse Event (including Death)|28|||
30916735|NCT01626872|58952408|FG002|Overall Study|Adverse Event (including Death)|8|||
30916736|NCT01626872|58952406|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
30916737|NCT01626872|58952407|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
30916738|NCT01626872|58952408|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
30916739|NCT01598090|58952419|FG000|Treatment Period|Poor/non-compliance|0|||
30916740|NCT01598090|58952420|FG001|Treatment Period|Poor/non-compliance|2|||
30916741|NCT01598090|58952421|FG002|Treatment Period|Poor/non-compliance|0|||
30916742|NCT01598090|58952419|FG000|Treatment Period|No longer meet study criteria|0|||
30916743|NCT01598090|58952420|FG001|Treatment Period|No longer meet study criteria|1|||
30916744|NCT01598090|58952421|FG002|Treatment Period|No longer meet study criteria|0|||
30916745|NCT01598090|58952419|FG000|Treatment Period|Lack of Efficacy|5|||
30916746|NCT01598090|58952420|FG001|Treatment Period|Lack of Efficacy|14|||
30916747|NCT01598090|58952421|FG002|Treatment Period|Lack of Efficacy|6|||
30916748|NCT01598090|58952419|FG000|Treatment Period|Adverse Event|2|||
30916749|NCT01598090|58952420|FG001|Treatment Period|Adverse Event|33|||
30916750|NCT01598090|58952421|FG002|Treatment Period|Adverse Event|17|||
30916751|NCT01598090|58952419|FG000|Treatment Period|Other reasons|0|||
30916752|NCT01598090|58952420|FG001|Treatment Period|Other reasons|4|||
30623234|NCT01163916|58635075|FG002|Overall Study|Withdrawal by Subject|2|||
30623235|NCT01163916|58635073|FG000|Overall Study|Adverse Event|2|||
30916753|NCT01598090|58952421|FG002|Treatment Period|Other reasons|1|||
30916754|NCT01598090|58952419|FG000|Treatment Period|Withdrawal by Subject|3|||
30916755|NCT01598090|58952420|FG001|Treatment Period|Withdrawal by Subject|13|||
30916756|NCT01598090|58952421|FG002|Treatment Period|Withdrawal by Subject|10|||
30916757|NCT01598090|58952419|FG000|Treatment Period|Lost to Follow-up|1|||
30916758|NCT01598090|58952420|FG001|Treatment Period|Lost to Follow-up|5|||
30916759|NCT01598090|58952421|FG002|Treatment Period|Lost to Follow-up|1|||
30916760|NCT01598090|58952419|FG000|Follow-up Period|Death|0|||
30916761|NCT01598090|58952420|FG001|Follow-up Period|Death|1|||
30916762|NCT01598090|58952421|FG002|Follow-up Period|Death|0|||
30916763|NCT01598090|58952419|FG000|Follow-up Period|No longer required per protocol|1|||
30916764|NCT01598090|58952420|FG001|Follow-up Period|No longer required per protocol|3|||
30916765|NCT01598090|58952421|FG002|Follow-up Period|No longer required per protocol|2|||
30916766|NCT01598090|58952419|FG000|Follow-up Period|Not reported|0|||
30916767|NCT01598090|58952420|FG001|Follow-up Period|Not reported|10|||
30916768|NCT01598090|58952421|FG002|Follow-up Period|Not reported|4|||
30916769|NCT01598090|58952419|FG000|Follow-up Period|Withdrawal by Subject|0|||
30916770|NCT01598090|58952420|FG001|Follow-up Period|Withdrawal by Subject|3|||
30916771|NCT01598090|58952421|FG002|Follow-up Period|Withdrawal by Subject|2|||
30916772|NCT01598090|58952419|FG000|Follow-up Period|Other reasons|2|||
30916773|NCT01598090|58952420|FG001|Follow-up Period|Other reasons|8|||
30916774|NCT01598090|58952421|FG002|Follow-up Period|Other reasons|8|||
30916775|NCT01598090|58952419|FG000|Follow-up Period|Lost to Follow-up|2|||
30916776|NCT01598090|58952420|FG001|Follow-up Period|Lost to Follow-up|10|||
30916777|NCT01598090|58952421|FG002|Follow-up Period|Lost to Follow-up|12|||
30916778|NCT02105012|58952432|FG000|Overall Study|Withdrawal by Subject|11|||
30916779|NCT02105012|58952432|FG000|Overall Study|Protocol Specified Criteria|9|||
30916780|NCT02105012|58952432|FG000|Overall Study|Lost to Follow-up|4|||
30916781|NCT02105012|58952432|FG000|Overall Study|Protocol Violation|4|||
30916782|NCT02105012|58952432|FG000|Overall Study|Physician Decision|3|||
30916783|NCT02105012|58952432|FG000|Overall Study|Adverse Event|1|||
30916784|NCT02105012|58952432|FG000|Overall Study|Lack of Efficacy|1|||
30916785|NCT02145182|58952446|FG000|Overall Study|Adverse Event|4|||
30916786|NCT02145182|58952447|FG001|Overall Study|Adverse Event|1|||
30916787|NCT02145182|58952446|FG000|Overall Study|Death|7|||
30916788|NCT02145182|58952447|FG001|Overall Study|Death|7|||
30916789|NCT02145182|58952446|FG000|Overall Study|Lost to Follow-up|2|||
30916790|NCT02145182|58952447|FG001|Overall Study|Lost to Follow-up|2|||
30916791|NCT02145182|58952446|FG000|Overall Study|Pre-transplant Withdrawal|0|||
30916792|NCT02145182|58952447|FG001|Overall Study|Pre-transplant Withdrawal|2|||
30916793|NCT02145182|58952446|FG000|Overall Study|Withdrawal by Subject|5|||
30916794|NCT02145182|58952447|FG001|Overall Study|Withdrawal by Subject|4|||
30916795|NCT02145026|58952453|FG000|Overall Study|Adverse Event|2|||
30916796|NCT02145026|58952453|FG000|Overall Study|Death|4|||
30916797|NCT02145026|58952453|FG000|Overall Study|Withdrawal by Subject|2|||
30623236|NCT01163916|58635074|FG001|Overall Study|Adverse Event|0|||
30825712|NCT01307423|58848327|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30825713|NCT01307423|58848319|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
30825714|NCT01307423|58848320|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
30825715|NCT01307423|58848321|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
30825716|NCT01307423|58848322|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30825717|NCT01307423|58848323|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30825718|NCT01307423|58848324|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30825719|NCT01307423|58848325|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30825720|NCT01307423|58848326|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30825721|NCT01307423|58848327|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30825722|NCT01307423|58848319|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30825723|NCT01307423|58848320|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30825724|NCT01307423|58848321|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
30825725|NCT01307423|58848322|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30825726|NCT01307423|58848323|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30825727|NCT01307423|58848324|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30825728|NCT01307423|58848325|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30825729|NCT01307423|58848326|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30825730|NCT01307423|58848327|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30916798|NCT02145026|58952453|FG000|Overall Study|Physician Decision|4|||
30916799|NCT02144012|58952459|FG000|Overall Study|Adverse Event|1|||
30916800|NCT02144012|58952460|FG001|Overall Study|Adverse Event|0|||
30916801|NCT02144012|58952459|FG000|Overall Study|Death|1|||
30916802|NCT02144012|58952460|FG001|Overall Study|Death|0|||
30916803|NCT02144012|58952459|FG000|Overall Study|Withdrawal by Subject|11|||
30916804|NCT02144012|58952460|FG001|Overall Study|Withdrawal by Subject|3|||
30916805|NCT02144012|58952459|FG000|Overall Study|Study Terminated by Sponsor|18|||
30916806|NCT02144012|58952460|FG001|Overall Study|Study Terminated by Sponsor|12|||
30916807|NCT02144012|58952459|FG000|Overall Study|Other|3|||
30916808|NCT02144012|58952460|FG001|Overall Study|Other|0|||
30916809|NCT02103062|58952468|FG000|Overall Study|Adverse Event|1|||
30916810|NCT02103062|58952469|FG001|Overall Study|Adverse Event|2|||
30916811|NCT02103062|58952468|FG000|Overall Study|Progressive Disease|17|||
30916812|NCT02103062|58952469|FG001|Overall Study|Progressive Disease|20|||
30916813|NCT02103062|58952468|FG000|Overall Study|Death|0|||
30916814|NCT02103062|58952469|FG001|Overall Study|Death|1|||
30916815|NCT02141984|58952477|FG000|Overall Study|Lack of Efficacy|2|||
30916816|NCT02141672|58952484|FG000|Overall Study|Adverse Event|0|||
30916817|NCT02141672|58952485|FG001|Overall Study|Adverse Event|1|||
30916818|NCT02141672|58952486|FG002|Overall Study|Adverse Event|0|||
30916819|NCT02141672|58952484|FG000|Overall Study|Death|10|||
30916820|NCT02141672|58952485|FG001|Overall Study|Death|2|||
30916821|NCT02141672|58952486|FG002|Overall Study|Death|1|||
30916822|NCT02141672|58952484|FG000|Overall Study|Lack of Efficacy|0|||
30916823|NCT02141672|58952485|FG001|Overall Study|Lack of Efficacy|0|||
30916824|NCT02141672|58952486|FG002|Overall Study|Lack of Efficacy|2|||
30916825|NCT02141672|58952484|FG000|Overall Study|Lost to Follow-up|1|||
30916826|NCT02141672|58952485|FG001|Overall Study|Lost to Follow-up|1|||
30916827|NCT02141672|58952486|FG002|Overall Study|Lost to Follow-up|3|||
30916828|NCT02141672|58952484|FG000|Overall Study|Physician Decision|1|||
30916829|NCT02141672|58952485|FG001|Overall Study|Physician Decision|2|||
30916830|NCT02141672|58952486|FG002|Overall Study|Physician Decision|5|||
30916831|NCT02141672|58952484|FG000|Overall Study|Protocol Violation|0|||
30916832|NCT02141672|58952485|FG001|Overall Study|Protocol Violation|0|||
30916833|NCT02141672|58952486|FG002|Overall Study|Protocol Violation|1|||
30916834|NCT02141672|58952484|FG000|Overall Study|Withdrawal by Subject|3|||
30916835|NCT02141672|58952485|FG001|Overall Study|Withdrawal by Subject|2|||
30916836|NCT02141672|58952486|FG002|Overall Study|Withdrawal by Subject|5|||
30916837|NCT02141672|58952484|FG000|Overall Study|refused to follow-up|1|||
30916838|NCT02141672|58952485|FG001|Overall Study|refused to follow-up|0|||
30916839|NCT02141672|58952486|FG002|Overall Study|refused to follow-up|1|||
30916840|NCT02141516|58952497|FG000|Overall Study|Adverse Event|0|||
30916841|NCT02141516|58952498|FG001|Overall Study|Adverse Event|1|||
30916842|NCT02141516|58952499|FG002|Overall Study|Adverse Event|0|||
30916843|NCT02141516|58952497|FG000|Overall Study|Lost to Follow-up|0|||
30916844|NCT02141516|58952498|FG001|Overall Study|Lost to Follow-up|1|||
30916845|NCT02141516|58952499|FG002|Overall Study|Lost to Follow-up|0|||
30916846|NCT02141516|58952497|FG000|Overall Study|Other|0|||
30916847|NCT02141516|58952498|FG001|Overall Study|Other|3|||
30916848|NCT02141516|58952499|FG002|Overall Study|Other|0|||
30916849|NCT02141360|58952513|FG000|Overall Study|Withdrawal by Subject|6|||
30916850|NCT02141360|58952514|FG001|Overall Study|Withdrawal by Subject|0|||
30753791|NCT00134784|58763472|FG003|Overall Study|Withdrawal by Subject|1|||
30753792|NCT00134082|58763479|FG000|Overall Study|Adverse Event|2|||
30753793|NCT00134082|58763479|FG000|Overall Study|Death|1|||
30753794|NCT03703336|58763485|FG000|Overall Study|Parent withdrew consent|29|||
30753795|NCT03703336|58763486|FG001|Overall Study|Parent withdrew consent|8|||
30753796|NCT03703336|58763485|FG000|Overall Study|Migration|3|||
30753797|NCT03703336|58763486|FG001|Overall Study|Migration|3|||
30753798|NCT03703336|58763485|FG000|Overall Study|Protocol Violation|3|||
30753799|NCT03703336|58763486|FG001|Overall Study|Protocol Violation|1|||
30753800|NCT03703336|58763485|FG000|Overall Study|Physician Decision|2|||
30753801|NCT03703336|58763486|FG001|Overall Study|Physician Decision|0|||
30753802|NCT03703336|58763485|FG000|Overall Study|Adverse Event|0|||
30753803|NCT03703336|58763486|FG001|Overall Study|Adverse Event|2|||
30753804|NCT03703336|58763485|FG000|Overall Study|Lost to Follow-up|1|||
30753805|NCT03703336|58763486|FG001|Overall Study|Lost to Follow-up|0|||
30753806|NCT03702166|58763492|FG000|Overall Study|Lost to Follow-up|1|||
30753807|NCT03702166|58763492|FG000|Overall Study|Withdrawal by Subject|1|||
30753808|NCT00132678|58763499|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
30753809|NCT00132678|58763500|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
30825731|NCT01307423|58848319|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
30825732|NCT01307423|58848320|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
30825733|NCT01307423|58848321|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
30825734|NCT01307423|58848322|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30825735|NCT01307423|58848323|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30825736|NCT01307423|58848324|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30825737|NCT01307423|58848325|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30825738|NCT01307423|58848326|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30916851|NCT02141360|58952515|FG002|Overall Study|Withdrawal by Subject|0|||
30916852|NCT02141360|58952513|FG000|Overall Study|Study Terminated before Visit|1|||
30753810|NCT00132678|58763501|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
30753811|NCT00132678|58763499|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
30753812|NCT00132678|58763500|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
30916853|NCT02141360|58952514|FG001|Overall Study|Study Terminated before Visit|0|||
30916854|NCT02141360|58952515|FG002|Overall Study|Study Terminated before Visit|0|||
30916855|NCT01628198|58952523|FG000|Overall Study|Lost to Follow-up|7|||
30916856|NCT01628198|58952523|FG000|Overall Study|Withdrawal by Subject|10|||
30916857|NCT01628198|58952523|FG000|Overall Study|Screen failure|1|||
30916858|NCT01628120|58952527|FG000|Overall Study|Withdrawal by Subject|7|||
30916859|NCT01628120|58952527|FG000|Overall Study|Adverse Event|12|||
30916860|NCT01628120|58952527|FG000|Overall Study|Lost to Follow-up|1|||
30916861|NCT01628120|58952527|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
30916862|NCT01628120|58952527|FG000|Overall Study|Non-compliant with Study Procedures|1|||
30916863|NCT01628120|58952527|FG000|Overall Study|Not Treated|3|||
30916864|NCT01628120|58952527|FG000|Overall Study|Sponsor Decision|5|||
30916865|NCT01628120|58952527|FG000|Overall Study|Switched Dialysis Method|2|||
30825739|NCT01307423|58848327|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30825740|NCT01307423|58848319|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
30825741|NCT01307423|58848320|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30916866|NCT01628120|58952527|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
30916867|NCT01628120|58952527|FG000|Overall Study|Moved or Relocated|5|||
30916868|NCT01628120|58952527|FG000|Overall Study|Kidney Transplant|2|||
30916869|NCT01628120|58952527|FG000|Overall Study|Use of Standard of Care|1|||
30916870|NCT01627340|58952533|FG000|Overall Study|Adverse Event|1|||
30916871|NCT01627340|58952534|FG001|Overall Study|Adverse Event|0|||
30916872|NCT01627340|58952533|FG000|Overall Study|Lost to Follow-up|8|||
30916873|NCT01627340|58952534|FG001|Overall Study|Lost to Follow-up|4|||
30916874|NCT01627340|58952533|FG000|Overall Study|Pregnancy|1|||
30916875|NCT01627340|58952534|FG001|Overall Study|Pregnancy|0|||
30916876|NCT01627340|58952533|FG000|Overall Study|Withdrawal by Subject|2|||
30916877|NCT01627340|58952534|FG001|Overall Study|Withdrawal by Subject|0|||
30916878|NCT02125838|58952544|FG000|Overall Study|Lost to Follow-up|4|||
30916879|NCT02125838|58952545|FG001|Overall Study|Lost to Follow-up|4|||
30916880|NCT02125604|58952551|FG000|Overall Study|Other|4|||
30916881|NCT02125604|58952551|FG000|Overall Study|Investigator Decision|1|||
30916882|NCT02125604|58952551|FG000|Overall Study|Lost to Follow-up|2|||
30916883|NCT02125604|58952551|FG000|Overall Study|Consent Withdrawn|4|||
30916884|NCT02125604|58952551|FG000|Overall Study|Adverse Event|20|||
30916885|NCT02124746|58952558|FG000|Overall Study|Adverse Event|2|||
30916886|NCT02124746|58952559|FG001|Overall Study|Adverse Event|1|||
30916887|NCT02124746|58952560|FG002|Overall Study|Adverse Event|2|||
30916888|NCT02124746|58952558|FG000|Overall Study|Death|2|||
30916889|NCT02124746|58952559|FG001|Overall Study|Death|1|||
30916890|NCT02124746|58952560|FG002|Overall Study|Death|3|||
30916891|NCT02124746|58952558|FG000|Overall Study|Lack of Efficacy|3|||
30916892|NCT02124746|58952559|FG001|Overall Study|Lack of Efficacy|2|||
30916893|NCT02124746|58952560|FG002|Overall Study|Lack of Efficacy|2|||
30916894|NCT02124746|58952558|FG000|Overall Study|Physician Decision|6|||
30916895|NCT02124746|58952559|FG001|Overall Study|Physician Decision|4|||
30916896|NCT02124746|58952560|FG002|Overall Study|Physician Decision|5|||
30916897|NCT02124746|58952558|FG000|Overall Study|Non-Compliance with Study Drug|0|||
30916898|NCT02124746|58952559|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30916899|NCT02124746|58952560|FG002|Overall Study|Non-Compliance with Study Drug|0|||
30916900|NCT02124746|58952558|FG000|Overall Study|Withdrawal by Subject|3|||
30916901|NCT02124746|58952559|FG001|Overall Study|Withdrawal by Subject|3|||
30825742|NCT01307423|58848321|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30825743|NCT01307423|58848322|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30825744|NCT01307423|58848323|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30825745|NCT01307423|58848324|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30825746|NCT01307423|58848325|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30825747|NCT01307423|58848326|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30825748|NCT01307423|58848327|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30825749|NCT01307423|58848319|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
30825750|NCT01307423|58848320|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
30825751|NCT01307423|58848321|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30825752|NCT01307423|58848322|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30825753|NCT01307423|58848323|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30825754|NCT01307423|58848324|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30825755|NCT01307423|58848325|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30916902|NCT02124746|58952560|FG002|Overall Study|Withdrawal by Subject|0|||
30916903|NCT02124746|58952558|FG000|Overall Study|Study Terminated by Sponsor|0|||
30916904|NCT02124746|58952559|FG001|Overall Study|Study Terminated by Sponsor|0|||
30916905|NCT02124746|58952560|FG002|Overall Study|Study Terminated by Sponsor|6|||
30916906|NCT02124746|58952558|FG000|Overall Study|Disease Progression|3|||
30916907|NCT02124746|58952559|FG001|Overall Study|Disease Progression|6|||
30916908|NCT02124746|58952560|FG002|Overall Study|Disease Progression|4|||
30825756|NCT01307423|58848326|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30916909|NCT02123966|58952568|FG000|Overall Study|Intercurrent Illness|1|||
30916910|NCT02123576|58952574|FG000|Overall Study|Adverse Event|1|||
30916911|NCT02123576|58952575|FG001|Overall Study|Adverse Event|0|||
30916912|NCT01177397|58952593|FG000|Overall Study|Protocol Violation|0|||
30825757|NCT01307423|58848327|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30825758|NCT01307423|58848319|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
30825759|NCT01307423|58848320|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
30825760|NCT01307423|58848321|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
30825761|NCT01307423|58848322|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
30825762|NCT01307423|58848323|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
30825763|NCT01307423|58848324|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
30825764|NCT01307423|58848325|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
30825765|NCT01307423|58848326|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
30825766|NCT01307423|58848327|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
30825767|NCT01307423|58848319|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
30825768|NCT01307423|58848320|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
30825769|NCT01307423|58848321|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
30916913|NCT01177397|58952594|FG001|Overall Study|Protocol Violation|0|||
30916914|NCT01177397|58952595|FG002|Overall Study|Protocol Violation|0|||
30916915|NCT01177397|58952596|FG003|Overall Study|Protocol Violation|0|||
30916916|NCT01177397|58952597|FG004|Overall Study|Protocol Violation|0|||
30916917|NCT01177397|58952598|FG005|Overall Study|Protocol Violation|1|||
30916918|NCT01177397|58952599|FG006|Overall Study|Protocol Violation|0|||
30916919|NCT01177397|58952600|FG007|Overall Study|Protocol Violation|0|||
30916920|NCT01177397|58952601|FG008|Overall Study|Protocol Violation|0|||
30916921|NCT01177397|58952602|FG009|Overall Study|Protocol Violation|0|||
30916922|NCT01177397|58952603|FG010|Overall Study|Protocol Violation|0|||
30916923|NCT01177397|58952604|FG011|Overall Study|Protocol Violation|0|||
30916924|NCT01177397|58952593|FG000|Overall Study|Lost to Follow-up|0|||
30916925|NCT01177397|58952594|FG001|Overall Study|Lost to Follow-up|0|||
30916926|NCT01177397|58952595|FG002|Overall Study|Lost to Follow-up|0|||
30916927|NCT01177397|58952596|FG003|Overall Study|Lost to Follow-up|0|||
30916928|NCT01177397|58952597|FG004|Overall Study|Lost to Follow-up|1|||
30916929|NCT01177397|58952598|FG005|Overall Study|Lost to Follow-up|0|||
30916930|NCT01177397|58952599|FG006|Overall Study|Lost to Follow-up|0|||
30916931|NCT01177397|58952600|FG007|Overall Study|Lost to Follow-up|2|||
30916932|NCT01177397|58952601|FG008|Overall Study|Lost to Follow-up|0|||
30753813|NCT00132678|58763501|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
30916933|NCT01177397|58952602|FG009|Overall Study|Lost to Follow-up|0|||
30916934|NCT01177397|58952603|FG010|Overall Study|Lost to Follow-up|0|||
30916935|NCT01177397|58952604|FG011|Overall Study|Lost to Follow-up|0|||
30916936|NCT01177397|58952593|FG000|Overall Study|Death|0|||
30916937|NCT01177397|58952594|FG001|Overall Study|Death|0|||
30916938|NCT01177397|58952595|FG002|Overall Study|Death|1|||
30916939|NCT01177397|58952596|FG003|Overall Study|Death|1|||
30753814|NCT00132678|58763499|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
30753815|NCT00132678|58763500|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
30753816|NCT00132678|58763501|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
30753817|NCT00132678|58763499|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
30753818|NCT00132678|58763500|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
30753819|NCT00132678|58763501|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
30753820|NCT00132678|58763499|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
30753821|NCT00132678|58763500|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
30753822|NCT00132678|58763501|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
30753823|NCT00132678|58763499|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
30753824|NCT00132678|58763500|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
30753825|NCT00132678|58763501|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
30753826|NCT00132678|58763499|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
30753827|NCT00132678|58763500|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
30753828|NCT00132678|58763501|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
30753829|NCT00132678|58763499|FG000|Period III (Open-Label Stabilization)|Death|2|||
30753830|NCT00132678|58763500|FG001|Period III (Open-Label Stabilization)|Death|0|||
30753831|NCT00132678|58763501|FG002|Period III (Open-Label Stabilization)|Death|0|||
30753832|NCT00132678|58763499|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
30916940|NCT01177397|58952597|FG004|Overall Study|Death|0|||
30916941|NCT01177397|58952598|FG005|Overall Study|Death|0|||
30916942|NCT01177397|58952599|FG006|Overall Study|Death|0|||
30916943|NCT01177397|58952600|FG007|Overall Study|Death|5|||
30916944|NCT01177397|58952601|FG008|Overall Study|Death|2|||
30916945|NCT01177397|58952602|FG009|Overall Study|Death|1|||
30916946|NCT01177397|58952603|FG010|Overall Study|Death|0|||
30916947|NCT01177397|58952604|FG011|Overall Study|Death|0|||
30916948|NCT01177397|58952593|FG000|Overall Study|Withdrawal by Subject|0|||
30916949|NCT01177397|58952594|FG001|Overall Study|Withdrawal by Subject|0|||
30916950|NCT01177397|58952595|FG002|Overall Study|Withdrawal by Subject|1|||
30916951|NCT01177397|58952596|FG003|Overall Study|Withdrawal by Subject|1|||
30916952|NCT01177397|58952597|FG004|Overall Study|Withdrawal by Subject|1|||
30916953|NCT01177397|58952598|FG005|Overall Study|Withdrawal by Subject|2|||
30916954|NCT01177397|58952599|FG006|Overall Study|Withdrawal by Subject|0|||
30916955|NCT01177397|58952600|FG007|Overall Study|Withdrawal by Subject|5|||
30916956|NCT01177397|58952601|FG008|Overall Study|Withdrawal by Subject|9|||
30916957|NCT01177397|58952602|FG009|Overall Study|Withdrawal by Subject|1|||
30916958|NCT01177397|58952603|FG010|Overall Study|Withdrawal by Subject|1|||
30916959|NCT01177397|58952604|FG011|Overall Study|Withdrawal by Subject|0|||
30916960|NCT01177397|58952593|FG000|Overall Study|Adverse Event|0|||
30916961|NCT01177397|58952594|FG001|Overall Study|Adverse Event|0|||
30916962|NCT01177397|58952595|FG002|Overall Study|Adverse Event|1|||
30916963|NCT01177397|58952596|FG003|Overall Study|Adverse Event|2|||
30916964|NCT01177397|58952597|FG004|Overall Study|Adverse Event|0|||
30916965|NCT01177397|58952598|FG005|Overall Study|Adverse Event|12|||
30916966|NCT01177397|58952599|FG006|Overall Study|Adverse Event|1|||
30916967|NCT01177397|58952600|FG007|Overall Study|Adverse Event|14|||
30916968|NCT01177397|58952601|FG008|Overall Study|Adverse Event|8|||
30916969|NCT01177397|58952602|FG009|Overall Study|Adverse Event|6|||
30916970|NCT01177397|58952603|FG010|Overall Study|Adverse Event|3|||
30916971|NCT01177397|58952604|FG011|Overall Study|Adverse Event|7|||
30916972|NCT01177397|58952593|FG000|Overall Study|Disease progression|1|||
30916973|NCT01177397|58952594|FG001|Overall Study|Disease progression|2|||
30916974|NCT01177397|58952595|FG002|Overall Study|Disease progression|5|||
30916975|NCT01177397|58952596|FG003|Overall Study|Disease progression|5|||
30916976|NCT01177397|58952597|FG004|Overall Study|Disease progression|4|||
30916977|NCT01177397|58952598|FG005|Overall Study|Disease progression|10|||
30916978|NCT01177397|58952599|FG006|Overall Study|Disease progression|10|||
30753833|NCT00132678|58763500|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
30825770|NCT01307423|58848322|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
30825771|NCT01307423|58848323|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
30825772|NCT01307423|58848324|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
30825773|NCT01307423|58848325|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
30825774|NCT01307423|58848326|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
30825775|NCT01307423|58848327|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
30825776|NCT01307423|58848319|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
30825777|NCT01307423|58848320|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
30825778|NCT01307423|58848321|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
30825779|NCT01307423|58848322|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
30825780|NCT01307423|58848323|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
30825781|NCT01307423|58848324|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
30825782|NCT01307423|58848325|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
30825783|NCT01307423|58848326|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
30825784|NCT01307423|58848327|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
30825785|NCT01307423|58848319|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
30825786|NCT01307423|58848320|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
30916979|NCT01177397|58952600|FG007|Overall Study|Disease progression|21|||
30916980|NCT01177397|58952601|FG008|Overall Study|Disease progression|18|||
30916981|NCT01177397|58952602|FG009|Overall Study|Disease progression|12|||
30916982|NCT01177397|58952603|FG010|Overall Study|Disease progression|10|||
30916983|NCT01177397|58952604|FG011|Overall Study|Disease progression|8|||
30753834|NCT00132678|58763501|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
30753835|NCT00132678|58763499|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
30753836|NCT00132678|58763500|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
30753837|NCT00132678|58763501|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
30753838|NCT00132678|58763499|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
30753839|NCT00132678|58763500|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
30916984|NCT01177397|58952593|FG000|Overall Study|Other reasons|0|||
30916985|NCT01177397|58952594|FG001|Overall Study|Other reasons|0|||
30916986|NCT01177397|58952595|FG002|Overall Study|Other reasons|1|||
30916987|NCT01177397|58952596|FG003|Overall Study|Other reasons|0|||
30916988|NCT01177397|58952597|FG004|Overall Study|Other reasons|1|||
30916989|NCT01177397|58952598|FG005|Overall Study|Other reasons|1|||
30916990|NCT01177397|58952599|FG006|Overall Study|Other reasons|2|||
30916991|NCT01177397|58952600|FG007|Overall Study|Other reasons|6|||
30916992|NCT01177397|58952601|FG008|Overall Study|Other reasons|10|||
30916993|NCT01177397|58952602|FG009|Overall Study|Other reasons|8|||
30916994|NCT01177397|58952603|FG010|Overall Study|Other reasons|0|||
30916995|NCT01177397|58952604|FG011|Overall Study|Other reasons|2|||
30916996|NCT00864227|58952645|FG000|Overall Study|Withdrawal by Subject|1|||
30916997|NCT00864227|58952645|FG000|Overall Study|Disease Relapse/Progression|3|||
30916998|NCT02102204|58952649|FG000|Overall Study|Withdrawal by Subject|137|||
30916999|NCT02102204|58952649|FG000|Overall Study|Death|92|||
30917000|NCT02102204|58952649|FG000|Overall Study|Lost to Follow-up|65|||
30917001|NCT02102204|58952649|FG000|Overall Study|Sponsor Decision|5|||
30917002|NCT02102204|58952649|FG000|Overall Study|Ongoing|5|||
30623237|NCT01163916|58635075|FG002|Overall Study|Adverse Event|1|||
30917003|NCT02141204|58952655|FG000|Overall Study|Lost to Follow-up|2|||
30917004|NCT02141204|58952656|FG001|Overall Study|Lost to Follow-up|1|||
30917005|NCT02141204|58952655|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
30917006|NCT02141204|58952656|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
30917007|NCT02141204|58952655|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
30917008|NCT02141204|58952656|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
30917009|NCT02141204|58952655|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
30917010|NCT02141204|58952656|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
30917011|NCT02140970|58952664|FG000|Overall Study|Lost to Follow-up|1|||
30917012|NCT02140970|58952665|FG001|Overall Study|Lost to Follow-up|2|||
30917013|NCT02140970|58952664|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
30917014|NCT02140970|58952665|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
30917015|NCT02140970|58952664|FG000|Overall Study|Did not meet inclusion criteria|0|||
30917016|NCT02140970|58952665|FG001|Overall Study|Did not meet inclusion criteria|1|||
30917017|NCT02101112|58952671|FG000|Overall Study|Adverse Event|0|||
30917018|NCT02101112|58952672|FG001|Overall Study|Adverse Event|0|||
30917019|NCT02101112|58952673|FG002|Overall Study|Adverse Event|1|||
30917020|NCT02101112|58952674|FG003|Overall Study|Adverse Event|0|||
30917021|NCT02101112|58952675|FG004|Overall Study|Adverse Event|0|||
30917022|NCT02101112|58952676|FG005|Overall Study|Adverse Event|0|||
30917023|NCT02101112|58952671|FG000|Overall Study|Withdrawal by Subject|0|||
30917024|NCT02101112|58952672|FG001|Overall Study|Withdrawal by Subject|0|||
30917025|NCT02101112|58952673|FG002|Overall Study|Withdrawal by Subject|0|||
30917026|NCT02101112|58952674|FG003|Overall Study|Withdrawal by Subject|0|||
30917027|NCT02101112|58952675|FG004|Overall Study|Withdrawal by Subject|1|||
30917028|NCT02101112|58952676|FG005|Overall Study|Withdrawal by Subject|0|||
30917029|NCT02139644|58952691|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
30917030|NCT02139644|58952692|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30917031|NCT02139644|58952693|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30917032|NCT02139644|58952694|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30917033|NCT02139644|58952695|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30917034|NCT02139644|58952696|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30917035|NCT02139644|58952691|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
30917036|NCT02139644|58952692|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30917037|NCT02139644|58952693|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30917038|NCT02139644|58952694|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30917039|NCT02139644|58952695|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30917040|NCT02139644|58952696|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30917041|NCT02139644|58952691|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
30917042|NCT02139644|58952692|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30917043|NCT02139644|58952693|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30917044|NCT02139644|58952694|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30917045|NCT02139644|58952695|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30917046|NCT02139644|58952696|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30917047|NCT02139644|58952691|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
30917048|NCT02139644|58952692|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30917049|NCT02139644|58952693|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30917050|NCT02139644|58952694|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30917051|NCT02139644|58952695|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30917052|NCT02139644|58952696|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30917053|NCT02139644|58952691|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
30917054|NCT02139644|58952692|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30917055|NCT02139644|58952693|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30917056|NCT02139644|58952694|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30917057|NCT02139644|58952695|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30917058|NCT02139644|58952696|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30917059|NCT02139644|58952691|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
30917060|NCT02139644|58952692|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
30917061|NCT02139644|58952693|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
30917062|NCT02139644|58952694|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
30917063|NCT02139644|58952695|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
30917064|NCT02139644|58952696|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
30917065|NCT02139644|58952691|FG000|Run-In Period (Pre-assignment)|Other|6|||
30917066|NCT02139644|58952692|FG001|Run-In Period (Pre-assignment)|Other|0|||
30917067|NCT02139644|58952693|FG002|Run-In Period (Pre-assignment)|Other|0|||
30917068|NCT02139644|58952694|FG003|Run-In Period (Pre-assignment)|Other|0|||
30917069|NCT02139644|58952695|FG004|Run-In Period (Pre-assignment)|Other|0|||
30825787|NCT01307423|58848321|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
30825788|NCT01307423|58848322|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
30825789|NCT01307423|58848323|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
30825790|NCT01307423|58848324|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
30825791|NCT01307423|58848325|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
30825792|NCT01307423|58848326|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
30917070|NCT02139644|58952696|FG005|Run-In Period (Pre-assignment)|Other|0|||
30917071|NCT02139644|58952691|FG000|Treatment Period|Adverse Event|0|||
30917072|NCT02139644|58952692|FG001|Treatment Period|Adverse Event|0|||
30917073|NCT02139644|58952693|FG002|Treatment Period|Adverse Event|3|||
30917074|NCT02139644|58952694|FG003|Treatment Period|Adverse Event|2|||
30917075|NCT02139644|58952695|FG004|Treatment Period|Adverse Event|1|||
30917076|NCT02139644|58952696|FG005|Treatment Period|Adverse Event|6|||
30917077|NCT02139644|58952691|FG000|Treatment Period|Withdrawal by Subject|0|||
30917078|NCT02139644|58952692|FG001|Treatment Period|Withdrawal by Subject|0|||
30917079|NCT02139644|58952693|FG002|Treatment Period|Withdrawal by Subject|2|||
30917080|NCT02139644|58952694|FG003|Treatment Period|Withdrawal by Subject|2|||
30917081|NCT02139644|58952695|FG004|Treatment Period|Withdrawal by Subject|3|||
30917082|NCT02139644|58952696|FG005|Treatment Period|Withdrawal by Subject|2|||
30917083|NCT02139644|58952691|FG000|Treatment Period|Non-compliance|0|||
30917084|NCT02139644|58952692|FG001|Treatment Period|Non-compliance|0|||
30917085|NCT02139644|58952693|FG002|Treatment Period|Non-compliance|0|||
30917086|NCT02139644|58952694|FG003|Treatment Period|Non-compliance|1|||
30917087|NCT02139644|58952695|FG004|Treatment Period|Non-compliance|0|||
30917088|NCT02139644|58952696|FG005|Treatment Period|Non-compliance|0|||
30917089|NCT02139644|58952691|FG000|Treatment Period|Protocol Violation|0|||
30917090|NCT02139644|58952692|FG001|Treatment Period|Protocol Violation|0|||
30917091|NCT02139644|58952693|FG002|Treatment Period|Protocol Violation|0|||
30917092|NCT02139644|58952694|FG003|Treatment Period|Protocol Violation|1|||
30917093|NCT02139644|58952695|FG004|Treatment Period|Protocol Violation|1|||
30917094|NCT02139644|58952696|FG005|Treatment Period|Protocol Violation|1|||
30917095|NCT02139644|58952691|FG000|Treatment Period|Disease progression|0|||
30917096|NCT02139644|58952692|FG001|Treatment Period|Disease progression|0|||
30917097|NCT02139644|58952693|FG002|Treatment Period|Disease progression|0|||
30917098|NCT02139644|58952694|FG003|Treatment Period|Disease progression|1|||
30917099|NCT02139644|58952695|FG004|Treatment Period|Disease progression|1|||
30917100|NCT02139644|58952696|FG005|Treatment Period|Disease progression|2|||
30917101|NCT02139644|58952691|FG000|Treatment Period|Lost to Follow-up|0|||
30917102|NCT02139644|58952692|FG001|Treatment Period|Lost to Follow-up|0|||
30917103|NCT02139644|58952693|FG002|Treatment Period|Lost to Follow-up|1|||
30917104|NCT02139644|58952694|FG003|Treatment Period|Lost to Follow-up|1|||
30917105|NCT02139644|58952695|FG004|Treatment Period|Lost to Follow-up|1|||
30917106|NCT02139644|58952696|FG005|Treatment Period|Lost to Follow-up|1|||
30917107|NCT02139644|58952691|FG000|Treatment Period|Lack of Efficacy|0|||
30917108|NCT02139644|58952692|FG001|Treatment Period|Lack of Efficacy|0|||
30917109|NCT02139644|58952693|FG002|Treatment Period|Lack of Efficacy|1|||
30917110|NCT02139644|58952694|FG003|Treatment Period|Lack of Efficacy|0|||
30917111|NCT02139644|58952695|FG004|Treatment Period|Lack of Efficacy|1|||
30917112|NCT02139644|58952696|FG005|Treatment Period|Lack of Efficacy|4|||
30917113|NCT02139644|58952691|FG000|Treatment Period|Other|0|||
30825793|NCT01307423|58848327|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
30825794|NCT01307423|58848319|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
30825795|NCT01307423|58848320|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
30825796|NCT01307423|58848321|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
30825797|NCT01307423|58848322|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
30825798|NCT01307423|58848323|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
30917114|NCT02139644|58952692|FG001|Treatment Period|Other|3|||
30917115|NCT02139644|58952693|FG002|Treatment Period|Other|1|||
30917116|NCT02139644|58952694|FG003|Treatment Period|Other|1|||
30917117|NCT02139644|58952695|FG004|Treatment Period|Other|0|||
30917118|NCT02139644|58952696|FG005|Treatment Period|Other|1|||
30917119|NCT02100644|58952708|FG000|LTG Escalation Phase|Adverse Event|9|||
30917120|NCT02100644|58952709|FG001|LTG Escalation Phase|Adverse Event|0|||
30917121|NCT02100644|58952710|FG002|LTG Escalation Phase|Adverse Event|0|||
30917122|NCT02100644|58952708|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
30917123|NCT02100644|58952709|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
30917124|NCT02100644|58952710|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
30917125|NCT02100644|58952708|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
30917126|NCT02100644|58952709|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
30917127|NCT02100644|58952710|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
30917128|NCT02074982|58952716|FG000|Overall Study|Adverse Event|15|||
30917129|NCT02074982|58952717|FG001|Overall Study|Adverse Event|7|||
30917130|NCT02074982|58952716|FG000|Overall Study|Lack of Efficacy|6|||
30917131|NCT02074982|58952717|FG001|Overall Study|Lack of Efficacy|1|||
30917132|NCT02074982|58952716|FG000|Overall Study|Lost to Follow-up|9|||
30917133|NCT02074982|58952717|FG001|Overall Study|Lost to Follow-up|10|||
30917134|NCT02074982|58952716|FG000|Overall Study|Non-compliance with study treatment|0|||
30917135|NCT02074982|58952717|FG001|Overall Study|Non-compliance with study treatment|2|||
30917136|NCT02074982|58952716|FG000|Overall Study|Physician Decision|1|||
30917137|NCT02074982|58952717|FG001|Overall Study|Physician Decision|1|||
30917138|NCT02074982|58952716|FG000|Overall Study|Pregnancy|1|||
30917139|NCT02074982|58952717|FG001|Overall Study|Pregnancy|2|||
30917140|NCT02074982|58952716|FG000|Overall Study|Protocol deviation|4|||
30917141|NCT02074982|58952717|FG001|Overall Study|Protocol deviation|3|||
30917142|NCT02074982|58952716|FG000|Overall Study|Technical problems|0|||
30917143|NCT02074982|58952717|FG001|Overall Study|Technical problems|2|||
30917144|NCT02074982|58952716|FG000|Overall Study|Subject/guardian decision|15|||
30917145|NCT02074982|58952717|FG001|Overall Study|Subject/guardian decision|24|||
30917146|NCT02074982|58952716|FG000|Overall Study|Death|0|||
30917147|NCT02074982|58952717|FG001|Overall Study|Death|2|||
30917148|NCT02074514|58952727|FG000|Overall Study|Lack of Efficacy|3|||
30917149|NCT02074514|58952728|FG001|Overall Study|Lack of Efficacy|2|||
30917150|NCT02074514|58952727|FG000|Overall Study|Lost to Follow-up|0|||
30917151|NCT02074514|58952728|FG001|Overall Study|Lost to Follow-up|1|||
30917152|NCT02074514|58952727|FG000|Overall Study|Withdrew Consent|0|||
30917153|NCT02074514|58952728|FG001|Overall Study|Withdrew Consent|1|||
30917154|NCT02099708|58952738|FG000|Overall Study|Data Not Available|30|||
30917155|NCT02099708|58952738|FG000|Overall Study|Lost to Follow-up|141|||
30917156|NCT02099708|58952738|FG000|Overall Study|Other|29|||
30917157|NCT02073656|58952742|FG000|Primary Study|Lost to Follow-up|6|||
30917158|NCT02073656|58952742|FG000|Primary Study|Death|1|||
30917159|NCT02073656|58952742|FG000|Primary Study|Withdrew Consent|1|||
30917160|NCT02242643|58952750|FG000|Overall Study|Protocol Violation|1|||
30917161|NCT02242643|58952751|FG001|Overall Study|Protocol Violation|2|||
30917162|NCT02242643|58952750|FG000|Overall Study|Withdrawal by Subject|15|||
30917163|NCT02242643|58952751|FG001|Overall Study|Withdrawal by Subject|10|||
30917164|NCT02242643|58952750|FG000|Overall Study|Migrated/moved from study area|1|||
30917165|NCT02242643|58952751|FG001|Overall Study|Migrated/moved from study area|3|||
30917166|NCT02242643|58952750|FG000|Overall Study|Lost to Follow-up|54|||
30917167|NCT02242643|58952751|FG001|Overall Study|Lost to Follow-up|61|||
30917168|NCT02242643|58952750|FG000|Overall Study|Child placed in foster care by family|0|||
30917169|NCT02242643|58952751|FG001|Overall Study|Child placed in foster care by family|1|||
30917170|NCT02242643|58952750|FG000|Overall Study|Non-compliance|1|||
30917171|NCT02242643|58952751|FG001|Overall Study|Non-compliance|0|||
30917172|NCT02242643|58952750|FG000|Overall Study|Consent withdrawal by parent|1|||
30917173|NCT02242643|58952751|FG001|Overall Study|Consent withdrawal by parent|0|||
30917174|NCT02242643|58952750|FG000|Overall Study|Protocol requirements not followed|1|||
30917175|NCT02242643|58952751|FG001|Overall Study|Protocol requirements not followed|0|||
30917176|NCT02242643|58952750|FG000|Overall Study|Language barrier|1|||
30917177|NCT02242643|58952751|FG001|Overall Study|Language barrier|0|||
30917178|NCT02242643|58952750|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
30917179|NCT02242643|58952751|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
30917180|NCT02097290|58952759|FG000|Overall Study|Death|6|||
30917181|NCT02097290|58952759|FG000|Overall Study|Total Withdrawals|3|||
30917182|NCT02097290|58952759|FG000|Overall Study|Attempt|8|||
30917183|NCT02072174|58952765|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
30917184|NCT02072174|58952766|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
30917185|NCT02072174|58952765|FG000|Overall Study|Protocol Violation|16|||
30917186|NCT02072174|58952766|FG001|Overall Study|Protocol Violation|23|||
30917187|NCT02072174|58952765|FG000|Overall Study|Physician Decision|0|||
30917188|NCT02072174|58952766|FG001|Overall Study|Physician Decision|1|||
30917189|NCT02072174|58952765|FG000|Overall Study|Non-compliance with protocol requirement|2|||
30917190|NCT02072174|58952766|FG001|Overall Study|Non-compliance with protocol requirement|0|||
30917191|NCT02209181|58952778|FG000|Overall Study|Adverse Event|1|||
30917192|NCT02209181|58952779|FG001|Overall Study|Adverse Event|0|||
30917193|NCT02209181|58952780|FG002|Overall Study|Adverse Event|1|||
30917194|NCT02209181|58952781|FG003|Overall Study|Adverse Event|0|||
30917195|NCT02209181|58952778|FG000|Overall Study|Withdrawal by Subject|0|||
30917196|NCT02209181|58952779|FG001|Overall Study|Withdrawal by Subject|1|||
30917197|NCT02209181|58952780|FG002|Overall Study|Withdrawal by Subject|0|||
30917198|NCT02209181|58952781|FG003|Overall Study|Withdrawal by Subject|0|||
30917199|NCT02208089|58952793|FG000|Overall Study|Withdrawal by Subject|1|||
30917200|NCT02208089|58952794|FG001|Overall Study|Withdrawal by Subject|0|||
30917201|NCT02208089|58952793|FG000|Overall Study|Lost to Follow-up|6|||
30917202|NCT02208089|58952794|FG001|Overall Study|Lost to Follow-up|0|||
30917203|NCT02242487|58952803|FG000|Overall Study|Adverse Event|13|||
30917204|NCT02242487|58952804|FG001|Overall Study|Adverse Event|15|||
30917205|NCT02242487|58952803|FG000|Overall Study|Lack of Efficacy|4|||
30917206|NCT02242487|58952804|FG001|Overall Study|Lack of Efficacy|6|||
30917207|NCT02242487|58952803|FG000|Overall Study|Protocol Violation|2|||
30917208|NCT02242487|58952804|FG001|Overall Study|Protocol Violation|0|||
30917209|NCT02242487|58952803|FG000|Overall Study|Lost to Follow-up|2|||
30917210|NCT02242487|58952804|FG001|Overall Study|Lost to Follow-up|1|||
30917211|NCT02242487|58952803|FG000|Overall Study|Other - Miscellaneous|4|||
30917212|NCT02242487|58952804|FG001|Overall Study|Other - Miscellaneous|6|||
30917213|NCT02242487|58952803|FG000|Overall Study|Withdrawal by Subject|37|||
30917214|NCT02242487|58952804|FG001|Overall Study|Withdrawal by Subject|19|||
30917215|NCT02241785|58952812|FG000|Overall Study|Sponsor Termination|43|||
30917216|NCT02241785|58952812|FG000|Overall Study|Withdrawal by Subject|1|||
30917217|NCT02241785|58952812|FG000|Overall Study|Lost to Follow-up|2|||
30917218|NCT02241785|58952812|FG000|Overall Study|Adverse Event|1|||
30917219|NCT02241551|58952818|FG000|Overall Study|Adverse Event|1|||
30917220|NCT02241551|58952819|FG001|Overall Study|Adverse Event|0|||
30825799|NCT01307423|58848324|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
30825800|NCT01307423|58848325|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
30825801|NCT01307423|58848326|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
30825802|NCT01307423|58848327|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
30825803|NCT01307423|58848319|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
30825804|NCT01307423|58848320|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
30825805|NCT01307423|58848321|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
30825806|NCT01307423|58848322|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
30825807|NCT01307423|58848323|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
30825808|NCT01307423|58848324|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
30825809|NCT01307423|58848325|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
30825810|NCT01307423|58848326|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
30825811|NCT01307423|58848327|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
30825812|NCT01307423|58848319|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
30825813|NCT01307423|58848320|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
30825814|NCT01307423|58848321|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
30825815|NCT01307423|58848322|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
30917221|NCT02207621|58952830|FG000|Overall Study|Adverse Event|71|||
30917222|NCT02207621|58952831|FG001|Overall Study|Adverse Event|15|||
30917223|NCT02207621|58952832|FG002|Overall Study|Adverse Event|132|||
30917224|NCT02207621|58952830|FG000|Overall Study|Withdrawal by Subject|9|||
30917225|NCT02207621|58952831|FG001|Overall Study|Withdrawal by Subject|9|||
30917226|NCT02207621|58952832|FG002|Overall Study|Withdrawal by Subject|13|||
30917227|NCT02207621|58952830|FG000|Overall Study|Non-Compliant|3|||
30917228|NCT02207621|58952831|FG001|Overall Study|Non-Compliant|3|||
30917229|NCT02207621|58952832|FG002|Overall Study|Non-Compliant|1|||
30917230|NCT02207621|58952830|FG000|Overall Study|Lost to Follow-up|1|||
30917231|NCT02207621|58952831|FG001|Overall Study|Lost to Follow-up|0|||
30917232|NCT02207621|58952832|FG002|Overall Study|Lost to Follow-up|3|||
30917233|NCT02207621|58952830|FG000|Overall Study|Lack of Efficacy|10|||
30917234|NCT02207621|58952831|FG001|Overall Study|Lack of Efficacy|2|||
30917235|NCT02207621|58952832|FG002|Overall Study|Lack of Efficacy|4|||
30917236|NCT02207621|58952830|FG000|Overall Study|Disallowed Concurrent Medication|2|||
30917237|NCT02207621|58952831|FG001|Overall Study|Disallowed Concurrent Medication|5|||
30917238|NCT02207621|58952832|FG002|Overall Study|Disallowed Concurrent Medication|2|||
30917239|NCT02207621|58952830|FG000|Overall Study|Physician Decision|1|||
30917240|NCT02207621|58952831|FG001|Overall Study|Physician Decision|2|||
30917241|NCT02207621|58952832|FG002|Overall Study|Physician Decision|2|||
30917242|NCT02207621|58952830|FG000|Overall Study|Protocol Violation|4|||
30917243|NCT02207621|58952831|FG001|Overall Study|Protocol Violation|10|||
30917244|NCT02207621|58952832|FG002|Overall Study|Protocol Violation|6|||
30917245|NCT02207621|58952830|FG000|Overall Study|Death|2|||
30917246|NCT02207621|58952831|FG001|Overall Study|Death|0|||
30917247|NCT02207621|58952832|FG002|Overall Study|Death|0|||
30917248|NCT02207621|58952830|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
30917249|NCT02207621|58952831|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
30917250|NCT02207621|58952832|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
30917251|NCT02240693|58952846|FG000|Overall Study|Adverse Event|0|||
30917252|NCT02240693|58952847|FG001|Overall Study|Adverse Event|0|||
30917253|NCT02240693|58952848|FG002|Overall Study|Adverse Event|0|||
30917254|NCT02240693|58952849|FG003|Overall Study|Adverse Event|0|||
30917255|NCT02240693|58952850|FG004|Overall Study|Adverse Event|1|||
30917256|NCT02240693|58952846|FG000|Overall Study|Withdrawal by Subject|0|||
30917257|NCT02240693|58952847|FG001|Overall Study|Withdrawal by Subject|0|||
30917258|NCT02240693|58952848|FG002|Overall Study|Withdrawal by Subject|2|||
30917259|NCT02240693|58952849|FG003|Overall Study|Withdrawal by Subject|1|||
30917260|NCT02240693|58952850|FG004|Overall Study|Withdrawal by Subject|0|||
30917261|NCT02240693|58952846|FG000|Overall Study|Other than specified|0|||
30917262|NCT02240693|58952847|FG001|Overall Study|Other than specified|0|||
30917263|NCT02240693|58952848|FG002|Overall Study|Other than specified|2|||
30917264|NCT02240693|58952849|FG003|Overall Study|Other than specified|0|||
30917265|NCT02240693|58952850|FG004|Overall Study|Other than specified|0|||
30917266|NCT02239679|58952867|FG000|Overall Study|Lost to Follow-up|1|||
30917267|NCT02239679|58952868|FG001|Overall Study|Lost to Follow-up|0|||
30917268|NCT02239679|58952869|FG002|Overall Study|Lost to Follow-up|0|||
30917269|NCT02239679|58952867|FG000|Overall Study|Withdrawal by Subject|2|||
30917270|NCT02239679|58952868|FG001|Overall Study|Withdrawal by Subject|3|||
30917271|NCT02239679|58952869|FG002|Overall Study|Withdrawal by Subject|1|||
30917272|NCT02072096|58952879|FG000|Overall Study|Lack of Efficacy|18|||
30917273|NCT02072096|58952880|FG001|Overall Study|Lack of Efficacy|29|||
30917274|NCT02072096|58952879|FG000|Overall Study|Protocol Violation|7|||
30917275|NCT02072096|58952880|FG001|Overall Study|Protocol Violation|7|||
30917276|NCT02072096|58952879|FG000|Overall Study|Withdrawal by Subject|5|||
30917277|NCT02072096|58952880|FG001|Overall Study|Withdrawal by Subject|7|||
30917278|NCT02072096|58952879|FG000|Overall Study|Adverse Event|5|||
30917279|NCT02072096|58952880|FG001|Overall Study|Adverse Event|2|||
30917280|NCT02072096|58952879|FG000|Overall Study|No Reason Provided|4|||
30917281|NCT02072096|58952880|FG001|Overall Study|No Reason Provided|2|||
30917282|NCT02072096|58952879|FG000|Overall Study|Death|2|||
30917283|NCT02072096|58952880|FG001|Overall Study|Death|0|||
30917284|NCT02072096|58952879|FG000|Overall Study|Physician Decision|0|||
30917285|NCT02072096|58952880|FG001|Overall Study|Physician Decision|1|||
30917286|NCT02072096|58952879|FG000|Overall Study|Study Terminated by Sponsor|43|||
30917287|NCT02072096|58952880|FG001|Overall Study|Study Terminated by Sponsor|30|||
30917288|NCT02072096|58952879|FG000|Overall Study|Lost to Follow-up|1|||
30917289|NCT02072096|58952880|FG001|Overall Study|Lost to Follow-up|0|||
30917290|NCT02071706|58952887|FG000|Overall Study|Adverse Event|1|||
30917291|NCT02071706|58952887|FG000|Overall Study|Withdrawal by Subject|2|||
30917292|NCT01631825|58952891|FG000|Overall Study|Adverse Event|42|||
30917293|NCT01631825|58952891|FG000|Overall Study|Lack of Efficacy|7|||
30917294|NCT01631825|58952891|FG000|Overall Study|Withdrawal by Subject|9|||
30917295|NCT01631825|58952891|FG000|Overall Study|Protocol Violation|4|||
30917296|NCT01631825|58952891|FG000|Overall Study|Discontinuation criteria|1|||
30917297|NCT01631825|58952891|FG000|Overall Study|Physician Decision|2|||
30917298|NCT02071082|58952897|FG000|Overall Study|Enrolled and Never Treated|1|||
30917299|NCT02071082|58952898|FG001|Overall Study|Enrolled and Never Treated|1|||
30917300|NCT02071082|58952897|FG000|Overall Study|Adverse Event|0|||
30917301|NCT02071082|58952898|FG001|Overall Study|Adverse Event|1|||
30917302|NCT02071082|58952897|FG000|Overall Study|Withdrew Consent|0|||
30917303|NCT02071082|58952898|FG001|Overall Study|Withdrew Consent|4|||
30917304|NCT02071082|58952897|FG000|Overall Study|Lost to Follow-up|1|||
30917305|NCT02071082|58952898|FG001|Overall Study|Lost to Follow-up|1|||
30917306|NCT02123108|58952906|FG000|Overall Study|Death|2|||
30917307|NCT02123108|58952907|FG001|Overall Study|Death|3|||
30917308|NCT02121392|58952915|FG000|Prior to Intervention|Protocol Violation|40|||
30917309|NCT02121392|58952916|FG001|Prior to Intervention|Protocol Violation|35|||
30917310|NCT02121392|58952915|FG000|Prior to Intervention|Withdrawal by Subject|8|||
30917311|NCT02121392|58952916|FG001|Prior to Intervention|Withdrawal by Subject|6|||
30917312|NCT02121392|58952915|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
30917313|NCT02121392|58952916|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
30917314|NCT02121392|58952915|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
30917315|NCT02121392|58952916|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
30917316|NCT02097056|58952922|FG000|Overall Study|Protocol Violation|2|||
30917317|NCT02097056|58952922|FG000|Overall Study|Withdrawal by Subject|15|||
30917318|NCT02097056|58952922|FG000|Overall Study|Lost to Follow-up|2|||
30917319|NCT02097056|58952922|FG000|Overall Study|Adverse Event|37|||
30825816|NCT01307423|58848323|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
30917320|NCT02097056|58952922|FG000|Overall Study|Other|2|||
30917321|NCT02121002|58952929|FG000|Overall Study|Physician Decision|2|||
30917322|NCT02121002|58952930|FG001|Overall Study|Physician Decision|0|||
30917323|NCT02121002|58952931|FG002|Overall Study|Physician Decision|0|||
30917324|NCT02121002|58952929|FG000|Overall Study|Withdrawal by Subject|3|||
30917325|NCT02121002|58952930|FG001|Overall Study|Withdrawal by Subject|1|||
30917326|NCT02121002|58952931|FG002|Overall Study|Withdrawal by Subject|4|||
30917327|NCT02121002|58952929|FG000|Overall Study|Protocol Violation|1|||
30917328|NCT02121002|58952930|FG001|Overall Study|Protocol Violation|2|||
30917329|NCT02121002|58952931|FG002|Overall Study|Protocol Violation|4|||
30917330|NCT02121002|58952929|FG000|Overall Study|Concomitant therapy|0|||
30917331|NCT02121002|58952930|FG001|Overall Study|Concomitant therapy|1|||
30917332|NCT02121002|58952931|FG002|Overall Study|Concomitant therapy|1|||
30917333|NCT02121002|58952929|FG000|Overall Study|Others|1|||
30917334|NCT02121002|58952930|FG001|Overall Study|Others|0|||
30917335|NCT02121002|58952931|FG002|Overall Study|Others|1|||
30917336|NCT02096900|58952941|FG000|Overall Study|Did not receive medication|3|||
30917337|NCT02096900|58952942|FG001|Overall Study|Did not receive medication|1|||
30917338|NCT02096900|58952941|FG000|Overall Study|Surgery cancelled- medication received|1|||
30917339|NCT02096900|58952942|FG001|Overall Study|Surgery cancelled- medication received|1|||
30917340|NCT02120924|58952951|FG000|Overall Study|Lack of Efficacy|1|||
30917341|NCT02120924|58952952|FG001|Overall Study|Lack of Efficacy|2|||
30917342|NCT02120924|58952953|FG002|Overall Study|Lack of Efficacy|3|||
30917343|NCT02120924|58952951|FG000|Overall Study|Adverse Event|0|||
30917344|NCT02120924|58952952|FG001|Overall Study|Adverse Event|1|||
30917345|NCT02120924|58952953|FG002|Overall Study|Adverse Event|3|||
30917346|NCT02120924|58952951|FG000|Overall Study|Withdrawal by Subject|16|||
30917347|NCT02120924|58952952|FG001|Overall Study|Withdrawal by Subject|20|||
30917348|NCT02120924|58952953|FG002|Overall Study|Withdrawal by Subject|8|||
30917349|NCT02120924|58952951|FG000|Overall Study|Lost to Follow-up|14|||
30825817|NCT01307423|58848324|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
30825818|NCT01307423|58848325|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
30825819|NCT01307423|58848326|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
30825820|NCT01307423|58848327|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
30825821|NCT01307423|58848319|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
30825822|NCT01307423|58848320|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
30825823|NCT01307423|58848321|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
30825824|NCT01307423|58848322|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
30825825|NCT01307423|58848323|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
30825826|NCT01307423|58848324|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
30917350|NCT02120924|58952952|FG001|Overall Study|Lost to Follow-up|14|||
30917351|NCT02120924|58952953|FG002|Overall Study|Lost to Follow-up|11|||
30917352|NCT02120924|58952951|FG000|Overall Study|Pregnancy|2|||
30917353|NCT02120924|58952952|FG001|Overall Study|Pregnancy|0|||
30917354|NCT02120924|58952953|FG002|Overall Study|Pregnancy|0|||
30917355|NCT02120924|58952951|FG000|Overall Study|Protocol Violation|3|||
30917356|NCT02120924|58952952|FG001|Overall Study|Protocol Violation|7|||
30917357|NCT02120924|58952953|FG002|Overall Study|Protocol Violation|2|||
30917358|NCT02120924|58952951|FG000|Overall Study|Physician Decision|0|||
30917359|NCT02120924|58952952|FG001|Overall Study|Physician Decision|1|||
30917360|NCT02120924|58952953|FG002|Overall Study|Physician Decision|1|||
30917361|NCT02120924|58952951|FG000|Overall Study|Death|1|||
30917362|NCT02120924|58952952|FG001|Overall Study|Death|0|||
30917363|NCT02120924|58952953|FG002|Overall Study|Death|0|||
30917364|NCT02120924|58952951|FG000|Overall Study|Compliance with IP|5|||
30917365|NCT02120924|58952952|FG001|Overall Study|Compliance with IP|1|||
30825827|NCT01307423|58848325|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
30917366|NCT02120924|58952953|FG002|Overall Study|Compliance with IP|1|||
30917367|NCT02096744|58952962|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
30917368|NCT02096744|58952963|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
30917369|NCT02096744|58952962|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
30917370|NCT02096744|58952963|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
30917371|NCT02096744|58952962|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
30917372|NCT02096744|58952963|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
30917373|NCT02096042|58952971|FG000|Overall Study|Disease Progression|1|||
30917374|NCT02096042|58952972|FG001|Overall Study|Disease Progression|0|||
30917375|NCT02096042|58952973|FG002|Overall Study|Disease Progression|0|||
30917376|NCT02120456|58952989|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
30917377|NCT02120456|58952990|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
30917378|NCT02120456|58952991|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
30917379|NCT02120456|58952992|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
30917380|NCT02120456|58952993|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
30917381|NCT02120456|58952994|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
30917382|NCT02120456|58952995|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
30917383|NCT02120456|58952996|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
30825828|NCT01307423|58848326|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
30825829|NCT01307423|58848327|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
30825830|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
30825831|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
30825832|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
30917384|NCT02120456|58952997|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
30917385|NCT02120456|58952989|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
30917386|NCT02120456|58952990|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
30917387|NCT02120456|58952991|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
30917388|NCT02120456|58952992|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
30917389|NCT02120456|58952993|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
30917390|NCT02120456|58952994|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
30917391|NCT02120456|58952995|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
30917392|NCT02120456|58952996|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
30917393|NCT02120456|58952997|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
30917394|NCT02120456|58952989|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
30917395|NCT02120456|58952990|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
30917396|NCT02120456|58952991|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
30917397|NCT02120456|58952992|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
30917398|NCT02120456|58952993|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
30917399|NCT02120456|58952994|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
30917400|NCT02120456|58952995|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
30917401|NCT02120456|58952996|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
30917402|NCT02120456|58952997|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
30917403|NCT02120300|58953021|FG000|Overall Study|Enrolled but Never Treated|2|||
30917404|NCT02120300|58953022|FG001|Overall Study|Enrolled but Never Treated|0|||
30917405|NCT02120300|58953023|FG002|Overall Study|Enrolled but Never Treated|0|||
30917406|NCT02120300|58953024|FG003|Overall Study|Enrolled but Never Treated|0|||
30917407|NCT02120300|58953021|FG000|Overall Study|Lack of Efficacy|0|||
30917408|NCT02120300|58953022|FG001|Overall Study|Lack of Efficacy|0|||
30917409|NCT02120300|58953023|FG002|Overall Study|Lack of Efficacy|0|||
30917410|NCT02120300|58953024|FG003|Overall Study|Lack of Efficacy|1|||
30917411|NCT02120300|58953021|FG000|Overall Study|Lost to Follow-up|1|||
30917412|NCT02120300|58953022|FG001|Overall Study|Lost to Follow-up|0|||
30917413|NCT02120300|58953023|FG002|Overall Study|Lost to Follow-up|0|||
30917414|NCT02120300|58953024|FG003|Overall Study|Lost to Follow-up|0|||
30917415|NCT02070380|58953040|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
30917416|NCT02070380|58953041|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
30917417|NCT02070380|58953042|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
30917418|NCT02070380|58953043|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
30917419|NCT02070380|58953040|FG000|Second Injection|Image sets missing or technically inadeq|0|||
30917420|NCT02070380|58953041|FG001|Second Injection|Image sets missing or technically inadeq|1|||
30917421|NCT02070380|58953042|FG002|Second Injection|Image sets missing or technically inadeq|0|||
30917422|NCT02070380|58953043|FG003|Second Injection|Image sets missing or technically inadeq|0|||
30917423|NCT02070380|58953040|FG000|Second Injection|Protocol Violation|0|||
30917424|NCT02070380|58953041|FG001|Second Injection|Protocol Violation|1|||
30917425|NCT02070380|58953042|FG002|Second Injection|Protocol Violation|1|||
30917426|NCT02070380|58953043|FG003|Second Injection|Protocol Violation|5|||
30917427|NCT02069366|58953061|FG000|Overall Study|Lost to Follow-up|0|||
30917428|NCT02069366|58953062|FG001|Overall Study|Lost to Follow-up|0|||
30917429|NCT02069366|58953063|FG002|Overall Study|Lost to Follow-up|1|||
30917430|NCT02069366|58953064|FG003|Overall Study|Lost to Follow-up|0|||
30917431|NCT02069366|58953065|FG004|Overall Study|Lost to Follow-up|0|||
30917432|NCT02069366|58953066|FG005|Overall Study|Lost to Follow-up|2|||
30917433|NCT02069366|58953061|FG000|Overall Study|Protocol Violation|0|||
30917434|NCT02069366|58953062|FG001|Overall Study|Protocol Violation|0|||
30825833|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
30825834|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
30825835|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
30825836|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
30825837|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
30825838|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
30825839|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
30825840|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
30825841|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
30825842|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
30825843|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
30825844|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
30825845|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
30825846|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
30825847|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
30825848|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
30825849|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
30825850|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
30825851|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
30825852|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
30825853|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
30825854|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
30825855|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
30825856|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
30917435|NCT02069366|58953063|FG002|Overall Study|Protocol Violation|1|||
30917436|NCT02069366|58953064|FG003|Overall Study|Protocol Violation|0|||
30917437|NCT02069366|58953065|FG004|Overall Study|Protocol Violation|0|||
30917438|NCT02069366|58953066|FG005|Overall Study|Protocol Violation|0|||
30917439|NCT02069366|58953061|FG000|Overall Study|Withdrawal by Subject|1|||
30917440|NCT02069366|58953062|FG001|Overall Study|Withdrawal by Subject|0|||
30917441|NCT02069366|58953063|FG002|Overall Study|Withdrawal by Subject|1|||
30917442|NCT02069366|58953064|FG003|Overall Study|Withdrawal by Subject|2|||
30917443|NCT02069366|58953065|FG004|Overall Study|Withdrawal by Subject|0|||
30917444|NCT02069366|58953066|FG005|Overall Study|Withdrawal by Subject|0|||
30917445|NCT02068508|58953081|FG000|Overall Study|Case report forms uncollected|27|||
30917446|NCT02068508|58953081|FG000|Overall Study|Patient did not visit the study site|1|||
30917447|NCT02068508|58953081|FG000|Overall Study|Protocol Violation|4|||
30917448|NCT02068352|58953088|FG000|Overall Study|Lost to Follow-up|0|||
30917449|NCT02068352|58953089|FG001|Overall Study|Lost to Follow-up|2|||
30917450|NCT02068352|58953090|FG002|Overall Study|Lost to Follow-up|0|||
30917451|NCT02068352|58953088|FG000|Overall Study|Adverse Event|4|||
30917452|NCT02068352|58953089|FG001|Overall Study|Adverse Event|2|||
30917453|NCT02068352|58953090|FG002|Overall Study|Adverse Event|7|||
30917454|NCT02068352|58953088|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
30917455|NCT02068352|58953089|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
30917456|NCT02068352|58953090|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
30917457|NCT02068352|58953088|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
30917458|NCT02068352|58953089|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
30917459|NCT02068352|58953090|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
30917460|NCT02068352|58953088|FG000|Overall Study|Protocol Deviation|0|||
30917461|NCT02068352|58953089|FG001|Overall Study|Protocol Deviation|0|||
30917462|NCT02068352|58953090|FG002|Overall Study|Protocol Deviation|1|||
30917463|NCT02207231|58953101|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
30825857|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30825858|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
30917464|NCT02207231|58953102|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
30917465|NCT02207231|58953103|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
30917466|NCT02207231|58953104|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
30917467|NCT02207231|58953101|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
30917468|NCT02207231|58953102|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
30917469|NCT02207231|58953103|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
30917470|NCT02207231|58953104|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
30917471|NCT02207231|58953101|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
30917472|NCT02207231|58953102|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
30917473|NCT02207231|58953103|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
30917474|NCT02207231|58953104|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
30917475|NCT02207231|58953101|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
30917476|NCT02207231|58953102|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
30917477|NCT02207231|58953103|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
30917478|NCT02207231|58953104|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
30917479|NCT02207231|58953101|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
30917480|NCT02207231|58953102|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
30917481|NCT02207231|58953103|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
30917482|NCT02207231|58953104|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
30917483|NCT02207231|58953101|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
30917484|NCT02207231|58953102|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
30917485|NCT02207231|58953103|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
30917486|NCT02207231|58953104|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
30917487|NCT02207231|58953101|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
30917488|NCT02207231|58953102|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
30917489|NCT02207231|58953103|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
30917490|NCT02207231|58953104|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
30917491|NCT02207231|58953101|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
30917492|NCT02207231|58953102|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
30917493|NCT02207231|58953103|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
30917494|NCT02207231|58953104|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
30917495|NCT02207231|58953101|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
30917496|NCT02207231|58953102|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
30917497|NCT02207231|58953103|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
30917498|NCT02207231|58953104|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
30917499|NCT02207231|58953101|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
30917500|NCT02207231|58953102|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
30917501|NCT02207231|58953103|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
30917502|NCT02207231|58953104|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
30917503|NCT02207231|58953101|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
30917504|NCT02207231|58953102|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
30917505|NCT02207231|58953103|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
30917506|NCT02207231|58953104|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
30917507|NCT02207231|58953101|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
30917508|NCT02207231|58953102|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
30917509|NCT02207231|58953103|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
30917510|NCT02207231|58953104|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
30917511|NCT02207231|58953101|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
30917512|NCT02207231|58953102|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
30917513|NCT02207231|58953103|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
30917514|NCT02207231|58953104|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
30917515|NCT02207231|58953101|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
30917516|NCT02207231|58953102|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
30917517|NCT02207231|58953103|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
30917518|NCT02207231|58953104|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
30917519|NCT02207231|58953101|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
30917520|NCT02207231|58953102|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
30917521|NCT02207231|58953103|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
30917522|NCT02207231|58953104|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
30825859|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
30825860|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30825861|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30825862|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30825863|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30825864|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
30825865|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
30825866|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30825867|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
30825868|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30825869|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30825870|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30825871|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30825872|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30825873|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
30825874|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
30825875|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
30825876|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
30917523|NCT02207231|58953101|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
30917524|NCT02207231|58953102|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
30917525|NCT02207231|58953103|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
30917526|NCT02207231|58953104|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
30917527|NCT02207231|58953101|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
30917528|NCT02207231|58953102|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
30917529|NCT02207231|58953103|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
30917530|NCT02207231|58953104|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
30917531|NCT02207231|58953101|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
30917532|NCT02207231|58953102|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
30917533|NCT02207231|58953103|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
30917534|NCT02207231|58953104|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
30917535|NCT02207231|58953101|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
30917536|NCT02207231|58953102|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
30917537|NCT02207231|58953103|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
30917538|NCT02207231|58953104|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
30917539|NCT02207231|58953101|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
30825877|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
30825878|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
30825879|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
30825880|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
30917540|NCT02207231|58953102|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
30917541|NCT02207231|58953103|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
30917542|NCT02207231|58953104|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
30917543|NCT02207231|58953101|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
30917544|NCT02207231|58953102|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
30917545|NCT02207231|58953103|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
30917546|NCT02207231|58953104|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
30917547|NCT02239601|58953124|FG000|Overall Study|Withdrawal by Subject|3|||
30825881|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
30825882|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
30825883|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
30917548|NCT02239601|58953125|FG001|Overall Study|Withdrawal by Subject|4|||
30917549|NCT02239601|58953124|FG000|Overall Study|Protocol Violation|4|||
30917550|NCT02239601|58953125|FG001|Overall Study|Protocol Violation|2|||
30917551|NCT02236559|58953138|FG000|Overall Study|Met Exclusion|3|||
30917552|NCT02236559|58953139|FG001|Overall Study|Met Exclusion|6|||
30917553|NCT02236559|58953138|FG000|Overall Study|Did not Meet Inclusion|3|||
30917554|NCT02236559|58953139|FG001|Overall Study|Did not Meet Inclusion|3|||
30917555|NCT02236559|58953138|FG000|Overall Study|Subject Did Not Consent|4|||
30917556|NCT02236559|58953139|FG001|Overall Study|Subject Did Not Consent|2|||
30917557|NCT02236559|58953138|FG000|Overall Study|Physician Decision|1|||
30917558|NCT02236559|58953139|FG001|Overall Study|Physician Decision|1|||
30917559|NCT02236559|58953138|FG000|Overall Study|Withdrawal by Subject|1|||
30917560|NCT02236559|58953139|FG001|Overall Study|Withdrawal by Subject|0|||
30917561|NCT02206685|58953147|FG000|Overall Study|Surgery cancelled/changed|2|||
30917562|NCT02206685|58953148|FG001|Overall Study|Surgery cancelled/changed|3|||
30917563|NCT02206685|58953147|FG000|Overall Study|Withdrawal by Subject|1|||
30917564|NCT02206685|58953148|FG001|Overall Study|Withdrawal by Subject|2|||
30917565|NCT02206685|58953147|FG000|Overall Study|Protocol Violation|2|||
30917566|NCT02206685|58953148|FG001|Overall Study|Protocol Violation|2|||
30917567|NCT02206607|58953154|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
30917568|NCT02206607|58953155|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
30917569|NCT02206607|58953156|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
30917570|NCT02206607|58953157|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
30917571|NCT02206607|58953158|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
30917572|NCT02206607|58953154|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
30917573|NCT02206607|58953155|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
30917574|NCT02206607|58953156|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
30917575|NCT02206607|58953157|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
30917576|NCT02206607|58953158|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
30753840|NCT00132678|58763501|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
30753841|NCT00132678|58763499|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
30753842|NCT00132678|58763500|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
30753843|NCT00132678|58763501|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
30753844|NCT00132678|58763499|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
30753845|NCT00132678|58763500|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
30753846|NCT00132678|58763501|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
30753847|NCT00132678|58763499|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
30825884|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
30825885|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
30825886|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
30825887|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
30825888|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
30825889|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
30825890|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
30825891|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
30825892|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
30825893|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
30825894|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
30825895|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
30825896|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
30825897|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
30825898|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
30753848|NCT00132678|58763500|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
30753849|NCT00132678|58763501|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
30825899|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
30917577|NCT02119676|58953178|FG000|Overall Study|Adverse Event|9|||
30917578|NCT02119676|58953179|FG001|Overall Study|Adverse Event|17|||
30917579|NCT02119676|58953180|FG002|Overall Study|Adverse Event|10|||
30917580|NCT02119676|58953181|FG003|Overall Study|Adverse Event|10|||
30917581|NCT02119676|58953178|FG000|Overall Study|Disease progression|53|||
30917582|NCT02119676|58953179|FG001|Overall Study|Disease progression|55|||
30917583|NCT02119676|58953180|FG002|Overall Study|Disease progression|68|||
30917584|NCT02119676|58953181|FG003|Overall Study|Disease progression|73|||
30917585|NCT02119676|58953178|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
30917586|NCT02119676|58953179|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
30917587|NCT02119676|58953180|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
30917588|NCT02119676|58953181|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
30917589|NCT02119676|58953178|FG000|Overall Study|Physician Decision|4|||
30917590|NCT02119676|58953179|FG001|Overall Study|Physician Decision|2|||
30917591|NCT02119676|58953180|FG002|Overall Study|Physician Decision|3|||
30917592|NCT02119676|58953181|FG003|Overall Study|Physician Decision|2|||
30917593|NCT02119676|58953178|FG000|Overall Study|Death|9|||
30917594|NCT02119676|58953179|FG001|Overall Study|Death|3|||
30917595|NCT02119676|58953180|FG002|Overall Study|Death|2|||
30917596|NCT02119676|58953181|FG003|Overall Study|Death|1|||
30917597|NCT02119676|58953178|FG000|Overall Study|Noncompliance|0|||
30917598|NCT02119676|58953179|FG001|Overall Study|Noncompliance|1|||
30917599|NCT02119676|58953180|FG002|Overall Study|Noncompliance|0|||
30917600|NCT02119676|58953181|FG003|Overall Study|Noncompliance|0|||
30917601|NCT02119676|58953178|FG000|Overall Study|Lost to Follow-up|0|||
30917602|NCT02119676|58953179|FG001|Overall Study|Lost to Follow-up|0|||
30917603|NCT02119676|58953180|FG002|Overall Study|Lost to Follow-up|1|||
30917604|NCT02119676|58953181|FG003|Overall Study|Lost to Follow-up|0|||
30917605|NCT02119676|58953178|FG000|Overall Study|Protocol deviation|0|||
30917606|NCT02119676|58953179|FG001|Overall Study|Protocol deviation|0|||
30917607|NCT02119676|58953180|FG002|Overall Study|Protocol deviation|1|||
30917608|NCT02119676|58953181|FG003|Overall Study|Protocol deviation|0|||
30825900|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
30825901|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
30825902|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30825903|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
30825904|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
30825905|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30825906|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30825907|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30825908|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30825909|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
30825910|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
30825911|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30825912|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
30825913|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
30825914|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30825915|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30825916|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30825917|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30825918|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
30825919|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
30825920|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30825921|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
30825922|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30825923|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30825924|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30825925|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30825926|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30825927|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
30825928|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30825929|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30825930|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
30825931|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30825932|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30825933|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30825934|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30825935|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30825936|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30825937|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30917609|NCT02119676|58953178|FG000|Overall Study|Other, unspecified|2|||
30917610|NCT02119676|58953179|FG001|Overall Study|Other, unspecified|1|||
30917611|NCT02119676|58953180|FG002|Overall Study|Other, unspecified|3|||
30917612|NCT02119676|58953181|FG003|Overall Study|Other, unspecified|4|||
30917613|NCT02119676|58953178|FG000|Overall Study|Did not receive study med|2|||
30917614|NCT02119676|58953179|FG001|Overall Study|Did not receive study med|2|||
30917615|NCT02119676|58953180|FG002|Overall Study|Did not receive study med|4|||
30917616|NCT02119676|58953181|FG003|Overall Study|Did not receive study med|5|||
30917617|NCT02206061|58953194|FG000|Overall Study|Withdrawal by Subject|4|||
30917618|NCT02206061|58953195|FG001|Overall Study|Withdrawal by Subject|7|||
30917619|NCT02206061|58953196|FG002|Overall Study|Withdrawal by Subject|1|||
30917620|NCT02206061|58953194|FG000|Overall Study|Lost to Follow-up|14|||
30917621|NCT02206061|58953195|FG001|Overall Study|Lost to Follow-up|7|||
30917622|NCT02206061|58953196|FG002|Overall Study|Lost to Follow-up|20|||
30917623|NCT02095106|58953206|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
30917624|NCT02095106|58953207|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
30917625|NCT01631747|58953219|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
30917626|NCT01631747|58953220|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
30917627|NCT01631747|58953219|FG000|Live Birth|Pregnancy Termination|1|||
30917628|NCT01631747|58953220|FG001|Live Birth|Pregnancy Termination|0|||
30917629|NCT01631747|58953219|FG000|Live Birth|MIscarriage|2|||
30917630|NCT01631747|58953220|FG001|Live Birth|MIscarriage|0|||
30917631|NCT01631747|58953219|FG000|Live Birth|Stillbirth|1|||
30917632|NCT01631747|58953220|FG001|Live Birth|Stillbirth|1|||
30917633|NCT01631747|58953219|FG000|One Year Infant Outcomes|Patient Refused|13|||
30917634|NCT01631747|58953220|FG001|One Year Infant Outcomes|Patient Refused|9|||
30917635|NCT02068118|58953229|FG000|18-month Comparative Study Period|Death|90|||
30917636|NCT02068118|58953230|FG001|18-month Comparative Study Period|Death|97|||
30917637|NCT02068118|58953229|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
30917638|NCT02068118|58953230|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
30917639|NCT02068118|58953229|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
30917640|NCT02068118|58953230|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
30917641|NCT02068118|58953229|FG000|18-month Comparative Study Period|Heart transplant|9|||
30917642|NCT02068118|58953230|FG001|18-month Comparative Study Period|Heart transplant|15|||
30917643|NCT02068118|58953229|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
30917644|NCT02068118|58953230|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
30917645|NCT02068118|58953229|FG000|18-month Comparative Study Period|Hemiplegia|0|||
30917646|NCT02068118|58953230|FG001|18-month Comparative Study Period|Hemiplegia|1|||
30917647|NCT02068118|58953229|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
30917648|NCT02068118|58953230|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
30917649|NCT02068118|58953229|FG000|18-month Comparative Study Period|Move|0|||
30917650|NCT02068118|58953230|FG001|18-month Comparative Study Period|Move|1|||
30917651|NCT02068118|58953229|FG000|18-month Comparative Study Period|Hearing loss|0|||
30917652|NCT02068118|58953230|FG001|18-month Comparative Study Period|Hearing loss|1|||
30917653|NCT02068118|58953229|FG000|Extension Period|Death|0|||
30917654|NCT02068118|58953230|FG001|Extension Period|Death|2|||
30917655|NCT02068118|58953229|FG000|Extension Period|Withdrawal by Subject|1|||
30917656|NCT02068118|58953230|FG001|Extension Period|Withdrawal by Subject|0|||
30917657|NCT02068118|58953229|FG000|Extension Period|Heart transplant|1|||
30917658|NCT02068118|58953230|FG001|Extension Period|Heart transplant|0|||
30917659|NCT02068118|58953229|FG000|Extension Period|Wrong device use|0|||
30917660|NCT02068118|58953230|FG001|Extension Period|Wrong device use|1|||
30917661|NCT01623830|58953240|FG000|Overall Study|Withdrawal by Subject|6|||
30917662|NCT01623830|58953241|FG001|Overall Study|Withdrawal by Subject|7|||
30917663|NCT01623830|58953240|FG000|Overall Study|Exclusion from Study|1|||
30917664|NCT01623830|58953241|FG001|Overall Study|Exclusion from Study|2|||
30753850|NCT00132678|58763499|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
30825938|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30825939|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
30825940|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30825941|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30825942|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30825943|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30825944|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30825945|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30753851|NCT00132678|58763500|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
30753852|NCT00132678|58763501|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
30753853|NCT00132678|58763499|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
30753854|NCT00132678|58763500|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
30753855|NCT00132678|58763501|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
30753856|NCT00132678|58763499|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
30753857|NCT00132678|58763500|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
30825946|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
30825947|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30825948|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
30917665|NCT01634165|58953247|FG000|Period 2|Adverse Event|0|||
30917666|NCT01634165|58953248|FG001|Period 2|Adverse Event|1|||
30917667|NCT01634165|58953249|FG002|Period 2|Adverse Event|0|||
30917668|NCT01634165|58953250|FG003|Period 2|Adverse Event|0|||
30917669|NCT03575897|58953262|FG000|Overall Study|Lost to Follow-up|12|||
30825949|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
30825950|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30825951|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30825952|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30825953|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30825954|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
30825955|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
30825956|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30825957|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30825958|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
30825959|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30825960|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30825961|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30825962|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30825963|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30825964|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30825965|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30825966|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30825967|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30825968|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30825969|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30825970|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30825971|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30825972|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
30825973|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30825974|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30825975|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
30825976|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
30825977|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30825978|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30825979|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30825980|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30825981|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30825982|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
30917670|NCT03575897|58953263|FG001|Overall Study|Lost to Follow-up|13|||
30917671|NCT02235311|58953271|FG000|Overall Study|Lost to Follow-up|0|||
30917672|NCT02235311|58953272|FG001|Overall Study|Lost to Follow-up|1|||
30917673|NCT02235311|58953271|FG000|Overall Study|Protocol Violation|0|||
30917674|NCT02235311|58953272|FG001|Overall Study|Protocol Violation|1|||
30917675|NCT02204579|58953278|FG000|Overall Study|Screen failures|2|||
30917676|NCT02235077|58953289|FG000|Overall Study|Death|5|||
30917677|NCT02235077|58953290|FG001|Overall Study|Death|7|||
30917678|NCT02235077|58953289|FG000|Overall Study|Lost to Follow-up|5|||
30917679|NCT02235077|58953290|FG001|Overall Study|Lost to Follow-up|6|||
30917680|NCT02235077|58953289|FG000|Overall Study|Withdrawal by Subject|8|||
30917681|NCT02235077|58953290|FG001|Overall Study|Withdrawal by Subject|5|||
30917682|NCT02235077|58953289|FG000|Overall Study|Physician Decision|0|||
30917683|NCT02235077|58953290|FG001|Overall Study|Physician Decision|1|||
30917684|NCT02234141|58953300|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
30917685|NCT02234141|58953301|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
30753858|NCT00132678|58763501|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
30753859|NCT00132678|58763499|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
30753860|NCT00132678|58763500|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
30753861|NCT00132678|58763501|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
30753862|NCT00132678|58763499|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
30753863|NCT00132678|58763500|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
30753864|NCT00132678|58763501|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
30753865|NCT00132678|58763499|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
30753866|NCT00132678|58763500|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
30753867|NCT00132678|58763501|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
30753868|NCT00132678|58763499|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
30753869|NCT00132678|58763500|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
30825983|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30825984|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
30825985|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
30825986|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30917686|NCT02234141|58953302|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
30917687|NCT02234141|58953303|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
30917688|NCT02234141|58953304|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
30917689|NCT02234141|58953305|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
30917690|NCT02234141|58953306|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
30917691|NCT02234141|58953300|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
30917692|NCT02234141|58953301|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
30917693|NCT02234141|58953302|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
30917694|NCT02234141|58953303|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
30917695|NCT02234141|58953304|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
30917696|NCT02234141|58953305|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
30753870|NCT00132678|58763501|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
30753871|NCT00132678|58763499|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
30753872|NCT00132678|58763500|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
30753873|NCT00132678|58763501|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
30753874|NCT00132678|58763499|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
30753875|NCT00132678|58763500|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
30753876|NCT00132678|58763501|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
30753877|NCT00101868|58763511|FG000|Overall Study|Death|10|||
30753878|NCT00101868|58763512|FG001|Overall Study|Death|10|||
30753879|NCT00101868|58763511|FG000|Overall Study|Withdrawal by Subject|8|||
30825987|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30825988|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30825989|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30825990|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30825991|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30825992|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30825993|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
30825994|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
30825995|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30825996|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30825997|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30825998|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30825999|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30826000|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
30826001|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
30826002|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
30826003|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
30826004|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
30826005|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
30826006|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
30826007|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
30826008|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
30826009|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
30826010|NCT01307423|58848319|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30826011|NCT01307423|58848320|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30826012|NCT01307423|58848321|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
30826013|NCT01307423|58848322|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30826014|NCT01307423|58848323|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30826015|NCT01307423|58848324|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30826016|NCT01307423|58848325|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30826017|NCT01307423|58848326|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
30826018|NCT01307423|58848327|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
30826019|NCT02778074|58848361|FG000|Overall Study|Lost to Follow-up|7|||
30826020|NCT02778074|58848362|FG001|Overall Study|Lost to Follow-up|10|||
30826021|NCT02768792|58848377|FG000|Overall Study|Adverse Event|1|||
30826022|NCT02775344|58848383|FG000|Overall Study|No ovarian cyst identified|3|||
30826023|NCT02775344|58848384|FG001|Overall Study|No ovarian cyst identified|2|||
30826024|NCT02777918|58848392|FG000|Overall Study|Medical reasons|1|||
30826025|NCT02777918|58848393|FG001|Overall Study|Medical reasons|2|||
30826026|NCT02777918|58848392|FG000|Overall Study|Too busy / stressed|1|||
30826027|NCT02777918|58848393|FG001|Overall Study|Too busy / stressed|1|||
30826028|NCT02777918|58848392|FG000|Overall Study|Withdrawal by Subject|1|||
30826029|NCT02777918|58848393|FG001|Overall Study|Withdrawal by Subject|1|||
30826030|NCT02927795|58848399|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
30826031|NCT02927795|58848399|FG000|Overall Study|Not Treated|4|||
30826032|NCT02767856|58848405|FG000|Overall Study|Lost to Follow-up|9|||
30826033|NCT02767856|58848406|FG001|Overall Study|Lost to Follow-up|1|||
30826034|NCT02767856|58848405|FG000|Overall Study|Withdrawal by Subject|2|||
30826035|NCT02767856|58848406|FG001|Overall Study|Withdrawal by Subject|1|||
30826036|NCT03087851|58848415|FG000|Overall Study|Withdraw on medical grounds|0|||
30826037|NCT03087851|58848416|FG001|Overall Study|Withdraw on medical grounds|1|||
30826038|NCT03087851|58848417|FG002|Overall Study|Withdraw on medical grounds|2|||
30826039|NCT03092375|58848429|FG000|Overall Study|Lack of Efficacy|0|||
30826040|NCT03092375|58848430|FG001|Overall Study|Lack of Efficacy|1|||
30917697|NCT02234141|58953306|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
30917698|NCT02234141|58953300|FG000|Treatment Period (24 Weeks)|Death|1|||
30917699|NCT02234141|58953301|FG001|Treatment Period (24 Weeks)|Death|2|||
30917700|NCT02234141|58953302|FG002|Treatment Period (24 Weeks)|Death|0|||
30917701|NCT02234141|58953303|FG003|Treatment Period (24 Weeks)|Death|1|||
30917702|NCT02234141|58953304|FG004|Treatment Period (24 Weeks)|Death|0|||
30917703|NCT02234141|58953305|FG005|Treatment Period (24 Weeks)|Death|0|||
30917704|NCT02234141|58953306|FG006|Treatment Period (24 Weeks)|Death|0|||
30917705|NCT02234141|58953300|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
30917706|NCT02234141|58953301|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
30917707|NCT02234141|58953302|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
30917708|NCT02234141|58953303|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
30917709|NCT02234141|58953304|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
30917710|NCT02234141|58953305|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
30917711|NCT02234141|58953306|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
30917712|NCT02234141|58953300|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
30917713|NCT02234141|58953301|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
30917714|NCT02234141|58953302|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
30917715|NCT02234141|58953303|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
30917716|NCT02234141|58953304|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
30917717|NCT02234141|58953305|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
30917718|NCT02234141|58953306|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
30917719|NCT02234141|58953300|FG000|Long-Term Treatment Period|Death|0|||
30917720|NCT02234141|58953301|FG001|Long-Term Treatment Period|Death|0|||
30917721|NCT02234141|58953302|FG002|Long-Term Treatment Period|Death|0|||
30917722|NCT02234141|58953303|FG003|Long-Term Treatment Period|Death|0|||
30917723|NCT02234141|58953304|FG004|Long-Term Treatment Period|Death|0|||
30917724|NCT02234141|58953305|FG005|Long-Term Treatment Period|Death|1|||
30917725|NCT02234141|58953306|FG006|Long-Term Treatment Period|Death|0|||
30917726|NCT02234141|58953300|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
30917727|NCT02234141|58953301|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
30917728|NCT02234141|58953302|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
30917729|NCT02234141|58953303|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
30917730|NCT02234141|58953304|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
30917731|NCT02234141|58953305|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
30917732|NCT02234141|58953306|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
30917733|NCT02234141|58953300|FG000|Long-Term Treatment Period|Adverse Event|4|||
30917734|NCT02234141|58953301|FG001|Long-Term Treatment Period|Adverse Event|0|||
30917735|NCT02234141|58953302|FG002|Long-Term Treatment Period|Adverse Event|5|||
30917736|NCT02234141|58953303|FG003|Long-Term Treatment Period|Adverse Event|0|||
30917737|NCT02234141|58953304|FG004|Long-Term Treatment Period|Adverse Event|1|||
30917738|NCT02234141|58953305|FG005|Long-Term Treatment Period|Adverse Event|1|||
30917739|NCT02234141|58953306|FG006|Long-Term Treatment Period|Adverse Event|1|||
30917740|NCT02234141|58953300|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
30917741|NCT02234141|58953301|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
30917742|NCT02234141|58953302|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
30917743|NCT02234141|58953303|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
30917744|NCT02234141|58953304|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
30917745|NCT02234141|58953305|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
30917746|NCT02234141|58953306|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
30917747|NCT02234141|58953300|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
30917748|NCT02234141|58953301|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
30917749|NCT02234141|58953302|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
30917750|NCT02234141|58953303|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
30917751|NCT02234141|58953304|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
30917752|NCT02234141|58953305|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
30917753|NCT02234141|58953306|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
30917754|NCT02234063|58953319|FG000|Overall Study|Lost to Follow-up|235|||
30917755|NCT02234063|58953320|FG001|Overall Study|Lost to Follow-up|42|||
30917756|NCT02234063|58953319|FG000|Overall Study|Withdrawal by Subject|20|||
30917757|NCT02234063|58953320|FG001|Overall Study|Withdrawal by Subject|1|||
30917758|NCT02232893|58953333|FG000|Overall Study|Withdrawal by Subject|4|||
30917759|NCT02232893|58953334|FG001|Overall Study|Withdrawal by Subject|1|||
30917760|NCT02232893|58953333|FG000|Overall Study|Adverse Event|0|||
30623238|NCT01163916|58635073|FG000|Overall Study|Lack of Efficacy|2|||
30826041|NCT03092375|58848431|FG002|Overall Study|Lack of Efficacy|1|||
30917761|NCT02232893|58953334|FG001|Overall Study|Adverse Event|1|||
30917762|NCT02232893|58953333|FG000|Overall Study|Sponsor request early termination|0|||
30917763|NCT02232893|58953334|FG001|Overall Study|Sponsor request early termination|1|||
30917764|NCT02232893|58953333|FG000|Overall Study|Developed exclusion criteria|0|||
30917765|NCT02232893|58953334|FG001|Overall Study|Developed exclusion criteria|1|||
30917766|NCT02232893|58953333|FG000|Overall Study|Other|0|||
30917767|NCT02232893|58953334|FG001|Overall Study|Other|3|||
30826042|NCT03092375|58848432|FG003|Overall Study|Lack of Efficacy|0|||
30826043|NCT01995513|58848449|FG000|Open Label Treatment Period|Other|9|||
30826044|NCT01995513|58848450|FG001|Open Label Treatment Period|Other|0|||
30826045|NCT01995513|58848451|FG002|Open Label Treatment Period|Other|0|||
30826046|NCT01995513|58848449|FG000|Open Label Treatment Period|Withdrawal by Subject|14|||
30826047|NCT01995513|58848450|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
30826048|NCT01995513|58848451|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
30826049|NCT01995513|58848449|FG000|Open Label Treatment Period|Protocol Violation|1|||
30826050|NCT01995513|58848450|FG001|Open Label Treatment Period|Protocol Violation|0|||
30826051|NCT01995513|58848451|FG002|Open Label Treatment Period|Protocol Violation|0|||
30826052|NCT01995513|58848449|FG000|Open Label Treatment Period|Disease Progression|64|||
30826053|NCT01995513|58848450|FG001|Open Label Treatment Period|Disease Progression|0|||
30826054|NCT01995513|58848451|FG002|Open Label Treatment Period|Disease Progression|0|||
30826055|NCT01995513|58848449|FG000|Open Label Treatment Period|No PSA response at week 13|43|||
30826056|NCT01995513|58848450|FG001|Open Label Treatment Period|No PSA response at week 13|0|||
30826057|NCT01995513|58848451|FG002|Open Label Treatment Period|No PSA response at week 13|0|||
30826058|NCT01995513|58848449|FG000|Open Label Treatment Period|Adverse Event|35|||
30917768|NCT02203721|58953342|FG000|Overall Study|Lost to Follow-up|1|||
30917769|NCT02203721|58953343|FG001|Overall Study|Lost to Follow-up|0|||
30917770|NCT02203721|58953342|FG000|Overall Study|Death|0|||
30917771|NCT02203721|58953343|FG001|Overall Study|Death|2|||
30917772|NCT02203721|58953342|FG000|Overall Study|Illness|0|||
30917773|NCT02203721|58953343|FG001|Overall Study|Illness|1|||
30917774|NCT01618695|58953353|FG000|Core Phase|Adverse Event|4|||
30917775|NCT01618695|58953354|FG001|Core Phase|Adverse Event|5|||
30917776|NCT01618695|58953355|FG002|Core Phase|Adverse Event|15|||
30917777|NCT01618695|58953356|FG003|Core Phase|Adverse Event|20|||
30917778|NCT01618695|58953353|FG000|Core Phase|Lost to Follow-up|0|||
30917779|NCT01618695|58953354|FG001|Core Phase|Lost to Follow-up|0|||
30917780|NCT01618695|58953355|FG002|Core Phase|Lost to Follow-up|1|||
30917781|NCT01618695|58953356|FG003|Core Phase|Lost to Follow-up|0|||
30917782|NCT01618695|58953353|FG000|Core Phase|Withdrawal by Subject|16|||
30917783|NCT01618695|58953354|FG001|Core Phase|Withdrawal by Subject|11|||
30917784|NCT01618695|58953355|FG002|Core Phase|Withdrawal by Subject|9|||
30917785|NCT01618695|58953356|FG003|Core Phase|Withdrawal by Subject|13|||
30917786|NCT01618695|58953353|FG000|Core Phase|Pregnancy|2|||
30917787|NCT01618695|58953354|FG001|Core Phase|Pregnancy|0|||
30917788|NCT01618695|58953355|FG002|Core Phase|Pregnancy|0|||
30917789|NCT01618695|58953356|FG003|Core Phase|Pregnancy|0|||
30917790|NCT01618695|58953353|FG000|Core Phase|Lack of Efficacy|1|||
30917791|NCT01618695|58953354|FG001|Core Phase|Lack of Efficacy|2|||
30917792|NCT01618695|58953355|FG002|Core Phase|Lack of Efficacy|1|||
30917793|NCT01618695|58953356|FG003|Core Phase|Lack of Efficacy|1|||
30917794|NCT01618695|58953353|FG000|Core Phase|Other than specified|1|||
30917795|NCT01618695|58953354|FG001|Core Phase|Other than specified|2|||
30917796|NCT01618695|58953355|FG002|Core Phase|Other than specified|2|||
30917797|NCT01618695|58953356|FG003|Core Phase|Other than specified|2|||
30917798|NCT01618695|58953353|FG000|Core Phase|Not treated|1|||
30917799|NCT01618695|58953354|FG001|Core Phase|Not treated|0|||
30917800|NCT01618695|58953355|FG002|Core Phase|Not treated|2|||
30917801|NCT01618695|58953356|FG003|Core Phase|Not treated|0|||
30917802|NCT01618695|58953353|FG000|Extension Phase|Lack of Efficacy|17|||
30917803|NCT01618695|58953354|FG001|Extension Phase|Lack of Efficacy|33|||
30917804|NCT01618695|58953355|FG002|Extension Phase|Lack of Efficacy|26|||
30917805|NCT01618695|58953356|FG003|Extension Phase|Lack of Efficacy|24|||
30917806|NCT01618695|58953353|FG000|Extension Phase|Pregnancy|2|||
30623239|NCT01163916|58635074|FG001|Overall Study|Lack of Efficacy|0|||
30753880|NCT00101868|58763512|FG001|Overall Study|Withdrawal by Subject|9|||
30753881|NCT00101868|58763511|FG000|Overall Study|Protocol Violation|3|||
30753882|NCT00101868|58763512|FG001|Overall Study|Protocol Violation|0|||
30753883|NCT00101868|58763511|FG000|Overall Study|Lost to Follow-up|8|||
30753884|NCT00101868|58763512|FG001|Overall Study|Lost to Follow-up|13|||
30753885|NCT00101400|58763520|FG000|Survival Follow-Up|Alive|7|||
30753886|NCT03821064|58763524|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
30753887|NCT00141518|58763531|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
30826059|NCT01995513|58848450|FG001|Open Label Treatment Period|Adverse Event|0|||
30826060|NCT01995513|58848451|FG002|Open Label Treatment Period|Adverse Event|0|||
30917807|NCT01618695|58953354|FG001|Extension Phase|Pregnancy|0|||
30917808|NCT01618695|58953355|FG002|Extension Phase|Pregnancy|1|||
30917809|NCT01618695|58953356|FG003|Extension Phase|Pregnancy|1|||
30917810|NCT01618695|58953353|FG000|Extension Phase|Withdrawal by Subject|43|||
30917811|NCT01618695|58953354|FG001|Extension Phase|Withdrawal by Subject|48|||
30917812|NCT01618695|58953355|FG002|Extension Phase|Withdrawal by Subject|42|||
30917813|NCT01618695|58953356|FG003|Extension Phase|Withdrawal by Subject|33|||
30917814|NCT01618695|58953353|FG000|Extension Phase|Adverse Event|18|||
30917815|NCT01618695|58953354|FG001|Extension Phase|Adverse Event|16|||
30826061|NCT01995513|58848449|FG000|Open Label Treatment Period|Death|8|||
30826062|NCT01995513|58848450|FG001|Open Label Treatment Period|Death|0|||
30826063|NCT01995513|58848451|FG002|Open Label Treatment Period|Death|0|||
30826064|NCT01995513|58848449|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84|||
30826065|NCT01995513|58848450|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
30826066|NCT01995513|58848451|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
30826067|NCT01995513|58848449|FG000|Double Blind Treatment Period|Adverse Event|0|||
30826068|NCT01995513|58848450|FG001|Double Blind Treatment Period|Adverse Event|12|||
30826069|NCT01995513|58848451|FG002|Double Blind Treatment Period|Adverse Event|5|||
30826070|NCT01995513|58848449|FG000|Double Blind Treatment Period|Other|0|||
30826071|NCT01995513|58848450|FG001|Double Blind Treatment Period|Other|1|||
30826072|NCT01995513|58848451|FG002|Double Blind Treatment Period|Other|2|||
30826073|NCT01995513|58848449|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
30826074|NCT01995513|58848450|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
30826075|NCT01995513|58848451|FG002|Double Blind Treatment Period|Withdrawal by Subject|6|||
30826076|NCT01995513|58848449|FG000|Double Blind Treatment Period|Death|0|||
30826077|NCT01995513|58848450|FG001|Double Blind Treatment Period|Death|0|||
30826078|NCT01995513|58848451|FG002|Double Blind Treatment Period|Death|1|||
30826079|NCT01995513|58848449|FG000|Double Blind Treatment Period|Disease Progression|0|||
30826080|NCT01995513|58848450|FG001|Double Blind Treatment Period|Disease Progression|82|||
30826081|NCT01995513|58848451|FG002|Double Blind Treatment Period|Disease Progression|93|||
30826082|NCT01995513|58848449|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
30826083|NCT01995513|58848450|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27|||
30623240|NCT01163916|58635075|FG002|Overall Study|Lack of Efficacy|1|||
30623241|NCT01163916|58635073|FG000|Overall Study|Other|24|||
30753888|NCT00141518|58763532|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
30826084|NCT01995513|58848451|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18|||
30826085|NCT02927171|58848463|FG000|Overall Study|Lost to Follow-up|0|||
30826086|NCT02927171|58848464|FG001|Overall Study|Lost to Follow-up|1|||
30826087|NCT03087617|58848474|FG000|Overall Study|Lost to Follow-up|32|||
30826088|NCT03087617|58848475|FG001|Overall Study|Lost to Follow-up|30|||
30826089|NCT03087617|58848476|FG002|Overall Study|Lost to Follow-up|30|||
30826090|NCT03087617|58848477|FG003|Overall Study|Lost to Follow-up|39|||
30826091|NCT00103610|58848489|FG000|Overall Study|Entered Rescue Procedure|10|||
30623242|NCT01163916|58635074|FG001|Overall Study|Other|4|||
30753889|NCT00141518|58763533|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
30753890|NCT00141518|58763531|FG000|Overall Study|Adverse Event|7|||
30753891|NCT00141518|58763532|FG001|Overall Study|Adverse Event|5|||
30753892|NCT00141518|58763533|FG002|Overall Study|Adverse Event|2|||
30753893|NCT00141518|58763531|FG000|Overall Study|Withdrawal by Subject|2|||
30753894|NCT00141518|58763532|FG001|Overall Study|Withdrawal by Subject|0|||
30753895|NCT00141518|58763533|FG002|Overall Study|Withdrawal by Subject|2|||
30753896|NCT00141518|58763531|FG000|Overall Study|Protocol Violation|1|||
30753897|NCT00141518|58763532|FG001|Overall Study|Protocol Violation|1|||
30753898|NCT00141518|58763533|FG002|Overall Study|Protocol Violation|2|||
30753899|NCT00141518|58763531|FG000|Overall Study|Lack of Efficacy|5|||
30753900|NCT00141518|58763532|FG001|Overall Study|Lack of Efficacy|0|||
30753901|NCT00141518|58763533|FG002|Overall Study|Lack of Efficacy|0|||
30753902|NCT00253448|58763543|FG000|Overall Study|Withdrawal by Subject|1|||
30753903|NCT00098748|58763550|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
30753904|NCT00098748|58763551|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
30753905|NCT00098748|58763552|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
30753906|NCT00098748|58763550|FG000|Received Study Treatment|Death|2|||
30753907|NCT00098748|58763551|FG001|Received Study Treatment|Death|1|||
30753908|NCT00098748|58763552|FG002|Received Study Treatment|Death|2|||
30753909|NCT00098748|58763550|FG000|Received Study Treatment|Adverse Event|1|||
30753910|NCT00098748|58763551|FG001|Received Study Treatment|Adverse Event|2|||
30753911|NCT00098748|58763552|FG002|Received Study Treatment|Adverse Event|5|||
30826092|NCT00103610|58848490|FG001|Overall Study|Entered Rescue Procedure|52|||
30826093|NCT00103610|58848489|FG000|Overall Study|Death|16|||
30753912|NCT00098748|58763550|FG000|Received Study Treatment|Lack of Efficacy|40|||
30753913|NCT00098748|58763551|FG001|Received Study Treatment|Lack of Efficacy|27|||
30753914|NCT00098748|58763552|FG002|Received Study Treatment|Lack of Efficacy|27|||
30826094|NCT00103610|58848490|FG001|Overall Study|Death|12|||
30826095|NCT00103610|58848489|FG000|Overall Study|Elective Withdrawal|4|||
30826096|NCT00103610|58848490|FG001|Overall Study|Elective Withdrawal|0|||
30917816|NCT01618695|58953355|FG002|Extension Phase|Adverse Event|9|||
30623243|NCT01163916|58635075|FG002|Overall Study|Other|16|||
30826097|NCT00103610|58848489|FG000|Overall Study|Lost to Follow-up|3|||
30826098|NCT00103610|58848490|FG001|Overall Study|Lost to Follow-up|1|||
30826099|NCT00103610|58848489|FG000|Overall Study|Adverse Event|2|||
30826100|NCT00103610|58848490|FG001|Overall Study|Adverse Event|2|||
30826101|NCT00103610|58848489|FG000|Overall Study|Other|2|||
30826102|NCT00103610|58848490|FG001|Overall Study|Other|7|||
30826103|NCT00103610|58848489|FG000|Overall Study|Failed mobilization|1|||
30826104|NCT00103610|58848490|FG001|Overall Study|Failed mobilization|5|||
30826105|NCT00103610|58848489|FG000|Overall Study|Noncompliance|0|||
30826106|NCT00103610|58848490|FG001|Overall Study|Noncompliance|1|||
30826107|NCT03091439|58848499|FG000|Overall Study|Study Terminated by the Sponsor|1|||
30826108|NCT03091439|58848500|FG001|Overall Study|Study Terminated by the Sponsor|0|||
30826109|NCT03086447|58848508|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
30826110|NCT03086447|58848509|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
30826111|NCT03086447|58848508|FG000|Overall Study|Lost Lens|2|||
30826112|NCT03086447|58848509|FG001|Overall Study|Lost Lens|5|||
30826113|NCT03086447|58848508|FG000|Overall Study|Product quality complaint|0|||
30917817|NCT01618695|58953356|FG003|Extension Phase|Adverse Event|20|||
30917818|NCT01618695|58953353|FG000|Extension Phase|Lost to Follow-up|2|||
30917819|NCT01618695|58953354|FG001|Extension Phase|Lost to Follow-up|1|||
30917820|NCT01618695|58953355|FG002|Extension Phase|Lost to Follow-up|1|||
30917821|NCT01618695|58953356|FG003|Extension Phase|Lost to Follow-up|1|||
30917822|NCT01618695|58953353|FG000|Extension Phase|Other than specified|13|||
30917823|NCT01618695|58953354|FG001|Extension Phase|Other than specified|18|||
30917824|NCT01618695|58953355|FG002|Extension Phase|Other than specified|13|||
30917825|NCT01618695|58953356|FG003|Extension Phase|Other than specified|18|||
30917826|NCT01896531|58953369|FG000|Overall Study|Death|57|||
30917827|NCT01896531|58953370|FG001|Overall Study|Death|59|||
30917828|NCT01896531|58953369|FG000|Overall Study|Lost to Follow-up|3|||
30917829|NCT01896531|58953370|FG001|Overall Study|Lost to Follow-up|0|||
30917830|NCT01896531|58953369|FG000|Overall Study|Non-compliance|0|||
30917831|NCT01896531|58953370|FG001|Overall Study|Non-compliance|1|||
30917832|NCT01896531|58953369|FG000|Overall Study|Study Ended by Sponsor|7|||
30917833|NCT01896531|58953370|FG001|Overall Study|Study Ended by Sponsor|20|||
30917834|NCT01896531|58953369|FG000|Overall Study|Withdrawal by Subject|3|||
30917835|NCT01896531|58953370|FG001|Overall Study|Withdrawal by Subject|2|||
30917836|NCT01896531|58953369|FG000|Overall Study|Death Prior to Treatment|1|||
30917837|NCT01896531|58953370|FG001|Overall Study|Death Prior to Treatment|0|||
30917838|NCT01618305|58953378|FG000|Overall Study|Death|0|||
30917839|NCT01618305|58953379|FG001|Overall Study|Death|1|||
30917840|NCT01618305|58953378|FG000|Overall Study|Lost to Follow-up|11|||
30917841|NCT01618305|58953379|FG001|Overall Study|Lost to Follow-up|7|||
30917842|NCT01618305|58953378|FG000|Overall Study|Protocol Violation|1|||
30917843|NCT01618305|58953379|FG001|Overall Study|Protocol Violation|0|||
30917844|NCT01618305|58953378|FG000|Overall Study|Withdrawal by Subject|3|||
30917845|NCT01618305|58953379|FG001|Overall Study|Withdrawal by Subject|2|||
30917846|NCT01886313|58953391|FG000|Overall Study|Adverse Event|1|||
30917847|NCT01886313|58953392|FG001|Overall Study|Adverse Event|1|||
30917848|NCT01896297|58953398|FG000|Overall Study|Died in post treatment phase|1|||
30917849|NCT01884675|58953404|FG000|Overall Study|Study closed/terminated|3|||
30917850|NCT01884675|58953405|FG001|Overall Study|Study closed/terminated|2|||
30917851|NCT01884597|58953416|FG000|Overall Study|Adverse Event|0|||
30917852|NCT01884597|58953417|FG001|Overall Study|Adverse Event|0|||
30917853|NCT01884597|58953418|FG002|Overall Study|Adverse Event|1|||
30917854|NCT01884597|58953416|FG000|Overall Study|Lack of Efficacy|1|||
30917855|NCT01884597|58953417|FG001|Overall Study|Lack of Efficacy|0|||
30753915|NCT00098748|58763550|FG000|Received Study Treatment|Other|2|||
30753916|NCT00098748|58763551|FG001|Received Study Treatment|Other|2|||
30753917|NCT00098748|58763552|FG002|Received Study Treatment|Other|6|||
30753918|NCT00098748|58763550|FG000|Received Study Treatment|Subject defaulted|3|||
30753919|NCT00098748|58763551|FG001|Received Study Treatment|Subject defaulted|4|||
30753920|NCT00098748|58763552|FG002|Received Study Treatment|Subject defaulted|4|||
30753921|NCT00098748|58763550|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
30753922|NCT00098748|58763551|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
30753923|NCT00098748|58763552|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
30753924|NCT00098748|58763550|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
30917856|NCT01884597|58953418|FG002|Overall Study|Lack of Efficacy|0|||
30917857|NCT01884597|58953416|FG000|Overall Study|Death|0|||
30753925|NCT00098748|58763551|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
30826114|NCT03086447|58848509|FG001|Overall Study|Product quality complaint|1|||
30826115|NCT03086447|58848508|FG000|Overall Study|Lens Damage|1|||
30917858|NCT01884597|58953417|FG001|Overall Study|Death|1|||
30917859|NCT01884597|58953418|FG002|Overall Study|Death|0|||
30917860|NCT01895361|58953435|FG000|Overall Study|Adverse Event|1|||
30826116|NCT03086447|58848509|FG001|Overall Study|Lens Damage|6|||
30917861|NCT01895361|58953436|FG001|Overall Study|Adverse Event|1|||
30917862|NCT01895361|58953437|FG002|Overall Study|Adverse Event|3|||
30917863|NCT01895361|58953435|FG000|Overall Study|Death|2|||
30917864|NCT01895361|58953436|FG001|Overall Study|Death|1|||
30917865|NCT01895361|58953437|FG002|Overall Study|Death|2|||
30917866|NCT01895361|58953435|FG000|Overall Study|Lost to Follow-up|4|||
30917867|NCT01895361|58953436|FG001|Overall Study|Lost to Follow-up|4|||
30826117|NCT03086447|58848508|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
30826118|NCT03086447|58848509|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
30826119|NCT03086447|58848508|FG000|Overall Study|Test Article No Longer Available|1|||
30826120|NCT03086447|58848509|FG001|Overall Study|Test Article No Longer Available|0|||
30826121|NCT03086447|58848508|FG000|Overall Study|Protocol Violation|2|||
30826122|NCT03086447|58848509|FG001|Overall Study|Protocol Violation|4|||
30826123|NCT03086447|58848508|FG000|Overall Study|Lost to Follow-up|0|||
30826124|NCT03086447|58848509|FG001|Overall Study|Lost to Follow-up|1|||
30917868|NCT01895361|58953437|FG002|Overall Study|Lost to Follow-up|6|||
30917869|NCT01895361|58953435|FG000|Overall Study|Non-compliance with study|1|||
30917870|NCT01895361|58953436|FG001|Overall Study|Non-compliance with study|3|||
30826125|NCT03086447|58848508|FG000|Overall Study|Adverse Event|3|||
30826126|NCT03086447|58848509|FG001|Overall Study|Adverse Event|0|||
30826127|NCT03086447|58848508|FG000|Overall Study|Lens Discomfort|2|||
30826128|NCT03086447|58848509|FG001|Overall Study|Lens Discomfort|1|||
30826129|NCT03083639|58848540|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
30826130|NCT03083639|58848541|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
30826131|NCT03083639|58848540|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
30826132|NCT03083639|58848541|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
30826133|NCT02927431|58848550|FG000|Overall Study|Withdrawal by Subject|0|||
30826134|NCT02927431|58848551|FG001|Overall Study|Withdrawal by Subject|0|||
30826135|NCT02927431|58848552|FG002|Overall Study|Withdrawal by Subject|1|||
30826136|NCT03083483|58848565|FG000|Overall Study|Adverse Event|1|||
30826137|NCT03083483|58848566|FG001|Overall Study|Adverse Event|1|||
30826138|NCT03083483|58848567|FG002|Overall Study|Adverse Event|1|||
30826139|NCT03083483|58848565|FG000|Overall Study|Lost to Follow-up|2|||
30826140|NCT03083483|58848566|FG001|Overall Study|Lost to Follow-up|1|||
30826141|NCT03083483|58848567|FG002|Overall Study|Lost to Follow-up|1|||
30826142|NCT03083483|58848565|FG000|Overall Study|technological issues|1|||
30826143|NCT03083483|58848566|FG001|Overall Study|technological issues|0|||
30826144|NCT03083483|58848567|FG002|Overall Study|technological issues|1|||
30826145|NCT03085927|58848579|FG000|Overall Study|Withdrawal by Subject|1|||
30826146|NCT03085927|58848580|FG001|Overall Study|Withdrawal by Subject|4|||
30826147|NCT03085927|58848579|FG000|Overall Study|Lost to Follow-up|3|||
30826148|NCT03085927|58848580|FG001|Overall Study|Lost to Follow-up|1|||
30826149|NCT03085927|58848579|FG000|Overall Study|Death|1|||
30826150|NCT03085927|58848580|FG001|Overall Study|Death|0|||
30826151|NCT03085927|58848579|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
30826152|NCT03085927|58848580|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
30826153|NCT03085927|58848579|FG000|Overall Study|Dyad Became Ineligible|0|||
30826154|NCT03085927|58848580|FG001|Overall Study|Dyad Became Ineligible|1|||
30826155|NCT04392583|58848588|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
30826156|NCT04497987|58848594|FG000|Overall Study|Adverse Event|1|||
30826157|NCT04497987|58848595|FG001|Overall Study|Adverse Event|0|||
30826158|NCT04497987|58848594|FG000|Overall Study|Death|21|||
30826159|NCT04497987|58848595|FG001|Overall Study|Death|13|||
30826160|NCT04497987|58848594|FG000|Overall Study|Lost to Follow-up|19|||
30826161|NCT04497987|58848595|FG001|Overall Study|Lost to Follow-up|17|||
30826162|NCT04497987|58848594|FG000|Overall Study|Other - as reported by the investigator|22|||
30826163|NCT04497987|58848595|FG001|Overall Study|Other - as reported by the investigator|16|||
30826164|NCT04497987|58848594|FG000|Overall Study|Physician Decision|1|||
30826165|NCT04497987|58848595|FG001|Overall Study|Physician Decision|0|||
30826166|NCT04497987|58848594|FG000|Overall Study|Withdrawal by Subject|35|||
30826167|NCT04497987|58848595|FG001|Overall Study|Withdrawal by Subject|21|||
30826168|NCT00974571|58848605|FG000|Overall Study|Adverse Event|31|||
30826169|NCT00974571|58848606|FG001|Overall Study|Adverse Event|4|||
30826170|NCT00974571|58848607|FG002|Overall Study|Adverse Event|27|||
30826171|NCT00974571|58848605|FG000|Overall Study|Lack of Efficacy|3|||
30826172|NCT00974571|58848606|FG001|Overall Study|Lack of Efficacy|2|||
30826173|NCT00974571|58848607|FG002|Overall Study|Lack of Efficacy|9|||
30826174|NCT00974571|58848605|FG000|Overall Study|Lost to Follow-up|2|||
30826175|NCT00974571|58848606|FG001|Overall Study|Lost to Follow-up|1|||
30826176|NCT00974571|58848607|FG002|Overall Study|Lost to Follow-up|2|||
30826177|NCT00974571|58848605|FG000|Overall Study|Protocol Violation|13|||
30826178|NCT00974571|58848606|FG001|Overall Study|Protocol Violation|4|||
30826179|NCT00974571|58848607|FG002|Overall Study|Protocol Violation|18|||
30826180|NCT00974571|58848605|FG000|Overall Study|Withdrawal by Subject|14|||
30826181|NCT00974571|58848606|FG001|Overall Study|Withdrawal by Subject|5|||
30826182|NCT00974571|58848607|FG002|Overall Study|Withdrawal by Subject|16|||
30826183|NCT00974571|58848605|FG000|Overall Study|Patient Moved|1|||
30826184|NCT00974571|58848606|FG001|Overall Study|Patient Moved|0|||
30917871|NCT01895361|58953437|FG002|Overall Study|Non-compliance with study|1|||
30826185|NCT00974571|58848607|FG002|Overall Study|Patient Moved|1|||
30826186|NCT00974571|58848605|FG000|Overall Study|Other|4|||
30826187|NCT00974571|58848606|FG001|Overall Study|Other|0|||
30826188|NCT00974571|58848607|FG002|Overall Study|Other|10|||
30826189|NCT02766608|58848620|FG000|Overall Study|Adverse Event|27|||
30917872|NCT01895361|58953435|FG000|Overall Study|Physician Decision|2|||
30917873|NCT01895361|58953436|FG001|Overall Study|Physician Decision|2|||
30917874|NCT01895361|58953437|FG002|Overall Study|Physician Decision|2|||
30917875|NCT01895361|58953435|FG000|Overall Study|Withdrawal by Subject|7|||
30917876|NCT01895361|58953436|FG001|Overall Study|Withdrawal by Subject|6|||
30917877|NCT01895361|58953437|FG002|Overall Study|Withdrawal by Subject|6|||
30917878|NCT01895361|58953435|FG000|Overall Study|Lack of Efficacy|0|||
30917879|NCT01895361|58953436|FG001|Overall Study|Lack of Efficacy|1|||
30917880|NCT01895361|58953437|FG002|Overall Study|Lack of Efficacy|0|||
30917881|NCT01895361|58953435|FG000|Overall Study|Reasons different from categories above|7|||
30917882|NCT01895361|58953436|FG001|Overall Study|Reasons different from categories above|3|||
30917883|NCT01895361|58953437|FG002|Overall Study|Reasons different from categories above|4|||
30917884|NCT01883895|58953445|FG000|Overall Study|Lost to Follow-up|2|||
30917885|NCT01864005|58953451|FG000|Overall Study|Protocol Violation|0|||
30917886|NCT01864005|58953452|FG001|Overall Study|Protocol Violation|1|||
30917887|NCT01864005|58953451|FG000|Overall Study|Withdrawal by Subject|0|||
30917888|NCT01864005|58953452|FG001|Overall Study|Withdrawal by Subject|1|||
30917889|NCT01864005|58953451|FG000|Overall Study|Incorrect enrolment|1|||
30917890|NCT01864005|58953452|FG001|Overall Study|Incorrect enrolment|0|||
30917891|NCT01864005|58953451|FG000|Overall Study|Disease need|1|||
30917892|NCT01864005|58953452|FG001|Overall Study|Disease need|1|||
30917893|NCT01864005|58953451|FG000|Overall Study|Need GP IIb/IIIa|1|||
30917894|NCT01864005|58953452|FG001|Overall Study|Need GP IIb/IIIa|3|||
30917895|NCT01863849|58953460|FG000|Overall Study|Lost to Follow-up|1|||
30826190|NCT02766608|58848621|FG001|Overall Study|Adverse Event|22|||
30826191|NCT02766608|58848622|FG002|Overall Study|Adverse Event|17|||
30826192|NCT02766608|58848623|FG003|Overall Study|Adverse Event|13|||
30826193|NCT02766608|58848624|FG004|Overall Study|Adverse Event|12|||
30826194|NCT02766608|58848620|FG000|Overall Study|Withdrawal by Subject|21|||
30826195|NCT02766608|58848621|FG001|Overall Study|Withdrawal by Subject|20|||
30826196|NCT02766608|58848622|FG002|Overall Study|Withdrawal by Subject|24|||
30826197|NCT02766608|58848623|FG003|Overall Study|Withdrawal by Subject|13|||
30826198|NCT02766608|58848624|FG004|Overall Study|Withdrawal by Subject|10|||
30826199|NCT02766608|58848620|FG000|Overall Study|Lack of Efficacy|16|||
30826200|NCT02766608|58848621|FG001|Overall Study|Lack of Efficacy|15|||
30826201|NCT02766608|58848622|FG002|Overall Study|Lack of Efficacy|32|||
30826202|NCT02766608|58848623|FG003|Overall Study|Lack of Efficacy|8|||
30826203|NCT02766608|58848624|FG004|Overall Study|Lack of Efficacy|2|||
30826204|NCT02766608|58848620|FG000|Overall Study|Lost to Follow-up|6|||
30826205|NCT02766608|58848621|FG001|Overall Study|Lost to Follow-up|3|||
30826206|NCT02766608|58848622|FG002|Overall Study|Lost to Follow-up|5|||
30826207|NCT02766608|58848623|FG003|Overall Study|Lost to Follow-up|2|||
30826208|NCT02766608|58848624|FG004|Overall Study|Lost to Follow-up|2|||
30826209|NCT02766608|58848620|FG000|Overall Study|Physician Decision|3|||
30826210|NCT02766608|58848621|FG001|Overall Study|Physician Decision|2|||
30826211|NCT02766608|58848622|FG002|Overall Study|Physician Decision|3|||
30826212|NCT02766608|58848623|FG003|Overall Study|Physician Decision|1|||
30826213|NCT02766608|58848624|FG004|Overall Study|Physician Decision|2|||
30826214|NCT02766608|58848620|FG000|Overall Study|Protocol disc criteria|3|||
30826215|NCT02766608|58848621|FG001|Overall Study|Protocol disc criteria|3|||
30826216|NCT02766608|58848622|FG002|Overall Study|Protocol disc criteria|4|||
30826217|NCT02766608|58848623|FG003|Overall Study|Protocol disc criteria|0|||
30826218|NCT02766608|58848624|FG004|Overall Study|Protocol disc criteria|0|||
30826219|NCT02766608|58848620|FG000|Overall Study|Protocol Violation|0|||
30917896|NCT01863849|58953461|FG001|Overall Study|Lost to Follow-up|0|||
30917897|NCT01863771|58953468|FG000|Induction Phase|Adverse Event|9|||
30917898|NCT01863771|58953469|FG001|Induction Phase|Adverse Event|0|||
30917899|NCT01863771|58953470|FG002|Induction Phase|Adverse Event|0|||
30917900|NCT01863771|58953471|FG003|Induction Phase|Adverse Event|0|||
30917901|NCT01863771|58953468|FG000|Induction Phase|Lack of Efficacy|10|||
30917902|NCT01863771|58953469|FG001|Induction Phase|Lack of Efficacy|0|||
30917903|NCT01863771|58953470|FG002|Induction Phase|Lack of Efficacy|0|||
30917904|NCT01863771|58953471|FG003|Induction Phase|Lack of Efficacy|0|||
30826220|NCT02766608|58848621|FG001|Overall Study|Protocol Violation|4|||
30826221|NCT02766608|58848622|FG002|Overall Study|Protocol Violation|4|||
30826222|NCT02766608|58848623|FG003|Overall Study|Protocol Violation|0|||
30917905|NCT01863771|58953468|FG000|Induction Phase|Withdrawal by Subject|2|||
30917906|NCT01863771|58953469|FG001|Induction Phase|Withdrawal by Subject|0|||
30917907|NCT01863771|58953470|FG002|Induction Phase|Withdrawal by Subject|0|||
30917908|NCT01863771|58953471|FG003|Induction Phase|Withdrawal by Subject|0|||
30917909|NCT01863771|58953468|FG000|Maintenance Phase|Adverse Event|0|||
30826223|NCT02766608|58848624|FG004|Overall Study|Protocol Violation|1|||
30826224|NCT02766608|58848620|FG000|Overall Study|Administrative Reasons|3|||
30826225|NCT02766608|58848621|FG001|Overall Study|Administrative Reasons|1|||
30826226|NCT02766608|58848622|FG002|Overall Study|Administrative Reasons|1|||
30826227|NCT02766608|58848623|FG003|Overall Study|Administrative Reasons|0|||
30826228|NCT02766608|58848624|FG004|Overall Study|Administrative Reasons|0|||
30917910|NCT01863771|58953469|FG001|Maintenance Phase|Adverse Event|0|||
30917911|NCT01863771|58953470|FG002|Maintenance Phase|Adverse Event|1|||
30917912|NCT01863771|58953471|FG003|Maintenance Phase|Adverse Event|1|||
30917913|NCT01863771|58953468|FG000|Maintenance Phase|Lack of Efficacy|0|||
30917914|NCT01863771|58953469|FG001|Maintenance Phase|Lack of Efficacy|3|||
30917915|NCT01863771|58953470|FG002|Maintenance Phase|Lack of Efficacy|7|||
30917916|NCT01863771|58953471|FG003|Maintenance Phase|Lack of Efficacy|38|||
30917917|NCT01863771|58953468|FG000|Maintenance Phase|Physician Decision|0|||
30917918|NCT01863771|58953469|FG001|Maintenance Phase|Physician Decision|0|||
30917919|NCT01863771|58953470|FG002|Maintenance Phase|Physician Decision|2|||
30917920|NCT01863771|58953471|FG003|Maintenance Phase|Physician Decision|1|||
30917921|NCT01863771|58953468|FG000|Maintenance Phase|Pregnancy|0|||
30917922|NCT01863771|58953469|FG001|Maintenance Phase|Pregnancy|1|||
30917923|NCT01863771|58953470|FG002|Maintenance Phase|Pregnancy|0|||
30917924|NCT01863771|58953471|FG003|Maintenance Phase|Pregnancy|0|||
30917925|NCT01863771|58953468|FG000|Maintenance Phase|Withdrawal by Subject|0|||
30917926|NCT01863771|58953469|FG001|Maintenance Phase|Withdrawal by Subject|1|||
30917927|NCT01863771|58953470|FG002|Maintenance Phase|Withdrawal by Subject|2|||
30826229|NCT00960141|58848642|FG000|Overall Study|Adverse Event|4|||
30826230|NCT00960141|58848643|FG001|Overall Study|Adverse Event|8|||
30826231|NCT00960141|58848644|FG002|Overall Study|Adverse Event|2|||
30826232|NCT00960141|58848642|FG000|Overall Study|Lack of Efficacy|3|||
30826233|NCT00960141|58848643|FG001|Overall Study|Lack of Efficacy|4|||
30826234|NCT00960141|58848644|FG002|Overall Study|Lack of Efficacy|2|||
30826235|NCT00960141|58848642|FG000|Overall Study|Lost to Follow-up|1|||
30826236|NCT00960141|58848643|FG001|Overall Study|Lost to Follow-up|0|||
30826237|NCT00960141|58848644|FG002|Overall Study|Lost to Follow-up|0|||
30826238|NCT00960141|58848642|FG000|Overall Study|Protocol Violation|1|||
30826239|NCT00960141|58848643|FG001|Overall Study|Protocol Violation|3|||
30826240|NCT00960141|58848644|FG002|Overall Study|Protocol Violation|2|||
30826241|NCT00960141|58848642|FG000|Overall Study|Withdrawal by Subject|1|||
30826242|NCT00960141|58848643|FG001|Overall Study|Withdrawal by Subject|2|||
30826243|NCT00960141|58848644|FG002|Overall Study|Withdrawal by Subject|1|||
30826244|NCT02771522|58848652|FG000|Overall Study|Lost to Follow-up|3|||
30826245|NCT02771522|58848652|FG000|Overall Study|Withdrawal by Subject|2|||
30826246|NCT02771522|58848652|FG000|Overall Study|No white spot lesions|3|||
30826247|NCT00759655|58848661|FG000|Overall Study|Termination of the study by sponsor|1|||
30826248|NCT02771366|58848667|FG000|Period 1|Withdrawal by Subject|0|||
30917928|NCT01863771|58953471|FG003|Maintenance Phase|Withdrawal by Subject|3|||
30917929|NCT01894581|58953481|FG000|Overall Study|Withdrawal by Subject|2|||
30917930|NCT01894581|58953482|FG001|Overall Study|Withdrawal by Subject|3|||
30917931|NCT01894581|58953481|FG000|Overall Study|Screen Failure|3|||
30917932|NCT01894581|58953482|FG001|Overall Study|Screen Failure|4|||
30917933|NCT02203331|58953494|FG000|Overall Study|Pregnancy|1|||
30917934|NCT02203331|58953495|FG001|Overall Study|Pregnancy|0|||
30917935|NCT02203331|58953496|FG002|Overall Study|Pregnancy|0|||
30917936|NCT02203331|58953497|FG003|Overall Study|Pregnancy|0|||
30917937|NCT02203331|58953498|FG004|Overall Study|Pregnancy|2|||
30917938|NCT02203331|58953499|FG005|Overall Study|Pregnancy|0|||
30917939|NCT02203331|58953494|FG000|Overall Study|Withdrawal by Subject|1|||
30917940|NCT02203331|58953495|FG001|Overall Study|Withdrawal by Subject|0|||
30917941|NCT02203331|58953496|FG002|Overall Study|Withdrawal by Subject|1|||
30917942|NCT02203331|58953497|FG003|Overall Study|Withdrawal by Subject|0|||
30917943|NCT02203331|58953498|FG004|Overall Study|Withdrawal by Subject|0|||
30917944|NCT02203331|58953499|FG005|Overall Study|Withdrawal by Subject|3|||
30917945|NCT02203331|58953494|FG000|Overall Study|Adverse Event|4|||
30917946|NCT02203331|58953495|FG001|Overall Study|Adverse Event|8|||
30917947|NCT02203331|58953496|FG002|Overall Study|Adverse Event|3|||
30917948|NCT02203331|58953497|FG003|Overall Study|Adverse Event|4|||
30917949|NCT02203331|58953498|FG004|Overall Study|Adverse Event|3|||
30917950|NCT02203331|58953499|FG005|Overall Study|Adverse Event|3|||
30917951|NCT02203331|58953494|FG000|Overall Study|Other Reasons|1|||
30917952|NCT02203331|58953495|FG001|Overall Study|Other Reasons|2|||
30917953|NCT02203331|58953496|FG002|Overall Study|Other Reasons|0|||
30826249|NCT02771366|58848668|FG001|Period 1|Withdrawal by Subject|2|||
30917954|NCT02203331|58953497|FG003|Overall Study|Other Reasons|2|||
30917955|NCT02203331|58953498|FG004|Overall Study|Other Reasons|0|||
30917956|NCT02203331|58953499|FG005|Overall Study|Other Reasons|0|||
30917957|NCT02203331|58953494|FG000|Overall Study|Lack of Efficacy|0|||
30917958|NCT02203331|58953495|FG001|Overall Study|Lack of Efficacy|2|||
30917959|NCT02203331|58953496|FG002|Overall Study|Lack of Efficacy|1|||
30826250|NCT02771366|58848667|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
30826251|NCT02771366|58848668|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
30917960|NCT02203331|58953497|FG003|Overall Study|Lack of Efficacy|0|||
30917961|NCT02203331|58953498|FG004|Overall Study|Lack of Efficacy|0|||
30917962|NCT02203331|58953499|FG005|Overall Study|Lack of Efficacy|1|||
30917963|NCT02203331|58953494|FG000|Overall Study|Protocol Violation|0|||
30917964|NCT02203331|58953495|FG001|Overall Study|Protocol Violation|2|||
30917965|NCT02203331|58953496|FG002|Overall Study|Protocol Violation|0|||
30917966|NCT02203331|58953497|FG003|Overall Study|Protocol Violation|1|||
30917967|NCT02203331|58953498|FG004|Overall Study|Protocol Violation|1|||
30917968|NCT02203331|58953499|FG005|Overall Study|Protocol Violation|0|||
30917969|NCT02203331|58953494|FG000|Overall Study|Lost to Follow-up|0|||
30917970|NCT02203331|58953495|FG001|Overall Study|Lost to Follow-up|0|||
30917971|NCT02203331|58953496|FG002|Overall Study|Lost to Follow-up|0|||
30917972|NCT02203331|58953497|FG003|Overall Study|Lost to Follow-up|0|||
30917973|NCT02203331|58953498|FG004|Overall Study|Lost to Follow-up|1|||
30917974|NCT02203331|58953499|FG005|Overall Study|Lost to Follow-up|0|||
30917975|NCT01893411|58953516|FG000|Overall Study|Protocol Violation|1|||
30917976|NCT01893411|58953517|FG001|Overall Study|Protocol Violation|0|||
30917977|NCT01893411|58953518|FG002|Overall Study|Protocol Violation|0|||
30917978|NCT01893411|58953516|FG000|Overall Study|Physician Decision|1|||
30917979|NCT01893411|58953517|FG001|Overall Study|Physician Decision|1|||
30917980|NCT01893411|58953518|FG002|Overall Study|Physician Decision|2|||
30917981|NCT01893411|58953516|FG000|Overall Study|Lack of Efficacy|2|||
30917982|NCT01893411|58953517|FG001|Overall Study|Lack of Efficacy|1|||
30917983|NCT01893411|58953518|FG002|Overall Study|Lack of Efficacy|0|||
30917984|NCT01893411|58953516|FG000|Overall Study|Other|3|||
30917985|NCT01893411|58953517|FG001|Overall Study|Other|1|||
30917986|NCT01893411|58953518|FG002|Overall Study|Other|3|||
30917987|NCT01893411|58953516|FG000|Overall Study|Adverse Event|1|||
30917988|NCT01893411|58953517|FG001|Overall Study|Adverse Event|0|||
30917989|NCT01893411|58953518|FG002|Overall Study|Adverse Event|0|||
30917990|NCT01893411|58953516|FG000|Overall Study|Withdrawal by Subject|7|||
30917991|NCT01893411|58953517|FG001|Overall Study|Withdrawal by Subject|4|||
30917992|NCT01893411|58953518|FG002|Overall Study|Withdrawal by Subject|3|||
30917993|NCT01893411|58953516|FG000|Overall Study|Lost to Follow-up|2|||
30917994|NCT01893411|58953517|FG001|Overall Study|Lost to Follow-up|0|||
30917995|NCT01893411|58953518|FG002|Overall Study|Lost to Follow-up|1|||
30917996|NCT02232425|58953528|FG000|Overall Study|Lost to Follow-up|6|||
30917997|NCT02232425|58953529|FG001|Overall Study|Lost to Follow-up|2|||
30917998|NCT02232425|58953528|FG000|Overall Study|Adverse Event|2|||
30917999|NCT02232425|58953529|FG001|Overall Study|Adverse Event|0|||
30918000|NCT02232425|58953528|FG000|Overall Study|Withdrawal by Subject|5|||
30918001|NCT02232425|58953529|FG001|Overall Study|Withdrawal by Subject|6|||
30918002|NCT02232425|58953528|FG000|Overall Study|Lack of Efficacy|1|||
30918003|NCT02232425|58953529|FG001|Overall Study|Lack of Efficacy|0|||
30918004|NCT01631435|58953535|FG000|Overall Study|Adverse Event|2|||
30918005|NCT01631435|58953535|FG000|Overall Study|Withdrawal by Subject|2|||
30918006|NCT01631435|58953535|FG000|Overall Study|incomplete study procedure|5|||
30918007|NCT02230085|58953540|FG000|Overall Study|Physician Decision|1|||
30918008|NCT02230085|58953540|FG000|Overall Study|Withdrawal by Subject|3|||
30918009|NCT01882803|58953544|FG000|Overall Study|Disease Progression|53|||
30918010|NCT01882803|58953544|FG000|Overall Study|Adverse Event|22|||
30918011|NCT01882803|58953544|FG000|Overall Study|Death|7|||
30918012|NCT01882803|58953544|FG000|Overall Study|Physician Decision|7|||
30918013|NCT01882803|58953544|FG000|Overall Study|Protocol Violation|1|||
30918014|NCT01882803|58953544|FG000|Overall Study|Withdrawal by Subject|4|||
30918015|NCT02202785|58953552|FG000|Overall Study|Study Terminated by Sponsor|1|||
30918016|NCT02202785|58953553|FG001|Overall Study|Study Terminated by Sponsor|6|||
30918017|NCT02202785|58953554|FG002|Overall Study|Study Terminated by Sponsor|4|||
30918018|NCT02202785|58953552|FG000|Overall Study|Withdrawal by Subject|0|||
30918019|NCT02202785|58953553|FG001|Overall Study|Withdrawal by Subject|1|||
30918020|NCT02202785|58953554|FG002|Overall Study|Withdrawal by Subject|0|||
30918021|NCT02202785|58953552|FG000|Overall Study|Lost to Follow-up|0|||
30918022|NCT02202785|58953553|FG001|Overall Study|Lost to Follow-up|1|||
30918023|NCT02202785|58953554|FG002|Overall Study|Lost to Follow-up|0|||
30918024|NCT02202785|58953552|FG000|Overall Study|Reason not Specified|10|||
30918025|NCT02202785|58953553|FG001|Overall Study|Reason not Specified|7|||
30918026|NCT02202785|58953554|FG002|Overall Study|Reason not Specified|13|||
30918027|NCT01882647|58953564|FG000|Overall Study|Lost to Follow-up|2|||
30918028|NCT01882647|58953565|FG001|Overall Study|Lost to Follow-up|2|||
30918029|NCT01882647|58953564|FG000|Overall Study|Withdrawal by Subject|0|||
30918030|NCT01882647|58953565|FG001|Overall Study|Withdrawal by Subject|4|||
30918031|NCT01882257|58953574|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
30918032|NCT01882257|58953575|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
30918033|NCT01882257|58953576|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
30918034|NCT01882257|58953574|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
30918035|NCT01882257|58953575|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
30918036|NCT01882257|58953576|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
30918037|NCT01862991|58953586|FG000|Overall Study|Lost to Follow-up|2|||
30918038|NCT01862991|58953587|FG001|Overall Study|Lost to Follow-up|1|||
30918039|NCT01862991|58953588|FG002|Overall Study|Lost to Follow-up|1|||
30918040|NCT01862991|58953586|FG000|Overall Study|Protocol Violation|1|||
30918041|NCT01862991|58953587|FG001|Overall Study|Protocol Violation|0|||
30918042|NCT01862991|58953588|FG002|Overall Study|Protocol Violation|0|||
30918043|NCT02202551|58953600|FG000|Overall Study|Adverse Event|8|||
30918044|NCT02202551|58953601|FG001|Overall Study|Adverse Event|19|||
30918045|NCT02202551|58953602|FG002|Overall Study|Adverse Event|5|||
30918046|NCT02202551|58953603|FG003|Overall Study|Adverse Event|9|||
30918047|NCT02202551|58953600|FG000|Overall Study|Death|3|||
30918048|NCT02202551|58953601|FG001|Overall Study|Death|2|||
30918049|NCT02202551|58953602|FG002|Overall Study|Death|1|||
30918050|NCT02202551|58953603|FG003|Overall Study|Death|1|||
30918051|NCT02202551|58953600|FG000|Overall Study|Lost to Follow-up|0|||
30918052|NCT02202551|58953601|FG001|Overall Study|Lost to Follow-up|1|||
30918053|NCT02202551|58953602|FG002|Overall Study|Lost to Follow-up|0|||
30918054|NCT02202551|58953603|FG003|Overall Study|Lost to Follow-up|1|||
30918055|NCT02202551|58953600|FG000|Overall Study|Needed to take excluded medication|0|||
30918056|NCT02202551|58953601|FG001|Overall Study|Needed to take excluded medication|2|||
30918057|NCT02202551|58953602|FG002|Overall Study|Needed to take excluded medication|0|||
30918058|NCT02202551|58953603|FG003|Overall Study|Needed to take excluded medication|1|||
30918059|NCT02202551|58953600|FG000|Overall Study|Subject moved away|0|||
30918060|NCT02202551|58953601|FG001|Overall Study|Subject moved away|1|||
30918061|NCT02202551|58953602|FG002|Overall Study|Subject moved away|0|||
30918062|NCT02202551|58953603|FG003|Overall Study|Subject moved away|0|||
30918063|NCT02202551|58953600|FG000|Overall Study|DBS surgery|3|||
30918064|NCT02202551|58953601|FG001|Overall Study|DBS surgery|0|||
30918065|NCT02202551|58953602|FG002|Overall Study|DBS surgery|0|||
30918066|NCT02202551|58953603|FG003|Overall Study|DBS surgery|0|||
30918067|NCT02202551|58953600|FG000|Overall Study|Dyskinesia upon taper|1|||
30918068|NCT02202551|58953601|FG001|Overall Study|Dyskinesia upon taper|0|||
30918069|NCT02202551|58953602|FG002|Overall Study|Dyskinesia upon taper|0|||
30918070|NCT02202551|58953603|FG003|Overall Study|Dyskinesia upon taper|0|||
30918071|NCT02202551|58953600|FG000|Overall Study|Lack of Efficacy|0|||
30918072|NCT02202551|58953601|FG001|Overall Study|Lack of Efficacy|1|||
30918073|NCT02202551|58953602|FG002|Overall Study|Lack of Efficacy|0|||
30918074|NCT02202551|58953603|FG003|Overall Study|Lack of Efficacy|0|||
30918075|NCT02202551|58953600|FG000|Overall Study|Physician Decision|1|||
30918076|NCT02202551|58953601|FG001|Overall Study|Physician Decision|0|||
30918077|NCT02202551|58953602|FG002|Overall Study|Physician Decision|0|||
30918078|NCT02202551|58953603|FG003|Overall Study|Physician Decision|0|||
30918079|NCT02202551|58953600|FG000|Overall Study|Site closure|3|||
30918080|NCT02202551|58953601|FG001|Overall Study|Site closure|0|||
30918081|NCT02202551|58953602|FG002|Overall Study|Site closure|0|||
30918082|NCT02202551|58953603|FG003|Overall Study|Site closure|1|||
30918083|NCT02202551|58953600|FG000|Overall Study|Unable to complete visits per protocol|1|||
30918084|NCT02202551|58953601|FG001|Overall Study|Unable to complete visits per protocol|0|||
30918085|NCT02202551|58953602|FG002|Overall Study|Unable to complete visits per protocol|0|||
30918086|NCT02202551|58953603|FG003|Overall Study|Unable to complete visits per protocol|0|||
30918087|NCT02202551|58953600|FG000|Overall Study|Worsening Dyskinesia|0|||
30918088|NCT02202551|58953601|FG001|Overall Study|Worsening Dyskinesia|0|||
30918089|NCT02202551|58953602|FG002|Overall Study|Worsening Dyskinesia|0|||
30918090|NCT02202551|58953603|FG003|Overall Study|Worsening Dyskinesia|1|||
30918091|NCT02202551|58953600|FG000|Overall Study|Protocol Violation|0|||
30918092|NCT02202551|58953601|FG001|Overall Study|Protocol Violation|1|||
30918093|NCT02202551|58953602|FG002|Overall Study|Protocol Violation|0|||
30918094|NCT02202551|58953603|FG003|Overall Study|Protocol Violation|0|||
30918095|NCT02202551|58953600|FG000|Overall Study|Sponsor's decision|2|||
30918096|NCT02202551|58953601|FG001|Overall Study|Sponsor's decision|0|||
30918097|NCT02202551|58953602|FG002|Overall Study|Sponsor's decision|0|||
30918098|NCT02202551|58953603|FG003|Overall Study|Sponsor's decision|0|||
30918099|NCT02202551|58953600|FG000|Overall Study|Subject unwilling to proceed|1|||
30918100|NCT02202551|58953601|FG001|Overall Study|Subject unwilling to proceed|5|||
30918101|NCT02202551|58953602|FG002|Overall Study|Subject unwilling to proceed|3|||
30918102|NCT02202551|58953603|FG003|Overall Study|Subject unwilling to proceed|5|||
30918103|NCT02202551|58953600|FG000|Overall Study|Subject consent withdrawn|0|||
30918104|NCT02202551|58953601|FG001|Overall Study|Subject consent withdrawn|3|||
30918105|NCT02202551|58953602|FG002|Overall Study|Subject consent withdrawn|1|||
30918106|NCT02202551|58953603|FG003|Overall Study|Subject consent withdrawn|2|||
30918107|NCT02202551|58953600|FG000|Overall Study|eGFR<50mL/min/m2|2|||
30918108|NCT02202551|58953601|FG001|Overall Study|eGFR<50mL/min/m2|2|||
30918109|NCT02202551|58953602|FG002|Overall Study|eGFR<50mL/min/m2|0|||
30918110|NCT02202551|58953603|FG003|Overall Study|eGFR<50mL/min/m2|1|||
30918111|NCT02202317|58953617|FG000|Overall Study|Lost to Follow-up|1|||
30918112|NCT02118337|58953630|FG000|Overall Study|Other|1|||
30918113|NCT02118337|58953631|FG001|Overall Study|Other|0|||
30918114|NCT02118337|58953632|FG002|Overall Study|Other|0|||
30918115|NCT02118337|58953633|FG003|Overall Study|Other|0|||
30918116|NCT02118337|58953634|FG004|Overall Study|Other|2|||
30918117|NCT02118337|58953635|FG005|Overall Study|Other|3|||
30918118|NCT02118337|58953636|FG006|Overall Study|Other|1|||
30918119|NCT02118337|58953637|FG007|Overall Study|Other|28|||
30918120|NCT02118337|58953638|FG008|Overall Study|Other|15|||
30918121|NCT02118337|58953630|FG000|Overall Study|Lost to Follow-up|0|||
30918122|NCT02118337|58953631|FG001|Overall Study|Lost to Follow-up|0|||
30918123|NCT02118337|58953632|FG002|Overall Study|Lost to Follow-up|0|||
30918124|NCT02118337|58953633|FG003|Overall Study|Lost to Follow-up|0|||
30918125|NCT02118337|58953634|FG004|Overall Study|Lost to Follow-up|0|||
30918126|NCT02118337|58953635|FG005|Overall Study|Lost to Follow-up|0|||
30918127|NCT02118337|58953636|FG006|Overall Study|Lost to Follow-up|0|||
30918128|NCT02118337|58953637|FG007|Overall Study|Lost to Follow-up|1|||
30918129|NCT02118337|58953638|FG008|Overall Study|Lost to Follow-up|0|||
30918130|NCT02118337|58953630|FG000|Overall Study|Withdrawal by Subject|1|||
30918131|NCT02118337|58953631|FG001|Overall Study|Withdrawal by Subject|3|||
30918132|NCT02118337|58953632|FG002|Overall Study|Withdrawal by Subject|2|||
30918133|NCT02118337|58953633|FG003|Overall Study|Withdrawal by Subject|1|||
30918134|NCT02118337|58953634|FG004|Overall Study|Withdrawal by Subject|2|||
30918135|NCT02118337|58953635|FG005|Overall Study|Withdrawal by Subject|2|||
30918136|NCT02118337|58953636|FG006|Overall Study|Withdrawal by Subject|1|||
30918137|NCT02118337|58953637|FG007|Overall Study|Withdrawal by Subject|4|||
30918138|NCT02118337|58953638|FG008|Overall Study|Withdrawal by Subject|2|||
30918139|NCT02118337|58953630|FG000|Overall Study|Death|2|||
30918140|NCT02118337|58953631|FG001|Overall Study|Death|2|||
30918141|NCT02118337|58953632|FG002|Overall Study|Death|1|||
30918142|NCT02118337|58953633|FG003|Overall Study|Death|2|||
30918143|NCT02118337|58953634|FG004|Overall Study|Death|5|||
30918144|NCT02118337|58953635|FG005|Overall Study|Death|1|||
30918145|NCT02118337|58953636|FG006|Overall Study|Death|2|||
30826252|NCT03396471|58848675|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
30826253|NCT03396471|58848675|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
30826254|NCT03396471|58848675|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
30826255|NCT03396471|58848675|FG000|Study Treatment - Up to 22 Months|Death|2|||
30826256|NCT03396471|58848675|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
30826257|NCT03396471|58848675|FG000|Follow up - Up to 2 Years|Death|9|||
30826258|NCT03396471|58848675|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
30826259|NCT03396471|58848675|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
30826260|NCT03396471|58848675|FG000|Follow up - Up to 2 Years|study terminated|1|||
30826261|NCT03396471|58848675|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
30826262|NCT03396471|58848675|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
30826263|NCT00103142|58848681|FG000|Overall Study|Adverse Event|1|||
30826264|NCT00103142|58848682|FG001|Overall Study|Adverse Event|0|||
30826265|NCT00103142|58848681|FG000|Overall Study|Progression of disease|2|||
30826266|NCT00103142|58848682|FG001|Overall Study|Progression of disease|1|||
30826267|NCT00943683|58848692|FG000|Overall Study|Adverse Event|3|||
30826268|NCT00943683|58848693|FG001|Overall Study|Adverse Event|3|||
30826269|NCT00943683|58848692|FG000|Overall Study|Lost to Follow-up|1|||
30826270|NCT00943683|58848693|FG001|Overall Study|Lost to Follow-up|1|||
30826271|NCT00943683|58848692|FG000|Overall Study|Protocol Violation|1|||
30826272|NCT00943683|58848693|FG001|Overall Study|Protocol Violation|2|||
30826273|NCT00943683|58848692|FG000|Overall Study|Withdrawal by Subject|1|||
30826274|NCT00943683|58848693|FG001|Overall Study|Withdrawal by Subject|0|||
30826275|NCT00943683|58848692|FG000|Overall Study|Patient Moved|1|||
30826276|NCT00943683|58848693|FG001|Overall Study|Patient Moved|0|||
30826277|NCT00911547|58848703|FG000|Overall Study|Adverse Event|8|||
30826278|NCT00911547|58848704|FG001|Overall Study|Adverse Event|27|||
30826279|NCT00911547|58848705|FG002|Overall Study|Adverse Event|11|||
30826280|NCT00911547|58848706|FG003|Overall Study|Adverse Event|6|||
30826281|NCT00911547|58848703|FG000|Overall Study|Lost to Follow-up|0|||
30826282|NCT00911547|58848704|FG001|Overall Study|Lost to Follow-up|0|||
30826283|NCT00911547|58848705|FG002|Overall Study|Lost to Follow-up|2|||
30826284|NCT00911547|58848706|FG003|Overall Study|Lost to Follow-up|1|||
30826285|NCT00911547|58848703|FG000|Overall Study|Protocol Violation|0|||
30918146|NCT02118337|58953637|FG007|Overall Study|Death|9|||
30826286|NCT00911547|58848704|FG001|Overall Study|Protocol Violation|5|||
30826287|NCT00911547|58848705|FG002|Overall Study|Protocol Violation|5|||
30826288|NCT00911547|58848706|FG003|Overall Study|Protocol Violation|1|||
30826289|NCT00911547|58848703|FG000|Overall Study|Withdrawal by Subject|3|||
30826290|NCT00911547|58848704|FG001|Overall Study|Withdrawal by Subject|10|||
30918147|NCT02118337|58953638|FG008|Overall Study|Death|4|||
30918148|NCT02117713|58953662|FG000|Week 48|Adverse Event|4|||
30918149|NCT02117713|58953662|FG000|Week 48|Withdrawal by caregiver|2|||
30918150|NCT02117713|58953662|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
30918151|NCT02117713|58953662|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
30918152|NCT02117713|58953662|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
30918153|NCT02117713|58953662|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
30918154|NCT02105467|58953676|FG000|Period 1|Lost to Follow-up|1|||
30918155|NCT02105467|58953677|FG001|Period 1|Lost to Follow-up|0|||
30918156|NCT02105467|58953676|FG000|Period 1|Death|1|||
30918157|NCT02105467|58953677|FG001|Period 1|Death|0|||
30918158|NCT02105467|58953676|FG000|Period 2|Lost to Follow-up|1|||
30918159|NCT02105467|58953677|FG001|Period 2|Lost to Follow-up|0|||
30918160|NCT02105467|58953676|FG000|Period 2|Death|1|||
30918161|NCT02105467|58953677|FG001|Period 2|Death|0|||
30918162|NCT02105467|58953676|FG000|Period 2|Withdrawal by Subject|0|||
30918163|NCT02105467|58953677|FG001|Period 2|Withdrawal by Subject|2|||
30918164|NCT02105467|58953676|FG000|Period 3|Lost to Follow-up|0|||
30918165|NCT02105467|58953677|FG001|Period 3|Lost to Follow-up|1|||
30918166|NCT02202161|58953692|FG000|Overall Study|Adverse Event|1|||
30918167|NCT02202161|58953693|FG001|Overall Study|Adverse Event|1|||
30918168|NCT02202161|58953694|FG002|Overall Study|Adverse Event|0|||
30918169|NCT02202161|58953695|FG003|Overall Study|Adverse Event|0|||
30918170|NCT02202161|58953696|FG004|Overall Study|Adverse Event|0|||
30918171|NCT02202161|58953697|FG005|Overall Study|Adverse Event|1|||
30918172|NCT02202161|58953698|FG006|Overall Study|Adverse Event|0|||
30918173|NCT02202161|58953699|FG007|Overall Study|Adverse Event|0|||
30918174|NCT02202161|58953692|FG000|Overall Study|Did not meet continuation criteria|0|||
30918175|NCT02202161|58953693|FG001|Overall Study|Did not meet continuation criteria|0|||
30918176|NCT02202161|58953694|FG002|Overall Study|Did not meet continuation criteria|0|||
30918177|NCT02202161|58953695|FG003|Overall Study|Did not meet continuation criteria|0|||
30918178|NCT02202161|58953696|FG004|Overall Study|Did not meet continuation criteria|0|||
30918179|NCT02202161|58953697|FG005|Overall Study|Did not meet continuation criteria|0|||
30918180|NCT02202161|58953698|FG006|Overall Study|Did not meet continuation criteria|0|||
30623244|NCT01122576|58635091|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
30826291|NCT00911547|58848705|FG002|Overall Study|Withdrawal by Subject|4|||
30826292|NCT00911547|58848706|FG003|Overall Study|Withdrawal by Subject|8|||
30826293|NCT00899379|58848721|FG000|Overall Study|Adverse Event|2|||
30826294|NCT00899379|58848722|FG001|Overall Study|Adverse Event|2|||
30826295|NCT00899379|58848723|FG002|Overall Study|Adverse Event|1|||
30826296|NCT00899379|58848724|FG003|Overall Study|Adverse Event|1|||
30826297|NCT00899379|58848725|FG004|Overall Study|Adverse Event|2|||
30826298|NCT00899379|58848721|FG000|Overall Study|Lack of Efficacy|0|||
30826299|NCT00899379|58848722|FG001|Overall Study|Lack of Efficacy|4|||
30826300|NCT00899379|58848723|FG002|Overall Study|Lack of Efficacy|3|||
30826301|NCT00899379|58848724|FG003|Overall Study|Lack of Efficacy|0|||
30826302|NCT00899379|58848725|FG004|Overall Study|Lack of Efficacy|1|||
30826303|NCT00899379|58848721|FG000|Overall Study|Lost to Follow-up|9|||
30918181|NCT02202161|58953699|FG007|Overall Study|Did not meet continuation criteria|3|||
30918182|NCT02202161|58953692|FG000|Overall Study|Physician Decision|0|||
30918183|NCT02202161|58953693|FG001|Overall Study|Physician Decision|0|||
30918184|NCT02202161|58953694|FG002|Overall Study|Physician Decision|0|||
30623245|NCT01122576|58635092|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
30623246|NCT01122576|58635093|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
30753926|NCT00098748|58763552|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
30753927|NCT00098748|58763550|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
30753928|NCT00098748|58763551|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
30753929|NCT00098748|58763552|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
30753930|NCT00098748|58763550|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
30753931|NCT00098748|58763551|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
30753932|NCT00098748|58763552|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
30753933|NCT00098748|58763550|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
30753934|NCT00098748|58763551|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
30753935|NCT00098748|58763552|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
30753936|NCT00130520|58763560|FG000|Overall Study|Adverse Event|11|||
30753937|NCT00130520|58763560|FG000|Overall Study|Death|1|||
30753938|NCT00130520|58763560|FG000|Overall Study|Physician Decision|1|||
30753939|NCT00130520|58763560|FG000|Overall Study|Withdrawal by Subject|1|||
30753940|NCT00130520|58763560|FG000|Overall Study|Disease Progression|23|||
30753941|NCT00130520|58763560|FG000|Overall Study|Protocol non-compliance|1|||
30753942|NCT00130520|58763560|FG000|Overall Study|Did not meet re-treatment criteria|1|||
30753943|NCT00132132|58763566|FG000|Overall Study|Lost to Follow-up|7|||
30753944|NCT00132132|58763567|FG001|Overall Study|Lost to Follow-up|2|||
30753945|NCT00130442|58763575|FG000|Overall Study|Withdrawal by Subject|0|||
30753946|NCT00130442|58763576|FG001|Overall Study|Withdrawal by Subject|1|||
30753947|NCT00130442|58763575|FG000|Overall Study|did not meet criteria|1|||
30753948|NCT00130442|58763576|FG001|Overall Study|did not meet criteria|1|||
30753949|NCT00130208|58763586|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
30753950|NCT00130208|58763587|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
30826304|NCT00899379|58848722|FG001|Overall Study|Lost to Follow-up|3|||
30918185|NCT02202161|58953695|FG003|Overall Study|Physician Decision|0|||
30918186|NCT02202161|58953696|FG004|Overall Study|Physician Decision|0|||
30918187|NCT02202161|58953697|FG005|Overall Study|Physician Decision|0|||
30918188|NCT02202161|58953698|FG006|Overall Study|Physician Decision|0|||
30918189|NCT02202161|58953699|FG007|Overall Study|Physician Decision|3|||
30918190|NCT02202161|58953692|FG000|Overall Study|Withdrawal by Subject|0|||
30918191|NCT02202161|58953693|FG001|Overall Study|Withdrawal by Subject|0|||
30918192|NCT02202161|58953694|FG002|Overall Study|Withdrawal by Subject|0|||
30918193|NCT02202161|58953695|FG003|Overall Study|Withdrawal by Subject|0|||
30918194|NCT02202161|58953696|FG004|Overall Study|Withdrawal by Subject|1|||
30918195|NCT02202161|58953697|FG005|Overall Study|Withdrawal by Subject|0|||
30918196|NCT02202161|58953698|FG006|Overall Study|Withdrawal by Subject|0|||
30918197|NCT02202161|58953699|FG007|Overall Study|Withdrawal by Subject|0|||
30918198|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Adverse Event|76|||
30918199|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Adverse Event|0|||
30918200|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Adverse Event|0|||
30918201|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Death|3|||
30918202|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Death|0|||
30918203|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Death|0|||
30918204|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
30918205|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
30918206|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
30918207|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Physician Decision|9|||
30918208|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Physician Decision|0|||
30918209|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Physician Decision|0|||
30918210|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
30918211|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
30918212|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
30918213|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Disease progression|45|||
30918214|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Disease progression|0|||
30918215|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Disease progression|0|||
30918216|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
30918217|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
30918218|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
30918219|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
30918220|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
30918221|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
30918222|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
30918223|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
30918224|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
30918225|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
30918226|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
30918227|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
30918228|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
30918229|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
30918230|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
30918231|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
30918232|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
30918233|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
30918234|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
30918235|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
30918236|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
30918237|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
30918238|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
30918239|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
30918240|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
30826305|NCT00899379|58848723|FG002|Overall Study|Lost to Follow-up|0|||
30826306|NCT00899379|58848724|FG003|Overall Study|Lost to Follow-up|6|||
30826307|NCT00899379|58848725|FG004|Overall Study|Lost to Follow-up|2|||
30826308|NCT00899379|58848721|FG000|Overall Study|Protocol Violation|0|||
30826309|NCT00899379|58848722|FG001|Overall Study|Protocol Violation|0|||
30826310|NCT00899379|58848723|FG002|Overall Study|Protocol Violation|1|||
30826311|NCT00899379|58848724|FG003|Overall Study|Protocol Violation|1|||
30826312|NCT00899379|58848725|FG004|Overall Study|Protocol Violation|0|||
30826313|NCT00899379|58848721|FG000|Overall Study|Withdrawal by Subject|2|||
30826314|NCT00899379|58848722|FG001|Overall Study|Withdrawal by Subject|4|||
30918241|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
30918242|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
30918243|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Promotor request|1|||
30826315|NCT00899379|58848723|FG002|Overall Study|Withdrawal by Subject|2|||
30826316|NCT00899379|58848724|FG003|Overall Study|Withdrawal by Subject|3|||
30918244|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Promotor request|0|||
30918245|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Promotor request|0|||
30918246|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
30918247|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
30918248|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
30918249|NCT01461928|58953718|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
30918250|NCT01461928|58953719|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
30918251|NCT01461928|58953720|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
30918252|NCT01461928|58953718|FG000|Maintenance I (24 Months)|Death|3|||
30918253|NCT01461928|58953719|FG001|Maintenance I (24 Months)|Death|0|||
30918254|NCT01461928|58953720|FG002|Maintenance I (24 Months)|Death|0|||
30918255|NCT01461928|58953718|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
30918256|NCT01461928|58953719|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
30918257|NCT01461928|58953720|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
30918258|NCT01461928|58953718|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
30918259|NCT01461928|58953719|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
30918260|NCT01461928|58953720|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
30918261|NCT01461928|58953718|FG000|Maintenance I (24 Months)|Diseases progression|91|||
30918262|NCT01461928|58953719|FG001|Maintenance I (24 Months)|Diseases progression|0|||
30918263|NCT01461928|58953720|FG002|Maintenance I (24 Months)|Diseases progression|0|||
30918264|NCT01461928|58953718|FG000|Maintenance I (24 Months)|Adverse Event|70|||
30918265|NCT01461928|58953719|FG001|Maintenance I (24 Months)|Adverse Event|0|||
30918266|NCT01461928|58953720|FG002|Maintenance I (24 Months)|Adverse Event|0|||
30918267|NCT01461928|58953718|FG000|Maintenance I (24 Months)|Physician Decision|9|||
30918268|NCT01461928|58953719|FG001|Maintenance I (24 Months)|Physician Decision|0|||
30918269|NCT01461928|58953720|FG002|Maintenance I (24 Months)|Physician Decision|0|||
30918270|NCT01461928|58953718|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
30918271|NCT01461928|58953719|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
30918272|NCT01461928|58953720|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
30918273|NCT01461928|58953718|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
30918274|NCT01461928|58953719|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
30918275|NCT01461928|58953720|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
30918276|NCT01461928|58953718|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
30918277|NCT01461928|58953719|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
30918278|NCT01461928|58953720|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
30918279|NCT01461928|58953718|FG000|Maintenance I (24 Months)|Not compliant|1|||
30918280|NCT01461928|58953719|FG001|Maintenance I (24 Months)|Not compliant|0|||
30918281|NCT01461928|58953720|FG002|Maintenance I (24 Months)|Not compliant|0|||
30918282|NCT01461928|58953718|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
30918283|NCT01461928|58953719|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
30918284|NCT01461928|58953720|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
30918285|NCT01461928|58953718|FG000|Maintenance II (15 Months)|Adverse Event|0|||
30918286|NCT01461928|58953719|FG001|Maintenance II (15 Months)|Adverse Event|2|||
30918287|NCT01461928|58953720|FG002|Maintenance II (15 Months)|Adverse Event|0|||
30918288|NCT01461928|58953718|FG000|Maintenance II (15 Months)|Death|0|||
30918289|NCT01461928|58953719|FG001|Maintenance II (15 Months)|Death|10|||
30918290|NCT01461928|58953720|FG002|Maintenance II (15 Months)|Death|8|||
30918291|NCT01461928|58953718|FG000|Maintenance II (15 Months)|Physician Decision|0|||
30623247|NCT01122576|58635091|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
30826317|NCT00899379|58848725|FG004|Overall Study|Withdrawal by Subject|6|||
30826318|NCT00899379|58848721|FG000|Overall Study|Pregnancy|0|||
30826319|NCT00899379|58848722|FG001|Overall Study|Pregnancy|0|||
30826320|NCT00899379|58848723|FG002|Overall Study|Pregnancy|1|||
30826321|NCT00899379|58848724|FG003|Overall Study|Pregnancy|0|||
30826322|NCT00899379|58848725|FG004|Overall Study|Pregnancy|1|||
30826323|NCT00899379|58848721|FG000|Overall Study|Patient Uncooperative|0|||
30826324|NCT00899379|58848722|FG001|Overall Study|Patient Uncooperative|1|||
30826325|NCT00899379|58848723|FG002|Overall Study|Patient Uncooperative|0|||
30826326|NCT00899379|58848724|FG003|Overall Study|Patient Uncooperative|1|||
30826327|NCT00899379|58848725|FG004|Overall Study|Patient Uncooperative|2|||
30826328|NCT00899379|58848721|FG000|Overall Study|Abnormal Baseline ECG|0|||
30826329|NCT00899379|58848722|FG001|Overall Study|Abnormal Baseline ECG|0|||
30826330|NCT00899379|58848723|FG002|Overall Study|Abnormal Baseline ECG|0|||
30826331|NCT00899379|58848724|FG003|Overall Study|Abnormal Baseline ECG|1|||
30826332|NCT00899379|58848725|FG004|Overall Study|Abnormal Baseline ECG|0|||
30826333|NCT00899379|58848721|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
30918292|NCT01461928|58953719|FG001|Maintenance II (15 Months)|Physician Decision|0|||
30623248|NCT01122576|58635092|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
30826334|NCT00899379|58848722|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
30826335|NCT00899379|58848723|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
30826336|NCT00899379|58848724|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
30826337|NCT00899379|58848725|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
30826338|NCT00899379|58848721|FG000|Overall Study|Not Completed/Entered Extn|5|||
30826339|NCT00899379|58848722|FG001|Overall Study|Not Completed/Entered Extn|1|||
30826340|NCT00899379|58848723|FG002|Overall Study|Not Completed/Entered Extn|6|||
30826341|NCT00899379|58848724|FG003|Overall Study|Not Completed/Entered Extn|4|||
30826342|NCT00899379|58848725|FG004|Overall Study|Not Completed/Entered Extn|3|||
30826343|NCT00899379|58848721|FG000|Overall Study|Study Terminated|3|||
30826344|NCT00899379|58848722|FG001|Overall Study|Study Terminated|0|||
30826345|NCT00899379|58848723|FG002|Overall Study|Study Terminated|3|||
30826346|NCT00899379|58848724|FG003|Overall Study|Study Terminated|3|||
30826347|NCT00899379|58848725|FG004|Overall Study|Study Terminated|1|||
30826348|NCT00899379|58848721|FG000|Overall Study|Lost to Follow-up|3|||
30826349|NCT00899379|58848722|FG001|Overall Study|Lost to Follow-up|1|||
30826350|NCT00899379|58848723|FG002|Overall Study|Lost to Follow-up|0|||
30826351|NCT00899379|58848724|FG003|Overall Study|Lost to Follow-up|2|||
30826352|NCT00899379|58848725|FG004|Overall Study|Lost to Follow-up|5|||
30826353|NCT00899379|58848721|FG000|Overall Study|Withdrawal by Subject|4|||
30826354|NCT00899379|58848722|FG001|Overall Study|Withdrawal by Subject|7|||
30826355|NCT00899379|58848723|FG002|Overall Study|Withdrawal by Subject|4|||
30826356|NCT00899379|58848724|FG003|Overall Study|Withdrawal by Subject|7|||
30826357|NCT00899379|58848725|FG004|Overall Study|Withdrawal by Subject|2|||
30826358|NCT00899379|58848721|FG000|Overall Study|Pregnancy|1|||
30826359|NCT00899379|58848722|FG001|Overall Study|Pregnancy|0|||
30918293|NCT01461928|58953720|FG002|Maintenance II (15 Months)|Physician Decision|4|||
30918294|NCT01461928|58953718|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
30918295|NCT01461928|58953719|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
30918296|NCT01461928|58953720|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
30918297|NCT01461928|58953718|FG000|Maintenance II (15 Months)|Moved to another town|0|||
30918298|NCT01461928|58953719|FG001|Maintenance II (15 Months)|Moved to another town|1|||
30918299|NCT01461928|58953720|FG002|Maintenance II (15 Months)|Moved to another town|0|||
30918300|NCT01461928|58953718|FG000|Maintenance II (15 Months)|Disease progression|0|||
30918301|NCT01461928|58953719|FG001|Maintenance II (15 Months)|Disease progression|0|||
30918302|NCT01461928|58953720|FG002|Maintenance II (15 Months)|Disease progression|3|||
30918303|NCT01461928|58953718|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
30918304|NCT01461928|58953719|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
30918305|NCT01461928|58953720|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
30918306|NCT01461928|58953718|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
30918307|NCT01461928|58953719|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
30918308|NCT01461928|58953720|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
30918309|NCT01461928|58953718|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
30918310|NCT01461928|58953719|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
30918311|NCT01461928|58953720|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
30918312|NCT01461928|58953718|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
30918313|NCT01461928|58953719|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
30918314|NCT01461928|58953720|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
30918315|NCT01461928|58953718|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
30918316|NCT01461928|58953719|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
30918317|NCT01461928|58953720|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
30918318|NCT03097991|58953733|FG000|Overall Study|Didn't meet study criteria|8|||
30918319|NCT03097991|58953734|FG001|Overall Study|Didn't meet study criteria|0|||
30918320|NCT03097991|58953733|FG000|Overall Study|Withdrawal by Subject|12|||
30918321|NCT03097991|58953734|FG001|Overall Study|Withdrawal by Subject|6|||
30918322|NCT03097991|58953733|FG000|Overall Study|Death of Baby|3|||
30918323|NCT03097991|58953734|FG001|Overall Study|Death of Baby|1|||
30918324|NCT03097991|58953733|FG000|Overall Study|Lost to Follow-up|24|||
30918325|NCT03097991|58953734|FG001|Overall Study|Lost to Follow-up|38|||
30918326|NCT03097991|58953733|FG000|Overall Study|Adverse Event|3|||
30918327|NCT03097991|58953734|FG001|Overall Study|Adverse Event|5|||
30918328|NCT02623205|58953746|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
30918329|NCT02623205|58953747|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
30826360|NCT00899379|58848723|FG002|Overall Study|Pregnancy|0|||
30918330|NCT01500694|58953756|FG000|Overall Study|Adverse Event|4|||
30918331|NCT01500694|58953757|FG001|Overall Study|Adverse Event|3|||
30918332|NCT01500694|58953756|FG000|Overall Study|Protocol Violation|0|||
30918333|NCT01500694|58953757|FG001|Overall Study|Protocol Violation|1|||
30826361|NCT00899379|58848724|FG003|Overall Study|Pregnancy|0|||
30826362|NCT00899379|58848725|FG004|Overall Study|Pregnancy|0|||
30826363|NCT00899379|58848721|FG000|Overall Study|Patient Uncooperative|0|||
30826364|NCT00899379|58848722|FG001|Overall Study|Patient Uncooperative|0|||
30918334|NCT01500694|58953756|FG000|Overall Study|Withdrawal by Subject|23|||
30918335|NCT01500694|58953757|FG001|Overall Study|Withdrawal by Subject|14|||
30918336|NCT01500694|58953756|FG000|Overall Study|Lost to Follow-up|2|||
30918337|NCT01500694|58953757|FG001|Overall Study|Lost to Follow-up|3|||
30918338|NCT01500694|58953756|FG000|Overall Study|Lack of Efficacy|14|||
30918339|NCT01500694|58953757|FG001|Overall Study|Lack of Efficacy|5|||
30918340|NCT01500694|58953756|FG000|Overall Study|Other|9|||
30918341|NCT01500694|58953757|FG001|Overall Study|Other|3|||
30918342|NCT01500382|58953767|FG000|Washout Period|Study site went out of business|0|||
30918343|NCT01500382|58953768|FG001|Washout Period|Study site went out of business|0|||
30918344|NCT01500382|58953769|FG002|Washout Period|Study site went out of business|1|||
30918345|NCT01500382|58953770|FG003|Washout Period|Study site went out of business|0|||
30918346|NCT02137837|58953783|FG000|Overall Study|Adverse Event|0|||
30918347|NCT02137837|58953784|FG001|Overall Study|Adverse Event|2|||
30918348|NCT02137837|58953785|FG002|Overall Study|Adverse Event|1|||
30918349|NCT02137837|58953783|FG000|Overall Study|Refusal unrelated to adverse event|2|||
30918350|NCT02137837|58953784|FG001|Overall Study|Refusal unrelated to adverse event|2|||
30918351|NCT02137837|58953785|FG002|Overall Study|Refusal unrelated to adverse event|1|||
30623249|NCT01122576|58635093|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
30623250|NCT01122576|58635091|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
30623251|NCT01122576|58635092|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
30623252|NCT01122576|58635093|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
30623253|NCT00965523|58635104|FG000|Study 221|Progressive Disease|4|||
30623254|NCT00965523|58635104|FG000|Study 221|Physician Decision|3|||
30623255|NCT00965523|58635104|FG000|Study 224|Progressive Disease|5|||
30623256|NCT00965523|58635104|FG000|Study 224|Physician Decision|1|||
30623257|NCT01122264|58635111|FG000|Overall Study|Adverse Event|6|||
30623258|NCT01122264|58635112|FG001|Overall Study|Adverse Event|5|||
30623259|NCT01122264|58635113|FG002|Overall Study|Adverse Event|7|||
30623260|NCT01122264|58635111|FG000|Overall Study|Death|1|||
30623261|NCT01122264|58635112|FG001|Overall Study|Death|0|||
30623262|NCT01122264|58635113|FG002|Overall Study|Death|0|||
30623263|NCT01122264|58635111|FG000|Overall Study|Lost to Follow-up|5|||
30623264|NCT01122264|58635112|FG001|Overall Study|Lost to Follow-up|9|||
30623265|NCT01122264|58635113|FG002|Overall Study|Lost to Follow-up|13|||
30623266|NCT01122264|58635111|FG000|Overall Study|Entry Criteria Not Met|1|||
30623267|NCT01122264|58635112|FG001|Overall Study|Entry Criteria Not Met|0|||
30623268|NCT01122264|58635113|FG002|Overall Study|Entry Criteria Not Met|0|||
30623269|NCT01122264|58635111|FG000|Overall Study|Protocol Violation|7|||
30623270|NCT01122264|58635112|FG001|Overall Study|Protocol Violation|7|||
30623271|NCT01122264|58635113|FG002|Overall Study|Protocol Violation|9|||
30623272|NCT01122264|58635111|FG000|Overall Study|Withdrawal by Subject|6|||
30623273|NCT01122264|58635112|FG001|Overall Study|Withdrawal by Subject|6|||
30623274|NCT01122264|58635113|FG002|Overall Study|Withdrawal by Subject|16|||
30623275|NCT01122264|58635111|FG000|Overall Study|Physician Decision|3|||
30623276|NCT01122264|58635112|FG001|Overall Study|Physician Decision|1|||
30623277|NCT01122264|58635113|FG002|Overall Study|Physician Decision|1|||
30826365|NCT00899379|58848723|FG002|Overall Study|Patient Uncooperative|0|||
30826366|NCT00899379|58848724|FG003|Overall Study|Patient Uncooperative|1|||
30826367|NCT00899379|58848725|FG004|Overall Study|Patient Uncooperative|0|||
30826368|NCT00899379|58848721|FG000|Overall Study|Abnormal Prestudy Labs|0|||
30826369|NCT00899379|58848722|FG001|Overall Study|Abnormal Prestudy Labs|0|||
30826370|NCT00899379|58848723|FG002|Overall Study|Abnormal Prestudy Labs|0|||
30826371|NCT00899379|58848724|FG003|Overall Study|Abnormal Prestudy Labs|0|||
30826372|NCT00899379|58848725|FG004|Overall Study|Abnormal Prestudy Labs|2|||
30826373|NCT00899379|58848721|FG000|Overall Study|Abnormal Baseline ECG|0|||
30826374|NCT00899379|58848722|FG001|Overall Study|Abnormal Baseline ECG|0|||
30918352|NCT02137837|58953783|FG000|Overall Study|Progression/relapse|9|||
30918353|NCT02137837|58953784|FG001|Overall Study|Progression/relapse|7|||
30918354|NCT02137837|58953785|FG002|Overall Study|Progression/relapse|7|||
30623278|NCT01122264|58635111|FG000|Overall Study|Lack of Efficacy|3|||
30623279|NCT01122264|58635112|FG001|Overall Study|Lack of Efficacy|1|||
30623280|NCT01122264|58635113|FG002|Overall Study|Lack of Efficacy|1|||
30623281|NCT00920218|58635129|FG000|Overall Study|Serious Adverse Event|2|||
30623282|NCT00920218|58635130|FG001|Overall Study|Serious Adverse Event|0|||
30623283|NCT00920218|58635131|FG002|Overall Study|Serious Adverse Event|2|||
30623284|NCT00920218|58635132|FG003|Overall Study|Serious Adverse Event|1|||
30623285|NCT00920218|58635129|FG000|Overall Study|Withdrawal by Subject|0|||
30918355|NCT02137837|58953783|FG000|Overall Study|Not protocol specified|2|||
30826375|NCT00899379|58848723|FG002|Overall Study|Abnormal Baseline ECG|1|||
30826376|NCT00899379|58848724|FG003|Overall Study|Abnormal Baseline ECG|1|||
30826377|NCT00899379|58848725|FG004|Overall Study|Abnormal Baseline ECG|0|||
30826378|NCT00899379|58848721|FG000|Overall Study|No Attack Pretreatment|3|||
30623286|NCT00920218|58635130|FG001|Overall Study|Withdrawal by Subject|3|||
30623287|NCT00920218|58635131|FG002|Overall Study|Withdrawal by Subject|2|||
30623288|NCT00920218|58635132|FG003|Overall Study|Withdrawal by Subject|0|||
30623289|NCT00920218|58635129|FG000|Overall Study|Migrated/moved from study area|0|||
30623290|NCT00920218|58635130|FG001|Overall Study|Migrated/moved from study area|0|||
30623291|NCT00920218|58635131|FG002|Overall Study|Migrated/moved from study area|1|||
30623292|NCT00920218|58635132|FG003|Overall Study|Migrated/moved from study area|0|||
30623293|NCT00920218|58635129|FG000|Overall Study|Lost to Follow-up|0|||
30623294|NCT00920218|58635130|FG001|Overall Study|Lost to Follow-up|1|||
30623295|NCT00920218|58635131|FG002|Overall Study|Lost to Follow-up|0|||
30623296|NCT00920218|58635132|FG003|Overall Study|Lost to Follow-up|3|||
30623297|NCT00920218|58635129|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
30826379|NCT00899379|58848722|FG001|Overall Study|No Attack Pretreatment|5|||
30826380|NCT00899379|58848723|FG002|Overall Study|No Attack Pretreatment|5|||
30826381|NCT00899379|58848724|FG003|Overall Study|No Attack Pretreatment|6|||
30826382|NCT00899379|58848725|FG004|Overall Study|No Attack Pretreatment|4|||
30826383|NCT00899379|58848721|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
30826384|NCT00899379|58848722|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
30826385|NCT00899379|58848723|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
30826386|NCT00899379|58848724|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
30826387|NCT00899379|58848725|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
30826388|NCT00899379|58848721|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
30826389|NCT00899379|58848722|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
30623298|NCT00920218|58635130|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
30623299|NCT00920218|58635131|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
30826390|NCT00899379|58848723|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
30918356|NCT02137837|58953784|FG001|Overall Study|Not protocol specified|1|||
30918357|NCT02137837|58953785|FG002|Overall Study|Not protocol specified|3|||
30918358|NCT01483690|58953800|FG000|Overall Study|Adverse Event|1|||
30918359|NCT01483690|58953801|FG001|Overall Study|Adverse Event|2|||
30918360|NCT01483690|58953800|FG000|Overall Study|clinical deterioration|1|||
30918361|NCT01483690|58953801|FG001|Overall Study|clinical deterioration|0|||
30918362|NCT01483690|58953800|FG000|Overall Study|Physician Decision|0|||
30918363|NCT01483690|58953801|FG001|Overall Study|Physician Decision|2|||
30918364|NCT01483690|58953800|FG000|Overall Study|exclusionary procedure|0|||
30918365|NCT01483690|58953801|FG001|Overall Study|exclusionary procedure|1|||
30918366|NCT02104765|58953814|FG000|Overall Study|Lost to Follow-up|0|||
30918367|NCT02104765|58953815|FG001|Overall Study|Lost to Follow-up|0|||
30918368|NCT02104765|58953816|FG002|Overall Study|Lost to Follow-up|1|||
30918369|NCT02104765|58953817|FG003|Overall Study|Lost to Follow-up|0|||
30918370|NCT02104765|58953818|FG004|Overall Study|Lost to Follow-up|0|||
30918371|NCT02104765|58953819|FG005|Overall Study|Lost to Follow-up|0|||
30918372|NCT02104765|58953820|FG006|Overall Study|Lost to Follow-up|0|||
30918373|NCT02104765|58953814|FG000|Overall Study|Withdrawal by Subject|0|||
30918374|NCT02104765|58953815|FG001|Overall Study|Withdrawal by Subject|0|||
30918375|NCT02104765|58953816|FG002|Overall Study|Withdrawal by Subject|0|||
30918376|NCT02104765|58953817|FG003|Overall Study|Withdrawal by Subject|1|||
30918377|NCT02104765|58953818|FG004|Overall Study|Withdrawal by Subject|1|||
30918378|NCT02104765|58953819|FG005|Overall Study|Withdrawal by Subject|0|||
30918379|NCT02104765|58953820|FG006|Overall Study|Withdrawal by Subject|1|||
30918380|NCT01483144|58953845|FG000|Overall Study|Adverse Event|9|||
30918381|NCT01483144|58953846|FG001|Overall Study|Adverse Event|4|||
30918382|NCT01483144|58953847|FG002|Overall Study|Adverse Event|6|||
30918383|NCT01483144|58953845|FG000|Overall Study|Withdrawal by Subject|0|||
30918384|NCT01483144|58953846|FG001|Overall Study|Withdrawal by Subject|2|||
30918385|NCT01483144|58953847|FG002|Overall Study|Withdrawal by Subject|5|||
30918386|NCT01483144|58953845|FG000|Overall Study|Physician Decision|1|||
30918387|NCT01483144|58953846|FG001|Overall Study|Physician Decision|0|||
30918388|NCT01483144|58953847|FG002|Overall Study|Physician Decision|0|||
30918389|NCT01483144|58953845|FG000|Overall Study|Lost to Follow-up|2|||
30918390|NCT01483144|58953846|FG001|Overall Study|Lost to Follow-up|4|||
30918391|NCT01483144|58953847|FG002|Overall Study|Lost to Follow-up|1|||
30918392|NCT01483144|58953845|FG000|Overall Study|Protocol Violation|3|||
30918393|NCT01483144|58953846|FG001|Overall Study|Protocol Violation|3|||
30623300|NCT00920218|58635132|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
30623301|NCT00920218|58635129|FG000|Overall Study|Other|0|||
30623302|NCT00920218|58635130|FG001|Overall Study|Other|0|||
30623303|NCT00920218|58635131|FG002|Overall Study|Other|1|||
30623304|NCT00920218|58635132|FG003|Overall Study|Other|0|||
30623305|NCT01121562|58635146|FG000|Overall Study|Objective progression or relapse|8|||
30918394|NCT01483144|58953847|FG002|Overall Study|Protocol Violation|3|||
30918395|NCT01881789|58953861|FG000|Overall Study|Withdrawal by Subject|0|||
30918396|NCT01881789|58953862|FG001|Overall Study|Withdrawal by Subject|2|||
30918397|NCT01881789|58953863|FG002|Overall Study|Withdrawal by Subject|1|||
30918398|NCT01881789|58953864|FG003|Overall Study|Withdrawal by Subject|0|||
30918399|NCT01881789|58953865|FG004|Overall Study|Withdrawal by Subject|1|||
30918400|NCT01881789|58953866|FG005|Overall Study|Withdrawal by Subject|1|||
30918401|NCT01881789|58953861|FG000|Overall Study|Study Terminated by Sponsor|0|||
30918402|NCT01881789|58953862|FG001|Overall Study|Study Terminated by Sponsor|0|||
30918403|NCT01881789|58953863|FG002|Overall Study|Study Terminated by Sponsor|0|||
30918404|NCT01881789|58953864|FG003|Overall Study|Study Terminated by Sponsor|0|||
30918405|NCT01881789|58953865|FG004|Overall Study|Study Terminated by Sponsor|0|||
30918406|NCT01881789|58953866|FG005|Overall Study|Study Terminated by Sponsor|1|||
30918407|NCT01881789|58953861|FG000|Overall Study|Other|3|||
30918408|NCT01881789|58953862|FG001|Overall Study|Other|5|||
30918409|NCT01881789|58953863|FG002|Overall Study|Other|2|||
30918410|NCT01881789|58953864|FG003|Overall Study|Other|3|||
30918411|NCT01881789|58953865|FG004|Overall Study|Other|1|||
30918412|NCT01881789|58953866|FG005|Overall Study|Other|1|||
30918413|NCT02075203|58953884|FG000|Overall Study|Withdrawal by Subject|1|||
30918414|NCT02075203|58953885|FG001|Overall Study|Withdrawal by Subject|0|||
30918415|NCT02075203|58953886|FG002|Overall Study|Withdrawal by Subject|1|||
30918416|NCT02075203|58953884|FG000|Overall Study|Adverse Event|1|||
30918417|NCT02075203|58953885|FG001|Overall Study|Adverse Event|0|||
30918418|NCT02075203|58953886|FG002|Overall Study|Adverse Event|0|||
30918419|NCT02075203|58953884|FG000|Overall Study|participant refused to use contraception|1|||
30918420|NCT02075203|58953885|FG001|Overall Study|participant refused to use contraception|0|||
30918421|NCT02075203|58953886|FG002|Overall Study|participant refused to use contraception|0|||
30918422|NCT01892163|58953896|FG000|Overall Study|Death|1|||
30918423|NCT01892163|58953897|FG001|Overall Study|Death|1|||
30918424|NCT01892163|58953896|FG000|Overall Study|Lost to Follow-up|1|||
30918425|NCT01892163|58953897|FG001|Overall Study|Lost to Follow-up|0|||
30918426|NCT01881009|58953905|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
30918427|NCT01881009|58953906|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
30918428|NCT01500226|58953915|FG000|Overall Study|Adverse Event|31|||
30918429|NCT01500226|58953916|FG001|Overall Study|Adverse Event|38|||
30918430|NCT01500226|58953915|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
30918431|NCT01500226|58953916|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
30918432|NCT01500226|58953915|FG000|Overall Study|Withdrawal by Subject|93|||
30826391|NCT00899379|58848724|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
30826392|NCT00899379|58848725|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
30826393|NCT04326439|58848733|FG000|Overall Study|Withdrawal by Subject|1|||
30918433|NCT01500226|58953916|FG001|Overall Study|Withdrawal by Subject|96|||
30918434|NCT01500226|58953915|FG000|Overall Study|Death|12|||
30918435|NCT01500226|58953916|FG001|Overall Study|Death|4|||
30918436|NCT01500226|58953915|FG000|Overall Study|Disease Progression|16|||
30918437|NCT01500226|58953916|FG001|Overall Study|Disease Progression|14|||
30918438|NCT01500226|58953915|FG000|Overall Study|Protocol Violation|53|||
30918439|NCT01500226|58953916|FG001|Overall Study|Protocol Violation|39|||
30918440|NCT01500226|58953915|FG000|Overall Study|Physician Decision|17|||
30918441|NCT01500226|58953916|FG001|Overall Study|Physician Decision|15|||
30918442|NCT01500226|58953915|FG000|Overall Study|Lack of Efficacy|14|||
30918443|NCT01500226|58953916|FG001|Overall Study|Lack of Efficacy|30|||
30918444|NCT01500226|58953915|FG000|Overall Study|Lost to Follow-up|9|||
30918445|NCT01500226|58953916|FG001|Overall Study|Lost to Follow-up|5|||
30918446|NCT01500226|58953915|FG000|Overall Study|Other Reasons|19|||
30918447|NCT01500226|58953916|FG001|Overall Study|Other Reasons|16|||
30918448|NCT02075047|58953924|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
30826394|NCT04326439|58848734|FG001|Overall Study|Withdrawal by Subject|0|||
30826395|NCT04326439|58848733|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
30826396|NCT04326439|58848734|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
30826397|NCT04326439|58848733|FG000|Overall Study|Relapse after Induction 2|0|||
30826398|NCT04326439|58848734|FG001|Overall Study|Relapse after Induction 2|1|||
30826399|NCT04326439|58848733|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
30918449|NCT02075047|58953925|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
30918450|NCT02075047|58953924|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
30826400|NCT04326439|58848734|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
30918451|NCT02075047|58953925|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
30918452|NCT02075047|58953924|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
30918453|NCT02075047|58953925|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
30918454|NCT02075047|58953924|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
30826401|NCT00145795|58848748|FG000|Overall Study|Adverse Event|1|||
30918455|NCT02075047|58953925|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
30918456|NCT02075047|58953924|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
30918457|NCT02075047|58953925|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
30918458|NCT02075047|58953924|FG000|Treatment Phase (4 Weeks)|Other|1|||
30918459|NCT02075047|58953925|FG001|Treatment Phase (4 Weeks)|Other|1|||
30918460|NCT02075047|58953924|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
30918461|NCT02075047|58953925|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
30918462|NCT02075047|58953924|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
30918463|NCT02075047|58953925|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
30918464|NCT02075047|58953924|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
30918465|NCT02075047|58953925|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
30918466|NCT02075047|58953924|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
30918467|NCT02075047|58953925|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
30826402|NCT00145795|58848749|FG001|Overall Study|Adverse Event|0|||
30826403|NCT02771210|58848757|FG000|Period 1|Adverse Event|5|||
30826404|NCT02771210|58848758|FG001|Period 1|Adverse Event|3|||
30826405|NCT02771210|58848757|FG000|Period 1|Lack of Efficacy|3|||
30826406|NCT02771210|58848758|FG001|Period 1|Lack of Efficacy|6|||
30826407|NCT02771210|58848757|FG000|Period 1|Lost to Follow-up|2|||
30826408|NCT02771210|58848758|FG001|Period 1|Lost to Follow-up|0|||
30826409|NCT02771210|58848757|FG000|Period 1|Physician Decision|0|||
30918468|NCT02075047|58953924|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
30918469|NCT02075047|58953925|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
30918470|NCT02075047|58953924|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
30918471|NCT02075047|58953925|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
30918472|NCT02075047|58953924|FG000|Follow up Phase (5 Weeks)|Other|1|||
30918473|NCT02075047|58953925|FG001|Follow up Phase (5 Weeks)|Other|2|||
30918474|NCT02075047|58953924|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
30918475|NCT02075047|58953925|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
30918476|NCT01859949|58953933|FG000|Overall Study|Family Matters|0|||
30918477|NCT01859949|58953934|FG001|Overall Study|Family Matters|1|||
30918478|NCT01859949|58953933|FG000|Overall Study|Physician Decision|2|||
30918479|NCT01859949|58953934|FG001|Overall Study|Physician Decision|4|||
30918480|NCT01859949|58953933|FG000|Overall Study|Withdrawal by Subject|11|||
30918481|NCT01859949|58953934|FG001|Overall Study|Withdrawal by Subject|10|||
30918482|NCT01859949|58953933|FG000|Overall Study|Protocol Violation|1|||
30918483|NCT01859949|58953934|FG001|Overall Study|Protocol Violation|1|||
30918484|NCT01859949|58953933|FG000|Overall Study|Adverse Event|0|||
30918485|NCT01859949|58953934|FG001|Overall Study|Adverse Event|1|||
30918486|NCT01859793|58953942|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
30918487|NCT01859793|58953943|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
30918488|NCT01859793|58953942|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
30918489|NCT01859793|58953943|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
30918490|NCT01859793|58953942|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
30918491|NCT01859793|58953943|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
30918492|NCT01859793|58953942|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
30918493|NCT01859793|58953943|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
30918494|NCT01859715|58953952|FG000|Overall Study|No 2nd VAS|16|||
30918495|NCT01859715|58953953|FG001|Overall Study|No 2nd VAS|8|||
30918496|NCT01859715|58953954|FG002|Overall Study|No 2nd VAS|23|||
30918497|NCT01890915|58953966|FG000|Overall Study|Adverse Event|1|||
30918498|NCT01890915|58953967|FG001|Overall Study|Adverse Event|0|||
30918499|NCT01890915|58953966|FG000|Overall Study|Protocol Violation|2|||
30918500|NCT01890915|58953967|FG001|Overall Study|Protocol Violation|0|||
30918501|NCT01890915|58953966|FG000|Overall Study|Equipment Malfunction|0|||
30918502|NCT01890915|58953967|FG001|Overall Study|Equipment Malfunction|1|||
30918503|NCT01615263|58953975|FG000|Overall Study|Post-randomization exclusion|0|||
30918504|NCT01615263|58953976|FG001|Overall Study|Post-randomization exclusion|2|||
30918505|NCT01859403|58953993|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
30918506|NCT01859403|58953994|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
30918507|NCT01859403|58953993|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
30918508|NCT01859403|58953994|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
30918509|NCT01859403|58953993|FG000|Primary Endpoint Measure|Physician Decision|0|||
30623306|NCT01121562|58635146|FG000|Overall Study|Withdrawal by Subject|1|||
30826410|NCT02771210|58848758|FG001|Period 1|Physician Decision|1|||
30826411|NCT02771210|58848757|FG000|Period 1|Withdrawal by Subject|0|||
30826412|NCT02771210|58848758|FG001|Period 1|Withdrawal by Subject|3|||
30918510|NCT01859403|58953994|FG001|Primary Endpoint Measure|Physician Decision|1|||
30918511|NCT01859403|58953993|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
30918512|NCT01859403|58953994|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
30918513|NCT01858701|58954000|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
30918514|NCT01858701|58954001|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
30918515|NCT01858701|58954000|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
30826413|NCT02771210|58848757|FG000|Period 1|Withdrawal of informed consent|1|||
30826414|NCT02771210|58848758|FG001|Period 1|Withdrawal of informed consent|5|||
30826415|NCT02771210|58848757|FG000|Period 2|Adverse Event|1|||
30918516|NCT01858701|58954001|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
30918517|NCT01858701|58954000|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
30918518|NCT01858701|58954001|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
30918519|NCT01858701|58954000|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
30918520|NCT01858701|58954001|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
30918521|NCT01461538|58954010|FG000|Overall Study|Death|15|||
30918522|NCT01461538|58954011|FG001|Overall Study|Death|6|||
30918523|NCT01461538|58954012|FG002|Overall Study|Death|2|||
30918524|NCT01461538|58954010|FG000|Overall Study|Study Stopped by Sponsor|2|||
30918525|NCT01461538|58954011|FG001|Overall Study|Study Stopped by Sponsor|1|||
30918526|NCT01461538|58954012|FG002|Overall Study|Study Stopped by Sponsor|0|||
30918527|NCT01461538|58954010|FG000|Overall Study|Withdrawal by Subject|1|||
30918528|NCT01461538|58954011|FG001|Overall Study|Withdrawal by Subject|1|||
30918529|NCT01461538|58954012|FG002|Overall Study|Withdrawal by Subject|0|||
30918530|NCT02117479|58954024|FG000|Overall Study|Death|13|||
30918531|NCT02117479|58954025|FG001|Overall Study|Death|8|||
30918532|NCT02117479|58954024|FG000|Overall Study|Adverse Event|8|||
30918533|NCT02117479|58954025|FG001|Overall Study|Adverse Event|16|||
30826416|NCT02771210|58848758|FG001|Period 2|Adverse Event|0|||
30826417|NCT02771210|58848757|FG000|Period 2|Lack of Efficacy|0|||
30826418|NCT02771210|58848758|FG001|Period 2|Lack of Efficacy|1|||
30826419|NCT02771210|58848757|FG000|Period 2|Withdrawal by Subject|1|||
30826420|NCT02771210|58848758|FG001|Period 2|Withdrawal by Subject|0|||
30826421|NCT02771210|58848757|FG000|Period 2|Withdrawal of informed consent|0|||
30826422|NCT02771210|58848758|FG001|Period 2|Withdrawal of informed consent|2|||
30826423|NCT00898677|58848768|FG000|Overall Study|Adverse Event|0|||
30826424|NCT00898677|58848769|FG001|Overall Study|Adverse Event|0|||
30826425|NCT00898677|58848770|FG002|Overall Study|Adverse Event|1|||
30826426|NCT00898677|58848771|FG003|Overall Study|Adverse Event|0|||
30826427|NCT00898677|58848768|FG000|Overall Study|Lost to Follow-up|0|||
30826428|NCT00898677|58848769|FG001|Overall Study|Lost to Follow-up|0|||
30826429|NCT00898677|58848770|FG002|Overall Study|Lost to Follow-up|2|||
30826430|NCT00898677|58848771|FG003|Overall Study|Lost to Follow-up|0|||
30826431|NCT00898677|58848768|FG000|Overall Study|Protocol Violation|1|||
30826432|NCT00898677|58848769|FG001|Overall Study|Protocol Violation|1|||
30826433|NCT00898677|58848770|FG002|Overall Study|Protocol Violation|2|||
30918534|NCT02117479|58954024|FG000|Overall Study|Subject decision|8|||
30918535|NCT02117479|58954025|FG001|Overall Study|Subject decision|9|||
30918536|NCT02117479|58954024|FG000|Overall Study|Disease progression|104|||
30918537|NCT02117479|58954025|FG001|Overall Study|Disease progression|108|||
30918538|NCT02117479|58954024|FG000|Overall Study|Noncompliance with study treatment|1|||
30918539|NCT02117479|58954025|FG001|Overall Study|Noncompliance with study treatment|0|||
30918540|NCT02117479|58954024|FG000|Overall Study|Study terminated by the sponsor|4|||
30826434|NCT00898677|58848771|FG003|Overall Study|Protocol Violation|0|||
30826435|NCT00898677|58848768|FG000|Overall Study|Withdrawal by Subject|0|||
30826436|NCT00898677|58848769|FG001|Overall Study|Withdrawal by Subject|0|||
30826437|NCT00898677|58848770|FG002|Overall Study|Withdrawal by Subject|0|||
30826438|NCT00898677|58848771|FG003|Overall Study|Withdrawal by Subject|1|||
30826439|NCT00898677|58848768|FG000|Overall Study|Not Treated: Adverse Event|0|||
30826440|NCT00898677|58848769|FG001|Overall Study|Not Treated: Adverse Event|2|||
30826441|NCT00898677|58848770|FG002|Overall Study|Not Treated: Adverse Event|1|||
30826442|NCT00898677|58848771|FG003|Overall Study|Not Treated: Adverse Event|0|||
30826443|NCT00898677|58848768|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
30826444|NCT00898677|58848769|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
30826445|NCT00898677|58848770|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
30826446|NCT00898677|58848771|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
30826447|NCT00898677|58848768|FG000|Overall Study|Not Treated: Pregnancy|0|||
30826448|NCT00898677|58848769|FG001|Overall Study|Not Treated: Pregnancy|0|||
30826449|NCT00898677|58848770|FG002|Overall Study|Not Treated: Pregnancy|1|||
30826450|NCT00898677|58848771|FG003|Overall Study|Not Treated: Pregnancy|0|||
30826451|NCT00898677|58848768|FG000|Overall Study|Not Treated: Protocol Violation|2|||
30826452|NCT00898677|58848769|FG001|Overall Study|Not Treated: Protocol Violation|0|||
30826453|NCT00898677|58848770|FG002|Overall Study|Not Treated: Protocol Violation|2|||
30826454|NCT00898677|58848771|FG003|Overall Study|Not Treated: Protocol Violation|0|||
30826455|NCT00898677|58848768|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
30918541|NCT02117479|58954025|FG001|Overall Study|Study terminated by the sponsor|6|||
30918542|NCT02117479|58954024|FG000|Overall Study|Physician Decision|7|||
30918543|NCT02117479|58954025|FG001|Overall Study|Physician Decision|2|||
30918544|NCT02117479|58954024|FG000|Overall Study|Other unspecified|11|||
30918545|NCT02117479|58954025|FG001|Overall Study|Other unspecified|7|||
30826456|NCT00898677|58848769|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
30826457|NCT00898677|58848770|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
30826458|NCT00898677|58848771|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
30918546|NCT02229851|58954034|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
30918547|NCT02229851|58954035|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
30918548|NCT02229851|58954036|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
30826459|NCT00898677|58848768|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
30826460|NCT00898677|58848769|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
30826461|NCT00898677|58848770|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
30826462|NCT00898677|58848771|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
30826463|NCT00898677|58848768|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
30826464|NCT00898677|58848769|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
30826465|NCT00898677|58848770|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
30918549|NCT02229851|58954037|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
30918550|NCT02229851|58954038|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
30918551|NCT02229851|58954039|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
30918552|NCT02229851|58954040|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
30918553|NCT02229851|58954034|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
30918554|NCT02229851|58954035|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
30918555|NCT02229851|58954036|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
30918556|NCT02229851|58954037|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
30918557|NCT02229851|58954038|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
30918558|NCT02229851|58954039|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
30918559|NCT02229851|58954040|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
30918560|NCT02229851|58954034|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
30918561|NCT02229851|58954035|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
30918562|NCT02229851|58954036|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
30918563|NCT02229851|58954037|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
30918564|NCT02229851|58954038|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
30918565|NCT02229851|58954039|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
30918566|NCT02229851|58954040|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
30918567|NCT02229851|58954034|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
30918568|NCT02229851|58954035|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
30918569|NCT02229851|58954036|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
30918570|NCT02229851|58954037|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
30918571|NCT02229851|58954038|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
30918572|NCT02229851|58954039|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
30918573|NCT02229851|58954040|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
30918574|NCT02229851|58954034|FG000|Main Phase (Double-blind Phase)|Death|1|||
30918575|NCT02229851|58954035|FG001|Main Phase (Double-blind Phase)|Death|1|||
30918576|NCT02229851|58954036|FG002|Main Phase (Double-blind Phase)|Death|0|||
30918577|NCT02229851|58954037|FG003|Main Phase (Double-blind Phase)|Death|0|||
30918578|NCT02229851|58954038|FG004|Main Phase (Double-blind Phase)|Death|0|||
30918579|NCT02229851|58954039|FG005|Main Phase (Double-blind Phase)|Death|0|||
30918580|NCT02229851|58954040|FG006|Main Phase (Double-blind Phase)|Death|0|||
30826466|NCT00898677|58848771|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
30826467|NCT00898677|58848768|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
30826468|NCT00898677|58848769|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
30826469|NCT00898677|58848770|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
30826470|NCT00898677|58848771|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
30826471|NCT00898677|58848768|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
30826472|NCT00898677|58848769|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
30826473|NCT00898677|58848770|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
30826474|NCT00898677|58848771|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
30826475|NCT00898677|58848768|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
30826476|NCT00898677|58848769|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
30826477|NCT00898677|58848770|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
30826478|NCT00898677|58848771|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
30826479|NCT00898677|58848768|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
30826480|NCT00898677|58848769|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
30918581|NCT02229851|58954034|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
30918582|NCT02229851|58954035|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
30753951|NCT00130208|58763586|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
30753952|NCT00130208|58763587|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
30753953|NCT00130208|58763586|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
30753954|NCT00130208|58763587|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
30753955|NCT00130208|58763586|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
30753956|NCT00130208|58763587|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
30753957|NCT00130208|58763586|FG000|Maintenance Period (26 Weeks)|Other|1|||
30753958|NCT00130208|58763587|FG001|Maintenance Period (26 Weeks)|Other|1|||
30753959|NCT00130208|58763586|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
30826481|NCT00898677|58848770|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
30826482|NCT00898677|58848771|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
30826483|NCT02770820|58848781|FG000|Overall Study|Death|1|||
30826484|NCT02770820|58848781|FG000|Overall Study|Physician Decision|2|||
30918583|NCT02229851|58954036|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
30918584|NCT02229851|58954037|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
30918585|NCT02229851|58954038|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
30918586|NCT02229851|58954039|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
30918587|NCT02229851|58954040|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
30918588|NCT02229851|58954034|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
30918589|NCT02229851|58954035|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
30918590|NCT02229851|58954036|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
30918591|NCT02229851|58954037|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
30918592|NCT02229851|58954038|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
30918593|NCT02229851|58954039|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
30918594|NCT02229851|58954040|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
30918595|NCT02229851|58954034|FG000|Extension Phase (Open-label Phase)|Death|0|||
30918596|NCT02229851|58954035|FG001|Extension Phase (Open-label Phase)|Death|0|||
30918597|NCT02229851|58954036|FG002|Extension Phase (Open-label Phase)|Death|0|||
30918598|NCT02229851|58954037|FG003|Extension Phase (Open-label Phase)|Death|1|||
30918599|NCT02229851|58954038|FG004|Extension Phase (Open-label Phase)|Death|0|||
30918600|NCT02229851|58954039|FG005|Extension Phase (Open-label Phase)|Death|1|||
30918601|NCT02229851|58954040|FG006|Extension Phase (Open-label Phase)|Death|1|||
30918602|NCT01482910|58954057|FG000|Overall Study|Adverse Event|6|||
30918603|NCT01482910|58954058|FG001|Overall Study|Adverse Event|5|||
30918604|NCT01482910|58954057|FG000|Overall Study|Lost to Follow-up|0|||
30918605|NCT01482910|58954058|FG001|Overall Study|Lost to Follow-up|1|||
30918606|NCT01482910|58954057|FG000|Overall Study|Protocol Violation|1|||
30918607|NCT01482910|58954058|FG001|Overall Study|Protocol Violation|1|||
30918608|NCT01482910|58954057|FG000|Overall Study|Withdrawal by Subject|7|||
30826485|NCT03082729|58848785|FG000|Overall Study|Lost to Follow-up|7|||
30826486|NCT03082729|58848785|FG000|Overall Study|Physician Decision|2|||
30826487|NCT03082729|58848785|FG000|Overall Study|Withdrawal by Subject|1|||
30826488|NCT03082729|58848785|FG000|Overall Study|Lack of Efficacy|9|||
30826489|NCT03082729|58848785|FG000|Overall Study|Adverse Event|4|||
30826490|NCT03082729|58848785|FG000|Overall Study|Protocol Violation|6|||
30826491|NCT03082729|58848785|FG000|Overall Study|Fear of study procedure|1|||
30918609|NCT01482910|58954058|FG001|Overall Study|Withdrawal by Subject|2|||
30918610|NCT01482910|58954057|FG000|Overall Study|Death|1|||
30918611|NCT01482910|58954058|FG001|Overall Study|Death|0|||
30918612|NCT01626391|58954068|FG000|Overall Study|Physician Decision|1|||
30918613|NCT01626391|58954069|FG001|Overall Study|Physician Decision|0|||
30918614|NCT01626391|58954068|FG000|Overall Study|Withdrawal by Subject|1|||
30918615|NCT01626391|58954069|FG001|Overall Study|Withdrawal by Subject|0|||
30918616|NCT02103439|58954077|FG000|Overall Study|Adverse Event|0|||
30918617|NCT02103439|58954078|FG001|Overall Study|Adverse Event|2|||
30918618|NCT02103439|58954077|FG000|Overall Study|Withdrawal by Subject|3|||
30918619|NCT02103439|58954078|FG001|Overall Study|Withdrawal by Subject|1|||
30918620|NCT02229539|58954091|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
30918621|NCT02229539|58954092|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
30918622|NCT02229539|58954093|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
30918623|NCT02229539|58954091|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
30918624|NCT02229539|58954092|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
30918625|NCT02229539|58954093|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
30918626|NCT02229539|58954091|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
30918627|NCT02229539|58954092|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
30918628|NCT02229539|58954093|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
30918629|NCT02229539|58954091|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
30918630|NCT02229539|58954092|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
30918631|NCT02229539|58954093|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
30918632|NCT02229539|58954091|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
30918633|NCT02229539|58954092|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
30918634|NCT02229539|58954093|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
30918635|NCT02229539|58954091|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
30918636|NCT02229539|58954092|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
30918637|NCT02229539|58954093|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
30918638|NCT02229539|58954091|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
30918639|NCT02229539|58954092|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
30918640|NCT02229539|58954093|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
30918641|NCT02229539|58954091|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
30918642|NCT02229539|58954092|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
30918643|NCT02229539|58954093|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
30918644|NCT02229539|58954091|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
30826492|NCT03082729|58848785|FG000|Overall Study|Scheduling conflict|1|||
30918645|NCT02229539|58954092|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
30918646|NCT02229539|58954093|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
30918647|NCT01835223|58954103|FG000|Overall Study|Adverse Event|1|||
30918648|NCT01835223|58954104|FG001|Overall Study|Adverse Event|0|||
30918649|NCT01835223|58954103|FG000|Overall Study|Withdrawal by Subject|2|||
30918650|NCT01835223|58954104|FG001|Overall Study|Withdrawal by Subject|0|||
30918651|NCT01835223|58954103|FG000|Overall Study|Disease progression|2|||
30918652|NCT01835223|58954104|FG001|Overall Study|Disease progression|1|||
30918653|NCT01835223|58954103|FG000|Overall Study|Became Inelligible|4|||
30918654|NCT01835223|58954104|FG001|Overall Study|Became Inelligible|0|||
30918655|NCT01482598|58954114|FG000|Overall Study|Death|7|||
30918656|NCT01482598|58954115|FG001|Overall Study|Death|10|||
30918657|NCT01482598|58954114|FG000|Overall Study|Physician Decision|0|||
30918658|NCT01482598|58954115|FG001|Overall Study|Physician Decision|3|||
30918659|NCT01482598|58954114|FG000|Overall Study|Withdrawal by Subject|4|||
30918660|NCT01482598|58954115|FG001|Overall Study|Withdrawal by Subject|5|||
30918661|NCT01482598|58954114|FG000|Overall Study|Lost to Follow-up|5|||
30918662|NCT01482598|58954115|FG001|Overall Study|Lost to Follow-up|4|||
30918663|NCT01460446|58954123|FG000|Overall Study|Non-compliance|2|||
30918664|NCT01460446|58954124|FG001|Overall Study|Non-compliance|9|||
30918665|NCT01460446|58954123|FG000|Overall Study|Consent Withdrawn|0|||
30918666|NCT01460446|58954124|FG001|Overall Study|Consent Withdrawn|4|||
30918667|NCT01460446|58954123|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
30918668|NCT01460446|58954124|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
30918669|NCT01460446|58954123|FG000|Overall Study|Surgery/Illness|1|||
30918670|NCT01460446|58954124|FG001|Overall Study|Surgery/Illness|1|||
30918671|NCT01460446|58954123|FG000|Overall Study|Pregnancy|1|||
30918672|NCT01460446|58954124|FG001|Overall Study|Pregnancy|0|||
30918673|NCT01460446|58954123|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
30918674|NCT01460446|58954124|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
30918675|NCT02229383|58954133|FG000|Overall Study|Adverse Event|7|||
30918676|NCT02229383|58954134|FG001|Overall Study|Adverse Event|4|||
30918677|NCT02229383|58954133|FG000|Overall Study|Death|0|||
30918678|NCT02229383|58954134|FG001|Overall Study|Death|1|||
30918679|NCT02229383|58954133|FG000|Overall Study|Lost to Follow-up|5|||
30918680|NCT02229383|58954134|FG001|Overall Study|Lost to Follow-up|3|||
30918681|NCT02229383|58954133|FG000|Overall Study|Withdrawal by Subject|4|||
30918682|NCT02229383|58954134|FG001|Overall Study|Withdrawal by Subject|6|||
30918683|NCT02229383|58954133|FG000|Overall Study|Did not receive treatment|1|||
30918684|NCT02229383|58954134|FG001|Overall Study|Did not receive treatment|0|||
30918685|NCT02229383|58954133|FG000|Overall Study|Other|3|||
30918686|NCT02229383|58954134|FG001|Overall Study|Other|8|||
30918687|NCT01499368|58954143|FG000|Overall Study|Did not meet I/E criteria|8|||
30918688|NCT01499368|58954144|FG001|Overall Study|Did not meet I/E criteria|4|||
30918689|NCT01499368|58954145|FG002|Overall Study|Did not meet I/E criteria|4|||
30918690|NCT01499368|58954143|FG000|Overall Study|Prohibited Concomitant medication|1|||
30918691|NCT01499368|58954144|FG001|Overall Study|Prohibited Concomitant medication|1|||
30918692|NCT01499368|58954145|FG002|Overall Study|Prohibited Concomitant medication|0|||
30918693|NCT01499368|58954143|FG000|Overall Study|Withdrawal by Subject|11|||
30918694|NCT01499368|58954144|FG001|Overall Study|Withdrawal by Subject|10|||
30918695|NCT01499368|58954145|FG002|Overall Study|Withdrawal by Subject|8|||
30918696|NCT01499368|58954143|FG000|Overall Study|Lost to Follow-up|3|||
30918697|NCT01499368|58954144|FG001|Overall Study|Lost to Follow-up|2|||
30918698|NCT01499368|58954145|FG002|Overall Study|Lost to Follow-up|5|||
30918699|NCT01499368|58954143|FG000|Overall Study|Adverse Event|4|||
30918700|NCT01499368|58954144|FG001|Overall Study|Adverse Event|0|||
30918701|NCT01499368|58954145|FG002|Overall Study|Adverse Event|2|||
30918702|NCT01499368|58954143|FG000|Overall Study|Physician Decision|0|||
30918703|NCT01499368|58954144|FG001|Overall Study|Physician Decision|1|||
30918704|NCT01499368|58954145|FG002|Overall Study|Physician Decision|0|||
30918705|NCT01499368|58954143|FG000|Overall Study|Deviation from visit window|0|||
30918706|NCT01499368|58954144|FG001|Overall Study|Deviation from visit window|0|||
30918707|NCT01499368|58954145|FG002|Overall Study|Deviation from visit window|1|||
30918708|NCT01499368|58954143|FG000|Overall Study|Error of Prescriptions|0|||
30918709|NCT01499368|58954144|FG001|Overall Study|Error of Prescriptions|0|||
30918710|NCT01499368|58954145|FG002|Overall Study|Error of Prescriptions|1|||
30918711|NCT01835145|58954155|FG000|Overall Study|Ineligible prior to treatment|1|||
30918712|NCT01835145|58954156|FG001|Overall Study|Ineligible prior to treatment|0|||
30918713|NCT02229227|58954166|FG000|Overall Study|Adverse Event|14|||
30918714|NCT02229227|58954167|FG001|Overall Study|Adverse Event|9|||
30918715|NCT02229227|58954166|FG000|Overall Study|Lack of Efficacy|3|||
30918716|NCT02229227|58954167|FG001|Overall Study|Lack of Efficacy|3|||
30918717|NCT02229227|58954166|FG000|Overall Study|Protocol Violation|6|||
30918718|NCT02229227|58954167|FG001|Overall Study|Protocol Violation|8|||
30918719|NCT02229227|58954166|FG000|Overall Study|Protocol defined stopping criteria|1|||
30918720|NCT02229227|58954167|FG001|Overall Study|Protocol defined stopping criteria|3|||
30918721|NCT02229227|58954166|FG000|Overall Study|Lost to Follow-up|3|||
30918722|NCT02229227|58954167|FG001|Overall Study|Lost to Follow-up|3|||
30918723|NCT02229227|58954166|FG000|Overall Study|Study terminated by sponsor|11|||
30918724|NCT02229227|58954167|FG001|Overall Study|Study terminated by sponsor|11|||
30918725|NCT02229227|58954166|FG000|Overall Study|Withdrawal by Subject|8|||
30918726|NCT02229227|58954167|FG001|Overall Study|Withdrawal by Subject|12|||
30918727|NCT02229227|58954166|FG000|Overall Study|Other|0|||
30918728|NCT02229227|58954167|FG001|Overall Study|Other|1|||
30918729|NCT02229227|58954166|FG000|Overall Study|Physician Decision|5|||
30918730|NCT02229227|58954167|FG001|Overall Study|Physician Decision|12|||
30918731|NCT01499290|58954175|FG000|Overall Study|Withdrawal by Subject|22|||
30918732|NCT01499290|58954176|FG001|Overall Study|Withdrawal by Subject|15|||
30918733|NCT01499290|58954175|FG000|Overall Study|Not specified in study report|11|||
30918734|NCT01499290|58954176|FG001|Overall Study|Not specified in study report|5|||
30918735|NCT01499290|58954175|FG000|Overall Study|Condition improved/subject recovered|1|||
30918736|NCT01499290|58954176|FG001|Overall Study|Condition improved/subject recovered|0|||
30918737|NCT01499290|58954175|FG000|Overall Study|Lack of Efficacy|7|||
30918738|NCT01499290|58954176|FG001|Overall Study|Lack of Efficacy|8|||
30918739|NCT01499290|58954175|FG000|Overall Study|Adverse Event|14|||
30918740|NCT01499290|58954176|FG001|Overall Study|Adverse Event|7|||
30918741|NCT01833897|58954201|FG000|Overall Study|Lack of Efficacy|1|||
30918742|NCT01481896|58954205|FG000|Overall Study|Lost to Follow-up|12|||
30918743|NCT02226653|58954221|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
30826493|NCT02764190|58848797|FG000|Overall Study|Lost to Follow-up|17|||
30826494|NCT02764190|58848798|FG001|Overall Study|Lost to Follow-up|13|||
30826495|NCT03077659|58848807|FG000|Overall Study|Withdrawal by Subject|0|||
30826496|NCT03077659|58848808|FG001|Overall Study|Withdrawal by Subject|0|||
30826497|NCT03077659|58848809|FG002|Overall Study|Withdrawal by Subject|1|||
30826498|NCT02807883|58848820|FG000|Overall Study|Withdrawal by Subject|2|||
30826499|NCT03082261|58848824|FG000|Overall Study|Death|4|||
30826500|NCT03082261|58848824|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
30826501|NCT03082261|58848824|FG000|Overall Study|Insurance denial|1|||
30826502|NCT03082261|58848824|FG000|Overall Study|Peripheral lead added|1|||
30826503|NCT03082261|58848824|FG000|Overall Study|Withdrawal by Subject|40|||
30826504|NCT03082261|58848824|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
30826505|NCT03082261|58848824|FG000|Overall Study|Subject implanted with device other than study device|1|||
30826506|NCT03082261|58848824|FG000|Overall Study|Lost to Follow-up|14|||
30826507|NCT03082261|58848824|FG000|Overall Study|Subject moved to a different state|1|||
30753960|NCT00130208|58763587|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
30753961|NCT00130208|58763586|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
30753962|NCT00130208|58763587|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
30753963|NCT00130208|58763586|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
30753964|NCT00130208|58763587|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
30753965|NCT00130208|58763586|FG000|Washout Period (8 Weeks)|Other|1|||
30753966|NCT00130208|58763587|FG001|Washout Period (8 Weeks)|Other|1|||
30753967|NCT00253370|58763593|FG000|Overall Study|Adverse Event|18|||
30753968|NCT00253370|58763593|FG000|Overall Study|Disease progression|13|||
30753969|NCT00253370|58763593|FG000|Overall Study|Death|2|||
30753970|NCT00253370|58763593|FG000|Overall Study|Withdrawal by Subject|6|||
30826508|NCT03082261|58848824|FG000|Overall Study|Subject non-compliance|2|||
30826509|NCT03082261|58848824|FG000|Overall Study|Subject participation terminated by investigator|9|||
30826510|NCT03082261|58848824|FG000|Overall Study|Subject participation terminated by sponsor|4|||
30918744|NCT02226653|58954222|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
30918745|NCT02226653|58954221|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
30918746|NCT02226653|58954222|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
30918747|NCT02201771|58954238|FG000|Overall Study|Death|3|||
30918748|NCT02201771|58954239|FG001|Overall Study|Death|2|||
30918749|NCT02201771|58954240|FG002|Overall Study|Death|0|||
30918750|NCT02201771|58954238|FG000|Overall Study|Protocol Violation|10|||
30918751|NCT02201771|58954239|FG001|Overall Study|Protocol Violation|8|||
30918752|NCT02201771|58954240|FG002|Overall Study|Protocol Violation|10|||
30918753|NCT01460368|58954250|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
30918754|NCT01460368|58954251|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
30826511|NCT03082261|58848824|FG000|Overall Study|System explant|19|||
30918755|NCT01460368|58954252|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
30918756|NCT01460368|58954253|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
30918757|NCT01460368|58954254|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
30918758|NCT01460368|58954255|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
30918759|NCT01460368|58954256|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
30918760|NCT01460368|58954250|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
30918761|NCT01460368|58954251|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
30918762|NCT01460368|58954252|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
30918763|NCT01460368|58954253|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
30918764|NCT01460368|58954254|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
30918765|NCT01460368|58954255|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
30918766|NCT01460368|58954256|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
30918767|NCT01460368|58954250|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
30826512|NCT03082261|58848824|FG000|Overall Study|Unable to place lead(s)|2|||
30826513|NCT03082261|58848824|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
30826514|NCT00102440|58848831|FG000|Overall Study|Lost to Follow-up|25|||
30826515|NCT00102440|58848832|FG001|Overall Study|Lost to Follow-up|18|||
30826516|NCT00102440|58848833|FG002|Overall Study|Lost to Follow-up|21|||
30826517|NCT00102440|58848831|FG000|Overall Study|Adverse Event|16|||
30826518|NCT00102440|58848832|FG001|Overall Study|Adverse Event|23|||
30826519|NCT00102440|58848833|FG002|Overall Study|Adverse Event|8|||
30826520|NCT00102440|58848831|FG000|Overall Study|Gout Flare|10|||
30826521|NCT00102440|58848832|FG001|Overall Study|Gout Flare|28|||
30826522|NCT00102440|58848833|FG002|Overall Study|Gout Flare|9|||
30826523|NCT00102440|58848831|FG000|Overall Study|Personal Reason(s)|19|||
30826524|NCT00102440|58848832|FG001|Overall Study|Personal Reason(s)|13|||
30826525|NCT00102440|58848833|FG002|Overall Study|Personal Reason(s)|13|||
30826526|NCT00102440|58848831|FG000|Overall Study|Other|11|||
30826527|NCT00102440|58848832|FG001|Overall Study|Other|14|||
30826528|NCT00102440|58848833|FG002|Overall Study|Other|14|||
30826529|NCT00102440|58848831|FG000|Overall Study|Protocol Violation|7|||
30826530|NCT00102440|58848832|FG001|Overall Study|Protocol Violation|2|||
30826531|NCT00102440|58848833|FG002|Overall Study|Protocol Violation|1|||
30826532|NCT02762084|58848857|FG000|Overall Study|Withdrawal by Subject|1|||
30826533|NCT02762084|58848858|FG001|Overall Study|Withdrawal by Subject|0|||
30826534|NCT02762084|58848859|FG002|Overall Study|Withdrawal by Subject|0|||
30826535|NCT02762084|58848857|FG000|Overall Study|Adverse Event|0|||
30826536|NCT02762084|58848858|FG001|Overall Study|Adverse Event|0|||
30826537|NCT02762084|58848859|FG002|Overall Study|Adverse Event|1|||
30826538|NCT02763644|58848871|FG000|Overall Study|Patient/guardian decision|1|||
30918768|NCT01460368|58954251|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
30826539|NCT02763644|58848872|FG001|Overall Study|Patient/guardian decision|0|||
30826540|NCT02763644|58848871|FG000|Overall Study|Death|1|||
30826541|NCT02763644|58848872|FG001|Overall Study|Death|1|||
30826542|NCT02763644|58848871|FG000|Overall Study|Adverse Event|1|||
30826543|NCT02763644|58848872|FG001|Overall Study|Adverse Event|1|||
30826544|NCT02807844|58848890|FG000|Overall Study|Physician Decision|0|||
30826545|NCT02807844|58848891|FG001|Overall Study|Physician Decision|0|||
30826546|NCT02807844|58848892|FG002|Overall Study|Physician Decision|0|||
30826547|NCT02807844|58848893|FG003|Overall Study|Physician Decision|0|||
30826548|NCT02807844|58848894|FG004|Overall Study|Physician Decision|0|||
30826549|NCT02807844|58848895|FG005|Overall Study|Physician Decision|0|||
30826550|NCT02807844|58848896|FG006|Overall Study|Physician Decision|3|||
30826551|NCT02807844|58848897|FG007|Overall Study|Physician Decision|0|||
30826552|NCT02807844|58848898|FG008|Overall Study|Physician Decision|1|||
30623307|NCT01121562|58635146|FG000|Overall Study|Adverse Event|1|||
30826553|NCT02807844|58848899|FG009|Overall Study|Physician Decision|2|||
30826554|NCT02807844|58848890|FG000|Overall Study|Death|0|||
30826555|NCT02807844|58848891|FG001|Overall Study|Death|0|||
30826556|NCT02807844|58848892|FG002|Overall Study|Death|2|||
30826557|NCT02807844|58848893|FG003|Overall Study|Death|4|||
30826558|NCT02807844|58848894|FG004|Overall Study|Death|1|||
30826559|NCT02807844|58848895|FG005|Overall Study|Death|2|||
30826560|NCT02807844|58848896|FG006|Overall Study|Death|1|||
30918769|NCT01460368|58954252|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
30918770|NCT01460368|58954253|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
30918771|NCT01460368|58954254|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
30918772|NCT01460368|58954255|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
30918773|NCT01460368|58954256|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
30918774|NCT01460368|58954250|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
30918775|NCT01460368|58954251|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
30918776|NCT01460368|58954252|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
30918777|NCT01460368|58954253|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
30918778|NCT01460368|58954254|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
30918779|NCT01460368|58954255|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
30918780|NCT01460368|58954256|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
30918781|NCT01460368|58954250|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
30918782|NCT01460368|58954251|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
30918783|NCT01460368|58954252|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
30918784|NCT01460368|58954253|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
30918785|NCT01460368|58954254|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
30918786|NCT01460368|58954255|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
30918787|NCT01460368|58954256|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
30918788|NCT01460290|58954265|FG000|Overall Study|Adverse Event|3|||
30918789|NCT01460290|58954265|FG000|Overall Study|Elevated liver function|1|||
30918790|NCT02200211|58954274|FG000|Overall Study|Lost to Follow-up|7|||
30918791|NCT02200211|58954275|FG001|Overall Study|Lost to Follow-up|7|||
30918792|NCT02200211|58954276|FG002|Overall Study|Lost to Follow-up|1|||
30918793|NCT02200211|58954277|FG003|Overall Study|Lost to Follow-up|2|||
30918794|NCT02200211|58954274|FG000|Overall Study|Withdrawal by Subject|1|||
30918795|NCT02200211|58954275|FG001|Overall Study|Withdrawal by Subject|0|||
30918796|NCT02200211|58954276|FG002|Overall Study|Withdrawal by Subject|0|||
30918797|NCT02200211|58954277|FG003|Overall Study|Withdrawal by Subject|0|||
30918798|NCT01459666|58954297|FG000|Overall Study|PI left institution|5|||
30918799|NCT01459666|58954298|FG001|Overall Study|PI left institution|4|||
30918800|NCT01858389|58954306|FG000|Overall Study|Death|1|||
30918801|NCT01858389|58954307|FG001|Overall Study|Death|3|||
30918802|NCT01858389|58954306|FG000|Overall Study|Study terminated by sponsor|0|||
30918803|NCT01858389|58954307|FG001|Overall Study|Study terminated by sponsor|2|||
30918804|NCT01858389|58954306|FG000|Overall Study|Withdrawal by Subject|0|||
30918805|NCT01858389|58954307|FG001|Overall Study|Withdrawal by Subject|1|||
30918806|NCT01858389|58954306|FG000|Overall Study|Progressive disease|10|||
30918807|NCT01858389|58954307|FG001|Overall Study|Progressive disease|11|||
30918808|NCT01858389|58954306|FG000|Overall Study|Other|2|||
30918809|NCT01858389|58954307|FG001|Overall Study|Other|4|||
30918810|NCT01858389|58954306|FG000|Overall Study|Adverse Event|3|||
30918811|NCT01858389|58954307|FG001|Overall Study|Adverse Event|1|||
30918812|NCT01858389|58954306|FG000|Overall Study|Did not receive treatment|0|||
30918813|NCT01858389|58954307|FG001|Overall Study|Did not receive treatment|3|||
30918814|NCT02199509|58954315|FG000|Overall Study|Suicidal Ideation|0|||
30826561|NCT02807844|58848897|FG007|Overall Study|Death|2|||
30826562|NCT02807844|58848898|FG008|Overall Study|Death|0|||
30826563|NCT02807844|58848899|FG009|Overall Study|Death|1|||
30826564|NCT02807844|58848890|FG000|Overall Study|Withdrawal by Subject|0|||
30826565|NCT02807844|58848891|FG001|Overall Study|Withdrawal by Subject|0|||
30826566|NCT02807844|58848892|FG002|Overall Study|Withdrawal by Subject|2|||
30826567|NCT02807844|58848893|FG003|Overall Study|Withdrawal by Subject|1|||
30826568|NCT02807844|58848894|FG004|Overall Study|Withdrawal by Subject|1|||
30826569|NCT02807844|58848895|FG005|Overall Study|Withdrawal by Subject|0|||
30826570|NCT02807844|58848896|FG006|Overall Study|Withdrawal by Subject|1|||
30826571|NCT02807844|58848897|FG007|Overall Study|Withdrawal by Subject|0|||
30826572|NCT02807844|58848898|FG008|Overall Study|Withdrawal by Subject|0|||
30826573|NCT02807844|58848899|FG009|Overall Study|Withdrawal by Subject|0|||
30826574|NCT02807844|58848890|FG000|Overall Study|Progressive disease|5|||
30826575|NCT02807844|58848891|FG001|Overall Study|Progressive disease|12|||
30826576|NCT02807844|58848892|FG002|Overall Study|Progressive disease|8|||
30826577|NCT02807844|58848893|FG003|Overall Study|Progressive disease|8|||
30826578|NCT02807844|58848894|FG004|Overall Study|Progressive disease|3|||
30826579|NCT02807844|58848895|FG005|Overall Study|Progressive disease|8|||
30826580|NCT02807844|58848896|FG006|Overall Study|Progressive disease|14|||
30826581|NCT02807844|58848897|FG007|Overall Study|Progressive disease|17|||
30826582|NCT02807844|58848898|FG008|Overall Study|Progressive disease|19|||
30826583|NCT02807844|58848899|FG009|Overall Study|Progressive disease|15|||
30826584|NCT02807844|58848890|FG000|Overall Study|Adverse Event|1|||
30826585|NCT02807844|58848891|FG001|Overall Study|Adverse Event|0|||
30826586|NCT02807844|58848892|FG002|Overall Study|Adverse Event|0|||
30826587|NCT02807844|58848893|FG003|Overall Study|Adverse Event|0|||
30918815|NCT02199509|58954316|FG001|Overall Study|Suicidal Ideation|1|||
30918816|NCT02199509|58954315|FG000|Overall Study|Misunderstood titration schedule|1|||
30918817|NCT02199509|58954316|FG001|Overall Study|Misunderstood titration schedule|0|||
30918818|NCT01458574|58954329|FG000|Overall Study|Adverse Event|5|||
30918819|NCT01458574|58954330|FG001|Overall Study|Adverse Event|9|||
30918820|NCT01458574|58954331|FG002|Overall Study|Adverse Event|7|||
30918821|NCT01458574|58954329|FG000|Overall Study|Lack of Efficacy|70|||
30918822|NCT01458574|58954330|FG001|Overall Study|Lack of Efficacy|53|||
30918823|NCT01458574|58954331|FG002|Overall Study|Lack of Efficacy|132|||
30918824|NCT01458574|58954329|FG000|Overall Study|Lost to Follow-up|3|||
30918825|NCT01458574|58954330|FG001|Overall Study|Lost to Follow-up|2|||
30918826|NCT01458574|58954331|FG002|Overall Study|Lost to Follow-up|1|||
30918827|NCT01458574|58954329|FG000|Overall Study|Pregnancy|1|||
30918828|NCT01458574|58954330|FG001|Overall Study|Pregnancy|1|||
30918829|NCT01458574|58954331|FG002|Overall Study|Pregnancy|0|||
30918830|NCT01458574|58954329|FG000|Overall Study|Protocol Violation|0|||
30918831|NCT01458574|58954330|FG001|Overall Study|Protocol Violation|1|||
30918832|NCT01458574|58954331|FG002|Overall Study|Protocol Violation|0|||
30918833|NCT01458574|58954329|FG000|Overall Study|Withdrawal by Subject|6|||
30918834|NCT01458574|58954330|FG001|Overall Study|Withdrawal by Subject|3|||
30918835|NCT01458574|58954331|FG002|Overall Study|Withdrawal by Subject|5|||
30918836|NCT01458574|58954329|FG000|Overall Study|Other|2|||
30918837|NCT01458574|58954330|FG001|Overall Study|Other|1|||
30918838|NCT01458574|58954331|FG002|Overall Study|Other|0|||
30918839|NCT01458574|58954329|FG000|Overall Study|Randomized but not treated|0|||
30918840|NCT01458574|58954330|FG001|Overall Study|Randomized but not treated|1|||
30918841|NCT01458574|58954331|FG002|Overall Study|Randomized but not treated|0|||
30918842|NCT02224703|58954342|FG000|Overall Study|Adverse Event|0|||
30918843|NCT02224703|58954343|FG001|Overall Study|Adverse Event|5|||
30918844|NCT02224703|58954344|FG002|Overall Study|Adverse Event|0|||
30918845|NCT02224703|58954342|FG000|Overall Study|Withdrawn by investigator|1|||
30918846|NCT02224703|58954343|FG001|Overall Study|Withdrawn by investigator|0|||
30918847|NCT02224703|58954344|FG002|Overall Study|Withdrawn by investigator|0|||
30918848|NCT02224703|58954342|FG000|Overall Study|Advised by medical monitor|1|||
30918849|NCT02224703|58954343|FG001|Overall Study|Advised by medical monitor|0|||
30918850|NCT02224703|58954344|FG002|Overall Study|Advised by medical monitor|0|||
30918851|NCT02224703|58954342|FG000|Overall Study|Withdrawn by parent/guardian|0|||
30918852|NCT02224703|58954343|FG001|Overall Study|Withdrawn by parent/guardian|1|||
30918853|NCT02224703|58954344|FG002|Overall Study|Withdrawn by parent/guardian|0|||
30918854|NCT02224703|58954342|FG000|Overall Study|Lack of Efficacy|1|||
30918855|NCT02224703|58954343|FG001|Overall Study|Lack of Efficacy|0|||
30918856|NCT02224703|58954344|FG002|Overall Study|Lack of Efficacy|0|||
30918857|NCT02198963|58954353|FG000|Overall Study|Adverse Event|1|||
30918858|NCT02198963|58954353|FG000|Overall Study|Withdrawal by Subject|6|||
30918859|NCT01458106|58954377|FG000|Overall Study|Withdrawal by Subject|2|||
30918860|NCT01458106|58954378|FG001|Overall Study|Withdrawal by Subject|0|||
30918861|NCT01458106|58954377|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
30918862|NCT01458106|58954378|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
30918863|NCT01458106|58954377|FG000|Overall Study|Withdrawn Per Protocol|0|||
30918864|NCT01458106|58954378|FG001|Overall Study|Withdrawn Per Protocol|1|||
30918865|NCT01457950|58954389|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
30918866|NCT01457950|58954390|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
30918867|NCT01457950|58954391|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
30918868|NCT01457950|58954392|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
30918869|NCT01457950|58954389|FG000|Double-Blind Phase|Protocol Violation|2|||
30918870|NCT01457950|58954390|FG001|Double-Blind Phase|Protocol Violation|1|||
30918871|NCT01457950|58954391|FG002|Double-Blind Phase|Protocol Violation|0|||
30918872|NCT01457950|58954392|FG003|Double-Blind Phase|Protocol Violation|0|||
30918873|NCT01457950|58954389|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
30918874|NCT01457950|58954390|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
30918875|NCT01457950|58954391|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
30918876|NCT01457950|58954392|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
30918877|NCT01457950|58954389|FG000|Open-Label Phase|Adverse Event|0|||
30918878|NCT01457950|58954390|FG001|Open-Label Phase|Adverse Event|0|||
30918879|NCT01457950|58954391|FG002|Open-Label Phase|Adverse Event|0|||
30918880|NCT01457950|58954392|FG003|Open-Label Phase|Adverse Event|1|||
30918881|NCT01457950|58954389|FG000|Open-Label Phase|Protocol Violation|0|||
30918882|NCT01457950|58954390|FG001|Open-Label Phase|Protocol Violation|0|||
30918883|NCT01457950|58954391|FG002|Open-Label Phase|Protocol Violation|0|||
30918884|NCT01457950|58954392|FG003|Open-Label Phase|Protocol Violation|1|||
30918885|NCT01457950|58954389|FG000|Open-Label Phase|Withdrawal by Subject|0|||
30918886|NCT01457950|58954390|FG001|Open-Label Phase|Withdrawal by Subject|0|||
30918887|NCT01457950|58954391|FG002|Open-Label Phase|Withdrawal by Subject|2|||
30918888|NCT01457950|58954392|FG003|Open-Label Phase|Withdrawal by Subject|0|||
30918889|NCT01499134|58954405|FG000|Overall Study|Withdrawal by Subject|0|||
30918890|NCT01499134|58954406|FG001|Overall Study|Withdrawal by Subject|1|||
30918891|NCT02198651|58954412|FG000|Lead-in Period|Withdrew consent|13|||
30918892|NCT02198651|58954413|FG001|Lead-in Period|Withdrew consent|0|||
30918893|NCT02198651|58954414|FG002|Lead-in Period|Withdrew consent|0|||
30918894|NCT02198651|58954415|FG003|Lead-in Period|Withdrew consent|0|||
30918895|NCT02198651|58954416|FG004|Lead-in Period|Withdrew consent|0|||
30918896|NCT02198651|58954412|FG000|Lead-in Period|Adverse Event|2|||
30918897|NCT02198651|58954413|FG001|Lead-in Period|Adverse Event|0|||
30918898|NCT02198651|58954414|FG002|Lead-in Period|Adverse Event|0|||
30918899|NCT02198651|58954415|FG003|Lead-in Period|Adverse Event|0|||
30918900|NCT02198651|58954416|FG004|Lead-in Period|Adverse Event|0|||
30918901|NCT02198651|58954412|FG000|Lead-in Period|Other, not specified|22|||
30918902|NCT02198651|58954413|FG001|Lead-in Period|Other, not specified|0|||
30918903|NCT02198651|58954414|FG002|Lead-in Period|Other, not specified|0|||
30918904|NCT02198651|58954415|FG003|Lead-in Period|Other, not specified|0|||
30918905|NCT02198651|58954416|FG004|Lead-in Period|Other, not specified|0|||
30918906|NCT02198651|58954412|FG000|Double-blind Period|Withdrew consent|0|||
30918907|NCT02198651|58954413|FG001|Double-blind Period|Withdrew consent|4|||
30918908|NCT02198651|58954414|FG002|Double-blind Period|Withdrew consent|0|||
30918909|NCT02198651|58954415|FG003|Double-blind Period|Withdrew consent|0|||
30623308|NCT01121562|58635146|FG000|Overall Study|Sponsor Decision|1|||
30623309|NCT01121562|58635146|FG000|Overall Study|Met study discontinuation criteria|1|||
30623310|NCT01121484|58635152|FG000|Overall Study|Adverse Event|12|||
30623311|NCT01121484|58635153|FG001|Overall Study|Adverse Event|5|||
30623312|NCT01121484|58635152|FG000|Overall Study|Lack of Efficacy|3|||
30623313|NCT01121484|58635153|FG001|Overall Study|Lack of Efficacy|11|||
30918910|NCT02198651|58954416|FG004|Double-blind Period|Withdrew consent|0|||
30918911|NCT02198651|58954412|FG000|Double-blind Period|Adverse Event|0|||
30918912|NCT02198651|58954413|FG001|Double-blind Period|Adverse Event|1|||
30918913|NCT02198651|58954414|FG002|Double-blind Period|Adverse Event|0|||
30918914|NCT02198651|58954415|FG003|Double-blind Period|Adverse Event|0|||
30918915|NCT02198651|58954416|FG004|Double-blind Period|Adverse Event|0|||
30918916|NCT02198651|58954412|FG000|Double-blind Period|Other, not specified|0|||
30918917|NCT02198651|58954413|FG001|Double-blind Period|Other, not specified|4|||
30918918|NCT02198651|58954414|FG002|Double-blind Period|Other, not specified|1|||
30918919|NCT02198651|58954415|FG003|Double-blind Period|Other, not specified|0|||
30918920|NCT02198651|58954416|FG004|Double-blind Period|Other, not specified|0|||
30918921|NCT02198651|58954412|FG000|Open-label Rescue Period|Withdrew consent|0|||
30918922|NCT02198651|58954413|FG001|Open-label Rescue Period|Withdrew consent|0|||
30918923|NCT02198651|58954414|FG002|Open-label Rescue Period|Withdrew consent|0|||
30918924|NCT02198651|58954415|FG003|Open-label Rescue Period|Withdrew consent|2|||
30918925|NCT02198651|58954416|FG004|Open-label Rescue Period|Withdrew consent|0|||
30918926|NCT02198651|58954412|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
30918927|NCT02198651|58954413|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
30918928|NCT02198651|58954414|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
30918929|NCT02198651|58954415|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
30918930|NCT02198651|58954416|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
30918931|NCT01498822|58954431|FG000|Overall Study|Protocol Violation|8|||
30918932|NCT01498822|58954432|FG001|Overall Study|Protocol Violation|4|||
30918933|NCT01498822|58954431|FG000|Overall Study|Other Reason|5|||
30918934|NCT01498822|58954432|FG001|Overall Study|Other Reason|2|||
30918935|NCT01498822|58954431|FG000|Overall Study|Lack of Efficacy|7|||
30918936|NCT01498822|58954432|FG001|Overall Study|Lack of Efficacy|2|||
30918937|NCT01498822|58954431|FG000|Overall Study|AE, non-serious non-fatal|8|||
30918938|NCT01498822|58954432|FG001|Overall Study|AE, non-serious non-fatal|17|||
30918939|NCT01498822|58954431|FG000|Overall Study|SAE, non-fatal|2|||
30918940|NCT01498822|58954432|FG001|Overall Study|SAE, non-fatal|2|||
30918941|NCT01498822|58954431|FG000|Overall Study|Adverse Event, serious fatal|1|||
30918942|NCT01498822|58954432|FG001|Overall Study|Adverse Event, serious fatal|1|||
30918943|NCT01498822|58954431|FG000|Overall Study|Withdrawal by Subject|15|||
30918944|NCT01498822|58954432|FG001|Overall Study|Withdrawal by Subject|25|||
30918945|NCT01498822|58954431|FG000|Overall Study|Lost to Follow-up|8|||
30918946|NCT01498822|58954432|FG001|Overall Study|Lost to Follow-up|3|||
30918947|NCT01498120|58954440|FG000|Overall Study|Lost to Follow-up|1|||
30918948|NCT01498120|58954440|FG000|Overall Study|Withdrawal by Subject|5|||
30918949|NCT01498120|58954440|FG000|Overall Study|AE, non-serious non-fatal|3|||
30918950|NCT01498120|58954440|FG000|Overall Study|Other|4|||
30918951|NCT01497262|58954444|FG000|Overall Study|Abnormal Lab Values|4|||
30918952|NCT01497262|58954444|FG000|Overall Study|Abnormal Test Procedure Result|1|||
30918953|NCT01497262|58954444|FG000|Overall Study|Physician Decision|1|||
30918954|NCT01497262|58954444|FG000|Overall Study|Withdrawal by Subject|2|||
30918955|NCT01497262|58954444|FG000|Overall Study|Adverse Event|2|||
30918956|NCT01497262|58954444|FG000|Overall Study|Protocol Violation|1|||
30623314|NCT01121484|58635152|FG000|Overall Study|Lost to Follow-up|5|||
30623315|NCT01121484|58635153|FG001|Overall Study|Lost to Follow-up|9|||
30623316|NCT01121484|58635152|FG000|Overall Study|Physician Decision|0|||
30918957|NCT02224625|58954448|FG000|Irritation|Adverse Event|6|||
30918958|NCT02224625|58954448|FG000|Sensitization|Adverse Event|55|||
30918959|NCT02197247|58954460|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
30918960|NCT02197247|58954460|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
30918961|NCT02197247|58954460|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
30918962|NCT02197247|58954460|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
30918963|NCT02197247|58954460|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
30918964|NCT02197247|58954460|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
30918965|NCT02197247|58954460|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
30918966|NCT02197247|58954460|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
30918967|NCT02224157|58954472|FG000|Overall Study|Severe non-compliance to protocol|2|||
30918968|NCT02224157|58954473|FG001|Overall Study|Severe non-compliance to protocol|2|||
30918969|NCT02224157|58954472|FG000|Overall Study|Other|13|||
30826588|NCT02807844|58848894|FG004|Overall Study|Adverse Event|1|||
30826589|NCT02807844|58848895|FG005|Overall Study|Adverse Event|1|||
30826590|NCT02807844|58848896|FG006|Overall Study|Adverse Event|1|||
30826591|NCT02807844|58848897|FG007|Overall Study|Adverse Event|1|||
30826592|NCT02807844|58848898|FG008|Overall Study|Adverse Event|1|||
30826593|NCT02807844|58848899|FG009|Overall Study|Adverse Event|2|||
30826594|NCT02763566|58848929|FG000|Overall Study|Lost to Follow-up|1|||
30826595|NCT02763566|58848930|FG001|Overall Study|Lost to Follow-up|4|||
30826596|NCT02763566|58848931|FG002|Overall Study|Lost to Follow-up|0|||
30826597|NCT02763566|58848932|FG003|Overall Study|Lost to Follow-up|1|||
30826598|NCT02763566|58848929|FG000|Overall Study|On study treatment at study conclusion|114|||
30826599|NCT02763566|58848930|FG001|Overall Study|On study treatment at study conclusion|34|||
30826600|NCT02763566|58848931|FG002|Overall Study|On study treatment at study conclusion|54|||
30826601|NCT02763566|58848932|FG003|Overall Study|On study treatment at study conclusion|13|||
30826602|NCT02763566|58848929|FG000|Overall Study|Withdrawal by Subject|3|||
30918970|NCT02224157|58954473|FG001|Overall Study|Other|10|||
30918971|NCT02224157|58954472|FG000|Overall Study|Subject decision|58|||
30918972|NCT02224157|58954473|FG001|Overall Study|Subject decision|50|||
30918973|NCT02224157|58954472|FG000|Overall Study|Prematurely closed site|4|||
30918974|NCT02224157|58954473|FG001|Overall Study|Prematurely closed site|2|||
30918975|NCT02224157|58954472|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
30918976|NCT02224157|58954473|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
30918977|NCT02224157|58954472|FG000|Overall Study|Lost to Follow-up|27|||
30918978|NCT02224157|58954473|FG001|Overall Study|Lost to Follow-up|35|||
30918979|NCT02224157|58954472|FG000|Overall Study|Death|1|||
30918980|NCT02224157|58954473|FG001|Overall Study|Death|1|||
30918981|NCT02224157|58954472|FG000|Overall Study|Adverse Event|1|||
30918982|NCT02224157|58954473|FG001|Overall Study|Adverse Event|3|||
30918983|NCT02196701|58954481|FG000|Overall Study|Adverse Event|1|||
30918984|NCT02196701|58954481|FG000|Overall Study|Lost to Follow-up|1|||
30918985|NCT02196701|58954481|FG000|Overall Study|Non-adherence to Protocol|1|||
30918986|NCT01481116|58954491|FG000|Overall Study|Adverse Event|26|||
30918987|NCT01481116|58954492|FG001|Overall Study|Adverse Event|26|||
30918988|NCT01481116|58954493|FG002|Overall Study|Adverse Event|42|||
30918989|NCT01481116|58954491|FG000|Overall Study|Major Protocol Deviation|3|||
30918990|NCT01481116|58954492|FG001|Overall Study|Major Protocol Deviation|7|||
30918991|NCT01481116|58954493|FG002|Overall Study|Major Protocol Deviation|1|||
30918992|NCT01481116|58954491|FG000|Overall Study|Lost to Follow-up|8|||
30918993|NCT01481116|58954492|FG001|Overall Study|Lost to Follow-up|12|||
30918994|NCT01481116|58954493|FG002|Overall Study|Lost to Follow-up|11|||
30918995|NCT01481116|58954491|FG000|Overall Study|Withdrawal by Subject|37|||
30918996|NCT01481116|58954492|FG001|Overall Study|Withdrawal by Subject|33|||
30918997|NCT01481116|58954493|FG002|Overall Study|Withdrawal by Subject|37|||
30918998|NCT01481116|58954491|FG000|Overall Study|Study Termination|730|||
30918999|NCT01481116|58954492|FG001|Overall Study|Study Termination|729|||
30919000|NCT01481116|58954493|FG002|Overall Study|Study Termination|713|||
30919001|NCT01481116|58954491|FG000|Overall Study|Pregnancy|0|||
30919002|NCT01481116|58954492|FG001|Overall Study|Pregnancy|0|||
30919003|NCT01481116|58954493|FG002|Overall Study|Pregnancy|1|||
30919004|NCT01481116|58954491|FG000|Overall Study|Lack of Efficacy|3|||
30919005|NCT01481116|58954492|FG001|Overall Study|Lack of Efficacy|3|||
30919006|NCT01481116|58954493|FG002|Overall Study|Lack of Efficacy|1|||
30826603|NCT02763566|58848930|FG001|Overall Study|Withdrawal by Subject|1|||
30919007|NCT01481116|58954491|FG000|Overall Study|Contraindications|1|||
30919008|NCT01481116|58954492|FG001|Overall Study|Contraindications|1|||
30919009|NCT01481116|58954493|FG002|Overall Study|Contraindications|0|||
30919010|NCT01481116|58954491|FG000|Overall Study|Other|1|||
30919011|NCT01481116|58954492|FG001|Overall Study|Other|1|||
30919012|NCT01481116|58954493|FG002|Overall Study|Other|0|||
30919013|NCT01481116|58954491|FG000|Overall Study|Participant Started Taking Glipizide|1|||
30919014|NCT01481116|58954492|FG001|Overall Study|Participant Started Taking Glipizide|0|||
30919015|NCT01481116|58954493|FG002|Overall Study|Participant Started Taking Glipizide|0|||
30919016|NCT01481116|58954491|FG000|Overall Study|Participant Moved Out of Area|2|||
30919017|NCT01481116|58954492|FG001|Overall Study|Participant Moved Out of Area|0|||
30919018|NCT01481116|58954493|FG002|Overall Study|Participant Moved Out of Area|1|||
30919019|NCT01481116|58954491|FG000|Overall Study|Participant Moved Out of Country|1|||
30919020|NCT01481116|58954492|FG001|Overall Study|Participant Moved Out of Country|0|||
30919021|NCT01481116|58954493|FG002|Overall Study|Participant Moved Out of Country|1|||
30919022|NCT01481116|58954491|FG000|Overall Study|Investigator Decision|3|||
30919023|NCT01481116|58954492|FG001|Overall Study|Investigator Decision|2|||
30919024|NCT01481116|58954493|FG002|Overall Study|Investigator Decision|1|||
30919025|NCT01481116|58954491|FG000|Overall Study|Sponsor Decision|0|||
30919026|NCT01481116|58954492|FG001|Overall Study|Sponsor Decision|1|||
30919027|NCT01481116|58954493|FG002|Overall Study|Sponsor Decision|3|||
30919028|NCT01481116|58954491|FG000|Overall Study|Non-Compliant With Study Drug|0|||
30919029|NCT01481116|58954492|FG001|Overall Study|Non-Compliant With Study Drug|1|||
30919030|NCT01481116|58954493|FG002|Overall Study|Non-Compliant With Study Drug|1|||
30919031|NCT01481116|58954491|FG000|Overall Study|Investigator's Discretion|2|||
30919032|NCT01481116|58954492|FG001|Overall Study|Investigator's Discretion|0|||
30919033|NCT01481116|58954493|FG002|Overall Study|Investigator's Discretion|0|||
30919034|NCT01481116|58954491|FG000|Overall Study|Death|2|||
30919035|NCT01481116|58954492|FG001|Overall Study|Death|1|||
30826604|NCT02763566|58848931|FG002|Overall Study|Withdrawal by Subject|0|||
30826605|NCT02763566|58848932|FG003|Overall Study|Withdrawal by Subject|0|||
30826606|NCT02763254|58848946|FG000|Overall Study|Adverse Event|1|||
30826607|NCT02805972|58848952|FG000|Washout Period|Lost to Follow-up|3|||
30826608|NCT02805972|58848953|FG001|Washout Period|Lost to Follow-up|0|||
30919036|NCT01481116|58954493|FG002|Overall Study|Death|0|||
30919037|NCT01481116|58954491|FG000|Overall Study|Hypoglycemic Event|4|||
30919038|NCT01481116|58954492|FG001|Overall Study|Hypoglycemic Event|0|||
30919039|NCT01481116|58954493|FG002|Overall Study|Hypoglycemic Event|0|||
30919040|NCT02222207|58954501|FG000|Overall Study|Death|1|||
30919041|NCT02222207|58954501|FG000|Overall Study|Other reasons|2|||
30919042|NCT02222207|58954501|FG000|Overall Study|Adverse Event|1|||
30919043|NCT01457014|58954505|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
30919044|NCT01457014|58954506|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
30919045|NCT01457014|58954507|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
30919046|NCT01457014|58954508|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
30919047|NCT01457014|58954505|FG000|First Night|Withdrawal by Subject|3|||
30919048|NCT01457014|58954506|FG001|First Night|Withdrawal by Subject|0|||
30919049|NCT01457014|58954507|FG002|First Night|Withdrawal by Subject|0|||
30919050|NCT01457014|58954508|FG003|First Night|Withdrawal by Subject|0|||
30919051|NCT02254421|58954518|FG000|Overall Study|Randomized but Not Treated|1|||
30919052|NCT02254421|58954519|FG001|Overall Study|Randomized but Not Treated|0|||
30919053|NCT02254421|58954518|FG000|Overall Study|Death|0|||
30919054|NCT02254421|58954519|FG001|Overall Study|Death|2|||
30919055|NCT02254421|58954518|FG000|Overall Study|Withdrew Consent|1|||
30919056|NCT02254421|58954519|FG001|Overall Study|Withdrew Consent|1|||
30919057|NCT02252939|58954525|FG000|Overall Study|Lost to Follow-up|3|||
30919058|NCT02196077|58954534|FG000|Overall Study|Adverse Event|4|||
30919059|NCT02196077|58954534|FG000|Overall Study|Lack of Efficacy|1|||
30919060|NCT02196077|58954534|FG000|Overall Study|Withdrawal by Subject|14|||
30919061|NCT02196077|58954534|FG000|Overall Study|Physician Decision|1|||
30919062|NCT02196077|58954534|FG000|Overall Study|Lost to Follow-up|3|||
30919063|NCT02196077|58954534|FG000|Overall Study|Protocol Violation|24|||
30919064|NCT02195687|58954548|FG000|Overall Study|Personal Reasons|1|||
30919065|NCT02195687|58954549|FG001|Overall Study|Personal Reasons|1|||
30919066|NCT02195687|58954548|FG000|Overall Study|Lost to Follow-up|4|||
30919067|NCT02195687|58954549|FG001|Overall Study|Lost to Follow-up|1|||
30919068|NCT02195531|58954558|FG000|Overall Study|Withdrawal by Subject|1|||
30919069|NCT02195531|58954559|FG001|Overall Study|Withdrawal by Subject|1|||
30919070|NCT02195531|58954560|FG002|Overall Study|Withdrawal by Subject|1|||
30919071|NCT02252081|58954570|FG000|Overall Study|Withdrawal by Subject|2|||
30919072|NCT02252081|58954571|FG001|Overall Study|Withdrawal by Subject|1|||
30919073|NCT02252081|58954570|FG000|Overall Study|Adverse Event|4|||
30919074|NCT02252081|58954571|FG001|Overall Study|Adverse Event|1|||
30919075|NCT02252081|58954570|FG000|Overall Study|non compliance & others|0|||
30919076|NCT02252081|58954571|FG001|Overall Study|non compliance & others|2|||
30919077|NCT01623752|58954585|FG000|Phase 1 (78 Weeks)|No Data|249|||
30919078|NCT01623752|58954586|FG001|Phase 1 (78 Weeks)|No Data|66|||
30919079|NCT01623752|58954587|FG002|Phase 1 (78 Weeks)|No Data|2|||
30919080|NCT01623752|58954585|FG000|Phase 1 (78 Weeks)|Other|33|||
30919081|NCT01623752|58954586|FG001|Phase 1 (78 Weeks)|Other|20|||
30826609|NCT03032523|58848971|FG000|Overall Study|Withdrawal by Subject|2|||
30919082|NCT01623752|58954587|FG002|Phase 1 (78 Weeks)|Other|0|||
30919083|NCT01623752|58954585|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
30919084|NCT01623752|58954586|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
30919085|NCT01623752|58954587|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
30919086|NCT01623752|58954585|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
30919087|NCT01623752|58954586|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
30919088|NCT01623752|58954587|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
30919089|NCT01623752|58954585|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
30919090|NCT01623752|58954586|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
30919091|NCT01623752|58954587|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
30919092|NCT01623752|58954585|FG000|Phase 2 (78 Weeks)|Other|5|||
30919093|NCT01623752|58954586|FG001|Phase 2 (78 Weeks)|Other|1|||
30919094|NCT01623752|58954587|FG002|Phase 2 (78 Weeks)|Other|0|||
30919095|NCT01623752|58954585|FG000|Phase 2 (78 Weeks)|No Data|43|||
30919096|NCT01623752|58954586|FG001|Phase 2 (78 Weeks)|No Data|11|||
30919097|NCT01623752|58954587|FG002|Phase 2 (78 Weeks)|No Data|0|||
30919098|NCT01623752|58954585|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
30919099|NCT01623752|58954586|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
30919100|NCT01623752|58954587|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
30919101|NCT01623596|58954598|FG000|Overall Study|Abnormal laboratory values|2|||
30919102|NCT01623596|58954599|FG001|Overall Study|Abnormal laboratory values|0|||
30919103|NCT01623596|58954598|FG000|Overall Study|Administrative problems|9|||
30919104|NCT01623596|58954599|FG001|Overall Study|Administrative problems|13|||
30919105|NCT01623596|58954598|FG000|Overall Study|Adverse Event|20|||
30919106|NCT01623596|58954599|FG001|Overall Study|Adverse Event|29|||
30919107|NCT01623596|58954598|FG000|Overall Study|Death|0|||
30919108|NCT01623596|58954599|FG001|Overall Study|Death|2|||
30919109|NCT01623596|58954598|FG000|Overall Study|Lost to Follow-up|12|||
30919110|NCT01623596|58954599|FG001|Overall Study|Lost to Follow-up|16|||
30919111|NCT01623596|58954598|FG000|Overall Study|Withdrawal by Subject|13|||
30919112|NCT01623596|58954599|FG001|Overall Study|Withdrawal by Subject|31|||
30919113|NCT01623596|58954598|FG000|Overall Study|Patient no longer requires study drug|1|||
30919114|NCT01623596|58954599|FG001|Overall Study|Patient no longer requires study drug|0|||
30919115|NCT01623596|58954598|FG000|Overall Study|Protocol Violation|0|||
30919116|NCT01623596|58954599|FG001|Overall Study|Protocol Violation|6|||
30919117|NCT01623596|58954598|FG000|Overall Study|Lack of Efficacy|5|||
30919118|NCT01623596|58954599|FG001|Overall Study|Lack of Efficacy|3|||
30919119|NCT02219477|58954610|FG000|Overall Study|Adverse Event|0|||
30919120|NCT02219477|58954611|FG001|Overall Study|Adverse Event|1|||
30826610|NCT03032523|58848972|FG001|Overall Study|Withdrawal by Subject|2|||
30826611|NCT03032523|58848971|FG000|Overall Study|Physician Decision|1|||
30826612|NCT03032523|58848972|FG001|Overall Study|Physician Decision|0|||
30826613|NCT03031899|58848979|FG000|Overall Study|Protocol Violation|1|||
30826614|NCT03031899|58848979|FG000|Overall Study|lesion disappeared after stopping habit|1|||
30826615|NCT03086369|58848992|FG000|Overall Study|Lost to Follow-up|1|||
30826616|NCT03086369|58848993|FG001|Overall Study|Lost to Follow-up|0|||
30826617|NCT03086369|58848994|FG002|Overall Study|Lost to Follow-up|0|||
30826618|NCT03086369|58848995|FG003|Overall Study|Lost to Follow-up|2|||
30826619|NCT03086369|58848996|FG004|Overall Study|Lost to Follow-up|1|||
30826620|NCT03086369|58848992|FG000|Overall Study|Physician Decision|0|||
30826621|NCT03086369|58848993|FG001|Overall Study|Physician Decision|0|||
30826622|NCT03086369|58848994|FG002|Overall Study|Physician Decision|0|||
30826623|NCT03086369|58848995|FG003|Overall Study|Physician Decision|1|||
30826624|NCT03086369|58848996|FG004|Overall Study|Physician Decision|2|||
30826625|NCT03086369|58848992|FG000|Overall Study|Withdrawal by Subject|0|||
30826626|NCT03086369|58848993|FG001|Overall Study|Withdrawal by Subject|0|||
30826627|NCT03086369|58848994|FG002|Overall Study|Withdrawal by Subject|0|||
30826628|NCT03086369|58848995|FG003|Overall Study|Withdrawal by Subject|5|||
30826629|NCT03086369|58848996|FG004|Overall Study|Withdrawal by Subject|3|||
30826630|NCT03086369|58848992|FG000|Overall Study|Progressive Disease|0|||
30826631|NCT03086369|58848993|FG001|Overall Study|Progressive Disease|0|||
30826632|NCT03086369|58848994|FG002|Overall Study|Progressive Disease|0|||
30919121|NCT02219477|58954612|FG002|Overall Study|Adverse Event|1|||
30919122|NCT02219477|58954610|FG000|Overall Study|Withdrawal by Subject|0|||
30919123|NCT02219477|58954611|FG001|Overall Study|Withdrawal by Subject|1|||
30919124|NCT02219477|58954612|FG002|Overall Study|Withdrawal by Subject|0|||
30919125|NCT02119286|58954624|FG000|Overall Study|Adverse Event|9|||
30919126|NCT02119286|58954625|FG001|Overall Study|Adverse Event|7|||
30919127|NCT02119286|58954626|FG002|Overall Study|Adverse Event|2|||
30919128|NCT02119286|58954624|FG000|Overall Study|Lack of Efficacy|11|||
30919129|NCT02119286|58954625|FG001|Overall Study|Lack of Efficacy|3|||
30919130|NCT02119286|58954626|FG002|Overall Study|Lack of Efficacy|4|||
30919131|NCT02119286|58954624|FG000|Overall Study|Lost to Follow-up|2|||
30826633|NCT03086369|58848995|FG003|Overall Study|Progressive Disease|1|||
30826634|NCT03086369|58848996|FG004|Overall Study|Progressive Disease|1|||
30826635|NCT00101582|58849012|FG000|Overall Study|Ineligibility determined|0|||
30826636|NCT00101582|58849013|FG001|Overall Study|Ineligibility determined|1|||
30919132|NCT02119286|58954625|FG001|Overall Study|Lost to Follow-up|0|||
30919133|NCT02119286|58954626|FG002|Overall Study|Lost to Follow-up|1|||
30919134|NCT02119286|58954624|FG000|Overall Study|Withdrawal by Subject|4|||
30919135|NCT02119286|58954625|FG001|Overall Study|Withdrawal by Subject|1|||
30919136|NCT02119286|58954626|FG002|Overall Study|Withdrawal by Subject|0|||
30919137|NCT02250443|58954634|FG000|Overall Study|Administrative problems|7|||
30919138|NCT02250443|58954634|FG000|Overall Study|Adverse Event|3|||
30919139|NCT02093390|58954640|FG000|Overall Study|Withdrawal by Subject|0|||
30919140|NCT02093390|58954641|FG001|Overall Study|Withdrawal by Subject|1|||
30919141|NCT02194985|58954648|FG000|Overall Study|Adverse Event|1|||
30919142|NCT02194985|58954648|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
30919143|NCT02194985|58954648|FG000|Overall Study|Physician Decision|4|||
30919144|NCT02194985|58954648|FG000|Overall Study|Lost to Follow-up|1|||
30919145|NCT02194985|58954648|FG000|Overall Study|Withdrawal by Subject|2|||
30919146|NCT02219087|58954654|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
30919147|NCT02219087|58954655|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
30919148|NCT02248961|58954663|FG000|Overall Study|Adverse Event|1|||
30919149|NCT02248961|58954664|FG001|Overall Study|Adverse Event|0|||
30919150|NCT02248961|58954663|FG000|Overall Study|Withdrawal by Subject|1|||
30919151|NCT02248961|58954664|FG001|Overall Study|Withdrawal by Subject|2|||
30919152|NCT02248961|58954663|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
30919153|NCT02248961|58954664|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
30919154|NCT02219009|58954672|FG000|Overall Study|Withdrawal by Subject|5|||
30919155|NCT02219009|58954673|FG001|Overall Study|Withdrawal by Subject|1|||
30919156|NCT02219009|58954672|FG000|Overall Study|Adverse Event|2|||
30919157|NCT02219009|58954673|FG001|Overall Study|Adverse Event|4|||
30919158|NCT02219009|58954672|FG000|Overall Study|Lost to Follow-up|2|||
30919159|NCT02219009|58954673|FG001|Overall Study|Lost to Follow-up|2|||
30919160|NCT02219009|58954672|FG000|Overall Study|Protocol deviation|1|||
30919161|NCT02219009|58954673|FG001|Overall Study|Protocol deviation|0|||
30919162|NCT02219009|58954672|FG000|Overall Study|Physician Decision|0|||
30919163|NCT02219009|58954673|FG001|Overall Study|Physician Decision|1|||
30919164|NCT02248649|58954681|FG000|Overall Study|Death|7|||
30919165|NCT02248649|58954682|FG001|Overall Study|Death|11|||
30919166|NCT02248649|58954681|FG000|Overall Study|Lost to Follow-up|14|||
30919167|NCT02248649|58954682|FG001|Overall Study|Lost to Follow-up|10|||
30919168|NCT02218541|58954690|FG000|Overall Study|Lost to Follow-up|2|||
30919169|NCT02218541|58954691|FG001|Overall Study|Lost to Follow-up|1|||
30919170|NCT02218541|58954690|FG000|Overall Study|Implant Failure|4|||
30919171|NCT02218541|58954691|FG001|Overall Study|Implant Failure|1|||
30919172|NCT02217527|58954700|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
30919173|NCT02217527|58954701|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
30919174|NCT02217527|58954700|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
30919175|NCT02217527|58954701|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
30919176|NCT01456936|58954711|FG000|Overall Study|Other reason|41|||
30919177|NCT01456936|58954712|FG001|Overall Study|Other reason|30|||
30919178|NCT01456936|58954713|FG002|Overall Study|Other reason|36|||
30919179|NCT01456936|58954714|FG003|Overall Study|Other reason|33|||
30919180|NCT01456936|58954711|FG000|Overall Study|No longer meets eligibility criteria|4|||
30919181|NCT01456936|58954712|FG001|Overall Study|No longer meets eligibility criteria|8|||
30826637|NCT00101582|58849012|FG000|Overall Study|Adverse Event|1|||
30826638|NCT00101582|58849013|FG001|Overall Study|Adverse Event|4|||
30826639|NCT00101582|58849012|FG000|Overall Study|Withdrawal by Subject|6|||
30826640|NCT00101582|58849013|FG001|Overall Study|Withdrawal by Subject|4|||
30826641|NCT00101582|58849012|FG000|Overall Study|Physician Decision|1|||
30826642|NCT00101582|58849013|FG001|Overall Study|Physician Decision|0|||
30826643|NCT00101582|58849012|FG000|Overall Study|Death|3|||
30826644|NCT00101582|58849013|FG001|Overall Study|Death|5|||
30826645|NCT00101582|58849012|FG000|Overall Study|Other|0|||
30826646|NCT00101582|58849013|FG001|Overall Study|Other|1|||
30826647|NCT03086135|58849044|FG000|Overall Study|Adverse Event|1|||
30826648|NCT03086135|58849044|FG000|Overall Study|Lost to Follow-up|2|||
30826649|NCT02762708|58849061|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
30826650|NCT02762708|58849062|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
30919182|NCT01456936|58954713|FG002|Overall Study|No longer meets eligibility criteria|6|||
30919183|NCT01456936|58954714|FG003|Overall Study|No longer meets eligibility criteria|5|||
30919184|NCT01456936|58954711|FG000|Overall Study|Protocol Violation|4|||
30919185|NCT01456936|58954712|FG001|Overall Study|Protocol Violation|2|||
30919186|NCT01456936|58954713|FG002|Overall Study|Protocol Violation|5|||
30919187|NCT01456936|58954714|FG003|Overall Study|Protocol Violation|5|||
30919188|NCT01456936|58954711|FG000|Overall Study|Pregnancy|1|||
30919189|NCT01456936|58954712|FG001|Overall Study|Pregnancy|0|||
30919190|NCT01456936|58954713|FG002|Overall Study|Pregnancy|0|||
30919191|NCT01456936|58954714|FG003|Overall Study|Pregnancy|1|||
30826651|NCT02762708|58849063|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
30826652|NCT02762708|58849064|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
30919192|NCT01456936|58954711|FG000|Overall Study|Insufficient clinical response|4|||
30919193|NCT01456936|58954712|FG001|Overall Study|Insufficient clinical response|4|||
30919194|NCT01456936|58954713|FG002|Overall Study|Insufficient clinical response|14|||
30919195|NCT01456936|58954714|FG003|Overall Study|Insufficient clinical response|13|||
30919196|NCT01456936|58954711|FG000|Overall Study|No longer willing to participate|195|||
30919197|NCT01456936|58954712|FG001|Overall Study|No longer willing to participate|218|||
30919198|NCT01456936|58954713|FG002|Overall Study|No longer willing to participate|224|||
30919199|NCT01456936|58954714|FG003|Overall Study|No longer willing to participate|248|||
30919200|NCT01456936|58954711|FG000|Overall Study|Lost to Follow-up|135|||
30919201|NCT01456936|58954712|FG001|Overall Study|Lost to Follow-up|126|||
30919202|NCT01456936|58954713|FG002|Overall Study|Lost to Follow-up|144|||
30919203|NCT01456936|58954714|FG003|Overall Study|Lost to Follow-up|127|||
30919204|NCT01456936|58954711|FG000|Overall Study|Medication error|0|||
30919205|NCT01456936|58954712|FG001|Overall Study|Medication error|1|||
30919206|NCT01456936|58954713|FG002|Overall Study|Medication error|0|||
30919207|NCT01456936|58954714|FG003|Overall Study|Medication error|1|||
30919208|NCT01456936|58954711|FG000|Overall Study|Adverse event (study drug)|25|||
30919209|NCT01456936|58954712|FG001|Overall Study|Adverse event (study drug)|21|||
30919210|NCT01456936|58954713|FG002|Overall Study|Adverse event (study drug)|26|||
30919211|NCT01456936|58954714|FG003|Overall Study|Adverse event (study drug)|17|||
30919212|NCT01456936|58954711|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
30919213|NCT01456936|58954712|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
30919214|NCT01456936|58954713|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
30919215|NCT01456936|58954714|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
30919216|NCT01456936|58954711|FG000|Overall Study|Death|0|||
30919217|NCT01456936|58954712|FG001|Overall Study|Death|3|||
30919218|NCT01456936|58954713|FG002|Overall Study|Death|1|||
30919219|NCT01456936|58954714|FG003|Overall Study|Death|3|||
30919220|NCT01456936|58954711|FG000|Overall Study|Randomized but not treated|21|||
30919221|NCT01456936|58954712|FG001|Overall Study|Randomized but not treated|28|||
30919222|NCT01456936|58954713|FG002|Overall Study|Randomized but not treated|16|||
30919223|NCT01456936|58954714|FG003|Overall Study|Randomized but not treated|21|||
30919224|NCT01456780|58954727|FG000|Overall Study|Lost to Follow-up|3|||
30919225|NCT01456780|58954728|FG001|Overall Study|Lost to Follow-up|3|||
30919226|NCT01456780|58954729|FG002|Overall Study|Lost to Follow-up|0|||
30919227|NCT01480258|58954739|FG000|Infant Series|Protocol Violation|2|||
30919228|NCT01480258|58954740|FG001|Infant Series|Protocol Violation|0|||
30919229|NCT01480258|58954739|FG000|Infant Series|Physician Decision|0|||
30919230|NCT01480258|58954740|FG001|Infant Series|Physician Decision|1|||
30919231|NCT01480258|58954739|FG000|Infant Series|Not Vaccinated|3|||
30919232|NCT01480258|58954740|FG001|Infant Series|Not Vaccinated|0|||
30919233|NCT01480258|58954739|FG000|Infant Series|Adverse Event|1|||
30919234|NCT01480258|58954740|FG001|Infant Series|Adverse Event|1|||
30919235|NCT01480258|58954739|FG000|Infant Series|Withdrawal by Subject|1|||
30919236|NCT01480258|58954740|FG001|Infant Series|Withdrawal by Subject|6|||
30919237|NCT01480258|58954739|FG000|Interim Period|Lost to Follow-up|0|||
30919238|NCT01480258|58954740|FG001|Interim Period|Lost to Follow-up|2|||
30826653|NCT02760602|58849076|FG000|Overall Study|Withdrawal by Subject|1|||
30826654|NCT02760602|58849077|FG001|Overall Study|Withdrawal by Subject|0|||
30826655|NCT02760602|58849076|FG000|Overall Study|Terminated by sponsor|12|||
30826656|NCT02760602|58849077|FG001|Overall Study|Terminated by sponsor|13|||
30826657|NCT03852719|58849086|FG000|Overall Study|Still on study|50|||
30826658|NCT03852719|58849087|FG001|Overall Study|Still on study|48|||
30826659|NCT03852719|58849088|FG002|Overall Study|Still on study|47|||
30826660|NCT03852719|58849086|FG000|Overall Study|Withdrawal of consent|0|||
30826661|NCT03852719|58849087|FG001|Overall Study|Withdrawal of consent|1|||
30826662|NCT03852719|58849088|FG002|Overall Study|Withdrawal of consent|2|||
30826663|NCT03852719|58849086|FG000|Overall Study|Physician Decision|0|||
30826664|NCT03852719|58849087|FG001|Overall Study|Physician Decision|0|||
30826665|NCT03852719|58849088|FG002|Overall Study|Physician Decision|1|||
30826666|NCT03852719|58849086|FG000|Overall Study|Pregnancy|1|||
30919239|NCT01480258|58954739|FG000|Interim Period|Physician Decision|1|||
30919240|NCT01480258|58954740|FG001|Interim Period|Physician Decision|0|||
30919241|NCT01480258|58954739|FG000|Interim Period|Protocol Violation|0|||
30919242|NCT01480258|58954740|FG001|Interim Period|Protocol Violation|1|||
30919243|NCT01480258|58954739|FG000|Interim Period|Withdrawal by Subject|9|||
30919244|NCT01480258|58954740|FG001|Interim Period|Withdrawal by Subject|6|||
30919245|NCT01479868|58954746|FG000|Overall Study|Adverse Event|1|||
30919246|NCT01479868|58954746|FG000|Overall Study|Lost to Follow-up|4|||
30919247|NCT01479868|58954746|FG000|Overall Study|Protocol Violation|1|||
30919248|NCT01479868|58954746|FG000|Overall Study|Withdrawal by Subject|1|||
30919249|NCT01479868|58954746|FG000|Overall Study|Sponsor's Decision|1|||
30919250|NCT01479868|58954746|FG000|Overall Study|Initiation of new HCV Therapy|1|||
30919251|NCT01478620|58954750|FG000|Overall Study|Lost to Follow-up|6|||
30826667|NCT03852719|58849087|FG001|Overall Study|Pregnancy|0|||
30826668|NCT03852719|58849088|FG002|Overall Study|Pregnancy|0|||
30919252|NCT01455220|58954754|FG000|Overall Study|screen fail|30|||
30919253|NCT01454830|58954763|FG000|Overall Study|Withdrawal by Subject|4|||
30919254|NCT01454830|58954764|FG001|Overall Study|Withdrawal by Subject|4|||
30919255|NCT01454830|58954763|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
30919256|NCT01454830|58954764|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
30919257|NCT01454830|58954763|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
30919258|NCT01454830|58954764|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
30919259|NCT01454830|58954763|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
30919260|NCT01454830|58954764|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
30919261|NCT01454830|58954763|FG000|Overall Study|Withdrawal - no polysomnography|3|||
30919262|NCT01454830|58954764|FG001|Overall Study|Withdrawal - no polysomnography|2|||
30753971|NCT00253370|58763593|FG000|Overall Study|Non-protocol therapy|1|||
30753972|NCT00253370|58763593|FG000|Overall Study|Physician Decision|1|||
30753973|NCT00253370|58763593|FG000|Overall Study|Protocol Violation|1|||
30753974|NCT00253370|58763593|FG000|Overall Study|Abdominal pain due to disease|1|||
30753975|NCT00140426|58763600|FG000|Overall Study|Withdrawal by Subject|0|||
30753976|NCT00140426|58763601|FG001|Overall Study|Withdrawal by Subject|3|||
30753977|NCT00121134|58763616|FG000|Overall Study|Progression of Disease|5|||
30753978|NCT00121134|58763617|FG001|Overall Study|Progression of Disease|3|||
30753979|NCT00121134|58763618|FG002|Overall Study|Progression of Disease|4|||
30753980|NCT00121134|58763619|FG003|Overall Study|Progression of Disease|2|||
30753981|NCT00121134|58763616|FG000|Overall Study|Toxicity|4|||
30753982|NCT00121134|58763617|FG001|Overall Study|Toxicity|7|||
30753983|NCT00121134|58763618|FG002|Overall Study|Toxicity|13|||
30753984|NCT00121134|58763619|FG003|Overall Study|Toxicity|5|||
30753985|NCT00121134|58763616|FG000|Overall Study|Physician Decision|6|||
30826669|NCT00210249|58849096|FG000|Overall Study|Lost to Follow-up|5|||
30826670|NCT00210249|58849096|FG000|Overall Study|Protocol Violation|11|||
30826671|NCT03086057|58849104|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
30826672|NCT03086057|58849105|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
30826673|NCT03086057|58849106|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
30826674|NCT03086057|58849107|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
30826675|NCT03086057|58849104|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
30826676|NCT03086057|58849105|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
30826677|NCT03086057|58849106|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
30826678|NCT03086057|58849107|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
30826679|NCT03086057|58849104|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
30826680|NCT03086057|58849105|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
30826681|NCT03086057|58849106|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
30826682|NCT03086057|58849107|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
30826683|NCT03086057|58849104|FG000|Stage 1: PrEP Uptake|Death|1|||
30826684|NCT03086057|58849105|FG001|Stage 1: PrEP Uptake|Death|0|||
30826685|NCT03086057|58849106|FG002|Stage 1: PrEP Uptake|Death|0|||
30826686|NCT03086057|58849107|FG003|Stage 1: PrEP Uptake|Death|0|||
30826687|NCT03086057|58849104|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
30826688|NCT03086057|58849105|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
30826689|NCT03086057|58849106|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
30826690|NCT03086057|58849107|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
30826691|NCT03086057|58849104|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
30826692|NCT03086057|58849105|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
30826693|NCT03086057|58849106|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
30826694|NCT03086057|58849107|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
30826695|NCT03086057|58849104|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
30826696|NCT03086057|58849105|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
30826697|NCT03086057|58849106|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
30826698|NCT03086057|58849107|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
30826699|NCT02759120|58849119|FG000|Overall Study|Death|34|||
30826700|NCT02759120|58849120|FG001|Overall Study|Death|36|||
30826701|NCT02759120|58849119|FG000|Overall Study|Lost to Follow-up|4|||
30826702|NCT02759120|58849120|FG001|Overall Study|Lost to Follow-up|7|||
30826703|NCT02759120|58849119|FG000|Overall Study|Physician Decision|3|||
30826704|NCT02759120|58849120|FG001|Overall Study|Physician Decision|0|||
30826705|NCT02759120|58849119|FG000|Overall Study|Withdrawal by Subject|28|||
30826706|NCT02759120|58849120|FG001|Overall Study|Withdrawal by Subject|15|||
30919263|NCT01454596|58954782|FG000|Overall Study|Death|0|||
30919264|NCT01454596|58954783|FG001|Overall Study|Death|0|||
30753986|NCT00121134|58763617|FG001|Overall Study|Physician Decision|4|||
30753987|NCT00121134|58763618|FG002|Overall Study|Physician Decision|4|||
30753988|NCT00121134|58763619|FG003|Overall Study|Physician Decision|1|||
30826707|NCT02759120|58849119|FG000|Overall Study|Moved out of area|3|||
30826708|NCT02759120|58849120|FG001|Overall Study|Moved out of area|4|||
30826709|NCT02759120|58849119|FG000|Overall Study|Lung transplant|3|||
30826710|NCT02759120|58849120|FG001|Overall Study|Lung transplant|5|||
30826711|NCT02759120|58849119|FG000|Overall Study|Other reason not completed|10|||
30826712|NCT02759120|58849120|FG001|Overall Study|Other reason not completed|12|||
30826713|NCT00101192|58849126|FG000|Overall Study|Ineligible|6|||
30826714|NCT00101192|58849126|FG000|Overall Study|Inevaluable|1|||
30919265|NCT01454596|58954784|FG002|Overall Study|Death|0|||
30919266|NCT01454596|58954785|FG003|Overall Study|Death|0|||
30919267|NCT01454596|58954786|FG004|Overall Study|Death|0|||
30919268|NCT01454596|58954787|FG005|Overall Study|Death|0|||
30919269|NCT01454596|58954788|FG006|Overall Study|Death|0|||
30919270|NCT01454596|58954789|FG007|Overall Study|Death|0|||
30919271|NCT01454596|58954790|FG008|Overall Study|Death|0|||
30919272|NCT01454596|58954791|FG009|Overall Study|Death|1|||
30919273|NCT01454596|58954792|FG010|Overall Study|Death|1|||
30919274|NCT01454596|58954793|FG011|Overall Study|Death|0|||
30919275|NCT02247479|58954822|FG000|Overall Study|Adverse Event|8|||
30919276|NCT02247479|58954823|FG001|Overall Study|Adverse Event|9|||
30919277|NCT02247479|58954824|FG002|Overall Study|Adverse Event|8|||
30919278|NCT02247479|58954822|FG000|Overall Study|Death|5|||
30919279|NCT02247479|58954823|FG001|Overall Study|Death|4|||
30919280|NCT02247479|58954824|FG002|Overall Study|Death|6|||
30919281|NCT02247479|58954822|FG000|Overall Study|Lost to Follow-up|3|||
30919282|NCT02247479|58954823|FG001|Overall Study|Lost to Follow-up|3|||
30919283|NCT02247479|58954824|FG002|Overall Study|Lost to Follow-up|1|||
30919284|NCT02247479|58954822|FG000|Overall Study|Non-compliance|0|||
30919285|NCT02247479|58954823|FG001|Overall Study|Non-compliance|0|||
30919286|NCT02247479|58954824|FG002|Overall Study|Non-compliance|1|||
30919287|NCT02247479|58954822|FG000|Overall Study|Withdrawal by Subject|25|||
30919288|NCT02247479|58954823|FG001|Overall Study|Withdrawal by Subject|29|||
30919289|NCT02247479|58954824|FG002|Overall Study|Withdrawal by Subject|24|||
30826715|NCT03031431|58849130|FG000|Overall Study|Infant removed by maternal request|1|||
30826716|NCT03029247|58849136|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
30826717|NCT03029247|58849137|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
30919290|NCT02247479|58954822|FG000|Overall Study|Study Terminated by Sponsor|98|||
30919291|NCT02247479|58954823|FG001|Overall Study|Study Terminated by Sponsor|88|||
30919292|NCT02247479|58954824|FG002|Overall Study|Study Terminated by Sponsor|94|||
30919293|NCT02247479|58954822|FG000|Overall Study|Physician Decision|1|||
30919294|NCT02247479|58954823|FG001|Overall Study|Physician Decision|0|||
30919295|NCT02247479|58954824|FG002|Overall Study|Physician Decision|2|||
30919296|NCT02247479|58954822|FG000|Overall Study|Unspecified Reason|2|||
30919297|NCT02247479|58954823|FG001|Overall Study|Unspecified Reason|5|||
30919298|NCT02247479|58954824|FG002|Overall Study|Unspecified Reason|2|||
30919299|NCT01454284|58954834|FG000|Overall Study|Adverse Event|20|||
30919300|NCT01454284|58954835|FG001|Overall Study|Adverse Event|7|||
30919301|NCT01454284|58954834|FG000|Overall Study|Death|0|||
30919302|NCT01454284|58954835|FG001|Overall Study|Death|3|||
30919303|NCT01454284|58954834|FG000|Overall Study|Lost to Follow-up|13|||
30919304|NCT01454284|58954835|FG001|Overall Study|Lost to Follow-up|8|||
30919305|NCT01454284|58954834|FG000|Overall Study|Protocol Violation|9|||
30919306|NCT01454284|58954835|FG001|Overall Study|Protocol Violation|6|||
30919307|NCT01454284|58954834|FG000|Overall Study|Withdrawal by Subject|58|||
30919308|NCT01454284|58954835|FG001|Overall Study|Withdrawal by Subject|36|||
30919309|NCT01454284|58954834|FG000|Overall Study|Physician Decision|16|||
30919310|NCT01454284|58954835|FG001|Overall Study|Physician Decision|11|||
30919311|NCT01454284|58954834|FG000|Overall Study|Sponsor Decision|0|||
30919312|NCT01454284|58954835|FG001|Overall Study|Sponsor Decision|2|||
30919313|NCT02247401|58954844|FG000|Overall Study|Adverse Event|1|||
30919314|NCT02247401|58954845|FG001|Overall Study|Adverse Event|0|||
30919315|NCT02247401|58954846|FG002|Overall Study|Adverse Event|0|||
30919316|NCT02247401|58954844|FG000|Overall Study|Withdrawal by Subject|4|||
30919317|NCT02247401|58954845|FG001|Overall Study|Withdrawal by Subject|1|||
30826718|NCT03029247|58849136|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
30826719|NCT03029247|58849137|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
30826720|NCT03029247|58849136|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
30826721|NCT03029247|58849137|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
30826722|NCT03029247|58849136|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
30826723|NCT03029247|58849137|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
30826724|NCT04313283|58849143|FG000|Overall Study|did not complete intervention|4|||
30826725|NCT02760368|58849150|FG000|Overall Study|Withdrawal by Subject|12|||
30919318|NCT02247401|58954846|FG002|Overall Study|Withdrawal by Subject|1|||
30919319|NCT02247401|58954844|FG000|Overall Study|Lost to Follow-up|1|||
30919320|NCT02247401|58954845|FG001|Overall Study|Lost to Follow-up|1|||
30919321|NCT02247401|58954846|FG002|Overall Study|Lost to Follow-up|1|||
30919322|NCT02247011|58954857|FG000|Overall Study|Poor quality of radiological results|125|||
30826726|NCT02760368|58849151|FG001|Overall Study|Withdrawal by Subject|8|||
30826727|NCT02760368|58849152|FG002|Overall Study|Withdrawal by Subject|9|||
30919323|NCT02246777|58954864|FG000|Overall Study|Adverse Event|2|||
30919324|NCT02246777|58954864|FG000|Overall Study|Change of residence|1|||
30919325|NCT01495702|58954875|FG000|Randomized Phase|Randomized But Not Treated|1|||
30919326|NCT01495702|58954876|FG001|Randomized Phase|Randomized But Not Treated|4|||
30919327|NCT01495702|58954875|FG000|Randomized Phase|Adverse Event|2|||
30919328|NCT01495702|58954876|FG001|Randomized Phase|Adverse Event|2|||
30919329|NCT01495702|58954875|FG000|Randomized Phase|Death|1|||
30753989|NCT00121134|58763616|FG000|Overall Study|Treatment Delay|1|||
30753990|NCT00121134|58763617|FG001|Overall Study|Treatment Delay|0|||
30753991|NCT00121134|58763618|FG002|Overall Study|Treatment Delay|0|||
30753992|NCT00121134|58763619|FG003|Overall Study|Treatment Delay|0|||
30753993|NCT00121134|58763616|FG000|Overall Study|Intercurrent Illness|0|||
30753994|NCT00121134|58763617|FG001|Overall Study|Intercurrent Illness|0|||
30753995|NCT00121134|58763618|FG002|Overall Study|Intercurrent Illness|0|||
30753996|NCT00121134|58763619|FG003|Overall Study|Intercurrent Illness|1|||
30753997|NCT00121134|58763616|FG000|Overall Study|Patient Personal Reasons|0|||
30753998|NCT00121134|58763617|FG001|Overall Study|Patient Personal Reasons|1|||
30753999|NCT00121134|58763618|FG002|Overall Study|Patient Personal Reasons|0|||
30754000|NCT00121134|58763619|FG003|Overall Study|Patient Personal Reasons|0|||
30754001|NCT02657434|58763631|FG000|Overall Study|On-Going in Study|77|||
30754002|NCT02657434|58763632|FG001|Overall Study|On-Going in Study|91|||
30754003|NCT02657434|58763631|FG000|Overall Study|Death|177|||
30754004|NCT02657434|58763632|FG001|Overall Study|Death|183|||
30754005|NCT02657434|58763631|FG000|Overall Study|Lost to Follow-up|2|||
30754006|NCT02657434|58763632|FG001|Overall Study|Lost to Follow-up|2|||
30754007|NCT02657434|58763631|FG000|Overall Study|Randomization by Error|2|||
30754008|NCT02657434|58763632|FG001|Overall Study|Randomization by Error|0|||
30754009|NCT02657434|58763631|FG000|Overall Study|Withdrawal by Subject|27|||
30754010|NCT02657434|58763632|FG001|Overall Study|Withdrawal by Subject|16|||
30754011|NCT02657434|58763631|FG000|Overall Study|Protocol Violation|1|||
30754012|NCT02657434|58763632|FG001|Overall Study|Protocol Violation|0|||
30754013|NCT00119262|58763641|FG000|Overall Study|Lack of Efficacy|0|||
30754014|NCT00119262|58763642|FG001|Overall Study|Lack of Efficacy|3|||
30754015|NCT00119262|58763641|FG000|Overall Study|Withdrawal by Subject|12|||
30754016|NCT00119262|58763642|FG001|Overall Study|Withdrawal by Subject|11|||
30754017|NCT00119262|58763641|FG000|Overall Study|Adverse Event|33|||
30826728|NCT02760368|58849150|FG000|Overall Study|Screen Failure|0|||
30826729|NCT02760368|58849151|FG001|Overall Study|Screen Failure|0|||
30826730|NCT02760368|58849152|FG002|Overall Study|Screen Failure|1|||
30826731|NCT02760368|58849150|FG000|Overall Study|Death|1|||
30826732|NCT02760368|58849151|FG001|Overall Study|Death|0|||
30826733|NCT02760368|58849152|FG002|Overall Study|Death|0|||
30826734|NCT02760368|58849150|FG000|Overall Study|Withdrawal by Sponsor|0|||
30826735|NCT02760368|58849151|FG001|Overall Study|Withdrawal by Sponsor|0|||
30826736|NCT02760368|58849152|FG002|Overall Study|Withdrawal by Sponsor|1|||
30826737|NCT02754440|58849164|FG000|Overall Study|Protocol Violation|3|||
30826738|NCT02754440|58849165|FG001|Overall Study|Protocol Violation|2|||
30826739|NCT02754440|58849166|FG002|Overall Study|Protocol Violation|2|||
30826740|NCT02754440|58849167|FG003|Overall Study|Protocol Violation|6|||
30826741|NCT02754440|58849164|FG000|Overall Study|Adverse Event|3|||
30826742|NCT02754440|58849165|FG001|Overall Study|Adverse Event|1|||
30826743|NCT02754440|58849166|FG002|Overall Study|Adverse Event|0|||
30826744|NCT02754440|58849167|FG003|Overall Study|Adverse Event|9|||
30826745|NCT02754440|58849164|FG000|Overall Study|Withdrawal by Subject|0|||
30826746|NCT02754440|58849165|FG001|Overall Study|Withdrawal by Subject|0|||
30826747|NCT02754440|58849166|FG002|Overall Study|Withdrawal by Subject|0|||
30826748|NCT02754440|58849167|FG003|Overall Study|Withdrawal by Subject|1|||
30826749|NCT02754440|58849164|FG000|Overall Study|Equipment failure|0|||
30826750|NCT02754440|58849165|FG001|Overall Study|Equipment failure|5|||
30826751|NCT02754440|58849166|FG002|Overall Study|Equipment failure|5|||
30826752|NCT02754440|58849167|FG003|Overall Study|Equipment failure|7|||
30826753|NCT02754440|58849164|FG000|Overall Study|Subject issues not resulting in AE|0|||
30826754|NCT02754440|58849165|FG001|Overall Study|Subject issues not resulting in AE|0|||
30826755|NCT02754440|58849166|FG002|Overall Study|Subject issues not resulting in AE|0|||
30826756|NCT02754440|58849167|FG003|Overall Study|Subject issues not resulting in AE|12|||
30826757|NCT02753816|58849179|FG000|Overall Study|Protocol Violation|0|||
30826758|NCT02753816|58849180|FG001|Overall Study|Protocol Violation|1|||
30826759|NCT02753816|58849181|FG002|Overall Study|Protocol Violation|0|||
30826760|NCT02752802|58849189|FG000|Overall Study|Contrast Volume Not Collected|1|||
30826761|NCT02752802|58849190|FG001|Overall Study|Contrast Volume Not Collected|0|||
30826762|NCT02756078|58849207|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
30826763|NCT02756078|58849208|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
30754018|NCT00119262|58763642|FG001|Overall Study|Adverse Event|35|||
30754019|NCT00119262|58763641|FG000|Overall Study|other disease|0|||
30754020|NCT00119262|58763642|FG001|Overall Study|other disease|2|||
30754021|NCT00119262|58763641|FG000|Overall Study|ineligble|1|||
30754022|NCT00119262|58763642|FG001|Overall Study|ineligble|2|||
30754023|NCT00119262|58763641|FG000|Overall Study|others|0|||
30754024|NCT00119262|58763642|FG001|Overall Study|others|5|||
30826764|NCT02756078|58849207|FG000|Period 1|Lost to Follow-up|0|||
30826765|NCT02756078|58849208|FG001|Period 1|Lost to Follow-up|2|||
30826766|NCT02756078|58849207|FG000|Period 1|Protocol Violation|0|||
30826767|NCT02756078|58849208|FG001|Period 1|Protocol Violation|1|||
30826768|NCT02756078|58849207|FG000|Period 1|Adverse Event|1|||
30826769|NCT02756078|58849208|FG001|Period 1|Adverse Event|10|||
30826770|NCT02756078|58849207|FG000|Period 1|Withdrawal by Subject|6|||
30826771|NCT02756078|58849208|FG001|Period 1|Withdrawal by Subject|6|||
30826772|NCT02756078|58849207|FG000|Period 1|Lens Discomfort|2|||
30919330|NCT01495702|58954876|FG001|Randomized Phase|Death|0|||
30919331|NCT01495702|58954875|FG000|Randomized Phase|Lack of Efficacy|2|||
30919332|NCT01495702|58954876|FG001|Randomized Phase|Lack of Efficacy|0|||
30919333|NCT01495702|58954875|FG000|Randomized Phase|Investigators Discretion|2|||
30919334|NCT01495702|58954876|FG001|Randomized Phase|Investigators Discretion|0|||
30919335|NCT01495702|58954875|FG000|Randomized Phase|Withdrew Consent|10|||
30919336|NCT01495702|58954876|FG001|Randomized Phase|Withdrew Consent|18|||
30919337|NCT01495702|58954875|FG000|Randomized Phase|Lost to Follow-up|4|||
30919338|NCT01495702|58954876|FG001|Randomized Phase|Lost to Follow-up|3|||
30919339|NCT01495702|58954875|FG000|Randomized Phase|Participant Noncompliance|1|||
30919340|NCT01495702|58954876|FG001|Randomized Phase|Participant Noncompliance|0|||
30919341|NCT01495702|58954875|FG000|Randomized Phase|Protocol Violation|3|||
30919342|NCT01495702|58954876|FG001|Randomized Phase|Protocol Violation|1|||
30919343|NCT01630889|58954883|FG000|Overall Study|Death|2|||
30919344|NCT01630889|58954883|FG000|Overall Study|Withdrawal by Subject|1|||
30919345|NCT01630889|58954883|FG000|Overall Study|Other than Specified|2|||
30919346|NCT01630889|58954883|FG000|Overall Study|Lost to Follow-up|4|||
30919347|NCT01630889|58954883|FG000|Overall Study|Other|1|||
30919348|NCT01495000|58954889|FG000|Overall Study|Lost to Follow-up|2|||
30919349|NCT01495000|58954890|FG001|Overall Study|Lost to Follow-up|2|||
30919350|NCT01495000|58954889|FG000|Overall Study|Protocol Violation|1|||
30919351|NCT01495000|58954890|FG001|Overall Study|Protocol Violation|0|||
30919352|NCT01495000|58954889|FG000|Overall Study|Withdrawal by Subject|10|||
30919353|NCT01495000|58954890|FG001|Overall Study|Withdrawal by Subject|10|||
30919354|NCT01494922|58954896|FG000|Overall Study|Adverse Event|1|||
30919355|NCT02192099|58954900|FG000|Overall Study|Adverse Event|1|||
30919356|NCT02192099|58954900|FG000|Overall Study|Lost to Follow-up|2|||
30919357|NCT02192099|58954900|FG000|Overall Study|Physician Decision|1|||
30919358|NCT02192099|58954900|FG000|Overall Study|Pregnancy|1|||
30919359|NCT02192099|58954900|FG000|Overall Study|Protocol Violation|8|||
30919360|NCT02192099|58954900|FG000|Overall Study|Study Terminated by Sponsor|32|||
30919361|NCT02192099|58954900|FG000|Overall Study|Withdrawal by Subject|11|||
30919362|NCT02192099|58954900|FG000|Overall Study|Miscellaneous Reasons|5|||
30919363|NCT01494610|58954904|FG000|Period 1|Withdrawal by Subject|1|||
30919364|NCT01494610|58954905|FG001|Period 1|Withdrawal by Subject|1|||
30919365|NCT01494610|58954904|FG000|Period 3|Adverse Event|1|||
30919366|NCT01494610|58954905|FG001|Period 3|Adverse Event|0|||
30919367|NCT01494610|58954904|FG000|Period 3|Withdrawal by Subject|1|||
30919368|NCT01494610|58954905|FG001|Period 3|Withdrawal by Subject|0|||
30919369|NCT01494610|58954904|FG000|Period 4|Protocol Violation|1|||
30919370|NCT01494610|58954905|FG001|Period 4|Protocol Violation|0|||
30919371|NCT02116777|58954924|FG000|Overall Study|Adverse Event|0|||
30919372|NCT02116777|58954925|FG001|Overall Study|Adverse Event|0|||
30919373|NCT02116777|58954926|FG002|Overall Study|Adverse Event|0|||
30919374|NCT02116777|58954927|FG003|Overall Study|Adverse Event|0|||
30919375|NCT02116777|58954928|FG004|Overall Study|Adverse Event|2|||
30919376|NCT02116777|58954929|FG005|Overall Study|Adverse Event|2|||
30919377|NCT02116777|58954930|FG006|Overall Study|Adverse Event|0|||
30919378|NCT02116777|58954924|FG000|Overall Study|Death|0|||
30919379|NCT02116777|58954925|FG001|Overall Study|Death|0|||
30919380|NCT02116777|58954926|FG002|Overall Study|Death|0|||
30919381|NCT02116777|58954927|FG003|Overall Study|Death|1|||
30919382|NCT02116777|58954928|FG004|Overall Study|Death|0|||
30919383|NCT02116777|58954929|FG005|Overall Study|Death|0|||
30919384|NCT02116777|58954930|FG006|Overall Study|Death|0|||
30919385|NCT02116777|58954924|FG000|Overall Study|Lack of Efficacy|3|||
30623317|NCT01121484|58635153|FG001|Overall Study|Physician Decision|3|||
30623318|NCT01121484|58635152|FG000|Overall Study|Protocol Violation|1|||
30623319|NCT01121484|58635153|FG001|Overall Study|Protocol Violation|0|||
30623320|NCT01121484|58635152|FG000|Overall Study|Withdrawal by Subject|8|||
30623321|NCT01121484|58635153|FG001|Overall Study|Withdrawal by Subject|7|||
30754025|NCT03703882|58763650|FG000|Overall Study|Adverse Event|1|||
30754026|NCT03703882|58763651|FG001|Overall Study|Adverse Event|0|||
30623322|NCT01121484|58635152|FG000|Overall Study|Discontinuation of study by sponsor|0|||
30623323|NCT01121484|58635153|FG001|Overall Study|Discontinuation of study by sponsor|1|||
30623324|NCT01121484|58635152|FG000|Overall Study|Other|3|||
30754027|NCT03703882|58763650|FG000|Overall Study|Lost to Follow-up|0|||
30754028|NCT03703882|58763651|FG001|Overall Study|Lost to Follow-up|2|||
30754029|NCT03703882|58763650|FG000|Overall Study|Non-compliance with study drug|0|||
30754030|NCT03703882|58763651|FG001|Overall Study|Non-compliance with study drug|1|||
30754031|NCT03703882|58763650|FG000|Overall Study|Physician Decision|0|||
30754032|NCT03703882|58763651|FG001|Overall Study|Physician Decision|1|||
30919386|NCT02116777|58954925|FG001|Overall Study|Lack of Efficacy|3|||
30919387|NCT02116777|58954926|FG002|Overall Study|Lack of Efficacy|3|||
30826773|NCT02756078|58849208|FG001|Period 1|Lens Discomfort|2|||
30919388|NCT02116777|58954927|FG003|Overall Study|Lack of Efficacy|8|||
30919389|NCT02116777|58954928|FG004|Overall Study|Lack of Efficacy|4|||
30919390|NCT02116777|58954929|FG005|Overall Study|Lack of Efficacy|1|||
30919391|NCT02116777|58954930|FG006|Overall Study|Lack of Efficacy|9|||
30919392|NCT02116777|58954924|FG000|Overall Study|Physician Decision|0|||
30919393|NCT02116777|58954925|FG001|Overall Study|Physician Decision|0|||
30919394|NCT02116777|58954926|FG002|Overall Study|Physician Decision|0|||
30919395|NCT02116777|58954927|FG003|Overall Study|Physician Decision|2|||
30919396|NCT02116777|58954928|FG004|Overall Study|Physician Decision|0|||
30919397|NCT02116777|58954929|FG005|Overall Study|Physician Decision|0|||
30919398|NCT02116777|58954930|FG006|Overall Study|Physician Decision|0|||
30919399|NCT02116777|58954924|FG000|Overall Study|Protocol Violation|0|||
30919400|NCT02116777|58954925|FG001|Overall Study|Protocol Violation|0|||
30919401|NCT02116777|58954926|FG002|Overall Study|Protocol Violation|0|||
30919402|NCT02116777|58954927|FG003|Overall Study|Protocol Violation|1|||
30919403|NCT02116777|58954928|FG004|Overall Study|Protocol Violation|0|||
30919404|NCT02116777|58954929|FG005|Overall Study|Protocol Violation|0|||
30919405|NCT02116777|58954930|FG006|Overall Study|Protocol Violation|0|||
30919406|NCT02116777|58954924|FG000|Overall Study|Withdrawal by Subject|0|||
30919407|NCT02116777|58954925|FG001|Overall Study|Withdrawal by Subject|0|||
30919408|NCT02116777|58954926|FG002|Overall Study|Withdrawal by Subject|0|||
30919409|NCT02116777|58954927|FG003|Overall Study|Withdrawal by Subject|1|||
30919410|NCT02116777|58954928|FG004|Overall Study|Withdrawal by Subject|0|||
30919411|NCT02116777|58954929|FG005|Overall Study|Withdrawal by Subject|0|||
30919412|NCT02116777|58954930|FG006|Overall Study|Withdrawal by Subject|0|||
30919413|NCT01494532|58954955|FG000|Overall Study|Adverse Event|4|||
30919414|NCT01494532|58954956|FG001|Overall Study|Adverse Event|1|||
30919415|NCT01494532|58954957|FG002|Overall Study|Adverse Event|8|||
30919416|NCT01494532|58954958|FG003|Overall Study|Adverse Event|6|||
30919417|NCT01494532|58954959|FG004|Overall Study|Adverse Event|5|||
30919418|NCT01494532|58954960|FG005|Overall Study|Adverse Event|0|||
30826774|NCT02756078|58849207|FG000|Period 2|Adverse Event|3|||
30826775|NCT02756078|58849208|FG001|Period 2|Adverse Event|5|||
30919419|NCT01494532|58954955|FG000|Overall Study|Lack of Efficacy|0|||
30919420|NCT01494532|58954956|FG001|Overall Study|Lack of Efficacy|0|||
30919421|NCT01494532|58954957|FG002|Overall Study|Lack of Efficacy|0|||
30826776|NCT02756078|58849207|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
30826777|NCT02756078|58849208|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
30826778|NCT02756078|58849207|FG000|Period 2|Withdrawal by Subject|3|||
30826779|NCT02756078|58849208|FG001|Period 2|Withdrawal by Subject|1|||
30919422|NCT01494532|58954958|FG003|Overall Study|Lack of Efficacy|0|||
30919423|NCT01494532|58954959|FG004|Overall Study|Lack of Efficacy|2|||
30826780|NCT03813147|58849216|FG000|Overall Study|Lack of Efficacy|4|||
30826781|NCT03813147|58849217|FG001|Overall Study|Lack of Efficacy|4|||
30826782|NCT03813147|58849216|FG000|Overall Study|Physician Decision|2|||
30826783|NCT03813147|58849217|FG001|Overall Study|Physician Decision|1|||
30826784|NCT02752958|58849223|FG000|Overall Study|Adverse Event|3|||
30826785|NCT02752958|58849223|FG000|Overall Study|Lost to Follow-up|1|||
30826786|NCT02752958|58849223|FG000|Overall Study|Protocol Violation|1|||
30826787|NCT02752958|58849223|FG000|Overall Study|Withdrawal by Subject|2|||
30826788|NCT02752958|58849223|FG000|Overall Study|Other (Reason not specified)|2|||
30826789|NCT02805660|58849236|FG000|Overall Study|Death|5|||
30826790|NCT02805660|58849237|FG001|Overall Study|Death|2|||
30826791|NCT02805660|58849238|FG002|Overall Study|Death|9|||
30826792|NCT02805660|58849239|FG003|Overall Study|Death|5|||
30826793|NCT02805660|58849240|FG004|Overall Study|Death|0|||
30826794|NCT02805660|58849241|FG005|Overall Study|Death|14|||
30826795|NCT02805660|58849242|FG006|Overall Study|Death|12|||
30826796|NCT02805660|58849236|FG000|Overall Study|Lost to Follow-up|0|||
30826797|NCT02805660|58849237|FG001|Overall Study|Lost to Follow-up|1|||
30826798|NCT02805660|58849238|FG002|Overall Study|Lost to Follow-up|1|||
30826799|NCT02805660|58849239|FG003|Overall Study|Lost to Follow-up|2|||
30826800|NCT02805660|58849240|FG004|Overall Study|Lost to Follow-up|0|||
30826801|NCT02805660|58849241|FG005|Overall Study|Lost to Follow-up|0|||
30826802|NCT02805660|58849242|FG006|Overall Study|Lost to Follow-up|0|||
30826803|NCT02805660|58849236|FG000|Overall Study|Withdrawal by Subject|0|||
30919424|NCT01494532|58954960|FG005|Overall Study|Lack of Efficacy|0|||
30919425|NCT01494532|58954955|FG000|Overall Study|Protocol deviation|2|||
30919426|NCT01494532|58954956|FG001|Overall Study|Protocol deviation|1|||
30919427|NCT01494532|58954957|FG002|Overall Study|Protocol deviation|3|||
30826804|NCT02805660|58849237|FG001|Overall Study|Withdrawal by Subject|0|||
30826805|NCT02805660|58849238|FG002|Overall Study|Withdrawal by Subject|0|||
30826806|NCT02805660|58849239|FG003|Overall Study|Withdrawal by Subject|3|||
30826807|NCT02805660|58849240|FG004|Overall Study|Withdrawal by Subject|1|||
30826808|NCT02805660|58849241|FG005|Overall Study|Withdrawal by Subject|0|||
30826809|NCT02805660|58849242|FG006|Overall Study|Withdrawal by Subject|2|||
30826810|NCT02805660|58849236|FG000|Overall Study|Study terminated by Sponsor|0|||
30919428|NCT01494532|58954958|FG003|Overall Study|Protocol deviation|2|||
30919429|NCT01494532|58954959|FG004|Overall Study|Protocol deviation|3|||
30826811|NCT02805660|58849237|FG001|Overall Study|Study terminated by Sponsor|0|||
30826812|NCT02805660|58849238|FG002|Overall Study|Study terminated by Sponsor|1|||
30919430|NCT01494532|58954960|FG005|Overall Study|Protocol deviation|0|||
30919431|NCT01494532|58954955|FG000|Overall Study|Protocol-defined stopping criteria|0|||
30919432|NCT01494532|58954956|FG001|Overall Study|Protocol-defined stopping criteria|0|||
30919433|NCT01494532|58954957|FG002|Overall Study|Protocol-defined stopping criteria|1|||
30919434|NCT01494532|58954958|FG003|Overall Study|Protocol-defined stopping criteria|0|||
30919435|NCT01494532|58954959|FG004|Overall Study|Protocol-defined stopping criteria|0|||
30919436|NCT01494532|58954960|FG005|Overall Study|Protocol-defined stopping criteria|0|||
30919437|NCT01494532|58954955|FG000|Overall Study|Lost to Follow-up|1|||
30919438|NCT01494532|58954956|FG001|Overall Study|Lost to Follow-up|0|||
30919439|NCT01494532|58954957|FG002|Overall Study|Lost to Follow-up|0|||
30919440|NCT01494532|58954958|FG003|Overall Study|Lost to Follow-up|2|||
30919441|NCT01494532|58954959|FG004|Overall Study|Lost to Follow-up|0|||
30919442|NCT01494532|58954960|FG005|Overall Study|Lost to Follow-up|0|||
30919443|NCT01494532|58954955|FG000|Overall Study|Physician Decision|0|||
30919444|NCT01494532|58954956|FG001|Overall Study|Physician Decision|1|||
30919445|NCT01494532|58954957|FG002|Overall Study|Physician Decision|1|||
30919446|NCT01494532|58954958|FG003|Overall Study|Physician Decision|2|||
30919447|NCT01494532|58954959|FG004|Overall Study|Physician Decision|0|||
30919448|NCT01494532|58954960|FG005|Overall Study|Physician Decision|0|||
30919449|NCT01494532|58954955|FG000|Overall Study|Withdrawal by Subject|3|||
30919450|NCT01494532|58954956|FG001|Overall Study|Withdrawal by Subject|1|||
30919451|NCT01494532|58954957|FG002|Overall Study|Withdrawal by Subject|4|||
30919452|NCT01494532|58954958|FG003|Overall Study|Withdrawal by Subject|3|||
30919453|NCT01494532|58954959|FG004|Overall Study|Withdrawal by Subject|2|||
30919454|NCT01494532|58954960|FG005|Overall Study|Withdrawal by Subject|0|||
30919455|NCT02191397|58954977|FG000|Overall Study|Adverse Event|28|||
30919456|NCT02191397|58954978|FG001|Overall Study|Adverse Event|17|||
30919457|NCT02191397|58954977|FG000|Overall Study|Lack of Efficacy|10|||
30919458|NCT02191397|58954978|FG001|Overall Study|Lack of Efficacy|5|||
30919459|NCT02191397|58954977|FG000|Overall Study|Protocol Violation|0|||
30919460|NCT02191397|58954978|FG001|Overall Study|Protocol Violation|3|||
30919461|NCT02191397|58954977|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
30919462|NCT02191397|58954978|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
30919463|NCT02191397|58954977|FG000|Overall Study|Lost to Follow-up|10|||
30919464|NCT02191397|58954978|FG001|Overall Study|Lost to Follow-up|11|||
30919465|NCT02191397|58954977|FG000|Overall Study|Physician Decision|8|||
30919466|NCT02191397|58954978|FG001|Overall Study|Physician Decision|3|||
30919467|NCT02191397|58954977|FG000|Overall Study|Withdrawal by Subject|22|||
30919468|NCT02191397|58954978|FG001|Overall Study|Withdrawal by Subject|27|||
30919469|NCT01630811|58954984|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
30919470|NCT01630811|58954985|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
30919471|NCT01494298|58954995|FG000|Overall Study|Protocol Violation|2|||
30919472|NCT01494298|58954996|FG001|Overall Study|Protocol Violation|8|||
30919473|NCT02170025|58955006|FG000|Overall Study|Adverse Event|2|||
30919474|NCT02170025|58955007|FG001|Overall Study|Adverse Event|0|||
30919475|NCT02169791|58955013|FG000|Overall Study|Death|6|||
30919476|NCT02169791|58955013|FG000|Overall Study|patient withdrew consent|1|||
30919477|NCT02216591|58955019|FG000|Overall Study|Lost to Follow-up|0|||
30919478|NCT02216591|58955020|FG001|Overall Study|Lost to Follow-up|1|||
30919479|NCT02216357|58955028|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
30919480|NCT02216357|58955029|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
30919481|NCT01492426|58955037|FG000|Treatment|Death|0|||
30919482|NCT01492426|58955038|FG001|Treatment|Death|1|||
30919483|NCT01492426|58955037|FG000|Treatment|Other|1|||
30919484|NCT01492426|58955038|FG001|Treatment|Other|0|||
30919485|NCT01492426|58955037|FG000|Treatment|Adverse Event|25|||
30919486|NCT01492426|58955038|FG001|Treatment|Adverse Event|25|||
30919487|NCT01492426|58955037|FG000|Treatment|Lack of Efficacy|38|||
30919488|NCT01492426|58955038|FG001|Treatment|Lack of Efficacy|5|||
30919489|NCT01492426|58955037|FG000|Treatment|Participant withdrew consent|1|||
30919490|NCT01492426|58955038|FG001|Treatment|Participant withdrew consent|2|||
30919491|NCT01492426|58955037|FG000|Treatment|Poor compliance/noncompliance|1|||
30919492|NCT01492426|58955038|FG001|Treatment|Poor compliance/noncompliance|0|||
30919493|NCT01492426|58955037|FG000|Treatment|Subject requested discontinue study drug|7|||
30919494|NCT01492426|58955038|FG001|Treatment|Subject requested discontinue study drug|3|||
30919495|NCT01492426|58955037|FG000|Treatment|Lost to Follow-up|9|||
30919496|NCT01492426|58955038|FG001|Treatment|Lost to Follow-up|4|||
30919497|NCT01492426|58955037|FG000|Treatment|Participant does not meet study criteria|1|||
30919498|NCT01492426|58955038|FG001|Treatment|Participant does not meet study criteria|0|||
30919499|NCT01492426|58955037|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
30919500|NCT01492426|58955038|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
30919501|NCT01492426|58955037|FG000|Follow-Up|Death|1|||
30919502|NCT01492426|58955038|FG001|Follow-Up|Death|0|||
30919503|NCT01492426|58955037|FG000|Follow-Up|Other|4|||
30919504|NCT01492426|58955038|FG001|Follow-Up|Other|2|||
30919505|NCT01492426|58955037|FG000|Follow-Up|Participant Withdrew Consent|6|||
30919506|NCT01492426|58955038|FG001|Follow-Up|Participant Withdrew Consent|1|||
30919507|NCT01492426|58955037|FG000|Follow-Up|Lost to Follow-up|12|||
30919508|NCT01492426|58955038|FG001|Follow-Up|Lost to Follow-up|6|||
30919509|NCT01453348|58955051|FG000|Overall Study|Death|0|||
30919510|NCT01453348|58955052|FG001|Overall Study|Death|0|||
30919511|NCT01453348|58955053|FG002|Overall Study|Death|1|||
30919512|NCT01453348|58955051|FG000|Overall Study|Withdrawal by Subject|0|||
30919513|NCT01453348|58955052|FG001|Overall Study|Withdrawal by Subject|1|||
30919514|NCT01453348|58955053|FG002|Overall Study|Withdrawal by Subject|0|||
30919515|NCT01453348|58955051|FG000|Overall Study|Protocol Violation|1|||
30919516|NCT01453348|58955052|FG001|Overall Study|Protocol Violation|0|||
30919517|NCT01453348|58955053|FG002|Overall Study|Protocol Violation|0|||
30919518|NCT01453036|58955067|FG000|Overall Study|Lost to Follow-up|26|||
30919519|NCT01453036|58955068|FG001|Overall Study|Lost to Follow-up|115|||
30919520|NCT01453036|58955069|FG002|Overall Study|Lost to Follow-up|31|||
30919521|NCT01475734|58955079|FG000|Overall Study|Withdrawal by Subject|1|||
30919522|NCT01475734|58955080|FG001|Overall Study|Withdrawal by Subject|0|||
30919523|NCT01475734|58955079|FG000|Overall Study|Protocol Violation|1|||
30919524|NCT01475734|58955080|FG001|Overall Study|Protocol Violation|0|||
30919525|NCT01475734|58955079|FG000|Overall Study|Physician Decision|0|||
30919526|NCT01475734|58955080|FG001|Overall Study|Physician Decision|1|||
30919527|NCT01452412|58955088|FG000|Overall Study|Withdrawal by Subject|15|||
30919528|NCT01452412|58955089|FG001|Overall Study|Withdrawal by Subject|11|||
30919529|NCT01452412|58955088|FG000|Overall Study|Adverse Event|4|||
30919530|NCT01452412|58955089|FG001|Overall Study|Adverse Event|3|||
30919531|NCT01452412|58955088|FG000|Overall Study|Lost to Follow-up|5|||
30919532|NCT01452412|58955089|FG001|Overall Study|Lost to Follow-up|3|||
30919533|NCT01452412|58955088|FG000|Overall Study|Death|1|||
30919534|NCT01452412|58955089|FG001|Overall Study|Death|0|||
30919535|NCT01452412|58955088|FG000|Overall Study|Initiated dialysis|1|||
30919536|NCT01452412|58955089|FG001|Overall Study|Initiated dialysis|0|||
30919537|NCT01452412|58955088|FG000|Overall Study|Other|2|||
30919538|NCT01452412|58955089|FG001|Overall Study|Other|0|||
30919539|NCT01474876|58955098|FG000|Overall Study|Adverse Event|11|||
30919540|NCT01474876|58955099|FG001|Overall Study|Adverse Event|5|||
30919541|NCT01474876|58955100|FG002|Overall Study|Adverse Event|0|||
30919542|NCT01474876|58955098|FG000|Overall Study|Serious Adverse Event|2|||
30919543|NCT01474876|58955099|FG001|Overall Study|Serious Adverse Event|3|||
30919544|NCT01474876|58955100|FG002|Overall Study|Serious Adverse Event|0|||
30919545|NCT01474876|58955098|FG000|Overall Study|Lost to Follow-up|5|||
30919546|NCT01474876|58955099|FG001|Overall Study|Lost to Follow-up|4|||
30919547|NCT01474876|58955100|FG002|Overall Study|Lost to Follow-up|0|||
30919548|NCT01474876|58955098|FG000|Overall Study|Investigator's decision|28|||
30919549|NCT01474876|58955099|FG001|Overall Study|Investigator's decision|6|||
30919550|NCT01474876|58955100|FG002|Overall Study|Investigator's decision|0|||
30919551|NCT01474876|58955098|FG000|Overall Study|Patient's request|19|||
30919552|NCT01474876|58955099|FG001|Overall Study|Patient's request|5|||
30919553|NCT01474876|58955100|FG002|Overall Study|Patient's request|0|||
30919554|NCT01474876|58955098|FG000|Overall Study|Investigator's decision and pt request|1|||
30919555|NCT01474876|58955099|FG001|Overall Study|Investigator's decision and pt request|0|||
30919556|NCT01474876|58955100|FG002|Overall Study|Investigator's decision and pt request|0|||
30919557|NCT01491802|58955106|FG000|Overall Study|Adverse Event|1|||
30919558|NCT01491802|58955107|FG001|Overall Study|Adverse Event|1|||
30919559|NCT01491802|58955106|FG000|Overall Study|Withdrawal by Subject|0|||
30919560|NCT01491802|58955107|FG001|Overall Study|Withdrawal by Subject|1|||
30919561|NCT02168777|58955117|FG000|Overall Study|Withdrawal by Subject|1|||
30919562|NCT02168777|58955118|FG001|Overall Study|Withdrawal by Subject|0|||
30919563|NCT02168777|58955119|FG002|Overall Study|Withdrawal by Subject|2|||
30919564|NCT02168777|58955117|FG000|Overall Study|Adverse Event|1|||
30919565|NCT02168777|58955118|FG001|Overall Study|Adverse Event|0|||
30919566|NCT02168777|58955119|FG002|Overall Study|Adverse Event|1|||
30919567|NCT02168777|58955117|FG000|Overall Study|Disease recurrence|0|||
30919568|NCT02168777|58955118|FG001|Overall Study|Disease recurrence|0|||
30919569|NCT02168777|58955119|FG002|Overall Study|Disease recurrence|1|||
30919570|NCT02168777|58955117|FG000|Overall Study|Radiological disease progression|0|||
30919571|NCT02168777|58955118|FG001|Overall Study|Radiological disease progression|5|||
30919572|NCT02168777|58955119|FG002|Overall Study|Radiological disease progression|5|||
30919573|NCT02168777|58955117|FG000|Overall Study|Clinical disease progression|0|||
30919574|NCT02168777|58955118|FG001|Overall Study|Clinical disease progression|1|||
30919575|NCT02168777|58955119|FG002|Overall Study|Clinical disease progression|2|||
30919576|NCT02168777|58955117|FG000|Overall Study|Other reason|0|||
30919577|NCT02168777|58955118|FG001|Overall Study|Other reason|1|||
30919578|NCT02168777|58955119|FG002|Overall Study|Other reason|0|||
30919579|NCT01491178|58955130|FG000|Overall Study|Adverse Event|1016|||
30919580|NCT01491178|58955130|FG000|Overall Study|Improvement of NVAF|210|||
30919581|NCT01491178|58955130|FG000|Overall Study|To conduct invasive treatment|59|||
30919582|NCT01491178|58955130|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
30919583|NCT01491178|58955130|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
30919584|NCT01491178|58955130|FG000|Overall Study|To take a contraindication|20|||
30919585|NCT01491178|58955130|FG000|Overall Study|Other than specified above|657|||
30919586|NCT02189837|58955138|FG000|Overall Study|Withdrawal by Subject|2|||
30919587|NCT02189837|58955139|FG001|Overall Study|Withdrawal by Subject|1|||
30919588|NCT02189837|58955140|FG002|Overall Study|Withdrawal by Subject|3|||
30919589|NCT02189837|58955141|FG003|Overall Study|Withdrawal by Subject|1|||
30919590|NCT02189837|58955138|FG000|Overall Study|Sponsor Decision|0|||
30919591|NCT02189837|58955139|FG001|Overall Study|Sponsor Decision|0|||
30919592|NCT02189837|58955140|FG002|Overall Study|Sponsor Decision|0|||
30919593|NCT02189837|58955141|FG003|Overall Study|Sponsor Decision|1|||
30919594|NCT02216123|58955153|FG000|Overall Study|Lost to Follow-up|4|||
30919595|NCT02216123|58955154|FG001|Overall Study|Lost to Follow-up|2|||
30919596|NCT02216123|58955153|FG000|Overall Study|Withdrawal by Subject|2|||
30919597|NCT02216123|58955154|FG001|Overall Study|Withdrawal by Subject|0|||
30919598|NCT02189759|58955168|FG000|Overall Study|Lost to Follow-up|0|||
30919599|NCT02189759|58955169|FG001|Overall Study|Lost to Follow-up|0|||
30919600|NCT02189759|58955170|FG002|Overall Study|Lost to Follow-up|2|||
30919601|NCT02189759|58955171|FG003|Overall Study|Lost to Follow-up|5|||
30919602|NCT01490866|58955183|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
30919603|NCT01490866|58955183|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
30919604|NCT01490866|58955183|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
30919605|NCT01490866|58955183|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
30919606|NCT01490866|58955183|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
30919607|NCT01490866|58955183|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
30919608|NCT01490866|58955183|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
30919609|NCT01490866|58955183|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
30919610|NCT01490866|58955183|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
30919611|NCT01490866|58955183|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
30919612|NCT01490866|58955183|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
30919613|NCT02215967|58955194|FG000|Overall Study|Patient became ineligible for treatment|0|||
30919614|NCT02215967|58955195|FG001|Overall Study|Patient became ineligible for treatment|0|||
30919615|NCT02215967|58955196|FG002|Overall Study|Patient became ineligible for treatment|0|||
30919616|NCT02215967|58955197|FG003|Overall Study|Patient became ineligible for treatment|3|||
30919617|NCT02215967|58955194|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
30919618|NCT02215967|58955195|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
30919619|NCT02215967|58955196|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
30919620|NCT02215967|58955197|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
30919621|NCT02168387|58955209|FG000|Overall Study|Planned exubation|6|||
30919622|NCT02168387|58955210|FG001|Overall Study|Planned exubation|3|||
30919623|NCT02168387|58955209|FG000|Overall Study|Death|1|||
30919624|NCT02168387|58955210|FG001|Overall Study|Death|0|||
30919625|NCT02188589|58955216|FG000|Overall Study|Withdrawal by Subject|5|||
30919626|NCT02167451|58955221|FG000|Overall Study|Withdrawal by Subject|1|||
30919627|NCT02167139|58955227|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
30919628|NCT02167139|58955228|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
30919629|NCT02167139|58955229|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
30919630|NCT02167139|58955230|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
30919631|NCT02167139|58955227|FG000|Randomised, Double-blind|Adverse Event|2|||
30919632|NCT02167139|58955228|FG001|Randomised, Double-blind|Adverse Event|9|||
30919633|NCT02167139|58955229|FG002|Randomised, Double-blind|Adverse Event|0|||
30919634|NCT02167139|58955230|FG003|Randomised, Double-blind|Adverse Event|0|||
30919635|NCT02167139|58955227|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
30919636|NCT02167139|58955228|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
30919637|NCT02167139|58955229|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
30919638|NCT02167139|58955230|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
30919639|NCT02167139|58955227|FG000|Randomised, Double-blind|Other|3|||
30919640|NCT02167139|58955228|FG001|Randomised, Double-blind|Other|0|||
30919641|NCT02167139|58955229|FG002|Randomised, Double-blind|Other|0|||
30919642|NCT02167139|58955230|FG003|Randomised, Double-blind|Other|0|||
30919643|NCT02167139|58955227|FG000|Transition-extension|Adverse Event|2|||
30919644|NCT02167139|58955228|FG001|Transition-extension|Adverse Event|0|||
30919645|NCT02167139|58955229|FG002|Transition-extension|Adverse Event|2|||
30919646|NCT02167139|58955230|FG003|Transition-extension|Adverse Event|3|||
30919647|NCT02167139|58955227|FG000|Transition-extension|Withdrawal by Subject|2|||
30919648|NCT02167139|58955228|FG001|Transition-extension|Withdrawal by Subject|0|||
30919649|NCT02167139|58955229|FG002|Transition-extension|Withdrawal by Subject|4|||
30919650|NCT02167139|58955230|FG003|Transition-extension|Withdrawal by Subject|1|||
30919651|NCT02167139|58955227|FG000|Transition-extension|Lack of Efficacy|0|||
30919652|NCT02167139|58955228|FG001|Transition-extension|Lack of Efficacy|0|||
30919653|NCT02167139|58955229|FG002|Transition-extension|Lack of Efficacy|1|||
30919654|NCT02167139|58955230|FG003|Transition-extension|Lack of Efficacy|1|||
30919655|NCT02167139|58955227|FG000|Transition-extension|Other|1|||
30919656|NCT02167139|58955228|FG001|Transition-extension|Other|0|||
30919657|NCT02167139|58955229|FG002|Transition-extension|Other|1|||
30919658|NCT02167139|58955230|FG003|Transition-extension|Other|0|||
30919659|NCT02167139|58955227|FG000|Transition-extension|Lost to Follow-up|1|||
30919660|NCT02167139|58955228|FG001|Transition-extension|Lost to Follow-up|0|||
30919661|NCT02167139|58955229|FG002|Transition-extension|Lost to Follow-up|0|||
30919662|NCT02167139|58955230|FG003|Transition-extension|Lost to Follow-up|0|||
30919663|NCT02116621|58955246|FG000|Baseline|Withdrawal by Subject|0|||
30919664|NCT02116621|58955247|FG001|Baseline|Withdrawal by Subject|4|||
30919665|NCT02116621|58955246|FG000|Three Month Follow-up|Death|1|||
30919666|NCT02116621|58955247|FG001|Three Month Follow-up|Death|1|||
30919667|NCT02116621|58955246|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
30919668|NCT02116621|58955247|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
30919669|NCT02116621|58955246|FG000|Three Month Follow-up|Lost to Follow-up|0|||
30919670|NCT02116621|58955247|FG001|Three Month Follow-up|Lost to Follow-up|1|||
30919671|NCT02116621|58955246|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
30919672|NCT02116621|58955247|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
30919673|NCT02116621|58955246|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
30919674|NCT02116621|58955247|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
30919675|NCT02116621|58955246|FG000|Six Month Follow-up|Lost to Follow-up|2|||
30919676|NCT02116621|58955247|FG001|Six Month Follow-up|Lost to Follow-up|1|||
30919677|NCT02116621|58955246|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
30919678|NCT02116621|58955247|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
30919679|NCT02116621|58955246|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
30919680|NCT02116621|58955247|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
30919681|NCT02116621|58955246|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
30919682|NCT02116621|58955247|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
30919683|NCT02116621|58955246|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
30919684|NCT02116621|58955247|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
30919685|NCT02116621|58955246|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
30919686|NCT02116621|58955247|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
30919687|NCT02116309|58955255|FG000|Overall Study|Lost to Follow-up|0|||
30919688|NCT02116309|58955256|FG001|Overall Study|Lost to Follow-up|1|||
30919689|NCT02115607|58955262|FG000|Overall Study|Withdrawal by Subject|1|||
30919690|NCT01490632|58955271|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
30919691|NCT01490632|58955272|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
30919692|NCT01490632|58955273|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
30919693|NCT01490632|58955274|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
30919694|NCT01490632|58955275|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
30919695|NCT01490632|58955276|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
30919696|NCT01490632|58955277|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
30919697|NCT01490632|58955278|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
30919698|NCT01490632|58955279|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
30919699|NCT01490632|58955280|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
30919700|NCT01490632|58955281|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
30919701|NCT01490632|58955282|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
30919702|NCT01490632|58955283|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
30919703|NCT01490632|58955284|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
30919704|NCT01490632|58955285|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
30919705|NCT01490632|58955286|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
30919706|NCT01490632|58955287|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
30919707|NCT01490632|58955288|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
30919708|NCT01490632|58955289|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
30919709|NCT01490632|58955290|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
30919710|NCT01490632|58955271|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
30919711|NCT01490632|58955272|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
30919712|NCT01490632|58955273|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
30919713|NCT01490632|58955274|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
30826813|NCT02805660|58849239|FG003|Overall Study|Study terminated by Sponsor|4|||
30826814|NCT02805660|58849240|FG004|Overall Study|Study terminated by Sponsor|2|||
30826815|NCT02805660|58849241|FG005|Overall Study|Study terminated by Sponsor|3|||
30826816|NCT02805660|58849242|FG006|Overall Study|Study terminated by Sponsor|1|||
30826817|NCT02805660|58849236|FG000|Overall Study|Miscellaneous|0|||
30826818|NCT02805660|58849237|FG001|Overall Study|Miscellaneous|1|||
30919714|NCT01490632|58955275|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919715|NCT01490632|58955276|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919716|NCT01490632|58955277|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919717|NCT01490632|58955278|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919718|NCT01490632|58955279|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919719|NCT01490632|58955280|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919720|NCT01490632|58955281|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919721|NCT01490632|58955282|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919722|NCT01490632|58955283|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919723|NCT01490632|58955284|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919724|NCT01490632|58955285|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919725|NCT01490632|58955286|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919726|NCT01490632|58955287|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919727|NCT01490632|58955288|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919728|NCT01490632|58955289|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919729|NCT01490632|58955290|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
30919730|NCT01490632|58955271|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919731|NCT01490632|58955272|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919732|NCT01490632|58955273|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
30919733|NCT01490632|58955274|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
30919734|NCT01490632|58955275|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
30919735|NCT01490632|58955276|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919736|NCT01490632|58955277|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919737|NCT01490632|58955278|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919738|NCT01490632|58955279|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919739|NCT01490632|58955280|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919740|NCT01490632|58955281|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919741|NCT01490632|58955282|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919742|NCT01490632|58955283|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919743|NCT01490632|58955284|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919744|NCT01490632|58955285|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919745|NCT01490632|58955286|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919746|NCT01490632|58955287|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919747|NCT01490632|58955288|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919748|NCT01490632|58955289|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919749|NCT01490632|58955290|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
30919750|NCT01490632|58955271|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
30919751|NCT01490632|58955272|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
30919752|NCT01490632|58955273|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
30919753|NCT01490632|58955274|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
30826819|NCT02805660|58849238|FG002|Overall Study|Miscellaneous|0|||
30919754|NCT01490632|58955275|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
30919755|NCT01490632|58955276|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
30919756|NCT01490632|58955277|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
30919757|NCT01490632|58955278|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
30919758|NCT01490632|58955279|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
30919759|NCT01490632|58955280|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
30754033|NCT03703882|58763650|FG000|Overall Study|Progressive disease|1|||
30754034|NCT03703882|58763651|FG001|Overall Study|Progressive disease|0|||
30754035|NCT03703882|58763650|FG000|Overall Study|Withdrawal by parent/guardian|1|||
30754036|NCT03703882|58763651|FG001|Overall Study|Withdrawal by parent/guardian|0|||
30754037|NCT03703882|58763650|FG000|Overall Study|Starting another treatment|0|||
30754038|NCT03703882|58763651|FG001|Overall Study|Starting another treatment|1|||
30826820|NCT02805660|58849239|FG003|Overall Study|Miscellaneous|4|||
30826821|NCT02805660|58849240|FG004|Overall Study|Miscellaneous|0|||
30826822|NCT02805660|58849241|FG005|Overall Study|Miscellaneous|6|||
30754039|NCT03703882|58763650|FG000|Overall Study|noncompliance with study procedures|0|||
30754040|NCT03703882|58763651|FG001|Overall Study|noncompliance with study procedures|1|||
30754041|NCT00131664|58763660|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
30754042|NCT00131664|58763661|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
30826823|NCT02805660|58849242|FG006|Overall Study|Miscellaneous|4|||
30919760|NCT01490632|58955281|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
30919761|NCT01490632|58955282|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
30919762|NCT01490632|58955283|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
30919763|NCT01490632|58955284|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
30919764|NCT01490632|58955285|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
30919765|NCT01490632|58955286|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
30919766|NCT01490632|58955287|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
30919767|NCT01490632|58955288|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
30919768|NCT01490632|58955289|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
30919769|NCT01490632|58955290|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
30919770|NCT01490632|58955271|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
30919771|NCT01490632|58955272|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919772|NCT01490632|58955273|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919773|NCT01490632|58955274|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919774|NCT01490632|58955275|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919775|NCT01490632|58955276|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919776|NCT01490632|58955277|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919777|NCT01490632|58955278|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919778|NCT01490632|58955279|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919779|NCT01490632|58955280|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919780|NCT01490632|58955281|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919781|NCT01490632|58955282|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919782|NCT01490632|58955283|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919783|NCT01490632|58955284|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919784|NCT01490632|58955285|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919785|NCT01490632|58955286|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919786|NCT01490632|58955287|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919787|NCT01490632|58955288|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919788|NCT01490632|58955289|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919789|NCT01490632|58955290|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
30919790|NCT01490632|58955271|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
30919791|NCT01490632|58955272|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
30919792|NCT01490632|58955273|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919793|NCT01490632|58955274|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
30919794|NCT01490632|58955275|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
30919795|NCT01490632|58955276|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919796|NCT01490632|58955277|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919797|NCT01490632|58955278|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919798|NCT01490632|58955279|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919799|NCT01490632|58955280|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919800|NCT01490632|58955281|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919801|NCT01490632|58955282|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919802|NCT01490632|58955283|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919803|NCT01490632|58955284|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919804|NCT01490632|58955285|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919805|NCT01490632|58955286|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919806|NCT01490632|58955287|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919807|NCT01490632|58955288|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919808|NCT01490632|58955289|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919809|NCT01490632|58955290|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
30919810|NCT01490632|58955271|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919811|NCT01490632|58955272|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919812|NCT01490632|58955273|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919813|NCT01490632|58955274|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919814|NCT01490632|58955275|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
30919815|NCT01490632|58955276|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919816|NCT01490632|58955277|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919817|NCT01490632|58955278|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30754043|NCT00131664|58763662|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
30754044|NCT00131664|58763663|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
30754045|NCT00131664|58763664|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
30754046|NCT00131664|58763665|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
30754047|NCT00131664|58763660|FG000|First Period (First 6 Months)|Death|0|||
30754048|NCT00131664|58763661|FG001|First Period (First 6 Months)|Death|1|||
30754049|NCT00131664|58763662|FG002|First Period (First 6 Months)|Death|0|||
30754050|NCT00131664|58763663|FG003|First Period (First 6 Months)|Death|0|||
30826824|NCT02807376|58849273|FG000|Overall Study|Intra-operative exclusion criteria|3|||
30826825|NCT02807376|58849274|FG001|Overall Study|Intra-operative exclusion criteria|0|||
30826826|NCT02807376|58849273|FG000|Overall Study|Lost to Follow-up|0|||
30826827|NCT02807376|58849274|FG001|Overall Study|Lost to Follow-up|1|||
30826828|NCT02804178|58849293|FG000|Overall Study|Adverse Event|1|||
30826829|NCT02917941|58849297|FG000|Treatment Period|Adverse Event|11|||
30826830|NCT02917941|58849297|FG000|Treatment Period|Progressive Disease|11|||
30826831|NCT02917941|58849297|FG000|Treatment Period|Reason not Specified|2|||
30826832|NCT02917941|58849297|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
30826833|NCT02917941|58849297|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
30919818|NCT01490632|58955279|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919819|NCT01490632|58955280|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919820|NCT01490632|58955281|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919821|NCT01490632|58955282|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919822|NCT01490632|58955283|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919823|NCT01490632|58955284|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919824|NCT01490632|58955285|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919825|NCT01490632|58955286|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919826|NCT01490632|58955287|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919827|NCT01490632|58955288|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919828|NCT01490632|58955289|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30919829|NCT01490632|58955290|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
30754051|NCT00131664|58763664|FG004|First Period (First 6 Months)|Death|0|||
30919830|NCT01490632|58955271|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919831|NCT01490632|58955272|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919832|NCT01490632|58955273|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919833|NCT01490632|58955274|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919834|NCT01490632|58955275|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919835|NCT01490632|58955276|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
30919836|NCT01490632|58955277|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
30919837|NCT01490632|58955278|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919838|NCT01490632|58955279|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919839|NCT01490632|58955280|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
30919840|NCT01490632|58955281|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
30919841|NCT01490632|58955282|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
30919842|NCT01490632|58955283|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919843|NCT01490632|58955284|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919844|NCT01490632|58955285|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919845|NCT01490632|58955286|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919846|NCT01490632|58955287|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919847|NCT01490632|58955288|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919848|NCT01490632|58955289|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919849|NCT01490632|58955290|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
30919850|NCT01490632|58955271|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919851|NCT01490632|58955272|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919852|NCT01490632|58955273|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919853|NCT01490632|58955274|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919854|NCT01490632|58955275|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919855|NCT01490632|58955276|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919856|NCT01490632|58955277|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
30919857|NCT01490632|58955278|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919858|NCT01490632|58955279|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
30919859|NCT01490632|58955280|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
30919860|NCT01490632|58955281|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
30919861|NCT01490632|58955282|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919862|NCT01490632|58955283|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919863|NCT01490632|58955284|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919864|NCT01490632|58955285|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919865|NCT01490632|58955286|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919866|NCT01490632|58955287|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919867|NCT01490632|58955288|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919868|NCT01490632|58955289|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919869|NCT01490632|58955290|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
30919870|NCT01490632|58955271|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919871|NCT01490632|58955272|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919872|NCT01490632|58955273|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919873|NCT01490632|58955274|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919874|NCT01490632|58955275|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919875|NCT01490632|58955276|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919876|NCT01490632|58955277|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
30919877|NCT01490632|58955278|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919878|NCT01490632|58955279|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919879|NCT01490632|58955280|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
30919880|NCT01490632|58955281|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919881|NCT01490632|58955282|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919882|NCT01490632|58955283|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919883|NCT01490632|58955284|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919884|NCT01490632|58955285|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919885|NCT01490632|58955286|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919886|NCT01490632|58955287|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919887|NCT01490632|58955288|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919888|NCT01490632|58955289|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919889|NCT01490632|58955290|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
30919890|NCT01490632|58955271|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919891|NCT01490632|58955272|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919892|NCT01490632|58955273|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919893|NCT01490632|58955274|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919894|NCT01490632|58955275|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919895|NCT01490632|58955276|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919896|NCT01490632|58955277|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
30919897|NCT01490632|58955278|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919898|NCT01490632|58955279|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919899|NCT01490632|58955280|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919900|NCT01490632|58955281|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919901|NCT01490632|58955282|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919902|NCT01490632|58955283|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919903|NCT01490632|58955284|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919904|NCT01490632|58955285|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919905|NCT01490632|58955286|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919906|NCT01490632|58955287|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919907|NCT01490632|58955288|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919908|NCT01490632|58955289|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919909|NCT01490632|58955290|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
30919910|NCT01490632|58955271|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919911|NCT01490632|58955272|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919912|NCT01490632|58955273|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919913|NCT01490632|58955274|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919914|NCT01490632|58955275|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919915|NCT01490632|58955276|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
30919916|NCT01490632|58955277|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919917|NCT01490632|58955278|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919918|NCT01490632|58955279|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919919|NCT01490632|58955280|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919920|NCT01490632|58955281|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919921|NCT01490632|58955282|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919922|NCT01490632|58955283|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919923|NCT01490632|58955284|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919924|NCT01490632|58955285|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919925|NCT01490632|58955286|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919926|NCT01490632|58955287|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919927|NCT01490632|58955288|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919928|NCT01490632|58955289|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919929|NCT01490632|58955290|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
30919930|NCT01490632|58955271|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919931|NCT01490632|58955272|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919932|NCT01490632|58955273|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919933|NCT01490632|58955274|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919934|NCT01490632|58955275|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919935|NCT01490632|58955276|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919936|NCT01490632|58955277|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
30919937|NCT01490632|58955278|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919938|NCT01490632|58955279|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
30919939|NCT01490632|58955280|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919940|NCT01490632|58955281|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
30919941|NCT01490632|58955282|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
30919942|NCT01490632|58955283|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919943|NCT01490632|58955284|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919944|NCT01490632|58955285|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919945|NCT01490632|58955286|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919946|NCT01490632|58955287|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919947|NCT01490632|58955288|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919948|NCT01490632|58955289|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919949|NCT01490632|58955290|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
30919950|NCT01490632|58955271|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919951|NCT01490632|58955272|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919952|NCT01490632|58955273|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30826834|NCT01333956|58849305|FG000|Overall Study|Lost to Follow-up|1|||
30826835|NCT01333956|58849306|FG001|Overall Study|Lost to Follow-up|2|||
30919953|NCT01490632|58955274|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919954|NCT01490632|58955275|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919955|NCT01490632|58955276|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
30919956|NCT01490632|58955277|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
30919957|NCT01490632|58955278|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
30919958|NCT01490632|58955279|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
30919959|NCT01490632|58955280|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
30919960|NCT01490632|58955281|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
30919961|NCT01490632|58955282|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
30919962|NCT01490632|58955283|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919963|NCT01490632|58955284|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919964|NCT01490632|58955285|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919965|NCT01490632|58955286|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919966|NCT01490632|58955287|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919967|NCT01490632|58955288|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919968|NCT01490632|58955289|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919969|NCT01490632|58955290|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
30919970|NCT01490632|58955271|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919971|NCT01490632|58955272|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919972|NCT01490632|58955273|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919973|NCT01490632|58955274|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919974|NCT01490632|58955275|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919975|NCT01490632|58955276|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919976|NCT01490632|58955277|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919977|NCT01490632|58955278|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919978|NCT01490632|58955279|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919979|NCT01490632|58955280|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919980|NCT01490632|58955281|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919981|NCT01490632|58955282|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919982|NCT01490632|58955283|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919983|NCT01490632|58955284|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919984|NCT01490632|58955285|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
30919985|NCT01490632|58955286|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
30919986|NCT01490632|58955287|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919987|NCT01490632|58955288|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919988|NCT01490632|58955289|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919989|NCT01490632|58955290|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
30919990|NCT01490632|58955271|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30919991|NCT01490632|58955272|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30919992|NCT01490632|58955273|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30919993|NCT01490632|58955274|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30919994|NCT01490632|58955275|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30919995|NCT01490632|58955276|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30919996|NCT01490632|58955277|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30919997|NCT01490632|58955278|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30919998|NCT01490632|58955279|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30919999|NCT01490632|58955280|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30920000|NCT01490632|58955281|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30920001|NCT01490632|58955282|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30920002|NCT01490632|58955283|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30920003|NCT01490632|58955284|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
30920004|NCT01490632|58955285|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30920005|NCT01490632|58955286|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30920006|NCT01490632|58955287|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30920007|NCT01490632|58955288|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30920008|NCT01490632|58955289|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30920009|NCT01490632|58955290|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
30920010|NCT01490632|58955271|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920011|NCT01490632|58955272|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920012|NCT01490632|58955273|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920013|NCT01490632|58955274|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30754052|NCT00131664|58763665|FG005|First Period (First 6 Months)|Death|0|||
30754053|NCT00131664|58763660|FG000|First Period (First 6 Months)|Protocol Violation|2|||
30920014|NCT01490632|58955275|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920015|NCT01490632|58955276|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920016|NCT01490632|58955277|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920017|NCT01490632|58955278|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920018|NCT01490632|58955279|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920019|NCT01490632|58955280|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920020|NCT01490632|58955281|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920021|NCT01490632|58955282|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920022|NCT01490632|58955283|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920023|NCT01490632|58955284|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920024|NCT01490632|58955285|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
30920025|NCT01490632|58955286|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
30920026|NCT01490632|58955287|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920027|NCT01490632|58955288|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920028|NCT01490632|58955289|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920029|NCT01490632|58955290|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
30920030|NCT01490632|58955271|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920031|NCT01490632|58955272|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920032|NCT01490632|58955273|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920033|NCT01490632|58955274|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920034|NCT01490632|58955275|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920035|NCT01490632|58955276|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920036|NCT01490632|58955277|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920037|NCT01490632|58955278|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920038|NCT01490632|58955279|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920039|NCT01490632|58955280|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920040|NCT01490632|58955281|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920041|NCT01490632|58955282|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920042|NCT01490632|58955283|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
30920043|NCT01490632|58955284|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
30826836|NCT01333956|58849307|FG002|Overall Study|Lost to Follow-up|0|||
30826837|NCT01333956|58849308|FG003|Overall Study|Lost to Follow-up|1|||
30826838|NCT01333956|58849305|FG000|Overall Study|Unable to complete study procedure|1|||
30826839|NCT01333956|58849306|FG001|Overall Study|Unable to complete study procedure|0|||
30826840|NCT01333956|58849307|FG002|Overall Study|Unable to complete study procedure|0|||
30826841|NCT01333956|58849308|FG003|Overall Study|Unable to complete study procedure|1|||
30826842|NCT01333956|58849305|FG000|Overall Study|Withdrawal by Subject|0|||
30826843|NCT01333956|58849306|FG001|Overall Study|Withdrawal by Subject|2|||
30826844|NCT01333956|58849307|FG002|Overall Study|Withdrawal by Subject|1|||
30826845|NCT01333956|58849308|FG003|Overall Study|Withdrawal by Subject|0|||
30826846|NCT01333722|58849321|FG000|Overall Study|Lack of Efficacy|0|||
30826847|NCT01333722|58849322|FG001|Overall Study|Lack of Efficacy|2|||
30826848|NCT01333722|58849321|FG000|Overall Study|Withdrawal by Subject|0|||
30826849|NCT01333722|58849322|FG001|Overall Study|Withdrawal by Subject|1|||
30826850|NCT01370694|58849330|FG000|Overall Study|Switched to rituximab|4|||
30826851|NCT01370694|58849330|FG000|Overall Study|Progressive disease|2|||
30826852|NCT03315143|58849336|FG000|Overall Study|Death|240|||
30826853|NCT03315143|58849337|FG001|Overall Study|Death|246|||
30826854|NCT03315143|58849336|FG000|Overall Study|Withdrawal by Subject|57|||
30826855|NCT03315143|58849337|FG001|Overall Study|Withdrawal by Subject|68|||
30826856|NCT03315143|58849336|FG000|Overall Study|Site Terminated by Sponsor|256|||
30826857|NCT03315143|58849337|FG001|Overall Study|Site Terminated by Sponsor|282|||
30826858|NCT03315143|58849336|FG000|Overall Study|Study Terminated by Sponsor|4723|||
30826859|NCT03315143|58849337|FG001|Overall Study|Study Terminated by Sponsor|4664|||
30826860|NCT03315143|58849336|FG000|Overall Study|Reason not Specified|16|||
30826861|NCT03315143|58849337|FG001|Overall Study|Reason not Specified|32|||
30826862|NCT02797080|58849343|FG000|Overall Study|Lost to Follow-up|1|||
30826863|NCT02797080|58849343|FG000|Overall Study|Withdrawal by Subject|1|||
30826864|NCT02915835|58849349|FG000|Overall Study|Physician Decision|1|||
30826865|NCT02915835|58849350|FG001|Overall Study|Physician Decision|0|||
30826866|NCT02915835|58849349|FG000|Overall Study|Withdrawal by Subject|0|||
30826867|NCT02915835|58849350|FG001|Overall Study|Withdrawal by Subject|1|||
30826868|NCT01370616|58849358|FG000|Overall Study|Adverse Event|11|||
30826869|NCT01370616|58849359|FG001|Overall Study|Adverse Event|16|||
30826870|NCT01370616|58849358|FG000|Overall Study|Death|1|||
30623325|NCT01121484|58635153|FG001|Overall Study|Other|3|||
30826871|NCT01370616|58849359|FG001|Overall Study|Death|0|||
30826872|NCT01370616|58849358|FG000|Overall Study|Lack of Efficacy|6|||
30826873|NCT01370616|58849359|FG001|Overall Study|Lack of Efficacy|2|||
30826874|NCT01370616|58849358|FG000|Overall Study|Lost to Follow-up|0|||
30826875|NCT01370616|58849359|FG001|Overall Study|Lost to Follow-up|3|||
30920044|NCT01490632|58955285|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
30920045|NCT01490632|58955286|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
30920046|NCT01490632|58955287|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920047|NCT01490632|58955288|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920048|NCT01490632|58955289|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920049|NCT01490632|58955290|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
30920050|NCT01490632|58955271|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
30920051|NCT01490632|58955272|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
30920052|NCT01490632|58955273|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
30920053|NCT01490632|58955274|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
30920054|NCT01490632|58955275|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
30920055|NCT01490632|58955276|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
30920056|NCT01490632|58955277|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
30920057|NCT01490632|58955278|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
30920058|NCT01490632|58955279|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
30920059|NCT01490632|58955280|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
30920060|NCT01490632|58955281|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
30920061|NCT01490632|58955282|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
30920062|NCT01490632|58955283|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
30920063|NCT01490632|58955284|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
30920064|NCT01490632|58955285|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
30920065|NCT01490632|58955286|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
30920066|NCT01490632|58955287|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
30920067|NCT01490632|58955288|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
30920068|NCT01490632|58955289|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
30920069|NCT01490632|58955290|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
30920070|NCT01490632|58955271|FG000|Part D: Re-Treatment Period|Death|0|||
30920071|NCT01490632|58955272|FG001|Part D: Re-Treatment Period|Death|0|||
30920072|NCT01490632|58955273|FG002|Part D: Re-Treatment Period|Death|0|||
30920073|NCT01490632|58955274|FG003|Part D: Re-Treatment Period|Death|0|||
30920074|NCT01490632|58955275|FG004|Part D: Re-Treatment Period|Death|0|||
30920075|NCT01490632|58955276|FG005|Part D: Re-Treatment Period|Death|0|||
30920076|NCT01490632|58955277|FG006|Part D: Re-Treatment Period|Death|0|||
30920077|NCT01490632|58955278|FG007|Part D: Re-Treatment Period|Death|0|||
30920078|NCT01490632|58955279|FG008|Part D: Re-Treatment Period|Death|0|||
30920079|NCT01490632|58955280|FG009|Part D: Re-Treatment Period|Death|0|||
30920080|NCT01490632|58955281|FG010|Part D: Re-Treatment Period|Death|0|||
30920081|NCT01490632|58955282|FG011|Part D: Re-Treatment Period|Death|0|||
30920082|NCT01490632|58955283|FG012|Part D: Re-Treatment Period|Death|0|||
30920083|NCT01490632|58955284|FG013|Part D: Re-Treatment Period|Death|0|||
30920084|NCT01490632|58955285|FG014|Part D: Re-Treatment Period|Death|0|||
30920085|NCT01490632|58955286|FG015|Part D: Re-Treatment Period|Death|0|||
30920086|NCT01490632|58955287|FG016|Part D: Re-Treatment Period|Death|0|||
30920087|NCT01490632|58955288|FG017|Part D: Re-Treatment Period|Death|0|||
30920088|NCT01490632|58955289|FG018|Part D: Re-Treatment Period|Death|1|||
30920089|NCT01490632|58955290|FG019|Part D: Re-Treatment Period|Death|0|||
30920090|NCT01490632|58955271|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920091|NCT01490632|58955272|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920092|NCT01490632|58955273|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920093|NCT01490632|58955274|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920094|NCT01490632|58955275|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920095|NCT01490632|58955276|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920096|NCT01490632|58955277|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920097|NCT01490632|58955278|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920098|NCT01490632|58955279|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920099|NCT01490632|58955280|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920100|NCT01490632|58955281|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920101|NCT01490632|58955282|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920102|NCT01490632|58955283|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920103|NCT01490632|58955284|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920104|NCT01490632|58955285|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920105|NCT01490632|58955286|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920106|NCT01490632|58955287|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
30920107|NCT01490632|58955288|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
30920108|NCT01490632|58955289|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
30920109|NCT01490632|58955290|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
30920110|NCT01490632|58955271|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920111|NCT01490632|58955272|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920112|NCT01490632|58955273|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920113|NCT01490632|58955274|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920114|NCT01490632|58955275|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920115|NCT01490632|58955276|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920116|NCT01490632|58955277|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920117|NCT01490632|58955278|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920118|NCT01490632|58955279|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920119|NCT01490632|58955280|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920120|NCT01490632|58955281|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920121|NCT01490632|58955282|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920122|NCT01490632|58955283|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920123|NCT01490632|58955284|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920124|NCT01490632|58955285|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920125|NCT01490632|58955286|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920126|NCT01490632|58955287|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920127|NCT01490632|58955288|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920128|NCT01490632|58955289|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
30920129|NCT01490632|58955290|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
30920130|NCT01490632|58955271|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
30920131|NCT01490632|58955272|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
30920132|NCT01490632|58955273|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
30920133|NCT01490632|58955274|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
30920134|NCT01490632|58955275|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
30920135|NCT01490632|58955276|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
30920136|NCT01490632|58955277|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
30920137|NCT01490632|58955278|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
30920138|NCT01490632|58955279|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
30920139|NCT01490632|58955280|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
30920140|NCT01490632|58955281|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
30920141|NCT01490632|58955282|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
30920142|NCT01490632|58955283|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
30920143|NCT01490632|58955284|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
30920144|NCT01490632|58955285|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
30920145|NCT01490632|58955286|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
30920146|NCT01490632|58955287|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
30920147|NCT01490632|58955288|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
30920148|NCT01490632|58955289|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
30920149|NCT01490632|58955290|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
30920150|NCT01490632|58955271|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
30920151|NCT01490632|58955272|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
30920152|NCT01490632|58955273|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
30920153|NCT01490632|58955274|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
30920154|NCT01490632|58955275|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
30920155|NCT01490632|58955276|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
30920156|NCT01490632|58955277|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
30920157|NCT01490632|58955278|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
30920158|NCT01490632|58955279|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
30920159|NCT01490632|58955280|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
30920160|NCT01490632|58955281|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
30920161|NCT01490632|58955282|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
30920162|NCT01490632|58955283|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
30920163|NCT01490632|58955284|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
30920164|NCT01490632|58955285|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
30920165|NCT01490632|58955286|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
30920166|NCT01490632|58955287|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
30920167|NCT01490632|58955288|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
30920168|NCT01490632|58955289|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
30920169|NCT01490632|58955290|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
30920170|NCT01490632|58955271|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920171|NCT01490632|58955272|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920172|NCT01490632|58955273|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920173|NCT01490632|58955274|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920174|NCT01490632|58955275|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920175|NCT01490632|58955276|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920176|NCT01490632|58955277|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920177|NCT01490632|58955278|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920178|NCT01490632|58955279|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920179|NCT01490632|58955280|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920180|NCT01490632|58955281|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920181|NCT01490632|58955282|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920182|NCT01490632|58955283|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920183|NCT01490632|58955284|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920184|NCT01490632|58955285|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920185|NCT01490632|58955286|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920186|NCT01490632|58955287|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
30920187|NCT01490632|58955288|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
30920188|NCT01490632|58955289|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
30920189|NCT01490632|58955290|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
30920190|NCT02073643|58955333|FG000|Overall Study|Lost to Follow-up|24|||
30920191|NCT01451554|58955339|FG000|Overall Study|Withdrawal by Subject|14|||
30920192|NCT01451554|58955340|FG001|Overall Study|Withdrawal by Subject|9|||
30920193|NCT01474486|58955346|FG000|Overall Study|Death|2|||
30920194|NCT01474486|58955346|FG000|Overall Study|Withdrawal by Subject|4|||
30920195|NCT01474486|58955346|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
30920196|NCT01451398|58955356|FG000|Overall Study|Adverse Event|7|||
30920197|NCT01451398|58955357|FG001|Overall Study|Adverse Event|9|||
30920198|NCT01451398|58955356|FG000|Overall Study|Protocol Violation|1|||
30920199|NCT01451398|58955357|FG001|Overall Study|Protocol Violation|2|||
30920200|NCT01451398|58955356|FG000|Overall Study|Physician Decision|1|||
30920201|NCT01451398|58955357|FG001|Overall Study|Physician Decision|1|||
30920202|NCT01451398|58955356|FG000|Overall Study|Withdrawal by Subject|10|||
30920203|NCT01451398|58955357|FG001|Overall Study|Withdrawal by Subject|14|||
30920204|NCT01451398|58955356|FG000|Overall Study|Lost to Follow-up|6|||
30920205|NCT01451398|58955357|FG001|Overall Study|Lost to Follow-up|4|||
30920206|NCT01451398|58955356|FG000|Overall Study|Non-compliance with study drug|1|||
30920207|NCT01451398|58955357|FG001|Overall Study|Non-compliance with study drug|3|||
30920208|NCT01451398|58955356|FG000|Overall Study|Non-compliance with protocol|1|||
30920209|NCT01451398|58955357|FG001|Overall Study|Non-compliance with protocol|1|||
30920210|NCT01451398|58955356|FG000|Overall Study|Moved out of country|0|||
30920211|NCT01451398|58955357|FG001|Overall Study|Moved out of country|1|||
30920212|NCT01451398|58955356|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
30920213|NCT01451398|58955357|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
30920214|NCT01451398|58955356|FG000|Overall Study|Lack of Efficacy|0|||
30920215|NCT01451398|58955357|FG001|Overall Study|Lack of Efficacy|1|||
30920216|NCT02073565|58955365|FG000|Cohort A|Withdrawal by Subject|1|||
30920217|NCT02073565|58955366|FG001|Cohort A|Withdrawal by Subject|0|||
30920218|NCT02073565|58955365|FG000|Cohort B|Withdrawal by Subject|1|||
30920219|NCT02073565|58955366|FG001|Cohort B|Withdrawal by Subject|2|||
30920220|NCT02073565|58955365|FG000|Cohort C|Withdrawal by Subject|0|||
30920221|NCT02073565|58955366|FG001|Cohort C|Withdrawal by Subject|2|||
30920222|NCT02073565|58955365|FG000|Cohort C|Lost to Follow-up|0|||
30920223|NCT02073565|58955366|FG001|Cohort C|Lost to Follow-up|2|||
30920224|NCT02072941|58955374|FG000|Overall Study|Withdrawal by Subject|29|||
30920225|NCT02072941|58955375|FG001|Overall Study|Withdrawal by Subject|21|||
30920226|NCT02072941|58955374|FG000|Overall Study|Lost to Follow-up|4|||
30920227|NCT02072941|58955375|FG001|Overall Study|Lost to Follow-up|4|||
30920228|NCT02072941|58955374|FG000|Overall Study|Death|3|||
30920229|NCT02072941|58955375|FG001|Overall Study|Death|2|||
30920230|NCT02072941|58955374|FG000|Overall Study|Removed by Study Staff|2|||
30920231|NCT02072941|58955375|FG001|Overall Study|Removed by Study Staff|2|||
30920232|NCT02100631|58955384|FG000|Overall Study|Withdrawal by Subject|1|||
30920233|NCT02100631|58955385|FG001|Overall Study|Withdrawal by Subject|0|||
30920234|NCT02100631|58955386|FG002|Overall Study|Withdrawal by Subject|0|||
30920235|NCT02100631|58955384|FG000|Overall Study|Lost to Follow-up|3|||
30920236|NCT02100631|58955385|FG001|Overall Study|Lost to Follow-up|4|||
30920237|NCT02100631|58955386|FG002|Overall Study|Lost to Follow-up|0|||
30920238|NCT02100631|58955384|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
30920239|NCT02100631|58955385|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
30920240|NCT02100631|58955386|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
30920241|NCT01451164|58955398|FG000|Overall Study|Adverse Event|19|||
30920242|NCT01451164|58955399|FG001|Overall Study|Adverse Event|12|||
30920243|NCT01451164|58955400|FG002|Overall Study|Adverse Event|18|||
30920244|NCT01451164|58955401|FG003|Overall Study|Adverse Event|21|||
30920245|NCT01451164|58955398|FG000|Overall Study|Withdrawal Criteria|1|||
30920246|NCT01451164|58955399|FG001|Overall Study|Withdrawal Criteria|1|||
30920247|NCT01451164|58955400|FG002|Overall Study|Withdrawal Criteria|1|||
30920248|NCT01451164|58955401|FG003|Overall Study|Withdrawal Criteria|1|||
30623326|NCT01121484|58635152|FG000|Overall Study|Randomized, not treated|1|||
30754054|NCT00131664|58763661|FG001|First Period (First 6 Months)|Protocol Violation|2|||
30920249|NCT01451164|58955398|FG000|Overall Study|Physician Decision|2|||
30920250|NCT01451164|58955399|FG001|Overall Study|Physician Decision|0|||
30920251|NCT01451164|58955400|FG002|Overall Study|Physician Decision|1|||
30920252|NCT01451164|58955401|FG003|Overall Study|Physician Decision|0|||
30920253|NCT01451164|58955398|FG000|Overall Study|Withdrawal by Subject|14|||
30920254|NCT01451164|58955399|FG001|Overall Study|Withdrawal by Subject|11|||
30623327|NCT01121484|58635153|FG001|Overall Study|Randomized, not treated|4|||
30754055|NCT00131664|58763662|FG002|First Period (First 6 Months)|Protocol Violation|1|||
30754056|NCT00131664|58763663|FG003|First Period (First 6 Months)|Protocol Violation|0|||
30920255|NCT01451164|58955400|FG002|Overall Study|Withdrawal by Subject|16|||
30920256|NCT01451164|58955401|FG003|Overall Study|Withdrawal by Subject|17|||
30920257|NCT01451164|58955398|FG000|Overall Study|Protocol Violation|0|||
30920258|NCT01451164|58955399|FG001|Overall Study|Protocol Violation|1|||
30920259|NCT01451164|58955400|FG002|Overall Study|Protocol Violation|0|||
30920260|NCT01451164|58955401|FG003|Overall Study|Protocol Violation|0|||
30920261|NCT01451164|58955398|FG000|Overall Study|Lack of Efficacy|7|||
30920262|NCT01451164|58955399|FG001|Overall Study|Lack of Efficacy|9|||
30920263|NCT01451164|58955400|FG002|Overall Study|Lack of Efficacy|9|||
30920264|NCT01451164|58955401|FG003|Overall Study|Lack of Efficacy|7|||
30920265|NCT02071849|58955411|FG000|6-month Primary Endpoint|Did not receive device|4|||
30920266|NCT02071849|58955411|FG000|6-month Primary Endpoint|Adverse Event|1|||
30920267|NCT02071849|58955411|FG000|2-year Extended Follow-up|Adverse Event|1|||
30920268|NCT02071771|58955415|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
30920269|NCT02071771|58955416|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
30920270|NCT02071771|58955415|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
30920271|NCT02071771|58955416|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
30920272|NCT02071225|58955422|FG000|Overall Study|Withdrawal of Consent|2|||
30920273|NCT02071225|58955422|FG000|Overall Study|Protocol Deviation|1|||
30920274|NCT02071225|58955422|FG000|Overall Study|Lost to Follow-up|2|||
30920275|NCT02071225|58955422|FG000|Overall Study|Death|25|||
30920276|NCT01450696|58955428|FG000|Overall Study|Never Treated|1|||
30920277|NCT01450696|58955429|FG001|Overall Study|Never Treated|1|||
30920278|NCT01450696|58955428|FG000|Overall Study|Death|77|||
30920279|NCT01450696|58955429|FG001|Overall Study|Death|84|||
30920280|NCT01450696|58955428|FG000|Overall Study|Lost to Follow-up|3|||
30920281|NCT01450696|58955429|FG001|Overall Study|Lost to Follow-up|3|||
30920282|NCT01450696|58955428|FG000|Overall Study|Non-Compliance|1|||
30920283|NCT01450696|58955429|FG001|Overall Study|Non-Compliance|0|||
30920284|NCT01450696|58955428|FG000|Overall Study|Withdrawal by Subject|13|||
30920285|NCT01450696|58955429|FG001|Overall Study|Withdrawal by Subject|2|||
30920286|NCT01450696|58955428|FG000|Overall Study|Study Terminated by Sponsor|53|||
30920287|NCT01450696|58955429|FG001|Overall Study|Study Terminated by Sponsor|58|||
30920288|NCT02070991|58955437|FG000|Overall Study|Death|2|||
30920289|NCT02070991|58955438|FG001|Overall Study|Death|0|||
30920290|NCT02070991|58955437|FG000|Overall Study|Withdrawal by Subject|1|||
30920291|NCT02070991|58955438|FG001|Overall Study|Withdrawal by Subject|0|||
30920292|NCT02114515|58955446|FG000|Overall Study|Lost to Follow-up|52|||
30920293|NCT02114515|58955447|FG001|Overall Study|Lost to Follow-up|55|||
30920294|NCT02114515|58955446|FG000|Overall Study|Death|12|||
30920295|NCT02114515|58955447|FG001|Overall Study|Death|12|||
30920296|NCT02114515|58955446|FG000|Overall Study|Withdrawal by Subject|4|||
30920297|NCT02114515|58955447|FG001|Overall Study|Withdrawal by Subject|22|||
30920298|NCT02114515|58955446|FG000|Overall Study|Other|65|||
30920299|NCT02114515|58955447|FG001|Overall Study|Other|61|||
30920300|NCT01490086|58955458|FG000|Overall Study|Consent withdrawn|4|||
30920301|NCT01490086|58955459|FG001|Overall Study|Consent withdrawn|4|||
30920302|NCT01490086|58955460|FG002|Overall Study|Consent withdrawn|3|||
30920303|NCT01490086|58955461|FG003|Overall Study|Consent withdrawn|0|||
30920304|NCT01490086|58955462|FG004|Overall Study|Consent withdrawn|1|||
30920305|NCT01490086|58955458|FG000|Overall Study|Non-compliance|0|||
30920306|NCT01490086|58955459|FG001|Overall Study|Non-compliance|1|||
30920307|NCT01490086|58955460|FG002|Overall Study|Non-compliance|0|||
30920308|NCT01490086|58955461|FG003|Overall Study|Non-compliance|0|||
30920309|NCT01490086|58955462|FG004|Overall Study|Non-compliance|0|||
30920310|NCT01490086|58955458|FG000|Overall Study|Abnormal laboratory findings|1|||
30920311|NCT01490086|58955459|FG001|Overall Study|Abnormal laboratory findings|0|||
30920312|NCT01490086|58955460|FG002|Overall Study|Abnormal laboratory findings|0|||
30623328|NCT01169675|58635164|FG000|Overall Study|Progressive disease|13|||
30623329|NCT01169675|58635165|FG001|Overall Study|Progressive disease|2|||
30920313|NCT01490086|58955461|FG003|Overall Study|Abnormal laboratory findings|0|||
30920314|NCT01490086|58955462|FG004|Overall Study|Abnormal laboratory findings|0|||
30920315|NCT01490086|58955458|FG000|Overall Study|Lost to Follow-up|0|||
30920316|NCT01490086|58955459|FG001|Overall Study|Lost to Follow-up|0|||
30920317|NCT01490086|58955460|FG002|Overall Study|Lost to Follow-up|0|||
30920318|NCT01490086|58955461|FG003|Overall Study|Lost to Follow-up|0|||
30920319|NCT01490086|58955462|FG004|Overall Study|Lost to Follow-up|1|||
30920320|NCT01490086|58955458|FG000|Overall Study|Physician Decision|3|||
30920321|NCT01490086|58955459|FG001|Overall Study|Physician Decision|4|||
30920322|NCT01490086|58955460|FG002|Overall Study|Physician Decision|2|||
30623330|NCT01169675|58635166|FG002|Overall Study|Progressive disease|5|||
30623331|NCT01169675|58635167|FG003|Overall Study|Progressive disease|15|||
30920323|NCT01490086|58955461|FG003|Overall Study|Physician Decision|3|||
30920324|NCT01490086|58955462|FG004|Overall Study|Physician Decision|1|||
30920325|NCT01490086|58955458|FG000|Overall Study|Adverse Event|0|||
30920326|NCT01490086|58955459|FG001|Overall Study|Adverse Event|0|||
30920327|NCT01490086|58955460|FG002|Overall Study|Adverse Event|1|||
30920328|NCT01490086|58955461|FG003|Overall Study|Adverse Event|2|||
30920329|NCT01490086|58955462|FG004|Overall Study|Adverse Event|0|||
30920330|NCT01490086|58955458|FG000|Overall Study|Lack of Efficacy|0|||
30920331|NCT01490086|58955459|FG001|Overall Study|Lack of Efficacy|3|||
30920332|NCT01490086|58955460|FG002|Overall Study|Lack of Efficacy|1|||
30920333|NCT01490086|58955461|FG003|Overall Study|Lack of Efficacy|0|||
30920334|NCT01490086|58955462|FG004|Overall Study|Lack of Efficacy|8|||
30920335|NCT01490086|58955458|FG000|Overall Study|Worsening of symptoms|0|||
30920336|NCT01490086|58955459|FG001|Overall Study|Worsening of symptoms|1|||
30920337|NCT01490086|58955460|FG002|Overall Study|Worsening of symptoms|0|||
30920338|NCT01490086|58955461|FG003|Overall Study|Worsening of symptoms|1|||
30920339|NCT01490086|58955462|FG004|Overall Study|Worsening of symptoms|0|||
30920340|NCT01490086|58955458|FG000|Overall Study|Subject uncontrollable and abusive|0|||
30920341|NCT01490086|58955459|FG001|Overall Study|Subject uncontrollable and abusive|1|||
30920342|NCT01490086|58955460|FG002|Overall Study|Subject uncontrollable and abusive|0|||
30920343|NCT01490086|58955461|FG003|Overall Study|Subject uncontrollable and abusive|0|||
30920344|NCT01490086|58955462|FG004|Overall Study|Subject uncontrollable and abusive|0|||
30920345|NCT01490086|58955458|FG000|Overall Study|Subject left hospital|0|||
30920346|NCT01490086|58955459|FG001|Overall Study|Subject left hospital|1|||
30920347|NCT01490086|58955460|FG002|Overall Study|Subject left hospital|0|||
30920348|NCT01490086|58955461|FG003|Overall Study|Subject left hospital|1|||
30920349|NCT01490086|58955462|FG004|Overall Study|Subject left hospital|0|||
30920350|NCT02114203|58955477|FG000|Overall Study|Adverse Event|0|||
30920351|NCT02114203|58955478|FG001|Overall Study|Adverse Event|1|||
30920352|NCT02114203|58955479|FG002|Overall Study|Adverse Event|0|||
30920353|NCT02114203|58955477|FG000|Overall Study|Withdrawal by Subject|0|||
30920354|NCT02114203|58955478|FG001|Overall Study|Withdrawal by Subject|1|||
30920355|NCT02114203|58955479|FG002|Overall Study|Withdrawal by Subject|0|||
30920356|NCT02113579|58955489|FG000|Overall Study|Adverse Event|1|||
30920357|NCT02113579|58955490|FG001|Overall Study|Adverse Event|0|||
30920358|NCT02113579|58955489|FG000|Overall Study|Withdrawal by Subject|3|||
30920359|NCT02113579|58955490|FG001|Overall Study|Withdrawal by Subject|2|||
30920360|NCT02113579|58955489|FG000|Overall Study|Lost to Follow-up|6|||
30920361|NCT02113579|58955490|FG001|Overall Study|Lost to Follow-up|2|||
30920362|NCT01474018|58955498|FG000|Overall Study|Lost to Follow-up|0|||
30920363|NCT01474018|58955499|FG001|Overall Study|Lost to Follow-up|1|||
30920364|NCT01474018|58955498|FG000|Overall Study|Withdrawal by Subject|0|||
30920365|NCT01474018|58955499|FG001|Overall Study|Withdrawal by Subject|2|||
30920366|NCT02100475|58955507|FG000|Overall Study|Unclassified|1|||
30920367|NCT02100475|58955508|FG001|Overall Study|Unclassified|2|||
30920368|NCT02100475|58955507|FG000|Overall Study|Withdrawal criteria|1|||
30920369|NCT02100475|58955508|FG001|Overall Study|Withdrawal criteria|0|||
30920370|NCT02113189|58955517|FG000|Overall Study|Lost to follow up|2|||
30920371|NCT02113189|58955518|FG001|Overall Study|Lost to follow up|1|||
30920372|NCT02113189|58955519|FG002|Overall Study|Lost to follow up|3|||
30920373|NCT01440946|58955532|FG000|Overall Study|Lost to Follow-up|1|||
30920374|NCT01440946|58955533|FG001|Overall Study|Lost to Follow-up|1|||
30920375|NCT01440946|58955532|FG000|Overall Study|Physician Decision|1|||
30920376|NCT01440946|58955533|FG001|Overall Study|Physician Decision|0|||
30920377|NCT01450540|58955542|FG000|Overall Study|Withdrawal by Subject|19|||
30920378|NCT01450540|58955543|FG001|Overall Study|Withdrawal by Subject|13|||
30920379|NCT01450540|58955542|FG000|Overall Study|protocol deviation|3|||
30920380|NCT01450540|58955543|FG001|Overall Study|protocol deviation|23|||
30920381|NCT02070757|58955553|FG000|Overall Study|Adverse Event|107|||
30920382|NCT02070757|58955554|FG001|Overall Study|Adverse Event|99|||
30920383|NCT02070757|58955553|FG000|Overall Study|Lost to Follow-up|7|||
30920384|NCT02070757|58955554|FG001|Overall Study|Lost to Follow-up|4|||
30920385|NCT02070757|58955553|FG000|Overall Study|Protocol Violation|0|||
30920386|NCT02070757|58955554|FG001|Overall Study|Protocol Violation|4|||
30920387|NCT02070757|58955553|FG000|Overall Study|Withdrawal by Subject|1|||
30920388|NCT02070757|58955554|FG001|Overall Study|Withdrawal by Subject|3|||
30920389|NCT02070757|58955553|FG000|Overall Study|Investigator Decision|0|||
30920390|NCT02070757|58955554|FG001|Overall Study|Investigator Decision|2|||
30920391|NCT02070757|58955553|FG000|Overall Study|Discharged from Study Hospital|2|||
30920392|NCT02070757|58955554|FG001|Overall Study|Discharged from Study Hospital|2|||
30920393|NCT02100319|58955560|FG000|Overall Study|Case Report Forms Uncollected|11|||
30920394|NCT02100319|58955560|FG000|Overall Study|Protocol Deviation|5|||
30920395|NCT01625845|58955566|FG000|Overall Study|Adverse Event|1|||
30623332|NCT01169675|58635168|FG004|Overall Study|Progressive disease|1|||
30920396|NCT01625845|58955567|FG001|Overall Study|Adverse Event|2|||
30920397|NCT01625845|58955566|FG000|Overall Study|Lost to Follow-up|2|||
30920398|NCT01625845|58955567|FG001|Overall Study|Lost to Follow-up|1|||
30920399|NCT01625845|58955566|FG000|Overall Study|Withdrawal by Subject|2|||
30920400|NCT01625845|58955567|FG001|Overall Study|Withdrawal by Subject|0|||
30920401|NCT01473940|58955577|FG000|Induction Therapy|Death|0|||
30920402|NCT01473940|58955578|FG001|Induction Therapy|Death|0|||
30920403|NCT01473940|58955579|FG002|Induction Therapy|Death|1|||
30920404|NCT01473940|58955580|FG003|Induction Therapy|Death|1|||
30920405|NCT01473940|58955577|FG000|Induction Therapy|Progressive Disease|0|||
30920406|NCT01473940|58955578|FG001|Induction Therapy|Progressive Disease|1|||
30920407|NCT01473940|58955579|FG002|Induction Therapy|Progressive Disease|1|||
30920408|NCT01473940|58955580|FG003|Induction Therapy|Progressive Disease|0|||
30920409|NCT01473940|58955577|FG000|Maintenance Therapy|Progressive Disease|1|||
30920410|NCT01473940|58955578|FG001|Maintenance Therapy|Progressive Disease|2|||
30920411|NCT01473940|58955579|FG002|Maintenance Therapy|Progressive Disease|1|||
30920412|NCT01473940|58955580|FG003|Maintenance Therapy|Progressive Disease|4|||
30920413|NCT01832727|58955602|FG000|Overall Study|Adverse Event|4|||
30920414|NCT01832727|58955603|FG001|Overall Study|Adverse Event|6|||
30920415|NCT01832727|58955604|FG002|Overall Study|Adverse Event|1|||
30920416|NCT01832727|58955605|FG003|Overall Study|Adverse Event|0|||
30920417|NCT01832727|58955606|FG004|Overall Study|Adverse Event|1|||
30920418|NCT01832727|58955607|FG005|Overall Study|Adverse Event|1|||
30920419|NCT01832727|58955608|FG006|Overall Study|Adverse Event|2|||
30920420|NCT01832727|58955609|FG007|Overall Study|Adverse Event|1|||
30920421|NCT01832727|58955610|FG008|Overall Study|Adverse Event|9|||
30920422|NCT01832727|58955602|FG000|Overall Study|Disease progression|3|||
30920423|NCT01832727|58955603|FG001|Overall Study|Disease progression|0|||
30920424|NCT01832727|58955604|FG002|Overall Study|Disease progression|2|||
30920425|NCT01832727|58955605|FG003|Overall Study|Disease progression|1|||
30920426|NCT01832727|58955606|FG004|Overall Study|Disease progression|3|||
30920427|NCT01832727|58955607|FG005|Overall Study|Disease progression|3|||
30920428|NCT01832727|58955608|FG006|Overall Study|Disease progression|6|||
30920429|NCT01832727|58955609|FG007|Overall Study|Disease progression|2|||
30920430|NCT01832727|58955610|FG008|Overall Study|Disease progression|7|||
30920431|NCT01832727|58955602|FG000|Overall Study|Lost to Follow-up|0|||
30920432|NCT01832727|58955603|FG001|Overall Study|Lost to Follow-up|0|||
30920433|NCT01832727|58955604|FG002|Overall Study|Lost to Follow-up|0|||
30920434|NCT01832727|58955605|FG003|Overall Study|Lost to Follow-up|1|||
30920435|NCT01832727|58955606|FG004|Overall Study|Lost to Follow-up|0|||
30920436|NCT01832727|58955607|FG005|Overall Study|Lost to Follow-up|0|||
30920437|NCT01832727|58955608|FG006|Overall Study|Lost to Follow-up|0|||
30920438|NCT01832727|58955609|FG007|Overall Study|Lost to Follow-up|0|||
30920439|NCT01832727|58955610|FG008|Overall Study|Lost to Follow-up|0|||
30920440|NCT01832727|58955602|FG000|Overall Study|Physician Decision|1|||
30920441|NCT01832727|58955603|FG001|Overall Study|Physician Decision|0|||
30920442|NCT01832727|58955604|FG002|Overall Study|Physician Decision|0|||
30920443|NCT01832727|58955605|FG003|Overall Study|Physician Decision|1|||
30920444|NCT01832727|58955606|FG004|Overall Study|Physician Decision|0|||
30920445|NCT01832727|58955607|FG005|Overall Study|Physician Decision|1|||
30920446|NCT01832727|58955608|FG006|Overall Study|Physician Decision|0|||
30920447|NCT01832727|58955609|FG007|Overall Study|Physician Decision|0|||
30920448|NCT01832727|58955610|FG008|Overall Study|Physician Decision|0|||
30920449|NCT01832727|58955602|FG000|Overall Study|Withdrawal by Subject|1|||
30920450|NCT01832727|58955603|FG001|Overall Study|Withdrawal by Subject|1|||
30920451|NCT01832727|58955604|FG002|Overall Study|Withdrawal by Subject|0|||
30920452|NCT01832727|58955605|FG003|Overall Study|Withdrawal by Subject|1|||
30920453|NCT01832727|58955606|FG004|Overall Study|Withdrawal by Subject|0|||
30920454|NCT01832727|58955607|FG005|Overall Study|Withdrawal by Subject|1|||
30920455|NCT01832727|58955608|FG006|Overall Study|Withdrawal by Subject|0|||
30920456|NCT01832727|58955609|FG007|Overall Study|Withdrawal by Subject|2|||
30826876|NCT01370616|58849358|FG000|Overall Study|Physician Decision|6|||
30826877|NCT01370616|58849359|FG001|Overall Study|Physician Decision|6|||
30826878|NCT01370616|58849358|FG000|Overall Study|Progressive Disease|0|||
30826879|NCT01370616|58849359|FG001|Overall Study|Progressive Disease|1|||
30826880|NCT01370616|58849358|FG000|Overall Study|Recovery|1|||
30826881|NCT01370616|58849359|FG001|Overall Study|Recovery|0|||
30826882|NCT01370616|58849358|FG000|Overall Study|Technical Problems|3|||
30826883|NCT01370616|58849359|FG001|Overall Study|Technical Problems|5|||
30826884|NCT01370616|58849358|FG000|Overall Study|Withdrawal by Subject|34|||
30920457|NCT01832727|58955610|FG008|Overall Study|Withdrawal by Subject|1|||
30920458|NCT01832727|58955602|FG000|Overall Study|Study terminated by sponsor|0|||
30920459|NCT01832727|58955603|FG001|Overall Study|Study terminated by sponsor|0|||
30920460|NCT01832727|58955604|FG002|Overall Study|Study terminated by sponsor|0|||
30920461|NCT01832727|58955605|FG003|Overall Study|Study terminated by sponsor|0|||
30920462|NCT01832727|58955606|FG004|Overall Study|Study terminated by sponsor|0|||
30826885|NCT01370616|58849359|FG001|Overall Study|Withdrawal by Subject|34|||
30826886|NCT02916927|58849372|FG000|Overall Study|Discharged prior to study drug receipt|0|||
30826887|NCT02916927|58849373|FG001|Overall Study|Discharged prior to study drug receipt|2|||
30920463|NCT01832727|58955607|FG005|Overall Study|Study terminated by sponsor|0|||
30920464|NCT01832727|58955608|FG006|Overall Study|Study terminated by sponsor|0|||
30920465|NCT01832727|58955609|FG007|Overall Study|Study terminated by sponsor|1|||
30920466|NCT01832727|58955610|FG008|Overall Study|Study terminated by sponsor|1|||
30920467|NCT01473394|58955641|FG000|Overall Study|Adverse Event|13|||
30920468|NCT01473394|58955642|FG001|Overall Study|Adverse Event|16|||
30920469|NCT01473394|58955641|FG000|Overall Study|Insufficient Therapeutic Response|4|||
30920470|NCT01473394|58955642|FG001|Overall Study|Insufficient Therapeutic Response|1|||
30920471|NCT01473394|58955641|FG000|Overall Study|Protocol Violation|7|||
30920472|NCT01473394|58955642|FG001|Overall Study|Protocol Violation|5|||
30920473|NCT01473394|58955641|FG000|Overall Study|Withdrew Consent|12|||
30920474|NCT01473394|58955642|FG001|Overall Study|Withdrew Consent|10|||
30920475|NCT01473394|58955641|FG000|Overall Study|Lost to Follow-up|9|||
30920476|NCT01473394|58955642|FG001|Overall Study|Lost to Follow-up|11|||
30920477|NCT01449682|58955650|FG000|Overall Study|Death|0|||
30920478|NCT01449682|58955651|FG001|Overall Study|Death|1|||
30920479|NCT01449682|58955650|FG000|Overall Study|Adverse Event|1|||
30920480|NCT01449682|58955651|FG001|Overall Study|Adverse Event|0|||
30920481|NCT01449526|58955659|FG000|Overall Study|Lost to Follow-up|1|||
30920482|NCT01449526|58955660|FG001|Overall Study|Lost to Follow-up|2|||
30920483|NCT01449526|58955659|FG000|Overall Study|Withdrawal by Subject|1|||
30920484|NCT01449526|58955660|FG001|Overall Study|Withdrawal by Subject|1|||
30920485|NCT01449526|58955659|FG000|Overall Study|Symptoms/complaints|0|||
30920486|NCT01449526|58955660|FG001|Overall Study|Symptoms/complaints|1|||
30920487|NCT01449526|58955659|FG000|Overall Study|Lack of Motivation|0|||
30920488|NCT01449526|58955660|FG001|Overall Study|Lack of Motivation|1|||
30920489|NCT01449526|58955659|FG000|Overall Study|Cannot maintain visits|0|||
30920490|NCT01449526|58955660|FG001|Overall Study|Cannot maintain visits|1|||
30920491|NCT01440322|58955668|FG000|Overall Study|Discomfort|2|||
30920492|NCT01440322|58955669|FG001|Overall Study|Discomfort|0|||
30920493|NCT01440322|58955668|FG000|Overall Study|Biomicroscopy|1|||
30920494|NCT01440322|58955669|FG001|Overall Study|Biomicroscopy|0|||
30920495|NCT01440322|58955668|FG000|Overall Study|Symptoms and Problems|1|||
30920496|NCT01440322|58955669|FG001|Overall Study|Symptoms and Problems|0|||
30920497|NCT01440322|58955668|FG000|Overall Study|Unacceptable Subjective Vision|1|||
30920498|NCT01440322|58955669|FG001|Overall Study|Unacceptable Subjective Vision|0|||
30920499|NCT01440322|58955668|FG000|Overall Study|Other Product Related|1|||
30920500|NCT01440322|58955669|FG001|Overall Study|Other Product Related|0|||
30920501|NCT01440322|58955668|FG000|Overall Study|Unrelated Medical Problem|0|||
30920502|NCT01440322|58955669|FG001|Overall Study|Unrelated Medical Problem|1|||
30920503|NCT01440322|58955668|FG000|Overall Study|Other Non-Product Related|1|||
30920504|NCT01440322|58955669|FG001|Overall Study|Other Non-Product Related|0|||
30920505|NCT01832493|58955675|FG000|Overall Study|Physician Decision|2|||
30920506|NCT01832493|58955675|FG000|Overall Study|Protocol Violation|4|||
30920507|NCT01832493|58955675|FG000|Overall Study|Unable to place LV lead|2|||
30920508|NCT01831791|58955679|FG000|Overall Study|Withdrawal by Subject|10|||
30920509|NCT01857531|58955683|FG000|Overall Study|Withdrawal by Subject|4|||
30920510|NCT02166047|58955699|FG000|Overall Study|Withdrawal by Participant|0|||
30920511|NCT02166047|58955700|FG001|Overall Study|Withdrawal by Participant|1|||
30920512|NCT02166047|58955701|FG002|Overall Study|Withdrawal by Participant|2|||
30920513|NCT02166047|58955702|FG003|Overall Study|Withdrawal by Participant|0|||
30920514|NCT02166047|58955703|FG004|Overall Study|Withdrawal by Participant|0|||
30826888|NCT02916927|58849372|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
30826889|NCT02916927|58849373|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
30826890|NCT02916927|58849372|FG000|Overall Study|Withdrawal before first time point|1|||
30826891|NCT02916927|58849373|FG001|Overall Study|Withdrawal before first time point|0|||
30826892|NCT02916693|58849379|FG000|Overall Study|Lost to Follow-up|7|||
30826893|NCT02574455|58849389|FG000|Overall Study|Death|197|||
30826894|NCT02574455|58849390|FG001|Overall Study|Death|210|||
30826895|NCT02574455|58849389|FG000|Overall Study|Withdrawal of Consent|11|||
30826896|NCT02574455|58849390|FG001|Overall Study|Withdrawal of Consent|28|||
30826897|NCT02574455|58849389|FG000|Overall Study|Lost to Follow-up|4|||
30826898|NCT02574455|58849390|FG001|Overall Study|Lost to Follow-up|4|||
30826899|NCT02574455|58849389|FG000|Overall Study|Sponsor's Decision|55|||
30826900|NCT02574455|58849390|FG001|Overall Study|Sponsor's Decision|20|||
30826901|NCT02795832|58849402|FG000|Overall Study|Adverse Event|0|||
30826902|NCT02795832|58849403|FG001|Overall Study|Adverse Event|0|||
30826903|NCT02795832|58849404|FG002|Overall Study|Adverse Event|0|||
30920515|NCT02166047|58955704|FG005|Overall Study|Withdrawal by Participant|0|||
30826904|NCT02795832|58849405|FG003|Overall Study|Adverse Event|0|||
30826905|NCT02795832|58849406|FG004|Overall Study|Adverse Event|0|||
30826906|NCT02795832|58849407|FG005|Overall Study|Adverse Event|3|||
30826907|NCT02794974|58849431|FG000|Overall Study|Physician Decision|0|||
30826908|NCT02794974|58849432|FG001|Overall Study|Physician Decision|1|||
30920516|NCT02166047|58955705|FG006|Overall Study|Withdrawal by Participant|1|||
30920517|NCT02166047|58955706|FG007|Overall Study|Withdrawal by Participant|0|||
30920518|NCT02166047|58955707|FG008|Overall Study|Withdrawal by Participant|0|||
30920519|NCT02166047|58955708|FG009|Overall Study|Withdrawal by Participant|0|||
30826909|NCT02419417|58849449|FG000|Overall Study|Disease progression|5|||
30920520|NCT02166047|58955709|FG010|Overall Study|Withdrawal by Participant|0|||
30920521|NCT02166047|58955710|FG011|Overall Study|Withdrawal by Participant|0|||
30920522|NCT02166047|58955699|FG000|Overall Study|Adverse Event|0|||
30920523|NCT02166047|58955700|FG001|Overall Study|Adverse Event|0|||
30920524|NCT02166047|58955701|FG002|Overall Study|Adverse Event|0|||
30920525|NCT02166047|58955702|FG003|Overall Study|Adverse Event|0|||
30920526|NCT02166047|58955703|FG004|Overall Study|Adverse Event|1|||
30920527|NCT02166047|58955704|FG005|Overall Study|Adverse Event|0|||
30920528|NCT02166047|58955705|FG006|Overall Study|Adverse Event|1|||
30920529|NCT02166047|58955706|FG007|Overall Study|Adverse Event|0|||
30920530|NCT02166047|58955707|FG008|Overall Study|Adverse Event|0|||
30920531|NCT02166047|58955708|FG009|Overall Study|Adverse Event|0|||
30920532|NCT02166047|58955709|FG010|Overall Study|Adverse Event|2|||
30920533|NCT02166047|58955710|FG011|Overall Study|Adverse Event|0|||
30920534|NCT01493284|58955736|FG000|Overall Study|Death|29|||
30920535|NCT01493284|58955736|FG000|Overall Study|Withdrawal by Subject|32|||
30920536|NCT02165735|58955742|FG000|Overall Study|Lost to Follow-up|12|||
30920537|NCT02165735|58955743|FG001|Overall Study|Lost to Follow-up|10|||
30920538|NCT02165735|58955742|FG000|Overall Study|Withdrawal by Subject|3|||
30920539|NCT02165735|58955743|FG001|Overall Study|Withdrawal by Subject|0|||
30920540|NCT02165735|58955742|FG000|Overall Study|Participant indicated lack of time|1|||
30920541|NCT02165735|58955743|FG001|Overall Study|Participant indicated lack of time|3|||
30920542|NCT02165735|58955742|FG000|Overall Study|Protocol Violation|0|||
30920543|NCT02165735|58955743|FG001|Overall Study|Protocol Violation|1|||
30920544|NCT02069899|58955752|FG000|Overall Study|Adverse Event|6|||
30920545|NCT02069899|58955753|FG001|Overall Study|Adverse Event|0|||
30920546|NCT02069899|58955754|FG002|Overall Study|Adverse Event|1|||
30920547|NCT02069899|58955752|FG000|Overall Study|Withdrawal by Participant|2|||
30920548|NCT02069899|58955753|FG001|Overall Study|Withdrawal by Participant|0|||
30920549|NCT02069899|58955754|FG002|Overall Study|Withdrawal by Participant|0|||
30920550|NCT02069899|58955752|FG000|Overall Study|Lost to Follow-up|1|||
30920551|NCT02069899|58955753|FG001|Overall Study|Lost to Follow-up|0|||
30920552|NCT02069899|58955754|FG002|Overall Study|Lost to Follow-up|1|||
30920553|NCT02069899|58955752|FG000|Overall Study|Other|4|||
30920554|NCT02069899|58955753|FG001|Overall Study|Other|0|||
30920555|NCT02069899|58955754|FG002|Overall Study|Other|0|||
30920556|NCT02069899|58955752|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
30920557|NCT02069899|58955753|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
30920558|NCT02069899|58955754|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
30920559|NCT02069899|58955752|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
30920560|NCT02069899|58955753|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
30920561|NCT02069899|58955754|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
30920562|NCT01831089|58955769|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
30920563|NCT01831089|58955770|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
30920564|NCT01831089|58955771|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
30920565|NCT01831089|58955772|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
30920566|NCT01831089|58955773|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
30920567|NCT01831089|58955774|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
30920568|NCT01831089|58955769|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
30920569|NCT01831089|58955770|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
30920570|NCT01831089|58955771|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
30920571|NCT01831089|58955772|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
30920572|NCT01831089|58955773|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
30920573|NCT01831089|58955774|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
30920574|NCT01831089|58955769|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
30920575|NCT01831089|58955770|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
30920576|NCT01831089|58955771|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
30826910|NCT02419417|58849450|FG001|Overall Study|Disease progression|4|||
30826911|NCT02419417|58849451|FG002|Overall Study|Disease progression|13|||
30826912|NCT02419417|58849452|FG003|Overall Study|Disease progression|10|||
30826913|NCT02419417|58849453|FG004|Overall Study|Disease progression|10|||
30826914|NCT02419417|58849454|FG005|Overall Study|Disease progression|3|||
30826915|NCT02419417|58849455|FG006|Overall Study|Disease progression|4|||
30920577|NCT01831089|58955772|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
30920578|NCT01831089|58955773|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
30920579|NCT01831089|58955774|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
30920580|NCT01831089|58955769|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
30920581|NCT01831089|58955770|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
30920582|NCT01831089|58955771|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
30920583|NCT01831089|58955772|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
30920584|NCT01831089|58955773|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
30920585|NCT01831089|58955774|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
30920586|NCT01831089|58955769|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
30920587|NCT01831089|58955770|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
30826916|NCT02419417|58849456|FG007|Overall Study|Disease progression|5|||
30826917|NCT02419417|58849457|FG008|Overall Study|Disease progression|13|||
30826918|NCT02419417|58849458|FG009|Overall Study|Disease progression|9|||
30826919|NCT02419417|58849459|FG010|Overall Study|Disease progression|0|||
30826920|NCT02419417|58849449|FG000|Overall Study|Study drug toxicity|0|||
30826921|NCT02419417|58849450|FG001|Overall Study|Study drug toxicity|0|||
30826922|NCT02419417|58849451|FG002|Overall Study|Study drug toxicity|0|||
30826923|NCT02419417|58849452|FG003|Overall Study|Study drug toxicity|0|||
30826924|NCT02419417|58849453|FG004|Overall Study|Study drug toxicity|1|||
30826925|NCT02419417|58849454|FG005|Overall Study|Study drug toxicity|0|||
30826926|NCT02419417|58849455|FG006|Overall Study|Study drug toxicity|0|||
30826927|NCT02419417|58849456|FG007|Overall Study|Study drug toxicity|0|||
30920588|NCT01831089|58955771|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
30920589|NCT01831089|58955772|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
30920590|NCT01831089|58955773|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
30920591|NCT01831089|58955774|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
30920592|NCT01831089|58955769|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
30920593|NCT01831089|58955770|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
30920594|NCT01831089|58955771|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
30920595|NCT01831089|58955772|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
30920596|NCT01831089|58955773|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
30920597|NCT01831089|58955774|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
30920598|NCT01831089|58955769|FG000|Cohort III: Dose Level 3|Global end of study|0|||
30920599|NCT01831089|58955770|FG001|Cohort III: Dose Level 3|Global end of study|0|||
30920600|NCT01831089|58955771|FG002|Cohort III: Dose Level 3|Global end of study|1|||
30920601|NCT01831089|58955772|FG003|Cohort III: Dose Level 3|Global end of study|0|||
30920602|NCT01831089|58955773|FG004|Cohort III: Dose Level 3|Global end of study|0|||
30920603|NCT01831089|58955774|FG005|Cohort III: Dose Level 3|Global end of study|0|||
30920604|NCT01831089|58955769|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
30920605|NCT01831089|58955770|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
30920606|NCT01831089|58955771|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
30920607|NCT01831089|58955772|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
30920608|NCT01831089|58955773|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
30920609|NCT01831089|58955774|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
30920610|NCT01831089|58955769|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
30920611|NCT01831089|58955770|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
30920612|NCT01831089|58955771|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
30920613|NCT01831089|58955772|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
30920614|NCT01831089|58955773|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
30920615|NCT01831089|58955774|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
30920616|NCT01831089|58955769|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
30920617|NCT01831089|58955770|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
30920618|NCT01831089|58955771|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
30920619|NCT01831089|58955772|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
30826928|NCT02419417|58849457|FG008|Overall Study|Study drug toxicity|0|||
30826929|NCT02419417|58849458|FG009|Overall Study|Study drug toxicity|0|||
30826930|NCT02419417|58849459|FG010|Overall Study|Study drug toxicity|0|||
30826931|NCT02419417|58849449|FG000|Overall Study|Adverse event unrelated to study drug|0|||
30826932|NCT02419417|58849450|FG001|Overall Study|Adverse event unrelated to study drug|0|||
30826933|NCT02419417|58849451|FG002|Overall Study|Adverse event unrelated to study drug|0|||
30826934|NCT02419417|58849452|FG003|Overall Study|Adverse event unrelated to study drug|0|||
30826935|NCT02419417|58849453|FG004|Overall Study|Adverse event unrelated to study drug|2|||
30826936|NCT02419417|58849454|FG005|Overall Study|Adverse event unrelated to study drug|1|||
30826937|NCT02419417|58849455|FG006|Overall Study|Adverse event unrelated to study drug|0|||
30826938|NCT02419417|58849456|FG007|Overall Study|Adverse event unrelated to study drug|1|||
30826939|NCT02419417|58849457|FG008|Overall Study|Adverse event unrelated to study drug|0|||
30826940|NCT02419417|58849458|FG009|Overall Study|Adverse event unrelated to study drug|0|||
30826941|NCT02419417|58849459|FG010|Overall Study|Adverse event unrelated to study drug|0|||
30826942|NCT02419417|58849449|FG000|Overall Study|Participant request to discontinue|0|||
30826943|NCT02419417|58849450|FG001|Overall Study|Participant request to discontinue|0|||
30826944|NCT02419417|58849451|FG002|Overall Study|Participant request to discontinue|0|||
30826945|NCT02419417|58849452|FG003|Overall Study|Participant request to discontinue|0|||
30826946|NCT02419417|58849453|FG004|Overall Study|Participant request to discontinue|0|||
30826947|NCT02419417|58849454|FG005|Overall Study|Participant request to discontinue|0|||
30826948|NCT02419417|58849455|FG006|Overall Study|Participant request to discontinue|0|||
30826949|NCT02419417|58849456|FG007|Overall Study|Participant request to discontinue|0|||
30826950|NCT02419417|58849457|FG008|Overall Study|Participant request to discontinue|0|||
30920620|NCT01831089|58955773|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
30920621|NCT01831089|58955774|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
30920622|NCT01831089|58955769|FG000|Cohort V: Dose Level 5|Death|0|||
30920623|NCT01831089|58955770|FG001|Cohort V: Dose Level 5|Death|0|||
30920624|NCT01831089|58955771|FG002|Cohort V: Dose Level 5|Death|0|||
30826951|NCT02419417|58849458|FG009|Overall Study|Participant request to discontinue|1|||
30920625|NCT01831089|58955772|FG003|Cohort V: Dose Level 5|Death|0|||
30920626|NCT01831089|58955773|FG004|Cohort V: Dose Level 5|Death|1|||
30920627|NCT01831089|58955774|FG005|Cohort V: Dose Level 5|Death|0|||
30920628|NCT01831089|58955769|FG000|Cohort V: Dose Level 5|Global end of study|0|||
30920629|NCT01831089|58955770|FG001|Cohort V: Dose Level 5|Global end of study|0|||
30920630|NCT01831089|58955771|FG002|Cohort V: Dose Level 5|Global end of study|0|||
30826952|NCT02419417|58849459|FG010|Overall Study|Participant request to discontinue|0|||
30826953|NCT02419417|58849449|FG000|Overall Study|Withdrawal by Subject|0|||
30826954|NCT02419417|58849450|FG001|Overall Study|Withdrawal by Subject|0|||
30826955|NCT02419417|58849451|FG002|Overall Study|Withdrawal by Subject|0|||
30920631|NCT01831089|58955772|FG003|Cohort V: Dose Level 5|Global end of study|0|||
30920632|NCT01831089|58955773|FG004|Cohort V: Dose Level 5|Global end of study|2|||
30920633|NCT01831089|58955774|FG005|Cohort V: Dose Level 5|Global end of study|0|||
30920634|NCT01831089|58955769|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
30920635|NCT01831089|58955770|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
30920636|NCT01831089|58955771|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
30920637|NCT01831089|58955772|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
30920638|NCT01831089|58955773|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
30920639|NCT01831089|58955774|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
30920640|NCT01831089|58955769|FG000|Cohort B: Arm B|Progressive disease|0|||
30826956|NCT02419417|58849452|FG003|Overall Study|Withdrawal by Subject|0|||
30826957|NCT02419417|58849453|FG004|Overall Study|Withdrawal by Subject|0|||
30826958|NCT02419417|58849454|FG005|Overall Study|Withdrawal by Subject|0|||
30826959|NCT02419417|58849455|FG006|Overall Study|Withdrawal by Subject|0|||
30826960|NCT02419417|58849456|FG007|Overall Study|Withdrawal by Subject|0|||
30826961|NCT02419417|58849457|FG008|Overall Study|Withdrawal by Subject|0|||
30826962|NCT02419417|58849458|FG009|Overall Study|Withdrawal by Subject|0|||
30826963|NCT02419417|58849459|FG010|Overall Study|Withdrawal by Subject|1|||
30826964|NCT00777491|58849500|FG000|Overall Study|Protocol Violation|0|||
30826965|NCT00777491|58849501|FG001|Overall Study|Protocol Violation|2|||
30826966|NCT00777491|58849500|FG000|Overall Study|Did not receive any protocol treatment|2|||
30826967|NCT00777491|58849501|FG001|Overall Study|Did not receive any protocol treatment|0|||
30826968|NCT02066532|58849511|FG000|Phase II|Withdrawal by Subject|1|||
30826969|NCT02066532|58849512|FG001|Phase II|Withdrawal by Subject|0|||
30920641|NCT01831089|58955770|FG001|Cohort B: Arm B|Progressive disease|0|||
30920642|NCT01831089|58955771|FG002|Cohort B: Arm B|Progressive disease|0|||
30920643|NCT01831089|58955772|FG003|Cohort B: Arm B|Progressive disease|0|||
30920644|NCT01831089|58955773|FG004|Cohort B: Arm B|Progressive disease|0|||
30920645|NCT01831089|58955774|FG005|Cohort B: Arm B|Progressive disease|8|||
30920646|NCT01831089|58955769|FG000|Cohort B: Arm B|Physician Decision|0|||
30920647|NCT01831089|58955770|FG001|Cohort B: Arm B|Physician Decision|0|||
30920648|NCT01831089|58955771|FG002|Cohort B: Arm B|Physician Decision|0|||
30920649|NCT01831089|58955772|FG003|Cohort B: Arm B|Physician Decision|0|||
30920650|NCT01831089|58955773|FG004|Cohort B: Arm B|Physician Decision|0|||
30920651|NCT01831089|58955774|FG005|Cohort B: Arm B|Physician Decision|2|||
30920652|NCT01831089|58955769|FG000|Cohort B: Arm B|Never treated|0|||
30920653|NCT01831089|58955770|FG001|Cohort B: Arm B|Never treated|0|||
30920654|NCT01831089|58955771|FG002|Cohort B: Arm B|Never treated|0|||
30826970|NCT02066532|58849513|FG002|Phase II|Withdrawal by Subject|0|||
30826971|NCT02066532|58849514|FG003|Phase II|Withdrawal by Subject|0|||
30826972|NCT03077711|58849521|FG000|Overall Study|Lost to Follow-up|2|||
30826973|NCT03077711|58849522|FG001|Overall Study|Lost to Follow-up|2|||
30826974|NCT03077711|58849521|FG000|Overall Study|noncompliant taking medication|2|||
30826975|NCT03077711|58849522|FG001|Overall Study|noncompliant taking medication|0|||
30826976|NCT04311463|58849549|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
30826977|NCT04311463|58849550|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
30826978|NCT04311463|58849549|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
30826979|NCT04311463|58849550|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
30826980|NCT04311463|58849549|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
30826981|NCT04311463|58849550|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
30826982|NCT01370538|58849563|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
30920655|NCT01831089|58955772|FG003|Cohort B: Arm B|Never treated|0|||
30920656|NCT01831089|58955773|FG004|Cohort B: Arm B|Never treated|0|||
30920657|NCT01831089|58955774|FG005|Cohort B: Arm B|Never treated|2|||
30826983|NCT01370538|58849564|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
30826984|NCT01370538|58849563|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30826985|NCT01370538|58849564|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
30826986|NCT01370538|58849563|FG000|Overall Study|Adverse Event|1|||
30826987|NCT01370538|58849564|FG001|Overall Study|Adverse Event|0|||
30826988|NCT01370538|58849563|FG000|Overall Study|Protocol Violation|8|||
30826989|NCT01370538|58849564|FG001|Overall Study|Protocol Violation|5|||
30920658|NCT01831089|58955769|FG000|Cohort B: Arm B|Adverse Event|0|||
30920659|NCT01831089|58955770|FG001|Cohort B: Arm B|Adverse Event|0|||
30920660|NCT01831089|58955771|FG002|Cohort B: Arm B|Adverse Event|0|||
30920661|NCT01831089|58955772|FG003|Cohort B: Arm B|Adverse Event|0|||
30920662|NCT01831089|58955773|FG004|Cohort B: Arm B|Adverse Event|0|||
30920663|NCT01831089|58955774|FG005|Cohort B: Arm B|Adverse Event|1|||
30920664|NCT01831089|58955769|FG000|Cohort B: Arm B|Global end of study|0|||
30623333|NCT01169675|58635164|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
30623334|NCT01169675|58635165|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30623335|NCT01169675|58635166|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30623336|NCT01169675|58635167|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30623337|NCT01169675|58635168|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
30623338|NCT01169675|58635164|FG000|Overall Study|Adverse Event|5|||
30623339|NCT01169675|58635165|FG001|Overall Study|Adverse Event|1|||
30623340|NCT01169675|58635166|FG002|Overall Study|Adverse Event|2|||
30623341|NCT01169675|58635167|FG003|Overall Study|Adverse Event|0|||
30623342|NCT01169675|58635168|FG004|Overall Study|Adverse Event|0|||
30623343|NCT01169675|58635164|FG000|Overall Study|Withdrawal by Subject|1|||
30623344|NCT01169675|58635165|FG001|Overall Study|Withdrawal by Subject|0|||
30623345|NCT01169675|58635166|FG002|Overall Study|Withdrawal by Subject|0|||
30623346|NCT01169675|58635167|FG003|Overall Study|Withdrawal by Subject|1|||
30623347|NCT01169675|58635168|FG004|Overall Study|Withdrawal by Subject|2|||
30623348|NCT01169675|58635164|FG000|Overall Study|Other Reason Not Defined Above|0|||
30623349|NCT01169675|58635165|FG001|Overall Study|Other Reason Not Defined Above|0|||
30920665|NCT01831089|58955770|FG001|Cohort B: Arm B|Global end of study|0|||
30920666|NCT01831089|58955771|FG002|Cohort B: Arm B|Global end of study|0|||
30920667|NCT01831089|58955772|FG003|Cohort B: Arm B|Global end of study|0|||
30920668|NCT01831089|58955773|FG004|Cohort B: Arm B|Global end of study|0|||
30920669|NCT01831089|58955774|FG005|Cohort B: Arm B|Global end of study|1|||
30920670|NCT02112877|58955791|FG000|Overall Study|Withdrawal by Subject|1|||
30920671|NCT02112877|58955792|FG001|Overall Study|Withdrawal by Subject|7|||
30920672|NCT02112877|58955791|FG000|Overall Study|Visit Missed|1|||
30920673|NCT02112877|58955792|FG001|Overall Study|Visit Missed|6|||
30920674|NCT02098369|58955803|FG000|Overall Study|Withdrawal by Subject|1|||
30920675|NCT02098369|58955804|FG001|Overall Study|Withdrawal by Subject|5|||
30920676|NCT02098369|58955805|FG002|Overall Study|Withdrawal by Subject|0|||
30920677|NCT02098369|58955803|FG000|Overall Study|Lost to Follow-up|5|||
30920678|NCT02098369|58955804|FG001|Overall Study|Lost to Follow-up|1|||
30920679|NCT02098369|58955805|FG002|Overall Study|Lost to Follow-up|3|||
30920680|NCT02098369|58955803|FG000|Overall Study|Death|1|||
30920681|NCT02098369|58955804|FG001|Overall Study|Death|1|||
30920682|NCT02098369|58955805|FG002|Overall Study|Death|1|||
30920683|NCT02098369|58955803|FG000|Overall Study|Other|0|||
30920684|NCT02098369|58955804|FG001|Overall Study|Other|2|||
30920685|NCT02098369|58955805|FG002|Overall Study|Other|1|||
30920686|NCT02111785|58955817|FG000|Overall Study|Death|0|||
30920687|NCT02111785|58955818|FG001|Overall Study|Death|1|||
30920688|NCT02111785|58955819|FG002|Overall Study|Death|0|||
30920689|NCT02111785|58955820|FG003|Overall Study|Death|0|||
30920690|NCT02068885|58955837|FG000|Overall Study|Withdrew|3|||
30920691|NCT02068885|58955838|FG001|Overall Study|Withdrew|5|||
30920692|NCT02068885|58955839|FG002|Overall Study|Withdrew|8|||
30920693|NCT02068495|58955848|FG000|Overall Study|Case Report Forms Uncollected|60|||
30920694|NCT02068495|58955848|FG000|Overall Study|Protocol Deviation|49|||
30920695|NCT02097823|58955854|FG000|Overall Study|Withdrawal by Subject|1|||
30920696|NCT02097823|58955855|FG001|Overall Study|Withdrawal by Subject|1|||
30920697|NCT01830855|58955866|FG000|Overall Study|Other|7|||
30920698|NCT01830855|58955867|FG001|Overall Study|Other|1|||
30920699|NCT01830855|58955868|FG002|Overall Study|Other|4|||
30920700|NCT01830855|58955869|FG003|Overall Study|Other|4|||
30920701|NCT01830855|58955866|FG000|Overall Study|Medication error without associated AE|1|||
30920702|NCT01830855|58955867|FG001|Overall Study|Medication error without associated AE|0|||
30920703|NCT01830855|58955868|FG002|Overall Study|Medication error without associated AE|0|||
30920704|NCT01830855|58955869|FG003|Overall Study|Medication error without associated AE|1|||
30920705|NCT01830855|58955866|FG000|Overall Study|Pregnancy|3|||
30920706|NCT01830855|58955867|FG001|Overall Study|Pregnancy|1|||
30920707|NCT01830855|58955868|FG002|Overall Study|Pregnancy|2|||
30920708|NCT01830855|58955869|FG003|Overall Study|Pregnancy|1|||
30920709|NCT01830855|58955866|FG000|Overall Study|No longer meets eligibility criteria|11|||
30623350|NCT01169675|58635166|FG002|Overall Study|Other Reason Not Defined Above|0|||
30623351|NCT01169675|58635167|FG003|Overall Study|Other Reason Not Defined Above|1|||
30623352|NCT01169675|58635168|FG004|Overall Study|Other Reason Not Defined Above|1|||
30623353|NCT00924664|58635182|FG000|Overall Study|Adverse Event|23|||
30623354|NCT00924664|58635183|FG001|Overall Study|Adverse Event|39|||
30920710|NCT01830855|58955867|FG001|Overall Study|No longer meets eligibility criteria|2|||
30920711|NCT01830855|58955868|FG002|Overall Study|No longer meets eligibility criteria|3|||
30920712|NCT01830855|58955869|FG003|Overall Study|No longer meets eligibility criteria|5|||
30920713|NCT01830855|58955866|FG000|Overall Study|Adverse Event|11|||
30920714|NCT01830855|58955867|FG001|Overall Study|Adverse Event|5|||
30920715|NCT01830855|58955868|FG002|Overall Study|Adverse Event|6|||
30920716|NCT01830855|58955869|FG003|Overall Study|Adverse Event|3|||
30920717|NCT01830855|58955866|FG000|Overall Study|Protocol deviation|10|||
30920718|NCT01830855|58955867|FG001|Overall Study|Protocol deviation|5|||
30920719|NCT01830855|58955868|FG002|Overall Study|Protocol deviation|6|||
30920720|NCT01830855|58955869|FG003|Overall Study|Protocol deviation|6|||
30920721|NCT01830855|58955866|FG000|Overall Study|Withdrawal by Subject|33|||
30920722|NCT01830855|58955867|FG001|Overall Study|Withdrawal by Subject|14|||
30920723|NCT01830855|58955868|FG002|Overall Study|Withdrawal by Subject|10|||
30920724|NCT01830855|58955869|FG003|Overall Study|Withdrawal by Subject|12|||
30920725|NCT01830855|58955866|FG000|Overall Study|No longer willing to participate|32|||
30920726|NCT01830855|58955867|FG001|Overall Study|No longer willing to participate|13|||
30920727|NCT01830855|58955868|FG002|Overall Study|No longer willing to participate|12|||
30920728|NCT01830855|58955869|FG003|Overall Study|No longer willing to participate|17|||
30920729|NCT01830855|58955866|FG000|Overall Study|Lost to Follow-up|47|||
30920730|NCT01830855|58955867|FG001|Overall Study|Lost to Follow-up|20|||
30920731|NCT01830855|58955868|FG002|Overall Study|Lost to Follow-up|23|||
30920732|NCT01830855|58955869|FG003|Overall Study|Lost to Follow-up|33|||
30920733|NCT01857063|58955886|FG000|Period 1 (7 Days)|Adverse Event|0|||
30920734|NCT01857063|58955887|FG001|Period 1 (7 Days)|Adverse Event|1|||
30920735|NCT01857063|58955886|FG000|Period 1 (7 Days)|Physician Decision|1|||
30920736|NCT01857063|58955887|FG001|Period 1 (7 Days)|Physician Decision|0|||
30920737|NCT01857063|58955886|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
30920738|NCT01857063|58955887|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
30920739|NCT01857063|58955886|FG000|Period 2 (7 Days)|Adverse Event|2|||
30920740|NCT01857063|58955887|FG001|Period 2 (7 Days)|Adverse Event|1|||
30920741|NCT01857063|58955886|FG000|Period 2 (7 Days)|Physician Decision|1|||
30920742|NCT01857063|58955887|FG001|Period 2 (7 Days)|Physician Decision|1|||
30920743|NCT01857063|58955886|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
30920744|NCT01857063|58955887|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
30920745|NCT01856907|58955896|FG000|Overall Study|Pregnancy|0|||
30920746|NCT01856907|58955897|FG001|Overall Study|Pregnancy|1|||
30920747|NCT01856907|58955898|FG002|Overall Study|Pregnancy|0|||
30826990|NCT01370538|58849563|FG000|Overall Study|Development of study specific withdrawal|1|||
30826991|NCT01370538|58849564|FG001|Overall Study|Development of study specific withdrawal|1|||
30826992|NCT01370538|58849563|FG000|Overall Study|Lost to follow up|6|||
30826993|NCT01370538|58849564|FG001|Overall Study|Lost to follow up|10|||
30826994|NCT03402841|58849583|FG000|Overall Study|Withdrawal by Subject|3|||
30826995|NCT03402841|58849583|FG000|Overall Study|Lost to Follow-up|2|||
30826996|NCT03402841|58849583|FG000|Overall Study|Death|146|||
30826997|NCT02881957|58849598|FG000|Overall Study|Comfort care|0|||
30920748|NCT01856907|58955896|FG000|Overall Study|Pregnancy|0|||
30920749|NCT01856907|58955897|FG001|Overall Study|Pregnancy|1|||
30920750|NCT01856907|58955898|FG002|Overall Study|Pregnancy|0|||
30920751|NCT01856907|58955896|FG000|Overall Study|Withdrawal by Subject|0|||
30920752|NCT01856907|58955897|FG001|Overall Study|Withdrawal by Subject|1|||
30920753|NCT01856907|58955898|FG002|Overall Study|Withdrawal by Subject|0|||
30920754|NCT02212457|58955915|FG000|Overall Study|Adverse Event|1|||
30826998|NCT02881957|58849599|FG001|Overall Study|Comfort care|1|||
30826999|NCT02881957|58849598|FG000|Overall Study|Concurrent trial enrollment|0|||
30827000|NCT02881957|58849599|FG001|Overall Study|Concurrent trial enrollment|1|||
30827001|NCT02881957|58849598|FG000|Overall Study|Discharged within 48 hours|0|||
30827002|NCT02881957|58849599|FG001|Overall Study|Discharged within 48 hours|1|||
30827003|NCT02881957|58849598|FG000|Overall Study|Withdrawal by Subject|2|||
30827004|NCT02881957|58849599|FG001|Overall Study|Withdrawal by Subject|1|||
30827005|NCT02881957|58849598|FG000|Overall Study|Protocol Violation|1|||
30827006|NCT02881957|58849599|FG001|Overall Study|Protocol Violation|0|||
30827007|NCT03022461|58849605|FG000|Overall Study|Death|3|||
30827008|NCT02750930|58849610|FG000|Overall Study|Study closed/terminated|8|||
30827009|NCT03078907|58849616|FG000|Overall Study|Adverse Event|2|||
30827010|NCT03078907|58849617|FG001|Overall Study|Adverse Event|0|||
30827011|NCT03078907|58849616|FG000|Overall Study|Other|1|||
30827012|NCT03078907|58849617|FG001|Overall Study|Other|0|||
30827013|NCT03078907|58849616|FG000|Overall Study|Protocol Violation|0|||
30827014|NCT03078907|58849617|FG001|Overall Study|Protocol Violation|1|||
30827015|NCT03249714|58849625|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
30827016|NCT03249714|58849626|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
30920755|NCT02212457|58955916|FG001|Overall Study|Adverse Event|2|||
30920756|NCT02212457|58955917|FG002|Overall Study|Adverse Event|2|||
30920757|NCT02212457|58955918|FG003|Overall Study|Adverse Event|2|||
30920758|NCT02212457|58955919|FG004|Overall Study|Adverse Event|0|||
30827017|NCT03249714|58849625|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
30827018|NCT03249714|58849626|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
30827019|NCT03249714|58849625|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
30920759|NCT02212457|58955920|FG005|Overall Study|Adverse Event|1|||
30920760|NCT02212457|58955915|FG000|Overall Study|Withdrawal by Subject|8|||
30920761|NCT02212457|58955916|FG001|Overall Study|Withdrawal by Subject|10|||
30920762|NCT02212457|58955917|FG002|Overall Study|Withdrawal by Subject|8|||
30920763|NCT02212457|58955918|FG003|Overall Study|Withdrawal by Subject|6|||
30920764|NCT02212457|58955919|FG004|Overall Study|Withdrawal by Subject|5|||
30920765|NCT02212457|58955920|FG005|Overall Study|Withdrawal by Subject|4|||
30920766|NCT02212457|58955915|FG000|Overall Study|Lost to Follow-up|6|||
30920767|NCT02212457|58955916|FG001|Overall Study|Lost to Follow-up|7|||
30920768|NCT02212457|58955917|FG002|Overall Study|Lost to Follow-up|4|||
30920769|NCT02212457|58955918|FG003|Overall Study|Lost to Follow-up|1|||
30920770|NCT02212457|58955919|FG004|Overall Study|Lost to Follow-up|8|||
30920771|NCT02212457|58955920|FG005|Overall Study|Lost to Follow-up|4|||
30920772|NCT02212457|58955915|FG000|Overall Study|Protocol Violation|2|||
30920773|NCT02212457|58955916|FG001|Overall Study|Protocol Violation|1|||
30920774|NCT02212457|58955917|FG002|Overall Study|Protocol Violation|0|||
30920775|NCT02212457|58955918|FG003|Overall Study|Protocol Violation|1|||
30920776|NCT02212457|58955919|FG004|Overall Study|Protocol Violation|2|||
30920777|NCT02212457|58955920|FG005|Overall Study|Protocol Violation|3|||
30920778|NCT02212457|58955915|FG000|Overall Study|Other|2|||
30920779|NCT02212457|58955916|FG001|Overall Study|Other|1|||
30920780|NCT02212457|58955917|FG002|Overall Study|Other|2|||
30920781|NCT02212457|58955918|FG003|Overall Study|Other|1|||
30920782|NCT02212457|58955919|FG004|Overall Study|Other|0|||
30920783|NCT02212457|58955920|FG005|Overall Study|Other|1|||
30920784|NCT02097745|58955941|FG000|Overall Study|Adverse Event|25|||
30920785|NCT02097745|58955941|FG000|Overall Study|Death|16|||
30920786|NCT02097745|58955941|FG000|Overall Study|Failure to Return|14|||
30920787|NCT02097745|58955941|FG000|Overall Study|Administrative/Other|27|||
30920788|NCT02097745|58955941|FG000|Overall Study|Reason Not Specified|96|||
30920789|NCT02111083|58955950|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
30920790|NCT02111083|58955951|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
30920791|NCT01629563|58955959|FG000|Overall Study|Adverse Event|16|||
30920792|NCT01629563|58955960|FG001|Overall Study|Adverse Event|16|||
30920793|NCT01629563|58955959|FG000|Overall Study|Death|2|||
30920794|NCT01629563|58955960|FG001|Overall Study|Death|0|||
30920795|NCT01629563|58955959|FG000|Overall Study|Lack of Efficacy|2|||
30920796|NCT01629563|58955960|FG001|Overall Study|Lack of Efficacy|3|||
30920797|NCT01629563|58955959|FG000|Overall Study|Lost to Follow-up|1|||
30827020|NCT03249714|58849626|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
30827021|NCT03249714|58849625|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
30827022|NCT03249714|58849626|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
30827023|NCT02925117|58849652|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
30827024|NCT02925117|58849653|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
30827025|NCT02925117|58849654|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
30827026|NCT02925117|58849655|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
30827027|NCT02925117|58849656|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
30827028|NCT02925117|58849657|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
30827029|NCT02925117|58849658|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
30827030|NCT02925117|58849659|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
30827031|NCT02925117|58849660|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
30827032|NCT02925117|58849661|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
30827033|NCT02925117|58849662|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
30827034|NCT02925117|58849663|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
30827035|NCT02925117|58849652|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
30920798|NCT01629563|58955960|FG001|Overall Study|Lost to Follow-up|0|||
30920799|NCT01629563|58955959|FG000|Overall Study|Pregnancy|1|||
30920800|NCT01629563|58955960|FG001|Overall Study|Pregnancy|2|||
30920801|NCT01629563|58955959|FG000|Overall Study|Protocol Violation|0|||
30920802|NCT01629563|58955960|FG001|Overall Study|Protocol Violation|1|||
30920803|NCT01629563|58955959|FG000|Overall Study|Withdrawal by Subject|27|||
30920804|NCT01629563|58955960|FG001|Overall Study|Withdrawal by Subject|20|||
30920805|NCT01629563|58955959|FG000|Overall Study|surgery|0|||
30920806|NCT01629563|58955960|FG001|Overall Study|surgery|3|||
30920807|NCT01629563|58955959|FG000|Overall Study|Lack of return of menses|12|||
30827036|NCT02925117|58849653|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
30920808|NCT01629563|58955960|FG001|Overall Study|Lack of return of menses|7|||
30920809|NCT01629563|58955959|FG000|Overall Study|Protocol Violation|0|||
30920810|NCT01629563|58955960|FG001|Overall Study|Protocol Violation|1|||
30920811|NCT02097277|58955971|FG000|Overall Study|Subject no longer meets study criteria|0|||
30920812|NCT02097277|58955972|FG001|Overall Study|Subject no longer meets study criteria|1|||
30920813|NCT02097277|58955973|FG002|Overall Study|Subject no longer meets study criteria|0|||
30920814|NCT02097277|58955974|FG003|Overall Study|Subject no longer meets study criteria|1|||
30920815|NCT02097277|58955975|FG004|Overall Study|Subject no longer meets study criteria|0|||
30920816|NCT02097277|58955971|FG000|Overall Study|Subject request to discontinue treatment|0|||
30920817|NCT02097277|58955972|FG001|Overall Study|Subject request to discontinue treatment|0|||
30920818|NCT02097277|58955973|FG002|Overall Study|Subject request to discontinue treatment|0|||
30827037|NCT02925117|58849654|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
30827038|NCT02925117|58849655|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
30920819|NCT02097277|58955974|FG003|Overall Study|Subject request to discontinue treatment|0|||
30920820|NCT02097277|58955975|FG004|Overall Study|Subject request to discontinue treatment|1|||
30920821|NCT02097277|58955971|FG000|Overall Study|Lost to Follow-up|0|||
30920822|NCT02097277|58955972|FG001|Overall Study|Lost to Follow-up|1|||
30920823|NCT02097277|58955973|FG002|Overall Study|Lost to Follow-up|1|||
30920824|NCT02097277|58955974|FG003|Overall Study|Lost to Follow-up|0|||
30920825|NCT02097277|58955975|FG004|Overall Study|Lost to Follow-up|0|||
30920826|NCT02097277|58955971|FG000|Overall Study|Withdrawal by Subject|2|||
30920827|NCT02097277|58955972|FG001|Overall Study|Withdrawal by Subject|1|||
30920828|NCT02097277|58955973|FG002|Overall Study|Withdrawal by Subject|0|||
30920829|NCT02097277|58955974|FG003|Overall Study|Withdrawal by Subject|1|||
30920830|NCT02097277|58955975|FG004|Overall Study|Withdrawal by Subject|0|||
30920831|NCT02097277|58955971|FG000|Overall Study|Adverse Event|0|||
30920832|NCT02097277|58955972|FG001|Overall Study|Adverse Event|0|||
30827039|NCT02925117|58849656|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
30827040|NCT02925117|58849657|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
30827041|NCT02925117|58849658|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
30827042|NCT02925117|58849659|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
30920833|NCT02097277|58955973|FG002|Overall Study|Adverse Event|1|||
30920834|NCT02097277|58955974|FG003|Overall Study|Adverse Event|2|||
30920835|NCT02097277|58955975|FG004|Overall Study|Adverse Event|0|||
30920836|NCT02212379|58955991|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
30920837|NCT02212379|58955991|FG000|From Baseline to Week 48|Adverse Event|7|||
30920838|NCT02212379|58955991|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
30920839|NCT02212379|58955991|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
30920840|NCT02212379|58955991|FG000|From Week 48 to Week 96|Adverse Event|1|||
30920841|NCT02212379|58955991|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
30920842|NCT02110693|58955998|FG000|Overall Study|Withdrawal by Subject|6|||
30920843|NCT02110693|58955999|FG001|Overall Study|Withdrawal by Subject|7|||
30920844|NCT02110693|58955998|FG000|Overall Study|skipped assessment|15|||
30920845|NCT02110693|58955999|FG001|Overall Study|skipped assessment|18|||
30920846|NCT02110693|58955998|FG000|Overall Study|technical difficulties|6|||
30920847|NCT02110693|58955999|FG001|Overall Study|technical difficulties|4|||
30920848|NCT02110693|58955998|FG000|Overall Study|Other|1|||
30920849|NCT02110693|58955999|FG001|Overall Study|Other|0|||
30920850|NCT02212301|58956019|FG000|Period 1|Lost to Follow-up|0|||
30920851|NCT02212301|58956020|FG001|Period 1|Lost to Follow-up|1|||
30920852|NCT02211209|58956029|FG000|Overall Study|Investigator judgment|0|||
30920853|NCT02211209|58956030|FG001|Overall Study|Investigator judgment|1|||
30827043|NCT02925117|58849660|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
30827044|NCT02925117|58849661|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
30827045|NCT02925117|58849662|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
30827046|NCT02925117|58849663|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
30827047|NCT02925117|58849652|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
30827048|NCT02925117|58849653|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
30827049|NCT02925117|58849654|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
30827050|NCT02925117|58849655|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
30827051|NCT02925117|58849656|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
30827052|NCT02925117|58849657|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
30827053|NCT02925117|58849658|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
30827054|NCT02925117|58849659|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
30827055|NCT02925117|58849660|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
30827056|NCT02925117|58849661|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
30827057|NCT02925117|58849662|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
30827058|NCT02925117|58849663|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
30827059|NCT02925117|58849652|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
30827060|NCT02925117|58849653|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
30827061|NCT02925117|58849654|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
30827062|NCT02925117|58849655|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
30827063|NCT02925117|58849656|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
30827064|NCT02925117|58849657|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
30827065|NCT02925117|58849658|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
30920854|NCT02211209|58956029|FG000|Overall Study|Voluntary withdrawal|1|||
30920855|NCT02211209|58956030|FG001|Overall Study|Voluntary withdrawal|4|||
30920856|NCT02211209|58956029|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
30920857|NCT02211209|58956030|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
30827066|NCT02925117|58849659|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
30827067|NCT02925117|58849660|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
30827068|NCT02925117|58849661|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
30827069|NCT02925117|58849662|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
30827070|NCT02925117|58849663|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
30920858|NCT02211209|58956029|FG000|Overall Study|Reason Not Specified|1|||
30920859|NCT02211209|58956030|FG001|Overall Study|Reason Not Specified|0|||
30920860|NCT02187809|58956036|FG000|Overall Study|The study was terminated|3|||
30920861|NCT02110225|58956043|FG000|Overall Study|Lost to Follow-up|0|||
30920862|NCT02110225|58956044|FG001|Overall Study|Lost to Follow-up|1|||
30920863|NCT02110225|58956045|FG002|Overall Study|Lost to Follow-up|0|||
30920864|NCT02187029|58956058|FG000|Overall Study|Adverse Event|0|||
30920865|NCT02187029|58956059|FG001|Overall Study|Adverse Event|1|||
30920866|NCT02187029|58956060|FG002|Overall Study|Adverse Event|1|||
30920867|NCT02187029|58956061|FG003|Overall Study|Adverse Event|0|||
30920868|NCT02187029|58956058|FG000|Overall Study|Study Terminated by Sponsor|0|||
30920869|NCT02187029|58956059|FG001|Overall Study|Study Terminated by Sponsor|0|||
30920870|NCT02187029|58956060|FG002|Overall Study|Study Terminated by Sponsor|10|||
30920871|NCT02187029|58956061|FG003|Overall Study|Study Terminated by Sponsor|3|||
30920872|NCT02187029|58956058|FG000|Overall Study|Withdrawal by Subject|1|||
30920873|NCT02187029|58956059|FG001|Overall Study|Withdrawal by Subject|0|||
30920874|NCT02187029|58956060|FG002|Overall Study|Withdrawal by Subject|0|||
30920875|NCT02187029|58956061|FG003|Overall Study|Withdrawal by Subject|0|||
30920876|NCT02163395|58956071|FG000|Overall Study|Withdrawal by Subject|1|||
30754057|NCT00131664|58763664|FG004|First Period (First 6 Months)|Protocol Violation|0|||
30754058|NCT00131664|58763665|FG005|First Period (First 6 Months)|Protocol Violation|0|||
30754059|NCT00131664|58763660|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
30754060|NCT00131664|58763661|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
30754061|NCT00131664|58763662|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
30754062|NCT00131664|58763663|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
30754063|NCT00131664|58763664|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
30754064|NCT00131664|58763665|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
30827071|NCT02925117|58849652|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
30827072|NCT02925117|58849653|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
30827073|NCT02925117|58849654|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
30827074|NCT02925117|58849655|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
30827075|NCT02925117|58849656|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
30827076|NCT02925117|58849657|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
30827077|NCT02925117|58849658|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
30827078|NCT02925117|58849659|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
30827079|NCT02925117|58849660|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
30827080|NCT02925117|58849661|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
30827081|NCT02925117|58849662|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
30827082|NCT02925117|58849663|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
30827083|NCT02925117|58849652|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
30827084|NCT02925117|58849653|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
30827085|NCT02925117|58849654|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
30920877|NCT02163395|58956071|FG000|Overall Study|Lost to Follow-up|3|||
30754065|NCT00131664|58763660|FG000|First Period (First 6 Months)|Adverse Event|9|||
30827086|NCT02925117|58849655|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
30920878|NCT02163395|58956071|FG000|Overall Study|Adverse Event|1|||
30920879|NCT02162771|58956077|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
30920880|NCT02162771|58956078|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
30920881|NCT02162771|58956077|FG000|Core Study Period (Part 2)|Adverse Event|4|||
30920882|NCT02162771|58956078|FG001|Core Study Period (Part 2)|Adverse Event|1|||
30920883|NCT02162771|58956077|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
30920884|NCT02162771|58956078|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
30920885|NCT02162771|58956077|FG000|Core Study Period (Part 2)|Physician Decision|0|||
30920886|NCT02162771|58956078|FG001|Core Study Period (Part 2)|Physician Decision|2|||
30920887|NCT02162771|58956077|FG000|Core Study Period (Part 2)|Death|1|||
30920888|NCT02162771|58956078|FG001|Core Study Period (Part 2)|Death|0|||
30920889|NCT02162771|58956077|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
30920890|NCT02162771|58956078|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
30920891|NCT02162771|58956077|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
30920892|NCT02162771|58956078|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
30920893|NCT02162771|58956077|FG000|Maintenance Study Period (Part 2)|Death|2|||
30920894|NCT02162771|58956078|FG001|Maintenance Study Period (Part 2)|Death|1|||
30920895|NCT02162771|58956077|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
30920896|NCT02162771|58956078|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
30920897|NCT02162771|58956077|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
30920898|NCT02162771|58956078|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
30920899|NCT02162771|58956077|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
30920900|NCT02162771|58956078|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
30920901|NCT02161757|58956087|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
30920902|NCT02161757|58956088|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
30920903|NCT02161757|58956089|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
30920904|NCT02161757|58956087|FG000|Treatment Through Study Completion|Adverse Event|1|||
30920905|NCT02161757|58956088|FG001|Treatment Through Study Completion|Adverse Event|1|||
30920906|NCT02161757|58956089|FG002|Treatment Through Study Completion|Adverse Event|0|||
30920907|NCT02161757|58956087|FG000|Treatment Through Study Completion|Protocol Violation|0|||
30920908|NCT02161757|58956088|FG001|Treatment Through Study Completion|Protocol Violation|1|||
30920909|NCT02161757|58956089|FG002|Treatment Through Study Completion|Protocol Violation|2|||
30920910|NCT02161757|58956087|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
30920911|NCT02161757|58956088|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
30920912|NCT02161757|58956089|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
30920913|NCT02161757|58956087|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
30920914|NCT02161757|58956088|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
30920915|NCT02161757|58956089|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
30920916|NCT02161757|58956087|FG000|Treatment Through Study Completion|Other|20|||
30920917|NCT02161757|58956088|FG001|Treatment Through Study Completion|Other|19|||
30920918|NCT02161757|58956089|FG002|Treatment Through Study Completion|Other|12|||
30920919|NCT02161757|58956087|FG000|Treatment Through Study Completion|Death|2|||
30920920|NCT02161757|58956088|FG001|Treatment Through Study Completion|Death|1|||
30920921|NCT02161757|58956089|FG002|Treatment Through Study Completion|Death|1|||
30920922|NCT02160977|58956099|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
30920923|NCT02160977|58956100|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
30920924|NCT02160977|58956099|FG000|Three Months After Surgery|Lost to Follow-up|0|||
30920925|NCT02160977|58956100|FG001|Three Months After Surgery|Lost to Follow-up|2|||
30920926|NCT02160977|58956099|FG000|Six Months After Surgery|Lost to Follow-up|2|||
30920927|NCT02160977|58956100|FG001|Six Months After Surgery|Lost to Follow-up|1|||
30827087|NCT02925117|58849656|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
30827088|NCT02925117|58849657|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
30827089|NCT02925117|58849658|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
30827090|NCT02925117|58849659|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
30827091|NCT02925117|58849660|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
30827092|NCT02925117|58849661|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
30827093|NCT02925117|58849662|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
30827094|NCT02925117|58849663|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
30920928|NCT02160899|58956112|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
30920929|NCT02160899|58956113|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
30920930|NCT02160899|58956114|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
30920931|NCT02160899|58956115|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
30920932|NCT02160899|58956116|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
30920933|NCT02160899|58956117|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
30920934|NCT02160041|58956131|FG000|Overall Study|Adverse Event|11|||
30920935|NCT02160041|58956131|FG000|Overall Study|Death|2|||
30920936|NCT02160041|58956131|FG000|Overall Study|disease progression|57|||
30920937|NCT02160041|58956131|FG000|Overall Study|Protocol Violation|1|||
30623355|NCT00924664|58635182|FG000|Overall Study|Lack of Efficacy|10|||
30623356|NCT00924664|58635183|FG001|Overall Study|Lack of Efficacy|15|||
30623357|NCT00924664|58635182|FG000|Overall Study|Lost to Follow-up|10|||
30623358|NCT00924664|58635183|FG001|Overall Study|Lost to Follow-up|12|||
30754066|NCT00131664|58763661|FG001|First Period (First 6 Months)|Adverse Event|4|||
30754067|NCT00131664|58763662|FG002|First Period (First 6 Months)|Adverse Event|5|||
30754068|NCT00131664|58763663|FG003|First Period (First 6 Months)|Adverse Event|0|||
30754069|NCT00131664|58763664|FG004|First Period (First 6 Months)|Adverse Event|0|||
30754070|NCT00131664|58763665|FG005|First Period (First 6 Months)|Adverse Event|0|||
30754071|NCT00131664|58763660|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
30754072|NCT00131664|58763661|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
30754073|NCT00131664|58763662|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
30754074|NCT00131664|58763663|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
30754075|NCT00131664|58763664|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
30827095|NCT02925117|58849652|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
30827096|NCT02925117|58849653|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
30827097|NCT02925117|58849654|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
30827098|NCT02925117|58849655|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
30827099|NCT02925117|58849656|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
30827100|NCT02925117|58849657|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
30827101|NCT02925117|58849658|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
30827102|NCT02925117|58849659|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
30827103|NCT02925117|58849660|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
30920938|NCT02160041|58956131|FG000|Overall Study|non-compliance with study|1|||
30754076|NCT00131664|58763665|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
30754077|NCT00131664|58763660|FG000|First Period (First 6 Months)|Administrative reasons|2|||
30754078|NCT00131664|58763661|FG001|First Period (First 6 Months)|Administrative reasons|0|||
30754079|NCT00131664|58763662|FG002|First Period (First 6 Months)|Administrative reasons|5|||
30754080|NCT00131664|58763663|FG003|First Period (First 6 Months)|Administrative reasons|0|||
30754081|NCT00131664|58763664|FG004|First Period (First 6 Months)|Administrative reasons|0|||
30754082|NCT00131664|58763665|FG005|First Period (First 6 Months)|Administrative reasons|0|||
30754083|NCT00131664|58763660|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
30754084|NCT00131664|58763661|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
30754085|NCT00131664|58763662|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
30754086|NCT00131664|58763663|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
30754087|NCT00131664|58763664|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
30754088|NCT00131664|58763665|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
30754089|NCT00131664|58763660|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
30754090|NCT00131664|58763661|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
30754091|NCT00131664|58763662|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
30754092|NCT00131664|58763663|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
30754093|NCT00131664|58763664|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
30754094|NCT00131664|58763665|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
30754095|NCT00131664|58763660|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
30754096|NCT00131664|58763661|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
30754097|NCT00131664|58763662|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
30754098|NCT00131664|58763663|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
30754099|NCT00131664|58763664|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
30754100|NCT00131664|58763665|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
30754101|NCT00131664|58763660|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
30754102|NCT00131664|58763661|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
30754103|NCT00131664|58763662|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
30754104|NCT00131664|58763663|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
30920939|NCT02160041|58956131|FG000|Overall Study|Physician Decision|3|||
30623359|NCT00924664|58635182|FG000|Overall Study|Withdrawal by Subject|47|||
30623360|NCT00924664|58635183|FG001|Overall Study|Withdrawal by Subject|71|||
30623361|NCT00924664|58635182|FG000|Overall Study|Protocol Violation|2|||
30920940|NCT02160041|58956131|FG000|Overall Study|Withdrawal by Subject|8|||
30920941|NCT02160041|58956131|FG000|Overall Study|study terminated by by sponsor|1|||
30920942|NCT02186873|58956137|FG000|Overall Study|Adverse Event|1|||
30920943|NCT02186873|58956138|FG001|Overall Study|Adverse Event|3|||
30920944|NCT02186873|58956137|FG000|Overall Study|Lack of Efficacy|0|||
30920945|NCT02186873|58956138|FG001|Overall Study|Lack of Efficacy|1|||
30920946|NCT02186873|58956137|FG000|Overall Study|Lost to Follow-up|1|||
30920947|NCT02186873|58956138|FG001|Overall Study|Lost to Follow-up|2|||
30920948|NCT02186873|58956137|FG000|Overall Study|Withdrawal by Subject|7|||
30920949|NCT02186873|58956138|FG001|Overall Study|Withdrawal by Subject|2|||
30920950|NCT02096263|58956148|FG000|Overall Study|Adverse Event|1|||
30920951|NCT02096263|58956149|FG001|Overall Study|Adverse Event|0|||
30920952|NCT02096263|58956150|FG002|Overall Study|Adverse Event|1|||
30920953|NCT02096263|58956148|FG000|Overall Study|Lost to Follow-up|14|||
30920954|NCT02096263|58956149|FG001|Overall Study|Lost to Follow-up|18|||
30920955|NCT02096263|58956150|FG002|Overall Study|Lost to Follow-up|15|||
30920956|NCT02096263|58956148|FG000|Overall Study|Other|7|||
30920957|NCT02096263|58956149|FG001|Overall Study|Other|9|||
30920958|NCT02096263|58956150|FG002|Overall Study|Other|6|||
30920959|NCT02096263|58956148|FG000|Overall Study|Sponsor study termination|0|||
30920960|NCT02096263|58956149|FG001|Overall Study|Sponsor study termination|0|||
30920961|NCT02096263|58956150|FG002|Overall Study|Sponsor study termination|1|||
30920962|NCT02096263|58956148|FG000|Overall Study|Protocol Violation|7|||
30920963|NCT02096263|58956149|FG001|Overall Study|Protocol Violation|2|||
30920964|NCT02096263|58956150|FG002|Overall Study|Protocol Violation|8|||
30920965|NCT02096263|58956148|FG000|Overall Study|Withdrawal by Subject|5|||
30920966|NCT02096263|58956149|FG001|Overall Study|Withdrawal by Subject|7|||
30920967|NCT02096263|58956150|FG002|Overall Study|Withdrawal by Subject|8|||
30920968|NCT01830543|58956161|FG000|Overall Study|Subject Decision|19|||
30920969|NCT01830543|58956162|FG001|Overall Study|Subject Decision|21|||
30920970|NCT01830543|58956163|FG002|Overall Study|Subject Decision|57|||
30920971|NCT01830543|58956161|FG000|Overall Study|Adverse Event|91|||
30920972|NCT01830543|58956162|FG001|Overall Study|Adverse Event|77|||
30920973|NCT01830543|58956163|FG002|Overall Study|Adverse Event|76|||
30920974|NCT01830543|58956161|FG000|Overall Study|Death|20|||
30920975|NCT01830543|58956162|FG001|Overall Study|Death|22|||
30920976|NCT01830543|58956163|FG002|Overall Study|Death|22|||
30920977|NCT01830543|58956161|FG000|Overall Study|Protocol Violation|3|||
30920978|NCT01830543|58956162|FG001|Overall Study|Protocol Violation|7|||
30920979|NCT01830543|58956163|FG002|Overall Study|Protocol Violation|7|||
30920980|NCT01830543|58956161|FG000|Overall Study|Physician Decision|11|||
30920981|NCT01830543|58956162|FG001|Overall Study|Physician Decision|5|||
30920982|NCT01830543|58956163|FG002|Overall Study|Physician Decision|12|||
30920983|NCT01830543|58956161|FG000|Overall Study|Withdrawal by consent|3|||
30920984|NCT01830543|58956162|FG001|Overall Study|Withdrawal by consent|3|||
30920985|NCT01830543|58956163|FG002|Overall Study|Withdrawal by consent|3|||
30920986|NCT01830543|58956161|FG000|Overall Study|Other|12|||
30920987|NCT01830543|58956162|FG001|Overall Study|Other|17|||
30920988|NCT01830543|58956163|FG002|Overall Study|Other|37|||
30920989|NCT02109445|58956171|FG000|Overall Study|Symptomatic deterioration|2|||
30920990|NCT02109445|58956171|FG000|Overall Study|Adverse Event|1|||
30920991|NCT02109133|58956177|FG000|Overall Study|Lost to Follow-up|1|||
30920992|NCT02109133|58956178|FG001|Overall Study|Lost to Follow-up|0|||
30754105|NCT00131664|58763664|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
30754106|NCT00131664|58763665|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
30754107|NCT00131664|58763660|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
30754108|NCT00131664|58763661|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
30754109|NCT00131664|58763662|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
30920993|NCT01623271|58956186|FG000|Overall Study|Withdrawal by Subject|2|||
30920994|NCT01856673|58956193|FG000|Overall Study|Withdrawal by Subject|44|||
30920995|NCT01856673|58956194|FG001|Overall Study|Withdrawal by Subject|50|||
30920996|NCT01856673|58956195|FG002|Overall Study|Withdrawal by Subject|33|||
30920997|NCT01856673|58956193|FG000|Overall Study|Lost to Follow-up|31|||
30920998|NCT01856673|58956194|FG001|Overall Study|Lost to Follow-up|34|||
30920999|NCT01856673|58956195|FG002|Overall Study|Lost to Follow-up|0|||
30921000|NCT01856673|58956193|FG000|Overall Study|Unknown reasons|9|||
30921001|NCT01856673|58956194|FG001|Overall Study|Unknown reasons|0|||
30921002|NCT01856673|58956195|FG002|Overall Study|Unknown reasons|0|||
30921003|NCT01856673|58956193|FG000|Overall Study|Psychologist decision|1|||
30921004|NCT01856673|58956194|FG001|Overall Study|Psychologist decision|0|||
30921005|NCT01856673|58956195|FG002|Overall Study|Psychologist decision|0|||
30921006|NCT01856673|58956193|FG000|Overall Study|Paperwork errors|8|||
30921007|NCT01856673|58956194|FG001|Overall Study|Paperwork errors|0|||
30921008|NCT01856673|58956195|FG002|Overall Study|Paperwork errors|0|||
30921009|NCT01856673|58956193|FG000|Overall Study|Death|1|||
30921010|NCT01856673|58956194|FG001|Overall Study|Death|1|||
30921011|NCT01856673|58956195|FG002|Overall Study|Death|0|||
30921012|NCT01856673|58956193|FG000|Overall Study|Protocol Violation|1|||
30921013|NCT01856673|58956194|FG001|Overall Study|Protocol Violation|0|||
30921014|NCT01856673|58956195|FG002|Overall Study|Protocol Violation|1|||
30921015|NCT02095951|58956205|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
30921016|NCT02095951|58956206|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
30921017|NCT02095873|58956218|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
30921018|NCT02095873|58956219|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
30921019|NCT02095873|58956218|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
30921020|NCT02095873|58956219|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
30921021|NCT02095873|58956218|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
30921022|NCT02095873|58956219|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
30921023|NCT02094937|58956227|FG000|8 Weeks in Period 1|Adverse Event|9|||
30921024|NCT02094937|58956228|FG001|8 Weeks in Period 1|Adverse Event|0|||
30921025|NCT02094937|58956229|FG002|8 Weeks in Period 1|Adverse Event|0|||
30921026|NCT02094937|58956230|FG003|8 Weeks in Period 1|Adverse Event|0|||
30921027|NCT02094937|58956227|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
30921028|NCT02094937|58956228|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
30921029|NCT02094937|58956229|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
30921030|NCT02094937|58956230|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
30921031|NCT02094937|58956227|FG000|8 Weeks in Period 1|Protocol Violation|2|||
30921032|NCT02094937|58956228|FG001|8 Weeks in Period 1|Protocol Violation|0|||
30921033|NCT02094937|58956229|FG002|8 Weeks in Period 1|Protocol Violation|0|||
30921034|NCT02094937|58956230|FG003|8 Weeks in Period 1|Protocol Violation|0|||
30921035|NCT02094937|58956227|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
30921036|NCT02094937|58956228|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
30921037|NCT02094937|58956229|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
30921038|NCT02094937|58956230|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
30921039|NCT02094937|58956227|FG000|8 Weeks in Period 1|Physician Decision|1|||
30921040|NCT02094937|58956228|FG001|8 Weeks in Period 1|Physician Decision|0|||
30921041|NCT02094937|58956229|FG002|8 Weeks in Period 1|Physician Decision|0|||
30921042|NCT02094937|58956230|FG003|8 Weeks in Period 1|Physician Decision|0|||
30921043|NCT02094937|58956227|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
30921044|NCT02094937|58956228|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
30921045|NCT02094937|58956229|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
30921046|NCT02094937|58956230|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
30921047|NCT02094937|58956227|FG000|12 Weeks in Period 2|Adverse Event|0|||
30921048|NCT02094937|58956228|FG001|12 Weeks in Period 2|Adverse Event|2|||
30921049|NCT02094937|58956229|FG002|12 Weeks in Period 2|Adverse Event|4|||
30921050|NCT02094937|58956230|FG003|12 Weeks in Period 2|Adverse Event|1|||
30921051|NCT02094937|58956227|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
30921052|NCT02094937|58956228|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
30921053|NCT02094937|58956229|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
30921054|NCT02094937|58956230|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
30921055|NCT02094937|58956227|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
30921056|NCT02094937|58956228|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
30921057|NCT02094937|58956229|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
30921058|NCT02094937|58956230|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
30921059|NCT02094937|58956227|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
30921060|NCT02094937|58956228|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
30921061|NCT02094937|58956229|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
30921062|NCT02094937|58956230|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
30921063|NCT02094937|58956227|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
30921064|NCT02094937|58956228|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
30921065|NCT02094937|58956229|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
30921066|NCT02094937|58956230|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
30921067|NCT02093923|58956244|FG000|Overall Study|Lost to Follow-up|0|||
30921068|NCT02093923|58956245|FG001|Overall Study|Lost to Follow-up|0|||
30921069|NCT02093923|58956246|FG002|Overall Study|Lost to Follow-up|0|||
30921070|NCT02093923|58956247|FG003|Overall Study|Lost to Follow-up|1|||
30921071|NCT02093923|58956248|FG004|Overall Study|Lost to Follow-up|0|||
30921072|NCT02093923|58956244|FG000|Overall Study|Screen failure after randomization|0|||
30921073|NCT02093923|58956245|FG001|Overall Study|Screen failure after randomization|0|||
30921074|NCT02093923|58956246|FG002|Overall Study|Screen failure after randomization|0|||
30921075|NCT02093923|58956247|FG003|Overall Study|Screen failure after randomization|1|||
30921076|NCT02093923|58956248|FG004|Overall Study|Screen failure after randomization|0|||
30921077|NCT02186561|58956264|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
30921078|NCT02186561|58956264|FG000|Enrollment|Enrollment Cap Reached|5|||
30921079|NCT02186561|58956264|FG000|Enrollment|Insurance Denial|2|||
30921080|NCT02186561|58956264|FG000|Enrollment|Withdrawal by Subject|2|||
30921081|NCT02186561|58956264|FG000|Enrollment|Investigator Withdrew Consent|1|||
30921082|NCT02186561|58956264|FG000|30-Day Post Index Procedure Visit|Death|1|||
30921083|NCT02186561|58956264|FG000|1- Year Post Index Procedure Visit|Death|1|||
30921084|NCT02186561|58956264|FG000|1- Year Post Index Procedure Visit|Missed|1|||
30921085|NCT02066467|58956270|FG000|Overall Study|Did not undergo implant procedure|24|||
30921086|NCT02066467|58956270|FG000|Overall Study|Attempted to implant withoput success|43|||
30921087|NCT02066467|58956270|FG000|Overall Study|Consent ineligible|1|||
30921088|NCT02066467|58956270|FG000|Overall Study|Death|54|||
30921089|NCT02066467|58956270|FG000|Overall Study|Lost to Follow-up|51|||
30921090|NCT02066467|58956270|FG000|Overall Study|Adverse Event|20|||
30921091|NCT02066467|58956270|FG000|Overall Study|Withdrawal by Subject|16|||
30921092|NCT02066467|58956270|FG000|Overall Study|Physician Decision|2|||
30921093|NCT02066467|58956270|FG000|Overall Study|Not defined|4|||
30921094|NCT02186171|58956276|FG000|Overall Study|Withdrawal by Subject|1|||
30921095|NCT02186171|58956277|FG001|Overall Study|Withdrawal by Subject|9|||
30921096|NCT02186171|58956276|FG000|Overall Study|Lost to Follow-up|2|||
30921097|NCT02186171|58956277|FG001|Overall Study|Lost to Follow-up|2|||
30921098|NCT02186171|58956276|FG000|Overall Study|Death|1|||
30921099|NCT02186171|58956277|FG001|Overall Study|Death|2|||
30921100|NCT02186171|58956276|FG000|Overall Study|Protocol-specified Criteria|0|||
30827104|NCT02925117|58849661|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
30827105|NCT02925117|58849662|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
30827106|NCT02925117|58849663|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
30827107|NCT02925117|58849652|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
30827108|NCT02925117|58849653|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
30827109|NCT02925117|58849654|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
30827110|NCT02925117|58849655|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
30827111|NCT02925117|58849656|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
30827112|NCT02925117|58849657|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
30827113|NCT02925117|58849658|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
30827114|NCT02925117|58849659|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
30827115|NCT02925117|58849660|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
30827116|NCT02925117|58849661|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
30827117|NCT02925117|58849662|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
30827118|NCT02925117|58849663|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
30827119|NCT03075163|58849687|FG000|Overall Study|not eligible for treatment limb|138|||
30827120|NCT03075163|58849688|FG001|Overall Study|not eligible for treatment limb|138|||
30827121|NCT03078751|58849696|FG000|Overall Study|Adverse Event|4|||
30827122|NCT03078751|58849697|FG001|Overall Study|Adverse Event|0|||
30827123|NCT03078751|58849696|FG000|Overall Study|Physician Decision|1|||
30827124|NCT03078751|58849697|FG001|Overall Study|Physician Decision|0|||
30827125|NCT03078751|58849696|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
30827126|NCT03078751|58849697|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
30827127|NCT03078751|58849696|FG000|Overall Study|Subject/guardian decision|8|||
30827128|NCT03078751|58849697|FG001|Overall Study|Subject/guardian decision|1|||
30827129|NCT03078751|58849696|FG000|Overall Study|Untreated|0|||
30827130|NCT03078751|58849697|FG001|Overall Study|Untreated|4|||
30827131|NCT02924883|58849705|FG000|Overall Study|Death|39|||
30827132|NCT02924883|58849706|FG001|Overall Study|Death|20|||
30827133|NCT02924883|58849705|FG000|Overall Study|Lost to Follow-up|1|||
30921101|NCT02186171|58956277|FG001|Overall Study|Protocol-specified Criteria|2|||
30921102|NCT02186015|58956285|FG000|Overall Study|Physician Decision|1|||
30827134|NCT02924883|58849706|FG001|Overall Study|Lost to Follow-up|0|||
30827135|NCT02924883|58849705|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
30827136|NCT02924883|58849706|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
30827137|NCT02924883|58849705|FG000|Overall Study|Protocol Violation|1|||
30827138|NCT02924883|58849706|FG001|Overall Study|Protocol Violation|0|||
30827139|NCT02924883|58849705|FG000|Overall Study|Withdrawal by Subject|22|||
30921103|NCT02186015|58956286|FG001|Overall Study|Physician Decision|0|||
30921104|NCT02066389|58956299|FG000|Overall Study|Adverse Event|1|||
30921105|NCT02066389|58956300|FG001|Overall Study|Adverse Event|1|||
30921106|NCT02066389|58956301|FG002|Overall Study|Adverse Event|1|||
30921107|NCT02066389|58956302|FG003|Overall Study|Adverse Event|1|||
30921108|NCT02066389|58956303|FG004|Overall Study|Adverse Event|5|||
30921109|NCT02066389|58956304|FG005|Overall Study|Adverse Event|1|||
30921110|NCT02066389|58956299|FG000|Overall Study|Withdrawal by Subject|4|||
30921111|NCT02066389|58956300|FG001|Overall Study|Withdrawal by Subject|0|||
30921112|NCT02066389|58956301|FG002|Overall Study|Withdrawal by Subject|5|||
30921113|NCT02066389|58956302|FG003|Overall Study|Withdrawal by Subject|1|||
30921114|NCT02066389|58956303|FG004|Overall Study|Withdrawal by Subject|1|||
30921115|NCT02066389|58956304|FG005|Overall Study|Withdrawal by Subject|2|||
30921116|NCT02066389|58956299|FG000|Overall Study|Lost to Follow-up|0|||
30921117|NCT02066389|58956300|FG001|Overall Study|Lost to Follow-up|0|||
30921118|NCT02066389|58956301|FG002|Overall Study|Lost to Follow-up|0|||
30921119|NCT02066389|58956302|FG003|Overall Study|Lost to Follow-up|1|||
30921120|NCT02066389|58956303|FG004|Overall Study|Lost to Follow-up|1|||
30921121|NCT02066389|58956304|FG005|Overall Study|Lost to Follow-up|1|||
30921122|NCT02066389|58956299|FG000|Overall Study|Randomized in Error|0|||
30921123|NCT02066389|58956300|FG001|Overall Study|Randomized in Error|0|||
30921124|NCT02066389|58956301|FG002|Overall Study|Randomized in Error|0|||
30921125|NCT02066389|58956302|FG003|Overall Study|Randomized in Error|0|||
30921126|NCT02066389|58956303|FG004|Overall Study|Randomized in Error|0|||
30921127|NCT02066389|58956304|FG005|Overall Study|Randomized in Error|1|||
30921128|NCT02106403|58956318|FG000|Follow-Up Visit 3|Other Reason|0|||
30921129|NCT02106403|58956319|FG001|Follow-Up Visit 3|Other Reason|0|||
30921130|NCT02106403|58956320|FG002|Follow-Up Visit 3|Other Reason|0|||
30921131|NCT02106403|58956321|FG003|Follow-Up Visit 3|Other Reason|0|||
30921132|NCT02106403|58956322|FG004|Follow-Up Visit 3|Other Reason|0|||
30921133|NCT02106403|58956323|FG005|Follow-Up Visit 3|Other Reason|1|||
30921134|NCT02133131|58956340|FG000|Overall Study|Adverse Event|0|||
30921135|NCT02133131|58956341|FG001|Overall Study|Adverse Event|0|||
30921136|NCT02133131|58956342|FG002|Overall Study|Adverse Event|0|||
30921137|NCT02133131|58956343|FG003|Overall Study|Adverse Event|1|||
30921138|NCT02133131|58956344|FG004|Overall Study|Adverse Event|0|||
30921139|NCT02133131|58956345|FG005|Overall Study|Adverse Event|0|||
30921140|NCT02133131|58956346|FG006|Overall Study|Adverse Event|0|||
30921141|NCT02133131|58956340|FG000|Overall Study|Lost to Follow-up|1|||
30921142|NCT02133131|58956341|FG001|Overall Study|Lost to Follow-up|0|||
30921143|NCT02133131|58956342|FG002|Overall Study|Lost to Follow-up|0|||
30921144|NCT02133131|58956343|FG003|Overall Study|Lost to Follow-up|1|||
30921145|NCT02133131|58956344|FG004|Overall Study|Lost to Follow-up|0|||
30921146|NCT02133131|58956345|FG005|Overall Study|Lost to Follow-up|0|||
30921147|NCT02133131|58956346|FG006|Overall Study|Lost to Follow-up|0|||
30921148|NCT02133131|58956340|FG000|Overall Study|Status not recorded|4|||
30921149|NCT02133131|58956341|FG001|Overall Study|Status not recorded|5|||
30921150|NCT02133131|58956342|FG002|Overall Study|Status not recorded|1|||
30921151|NCT02133131|58956343|FG003|Overall Study|Status not recorded|4|||
30921152|NCT02133131|58956344|FG004|Overall Study|Status not recorded|0|||
30921153|NCT02133131|58956345|FG005|Overall Study|Status not recorded|0|||
30921154|NCT02133131|58956346|FG006|Overall Study|Status not recorded|0|||
30921155|NCT02133131|58956340|FG000|Overall Study|Ongoing in study|0|||
30921156|NCT02133131|58956341|FG001|Overall Study|Ongoing in study|0|||
30921157|NCT02133131|58956342|FG002|Overall Study|Ongoing in study|0|||
30921158|NCT02133131|58956343|FG003|Overall Study|Ongoing in study|0|||
30921159|NCT02133131|58956344|FG004|Overall Study|Ongoing in study|15|||
30921160|NCT02133131|58956345|FG005|Overall Study|Ongoing in study|14|||
30921161|NCT02133131|58956346|FG006|Overall Study|Ongoing in study|11|||
30921162|NCT02133131|58956340|FG000|Overall Study|Protocol Violation|0|||
30921163|NCT02133131|58956341|FG001|Overall Study|Protocol Violation|0|||
30921164|NCT02133131|58956342|FG002|Overall Study|Protocol Violation|0|||
30921165|NCT02133131|58956343|FG003|Overall Study|Protocol Violation|0|||
30921166|NCT02133131|58956344|FG004|Overall Study|Protocol Violation|0|||
30921167|NCT02133131|58956345|FG005|Overall Study|Protocol Violation|0|||
30921168|NCT02133131|58956346|FG006|Overall Study|Protocol Violation|1|||
30921169|NCT02106325|58956364|FG000|Phase 1|Lost to Follow-up|2|||
30921170|NCT02106325|58956365|FG001|Phase 1|Lost to Follow-up|2|||
30921171|NCT02106325|58956364|FG000|Phase 2|Lost to Follow-up|2|||
30921172|NCT02106325|58956365|FG001|Phase 2|Lost to Follow-up|3|||
30921173|NCT02106325|58956364|FG000|Phase 3|Lost to Follow-up|2|||
30921174|NCT02106325|58956365|FG001|Phase 3|Lost to Follow-up|1|||
30921175|NCT01625689|58956373|FG000|Overall Study|Migration|2|||
30921176|NCT01625689|58956374|FG001|Overall Study|Migration|1|||
30921177|NCT02184611|58956382|FG000|Overall Study|Lack of Efficacy|11|||
30921178|NCT02184611|58956383|FG001|Overall Study|Lack of Efficacy|15|||
30921179|NCT02184611|58956382|FG000|Overall Study|Withdrawal by Subject|5|||
30921180|NCT02184611|58956383|FG001|Overall Study|Withdrawal by Subject|6|||
30921181|NCT02184611|58956382|FG000|Overall Study|Adverse Event|4|||
30921182|NCT02184611|58956383|FG001|Overall Study|Adverse Event|5|||
30921183|NCT02184611|58956382|FG000|Overall Study|Protocol Violation|1|||
30921184|NCT02184611|58956383|FG001|Overall Study|Protocol Violation|1|||
30921185|NCT02184611|58956382|FG000|Overall Study|Protocol defined stopping criteria|0|||
30921186|NCT02184611|58956383|FG001|Overall Study|Protocol defined stopping criteria|1|||
30921187|NCT02066311|58956389|FG000|Overall Study|Adverse Event|4|||
30921188|NCT02066311|58956389|FG000|Overall Study|Withdrawal by Subject|1|||
30921189|NCT02184455|58956393|FG000|Overall Study|Lost to Follow-up|1|||
30921190|NCT02184143|58956399|FG000|Overall Study|Withdrawal by Subject|4|||
30921191|NCT02184143|58956400|FG001|Overall Study|Withdrawal by Subject|4|||
30921192|NCT02184143|58956399|FG000|Overall Study|Lost to Follow-up|5|||
30921193|NCT02184143|58956400|FG001|Overall Study|Lost to Follow-up|3|||
30921194|NCT02184143|58956399|FG000|Overall Study|Death|1|||
30921195|NCT02184143|58956400|FG001|Overall Study|Death|0|||
30921196|NCT01625611|58956410|FG000|Overall Study|No adlib drinks Lab 1|3|||
30921197|NCT01625611|58956411|FG001|Overall Study|No adlib drinks Lab 1|0|||
30921198|NCT01625611|58956410|FG000|Overall Study|Technical issues with PET|1|||
30921199|NCT01625611|58956411|FG001|Overall Study|Technical issues with PET|0|||
30921200|NCT01625611|58956410|FG000|Overall Study|Unable to complete study procedures|1|||
30921201|NCT01625611|58956411|FG001|Overall Study|Unable to complete study procedures|0|||
30921202|NCT01625611|58956410|FG000|Overall Study|Withdrawal by Subject|3|||
30921203|NCT01625611|58956411|FG001|Overall Study|Withdrawal by Subject|0|||
30921204|NCT02159807|58956421|FG000|Overall Study|Adverse Event|0|||
30921205|NCT02159807|58956422|FG001|Overall Study|Adverse Event|0|||
30921206|NCT02159807|58956423|FG002|Overall Study|Adverse Event|1|||
30921207|NCT02159807|58956421|FG000|Overall Study|No CSF|1|||
30827140|NCT02924883|58849706|FG001|Overall Study|Withdrawal by Subject|16|||
30827141|NCT02924883|58849705|FG000|Overall Study|Progressive Disease|1|||
30827142|NCT02924883|58849706|FG001|Overall Study|Progressive Disease|0|||
30827143|NCT02924883|58849705|FG000|Overall Study|Study Terminated by Sponsor|69|||
30827144|NCT02924883|58849706|FG001|Overall Study|Study Terminated by Sponsor|32|||
30827145|NCT01369680|58849729|FG000|Overall Study|Lost to Follow-up|0|||
30827146|NCT01369680|58849730|FG001|Overall Study|Lost to Follow-up|0|||
30827147|NCT01369680|58849731|FG002|Overall Study|Lost to Follow-up|1|||
30827148|NCT01369680|58849732|FG003|Overall Study|Lost to Follow-up|2|||
30827149|NCT03074149|58849764|FG000|Overall Study|Reason unknown|22|||
30827150|NCT03074149|58849765|FG001|Overall Study|Reason unknown|35|||
30827151|NCT03074149|58849764|FG000|Overall Study|Death|10|||
30827152|NCT03074149|58849765|FG001|Overall Study|Death|45|||
30827153|NCT02751320|58849773|FG000|Overall Study|Adverse Event|2|||
30827154|NCT02751320|58849773|FG000|Overall Study|Withdrawal by Subject|1|||
30827155|NCT02206035|58849801|FG000|Overall Study|Physician Decision|10|||
30827156|NCT02206035|58849802|FG001|Overall Study|Physician Decision|0|||
30827157|NCT02206035|58849803|FG002|Overall Study|Physician Decision|175|||
30827158|NCT02746471|58849810|FG000|Overall Study|Death|43|||
30827159|NCT02746471|58849810|FG000|Overall Study|Exited before 36 months|1119|||
30827160|NCT02591953|58849817|FG000|Overall Study|Lost to Follow-up|6|||
30921208|NCT02159807|58956422|FG001|Overall Study|No CSF|1|||
30921209|NCT02159807|58956423|FG002|Overall Study|No CSF|1|||
30921210|NCT02159807|58956421|FG000|Overall Study|elevated blood pressure|0|||
30921211|NCT02159807|58956422|FG001|Overall Study|elevated blood pressure|0|||
30921212|NCT02159807|58956423|FG002|Overall Study|elevated blood pressure|1|||
30827161|NCT02591953|58849818|FG001|Overall Study|Lost to Follow-up|6|||
30827162|NCT03073213|58849826|FG000|Multiple Dose Period|Protocol Violation|0|||
30827163|NCT03073213|58849827|FG001|Multiple Dose Period|Protocol Violation|0|||
30827164|NCT03073213|58849828|FG002|Multiple Dose Period|Protocol Violation|1|||
30827165|NCT03070483|58849837|FG000|Overall Study|Lost to Follow-up|2|||
30827166|NCT02231762|58849842|FG000|Combination Phase|Adverse Event|10|||
30827167|NCT02231762|58849843|FG001|Combination Phase|Adverse Event|0|||
30827168|NCT02231762|58849844|FG002|Combination Phase|Adverse Event|0|||
30827169|NCT02231762|58849845|FG003|Combination Phase|Adverse Event|0|||
30827170|NCT02231762|58849842|FG000|Combination Phase|Withdrawal by Subject|2|||
30827171|NCT02231762|58849843|FG001|Combination Phase|Withdrawal by Subject|0|||
30827172|NCT02231762|58849844|FG002|Combination Phase|Withdrawal by Subject|0|||
30827173|NCT02231762|58849845|FG003|Combination Phase|Withdrawal by Subject|0|||
30827174|NCT02231762|58849842|FG000|Combination Phase|Disease Progression|6|||
30827175|NCT02231762|58849843|FG001|Combination Phase|Disease Progression|0|||
30827176|NCT02231762|58849844|FG002|Combination Phase|Disease Progression|0|||
30827177|NCT02231762|58849845|FG003|Combination Phase|Disease Progression|0|||
30827178|NCT02231762|58849842|FG000|Combination Phase|Did not meet inclusion criteria|1|||
30921213|NCT02066233|58956433|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
30921214|NCT02066233|58956434|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
30921215|NCT02159729|58956442|FG000|Overall Study|Adverse Event|0|||
30921216|NCT02159729|58956443|FG001|Overall Study|Adverse Event|1|||
30921217|NCT02159729|58956442|FG000|Overall Study|Subject's Request|13|||
30827179|NCT02231762|58849843|FG001|Combination Phase|Did not meet inclusion criteria|0|||
30827180|NCT02231762|58849844|FG002|Combination Phase|Did not meet inclusion criteria|0|||
30827181|NCT02231762|58849845|FG003|Combination Phase|Did not meet inclusion criteria|0|||
30827182|NCT02231762|58849842|FG000|Combination Phase|Protocol Violation|1|||
30827183|NCT02231762|58849843|FG001|Combination Phase|Protocol Violation|0|||
30827184|NCT02231762|58849844|FG002|Combination Phase|Protocol Violation|0|||
30827185|NCT02231762|58849845|FG003|Combination Phase|Protocol Violation|0|||
30827186|NCT02231762|58849842|FG000|Maintenance Phase|Disease progression|0|||
30921218|NCT02159729|58956443|FG001|Overall Study|Subject's Request|10|||
30921219|NCT02159729|58956442|FG000|Overall Study|Lost to Follow-up|24|||
30827187|NCT02231762|58849843|FG001|Maintenance Phase|Disease progression|3|||
30827188|NCT02231762|58849844|FG002|Maintenance Phase|Disease progression|4|||
30921220|NCT02159729|58956443|FG001|Overall Study|Lost to Follow-up|9|||
30921221|NCT02159729|58956442|FG000|Overall Study|Non compliance|2|||
30921222|NCT02159729|58956443|FG001|Overall Study|Non compliance|0|||
30754110|NCT00131664|58763663|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
30754111|NCT00131664|58763664|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
30921223|NCT02159729|58956442|FG000|Overall Study|Other Unspecified|3|||
30921224|NCT02159729|58956443|FG001|Overall Study|Other Unspecified|1|||
30921225|NCT02159183|58956451|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
30754112|NCT00131664|58763665|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
30754113|NCT00131664|58763660|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
30754114|NCT00131664|58763661|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
30754115|NCT00131664|58763662|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
30827189|NCT02231762|58849845|FG003|Maintenance Phase|Disease progression|3|||
30827190|NCT02231762|58849842|FG000|Maintenance Phase|Adverse Event|0|||
30827191|NCT02231762|58849843|FG001|Maintenance Phase|Adverse Event|0|||
30827192|NCT02231762|58849844|FG002|Maintenance Phase|Adverse Event|1|||
30827193|NCT02231762|58849845|FG003|Maintenance Phase|Adverse Event|2|||
30827194|NCT03023397|58849862|FG000|Run-In|Failed screening allergen challenge|1|||
30827195|NCT03023397|58849863|FG001|Run-In|Failed screening allergen challenge|0|||
30827196|NCT03023397|58849864|FG002|Run-In|Failed screening allergen challenge|0|||
30827197|NCT03023397|58849862|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
30827198|NCT03023397|58849863|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
30827199|NCT03023397|58849864|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
30827200|NCT04325906|58849875|FG000|Overall Study|Withdrawal by Subject|2|||
30827201|NCT04325906|58849876|FG001|Overall Study|Withdrawal by Subject|0|||
30827202|NCT03068455|58849884|FG000|Pre-treatment Period|Disease progression|0|||
30827203|NCT03068455|58849885|FG001|Pre-treatment Period|Disease progression|1|||
30827204|NCT03068455|58849884|FG000|Pre-treatment Period|Participant withdrew consent|1|||
30827205|NCT03068455|58849885|FG001|Pre-treatment Period|Participant withdrew consent|1|||
30827206|NCT03068455|58849884|FG000|Pre-treatment Period|Poor/non-compliance|0|||
30827207|NCT03068455|58849885|FG001|Pre-treatment Period|Poor/non-compliance|1|||
30827208|NCT03068455|58849884|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
30827209|NCT03068455|58849885|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
30827210|NCT03068455|58849884|FG000|Pre-treatment Period|Not reported|2|||
30827211|NCT03068455|58849885|FG001|Pre-treatment Period|Not reported|1|||
30827212|NCT03068455|58849884|FG000|Treatment Period|Disease progression|166|||
30827213|NCT03068455|58849885|FG001|Treatment Period|Disease progression|208|||
30827214|NCT03068455|58849884|FG000|Treatment Period|Study drug toxicity|317|||
30827215|NCT03068455|58849885|FG001|Treatment Period|Study drug toxicity|104|||
30827216|NCT03068455|58849884|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
30827217|NCT03068455|58849885|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
30827218|NCT03068455|58849884|FG000|Treatment Period|Participant request to stop therapy|33|||
30827219|NCT03068455|58849885|FG001|Treatment Period|Participant request to stop therapy|20|||
30827220|NCT03068455|58849884|FG000|Treatment Period|Participant withdrew consent|5|||
30827221|NCT03068455|58849885|FG001|Treatment Period|Participant withdrew consent|10|||
30827222|NCT03068455|58849884|FG000|Treatment Period|Poor/non-compliance|3|||
30827223|NCT03068455|58849885|FG001|Treatment Period|Poor/non-compliance|0|||
30921226|NCT02159183|58956452|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
30921227|NCT02159183|58956451|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
30754116|NCT00131664|58763663|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
30754117|NCT00131664|58763664|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
30754118|NCT00131664|58763665|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
30754119|NCT00131508|58763678|FG000|Overall Study|Disease progression|0|||
30754120|NCT00131508|58763679|FG001|Overall Study|Disease progression|2|||
30921228|NCT02159183|58956452|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
30921229|NCT02159183|58956451|FG000|Analysis After the 36 Months Follow-up|Death|0|||
30921230|NCT02159183|58956452|FG001|Analysis After the 36 Months Follow-up|Death|1|||
30921231|NCT02159183|58956451|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
30921232|NCT02159183|58956452|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
30921233|NCT02159183|58956451|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
30921234|NCT02159183|58956452|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
30921235|NCT02183675|58956464|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
30921236|NCT02183675|58956465|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
30921237|NCT02183675|58956466|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
30921238|NCT02183675|58956467|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
30921239|NCT02183675|58956468|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
30921240|NCT02183675|58956469|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
30921241|NCT02183519|58956481|FG000|Overall Study|computer error|3|||
30921242|NCT02183519|58956482|FG001|Overall Study|computer error|0|||
30921243|NCT02183519|58956481|FG000|Overall Study|Did not respond to cough inducter|0|||
30921244|NCT02183519|58956482|FG001|Overall Study|Did not respond to cough inducter|3|||
30921245|NCT02132195|58956491|FG000|Initial Assignment|Relapsed|14|||
30921246|NCT02132195|58956492|FG001|Initial Assignment|Relapsed|0|||
30921247|NCT02132195|58956493|FG002|Initial Assignment|Relapsed|0|||
30921248|NCT02132195|58956491|FG000|Rescue Therapy|Relapsed|0|||
30921249|NCT02132195|58956492|FG001|Rescue Therapy|Relapsed|0|||
30921250|NCT02132195|58956493|FG002|Rescue Therapy|Relapsed|7|||
30921251|NCT02132195|58956491|FG000|Rescue Therapy|Physician Decision|0|||
30921252|NCT02132195|58956492|FG001|Rescue Therapy|Physician Decision|0|||
30921253|NCT02132195|58956493|FG002|Rescue Therapy|Physician Decision|1|||
30921254|NCT02132195|58956491|FG000|Rescue Therapy|Withdrawal by Subject|0|||
30921255|NCT02132195|58956492|FG001|Rescue Therapy|Withdrawal by Subject|0|||
30921256|NCT02132195|58956493|FG002|Rescue Therapy|Withdrawal by Subject|1|||
30921257|NCT02132195|58956491|FG000|Rescue Therapy|Adverse Event|0|||
30921258|NCT02132195|58956492|FG001|Rescue Therapy|Adverse Event|0|||
30921259|NCT02132195|58956493|FG002|Rescue Therapy|Adverse Event|2|||
30921260|NCT02182973|58956503|FG000|Overall Study|Withdrawal by Subject|3|||
30921261|NCT02182973|58956504|FG001|Overall Study|Withdrawal by Subject|0|||
30921262|NCT02182895|58956513|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
30921263|NCT02182895|58956514|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
30921264|NCT01625377|58956522|FG000|Overall Study|Death|1|||
30921265|NCT01625377|58956523|FG001|Overall Study|Death|1|||
30921266|NCT01625377|58956522|FG000|Overall Study|Administrative Problem|1|||
30921267|NCT01625377|58956523|FG001|Overall Study|Administrative Problem|1|||
30921268|NCT01625377|58956522|FG000|Overall Study|Protocol Violation|0|||
30921269|NCT01625377|58956523|FG001|Overall Study|Protocol Violation|3|||
30921270|NCT01625377|58956522|FG000|Overall Study|Adverse Event|3|||
30921271|NCT01625377|58956523|FG001|Overall Study|Adverse Event|16|||
30921272|NCT01625377|58956522|FG000|Overall Study|Graft loss|1|||
30921273|NCT01625377|58956523|FG001|Overall Study|Graft loss|0|||
30921274|NCT01625377|58956522|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30921275|NCT01625377|58956523|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30921276|NCT01625377|58956522|FG000|Overall Study|Abnormal laboratory values|1|||
30921277|NCT01625377|58956523|FG001|Overall Study|Abnormal laboratory values|0|||
30921278|NCT02158949|58956531|FG000|Overall Study|Withdrawal by Subject|1|||
30754121|NCT00131508|58763678|FG000|Overall Study|Non-Compliance|2|||
30754122|NCT00131508|58763679|FG001|Overall Study|Non-Compliance|4|||
30754123|NCT00131508|58763678|FG000|Overall Study|Withdrawal by Subject|1|||
30754124|NCT00131508|58763679|FG001|Overall Study|Withdrawal by Subject|2|||
30754125|NCT05050318|58763688|FG000|Overall Study|Protocol Deviation|1|||
30754126|NCT05050318|58763689|FG001|Overall Study|Protocol Deviation|0|||
30754127|NCT05050318|58763690|FG002|Overall Study|Protocol Deviation|0|||
30754128|NCT03699124|58763701|FG000|Overall Study|Adverse Event|6|||
30754129|NCT03699124|58763702|FG001|Overall Study|Adverse Event|5|||
30754130|NCT03699124|58763703|FG002|Overall Study|Adverse Event|2|||
30921279|NCT02158949|58956532|FG001|Overall Study|Withdrawal by Subject|0|||
30754131|NCT03699124|58763701|FG000|Overall Study|Death|0|||
30921280|NCT02158949|58956531|FG000|Overall Study|Lost to Follow-up|5|||
30921281|NCT02158949|58956532|FG001|Overall Study|Lost to Follow-up|11|||
30921282|NCT02132117|58956540|FG000|Overall Study|Adverse Event|6|||
30921283|NCT02132117|58956541|FG001|Overall Study|Adverse Event|1|||
30921284|NCT02132117|58956540|FG000|Overall Study|Lost to Follow-up|2|||
30921285|NCT02132117|58956541|FG001|Overall Study|Lost to Follow-up|2|||
30921286|NCT02132117|58956540|FG000|Overall Study|Personal Reasons|1|||
30921287|NCT02132117|58956541|FG001|Overall Study|Personal Reasons|2|||
30921288|NCT02132117|58956540|FG000|Overall Study|Other Miscellaneous Reasons|2|||
30921289|NCT02132117|58956541|FG001|Overall Study|Other Miscellaneous Reasons|0|||
30754132|NCT03699124|58763702|FG001|Overall Study|Death|2|||
30754133|NCT03699124|58763703|FG002|Overall Study|Death|0|||
30921290|NCT02093689|58956550|FG000|Overall Study|Physician Decision|4|||
30921291|NCT02093689|58956551|FG001|Overall Study|Physician Decision|0|||
30921292|NCT02093689|58956552|FG002|Overall Study|Physician Decision|0|||
30921293|NCT02047045|58956560|FG000|Baseline|Withdrawal by Subject|3|||
30921294|NCT02047045|58956561|FG001|Baseline|Withdrawal by Subject|2|||
30921295|NCT02047045|58956560|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
30921296|NCT02047045|58956561|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
30921297|NCT02047045|58956560|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
30921298|NCT02047045|58956561|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
30921299|NCT02047045|58956560|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
30921300|NCT02047045|58956561|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
30921301|NCT02047045|58956560|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
30921302|NCT02047045|58956561|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
30921303|NCT02047045|58956560|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
30921304|NCT02047045|58956561|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
30921305|NCT02047045|58956560|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
30921306|NCT02047045|58956561|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
30921307|NCT02047045|58956560|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
30754134|NCT03699124|58763701|FG000|Overall Study|Lost to Follow-up|20|||
30754135|NCT03699124|58763702|FG001|Overall Study|Lost to Follow-up|16|||
30754136|NCT03699124|58763703|FG002|Overall Study|Lost to Follow-up|15|||
30754137|NCT03699124|58763701|FG000|Overall Study|Protocol Violation|1|||
30754138|NCT03699124|58763702|FG001|Overall Study|Protocol Violation|0|||
30754139|NCT03699124|58763703|FG002|Overall Study|Protocol Violation|0|||
30754140|NCT03699124|58763701|FG000|Overall Study|Withdrawal by Subject|13|||
30754141|NCT03699124|58763702|FG001|Overall Study|Withdrawal by Subject|14|||
30754142|NCT03699124|58763703|FG002|Overall Study|Withdrawal by Subject|13|||
30754143|NCT03699124|58763701|FG000|Overall Study|Other reasons|5|||
30754144|NCT03699124|58763702|FG001|Overall Study|Other reasons|3|||
30754145|NCT03699124|58763703|FG002|Overall Study|Other reasons|10|||
30754146|NCT05002972|58763711|FG000|Overall Study|Withdrawal by Subject|2|||
30754147|NCT04651114|58763715|FG000|Overall Study|Withdrawal by Subject|8|||
30754148|NCT04980040|58763719|FG000|Overall Study|Violated the Inclusion Criteria|260|||
30754149|NCT04980040|58763719|FG000|Overall Study|Violated the Administration & Dosage|225|||
30754150|NCT04980040|58763719|FG000|Overall Study|Lost to Safety-Follow-up|4|||
30754151|NCT04980040|58763719|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
30754152|NCT00131352|58763725|FG000|Initial Treatment Period|Adverse Event|1|||
30754153|NCT00131352|58763726|FG001|Initial Treatment Period|Adverse Event|3|||
30754154|NCT00131352|58763725|FG000|Initial Treatment Period|Non-compliant|1|||
30754155|NCT00131352|58763726|FG001|Initial Treatment Period|Non-compliant|2|||
30827224|NCT03068455|58849884|FG000|Treatment Period|Participant no longer meets study criteria|1|||
30827225|NCT03068455|58849885|FG001|Treatment Period|Participant no longer meets study criteria|3|||
30827226|NCT03068455|58849884|FG000|Treatment Period|Other reasons|12|||
30827227|NCT03068455|58849885|FG001|Treatment Period|Other reasons|4|||
30827228|NCT03067987|58849893|FG000|Overall Study|Lost to Follow-up|7|||
30827229|NCT03067987|58849894|FG001|Overall Study|Lost to Follow-up|10|||
30827230|NCT03067987|58849893|FG000|Overall Study|Protocol Violation|1|||
30827231|NCT03067987|58849894|FG001|Overall Study|Protocol Violation|2|||
30827232|NCT03067987|58849893|FG000|Overall Study|Withdrawal by Subject|2|||
30921308|NCT02047045|58956561|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
30921309|NCT02047045|58956560|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
30827233|NCT03067987|58849894|FG001|Overall Study|Withdrawal by Subject|1|||
30921310|NCT02047045|58956561|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
30921311|NCT02131259|58956567|FG000|Overall Study|Progressive disease|751|||
30827234|NCT03197870|58849903|FG000|Overall Study|Adverse Event|9|||
30827235|NCT03197870|58849904|FG001|Overall Study|Adverse Event|4|||
30754156|NCT00131352|58763725|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
30754157|NCT00131352|58763726|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
30754158|NCT00131352|58763725|FG000|Initial Treatment Period|Lack of Efficacy|6|||
30921312|NCT02131259|58956567|FG000|Overall Study|Adverse Event|341|||
30921313|NCT02131259|58956567|FG000|Overall Study|Lost to Follow-up|7|||
30921314|NCT02131259|58956567|FG000|Overall Study|Relocation|32|||
30921315|NCT02131259|58956567|FG000|Overall Study|Other|63|||
30921316|NCT02131259|58956567|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
30921317|NCT02131259|58956567|FG000|Overall Study|Progressive disease/relocation|1|||
30921318|NCT02131259|58956567|FG000|Overall Study|Progressive disease/other|2|||
30921319|NCT02131259|58956567|FG000|Overall Study|AE/lost to follow-up|1|||
30921320|NCT02131259|58956567|FG000|Overall Study|AE/other|1|||
30921321|NCT02131259|58956567|FG000|Overall Study|Progressive disease/AE/other|1|||
30921322|NCT02131259|58956567|FG000|Overall Study|Missing|3|||
30921323|NCT01856595|58956580|FG000|Overall Study|Withdrawal by Subject|0|||
30921324|NCT01856595|58956581|FG001|Overall Study|Withdrawal by Subject|1|||
30921325|NCT01856595|58956582|FG002|Overall Study|Withdrawal by Subject|0|||
30921326|NCT01856595|58956583|FG003|Overall Study|Withdrawal by Subject|0|||
30921327|NCT01856595|58956584|FG004|Overall Study|Withdrawal by Subject|0|||
30921328|NCT01856595|58956585|FG005|Overall Study|Withdrawal by Subject|0|||
30921329|NCT01856595|58956586|FG006|Overall Study|Withdrawal by Subject|1|||
30921330|NCT01856595|58956587|FG007|Overall Study|Withdrawal by Subject|0|||
30921331|NCT01856595|58956588|FG008|Overall Study|Withdrawal by Subject|0|||
30921332|NCT02158247|58956625|FG000|Overall Study|Invisible vocal cords|5|||
30921333|NCT01829295|58956647|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
30921334|NCT01829295|58956648|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
30921335|NCT01829295|58956649|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
30921336|NCT01829295|58956650|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
30921337|NCT01829295|58956647|FG000|6-12 Months|Adverse Event|0|||
30921338|NCT01829295|58956648|FG001|6-12 Months|Adverse Event|0|||
30921339|NCT01829295|58956649|FG002|6-12 Months|Adverse Event|3|||
30921340|NCT01829295|58956650|FG003|6-12 Months|Adverse Event|2|||
30921341|NCT01829295|58956647|FG000|6-12 Months|Lost to Follow-up|2|||
30921342|NCT01829295|58956648|FG001|6-12 Months|Lost to Follow-up|0|||
30921343|NCT01829295|58956649|FG002|6-12 Months|Lost to Follow-up|0|||
30921344|NCT01829295|58956650|FG003|6-12 Months|Lost to Follow-up|0|||
30921345|NCT01829295|58956647|FG000|6-12 Months|Withdrawal by Subject|2|||
30921346|NCT01829295|58956648|FG001|6-12 Months|Withdrawal by Subject|2|||
30921347|NCT01829295|58956649|FG002|6-12 Months|Withdrawal by Subject|0|||
30921348|NCT01829295|58956650|FG003|6-12 Months|Withdrawal by Subject|0|||
30921349|NCT02157935|58956662|FG000|Overall Study|Withdrawal by Subject|25|||
30921350|NCT02157935|58956663|FG001|Overall Study|Withdrawal by Subject|39|||
30921351|NCT02157935|58956662|FG000|Overall Study|Screen failure|1|||
30921352|NCT02157935|58956663|FG001|Overall Study|Screen failure|2|||
30921353|NCT02157935|58956662|FG000|Overall Study|Protocol Violation|1|||
30921354|NCT02157935|58956663|FG001|Overall Study|Protocol Violation|0|||
30921355|NCT02157935|58956662|FG000|Overall Study|Progressive disease|0|||
30921356|NCT02157935|58956663|FG001|Overall Study|Progressive disease|2|||
30921357|NCT02157935|58956662|FG000|Overall Study|Other|5|||
30921358|NCT02157935|58956663|FG001|Overall Study|Other|12|||
30921359|NCT02157935|58956662|FG000|Overall Study|Lack of Efficacy|0|||
30921360|NCT02157935|58956663|FG001|Overall Study|Lack of Efficacy|1|||
30921361|NCT02157935|58956662|FG000|Overall Study|Death|4|||
30921362|NCT02157935|58956663|FG001|Overall Study|Death|4|||
30921363|NCT02157935|58956662|FG000|Overall Study|Adverse Event|3|||
30921364|NCT02157935|58956663|FG001|Overall Study|Adverse Event|5|||
30921365|NCT02157779|58956671|FG000|Overall Study|Logistical|9|||
30921366|NCT02157779|58956672|FG001|Overall Study|Logistical|3|||
30921367|NCT02157779|58956671|FG000|Overall Study|Stopped attending, reason unknown|11|||
30921368|NCT02157779|58956672|FG001|Overall Study|Stopped attending, reason unknown|7|||
30921369|NCT02157779|58956671|FG000|Overall Study|No response to outreach after Baseline|1|||
30921370|NCT02157779|58956672|FG001|Overall Study|No response to outreach after Baseline|1|||
30921371|NCT02157779|58956671|FG000|Overall Study|Moved|1|||
30921372|NCT02157779|58956672|FG001|Overall Study|Moved|0|||
30921373|NCT02157779|58956671|FG000|Overall Study|Medical|1|||
30921374|NCT02157779|58956672|FG001|Overall Study|Medical|0|||
30921375|NCT02157779|58956671|FG000|Overall Study|Legal issue|1|||
30921376|NCT02157779|58956672|FG001|Overall Study|Legal issue|0|||
30921377|NCT02093221|58956686|FG000|Overall Study|Adverse Event|1|||
30921378|NCT02093221|58956687|FG001|Overall Study|Adverse Event|0|||
30921379|NCT02093221|58956688|FG002|Overall Study|Adverse Event|0|||
30921380|NCT02093221|58956689|FG003|Overall Study|Adverse Event|0|||
30921381|NCT02093221|58956690|FG004|Overall Study|Adverse Event|0|||
30921382|NCT02093221|58956686|FG000|Overall Study|Withdrawal by Subject|1|||
30921383|NCT02093221|58956687|FG001|Overall Study|Withdrawal by Subject|1|||
30921384|NCT02093221|58956688|FG002|Overall Study|Withdrawal by Subject|4|||
30921385|NCT02093221|58956689|FG003|Overall Study|Withdrawal by Subject|1|||
30921386|NCT02093221|58956690|FG004|Overall Study|Withdrawal by Subject|1|||
30921387|NCT02093221|58956686|FG000|Overall Study|Lost to Follow-up|2|||
30921388|NCT02093221|58956687|FG001|Overall Study|Lost to Follow-up|0|||
30921389|NCT02093221|58956688|FG002|Overall Study|Lost to Follow-up|1|||
30921390|NCT02093221|58956689|FG003|Overall Study|Lost to Follow-up|1|||
30921391|NCT02093221|58956690|FG004|Overall Study|Lost to Follow-up|0|||
30921392|NCT02093221|58956686|FG000|Overall Study|Death|0|||
30921393|NCT02093221|58956687|FG001|Overall Study|Death|1|||
30921394|NCT02093221|58956688|FG002|Overall Study|Death|0|||
30921395|NCT02093221|58956689|FG003|Overall Study|Death|0|||
30921396|NCT02093221|58956690|FG004|Overall Study|Death|0|||
30921397|NCT02093221|58956686|FG000|Overall Study|Protocol Violation|0|||
30921398|NCT02093221|58956687|FG001|Overall Study|Protocol Violation|1|||
30921399|NCT02093221|58956688|FG002|Overall Study|Protocol Violation|0|||
30921400|NCT02093221|58956689|FG003|Overall Study|Protocol Violation|0|||
30921401|NCT02093221|58956690|FG004|Overall Study|Protocol Violation|0|||
30921402|NCT02093221|58956686|FG000|Overall Study|Study termination|6|||
30921403|NCT02093221|58956687|FG001|Overall Study|Study termination|5|||
30921404|NCT02093221|58956688|FG002|Overall Study|Study termination|4|||
30921405|NCT02093221|58956689|FG003|Overall Study|Study termination|6|||
30921406|NCT02093221|58956690|FG004|Overall Study|Study termination|7|||
30921407|NCT02092909|58956706|FG000|Overall Study|Adverse Event|0|||
30921408|NCT02092909|58956707|FG001|Overall Study|Adverse Event|0|||
30921409|NCT02092909|58956708|FG002|Overall Study|Adverse Event|4|||
30921410|NCT02092909|58956709|FG003|Overall Study|Adverse Event|2|||
30921411|NCT02092909|58956706|FG000|Overall Study|Lack of Efficacy|0|||
30827236|NCT03197870|58849905|FG002|Overall Study|Adverse Event|6|||
30827237|NCT03197870|58849903|FG000|Overall Study|Withdrawal by Subject|2|||
30827238|NCT03197870|58849904|FG001|Overall Study|Withdrawal by Subject|3|||
30827239|NCT03197870|58849905|FG002|Overall Study|Withdrawal by Subject|0|||
30827240|NCT03197870|58849903|FG000|Overall Study|Lost to Follow-up|2|||
30827241|NCT03197870|58849904|FG001|Overall Study|Lost to Follow-up|2|||
30827242|NCT03197870|58849905|FG002|Overall Study|Lost to Follow-up|0|||
30827243|NCT03197870|58849903|FG000|Overall Study|data not available|1|||
30827244|NCT03197870|58849904|FG001|Overall Study|data not available|1|||
30827245|NCT03197870|58849905|FG002|Overall Study|data not available|0|||
30827246|NCT04889222|58849916|FG000|Overall Study|Did not meet eligibility criteria|8|||
30827247|NCT04889222|58849916|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
30827248|NCT04889222|58849916|FG000|Overall Study|Did not proceed due to time constraints|5|||
30827249|NCT03067441|58849948|FG000|Overall Study|Withdrawal by Subject|16|||
30827250|NCT03067441|58849949|FG001|Overall Study|Withdrawal by Subject|34|||
30827251|NCT03067441|58849948|FG000|Overall Study|Lost to Follow-up|7|||
30827252|NCT03067441|58849949|FG001|Overall Study|Lost to Follow-up|5|||
30827253|NCT03067441|58849948|FG000|Overall Study|Adverse Event|7|||
30827254|NCT03067441|58849949|FG001|Overall Study|Adverse Event|14|||
30827255|NCT03067441|58849948|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
30827256|NCT03067441|58849949|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
30827257|NCT03067441|58849948|FG000|Overall Study|Physician Decision|1|||
30827258|NCT03067441|58849949|FG001|Overall Study|Physician Decision|3|||
30827259|NCT03067441|58849948|FG000|Overall Study|Other|1|||
30827260|NCT03067441|58849949|FG001|Overall Study|Other|1|||
30827261|NCT02600923|58849958|FG000|Overall Study|Death|10|||
30827262|NCT02600923|58849958|FG000|Overall Study|Adverse Event|3|||
30827263|NCT02600923|58849958|FG000|Overall Study|Global deterioration of health status|2|||
30827264|NCT02600923|58849958|FG000|Overall Study|Insufficient clinical response|6|||
30827265|NCT02600923|58849958|FG000|Overall Study|Lost to Follow-up|1|||
30827266|NCT02600923|58849958|FG000|Overall Study|Withdrawal by Subject|5|||
30827267|NCT02600923|58849958|FG000|Overall Study|Objective progression or relapse|50|||
30827268|NCT02600923|58849958|FG000|Overall Study|Study terminated by Sponsor|53|||
30827269|NCT02600923|58849958|FG000|Overall Study|Not treated|1|||
30827270|NCT03070171|58849964|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
30827271|NCT03070171|58849965|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
30827272|NCT03070171|58849964|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
30827273|NCT03070171|58849965|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
30827274|NCT03644017|58849971|FG000|Overall Study|Access Abandonment|5|||
30827275|NCT03644017|58849971|FG000|Overall Study|Kidney Transplant|2|||
30827276|NCT00158054|58849977|FG000|Overall Study|Refused to continue|3|||
30827277|NCT00158054|58849978|FG001|Overall Study|Refused to continue|0|||
30921412|NCT02092909|58956707|FG001|Overall Study|Lack of Efficacy|2|||
30921413|NCT02092909|58956708|FG002|Overall Study|Lack of Efficacy|1|||
30921414|NCT02092909|58956709|FG003|Overall Study|Lack of Efficacy|0|||
30827278|NCT00158054|58849977|FG000|Overall Study|Unavailable for follow up|7|||
30827279|NCT00158054|58849978|FG001|Overall Study|Unavailable for follow up|3|||
30827280|NCT01337960|58849987|FG000|Overall Study|Lost to Follow-up|1|||
30827281|NCT01337960|58849988|FG001|Overall Study|Lost to Follow-up|0|||
30921415|NCT02092909|58956706|FG000|Overall Study|Withdrawal by Subject|0|||
30921416|NCT02092909|58956707|FG001|Overall Study|Withdrawal by Subject|0|||
30921417|NCT02092909|58956708|FG002|Overall Study|Withdrawal by Subject|2|||
30921418|NCT02092909|58956709|FG003|Overall Study|Withdrawal by Subject|1|||
30921419|NCT02092909|58956706|FG000|Overall Study|Study terminated by Sponsor|0|||
30921420|NCT02092909|58956707|FG001|Overall Study|Study terminated by Sponsor|0|||
30921421|NCT02092909|58956708|FG002|Overall Study|Study terminated by Sponsor|0|||
30921422|NCT02092909|58956709|FG003|Overall Study|Study terminated by Sponsor|2|||
30921423|NCT02092909|58956706|FG000|Overall Study|Miscellaneous|1|||
30921424|NCT02092909|58956707|FG001|Overall Study|Miscellaneous|1|||
30827282|NCT01337960|58849989|FG002|Overall Study|Lost to Follow-up|0|||
30827283|NCT01337960|58849987|FG000|Overall Study|Withdrawal by Subject|1|||
30827284|NCT01337960|58849988|FG001|Overall Study|Withdrawal by Subject|0|||
30827285|NCT01337960|58849989|FG002|Overall Study|Withdrawal by Subject|0|||
30827286|NCT02750306|58850008|FG000|Overall Study|Withdrawal by Subject|5|||
30827287|NCT02750306|58850009|FG001|Overall Study|Withdrawal by Subject|2|||
30921425|NCT02092909|58956708|FG002|Overall Study|Miscellaneous|2|||
30921426|NCT02092909|58956709|FG003|Overall Study|Miscellaneous|1|||
30921427|NCT01623115|58956721|FG000|Overall Study|Randomized but not treated|0|||
30921428|NCT01623115|58956722|FG001|Overall Study|Randomized but not treated|1|||
30921429|NCT01623115|58956721|FG000|Overall Study|Physician Decision|1|||
30921430|NCT01623115|58956722|FG001|Overall Study|Physician Decision|0|||
30921431|NCT01623115|58956721|FG000|Overall Study|Participants moved|1|||
30921432|NCT01623115|58956722|FG001|Overall Study|Participants moved|5|||
30921433|NCT01623115|58956721|FG000|Overall Study|Adverse Event|10|||
30921434|NCT01623115|58956722|FG001|Overall Study|Adverse Event|13|||
30921435|NCT01623115|58956721|FG000|Overall Study|Poor compliance to protocol|4|||
30921436|NCT01623115|58956722|FG001|Overall Study|Poor compliance to protocol|10|||
30921437|NCT01623115|58956721|FG000|Overall Study|Consent withdrawn by participant|2|||
30921438|NCT01623115|58956722|FG001|Overall Study|Consent withdrawn by participant|6|||
30921439|NCT01623115|58956721|FG000|Overall Study|Related to study drug administration|0|||
30921440|NCT01623115|58956722|FG001|Overall Study|Related to study drug administration|2|||
30921441|NCT01623115|58956721|FG000|Overall Study|Last visit outside protocol visit window|14|||
30921442|NCT01623115|58956722|FG001|Overall Study|Last visit outside protocol visit window|26|||
30921443|NCT01623115|58956721|FG000|Overall Study|Site closure|1|||
30921444|NCT01623115|58956722|FG001|Overall Study|Site closure|7|||
30921445|NCT01623115|58956721|FG000|Overall Study|Death|0|||
30921446|NCT01623115|58956722|FG001|Overall Study|Death|4|||
30921447|NCT01623115|58956721|FG000|Overall Study|Other than specified above|0|||
30921448|NCT01623115|58956722|FG001|Overall Study|Other than specified above|3|||
30921449|NCT02092285|58956728|FG000|Induction Phase|Adverse Event|7|||
30921450|NCT02092285|58956728|FG000|Induction Phase|Physician Decision|4|||
30827288|NCT02750306|58850008|FG000|Overall Study|Protocol Violation|1|||
30827289|NCT02750306|58850009|FG001|Overall Study|Protocol Violation|0|||
30921451|NCT02092285|58956728|FG000|Induction Phase|Pregnancy|1|||
30827290|NCT01816165|58850017|FG000|Overall Study|Adverse Event|1|||
30827291|NCT01816165|58850018|FG001|Overall Study|Adverse Event|0|||
30827292|NCT01816165|58850019|FG002|Overall Study|Adverse Event|0|||
30827293|NCT01816165|58850020|FG003|Overall Study|Adverse Event|0|||
30827294|NCT01677988|58850049|FG000|Overall Study|Lack of Efficacy|2|||
30921452|NCT02092285|58956728|FG000|Induction Phase|Relapse/Recurrence|7|||
30921453|NCT02092285|58956728|FG000|Induction Phase|Withdrawal by Subject|2|||
30921454|NCT02092285|58956728|FG000|Induction Phase|Lack of Efficacy|14|||
30921455|NCT02092285|58956728|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
30921456|NCT02092285|58956728|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
30921457|NCT02092285|58956728|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
30921458|NCT02092285|58956728|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
30921459|NCT02092285|58956728|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
30921460|NCT02092285|58956728|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
30921461|NCT02092285|58956728|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
30921462|NCT02092285|58956728|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
30921463|NCT02092285|58956728|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
30921464|NCT02091739|58956735|FG000|MP: 16 Weeks|Adverse Event|1|||
30921465|NCT02091739|58956736|FG001|MP: 16 Weeks|Adverse Event|1|||
30921466|NCT02091739|58956737|FG002|MP: 16 Weeks|Adverse Event|1|||
30921467|NCT02091739|58956738|FG003|MP: 16 Weeks|Adverse Event|0|||
30921468|NCT02091739|58956739|FG004|MP: 16 Weeks|Adverse Event|0|||
30921469|NCT02091739|58956735|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
30827295|NCT02926573|58850056|FG000|Overall Study|Nausea|1|||
30827296|NCT02926573|58850057|FG001|Overall Study|Nausea|0|||
30827297|NCT02926573|58850056|FG000|Overall Study|Remain intubated|2|||
30827298|NCT02926573|58850057|FG001|Overall Study|Remain intubated|2|||
30827299|NCT02926573|58850056|FG000|Overall Study|Change in surgery plan|3|||
30827300|NCT02926573|58850057|FG001|Overall Study|Change in surgery plan|1|||
30827301|NCT02926573|58850056|FG000|Overall Study|Change to outpatient status|5|||
30827302|NCT02926573|58850057|FG001|Overall Study|Change to outpatient status|1|||
30827303|NCT02926573|58850056|FG000|Overall Study|Withdrawal by Subject|0|||
30827304|NCT02926573|58850057|FG001|Overall Study|Withdrawal by Subject|2|||
30921470|NCT02091739|58956736|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
30921471|NCT02091739|58956737|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
30921472|NCT02091739|58956738|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
30921473|NCT02091739|58956739|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
30921474|NCT02091739|58956735|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
30921475|NCT02091739|58956736|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
30921476|NCT02091739|58956737|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
30921477|NCT02091739|58956738|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
30827305|NCT02926573|58850056|FG000|Overall Study|Return to operating room|0|||
30827306|NCT02926573|58850057|FG001|Overall Study|Return to operating room|2|||
30827307|NCT02926573|58850056|FG000|Overall Study|Delirium|0|||
30827308|NCT02926573|58850057|FG001|Overall Study|Delirium|1|||
30827309|NCT00158860|58850065|FG000|Overall Study|Adverse Event|3|||
30827310|NCT00158860|58850066|FG001|Overall Study|Adverse Event|6|||
30827311|NCT00158860|58850065|FG000|Overall Study|Lost to Follow-up|11|||
30827312|NCT00158860|58850066|FG001|Overall Study|Lost to Follow-up|17|||
30827313|NCT00158860|58850065|FG000|Overall Study|Protocol Violation|8|||
30827314|NCT00158860|58850066|FG001|Overall Study|Protocol Violation|23|||
30827315|NCT00158860|58850065|FG000|Overall Study|Withdrawal by Subject|7|||
30827316|NCT00158860|58850066|FG001|Overall Study|Withdrawal by Subject|17|||
30827317|NCT00158860|58850065|FG000|Overall Study|MOVING OUT OF STATE|1|||
30827318|NCT00158860|58850066|FG001|Overall Study|MOVING OUT OF STATE|0|||
30827319|NCT00158860|58850065|FG000|Overall Study|Pregnancy|3|||
30827320|NCT00158860|58850066|FG001|Overall Study|Pregnancy|3|||
30827321|NCT00158860|58850065|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
30827322|NCT00158860|58850066|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
30827323|NCT00158860|58850065|FG000|Overall Study|SPONSOR REQUEST|0|||
30827324|NCT00158860|58850066|FG001|Overall Study|SPONSOR REQUEST|1|||
30827325|NCT00158860|58850065|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
30827326|NCT00158860|58850066|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
30827327|NCT00158860|58850065|FG000|Overall Study|Closed per sponsor|0|||
30827328|NCT00158860|58850066|FG001|Overall Study|Closed per sponsor|1|||
30827329|NCT03067129|58850077|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
30827330|NCT03067129|58850078|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
30827331|NCT03067129|58850079|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
30827332|NCT03067129|58850080|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
30827333|NCT03067129|58850077|FG000|Overall Study|Withdrawal by Subject|0|||
30827334|NCT03067129|58850078|FG001|Overall Study|Withdrawal by Subject|0|||
30827335|NCT03067129|58850079|FG002|Overall Study|Withdrawal by Subject|1|||
30827336|NCT03067129|58850080|FG003|Overall Study|Withdrawal by Subject|2|||
30921478|NCT02091739|58956739|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
30921479|NCT02091739|58956735|FG000|EP: 48 Weeks|Other|0|||
30827337|NCT03067129|58850077|FG000|Overall Study|Lost to Follow-up|5|||
30827338|NCT03067129|58850078|FG001|Overall Study|Lost to Follow-up|5|||
30827339|NCT03067129|58850079|FG002|Overall Study|Lost to Follow-up|4|||
30827340|NCT03067129|58850080|FG003|Overall Study|Lost to Follow-up|3|||
30827341|NCT01679236|58850102|FG000|Overall Study|Lost to Follow-up|15|||
30827342|NCT01679236|58850103|FG001|Overall Study|Lost to Follow-up|15|||
30827343|NCT01679002|58850112|FG000|Overall Study|Adverse Event|1|||
30827344|NCT01679002|58850113|FG001|Overall Study|Adverse Event|1|||
30827345|NCT01679002|58850114|FG002|Overall Study|Adverse Event|0|||
30827346|NCT04409509|58850124|FG000|Overall Study|Failure to meet randomization requirement|1|||
30827347|NCT04409509|58850125|FG001|Overall Study|Failure to meet randomization requirement|0|||
30827348|NCT04409509|58850124|FG000|Overall Study|Adverse Event|0|||
30827349|NCT04409509|58850125|FG001|Overall Study|Adverse Event|1|||
30827350|NCT04409509|58850124|FG000|Overall Study|Death|11|||
30827351|NCT04409509|58850125|FG001|Overall Study|Death|10|||
30827352|NCT04409509|58850124|FG000|Overall Study|Non-compliance with study drug|0|||
30827353|NCT04409509|58850125|FG001|Overall Study|Non-compliance with study drug|1|||
30827354|NCT04409509|58850124|FG000|Overall Study|Lost to Follow-up|0|||
30827355|NCT04409509|58850125|FG001|Overall Study|Lost to Follow-up|3|||
30827356|NCT04409509|58850124|FG000|Overall Study|Withdrawal by Subject|0|||
30827357|NCT04409509|58850125|FG001|Overall Study|Withdrawal by Subject|3|||
30827358|NCT04409509|58850124|FG000|Overall Study|Randomized by mistake|0|||
30827359|NCT04409509|58850125|FG001|Overall Study|Randomized by mistake|1|||
30827360|NCT04409509|58850124|FG000|Overall Study|Other|1|||
30921480|NCT02091739|58956736|FG001|EP: 48 Weeks|Other|0|||
30921481|NCT02091739|58956737|FG002|EP: 48 Weeks|Other|0|||
30921482|NCT02091739|58956738|FG003|EP: 48 Weeks|Other|1|||
30921483|NCT02091739|58956739|FG004|EP: 48 Weeks|Other|0|||
30921484|NCT02091739|58956735|FG000|EP: 48 Weeks|Death|0|||
30827361|NCT04409509|58850125|FG001|Overall Study|Other|1|||
30827362|NCT01678924|58850136|FG000|Overall Study|Adverse Event|1|||
30827363|NCT01678924|58850137|FG001|Overall Study|Adverse Event|1|||
30827364|NCT01678924|58850138|FG002|Overall Study|Adverse Event|0|||
30827365|NCT01678924|58850139|FG003|Overall Study|Adverse Event|1|||
30827366|NCT01678924|58850136|FG000|Overall Study|Lack of Efficacy|7|||
30827367|NCT01678924|58850137|FG001|Overall Study|Lack of Efficacy|2|||
30827368|NCT01678924|58850138|FG002|Overall Study|Lack of Efficacy|0|||
30827369|NCT01678924|58850139|FG003|Overall Study|Lack of Efficacy|5|||
30827370|NCT01678924|58850136|FG000|Overall Study|Lost to Follow-up|0|||
30827371|NCT01678924|58850137|FG001|Overall Study|Lost to Follow-up|4|||
30827372|NCT01678924|58850138|FG002|Overall Study|Lost to Follow-up|0|||
30827373|NCT01678924|58850139|FG003|Overall Study|Lost to Follow-up|2|||
30827374|NCT01678924|58850136|FG000|Overall Study|Personal Reasons|2|||
30827375|NCT01678924|58850137|FG001|Overall Study|Personal Reasons|2|||
30827376|NCT01678924|58850138|FG002|Overall Study|Personal Reasons|2|||
30827377|NCT01678924|58850139|FG003|Overall Study|Personal Reasons|7|||
30827378|NCT01678924|58850136|FG000|Overall Study|Withdrawal by Subject|0|||
30754159|NCT00131352|58763726|FG001|Initial Treatment Period|Lack of Efficacy|4|||
30754160|NCT00131352|58763725|FG000|Initial Treatment Period|Other|0|||
30754161|NCT00131352|58763726|FG001|Initial Treatment Period|Other|2|||
30754162|NCT00131352|58763725|FG000|Repeat Treatment Period|Adverse Event|1|||
30754163|NCT00131352|58763726|FG001|Repeat Treatment Period|Adverse Event|0|||
30754164|NCT00131352|58763725|FG000|Repeat Treatment Period|Other|1|||
30754165|NCT00131352|58763726|FG001|Repeat Treatment Period|Other|0|||
30754166|NCT04633642|58763736|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
30754167|NCT04633642|58763737|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
30754168|NCT00136916|58763745|FG000|Overall Study|Never received study treatment|3|||
30754169|NCT00136916|58763746|FG001|Overall Study|Never received study treatment|5|||
30754170|NCT00136916|58763745|FG000|Overall Study|Death|1|||
30754171|NCT00136916|58763746|FG001|Overall Study|Death|3|||
30754172|NCT00136916|58763745|FG000|Overall Study|Adverse Event|27|||
30754173|NCT00136916|58763746|FG001|Overall Study|Adverse Event|8|||
30754174|NCT00136916|58763745|FG000|Overall Study|Laboratory abnormality|0|||
30827379|NCT01678924|58850137|FG001|Overall Study|Withdrawal by Subject|3|||
30827380|NCT01678924|58850138|FG002|Overall Study|Withdrawal by Subject|0|||
30827381|NCT01678924|58850139|FG003|Overall Study|Withdrawal by Subject|2|||
30827382|NCT01678924|58850136|FG000|Overall Study|Unable to attend scheduled visits|0|||
30827383|NCT01678924|58850137|FG001|Overall Study|Unable to attend scheduled visits|0|||
30827384|NCT01678924|58850138|FG002|Overall Study|Unable to attend scheduled visits|0|||
30827385|NCT01678924|58850139|FG003|Overall Study|Unable to attend scheduled visits|1|||
30827386|NCT02925793|58850153|FG000|Overall Study|Adverse Event|3|||
30827387|NCT02925793|58850154|FG001|Overall Study|Adverse Event|3|||
30754175|NCT00136916|58763746|FG001|Overall Study|Laboratory abnormality|1|||
30754176|NCT00136916|58763745|FG000|Overall Study|Lack of Efficacy|13|||
30754177|NCT00136916|58763746|FG001|Overall Study|Lack of Efficacy|3|||
30754178|NCT00136916|58763745|FG000|Overall Study|Lost to Follow-up|12|||
30754179|NCT00136916|58763746|FG001|Overall Study|Lost to Follow-up|14|||
30754180|NCT00136916|58763745|FG000|Overall Study|Withdrawal by Subject|44|||
30754181|NCT00136916|58763746|FG001|Overall Study|Withdrawal by Subject|46|||
30754182|NCT00136916|58763745|FG000|Overall Study|Other|22|||
30754183|NCT00136916|58763746|FG001|Overall Study|Other|24|||
30754184|NCT00136916|58763745|FG000|Overall Study|Discontinued in follow up period|3|||
30754185|NCT00136916|58763746|FG001|Overall Study|Discontinued in follow up period|0|||
30754186|NCT04633564|58763756|FG000|Period 1|Adverse Event|28|||
30827388|NCT02925793|58850155|FG002|Overall Study|Adverse Event|6|||
30827389|NCT02925793|58850153|FG000|Overall Study|Withdrawal by Subject|16|||
30827390|NCT02925793|58850154|FG001|Overall Study|Withdrawal by Subject|15|||
30827391|NCT02925793|58850155|FG002|Overall Study|Withdrawal by Subject|13|||
30827392|NCT02925793|58850153|FG000|Overall Study|Investigator Discretion|0|||
30827393|NCT02925793|58850154|FG001|Overall Study|Investigator Discretion|1|||
30754187|NCT04633564|58763757|FG001|Period 1|Adverse Event|19|||
30754188|NCT04633564|58763756|FG000|Period 1|Death|8|||
30754189|NCT04633564|58763757|FG001|Period 1|Death|7|||
30754190|NCT04633564|58763756|FG000|Period 1|Lost to Follow-up|3|||
30754191|NCT04633564|58763757|FG001|Period 1|Lost to Follow-up|5|||
30754192|NCT04633564|58763756|FG000|Period 1|Physician Decision|4|||
30754193|NCT04633564|58763757|FG001|Period 1|Physician Decision|12|||
30754194|NCT04633564|58763756|FG000|Period 1|Protocol Violation|0|||
30827394|NCT02925793|58850155|FG002|Overall Study|Investigator Discretion|1|||
30827395|NCT02925793|58850153|FG000|Overall Study|Lost to Follow-up|2|||
30827396|NCT02925793|58850154|FG001|Overall Study|Lost to Follow-up|3|||
30827397|NCT02925793|58850155|FG002|Overall Study|Lost to Follow-up|1|||
30827398|NCT02925793|58850153|FG000|Overall Study|Lack of Efficacy|2|||
30827399|NCT02925793|58850154|FG001|Overall Study|Lack of Efficacy|6|||
30827400|NCT02925793|58850155|FG002|Overall Study|Lack of Efficacy|4|||
30827401|NCT02925793|58850153|FG000|Overall Study|Other:|2|||
30827402|NCT02925793|58850154|FG001|Overall Study|Other:|1|||
30827403|NCT02925793|58850155|FG002|Overall Study|Other:|3|||
30754195|NCT04633564|58763757|FG001|Period 1|Protocol Violation|1|||
30754196|NCT04633564|58763756|FG000|Period 1|Withdrawal by Subject|10|||
30754197|NCT04633564|58763757|FG001|Period 1|Withdrawal by Subject|8|||
30754198|NCT04633564|58763756|FG000|Period 1|Progressive disease|47|||
30754199|NCT04633564|58763757|FG001|Period 1|Progressive disease|51|||
30754200|NCT04633564|58763756|FG000|Period 1|Terminated by Sponsor|8|||
30754201|NCT04633564|58763757|FG001|Period 1|Terminated by Sponsor|6|||
30754202|NCT04633564|58763756|FG000|Period 2|Adverse Event|3|||
30827404|NCT03071263|58850165|FG000|Overall Study|Adverse Event|1|||
30827405|NCT03071263|58850166|FG001|Overall Study|Adverse Event|3|||
30827406|NCT03071263|58850165|FG000|Overall Study|Withdrawal by Subject|1|||
30827407|NCT03071263|58850166|FG001|Overall Study|Withdrawal by Subject|3|||
30827408|NCT03071263|58850165|FG000|Overall Study|Physician Decision|1|||
30827409|NCT03071263|58850166|FG001|Overall Study|Physician Decision|0|||
30827410|NCT03071263|58850165|FG000|Overall Study|Participant moved to another city|0|||
30827411|NCT03071263|58850166|FG001|Overall Study|Participant moved to another city|1|||
30827412|NCT00157196|58850178|FG000|Overall Study|Ongoing at data cut-off|9|||
30827413|NCT03066193|58850182|FG000|Overall Study|Withdrawal by Subject|1|||
30827414|NCT03922321|58850186|FG000|Overall Study|Participant Moved|1|||
30827415|NCT03922321|58850186|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
30827416|NCT01677910|58850193|FG000|Double-Blind Treatment Period|Adverse Event|6|||
30827417|NCT01677910|58850194|FG001|Double-Blind Treatment Period|Adverse Event|2|||
30827418|NCT01677910|58850195|FG002|Double-Blind Treatment Period|Adverse Event|3|||
30827419|NCT01677910|58850196|FG003|Double-Blind Treatment Period|Adverse Event|0|||
30827420|NCT01677910|58850193|FG000|Double-Blind Treatment Period|Physician Decision|0|||
30827421|NCT01677910|58850194|FG001|Double-Blind Treatment Period|Physician Decision|0|||
30827422|NCT01677910|58850195|FG002|Double-Blind Treatment Period|Physician Decision|1|||
30827423|NCT01677910|58850196|FG003|Double-Blind Treatment Period|Physician Decision|0|||
30827424|NCT01677910|58850193|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
30827425|NCT01677910|58850194|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
30827426|NCT01677910|58850195|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
30827427|NCT01677910|58850196|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
30827428|NCT01677910|58850193|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
30827429|NCT01677910|58850194|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
30827430|NCT01677910|58850195|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
30827431|NCT01677910|58850196|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
30827432|NCT01677910|58850193|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
30827433|NCT01677910|58850194|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
30827434|NCT01677910|58850195|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
30827435|NCT01677910|58850196|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
30921485|NCT02091739|58956736|FG001|EP: 48 Weeks|Death|0|||
30921486|NCT02091739|58956737|FG002|EP: 48 Weeks|Death|0|||
30921487|NCT02091739|58956738|FG003|EP: 48 Weeks|Death|3|||
30921488|NCT02091739|58956739|FG004|EP: 48 Weeks|Death|2|||
30921489|NCT02091739|58956735|FG000|EP: 48 Weeks|Adverse Event|0|||
30754203|NCT04633564|58763757|FG001|Period 2|Adverse Event|4|||
30827436|NCT01677910|58850193|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
30827437|NCT01677910|58850194|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
30827438|NCT01677910|58850195|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
30754204|NCT04633564|58763756|FG000|Period 2|Death|0|||
30754205|NCT04633564|58763757|FG001|Period 2|Death|2|||
30754206|NCT04633564|58763756|FG000|Period 2|Lost to Follow-up|0|||
30754207|NCT04633564|58763757|FG001|Period 2|Lost to Follow-up|1|||
30921490|NCT02091739|58956736|FG001|EP: 48 Weeks|Adverse Event|0|||
30921491|NCT02091739|58956737|FG002|EP: 48 Weeks|Adverse Event|0|||
30754208|NCT04633564|58763756|FG000|Period 2|Physician Decision|2|||
30827439|NCT01677910|58850196|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
30827440|NCT01677910|58850193|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
30827441|NCT01677910|58850194|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
30827442|NCT01677910|58850195|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
30827443|NCT01677910|58850196|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
30827444|NCT01677910|58850193|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
30827445|NCT01677910|58850194|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
30827446|NCT01677910|58850195|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
30827447|NCT01677910|58850196|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
30827448|NCT01677910|58850193|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
30827449|NCT01677910|58850194|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
30827450|NCT01677910|58850195|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
30827451|NCT01677910|58850196|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
30827452|NCT01677910|58850193|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
30827453|NCT01677910|58850194|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
30827454|NCT01677910|58850195|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
30827455|NCT01677910|58850196|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
30754209|NCT04633564|58763757|FG001|Period 2|Physician Decision|4|||
30827456|NCT03911713|58850211|FG000|Overall Study|Lost to Follow-up|0|||
30827457|NCT03911713|58850212|FG001|Overall Study|Lost to Follow-up|2|||
30827458|NCT03911713|58850213|FG002|Overall Study|Lost to Follow-up|0|||
30921492|NCT02091739|58956738|FG003|EP: 48 Weeks|Adverse Event|2|||
30921493|NCT02091739|58956739|FG004|EP: 48 Weeks|Adverse Event|6|||
30921494|NCT02091739|58956735|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
30754210|NCT04633564|58763756|FG000|Period 2|Withdrawal by Subject|5|||
30921495|NCT02091739|58956736|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
30921496|NCT02091739|58956737|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
30921497|NCT02091739|58956738|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
30921498|NCT02091739|58956739|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
30921499|NCT02045875|58956751|FG000|Overall Study|Lost to Follow-up|3|||
30921500|NCT02045875|58956752|FG001|Overall Study|Lost to Follow-up|0|||
30921501|NCT02045875|58956751|FG000|Overall Study|Withdrawal by Subject|4|||
30623362|NCT00924664|58635183|FG001|Overall Study|Protocol Violation|5|||
30754211|NCT04633564|58763757|FG001|Period 2|Withdrawal by Subject|1|||
30754212|NCT04633564|58763756|FG000|Period 2|Progressive Disease|74|||
30754213|NCT04633564|58763757|FG001|Period 2|Progressive Disease|82|||
30754214|NCT04633564|58763756|FG000|Period 2|Terminated by Sponsor|9|||
30754215|NCT04633564|58763757|FG001|Period 2|Terminated by Sponsor|3|||
30754216|NCT04960228|58763765|FG000|Overall Study|Withdrawal by Subject|216|||
30754217|NCT04960228|58763766|FG001|Overall Study|Withdrawal by Subject|35|||
30754218|NCT04960228|58763765|FG000|Overall Study|Failed attention check|69|||
30754219|NCT04960228|58763766|FG001|Overall Study|Failed attention check|148|||
30754220|NCT04960228|58763765|FG000|Overall Study|Flagged for response quality by Dynata|3|||
30754221|NCT04960228|58763766|FG001|Overall Study|Flagged for response quality by Dynata|3|||
30754222|NCT04619992|58763774|FG000|Overall Study|Withdrawal by Subject|1|||
30754223|NCT04619992|58763775|FG001|Overall Study|Withdrawal by Subject|0|||
30754224|NCT00136604|58763786|FG000|Overall Study|Lost to Follow-up|1|||
30754225|NCT00136604|58763787|FG001|Overall Study|Lost to Follow-up|0|||
30754226|NCT00136604|58763788|FG002|Overall Study|Lost to Follow-up|0|||
30754227|NCT00136604|58763789|FG003|Overall Study|Lost to Follow-up|0|||
30754228|NCT00136604|58763790|FG004|Overall Study|Lost to Follow-up|1|||
30754229|NCT00136604|58763786|FG000|Overall Study|Migrated/moved from study area|0|||
30754230|NCT00136604|58763787|FG001|Overall Study|Migrated/moved from study area|1|||
30754231|NCT00136604|58763788|FG002|Overall Study|Migrated/moved from study area|0|||
30754232|NCT00136604|58763789|FG003|Overall Study|Migrated/moved from study area|0|||
30754233|NCT00136604|58763790|FG004|Overall Study|Migrated/moved from study area|0|||
30754234|NCT00135512|58763806|FG000|Overall Study|Adverse Event|56|||
30754235|NCT00135512|58763806|FG000|Overall Study|Lack of Efficacy|25|||
30754236|NCT00135512|58763806|FG000|Overall Study|Other|42|||
30754237|NCT00130728|58763812|FG000|Overall Study|Death|258|||
30754238|NCT00130728|58763813|FG001|Overall Study|Death|258|||
30754239|NCT00130728|58763812|FG000|Overall Study|Lost to Follow-up|4|||
30754240|NCT00130728|58763813|FG001|Overall Study|Lost to Follow-up|0|||
30754241|NCT00130728|58763812|FG000|Overall Study|Withdrawal by Subject|0|||
30754242|NCT00130728|58763813|FG001|Overall Study|Withdrawal by Subject|2|||
30754243|NCT00129974|58763819|FG000|Overall Study|Other|1|||
30754244|NCT04947436|58763826|FG000|Overall Study|Lost to Follow-up|3|||
30754245|NCT04947436|58763827|FG001|Overall Study|Lost to Follow-up|7|||
30754246|NCT04947436|58763828|FG002|Overall Study|Lost to Follow-up|5|||
30754247|NCT04947436|58763826|FG000|Overall Study|Death|1|||
30754248|NCT04947436|58763827|FG001|Overall Study|Death|1|||
30754249|NCT04947436|58763828|FG002|Overall Study|Death|1|||
30754250|NCT00119106|58763838|FG000|Overall Study|HIV infected at baseline|179|||
30921502|NCT02045875|58956752|FG001|Overall Study|Withdrawal by Subject|3|||
30827459|NCT03911713|58850214|FG003|Overall Study|Lost to Follow-up|0|||
30921503|NCT01597635|58956761|FG000|Part A|Adverse Event|3|||
30754251|NCT00119106|58763839|FG001|Overall Study|HIV infected at baseline|178|||
30754252|NCT00135356|58763855|FG000|Overall Study|Adverse Event|6|||
30754253|NCT00135356|58763856|FG001|Overall Study|Adverse Event|2|||
30623363|NCT00924664|58635182|FG000|Overall Study|Pregnancy|1|||
30623364|NCT00924664|58635183|FG001|Overall Study|Pregnancy|1|||
30623365|NCT00924664|58635182|FG000|Overall Study|Death|0|||
30623366|NCT00924664|58635183|FG001|Overall Study|Death|2|||
30921504|NCT01597635|58956762|FG001|Part A|Adverse Event|0|||
30921505|NCT01597635|58956763|FG002|Part A|Adverse Event|0|||
30921506|NCT01597635|58956761|FG000|Part B|Adverse Event|0|||
30921507|NCT01597635|58956762|FG001|Part B|Adverse Event|0|||
30921508|NCT01597635|58956763|FG002|Part B|Adverse Event|1|||
30921509|NCT01597635|58956761|FG000|Part B|Protocol Violation|0|||
30921510|NCT01597635|58956762|FG001|Part B|Protocol Violation|1|||
30921511|NCT01597635|58956763|FG002|Part B|Protocol Violation|0|||
30921512|NCT01597635|58956761|FG000|Part B|Protocol-defined stopping criteria|0|||
30921513|NCT01597635|58956762|FG001|Part B|Protocol-defined stopping criteria|4|||
30921514|NCT01597635|58956763|FG002|Part B|Protocol-defined stopping criteria|3|||
30754254|NCT00135356|58763855|FG000|Overall Study|Lack of Efficacy|2|||
30754255|NCT00135356|58763856|FG001|Overall Study|Lack of Efficacy|0|||
30754256|NCT00135356|58763855|FG000|Overall Study|Lost to Follow-up|3|||
30754257|NCT00135356|58763856|FG001|Overall Study|Lost to Follow-up|1|||
30754258|NCT00135356|58763855|FG000|Overall Study|Surgery for abdominal fat|1|||
30754259|NCT00135356|58763856|FG001|Overall Study|Surgery for abdominal fat|0|||
30754260|NCT00135356|58763855|FG000|Overall Study|Change in antiviral regimen|0|||
30754261|NCT00135356|58763856|FG001|Overall Study|Change in antiviral regimen|1|||
30754262|NCT00135356|58763855|FG000|Overall Study|Poor/noncompliance|1|||
30754263|NCT00135356|58763856|FG001|Overall Study|Poor/noncompliance|1|||
30754264|NCT00135356|58763855|FG000|Overall Study|No longer meets study criteria|2|||
30754265|NCT00135356|58763856|FG001|Overall Study|No longer meets study criteria|0|||
30754266|NCT00135356|58763855|FG000|Overall Study|Withdrawal by Subject|2|||
30754267|NCT00135356|58763856|FG001|Overall Study|Withdrawal by Subject|4|||
30754268|NCT00118716|58763864|FG000|Overall Study|Adverse Event|2|||
30827460|NCT03911713|58850215|FG004|Overall Study|Lost to Follow-up|0|||
30827461|NCT03911713|58850211|FG000|Overall Study|Other|0|||
30827462|NCT03911713|58850212|FG001|Overall Study|Other|0|||
30827463|NCT03911713|58850213|FG002|Overall Study|Other|0|||
30827464|NCT03911713|58850214|FG003|Overall Study|Other|1|||
30827465|NCT03911713|58850215|FG004|Overall Study|Other|0|||
30827466|NCT03911713|58850211|FG000|Overall Study|Randomized, Never Dosed|1|||
30827467|NCT03911713|58850212|FG001|Overall Study|Randomized, Never Dosed|0|||
30827468|NCT03911713|58850213|FG002|Overall Study|Randomized, Never Dosed|0|||
30827469|NCT03911713|58850214|FG003|Overall Study|Randomized, Never Dosed|1|||
30754269|NCT00118716|58763865|FG001|Overall Study|Adverse Event|7|||
30754270|NCT00118716|58763864|FG000|Overall Study|Protocol Violation|5|||
30754271|NCT00118716|58763865|FG001|Overall Study|Protocol Violation|4|||
30754272|NCT00118716|58763864|FG000|Overall Study|Withdrawal by Subject|0|||
30754273|NCT00118716|58763865|FG001|Overall Study|Withdrawal by Subject|1|||
30754274|NCT00118716|58763864|FG000|Overall Study|Exacerbation|2|||
30754275|NCT00118716|58763865|FG001|Overall Study|Exacerbation|2|||
30754276|NCT00118716|58763864|FG000|Overall Study|Discontinued by sponsor|1|||
30754277|NCT00118716|58763865|FG001|Overall Study|Discontinued by sponsor|1|||
30754278|NCT00118716|58763864|FG000|Overall Study|Non-compliance|1|||
30754279|NCT00118716|58763865|FG001|Overall Study|Non-compliance|3|||
30827470|NCT03911713|58850215|FG004|Overall Study|Randomized, Never Dosed|0|||
30827471|NCT03065023|58850233|FG000|Overall Study|Progressive Disease|0|||
30827472|NCT03065023|58850234|FG001|Overall Study|Progressive Disease|1|||
30827473|NCT03065023|58850235|FG002|Overall Study|Progressive Disease|0|||
30827474|NCT03065023|58850236|FG003|Overall Study|Progressive Disease|0|||
30827475|NCT03065023|58850237|FG004|Overall Study|Progressive Disease|0|||
30827476|NCT03065023|58850233|FG000|Overall Study|Death|2|||
30827477|NCT03065023|58850234|FG001|Overall Study|Death|0|||
30827478|NCT03065023|58850235|FG002|Overall Study|Death|1|||
30827479|NCT03065023|58850236|FG003|Overall Study|Death|1|||
30827480|NCT03065023|58850237|FG004|Overall Study|Death|0|||
30921515|NCT01597635|58956761|FG000|Part B|Withdrawal by Subject|0|||
30921516|NCT01597635|58956762|FG001|Part B|Withdrawal by Subject|1|||
30623367|NCT00924664|58635182|FG000|Overall Study|Study terminated by sponsor|199|||
30623368|NCT00924664|58635183|FG001|Overall Study|Study terminated by sponsor|330|||
30754280|NCT00118716|58763864|FG000|Overall Study|misrandomized|1|||
30754281|NCT00118716|58763865|FG001|Overall Study|misrandomized|1|||
30754282|NCT00118716|58763864|FG000|Overall Study|Expired drug use|1|||
30754283|NCT00118716|58763865|FG001|Overall Study|Expired drug use|2|||
30827481|NCT03065023|58850233|FG000|Overall Study|Lost to Follow-up|0|||
30827482|NCT03065023|58850234|FG001|Overall Study|Lost to Follow-up|1|||
30827483|NCT03065023|58850235|FG002|Overall Study|Lost to Follow-up|0|||
30827484|NCT03065023|58850236|FG003|Overall Study|Lost to Follow-up|0|||
30827485|NCT03065023|58850237|FG004|Overall Study|Lost to Follow-up|0|||
30623369|NCT00924664|58635182|FG000|Overall Study|Other|29|||
30827486|NCT03065023|58850233|FG000|Overall Study|Participant Decision|0|||
30921517|NCT01597635|58956763|FG002|Part B|Withdrawal by Subject|0|||
30827487|NCT03065023|58850234|FG001|Overall Study|Participant Decision|0|||
30827488|NCT03065023|58850235|FG002|Overall Study|Participant Decision|0|||
30827489|NCT03065023|58850236|FG003|Overall Study|Participant Decision|1|||
30827490|NCT03065023|58850237|FG004|Overall Study|Participant Decision|0|||
30827491|NCT03065023|58850233|FG000|Overall Study|Withdrawal by Subject|0|||
30827492|NCT03065023|58850234|FG001|Overall Study|Withdrawal by Subject|0|||
30827493|NCT03065023|58850235|FG002|Overall Study|Withdrawal by Subject|0|||
30827494|NCT03065023|58850236|FG003|Overall Study|Withdrawal by Subject|1|||
30827495|NCT03065023|58850237|FG004|Overall Study|Withdrawal by Subject|0|||
30827496|NCT03614923|58850250|FG000|Overall Study|Withdrawal by Subject|2|||
30827497|NCT03614923|58850251|FG001|Overall Study|Withdrawal by Subject|1|||
30827498|NCT03614923|58850252|FG002|Overall Study|Withdrawal by Subject|1|||
30827499|NCT03614923|58850250|FG000|Overall Study|Adverse Event|0|||
30827500|NCT03614923|58850251|FG001|Overall Study|Adverse Event|2|||
30827501|NCT03614923|58850252|FG002|Overall Study|Adverse Event|1|||
30827502|NCT03614923|58850250|FG000|Overall Study|Lost to Follow-up|1|||
30827503|NCT03614923|58850251|FG001|Overall Study|Lost to Follow-up|0|||
30827504|NCT03614923|58850252|FG002|Overall Study|Lost to Follow-up|1|||
30827505|NCT03614923|58850250|FG000|Overall Study|Lack of Efficacy|2|||
30827506|NCT03614923|58850251|FG001|Overall Study|Lack of Efficacy|0|||
30827507|NCT03614923|58850252|FG002|Overall Study|Lack of Efficacy|1|||
30827508|NCT03614923|58850250|FG000|Overall Study|Non-compliance|0|||
30827509|NCT03614923|58850251|FG001|Overall Study|Non-compliance|1|||
30827510|NCT03614923|58850252|FG002|Overall Study|Non-compliance|0|||
30827511|NCT03614923|58850250|FG000|Overall Study|Other|0|||
30827512|NCT03614923|58850251|FG001|Overall Study|Other|1|||
30827513|NCT03614923|58850252|FG002|Overall Study|Other|1|||
30827514|NCT02915016|58850268|FG000|Overall Study|Lost to Follow-up|4|||
30827515|NCT02915016|58850269|FG001|Overall Study|Lost to Follow-up|2|||
30827516|NCT02915016|58850270|FG002|Overall Study|Lost to Follow-up|5|||
30827517|NCT02915016|58850271|FG003|Overall Study|Lost to Follow-up|3|||
30827518|NCT02915016|58850272|FG004|Overall Study|Lost to Follow-up|5|||
30827519|NCT02915016|58850273|FG005|Overall Study|Lost to Follow-up|2|||
30827520|NCT02915016|58850274|FG006|Overall Study|Lost to Follow-up|8|||
30827521|NCT02915016|58850275|FG007|Overall Study|Lost to Follow-up|2|||
30827522|NCT02915016|58850268|FG000|Overall Study|Physician Decision|0|||
30827523|NCT02915016|58850269|FG001|Overall Study|Physician Decision|0|||
30827524|NCT02915016|58850270|FG002|Overall Study|Physician Decision|1|||
30827525|NCT02915016|58850271|FG003|Overall Study|Physician Decision|0|||
30827526|NCT02915016|58850272|FG004|Overall Study|Physician Decision|0|||
30827527|NCT02915016|58850273|FG005|Overall Study|Physician Decision|1|||
30827528|NCT02915016|58850274|FG006|Overall Study|Physician Decision|2|||
30827529|NCT02915016|58850275|FG007|Overall Study|Physician Decision|0|||
30827530|NCT02915016|58850268|FG000|Overall Study|Withdrawal by Subject|2|||
30827531|NCT02915016|58850269|FG001|Overall Study|Withdrawal by Subject|0|||
30827532|NCT02915016|58850270|FG002|Overall Study|Withdrawal by Subject|1|||
30827533|NCT02915016|58850271|FG003|Overall Study|Withdrawal by Subject|0|||
30827534|NCT02915016|58850272|FG004|Overall Study|Withdrawal by Subject|1|||
30827535|NCT02915016|58850273|FG005|Overall Study|Withdrawal by Subject|3|||
30827536|NCT02915016|58850274|FG006|Overall Study|Withdrawal by Subject|1|||
30827537|NCT02915016|58850275|FG007|Overall Study|Withdrawal by Subject|1|||
30827538|NCT02915016|58850268|FG000|Overall Study|Elected not to continue|0|||
30827539|NCT02915016|58850269|FG001|Overall Study|Elected not to continue|0|||
30827540|NCT02915016|58850270|FG002|Overall Study|Elected not to continue|0|||
30827541|NCT02915016|58850271|FG003|Overall Study|Elected not to continue|1|||
30827542|NCT02915016|58850272|FG004|Overall Study|Elected not to continue|0|||
30827543|NCT02915016|58850273|FG005|Overall Study|Elected not to continue|0|||
30827544|NCT02915016|58850274|FG006|Overall Study|Elected not to continue|1|||
30827545|NCT02915016|58850275|FG007|Overall Study|Elected not to continue|0|||
30827546|NCT02915016|58850268|FG000|Overall Study|HIV infection|1|||
30827547|NCT02915016|58850269|FG001|Overall Study|HIV infection|1|||
30827548|NCT02915016|58850270|FG002|Overall Study|HIV infection|1|||
30827549|NCT02915016|58850271|FG003|Overall Study|HIV infection|0|||
30827550|NCT02915016|58850272|FG004|Overall Study|HIV infection|1|||
30827551|NCT02915016|58850273|FG005|Overall Study|HIV infection|0|||
30827552|NCT02915016|58850274|FG006|Overall Study|HIV infection|0|||
30827553|NCT02915016|58850275|FG007|Overall Study|HIV infection|0|||
30827554|NCT02915016|58850268|FG000|Overall Study|Participant unable to adhere|0|||
30827555|NCT02915016|58850269|FG001|Overall Study|Participant unable to adhere|0|||
30827556|NCT02915016|58850270|FG002|Overall Study|Participant unable to adhere|0|||
30827557|NCT02915016|58850271|FG003|Overall Study|Participant unable to adhere|0|||
30827558|NCT02915016|58850272|FG004|Overall Study|Participant unable to adhere|0|||
30827559|NCT02915016|58850273|FG005|Overall Study|Participant unable to adhere|0|||
30827560|NCT02915016|58850274|FG006|Overall Study|Participant unable to adhere|0|||
30827561|NCT02915016|58850275|FG007|Overall Study|Participant unable to adhere|1|||
30754284|NCT00118716|58763864|FG000|Overall Study|Investigator discretion|0|||
30754285|NCT00118716|58763865|FG001|Overall Study|Investigator discretion|1|||
30754286|NCT04584346|58763873|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
30827562|NCT03323749|58850295|FG000|Double-blind Period|Lost to Follow-up|4|||
30827563|NCT03323749|58850296|FG001|Double-blind Period|Lost to Follow-up|5|||
30827564|NCT03323749|58850295|FG000|Double-blind Period|Adverse Event|3|||
30827565|NCT03323749|58850296|FG001|Double-blind Period|Adverse Event|1|||
30827566|NCT03323749|58850295|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
30827567|NCT03323749|58850296|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
30827568|NCT03323749|58850295|FG000|Open-Label Period|Adverse Event|3|||
30827569|NCT03323749|58850296|FG001|Open-Label Period|Adverse Event|10|||
30827570|NCT03323749|58850295|FG000|Open-Label Period|Withdrawal by Subject|7|||
30921518|NCT01828281|58956774|FG000|Overall Study|Withdrawal by Subject|1|||
30921519|NCT01828281|58956775|FG001|Overall Study|Withdrawal by Subject|0|||
30921520|NCT01827267|58956784|FG000|Overall Study|Did not receive study drug|1|||
30921521|NCT01827267|58956785|FG001|Overall Study|Did not receive study drug|1|||
30921522|NCT01827267|58956784|FG000|Overall Study|Physician Decision|1|||
30921523|NCT01827267|58956785|FG001|Overall Study|Physician Decision|0|||
30921524|NCT01827267|58956784|FG000|Overall Study|Disease Progression|1|||
30921525|NCT01827267|58956785|FG001|Overall Study|Disease Progression|1|||
30921526|NCT01827267|58956784|FG000|Overall Study|Sponsor Discontinued Study|2|||
30921527|NCT01827267|58956785|FG001|Overall Study|Sponsor Discontinued Study|8|||
30921528|NCT01827267|58956784|FG000|Overall Study|Still on study|0|||
30921529|NCT01827267|58956785|FG001|Overall Study|Still on study|2|||
30921530|NCT01855425|58956792|FG000|Overall Study|Physician Decision|20|||
30921531|NCT01854879|58956796|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
30921532|NCT01854879|58956796|FG000|Overall Study|screen fail|3|||
30921533|NCT01854879|58956796|FG000|Overall Study|incomplete data set|1|||
30921534|NCT01827111|58956800|FG000|Overall Study|Disease Progression|1|||
30921535|NCT02045095|58956804|FG000|Overall Study|Other|0|||
30921536|NCT02045095|58956805|FG001|Overall Study|Other|0|||
30754287|NCT04584346|58763874|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
30754288|NCT00118482|58763884|FG000|Overall Study|Lost to Follow-up|7|||
30754289|NCT00118482|58763885|FG001|Overall Study|Lost to Follow-up|7|||
30754290|NCT00118482|58763884|FG000|Overall Study|Withdrawal by Subject|23|||
30754291|NCT00118482|58763885|FG001|Overall Study|Withdrawal by Subject|22|||
30754292|NCT00129272|58763893|FG000|Overall Study|Lost to Follow-up|12|||
30754293|NCT00129272|58763894|FG001|Overall Study|Lost to Follow-up|11|||
30754294|NCT00129272|58763893|FG000|Overall Study|Withdrawal by Subject|5|||
30754295|NCT00129272|58763894|FG001|Overall Study|Withdrawal by Subject|11|||
30754296|NCT04899232|58763903|FG000|Screening Period|Physician Decision|1|||
30754297|NCT04899232|58763904|FG001|Screening Period|Physician Decision|0|||
30754298|NCT04899232|58763905|FG002|Screening Period|Physician Decision|0|||
30754299|NCT04899232|58763903|FG000|Screening Period|Withdrawal by Subject|1|||
30827571|NCT03323749|58850296|FG001|Open-Label Period|Withdrawal by Subject|5|||
30827572|NCT02208024|58850315|FG000|Overall Study|Withdrawal by Subject|1|||
30754300|NCT04899232|58763904|FG001|Screening Period|Withdrawal by Subject|0|||
30754301|NCT04899232|58763905|FG002|Screening Period|Withdrawal by Subject|0|||
30754302|NCT04899232|58763903|FG000|Screening Period|Participant discharged before receiving intervention|3|||
30754303|NCT04899232|58763904|FG001|Screening Period|Participant discharged before receiving intervention|0|||
30754304|NCT04899232|58763905|FG002|Screening Period|Participant discharged before receiving intervention|0|||
30827573|NCT02660086|58850321|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
30827574|NCT02660086|58850322|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
30827575|NCT02660086|58850321|FG000|Overall Study- 12-month|Left full-time employment|12|||
30827576|NCT02660086|58850322|FG001|Overall Study- 12-month|Left full-time employment|20|||
30827577|NCT02660086|58850321|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
30827578|NCT02660086|58850322|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
30827579|NCT02660086|58850321|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
30921537|NCT02045095|58956806|FG002|Overall Study|Other|1|||
30921538|NCT02045095|58956807|FG003|Overall Study|Other|0|||
30921539|NCT02045095|58956808|FG004|Overall Study|Other|0|||
30921540|NCT02045095|58956809|FG005|Overall Study|Other|2|||
30921541|NCT02045095|58956810|FG006|Overall Study|Other|0|||
30921542|NCT02045095|58956804|FG000|Overall Study|Progressive Disease|3|||
30921543|NCT02045095|58956805|FG001|Overall Study|Progressive Disease|3|||
30921544|NCT02045095|58956806|FG002|Overall Study|Progressive Disease|2|||
30827580|NCT02660086|58850322|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
30827581|NCT02660086|58850321|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
30921545|NCT02045095|58956807|FG003|Overall Study|Progressive Disease|4|||
30921546|NCT02045095|58956808|FG004|Overall Study|Progressive Disease|2|||
30754305|NCT04559698|58763924|FG000|Overall Study|Lost to Follow-up|14|||
30754306|NCT04559698|58763925|FG001|Overall Study|Lost to Follow-up|15|||
30921547|NCT02045095|58956809|FG005|Overall Study|Progressive Disease|4|||
30827582|NCT02660086|58850322|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
30827583|NCT02660086|58850321|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
30827584|NCT02660086|58850322|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
30827585|NCT01678144|58850328|FG000|Stage 1: MAR Classic|Adverse Event|1|||
30827586|NCT00153920|58850332|FG000|Overall Study|Adverse Event|9|||
30827587|NCT00153920|58850332|FG000|Overall Study|Progressive Disease|9|||
30827588|NCT00153920|58850332|FG000|Overall Study|Physician Decision|3|||
30827589|NCT00153920|58850332|FG000|Overall Study|Lack of Response|3|||
30827590|NCT00153920|58850332|FG000|Overall Study|Death|2|||
30827591|NCT00153920|58850332|FG000|Overall Study|Withdrawal by Subject|1|||
30827592|NCT00153920|58850332|FG000|Overall Study|Non-Protocol Therapy|1|||
30827593|NCT00153920|58850332|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
30827594|NCT00153920|58850332|FG000|Overall Study|Progressive Disease before Trt|1|||
30827595|NCT02660242|58850336|FG000|Glucose Tabs|Lost to Follow-up|1|||
30827596|NCT02660242|58850336|FG000|Glucagon Injection|Lost to Follow-up|1|||
30827597|NCT03072043|58850352|FG000|Overall Study|Death|0|||
30827598|NCT03072043|58850353|FG001|Overall Study|Death|0|||
30827599|NCT03072043|58850354|FG002|Overall Study|Death|3|||
30827600|NCT03072043|58850352|FG000|Overall Study|Adverse Event|0|||
30827601|NCT03072043|58850353|FG001|Overall Study|Adverse Event|0|||
30827602|NCT03072043|58850354|FG002|Overall Study|Adverse Event|2|||
30921548|NCT02045095|58956810|FG006|Overall Study|Progressive Disease|1|||
30827603|NCT03072043|58850352|FG000|Overall Study|Withdrawal by Subject|0|||
30827604|NCT03072043|58850353|FG001|Overall Study|Withdrawal by Subject|0|||
30827605|NCT03072043|58850354|FG002|Overall Study|Withdrawal by Subject|4|||
30827606|NCT03069313|58850366|FG000|Overall Study|Adverse Event|5|||
30827607|NCT03068767|58850372|FG000|Overall Study|Lost to Follow-up|7|||
30754307|NCT04559698|58763924|FG000|Overall Study|Withdrawal by Subject|0|||
30827608|NCT03068767|58850373|FG001|Overall Study|Lost to Follow-up|3|||
30827609|NCT03068767|58850372|FG000|Overall Study|Protocol Violation|3|||
30827610|NCT03068767|58850373|FG001|Overall Study|Protocol Violation|0|||
30754308|NCT04559698|58763925|FG001|Overall Study|Withdrawal by Subject|1|||
30754309|NCT00133952|58763933|FG000|Overall Study|Adverse Event|1|||
30921549|NCT02045095|58956804|FG000|Overall Study|Withdrawal by Subject|0|||
30754310|NCT00133952|58763934|FG001|Overall Study|Adverse Event|2|||
30754311|NCT00133952|58763933|FG000|Overall Study|Death|3|||
30754312|NCT00133952|58763934|FG001|Overall Study|Death|2|||
30754313|NCT00133952|58763933|FG000|Overall Study|Lost to Follow-up|9|||
30754314|NCT00133952|58763934|FG001|Overall Study|Lost to Follow-up|14|||
30754315|NCT00133952|58763933|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
30754316|NCT00133952|58763934|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
30754317|NCT00133952|58763933|FG000|Overall Study|Protocol Violation|1|||
30623370|NCT00924664|58635183|FG001|Overall Study|Other|52|||
30827611|NCT03020745|58850387|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
30827612|NCT03020745|58850388|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
30827613|NCT03020745|58850389|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
30827614|NCT03020745|58850390|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
30827615|NCT03020745|58850391|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
30827616|NCT03020745|58850392|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
30827617|NCT03020745|58850393|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
30921550|NCT02045095|58956805|FG001|Overall Study|Withdrawal by Subject|0|||
30921551|NCT02045095|58956806|FG002|Overall Study|Withdrawal by Subject|0|||
30921552|NCT02045095|58956807|FG003|Overall Study|Withdrawal by Subject|0|||
30921553|NCT02045095|58956808|FG004|Overall Study|Withdrawal by Subject|3|||
30921554|NCT02045095|58956809|FG005|Overall Study|Withdrawal by Subject|0|||
30921555|NCT02045095|58956810|FG006|Overall Study|Withdrawal by Subject|0|||
30921556|NCT02045095|58956804|FG000|Overall Study|Adverse Event|0|||
30921557|NCT02045095|58956805|FG001|Overall Study|Adverse Event|1|||
30921558|NCT02045095|58956806|FG002|Overall Study|Adverse Event|1|||
30754318|NCT00133952|58763934|FG001|Overall Study|Protocol Violation|1|||
30754319|NCT00133952|58763933|FG000|Overall Study|Withdrawal by Subject|20|||
30754320|NCT00133952|58763934|FG001|Overall Study|Withdrawal by Subject|4|||
30754321|NCT00133952|58763933|FG000|Overall Study|Physician Decision|4|||
30754322|NCT00133952|58763934|FG001|Overall Study|Physician Decision|3|||
30754323|NCT00133952|58763933|FG000|Overall Study|Sponsor Decision|0|||
30754324|NCT00133952|58763934|FG001|Overall Study|Sponsor Decision|1|||
30754325|NCT00118092|58763940|FG000|Overall Study|Withdrawal by Subject|1|||
30754326|NCT00118092|58763940|FG000|Overall Study|Protocol Violation|1|||
30754327|NCT04555096|58763947|FG000|Overall Study|Death|4|||
30754328|NCT04555096|58763948|FG001|Overall Study|Death|4|||
30754329|NCT04555096|58763947|FG000|Overall Study|Withdrawal by Subject|1|||
30754330|NCT04555096|58763948|FG001|Overall Study|Withdrawal by Subject|0|||
30754331|NCT04555096|58763947|FG000|Overall Study|Other|0|||
30754332|NCT04555096|58763948|FG001|Overall Study|Other|1|||
30754333|NCT00097500|58763956|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
30754334|NCT00097500|58763957|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
30754335|NCT00097500|58763956|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
30754336|NCT00097500|58763957|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
30754337|NCT00097500|58763956|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
30754338|NCT00097500|58763957|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
30754339|NCT00097500|58763956|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
30754340|NCT00097500|58763957|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
30754341|NCT00097500|58763956|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
30754342|NCT00097500|58763957|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
30754343|NCT00097500|58763956|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
30754344|NCT00097500|58763957|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
30754345|NCT00097500|58763956|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
30754346|NCT00097500|58763957|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
30754347|NCT04551898|58763967|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
30754348|NCT04551898|58763968|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
30754349|NCT04551898|58763969|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
30827618|NCT03020745|58850394|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
30921559|NCT02045095|58956807|FG003|Overall Study|Adverse Event|0|||
30827619|NCT03020745|58850395|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
30827620|NCT03020745|58850396|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
30921560|NCT02045095|58956808|FG004|Overall Study|Adverse Event|0|||
30921561|NCT02045095|58956809|FG005|Overall Study|Adverse Event|2|||
30921562|NCT02045095|58956810|FG006|Overall Study|Adverse Event|0|||
30921563|NCT02181803|58956835|FG000|Overall Study|Withdrawal by Subject|0|||
30754350|NCT04551898|58763970|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
30754351|NCT04551898|58763967|FG000|Overall Study|Withdrawal by Subject|5|||
30754352|NCT04551898|58763968|FG001|Overall Study|Withdrawal by Subject|1|||
30754353|NCT04551898|58763969|FG002|Overall Study|Withdrawal by Subject|2|||
30754354|NCT04551898|58763970|FG003|Overall Study|Withdrawal by Subject|2|||
30754355|NCT04551898|58763967|FG000|Overall Study|Lost to Follow-up|2|||
30754356|NCT04551898|58763968|FG001|Overall Study|Lost to Follow-up|1|||
30754357|NCT04551898|58763969|FG002|Overall Study|Lost to Follow-up|2|||
30754358|NCT04551898|58763970|FG003|Overall Study|Lost to Follow-up|2|||
30754359|NCT04551898|58763967|FG000|Overall Study|Death|1|||
30754360|NCT04551898|58763968|FG001|Overall Study|Death|0|||
30754361|NCT04551898|58763969|FG002|Overall Study|Death|0|||
30754362|NCT04551898|58763970|FG003|Overall Study|Death|0|||
30754363|NCT04551898|58763967|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
30754364|NCT04551898|58763968|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
30754365|NCT04551898|58763969|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
30754366|NCT04551898|58763970|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
30754367|NCT04849780|58763988|FG000|Period 1|Covid-19 Related|1|||
30754368|NCT04849780|58763989|FG001|Period 1|Covid-19 Related|0|||
30754369|NCT04849780|58763988|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
30754370|NCT04849780|58763989|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
30754371|NCT04849780|58763988|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
30754372|NCT04849780|58763989|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
30754373|NCT04823494|58764003|FG000|Overall Study|Programming software malfunction.|1|||
30754374|NCT04823494|58764004|FG001|Overall Study|Programming software malfunction.|0|||
30754375|NCT04823494|58764003|FG000|Overall Study|Withdrawal by Subject|1|||
30754376|NCT04823494|58764004|FG001|Overall Study|Withdrawal by Subject|0|||
30754377|NCT04823494|58764003|FG000|Overall Study|Devices lost|0|||
30754378|NCT04823494|58764004|FG001|Overall Study|Devices lost|1|||
30754379|NCT04542694|58764014|FG000|Overall Study|The need for prohibited therapy|2|||
30754380|NCT04542694|58764015|FG001|Overall Study|The need for prohibited therapy|0|||
30754381|NCT04542694|58764014|FG000|Overall Study|Adverse Event|1|||
30754382|NCT04542694|58764015|FG001|Overall Study|Adverse Event|0|||
30754383|NCT04542694|58764014|FG000|Overall Study|Protocol Violation|1|||
30754384|NCT04542694|58764015|FG001|Overall Study|Protocol Violation|0|||
30754385|NCT00117312|58764025|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
30754386|NCT00117312|58764026|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
30754387|NCT00117312|58764027|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
30754388|NCT00117312|58764028|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
30754389|NCT00117312|58764025|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
30754390|NCT00117312|58764026|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
30754391|NCT00117312|58764027|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
30754392|NCT00117312|58764028|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
30754393|NCT00117312|58764025|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
30754394|NCT00117312|58764026|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
30754395|NCT00117312|58764027|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
30827621|NCT03020745|58850387|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
30827622|NCT03020745|58850388|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
30827623|NCT03020745|58850389|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
30827624|NCT03020745|58850390|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
30827625|NCT03020745|58850391|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
30827626|NCT03020745|58850392|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
30827627|NCT03020745|58850393|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
30827628|NCT03020745|58850394|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
30827629|NCT03020745|58850395|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
30827630|NCT03020745|58850396|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
30827631|NCT03020745|58850387|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
30827632|NCT03020745|58850388|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
30827633|NCT03020745|58850389|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
30827634|NCT03020745|58850390|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
30827635|NCT03020745|58850391|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
30827636|NCT03020745|58850392|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
30827637|NCT03020745|58850393|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
30827638|NCT03020745|58850394|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
30827639|NCT03020745|58850395|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
30827640|NCT03020745|58850396|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
30827641|NCT03020745|58850387|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
30827642|NCT03020745|58850388|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
30827643|NCT03020745|58850389|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
30827644|NCT03020745|58850390|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
30827645|NCT03020745|58850391|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
30827646|NCT03020745|58850392|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
30827647|NCT03020745|58850393|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
30827648|NCT03020745|58850394|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
30827649|NCT03020745|58850395|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
30827650|NCT03020745|58850396|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
30827651|NCT03019965|58850431|FG000|Overall Study|Withdrawal by Subject|1|||
30827652|NCT03019965|58850432|FG001|Overall Study|Withdrawal by Subject|0|||
30827653|NCT03019965|58850431|FG000|Overall Study|Protocol Violation|1|||
30827654|NCT03019965|58850432|FG001|Overall Study|Protocol Violation|3|||
30754396|NCT00117312|58764028|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
30754397|NCT00117312|58764025|FG000|Overall Study|Other|0|||
30754398|NCT00117312|58764026|FG001|Overall Study|Other|1|||
30754399|NCT00117312|58764027|FG002|Overall Study|Other|3|||
30754400|NCT00117312|58764028|FG003|Overall Study|Other|1|||
30754401|NCT00117312|58764025|FG000|Overall Study|Patient choice|0|||
30754402|NCT00117312|58764026|FG001|Overall Study|Patient choice|0|||
30754403|NCT00117312|58764027|FG002|Overall Study|Patient choice|2|||
30754404|NCT00117312|58764028|FG003|Overall Study|Patient choice|1|||
30754405|NCT00117312|58764025|FG000|Overall Study|Adverse Event|0|||
30754406|NCT00117312|58764026|FG001|Overall Study|Adverse Event|2|||
30754407|NCT00117312|58764027|FG002|Overall Study|Adverse Event|0|||
30754408|NCT00117312|58764028|FG003|Overall Study|Adverse Event|0|||
30754409|NCT00117312|58764025|FG000|Overall Study|Protocol Violation|0|||
30754410|NCT00117312|58764026|FG001|Overall Study|Protocol Violation|1|||
30754411|NCT00117312|58764027|FG002|Overall Study|Protocol Violation|3|||
30754412|NCT00117312|58764028|FG003|Overall Study|Protocol Violation|0|||
30754413|NCT00117312|58764025|FG000|Overall Study|PSA decrease <=50%|0|||
30754414|NCT00117312|58764026|FG001|Overall Study|PSA decrease <=50%|2|||
30754415|NCT00117312|58764027|FG002|Overall Study|PSA decrease <=50%|2|||
30754416|NCT00117312|58764028|FG003|Overall Study|PSA decrease <=50%|4|||
30754417|NCT00117312|58764025|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
30754418|NCT00117312|58764026|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
30827655|NCT03019965|58850431|FG000|Overall Study|viral or fungal infection|3|||
30754419|NCT00117312|58764027|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
30754420|NCT00117312|58764028|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
30827656|NCT03019965|58850432|FG001|Overall Study|viral or fungal infection|4|||
30827657|NCT03019965|58850431|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
30827658|NCT03019965|58850432|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
30827659|NCT03019965|58850431|FG000|Overall Study|Physician Decision|1|||
30623371|NCT00924664|58635182|FG000|Overall Study|Randomized but not Treated|1|||
30754421|NCT00117312|58764025|FG000|Overall Study|Hepatic abnormality|0|||
30754422|NCT00117312|58764026|FG001|Overall Study|Hepatic abnormality|1|||
30754423|NCT00117312|58764027|FG002|Overall Study|Hepatic abnormality|0|||
30754424|NCT00117312|58764028|FG003|Overall Study|Hepatic abnormality|1|||
30754425|NCT00117312|58764025|FG000|Overall Study|Withdrawal by Subject|0|||
30754426|NCT00117312|58764026|FG001|Overall Study|Withdrawal by Subject|2|||
30754427|NCT00117312|58764027|FG002|Overall Study|Withdrawal by Subject|0|||
30754428|NCT00117312|58764028|FG003|Overall Study|Withdrawal by Subject|0|||
30754429|NCT00129116|58764043|FG000|Primary Phase|Lost to Follow-up|1|||
30754430|NCT00129116|58764044|FG001|Primary Phase|Lost to Follow-up|1|||
30754431|NCT00129116|58764045|FG002|Primary Phase|Lost to Follow-up|0|||
30754432|NCT00129116|58764046|FG003|Primary Phase|Lost to Follow-up|1|||
30754433|NCT00129116|58764047|FG004|Primary Phase|Lost to Follow-up|1|||
30754434|NCT00129116|58764043|FG000|Primary Phase|Protocol Violation|0|||
30754435|NCT00129116|58764044|FG001|Primary Phase|Protocol Violation|1|||
30754436|NCT00129116|58764045|FG002|Primary Phase|Protocol Violation|0|||
30754437|NCT00129116|58764046|FG003|Primary Phase|Protocol Violation|0|||
30754438|NCT00129116|58764047|FG004|Primary Phase|Protocol Violation|0|||
30754439|NCT00129116|58764043|FG000|Primary Phase|Adverse Event|1|||
30754440|NCT00129116|58764044|FG001|Primary Phase|Adverse Event|1|||
30754441|NCT00129116|58764045|FG002|Primary Phase|Adverse Event|0|||
30827660|NCT03019965|58850432|FG001|Overall Study|Physician Decision|1|||
30827661|NCT01675882|58850451|FG000|Overall Study|Adverse Event|0|||
30827662|NCT01675882|58850452|FG001|Overall Study|Adverse Event|2|||
30827663|NCT01675882|58850453|FG002|Overall Study|Adverse Event|1|||
30754442|NCT00129116|58764046|FG003|Primary Phase|Adverse Event|0|||
30754443|NCT00129116|58764047|FG004|Primary Phase|Adverse Event|0|||
30754444|NCT00129116|58764043|FG000|Primary Phase|Withdrawal by Subject|0|||
30754445|NCT00129116|58764044|FG001|Primary Phase|Withdrawal by Subject|1|||
30754446|NCT00129116|58764045|FG002|Primary Phase|Withdrawal by Subject|0|||
30754447|NCT00129116|58764046|FG003|Primary Phase|Withdrawal by Subject|0|||
30754448|NCT00129116|58764047|FG004|Primary Phase|Withdrawal by Subject|0|||
30754449|NCT00129116|58764043|FG000|Primary Phase|Other|0|||
30754450|NCT00129116|58764044|FG001|Primary Phase|Other|0|||
30754451|NCT00129116|58764045|FG002|Primary Phase|Other|1|||
30754452|NCT00129116|58764046|FG003|Primary Phase|Other|0|||
30754453|NCT00129116|58764047|FG004|Primary Phase|Other|0|||
30827664|NCT01675882|58850454|FG003|Overall Study|Adverse Event|0|||
30827665|NCT01675882|58850451|FG000|Overall Study|Participant unwilling to continue|2|||
30921564|NCT02181803|58956836|FG001|Overall Study|Withdrawal by Subject|2|||
30921565|NCT02181803|58956837|FG002|Overall Study|Withdrawal by Subject|0|||
30921566|NCT02181803|58956838|FG003|Overall Study|Withdrawal by Subject|0|||
30921567|NCT02181803|58956839|FG004|Overall Study|Withdrawal by Subject|0|||
30921568|NCT02181803|58956840|FG005|Overall Study|Withdrawal by Subject|0|||
30921569|NCT02181803|58956841|FG006|Overall Study|Withdrawal by Subject|0|||
30921570|NCT02181803|58956842|FG007|Overall Study|Withdrawal by Subject|0|||
30921571|NCT02181803|58956843|FG008|Overall Study|Withdrawal by Subject|0|||
30921572|NCT02181803|58956835|FG000|Overall Study|Physician Decision|0|||
30921573|NCT02181803|58956836|FG001|Overall Study|Physician Decision|0|||
30921574|NCT02181803|58956837|FG002|Overall Study|Physician Decision|0|||
30921575|NCT02181803|58956838|FG003|Overall Study|Physician Decision|1|||
30921576|NCT02181803|58956839|FG004|Overall Study|Physician Decision|0|||
30921577|NCT02181803|58956840|FG005|Overall Study|Physician Decision|0|||
30827666|NCT01675882|58850452|FG001|Overall Study|Participant unwilling to continue|4|||
30827667|NCT01675882|58850453|FG002|Overall Study|Participant unwilling to continue|2|||
30827668|NCT01675882|58850454|FG003|Overall Study|Participant unwilling to continue|1|||
30827669|NCT01675882|58850451|FG000|Overall Study|Lost to Follow-up|0|||
30827670|NCT01675882|58850452|FG001|Overall Study|Lost to Follow-up|1|||
30827671|NCT01675882|58850453|FG002|Overall Study|Lost to Follow-up|0|||
30827672|NCT01675882|58850454|FG003|Overall Study|Lost to Follow-up|0|||
30827673|NCT01675882|58850451|FG000|Overall Study|Non-compliance|0|||
30827674|NCT01675882|58850452|FG001|Overall Study|Non-compliance|0|||
30827675|NCT01675882|58850453|FG002|Overall Study|Non-compliance|0|||
30827676|NCT01675882|58850454|FG003|Overall Study|Non-compliance|1|||
30827677|NCT03018249|58850466|FG000|Overall Study|Withdrawal by Subject|2|||
30827678|NCT03018249|58850467|FG001|Overall Study|Withdrawal by Subject|2|||
30827679|NCT02923245|58850485|FG000|Overall Study|ultrasound order was cancelled|2|||
30827680|NCT02923245|58850486|FG001|Overall Study|ultrasound order was cancelled|1|||
30827681|NCT00905606|58850502|FG000|Period 1|Adverse Event|0|||
30827682|NCT00905606|58850503|FG001|Period 1|Adverse Event|1|||
30827683|NCT00905606|58850502|FG000|Washout|Withdrawal by Subject|1|||
30921578|NCT02181803|58956841|FG006|Overall Study|Physician Decision|0|||
30921579|NCT02181803|58956842|FG007|Overall Study|Physician Decision|1|||
30921580|NCT02181803|58956843|FG008|Overall Study|Physician Decision|0|||
30921581|NCT02181803|58956835|FG000|Overall Study|Adverse Event|0|||
30754454|NCT00129116|58764043|FG000|Booster Phase|Lost to Follow-up|2|||
30754455|NCT00129116|58764044|FG001|Booster Phase|Lost to Follow-up|0|||
30754456|NCT00129116|58764045|FG002|Booster Phase|Lost to Follow-up|0|||
30754457|NCT00129116|58764046|FG003|Booster Phase|Lost to Follow-up|0|||
30754458|NCT00129116|58764047|FG004|Booster Phase|Lost to Follow-up|1|||
30754459|NCT00117156|58764059|FG000|Overall Study|Adverse Event|9|||
30754460|NCT00117156|58764059|FG000|Overall Study|Physician Decision|1|||
30754461|NCT00117156|58764059|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
30754462|NCT00096954|58764065|FG000|Overall Study|Adverse Event|3|||
30754463|NCT00096954|58764066|FG001|Overall Study|Adverse Event|1|||
30754464|NCT00096954|58764065|FG000|Overall Study|Withdrawal by Subject|9|||
30827684|NCT00905606|58850503|FG001|Washout|Withdrawal by Subject|0|||
30827685|NCT01676896|58850510|FG000|Overall Study|Withdrawal by Subject|12|||
30827686|NCT01676896|58850511|FG001|Overall Study|Withdrawal by Subject|7|||
30827687|NCT01676896|58850512|FG002|Overall Study|Withdrawal by Subject|19|||
30827688|NCT03017235|58850522|FG000|Overall Study|Withdrawal by Subject|4|||
30827689|NCT03017235|58850523|FG001|Overall Study|Withdrawal by Subject|3|||
30921582|NCT02181803|58956836|FG001|Overall Study|Adverse Event|2|||
30921583|NCT02181803|58956837|FG002|Overall Study|Adverse Event|0|||
30921584|NCT02181803|58956838|FG003|Overall Study|Adverse Event|1|||
30921585|NCT02181803|58956839|FG004|Overall Study|Adverse Event|0|||
30921586|NCT02181803|58956840|FG005|Overall Study|Adverse Event|0|||
30921587|NCT02181803|58956841|FG006|Overall Study|Adverse Event|1|||
30921588|NCT02181803|58956842|FG007|Overall Study|Adverse Event|0|||
30921589|NCT02181803|58956843|FG008|Overall Study|Adverse Event|0|||
30921590|NCT01826487|58956890|FG000|Overall Study|Adverse Event|1|||
30921591|NCT01826487|58956891|FG001|Overall Study|Adverse Event|1|||
30921592|NCT01826487|58956890|FG000|Overall Study|Lost to Follow-up|1|||
30921593|NCT01826487|58956891|FG001|Overall Study|Lost to Follow-up|0|||
30921594|NCT01826487|58956890|FG000|Overall Study|Withdrawal by Subject|1|||
30623372|NCT00924664|58635183|FG001|Overall Study|Randomized but not Treated|0|||
30623373|NCT00600067|58635191|FG000|Overall Study|Adverse Event|0|||
30623374|NCT00600067|58635192|FG001|Overall Study|Adverse Event|1|||
30623375|NCT00600067|58635191|FG000|Overall Study|Lost to Follow-up|2|||
30623376|NCT00600067|58635192|FG001|Overall Study|Lost to Follow-up|3|||
30623377|NCT00600067|58635191|FG000|Overall Study|protocol non-compliance|0|||
30827690|NCT03017235|58850522|FG000|Overall Study|Lost to Follow-up|2|||
30827691|NCT03017235|58850523|FG001|Overall Study|Lost to Follow-up|7|||
30827692|NCT03017235|58850522|FG000|Overall Study|Adverse Event|0|||
30827693|NCT03017235|58850523|FG001|Overall Study|Adverse Event|1|||
30827694|NCT03017235|58850522|FG000|Overall Study|Protocol Violation|2|||
30827695|NCT03017235|58850523|FG001|Overall Study|Protocol Violation|1|||
30827696|NCT03017235|58850522|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
30827697|NCT03017235|58850523|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
30827698|NCT03017079|58850531|FG000|Overall Study|Physician Decision|1|||
30827699|NCT03017079|58850532|FG001|Overall Study|Physician Decision|1|||
30827700|NCT03017079|58850531|FG000|Overall Study|Death|3|||
30827701|NCT03017079|58850532|FG001|Overall Study|Death|2|||
30827702|NCT03017079|58850531|FG000|Overall Study|Lack of Efficacy|2|||
30827703|NCT03017079|58850532|FG001|Overall Study|Lack of Efficacy|2|||
30827704|NCT03017079|58850531|FG000|Overall Study|Protocol Violation|0|||
30827705|NCT03017079|58850532|FG001|Overall Study|Protocol Violation|1|||
30827706|NCT03015363|58850545|FG000|Overall Study|Physician Decision|14|||
30827707|NCT03015363|58850545|FG000|Overall Study|Withdrawal by Subject|3|||
30827708|NCT02880371|58850557|FG000|Phase 1b|Lost to Follow-up|1|||
30827709|NCT02880371|58850558|FG001|Phase 1b|Lost to Follow-up|0|||
30827710|NCT02880371|58850559|FG002|Phase 1b|Lost to Follow-up|0|||
30827711|NCT02880371|58850560|FG003|Phase 1b|Lost to Follow-up|0|||
30827712|NCT02880371|58850561|FG004|Phase 1b|Lost to Follow-up|0|||
30827713|NCT02880371|58850562|FG005|Phase 1b|Lost to Follow-up|0|||
30827714|NCT02880371|58850563|FG006|Phase 1b|Lost to Follow-up|0|||
30827715|NCT02880371|58850564|FG007|Phase 1b|Lost to Follow-up|0|||
30827716|NCT02880371|58850557|FG000|Phase 1b|Participants terminated by Sponsor|1|||
30827717|NCT02880371|58850558|FG001|Phase 1b|Participants terminated by Sponsor|0|||
30827718|NCT02880371|58850559|FG002|Phase 1b|Participants terminated by Sponsor|0|||
30827719|NCT02880371|58850560|FG003|Phase 1b|Participants terminated by Sponsor|0|||
30827720|NCT02880371|58850561|FG004|Phase 1b|Participants terminated by Sponsor|0|||
30827721|NCT02880371|58850562|FG005|Phase 1b|Participants terminated by Sponsor|0|||
30827722|NCT02880371|58850563|FG006|Phase 1b|Participants terminated by Sponsor|0|||
30827723|NCT02880371|58850564|FG007|Phase 1b|Participants terminated by Sponsor|0|||
30827724|NCT02880371|58850557|FG000|Phase 1b|Withdrawal by Subject|0|||
30827725|NCT02880371|58850558|FG001|Phase 1b|Withdrawal by Subject|0|||
30827726|NCT02880371|58850559|FG002|Phase 1b|Withdrawal by Subject|1|||
30827727|NCT02880371|58850560|FG003|Phase 1b|Withdrawal by Subject|0|||
30827728|NCT02880371|58850561|FG004|Phase 1b|Withdrawal by Subject|0|||
30827729|NCT02880371|58850562|FG005|Phase 1b|Withdrawal by Subject|0|||
30827730|NCT02880371|58850563|FG006|Phase 1b|Withdrawal by Subject|0|||
30921595|NCT01826487|58956891|FG001|Overall Study|Withdrawal by Subject|3|||
30921596|NCT01826487|58956890|FG000|Overall Study|Protocol Violation|1|||
30827731|NCT02880371|58850564|FG007|Phase 1b|Withdrawal by Subject|0|||
30827732|NCT02880371|58850557|FG000|Phase 1b|Death|4|||
30623378|NCT00600067|58635192|FG001|Overall Study|protocol non-compliance|3|||
30827733|NCT02880371|58850558|FG001|Phase 1b|Death|6|||
30827734|NCT02880371|58850559|FG002|Phase 1b|Death|5|||
30623379|NCT00600067|58635191|FG000|Overall Study|Lack of Efficacy|1|||
30623380|NCT00600067|58635192|FG001|Overall Study|Lack of Efficacy|0|||
30623381|NCT00970593|58635206|FG000|Overall Study|Adverse Event|1|||
30827735|NCT02880371|58850560|FG003|Phase 1b|Death|1|||
30827736|NCT02880371|58850561|FG004|Phase 1b|Death|0|||
30921597|NCT01826487|58956891|FG001|Overall Study|Protocol Violation|1|||
30921598|NCT02064439|58956901|FG000|Overall Study|Adverse Event|51|||
30827737|NCT02880371|58850562|FG005|Phase 1b|Death|0|||
30827738|NCT02880371|58850563|FG006|Phase 1b|Death|0|||
30827739|NCT02880371|58850564|FG007|Phase 1b|Death|0|||
30827740|NCT02880371|58850557|FG000|Phase 1b|Enrolled but not Treated|0|||
30827741|NCT02880371|58850558|FG001|Phase 1b|Enrolled but not Treated|1|||
30827742|NCT02880371|58850559|FG002|Phase 1b|Enrolled but not Treated|0|||
30623382|NCT00970593|58635207|FG001|Overall Study|Adverse Event|1|||
30623383|NCT00970593|58635208|FG002|Overall Study|Adverse Event|0|||
30623384|NCT00970593|58635209|FG003|Overall Study|Adverse Event|0|||
30623385|NCT00970593|58635210|FG004|Overall Study|Adverse Event|0|||
30623386|NCT00970593|58635211|FG005|Overall Study|Adverse Event|0|||
30754465|NCT00096954|58764066|FG001|Overall Study|Withdrawal by Subject|8|||
30921599|NCT02064439|58956902|FG001|Overall Study|Adverse Event|47|||
30921600|NCT02064439|58956903|FG002|Overall Study|Adverse Event|46|||
30921601|NCT02064439|58956901|FG000|Overall Study|Death|0|||
30921602|NCT02064439|58956902|FG001|Overall Study|Death|2|||
30921603|NCT02064439|58956903|FG002|Overall Study|Death|3|||
30921604|NCT02064439|58956901|FG000|Overall Study|Withdrawal by Subject|29|||
30921605|NCT02064439|58956902|FG001|Overall Study|Withdrawal by Subject|18|||
30921606|NCT02064439|58956903|FG002|Overall Study|Withdrawal by Subject|26|||
30921607|NCT02064439|58956901|FG000|Overall Study|Protocol Violation|3|||
30921608|NCT02064439|58956902|FG001|Overall Study|Protocol Violation|5|||
30921609|NCT02064439|58956903|FG002|Overall Study|Protocol Violation|3|||
30921610|NCT02064439|58956901|FG000|Overall Study|Lost to Follow-up|1|||
30921611|NCT02064439|58956902|FG001|Overall Study|Lost to Follow-up|3|||
30921612|NCT02064439|58956903|FG002|Overall Study|Lost to Follow-up|4|||
30921613|NCT02064439|58956901|FG000|Overall Study|Non-compliance with study medication|21|||
30921614|NCT02064439|58956902|FG001|Overall Study|Non-compliance with study medication|19|||
30921615|NCT02064439|58956903|FG002|Overall Study|Non-compliance with study medication|23|||
30921616|NCT02064439|58956901|FG000|Overall Study|Physician Decision|0|||
30921617|NCT02064439|58956902|FG001|Overall Study|Physician Decision|1|||
30921618|NCT02064439|58956903|FG002|Overall Study|Physician Decision|1|||
30921619|NCT02064439|58956901|FG000|Overall Study|Logistical difficulties|6|||
30921620|NCT02064439|58956902|FG001|Overall Study|Logistical difficulties|5|||
30921621|NCT02064439|58956903|FG002|Overall Study|Logistical difficulties|2|||
30921622|NCT02064439|58956901|FG000|Overall Study|Efficacy outcome reached|18|||
30921623|NCT02064439|58956902|FG001|Overall Study|Efficacy outcome reached|16|||
30921624|NCT02064439|58956903|FG002|Overall Study|Efficacy outcome reached|57|||
30921625|NCT02064439|58956901|FG000|Overall Study|Safety outcome reached|12|||
30921626|NCT02064439|58956902|FG001|Overall Study|Safety outcome reached|20|||
30921627|NCT02064439|58956903|FG002|Overall Study|Safety outcome reached|10|||
30921628|NCT02064439|58956901|FG000|Overall Study|Other|2|||
30921629|NCT02064439|58956902|FG001|Overall Study|Other|2|||
30921630|NCT02064439|58956903|FG002|Overall Study|Other|7|||
30921631|NCT02130557|58956913|FG000|Overall Study|Withdrawal by Subject|12|||
30921632|NCT02130557|58956914|FG001|Overall Study|Withdrawal by Subject|12|||
30921633|NCT02130557|58956913|FG000|Overall Study|Investigator Request|0|||
30754466|NCT00096954|58764065|FG000|Overall Study|Physician Decision|1|||
30754467|NCT00096954|58764066|FG001|Overall Study|Physician Decision|1|||
30754468|NCT00096954|58764065|FG000|Overall Study|Sponsors Decision|1|||
30754469|NCT00096954|58764066|FG001|Overall Study|Sponsors Decision|1|||
30754470|NCT00096954|58764065|FG000|Overall Study|Pregnancy|1|||
30754471|NCT00096954|58764066|FG001|Overall Study|Pregnancy|1|||
30754472|NCT00096954|58764065|FG000|Overall Study|Initiation of immunotherapy|1|||
30754473|NCT00096954|58764066|FG001|Overall Study|Initiation of immunotherapy|0|||
30754474|NCT00096954|58764065|FG000|Overall Study|Non-compliance|0|||
30754475|NCT00096954|58764066|FG001|Overall Study|Non-compliance|3|||
30754476|NCT00096954|58764065|FG000|Overall Study|Lost to Follow-up|8|||
30754477|NCT00096954|58764066|FG001|Overall Study|Lost to Follow-up|5|||
30754478|NCT00096486|58764076|FG000|Overall Study|Withdrawal by Subject|0|||
30754479|NCT00096486|58764077|FG001|Overall Study|Withdrawal by Subject|0|||
30754480|NCT00096486|58764078|FG002|Overall Study|Withdrawal by Subject|1|||
30754481|NCT00096486|58764079|FG003|Overall Study|Withdrawal by Subject|1|||
30827743|NCT02880371|58850560|FG003|Phase 1b|Enrolled but not Treated|0|||
30827744|NCT02880371|58850561|FG004|Phase 1b|Enrolled but not Treated|0|||
30827745|NCT02880371|58850562|FG005|Phase 1b|Enrolled but not Treated|0|||
30827746|NCT02880371|58850563|FG006|Phase 1b|Enrolled but not Treated|0|||
30827747|NCT02880371|58850564|FG007|Phase 1b|Enrolled but not Treated|0|||
30827748|NCT02880371|58850557|FG000|Phase 2|Enrolled but not Treated|0|||
30827749|NCT02880371|58850558|FG001|Phase 2|Enrolled but not Treated|0|||
30921634|NCT02130557|58956914|FG001|Overall Study|Investigator Request|2|||
30921635|NCT02130557|58956913|FG000|Overall Study|Deceased|14|||
30921636|NCT02130557|58956914|FG001|Overall Study|Deceased|14|||
30754482|NCT00096486|58764076|FG000|Overall Study|Not Treated|0|||
30754483|NCT00096486|58764077|FG001|Overall Study|Not Treated|0|||
30754484|NCT00096486|58764078|FG002|Overall Study|Not Treated|1|||
30827750|NCT02880371|58850559|FG002|Phase 2|Enrolled but not Treated|0|||
30921637|NCT02130557|58956913|FG000|Overall Study|Lost to Follow-up|6|||
30921638|NCT02130557|58956914|FG001|Overall Study|Lost to Follow-up|7|||
30827751|NCT02880371|58850560|FG003|Phase 2|Enrolled but not Treated|0|||
30827752|NCT02880371|58850561|FG004|Phase 2|Enrolled but not Treated|0|||
30827753|NCT02880371|58850562|FG005|Phase 2|Enrolled but not Treated|1|||
30827754|NCT02880371|58850563|FG006|Phase 2|Enrolled but not Treated|1|||
30921639|NCT02130557|58956913|FG000|Overall Study|Other|2|||
30921640|NCT02130557|58956914|FG001|Overall Study|Other|1|||
30921641|NCT02130557|58956913|FG000|Overall Study|Missing|2|||
30921642|NCT02130557|58956914|FG001|Overall Study|Missing|1|||
30827755|NCT02880371|58850564|FG007|Phase 2|Enrolled but not Treated|0|||
30827756|NCT02880371|58850557|FG000|Phase 2|Other|0|||
30827757|NCT02880371|58850558|FG001|Phase 2|Other|0|||
30921643|NCT01854645|58956925|FG000|Overall Study|Protocol-Specified Criteria|13|||
30921644|NCT01854645|58956926|FG001|Overall Study|Protocol-Specified Criteria|10|||
30754485|NCT00096486|58764079|FG003|Overall Study|Not Treated|1|||
30754486|NCT00116844|58764091|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
30754487|NCT00116844|58764092|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
30754488|NCT00116844|58764091|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
30754489|NCT00116844|58764092|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
30754490|NCT00116844|58764091|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
30754491|NCT00116844|58764092|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
30754492|NCT00116844|58764091|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
30754493|NCT00116844|58764092|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
30754494|NCT00116844|58764091|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
30754495|NCT00116844|58764092|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
30754496|NCT00116844|58764091|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
30754497|NCT00116844|58764092|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
30754498|NCT00116844|58764091|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
30827758|NCT02880371|58850559|FG002|Phase 2|Other|0|||
30827759|NCT02880371|58850560|FG003|Phase 2|Other|0|||
30827760|NCT02880371|58850561|FG004|Phase 2|Other|0|||
30827761|NCT02880371|58850562|FG005|Phase 2|Other|1|||
30827762|NCT02880371|58850563|FG006|Phase 2|Other|2|||
30827763|NCT02880371|58850564|FG007|Phase 2|Other|1|||
30827764|NCT02880371|58850557|FG000|Phase 2|Participants terminated by Sponsor|0|||
30827765|NCT02880371|58850558|FG001|Phase 2|Participants terminated by Sponsor|0|||
30827766|NCT02880371|58850559|FG002|Phase 2|Participants terminated by Sponsor|0|||
30827767|NCT02880371|58850560|FG003|Phase 2|Participants terminated by Sponsor|0|||
30827768|NCT02880371|58850561|FG004|Phase 2|Participants terminated by Sponsor|1|||
30827769|NCT02880371|58850562|FG005|Phase 2|Participants terminated by Sponsor|6|||
30827770|NCT02880371|58850563|FG006|Phase 2|Participants terminated by Sponsor|1|||
30827771|NCT02880371|58850564|FG007|Phase 2|Participants terminated by Sponsor|5|||
30827772|NCT02880371|58850557|FG000|Phase 2|Death|0|||
30827773|NCT02880371|58850558|FG001|Phase 2|Death|0|||
30827774|NCT02880371|58850559|FG002|Phase 2|Death|0|||
30827775|NCT02880371|58850560|FG003|Phase 2|Death|0|||
30827776|NCT02880371|58850561|FG004|Phase 2|Death|1|||
30827777|NCT02880371|58850562|FG005|Phase 2|Death|10|||
30827778|NCT02880371|58850563|FG006|Phase 2|Death|20|||
30827779|NCT02880371|58850564|FG007|Phase 2|Death|5|||
30827780|NCT02880371|58850557|FG000|Phase 2|Lost to Follow-up|0|||
30827781|NCT02880371|58850558|FG001|Phase 2|Lost to Follow-up|0|||
30827782|NCT02880371|58850559|FG002|Phase 2|Lost to Follow-up|0|||
30827783|NCT02880371|58850560|FG003|Phase 2|Lost to Follow-up|0|||
30827784|NCT02880371|58850561|FG004|Phase 2|Lost to Follow-up|0|||
30827785|NCT02880371|58850562|FG005|Phase 2|Lost to Follow-up|0|||
30827786|NCT02880371|58850563|FG006|Phase 2|Lost to Follow-up|3|||
30827787|NCT02880371|58850564|FG007|Phase 2|Lost to Follow-up|0|||
30827788|NCT02880371|58850557|FG000|Phase 2|Withdrawal by Subject|0|||
30827789|NCT02880371|58850558|FG001|Phase 2|Withdrawal by Subject|0|||
30827790|NCT02880371|58850559|FG002|Phase 2|Withdrawal by Subject|0|||
30827791|NCT02880371|58850560|FG003|Phase 2|Withdrawal by Subject|0|||
30827792|NCT02880371|58850561|FG004|Phase 2|Withdrawal by Subject|0|||
30827793|NCT02880371|58850562|FG005|Phase 2|Withdrawal by Subject|1|||
30827794|NCT02880371|58850563|FG006|Phase 2|Withdrawal by Subject|1|||
30827795|NCT02880371|58850564|FG007|Phase 2|Withdrawal by Subject|0|||
30827796|NCT02880371|58850557|FG000|Phase 2|End of Study page not completed by error|0|||
30827797|NCT02880371|58850558|FG001|Phase 2|End of Study page not completed by error|0|||
30827798|NCT02880371|58850559|FG002|Phase 2|End of Study page not completed by error|0|||
30827799|NCT02880371|58850560|FG003|Phase 2|End of Study page not completed by error|0|||
30623387|NCT00970593|58635212|FG006|Overall Study|Adverse Event|0|||
30827800|NCT02880371|58850561|FG004|Phase 2|End of Study page not completed by error|0|||
30827801|NCT02880371|58850562|FG005|Phase 2|End of Study page not completed by error|1|||
30827802|NCT02880371|58850563|FG006|Phase 2|End of Study page not completed by error|0|||
30827803|NCT02880371|58850564|FG007|Phase 2|End of Study page not completed by error|0|||
30827804|NCT02837029|58850587|FG000|Screening|Failed to meet screening requirements.|7|||
30921645|NCT01854645|58956927|FG002|Overall Study|Protocol-Specified Criteria|8|||
30921646|NCT01854645|58956928|FG003|Overall Study|Protocol-Specified Criteria|5|||
30827805|NCT02837029|58850588|FG001|Screening|Failed to meet screening requirements.|3|||
30827806|NCT02837029|58850589|FG002|Screening|Failed to meet screening requirements.|0|||
30827807|NCT02837029|58850587|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
30827808|NCT02837029|58850588|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
30827809|NCT02837029|58850589|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
30827810|NCT02837029|58850587|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
30827811|NCT02837029|58850588|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
30827812|NCT02837029|58850589|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
30827813|NCT02837029|58850587|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
30827814|NCT02837029|58850588|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
30827815|NCT02837029|58850589|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
30827816|NCT02837029|58850587|FG000|Cycle 2 and Beyond|Adverse Event|1|||
30827817|NCT02837029|58850588|FG001|Cycle 2 and Beyond|Adverse Event|0|||
30827818|NCT02837029|58850589|FG002|Cycle 2 and Beyond|Adverse Event|0|||
30827819|NCT02837029|58850587|FG000|2 Year Follow-up|Death|6|||
30827820|NCT02837029|58850588|FG001|2 Year Follow-up|Death|7|||
30827821|NCT02837029|58850589|FG002|2 Year Follow-up|Death|0|||
30827822|NCT03010527|58850601|FG000|Overall Study|Death|0|||
30827823|NCT03010527|58850602|FG001|Overall Study|Death|0|||
30827824|NCT03010527|58850603|FG002|Overall Study|Death|1|||
30827825|NCT03010527|58850601|FG000|Overall Study|Adverse Event|0|||
30827826|NCT03010527|58850602|FG001|Overall Study|Adverse Event|4|||
30827827|NCT03010527|58850603|FG002|Overall Study|Adverse Event|2|||
30827828|NCT03010527|58850601|FG000|Overall Study|Protocol Violation|0|||
30827829|NCT03010527|58850602|FG001|Overall Study|Protocol Violation|1|||
30827830|NCT03010527|58850603|FG002|Overall Study|Protocol Violation|0|||
30827831|NCT03010527|58850601|FG000|Overall Study|Lost to Follow-up|0|||
30827832|NCT03010527|58850602|FG001|Overall Study|Lost to Follow-up|2|||
30827833|NCT03010527|58850603|FG002|Overall Study|Lost to Follow-up|1|||
30827834|NCT03010527|58850601|FG000|Overall Study|Withdrawal by Subject|0|||
30827835|NCT03010527|58850602|FG001|Overall Study|Withdrawal by Subject|3|||
30827836|NCT03010527|58850603|FG002|Overall Study|Withdrawal by Subject|4|||
30827837|NCT03010527|58850601|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
30827838|NCT03010527|58850602|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
30827839|NCT03010527|58850603|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
30827840|NCT03010527|58850601|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
30827841|NCT03010527|58850602|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
30827842|NCT03010527|58850603|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
30827843|NCT03010527|58850601|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
30827844|NCT03010527|58850602|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
30827845|NCT03010527|58850603|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
30827846|NCT00794924|58850636|FG000|Overall Study|Lost to Follow-up|6|||
30827847|NCT00794924|58850637|FG001|Overall Study|Lost to Follow-up|8|||
30827848|NCT00794924|58850636|FG000|Overall Study|Withdrawal by Subject|48|||
30827849|NCT00794924|58850637|FG001|Overall Study|Withdrawal by Subject|60|||
30827850|NCT00794924|58850636|FG000|Overall Study|Adverse Event|6|||
30827851|NCT00794924|58850637|FG001|Overall Study|Adverse Event|2|||
30827852|NCT02914275|58850643|FG000|Overall Study|Lost to Follow-up|84|||
30827853|NCT02914275|58850644|FG001|Overall Study|Lost to Follow-up|29|||
30827854|NCT02914275|58850643|FG000|Overall Study|Withdrawal by Subject|26|||
30827855|NCT02914275|58850644|FG001|Overall Study|Withdrawal by Subject|10|||
30827856|NCT02914275|58850643|FG000|Overall Study|Protocol Violation|1|||
30827857|NCT02914275|58850644|FG001|Overall Study|Protocol Violation|1|||
30827858|NCT02914275|58850643|FG000|Overall Study|Physician Decision|3|||
30827859|NCT02914275|58850644|FG001|Overall Study|Physician Decision|1|||
30827860|NCT02914275|58850643|FG000|Overall Study|Other|4|||
30827861|NCT02914275|58850644|FG001|Overall Study|Other|1|||
30827862|NCT02914275|58850643|FG000|Overall Study|Excluded due to invalid informed consent|3|||
30921647|NCT01854645|58956929|FG004|Overall Study|Protocol-Specified Criteria|7|||
30921648|NCT01854645|58956925|FG000|Overall Study|Administrative Reasons / Missing|0|||
30921649|NCT01854645|58956926|FG001|Overall Study|Administrative Reasons / Missing|0|||
30921650|NCT01854645|58956927|FG002|Overall Study|Administrative Reasons / Missing|0|||
30827863|NCT02914275|58850644|FG001|Overall Study|Excluded due to invalid informed consent|0|||
30827864|NCT00792116|58850656|FG000|Overall Study|Lost to Follow-up|0|||
30827865|NCT00792116|58850657|FG001|Overall Study|Lost to Follow-up|1|||
30827866|NCT00792116|58850656|FG000|Overall Study|Discontnued intervention|1|||
30827867|NCT00792116|58850657|FG001|Overall Study|Discontnued intervention|0|||
30827868|NCT00489827|58850672|FG000|Overall Study|Intraoperative exclusion criteria|1|||
30827869|NCT00489827|58850673|FG001|Overall Study|Intraoperative exclusion criteria|1|||
30827870|NCT00489827|58850672|FG000|Overall Study|Intraoperative exclusion criteria|1|||
30827871|NCT00489827|58850673|FG001|Overall Study|Intraoperative exclusion criteria|1|||
30921651|NCT01854645|58956928|FG003|Overall Study|Administrative Reasons / Missing|1|||
30827872|NCT02604433|58850681|FG000|Overall Study|Withdrawal by Subject|37|||
30921652|NCT01854645|58956929|FG004|Overall Study|Administrative Reasons / Missing|1|||
30827873|NCT02604433|58850682|FG001|Overall Study|Withdrawal by Subject|16|||
30827874|NCT02604433|58850681|FG000|Overall Study|Adverse Event|4|||
30827875|NCT02604433|58850682|FG001|Overall Study|Adverse Event|0|||
30827876|NCT02604433|58850681|FG000|Overall Study|Other reasons|3|||
30827877|NCT02604433|58850682|FG001|Overall Study|Other reasons|5|||
30827878|NCT02604433|58850681|FG000|Overall Study|Death|4|||
30754499|NCT00116844|58764092|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
30754500|NCT00116844|58764091|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
30827879|NCT02604433|58850682|FG001|Overall Study|Death|1|||
30827880|NCT02604433|58850681|FG000|Overall Study|Transition to Rollover Protocol|169|||
30827881|NCT02604433|58850682|FG001|Overall Study|Transition to Rollover Protocol|82|||
30827882|NCT02604433|58850681|FG000|Overall Study|Physician Decision|1|||
30827883|NCT02604433|58850682|FG001|Overall Study|Physician Decision|1|||
30827884|NCT02604433|58850681|FG000|Overall Study|Lack of Efficacy|0|||
30827885|NCT02604433|58850682|FG001|Overall Study|Lack of Efficacy|1|||
30827886|NCT02659150|58850688|FG000|Subject Enrollment|Physician Decision|3|||
30827887|NCT02659150|58850688|FG000|Subject Enrollment|Withdrawal by Subject|2|||
30827888|NCT02659150|58850688|FG000|Baseline Imaging|Withdrawal by Subject|1|||
30827889|NCT02659150|58850688|FG000|Baseline Imaging|Physician Decision|1|||
30827890|NCT02659150|58850688|FG000|Study Drug Dosing|Adverse Event|1|||
30827891|NCT03006393|58850695|FG000|Overall Study|Withdrawal by Subject|1|||
30827892|NCT03006393|58850696|FG001|Overall Study|Withdrawal by Subject|1|||
30827893|NCT03006393|58850695|FG000|Overall Study|Pregnancy|0|||
30827894|NCT03006393|58850696|FG001|Overall Study|Pregnancy|1|||
30827895|NCT03006393|58850695|FG000|Overall Study|Lost to Follow-up|0|||
30827896|NCT03006393|58850696|FG001|Overall Study|Lost to Follow-up|1|||
30827897|NCT00882440|58850713|FG000|Overall Study|Adverse Event|2|||
30827898|NCT00882440|58850714|FG001|Overall Study|Adverse Event|2|||
30827899|NCT00882440|58850715|FG002|Overall Study|Adverse Event|2|||
30827900|NCT00882440|58850716|FG003|Overall Study|Adverse Event|1|||
30827901|NCT00882440|58850717|FG004|Overall Study|Adverse Event|1|||
30827902|NCT00882440|58850718|FG005|Overall Study|Adverse Event|4|||
30827903|NCT00882440|58850719|FG006|Overall Study|Adverse Event|2|||
30754501|NCT00116844|58764092|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
30754502|NCT00116844|58764091|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
30754503|NCT00116844|58764092|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
30754504|NCT00128492|58764100|FG000|Overall Study|AE unrelated to study|2|||
30754505|NCT00128492|58764101|FG001|Overall Study|AE unrelated to study|9|||
30754506|NCT00128492|58764100|FG000|Overall Study|Study drug intolerance (AE)|2|||
30754507|NCT00128492|58764101|FG001|Overall Study|Study drug intolerance (AE)|8|||
30754508|NCT00128492|58764100|FG000|Overall Study|AE related to study|1|||
30754509|NCT00128492|58764101|FG001|Overall Study|AE related to study|4|||
30754510|NCT00128492|58764100|FG000|Overall Study|Death|1|||
30754511|NCT00128492|58764101|FG001|Overall Study|Death|0|||
30754512|NCT00128492|58764100|FG000|Overall Study|Lost to Follow-up|1|||
30827904|NCT00882440|58850713|FG000|Overall Study|Lack of Efficacy|3|||
30921653|NCT01854645|58956925|FG000|Overall Study|Protocol Violation|3|||
30921654|NCT01854645|58956926|FG001|Overall Study|Protocol Violation|0|||
30827905|NCT00882440|58850714|FG001|Overall Study|Lack of Efficacy|5|||
30827906|NCT00882440|58850715|FG002|Overall Study|Lack of Efficacy|2|||
30827907|NCT00882440|58850716|FG003|Overall Study|Lack of Efficacy|0|||
30754513|NCT00128492|58764101|FG001|Overall Study|Lost to Follow-up|5|||
30827908|NCT00882440|58850717|FG004|Overall Study|Lack of Efficacy|0|||
30827909|NCT00882440|58850718|FG005|Overall Study|Lack of Efficacy|3|||
30754514|NCT00128492|58764100|FG000|Overall Study|Noncompliance|0|||
30754515|NCT00128492|58764101|FG001|Overall Study|Noncompliance|5|||
30754516|NCT00128492|58764100|FG000|Overall Study|Personal or administrative|10|||
30754517|NCT00128492|58764101|FG001|Overall Study|Personal or administrative|22|||
30754518|NCT00128492|58764100|FG000|Overall Study|Withdrawal by Subject|3|||
30754519|NCT00128492|58764101|FG001|Overall Study|Withdrawal by Subject|5|||
30827910|NCT00882440|58850719|FG006|Overall Study|Lack of Efficacy|0|||
30827911|NCT00882440|58850713|FG000|Overall Study|Lost to Follow-up|2|||
30921655|NCT01854645|58956927|FG002|Overall Study|Protocol Violation|5|||
30921656|NCT01854645|58956928|FG003|Overall Study|Protocol Violation|4|||
30921657|NCT01854645|58956929|FG004|Overall Study|Protocol Violation|1|||
30754520|NCT00128492|58764100|FG000|Overall Study|Pregnancy|0|||
30754521|NCT00128492|58764101|FG001|Overall Study|Pregnancy|1|||
30827912|NCT00882440|58850714|FG001|Overall Study|Lost to Follow-up|0|||
30827913|NCT00882440|58850715|FG002|Overall Study|Lost to Follow-up|1|||
30827914|NCT00882440|58850716|FG003|Overall Study|Lost to Follow-up|1|||
30827915|NCT00882440|58850717|FG004|Overall Study|Lost to Follow-up|1|||
30827916|NCT00882440|58850718|FG005|Overall Study|Lost to Follow-up|0|||
30827917|NCT00882440|58850719|FG006|Overall Study|Lost to Follow-up|1|||
30827918|NCT00882440|58850713|FG000|Overall Study|Protocol Violation|0|||
30827919|NCT00882440|58850714|FG001|Overall Study|Protocol Violation|0|||
30827920|NCT00882440|58850715|FG002|Overall Study|Protocol Violation|1|||
30827921|NCT00882440|58850716|FG003|Overall Study|Protocol Violation|1|||
30827922|NCT00882440|58850717|FG004|Overall Study|Protocol Violation|1|||
30827923|NCT00882440|58850718|FG005|Overall Study|Protocol Violation|0|||
30827924|NCT00882440|58850719|FG006|Overall Study|Protocol Violation|0|||
30827925|NCT00882440|58850713|FG000|Overall Study|Withdrawal by Subject|2|||
30827926|NCT00882440|58850714|FG001|Overall Study|Withdrawal by Subject|1|||
30827927|NCT00882440|58850715|FG002|Overall Study|Withdrawal by Subject|1|||
30827928|NCT00882440|58850716|FG003|Overall Study|Withdrawal by Subject|0|||
30827929|NCT00882440|58850717|FG004|Overall Study|Withdrawal by Subject|6|||
30827930|NCT00882440|58850718|FG005|Overall Study|Withdrawal by Subject|0|||
30827931|NCT00882440|58850719|FG006|Overall Study|Withdrawal by Subject|1|||
30827932|NCT00882440|58850713|FG000|Overall Study|Patient Uncooperative|2|||
30827933|NCT00882440|58850714|FG001|Overall Study|Patient Uncooperative|0|||
30827934|NCT00882440|58850715|FG002|Overall Study|Patient Uncooperative|0|||
30827935|NCT00882440|58850716|FG003|Overall Study|Patient Uncooperative|0|||
30827936|NCT00882440|58850717|FG004|Overall Study|Patient Uncooperative|1|||
30827937|NCT00882440|58850718|FG005|Overall Study|Patient Uncooperative|0|||
30827938|NCT00882440|58850719|FG006|Overall Study|Patient Uncooperative|0|||
30827939|NCT03005067|58850730|FG000|Overall Study|Withdrawal by Subject|3|||
30827940|NCT03005067|58850731|FG001|Overall Study|Withdrawal by Subject|2|||
30827941|NCT03005067|58850730|FG000|Overall Study|Adverse Event|4|||
30827942|NCT03005067|58850731|FG001|Overall Study|Adverse Event|3|||
30827943|NCT03005067|58850730|FG000|Overall Study|Other (reason not specified)|3|||
30827944|NCT03005067|58850731|FG001|Overall Study|Other (reason not specified)|1|||
30827945|NCT03005067|58850730|FG000|Overall Study|Protocol Violation|0|||
30827946|NCT03005067|58850731|FG001|Overall Study|Protocol Violation|1|||
30827947|NCT02658448|58850737|FG000|Overall Study|Lost to Follow-up|1|||
30827948|NCT00870818|58850746|FG000|Overall Study|Lost to Follow-up|3|||
30827949|NCT00870818|58850747|FG001|Overall Study|Lost to Follow-up|2|||
30827950|NCT00870818|58850748|FG002|Overall Study|Lost to Follow-up|1|||
30754522|NCT00132314|58764109|FG000|Overall Study|Lost to Follow-up|70|||
30754523|NCT00132314|58764110|FG001|Overall Study|Lost to Follow-up|62|||
30754524|NCT00132314|58764109|FG000|Overall Study|Lacked SSN|1|||
30754525|NCT00132314|58764110|FG001|Overall Study|Lacked SSN|3|||
30754526|NCT00132314|58764109|FG000|Overall Study|Refused intervention at baseline|2|||
30754527|NCT00132314|58764110|FG001|Overall Study|Refused intervention at baseline|7|||
30754528|NCT04539262|58764124|FG000|Overall Study|Adverse Event|0|||
30754529|NCT04539262|58764125|FG001|Overall Study|Adverse Event|0|||
30754530|NCT04539262|58764126|FG002|Overall Study|Adverse Event|1|||
30754531|NCT04539262|58764127|FG003|Overall Study|Adverse Event|0|||
30754532|NCT04539262|58764128|FG004|Overall Study|Adverse Event|0|||
30754533|NCT04539262|58764129|FG005|Overall Study|Adverse Event|0|||
30754534|NCT04539262|58764130|FG006|Overall Study|Adverse Event|0|||
30754535|NCT04539262|58764131|FG007|Overall Study|Adverse Event|0|||
30754536|NCT04539262|58764124|FG000|Overall Study|Withdrew Consent|0|||
30754537|NCT04539262|58764125|FG001|Overall Study|Withdrew Consent|0|||
30754538|NCT04539262|58764126|FG002|Overall Study|Withdrew Consent|0|||
30754539|NCT04539262|58764127|FG003|Overall Study|Withdrew Consent|1|||
30827951|NCT00870818|58850749|FG003|Overall Study|Lost to Follow-up|0|||
30827952|NCT00870818|58850750|FG004|Overall Study|Lost to Follow-up|0|||
30827953|NCT00870818|58850746|FG000|Overall Study|Withdrawal by Subject|0|||
30827954|NCT00870818|58850747|FG001|Overall Study|Withdrawal by Subject|0|||
30827955|NCT00870818|58850748|FG002|Overall Study|Withdrawal by Subject|1|||
30827956|NCT00870818|58850749|FG003|Overall Study|Withdrawal by Subject|2|||
30827957|NCT00870818|58850750|FG004|Overall Study|Withdrawal by Subject|0|||
30827958|NCT00870818|58850746|FG000|Overall Study|Terminated by sponsor|29|||
30827959|NCT00870818|58850747|FG001|Overall Study|Terminated by sponsor|70|||
30827960|NCT00870818|58850748|FG002|Overall Study|Terminated by sponsor|36|||
30827961|NCT00870818|58850749|FG003|Overall Study|Terminated by sponsor|36|||
30827962|NCT00870818|58850750|FG004|Overall Study|Terminated by sponsor|38|||
30827963|NCT00870818|58850746|FG000|Overall Study|Other|0|||
30827964|NCT00870818|58850747|FG001|Overall Study|Other|1|||
30827965|NCT00870818|58850748|FG002|Overall Study|Other|0|||
30827966|NCT00870818|58850749|FG003|Overall Study|Other|0|||
30827967|NCT00870818|58850750|FG004|Overall Study|Other|0|||
30827968|NCT03075761|58850764|FG000|Overall Study|Lost to Follow-up|1|||
30827969|NCT03075761|58850765|FG001|Overall Study|Lost to Follow-up|6|||
30827970|NCT03000075|58850779|FG000|Part A|Adverse Event|4|||
30827971|NCT03000075|58850780|FG001|Part A|Adverse Event|0|||
30827972|NCT03000075|58850781|FG002|Part A|Adverse Event|0|||
30827973|NCT03000075|58850782|FG003|Part A|Adverse Event|0|||
30827974|NCT03000075|58850783|FG004|Part A|Adverse Event|0|||
30827975|NCT03000075|58850784|FG005|Part A|Adverse Event|0|||
30827976|NCT03000075|58850785|FG006|Part A|Adverse Event|0|||
30827977|NCT03000075|58850779|FG000|Part B|Not dosed due to AE|0|||
30827978|NCT03000075|58850780|FG001|Part B|Not dosed due to AE|0|||
30827979|NCT03000075|58850781|FG002|Part B|Not dosed due to AE|0|||
30827980|NCT03000075|58850782|FG003|Part B|Not dosed due to AE|0|||
30827981|NCT03000075|58850783|FG004|Part B|Not dosed due to AE|0|||
30827982|NCT03000075|58850784|FG005|Part B|Not dosed due to AE|2|||
30827983|NCT03000075|58850785|FG006|Part B|Not dosed due to AE|1|||
30827984|NCT03000075|58850779|FG000|Part B|Adverse Event|0|||
30827985|NCT03000075|58850780|FG001|Part B|Adverse Event|0|||
30827986|NCT03000075|58850781|FG002|Part B|Adverse Event|0|||
30827987|NCT03000075|58850782|FG003|Part B|Adverse Event|0|||
30827988|NCT03000075|58850783|FG004|Part B|Adverse Event|1|||
30827989|NCT03000075|58850784|FG005|Part B|Adverse Event|0|||
30827990|NCT03000075|58850785|FG006|Part B|Adverse Event|0|||
30827991|NCT03073109|58850803|FG000|Overall Study|Adverse Event|0|||
30827992|NCT03073109|58850804|FG001|Overall Study|Adverse Event|1|||
30827993|NCT03073109|58850803|FG000|Overall Study|Other|2|||
30827994|NCT03073109|58850804|FG001|Overall Study|Other|0|||
30827995|NCT03073109|58850803|FG000|Overall Study|Lost to Follow-up|8|||
30827996|NCT03073109|58850804|FG001|Overall Study|Lost to Follow-up|1|||
30827997|NCT02371889|58850826|FG000|Overall Study|Adverse medication effect|11|||
30827998|NCT02371889|58850827|FG001|Overall Study|Adverse medication effect|2|||
30827999|NCT02371889|58850826|FG000|Overall Study|Lost to Follow-up|6|||
30828000|NCT02371889|58850827|FG001|Overall Study|Lost to Follow-up|5|||
30828001|NCT02371889|58850826|FG000|Overall Study|Personal time constraints|2|||
30828002|NCT02371889|58850827|FG001|Overall Study|Personal time constraints|4|||
30754540|NCT04539262|58764128|FG004|Overall Study|Withdrew Consent|0|||
30754541|NCT04539262|58764129|FG005|Overall Study|Withdrew Consent|0|||
30754542|NCT04539262|58764130|FG006|Overall Study|Withdrew Consent|0|||
30754543|NCT04539262|58764131|FG007|Overall Study|Withdrew Consent|0|||
30754544|NCT04539262|58764124|FG000|Overall Study|Randomized, Not treated|0|||
30754545|NCT04539262|58764125|FG001|Overall Study|Randomized, Not treated|1|||
30754546|NCT04539262|58764126|FG002|Overall Study|Randomized, Not treated|0|||
30754547|NCT04539262|58764127|FG003|Overall Study|Randomized, Not treated|0|||
30754548|NCT04539262|58764128|FG004|Overall Study|Randomized, Not treated|0|||
30754549|NCT04539262|58764129|FG005|Overall Study|Randomized, Not treated|0|||
30754550|NCT04539262|58764130|FG006|Overall Study|Randomized, Not treated|1|||
30754551|NCT04539262|58764131|FG007|Overall Study|Randomized, Not treated|0|||
30754552|NCT03702010|58764154|FG000|Follow-up (30days)|Lack of Efficacy|2|||
30754553|NCT03702010|58764155|FG001|Follow-up (30days)|Lack of Efficacy|2|||
30828003|NCT02371889|58850826|FG000|Overall Study|Lack of Efficacy|0|||
30828004|NCT02371889|58850827|FG001|Overall Study|Lack of Efficacy|2|||
30828005|NCT02371889|58850826|FG000|Overall Study|Relapse|0|||
30828006|NCT02371889|58850827|FG001|Overall Study|Relapse|1|||
30828007|NCT03072875|58850837|FG000|Overall Study|Lost to Follow-up|1|||
30828008|NCT04250077|58850845|FG000|Overall Study|Withdrawal by Subject|0|||
30828009|NCT04250077|58850846|FG001|Overall Study|Withdrawal by Subject|1|||
30828010|NCT04250077|58850847|FG002|Overall Study|Withdrawal by Subject|0|||
30828011|NCT04250077|58850845|FG000|Overall Study|Lost to Follow-up|2|||
30828012|NCT04250077|58850846|FG001|Overall Study|Lost to Follow-up|3|||
30828013|NCT04250077|58850847|FG002|Overall Study|Lost to Follow-up|0|||
30754554|NCT04538170|58764169|FG000|Overall Study|Withdrawal by Subject|104|||
30754555|NCT04538170|58764170|FG001|Overall Study|Withdrawal by Subject|210|||
30754556|NCT04537234|58764182|FG000|Overall Study|Withdrawal by Subject|2|||
30828014|NCT00859430|58850859|FG000|First Intervention|Withdrawal by Subject|0|||
30828015|NCT00859430|58850860|FG001|First Intervention|Withdrawal by Subject|1|||
30828016|NCT02913105|58850877|FG000|Overall Study|Adverse Event|11|||
30828017|NCT02913105|58850878|FG001|Overall Study|Adverse Event|0|||
30828018|NCT02913105|58850879|FG002|Overall Study|Adverse Event|4|||
30828019|NCT02913105|58850877|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30828020|NCT02913105|58850878|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30828021|NCT02913105|58850879|FG002|Overall Study|Non-Compliance With Study Drug|1|||
30754557|NCT04537234|58764183|FG001|Overall Study|Withdrawal by Subject|0|||
30754558|NCT04537078|58764191|FG000|Overall Study|Protocol Violation|3|||
30754559|NCT04537078|58764192|FG001|Overall Study|Protocol Violation|2|||
30754560|NCT04537078|58764191|FG000|Overall Study|Lost to Follow-up|1|||
30754561|NCT04537078|58764192|FG001|Overall Study|Lost to Follow-up|0|||
30754562|NCT04537078|58764191|FG000|Overall Study|Withdrawal by Subject|0|||
30754563|NCT04537078|58764192|FG001|Overall Study|Withdrawal by Subject|1|||
30754564|NCT04532164|58764205|FG000|Overall Study|Adverse Event|1|||
30754565|NCT04532164|58764205|FG000|Overall Study|Protocol Violation|5|||
30828022|NCT02913105|58850877|FG000|Overall Study|Reason Not Specified|3|||
30828023|NCT02913105|58850878|FG001|Overall Study|Reason Not Specified|1|||
30828024|NCT02913105|58850879|FG002|Overall Study|Reason Not Specified|1|||
30828025|NCT02913105|58850877|FG000|Overall Study|Physician Decision|1|||
30828026|NCT02913105|58850878|FG001|Overall Study|Physician Decision|1|||
30828027|NCT02913105|58850879|FG002|Overall Study|Physician Decision|0|||
30828028|NCT02913105|58850877|FG000|Overall Study|Withdrawal by Subject|0|||
30828029|NCT02913105|58850878|FG001|Overall Study|Withdrawal by Subject|3|||
30828030|NCT02913105|58850879|FG002|Overall Study|Withdrawal by Subject|1|||
30828031|NCT00840632|58850897|FG000|First Intervention|Withdrawal by Subject|0|||
30828032|NCT00840632|58850898|FG001|First Intervention|Withdrawal by Subject|1|||
30828033|NCT00840632|58850897|FG000|Washout|Withdrawal by Subject|1|||
30828034|NCT00840632|58850898|FG001|Washout|Withdrawal by Subject|1|||
30828035|NCT01602562|58850915|FG000|Overall Study|Adverse Event|3|||
30828036|NCT01602562|58850916|FG001|Overall Study|Adverse Event|1|||
30828037|NCT01602562|58850915|FG000|Overall Study|Physician Decision|1|||
30828038|NCT01602562|58850916|FG001|Overall Study|Physician Decision|1|||
30828039|NCT01602562|58850915|FG000|Overall Study|Withdrawal by Subject|1|||
30828040|NCT01602562|58850916|FG001|Overall Study|Withdrawal by Subject|1|||
30828041|NCT01945775|58850925|FG000|Overall Study|Death|214|||
30828042|NCT01945775|58850926|FG001|Overall Study|Death|98|||
30828043|NCT01945775|58850925|FG000|Overall Study|Lost to Follow-up|12|||
30828044|NCT01945775|58850926|FG001|Overall Study|Lost to Follow-up|7|||
30828045|NCT01945775|58850925|FG000|Overall Study|Withdrawal by Subject|11|||
30828046|NCT01945775|58850926|FG001|Overall Study|Withdrawal by Subject|21|||
30828047|NCT01945775|58850925|FG000|Overall Study|Other|50|||
30828048|NCT01945775|58850926|FG001|Overall Study|Other|18|||
30921658|NCT01854645|58956925|FG000|Overall Study|Lost to Follow-up|10|||
30921659|NCT01854645|58956926|FG001|Overall Study|Lost to Follow-up|7|||
30828049|NCT03072719|58850954|FG000|Overall Study|Adverse Event|1|||
30828050|NCT03072719|58850955|FG001|Overall Study|Adverse Event|1|||
30828051|NCT00835796|58850963|FG000|First Intervention|Withdrawal by Subject|0|||
30828052|NCT00835796|58850964|FG001|First Intervention|Withdrawal by Subject|1|||
30828053|NCT00835640|58850970|FG000|Second Intervention|Protocol Violation|1|||
30828054|NCT00835640|58850971|FG001|Second Intervention|Protocol Violation|0|||
30828055|NCT02942017|58850977|FG000|Overall Study|Adverse Event|0|||
30828056|NCT02942017|58850978|FG001|Overall Study|Adverse Event|1|||
30828057|NCT02942017|58850977|FG000|Overall Study|Withdrawal by Subject|0|||
30828058|NCT02942017|58850978|FG001|Overall Study|Withdrawal by Subject|1|||
30828059|NCT02942017|58850977|FG000|Overall Study|Lost to Follow-up|1|||
30828060|NCT02942017|58850978|FG001|Overall Study|Lost to Follow-up|1|||
30828061|NCT02942017|58850977|FG000|Overall Study|Randomized but not dosed|1|||
30828062|NCT02942017|58850978|FG001|Overall Study|Randomized but not dosed|3|||
30828063|NCT00835406|58850993|FG000|Period: First Intervention|Adverse Event|0|||
30828064|NCT00835406|58850994|FG001|Period: First Intervention|Adverse Event|1|||
30828065|NCT00835406|58850993|FG000|Period: First Intervention|Withdrawal by Subject|2|||
30828066|NCT00835406|58850994|FG001|Period: First Intervention|Withdrawal by Subject|0|||
30828067|NCT00835406|58850993|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
30921660|NCT01854645|58956927|FG002|Overall Study|Lost to Follow-up|8|||
30921661|NCT01854645|58956928|FG003|Overall Study|Lost to Follow-up|5|||
30754566|NCT04532164|58764205|FG000|Overall Study|Lost to Follow-up|1|||
30754567|NCT04532164|58764205|FG000|Overall Study|Found to be Ineligible|3|||
30754568|NCT04532164|58764205|FG000|Overall Study|Withdrawal by Subject|14|||
30828068|NCT00835406|58850994|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
30828069|NCT00835172|58851000|FG000|Washout|Protocol Violation|0|||
30828070|NCT00835172|58851001|FG001|Washout|Protocol Violation|1|||
30828071|NCT01676116|58851007|FG000|Overall Study|Withdrawal criteria|2|||
30828072|NCT01676116|58851008|FG001|Overall Study|Withdrawal criteria|14|||
30754569|NCT00116688|58764212|FG000|Overall Study|Protocol deviation|1|||
30828073|NCT01676116|58851007|FG000|Overall Study|Adverse Event|1|||
30828074|NCT01676116|58851008|FG001|Overall Study|Adverse Event|2|||
30828075|NCT01676116|58851007|FG000|Overall Study|Unclassified|4|||
30921662|NCT01854645|58956929|FG004|Overall Study|Lost to Follow-up|0|||
30754570|NCT00116688|58764213|FG001|Overall Study|Protocol deviation|0|||
30754571|NCT00116688|58764212|FG000|Overall Study|Noncompliance|3|||
30754572|NCT00116688|58764213|FG001|Overall Study|Noncompliance|1|||
30754573|NCT00116688|58764212|FG000|Overall Study|Adverse Event|11|||
30754574|NCT00116688|58764213|FG001|Overall Study|Adverse Event|0|||
30754575|NCT00116688|58764212|FG000|Overall Study|Withdrawal by Subject|26|||
30754576|NCT00116688|58764213|FG001|Overall Study|Withdrawal by Subject|2|||
30754577|NCT00116688|58764212|FG000|Overall Study|Requirement for alternative therapy|11|||
30754578|NCT00116688|58764213|FG001|Overall Study|Requirement for alternative therapy|1|||
30754579|NCT00116688|58764212|FG000|Overall Study|Physician Decision|7|||
30754580|NCT00116688|58764213|FG001|Overall Study|Physician Decision|0|||
30754581|NCT00116688|58764212|FG000|Overall Study|Lost to Follow-up|3|||
30754582|NCT00116688|58764213|FG001|Overall Study|Lost to Follow-up|0|||
30754583|NCT00116688|58764212|FG000|Overall Study|Death|15|||
30754584|NCT00116688|58764213|FG001|Overall Study|Death|0|||
30828076|NCT01676116|58851008|FG001|Overall Study|Unclassified|10|||
30828077|NCT01676116|58851007|FG000|Overall Study|Protocol Violation|9|||
30828078|NCT01676116|58851008|FG001|Overall Study|Protocol Violation|3|||
30828079|NCT00740480|58851014|FG000|Overall Study|Adverse Event|1|||
30828080|NCT00740480|58851014|FG000|Overall Study|Physician Decision|1|||
30828081|NCT02743520|58851017|FG000|Overall Study|Withdrawal by Subject|1|||
30828082|NCT03001557|58851036|FG000|Core Phase|Randomized but not treated|0|||
30828083|NCT03001557|58851037|FG001|Core Phase|Randomized but not treated|0|||
30828084|NCT03001557|58851038|FG002|Core Phase|Randomized but not treated|1|||
30828085|NCT03001557|58851039|FG003|Core Phase|Randomized but not treated|0|||
30828086|NCT03001557|58851040|FG004|Core Phase|Randomized but not treated|0|||
30828087|NCT03001557|58851041|FG005|Core Phase|Randomized but not treated|0|||
30828088|NCT03001557|58851042|FG006|Core Phase|Randomized but not treated|0|||
30828089|NCT03001557|58851043|FG007|Core Phase|Randomized but not treated|0|||
30828090|NCT03001557|58851036|FG000|Extension Phase|Adverse Event|0|||
30828091|NCT03001557|58851037|FG001|Extension Phase|Adverse Event|0|||
30828092|NCT03001557|58851038|FG002|Extension Phase|Adverse Event|0|||
30828093|NCT03001557|58851039|FG003|Extension Phase|Adverse Event|0|||
30828094|NCT03001557|58851040|FG004|Extension Phase|Adverse Event|0|||
30828095|NCT03001557|58851041|FG005|Extension Phase|Adverse Event|2|||
30828096|NCT03001557|58851042|FG006|Extension Phase|Adverse Event|0|||
30828097|NCT03001557|58851043|FG007|Extension Phase|Adverse Event|0|||
30828098|NCT03001557|58851036|FG000|Extension Phase|Withdrawal by Subject|0|||
30828099|NCT03001557|58851037|FG001|Extension Phase|Withdrawal by Subject|0|||
30828100|NCT03001557|58851038|FG002|Extension Phase|Withdrawal by Subject|0|||
30828101|NCT03001557|58851039|FG003|Extension Phase|Withdrawal by Subject|0|||
30828102|NCT03001557|58851040|FG004|Extension Phase|Withdrawal by Subject|0|||
30828103|NCT03001557|58851041|FG005|Extension Phase|Withdrawal by Subject|1|||
30828104|NCT03001557|58851042|FG006|Extension Phase|Withdrawal by Subject|5|||
30828105|NCT03001557|58851043|FG007|Extension Phase|Withdrawal by Subject|2|||
30828106|NCT03001557|58851036|FG000|Extension Phase|Lost to Follow-up|0|||
30828107|NCT03001557|58851037|FG001|Extension Phase|Lost to Follow-up|0|||
30828108|NCT03001557|58851038|FG002|Extension Phase|Lost to Follow-up|0|||
30828109|NCT03001557|58851039|FG003|Extension Phase|Lost to Follow-up|0|||
30921663|NCT01854645|58956925|FG000|Overall Study|Physician Decision|1|||
30921664|NCT01854645|58956926|FG001|Overall Study|Physician Decision|5|||
30828110|NCT03001557|58851040|FG004|Extension Phase|Lost to Follow-up|0|||
30828111|NCT03001557|58851041|FG005|Extension Phase|Lost to Follow-up|0|||
30828112|NCT03001557|58851042|FG006|Extension Phase|Lost to Follow-up|2|||
30828113|NCT03001557|58851043|FG007|Extension Phase|Lost to Follow-up|1|||
30828114|NCT03001557|58851036|FG000|Extension Phase|Administrative Reason|0|||
30828115|NCT03001557|58851037|FG001|Extension Phase|Administrative Reason|0|||
30921665|NCT01854645|58956927|FG002|Overall Study|Physician Decision|3|||
30828116|NCT03001557|58851038|FG002|Extension Phase|Administrative Reason|0|||
30828117|NCT03001557|58851039|FG003|Extension Phase|Administrative Reason|0|||
30828118|NCT03001557|58851040|FG004|Extension Phase|Administrative Reason|0|||
30921666|NCT01854645|58956928|FG003|Overall Study|Physician Decision|3|||
30754585|NCT00116688|58764212|FG000|Overall Study|Protocol-specified criteria|3|||
30754586|NCT00116688|58764213|FG001|Overall Study|Protocol-specified criteria|0|||
30828119|NCT03001557|58851041|FG005|Extension Phase|Administrative Reason|1|||
30828120|NCT03001557|58851042|FG006|Extension Phase|Administrative Reason|3|||
30828121|NCT03001557|58851043|FG007|Extension Phase|Administrative Reason|3|||
30828122|NCT03001557|58851036|FG000|Extension Phase|Loss of caregiver|0|||
30828123|NCT03001557|58851037|FG001|Extension Phase|Loss of caregiver|0|||
30828124|NCT03001557|58851038|FG002|Extension Phase|Loss of caregiver|0|||
30828125|NCT03001557|58851039|FG003|Extension Phase|Loss of caregiver|0|||
30828126|NCT03001557|58851040|FG004|Extension Phase|Loss of caregiver|0|||
30828127|NCT03001557|58851041|FG005|Extension Phase|Loss of caregiver|0|||
30828128|NCT03001557|58851042|FG006|Extension Phase|Loss of caregiver|1|||
30828129|NCT03001557|58851043|FG007|Extension Phase|Loss of caregiver|0|||
30828130|NCT03001557|58851036|FG000|Extension Phase|Others|0|||
30828131|NCT03001557|58851037|FG001|Extension Phase|Others|0|||
30828132|NCT03001557|58851038|FG002|Extension Phase|Others|0|||
30828133|NCT03001557|58851039|FG003|Extension Phase|Others|0|||
30828134|NCT03001557|58851040|FG004|Extension Phase|Others|0|||
30828135|NCT03001557|58851041|FG005|Extension Phase|Others|1|||
30828136|NCT03001557|58851042|FG006|Extension Phase|Others|3|||
30828137|NCT03001557|58851043|FG007|Extension Phase|Others|0|||
30828138|NCT00830336|58851080|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
30828139|NCT00830336|58851081|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
30828140|NCT00830258|58851087|FG000|First Intervention|Adverse Event|1|||
30828141|NCT00830258|58851088|FG001|First Intervention|Adverse Event|0|||
30828142|NCT00830258|58851087|FG000|Washout: 7 Days|Protocol Violation|1|||
30828143|NCT00830258|58851088|FG001|Washout: 7 Days|Protocol Violation|0|||
30828144|NCT03349775|58851094|FG000|Overall Study|Side Effects|1|||
30828145|NCT03349775|58851095|FG001|Overall Study|Side Effects|2|||
30828146|NCT03349775|58851094|FG000|Overall Study|Withdrawal by Subject|1|||
30828147|NCT03349775|58851095|FG001|Overall Study|Withdrawal by Subject|1|||
30828148|NCT03349775|58851094|FG000|Overall Study|No primary outcome measurements|0|||
30828149|NCT03349775|58851095|FG001|Overall Study|No primary outcome measurements|1|||
30828150|NCT00830024|58851103|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
30828151|NCT00830024|58851104|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
30828152|NCT00829868|58851110|FG000|Washout|Physician Decision|1|||
30828153|NCT00829868|58851111|FG001|Washout|Physician Decision|0|||
30828154|NCT00829790|58851117|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
30828155|NCT00829790|58851118|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
30828156|NCT03207815|58851124|FG000|Overall Study|Protocol Violation|3|||
30828157|NCT03207815|58851125|FG001|Overall Study|Protocol Violation|1|||
30828158|NCT03207815|58851124|FG000|Overall Study|Adverse Event|1|||
30828159|NCT03207815|58851125|FG001|Overall Study|Adverse Event|2|||
30828160|NCT03207815|58851124|FG000|Overall Study|Lost to Follow-up|1|||
30828161|NCT03207815|58851125|FG001|Overall Study|Lost to Follow-up|2|||
30828162|NCT03207815|58851124|FG000|Overall Study|Investigator's Discretion|1|||
30828163|NCT03207815|58851125|FG001|Overall Study|Investigator's Discretion|1|||
30828164|NCT03207815|58851124|FG000|Overall Study|Lack of Efficacy|0|||
30828165|NCT03207815|58851125|FG001|Overall Study|Lack of Efficacy|1|||
30828166|NCT03207815|58851124|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
30828167|NCT03207815|58851125|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
30828168|NCT03207815|58851124|FG000|Overall Study|Withdrew Consent|1|||
30828169|NCT03207815|58851125|FG001|Overall Study|Withdrew Consent|0|||
30828170|NCT02911935|58851133|FG000|Overall Study|Lost to Follow-up|5|||
30828171|NCT02911935|58851134|FG001|Overall Study|Lost to Follow-up|7|||
30828172|NCT00829712|58851142|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
30921667|NCT01854645|58956929|FG004|Overall Study|Physician Decision|7|||
30921668|NCT01854645|58956925|FG000|Overall Study|Withdrawal by Subject|31|||
30921669|NCT01854645|58956926|FG001|Overall Study|Withdrawal by Subject|41|||
30921670|NCT01854645|58956927|FG002|Overall Study|Withdrawal by Subject|30|||
30828173|NCT00829712|58851143|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
30828174|NCT03069989|58851158|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
30828175|NCT03069989|58851159|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
30921671|NCT01854645|58956928|FG003|Overall Study|Withdrawal by Subject|21|||
30921672|NCT01854645|58956929|FG004|Overall Study|Withdrawal by Subject|24|||
30921673|NCT01854645|58956925|FG000|Overall Study|Lack of Efficacy|7|||
30921674|NCT01854645|58956926|FG001|Overall Study|Lack of Efficacy|12|||
30921675|NCT01854645|58956927|FG002|Overall Study|Lack of Efficacy|9|||
30921676|NCT01854645|58956928|FG003|Overall Study|Lack of Efficacy|3|||
30828176|NCT02698163|58851186|FG000|Overall Study|Lost to Follow-up|0|||
30828177|NCT02698163|58851187|FG001|Overall Study|Lost to Follow-up|1|||
30828178|NCT03817190|58851195|FG000|Overall Study|Early Termination|13|||
30921677|NCT01854645|58956929|FG004|Overall Study|Lack of Efficacy|9|||
30921678|NCT01854645|58956925|FG000|Overall Study|Adverse Event|33|||
30828179|NCT03817190|58851196|FG001|Overall Study|Early Termination|20|||
30828180|NCT03817190|58851195|FG000|Overall Study|Adverse Event|10|||
30828181|NCT03817190|58851196|FG001|Overall Study|Adverse Event|17|||
30828182|NCT03817190|58851195|FG000|Overall Study|Withdrawal by Subject|12|||
30828183|NCT03817190|58851196|FG001|Overall Study|Withdrawal by Subject|8|||
30828184|NCT03817190|58851195|FG000|Overall Study|Lost to Follow-up|11|||
30828185|NCT03817190|58851196|FG001|Overall Study|Lost to Follow-up|7|||
30828186|NCT03817190|58851195|FG000|Overall Study|Lack of Efficacy|7|||
30828187|NCT03817190|58851196|FG001|Overall Study|Lack of Efficacy|5|||
30828188|NCT03817190|58851195|FG000|Overall Study|Investigator Decision|5|||
30828189|NCT03817190|58851196|FG001|Overall Study|Investigator Decision|1|||
30828190|NCT03817190|58851195|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
30828191|NCT03817190|58851196|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
30828192|NCT03817190|58851195|FG000|Overall Study|Lack of Contact|1|||
30828193|NCT03817190|58851196|FG001|Overall Study|Lack of Contact|0|||
30828194|NCT03817190|58851195|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
30828195|NCT03817190|58851196|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
30828196|NCT03797222|58851215|FG000|Overall Study|Withdrawal by Subject|1|||
30828197|NCT02742818|58851225|FG000|Overall Study|Adverse Event|0|||
30828198|NCT02742818|58851226|FG001|Overall Study|Adverse Event|1|||
30828199|NCT02742818|58851225|FG000|Overall Study|Protocol Violation|0|||
30828200|NCT02742818|58851226|FG001|Overall Study|Protocol Violation|1|||
30828201|NCT03069365|58851234|FG000|Overall Study|Adverse Event|1|||
30828202|NCT03065933|58851238|FG000|Overall Study|study terminated|5|||
30828203|NCT04256629|58851248|FG000|Overall Study|Adverse Event|0|||
30828204|NCT04256629|58851249|FG001|Overall Study|Adverse Event|0|||
30828205|NCT04256629|58851250|FG002|Overall Study|Adverse Event|0|||
30828206|NCT04256629|58851251|FG003|Overall Study|Adverse Event|0|||
30828207|NCT04256629|58851252|FG004|Overall Study|Adverse Event|0|||
30828208|NCT04256629|58851253|FG005|Overall Study|Adverse Event|1|||
30828209|NCT04256629|58851248|FG000|Overall Study|Protocol Violation|0|||
30828210|NCT04256629|58851249|FG001|Overall Study|Protocol Violation|1|||
30828211|NCT04256629|58851250|FG002|Overall Study|Protocol Violation|0|||
30828212|NCT04256629|58851251|FG003|Overall Study|Protocol Violation|0|||
30828213|NCT04256629|58851252|FG004|Overall Study|Protocol Violation|0|||
30828214|NCT04256629|58851253|FG005|Overall Study|Protocol Violation|0|||
30828215|NCT01346293|58851263|FG000|Overall Study|Protocol Violation|30|||
30828216|NCT01346293|58851264|FG001|Overall Study|Protocol Violation|9|||
30828217|NCT01346293|58851263|FG000|Overall Study|Lost to Follow-up|21|||
30754587|NCT00116688|58764212|FG000|Overall Study|Pregnancy|1|||
30754588|NCT00116688|58764213|FG001|Overall Study|Pregnancy|0|||
30754589|NCT00116688|58764212|FG000|Overall Study|Other|11|||
30754590|NCT00116688|58764213|FG001|Overall Study|Other|0|||
30828218|NCT01346293|58851264|FG001|Overall Study|Lost to Follow-up|8|||
30828219|NCT01346293|58851263|FG000|Overall Study|Withdrawal by Subject|15|||
30828220|NCT01346293|58851264|FG001|Overall Study|Withdrawal by Subject|4|||
30828221|NCT01346293|58851263|FG000|Overall Study|Other|1|||
30828222|NCT01346293|58851264|FG001|Overall Study|Other|0|||
30828223|NCT03502187|58851275|FG000|Overall Study|Withdrawal by Subject|4|||
30828224|NCT03502187|58851276|FG001|Overall Study|Withdrawal by Subject|3|||
30828225|NCT03502187|58851277|FG002|Overall Study|Withdrawal by Subject|3|||
30828226|NCT03502187|58851275|FG000|Overall Study|Lost to Follow-up|5|||
30828227|NCT03502187|58851276|FG001|Overall Study|Lost to Follow-up|4|||
30828228|NCT03502187|58851277|FG002|Overall Study|Lost to Follow-up|5|||
30828229|NCT03058705|58851285|FG000|Overall Study|Withdrawal by Subject|2|||
30828230|NCT03058705|58851285|FG000|Overall Study|Physician Decision|2|||
30828231|NCT02998671|58851294|FG000|Period 1|Study Terminated By Sponsor|2|||
30828232|NCT02998671|58851295|FG001|Period 1|Study Terminated By Sponsor|1|||
30921679|NCT01854645|58956926|FG001|Overall Study|Adverse Event|31|||
30921680|NCT01854645|58956927|FG002|Overall Study|Adverse Event|19|||
30754591|NCT04531540|58764219|FG000|Overall Study|Adverse Event|1|||
30754592|NCT04531540|58764219|FG000|Overall Study|Protocol Violation|3|||
30754593|NCT04531540|58764219|FG000|Overall Study|Withdrawal by Subject|4|||
30754594|NCT04531540|58764219|FG000|Overall Study|Found to be Ineligible|1|||
30754595|NCT04799782|58764223|FG000|Washout|Physician Decision|2|||
30754596|NCT04799782|58764224|FG001|Washout|Physician Decision|0|||
30754597|NCT04799782|58764223|FG000|Washout|Withdrawal by Subject|0|||
30754598|NCT04799782|58764224|FG001|Washout|Withdrawal by Subject|2|||
30754599|NCT04799782|58764223|FG000|Washout|Lost to Follow-up|0|||
30754600|NCT04799782|58764224|FG001|Washout|Lost to Follow-up|1|||
30754601|NCT03697252|58764232|FG000|Overall Study|Adverse Event|3|||
30754602|NCT03697252|58764233|FG001|Overall Study|Adverse Event|2|||
30754603|NCT03697252|58764232|FG000|Overall Study|Withdrawal by Subject|14|||
30828233|NCT02998671|58851296|FG002|Period 1|Study Terminated By Sponsor|0|||
30828234|NCT02998671|58851297|FG003|Period 1|Study Terminated By Sponsor|0|||
30828235|NCT02998671|58851298|FG004|Period 1|Study Terminated By Sponsor|1|||
30828236|NCT02998671|58851294|FG000|Period 1|Withdrawal by Subject|1|||
30828237|NCT02998671|58851295|FG001|Period 1|Withdrawal by Subject|2|||
30828238|NCT02998671|58851296|FG002|Period 1|Withdrawal by Subject|0|||
30828239|NCT02998671|58851297|FG003|Period 1|Withdrawal by Subject|0|||
30828240|NCT02998671|58851298|FG004|Period 1|Withdrawal by Subject|2|||
30828241|NCT02998671|58851294|FG000|Period 1|Pregnancy|1|||
30828242|NCT02998671|58851295|FG001|Period 1|Pregnancy|0|||
30828243|NCT02998671|58851296|FG002|Period 1|Pregnancy|0|||
30828244|NCT02998671|58851297|FG003|Period 1|Pregnancy|0|||
30828245|NCT02998671|58851298|FG004|Period 1|Pregnancy|0|||
30828246|NCT02998671|58851294|FG000|Period 1|Adverse Event|0|||
30828247|NCT02998671|58851295|FG001|Period 1|Adverse Event|0|||
30828248|NCT02998671|58851296|FG002|Period 1|Adverse Event|0|||
30828249|NCT02998671|58851297|FG003|Period 1|Adverse Event|0|||
30828250|NCT02998671|58851298|FG004|Period 1|Adverse Event|1|||
30828251|NCT02998671|58851294|FG000|Period 2|Adverse Event|0|||
30828252|NCT02998671|58851295|FG001|Period 2|Adverse Event|1|||
30828253|NCT02998671|58851296|FG002|Period 2|Adverse Event|0|||
30754604|NCT03697252|58764233|FG001|Overall Study|Withdrawal by Subject|14|||
30754605|NCT03697252|58764232|FG000|Overall Study|Lost to Follow-up|0|||
30921681|NCT01854645|58956928|FG003|Overall Study|Adverse Event|20|||
30921682|NCT01854645|58956929|FG004|Overall Study|Adverse Event|11|||
30921683|NCT01825941|58956943|FG000|Overall Study|Lost to Follow-up|4|||
30921684|NCT01825941|58956944|FG001|Overall Study|Lost to Follow-up|1|||
30921685|NCT02064205|58956950|FG000|Overall Study|Withdrawal by Subject|1|||
30921686|NCT02090959|58956966|FG000|Overall Study|Withdrawal by Subject|10|||
30921687|NCT02090959|58956966|FG000|Overall Study|Adverse Event|1|||
30921688|NCT02090959|58956966|FG000|Overall Study|Investigator decision|2|||
30921689|NCT02090959|58956966|FG000|Overall Study|Study termination|6|||
30921690|NCT02090959|58956966|FG000|Overall Study|Enrolled but not treated|1|||
30921691|NCT02090959|58956966|FG000|Overall Study|Transfer for compassionate use medicine|4|||
30921692|NCT02090959|58956966|FG000|Overall Study|Move to medical need program|3|||
30921693|NCT02090959|58956966|FG000|Overall Study|Entered in to other study|34|||
30921694|NCT02090959|58956966|FG000|Overall Study|Switched to commercial supply|88|||
30921695|NCT02090959|58956966|FG000|Overall Study|Other than specified|2|||
30921696|NCT02044159|58956972|FG000|Overall Study|Consent declined (deferred consent)|2|||
30921697|NCT02044159|58956973|FG001|Overall Study|Consent declined (deferred consent)|4|||
30921698|NCT02044159|58956972|FG000|Overall Study|No longer eligible, drug not given|1|||
30828254|NCT02998671|58851297|FG003|Period 2|Adverse Event|0|||
30828255|NCT02998671|58851298|FG004|Period 2|Adverse Event|0|||
30828256|NCT02998671|58851294|FG000|Period 2|Study Terminated By Sponsor|3|||
30828257|NCT02998671|58851295|FG001|Period 2|Study Terminated By Sponsor|5|||
30828258|NCT02998671|58851296|FG002|Period 2|Study Terminated By Sponsor|1|||
30921699|NCT02044159|58956973|FG001|Overall Study|No longer eligible, drug not given|0|||
30754606|NCT03697252|58764233|FG001|Overall Study|Lost to Follow-up|1|||
30754607|NCT03697252|58764232|FG000|Overall Study|Physician Decision|1|||
30921700|NCT02044159|58956972|FG000|Overall Study|Nurse declined to give study drug|1|||
30921701|NCT02044159|58956973|FG001|Overall Study|Nurse declined to give study drug|0|||
30921702|NCT02090725|58956982|FG000|Overall Study|Withdrawal by Subject|1|||
30921703|NCT02090725|58956982|FG000|Overall Study|participants moved from area|3|||
30921704|NCT02180165|58956990|FG000|Overall Study|Not Treated|0|||
30921705|NCT02180165|58956991|FG001|Overall Study|Not Treated|0|||
30921706|NCT02180165|58956992|FG002|Overall Study|Not Treated|1|||
30921707|NCT02180165|58956993|FG003|Overall Study|Not Treated|0|||
30921708|NCT02180165|58956990|FG000|Overall Study|Adverse Event|7|||
30921709|NCT02180165|58956991|FG001|Overall Study|Adverse Event|0|||
30754608|NCT03697252|58764233|FG001|Overall Study|Physician Decision|1|||
30754609|NCT03697252|58764232|FG000|Overall Study|Other|0|||
30754610|NCT03697252|58764233|FG001|Overall Study|Other|1|||
30754611|NCT03701074|58764241|FG000|Overall Study|Physician Decision|1|||
30754612|NCT03701074|58764242|FG001|Overall Study|Physician Decision|0|||
30754613|NCT04728802|58764250|FG000|Overall Study|Withdrawal by Subject|4|||
30754614|NCT04728802|58764251|FG001|Overall Study|Withdrawal by Subject|20|||
30754615|NCT04728802|58764250|FG000|Overall Study|Physician Decision|7|||
30921710|NCT02180165|58956992|FG002|Overall Study|Adverse Event|18|||
30921711|NCT02180165|58956993|FG003|Overall Study|Adverse Event|3|||
30754616|NCT04728802|58764251|FG001|Overall Study|Physician Decision|7|||
30921712|NCT02180165|58956990|FG000|Overall Study|Lack of Efficacy|0|||
30754617|NCT04728802|58764250|FG000|Overall Study|Protocol Violation|10|||
30828259|NCT02998671|58851297|FG003|Period 2|Study Terminated By Sponsor|3|||
30828260|NCT02998671|58851298|FG004|Period 2|Study Terminated By Sponsor|0|||
30828261|NCT02998671|58851294|FG000|Period 2|Withdrawal by Subject|0|||
30828262|NCT02998671|58851295|FG001|Period 2|Withdrawal by Subject|1|||
30828263|NCT02998671|58851296|FG002|Period 2|Withdrawal by Subject|0|||
30921713|NCT02180165|58956991|FG001|Overall Study|Lack of Efficacy|1|||
30921714|NCT02180165|58956992|FG002|Overall Study|Lack of Efficacy|3|||
30921715|NCT02180165|58956993|FG003|Overall Study|Lack of Efficacy|2|||
30921716|NCT02180165|58956990|FG000|Overall Study|Physician Decision|1|||
30921717|NCT02180165|58956991|FG001|Overall Study|Physician Decision|0|||
30921718|NCT02180165|58956992|FG002|Overall Study|Physician Decision|5|||
30921719|NCT02180165|58956993|FG003|Overall Study|Physician Decision|0|||
30921720|NCT02180165|58956990|FG000|Overall Study|Withdrawal by Subject|3|||
30828264|NCT02998671|58851297|FG003|Period 2|Withdrawal by Subject|0|||
30828265|NCT02998671|58851298|FG004|Period 2|Withdrawal by Subject|0|||
30828266|NCT02998671|58851294|FG000|Period 2|Lost to Follow-up|0|||
30828267|NCT02998671|58851295|FG001|Period 2|Lost to Follow-up|0|||
30828268|NCT02998671|58851296|FG002|Period 2|Lost to Follow-up|0|||
30828269|NCT02998671|58851297|FG003|Period 2|Lost to Follow-up|1|||
30828270|NCT02998671|58851298|FG004|Period 2|Lost to Follow-up|0|||
30828271|NCT02660827|58851318|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
30828272|NCT02660827|58851318|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
30828273|NCT02660827|58851318|FG000|From Study to End of Continued Access|Adverse Event|3|||
30828274|NCT02660827|58851318|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
30828275|NCT02660827|58851318|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
30828276|NCT02660827|58851318|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
30828277|NCT02660827|58851318|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
30828278|NCT02660827|58851318|FG000|Period 2: Continued Access Period|Adverse Event|3|||
30828279|NCT01069419|58851339|FG000|Overall Study|Adverse Event|233|||
30828280|NCT01069419|58851339|FG000|Overall Study|Lack of Efficacy|332|||
30828281|NCT01069419|58851339|FG000|Overall Study|Lost to Follow-up|49|||
30828282|NCT01069419|58851339|FG000|Overall Study|Remission of disease|11|||
30828283|NCT01069419|58851339|FG000|Overall Study|Withdrawal by Subject|34|||
30828284|NCT01069419|58851339|FG000|Overall Study|Other Reason|43|||
30828285|NCT01069419|58851339|FG000|Overall Study|Missing termination information|13|||
30828286|NCT01069341|58851343|FG000|Overall Study|Lost to Follow-up|1|||
30828287|NCT02996097|58851347|FG000|Overall Study|Lost to Follow-up|11|||
30828288|NCT02996097|58851348|FG001|Overall Study|Lost to Follow-up|11|||
30828289|NCT02992899|58851355|FG000|Overall Study|Withdrawal by Subject|1|||
30828290|NCT02992899|58851356|FG001|Overall Study|Withdrawal by Subject|0|||
30828291|NCT02992899|58851355|FG000|Overall Study|Lost to Follow-up|1|||
30828292|NCT02992899|58851356|FG001|Overall Study|Lost to Follow-up|3|||
30828293|NCT01602484|58851364|FG000|Overall Study|Airway issues unrelated to study|0|||
30828294|NCT01602484|58851365|FG001|Overall Study|Airway issues unrelated to study|1|||
30828295|NCT02989389|58851385|FG000|Period 1|Lost to Follow-up|0|||
30828296|NCT02989389|58851386|FG001|Period 1|Lost to Follow-up|1|||
30828297|NCT02989389|58851387|FG002|Period 1|Lost to Follow-up|0|||
30828298|NCT02989389|58851388|FG003|Period 1|Lost to Follow-up|0|||
30828299|NCT02989389|58851389|FG004|Period 1|Lost to Follow-up|0|||
30828300|NCT02989389|58851390|FG005|Period 1|Lost to Follow-up|0|||
30828301|NCT02989389|58851391|FG006|Period 1|Lost to Follow-up|0|||
30828302|NCT02989389|58851392|FG007|Period 1|Lost to Follow-up|0|||
30828303|NCT02989389|58851393|FG008|Period 1|Lost to Follow-up|0|||
30828304|NCT02989389|58851394|FG009|Period 1|Lost to Follow-up|0|||
30828305|NCT02989389|58851385|FG000|Period 1|Physician Decision|0|||
30828306|NCT02989389|58851386|FG001|Period 1|Physician Decision|0|||
30828307|NCT02989389|58851387|FG002|Period 1|Physician Decision|0|||
30828308|NCT02989389|58851388|FG003|Period 1|Physician Decision|0|||
30921721|NCT02180165|58956991|FG001|Overall Study|Withdrawal by Subject|0|||
30921722|NCT02180165|58956992|FG002|Overall Study|Withdrawal by Subject|2|||
30754618|NCT04728802|58764251|FG001|Overall Study|Protocol Violation|4|||
30754619|NCT04728802|58764250|FG000|Overall Study|Transfer|1|||
30754620|NCT04728802|58764251|FG001|Overall Study|Transfer|0|||
30754621|NCT04728802|58764250|FG000|Overall Study|Death|4|||
30754622|NCT04728802|58764251|FG001|Overall Study|Death|5|||
30754623|NCT04728802|58764250|FG000|Overall Study|Other|3|||
30754624|NCT04728802|58764251|FG001|Overall Study|Other|0|||
30754625|NCT04715932|58764259|FG000|Overall Study|Lost to Follow-up|1|||
30754626|NCT04715932|58764260|FG001|Overall Study|Lost to Follow-up|0|||
30754627|NCT00130832|58764268|FG000|Overall Study|Adverse Event|1|||
30754628|NCT00130832|58764269|FG001|Overall Study|Adverse Event|1|||
30754629|NCT00130832|58764268|FG000|Overall Study|Lost to Follow-up|1|||
30754630|NCT00130832|58764269|FG001|Overall Study|Lost to Follow-up|2|||
30828309|NCT02989389|58851389|FG004|Period 1|Physician Decision|0|||
30828310|NCT02989389|58851390|FG005|Period 1|Physician Decision|0|||
30828311|NCT02989389|58851391|FG006|Period 1|Physician Decision|0|||
30828312|NCT02989389|58851392|FG007|Period 1|Physician Decision|0|||
30828313|NCT02989389|58851393|FG008|Period 1|Physician Decision|1|||
30828314|NCT02989389|58851394|FG009|Period 1|Physician Decision|0|||
30828315|NCT02653300|58851434|FG000|Overall Study|Withdrawal by Subject|2|||
30754631|NCT00130832|58764268|FG000|Overall Study|Protocol Violation|6|||
30828316|NCT01757665|58851440|FG000|Overall Study|Still on Study - Visit Completed|240|||
30828317|NCT01757665|58851441|FG001|Overall Study|Still on Study - Visit Completed|30|||
30828318|NCT01757665|58851440|FG000|Overall Study|Still on Study - Visit Pending|398|||
30921723|NCT02180165|58956993|FG003|Overall Study|Withdrawal by Subject|1|||
30921724|NCT02155985|58957008|FG000|Overall Study|Withdrawal by Subject|0|||
30828319|NCT01757665|58851441|FG001|Overall Study|Still on Study - Visit Pending|40|||
30828320|NCT01757665|58851440|FG000|Overall Study|Still on Study - Missed Visit|14|||
30828321|NCT01757665|58851441|FG001|Overall Study|Still on Study - Missed Visit|1|||
30828322|NCT01757665|58851440|FG000|Overall Study|Death|25|||
30828323|NCT01757665|58851441|FG001|Overall Study|Death|8|||
30828324|NCT01757665|58851440|FG000|Overall Study|Explant|1|||
30828325|NCT01757665|58851441|FG001|Overall Study|Explant|2|||
30921725|NCT02155985|58957009|FG001|Overall Study|Withdrawal by Subject|0|||
30921726|NCT02155985|58957010|FG002|Overall Study|Withdrawal by Subject|1|||
30921727|NCT02155985|58957008|FG000|Overall Study|Lost to Follow-up|1|||
30921728|NCT02155985|58957009|FG001|Overall Study|Lost to Follow-up|0|||
30921729|NCT02155985|58957010|FG002|Overall Study|Lost to Follow-up|0|||
30921730|NCT02155829|58957020|FG000|Overall Study|Adverse Event|1|||
30828326|NCT01757665|58851440|FG000|Overall Study|Withdrawal by Subject|10|||
30828327|NCT01757665|58851441|FG001|Overall Study|Withdrawal by Subject|0|||
30828328|NCT01757665|58851440|FG000|Overall Study|Lost to Follow-up|1|||
30828329|NCT01757665|58851441|FG001|Overall Study|Lost to Follow-up|1|||
30828330|NCT01757665|58851440|FG000|Overall Study|Not Implanted with Device|5|||
30828331|NCT01757665|58851441|FG001|Overall Study|Not Implanted with Device|1|||
30828332|NCT00430508|58851466|FG000|Overall Study|Adverse Event|2|||
30828333|NCT00430508|58851467|FG001|Overall Study|Adverse Event|3|||
30828334|NCT00430508|58851468|FG002|Overall Study|Adverse Event|5|||
30828335|NCT00430508|58851469|FG003|Overall Study|Adverse Event|3|||
30828336|NCT00430508|58851466|FG000|Overall Study|Withdrawal by Subject|0|||
30828337|NCT00430508|58851467|FG001|Overall Study|Withdrawal by Subject|1|||
30828338|NCT00430508|58851468|FG002|Overall Study|Withdrawal by Subject|1|||
30828339|NCT00430508|58851469|FG003|Overall Study|Withdrawal by Subject|1|||
30828340|NCT00430508|58851466|FG000|Overall Study|responder at visit 4|0|||
30828341|NCT00430508|58851467|FG001|Overall Study|responder at visit 4|0|||
30921731|NCT02155829|58957021|FG001|Overall Study|Adverse Event|0|||
30828342|NCT00430508|58851468|FG002|Overall Study|responder at visit 4|2|||
30828343|NCT00430508|58851469|FG003|Overall Study|responder at visit 4|0|||
30828344|NCT00430508|58851466|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
30828345|NCT00430508|58851467|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
30828346|NCT00430508|58851468|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
30828347|NCT00430508|58851469|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
30828348|NCT00430508|58851466|FG000|Overall Study|Other|1|||
30828349|NCT00430508|58851467|FG001|Overall Study|Other|1|||
30921732|NCT02155829|58957020|FG000|Overall Study|Withdrawal by Subject|3|||
30921733|NCT02155829|58957021|FG001|Overall Study|Withdrawal by Subject|3|||
30921734|NCT02155829|58957020|FG000|Overall Study|Protocol Violation|2|||
30921735|NCT02155829|58957021|FG001|Overall Study|Protocol Violation|0|||
30921736|NCT02129777|58957033|FG000|Double-Blind Period|Adverse Event|0|||
30921737|NCT02129777|58957034|FG001|Double-Blind Period|Adverse Event|0|||
30921738|NCT02129777|58957035|FG002|Double-Blind Period|Adverse Event|0|||
30754632|NCT00130832|58764269|FG001|Overall Study|Protocol Violation|8|||
30754633|NCT00130832|58764268|FG000|Overall Study|Withdrawal by Subject|6|||
30754634|NCT00130832|58764269|FG001|Overall Study|Withdrawal by Subject|1|||
30754635|NCT00130832|58764268|FG000|Overall Study|Moved|2|||
30754636|NCT00130832|58764269|FG001|Overall Study|Moved|2|||
30828350|NCT00430508|58851468|FG002|Overall Study|Other|3|||
30828351|NCT00430508|58851469|FG003|Overall Study|Other|0|||
30828352|NCT02988219|58851477|FG000|Overall Study|Lack of Efficacy|1|||
30828353|NCT02988219|58851478|FG001|Overall Study|Lack of Efficacy|1|||
30828354|NCT02988219|58851477|FG000|Overall Study|Withdrawal by Subject|0|||
30828355|NCT02988219|58851478|FG001|Overall Study|Withdrawal by Subject|2|||
30921739|NCT02129777|58957036|FG003|Double-Blind Period|Adverse Event|0|||
30921740|NCT02129777|58957037|FG004|Double-Blind Period|Adverse Event|1|||
30921741|NCT02129777|58957038|FG005|Double-Blind Period|Adverse Event|0|||
30921742|NCT02129777|58957039|FG006|Double-Blind Period|Adverse Event|0|||
30754637|NCT00130832|58764268|FG000|Overall Study|Other|0|||
30754638|NCT00130832|58764269|FG001|Overall Study|Other|3|||
30754639|NCT00096018|58764277|FG000|Overall Study|Became Ineligible (not treated)|0|||
30754640|NCT00096018|58764278|FG001|Overall Study|Became Ineligible (not treated)|3|||
30754641|NCT00096018|58764277|FG000|Overall Study|Miscellaneous (not treated)|0|||
30754642|NCT00096018|58764278|FG001|Overall Study|Miscellaneous (not treated)|2|||
30754643|NCT00096018|58764277|FG000|Overall Study|Adverse Event|0|||
30828356|NCT01346059|58851486|FG000|Overall Study|Withdrawal by Subject|1|||
30828357|NCT01346059|58851487|FG001|Overall Study|Withdrawal by Subject|0|||
30828358|NCT01318915|58851493|FG000|Overall Study|Lost to Follow-up|1|||
30828359|NCT02987205|58851499|FG000|Overall Study|Adverse Event|1|||
30828360|NCT02987205|58851499|FG000|Overall Study|Withdrawal by Subject|3|||
30828361|NCT02926937|58851521|FG000|Overall Study|Adverse Event|0|||
30828362|NCT02926937|58851522|FG001|Overall Study|Adverse Event|1|||
30828363|NCT02926937|58851523|FG002|Overall Study|Adverse Event|1|||
30828364|NCT02926937|58851521|FG000|Overall Study|Poor Compliance to Protocol|1|||
30828365|NCT02926937|58851522|FG001|Overall Study|Poor Compliance to Protocol|0|||
30921743|NCT02129777|58957033|FG000|Double-Blind Period|Lost to Follow-up|1|||
30828366|NCT02926937|58851523|FG002|Overall Study|Poor Compliance to Protocol|0|||
30828367|NCT02926937|58851521|FG000|Overall Study|Lost to Follow-up|4|||
30828368|NCT02926937|58851522|FG001|Overall Study|Lost to Follow-up|5|||
30828369|NCT02926937|58851523|FG002|Overall Study|Lost to Follow-up|0|||
30828370|NCT02926937|58851521|FG000|Overall Study|At the Participant's own Request|11|||
30828371|NCT02926937|58851522|FG001|Overall Study|At the Participant's own Request|5|||
30828372|NCT02926937|58851523|FG002|Overall Study|At the Participant's own Request|8|||
30828373|NCT02926937|58851521|FG000|Overall Study|Reason not Specified|3|||
30828374|NCT02926937|58851522|FG001|Overall Study|Reason not Specified|4|||
30828375|NCT02926937|58851523|FG002|Overall Study|Reason not Specified|2|||
30828376|NCT04189588|58851534|FG000|Overall Study|Death|0|||
30828377|NCT04189588|58851535|FG001|Overall Study|Death|1|||
30828378|NCT04189588|58851534|FG000|Overall Study|Lost to Follow-up|0|||
30828379|NCT04189588|58851535|FG001|Overall Study|Lost to Follow-up|1|||
30828380|NCT00151892|58851543|FG000|Overall Study|Lack of Efficacy|50|||
30828381|NCT00151892|58851544|FG001|Overall Study|Lack of Efficacy|57|||
30828382|NCT00151892|58851543|FG000|Overall Study|Patient request|10|||
30921744|NCT02129777|58957034|FG001|Double-Blind Period|Lost to Follow-up|1|||
30921745|NCT02129777|58957035|FG002|Double-Blind Period|Lost to Follow-up|1|||
30921746|NCT02129777|58957036|FG003|Double-Blind Period|Lost to Follow-up|2|||
30623388|NCT00970593|58635206|FG000|Overall Study|Discontinuation of study by sponsor|0|||
30754644|NCT00096018|58764278|FG001|Overall Study|Adverse Event|5|||
30754645|NCT00096018|58764277|FG000|Overall Study|Death|0|||
30754646|NCT00096018|58764278|FG001|Overall Study|Death|1|||
30754647|NCT00096018|58764277|FG000|Overall Study|Withdrawal by Subject|0|||
30754648|NCT00096018|58764278|FG001|Overall Study|Withdrawal by Subject|2|||
30754649|NCT00096018|58764277|FG000|Overall Study|Miscellaneous|2|||
30754650|NCT00096018|58764278|FG001|Overall Study|Miscellaneous|1|||
30754651|NCT04713748|58764284|FG000|Overall Study|Not enough kits allocated|35|||
30754652|NCT04702984|58764288|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
30754653|NCT04701658|58764294|FG000|Overall Study|Lost to Follow-up|6|||
30754654|NCT00128102|58764300|FG000|Overall Study|Site Discontinued|3|||
30754655|NCT00128102|58764301|FG001|Overall Study|Site Discontinued|6|||
30754656|NCT00128102|58764300|FG000|Overall Study|Other|0|||
30754657|NCT00128102|58764301|FG001|Overall Study|Other|1|||
30754658|NCT00128102|58764300|FG000|Overall Study|Progressive Disease|255|||
30754659|NCT00128102|58764301|FG001|Overall Study|Progressive Disease|285|||
30754660|NCT00128102|58764300|FG000|Overall Study|Adverse Event|34|||
30754661|NCT00128102|58764301|FG001|Overall Study|Adverse Event|11|||
30754662|NCT00128102|58764300|FG000|Overall Study|Death|12|||
30828383|NCT00151892|58851544|FG001|Overall Study|Patient request|7|||
30828384|NCT00151892|58851543|FG000|Overall Study|Lost to Follow-up|5|||
30828385|NCT00151892|58851544|FG001|Overall Study|Lost to Follow-up|10|||
30828386|NCT00151892|58851543|FG000|Overall Study|Adverse Event|6|||
30828387|NCT00151892|58851544|FG001|Overall Study|Adverse Event|3|||
30828388|NCT00151892|58851543|FG000|Overall Study|Protocol Violation|3|||
30828389|NCT00151892|58851544|FG001|Overall Study|Protocol Violation|3|||
30828390|NCT00151892|58851543|FG000|Overall Study|Non-compliance|0|||
30828391|NCT00151892|58851544|FG001|Overall Study|Non-compliance|1|||
30828392|NCT00151892|58851543|FG000|Overall Study|Pregnancy|0|||
30828393|NCT00151892|58851544|FG001|Overall Study|Pregnancy|1|||
30828394|NCT00151892|58851543|FG000|Overall Study|Did not return for a visit|1|||
30828395|NCT00151892|58851544|FG001|Overall Study|Did not return for a visit|0|||
30828396|NCT00151892|58851543|FG000|Overall Study|Used prohibited corticosteroids|1|||
30828397|NCT00151892|58851544|FG001|Overall Study|Used prohibited corticosteroids|0|||
30828398|NCT00151892|58851543|FG000|Overall Study|Lack of study medication at center|0|||
30828399|NCT00151892|58851544|FG001|Overall Study|Lack of study medication at center|1|||
30828400|NCT03055195|58851568|FG000|Overall Study|Lack of Efficacy|1|||
30828401|NCT03055195|58851569|FG001|Overall Study|Lack of Efficacy|0|||
30828402|NCT03055195|58851568|FG000|Overall Study|Withdrawal by Subject|6|||
30828403|NCT03055195|58851569|FG001|Overall Study|Withdrawal by Subject|7|||
30828404|NCT03055195|58851568|FG000|Overall Study|Study Terminated by Sponsor|2|||
30828405|NCT03055195|58851569|FG001|Overall Study|Study Terminated by Sponsor|6|||
30754663|NCT00128102|58764301|FG001|Overall Study|Death|13|||
30754664|NCT00128102|58764300|FG000|Overall Study|Physician Decision|3|||
30754665|NCT00128102|58764301|FG001|Overall Study|Physician Decision|3|||
30754666|NCT00128102|58764300|FG000|Overall Study|Withdrawal by Subject|19|||
30828406|NCT03055195|58851568|FG000|Overall Study|Protocol Violation|2|||
30921747|NCT02129777|58957037|FG004|Double-Blind Period|Lost to Follow-up|0|||
30754667|NCT00128102|58764301|FG001|Overall Study|Withdrawal by Subject|11|||
30754668|NCT00128102|58764300|FG000|Overall Study|Protocol Violation|2|||
30828407|NCT03055195|58851569|FG001|Overall Study|Protocol Violation|1|||
30828408|NCT03055195|58851568|FG000|Overall Study|Physician Decision|1|||
30828409|NCT03055195|58851569|FG001|Overall Study|Physician Decision|0|||
30921748|NCT02129777|58957038|FG005|Double-Blind Period|Lost to Follow-up|0|||
30754669|NCT00128102|58764301|FG001|Overall Study|Protocol Violation|2|||
30754670|NCT04668274|58764307|FG000|Part 1 Study Period 1|Adverse Event|3|||
30828410|NCT02921919|58851577|FG000|Overall Study|Other|5|||
30828411|NCT02921919|58851578|FG001|Overall Study|Other|6|||
30921749|NCT02129777|58957039|FG006|Double-Blind Period|Lost to Follow-up|0|||
30921750|NCT02129777|58957033|FG000|Double-Blind Period|Withdrawal by Subject|2|||
30921751|NCT02129777|58957034|FG001|Double-Blind Period|Withdrawal by Subject|4|||
30921752|NCT02129777|58957035|FG002|Double-Blind Period|Withdrawal by Subject|3|||
30921753|NCT02129777|58957036|FG003|Double-Blind Period|Withdrawal by Subject|2|||
30921754|NCT02129777|58957037|FG004|Double-Blind Period|Withdrawal by Subject|3|||
30921755|NCT02129777|58957038|FG005|Double-Blind Period|Withdrawal by Subject|0|||
30921756|NCT02129777|58957039|FG006|Double-Blind Period|Withdrawal by Subject|0|||
30921757|NCT02129777|58957033|FG000|Double-Blind Period|Pregnancy|0|||
30921758|NCT02129777|58957034|FG001|Double-Blind Period|Pregnancy|0|||
30921759|NCT02129777|58957035|FG002|Double-Blind Period|Pregnancy|0|||
30921760|NCT02129777|58957036|FG003|Double-Blind Period|Pregnancy|0|||
30921761|NCT02129777|58957037|FG004|Double-Blind Period|Pregnancy|1|||
30921762|NCT02129777|58957038|FG005|Double-Blind Period|Pregnancy|0|||
30921763|NCT02129777|58957039|FG006|Double-Blind Period|Pregnancy|0|||
30921764|NCT02129777|58957033|FG000|Double-Blind Period|Lack of Efficacy|3|||
30921765|NCT02129777|58957034|FG001|Double-Blind Period|Lack of Efficacy|1|||
30921766|NCT02129777|58957035|FG002|Double-Blind Period|Lack of Efficacy|0|||
30921767|NCT02129777|58957036|FG003|Double-Blind Period|Lack of Efficacy|3|||
30921768|NCT02129777|58957037|FG004|Double-Blind Period|Lack of Efficacy|2|||
30921769|NCT02129777|58957038|FG005|Double-Blind Period|Lack of Efficacy|0|||
30921770|NCT02129777|58957039|FG006|Double-Blind Period|Lack of Efficacy|0|||
30921771|NCT02129777|58957033|FG000|Double-Blind Period|Other|1|||
30921772|NCT02129777|58957034|FG001|Double-Blind Period|Other|2|||
30921773|NCT02129777|58957035|FG002|Double-Blind Period|Other|0|||
30921774|NCT02129777|58957036|FG003|Double-Blind Period|Other|0|||
30921775|NCT02129777|58957037|FG004|Double-Blind Period|Other|0|||
30921776|NCT02129777|58957038|FG005|Double-Blind Period|Other|0|||
30921777|NCT02129777|58957039|FG006|Double-Blind Period|Other|0|||
30921778|NCT02129777|58957033|FG000|Open-Label Period|Lack of Efficacy|0|||
30921779|NCT02129777|58957034|FG001|Open-Label Period|Lack of Efficacy|0|||
30921780|NCT02129777|58957035|FG002|Open-Label Period|Lack of Efficacy|0|||
30921781|NCT02129777|58957036|FG003|Open-Label Period|Lack of Efficacy|0|||
30921782|NCT02129777|58957037|FG004|Open-Label Period|Lack of Efficacy|0|||
30921783|NCT02129777|58957038|FG005|Open-Label Period|Lack of Efficacy|0|||
30921784|NCT02129777|58957039|FG006|Open-Label Period|Lack of Efficacy|5|||
30921785|NCT02129777|58957033|FG000|Open-Label Period|Lost to Follow-up|0|||
30921786|NCT02129777|58957034|FG001|Open-Label Period|Lost to Follow-up|0|||
30921787|NCT02129777|58957035|FG002|Open-Label Period|Lost to Follow-up|0|||
30921788|NCT02129777|58957036|FG003|Open-Label Period|Lost to Follow-up|0|||
30921789|NCT02129777|58957037|FG004|Open-Label Period|Lost to Follow-up|0|||
30921790|NCT02129777|58957038|FG005|Open-Label Period|Lost to Follow-up|1|||
30921791|NCT02129777|58957039|FG006|Open-Label Period|Lost to Follow-up|1|||
30921792|NCT02129777|58957033|FG000|Open-Label Period|Withdrawal by Subject|0|||
30921793|NCT02129777|58957034|FG001|Open-Label Period|Withdrawal by Subject|0|||
30921794|NCT02129777|58957035|FG002|Open-Label Period|Withdrawal by Subject|0|||
30921795|NCT02129777|58957036|FG003|Open-Label Period|Withdrawal by Subject|0|||
30921796|NCT02129777|58957037|FG004|Open-Label Period|Withdrawal by Subject|0|||
30921797|NCT02129777|58957038|FG005|Open-Label Period|Withdrawal by Subject|1|||
30921798|NCT02129777|58957039|FG006|Open-Label Period|Withdrawal by Subject|3|||
30754671|NCT04668274|58764308|FG001|Part 1 Study Period 1|Adverse Event|0|||
30754672|NCT04668274|58764309|FG002|Part 1 Study Period 1|Adverse Event|0|||
30754673|NCT04668274|58764310|FG003|Part 1 Study Period 1|Adverse Event|0|||
30754674|NCT04668274|58764307|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
30754675|NCT04668274|58764308|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
30754676|NCT04668274|58764309|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
30754677|NCT04668274|58764310|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
30754678|NCT04668274|58764307|FG000|Part 1 Study Period 2|Other|0|||
30754679|NCT04668274|58764308|FG001|Part 1 Study Period 2|Other|1|||
30754680|NCT04668274|58764309|FG002|Part 1 Study Period 2|Other|0|||
30754681|NCT04668274|58764310|FG003|Part 1 Study Period 2|Other|0|||
30754682|NCT04668274|58764307|FG000|Part 1 Study Period 3|Adverse Event|0|||
30754683|NCT04668274|58764308|FG001|Part 1 Study Period 3|Adverse Event|0|||
30754684|NCT04668274|58764309|FG002|Part 1 Study Period 3|Adverse Event|1|||
30754685|NCT04668274|58764310|FG003|Part 1 Study Period 3|Adverse Event|0|||
30754686|NCT04668274|58764307|FG000|Part 1 Study Period 3|Other|0|||
30754687|NCT04668274|58764308|FG001|Part 1 Study Period 3|Other|0|||
30754688|NCT04668274|58764309|FG002|Part 1 Study Period 3|Other|2|||
30828412|NCT02921919|58851577|FG000|Overall Study|Lost to Follow-up|0|||
30921799|NCT02129777|58957033|FG000|Open-Label Period|Study Termination|0|||
30921800|NCT02129777|58957034|FG001|Open-Label Period|Study Termination|0|||
30921801|NCT02129777|58957035|FG002|Open-Label Period|Study Termination|0|||
30921802|NCT02129777|58957036|FG003|Open-Label Period|Study Termination|0|||
30921803|NCT02129777|58957037|FG004|Open-Label Period|Study Termination|0|||
30828413|NCT02921919|58851578|FG001|Overall Study|Lost to Follow-up|1|||
30921804|NCT02129777|58957038|FG005|Open-Label Period|Study Termination|10|||
30921805|NCT02129777|58957039|FG006|Open-Label Period|Study Termination|39|||
30828414|NCT02921919|58851577|FG000|Overall Study|Withdrawal by Subject|5|||
30828415|NCT02921919|58851578|FG001|Overall Study|Withdrawal by Subject|1|||
30828416|NCT02921919|58851577|FG000|Overall Study|Disease Progression|47|||
30828417|NCT02921919|58851578|FG001|Overall Study|Disease Progression|38|||
30828418|NCT02921919|58851577|FG000|Overall Study|Physician Decision|3|||
30828419|NCT02921919|58851578|FG001|Overall Study|Physician Decision|2|||
30828420|NCT02921919|58851577|FG000|Overall Study|Adverse Event|6|||
30828421|NCT02921919|58851578|FG001|Overall Study|Adverse Event|4|||
30828422|NCT02910219|58851600|FG000|Overall Study|Withdrawal by Subject|1|||
30828423|NCT02910219|58851601|FG001|Overall Study|Withdrawal by Subject|1|||
30828424|NCT01068717|58851607|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
30828425|NCT01068717|58851608|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
30828426|NCT01068717|58851609|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
30921806|NCT02178995|58957060|FG000|Double Blind|Adverse Event|0|||
30754689|NCT04668274|58764310|FG003|Part 1 Study Period 3|Other|0|||
30754690|NCT04668274|58764307|FG000|Part 2 Study Period 4|Other|0|||
30754691|NCT04668274|58764308|FG001|Part 2 Study Period 4|Other|0|||
30754692|NCT04668274|58764309|FG002|Part 2 Study Period 4|Other|0|||
30754693|NCT04668274|58764310|FG003|Part 2 Study Period 4|Other|1|||
30754694|NCT04406194|58764325|FG000|Period 1|Withdrawal by Subject|0|||
30754695|NCT04406194|58764326|FG001|Period 1|Withdrawal by Subject|1|||
30754696|NCT03822884|58764341|FG000|Overall Study|Withdrawal by Subject|0|||
30754697|NCT03822884|58764342|FG001|Overall Study|Withdrawal by Subject|0|||
30754698|NCT03822884|58764343|FG002|Overall Study|Withdrawal by Subject|0|||
30754699|NCT03822884|58764344|FG003|Overall Study|Withdrawal by Subject|0|||
30754700|NCT03822884|58764345|FG004|Overall Study|Withdrawal by Subject|1|||
30754701|NCT03822884|58764346|FG005|Overall Study|Withdrawal by Subject|0|||
30754702|NCT03822416|58764356|FG000|Overall Study|Lost to Follow-up|1|||
30754703|NCT03822416|58764357|FG001|Overall Study|Lost to Follow-up|0|||
30754704|NCT03822416|58764356|FG000|Overall Study|Withdrawal by Subject|0|||
30754705|NCT03822416|58764357|FG001|Overall Study|Withdrawal by Subject|1|||
30754706|NCT04405570|58764367|FG000|Overall Study|Adverse Event|0|||
30754707|NCT04405570|58764368|FG001|Overall Study|Adverse Event|1|||
30754708|NCT04405570|58764369|FG002|Overall Study|Adverse Event|1|||
30754709|NCT04405570|58764370|FG003|Overall Study|Adverse Event|1|||
30754710|NCT04405570|58764367|FG000|Overall Study|Lost to Follow-up|0|||
30754711|NCT04405570|58764368|FG001|Overall Study|Lost to Follow-up|1|||
30754712|NCT04405570|58764369|FG002|Overall Study|Lost to Follow-up|0|||
30754713|NCT04405570|58764370|FG003|Overall Study|Lost to Follow-up|0|||
30754714|NCT04405570|58764367|FG000|Overall Study|Physician Decision|0|||
30754715|NCT04405570|58764368|FG001|Overall Study|Physician Decision|0|||
30754716|NCT04405570|58764369|FG002|Overall Study|Physician Decision|1|||
30754717|NCT04405570|58764370|FG003|Overall Study|Physician Decision|0|||
30754718|NCT04405570|58764367|FG000|Overall Study|Withdrawal by Subject|0|||
30754719|NCT04405570|58764368|FG001|Overall Study|Withdrawal by Subject|1|||
30754720|NCT04405570|58764369|FG002|Overall Study|Withdrawal by Subject|1|||
30754721|NCT04405570|58764370|FG003|Overall Study|Withdrawal by Subject|0|||
30754722|NCT04405570|58764367|FG000|Overall Study|Randomized not dosed|0|||
30754723|NCT04405570|58764368|FG001|Overall Study|Randomized not dosed|2|||
30754724|NCT04405570|58764369|FG002|Overall Study|Randomized not dosed|0|||
30754725|NCT04405570|58764370|FG003|Overall Study|Randomized not dosed|0|||
30754726|NCT00127712|58764385|FG000|Overall Study|Adverse Event|3|||
30754727|NCT00127712|58764386|FG001|Overall Study|Adverse Event|0|||
30754728|NCT00127712|58764385|FG000|Overall Study|Lack of GI access to continue|2|||
30754729|NCT00127712|58764386|FG001|Overall Study|Lack of GI access to continue|0|||
30754730|NCT04404010|58764394|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
30754731|NCT04404010|58764395|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
30754732|NCT04401202|58764405|FG000|Overall Study|Lost to Follow-up|2|||
30754733|NCT04401202|58764406|FG001|Overall Study|Lost to Follow-up|2|||
30754734|NCT04401202|58764405|FG000|Overall Study|Adverse Event|0|||
30754735|NCT04401202|58764406|FG001|Overall Study|Adverse Event|1|||
30828427|NCT01068717|58851610|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
30921807|NCT02178995|58957061|FG001|Double Blind|Adverse Event|0|||
30754736|NCT04401202|58764405|FG000|Overall Study|Hospitalized|4|||
30754737|NCT04401202|58764406|FG001|Overall Study|Hospitalized|1|||
30754738|NCT00096356|58764415|FG000|Overall Study|Adverse Event|11|||
30754739|NCT00096356|58764416|FG001|Overall Study|Adverse Event|9|||
30754740|NCT00096356|58764415|FG000|Overall Study|Physician Decision|5|||
30754741|NCT00096356|58764416|FG001|Overall Study|Physician Decision|3|||
30921808|NCT02178995|58957062|FG002|Double Blind|Adverse Event|0|||
30921809|NCT02178995|58957063|FG003|Double Blind|Adverse Event|0|||
30754742|NCT00096356|58764415|FG000|Overall Study|Withdrawal by Subject|17|||
30754743|NCT00096356|58764416|FG001|Overall Study|Withdrawal by Subject|23|||
30754744|NCT00096356|58764415|FG000|Overall Study|Lack of Efficacy|1|||
30754745|NCT00096356|58764416|FG001|Overall Study|Lack of Efficacy|0|||
30754746|NCT00096356|58764415|FG000|Overall Study|multiple reasons|10|||
30754747|NCT00096356|58764416|FG001|Overall Study|multiple reasons|18|||
30754748|NCT04358068|58764425|FG000|Overall Study|Did not initiate study treatment|2|||
30754749|NCT04358068|58764426|FG001|Overall Study|Did not initiate study treatment|2|||
30754750|NCT03694210|58764432|FG000|Overall Study|Death|1|||
30754751|NCT03694210|58764432|FG000|Overall Study|Screen Failure|7|||
30754752|NCT04339972|58764440|FG000|Overall Study|Scheduling Issues|3|||
30754753|NCT04339972|58764441|FG001|Overall Study|Scheduling Issues|3|||
30754754|NCT04339972|58764440|FG000|Overall Study|dropout|1|||
30754755|NCT04339972|58764441|FG001|Overall Study|dropout|1|||
30754756|NCT04339972|58764440|FG000|Overall Study|Technical issues|1|||
30754757|NCT04339972|58764441|FG001|Overall Study|Technical issues|0|||
30754758|NCT04339972|58764440|FG000|Overall Study|Claustraphobia|0|||
30754759|NCT04339972|58764441|FG001|Overall Study|Claustraphobia|1|||
30754760|NCT00096278|58764449|FG000|Overall Study|No follow-up data|15|||
30754761|NCT00096278|58764450|FG001|Overall Study|No follow-up data|18|||
30754762|NCT00096278|58764449|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
30754763|NCT00096278|58764450|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
30754764|NCT00095940|58764465|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
30754765|NCT00095940|58764466|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
30754766|NCT00095940|58764467|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
30754767|NCT00095940|58764468|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
30754768|NCT00095940|58764469|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
30754769|NCT00095940|58764470|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
30754770|NCT00095940|58764471|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
30754771|NCT00095940|58764472|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
30754772|NCT00095940|58764473|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
30754773|NCT00095940|58764465|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
30754774|NCT00095940|58764466|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
30754775|NCT00095940|58764467|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
30754776|NCT00095940|58764468|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
30754777|NCT00095940|58764469|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
30828428|NCT02921763|58851624|FG000|Overall Study|Adverse Event|4|||
30828429|NCT02921763|58851624|FG000|Overall Study|Lost to Follow-up|4|||
30828430|NCT02921763|58851624|FG000|Overall Study|Lack of Efficacy|3|||
30921810|NCT02178995|58957064|FG004|Double Blind|Adverse Event|0|||
30921811|NCT02178995|58957065|FG005|Double Blind|Adverse Event|1|||
30828431|NCT02921763|58851624|FG000|Overall Study|Protocol Violation|2|||
30828432|NCT02921763|58851624|FG000|Overall Study|Withdrawal by Subject|2|||
30828433|NCT02921763|58851624|FG000|Overall Study|Physician Decision|1|||
30828434|NCT02921763|58851624|FG000|Overall Study|No data obtained|2|||
30828435|NCT01318135|58851646|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
30828436|NCT01318135|58851647|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30828437|NCT01318135|58851648|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30828438|NCT01318135|58851649|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30828439|NCT01318135|58851650|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30828440|NCT01318135|58851651|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30828441|NCT01318135|58851652|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30828442|NCT01318135|58851653|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30828443|NCT01318135|58851646|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
30828444|NCT01318135|58851647|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
30828445|NCT01318135|58851648|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
30828446|NCT01318135|58851649|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
30828447|NCT01318135|58851650|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
30828448|NCT01318135|58851651|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
30828449|NCT01318135|58851652|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
30828450|NCT01318135|58851653|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
30828451|NCT01318135|58851646|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
30828452|NCT01318135|58851647|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
30828453|NCT01318135|58851648|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
30921812|NCT02178995|58957066|FG006|Double Blind|Adverse Event|0|||
30754778|NCT00095940|58764470|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
30754779|NCT00095940|58764471|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
30754780|NCT00095940|58764472|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
30754781|NCT00095940|58764473|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
30754782|NCT00095940|58764465|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
30828454|NCT01318135|58851649|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
30828455|NCT01318135|58851650|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
30828456|NCT01318135|58851651|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
30828457|NCT01318135|58851652|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
30828458|NCT01318135|58851653|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
30828459|NCT01318135|58851646|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
30828460|NCT01318135|58851647|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
30828461|NCT01318135|58851648|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
30623389|NCT00970593|58635207|FG001|Overall Study|Discontinuation of study by sponsor|0|||
30623390|NCT00970593|58635208|FG002|Overall Study|Discontinuation of study by sponsor|5|||
30623391|NCT00970593|58635209|FG003|Overall Study|Discontinuation of study by sponsor|0|||
30623392|NCT00970593|58635210|FG004|Overall Study|Discontinuation of study by sponsor|0|||
30754783|NCT00095940|58764466|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
30754784|NCT00095940|58764467|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
30754785|NCT00095940|58764468|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
30754786|NCT00095940|58764469|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
30754787|NCT00095940|58764470|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
30754788|NCT00095940|58764471|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
30754789|NCT00095940|58764472|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
30754790|NCT00095940|58764473|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
30754791|NCT00114218|58764491|FG000|Overall Study|Wrong Cell Type|2|||
30754792|NCT00114218|58764491|FG000|Overall Study|Wrong Primary|1|||
30754793|NCT00114218|58764491|FG000|Overall Study|Never Treated|1|||
30754794|NCT00095628|58764495|FG000|Overall Study|Disease progression prior to treatment|1|||
30754795|NCT04380142|58764501|FG000|LD/CD Stabilization Period|Adverse Event|3|||
30754796|NCT04380142|58764502|FG001|LD/CD Stabilization Period|Adverse Event|0|||
30754797|NCT04380142|58764503|FG002|LD/CD Stabilization Period|Adverse Event|0|||
30754798|NCT04380142|58764501|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
30754799|NCT04380142|58764502|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
30754800|NCT04380142|58764503|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
30754801|NCT04380142|58764501|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
30754802|NCT04380142|58764502|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
30754803|NCT04380142|58764503|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
30754804|NCT04380142|58764501|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
30754805|NCT04380142|58764502|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
30754806|NCT04380142|58764503|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
30754807|NCT04380142|58764501|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
30754808|NCT04380142|58764502|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
30754809|NCT04380142|58764503|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
30754810|NCT04380142|58764501|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
30754811|NCT04380142|58764502|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
30754812|NCT04380142|58764503|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
30754813|NCT04380142|58764501|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30754814|NCT04380142|58764502|FG001|Double-Blind Treatment Period|Adverse Event|1|||
30754815|NCT04380142|58764503|FG002|Double-Blind Treatment Period|Adverse Event|14|||
30754816|NCT04380142|58764501|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
30754817|NCT04380142|58764502|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
30754818|NCT04380142|58764503|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
30754819|NCT04380142|58764501|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
30754820|NCT04380142|58764502|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
30754821|NCT04380142|58764503|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
30754822|NCT04380142|58764501|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
30754823|NCT04380142|58764502|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
30754824|NCT04380142|58764503|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
30754825|NCT04380142|58764501|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
30754826|NCT04380142|58764502|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
30828462|NCT01318135|58851649|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
30623393|NCT00970593|58635211|FG005|Overall Study|Discontinuation of study by sponsor|0|||
30623394|NCT00970593|58635212|FG006|Overall Study|Discontinuation of study by sponsor|2|||
30623395|NCT00970593|58635206|FG000|Overall Study|Withdrawal by Subject|0|||
30623396|NCT00970593|58635207|FG001|Overall Study|Withdrawal by Subject|0|||
30623397|NCT00970593|58635208|FG002|Overall Study|Withdrawal by Subject|1|||
30623398|NCT00970593|58635209|FG003|Overall Study|Withdrawal by Subject|0|||
30623399|NCT00970593|58635210|FG004|Overall Study|Withdrawal by Subject|0|||
30623400|NCT00970593|58635211|FG005|Overall Study|Withdrawal by Subject|0|||
30623401|NCT00970593|58635212|FG006|Overall Study|Withdrawal by Subject|0|||
30623402|NCT00962013|58635232|FG000|Overall Study|Did not have surgery|1|||
30921813|NCT02178995|58957067|FG007|Double Blind|Adverse Event|1|||
30623403|NCT00962013|58635232|FG000|Overall Study|Death|8|||
30623404|NCT00962013|58635232|FG000|Overall Study|Lost to Follow-up|12|||
30623405|NCT00962013|58635232|FG000|Overall Study|Unable/Unwilling to return|6|||
30623406|NCT00962013|58635232|FG000|Overall Study|Withdrawal by Subject|8|||
30623407|NCT00962013|58635232|FG000|Overall Study|Removal of study device|3|||
30623408|NCT00962013|58635232|FG000|Overall Study|Site Termination|24|||
30623409|NCT00962013|58635232|FG000|Overall Study|No 5 year evaluation|6|||
30623410|NCT00970359|58635236|FG000|Overall Study|Not Treated|4|||
30623411|NCT01121406|58635242|FG000|Overall Study|Progressive disease RECIST|44|||
30623412|NCT01121406|58635243|FG001|Overall Study|Progressive disease RECIST|28|||
30623413|NCT01121406|58635242|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
30623414|NCT01121406|58635243|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
30623415|NCT01121406|58635242|FG000|Overall Study|Other AE|3|||
30623416|NCT01121406|58635243|FG001|Overall Study|Other AE|10|||
30623417|NCT01121406|58635242|FG000|Overall Study|Non-compliant with protocol|0|||
30623418|NCT01121406|58635243|FG001|Overall Study|Non-compliant with protocol|2|||
30623419|NCT01121406|58635242|FG000|Overall Study|Lost to Follow-up|0|||
30623420|NCT01121406|58635243|FG001|Overall Study|Lost to Follow-up|1|||
30623421|NCT01121406|58635242|FG000|Overall Study|Refused continuation of study med.|1|||
30623422|NCT01121406|58635243|FG001|Overall Study|Refused continuation of study med.|2|||
30623423|NCT01121406|58635242|FG000|Overall Study|Reason other than specified above|2|||
30623424|NCT01121406|58635243|FG001|Overall Study|Reason other than specified above|6|||
30623425|NCT01121406|58635242|FG000|Overall Study|Not treated|1|||
30623426|NCT01121406|58635243|FG001|Overall Study|Not treated|0|||
30623427|NCT00960687|58635252|FG000|Washout Period of 7 Days|Adverse Event|3|||
30623428|NCT00960687|58635253|FG001|Washout Period of 7 Days|Adverse Event|2|||
30828463|NCT01318135|58851650|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
30828464|NCT01318135|58851651|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
30828465|NCT01318135|58851652|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
30828466|NCT01318135|58851653|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
30828467|NCT01318135|58851646|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
30828468|NCT01318135|58851647|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
30828469|NCT01318135|58851648|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
30828470|NCT01318135|58851649|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
30828471|NCT01318135|58851650|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
30828472|NCT01318135|58851651|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
30828473|NCT01318135|58851652|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
30828474|NCT01318135|58851653|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
30828475|NCT01318135|58851646|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
30921814|NCT02178995|58957068|FG008|Double Blind|Adverse Event|1|||
30921815|NCT02178995|58957060|FG000|Double Blind|Lost to Follow-up|0|||
30921816|NCT02178995|58957061|FG001|Double Blind|Lost to Follow-up|1|||
30921817|NCT02178995|58957062|FG002|Double Blind|Lost to Follow-up|0|||
30921818|NCT02178995|58957063|FG003|Double Blind|Lost to Follow-up|0|||
30921819|NCT02178995|58957064|FG004|Double Blind|Lost to Follow-up|0|||
30921820|NCT02178995|58957065|FG005|Double Blind|Lost to Follow-up|0|||
30921821|NCT02178995|58957066|FG006|Double Blind|Lost to Follow-up|0|||
30921822|NCT02178995|58957067|FG007|Double Blind|Lost to Follow-up|1|||
30921823|NCT02178995|58957068|FG008|Double Blind|Lost to Follow-up|0|||
30623429|NCT00960687|58635252|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
30623430|NCT00960687|58635253|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
30623431|NCT00920140|58635264|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
30623432|NCT00920140|58635265|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
30623433|NCT00920140|58635266|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
30921824|NCT02178995|58957060|FG000|Open Label|Adverse Event|2|||
30623434|NCT00920140|58635267|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
30623435|NCT00920140|58635268|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
30623436|NCT00920140|58635264|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
30921825|NCT02178995|58957061|FG001|Open Label|Adverse Event|0|||
30754827|NCT04380142|58764503|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
30754828|NCT04380142|58764501|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
30754829|NCT04380142|58764502|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
30754830|NCT04380142|58764503|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
30754831|NCT04335136|58764513|FG000|Overall Study|Death|8|||
30754832|NCT04335136|58764514|FG001|Overall Study|Death|4|||
30754833|NCT04335136|58764513|FG000|Overall Study|Lost to Follow-up|2|||
30754834|NCT04335136|58764514|FG001|Overall Study|Lost to Follow-up|0|||
30754835|NCT04335136|58764513|FG000|Overall Study|Protocol Violation|1|||
30754836|NCT04335136|58764514|FG001|Overall Study|Protocol Violation|0|||
30754837|NCT04335136|58764513|FG000|Overall Study|Withdrawal by Subject|1|||
30754838|NCT04335136|58764514|FG001|Overall Study|Withdrawal by Subject|1|||
30754839|NCT04335136|58764513|FG000|Overall Study|Health-threatening condition|0|||
30754840|NCT04335136|58764514|FG001|Overall Study|Health-threatening condition|1|||
30754841|NCT04335136|58764513|FG000|Overall Study|Adverse Event|0|||
30754842|NCT04335136|58764514|FG001|Overall Study|Adverse Event|1|||
30754843|NCT04335136|58764513|FG000|Overall Study|Erroneously randomized|2|||
30754844|NCT04335136|58764514|FG001|Overall Study|Erroneously randomized|0|||
30754845|NCT04171414|58764520|FG000|Overall Study|Death|1|||
30754846|NCT04171414|58764520|FG000|Overall Study|Withdrawal by Subject|1|||
30754847|NCT04167670|58764527|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
30754848|NCT04167670|58764528|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
30754849|NCT04167670|58764529|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
30754850|NCT04167670|58764527|FG000|Overall Study|Significant protocol deviation|3|||
30754851|NCT04167670|58764528|FG001|Overall Study|Significant protocol deviation|1|||
30754852|NCT04167670|58764529|FG002|Overall Study|Significant protocol deviation|0|||
30754853|NCT04167670|58764527|FG000|Overall Study|Lost to Follow-up|0|||
30754854|NCT04167670|58764528|FG001|Overall Study|Lost to Follow-up|3|||
30921826|NCT02178995|58957062|FG002|Open Label|Adverse Event|0|||
30828476|NCT01318135|58851647|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
30828477|NCT01318135|58851648|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
30828478|NCT01318135|58851649|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
30828479|NCT01318135|58851650|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
30828480|NCT01318135|58851651|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
30828481|NCT01318135|58851652|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
30828482|NCT01318135|58851653|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
30828483|NCT01318135|58851646|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
30828484|NCT01318135|58851647|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
30828485|NCT01318135|58851648|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
30828486|NCT01318135|58851649|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
30828487|NCT01318135|58851650|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
30828488|NCT01318135|58851651|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
30828489|NCT01318135|58851652|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
30828490|NCT01318135|58851653|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
30828491|NCT02922153|58851665|FG000|Overall Study|Death|8|||
30828492|NCT02922153|58851666|FG001|Overall Study|Death|1|||
30828493|NCT02922153|58851665|FG000|Overall Study|Lost to Follow-up|1|||
30828494|NCT02922153|58851666|FG001|Overall Study|Lost to Follow-up|0|||
30828495|NCT02922153|58851665|FG000|Overall Study|Physician Decision|1|||
30828496|NCT02922153|58851666|FG001|Overall Study|Physician Decision|1|||
30828497|NCT02920983|58851672|FG000|Dispense 1|Unacceptable Lens Fit|0|||
30828498|NCT02920983|58851673|FG001|Dispense 1|Unacceptable Lens Fit|0|||
30828499|NCT02920983|58851674|FG002|Dispense 1|Unacceptable Lens Fit|0|||
30828500|NCT02920983|58851675|FG003|Dispense 1|Unacceptable Lens Fit|0|||
30828501|NCT02920983|58851676|FG004|Dispense 1|Unacceptable Lens Fit|1|||
30828502|NCT02920983|58851677|FG005|Dispense 1|Unacceptable Lens Fit|0|||
30754855|NCT04167670|58764529|FG002|Overall Study|Lost to Follow-up|3|||
30754856|NCT04167670|58764527|FG000|Overall Study|Voluntary Withdrawal|0|||
30754857|NCT04167670|58764528|FG001|Overall Study|Voluntary Withdrawal|1|||
30754858|NCT04167670|58764529|FG002|Overall Study|Voluntary Withdrawal|1|||
30754859|NCT04167670|58764527|FG000|Overall Study|Withdrawal of Consent|4|||
30754860|NCT04167670|58764528|FG001|Overall Study|Withdrawal of Consent|1|||
30754861|NCT04167670|58764529|FG002|Overall Study|Withdrawal of Consent|3|||
30754862|NCT04167670|58764527|FG000|Overall Study|Miscellaneous|7|||
30754863|NCT04167670|58764528|FG001|Overall Study|Miscellaneous|5|||
30754864|NCT04167670|58764529|FG002|Overall Study|Miscellaneous|3|||
30754865|NCT00113516|58764537|FG000|Part 1|Adverse Event|6|||
30754866|NCT00113516|58764538|FG001|Part 1|Adverse Event|0|||
30754867|NCT00113516|58764537|FG000|Part 1|Death|3|||
30754868|NCT00113516|58764538|FG001|Part 1|Death|0|||
30754869|NCT00113516|58764537|FG000|Part 1|Other|3|||
30754870|NCT00113516|58764538|FG001|Part 1|Other|0|||
30754871|NCT00113516|58764537|FG000|Part 1|Withdrawal by Subject|2|||
30754872|NCT00113516|58764538|FG001|Part 1|Withdrawal by Subject|0|||
30754873|NCT00113516|58764537|FG000|Part 1|Lack of Efficacy|2|||
30754874|NCT00113516|58764538|FG001|Part 1|Lack of Efficacy|0|||
30754875|NCT00113516|58764537|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
30754876|NCT00113516|58764538|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
30754877|NCT00113516|58764537|FG000|Part 1|Laboratory Abnormality|1|||
30754878|NCT00113516|58764538|FG001|Part 1|Laboratory Abnormality|0|||
30754879|NCT00113516|58764537|FG000|Part 1|Ongoing|1|||
30754880|NCT00113516|58764538|FG001|Part 1|Ongoing|0|||
30754881|NCT00113516|58764537|FG000|Part 1|Missing|65|||
30754882|NCT00113516|58764538|FG001|Part 1|Missing|0|||
30754883|NCT00113516|58764537|FG000|Part 2|Adverse Event|0|||
30754884|NCT00113516|58764538|FG001|Part 2|Adverse Event|16|||
30754885|NCT00113516|58764537|FG000|Part 2|Death|0|||
30754886|NCT00113516|58764538|FG001|Part 2|Death|5|||
30754887|NCT00113516|58764537|FG000|Part 2|Lack of Efficacy|0|||
30754888|NCT00113516|58764538|FG001|Part 2|Lack of Efficacy|37|||
30754889|NCT00113516|58764537|FG000|Part 2|Withdrawal by Subject|0|||
30754890|NCT00113516|58764538|FG001|Part 2|Withdrawal by Subject|3|||
30754891|NCT00113516|58764537|FG000|Part 2|Other|0|||
30754892|NCT00113516|58764538|FG001|Part 2|Other|3|||
30754893|NCT00113516|58764537|FG000|Part 2|Laboratory Abnormality|0|||
30754894|NCT00113516|58764538|FG001|Part 2|Laboratory Abnormality|1|||
30754895|NCT00113516|58764537|FG000|Part 2|Ongoing|0|||
30828503|NCT02920983|58851672|FG000|Dispense 2|Unscceptable lens fit|1|||
30828504|NCT02920983|58851673|FG001|Dispense 2|Unscceptable lens fit|0|||
30754896|NCT00113516|58764538|FG001|Part 2|Ongoing|1|||
30754897|NCT04142242|58764550|FG000|Overall Study|Non-compliance with the protocol|1|||
30754898|NCT04142242|58764551|FG001|Overall Study|Non-compliance with the protocol|0|||
30754899|NCT04142242|58764552|FG002|Overall Study|Non-compliance with the protocol|0|||
30754900|NCT04142242|58764553|FG003|Overall Study|Non-compliance with the protocol|0|||
30754901|NCT04142242|58764554|FG004|Overall Study|Non-compliance with the protocol|0|||
30754902|NCT04142242|58764555|FG005|Overall Study|Non-compliance with the protocol|1|||
30828505|NCT02920983|58851674|FG002|Dispense 2|Unscceptable lens fit|0|||
30828506|NCT02920983|58851675|FG003|Dispense 2|Unscceptable lens fit|0|||
30828507|NCT02920983|58851676|FG004|Dispense 2|Unscceptable lens fit|1|||
30828508|NCT02920983|58851677|FG005|Dispense 2|Unscceptable lens fit|0|||
30754903|NCT04142242|58764550|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
30754904|NCT04142242|58764551|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1|||
30754905|NCT04142242|58764552|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
30828509|NCT02920983|58851672|FG000|Dispense 3|Unacceptable Lens Fit|1|||
30828510|NCT02920983|58851673|FG001|Dispense 3|Unacceptable Lens Fit|1|||
30828511|NCT02920983|58851674|FG002|Dispense 3|Unacceptable Lens Fit|0|||
30828512|NCT02920983|58851675|FG003|Dispense 3|Unacceptable Lens Fit|0|||
30828513|NCT02920983|58851676|FG004|Dispense 3|Unacceptable Lens Fit|1|||
30828514|NCT02920983|58851677|FG005|Dispense 3|Unacceptable Lens Fit|0|||
30828515|NCT02654002|58851694|FG000|Overall Study|Adverse Event|0|||
30828516|NCT02654002|58851695|FG001|Overall Study|Adverse Event|0|||
30828517|NCT02654002|58851696|FG002|Overall Study|Adverse Event|0|||
30828518|NCT02654002|58851697|FG003|Overall Study|Adverse Event|0|||
30828519|NCT02654002|58851698|FG004|Overall Study|Adverse Event|0|||
30828520|NCT02654002|58851699|FG005|Overall Study|Adverse Event|0|||
30828521|NCT02654002|58851700|FG006|Overall Study|Adverse Event|1|||
30828522|NCT02654002|58851701|FG007|Overall Study|Adverse Event|0|||
30754906|NCT04142242|58764553|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
30754907|NCT04142242|58764554|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
30754908|NCT04142242|58764555|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
30754909|NCT04142242|58764550|FG000|Overall Study|Ongoing|0|||
30754910|NCT04142242|58764551|FG001|Overall Study|Ongoing|0|||
30754911|NCT04142242|58764552|FG002|Overall Study|Ongoing|31|||
30828523|NCT02654002|58851702|FG008|Overall Study|Adverse Event|0|||
30828524|NCT02654002|58851694|FG000|Overall Study|Withdrew Consent|0|||
30828525|NCT02654002|58851695|FG001|Overall Study|Withdrew Consent|0|||
30828526|NCT02654002|58851696|FG002|Overall Study|Withdrew Consent|0|||
30828527|NCT02654002|58851697|FG003|Overall Study|Withdrew Consent|0|||
30828528|NCT02654002|58851698|FG004|Overall Study|Withdrew Consent|0|||
30828529|NCT02654002|58851699|FG005|Overall Study|Withdrew Consent|1|||
30828530|NCT02654002|58851700|FG006|Overall Study|Withdrew Consent|0|||
30828531|NCT02654002|58851701|FG007|Overall Study|Withdrew Consent|1|||
30828532|NCT02654002|58851702|FG008|Overall Study|Withdrew Consent|0|||
30828533|NCT01675492|58851737|FG000|Overall Study|study completed early - product approval|42|||
30828534|NCT03924622|58851748|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
30828535|NCT03924622|58851749|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
30828536|NCT03924622|58851750|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
30828537|NCT03924622|58851751|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
30828538|NCT03924622|58851752|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
30828539|NCT03924622|58851753|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
30828540|NCT04044664|58851770|FG000|Stage 1|Adverse Event|3|||
30828541|NCT04044664|58851771|FG001|Stage 1|Adverse Event|3|||
30828542|NCT04044664|58851772|FG002|Stage 1|Adverse Event|1|||
30828543|NCT04044664|58851770|FG000|Stage 1|Lost to Follow-up|3|||
30828544|NCT04044664|58851771|FG001|Stage 1|Lost to Follow-up|2|||
30828545|NCT04044664|58851772|FG002|Stage 1|Lost to Follow-up|2|||
30828546|NCT04044664|58851770|FG000|Stage 1|Withdrawal by Subject|9|||
30828547|NCT04044664|58851771|FG001|Stage 1|Withdrawal by Subject|1|||
30828548|NCT04044664|58851772|FG002|Stage 1|Withdrawal by Subject|0|||
30828549|NCT04044664|58851770|FG000|Stage 1|noncompliance, personal reason|2|||
30828550|NCT04044664|58851771|FG001|Stage 1|noncompliance, personal reason|0|||
30828551|NCT04044664|58851772|FG002|Stage 1|noncompliance, personal reason|0|||
30828552|NCT04044664|58851770|FG000|Stage 1|randomization error|0|||
30828553|NCT04044664|58851771|FG001|Stage 1|randomization error|1|||
30828554|NCT04044664|58851772|FG002|Stage 1|randomization error|0|||
30828555|NCT04044664|58851770|FG000|Stage 2|Adverse Event|2|||
30828556|NCT04044664|58851771|FG001|Stage 2|Adverse Event|0|||
30828557|NCT04044664|58851772|FG002|Stage 2|Adverse Event|0|||
30828558|NCT04044664|58851770|FG000|Stage 2|Lost to Follow-up|3|||
30828559|NCT04044664|58851771|FG001|Stage 2|Lost to Follow-up|2|||
30828560|NCT04044664|58851772|FG002|Stage 2|Lost to Follow-up|1|||
30828561|NCT04044664|58851770|FG000|Stage 2|Withdrawal by Subject|3|||
30828562|NCT04044664|58851771|FG001|Stage 2|Withdrawal by Subject|0|||
30828563|NCT04044664|58851772|FG002|Stage 2|Withdrawal by Subject|0|||
30828564|NCT04044664|58851770|FG000|Stage 2|protocol deviation|1|||
30828565|NCT04044664|58851771|FG001|Stage 2|protocol deviation|0|||
30828566|NCT04044664|58851772|FG002|Stage 2|protocol deviation|0|||
30828567|NCT00150176|58851782|FG000|Overall Study|Adverse Event|16|||
30828568|NCT00150176|58851783|FG001|Overall Study|Adverse Event|53|||
30828569|NCT00150176|58851782|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
30828570|NCT00150176|58851783|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
30828571|NCT00150176|58851782|FG000|Overall Study|Withdrawal by Subject|19|||
30828572|NCT00150176|58851783|FG001|Overall Study|Withdrawal by Subject|12|||
30828573|NCT00150176|58851782|FG000|Overall Study|Lost to Follow-up|3|||
30828574|NCT00150176|58851783|FG001|Overall Study|Lost to Follow-up|3|||
30828575|NCT00150176|58851782|FG000|Overall Study|OTHER|11|||
30828576|NCT00150176|58851783|FG001|Overall Study|OTHER|13|||
30828577|NCT02985879|58851793|FG000|Overall Study|Adverse Event|7|||
30828578|NCT02985879|58851794|FG001|Overall Study|Adverse Event|9|||
30828579|NCT02985879|58851795|FG002|Overall Study|Adverse Event|7|||
30828580|NCT02985879|58851793|FG000|Overall Study|Withdrew consent|6|||
30828581|NCT02985879|58851794|FG001|Overall Study|Withdrew consent|8|||
30828582|NCT02985879|58851795|FG002|Overall Study|Withdrew consent|10|||
30828583|NCT02985879|58851793|FG000|Overall Study|Lost to Follow-up|1|||
30828584|NCT02985879|58851794|FG001|Overall Study|Lost to Follow-up|0|||
30828585|NCT02985879|58851795|FG002|Overall Study|Lost to Follow-up|2|||
30828586|NCT02985879|58851793|FG000|Overall Study|Other, not specified|62|||
30921827|NCT02178995|58957063|FG003|Open Label|Adverse Event|0|||
30828587|NCT02985879|58851794|FG001|Overall Study|Other, not specified|58|||
30828588|NCT02985879|58851795|FG002|Overall Study|Other, not specified|58|||
30828589|NCT01067469|58851811|FG000|Overall Study|Withdrawal by Subject|0|||
30828590|NCT01067469|58851812|FG001|Overall Study|Withdrawal by Subject|1|||
30828591|NCT01067469|58851811|FG000|Overall Study|Disease Progression|0|||
30828592|NCT01067469|58851812|FG001|Overall Study|Disease Progression|1|||
30828593|NCT02985021|58851818|FG000|Overall Study|Inability to comply with study procedures|1|||
30828594|NCT01066923|58851826|FG000|Overall Study|Withdrawal by Subject|3|||
30828595|NCT01066923|58851827|FG001|Overall Study|Withdrawal by Subject|3|||
30921828|NCT02178995|58957064|FG004|Open Label|Adverse Event|0|||
30828596|NCT01066923|58851828|FG002|Overall Study|Withdrawal by Subject|8|||
30828597|NCT01066923|58851829|FG003|Overall Study|Withdrawal by Subject|8|||
30828598|NCT02919267|58851854|FG000|Overall Study|Protocol Violation|0|||
30828599|NCT02919267|58851855|FG001|Overall Study|Protocol Violation|3|||
30828600|NCT02919267|58851856|FG002|Overall Study|Protocol Violation|3|||
30828601|NCT02919267|58851857|FG003|Overall Study|Protocol Violation|4|||
30828602|NCT01368900|58851867|FG000|Overall Study|Lost to Follow-up|7|||
30828603|NCT02910063|58851873|FG000|Phase 2|Withdrawal by Subject|3|||
30828604|NCT02910063|58851874|FG001|Phase 2|Withdrawal by Subject|0|||
30828605|NCT02910063|58851875|FG002|Phase 2|Withdrawal by Subject|0|||
30828606|NCT02910063|58851873|FG000|Phase 2|Lost to Follow-up|1|||
30623437|NCT00920140|58635265|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
30623438|NCT00920140|58635266|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
30623439|NCT00920140|58635267|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
30623440|NCT00920140|58635268|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
30623441|NCT00920140|58635264|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
30623442|NCT00920140|58635265|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
30623443|NCT00920140|58635266|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
30623444|NCT00920140|58635267|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
30623445|NCT00920140|58635268|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
30921829|NCT02178995|58957065|FG005|Open Label|Adverse Event|0|||
30921830|NCT02178995|58957066|FG006|Open Label|Adverse Event|0|||
30921831|NCT02178995|58957067|FG007|Open Label|Adverse Event|0|||
30921832|NCT02178995|58957068|FG008|Open Label|Adverse Event|0|||
30921833|NCT02128997|58957094|FG000|Overall Study|Lost to Follow-up|6|||
30921834|NCT02128997|58957095|FG001|Overall Study|Lost to Follow-up|11|||
30921835|NCT02155283|58957101|FG000|Overall Study|Lost to Follow-up|3|||
30623446|NCT00920140|58635264|FG000|Phase 2|Adverse Event|0|||
30754912|NCT04142242|58764553|FG003|Overall Study|Ongoing|39|||
30754913|NCT04142242|58764554|FG004|Overall Study|Ongoing|0|||
30754914|NCT04142242|58764555|FG005|Overall Study|Ongoing|0|||
30754915|NCT04140292|58764583|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
30754916|NCT04140292|58764584|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
30754917|NCT04138810|58764593|FG000|Overall Study|Withdrawal by Subject|0|||
30623447|NCT00920140|58635265|FG001|Phase 2|Adverse Event|0|||
30828607|NCT02910063|58851874|FG001|Phase 2|Lost to Follow-up|0|||
30828608|NCT02910063|58851875|FG002|Phase 2|Lost to Follow-up|0|||
30828609|NCT02910063|58851873|FG000|Phase 2|Death|24|||
30828610|NCT02910063|58851874|FG001|Phase 2|Death|0|||
30828611|NCT02910063|58851875|FG002|Phase 2|Death|0|||
30828612|NCT02909907|58851886|FG000|Overall Study|Withdrawal by Subject|0|||
30828613|NCT02909907|58851887|FG001|Overall Study|Withdrawal by Subject|1|||
30828614|NCT02651194|58851893|FG000|Overall Study|Lost to Follow-up|3|||
30828615|NCT02651194|58851893|FG000|Overall Study|Other|2|||
30828616|NCT02907177|58851899|FG000|Overall Study|Death|0|||
30828617|NCT02907177|58851900|FG001|Overall Study|Death|1|||
30828618|NCT02907177|58851899|FG000|Overall Study|Physician Decision|3|||
30828619|NCT02907177|58851900|FG001|Overall Study|Physician Decision|3|||
30828620|NCT02907177|58851899|FG000|Overall Study|Withdrawal by Subject|15|||
30828621|NCT02907177|58851900|FG001|Overall Study|Withdrawal by Subject|7|||
30828622|NCT02907177|58851899|FG000|Overall Study|Sponsor's Decision|50|||
30828623|NCT02907177|58851900|FG001|Overall Study|Sponsor's Decision|57|||
30828624|NCT02652442|58851906|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
30828625|NCT02906709|58851920|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
30828626|NCT02906709|58851921|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
30828627|NCT02906709|58851920|FG000|Phase A (Week 0 to Week 16)|Death|0|||
30828628|NCT02906709|58851921|FG001|Phase A (Week 0 to Week 16)|Death|1|||
30828629|NCT02906709|58851920|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
30828630|NCT02906709|58851921|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
30828631|NCT02906709|58851920|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
30828632|NCT02906709|58851921|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
30828633|NCT00318656|58851935|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
30828634|NCT00318656|58851936|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
30828635|NCT00318656|58851935|FG000|Overall Study|Did not receive any treatment|0|||
30828636|NCT00318656|58851936|FG001|Overall Study|Did not receive any treatment|1|||
30828637|NCT02908347|58851942|FG000|Overall Study|Adverse Event|0|||
30828638|NCT02908347|58851943|FG001|Overall Study|Adverse Event|1|||
30828639|NCT02908347|58851942|FG000|Overall Study|Lost to Follow-up|1|||
30828640|NCT02908347|58851943|FG001|Overall Study|Lost to Follow-up|0|||
30828641|NCT02983305|58851965|FG000|Overall Study|incomplete data|2|||
30623448|NCT00920140|58635266|FG002|Phase 2|Adverse Event|14|||
30754918|NCT04138810|58764594|FG001|Overall Study|Withdrawal by Subject|1|||
30754919|NCT04138810|58764593|FG000|Overall Study|Subject cancelled surgery|1|||
30754920|NCT04138810|58764594|FG001|Overall Study|Subject cancelled surgery|0|||
30754921|NCT00127166|58764602|FG000|Period I|Protocol Violation|0|||
30828642|NCT02983305|58851966|FG001|Overall Study|incomplete data|0|||
30828643|NCT03663166|58851972|FG000|Overall Study|Withdrawal by Subject|1|||
30921836|NCT02155283|58957101|FG000|Overall Study|Withdrawal by Subject|1|||
30828644|NCT02983227|58851979|FG000|Overall Study|Adverse Event|21|||
30828645|NCT02983227|58851980|FG001|Overall Study|Adverse Event|3|||
30828646|NCT02983227|58851979|FG000|Overall Study|Death|3|||
30828647|NCT02983227|58851980|FG001|Overall Study|Death|0|||
30828648|NCT02983227|58851979|FG000|Overall Study|Lack of Efficacy|8|||
30828649|NCT02983227|58851980|FG001|Overall Study|Lack of Efficacy|1|||
30921837|NCT02155283|58957101|FG000|Overall Study|Protocol Violation|3|||
30921838|NCT02154581|58957107|FG000|Overall Study|Lost to Follow-up|7|||
30921839|NCT02154581|58957108|FG001|Overall Study|Lost to Follow-up|8|||
30921840|NCT02154425|58957116|FG000|Screening Period|Adverse Event|1|||
30828650|NCT02983227|58851979|FG000|Overall Study|Lost to Follow-up|3|||
30828651|NCT02983227|58851980|FG001|Overall Study|Lost to Follow-up|0|||
30828652|NCT02983227|58851979|FG000|Overall Study|Multiple Reasons|2|||
30828653|NCT02983227|58851980|FG001|Overall Study|Multiple Reasons|1|||
30828654|NCT02983227|58851979|FG000|Overall Study|Physician Decision|3|||
30828655|NCT02983227|58851980|FG001|Overall Study|Physician Decision|1|||
30828656|NCT02983227|58851979|FG000|Overall Study|Withdrawal by Subject|19|||
30828657|NCT02983227|58851980|FG001|Overall Study|Withdrawal by Subject|8|||
30828658|NCT00301262|58851988|FG000|Double Blind Phase (DB)|Adverse Event|1|||
30828659|NCT00301262|58851989|FG001|Double Blind Phase (DB)|Adverse Event|0|||
30828660|NCT00301262|58851988|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
30828661|NCT00301262|58851989|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
30828662|NCT00301262|58851988|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
30828663|NCT00301262|58851989|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
30828664|NCT00301262|58851988|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
30828665|NCT00301262|58851989|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
30828666|NCT00301262|58851988|FG000|Double Blind Phase (DB)|Other|1|||
30828667|NCT00301262|58851989|FG001|Double Blind Phase (DB)|Other|4|||
30828668|NCT00301262|58851988|FG000|Open Label Phase (OL)|Adverse Event|1|||
30828669|NCT00301262|58851989|FG001|Open Label Phase (OL)|Adverse Event|0|||
30828670|NCT00301262|58851988|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
30828671|NCT00301262|58851989|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
30828672|NCT00301262|58851988|FG000|Open Label Phase (OL)|Other|2|||
30828673|NCT00301262|58851989|FG001|Open Label Phase (OL)|Other|0|||
30828674|NCT02905149|58852016|FG000|Overall Study|Lost to Follow-up|2|||
30828675|NCT02905149|58852017|FG001|Overall Study|Lost to Follow-up|0|||
30828676|NCT02790606|58852023|FG000|Overall Study|Death|27|||
30828677|NCT02790606|58852023|FG000|Overall Study|Lost to Follow-up|4|||
30828678|NCT02790606|58852023|FG000|Overall Study|Physician Decision|3|||
30828679|NCT02790606|58852023|FG000|Overall Study|Withdrawal by Subject|1|||
30828680|NCT03077620|58852031|FG000|Overall Study|Unable to place lumbar catheter|1|||
30828681|NCT03077620|58852032|FG001|Overall Study|Unable to place lumbar catheter|0|||
30828682|NCT03077620|58852033|FG002|Overall Study|Unable to place lumbar catheter|1|||
30828683|NCT03077620|58852034|FG003|Overall Study|Unable to place lumbar catheter|0|||
30921841|NCT02154347|58957126|FG000|Double-blind Period|Adverse Event|1|||
30921842|NCT02154347|58957127|FG001|Double-blind Period|Adverse Event|2|||
30921843|NCT02154347|58957126|FG000|Double-blind Period|Lack of Efficacy|1|||
30921844|NCT02154347|58957127|FG001|Double-blind Period|Lack of Efficacy|0|||
30754922|NCT00127166|58764603|FG001|Period I|Protocol Violation|2|||
30754923|NCT00127166|58764602|FG000|Period I|Withdrawal by Subject|2|||
30754924|NCT00127166|58764603|FG001|Period I|Withdrawal by Subject|0|||
30754925|NCT00127166|58764602|FG000|Period I|Patient did not meet inclusion criteria|1|||
30754926|NCT00127166|58764603|FG001|Period I|Patient did not meet inclusion criteria|0|||
30754927|NCT00127166|58764602|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
30754928|NCT00127166|58764603|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
30754929|NCT00127166|58764602|FG000|Period II|Withdrawal by Subject|2|||
30754930|NCT00127166|58764603|FG001|Period II|Withdrawal by Subject|0|||
30754931|NCT00127166|58764602|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
30754932|NCT00127166|58764603|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
30754933|NCT00125138|58764613|FG000|Overall Study|Adverse Event|1|||
30754934|NCT00125138|58764614|FG001|Overall Study|Adverse Event|0|||
30754935|NCT00125138|58764615|FG002|Overall Study|Adverse Event|3|||
30754936|NCT00125138|58764616|FG003|Overall Study|Adverse Event|2|||
30754937|NCT00125138|58764613|FG000|Overall Study|Withdrawal by Subject|2|||
30754938|NCT00125138|58764614|FG001|Overall Study|Withdrawal by Subject|3|||
30754939|NCT00125138|58764615|FG002|Overall Study|Withdrawal by Subject|1|||
30754940|NCT00125138|58764616|FG003|Overall Study|Withdrawal by Subject|1|||
30754941|NCT00125138|58764613|FG000|Overall Study|Lack of Efficacy|0|||
30754942|NCT00125138|58764614|FG001|Overall Study|Lack of Efficacy|0|||
30754943|NCT00125138|58764615|FG002|Overall Study|Lack of Efficacy|0|||
30754944|NCT00125138|58764616|FG003|Overall Study|Lack of Efficacy|1|||
30754945|NCT00125138|58764613|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
30754946|NCT00125138|58764614|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
30754947|NCT00125138|58764615|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
30921845|NCT02154347|58957126|FG000|Double-blind Period|Physician Decision|0|||
30921846|NCT02154347|58957127|FG001|Double-blind Period|Physician Decision|1|||
30921847|NCT02154347|58957126|FG000|Double-blind Period|Withdrawal by Subject|1|||
30754948|NCT00125138|58764616|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
30754949|NCT04132336|58764633|FG000|Overall Study|Investigator Decision|0|||
30754950|NCT04132336|58764634|FG001|Overall Study|Investigator Decision|1|||
30754951|NCT04132336|58764635|FG002|Overall Study|Investigator Decision|0|||
30754952|NCT04132336|58764636|FG003|Overall Study|Investigator Decision|0|||
30754953|NCT04132336|58764637|FG004|Overall Study|Investigator Decision|0|||
30754954|NCT04132336|58764638|FG005|Overall Study|Investigator Decision|0|||
30754955|NCT04132336|58764639|FG006|Overall Study|Investigator Decision|0|||
30754956|NCT04131556|58764655|FG000|Overall Study|Adverse Event|1|||
30754957|NCT04131556|58764655|FG000|Overall Study|Withdrawal by Subject|1|||
30754958|NCT04295356|58764664|FG000|Overall Study|Physician Decision|1|||
30754959|NCT04295356|58764665|FG001|Overall Study|Physician Decision|0|||
30828684|NCT03077620|58852031|FG000|Overall Study|Withdrawal by Subject|0|||
30828685|NCT03077620|58852032|FG001|Overall Study|Withdrawal by Subject|1|||
30828686|NCT03077620|58852033|FG002|Overall Study|Withdrawal by Subject|0|||
30921848|NCT02154347|58957127|FG001|Double-blind Period|Withdrawal by Subject|1|||
30921849|NCT02154347|58957126|FG000|Open-label Period|Adverse Event|3|||
30828687|NCT03077620|58852034|FG003|Overall Study|Withdrawal by Subject|0|||
30828688|NCT03077620|58852031|FG000|Overall Study|Physician Decision|0|||
30828689|NCT03077620|58852032|FG001|Overall Study|Physician Decision|0|||
30828690|NCT03077620|58852033|FG002|Overall Study|Physician Decision|1|||
30828691|NCT03077620|58852034|FG003|Overall Study|Physician Decision|0|||
30828692|NCT02982213|58852055|FG000|Overall Study|Did not complete follow up questionnaire|5|||
30828693|NCT02982213|58852056|FG001|Overall Study|Did not complete follow up questionnaire|1|||
30828694|NCT02649634|58852064|FG000|Overall Study|Withdrawal by Subject|3|||
30828695|NCT02649634|58852065|FG001|Overall Study|Withdrawal by Subject|5|||
30828696|NCT02649634|58852064|FG000|Overall Study|Lost to Follow-up|0|||
30828697|NCT02649634|58852065|FG001|Overall Study|Lost to Follow-up|1|||
30828698|NCT01066143|58852071|FG000|Overall Study|ineligible for the study|8|||
30828699|NCT02980107|58852077|FG000|Overall Study|Withdrawal by Subject|51|||
30828700|NCT02980107|58852078|FG001|Overall Study|Withdrawal by Subject|62|||
30828701|NCT02652130|58852084|FG000|Overall Study|Death|1|||
30828702|NCT02979639|58852088|FG000|Overall Study|Withdrawal based on medical judgement|1|||
30828703|NCT02979639|58852088|FG000|Overall Study|Lost to Follow-up|8|||
30828704|NCT02979639|58852088|FG000|Overall Study|Withdrawal by Subject|3|||
30828705|NCT02979639|58852088|FG000|Overall Study|Adverse Event|2|||
30828706|NCT01674634|58852092|FG000|Overall Study|Withdrawal by Subject|3|||
30828707|NCT01674634|58852092|FG000|Overall Study|Lost to Follow-up|3|||
30828708|NCT02979249|58852100|FG000|Overall Study|Lost to Follow-up|2|||
30828709|NCT02979249|58852100|FG000|Overall Study|Withdrawal by Subject|4|||
30828710|NCT02112552|58852104|FG000|Overall Study|Withdrawal by Subject|1|||
30828711|NCT02112552|58852104|FG000|Overall Study|Adverse Event|1|||
30828712|NCT02976519|58852115|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
30828713|NCT02976519|58852116|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
30828714|NCT02976519|58852117|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
30921850|NCT02154347|58957127|FG001|Open-label Period|Adverse Event|4|||
30921851|NCT02154347|58957126|FG000|Open-label Period|Lack of Efficacy|4|||
30921852|NCT02154347|58957127|FG001|Open-label Period|Lack of Efficacy|19|||
30921853|NCT02154347|58957126|FG000|Open-label Period|Protocol Violation|0|||
30921854|NCT02154347|58957127|FG001|Open-label Period|Protocol Violation|1|||
30921855|NCT02154347|58957126|FG000|Open-label Period|Withdrawal by Subject|0|||
30921856|NCT02154347|58957127|FG001|Open-label Period|Withdrawal by Subject|1|||
30921857|NCT01627067|58957134|FG000|Overall Study|Screen Failure|1|||
30921858|NCT02178059|58957140|FG000|Washout|Physician Decision|1|||
30921859|NCT02178059|58957141|FG001|Washout|Physician Decision|0|||
30921860|NCT01626989|58957147|FG000|Screening Period|Screen Failure|15|||
30921861|NCT01626989|58957148|FG001|Screening Period|Screen Failure|0|||
30921862|NCT01626989|58957149|FG002|Screening Period|Screen Failure|0|||
30921863|NCT01626989|58957147|FG000|Screening Period|Withdrawal by Subject|2|||
30921864|NCT01626989|58957148|FG001|Screening Period|Withdrawal by Subject|0|||
30828715|NCT02976519|58852118|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
30828716|NCT02976519|58852119|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
30828717|NCT02976519|58852120|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
30828718|NCT02976519|58852121|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
30623449|NCT00920140|58635267|FG003|Phase 2|Adverse Event|2|||
30754960|NCT04295356|58764664|FG000|Overall Study|Lost to Follow-up|0|||
30828719|NCT02976519|58852115|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
30754961|NCT04295356|58764665|FG001|Overall Study|Lost to Follow-up|3|||
30828720|NCT02976519|58852116|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
30921865|NCT01626989|58957149|FG002|Screening Period|Withdrawal by Subject|0|||
30921866|NCT02128217|58957160|FG000|Overall Study|Lost to Follow-up|0|||
30921867|NCT02128217|58957161|FG001|Overall Study|Lost to Follow-up|1|||
30921868|NCT01629953|58957174|FG000|Overall Study|Death|3|||
30921869|NCT01629953|58957175|FG001|Overall Study|Death|1|||
30921870|NCT01629953|58957174|FG000|Overall Study|Lost to Follow-up|10|||
30921871|NCT01629953|58957175|FG001|Overall Study|Lost to Follow-up|14|||
30921872|NCT02127281|58957183|FG000|Overall Study|Lost to Follow-up|1|||
30921873|NCT02127281|58957184|FG001|Overall Study|Lost to Follow-up|0|||
30921874|NCT01628549|58957194|FG000|Overall Study|Adverse Event|1|||
30921875|NCT01628549|58957195|FG001|Overall Study|Adverse Event|1|||
30921876|NCT01628549|58957196|FG002|Overall Study|Adverse Event|0|||
30921877|NCT01628549|58957197|FG003|Overall Study|Adverse Event|4|||
30921878|NCT01628549|58957194|FG000|Overall Study|Lost to Follow-up|3|||
30828721|NCT02976519|58852117|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
30828722|NCT02976519|58852118|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
30828723|NCT02976519|58852119|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
30828724|NCT02976519|58852120|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
30828725|NCT02976519|58852121|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
30828726|NCT02976519|58852115|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
30828727|NCT02976519|58852116|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
30828728|NCT02976519|58852117|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
30828729|NCT02976519|58852118|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
30828730|NCT02976519|58852119|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
30828731|NCT02976519|58852120|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
30828732|NCT02976519|58852121|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
30828733|NCT02976519|58852115|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
30828734|NCT02976519|58852116|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
30828735|NCT02976519|58852117|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
30828736|NCT02976519|58852118|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
30828737|NCT02976519|58852119|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
30828738|NCT02976519|58852120|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
30828739|NCT02976519|58852121|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
30828740|NCT02976519|58852115|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
30828741|NCT02976519|58852116|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
30828742|NCT02976519|58852117|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
30828743|NCT02976519|58852118|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
30828744|NCT02976519|58852119|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
30828745|NCT02976519|58852120|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
30828746|NCT02976519|58852121|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
30828747|NCT02975973|58852226|FG000|Overall Study|Adverse Event|1|||
30828748|NCT02975973|58852227|FG001|Overall Study|Adverse Event|1|||
30828749|NCT02975973|58852228|FG002|Overall Study|Adverse Event|1|||
30828750|NCT02975973|58852229|FG003|Overall Study|Adverse Event|0|||
30828751|NCT01362322|58852241|FG000|Overall Study|Withdrawal by Subject|3|||
30828752|NCT01362322|58852242|FG001|Overall Study|Withdrawal by Subject|1|||
30828753|NCT01362322|58852241|FG000|Overall Study|Lost to Follow-up|2|||
30828754|NCT01362322|58852242|FG001|Overall Study|Lost to Follow-up|6|||
30828755|NCT02918877|58852250|FG000|Overall Study|Withdrawal by Subject|2|||
30828756|NCT02918877|58852251|FG001|Overall Study|Withdrawal by Subject|2|||
30828757|NCT02918877|58852250|FG000|Overall Study|Surgery cancelled|1|||
30828758|NCT02918877|58852251|FG001|Overall Study|Surgery cancelled|0|||
30828759|NCT02918877|58852250|FG000|Overall Study|Physician Decision|1|||
30828760|NCT02918877|58852251|FG001|Overall Study|Physician Decision|0|||
30828761|NCT02918877|58852250|FG000|Overall Study|Received intraoperative steroids|1|||
30828762|NCT02918877|58852251|FG001|Overall Study|Received intraoperative steroids|0|||
30828763|NCT02918877|58852250|FG000|Overall Study|Unable to obtain lab samples|1|||
30828764|NCT02918877|58852251|FG001|Overall Study|Unable to obtain lab samples|0|||
30828765|NCT02918877|58852250|FG000|Overall Study|Unsafe to perform BAL|0|||
30828766|NCT02918877|58852251|FG001|Overall Study|Unsafe to perform BAL|1|||
30828767|NCT01674712|58852262|FG000|Overall Study|Adverse Event|5|||
30828768|NCT01674712|58852263|FG001|Overall Study|Adverse Event|6|||
30828769|NCT01674712|58852264|FG002|Overall Study|Adverse Event|3|||
30828770|NCT01674712|58852265|FG003|Overall Study|Adverse Event|4|||
30828771|NCT01674712|58852266|FG004|Overall Study|Adverse Event|6|||
30828772|NCT01674712|58852262|FG000|Overall Study|Lost to Follow-up|1|||
30828773|NCT01674712|58852263|FG001|Overall Study|Lost to Follow-up|0|||
30828774|NCT01674712|58852264|FG002|Overall Study|Lost to Follow-up|0|||
30828775|NCT01674712|58852265|FG003|Overall Study|Lost to Follow-up|0|||
30828776|NCT01674712|58852266|FG004|Overall Study|Lost to Follow-up|0|||
30921879|NCT01628549|58957195|FG001|Overall Study|Lost to Follow-up|4|||
30921880|NCT01628549|58957196|FG002|Overall Study|Lost to Follow-up|3|||
30828777|NCT01674712|58852262|FG000|Overall Study|Protocol Violation|2|||
30828778|NCT01674712|58852263|FG001|Overall Study|Protocol Violation|0|||
30828779|NCT01674712|58852264|FG002|Overall Study|Protocol Violation|0|||
30828780|NCT01674712|58852265|FG003|Overall Study|Protocol Violation|0|||
30828781|NCT01674712|58852266|FG004|Overall Study|Protocol Violation|0|||
30828782|NCT01674712|58852262|FG000|Overall Study|Withdrawal by Subject|2|||
30828783|NCT01674712|58852263|FG001|Overall Study|Withdrawal by Subject|2|||
30828784|NCT01674712|58852264|FG002|Overall Study|Withdrawal by Subject|5|||
30828785|NCT01674712|58852265|FG003|Overall Study|Withdrawal by Subject|4|||
30828786|NCT01674712|58852266|FG004|Overall Study|Withdrawal by Subject|3|||
30828787|NCT01674712|58852262|FG000|Overall Study|Administrative|0|||
30828788|NCT01674712|58852263|FG001|Overall Study|Administrative|1|||
30828789|NCT01674712|58852264|FG002|Overall Study|Administrative|0|||
30828790|NCT01674712|58852265|FG003|Overall Study|Administrative|0|||
30828791|NCT01674712|58852266|FG004|Overall Study|Administrative|1|||
30828792|NCT01674712|58852262|FG000|Overall Study|Lack of Efficacy|0|||
30828793|NCT01674712|58852263|FG001|Overall Study|Lack of Efficacy|0|||
30828794|NCT01674712|58852264|FG002|Overall Study|Lack of Efficacy|1|||
30828795|NCT01674712|58852265|FG003|Overall Study|Lack of Efficacy|0|||
30623450|NCT00920140|58635268|FG004|Phase 2|Adverse Event|3|||
30623451|NCT00920140|58635264|FG000|Phase 2|Lack of Efficacy|0|||
30623452|NCT00920140|58635265|FG001|Phase 2|Lack of Efficacy|0|||
30754962|NCT04295356|58764664|FG000|Overall Study|Protocol Violation|0|||
30623453|NCT00920140|58635266|FG002|Phase 2|Lack of Efficacy|29|||
30623454|NCT00920140|58635267|FG003|Phase 2|Lack of Efficacy|14|||
30623455|NCT00920140|58635268|FG004|Phase 2|Lack of Efficacy|5|||
30623456|NCT00920140|58635264|FG000|Phase 2|Lost to Follow-up|0|||
30623457|NCT00920140|58635265|FG001|Phase 2|Lost to Follow-up|0|||
30623458|NCT00920140|58635266|FG002|Phase 2|Lost to Follow-up|0|||
30623459|NCT00920140|58635267|FG003|Phase 2|Lost to Follow-up|1|||
30623460|NCT00920140|58635268|FG004|Phase 2|Lost to Follow-up|0|||
30623461|NCT00920140|58635264|FG000|Phase 2|Physician Decision|0|||
30623462|NCT00920140|58635265|FG001|Phase 2|Physician Decision|0|||
30623463|NCT00920140|58635266|FG002|Phase 2|Physician Decision|3|||
30828796|NCT01674712|58852266|FG004|Overall Study|Lack of Efficacy|1|||
30828797|NCT01368432|58852280|FG000|Overall Study|Lost to Follow-up|0|||
30828798|NCT01368432|58852281|FG001|Overall Study|Lost to Follow-up|1|||
30828799|NCT01063881|58852304|FG000|Overall Study|Adverse Event|12|||
30828800|NCT01063881|58852305|FG001|Overall Study|Adverse Event|2|||
30828801|NCT01063881|58852306|FG002|Overall Study|Adverse Event|0|||
30828802|NCT01063881|58852304|FG000|Overall Study|Lost to Follow-up|13|||
30828803|NCT01063881|58852305|FG001|Overall Study|Lost to Follow-up|7|||
30828804|NCT01063881|58852306|FG002|Overall Study|Lost to Follow-up|1|||
30828805|NCT01063881|58852304|FG000|Overall Study|Withdrawal by Subject|25|||
30828806|NCT01063881|58852305|FG001|Overall Study|Withdrawal by Subject|1|||
30828807|NCT01063881|58852306|FG002|Overall Study|Withdrawal by Subject|0|||
30828808|NCT01063881|58852304|FG000|Overall Study|Reason for not completed not specified|5|||
30828809|NCT01063881|58852305|FG001|Overall Study|Reason for not completed not specified|1|||
30828810|NCT01063881|58852306|FG002|Overall Study|Reason for not completed not specified|0|||
30828811|NCT01062555|58852323|FG000|Phase 1|Death|10|||
30828812|NCT01062555|58852324|FG001|Phase 1|Death|17|||
30828813|NCT01062555|58852325|FG002|Phase 1|Death|0|||
30828814|NCT01062555|58852326|FG003|Phase 1|Death|0|||
30828815|NCT01062555|58852323|FG000|Phase 1|Graft Failure|12|||
30828816|NCT01062555|58852324|FG001|Phase 1|Graft Failure|8|||
30754963|NCT04295356|58764665|FG001|Overall Study|Protocol Violation|1|||
30754964|NCT03691948|58764673|FG000|Overall Study|Lost to Follow-up|1|||
30754965|NCT03691948|58764674|FG001|Overall Study|Lost to Follow-up|3|||
30754966|NCT04126174|58764681|FG000|Overall Study|Lost to Follow-up|3|||
30754967|NCT04126174|58764682|FG001|Overall Study|Lost to Follow-up|3|||
30754968|NCT04124926|58764690|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
30754969|NCT04124926|58764691|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
30754970|NCT04124926|58764692|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
30828817|NCT01062555|58852325|FG002|Phase 1|Graft Failure|0|||
30828818|NCT01062555|58852326|FG003|Phase 1|Graft Failure|0|||
30828819|NCT01062555|58852323|FG000|Phase 1|Withdrawal by Subject|1|||
30828820|NCT01062555|58852324|FG001|Phase 1|Withdrawal by Subject|1|||
30828821|NCT01062555|58852325|FG002|Phase 1|Withdrawal by Subject|0|||
30828822|NCT01062555|58852326|FG003|Phase 1|Withdrawal by Subject|0|||
30623464|NCT00920140|58635267|FG003|Phase 2|Physician Decision|3|||
30754971|NCT04124926|58764693|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
30828823|NCT01062555|58852323|FG000|Phase 2|Death|0|||
30828824|NCT01062555|58852324|FG001|Phase 2|Death|0|||
30828825|NCT01062555|58852325|FG002|Phase 2|Death|8|||
30828826|NCT01062555|58852326|FG003|Phase 2|Death|3|||
30828827|NCT01062555|58852323|FG000|Phase 2|Graft failure|0|||
30623465|NCT00920140|58635268|FG004|Phase 2|Physician Decision|2|||
30828828|NCT01062555|58852324|FG001|Phase 2|Graft failure|0|||
30828829|NCT01062555|58852325|FG002|Phase 2|Graft failure|7|||
30828830|NCT01062555|58852326|FG003|Phase 2|Graft failure|4|||
30623466|NCT00920140|58635264|FG000|Phase 2|Withdrawal by Subject|0|||
30828831|NCT01062555|58852323|FG000|Phase 2|Withdrawal by Subject|0|||
30828832|NCT01062555|58852324|FG001|Phase 2|Withdrawal by Subject|0|||
30828833|NCT01062555|58852325|FG002|Phase 2|Withdrawal by Subject|0|||
30828834|NCT01062555|58852326|FG003|Phase 2|Withdrawal by Subject|7|||
30828835|NCT01062555|58852323|FG000|Phase 2|Protocol Violation|0|||
30828836|NCT01062555|58852324|FG001|Phase 2|Protocol Violation|0|||
30828837|NCT01062555|58852325|FG002|Phase 2|Protocol Violation|0|||
30828838|NCT01062555|58852326|FG003|Phase 2|Protocol Violation|3|||
30828839|NCT01062555|58852323|FG000|Phase 2|Physician Decision|0|||
30828840|NCT01062555|58852324|FG001|Phase 2|Physician Decision|0|||
30828841|NCT01062555|58852325|FG002|Phase 2|Physician Decision|0|||
30828842|NCT01062555|58852326|FG003|Phase 2|Physician Decision|17|||
30828843|NCT01064817|58852338|FG000|Study Completion|Physician Decision|1|||
30828844|NCT01064817|58852339|FG001|Study Completion|Physician Decision|0|||
30828845|NCT01064817|58852338|FG000|Study Completion|Withdrawal by Subject|1|||
30828846|NCT01064817|58852339|FG001|Study Completion|Withdrawal by Subject|0|||
30828847|NCT01368276|58852347|FG000|Overall Study|Death|1|||
30828848|NCT01368276|58852348|FG001|Overall Study|Death|10|||
30828849|NCT01064739|58852354|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
30828850|NCT02741570|58852366|FG000|Pre-Treatment Period|Other reasons|0|||
30828851|NCT02741570|58852367|FG001|Pre-Treatment Period|Other reasons|3|||
30828852|NCT02741570|58852366|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
30828853|NCT02741570|58852367|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
30828854|NCT02741570|58852366|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
30828855|NCT02741570|58852367|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
30828856|NCT02741570|58852366|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
30828857|NCT02741570|58852367|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
30828858|NCT02741570|58852366|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
30828859|NCT02741570|58852367|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
30828860|NCT02741570|58852366|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
30828861|NCT02741570|58852367|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
30828862|NCT02741570|58852366|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
30828863|NCT02741570|58852367|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
30828864|NCT02741570|58852366|FG000|Pre-Treatment Period|Death|0|||
30828865|NCT02741570|58852367|FG001|Pre-Treatment Period|Death|1|||
30828866|NCT02741570|58852366|FG000|Pre-Treatment Period|Disease progression|0|||
30828867|NCT02741570|58852367|FG001|Pre-Treatment Period|Disease progression|1|||
30828868|NCT02741570|58852366|FG000|Treatment Period|Other reasons|47|||
30828869|NCT02741570|58852367|FG001|Treatment Period|Other reasons|8|||
30828870|NCT02741570|58852366|FG000|Treatment Period|Poor/non-compliance|0|||
30828871|NCT02741570|58852367|FG001|Treatment Period|Poor/non-compliance|1|||
30828872|NCT02741570|58852366|FG000|Treatment Period|Maximum clinical benefit|3|||
30828873|NCT02741570|58852367|FG001|Treatment Period|Maximum clinical benefit|5|||
30828874|NCT02741570|58852366|FG000|Treatment Period|Lost to Follow-up|1|||
30828875|NCT02741570|58852367|FG001|Treatment Period|Lost to Follow-up|3|||
30921881|NCT01628549|58957197|FG003|Overall Study|Lost to Follow-up|3|||
30921882|NCT01628549|58957194|FG000|Overall Study|Withdrawal by Subject|3|||
30921883|NCT01628549|58957195|FG001|Overall Study|Withdrawal by Subject|4|||
30921884|NCT01628549|58957196|FG002|Overall Study|Withdrawal by Subject|4|||
30921885|NCT01628549|58957197|FG003|Overall Study|Withdrawal by Subject|1|||
30921886|NCT01628549|58957194|FG000|Overall Study|Protocol Violation|2|||
30921887|NCT01628549|58957195|FG001|Overall Study|Protocol Violation|1|||
30921888|NCT01628549|58957196|FG002|Overall Study|Protocol Violation|1|||
30921889|NCT01628549|58957197|FG003|Overall Study|Protocol Violation|0|||
30921890|NCT01628549|58957194|FG000|Overall Study|withdrawn for noncompliance|0|||
30921891|NCT01628549|58957195|FG001|Overall Study|withdrawn for noncompliance|2|||
30921892|NCT01628549|58957196|FG002|Overall Study|withdrawn for noncompliance|1|||
30828876|NCT02741570|58852366|FG000|Treatment Period|Participant withdrew consent|9|||
30828877|NCT02741570|58852367|FG001|Treatment Period|Participant withdrew consent|13|||
30828878|NCT02741570|58852366|FG000|Treatment Period|Participant request to discontinue treatment|8|||
30828879|NCT02741570|58852367|FG001|Treatment Period|Participant request to discontinue treatment|23|||
30828880|NCT02741570|58852366|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
30828881|NCT02741570|58852367|FG001|Treatment Period|Adverse event unrelated to study drug|25|||
30828882|NCT02741570|58852366|FG000|Treatment Period|Death|9|||
30828883|NCT02741570|58852367|FG001|Treatment Period|Death|7|||
30828884|NCT02741570|58852366|FG000|Treatment Period|Study drug toxicity|55|||
30828885|NCT02741570|58852367|FG001|Treatment Period|Study drug toxicity|45|||
30921893|NCT01628549|58957197|FG003|Overall Study|withdrawn for noncompliance|0|||
30921894|NCT01628549|58957194|FG000|Overall Study|abnormal laboratory test results|0|||
30921895|NCT01628549|58957195|FG001|Overall Study|abnormal laboratory test results|0|||
30623467|NCT00920140|58635265|FG001|Phase 2|Withdrawal by Subject|0|||
30921896|NCT01628549|58957196|FG002|Overall Study|abnormal laboratory test results|1|||
30921897|NCT01628549|58957197|FG003|Overall Study|abnormal laboratory test results|0|||
30921898|NCT01628549|58957194|FG000|Overall Study|positive pregnancy test|0|||
30921899|NCT01628549|58957195|FG001|Overall Study|positive pregnancy test|0|||
30921900|NCT01628549|58957196|FG002|Overall Study|positive pregnancy test|0|||
30921901|NCT01628549|58957197|FG003|Overall Study|positive pregnancy test|1|||
30921902|NCT02127125|58957216|FG000|Overall Study|Lost to Follow-up|0|||
30921903|NCT02127125|58957217|FG001|Overall Study|Lost to Follow-up|0|||
30921904|NCT02127125|58957218|FG002|Overall Study|Lost to Follow-up|0|||
30921905|NCT02127125|58957219|FG003|Overall Study|Lost to Follow-up|0|||
30921906|NCT02127125|58957220|FG004|Overall Study|Lost to Follow-up|2|||
30921907|NCT02127125|58957221|FG005|Overall Study|Lost to Follow-up|1|||
30921908|NCT02127125|58957222|FG006|Overall Study|Lost to Follow-up|0|||
30921909|NCT02127125|58957223|FG007|Overall Study|Lost to Follow-up|0|||
30921910|NCT02127125|58957224|FG008|Overall Study|Lost to Follow-up|0|||
30921911|NCT02127125|58957216|FG000|Overall Study|Withdrawal by Subject|0|||
30921912|NCT02127125|58957217|FG001|Overall Study|Withdrawal by Subject|0|||
30828886|NCT02741570|58852366|FG000|Treatment Period|Disease progression|295|||
30828887|NCT02741570|58852367|FG001|Treatment Period|Disease progression|304|||
30828888|NCT01061775|58852373|FG000|Overall Study|Physician Decision|2|||
30828889|NCT01061775|58852373|FG000|Overall Study|Lost to Follow-up|1|||
30828890|NCT02651116|58852380|FG000|Overall Study|Adverse Event|0|||
30828891|NCT02651116|58852381|FG001|Overall Study|Adverse Event|1|||
30828892|NCT02651116|58852380|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
30828893|NCT02651116|58852381|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
30828894|NCT01061385|58852389|FG000|Overall Study|Lost to Follow-up|1|||
30828895|NCT01061385|58852390|FG001|Overall Study|Lost to Follow-up|0|||
30828896|NCT01061385|58852389|FG000|Overall Study|subject decision not related to AE|0|||
30828897|NCT01061385|58852390|FG001|Overall Study|subject decision not related to AE|1|||
30828898|NCT02973477|58852399|FG000|First Intervention|Lost to Follow-up|0|||
30828899|NCT02973477|58852400|FG001|First Intervention|Lost to Follow-up|2|||
30828900|NCT02973477|58852399|FG000|Washout|Withdrawal by Subject|1|||
30828901|NCT02973477|58852400|FG001|Washout|Withdrawal by Subject|0|||
30828902|NCT02973477|58852399|FG000|Second Intervention|Lost to Follow-up|1|||
30828903|NCT02973477|58852400|FG001|Second Intervention|Lost to Follow-up|0|||
30828904|NCT02788656|58852414|FG000|Overall Study|Withdrawal by Subject|1|||
30828905|NCT02788656|58852415|FG001|Overall Study|Withdrawal by Subject|0|||
30828906|NCT00283868|58852423|FG000|Overall Study|Lost to Follow-up|7|||
30828907|NCT00283868|58852424|FG001|Overall Study|Lost to Follow-up|8|||
30828908|NCT02973087|58852430|FG000|Overall Study|Withdrawal by Subject|2|||
30828909|NCT02973087|58852431|FG001|Overall Study|Withdrawal by Subject|1|||
30828910|NCT02973087|58852430|FG000|Overall Study|Adverse Event|1|||
30828911|NCT02973087|58852431|FG001|Overall Study|Adverse Event|0|||
30828912|NCT02973087|58852430|FG000|Overall Study|other|1|||
30828913|NCT02973087|58852431|FG001|Overall Study|other|1|||
30828914|NCT00271544|58852451|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
30828915|NCT00271544|58852451|FG000|Overall Study|Model 4196 lead not attempted|9|||
30828916|NCT00271544|58852451|FG000|Overall Study|Implant not attempted|4|||
30828917|NCT05342532|58852469|FG000|Overall Study|Adverse Event|5|||
30828918|NCT05342532|58852470|FG001|Overall Study|Adverse Event|20|||
30828919|NCT05342532|58852469|FG000|Overall Study|Lost to Follow-up|10|||
30828920|NCT05342532|58852470|FG001|Overall Study|Lost to Follow-up|15|||
30828921|NCT02984943|58852476|FG000|Overall Study|Withdrawal by Subject|3|||
30828922|NCT02984943|58852476|FG000|Overall Study|Physician Decision|1|||
30828923|NCT02787408|58852480|FG000|Overall Study|Death|16|||
30828924|NCT02787408|58852480|FG000|Overall Study|Withdrawal by Subject|1|||
30828925|NCT02787408|58852480|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
30828926|NCT02971605|58852484|FG000|Overall Study|Withdrawal by Subject|1|||
30828927|NCT03054337|58852496|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
30828928|NCT03054337|58852497|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
30828929|NCT03054337|58852498|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
30828930|NCT03054337|58852499|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
30828931|NCT03054337|58852500|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
30828932|NCT03054337|58852501|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
30828933|NCT01060059|58852534|FG000|Overall Study|Adverse Event|1|||
30828934|NCT01060059|58852535|FG001|Overall Study|Adverse Event|1|||
30828935|NCT01060059|58852534|FG000|Overall Study|Death|2|||
30828936|NCT01060059|58852535|FG001|Overall Study|Death|3|||
30828937|NCT01060059|58852534|FG000|Overall Study|Lost to Follow-up|18|||
30828938|NCT01060059|58852535|FG001|Overall Study|Lost to Follow-up|34|||
30828939|NCT01060059|58852534|FG000|Overall Study|entry criteria not met|4|||
30828940|NCT01060059|58852535|FG001|Overall Study|entry criteria not met|3|||
30921913|NCT02127125|58957218|FG002|Overall Study|Withdrawal by Subject|0|||
30921914|NCT02127125|58957219|FG003|Overall Study|Withdrawal by Subject|1|||
30921915|NCT02127125|58957220|FG004|Overall Study|Withdrawal by Subject|0|||
30921916|NCT02127125|58957221|FG005|Overall Study|Withdrawal by Subject|0|||
30828941|NCT01060059|58852534|FG000|Overall Study|Withdrawal by Subject|35|||
30828942|NCT01060059|58852535|FG001|Overall Study|Withdrawal by Subject|23|||
30828943|NCT01060059|58852534|FG000|Overall Study|lack of glycemic control|2|||
30828944|NCT01060059|58852535|FG001|Overall Study|lack of glycemic control|1|||
30828945|NCT01060059|58852534|FG000|Overall Study|lack of compliance|5|||
30828946|NCT01060059|58852535|FG001|Overall Study|lack of compliance|2|||
30828947|NCT02648932|58852549|FG000|Overall Study|No transplant|3|||
30828948|NCT02648932|58852550|FG001|Overall Study|No transplant|1|||
30828949|NCT02122458|58852563|FG000|Overall Study|Withdrawal by Subject|0|||
30828950|NCT02122458|58852564|FG001|Overall Study|Withdrawal by Subject|0|||
30828951|NCT02122458|58852565|FG002|Overall Study|Withdrawal by Subject|0|||
30828952|NCT02122458|58852566|FG003|Overall Study|Withdrawal by Subject|4|||
30828953|NCT02122458|58852567|FG004|Overall Study|Withdrawal by Subject|4|||
30828954|NCT02122458|58852568|FG005|Overall Study|Withdrawal by Subject|4|||
30828955|NCT02122458|58852569|FG006|Overall Study|Withdrawal by Subject|0|||
30828956|NCT02122458|58852563|FG000|Overall Study|Lost to Follow-up|1|||
30828957|NCT02122458|58852564|FG001|Overall Study|Lost to Follow-up|3|||
30828958|NCT02122458|58852565|FG002|Overall Study|Lost to Follow-up|0|||
30828959|NCT02122458|58852566|FG003|Overall Study|Lost to Follow-up|7|||
30828960|NCT02122458|58852567|FG004|Overall Study|Lost to Follow-up|5|||
30828961|NCT02122458|58852568|FG005|Overall Study|Lost to Follow-up|15|||
30828962|NCT02122458|58852569|FG006|Overall Study|Lost to Follow-up|1|||
30828963|NCT02122458|58852563|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
30828964|NCT02122458|58852564|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
30828965|NCT02122458|58852565|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
30828966|NCT02122458|58852566|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
30828967|NCT02122458|58852567|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
30828968|NCT02122458|58852568|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
30828969|NCT02122458|58852569|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
30828970|NCT02122458|58852563|FG000|Overall Study|Adverse Event|1|||
30828971|NCT02122458|58852564|FG001|Overall Study|Adverse Event|0|||
30828972|NCT02122458|58852565|FG002|Overall Study|Adverse Event|0|||
30828973|NCT02122458|58852566|FG003|Overall Study|Adverse Event|0|||
30921917|NCT02127125|58957222|FG006|Overall Study|Withdrawal by Subject|0|||
30921918|NCT02127125|58957223|FG007|Overall Study|Withdrawal by Subject|0|||
30828974|NCT02122458|58852567|FG004|Overall Study|Adverse Event|0|||
30828975|NCT02122458|58852568|FG005|Overall Study|Adverse Event|0|||
30828976|NCT02122458|58852569|FG006|Overall Study|Adverse Event|0|||
30828977|NCT02122458|58852563|FG000|Overall Study|Experimental Error|0|||
30828978|NCT02122458|58852564|FG001|Overall Study|Experimental Error|0|||
30828979|NCT02122458|58852565|FG002|Overall Study|Experimental Error|0|||
30828980|NCT02122458|58852566|FG003|Overall Study|Experimental Error|0|||
30828981|NCT02122458|58852567|FG004|Overall Study|Experimental Error|3|||
30828982|NCT02122458|58852568|FG005|Overall Study|Experimental Error|0|||
30828983|NCT02122458|58852569|FG006|Overall Study|Experimental Error|0|||
30828984|NCT02122458|58852563|FG000|Overall Study|Deployed or Moved|0|||
30828985|NCT02122458|58852564|FG001|Overall Study|Deployed or Moved|0|||
30828986|NCT02122458|58852565|FG002|Overall Study|Deployed or Moved|0|||
30828987|NCT02122458|58852566|FG003|Overall Study|Deployed or Moved|0|||
30828988|NCT02122458|58852567|FG004|Overall Study|Deployed or Moved|1|||
30828989|NCT02122458|58852568|FG005|Overall Study|Deployed or Moved|0|||
30828990|NCT02122458|58852569|FG006|Overall Study|Deployed or Moved|0|||
30828991|NCT02122458|58852563|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
30828992|NCT02122458|58852564|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
30828993|NCT02122458|58852565|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
30828994|NCT02122458|58852566|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
30828995|NCT02122458|58852567|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
30828996|NCT02122458|58852568|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
30828997|NCT02122458|58852569|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
30828998|NCT02122458|58852563|FG000|Overall Study|Noncompliance|0|||
30828999|NCT02122458|58852564|FG001|Overall Study|Noncompliance|1|||
30829000|NCT02122458|58852565|FG002|Overall Study|Noncompliance|0|||
30829001|NCT02122458|58852566|FG003|Overall Study|Noncompliance|0|||
30829002|NCT02122458|58852567|FG004|Overall Study|Noncompliance|0|||
30829003|NCT02122458|58852568|FG005|Overall Study|Noncompliance|0|||
30829004|NCT02122458|58852569|FG006|Overall Study|Noncompliance|0|||
30921919|NCT02127125|58957224|FG008|Overall Study|Withdrawal by Subject|0|||
30921920|NCT02127125|58957216|FG000|Overall Study|Physician Decision|0|||
30623468|NCT00920140|58635266|FG002|Phase 2|Withdrawal by Subject|4|||
30829005|NCT02903511|58852585|FG000|Overall Study|Withdrawal by Subject|1|||
30921921|NCT02127125|58957217|FG001|Overall Study|Physician Decision|0|||
30829006|NCT02903511|58852586|FG001|Overall Study|Withdrawal by Subject|0|||
30829007|NCT02903511|58852585|FG000|Overall Study|Lost to Follow-up|3|||
30829008|NCT02903511|58852586|FG001|Overall Study|Lost to Follow-up|2|||
30829009|NCT01368042|58852603|FG000|Overall Study|Death|14|||
30829010|NCT01368042|58852603|FG000|Overall Study|Protocol Violation|11|||
30829011|NCT01368042|58852603|FG000|Overall Study|Lost to Follow-up|4|||
30829012|NCT01368042|58852603|FG000|Overall Study|Transplanted|1|||
30829013|NCT00126776|58852609|FG000|Overall Study|follow up complete on all patients|0|||
30829014|NCT00126776|58852610|FG001|Overall Study|follow up complete on all patients|0|||
30829015|NCT01674010|58852614|FG000|Open Treatment Phase 1|Adverse Event|10|||
30829016|NCT01674010|58852615|FG001|Open Treatment Phase 1|Adverse Event|0|||
30829017|NCT01674010|58852616|FG002|Open Treatment Phase 1|Adverse Event|0|||
30829018|NCT01674010|58852614|FG000|Open Treatment Phase 1|Death|1|||
30829019|NCT01674010|58852615|FG001|Open Treatment Phase 1|Death|0|||
30829020|NCT01674010|58852616|FG002|Open Treatment Phase 1|Death|0|||
30829021|NCT01674010|58852614|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
30829022|NCT01674010|58852615|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
30829023|NCT01674010|58852616|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
30829024|NCT01674010|58852614|FG000|Open Treatment Phase 1|Physician Decision|9|||
30921922|NCT02127125|58957218|FG002|Overall Study|Physician Decision|1|||
30921923|NCT02127125|58957219|FG003|Overall Study|Physician Decision|0|||
30829025|NCT01674010|58852615|FG001|Open Treatment Phase 1|Physician Decision|0|||
30829026|NCT01674010|58852616|FG002|Open Treatment Phase 1|Physician Decision|0|||
30829027|NCT01674010|58852614|FG000|Open Treatment Phase 1|Protocol Violation|7|||
30829028|NCT01674010|58852615|FG001|Open Treatment Phase 1|Protocol Violation|0|||
30829029|NCT01674010|58852616|FG002|Open Treatment Phase 1|Protocol Violation|0|||
30829030|NCT01674010|58852614|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
30829031|NCT01674010|58852615|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
30829032|NCT01674010|58852616|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
30829033|NCT01674010|58852614|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
30829034|NCT01674010|58852615|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
30829035|NCT01674010|58852616|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
30829036|NCT01674010|58852614|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
30829037|NCT01674010|58852615|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
30829038|NCT01674010|58852616|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
30829039|NCT01674010|58852614|FG000|Randomization Phase 2|Adverse Event|0|||
30829040|NCT01674010|58852615|FG001|Randomization Phase 2|Adverse Event|1|||
30829041|NCT01674010|58852616|FG002|Randomization Phase 2|Adverse Event|1|||
30829042|NCT01674010|58852614|FG000|Randomization Phase 2|Lost to Follow-up|0|||
30829043|NCT01674010|58852615|FG001|Randomization Phase 2|Lost to Follow-up|1|||
30829044|NCT01674010|58852616|FG002|Randomization Phase 2|Lost to Follow-up|2|||
30829045|NCT01674010|58852614|FG000|Randomization Phase 2|Mood episode recurrence|0|||
30829046|NCT01674010|58852615|FG001|Randomization Phase 2|Mood episode recurrence|8|||
30829047|NCT01674010|58852616|FG002|Randomization Phase 2|Mood episode recurrence|2|||
30829048|NCT01674010|58852614|FG000|Randomization Phase 2|Physician Decision|0|||
30829049|NCT01674010|58852615|FG001|Randomization Phase 2|Physician Decision|0|||
30829050|NCT01674010|58852616|FG002|Randomization Phase 2|Physician Decision|2|||
30829051|NCT01674010|58852614|FG000|Randomization Phase 2|Pregnancy|0|||
30829052|NCT01674010|58852615|FG001|Randomization Phase 2|Pregnancy|1|||
30829053|NCT01674010|58852616|FG002|Randomization Phase 2|Pregnancy|1|||
30829054|NCT01674010|58852614|FG000|Randomization Phase 2|Protocol Violation|0|||
30829055|NCT01674010|58852615|FG001|Randomization Phase 2|Protocol Violation|1|||
30829056|NCT01674010|58852616|FG002|Randomization Phase 2|Protocol Violation|1|||
30829057|NCT01674010|58852614|FG000|Randomization Phase 2|Sponsor Decision|0|||
30829058|NCT01674010|58852615|FG001|Randomization Phase 2|Sponsor Decision|42|||
30829059|NCT01674010|58852616|FG002|Randomization Phase 2|Sponsor Decision|45|||
30921924|NCT02127125|58957220|FG004|Overall Study|Physician Decision|1|||
30754972|NCT04124926|58764694|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
30754973|NCT04124926|58764690|FG000|Healing Phase|Protocol Violation|0|||
30754974|NCT04124926|58764691|FG001|Healing Phase|Protocol Violation|1|||
30754975|NCT04124926|58764692|FG002|Healing Phase|Protocol Violation|0|||
30754976|NCT04124926|58764693|FG003|Healing Phase|Protocol Violation|0|||
30754977|NCT04124926|58764694|FG004|Healing Phase|Protocol Violation|0|||
30754978|NCT04124926|58764690|FG000|Healing Phase|Lost to Follow-up|5|||
30754979|NCT04124926|58764691|FG001|Healing Phase|Lost to Follow-up|4|||
30754980|NCT04124926|58764692|FG002|Healing Phase|Lost to Follow-up|0|||
30754981|NCT04124926|58764693|FG003|Healing Phase|Lost to Follow-up|0|||
30754982|NCT04124926|58764694|FG004|Healing Phase|Lost to Follow-up|0|||
30754983|NCT04124926|58764690|FG000|Healing Phase|Voluntary Withdrawal|10|||
30829060|NCT01674010|58852614|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
30829061|NCT01674010|58852615|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
30829062|NCT01674010|58852616|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
30829063|NCT01345669|58852626|FG000|Overall Study|Primary tumour recurrence|53|||
30829064|NCT01345669|58852627|FG001|Overall Study|Primary tumour recurrence|32|||
30829065|NCT01345669|58852626|FG000|Overall Study|Second primary tumour|4|||
30921925|NCT02127125|58957221|FG005|Overall Study|Physician Decision|2|||
30829066|NCT01345669|58852627|FG001|Overall Study|Second primary tumour|3|||
30829067|NCT01345669|58852626|FG000|Overall Study|Adverse Event|63|||
30829068|NCT01345669|58852627|FG001|Overall Study|Adverse Event|9|||
30829069|NCT01345669|58852626|FG000|Overall Study|Protocol Violation|3|||
30829070|NCT01345669|58852627|FG001|Overall Study|Protocol Violation|1|||
30754984|NCT04124926|58764691|FG001|Healing Phase|Voluntary Withdrawal|7|||
30754985|NCT04124926|58764692|FG002|Healing Phase|Voluntary Withdrawal|0|||
30754986|NCT04124926|58764693|FG003|Healing Phase|Voluntary Withdrawal|0|||
30754987|NCT04124926|58764694|FG004|Healing Phase|Voluntary Withdrawal|0|||
30754988|NCT04124926|58764690|FG000|Healing Phase|Withdrawal of Consent|5|||
30754989|NCT04124926|58764691|FG001|Healing Phase|Withdrawal of Consent|3|||
30754990|NCT04124926|58764692|FG002|Healing Phase|Withdrawal of Consent|0|||
30921926|NCT02127125|58957222|FG006|Overall Study|Physician Decision|0|||
30754991|NCT04124926|58764693|FG003|Healing Phase|Withdrawal of Consent|0|||
30754992|NCT04124926|58764694|FG004|Healing Phase|Withdrawal of Consent|0|||
30754993|NCT04124926|58764690|FG000|Healing Phase|Miscellaneous|8|||
30754994|NCT04124926|58764691|FG001|Healing Phase|Miscellaneous|7|||
30754995|NCT04124926|58764692|FG002|Healing Phase|Miscellaneous|0|||
30754996|NCT04124926|58764693|FG003|Healing Phase|Miscellaneous|0|||
30754997|NCT04124926|58764694|FG004|Healing Phase|Miscellaneous|0|||
30754998|NCT04124926|58764690|FG000|Healing Phase|Randomized but not Treated|0|||
30754999|NCT04124926|58764691|FG001|Healing Phase|Randomized but not Treated|3|||
30755000|NCT04124926|58764692|FG002|Healing Phase|Randomized but not Treated|0|||
30755001|NCT04124926|58764693|FG003|Healing Phase|Randomized but not Treated|0|||
30755002|NCT04124926|58764694|FG004|Healing Phase|Randomized but not Treated|0|||
30755003|NCT04124926|58764690|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
30755004|NCT04124926|58764691|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
30755005|NCT04124926|58764692|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
30755006|NCT04124926|58764693|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
30755007|NCT04124926|58764694|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
30921927|NCT02127125|58957223|FG007|Overall Study|Physician Decision|0|||
30921928|NCT02127125|58957224|FG008|Overall Study|Physician Decision|0|||
30921929|NCT02090413|58957247|FG000|Overall Study|Adverse Event|11|||
30921930|NCT02090413|58957248|FG001|Overall Study|Adverse Event|15|||
30921931|NCT02090413|58957249|FG002|Overall Study|Adverse Event|20|||
30921932|NCT02090413|58957247|FG000|Overall Study|Flushing event|2|||
30921933|NCT02090413|58957248|FG001|Overall Study|Flushing event|0|||
30921934|NCT02090413|58957249|FG002|Overall Study|Flushing event|1|||
30921935|NCT02090413|58957247|FG000|Overall Study|Withdrawal by Subject|2|||
30921936|NCT02090413|58957248|FG001|Overall Study|Withdrawal by Subject|2|||
30921937|NCT02090413|58957249|FG002|Overall Study|Withdrawal by Subject|2|||
30921938|NCT02090413|58957247|FG000|Overall Study|Investigator Decision|1|||
30921939|NCT02090413|58957248|FG001|Overall Study|Investigator Decision|1|||
30921940|NCT02090413|58957249|FG002|Overall Study|Investigator Decision|0|||
30921941|NCT02090413|58957247|FG000|Overall Study|Other|2|||
30921942|NCT02090413|58957248|FG001|Overall Study|Other|1|||
30921943|NCT02090413|58957249|FG002|Overall Study|Other|0|||
30921944|NCT02090413|58957247|FG000|Overall Study|Lost to Follow-up|1|||
30921945|NCT02090413|58957248|FG001|Overall Study|Lost to Follow-up|1|||
30755008|NCT04124926|58764690|FG000|Maintenance Phase|Protocol Violation|0|||
30755009|NCT04124926|58764691|FG001|Maintenance Phase|Protocol Violation|0|||
30755010|NCT04124926|58764692|FG002|Maintenance Phase|Protocol Violation|3|||
30755011|NCT04124926|58764693|FG003|Maintenance Phase|Protocol Violation|0|||
30755012|NCT04124926|58764694|FG004|Maintenance Phase|Protocol Violation|0|||
30755013|NCT04124926|58764690|FG000|Maintenance Phase|Lost to Follow-up|0|||
30755014|NCT04124926|58764691|FG001|Maintenance Phase|Lost to Follow-up|0|||
30755015|NCT04124926|58764692|FG002|Maintenance Phase|Lost to Follow-up|7|||
30755016|NCT04124926|58764693|FG003|Maintenance Phase|Lost to Follow-up|8|||
30755017|NCT04124926|58764694|FG004|Maintenance Phase|Lost to Follow-up|9|||
30755018|NCT04124926|58764690|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
30755019|NCT04124926|58764691|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
30755020|NCT04124926|58764692|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
30829071|NCT01345669|58852626|FG000|Overall Study|Lost to Follow-up|1|||
30921946|NCT02090413|58957249|FG002|Overall Study|Lost to Follow-up|0|||
30623469|NCT00920140|58635267|FG003|Phase 2|Withdrawal by Subject|2|||
30755021|NCT04124926|58764693|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
30755022|NCT04124926|58764694|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
30829072|NCT01345669|58852627|FG001|Overall Study|Lost to Follow-up|1|||
30755023|NCT04124926|58764690|FG000|Maintenance Phase|Pregnancy|0|||
30829073|NCT01345669|58852626|FG000|Overall Study|Withdrawal by Subject|52|||
30921947|NCT02063737|58957260|FG000|Overall Study|Lost to Follow-up|11|||
30921948|NCT02063737|58957261|FG001|Overall Study|Lost to Follow-up|4|||
30921949|NCT02125877|58957269|FG000|Overall Study|Physician Decision|1|||
30921950|NCT02125877|58957270|FG001|Overall Study|Physician Decision|0|||
30921951|NCT02125877|58957269|FG000|Overall Study|Death|0|||
30921952|NCT02125877|58957270|FG001|Overall Study|Death|1|||
30921953|NCT02125877|58957269|FG000|Overall Study|Administrative problems|0|||
30921954|NCT02125877|58957270|FG001|Overall Study|Administrative problems|1|||
30921955|NCT02125877|58957269|FG000|Overall Study|Participant/guardian decision|0|||
30921956|NCT02125877|58957270|FG001|Overall Study|Participant/guardian decision|2|||
30755024|NCT04124926|58764691|FG001|Maintenance Phase|Pregnancy|0|||
30755025|NCT04124926|58764692|FG002|Maintenance Phase|Pregnancy|0|||
30755026|NCT04124926|58764693|FG003|Maintenance Phase|Pregnancy|1|||
30755027|NCT04124926|58764694|FG004|Maintenance Phase|Pregnancy|0|||
30755028|NCT04124926|58764690|FG000|Maintenance Phase|Lack of Efficacy|0|||
30755029|NCT04124926|58764691|FG001|Maintenance Phase|Lack of Efficacy|0|||
30755030|NCT04124926|58764692|FG002|Maintenance Phase|Lack of Efficacy|0|||
30755031|NCT04124926|58764693|FG003|Maintenance Phase|Lack of Efficacy|0|||
30755032|NCT04124926|58764694|FG004|Maintenance Phase|Lack of Efficacy|1|||
30755033|NCT04124926|58764690|FG000|Maintenance Phase|Withdrawal of Consent|0|||
30755034|NCT04124926|58764691|FG001|Maintenance Phase|Withdrawal of Consent|0|||
30755035|NCT04124926|58764692|FG002|Maintenance Phase|Withdrawal of Consent|5|||
30755036|NCT04124926|58764693|FG003|Maintenance Phase|Withdrawal of Consent|5|||
30755037|NCT04124926|58764694|FG004|Maintenance Phase|Withdrawal of Consent|5|||
30755038|NCT04124926|58764690|FG000|Maintenance Phase|Miscellaneous|0|||
30829074|NCT01345669|58852627|FG001|Overall Study|Withdrawal by Subject|13|||
30829075|NCT01345669|58852626|FG000|Overall Study|Other Reasons|111|||
30829076|NCT01345669|58852627|FG001|Overall Study|Other Reasons|60|||
30829077|NCT05334212|58852633|FG000|Overall Study|Study terminated prematurely|7|||
30921957|NCT02125877|58957269|FG000|Overall Study|Withdrawal by Subject|2|||
30921958|NCT02125877|58957270|FG001|Overall Study|Withdrawal by Subject|1|||
30921959|NCT02125877|58957269|FG000|Overall Study|Protocol deviation|4|||
30921960|NCT02125877|58957270|FG001|Overall Study|Protocol deviation|1|||
30921961|NCT02125877|58957269|FG000|Overall Study|Adverse Event|6|||
30921962|NCT02125877|58957270|FG001|Overall Study|Adverse Event|4|||
30921963|NCT01598987|58957276|FG000|Baseline to Month 12|Administrative problems|2|||
30829078|NCT01673854|58852637|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
30829079|NCT01673854|58852637|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
30829080|NCT01673854|58852637|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
30829081|NCT01673854|58852637|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
30829082|NCT01673854|58852637|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
30829083|NCT01673854|58852637|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
30829084|NCT01673854|58852637|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
30829085|NCT01673854|58852637|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
30829086|NCT01673854|58852637|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
30921964|NCT01598987|58957276|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
30921965|NCT01598987|58957276|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
30921966|NCT01598987|58957276|FG000|Baseline to 24 Month|Administrative problems|2|||
30921967|NCT01598987|58957276|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
30921968|NCT02063659|58957290|FG000|Double-Blind Treatment Period|Adverse Event|1|||
30921969|NCT02063659|58957291|FG001|Double-Blind Treatment Period|Adverse Event|2|||
30921970|NCT02063659|58957292|FG002|Double-Blind Treatment Period|Adverse Event|0|||
30921971|NCT02063659|58957293|FG003|Double-Blind Treatment Period|Adverse Event|0|||
30921972|NCT02063659|58957290|FG000|Double-Blind Treatment Period|Physician Decision|1|||
30921973|NCT02063659|58957291|FG001|Double-Blind Treatment Period|Physician Decision|0|||
30921974|NCT02063659|58957292|FG002|Double-Blind Treatment Period|Physician Decision|0|||
30829087|NCT01673854|58852637|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
30829088|NCT01673854|58852637|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
30829089|NCT01673854|58852637|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
30829090|NCT01343407|58852641|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
30829091|NCT01343407|58852642|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
30829092|NCT01343407|58852643|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
30829093|NCT01343407|58852644|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
30829094|NCT01343407|58852645|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
30829095|NCT01343407|58852646|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
30829096|NCT01343407|58852641|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
30829097|NCT01343407|58852642|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
30829098|NCT01343407|58852643|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
30829099|NCT01343407|58852644|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
30829100|NCT01343407|58852645|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
30829101|NCT01343407|58852646|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
30921975|NCT02063659|58957293|FG003|Double-Blind Treatment Period|Physician Decision|0|||
30921976|NCT02063659|58957290|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
30755039|NCT04124926|58764691|FG001|Maintenance Phase|Miscellaneous|0|||
30755040|NCT04124926|58764692|FG002|Maintenance Phase|Miscellaneous|1|||
30755041|NCT04124926|58764693|FG003|Maintenance Phase|Miscellaneous|2|||
30755042|NCT04124926|58764694|FG004|Maintenance Phase|Miscellaneous|4|||
30829102|NCT01367886|58852654|FG000|Overall Study|Lost to Follow-up|4|||
30829103|NCT01367886|58852654|FG000|Overall Study|Lack of Efficacy|2|||
30829104|NCT01367886|58852654|FG000|Overall Study|Death|1|||
30829105|NCT01673698|58852661|FG000|Overall Study|Lost to Follow-up|51|||
30829106|NCT01673698|58852662|FG001|Overall Study|Lost to Follow-up|13|||
30829107|NCT02786004|58852671|FG000|Overall Study|Withdrawal by Subject|0|||
30829108|NCT02786004|58852672|FG001|Overall Study|Withdrawal by Subject|1|||
30829109|NCT03051607|58852680|FG000|Overall Study|Adverse Event|66|||
30829110|NCT01062399|58852689|FG000|Overall Study|Protocol Violation|0|||
30829111|NCT01062399|58852690|FG001|Overall Study|Protocol Violation|1|||
30829112|NCT01062399|58852691|FG002|Overall Study|Protocol Violation|0|||
30829113|NCT01062399|58852692|FG003|Overall Study|Protocol Violation|6|||
30829114|NCT01062399|58852693|FG004|Overall Study|Protocol Violation|4|||
30829115|NCT01317277|58852707|FG000|Overall Study|Lost to Follow-up|3|||
30829116|NCT01317277|58852708|FG001|Overall Study|Lost to Follow-up|1|||
30829117|NCT01317277|58852707|FG000|Overall Study|Lost MEMS|1|||
30829118|NCT01317277|58852708|FG001|Overall Study|Lost MEMS|1|||
30829119|NCT01317277|58852707|FG000|Overall Study|Unable to comply with intervention|1|||
30829120|NCT01317277|58852708|FG001|Overall Study|Unable to comply with intervention|0|||
30829121|NCT01317277|58852707|FG000|Overall Study|Withdrawal by Subject|1|||
30829122|NCT01317277|58852708|FG001|Overall Study|Withdrawal by Subject|0|||
30829123|NCT01317277|58852707|FG000|Overall Study|Adverse Event|1|||
30829124|NCT01317277|58852708|FG001|Overall Study|Adverse Event|0|||
30829125|NCT02740478|58852714|FG000|Overall Study|Withdrawal by Subject|1|||
30829126|NCT02969655|58852720|FG000|Overall Study|Withdrawal by Subject|3|||
30829127|NCT02969655|58852721|FG001|Overall Study|Withdrawal by Subject|2|||
30829128|NCT02969655|58852720|FG000|Overall Study|Physician Decision|4|||
30829129|NCT02969655|58852721|FG001|Overall Study|Physician Decision|3|||
30829130|NCT02969655|58852720|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
30829131|NCT02969655|58852721|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
30829132|NCT02969655|58852720|FG000|Overall Study|Adverse Event|10|||
30829133|NCT02969655|58852721|FG001|Overall Study|Adverse Event|8|||
30829134|NCT01317199|58852732|FG000|Dose-escalation Phase 1|Physician Decision|5|||
30829135|NCT01317199|58852733|FG001|Dose-escalation Phase 1|Physician Decision|0|||
30829136|NCT01317199|58852734|FG002|Dose-escalation Phase 1|Physician Decision|0|||
30829137|NCT01317199|58852735|FG003|Dose-escalation Phase 1|Physician Decision|0|||
30829138|NCT01317199|58852732|FG000|Dose-escalation Phase 1|Disease progression|1|||
30829139|NCT01317199|58852733|FG001|Dose-escalation Phase 1|Disease progression|0|||
30829140|NCT01317199|58852734|FG002|Dose-escalation Phase 1|Disease progression|0|||
30829141|NCT01317199|58852735|FG003|Dose-escalation Phase 1|Disease progression|0|||
30829142|NCT01317199|58852732|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
30829143|NCT01317199|58852733|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
30829144|NCT01317199|58852734|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
30829145|NCT01317199|58852735|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
30829146|NCT01317199|58852732|FG000|Randomized Phase 2|Disease progression|0|||
30829147|NCT01317199|58852733|FG001|Randomized Phase 2|Disease progression|3|||
30829148|NCT01317199|58852734|FG002|Randomized Phase 2|Disease progression|7|||
30829149|NCT01317199|58852735|FG003|Randomized Phase 2|Disease progression|5|||
30829150|NCT01317199|58852732|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
30829151|NCT01317199|58852733|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
30829152|NCT01317199|58852734|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
30829153|NCT01317199|58852735|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
30829154|NCT01317199|58852732|FG000|Randomized Phase 2|Adverse Event|0|||
30829155|NCT01317199|58852733|FG001|Randomized Phase 2|Adverse Event|0|||
30829156|NCT01317199|58852734|FG002|Randomized Phase 2|Adverse Event|0|||
30829157|NCT01317199|58852735|FG003|Randomized Phase 2|Adverse Event|1|||
30829158|NCT01317199|58852732|FG000|Randomized Phase 2|Comorbidities|0|||
30829159|NCT01317199|58852733|FG001|Randomized Phase 2|Comorbidities|2|||
30829160|NCT01317199|58852734|FG002|Randomized Phase 2|Comorbidities|2|||
30829161|NCT01317199|58852735|FG003|Randomized Phase 2|Comorbidities|2|||
30829162|NCT01317199|58852732|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
30829163|NCT01317199|58852733|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
30829164|NCT01317199|58852734|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
30829165|NCT01317199|58852735|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
30829166|NCT01317199|58852732|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
30829167|NCT01317199|58852733|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
30829168|NCT01317199|58852734|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
30829169|NCT01317199|58852735|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
30623470|NCT00920140|58635268|FG004|Phase 2|Withdrawal by Subject|1|||
30829170|NCT01317199|58852732|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
30829171|NCT01317199|58852733|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
30829172|NCT01317199|58852734|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
30829173|NCT01317199|58852735|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
30829174|NCT01317199|58852732|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
30829175|NCT01317199|58852733|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
30829176|NCT01317199|58852734|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
30829177|NCT01317199|58852735|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
30829178|NCT02648698|58852754|FG000|Overall Study|Protocol Violation|1|||
30829179|NCT02648698|58852755|FG001|Overall Study|Protocol Violation|5|||
30829180|NCT02970669|58852763|FG000|Double-blind Period|Adverse Event|4|||
30829181|NCT02970669|58852764|FG001|Double-blind Period|Adverse Event|0|||
30829182|NCT02970669|58852763|FG000|Double-blind Period|Death|1|||
30829183|NCT02970669|58852764|FG001|Double-blind Period|Death|0|||
30829184|NCT02970669|58852763|FG000|Double-blind Period|Study terminated by sponsor|1|||
30829185|NCT02970669|58852764|FG001|Double-blind Period|Study terminated by sponsor|2|||
30829186|NCT02970669|58852763|FG000|Double-blind Period|Physician Decision|0|||
30829187|NCT02970669|58852764|FG001|Double-blind Period|Physician Decision|2|||
30829188|NCT02970669|58852763|FG000|Double-blind Period|Withdrawal by Subject|2|||
30829189|NCT02970669|58852764|FG001|Double-blind Period|Withdrawal by Subject|2|||
30829190|NCT02970669|58852763|FG000|Open-label Period|Withdrawal by Subject|2|||
30829191|NCT02970669|58852764|FG001|Open-label Period|Withdrawal by Subject|2|||
30829192|NCT02970669|58852763|FG000|Open-label Period|Adverse Event|1|||
30829193|NCT02970669|58852764|FG001|Open-label Period|Adverse Event|0|||
30829194|NCT02970669|58852763|FG000|Open-label Period|Physician Decision|1|||
30829195|NCT02970669|58852764|FG001|Open-label Period|Physician Decision|0|||
30829196|NCT02902965|58852772|FG000|Overall Study|Withdrawal by Subject|10|||
30829197|NCT02902809|58852777|FG000|Overall Study|Discontinuation of asthma program|28|||
30829198|NCT01362244|58852783|FG000|Overall Study|Adverse Event|3|||
30829199|NCT01362244|58852784|FG001|Overall Study|Adverse Event|5|||
30829200|NCT01362244|58852783|FG000|Overall Study|Lack of Efficacy|5|||
30829201|NCT01362244|58852784|FG001|Overall Study|Lack of Efficacy|11|||
30829202|NCT01362244|58852783|FG000|Overall Study|Lost to Follow-up|0|||
30829203|NCT01362244|58852784|FG001|Overall Study|Lost to Follow-up|2|||
30829204|NCT01362244|58852783|FG000|Overall Study|Protocol Violation|5|||
30829205|NCT01362244|58852784|FG001|Overall Study|Protocol Violation|1|||
30829206|NCT01362244|58852783|FG000|Overall Study|Withdrawal by Subject|2|||
30829207|NCT01362244|58852784|FG001|Overall Study|Withdrawal by Subject|1|||
30829208|NCT01362244|58852783|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
30829209|NCT01362244|58852784|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
30829210|NCT01362244|58852783|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
30829211|NCT01362244|58852784|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
30829212|NCT02969187|58852792|FG000|Overall Study|Physician Decision|12|||
30829213|NCT02969187|58852793|FG001|Overall Study|Physician Decision|13|||
30829214|NCT03050359|58852803|FG000|Overall Study|Randomized But Not Treated|2|||
30829215|NCT03050359|58852804|FG001|Overall Study|Randomized But Not Treated|0|||
30829216|NCT03050359|58852803|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
30829217|NCT03050359|58852804|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
30829218|NCT03050359|58852803|FG000|Overall Study|Significant Protocol Deviation|2|||
30829219|NCT03050359|58852804|FG001|Overall Study|Significant Protocol Deviation|3|||
30829220|NCT03050359|58852803|FG000|Overall Study|Lost to Follow-up|2|||
30829221|NCT03050359|58852804|FG001|Overall Study|Lost to Follow-up|1|||
30829222|NCT03050359|58852803|FG000|Overall Study|Voluntary Withdrawal|4|||
30829223|NCT03050359|58852804|FG001|Overall Study|Voluntary Withdrawal|6|||
30829224|NCT03050359|58852803|FG000|Overall Study|Pregnancy|1|||
30829225|NCT03050359|58852804|FG001|Overall Study|Pregnancy|0|||
30829226|NCT03050359|58852803|FG000|Overall Study|Reason Not Specified|1|||
30829227|NCT03050359|58852804|FG001|Overall Study|Reason Not Specified|0|||
30829228|NCT02785770|58852812|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
30829229|NCT02785770|58852813|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
30829230|NCT02785770|58852814|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
30829231|NCT02785770|58852815|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
30829232|NCT02785770|58852812|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
30829233|NCT02785770|58852813|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
30829234|NCT02785770|58852814|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
30829235|NCT02785770|58852815|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
30829236|NCT02785770|58852812|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
30829237|NCT02785770|58852813|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
30829238|NCT02785770|58852814|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
30829239|NCT02785770|58852815|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
30829240|NCT02965833|58852828|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
30829241|NCT02965833|58852829|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
30829242|NCT02965833|58852828|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
30829243|NCT02965833|58852829|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
30829244|NCT02965833|58852828|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
30829245|NCT02965833|58852829|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
30829246|NCT02965833|58852828|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
30829247|NCT02965833|58852829|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
30829248|NCT02965833|58852828|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
30829249|NCT02965833|58852829|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
30829250|NCT02968173|58852835|FG000|Overall Study|Withdrawal by Subject|1|||
30829251|NCT02785458|58852842|FG000|1 Month|Withdrawal by Subject|2|||
30829252|NCT02785458|58852843|FG001|1 Month|Withdrawal by Subject|1|||
30829253|NCT02785458|58852842|FG000|1 Month|Lost to Follow-up|38|||
30829254|NCT02785458|58852843|FG001|1 Month|Lost to Follow-up|31|||
30829255|NCT02785458|58852842|FG000|1 Month|Deemed Ineligible|1|||
30829256|NCT02785458|58852843|FG001|1 Month|Deemed Ineligible|0|||
30829257|NCT02785458|58852842|FG000|1 Month|Completed Evaluation by Baseline|42|||
30829258|NCT02785458|58852843|FG001|1 Month|Completed Evaluation by Baseline|39|||
30921977|NCT02063659|58957291|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
30921978|NCT02063659|58957292|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
30921979|NCT02063659|58957293|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
30921980|NCT02063659|58957290|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
30921981|NCT02063659|58957291|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
30921982|NCT02063659|58957292|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
30921983|NCT02063659|58957293|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
30921984|NCT02063659|58957290|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
30921985|NCT02063659|58957291|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
30921986|NCT02063659|58957292|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
30921987|NCT02063659|58957293|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
30921988|NCT02063659|58957290|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
30921989|NCT02063659|58957291|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
30921990|NCT02063659|58957292|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
30921991|NCT02063659|58957293|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
30921992|NCT02063659|58957290|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
30921993|NCT02063659|58957291|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
30921994|NCT02063659|58957292|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
30921995|NCT02063659|58957293|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
30921996|NCT02063659|58957290|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
30921997|NCT02063659|58957291|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
30921998|NCT02063659|58957292|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
30921999|NCT02063659|58957293|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
30922000|NCT02062879|58957309|FG000|Overall Study|Withdrawal by Subject|4|||
30922001|NCT02062879|58957310|FG001|Overall Study|Withdrawal by Subject|1|||
30922002|NCT02062645|58957316|FG000|Overall Study|Adverse Event|2|||
30922003|NCT02062645|58957316|FG000|Overall Study|Protocol Violation|8|||
30922004|NCT02062645|58957316|FG000|Overall Study|Lost to Follow-up|5|||
30922005|NCT02088697|58957322|FG000|Period I|Physician Decision|1|||
30922006|NCT02088697|58957323|FG001|Period I|Physician Decision|4|||
30922007|NCT02088697|58957322|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
30922008|NCT02088697|58957323|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
30922009|NCT01825785|58957336|FG000|Overall Study|Adverse Event|0|||
30922010|NCT01825785|58957337|FG001|Overall Study|Adverse Event|0|||
30922011|NCT01825785|58957338|FG002|Overall Study|Adverse Event|0|||
30922012|NCT01825785|58957339|FG003|Overall Study|Adverse Event|0|||
30922013|NCT01825785|58957340|FG004|Overall Study|Adverse Event|1|||
30922014|NCT01825785|58957341|FG005|Overall Study|Adverse Event|0|||
30922015|NCT01825785|58957342|FG006|Overall Study|Adverse Event|0|||
30922016|NCT01825785|58957336|FG000|Overall Study|Withdrawal by Subject|0|||
30755043|NCT04124926|58764690|FG000|Maintenance Phase|Randomized but not Treated|0|||
30755044|NCT04124926|58764691|FG001|Maintenance Phase|Randomized but not Treated|0|||
30755045|NCT04124926|58764692|FG002|Maintenance Phase|Randomized but not Treated|2|||
30755046|NCT04124926|58764693|FG003|Maintenance Phase|Randomized but not Treated|2|||
30755047|NCT04124926|58764694|FG004|Maintenance Phase|Randomized but not Treated|0|||
30755048|NCT04274686|58764706|FG000|Overall Study|Physician Decision|1|||
30755049|NCT04274686|58764707|FG001|Overall Study|Physician Decision|0|||
30755050|NCT04113694|58764715|FG000|Overall Study|Adverse Event|2|||
30829259|NCT02785458|58852842|FG000|1 Month|Partial Interview|0|||
30829260|NCT02785458|58852843|FG001|1 Month|Partial Interview|4|||
30829261|NCT02785458|58852842|FG000|3 Months|Withdrawal by Subject|3|||
30829262|NCT02785458|58852843|FG001|3 Months|Withdrawal by Subject|1|||
30922017|NCT01825785|58957337|FG001|Overall Study|Withdrawal by Subject|0|||
30922018|NCT01825785|58957338|FG002|Overall Study|Withdrawal by Subject|0|||
30922019|NCT01825785|58957339|FG003|Overall Study|Withdrawal by Subject|0|||
30922020|NCT01825785|58957340|FG004|Overall Study|Withdrawal by Subject|1|||
30922021|NCT01825785|58957341|FG005|Overall Study|Withdrawal by Subject|1|||
30755051|NCT04113694|58764715|FG000|Overall Study|Lost to Follow-up|2|||
30922022|NCT01825785|58957342|FG006|Overall Study|Withdrawal by Subject|0|||
30922023|NCT02043301|58957367|FG000|Overall Study|Discontinued|0|||
30922024|NCT02043301|58957368|FG001|Overall Study|Discontinued|1|||
30922025|NCT02043301|58957369|FG002|Overall Study|Discontinued|0|||
30922026|NCT01598753|58957381|FG000|Overall Study|Adverse Event|1|||
30922027|NCT01598753|58957382|FG001|Overall Study|Adverse Event|9|||
30922028|NCT01598753|58957383|FG002|Overall Study|Adverse Event|1|||
30922029|NCT01598753|58957384|FG003|Overall Study|Adverse Event|7|||
30922030|NCT01598753|58957381|FG000|Overall Study|Lost to Follow-up|4|||
30922031|NCT01598753|58957382|FG001|Overall Study|Lost to Follow-up|3|||
30922032|NCT01598753|58957383|FG002|Overall Study|Lost to Follow-up|7|||
30922033|NCT01598753|58957384|FG003|Overall Study|Lost to Follow-up|5|||
30922034|NCT01598753|58957381|FG000|Overall Study|Physician Decision|0|||
30922035|NCT01598753|58957382|FG001|Overall Study|Physician Decision|1|||
30922036|NCT01598753|58957383|FG002|Overall Study|Physician Decision|0|||
30922037|NCT01598753|58957384|FG003|Overall Study|Physician Decision|2|||
30922038|NCT01598753|58957381|FG000|Overall Study|Withdrawal by Subject|7|||
30922039|NCT01598753|58957382|FG001|Overall Study|Withdrawal by Subject|2|||
30922040|NCT01598753|58957383|FG002|Overall Study|Withdrawal by Subject|0|||
30922041|NCT01598753|58957384|FG003|Overall Study|Withdrawal by Subject|1|||
30829263|NCT02785458|58852842|FG000|3 Months|Lost to Follow-up|25|||
30829264|NCT02785458|58852843|FG001|3 Months|Lost to Follow-up|21|||
30829265|NCT02785458|58852842|FG000|3 Months|Completed Evaluation at 1 Month|100|||
30829266|NCT02785458|58852843|FG001|3 Months|Completed Evaluation at 1 Month|89|||
30829267|NCT02784834|58852849|FG000|Overall Study|Lack of Efficacy|1|||
30829268|NCT02966223|58852853|FG000|Overall Study|Physician Decision|3|||
30829269|NCT02966223|58852853|FG000|Overall Study|Withdrawal by Subject|11|||
30829270|NCT02966223|58852853|FG000|Overall Study|Lost to Follow-up|1|||
30829271|NCT03049735|58852860|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
30829272|NCT03049735|58852861|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
30829273|NCT03049735|58852862|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
30829274|NCT03049735|58852860|FG000|Overall Study|Other|5|||
30829275|NCT03049735|58852861|FG001|Overall Study|Other|3|||
30829276|NCT03049735|58852862|FG002|Overall Study|Other|1|||
30829277|NCT03049735|58852860|FG000|Overall Study|Lack of Efficacy|4|||
30829278|NCT03049735|58852861|FG001|Overall Study|Lack of Efficacy|0|||
30829279|NCT03049735|58852862|FG002|Overall Study|Lack of Efficacy|3|||
30829280|NCT03049735|58852860|FG000|Overall Study|Protocol deviation|1|||
30829281|NCT03049735|58852861|FG001|Overall Study|Protocol deviation|0|||
30829282|NCT03049735|58852862|FG002|Overall Study|Protocol deviation|0|||
30829283|NCT03049735|58852860|FG000|Overall Study|Pregnancy|0|||
30829284|NCT03049735|58852861|FG001|Overall Study|Pregnancy|0|||
30829285|NCT03049735|58852862|FG002|Overall Study|Pregnancy|1|||
30829286|NCT03049735|58852860|FG000|Overall Study|Adverse Event|7|||
30829287|NCT03049735|58852861|FG001|Overall Study|Adverse Event|18|||
30829288|NCT03049735|58852862|FG002|Overall Study|Adverse Event|5|||
30829289|NCT03049735|58852860|FG000|Overall Study|Withdrawal by Subject|10|||
30829290|NCT03049735|58852861|FG001|Overall Study|Withdrawal by Subject|3|||
30829291|NCT03049735|58852862|FG002|Overall Study|Withdrawal by Subject|7|||
30829292|NCT03049735|58852860|FG000|Overall Study|Lost to Follow-up|1|||
30829293|NCT03049735|58852861|FG001|Overall Study|Lost to Follow-up|5|||
30829294|NCT03049735|58852862|FG002|Overall Study|Lost to Follow-up|5|||
30922042|NCT02177123|58957394|FG000|Overall Study|Lost to Follow-up|6|||
30922043|NCT02177123|58957394|FG000|Overall Study|Withdrawal by Subject|4|||
30922044|NCT02177123|58957394|FG000|Overall Study|Adverse Event|4|||
30922045|NCT02177123|58957394|FG000|Overall Study|Physician Decision|3|||
30922046|NCT02177123|58957394|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
30922047|NCT02177123|58957394|FG000|Overall Study|Excluded for medical reasons|2|||
30922048|NCT02177123|58957394|FG000|Overall Study|Death|1|||
30922049|NCT02177123|58957394|FG000|Overall Study|Other|1|||
30922050|NCT02177123|58957394|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
30922051|NCT01824693|58957404|FG000|Overall Study|Death|0|||
30922052|NCT01824693|58957405|FG001|Overall Study|Death|1|||
30922053|NCT01824693|58957406|FG002|Overall Study|Death|0|||
30922054|NCT01824693|58957404|FG000|Overall Study|Physician Decision|1|||
30829295|NCT01295944|58852870|FG000|Overall Study|Switched to alternative treatment|1|||
30829296|NCT01295944|58852870|FG000|Overall Study|Ineligible|9|||
30829297|NCT01295944|58852870|FG000|Overall Study|Withdrawal by Subject|4|||
30829298|NCT01295944|58852870|FG000|Overall Study|Participant chose to be treated in Peru|1|||
30922055|NCT01824693|58957405|FG001|Overall Study|Physician Decision|1|||
30829299|NCT01295944|58852870|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
30829300|NCT01295944|58852870|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
30843623|NCT02101853|58869614|FG002|Blinatumomab Salvage Therapy|Death|0|||
30843624|NCT02101853|58869615|FG003|Blinatumomab Salvage Therapy|Death|0|||
30843625|NCT02101853|58869616|FG004|Blinatumomab Salvage Therapy|Death|0|||
30843626|NCT02101853|58869617|FG005|Blinatumomab Salvage Therapy|Death|2|||
30843627|NCT02101853|58869612|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
30843628|NCT02101853|58869613|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
30843629|NCT02101853|58869614|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
30922056|NCT01824693|58957406|FG002|Overall Study|Physician Decision|1|||
30922057|NCT01824693|58957404|FG000|Overall Study|Withdrawal by Subject|0|||
30922058|NCT01824693|58957405|FG001|Overall Study|Withdrawal by Subject|0|||
30829301|NCT01295944|58852870|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
30829302|NCT02965599|58852876|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
30829303|NCT02965599|58852877|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
30829304|NCT02898597|58852886|FG000|Overall Study|Protocol Violation|4|||
30829305|NCT02898597|58852887|FG001|Overall Study|Protocol Violation|2|||
30829306|NCT02898597|58852886|FG000|Overall Study|Lost to Follow-up|0|||
30829307|NCT02898597|58852887|FG001|Overall Study|Lost to Follow-up|9|||
30829308|NCT02898597|58852886|FG000|Overall Study|Death|0|||
30829309|NCT02898597|58852887|FG001|Overall Study|Death|1|||
30829310|NCT02899377|58852895|FG000|Overall Study|Adverse Event|1|||
30829311|NCT02899377|58852896|FG001|Overall Study|Adverse Event|0|||
30829312|NCT01316887|58852907|FG000|Overall Study|Adverse Event|13|||
30829313|NCT01316887|58852908|FG001|Overall Study|Adverse Event|21|||
30829314|NCT01316887|58852909|FG002|Overall Study|Adverse Event|17|||
30829315|NCT01316887|58852907|FG000|Overall Study|Lack of Efficacy|9|||
30829316|NCT01316887|58852908|FG001|Overall Study|Lack of Efficacy|3|||
30829317|NCT01316887|58852909|FG002|Overall Study|Lack of Efficacy|1|||
30829318|NCT01316887|58852907|FG000|Overall Study|Protocol Violation|2|||
30829319|NCT01316887|58852908|FG001|Overall Study|Protocol Violation|6|||
30829320|NCT01316887|58852909|FG002|Overall Study|Protocol Violation|6|||
30829321|NCT01316887|58852907|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
30829322|NCT01316887|58852908|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
30829323|NCT01316887|58852909|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
30829324|NCT01316887|58852907|FG000|Overall Study|Study Closed/Terminated|2|||
30829325|NCT01316887|58852908|FG001|Overall Study|Study Closed/Terminated|4|||
30829326|NCT01316887|58852909|FG002|Overall Study|Study Closed/Terminated|3|||
30829327|NCT01316887|58852907|FG000|Overall Study|Lost to Follow-up|1|||
30829328|NCT01316887|58852908|FG001|Overall Study|Lost to Follow-up|7|||
30829329|NCT01316887|58852909|FG002|Overall Study|Lost to Follow-up|5|||
30829330|NCT01316887|58852907|FG000|Overall Study|Withdrawal by Subject|8|||
30829331|NCT01316887|58852908|FG001|Overall Study|Withdrawal by Subject|16|||
30829332|NCT01316887|58852909|FG002|Overall Study|Withdrawal by Subject|15|||
30829333|NCT02897349|58852920|FG000|Overall Study|Lost to Follow-up|2|||
30829334|NCT02897349|58852921|FG001|Overall Study|Lost to Follow-up|2|||
30829335|NCT02897349|58852920|FG000|Overall Study|Adverse Event|3|||
30829336|NCT02897349|58852921|FG001|Overall Study|Adverse Event|3|||
30829337|NCT02897349|58852920|FG000|Overall Study|Other than listed above|0|||
30829338|NCT02897349|58852921|FG001|Overall Study|Other than listed above|1|||
30829339|NCT03047551|58852938|FG000|Overall Study|Did not receive TAS|1|||
30829340|NCT03047551|58852939|FG001|Overall Study|Did not receive TAS|0|||
30829341|NCT03047551|58852938|FG000|Overall Study|Physician Decision|1|||
30829342|NCT03047551|58852939|FG001|Overall Study|Physician Decision|0|||
30829343|NCT03047551|58852938|FG000|Overall Study|Withdrawal by Subject|0|||
30829344|NCT03047551|58852939|FG001|Overall Study|Withdrawal by Subject|1|||
30829345|NCT03047551|58852938|FG000|Overall Study|Probe malfunction|0|||
30829346|NCT03047551|58852939|FG001|Overall Study|Probe malfunction|1|||
30829347|NCT03047551|58852938|FG000|Overall Study|Ineligible|0|||
30829348|NCT03047551|58852939|FG001|Overall Study|Ineligible|1|||
30829349|NCT02964741|58852948|FG000|Overall Study|Protocol Violation|1|||
30829350|NCT02964741|58852949|FG001|Overall Study|Protocol Violation|0|||
30829351|NCT02964741|58852950|FG002|Overall Study|Protocol Violation|0|||
30829352|NCT02964741|58852948|FG000|Overall Study|Withdrawal by Subject|0|||
30829353|NCT02964741|58852949|FG001|Overall Study|Withdrawal by Subject|1|||
30829354|NCT02964741|58852950|FG002|Overall Study|Withdrawal by Subject|0|||
30829355|NCT02964741|58852948|FG000|Overall Study|claustrophobia|1|||
30922059|NCT01824693|58957406|FG002|Overall Study|Withdrawal by Subject|1|||
30922060|NCT01824693|58957404|FG000|Overall Study|Progressive Disease|0|||
30922061|NCT01824693|58957405|FG001|Overall Study|Progressive Disease|5|||
30829356|NCT02964741|58852949|FG001|Overall Study|claustrophobia|0|||
30829357|NCT02964741|58852950|FG002|Overall Study|claustrophobia|0|||
30829358|NCT01316419|58852956|FG000|Overall Study|Not treated|103|||
30829359|NCT01316419|58852956|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
30829360|NCT01316419|58852956|FG000|Overall Study|Lost to Follow-up|19|||
30829361|NCT02964039|58852963|FG000|Overall Study|Medical reason unrelated to study participation|1|||
30829362|NCT02964039|58852964|FG001|Overall Study|Medical reason unrelated to study participation|0|||
30829363|NCT02964039|58852965|FG002|Overall Study|Medical reason unrelated to study participation|3|||
30829364|NCT02964039|58852963|FG000|Overall Study|Research shutdown due to pandemic|2|||
30829365|NCT02964039|58852964|FG001|Overall Study|Research shutdown due to pandemic|0|||
30829366|NCT02964039|58852965|FG002|Overall Study|Research shutdown due to pandemic|1|||
30922062|NCT01824693|58957406|FG002|Overall Study|Progressive Disease|0|||
30922063|NCT01824693|58957404|FG000|Overall Study|Ineligible|0|||
30829367|NCT02964039|58852963|FG000|Overall Study|Withdrawal by Subject|0|||
30829368|NCT02964039|58852964|FG001|Overall Study|Withdrawal by Subject|1|||
30829369|NCT02964039|58852965|FG002|Overall Study|Withdrawal by Subject|0|||
30829370|NCT02964039|58852963|FG000|Overall Study|Lost to Follow-up|1|||
30829371|NCT02964039|58852964|FG001|Overall Study|Lost to Follow-up|0|||
30829372|NCT02964039|58852965|FG002|Overall Study|Lost to Follow-up|1|||
30829373|NCT02897115|58852975|FG000|Overall Study|Early termination of study by sponsor|11|||
30829374|NCT02897115|58852976|FG001|Overall Study|Early termination of study by sponsor|8|||
30829375|NCT02896569|58852984|FG000|Overall Study|Lost to Follow-up|2|||
30829376|NCT02896569|58852985|FG001|Overall Study|Lost to Follow-up|1|||
30829377|NCT02896569|58852984|FG000|Overall Study|Physician Decision|1|||
30829378|NCT02896569|58852985|FG001|Overall Study|Physician Decision|3|||
30922064|NCT01824693|58957405|FG001|Overall Study|Ineligible|0|||
30922065|NCT01824693|58957406|FG002|Overall Study|Ineligible|3|||
30922066|NCT01824693|58957404|FG000|Overall Study|No Transplant Planned|0|||
30922067|NCT01824693|58957405|FG001|Overall Study|No Transplant Planned|0|||
30922068|NCT01824693|58957406|FG002|Overall Study|No Transplant Planned|10|||
30922069|NCT02176655|58957413|FG000|Overall Study|Subjects did not treat|6|||
30922070|NCT02125331|58957420|FG000|Overall Study|Protocol Violation|1|||
30922071|NCT02125331|58957421|FG001|Overall Study|Protocol Violation|0|||
30922072|NCT02125331|58957420|FG000|Overall Study|technical problem|2|||
30922073|NCT02125331|58957421|FG001|Overall Study|technical problem|0|||
30922074|NCT02125331|58957420|FG000|Overall Study|screen failure|2|||
30922075|NCT02125331|58957421|FG001|Overall Study|screen failure|0|||
30922076|NCT01622569|58957431|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
30922077|NCT01622569|58957432|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
30922078|NCT01622569|58957433|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
30922079|NCT01622569|58957434|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
30922080|NCT01622569|58957431|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
30922081|NCT01622569|58957432|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
30922082|NCT01622569|58957433|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
30922083|NCT01622569|58957434|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
30922084|NCT01622569|58957431|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
30922085|NCT01622569|58957432|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
30922086|NCT01622569|58957433|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
30922087|NCT01622569|58957434|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
30922088|NCT01622569|58957431|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
30922089|NCT01622569|58957432|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
30922090|NCT01622569|58957433|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
30922091|NCT01622569|58957434|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
30922092|NCT01622569|58957431|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
30922093|NCT01622569|58957432|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
30922094|NCT01622569|58957433|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
30922095|NCT01622569|58957434|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
30922096|NCT01622569|58957431|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
30922097|NCT01622569|58957432|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
30922098|NCT01622569|58957433|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
30922099|NCT01622569|58957434|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
30922100|NCT01622569|58957431|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
30922101|NCT01622569|58957432|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
30922102|NCT01622569|58957433|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
30922103|NCT01622569|58957434|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
30922104|NCT01622569|58957431|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
30922105|NCT01622569|58957432|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
30922106|NCT01622569|58957433|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
30922107|NCT01622569|58957434|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
30922108|NCT01824303|58957456|FG000|Randomized Study|Withdrawal by Subject|1|||
30922109|NCT01824303|58957457|FG001|Randomized Study|Withdrawal by Subject|1|||
30922110|NCT01824303|58957456|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
30922111|NCT01824303|58957457|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
30922112|NCT01853397|58957469|FG000|Overall Study|Withdrawal by Subject|0|||
30922113|NCT01853397|58957470|FG001|Overall Study|Withdrawal by Subject|0|||
30922114|NCT01853397|58957471|FG002|Overall Study|Withdrawal by Subject|0|||
30922115|NCT01853397|58957472|FG003|Overall Study|Withdrawal by Subject|1|||
30922116|NCT01853397|58957469|FG000|Overall Study|Subject Noncompliance|0|||
30922117|NCT01853397|58957470|FG001|Overall Study|Subject Noncompliance|0|||
30922118|NCT01853397|58957471|FG002|Overall Study|Subject Noncompliance|0|||
30829379|NCT02896569|58852984|FG000|Overall Study|Adverse Event|0|||
30829380|NCT02896569|58852985|FG001|Overall Study|Adverse Event|1|||
30829381|NCT02896569|58852984|FG000|Overall Study|Withdrawal by Subject|1|||
30922119|NCT01853397|58957472|FG003|Overall Study|Subject Noncompliance|1|||
30922120|NCT02088073|58957487|FG000|Acute Phase|Withdrawal by Subject|5|||
30922121|NCT02088073|58957488|FG001|Acute Phase|Withdrawal by Subject|0|||
30922122|NCT02088073|58957489|FG002|Acute Phase|Withdrawal by Subject|0|||
30922123|NCT02088073|58957490|FG003|Acute Phase|Withdrawal by Subject|0|||
30922124|NCT02088073|58957491|FG004|Acute Phase|Withdrawal by Subject|0|||
30922125|NCT02088073|58957487|FG000|Acute Phase|Hyperkalemia|2|||
30922126|NCT02088073|58957488|FG001|Acute Phase|Hyperkalemia|0|||
30922127|NCT02088073|58957489|FG002|Acute Phase|Hyperkalemia|0|||
30922128|NCT02088073|58957490|FG003|Acute Phase|Hyperkalemia|0|||
30922129|NCT02088073|58957491|FG004|Acute Phase|Hyperkalemia|0|||
30922130|NCT02088073|58957487|FG000|Maintanance Phase|Withdrawal by Subject|0|||
30922131|NCT02088073|58957488|FG001|Maintanance Phase|Withdrawal by Subject|2|||
30922132|NCT02088073|58957489|FG002|Maintanance Phase|Withdrawal by Subject|0|||
30922133|NCT02088073|58957490|FG003|Maintanance Phase|Withdrawal by Subject|0|||
30922134|NCT02088073|58957491|FG004|Maintanance Phase|Withdrawal by Subject|0|||
30922135|NCT02088073|58957487|FG000|Maintanance Phase|Adverse Event|0|||
30922136|NCT02088073|58957488|FG001|Maintanance Phase|Adverse Event|0|||
30922137|NCT02088073|58957489|FG002|Maintanance Phase|Adverse Event|3|||
30922138|NCT02088073|58957490|FG003|Maintanance Phase|Adverse Event|0|||
30922139|NCT02088073|58957491|FG004|Maintanance Phase|Adverse Event|1|||
30922140|NCT02088073|58957487|FG000|Maintanance Phase|Physician Decision|0|||
30922141|NCT02088073|58957488|FG001|Maintanance Phase|Physician Decision|0|||
30922142|NCT02088073|58957489|FG002|Maintanance Phase|Physician Decision|0|||
30922143|NCT02088073|58957490|FG003|Maintanance Phase|Physician Decision|0|||
30922144|NCT02088073|58957491|FG004|Maintanance Phase|Physician Decision|1|||
30922145|NCT02088073|58957487|FG000|Maintanance Phase|Sponsor's decision|0|||
30922146|NCT02088073|58957488|FG001|Maintanance Phase|Sponsor's decision|2|||
30922147|NCT02088073|58957489|FG002|Maintanance Phase|Sponsor's decision|0|||
30922148|NCT02088073|58957490|FG003|Maintanance Phase|Sponsor's decision|2|||
30922149|NCT02088073|58957491|FG004|Maintanance Phase|Sponsor's decision|1|||
30922150|NCT02088073|58957487|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
30922151|NCT02088073|58957488|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
30922152|NCT02088073|58957489|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
30922153|NCT02088073|58957490|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
30922154|NCT02088073|58957491|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
30922155|NCT02088073|58957487|FG000|Maintanance Phase|Miscellaneous|0|||
30922156|NCT02088073|58957488|FG001|Maintanance Phase|Miscellaneous|2|||
30922157|NCT02088073|58957489|FG002|Maintanance Phase|Miscellaneous|1|||
30922158|NCT02088073|58957490|FG003|Maintanance Phase|Miscellaneous|2|||
30922159|NCT02088073|58957491|FG004|Maintanance Phase|Miscellaneous|1|||
30922160|NCT02088073|58957487|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
30922161|NCT02088073|58957488|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
30922162|NCT02088073|58957489|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
30922163|NCT02088073|58957490|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
30922164|NCT02088073|58957491|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
30922165|NCT02088073|58957487|FG000|Maintanance Phase|Subject compliance|0|||
30922166|NCT02088073|58957488|FG001|Maintanance Phase|Subject compliance|1|||
30922167|NCT02088073|58957489|FG002|Maintanance Phase|Subject compliance|0|||
30922168|NCT02088073|58957490|FG003|Maintanance Phase|Subject compliance|0|||
30922169|NCT02088073|58957491|FG004|Maintanance Phase|Subject compliance|0|||
30922170|NCT01823991|58957506|FG000|Overall Study|Withdrawal by Subject|8|||
30922171|NCT01823991|58957507|FG001|Overall Study|Withdrawal by Subject|5|||
30922172|NCT02087059|58957517|FG000|Overall Study|Disease Progression|1|||
30922173|NCT02087059|58957517|FG000|Overall Study|Adverse Event|5|||
30922174|NCT02087059|58957517|FG000|Overall Study|Lost to Follow-up|1|||
30922175|NCT02152631|58957523|FG000|Overall Study|Adverse Event|32|||
30922176|NCT02152631|58957524|FG001|Overall Study|Adverse Event|4|||
30922177|NCT02152631|58957523|FG000|Overall Study|Withdrawal by Subject|13|||
30922178|NCT02152631|58957524|FG001|Overall Study|Withdrawal by Subject|16|||
30922179|NCT02152631|58957523|FG000|Overall Study|Noncompliance with study drug|1|||
30922180|NCT02152631|58957524|FG001|Overall Study|Noncompliance with study drug|0|||
30922181|NCT02152631|58957523|FG000|Overall Study|Physician Decision|1|||
30922182|NCT02152631|58957524|FG001|Overall Study|Physician Decision|2|||
30922183|NCT02152631|58957523|FG000|Overall Study|Lost to Follow-up|0|||
30922184|NCT02152631|58957524|FG001|Overall Study|Lost to Follow-up|1|||
30922185|NCT02152631|58957523|FG000|Overall Study|On Treatment|19|||
30922186|NCT02152631|58957524|FG001|Overall Study|On Treatment|3|||
30922187|NCT02152163|58957532|FG000|Overall Study|Physician Decision|12|||
30922188|NCT02152163|58957533|FG001|Overall Study|Physician Decision|13|||
30922189|NCT02152007|58957539|FG000|Overall Study|Withdrawal by Subject|1|||
30922190|NCT02151851|58957546|FG000|Overall Study|Lack of Efficacy|67|||
30829382|NCT02896569|58852985|FG001|Overall Study|Withdrawal by Subject|0|||
30829383|NCT04030195|58852994|FG000|Overall Study|Withdrawal by Subject|2|||
30829384|NCT04030195|58852995|FG001|Overall Study|Withdrawal by Subject|0|||
30829385|NCT04030195|58852996|FG002|Overall Study|Withdrawal by Subject|0|||
30829386|NCT01673620|58853007|FG000|Overall Study|Adverse Event|1|||
30829387|NCT01673620|58853008|FG001|Overall Study|Adverse Event|0|||
30829388|NCT03044197|58853022|FG000|Overall Study|Withdrawal by Subject|3|||
30829389|NCT03044197|58853023|FG001|Overall Study|Withdrawal by Subject|1|||
30829390|NCT03575325|58853042|FG000|Overall Study|Death|1|||
30829391|NCT03043651|58853057|FG000|Overall Study|Death|1|||
30829392|NCT03043651|58853057|FG000|Overall Study|Progressive Disease|2|||
30829393|NCT03043651|58853057|FG000|Overall Study|Adverse Event|2|||
30829394|NCT03043651|58853057|FG000|Overall Study|Withdrawal by Subject|4|||
30829395|NCT03043651|58853057|FG000|Overall Study|Study Terminated by Sponsor|39|||
30829396|NCT03536143|58853061|FG000|Overall Study|Early termination, Sponsor decision|1|||
30829397|NCT01344759|58853071|FG000|Overall Study|Patients failed to reach sedation level|0|||
30829398|NCT01344759|58853072|FG001|Overall Study|Patients failed to reach sedation level|2|||
30829399|NCT05027451|58853095|FG000|Overall Study|Lost to Follow-up|1|||
30829400|NCT05027451|58853096|FG001|Overall Study|Lost to Follow-up|1|||
30829401|NCT04757649|58853128|FG000|Overall Study|Withdrawal by Subject|1|||
30829402|NCT04757649|58853128|FG000|Overall Study|Adverse Event|1|||
30829403|NCT04621786|58853132|FG000|Overall Study|Lost to Follow-up|9|||
30829404|NCT04621786|58853132|FG000|Overall Study|Protocol Violation|3|||
30829405|NCT04549454|58853138|FG000|T1 to T2|Lost to Follow-up|22|||
30829406|NCT04549454|58853139|FG001|T1 to T2|Lost to Follow-up|26|||
30829407|NCT04549454|58853138|FG000|T1 to T3|Lost to Follow-up|31|||
30829408|NCT04549454|58853139|FG001|T1 to T3|Lost to Follow-up|36|||
30829409|NCT03519256|58853186|FG000|Overall Study|Disease recurrence|4|||
30829410|NCT03519256|58853187|FG001|Overall Study|Disease recurrence|4|||
30829411|NCT03519256|58853188|FG002|Overall Study|Disease recurrence|5|||
30829412|NCT03519256|58853189|FG003|Overall Study|Disease recurrence|2|||
30829413|NCT03519256|58853186|FG000|Overall Study|Study drug toxicity|0|||
30829414|NCT03519256|58853187|FG001|Overall Study|Study drug toxicity|2|||
30829415|NCT03519256|58853188|FG002|Overall Study|Study drug toxicity|5|||
30829416|NCT03519256|58853189|FG003|Overall Study|Study drug toxicity|2|||
30829417|NCT03519256|58853186|FG000|Overall Study|Adverse event unrelated to study drug|0|||
30922191|NCT02151851|58957547|FG001|Overall Study|Lack of Efficacy|94|||
30922192|NCT02151851|58957546|FG000|Overall Study|Protocol Violation|0|||
30922193|NCT02151851|58957547|FG001|Overall Study|Protocol Violation|1|||
30922194|NCT02151851|58957546|FG000|Overall Study|Withdrawal by Subject|2|||
30922195|NCT02151851|58957547|FG001|Overall Study|Withdrawal by Subject|5|||
30922196|NCT02151851|58957546|FG000|Overall Study|Medical impairment|1|||
30922197|NCT02151851|58957547|FG001|Overall Study|Medical impairment|0|||
30922198|NCT02151851|58957546|FG000|Overall Study|Low compliance to study visits|0|||
30829418|NCT03519256|58853187|FG001|Overall Study|Adverse event unrelated to study drug|1|||
30829419|NCT03519256|58853188|FG002|Overall Study|Adverse event unrelated to study drug|1|||
30829420|NCT03519256|58853189|FG003|Overall Study|Adverse event unrelated to study drug|0|||
30829421|NCT03519256|58853186|FG000|Overall Study|Participant request to discontinue study treatment|0|||
30829422|NCT03519256|58853187|FG001|Overall Study|Participant request to discontinue study treatment|0|||
30829423|NCT03519256|58853188|FG002|Overall Study|Participant request to discontinue study treatment|0|||
30829424|NCT03519256|58853189|FG003|Overall Study|Participant request to discontinue study treatment|2|||
30829425|NCT03519256|58853186|FG000|Overall Study|Other reasons|0|||
30829426|NCT03519256|58853187|FG001|Overall Study|Other reasons|0|||
30829427|NCT03519256|58853188|FG002|Overall Study|Other reasons|2|||
30829428|NCT03519256|58853189|FG003|Overall Study|Other reasons|0|||
30829429|NCT03519256|58853186|FG000|Overall Study|Disease progression|6|||
30829430|NCT03519256|58853187|FG001|Overall Study|Disease progression|3|||
30829431|NCT03519256|58853188|FG002|Overall Study|Disease progression|2|||
30829432|NCT03519256|58853189|FG003|Overall Study|Disease progression|1|||
30829433|NCT03519256|58853186|FG000|Overall Study|Lost to Follow-up|0|||
30829434|NCT03519256|58853187|FG001|Overall Study|Lost to Follow-up|1|||
30829435|NCT03519256|58853188|FG002|Overall Study|Lost to Follow-up|0|||
30829436|NCT03519256|58853189|FG003|Overall Study|Lost to Follow-up|0|||
30829437|NCT03343054|58853212|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
30829438|NCT03343054|58853213|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
30922199|NCT02151851|58957547|FG001|Overall Study|Low compliance to study visits|1|||
30922200|NCT02151851|58957546|FG000|Overall Study|Subject entered into study in error|0|||
30829439|NCT03343054|58853214|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
30829440|NCT03343054|58853212|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
30922201|NCT02151851|58957547|FG001|Overall Study|Subject entered into study in error|1|||
30829441|NCT03343054|58853213|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
30829442|NCT03343054|58853214|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
30829443|NCT03343054|58853212|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
30829444|NCT03343054|58853213|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
30829445|NCT03343054|58853214|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
30829446|NCT03343054|58853212|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
30829447|NCT03343054|58853213|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
30829448|NCT03343054|58853214|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
30829449|NCT03330847|58853226|FG000|Overall Study|Patients ongoing study|62|||
30829450|NCT03330847|58853227|FG001|Overall Study|Patients ongoing study|65|||
30829451|NCT03330847|58853228|FG002|Overall Study|Patients ongoing study|15|||
30829452|NCT02799602|58853254|FG000|Overall Study|Protocol Violation|1|||
30829453|NCT02799602|58853255|FG001|Overall Study|Protocol Violation|0|||
30829454|NCT02799602|58853254|FG000|Overall Study|Physician Decision|3|||
30829455|NCT02799602|58853255|FG001|Overall Study|Physician Decision|7|||
30829456|NCT02799602|58853254|FG000|Overall Study|COVID-19 pandemic related other reason|0|||
30829457|NCT02799602|58853255|FG001|Overall Study|COVID-19 pandemic related other reason|1|||
30829458|NCT02799602|58853254|FG000|Overall Study|Lost to Follow-up|4|||
30829459|NCT02799602|58853255|FG001|Overall Study|Lost to Follow-up|1|||
30829460|NCT02799602|58853254|FG000|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|11|||
30829461|NCT02799602|58853255|FG001|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|6|||
30829462|NCT02799602|58853254|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|14|||
30829463|NCT02799602|58853255|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|12|||
30829464|NCT02799602|58853254|FG000|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|24|||
30829465|NCT02799602|58853255|FG001|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|26|||
30829466|NCT02799602|58853254|FG000|Overall Study|Withdrawal by Subject|25|||
30829467|NCT02799602|58853255|FG001|Overall Study|Withdrawal by Subject|37|||
30829468|NCT02799602|58853254|FG000|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|48|||
30829469|NCT02799602|58853255|FG001|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|27|||
30829470|NCT02799602|58853254|FG000|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|84|||
30829471|NCT02799602|58853255|FG001|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|132|||
30829472|NCT02799602|58853254|FG000|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|127|||
30829473|NCT02799602|58853255|FG001|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|272|||
30829474|NCT02799602|58853254|FG000|Overall Study|Death|8|||
30829475|NCT02799602|58853255|FG001|Overall Study|Death|5|||
30829476|NCT02799602|58853254|FG000|Overall Study|Other|3|||
30829477|NCT02799602|58853255|FG001|Overall Study|Other|3|||
30829478|NCT02799602|58853254|FG000|Overall Study|GCP violation|1|||
30829479|NCT02799602|58853255|FG001|Overall Study|GCP violation|0|||
30829480|NCT02243709|58853272|FG000|Phase 1|Lost to Follow-up|0|||
30829481|NCT02243709|58853273|FG001|Phase 1|Lost to Follow-up|1|||
30829482|NCT02243709|58853272|FG000|Phase 1|Withdrawal by Subject|1|||
30829483|NCT02243709|58853273|FG001|Phase 1|Withdrawal by Subject|0|||
30829484|NCT02243709|58853272|FG000|Phase 1|Protocol Violation|0|||
30829485|NCT02243709|58853273|FG001|Phase 1|Protocol Violation|1|||
30829486|NCT02243709|58853272|FG000|Phase 1|Adverse Event|0|||
30829487|NCT02243709|58853273|FG001|Phase 1|Adverse Event|1|||
30829488|NCT01891396|58853285|FG000|Overall Study|Withdrawal by Subject|4|||
30829489|NCT01891396|58853286|FG001|Overall Study|Withdrawal by Subject|4|||
30829490|NCT01891396|58853287|FG002|Overall Study|Withdrawal by Subject|3|||
30829491|NCT01891396|58853285|FG000|Overall Study|Lost to Follow-up|0|||
30829492|NCT01891396|58853286|FG001|Overall Study|Lost to Follow-up|1|||
30829493|NCT01891396|58853287|FG002|Overall Study|Lost to Follow-up|0|||
30829494|NCT01746225|58853302|FG000|Overall Study|Death|1|||
30829495|NCT01746225|58853303|FG001|Overall Study|Death|0|||
30829496|NCT01746225|58853304|FG002|Overall Study|Death|1|||
30829497|NCT01746225|58853302|FG000|Overall Study|Withdrawal by Subject|5|||
30829498|NCT01746225|58853303|FG001|Overall Study|Withdrawal by Subject|15|||
30829499|NCT01746225|58853304|FG002|Overall Study|Withdrawal by Subject|19|||
30829500|NCT01746225|58853302|FG000|Overall Study|Physician Decision|14|||
30829501|NCT01746225|58853303|FG001|Overall Study|Physician Decision|11|||
30829502|NCT01746225|58853304|FG002|Overall Study|Physician Decision|3|||
30829503|NCT01746225|58853302|FG000|Overall Study|Adverse Event|15|||
30829504|NCT01746225|58853303|FG001|Overall Study|Adverse Event|12|||
30829505|NCT01746225|58853304|FG002|Overall Study|Adverse Event|17|||
30829506|NCT01746225|58853302|FG000|Overall Study|Continuing Treatment|5|||
30829507|NCT01746225|58853303|FG001|Overall Study|Continuing Treatment|8|||
30829508|NCT01746225|58853304|FG002|Overall Study|Continuing Treatment|3|||
30829509|NCT01471522|58853325|FG000|Overall Study|Withdrawal by Subject|28|||
30829510|NCT01471522|58853326|FG001|Overall Study|Withdrawal by Subject|22|||
30829511|NCT01471522|58853325|FG000|Overall Study|Lost to Follow-up|36|||
30829512|NCT01471522|58853326|FG001|Overall Study|Lost to Follow-up|26|||
30829513|NCT01191008|58853333|FG000|Overall Study|Protocol Violation|7|||
30829514|NCT01191008|58853333|FG000|Overall Study|Lost to Follow-up|8|||
30829515|NCT00821587|58853339|FG000|Overall Study|Physician Decision|0|||
30829516|NCT00821587|58853340|FG001|Overall Study|Physician Decision|1|||
30829517|NCT00645801|58853348|FG000|Overall Study|unclear if patient took all the medication.|1|||
30829518|NCT00645801|58853349|FG001|Overall Study|unclear if patient took all the medication.|0|||
30829519|NCT00645801|58853348|FG000|Overall Study|Lost to Follow-up|19|||
30829520|NCT00645801|58853349|FG001|Overall Study|Lost to Follow-up|15|||
30829521|NCT00424099|58853363|FG000|Overall Study|Adverse Event|0|||
30829522|NCT00424099|58853364|FG001|Overall Study|Adverse Event|1|||
30829523|NCT00424099|58853365|FG002|Overall Study|Adverse Event|1|||
30829524|NCT00424099|58853366|FG003|Overall Study|Adverse Event|0|||
30829525|NCT00424099|58853363|FG000|Overall Study|Death|0|||
30829526|NCT00424099|58853364|FG001|Overall Study|Death|1|||
30829527|NCT00424099|58853365|FG002|Overall Study|Death|0|||
30829528|NCT00424099|58853366|FG003|Overall Study|Death|0|||
30829529|NCT00424099|58853363|FG000|Overall Study|Illness|2|||
30829530|NCT00424099|58853364|FG001|Overall Study|Illness|0|||
30829531|NCT00424099|58853365|FG002|Overall Study|Illness|1|||
30829532|NCT00424099|58853366|FG003|Overall Study|Illness|4|||
30829533|NCT00424099|58853363|FG000|Overall Study|Lost to Follow-up|0|||
30829534|NCT00424099|58853364|FG001|Overall Study|Lost to Follow-up|0|||
30829535|NCT00424099|58853365|FG002|Overall Study|Lost to Follow-up|3|||
30829536|NCT00424099|58853366|FG003|Overall Study|Lost to Follow-up|0|||
30829537|NCT00424099|58853363|FG000|Overall Study|Hospitalized|1|||
30829538|NCT00424099|58853364|FG001|Overall Study|Hospitalized|2|||
30829539|NCT00424099|58853365|FG002|Overall Study|Hospitalized|1|||
30829540|NCT00424099|58853366|FG003|Overall Study|Hospitalized|3|||
30829541|NCT00424099|58853363|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
30829542|NCT00424099|58853364|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
30829543|NCT00424099|58853365|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
30829544|NCT00424099|58853366|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
30829545|NCT00424099|58853363|FG000|Overall Study|Withdrawal by Subject|1|||
30829546|NCT00424099|58853364|FG001|Overall Study|Withdrawal by Subject|9|||
30829547|NCT00424099|58853365|FG002|Overall Study|Withdrawal by Subject|4|||
30829548|NCT00424099|58853366|FG003|Overall Study|Withdrawal by Subject|6|||
30829549|NCT00424099|58853363|FG000|Overall Study|Physician Decision|0|||
30829550|NCT00424099|58853364|FG001|Overall Study|Physician Decision|0|||
30829551|NCT00424099|58853365|FG002|Overall Study|Physician Decision|1|||
30829552|NCT00424099|58853366|FG003|Overall Study|Physician Decision|0|||
30829553|NCT00424099|58853363|FG000|Overall Study|Missing|0|||
30829554|NCT00424099|58853364|FG001|Overall Study|Missing|0|||
30829555|NCT00424099|58853365|FG002|Overall Study|Missing|1|||
30829556|NCT00424099|58853366|FG003|Overall Study|Missing|0|||
30829557|NCT02988661|58853389|FG000|Overall Study|Death|2|||
30829558|NCT02988661|58853390|FG001|Overall Study|Death|18|||
30829559|NCT02988661|58853389|FG000|Overall Study|Lost to Follow-up|0|||
30829560|NCT02988661|58853390|FG001|Overall Study|Lost to Follow-up|33|||
30829561|NCT02988661|58853389|FG000|Overall Study|Withdrawal by Subject|0|||
30829562|NCT02988661|58853390|FG001|Overall Study|Withdrawal by Subject|6|||
30829563|NCT02988661|58853389|FG000|Overall Study|Unable to complete the 18-month survey|1|||
30829564|NCT02988661|58853390|FG001|Overall Study|Unable to complete the 18-month survey|27|||
30829565|NCT03738397|58853398|FG000|Overall Study|Adverse Event|3|||
30829566|NCT03738397|58853399|FG001|Overall Study|Adverse Event|7|||
30829567|NCT03738397|58853398|FG000|Overall Study|Withdrawal by Subject|8|||
30829568|NCT03738397|58853399|FG001|Overall Study|Withdrawal by Subject|11|||
30829569|NCT03738397|58853398|FG000|Overall Study|Lost to Follow-up|8|||
30829570|NCT03738397|58853399|FG001|Overall Study|Lost to Follow-up|5|||
30829571|NCT03738397|58853398|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
30829572|NCT03738397|58853399|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
30829573|NCT03738397|58853398|FG000|Overall Study|Other|4|||
30829574|NCT03738397|58853399|FG001|Overall Study|Other|6|||
30829575|NCT02960217|58853407|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
30829576|NCT02960217|58853408|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
30829577|NCT02960217|58853407|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
30829578|NCT02960217|58853408|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
30829579|NCT02960217|58853407|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
30829580|NCT02960217|58853408|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
30829581|NCT02960217|58853407|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
30829582|NCT02960217|58853408|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
30922202|NCT02151851|58957546|FG000|Overall Study|Adverse Event|6|||
30922203|NCT02151851|58957547|FG001|Overall Study|Adverse Event|28|||
30922204|NCT02176421|58957553|FG000|Overall Study|Lost to Follow-up|4|||
30922205|NCT02176421|58957553|FG000|Overall Study|Adverse Event|1|||
30829583|NCT02960217|58853407|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
30922206|NCT02042443|58957559|FG000|Overall Study|Adverse Event|2|||
30922207|NCT02042443|58957560|FG001|Overall Study|Adverse Event|1|||
30922208|NCT02042443|58957559|FG000|Overall Study|Withdrawal by Subject|0|||
30829584|NCT02960217|58853408|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
30829585|NCT02960217|58853407|FG000|Open-Label Extension Phase|Adverse Event|1|||
30829586|NCT02960217|58853408|FG001|Open-Label Extension Phase|Adverse Event|0|||
30829587|NCT02960217|58853407|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
30829588|NCT02960217|58853408|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
30829589|NCT02960217|58853407|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
30829590|NCT02960217|58853408|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
30829591|NCT02960217|58853407|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
30829592|NCT02960217|58853408|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
30829593|NCT02959983|58853420|FG000|Overall Study|Protocol Violation|0|||
30829594|NCT02959983|58853421|FG001|Overall Study|Protocol Violation|1|||
30829595|NCT02959983|58853420|FG000|Overall Study|Lack of Efficacy|0|||
30829596|NCT02959983|58853421|FG001|Overall Study|Lack of Efficacy|1|||
30829597|NCT02959983|58853420|FG000|Overall Study|Lost to Follow-up|12|||
30829598|NCT02959983|58853421|FG001|Overall Study|Lost to Follow-up|9|||
30829599|NCT02959983|58853420|FG000|Overall Study|Other|1|||
30829600|NCT02959983|58853421|FG001|Overall Study|Other|1|||
30829601|NCT02959983|58853420|FG000|Overall Study|Physician Decision|1|||
30829602|NCT02959983|58853421|FG001|Overall Study|Physician Decision|0|||
30829603|NCT02959983|58853420|FG000|Overall Study|Adverse Event|5|||
30829604|NCT02959983|58853421|FG001|Overall Study|Adverse Event|1|||
30829605|NCT02959983|58853420|FG000|Overall Study|Withdrawal by Subject|7|||
30829606|NCT02959983|58853421|FG001|Overall Study|Withdrawal by Subject|12|||
30829607|NCT01344447|58853427|FG000|Overall Study|Adverse Event|1|||
30829608|NCT01344447|58853427|FG000|Overall Study|Protocol Violation|1|||
30829609|NCT01344447|58853427|FG000|Overall Study|Withdrawal by Subject|1|||
30623471|NCT01120782|58635281|FG000|Overall Study|Test article shipping error|11|||
30623472|NCT01120626|58635287|FG000|Overall Study|Withdrawal by Subject|1|||
30623473|NCT01120626|58635288|FG001|Overall Study|Withdrawal by Subject|0|||
30623474|NCT00924508|58635294|FG000|Overall Study|Withdrawal by Subject|3|||
30623475|NCT01139658|58635303|FG000|Overall Study|Adverse Event|10|||
30623476|NCT01139658|58635304|FG001|Overall Study|Adverse Event|27|||
30623477|NCT01139658|58635303|FG000|Overall Study|Lack of Efficacy|15|||
30623478|NCT01139658|58635304|FG001|Overall Study|Lack of Efficacy|7|||
30623479|NCT01139658|58635303|FG000|Overall Study|Withdrawal by Subject|2|||
30623480|NCT01139658|58635304|FG001|Overall Study|Withdrawal by Subject|4|||
30623481|NCT01139658|58635303|FG000|Overall Study|No documentation of treatment|1|||
30623482|NCT01139658|58635304|FG001|Overall Study|No documentation of treatment|0|||
30623483|NCT01139658|58635303|FG000|Overall Study|Other|28|||
30623484|NCT01139658|58635304|FG001|Overall Study|Other|75|||
30623485|NCT01139580|58635312|FG000|Overall Study|Adverse Event|5|||
30755052|NCT04113694|58764715|FG000|Overall Study|Withdrawal by Subject|6|||
30755053|NCT04113694|58764715|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
30755054|NCT04105972|58764724|FG000|Overall Study|Adverse Event|2|||
30755055|NCT04105972|58764725|FG001|Overall Study|Adverse Event|1|||
30755056|NCT04102540|58764731|FG000|Overall Study|Withdrawn by PI|2|||
30755057|NCT04102540|58764731|FG000|Overall Study|Lost to Follow-up|6|||
30755058|NCT00124982|58764737|FG000|Short-term Period|Death|1|||
30755059|NCT00124982|58764738|FG001|Short-term Period|Death|1|||
30755060|NCT00124982|58764739|FG002|Short-term Period|Death|0|||
30755061|NCT00124982|58764737|FG000|Short-term Period|Adverse Event|17|||
30755062|NCT00124982|58764738|FG001|Short-term Period|Adverse Event|22|||
30755063|NCT00124982|58764739|FG002|Short-term Period|Adverse Event|0|||
30755064|NCT00124982|58764737|FG000|Short-term Period|Lack of Efficacy|32|||
30755065|NCT00124982|58764738|FG001|Short-term Period|Lack of Efficacy|73|||
30755066|NCT00124982|58764739|FG002|Short-term Period|Lack of Efficacy|0|||
30755067|NCT00124982|58764737|FG000|Short-term Period|Lost to Follow-up|8|||
30755068|NCT00124982|58764738|FG001|Short-term Period|Lost to Follow-up|5|||
30755069|NCT00124982|58764739|FG002|Short-term Period|Lost to Follow-up|0|||
30755070|NCT00124982|58764737|FG000|Short-term Period|Withdrawal of Consent|7|||
30755071|NCT00124982|58764738|FG001|Short-term Period|Withdrawal of Consent|9|||
30755072|NCT00124982|58764739|FG002|Short-term Period|Withdrawal of Consent|0|||
30755073|NCT00124982|58764737|FG000|Short-term Period|Poor/Non-compliance|3|||
30755074|NCT00124982|58764738|FG001|Short-term Period|Poor/Non-compliance|1|||
30755075|NCT00124982|58764739|FG002|Short-term Period|Poor/Non-compliance|0|||
30755076|NCT00124982|58764737|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
30755077|NCT00124982|58764738|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
30829610|NCT01344447|58853427|FG000|Overall Study|The contrast was not seen|1|||
30623486|NCT01139580|58635313|FG001|Overall Study|Adverse Event|4|||
30623487|NCT01139580|58635312|FG000|Overall Study|Lost to Follow-up|9|||
30623488|NCT01139580|58635313|FG001|Overall Study|Lost to Follow-up|1|||
30623489|NCT01139580|58635312|FG000|Overall Study|Lack of Efficacy|0|||
30623490|NCT01139580|58635313|FG001|Overall Study|Lack of Efficacy|2|||
30623491|NCT01139580|58635312|FG000|Overall Study|Withdrawal by Subject|6|||
30623492|NCT01139580|58635313|FG001|Overall Study|Withdrawal by Subject|9|||
30829611|NCT01344447|58853427|FG000|Overall Study|Physician Decision|1|||
30829612|NCT01344447|58853427|FG000|Overall Study|MRA unsuccessful|1|||
30829613|NCT01344447|58853427|FG000|Overall Study|Bolus tracking failed|1|||
30829614|NCT01344447|58853427|FG000|Overall Study|Error of power injector|1|||
30829615|NCT03513068|58853437|FG000|Overall Study|Death|1|||
30829616|NCT03513068|58853438|FG001|Overall Study|Death|0|||
30829617|NCT03513068|58853437|FG000|Overall Study|Withdrawal by Subject|4|||
30829618|NCT03513068|58853438|FG001|Overall Study|Withdrawal by Subject|6|||
30829619|NCT01348425|58853446|FG000|Overall Study|Imaging was not taken.|1|||
30829620|NCT01348425|58853447|FG001|Overall Study|Imaging was not taken.|1|||
30829621|NCT03041701|58853455|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
30829622|NCT03041701|58853456|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
30829623|NCT03041701|58853457|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
30829624|NCT03041701|58853455|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
30829625|NCT03041701|58853456|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
30829626|NCT03041701|58853457|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
30829627|NCT02956629|58853474|FG000|Overall Study|Adverse Event|0|||
30829628|NCT02956629|58853475|FG001|Overall Study|Adverse Event|0|||
30829629|NCT02956629|58853476|FG002|Overall Study|Adverse Event|1|||
30829630|NCT02956629|58853477|FG003|Overall Study|Adverse Event|0|||
30829631|NCT02956629|58853478|FG004|Overall Study|Adverse Event|0|||
30829632|NCT02956629|58853479|FG005|Overall Study|Adverse Event|0|||
30829633|NCT02956629|58853474|FG000|Overall Study|Lost to Follow-up|2|||
30829634|NCT02956629|58853475|FG001|Overall Study|Lost to Follow-up|5|||
30829635|NCT02956629|58853476|FG002|Overall Study|Lost to Follow-up|3|||
30829636|NCT02956629|58853477|FG003|Overall Study|Lost to Follow-up|1|||
30829637|NCT02956629|58853478|FG004|Overall Study|Lost to Follow-up|0|||
30829638|NCT02956629|58853479|FG005|Overall Study|Lost to Follow-up|1|||
30829639|NCT02956629|58853474|FG000|Overall Study|Withdrawal by Subject|3|||
30829640|NCT02956629|58853475|FG001|Overall Study|Withdrawal by Subject|1|||
30829641|NCT02956629|58853476|FG002|Overall Study|Withdrawal by Subject|0|||
30829642|NCT02956629|58853477|FG003|Overall Study|Withdrawal by Subject|0|||
30829643|NCT02956629|58853478|FG004|Overall Study|Withdrawal by Subject|0|||
30829644|NCT02956629|58853479|FG005|Overall Study|Withdrawal by Subject|0|||
30829645|NCT01348347|58853496|FG000|Overall Study|Withdrawal by Subject|1|||
30829646|NCT01348347|58853497|FG001|Overall Study|Withdrawal by Subject|1|||
30829647|NCT01348347|58853498|FG002|Overall Study|Withdrawal by Subject|1|||
30829648|NCT01348347|58853496|FG000|Overall Study|Progressive disease|2|||
30829649|NCT01348347|58853497|FG001|Overall Study|Progressive disease|5|||
30829650|NCT01348347|58853498|FG002|Overall Study|Progressive disease|5|||
30829651|NCT02959671|58853507|FG000|Overall Study|Adverse Event|2|||
30829652|NCT02959671|58853507|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
30829653|NCT01597258|58853511|FG000|Overall Study|No Drug Administration|1|||
30829654|NCT02958267|58853517|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
30829655|NCT02958267|58853518|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
30829656|NCT02958267|58853517|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
30829657|NCT02958267|58853518|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
30829658|NCT02958267|58853517|FG000|Follow-up Visits|Additional treatment pursued|2|||
30829659|NCT02958267|58853518|FG001|Follow-up Visits|Additional treatment pursued|1|||
30829660|NCT01952574|58853528|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
30829661|NCT01952574|58853529|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
30829662|NCT01952574|58853530|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
30829663|NCT01952574|58853531|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
30829664|NCT01952574|58853532|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
30829665|NCT01952574|58853533|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
30829666|NCT01952574|58853534|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
30829667|NCT01952574|58853528|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
30623493|NCT01139580|58635312|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
30623494|NCT01139580|58635313|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
30829668|NCT01952574|58853529|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
30829669|NCT01952574|58853530|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
30829670|NCT01952574|58853531|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
30829671|NCT01952574|58853532|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
30829672|NCT01952574|58853533|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
30623495|NCT01139580|58635312|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
30829673|NCT01952574|58853534|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
30829674|NCT01952574|58853528|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
30829675|NCT01952574|58853529|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
30829676|NCT01952574|58853530|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
30829677|NCT01952574|58853531|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
30829678|NCT01952574|58853532|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
30829679|NCT01952574|58853533|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
30829680|NCT01952574|58853534|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
30829681|NCT01952574|58853528|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
30829682|NCT01952574|58853529|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
30829683|NCT01952574|58853530|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
30829684|NCT01952574|58853531|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
30829685|NCT01952574|58853532|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
30829686|NCT01952574|58853533|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
30829687|NCT01952574|58853534|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
30829688|NCT01952574|58853528|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
30829689|NCT01952574|58853529|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
30829690|NCT01952574|58853530|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
30829691|NCT01952574|58853531|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
30829692|NCT01952574|58853532|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
30829693|NCT01952574|58853533|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
30829694|NCT01952574|58853534|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
30829695|NCT01952574|58853528|FG000|Open-label Treatment Phase|Missing|0|||
30829696|NCT01952574|58853529|FG001|Open-label Treatment Phase|Missing|0|||
30829697|NCT01952574|58853530|FG002|Open-label Treatment Phase|Missing|0|||
30829698|NCT01952574|58853531|FG003|Open-label Treatment Phase|Missing|0|||
30829699|NCT01952574|58853532|FG004|Open-label Treatment Phase|Missing|4|||
30829700|NCT01952574|58853533|FG005|Open-label Treatment Phase|Missing|0|||
30829701|NCT01952574|58853534|FG006|Open-label Treatment Phase|Missing|0|||
30829702|NCT01952574|58853528|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
30829703|NCT01952574|58853529|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
30829704|NCT01952574|58853530|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
30829705|NCT01952574|58853531|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
30829706|NCT01952574|58853532|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
30829707|NCT01952574|58853533|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
30829708|NCT01952574|58853534|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
30829709|NCT01952574|58853528|FG000|Open-label Treatment Phase|Death|0|||
30829710|NCT01952574|58853529|FG001|Open-label Treatment Phase|Death|0|||
30829711|NCT01952574|58853530|FG002|Open-label Treatment Phase|Death|0|||
30829712|NCT01952574|58853531|FG003|Open-label Treatment Phase|Death|0|||
30829713|NCT01952574|58853532|FG004|Open-label Treatment Phase|Death|1|||
30829714|NCT01952574|58853533|FG005|Open-label Treatment Phase|Death|0|||
30829715|NCT01952574|58853534|FG006|Open-label Treatment Phase|Death|0|||
30829716|NCT01952574|58853528|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
30829717|NCT01952574|58853529|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
30829718|NCT01952574|58853530|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
30829719|NCT01952574|58853531|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
30829720|NCT01952574|58853532|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
30829721|NCT01952574|58853533|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
30829722|NCT01952574|58853534|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
30829723|NCT01952574|58853528|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
30829724|NCT01952574|58853529|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
30829725|NCT01952574|58853530|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
30829726|NCT01952574|58853531|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
30829727|NCT01952574|58853532|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
30829728|NCT01952574|58853533|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
30829729|NCT01952574|58853534|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
30829730|NCT02959437|58853563|FG000|Overall Study|Death|33|||
30829731|NCT02959437|58853564|FG001|Overall Study|Death|3|||
30829732|NCT02959437|58853565|FG002|Overall Study|Death|0|||
30829733|NCT02959437|58853566|FG003|Overall Study|Death|0|||
30829734|NCT02959437|58853563|FG000|Overall Study|Lost to Follow-up|3|||
30829735|NCT02959437|58853564|FG001|Overall Study|Lost to Follow-up|1|||
30829736|NCT02959437|58853565|FG002|Overall Study|Lost to Follow-up|0|||
30829737|NCT02959437|58853566|FG003|Overall Study|Lost to Follow-up|0|||
30829738|NCT02959437|58853563|FG000|Overall Study|Withdrawal by Subject|11|||
30829739|NCT02959437|58853564|FG001|Overall Study|Withdrawal by Subject|3|||
30829740|NCT02959437|58853565|FG002|Overall Study|Withdrawal by Subject|0|||
30829741|NCT02959437|58853566|FG003|Overall Study|Withdrawal by Subject|0|||
30829742|NCT02959437|58853563|FG000|Overall Study|Progressive Disease|9|||
30829743|NCT02959437|58853564|FG001|Overall Study|Progressive Disease|1|||
30829744|NCT02959437|58853565|FG002|Overall Study|Progressive Disease|0|||
30829745|NCT02959437|58853566|FG003|Overall Study|Progressive Disease|0|||
30829746|NCT02959437|58853563|FG000|Overall Study|Study Terminated by Sponsor|4|||
30829747|NCT02959437|58853564|FG001|Overall Study|Study Terminated by Sponsor|0|||
30829748|NCT02959437|58853565|FG002|Overall Study|Study Terminated by Sponsor|0|||
30829749|NCT02959437|58853566|FG003|Overall Study|Study Terminated by Sponsor|0|||
30829750|NCT02959437|58853563|FG000|Overall Study|Other Unspecified|2|||
30829751|NCT02959437|58853564|FG001|Overall Study|Other Unspecified|0|||
30829752|NCT02959437|58853565|FG002|Overall Study|Other Unspecified|0|||
30829753|NCT02959437|58853566|FG003|Overall Study|Other Unspecified|0|||
30829754|NCT02957331|58853579|FG000|Overall Study|Protocol Violation|1|||
30829755|NCT02957331|58853580|FG001|Overall Study|Protocol Violation|0|||
30829756|NCT05212883|58853586|FG000|Overall Study|Invalid test result|125|||
30829757|NCT04995055|58853594|FG000|Period 1|COVID-19 Related|1|||
30829758|NCT04995055|58853595|FG001|Period 1|COVID-19 Related|0|||
30829759|NCT04995055|58853594|FG000|Period 1|Withdrawal by Subject|0|||
30829760|NCT04995055|58853595|FG001|Period 1|Withdrawal by Subject|1|||
30829761|NCT04995055|58853594|FG000|Period 1|Subject discontinued due to timing|4|||
30829762|NCT04995055|58853595|FG001|Period 1|Subject discontinued due to timing|4|||
30829763|NCT04778592|58853603|FG000|Overall Study|Adverse Event|1|||
30829764|NCT04778592|58853604|FG001|Overall Study|Adverse Event|2|||
30829765|NCT04778592|58853603|FG000|Overall Study|Withdrawal by Subject|1|||
30829766|NCT04778592|58853604|FG001|Overall Study|Withdrawal by Subject|2|||
30829767|NCT04743635|58853612|FG000|Overall Study|Lost to Follow-up|2|||
30829768|NCT04743635|58853613|FG001|Overall Study|Lost to Follow-up|0|||
30829769|NCT04712110|58853620|FG000|Overall Study|Lost to Follow-up|0|||
30829770|NCT04712110|58853621|FG001|Overall Study|Lost to Follow-up|1|||
30829771|NCT04712110|58853620|FG000|Overall Study|Withdrawal by Subject|0|||
30829772|NCT04712110|58853621|FG001|Overall Study|Withdrawal by Subject|4|||
30829773|NCT04712110|58853620|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
30829774|NCT04712110|58853621|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
30829775|NCT04143594|58853635|FG000|Overall Study|Still on study|48|||
30829776|NCT04143594|58853636|FG001|Overall Study|Still on study|42|||
30829777|NCT04143594|58853637|FG002|Overall Study|Still on study|48|||
30829778|NCT04143594|58853638|FG003|Overall Study|Still on study|18|||
30829779|NCT04143594|58853635|FG000|Overall Study|Withdrew consent|0|||
30829780|NCT04143594|58853636|FG001|Overall Study|Withdrew consent|6|||
30829781|NCT04143594|58853637|FG002|Overall Study|Withdrew consent|1|||
30829782|NCT04143594|58853638|FG003|Overall Study|Withdrew consent|1|||
30829783|NCT04143594|58853635|FG000|Overall Study|Lost to Follow-up|2|||
30829784|NCT04143594|58853636|FG001|Overall Study|Lost to Follow-up|2|||
30829785|NCT04143594|58853637|FG002|Overall Study|Lost to Follow-up|3|||
30829786|NCT04143594|58853638|FG003|Overall Study|Lost to Follow-up|0|||
30829787|NCT04143594|58853635|FG000|Overall Study|Investigator's discretion|1|||
30829788|NCT04143594|58853636|FG001|Overall Study|Investigator's discretion|2|||
30829789|NCT04143594|58853637|FG002|Overall Study|Investigator's discretion|0|||
30829790|NCT04143594|58853638|FG003|Overall Study|Investigator's discretion|0|||
30829791|NCT04143594|58853635|FG000|Overall Study|Lack of Efficacy|0|||
30829792|NCT04143594|58853636|FG001|Overall Study|Lack of Efficacy|1|||
30829793|NCT04143594|58853637|FG002|Overall Study|Lack of Efficacy|0|||
30829794|NCT04143594|58853638|FG003|Overall Study|Lack of Efficacy|0|||
30829795|NCT04143594|58853635|FG000|Overall Study|Protocol Violation|0|||
30829796|NCT04143594|58853636|FG001|Overall Study|Protocol Violation|0|||
30829797|NCT04143594|58853637|FG002|Overall Study|Protocol Violation|0|||
30829798|NCT04143594|58853638|FG003|Overall Study|Protocol Violation|1|||
30829799|NCT03877510|58853651|FG000|Overall Study|Death|6|||
30829800|NCT03877510|58853651|FG000|Overall Study|Lost to Follow-up|2|||
30829801|NCT03877510|58853651|FG000|Overall Study|Non-compliance with study drug|2|||
30829802|NCT03877510|58853651|FG000|Overall Study|Lack of Efficacy|14|||
30829803|NCT03877510|58853651|FG000|Overall Study|Adverse Event|20|||
30829804|NCT03877510|58853651|FG000|Overall Study|Withdrawal by Subject|22|||
30829805|NCT03877510|58853651|FG000|Overall Study|Miscellaneous|1|||
30829806|NCT03846427|58853655|FG000|Overall Study|Death|13|||
30829807|NCT03846427|58853655|FG000|Overall Study|Withdrawal by Subject|3|||
30829808|NCT03846427|58853655|FG000|Overall Study|Physician Decision|1|||
30829809|NCT03706079|58853684|FG000|Predecessor Study|Death|0|||
30829810|NCT03706079|58853685|FG001|Predecessor Study|Death|2|||
30829811|NCT03706079|58853686|FG002|Predecessor Study|Death|0|||
30829812|NCT03706079|58853687|FG003|Predecessor Study|Death|1|||
30829813|NCT03706079|58853688|FG004|Predecessor Study|Death|0|||
30829814|NCT03706079|58853689|FG005|Predecessor Study|Death|0|||
30829815|NCT03706079|58853684|FG000|Predecessor Study|Lost to Follow-up|5|||
30829816|NCT03706079|58853685|FG001|Predecessor Study|Lost to Follow-up|2|||
30829817|NCT03706079|58853686|FG002|Predecessor Study|Lost to Follow-up|0|||
30829818|NCT03706079|58853687|FG003|Predecessor Study|Lost to Follow-up|0|||
30829819|NCT03706079|58853688|FG004|Predecessor Study|Lost to Follow-up|1|||
30922209|NCT02042443|58957560|FG001|Overall Study|Withdrawal by Subject|1|||
30829820|NCT03706079|58853689|FG005|Predecessor Study|Lost to Follow-up|0|||
30829821|NCT03706079|58853684|FG000|Predecessor Study|Withdrawal by Subject|8|||
30829822|NCT03706079|58853685|FG001|Predecessor Study|Withdrawal by Subject|15|||
30829823|NCT03706079|58853686|FG002|Predecessor Study|Withdrawal by Subject|0|||
30829824|NCT03706079|58853687|FG003|Predecessor Study|Withdrawal by Subject|5|||
30829825|NCT03706079|58853688|FG004|Predecessor Study|Withdrawal by Subject|2|||
30829826|NCT03706079|58853689|FG005|Predecessor Study|Withdrawal by Subject|0|||
30829827|NCT03706079|58853684|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
30829828|NCT03706079|58853685|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
30829829|NCT03706079|58853686|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
30922210|NCT02042443|58957559|FG000|Overall Study|Progression|21|||
30922211|NCT02042443|58957560|FG001|Overall Study|Progression|17|||
30829830|NCT03706079|58853687|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
30829831|NCT03706079|58853688|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
30829832|NCT03706079|58853689|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
30829833|NCT03706079|58853684|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
30829834|NCT03706079|58853685|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
30829835|NCT03706079|58853686|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
30829836|NCT03706079|58853687|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
30829837|NCT03706079|58853688|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
30829838|NCT03706079|58853689|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
30829839|NCT03706079|58853684|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
30829840|NCT03706079|58853685|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
30829841|NCT03706079|58853686|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
30829842|NCT03706079|58853687|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
30829843|NCT03706079|58853688|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
30829844|NCT03706079|58853689|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
30829845|NCT03706079|58853684|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
30829846|NCT03706079|58853685|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
30829847|NCT03706079|58853686|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
30829848|NCT03706079|58853687|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
30829849|NCT03706079|58853688|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
30829850|NCT03706079|58853689|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
30829851|NCT03706079|58853684|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
30829852|NCT03706079|58853685|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
30829853|NCT03706079|58853686|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
30829854|NCT03706079|58853687|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
30829855|NCT03706079|58853688|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
30829856|NCT03706079|58853689|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
30829857|NCT03706079|58853684|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
30829858|NCT03706079|58853685|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
30829859|NCT03706079|58853686|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
30829860|NCT03706079|58853687|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
30829861|NCT03706079|58853688|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
30829862|NCT03706079|58853689|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
30829863|NCT03706079|58853684|FG000|Long Term Extension (DESTINATION)|Death|8|||
30829864|NCT03706079|58853685|FG001|Long Term Extension (DESTINATION)|Death|2|||
30829865|NCT03706079|58853686|FG002|Long Term Extension (DESTINATION)|Death|2|||
30829866|NCT03706079|58853687|FG003|Long Term Extension (DESTINATION)|Death|1|||
30829867|NCT03706079|58853688|FG004|Long Term Extension (DESTINATION)|Death|0|||
30829868|NCT03706079|58853689|FG005|Long Term Extension (DESTINATION)|Death|0|||
30829869|NCT03657160|58853703|FG000|Overall Study|Adverse Event|5|||
30829870|NCT03657160|58853704|FG001|Overall Study|Adverse Event|6|||
30829871|NCT03657160|58853703|FG000|Overall Study|Protocol Deviation|3|||
30829872|NCT03657160|58853704|FG001|Overall Study|Protocol Deviation|0|||
30829873|NCT03657160|58853703|FG000|Overall Study|Withdrawal by Subject|18|||
30829874|NCT03657160|58853704|FG001|Overall Study|Withdrawal by Subject|16|||
30829875|NCT03657160|58853703|FG000|Overall Study|Site Termination|1|||
30829876|NCT03657160|58853704|FG001|Overall Study|Site Termination|0|||
30829877|NCT03657160|58853703|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
30829878|NCT03657160|58853704|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
30829879|NCT03657160|58853703|FG000|Overall Study|Death|33|||
30829880|NCT03657160|58853704|FG001|Overall Study|Death|26|||
30829881|NCT03657160|58853703|FG000|Overall Study|Death (COVID-19-Related)|1|||
30829882|NCT03657160|58853704|FG001|Overall Study|Death (COVID-19-Related)|0|||
30829883|NCT03657160|58853703|FG000|Overall Study|Reason Not Specified|5|||
30829884|NCT03657160|58853704|FG001|Overall Study|Reason Not Specified|5|||
30829885|NCT03657160|58853703|FG000|Overall Study|Other (COVID-19-Related)|0|||
30623496|NCT01139580|58635313|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
30829886|NCT03657160|58853704|FG001|Overall Study|Other (COVID-19-Related)|1|||
30829887|NCT03635320|58853714|FG000|Overall Study|not implanted the device|1|||
30829888|NCT03635320|58853715|FG001|Overall Study|not implanted the device|2|||
30829889|NCT03635320|58853714|FG000|Overall Study|Withdrawal by Subject|11|||
30829890|NCT03635320|58853715|FG001|Overall Study|Withdrawal by Subject|6|||
30829891|NCT03508726|58853732|FG000|Overall Study|Withdrawal by Subject|0|||
30829892|NCT03508726|58853733|FG001|Overall Study|Withdrawal by Subject|1|||
30829893|NCT03499964|58853742|FG000|Overall Study|Lack of Efficacy|6|||
30829894|NCT03499964|58853743|FG001|Overall Study|Lack of Efficacy|26|||
30829895|NCT03499964|58853742|FG000|Overall Study|Adverse Event|1|||
30829896|NCT03499964|58853743|FG001|Overall Study|Adverse Event|0|||
30829897|NCT03499964|58853742|FG000|Overall Study|Death|1|||
30829898|NCT03499964|58853743|FG001|Overall Study|Death|0|||
30829899|NCT03499964|58853742|FG000|Overall Study|Withdrawal by Subject|2|||
30829900|NCT03499964|58853743|FG001|Overall Study|Withdrawal by Subject|1|||
30829901|NCT03499964|58853742|FG000|Overall Study|Lost to Follow-up|1|||
30829902|NCT03499964|58853743|FG001|Overall Study|Lost to Follow-up|0|||
30829903|NCT03345784|58853751|FG000|Overall Study|Withdrawal by Subject|2|||
30829904|NCT03345784|58853752|FG001|Overall Study|Withdrawal by Subject|1|||
30829905|NCT03279692|58853758|FG000|Overall Study|Withdrawal by Subject|1|||
30829906|NCT03001882|58853775|FG000|Overall Study|Death|1|||
30829907|NCT03001882|58853776|FG001|Overall Study|Death|0|||
30829908|NCT03001882|58853777|FG002|Overall Study|Death|0|||
30829909|NCT03001882|58853778|FG003|Overall Study|Death|3|||
30829910|NCT03001882|58853775|FG000|Overall Study|Participant withdrew consent|0|||
30829911|NCT03001882|58853776|FG001|Overall Study|Participant withdrew consent|1|||
30829912|NCT03001882|58853777|FG002|Overall Study|Participant withdrew consent|0|||
30829913|NCT03001882|58853778|FG003|Overall Study|Participant withdrew consent|5|||
30829914|NCT03001882|58853775|FG000|Overall Study|Other reasons|1|||
30829915|NCT03001882|58853776|FG001|Overall Study|Other reasons|2|||
30829916|NCT03001882|58853777|FG002|Overall Study|Other reasons|0|||
30829917|NCT03001882|58853778|FG003|Overall Study|Other reasons|5|||
30922212|NCT02042443|58957559|FG000|Overall Study|not protocol specified|1|||
30922213|NCT02042443|58957560|FG001|Overall Study|not protocol specified|1|||
30922214|NCT02042443|58957559|FG000|Overall Study|Not eligible/not analyzable|3|||
30922215|NCT02042443|58957560|FG001|Overall Study|Not eligible/not analyzable|6|||
30922216|NCT02118896|58957577|FG000|Overall Study|Death|4|||
30922217|NCT02118896|58957578|FG001|Overall Study|Death|0|||
30922218|NCT02118896|58957579|FG002|Overall Study|Death|4|||
30922219|NCT02118896|58957580|FG003|Overall Study|Death|6|||
30922220|NCT02118896|58957581|FG004|Overall Study|Death|3|||
30829918|NCT03001882|58853775|FG000|Overall Study|Administrative reason by sponsor|0|||
30829919|NCT03001882|58853776|FG001|Overall Study|Administrative reason by sponsor|0|||
30829920|NCT03001882|58853777|FG002|Overall Study|Administrative reason by sponsor|0|||
30829921|NCT03001882|58853778|FG003|Overall Study|Administrative reason by sponsor|1|||
30829922|NCT03001882|58853775|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
30829923|NCT03001882|58853776|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
30829924|NCT03001882|58853777|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
30829925|NCT03001882|58853778|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
30829926|NCT03001882|58853775|FG000|Overall Study|Not reported|0|||
30829927|NCT03001882|58853776|FG001|Overall Study|Not reported|0|||
30829928|NCT03001882|58853777|FG002|Overall Study|Not reported|0|||
30829929|NCT03001882|58853778|FG003|Overall Study|Not reported|6|||
30829930|NCT03001882|58853775|FG000|Overall Study|Maximum clinical benefit|1|||
30829931|NCT03001882|58853776|FG001|Overall Study|Maximum clinical benefit|2|||
30829932|NCT03001882|58853777|FG002|Overall Study|Maximum clinical benefit|0|||
30829933|NCT03001882|58853778|FG003|Overall Study|Maximum clinical benefit|10|||
30829934|NCT03001882|58853775|FG000|Overall Study|AE unrelated to study drug|3|||
30829935|NCT03001882|58853776|FG001|Overall Study|AE unrelated to study drug|3|||
30829936|NCT03001882|58853777|FG002|Overall Study|AE unrelated to study drug|0|||
30829937|NCT03001882|58853778|FG003|Overall Study|AE unrelated to study drug|11|||
30829938|NCT03001882|58853775|FG000|Overall Study|Study Drug Toxicity|8|||
30922221|NCT02118896|58957582|FG005|Overall Study|Death|1|||
30922222|NCT02118896|58957583|FG006|Overall Study|Death|0|||
30922223|NCT02118896|58957584|FG007|Overall Study|Death|0|||
30829939|NCT03001882|58853776|FG001|Overall Study|Study Drug Toxicity|5|||
30829940|NCT03001882|58853777|FG002|Overall Study|Study Drug Toxicity|0|||
30829941|NCT03001882|58853778|FG003|Overall Study|Study Drug Toxicity|37|||
30922224|NCT02118896|58957585|FG008|Overall Study|Death|0|||
30623497|NCT01139580|58635312|FG000|Overall Study|Misrandomized|1|||
30829942|NCT03001882|58853775|FG000|Overall Study|Disease progression|15|||
30829943|NCT03001882|58853776|FG001|Overall Study|Disease progression|14|||
30829944|NCT03001882|58853777|FG002|Overall Study|Disease progression|2|||
30829945|NCT03001882|58853778|FG003|Overall Study|Disease progression|90|||
30829946|NCT02985151|58853795|FG000|Original Randomization|Withdrawal by Subject|0|||
30922225|NCT02118896|58957586|FG009|Overall Study|Death|0|||
30922226|NCT02118896|58957577|FG000|Overall Study|Adverse Event|5|||
30922227|NCT02118896|58957578|FG001|Overall Study|Adverse Event|4|||
30755078|NCT00124982|58764739|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
30755079|NCT00124982|58764737|FG000|Short-term Period|Participant Decision|1|||
30755080|NCT00124982|58764738|FG001|Short-term Period|Participant Decision|0|||
30755081|NCT00124982|58764739|FG002|Short-term Period|Participant Decision|0|||
30755082|NCT00124982|58764737|FG000|Short-term Period|Participant Chose Own Doctor|0|||
30755083|NCT00124982|58764738|FG001|Short-term Period|Participant Chose Own Doctor|1|||
30755084|NCT00124982|58764739|FG002|Short-term Period|Participant Chose Own Doctor|0|||
30755085|NCT00124982|58764737|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
30755086|NCT00124982|58764738|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
30755087|NCT00124982|58764739|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
30755088|NCT00124982|58764737|FG000|Short-term Period|Participant Had Lymphopenia|1|||
30755089|NCT00124982|58764738|FG001|Short-term Period|Participant Had Lymphopenia|0|||
30922228|NCT02118896|58957579|FG002|Overall Study|Adverse Event|4|||
30922229|NCT02118896|58957580|FG003|Overall Study|Adverse Event|5|||
30922230|NCT02118896|58957581|FG004|Overall Study|Adverse Event|5|||
30922231|NCT02118896|58957582|FG005|Overall Study|Adverse Event|9|||
30922232|NCT02118896|58957583|FG006|Overall Study|Adverse Event|1|||
30922233|NCT02118896|58957584|FG007|Overall Study|Adverse Event|1|||
30922234|NCT02118896|58957585|FG008|Overall Study|Adverse Event|4|||
30922235|NCT02118896|58957586|FG009|Overall Study|Adverse Event|0|||
30922236|NCT02118896|58957577|FG000|Overall Study|Consent withdrawn|2|||
30922237|NCT02118896|58957578|FG001|Overall Study|Consent withdrawn|0|||
30922238|NCT02118896|58957579|FG002|Overall Study|Consent withdrawn|3|||
30922239|NCT02118896|58957580|FG003|Overall Study|Consent withdrawn|4|||
30922240|NCT02118896|58957581|FG004|Overall Study|Consent withdrawn|1|||
30922241|NCT02118896|58957582|FG005|Overall Study|Consent withdrawn|4|||
30922242|NCT02118896|58957583|FG006|Overall Study|Consent withdrawn|0|||
30922243|NCT02118896|58957584|FG007|Overall Study|Consent withdrawn|0|||
30922244|NCT02118896|58957585|FG008|Overall Study|Consent withdrawn|0|||
30922245|NCT02118896|58957586|FG009|Overall Study|Consent withdrawn|0|||
30922246|NCT02118896|58957577|FG000|Overall Study|Non-compliance|2|||
30922247|NCT02118896|58957578|FG001|Overall Study|Non-compliance|1|||
30922248|NCT02118896|58957579|FG002|Overall Study|Non-compliance|1|||
30922249|NCT02118896|58957580|FG003|Overall Study|Non-compliance|5|||
30922250|NCT02118896|58957581|FG004|Overall Study|Non-compliance|0|||
30922251|NCT02118896|58957582|FG005|Overall Study|Non-compliance|1|||
30922252|NCT02118896|58957583|FG006|Overall Study|Non-compliance|0|||
30922253|NCT02118896|58957584|FG007|Overall Study|Non-compliance|1|||
30922254|NCT02118896|58957585|FG008|Overall Study|Non-compliance|0|||
30922255|NCT02118896|58957586|FG009|Overall Study|Non-compliance|0|||
30922256|NCT02118896|58957577|FG000|Overall Study|Pregnancy|1|||
30922257|NCT02118896|58957578|FG001|Overall Study|Pregnancy|1|||
30922258|NCT02118896|58957579|FG002|Overall Study|Pregnancy|0|||
30922259|NCT02118896|58957580|FG003|Overall Study|Pregnancy|0|||
30922260|NCT02118896|58957581|FG004|Overall Study|Pregnancy|1|||
30922261|NCT02118896|58957582|FG005|Overall Study|Pregnancy|3|||
30922262|NCT02118896|58957583|FG006|Overall Study|Pregnancy|1|||
30922263|NCT02118896|58957584|FG007|Overall Study|Pregnancy|0|||
30922264|NCT02118896|58957585|FG008|Overall Study|Pregnancy|0|||
30922265|NCT02118896|58957586|FG009|Overall Study|Pregnancy|0|||
30922266|NCT02118896|58957577|FG000|Overall Study|Lost to Follow-up|1|||
30922267|NCT02118896|58957578|FG001|Overall Study|Lost to Follow-up|2|||
30922268|NCT02118896|58957579|FG002|Overall Study|Lost to Follow-up|1|||
30922269|NCT02118896|58957580|FG003|Overall Study|Lost to Follow-up|0|||
30922270|NCT02118896|58957581|FG004|Overall Study|Lost to Follow-up|2|||
30922271|NCT02118896|58957582|FG005|Overall Study|Lost to Follow-up|1|||
30922272|NCT02118896|58957583|FG006|Overall Study|Lost to Follow-up|0|||
30922273|NCT02118896|58957584|FG007|Overall Study|Lost to Follow-up|0|||
30922274|NCT02118896|58957585|FG008|Overall Study|Lost to Follow-up|0|||
30922275|NCT02118896|58957586|FG009|Overall Study|Lost to Follow-up|0|||
30755090|NCT00124982|58764739|FG002|Short-term Period|Participant Had Lymphopenia|0|||
30755091|NCT00124982|58764737|FG000|Long-term Period|Death|0|||
30755092|NCT00124982|58764738|FG001|Long-term Period|Death|0|||
30922276|NCT02118896|58957577|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
30922277|NCT02118896|58957578|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
30922278|NCT02118896|58957579|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
30922279|NCT02118896|58957580|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
30922280|NCT02118896|58957581|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
30755093|NCT00124982|58764739|FG002|Long-term Period|Death|1|||
30755094|NCT00124982|58764737|FG000|Long-term Period|Adverse Event|0|||
30922281|NCT02118896|58957582|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
30755095|NCT00124982|58764738|FG001|Long-term Period|Adverse Event|0|||
30755096|NCT00124982|58764739|FG002|Long-term Period|Adverse Event|17|||
30755097|NCT00124982|58764737|FG000|Long-term Period|Lack of Efficacy|0|||
30755098|NCT00124982|58764738|FG001|Long-term Period|Lack of Efficacy|0|||
30922282|NCT02118896|58957583|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
30922283|NCT02118896|58957584|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
30922284|NCT02118896|58957585|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
30922285|NCT02118896|58957586|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
30922286|NCT02118896|58957577|FG000|Overall Study|Prohibited medication|0|||
30755099|NCT00124982|58764739|FG002|Long-term Period|Lack of Efficacy|46|||
30755100|NCT00124982|58764737|FG000|Long-term Period|Lost to Follow-up|0|||
30922287|NCT02118896|58957578|FG001|Overall Study|Prohibited medication|0|||
30922288|NCT02118896|58957579|FG002|Overall Study|Prohibited medication|0|||
30922289|NCT02118896|58957580|FG003|Overall Study|Prohibited medication|0|||
30922290|NCT02118896|58957581|FG004|Overall Study|Prohibited medication|1|||
30922291|NCT02118896|58957582|FG005|Overall Study|Prohibited medication|3|||
30623498|NCT01139580|58635313|FG001|Overall Study|Misrandomized|0|||
30623499|NCT01139580|58635312|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
30755101|NCT00124982|58764738|FG001|Long-term Period|Lost to Follow-up|0|||
30755102|NCT00124982|58764739|FG002|Long-term Period|Lost to Follow-up|4|||
30755103|NCT00124982|58764737|FG000|Long-term Period|Withdrawal by Subject|0|||
30755104|NCT00124982|58764738|FG001|Long-term Period|Withdrawal by Subject|0|||
30755105|NCT00124982|58764739|FG002|Long-term Period|Withdrawal by Subject|16|||
30755106|NCT00124982|58764737|FG000|Long-term Period|Pregnancy|0|||
30755107|NCT00124982|58764738|FG001|Long-term Period|Pregnancy|0|||
30755108|NCT00124982|58764739|FG002|Long-term Period|Pregnancy|1|||
30755109|NCT00124982|58764737|FG000|Long-term Period|Poor/Non-compliance|0|||
30755110|NCT00124982|58764738|FG001|Long-term Period|Poor/Non-compliance|0|||
30755111|NCT00124982|58764739|FG002|Long-term Period|Poor/Non-compliance|2|||
30755112|NCT00124982|58764737|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
30755113|NCT00124982|58764738|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
30755114|NCT00124982|58764739|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
30755115|NCT00124982|58764737|FG000|Long-term Period|Neurologist Recommendation|0|||
30755116|NCT00124982|58764738|FG001|Long-term Period|Neurologist Recommendation|0|||
30755117|NCT00124982|58764739|FG002|Long-term Period|Neurologist Recommendation|1|||
30755118|NCT04263142|58764753|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
30755119|NCT04263142|58764754|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
30755120|NCT04263142|58764755|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
30755121|NCT04263142|58764756|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
30755122|NCT04263142|58764757|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
30755123|NCT04263142|58764753|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
30755124|NCT04263142|58764754|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
30755125|NCT04263142|58764755|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
30755126|NCT04263142|58764756|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
30755127|NCT04263142|58764757|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
30755128|NCT04095286|58764770|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
30755129|NCT04095286|58764771|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
30755130|NCT04095286|58764772|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
30755131|NCT04095286|58764773|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
30755132|NCT04095286|58764774|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
30755133|NCT04095286|58764775|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
30755134|NCT04095286|58764770|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
30755135|NCT04095286|58764771|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
30755136|NCT04095286|58764772|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
30755137|NCT04095286|58764773|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
30755138|NCT04095286|58764774|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
30755139|NCT04095286|58764775|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
30755140|NCT04095286|58764770|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
30755141|NCT04095286|58764771|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
30922292|NCT02118896|58957583|FG006|Overall Study|Prohibited medication|0|||
30922293|NCT02118896|58957584|FG007|Overall Study|Prohibited medication|0|||
30922294|NCT02118896|58957585|FG008|Overall Study|Prohibited medication|0|||
30922295|NCT02118896|58957586|FG009|Overall Study|Prohibited medication|0|||
30922296|NCT02118896|58957577|FG000|Overall Study|Miscellaneous|1|||
30922297|NCT02118896|58957578|FG001|Overall Study|Miscellaneous|2|||
30922298|NCT02118896|58957579|FG002|Overall Study|Miscellaneous|0|||
30922299|NCT02118896|58957580|FG003|Overall Study|Miscellaneous|2|||
30922300|NCT02118896|58957581|FG004|Overall Study|Miscellaneous|0|||
30922301|NCT02118896|58957582|FG005|Overall Study|Miscellaneous|4|||
30922302|NCT02118896|58957583|FG006|Overall Study|Miscellaneous|0|||
30922303|NCT02118896|58957584|FG007|Overall Study|Miscellaneous|0|||
30922304|NCT02118896|58957585|FG008|Overall Study|Miscellaneous|0|||
30922305|NCT02118896|58957586|FG009|Overall Study|Miscellaneous|0|||
30922306|NCT02124707|58957609|FG000|Overall Study|Adverse Event|5|||
30922307|NCT02124707|58957609|FG000|Overall Study|Physician Decision|1|||
30922308|NCT02124707|58957609|FG000|Overall Study|Death|1|||
30755142|NCT04095286|58764772|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
30623500|NCT01139580|58635313|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
30755143|NCT04095286|58764773|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
30755144|NCT04095286|58764774|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
30755145|NCT04095286|58764775|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
30755146|NCT04095286|58764770|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
30755147|NCT04095286|58764771|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
30755148|NCT04095286|58764772|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
30755149|NCT04095286|58764773|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
30755150|NCT04095286|58764774|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
30755151|NCT04095286|58764775|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
30755152|NCT04095286|58764770|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
30755153|NCT04095286|58764771|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
30755154|NCT04095286|58764772|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
30755155|NCT04095286|58764773|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
30755156|NCT04095286|58764774|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
30755157|NCT04095286|58764775|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
30755158|NCT04093414|58764785|FG000|3 Month Follow up|Physician Decision|0|||
30755159|NCT04093414|58764786|FG001|3 Month Follow up|Physician Decision|1|||
30755160|NCT04093414|58764785|FG000|6month Follow up|Physician Decision|1|||
30755161|NCT04093414|58764786|FG001|6month Follow up|Physician Decision|3|||
30755162|NCT04093258|58764792|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
30755163|NCT04093258|58764793|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
30755164|NCT04253236|58764801|FG000|Overall Study|Adverse Event|1|||
30755165|NCT04253236|58764802|FG001|Overall Study|Adverse Event|0|||
30755166|NCT04253236|58764801|FG000|Overall Study|Safety Concerns|1|||
30755167|NCT04253236|58764802|FG001|Overall Study|Safety Concerns|0|||
30755168|NCT04253236|58764801|FG000|Overall Study|Study Terminated by Sponsor|1|||
30755169|NCT04253236|58764802|FG001|Overall Study|Study Terminated by Sponsor|0|||
30755170|NCT04087720|58764808|FG000|Overall Study|Withdrawal by Subject|2|||
30755171|NCT04087720|58764808|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
30755172|NCT04086472|58764817|FG000|Overall Study|Lost to Follow-up|1|||
30755173|NCT04086472|58764818|FG001|Overall Study|Lost to Follow-up|0|||
30755174|NCT04086472|58764819|FG002|Overall Study|Lost to Follow-up|0|||
30755175|NCT04086472|58764820|FG003|Overall Study|Lost to Follow-up|0|||
30755176|NCT04086472|58764821|FG004|Overall Study|Lost to Follow-up|1|||
30755177|NCT04086472|58764817|FG000|Overall Study|Physician Decision|0|||
30755178|NCT04086472|58764818|FG001|Overall Study|Physician Decision|1|||
30755179|NCT04086472|58764819|FG002|Overall Study|Physician Decision|1|||
30755180|NCT04086472|58764820|FG003|Overall Study|Physician Decision|0|||
30755181|NCT04086472|58764821|FG004|Overall Study|Physician Decision|0|||
30755182|NCT04086472|58764817|FG000|Overall Study|Withdrawal by Subject|1|||
30755183|NCT04086472|58764818|FG001|Overall Study|Withdrawal by Subject|1|||
30755184|NCT04086472|58764819|FG002|Overall Study|Withdrawal by Subject|1|||
30755185|NCT04086472|58764820|FG003|Overall Study|Withdrawal by Subject|0|||
30755186|NCT04086472|58764821|FG004|Overall Study|Withdrawal by Subject|0|||
30755187|NCT04086472|58764817|FG000|Overall Study|Various reasons|2|||
30755188|NCT04086472|58764818|FG001|Overall Study|Various reasons|0|||
30922309|NCT02067728|58957616|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
30922310|NCT02067728|58957617|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
30922311|NCT02067728|58957616|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
30755189|NCT04086472|58764819|FG002|Overall Study|Various reasons|0|||
30755190|NCT04086472|58764820|FG003|Overall Study|Various reasons|3|||
30755191|NCT04086472|58764821|FG004|Overall Study|Various reasons|1|||
30755192|NCT04249336|58764837|FG000|Overall Study|Lost to Follow-up|3|||
30755193|NCT04249336|58764838|FG001|Overall Study|Lost to Follow-up|3|||
30755194|NCT04249336|58764839|FG002|Overall Study|Lost to Follow-up|3|||
30755195|NCT04249336|58764840|FG003|Overall Study|Lost to Follow-up|3|||
30755196|NCT04245202|58764852|FG000|Overall Study|Lack of Efficacy|10|||
30755197|NCT04245202|58764853|FG001|Overall Study|Lack of Efficacy|1|||
30755198|NCT04079842|58764860|FG000|Overall Study|Request of subject|2|||
30755199|NCT04079842|58764860|FG000|Overall Study|Unable to draw Arterial samples|1|||
30755200|NCT04078126|58764864|FG000|Washout|Study put on hold due to COVID-19|0|||
30755201|NCT04078126|58764865|FG001|Washout|Study put on hold due to COVID-19|2|||
30755202|NCT04078126|58764864|FG000|Period 2|Study put on hold due to COVID-19|1|||
30755203|NCT04078126|58764865|FG001|Period 2|Study put on hold due to COVID-19|1|||
30755204|NCT04073368|58764875|FG000|Overall Study|Adverse Event|2|||
30755205|NCT04073368|58764876|FG001|Overall Study|Adverse Event|0|||
30755206|NCT04073368|58764877|FG002|Overall Study|Adverse Event|1|||
30755207|NCT04073368|58764878|FG003|Overall Study|Adverse Event|1|||
30755208|NCT04073368|58764875|FG000|Overall Study|Withdrawal by Subject|2|||
30755209|NCT04073368|58764876|FG001|Overall Study|Withdrawal by Subject|2|||
30755210|NCT04073368|58764877|FG002|Overall Study|Withdrawal by Subject|1|||
30755211|NCT04073368|58764878|FG003|Overall Study|Withdrawal by Subject|1|||
30755212|NCT04073368|58764875|FG000|Overall Study|Lost to Follow-up|1|||
30755213|NCT04073368|58764876|FG001|Overall Study|Lost to Follow-up|1|||
30755214|NCT04073368|58764877|FG002|Overall Study|Lost to Follow-up|1|||
30755215|NCT04073368|58764878|FG003|Overall Study|Lost to Follow-up|0|||
30755216|NCT04073368|58764875|FG000|Overall Study|Protocol Violation|0|||
30755217|NCT04073368|58764876|FG001|Overall Study|Protocol Violation|1|||
30755218|NCT04073368|58764877|FG002|Overall Study|Protocol Violation|0|||
30755219|NCT04073368|58764878|FG003|Overall Study|Protocol Violation|0|||
30755220|NCT04073368|58764875|FG000|Overall Study|Subject noncompliance|7|||
30755221|NCT04073368|58764876|FG001|Overall Study|Subject noncompliance|4|||
30755222|NCT04073368|58764877|FG002|Overall Study|Subject noncompliance|0|||
30755223|NCT04073368|58764878|FG003|Overall Study|Subject noncompliance|0|||
30755224|NCT04380688|58764890|FG000|Overall Study|Death|2|||
30755225|NCT04380688|58764891|FG001|Overall Study|Death|2|||
30755226|NCT04380688|58764890|FG000|Overall Study|Lost to Follow-up|2|||
30755227|NCT04380688|58764891|FG001|Overall Study|Lost to Follow-up|4|||
30755228|NCT04380688|58764890|FG000|Overall Study|Withdrawal by Subject|3|||
30755229|NCT04380688|58764891|FG001|Overall Study|Withdrawal by Subject|3|||
30755230|NCT00124748|58764899|FG000|Overall Study|Adverse Event|8|||
30755231|NCT00124748|58764900|FG001|Overall Study|Adverse Event|39|||
30755232|NCT00124748|58764899|FG000|Overall Study|Abnormal laboratory Value|2|||
30755233|NCT00124748|58764900|FG001|Overall Study|Abnormal laboratory Value|2|||
30829947|NCT02985151|58853796|FG001|Original Randomization|Withdrawal by Subject|1|||
30829948|NCT02603432|58853868|FG000|Overall Study|Ongoing|184|||
30829949|NCT02603432|58853869|FG001|Overall Study|Ongoing|144|||
30829950|NCT02603432|58853868|FG000|Overall Study|Adverse Event|1|||
30829951|NCT02603432|58853869|FG001|Overall Study|Adverse Event|0|||
30829952|NCT02603432|58853868|FG000|Overall Study|Death|144|||
30829953|NCT02603432|58853869|FG001|Overall Study|Death|177|||
30829954|NCT02603432|58853868|FG000|Overall Study|Lost to Follow-up|4|||
30829955|NCT02603432|58853869|FG001|Overall Study|Lost to Follow-up|6|||
30829956|NCT02603432|58853868|FG000|Overall Study|Progressive Disease|5|||
30829957|NCT02603432|58853869|FG001|Overall Study|Progressive Disease|5|||
30829958|NCT02603432|58853868|FG000|Overall Study|Withdrawal by Subject|9|||
30829959|NCT02603432|58853869|FG001|Overall Study|Withdrawal by Subject|17|||
30829960|NCT02603432|58853868|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
30829961|NCT02603432|58853869|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
30829962|NCT02603432|58853868|FG000|Overall Study|Other|0|||
30829963|NCT02603432|58853869|FG001|Overall Study|Other|1|||
30829964|NCT02582866|58853875|FG000|Overall Study|Death|1|||
30829965|NCT02582866|58853875|FG000|Overall Study|Lack of Efficacy|2|||
30829966|NCT02582866|58853875|FG000|Overall Study|Lost to Follow-up|2|||
30829967|NCT02582866|58853875|FG000|Overall Study|Withdrawal by Subject|7|||
30829968|NCT02582866|58853875|FG000|Overall Study|Investigator decision|5|||
30829969|NCT02582866|58853875|FG000|Overall Study|Participant wants to get pregnant|1|||
30829970|NCT02582866|58853875|FG000|Overall Study|Pregnancy|2|||
30829971|NCT02582866|58853875|FG000|Overall Study|Sponsor decision|1|||
30829972|NCT02582866|58853875|FG000|Overall Study|Withdrawal due to personal reasons|1|||
30829973|NCT02395666|58853881|FG000|Overall Study|Physician Decision|3|||
30829974|NCT02395666|58853882|FG001|Overall Study|Physician Decision|0|||
30829975|NCT02395666|58853881|FG000|Overall Study|Lost to Follow-up|1|||
30829976|NCT02395666|58853882|FG001|Overall Study|Lost to Follow-up|0|||
30829977|NCT02395666|58853881|FG000|Overall Study|Withdrawal by Subject|2|||
30755234|NCT00124748|58764899|FG000|Overall Study|Abnormal Procedure|0|||
30755235|NCT00124748|58764900|FG001|Overall Study|Abnormal Procedure|1|||
30755236|NCT00124748|58764899|FG000|Overall Study|Lack of Efficacy|20|||
30755237|NCT00124748|58764900|FG001|Overall Study|Lack of Efficacy|41|||
30755238|NCT00124748|58764899|FG000|Overall Study|No longer requires study drug|1|||
30755239|NCT00124748|58764900|FG001|Overall Study|No longer requires study drug|1|||
30755240|NCT00124748|58764899|FG000|Overall Study|Protocol Violation|3|||
30755241|NCT00124748|58764900|FG001|Overall Study|Protocol Violation|1|||
30755242|NCT00124748|58764899|FG000|Overall Study|Withdrawal by Subject|5|||
30755243|NCT00124748|58764900|FG001|Overall Study|Withdrawal by Subject|15|||
30755244|NCT00124748|58764899|FG000|Overall Study|Lost to Follow-up|2|||
30755245|NCT00124748|58764900|FG001|Overall Study|Lost to Follow-up|7|||
30755246|NCT00124748|58764899|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
30755247|NCT00124748|58764900|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
30829978|NCT02395666|58853882|FG001|Overall Study|Withdrawal by Subject|1|||
30829979|NCT02180867|58853899|FG000|Overall Study|Adverse Event|3|||
30829980|NCT02180867|58853900|FG001|Overall Study|Adverse Event|4|||
30829981|NCT02180867|58853901|FG002|Overall Study|Adverse Event|1|||
30829982|NCT02180867|58853902|FG003|Overall Study|Adverse Event|5|||
30829983|NCT02180867|58853903|FG004|Overall Study|Adverse Event|0|||
30922312|NCT02067728|58957617|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
30922313|NCT02067728|58957616|FG000|6 Month Measurements|Unable to attend|114|||
30922314|NCT02067728|58957617|FG001|6 Month Measurements|Unable to attend|97|||
30922315|NCT02118428|58957625|FG000|Overall Study|Physician Decision|0|||
30922316|NCT02118428|58957626|FG001|Overall Study|Physician Decision|1|||
30922317|NCT02118428|58957627|FG002|Overall Study|Physician Decision|0|||
30922318|NCT02118428|58957625|FG000|Overall Study|Withdrawal by Subject|2|||
30922319|NCT02118428|58957626|FG001|Overall Study|Withdrawal by Subject|2|||
30922320|NCT02118428|58957627|FG002|Overall Study|Withdrawal by Subject|0|||
30922321|NCT02118428|58957625|FG000|Overall Study|Death|7|||
30922322|NCT02118428|58957626|FG001|Overall Study|Death|5|||
30922323|NCT02118428|58957627|FG002|Overall Study|Death|0|||
30922324|NCT02118428|58957625|FG000|Overall Study|Lost to Follow-up|3|||
30922325|NCT02118428|58957626|FG001|Overall Study|Lost to Follow-up|1|||
30922326|NCT02118428|58957627|FG002|Overall Study|Lost to Follow-up|0|||
30922327|NCT02118428|58957625|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
30922328|NCT02118428|58957626|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
30922329|NCT02118428|58957627|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
30922330|NCT02067104|58957635|FG000|Overall Study|Study termination due to low accrual|4|||
30922331|NCT02067104|58957636|FG001|Overall Study|Study termination due to low accrual|5|||
30922332|NCT02092220|58957642|FG000|Period 1|Unrelated Illness|0|||
30922333|NCT02092220|58957643|FG001|Period 1|Unrelated Illness|2|||
30922334|NCT02092220|58957642|FG000|Period 2|Severe Hypoglycaemia|1|||
30922335|NCT02092220|58957643|FG001|Period 2|Severe Hypoglycaemia|0|||
30922336|NCT02092220|58957642|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
30922337|NCT02092220|58957643|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
30922338|NCT02066402|58957653|FG000|Overall Study|Adverse Event|1|||
30829984|NCT02180867|58853904|FG005|Overall Study|Adverse Event|0|||
30829985|NCT02180867|58853905|FG006|Overall Study|Adverse Event|0|||
30829986|NCT02180867|58853899|FG000|Overall Study|Death|0|||
30829987|NCT02180867|58853900|FG001|Overall Study|Death|0|||
30829988|NCT02180867|58853901|FG002|Overall Study|Death|0|||
30829989|NCT02180867|58853902|FG003|Overall Study|Death|0|||
30829990|NCT02180867|58853903|FG004|Overall Study|Death|1|||
30829991|NCT02180867|58853904|FG005|Overall Study|Death|0|||
30829992|NCT02180867|58853905|FG006|Overall Study|Death|0|||
30829993|NCT02180867|58853899|FG000|Overall Study|Lack of Efficacy|0|||
30829994|NCT02180867|58853900|FG001|Overall Study|Lack of Efficacy|2|||
30829995|NCT02180867|58853901|FG002|Overall Study|Lack of Efficacy|0|||
30829996|NCT02180867|58853902|FG003|Overall Study|Lack of Efficacy|1|||
30829997|NCT02180867|58853903|FG004|Overall Study|Lack of Efficacy|6|||
30829998|NCT02180867|58853904|FG005|Overall Study|Lack of Efficacy|0|||
30829999|NCT02180867|58853905|FG006|Overall Study|Lack of Efficacy|1|||
30830000|NCT02180867|58853899|FG000|Overall Study|Physician Decision|1|||
30830001|NCT02180867|58853900|FG001|Overall Study|Physician Decision|3|||
30830002|NCT02180867|58853901|FG002|Overall Study|Physician Decision|1|||
30830003|NCT02180867|58853902|FG003|Overall Study|Physician Decision|10|||
30830004|NCT02180867|58853903|FG004|Overall Study|Physician Decision|9|||
30830005|NCT02180867|58853904|FG005|Overall Study|Physician Decision|3|||
30830006|NCT02180867|58853905|FG006|Overall Study|Physician Decision|4|||
30830007|NCT02180867|58853899|FG000|Overall Study|Withdrawal by Subject|0|||
30830008|NCT02180867|58853900|FG001|Overall Study|Withdrawal by Subject|0|||
30830009|NCT02180867|58853901|FG002|Overall Study|Withdrawal by Subject|0|||
30830010|NCT02180867|58853902|FG003|Overall Study|Withdrawal by Subject|1|||
30830011|NCT02180867|58853903|FG004|Overall Study|Withdrawal by Subject|1|||
30830012|NCT02180867|58853904|FG005|Overall Study|Withdrawal by Subject|0|||
30830013|NCT02180867|58853905|FG006|Overall Study|Withdrawal by Subject|0|||
30830014|NCT02180867|58853899|FG000|Overall Study|Ineligible|1|||
30830015|NCT02180867|58853900|FG001|Overall Study|Ineligible|2|||
30830016|NCT02180867|58853901|FG002|Overall Study|Ineligible|0|||
30830017|NCT02180867|58853902|FG003|Overall Study|Ineligible|3|||
30830018|NCT02180867|58853903|FG004|Overall Study|Ineligible|5|||
30830019|NCT02180867|58853904|FG005|Overall Study|Ineligible|0|||
30922339|NCT02066402|58957654|FG001|Overall Study|Adverse Event|2|||
30922340|NCT02066402|58957653|FG000|Overall Study|Lost to Follow-up|11|||
30830020|NCT02180867|58853905|FG006|Overall Study|Ineligible|0|||
30830021|NCT02180867|58853899|FG000|Overall Study|Repeat Eligibility Studies|0|||
30922341|NCT02066402|58957654|FG001|Overall Study|Lost to Follow-up|8|||
30830022|NCT02180867|58853900|FG001|Overall Study|Repeat Eligibility Studies|0|||
30922342|NCT02066402|58957653|FG000|Overall Study|Withdrawal by Subject|14|||
30922343|NCT02066402|58957654|FG001|Overall Study|Withdrawal by Subject|11|||
30922344|NCT02066402|58957653|FG000|Overall Study|Progressive disease-clinical progression|0|||
30922345|NCT02066402|58957654|FG001|Overall Study|Progressive disease-clinical progression|1|||
30830023|NCT02180867|58853901|FG002|Overall Study|Repeat Eligibility Studies|0|||
30830024|NCT02180867|58853902|FG003|Overall Study|Repeat Eligibility Studies|0|||
30830025|NCT02180867|58853903|FG004|Overall Study|Repeat Eligibility Studies|1|||
30830026|NCT02180867|58853904|FG005|Overall Study|Repeat Eligibility Studies|0|||
30830027|NCT02180867|58853905|FG006|Overall Study|Repeat Eligibility Studies|0|||
30830028|NCT02180867|58853899|FG000|Overall Study|Refusal of further protocol therapy|1|||
30830029|NCT02180867|58853900|FG001|Overall Study|Refusal of further protocol therapy|0|||
30830030|NCT02180867|58853901|FG002|Overall Study|Refusal of further protocol therapy|2|||
30830031|NCT02180867|58853902|FG003|Overall Study|Refusal of further protocol therapy|6|||
30830032|NCT02180867|58853903|FG004|Overall Study|Refusal of further protocol therapy|4|||
30830033|NCT02180867|58853904|FG005|Overall Study|Refusal of further protocol therapy|0|||
30830034|NCT02180867|58853905|FG006|Overall Study|Refusal of further protocol therapy|0|||
30830035|NCT01734928|58853939|FG000|Randomization|Physician Decision|0|||
30830036|NCT01734928|58853940|FG001|Randomization|Physician Decision|1|||
30830037|NCT01734928|58853939|FG000|Randomization|clinical progression|0|||
30830038|NCT01734928|58853940|FG001|Randomization|clinical progression|1|||
30830039|NCT01734928|58853939|FG000|Randomization|progressive disease|0|||
30830040|NCT01734928|58853940|FG001|Randomization|progressive disease|2|||
30830041|NCT01734928|58853939|FG000|Randomization|Withdrew informed consent|0|||
30830042|NCT01734928|58853940|FG001|Randomization|Withdrew informed consent|4|||
30830043|NCT01734928|58853939|FG000|Randomization|Death|1|||
30830044|NCT01734928|58853940|FG001|Randomization|Death|0|||
30830045|NCT01734928|58853939|FG000|Randomization|Randomization error|1|||
30830046|NCT01734928|58853940|FG001|Randomization|Randomization error|0|||
30830047|NCT01734928|58853939|FG000|Randomization|Lost to Follow-up|1|||
30830048|NCT01734928|58853940|FG001|Randomization|Lost to Follow-up|0|||
30830049|NCT01734928|58853939|FG000|Treatment Period|Lost to Follow-up|0|||
30830050|NCT01734928|58853940|FG001|Treatment Period|Lost to Follow-up|2|||
30830051|NCT01734928|58853939|FG000|Treatment Period|Progressive Disease|167|||
30830052|NCT01734928|58853940|FG001|Treatment Period|Progressive Disease|165|||
30830053|NCT01734928|58853939|FG000|Treatment Period|Adverse Event|39|||
30830054|NCT01734928|58853940|FG001|Treatment Period|Adverse Event|52|||
30830055|NCT01734928|58853939|FG000|Treatment Period|Withdrawal of Consent|25|||
30830056|NCT01734928|58853940|FG001|Treatment Period|Withdrawal of Consent|22|||
30830057|NCT01734928|58853939|FG000|Treatment Period|Death|20|||
30830058|NCT01734928|58853940|FG001|Treatment Period|Death|9|||
30830059|NCT01734928|58853939|FG000|Treatment Period|Other Reasons|27|||
30830060|NCT01734928|58853940|FG001|Treatment Period|Other Reasons|19|||
30830061|NCT01734928|58853939|FG000|Treatment Period|Pregnancy|0|||
30830062|NCT01734928|58853940|FG001|Treatment Period|Pregnancy|1|||
30830063|NCT00667459|58853957|FG000|Overall Study|Death|0|||
30830064|NCT00667459|58853958|FG001|Overall Study|Death|2|||
30830065|NCT00667459|58853957|FG000|Overall Study|Lost to Follow-up|8|||
30830066|NCT00667459|58853958|FG001|Overall Study|Lost to Follow-up|43|||
30830067|NCT00453544|58853972|FG000|Overall Study|Withdrawal by Subject|1|||
30830068|NCT00453544|58853973|FG001|Overall Study|Withdrawal by Subject|0|||
30830069|NCT00453544|58853974|FG002|Overall Study|Withdrawal by Subject|0|||
30830070|NCT00453544|58853975|FG003|Overall Study|Withdrawal by Subject|0|||
30830071|NCT00453544|58853972|FG000|Overall Study|Primary outcome measure not completed|1|||
30830072|NCT00453544|58853973|FG001|Overall Study|Primary outcome measure not completed|1|||
30830073|NCT00453544|58853974|FG002|Overall Study|Primary outcome measure not completed|0|||
30830074|NCT00453544|58853975|FG003|Overall Study|Primary outcome measure not completed|1|||
30830075|NCT02646124|58853999|FG000|Overall Study|Lost to Follow-up|0|||
30830076|NCT02646124|58854000|FG001|Overall Study|Lost to Follow-up|2|||
30830077|NCT01597492|58854008|FG000|Overall Study|Withdrawal by Subject|1|||
30830078|NCT01597492|58854009|FG001|Overall Study|Withdrawal by Subject|2|||
30755248|NCT00124748|58764899|FG000|Overall Study|Death|1|||
30755249|NCT00124748|58764900|FG001|Overall Study|Death|3|||
30755250|NCT04070326|58764908|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
30755251|NCT04070326|58764909|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
30755252|NCT03689452|58764919|FG000|Overall Study|Lost to Follow-up|1|||
30755253|NCT03689452|58764920|FG001|Overall Study|Lost to Follow-up|1|||
30755254|NCT04067050|58764928|FG000|One Month|Lost to Follow-up|4|||
30755255|NCT04067050|58764929|FG001|One Month|Lost to Follow-up|0|||
30755256|NCT04067050|58764928|FG000|Two Month|Lost to Follow-up|1|||
30755257|NCT04067050|58764929|FG001|Two Month|Lost to Follow-up|0|||
30755258|NCT04067050|58764928|FG000|Two Month|Adverse Event|1|||
30755259|NCT04067050|58764929|FG001|Two Month|Adverse Event|0|||
30755260|NCT04060654|58764935|FG000|Overall Study|Withdrawal by Subject|1|||
30755261|NCT04060654|58764935|FG000|Overall Study|Lost to Follow-up|5|||
30755262|NCT00096200|58764942|FG000|Overall Study|Adverse Event|0|||
30755263|NCT00096200|58764943|FG001|Overall Study|Adverse Event|4|||
30755264|NCT00096200|58764944|FG002|Overall Study|Adverse Event|0|||
30755265|NCT00096200|58764942|FG000|Overall Study|Withdrawal by Subject|1|||
30755266|NCT00096200|58764943|FG001|Overall Study|Withdrawal by Subject|2|||
30830079|NCT01597492|58854008|FG000|Overall Study|Adverse Event|3|||
30830080|NCT01597492|58854009|FG001|Overall Study|Adverse Event|0|||
30830081|NCT01597492|58854008|FG000|Overall Study|Lost to Follow-up|0|||
30830082|NCT01597492|58854009|FG001|Overall Study|Lost to Follow-up|2|||
30755267|NCT00096200|58764944|FG002|Overall Study|Withdrawal by Subject|0|||
30830083|NCT01597492|58854008|FG000|Overall Study|Other Reason|2|||
30830084|NCT01597492|58854009|FG001|Overall Study|Other Reason|0|||
30830085|NCT03423602|58854015|FG000|Overall Study|Death|1|||
30830086|NCT03423602|58854015|FG000|Overall Study|Lost to Follow-up|6|||
30830087|NCT03423602|58854015|FG000|Overall Study|Protocol Violation|1|||
30830088|NCT03423602|58854015|FG000|Overall Study|Withdrawal by Subject|4|||
30830089|NCT00109590|58854022|FG000|Overall Study|Lost to Follow-up|1|||
30830090|NCT00109590|58854023|FG001|Overall Study|Lost to Follow-up|0|||
30830091|NCT00109590|58854024|FG002|Overall Study|Lost to Follow-up|1|||
30830092|NCT00109590|58854022|FG000|Overall Study|Never Started Treatment|1|||
30830093|NCT00109590|58854023|FG001|Overall Study|Never Started Treatment|2|||
30830094|NCT00109590|58854024|FG002|Overall Study|Never Started Treatment|3|||
30830095|NCT02781558|58854048|FG000|Overall Study|Lost to Follow-up|2|||
30830096|NCT02781558|58854049|FG001|Overall Study|Lost to Follow-up|2|||
30830097|NCT02781558|58854048|FG000|Overall Study|Adverse Event|1|||
30830098|NCT02781558|58854049|FG001|Overall Study|Adverse Event|0|||
30830099|NCT03041311|58854058|FG000|Overall Study|Death|39|||
30830100|NCT03041311|58854059|FG001|Overall Study|Death|42|||
30830101|NCT03041311|58854058|FG000|Overall Study|Lost to Follow-up|0|||
30830102|NCT03041311|58854059|FG001|Overall Study|Lost to Follow-up|1|||
30830103|NCT03041311|58854058|FG000|Overall Study|Withdrawal by Subject|8|||
30830104|NCT03041311|58854059|FG001|Overall Study|Withdrawal by Subject|5|||
30830105|NCT03041311|58854058|FG000|Overall Study|Sponsor Terminated Study|2|||
30830106|NCT03041311|58854059|FG001|Overall Study|Sponsor Terminated Study|4|||
30830107|NCT03041311|58854058|FG000|Overall Study|Disease Progression|3|||
30830108|NCT03041311|58854059|FG001|Overall Study|Disease Progression|1|||
30830109|NCT03041311|58854058|FG000|Overall Study|Randomized in error, did not receive drug|2|||
30830110|NCT03041311|58854059|FG001|Overall Study|Randomized in error, did not receive drug|0|||
30830111|NCT02644096|58854075|FG000|Overall Study|Withdrawal by Subject|28|||
30830112|NCT02644096|58854076|FG001|Overall Study|Withdrawal by Subject|25|||
30830113|NCT02643628|58854084|FG000|Overall Study|Lost to Follow-up|1|||
30830114|NCT02643628|58854085|FG001|Overall Study|Lost to Follow-up|4|||
30830115|NCT02643628|58854084|FG000|Overall Study|Withdrawal by Subject|0|||
30830116|NCT02643628|58854085|FG001|Overall Study|Withdrawal by Subject|1|||
30830117|NCT02643628|58854084|FG000|Overall Study|Relocated out of state|0|||
30830118|NCT02643628|58854085|FG001|Overall Study|Relocated out of state|1|||
30830119|NCT02643472|58854095|FG000|Overall Study|Death|2|||
30830120|NCT02643472|58854096|FG001|Overall Study|Death|5|||
30830121|NCT02643472|58854095|FG000|Overall Study|Withdrawal by Subject|3|||
30830122|NCT02643472|58854096|FG001|Overall Study|Withdrawal by Subject|2|||
30830123|NCT02643472|58854095|FG000|Overall Study|Protocol Violation|0|||
30830124|NCT02643472|58854096|FG001|Overall Study|Protocol Violation|1|||
30830125|NCT02643472|58854095|FG000|Overall Study|Lost to Follow-up|22|||
30830126|NCT02643472|58854096|FG001|Overall Study|Lost to Follow-up|26|||
30830127|NCT02738840|58854104|FG000|Overall Study|MRI Scan not Performed|5|||
30830128|NCT02738840|58854104|FG000|Overall Study|Lost to Follow-up|1|||
30830129|NCT02738840|58854104|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
30830130|NCT02738840|58854104|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
30830131|NCT02643394|58854110|FG000|Overall Study|Protocol Violation|4|||
30830132|NCT02643394|58854111|FG001|Overall Study|Protocol Violation|5|||
30830133|NCT03538158|58854119|FG000|Overall Study|Lost to Follow-up|13|||
30830134|NCT03538158|58854120|FG001|Overall Study|Lost to Follow-up|7|||
30830135|NCT03538158|58854119|FG000|Overall Study|Withdrawal by Subject|2|||
30830136|NCT03538158|58854120|FG001|Overall Study|Withdrawal by Subject|1|||
30830137|NCT02643082|58854126|FG000|Period 1|Adverse Event|1|||
30830138|NCT02643082|58854127|FG001|Period 1|Adverse Event|0|||
30830139|NCT00353496|58854136|FG000|Overall Study|Adverse Event|1|||
30830140|NCT00353496|58854137|FG001|Overall Study|Adverse Event|0|||
30830141|NCT00353496|58854136|FG000|Overall Study|Protocol Violation|2|||
30830142|NCT00353496|58854137|FG001|Overall Study|Protocol Violation|2|||
30830143|NCT00353496|58854136|FG000|Overall Study|Withdrawal by Subject|3|||
30830144|NCT00353496|58854137|FG001|Overall Study|Withdrawal by Subject|4|||
30830145|NCT00353496|58854136|FG000|Overall Study|Physician Decision|6|||
30830146|NCT00353496|58854137|FG001|Overall Study|Physician Decision|9|||
30830147|NCT00353496|58854136|FG000|Overall Study|Not otherwise specified|4|||
30830148|NCT00353496|58854137|FG001|Overall Study|Not otherwise specified|2|||
30830149|NCT01361464|58854153|FG000|Overall Study|Death|1|||
30830150|NCT01361464|58854153|FG000|Overall Study|Withdrawal by Subject|2|||
30830151|NCT03486912|58854161|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
30830152|NCT03486912|58854162|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
30830153|NCT03486912|58854163|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
30830154|NCT03486912|58854164|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
30830155|NCT03486912|58854161|FG000|Treatment Period|Withdrawal by Subject|3|||
30830156|NCT03486912|58854162|FG001|Treatment Period|Withdrawal by Subject|3|||
30830157|NCT03486912|58854163|FG002|Treatment Period|Withdrawal by Subject|3|||
30830158|NCT03486912|58854164|FG003|Treatment Period|Withdrawal by Subject|2|||
30830159|NCT03486912|58854161|FG000|Treatment Period|Other Reasons|0|||
30830160|NCT03486912|58854162|FG001|Treatment Period|Other Reasons|2|||
30830161|NCT03486912|58854163|FG002|Treatment Period|Other Reasons|1|||
30830162|NCT03486912|58854164|FG003|Treatment Period|Other Reasons|1|||
30830163|NCT03486912|58854161|FG000|Treatment Period|Adverse Event|0|||
30623501|NCT01139580|58635312|FG000|Overall Study|Participant Randomization in Error|0|||
30623502|NCT01139580|58635313|FG001|Overall Study|Participant Randomization in Error|1|||
30623503|NCT00917644|58635319|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
30755268|NCT00096200|58764942|FG000|Overall Study|Ineligible pathology|0|||
30755269|NCT00096200|58764943|FG001|Overall Study|Ineligible pathology|1|||
30755270|NCT00096200|58764944|FG002|Overall Study|Ineligible pathology|0|||
30755271|NCT04059094|58764957|FG000|Overall Study|Adverse Event|0|||
30755272|NCT04059094|58764958|FG001|Overall Study|Adverse Event|0|||
30755273|NCT04059094|58764959|FG002|Overall Study|Adverse Event|0|||
30755274|NCT04059094|58764960|FG003|Overall Study|Adverse Event|0|||
30755275|NCT04059094|58764961|FG004|Overall Study|Adverse Event|1|||
30755276|NCT04059094|58764957|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
30755277|NCT04059094|58764958|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
30755278|NCT04059094|58764959|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
30755279|NCT04059094|58764960|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
30755280|NCT04059094|58764961|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
30755281|NCT00096044|58764977|FG000|Overall Study|Withdrawal by Subject|9|||
30755282|NCT00096044|58764977|FG000|Overall Study|Adverse Event|21|||
30755283|NCT00096044|58764977|FG000|Overall Study|Disease Progression|4|||
30755284|NCT03689374|58764983|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
30755285|NCT03689374|58764984|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
30755286|NCT03689374|58764985|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
30755287|NCT03689374|58764983|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
30755288|NCT03689374|58764984|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
30755289|NCT03689374|58764985|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
30755290|NCT03689374|58764983|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
30755291|NCT03689374|58764984|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
30755292|NCT03689374|58764985|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
30755293|NCT03689374|58764983|FG000|Treatment Period (Week 0 to 52)|Death|0|||
30755294|NCT03689374|58764984|FG001|Treatment Period (Week 0 to 52)|Death|11|||
30755295|NCT03689374|58764985|FG002|Treatment Period (Week 0 to 52)|Death|1|||
30755296|NCT00113360|58764991|FG000|Overall Study|Adverse Event|3|||
30755297|NCT00113360|58764991|FG000|Overall Study|Subject required surgery|1|||
30755298|NCT00113360|58764991|FG000|Overall Study|Did not meet eligibility criteria|3|||
30755299|NCT00123734|58764995|FG000|Overall Study|Death|3|||
30755300|NCT00123734|58764995|FG000|Overall Study|Lost to Follow-up|3|||
30755301|NCT00123734|58764995|FG000|Overall Study|Dropout|1|||
30755302|NCT00123734|58764995|FG000|Overall Study|Withdrawal by Subject|1|||
30755303|NCT00112736|58765005|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
30755304|NCT00112736|58765006|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
30755305|NCT00123422|58765021|FG000|Overall Study|Physician Decision|2|||
30755306|NCT00123422|58765022|FG001|Overall Study|Physician Decision|2|||
30755307|NCT00123422|58765023|FG002|Overall Study|Physician Decision|6|||
30755308|NCT00123422|58765021|FG000|Overall Study|Withdrawal by Subject|1|||
30755309|NCT00123422|58765022|FG001|Overall Study|Withdrawal by Subject|2|||
30755310|NCT00123422|58765023|FG002|Overall Study|Withdrawal by Subject|2|||
30755311|NCT00123422|58765021|FG000|Overall Study|Lost to Follow-up|1|||
30755312|NCT00123422|58765022|FG001|Overall Study|Lost to Follow-up|2|||
30755313|NCT00123422|58765023|FG002|Overall Study|Lost to Follow-up|2|||
30755314|NCT04052620|58765033|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
30755315|NCT04052620|58765034|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
30755316|NCT04052620|58765033|FG000|Overall Study|Withdrawal by Subject|1|||
30755317|NCT04052620|58765034|FG001|Overall Study|Withdrawal by Subject|0|||
30755318|NCT04052620|58765033|FG000|Overall Study|Lost to Follow-up|1|||
30830164|NCT03486912|58854162|FG001|Treatment Period|Adverse Event|1|||
30755319|NCT04052620|58765034|FG001|Overall Study|Lost to Follow-up|1|||
30755320|NCT04052620|58765033|FG000|Overall Study|Adverse Event|1|||
30755321|NCT04052620|58765034|FG001|Overall Study|Adverse Event|0|||
30755322|NCT04052620|58765033|FG000|Overall Study|Subject did not meet study Criteria|0|||
30755323|NCT04052620|58765034|FG001|Overall Study|Subject did not meet study Criteria|1|||
30755324|NCT04052620|58765033|FG000|Overall Study|Screened failure, randomized by mistake|0|||
30830165|NCT03486912|58854163|FG002|Treatment Period|Adverse Event|1|||
30830166|NCT03486912|58854164|FG003|Treatment Period|Adverse Event|0|||
30830167|NCT03486912|58854161|FG000|Treatment Period|Lost to Follow-up|1|||
30830168|NCT03486912|58854162|FG001|Treatment Period|Lost to Follow-up|0|||
30830169|NCT03486912|58854163|FG002|Treatment Period|Lost to Follow-up|0|||
30830170|NCT03486912|58854164|FG003|Treatment Period|Lost to Follow-up|2|||
30830171|NCT03345342|58854174|FG000|Open-Label Phase|Adverse Event|30|||
30830172|NCT03345342|58854175|FG001|Open-Label Phase|Adverse Event|0|||
30830173|NCT03345342|58854176|FG002|Open-Label Phase|Adverse Event|0|||
30830174|NCT03345342|58854177|FG003|Open-Label Phase|Adverse Event|0|||
30830175|NCT03345342|58854178|FG004|Open-Label Phase|Adverse Event|0|||
30830176|NCT03345342|58854174|FG000|Open-Label Phase|Death|1|||
30830177|NCT03345342|58854175|FG001|Open-Label Phase|Death|0|||
30830178|NCT03345342|58854176|FG002|Open-Label Phase|Death|0|||
30830179|NCT03345342|58854177|FG003|Open-Label Phase|Death|0|||
30830180|NCT03345342|58854178|FG004|Open-Label Phase|Death|0|||
30830181|NCT03345342|58854174|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
30830182|NCT03345342|58854175|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
30830183|NCT03345342|58854176|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
30830184|NCT03345342|58854177|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
30830185|NCT03345342|58854178|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
30830186|NCT03345342|58854174|FG000|Open-Label Phase|Lack of Efficacy|6|||
30830187|NCT03345342|58854175|FG001|Open-Label Phase|Lack of Efficacy|0|||
30830188|NCT03345342|58854176|FG002|Open-Label Phase|Lack of Efficacy|0|||
30830189|NCT03345342|58854177|FG003|Open-Label Phase|Lack of Efficacy|0|||
30830190|NCT03345342|58854178|FG004|Open-Label Phase|Lack of Efficacy|0|||
30830191|NCT03345342|58854174|FG000|Open-Label Phase|Lost to Follow-up|9|||
30830192|NCT03345342|58854175|FG001|Open-Label Phase|Lost to Follow-up|0|||
30830193|NCT03345342|58854176|FG002|Open-Label Phase|Lost to Follow-up|0|||
30830194|NCT03345342|58854177|FG003|Open-Label Phase|Lost to Follow-up|0|||
30830195|NCT03345342|58854178|FG004|Open-Label Phase|Lost to Follow-up|0|||
30830196|NCT03345342|58854174|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
30830197|NCT03345342|58854175|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
30830198|NCT03345342|58854176|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
30830199|NCT03345342|58854177|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
30830200|NCT03345342|58854178|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
30830201|NCT03345342|58854174|FG000|Open-Label Phase|Physician Decision|4|||
30830202|NCT03345342|58854175|FG001|Open-Label Phase|Physician Decision|0|||
30830203|NCT03345342|58854176|FG002|Open-Label Phase|Physician Decision|0|||
30830204|NCT03345342|58854177|FG003|Open-Label Phase|Physician Decision|0|||
30830205|NCT03345342|58854178|FG004|Open-Label Phase|Physician Decision|0|||
30830206|NCT03345342|58854174|FG000|Open-Label Phase|Protocol Violation|8|||
30830207|NCT03345342|58854175|FG001|Open-Label Phase|Protocol Violation|0|||
30830208|NCT03345342|58854176|FG002|Open-Label Phase|Protocol Violation|0|||
30830209|NCT03345342|58854177|FG003|Open-Label Phase|Protocol Violation|0|||
30830210|NCT03345342|58854178|FG004|Open-Label Phase|Protocol Violation|0|||
30830211|NCT03345342|58854174|FG000|Open-Label Phase|Withdrawal by Subject|57|||
30830212|NCT03345342|58854175|FG001|Open-Label Phase|Withdrawal by Subject|0|||
30830213|NCT03345342|58854176|FG002|Open-Label Phase|Withdrawal by Subject|0|||
30922346|NCT02066402|58957653|FG000|Overall Study|Protocol driven decision point|0|||
30922347|NCT02066402|58957654|FG001|Overall Study|Protocol driven decision point|1|||
30922348|NCT02060383|58957665|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
30922349|NCT02060383|58957666|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
30922350|NCT02060383|58957667|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
30922351|NCT02060383|58957668|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
30922352|NCT02060383|58957669|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
30922353|NCT02060383|58957665|FG000|Core Phase|Adverse Event|2|||
30922354|NCT02060383|58957666|FG001|Core Phase|Adverse Event|0|||
30922355|NCT02060383|58957667|FG002|Core Phase|Adverse Event|0|||
30922356|NCT02060383|58957668|FG003|Core Phase|Adverse Event|2|||
30922357|NCT02060383|58957669|FG004|Core Phase|Adverse Event|6|||
30922358|NCT02060383|58957665|FG000|Core Phase|Administrative problems|0|||
30922359|NCT02060383|58957666|FG001|Core Phase|Administrative problems|1|||
30922360|NCT02060383|58957667|FG002|Core Phase|Administrative problems|0|||
30922361|NCT02060383|58957668|FG003|Core Phase|Administrative problems|0|||
30922362|NCT02060383|58957669|FG004|Core Phase|Administrative problems|0|||
30922363|NCT02060383|58957665|FG000|Core Phase|Protocol Violation|0|||
30922364|NCT02060383|58957666|FG001|Core Phase|Protocol Violation|0|||
30830214|NCT03345342|58854177|FG003|Open-Label Phase|Withdrawal by Subject|0|||
30830215|NCT03345342|58854178|FG004|Open-Label Phase|Withdrawal by Subject|0|||
30830216|NCT03345342|58854174|FG000|Open-Label Phase|Other|15|||
30922365|NCT02060383|58957667|FG002|Core Phase|Protocol Violation|0|||
30830217|NCT03345342|58854175|FG001|Open-Label Phase|Other|0|||
30830218|NCT03345342|58854176|FG002|Open-Label Phase|Other|0|||
30830219|NCT03345342|58854177|FG003|Open-Label Phase|Other|0|||
30830220|NCT03345342|58854178|FG004|Open-Label Phase|Other|0|||
30830221|NCT03345342|58854174|FG000|Double-Blind Phase|Adverse Event|0|||
30830222|NCT03345342|58854175|FG001|Double-Blind Phase|Adverse Event|1|||
30830223|NCT03345342|58854176|FG002|Double-Blind Phase|Adverse Event|6|||
30830224|NCT03345342|58854177|FG003|Double-Blind Phase|Adverse Event|0|||
30830225|NCT03345342|58854178|FG004|Double-Blind Phase|Adverse Event|0|||
30830226|NCT03345342|58854174|FG000|Double-Blind Phase|Death|0|||
30830227|NCT03345342|58854175|FG001|Double-Blind Phase|Death|2|||
30830228|NCT03345342|58854176|FG002|Double-Blind Phase|Death|1|||
30830229|NCT03345342|58854177|FG003|Double-Blind Phase|Death|0|||
30830230|NCT03345342|58854178|FG004|Double-Blind Phase|Death|0|||
30830231|NCT03345342|58854174|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
30830232|NCT03345342|58854175|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
30830233|NCT03345342|58854176|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
30830234|NCT03345342|58854177|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
30830235|NCT03345342|58854178|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
30830236|NCT03345342|58854174|FG000|Double-Blind Phase|Lost to Follow-up|0|||
30830237|NCT03345342|58854175|FG001|Double-Blind Phase|Lost to Follow-up|1|||
30830238|NCT03345342|58854176|FG002|Double-Blind Phase|Lost to Follow-up|7|||
30830239|NCT03345342|58854177|FG003|Double-Blind Phase|Lost to Follow-up|0|||
30830240|NCT03345342|58854178|FG004|Double-Blind Phase|Lost to Follow-up|0|||
30830241|NCT03345342|58854174|FG000|Double-Blind Phase|Physician Decision|0|||
30830242|NCT03345342|58854175|FG001|Double-Blind Phase|Physician Decision|1|||
30830243|NCT03345342|58854176|FG002|Double-Blind Phase|Physician Decision|4|||
30830244|NCT03345342|58854177|FG003|Double-Blind Phase|Physician Decision|0|||
30830245|NCT03345342|58854178|FG004|Double-Blind Phase|Physician Decision|0|||
30830246|NCT03345342|58854174|FG000|Double-Blind Phase|Protocol Violation|0|||
30830247|NCT03345342|58854175|FG001|Double-Blind Phase|Protocol Violation|0|||
30830248|NCT03345342|58854176|FG002|Double-Blind Phase|Protocol Violation|1|||
30830249|NCT03345342|58854177|FG003|Double-Blind Phase|Protocol Violation|0|||
30830250|NCT03345342|58854178|FG004|Double-Blind Phase|Protocol Violation|0|||
30830251|NCT03345342|58854174|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
30830252|NCT03345342|58854175|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
30830253|NCT03345342|58854176|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
30830254|NCT03345342|58854177|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
30830255|NCT03345342|58854178|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
30830256|NCT03345342|58854174|FG000|Double-Blind Phase|Other|0|||
30830257|NCT03345342|58854175|FG001|Double-Blind Phase|Other|1|||
30830258|NCT03345342|58854176|FG002|Double-Blind Phase|Other|3|||
30830259|NCT03345342|58854177|FG003|Double-Blind Phase|Other|0|||
30830260|NCT03345342|58854178|FG004|Double-Blind Phase|Other|0|||
30830261|NCT03345342|58854174|FG000|Follow-Up Phase|Adverse Event|0|||
30830262|NCT03345342|58854175|FG001|Follow-Up Phase|Adverse Event|0|||
30830263|NCT03345342|58854176|FG002|Follow-Up Phase|Adverse Event|0|||
30830264|NCT03345342|58854177|FG003|Follow-Up Phase|Adverse Event|0|||
30830265|NCT03345342|58854178|FG004|Follow-Up Phase|Adverse Event|4|||
30830266|NCT03345342|58854174|FG000|Follow-Up Phase|Lost to Follow-up|0|||
30830267|NCT03345342|58854175|FG001|Follow-Up Phase|Lost to Follow-up|0|||
30830268|NCT03345342|58854176|FG002|Follow-Up Phase|Lost to Follow-up|0|||
30830269|NCT03345342|58854177|FG003|Follow-Up Phase|Lost to Follow-up|0|||
30830270|NCT03345342|58854178|FG004|Follow-Up Phase|Lost to Follow-up|6|||
30830271|NCT03345342|58854174|FG000|Follow-Up Phase|Physician Decision|0|||
30830272|NCT03345342|58854175|FG001|Follow-Up Phase|Physician Decision|0|||
30830273|NCT03345342|58854176|FG002|Follow-Up Phase|Physician Decision|0|||
30830274|NCT03345342|58854177|FG003|Follow-Up Phase|Physician Decision|0|||
30830275|NCT03345342|58854178|FG004|Follow-Up Phase|Physician Decision|5|||
30830276|NCT03345342|58854174|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
30830277|NCT03345342|58854175|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
30830278|NCT03345342|58854176|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
30830279|NCT03345342|58854177|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
30830280|NCT03345342|58854178|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
30830281|NCT03345342|58854174|FG000|Follow-Up Phase|Other|0|||
30830282|NCT03345342|58854175|FG001|Follow-Up Phase|Other|0|||
30830283|NCT03345342|58854176|FG002|Follow-Up Phase|Other|0|||
30830284|NCT03345342|58854177|FG003|Follow-Up Phase|Other|3|||
30830285|NCT03345342|58854178|FG004|Follow-Up Phase|Other|1|||
30830286|NCT02642614|58854194|FG000|Overall Study|Adverse Event|1|||
30830287|NCT02642614|58854195|FG001|Overall Study|Adverse Event|1|||
30623504|NCT00917644|58635320|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
30830288|NCT02642614|58854196|FG002|Overall Study|Adverse Event|2|||
30830289|NCT02642614|58854197|FG003|Overall Study|Adverse Event|2|||
30830290|NCT02642614|58854194|FG000|Overall Study|Lost to Follow-up|1|||
30830291|NCT02642614|58854195|FG001|Overall Study|Lost to Follow-up|0|||
30830292|NCT02642614|58854196|FG002|Overall Study|Lost to Follow-up|0|||
30830293|NCT02642614|58854197|FG003|Overall Study|Lost to Follow-up|0|||
30830294|NCT02642614|58854194|FG000|Overall Study|Withdrawal by Subject|1|||
30830295|NCT02642614|58854195|FG001|Overall Study|Withdrawal by Subject|1|||
30830296|NCT02642614|58854196|FG002|Overall Study|Withdrawal by Subject|0|||
30830297|NCT02642614|58854197|FG003|Overall Study|Withdrawal by Subject|0|||
30830298|NCT02781324|58854212|FG000|Overall Study|Withdrawal by Subject|1|||
30830299|NCT02781324|58854213|FG001|Overall Study|Withdrawal by Subject|0|||
30830300|NCT02781324|58854212|FG000|Overall Study|Physician Decision|1|||
30830301|NCT02781324|58854213|FG001|Overall Study|Physician Decision|2|||
30830302|NCT03292146|58854223|FG000|Baseline to 12 Months|Relocation|1|||
30830303|NCT03292146|58854224|FG001|Baseline to 12 Months|Relocation|0|||
30830304|NCT03292146|58854223|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
30830305|NCT03292146|58854224|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
30830306|NCT03292146|58854223|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
30830307|NCT03292146|58854224|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
30830308|NCT03292146|58854223|FG000|12 Months to 24 Months|Planning pregnancy|2|||
30830309|NCT03292146|58854224|FG001|12 Months to 24 Months|Planning pregnancy|2|||
30830310|NCT03292146|58854223|FG000|12 Months to 24 Months|Personal reasons|1|||
30830311|NCT03292146|58854224|FG001|12 Months to 24 Months|Personal reasons|0|||
30830312|NCT03292146|58854223|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
30830313|NCT03292146|58854224|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
30830314|NCT01360996|58854233|FG000|Overall Study|Withdrawal by Subject|4|||
30830315|NCT01360996|58854234|FG001|Overall Study|Withdrawal by Subject|3|||
30830316|NCT01360996|58854235|FG002|Overall Study|Withdrawal by Subject|2|||
30830317|NCT01360996|58854233|FG000|Overall Study|Noncompliant|2|||
30830318|NCT01360996|58854234|FG001|Overall Study|Noncompliant|0|||
30830319|NCT01360996|58854235|FG002|Overall Study|Noncompliant|0|||
30830320|NCT01951885|58854244|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
30830321|NCT01951885|58854245|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
30830322|NCT01951885|58854244|FG000|Overall Study|Adverse Event|1|||
30830323|NCT01951885|58854245|FG001|Overall Study|Adverse Event|0|||
30830324|NCT01951885|58854244|FG000|Overall Study|Withdrawal by Subject|0|||
30830325|NCT01951885|58854245|FG001|Overall Study|Withdrawal by Subject|1|||
30830326|NCT01951885|58854244|FG000|Overall Study|ineligible due to a change in donor|0|||
30830327|NCT01951885|58854245|FG001|Overall Study|ineligible due to a change in donor|1|||
30830328|NCT01951885|58854244|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
30830329|NCT01951885|58854245|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
30830330|NCT02639338|58854253|FG000|Overall Study|Lost to Follow-up|2|||
30830331|NCT02639338|58854254|FG001|Overall Study|Lost to Follow-up|2|||
30830332|NCT02639338|58854253|FG000|Overall Study|Withdrew Consent|1|||
30830333|NCT02639338|58854254|FG001|Overall Study|Withdrew Consent|2|||
30830334|NCT02639338|58854253|FG000|Overall Study|Death|1|||
30830335|NCT02639338|58854254|FG001|Overall Study|Death|0|||
30830336|NCT02639338|58854253|FG000|Overall Study|Randomized but Not Treated|0|||
30830337|NCT02639338|58854254|FG001|Overall Study|Randomized but Not Treated|1|||
30830338|NCT01754857|58854260|FG000|Overall Study|Adverse Event|7|||
30830339|NCT01754857|58854260|FG000|Overall Study|Disease progression|3|||
30830340|NCT01754857|58854260|FG000|Overall Study|Physician Decision|2|||
30830341|NCT01754857|58854260|FG000|Overall Study|Withdrawal by Subject|3|||
30830342|NCT01754857|58854260|FG000|Overall Study|other complicating disease|1|||
30830343|NCT01754857|58854260|FG000|Overall Study|ineligible to continue onto maintenance|1|||
30922366|NCT02060383|58957668|FG003|Core Phase|Protocol Violation|1|||
30922367|NCT02060383|58957669|FG004|Core Phase|Protocol Violation|0|||
30922368|NCT02060383|58957665|FG000|Core Phase|Withdrawal by Subject|0|||
30755325|NCT04052620|58765034|FG001|Overall Study|Screened failure, randomized by mistake|1|||
30830344|NCT01754857|58854260|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
30830345|NCT01754857|58854260|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
30830346|NCT02900352|58854266|FG000|Overall Study|Lost to Follow-up|28|||
30830347|NCT02900352|58854267|FG001|Overall Study|Lost to Follow-up|17|||
30922369|NCT02060383|58957666|FG001|Core Phase|Withdrawal by Subject|0|||
30922370|NCT02060383|58957667|FG002|Core Phase|Withdrawal by Subject|0|||
30755326|NCT04052620|58765033|FG000|Overall Study|Personal reasons|2|||
30755327|NCT04052620|58765034|FG001|Overall Study|Personal reasons|4|||
30755328|NCT04052620|58765033|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
30755329|NCT04052620|58765034|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
30755330|NCT00112580|58765042|FG000|Overall Study|Adverse Event|1|||
30755331|NCT00112580|58765043|FG001|Overall Study|Adverse Event|2|||
30755332|NCT00112580|58765042|FG000|Overall Study|Disease progression|5|||
30755333|NCT00112580|58765043|FG001|Overall Study|Disease progression|16|||
30755334|NCT00112580|58765042|FG000|Overall Study|Participant withdrew consent|2|||
30755335|NCT00112580|58765043|FG001|Overall Study|Participant withdrew consent|1|||
30755336|NCT04238650|58765050|FG000|Overall Study|Withdrawal by Subject|0|||
30830348|NCT03040687|58854276|FG000|Overall Study|Withdrawal by Subject|1|||
30830349|NCT03040687|58854277|FG001|Overall Study|Withdrawal by Subject|0|||
30830350|NCT03040687|58854278|FG002|Overall Study|Withdrawal by Subject|0|||
30830351|NCT03042559|58854288|FG000|Overall Study|drop out|1|||
30830352|NCT03042559|58854289|FG001|Overall Study|drop out|1|||
30830353|NCT02780856|58854295|FG000|Overall Study|Lost to Follow-up|1|||
30830354|NCT00108732|58854324|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
30922371|NCT02060383|58957668|FG003|Core Phase|Withdrawal by Subject|4|||
30755337|NCT04238650|58765051|FG001|Overall Study|Withdrawal by Subject|1|||
30755338|NCT00095576|58765059|FG000|Overall Study|Adverse Event|5|||
30830355|NCT00108732|58854324|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
30830356|NCT00108732|58854324|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
30830357|NCT00108732|58854324|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
30830358|NCT00108732|58854324|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
30830359|NCT00108732|58854324|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
30830360|NCT00108732|58854324|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
30830361|NCT00107952|58854330|FG000|Overall Study|Death|75|||
30830362|NCT00107952|58854331|FG001|Overall Study|Death|61|||
30830363|NCT00107952|58854330|FG000|Overall Study|Lost to Follow-up|0|||
30830364|NCT00107952|58854331|FG001|Overall Study|Lost to Follow-up|3|||
30830365|NCT00107952|58854330|FG000|Overall Study|Withdrawal by Subject|9|||
30830366|NCT00107952|58854331|FG001|Overall Study|Withdrawal by Subject|6|||
30830367|NCT00107952|58854330|FG000|Overall Study|Other|2|||
30830368|NCT00107952|58854331|FG001|Overall Study|Other|5|||
30830369|NCT00107952|58854330|FG000|Overall Study|Never received study treatment|9|||
30830370|NCT00107952|58854331|FG001|Overall Study|Never received study treatment|6|||
30830371|NCT01366638|58854349|FG000|Overall Study|Withdrawal by Subject|0|||
30830372|NCT01366638|58854350|FG001|Overall Study|Withdrawal by Subject|0|||
30830373|NCT01366638|58854351|FG002|Overall Study|Withdrawal by Subject|6|||
30830374|NCT01366638|58854349|FG000|Overall Study|Other|1|||
30830375|NCT01366638|58854350|FG001|Overall Study|Other|0|||
30830376|NCT01366638|58854351|FG002|Overall Study|Other|0|||
30830377|NCT02780700|58854359|FG000|Overall Study|Progressive disease|1|||
30830378|NCT04230122|58854397|FG000|Overall Study|Lost to Follow-up|1|||
30830379|NCT04230122|58854398|FG001|Overall Study|Lost to Follow-up|0|||
30830380|NCT02780388|58854409|FG000|Overall Study|Lost to Follow-up|0|||
30830381|NCT02780388|58854410|FG001|Overall Study|Lost to Follow-up|1|||
30830382|NCT02780388|58854411|FG002|Overall Study|Lost to Follow-up|0|||
30830383|NCT02780388|58854412|FG003|Overall Study|Lost to Follow-up|0|||
30830384|NCT02780388|58854413|FG004|Overall Study|Lost to Follow-up|0|||
30830385|NCT02780388|58854409|FG000|Overall Study|Withdrawal by Subject|1|||
30830386|NCT02780388|58854410|FG001|Overall Study|Withdrawal by Subject|1|||
30830387|NCT02780388|58854411|FG002|Overall Study|Withdrawal by Subject|0|||
30830388|NCT02780388|58854412|FG003|Overall Study|Withdrawal by Subject|0|||
30830389|NCT02780388|58854413|FG004|Overall Study|Withdrawal by Subject|0|||
30830390|NCT03491462|58854431|FG000|Overall Study|Lost to Follow-up|2|||
30830391|NCT03491462|58854432|FG001|Overall Study|Lost to Follow-up|0|||
30830392|NCT03491462|58854431|FG000|Overall Study|Adverse Event|11|||
30830393|NCT03491462|58854432|FG001|Overall Study|Adverse Event|1|||
30830394|NCT03491462|58854431|FG000|Overall Study|Physician Decision|3|||
30830395|NCT03491462|58854432|FG001|Overall Study|Physician Decision|0|||
30830396|NCT03491462|58854431|FG000|Overall Study|Withdrawal by Subject|22|||
30830397|NCT03491462|58854432|FG001|Overall Study|Withdrawal by Subject|15|||
30830398|NCT02224573|58854440|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
30830399|NCT02224573|58854441|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
30922372|NCT02060383|58957669|FG004|Core Phase|Withdrawal by Subject|2|||
30922373|NCT02060383|58957665|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
30922374|NCT02060383|58957666|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
30922375|NCT02060383|58957667|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
30922376|NCT02060383|58957668|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
30922377|NCT02060383|58957669|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
30922378|NCT02060383|58957665|FG000|Extension Phase|Adverse Event|1|||
30922379|NCT02060383|58957666|FG001|Extension Phase|Adverse Event|1|||
30922380|NCT02060383|58957667|FG002|Extension Phase|Adverse Event|2|||
30922381|NCT02060383|58957668|FG003|Extension Phase|Adverse Event|0|||
30922382|NCT02060383|58957669|FG004|Extension Phase|Adverse Event|1|||
30922383|NCT02060383|58957665|FG000|Extension Phase|Withdrawal by Subject|0|||
30922384|NCT02060383|58957666|FG001|Extension Phase|Withdrawal by Subject|1|||
30830400|NCT02224573|58854440|FG000|Treatment Phase|Started on Other IMP|1|||
30830401|NCT02224573|58854441|FG001|Treatment Phase|Started on Other IMP|0|||
30830402|NCT02224573|58854440|FG000|Treatment Phase|Participant Discontinued IMP|0|||
30830403|NCT02224573|58854441|FG001|Treatment Phase|Participant Discontinued IMP|1|||
30830404|NCT02224573|58854440|FG000|Treatment Phase|Lack of Efficacy|15|||
30830405|NCT02224573|58854441|FG001|Treatment Phase|Lack of Efficacy|8|||
30830406|NCT02224573|58854440|FG000|Treatment Phase|Began Commercial Product|1|||
30830407|NCT02224573|58854441|FG001|Treatment Phase|Began Commercial Product|0|||
30922385|NCT02060383|58957667|FG002|Extension Phase|Withdrawal by Subject|0|||
30830408|NCT02224573|58854440|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
30830409|NCT02224573|58854441|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
30830410|NCT02224573|58854440|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
30922386|NCT02060383|58957668|FG003|Extension Phase|Withdrawal by Subject|0|||
30922387|NCT02060383|58957669|FG004|Extension Phase|Withdrawal by Subject|2|||
30830411|NCT02224573|58854441|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
30830412|NCT02224573|58854440|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
30830413|NCT02224573|58854441|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
30830414|NCT02224573|58854440|FG000|Treatment Phase|Continued Compassionate Use|1|||
30830415|NCT02224573|58854441|FG001|Treatment Phase|Continued Compassionate Use|0|||
30830416|NCT02224573|58854440|FG000|Treatment Phase|Lack of Efficiency|2|||
30830417|NCT02224573|58854441|FG001|Treatment Phase|Lack of Efficiency|1|||
30830418|NCT02224573|58854440|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
30830419|NCT02224573|58854441|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
30830420|NCT02224573|58854440|FG000|Treatment Phase|Participant Moved|2|||
30830421|NCT02224573|58854441|FG001|Treatment Phase|Participant Moved|0|||
30830422|NCT02224573|58854440|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
30922388|NCT02060383|58957665|FG000|Extension Phase|Administrative problems|1|||
30922389|NCT02060383|58957666|FG001|Extension Phase|Administrative problems|0|||
30922390|NCT02060383|58957667|FG002|Extension Phase|Administrative problems|0|||
30922391|NCT02060383|58957668|FG003|Extension Phase|Administrative problems|0|||
30922392|NCT02060383|58957669|FG004|Extension Phase|Administrative problems|0|||
30922393|NCT02060383|58957665|FG000|Extension Phase|Death|0|||
30922394|NCT02060383|58957666|FG001|Extension Phase|Death|0|||
30922395|NCT02060383|58957667|FG002|Extension Phase|Death|1|||
30922396|NCT02060383|58957668|FG003|Extension Phase|Death|0|||
30922397|NCT02060383|58957669|FG004|Extension Phase|Death|1|||
30922398|NCT02060383|58957665|FG000|Extension Phase|Protocol Violation|0|||
30922399|NCT02060383|58957666|FG001|Extension Phase|Protocol Violation|0|||
30755339|NCT00095576|58765060|FG001|Overall Study|Adverse Event|3|||
30755340|NCT00095576|58765059|FG000|Overall Study|Lost to Follow-up|233|||
30755341|NCT00095576|58765060|FG001|Overall Study|Lost to Follow-up|229|||
30830423|NCT02224573|58854441|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
30830424|NCT02224573|58854440|FG000|Treatment Phase|Refused Medication|1|||
30830425|NCT02224573|58854441|FG001|Treatment Phase|Refused Medication|1|||
30830426|NCT02224573|58854440|FG000|Treatment Phase|Adverse Event|26|||
30830427|NCT02224573|58854441|FG001|Treatment Phase|Adverse Event|38|||
30830428|NCT02224573|58854440|FG000|Treatment Phase|Placed in Group Home|0|||
30830429|NCT02224573|58854441|FG001|Treatment Phase|Placed in Group Home|1|||
30830430|NCT02224573|58854440|FG000|Treatment Phase|Pursued Other Trials|1|||
30830431|NCT02224573|58854441|FG001|Treatment Phase|Pursued Other Trials|0|||
30830432|NCT02224573|58854440|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
30830433|NCT02224573|58854441|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
30830434|NCT02224573|58854440|FG000|Treatment Phase|Lost to Follow-up|2|||
30830435|NCT02224573|58854441|FG001|Treatment Phase|Lost to Follow-up|1|||
30830436|NCT02224573|58854440|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
30830437|NCT02224573|58854441|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
30830438|NCT02224573|58854440|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
30830439|NCT02224573|58854441|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
30830440|NCT02224573|58854440|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
30830441|NCT02224573|58854441|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
30830442|NCT02224573|58854440|FG000|Taper Phase|Adverse Event|1|||
30830443|NCT02224573|58854441|FG001|Taper Phase|Adverse Event|1|||
30830444|NCT01360840|58854451|FG000|Overall Study|Ongoing at data cut-off|10|||
30755342|NCT00095576|58765059|FG000|Overall Study|Protocol Violation|1|||
30755343|NCT00095576|58765060|FG001|Overall Study|Protocol Violation|0|||
30755344|NCT00095576|58765059|FG000|Overall Study|Withdrawal by Subject|34|||
30755345|NCT00095576|58765060|FG001|Overall Study|Withdrawal by Subject|47|||
30755346|NCT00095576|58765059|FG000|Overall Study|Option to switch to a rollover study|1097|||
30755347|NCT00095576|58765060|FG001|Overall Study|Option to switch to a rollover study|1099|||
30755348|NCT00095576|58765059|FG000|Overall Study|Site terminated|75|||
30755349|NCT00095576|58765060|FG001|Overall Study|Site terminated|67|||
30755350|NCT00095576|58765059|FG000|Overall Study|Subject moved|30|||
30755351|NCT00095576|58765060|FG001|Overall Study|Subject moved|36|||
30755352|NCT04049578|58765066|FG000|Overall Study|Physician Decision|1|||
30755353|NCT04044352|58765070|FG000|Overall Study|Lost to Follow-up|9|||
30755354|NCT04044352|58765070|FG000|Overall Study|Withdrawal by Subject|2|||
30755355|NCT04043962|58765075|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
30755356|NCT04043962|58765075|FG000|Post-Treatment|Withdrawal by Subject|5|||
30755357|NCT04043962|58765075|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
30755358|NCT04043728|58765082|FG000|Overall Study|Lost to Follow-up|1|||
30830445|NCT01360840|58854452|FG001|Overall Study|Ongoing at data cut-off|10|||
30830446|NCT01360840|58854453|FG002|Overall Study|Ongoing at data cut-off|9|||
30922400|NCT02060383|58957667|FG002|Extension Phase|Protocol Violation|0|||
30830447|NCT03350984|58854465|FG000|Overall Study|Death|1|||
30830448|NCT03350984|58854466|FG001|Overall Study|Death|0|||
30830449|NCT03350984|58854465|FG000|Overall Study|Lost to Follow-up|5|||
30922401|NCT02060383|58957668|FG003|Extension Phase|Protocol Violation|0|||
30922402|NCT02060383|58957669|FG004|Extension Phase|Protocol Violation|1|||
30922403|NCT02086591|58957681|FG000|Overall Study|Adverse Event|1|||
30755359|NCT04043728|58765083|FG001|Overall Study|Lost to Follow-up|2|||
30755360|NCT04043728|58765084|FG002|Overall Study|Lost to Follow-up|0|||
30755361|NCT04043416|58765094|FG000|Washout|Change in health condition|0|||
30830450|NCT03350984|58854466|FG001|Overall Study|Lost to Follow-up|6|||
30830451|NCT03350984|58854465|FG000|Overall Study|Protocol Violation|1|||
30830452|NCT03350984|58854466|FG001|Overall Study|Protocol Violation|2|||
30830453|NCT03350984|58854465|FG000|Overall Study|Physician Decision|1|||
30830454|NCT03350984|58854466|FG001|Overall Study|Physician Decision|0|||
30830455|NCT05176717|58854484|FG000|Overall Study|Sponsor Decision|1|||
30830456|NCT05176717|58854485|FG001|Overall Study|Sponsor Decision|2|||
30830457|NCT05176717|58854486|FG002|Overall Study|Sponsor Decision|2|||
30922404|NCT02086591|58957681|FG000|Overall Study|Withdrawal by Subject|1|||
30922405|NCT02086591|58957681|FG000|Overall Study|protocol terminated|3|||
30922406|NCT02065622|58957687|FG000|Induction Study|Adverse Event|13|||
30922407|NCT02065622|58957688|FG001|Induction Study|Adverse Event|19|||
30922408|NCT02065622|58957689|FG002|Induction Study|Adverse Event|0|||
30922409|NCT02065622|58957690|FG003|Induction Study|Adverse Event|0|||
30922410|NCT02065622|58957691|FG004|Induction Study|Adverse Event|0|||
30922411|NCT02065622|58957687|FG000|Induction Study|Withdrawal by Subject|3|||
30830458|NCT02770248|58854496|FG000|Overall Study|Adverse Event|0|||
30830459|NCT02770248|58854497|FG001|Overall Study|Adverse Event|1|||
30830460|NCT02770248|58854496|FG000|Overall Study|Randomized in error, prior to treatment|0|||
30830461|NCT02770248|58854497|FG001|Overall Study|Randomized in error, prior to treatment|1|||
30830462|NCT01344369|58854505|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
30830463|NCT01344369|58854506|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
30830464|NCT01344369|58854505|FG000|Washout of 28 Days|Physician Decision|0|||
30830465|NCT01344369|58854506|FG001|Washout of 28 Days|Physician Decision|1|||
30830466|NCT01344369|58854505|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
30830467|NCT01344369|58854506|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
30830468|NCT03179462|58854515|FG000|Overall Study|screening failure|1|||
30830469|NCT03179462|58854516|FG001|Overall Study|screening failure|2|||
30830470|NCT03179462|58854517|FG002|Overall Study|screening failure|0|||
30830471|NCT01314703|58854525|FG000|Overall Study|screen failure and closed enrollment|8|||
30830472|NCT01360762|58854530|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
30830473|NCT01360762|58854530|FG000|Main Study Period (12-month Treatment)|Death|5|||
30830474|NCT01360762|58854530|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
30830475|NCT01360762|58854530|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
30830476|NCT01360762|58854530|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
30830477|NCT01360762|58854530|FG000|Whole Study Period|Lost to Follow-up|10|||
30830478|NCT01360762|58854530|FG000|Whole Study Period|Death|7|||
30830479|NCT01360762|58854530|FG000|Whole Study Period|Patient relapsed|18|||
30830480|NCT01360762|58854530|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
30830481|NCT04382924|58854537|FG000|Overall Study|Death|2|||
30830482|NCT04382924|58854538|FG001|Overall Study|Death|5|||
30830483|NCT04382924|58854539|FG002|Overall Study|Death|4|||
30830484|NCT04382924|58854537|FG000|Overall Study|Protocol Violation|0|||
30830485|NCT04382924|58854538|FG001|Overall Study|Protocol Violation|1|||
30830486|NCT04382924|58854539|FG002|Overall Study|Protocol Violation|1|||
30830487|NCT04382924|58854537|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
30830488|NCT04382924|58854538|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
30830489|NCT04382924|58854539|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
30830490|NCT04382924|58854537|FG000|Overall Study|Withdrawal by Subject|6|||
30830491|NCT04382924|58854538|FG001|Overall Study|Withdrawal by Subject|3|||
30830492|NCT04382924|58854539|FG002|Overall Study|Withdrawal by Subject|6|||
30830493|NCT03044431|58854553|FG000|Overall Study|Lost to Follow-up|59|||
30830494|NCT02770170|58854561|FG000|Overall Study|Withdrawal by Subject|0|||
30830495|NCT02770170|58854562|FG001|Overall Study|Withdrawal by Subject|0|||
30830496|NCT02770170|58854563|FG002|Overall Study|Withdrawal by Subject|0|||
30830497|NCT02770170|58854564|FG003|Overall Study|Withdrawal by Subject|2|||
30830498|NCT02770170|58854561|FG000|Overall Study|due to pregnancy|1|||
30830499|NCT02770170|58854562|FG001|Overall Study|due to pregnancy|0|||
30830500|NCT02770170|58854563|FG002|Overall Study|due to pregnancy|0|||
30830501|NCT02770170|58854564|FG003|Overall Study|due to pregnancy|0|||
30830502|NCT02770170|58854561|FG000|Overall Study|Lack of Efficacy|2|||
30830503|NCT02770170|58854562|FG001|Overall Study|Lack of Efficacy|0|||
30922412|NCT02065622|58957688|FG001|Induction Study|Withdrawal by Subject|5|||
30922413|NCT02065622|58957689|FG002|Induction Study|Withdrawal by Subject|0|||
30922414|NCT02065622|58957690|FG003|Induction Study|Withdrawal by Subject|0|||
30922415|NCT02065622|58957691|FG004|Induction Study|Withdrawal by Subject|0|||
30922416|NCT02065622|58957687|FG000|Induction Study|Lost to Follow-up|1|||
30922417|NCT02065622|58957688|FG001|Induction Study|Lost to Follow-up|0|||
30922418|NCT02065622|58957689|FG002|Induction Study|Lost to Follow-up|0|||
30830504|NCT02770170|58854563|FG002|Overall Study|Lack of Efficacy|0|||
30922419|NCT02065622|58957690|FG003|Induction Study|Lost to Follow-up|0|||
30830505|NCT02770170|58854564|FG003|Overall Study|Lack of Efficacy|1|||
30830506|NCT02770170|58854561|FG000|Overall Study|Adverse Event|4|||
30830507|NCT02770170|58854562|FG001|Overall Study|Adverse Event|3|||
30830508|NCT02770170|58854563|FG002|Overall Study|Adverse Event|5|||
30830509|NCT02770170|58854564|FG003|Overall Study|Adverse Event|3|||
30830510|NCT02770170|58854561|FG000|Overall Study|due to disease worsening|0|||
30830511|NCT02770170|58854562|FG001|Overall Study|due to disease worsening|0|||
30830512|NCT02770170|58854563|FG002|Overall Study|due to disease worsening|0|||
30830513|NCT02770170|58854564|FG003|Overall Study|due to disease worsening|1|||
30830514|NCT02769858|58854574|FG000|Overall Study|Withdrawal by Subject|2|||
30830515|NCT02769624|58854578|FG000|Overall Study|Lost to Follow-up|0|||
30830516|NCT02769624|58854579|FG001|Overall Study|Lost to Follow-up|1|||
30830517|NCT03446768|58854587|FG000|Overall Study|Withdrawal by Subject|0|||
30830518|NCT03446768|58854588|FG001|Overall Study|Withdrawal by Subject|1|||
30830519|NCT02676284|58854594|FG000|Overall Study|Withdrawal by Subject|1|||
30830520|NCT02769312|58854600|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
30830521|NCT02769312|58854601|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
30830522|NCT02769312|58854600|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
30830523|NCT02769312|58854601|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
30830524|NCT02769312|58854600|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
30830525|NCT02769312|58854601|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
30830526|NCT02769312|58854600|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
30830527|NCT02769312|58854601|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
30830528|NCT02769312|58854600|FG000|Follow-up|Lost to Follow-up|1|||
30830529|NCT02769312|58854601|FG001|Follow-up|Lost to Follow-up|1|||
30830530|NCT01673386|58854608|FG000|Overall Study|Study terminated by sponsor|16|||
30830531|NCT01673386|58854609|FG001|Overall Study|Study terminated by sponsor|22|||
30830532|NCT01673386|58854608|FG000|Overall Study|Adverse Event|5|||
30830533|NCT01673386|58854609|FG001|Overall Study|Adverse Event|2|||
30830534|NCT01673386|58854608|FG000|Overall Study|Progressive disease|4|||
30830535|NCT01673386|58854609|FG001|Overall Study|Progressive disease|1|||
30830536|NCT01673386|58854608|FG000|Overall Study|Withdrawal by Subject|0|||
30830537|NCT01673386|58854609|FG001|Overall Study|Withdrawal by Subject|2|||
30830538|NCT00103740|58854617|FG000|Period 1 - Core|Adverse Event|1|||
30830539|NCT00103740|58854618|FG001|Period 1 - Core|Adverse Event|0|||
30830540|NCT00103740|58854617|FG000|Period 1 - Core|Protocol Violation|3|||
30830541|NCT00103740|58854618|FG001|Period 1 - Core|Protocol Violation|2|||
30830542|NCT00103740|58854617|FG000|Period 1 - Core|Patient withdrew consent|3|||
30830543|NCT00103740|58854618|FG001|Period 1 - Core|Patient withdrew consent|2|||
30830544|NCT00103740|58854617|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
30830545|NCT00103740|58854618|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
30830546|NCT00103740|58854617|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
30830547|NCT00103740|58854618|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
30830548|NCT00103740|58854617|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
30830549|NCT00103740|58854618|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
30830550|NCT00103740|58854617|FG000|Period 2 - Extended Observation Period|Death|6|||
30830551|NCT00103740|58854618|FG001|Period 2 - Extended Observation Period|Death|2|||
30830552|NCT00103740|58854617|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
30830553|NCT00103740|58854618|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
30830554|NCT01281644|58854624|FG000|Overall Study|Lost to Follow-up|3|||
30830555|NCT01281644|58854624|FG000|Overall Study|Withdrawal by Subject|2|||
30830556|NCT02869893|58854630|FG000|Overall Study|participant aversion to IV|5|||
30830557|NCT02869893|58854630|FG000|Overall Study|participant fear of MRI scanner|2|||
30830558|NCT02872311|58854663|FG000|Overall Study|Death|2|||
30830559|NCT02872311|58854664|FG001|Overall Study|Death|0|||
30830560|NCT02872311|58854665|FG002|Overall Study|Death|0|||
30830561|NCT02872311|58854666|FG003|Overall Study|Death|0|||
30830562|NCT02872311|58854667|FG004|Overall Study|Death|0|||
30830563|NCT02872311|58854663|FG000|Overall Study|Lost to Follow-up|2|||
30830564|NCT02872311|58854664|FG001|Overall Study|Lost to Follow-up|0|||
30830565|NCT02872311|58854665|FG002|Overall Study|Lost to Follow-up|0|||
30830566|NCT02872311|58854666|FG003|Overall Study|Lost to Follow-up|0|||
30830567|NCT02872311|58854667|FG004|Overall Study|Lost to Follow-up|0|||
30830568|NCT02872311|58854663|FG000|Overall Study|Protocol Violation|0|||
30830569|NCT02872311|58854664|FG001|Overall Study|Protocol Violation|2|||
30830570|NCT02872311|58854665|FG002|Overall Study|Protocol Violation|1|||
30830571|NCT02872311|58854666|FG003|Overall Study|Protocol Violation|0|||
30830572|NCT02872311|58854667|FG004|Overall Study|Protocol Violation|0|||
30830573|NCT02871375|58854695|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
30830574|NCT02871375|58854696|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
30830575|NCT02867709|58854707|FG000|Treatment Period|Adverse Event|1|||
30830576|NCT02867709|58854708|FG001|Treatment Period|Adverse Event|1|||
30830577|NCT02867709|58854709|FG002|Treatment Period|Adverse Event|2|||
30830578|NCT02867709|58854707|FG000|Treatment Period|Withdrawal of Consent|7|||
30922420|NCT02065622|58957691|FG004|Induction Study|Lost to Follow-up|0|||
30830579|NCT02867709|58854708|FG001|Treatment Period|Withdrawal of Consent|9|||
30830580|NCT02867709|58854709|FG002|Treatment Period|Withdrawal of Consent|8|||
30830581|NCT02867709|58854707|FG000|Treatment Period|Lost to Follow-up|17|||
30830582|NCT02867709|58854708|FG001|Treatment Period|Lost to Follow-up|20|||
30830583|NCT02867709|58854709|FG002|Treatment Period|Lost to Follow-up|20|||
30830584|NCT02867709|58854707|FG000|Treatment Period|Lack of Qualifying Event|42|||
30755362|NCT04043416|58765095|FG001|Washout|Change in health condition|1|||
30830585|NCT02867709|58854708|FG001|Treatment Period|Lack of Qualifying Event|55|||
30830586|NCT02867709|58854709|FG002|Treatment Period|Lack of Qualifying Event|42|||
30830587|NCT02867709|58854707|FG000|Treatment Period|Protocol Violation|3|||
30830588|NCT02867709|58854708|FG001|Treatment Period|Protocol Violation|2|||
30830589|NCT02867709|58854709|FG002|Treatment Period|Protocol Violation|3|||
30830590|NCT02867709|58854707|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
30830591|NCT02867709|58854708|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
30830592|NCT02867709|58854709|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
30830593|NCT02867709|58854707|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
30830594|NCT02867709|58854708|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
30830595|NCT02867709|58854709|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
30830596|NCT02867709|58854707|FG000|Safety Follow-up Period|Pregnancy|0|||
30830597|NCT02867709|58854708|FG001|Safety Follow-up Period|Pregnancy|1|||
30830598|NCT02867709|58854709|FG002|Safety Follow-up Period|Pregnancy|0|||
30830599|NCT02867709|58854707|FG000|Safety Follow-up Period|Protocol Violation|0|||
30830600|NCT02867709|58854708|FG001|Safety Follow-up Period|Protocol Violation|1|||
30830601|NCT02867709|58854709|FG002|Safety Follow-up Period|Protocol Violation|1|||
30830602|NCT03044353|58854720|FG000|Overall Study|Adverse Event|0|||
30830603|NCT03044353|58854721|FG001|Overall Study|Adverse Event|1|||
30830604|NCT03044353|58854722|FG002|Overall Study|Adverse Event|0|||
30830605|NCT01361308|58854731|FG000|Overall Study|Withdrawal by Subject|9|||
30830606|NCT01361308|58854732|FG001|Overall Study|Withdrawal by Subject|13|||
30830607|NCT01361308|58854731|FG000|Overall Study|Physician Decision|3|||
30830608|NCT01361308|58854732|FG001|Overall Study|Physician Decision|3|||
30830609|NCT01361308|58854731|FG000|Overall Study|Lack of Efficacy|2|||
30830610|NCT01361308|58854732|FG001|Overall Study|Lack of Efficacy|0|||
30830611|NCT01361308|58854731|FG000|Overall Study|Protocol Violation|1|||
30830612|NCT01361308|58854732|FG001|Overall Study|Protocol Violation|0|||
30830613|NCT01361308|58854731|FG000|Overall Study|Lost to Follow-up|5|||
30830614|NCT01361308|58854732|FG001|Overall Study|Lost to Follow-up|4|||
30830615|NCT01361308|58854731|FG000|Overall Study|Adverse Event|8|||
30830616|NCT01361308|58854732|FG001|Overall Study|Adverse Event|4|||
30755363|NCT00095498|58765107|FG000|Overall Study|Physician Decision|9|||
30755364|NCT00095498|58765108|FG001|Overall Study|Physician Decision|10|||
30755365|NCT00095498|58765109|FG002|Overall Study|Physician Decision|8|||
30755366|NCT00095498|58765107|FG000|Overall Study|Adverse Event|1|||
30755367|NCT00095498|58765108|FG001|Overall Study|Adverse Event|0|||
30755368|NCT00095498|58765109|FG002|Overall Study|Adverse Event|1|||
30755369|NCT00095498|58765107|FG000|Overall Study|Withdrawal by Subject|15|||
30755370|NCT00095498|58765108|FG001|Overall Study|Withdrawal by Subject|16|||
30755371|NCT00095498|58765109|FG002|Overall Study|Withdrawal by Subject|15|||
30755372|NCT00095498|58765107|FG000|Overall Study|Disease progression|0|||
30755373|NCT00095498|58765108|FG001|Overall Study|Disease progression|1|||
30755374|NCT00095498|58765109|FG002|Overall Study|Disease progression|1|||
30755375|NCT00095498|58765107|FG000|Overall Study|Ineligibility determined|3|||
30755376|NCT00095498|58765108|FG001|Overall Study|Ineligibility determined|0|||
30755377|NCT00095498|58765109|FG002|Overall Study|Ineligibility determined|2|||
30755378|NCT00095498|58765107|FG000|Overall Study|Lost to Follow-up|1|||
30755379|NCT00095498|58765108|FG001|Overall Study|Lost to Follow-up|1|||
30830617|NCT01361308|58854731|FG000|Overall Study|Eligibility Criteria Not Met|2|||
30830618|NCT01361308|58854732|FG001|Overall Study|Eligibility Criteria Not Met|3|||
30755380|NCT00095498|58765109|FG002|Overall Study|Lost to Follow-up|2|||
30755381|NCT00095498|58765107|FG000|Overall Study|Noncompliance|1|||
30755382|NCT00095498|58765108|FG001|Overall Study|Noncompliance|0|||
30830619|NCT01361308|58854731|FG000|Overall Study|Failed C-SSRS|5|||
30830620|NCT01361308|58854732|FG001|Overall Study|Failed C-SSRS|2|||
30922421|NCT02065622|58957687|FG000|Induction Study|Lack of Efficacy|22|||
30755383|NCT00095498|58765109|FG002|Overall Study|Noncompliance|1|||
30755384|NCT00095498|58765107|FG000|Overall Study|Other|6|||
30830621|NCT01361308|58854731|FG000|Overall Study|Other|0|||
30830622|NCT01361308|58854732|FG001|Overall Study|Other|1|||
30830623|NCT02872935|58854744|FG000|Overall Study|Other|0|||
30830624|NCT02872935|58854745|FG001|Overall Study|Other|1|||
30830625|NCT00103662|58854753|FG000|Overall Study|Entered Rescue Procedure|0|||
30830626|NCT00103662|58854754|FG001|Overall Study|Entered Rescue Procedure|7|||
30830627|NCT00103662|58854753|FG000|Overall Study|Death|7|||
30830628|NCT00103662|58854754|FG001|Overall Study|Death|7|||
30830629|NCT00103662|58854753|FG000|Overall Study|Elective Withdrawal|5|||
30830630|NCT00103662|58854754|FG001|Overall Study|Elective Withdrawal|5|||
30830631|NCT00103662|58854753|FG000|Overall Study|Lost to Follow-up|0|||
30830632|NCT00103662|58854754|FG001|Overall Study|Lost to Follow-up|1|||
30830633|NCT00103662|58854753|FG000|Overall Study|Other|6|||
30830634|NCT00103662|58854754|FG001|Overall Study|Other|9|||
30830635|NCT00103662|58854753|FG000|Overall Study|Failed mobilization|0|||
30830636|NCT00103662|58854754|FG001|Overall Study|Failed mobilization|4|||
30830637|NCT00103662|58854753|FG000|Overall Study|Intercurrent illness|1|||
30830638|NCT00103662|58854754|FG001|Overall Study|Intercurrent illness|0|||
30830639|NCT02865915|58854762|FG000|Overall Study|Pregnancy|1|||
30830640|NCT02865915|58854763|FG001|Overall Study|Pregnancy|0|||
30830641|NCT02865915|58854762|FG000|Overall Study|Withdrawal by Subject|1|||
30830642|NCT02865915|58854763|FG001|Overall Study|Withdrawal by Subject|1|||
30830643|NCT02865915|58854762|FG000|Overall Study|Adverse Event|0|||
30830644|NCT02865915|58854763|FG001|Overall Study|Adverse Event|4|||
30830645|NCT02865915|58854762|FG000|Overall Study|Lost to Follow-up|0|||
30830646|NCT02865915|58854763|FG001|Overall Study|Lost to Follow-up|1|||
30830647|NCT02865915|58854762|FG000|Overall Study|Protocol Violation|0|||
30830648|NCT02865915|58854763|FG001|Overall Study|Protocol Violation|1|||
30830649|NCT02865915|58854762|FG000|Overall Study|Study terminated by sponsor|23|||
30830650|NCT02865915|58854763|FG001|Overall Study|Study terminated by sponsor|18|||
30830651|NCT02865915|58854762|FG000|Overall Study|Dosing group discontinued|0|||
30830652|NCT02865915|58854763|FG001|Overall Study|Dosing group discontinued|5|||
30830653|NCT00104676|58854771|FG000|Overall Study|Death|3|||
30830654|NCT00104676|58854772|FG001|Overall Study|Death|2|||
30830655|NCT00104676|58854771|FG000|Overall Study|Withdrawal by Subject|0|||
30830656|NCT00104676|58854772|FG001|Overall Study|Withdrawal by Subject|2|||
30830657|NCT00104676|58854771|FG000|Overall Study|treatment interruption|4|||
30830658|NCT00104676|58854772|FG001|Overall Study|treatment interruption|10|||
30830659|NCT00354835|58854780|FG000|Overall Study|Death|1|||
30830660|NCT00354835|58854781|FG001|Overall Study|Death|1|||
30830661|NCT00354835|58854780|FG000|Overall Study|Physician Decision|8|||
30830662|NCT00354835|58854781|FG001|Overall Study|Physician Decision|13|||
30830663|NCT00354835|58854780|FG000|Overall Study|Withdrawal by Subject|2|||
30830664|NCT00354835|58854781|FG001|Overall Study|Withdrawal by Subject|1|||
30830665|NCT00354835|58854780|FG000|Overall Study|Ineligible|17|||
30830666|NCT00354835|58854781|FG001|Overall Study|Ineligible|16|||
30830667|NCT00354835|58854780|FG000|Overall Study|Disease progression or relapse|15|||
30830668|NCT00354835|58854781|FG001|Overall Study|Disease progression or relapse|22|||
30830669|NCT00354835|58854780|FG000|Overall Study|Adverse Event|6|||
30830670|NCT00354835|58854781|FG001|Overall Study|Adverse Event|0|||
30830671|NCT00354835|58854780|FG000|Overall Study|Refusal of further therapy|3|||
30830672|NCT00354835|58854781|FG001|Overall Study|Refusal of further therapy|8|||
30830673|NCT02768298|58854804|FG000|Overall Study|Adverse Event|1|||
30830674|NCT02768298|58854805|FG001|Overall Study|Adverse Event|4|||
30830675|NCT02768298|58854804|FG000|Overall Study|Death|2|||
30830676|NCT02768298|58854805|FG001|Overall Study|Death|1|||
30830677|NCT02768298|58854804|FG000|Overall Study|Non-compliance with study treatment|0|||
30830678|NCT02768298|58854805|FG001|Overall Study|Non-compliance with study treatment|1|||
30830679|NCT02768298|58854804|FG000|Overall Study|Subject/guardian decision|1|||
30830680|NCT02768298|58854805|FG001|Overall Study|Subject/guardian decision|0|||
30830681|NCT02768298|58854804|FG000|Overall Study|Withdrawal of informed consent|0|||
30830682|NCT02768298|58854805|FG001|Overall Study|Withdrawal of informed consent|1|||
30830683|NCT02775864|58854815|FG000|Overall Study|Data ended end of 2010|1764|||
30830684|NCT02775864|58854816|FG001|Overall Study|Data ended end of 2010|2880|||
30830685|NCT02775864|58854817|FG002|Overall Study|Data ended end of 2010|1140|||
30830686|NCT02775864|58854818|FG003|Overall Study|Data ended end of 2010|1194|||
30830687|NCT02775864|58854815|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
30830688|NCT02775864|58854816|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
30830689|NCT02775864|58854817|FG002|Overall Study|Medicaid eligibility discontinued|720|||
30830690|NCT02775864|58854818|FG003|Overall Study|Medicaid eligibility discontinued|890|||
30830691|NCT02964273|58854831|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
30830692|NCT02964273|58854832|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
30830693|NCT02964273|58854833|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
30830694|NCT02964273|58854834|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
30830695|NCT02964273|58854831|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
30830696|NCT02964273|58854832|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
30830697|NCT02964273|58854833|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
30830698|NCT02964273|58854834|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
30830699|NCT02964273|58854831|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
30830700|NCT02964273|58854832|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
30830701|NCT02964273|58854833|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
30830702|NCT02964273|58854834|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
30830703|NCT02964273|58854831|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
30830704|NCT02964273|58854832|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
30830705|NCT02964273|58854833|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
30830706|NCT02964273|58854834|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
30830707|NCT02964273|58854831|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
30830708|NCT02964273|58854832|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
30830709|NCT02964273|58854833|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
30830710|NCT02964273|58854834|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
30830711|NCT02964273|58854831|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
30830712|NCT02964273|58854832|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
30830713|NCT02964273|58854833|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
30830714|NCT02964273|58854834|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
30830715|NCT02773446|58854853|FG000|First Admission|Withdrawal by Subject|0|||
30922422|NCT02065622|58957688|FG001|Induction Study|Lack of Efficacy|27|||
30922423|NCT02065622|58957689|FG002|Induction Study|Lack of Efficacy|0|||
30922424|NCT02065622|58957690|FG003|Induction Study|Lack of Efficacy|0|||
30830716|NCT02773446|58854854|FG001|First Admission|Withdrawal by Subject|0|||
30830717|NCT02773446|58854855|FG002|First Admission|Withdrawal by Subject|0|||
30830718|NCT02773446|58854856|FG003|First Admission|Withdrawal by Subject|1|||
30830719|NCT02773446|58854857|FG004|First Admission|Withdrawal by Subject|0|||
30922425|NCT02065622|58957691|FG004|Induction Study|Lack of Efficacy|0|||
30922426|NCT02065622|58957687|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
30922427|NCT02065622|58957688|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
30922428|NCT02065622|58957689|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
30922429|NCT02065622|58957690|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
30922430|NCT02065622|58957691|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
30922431|NCT02065622|58957687|FG000|Induction Study|Subject Noncompliance|1|||
30922432|NCT02065622|58957688|FG001|Induction Study|Subject Noncompliance|1|||
30922433|NCT02065622|58957689|FG002|Induction Study|Subject Noncompliance|0|||
30922434|NCT02065622|58957690|FG003|Induction Study|Subject Noncompliance|0|||
30830720|NCT02773446|58854858|FG005|First Admission|Withdrawal by Subject|0|||
30830721|NCT02773446|58854853|FG000|First Admission|Lost to Follow-up|1|||
30830722|NCT02773446|58854854|FG001|First Admission|Lost to Follow-up|0|||
30830723|NCT02773446|58854855|FG002|First Admission|Lost to Follow-up|0|||
30830724|NCT02773446|58854856|FG003|First Admission|Lost to Follow-up|0|||
30830725|NCT02773446|58854857|FG004|First Admission|Lost to Follow-up|0|||
30830726|NCT02773446|58854858|FG005|First Admission|Lost to Follow-up|0|||
30830727|NCT02773368|58854877|FG000|Overall Study|Lost to Follow-up|4|||
30830728|NCT02773368|58854878|FG001|Overall Study|Lost to Follow-up|1|||
30830729|NCT02773368|58854877|FG000|Overall Study|Withdrawal by Subject|5|||
30830730|NCT02773368|58854878|FG001|Overall Study|Withdrawal by Subject|1|||
30830731|NCT02773368|58854877|FG000|Overall Study|Unclassified|1|||
30830732|NCT02773368|58854878|FG001|Overall Study|Unclassified|1|||
30830733|NCT02773368|58854877|FG000|Overall Study|Missing|0|||
30830734|NCT02773368|58854878|FG001|Overall Study|Missing|1|||
30830735|NCT01336647|58854887|FG000|Overall Study|Lost to Follow-up|4|||
30830736|NCT01336647|58854888|FG001|Overall Study|Lost to Follow-up|1|||
30830737|NCT01336647|58854889|FG002|Overall Study|Lost to Follow-up|3|||
30830738|NCT01336569|58854899|FG000|Overall Study|Lost to Follow-up|4|||
30830739|NCT02772978|58854903|FG000|Overall Study|Withdrawal by Subject|1|||
30830740|NCT02772978|58854904|FG001|Overall Study|Withdrawal by Subject|1|||
30830741|NCT00104052|58854909|FG000|Overall Study|Adverse Event|1|||
30830742|NCT00104052|58854909|FG000|Overall Study|Lack of Efficacy|26|||
30830743|NCT00104052|58854909|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
30830744|NCT02777970|58854916|FG000|Overall Study|Lost to Follow-up|0|||
30830745|NCT02777970|58854917|FG001|Overall Study|Lost to Follow-up|1|||
30830746|NCT02777970|58854918|FG002|Overall Study|Lost to Follow-up|0|||
30830747|NCT02777970|58854916|FG000|Overall Study|Protocol Violation|1|||
30830748|NCT02777970|58854917|FG001|Overall Study|Protocol Violation|0|||
30830749|NCT02777970|58854918|FG002|Overall Study|Protocol Violation|0|||
30830750|NCT03037489|58854930|FG000|Overall Study|Adverse Event|4|||
30830751|NCT03037489|58854931|FG001|Overall Study|Adverse Event|0|||
30922435|NCT02065622|58957691|FG004|Induction Study|Subject Noncompliance|0|||
30830752|NCT03037489|58854930|FG000|Overall Study|Withdrawal by Subject|3|||
30830753|NCT03037489|58854931|FG001|Overall Study|Withdrawal by Subject|0|||
30830754|NCT01336023|58854940|FG000|Week 0 to Week 26|Adverse Event|8|||
30830755|NCT01336023|58854941|FG001|Week 0 to Week 26|Adverse Event|10|||
30830756|NCT01336023|58854942|FG002|Week 0 to Week 26|Adverse Event|24|||
30830757|NCT01336023|58854940|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
30922436|NCT02065622|58957687|FG000|Induction Study|Other, Not Specified|3|||
30830758|NCT01336023|58854941|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
30830759|NCT01336023|58854942|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
30830760|NCT01336023|58854940|FG000|Week 0 to Week 26|Protocol Violation|1|||
30830761|NCT01336023|58854941|FG001|Week 0 to Week 26|Protocol Violation|2|||
30830762|NCT01336023|58854942|FG002|Week 0 to Week 26|Protocol Violation|0|||
30830763|NCT01336023|58854940|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
30830764|NCT01336023|58854941|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
30830765|NCT01336023|58854942|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
30830766|NCT01336023|58854940|FG000|Week 0 to Week 26|Unclassified|5|||
30830767|NCT01336023|58854941|FG001|Week 0 to Week 26|Unclassified|16|||
30830768|NCT01336023|58854942|FG002|Week 0 to Week 26|Unclassified|9|||
30922437|NCT02065622|58957688|FG001|Induction Study|Other, Not Specified|2|||
30922438|NCT02065622|58957689|FG002|Induction Study|Other, Not Specified|0|||
30922439|NCT02065622|58957690|FG003|Induction Study|Other, Not Specified|0|||
30922440|NCT02065622|58957691|FG004|Induction Study|Other, Not Specified|0|||
30922441|NCT02065622|58957687|FG000|Maintenance Study|Adverse Event|0|||
30922442|NCT02065622|58957688|FG001|Maintenance Study|Adverse Event|0|||
30922443|NCT02065622|58957689|FG002|Maintenance Study|Adverse Event|25|||
30922444|NCT02065622|58957690|FG003|Maintenance Study|Adverse Event|22|||
30922445|NCT02065622|58957691|FG004|Maintenance Study|Adverse Event|11|||
30755385|NCT00095498|58765108|FG001|Overall Study|Other|7|||
30755386|NCT00095498|58765109|FG002|Overall Study|Other|6|||
30755387|NCT00095498|58765107|FG000|Overall Study|Protocol Violation|0|||
30755388|NCT00095498|58765108|FG001|Overall Study|Protocol Violation|0|||
30755389|NCT00095498|58765109|FG002|Overall Study|Protocol Violation|1|||
30755390|NCT00095498|58765107|FG000|Overall Study|Requirement for alternative therapy|1|||
30755391|NCT00095498|58765108|FG001|Overall Study|Requirement for alternative therapy|0|||
30755392|NCT00095498|58765109|FG002|Overall Study|Requirement for alternative therapy|2|||
30755393|NCT04237792|58765123|FG000|Treatment (Day 1)|Adverse Event|1|||
30755394|NCT04237792|58765124|FG001|Treatment (Day 1)|Adverse Event|0|||
30755395|NCT04237792|58765125|FG002|Treatment (Day 1)|Adverse Event|0|||
30755396|NCT04237792|58765126|FG003|Treatment (Day 1)|Adverse Event|0|||
30755397|NCT04237792|58765127|FG004|Treatment (Day 1)|Adverse Event|1|||
30755398|NCT04237792|58765128|FG005|Treatment (Day 1)|Adverse Event|1|||
30755399|NCT04237792|58765123|FG000|Treatment (Day 1)|Other|0|||
30755400|NCT04237792|58765124|FG001|Treatment (Day 1)|Other|0|||
30755401|NCT04237792|58765125|FG002|Treatment (Day 1)|Other|1|||
30755402|NCT04237792|58765126|FG003|Treatment (Day 1)|Other|0|||
30755403|NCT04237792|58765127|FG004|Treatment (Day 1)|Other|0|||
30755404|NCT04237792|58765128|FG005|Treatment (Day 1)|Other|1|||
30755405|NCT04237792|58765123|FG000|Treatment (Day 1)|Not treated|1|||
30755406|NCT04237792|58765124|FG001|Treatment (Day 1)|Not treated|1|||
30755407|NCT04237792|58765125|FG002|Treatment (Day 1)|Not treated|2|||
30755408|NCT04237792|58765126|FG003|Treatment (Day 1)|Not treated|1|||
30755409|NCT04237792|58765127|FG004|Treatment (Day 1)|Not treated|0|||
30755410|NCT04237792|58765128|FG005|Treatment (Day 1)|Not treated|1|||
30755411|NCT00122954|58765159|FG000|Overall Study|Withdrawal by Subject|2|||
30755412|NCT00122954|58765160|FG001|Overall Study|Withdrawal by Subject|2|||
30755413|NCT00122954|58765159|FG000|Overall Study|Protocol Violation|0|||
30755414|NCT00122954|58765160|FG001|Overall Study|Protocol Violation|1|||
30755415|NCT04491994|58765168|FG000|Overall Study|Withdrawal by Subject|10|||
30755416|NCT04491994|58765169|FG001|Overall Study|Withdrawal by Subject|5|||
30755417|NCT04491994|58765168|FG000|Overall Study|developed fever > 3 days|4|||
30755418|NCT04491994|58765169|FG001|Overall Study|developed fever > 3 days|1|||
30755419|NCT04491994|58765168|FG000|Overall Study|Protocol Violation|11|||
30755420|NCT04491994|58765169|FG001|Overall Study|Protocol Violation|2|||
30755421|NCT04491994|58765168|FG000|Overall Study|Lost to Follow-up|4|||
30755422|NCT04491994|58765169|FG001|Overall Study|Lost to Follow-up|3|||
30755423|NCT04041700|58765175|FG000|Overall Study|Pregnancy|1|||
30755424|NCT04041700|58765175|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
30755425|NCT04227340|58765181|FG000|Overall Study|Withdrawal by Subject|3|||
30755426|NCT04033432|58765188|FG000|Overall Study|Progressive Disease|8|||
30755427|NCT04033432|58765188|FG000|Overall Study|Adverse Event|4|||
30755428|NCT04033432|58765188|FG000|Overall Study|Death|1|||
30755429|NCT04223830|58765193|FG000|Overall Study|Lost to Follow-up|9|||
30830769|NCT01336023|58854940|FG000|Week 27 to 52|Adverse Event|1|||
30830770|NCT01336023|58854941|FG001|Week 27 to 52|Adverse Event|5|||
30830771|NCT01336023|58854942|FG002|Week 27 to 52|Adverse Event|2|||
30830772|NCT01336023|58854940|FG000|Week 27 to 52|Protocol Violation|0|||
30922446|NCT02065622|58957687|FG000|Maintenance Study|Withdrawal by Subject|0|||
30755430|NCT04223830|58765193|FG000|Overall Study|Adverse Event|1|||
30755431|NCT04032652|58765200|FG000|Overall Study|The study was terminated and the PI has|1|||
30755432|NCT04032652|58765201|FG001|Overall Study|The study was terminated and the PI has|1|||
30755433|NCT04031404|58765207|FG000|Baseline|Lost to Follow-up|0|||
30755434|NCT04031404|58765208|FG001|Baseline|Lost to Follow-up|1|||
30755435|NCT04031404|58765207|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
30755436|NCT04031404|58765208|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
30922447|NCT02065622|58957688|FG001|Maintenance Study|Withdrawal by Subject|0|||
30922448|NCT02065622|58957689|FG002|Maintenance Study|Withdrawal by Subject|11|||
30922449|NCT02065622|58957690|FG003|Maintenance Study|Withdrawal by Subject|5|||
30922450|NCT02065622|58957691|FG004|Maintenance Study|Withdrawal by Subject|7|||
30922451|NCT02065622|58957687|FG000|Maintenance Study|Lost to Follow-up|0|||
30922452|NCT02065622|58957688|FG001|Maintenance Study|Lost to Follow-up|0|||
30922453|NCT02065622|58957689|FG002|Maintenance Study|Lost to Follow-up|4|||
30922454|NCT02065622|58957690|FG003|Maintenance Study|Lost to Follow-up|1|||
30922455|NCT02065622|58957691|FG004|Maintenance Study|Lost to Follow-up|1|||
30922456|NCT02065622|58957687|FG000|Maintenance Study|Lack of Efficacy|0|||
30922457|NCT02065622|58957688|FG001|Maintenance Study|Lack of Efficacy|0|||
30922458|NCT02065622|58957689|FG002|Maintenance Study|Lack of Efficacy|70|||
30922459|NCT02065622|58957690|FG003|Maintenance Study|Lack of Efficacy|55|||
30922460|NCT02065622|58957691|FG004|Maintenance Study|Lack of Efficacy|19|||
30922461|NCT02065622|58957687|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
30922462|NCT02065622|58957688|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
30922463|NCT02065622|58957689|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
30922464|NCT02065622|58957690|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
30922465|NCT02065622|58957691|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
30922466|NCT02065622|58957687|FG000|Maintenance Study|Subject Non-Compliance|0|||
30922467|NCT02065622|58957688|FG001|Maintenance Study|Subject Non-Compliance|0|||
30922468|NCT02065622|58957689|FG002|Maintenance Study|Subject Non-Compliance|1|||
30922469|NCT02065622|58957690|FG003|Maintenance Study|Subject Non-Compliance|3|||
30922470|NCT02065622|58957691|FG004|Maintenance Study|Subject Non-Compliance|2|||
30922471|NCT02065622|58957687|FG000|Maintenance Study|Other, Not Specified|0|||
30922472|NCT02065622|58957688|FG001|Maintenance Study|Other, Not Specified|0|||
30922473|NCT02065622|58957689|FG002|Maintenance Study|Other, Not Specified|6|||
30922474|NCT02065622|58957690|FG003|Maintenance Study|Other, Not Specified|14|||
30922475|NCT02065622|58957691|FG004|Maintenance Study|Other, Not Specified|2|||
30922476|NCT02065622|58957687|FG000|Maintenance Study|Unknown Reason|0|||
30922477|NCT02065622|58957688|FG001|Maintenance Study|Unknown Reason|0|||
30922478|NCT02065622|58957689|FG002|Maintenance Study|Unknown Reason|0|||
30922479|NCT02065622|58957690|FG003|Maintenance Study|Unknown Reason|1|||
30922480|NCT02065622|58957691|FG004|Maintenance Study|Unknown Reason|0|||
30922481|NCT02117648|58957706|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
30922482|NCT02117648|58957706|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
30922483|NCT02117648|58957706|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
30922484|NCT02117648|58957706|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
30922485|NCT02117648|58957706|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
30922486|NCT02117648|58957706|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
30922487|NCT02117648|58957706|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
30922488|NCT02117648|58957706|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
30922489|NCT02117648|58957706|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
30922490|NCT02117648|58957706|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
30922491|NCT02117648|58957706|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
30922492|NCT02124161|58957716|FG000|Overall Study|Other unspecified|0|||
30922493|NCT02124161|58957717|FG001|Overall Study|Other unspecified|1|||
30922494|NCT02124161|58957716|FG000|Overall Study|Death|1|||
30922495|NCT02124161|58957717|FG001|Overall Study|Death|0|||
30922496|NCT02124161|58957716|FG000|Overall Study|Protocol Violation|2|||
30922497|NCT02124161|58957717|FG001|Overall Study|Protocol Violation|1|||
30922498|NCT02124161|58957716|FG000|Overall Study|Withdrawal by Subject|1|||
30922499|NCT02124161|58957717|FG001|Overall Study|Withdrawal by Subject|2|||
30922500|NCT02124161|58957716|FG000|Overall Study|Adverse Event|2|||
30922501|NCT02124161|58957717|FG001|Overall Study|Adverse Event|0|||
30922502|NCT02124161|58957716|FG000|Overall Study|Does not meet entrance criteria|2|||
30922503|NCT02124161|58957717|FG001|Overall Study|Does not meet entrance criteria|3|||
30755437|NCT04031404|58765207|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
30755438|NCT04031404|58765208|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
30755439|NCT04031404|58765207|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
30755440|NCT04031404|58765208|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
30755441|NCT04031404|58765207|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
30922504|NCT02124161|58957716|FG000|Overall Study|No longer meets eligibility criteria|5|||
30922505|NCT02124161|58957717|FG001|Overall Study|No longer meets eligibility criteria|4|||
30922506|NCT02124161|58957716|FG000|Overall Study|Lost to Follow-up|3|||
30922507|NCT02124161|58957717|FG001|Overall Study|Lost to Follow-up|4|||
30922508|NCT02175641|58957732|FG000|Overall Study|Death|3|||
30922509|NCT02175641|58957733|FG001|Overall Study|Death|4|||
30922510|NCT02175641|58957732|FG000|Overall Study|Lost to Follow-up|4|||
30755442|NCT04031404|58765208|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
30755443|NCT04476784|58765224|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
30755444|NCT04476784|58765225|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
30755445|NCT04026568|58765236|FG000|Overall Study|study terminated|0|||
30922511|NCT02175641|58957733|FG001|Overall Study|Lost to Follow-up|4|||
30922512|NCT02175641|58957732|FG000|Overall Study|Withdrawal by Subject|7|||
30922513|NCT02175641|58957733|FG001|Overall Study|Withdrawal by Subject|4|||
30922514|NCT02175641|58957732|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
30922515|NCT02175641|58957733|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
30922516|NCT02175641|58957732|FG000|Overall Study|Developed Contraindicated Condition|8|||
30922517|NCT02175641|58957733|FG001|Overall Study|Developed Contraindicated Condition|0|||
30922518|NCT02117570|58957742|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
30922519|NCT02117570|58957743|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
30922520|NCT02117570|58957744|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
30922521|NCT02117570|58957742|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
30922522|NCT02117570|58957743|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
30922523|NCT02117570|58957744|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
30922524|NCT02117570|58957742|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
30830773|NCT01336023|58854941|FG001|Week 27 to 52|Protocol Violation|2|||
30830774|NCT01336023|58854942|FG002|Week 27 to 52|Protocol Violation|1|||
30830775|NCT01336023|58854940|FG000|Week 27 to 52|Withdrawal Criteria|14|||
30830776|NCT01336023|58854941|FG001|Week 27 to 52|Withdrawal Criteria|19|||
30830777|NCT01336023|58854942|FG002|Week 27 to 52|Withdrawal Criteria|16|||
30830778|NCT01336023|58854940|FG000|Week 27 to 52|Unclassified|13|||
30830779|NCT01336023|58854941|FG001|Week 27 to 52|Unclassified|18|||
30830780|NCT01336023|58854942|FG002|Week 27 to 52|Unclassified|9|||
30922525|NCT02117570|58957743|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
30922526|NCT02117570|58957744|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
30922527|NCT02117570|58957742|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
30922528|NCT02117570|58957743|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
30922529|NCT02117570|58957744|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
30922530|NCT02117570|58957742|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
30922531|NCT02117570|58957743|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
30922532|NCT02117570|58957744|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
30922533|NCT02117570|58957742|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
30922534|NCT02117570|58957743|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
30922535|NCT02117570|58957744|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
30922536|NCT02117570|58957742|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
30922537|NCT02117570|58957743|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
30922538|NCT02117570|58957744|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
30922539|NCT02123459|58957755|FG000|Washout Period (1 Day)|Adverse Event|1|||
30922540|NCT02123459|58957756|FG001|Washout Period (1 Day)|Adverse Event|0|||
30922541|NCT01853475|58957765|FG000|Overall Study|Withdrawal by Subject|0|||
30922542|NCT01853475|58957766|FG001|Overall Study|Withdrawal by Subject|1|||
30922543|NCT01853475|58957767|FG002|Overall Study|Withdrawal by Subject|0|||
30922544|NCT02151773|58957775|FG000|Overall Study|Protocol Deviation|64|||
30922545|NCT02151461|58957783|FG000|Overall Study|Adverse Event|5|||
30922546|NCT02151461|58957784|FG001|Overall Study|Adverse Event|1|||
30922547|NCT02151461|58957785|FG002|Overall Study|Adverse Event|0|||
30922548|NCT02151461|58957786|FG003|Overall Study|Adverse Event|2|||
30922549|NCT02151461|58957783|FG000|Overall Study|Lost to Follow-up|0|||
30922550|NCT02151461|58957784|FG001|Overall Study|Lost to Follow-up|0|||
30922551|NCT02151461|58957785|FG002|Overall Study|Lost to Follow-up|1|||
30922552|NCT02151461|58957786|FG003|Overall Study|Lost to Follow-up|1|||
30922553|NCT02151461|58957783|FG000|Overall Study|Withdrawal by Subject|1|||
30922554|NCT02151461|58957784|FG001|Overall Study|Withdrawal by Subject|0|||
30922555|NCT02151461|58957785|FG002|Overall Study|Withdrawal by Subject|1|||
30922556|NCT02151461|58957786|FG003|Overall Study|Withdrawal by Subject|1|||
30922557|NCT02151461|58957783|FG000|Overall Study|Treatment discontinuation|0|||
30922558|NCT02151461|58957784|FG001|Overall Study|Treatment discontinuation|0|||
30922559|NCT02151461|58957785|FG002|Overall Study|Treatment discontinuation|1|||
30922560|NCT02151461|58957786|FG003|Overall Study|Treatment discontinuation|0|||
30922561|NCT02117414|58957798|FG000|Overall Study|Death|5|||
30922562|NCT02117414|58957799|FG001|Overall Study|Death|2|||
30922563|NCT02117414|58957798|FG000|Overall Study|Withdrawal by Subject|10|||
30922564|NCT02117414|58957799|FG001|Overall Study|Withdrawal by Subject|4|||
30922565|NCT02091986|58957810|FG000|Overall Study|7 rand in error 1 patient decision|2|||
30922566|NCT02091986|58957811|FG001|Overall Study|7 rand in error 1 patient decision|3|||
30922567|NCT02091986|58957812|FG002|Overall Study|7 rand in error 1 patient decision|3|||
30922568|NCT02091986|58957810|FG000|Overall Study|Lost to Follow-up|1|||
30830781|NCT03039283|58854950|FG000|Overall Study|Protocol Violation|2|||
30922569|NCT02091986|58957811|FG001|Overall Study|Lost to Follow-up|0|||
30922570|NCT02091986|58957812|FG002|Overall Study|Lost to Follow-up|0|||
30830782|NCT02863575|58854972|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
30922571|NCT02091986|58957810|FG000|Overall Study|Withdrawal by Subject|4|||
30830783|NCT02863575|58854973|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
30922572|NCT02091986|58957811|FG001|Overall Study|Withdrawal by Subject|8|||
30922573|NCT02091986|58957812|FG002|Overall Study|Withdrawal by Subject|3|||
30922574|NCT02091986|58957810|FG000|Overall Study|Adverse Event|0|||
30922575|NCT02091986|58957811|FG001|Overall Study|Adverse Event|0|||
30922576|NCT02091986|58957812|FG002|Overall Study|Adverse Event|2|||
30830784|NCT02863575|58854974|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
30830785|NCT02863575|58854972|FG000|Overall Study|Withdrawal by Subject|0|||
30830786|NCT02863575|58854973|FG001|Overall Study|Withdrawal by Subject|1|||
30830787|NCT02863575|58854974|FG002|Overall Study|Withdrawal by Subject|1|||
30830788|NCT02863575|58854972|FG000|Overall Study|Adverse Event|0|||
30830789|NCT02863575|58854973|FG001|Overall Study|Adverse Event|1|||
30830790|NCT02863575|58854974|FG002|Overall Study|Adverse Event|0|||
30830791|NCT01227187|58854986|FG000|Overall Study|Physician Decision|0|||
30830792|NCT01227187|58854987|FG001|Overall Study|Physician Decision|0|||
30830793|NCT01227187|58854988|FG002|Overall Study|Physician Decision|0|||
30830794|NCT01227187|58854989|FG003|Overall Study|Physician Decision|1|||
30830795|NCT02638012|58855010|FG000|Overall Study|Lost to Follow-up|1|||
30830796|NCT00103506|58855016|FG000|Overall Study|Study closed by sponsor|34|||
30830797|NCT00103506|58855017|FG001|Overall Study|Study closed by sponsor|37|||
30830798|NCT00103506|58855016|FG000|Overall Study|Death|257|||
30830799|NCT00103506|58855017|FG001|Overall Study|Death|253|||
30830800|NCT00103506|58855016|FG000|Overall Study|Lost to Follow-up|13|||
30830801|NCT00103506|58855017|FG001|Overall Study|Lost to Follow-up|13|||
30830802|NCT00103506|58855016|FG000|Overall Study|Withdrawal by Subject|18|||
30830803|NCT00103506|58855017|FG001|Overall Study|Withdrawal by Subject|21|||
30830804|NCT02765490|58855025|FG000|Overall Study|Lost to Follow-up|1|||
30830805|NCT02765490|58855026|FG001|Overall Study|Lost to Follow-up|1|||
30830806|NCT02765490|58855025|FG000|Overall Study|Other|0|||
30830807|NCT02765490|58855026|FG001|Overall Study|Other|1|||
30830808|NCT02765490|58855025|FG000|Overall Study|Death|0|||
30922577|NCT02091752|58957820|FG000|Overall Study|Study terminated by Sponsor|2|||
30922578|NCT02091752|58957820|FG000|Overall Study|Adverse Event|1|||
30922579|NCT02117024|58957826|FG000|Overall Study|Progressive Disease|26|||
30922580|NCT02117024|58957827|FG001|Overall Study|Progressive Disease|9|||
30922581|NCT02117024|58957826|FG000|Overall Study|Significant Clinical Progression|7|||
30830809|NCT02765490|58855026|FG001|Overall Study|Death|1|||
30830810|NCT02762370|58855034|FG000|Overall Study|Protocol Violation|1|||
30830811|NCT02762370|58855035|FG001|Overall Study|Protocol Violation|0|||
30830812|NCT02639182|58855045|FG000|Overall Study|Disease Progression|50|||
30830813|NCT02639182|58855046|FG001|Overall Study|Disease Progression|49|||
30830814|NCT02639182|58855045|FG000|Overall Study|Adverse Event|7|||
30830815|NCT02639182|58855046|FG001|Overall Study|Adverse Event|5|||
30830816|NCT02639182|58855045|FG000|Overall Study|Physician Decision|3|||
30830817|NCT02639182|58855046|FG001|Overall Study|Physician Decision|3|||
30922582|NCT02117024|58957827|FG001|Overall Study|Significant Clinical Progression|4|||
30922583|NCT02117024|58957826|FG000|Overall Study|Death|5|||
30922584|NCT02117024|58957827|FG001|Overall Study|Death|0|||
30922585|NCT02117024|58957826|FG000|Overall Study|Withdrawal by Subject|3|||
30922586|NCT02117024|58957827|FG001|Overall Study|Withdrawal by Subject|1|||
30922587|NCT02117024|58957826|FG000|Overall Study|Protocol Violation|1|||
30922588|NCT02117024|58957827|FG001|Overall Study|Protocol Violation|0|||
30922589|NCT02117024|58957826|FG000|Overall Study|Adverse Event|1|||
30922590|NCT02117024|58957827|FG001|Overall Study|Adverse Event|2|||
30830818|NCT02639182|58855045|FG000|Overall Study|Withdrew Consent|5|||
30830819|NCT02639182|58855046|FG001|Overall Study|Withdrew Consent|4|||
30830820|NCT02639182|58855045|FG000|Overall Study|Lost to Follow-up|0|||
30922591|NCT02117024|58957826|FG000|Overall Study|Randomized in Error|1|||
30922592|NCT02117024|58957827|FG001|Overall Study|Randomized in Error|0|||
30922593|NCT02117024|58957826|FG000|Overall Study|Patient returned to primary oncologist|0|||
30922594|NCT02117024|58957827|FG001|Overall Study|Patient returned to primary oncologist|1|||
30922595|NCT02117024|58957826|FG000|Overall Study|Patient took treatment break|0|||
30922596|NCT02117024|58957827|FG001|Overall Study|Patient took treatment break|1|||
30922597|NCT02117024|58957826|FG000|Overall Study|Physician Decision|0|||
30922598|NCT02117024|58957827|FG001|Overall Study|Physician Decision|2|||
30922599|NCT02091440|58957833|FG000|Overall Study|Death|2|||
30922600|NCT02064920|58957839|FG000|Overall Study|Adverse Event|0|||
30830821|NCT02639182|58855046|FG001|Overall Study|Lost to Follow-up|1|||
30830822|NCT02639182|58855045|FG000|Overall Study|Study Closure|1|||
30922601|NCT02064920|58957840|FG001|Overall Study|Adverse Event|4|||
30922602|NCT02064920|58957839|FG000|Overall Study|Physician Decision|0|||
30830823|NCT02639182|58855046|FG001|Overall Study|Study Closure|2|||
30830824|NCT02639182|58855045|FG000|Overall Study|Sponsor Ended Study|0|||
30830825|NCT02639182|58855046|FG001|Overall Study|Sponsor Ended Study|1|||
30830826|NCT02639182|58855045|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
30830827|NCT02639182|58855046|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
30830828|NCT02863419|58855055|FG000|Overall Study|Lost to Follow-up|0|||
30922603|NCT02064920|58957840|FG001|Overall Study|Physician Decision|1|||
30922604|NCT02064920|58957839|FG000|Overall Study|Technical Problems|0|||
30922605|NCT02064920|58957840|FG001|Overall Study|Technical Problems|1|||
30830829|NCT02863419|58855056|FG001|Overall Study|Lost to Follow-up|1|||
30830830|NCT02863419|58855057|FG002|Overall Study|Lost to Follow-up|4|||
30830831|NCT02863419|58855055|FG000|Overall Study|Withdrawal by Subject|5|||
30830832|NCT02863419|58855056|FG001|Overall Study|Withdrawal by Subject|5|||
30830833|NCT02863419|58855057|FG002|Overall Study|Withdrawal by Subject|3|||
30830834|NCT02863419|58855055|FG000|Overall Study|Died|3|||
30830835|NCT02863419|58855056|FG001|Overall Study|Died|4|||
30830836|NCT02863419|58855057|FG002|Overall Study|Died|1|||
30830837|NCT02765100|58855067|FG000|Overall Study|subject found ineligible after baseline|1|||
30830838|NCT02765100|58855068|FG001|Overall Study|subject found ineligible after baseline|1|||
30830839|NCT02765100|58855067|FG000|Overall Study|Lost to Follow-up|0|||
30830840|NCT02765100|58855068|FG001|Overall Study|Lost to Follow-up|1|||
30830841|NCT02761980|58855078|FG000|Overall Study|Adverse Event|4|||
30830842|NCT02761980|58855079|FG001|Overall Study|Adverse Event|6|||
30830843|NCT02761980|58855080|FG002|Overall Study|Adverse Event|5|||
30830844|NCT02761980|58855081|FG003|Overall Study|Adverse Event|6|||
30830845|NCT02761980|58855078|FG000|Overall Study|Withdrawal by Subject|0|||
30830846|NCT02761980|58855079|FG001|Overall Study|Withdrawal by Subject|1|||
30830847|NCT02761980|58855080|FG002|Overall Study|Withdrawal by Subject|0|||
30830848|NCT02761980|58855081|FG003|Overall Study|Withdrawal by Subject|0|||
30830849|NCT02761980|58855078|FG000|Overall Study|Other|0|||
30830850|NCT02761980|58855079|FG001|Overall Study|Other|0|||
30830851|NCT02761980|58855080|FG002|Overall Study|Other|1|||
30830852|NCT02761980|58855081|FG003|Overall Study|Other|0|||
30830853|NCT02862171|58855100|FG000|Overall Study|Death|1|||
30830854|NCT02862171|58855100|FG000|Overall Study|Lost to Follow-up|13|||
30830855|NCT02862171|58855100|FG000|Overall Study|Withdrawal by Subject|57|||
30830856|NCT02862171|58855100|FG000|Overall Study|Non-compliance|4|||
30830857|NCT02862171|58855100|FG000|Overall Study|HIV-1 seroconversion|18|||
30830858|NCT02638948|58855108|FG000|Overall Study|Withdrawal by Subject|4|||
30830859|NCT02638948|58855109|FG001|Overall Study|Withdrawal by Subject|5|||
30830860|NCT02638948|58855110|FG002|Overall Study|Withdrawal by Subject|3|||
30830861|NCT02638948|58855111|FG003|Overall Study|Withdrawal by Subject|1|||
30830862|NCT02638948|58855108|FG000|Overall Study|Administrative Reason by Sponsor|0|||
30830863|NCT02638948|58855109|FG001|Overall Study|Administrative Reason by Sponsor|1|||
30830864|NCT02638948|58855110|FG002|Overall Study|Administrative Reason by Sponsor|0|||
30830865|NCT02638948|58855111|FG003|Overall Study|Administrative Reason by Sponsor|4|||
30830866|NCT02638948|58855108|FG000|Overall Study|Adverse Event|0|||
30830867|NCT02638948|58855109|FG001|Overall Study|Adverse Event|0|||
30830868|NCT02638948|58855110|FG002|Overall Study|Adverse Event|1|||
30830869|NCT02638948|58855111|FG003|Overall Study|Adverse Event|1|||
30830870|NCT02638948|58855108|FG000|Overall Study|Lack of Efficacy|1|||
30830871|NCT02638948|58855109|FG001|Overall Study|Lack of Efficacy|1|||
30830872|NCT02638948|58855110|FG002|Overall Study|Lack of Efficacy|0|||
30830873|NCT02638948|58855111|FG003|Overall Study|Lack of Efficacy|0|||
30830874|NCT02638948|58855108|FG000|Overall Study|Lost to Follow-up|0|||
30830875|NCT02638948|58855109|FG001|Overall Study|Lost to Follow-up|0|||
30830876|NCT02638948|58855110|FG002|Overall Study|Lost to Follow-up|1|||
30830877|NCT02638948|58855111|FG003|Overall Study|Lost to Follow-up|1|||
30830878|NCT02638948|58855108|FG000|Overall Study|Poor/Non-Compliance|0|||
30830879|NCT02638948|58855109|FG001|Overall Study|Poor/Non-Compliance|2|||
30623505|NCT00917644|58635319|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
30755446|NCT04026568|58765237|FG001|Overall Study|study terminated|1|||
30755447|NCT04025632|58765245|FG000|Overall Study|Adverse Event|1|||
30755448|NCT04025632|58765246|FG001|Overall Study|Adverse Event|1|||
30755449|NCT04025632|58765245|FG000|Overall Study|Withdrawal by Subject|1|||
30755450|NCT04025632|58765246|FG001|Overall Study|Withdrawal by Subject|1|||
30755451|NCT04025632|58765245|FG000|Overall Study|Study Terminated by Sponsor|10|||
30755452|NCT04025632|58765246|FG001|Overall Study|Study Terminated by Sponsor|9|||
30755453|NCT04025632|58765245|FG000|Overall Study|Physician Decision|3|||
30755454|NCT04025632|58765246|FG001|Overall Study|Physician Decision|1|||
30755455|NCT04024228|58765257|FG000|Overall Study|Adverse Event|1|||
30755456|NCT04024228|58765258|FG001|Overall Study|Adverse Event|0|||
30755457|NCT04024228|58765257|FG000|Overall Study|Protocol Deviation|0|||
30755458|NCT04024228|58765258|FG001|Overall Study|Protocol Deviation|2|||
30830880|NCT02638948|58855110|FG002|Overall Study|Poor/Non-Compliance|1|||
30830881|NCT02638948|58855111|FG003|Overall Study|Poor/Non-Compliance|0|||
30830882|NCT02638948|58855108|FG000|Overall Study|Participant no longer met study criteria|0|||
30830883|NCT02638948|58855109|FG001|Overall Study|Participant no longer met study criteria|1|||
30755459|NCT04024228|58765257|FG000|Overall Study|Withdrawal by Subject|3|||
30755460|NCT04024228|58765258|FG001|Overall Study|Withdrawal by Subject|4|||
30755461|NCT04023994|58765272|FG000|Overall Study|Lost to Follow-up|0|||
30830884|NCT02638948|58855110|FG002|Overall Study|Participant no longer met study criteria|0|||
30830885|NCT02638948|58855111|FG003|Overall Study|Participant no longer met study criteria|0|||
30830886|NCT02638948|58855108|FG000|Overall Study|Other than specified above|4|||
30830887|NCT02638948|58855109|FG001|Overall Study|Other than specified above|1|||
30830888|NCT02638948|58855110|FG002|Overall Study|Other than specified above|1|||
30830889|NCT02638948|58855111|FG003|Overall Study|Other than specified above|1|||
30830890|NCT00102960|58855127|FG000|Overall Study|Death|23|||
30922606|NCT02064920|58957839|FG000|Overall Study|Withdrawal by Subject|1|||
30922607|NCT02064920|58957840|FG001|Overall Study|Withdrawal by Subject|3|||
30922608|NCT02151149|58957848|FG000|Treatment Period|Death|2|||
30922609|NCT02151149|58957849|FG001|Treatment Period|Death|3|||
30922610|NCT02151149|58957848|FG000|Treatment Period|Adverse Event|17|||
30922611|NCT02151149|58957849|FG001|Treatment Period|Adverse Event|14|||
30922612|NCT02151149|58957848|FG000|Treatment Period|Progressive Disease|25|||
30922613|NCT02151149|58957849|FG001|Treatment Period|Progressive Disease|24|||
30922614|NCT02151149|58957848|FG000|Treatment Period|Symptomatic Deterioration|2|||
30922615|NCT02151149|58957849|FG001|Treatment Period|Symptomatic Deterioration|10|||
30830891|NCT00102960|58855128|FG001|Overall Study|Death|11|||
30830892|NCT00102960|58855129|FG002|Overall Study|Death|11|||
30830893|NCT00102960|58855127|FG000|Overall Study|Lost to Follow-up|6|||
30830894|NCT00102960|58855128|FG001|Overall Study|Lost to Follow-up|12|||
30830895|NCT00102960|58855129|FG002|Overall Study|Lost to Follow-up|16|||
30830896|NCT00102960|58855127|FG000|Overall Study|Withdrawal by Subject|1|||
30830897|NCT00102960|58855128|FG001|Overall Study|Withdrawal by Subject|0|||
30922616|NCT02151149|58957848|FG000|Treatment Period|Withdrawal by Subject|13|||
30922617|NCT02151149|58957849|FG001|Treatment Period|Withdrawal by Subject|11|||
30922618|NCT02151149|58957848|FG000|Treatment Period|Miscellaneous|8|||
30922619|NCT02151149|58957849|FG001|Treatment Period|Miscellaneous|7|||
30922620|NCT02151149|58957848|FG000|Treatment Period|Participants randomized but not treated|3|||
30755462|NCT04023994|58765273|FG001|Overall Study|Lost to Follow-up|1|||
30755463|NCT04023994|58765274|FG002|Overall Study|Lost to Follow-up|2|||
30755464|NCT04023994|58765275|FG003|Overall Study|Lost to Follow-up|0|||
30755465|NCT04023994|58765276|FG004|Overall Study|Lost to Follow-up|0|||
30755466|NCT04023994|58765277|FG005|Overall Study|Lost to Follow-up|0|||
30755467|NCT04023994|58765272|FG000|Overall Study|Withdrawal by Subject|0|||
30623506|NCT00917644|58635320|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
30755468|NCT04023994|58765273|FG001|Overall Study|Withdrawal by Subject|0|||
30755469|NCT04023994|58765274|FG002|Overall Study|Withdrawal by Subject|0|||
30755470|NCT04023994|58765275|FG003|Overall Study|Withdrawal by Subject|1|||
30755471|NCT04023994|58765276|FG004|Overall Study|Withdrawal by Subject|0|||
30755472|NCT04023994|58765277|FG005|Overall Study|Withdrawal by Subject|0|||
30755473|NCT04023682|58765296|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
30755474|NCT04018612|58765307|FG000|Overall Study|Withdrawal by Subject|1|||
30755475|NCT04018612|58765308|FG001|Overall Study|Withdrawal by Subject|0|||
30755476|NCT04018612|58765309|FG002|Overall Study|Withdrawal by Subject|1|||
30755477|NCT04018066|58765317|FG000|Overall Study|participants started taking medications during the study period|3|||
30755478|NCT04018066|58765317|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
30755479|NCT04209400|58765324|FG000|Overall Study|Withdrawal by Subject|0|||
30755480|NCT04209400|58765325|FG001|Overall Study|Withdrawal by Subject|1|||
30755481|NCT04207840|58765331|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
30755482|NCT04207840|58765332|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
30755483|NCT04207840|58765333|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
30755484|NCT04207840|58765331|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
30755485|NCT04207840|58765332|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
30755486|NCT04207840|58765333|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
30755487|NCT04006366|58765341|FG000|Overall Study|Withdrawal by Subject|1|||
30755488|NCT04191148|58765347|FG000|Overall Study|Withdrawal by Subject|1|||
30755489|NCT04191148|58765348|FG001|Overall Study|Withdrawal by Subject|0|||
30755490|NCT04191148|58765347|FG000|Overall Study|Adverse Event|1|||
30755491|NCT04191148|58765348|FG001|Overall Study|Adverse Event|0|||
30830898|NCT00102960|58855129|FG002|Overall Study|Withdrawal by Subject|1|||
30830899|NCT02858895|58855141|FG000|Overall Study|Disease progression|31|||
30830900|NCT02858895|58855141|FG000|Overall Study|Death|2|||
30922621|NCT02151149|58957849|FG001|Treatment Period|Participants randomized but not treated|2|||
30922622|NCT02151149|58957848|FG000|Follow-Up Period|Lost to Follow-up|2|||
30922623|NCT02151149|58957849|FG001|Follow-Up Period|Lost to Follow-up|3|||
30755492|NCT04004260|58765358|FG000|Overall Study|Withdrawal by Subject|7|||
30830901|NCT02858895|58855141|FG000|Overall Study|Adverse Event|1|||
30755493|NCT04004260|58765359|FG001|Overall Study|Withdrawal by Subject|3|||
30755494|NCT04004260|58765358|FG000|Overall Study|Lost to Follow-up|22|||
30830902|NCT02858895|58855141|FG000|Overall Study|Withdrawal by Subject|3|||
30830903|NCT02858895|58855141|FG000|Overall Study|hospice,|1|||
30922624|NCT02151149|58957848|FG000|Follow-Up Period|Death|37|||
30922625|NCT02151149|58957849|FG001|Follow-Up Period|Death|34|||
30830904|NCT02858895|58855141|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
30830905|NCT02637856|58855152|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
30830906|NCT02637856|58855153|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
30830907|NCT02637856|58855152|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
30830908|NCT02637856|58855153|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
30830909|NCT02637856|58855152|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
30830910|NCT02637856|58855153|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
30830911|NCT02637856|58855152|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
30830912|NCT02637856|58855153|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
30830913|NCT02637856|58855152|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
30830914|NCT02637856|58855153|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
30830915|NCT02637856|58855152|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
30830916|NCT02637856|58855153|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
30830917|NCT02637856|58855152|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
30830918|NCT02637856|58855153|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
30830919|NCT02637856|58855152|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
30830920|NCT02637856|58855153|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
30830921|NCT02637856|58855152|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
30830922|NCT02637856|58855153|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
30830923|NCT02637856|58855152|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
30830924|NCT02637856|58855153|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
30830925|NCT02637856|58855152|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
30830926|NCT02637856|58855153|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
30830927|NCT02637856|58855152|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
30830928|NCT02637856|58855153|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
30830929|NCT02637856|58855152|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
30830930|NCT02637856|58855153|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
30830931|NCT02858037|58855159|FG000|Overall Study|Death|1|||
30830932|NCT02858037|58855159|FG000|Overall Study|Withdrawal by Subject|18|||
30830933|NCT02858037|58855159|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
30830934|NCT02858037|58855159|FG000|Overall Study|Lost to Follow-up|3|||
30830935|NCT02858037|58855159|FG000|Overall Study|Other|4|||
30830936|NCT02856555|58855166|FG000|Overall Study|Adverse Event|1|||
30830937|NCT02856555|58855167|FG001|Overall Study|Adverse Event|0|||
30830938|NCT02856555|58855168|FG002|Overall Study|Adverse Event|0|||
30830939|NCT02856555|58855166|FG000|Overall Study|Lost to Follow-up|1|||
30830940|NCT02856555|58855167|FG001|Overall Study|Lost to Follow-up|3|||
30830941|NCT02856555|58855168|FG002|Overall Study|Lost to Follow-up|0|||
30830942|NCT02856555|58855166|FG000|Overall Study|Withdrawal by Subject|3|||
30830943|NCT02856555|58855167|FG001|Overall Study|Withdrawal by Subject|0|||
30830944|NCT02856555|58855168|FG002|Overall Study|Withdrawal by Subject|0|||
30830945|NCT02856555|58855166|FG000|Overall Study|Randomized but Never Treated|0|||
30830946|NCT02856555|58855167|FG001|Overall Study|Randomized but Never Treated|1|||
30830947|NCT02856555|58855168|FG002|Overall Study|Randomized but Never Treated|0|||
30830948|NCT02637232|58855206|FG000|Overall Study|Lost to Follow-up|42|||
30830949|NCT02637232|58855206|FG000|Overall Study|Adverse Event|11|||
30830950|NCT02637232|58855206|FG000|Overall Study|patient 's decision|2|||
30830951|NCT02855541|58855210|FG000|Overall Study|Change in health status|2|||
30830952|NCT02855541|58855210|FG000|Overall Study|Withdrawal by Subject|2|||
30830953|NCT02635984|58855216|FG000|Overall Study|Lost to Follow-up|2|||
30830954|NCT02635984|58855217|FG001|Overall Study|Lost to Follow-up|4|||
30830955|NCT02635984|58855216|FG000|Overall Study|Study Arm Closed|1|||
30830956|NCT02635984|58855217|FG001|Overall Study|Study Arm Closed|0|||
30830957|NCT01147653|58855225|FG000|Year 2|Withdrawal by Subject|2|||
30830958|NCT01147653|58855226|FG001|Year 2|Withdrawal by Subject|3|||
30830959|NCT02747043|58855247|FG000|Overall Study|Other|1|||
30830960|NCT02747043|58855248|FG001|Overall Study|Other|1|||
30830961|NCT02747043|58855247|FG000|Overall Study|Adverse Event|3|||
30830962|NCT02747043|58855248|FG001|Overall Study|Adverse Event|1|||
30830963|NCT02747043|58855247|FG000|Overall Study|Withdrawal by Subject|1|||
30830964|NCT02747043|58855248|FG001|Overall Study|Withdrawal by Subject|1|||
30830965|NCT02747043|58855247|FG000|Overall Study|Physician Decision|1|||
30830966|NCT02747043|58855248|FG001|Overall Study|Physician Decision|1|||
30830967|NCT02747043|58855247|FG000|Overall Study|Protocol Violation|0|||
30830968|NCT02747043|58855248|FG001|Overall Study|Protocol Violation|1|||
30830969|NCT02747043|58855247|FG000|Overall Study|Disease progression|4|||
30830970|NCT02747043|58855248|FG001|Overall Study|Disease progression|0|||
30830971|NCT02637076|58855256|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
30830972|NCT02637076|58855257|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
30830973|NCT02637076|58855256|FG000|Overall Study|Withdrawal by Subject|0|||
30830974|NCT02637076|58855257|FG001|Overall Study|Withdrawal by Subject|4|||
30830975|NCT02854605|58855266|FG000|Overall Study|Adverse Event|1|||
30830976|NCT02854605|58855267|FG001|Overall Study|Adverse Event|5|||
30830977|NCT02854605|58855268|FG002|Overall Study|Adverse Event|2|||
30830978|NCT02854605|58855266|FG000|Overall Study|Lost to Follow-up|0|||
30830979|NCT02854605|58855267|FG001|Overall Study|Lost to Follow-up|2|||
30830980|NCT02854605|58855268|FG002|Overall Study|Lost to Follow-up|0|||
30830981|NCT02854605|58855266|FG000|Overall Study|Withdrew Consent|1|||
30830982|NCT02854605|58855267|FG001|Overall Study|Withdrew Consent|0|||
30830983|NCT02854605|58855268|FG002|Overall Study|Withdrew Consent|1|||
30830984|NCT02854605|58855266|FG000|Overall Study|Investigator's Discretion|1|||
30830985|NCT02854605|58855267|FG001|Overall Study|Investigator's Discretion|0|||
30830986|NCT02854605|58855268|FG002|Overall Study|Investigator's Discretion|0|||
30830987|NCT02854605|58855266|FG000|Overall Study|Protocol Violation|0|||
30830988|NCT02854605|58855267|FG001|Overall Study|Protocol Violation|0|||
30830989|NCT02854605|58855268|FG002|Overall Study|Protocol Violation|1|||
30830990|NCT02854527|58855286|FG000|Overall Study|Adverse Event|0|||
30830991|NCT02854527|58855287|FG001|Overall Study|Adverse Event|0|||
30830992|NCT02854527|58855288|FG002|Overall Study|Adverse Event|0|||
30830993|NCT02854527|58855289|FG003|Overall Study|Adverse Event|0|||
30830994|NCT02854527|58855290|FG004|Overall Study|Adverse Event|1|||
30830995|NCT02854527|58855291|FG005|Overall Study|Adverse Event|0|||
30830996|NCT02854527|58855292|FG006|Overall Study|Adverse Event|0|||
30830997|NCT02854527|58855293|FG007|Overall Study|Adverse Event|0|||
30830998|NCT02854527|58855294|FG008|Overall Study|Adverse Event|0|||
30830999|NCT02854527|58855295|FG009|Overall Study|Adverse Event|0|||
30831000|NCT02854527|58855286|FG000|Overall Study|Lost to Follow-up|0|||
30831001|NCT02854527|58855287|FG001|Overall Study|Lost to Follow-up|0|||
30831002|NCT02854527|58855288|FG002|Overall Study|Lost to Follow-up|0|||
30831003|NCT02854527|58855289|FG003|Overall Study|Lost to Follow-up|1|||
30831004|NCT02854527|58855290|FG004|Overall Study|Lost to Follow-up|0|||
30831005|NCT02854527|58855291|FG005|Overall Study|Lost to Follow-up|0|||
30831006|NCT02854527|58855292|FG006|Overall Study|Lost to Follow-up|0|||
30831007|NCT02854527|58855293|FG007|Overall Study|Lost to Follow-up|0|||
30831008|NCT02854527|58855294|FG008|Overall Study|Lost to Follow-up|0|||
30831009|NCT02854527|58855295|FG009|Overall Study|Lost to Follow-up|0|||
30831010|NCT02853435|58855322|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
30831011|NCT02853435|58855323|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
30831012|NCT02853435|58855324|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
30831013|NCT02853435|58855325|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
30831014|NCT02853435|58855326|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
30831015|NCT02853435|58855327|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
30831016|NCT02635204|58855359|FG000|Overall Study|Adverse Event|1|||
30831017|NCT02635204|58855360|FG001|Overall Study|Adverse Event|0|||
30831018|NCT02635204|58855359|FG000|Overall Study|Lost to Follow-up|1|||
30831019|NCT02635204|58855360|FG001|Overall Study|Lost to Follow-up|1|||
30755495|NCT04004260|58765359|FG001|Overall Study|Lost to Follow-up|12|||
30755496|NCT04004260|58765358|FG000|Overall Study|Did not engage in intervention|13|||
30755497|NCT04004260|58765359|FG001|Overall Study|Did not engage in intervention|17|||
30755498|NCT04470622|58765367|FG000|Overall Study|Withdrawal by Subject|0|||
30755499|NCT04470622|58765368|FG001|Overall Study|Withdrawal by Subject|1|||
30755500|NCT04470622|58765367|FG000|Overall Study|Screen Failure|0|||
30755501|NCT04470622|58765368|FG001|Overall Study|Screen Failure|1|||
30755502|NCT04470622|58765367|FG000|Overall Study|Death|0|||
30755503|NCT04470622|58765368|FG001|Overall Study|Death|1|||
30755504|NCT04465630|58765374|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
30755505|NCT04465630|58765374|FG000|Overall Study|Screen failure|8|||
30755506|NCT04465630|58765374|FG000|Overall Study|Baseline failure|16|||
30831020|NCT00102804|58855368|FG000|Overall Study|Progressive Disease (PD)|307|||
30831021|NCT00102804|58855369|FG001|Overall Study|Progressive Disease (PD)|196|||
30831022|NCT00102804|58855368|FG000|Overall Study|Withdrawal by Subject|46|||
30831023|NCT00102804|58855369|FG001|Overall Study|Withdrawal by Subject|7|||
30831024|NCT00102804|58855368|FG000|Overall Study|Adverse Event|37|||
30831025|NCT00102804|58855369|FG001|Overall Study|Adverse Event|3|||
30831026|NCT00102804|58855368|FG000|Overall Study|Physician Decision|24|||
30831027|NCT00102804|58855369|FG001|Overall Study|Physician Decision|6|||
30831028|NCT00102804|58855368|FG000|Overall Study|Death|5|||
30831029|NCT00102804|58855369|FG001|Overall Study|Death|6|||
30831030|NCT00102804|58855368|FG000|Overall Study|Enrollment Criteria Not Met|6|||
30831031|NCT00102804|58855369|FG001|Overall Study|Enrollment Criteria Not Met|0|||
30831032|NCT00102804|58855368|FG000|Overall Study|Lost to Follow-up|4|||
30831033|NCT00102804|58855369|FG001|Overall Study|Lost to Follow-up|1|||
30831034|NCT00102804|58855368|FG000|Overall Study|Protocol Violation|2|||
30831035|NCT00102804|58855369|FG001|Overall Study|Protocol Violation|1|||
30831036|NCT00102804|58855368|FG000|Overall Study|Satisfactory Response|2|||
30831037|NCT00102804|58855369|FG001|Overall Study|Satisfactory Response|0|||
30831038|NCT00102804|58855368|FG000|Overall Study|Sponsor Decision|1|||
30831039|NCT00102804|58855369|FG001|Overall Study|Sponsor Decision|0|||
30831040|NCT00102804|58855368|FG000|Overall Study|Alive, Receiving Treatment|7|||
30831041|NCT00102804|58855369|FG001|Overall Study|Alive, Receiving Treatment|2|||
30831042|NCT01814072|58855407|FG000|Overall Study|Lost to Follow-up|2|||
30922626|NCT02150213|58957855|FG000|Overall Study|Lost to Follow-up|1|||
30922627|NCT02150213|58957855|FG000|Overall Study|Withdrawal by Subject|1|||
30922628|NCT02091362|58957861|FG000|Period 1|Protocol Violation|1|||
30922629|NCT02091362|58957862|FG001|Period 1|Protocol Violation|0|||
30922630|NCT02091362|58957861|FG000|Period 1|Withdrawal by Subject|2|||
30831043|NCT01814072|58855408|FG001|Overall Study|Lost to Follow-up|2|||
30831044|NCT01814072|58855409|FG002|Overall Study|Lost to Follow-up|2|||
30831045|NCT01814072|58855410|FG003|Overall Study|Lost to Follow-up|0|||
30831046|NCT01814072|58855411|FG004|Overall Study|Lost to Follow-up|2|||
30831047|NCT01814072|58855412|FG005|Overall Study|Lost to Follow-up|3|||
30831048|NCT01814072|58855413|FG006|Overall Study|Lost to Follow-up|3|||
30831049|NCT01814072|58855414|FG007|Overall Study|Lost to Follow-up|1|||
30831050|NCT01814072|58855415|FG008|Overall Study|Lost to Follow-up|2|||
30831051|NCT01814072|58855416|FG009|Overall Study|Lost to Follow-up|3|||
30831052|NCT01814072|58855417|FG010|Overall Study|Lost to Follow-up|1|||
30831053|NCT01814072|58855418|FG011|Overall Study|Lost to Follow-up|2|||
30831054|NCT01814072|58855419|FG012|Overall Study|Lost to Follow-up|2|||
30831055|NCT01814072|58855420|FG013|Overall Study|Lost to Follow-up|1|||
30831056|NCT01814072|58855421|FG014|Overall Study|Lost to Follow-up|2|||
30831057|NCT01814072|58855422|FG015|Overall Study|Lost to Follow-up|1|||
30831058|NCT01814072|58855423|FG016|Overall Study|Lost to Follow-up|3|||
30831059|NCT01814072|58855424|FG017|Overall Study|Lost to Follow-up|1|||
30831060|NCT01814072|58855425|FG018|Overall Study|Lost to Follow-up|3|||
30831061|NCT01814072|58855426|FG019|Overall Study|Lost to Follow-up|3|||
30831062|NCT01814072|58855427|FG020|Overall Study|Lost to Follow-up|2|||
30831063|NCT01814072|58855428|FG021|Overall Study|Lost to Follow-up|1|||
30831064|NCT01814072|58855429|FG022|Overall Study|Lost to Follow-up|3|||
30831065|NCT01814072|58855430|FG023|Overall Study|Lost to Follow-up|1|||
30831066|NCT01814072|58855431|FG024|Overall Study|Lost to Follow-up|4|||
30831067|NCT01814072|58855432|FG025|Overall Study|Lost to Follow-up|1|||
30831068|NCT01814072|58855433|FG026|Overall Study|Lost to Follow-up|1|||
30831069|NCT01814072|58855434|FG027|Overall Study|Lost to Follow-up|2|||
30831070|NCT01814072|58855435|FG028|Overall Study|Lost to Follow-up|3|||
30831071|NCT01814072|58855436|FG029|Overall Study|Lost to Follow-up|3|||
30831072|NCT01814072|58855437|FG030|Overall Study|Lost to Follow-up|2|||
30831073|NCT01814072|58855438|FG031|Overall Study|Lost to Follow-up|0|||
30831074|NCT01814072|58855407|FG000|Overall Study|Withdrawal by Subject|2|||
30831075|NCT01814072|58855408|FG001|Overall Study|Withdrawal by Subject|0|||
30831076|NCT01814072|58855409|FG002|Overall Study|Withdrawal by Subject|1|||
30831077|NCT01814072|58855410|FG003|Overall Study|Withdrawal by Subject|0|||
30922631|NCT02091362|58957862|FG001|Period 1|Withdrawal by Subject|3|||
30922632|NCT02091362|58957861|FG000|Period 1|Lost to Follow-up|0|||
30922633|NCT02091362|58957862|FG001|Period 1|Lost to Follow-up|1|||
30831078|NCT01814072|58855411|FG004|Overall Study|Withdrawal by Subject|2|||
30922634|NCT02091362|58957861|FG000|Period 1|Adverse Event|2|||
30831079|NCT01814072|58855412|FG005|Overall Study|Withdrawal by Subject|3|||
30922635|NCT02091362|58957862|FG001|Period 1|Adverse Event|0|||
30831080|NCT01814072|58855413|FG006|Overall Study|Withdrawal by Subject|1|||
30831081|NCT01814072|58855414|FG007|Overall Study|Withdrawal by Subject|0|||
30831082|NCT01814072|58855415|FG008|Overall Study|Withdrawal by Subject|1|||
30831083|NCT01814072|58855416|FG009|Overall Study|Withdrawal by Subject|2|||
30831084|NCT01814072|58855417|FG010|Overall Study|Withdrawal by Subject|0|||
30831085|NCT01814072|58855418|FG011|Overall Study|Withdrawal by Subject|0|||
30831086|NCT01814072|58855419|FG012|Overall Study|Withdrawal by Subject|1|||
30922636|NCT02091362|58957861|FG000|Wash-out|Lost to Follow-up|1|||
30922637|NCT02091362|58957862|FG001|Wash-out|Lost to Follow-up|1|||
30922638|NCT02091362|58957861|FG000|Wash-out|Withdrawal by Subject|0|||
30831087|NCT01814072|58855420|FG013|Overall Study|Withdrawal by Subject|1|||
30831088|NCT01814072|58855421|FG014|Overall Study|Withdrawal by Subject|1|||
30831089|NCT01814072|58855422|FG015|Overall Study|Withdrawal by Subject|1|||
30831090|NCT01814072|58855423|FG016|Overall Study|Withdrawal by Subject|0|||
30922639|NCT02091362|58957862|FG001|Wash-out|Withdrawal by Subject|2|||
30831091|NCT01814072|58855424|FG017|Overall Study|Withdrawal by Subject|0|||
30831092|NCT01814072|58855425|FG018|Overall Study|Withdrawal by Subject|0|||
30831093|NCT01814072|58855426|FG019|Overall Study|Withdrawal by Subject|2|||
30831094|NCT01814072|58855427|FG020|Overall Study|Withdrawal by Subject|0|||
30831095|NCT01814072|58855428|FG021|Overall Study|Withdrawal by Subject|0|||
30831096|NCT01814072|58855429|FG022|Overall Study|Withdrawal by Subject|1|||
30831097|NCT01814072|58855430|FG023|Overall Study|Withdrawal by Subject|0|||
30831098|NCT01814072|58855431|FG024|Overall Study|Withdrawal by Subject|2|||
30831099|NCT01814072|58855432|FG025|Overall Study|Withdrawal by Subject|1|||
30831100|NCT01814072|58855433|FG026|Overall Study|Withdrawal by Subject|1|||
30831101|NCT01814072|58855434|FG027|Overall Study|Withdrawal by Subject|2|||
30831102|NCT01814072|58855435|FG028|Overall Study|Withdrawal by Subject|1|||
30831103|NCT01814072|58855436|FG029|Overall Study|Withdrawal by Subject|0|||
30831104|NCT01814072|58855437|FG030|Overall Study|Withdrawal by Subject|0|||
30831105|NCT01814072|58855438|FG031|Overall Study|Withdrawal by Subject|0|||
30831106|NCT03038113|58855493|FG000|Overall Study|Withdrawal by Subject|0|||
30922640|NCT02091362|58957861|FG000|Period 2|Adverse Event|1|||
30922641|NCT02091362|58957862|FG001|Period 2|Adverse Event|0|||
30922642|NCT02091362|58957861|FG000|Period 2|Lost to Follow-up|0|||
30922643|NCT02091362|58957862|FG001|Period 2|Lost to Follow-up|1|||
30922644|NCT02091362|58957861|FG000|Period 2|Withdrawal by Subject|1|||
30922645|NCT02091362|58957862|FG001|Period 2|Withdrawal by Subject|1|||
30922646|NCT02150057|58957874|FG000|Overall Study|Lost to Follow-up|6|||
30831107|NCT03038113|58855494|FG001|Overall Study|Withdrawal by Subject|0|||
30831108|NCT03038113|58855495|FG002|Overall Study|Withdrawal by Subject|1|||
30831109|NCT03038113|58855496|FG003|Overall Study|Withdrawal by Subject|0|||
30831110|NCT03038113|58855497|FG004|Overall Study|Withdrawal by Subject|0|||
30831111|NCT03038113|58855498|FG005|Overall Study|Withdrawal by Subject|0|||
30831112|NCT03038113|58855499|FG006|Overall Study|Withdrawal by Subject|0|||
30831113|NCT03038113|58855500|FG007|Overall Study|Withdrawal by Subject|0|||
30831114|NCT03038113|58855501|FG008|Overall Study|Withdrawal by Subject|0|||
30831115|NCT03038113|58855502|FG009|Overall Study|Withdrawal by Subject|0|||
30831116|NCT03038113|58855503|FG010|Overall Study|Withdrawal by Subject|0|||
30831117|NCT03038113|58855504|FG011|Overall Study|Withdrawal by Subject|0|||
30831118|NCT03038113|58855505|FG012|Overall Study|Withdrawal by Subject|0|||
30831119|NCT03038113|58855506|FG013|Overall Study|Withdrawal by Subject|1|||
30831120|NCT03038113|58855493|FG000|Overall Study|Lost to Follow-up|0|||
30831121|NCT03038113|58855494|FG001|Overall Study|Lost to Follow-up|0|||
30831122|NCT03038113|58855495|FG002|Overall Study|Lost to Follow-up|0|||
30922647|NCT02150057|58957875|FG001|Overall Study|Lost to Follow-up|4|||
30922648|NCT02064296|58957884|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
30922649|NCT02064296|58957885|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
30922650|NCT02064296|58957886|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
30831123|NCT03038113|58855496|FG003|Overall Study|Lost to Follow-up|0|||
30831124|NCT03038113|58855497|FG004|Overall Study|Lost to Follow-up|0|||
30831125|NCT03038113|58855498|FG005|Overall Study|Lost to Follow-up|0|||
30922651|NCT02064296|58957884|FG000|Intervention|Withdrawal by Subject|0|||
30922652|NCT02064296|58957885|FG001|Intervention|Withdrawal by Subject|1|||
30922653|NCT02064296|58957886|FG002|Intervention|Withdrawal by Subject|2|||
30922654|NCT02063984|58957898|FG000|Overall Study|Lost to Follow-up|6|||
30922655|NCT02063984|58957899|FG001|Overall Study|Lost to Follow-up|5|||
30922656|NCT02091284|58957911|FG000|Overall Study|Withdrawal by Subject|2|||
30922657|NCT02091284|58957912|FG001|Overall Study|Withdrawal by Subject|1|||
30922658|NCT02091284|58957911|FG000|Overall Study|unreliable data|1|||
30922659|NCT02091284|58957912|FG001|Overall Study|unreliable data|0|||
30922660|NCT02115386|58957920|FG000|Overall Study|Protocol Violation|1|||
30922661|NCT02115386|58957920|FG000|Overall Study|Administrative - trial was terminated|6|||
30922662|NCT02091206|58957928|FG000|Treatment Period|Adverse Event|0|||
30922663|NCT02091206|58957929|FG001|Treatment Period|Adverse Event|1|||
30922664|NCT02091206|58957930|FG002|Treatment Period|Adverse Event|0|||
30922665|NCT02091206|58957931|FG003|Treatment Period|Adverse Event|0|||
30922666|NCT02091206|58957928|FG000|Treatment Period|Met withdrawal criteria|0|||
30922667|NCT02091206|58957929|FG001|Treatment Period|Met withdrawal criteria|0|||
30922668|NCT02091206|58957930|FG002|Treatment Period|Met withdrawal criteria|1|||
30831126|NCT03038113|58855499|FG006|Overall Study|Lost to Follow-up|1|||
30922669|NCT02091206|58957931|FG003|Treatment Period|Met withdrawal criteria|0|||
30831127|NCT03038113|58855500|FG007|Overall Study|Lost to Follow-up|0|||
30831128|NCT03038113|58855501|FG008|Overall Study|Lost to Follow-up|0|||
30831129|NCT03038113|58855502|FG009|Overall Study|Lost to Follow-up|0|||
30831130|NCT03038113|58855503|FG010|Overall Study|Lost to Follow-up|0|||
30922670|NCT02091206|58957928|FG000|Taper Period|Participant refused study drug|1|||
30831131|NCT03038113|58855504|FG011|Overall Study|Lost to Follow-up|0|||
30831132|NCT03038113|58855505|FG012|Overall Study|Lost to Follow-up|0|||
30831133|NCT03038113|58855506|FG013|Overall Study|Lost to Follow-up|0|||
30922671|NCT02091206|58957929|FG001|Taper Period|Participant refused study drug|0|||
30922672|NCT02091206|58957930|FG002|Taper Period|Participant refused study drug|0|||
30831134|NCT00968149|58855555|FG000|Overall Study|Adverse Event|5|||
30831135|NCT00968149|58855556|FG001|Overall Study|Adverse Event|1|||
30831136|NCT00968149|58855555|FG000|Overall Study|Lack of Efficacy|0|||
30831137|NCT00968149|58855556|FG001|Overall Study|Lack of Efficacy|4|||
30831138|NCT00968149|58855555|FG000|Overall Study|Lost to Follow-up|0|||
30831139|NCT00968149|58855556|FG001|Overall Study|Lost to Follow-up|1|||
30922673|NCT02091206|58957931|FG003|Taper Period|Participant refused study drug|1|||
30922674|NCT02091206|58957928|FG000|Taper Period|Lost to Follow-up|0|||
30831140|NCT00968149|58855555|FG000|Overall Study|Protocol Violation|4|||
30831141|NCT00968149|58855556|FG001|Overall Study|Protocol Violation|0|||
30831142|NCT00968149|58855555|FG000|Overall Study|Withdrawal by Subject|2|||
30831143|NCT00968149|58855556|FG001|Overall Study|Withdrawal by Subject|0|||
30922675|NCT02091206|58957929|FG001|Taper Period|Lost to Follow-up|0|||
30922676|NCT02091206|58957930|FG002|Taper Period|Lost to Follow-up|0|||
30922677|NCT02091206|58957931|FG003|Taper Period|Lost to Follow-up|1|||
30922678|NCT02090426|58957943|FG000|Overall Study|Lost to Follow-up|12|||
30831144|NCT00963469|58855565|FG000|Overall Study|Adverse Event|15|||
30831145|NCT00963469|58855566|FG001|Overall Study|Adverse Event|11|||
30831146|NCT00963469|58855567|FG002|Overall Study|Adverse Event|1|||
30831147|NCT00963469|58855565|FG000|Overall Study|Lack of Efficacy|10|||
30831148|NCT00963469|58855566|FG001|Overall Study|Lack of Efficacy|7|||
30831149|NCT00963469|58855567|FG002|Overall Study|Lack of Efficacy|2|||
30831150|NCT00963469|58855565|FG000|Overall Study|Lost to Follow-up|1|||
30831151|NCT00963469|58855566|FG001|Overall Study|Lost to Follow-up|1|||
30831152|NCT00963469|58855567|FG002|Overall Study|Lost to Follow-up|0|||
30831153|NCT00963469|58855565|FG000|Overall Study|Protocol Violation|5|||
30831154|NCT00963469|58855566|FG001|Overall Study|Protocol Violation|5|||
30831155|NCT00963469|58855567|FG002|Overall Study|Protocol Violation|3|||
30831156|NCT00963469|58855565|FG000|Overall Study|Withdrawal by Subject|4|||
30831157|NCT00963469|58855566|FG001|Overall Study|Withdrawal by Subject|1|||
30831158|NCT00963469|58855567|FG002|Overall Study|Withdrawal by Subject|1|||
30831159|NCT00963469|58855565|FG000|Overall Study|Pre-randomization Adverse Event|1|||
30831160|NCT00963469|58855566|FG001|Overall Study|Pre-randomization Adverse Event|2|||
30831161|NCT00963469|58855567|FG002|Overall Study|Pre-randomization Adverse Event|0|||
30831162|NCT00963469|58855565|FG000|Overall Study|Moved|1|||
30831163|NCT00963469|58855566|FG001|Overall Study|Moved|0|||
30831164|NCT00963469|58855567|FG002|Overall Study|Moved|0|||
30831165|NCT00963469|58855565|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
30922679|NCT02090426|58957944|FG001|Overall Study|Lost to Follow-up|6|||
30831166|NCT00963469|58855566|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
30831167|NCT00963469|58855567|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
30922680|NCT02063828|58957953|FG000|Overall Study|Withdrawal by Subject|4|||
30922681|NCT02063828|58957954|FG001|Overall Study|Withdrawal by Subject|6|||
30922682|NCT02063828|58957955|FG002|Overall Study|Withdrawal by Subject|3|||
30922683|NCT02063828|58957953|FG000|Overall Study|Death|0|||
30922684|NCT02063828|58957954|FG001|Overall Study|Death|0|||
30922685|NCT02063828|58957955|FG002|Overall Study|Death|1|||
30922686|NCT02063672|58957965|FG000|Overall Study|Ongoing Follow-up|27|||
30922687|NCT02063672|58957966|FG001|Overall Study|Ongoing Follow-up|14|||
30922688|NCT02063672|58957965|FG000|Overall Study|Death|5|||
30922689|NCT02063672|58957966|FG001|Overall Study|Death|3|||
30922690|NCT02063672|58957965|FG000|Overall Study|Lost to Follow-up|1|||
30922691|NCT02063672|58957966|FG001|Overall Study|Lost to Follow-up|3|||
30922692|NCT02063672|58957965|FG000|Overall Study|Withdrawal by Subject|2|||
30922693|NCT02063672|58957966|FG001|Overall Study|Withdrawal by Subject|2|||
30922694|NCT02062658|58957972|FG000|Overall Study|Withdrawal by Subject|1|||
30922695|NCT02062658|58957972|FG000|Overall Study|Lack of Efficacy|1|||
30922696|NCT02115308|58957978|FG000|Overall Study|Safety Screening|2|||
30922697|NCT02115308|58957979|FG001|Overall Study|Safety Screening|2|||
30922698|NCT02114684|58957991|FG000|Overall Study|Death|6|||
30922699|NCT02114684|58957992|FG001|Overall Study|Death|4|||
30922700|NCT02114684|58957991|FG000|Overall Study|Lost to Follow-up|1|||
30922701|NCT02114684|58957992|FG001|Overall Study|Lost to Follow-up|2|||
30623507|NCT00917644|58635319|FG000|Period 2: Second Intervention|family emergency|1|||
30623508|NCT00917644|58635320|FG001|Period 2: Second Intervention|family emergency|0|||
30831168|NCT00897949|58855578|FG000|Overall Study|Adverse Event|1|||
30831169|NCT00897949|58855579|FG001|Overall Study|Adverse Event|1|||
30831170|NCT00897949|58855580|FG002|Overall Study|Adverse Event|0|||
30831171|NCT00897949|58855578|FG000|Overall Study|Lost to Follow-up|0|||
30831172|NCT00897949|58855579|FG001|Overall Study|Lost to Follow-up|2|||
30831173|NCT00897949|58855580|FG002|Overall Study|Lost to Follow-up|1|||
30831174|NCT00897949|58855578|FG000|Overall Study|Protocol Violation|6|||
30831175|NCT00897949|58855579|FG001|Overall Study|Protocol Violation|3|||
30831176|NCT00897949|58855580|FG002|Overall Study|Protocol Violation|1|||
30831177|NCT00897949|58855578|FG000|Overall Study|Withdrawal by Subject|1|||
30922702|NCT02114684|58957991|FG000|Overall Study|Withdrawal by Subject|1|||
30922703|NCT02114684|58957992|FG001|Overall Study|Withdrawal by Subject|2|||
30922704|NCT02114684|58957991|FG000|Overall Study|Relocation|3|||
30831178|NCT00897949|58855579|FG001|Overall Study|Withdrawal by Subject|2|||
30831179|NCT00897949|58855580|FG002|Overall Study|Withdrawal by Subject|0|||
30831180|NCT00897949|58855578|FG000|Overall Study|Patient Uncoorperative|0|||
30831181|NCT00897949|58855579|FG001|Overall Study|Patient Uncoorperative|2|||
30831182|NCT00897949|58855580|FG002|Overall Study|Patient Uncoorperative|1|||
30831183|NCT00897949|58855578|FG000|Overall Study|Lost to Follow-up|30|||
30831184|NCT00897949|58855579|FG001|Overall Study|Lost to Follow-up|23|||
30831185|NCT00897949|58855580|FG002|Overall Study|Lost to Follow-up|17|||
30831186|NCT00897949|58855578|FG000|Overall Study|Withdrawal by Subject|24|||
30831187|NCT00897949|58855579|FG001|Overall Study|Withdrawal by Subject|31|||
30831188|NCT00897949|58855580|FG002|Overall Study|Withdrawal by Subject|17|||
30831189|NCT00897949|58855578|FG000|Overall Study|Abnormal Prestudy Labs|2|||
30831190|NCT00897949|58855579|FG001|Overall Study|Abnormal Prestudy Labs|3|||
30831191|NCT00897949|58855580|FG002|Overall Study|Abnormal Prestudy Labs|4|||
30831192|NCT00897949|58855578|FG000|Overall Study|Abnormal Baseline ECG|2|||
30831193|NCT00897949|58855579|FG001|Overall Study|Abnormal Baseline ECG|2|||
30831194|NCT00897949|58855580|FG002|Overall Study|Abnormal Baseline ECG|4|||
30831195|NCT00897949|58855578|FG000|Overall Study|Need for Concom. Med.|0|||
30831196|NCT00897949|58855579|FG001|Overall Study|Need for Concom. Med.|1|||
30831197|NCT00897949|58855580|FG002|Overall Study|Need for Concom. Med.|1|||
30831198|NCT00897949|58855578|FG000|Overall Study|Lack of Migraine Attack|29|||
30831199|NCT00897949|58855579|FG001|Overall Study|Lack of Migraine Attack|30|||
30831200|NCT00897949|58855580|FG002|Overall Study|Lack of Migraine Attack|19|||
30831201|NCT00897949|58855578|FG000|Overall Study|Did not take study drug|9|||
30831202|NCT00897949|58855579|FG001|Overall Study|Did not take study drug|3|||
30831203|NCT00897949|58855580|FG002|Overall Study|Did not take study drug|4|||
30831204|NCT02760810|58855594|FG000|Overall Study|Protocol Violation|1|||
30831205|NCT02760654|58855600|FG000|Overall Study|Lost to Follow-up|3|||
30922705|NCT02114684|58957992|FG001|Overall Study|Relocation|1|||
30922706|NCT02114684|58957991|FG000|Overall Study|Rifampicin resistant on culture|0|||
30922707|NCT02114684|58957992|FG001|Overall Study|Rifampicin resistant on culture|1|||
30922708|NCT02114684|58957991|FG000|Overall Study|Patient Incarcerated|1|||
30922709|NCT02114684|58957992|FG001|Overall Study|Patient Incarcerated|0|||
30922710|NCT02090114|58958006|FG000|Overall Study|Withdrawal by Subject|3|||
30922711|NCT02090114|58958007|FG001|Overall Study|Withdrawal by Subject|6|||
30922712|NCT02090114|58958008|FG002|Overall Study|Withdrawal by Subject|2|||
30922713|NCT02090114|58958009|FG003|Overall Study|Withdrawal by Subject|1|||
30922714|NCT02090114|58958006|FG000|Overall Study|Physician Decision|5|||
30922715|NCT02090114|58958007|FG001|Overall Study|Physician Decision|0|||
30922716|NCT02090114|58958008|FG002|Overall Study|Physician Decision|1|||
30831206|NCT02760654|58855601|FG001|Overall Study|Lost to Follow-up|3|||
30831207|NCT02760654|58855600|FG000|Overall Study|Withdrawal by Subject|4|||
30831208|NCT02760654|58855601|FG001|Overall Study|Withdrawal by Subject|3|||
30831209|NCT00725491|58855609|FG000|Overall Study|Adverse Event|3|||
30831210|NCT00725491|58855610|FG001|Overall Study|Adverse Event|2|||
30831211|NCT00725491|58855609|FG000|Overall Study|Pregnancy|0|||
30831212|NCT00725491|58855610|FG001|Overall Study|Pregnancy|3|||
30831213|NCT00725491|58855609|FG000|Overall Study|Risk for hyperstimulation|2|||
30922717|NCT02090114|58958009|FG003|Overall Study|Physician Decision|1|||
30922718|NCT02090114|58958006|FG000|Overall Study|Adverse Event|1|||
30922719|NCT02090114|58958007|FG001|Overall Study|Adverse Event|2|||
30922720|NCT02090114|58958008|FG002|Overall Study|Adverse Event|2|||
30922721|NCT02090114|58958009|FG003|Overall Study|Adverse Event|0|||
30831214|NCT00725491|58855610|FG001|Overall Study|Risk for hyperstimulation|9|||
30831215|NCT00725491|58855609|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
30831216|NCT00725491|58855610|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
30831217|NCT00725491|58855609|FG000|Overall Study|Fertilization failure|0|||
30831218|NCT00725491|58855610|FG001|Overall Study|Fertilization failure|1|||
30831219|NCT00725491|58855609|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
30831220|NCT00725491|58855610|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
30831221|NCT02634580|58855620|FG000|Double-blind Treatment Period|Subject Request|1|||
30831222|NCT02634580|58855621|FG001|Double-blind Treatment Period|Subject Request|0|||
30922722|NCT02090114|58958006|FG000|Overall Study|Progressive Disease|20|||
30922723|NCT02090114|58958007|FG001|Overall Study|Progressive Disease|21|||
30831223|NCT02634580|58855622|FG002|Double-blind Treatment Period|Subject Request|1|||
30831224|NCT02634580|58855623|FG003|Double-blind Treatment Period|Subject Request|1|||
30831225|NCT02634580|58855620|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
30831226|NCT02634580|58855621|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
30831227|NCT02634580|58855622|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
30831228|NCT02634580|58855623|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
30831229|NCT02225366|58855634|FG000|Overall Study|Lack of Efficacy|1|||
30831230|NCT02225366|58855635|FG001|Overall Study|Lack of Efficacy|0|||
30831231|NCT00697255|58855643|FG000|Stage 1a|Insufficient ovarian response|1|||
30831232|NCT00697255|58855644|FG001|Stage 1a|Insufficient ovarian response|0|||
30831233|NCT00697255|58855643|FG000|Stage 1a|Multifollicular growth|1|||
30831234|NCT00697255|58855644|FG001|Stage 1a|Multifollicular growth|0|||
30831235|NCT00697255|58855643|FG000|Stage 1a|Not growing of dominant follicle|1|||
30831236|NCT00697255|58855644|FG001|Stage 1a|Not growing of dominant follicle|0|||
30831237|NCT00697255|58855643|FG000|Stage 1b|Not growing of dominant follicle|0|||
30831238|NCT00697255|58855644|FG001|Stage 1b|Not growing of dominant follicle|1|||
30831239|NCT00697255|58855643|FG000|Stage 1b|Insufficient ovarian response|0|||
30831240|NCT00697255|58855644|FG001|Stage 1b|Insufficient ovarian response|1|||
30623509|NCT01137786|58635328|FG000|Overall Study|Lost to Follow-up|0|||
30623510|NCT01137786|58635329|FG001|Overall Study|Lost to Follow-up|2|||
30623511|NCT01137786|58635328|FG000|Overall Study|Withdrawal by Subject|1|||
30623512|NCT01137786|58635329|FG001|Overall Study|Withdrawal by Subject|1|||
30623513|NCT00599755|58635337|FG000|Overall Study|Adverse Event|11|||
30623514|NCT00599755|58635337|FG000|Overall Study|Withdrawal by Subject|2|||
30831241|NCT02764320|58855652|FG000|Overall Study|Withdrawal by Subject|35|||
30831242|NCT02764320|58855653|FG001|Overall Study|Withdrawal by Subject|38|||
30831243|NCT02764320|58855652|FG000|Overall Study|Protocol Violation|11|||
30831244|NCT02764320|58855653|FG001|Overall Study|Protocol Violation|6|||
30831245|NCT02764320|58855652|FG000|Overall Study|Adverse Event|2|||
30831246|NCT02764320|58855653|FG001|Overall Study|Adverse Event|0|||
30831247|NCT02764320|58855652|FG000|Overall Study|Health Issues unable to continue|2|||
30831248|NCT02764320|58855653|FG001|Overall Study|Health Issues unable to continue|0|||
30831249|NCT02764320|58855652|FG000|Overall Study|Did not meet inclusion criteria|1|||
30831250|NCT02764320|58855653|FG001|Overall Study|Did not meet inclusion criteria|0|||
30831251|NCT02764320|58855652|FG000|Overall Study|Subject moved|0|||
30831252|NCT02764320|58855653|FG001|Overall Study|Subject moved|2|||
30831253|NCT02764320|58855652|FG000|Overall Study|Overused medication unavailable|0|||
30831254|NCT02764320|58855653|FG001|Overall Study|Overused medication unavailable|1|||
30831255|NCT02764320|58855652|FG000|Overall Study|Seeking care outside site|0|||
30831256|NCT02764320|58855653|FG001|Overall Study|Seeking care outside site|1|||
30831257|NCT02764320|58855652|FG000|Overall Study|Technology barriers|0|||
30831258|NCT02764320|58855653|FG001|Overall Study|Technology barriers|1|||
30831259|NCT02851407|58855661|FG000|Overall Study|Withdrawal by parent/guardian|2|||
30831260|NCT02851407|58855662|FG001|Overall Study|Withdrawal by parent/guardian|7|||
30831261|NCT02851407|58855661|FG000|Overall Study|Protocol deviation|0|||
30831262|NCT02851407|58855662|FG001|Overall Study|Protocol deviation|1|||
30831263|NCT02851407|58855661|FG000|Overall Study|Transferred to another hospital to continue|1|||
30831264|NCT02851407|58855662|FG001|Overall Study|Transferred to another hospital to continue|0|||
30831265|NCT02851407|58855661|FG000|Overall Study|Other Death|30|||
30831266|NCT02851407|58855662|FG001|Overall Study|Other Death|20|||
30831267|NCT02851407|58855661|FG000|Overall Study|Adverse event, serious fatal|6|||
30831268|NCT02851407|58855662|FG001|Overall Study|Adverse event, serious fatal|8|||
30831269|NCT02851407|58855661|FG000|Overall Study|Consent withdrawn by participant|5|||
30623515|NCT00599755|58635337|FG000|Overall Study|Progression of Disease|3|||
30623516|NCT00599755|58635337|FG000|Overall Study|Other Reason|2|||
30623517|NCT00599755|58635337|FG000|Overall Study|No data available|1|||
30831270|NCT02851407|58855662|FG001|Overall Study|Consent withdrawn by participant|3|||
30831271|NCT02851407|58855661|FG000|Overall Study|Screen failure|2|||
30831272|NCT02851407|58855662|FG001|Overall Study|Screen failure|1|||
30831273|NCT02851407|58855661|FG000|Overall Study|Disease relapse|9|||
30831274|NCT02851407|58855662|FG001|Overall Study|Disease relapse|6|||
30831275|NCT02851407|58855661|FG000|Overall Study|Physician Decision|7|||
30831276|NCT02851407|58855662|FG001|Overall Study|Physician Decision|6|||
30831277|NCT02851407|58855661|FG000|Overall Study|Transferred to hospital closer to home|0|||
30831278|NCT02851407|58855662|FG001|Overall Study|Transferred to hospital closer to home|1|||
30831279|NCT02851407|58855661|FG000|Overall Study|Enrolled in an investigational study|0|||
30831280|NCT02851407|58855662|FG001|Overall Study|Enrolled in an investigational study|1|||
30831281|NCT02851407|58855661|FG000|Overall Study|Early recovery|1|||
30922724|NCT02090114|58958008|FG002|Overall Study|Progressive Disease|23|||
30831282|NCT02851407|58855662|FG001|Overall Study|Early recovery|0|||
30831283|NCT02851407|58855661|FG000|Overall Study|Adverse event, non-fatal|7|||
30922725|NCT02090114|58958009|FG003|Overall Study|Progressive Disease|6|||
30831284|NCT02851407|58855662|FG001|Overall Study|Adverse event, non-fatal|5|||
30922726|NCT02090114|58958006|FG000|Overall Study|Death|1|||
30922727|NCT02090114|58958007|FG001|Overall Study|Death|0|||
30623518|NCT00600613|58635341|FG000|Overall Study|Protocol Deviation|1|||
30623519|NCT01125930|58635347|FG000|Overall Study|Adverse Event|0|||
30623520|NCT01125930|58635348|FG001|Overall Study|Adverse Event|1|||
30623521|NCT01125930|58635347|FG000|Overall Study|Withdrawal by Subject|1|||
30623522|NCT01125930|58635348|FG001|Overall Study|Withdrawal by Subject|6|||
30623523|NCT01125930|58635347|FG000|Overall Study|Protocol Violation|0|||
30623524|NCT01125930|58635348|FG001|Overall Study|Protocol Violation|1|||
30623525|NCT01125930|58635347|FG000|Overall Study|Lost to Follow-up|0|||
30623526|NCT01125930|58635348|FG001|Overall Study|Lost to Follow-up|2|||
30623527|NCT00918346|58635379|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
30623528|NCT00918346|58635380|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
30623529|NCT00913978|58635391|FG000|Overall Study|Surgeon choice|1|||
30623530|NCT00913978|58635392|FG001|Overall Study|Surgeon choice|3|||
30623531|NCT01137474|58635402|FG000|Overall Study|Adverse Event|3|||
30623532|NCT01137474|58635403|FG001|Overall Study|Adverse Event|5|||
30623533|NCT01137474|58635404|FG002|Overall Study|Adverse Event|1|||
30623534|NCT01137474|58635405|FG003|Overall Study|Adverse Event|3|||
30623535|NCT01137474|58635402|FG000|Overall Study|Withdrawal by Subject|7|||
30623536|NCT01137474|58635403|FG001|Overall Study|Withdrawal by Subject|2|||
30623537|NCT01137474|58635404|FG002|Overall Study|Withdrawal by Subject|6|||
30623538|NCT01137474|58635405|FG003|Overall Study|Withdrawal by Subject|9|||
30623539|NCT01137474|58635402|FG000|Overall Study|No longer met study criteria|6|||
30623540|NCT01137474|58635403|FG001|Overall Study|No longer met study criteria|1|||
30623541|NCT01137474|58635404|FG002|Overall Study|No longer met study criteria|0|||
30623542|NCT01137474|58635405|FG003|Overall Study|No longer met study criteria|5|||
30623543|NCT01137474|58635402|FG000|Overall Study|Lost to Follow-up|5|||
30623544|NCT01137474|58635403|FG001|Overall Study|Lost to Follow-up|1|||
30623545|NCT01137474|58635404|FG002|Overall Study|Lost to Follow-up|0|||
30623546|NCT01137474|58635405|FG003|Overall Study|Lost to Follow-up|2|||
30623547|NCT01137474|58635402|FG000|Overall Study|Lack of Efficacy|0|||
30623548|NCT01137474|58635403|FG001|Overall Study|Lack of Efficacy|0|||
30623549|NCT01137474|58635404|FG002|Overall Study|Lack of Efficacy|0|||
30623550|NCT01137474|58635405|FG003|Overall Study|Lack of Efficacy|2|||
30755507|NCT04182880|58765381|FG000|Overall Study|Pregnancy|1|||
30755508|NCT04182880|58765382|FG001|Overall Study|Pregnancy|0|||
30755509|NCT04465396|58765392|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
30755510|NCT04465396|58765393|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
30755511|NCT04465396|58765394|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
30755512|NCT04465396|58765395|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
30755513|NCT03999892|58765420|FG000|Overall Study|Lost to Follow-up|1|||
30755514|NCT03996694|58765424|FG000|First Washout (7 Days)|positive urine drug screen|0|||
30755515|NCT03996694|58765425|FG001|First Washout (7 Days)|positive urine drug screen|0|||
30755516|NCT03996694|58765426|FG002|First Washout (7 Days)|positive urine drug screen|1|||
30755517|NCT03996694|58765427|FG003|First Washout (7 Days)|positive urine drug screen|0|||
30755518|NCT03996694|58765428|FG004|First Washout (7 Days)|positive urine drug screen|0|||
30831285|NCT02851407|58855661|FG000|Overall Study|Lost to Follow-up|0|||
30623551|NCT01137474|58635402|FG000|Overall Study|Other|3|||
30623552|NCT01137474|58635403|FG001|Overall Study|Other|1|||
30623553|NCT01137474|58635404|FG002|Overall Study|Other|0|||
30623554|NCT01137474|58635405|FG003|Overall Study|Other|0|||
30623555|NCT01137474|58635402|FG000|Overall Study|Pregnancy|0|||
30623556|NCT01137474|58635403|FG001|Overall Study|Pregnancy|1|||
30831286|NCT02851407|58855662|FG001|Overall Study|Lost to Follow-up|2|||
30922728|NCT02090114|58958008|FG002|Overall Study|Death|1|||
30922729|NCT02090114|58958009|FG003|Overall Study|Death|0|||
30623557|NCT01137474|58635404|FG002|Overall Study|Pregnancy|0|||
30623558|NCT01137474|58635405|FG003|Overall Study|Pregnancy|0|||
30623559|NCT01137474|58635402|FG000|Overall Study|Administrative reason by sponsor|0|||
30623560|NCT01137474|58635403|FG001|Overall Study|Administrative reason by sponsor|1|||
30623561|NCT01137474|58635404|FG002|Overall Study|Administrative reason by sponsor|0|||
30623562|NCT01137474|58635405|FG003|Overall Study|Administrative reason by sponsor|0|||
30623563|NCT01168973|58635417|FG000|Overall Study|Progressive Disease|341|||
30623564|NCT01168973|58635418|FG001|Overall Study|Progressive Disease|429|||
30623565|NCT01168973|58635417|FG000|Overall Study|Adverse Event|94|||
30623566|NCT01168973|58635418|FG001|Overall Study|Adverse Event|55|||
30623567|NCT01168973|58635417|FG000|Overall Study|Withdrawal by Subject|90|||
30623568|NCT01168973|58635418|FG001|Overall Study|Withdrawal by Subject|53|||
30623569|NCT01168973|58635417|FG000|Overall Study|Death|42|||
30623570|NCT01168973|58635418|FG001|Overall Study|Death|45|||
30623571|NCT01168973|58635417|FG000|Overall Study|Physician Decision|37|||
30623572|NCT01168973|58635418|FG001|Overall Study|Physician Decision|19|||
30623573|NCT01168973|58635417|FG000|Overall Study|Sponsor Decision|2|||
30623574|NCT01168973|58635418|FG001|Overall Study|Sponsor Decision|1|||
30623575|NCT01168973|58635417|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
30623576|NCT01168973|58635418|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
30623577|NCT03918109|58635428|FG000|Overall Study|Withdrawal by Subject|0|||
30623578|NCT03918109|58635429|FG001|Overall Study|Withdrawal by Subject|0|||
30623579|NCT03918109|58635430|FG002|Overall Study|Withdrawal by Subject|2|||
30623580|NCT03918109|58635431|FG003|Overall Study|Withdrawal by Subject|1|||
30623581|NCT03918109|58635428|FG000|Overall Study|Lost to Follow-up|0|||
30623582|NCT03918109|58635429|FG001|Overall Study|Lost to Follow-up|0|||
30623583|NCT03918109|58635430|FG002|Overall Study|Lost to Follow-up|0|||
30623584|NCT03918109|58635431|FG003|Overall Study|Lost to Follow-up|1|||
30623585|NCT01168427|58635441|FG000|Overall Study|Patient exited prior to implant|1|||
30623586|NCT01124916|58635447|FG000|Overall Study|Lost to Follow-up|3|||
30623587|NCT01124916|58635448|FG001|Overall Study|Lost to Follow-up|2|||
30623588|NCT00916006|58635456|FG000|Overall Study|Adverse Event|1|||
30623589|NCT00916006|58635457|FG001|Overall Study|Adverse Event|1|||
30623590|NCT00916006|58635456|FG000|Overall Study|Withdrawal by Subject|2|||
30623591|NCT00916006|58635457|FG001|Overall Study|Withdrawal by Subject|5|||
30623592|NCT00916006|58635456|FG000|Overall Study|Protocol Violation|0|||
30623593|NCT00916006|58635457|FG001|Overall Study|Protocol Violation|1|||
30623594|NCT01168349|58635474|FG000|Overall Study|Death|157|||
30623595|NCT01168349|58635474|FG000|Overall Study|Lost to Follow-up|34|||
30623596|NCT01168349|58635474|FG000|Overall Study|Withdrawal by Subject|9|||
30623597|NCT01168349|58635474|FG000|Overall Study|Kidney transplantation|3|||
30623598|NCT01168349|58635474|FG000|Overall Study|Other|22|||
30623599|NCT01168349|58635474|FG000|Overall Study|Protocol Violation|76|||
30755519|NCT03996694|58765429|FG005|First Washout (7 Days)|positive urine drug screen|0|||
30755520|NCT03996694|58765424|FG000|First Washout (7 Days)|Adverse Event|0|||
30831287|NCT02636608|58855668|FG000|Overall Study|Failure to Return|4|||
30623600|NCT00915772|58635497|FG000|Overall Study|Adverse Event|12|||
30623601|NCT00915772|58635498|FG001|Overall Study|Adverse Event|13|||
30623602|NCT00915772|58635499|FG002|Overall Study|Adverse Event|11|||
30623603|NCT00915772|58635497|FG000|Overall Study|Protocol Violation|4|||
30623604|NCT00915772|58635498|FG001|Overall Study|Protocol Violation|1|||
30623605|NCT00915772|58635499|FG002|Overall Study|Protocol Violation|2|||
30623606|NCT00915772|58635497|FG000|Overall Study|Lost to Follow-up|1|||
30623607|NCT00915772|58635498|FG001|Overall Study|Lost to Follow-up|2|||
30755521|NCT03996694|58765425|FG001|First Washout (7 Days)|Adverse Event|1|||
30755522|NCT03996694|58765426|FG002|First Washout (7 Days)|Adverse Event|0|||
30755523|NCT03996694|58765427|FG003|First Washout (7 Days)|Adverse Event|0|||
30755524|NCT03996694|58765428|FG004|First Washout (7 Days)|Adverse Event|0|||
30755525|NCT03996694|58765429|FG005|First Washout (7 Days)|Adverse Event|0|||
30755526|NCT03996694|58765424|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
30755527|NCT03996694|58765425|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
30755528|NCT03996694|58765426|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
30755529|NCT03996694|58765427|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
30755530|NCT03996694|58765428|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
30755531|NCT03996694|58765429|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
30755532|NCT03996694|58765424|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
30755533|NCT03996694|58765425|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
30755534|NCT03996694|58765426|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
30755535|NCT03996694|58765427|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
30755536|NCT03996694|58765428|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
30755537|NCT03996694|58765429|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
30755538|NCT04179838|58765445|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
30755539|NCT04179838|58765446|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
30755540|NCT04179838|58765445|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
30623608|NCT00915772|58635499|FG002|Overall Study|Lost to Follow-up|2|||
30623609|NCT00915772|58635497|FG000|Overall Study|Lack of Efficacy|9|||
30623610|NCT00915772|58635498|FG001|Overall Study|Lack of Efficacy|15|||
30623611|NCT00915772|58635499|FG002|Overall Study|Lack of Efficacy|3|||
30623612|NCT00915772|58635497|FG000|Overall Study|Refused to continue trial medication|6|||
30623613|NCT00915772|58635498|FG001|Overall Study|Refused to continue trial medication|8|||
30623614|NCT00915772|58635499|FG002|Overall Study|Refused to continue trial medication|4|||
30623615|NCT00915772|58635497|FG000|Overall Study|Any other reason|4|||
30623616|NCT00915772|58635498|FG001|Overall Study|Any other reason|7|||
30623617|NCT00915772|58635499|FG002|Overall Study|Any other reason|7|||
30623618|NCT00912964|58635511|FG000|Overall Study|Eligibility criterion not met|1|||
30623619|NCT00912964|58635512|FG001|Overall Study|Eligibility criterion not met|1|||
30623620|NCT00912964|58635513|FG002|Overall Study|Eligibility criterion not met|0|||
30623621|NCT00912964|58635511|FG000|Overall Study|Adverse Event|15|||
30623622|NCT00912964|58635512|FG001|Overall Study|Adverse Event|18|||
30623623|NCT00912964|58635513|FG002|Overall Study|Adverse Event|12|||
30623624|NCT00912964|58635511|FG000|Overall Study|Lack of Efficacy|11|||
30623625|NCT00912964|58635512|FG001|Overall Study|Lack of Efficacy|4|||
30623626|NCT00912964|58635513|FG002|Overall Study|Lack of Efficacy|3|||
30623627|NCT00912964|58635511|FG000|Overall Study|Withdrawal by Subject|20|||
30623628|NCT00912964|58635512|FG001|Overall Study|Withdrawal by Subject|12|||
30623629|NCT00912964|58635513|FG002|Overall Study|Withdrawal by Subject|18|||
30623630|NCT00912964|58635511|FG000|Overall Study|Lost to Follow-up|4|||
30623631|NCT00912964|58635512|FG001|Overall Study|Lost to Follow-up|3|||
30623632|NCT00912964|58635513|FG002|Overall Study|Lost to Follow-up|3|||
30623633|NCT00912964|58635511|FG000|Overall Study|Protocol Violation|5|||
30623634|NCT00912964|58635512|FG001|Overall Study|Protocol Violation|3|||
30623635|NCT00912964|58635513|FG002|Overall Study|Protocol Violation|8|||
30623636|NCT00912964|58635511|FG000|Overall Study|Taking exclusionary medications|7|||
30623637|NCT00912964|58635512|FG001|Overall Study|Taking exclusionary medications|4|||
30623638|NCT00912964|58635513|FG002|Overall Study|Taking exclusionary medications|8|||
30623639|NCT00912964|58635511|FG000|Overall Study|Medical History|1|||
30623640|NCT00912964|58635512|FG001|Overall Study|Medical History|0|||
30623641|NCT00912964|58635513|FG002|Overall Study|Medical History|0|||
30623642|NCT00912964|58635511|FG000|Overall Study|Non-compliance with study procedures|2|||
30623643|NCT00912964|58635512|FG001|Overall Study|Non-compliance with study procedures|0|||
30623644|NCT00912964|58635513|FG002|Overall Study|Non-compliance with study procedures|0|||
30623645|NCT00912964|58635511|FG000|Overall Study|Violation of exclusion criterion|0|||
30623646|NCT00912964|58635512|FG001|Overall Study|Violation of exclusion criterion|0|||
30623647|NCT00912964|58635513|FG002|Overall Study|Violation of exclusion criterion|2|||
30623648|NCT00912964|58635511|FG000|Overall Study|Randomized but never received study drug|0|||
30623649|NCT00912964|58635512|FG001|Overall Study|Randomized but never received study drug|1|||
30623650|NCT00912964|58635513|FG002|Overall Study|Randomized but never received study drug|0|||
30623651|NCT00913744|58635523|FG000|Overall Study|Adverse Event|2|||
30623652|NCT00913744|58635524|FG001|Overall Study|Adverse Event|0|||
30623653|NCT00913744|58635523|FG000|Overall Study|Withdrawal by Subject|2|||
30623654|NCT00913744|58635524|FG001|Overall Study|Withdrawal by Subject|1|||
30623655|NCT00913744|58635523|FG000|Overall Study|Death|1|||
30623656|NCT00913744|58635524|FG001|Overall Study|Death|0|||
30623657|NCT00912808|58635532|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
30623658|NCT00912808|58635533|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
30623659|NCT00912808|58635532|FG000|Washout|Withdrawal by Subject|0|||
30623660|NCT00912808|58635533|FG001|Washout|Withdrawal by Subject|1|||
30623661|NCT00912808|58635532|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
30623662|NCT00912808|58635533|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
30623663|NCT00912808|58635532|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
30623664|NCT00912808|58635533|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
30623665|NCT00960531|58635550|FG000|Overall Study|Lack of Efficacy|1|||
30623666|NCT00960531|58635551|FG001|Overall Study|Lack of Efficacy|0|||
30623667|NCT00960531|58635552|FG002|Overall Study|Lack of Efficacy|0|||
30623668|NCT00960531|58635553|FG003|Overall Study|Lack of Efficacy|0|||
30623669|NCT00960531|58635554|FG004|Overall Study|Lack of Efficacy|0|||
30623670|NCT00960531|58635555|FG005|Overall Study|Lack of Efficacy|0|||
30623671|NCT00960531|58635556|FG006|Overall Study|Lack of Efficacy|0|||
30623672|NCT00960531|58635557|FG007|Overall Study|Lack of Efficacy|0|||
30623673|NCT00960531|58635558|FG008|Overall Study|Lack of Efficacy|0|||
30623674|NCT00960531|58635559|FG009|Overall Study|Lack of Efficacy|0|||
30623675|NCT00960531|58635550|FG000|Overall Study|Withdrawal by Subject|1|||
30623676|NCT00960531|58635551|FG001|Overall Study|Withdrawal by Subject|0|||
30623677|NCT00960531|58635552|FG002|Overall Study|Withdrawal by Subject|5|||
30623678|NCT00960531|58635553|FG003|Overall Study|Withdrawal by Subject|2|||
30623679|NCT00960531|58635554|FG004|Overall Study|Withdrawal by Subject|0|||
30623680|NCT00960531|58635555|FG005|Overall Study|Withdrawal by Subject|0|||
30623681|NCT00960531|58635556|FG006|Overall Study|Withdrawal by Subject|2|||
30623682|NCT00960531|58635557|FG007|Overall Study|Withdrawal by Subject|0|||
30623683|NCT00960531|58635558|FG008|Overall Study|Withdrawal by Subject|1|||
30623684|NCT00960531|58635559|FG009|Overall Study|Withdrawal by Subject|0|||
30623685|NCT00960531|58635550|FG000|Overall Study|Caregiver Request|2|||
30623686|NCT00960531|58635551|FG001|Overall Study|Caregiver Request|0|||
30623687|NCT00960531|58635552|FG002|Overall Study|Caregiver Request|6|||
30623688|NCT00960531|58635553|FG003|Overall Study|Caregiver Request|5|||
30623689|NCT00960531|58635554|FG004|Overall Study|Caregiver Request|0|||
30623690|NCT00960531|58635555|FG005|Overall Study|Caregiver Request|2|||
30623691|NCT00960531|58635556|FG006|Overall Study|Caregiver Request|3|||
30623692|NCT00960531|58635557|FG007|Overall Study|Caregiver Request|1|||
30623693|NCT00960531|58635558|FG008|Overall Study|Caregiver Request|3|||
30623694|NCT00960531|58635559|FG009|Overall Study|Caregiver Request|0|||
30623695|NCT00960531|58635550|FG000|Overall Study|Investigator Request|0|||
30623696|NCT00960531|58635551|FG001|Overall Study|Investigator Request|0|||
30623697|NCT00960531|58635552|FG002|Overall Study|Investigator Request|1|||
30623698|NCT00960531|58635553|FG003|Overall Study|Investigator Request|0|||
30623699|NCT00960531|58635554|FG004|Overall Study|Investigator Request|0|||
30623700|NCT00960531|58635555|FG005|Overall Study|Investigator Request|0|||
30623701|NCT00960531|58635556|FG006|Overall Study|Investigator Request|0|||
30623702|NCT00960531|58635557|FG007|Overall Study|Investigator Request|0|||
30623703|NCT00960531|58635558|FG008|Overall Study|Investigator Request|0|||
30623704|NCT00960531|58635559|FG009|Overall Study|Investigator Request|0|||
30623705|NCT00960531|58635550|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
30623706|NCT00960531|58635551|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
30623707|NCT00960531|58635552|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
30623708|NCT00960531|58635553|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
30623709|NCT00960531|58635554|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
30623710|NCT00960531|58635555|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
30623711|NCT00960531|58635556|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
30623712|NCT00960531|58635557|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
30623713|NCT00960531|58635558|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
30623714|NCT00960531|58635559|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
30623715|NCT00960531|58635550|FG000|Overall Study|Lost to Follow-up|0|||
30623716|NCT00960531|58635551|FG001|Overall Study|Lost to Follow-up|0|||
30623717|NCT00960531|58635552|FG002|Overall Study|Lost to Follow-up|1|||
30623718|NCT00960531|58635553|FG003|Overall Study|Lost to Follow-up|0|||
30623719|NCT00960531|58635554|FG004|Overall Study|Lost to Follow-up|0|||
30623720|NCT00960531|58635555|FG005|Overall Study|Lost to Follow-up|0|||
30623721|NCT00960531|58635556|FG006|Overall Study|Lost to Follow-up|1|||
30623722|NCT00960531|58635557|FG007|Overall Study|Lost to Follow-up|0|||
30623723|NCT00960531|58635558|FG008|Overall Study|Lost to Follow-up|0|||
30623724|NCT00960531|58635559|FG009|Overall Study|Lost to Follow-up|0|||
30623725|NCT00960531|58635550|FG000|Overall Study|Failed to Return|2|||
30623726|NCT00960531|58635551|FG001|Overall Study|Failed to Return|0|||
30623727|NCT00960531|58635552|FG002|Overall Study|Failed to Return|0|||
30623728|NCT00960531|58635553|FG003|Overall Study|Failed to Return|0|||
30623729|NCT00960531|58635554|FG004|Overall Study|Failed to Return|0|||
30623730|NCT00960531|58635555|FG005|Overall Study|Failed to Return|0|||
30623731|NCT00960531|58635556|FG006|Overall Study|Failed to Return|0|||
30623732|NCT00960531|58635557|FG007|Overall Study|Failed to Return|2|||
30623733|NCT00960531|58635558|FG008|Overall Study|Failed to Return|0|||
30623734|NCT00960531|58635559|FG009|Overall Study|Failed to Return|0|||
30623735|NCT00960531|58635550|FG000|Overall Study|Adverse Event (AE)|2|||
30623736|NCT00960531|58635551|FG001|Overall Study|Adverse Event (AE)|0|||
30623737|NCT00960531|58635552|FG002|Overall Study|Adverse Event (AE)|0|||
30623738|NCT00960531|58635553|FG003|Overall Study|Adverse Event (AE)|0|||
30623739|NCT00960531|58635554|FG004|Overall Study|Adverse Event (AE)|0|||
30623740|NCT00960531|58635555|FG005|Overall Study|Adverse Event (AE)|1|||
30623741|NCT00960531|58635556|FG006|Overall Study|Adverse Event (AE)|2|||
30623742|NCT00960531|58635557|FG007|Overall Study|Adverse Event (AE)|0|||
30623743|NCT00960531|58635558|FG008|Overall Study|Adverse Event (AE)|2|||
30623744|NCT00960531|58635559|FG009|Overall Study|Adverse Event (AE)|0|||
30623745|NCT00960531|58635550|FG000|Overall Study|Reason not Specified|2|||
30623746|NCT00960531|58635551|FG001|Overall Study|Reason not Specified|1|||
30623747|NCT00960531|58635552|FG002|Overall Study|Reason not Specified|13|||
30623748|NCT00960531|58635553|FG003|Overall Study|Reason not Specified|1|||
30623749|NCT00960531|58635554|FG004|Overall Study|Reason not Specified|2|||
30623750|NCT00960531|58635555|FG005|Overall Study|Reason not Specified|0|||
30623751|NCT00960531|58635556|FG006|Overall Study|Reason not Specified|16|||
30623752|NCT00960531|58635557|FG007|Overall Study|Reason not Specified|0|||
30623753|NCT00960531|58635558|FG008|Overall Study|Reason not Specified|8|||
30623754|NCT00960531|58635559|FG009|Overall Study|Reason not Specified|1|||
30623755|NCT00960375|58635587|FG000|Overall Study|Lost to Follow-up|20|||
30623756|NCT00960375|58635588|FG001|Overall Study|Lost to Follow-up|22|||
30623757|NCT00957801|58635607|FG000|Overall Study|Withdrawal by Subject|0|||
30755541|NCT04179838|58765446|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
30623758|NCT00957801|58635608|FG001|Overall Study|Withdrawal by Subject|0|||
30623759|NCT00957801|58635609|FG002|Overall Study|Withdrawal by Subject|0|||
30755542|NCT03994120|58765454|FG000|Overall Study|Lost to Follow-up|3|||
30755543|NCT03994120|58765455|FG001|Overall Study|Lost to Follow-up|1|||
30755544|NCT04178590|58765461|FG000|Overall Study|Pregnancy|1|||
30623760|NCT00957801|58635610|FG003|Overall Study|Withdrawal by Subject|1|||
30623761|NCT00957723|58635620|FG000|Overall Study|Death|3|||
30623762|NCT00957723|58635620|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
30623763|NCT00957723|58635620|FG000|Overall Study|Lost to Follow-up|8|||
30623764|NCT00957723|58635620|FG000|Overall Study|Withdrawal by Subject|24|||
30623765|NCT00957723|58635620|FG000|Overall Study|Investigative Site Terminated|61|||
30623766|NCT00957723|58635620|FG000|Overall Study|Intercurrent Illness|2|||
30623767|NCT00957723|58635620|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
30623768|NCT03778021|58635628|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
30623769|NCT03778021|58635629|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
30623770|NCT00911170|58635638|FG000|Treatment Period|Randomized in error|1|||
30623771|NCT00911170|58635639|FG001|Treatment Period|Randomized in error|1|||
30623772|NCT00911170|58635638|FG000|Treatment Period|Ineligibility determined|1|||
30623773|NCT00911170|58635639|FG001|Treatment Period|Ineligibility determined|3|||
30623774|NCT00911170|58635638|FG000|Treatment Period|Protocol deviation|1|||
30623775|NCT00911170|58635639|FG001|Treatment Period|Protocol deviation|2|||
30623776|NCT00911170|58635638|FG000|Treatment Period|Adverse Event|9|||
30623777|NCT00911170|58635639|FG001|Treatment Period|Adverse Event|10|||
30623778|NCT00911170|58635638|FG000|Treatment Period|Withdrawal by Subject|4|||
30623779|NCT00911170|58635639|FG001|Treatment Period|Withdrawal by Subject|4|||
30623780|NCT00911170|58635638|FG000|Treatment Period|Disease progression|0|||
30623781|NCT00911170|58635639|FG001|Treatment Period|Disease progression|2|||
30623782|NCT00911170|58635638|FG000|Treatment Period|Physician Decision|5|||
30623783|NCT00911170|58635639|FG001|Treatment Period|Physician Decision|5|||
30623784|NCT00911170|58635638|FG000|Treatment Period|Lost to Follow-up|0|||
30623785|NCT00911170|58635639|FG001|Treatment Period|Lost to Follow-up|1|||
30623786|NCT00911170|58635638|FG000|Treatment Period|Death|6|||
30623787|NCT00911170|58635639|FG001|Treatment Period|Death|9|||
30623788|NCT00911170|58635638|FG000|Long Term Follow-Up|Continuing in study|274|||
30623789|NCT00911170|58635639|FG001|Long Term Follow-Up|Continuing in study|269|||
30623790|NCT00911170|58635638|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
30623791|NCT00911170|58635639|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
30623792|NCT00911170|58635638|FG000|Long Term Follow-Up|Physician Decision|5|||
30623793|NCT00911170|58635639|FG001|Long Term Follow-Up|Physician Decision|4|||
30623794|NCT00911170|58635638|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
30623795|NCT00911170|58635639|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
30623796|NCT00911170|58635638|FG000|Long Term Follow-Up|Death|116|||
30623797|NCT00911170|58635639|FG001|Long Term Follow-Up|Death|121|||
30623798|NCT01167881|58635647|FG000|Overall Study|Adverse Event|47|||
30623799|NCT01167881|58635648|FG001|Overall Study|Adverse Event|51|||
30623800|NCT01167881|58635647|FG000|Overall Study|Lack of Efficacy|4|||
30623801|NCT01167881|58635648|FG001|Overall Study|Lack of Efficacy|7|||
30623802|NCT01167881|58635647|FG000|Overall Study|Non compliant with protocol|9|||
30623803|NCT01167881|58635648|FG001|Overall Study|Non compliant with protocol|18|||
30623804|NCT01167881|58635647|FG000|Overall Study|Lost to Follow-up|19|||
30623805|NCT01167881|58635648|FG001|Overall Study|Lost to Follow-up|20|||
30623806|NCT01167881|58635647|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
30623807|NCT01167881|58635648|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
30623808|NCT01167881|58635647|FG000|Overall Study|Not treated|4|||
30623809|NCT01167881|58635648|FG001|Overall Study|Not treated|0|||
30623810|NCT01167881|58635647|FG000|Overall Study|Other not defined above|31|||
30623811|NCT01167881|58635648|FG001|Overall Study|Other not defined above|55|||
30623812|NCT00960063|58635657|FG000|Overall Study|Adverse Event|1|||
30755545|NCT04178590|58765461|FG000|Overall Study|Lost to Follow-up|1|||
30755546|NCT04175392|58765489|FG000|Overall Study|Withdrawal by Subject|3|||
30755547|NCT04175392|58765490|FG001|Overall Study|Withdrawal by Subject|2|||
30755548|NCT03986866|58765498|FG000|Overall Study|Withdrawal by Subject|0|||
30755549|NCT03986866|58765499|FG001|Overall Study|Withdrawal by Subject|3|||
30755550|NCT03986866|58765498|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
30623813|NCT00960063|58635658|FG001|Overall Study|Adverse Event|0|||
30623814|NCT00960063|58635659|FG002|Overall Study|Adverse Event|0|||
30623815|NCT00960063|58635657|FG000|Overall Study|Progression of Disease|0|||
30623816|NCT00960063|58635658|FG001|Overall Study|Progression of Disease|0|||
30755551|NCT03986866|58765499|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
30623817|NCT00960063|58635659|FG002|Overall Study|Progression of Disease|3|||
30623818|NCT00959907|58635669|FG000|Overall Study|Protocol Violation|0|||
30755552|NCT03980938|58765507|FG000|Treatment Period 1|Study Terminated|1|||
30623819|NCT00959907|58635670|FG001|Overall Study|Protocol Violation|1|||
30623820|NCT00959907|58635669|FG000|Overall Study|Adverse Event|1|||
30623821|NCT00959907|58635670|FG001|Overall Study|Adverse Event|0|||
30623822|NCT00959907|58635669|FG000|Overall Study|Withdrawal by Subject|2|||
30623823|NCT00959907|58635670|FG001|Overall Study|Withdrawal by Subject|0|||
30623824|NCT00912340|58635679|FG000|Overall Study|Adverse Event|2|||
30623825|NCT00912340|58635680|FG001|Overall Study|Adverse Event|4|||
30623826|NCT00912340|58635681|FG002|Overall Study|Adverse Event|0|||
30623827|NCT00912340|58635679|FG000|Overall Study|Protocol revised to remove arm|0|||
30623828|NCT00912340|58635680|FG001|Overall Study|Protocol revised to remove arm|0|||
30623829|NCT00912340|58635681|FG002|Overall Study|Protocol revised to remove arm|4|||
30623830|NCT01167257|58635691|FG000|Overall Study|Lost to Follow-up|2|||
30623831|NCT01167257|58635692|FG001|Overall Study|Lost to Follow-up|2|||
30755553|NCT03980938|58765508|FG001|Treatment Period 1|Study Terminated|1|||
30755554|NCT03980938|58765507|FG000|Treatment Period 2|Study Terminated|2|||
30831288|NCT02636608|58855668|FG000|Overall Study|Insufficient Virological Response|1|||
30831289|NCT02636608|58855668|FG000|Overall Study|Death|3|||
30831290|NCT02636608|58855668|FG000|Overall Study|Other|2|||
30831291|NCT02636608|58855668|FG000|Overall Study|Did Not Receive Treatment|1|||
30831292|NCT02759562|58855677|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
30831293|NCT02759562|58855678|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
30831294|NCT02759562|58855677|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
30831295|NCT02759562|58855678|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
30831296|NCT02746575|58855685|FG000|Overall Study|Surgery cancelled or time chaned|13|||
30831297|NCT02746575|58855685|FG000|Overall Study|Received epidural|10|||
30922730|NCT01623050|58958019|FG000|Overall Study|Lost to Follow-up|9|||
30922731|NCT02089334|58958027|FG000|Overall Study|Withdrawal by Subject|0|||
30922732|NCT02089334|58958028|FG001|Overall Study|Withdrawal by Subject|0|||
30922733|NCT02089334|58958029|FG002|Overall Study|Withdrawal by Subject|0|||
30922734|NCT02089334|58958030|FG003|Overall Study|Withdrawal by Subject|2|||
30922735|NCT02089334|58958027|FG000|Overall Study|Adverse Event|0|||
30922736|NCT02089334|58958028|FG001|Overall Study|Adverse Event|0|||
30755555|NCT03980938|58765508|FG001|Treatment Period 2|Study Terminated|2|||
30922737|NCT02089334|58958029|FG002|Overall Study|Adverse Event|0|||
30922738|NCT02089334|58958030|FG003|Overall Study|Adverse Event|2|||
30922739|NCT02089334|58958027|FG000|Overall Study|Progressive disease|0|||
30922740|NCT02089334|58958028|FG001|Overall Study|Progressive disease|0|||
30922741|NCT02089334|58958029|FG002|Overall Study|Progressive disease|0|||
30922742|NCT02089334|58958030|FG003|Overall Study|Progressive disease|2|||
30922743|NCT02089334|58958027|FG000|Overall Study|Physician Decision|0|||
30922744|NCT02089334|58958028|FG001|Overall Study|Physician Decision|0|||
30922745|NCT02089334|58958029|FG002|Overall Study|Physician Decision|1|||
30922746|NCT02089334|58958030|FG003|Overall Study|Physician Decision|1|||
30922747|NCT02114606|58958043|FG000|Overall Study|Unable to swallow Cytosponge|6|||
30922748|NCT02113436|58958049|FG000|Period 1: 8 Weeks|Adverse Event|1|||
30922749|NCT02113436|58958050|FG001|Period 1: 8 Weeks|Adverse Event|0|||
30623832|NCT01167257|58635691|FG000|Overall Study|Withdrew consent|1|||
30755556|NCT03656692|58765514|FG000|Overall Study|Worsening of disease activity|2|||
30755557|NCT03656692|58765514|FG000|Overall Study|Physician Decision|1|||
30755558|NCT04439266|58765518|FG000|Overall Study|Ineligible|1|||
30755559|NCT04439266|58765518|FG000|Overall Study|Adverse Event|1|||
30755560|NCT04439266|58765518|FG000|Overall Study|Death|1|||
30755561|NCT04439266|58765518|FG000|Overall Study|Disease progression|1|||
30755562|NCT04439266|58765518|FG000|Overall Study|Still on treatment|1|||
30755563|NCT03682120|58765526|FG000|Overall Study|Lost to Follow-up|11|||
30755564|NCT03682120|58765527|FG001|Overall Study|Lost to Follow-up|4|||
30755565|NCT03682120|58765528|FG002|Overall Study|Lost to Follow-up|5|||
30755566|NCT03682120|58765529|FG003|Overall Study|Lost to Follow-up|2|||
30831298|NCT02746575|58855685|FG000|Overall Study|Withdrawal by Subject|3|||
30831299|NCT02746575|58855685|FG000|Overall Study|Bradycardia/hypotension|9|||
30831300|NCT02746575|58855685|FG000|Overall Study|Study paused|8|||
30831301|NCT02746575|58855685|FG000|Overall Study|put on beta-blocker|3|||
30922750|NCT02113436|58958051|FG002|Period 1: 8 Weeks|Adverse Event|0|||
30922751|NCT02113436|58958052|FG003|Period 1: 8 Weeks|Adverse Event|0|||
30922752|NCT02113436|58958049|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
30922753|NCT02113436|58958050|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
30922754|NCT02113436|58958051|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
30922755|NCT02113436|58958052|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
30922756|NCT02113436|58958049|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
30831302|NCT02746575|58855685|FG000|Overall Study|type of surgery|1|||
30831303|NCT02746575|58855685|FG000|Overall Study|typ of surgery|1|||
30831304|NCT02746575|58855685|FG000|Overall Study|PI unavailable|1|||
30831305|NCT02746575|58855685|FG000|Overall Study|Unknown history of CVA|1|||
30831306|NCT03625466|58855691|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
30831307|NCT03625466|58855692|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
30831308|NCT03625466|58855693|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
30831309|NCT03625466|58855691|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
30831310|NCT03625466|58855692|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
30831311|NCT03625466|58855693|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
30831312|NCT03625466|58855691|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
30831313|NCT03625466|58855692|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
30831314|NCT03625466|58855693|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
30831315|NCT02853123|58855700|FG000|Treatment Period 1|Adverse Event|0|||
30831316|NCT02853123|58855701|FG001|Treatment Period 1|Adverse Event|3|||
30831317|NCT02853123|58855700|FG000|Washout Period|Worsening of COPD|0|||
30831318|NCT02853123|58855701|FG001|Washout Period|Worsening of COPD|3|||
30831319|NCT02853123|58855700|FG000|Washout Period|Adverse Event|1|||
30831320|NCT02853123|58855701|FG001|Washout Period|Adverse Event|0|||
30831321|NCT02634346|58855711|FG000|Overall Study|Withdrawal by Subject|8|||
30831322|NCT02634346|58855712|FG001|Overall Study|Withdrawal by Subject|9|||
30831323|NCT02634346|58855713|FG002|Overall Study|Withdrawal by Subject|8|||
30831324|NCT02634346|58855711|FG000|Overall Study|Adverse Event|2|||
30831325|NCT02634346|58855712|FG001|Overall Study|Adverse Event|2|||
30831326|NCT02634346|58855713|FG002|Overall Study|Adverse Event|7|||
30922757|NCT02113436|58958050|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
30922758|NCT02113436|58958051|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
30922759|NCT02113436|58958052|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
30922760|NCT02113436|58958049|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
30922761|NCT02113436|58958050|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
30922762|NCT02113436|58958051|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
30922763|NCT02113436|58958052|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
30922764|NCT02113436|58958049|FG000|Period 2: 16 Weeks|Adverse Event|0|||
30922765|NCT02113436|58958050|FG001|Period 2: 16 Weeks|Adverse Event|0|||
30922766|NCT02113436|58958051|FG002|Period 2: 16 Weeks|Adverse Event|4|||
30922767|NCT02113436|58958052|FG003|Period 2: 16 Weeks|Adverse Event|5|||
30922768|NCT02113436|58958049|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
30922769|NCT02113436|58958050|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
30922770|NCT02113436|58958051|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
30922771|NCT02113436|58958052|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
30922772|NCT02113436|58958049|FG000|Period 2: 16 Weeks|Physician Decision|0|||
30922773|NCT02113436|58958050|FG001|Period 2: 16 Weeks|Physician Decision|0|||
30922774|NCT02113436|58958051|FG002|Period 2: 16 Weeks|Physician Decision|2|||
30922775|NCT02113436|58958052|FG003|Period 2: 16 Weeks|Physician Decision|0|||
30922776|NCT02113436|58958049|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
30922777|NCT02113436|58958050|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
30922778|NCT02113436|58958051|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
30922779|NCT02113436|58958052|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
30922780|NCT02113124|58958063|FG000|Overall Study|Unable to retrieve blood sample|1|||
30755567|NCT03682120|58765526|FG000|Overall Study|Physician Decision|1|||
30755568|NCT03682120|58765527|FG001|Overall Study|Physician Decision|0|||
30755569|NCT03682120|58765528|FG002|Overall Study|Physician Decision|0|||
30755570|NCT03682120|58765529|FG003|Overall Study|Physician Decision|0|||
30755571|NCT03682120|58765526|FG000|Overall Study|Withdrawal by Subject|1|||
30755572|NCT03682120|58765527|FG001|Overall Study|Withdrawal by Subject|2|||
30755573|NCT03682120|58765528|FG002|Overall Study|Withdrawal by Subject|3|||
30755574|NCT03682120|58765529|FG003|Overall Study|Withdrawal by Subject|0|||
30755575|NCT03682120|58765526|FG000|Overall Study|Death|0|||
30755576|NCT03682120|58765527|FG001|Overall Study|Death|1|||
30755577|NCT03682120|58765528|FG002|Overall Study|Death|0|||
30755578|NCT03682120|58765529|FG003|Overall Study|Death|0|||
30831327|NCT02634346|58855711|FG000|Overall Study|Lack of Efficacy|1|||
30831328|NCT02634346|58855712|FG001|Overall Study|Lack of Efficacy|2|||
30831329|NCT02634346|58855713|FG002|Overall Study|Lack of Efficacy|8|||
30831330|NCT02634346|58855711|FG000|Overall Study|Lost to Follow-up|1|||
30831331|NCT02634346|58855712|FG001|Overall Study|Lost to Follow-up|0|||
30922781|NCT02113124|58958064|FG001|Overall Study|Unable to retrieve blood sample|1|||
30922782|NCT02087774|58958072|FG000|Overall Study|Were absent day of data collection|8|||
30922783|NCT02087774|58958073|FG001|Overall Study|Were absent day of data collection|20|||
30922784|NCT02111564|58958081|FG000|Overall Study|Death|109|||
30831332|NCT02634346|58855713|FG002|Overall Study|Lost to Follow-up|0|||
30831333|NCT02634346|58855711|FG000|Overall Study|Protocol Violation|0|||
30831334|NCT02634346|58855712|FG001|Overall Study|Protocol Violation|1|||
30831335|NCT02634346|58855713|FG002|Overall Study|Protocol Violation|0|||
30831336|NCT00849147|58855721|FG000|Overall Study|Withdrawal by Subject|1|||
30831337|NCT00849147|58855721|FG000|Overall Study|Protocol Violation|2|||
30831338|NCT00849147|58855721|FG000|Overall Study|Disease Relapse/Progression|2|||
30831339|NCT00101166|58855725|FG000|Overall Study|progressive disease|10|||
30831340|NCT02759016|58855731|FG000|Overall Study|Not treated with BI 836826|1|||
30831341|NCT02759016|58855732|FG001|Overall Study|Not treated with BI 836826|0|||
30831342|NCT02759016|58855731|FG000|Overall Study|Progressive disease|1|||
30831343|NCT02759016|58855732|FG001|Overall Study|Progressive disease|0|||
30831344|NCT02759016|58855731|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
30831345|NCT02759016|58855732|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
30831346|NCT02759016|58855731|FG000|Overall Study|Other not defined above|2|||
30831347|NCT02759016|58855732|FG001|Overall Study|Other not defined above|1|||
30831348|NCT02852967|58855744|FG000|Overall Study|Adverse Event|3|||
30831349|NCT02852967|58855745|FG001|Overall Study|Adverse Event|1|||
30831350|NCT02852967|58855746|FG002|Overall Study|Adverse Event|0|||
30831351|NCT02852967|58855747|FG003|Overall Study|Adverse Event|1|||
30831352|NCT02852967|58855748|FG004|Overall Study|Adverse Event|0|||
30831353|NCT02852967|58855744|FG000|Overall Study|Death|1|||
30831354|NCT02852967|58855745|FG001|Overall Study|Death|0|||
30922785|NCT02111564|58958082|FG001|Overall Study|Death|120|||
30922786|NCT02111564|58958081|FG000|Overall Study|Lost to Follow-up|2|||
30922787|NCT02111564|58958082|FG001|Overall Study|Lost to Follow-up|3|||
30922788|NCT02111564|58958081|FG000|Overall Study|Withdrawal by Subject|20|||
30922789|NCT02111564|58958082|FG001|Overall Study|Withdrawal by Subject|20|||
30922790|NCT02087150|58958091|FG000|Overall Study|Death|0|||
30922791|NCT02087150|58958092|FG001|Overall Study|Death|1|||
30755579|NCT03682120|58765526|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
30755580|NCT03682120|58765527|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
30755581|NCT03682120|58765528|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
30755582|NCT03682120|58765529|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
30755583|NCT04428502|58765541|FG000|Overall Study|Did not meet entrance criteria|14|||
30755584|NCT04428424|58765546|FG000|Overall Study|Does not meet entrance criteria|132|||
30755585|NCT04428424|58765546|FG000|Overall Study|Lost to Follow-up|115|||
30755586|NCT03655756|58765550|FG000|Overall Study|Death|1|||
30755587|NCT00095238|58765556|FG000|Overall Study|Lack of Efficacy|9|||
30755588|NCT00095238|58765557|FG001|Overall Study|Lack of Efficacy|9|||
30755589|NCT00095238|58765556|FG000|Overall Study|Adverse Event|331|||
30755590|NCT00095238|58765557|FG001|Overall Study|Adverse Event|287|||
30755591|NCT00095238|58765556|FG000|Overall Study|Subject Withdrew Consent|208|||
30755592|NCT00095238|58765557|FG001|Overall Study|Subject Withdrew Consent|223|||
30755593|NCT00095238|58765556|FG000|Overall Study|Death|154|||
30755594|NCT00095238|58765557|FG001|Overall Study|Death|170|||
30755595|NCT00095238|58765556|FG000|Overall Study|Lost to Follow-up|19|||
30755596|NCT00095238|58765557|FG001|Overall Study|Lost to Follow-up|24|||
30755597|NCT00095238|58765556|FG000|Overall Study|Noncompliance|44|||
30755598|NCT00095238|58765557|FG001|Overall Study|Noncompliance|45|||
30755599|NCT00095238|58765556|FG000|Overall Study|No longer met study criteria|4|||
30755600|NCT00095238|58765557|FG001|Overall Study|No longer met study criteria|5|||
30755601|NCT00095238|58765556|FG000|Overall Study|Study terminated by sponsor|0|||
30755602|NCT00095238|58765557|FG001|Overall Study|Study terminated by sponsor|1|||
30755603|NCT00095238|58765556|FG000|Overall Study|Missing|1|||
30755604|NCT00095238|58765557|FG001|Overall Study|Missing|0|||
30755605|NCT00095238|58765556|FG000|Overall Study|Other Reasons|87|||
30755606|NCT00095238|58765557|FG001|Overall Study|Other Reasons|88|||
30755607|NCT00082368|58765595|FG000|Overall Study|Not treated-pt had poor IV access|1|||
30755608|NCT00094770|58765601|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
30755609|NCT00094770|58765602|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
30755610|NCT00094770|58765601|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
30755611|NCT00094770|58765602|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
30831355|NCT02852967|58855746|FG002|Overall Study|Death|0|||
30831356|NCT02852967|58855747|FG003|Overall Study|Death|0|||
30831357|NCT02852967|58855748|FG004|Overall Study|Death|0|||
30831358|NCT02852967|58855744|FG000|Overall Study|Lost to Follow-up|1|||
30831359|NCT02852967|58855745|FG001|Overall Study|Lost to Follow-up|2|||
30831360|NCT02852967|58855746|FG002|Overall Study|Lost to Follow-up|3|||
30755612|NCT00094770|58765601|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
30755613|NCT00094770|58765602|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
30755614|NCT00094770|58765601|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
30755615|NCT00094770|58765602|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
30831361|NCT02852967|58855747|FG003|Overall Study|Lost to Follow-up|4|||
30831362|NCT02852967|58855748|FG004|Overall Study|Lost to Follow-up|4|||
30922792|NCT02087150|58958093|FG002|Overall Study|Death|0|||
30922793|NCT02087150|58958091|FG000|Overall Study|Lost to Follow-up|6|||
30922794|NCT02087150|58958092|FG001|Overall Study|Lost to Follow-up|13|||
30922795|NCT02087150|58958093|FG002|Overall Study|Lost to Follow-up|7|||
30922796|NCT02087150|58958091|FG000|Overall Study|Withdrawal by Subject|2|||
30922797|NCT02087150|58958092|FG001|Overall Study|Withdrawal by Subject|5|||
30922798|NCT02087150|58958093|FG002|Overall Study|Withdrawal by Subject|3|||
30922799|NCT02087150|58958091|FG000|Overall Study|Physician Decision|0|||
30922800|NCT02087150|58958092|FG001|Overall Study|Physician Decision|1|||
30922801|NCT02087150|58958093|FG002|Overall Study|Physician Decision|0|||
30922802|NCT02087150|58958091|FG000|Overall Study|Procedure not done|1|||
30831363|NCT02852967|58855744|FG000|Overall Study|Withdrawal by Subject|6|||
30831364|NCT02852967|58855745|FG001|Overall Study|Withdrawal by Subject|12|||
30831365|NCT02852967|58855746|FG002|Overall Study|Withdrawal by Subject|7|||
30831366|NCT02852967|58855747|FG003|Overall Study|Withdrawal by Subject|10|||
30831367|NCT02852967|58855748|FG004|Overall Study|Withdrawal by Subject|10|||
30831368|NCT02852967|58855744|FG000|Overall Study|SAE|0|||
30831369|NCT02852967|58855745|FG001|Overall Study|SAE|0|||
30831370|NCT02852967|58855746|FG002|Overall Study|SAE|0|||
30831371|NCT02852967|58855747|FG003|Overall Study|SAE|3|||
30831372|NCT02852967|58855748|FG004|Overall Study|SAE|0|||
30831373|NCT02852967|58855744|FG000|Overall Study|Elevated Liver Enzymes|2|||
30831374|NCT02852967|58855745|FG001|Overall Study|Elevated Liver Enzymes|0|||
30831375|NCT02852967|58855746|FG002|Overall Study|Elevated Liver Enzymes|0|||
30831376|NCT02852967|58855747|FG003|Overall Study|Elevated Liver Enzymes|2|||
30831377|NCT02852967|58855748|FG004|Overall Study|Elevated Liver Enzymes|2|||
30831378|NCT02852967|58855744|FG000|Overall Study|Physician Decision|0|||
30831379|NCT02852967|58855745|FG001|Overall Study|Physician Decision|0|||
30831380|NCT02852967|58855746|FG002|Overall Study|Physician Decision|0|||
30831381|NCT02852967|58855747|FG003|Overall Study|Physician Decision|1|||
30831382|NCT02852967|58855748|FG004|Overall Study|Physician Decision|0|||
30831383|NCT02852967|58855744|FG000|Overall Study|Lack of Efficacy|0|||
30831384|NCT02852967|58855745|FG001|Overall Study|Lack of Efficacy|1|||
30831385|NCT02852967|58855746|FG002|Overall Study|Lack of Efficacy|0|||
30831386|NCT02852967|58855747|FG003|Overall Study|Lack of Efficacy|0|||
30831387|NCT02852967|58855748|FG004|Overall Study|Lack of Efficacy|0|||
30831388|NCT02852967|58855744|FG000|Overall Study|Non-compliance|0|||
30831389|NCT02852967|58855745|FG001|Overall Study|Non-compliance|0|||
30831390|NCT02852967|58855746|FG002|Overall Study|Non-compliance|1|||
30831391|NCT02852967|58855747|FG003|Overall Study|Non-compliance|1|||
30831392|NCT02852967|58855748|FG004|Overall Study|Non-compliance|0|||
30831393|NCT02852967|58855744|FG000|Overall Study|Dispensing Drug Violation|0|||
30831394|NCT02852967|58855745|FG001|Overall Study|Dispensing Drug Violation|0|||
30922803|NCT02087150|58958092|FG001|Overall Study|Procedure not done|13|||
30922804|NCT02087150|58958093|FG002|Overall Study|Procedure not done|0|||
30922805|NCT02087150|58958091|FG000|Overall Study|F/U not completed w/in study window|0|||
30922806|NCT02087150|58958092|FG001|Overall Study|F/U not completed w/in study window|0|||
30922807|NCT02087150|58958093|FG002|Overall Study|F/U not completed w/in study window|1|||
30922808|NCT02087150|58958091|FG000|Overall Study|Other|1|||
30922809|NCT02087150|58958092|FG001|Overall Study|Other|0|||
30922810|NCT02087150|58958093|FG002|Overall Study|Other|0|||
30922811|NCT02087150|58958091|FG000|Overall Study|Pt moved out of town|0|||
30922812|NCT02087150|58958092|FG001|Overall Study|Pt moved out of town|1|||
30922813|NCT02087150|58958093|FG002|Overall Study|Pt moved out of town|0|||
30922814|NCT02111174|58958104|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
30922815|NCT02111174|58958105|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
30922816|NCT02111174|58958104|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
30922817|NCT02111174|58958105|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
30922818|NCT02111174|58958104|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
30922819|NCT02111174|58958105|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
30922820|NCT02111174|58958104|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
30922821|NCT02111174|58958105|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
30831395|NCT02852967|58855746|FG002|Overall Study|Dispensing Drug Violation|1|||
30831396|NCT02852967|58855747|FG003|Overall Study|Dispensing Drug Violation|0|||
30831397|NCT02852967|58855748|FG004|Overall Study|Dispensing Drug Violation|0|||
30922822|NCT02111096|58958114|FG000|Overall Study|Adverse Event|4|||
30922823|NCT02111096|58958115|FG001|Overall Study|Adverse Event|1|||
30922824|NCT02111096|58958116|FG002|Overall Study|Adverse Event|2|||
30831398|NCT02852967|58855744|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
30831399|NCT02852967|58855745|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
30831400|NCT02852967|58855746|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
30831401|NCT02852967|58855747|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
30831402|NCT02852967|58855748|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
30922825|NCT02111096|58958114|FG000|Overall Study|Non-Compliance with Study Drug|1|||
30922826|NCT02111096|58958115|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30922827|NCT02111096|58958116|FG002|Overall Study|Non-Compliance with Study Drug|0|||
30922828|NCT02111096|58958114|FG000|Overall Study|Lost to Follow Up|1|||
30922829|NCT02111096|58958115|FG001|Overall Study|Lost to Follow Up|1|||
30922830|NCT02111096|58958116|FG002|Overall Study|Lost to Follow Up|1|||
30922831|NCT02111096|58958114|FG000|Overall Study|Physician Decision|0|||
30922832|NCT02111096|58958115|FG001|Overall Study|Physician Decision|1|||
30922833|NCT02111096|58958116|FG002|Overall Study|Physician Decision|0|||
30922834|NCT02111096|58958114|FG000|Overall Study|Protocol Violation|1|||
30922835|NCT02111096|58958115|FG001|Overall Study|Protocol Violation|0|||
30922836|NCT02111096|58958116|FG002|Overall Study|Protocol Violation|1|||
30922837|NCT02111096|58958114|FG000|Overall Study|Terminated by Sponsor|53|||
30922838|NCT02111096|58958115|FG001|Overall Study|Terminated by Sponsor|35|||
30922839|NCT02111096|58958116|FG002|Overall Study|Terminated by Sponsor|54|||
30922840|NCT02111096|58958114|FG000|Overall Study|Withdrawal by Subject|4|||
30831403|NCT02762994|58855776|FG000|Overall Study|Withdrawal by Subject|0|||
30831404|NCT02762994|58855777|FG001|Overall Study|Withdrawal by Subject|1|||
30831405|NCT02762994|58855778|FG002|Overall Study|Withdrawal by Subject|2|||
30831406|NCT02762994|58855779|FG003|Overall Study|Withdrawal by Subject|0|||
30831407|NCT02762994|58855776|FG000|Overall Study|Protocol Violation|1|||
30831408|NCT02762994|58855777|FG001|Overall Study|Protocol Violation|0|||
30831409|NCT02762994|58855778|FG002|Overall Study|Protocol Violation|0|||
30831410|NCT02762994|58855779|FG003|Overall Study|Protocol Violation|2|||
30831411|NCT02852265|58855795|FG000|3-month Follow-up|Lost to Follow-up|1|||
30831412|NCT02852265|58855796|FG001|3-month Follow-up|Lost to Follow-up|1|||
30831413|NCT02633800|58855808|FG000|Overall Study|Death|3|||
30831414|NCT02633800|58855809|FG001|Overall Study|Death|3|||
30831415|NCT02633800|58855808|FG000|Overall Study|Reason not provided|1|||
30755616|NCT00094770|58765601|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
30922841|NCT02111096|58958115|FG001|Overall Study|Withdrawal by Subject|2|||
30922842|NCT02111096|58958116|FG002|Overall Study|Withdrawal by Subject|8|||
30922843|NCT02110706|58958129|FG000|Overall Study|Adverse Event|2|||
30922844|NCT02110706|58958130|FG001|Overall Study|Adverse Event|3|||
30922845|NCT02110706|58958129|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
30922846|NCT02110706|58958130|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
30922847|NCT02110238|58958140|FG000|12 Week Pivotal Phase|Adverse Event|3|||
30922848|NCT02110238|58958141|FG001|12 Week Pivotal Phase|Adverse Event|0|||
30922849|NCT02110238|58958140|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
30922850|NCT02110238|58958141|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
30922851|NCT02110238|58958140|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
30922852|NCT02110238|58958141|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
30831416|NCT02633800|58855809|FG001|Overall Study|Reason not provided|0|||
30831417|NCT02633800|58855808|FG000|Overall Study|Radiologic(al) progression|23|||
30831418|NCT02633800|58855809|FG001|Overall Study|Radiologic(al) progression|23|||
30831419|NCT02633800|58855808|FG000|Overall Study|Clinical progression|3|||
30831420|NCT02633800|58855809|FG001|Overall Study|Clinical progression|6|||
30831421|NCT02633800|58855808|FG000|Overall Study|Study terminated by sponsor|6|||
30831422|NCT02633800|58855809|FG001|Overall Study|Study terminated by sponsor|5|||
30922853|NCT02110238|58958140|FG000|12 Week Pivotal Phase|Physician Decision|0|||
30922854|NCT02110238|58958141|FG001|12 Week Pivotal Phase|Physician Decision|2|||
30755617|NCT00094770|58765602|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
30755618|NCT00094770|58765601|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
30755619|NCT00094770|58765602|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
30755620|NCT00094770|58765601|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
30755621|NCT00094770|58765602|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
30755622|NCT00094770|58765601|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
30755623|NCT00094770|58765602|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
30755624|NCT00094770|58765601|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
30755625|NCT00094770|58765602|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
30755626|NCT00094770|58765601|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
30831423|NCT02633800|58855808|FG000|Overall Study|Adverse event, non-fatal|7|||
30831424|NCT02633800|58855809|FG001|Overall Study|Adverse event, non-fatal|2|||
30831425|NCT02633800|58855808|FG000|Overall Study|Withdrawal by Subject|0|||
30922855|NCT02110238|58958140|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
30922856|NCT02110238|58958141|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
30922857|NCT02110238|58958140|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
30922858|NCT02110238|58958141|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
30755627|NCT00094770|58765602|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
30831426|NCT02633800|58855809|FG001|Overall Study|Withdrawal by Subject|3|||
30831427|NCT02633800|58855808|FG000|Overall Study|Patient Request|1|||
30831428|NCT02633800|58855809|FG001|Overall Study|Patient Request|1|||
30831429|NCT03829657|58855818|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
30831430|NCT03829657|58855819|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
30831431|NCT03829657|58855820|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
30831432|NCT03829657|58855821|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
30831433|NCT03829657|58855822|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
30831434|NCT03829657|58855818|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
30831435|NCT03829657|58855819|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
30831436|NCT03829657|58855820|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
30831437|NCT03829657|58855821|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
30831438|NCT03829657|58855822|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
30831439|NCT03829657|58855818|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
30831440|NCT03829657|58855819|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
30831441|NCT03829657|58855820|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
30831442|NCT03829657|58855821|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
30831443|NCT03829657|58855822|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
30831444|NCT03829657|58855818|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
30831445|NCT03829657|58855819|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
30831446|NCT03829657|58855820|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
30831447|NCT03829657|58855821|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
30831448|NCT03829657|58855822|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
30831449|NCT03829657|58855818|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
30831450|NCT03829657|58855819|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
30831451|NCT03829657|58855820|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
30831452|NCT03829657|58855821|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
30831453|NCT03829657|58855822|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
30831454|NCT03829657|58855818|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
30831455|NCT03829657|58855819|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
30831456|NCT03829657|58855820|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
30831457|NCT03829657|58855821|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
30831458|NCT03829657|58855822|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
30831459|NCT03829657|58855818|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
30831460|NCT03829657|58855819|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
30831461|NCT03829657|58855820|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
30831462|NCT03829657|58855821|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
30831463|NCT03829657|58855822|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
30831464|NCT03829657|58855818|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
30831465|NCT03829657|58855819|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
30843630|NCT02101853|58869615|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
30843631|NCT02101853|58869616|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
30843632|NCT02101853|58869617|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
30843633|NCT02101853|58869612|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
30843634|NCT02101853|58869613|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
30831466|NCT03829657|58855820|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
30831467|NCT03829657|58855821|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
30831468|NCT03829657|58855822|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
30831469|NCT03829657|58855818|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
30831470|NCT03829657|58855819|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
30831471|NCT03829657|58855820|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
30831472|NCT03829657|58855821|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
30922859|NCT02110238|58958140|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
30831473|NCT03829657|58855822|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
30831474|NCT03829657|58855818|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
30831475|NCT03829657|58855819|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
30831476|NCT03829657|58855820|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
30831477|NCT03829657|58855821|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
30831478|NCT03829657|58855822|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
30831479|NCT03035227|58855833|FG000|Overall Study|study stopped due to PI leaving institut|1|||
30831480|NCT03035227|58855834|FG001|Overall Study|study stopped due to PI leaving institut|1|||
30831481|NCT00100932|58855844|FG000|Overall Study|Adverse Event|11|||
30831482|NCT00100932|58855845|FG001|Overall Study|Adverse Event|2|||
30831483|NCT00100932|58855844|FG000|Overall Study|Withdrawal by Subject|6|||
30831484|NCT00100932|58855845|FG001|Overall Study|Withdrawal by Subject|0|||
30831485|NCT00100932|58855844|FG000|Overall Study|Progressive Disease|44|||
30831486|NCT00100932|58855845|FG001|Overall Study|Progressive Disease|18|||
30831487|NCT00100932|58855844|FG000|Overall Study|Physician Decision|7|||
30831488|NCT00100932|58855845|FG001|Overall Study|Physician Decision|5|||
30831489|NCT00100932|58855844|FG000|Overall Study|Other|5|||
30831490|NCT00100932|58855845|FG001|Overall Study|Other|2|||
30831491|NCT03180307|58855853|FG000|Overall Study|Lost to Follow-up|2|||
30831492|NCT03180307|58855854|FG001|Overall Study|Lost to Follow-up|0|||
30831493|NCT03180307|58855853|FG000|Overall Study|Death|1|||
30831494|NCT03180307|58855854|FG001|Overall Study|Death|0|||
30831495|NCT03180307|58855853|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
30831496|NCT03180307|58855854|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
30831497|NCT02848833|58855858|FG000|Overall Study|subject who are duplicated|1|||
30831498|NCT02848833|58855858|FG000|Overall Study|have not taken the study drug|11|||
30831499|NCT02848833|58855858|FG000|Overall Study|follow-up failure|6|||
30831500|NCT02848833|58855858|FG000|Overall Study|Protocol Violation|119|||
30831501|NCT03361189|58855864|FG000|Overall Study|Received heart transplant|1|||
30831502|NCT03361189|58855865|FG001|Overall Study|Received heart transplant|0|||
30831503|NCT03361189|58855864|FG000|Overall Study|Pacemake replacement|0|||
30831504|NCT03361189|58855865|FG001|Overall Study|Pacemake replacement|1|||
30831505|NCT00092131|58855873|FG000|Treatment Period I|Adverse Event|1|||
30831506|NCT00092131|58855874|FG001|Treatment Period I|Adverse Event|0|||
30831507|NCT00092131|58855873|FG000|Treatment Period II|Adverse Event|0|||
30831508|NCT00092131|58855874|FG001|Treatment Period II|Adverse Event|1|||
30831509|NCT02668783|58855882|FG000|Overall Study|Pregnancy|0|||
30831510|NCT02668783|58855883|FG001|Overall Study|Pregnancy|1|||
30831511|NCT02668783|58855882|FG000|Overall Study|Protocol Violation|2|||
30831512|NCT02668783|58855883|FG001|Overall Study|Protocol Violation|1|||
30831513|NCT02668783|58855882|FG000|Overall Study|Study terminated by sponsor|9|||
30831514|NCT02668783|58855883|FG001|Overall Study|Study terminated by sponsor|10|||
30831515|NCT02668783|58855882|FG000|Overall Study|Subject moved|1|||
30831516|NCT02668783|58855883|FG001|Overall Study|Subject moved|0|||
30831517|NCT02668783|58855882|FG000|Overall Study|Withdrawal by Subject|1|||
30831518|NCT02668783|58855883|FG001|Overall Study|Withdrawal by Subject|0|||
30831519|NCT00101010|58855889|FG000|Overall Study|Physician Decision|1|||
30831520|NCT02848599|58855895|FG000|Overall Study|Protocol Violation|7|||
30831521|NCT02848599|58855896|FG001|Overall Study|Protocol Violation|9|||
30831522|NCT00778999|58855927|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
30831523|NCT00778999|58855928|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
30831524|NCT00778999|58855927|FG000|Overall Study|Did not receive recFSH|14|||
30831525|NCT00778999|58855928|FG001|Overall Study|Did not receive recFSH|20|||
30831526|NCT02631850|58855938|FG000|Treatment Period|Lost to Follow-up|0|||
30831527|NCT02631850|58855939|FG001|Treatment Period|Lost to Follow-up|1|||
30831528|NCT02631850|58855940|FG002|Treatment Period|Lost to Follow-up|0|||
30831529|NCT02631850|58855941|FG003|Treatment Period|Lost to Follow-up|0|||
30831530|NCT02631850|58855938|FG000|Treatment Period|Protocol Violation|1|||
30831531|NCT02631850|58855939|FG001|Treatment Period|Protocol Violation|0|||
30831532|NCT02631850|58855940|FG002|Treatment Period|Protocol Violation|0|||
30831533|NCT02631850|58855941|FG003|Treatment Period|Protocol Violation|0|||
30831534|NCT02631850|58855938|FG000|Treatment Period|Withdrawal by Subject|0|||
30831535|NCT02631850|58855939|FG001|Treatment Period|Withdrawal by Subject|5|||
30831536|NCT02631850|58855940|FG002|Treatment Period|Withdrawal by Subject|2|||
30831537|NCT02631850|58855941|FG003|Treatment Period|Withdrawal by Subject|2|||
30831538|NCT02631850|58855938|FG000|Treatment Period|Adverse Event|1|||
30831539|NCT02631850|58855939|FG001|Treatment Period|Adverse Event|0|||
30831540|NCT02631850|58855940|FG002|Treatment Period|Adverse Event|2|||
30831541|NCT02631850|58855941|FG003|Treatment Period|Adverse Event|3|||
30831542|NCT02631850|58855938|FG000|Treatment Period|Family medical issue|1|||
30831543|NCT02631850|58855939|FG001|Treatment Period|Family medical issue|0|||
30831544|NCT02631850|58855940|FG002|Treatment Period|Family medical issue|0|||
30831545|NCT02631850|58855941|FG003|Treatment Period|Family medical issue|0|||
30831546|NCT02631850|58855938|FG000|6 Month Follow up|Lost to Follow-up|5|||
30831547|NCT02631850|58855939|FG001|6 Month Follow up|Lost to Follow-up|8|||
30831548|NCT02631850|58855940|FG002|6 Month Follow up|Lost to Follow-up|3|||
30831549|NCT02631850|58855941|FG003|6 Month Follow up|Lost to Follow-up|5|||
30831550|NCT02631850|58855938|FG000|6 Month Follow up|Withdrawal by Subject|1|||
30831551|NCT02631850|58855939|FG001|6 Month Follow up|Withdrawal by Subject|0|||
30831552|NCT02631850|58855940|FG002|6 Month Follow up|Withdrawal by Subject|0|||
30831553|NCT02631850|58855941|FG003|6 Month Follow up|Withdrawal by Subject|2|||
30831554|NCT02631850|58855938|FG000|6 Month Follow up|Adverse Event|1|||
30831555|NCT02631850|58855939|FG001|6 Month Follow up|Adverse Event|4|||
30831556|NCT02631850|58855940|FG002|6 Month Follow up|Adverse Event|1|||
30831557|NCT02631850|58855941|FG003|6 Month Follow up|Adverse Event|3|||
30831558|NCT02631850|58855938|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
30831559|NCT02631850|58855939|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
30831560|NCT02631850|58855940|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
30831561|NCT02631850|58855941|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
30831562|NCT00103038|58855952|FG000|Overall Study|Withdrawal by Subject|8|||
30831563|NCT00103038|58855952|FG000|Overall Study|Screen failure|3|||
30831564|NCT00103038|58855952|FG000|Overall Study|Death|1|||
30831565|NCT00103038|58855952|FG000|Overall Study|Physician Decision|1|||
30831566|NCT00620035|58855959|FG000|Overall Study|Adverse Event|106|||
30922860|NCT02110238|58958141|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
30922861|NCT02110238|58958140|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
30831567|NCT00620035|58855959|FG000|Overall Study|Withdrawal of Informed Consent|1|||
30831568|NCT00620035|58855959|FG000|Overall Study|Other Reason|38|||
30831569|NCT03034057|58855963|FG000|Overall Study|Withdrawal by Subject|10|||
30831570|NCT03034057|58855963|FG000|Overall Study|Protocol Violation|1|||
30831571|NCT03034057|58855963|FG000|Overall Study|Not defined|2|||
30831572|NCT03034057|58855963|FG000|Overall Study|Lost to Follow-up|19|||
30831573|NCT03034057|58855963|FG000|Overall Study|Adverse Event|22|||
30831574|NCT03034057|58855963|FG000|Overall Study|Medication error without associated AE|1|||
30831575|NCT02757768|58855969|FG000|Overall Study|Randomized Never Received Study Drug|3|||
30831576|NCT02757768|58855970|FG001|Overall Study|Randomized Never Received Study Drug|4|||
30831577|NCT02757768|58855969|FG000|Overall Study|Adverse Event|5|||
30831578|NCT02757768|58855970|FG001|Overall Study|Adverse Event|3|||
30831579|NCT02757768|58855969|FG000|Overall Study|Lack of Efficacy|2|||
30831580|NCT02757768|58855970|FG001|Overall Study|Lack of Efficacy|1|||
30831581|NCT02757768|58855969|FG000|Overall Study|Lost to Follow-up|1|||
30831582|NCT02757768|58855970|FG001|Overall Study|Lost to Follow-up|0|||
30831583|NCT02757768|58855969|FG000|Overall Study|Protocol Deviation|2|||
30831584|NCT02757768|58855970|FG001|Overall Study|Protocol Deviation|9|||
30831585|NCT02757768|58855969|FG000|Overall Study|Withdrawal by Subject|16|||
30922862|NCT02110238|58958141|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
30922863|NCT02110238|58958140|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
30831586|NCT02757768|58855970|FG001|Overall Study|Withdrawal by Subject|9|||
30831587|NCT02757768|58855969|FG000|Overall Study|Miscellaneous|4|||
30831588|NCT02757768|58855970|FG001|Overall Study|Miscellaneous|2|||
30831589|NCT05225389|58855978|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
30922864|NCT02110238|58958141|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
30922865|NCT02110238|58958140|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
30922866|NCT02110238|58958141|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
30922867|NCT02110238|58958140|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
30922868|NCT02110238|58958141|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
30922869|NCT02108912|58958149|FG000|Overall Study|Lost to Follow-up|1|||
30831590|NCT02753946|58855984|FG000|Overall Study|Adverse Event|7|||
30831591|NCT02753946|58855985|FG001|Overall Study|Adverse Event|6|||
30922870|NCT02108912|58958150|FG001|Overall Study|Lost to Follow-up|1|||
30922871|NCT02108912|58958149|FG000|Overall Study|lack of transportation|1|||
30922872|NCT02108912|58958150|FG001|Overall Study|lack of transportation|0|||
30922873|NCT02108912|58958149|FG000|Overall Study|high blood pressure|1|||
30922874|NCT02108912|58958150|FG001|Overall Study|high blood pressure|0|||
30922875|NCT02108600|58958158|FG000|Overall Study|Withdrawal by Subject|2|||
30922876|NCT02108600|58958159|FG001|Overall Study|Withdrawal by Subject|0|||
30922877|NCT02108600|58958158|FG000|Overall Study|Lost to Follow-up|1|||
30922878|NCT02108600|58958159|FG001|Overall Study|Lost to Follow-up|1|||
30922879|NCT02107898|58958167|FG000|Overall Study|Adverse Event|4|||
30922880|NCT02107898|58958168|FG001|Overall Study|Adverse Event|7|||
30922881|NCT02107898|58958167|FG000|Overall Study|Poor compliance to protocol|0|||
30922882|NCT02107898|58958168|FG001|Overall Study|Poor compliance to protocol|1|||
30922883|NCT02107898|58958167|FG000|Overall Study|Participant moved|0|||
30922884|NCT02107898|58958168|FG001|Overall Study|Participant moved|2|||
30922885|NCT02107898|58958167|FG000|Overall Study|Consent withdrawn by participant|2|||
30922886|NCT02107898|58958168|FG001|Overall Study|Consent withdrawn by participant|1|||
30922887|NCT02107898|58958167|FG000|Overall Study|Randomized but not treated|0|||
30922888|NCT02107898|58958168|FG001|Overall Study|Randomized but not treated|1|||
30922889|NCT02059148|58958174|FG000|Treatment 1|Protocol Violation|0|||
30922890|NCT02059148|58958175|FG001|Treatment 1|Protocol Violation|0|||
30831592|NCT02753946|58855984|FG000|Overall Study|Withdrawal by Subject|6|||
30831593|NCT02753946|58855985|FG001|Overall Study|Withdrawal by Subject|1|||
30831594|NCT02753946|58855984|FG000|Overall Study|Lack of Efficacy|1|||
30831595|NCT02753946|58855985|FG001|Overall Study|Lack of Efficacy|0|||
30831596|NCT02753946|58855984|FG000|Overall Study|Physician Decision|0|||
30831597|NCT02753946|58855985|FG001|Overall Study|Physician Decision|2|||
30831598|NCT02756832|58855991|FG000|Overall Study|Lost for Observation after Baseline|6|||
30831599|NCT02756832|58855991|FG000|Overall Study|Lost for Observation|13|||
30831600|NCT02756832|58855991|FG000|Overall Study|Patient's Unwillingness|12|||
30831601|NCT02756832|58855991|FG000|Overall Study|Insufficient Efficacy|2|||
30831602|NCT02756832|58855991|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
30831603|NCT02756832|58855991|FG000|Overall Study|Reason not Specified|9|||
30831604|NCT02756832|58855991|FG000|Overall Study|Protocol Deviation|10|||
30831605|NCT00106080|58855997|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
30831606|NCT00106080|58855998|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
30831607|NCT02633020|58856006|FG000|Overall Study|Adverse Event|1|||
30831608|NCT02633020|58856007|FG001|Overall Study|Adverse Event|0|||
30831609|NCT00106626|58856017|FG000|Overall Study|Adverse Event|5|||
30831610|NCT00106626|58856018|FG001|Overall Study|Adverse Event|4|||
30831611|NCT00106626|58856019|FG002|Overall Study|Adverse Event|3|||
30831612|NCT00106626|58856020|FG003|Overall Study|Adverse Event|3|||
30922891|NCT02059148|58958176|FG002|Treatment 1|Protocol Violation|0|||
30922892|NCT02059148|58958177|FG003|Treatment 1|Protocol Violation|0|||
30922893|NCT02059148|58958178|FG004|Treatment 1|Protocol Violation|0|||
30922894|NCT02059148|58958179|FG005|Treatment 1|Protocol Violation|1|||
30922895|NCT02058992|58958190|FG000|Overall Study|Lost to Follow-up|4|||
30922896|NCT02058992|58958190|FG000|Overall Study|Protocol Violation|92|||
30922897|NCT02058992|58958190|FG000|Overall Study|CRF Uncollected|20|||
30831613|NCT00106626|58856017|FG000|Overall Study|Progressive Disease|4|||
30831614|NCT00106626|58856018|FG001|Overall Study|Progressive Disease|1|||
30831615|NCT00106626|58856019|FG002|Overall Study|Progressive Disease|9|||
30831616|NCT00106626|58856020|FG003|Overall Study|Progressive Disease|10|||
30831617|NCT00106626|58856017|FG000|Overall Study|Received radiation on new therapy|1|||
30831618|NCT00106626|58856018|FG001|Overall Study|Received radiation on new therapy|0|||
30831619|NCT00106626|58856019|FG002|Overall Study|Received radiation on new therapy|0|||
30922898|NCT02058836|58958196|FG000|Overall Study|Withdrawal by Subject|1|||
30922899|NCT02058836|58958197|FG001|Overall Study|Withdrawal by Subject|1|||
30922900|NCT02107274|58958205|FG000|Treatment vs. Placebo|Adverse Event|3|||
30922901|NCT02107274|58958206|FG001|Treatment vs. Placebo|Adverse Event|0|||
30922902|NCT02107274|58958205|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
30623833|NCT01167257|58635692|FG001|Overall Study|Withdrew consent|1|||
30922903|NCT02107274|58958206|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
30922904|NCT02107274|58958205|FG000|Control Phase|Lost to Follow-up|1|||
30922905|NCT02107274|58958206|FG001|Control Phase|Lost to Follow-up|1|||
30922906|NCT02107274|58958205|FG000|Control Phase|Death|2|||
30922907|NCT02107274|58958206|FG001|Control Phase|Death|0|||
30831620|NCT00106626|58856020|FG003|Overall Study|Received radiation on new therapy|0|||
30831621|NCT00106626|58856017|FG000|Overall Study|> 14 day delay in therapy start|0|||
30831622|NCT00106626|58856018|FG001|Overall Study|> 14 day delay in therapy start|1|||
30831623|NCT00106626|58856019|FG002|Overall Study|> 14 day delay in therapy start|0|||
30831624|NCT00106626|58856020|FG003|Overall Study|> 14 day delay in therapy start|0|||
30831625|NCT02632786|58856037|FG000|Overall Study|Adverse Event|2|||
30831626|NCT02632786|58856038|FG001|Overall Study|Adverse Event|1|||
30831627|NCT02632786|58856037|FG000|Overall Study|Death|3|||
30831628|NCT02632786|58856038|FG001|Overall Study|Death|2|||
30831629|NCT02632786|58856037|FG000|Overall Study|Physician Decision|5|||
30831630|NCT02632786|58856038|FG001|Overall Study|Physician Decision|4|||
30831631|NCT02632786|58856037|FG000|Overall Study|Withdrawal by Subject|1|||
30922908|NCT02107274|58958205|FG000|Control Phase|Adverse Event|0|||
30922909|NCT02107274|58958206|FG001|Control Phase|Adverse Event|1|||
30922910|NCT02174627|58958214|FG000|Overall Study|Missing|0|||
30922911|NCT02174627|58958215|FG001|Overall Study|Missing|1|||
30922912|NCT02174627|58958214|FG000|Overall Study|Incorrect enrolment before randomization|0|||
30922913|NCT02174627|58958215|FG001|Overall Study|Incorrect enrolment before randomization|1|||
30922914|NCT02174627|58958214|FG000|Overall Study|Participant decision|84|||
30922915|NCT02174627|58958215|FG001|Overall Study|Participant decision|128|||
30922916|NCT02173769|58958221|FG000|Overall Study|Protocol Violation|4|||
30922917|NCT02121509|58958228|FG000|Washout Period (35 Days)|Adverse Event|1|||
30922918|NCT02121509|58958229|FG001|Washout Period (35 Days)|Adverse Event|1|||
30922919|NCT02121509|58958230|FG002|Washout Period (35 Days)|Adverse Event|0|||
30922920|NCT02121509|58958231|FG003|Washout Period (35 Days)|Adverse Event|0|||
30922921|NCT02121509|58958228|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
30922922|NCT02121509|58958229|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
30831632|NCT02632786|58856038|FG001|Overall Study|Withdrawal by Subject|0|||
30831633|NCT02755818|58856049|FG000|Overall Study|Withdrawal by Subject|0|||
30831634|NCT02755818|58856050|FG001|Overall Study|Withdrawal by Subject|0|||
30831635|NCT02755818|58856051|FG002|Overall Study|Withdrawal by Subject|0|||
30831636|NCT02755818|58856052|FG003|Overall Study|Withdrawal by Subject|2|||
30831637|NCT02755818|58856049|FG000|Overall Study|withdrawal by PI|0|||
30831638|NCT02755818|58856050|FG001|Overall Study|withdrawal by PI|0|||
30831639|NCT02755818|58856051|FG002|Overall Study|withdrawal by PI|1|||
30831640|NCT02755818|58856052|FG003|Overall Study|withdrawal by PI|1|||
30831641|NCT03033745|58856067|FG000|Overall Study|Protocol Violation|0|||
30831642|NCT03033745|58856068|FG001|Overall Study|Protocol Violation|0|||
30831643|NCT03033745|58856069|FG002|Overall Study|Protocol Violation|1|||
30831644|NCT03033745|58856067|FG000|Overall Study|Adverse Event|1|||
30831645|NCT03033745|58856068|FG001|Overall Study|Adverse Event|0|||
30831646|NCT03033745|58856069|FG002|Overall Study|Adverse Event|1|||
30831647|NCT03033745|58856067|FG000|Overall Study|Withdrawal by Subject|0|||
30831648|NCT03033745|58856068|FG001|Overall Study|Withdrawal by Subject|1|||
30831649|NCT03033745|58856069|FG002|Overall Study|Withdrawal by Subject|0|||
30831650|NCT01672294|58856088|FG000|Overall Study|Withdrawal by Subject|4|||
30831651|NCT01672294|58856089|FG001|Overall Study|Withdrawal by Subject|4|||
30831652|NCT01672294|58856090|FG002|Overall Study|Withdrawal by Subject|4|||
30831653|NCT01672294|58856091|FG003|Overall Study|Withdrawal by Subject|4|||
30831654|NCT01672294|58856088|FG000|Overall Study|Excluded by study|1|||
30831655|NCT01672294|58856089|FG001|Overall Study|Excluded by study|1|||
30831656|NCT01672294|58856090|FG002|Overall Study|Excluded by study|0|||
30831657|NCT01672294|58856091|FG003|Overall Study|Excluded by study|0|||
30831658|NCT01672294|58856088|FG000|Overall Study|Lost to Follow-up|1|||
30831659|NCT01672294|58856089|FG001|Overall Study|Lost to Follow-up|16|||
30831660|NCT01672294|58856090|FG002|Overall Study|Lost to Follow-up|7|||
30831661|NCT01672294|58856091|FG003|Overall Study|Lost to Follow-up|9|||
30831662|NCT02755116|58856103|FG000|Overall Study|surgery converted to open, pt admitted|3|||
30831663|NCT02755116|58856104|FG001|Overall Study|surgery converted to open, pt admitted|1|||
30831664|NCT02754492|58856114|FG000|Overall Study|Protocol Violation|2|||
30831665|NCT02754492|58856115|FG001|Overall Study|Protocol Violation|2|||
30831666|NCT02754492|58856116|FG002|Overall Study|Protocol Violation|0|||
30831667|NCT02754492|58856117|FG003|Overall Study|Protocol Violation|1|||
30831668|NCT02754492|58856114|FG000|Overall Study|Withdrawal by Subject|2|||
30831669|NCT02754492|58856115|FG001|Overall Study|Withdrawal by Subject|0|||
30831670|NCT02754492|58856116|FG002|Overall Study|Withdrawal by Subject|0|||
30831671|NCT02754492|58856117|FG003|Overall Study|Withdrawal by Subject|0|||
30922923|NCT02121509|58958230|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
30922924|NCT02121509|58958231|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
30922925|NCT02121509|58958228|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
30922926|NCT02121509|58958229|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
30922927|NCT02121509|58958230|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
30831672|NCT02754492|58856114|FG000|Overall Study|Equipment malfuntion|0|||
30831673|NCT02754492|58856115|FG001|Overall Study|Equipment malfuntion|0|||
30831674|NCT02754492|58856116|FG002|Overall Study|Equipment malfuntion|2|||
30831675|NCT02754492|58856117|FG003|Overall Study|Equipment malfuntion|5|||
30831676|NCT02754492|58856114|FG000|Overall Study|Adverse Event|0|||
30831677|NCT02754492|58856115|FG001|Overall Study|Adverse Event|0|||
30831678|NCT02754492|58856116|FG002|Overall Study|Adverse Event|0|||
30831679|NCT02754492|58856117|FG003|Overall Study|Adverse Event|13|||
30831680|NCT02754492|58856114|FG000|Overall Study|Venous access issues not resulting in AE|0|||
30831681|NCT02754492|58856115|FG001|Overall Study|Venous access issues not resulting in AE|0|||
30831682|NCT02754492|58856116|FG002|Overall Study|Venous access issues not resulting in AE|0|||
30831683|NCT02754492|58856117|FG003|Overall Study|Venous access issues not resulting in AE|4|||
30831684|NCT04068688|58856136|FG000|Overall Study|Lost to Follow-up|1|||
30831685|NCT04068688|58856137|FG001|Overall Study|Lost to Follow-up|1|||
30831686|NCT04068688|58856138|FG002|Overall Study|Lost to Follow-up|0|||
30831687|NCT04068688|58856139|FG003|Overall Study|Lost to Follow-up|0|||
30831688|NCT04068688|58856140|FG004|Overall Study|Lost to Follow-up|5|||
30831689|NCT04068688|58856141|FG005|Overall Study|Lost to Follow-up|5|||
30831690|NCT04068688|58856142|FG006|Overall Study|Lost to Follow-up|0|||
30831691|NCT04068688|58856143|FG007|Overall Study|Lost to Follow-up|0|||
30831692|NCT04068688|58856144|FG008|Overall Study|Lost to Follow-up|1|||
30831693|NCT04068688|58856145|FG009|Overall Study|Lost to Follow-up|0|||
30831694|NCT04068688|58856136|FG000|Overall Study|Withdrawal by Subject|1|||
30831695|NCT04068688|58856137|FG001|Overall Study|Withdrawal by Subject|1|||
30831696|NCT04068688|58856138|FG002|Overall Study|Withdrawal by Subject|0|||
30831697|NCT04068688|58856139|FG003|Overall Study|Withdrawal by Subject|0|||
30831698|NCT04068688|58856140|FG004|Overall Study|Withdrawal by Subject|0|||
30831699|NCT04068688|58856141|FG005|Overall Study|Withdrawal by Subject|0|||
30831700|NCT04068688|58856142|FG006|Overall Study|Withdrawal by Subject|0|||
30831701|NCT04068688|58856143|FG007|Overall Study|Withdrawal by Subject|0|||
30831702|NCT04068688|58856144|FG008|Overall Study|Withdrawal by Subject|0|||
30831703|NCT04068688|58856145|FG009|Overall Study|Withdrawal by Subject|0|||
30831704|NCT04068688|58856136|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
30831705|NCT04068688|58856137|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
30831706|NCT04068688|58856138|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
30922928|NCT02121509|58958231|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
30922929|NCT02149199|58958244|FG000|Overall Study|Study specific withdrawal criteria|4|||
30922930|NCT02149199|58958245|FG001|Overall Study|Study specific withdrawal criteria|21|||
30922931|NCT02149199|58958246|FG002|Overall Study|Study specific withdrawal criteria|6|||
30922932|NCT02149199|58958244|FG000|Overall Study|Other|20|||
30922933|NCT02149199|58958245|FG001|Overall Study|Other|25|||
30922934|NCT02149199|58958246|FG002|Overall Study|Other|20|||
30922935|NCT02149199|58958244|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
30922936|NCT02149199|58958245|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
30922937|NCT02149199|58958246|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
30922938|NCT02149199|58958244|FG000|Overall Study|Withdrawal by Subject|75|||
30922939|NCT02149199|58958245|FG001|Overall Study|Withdrawal by Subject|93|||
30922940|NCT02149199|58958246|FG002|Overall Study|Withdrawal by Subject|77|||
30922941|NCT02149199|58958244|FG000|Overall Study|Protocol Violation|16|||
30922942|NCT02149199|58958245|FG001|Overall Study|Protocol Violation|13|||
30922943|NCT02149199|58958246|FG002|Overall Study|Protocol Violation|15|||
30922944|NCT02149199|58958244|FG000|Overall Study|Lost to Follow-up|3|||
30922945|NCT02149199|58958245|FG001|Overall Study|Lost to Follow-up|12|||
30922946|NCT02149199|58958246|FG002|Overall Study|Lost to Follow-up|11|||
30922947|NCT02149199|58958244|FG000|Overall Study|Death|0|||
30922948|NCT02149199|58958245|FG001|Overall Study|Death|0|||
30922949|NCT02149199|58958246|FG002|Overall Study|Death|1|||
30922950|NCT02149199|58958244|FG000|Overall Study|Adverse Event|6|||
30922951|NCT02149199|58958245|FG001|Overall Study|Adverse Event|15|||
30922952|NCT02149199|58958246|FG002|Overall Study|Adverse Event|9|||
30922953|NCT02120417|58958256|FG000|Overall Study|Death|5|||
30922954|NCT02120417|58958257|FG001|Overall Study|Death|1|||
30922955|NCT02120417|58958256|FG000|Overall Study|Adverse Event|3|||
30922956|NCT02120417|58958257|FG001|Overall Study|Adverse Event|9|||
30922957|NCT02120417|58958256|FG000|Overall Study|Participant decision|4|||
30922958|NCT02120417|58958257|FG001|Overall Study|Participant decision|4|||
30922959|NCT02120417|58958256|FG000|Overall Study|Disease progression|41|||
30922960|NCT02120417|58958257|FG001|Overall Study|Disease progression|45|||
30922961|NCT02120417|58958256|FG000|Overall Study|Noncompliance with study treatment|0|||
30922962|NCT02120417|58958257|FG001|Overall Study|Noncompliance with study treatment|2|||
30831707|NCT04068688|58856139|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
30831708|NCT04068688|58856140|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
30831709|NCT04068688|58856141|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
30922963|NCT02120417|58958256|FG000|Overall Study|Physician Decision|2|||
30922964|NCT02120417|58958257|FG001|Overall Study|Physician Decision|3|||
30831710|NCT04068688|58856142|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
30831711|NCT04068688|58856143|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
30831712|NCT04068688|58856144|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
30831713|NCT04068688|58856145|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
30831714|NCT01671748|58856173|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
30831715|NCT01671748|58856174|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
30831716|NCT01671748|58856173|FG000|4 Week run-in Phase|Adverse Event|1|||
30831717|NCT01671748|58856174|FG001|4 Week run-in Phase|Adverse Event|0|||
30831718|NCT01671748|58856173|FG000|4 Week run-in Phase|Not eligible|9|||
30831719|NCT01671748|58856174|FG001|4 Week run-in Phase|Not eligible|0|||
30831720|NCT02657889|58856184|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
30831721|NCT02657889|58856185|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
30922965|NCT02120417|58958256|FG000|Overall Study|Other unspecified|5|||
30922966|NCT02120417|58958257|FG001|Overall Study|Other unspecified|4|||
30922967|NCT02148263|58958265|FG000|Overall Study|Withdrawal by Subject|3|||
30922968|NCT02148263|58958266|FG001|Overall Study|Withdrawal by Subject|2|||
30922969|NCT02147561|58958272|FG000|Overall Study|Lost to Follow-up|3|||
30922970|NCT02147561|58958272|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
30922971|NCT02058368|58958278|FG000|Overall Study|Adverse Event|15|||
30922972|NCT02058368|58958279|FG001|Overall Study|Adverse Event|20|||
30922973|NCT02058368|58958278|FG000|Overall Study|Lack of Efficacy|0|||
30922974|NCT02058368|58958279|FG001|Overall Study|Lack of Efficacy|1|||
30922975|NCT02058368|58958278|FG000|Overall Study|Protocol Violation|0|||
30922976|NCT02058368|58958279|FG001|Overall Study|Protocol Violation|4|||
30922977|NCT02058368|58958278|FG000|Overall Study|Lost to Follow-up|2|||
30922978|NCT02058368|58958279|FG001|Overall Study|Lost to Follow-up|0|||
30922979|NCT02058368|58958278|FG000|Overall Study|Physician Decision|2|||
30922980|NCT02058368|58958279|FG001|Overall Study|Physician Decision|3|||
30922981|NCT02058368|58958278|FG000|Overall Study|Withdrawal by Subject|22|||
30922982|NCT02058368|58958279|FG001|Overall Study|Withdrawal by Subject|26|||
30922983|NCT02107196|58958287|FG000|12-week Treatment Period|Adverse Event|6|||
30922984|NCT02107196|58958288|FG001|12-week Treatment Period|Adverse Event|3|||
30922985|NCT02107196|58958287|FG000|12-week Treatment Period|Lack of Efficacy|2|||
30922986|NCT02107196|58958288|FG001|12-week Treatment Period|Lack of Efficacy|1|||
30922987|NCT02107196|58958287|FG000|12-week Treatment Period|Lost to Follow-up|3|||
30922988|NCT02107196|58958288|FG001|12-week Treatment Period|Lost to Follow-up|6|||
30922989|NCT02107196|58958287|FG000|12-week Treatment Period|Physician Decision|0|||
30922990|NCT02107196|58958288|FG001|12-week Treatment Period|Physician Decision|1|||
30922991|NCT02107196|58958287|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
30922992|NCT02107196|58958288|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
30831722|NCT02657889|58856186|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
30831723|NCT02657889|58856187|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
30831724|NCT02657889|58856184|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
30831725|NCT02657889|58856185|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
30831726|NCT02657889|58856186|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
30922993|NCT02107196|58958287|FG000|12-week Treatment Period|Protocol Violation|7|||
30922994|NCT02107196|58958288|FG001|12-week Treatment Period|Protocol Violation|8|||
30755628|NCT00094770|58765601|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
30755629|NCT00094770|58765602|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
30755630|NCT00094770|58765601|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
30755631|NCT00094770|58765602|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
30755632|NCT00094770|58765601|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
30755633|NCT00094770|58765602|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
30755634|NCT00094770|58765601|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
30755635|NCT00094770|58765602|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
30755636|NCT00094770|58765601|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
30755637|NCT00094770|58765602|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
30755638|NCT00094770|58765601|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
30755639|NCT00094770|58765602|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
30831727|NCT02657889|58856187|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
30831728|NCT02657889|58856184|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
30831729|NCT02657889|58856185|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
30831730|NCT02657889|58856186|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
30831731|NCT02657889|58856187|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
30831732|NCT02657889|58856184|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
30831733|NCT02657889|58856185|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
30831734|NCT02657889|58856186|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
30831735|NCT02657889|58856187|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
30831736|NCT02657889|58856184|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
30831737|NCT02657889|58856185|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
30755640|NCT00094770|58765601|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
30755641|NCT00094770|58765602|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
30755642|NCT00094770|58765601|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
30755643|NCT00094770|58765602|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
30755644|NCT00069576|58765610|FG000|Original Trial|Lost to Follow-up|25|||
30755645|NCT00069576|58765611|FG001|Original Trial|Lost to Follow-up|33|||
30831738|NCT02657889|58856186|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
30831739|NCT02657889|58856187|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
30831740|NCT02657889|58856184|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
30755646|NCT00069576|58765610|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
30755647|NCT00069576|58765611|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
30755648|NCT00069264|58765617|FG000|Overall Study|Adverse Event|3|||
30755649|NCT00069264|58765617|FG000|Overall Study|Progressive Disease|23|||
30755650|NCT00069264|58765617|FG000|Overall Study|Withdrawal by Subject|3|||
30755651|NCT00069264|58765617|FG000|Overall Study|Discon Therapy|3|||
30755652|NCT00069108|58765623|FG000|Overall Study|Withdrawal by Subject|5|||
30755653|NCT00069108|58765624|FG001|Overall Study|Withdrawal by Subject|9|||
30755654|NCT00069108|58765623|FG000|Overall Study|Adverse Event|64|||
30755655|NCT00069108|58765624|FG001|Overall Study|Adverse Event|42|||
30755656|NCT00069108|58765623|FG000|Overall Study|Death|6|||
30755657|NCT00069108|58765624|FG001|Overall Study|Death|6|||
30755658|NCT00069108|58765623|FG000|Overall Study|Administration|15|||
30755659|NCT00069108|58765624|FG001|Overall Study|Administration|4|||
30755660|NCT00069108|58765623|FG000|Overall Study|Insufficient therapy|117|||
30831741|NCT02657889|58856185|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
30831742|NCT02657889|58856186|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
30831743|NCT02657889|58856187|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
30831744|NCT02657889|58856184|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
30755661|NCT00069108|58765624|FG001|Overall Study|Insufficient therapy|144|||
30755662|NCT00069108|58765623|FG000|Overall Study|Violation criteria|1|||
30755663|NCT00069108|58765624|FG001|Overall Study|Violation criteria|4|||
30755664|NCT00069108|58765623|FG000|Overall Study|Refused treatment|5|||
30831745|NCT02657889|58856185|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
30831746|NCT02657889|58856186|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
30831747|NCT02657889|58856187|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
30755665|NCT00069108|58765624|FG001|Overall Study|Refused treatment|10|||
30755666|NCT00094536|58765631|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
30831748|NCT02657889|58856184|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
30831749|NCT02657889|58856185|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
30831750|NCT02657889|58856186|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
30831751|NCT02657889|58856187|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
30831752|NCT02657889|58856184|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
30831753|NCT02657889|58856185|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
30831754|NCT02657889|58856186|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
30831755|NCT02657889|58856187|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
30831756|NCT02657889|58856184|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
30831757|NCT02657889|58856185|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
30831758|NCT02657889|58856186|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
30831759|NCT02657889|58856187|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
30831760|NCT02657889|58856184|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
30922995|NCT02107196|58958287|FG000|12-week Treatment Period|Reason Missing|11|||
30922996|NCT02107196|58958288|FG001|12-week Treatment Period|Reason Missing|8|||
30755667|NCT00094536|58765631|FG000|Treatment and Follow-up|Adverse Event|4|||
30922997|NCT02107196|58958287|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
30755668|NCT00094536|58765631|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
30755669|NCT00094536|58765631|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
30755670|NCT00094536|58765631|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
30755671|NCT00094536|58765631|FG000|Treatment and Follow-up|Subject non-compliance|9|||
30831761|NCT02657889|58856185|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
30831762|NCT02657889|58856186|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
30831763|NCT02657889|58856187|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
30831764|NCT02657889|58856184|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
30831765|NCT02657889|58856185|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
30831766|NCT02657889|58856186|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
30831767|NCT02657889|58856187|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
30831768|NCT03034915|58856202|FG000|Overall Study|Adverse Event|29|||
30831769|NCT03034915|58856203|FG001|Overall Study|Adverse Event|32|||
30755672|NCT00094536|58765631|FG000|Treatment and Follow-up|Unable to attend visits|1|||
30755673|NCT00405587|58765639|FG000|Overall Study|Death|0|||
30755674|NCT00405587|58765640|FG001|Overall Study|Death|0|||
30755675|NCT00405587|58765641|FG002|Overall Study|Death|0|||
30755676|NCT00405587|58765642|FG003|Overall Study|Death|1|||
30755677|NCT00405587|58765639|FG000|Overall Study|Disease Progression|22|||
30755678|NCT00405587|58765640|FG001|Overall Study|Disease Progression|23|||
30755679|NCT00405587|58765641|FG002|Overall Study|Disease Progression|21|||
30755680|NCT00405587|58765642|FG003|Overall Study|Disease Progression|17|||
30755681|NCT00405587|58765639|FG000|Overall Study|Physician Decision|3|||
30755682|NCT00405587|58765640|FG001|Overall Study|Physician Decision|2|||
30755683|NCT00405587|58765641|FG002|Overall Study|Physician Decision|0|||
30755684|NCT00405587|58765642|FG003|Overall Study|Physician Decision|0|||
30755685|NCT00405587|58765639|FG000|Overall Study|Adverse Event|1|||
30755686|NCT00405587|58765640|FG001|Overall Study|Adverse Event|0|||
30755687|NCT00405587|58765641|FG002|Overall Study|Adverse Event|0|||
30755688|NCT00405587|58765642|FG003|Overall Study|Adverse Event|0|||
30755689|NCT00405587|58765639|FG000|Overall Study|Lost to Follow-up|0|||
30755690|NCT00405587|58765640|FG001|Overall Study|Lost to Follow-up|1|||
30755691|NCT00405587|58765641|FG002|Overall Study|Lost to Follow-up|1|||
30755692|NCT00405587|58765642|FG003|Overall Study|Lost to Follow-up|0|||
30755693|NCT00405587|58765639|FG000|Overall Study|Radiation induced necrosis|0|||
30755694|NCT00405587|58765640|FG001|Overall Study|Radiation induced necrosis|1|||
30755695|NCT00405587|58765641|FG002|Overall Study|Radiation induced necrosis|0|||
30755696|NCT00405587|58765642|FG003|Overall Study|Radiation induced necrosis|0|||
30922998|NCT02107196|58958288|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
30922999|NCT02107196|58958287|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
30923000|NCT02107196|58958288|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
30923001|NCT02107196|58958287|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
30923002|NCT02107196|58958288|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
30923003|NCT02107196|58958287|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
30923004|NCT02107196|58958288|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
30923005|NCT02058290|58958296|FG000|Overall Study|Protocol Violation|2|||
30923006|NCT02058290|58958297|FG001|Overall Study|Protocol Violation|1|||
30923007|NCT02058290|58958296|FG000|Overall Study|Physician Decision|1|||
30923008|NCT02058290|58958297|FG001|Overall Study|Physician Decision|0|||
30831770|NCT03034915|58856204|FG002|Overall Study|Adverse Event|22|||
30831771|NCT03034915|58856202|FG000|Overall Study|Lost to Follow-up|5|||
30831772|NCT03034915|58856203|FG001|Overall Study|Lost to Follow-up|13|||
30831773|NCT03034915|58856204|FG002|Overall Study|Lost to Follow-up|3|||
30831774|NCT03034915|58856202|FG000|Overall Study|Withdrawal by Subject|29|||
30831775|NCT03034915|58856203|FG001|Overall Study|Withdrawal by Subject|46|||
30923009|NCT02058290|58958296|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
30923010|NCT02058290|58958297|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
30923011|NCT02058290|58958296|FG000|Overall Study|Withdrawal by Subject|0|||
30923012|NCT02058290|58958297|FG001|Overall Study|Withdrawal by Subject|1|||
30923013|NCT02082158|58958309|FG000|Overall Study|Withdrawal by Subject|0|||
30923014|NCT02082158|58958310|FG001|Overall Study|Withdrawal by Subject|0|||
30923015|NCT02082158|58958311|FG002|Overall Study|Withdrawal by Subject|0|||
30623834|NCT01119846|58635705|FG000|Overall Study|Adverse Event|1|||
30755697|NCT00405587|58765639|FG000|Overall Study|Withdrawal by Subject|0|||
30755698|NCT00405587|58765640|FG001|Overall Study|Withdrawal by Subject|0|||
30831776|NCT03034915|58856204|FG002|Overall Study|Withdrawal by Subject|41|||
30831777|NCT03034915|58856202|FG000|Overall Study|Protocol Deviation|2|||
30831778|NCT03034915|58856203|FG001|Overall Study|Protocol Deviation|14|||
30755699|NCT00405587|58765641|FG002|Overall Study|Withdrawal by Subject|0|||
30755700|NCT00405587|58765642|FG003|Overall Study|Withdrawal by Subject|2|||
30755701|NCT00405587|58765639|FG000|Overall Study|Participant not dosed|0|||
30755702|NCT00405587|58765640|FG001|Overall Study|Participant not dosed|1|||
30755703|NCT00405587|58765641|FG002|Overall Study|Participant not dosed|0|||
30755704|NCT00405587|58765642|FG003|Overall Study|Participant not dosed|0|||
30755705|NCT00405275|58765680|FG000|Overall Study|Death|1|||
30755706|NCT00405275|58765681|FG001|Overall Study|Death|0|||
30755707|NCT00405275|58765680|FG000|Overall Study|Lost to Follow-up|5|||
30831779|NCT03034915|58856204|FG002|Overall Study|Protocol Deviation|7|||
30923016|NCT02082158|58958312|FG003|Overall Study|Withdrawal by Subject|0|||
30831780|NCT03034915|58856202|FG000|Overall Study|Lack of Efficacy|8|||
30831781|NCT03034915|58856203|FG001|Overall Study|Lack of Efficacy|16|||
30831782|NCT03034915|58856204|FG002|Overall Study|Lack of Efficacy|18|||
30831783|NCT03034915|58856202|FG000|Overall Study|Site closed|2|||
30831784|NCT03034915|58856203|FG001|Overall Study|Site closed|2|||
30831785|NCT03034915|58856204|FG002|Overall Study|Site closed|4|||
30831786|NCT03034915|58856202|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
30831787|NCT03034915|58856203|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
30831788|NCT03034915|58856204|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
30831789|NCT03034915|58856202|FG000|Overall Study|Physician Decision|1|||
30831790|NCT03034915|58856203|FG001|Overall Study|Physician Decision|5|||
30831791|NCT03034915|58856204|FG002|Overall Study|Physician Decision|2|||
30831792|NCT02631538|58856216|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
30831793|NCT02631538|58856217|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
30831794|NCT02631538|58856218|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
30831795|NCT02631538|58856219|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
30831796|NCT02631538|58856216|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
30831797|NCT02631538|58856217|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
30831798|NCT02631538|58856218|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
30831799|NCT02631538|58856219|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
30831800|NCT02631538|58856216|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
30831801|NCT02631538|58856217|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
30831802|NCT02631538|58856218|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
30831803|NCT02631538|58856219|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
30831804|NCT02631538|58856216|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
30831805|NCT02631538|58856217|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
30831806|NCT02631538|58856218|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
30831807|NCT02631538|58856219|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
30831808|NCT02631538|58856216|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
30831809|NCT02631538|58856217|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
30831810|NCT02631538|58856218|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
30831811|NCT02631538|58856219|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
30831812|NCT02631538|58856216|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
30831813|NCT02631538|58856217|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
30831814|NCT02631538|58856218|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
30831815|NCT02631538|58856219|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
30831816|NCT02631148|58856242|FG000|Overall Study|8 were ineligible|8|||
30923017|NCT02082158|58958313|FG004|Overall Study|Withdrawal by Subject|1|||
30923018|NCT02082158|58958314|FG005|Overall Study|Withdrawal by Subject|0|||
30923019|NCT02082158|58958309|FG000|Overall Study|Failed Fit-testing|8|||
30923020|NCT02082158|58958310|FG001|Overall Study|Failed Fit-testing|8|||
30923021|NCT02082158|58958311|FG002|Overall Study|Failed Fit-testing|14|||
30923022|NCT02082158|58958312|FG003|Overall Study|Failed Fit-testing|4|||
30923023|NCT02082158|58958313|FG004|Overall Study|Failed Fit-testing|3|||
30755708|NCT00405275|58765681|FG001|Overall Study|Lost to Follow-up|1|||
30755709|NCT00405275|58765680|FG000|Overall Study|Withdrawal by Subject|7|||
30831817|NCT02631148|58856243|FG001|Overall Study|8 were ineligible|0|||
30831818|NCT02631148|58856242|FG000|Overall Study|Withdrawal by Subject|1|||
30831819|NCT02631148|58856243|FG001|Overall Study|Withdrawal by Subject|0|||
30831820|NCT02631148|58856242|FG000|Overall Study|PAH not available to study participant|1|||
30831821|NCT02631148|58856243|FG001|Overall Study|PAH not available to study participant|0|||
30831822|NCT02753400|58856251|FG000|Overall Study|Adverse Event|3|||
30831823|NCT02753400|58856252|FG001|Overall Study|Adverse Event|0|||
30831824|NCT02753400|58856251|FG000|Overall Study|Withdrawal by Subject|2|||
30831825|NCT02753400|58856252|FG001|Overall Study|Withdrawal by Subject|1|||
30923024|NCT02082158|58958314|FG005|Overall Study|Failed Fit-testing|7|||
30923025|NCT02106884|58958336|FG000|Overall Study|Change of diagnosis/exclusion|0|||
30755710|NCT00405275|58765681|FG001|Overall Study|Withdrawal by Subject|9|||
30755711|NCT00405275|58765680|FG000|Overall Study|Unwilling to continue|10|||
30755712|NCT00405275|58765681|FG001|Overall Study|Unwilling to continue|9|||
30755713|NCT00404651|58765691|FG000|Overall Study|Serious Adverse Event|0|||
30755714|NCT00404651|58765692|FG001|Overall Study|Serious Adverse Event|0|||
30755715|NCT00404651|58765693|FG002|Overall Study|Serious Adverse Event|2|||
30755716|NCT00404651|58765694|FG003|Overall Study|Serious Adverse Event|0|||
30755717|NCT00404651|58765691|FG000|Overall Study|Protocol Violation|10|||
30831826|NCT03943147|58856269|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
30831827|NCT03943147|58856270|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
30831828|NCT03943147|58856269|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
30923026|NCT02106884|58958337|FG001|Overall Study|Change of diagnosis/exclusion|1|||
30923027|NCT02081846|58958348|FG000|Overall Study|Withdrawal by Subject|1|||
30923028|NCT02081846|58958349|FG001|Overall Study|Withdrawal by Subject|0|||
30755718|NCT00404651|58765692|FG001|Overall Study|Protocol Violation|5|||
30755719|NCT00404651|58765693|FG002|Overall Study|Protocol Violation|14|||
30831829|NCT03943147|58856270|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
30831830|NCT03943147|58856269|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
30831831|NCT03943147|58856270|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
30831832|NCT03943147|58856269|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
30831833|NCT03943147|58856270|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
30831834|NCT03943147|58856269|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
30831835|NCT03943147|58856270|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
30831836|NCT03943147|58856269|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
30831837|NCT03943147|58856270|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
30831838|NCT03730987|58856288|FG000|Overall Study|Lost to Follow-up|2|||
30831839|NCT03730987|58856289|FG001|Overall Study|Lost to Follow-up|0|||
30831840|NCT03730987|58856290|FG002|Overall Study|Lost to Follow-up|2|||
30831841|NCT03730987|58856291|FG003|Overall Study|Lost to Follow-up|0|||
30831842|NCT03556891|58856302|FG000|Overall Study|Adverse Event|4|||
30831843|NCT03556891|58856302|FG000|Overall Study|MRI Need|3|||
30831844|NCT03556891|58856302|FG000|Overall Study|Device Failure|1|||
30831845|NCT03556891|58856302|FG000|Overall Study|Death|1|||
30831846|NCT03556891|58856302|FG000|Overall Study|Lost to Follow-up|1|||
30831847|NCT03556891|58856302|FG000|Overall Study|Missing at random|1|||
30831848|NCT03556891|58856302|FG000|Overall Study|Missing due to COVID|1|||
30831849|NCT03556891|58856302|FG000|Overall Study|Protocol Violation|1|||
30831850|NCT02844543|58856306|FG000|Overall Study|Withdrawal by Subject|4|||
30831851|NCT02844543|58856306|FG000|Overall Study|Did not meet eligibility criteria|1|||
30831852|NCT03034135|58856310|FG000|Overall Study|Withdrawal by Subject|2|||
30831853|NCT01671280|58856314|FG000|Overall Study|Withdrawal by Subject|2|||
30831854|NCT01405963|58856320|FG000|Overall Study|Moved Away|2|||
30831855|NCT01405963|58856321|FG001|Overall Study|Moved Away|0|||
30831856|NCT01405963|58856320|FG000|Overall Study|Adverse Event|0|||
30831857|NCT01405963|58856321|FG001|Overall Study|Adverse Event|1|||
30831858|NCT01405963|58856320|FG000|Overall Study|Lost to Follow-up|0|||
30831859|NCT01405963|58856321|FG001|Overall Study|Lost to Follow-up|1|||
30831860|NCT02846415|58856330|FG000|Overall Study|Lost to Follow-up|2|||
30831861|NCT02846415|58856331|FG001|Overall Study|Lost to Follow-up|0|||
30923029|NCT02081846|58958348|FG000|Overall Study|invalid consent|1|||
30831862|NCT02846415|58856330|FG000|Overall Study|Withdrawal by Subject|1|||
30831863|NCT02846415|58856331|FG001|Overall Study|Withdrawal by Subject|1|||
30831864|NCT02628418|58856350|FG000|Overall Study|Lost to Follow-up|1|||
30831865|NCT02628418|58856351|FG001|Overall Study|Lost to Follow-up|2|||
30831866|NCT02752776|58856379|FG000|Overall Study|Adverse Event|15|||
30831867|NCT02752776|58856380|FG001|Overall Study|Adverse Event|23|||
30831868|NCT02752776|58856381|FG002|Overall Study|Adverse Event|11|||
30831869|NCT02752776|58856379|FG000|Overall Study|Lack of Efficacy|2|||
30831870|NCT02752776|58856380|FG001|Overall Study|Lack of Efficacy|6|||
30923030|NCT02081846|58958349|FG001|Overall Study|invalid consent|0|||
30831871|NCT02752776|58856381|FG002|Overall Study|Lack of Efficacy|14|||
30831872|NCT02752776|58856379|FG000|Overall Study|Lost to Follow-up|11|||
30831873|NCT02752776|58856380|FG001|Overall Study|Lost to Follow-up|12|||
30831874|NCT02752776|58856381|FG002|Overall Study|Lost to Follow-up|4|||
30831875|NCT02752776|58856379|FG000|Overall Study|Non-compliance with study treatment|0|||
30831876|NCT02752776|58856380|FG001|Overall Study|Non-compliance with study treatment|0|||
30831877|NCT02752776|58856381|FG002|Overall Study|Non-compliance with study treatment|1|||
30831878|NCT02752776|58856379|FG000|Overall Study|Physician Decision|2|||
30831879|NCT02752776|58856380|FG001|Overall Study|Physician Decision|6|||
30831880|NCT02752776|58856381|FG002|Overall Study|Physician Decision|2|||
30831881|NCT02752776|58856379|FG000|Overall Study|Pregnancy|1|||
30831882|NCT02752776|58856380|FG001|Overall Study|Pregnancy|6|||
30831883|NCT02752776|58856381|FG002|Overall Study|Pregnancy|3|||
30831884|NCT02752776|58856379|FG000|Overall Study|Protocol Violation|10|||
30831885|NCT02752776|58856380|FG001|Overall Study|Protocol Violation|13|||
30831886|NCT02752776|58856381|FG002|Overall Study|Protocol Violation|6|||
30831887|NCT02752776|58856379|FG000|Overall Study|Subject/guardian decision|8|||
30831888|NCT02752776|58856380|FG001|Overall Study|Subject/guardian decision|6|||
30831889|NCT02752776|58856381|FG002|Overall Study|Subject/guardian decision|4|||
30831890|NCT02752776|58856379|FG000|Overall Study|Death|0|||
30831891|NCT02752776|58856380|FG001|Overall Study|Death|0|||
30923031|NCT02081690|58958355|FG000|Overall Study|Death|3|||
30831892|NCT02752776|58856381|FG002|Overall Study|Death|1|||
30831893|NCT02752776|58856379|FG000|Overall Study|Withdrawal by Subject|3|||
30831894|NCT02752776|58856380|FG001|Overall Study|Withdrawal by Subject|4|||
30831895|NCT02752776|58856381|FG002|Overall Study|Withdrawal by Subject|2|||
30831896|NCT01342965|58856393|FG000|Overall Study|Death|58|||
30831897|NCT01342965|58856394|FG001|Overall Study|Death|57|||
30831898|NCT01342965|58856393|FG000|Overall Study|Lost to Follow-up|5|||
30831899|NCT01342965|58856394|FG001|Overall Study|Lost to Follow-up|3|||
30831900|NCT01342965|58856393|FG000|Overall Study|Other Reasons- Unspecified|44|||
30831901|NCT01342965|58856394|FG001|Overall Study|Other Reasons- Unspecified|38|||
30831902|NCT01342965|58856393|FG000|Overall Study|Withdrawal by Subject|2|||
30923032|NCT02081690|58958355|FG000|Overall Study|Physician Decision|3|||
30831903|NCT01342965|58856394|FG001|Overall Study|Withdrawal by Subject|9|||
30831904|NCT02629822|58856400|FG000|Base Study|Lost to Follow-up|2|||
30831905|NCT02629822|58856400|FG000|Base Study|Non-Compliance With Study Drug|1|||
30831906|NCT02629822|58856400|FG000|Extension Study|Adverse Event|1|||
30831907|NCT02629822|58856400|FG000|Extension Study|Lost to Follow-up|1|||
30831908|NCT02840721|58856405|FG000|Treatment Period|Adverse Event|1|||
30831909|NCT02840721|58856405|FG000|Follow-Up|Lack of Efficacy|1|||
30831910|NCT02840721|58856405|FG000|Follow-Up|Withdrawal by Subject|4|||
30831911|NCT02840721|58856405|FG000|Follow-Up|Withdrawal of Consent|2|||
30831912|NCT03462706|58856413|FG000|Overall Study|Polyp was pedunculated|1|||
30831913|NCT03462706|58856414|FG001|Overall Study|Polyp was pedunculated|0|||
30831914|NCT03462706|58856415|FG002|Overall Study|Polyp was pedunculated|1|||
30831915|NCT03462706|58856416|FG003|Overall Study|Polyp was pedunculated|0|||
30831916|NCT03462706|58856413|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
30831917|NCT03462706|58856414|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
30831918|NCT03462706|58856415|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
30831919|NCT03462706|58856416|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
30831920|NCT02840253|58856426|FG000|Overall Study|Unsuccessful block|4|||
30831921|NCT02752074|58856432|FG000|Overall Study|Lost to Follow-up|1|||
30831922|NCT02752074|58856433|FG001|Overall Study|Lost to Follow-up|4|||
30923033|NCT02081690|58958355|FG000|Overall Study|Withdrawal by Subject|1|||
30923034|NCT02057666|58958361|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
30831923|NCT02752074|58856432|FG000|Overall Study|Death|146|||
30831924|NCT02752074|58856433|FG001|Overall Study|Death|129|||
30831925|NCT02752074|58856432|FG000|Overall Study|Withdrawal by Subject|9|||
30831926|NCT02752074|58856433|FG001|Overall Study|Withdrawal by Subject|10|||
30831927|NCT02835495|58856441|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
30831928|NCT02835495|58856442|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
30831929|NCT02835495|58856441|FG000|Overall Study|Declined in-person follow-up visit|4|||
30831930|NCT02835495|58856442|FG001|Overall Study|Declined in-person follow-up visit|2|||
30923035|NCT02057666|58958362|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
30923036|NCT02057666|58958361|FG000|Double Blind Treatment Period|Poor tolerability|7|||
30923037|NCT02057666|58958362|FG001|Double Blind Treatment Period|Poor tolerability|2|||
30923038|NCT02057666|58958361|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
30923039|NCT02057666|58958362|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
30923040|NCT02057666|58958361|FG000|Double Blind Treatment Period|Physician Decision|1|||
30923041|NCT02057666|58958362|FG001|Double Blind Treatment Period|Physician Decision|0|||
30923042|NCT02057666|58958361|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
30923043|NCT02057666|58958362|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
30923044|NCT02057666|58958361|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
30923045|NCT02057666|58958362|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
30923046|NCT02057666|58958361|FG000|Double Blind Treatment Period|Sponsor's request|70|||
30923047|NCT02057666|58958362|FG001|Double Blind Treatment Period|Sponsor's request|34|||
30923048|NCT02057666|58958361|FG000|Open-Label Treatment Period|Poor tolerability|0|||
30923049|NCT02057666|58958362|FG001|Open-Label Treatment Period|Poor tolerability|1|||
30923050|NCT02057666|58958361|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
30831931|NCT02835339|58856452|FG000|Overall Study|Did not receive allocated intervention|13|||
30831932|NCT02835339|58856453|FG001|Overall Study|Did not receive allocated intervention|16|||
30831933|NCT02832063|58856461|FG000|Overall Study|Adverse Event|2|||
30831934|NCT02832063|58856462|FG001|Overall Study|Adverse Event|1|||
30831935|NCT02832063|58856461|FG000|Overall Study|Physician Decision|5|||
30923051|NCT02057666|58958362|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
30831936|NCT02832063|58856462|FG001|Overall Study|Physician Decision|7|||
30831937|NCT02832063|58856461|FG000|Overall Study|Lost to Follow-up|15|||
30831938|NCT02832063|58856462|FG001|Overall Study|Lost to Follow-up|8|||
30831939|NCT02832063|58856461|FG000|Overall Study|Withdrawal by Subject|10|||
30831940|NCT02832063|58856462|FG001|Overall Study|Withdrawal by Subject|21|||
30831941|NCT02832063|58856461|FG000|Overall Study|Other|2|||
30831942|NCT02832063|58856462|FG001|Overall Study|Other|1|||
30831943|NCT03125902|58856481|FG000|Overall Study|Death|52|||
30923052|NCT02057666|58958361|FG000|Open-Label Treatment Period|Sponsor's request|0|||
30923053|NCT02057666|58958362|FG001|Open-Label Treatment Period|Sponsor's request|4|||
30923054|NCT01625000|58958373|FG000|Overall Study|Physician Decision|15|||
30831944|NCT03125902|58856482|FG001|Overall Study|Death|123|||
30831945|NCT03125902|58856481|FG000|Overall Study|Lost to Follow-up|1|||
30831946|NCT03125902|58856482|FG001|Overall Study|Lost to Follow-up|0|||
30831947|NCT03125902|58856481|FG000|Overall Study|Mastectomy|0|||
30831948|NCT03125902|58856482|FG001|Overall Study|Mastectomy|1|||
30831949|NCT03125902|58856481|FG000|Overall Study|Physician Decision|1|||
30831950|NCT03125902|58856482|FG001|Overall Study|Physician Decision|0|||
30831951|NCT03125902|58856481|FG000|Overall Study|Withdrawal by Subject|13|||
30831952|NCT03125902|58856482|FG001|Overall Study|Withdrawal by Subject|25|||
30923055|NCT01625000|58958374|FG001|Overall Study|Physician Decision|7|||
30923056|NCT01625000|58958375|FG002|Overall Study|Physician Decision|7|||
30831953|NCT03125902|58856481|FG000|Overall Study|Study is ongoing|153|||
30831954|NCT03125902|58856482|FG001|Overall Study|Study is ongoing|282|||
30831955|NCT04412707|58856491|FG000|Cycle 1|Death|0|||
30831956|NCT04412707|58856492|FG001|Cycle 1|Death|3|||
30831957|NCT04412707|58856491|FG000|Cycle 1|Disease progression|1|||
30831958|NCT04412707|58856492|FG001|Cycle 1|Disease progression|2|||
30831959|NCT04412707|58856491|FG000|Cycle 2|Death|0|||
30831960|NCT04412707|58856492|FG001|Cycle 2|Death|1|||
30831961|NCT04412707|58856491|FG000|Cycle 2|Disease progression|3|||
30831962|NCT04412707|58856492|FG001|Cycle 2|Disease progression|0|||
30831963|NCT04412707|58856491|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
30831964|NCT04412707|58856492|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
30831965|NCT04412707|58856491|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
30755720|NCT00404651|58765694|FG003|Overall Study|Protocol Violation|5|||
30831966|NCT04412707|58856492|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
30831967|NCT04412707|58856491|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
30831968|NCT04412707|58856492|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
30831969|NCT04412707|58856491|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
30831970|NCT04412707|58856492|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
30831971|NCT01358721|58856511|FG000|Overall Study|Withdrawal by Subject|0|||
30831972|NCT01358721|58856512|FG001|Overall Study|Withdrawal by Subject|0|||
30831973|NCT01358721|58856513|FG002|Overall Study|Withdrawal by Subject|0|||
30831974|NCT01358721|58856514|FG003|Overall Study|Withdrawal by Subject|1|||
30831975|NCT01358721|58856511|FG000|Overall Study|Death|0|||
30831976|NCT01358721|58856512|FG001|Overall Study|Death|2|||
30831977|NCT01358721|58856513|FG002|Overall Study|Death|0|||
30831978|NCT01358721|58856514|FG003|Overall Study|Death|0|||
30831979|NCT01358721|58856511|FG000|Overall Study|Study Drug Toxicity|1|||
30831980|NCT01358721|58856512|FG001|Overall Study|Study Drug Toxicity|3|||
30831981|NCT01358721|58856513|FG002|Overall Study|Study Drug Toxicity|4|||
30831982|NCT01358721|58856514|FG003|Overall Study|Study Drug Toxicity|5|||
30831983|NCT01358721|58856511|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
30831984|NCT01358721|58856512|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
30831985|NCT01358721|58856513|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
30831986|NCT01358721|58856514|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
30831987|NCT01358721|58856511|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
30831988|NCT01358721|58856512|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
30831989|NCT01358721|58856513|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
30831990|NCT01358721|58856514|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
30831991|NCT01358721|58856511|FG000|Overall Study|Adverse Event related to study drug|1|||
30831992|NCT01358721|58856512|FG001|Overall Study|Adverse Event related to study drug|0|||
30831993|NCT01358721|58856513|FG002|Overall Study|Adverse Event related to study drug|0|||
30831994|NCT01358721|58856514|FG003|Overall Study|Adverse Event related to study drug|1|||
30831995|NCT01358721|58856511|FG000|Overall Study|Disease Progression|19|||
30923057|NCT01625000|58958376|FG003|Overall Study|Physician Decision|2|||
30923058|NCT01625000|58958377|FG004|Overall Study|Physician Decision|15|||
30831996|NCT01358721|58856512|FG001|Overall Study|Disease Progression|15|||
30831997|NCT01358721|58856513|FG002|Overall Study|Disease Progression|17|||
30831998|NCT01358721|58856514|FG003|Overall Study|Disease Progression|15|||
30831999|NCT01358721|58856511|FG000|Overall Study|Out of State/Unmet Criteria|0|||
30832000|NCT01358721|58856512|FG001|Overall Study|Out of State/Unmet Criteria|0|||
30832001|NCT01358721|58856513|FG002|Overall Study|Out of State/Unmet Criteria|1|||
30832002|NCT01358721|58856514|FG003|Overall Study|Out of State/Unmet Criteria|0|||
30832003|NCT01341639|58856526|FG000|Infant Series|Protocol Violation|1|||
30832004|NCT01341639|58856527|FG001|Infant Series|Protocol Violation|0|||
30832005|NCT01341639|58856526|FG000|Infant Series|Not Vaccinated|0|||
30832006|NCT01341639|58856527|FG001|Infant Series|Not Vaccinated|1|||
30923059|NCT01625000|58958373|FG000|Overall Study|Protocol Violation|3|||
30755721|NCT00404651|58765691|FG000|Overall Study|Lost to Follow-up|15|||
30755722|NCT00404651|58765692|FG001|Overall Study|Lost to Follow-up|11|||
30755723|NCT00404651|58765693|FG002|Overall Study|Lost to Follow-up|13|||
30755724|NCT00404651|58765694|FG003|Overall Study|Lost to Follow-up|10|||
30755725|NCT00404651|58765691|FG000|Overall Study|Withdrawal by Subject|14|||
30755726|NCT00404651|58765692|FG001|Overall Study|Withdrawal by Subject|12|||
30755727|NCT00404651|58765693|FG002|Overall Study|Withdrawal by Subject|16|||
30755728|NCT00404651|58765694|FG003|Overall Study|Withdrawal by Subject|6|||
30755729|NCT00404495|58765706|FG000|Overall Study|Death|37|||
30755730|NCT00404495|58765707|FG001|Overall Study|Death|11|||
30832007|NCT01341639|58856526|FG000|Infant Series|Adverse Event|0|||
30755731|NCT00404495|58765706|FG000|Overall Study|Lost to Follow-up|5|||
30755732|NCT00404495|58765707|FG001|Overall Study|Lost to Follow-up|0|||
30755733|NCT00404495|58765706|FG000|Overall Study|Other|1|||
30755734|NCT00404495|58765707|FG001|Overall Study|Other|0|||
30832008|NCT01341639|58856527|FG001|Infant Series|Adverse Event|5|||
30832009|NCT01341639|58856526|FG000|Infant Series|Withdrawal by Subject|11|||
30923060|NCT01625000|58958374|FG001|Overall Study|Protocol Violation|10|||
30832010|NCT01341639|58856527|FG001|Infant Series|Withdrawal by Subject|8|||
30832011|NCT01341639|58856526|FG000|Infant Series|Lost to Follow-up|0|||
30832012|NCT01341639|58856527|FG001|Infant Series|Lost to Follow-up|2|||
30832013|NCT01341639|58856526|FG000|Infant Series|Site 0048 Participants|17|||
30832014|NCT01341639|58856527|FG001|Infant Series|Site 0048 Participants|16|||
30832015|NCT01341639|58856526|FG000|Interim Period|Withdrawal by Subject|6|||
30832016|NCT01341639|58856527|FG001|Interim Period|Withdrawal by Subject|7|||
30832017|NCT01341639|58856526|FG000|Interim Period|Lost to Follow-up|2|||
30832018|NCT01341639|58856527|FG001|Interim Period|Lost to Follow-up|0|||
30832019|NCT01341639|58856526|FG000|Interim Period|Physician Decision|0|||
30832020|NCT01341639|58856527|FG001|Interim Period|Physician Decision|1|||
30832021|NCT01341639|58856526|FG000|Interim Period|Protocol Violation|0|||
30832022|NCT01341639|58856527|FG001|Interim Period|Protocol Violation|1|||
30832023|NCT01341639|58856526|FG000|Post-Treatment|Withdrawal by Subject|0|||
30832024|NCT01341639|58856527|FG001|Post-Treatment|Withdrawal by Subject|1|||
30832025|NCT01341639|58856526|FG000|Post-Treatment|Adverse Event|0|||
30832026|NCT01341639|58856527|FG001|Post-Treatment|Adverse Event|2|||
30832027|NCT02628028|58856541|FG000|Dosing Period|Withdrawal by Subject|0|||
30832028|NCT02628028|58856542|FG001|Dosing Period|Withdrawal by Subject|0|||
30832029|NCT02628028|58856543|FG002|Dosing Period|Withdrawal by Subject|1|||
30832030|NCT02628028|58856544|FG003|Dosing Period|Withdrawal by Subject|0|||
30832031|NCT02628028|58856545|FG004|Dosing Period|Withdrawal by Subject|2|||
30832032|NCT02628028|58856546|FG005|Dosing Period|Withdrawal by Subject|4|||
30832033|NCT02628028|58856547|FG006|Dosing Period|Withdrawal by Subject|1|||
30832034|NCT02628028|58856548|FG007|Dosing Period|Withdrawal by Subject|1|||
30832035|NCT02628028|58856541|FG000|Dosing Period|Adverse Event|0|||
30832036|NCT02628028|58856542|FG001|Dosing Period|Adverse Event|0|||
30832037|NCT02628028|58856543|FG002|Dosing Period|Adverse Event|0|||
30832038|NCT02628028|58856544|FG003|Dosing Period|Adverse Event|0|||
30832039|NCT02628028|58856545|FG004|Dosing Period|Adverse Event|2|||
30832040|NCT02628028|58856546|FG005|Dosing Period|Adverse Event|1|||
30832041|NCT02628028|58856547|FG006|Dosing Period|Adverse Event|3|||
30832042|NCT02628028|58856548|FG007|Dosing Period|Adverse Event|2|||
30923061|NCT01625000|58958375|FG002|Overall Study|Protocol Violation|4|||
30923062|NCT01625000|58958376|FG003|Overall Study|Protocol Violation|1|||
30923063|NCT01625000|58958377|FG004|Overall Study|Protocol Violation|2|||
30923064|NCT01625000|58958373|FG000|Overall Study|Withdrawal by Subject|19|||
30923065|NCT01625000|58958374|FG001|Overall Study|Withdrawal by Subject|16|||
30832043|NCT02628028|58856541|FG000|Dosing Period|Death|0|||
30832044|NCT02628028|58856542|FG001|Dosing Period|Death|0|||
30832045|NCT02628028|58856543|FG002|Dosing Period|Death|0|||
30832046|NCT02628028|58856544|FG003|Dosing Period|Death|0|||
30832047|NCT02628028|58856545|FG004|Dosing Period|Death|0|||
30832048|NCT02628028|58856546|FG005|Dosing Period|Death|0|||
30832049|NCT02628028|58856547|FG006|Dosing Period|Death|0|||
30832050|NCT02628028|58856548|FG007|Dosing Period|Death|1|||
30832051|NCT02628028|58856541|FG000|Dosing Period|Lack of Efficacy|0|||
30832052|NCT02628028|58856542|FG001|Dosing Period|Lack of Efficacy|0|||
30832053|NCT02628028|58856543|FG002|Dosing Period|Lack of Efficacy|0|||
30832054|NCT02628028|58856544|FG003|Dosing Period|Lack of Efficacy|0|||
30832055|NCT02628028|58856545|FG004|Dosing Period|Lack of Efficacy|3|||
30832056|NCT02628028|58856546|FG005|Dosing Period|Lack of Efficacy|0|||
30832057|NCT02628028|58856547|FG006|Dosing Period|Lack of Efficacy|1|||
30832058|NCT02628028|58856548|FG007|Dosing Period|Lack of Efficacy|0|||
30832059|NCT02628028|58856541|FG000|Dosing Period|Study Terminated by Sponsor|0|||
30832060|NCT02628028|58856542|FG001|Dosing Period|Study Terminated by Sponsor|0|||
30832061|NCT02628028|58856543|FG002|Dosing Period|Study Terminated by Sponsor|0|||
30832062|NCT02628028|58856544|FG003|Dosing Period|Study Terminated by Sponsor|0|||
30832063|NCT02628028|58856545|FG004|Dosing Period|Study Terminated by Sponsor|7|||
30832064|NCT02628028|58856546|FG005|Dosing Period|Study Terminated by Sponsor|6|||
30832065|NCT02628028|58856547|FG006|Dosing Period|Study Terminated by Sponsor|7|||
30832066|NCT02628028|58856548|FG007|Dosing Period|Study Terminated by Sponsor|7|||
30923066|NCT01625000|58958375|FG002|Overall Study|Withdrawal by Subject|11|||
30923067|NCT01625000|58958376|FG003|Overall Study|Withdrawal by Subject|9|||
30923068|NCT01625000|58958377|FG004|Overall Study|Withdrawal by Subject|17|||
30923069|NCT01625000|58958373|FG000|Overall Study|Adverse Event (including Death)|15|||
30923070|NCT01625000|58958374|FG001|Overall Study|Adverse Event (including Death)|19|||
30832067|NCT02628028|58856541|FG000|Dosing Period|Physician Decision|0|||
30832068|NCT02628028|58856542|FG001|Dosing Period|Physician Decision|0|||
30832069|NCT02628028|58856543|FG002|Dosing Period|Physician Decision|0|||
30832070|NCT02628028|58856544|FG003|Dosing Period|Physician Decision|0|||
30832071|NCT02628028|58856545|FG004|Dosing Period|Physician Decision|0|||
30832072|NCT02628028|58856546|FG005|Dosing Period|Physician Decision|1|||
30832073|NCT02628028|58856547|FG006|Dosing Period|Physician Decision|0|||
30832074|NCT02628028|58856548|FG007|Dosing Period|Physician Decision|0|||
30832075|NCT02628028|58856541|FG000|Dosing Period|Site Terminated by Sponsor|0|||
30832076|NCT02628028|58856542|FG001|Dosing Period|Site Terminated by Sponsor|0|||
30832077|NCT02628028|58856543|FG002|Dosing Period|Site Terminated by Sponsor|0|||
30923071|NCT01625000|58958375|FG002|Overall Study|Adverse Event (including Death)|11|||
30832078|NCT02628028|58856544|FG003|Dosing Period|Site Terminated by Sponsor|0|||
30832079|NCT02628028|58856545|FG004|Dosing Period|Site Terminated by Sponsor|0|||
30832080|NCT02628028|58856546|FG005|Dosing Period|Site Terminated by Sponsor|1|||
30832081|NCT02628028|58856547|FG006|Dosing Period|Site Terminated by Sponsor|1|||
30832082|NCT02628028|58856548|FG007|Dosing Period|Site Terminated by Sponsor|0|||
30923072|NCT01625000|58958376|FG003|Overall Study|Adverse Event (including Death)|7|||
30923073|NCT01625000|58958377|FG004|Overall Study|Adverse Event (including Death)|21|||
30923074|NCT02081534|58958396|FG000|Overall Study|Adverse Event|5|||
30923075|NCT02081534|58958397|FG001|Overall Study|Adverse Event|4|||
30923076|NCT02081534|58958398|FG002|Overall Study|Adverse Event|3|||
30923077|NCT02081534|58958399|FG003|Overall Study|Adverse Event|10|||
30923078|NCT02081534|58958400|FG004|Overall Study|Adverse Event|2|||
30923079|NCT02081534|58958401|FG005|Overall Study|Adverse Event|8|||
30923080|NCT02081534|58958402|FG006|Overall Study|Adverse Event|2|||
30923081|NCT02081534|58958396|FG000|Overall Study|Withdrawal by Subject|0|||
30923082|NCT02081534|58958397|FG001|Overall Study|Withdrawal by Subject|1|||
30923083|NCT02081534|58958398|FG002|Overall Study|Withdrawal by Subject|1|||
30923084|NCT02081534|58958399|FG003|Overall Study|Withdrawal by Subject|1|||
30923085|NCT02081534|58958400|FG004|Overall Study|Withdrawal by Subject|1|||
30923086|NCT02081534|58958401|FG005|Overall Study|Withdrawal by Subject|0|||
30923087|NCT02081534|58958402|FG006|Overall Study|Withdrawal by Subject|1|||
30923088|NCT02081534|58958396|FG000|Overall Study|Protocol Violation|0|||
30923089|NCT02081534|58958397|FG001|Overall Study|Protocol Violation|3|||
30923090|NCT02081534|58958398|FG002|Overall Study|Protocol Violation|0|||
30923091|NCT02081534|58958399|FG003|Overall Study|Protocol Violation|0|||
30923092|NCT02081534|58958400|FG004|Overall Study|Protocol Violation|0|||
30923093|NCT02081534|58958401|FG005|Overall Study|Protocol Violation|0|||
30923094|NCT02081534|58958402|FG006|Overall Study|Protocol Violation|1|||
30923095|NCT02081534|58958396|FG000|Overall Study|Lost to Follow-up|0|||
30923096|NCT02081534|58958397|FG001|Overall Study|Lost to Follow-up|0|||
30923097|NCT02081534|58958398|FG002|Overall Study|Lost to Follow-up|0|||
30923098|NCT02081534|58958399|FG003|Overall Study|Lost to Follow-up|2|||
30923099|NCT02081534|58958400|FG004|Overall Study|Lost to Follow-up|1|||
30923100|NCT02081534|58958401|FG005|Overall Study|Lost to Follow-up|1|||
30923101|NCT02081534|58958402|FG006|Overall Study|Lost to Follow-up|0|||
30923102|NCT02057198|58958421|FG000|Overall Study|Death|0|||
30755735|NCT00404495|58765706|FG000|Overall Study|Withdrawal by Subject|1|||
30755736|NCT00404495|58765707|FG001|Overall Study|Withdrawal by Subject|0|||
30755737|NCT00409409|58765715|FG000|Overall Study|Adverse Event|7|||
30755738|NCT00409409|58765716|FG001|Overall Study|Adverse Event|2|||
30832083|NCT02628028|58856541|FG000|Dosing Period|Lost to Follow-up|0|||
30832084|NCT02628028|58856542|FG001|Dosing Period|Lost to Follow-up|0|||
30755739|NCT00409409|58765715|FG000|Overall Study|Withdrawal by Subject|1|||
30755740|NCT00409409|58765716|FG001|Overall Study|Withdrawal by Subject|1|||
30755741|NCT00409409|58765715|FG000|Overall Study|Any other reason not above-mentioned|0|||
30755742|NCT00409409|58765716|FG001|Overall Study|Any other reason not above-mentioned|1|||
30755743|NCT00409331|58765722|FG000|Overall Study|Physician Decision|1|||
30755744|NCT00409175|58765728|FG000|Overall Study|Adverse Event|4|||
30755745|NCT00409175|58765729|FG001|Overall Study|Adverse Event|3|||
30755746|NCT00409175|58765728|FG000|Overall Study|Withdrawal by Subject|1|||
30755747|NCT00409175|58765729|FG001|Overall Study|Withdrawal by Subject|2|||
30755748|NCT00409175|58765728|FG000|Overall Study|Negative genotype|0|||
30755749|NCT00409175|58765729|FG001|Overall Study|Negative genotype|1|||
30755750|NCT00409175|58765728|FG000|Overall Study|Liver transplantation|13|||
30755751|NCT00409175|58765729|FG001|Overall Study|Liver transplantation|13|||
30755752|NCT00408629|58765737|FG000|Overall Study|Adverse Event|13|||
30755753|NCT00408629|58765738|FG001|Overall Study|Adverse Event|27|||
30755754|NCT00408629|58765737|FG000|Overall Study|Withdrawal by Subject|8|||
30923103|NCT02057198|58958422|FG001|Overall Study|Death|0|||
30923104|NCT02057198|58958423|FG002|Overall Study|Death|1|||
30923105|NCT02057198|58958421|FG000|Overall Study|Discharged early; lost to followup|0|||
30923106|NCT02057198|58958422|FG001|Overall Study|Discharged early; lost to followup|1|||
30923107|NCT02057198|58958423|FG002|Overall Study|Discharged early; lost to followup|0|||
30923108|NCT02056652|58958433|FG000|Overall Study|Withdrawal by Subject|1|||
30923109|NCT02056652|58958434|FG001|Overall Study|Withdrawal by Subject|0|||
30755755|NCT00408629|58765738|FG001|Overall Study|Withdrawal by Subject|4|||
30755756|NCT00408629|58765737|FG000|Overall Study|Lost to Follow-up|1|||
30755757|NCT00408629|58765738|FG001|Overall Study|Lost to Follow-up|1|||
30755758|NCT00408629|58765737|FG000|Overall Study|Lack of Efficacy|63|||
30755759|NCT00408629|58765738|FG001|Overall Study|Lack of Efficacy|73|||
30755760|NCT00408629|58765737|FG000|Overall Study|Protocol Violation|1|||
30755761|NCT00408629|58765738|FG001|Overall Study|Protocol Violation|5|||
30755762|NCT00408629|58765737|FG000|Overall Study|Miscellaneous|11|||
30832085|NCT02628028|58856543|FG002|Dosing Period|Lost to Follow-up|0|||
30923110|NCT02056652|58958433|FG000|Overall Study|Lost to Follow-up|0|||
30923111|NCT02056652|58958434|FG001|Overall Study|Lost to Follow-up|3|||
30923112|NCT02056340|58958442|FG000|Overall Study|Lost to Follow-up|5|||
30923113|NCT02056340|58958443|FG001|Overall Study|Lost to Follow-up|5|||
30832086|NCT02628028|58856544|FG003|Dosing Period|Lost to Follow-up|0|||
30832087|NCT02628028|58856545|FG004|Dosing Period|Lost to Follow-up|0|||
30832088|NCT02628028|58856546|FG005|Dosing Period|Lost to Follow-up|0|||
30832089|NCT02628028|58856547|FG006|Dosing Period|Lost to Follow-up|1|||
30832090|NCT02628028|58856548|FG007|Dosing Period|Lost to Follow-up|0|||
30832091|NCT02628028|58856541|FG000|Dosing Period|Other|0|||
30832092|NCT02628028|58856542|FG001|Dosing Period|Other|0|||
30832093|NCT02628028|58856543|FG002|Dosing Period|Other|0|||
30832094|NCT02628028|58856544|FG003|Dosing Period|Other|0|||
30832095|NCT02628028|58856545|FG004|Dosing Period|Other|2|||
30832096|NCT02628028|58856546|FG005|Dosing Period|Other|1|||
30832097|NCT02628028|58856547|FG006|Dosing Period|Other|2|||
30832098|NCT02628028|58856548|FG007|Dosing Period|Other|4|||
30832099|NCT02628028|58856541|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
30832100|NCT02628028|58856542|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
30832101|NCT02628028|58856543|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
30832102|NCT02628028|58856544|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
30832103|NCT02628028|58856545|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
30832104|NCT02628028|58856546|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
30832105|NCT02628028|58856547|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
30832106|NCT02628028|58856548|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
30832107|NCT02628028|58856541|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
30832108|NCT02628028|58856542|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
30832109|NCT02628028|58856543|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
30832110|NCT02628028|58856544|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
30832111|NCT02628028|58856545|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
30832112|NCT02628028|58856546|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
30832113|NCT02628028|58856547|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
30832114|NCT02628028|58856548|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
30832115|NCT02628028|58856541|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
30832116|NCT02628028|58856542|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
30832117|NCT02628028|58856543|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
30832118|NCT02628028|58856544|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
30832119|NCT02628028|58856545|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
30832120|NCT02628028|58856546|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
30832121|NCT02628028|58856547|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
30832122|NCT02628028|58856548|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
30832123|NCT02628028|58856541|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
30832124|NCT02628028|58856542|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
30832125|NCT02628028|58856543|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
30832126|NCT02628028|58856544|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
30832127|NCT02628028|58856545|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
30832128|NCT02628028|58856546|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
30832129|NCT02628028|58856547|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
30832130|NCT02628028|58856548|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
30832131|NCT02628028|58856541|FG000|Long-term Extension (LTE) Period|Other|0|||
30832132|NCT02628028|58856542|FG001|Long-term Extension (LTE) Period|Other|0|||
30832133|NCT02628028|58856543|FG002|Long-term Extension (LTE) Period|Other|0|||
30832134|NCT02628028|58856544|FG003|Long-term Extension (LTE) Period|Other|0|||
30832135|NCT02628028|58856545|FG004|Long-term Extension (LTE) Period|Other|0|||
30832136|NCT02628028|58856546|FG005|Long-term Extension (LTE) Period|Other|3|||
30832137|NCT02628028|58856547|FG006|Long-term Extension (LTE) Period|Other|4|||
30832138|NCT02628028|58856548|FG007|Long-term Extension (LTE) Period|Other|3|||
30832139|NCT03977701|58856580|FG000|Overall Study|COVID-19 pandemic|0|||
30832140|NCT03977701|58856581|FG001|Overall Study|COVID-19 pandemic|0|||
30832141|NCT03977701|58856582|FG002|Overall Study|COVID-19 pandemic|0|||
30832142|NCT03977701|58856583|FG003|Overall Study|COVID-19 pandemic|0|||
30832143|NCT03977701|58856584|FG004|Overall Study|COVID-19 pandemic|0|||
30832144|NCT03977701|58856585|FG005|Overall Study|COVID-19 pandemic|1|||
30832145|NCT03977701|58856586|FG006|Overall Study|COVID-19 pandemic|0|||
30832146|NCT03977701|58856587|FG007|Overall Study|COVID-19 pandemic|1|||
30832147|NCT03977701|58856588|FG008|Overall Study|COVID-19 pandemic|0|||
30832148|NCT03977701|58856589|FG009|Overall Study|COVID-19 pandemic|0|||
30832149|NCT02814526|58856628|FG000|Overall Study|Adverse Event|4|||
30832150|NCT02814526|58856629|FG001|Overall Study|Adverse Event|3|||
30832151|NCT02814526|58856628|FG000|Overall Study|Death|1|||
30832152|NCT02814526|58856629|FG001|Overall Study|Death|1|||
30832153|NCT02814526|58856628|FG000|Overall Study|Lost to Follow-up|3|||
30832154|NCT02814526|58856629|FG001|Overall Study|Lost to Follow-up|4|||
30623835|NCT01119846|58635706|FG001|Overall Study|Adverse Event|0|||
30832155|NCT02814526|58856628|FG000|Overall Study|non site physician decision|1|||
30923114|NCT02056340|58958442|FG000|Overall Study|Withdrawal by Subject|2|||
30923115|NCT02056340|58958443|FG001|Overall Study|Withdrawal by Subject|6|||
30923116|NCT02046122|58958449|FG000|Overall Study|Physician Decision|8|||
30923117|NCT02046122|58958449|FG000|Overall Study|Withdrawal by Subject|1|||
30923118|NCT02080832|58958456|FG000|Overall Study|Excluded from analysis by MRI|9|||
30923119|NCT02080832|58958457|FG001|Overall Study|Excluded from analysis by MRI|10|||
30832156|NCT02814526|58856629|FG001|Overall Study|non site physician decision|0|||
30832157|NCT02814526|58856628|FG000|Overall Study|participant noncompliance|1|||
30832158|NCT02814526|58856629|FG001|Overall Study|participant noncompliance|1|||
30832159|NCT02814526|58856628|FG000|Overall Study|Withdrawal by Subject|20|||
30832160|NCT02814526|58856629|FG001|Overall Study|Withdrawal by Subject|14|||
30832161|NCT02814526|58856628|FG000|Overall Study|safety risk|2|||
30832162|NCT02814526|58856629|FG001|Overall Study|safety risk|1|||
30832163|NCT02814526|58856628|FG000|Overall Study|early termination-study terminated|1|||
30832164|NCT02814526|58856629|FG001|Overall Study|early termination-study terminated|2|||
30832165|NCT02814526|58856628|FG000|Overall Study|Other|0|||
30832166|NCT02814526|58856629|FG001|Overall Study|Other|4|||
30832167|NCT02329834|58856637|FG000|Overall Study|Physician Decision|1|||
30832168|NCT02329834|58856638|FG001|Overall Study|Physician Decision|0|||
30832169|NCT01340937|58856649|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
30832170|NCT01340937|58856650|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
30832171|NCT01340937|58856651|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
30832172|NCT01340937|58856652|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
30832173|NCT01340937|58856649|FG000|Period 1: Infant Series|Adverse Event|0|||
30832174|NCT01340937|58856650|FG001|Period 1: Infant Series|Adverse Event|1|||
30832175|NCT01340937|58856651|FG002|Period 1: Infant Series|Adverse Event|4|||
30832176|NCT01340937|58856652|FG003|Period 1: Infant Series|Adverse Event|0|||
30832177|NCT01340937|58856649|FG000|Period 1: Infant Series|Death|2|||
30832178|NCT01340937|58856650|FG001|Period 1: Infant Series|Death|0|||
30923120|NCT02080832|58958458|FG002|Overall Study|Excluded from analysis by MRI|14|||
30923121|NCT02080832|58958456|FG000|Overall Study|Lost to Follow-up|0|||
30923122|NCT02080832|58958457|FG001|Overall Study|Lost to Follow-up|2|||
30923123|NCT02080832|58958458|FG002|Overall Study|Lost to Follow-up|2|||
30923124|NCT02080364|58958472|FG000|Baseline Period|Protocol Violation|2|||
30923125|NCT02080364|58958473|FG001|Baseline Period|Protocol Violation|1|||
30923126|NCT02080364|58958474|FG002|Baseline Period|Protocol Violation|0|||
30923127|NCT02080364|58958475|FG003|Baseline Period|Protocol Violation|0|||
30923128|NCT02080364|58958472|FG000|Baseline Period|Other|0|||
30923129|NCT02080364|58958473|FG001|Baseline Period|Other|1|||
30923130|NCT02080364|58958474|FG002|Baseline Period|Other|1|||
30923131|NCT02080364|58958475|FG003|Baseline Period|Other|0|||
30923132|NCT02080364|58958472|FG000|Treatment Period|Adverse Event|10|||
30923133|NCT02080364|58958473|FG001|Treatment Period|Adverse Event|15|||
30923134|NCT02080364|58958474|FG002|Treatment Period|Adverse Event|11|||
30923135|NCT02080364|58958475|FG003|Treatment Period|Adverse Event|14|||
30923136|NCT02080364|58958472|FG000|Treatment Period|Lost to Follow-up|2|||
30923137|NCT02080364|58958473|FG001|Treatment Period|Lost to Follow-up|3|||
30923138|NCT02080364|58958474|FG002|Treatment Period|Lost to Follow-up|5|||
30923139|NCT02080364|58958475|FG003|Treatment Period|Lost to Follow-up|0|||
30923140|NCT02080364|58958472|FG000|Treatment Period|Protocol Violation|5|||
30923141|NCT02080364|58958473|FG001|Treatment Period|Protocol Violation|3|||
30923142|NCT02080364|58958474|FG002|Treatment Period|Protocol Violation|5|||
30832179|NCT01340937|58856651|FG002|Period 1: Infant Series|Death|2|||
30832180|NCT01340937|58856652|FG003|Period 1: Infant Series|Death|0|||
30832181|NCT01340937|58856649|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
30832182|NCT01340937|58856650|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
30832183|NCT01340937|58856651|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
30832184|NCT01340937|58856652|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
30832185|NCT01340937|58856649|FG000|Period 1: Infant Series|Physician Decision|2|||
30832186|NCT01340937|58856650|FG001|Period 1: Infant Series|Physician Decision|3|||
30832187|NCT01340937|58856651|FG002|Period 1: Infant Series|Physician Decision|1|||
30832188|NCT01340937|58856652|FG003|Period 1: Infant Series|Physician Decision|0|||
30832189|NCT01340937|58856649|FG000|Period 1: Infant Series|Protocol Violation|1|||
30832190|NCT01340937|58856650|FG001|Period 1: Infant Series|Protocol Violation|4|||
30832191|NCT01340937|58856651|FG002|Period 1: Infant Series|Protocol Violation|4|||
30832192|NCT01340937|58856652|FG003|Period 1: Infant Series|Protocol Violation|3|||
30832193|NCT01340937|58856649|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
30832194|NCT01340937|58856650|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
30832195|NCT01340937|58856651|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
30923143|NCT02080364|58958475|FG003|Treatment Period|Protocol Violation|1|||
30923144|NCT02080364|58958472|FG000|Treatment Period|Withdrawal by Subject|16|||
30923145|NCT02080364|58958473|FG001|Treatment Period|Withdrawal by Subject|16|||
30923146|NCT02080364|58958474|FG002|Treatment Period|Withdrawal by Subject|15|||
30832196|NCT01340937|58856652|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
30832197|NCT01340937|58856649|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
30832198|NCT01340937|58856650|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
30832199|NCT01340937|58856651|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
30832200|NCT01340937|58856652|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
30832201|NCT01340937|58856649|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
30832202|NCT01340937|58856650|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
30832203|NCT01340937|58856651|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
30832204|NCT01340937|58856652|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
30832205|NCT01340937|58856649|FG000|Period 2: Interim Period|Adverse Event|1|||
30832206|NCT01340937|58856650|FG001|Period 2: Interim Period|Adverse Event|0|||
30832207|NCT01340937|58856651|FG002|Period 2: Interim Period|Adverse Event|1|||
30832208|NCT01340937|58856652|FG003|Period 2: Interim Period|Adverse Event|0|||
30832209|NCT01340937|58856649|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
30832210|NCT01340937|58856650|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
30832211|NCT01340937|58856651|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
30832212|NCT01340937|58856652|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
30832213|NCT01340937|58856649|FG000|Period 2: Interim Period|Physician Decision|0|||
30832214|NCT01340937|58856650|FG001|Period 2: Interim Period|Physician Decision|1|||
30832215|NCT01340937|58856651|FG002|Period 2: Interim Period|Physician Decision|1|||
30832216|NCT01340937|58856652|FG003|Period 2: Interim Period|Physician Decision|0|||
30832217|NCT01340937|58856649|FG000|Period 2: Interim Period|Protocol Violation|5|||
30832218|NCT01340937|58856650|FG001|Period 2: Interim Period|Protocol Violation|3|||
30832219|NCT01340937|58856651|FG002|Period 2: Interim Period|Protocol Violation|6|||
30832220|NCT01340937|58856652|FG003|Period 2: Interim Period|Protocol Violation|3|||
30832221|NCT01340937|58856649|FG000|Period 2: Interim Period|Technical problems|4|||
30832222|NCT01340937|58856650|FG001|Period 2: Interim Period|Technical problems|4|||
30832223|NCT01340937|58856651|FG002|Period 2: Interim Period|Technical problems|6|||
30832224|NCT01340937|58856652|FG003|Period 2: Interim Period|Technical problems|3|||
30832225|NCT01340937|58856649|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
30832226|NCT01340937|58856650|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
30832227|NCT01340937|58856651|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
30832228|NCT01340937|58856652|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
30832229|NCT01340937|58856649|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
30832230|NCT01340937|58856650|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
30832231|NCT01340937|58856651|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
30832232|NCT01340937|58856652|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
30832233|NCT01340937|58856649|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
30832234|NCT01340937|58856650|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
30832235|NCT01340937|58856651|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
30832236|NCT01340937|58856652|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
30832237|NCT01340937|58856649|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
30832238|NCT01340937|58856650|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
30832239|NCT01340937|58856651|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
30832240|NCT01340937|58856652|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
30832241|NCT03028129|58856670|FG000|Overall Study|Adverse Event|13|||
30832242|NCT03028129|58856671|FG001|Overall Study|Adverse Event|2|||
30832243|NCT03028129|58856670|FG000|Overall Study|Lost to Follow-up|50|||
30832244|NCT03028129|58856671|FG001|Overall Study|Lost to Follow-up|38|||
30832245|NCT03028129|58856670|FG000|Overall Study|Physician Decision|0|||
30832246|NCT03028129|58856671|FG001|Overall Study|Physician Decision|1|||
30832247|NCT03028129|58856670|FG000|Overall Study|Protocol Violation|1|||
30832248|NCT03028129|58856671|FG001|Overall Study|Protocol Violation|1|||
30832249|NCT03028129|58856670|FG000|Overall Study|Withdrawal by Subject|62|||
30832250|NCT03028129|58856671|FG001|Overall Study|Withdrawal by Subject|45|||
30832251|NCT01309672|58856677|FG000|Overall Study|Lack of Efficacy|20|||
30832252|NCT01309672|58856677|FG000|Overall Study|Other|9|||
30832253|NCT01309672|58856677|FG000|Overall Study|Adverse Event|5|||
30832254|NCT01309672|58856677|FG000|Overall Study|Withdrawal by Subject|3|||
30832255|NCT03026257|58856688|FG000|Overall Study|Adverse Event|3|||
30832256|NCT03026257|58856689|FG001|Overall Study|Adverse Event|0|||
30832257|NCT03026257|58856690|FG002|Overall Study|Adverse Event|0|||
30832258|NCT03026257|58856691|FG003|Overall Study|Adverse Event|0|||
30832259|NCT03026257|58856692|FG004|Overall Study|Adverse Event|0|||
30832260|NCT03026257|58856693|FG005|Overall Study|Adverse Event|0|||
30832261|NCT03026257|58856688|FG000|Overall Study|Lost to Follow-up|1|||
30832262|NCT03026257|58856689|FG001|Overall Study|Lost to Follow-up|0|||
30832263|NCT03026257|58856690|FG002|Overall Study|Lost to Follow-up|0|||
30832264|NCT03026257|58856691|FG003|Overall Study|Lost to Follow-up|0|||
30832265|NCT03026257|58856692|FG004|Overall Study|Lost to Follow-up|0|||
30832266|NCT03026257|58856693|FG005|Overall Study|Lost to Follow-up|0|||
30832267|NCT03026257|58856688|FG000|Overall Study|Protocol Violation|1|||
30832268|NCT03026257|58856689|FG001|Overall Study|Protocol Violation|0|||
30832269|NCT03026257|58856690|FG002|Overall Study|Protocol Violation|0|||
30832270|NCT03026257|58856691|FG003|Overall Study|Protocol Violation|1|||
30832271|NCT03026257|58856692|FG004|Overall Study|Protocol Violation|1|||
30832272|NCT03026257|58856693|FG005|Overall Study|Protocol Violation|0|||
30832273|NCT03026257|58856688|FG000|Overall Study|Withdrawal by Subject|1|||
30832274|NCT03026257|58856689|FG001|Overall Study|Withdrawal by Subject|1|||
30832275|NCT03026257|58856690|FG002|Overall Study|Withdrawal by Subject|0|||
30832276|NCT03026257|58856691|FG003|Overall Study|Withdrawal by Subject|0|||
30923147|NCT02080364|58958475|FG003|Treatment Period|Withdrawal by Subject|10|||
30923148|NCT02080364|58958472|FG000|Treatment Period|Study Terminated by Sponsor|0|||
30923149|NCT02080364|58958473|FG001|Treatment Period|Study Terminated by Sponsor|0|||
30923150|NCT02080364|58958474|FG002|Treatment Period|Study Terminated by Sponsor|180|||
30923151|NCT02080364|58958475|FG003|Treatment Period|Study Terminated by Sponsor|183|||
30923152|NCT02080364|58958472|FG000|Treatment Period|Other|14|||
30923153|NCT02080364|58958473|FG001|Treatment Period|Other|12|||
30923154|NCT02080364|58958474|FG002|Treatment Period|Other|21|||
30923155|NCT02080364|58958475|FG003|Treatment Period|Other|16|||
30923156|NCT02079038|58958487|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
30923157|NCT02079038|58958488|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
30923158|NCT02079038|58958487|FG000|Modified Intent to Treat Population|Death|1|||
30923159|NCT02079038|58958488|FG001|Modified Intent to Treat Population|Death|0|||
30923160|NCT02079038|58958487|FG000|Completed 6 Months|Lost to Follow-up|2|||
30923161|NCT02079038|58958488|FG001|Completed 6 Months|Lost to Follow-up|1|||
30923162|NCT02045732|58958496|FG000|Overall Study|At the discretion of the investigator|1|||
30923163|NCT02045732|58958497|FG001|Overall Study|At the discretion of the investigator|1|||
30923164|NCT02044874|58958506|FG000|Overall Study|Adverse Event|5|||
30923165|NCT02044874|58958507|FG001|Overall Study|Adverse Event|6|||
30923166|NCT02044874|58958508|FG002|Overall Study|Adverse Event|6|||
30923167|NCT02044874|58958506|FG000|Overall Study|Withdrawal by Subject|8|||
30923168|NCT02044874|58958507|FG001|Overall Study|Withdrawal by Subject|16|||
30923169|NCT02044874|58958508|FG002|Overall Study|Withdrawal by Subject|23|||
30923170|NCT02044874|58958506|FG000|Overall Study|Physician Decision|0|||
30923171|NCT02044874|58958507|FG001|Overall Study|Physician Decision|2|||
30923172|NCT02044874|58958508|FG002|Overall Study|Physician Decision|1|||
30923173|NCT02044874|58958506|FG000|Overall Study|Lost to Follow-up|10|||
30923174|NCT02044874|58958507|FG001|Overall Study|Lost to Follow-up|27|||
30923175|NCT02044874|58958508|FG002|Overall Study|Lost to Follow-up|21|||
30923176|NCT02044874|58958506|FG000|Overall Study|Sponsor Decision|0|||
30923177|NCT02044874|58958507|FG001|Overall Study|Sponsor Decision|1|||
30923178|NCT02044874|58958508|FG002|Overall Study|Sponsor Decision|1|||
30923179|NCT02044874|58958506|FG000|Overall Study|Other|7|||
30923180|NCT02044874|58958507|FG001|Overall Study|Other|3|||
30923181|NCT02044874|58958508|FG002|Overall Study|Other|8|||
30923182|NCT02078960|58958521|FG000|Treatment Period|Other|0|||
30923183|NCT02078960|58958522|FG001|Treatment Period|Other|0|||
30923184|NCT02078960|58958523|FG002|Treatment Period|Other|1|||
30923185|NCT02078960|58958521|FG000|Treatment Period|Lack of Efficacy|0|||
30923186|NCT02078960|58958522|FG001|Treatment Period|Lack of Efficacy|1|||
30923187|NCT02078960|58958523|FG002|Treatment Period|Lack of Efficacy|0|||
30923188|NCT02078960|58958521|FG000|Treatment Period|Disease progression - accelerated phase|0|||
30923189|NCT02078960|58958522|FG001|Treatment Period|Disease progression - accelerated phase|1|||
30923190|NCT02078960|58958523|FG002|Treatment Period|Disease progression - accelerated phase|0|||
30923191|NCT02078960|58958521|FG000|Treatment Period|Disease progression - blast phase|1|||
30923192|NCT02078960|58958522|FG001|Treatment Period|Disease progression - blast phase|0|||
30923193|NCT02078960|58958523|FG002|Treatment Period|Disease progression - blast phase|0|||
30923194|NCT02078960|58958521|FG000|Treatment Period|Withdrawal by Subject|0|||
30923195|NCT02078960|58958522|FG001|Treatment Period|Withdrawal by Subject|1|||
30923196|NCT02078960|58958523|FG002|Treatment Period|Withdrawal by Subject|1|||
30923197|NCT02078960|58958521|FG000|Treatment Period|Adverse Event|1|||
30923198|NCT02078960|58958522|FG001|Treatment Period|Adverse Event|0|||
30923199|NCT02078960|58958523|FG002|Treatment Period|Adverse Event|0|||
30923200|NCT02078960|58958521|FG000|Treatment Period|Death|0|||
30923201|NCT02078960|58958522|FG001|Treatment Period|Death|0|||
30923202|NCT02078960|58958523|FG002|Treatment Period|Death|1|||
30923203|NCT02078960|58958521|FG000|Follow-up Period|Death|2|||
30923204|NCT02078960|58958522|FG001|Follow-up Period|Death|0|||
30923205|NCT02078960|58958523|FG002|Follow-up Period|Death|0|||
30923206|NCT02078960|58958521|FG000|Follow-up Period|Lost to Follow-up|0|||
30923207|NCT02078960|58958522|FG001|Follow-up Period|Lost to Follow-up|1|||
30923208|NCT02078960|58958523|FG002|Follow-up Period|Lost to Follow-up|0|||
30923209|NCT02078102|58958535|FG000|Overall Study|Adverse Event|1|||
30923210|NCT02078102|58958536|FG001|Overall Study|Adverse Event|0|||
30923211|NCT02078102|58958535|FG000|Overall Study|Withdrawal by Subject|1|||
30923212|NCT02078102|58958536|FG001|Overall Study|Withdrawal by Subject|0|||
30832277|NCT03026257|58856692|FG004|Overall Study|Withdrawal by Subject|0|||
30832278|NCT03026257|58856693|FG005|Overall Study|Withdrawal by Subject|0|||
30923213|NCT02078102|58958535|FG000|Overall Study|Physician Decision|0|||
30923214|NCT02078102|58958536|FG001|Overall Study|Physician Decision|1|||
30832279|NCT01670188|58856709|FG000|Overall Study|Death|0|||
30923215|NCT02054702|58958545|FG000|Overall Study|Lost to Follow-up|3|||
30923216|NCT02054702|58958546|FG001|Overall Study|Lost to Follow-up|5|||
30923217|NCT02054702|58958545|FG000|Overall Study|Adverse Event|3|||
30923218|NCT02054702|58958546|FG001|Overall Study|Adverse Event|1|||
30923219|NCT02054702|58958545|FG000|Overall Study|Met Withdrawal Criteria|4|||
30923220|NCT02054702|58958546|FG001|Overall Study|Met Withdrawal Criteria|1|||
30923221|NCT02054702|58958545|FG000|Overall Study|Physician Decision|0|||
30923222|NCT02054702|58958546|FG001|Overall Study|Physician Decision|1|||
30923223|NCT02054702|58958545|FG000|Overall Study|Withdrawal by Subject|14|||
30923224|NCT02054702|58958546|FG001|Overall Study|Withdrawal by Subject|4|||
30832280|NCT01670188|58856710|FG001|Overall Study|Death|1|||
30832281|NCT01933048|58856718|FG000|Overall Study|Lost to Follow-up|15|||
30832282|NCT01933048|58856719|FG001|Overall Study|Lost to Follow-up|18|||
30832283|NCT01933048|58856718|FG000|Overall Study|personal reasons|1|||
30832284|NCT01933048|58856719|FG001|Overall Study|personal reasons|1|||
30832285|NCT01933048|58856718|FG000|Overall Study|Protocol Violation|7|||
30832286|NCT01933048|58856719|FG001|Overall Study|Protocol Violation|8|||
30832287|NCT01933048|58856718|FG000|Overall Study|Physician Decision|1|||
30832288|NCT01933048|58856719|FG001|Overall Study|Physician Decision|0|||
30832289|NCT01933048|58856718|FG000|Overall Study|unknown reasons|1|||
30832290|NCT01933048|58856719|FG001|Overall Study|unknown reasons|1|||
30832291|NCT02751450|58856730|FG000|Overall Study|Adverse Event|1|||
30832292|NCT02751450|58856731|FG001|Overall Study|Adverse Event|0|||
30832293|NCT01515748|58856741|FG000|Overall Study|Withdrawal by Subject|32|||
30832294|NCT01515748|58856742|FG001|Overall Study|Withdrawal by Subject|41|||
30832295|NCT01515748|58856741|FG000|Overall Study|Lost to Follow-up|2|||
30832296|NCT01515748|58856742|FG001|Overall Study|Lost to Follow-up|4|||
30832297|NCT01515748|58856741|FG000|Overall Study|Ongoing|86|||
30832298|NCT01515748|58856742|FG001|Overall Study|Ongoing|90|||
30923225|NCT02044094|58958552|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
30923226|NCT02044094|58958552|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
30923227|NCT02044094|58958552|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
30923228|NCT02044094|58958552|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
30923229|NCT02044094|58958552|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
30923230|NCT02044094|58958552|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
30923231|NCT02044094|58958552|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
30923232|NCT02044094|58958552|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
30923233|NCT02043938|58958567|FG000|Overall Study|Withdrawal by Subject|7|||
30755763|NCT00408629|58765738|FG001|Overall Study|Miscellaneous|15|||
30755764|NCT00408317|58765745|FG000|First Intervention Period|Adverse Event|0|||
30755765|NCT00408317|58765746|FG001|First Intervention Period|Adverse Event|1|||
30755766|NCT00408317|58765745|FG000|Second Intervention Period|Adverse Event|2|||
30755767|NCT00408317|58765746|FG001|Second Intervention Period|Adverse Event|0|||
30755768|NCT00408317|58765745|FG000|Second Intervention Period|Protocol Violation|0|||
30755769|NCT00408317|58765746|FG001|Second Intervention Period|Protocol Violation|1|||
30755770|NCT00408317|58765745|FG000|Second Intervention Period|Withdrawal of consent|0|||
30755771|NCT00408317|58765746|FG001|Second Intervention Period|Withdrawal of consent|1|||
30755772|NCT00112502|58765760|FG000|Overall Study|Withdrawal by Subject|0|||
30755773|NCT00112502|58765761|FG001|Overall Study|Withdrawal by Subject|1|||
30755774|NCT00112502|58765762|FG002|Overall Study|Withdrawal by Subject|1|||
30755775|NCT00112502|58765763|FG003|Overall Study|Withdrawal by Subject|4|||
30755776|NCT00112502|58765764|FG004|Overall Study|Withdrawal by Subject|2|||
30755777|NCT00112502|58765765|FG005|Overall Study|Withdrawal by Subject|5|||
30755778|NCT00112502|58765766|FG006|Overall Study|Withdrawal by Subject|3|||
30755779|NCT00112502|58765767|FG007|Overall Study|Withdrawal by Subject|7|||
30755780|NCT03822182|58765798|FG000|Overall Study|Protocol Violation|0|||
30755781|NCT03822182|58765799|FG001|Overall Study|Protocol Violation|1|||
30755782|NCT03822182|58765800|FG002|Overall Study|Protocol Violation|1|||
30832299|NCT01358175|58856752|FG000|Overall Study|Death|1|||
30832300|NCT01358175|58856753|FG001|Overall Study|Death|0|||
30923234|NCT02043938|58958567|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
30923235|NCT02043938|58958567|FG000|Overall Study|No show by subject|1|||
30923236|NCT02043938|58958567|FG000|Overall Study|Investigator decision|1|||
30923237|NCT02053610|58958576|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
30923238|NCT02053610|58958577|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
30923239|NCT02053610|58958576|FG000|Overall Study|Withdrew Consent|2|||
30923240|NCT02053610|58958577|FG001|Overall Study|Withdrew Consent|9|||
30755783|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
30832301|NCT01358175|58856754|FG002|Overall Study|Death|1|||
30832302|NCT01358175|58856752|FG000|Overall Study|Withdrawal by Subject|9|||
30832303|NCT01358175|58856753|FG001|Overall Study|Withdrawal by Subject|5|||
30755784|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
30755785|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
30755786|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
30832304|NCT01358175|58856754|FG002|Overall Study|Withdrawal by Subject|10|||
30832305|NCT01358175|58856752|FG000|Overall Study|Technical issues|0|||
30832306|NCT01358175|58856753|FG001|Overall Study|Technical issues|1|||
30832307|NCT01358175|58856754|FG002|Overall Study|Technical issues|0|||
30832308|NCT01358175|58856752|FG000|Overall Study|Pregnancy|0|||
30832309|NCT01358175|58856753|FG001|Overall Study|Pregnancy|1|||
30832310|NCT01358175|58856754|FG002|Overall Study|Pregnancy|0|||
30832311|NCT01358175|58856752|FG000|Overall Study|Physician Decision|1|||
30832312|NCT01358175|58856753|FG001|Overall Study|Physician Decision|0|||
30832313|NCT01358175|58856754|FG002|Overall Study|Physician Decision|0|||
30832314|NCT01358175|58856752|FG000|Overall Study|Non Compliance with Study Treatment|0|||
30832315|NCT01358175|58856753|FG001|Overall Study|Non Compliance with Study Treatment|1|||
30923241|NCT02053610|58958576|FG000|Overall Study|Death|5|||
30923242|NCT02053610|58958577|FG001|Overall Study|Death|5|||
30923243|NCT02053610|58958576|FG000|Overall Study|Administrative/Other|1|||
30923244|NCT02053610|58958577|FG001|Overall Study|Administrative/Other|1|||
30923245|NCT02053610|58958576|FG000|Overall Study|Disease Progression|2|||
30923246|NCT02053610|58958577|FG001|Overall Study|Disease Progression|3|||
30832316|NCT01358175|58856754|FG002|Overall Study|Non Compliance with Study Treatment|1|||
30832317|NCT01358175|58856752|FG000|Overall Study|Lost to Follow-up|1|||
30832318|NCT01358175|58856753|FG001|Overall Study|Lost to Follow-up|1|||
30832319|NCT01358175|58856754|FG002|Overall Study|Lost to Follow-up|3|||
30832320|NCT01358175|58856752|FG000|Overall Study|Lack of Efficacy|3|||
30832321|NCT01358175|58856753|FG001|Overall Study|Lack of Efficacy|8|||
30832322|NCT01358175|58856754|FG002|Overall Study|Lack of Efficacy|6|||
30832323|NCT01358175|58856752|FG000|Overall Study|Adverse Event|6|||
30832324|NCT01358175|58856753|FG001|Overall Study|Adverse Event|11|||
30832325|NCT01358175|58856754|FG002|Overall Study|Adverse Event|11|||
30832326|NCT04116229|58856768|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
30832327|NCT04116229|58856769|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
30832328|NCT04116229|58856768|FG000|Overall Study|Scheduling not possible.|0|||
30832329|NCT04116229|58856769|FG001|Overall Study|Scheduling not possible.|1|||
30832330|NCT02210832|58856778|FG000|Overall Study|Pregnancy termination .|3|||
30832331|NCT02210832|58856779|FG001|Overall Study|Pregnancy termination .|4|||
30832332|NCT02210832|58856780|FG002|Overall Study|Pregnancy termination .|1|||
30832333|NCT02210832|58856778|FG000|Overall Study|Lost to Follow-up|26|||
30832334|NCT02210832|58856779|FG001|Overall Study|Lost to Follow-up|32|||
30755787|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
30755788|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
30832335|NCT02210832|58856780|FG002|Overall Study|Lost to Follow-up|17|||
30923247|NCT02053610|58958576|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
30923248|NCT02053610|58958577|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
30923249|NCT02053610|58958576|FG000|Overall Study|Did not Receive Treatment|4|||
30923250|NCT02053610|58958577|FG001|Overall Study|Did not Receive Treatment|2|||
30923251|NCT02053610|58958576|FG000|Overall Study|Insufficient Therapeutic Response|1|||
30923252|NCT02053610|58958577|FG001|Overall Study|Insufficient Therapeutic Response|1|||
30923253|NCT02053610|58958576|FG000|Overall Study|Violation of Selection Criteria|1|||
30923254|NCT02053610|58958577|FG001|Overall Study|Violation of Selection Criteria|0|||
30923255|NCT02075606|58958583|FG000|Overall Study|Adverse Event|5|||
30923256|NCT02075606|58958583|FG000|Overall Study|Withdrawal by Subject|1|||
30923257|NCT02075606|58958583|FG000|Overall Study|Death|1|||
30923258|NCT02075606|58958583|FG000|Overall Study|Investigator's decision|1|||
30923259|NCT02075606|58958583|FG000|Overall Study|Symptom management|1|||
30923260|NCT02075606|58958583|FG000|Overall Study|Increasing Symptoms|1|||
30923261|NCT02043782|58958592|FG000|Period 1|Adverse Event|0|||
30923262|NCT02043782|58958593|FG001|Period 1|Adverse Event|0|||
30923263|NCT02043782|58958594|FG002|Period 1|Adverse Event|1|||
30832336|NCT02833077|58856793|FG000|Overall Study|Adverse Event|1|||
30832337|NCT02833077|58856794|FG001|Overall Study|Adverse Event|2|||
30923264|NCT02043782|58958595|FG003|Period 1|Adverse Event|0|||
30923265|NCT02043782|58958596|FG004|Period 1|Adverse Event|0|||
30923266|NCT02043782|58958597|FG005|Period 1|Adverse Event|0|||
30923267|NCT02052596|58958607|FG000|Active Phase|Adverse Event|3|||
30923268|NCT02052596|58958608|FG001|Active Phase|Adverse Event|2|||
30923269|NCT02052596|58958607|FG000|Active Phase|Lost to Follow-up|8|||
30923270|NCT02052596|58958608|FG001|Active Phase|Lost to Follow-up|11|||
30755789|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
30755790|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
30755791|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
30755792|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
30755793|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
30755794|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
30755795|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
30755796|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
30832338|NCT02833077|58856793|FG000|Overall Study|Lost to Follow-up|10|||
30832339|NCT02833077|58856794|FG001|Overall Study|Lost to Follow-up|1|||
30923271|NCT02052596|58958607|FG000|Active Phase|Protocol Violation|1|||
30923272|NCT02052596|58958608|FG001|Active Phase|Protocol Violation|2|||
30832340|NCT02833077|58856793|FG000|Overall Study|Personal Reasons|6|||
30832341|NCT02833077|58856794|FG001|Overall Study|Personal Reasons|4|||
30832342|NCT02833077|58856793|FG000|Overall Study|Protocol Deviation|0|||
30832343|NCT02833077|58856794|FG001|Overall Study|Protocol Deviation|1|||
30832344|NCT01355679|58856801|FG000|Overall Study|benign tumor types found at biopsy|2|||
30832345|NCT02832375|58856808|FG000|Overall Study|Lost to Follow-up|1|||
30832346|NCT02832375|58856809|FG001|Overall Study|Lost to Follow-up|0|||
30832347|NCT02832375|58856808|FG000|Overall Study|Withdrawal of Consent|1|||
30832348|NCT02832375|58856809|FG001|Overall Study|Withdrawal of Consent|0|||
30832349|NCT02925403|58856818|FG000|Overall Study|Lost to Follow-up|0|||
30832350|NCT02925403|58856819|FG001|Overall Study|Lost to Follow-up|1|||
30832351|NCT02626780|58856825|FG000|Overall Study|Withdrawal by Subject|3|||
30832352|NCT02831673|58856840|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
30832353|NCT02831673|58856841|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
30832354|NCT02831673|58856842|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
30832355|NCT02831673|58856843|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
30832356|NCT02831673|58856844|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
30832357|NCT02831673|58856840|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
30832358|NCT02831673|58856841|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
30832359|NCT02831673|58856842|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
30832360|NCT02831673|58856843|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
30832361|NCT02831673|58856844|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
30832362|NCT02831673|58856840|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
30832363|NCT02831673|58856841|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
30832364|NCT02831673|58856842|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
30832365|NCT02831673|58856843|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
30832366|NCT02831673|58856844|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
30832367|NCT02831673|58856840|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
30832368|NCT02831673|58856841|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
30832369|NCT02831673|58856842|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
30832370|NCT02831673|58856843|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
30832371|NCT02831673|58856844|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
30832372|NCT02831673|58856840|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
30832373|NCT02831673|58856841|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
30832374|NCT02831673|58856842|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
30832375|NCT02831673|58856843|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
30832376|NCT02831673|58856844|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
30832377|NCT02831673|58856840|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
30832378|NCT02831673|58856841|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
30832379|NCT02831673|58856842|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
30832380|NCT02831673|58856843|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
30832381|NCT02831673|58856844|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
30832382|NCT02831673|58856840|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
30832383|NCT02831673|58856841|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
30832384|NCT02831673|58856842|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
30832385|NCT02831673|58856843|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
30832386|NCT02831673|58856844|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
30832387|NCT02831673|58856840|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
30832388|NCT02831673|58856841|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
30832389|NCT02831673|58856842|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
30832390|NCT02831673|58856843|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
30832391|NCT02831673|58856844|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
30832392|NCT02831673|58856840|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
30832393|NCT02831673|58856841|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
30832394|NCT02831673|58856842|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
30832395|NCT02831673|58856843|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
30832396|NCT02831673|58856844|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
30832397|NCT02831673|58856840|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
30832398|NCT02831673|58856841|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
30832399|NCT02831673|58856842|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
30832400|NCT02831673|58856843|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
30923273|NCT02052596|58958607|FG000|Active Phase|Withdrawal by Subject|3|||
30923274|NCT02052596|58958608|FG001|Active Phase|Withdrawal by Subject|4|||
30923275|NCT02052596|58958607|FG000|Active Phase|Enrolled in error|1|||
30923276|NCT02052596|58958608|FG001|Active Phase|Enrolled in error|0|||
30923277|NCT02052596|58958607|FG000|Active Phase|Lost due to Crohn's disease|0|||
30923278|NCT02052596|58958608|FG001|Active Phase|Lost due to Crohn's disease|1|||
30923279|NCT02052596|58958607|FG000|Safety Phase|Adverse Event|6|||
30923280|NCT02052596|58958608|FG001|Safety Phase|Adverse Event|3|||
30755797|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
30832401|NCT02831673|58856844|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
30832402|NCT02831673|58856840|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
30832403|NCT02831673|58856841|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
30832404|NCT02831673|58856842|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
30832405|NCT02831673|58856843|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
30832406|NCT02831673|58856844|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
30832407|NCT02831673|58856840|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
30832408|NCT02831673|58856841|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
30832409|NCT02831673|58856842|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
30832410|NCT02831673|58856843|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
30832411|NCT02831673|58856844|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
30832412|NCT02831673|58856840|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
30832413|NCT02831673|58856841|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
30832414|NCT02831673|58856842|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
30832415|NCT02831673|58856843|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
30832416|NCT02831673|58856844|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
30832417|NCT02831673|58856840|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
30832418|NCT02831673|58856841|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
30755798|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
30755799|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
30832419|NCT02831673|58856842|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
30832420|NCT02831673|58856843|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
30832421|NCT02831673|58856844|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
30832422|NCT02831673|58856840|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
30832423|NCT02831673|58856841|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
30832424|NCT02831673|58856842|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
30832425|NCT02831673|58856843|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
30832426|NCT02831673|58856844|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
30832427|NCT02831673|58856840|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
30832428|NCT02831673|58856841|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
30832429|NCT02831673|58856842|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
30832430|NCT02831673|58856843|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
30832431|NCT02831673|58856844|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
30832432|NCT02831673|58856840|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
30832433|NCT02831673|58856841|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
30832434|NCT02831673|58856842|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
30832435|NCT02831673|58856843|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
30832436|NCT02831673|58856844|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
30832437|NCT02831673|58856840|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
30832438|NCT02831673|58856841|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
30832439|NCT02831673|58856842|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
30832440|NCT02831673|58856843|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
30832441|NCT02831673|58856844|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
30832442|NCT02831673|58856840|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
30832443|NCT02831673|58856841|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
30832444|NCT02831673|58856842|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
30832445|NCT02831673|58856843|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
30923281|NCT02052596|58958607|FG000|Safety Phase|Lost to Follow-up|11|||
30755800|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
30755801|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
30755802|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
30755803|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
30755804|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
30755805|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
30755806|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
30755807|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
30755808|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
30755809|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
30755810|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
30755811|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
30755812|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
30755813|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
30755814|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
30755815|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
30832446|NCT02831673|58856844|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
30832447|NCT02831673|58856840|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
30832448|NCT02831673|58856841|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
30923282|NCT02052596|58958608|FG001|Safety Phase|Lost to Follow-up|18|||
30923283|NCT02052596|58958607|FG000|Safety Phase|Protocol Violation|1|||
30923284|NCT02052596|58958608|FG001|Safety Phase|Protocol Violation|2|||
30923285|NCT02052596|58958607|FG000|Safety Phase|Withdrawal by Subject|8|||
30923286|NCT02052596|58958608|FG001|Safety Phase|Withdrawal by Subject|11|||
30923287|NCT02052596|58958607|FG000|Safety Phase|Enrolled in error|1|||
30923288|NCT02052596|58958608|FG001|Safety Phase|Enrolled in error|0|||
30923289|NCT02052596|58958607|FG000|Safety Phase|Lost due to Crohn's disease|0|||
30923290|NCT02052596|58958608|FG001|Safety Phase|Lost due to Crohn's disease|1|||
30923291|NCT02052440|58958616|FG000|Overall Study|Withdrawal by Subject|0|||
30923292|NCT02052440|58958617|FG001|Overall Study|Withdrawal by Subject|1|||
30923293|NCT02049944|58958623|FG000|Overall Study|Protocol Violation|2|||
30923294|NCT02043548|58958629|FG000|Overall Study|Lack of Efficacy|1|||
30923295|NCT02043548|58958630|FG001|Overall Study|Lack of Efficacy|0|||
30923296|NCT02043548|58958629|FG000|Overall Study|Adverse Event|0|||
30923297|NCT02043548|58958630|FG001|Overall Study|Adverse Event|1|||
30923298|NCT01622348|58958639|FG000|Overall Study|Withdrawal by Subject|1|||
30923299|NCT01622348|58958640|FG001|Overall Study|Withdrawal by Subject|0|||
30923300|NCT01622348|58958641|FG002|Overall Study|Withdrawal by Subject|1|||
30923301|NCT01621880|58958651|FG000|Overall Study|Adverse Event|5|||
30923302|NCT01621880|58958652|FG001|Overall Study|Adverse Event|1|||
30923303|NCT01621880|58958651|FG000|Overall Study|Withdrawal by Subject|5|||
30923304|NCT01621880|58958652|FG001|Overall Study|Withdrawal by Subject|4|||
30923305|NCT01621802|58958665|FG000|Overall Study|Protocol Violation|0|||
30923306|NCT01621802|58958666|FG001|Overall Study|Protocol Violation|0|||
30923307|NCT01621802|58958667|FG002|Overall Study|Protocol Violation|0|||
30755816|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
30832449|NCT02831673|58856842|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
30832450|NCT02831673|58856843|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
30832451|NCT02831673|58856844|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
30832452|NCT02830893|58856862|FG000|Overall Study|Relocation to out of the country|1|||
30832453|NCT02830893|58856863|FG001|Overall Study|Relocation to out of the country|0|||
30832454|NCT02830893|58856862|FG000|Overall Study|Lost to Follow-up|0|||
30832455|NCT02830893|58856863|FG001|Overall Study|Lost to Follow-up|2|||
30832456|NCT02830893|58856862|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
30832457|NCT02830893|58856863|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
30832458|NCT02625922|58856871|FG000|Overall Study|Non-availability of IMP|1|||
30832459|NCT02625922|58856872|FG001|Overall Study|Non-availability of IMP|1|||
30832460|NCT02625922|58856871|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
30832461|NCT02625922|58856872|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
30832462|NCT03350035|58856884|FG000|Overall Study|Lack of Efficacy|2|||
30832463|NCT03350035|58856885|FG001|Overall Study|Lack of Efficacy|0|||
30832464|NCT03350035|58856886|FG002|Overall Study|Lack of Efficacy|0|||
30832465|NCT03350035|58856884|FG000|Overall Study|Subject discharged to hospice|0|||
30832466|NCT03350035|58856885|FG001|Overall Study|Subject discharged to hospice|0|||
30832467|NCT03350035|58856886|FG002|Overall Study|Subject discharged to hospice|1|||
30832468|NCT01358331|58856920|FG000|Overall Study|Lost to Follow-up|0|||
30923308|NCT01621802|58958668|FG003|Overall Study|Protocol Violation|0|||
30923309|NCT01621802|58958669|FG004|Overall Study|Protocol Violation|0|||
30923310|NCT01621802|58958670|FG005|Overall Study|Protocol Violation|1|||
30923311|NCT01621802|58958665|FG000|Overall Study|Withdrawal by Subject|8|||
30923312|NCT01621802|58958666|FG001|Overall Study|Withdrawal by Subject|4|||
30755817|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
30755818|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
30755819|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
30755820|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
30755821|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
30755822|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
30755823|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
30755824|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
30923313|NCT01621802|58958667|FG002|Overall Study|Withdrawal by Subject|4|||
30923314|NCT01621802|58958668|FG003|Overall Study|Withdrawal by Subject|2|||
30923315|NCT01621802|58958669|FG004|Overall Study|Withdrawal by Subject|2|||
30923316|NCT01621802|58958670|FG005|Overall Study|Withdrawal by Subject|0|||
30923317|NCT01621802|58958665|FG000|Overall Study|Migrated/moved from study area|0|||
30923318|NCT01621802|58958666|FG001|Overall Study|Migrated/moved from study area|0|||
30832469|NCT01358331|58856921|FG001|Overall Study|Lost to Follow-up|0|||
30832470|NCT01358331|58856922|FG002|Overall Study|Lost to Follow-up|0|||
30832471|NCT01358331|58856923|FG003|Overall Study|Lost to Follow-up|1|||
30832472|NCT01358331|58856924|FG004|Overall Study|Lost to Follow-up|0|||
30832473|NCT01358331|58856925|FG005|Overall Study|Lost to Follow-up|0|||
30832474|NCT01358331|58856920|FG000|Overall Study|Withdrawal by Subject|0|||
30832475|NCT01358331|58856921|FG001|Overall Study|Withdrawal by Subject|0|||
30832476|NCT01358331|58856922|FG002|Overall Study|Withdrawal by Subject|0|||
30832477|NCT01358331|58856923|FG003|Overall Study|Withdrawal by Subject|1|||
30832478|NCT01358331|58856924|FG004|Overall Study|Withdrawal by Subject|1|||
30832479|NCT01358331|58856925|FG005|Overall Study|Withdrawal by Subject|1|||
30832480|NCT01358331|58856920|FG000|Overall Study|Adverse Events|1|||
30923319|NCT01621802|58958667|FG002|Overall Study|Migrated/moved from study area|2|||
30923320|NCT01621802|58958668|FG003|Overall Study|Migrated/moved from study area|0|||
30923321|NCT01621802|58958669|FG004|Overall Study|Migrated/moved from study area|1|||
30923322|NCT01621802|58958670|FG005|Overall Study|Migrated/moved from study area|0|||
30923323|NCT01621802|58958665|FG000|Overall Study|Others|3|||
30923324|NCT01621802|58958666|FG001|Overall Study|Others|3|||
30923325|NCT01621802|58958667|FG002|Overall Study|Others|3|||
30923326|NCT01621802|58958668|FG003|Overall Study|Others|2|||
30923327|NCT01621802|58958669|FG004|Overall Study|Others|1|||
30923328|NCT01621802|58958670|FG005|Overall Study|Others|0|||
30923329|NCT01621802|58958665|FG000|Overall Study|Lost to Follow-up|36|||
30923330|NCT01621802|58958666|FG001|Overall Study|Lost to Follow-up|16|||
30923331|NCT01621802|58958667|FG002|Overall Study|Lost to Follow-up|24|||
30923332|NCT01621802|58958668|FG003|Overall Study|Lost to Follow-up|7|||
30923333|NCT01621802|58958669|FG004|Overall Study|Lost to Follow-up|31|||
30923334|NCT01621802|58958670|FG005|Overall Study|Lost to Follow-up|11|||
30923335|NCT02059291|58958696|FG000|Epoch 2|Lack of Efficacy|0|||
30923336|NCT02059291|58958697|FG001|Epoch 2|Lack of Efficacy|0|||
30923337|NCT02059291|58958698|FG002|Epoch 2|Lack of Efficacy|0|||
30923338|NCT02059291|58958699|FG003|Epoch 2|Lack of Efficacy|1|||
30923339|NCT02059291|58958700|FG004|Epoch 2|Lack of Efficacy|0|||
30923340|NCT02059291|58958701|FG005|Epoch 2|Lack of Efficacy|1|||
30923341|NCT02059291|58958702|FG006|Epoch 2|Lack of Efficacy|0|||
30923342|NCT02059291|58958703|FG007|Epoch 2|Lack of Efficacy|0|||
30923343|NCT02059291|58958704|FG008|Epoch 2|Lack of Efficacy|0|||
30923344|NCT02059291|58958705|FG009|Epoch 2|Lack of Efficacy|0|||
30923345|NCT02059291|58958706|FG010|Epoch 2|Lack of Efficacy|0|||
30832481|NCT01358331|58856921|FG001|Overall Study|Adverse Events|1|||
30832482|NCT01358331|58856922|FG002|Overall Study|Adverse Events|1|||
30832483|NCT01358331|58856923|FG003|Overall Study|Adverse Events|0|||
30832484|NCT01358331|58856924|FG004|Overall Study|Adverse Events|1|||
30832485|NCT01358331|58856925|FG005|Overall Study|Adverse Events|5|||
30832486|NCT01358331|58856920|FG000|Overall Study|Symptomatic Deterioration|0|||
30832487|NCT01358331|58856921|FG001|Overall Study|Symptomatic Deterioration|0|||
30832488|NCT01358331|58856922|FG002|Overall Study|Symptomatic Deterioration|0|||
30832489|NCT01358331|58856923|FG003|Overall Study|Symptomatic Deterioration|0|||
30832490|NCT01358331|58856924|FG004|Overall Study|Symptomatic Deterioration|1|||
30832491|NCT01358331|58856925|FG005|Overall Study|Symptomatic Deterioration|0|||
30832492|NCT01358331|58856920|FG000|Overall Study|Participants did not wish to continue|0|||
30832493|NCT01358331|58856921|FG001|Overall Study|Participants did not wish to continue|0|||
30832494|NCT01358331|58856922|FG002|Overall Study|Participants did not wish to continue|0|||
30832495|NCT01358331|58856923|FG003|Overall Study|Participants did not wish to continue|0|||
30832496|NCT01358331|58856924|FG004|Overall Study|Participants did not wish to continue|1|||
30832497|NCT01358331|58856925|FG005|Overall Study|Participants did not wish to continue|0|||
30832498|NCT01358331|58856920|FG000|Overall Study|Progress of disease under investigation|1|||
30832499|NCT01358331|58856921|FG001|Overall Study|Progress of disease under investigation|2|||
30832500|NCT01358331|58856922|FG002|Overall Study|Progress of disease under investigation|3|||
30832501|NCT01358331|58856923|FG003|Overall Study|Progress of disease under investigation|1|||
30832502|NCT01358331|58856924|FG004|Overall Study|Progress of disease under investigation|3|||
30923346|NCT02059291|58958707|FG011|Epoch 2|Lack of Efficacy|0|||
30923347|NCT02059291|58958708|FG012|Epoch 2|Lack of Efficacy|0|||
30923348|NCT02059291|58958709|FG013|Epoch 2|Lack of Efficacy|0|||
30832503|NCT01358331|58856925|FG005|Overall Study|Progress of disease under investigation|0|||
30832504|NCT02828241|58856941|FG000|Overall Study|Adverse Event|7|||
30832505|NCT02828241|58856942|FG001|Overall Study|Adverse Event|2|||
30832506|NCT02828241|58856941|FG000|Overall Study|Protocol Violation|1|||
30923349|NCT02059291|58958710|FG014|Epoch 2|Lack of Efficacy|0|||
30923350|NCT02059291|58958711|FG015|Epoch 2|Lack of Efficacy|0|||
30923351|NCT02059291|58958712|FG016|Epoch 2|Lack of Efficacy|0|||
30923352|NCT02059291|58958713|FG017|Epoch 2|Lack of Efficacy|0|||
30923353|NCT02059291|58958714|FG018|Epoch 2|Lack of Efficacy|0|||
30923354|NCT02059291|58958715|FG019|Epoch 2|Lack of Efficacy|0|||
30923355|NCT02059291|58958716|FG020|Epoch 2|Lack of Efficacy|0|||
30923356|NCT02059291|58958717|FG021|Epoch 2|Lack of Efficacy|0|||
30923357|NCT02059291|58958718|FG022|Epoch 2|Lack of Efficacy|0|||
30923358|NCT02059291|58958719|FG023|Epoch 2|Lack of Efficacy|0|||
30923359|NCT02059291|58958720|FG024|Epoch 2|Lack of Efficacy|0|||
30923360|NCT02059291|58958696|FG000|Epoch 2|Adverse Event|0|||
30923361|NCT02059291|58958697|FG001|Epoch 2|Adverse Event|0|||
30923362|NCT02059291|58958698|FG002|Epoch 2|Adverse Event|1|||
30923363|NCT02059291|58958699|FG003|Epoch 2|Adverse Event|1|||
30923364|NCT02059291|58958700|FG004|Epoch 2|Adverse Event|0|||
30923365|NCT02059291|58958701|FG005|Epoch 2|Adverse Event|0|||
30923366|NCT02059291|58958702|FG006|Epoch 2|Adverse Event|0|||
30923367|NCT02059291|58958703|FG007|Epoch 2|Adverse Event|1|||
30923368|NCT02059291|58958704|FG008|Epoch 2|Adverse Event|1|||
30923369|NCT02059291|58958705|FG009|Epoch 2|Adverse Event|0|||
30923370|NCT02059291|58958706|FG010|Epoch 2|Adverse Event|0|||
30923371|NCT02059291|58958707|FG011|Epoch 2|Adverse Event|0|||
30923372|NCT02059291|58958708|FG012|Epoch 2|Adverse Event|0|||
30923373|NCT02059291|58958709|FG013|Epoch 2|Adverse Event|0|||
30923374|NCT02059291|58958710|FG014|Epoch 2|Adverse Event|0|||
30923375|NCT02059291|58958711|FG015|Epoch 2|Adverse Event|0|||
30923376|NCT02059291|58958712|FG016|Epoch 2|Adverse Event|0|||
30832507|NCT02828241|58856942|FG001|Overall Study|Protocol Violation|0|||
30832508|NCT01355523|58856951|FG000|Overall Study|Withdrawal by Subject|1|||
30832509|NCT01355523|58856952|FG001|Overall Study|Withdrawal by Subject|4|||
30832510|NCT01355523|58856951|FG000|Overall Study|Lost to Follow-up|0|||
30832511|NCT01355523|58856952|FG001|Overall Study|Lost to Follow-up|2|||
30832512|NCT01355523|58856951|FG000|Overall Study|Protocol Violation|0|||
30832513|NCT01355523|58856952|FG001|Overall Study|Protocol Violation|2|||
30832514|NCT01355523|58856951|FG000|Overall Study|Adverse Event|0|||
30832515|NCT01355523|58856952|FG001|Overall Study|Adverse Event|2|||
30923377|NCT02059291|58958713|FG017|Epoch 2|Adverse Event|0|||
30923378|NCT02059291|58958714|FG018|Epoch 2|Adverse Event|0|||
30923379|NCT02059291|58958715|FG019|Epoch 2|Adverse Event|0|||
30923380|NCT02059291|58958716|FG020|Epoch 2|Adverse Event|0|||
30923381|NCT02059291|58958717|FG021|Epoch 2|Adverse Event|0|||
30923382|NCT02059291|58958718|FG022|Epoch 2|Adverse Event|0|||
30923383|NCT02059291|58958719|FG023|Epoch 2|Adverse Event|0|||
30923384|NCT02059291|58958720|FG024|Epoch 2|Adverse Event|0|||
30923385|NCT02059291|58958696|FG000|Epoch 2|Withdrawal by Subject|0|||
30923386|NCT02059291|58958697|FG001|Epoch 2|Withdrawal by Subject|1|||
30923387|NCT02059291|58958698|FG002|Epoch 2|Withdrawal by Subject|0|||
30923388|NCT02059291|58958699|FG003|Epoch 2|Withdrawal by Subject|0|||
30923389|NCT02059291|58958700|FG004|Epoch 2|Withdrawal by Subject|0|||
30923390|NCT02059291|58958701|FG005|Epoch 2|Withdrawal by Subject|1|||
30923391|NCT02059291|58958702|FG006|Epoch 2|Withdrawal by Subject|0|||
30923392|NCT02059291|58958703|FG007|Epoch 2|Withdrawal by Subject|0|||
30923393|NCT02059291|58958704|FG008|Epoch 2|Withdrawal by Subject|1|||
30923394|NCT02059291|58958705|FG009|Epoch 2|Withdrawal by Subject|0|||
30755825|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
30755826|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
30755827|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
30755828|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
30755829|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
30755830|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
30755831|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
30755832|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
30755833|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
30755834|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
30755835|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
30755836|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
30832516|NCT02625220|58856958|FG000|Overall Study|Adverse Event|2|||
30832517|NCT02625220|58856958|FG000|Overall Study|Lost to Follow-up|2|||
30832518|NCT02625220|58856958|FG000|Overall Study|Protocol Violation|1|||
30832519|NCT02625220|58856958|FG000|Overall Study|Study discontinued at site|2|||
30832520|NCT02826603|58856964|FG000|Overall Study|Adverse Event|17|||
30832521|NCT02826603|58856965|FG001|Overall Study|Adverse Event|9|||
30832522|NCT02826603|58856964|FG000|Overall Study|Lack of Efficacy|4|||
30923395|NCT02059291|58958706|FG010|Epoch 2|Withdrawal by Subject|0|||
30923396|NCT02059291|58958707|FG011|Epoch 2|Withdrawal by Subject|0|||
30923397|NCT02059291|58958708|FG012|Epoch 2|Withdrawal by Subject|0|||
30923398|NCT02059291|58958709|FG013|Epoch 2|Withdrawal by Subject|0|||
30923399|NCT02059291|58958710|FG014|Epoch 2|Withdrawal by Subject|0|||
30923400|NCT02059291|58958711|FG015|Epoch 2|Withdrawal by Subject|0|||
30923401|NCT02059291|58958712|FG016|Epoch 2|Withdrawal by Subject|0|||
30923402|NCT02059291|58958713|FG017|Epoch 2|Withdrawal by Subject|0|||
30923403|NCT02059291|58958714|FG018|Epoch 2|Withdrawal by Subject|0|||
30923404|NCT02059291|58958715|FG019|Epoch 2|Withdrawal by Subject|0|||
30923405|NCT02059291|58958716|FG020|Epoch 2|Withdrawal by Subject|0|||
30923406|NCT02059291|58958717|FG021|Epoch 2|Withdrawal by Subject|0|||
30923407|NCT02059291|58958718|FG022|Epoch 2|Withdrawal by Subject|0|||
30832523|NCT02826603|58856965|FG001|Overall Study|Lack of Efficacy|9|||
30832524|NCT02826603|58856964|FG000|Overall Study|Lost to Follow-up|13|||
30832525|NCT02826603|58856965|FG001|Overall Study|Lost to Follow-up|12|||
30832526|NCT02826603|58856964|FG000|Overall Study|Noncompliance with treatment|0|||
30832527|NCT02826603|58856965|FG001|Overall Study|Noncompliance with treatment|2|||
30832528|NCT02826603|58856964|FG000|Overall Study|Physician Decision|1|||
30832529|NCT02826603|58856965|FG001|Overall Study|Physician Decision|7|||
30832530|NCT02826603|58856964|FG000|Overall Study|Pregnancy|1|||
30832531|NCT02826603|58856965|FG001|Overall Study|Pregnancy|2|||
30832532|NCT02826603|58856964|FG000|Overall Study|Protocol Violation|3|||
30832533|NCT02826603|58856965|FG001|Overall Study|Protocol Violation|3|||
30832534|NCT02826603|58856964|FG000|Overall Study|Withdrawal by Subject|20|||
30832535|NCT02826603|58856965|FG001|Overall Study|Withdrawal by Subject|19|||
30832536|NCT02826603|58856964|FG000|Overall Study|Death|2|||
30832537|NCT02826603|58856965|FG001|Overall Study|Death|0|||
30832538|NCT02826603|58856964|FG000|Overall Study|New therapy for study indication|0|||
30832539|NCT02826603|58856965|FG001|Overall Study|New therapy for study indication|1|||
30832540|NCT05270460|58856981|FG000|Overall Study|Adverse Event|0|||
30832541|NCT05270460|58856982|FG001|Overall Study|Adverse Event|1|||
30832542|NCT05270460|58856983|FG002|Overall Study|Adverse Event|0|||
30832543|NCT05270460|58856981|FG000|Overall Study|Early Termination|0|||
30832544|NCT05270460|58856982|FG001|Overall Study|Early Termination|1|||
30832545|NCT05270460|58856983|FG002|Overall Study|Early Termination|0|||
30832546|NCT04622592|58856999|FG000|Overall Study|Death|0|||
30832547|NCT04622592|58857000|FG001|Overall Study|Death|0|||
30832548|NCT04622592|58857001|FG002|Overall Study|Death|1|||
30832549|NCT04622592|58857002|FG003|Overall Study|Death|0|||
30832550|NCT04622592|58857003|FG004|Overall Study|Death|0|||
30832551|NCT04622592|58857004|FG005|Overall Study|Death|0|||
30832552|NCT04622592|58857005|FG006|Overall Study|Death|0|||
30832553|NCT04622592|58857006|FG007|Overall Study|Death|1|||
30832554|NCT04622592|58856999|FG000|Overall Study|Lost to Follow-up|0|||
30832555|NCT04622592|58857000|FG001|Overall Study|Lost to Follow-up|0|||
30832556|NCT04622592|58857001|FG002|Overall Study|Lost to Follow-up|0|||
30832557|NCT04622592|58857002|FG003|Overall Study|Lost to Follow-up|3|||
30832558|NCT04622592|58857003|FG004|Overall Study|Lost to Follow-up|1|||
30832559|NCT04622592|58857004|FG005|Overall Study|Lost to Follow-up|0|||
30832560|NCT04622592|58857005|FG006|Overall Study|Lost to Follow-up|2|||
30832561|NCT04622592|58857006|FG007|Overall Study|Lost to Follow-up|2|||
30832562|NCT04622592|58856999|FG000|Overall Study|Physician Decision|0|||
30832563|NCT04622592|58857000|FG001|Overall Study|Physician Decision|0|||
30832564|NCT04622592|58857001|FG002|Overall Study|Physician Decision|0|||
30832565|NCT04622592|58857002|FG003|Overall Study|Physician Decision|0|||
30832566|NCT04622592|58857003|FG004|Overall Study|Physician Decision|1|||
30832567|NCT04622592|58857004|FG005|Overall Study|Physician Decision|0|||
30832568|NCT04622592|58857005|FG006|Overall Study|Physician Decision|0|||
30832569|NCT04622592|58857006|FG007|Overall Study|Physician Decision|0|||
30832570|NCT04622592|58856999|FG000|Overall Study|Withdrawal by Subject|1|||
30832571|NCT04622592|58857000|FG001|Overall Study|Withdrawal by Subject|0|||
30832572|NCT04622592|58857001|FG002|Overall Study|Withdrawal by Subject|2|||
30832573|NCT04622592|58857002|FG003|Overall Study|Withdrawal by Subject|0|||
30832574|NCT04622592|58857003|FG004|Overall Study|Withdrawal by Subject|0|||
30832575|NCT04622592|58857004|FG005|Overall Study|Withdrawal by Subject|0|||
30832576|NCT04622592|58857005|FG006|Overall Study|Withdrawal by Subject|1|||
30832577|NCT04622592|58857006|FG007|Overall Study|Withdrawal by Subject|4|||
30832578|NCT04622592|58856999|FG000|Overall Study|Other than specified above|0|||
30832579|NCT04622592|58857000|FG001|Overall Study|Other than specified above|0|||
30832580|NCT04622592|58857001|FG002|Overall Study|Other than specified above|1|||
30832581|NCT04622592|58857002|FG003|Overall Study|Other than specified above|0|||
30832582|NCT04622592|58857003|FG004|Overall Study|Other than specified above|0|||
30832583|NCT04622592|58857004|FG005|Overall Study|Other than specified above|0|||
30832584|NCT04622592|58857005|FG006|Overall Study|Other than specified above|0|||
30832585|NCT04622592|58857006|FG007|Overall Study|Other than specified above|0|||
30832586|NCT04523220|58857027|FG000|Main Treatment Period|Physician Decision|1|||
30832587|NCT04523220|58857028|FG001|Main Treatment Period|Physician Decision|1|||
30832588|NCT04523220|58857029|FG002|Main Treatment Period|Physician Decision|0|||
30832589|NCT04523220|58857027|FG000|Main Treatment Period|Other|5|||
30832590|NCT04523220|58857028|FG001|Main Treatment Period|Other|2|||
30832591|NCT04523220|58857029|FG002|Main Treatment Period|Other|4|||
30832592|NCT04523220|58857027|FG000|Main Treatment Period|Subject Decision|5|||
30832593|NCT04523220|58857028|FG001|Main Treatment Period|Subject Decision|7|||
30832594|NCT04523220|58857029|FG002|Main Treatment Period|Subject Decision|3|||
30832595|NCT04523220|58857027|FG000|Main Treatment Period|Death|5|||
30832596|NCT04523220|58857028|FG001|Main Treatment Period|Death|11|||
30832597|NCT04523220|58857029|FG002|Main Treatment Period|Death|4|||
30832598|NCT04523220|58857027|FG000|Main Treatment Period|Adverse Event|11|||
30832599|NCT04523220|58857028|FG001|Main Treatment Period|Adverse Event|9|||
30832600|NCT04523220|58857029|FG002|Main Treatment Period|Adverse Event|9|||
30832601|NCT04523220|58857027|FG000|Main Treatment Period|Withdrawal by Subject|3|||
30832602|NCT04523220|58857028|FG001|Main Treatment Period|Withdrawal by Subject|3|||
30832603|NCT04523220|58857029|FG002|Main Treatment Period|Withdrawal by Subject|4|||
30832604|NCT04523220|58857027|FG000|Main Treatment Period|Study drug never adminstered|10|||
30832605|NCT04523220|58857028|FG001|Main Treatment Period|Study drug never adminstered|3|||
30832606|NCT04523220|58857029|FG002|Main Treatment Period|Study drug never adminstered|5|||
30832607|NCT04523220|58857027|FG000|Extension Treatment Period|Physician Decision|1|||
30832608|NCT04523220|58857028|FG001|Extension Treatment Period|Physician Decision|0|||
30832609|NCT04523220|58857029|FG002|Extension Treatment Period|Physician Decision|3|||
30832610|NCT04523220|58857027|FG000|Extension Treatment Period|Other|2|||
30832611|NCT04523220|58857028|FG001|Extension Treatment Period|Other|6|||
30832612|NCT04523220|58857029|FG002|Extension Treatment Period|Other|6|||
30832613|NCT04523220|58857027|FG000|Extension Treatment Period|Subject Decision|5|||
30832614|NCT04523220|58857028|FG001|Extension Treatment Period|Subject Decision|2|||
30832615|NCT04523220|58857029|FG002|Extension Treatment Period|Subject Decision|4|||
30832616|NCT04523220|58857027|FG000|Extension Treatment Period|Death|6|||
30832617|NCT04523220|58857028|FG001|Extension Treatment Period|Death|4|||
30832618|NCT04523220|58857029|FG002|Extension Treatment Period|Death|7|||
30832619|NCT04523220|58857027|FG000|Extension Treatment Period|Adverse Event|6|||
30832620|NCT04523220|58857028|FG001|Extension Treatment Period|Adverse Event|7|||
30832621|NCT04523220|58857029|FG002|Extension Treatment Period|Adverse Event|9|||
30832622|NCT04523220|58857027|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
30832623|NCT04523220|58857028|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
30832624|NCT04523220|58857029|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
30832625|NCT04523220|58857027|FG000|Extension Treatment Period|Study drug never administered|0|||
30832626|NCT04523220|58857028|FG001|Extension Treatment Period|Study drug never administered|1|||
30832627|NCT04523220|58857029|FG002|Extension Treatment Period|Study drug never administered|0|||
30832628|NCT04222088|58857060|FG000|Overall Study|Lost to Follow-up|5|||
30832629|NCT04222088|58857061|FG001|Overall Study|Lost to Follow-up|1|||
30832630|NCT04222088|58857060|FG000|Overall Study|Withdrawal by Subject|4|||
30832631|NCT04222088|58857061|FG001|Overall Study|Withdrawal by Subject|0|||
30832632|NCT03981614|58857070|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
30832633|NCT03981614|58857071|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
30832634|NCT03981614|58857072|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
30832635|NCT03978520|58857088|FG000|Overall Study|Adverse Event|2|||
30832636|NCT03978520|58857089|FG001|Overall Study|Adverse Event|5|||
30832637|NCT03978520|58857090|FG002|Overall Study|Adverse Event|3|||
30832638|NCT03978520|58857091|FG003|Overall Study|Adverse Event|5|||
30832639|NCT03978520|58857092|FG004|Overall Study|Adverse Event|6|||
30832640|NCT03978520|58857088|FG000|Overall Study|Withdrawal by Subject|10|||
30832641|NCT03978520|58857089|FG001|Overall Study|Withdrawal by Subject|4|||
30832642|NCT03978520|58857090|FG002|Overall Study|Withdrawal by Subject|5|||
30832643|NCT03978520|58857091|FG003|Overall Study|Withdrawal by Subject|6|||
30832644|NCT03978520|58857092|FG004|Overall Study|Withdrawal by Subject|5|||
30923408|NCT02059291|58958719|FG023|Epoch 2|Withdrawal by Subject|0|||
30923409|NCT02059291|58958720|FG024|Epoch 2|Withdrawal by Subject|0|||
30923410|NCT02059291|58958696|FG000|Epoch 3|Physician Decision|0|||
30923411|NCT02059291|58958697|FG001|Epoch 3|Physician Decision|0|||
30923412|NCT02059291|58958698|FG002|Epoch 3|Physician Decision|0|||
30923413|NCT02059291|58958699|FG003|Epoch 3|Physician Decision|0|||
30923414|NCT02059291|58958700|FG004|Epoch 3|Physician Decision|0|||
30923415|NCT02059291|58958701|FG005|Epoch 3|Physician Decision|0|||
30923416|NCT02059291|58958702|FG006|Epoch 3|Physician Decision|0|||
30832645|NCT03978520|58857088|FG000|Overall Study|Lost to Follow-up|2|||
30832646|NCT03978520|58857089|FG001|Overall Study|Lost to Follow-up|2|||
30832647|NCT03978520|58857090|FG002|Overall Study|Lost to Follow-up|2|||
30832648|NCT03978520|58857091|FG003|Overall Study|Lost to Follow-up|0|||
30832649|NCT03978520|58857092|FG004|Overall Study|Lost to Follow-up|1|||
30832650|NCT03978520|58857088|FG000|Overall Study|COVID-19 infection|0|||
30923417|NCT02059291|58958703|FG007|Epoch 3|Physician Decision|0|||
30923418|NCT02059291|58958704|FG008|Epoch 3|Physician Decision|0|||
30923419|NCT02059291|58958705|FG009|Epoch 3|Physician Decision|0|||
30832651|NCT03978520|58857089|FG001|Overall Study|COVID-19 infection|1|||
30832652|NCT03978520|58857090|FG002|Overall Study|COVID-19 infection|0|||
30832653|NCT03978520|58857091|FG003|Overall Study|COVID-19 infection|0|||
30832654|NCT03978520|58857092|FG004|Overall Study|COVID-19 infection|0|||
30832655|NCT03978520|58857088|FG000|Overall Study|Other, not specified|9|||
30832656|NCT03978520|58857089|FG001|Overall Study|Other, not specified|4|||
30832657|NCT03978520|58857090|FG002|Overall Study|Other, not specified|1|||
30923420|NCT02059291|58958706|FG010|Epoch 3|Physician Decision|0|||
30923421|NCT02059291|58958707|FG011|Epoch 3|Physician Decision|0|||
30923422|NCT02059291|58958708|FG012|Epoch 3|Physician Decision|0|||
30923423|NCT02059291|58958709|FG013|Epoch 3|Physician Decision|1|||
30832658|NCT03978520|58857091|FG003|Overall Study|Other, not specified|1|||
30832659|NCT03978520|58857092|FG004|Overall Study|Other, not specified|2|||
30923424|NCT02059291|58958710|FG014|Epoch 3|Physician Decision|0|||
30923425|NCT02059291|58958711|FG015|Epoch 3|Physician Decision|1|||
30832660|NCT03978520|58857088|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
30923426|NCT02059291|58958712|FG016|Epoch 3|Physician Decision|0|||
30923427|NCT02059291|58958713|FG017|Epoch 3|Physician Decision|0|||
30923428|NCT02059291|58958714|FG018|Epoch 3|Physician Decision|0|||
30923429|NCT02059291|58958715|FG019|Epoch 3|Physician Decision|0|||
30923430|NCT02059291|58958716|FG020|Epoch 3|Physician Decision|0|||
30923431|NCT02059291|58958717|FG021|Epoch 3|Physician Decision|0|||
30923432|NCT02059291|58958718|FG022|Epoch 3|Physician Decision|0|||
30923433|NCT02059291|58958719|FG023|Epoch 3|Physician Decision|0|||
30923434|NCT02059291|58958720|FG024|Epoch 3|Physician Decision|0|||
30923435|NCT02059291|58958696|FG000|Epoch 3|Adverse Event|0|||
30923436|NCT02059291|58958697|FG001|Epoch 3|Adverse Event|0|||
30923437|NCT02059291|58958698|FG002|Epoch 3|Adverse Event|0|||
30923438|NCT02059291|58958699|FG003|Epoch 3|Adverse Event|0|||
30923439|NCT02059291|58958700|FG004|Epoch 3|Adverse Event|0|||
30923440|NCT02059291|58958701|FG005|Epoch 3|Adverse Event|0|||
30923441|NCT02059291|58958702|FG006|Epoch 3|Adverse Event|0|||
30923442|NCT02059291|58958703|FG007|Epoch 3|Adverse Event|0|||
30923443|NCT02059291|58958704|FG008|Epoch 3|Adverse Event|0|||
30923444|NCT02059291|58958705|FG009|Epoch 3|Adverse Event|0|||
30923445|NCT02059291|58958706|FG010|Epoch 3|Adverse Event|0|||
30923446|NCT02059291|58958707|FG011|Epoch 3|Adverse Event|0|||
30923447|NCT02059291|58958708|FG012|Epoch 3|Adverse Event|0|||
30923448|NCT02059291|58958709|FG013|Epoch 3|Adverse Event|0|||
30923449|NCT02059291|58958710|FG014|Epoch 3|Adverse Event|0|||
30923450|NCT02059291|58958711|FG015|Epoch 3|Adverse Event|1|||
30923451|NCT02059291|58958712|FG016|Epoch 3|Adverse Event|0|||
30923452|NCT02059291|58958713|FG017|Epoch 3|Adverse Event|0|||
30923453|NCT02059291|58958714|FG018|Epoch 3|Adverse Event|0|||
30923454|NCT02059291|58958715|FG019|Epoch 3|Adverse Event|0|||
30832661|NCT03978520|58857089|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
30832662|NCT03978520|58857090|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
30832663|NCT03978520|58857091|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
30923455|NCT02059291|58958716|FG020|Epoch 3|Adverse Event|0|||
30923456|NCT02059291|58958717|FG021|Epoch 3|Adverse Event|0|||
30923457|NCT02059291|58958718|FG022|Epoch 3|Adverse Event|0|||
30923458|NCT02059291|58958719|FG023|Epoch 3|Adverse Event|0|||
30923459|NCT02059291|58958720|FG024|Epoch 3|Adverse Event|0|||
30923460|NCT02059291|58958696|FG000|Epoch 3|Lack of Efficacy|0|||
30923461|NCT02059291|58958697|FG001|Epoch 3|Lack of Efficacy|0|||
30923462|NCT02059291|58958698|FG002|Epoch 3|Lack of Efficacy|0|||
30923463|NCT02059291|58958699|FG003|Epoch 3|Lack of Efficacy|0|||
30923464|NCT02059291|58958700|FG004|Epoch 3|Lack of Efficacy|0|||
30923465|NCT02059291|58958701|FG005|Epoch 3|Lack of Efficacy|0|||
30923466|NCT02059291|58958702|FG006|Epoch 3|Lack of Efficacy|0|||
30923467|NCT02059291|58958703|FG007|Epoch 3|Lack of Efficacy|0|||
30923468|NCT02059291|58958704|FG008|Epoch 3|Lack of Efficacy|0|||
30923469|NCT02059291|58958705|FG009|Epoch 3|Lack of Efficacy|0|||
30923470|NCT02059291|58958706|FG010|Epoch 3|Lack of Efficacy|0|||
30923471|NCT02059291|58958707|FG011|Epoch 3|Lack of Efficacy|0|||
30832664|NCT03978520|58857092|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
30832665|NCT03929393|58857104|FG000|Overall Study|Death|1|||
30832666|NCT03929393|58857105|FG001|Overall Study|Death|0|||
30832667|NCT03929393|58857104|FG000|Overall Study|Time Commitment|2|||
30832668|NCT03929393|58857105|FG001|Overall Study|Time Commitment|5|||
30832669|NCT03929393|58857104|FG000|Overall Study|Motor Vehicle Accident|0|||
30832670|NCT03929393|58857105|FG001|Overall Study|Motor Vehicle Accident|1|||
30832671|NCT03929393|58857104|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
30832672|NCT03929393|58857105|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
30832673|NCT03929393|58857104|FG000|Overall Study|Other|1|||
30923472|NCT02059291|58958708|FG012|Epoch 3|Lack of Efficacy|0|||
30923473|NCT02059291|58958709|FG013|Epoch 3|Lack of Efficacy|0|||
30923474|NCT02059291|58958710|FG014|Epoch 3|Lack of Efficacy|0|||
30923475|NCT02059291|58958711|FG015|Epoch 3|Lack of Efficacy|3|||
30923476|NCT02059291|58958712|FG016|Epoch 3|Lack of Efficacy|0|||
30923477|NCT02059291|58958713|FG017|Epoch 3|Lack of Efficacy|0|||
30832674|NCT03929393|58857105|FG001|Overall Study|Other|3|||
30832675|NCT03874715|58857113|FG000|Overall Study|Adverse Event|2|||
30832676|NCT03874715|58857114|FG001|Overall Study|Adverse Event|0|||
30923478|NCT02059291|58958714|FG018|Epoch 3|Lack of Efficacy|0|||
30923479|NCT02059291|58958715|FG019|Epoch 3|Lack of Efficacy|0|||
30923480|NCT02059291|58958716|FG020|Epoch 3|Lack of Efficacy|0|||
30923481|NCT02059291|58958717|FG021|Epoch 3|Lack of Efficacy|0|||
30923482|NCT02059291|58958718|FG022|Epoch 3|Lack of Efficacy|0|||
30923483|NCT02059291|58958719|FG023|Epoch 3|Lack of Efficacy|0|||
30923484|NCT02059291|58958720|FG024|Epoch 3|Lack of Efficacy|0|||
30923485|NCT02059291|58958696|FG000|Epoch 3|Withdrawal by Subject|0|||
30923486|NCT02059291|58958697|FG001|Epoch 3|Withdrawal by Subject|0|||
30923487|NCT02059291|58958698|FG002|Epoch 3|Withdrawal by Subject|0|||
30923488|NCT02059291|58958699|FG003|Epoch 3|Withdrawal by Subject|0|||
30923489|NCT02059291|58958700|FG004|Epoch 3|Withdrawal by Subject|0|||
30923490|NCT02059291|58958701|FG005|Epoch 3|Withdrawal by Subject|0|||
30923491|NCT02059291|58958702|FG006|Epoch 3|Withdrawal by Subject|0|||
30832677|NCT03874715|58857113|FG000|Overall Study|Poor compliance to protocol|5|||
30832678|NCT03874715|58857114|FG001|Overall Study|Poor compliance to protocol|1|||
30923492|NCT02059291|58958703|FG007|Epoch 3|Withdrawal by Subject|0|||
30923493|NCT02059291|58958704|FG008|Epoch 3|Withdrawal by Subject|0|||
30923494|NCT02059291|58958705|FG009|Epoch 3|Withdrawal by Subject|0|||
30923495|NCT02059291|58958706|FG010|Epoch 3|Withdrawal by Subject|0|||
30923496|NCT02059291|58958707|FG011|Epoch 3|Withdrawal by Subject|0|||
30923497|NCT02059291|58958708|FG012|Epoch 3|Withdrawal by Subject|0|||
30923498|NCT02059291|58958709|FG013|Epoch 3|Withdrawal by Subject|0|||
30923499|NCT02059291|58958710|FG014|Epoch 3|Withdrawal by Subject|0|||
30923500|NCT02059291|58958711|FG015|Epoch 3|Withdrawal by Subject|1|||
30923501|NCT02059291|58958712|FG016|Epoch 3|Withdrawal by Subject|0|||
30923502|NCT02059291|58958713|FG017|Epoch 3|Withdrawal by Subject|0|||
30923503|NCT02059291|58958714|FG018|Epoch 3|Withdrawal by Subject|0|||
30923504|NCT02059291|58958715|FG019|Epoch 3|Withdrawal by Subject|0|||
30923505|NCT02059291|58958716|FG020|Epoch 3|Withdrawal by Subject|0|||
30923506|NCT02059291|58958717|FG021|Epoch 3|Withdrawal by Subject|0|||
30923507|NCT02059291|58958718|FG022|Epoch 3|Withdrawal by Subject|0|||
30923508|NCT02059291|58958719|FG023|Epoch 3|Withdrawal by Subject|0|||
30923509|NCT02059291|58958720|FG024|Epoch 3|Withdrawal by Subject|0|||
30923510|NCT02059291|58958696|FG000|Epoch 4|Adverse Event|0|||
30923511|NCT02059291|58958697|FG001|Epoch 4|Adverse Event|0|||
30923512|NCT02059291|58958698|FG002|Epoch 4|Adverse Event|0|||
30923513|NCT02059291|58958699|FG003|Epoch 4|Adverse Event|0|||
30923514|NCT02059291|58958700|FG004|Epoch 4|Adverse Event|0|||
30923515|NCT02059291|58958701|FG005|Epoch 4|Adverse Event|0|||
30923516|NCT02059291|58958702|FG006|Epoch 4|Adverse Event|0|||
30923517|NCT02059291|58958703|FG007|Epoch 4|Adverse Event|0|||
30923518|NCT02059291|58958704|FG008|Epoch 4|Adverse Event|0|||
30923519|NCT02059291|58958705|FG009|Epoch 4|Adverse Event|0|||
30923520|NCT02059291|58958706|FG010|Epoch 4|Adverse Event|0|||
30923521|NCT02059291|58958707|FG011|Epoch 4|Adverse Event|0|||
30923522|NCT02059291|58958708|FG012|Epoch 4|Adverse Event|0|||
30832679|NCT03874715|58857113|FG000|Overall Study|Withdrawal by Subject|1|||
30832680|NCT03874715|58857114|FG001|Overall Study|Withdrawal by Subject|0|||
30832681|NCT03874715|58857113|FG000|Overall Study|Other-unspecified|1|||
30832682|NCT03874715|58857114|FG001|Overall Study|Other-unspecified|0|||
30832683|NCT03502200|58857126|FG000|Overall Study|Adverse Event|1|||
30832684|NCT03502200|58857127|FG001|Overall Study|Adverse Event|0|||
30832685|NCT03502200|58857126|FG000|Overall Study|Lost to Follow-up|36|||
30832686|NCT03502200|58857127|FG001|Overall Study|Lost to Follow-up|38|||
30832687|NCT03502200|58857126|FG000|Overall Study|Study Team Decision|1|||
30832688|NCT03502200|58857127|FG001|Overall Study|Study Team Decision|1|||
30832689|NCT03502200|58857126|FG000|Overall Study|Withdrawal by Subject|5|||
30832690|NCT03502200|58857127|FG001|Overall Study|Withdrawal by Subject|7|||
30832691|NCT03502200|58857126|FG000|Overall Study|Death|0|||
30832692|NCT03502200|58857127|FG001|Overall Study|Death|2|||
30832693|NCT03361306|58857133|FG000|Overall Study|Death|5|||
30832694|NCT03361306|58857133|FG000|Overall Study|Still On Study (on study treatment)|3|||
30832695|NCT03361306|58857133|FG000|Overall Study|Still On Study (in follow up)|7|||
30832696|NCT03336242|58857139|FG000|Overall Study|Adverse Event|0|||
30832697|NCT03336242|58857140|FG001|Overall Study|Adverse Event|1|||
30832698|NCT03334435|58857151|FG000|Overall Study|Ongoing as of Week 52|70|||
30832699|NCT03334435|58857152|FG001|Overall Study|Ongoing as of Week 52|32|||
30832700|NCT03334435|58857153|FG002|Overall Study|Ongoing as of Week 52|379|||
30832701|NCT03334435|58857154|FG003|Overall Study|Ongoing as of Week 52|519|||
30832702|NCT03334435|58857155|FG004|Overall Study|Ongoing as of Week 52|146|||
30832703|NCT03334435|58857151|FG000|Overall Study|Lack of Efficacy|3|||
30832704|NCT03334435|58857152|FG001|Overall Study|Lack of Efficacy|5|||
30832705|NCT03334435|58857153|FG002|Overall Study|Lack of Efficacy|76|||
30832706|NCT03334435|58857154|FG003|Overall Study|Lack of Efficacy|140|||
30832707|NCT03334435|58857155|FG004|Overall Study|Lack of Efficacy|61|||
30923523|NCT02059291|58958709|FG013|Epoch 4|Adverse Event|0|||
30923524|NCT02059291|58958710|FG014|Epoch 4|Adverse Event|0|||
30923525|NCT02059291|58958711|FG015|Epoch 4|Adverse Event|0|||
30923526|NCT02059291|58958712|FG016|Epoch 4|Adverse Event|1|||
30832708|NCT03334435|58857151|FG000|Overall Study|Adverse Event|2|||
30832709|NCT03334435|58857152|FG001|Overall Study|Adverse Event|1|||
30832710|NCT03334435|58857153|FG002|Overall Study|Adverse Event|9|||
30832711|NCT03334435|58857154|FG003|Overall Study|Adverse Event|23|||
30623836|NCT01119846|58635707|FG002|Overall Study|Adverse Event|6|||
30832712|NCT03334435|58857155|FG004|Overall Study|Adverse Event|13|||
30832713|NCT03334435|58857151|FG000|Overall Study|Withdrawal by Subject|11|||
30832714|NCT03334435|58857152|FG001|Overall Study|Withdrawal by Subject|4|||
30832715|NCT03334435|58857153|FG002|Overall Study|Withdrawal by Subject|38|||
30923527|NCT02059291|58958713|FG017|Epoch 4|Adverse Event|0|||
30923528|NCT02059291|58958714|FG018|Epoch 4|Adverse Event|0|||
30923529|NCT02059291|58958715|FG019|Epoch 4|Adverse Event|0|||
30923530|NCT02059291|58958716|FG020|Epoch 4|Adverse Event|0|||
30923531|NCT02059291|58958717|FG021|Epoch 4|Adverse Event|0|||
30923532|NCT02059291|58958718|FG022|Epoch 4|Adverse Event|1|||
30923533|NCT02059291|58958719|FG023|Epoch 4|Adverse Event|0|||
30923534|NCT02059291|58958720|FG024|Epoch 4|Adverse Event|0|||
30923535|NCT02059291|58958696|FG000|Epoch 4|Pregnancy|0|||
30923536|NCT02059291|58958697|FG001|Epoch 4|Pregnancy|0|||
30923537|NCT02059291|58958698|FG002|Epoch 4|Pregnancy|0|||
30923538|NCT02059291|58958699|FG003|Epoch 4|Pregnancy|0|||
30923539|NCT02059291|58958700|FG004|Epoch 4|Pregnancy|0|||
30923540|NCT02059291|58958701|FG005|Epoch 4|Pregnancy|0|||
30923541|NCT02059291|58958702|FG006|Epoch 4|Pregnancy|0|||
30923542|NCT02059291|58958703|FG007|Epoch 4|Pregnancy|0|||
30923543|NCT02059291|58958704|FG008|Epoch 4|Pregnancy|0|||
30923544|NCT02059291|58958705|FG009|Epoch 4|Pregnancy|0|||
30923545|NCT02059291|58958706|FG010|Epoch 4|Pregnancy|0|||
30923546|NCT02059291|58958707|FG011|Epoch 4|Pregnancy|0|||
30923547|NCT02059291|58958708|FG012|Epoch 4|Pregnancy|0|||
30923548|NCT02059291|58958709|FG013|Epoch 4|Pregnancy|0|||
30923549|NCT02059291|58958710|FG014|Epoch 4|Pregnancy|0|||
30923550|NCT02059291|58958711|FG015|Epoch 4|Pregnancy|0|||
30923551|NCT02059291|58958712|FG016|Epoch 4|Pregnancy|1|||
30923552|NCT02059291|58958713|FG017|Epoch 4|Pregnancy|0|||
30923553|NCT02059291|58958714|FG018|Epoch 4|Pregnancy|0|||
30923554|NCT02059291|58958715|FG019|Epoch 4|Pregnancy|0|||
30923555|NCT02059291|58958716|FG020|Epoch 4|Pregnancy|0|||
30923556|NCT02059291|58958717|FG021|Epoch 4|Pregnancy|0|||
30923557|NCT02059291|58958718|FG022|Epoch 4|Pregnancy|0|||
30923558|NCT02059291|58958719|FG023|Epoch 4|Pregnancy|0|||
30923559|NCT02059291|58958720|FG024|Epoch 4|Pregnancy|0|||
30923560|NCT02059291|58958696|FG000|Epoch 4|Withdrawal by Subject|0|||
30923561|NCT02059291|58958697|FG001|Epoch 4|Withdrawal by Subject|0|||
30923562|NCT02059291|58958698|FG002|Epoch 4|Withdrawal by Subject|0|||
30923563|NCT02059291|58958699|FG003|Epoch 4|Withdrawal by Subject|0|||
30923564|NCT02059291|58958700|FG004|Epoch 4|Withdrawal by Subject|0|||
30923565|NCT02059291|58958701|FG005|Epoch 4|Withdrawal by Subject|0|||
30923566|NCT02059291|58958702|FG006|Epoch 4|Withdrawal by Subject|0|||
30923567|NCT02059291|58958703|FG007|Epoch 4|Withdrawal by Subject|0|||
30923568|NCT02059291|58958704|FG008|Epoch 4|Withdrawal by Subject|0|||
30923569|NCT02059291|58958705|FG009|Epoch 4|Withdrawal by Subject|0|||
30923570|NCT02059291|58958706|FG010|Epoch 4|Withdrawal by Subject|0|||
30923571|NCT02059291|58958707|FG011|Epoch 4|Withdrawal by Subject|0|||
30923572|NCT02059291|58958708|FG012|Epoch 4|Withdrawal by Subject|0|||
30832716|NCT03334435|58857154|FG003|Overall Study|Withdrawal by Subject|42|||
30832717|NCT03334435|58857155|FG004|Overall Study|Withdrawal by Subject|20|||
30832718|NCT03334435|58857151|FG000|Overall Study|Lost to Follow-up|3|||
30832719|NCT03334435|58857152|FG001|Overall Study|Lost to Follow-up|0|||
30832720|NCT03334435|58857153|FG002|Overall Study|Lost to Follow-up|2|||
30832721|NCT03334435|58857154|FG003|Overall Study|Lost to Follow-up|1|||
30832722|NCT03334435|58857155|FG004|Overall Study|Lost to Follow-up|1|||
30832723|NCT03334435|58857151|FG000|Overall Study|Death|0|||
30832724|NCT03334435|58857152|FG001|Overall Study|Death|0|||
30832725|NCT03334435|58857153|FG002|Overall Study|Death|0|||
30832726|NCT03334435|58857154|FG003|Overall Study|Death|1|||
30832727|NCT03334435|58857155|FG004|Overall Study|Death|0|||
30832728|NCT03334435|58857151|FG000|Overall Study|Other|0|||
30832729|NCT03334435|58857152|FG001|Overall Study|Other|1|||
30832730|NCT03334435|58857153|FG002|Overall Study|Other|3|||
30832731|NCT03334435|58857154|FG003|Overall Study|Other|2|||
30832732|NCT03334435|58857155|FG004|Overall Study|Other|1|||
30832733|NCT03143153|58857222|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
30832734|NCT03143153|58857223|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
30832735|NCT03143153|58857224|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
30832736|NCT03143153|58857222|FG000|Pre-Treatment|Participant withdrew consent|0|||
30832737|NCT03143153|58857223|FG001|Pre-Treatment|Participant withdrew consent|1|||
30923573|NCT02059291|58958709|FG013|Epoch 4|Withdrawal by Subject|0|||
30923574|NCT02059291|58958710|FG014|Epoch 4|Withdrawal by Subject|0|||
30923575|NCT02059291|58958711|FG015|Epoch 4|Withdrawal by Subject|0|||
30832738|NCT03143153|58857224|FG002|Pre-Treatment|Participant withdrew consent|12|||
30832739|NCT03143153|58857222|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
30923576|NCT02059291|58958712|FG016|Epoch 4|Withdrawal by Subject|0|||
30923577|NCT02059291|58958713|FG017|Epoch 4|Withdrawal by Subject|0|||
30923578|NCT02059291|58958714|FG018|Epoch 4|Withdrawal by Subject|0|||
30832740|NCT03143153|58857223|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
30923579|NCT02059291|58958715|FG019|Epoch 4|Withdrawal by Subject|0|||
30923580|NCT02059291|58958716|FG020|Epoch 4|Withdrawal by Subject|1|||
30923581|NCT02059291|58958717|FG021|Epoch 4|Withdrawal by Subject|0|||
30923582|NCT02059291|58958718|FG022|Epoch 4|Withdrawal by Subject|0|||
30923583|NCT02059291|58958719|FG023|Epoch 4|Withdrawal by Subject|0|||
30923584|NCT02059291|58958720|FG024|Epoch 4|Withdrawal by Subject|0|||
30923585|NCT02059291|58958696|FG000|Epoch 4|Lack of Efficacy|0|||
30923586|NCT02059291|58958697|FG001|Epoch 4|Lack of Efficacy|0|||
30923587|NCT02059291|58958698|FG002|Epoch 4|Lack of Efficacy|0|||
30923588|NCT02059291|58958699|FG003|Epoch 4|Lack of Efficacy|0|||
30832741|NCT03143153|58857224|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
30832742|NCT03143153|58857222|FG000|Pre-Treatment|Other Reasons|1|||
30832743|NCT03143153|58857223|FG001|Pre-Treatment|Other Reasons|2|||
30832744|NCT03143153|58857224|FG002|Pre-Treatment|Other Reasons|1|||
30832745|NCT03143153|58857222|FG000|Pre-Treatment|Disease Progression|1|||
30832746|NCT03143153|58857223|FG001|Pre-Treatment|Disease Progression|1|||
30832747|NCT03143153|58857224|FG002|Pre-Treatment|Disease Progression|2|||
30832748|NCT03143153|58857222|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
30832749|NCT03143153|58857223|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
30832750|NCT03143153|58857224|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
30832751|NCT03143153|58857222|FG000|Treatment|Disease progression|174|||
30832752|NCT03143153|58857223|FG001|Treatment|Disease progression|184|||
30832753|NCT03143153|58857224|FG002|Treatment|Disease progression|193|||
30832754|NCT03143153|58857222|FG000|Treatment|Study drug toxicity|59|||
30832755|NCT03143153|58857223|FG001|Treatment|Study drug toxicity|33|||
30832756|NCT03143153|58857224|FG002|Treatment|Study drug toxicity|40|||
30923589|NCT02059291|58958700|FG004|Epoch 4|Lack of Efficacy|0|||
30923590|NCT02059291|58958701|FG005|Epoch 4|Lack of Efficacy|0|||
30923591|NCT02059291|58958702|FG006|Epoch 4|Lack of Efficacy|0|||
30923592|NCT02059291|58958703|FG007|Epoch 4|Lack of Efficacy|0|||
30923593|NCT02059291|58958704|FG008|Epoch 4|Lack of Efficacy|0|||
30923594|NCT02059291|58958705|FG009|Epoch 4|Lack of Efficacy|0|||
30923595|NCT02059291|58958706|FG010|Epoch 4|Lack of Efficacy|0|||
30923596|NCT02059291|58958707|FG011|Epoch 4|Lack of Efficacy|0|||
30923597|NCT02059291|58958708|FG012|Epoch 4|Lack of Efficacy|0|||
30832757|NCT03143153|58857222|FG000|Treatment|Death|5|||
30832758|NCT03143153|58857223|FG001|Treatment|Death|3|||
30832759|NCT03143153|58857224|FG002|Treatment|Death|4|||
30832760|NCT03143153|58857222|FG000|Treatment|Adverse event unrelated to study drug|19|||
30832761|NCT03143153|58857223|FG001|Treatment|Adverse event unrelated to study drug|28|||
30832762|NCT03143153|58857224|FG002|Treatment|Adverse event unrelated to study drug|12|||
30832763|NCT03143153|58857222|FG000|Treatment|Participant request to discontinue study treatment|13|||
30832764|NCT03143153|58857223|FG001|Treatment|Participant request to discontinue study treatment|15|||
30832765|NCT03143153|58857224|FG002|Treatment|Participant request to discontinue study treatment|20|||
30832766|NCT03143153|58857222|FG000|Treatment|Participant withdrew consent|3|||
30832767|NCT03143153|58857223|FG001|Treatment|Participant withdrew consent|4|||
30832768|NCT03143153|58857224|FG002|Treatment|Participant withdrew consent|12|||
30832769|NCT03143153|58857222|FG000|Treatment|Pregnancy|1|||
30832770|NCT03143153|58857223|FG001|Treatment|Pregnancy|0|||
30832771|NCT03143153|58857224|FG002|Treatment|Pregnancy|0|||
30832772|NCT03143153|58857222|FG000|Treatment|Maximum clinical benefit|1|||
30832773|NCT03143153|58857223|FG001|Treatment|Maximum clinical benefit|3|||
30832774|NCT03143153|58857224|FG002|Treatment|Maximum clinical benefit|4|||
30832775|NCT03143153|58857222|FG000|Treatment|Completed treatment as per Protocol|13|||
30832776|NCT03143153|58857223|FG001|Treatment|Completed treatment as per Protocol|8|||
30832777|NCT03143153|58857224|FG002|Treatment|Completed treatment as per Protocol|0|||
30832778|NCT03143153|58857222|FG000|Treatment|Other reasons|12|||
30832779|NCT03143153|58857223|FG001|Treatment|Other reasons|7|||
30832780|NCT03143153|58857224|FG002|Treatment|Other reasons|15|||
30832781|NCT03143153|58857222|FG000|Treatment|Not reported|1|||
30832782|NCT03143153|58857223|FG001|Treatment|Not reported|0|||
30832783|NCT03143153|58857224|FG002|Treatment|Not reported|0|||
30923598|NCT02059291|58958709|FG013|Epoch 4|Lack of Efficacy|0|||
30923599|NCT02059291|58958710|FG014|Epoch 4|Lack of Efficacy|0|||
30755837|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
30755838|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
30755839|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
30755840|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
30755841|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
30755842|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
30755843|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
30832784|NCT02998528|58857235|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
30832785|NCT02998528|58857236|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
30832786|NCT02998528|58857237|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
30832787|NCT02998528|58857235|FG000|Randomization Period|Participant withdrew consent|0|||
30832788|NCT02998528|58857236|FG001|Randomization Period|Participant withdrew consent|3|||
30923600|NCT02059291|58958711|FG015|Epoch 4|Lack of Efficacy|0|||
30923601|NCT02059291|58958712|FG016|Epoch 4|Lack of Efficacy|0|||
30923602|NCT02059291|58958713|FG017|Epoch 4|Lack of Efficacy|0|||
30923603|NCT02059291|58958714|FG018|Epoch 4|Lack of Efficacy|0|||
30923604|NCT02059291|58958715|FG019|Epoch 4|Lack of Efficacy|0|||
30832789|NCT02998528|58857237|FG002|Randomization Period|Participant withdrew consent|0|||
30832790|NCT02998528|58857235|FG000|Randomization Period|Participant no longer meets study criteria|1|||
30832791|NCT02998528|58857236|FG001|Randomization Period|Participant no longer meets study criteria|3|||
30923605|NCT02059291|58958716|FG020|Epoch 4|Lack of Efficacy|0|||
30923606|NCT02059291|58958717|FG021|Epoch 4|Lack of Efficacy|0|||
30923607|NCT02059291|58958718|FG022|Epoch 4|Lack of Efficacy|0|||
30923608|NCT02059291|58958719|FG023|Epoch 4|Lack of Efficacy|1|||
30923609|NCT02059291|58958720|FG024|Epoch 4|Lack of Efficacy|0|||
30923610|NCT02042924|58958748|FG000|Overall Study|Early Death|1|||
30923611|NCT02041520|58958754|FG000|Overall Study|Adverse Event|2|||
30923612|NCT02041520|58958755|FG001|Overall Study|Adverse Event|1|||
30923613|NCT02041520|58958754|FG000|Overall Study|Withdrawal by Subject|3|||
30923614|NCT02041520|58958755|FG001|Overall Study|Withdrawal by Subject|4|||
30923615|NCT02041520|58958754|FG000|Overall Study|Protocol Violation|1|||
30923616|NCT02041520|58958755|FG001|Overall Study|Protocol Violation|0|||
30923617|NCT02041520|58958754|FG000|Overall Study|Lost to Follow-up|0|||
30923618|NCT02041520|58958755|FG001|Overall Study|Lost to Follow-up|1|||
30923619|NCT02041520|58958754|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
30923620|NCT02041520|58958755|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
30923621|NCT02041429|58958767|FG000|Overall Study|Progressive Disease|2|||
30923622|NCT02041429|58958768|FG001|Overall Study|Progressive Disease|2|||
30923623|NCT02041429|58958769|FG002|Overall Study|Progressive Disease|3|||
30923624|NCT02041429|58958770|FG003|Overall Study|Progressive Disease|2|||
30923625|NCT02041429|58958767|FG000|Overall Study|Toxicity|0|||
30923626|NCT02041429|58958768|FG001|Overall Study|Toxicity|1|||
30923627|NCT02041429|58958769|FG002|Overall Study|Toxicity|4|||
30923628|NCT02041429|58958770|FG003|Overall Study|Toxicity|2|||
30923629|NCT02041429|58958767|FG000|Overall Study|Withdrawal by Subject|0|||
30923630|NCT02041429|58958768|FG001|Overall Study|Withdrawal by Subject|1|||
30923631|NCT02041429|58958769|FG002|Overall Study|Withdrawal by Subject|0|||
30923632|NCT02041429|58958770|FG003|Overall Study|Withdrawal by Subject|0|||
30923633|NCT02041429|58958767|FG000|Overall Study|On Maintenance Therapy|1|||
30923634|NCT02041429|58958768|FG001|Overall Study|On Maintenance Therapy|0|||
30923635|NCT02041429|58958769|FG002|Overall Study|On Maintenance Therapy|0|||
30923636|NCT02041429|58958770|FG003|Overall Study|On Maintenance Therapy|2|||
30923637|NCT02083783|58958787|FG000|Overall Study|Withdrawal by Subject|1|||
30923638|NCT02083783|58958788|FG001|Overall Study|Withdrawal by Subject|0|||
30923639|NCT02083081|58958798|FG000|Overall Study|Lost to Follow-up|31|||
30923640|NCT02083081|58958799|FG001|Overall Study|Lost to Follow-up|9|||
30923641|NCT02040805|58958807|FG000|Overall Study|Lost to Follow-up|14|||
30923642|NCT02040805|58958808|FG001|Overall Study|Lost to Follow-up|9|||
30923643|NCT02040805|58958807|FG000|Overall Study|Withdrawal by Subject|28|||
30923644|NCT02040805|58958808|FG001|Overall Study|Withdrawal by Subject|41|||
30923645|NCT02040259|58958814|FG000|Overall Study|Death|280|||
30923646|NCT02040259|58958814|FG000|Overall Study|Lost to Follow-up|76|||
30923647|NCT02040259|58958814|FG000|Overall Study|Assessment not completed|3|||
30923648|NCT02040259|58958814|FG000|Overall Study|Withdrawal by Subject|4|||
30923649|NCT02059135|58958822|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
30923650|NCT02059135|58958823|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
30923651|NCT02059135|58958822|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
30923652|NCT02059135|58958823|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
30923653|NCT02059135|58958822|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
30923654|NCT02059135|58958823|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
30923655|NCT02059135|58958822|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
30923656|NCT02059135|58958823|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
30923657|NCT02059135|58958822|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
30755844|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
30755845|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
30755846|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
30755847|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
30755848|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
30755849|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
30755850|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
30755851|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
30755852|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
30755853|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
30755854|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
30755855|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
30923658|NCT02059135|58958823|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
30923659|NCT02059135|58958822|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
30923660|NCT02059135|58958823|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
30923661|NCT02059135|58958822|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
30923662|NCT02059135|58958823|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
30923663|NCT02059135|58958822|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
30923664|NCT02059135|58958823|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
30923665|NCT02081677|58958835|FG000|Overall Study|Adverse Event|0|||
30923666|NCT02081677|58958836|FG001|Overall Study|Adverse Event|0|||
30923667|NCT02081677|58958837|FG002|Overall Study|Adverse Event|1|||
30923668|NCT02081677|58958838|FG003|Overall Study|Adverse Event|0|||
30923669|NCT02081677|58958835|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
30923670|NCT02081677|58958836|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
30923671|NCT02081677|58958837|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
30923672|NCT02081677|58958838|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
30923673|NCT02081677|58958835|FG000|Overall Study|Not comfortable with lens care system|1|||
30923674|NCT02081677|58958836|FG001|Overall Study|Not comfortable with lens care system|0|||
30923675|NCT02081677|58958837|FG002|Overall Study|Not comfortable with lens care system|0|||
30923676|NCT02081677|58958838|FG003|Overall Study|Not comfortable with lens care system|0|||
30923677|NCT02081677|58958835|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
30923678|NCT02081677|58958836|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
30923679|NCT02081677|58958837|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
30923680|NCT02081677|58958838|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
30923681|NCT02038933|58958850|FG000|Overall Study|Disease progression|104|||
30923682|NCT02038933|58958850|FG000|Overall Study|Study drug toxicity|6|||
30923683|NCT02038933|58958850|FG000|Overall Study|Adverse event unrelated to study drug|6|||
30923684|NCT02038933|58958850|FG000|Overall Study|Participant request to discontinue treatment|2|||
30923685|NCT02038933|58958850|FG000|Overall Study|Lost to Follow-up|1|||
30923686|NCT02038933|58958850|FG000|Overall Study|Other reasons|2|||
30923687|NCT02081599|58958857|FG000|Period 1：Double-blind Period|Adverse Event|3|||
30923688|NCT02081599|58958858|FG001|Period 1：Double-blind Period|Adverse Event|0|||
30923689|NCT02081599|58958857|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
30923690|NCT02081599|58958858|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
30923691|NCT02081599|58958857|FG000|Period 1：Double-blind Period|Physician Decision|1|||
30923692|NCT02081599|58958858|FG001|Period 1：Double-blind Period|Physician Decision|0|||
30923693|NCT02081599|58958857|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
30923694|NCT02081599|58958858|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
30923695|NCT02081599|58958857|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
30923696|NCT02081599|58958858|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
30923697|NCT02081599|58958857|FG000|Period 1：Double-blind Period|stopping criteria|1|||
30923698|NCT02081599|58958858|FG001|Period 1：Double-blind Period|stopping criteria|0|||
30923699|NCT02081599|58958857|FG000|Period 2：Open-label Period|Adverse Event|1|||
30923700|NCT02081599|58958858|FG001|Period 2：Open-label Period|Adverse Event|0|||
30923701|NCT02081599|58958857|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
30923702|NCT02081599|58958858|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
30923703|NCT02081599|58958857|FG000|Period 2：Open-label Period|Physician Decision|1|||
30923704|NCT02081599|58958858|FG001|Period 2：Open-label Period|Physician Decision|0|||
30832792|NCT02998528|58857237|FG002|Randomization Period|Participant no longer meets study criteria|2|||
30832793|NCT02998528|58857235|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
30832794|NCT02998528|58857236|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
30832795|NCT02998528|58857237|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
30832796|NCT02998528|58857235|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
30832797|NCT02998528|58857236|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
30832798|NCT02998528|58857237|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
30832799|NCT02998528|58857235|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
30832800|NCT02998528|58857236|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
30832801|NCT02998528|58857237|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
30832802|NCT02998528|58857235|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
30832803|NCT02998528|58857236|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
30832804|NCT02998528|58857237|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
30832805|NCT02998528|58857235|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
30832806|NCT02998528|58857236|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
30832807|NCT02998528|58857237|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
30832808|NCT02998528|58857235|FG000|Neoadjuvant Treatment Period|Death|1|||
30832809|NCT02998528|58857236|FG001|Neoadjuvant Treatment Period|Death|0|||
30832810|NCT02998528|58857237|FG002|Neoadjuvant Treatment Period|Death|0|||
30832811|NCT02998528|58857235|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
30832812|NCT02998528|58857236|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
30832813|NCT02998528|58857237|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
30832814|NCT02998528|58857235|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
30832815|NCT02998528|58857236|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
30832816|NCT02998528|58857237|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
30832817|NCT02998528|58857235|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
30832818|NCT02998528|58857236|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
30832819|NCT02998528|58857237|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
30832820|NCT02998528|58857235|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
30923705|NCT02081599|58958857|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
30923706|NCT02081599|58958858|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
30923707|NCT02038543|58958870|FG000|Overall Study|Screen Failure|0|||
30923708|NCT02038543|58958871|FG001|Overall Study|Screen Failure|0|||
30923709|NCT02038543|58958872|FG002|Overall Study|Screen Failure|0|||
30923710|NCT02038543|58958873|FG003|Overall Study|Screen Failure|1|||
30923711|NCT02038543|58958870|FG000|Overall Study|Withdrawal by Subject|0|||
30923712|NCT02038543|58958871|FG001|Overall Study|Withdrawal by Subject|0|||
30923713|NCT02038543|58958872|FG002|Overall Study|Withdrawal by Subject|0|||
30923714|NCT02038543|58958873|FG003|Overall Study|Withdrawal by Subject|1|||
30923715|NCT02038153|58958883|FG000|Overall Study|Withdrawal by Subject|1|||
30923716|NCT02038075|58958889|FG000|Overall Study|Withdrawal by Subject|3|||
30923717|NCT02038075|58958890|FG001|Overall Study|Withdrawal by Subject|0|||
30923718|NCT02058589|58958898|FG000|Overall Study|Serious Adverse Event|1|||
30923719|NCT02058589|58958899|FG001|Overall Study|Serious Adverse Event|1|||
30923720|NCT02058589|58958898|FG000|Overall Study|Non-Serious Adverse Event|1|||
30923721|NCT02058589|58958899|FG001|Overall Study|Non-Serious Adverse Event|0|||
30923722|NCT02058589|58958898|FG000|Overall Study|Withdrawal by Subject|0|||
30923723|NCT02058589|58958899|FG001|Overall Study|Withdrawal by Subject|1|||
30923724|NCT02079805|58958909|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
30923725|NCT02079805|58958910|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
30923726|NCT02079805|58958909|FG000|Overall Study|Voluntary Withdrawal|0|||
30923727|NCT02079805|58958910|FG001|Overall Study|Voluntary Withdrawal|1|||
30923728|NCT02037295|58958920|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
30923729|NCT02037295|58958921|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
30923730|NCT02037295|58958922|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
30923731|NCT02037295|58958923|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
30923732|NCT02079649|58958939|FG000|Overall Study|Lost to Follow-up|0|||
30923733|NCT02079649|58958940|FG001|Overall Study|Lost to Follow-up|0|||
30923734|NCT02079649|58958941|FG002|Overall Study|Lost to Follow-up|0|||
30923735|NCT02079649|58958942|FG003|Overall Study|Lost to Follow-up|1|||
30923736|NCT02079649|58958939|FG000|Overall Study|Withdrawal by Subject|0|||
30923737|NCT02079649|58958940|FG001|Overall Study|Withdrawal by Subject|0|||
30923738|NCT02079649|58958941|FG002|Overall Study|Withdrawal by Subject|0|||
30923739|NCT02079649|58958942|FG003|Overall Study|Withdrawal by Subject|1|||
30923740|NCT02079649|58958939|FG000|Overall Study|Randomization error (prior to treatment)|1|||
30923741|NCT02079649|58958940|FG001|Overall Study|Randomization error (prior to treatment)|0|||
30923742|NCT02079649|58958941|FG002|Overall Study|Randomization error (prior to treatment)|1|||
30923743|NCT02079649|58958942|FG003|Overall Study|Randomization error (prior to treatment)|0|||
30923744|NCT02036515|58958956|FG000|Overall Study|Adverse Event|1|||
30923745|NCT02036515|58958957|FG001|Overall Study|Adverse Event|1|||
30923746|NCT02036515|58958958|FG002|Overall Study|Adverse Event|2|||
30923747|NCT02036515|58958956|FG000|Overall Study|Lost to Follow-up|0|||
30923748|NCT02036515|58958957|FG001|Overall Study|Lost to Follow-up|2|||
30923749|NCT02036515|58958958|FG002|Overall Study|Lost to Follow-up|0|||
30923750|NCT02036515|58958956|FG000|Overall Study|Non-compliance with study drug|0|||
30923751|NCT02036515|58958957|FG001|Overall Study|Non-compliance with study drug|0|||
30923752|NCT02036515|58958958|FG002|Overall Study|Non-compliance with study drug|2|||
30923753|NCT02036515|58958956|FG000|Overall Study|Screen failure|0|||
30923754|NCT02036515|58958957|FG001|Overall Study|Screen failure|2|||
30923755|NCT02036515|58958958|FG002|Overall Study|Screen failure|0|||
30923756|NCT02036515|58958956|FG000|Overall Study|Withdrawal by Subject|4|||
30923757|NCT02036515|58958957|FG001|Overall Study|Withdrawal by Subject|7|||
30923758|NCT02036515|58958958|FG002|Overall Study|Withdrawal by Subject|9|||
30923759|NCT02036515|58958956|FG000|Overall Study|Hyperglycemia|0|||
30923760|NCT02036515|58958957|FG001|Overall Study|Hyperglycemia|0|||
30923761|NCT02036515|58958958|FG002|Overall Study|Hyperglycemia|1|||
30923762|NCT02078713|58958970|FG000|Overall Study|Lost to Follow-up|49|||
30923763|NCT02078713|58958971|FG001|Overall Study|Lost to Follow-up|55|||
30923764|NCT02078713|58958972|FG002|Overall Study|Lost to Follow-up|0|||
30923765|NCT02078713|58958973|FG003|Overall Study|Lost to Follow-up|0|||
30923766|NCT02078713|58958970|FG000|Overall Study|Pregnant at baseline|3|||
30923767|NCT02078713|58958971|FG001|Overall Study|Pregnant at baseline|5|||
30923768|NCT02078713|58958972|FG002|Overall Study|Pregnant at baseline|0|||
30923769|NCT02078713|58958973|FG003|Overall Study|Pregnant at baseline|0|||
30923770|NCT02078713|58958970|FG000|Overall Study|Enrolled twice|0|||
30923771|NCT02078713|58958971|FG001|Overall Study|Enrolled twice|1|||
30923772|NCT02078713|58958972|FG002|Overall Study|Enrolled twice|0|||
30923773|NCT02078713|58958973|FG003|Overall Study|Enrolled twice|0|||
30923774|NCT02035267|58958989|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
30923775|NCT02035267|58958990|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
30923776|NCT02035267|58958991|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
30923777|NCT02035267|58958992|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
30923778|NCT02035267|58958989|FG000|Overall Study|Adverse Event|0|||
30923779|NCT02035267|58958990|FG001|Overall Study|Adverse Event|0|||
30923780|NCT02035267|58958991|FG002|Overall Study|Adverse Event|1|||
30923781|NCT02035267|58958992|FG003|Overall Study|Adverse Event|0|||
30923782|NCT02035267|58958989|FG000|Overall Study|Lost to Follow-up|0|||
30923783|NCT02035267|58958990|FG001|Overall Study|Lost to Follow-up|0|||
30923784|NCT02035267|58958991|FG002|Overall Study|Lost to Follow-up|0|||
30923785|NCT02035267|58958992|FG003|Overall Study|Lost to Follow-up|1|||
30923786|NCT02035267|58958989|FG000|Overall Study|Other unspecified|0|||
30923787|NCT02035267|58958990|FG001|Overall Study|Other unspecified|1|||
30923788|NCT02035267|58958991|FG002|Overall Study|Other unspecified|0|||
30923789|NCT02035267|58958992|FG003|Overall Study|Other unspecified|0|||
30923790|NCT04373460|58959026|FG000|Overall Study|Did not receive tranfusion|18|||
30923791|NCT04373460|58959027|FG001|Overall Study|Did not receive tranfusion|26|||
30923792|NCT04280081|58959037|FG000|Overall Study|Adverse Event|4|||
30923793|NCT04280081|58959037|FG000|Overall Study|Death|2|||
30923794|NCT04280081|58959037|FG000|Overall Study|Progressive Disease|6|||
30923795|NCT04159805|58959053|FG000|Overall Study|Withdrawal by Subject|0|||
30923796|NCT04159805|58959054|FG001|Overall Study|Withdrawal by Subject|2|||
30923797|NCT04159805|58959055|FG002|Overall Study|Withdrawal by Subject|2|||
30923798|NCT03901456|58959066|FG000|Overall Study|Withdrawal by Subject|0|||
30923799|NCT03901456|58959067|FG001|Overall Study|Withdrawal by Subject|0|||
30923800|NCT03901456|58959068|FG002|Overall Study|Withdrawal by Subject|1|||
30923801|NCT03901456|58959066|FG000|Overall Study|Lost to Follow-up|0|||
30923802|NCT03901456|58959067|FG001|Overall Study|Lost to Follow-up|1|||
30923803|NCT03901456|58959068|FG002|Overall Study|Lost to Follow-up|0|||
30923804|NCT03848845|58959081|FG000|Overall Study|Lost to Follow-up|0|||
30923805|NCT03848845|58959082|FG001|Overall Study|Lost to Follow-up|1|||
30923806|NCT03848845|58959083|FG002|Overall Study|Lost to Follow-up|0|||
30923807|NCT03848845|58959081|FG000|Overall Study|Withdrawal by Subject|3|||
30923808|NCT03848845|58959082|FG001|Overall Study|Withdrawal by Subject|2|||
30923809|NCT03848845|58959083|FG002|Overall Study|Withdrawal by Subject|6|||
30923810|NCT03848845|58959081|FG000|Overall Study|In Follow-up|0|||
30923811|NCT03848845|58959082|FG001|Overall Study|In Follow-up|1|||
30923812|NCT03848845|58959083|FG002|Overall Study|In Follow-up|12|||
30923813|NCT03848845|58959081|FG000|Overall Study|On Study Treatment|0|||
30923814|NCT03848845|58959082|FG001|Overall Study|On Study Treatment|0|||
30923815|NCT03848845|58959083|FG002|Overall Study|On Study Treatment|4|||
30923816|NCT03848845|58959081|FG000|Overall Study|Physician Decision|0|||
30923817|NCT03848845|58959082|FG001|Overall Study|Physician Decision|0|||
30923818|NCT03848845|58959083|FG002|Overall Study|Physician Decision|1|||
30923819|NCT03299166|58959134|FG000|Overall Study|Adverse Event|9|||
30923820|NCT03299166|58959135|FG001|Overall Study|Adverse Event|4|||
30923821|NCT03299166|58959134|FG000|Overall Study|Withdrawal by Subject|6|||
30923822|NCT03299166|58959135|FG001|Overall Study|Withdrawal by Subject|5|||
30923823|NCT03299166|58959134|FG000|Overall Study|Physician Decision|1|||
30755856|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
30755857|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
30755858|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
30755859|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
30755860|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
30755861|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
30755862|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
30832821|NCT02998528|58857236|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
30832822|NCT02998528|58857237|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
30832823|NCT02998528|58857235|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
30832824|NCT02998528|58857236|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
30832825|NCT02998528|58857237|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
30832826|NCT02998528|58857235|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
30832827|NCT02998528|58857236|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
30832828|NCT02998528|58857237|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
30832829|NCT02919449|58857253|FG000|Overall Study|Withdrawal by Subject|1|||
30832830|NCT02919449|58857253|FG000|Overall Study|Investigator decision|1|||
30832831|NCT02913482|58857260|FG000|Overall Study|Death|0|||
30832832|NCT02913482|58857261|FG001|Overall Study|Death|2|||
30832833|NCT02913482|58857262|FG002|Overall Study|Death|2|||
30832834|NCT02913482|58857260|FG000|Overall Study|Progressive Disease|1|||
30832835|NCT02913482|58857261|FG001|Overall Study|Progressive Disease|1|||
30832836|NCT02913482|58857262|FG002|Overall Study|Progressive Disease|1|||
30832837|NCT02769832|58857272|FG000|Overall Study|Death|30|||
30923824|NCT03299166|58959135|FG001|Overall Study|Physician Decision|1|||
30923825|NCT03299166|58959134|FG000|Overall Study|Sponsor Decision|3|||
30923826|NCT03299166|58959135|FG001|Overall Study|Sponsor Decision|0|||
30923827|NCT03299166|58959134|FG000|Overall Study|Lost to Follow-up|2|||
30923828|NCT03299166|58959135|FG001|Overall Study|Lost to Follow-up|4|||
30923829|NCT03299166|58959134|FG000|Overall Study|Randomization Error|0|||
30923830|NCT03299166|58959135|FG001|Overall Study|Randomization Error|1|||
30923831|NCT03299166|58959134|FG000|Overall Study|Subject unable to return due to COVID|1|||
30923832|NCT03299166|58959135|FG001|Overall Study|Subject unable to return due to COVID|0|||
30923833|NCT03299166|58959134|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
30923834|NCT03299166|58959135|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
30923835|NCT03286504|58959143|FG000|Overall Study|Lost to Follow-up|19|||
30832838|NCT02743494|58857279|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
30832839|NCT02743494|58857280|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
30832840|NCT02743494|58857279|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
30832841|NCT02743494|58857280|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
30832842|NCT02743494|58857279|FG000|Treatment Period|Completed treatment|229|||
30832843|NCT02743494|58857280|FG001|Treatment Period|Completed treatment|99|||
30923836|NCT03286504|58959144|FG001|Overall Study|Lost to Follow-up|16|||
30923837|NCT03226249|58959150|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
30923838|NCT03226249|58959150|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
30923839|NCT03226249|58959150|FG000|Survival Follow-up|Patients still in follow-up.|30|||
30923840|NCT02941926|58959154|FG000|Overall Study|Progressive disease|1109|||
30923841|NCT02941926|58959154|FG000|Overall Study|Adverse Event|504|||
30923842|NCT02941926|58959154|FG000|Overall Study|Subject/guardian decision|127|||
30923843|NCT02941926|58959154|FG000|Overall Study|Physician Decision|112|||
30923844|NCT02941926|58959154|FG000|Overall Study|Death|46|||
30923845|NCT02941926|58959154|FG000|Overall Study|Protocol deviation|34|||
30923846|NCT02941926|58959154|FG000|Overall Study|Lost to Follow-up|8|||
30923847|NCT02941926|58959154|FG000|Overall Study|Technical problems|5|||
30923848|NCT02849548|58959162|FG000|Overall Study|Lost to Follow-up|1|||
30923849|NCT02849548|58959163|FG001|Overall Study|Lost to Follow-up|2|||
30923850|NCT02849548|58959162|FG000|Overall Study|Protocol Violation|1|||
30923851|NCT02849548|58959163|FG001|Overall Study|Protocol Violation|0|||
30923852|NCT02411448|58959181|FG000|Overall Study|Withdrawal by Subject|1|||
30923853|NCT02411448|58959182|FG001|Overall Study|Withdrawal by Subject|14|||
30832844|NCT02743494|58857279|FG000|Treatment Period|Disease recurrence|149|||
30923854|NCT02411448|58959183|FG002|Overall Study|Withdrawal by Subject|9|||
30923855|NCT02411448|58959181|FG000|Overall Study|Other|0|||
30923856|NCT02411448|58959182|FG001|Overall Study|Other|2|||
30923857|NCT02411448|58959183|FG002|Overall Study|Other|0|||
30923858|NCT02411448|58959181|FG000|Overall Study|Did not receive study treatment|0|||
30923859|NCT02411448|58959182|FG001|Overall Study|Did not receive study treatment|3|||
30923860|NCT02411448|58959183|FG002|Overall Study|Did not receive study treatment|0|||
30923861|NCT02411448|58959181|FG000|Overall Study|Alive on study treatment|3|||
30755863|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
30755864|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
30755865|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
30755866|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
30755867|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
30755868|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
30755869|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
30755870|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
30755871|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
30755872|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
30755873|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
30755874|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
30755875|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
30755876|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
30755877|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
30755878|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
30755879|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
30755880|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
30755881|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
30755882|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
30832845|NCT02743494|58857280|FG001|Treatment Period|Disease recurrence|113|||
30832846|NCT02743494|58857279|FG000|Treatment Period|Study drug toxicity|57|||
30832847|NCT02743494|58857280|FG001|Treatment Period|Study drug toxicity|8|||
30832848|NCT02743494|58857279|FG000|Treatment Period|Death|1|||
30832849|NCT02743494|58857280|FG001|Treatment Period|Death|0|||
30832850|NCT02743494|58857279|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
30832851|NCT02743494|58857280|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
30832852|NCT02743494|58857279|FG000|Treatment Period|Participant request to discontinue treatment|30|||
30923862|NCT02411448|58959182|FG001|Overall Study|Alive on study treatment|64|||
30923863|NCT02411448|58959183|FG002|Overall Study|Alive on study treatment|43|||
30923864|NCT02321514|58959195|FG000|Overall Study|Death|15|||
30923865|NCT02321514|58959195|FG000|Overall Study|Missed Visit|7|||
30923866|NCT02321514|58959195|FG000|Overall Study|Study Exit|3|||
30923867|NCT02266134|58959203|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
30923868|NCT02266134|58959204|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
30923869|NCT02266134|58959205|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
30923870|NCT02266134|58959206|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
30923871|NCT02266134|58959203|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
30923872|NCT02266134|58959204|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
30923873|NCT02266134|58959205|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
30832853|NCT02743494|58857280|FG001|Treatment Period|Participant request to discontinue treatment|5|||
30832854|NCT02743494|58857279|FG000|Treatment Period|Participant withdrew consent|12|||
30832855|NCT02743494|58857280|FG001|Treatment Period|Participant withdrew consent|4|||
30832856|NCT02743494|58857279|FG000|Treatment Period|Lost to Follow-up|0|||
30832857|NCT02743494|58857280|FG001|Treatment Period|Lost to Follow-up|1|||
30832858|NCT02743494|58857279|FG000|Treatment Period|Poor/Non-compliance|1|||
30832859|NCT02743494|58857280|FG001|Treatment Period|Poor/Non-compliance|0|||
30832860|NCT02743494|58857279|FG000|Treatment Period|Other reasons|7|||
30832861|NCT02743494|58857280|FG001|Treatment Period|Other reasons|2|||
30832862|NCT02530970|58857290|FG000|Overall Study|Adverse Event|8|||
30832863|NCT02530970|58857290|FG000|Overall Study|Lost to Follow-up|88|||
30923874|NCT02266134|58959206|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
30832864|NCT02530970|58857290|FG000|Overall Study|Physician Decision|5|||
30923875|NCT02266134|58959203|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
30923876|NCT02266134|58959204|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
30923877|NCT02266134|58959205|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
30923878|NCT02266134|58959206|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
30923879|NCT02266134|58959203|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
30832865|NCT02530970|58857290|FG000|Overall Study|Withdrawal by Subject|14|||
30832866|NCT02530970|58857290|FG000|Overall Study|Death|6|||
30832867|NCT02530970|58857290|FG000|Overall Study|Hospitalization|1|||
30832868|NCT02530970|58857290|FG000|Overall Study|Insurance|2|||
30832869|NCT02530970|58857290|FG000|Overall Study|Explant|2|||
30832870|NCT02530970|58857290|FG000|Overall Study|Change in Provider|5|||
30832871|NCT02530970|58857290|FG000|Overall Study|Relocation|3|||
30832872|NCT02418156|58857294|FG000|Overall Study|Lost to Follow-up|12|||
30832873|NCT02418156|58857294|FG000|Overall Study|Death|2|||
30832874|NCT02418156|58857294|FG000|Overall Study|Physician Decision|1|||
30832875|NCT02418156|58857294|FG000|Overall Study|Withdrawal by Subject|1|||
30832876|NCT02418156|58857294|FG000|Overall Study|Subject refused to return|1|||
30832877|NCT02252172|58857321|FG000|Overall Study|Lost to Follow-up|3|||
30832878|NCT02252172|58857322|FG001|Overall Study|Lost to Follow-up|1|||
30832879|NCT02252172|58857321|FG000|Overall Study|Ongoing|276|||
30832880|NCT02252172|58857322|FG001|Overall Study|Ongoing|298|||
30832881|NCT02076009|58857330|FG000|Overall Study|Death|44|||
30832882|NCT02076009|58857331|FG001|Overall Study|Death|30|||
30832883|NCT02076009|58857330|FG000|Overall Study|Withdrawal by Subject|9|||
30832884|NCT02076009|58857331|FG001|Overall Study|Withdrawal by Subject|3|||
30832885|NCT02076009|58857330|FG000|Overall Study|Lost to Follow-up|1|||
30832886|NCT02076009|58857331|FG001|Overall Study|Lost to Follow-up|1|||
30832887|NCT02076009|58857330|FG000|Overall Study|Progressive disease|1|||
30832888|NCT02076009|58857331|FG001|Overall Study|Progressive disease|0|||
30832889|NCT02076009|58857330|FG000|Overall Study|Ongoing|226|||
30832890|NCT02076009|58857331|FG001|Overall Study|Ongoing|249|||
30832891|NCT02076009|58857330|FG000|Overall Study|Subjects randomized but not treated|2|||
30832892|NCT02076009|58857331|FG001|Overall Study|Subjects randomized but not treated|3|||
30832893|NCT02029443|58857355|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
30832894|NCT02029443|58857356|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
30832895|NCT02029443|58857357|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
30832896|NCT02029443|58857358|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
30832897|NCT02029443|58857359|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
30832898|NCT02029443|58857355|FG000|Overall Study|Death|13|||
30832899|NCT02029443|58857356|FG001|Overall Study|Death|2|||
30832900|NCT02029443|58857357|FG002|Overall Study|Death|2|||
30923880|NCT02266134|58959204|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
30923881|NCT02266134|58959205|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
30923882|NCT02266134|58959206|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
30832901|NCT02029443|58857358|FG003|Overall Study|Death|11|||
30832902|NCT02029443|58857359|FG004|Overall Study|Death|2|||
30832903|NCT02029443|58857355|FG000|Overall Study|Lost to Follow-up|1|||
30832904|NCT02029443|58857356|FG001|Overall Study|Lost to Follow-up|0|||
30832905|NCT02029443|58857357|FG002|Overall Study|Lost to Follow-up|1|||
30832906|NCT02029443|58857358|FG003|Overall Study|Lost to Follow-up|1|||
30832907|NCT02029443|58857359|FG004|Overall Study|Lost to Follow-up|0|||
30832908|NCT02029443|58857355|FG000|Overall Study|Started other anti-cancer therapy|17|||
30832909|NCT02029443|58857356|FG001|Overall Study|Started other anti-cancer therapy|4|||
30832910|NCT02029443|58857357|FG002|Overall Study|Started other anti-cancer therapy|7|||
30832911|NCT02029443|58857358|FG003|Overall Study|Started other anti-cancer therapy|9|||
30832912|NCT02029443|58857359|FG004|Overall Study|Started other anti-cancer therapy|3|||
30832913|NCT02029443|58857355|FG000|Overall Study|Withdrawal by Subject|3|||
30832914|NCT02029443|58857356|FG001|Overall Study|Withdrawal by Subject|1|||
30832915|NCT02029443|58857357|FG002|Overall Study|Withdrawal by Subject|1|||
30832916|NCT02029443|58857358|FG003|Overall Study|Withdrawal by Subject|1|||
30832917|NCT02029443|58857359|FG004|Overall Study|Withdrawal by Subject|0|||
30832918|NCT02029443|58857355|FG000|Overall Study|Other|6|||
30832919|NCT02029443|58857356|FG001|Overall Study|Other|6|||
30832920|NCT02029443|58857357|FG002|Overall Study|Other|4|||
30832921|NCT02029443|58857358|FG003|Overall Study|Other|2|||
30832922|NCT02029443|58857359|FG004|Overall Study|Other|0|||
30832923|NCT01850524|58857395|FG000|Overall Study|Lost to Follow-up|5|||
30832924|NCT01850524|58857396|FG001|Overall Study|Lost to Follow-up|10|||
30832925|NCT01850524|58857395|FG000|Overall Study|Withdrawal by Subject|24|||
30832926|NCT01850524|58857396|FG001|Overall Study|Withdrawal by Subject|22|||
30832927|NCT01850524|58857395|FG000|Overall Study|Reason not Specified|142|||
30832928|NCT01850524|58857396|FG001|Overall Study|Reason not Specified|141|||
30832929|NCT01609842|58857413|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
30832930|NCT01609842|58857414|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
30832931|NCT01569594|58857424|FG000|Overall Study|Physician Decision|4|||
30832932|NCT01569594|58857424|FG000|Overall Study|Death|13|||
30832933|NCT01569594|58857424|FG000|Overall Study|Lost to Follow-up|22|||
30832934|NCT01569594|58857424|FG000|Overall Study|Adverse Event|2|||
30832935|NCT01569594|58857424|FG000|Overall Study|Withdrawal by Subject|13|||
30832936|NCT01569594|58857424|FG000|Overall Study|Other|4|||
30832937|NCT01569594|58857424|FG000|Overall Study|No ECM used|9|||
30832938|NCT01207492|58857428|FG000|Overall Study|Still on study|1|||
30832939|NCT01207492|58857428|FG000|Overall Study|Withdrawal by Subject|9|||
30832940|NCT01207492|58857428|FG000|Overall Study|Physician Decision|1|||
30832941|NCT01207492|58857428|FG000|Overall Study|Progressive disease|3|||
30832942|NCT01207492|58857428|FG000|Overall Study|Toxicity|1|||
30923883|NCT02266134|58959203|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
30923884|NCT02266134|58959204|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
30923885|NCT02266134|58959205|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
30923886|NCT02266134|58959206|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
30923887|NCT02266134|58959203|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
30923888|NCT02266134|58959204|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
30755883|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
30755884|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
30755885|NCT00111800|58765815|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
30755886|NCT00111800|58765816|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
30755887|NCT00111800|58765817|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
30755888|NCT00111800|58765818|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
30755889|NCT00111800|58765819|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
30755890|NCT00111800|58765820|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
30755891|NCT00111800|58765815|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
30755892|NCT00111800|58765816|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
30755893|NCT00111800|58765817|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
30755894|NCT00111800|58765818|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
30755895|NCT00111800|58765819|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
30755896|NCT00111800|58765820|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
30755897|NCT00111800|58765815|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
30755898|NCT00111800|58765816|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
30755899|NCT00111800|58765817|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
30755900|NCT00111800|58765818|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
30755901|NCT00111800|58765819|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
30755902|NCT00111800|58765820|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
30755903|NCT00111800|58765815|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
30755904|NCT00111800|58765816|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
30755905|NCT00111800|58765817|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
30755906|NCT00111800|58765818|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
30832943|NCT00593840|58857432|FG000|Overall Study|Withdrawal by Subject|1|||
30832944|NCT01329900|58857465|FG000|Overall Study|Elevated creatinine/renal function|1|||
30832945|NCT02825043|58857469|FG000|Overall Study|Lost to Follow-up|4|||
30832946|NCT02750592|58857484|FG000|Overall Study|Adverse Event|3|||
30832947|NCT02750592|58857484|FG000|Overall Study|Lack of Efficacy|2|||
30832948|NCT02624986|58857496|FG000|Overall Study|Death|0|||
30832949|NCT02624986|58857497|FG001|Overall Study|Death|1|||
30923889|NCT02266134|58959205|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
30923890|NCT02266134|58959206|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
30923891|NCT01847274|58959234|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
30923892|NCT01847274|58959235|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
30923893|NCT01847274|58959236|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
30923894|NCT01847274|58959237|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
30923895|NCT01847274|58959238|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
30923896|NCT01847274|58959239|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
30923897|NCT01847274|58959240|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
30923898|NCT01847274|58959241|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
30923899|NCT01847274|58959242|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
30923900|NCT01847274|58959243|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
30923901|NCT01847274|58959244|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
30923902|NCT01847274|58959234|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
30923903|NCT01847274|58959235|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
30832950|NCT02624986|58857498|FG002|Overall Study|Death|2|||
30832951|NCT02624986|58857499|FG003|Overall Study|Death|2|||
30832952|NCT02624986|58857500|FG004|Overall Study|Death|2|||
30832953|NCT02624986|58857501|FG005|Overall Study|Death|0|||
30832954|NCT02624986|58857502|FG006|Overall Study|Death|0|||
30832955|NCT02624986|58857503|FG007|Overall Study|Death|1|||
30832956|NCT02624986|58857496|FG000|Overall Study|Study Terminated by Sponsor|1|||
30832957|NCT02624986|58857497|FG001|Overall Study|Study Terminated by Sponsor|1|||
30832958|NCT02624986|58857498|FG002|Overall Study|Study Terminated by Sponsor|0|||
30832959|NCT02624986|58857499|FG003|Overall Study|Study Terminated by Sponsor|1|||
30832960|NCT02624986|58857500|FG004|Overall Study|Study Terminated by Sponsor|2|||
30832961|NCT02624986|58857501|FG005|Overall Study|Study Terminated by Sponsor|2|||
30832962|NCT02624986|58857502|FG006|Overall Study|Study Terminated by Sponsor|4|||
30832963|NCT02624986|58857503|FG007|Overall Study|Study Terminated by Sponsor|3|||
30832964|NCT02624986|58857496|FG000|Overall Study|Progressive Disease|0|||
30832965|NCT02624986|58857497|FG001|Overall Study|Progressive Disease|1|||
30832966|NCT02624986|58857498|FG002|Overall Study|Progressive Disease|0|||
30832967|NCT02624986|58857499|FG003|Overall Study|Progressive Disease|0|||
30832968|NCT02624986|58857500|FG004|Overall Study|Progressive Disease|0|||
30832969|NCT02624986|58857501|FG005|Overall Study|Progressive Disease|0|||
30832970|NCT02624986|58857502|FG006|Overall Study|Progressive Disease|0|||
30832971|NCT02624986|58857503|FG007|Overall Study|Progressive Disease|0|||
30832972|NCT02624986|58857496|FG000|Overall Study|Protocol Violation|1|||
30832973|NCT02624986|58857497|FG001|Overall Study|Protocol Violation|0|||
30832974|NCT02624986|58857498|FG002|Overall Study|Protocol Violation|0|||
30832975|NCT02624986|58857499|FG003|Overall Study|Protocol Violation|0|||
30832976|NCT02624986|58857500|FG004|Overall Study|Protocol Violation|0|||
30923904|NCT01847274|58959236|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
30923905|NCT01847274|58959237|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
30923906|NCT01847274|58959238|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
30923907|NCT01847274|58959239|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
30923908|NCT01847274|58959240|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
30923909|NCT01847274|58959241|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
30923910|NCT01847274|58959242|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
30923911|NCT01847274|58959243|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
30923912|NCT01847274|58959244|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
30923913|NCT01847274|58959234|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
30923914|NCT01847274|58959235|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
30923915|NCT01847274|58959236|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
30923916|NCT01847274|58959237|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
30923917|NCT01847274|58959238|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
30923918|NCT01847274|58959239|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
30923919|NCT01847274|58959240|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
30923920|NCT01847274|58959241|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
30923921|NCT01847274|58959242|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
30923922|NCT01847274|58959243|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
30832977|NCT02624986|58857501|FG005|Overall Study|Protocol Violation|0|||
30832978|NCT02624986|58857502|FG006|Overall Study|Protocol Violation|0|||
30832979|NCT02624986|58857503|FG007|Overall Study|Protocol Violation|0|||
30832980|NCT02624986|58857496|FG000|Overall Study|Withdrawal by Subject|0|||
30832981|NCT02624986|58857497|FG001|Overall Study|Withdrawal by Subject|0|||
30623837|NCT01119846|58635705|FG000|Overall Study|Physician Decision|1|||
30832982|NCT02624986|58857498|FG002|Overall Study|Withdrawal by Subject|0|||
30832983|NCT02624986|58857499|FG003|Overall Study|Withdrawal by Subject|0|||
30923923|NCT01847274|58959244|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
30923924|NCT01847274|58959234|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
30923925|NCT01847274|58959235|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
30923926|NCT01847274|58959236|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
30923927|NCT01847274|58959237|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
30923928|NCT01847274|58959238|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
30923929|NCT01847274|58959239|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
30923930|NCT01847274|58959240|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
30923931|NCT01847274|58959241|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
30923932|NCT01847274|58959242|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
30923933|NCT01847274|58959243|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
30923934|NCT01847274|58959244|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
30923935|NCT01847274|58959234|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
30923936|NCT01847274|58959235|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
30923937|NCT01847274|58959236|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
30923938|NCT01847274|58959237|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
30923939|NCT01847274|58959238|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
30923940|NCT01847274|58959239|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
30923941|NCT01847274|58959240|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
30832984|NCT02624986|58857500|FG004|Overall Study|Withdrawal by Subject|0|||
30832985|NCT02624986|58857501|FG005|Overall Study|Withdrawal by Subject|0|||
30832986|NCT02624986|58857502|FG006|Overall Study|Withdrawal by Subject|0|||
30832987|NCT02624986|58857503|FG007|Overall Study|Withdrawal by Subject|1|||
30832988|NCT02587598|58857536|FG000|Overall Study|Death|4|||
30832989|NCT02587598|58857537|FG001|Overall Study|Death|8|||
30832990|NCT02587598|58857538|FG002|Overall Study|Death|4|||
30832991|NCT02587598|58857539|FG003|Overall Study|Death|16|||
30832992|NCT02587598|58857540|FG004|Overall Study|Death|9|||
30832993|NCT02587598|58857541|FG005|Overall Study|Death|4|||
30832994|NCT02587598|58857542|FG006|Overall Study|Death|6|||
30923942|NCT01847274|58959241|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
30923943|NCT01847274|58959242|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
30923944|NCT01847274|58959243|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
30923945|NCT01847274|58959244|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
30923946|NCT01847274|58959234|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
30923947|NCT01847274|58959235|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
30923948|NCT01847274|58959236|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
30755907|NCT00111800|58765819|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
30755908|NCT00111800|58765820|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
30755909|NCT00111800|58765815|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
30755910|NCT00111800|58765816|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
30755911|NCT00111800|58765817|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
30755912|NCT00111800|58765818|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
30755913|NCT00111800|58765819|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
30755914|NCT00111800|58765820|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
30755915|NCT00111800|58765815|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
30755916|NCT00111800|58765816|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
30832995|NCT02587598|58857543|FG007|Overall Study|Death|7|||
30832996|NCT02587598|58857544|FG008|Overall Study|Death|9|||
30832997|NCT02587598|58857545|FG009|Overall Study|Death|1|||
30832998|NCT02587598|58857546|FG010|Overall Study|Death|3|||
30832999|NCT02587598|58857536|FG000|Overall Study|Study Terminated by the Sponsor|0|||
30833000|NCT02587598|58857537|FG001|Overall Study|Study Terminated by the Sponsor|1|||
30833001|NCT02587598|58857538|FG002|Overall Study|Study Terminated by the Sponsor|0|||
30833002|NCT02587598|58857539|FG003|Overall Study|Study Terminated by the Sponsor|3|||
30833003|NCT02587598|58857540|FG004|Overall Study|Study Terminated by the Sponsor|0|||
30833004|NCT02587598|58857541|FG005|Overall Study|Study Terminated by the Sponsor|1|||
30833005|NCT02587598|58857542|FG006|Overall Study|Study Terminated by the Sponsor|0|||
30833006|NCT02587598|58857543|FG007|Overall Study|Study Terminated by the Sponsor|0|||
30833007|NCT02587598|58857544|FG008|Overall Study|Study Terminated by the Sponsor|0|||
30833008|NCT02587598|58857545|FG009|Overall Study|Study Terminated by the Sponsor|1|||
30755917|NCT00111800|58765817|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
30833009|NCT02587598|58857546|FG010|Overall Study|Study Terminated by the Sponsor|6|||
30833010|NCT02587598|58857536|FG000|Overall Study|Reason for study withdrawal not specified|0|||
30833011|NCT02587598|58857537|FG001|Overall Study|Reason for study withdrawal not specified|1|||
30833012|NCT02587598|58857538|FG002|Overall Study|Reason for study withdrawal not specified|0|||
30833013|NCT02587598|58857539|FG003|Overall Study|Reason for study withdrawal not specified|0|||
30923949|NCT01847274|58959237|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
30923950|NCT01847274|58959238|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
30923951|NCT01847274|58959239|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
30923952|NCT01847274|58959240|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
30923953|NCT01847274|58959241|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
30923954|NCT01847274|58959242|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
30923955|NCT01847274|58959243|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
30923956|NCT01847274|58959244|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
30923957|NCT01847274|58959234|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
30923958|NCT01847274|58959235|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
30923959|NCT01847274|58959236|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
30923960|NCT01847274|58959237|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
30923961|NCT01847274|58959238|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
30833014|NCT02587598|58857540|FG004|Overall Study|Reason for study withdrawal not specified|0|||
30833015|NCT02587598|58857541|FG005|Overall Study|Reason for study withdrawal not specified|0|||
30833016|NCT02587598|58857542|FG006|Overall Study|Reason for study withdrawal not specified|0|||
30833017|NCT02587598|58857543|FG007|Overall Study|Reason for study withdrawal not specified|0|||
30833018|NCT02587598|58857544|FG008|Overall Study|Reason for study withdrawal not specified|0|||
30833019|NCT02587598|58857545|FG009|Overall Study|Reason for study withdrawal not specified|0|||
30833020|NCT02587598|58857546|FG010|Overall Study|Reason for study withdrawal not specified|0|||
30833021|NCT02587598|58857536|FG000|Overall Study|Withdrawal by Subject|0|||
30923962|NCT01847274|58959239|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
30923963|NCT01847274|58959240|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
30923964|NCT01847274|58959241|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
30923965|NCT01847274|58959242|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
30923966|NCT01847274|58959243|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
30923967|NCT01847274|58959244|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
30923968|NCT01847274|58959234|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
30923969|NCT01847274|58959235|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
30923970|NCT01847274|58959236|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
30923971|NCT01847274|58959237|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
30923972|NCT01847274|58959238|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
30923973|NCT01847274|58959239|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
30923974|NCT01847274|58959240|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
30923975|NCT01847274|58959241|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
30923976|NCT01847274|58959242|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
30923977|NCT01847274|58959243|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
30923978|NCT01847274|58959244|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
30923979|NCT01847274|58959234|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
30923980|NCT01847274|58959235|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
30923981|NCT01847274|58959236|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
30923982|NCT01847274|58959237|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
30923983|NCT01847274|58959238|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
30923984|NCT01847274|58959239|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
30923985|NCT01847274|58959240|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
30923986|NCT01847274|58959241|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
30923987|NCT01847274|58959242|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
30923988|NCT01847274|58959243|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
30923989|NCT01847274|58959244|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
30923990|NCT01847274|58959234|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
30923991|NCT01847274|58959235|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
30923992|NCT01847274|58959236|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
30833022|NCT02587598|58857537|FG001|Overall Study|Withdrawal by Subject|1|||
30833023|NCT02587598|58857538|FG002|Overall Study|Withdrawal by Subject|0|||
30833024|NCT02587598|58857539|FG003|Overall Study|Withdrawal by Subject|2|||
30833025|NCT02587598|58857540|FG004|Overall Study|Withdrawal by Subject|3|||
30833026|NCT02587598|58857541|FG005|Overall Study|Withdrawal by Subject|1|||
30833027|NCT02587598|58857542|FG006|Overall Study|Withdrawal by Subject|0|||
30833028|NCT02587598|58857543|FG007|Overall Study|Withdrawal by Subject|0|||
30833029|NCT02587598|58857544|FG008|Overall Study|Withdrawal by Subject|0|||
30833030|NCT02587598|58857545|FG009|Overall Study|Withdrawal by Subject|1|||
30833031|NCT02587598|58857546|FG010|Overall Study|Withdrawal by Subject|2|||
30833032|NCT02587598|58857536|FG000|Overall Study|Physician Decision|0|||
30833033|NCT02587598|58857537|FG001|Overall Study|Physician Decision|0|||
30833034|NCT02587598|58857538|FG002|Overall Study|Physician Decision|0|||
30923993|NCT01847274|58959237|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
30923994|NCT01847274|58959238|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
30923995|NCT01847274|58959239|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
30923996|NCT01847274|58959240|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
30923997|NCT01847274|58959241|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
30923998|NCT01847274|58959242|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
30923999|NCT01847274|58959243|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
30924000|NCT01847274|58959244|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
30924001|NCT01847274|58959234|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
30924002|NCT01847274|58959235|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
30924003|NCT01847274|58959236|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
30924004|NCT01847274|58959237|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
30924005|NCT01847274|58959238|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
30924006|NCT01847274|58959239|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
30924007|NCT01847274|58959240|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
30924008|NCT01847274|58959241|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
30924009|NCT01847274|58959242|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
30924010|NCT01847274|58959243|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
30924011|NCT01847274|58959244|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
30924012|NCT01847274|58959234|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
30924013|NCT01847274|58959235|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
30924014|NCT01847274|58959236|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
30924015|NCT01847274|58959237|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
30924016|NCT01847274|58959238|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
30924017|NCT01847274|58959239|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
30924018|NCT01847274|58959240|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
30924019|NCT01847274|58959241|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
30924020|NCT01847274|58959242|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
30924021|NCT01847274|58959243|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
30924022|NCT01847274|58959244|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
30924023|NCT01847274|58959234|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
30924024|NCT01847274|58959235|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
30924025|NCT01847274|58959236|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
30924026|NCT01847274|58959237|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
30924027|NCT01847274|58959238|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
30924028|NCT01847274|58959239|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
30924029|NCT01847274|58959240|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
30924030|NCT01847274|58959241|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
30924031|NCT01847274|58959242|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
30924032|NCT01847274|58959243|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
30924033|NCT01847274|58959244|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
30623838|NCT01119846|58635706|FG001|Overall Study|Physician Decision|0|||
30623839|NCT01119846|58635707|FG002|Overall Study|Physician Decision|0|||
30623840|NCT01119846|58635705|FG000|Overall Study|Protocol Violation|0|||
30623841|NCT01119846|58635706|FG001|Overall Study|Protocol Violation|0|||
30623842|NCT01119846|58635707|FG002|Overall Study|Protocol Violation|1|||
30623843|NCT01119846|58635705|FG000|Overall Study|Withdrawal by Subject|0|||
30924034|NCT01847274|58959234|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
30924035|NCT01847274|58959235|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
30924036|NCT01847274|58959236|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
30924037|NCT01847274|58959237|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
30924038|NCT01847274|58959238|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
30924039|NCT01847274|58959239|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
30924040|NCT01847274|58959240|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
30924041|NCT01847274|58959241|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
30924042|NCT01847274|58959242|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
30924043|NCT01847274|58959243|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
30924044|NCT01847274|58959244|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
30924045|NCT01847274|58959234|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
30924046|NCT01847274|58959235|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
30924047|NCT01847274|58959236|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
30623844|NCT01119846|58635706|FG001|Overall Study|Withdrawal by Subject|0|||
30623845|NCT01119846|58635707|FG002|Overall Study|Withdrawal by Subject|4|||
30623846|NCT01167179|58635744|FG000|Overall Study|disease recurrence|4|||
30924048|NCT01847274|58959237|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
30924049|NCT01847274|58959238|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
30924050|NCT01847274|58959239|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
30924051|NCT01847274|58959240|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
30924052|NCT01847274|58959241|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
30924053|NCT01847274|58959242|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
30924054|NCT01847274|58959243|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
30924055|NCT01847274|58959244|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
30924056|NCT01847274|58959234|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
30924057|NCT01847274|58959235|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
30924058|NCT01847274|58959236|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
30924059|NCT01847274|58959237|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
30924060|NCT01847274|58959238|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
30924061|NCT01847274|58959239|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
30924062|NCT01847274|58959240|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
30924063|NCT01847274|58959241|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
30924064|NCT01847274|58959242|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
30924065|NCT01847274|58959243|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
30924066|NCT01847274|58959244|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
30924067|NCT01566695|58959283|FG000|Overall Study|Lack of Efficacy|18|||
30924068|NCT01566695|58959284|FG001|Overall Study|Lack of Efficacy|45|||
30924069|NCT01566695|58959283|FG000|Overall Study|Adverse Event|28|||
30924070|NCT01566695|58959284|FG001|Overall Study|Adverse Event|27|||
30924071|NCT01566695|58959283|FG000|Overall Study|Death|20|||
30924072|NCT01566695|58959284|FG001|Overall Study|Death|8|||
30924073|NCT01566695|58959283|FG000|Overall Study|Withdrawal by Subject|14|||
30924074|NCT01566695|58959284|FG001|Overall Study|Withdrawal by Subject|7|||
30924075|NCT01566695|58959283|FG000|Overall Study|Progressive Disease|11|||
30924076|NCT01566695|58959284|FG001|Overall Study|Progressive Disease|6|||
30924077|NCT01566695|58959283|FG000|Overall Study|Miscellaneous|4|||
30924078|NCT01566695|58959284|FG001|Overall Study|Miscellaneous|6|||
30924079|NCT01560819|58959292|FG000|Overall Study|Physician Decision|1|||
30924080|NCT01560819|58959293|FG001|Overall Study|Physician Decision|0|||
30924081|NCT01425528|58959299|FG000|Overall Study|Withdrawal by Subject|1|||
30924082|NCT01425528|58959300|FG001|Overall Study|Withdrawal by Subject|1|||
30924083|NCT00442104|58959306|FG000|Overall Study|Adverse Event|5|||
30924084|NCT00442104|58959306|FG000|Overall Study|Death|2|||
30924085|NCT00442104|58959306|FG000|Overall Study|Lost to Follow-up|3|||
30924086|NCT00442104|58959306|FG000|Overall Study|Withdrawal by Subject|5|||
30924087|NCT00442104|58959306|FG000|Overall Study|Insufficient Clinical Response|10|||
30924088|NCT00442104|58959306|FG000|Overall Study|Other|21|||
30924089|NCT00442104|58959306|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
30924090|NCT00441896|58959320|FG000|Overall Study|Withdrawal by Subject|0|||
30924091|NCT00441896|58959321|FG001|Overall Study|Withdrawal by Subject|0|||
30924092|NCT00441896|58959322|FG002|Overall Study|Withdrawal by Subject|0|||
30924093|NCT00441896|58959323|FG003|Overall Study|Withdrawal by Subject|1|||
30924094|NCT00441896|58959324|FG004|Overall Study|Withdrawal by Subject|0|||
30924095|NCT00441896|58959325|FG005|Overall Study|Withdrawal by Subject|0|||
30924096|NCT00441896|58959326|FG006|Overall Study|Withdrawal by Subject|0|||
30924097|NCT00441896|58959327|FG007|Overall Study|Withdrawal by Subject|0|||
30924098|NCT00441896|58959328|FG008|Overall Study|Withdrawal by Subject|0|||
30924099|NCT00441896|58959329|FG009|Overall Study|Withdrawal by Subject|0|||
30924100|NCT00441896|58959320|FG000|Overall Study|Other|0|||
30924101|NCT00441896|58959321|FG001|Overall Study|Other|0|||
30833035|NCT02587598|58857539|FG003|Overall Study|Physician Decision|0|||
30833036|NCT02587598|58857540|FG004|Overall Study|Physician Decision|0|||
30833037|NCT02587598|58857541|FG005|Overall Study|Physician Decision|0|||
30833038|NCT02587598|58857542|FG006|Overall Study|Physician Decision|0|||
30833039|NCT02587598|58857543|FG007|Overall Study|Physician Decision|0|||
30833040|NCT02587598|58857544|FG008|Overall Study|Physician Decision|0|||
30833041|NCT02587598|58857545|FG009|Overall Study|Physician Decision|0|||
30924102|NCT00441896|58959322|FG002|Overall Study|Other|0|||
30924103|NCT00441896|58959323|FG003|Overall Study|Other|0|||
30924104|NCT00441896|58959324|FG004|Overall Study|Other|1|||
30924105|NCT00441896|58959325|FG005|Overall Study|Other|0|||
30924106|NCT00441896|58959326|FG006|Overall Study|Other|0|||
30924107|NCT00441896|58959327|FG007|Overall Study|Other|0|||
30833042|NCT02587598|58857546|FG010|Overall Study|Physician Decision|3|||
30833043|NCT02485574|58857582|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
30833044|NCT02624284|58857594|FG000|Overall Study|Withdrawal by Subject|3|||
30924108|NCT00441896|58959328|FG008|Overall Study|Other|0|||
30924109|NCT00441896|58959329|FG009|Overall Study|Other|0|||
30924110|NCT02034877|58959357|FG000|Overall Study|Lost to Follow-up|0|||
30924111|NCT02034877|58959358|FG001|Overall Study|Lost to Follow-up|3|||
30924112|NCT02034877|58959357|FG000|Overall Study|No Longer Willing to Participate|0|||
30924113|NCT02034877|58959358|FG001|Overall Study|No Longer Willing to Participate|3|||
30924114|NCT02034799|58959366|FG000|Overall Study|Withdrawal by Subject|0|||
30924115|NCT02034799|58959367|FG001|Overall Study|Withdrawal by Subject|2|||
30924116|NCT02034799|58959366|FG000|Overall Study|Lost to Follow-up|0|||
30924117|NCT02034799|58959367|FG001|Overall Study|Lost to Follow-up|1|||
30924118|NCT02034799|58959366|FG000|Overall Study|Death|2|||
30924119|NCT02034799|58959367|FG001|Overall Study|Death|1|||
30924120|NCT02057575|58959377|FG000|Overall Study|Adverse Event|0|||
30924121|NCT02057575|58959378|FG001|Overall Study|Adverse Event|2|||
30924122|NCT02057575|58959379|FG002|Overall Study|Adverse Event|0|||
30924123|NCT02057575|58959380|FG003|Overall Study|Adverse Event|1|||
30924124|NCT02057575|58959377|FG000|Overall Study|Withdrawal by Subject|1|||
30924125|NCT02057575|58959378|FG001|Overall Study|Withdrawal by Subject|0|||
30924126|NCT02057575|58959379|FG002|Overall Study|Withdrawal by Subject|0|||
30924127|NCT02057575|58959380|FG003|Overall Study|Withdrawal by Subject|0|||
30924128|NCT02057575|58959377|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
30924129|NCT02057575|58959378|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
30924130|NCT02057575|58959379|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
30924131|NCT02057575|58959380|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
30924132|NCT02057575|58959377|FG000|Overall Study|Protocol Violation|0|||
30924133|NCT02057575|58959378|FG001|Overall Study|Protocol Violation|1|||
30924134|NCT02057575|58959379|FG002|Overall Study|Protocol Violation|0|||
30924135|NCT02057575|58959380|FG003|Overall Study|Protocol Violation|0|||
30755918|NCT00111800|58765818|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
30755919|NCT00111800|58765819|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
30755920|NCT00111800|58765820|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
30755921|NCT00111800|58765815|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
30833045|NCT02624284|58857595|FG001|Overall Study|Withdrawal by Subject|6|||
30833046|NCT02624284|58857596|FG002|Overall Study|Withdrawal by Subject|3|||
30833047|NCT02624284|58857594|FG000|Overall Study|Protocol Violation|9|||
30833048|NCT02624284|58857595|FG001|Overall Study|Protocol Violation|10|||
30833049|NCT02624284|58857596|FG002|Overall Study|Protocol Violation|7|||
30833050|NCT02624284|58857594|FG000|Overall Study|Revealed exclusionary condition|2|||
30833051|NCT02624284|58857595|FG001|Overall Study|Revealed exclusionary condition|2|||
30833052|NCT02624284|58857596|FG002|Overall Study|Revealed exclusionary condition|0|||
30833053|NCT02624284|58857594|FG000|Overall Study|Adverse Event|0|||
30833054|NCT02624284|58857595|FG001|Overall Study|Adverse Event|0|||
30833055|NCT02624284|58857596|FG002|Overall Study|Adverse Event|1|||
30833056|NCT02738450|58857608|FG000|Overall Study|Withdrawal by Subject|0|||
30833057|NCT02738450|58857609|FG001|Overall Study|Withdrawal by Subject|2|||
30833058|NCT02738450|58857610|FG002|Overall Study|Withdrawal by Subject|0|||
30833059|NCT02624050|58857621|FG000|Overall Study|Physician Decision|4|||
30833060|NCT02624050|58857622|FG001|Overall Study|Physician Decision|0|||
30833061|NCT02624050|58857621|FG000|Overall Study|Protocol Violation|2|||
30833062|NCT02624050|58857622|FG001|Overall Study|Protocol Violation|0|||
30924136|NCT02077465|58959392|FG000|Overall Study|Withdrew Consent|0|||
30924137|NCT02077465|58959393|FG001|Overall Study|Withdrew Consent|1|||
30755922|NCT00111800|58765816|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
30755923|NCT00111800|58765817|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
30755924|NCT00111800|58765818|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
30755925|NCT00111800|58765819|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
30755926|NCT00111800|58765820|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
30755927|NCT00111800|58765815|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
30755928|NCT00111800|58765816|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
30755929|NCT00111800|58765817|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
30755930|NCT00111800|58765818|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
30755931|NCT00111800|58765819|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
30833063|NCT01338987|58857638|FG000|Overall Study|enrolled on new protocol|0|||
30833064|NCT01338987|58857639|FG001|Overall Study|enrolled on new protocol|0|||
30833065|NCT01338987|58857640|FG002|Overall Study|enrolled on new protocol|1|||
30833066|NCT01338987|58857641|FG003|Overall Study|enrolled on new protocol|0|||
30833067|NCT01338987|58857642|FG004|Overall Study|enrolled on new protocol|0|||
30924138|NCT02077465|58959392|FG000|Overall Study|Lost to Follow-up|1|||
30924139|NCT02077465|58959393|FG001|Overall Study|Lost to Follow-up|0|||
30924140|NCT02034565|58959399|FG000|Overall Study|Adverse Event|1|||
30924141|NCT02034565|58959400|FG001|Overall Study|Adverse Event|0|||
30924142|NCT02075515|58959411|FG000|Overall Study|Serious Adverse Event|1|||
30924143|NCT02075515|58959412|FG001|Overall Study|Serious Adverse Event|1|||
30924144|NCT02075515|58959413|FG002|Overall Study|Serious Adverse Event|1|||
30755932|NCT00111800|58765820|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
30755933|NCT00111800|58765815|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
30755934|NCT00111800|58765816|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
30755935|NCT00111800|58765817|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
30833068|NCT01338987|58857638|FG000|Overall Study|Disease progression on study|2|||
30833069|NCT01338987|58857639|FG001|Overall Study|Disease progression on study|1|||
30833070|NCT01338987|58857640|FG002|Overall Study|Disease progression on study|1|||
30833071|NCT01338987|58857641|FG003|Overall Study|Disease progression on study|0|||
30924145|NCT02075515|58959411|FG000|Overall Study|Non-Serious Adverse Event|0|||
30924146|NCT02075515|58959412|FG001|Overall Study|Non-Serious Adverse Event|1|||
30924147|NCT02075515|58959413|FG002|Overall Study|Non-Serious Adverse Event|0|||
30924148|NCT02075515|58959411|FG000|Overall Study|Withdrawal by Subject|2|||
30924149|NCT02075515|58959412|FG001|Overall Study|Withdrawal by Subject|0|||
30924150|NCT02075515|58959413|FG002|Overall Study|Withdrawal by Subject|1|||
30924151|NCT02075515|58959411|FG000|Overall Study|Lost to Follow-up|1|||
30924152|NCT02075515|58959412|FG001|Overall Study|Lost to Follow-up|3|||
30924153|NCT02075515|58959413|FG002|Overall Study|Lost to Follow-up|6|||
30924154|NCT02034409|58959424|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
30924155|NCT02034409|58959425|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
30924156|NCT02034409|58959424|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
30924157|NCT02034409|58959425|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
30924158|NCT02034409|58959424|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
30924159|NCT02034409|58959425|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
30924160|NCT02034409|58959424|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
30924161|NCT02034409|58959425|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
30924162|NCT02034409|58959424|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
30924163|NCT02034409|58959425|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
30924164|NCT02034409|58959424|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
30924165|NCT02034409|58959425|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
30924166|NCT02021318|58959433|FG000|Overall Study|Adverse Event|2|||
30924167|NCT02021318|58959434|FG001|Overall Study|Adverse Event|1|||
30924168|NCT02021318|58959433|FG000|Overall Study|Death|33|||
30924169|NCT02021318|58959434|FG001|Overall Study|Death|34|||
30924170|NCT02021318|58959433|FG000|Overall Study|Lost to Follow-up|3|||
30924171|NCT02021318|58959434|FG001|Overall Study|Lost to Follow-up|3|||
30924172|NCT02021318|58959433|FG000|Overall Study|Progressive Disease|0|||
30924173|NCT02021318|58959434|FG001|Overall Study|Progressive Disease|1|||
30924174|NCT02021318|58959433|FG000|Overall Study|Withdrawal by Subject|30|||
30924175|NCT02021318|58959434|FG001|Overall Study|Withdrawal by Subject|18|||
30924176|NCT02021318|58959433|FG000|Overall Study|Physician Decision|3|||
30924177|NCT02021318|58959434|FG001|Overall Study|Physician Decision|3|||
30924178|NCT02021318|58959433|FG000|Overall Study|Miscellaneous|2|||
30924179|NCT02021318|58959434|FG001|Overall Study|Miscellaneous|3|||
30924180|NCT02041286|58959441|FG000|Overall Study|Adverse Event|1|||
30755936|NCT00111800|58765818|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
30755937|NCT00111800|58765819|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
30833072|NCT01338987|58857642|FG004|Overall Study|Disease progression on study|0|||
30833073|NCT03706430|58857656|FG000|Overall Study|No A-Line placed|5|||
30833074|NCT03706430|58857656|FG000|Overall Study|Subject had gel nail polish|1|||
30833075|NCT03706430|58857656|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
30833076|NCT03706430|58857656|FG000|Overall Study|Cancelled Case|6|||
30833077|NCT03706430|58857656|FG000|Overall Study|Physician Decision|2|||
30833078|NCT02738138|58857678|FG000|Overall Study|Adverse Event|0|||
30833079|NCT02738138|58857679|FG001|Overall Study|Adverse Event|1|||
30833080|NCT02738138|58857678|FG000|Overall Study|Lost to Follow-up|2|||
30833081|NCT02738138|58857679|FG001|Overall Study|Lost to Follow-up|0|||
30833082|NCT02738138|58857678|FG000|Overall Study|Other - not further specified|1|||
30833083|NCT02738138|58857679|FG001|Overall Study|Other - not further specified|0|||
30924181|NCT02020616|58959454|FG000|Overall Study|Adverse Event|0|||
30924182|NCT02020616|58959455|FG001|Overall Study|Adverse Event|0|||
30924183|NCT02020616|58959456|FG002|Overall Study|Adverse Event|0|||
30924184|NCT02020616|58959457|FG003|Overall Study|Adverse Event|0|||
30755938|NCT00111800|58765820|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
30833084|NCT01355289|58857688|FG000|Core Study|Adverse Event, Non-Fatal|1|||
30833085|NCT01355289|58857689|FG001|Core Study|Adverse Event, Non-Fatal|0|||
30833086|NCT01355289|58857690|FG002|Core Study|Adverse Event, Non-Fatal|0|||
30833087|NCT01355289|58857691|FG003|Core Study|Adverse Event, Non-Fatal|0|||
30924185|NCT02020616|58959458|FG004|Overall Study|Adverse Event|0|||
30924186|NCT02020616|58959459|FG005|Overall Study|Adverse Event|1|||
30833088|NCT01355289|58857692|FG004|Core Study|Adverse Event, Non-Fatal|0|||
30924187|NCT02020616|58959460|FG006|Overall Study|Adverse Event|1|||
30924188|NCT02020616|58959454|FG000|Overall Study|Physician Decision|0|||
30833089|NCT01355289|58857688|FG000|Core Study|Inadequate Therapeutic Effect|0|||
30833090|NCT01355289|58857689|FG001|Core Study|Inadequate Therapeutic Effect|0|||
30833091|NCT01355289|58857690|FG002|Core Study|Inadequate Therapeutic Effect|0|||
30833092|NCT01355289|58857691|FG003|Core Study|Inadequate Therapeutic Effect|1|||
30833093|NCT01355289|58857692|FG004|Core Study|Inadequate Therapeutic Effect|0|||
30833094|NCT01355289|58857688|FG000|Core Study|Other|0|||
30833095|NCT01355289|58857689|FG001|Core Study|Other|0|||
30833096|NCT01355289|58857690|FG002|Core Study|Other|0|||
30833097|NCT01355289|58857691|FG003|Core Study|Other|1|||
30833098|NCT01355289|58857692|FG004|Core Study|Other|0|||
30833099|NCT01355289|58857688|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
30833100|NCT01355289|58857689|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
30833101|NCT01355289|58857690|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
30833102|NCT01355289|58857691|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
30833103|NCT01355289|58857692|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
30833104|NCT01355289|58857688|FG000|Open Label Extension|Lost to Follow-up|0|||
30833105|NCT01355289|58857689|FG001|Open Label Extension|Lost to Follow-up|0|||
30833106|NCT01355289|58857690|FG002|Open Label Extension|Lost to Follow-up|0|||
30833107|NCT01355289|58857691|FG003|Open Label Extension|Lost to Follow-up|0|||
30833108|NCT01355289|58857692|FG004|Open Label Extension|Lost to Follow-up|1|||
30833109|NCT01355289|58857688|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
30833110|NCT01355289|58857689|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
30833111|NCT01355289|58857690|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
30833112|NCT01355289|58857691|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
30833113|NCT01355289|58857692|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
30833114|NCT01355289|58857688|FG000|Open Label Extension|Other|0|||
30833115|NCT01355289|58857689|FG001|Open Label Extension|Other|0|||
30833116|NCT01355289|58857690|FG002|Open Label Extension|Other|0|||
30833117|NCT01355289|58857691|FG003|Open Label Extension|Other|0|||
30833118|NCT01355289|58857692|FG004|Open Label Extension|Other|3|||
30833119|NCT02737592|58857705|FG000|Overall Study|Withdrawal by Subject|1|||
30833120|NCT02737358|58857732|FG000|Overall Study|Withdrawal by Subject|7|||
30833121|NCT02737358|58857733|FG001|Overall Study|Withdrawal by Subject|12|||
30833122|NCT02737358|58857732|FG000|Overall Study|Lost to Follow-up|2|||
30833123|NCT02737358|58857733|FG001|Overall Study|Lost to Follow-up|3|||
30833124|NCT01354431|58857742|FG000|Pre-Treatment Period|Not reported|1|||
30833125|NCT01354431|58857743|FG001|Pre-Treatment Period|Not reported|0|||
30833126|NCT01354431|58857744|FG002|Pre-Treatment Period|Not reported|0|||
30833127|NCT01354431|58857742|FG000|Treatment Period|Disease Progression|50|||
30833128|NCT01354431|58857743|FG001|Treatment Period|Disease Progression|40|||
30833129|NCT01354431|58857744|FG002|Treatment Period|Disease Progression|44|||
30833130|NCT01354431|58857742|FG000|Treatment Period|Study Drug Toxicity|5|||
30924189|NCT02020616|58959455|FG001|Overall Study|Physician Decision|0|||
30924190|NCT02020616|58959456|FG002|Overall Study|Physician Decision|0|||
30924191|NCT02020616|58959457|FG003|Overall Study|Physician Decision|0|||
30924192|NCT02020616|58959458|FG004|Overall Study|Physician Decision|0|||
30924193|NCT02020616|58959459|FG005|Overall Study|Physician Decision|1|||
30924194|NCT02020616|58959460|FG006|Overall Study|Physician Decision|2|||
30924195|NCT02020616|58959454|FG000|Overall Study|Withdrawal by Subject|0|||
30924196|NCT02020616|58959455|FG001|Overall Study|Withdrawal by Subject|0|||
30924197|NCT02020616|58959456|FG002|Overall Study|Withdrawal by Subject|1|||
30924198|NCT02020616|58959457|FG003|Overall Study|Withdrawal by Subject|0|||
30924199|NCT02020616|58959458|FG004|Overall Study|Withdrawal by Subject|0|||
30924200|NCT02020616|58959459|FG005|Overall Study|Withdrawal by Subject|1|||
30924201|NCT02020616|58959460|FG006|Overall Study|Withdrawal by Subject|1|||
30924202|NCT02020616|58959454|FG000|Overall Study|Lost to Follow-up|0|||
30755939|NCT00094328|58765843|FG000|Overall Study|Lost to Follow-up|1|||
30755940|NCT00094172|58765849|FG000|Overall Study|Adverse Event|0|||
30755941|NCT00094172|58765850|FG001|Overall Study|Adverse Event|1|||
30755942|NCT00094172|58765849|FG000|Overall Study|Lost to Follow-up|2|||
30755943|NCT00094172|58765850|FG001|Overall Study|Lost to Follow-up|0|||
30755944|NCT00094172|58765849|FG000|Overall Study|Protocol Violation|0|||
30755945|NCT00094172|58765850|FG001|Overall Study|Protocol Violation|1|||
30755946|NCT00094172|58765849|FG000|Overall Study|Withdrawal by Subject|10|||
30755947|NCT00094172|58765850|FG001|Overall Study|Withdrawal by Subject|5|||
30755948|NCT00094172|58765849|FG000|Overall Study|Primary endpoint met.|1|||
30833131|NCT01354431|58857743|FG001|Treatment Period|Study Drug Toxicity|8|||
30924203|NCT02020616|58959455|FG001|Overall Study|Lost to Follow-up|1|||
30833132|NCT01354431|58857744|FG002|Treatment Period|Study Drug Toxicity|4|||
30833133|NCT01354431|58857742|FG000|Treatment Period|Death|0|||
30833134|NCT01354431|58857743|FG001|Treatment Period|Death|1|||
30924204|NCT02020616|58959456|FG002|Overall Study|Lost to Follow-up|0|||
30924205|NCT02020616|58959457|FG003|Overall Study|Lost to Follow-up|1|||
30755949|NCT00094172|58765850|FG001|Overall Study|Primary endpoint met.|0|||
30755950|NCT00094172|58765849|FG000|Overall Study|Started other MS therapy due to disease|1|||
30833135|NCT01354431|58857744|FG002|Treatment Period|Death|0|||
30833136|NCT01354431|58857742|FG000|Treatment Period|AE unrelated to study drug|1|||
30924206|NCT02020616|58959458|FG004|Overall Study|Lost to Follow-up|1|||
30924207|NCT02020616|58959459|FG005|Overall Study|Lost to Follow-up|1|||
30924208|NCT02020616|58959460|FG006|Overall Study|Lost to Follow-up|0|||
30924209|NCT02020616|58959454|FG000|Overall Study|Early Termination Criteria Met|0|||
30924210|NCT02020616|58959455|FG001|Overall Study|Early Termination Criteria Met|0|||
30924211|NCT02020616|58959456|FG002|Overall Study|Early Termination Criteria Met|1|||
30924212|NCT02020616|58959457|FG003|Overall Study|Early Termination Criteria Met|0|||
30924213|NCT02020616|58959458|FG004|Overall Study|Early Termination Criteria Met|0|||
30924214|NCT02020616|58959459|FG005|Overall Study|Early Termination Criteria Met|1|||
30924215|NCT02020616|58959460|FG006|Overall Study|Early Termination Criteria Met|0|||
30924216|NCT02020616|58959454|FG000|Overall Study|Randomized in Error|0|||
30924217|NCT02020616|58959455|FG001|Overall Study|Randomized in Error|0|||
30924218|NCT02020616|58959456|FG002|Overall Study|Randomized in Error|0|||
30924219|NCT02020616|58959457|FG003|Overall Study|Randomized in Error|1|||
30833137|NCT01354431|58857743|FG001|Treatment Period|AE unrelated to study drug|2|||
30833138|NCT01354431|58857744|FG002|Treatment Period|AE unrelated to study drug|5|||
30833139|NCT01354431|58857742|FG000|Treatment Period|Participant request to discontinue|2|||
30833140|NCT01354431|58857743|FG001|Treatment Period|Participant request to discontinue|2|||
30833141|NCT01354431|58857744|FG002|Treatment Period|Participant request to discontinue|1|||
30833142|NCT01354431|58857742|FG000|Treatment Period|Participant withdrew consent|0|||
30833143|NCT01354431|58857743|FG001|Treatment Period|Participant withdrew consent|1|||
30833144|NCT01354431|58857744|FG002|Treatment Period|Participant withdrew consent|0|||
30833145|NCT01354431|58857742|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
30833146|NCT01354431|58857743|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
30833147|NCT01354431|58857744|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
30833148|NCT02736578|58857754|FG000|Overall Study|Adverse Event|1|||
30833149|NCT02736578|58857755|FG001|Overall Study|Adverse Event|0|||
30833150|NCT02622724|58857767|FG000|Overall Study|Death|51|||
30833151|NCT02622724|58857768|FG001|Overall Study|Death|53|||
30833152|NCT02622724|58857767|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
30833153|NCT02622724|58857768|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
30833154|NCT02622724|58857767|FG000|Overall Study|Early termination of study|38|||
30833155|NCT02622724|58857768|FG001|Overall Study|Early termination of study|43|||
30833156|NCT01354353|58857786|FG000|Overall Study|Adverse Event|1|||
30833157|NCT01354353|58857787|FG001|Overall Study|Adverse Event|0|||
30833158|NCT01354353|58857788|FG002|Overall Study|Adverse Event|0|||
30833159|NCT01354353|58857789|FG003|Overall Study|Adverse Event|4|||
30833160|NCT01354353|58857790|FG004|Overall Study|Adverse Event|0|||
30833161|NCT01354353|58857791|FG005|Overall Study|Adverse Event|5|||
30833162|NCT01354353|58857786|FG000|Overall Study|Entry Criteria Not Met|0|||
30833163|NCT01354353|58857787|FG001|Overall Study|Entry Criteria Not Met|0|||
30833164|NCT01354353|58857788|FG002|Overall Study|Entry Criteria Not Met|0|||
30833165|NCT01354353|58857789|FG003|Overall Study|Entry Criteria Not Met|1|||
30833166|NCT01354353|58857790|FG004|Overall Study|Entry Criteria Not Met|1|||
30833167|NCT01354353|58857791|FG005|Overall Study|Entry Criteria Not Met|0|||
30833168|NCT01354353|58857786|FG000|Overall Study|Physician Decision|0|||
30833169|NCT01354353|58857787|FG001|Overall Study|Physician Decision|1|||
30833170|NCT01354353|58857788|FG002|Overall Study|Physician Decision|1|||
30833171|NCT01354353|58857789|FG003|Overall Study|Physician Decision|0|||
30833172|NCT01354353|58857790|FG004|Overall Study|Physician Decision|0|||
30833173|NCT01354353|58857791|FG005|Overall Study|Physician Decision|0|||
30833174|NCT01354353|58857786|FG000|Overall Study|Withdrawal by Subject|2|||
30833175|NCT01354353|58857787|FG001|Overall Study|Withdrawal by Subject|0|||
30833176|NCT01354353|58857788|FG002|Overall Study|Withdrawal by Subject|1|||
30833177|NCT01354353|58857789|FG003|Overall Study|Withdrawal by Subject|0|||
30833178|NCT01354353|58857790|FG004|Overall Study|Withdrawal by Subject|0|||
30833179|NCT01354353|58857791|FG005|Overall Study|Withdrawal by Subject|1|||
30833180|NCT02622568|58857814|FG000|Overall Study|Lost to Follow-up|5|||
30833181|NCT02622568|58857815|FG001|Overall Study|Lost to Follow-up|5|||
30833182|NCT01354899|58857821|FG000|Overall Study|discharge from the hospital|2|||
30833183|NCT01354899|58857821|FG000|Overall Study|Protocol Violation|1|||
30833184|NCT01353963|58857825|FG000|Overall Study|Adverse Event|2|||
30833185|NCT02820597|58857834|FG000|Overall Study|Lost to Follow-up|12|||
30833186|NCT02822235|58857840|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
30833187|NCT02822235|58857841|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
30833188|NCT02822235|58857840|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
30924220|NCT02020616|58959458|FG004|Overall Study|Randomized in Error|0|||
30924221|NCT02020616|58959459|FG005|Overall Study|Randomized in Error|0|||
30833189|NCT02822235|58857841|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
30833190|NCT02822235|58857840|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
30833191|NCT02822235|58857841|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
30833192|NCT02822235|58857840|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
30833193|NCT02822235|58857841|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
30833194|NCT02822235|58857840|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
30833195|NCT02822235|58857841|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
30833196|NCT02822235|58857840|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
30833197|NCT02822235|58857841|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
30833198|NCT02817555|58857856|FG000|Overall Study|Death|1|||
30833199|NCT02817555|58857857|FG001|Overall Study|Death|3|||
30833200|NCT02817555|58857856|FG000|Overall Study|moved away|1|||
30833201|NCT02817555|58857857|FG001|Overall Study|moved away|0|||
30833202|NCT02817555|58857856|FG000|Overall Study|transplant|1|||
30833203|NCT02817555|58857857|FG001|Overall Study|transplant|1|||
30833204|NCT02817555|58857856|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
30833205|NCT02817555|58857857|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
30833206|NCT02817087|58857865|FG000|Overall Study|Withdrawal by Subject|2|||
30833207|NCT02817087|58857866|FG001|Overall Study|Withdrawal by Subject|0|||
30833208|NCT02813577|58857872|FG000|Overall Study|Study terminated|4|||
30833209|NCT02815293|58857879|FG000|Overall Study|Study termination by sponsor|10|||
30833210|NCT02815293|58857880|FG001|Overall Study|Study termination by sponsor|7|||
30833211|NCT02815293|58857881|FG002|Overall Study|Study termination by sponsor|0|||
30833212|NCT02815293|58857879|FG000|Overall Study|Participants not randomized|0|||
30833213|NCT02815293|58857880|FG001|Overall Study|Participants not randomized|0|||
30833214|NCT02815293|58857881|FG002|Overall Study|Participants not randomized|18|||
30833215|NCT02815293|58857879|FG000|Overall Study|Adverse Event|0|||
30833216|NCT02815293|58857880|FG001|Overall Study|Adverse Event|1|||
30833217|NCT02815293|58857881|FG002|Overall Study|Adverse Event|0|||
30924222|NCT02020616|58959460|FG006|Overall Study|Randomized in Error|0|||
30924223|NCT02020616|58959454|FG000|Overall Study|Lack of Efficacy|0|||
30924224|NCT02020616|58959455|FG001|Overall Study|Lack of Efficacy|0|||
30924225|NCT02020616|58959456|FG002|Overall Study|Lack of Efficacy|0|||
30924226|NCT02020616|58959457|FG003|Overall Study|Lack of Efficacy|0|||
30833218|NCT02813421|58857889|FG000|Overall Study|Withdrawal by Subject|1|||
30833219|NCT02813421|58857890|FG001|Overall Study|Withdrawal by Subject|2|||
30833220|NCT02813421|58857889|FG000|Overall Study|Lost to Follow-up|1|||
30833221|NCT02813421|58857890|FG001|Overall Study|Lost to Follow-up|1|||
30833222|NCT03672188|58857911|FG000|Overall Study|Withdrawal by Subject|0|||
30833223|NCT03672188|58857912|FG001|Overall Study|Withdrawal by Subject|0|||
30833224|NCT03672188|58857913|FG002|Overall Study|Withdrawal by Subject|0|||
30924227|NCT02020616|58959458|FG004|Overall Study|Lack of Efficacy|1|||
30924228|NCT02020616|58959459|FG005|Overall Study|Lack of Efficacy|0|||
30924229|NCT02020616|58959460|FG006|Overall Study|Lack of Efficacy|0|||
30924230|NCT02048072|58959490|FG000|Overall Study|Adverse Event|3|||
30924231|NCT02048072|58959490|FG000|Overall Study|Lost to Follow-up|1|||
30924232|NCT02047604|58959500|FG000|Overall Study|Withdrawal by Subject|0|||
30924233|NCT02047604|58959501|FG001|Overall Study|Withdrawal by Subject|0|||
30924234|NCT02047604|58959502|FG002|Overall Study|Withdrawal by Subject|0|||
30924235|NCT02047604|58959503|FG003|Overall Study|Withdrawal by Subject|0|||
30924236|NCT02047604|58959504|FG004|Overall Study|Withdrawal by Subject|1|||
30924237|NCT02047604|58959505|FG005|Overall Study|Withdrawal by Subject|1|||
30924238|NCT01622660|58959519|FG000|Overall Study|Adverse Event|1|||
30833225|NCT03672188|58857914|FG003|Overall Study|Withdrawal by Subject|3|||
30833226|NCT03672188|58857915|FG004|Overall Study|Withdrawal by Subject|0|||
30924239|NCT02019602|58959525|FG000|Screening Period|Ineligibility|4|||
30924240|NCT02019602|58959526|FG001|Screening Period|Ineligibility|0|||
30833227|NCT03672188|58857916|FG005|Overall Study|Withdrawal by Subject|0|||
30833228|NCT03672188|58857917|FG006|Overall Study|Withdrawal by Subject|0|||
30833229|NCT03672188|58857918|FG007|Overall Study|Withdrawal by Subject|0|||
30833230|NCT03672188|58857919|FG008|Overall Study|Withdrawal by Subject|0|||
30924241|NCT02019602|58959525|FG000|Screening Period|Adverse Event|1|||
30924242|NCT02019602|58959526|FG001|Screening Period|Adverse Event|0|||
30924243|NCT01994876|58959533|FG000|Test Period 1|Withdrawal by Subject|0|||
30924244|NCT01994876|58959534|FG001|Test Period 1|Withdrawal by Subject|1|||
30924245|NCT01994876|58959533|FG000|Test Period 1|Adverse Event|0|||
30924246|NCT01994876|58959534|FG001|Test Period 1|Adverse Event|1|||
30924247|NCT01994876|58959533|FG000|Test Period 2|Adverse Event|1|||
30924248|NCT01994876|58959534|FG001|Test Period 2|Adverse Event|0|||
30924249|NCT01994876|58959533|FG000|Test Period 2|Protocol Violation|0|||
30924250|NCT01994876|58959534|FG001|Test Period 2|Protocol Violation|1|||
30833231|NCT03672188|58857920|FG009|Overall Study|Withdrawal by Subject|0|||
30833232|NCT03672188|58857921|FG010|Overall Study|Withdrawal by Subject|0|||
30833233|NCT03672188|58857922|FG011|Overall Study|Withdrawal by Subject|0|||
30833234|NCT03672188|58857923|FG012|Overall Study|Withdrawal by Subject|0|||
30833235|NCT03672188|58857924|FG013|Overall Study|Withdrawal by Subject|0|||
30833236|NCT03672188|58857925|FG014|Overall Study|Withdrawal by Subject|0|||
30833237|NCT03672188|58857911|FG000|Overall Study|Death|0|||
30924251|NCT02040428|58959544|FG000|Overall Study|Death|4|||
30924252|NCT02040428|58959545|FG001|Overall Study|Death|3|||
30833238|NCT03672188|58857912|FG001|Overall Study|Death|0|||
30833239|NCT03672188|58857913|FG002|Overall Study|Death|0|||
30924253|NCT02040428|58959544|FG000|Overall Study|Withdrawal by Subject|1|||
30833240|NCT03672188|58857914|FG003|Overall Study|Death|0|||
30833241|NCT03672188|58857915|FG004|Overall Study|Death|0|||
30924254|NCT02040428|58959545|FG001|Overall Study|Withdrawal by Subject|1|||
30924255|NCT02018822|58959553|FG000|Overall Study|filling replaced by crown|0|||
30924256|NCT02018822|58959554|FG001|Overall Study|filling replaced by crown|1|||
30924257|NCT02018822|58959555|FG002|Overall Study|filling replaced by crown|0|||
30924258|NCT02018822|58959553|FG000|Overall Study|Physician Decision|0|||
30924259|NCT02018822|58959554|FG001|Overall Study|Physician Decision|1|||
30924260|NCT02018822|58959555|FG002|Overall Study|Physician Decision|1|||
30924261|NCT02018822|58959553|FG000|Overall Study|Lost to Follow-up|6|||
30924262|NCT02018822|58959554|FG001|Overall Study|Lost to Follow-up|6|||
30924263|NCT02018822|58959555|FG002|Overall Study|Lost to Follow-up|5|||
30924264|NCT02055157|58959570|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
30924265|NCT02055157|58959571|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
30924266|NCT02055157|58959572|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
30924267|NCT02055157|58959573|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
30924268|NCT02055157|58959570|FG000|Initial 6 Months|Adverse Event|0|||
30924269|NCT02055157|58959571|FG001|Initial 6 Months|Adverse Event|0|||
30924270|NCT02055157|58959572|FG002|Initial 6 Months|Adverse Event|0|||
30924271|NCT02055157|58959573|FG003|Initial 6 Months|Adverse Event|1|||
30924272|NCT02055157|58959570|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
30924273|NCT02055157|58959571|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
30924274|NCT02055157|58959572|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
30924275|NCT02055157|58959573|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
30924276|NCT02055157|58959570|FG000|18-month Extension|Investigator decision|0|||
30924277|NCT02055157|58959571|FG001|18-month Extension|Investigator decision|1|||
30924278|NCT02055157|58959572|FG002|18-month Extension|Investigator decision|0|||
30924279|NCT02055157|58959573|FG003|18-month Extension|Investigator decision|0|||
30924280|NCT02055157|58959570|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
30924281|NCT02055157|58959571|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
30924282|NCT02055157|58959572|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
30924283|NCT02055157|58959573|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
30924284|NCT02022007|58959597|FG000|Overall Study|Withdrawal by Subject|1|||
30924285|NCT02022007|58959598|FG001|Overall Study|Withdrawal by Subject|1|||
30924286|NCT02022007|58959599|FG002|Overall Study|Withdrawal by Subject|1|||
30924287|NCT02022007|58959597|FG000|Overall Study|Noncompliant|0|||
30833242|NCT03672188|58857916|FG005|Overall Study|Death|0|||
30833243|NCT03672188|58857917|FG006|Overall Study|Death|0|||
30833244|NCT03672188|58857918|FG007|Overall Study|Death|0|||
30833245|NCT03672188|58857919|FG008|Overall Study|Death|0|||
30833246|NCT03672188|58857920|FG009|Overall Study|Death|0|||
30833247|NCT03672188|58857921|FG010|Overall Study|Death|0|||
30833248|NCT03672188|58857922|FG011|Overall Study|Death|0|||
30833249|NCT03672188|58857923|FG012|Overall Study|Death|1|||
30833250|NCT03672188|58857924|FG013|Overall Study|Death|0|||
30833251|NCT03672188|58857925|FG014|Overall Study|Death|0|||
30833252|NCT03672188|58857911|FG000|Overall Study|Lost to Follow-up|0|||
30833253|NCT03672188|58857912|FG001|Overall Study|Lost to Follow-up|0|||
30833254|NCT03672188|58857913|FG002|Overall Study|Lost to Follow-up|1|||
30833255|NCT03672188|58857914|FG003|Overall Study|Lost to Follow-up|0|||
30833256|NCT03672188|58857915|FG004|Overall Study|Lost to Follow-up|0|||
30833257|NCT03672188|58857916|FG005|Overall Study|Lost to Follow-up|0|||
30833258|NCT03672188|58857917|FG006|Overall Study|Lost to Follow-up|0|||
30833259|NCT03672188|58857918|FG007|Overall Study|Lost to Follow-up|0|||
30833260|NCT03672188|58857919|FG008|Overall Study|Lost to Follow-up|0|||
30833261|NCT03672188|58857920|FG009|Overall Study|Lost to Follow-up|0|||
30833262|NCT03672188|58857921|FG010|Overall Study|Lost to Follow-up|0|||
30833263|NCT03672188|58857922|FG011|Overall Study|Lost to Follow-up|0|||
30833264|NCT03672188|58857923|FG012|Overall Study|Lost to Follow-up|0|||
30833265|NCT03672188|58857924|FG013|Overall Study|Lost to Follow-up|0|||
30833266|NCT03672188|58857925|FG014|Overall Study|Lost to Follow-up|0|||
30833267|NCT02620384|58857993|FG000|Overall Study|Adverse Event|2|||
30833268|NCT02620384|58857994|FG001|Overall Study|Adverse Event|1|||
30924288|NCT02022007|58959598|FG001|Overall Study|Noncompliant|0|||
30924289|NCT02022007|58959599|FG002|Overall Study|Noncompliant|1|||
30924290|NCT02031679|58959609|FG000|Overall Study|Protocol Violation|0|||
30924291|NCT02031679|58959610|FG001|Overall Study|Protocol Violation|1|||
30924292|NCT02031679|58959609|FG000|Overall Study|Lack of Efficacy|0|||
30924293|NCT02031679|58959610|FG001|Overall Study|Lack of Efficacy|1|||
30833269|NCT02620384|58857993|FG000|Overall Study|Discharged prior to 2nd dose|2|||
30833270|NCT02620384|58857994|FG001|Overall Study|Discharged prior to 2nd dose|5|||
30833271|NCT02620384|58857993|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
30833272|NCT02620384|58857994|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
30833273|NCT03915860|58858000|FG000|Overall Study|Adverse Event|3|||
30833274|NCT03915860|58858000|FG000|Overall Study|Withdrawal by Subject|6|||
30833275|NCT03915860|58858000|FG000|Overall Study|Lost to Follow-up|2|||
30833276|NCT03915860|58858000|FG000|Overall Study|Other than specified|3|||
30833277|NCT05047211|58858015|FG000|Overall Study|Lost to Follow-up|8|||
30833278|NCT05047211|58858016|FG001|Overall Study|Lost to Follow-up|5|||
30833279|NCT04958642|58858025|FG000|Overall Study|Transferred to OLEX program|3|||
30833280|NCT04958642|58858026|FG001|Overall Study|Transferred to OLEX program|0|||
30833281|NCT04958642|58858027|FG002|Overall Study|Transferred to OLEX program|5|||
30833282|NCT04958642|58858025|FG000|Overall Study|Death|0|||
30833283|NCT04958642|58858026|FG001|Overall Study|Death|0|||
30833284|NCT04958642|58858027|FG002|Overall Study|Death|1|||
30833285|NCT04958642|58858025|FG000|Overall Study|Withdrawal by Subject|4|||
30833286|NCT04958642|58858026|FG001|Overall Study|Withdrawal by Subject|9|||
30833287|NCT04958642|58858027|FG002|Overall Study|Withdrawal by Subject|13|||
30833288|NCT04958642|58858025|FG000|Overall Study|Investigator's Decision|0|||
30833289|NCT04958642|58858026|FG001|Overall Study|Investigator's Decision|0|||
30833290|NCT04958642|58858027|FG002|Overall Study|Investigator's Decision|1|||
30833291|NCT04958642|58858025|FG000|Overall Study|Adverse Event|1|||
30833292|NCT04958642|58858026|FG001|Overall Study|Adverse Event|0|||
30833293|NCT04958642|58858027|FG002|Overall Study|Adverse Event|1|||
30833294|NCT04958642|58858025|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
30833295|NCT04958642|58858026|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
30833296|NCT04958642|58858027|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
30833297|NCT04958642|58858025|FG000|Overall Study|Lost to Follow-up|1|||
30833298|NCT04958642|58858026|FG001|Overall Study|Lost to Follow-up|0|||
30833299|NCT04958642|58858027|FG002|Overall Study|Lost to Follow-up|0|||
30833300|NCT04958642|58858025|FG000|Overall Study|Transferred to EAP following study termination|0|||
30833301|NCT04958642|58858026|FG001|Overall Study|Transferred to EAP following study termination|0|||
30833302|NCT04958642|58858027|FG002|Overall Study|Transferred to EAP following study termination|1|||
30833303|NCT04958642|58858025|FG000|Overall Study|Transferred to Expanded Access Program|1|||
30833304|NCT04958642|58858026|FG001|Overall Study|Transferred to Expanded Access Program|0|||
30833305|NCT04958642|58858027|FG002|Overall Study|Transferred to Expanded Access Program|0|||
30833306|NCT04439357|58858035|FG000|Overall Study|Disease Progression|4|||
30833307|NCT04321343|58858043|FG000|Overall Study|Adverse Event|0|||
30833308|NCT04321343|58858044|FG001|Overall Study|Adverse Event|0|||
30833309|NCT04321343|58858045|FG002|Overall Study|Adverse Event|1|||
30833310|NCT04321343|58858046|FG003|Overall Study|Adverse Event|0|||
30924294|NCT02053753|58959618|FG000|Overall Study|Withdrawal by Subject|2|||
30924295|NCT02053753|58959619|FG001|Overall Study|Withdrawal by Subject|4|||
30924296|NCT02053753|58959618|FG000|Overall Study|Decision by Sponsor|1|||
30924297|NCT02053753|58959619|FG001|Overall Study|Decision by Sponsor|1|||
30924298|NCT02053753|58959618|FG000|Overall Study|Lost to Follow-up|4|||
30924299|NCT02053753|58959619|FG001|Overall Study|Lost to Follow-up|3|||
30924300|NCT02019979|58959625|FG000|Overall Study|study terminated|14|||
30924301|NCT02019667|58959629|FG000|First Intervention (6 Months)|Adverse Event|0|||
30924302|NCT02019667|58959630|FG001|First Intervention (6 Months)|Adverse Event|1|||
30924303|NCT02019667|58959629|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
30924304|NCT02019667|58959630|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
30924305|NCT02019667|58959629|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
30924306|NCT02019667|58959630|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
30924307|NCT02030821|58959642|FG000|Overall Study|Physician Decision|2|||
30924308|NCT02030821|58959643|FG001|Overall Study|Physician Decision|2|||
30924309|NCT02030821|58959644|FG002|Overall Study|Physician Decision|5|||
30833311|NCT04321343|58858043|FG000|Overall Study|Death|0|||
30833312|NCT04321343|58858044|FG001|Overall Study|Death|0|||
30833313|NCT04321343|58858045|FG002|Overall Study|Death|0|||
30833314|NCT04321343|58858046|FG003|Overall Study|Death|1|||
30833315|NCT04321343|58858043|FG000|Overall Study|Pregnancy|1|||
30833316|NCT04321343|58858044|FG001|Overall Study|Pregnancy|0|||
30833317|NCT04321343|58858045|FG002|Overall Study|Pregnancy|0|||
30833318|NCT04321343|58858046|FG003|Overall Study|Pregnancy|0|||
30833319|NCT04321343|58858043|FG000|Overall Study|Protocol Violation|1|||
30833320|NCT04321343|58858044|FG001|Overall Study|Protocol Violation|1|||
30833321|NCT04321343|58858045|FG002|Overall Study|Protocol Violation|1|||
30833322|NCT04321343|58858046|FG003|Overall Study|Protocol Violation|1|||
30833323|NCT04321343|58858043|FG000|Overall Study|Withdrawal by Subject|0|||
30833324|NCT04321343|58858044|FG001|Overall Study|Withdrawal by Subject|6|||
30924310|NCT02030821|58959645|FG003|Overall Study|Physician Decision|2|||
30924311|NCT02052739|58959657|FG000|Overall Study|Withdrew due to Adverse Event|3|||
30833325|NCT04321343|58858045|FG002|Overall Study|Withdrawal by Subject|0|||
30833326|NCT04321343|58858046|FG003|Overall Study|Withdrawal by Subject|2|||
30833327|NCT04321343|58858043|FG000|Overall Study|Lost to Follow-up|2|||
30833328|NCT04321343|58858044|FG001|Overall Study|Lost to Follow-up|2|||
30833329|NCT04321343|58858045|FG002|Overall Study|Lost to Follow-up|1|||
30833330|NCT04321343|58858046|FG003|Overall Study|Lost to Follow-up|3|||
30833331|NCT04238754|58858060|FG000|Washout - 1 Week|Lost to Follow-up|1|||
30924312|NCT02052739|58959658|FG001|Overall Study|Withdrew due to Adverse Event|0|||
30924313|NCT02052739|58959657|FG000|Overall Study|Participant Died|2|||
30924314|NCT02052739|58959658|FG001|Overall Study|Participant Died|1|||
30833332|NCT04238754|58858061|FG001|Washout - 1 Week|Lost to Follow-up|0|||
30833333|NCT04150068|58858083|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
30833334|NCT04150068|58858084|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
30833335|NCT04150068|58858085|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
30833336|NCT04150068|58858083|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
30833337|NCT04150068|58858084|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
30833338|NCT04150068|58858085|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
30833339|NCT03920293|58858094|FG000|Overall Study|Withdrawal by Subject|2|||
30833340|NCT03920293|58858095|FG001|Overall Study|Withdrawal by Subject|1|||
30833341|NCT03920293|58858094|FG000|Overall Study|Physician Decision|1|||
30833342|NCT03920293|58858095|FG001|Overall Study|Physician Decision|2|||
30833343|NCT03920293|58858094|FG000|Overall Study|Adverse Event|0|||
30833344|NCT03920293|58858095|FG001|Overall Study|Adverse Event|2|||
30833345|NCT03920293|58858094|FG000|Overall Study|Sponsor Decision|0|||
30833346|NCT03920293|58858095|FG001|Overall Study|Sponsor Decision|1|||
30833347|NCT03920293|58858094|FG000|Overall Study|Death|2|||
30833348|NCT03920293|58858095|FG001|Overall Study|Death|0|||
30833349|NCT03920293|58858094|FG000|Overall Study|Protocol Violation|1|||
30833350|NCT03920293|58858095|FG001|Overall Study|Protocol Violation|0|||
30833351|NCT03920293|58858094|FG000|Overall Study|Noncompliance|1|||
30833352|NCT03920293|58858095|FG001|Overall Study|Noncompliance|0|||
30833353|NCT03602586|58858110|FG000|Overall Study|Withdrawal by Subject|3|||
30833354|NCT03478956|58858116|FG000|Overall Study|Adverse Event|1|||
30833355|NCT03478956|58858117|FG001|Overall Study|Adverse Event|0|||
30833356|NCT03478956|58858116|FG000|Overall Study|Withdrawal by Subject|0|||
30833357|NCT03478956|58858117|FG001|Overall Study|Withdrawal by Subject|1|||
30833358|NCT03478956|58858116|FG000|Overall Study|Ongoing in the Study|11|||
30924315|NCT02019277|58959666|FG000|Overall Study|Withdrawal by Subject|3|||
30924316|NCT02019277|58959666|FG000|Overall Study|Death|7|||
30924317|NCT02019277|58959666|FG000|Overall Study|Did no Cooperate|1|||
30833359|NCT03478956|58858117|FG001|Overall Study|Ongoing in the Study|11|||
30833360|NCT03412565|58858127|FG000|Overall Study|Other|0|||
30833361|NCT03412565|58858128|FG001|Overall Study|Other|0|||
30833362|NCT03412565|58858129|FG002|Overall Study|Other|0|||
30833363|NCT03412565|58858130|FG003|Overall Study|Other|3|||
30833364|NCT03412565|58858127|FG000|Overall Study|Withdrawal by Subject|0|||
30833365|NCT03412565|58858128|FG001|Overall Study|Withdrawal by Subject|0|||
30833366|NCT03412565|58858129|FG002|Overall Study|Withdrawal by Subject|1|||
30833367|NCT03412565|58858130|FG003|Overall Study|Withdrawal by Subject|5|||
30833368|NCT03412565|58858127|FG000|Overall Study|Physician Decision|0|||
30833369|NCT03412565|58858128|FG001|Overall Study|Physician Decision|1|||
30833370|NCT03412565|58858129|FG002|Overall Study|Physician Decision|0|||
30833371|NCT03412565|58858130|FG003|Overall Study|Physician Decision|1|||
30833372|NCT03412565|58858127|FG000|Overall Study|Death|1|||
30833373|NCT03412565|58858128|FG001|Overall Study|Death|2|||
30833374|NCT03412565|58858129|FG002|Overall Study|Death|2|||
30833375|NCT03412565|58858130|FG003|Overall Study|Death|4|||
30833376|NCT03412565|58858127|FG000|Overall Study|Still ongoing|0|||
30833377|NCT03412565|58858128|FG001|Overall Study|Still ongoing|62|||
30833378|NCT03412565|58858129|FG002|Overall Study|Still ongoing|59|||
30833379|NCT03412565|58858130|FG003|Overall Study|Still ongoing|41|||
30833380|NCT03317496|58858153|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
30833381|NCT03317496|58858154|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
30833382|NCT03317496|58858155|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
30833383|NCT03317496|58858156|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
30833384|NCT03317496|58858157|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
30833385|NCT03317496|58858153|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
30833386|NCT03317496|58858154|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
30833387|NCT03317496|58858155|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
30833388|NCT03317496|58858156|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
30924318|NCT02019277|58959666|FG000|Overall Study|Adverse Event|1|||
30833389|NCT03317496|58858157|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
30833390|NCT03317496|58858153|FG000|Phase 1b Lead-in: Treatment|Death|0|||
30833391|NCT03317496|58858154|FG001|Phase 1b Lead-in: Treatment|Death|0|||
30833392|NCT03317496|58858155|FG002|Phase 1b Lead-in: Treatment|Death|1|||
30833393|NCT03317496|58858156|FG003|Phase 1b Lead-in: Treatment|Death|0|||
30833394|NCT03317496|58858157|FG004|Phase 1b Lead-in: Treatment|Death|0|||
30833395|NCT03317496|58858153|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
30833396|NCT03317496|58858154|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
30833397|NCT03317496|58858155|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
30833398|NCT03317496|58858156|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
30833399|NCT03317496|58858157|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
30833400|NCT03317496|58858153|FG000|Phase 1b Lead-in: Treatment|Other|2|||
30833401|NCT03317496|58858154|FG001|Phase 1b Lead-in: Treatment|Other|1|||
30833402|NCT03317496|58858155|FG002|Phase 1b Lead-in: Treatment|Other|0|||
30833403|NCT03317496|58858156|FG003|Phase 1b Lead-in: Treatment|Other|0|||
30924319|NCT02030119|58959674|FG000|Overall Study|Withdrawal by Subject|3|||
30833404|NCT03317496|58858157|FG004|Phase 1b Lead-in: Treatment|Other|0|||
30833405|NCT03317496|58858153|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
30833406|NCT03317496|58858154|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
30833407|NCT03317496|58858155|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
30833408|NCT03317496|58858156|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
30833409|NCT03317496|58858157|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
30833410|NCT03317496|58858153|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
30833411|NCT03317496|58858154|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
30833412|NCT03317496|58858155|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
30833413|NCT03317496|58858156|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
30833414|NCT03317496|58858157|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
30833415|NCT03317496|58858153|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
30833416|NCT03317496|58858154|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
30833417|NCT03317496|58858155|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
30833418|NCT03317496|58858156|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
30833419|NCT03317496|58858157|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
30833420|NCT03317496|58858153|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
30833421|NCT03317496|58858154|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
30833422|NCT03317496|58858155|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
30833423|NCT03317496|58858156|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
30833424|NCT03317496|58858157|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
30924320|NCT02030119|58959675|FG001|Overall Study|Withdrawal by Subject|1|||
30924321|NCT02030119|58959676|FG002|Overall Study|Withdrawal by Subject|5|||
30924322|NCT02030119|58959677|FG003|Overall Study|Withdrawal by Subject|3|||
30924323|NCT02030119|58959674|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
30924324|NCT02030119|58959675|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
30924325|NCT02030119|58959676|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
30924326|NCT02030119|58959677|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
30924327|NCT01823835|58959702|FG000|Overall Study|Adverse Event|0|||
30924328|NCT01823835|58959703|FG001|Overall Study|Adverse Event|0|||
30924329|NCT01823835|58959704|FG002|Overall Study|Adverse Event|0|||
30924330|NCT01823835|58959705|FG003|Overall Study|Adverse Event|0|||
30924331|NCT01823835|58959706|FG004|Overall Study|Adverse Event|1|||
30924332|NCT01823835|58959707|FG005|Overall Study|Adverse Event|0|||
30924333|NCT01823835|58959708|FG006|Overall Study|Adverse Event|1|||
30924334|NCT01823835|58959709|FG007|Overall Study|Adverse Event|0|||
30924335|NCT01823835|58959710|FG008|Overall Study|Adverse Event|0|||
30924336|NCT01823835|58959711|FG009|Overall Study|Adverse Event|0|||
30924337|NCT01823835|58959712|FG010|Overall Study|Adverse Event|1|||
30924338|NCT01823835|58959713|FG011|Overall Study|Adverse Event|2|||
30924339|NCT01823835|58959714|FG012|Overall Study|Adverse Event|0|||
30924340|NCT01823835|58959715|FG013|Overall Study|Adverse Event|0|||
30924341|NCT01823835|58959716|FG014|Overall Study|Adverse Event|0|||
30924342|NCT01823835|58959702|FG000|Overall Study|Physician Decision|0|||
30924343|NCT01823835|58959703|FG001|Overall Study|Physician Decision|0|||
30924344|NCT01823835|58959704|FG002|Overall Study|Physician Decision|0|||
30924345|NCT01823835|58959705|FG003|Overall Study|Physician Decision|0|||
30924346|NCT01823835|58959706|FG004|Overall Study|Physician Decision|0|||
30755951|NCT00094172|58765850|FG001|Overall Study|Started other MS therapy due to disease|0|||
30755952|NCT00094094|58765856|FG000|Overall Study|Death|2|||
30755953|NCT00094094|58765856|FG000|Overall Study|Lack of Efficacy|23|||
30755954|NCT00094094|58765856|FG000|Overall Study|Adverse Event|7|||
30755955|NCT00110396|58765860|FG000|Overall Study|Adverse Event|15|||
30755956|NCT00110396|58765860|FG000|Overall Study|Lost to Follow-up|1|||
30755957|NCT00110396|58765860|FG000|Overall Study|Administration of plasmapheresis|1|||
30755958|NCT00110396|58765860|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
30755959|NCT00110396|58765860|FG000|Overall Study|Lack of Efficacy|1|||
30755960|NCT00110396|58765860|FG000|Overall Study|Decided not to continue treatment|1|||
30755961|NCT00110396|58765860|FG000|Overall Study|Patient non-compliance|1|||
30755962|NCT00110396|58765860|FG000|Overall Study|Patient refused to continue|1|||
30755963|NCT00110396|58765860|FG000|Overall Study|Patient refused to participate|1|||
30755964|NCT00110396|58765860|FG000|Overall Study|Patient will|1|||
30755965|NCT00110396|58765860|FG000|Overall Study|Patient's decision|1|||
30833425|NCT03317496|58858153|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
30833426|NCT03317496|58858154|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
30924347|NCT01823835|58959707|FG005|Overall Study|Physician Decision|0|||
30924348|NCT01823835|58959708|FG006|Overall Study|Physician Decision|0|||
30924349|NCT01823835|58959709|FG007|Overall Study|Physician Decision|0|||
30924350|NCT01823835|58959710|FG008|Overall Study|Physician Decision|0|||
30924351|NCT01823835|58959711|FG009|Overall Study|Physician Decision|0|||
30924352|NCT01823835|58959712|FG010|Overall Study|Physician Decision|0|||
30924353|NCT01823835|58959713|FG011|Overall Study|Physician Decision|2|||
30755966|NCT00110396|58765860|FG000|Overall Study|Participation in MS vaccine study|1|||
30924354|NCT01823835|58959714|FG012|Overall Study|Physician Decision|0|||
30924355|NCT01823835|58959715|FG013|Overall Study|Physician Decision|0|||
30833427|NCT03317496|58858155|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
30833428|NCT03317496|58858156|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
30833429|NCT03317496|58858157|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
30924356|NCT01823835|58959716|FG014|Overall Study|Physician Decision|0|||
30924357|NCT01823835|58959702|FG000|Overall Study|Progressive Disease|3|||
30924358|NCT01823835|58959703|FG001|Overall Study|Progressive Disease|4|||
30924359|NCT01823835|58959704|FG002|Overall Study|Progressive Disease|3|||
30924360|NCT01823835|58959705|FG003|Overall Study|Progressive Disease|6|||
30924361|NCT01823835|58959706|FG004|Overall Study|Progressive Disease|4|||
30924362|NCT01823835|58959707|FG005|Overall Study|Progressive Disease|6|||
30924363|NCT01823835|58959708|FG006|Overall Study|Progressive Disease|5|||
30924364|NCT01823835|58959709|FG007|Overall Study|Progressive Disease|3|||
30924365|NCT01823835|58959710|FG008|Overall Study|Progressive Disease|3|||
30924366|NCT01823835|58959711|FG009|Overall Study|Progressive Disease|18|||
30833430|NCT03317496|58858153|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
30833431|NCT03317496|58858154|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
30924367|NCT01823835|58959712|FG010|Overall Study|Progressive Disease|8|||
30924368|NCT01823835|58959713|FG011|Overall Study|Progressive Disease|46|||
30924369|NCT01823835|58959714|FG012|Overall Study|Progressive Disease|18|||
30924370|NCT01823835|58959715|FG013|Overall Study|Progressive Disease|4|||
30924371|NCT01823835|58959716|FG014|Overall Study|Progressive Disease|6|||
30924372|NCT01823835|58959702|FG000|Overall Study|Study Termination|0|||
30924373|NCT01823835|58959703|FG001|Overall Study|Study Termination|0|||
30924374|NCT01823835|58959704|FG002|Overall Study|Study Termination|0|||
30755967|NCT00110396|58765860|FG000|Overall Study|Pregnancy|1|||
30755968|NCT00110396|58765860|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
30755969|NCT00110396|58765860|FG000|Overall Study|Protocol Violation|2|||
30755970|NCT00110396|58765860|FG000|Overall Study|Patient refused to come back|1|||
30755971|NCT00110396|58765860|FG000|Overall Study|The patient has refused|2|||
30755972|NCT00110396|58765860|FG000|Overall Study|The patient has refused to visit site|1|||
30755973|NCT00110396|58765860|FG000|Overall Study|Patient is to be administered copaxone|1|||
30755974|NCT03819218|58765864|FG000|Overall Study|Protocol Violation|1|||
30755975|NCT00093470|58765870|FG000|Overall Study|Disease progression|39|||
30755976|NCT00093470|58765871|FG001|Overall Study|Disease progression|0|||
30755977|NCT00093470|58765870|FG000|Overall Study|Adverse Event|15|||
30755978|NCT00093470|58765871|FG001|Overall Study|Adverse Event|0|||
30833432|NCT03317496|58858155|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
30833433|NCT03317496|58858156|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
30833434|NCT03317496|58858157|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
30833435|NCT03317496|58858153|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
30833436|NCT03317496|58858154|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
30833437|NCT03317496|58858155|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
30833438|NCT03317496|58858156|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
30833439|NCT03317496|58858157|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
30833440|NCT03317496|58858153|FG000|Phase 2: Treatment|Adverse Event|0|||
30833441|NCT03317496|58858154|FG001|Phase 2: Treatment|Adverse Event|0|||
30833442|NCT03317496|58858155|FG002|Phase 2: Treatment|Adverse Event|0|||
30755979|NCT00093470|58765870|FG000|Overall Study|Death|2|||
30755980|NCT00093470|58765871|FG001|Overall Study|Death|0|||
30755981|NCT00093470|58765870|FG000|Overall Study|Withdrawal by Subject|8|||
30755982|NCT00093470|58765871|FG001|Overall Study|Withdrawal by Subject|0|||
30755983|NCT00093470|58765870|FG000|Overall Study|Alternative therapy|2|||
30755984|NCT00093470|58765871|FG001|Overall Study|Alternative therapy|0|||
30755985|NCT00093470|58765870|FG000|Overall Study|Other complicating disease|3|||
30755986|NCT00093470|58765871|FG001|Overall Study|Other complicating disease|0|||
30755987|NCT00093470|58765870|FG000|Overall Study|Physician Decision|2|||
30755988|NCT00093470|58765871|FG001|Overall Study|Physician Decision|0|||
30755989|NCT00093470|58765870|FG000|Overall Study|Never started treatment|1|||
30755990|NCT00093470|58765871|FG001|Overall Study|Never started treatment|0|||
30755991|NCT00093470|58765870|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
30755992|NCT00093470|58765871|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
30833443|NCT03317496|58858156|FG003|Phase 2: Treatment|Adverse Event|0|||
30924375|NCT01823835|58959705|FG003|Overall Study|Study Termination|0|||
30924376|NCT01823835|58959706|FG004|Overall Study|Study Termination|1|||
30924377|NCT01823835|58959707|FG005|Overall Study|Study Termination|0|||
30924378|NCT01823835|58959708|FG006|Overall Study|Study Termination|0|||
30924379|NCT01823835|58959709|FG007|Overall Study|Study Termination|0|||
30755993|NCT00407537|58765879|FG000|Overall Study|Death|5|||
30755994|NCT00407537|58765880|FG001|Overall Study|Death|2|||
30755995|NCT00407537|58765879|FG000|Overall Study|Adverse Event|36|||
30755996|NCT00407537|58765880|FG001|Overall Study|Adverse Event|0|||
30755997|NCT00407537|58765879|FG000|Overall Study|Lost to Follow-up|12|||
30755998|NCT00407537|58765880|FG001|Overall Study|Lost to Follow-up|19|||
30755999|NCT00407537|58765879|FG000|Overall Study|Other|6|||
30756000|NCT00407537|58765880|FG001|Overall Study|Other|7|||
30756001|NCT00407537|58765879|FG000|Overall Study|Withdrawal by Subject|34|||
30756002|NCT00407537|58765880|FG001|Overall Study|Withdrawal by Subject|16|||
30756003|NCT00094458|58765889|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
30833444|NCT03317496|58858157|FG004|Phase 2: Treatment|Adverse Event|6|||
30833445|NCT03317496|58858153|FG000|Phase 2: Treatment|Progressive disease|0|||
30833446|NCT03317496|58858154|FG001|Phase 2: Treatment|Progressive disease|0|||
30833447|NCT03317496|58858155|FG002|Phase 2: Treatment|Progressive disease|0|||
30833448|NCT03317496|58858156|FG003|Phase 2: Treatment|Progressive disease|0|||
30833449|NCT03317496|58858157|FG004|Phase 2: Treatment|Progressive disease|22|||
30833450|NCT03317496|58858153|FG000|Phase 2: Treatment|Other|0|||
30833451|NCT03317496|58858154|FG001|Phase 2: Treatment|Other|0|||
30833452|NCT03317496|58858155|FG002|Phase 2: Treatment|Other|0|||
30833453|NCT03317496|58858156|FG003|Phase 2: Treatment|Other|0|||
30833454|NCT03317496|58858157|FG004|Phase 2: Treatment|Other|4|||
30833455|NCT03317496|58858153|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
30833456|NCT03317496|58858154|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
30833457|NCT03317496|58858155|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
30833458|NCT03317496|58858156|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
30833459|NCT03317496|58858157|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
30833460|NCT03317496|58858153|FG000|Phase 2: Treatment|Physician Decision|0|||
30833461|NCT03317496|58858154|FG001|Phase 2: Treatment|Physician Decision|0|||
30833462|NCT03317496|58858155|FG002|Phase 2: Treatment|Physician Decision|0|||
30833463|NCT03317496|58858156|FG003|Phase 2: Treatment|Physician Decision|0|||
30833464|NCT03317496|58858157|FG004|Phase 2: Treatment|Physician Decision|1|||
30833465|NCT03317496|58858153|FG000|Phase 2: Treatment|Death|0|||
30833466|NCT03317496|58858154|FG001|Phase 2: Treatment|Death|0|||
30833467|NCT03317496|58858155|FG002|Phase 2: Treatment|Death|0|||
30833468|NCT03317496|58858156|FG003|Phase 2: Treatment|Death|0|||
30756004|NCT00094458|58765890|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
30756005|NCT00094458|58765891|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
30756006|NCT00094458|58765892|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
30756007|NCT00094458|58765893|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
30756008|NCT00094458|58765894|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
30756009|NCT00094458|58765889|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
30833469|NCT03317496|58858157|FG004|Phase 2: Treatment|Death|1|||
30833470|NCT03317496|58858153|FG000|Phase 2: Follow-up|Death|0|||
30833471|NCT03317496|58858154|FG001|Phase 2: Follow-up|Death|0|||
30833472|NCT03317496|58858155|FG002|Phase 2: Follow-up|Death|0|||
30756010|NCT00094458|58765890|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
30756011|NCT00094458|58765891|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
30833473|NCT03317496|58858156|FG003|Phase 2: Follow-up|Death|0|||
30756012|NCT00094458|58765892|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
30833474|NCT03317496|58858157|FG004|Phase 2: Follow-up|Death|24|||
30833475|NCT03317496|58858153|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
30833476|NCT03317496|58858154|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
30833477|NCT03317496|58858155|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
30833478|NCT03317496|58858156|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
30833479|NCT03317496|58858157|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
30833480|NCT03317496|58858153|FG000|Phase 2: Follow-up|Other|0|||
30833481|NCT03317496|58858154|FG001|Phase 2: Follow-up|Other|0|||
30833482|NCT03317496|58858155|FG002|Phase 2: Follow-up|Other|0|||
30833483|NCT03317496|58858156|FG003|Phase 2: Follow-up|Other|0|||
30833484|NCT03317496|58858157|FG004|Phase 2: Follow-up|Other|1|||
30833485|NCT03317496|58858153|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
30833486|NCT03317496|58858154|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
30833487|NCT03317496|58858155|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
30833488|NCT03317496|58858156|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
30833489|NCT03317496|58858157|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
30833490|NCT03309878|58858172|FG000|Overall Study|Adverse Event|1|||
30833491|NCT03309878|58858173|FG001|Overall Study|Adverse Event|0|||
30833492|NCT03309878|58858174|FG002|Overall Study|Adverse Event|0|||
30833493|NCT03309878|58858175|FG003|Overall Study|Adverse Event|0|||
30833494|NCT03309878|58858172|FG000|Overall Study|Did not maintain eligibility|2|||
30833495|NCT03309878|58858173|FG001|Overall Study|Did not maintain eligibility|1|||
30756013|NCT00094458|58765893|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
30756014|NCT00094458|58765894|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
30756015|NCT00094458|58765889|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
30756016|NCT00094458|58765890|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
30756017|NCT00094458|58765891|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
30756018|NCT00094458|58765892|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
30756019|NCT00094458|58765893|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
30756020|NCT00094458|58765894|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
30756021|NCT00094458|58765889|FG000|Main Study: Through Week 30|Adverse Event|38|||
30756022|NCT00094458|58765890|FG001|Main Study: Through Week 30|Adverse Event|20|||
30756023|NCT00094458|58765891|FG002|Main Study: Through Week 30|Adverse Event|28|||
30756024|NCT00094458|58765892|FG003|Main Study: Through Week 30|Adverse Event|0|||
30756025|NCT00094458|58765893|FG004|Main Study: Through Week 30|Adverse Event|0|||
30756026|NCT00094458|58765894|FG005|Main Study: Through Week 30|Adverse Event|0|||
30756027|NCT00094458|58765889|FG000|Main Study: Through Week 30|Death|1|||
30756028|NCT00094458|58765890|FG001|Main Study: Through Week 30|Death|0|||
30756029|NCT00094458|58765891|FG002|Main Study: Through Week 30|Death|0|||
30756030|NCT00094458|58765892|FG003|Main Study: Through Week 30|Death|0|||
30756031|NCT00094458|58765893|FG004|Main Study: Through Week 30|Death|0|||
30756032|NCT00094458|58765894|FG005|Main Study: Through Week 30|Death|0|||
30756033|NCT00094458|58765889|FG000|Main Study: Through Week 30|Other|19|||
30756034|NCT00094458|58765890|FG001|Main Study: Through Week 30|Other|16|||
30756035|NCT00094458|58765891|FG002|Main Study: Through Week 30|Other|9|||
30756036|NCT00094458|58765892|FG003|Main Study: Through Week 30|Other|0|||
30756037|NCT00094458|58765893|FG004|Main Study: Through Week 30|Other|0|||
30756038|NCT00094458|58765894|FG005|Main Study: Through Week 30|Other|0|||
30756039|NCT00094458|58765889|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
30756040|NCT00094458|58765890|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
30756041|NCT00094458|58765891|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
30756042|NCT00094458|58765892|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
30756043|NCT00094458|58765893|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
30756044|NCT00094458|58765894|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
30756045|NCT00094458|58765889|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
30756046|NCT00094458|58765890|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
30756047|NCT00094458|58765891|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
30756048|NCT00094458|58765892|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
30756049|NCT00094458|58765893|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
30833496|NCT03309878|58858174|FG002|Overall Study|Did not maintain eligibility|0|||
30833497|NCT03309878|58858175|FG003|Overall Study|Did not maintain eligibility|0|||
30833498|NCT03309878|58858172|FG000|Overall Study|Withdrawal by Subject|0|||
30833499|NCT03309878|58858173|FG001|Overall Study|Withdrawal by Subject|1|||
30833500|NCT03309878|58858174|FG002|Overall Study|Withdrawal by Subject|0|||
30833501|NCT03309878|58858175|FG003|Overall Study|Withdrawal by Subject|0|||
30833502|NCT03096782|58858185|FG000|Overall Study|Death|1|||
30833503|NCT03096782|58858185|FG000|Overall Study|Participant Relapsed|1|||
30756050|NCT00094458|58765894|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
30833504|NCT02921256|58858193|FG000|Arm 1a v. Arm II|Adverse Event|6|||
30833505|NCT02921256|58858194|FG001|Arm 1a v. Arm II|Adverse Event|15|||
30833506|NCT02921256|58858195|FG002|Arm 1a v. Arm II|Adverse Event|0|||
30833507|NCT02921256|58858193|FG000|Arm 1a v. Arm II|Death|0|||
30833508|NCT02921256|58858194|FG001|Arm 1a v. Arm II|Death|2|||
30833509|NCT02921256|58858195|FG002|Arm 1a v. Arm II|Death|0|||
30833510|NCT02921256|58858193|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
30833511|NCT02921256|58858194|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
30833512|NCT02921256|58858195|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
30833513|NCT02921256|58858193|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
30833514|NCT02921256|58858194|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
30833515|NCT02921256|58858195|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
30833516|NCT02921256|58858193|FG000|Arm 1a v. Arm II|Physician Decision|1|||
30833517|NCT02921256|58858194|FG001|Arm 1a v. Arm II|Physician Decision|1|||
30833518|NCT02921256|58858195|FG002|Arm 1a v. Arm II|Physician Decision|0|||
30833519|NCT02921256|58858193|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
30833520|NCT02921256|58858194|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
30833521|NCT02921256|58858195|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
30833522|NCT02921256|58858193|FG000|Arm Ib v Arm III|Adverse Event|9|||
30833523|NCT02921256|58858194|FG001|Arm Ib v Arm III|Adverse Event|0|||
30833524|NCT02921256|58858195|FG002|Arm Ib v Arm III|Adverse Event|4|||
30833525|NCT02921256|58858193|FG000|Arm Ib v Arm III|Death|1|||
30833526|NCT02921256|58858194|FG001|Arm Ib v Arm III|Death|0|||
30833527|NCT02921256|58858195|FG002|Arm Ib v Arm III|Death|1|||
30833528|NCT02921256|58858193|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
30833529|NCT02921256|58858194|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
30833530|NCT02921256|58858195|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
30833531|NCT02921256|58858193|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
30833532|NCT02921256|58858194|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
30833533|NCT02921256|58858195|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
30833534|NCT02921256|58858193|FG000|Arm Ib v Arm III|Physician Decision|4|||
30833535|NCT02921256|58858194|FG001|Arm Ib v Arm III|Physician Decision|0|||
30833536|NCT02921256|58858195|FG002|Arm Ib v Arm III|Physician Decision|1|||
30833537|NCT02921256|58858193|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
30833538|NCT02921256|58858194|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
30833539|NCT02921256|58858195|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
30833540|NCT02836249|58858220|FG000|Overall Study|Randomized but Never Treated|0|||
30833541|NCT02836249|58858221|FG001|Overall Study|Randomized but Never Treated|1|||
30833542|NCT02836249|58858220|FG000|Overall Study|Pregnancy|2|||
30833543|NCT02836249|58858221|FG001|Overall Study|Pregnancy|0|||
30833544|NCT02836249|58858220|FG000|Overall Study|Withdrew Consent|0|||
30833545|NCT02836249|58858221|FG001|Overall Study|Withdrew Consent|1|||
30833546|NCT02836249|58858220|FG000|Overall Study|Lost to Follow-up|0|||
30833547|NCT02836249|58858221|FG001|Overall Study|Lost to Follow-up|1|||
30833548|NCT02836249|58858220|FG000|Overall Study|Still on Study|121|||
30756051|NCT00094458|58765889|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
30756052|NCT00094458|58765890|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
30756053|NCT00094458|58765891|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
30756054|NCT00094458|58765892|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
30756055|NCT00094458|58765893|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
30756056|NCT00094458|58765894|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
30756057|NCT00094458|58765889|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
30756058|NCT00094458|58765890|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
30756059|NCT00094458|58765891|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
30756060|NCT00094458|58765892|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
30756061|NCT00094458|58765893|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
30756062|NCT00094458|58765894|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
30756063|NCT00094458|58765889|FG000|OLE: Open-Label Extension|Adverse Event|0|||
30756064|NCT00094458|58765890|FG001|OLE: Open-Label Extension|Adverse Event|0|||
30833549|NCT02836249|58858221|FG001|Overall Study|Still on Study|55|||
30833550|NCT02195479|58858233|FG000|Overall Study|Lost to Follow-up|3|||
30833551|NCT02195479|58858234|FG001|Overall Study|Lost to Follow-up|0|||
30833552|NCT02195479|58858233|FG000|Overall Study|Death|48|||
30833553|NCT02195479|58858234|FG001|Overall Study|Death|45|||
30833554|NCT02195479|58858233|FG000|Overall Study|Physician Decision|1|||
30756065|NCT00094458|58765891|FG002|OLE: Open-Label Extension|Adverse Event|0|||
30756066|NCT00094458|58765892|FG003|OLE: Open-Label Extension|Adverse Event|0|||
30756067|NCT00094458|58765893|FG004|OLE: Open-Label Extension|Adverse Event|3|||
30833555|NCT02195479|58858234|FG001|Overall Study|Physician Decision|0|||
30833556|NCT02195479|58858233|FG000|Overall Study|Withdrawal by Subject|11|||
30833557|NCT02195479|58858234|FG001|Overall Study|Withdrawal by Subject|6|||
30833558|NCT02195479|58858233|FG000|Overall Study|Other|2|||
30833559|NCT02195479|58858234|FG001|Overall Study|Other|2|||
30833560|NCT02195479|58858233|FG000|Overall Study|Ongoing|291|||
30833561|NCT02195479|58858234|FG001|Overall Study|Ongoing|297|||
30833562|NCT02143414|58858242|FG000|Induction|Adverse Event|1|||
30833563|NCT02143414|58858243|FG001|Induction|Adverse Event|2|||
30833564|NCT02143414|58858242|FG000|Induction|Death|1|||
30833565|NCT02143414|58858243|FG001|Induction|Death|2|||
30833566|NCT02143414|58858242|FG000|Induction|Patient refusal|1|||
30833567|NCT02143414|58858243|FG001|Induction|Patient refusal|1|||
30833568|NCT02143414|58858242|FG000|Induction|Refractory|1|||
30833569|NCT02143414|58858243|FG001|Induction|Refractory|0|||
30833570|NCT02143414|58858242|FG000|Induction|Began alternative treatment|1|||
30833571|NCT02143414|58858243|FG001|Induction|Began alternative treatment|0|||
30833572|NCT02143414|58858242|FG000|Induction|Ineligible for postremission|5|||
30833573|NCT02143414|58858243|FG001|Induction|Ineligible for postremission|1|||
30833574|NCT02143414|58858242|FG000|Post-remission|Adverse Event|0|||
30833575|NCT02143414|58858243|FG001|Post-remission|Adverse Event|2|||
30833576|NCT02143414|58858242|FG000|Post-remission|Disease progression/relapse|5|||
30833577|NCT02143414|58858243|FG001|Post-remission|Disease progression/relapse|0|||
30833578|NCT02143414|58858242|FG000|Maintenance|Adverse Event|4|||
30833579|NCT02143414|58858243|FG001|Maintenance|Adverse Event|6|||
30833580|NCT02143414|58858242|FG000|Maintenance|Disease progression/relapse|3|||
30833581|NCT02143414|58858243|FG001|Maintenance|Disease progression/relapse|2|||
30833582|NCT02143414|58858242|FG000|Maintenance|Patient refusal|2|||
30833583|NCT02143414|58858243|FG001|Maintenance|Patient refusal|1|||
30833584|NCT02143414|58858242|FG000|Maintenance|Physician Decision|1|||
30833585|NCT02143414|58858243|FG001|Maintenance|Physician Decision|0|||
30833586|NCT02143414|58858242|FG000|Maintenance|Death|0|||
30833587|NCT02143414|58858243|FG001|Maintenance|Death|1|||
30833588|NCT02143414|58858242|FG000|Maintenance|On protocol treatment|0|||
30833589|NCT02143414|58858243|FG001|Maintenance|On protocol treatment|6|||
30833590|NCT02112916|58858264|FG000|Overall Study|Adverse Event|6|||
30833591|NCT02112916|58858265|FG001|Overall Study|Adverse Event|9|||
30833592|NCT02112916|58858266|FG002|Overall Study|Adverse Event|3|||
30924380|NCT01823835|58959710|FG008|Overall Study|Study Termination|0|||
30924381|NCT01823835|58959711|FG009|Overall Study|Study Termination|0|||
30924382|NCT01823835|58959712|FG010|Overall Study|Study Termination|0|||
30924383|NCT01823835|58959713|FG011|Overall Study|Study Termination|1|||
30924384|NCT01823835|58959714|FG012|Overall Study|Study Termination|0|||
30924385|NCT01823835|58959715|FG013|Overall Study|Study Termination|0|||
30924386|NCT01823835|58959716|FG014|Overall Study|Study Termination|0|||
30924387|NCT01823835|58959702|FG000|Overall Study|Withdrawal by Subject|0|||
30924388|NCT01823835|58959703|FG001|Overall Study|Withdrawal by Subject|0|||
30924389|NCT01823835|58959704|FG002|Overall Study|Withdrawal by Subject|1|||
30924390|NCT01823835|58959705|FG003|Overall Study|Withdrawal by Subject|0|||
30924391|NCT01823835|58959706|FG004|Overall Study|Withdrawal by Subject|0|||
30833593|NCT02112916|58858267|FG003|Overall Study|Adverse Event|2|||
30833594|NCT02112916|58858264|FG000|Overall Study|Death|9|||
30833595|NCT02112916|58858265|FG001|Overall Study|Death|9|||
30833596|NCT02112916|58858266|FG002|Overall Study|Death|3|||
30833597|NCT02112916|58858267|FG003|Overall Study|Death|4|||
30924392|NCT01823835|58959707|FG005|Overall Study|Withdrawal by Subject|0|||
30756068|NCT00094458|58765894|FG005|OLE: Open-Label Extension|Adverse Event|4|||
30756069|NCT00094458|58765889|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
30833598|NCT02112916|58858264|FG000|Overall Study|Lost to Follow-up|1|||
30833599|NCT02112916|58858265|FG001|Overall Study|Lost to Follow-up|0|||
30833600|NCT02112916|58858266|FG002|Overall Study|Lost to Follow-up|0|||
30833601|NCT02112916|58858267|FG003|Overall Study|Lost to Follow-up|0|||
30833602|NCT02112916|58858264|FG000|Overall Study|Physician Decision|94|||
30833603|NCT02112916|58858265|FG001|Overall Study|Physician Decision|72|||
30833604|NCT02112916|58858266|FG002|Overall Study|Physician Decision|24|||
30833605|NCT02112916|58858267|FG003|Overall Study|Physician Decision|15|||
30833606|NCT02112916|58858264|FG000|Overall Study|Withdrawal by Subject|5|||
30833607|NCT02112916|58858265|FG001|Overall Study|Withdrawal by Subject|3|||
30833608|NCT02112916|58858266|FG002|Overall Study|Withdrawal by Subject|1|||
30833609|NCT02112916|58858267|FG003|Overall Study|Withdrawal by Subject|1|||
30833610|NCT02112916|58858264|FG000|Overall Study|Ineligible|4|||
30833611|NCT02112916|58858265|FG001|Overall Study|Ineligible|8|||
30833612|NCT02112916|58858266|FG002|Overall Study|Ineligible|3|||
30833613|NCT02112916|58858267|FG003|Overall Study|Ineligible|8|||
30833614|NCT02112916|58858264|FG000|Overall Study|Inevaluable|6|||
30833615|NCT02112916|58858265|FG001|Overall Study|Inevaluable|4|||
30833616|NCT02112916|58858266|FG002|Overall Study|Inevaluable|5|||
30833617|NCT02112916|58858267|FG003|Overall Study|Inevaluable|5|||
30833618|NCT02112916|58858264|FG000|Overall Study|Refusal of further protocol therapy|19|||
30833619|NCT02112916|58858265|FG001|Overall Study|Refusal of further protocol therapy|16|||
30833620|NCT02112916|58858266|FG002|Overall Study|Refusal of further protocol therapy|1|||
30833621|NCT02112916|58858267|FG003|Overall Study|Refusal of further protocol therapy|7|||
30833622|NCT02112916|58858264|FG000|Overall Study|Development of SMN|1|||
30833623|NCT02112916|58858265|FG001|Overall Study|Development of SMN|0|||
30833624|NCT02112916|58858266|FG002|Overall Study|Development of SMN|0|||
30833625|NCT02112916|58858267|FG003|Overall Study|Development of SMN|1|||
30833626|NCT02112916|58858264|FG000|Overall Study|Relapse/Progression|10|||
30924393|NCT01823835|58959708|FG006|Overall Study|Withdrawal by Subject|0|||
30924394|NCT01823835|58959709|FG007|Overall Study|Withdrawal by Subject|0|||
30924395|NCT01823835|58959710|FG008|Overall Study|Withdrawal by Subject|0|||
30924396|NCT01823835|58959711|FG009|Overall Study|Withdrawal by Subject|1|||
30756070|NCT00094458|58765890|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
30756071|NCT00094458|58765891|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
30756072|NCT00094458|58765892|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
30756073|NCT00094458|58765893|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
30756074|NCT00094458|58765894|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
30756075|NCT00094458|58765889|FG000|OLE: Open-Label Extension|Patient decision|0|||
30756076|NCT00094458|58765890|FG001|OLE: Open-Label Extension|Patient decision|0|||
30756077|NCT00094458|58765891|FG002|OLE: Open-Label Extension|Patient decision|0|||
30756078|NCT00094458|58765892|FG003|OLE: Open-Label Extension|Patient decision|0|||
30756079|NCT00094458|58765893|FG004|OLE: Open-Label Extension|Patient decision|1|||
30756080|NCT00094458|58765894|FG005|OLE: Open-Label Extension|Patient decision|0|||
30833627|NCT02112916|58858265|FG001|Overall Study|Relapse/Progression|18|||
30833628|NCT02112916|58858266|FG002|Overall Study|Relapse/Progression|15|||
30833629|NCT02112916|58858267|FG003|Overall Study|Relapse/Progression|2|||
30833630|NCT02112916|58858264|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
30623847|NCT01167179|58635745|FG001|Overall Study|disease recurrence|4|||
30623848|NCT01167179|58635744|FG000|Overall Study|Death|4|||
30623849|NCT01167179|58635745|FG001|Overall Study|Death|10|||
30623850|NCT01167179|58635744|FG000|Overall Study|Withdrawal by Subject|1|||
30623851|NCT01167179|58635745|FG001|Overall Study|Withdrawal by Subject|2|||
30623852|NCT01167179|58635744|FG000|Overall Study|diverse|6|||
30623853|NCT01167179|58635745|FG001|Overall Study|diverse|5|||
30623854|NCT01167023|58635818|FG000|Overall Study|Lost to Follow-up|0|||
30623855|NCT01167023|58635819|FG001|Overall Study|Lost to Follow-up|1|||
30623856|NCT01167023|58635820|FG002|Overall Study|Lost to Follow-up|1|||
30623857|NCT01167023|58635818|FG000|Overall Study|Screen Failure|0|||
30623858|NCT01167023|58635819|FG001|Overall Study|Screen Failure|1|||
30623859|NCT01167023|58635820|FG002|Overall Study|Screen Failure|0|||
30623860|NCT01167023|58635818|FG000|Overall Study|Sponsor Decision|0|||
30623861|NCT01167023|58635819|FG001|Overall Study|Sponsor Decision|1|||
30623862|NCT01167023|58635820|FG002|Overall Study|Sponsor Decision|0|||
30623863|NCT01167023|58635818|FG000|Overall Study|Withdrawal by Subject|0|||
30623864|NCT01167023|58635819|FG001|Overall Study|Withdrawal by Subject|0|||
30924397|NCT01823835|58959712|FG010|Overall Study|Withdrawal by Subject|1|||
30924398|NCT01823835|58959713|FG011|Overall Study|Withdrawal by Subject|2|||
30924399|NCT01823835|58959714|FG012|Overall Study|Withdrawal by Subject|1|||
30924400|NCT01823835|58959715|FG013|Overall Study|Withdrawal by Subject|0|||
30924401|NCT01823835|58959716|FG014|Overall Study|Withdrawal by Subject|0|||
30924402|NCT02173379|58959758|FG000|Overall Study|Lost to Follow-up|48|||
30924403|NCT02173379|58959759|FG001|Overall Study|Lost to Follow-up|34|||
30924404|NCT02173379|58959758|FG000|Overall Study|Withdrawal by Subject|14|||
30924405|NCT02173379|58959759|FG001|Overall Study|Withdrawal by Subject|17|||
30924406|NCT02173379|58959758|FG000|Overall Study|Physician Decision|7|||
30924407|NCT02173379|58959759|FG001|Overall Study|Physician Decision|4|||
30924408|NCT02173379|58959758|FG000|Overall Study|Death|22|||
30924409|NCT02173379|58959759|FG001|Overall Study|Death|22|||
30924410|NCT01823679|58959766|FG000|Overall Study|Death|1|||
30924411|NCT01823289|58959771|FG000|Overall Study|Lost to Follow-up|5|||
30924412|NCT01823289|58959771|FG000|Overall Study|Adverse Event|5|||
30924413|NCT01823289|58959771|FG000|Overall Study|Lack of Efficacy|1|||
30924414|NCT01823289|58959771|FG000|Overall Study|Physician Decision|9|||
30924415|NCT01823289|58959771|FG000|Overall Study|Administered contraindicated medicine|1|||
30924416|NCT01823289|58959771|FG000|Overall Study|Transaminase increased more than 3 times|1|||
30924417|NCT01823289|58959771|FG000|Overall Study|Drug affected efficacy and safety|1|||
30924418|NCT01823289|58959771|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
30924419|NCT01822899|58959777|FG000|Overall Study|Adverse Event|6|||
30924420|NCT01822899|58959778|FG001|Overall Study|Adverse Event|5|||
30623865|NCT01167023|58635820|FG002|Overall Study|Withdrawal by Subject|1|||
30623866|NCT03484117|58635828|FG000|Overall Study|Lost to Follow-up|1|||
30623867|NCT03484117|58635829|FG001|Overall Study|Lost to Follow-up|3|||
30623868|NCT03484117|58635828|FG000|Overall Study|Declined participation in exit assess|1|||
30623869|NCT03484117|58635829|FG001|Overall Study|Declined participation in exit assess|1|||
30623870|NCT01166945|58635837|FG000|Randomized|diagnosed with Group A strep|4|||
30924421|NCT01822899|58959777|FG000|Overall Study|Lack of Efficacy|6|||
30924422|NCT01822899|58959778|FG001|Overall Study|Lack of Efficacy|3|||
30924423|NCT01822899|58959777|FG000|Overall Study|Protocol Violation|6|||
30924424|NCT01822899|58959778|FG001|Overall Study|Protocol Violation|3|||
30924425|NCT01822899|58959777|FG000|Overall Study|Lost to Follow-up|1|||
30924426|NCT01822899|58959778|FG001|Overall Study|Lost to Follow-up|0|||
30924427|NCT01822899|58959777|FG000|Overall Study|Withdrawal by Subject|5|||
30924428|NCT01822899|58959778|FG001|Overall Study|Withdrawal by Subject|7|||
30924429|NCT01822821|58959786|FG000|Overall Study|Eligible surgery cancelled|1|||
30924430|NCT01822821|58959787|FG001|Overall Study|Eligible surgery cancelled|1|||
30924431|NCT01822821|58959786|FG000|Overall Study|Other reasons|1|||
30924432|NCT01822821|58959787|FG001|Overall Study|Other reasons|0|||
30924433|NCT01822665|58959793|FG000|Overall Study|Adverse Event|3|||
30924434|NCT01822665|58959793|FG000|Overall Study|Other Reason|5|||
30924435|NCT02173301|58959815|FG000|Overall Study|Adverse Event|7|||
30924436|NCT02173301|58959816|FG001|Overall Study|Adverse Event|8|||
30924437|NCT02173301|58959817|FG002|Overall Study|Adverse Event|13|||
30924438|NCT02173301|58959818|FG003|Overall Study|Adverse Event|5|||
30924439|NCT02173301|58959815|FG000|Overall Study|Withdrawal by Subject|8|||
30924440|NCT02173301|58959816|FG001|Overall Study|Withdrawal by Subject|10|||
30924441|NCT02173301|58959817|FG002|Overall Study|Withdrawal by Subject|4|||
30924442|NCT02173301|58959818|FG003|Overall Study|Withdrawal by Subject|8|||
30924443|NCT02173301|58959815|FG000|Overall Study|Lost to Follow-up|4|||
30924444|NCT02173301|58959816|FG001|Overall Study|Lost to Follow-up|4|||
30924445|NCT02173301|58959817|FG002|Overall Study|Lost to Follow-up|2|||
30756081|NCT00406367|58765910|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
30756082|NCT00406367|58765911|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
30756083|NCT00406367|58765910|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
30756084|NCT00406367|58765911|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
30756085|NCT00406367|58765910|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
30756086|NCT00406367|58765911|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
30756087|NCT00406367|58765910|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
30756088|NCT00406367|58765911|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
30833631|NCT02112916|58858265|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
30833632|NCT02112916|58858266|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
30833633|NCT02112916|58858267|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
30833634|NCT02112916|58858264|FG000|Overall Study|Still on Therapy|44|||
30833635|NCT02112916|58858265|FG001|Overall Study|Still on Therapy|47|||
30833636|NCT02112916|58858266|FG002|Overall Study|Still on Therapy|3|||
30833637|NCT02112916|58858267|FG003|Overall Study|Still on Therapy|2|||
30833638|NCT02112916|58858264|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
30833639|NCT02112916|58858265|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
30833640|NCT02112916|58858266|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
30833641|NCT02112916|58858267|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
30833642|NCT02112916|58858264|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
30833643|NCT02112916|58858265|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
30833644|NCT02112916|58858266|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
30833645|NCT02112916|58858267|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
30833646|NCT01849562|58858285|FG000|Overall Study|Lost to Follow-up|1|||
30833647|NCT01849562|58858286|FG001|Overall Study|Lost to Follow-up|0|||
30924446|NCT02173301|58959818|FG003|Overall Study|Lost to Follow-up|2|||
30924447|NCT02173301|58959815|FG000|Overall Study|Protocol Violation|0|||
30833648|NCT01849562|58858287|FG002|Overall Study|Lost to Follow-up|0|||
30833649|NCT01849562|58858285|FG000|Overall Study|Non-compliance with Study Drug|1|||
30833650|NCT01849562|58858286|FG001|Overall Study|Non-compliance with Study Drug|0|||
30833651|NCT01849562|58858287|FG002|Overall Study|Non-compliance with Study Drug|0|||
30833652|NCT01700179|58858296|FG000|Overall Study|Physician Decision|2|||
30833653|NCT00665223|58858312|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
30833654|NCT00665223|58858313|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
30833655|NCT00665223|58858314|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
30833656|NCT00665223|58858312|FG000|Randomized Phase (26 Weeks)|Death|0|||
30833657|NCT00665223|58858313|FG001|Randomized Phase (26 Weeks)|Death|0|||
30833658|NCT00665223|58858314|FG002|Randomized Phase (26 Weeks)|Death|1|||
30833659|NCT00665223|58858312|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
30833660|NCT00665223|58858313|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
30833661|NCT00665223|58858314|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
30833662|NCT00665223|58858312|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
30756089|NCT00406367|58765910|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
30756090|NCT00406367|58765911|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
30756091|NCT00406367|58765910|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
30756092|NCT00406367|58765911|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
30756093|NCT00406367|58765910|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
30756094|NCT00406367|58765911|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
30756095|NCT00406367|58765910|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
30756096|NCT00406367|58765911|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
30756097|NCT00406367|58765910|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
30756098|NCT00406367|58765911|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
30756099|NCT00406367|58765910|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
30756100|NCT00406367|58765911|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
30756101|NCT00406367|58765910|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
30756102|NCT00406367|58765911|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
30833663|NCT00665223|58858313|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
30833664|NCT00665223|58858314|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
30833665|NCT00665223|58858312|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
30833666|NCT00665223|58858313|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
30833667|NCT00665223|58858314|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
30833668|NCT00665223|58858312|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
30833669|NCT00665223|58858313|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
30833670|NCT00665223|58858314|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
30833671|NCT00665223|58858312|FG000|Open-Label Period (26 Weeks)|Death|0|||
30833672|NCT00665223|58858313|FG001|Open-Label Period (26 Weeks)|Death|1|||
30833673|NCT00665223|58858314|FG002|Open-Label Period (26 Weeks)|Death|0|||
30833674|NCT00665223|58858312|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
30833675|NCT00665223|58858313|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
30833676|NCT00665223|58858314|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
30833677|NCT00665223|58858312|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
30833678|NCT00665223|58858313|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
30833679|NCT00665223|58858314|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
30833680|NCT00665223|58858312|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
30833681|NCT00665223|58858313|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
30833682|NCT00665223|58858314|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
30833683|NCT00665223|58858312|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
30833684|NCT00665223|58858313|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
30833685|NCT00665223|58858314|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
30843635|NCT02101853|58869614|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
30843636|NCT02101853|58869615|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
30843637|NCT02101853|58869616|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
30843638|NCT02101853|58869617|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
30843639|NCT02101853|58869612|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
30843640|NCT02101853|58869613|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
30843641|NCT02101853|58869614|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
30843642|NCT02101853|58869615|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
30843643|NCT02101853|58869616|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
30843644|NCT02101853|58869617|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
30843645|NCT01915498|58869647|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
30843646|NCT01915498|58869648|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
30843647|NCT01915498|58869649|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
30843648|NCT01915498|58869650|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
30843649|NCT01915498|58869651|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
30843650|NCT01915498|58869652|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
30843651|NCT01915498|58869653|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
30843652|NCT01915498|58869654|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
30843653|NCT01915498|58869655|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
30843654|NCT01915498|58869656|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
30843655|NCT01915498|58869657|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
30843656|NCT01915498|58869658|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
30843657|NCT01915498|58869659|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
30843658|NCT01915498|58869660|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
30843659|NCT01915498|58869661|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
30843660|NCT01915498|58869662|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
30843661|NCT01915498|58869663|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
30843662|NCT01915498|58869664|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
30843663|NCT01915498|58869665|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
30843664|NCT01915498|58869647|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
30843665|NCT01915498|58869648|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
30843666|NCT01915498|58869649|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
30843667|NCT01915498|58869650|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
30843668|NCT01915498|58869651|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
30843669|NCT01915498|58869652|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
30843670|NCT01915498|58869653|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
30843671|NCT01915498|58869654|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
30843672|NCT01915498|58869655|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
30843673|NCT01915498|58869656|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
30843674|NCT01915498|58869657|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
30843675|NCT01915498|58869658|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
30843676|NCT01915498|58869659|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
30843677|NCT01915498|58869660|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
30833686|NCT03786380|58858335|FG000|Overall Study|Adverse Event|1|||
30833687|NCT03786380|58858336|FG001|Overall Study|Adverse Event|0|||
30833688|NCT03786380|58858337|FG002|Overall Study|Adverse Event|0|||
30833689|NCT03786380|58858338|FG003|Overall Study|Adverse Event|3|||
30833690|NCT03786380|58858339|FG004|Overall Study|Adverse Event|1|||
30833691|NCT03786380|58858335|FG000|Overall Study|Lack of Efficacy|0|||
30833692|NCT03786380|58858336|FG001|Overall Study|Lack of Efficacy|0|||
30833693|NCT03786380|58858337|FG002|Overall Study|Lack of Efficacy|0|||
30833694|NCT03786380|58858338|FG003|Overall Study|Lack of Efficacy|0|||
30833695|NCT03786380|58858339|FG004|Overall Study|Lack of Efficacy|1|||
30833696|NCT03786380|58858335|FG000|Overall Study|Withdrawal by Subject|1|||
30833697|NCT03786380|58858336|FG001|Overall Study|Withdrawal by Subject|2|||
30833698|NCT03786380|58858337|FG002|Overall Study|Withdrawal by Subject|2|||
30833699|NCT03786380|58858338|FG003|Overall Study|Withdrawal by Subject|1|||
30833700|NCT03786380|58858339|FG004|Overall Study|Withdrawal by Subject|2|||
30833701|NCT03786380|58858335|FG000|Overall Study|Lost to Follow-up|3|||
30833702|NCT03786380|58858336|FG001|Overall Study|Lost to Follow-up|0|||
30833703|NCT03786380|58858337|FG002|Overall Study|Lost to Follow-up|1|||
30833704|NCT03786380|58858338|FG003|Overall Study|Lost to Follow-up|2|||
30833705|NCT03786380|58858339|FG004|Overall Study|Lost to Follow-up|0|||
30833706|NCT03786380|58858335|FG000|Overall Study|Physician Decision|0|||
30833707|NCT03786380|58858336|FG001|Overall Study|Physician Decision|0|||
30833708|NCT03786380|58858337|FG002|Overall Study|Physician Decision|1|||
30833709|NCT03786380|58858338|FG003|Overall Study|Physician Decision|0|||
30833710|NCT03786380|58858339|FG004|Overall Study|Physician Decision|0|||
30833711|NCT03786380|58858335|FG000|Overall Study|Study Terminated by the Sponsor|30|||
30833712|NCT03786380|58858336|FG001|Overall Study|Study Terminated by the Sponsor|20|||
30833713|NCT03786380|58858337|FG002|Overall Study|Study Terminated by the Sponsor|50|||
30833714|NCT03786380|58858338|FG003|Overall Study|Study Terminated by the Sponsor|57|||
30833715|NCT03786380|58858339|FG004|Overall Study|Study Terminated by the Sponsor|23|||
30833716|NCT03786380|58858335|FG000|Overall Study|Reason Not Specified|0|||
30833717|NCT03786380|58858336|FG001|Overall Study|Reason Not Specified|0|||
30833718|NCT03786380|58858337|FG002|Overall Study|Reason Not Specified|0|||
30833719|NCT03786380|58858338|FG003|Overall Study|Reason Not Specified|0|||
30833720|NCT03786380|58858339|FG004|Overall Study|Reason Not Specified|1|||
30833721|NCT02626000|58858351|FG000|Overall Study|Decision by Sponsor|1|||
30833722|NCT02626000|58858351|FG000|Overall Study|Death|29|||
30833723|NCT02736890|58858367|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
30833724|NCT02736890|58858368|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
30833725|NCT02736890|58858367|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
30833726|NCT02736890|58858368|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
30833727|NCT02779556|58858376|FG000|Baseline|Partial baseline interview completed|1|||
30833728|NCT02779556|58858377|FG001|Baseline|Partial baseline interview completed|0|||
30833729|NCT02779556|58858376|FG000|3 Months|Lost to Follow-up|40|||
30833730|NCT02779556|58858377|FG001|3 Months|Lost to Follow-up|29|||
30833731|NCT02779556|58858376|FG000|3 Months|Missed 3 month clinic visit|27|||
30833732|NCT02779556|58858377|FG001|3 Months|Missed 3 month clinic visit|19|||
30833733|NCT02779556|58858376|FG000|6 Month|Lost to Follow-up|33|||
30833734|NCT02779556|58858377|FG001|6 Month|Lost to Follow-up|39|||
30833735|NCT02779556|58858376|FG000|6 Month HbA1c|No value collected during window|69|||
30833736|NCT02779556|58858377|FG001|6 Month HbA1c|No value collected during window|50|||
30833737|NCT02779556|58858376|FG000|12 Month HbA1c|No value collected during window|138|||
30833738|NCT02779556|58858377|FG001|12 Month HbA1c|No value collected during window|102|||
30833739|NCT01669798|58858383|FG000|Overall Study|Physician Decision|5|||
30756103|NCT00406367|58765910|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
30756104|NCT00406367|58765911|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
30756105|NCT00394589|58765920|FG000|Overall Study|Adverse Event|2|||
30756106|NCT00394589|58765921|FG001|Overall Study|Adverse Event|1|||
30756107|NCT00394589|58765922|FG002|Overall Study|Adverse Event|2|||
30756108|NCT00394589|58765920|FG000|Overall Study|Lack of Efficacy|2|||
30756109|NCT00394589|58765921|FG001|Overall Study|Lack of Efficacy|2|||
30756110|NCT00394589|58765922|FG002|Overall Study|Lack of Efficacy|3|||
30756111|NCT00394589|58765920|FG000|Overall Study|Protocol Violation|4|||
30756112|NCT00394589|58765921|FG001|Overall Study|Protocol Violation|0|||
30756113|NCT00394589|58765922|FG002|Overall Study|Protocol Violation|2|||
30756114|NCT00068406|58765930|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
30833740|NCT02334722|58858389|FG000|Overall Study|Lost to Follow-up|4|||
30833741|NCT02334722|58858390|FG001|Overall Study|Lost to Follow-up|0|||
30833742|NCT02334722|58858389|FG000|Overall Study|6 week questionnaire not completed|2|||
30833743|NCT02334722|58858390|FG001|Overall Study|6 week questionnaire not completed|0|||
30833744|NCT02334722|58858389|FG000|Overall Study|Unable to obtain medication|1|||
30833745|NCT02334722|58858390|FG001|Overall Study|Unable to obtain medication|1|||
30833746|NCT02334722|58858389|FG000|Overall Study|Withdrawal by Subject|0|||
30833747|NCT02334722|58858390|FG001|Overall Study|Withdrawal by Subject|3|||
30833748|NCT02334722|58858389|FG000|Overall Study|Adverse Event|0|||
30756115|NCT00068406|58765930|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
30833749|NCT02334722|58858390|FG001|Overall Study|Adverse Event|2|||
30833750|NCT02334722|58858389|FG000|Overall Study|Physician Decision|0|||
30833751|NCT02334722|58858390|FG001|Overall Study|Physician Decision|1|||
30833752|NCT00812708|58858405|FG000|Overall Study|Device could not be implanted|2|||
30833753|NCT00812708|58858405|FG000|Overall Study|Lack of medical insurance|1|||
30833754|NCT00812708|58858405|FG000|Overall Study|Switched to another study|1|||
30833755|NCT00812708|58858405|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
30833756|NCT00812708|58858405|FG000|Overall Study|Signed consent but later withdrew|3|||
30833757|NCT03761810|58858421|FG000|Overall Study|Adverse Event|12|||
30833758|NCT03761810|58858422|FG001|Overall Study|Adverse Event|0|||
30833759|NCT03761810|58858421|FG000|Overall Study|Lost to Follow-up|15|||
30833760|NCT03761810|58858422|FG001|Overall Study|Lost to Follow-up|7|||
30833761|NCT03761810|58858421|FG000|Overall Study|Pregnancy|1|||
30833762|NCT03761810|58858422|FG001|Overall Study|Pregnancy|0|||
30833763|NCT03761810|58858421|FG000|Overall Study|Withdrawal by Subject|14|||
30833764|NCT03761810|58858422|FG001|Overall Study|Withdrawal by Subject|5|||
30833765|NCT03761810|58858421|FG000|Overall Study|Physician Decision|1|||
30833766|NCT03761810|58858422|FG001|Overall Study|Physician Decision|0|||
30833767|NCT03761810|58858421|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
30833768|NCT03761810|58858422|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
30833769|NCT03761810|58858421|FG000|Overall Study|Other Than Specified|1|||
30833770|NCT03761810|58858422|FG001|Overall Study|Other Than Specified|0|||
30833771|NCT02811159|58858433|FG000|Treatment Course 1|Lost to Follow-up|1|||
30833772|NCT01889186|58858439|FG000|Overall Study|Adverse event- not related to progression|18|||
30833773|NCT01889186|58858440|FG001|Overall Study|Adverse event- not related to progression|5|||
30833774|NCT01889186|58858439|FG000|Overall Study|Adverse event- related to progression|7|||
30833775|NCT01889186|58858440|FG001|Overall Study|Adverse event- related to progression|2|||
30833776|NCT01889186|58858439|FG000|Overall Study|COVID-19 logistical restrictions|1|||
30833777|NCT01889186|58858440|FG001|Overall Study|COVID-19 logistical restrictions|0|||
30833778|NCT01889186|58858439|FG000|Overall Study|Investigator request|1|||
30833779|NCT01889186|58858440|FG001|Overall Study|Investigator request|1|||
30833780|NCT01889186|58858439|FG000|Overall Study|Progressive disease- Richter's|12|||
30833781|NCT01889186|58858440|FG001|Overall Study|Progressive disease- Richter's|7|||
30833782|NCT01889186|58858439|FG000|Overall Study|Progressive disease per protocol|46|||
30833783|NCT01889186|58858440|FG001|Overall Study|Progressive disease per protocol|17|||
30833784|NCT01889186|58858439|FG000|Overall Study|Stem cell transplant|2|||
30833785|NCT01889186|58858440|FG001|Overall Study|Stem cell transplant|1|||
30833786|NCT01889186|58858439|FG000|Overall Study|Withdrew consent|2|||
30833787|NCT01889186|58858440|FG001|Overall Study|Withdrew consent|3|||
30833788|NCT01889186|58858439|FG000|Overall Study|Other, not specified|18|||
30833789|NCT01889186|58858440|FG001|Overall Study|Other, not specified|15|||
30833790|NCT01510184|58858450|FG000|Overall Study|Sponsor discretion|28|||
30833791|NCT01510184|58858451|FG001|Overall Study|Sponsor discretion|28|||
30833792|NCT01510184|58858450|FG000|Overall Study|Death|1|||
30833793|NCT01510184|58858451|FG001|Overall Study|Death|2|||
30833794|NCT01510184|58858450|FG000|Overall Study|Withdrawal by Subject|1|||
30833795|NCT01510184|58858451|FG001|Overall Study|Withdrawal by Subject|4|||
30833796|NCT01510184|58858450|FG000|Overall Study|Other|0|||
30756116|NCT00403559|58765936|FG000|Overall Study|Adverse Event|0|||
30756117|NCT00403559|58765937|FG001|Overall Study|Adverse Event|1|||
30756118|NCT00403559|58765936|FG000|Overall Study|Lost to Follow-up|3|||
30756119|NCT00403559|58765937|FG001|Overall Study|Lost to Follow-up|3|||
30756120|NCT00403559|58765936|FG000|Overall Study|Withdrawal by Subject|1|||
30756121|NCT00403559|58765937|FG001|Overall Study|Withdrawal by Subject|0|||
30756122|NCT00403481|58765945|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
30756123|NCT00403481|58765945|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
30756124|NCT00403481|58765945|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
30756125|NCT00403481|58765945|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
30756126|NCT00403481|58765945|FG000|Olm 40 mg|Adverse Event|2|||
30756127|NCT00403481|58765945|FG000|Olm 40 mg|Protocol Violation|1|||
30756128|NCT00403481|58765945|FG000|Olm 40 mg|Withdrawal by Subject|1|||
30756129|NCT00403481|58765945|FG000|Olm 40 mg|Other|1|||
30756130|NCT00403481|58765945|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
30756131|NCT00403481|58765945|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
30756132|NCT00403481|58765945|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
30833797|NCT01510184|58858451|FG001|Overall Study|Other|1|||
30833798|NCT02809833|58858476|FG000|Overall Study|Death|3|||
30833799|NCT02809833|58858476|FG000|Overall Study|Intolerance|54|||
30833800|NCT02809833|58858476|FG000|Overall Study|Lack of Efficacy|89|||
30833801|NCT02809833|58858476|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
30924448|NCT02173301|58959816|FG001|Overall Study|Protocol Violation|1|||
30833802|NCT02809833|58858476|FG000|Overall Study|Noncompliance|1|||
30833803|NCT02809833|58858476|FG000|Overall Study|Withdrawal by Subject|34|||
30833804|NCT02809833|58858476|FG000|Overall Study|Lost to Follow-up|35|||
30833805|NCT02809833|58858476|FG000|Overall Study|Adverse Event (AE)|24|||
30833806|NCT02809833|58858476|FG000|Overall Study|Other|5|||
30833807|NCT02809833|58858476|FG000|Overall Study|Missing Information|52|||
30833808|NCT02797262|58858482|FG000|Overall Study|Withdrawal by Subject|5|||
30833809|NCT02797262|58858483|FG001|Overall Study|Withdrawal by Subject|1|||
30833810|NCT02797262|58858482|FG000|Overall Study|Lost to Follow-up|10|||
30833811|NCT02797262|58858483|FG001|Overall Study|Lost to Follow-up|7|||
30833812|NCT02797262|58858482|FG000|Overall Study|Death|1|||
30833813|NCT02797262|58858483|FG001|Overall Study|Death|2|||
30833814|NCT02797262|58858482|FG000|Overall Study|Adverse Event|1|||
30833815|NCT02797262|58858483|FG001|Overall Study|Adverse Event|0|||
30833816|NCT02797262|58858482|FG000|Overall Study|COVID-19|2|||
30833817|NCT02797262|58858483|FG001|Overall Study|COVID-19|1|||
30833818|NCT02797262|58858482|FG000|Overall Study|Out-of-country|1|||
30833819|NCT02797262|58858483|FG001|Overall Study|Out-of-country|0|||
30833820|NCT02809053|58858491|FG000|Overall Study|Death|0|||
30833821|NCT02809053|58858492|FG001|Overall Study|Death|1|||
30833822|NCT02809053|58858491|FG000|Overall Study|Lost to Follow-up|3|||
30833823|NCT02809053|58858492|FG001|Overall Study|Lost to Follow-up|1|||
30833824|NCT02809053|58858491|FG000|Overall Study|Withdrawal by Subject|2|||
30833825|NCT02809053|58858492|FG001|Overall Study|Withdrawal by Subject|3|||
30833826|NCT02809053|58858491|FG000|Overall Study|Disease Progression|2|||
30833827|NCT02809053|58858492|FG001|Overall Study|Disease Progression|1|||
30833828|NCT02808975|58858500|FG000|Overall Study|Adverse Event|3|||
30833829|NCT02808975|58858501|FG001|Overall Study|Adverse Event|4|||
30833830|NCT02808975|58858500|FG000|Overall Study|Withdrew consent|9|||
30833831|NCT02808975|58858501|FG001|Overall Study|Withdrew consent|8|||
30833832|NCT02808975|58858500|FG000|Overall Study|Lost to Follow-up|4|||
30833833|NCT02808975|58858501|FG001|Overall Study|Lost to Follow-up|6|||
30833834|NCT02808975|58858500|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
30833835|NCT02808975|58858501|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
30833836|NCT02808975|58858500|FG000|Overall Study|Other, not specified|5|||
30833837|NCT02808975|58858501|FG001|Overall Study|Other, not specified|1|||
30833838|NCT02976038|58858507|FG000|Overall Study|Physician Decision|22|||
30833839|NCT02976038|58858507|FG000|Overall Study|Withdrawal by Subject|3|||
30833840|NCT02976038|58858507|FG000|Overall Study|Lost to Follow-up|2|||
30833841|NCT02976038|58858507|FG000|Overall Study|Adverse Event|1|||
30833842|NCT02808819|58858532|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
30833843|NCT02808819|58858533|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
30833844|NCT02808819|58858532|FG000|Overall Study|Withdrawal by Subject|10|||
30833845|NCT02808819|58858533|FG001|Overall Study|Withdrawal by Subject|13|||
30833846|NCT02808819|58858532|FG000|Overall Study|Site terminated by sponsor|2|||
30833847|NCT02808819|58858533|FG001|Overall Study|Site terminated by sponsor|0|||
30833848|NCT02808819|58858532|FG000|Overall Study|Pregnancy|1|||
30833849|NCT02808819|58858533|FG001|Overall Study|Pregnancy|0|||
30833850|NCT02808819|58858532|FG000|Overall Study|Lost to Follow-up|1|||
30833851|NCT02808819|58858533|FG001|Overall Study|Lost to Follow-up|6|||
30833852|NCT02808819|58858532|FG000|Overall Study|Protocol Violation|0|||
30833853|NCT02808819|58858533|FG001|Overall Study|Protocol Violation|1|||
30833854|NCT02808819|58858532|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
30756133|NCT00403481|58765945|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
30756134|NCT00403481|58765945|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
30756135|NCT00403481|58765945|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
30756136|NCT00402779|58765954|FG000|Overall Study|Screen Failure|77|||
30756137|NCT00402779|58765955|FG001|Overall Study|Screen Failure|76|||
30756138|NCT00394433|58765961|FG000|Overall Study|Adverse Event|2|||
30756139|NCT00394433|58765961|FG000|Overall Study|Alternative Therapy|1|||
30756140|NCT00092534|58765967|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
30756141|NCT00092534|58765968|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
30756142|NCT00092534|58765969|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
30756143|NCT00092534|58765970|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
30756144|NCT00092534|58765971|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
30756145|NCT00092534|58765967|FG000|Base Study Vaccination Period|Adverse Event|3|||
30756146|NCT00092534|58765968|FG001|Base Study Vaccination Period|Adverse Event|1|||
30756147|NCT00092534|58765969|FG002|Base Study Vaccination Period|Adverse Event|0|||
30756148|NCT00092534|58765970|FG003|Base Study Vaccination Period|Adverse Event|0|||
30756149|NCT00092534|58765971|FG004|Base Study Vaccination Period|Adverse Event|0|||
30833855|NCT02808819|58858533|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
30833856|NCT02808819|58858532|FG000|Overall Study|Death|1|||
30833857|NCT02808819|58858533|FG001|Overall Study|Death|0|||
30833858|NCT02808819|58858532|FG000|Overall Study|Adverse Event|3|||
30833859|NCT02808819|58858533|FG001|Overall Study|Adverse Event|4|||
30833860|NCT02808429|58858543|FG000|Overall Study|Lost to Follow-up|1|||
30833861|NCT02808429|58858544|FG001|Overall Study|Lost to Follow-up|0|||
30833862|NCT02808429|58858545|FG002|Overall Study|Lost to Follow-up|0|||
30833863|NCT02808429|58858543|FG000|Overall Study|Protocol Violation|0|||
30833864|NCT02808429|58858544|FG001|Overall Study|Protocol Violation|1|||
30833865|NCT02808429|58858545|FG002|Overall Study|Protocol Violation|0|||
30833866|NCT02808429|58858543|FG000|Overall Study|Premature study termination by sponsor|2|||
30833867|NCT02808429|58858544|FG001|Overall Study|Premature study termination by sponsor|0|||
30833868|NCT02808429|58858545|FG002|Overall Study|Premature study termination by sponsor|1|||
30833869|NCT02808429|58858543|FG000|Overall Study|Relocation|0|||
30833870|NCT02808429|58858544|FG001|Overall Study|Relocation|0|||
30833871|NCT02808429|58858545|FG002|Overall Study|Relocation|1|||
30833872|NCT01594762|58858555|FG000|Overall Study|Withdrawal by Subject|1|||
30833873|NCT01594762|58858556|FG001|Overall Study|Withdrawal by Subject|0|||
30833874|NCT01594762|58858555|FG000|Overall Study|Lost to Follow-up|10|||
30833875|NCT01594762|58858556|FG001|Overall Study|Lost to Follow-up|10|||
30833876|NCT02615470|58858564|FG000|Overall Study|Lost to Follow-up|21|||
30833877|NCT02615470|58858565|FG001|Overall Study|Lost to Follow-up|32|||
30833878|NCT02806947|58858573|FG000|Overall Study|Withdrawal by Subject|5|||
30833879|NCT02806947|58858574|FG001|Overall Study|Withdrawal by Subject|1|||
30833880|NCT02806713|58858582|FG000|Overall Study|Urethral injury during procedure|1|||
30833881|NCT02806713|58858583|FG001|Overall Study|Urethral injury during procedure|0|||
30833882|NCT02806713|58858582|FG000|Overall Study|cancelled surgery|1|||
30833883|NCT02806713|58858583|FG001|Overall Study|cancelled surgery|2|||
30833884|NCT02807493|58858591|FG000|Overall Study|Adverse Event|5|||
30833885|NCT02807493|58858592|FG001|Overall Study|Adverse Event|2|||
30833886|NCT02807493|58858591|FG000|Overall Study|Lost to Follow-up|6|||
30833887|NCT02807493|58858592|FG001|Overall Study|Lost to Follow-up|0|||
30833888|NCT02807493|58858591|FG000|Overall Study|Physician Decision|4|||
30833889|NCT02807493|58858592|FG001|Overall Study|Physician Decision|1|||
30833890|NCT02807493|58858591|FG000|Overall Study|Protocol Violation|7|||
30833891|NCT02807493|58858592|FG001|Overall Study|Protocol Violation|0|||
30833892|NCT02807493|58858591|FG000|Overall Study|Withdrawal by Subject|17|||
30833893|NCT02807493|58858592|FG001|Overall Study|Withdrawal by Subject|10|||
30833894|NCT02807493|58858591|FG000|Overall Study|Other withdrawal|17|||
30833895|NCT02807493|58858592|FG001|Overall Study|Other withdrawal|0|||
30833896|NCT02807493|58858591|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
30833897|NCT02807493|58858592|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
30833898|NCT02807259|58858600|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
30833899|NCT02807259|58858601|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
30833900|NCT02807259|58858600|FG000|Midline (3 Months)|migration, refusal, not available|30|||
30833901|NCT02807259|58858601|FG001|Midline (3 Months)|migration, refusal, not available|34|||
30833902|NCT02807259|58858600|FG000|Endline (3 Months)|migration, refusal, not available|35|||
30833903|NCT02807259|58858601|FG001|Endline (3 Months)|migration, refusal, not available|87|||
30833904|NCT02802345|58858611|FG000|Overall Study|Not Treated|0|||
30833905|NCT02802345|58858612|FG001|Overall Study|Not Treated|1|||
30833906|NCT02802345|58858611|FG000|Overall Study|Adverse Event|28|||
30833907|NCT02802345|58858612|FG001|Overall Study|Adverse Event|20|||
30833908|NCT02802345|58858611|FG000|Overall Study|Withdrawal by Subject|3|||
30833909|NCT02802345|58858612|FG001|Overall Study|Withdrawal by Subject|3|||
30833910|NCT02802345|58858611|FG000|Overall Study|Protocol Violation|0|||
30833911|NCT02802345|58858612|FG001|Overall Study|Protocol Violation|1|||
30833912|NCT02802345|58858611|FG000|Overall Study|Other than listed|1|||
30833913|NCT02802345|58858612|FG001|Overall Study|Other than listed|5|||
30833914|NCT02801877|58858622|FG000|Overall Study|Lost to Follow-up|1|||
30833915|NCT02801877|58858623|FG001|Overall Study|Lost to Follow-up|1|||
30833916|NCT02801877|58858624|FG002|Overall Study|Lost to Follow-up|2|||
30833917|NCT02801877|58858625|FG003|Overall Study|Lost to Follow-up|0|||
30924449|NCT02173301|58959817|FG002|Overall Study|Protocol Violation|0|||
30833918|NCT02801877|58858622|FG000|Overall Study|Never Started Treatment|2|||
30833919|NCT02801877|58858623|FG001|Overall Study|Never Started Treatment|0|||
30833920|NCT02801877|58858624|FG002|Overall Study|Never Started Treatment|4|||
30833921|NCT02801877|58858625|FG003|Overall Study|Never Started Treatment|0|||
30833922|NCT02805309|58858638|FG000|Overall Study|Lost to Follow-up|2|||
30833923|NCT02805309|58858639|FG001|Overall Study|Lost to Follow-up|2|||
30833924|NCT02805309|58858640|FG002|Overall Study|Lost to Follow-up|2|||
30833925|NCT02805309|58858638|FG000|Overall Study|Post-Randomization Exclusion|0|||
30833926|NCT02805309|58858639|FG001|Overall Study|Post-Randomization Exclusion|2|||
30833927|NCT02805309|58858640|FG002|Overall Study|Post-Randomization Exclusion|1|||
30833928|NCT02804763|58858652|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
30833929|NCT02804763|58858653|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
30833930|NCT02804763|58858654|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
30833931|NCT02804763|58858655|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
30833932|NCT02804763|58858652|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
30833933|NCT02804763|58858653|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
30833934|NCT02804763|58858654|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
30833935|NCT02804763|58858655|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
30924450|NCT02173301|58959818|FG003|Overall Study|Protocol Violation|0|||
30924451|NCT02173301|58959815|FG000|Overall Study|Physician Decision|0|||
30924452|NCT02173301|58959816|FG001|Overall Study|Physician Decision|0|||
30924453|NCT02173301|58959817|FG002|Overall Study|Physician Decision|1|||
30924454|NCT02173301|58959818|FG003|Overall Study|Physician Decision|0|||
30924455|NCT02173301|58959815|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
30924456|NCT02173301|58959816|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
30924457|NCT02173301|58959817|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
30924458|NCT02173301|58959818|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
30924459|NCT01822587|58959831|FG000|Overall Study|Lost to Follow-up|7|||
30924460|NCT01822587|58959832|FG001|Overall Study|Lost to Follow-up|9|||
30924461|NCT01822587|58959833|FG002|Overall Study|Lost to Follow-up|12|||
30924462|NCT01822587|58959831|FG000|Overall Study|Physician Decision|9|||
30924463|NCT01822587|58959832|FG001|Overall Study|Physician Decision|6|||
30924464|NCT01822587|58959833|FG002|Overall Study|Physician Decision|6|||
30924465|NCT01822353|58959844|FG000|Overall Study|Adverse Event|1|||
30924466|NCT01822353|58959845|FG001|Overall Study|Adverse Event|3|||
30924467|NCT01822353|58959846|FG002|Overall Study|Adverse Event|1|||
30924468|NCT01822353|58959844|FG000|Overall Study|Pregnancy|0|||
30924469|NCT01822353|58959845|FG001|Overall Study|Pregnancy|1|||
30924470|NCT01822353|58959846|FG002|Overall Study|Pregnancy|0|||
30833936|NCT02804763|58858652|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
30833937|NCT02804763|58858653|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
30833938|NCT02804763|58858654|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
30833939|NCT02804763|58858655|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
30833940|NCT02804763|58858652|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
30833941|NCT02804763|58858653|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
30924471|NCT01822353|58959844|FG000|Overall Study|Withdrawal by Subject|3|||
30924472|NCT01822353|58959845|FG001|Overall Study|Withdrawal by Subject|1|||
30756150|NCT00092534|58765967|FG000|Base Study Vaccination Period|Death|5|||
30756151|NCT00092534|58765968|FG001|Base Study Vaccination Period|Death|4|||
30756152|NCT00092534|58765969|FG002|Base Study Vaccination Period|Death|0|||
30756153|NCT00092534|58765970|FG003|Base Study Vaccination Period|Death|0|||
30756154|NCT00092534|58765971|FG004|Base Study Vaccination Period|Death|0|||
30756155|NCT00092534|58765967|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
30756156|NCT00092534|58765968|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
30756157|NCT00092534|58765969|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
30756158|NCT00092534|58765970|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
30756159|NCT00092534|58765971|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
30756160|NCT00092534|58765967|FG000|Base Study Vaccination Period|Physician Decision|1|||
30756161|NCT00092534|58765968|FG001|Base Study Vaccination Period|Physician Decision|0|||
30756162|NCT00092534|58765969|FG002|Base Study Vaccination Period|Physician Decision|0|||
30756163|NCT00092534|58765970|FG003|Base Study Vaccination Period|Physician Decision|0|||
30924473|NCT01822353|58959846|FG002|Overall Study|Withdrawal by Subject|0|||
30756164|NCT00092534|58765971|FG004|Base Study Vaccination Period|Physician Decision|0|||
30756165|NCT00092534|58765967|FG000|Base Study Vaccination Period|Pregnancy|9|||
30924474|NCT01821963|58959857|FG000|Overall Study|Adverse Event|1|||
30833942|NCT02804763|58858654|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
30756166|NCT00092534|58765968|FG001|Base Study Vaccination Period|Pregnancy|7|||
30756167|NCT00092534|58765969|FG002|Base Study Vaccination Period|Pregnancy|0|||
30756168|NCT00092534|58765970|FG003|Base Study Vaccination Period|Pregnancy|0|||
30756169|NCT00092534|58765971|FG004|Base Study Vaccination Period|Pregnancy|0|||
30756170|NCT00092534|58765967|FG000|Base Study Vaccination Period|Protocol Violation|2|||
30756171|NCT00092534|58765968|FG001|Base Study Vaccination Period|Protocol Violation|1|||
30756172|NCT00092534|58765969|FG002|Base Study Vaccination Period|Protocol Violation|0|||
30756173|NCT00092534|58765970|FG003|Base Study Vaccination Period|Protocol Violation|0|||
30756174|NCT00092534|58765971|FG004|Base Study Vaccination Period|Protocol Violation|0|||
30756175|NCT00092534|58765967|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
30756176|NCT00092534|58765968|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
30756177|NCT00092534|58765969|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
30756178|NCT00092534|58765970|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
30756179|NCT00092534|58765971|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
30756180|NCT00092534|58765967|FG000|Base Study Vaccination Period|Moved|14|||
30756181|NCT00092534|58765968|FG001|Base Study Vaccination Period|Moved|12|||
30756182|NCT00092534|58765969|FG002|Base Study Vaccination Period|Moved|0|||
30756183|NCT00092534|58765970|FG003|Base Study Vaccination Period|Moved|0|||
30756184|NCT00092534|58765971|FG004|Base Study Vaccination Period|Moved|0|||
30756185|NCT00092534|58765967|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
30756186|NCT00092534|58765968|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
30756187|NCT00092534|58765969|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
30756188|NCT00092534|58765970|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
30756189|NCT00092534|58765971|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
30756190|NCT00092534|58765967|FG000|Base Study Vaccination Period|Travel|1|||
30756191|NCT00092534|58765968|FG001|Base Study Vaccination Period|Travel|0|||
30756192|NCT00092534|58765969|FG002|Base Study Vaccination Period|Travel|0|||
30756193|NCT00092534|58765970|FG003|Base Study Vaccination Period|Travel|0|||
30756194|NCT00092534|58765971|FG004|Base Study Vaccination Period|Travel|0|||
30756195|NCT00092534|58765967|FG000|Base Study Vaccination Period|Site Closed|0|||
30756196|NCT00092534|58765968|FG001|Base Study Vaccination Period|Site Closed|1|||
30756197|NCT00092534|58765969|FG002|Base Study Vaccination Period|Site Closed|0|||
30756198|NCT00092534|58765970|FG003|Base Study Vaccination Period|Site Closed|0|||
30756199|NCT00092534|58765971|FG004|Base Study Vaccination Period|Site Closed|0|||
30756200|NCT00092534|58765967|FG000|Base Study Follow-Up Period|Adverse Event|2|||
30756201|NCT00092534|58765968|FG001|Base Study Follow-Up Period|Adverse Event|4|||
30623871|NCT01166945|58635838|FG001|Randomized|diagnosed with Group A strep|4|||
30623872|NCT01166945|58635837|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
30623873|NCT01166945|58635838|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
30623874|NCT01166945|58635837|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
30623875|NCT01166945|58635838|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
30623876|NCT01166945|58635837|FG000|Day 30|Lost to Follow-up|4|||
30623877|NCT01166945|58635838|FG001|Day 30|Lost to Follow-up|3|||
30623878|NCT00910000|58635852|FG000|Overall Study|Adverse Event|0|||
30756202|NCT00092534|58765969|FG002|Base Study Follow-Up Period|Adverse Event|0|||
30756203|NCT00092534|58765970|FG003|Base Study Follow-Up Period|Adverse Event|0|||
30756204|NCT00092534|58765971|FG004|Base Study Follow-Up Period|Adverse Event|0|||
30756205|NCT00092534|58765967|FG000|Base Study Follow-Up Period|Death|2|||
30756206|NCT00092534|58765968|FG001|Base Study Follow-Up Period|Death|1|||
30756207|NCT00092534|58765969|FG002|Base Study Follow-Up Period|Death|0|||
30756208|NCT00092534|58765970|FG003|Base Study Follow-Up Period|Death|0|||
30756209|NCT00092534|58765971|FG004|Base Study Follow-Up Period|Death|0|||
30756210|NCT00092534|58765967|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
30756211|NCT00092534|58765968|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
30756212|NCT00092534|58765969|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
30756213|NCT00092534|58765970|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
30756214|NCT00092534|58765971|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
30756215|NCT00092534|58765967|FG000|Base Study Follow-Up Period|Pregnancy|6|||
30756216|NCT00092534|58765968|FG001|Base Study Follow-Up Period|Pregnancy|10|||
30756217|NCT00092534|58765969|FG002|Base Study Follow-Up Period|Pregnancy|0|||
30756218|NCT00092534|58765970|FG003|Base Study Follow-Up Period|Pregnancy|0|||
30756219|NCT00092534|58765971|FG004|Base Study Follow-Up Period|Pregnancy|0|||
30756220|NCT00092534|58765967|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
30756221|NCT00092534|58765968|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
30833943|NCT02804763|58858655|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
30833944|NCT02804763|58858652|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
30623879|NCT00910000|58635853|FG001|Overall Study|Adverse Event|3|||
30756222|NCT00092534|58765969|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
30833945|NCT02804763|58858653|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
30623880|NCT00910000|58635854|FG002|Overall Study|Adverse Event|2|||
30623881|NCT00910000|58635855|FG003|Overall Study|Adverse Event|2|||
30833946|NCT02804763|58858654|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
30833947|NCT02804763|58858655|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
30833948|NCT02804763|58858652|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
30833949|NCT02804763|58858653|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
30833950|NCT02804763|58858654|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
30833951|NCT02804763|58858655|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
30833952|NCT02748057|58858671|FG000|Overall Study|Adverse Event|1|||
30833953|NCT02748057|58858672|FG001|Overall Study|Adverse Event|0|||
30833954|NCT02748057|58858671|FG000|Overall Study|Physician Decision|0|||
30833955|NCT02748057|58858672|FG001|Overall Study|Physician Decision|1|||
30833956|NCT02748057|58858671|FG000|Overall Study|Protocol Violation|2|||
30833957|NCT02748057|58858672|FG001|Overall Study|Protocol Violation|1|||
30833958|NCT02748057|58858671|FG000|Overall Study|Participant Moved|1|||
30833959|NCT02748057|58858672|FG001|Overall Study|Participant Moved|0|||
30833960|NCT02748057|58858671|FG000|Overall Study|Withdrawal by Subject|1|||
30833961|NCT02748057|58858672|FG001|Overall Study|Withdrawal by Subject|0|||
30833962|NCT02748213|58858680|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
30833963|NCT02748213|58858681|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
30833964|NCT02748213|58858680|FG000|Overall Study|Abnormal Laboratory Test|1|||
30833965|NCT02748213|58858681|FG001|Overall Study|Abnormal Laboratory Test|0|||
30833966|NCT02748213|58858680|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
30833967|NCT02748213|58858681|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
30833968|NCT02748213|58858680|FG000|Overall Study|Death|5|||
30833969|NCT02748213|58858681|FG001|Overall Study|Death|3|||
30833970|NCT02748213|58858680|FG000|Overall Study|Insufficient Therapeutic Response|56|||
30833971|NCT02748213|58858681|FG001|Overall Study|Insufficient Therapeutic Response|57|||
30833972|NCT02748213|58858680|FG000|Overall Study|Violation of Selection Criteria|2|||
30833973|NCT02748213|58858681|FG001|Overall Study|Violation of Selection Criteria|0|||
30833974|NCT02748213|58858680|FG000|Overall Study|Protocol Violation|6|||
30833975|NCT02748213|58858681|FG001|Overall Study|Protocol Violation|4|||
30833976|NCT02748213|58858680|FG000|Overall Study|Refused Treatment*|6|||
30833977|NCT02748213|58858681|FG001|Overall Study|Refused Treatment*|6|||
30833978|NCT02748213|58858680|FG000|Overall Study|Failure to Return|1|||
30833979|NCT02748213|58858681|FG001|Overall Study|Failure to Return|0|||
30833980|NCT02748213|58858680|FG000|Overall Study|Other|30|||
30833981|NCT02748213|58858681|FG001|Overall Study|Other|29|||
30833982|NCT02613910|58858687|FG000|Overall Study|Termination of study|1|||
30833983|NCT02802735|58858694|FG000|Overall Study|Withdrawal by Subject|0|||
30833984|NCT02802735|58858695|FG001|Overall Study|Withdrawal by Subject|1|||
30833985|NCT02802735|58858696|FG002|Overall Study|Withdrawal by Subject|0|||
30833986|NCT02802735|58858697|FG003|Overall Study|Withdrawal by Subject|0|||
30833987|NCT02802735|58858698|FG004|Overall Study|Withdrawal by Subject|0|||
30833988|NCT02799381|58858728|FG000|Overall Study|Withdrew consent|3|||
30756223|NCT00092534|58765970|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
30756224|NCT00092534|58765971|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
30756225|NCT00092534|58765967|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
30756226|NCT00092534|58765968|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
30833989|NCT02799381|58858729|FG001|Overall Study|Withdrew consent|2|||
30833990|NCT02799381|58858728|FG000|Overall Study|Adverse Event|0|||
30833991|NCT02799381|58858729|FG001|Overall Study|Adverse Event|1|||
30833992|NCT02799381|58858728|FG000|Overall Study|Participant did not take any study drug|1|||
30833993|NCT02799381|58858729|FG001|Overall Study|Participant did not take any study drug|0|||
30833994|NCT01333059|58858737|FG000|Overall Study|Physician Decision|3|||
30833995|NCT01333059|58858738|FG001|Overall Study|Physician Decision|3|||
30924475|NCT01821807|58959863|FG000|Overall Study|Lost to Follow-up|3|||
30924476|NCT01821807|58959864|FG001|Overall Study|Lost to Follow-up|1|||
30924477|NCT01821729|58959870|FG000|Overall Study|Withdrawal by Subject|1|||
30924478|NCT01820637|58959874|FG000|Overall Study|Death|2|||
30756227|NCT00092534|58765969|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
30756228|NCT00092534|58765970|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
30756229|NCT00092534|58765971|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
30833996|NCT01333059|58858737|FG000|Overall Study|Protocol Violation|3|||
30833997|NCT01333059|58858738|FG001|Overall Study|Protocol Violation|0|||
30833998|NCT01370733|58858748|FG000|Overall Study|Withdrawal by Subject|8|||
30924479|NCT01820637|58959874|FG000|Overall Study|Withdrawal by Subject|1|||
30756230|NCT00092534|58765967|FG000|Base Study Follow-Up Period|Moved|62|||
30833999|NCT01370733|58858749|FG001|Overall Study|Withdrawal by Subject|8|||
30834000|NCT01370733|58858748|FG000|Overall Study|Lost to Follow-up|3|||
30834001|NCT01370733|58858749|FG001|Overall Study|Lost to Follow-up|0|||
30834002|NCT01370733|58858748|FG000|Overall Study|Adverse Event|2|||
30834003|NCT01370733|58858749|FG001|Overall Study|Adverse Event|4|||
30834004|NCT01370733|58858748|FG000|Overall Study|Lack of Efficacy|3|||
30834005|NCT01370733|58858749|FG001|Overall Study|Lack of Efficacy|5|||
30834006|NCT01370733|58858748|FG000|Overall Study|Physician Decision|0|||
30756231|NCT00092534|58765968|FG001|Base Study Follow-Up Period|Moved|58|||
30924480|NCT02172911|58959880|FG000|Overall Study|Serious Adverse Event|0|||
30924481|NCT02172911|58959881|FG001|Overall Study|Serious Adverse Event|1|||
30924482|NCT02172911|58959880|FG000|Overall Study|Progression of Disease|0|||
30924483|NCT02172911|58959881|FG001|Overall Study|Progression of Disease|1|||
30924484|NCT02172911|58959880|FG000|Overall Study|Loss of insurance coverage|1|||
30924485|NCT02172911|58959881|FG001|Overall Study|Loss of insurance coverage|0|||
30924486|NCT02120027|58959889|FG000|Overall Study|Adverse Event|4|||
30924487|NCT02120027|58959890|FG001|Overall Study|Adverse Event|5|||
30924488|NCT02120027|58959889|FG000|Overall Study|Lack of Efficacy|3|||
30924489|NCT02120027|58959890|FG001|Overall Study|Lack of Efficacy|5|||
30924490|NCT02120027|58959889|FG000|Overall Study|Lost to Follow-up|5|||
30924491|NCT02120027|58959890|FG001|Overall Study|Lost to Follow-up|13|||
30924492|NCT02120027|58959889|FG000|Overall Study|Other|4|||
30924493|NCT02120027|58959890|FG001|Overall Study|Other|0|||
30924494|NCT02120027|58959889|FG000|Overall Study|Physician Decision|4|||
30924495|NCT02120027|58959890|FG001|Overall Study|Physician Decision|3|||
30924496|NCT02120027|58959889|FG000|Overall Study|Protocol Violation|18|||
30924497|NCT02120027|58959890|FG001|Overall Study|Protocol Violation|21|||
30924498|NCT02120027|58959889|FG000|Overall Study|Study terminated by Sponsor|45|||
30924499|NCT02120027|58959890|FG001|Overall Study|Study terminated by Sponsor|47|||
30924500|NCT02120027|58959889|FG000|Overall Study|Withdrawal by Subject|33|||
30924501|NCT02120027|58959890|FG001|Overall Study|Withdrawal by Subject|25|||
30924502|NCT01850823|58959899|FG000|Overall Study|Early Visit Window|0|||
30924503|NCT01850823|58959900|FG001|Overall Study|Early Visit Window|1|||
30924504|NCT01850823|58959901|FG002|Overall Study|Early Visit Window|4|||
30924505|NCT01850823|58959899|FG000|Overall Study|Enrolled in Error|0|||
30924506|NCT01850823|58959900|FG001|Overall Study|Enrolled in Error|1|||
30924507|NCT01850823|58959901|FG002|Overall Study|Enrolled in Error|2|||
30924508|NCT01850823|58959899|FG000|Overall Study|Lack of Efficacy|1|||
30924509|NCT01850823|58959900|FG001|Overall Study|Lack of Efficacy|0|||
30924510|NCT01850823|58959901|FG002|Overall Study|Lack of Efficacy|0|||
30924511|NCT01850823|58959899|FG000|Overall Study|Lost to Follow-up|0|||
30924512|NCT01850823|58959900|FG001|Overall Study|Lost to Follow-up|0|||
30924513|NCT01850823|58959901|FG002|Overall Study|Lost to Follow-up|1|||
30924514|NCT01850823|58959899|FG000|Overall Study|Restricted Medication|0|||
30924515|NCT01850823|58959900|FG001|Overall Study|Restricted Medication|0|||
30924516|NCT01850823|58959901|FG002|Overall Study|Restricted Medication|2|||
30924517|NCT01850823|58959899|FG000|Overall Study|Significant worstening of SAR|0|||
30924518|NCT01850823|58959900|FG001|Overall Study|Significant worstening of SAR|1|||
30924519|NCT01850823|58959901|FG002|Overall Study|Significant worstening of SAR|0|||
30924520|NCT01850823|58959899|FG000|Overall Study|Withdrawal by Subject|2|||
30924521|NCT01850823|58959900|FG001|Overall Study|Withdrawal by Subject|0|||
30924522|NCT01850823|58959901|FG002|Overall Study|Withdrawal by Subject|1|||
30924523|NCT01820559|58959914|FG000|Overall Study|Adverse Event|4|||
30924524|NCT01820559|58959915|FG001|Overall Study|Adverse Event|6|||
30924525|NCT01820559|58959916|FG002|Overall Study|Adverse Event|13|||
30924526|NCT01820559|58959914|FG000|Overall Study|Withdrawal by Subject|1|||
30924527|NCT01820559|58959915|FG001|Overall Study|Withdrawal by Subject|2|||
30924528|NCT01820559|58959916|FG002|Overall Study|Withdrawal by Subject|5|||
30924529|NCT01820559|58959914|FG000|Overall Study|Protocol Violation|2|||
30924530|NCT01820559|58959915|FG001|Overall Study|Protocol Violation|1|||
30924531|NCT01820559|58959916|FG002|Overall Study|Protocol Violation|3|||
30924532|NCT01820559|58959914|FG000|Overall Study|Subject's non-compliance|1|||
30924533|NCT01820559|58959915|FG001|Overall Study|Subject's non-compliance|0|||
30924534|NCT01820559|58959916|FG002|Overall Study|Subject's non-compliance|2|||
30924535|NCT01820559|58959914|FG000|Overall Study|Lost to Follow-up|3|||
30924536|NCT01820559|58959915|FG001|Overall Study|Lost to Follow-up|2|||
30924537|NCT01820559|58959916|FG002|Overall Study|Lost to Follow-up|2|||
30924538|NCT01820559|58959914|FG000|Overall Study|At sponsor request|0|||
30924539|NCT01820559|58959915|FG001|Overall Study|At sponsor request|0|||
30924540|NCT01820559|58959916|FG002|Overall Study|At sponsor request|1|||
30924541|NCT01820559|58959914|FG000|Overall Study|Lack of Efficacy|3|||
30924542|NCT01820559|58959915|FG001|Overall Study|Lack of Efficacy|2|||
30834007|NCT01370733|58858749|FG001|Overall Study|Physician Decision|2|||
30834008|NCT01370733|58858748|FG000|Overall Study|Protocol Violation|1|||
30834009|NCT01370733|58858749|FG001|Overall Study|Protocol Violation|3|||
30834010|NCT02613364|58858758|FG000|Overall Study|Other|19|||
30834011|NCT02613364|58858759|FG001|Overall Study|Other|29|||
30834012|NCT02613364|58858760|FG002|Overall Study|Other|17|||
30834013|NCT02613364|58858758|FG000|Overall Study|Too time consuming|21|||
30924543|NCT01820559|58959916|FG002|Overall Study|Lack of Efficacy|3|||
30924544|NCT01818765|58959924|FG000|Overall Study|Death|2|||
30924545|NCT01850589|58959931|FG000|Overall Study|Withdrawal by Subject|8|||
30834014|NCT02613364|58858759|FG001|Overall Study|Too time consuming|26|||
30834015|NCT02613364|58858760|FG002|Overall Study|Too time consuming|26|||
30834016|NCT02613364|58858758|FG000|Overall Study|Withdrawal by Subject|13|||
30924546|NCT01850589|58959932|FG001|Overall Study|Withdrawal by Subject|0|||
30924547|NCT01818531|58959940|FG000|Overall Study|Withdrawn for case delay after block|1|||
30924548|NCT01818531|58959941|FG001|Overall Study|Withdrawn for case delay after block|0|||
30924549|NCT01818531|58959940|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
30924550|NCT01818531|58959941|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
30924551|NCT01818531|58959940|FG000|Overall Study|Withdrawn for failure to place block|0|||
30924552|NCT01818531|58959941|FG001|Overall Study|Withdrawn for failure to place block|1|||
30924553|NCT02171429|58959950|FG000|Overall Study|Other|0|||
30924554|NCT02171429|58959951|FG001|Overall Study|Other|1|||
30924555|NCT02171429|58959952|FG002|Overall Study|Other|1|||
30924556|NCT02171429|58959950|FG000|Overall Study|Non-Compliance|0|||
30924557|NCT02171429|58959951|FG001|Overall Study|Non-Compliance|0|||
30924558|NCT02171429|58959952|FG002|Overall Study|Non-Compliance|1|||
30924559|NCT02171429|58959950|FG000|Overall Study|Physician Decision|0|||
30924560|NCT02171429|58959951|FG001|Overall Study|Physician Decision|0|||
30924561|NCT02171429|58959952|FG002|Overall Study|Physician Decision|1|||
30924562|NCT02171429|58959950|FG000|Overall Study|Withdrawal by Subject|1|||
30924563|NCT02171429|58959951|FG001|Overall Study|Withdrawal by Subject|1|||
30924564|NCT02171429|58959952|FG002|Overall Study|Withdrawal by Subject|1|||
30924565|NCT02171429|58959950|FG000|Overall Study|Lost to Follow-up|0|||
30924566|NCT02171429|58959951|FG001|Overall Study|Lost to Follow-up|1|||
30924567|NCT02171429|58959952|FG002|Overall Study|Lost to Follow-up|0|||
30924568|NCT02171429|58959950|FG000|Overall Study|Death|0|||
30924569|NCT02171429|58959951|FG001|Overall Study|Death|0|||
30924570|NCT02171429|58959952|FG002|Overall Study|Death|1|||
30924571|NCT01818297|58959965|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
30924572|NCT01818297|58959966|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
30924573|NCT01818297|58959965|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
30924574|NCT01818297|58959966|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
30924575|NCT01818297|58959965|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
30924576|NCT01818297|58959966|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
30924577|NCT01818141|58959974|FG000|Overall Study|Withdrawal by Subject|2|||
30924578|NCT01818141|58959975|FG001|Overall Study|Withdrawal by Subject|0|||
30924579|NCT01818141|58959974|FG000|Overall Study|No baseline C.diff colonies|1|||
30924580|NCT01818141|58959975|FG001|Overall Study|No baseline C.diff colonies|1|||
30924581|NCT01818141|58959974|FG000|Overall Study|Lost to Follow-up|0|||
30924582|NCT01818141|58959975|FG001|Overall Study|Lost to Follow-up|2|||
30924583|NCT01849497|58959983|FG000|Overall Study|Withdrawal by Subject|1|||
30924584|NCT01849497|58959984|FG001|Overall Study|Withdrawal by Subject|2|||
30924585|NCT01849497|58959983|FG000|Overall Study|Sponsor Decision|0|||
30924586|NCT01849497|58959984|FG001|Overall Study|Sponsor Decision|1|||
30924587|NCT01849497|58959983|FG000|Overall Study|Lost to Follow-up|0|||
30924588|NCT01849497|58959984|FG001|Overall Study|Lost to Follow-up|1|||
30924589|NCT02147093|58959992|FG000|Period 1|Lost to Follow-up|0|||
30924590|NCT02147093|58959993|FG001|Period 1|Lost to Follow-up|1|||
30924591|NCT02147093|58959992|FG000|Period 2|Protocol Violation|2|||
30924592|NCT02147093|58959993|FG001|Period 2|Protocol Violation|0|||
30924593|NCT02119325|58959999|FG000|Washout Period 1|Adverse Event|0|||
30924594|NCT02119325|58960000|FG001|Washout Period 1|Adverse Event|1|||
30924595|NCT01816893|58960010|FG000|Washout Period|Withdrawal by Subject|2|||
30924596|NCT01816893|58960011|FG001|Washout Period|Withdrawal by Subject|0|||
30924597|NCT01848483|58960019|FG000|Overall Study|Death|2|||
30924598|NCT01848483|58960020|FG001|Overall Study|Death|1|||
30834017|NCT02613364|58858759|FG001|Overall Study|Withdrawal by Subject|18|||
30834018|NCT02613364|58858760|FG002|Overall Study|Withdrawal by Subject|17|||
30834019|NCT02613364|58858758|FG000|Overall Study|Medical|12|||
30834020|NCT02613364|58858759|FG001|Overall Study|Medical|13|||
30834021|NCT02613364|58858760|FG002|Overall Study|Medical|9|||
30834022|NCT02613364|58858758|FG000|Overall Study|Disliked Study Procedure|1|||
30834023|NCT02613364|58858759|FG001|Overall Study|Disliked Study Procedure|1|||
30834024|NCT02613364|58858760|FG002|Overall Study|Disliked Study Procedure|4|||
30834025|NCT02613364|58858758|FG000|Overall Study|Disliked Intervention|0|||
30834026|NCT02613364|58858759|FG001|Overall Study|Disliked Intervention|3|||
30834027|NCT02613364|58858760|FG002|Overall Study|Disliked Intervention|3|||
30834028|NCT01370655|58858780|FG000|Period 1|Adverse Event|2|||
30834029|NCT01370655|58858781|FG001|Period 1|Adverse Event|0|||
30834030|NCT01370655|58858782|FG002|Period 1|Adverse Event|0|||
30834031|NCT01370655|58858783|FG003|Period 1|Adverse Event|0|||
30834032|NCT01370655|58858784|FG004|Period 1|Adverse Event|0|||
30834033|NCT01370655|58858785|FG005|Period 1|Adverse Event|0|||
30834034|NCT01370655|58858786|FG006|Period 1|Adverse Event|1|||
30834035|NCT01370655|58858787|FG007|Period 1|Adverse Event|0|||
30834036|NCT01370655|58858788|FG008|Period 1|Adverse Event|0|||
30834037|NCT01370655|58858789|FG009|Period 1|Adverse Event|0|||
30834038|NCT01370655|58858790|FG010|Period 1|Adverse Event|0|||
30834039|NCT01370655|58858791|FG011|Period 1|Adverse Event|0|||
30834040|NCT01370655|58858780|FG000|Period 2|Adverse Event|0|||
30834041|NCT01370655|58858781|FG001|Period 2|Adverse Event|0|||
30834042|NCT01370655|58858782|FG002|Period 2|Adverse Event|1|||
30623882|NCT00910000|58635856|FG004|Overall Study|Adverse Event|0|||
30834043|NCT01370655|58858783|FG003|Period 2|Adverse Event|0|||
30834044|NCT01370655|58858784|FG004|Period 2|Adverse Event|1|||
30834045|NCT01370655|58858785|FG005|Period 2|Adverse Event|0|||
30924599|NCT01848483|58960019|FG000|Overall Study|Lost to Follow-up|6|||
30924600|NCT01848483|58960020|FG001|Overall Study|Lost to Follow-up|8|||
30924601|NCT01848483|58960019|FG000|Overall Study|Withdrawal by Subject|1|||
30924602|NCT01848483|58960020|FG001|Overall Study|Withdrawal by Subject|0|||
30924603|NCT01848483|58960019|FG000|Overall Study|Incarceration|2|||
30924604|NCT01848483|58960020|FG001|Overall Study|Incarceration|2|||
30924605|NCT01610271|58960029|FG000|Overall Study|Surgery not complete|0|||
30924606|NCT01610271|58960030|FG001|Overall Study|Surgery not complete|1|||
30924607|NCT01610271|58960029|FG000|Overall Study|Prosthesis not implanted|2|||
30924608|NCT01610271|58960030|FG001|Overall Study|Prosthesis not implanted|3|||
30924609|NCT02170727|58960040|FG000|Overall Study|Lost to Follow-up|1|||
30924610|NCT02170727|58960041|FG001|Overall Study|Lost to Follow-up|0|||
30834046|NCT01370655|58858786|FG006|Period 2|Adverse Event|0|||
30834047|NCT01370655|58858787|FG007|Period 2|Adverse Event|1|||
30834048|NCT01370655|58858788|FG008|Period 2|Adverse Event|0|||
30834049|NCT01370655|58858789|FG009|Period 2|Adverse Event|0|||
30834050|NCT01370655|58858790|FG010|Period 2|Adverse Event|0|||
30834051|NCT01370655|58858791|FG011|Period 2|Adverse Event|0|||
30924611|NCT02170727|58960040|FG000|Overall Study|Withdrawal by Subject|2|||
30924612|NCT02170727|58960041|FG001|Overall Study|Withdrawal by Subject|0|||
30924613|NCT01847313|58960052|FG000|Overall Study|Death|0|||
30924614|NCT01847313|58960053|FG001|Overall Study|Death|1|||
30924615|NCT01847313|58960052|FG000|Overall Study|Withdrawal by Subject|0|||
30924616|NCT01847313|58960053|FG001|Overall Study|Withdrawal by Subject|1|||
30924617|NCT02144285|58960069|FG000|Overall Study|Withdrawal by Subject|0|||
30924618|NCT02144285|58960070|FG001|Overall Study|Withdrawal by Subject|0|||
30834052|NCT01370655|58858780|FG000|Period 2|met protocol specified stopping criteria|0|||
30834053|NCT01370655|58858781|FG001|Period 2|met protocol specified stopping criteria|0|||
30834054|NCT01370655|58858782|FG002|Period 2|met protocol specified stopping criteria|1|||
30834055|NCT01370655|58858783|FG003|Period 2|met protocol specified stopping criteria|0|||
30834056|NCT01370655|58858784|FG004|Period 2|met protocol specified stopping criteria|0|||
30834057|NCT01370655|58858785|FG005|Period 2|met protocol specified stopping criteria|0|||
30834058|NCT01370655|58858786|FG006|Period 2|met protocol specified stopping criteria|1|||
30834059|NCT01370655|58858787|FG007|Period 2|met protocol specified stopping criteria|0|||
30834060|NCT01370655|58858788|FG008|Period 2|met protocol specified stopping criteria|1|||
30834061|NCT01370655|58858789|FG009|Period 2|met protocol specified stopping criteria|0|||
30834062|NCT01370655|58858790|FG010|Period 2|met protocol specified stopping criteria|1|||
30834063|NCT01370655|58858791|FG011|Period 2|met protocol specified stopping criteria|0|||
30834064|NCT01370655|58858780|FG000|Period 2|Withdrawal by Subject|0|||
30834065|NCT01370655|58858781|FG001|Period 2|Withdrawal by Subject|0|||
30834066|NCT01370655|58858782|FG002|Period 2|Withdrawal by Subject|0|||
30924619|NCT02144285|58960071|FG002|Overall Study|Withdrawal by Subject|0|||
30924620|NCT02144285|58960072|FG003|Overall Study|Withdrawal by Subject|0|||
30756232|NCT00092534|58765969|FG002|Base Study Follow-Up Period|Moved|0|||
30756233|NCT00092534|58765970|FG003|Base Study Follow-Up Period|Moved|0|||
30756234|NCT00092534|58765971|FG004|Base Study Follow-Up Period|Moved|0|||
30756235|NCT00092534|58765967|FG000|Base Study Follow-Up Period|Travel|10|||
30756236|NCT00092534|58765968|FG001|Base Study Follow-Up Period|Travel|7|||
30756237|NCT00092534|58765969|FG002|Base Study Follow-Up Period|Travel|0|||
30756238|NCT00092534|58765970|FG003|Base Study Follow-Up Period|Travel|0|||
30756239|NCT00092534|58765971|FG004|Base Study Follow-Up Period|Travel|0|||
30756240|NCT00092534|58765967|FG000|Base Study Follow-Up Period|Site Closed|0|||
30756241|NCT00092534|58765968|FG001|Base Study Follow-Up Period|Site Closed|2|||
30756242|NCT00092534|58765969|FG002|Base Study Follow-Up Period|Site Closed|0|||
30756243|NCT00092534|58765970|FG003|Base Study Follow-Up Period|Site Closed|0|||
30756244|NCT00092534|58765971|FG004|Base Study Follow-Up Period|Site Closed|0|||
30756245|NCT00092534|58765967|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
30756246|NCT00092534|58765968|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
30756247|NCT00092534|58765969|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
30756248|NCT00092534|58765970|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
30756249|NCT00092534|58765971|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
30756250|NCT00092534|58765967|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
30756251|NCT00092534|58765968|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
30756252|NCT00092534|58765969|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
30756253|NCT00092534|58765970|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
30756254|NCT00092534|58765971|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
30756255|NCT00092534|58765967|FG000|Base Study EXT|Lost to Follow-up|0|||
30756256|NCT00092534|58765968|FG001|Base Study EXT|Lost to Follow-up|0|||
30834067|NCT01370655|58858783|FG003|Period 2|Withdrawal by Subject|0|||
30924621|NCT02144285|58960073|FG004|Overall Study|Withdrawal by Subject|1|||
30924622|NCT02144285|58960074|FG005|Overall Study|Withdrawal by Subject|0|||
30924623|NCT02144285|58960075|FG006|Overall Study|Withdrawal by Subject|0|||
30924624|NCT02144285|58960076|FG007|Overall Study|Withdrawal by Subject|0|||
30924625|NCT02144285|58960077|FG008|Overall Study|Withdrawal by Subject|0|||
30924626|NCT02144285|58960078|FG009|Overall Study|Withdrawal by Subject|0|||
30924627|NCT02117687|58960116|FG000|Overall Study|Lost to Follow-up|0|||
30924628|NCT02117687|58960117|FG001|Overall Study|Lost to Follow-up|1|||
30756257|NCT00092534|58765969|FG002|Base Study EXT|Lost to Follow-up|41|||
30756258|NCT00092534|58765970|FG003|Base Study EXT|Lost to Follow-up|0|||
30756259|NCT00092534|58765971|FG004|Base Study EXT|Lost to Follow-up|0|||
30756260|NCT00092534|58765967|FG000|Base Study EXT|Physician Decision|0|||
30834068|NCT01370655|58858784|FG004|Period 2|Withdrawal by Subject|0|||
30924629|NCT02117687|58960116|FG000|Overall Study|Adverse Event|0|||
30924630|NCT02117687|58960117|FG001|Overall Study|Adverse Event|2|||
30924631|NCT02117687|58960116|FG000|Overall Study|Other Reasons|1|||
30924632|NCT02117687|58960117|FG001|Overall Study|Other Reasons|1|||
30924633|NCT02143583|58960126|FG000|Overall Study|Withdrawal by Subject|1|||
30924634|NCT02143583|58960127|FG001|Overall Study|Withdrawal by Subject|0|||
30924635|NCT02143583|58960128|FG002|Overall Study|Withdrawal by Subject|1|||
30924636|NCT02143583|58960126|FG000|Overall Study|husband illness|0|||
30924637|NCT02143583|58960127|FG001|Overall Study|husband illness|0|||
30924638|NCT02143583|58960128|FG002|Overall Study|husband illness|1|||
30924639|NCT02105987|58960138|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
30924640|NCT02105987|58960139|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
30924641|NCT02105987|58960140|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
30924642|NCT02105987|58960141|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
30924643|NCT02105987|58960142|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
30924644|NCT02105987|58960143|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
30924645|NCT02105987|58960138|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
30924646|NCT02105987|58960139|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
30924647|NCT02105987|58960140|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
30924648|NCT02105987|58960141|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
30924649|NCT02105987|58960142|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
30924650|NCT02105987|58960143|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
30924651|NCT02105987|58960138|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
30924652|NCT02105987|58960139|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
30924653|NCT02105987|58960140|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
30924654|NCT02105987|58960141|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
30924655|NCT02105987|58960142|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
30924656|NCT02105987|58960143|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
30924657|NCT02105987|58960138|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
30924658|NCT02105987|58960139|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
30924659|NCT02105987|58960140|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
30924660|NCT02105987|58960141|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
30924661|NCT02105987|58960142|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
30924662|NCT02105987|58960143|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
30924663|NCT02105987|58960138|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
30924664|NCT02105987|58960139|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
30924665|NCT02105987|58960140|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
30924666|NCT02105987|58960141|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
30924667|NCT02105987|58960142|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
30756261|NCT00092534|58765968|FG001|Base Study EXT|Physician Decision|0|||
30756262|NCT00092534|58765969|FG002|Base Study EXT|Physician Decision|1|||
30834069|NCT01370655|58858785|FG005|Period 2|Withdrawal by Subject|0|||
30834070|NCT01370655|58858786|FG006|Period 2|Withdrawal by Subject|0|||
30834071|NCT01370655|58858787|FG007|Period 2|Withdrawal by Subject|0|||
30834072|NCT01370655|58858788|FG008|Period 2|Withdrawal by Subject|1|||
30834073|NCT01370655|58858789|FG009|Period 2|Withdrawal by Subject|0|||
30834074|NCT01370655|58858790|FG010|Period 2|Withdrawal by Subject|0|||
30756263|NCT00092534|58765970|FG003|Base Study EXT|Physician Decision|0|||
30756264|NCT00092534|58765971|FG004|Base Study EXT|Physician Decision|0|||
30756265|NCT00092534|58765967|FG000|Base Study EXT|Pregnancy|0|||
30834075|NCT01370655|58858791|FG011|Period 2|Withdrawal by Subject|0|||
30834076|NCT02612194|58858804|FG000|Overall Study|Death|5|||
30834077|NCT02612194|58858805|FG001|Overall Study|Death|0|||
30834078|NCT02612194|58858806|FG002|Overall Study|Death|2|||
30834079|NCT02612194|58858804|FG000|Overall Study|Early Study Termination|1|||
30756266|NCT00092534|58765968|FG001|Base Study EXT|Pregnancy|0|||
30756267|NCT00092534|58765969|FG002|Base Study EXT|Pregnancy|12|||
30756268|NCT00092534|58765970|FG003|Base Study EXT|Pregnancy|0|||
30756269|NCT00092534|58765971|FG004|Base Study EXT|Pregnancy|0|||
30756270|NCT00092534|58765967|FG000|Base Study EXT|Withdrawal by Subject|0|||
30756271|NCT00092534|58765968|FG001|Base Study EXT|Withdrawal by Subject|0|||
30834080|NCT02612194|58858805|FG001|Overall Study|Early Study Termination|0|||
30834081|NCT02612194|58858806|FG002|Overall Study|Early Study Termination|0|||
30834082|NCT02798211|58858816|FG000|Period 1|Adverse Event|1|||
30834083|NCT02798211|58858817|FG001|Period 1|Adverse Event|1|||
30834084|NCT02798211|58858818|FG002|Period 1|Adverse Event|0|||
30834085|NCT02798211|58858819|FG003|Period 1|Adverse Event|0|||
30924668|NCT02105987|58960143|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
30924669|NCT02105987|58960138|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
30924670|NCT02105987|58960139|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
30924671|NCT02105987|58960140|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
30924672|NCT02105987|58960141|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
30924673|NCT02105987|58960142|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
30924674|NCT02105987|58960143|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
30924675|NCT02105987|58960138|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
30924676|NCT02105987|58960139|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
30924677|NCT02105987|58960140|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
30924678|NCT02105987|58960141|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
30924679|NCT02105987|58960142|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
30924680|NCT02105987|58960143|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
30924681|NCT02105987|58960138|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
30924682|NCT02105987|58960139|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
30924683|NCT02105987|58960140|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
30924684|NCT02105987|58960141|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
30924685|NCT02105987|58960142|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
30924686|NCT02105987|58960143|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
30924687|NCT02105987|58960138|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
30924688|NCT02105987|58960139|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
30924689|NCT02105987|58960140|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
30924690|NCT02105987|58960141|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
30924691|NCT02105987|58960142|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
30924692|NCT02105987|58960143|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
30924693|NCT02105987|58960138|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
30924694|NCT02105987|58960139|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
30924695|NCT02105987|58960140|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
30924696|NCT02105987|58960141|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
30834086|NCT02798211|58858820|FG004|Period 1|Adverse Event|0|||
30834087|NCT02798211|58858821|FG005|Period 1|Adverse Event|0|||
30924697|NCT02105987|58960142|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
30924698|NCT02105987|58960143|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
30924699|NCT02105987|58960138|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
30924700|NCT02105987|58960139|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
30924701|NCT02105987|58960140|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
30924702|NCT02105987|58960141|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
30924703|NCT02105987|58960142|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
30924704|NCT02105987|58960143|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
30924705|NCT02105987|58960138|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
30924706|NCT02105987|58960139|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
30924707|NCT02105987|58960140|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
30924708|NCT02105987|58960141|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
30924709|NCT02105987|58960142|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
30834088|NCT02798211|58858816|FG000|Period 1|Lost to Follow-up|2|||
30834089|NCT02798211|58858817|FG001|Period 1|Lost to Follow-up|1|||
30834090|NCT02798211|58858818|FG002|Period 1|Lost to Follow-up|0|||
30834091|NCT02798211|58858819|FG003|Period 1|Lost to Follow-up|0|||
30924710|NCT02105987|58960143|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
30924711|NCT02105987|58960138|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
30924712|NCT02105987|58960139|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
30924713|NCT02105987|58960140|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
30924714|NCT02105987|58960141|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
30924715|NCT02105987|58960142|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
30924716|NCT02105987|58960143|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
30924717|NCT02105987|58960138|FG000|Continuation Phase|Protocol Violation|0|||
30924718|NCT02105987|58960139|FG001|Continuation Phase|Protocol Violation|0|||
30924719|NCT02105987|58960140|FG002|Continuation Phase|Protocol Violation|0|||
30924720|NCT02105987|58960141|FG003|Continuation Phase|Protocol Violation|0|||
30924721|NCT02105987|58960142|FG004|Continuation Phase|Protocol Violation|1|||
30834092|NCT02798211|58858820|FG004|Period 1|Lost to Follow-up|0|||
30834093|NCT02798211|58858821|FG005|Period 1|Lost to Follow-up|0|||
30924722|NCT02105987|58960143|FG005|Continuation Phase|Protocol Violation|0|||
30924723|NCT02141633|58960151|FG000|Overall Study|Physician Decision|1|||
30834094|NCT02798211|58858816|FG000|Period 1|Protocol Violation|0|||
30834095|NCT02798211|58858817|FG001|Period 1|Protocol Violation|0|||
30924724|NCT02141633|58960152|FG001|Overall Study|Physician Decision|0|||
30924725|NCT01846611|58960160|FG000|Overall Study|Lost to Follow-up|4|||
30924726|NCT01846611|58960161|FG001|Overall Study|Lost to Follow-up|6|||
30834096|NCT02798211|58858818|FG002|Period 1|Protocol Violation|2|||
30924727|NCT01846611|58960160|FG000|Overall Study|Withdrawal by Subject|15|||
30924728|NCT01846611|58960161|FG001|Overall Study|Withdrawal by Subject|19|||
30924729|NCT01846611|58960160|FG000|Overall Study|Other|19|||
30924730|NCT01846611|58960161|FG001|Overall Study|Other|18|||
30924731|NCT02141399|58960167|FG000|Overall Study|Adverse Event|158|||
30924732|NCT02141399|58960167|FG000|Overall Study|Lack of Efficacy|62|||
30924733|NCT02141399|58960167|FG000|Overall Study|Lost to Follow-up|151|||
30924734|NCT02141399|58960167|FG000|Overall Study|Non-compliance with study drug|18|||
30924735|NCT02141399|58960167|FG000|Overall Study|Other|45|||
30924736|NCT02141399|58960167|FG000|Overall Study|Physician Decision|17|||
30924737|NCT02141399|58960167|FG000|Overall Study|Pregnancy|3|||
30924738|NCT02141399|58960167|FG000|Overall Study|Protocol Violation|38|||
30924739|NCT02141399|58960167|FG000|Overall Study|Withdrawal by Subject|238|||
30924740|NCT02141399|58960167|FG000|Overall Study|Failure to meet eligibility criteria|14|||
30924741|NCT01846299|58960173|FG000|Overall Study|Physician Decision|4|||
30924742|NCT01846299|58960174|FG001|Overall Study|Physician Decision|2|||
30924743|NCT01846299|58960173|FG000|Overall Study|Protocol deviation|1|||
30924744|NCT01846299|58960174|FG001|Overall Study|Protocol deviation|0|||
30924745|NCT01846299|58960173|FG000|Overall Study|Death|1|||
30924746|NCT01846299|58960174|FG001|Overall Study|Death|2|||
30924747|NCT01846299|58960173|FG000|Overall Study|Lost to Follow-up|3|||
30924748|NCT01846299|58960174|FG001|Overall Study|Lost to Follow-up|0|||
30924749|NCT01846299|58960173|FG000|Overall Study|Withdrawal by Subject|1|||
30924750|NCT01846299|58960174|FG001|Overall Study|Withdrawal by Subject|6|||
30924751|NCT01846299|58960173|FG000|Overall Study|Adverse Event|2|||
30924752|NCT01846299|58960174|FG001|Overall Study|Adverse Event|0|||
30924753|NCT01628393|58960185|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
30924754|NCT01628393|58960186|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
30924755|NCT01628393|58960187|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
30924756|NCT01628393|58960188|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
30924757|NCT01628393|58960189|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
30924758|NCT01628393|58960185|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
30924759|NCT01628393|58960186|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
30924760|NCT01628393|58960187|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
30924761|NCT01628393|58960188|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
30924762|NCT01628393|58960189|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
30924763|NCT01628393|58960185|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
30924764|NCT01628393|58960186|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
30924765|NCT01628393|58960187|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
30924766|NCT01628393|58960188|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
30924767|NCT01628393|58960189|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
30834097|NCT02798211|58858819|FG003|Period 1|Protocol Violation|0|||
30834098|NCT02798211|58858820|FG004|Period 1|Protocol Violation|0|||
30834099|NCT02798211|58858821|FG005|Period 1|Protocol Violation|0|||
30834100|NCT02798211|58858816|FG000|Period 1|Withdrawal by Subject|1|||
30834101|NCT02798211|58858817|FG001|Period 1|Withdrawal by Subject|1|||
30834102|NCT02798211|58858818|FG002|Period 1|Withdrawal by Subject|0|||
30834103|NCT02798211|58858819|FG003|Period 1|Withdrawal by Subject|0|||
30924768|NCT01628393|58960185|FG000|Blinded Active Extension Period|Adverse Event|0|||
30924769|NCT01628393|58960186|FG001|Blinded Active Extension Period|Adverse Event|1|||
30924770|NCT01628393|58960187|FG002|Blinded Active Extension Period|Adverse Event|0|||
30924771|NCT01628393|58960188|FG003|Blinded Active Extension Period|Adverse Event|2|||
30924772|NCT01628393|58960189|FG004|Blinded Active Extension Period|Adverse Event|2|||
30924773|NCT01628393|58960185|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
30924774|NCT01628393|58960186|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
30924775|NCT01628393|58960187|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
30924776|NCT01628393|58960188|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
30924777|NCT01628393|58960189|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
30924778|NCT01628393|58960185|FG000|Blinded Active Extension Period|Physician Decision|0|||
30924779|NCT01628393|58960186|FG001|Blinded Active Extension Period|Physician Decision|3|||
30924780|NCT01628393|58960187|FG002|Blinded Active Extension Period|Physician Decision|0|||
30924781|NCT01628393|58960188|FG003|Blinded Active Extension Period|Physician Decision|1|||
30924782|NCT01628393|58960189|FG004|Blinded Active Extension Period|Physician Decision|0|||
30924783|NCT01628393|58960185|FG000|Blinded Active Extension Period|Protocol Violation|0|||
30924784|NCT01628393|58960186|FG001|Blinded Active Extension Period|Protocol Violation|0|||
30924785|NCT01628393|58960187|FG002|Blinded Active Extension Period|Protocol Violation|2|||
30834104|NCT02798211|58858820|FG004|Period 1|Withdrawal by Subject|0|||
30834105|NCT02798211|58858821|FG005|Period 1|Withdrawal by Subject|0|||
30924786|NCT01628393|58960188|FG003|Blinded Active Extension Period|Protocol Violation|1|||
30834106|NCT02798211|58858816|FG000|Period 1|Death|0|||
30623883|NCT00910000|58635857|FG005|Overall Study|Adverse Event|1|||
30834107|NCT02798211|58858817|FG001|Period 1|Death|0|||
30834108|NCT02798211|58858818|FG002|Period 1|Death|1|||
30924787|NCT01628393|58960189|FG004|Blinded Active Extension Period|Protocol Violation|0|||
30924788|NCT01628393|58960185|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
30924789|NCT01628393|58960186|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
30924790|NCT01628393|58960187|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
30924791|NCT01628393|58960188|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
30924792|NCT01628393|58960189|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
30924793|NCT01846221|58960205|FG000|Overall Study|Catheter Failure|2|||
30924794|NCT01846221|58960206|FG001|Overall Study|Catheter Failure|0|||
30834109|NCT02798211|58858819|FG003|Period 1|Death|0|||
30834110|NCT02798211|58858820|FG004|Period 1|Death|0|||
30834111|NCT02798211|58858821|FG005|Period 1|Death|0|||
30834112|NCT02798211|58858816|FG000|Period 1|Withdrawal of Informed Consent|2|||
30834113|NCT02798211|58858817|FG001|Period 1|Withdrawal of Informed Consent|7|||
30834114|NCT02798211|58858818|FG002|Period 1|Withdrawal of Informed Consent|3|||
30924795|NCT01846221|58960205|FG000|Overall Study|Age Exclusion|1|||
30924796|NCT01846221|58960206|FG001|Overall Study|Age Exclusion|0|||
30924797|NCT01815099|58960212|FG000|Overall Study|Lack of Efficacy|1|||
30924798|NCT01815099|58960212|FG000|Overall Study|unable to attend study visits|1|||
30834115|NCT02798211|58858819|FG003|Period 1|Withdrawal of Informed Consent|0|||
30834116|NCT02798211|58858820|FG004|Period 1|Withdrawal of Informed Consent|0|||
30834117|NCT02798211|58858821|FG005|Period 1|Withdrawal of Informed Consent|0|||
30834118|NCT02798211|58858816|FG000|Period 2|Withdrawal by Subject|2|||
30834119|NCT02798211|58858817|FG001|Period 2|Withdrawal by Subject|0|||
30834120|NCT02798211|58858818|FG002|Period 2|Withdrawal by Subject|0|||
30834121|NCT02798211|58858819|FG003|Period 2|Withdrawal by Subject|0|||
30834122|NCT02798211|58858820|FG004|Period 2|Withdrawal by Subject|2|||
30834123|NCT02798211|58858821|FG005|Period 2|Withdrawal by Subject|2|||
30834124|NCT02798211|58858816|FG000|Period 2|Adverse Event|5|||
30834125|NCT02798211|58858817|FG001|Period 2|Adverse Event|0|||
30834126|NCT02798211|58858818|FG002|Period 2|Adverse Event|0|||
30834127|NCT02798211|58858819|FG003|Period 2|Adverse Event|0|||
30834128|NCT02798211|58858820|FG004|Period 2|Adverse Event|1|||
30834129|NCT02798211|58858821|FG005|Period 2|Adverse Event|0|||
30834130|NCT02798211|58858816|FG000|Period 2|Lack of Efficacy|1|||
30834131|NCT02798211|58858817|FG001|Period 2|Lack of Efficacy|0|||
30834132|NCT02798211|58858818|FG002|Period 2|Lack of Efficacy|0|||
30834133|NCT02798211|58858819|FG003|Period 2|Lack of Efficacy|1|||
30834134|NCT02798211|58858820|FG004|Period 2|Lack of Efficacy|0|||
30834135|NCT02798211|58858821|FG005|Period 2|Lack of Efficacy|1|||
30834136|NCT02798211|58858816|FG000|Period 2|Lost to Follow-up|3|||
30834137|NCT02798211|58858817|FG001|Period 2|Lost to Follow-up|0|||
30834138|NCT02798211|58858818|FG002|Period 2|Lost to Follow-up|0|||
30834139|NCT02798211|58858819|FG003|Period 2|Lost to Follow-up|0|||
30834140|NCT02798211|58858820|FG004|Period 2|Lost to Follow-up|2|||
30834141|NCT02798211|58858821|FG005|Period 2|Lost to Follow-up|0|||
30834142|NCT02798211|58858816|FG000|Period 2|Physician Decision|1|||
30834143|NCT02798211|58858817|FG001|Period 2|Physician Decision|0|||
30834144|NCT02798211|58858818|FG002|Period 2|Physician Decision|0|||
30834145|NCT02798211|58858819|FG003|Period 2|Physician Decision|1|||
30834146|NCT02798211|58858820|FG004|Period 2|Physician Decision|1|||
30834147|NCT02798211|58858821|FG005|Period 2|Physician Decision|0|||
30834148|NCT02798211|58858816|FG000|Period 2|Pregnancy|0|||
30834149|NCT02798211|58858817|FG001|Period 2|Pregnancy|0|||
30834150|NCT02798211|58858818|FG002|Period 2|Pregnancy|0|||
30834151|NCT02798211|58858819|FG003|Period 2|Pregnancy|2|||
30834152|NCT02798211|58858820|FG004|Period 2|Pregnancy|0|||
30834153|NCT02798211|58858821|FG005|Period 2|Pregnancy|0|||
30834154|NCT02798211|58858816|FG000|Period 2|Technical problems|1|||
30834155|NCT02798211|58858817|FG001|Period 2|Technical problems|0|||
30834156|NCT02798211|58858818|FG002|Period 2|Technical problems|0|||
30834157|NCT02798211|58858819|FG003|Period 2|Technical problems|1|||
30834158|NCT02798211|58858820|FG004|Period 2|Technical problems|0|||
30834159|NCT02798211|58858821|FG005|Period 2|Technical problems|0|||
30834160|NCT02798211|58858816|FG000|Period 2|Withdrawal of Informed Consent|1|||
30834161|NCT02798211|58858817|FG001|Period 2|Withdrawal of Informed Consent|0|||
30834162|NCT02798211|58858818|FG002|Period 2|Withdrawal of Informed Consent|0|||
30834163|NCT02798211|58858819|FG003|Period 2|Withdrawal of Informed Consent|2|||
30834164|NCT02798211|58858820|FG004|Period 2|Withdrawal of Informed Consent|2|||
30834165|NCT02798211|58858821|FG005|Period 2|Withdrawal of Informed Consent|3|||
30834166|NCT02799069|58858836|FG000|Overall Study|Adverse Event|0|||
30924799|NCT01845831|58960219|FG000|Inpatient Phase|Withdrawal by Subject|1|||
30834167|NCT02799069|58858837|FG001|Overall Study|Adverse Event|2|||
30834168|NCT02799069|58858838|FG002|Overall Study|Adverse Event|2|||
30834169|NCT02799069|58858836|FG000|Overall Study|Lack of Efficacy|2|||
30834170|NCT02799069|58858837|FG001|Overall Study|Lack of Efficacy|0|||
30834171|NCT02799069|58858838|FG002|Overall Study|Lack of Efficacy|0|||
30834172|NCT02799069|58858836|FG000|Overall Study|Lost to Follow-up|1|||
30834173|NCT02799069|58858837|FG001|Overall Study|Lost to Follow-up|1|||
30834174|NCT02799069|58858838|FG002|Overall Study|Lost to Follow-up|0|||
30834175|NCT02799069|58858836|FG000|Overall Study|Withdrawal by Subject|4|||
30924800|NCT01845831|58960220|FG001|Inpatient Phase|Withdrawal by Subject|1|||
30924801|NCT01845831|58960221|FG002|Inpatient Phase|Withdrawal by Subject|0|||
30924802|NCT01845831|58960222|FG003|Inpatient Phase|Withdrawal by Subject|0|||
30924803|NCT01845831|58960223|FG004|Inpatient Phase|Withdrawal by Subject|0|||
30924804|NCT01627691|58960234|FG000|Overall Study|Death|11|||
30924805|NCT01627691|58960234|FG000|Overall Study|Lost to Follow-up|3|||
30924806|NCT01627691|58960234|FG000|Overall Study|Withdrawal by Subject|1|||
30924807|NCT01627691|58960234|FG000|Overall Study|Missed the visit|3|||
30834176|NCT02799069|58858837|FG001|Overall Study|Withdrawal by Subject|4|||
30834177|NCT02799069|58858838|FG002|Overall Study|Withdrawal by Subject|3|||
30834178|NCT02799069|58858836|FG000|Overall Study|Protocol Violation|1|||
30834179|NCT02799069|58858837|FG001|Overall Study|Protocol Violation|0|||
30834180|NCT02799069|58858838|FG002|Overall Study|Protocol Violation|2|||
30834181|NCT01669174|58858848|FG000|Overall Study|Subject withdrew consent|2|||
30924808|NCT01844895|58960238|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
30924809|NCT01844895|58960238|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
30924810|NCT01844895|58960238|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
30924811|NCT01844895|58960238|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
30924812|NCT01844895|58960238|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
30924813|NCT01844895|58960238|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
30924814|NCT01844895|58960238|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
30924815|NCT02116361|58960255|FG000|Overall Study|Pregnancy|0|||
30924816|NCT02116361|58960256|FG001|Overall Study|Pregnancy|0|||
30924817|NCT02116361|58960257|FG002|Overall Study|Pregnancy|0|||
30924818|NCT02116361|58960258|FG003|Overall Study|Pregnancy|1|||
30924819|NCT02116361|58960255|FG000|Overall Study|Protocol Violation|1|||
30924820|NCT02116361|58960256|FG001|Overall Study|Protocol Violation|0|||
30924821|NCT02116361|58960257|FG002|Overall Study|Protocol Violation|0|||
30924822|NCT02116361|58960258|FG003|Overall Study|Protocol Violation|2|||
30924823|NCT02116361|58960255|FG000|Overall Study|Physician Decision|2|||
30924824|NCT02116361|58960256|FG001|Overall Study|Physician Decision|3|||
30924825|NCT02116361|58960257|FG002|Overall Study|Physician Decision|0|||
30924826|NCT02116361|58960258|FG003|Overall Study|Physician Decision|0|||
30924827|NCT02116361|58960255|FG000|Overall Study|Adverse Event|1|||
30924828|NCT02116361|58960256|FG001|Overall Study|Adverse Event|0|||
30924829|NCT02116361|58960257|FG002|Overall Study|Adverse Event|0|||
30924830|NCT02116361|58960258|FG003|Overall Study|Adverse Event|3|||
30924831|NCT02116361|58960255|FG000|Overall Study|Other Reasons|3|||
30924832|NCT02116361|58960256|FG001|Overall Study|Other Reasons|3|||
30924833|NCT02116361|58960257|FG002|Overall Study|Other Reasons|3|||
30924834|NCT02116361|58960258|FG003|Overall Study|Other Reasons|3|||
30924835|NCT02116361|58960255|FG000|Overall Study|Lack of Efficacy|5|||
30924836|NCT02116361|58960256|FG001|Overall Study|Lack of Efficacy|7|||
30924837|NCT02116361|58960257|FG002|Overall Study|Lack of Efficacy|4|||
30924838|NCT02116361|58960258|FG003|Overall Study|Lack of Efficacy|3|||
30924839|NCT02116361|58960255|FG000|Overall Study|Lost to Follow-up|4|||
30756272|NCT00092534|58765969|FG002|Base Study EXT|Withdrawal by Subject|18|||
30756273|NCT00092534|58765970|FG003|Base Study EXT|Withdrawal by Subject|0|||
30756274|NCT00092534|58765971|FG004|Base Study EXT|Withdrawal by Subject|0|||
30756275|NCT00092534|58765967|FG000|Base Study EXT|Participant moved|0|||
30756276|NCT00092534|58765968|FG001|Base Study EXT|Participant moved|0|||
30756277|NCT00092534|58765969|FG002|Base Study EXT|Participant moved|6|||
30756278|NCT00092534|58765970|FG003|Base Study EXT|Participant moved|0|||
30756279|NCT00092534|58765971|FG004|Base Study EXT|Participant moved|0|||
30756280|NCT00092534|58765967|FG000|Base Study EXT|Travel|0|||
30756281|NCT00092534|58765968|FG001|Base Study EXT|Travel|0|||
30834182|NCT01669174|58858849|FG001|Overall Study|Subject withdrew consent|2|||
30834183|NCT01669174|58858848|FG000|Overall Study|Lost to Follow-up|1|||
30834184|NCT01669174|58858849|FG001|Overall Study|Lost to Follow-up|0|||
30834185|NCT01669174|58858848|FG000|Overall Study|Adverse Event|2|||
30834186|NCT01669174|58858849|FG001|Overall Study|Adverse Event|2|||
30834187|NCT01669174|58858848|FG000|Overall Study|Administrative problems|1|||
30834188|NCT01669174|58858849|FG001|Overall Study|Administrative problems|2|||
30834189|NCT02798835|58858858|FG000|Overall Study|Protocol Violation|0|||
30834190|NCT02798835|58858859|FG001|Overall Study|Protocol Violation|0|||
30834191|NCT02798835|58858860|FG002|Overall Study|Protocol Violation|3|||
30924840|NCT02116361|58960256|FG001|Overall Study|Lost to Follow-up|5|||
30756282|NCT00092534|58765969|FG002|Base Study EXT|Travel|2|||
30756283|NCT00092534|58765970|FG003|Base Study EXT|Travel|0|||
30756284|NCT00092534|58765971|FG004|Base Study EXT|Travel|0|||
30756285|NCT00092534|58765967|FG000|Base Study EXT|Site closed|0|||
30843678|NCT01915498|58869661|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
30924841|NCT02116361|58960257|FG002|Overall Study|Lost to Follow-up|7|||
30924842|NCT02116361|58960258|FG003|Overall Study|Lost to Follow-up|5|||
30924843|NCT02116361|58960255|FG000|Overall Study|Personal Reasons|6|||
30924844|NCT02116361|58960256|FG001|Overall Study|Personal Reasons|6|||
30623884|NCT00910000|58635852|FG000|Overall Study|Withdrawal by Subject|0|||
30834192|NCT02611882|58858871|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
30834193|NCT02611882|58858872|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
30834194|NCT02611882|58858873|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
30834195|NCT02796963|58858884|FG000|Overall Study|Lost to Follow-up|89|||
30834196|NCT02796963|58858885|FG001|Overall Study|Lost to Follow-up|76|||
30834197|NCT02796963|58858886|FG002|Overall Study|Lost to Follow-up|69|||
30834198|NCT02796963|58858887|FG003|Overall Study|Lost to Follow-up|72|||
30834199|NCT02796651|58858897|FG000|Overall Study|Adverse Event|6|||
30834200|NCT02796651|58858897|FG000|Overall Study|Lost to Follow-up|1|||
30834201|NCT02796651|58858897|FG000|Overall Study|Withdrawal by Subject|4|||
30834202|NCT02796651|58858897|FG000|Overall Study|Protocol Violation|4|||
30834203|NCT02796651|58858897|FG000|Overall Study|Lack of Efficacy|1|||
30834204|NCT02796651|58858897|FG000|Overall Study|Other|10|||
30834205|NCT02613208|58858912|FG000|Overall Study|Withdrawal by Subject|1|||
30834206|NCT02613208|58858912|FG000|Overall Study|Change of address|2|||
30834207|NCT02613208|58858912|FG000|Overall Study|Physician Decision|2|||
30834208|NCT02613208|58858912|FG000|Overall Study|Lost to Follow-up|5|||
30834209|NCT02613208|58858912|FG000|Overall Study|Death|37|||
30834210|NCT01668784|58858918|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
30834211|NCT01668784|58858919|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
30834212|NCT01668784|58858918|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
30834213|NCT01668784|58858919|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
30834214|NCT01668784|58858918|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
30834215|NCT01668784|58858919|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
30834216|NCT01668784|58858918|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
30834217|NCT01668784|58858919|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
30834218|NCT01668784|58858918|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
30924845|NCT02116361|58960257|FG002|Overall Study|Personal Reasons|4|||
30756286|NCT00092534|58765968|FG001|Base Study EXT|Site closed|0|||
30756287|NCT00092534|58765969|FG002|Base Study EXT|Site closed|21|||
30756288|NCT00092534|58765970|FG003|Base Study EXT|Site closed|0|||
30756289|NCT00092534|58765971|FG004|Base Study EXT|Site closed|0|||
30756290|NCT00092534|58765967|FG000|Base Study EXT|Study ended|0|||
30756291|NCT00092534|58765968|FG001|Base Study EXT|Study ended|0|||
30756292|NCT00092534|58765969|FG002|Base Study EXT|Study ended|29|||
30756293|NCT00092534|58765970|FG003|Base Study EXT|Study ended|0|||
30756294|NCT00092534|58765971|FG004|Base Study EXT|Study ended|0|||
30756295|NCT00092534|58765967|FG000|Base Study EXT|Protocol Violation|0|||
30756296|NCT00092534|58765968|FG001|Base Study EXT|Protocol Violation|0|||
30756297|NCT00092534|58765969|FG002|Base Study EXT|Protocol Violation|15|||
30756298|NCT00092534|58765970|FG003|Base Study EXT|Protocol Violation|0|||
30756299|NCT00092534|58765971|FG004|Base Study EXT|Protocol Violation|0|||
30756300|NCT00092534|58765967|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
30756301|NCT00092534|58765968|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
30756302|NCT00092534|58765969|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
30756303|NCT00092534|58765970|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
30756304|NCT00092534|58765971|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
30756305|NCT00068250|58765984|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
30756306|NCT00068250|58765985|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
30756307|NCT00068250|58765986|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
30756308|NCT00068250|58765987|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
30756309|NCT00393887|58765997|FG000|Overall Study|Physician Decision|5|||
30756310|NCT00393887|58765998|FG001|Overall Study|Physician Decision|0|||
30756311|NCT00393887|58765997|FG000|Overall Study|Lost to Follow-up|11|||
30756312|NCT00393887|58765998|FG001|Overall Study|Lost to Follow-up|9|||
30756313|NCT00393029|58766006|FG000|Overall Study|Not treated|0|||
30756314|NCT00393029|58766007|FG001|Overall Study|Not treated|1|||
30756315|NCT00402233|58766018|FG000|Overall Study|Adverse Event|1|||
30756316|NCT00402233|58766019|FG001|Overall Study|Adverse Event|7|||
30756317|NCT00402233|58766020|FG002|Overall Study|Adverse Event|9|||
30756318|NCT00402233|58766021|FG003|Overall Study|Adverse Event|9|||
30756319|NCT00402233|58766018|FG000|Overall Study|Protocol Violation|0|||
30756320|NCT00402233|58766019|FG001|Overall Study|Protocol Violation|1|||
30756321|NCT00402233|58766020|FG002|Overall Study|Protocol Violation|0|||
30756322|NCT00402233|58766021|FG003|Overall Study|Protocol Violation|0|||
30756323|NCT00402233|58766018|FG000|Overall Study|Withdrawal by Subject|2|||
30756324|NCT00402233|58766019|FG001|Overall Study|Withdrawal by Subject|1|||
30834219|NCT01668784|58858919|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
30834220|NCT01668784|58858918|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
30843679|NCT01915498|58869662|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
30924846|NCT02116361|58960258|FG003|Overall Study|Personal Reasons|9|||
30756325|NCT00402233|58766020|FG002|Overall Study|Withdrawal by Subject|2|||
30756326|NCT00402233|58766021|FG003|Overall Study|Withdrawal by Subject|2|||
30756327|NCT00402233|58766018|FG000|Overall Study|Worsening of disease under study|2|||
30924847|NCT02116361|58960255|FG000|Overall Study|Investigator Decision - Relapse|9|||
30924848|NCT02116361|58960256|FG001|Overall Study|Investigator Decision - Relapse|7|||
30924849|NCT02116361|58960257|FG002|Overall Study|Investigator Decision - Relapse|8|||
30924850|NCT02116361|58960258|FG003|Overall Study|Investigator Decision - Relapse|5|||
30924851|NCT02140775|58960270|FG000|Overall Study|Withdrawal by Subject|30|||
30924852|NCT02140775|58960271|FG001|Overall Study|Withdrawal by Subject|7|||
30924853|NCT01844817|58960281|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
30924854|NCT01844817|58960282|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
30924855|NCT01844817|58960281|FG000|Treatment|Progressive Disease|27|||
30924856|NCT01844817|58960282|FG001|Treatment|Progressive Disease|36|||
30924857|NCT01844817|58960281|FG000|Treatment|Adverse Event|17|||
30924858|NCT01844817|58960282|FG001|Treatment|Adverse Event|9|||
30924859|NCT01844817|58960281|FG000|Treatment|Withdrawal by Subject|10|||
30924860|NCT01844817|58960282|FG001|Treatment|Withdrawal by Subject|6|||
30924861|NCT01844817|58960281|FG000|Treatment|Death|10|||
30924862|NCT01844817|58960282|FG001|Treatment|Death|8|||
30924863|NCT01844817|58960281|FG000|Treatment|Lost to Follow-up|0|||
30924864|NCT01844817|58960282|FG001|Treatment|Lost to Follow-up|1|||
30924865|NCT01844817|58960281|FG000|Treatment|Other|0|||
30924866|NCT01844817|58960282|FG001|Treatment|Other|3|||
30924867|NCT01814553|58960291|FG000|Overall Study|PD per clinical progression|6|||
30924868|NCT01814553|58960292|FG001|Overall Study|PD per clinical progression|8|||
30924869|NCT01814553|58960291|FG000|Overall Study|Other Adverse Event|4|||
30924870|NCT01814553|58960292|FG001|Overall Study|Other Adverse Event|5|||
30924871|NCT01814553|58960291|FG000|Overall Study|Withdrawal by Subject|1|||
30924872|NCT01814553|58960292|FG001|Overall Study|Withdrawal by Subject|1|||
30924873|NCT01814553|58960291|FG000|Overall Study|Other than stated|7|||
30924874|NCT01814553|58960292|FG001|Overall Study|Other than stated|8|||
30924875|NCT02116205|58960302|FG000|Overall Study|Withdrawal by Subject|2|||
30924876|NCT02116205|58960303|FG001|Overall Study|Withdrawal by Subject|4|||
30924877|NCT02116205|58960304|FG002|Overall Study|Withdrawal by Subject|1|||
30924878|NCT02116205|58960305|FG003|Overall Study|Withdrawal by Subject|3|||
30924879|NCT02116205|58960302|FG000|Overall Study|Lost to Follow-up|0|||
30924880|NCT02116205|58960303|FG001|Overall Study|Lost to Follow-up|2|||
30924881|NCT02116205|58960304|FG002|Overall Study|Lost to Follow-up|1|||
30924882|NCT02116205|58960305|FG003|Overall Study|Lost to Follow-up|2|||
30924883|NCT02116205|58960302|FG000|Overall Study|Physician Decision|0|||
30924884|NCT02116205|58960303|FG001|Overall Study|Physician Decision|1|||
30924885|NCT02116205|58960304|FG002|Overall Study|Physician Decision|1|||
30924886|NCT02116205|58960305|FG003|Overall Study|Physician Decision|1|||
30756328|NCT00402233|58766019|FG001|Overall Study|Worsening of disease under study|0|||
30756329|NCT00402233|58766020|FG002|Overall Study|Worsening of disease under study|0|||
30756330|NCT00402233|58766021|FG003|Overall Study|Worsening of disease under study|0|||
30756331|NCT00402233|58766018|FG000|Overall Study|Worsening of other pre-existing disease|0|||
30924887|NCT02116205|58960302|FG000|Overall Study|Exclusion criteria|0|||
30924888|NCT02116205|58960303|FG001|Overall Study|Exclusion criteria|0|||
30924889|NCT02116205|58960304|FG002|Overall Study|Exclusion criteria|1|||
30756332|NCT00402233|58766019|FG001|Overall Study|Worsening of other pre-existing disease|1|||
30756333|NCT00402233|58766020|FG002|Overall Study|Worsening of other pre-existing disease|0|||
30756334|NCT00402233|58766021|FG003|Overall Study|Worsening of other pre-existing disease|0|||
30756335|NCT00092456|58766035|FG000|Overall Study|Adverse Event|0|||
30756336|NCT00092456|58766036|FG001|Overall Study|Adverse Event|0|||
30756337|NCT00092456|58766037|FG002|Overall Study|Adverse Event|1|||
30756338|NCT00092456|58766038|FG003|Overall Study|Adverse Event|1|||
30756339|NCT00092456|58766035|FG000|Overall Study|Lost to Follow-up|2|||
30834221|NCT01668784|58858919|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
30834222|NCT01668784|58858918|FG000|Treatment Period|Disease Progression|316|||
30834223|NCT01668784|58858919|FG001|Treatment Period|Disease Progression|293|||
30834224|NCT01668784|58858918|FG000|Treatment Period|Study Drug Toxicity|46|||
30834225|NCT01668784|58858919|FG001|Treatment Period|Study Drug Toxicity|53|||
30834226|NCT01668784|58858918|FG000|Treatment Period|Death|1|||
30834227|NCT01668784|58858919|FG001|Treatment Period|Death|1|||
30834228|NCT01668784|58858918|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
30834229|NCT01668784|58858919|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
30924890|NCT02116205|58960305|FG003|Overall Study|Exclusion criteria|0|||
30924891|NCT01844583|58960317|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
30924892|NCT01844583|58960318|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
30924893|NCT02115815|58960336|FG000|Overall Study|Withdrawal by Subject|2|||
30756340|NCT00092456|58766036|FG001|Overall Study|Lost to Follow-up|2|||
30756341|NCT00092456|58766037|FG002|Overall Study|Lost to Follow-up|1|||
30834230|NCT01668784|58858918|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
30924894|NCT02115815|58960337|FG001|Overall Study|Withdrawal by Subject|0|||
30924895|NCT02115815|58960338|FG002|Overall Study|Withdrawal by Subject|0|||
30924896|NCT02115815|58960339|FG003|Overall Study|Withdrawal by Subject|0|||
30924897|NCT02115815|58960340|FG004|Overall Study|Withdrawal by Subject|0|||
30924898|NCT02115815|58960341|FG005|Overall Study|Withdrawal by Subject|0|||
30924899|NCT02115815|58960342|FG006|Overall Study|Withdrawal by Subject|0|||
30924900|NCT02115815|58960336|FG000|Overall Study|Not enough drug to dose participant|0|||
30924901|NCT02115815|58960337|FG001|Overall Study|Not enough drug to dose participant|0|||
30924902|NCT02115815|58960338|FG002|Overall Study|Not enough drug to dose participant|0|||
30924903|NCT02115815|58960339|FG003|Overall Study|Not enough drug to dose participant|0|||
30924904|NCT02115815|58960340|FG004|Overall Study|Not enough drug to dose participant|0|||
30924905|NCT02115815|58960341|FG005|Overall Study|Not enough drug to dose participant|1|||
30924906|NCT02115815|58960342|FG006|Overall Study|Not enough drug to dose participant|0|||
30924907|NCT02115815|58960336|FG000|Overall Study|Missed appointment, randomized in error|0|||
30924908|NCT02115815|58960337|FG001|Overall Study|Missed appointment, randomized in error|0|||
30924909|NCT02115815|58960338|FG002|Overall Study|Missed appointment, randomized in error|0|||
30924910|NCT02115815|58960339|FG003|Overall Study|Missed appointment, randomized in error|0|||
30924911|NCT02115815|58960340|FG004|Overall Study|Missed appointment, randomized in error|0|||
30924912|NCT02115815|58960341|FG005|Overall Study|Missed appointment, randomized in error|1|||
30924913|NCT02115815|58960342|FG006|Overall Study|Missed appointment, randomized in error|0|||
30924914|NCT02115269|58960358|FG000|Overall Study|Lost to Follow-up|43|||
30924915|NCT02115269|58960358|FG000|Overall Study|Did not complete patient diary|3|||
30924916|NCT02115269|58960358|FG000|Overall Study|Moved to another city|7|||
30924917|NCT02115269|58960358|FG000|Overall Study|Withdrawal by Subject|2|||
30924918|NCT02115269|58960358|FG000|Overall Study|Didn't take study drug|2|||
30924919|NCT02115113|58960373|FG000|Participants in Run-in Period|Death|0|||
30924920|NCT02115113|58960374|FG001|Participants in Run-in Period|Death|0|||
30924921|NCT02115113|58960375|FG002|Participants in Run-in Period|Death|1|||
30924922|NCT02115113|58960373|FG000|Participants in Run-in Period|Administrative problems|0|||
30924923|NCT02115113|58960374|FG001|Participants in Run-in Period|Administrative problems|0|||
30924924|NCT02115113|58960375|FG002|Participants in Run-in Period|Administrative problems|1|||
30924925|NCT02115113|58960373|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
30924926|NCT02115113|58960374|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
30924927|NCT02115113|58960375|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
30924928|NCT02115113|58960373|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
30924929|NCT02115113|58960374|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
30924930|NCT02115113|58960375|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
30924931|NCT02115113|58960373|FG000|Participants Randomized|Lost to Follow-up|1|||
30924932|NCT02115113|58960374|FG001|Participants Randomized|Lost to Follow-up|0|||
30924933|NCT02115113|58960375|FG002|Participants Randomized|Lost to Follow-up|0|||
30924934|NCT02115113|58960373|FG000|Participants Randomized|Death|1|||
30924935|NCT02115113|58960374|FG001|Participants Randomized|Death|0|||
30924936|NCT02115113|58960375|FG002|Participants Randomized|Death|0|||
30924937|NCT02114879|58960386|FG000|Overall Study|Withdrawal by Subject|9|||
30924938|NCT02114879|58960387|FG001|Overall Study|Withdrawal by Subject|5|||
30924939|NCT02114879|58960386|FG000|Overall Study|Death|6|||
30924940|NCT02114879|58960387|FG001|Overall Study|Death|11|||
30924941|NCT02114879|58960386|FG000|Overall Study|Lost to Follow-up|4|||
30924942|NCT02114879|58960387|FG001|Overall Study|Lost to Follow-up|6|||
30924943|NCT02114879|58960386|FG000|Overall Study|Physician Decision|0|||
30924944|NCT02114879|58960387|FG001|Overall Study|Physician Decision|2|||
30924945|NCT02114177|58960395|FG000|Overall Study|Lost to Follow-up|1|||
30924946|NCT02114177|58960396|FG001|Overall Study|Lost to Follow-up|2|||
30924947|NCT02114177|58960395|FG000|Overall Study|Withdrawal by Subject|6|||
30924948|NCT02114177|58960396|FG001|Overall Study|Withdrawal by Subject|1|||
30924949|NCT02114177|58960395|FG000|Overall Study|Other|2|||
30924950|NCT02114177|58960396|FG001|Overall Study|Other|1|||
30924951|NCT02138825|58960404|FG000|Main Study Treatment|Adverse Event|11|||
30924952|NCT02138825|58960405|FG001|Main Study Treatment|Adverse Event|3|||
30924953|NCT02138825|58960404|FG000|Main Study Treatment|Death|1|||
30924954|NCT02138825|58960405|FG001|Main Study Treatment|Death|2|||
30834231|NCT01668784|58858919|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
30834232|NCT01668784|58858918|FG000|Treatment Period|Withdrawal by Subject|5|||
30834233|NCT01668784|58858919|FG001|Treatment Period|Withdrawal by Subject|3|||
30834234|NCT01668784|58858918|FG000|Treatment Period|Maximal Clinical Benefit|3|||
30834235|NCT01668784|58858919|FG001|Treatment Period|Maximal Clinical Benefit|3|||
30834236|NCT01668784|58858918|FG000|Treatment Period|Other|2|||
30834237|NCT01668784|58858919|FG001|Treatment Period|Other|8|||
30834238|NCT01668784|58858918|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
30924955|NCT02138825|58960404|FG000|Main Study Treatment|Protocol Violation|2|||
30924956|NCT02138825|58960405|FG001|Main Study Treatment|Protocol Violation|2|||
30924957|NCT02138825|58960404|FG000|Main Study Treatment|Sponsor decision|12|||
30834239|NCT01668784|58858919|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
30924958|NCT02138825|58960405|FG001|Main Study Treatment|Sponsor decision|18|||
30924959|NCT02138825|58960404|FG000|Main Study Treatment|Study terminated by sponsor|10|||
30834240|NCT02750514|58858930|FG000|Track 1|Disease progression|20|||
30924960|NCT02138825|58960405|FG001|Main Study Treatment|Study terminated by sponsor|9|||
30924961|NCT02138825|58960404|FG000|Main Study Treatment|Withdrawal by Subject|3|||
30924962|NCT02138825|58960405|FG001|Main Study Treatment|Withdrawal by Subject|1|||
30924963|NCT02138825|58960404|FG000|Main Study Treatment|Medical decision|1|||
30924964|NCT02138825|58960405|FG001|Main Study Treatment|Medical decision|0|||
30924965|NCT02138825|58960404|FG000|Long-term Extension|Study termination by sponsor|32|||
30924966|NCT02138825|58960405|FG001|Long-term Extension|Study termination by sponsor|38|||
30924967|NCT02138825|58960404|FG000|Safety Follow-up|Adverse Event|4|||
30924968|NCT02138825|58960405|FG001|Safety Follow-up|Adverse Event|3|||
30924969|NCT02138825|58960404|FG000|Safety Follow-up|Death|11|||
30924970|NCT02138825|58960405|FG001|Safety Follow-up|Death|5|||
30924971|NCT02138825|58960404|FG000|Safety Follow-up|Withdrawal by Subject|5|||
30924972|NCT02138825|58960405|FG001|Safety Follow-up|Withdrawal by Subject|3|||
30924973|NCT02138825|58960404|FG000|Safety Follow-up|clinic worsening|1|||
30924974|NCT02138825|58960405|FG001|Safety Follow-up|clinic worsening|0|||
30924975|NCT02138825|58960404|FG000|Safety Follow-up|withdrawal by PI|1|||
30924976|NCT02138825|58960405|FG001|Safety Follow-up|withdrawal by PI|0|||
30924977|NCT02138825|58960404|FG000|Safety Follow-up|logistical difficulties|0|||
30924978|NCT02138825|58960405|FG001|Safety Follow-up|logistical difficulties|1|||
30924979|NCT02138825|58960404|FG000|Safety Follow-up|progressive disease|0|||
30924980|NCT02138825|58960405|FG001|Safety Follow-up|progressive disease|2|||
30924981|NCT02138825|58960404|FG000|Safety Follow-up|too unwell to attend the visit|0|||
30924982|NCT02138825|58960405|FG001|Safety Follow-up|too unwell to attend the visit|1|||
30924983|NCT02138825|58960404|FG000|Safety Follow-up|treatment unblinded|0|||
30924984|NCT02138825|58960405|FG001|Safety Follow-up|treatment unblinded|1|||
30924985|NCT02138825|58960404|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
30924986|NCT02138825|58960405|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
30924987|NCT02138747|58960420|FG000|Treatment Period 1|Adverse Event|10|||
30924988|NCT02138747|58960421|FG001|Treatment Period 1|Adverse Event|14|||
30924989|NCT02138747|58960422|FG002|Treatment Period 1|Adverse Event|2|||
30924990|NCT02138747|58960423|FG003|Treatment Period 1|Adverse Event|1|||
30924991|NCT02138747|58960420|FG000|Treatment Period 1|Lost to Follow-up|0|||
30924992|NCT02138747|58960421|FG001|Treatment Period 1|Lost to Follow-up|1|||
30924993|NCT02138747|58960422|FG002|Treatment Period 1|Lost to Follow-up|1|||
30924994|NCT02138747|58960423|FG003|Treatment Period 1|Lost to Follow-up|0|||
30924995|NCT02138747|58960420|FG000|Treatment Period 1|Protocol Violation|0|||
30924996|NCT02138747|58960421|FG001|Treatment Period 1|Protocol Violation|2|||
30924997|NCT02138747|58960422|FG002|Treatment Period 1|Protocol Violation|0|||
30924998|NCT02138747|58960423|FG003|Treatment Period 1|Protocol Violation|0|||
30924999|NCT02138747|58960420|FG000|Treatment Period 1|Withdrawal by Subject|8|||
30925000|NCT02138747|58960421|FG001|Treatment Period 1|Withdrawal by Subject|4|||
30925001|NCT02138747|58960422|FG002|Treatment Period 1|Withdrawal by Subject|1|||
30925002|NCT02138747|58960423|FG003|Treatment Period 1|Withdrawal by Subject|3|||
30925003|NCT02138747|58960420|FG000|Treatment Period 1|Other - Miscellaneous|2|||
30925004|NCT02138747|58960421|FG001|Treatment Period 1|Other - Miscellaneous|4|||
30925005|NCT02138747|58960422|FG002|Treatment Period 1|Other - Miscellaneous|0|||
30925006|NCT02138747|58960423|FG003|Treatment Period 1|Other - Miscellaneous|0|||
30834241|NCT02750514|58858931|FG001|Track 1|Disease progression|1|||
30834242|NCT02750514|58858932|FG002|Track 1|Disease progression|0|||
30834243|NCT02750514|58858933|FG003|Track 1|Disease progression|1|||
30834244|NCT02750514|58858934|FG004|Track 1|Disease progression|0|||
30834245|NCT02750514|58858930|FG000|Track 1|Adverse event unrelated to study drug|1|||
30834246|NCT02750514|58858931|FG001|Track 1|Adverse event unrelated to study drug|0|||
30834247|NCT02750514|58858932|FG002|Track 1|Adverse event unrelated to study drug|0|||
30834248|NCT02750514|58858933|FG003|Track 1|Adverse event unrelated to study drug|0|||
30834249|NCT02750514|58858934|FG004|Track 1|Adverse event unrelated to study drug|0|||
30834250|NCT02750514|58858930|FG000|Track 1|Study drug toxicity|4|||
30834251|NCT02750514|58858931|FG001|Track 1|Study drug toxicity|1|||
30834252|NCT02750514|58858932|FG002|Track 1|Study drug toxicity|0|||
30834253|NCT02750514|58858933|FG003|Track 1|Study drug toxicity|1|||
30834254|NCT02750514|58858934|FG004|Track 1|Study drug toxicity|0|||
30834255|NCT02750514|58858930|FG000|Track 1|Participant request to discontinue|1|||
30834256|NCT02750514|58858931|FG001|Track 1|Participant request to discontinue|0|||
30834257|NCT02750514|58858932|FG002|Track 1|Participant request to discontinue|0|||
30834258|NCT02750514|58858933|FG003|Track 1|Participant request to discontinue|0|||
30834259|NCT02750514|58858934|FG004|Track 1|Participant request to discontinue|0|||
30834260|NCT02750514|58858930|FG000|Track 1|Other reasons|1|||
30834261|NCT02750514|58858931|FG001|Track 1|Other reasons|0|||
30834262|NCT02750514|58858932|FG002|Track 1|Other reasons|0|||
30834263|NCT02750514|58858933|FG003|Track 1|Other reasons|0|||
30834264|NCT02750514|58858934|FG004|Track 1|Other reasons|0|||
30834265|NCT02750514|58858930|FG000|Track 2|Disease progression|4|||
30834266|NCT02750514|58858931|FG001|Track 2|Disease progression|5|||
30834267|NCT02750514|58858932|FG002|Track 2|Disease progression|2|||
30834268|NCT02750514|58858933|FG003|Track 2|Disease progression|5|||
30834269|NCT02750514|58858934|FG004|Track 2|Disease progression|0|||
30834270|NCT02750514|58858930|FG000|Track 2|Adverse event unrelated to study drug|1|||
30834271|NCT02750514|58858931|FG001|Track 2|Adverse event unrelated to study drug|0|||
30834272|NCT02750514|58858932|FG002|Track 2|Adverse event unrelated to study drug|0|||
30834273|NCT02750514|58858933|FG003|Track 2|Adverse event unrelated to study drug|0|||
30834274|NCT02750514|58858934|FG004|Track 2|Adverse event unrelated to study drug|0|||
30834275|NCT02750514|58858930|FG000|Track 2|Study drug toxicity|1|||
30834276|NCT02750514|58858931|FG001|Track 2|Study drug toxicity|2|||
30834277|NCT02750514|58858932|FG002|Track 2|Study drug toxicity|0|||
30834278|NCT02750514|58858933|FG003|Track 2|Study drug toxicity|2|||
30834279|NCT02750514|58858934|FG004|Track 2|Study drug toxicity|0|||
30834280|NCT02750514|58858930|FG000|Track 2|Participant withdrew consent|0|||
30834281|NCT02750514|58858931|FG001|Track 2|Participant withdrew consent|1|||
30834282|NCT02750514|58858932|FG002|Track 2|Participant withdrew consent|0|||
30834283|NCT02750514|58858933|FG003|Track 2|Participant withdrew consent|0|||
30834284|NCT02750514|58858934|FG004|Track 2|Participant withdrew consent|0|||
30834285|NCT02750514|58858930|FG000|Track 3|Disease progression|0|||
30834286|NCT02750514|58858931|FG001|Track 3|Disease progression|24|||
30834287|NCT02750514|58858932|FG002|Track 3|Disease progression|13|||
30834288|NCT02750514|58858933|FG003|Track 3|Disease progression|14|||
30834289|NCT02750514|58858934|FG004|Track 3|Disease progression|0|||
30834290|NCT02750514|58858930|FG000|Track 3|Adverse event unrelated to study drug|0|||
30834291|NCT02750514|58858931|FG001|Track 3|Adverse event unrelated to study drug|1|||
30834292|NCT02750514|58858932|FG002|Track 3|Adverse event unrelated to study drug|1|||
30834293|NCT02750514|58858933|FG003|Track 3|Adverse event unrelated to study drug|1|||
30834294|NCT02750514|58858934|FG004|Track 3|Adverse event unrelated to study drug|0|||
30834295|NCT02750514|58858930|FG000|Track 3|Study drug toxicity|0|||
30834296|NCT02750514|58858931|FG001|Track 3|Study drug toxicity|3|||
30834297|NCT02750514|58858932|FG002|Track 3|Study drug toxicity|0|||
30834298|NCT02750514|58858933|FG003|Track 3|Study drug toxicity|1|||
30834299|NCT02750514|58858934|FG004|Track 3|Study drug toxicity|0|||
30834300|NCT02750514|58858930|FG000|Track 3|Participant request to discontinue|0|||
30834301|NCT02750514|58858931|FG001|Track 3|Participant request to discontinue|2|||
30834302|NCT02750514|58858932|FG002|Track 3|Participant request to discontinue|0|||
30834303|NCT02750514|58858933|FG003|Track 3|Participant request to discontinue|0|||
30834304|NCT02750514|58858934|FG004|Track 3|Participant request to discontinue|0|||
30834305|NCT02750514|58858930|FG000|Track 3|Participant withdrew consent|0|||
30834306|NCT02750514|58858931|FG001|Track 3|Participant withdrew consent|3|||
30834307|NCT02750514|58858932|FG002|Track 3|Participant withdrew consent|1|||
30834308|NCT02750514|58858933|FG003|Track 3|Participant withdrew consent|0|||
30834309|NCT02750514|58858934|FG004|Track 3|Participant withdrew consent|0|||
30834310|NCT02750514|58858930|FG000|Track 3|Other reasons|0|||
30834311|NCT02750514|58858931|FG001|Track 3|Other reasons|3|||
30834312|NCT02750514|58858932|FG002|Track 3|Other reasons|0|||
30834313|NCT02750514|58858933|FG003|Track 3|Other reasons|0|||
30834314|NCT02750514|58858934|FG004|Track 3|Other reasons|0|||
30834315|NCT02750514|58858930|FG000|Track 4|Study drug toxicity|0|||
30834316|NCT02750514|58858931|FG001|Track 4|Study drug toxicity|6|||
30834317|NCT02750514|58858932|FG002|Track 4|Study drug toxicity|0|||
30834318|NCT02750514|58858933|FG003|Track 4|Study drug toxicity|5|||
30834319|NCT02750514|58858934|FG004|Track 4|Study drug toxicity|0|||
30834320|NCT02750514|58858930|FG000|Track 4|Participant request to discontinue|0|||
30834321|NCT02750514|58858931|FG001|Track 4|Participant request to discontinue|1|||
30834322|NCT02750514|58858932|FG002|Track 4|Participant request to discontinue|0|||
30834323|NCT02750514|58858933|FG003|Track 4|Participant request to discontinue|1|||
30834324|NCT02750514|58858934|FG004|Track 4|Participant request to discontinue|0|||
30623885|NCT00910000|58635853|FG001|Overall Study|Withdrawal by Subject|0|||
30834325|NCT02750514|58858930|FG000|Track 4|Participant withdrew consent|0|||
30834326|NCT02750514|58858931|FG001|Track 4|Participant withdrew consent|1|||
30834327|NCT02750514|58858932|FG002|Track 4|Participant withdrew consent|0|||
30834328|NCT02750514|58858933|FG003|Track 4|Participant withdrew consent|0|||
30834329|NCT02750514|58858934|FG004|Track 4|Participant withdrew consent|0|||
30834330|NCT02750514|58858930|FG000|Track 4|Other reasons|0|||
30834331|NCT02750514|58858931|FG001|Track 4|Other reasons|5|||
30834332|NCT02750514|58858932|FG002|Track 4|Other reasons|0|||
30834333|NCT02750514|58858933|FG003|Track 4|Other reasons|3|||
30834334|NCT02750514|58858934|FG004|Track 4|Other reasons|0|||
30834335|NCT02750514|58858930|FG000|Track 4|Disease progression|0|||
30834336|NCT02750514|58858931|FG001|Track 4|Disease progression|33|||
30756342|NCT00092456|58766038|FG003|Overall Study|Lost to Follow-up|2|||
30756343|NCT00092456|58766035|FG000|Overall Study|Protocol Violation|5|||
30756344|NCT00092456|58766036|FG001|Overall Study|Protocol Violation|7|||
30756345|NCT00092456|58766037|FG002|Overall Study|Protocol Violation|8|||
30756346|NCT00092456|58766038|FG003|Overall Study|Protocol Violation|6|||
30756347|NCT00092456|58766035|FG000|Overall Study|Withdrawal by Subject|13|||
30756348|NCT00092456|58766036|FG001|Overall Study|Withdrawal by Subject|5|||
30756349|NCT00092456|58766037|FG002|Overall Study|Withdrawal by Subject|16|||
30756350|NCT00092456|58766038|FG003|Overall Study|Withdrawal by Subject|6|||
30756351|NCT00092456|58766035|FG000|Overall Study|Moved|1|||
30756352|NCT00092456|58766036|FG001|Overall Study|Moved|1|||
30756353|NCT00092456|58766037|FG002|Overall Study|Moved|0|||
30756354|NCT00092456|58766038|FG003|Overall Study|Moved|1|||
30756355|NCT00092456|58766035|FG000|Overall Study|Other|4|||
30756356|NCT00092456|58766036|FG001|Overall Study|Other|2|||
30756357|NCT00092456|58766037|FG002|Overall Study|Other|3|||
30756358|NCT00092456|58766038|FG003|Overall Study|Other|0|||
30756359|NCT00067470|58766050|FG000|Overall Study|Withdrawal by Subject|0|||
30756360|NCT00067470|58766051|FG001|Overall Study|Withdrawal by Subject|1|||
30756361|NCT00401843|58766060|FG000|Overall Study|Achieved Complete Response|1|||
30834337|NCT02750514|58858932|FG002|Track 4|Disease progression|0|||
30834338|NCT02750514|58858933|FG003|Track 4|Disease progression|32|||
30834339|NCT02750514|58858934|FG004|Track 4|Disease progression|0|||
30834340|NCT02750514|58858930|FG000|Track 4|Adverse event unrelated to study drug|0|||
30834341|NCT02750514|58858931|FG001|Track 4|Adverse event unrelated to study drug|5|||
30834342|NCT02750514|58858932|FG002|Track 4|Adverse event unrelated to study drug|0|||
30834343|NCT02750514|58858933|FG003|Track 4|Adverse event unrelated to study drug|0|||
30834344|NCT02750514|58858934|FG004|Track 4|Adverse event unrelated to study drug|0|||
30834345|NCT02750514|58858930|FG000|Track 4|Death|0|||
30834346|NCT02750514|58858931|FG001|Track 4|Death|0|||
30834347|NCT02750514|58858932|FG002|Track 4|Death|0|||
30834348|NCT02750514|58858933|FG003|Track 4|Death|1|||
30834349|NCT02750514|58858934|FG004|Track 4|Death|0|||
30834350|NCT02750514|58858930|FG000|Track 5|Disease progression|0|||
30834351|NCT02750514|58858931|FG001|Track 5|Disease progression|0|||
30834352|NCT02750514|58858932|FG002|Track 5|Disease progression|0|||
30834353|NCT02750514|58858933|FG003|Track 5|Disease progression|0|||
30834354|NCT02750514|58858934|FG004|Track 5|Disease progression|34|||
30834355|NCT02750514|58858930|FG000|Track 5|Adverse event unrelated to study drug|0|||
30834356|NCT02750514|58858931|FG001|Track 5|Adverse event unrelated to study drug|0|||
30834357|NCT02750514|58858932|FG002|Track 5|Adverse event unrelated to study drug|0|||
30834358|NCT02750514|58858933|FG003|Track 5|Adverse event unrelated to study drug|0|||
30834359|NCT02750514|58858934|FG004|Track 5|Adverse event unrelated to study drug|2|||
30834360|NCT02750514|58858930|FG000|Track 5|Study drug toxicity|0|||
30834361|NCT02750514|58858931|FG001|Track 5|Study drug toxicity|0|||
30834362|NCT02750514|58858932|FG002|Track 5|Study drug toxicity|0|||
30834363|NCT02750514|58858933|FG003|Track 5|Study drug toxicity|0|||
30834364|NCT02750514|58858934|FG004|Track 5|Study drug toxicity|2|||
30834365|NCT02750514|58858930|FG000|Track 5|Participant request to discontinue|0|||
30834366|NCT02750514|58858931|FG001|Track 5|Participant request to discontinue|0|||
30834367|NCT02750514|58858932|FG002|Track 5|Participant request to discontinue|0|||
30834368|NCT02750514|58858933|FG003|Track 5|Participant request to discontinue|0|||
30834369|NCT02750514|58858934|FG004|Track 5|Participant request to discontinue|3|||
30834370|NCT02750514|58858930|FG000|Track 5|Other reasons|0|||
30834371|NCT02750514|58858931|FG001|Track 5|Other reasons|0|||
30834372|NCT02750514|58858932|FG002|Track 5|Other reasons|0|||
30834373|NCT02750514|58858933|FG003|Track 5|Other reasons|0|||
30756362|NCT00401843|58766061|FG001|Overall Study|Achieved Complete Response|5|||
30834374|NCT02750514|58858934|FG004|Track 5|Other reasons|2|||
30834375|NCT02612428|58858956|FG000|VTL-308|Death|14|||
30834376|NCT02612428|58858957|FG001|VTL-308|Death|16|||
30834377|NCT02612428|58858956|FG000|VTL-308|Withdrawal by Subject|0|||
30834378|NCT02612428|58858957|FG001|VTL-308|Withdrawal by Subject|1|||
30834379|NCT02612428|58858956|FG000|VTL-308E|Death|9|||
30834380|NCT02612428|58858957|FG001|VTL-308E|Death|7|||
30834381|NCT02612428|58858956|FG000|VTL-308E|Lost to Follow-up|2|||
30756363|NCT00401843|58766062|FG002|Overall Study|Achieved Complete Response|11|||
30756364|NCT00401843|58766060|FG000|Overall Study|Adverse Event|7|||
30756365|NCT00401843|58766061|FG001|Overall Study|Adverse Event|26|||
30756366|NCT00401843|58766062|FG002|Overall Study|Adverse Event|27|||
30756367|NCT00401843|58766060|FG000|Overall Study|Death|0|||
30834382|NCT02612428|58858957|FG001|VTL-308E|Lost to Follow-up|0|||
30834383|NCT03679884|58858968|FG000|Overall Study|Other|12|||
30834384|NCT03679884|58858969|FG001|Overall Study|Other|12|||
30834385|NCT03679884|58858970|FG002|Overall Study|Other|12|||
30834386|NCT03679884|58858971|FG003|Overall Study|Other|7|||
30925007|NCT02138747|58960420|FG000|Treatment Period 2|Adverse Event|6|||
30925008|NCT02138747|58960421|FG001|Treatment Period 2|Adverse Event|3|||
30925009|NCT02138747|58960422|FG002|Treatment Period 2|Adverse Event|1|||
30925010|NCT02138747|58960423|FG003|Treatment Period 2|Adverse Event|1|||
30925011|NCT02138747|58960420|FG000|Treatment Period 2|Lost to Follow-up|2|||
30925012|NCT02138747|58960421|FG001|Treatment Period 2|Lost to Follow-up|0|||
30925013|NCT02138747|58960422|FG002|Treatment Period 2|Lost to Follow-up|0|||
30925014|NCT02138747|58960423|FG003|Treatment Period 2|Lost to Follow-up|0|||
30925015|NCT02138747|58960420|FG000|Treatment Period 2|Protocol Violation|1|||
30925016|NCT02138747|58960421|FG001|Treatment Period 2|Protocol Violation|0|||
30925017|NCT02138747|58960422|FG002|Treatment Period 2|Protocol Violation|0|||
30925018|NCT02138747|58960423|FG003|Treatment Period 2|Protocol Violation|0|||
30925019|NCT02138747|58960420|FG000|Treatment Period 2|Withdrawal by Subject|5|||
30925020|NCT02138747|58960421|FG001|Treatment Period 2|Withdrawal by Subject|4|||
30925021|NCT02138747|58960422|FG002|Treatment Period 2|Withdrawal by Subject|1|||
30925022|NCT02138747|58960423|FG003|Treatment Period 2|Withdrawal by Subject|2|||
30925023|NCT02138747|58960420|FG000|Treatment Period 2|Other - Miscellaneous|3|||
30925024|NCT02138747|58960421|FG001|Treatment Period 2|Other - Miscellaneous|0|||
30925025|NCT02138747|58960422|FG002|Treatment Period 2|Other - Miscellaneous|0|||
30925026|NCT02138747|58960423|FG003|Treatment Period 2|Other - Miscellaneous|0|||
30925027|NCT02105285|58960436|FG000|Overall Study|Adverse Event|1|||
30925028|NCT02105285|58960437|FG001|Overall Study|Adverse Event|1|||
30925029|NCT02105285|58960438|FG002|Overall Study|Adverse Event|0|||
30925030|NCT02105285|58960436|FG000|Overall Study|Protocol Violation|0|||
30925031|NCT02105285|58960437|FG001|Overall Study|Protocol Violation|1|||
30925032|NCT02105285|58960438|FG002|Overall Study|Protocol Violation|0|||
30925033|NCT02105285|58960436|FG000|Overall Study|Withdrawal by Subject|1|||
30925034|NCT02105285|58960437|FG001|Overall Study|Withdrawal by Subject|0|||
30925035|NCT02105285|58960438|FG002|Overall Study|Withdrawal by Subject|0|||
30925036|NCT02104895|58960447|FG000|Overall Study|Withdrawal by Subject|0|||
30925037|NCT02104895|58960448|FG001|Overall Study|Withdrawal by Subject|14|||
30925038|NCT01621490|58960463|FG000|Overall Study|Participant completed treatment|4|||
30925039|NCT01621490|58960464|FG001|Overall Study|Participant completed treatment|4|||
30925040|NCT01621490|58960465|FG002|Overall Study|Participant completed treatment|1|||
30925041|NCT01621490|58960466|FG003|Overall Study|Participant completed treatment|0|||
30925042|NCT01621490|58960467|FG004|Overall Study|Participant completed treatment|0|||
30925043|NCT01621490|58960468|FG005|Overall Study|Participant completed treatment|0|||
30925044|NCT01621490|58960469|FG006|Overall Study|Participant completed treatment|0|||
30925045|NCT01621490|58960470|FG007|Overall Study|Participant completed treatment|1|||
30925046|NCT01621490|58960471|FG008|Overall Study|Participant completed treatment|0|||
30925047|NCT01621490|58960463|FG000|Overall Study|Patient could not travel|1|||
30925048|NCT01621490|58960464|FG001|Overall Study|Patient could not travel|0|||
30925049|NCT01621490|58960465|FG002|Overall Study|Patient could not travel|0|||
30925050|NCT01621490|58960466|FG003|Overall Study|Patient could not travel|0|||
30925051|NCT01621490|58960467|FG004|Overall Study|Patient could not travel|0|||
30834387|NCT03679884|58858972|FG004|Overall Study|Other|8|||
30834388|NCT03679884|58858968|FG000|Overall Study|Lack of Efficacy|15|||
30834389|NCT03679884|58858969|FG001|Overall Study|Lack of Efficacy|29|||
30834390|NCT03679884|58858970|FG002|Overall Study|Lack of Efficacy|13|||
30834391|NCT03679884|58858971|FG003|Overall Study|Lack of Efficacy|29|||
30834392|NCT03679884|58858972|FG004|Overall Study|Lack of Efficacy|10|||
30834393|NCT03679884|58858968|FG000|Overall Study|Death|1|||
30834394|NCT03679884|58858969|FG001|Overall Study|Death|0|||
30834395|NCT03679884|58858970|FG002|Overall Study|Death|0|||
30834396|NCT03679884|58858971|FG003|Overall Study|Death|0|||
30834397|NCT03679884|58858972|FG004|Overall Study|Death|0|||
30834398|NCT03679884|58858968|FG000|Overall Study|Adverse Event|2|||
30834399|NCT03679884|58858969|FG001|Overall Study|Adverse Event|10|||
30834400|NCT03679884|58858970|FG002|Overall Study|Adverse Event|9|||
30834401|NCT03679884|58858971|FG003|Overall Study|Adverse Event|6|||
30834402|NCT03679884|58858972|FG004|Overall Study|Adverse Event|6|||
30834403|NCT03679884|58858968|FG000|Overall Study|Withdrawal by Subject|12|||
30925052|NCT01621490|58960468|FG005|Overall Study|Patient could not travel|0|||
30925053|NCT01621490|58960469|FG006|Overall Study|Patient could not travel|0|||
30925054|NCT01621490|58960470|FG007|Overall Study|Patient could not travel|0|||
30925055|NCT01621490|58960471|FG008|Overall Study|Patient could not travel|0|||
30925056|NCT01621490|58960463|FG000|Overall Study|Subject no longer meets study criteria|0|||
30925057|NCT01621490|58960464|FG001|Overall Study|Subject no longer meets study criteria|0|||
30925058|NCT01621490|58960465|FG002|Overall Study|Subject no longer meets study criteria|0|||
30925059|NCT01621490|58960466|FG003|Overall Study|Subject no longer meets study criteria|0|||
30925060|NCT01621490|58960467|FG004|Overall Study|Subject no longer meets study criteria|1|||
30834404|NCT03679884|58858969|FG001|Overall Study|Withdrawal by Subject|23|||
30925061|NCT01621490|58960468|FG005|Overall Study|Subject no longer meets study criteria|0|||
30925062|NCT01621490|58960469|FG006|Overall Study|Subject no longer meets study criteria|0|||
30925063|NCT01621490|58960470|FG007|Overall Study|Subject no longer meets study criteria|0|||
30925064|NCT01621490|58960471|FG008|Overall Study|Subject no longer meets study criteria|0|||
30925065|NCT01621490|58960463|FG000|Overall Study|Maximum clinical benefit|3|||
30925066|NCT01621490|58960464|FG001|Overall Study|Maximum clinical benefit|2|||
30925067|NCT01621490|58960465|FG002|Overall Study|Maximum clinical benefit|0|||
30925068|NCT01621490|58960466|FG003|Overall Study|Maximum clinical benefit|0|||
30925069|NCT01621490|58960467|FG004|Overall Study|Maximum clinical benefit|0|||
30925070|NCT01621490|58960468|FG005|Overall Study|Maximum clinical benefit|0|||
30925071|NCT01621490|58960469|FG006|Overall Study|Maximum clinical benefit|1|||
30925072|NCT01621490|58960470|FG007|Overall Study|Maximum clinical benefit|2|||
30834405|NCT03679884|58858970|FG002|Overall Study|Withdrawal by Subject|8|||
30834406|NCT03679884|58858971|FG003|Overall Study|Withdrawal by Subject|8|||
30834407|NCT03679884|58858972|FG004|Overall Study|Withdrawal by Subject|9|||
30834408|NCT03679884|58858968|FG000|Overall Study|Lost to Follow-up|1|||
30834409|NCT03679884|58858969|FG001|Overall Study|Lost to Follow-up|4|||
30834410|NCT03679884|58858970|FG002|Overall Study|Lost to Follow-up|2|||
30925073|NCT01621490|58960471|FG008|Overall Study|Maximum clinical benefit|0|||
30925074|NCT01621490|58960463|FG000|Overall Study|Withdrawal by Subject|1|||
30925075|NCT01621490|58960464|FG001|Overall Study|Withdrawal by Subject|0|||
30925076|NCT01621490|58960465|FG002|Overall Study|Withdrawal by Subject|0|||
30925077|NCT01621490|58960466|FG003|Overall Study|Withdrawal by Subject|0|||
30925078|NCT01621490|58960467|FG004|Overall Study|Withdrawal by Subject|0|||
30925079|NCT01621490|58960468|FG005|Overall Study|Withdrawal by Subject|3|||
30925080|NCT01621490|58960469|FG006|Overall Study|Withdrawal by Subject|0|||
30925081|NCT01621490|58960470|FG007|Overall Study|Withdrawal by Subject|0|||
30925082|NCT01621490|58960471|FG008|Overall Study|Withdrawal by Subject|0|||
30925083|NCT01621490|58960463|FG000|Overall Study|Subject request to discontinue study|1|||
30925084|NCT01621490|58960464|FG001|Overall Study|Subject request to discontinue study|3|||
30925085|NCT01621490|58960465|FG002|Overall Study|Subject request to discontinue study|1|||
30925086|NCT01621490|58960466|FG003|Overall Study|Subject request to discontinue study|1|||
30925087|NCT01621490|58960467|FG004|Overall Study|Subject request to discontinue study|0|||
30925088|NCT01621490|58960468|FG005|Overall Study|Subject request to discontinue study|2|||
30756368|NCT00401843|58766061|FG001|Overall Study|Death|8|||
30756369|NCT00401843|58766062|FG002|Overall Study|Death|10|||
30756370|NCT00401843|58766060|FG000|Overall Study|Disease progression|10|||
30756371|NCT00401843|58766061|FG001|Overall Study|Disease progression|60|||
30756372|NCT00401843|58766062|FG002|Overall Study|Disease progression|49|||
30756373|NCT00401843|58766060|FG000|Overall Study|End of Study|1|||
30756374|NCT00401843|58766061|FG001|Overall Study|End of Study|1|||
30756375|NCT00401843|58766062|FG002|Overall Study|End of Study|2|||
30756376|NCT00401843|58766060|FG000|Overall Study|Lost to Follow-up|0|||
30756377|NCT00401843|58766061|FG001|Overall Study|Lost to Follow-up|0|||
30756378|NCT00401843|58766062|FG002|Overall Study|Lost to Follow-up|2|||
30834411|NCT03679884|58858971|FG003|Overall Study|Lost to Follow-up|0|||
30834412|NCT03679884|58858972|FG004|Overall Study|Lost to Follow-up|3|||
30834413|NCT01329978|58858987|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
30834414|NCT01329978|58858988|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
30834415|NCT01329978|58858989|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
30834416|NCT01329978|58858990|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
30834417|NCT01329978|58858991|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
30834418|NCT01329978|58858987|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
30834419|NCT01329978|58858988|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
30834420|NCT01329978|58858989|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
30834421|NCT01329978|58858990|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
30834422|NCT01329978|58858991|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
30834423|NCT01329978|58858987|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
30834424|NCT01329978|58858988|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
30834425|NCT01329978|58858989|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
30834426|NCT01329978|58858990|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
30834427|NCT01329978|58858991|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
30834428|NCT01329978|58858987|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
30834429|NCT01329978|58858988|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
30834430|NCT01329978|58858989|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
30925089|NCT01621490|58960469|FG006|Overall Study|Subject request to discontinue study|1|||
30925090|NCT01621490|58960470|FG007|Overall Study|Subject request to discontinue study|0|||
30925091|NCT01621490|58960471|FG008|Overall Study|Subject request to discontinue study|1|||
30925092|NCT01621490|58960463|FG000|Overall Study|Adverse event unrelated to study drug|2|||
30756379|NCT00401843|58766060|FG000|Overall Study|Other Unspecified|0|||
30925093|NCT01621490|58960464|FG001|Overall Study|Adverse event unrelated to study drug|1|||
30756380|NCT00401843|58766061|FG001|Overall Study|Other Unspecified|3|||
30756381|NCT00401843|58766062|FG002|Overall Study|Other Unspecified|5|||
30756382|NCT00401843|58766060|FG000|Overall Study|Physician Decision|0|||
30756383|NCT00401843|58766061|FG001|Overall Study|Physician Decision|16|||
30756384|NCT00401843|58766062|FG002|Overall Study|Physician Decision|10|||
30756385|NCT00401843|58766060|FG000|Overall Study|Protocol Violation|0|||
30756386|NCT00401843|58766061|FG001|Overall Study|Protocol Violation|0|||
30756387|NCT00401843|58766062|FG002|Overall Study|Protocol Violation|1|||
30756388|NCT00401843|58766060|FG000|Overall Study|Withdrawal by Subject|1|||
30756389|NCT00401843|58766061|FG001|Overall Study|Withdrawal by Subject|5|||
30756390|NCT00401843|58766062|FG002|Overall Study|Withdrawal by Subject|5|||
30756391|NCT00401843|58766060|FG000|Overall Study|Withdrawal of consent to study agent|1|||
30756392|NCT00401843|58766061|FG001|Overall Study|Withdrawal of consent to study agent|15|||
30756393|NCT00401843|58766062|FG002|Overall Study|Withdrawal of consent to study agent|17|||
30756394|NCT00401843|58766060|FG000|Overall Study|Randomized but not Treated|0|||
30756395|NCT00401843|58766061|FG001|Overall Study|Randomized but not Treated|2|||
30756396|NCT00401843|58766062|FG002|Overall Study|Randomized but not Treated|3|||
30756397|NCT00401843|58766060|FG000|Overall Study|Received incorrect treatment|0|||
30756398|NCT00401843|58766061|FG001|Overall Study|Received incorrect treatment|3|||
30756399|NCT00401843|58766062|FG002|Overall Study|Received incorrect treatment|0|||
30756400|NCT00401531|58766074|FG000|Overall Study|Adverse Event|2|||
30756401|NCT00401531|58766075|FG001|Overall Study|Adverse Event|0|||
30756402|NCT00401531|58766074|FG000|Overall Study|Protocol Violation|3|||
30756403|NCT00401531|58766075|FG001|Overall Study|Protocol Violation|7|||
30756404|NCT00401531|58766074|FG000|Overall Study|Lost to Follow-up|1|||
30756405|NCT00401531|58766075|FG001|Overall Study|Lost to Follow-up|1|||
30756406|NCT00401531|58766074|FG000|Overall Study|Withdrawal by Subject|3|||
30756407|NCT00401531|58766075|FG001|Overall Study|Withdrawal by Subject|2|||
30756408|NCT00401375|58766084|FG000|Overall Study|Protocol Violation|2|||
30756409|NCT00401375|58766085|FG001|Overall Study|Protocol Violation|2|||
30756410|NCT00401375|58766086|FG002|Overall Study|Protocol Violation|1|||
30756411|NCT00401375|58766084|FG000|Overall Study|Adverse Event|6|||
30756412|NCT00401375|58766085|FG001|Overall Study|Adverse Event|11|||
30756413|NCT00401375|58766086|FG002|Overall Study|Adverse Event|10|||
30756414|NCT00401375|58766084|FG000|Overall Study|Withdrawal by Subject|9|||
30756415|NCT00401375|58766085|FG001|Overall Study|Withdrawal by Subject|7|||
30756416|NCT00401375|58766086|FG002|Overall Study|Withdrawal by Subject|7|||
30756417|NCT00401375|58766084|FG000|Overall Study|Lost to Follow-up|0|||
30756418|NCT00401375|58766085|FG001|Overall Study|Lost to Follow-up|1|||
30756419|NCT00401375|58766086|FG002|Overall Study|Lost to Follow-up|1|||
30756420|NCT00401375|58766084|FG000|Overall Study|Other than specified|2|||
30756421|NCT00401375|58766085|FG001|Overall Study|Other than specified|1|||
30756422|NCT00401375|58766086|FG002|Overall Study|Other than specified|3|||
30756423|NCT00401375|58766084|FG000|Overall Study|Randomized but not treated|3|||
30756424|NCT00401375|58766085|FG001|Overall Study|Randomized but not treated|3|||
30756425|NCT00401375|58766086|FG002|Overall Study|Randomized but not treated|3|||
30756426|NCT00400985|58766094|FG000|Overall Study|Withdrawal by Subject|5|||
30756427|NCT00400985|58766094|FG000|Overall Study|system modification|8|||
30756428|NCT00400985|58766094|FG000|Overall Study|Death|30|||
30756429|NCT00400985|58766094|FG000|Overall Study|Lost to Follow-up|9|||
30756430|NCT00400517|58766098|FG000|Overall Study|Withdrawal by Subject|1|||
30756431|NCT00400517|58766098|FG000|Overall Study|Physician Decision|1|||
30756432|NCT00392171|58766102|FG000|Overall Study|Did not meet inclusion criteria|4|||
30756433|NCT00392171|58766102|FG000|Overall Study|Disease progression|101|||
30756434|NCT00391625|58766106|FG000|Month 14|Withdrawal by Subject|1|||
30756435|NCT00391625|58766106|FG000|Month 50|Physician Decision|1|||
30756436|NCT00091832|58766139|FG000|Overall Study|Physician Decision|1|||
30756437|NCT00091832|58766140|FG001|Overall Study|Physician Decision|0|||
30756438|NCT00091832|58766141|FG002|Overall Study|Physician Decision|0|||
30756439|NCT00091832|58766142|FG003|Overall Study|Physician Decision|0|||
30756440|NCT00091832|58766143|FG004|Overall Study|Physician Decision|0|||
30834431|NCT01329978|58858990|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
30834432|NCT01329978|58858991|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
30834433|NCT01329978|58858987|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
30834434|NCT01329978|58858988|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
30834435|NCT01329978|58858989|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
30925094|NCT01621490|58960465|FG002|Overall Study|Adverse event unrelated to study drug|0|||
30925095|NCT01621490|58960466|FG003|Overall Study|Adverse event unrelated to study drug|0|||
30925096|NCT01621490|58960467|FG004|Overall Study|Adverse event unrelated to study drug|0|||
30756441|NCT00091832|58766144|FG005|Overall Study|Physician Decision|0|||
30756442|NCT00091832|58766139|FG000|Overall Study|Adverse Event|0|||
30756443|NCT00091832|58766140|FG001|Overall Study|Adverse Event|0|||
30756444|NCT00091832|58766141|FG002|Overall Study|Adverse Event|0|||
30756445|NCT00091832|58766142|FG003|Overall Study|Adverse Event|1|||
30756446|NCT00091832|58766143|FG004|Overall Study|Adverse Event|3|||
30756447|NCT00091832|58766144|FG005|Overall Study|Adverse Event|0|||
30756448|NCT00091832|58766139|FG000|Overall Study|Withdrawal by Subject|4|||
30756449|NCT00091832|58766140|FG001|Overall Study|Withdrawal by Subject|5|||
30756450|NCT00091832|58766141|FG002|Overall Study|Withdrawal by Subject|0|||
30756451|NCT00091832|58766142|FG003|Overall Study|Withdrawal by Subject|1|||
30756452|NCT00091832|58766143|FG004|Overall Study|Withdrawal by Subject|3|||
30756453|NCT00091832|58766144|FG005|Overall Study|Withdrawal by Subject|1|||
30756454|NCT00091832|58766139|FG000|Overall Study|Death|6|||
30756455|NCT00091832|58766140|FG001|Overall Study|Death|4|||
30756456|NCT00091832|58766141|FG002|Overall Study|Death|5|||
30756457|NCT00091832|58766142|FG003|Overall Study|Death|8|||
30756458|NCT00091832|58766143|FG004|Overall Study|Death|5|||
30756459|NCT00091832|58766144|FG005|Overall Study|Death|6|||
30756460|NCT00091832|58766139|FG000|Overall Study|Disease Progression|2|||
30756461|NCT00091832|58766140|FG001|Overall Study|Disease Progression|0|||
30756462|NCT00091832|58766141|FG002|Overall Study|Disease Progression|0|||
30756463|NCT00091832|58766142|FG003|Overall Study|Disease Progression|1|||
30756464|NCT00091832|58766143|FG004|Overall Study|Disease Progression|1|||
30756465|NCT00091832|58766144|FG005|Overall Study|Disease Progression|2|||
30756466|NCT00091832|58766139|FG000|Overall Study|Ineligibility Determined|0|||
30756467|NCT00091832|58766140|FG001|Overall Study|Ineligibility Determined|0|||
30756468|NCT00091832|58766141|FG002|Overall Study|Ineligibility Determined|1|||
30756469|NCT00091832|58766142|FG003|Overall Study|Ineligibility Determined|0|||
30756470|NCT00091832|58766143|FG004|Overall Study|Ineligibility Determined|1|||
30756471|NCT00091832|58766144|FG005|Overall Study|Ineligibility Determined|0|||
30756472|NCT00091832|58766139|FG000|Overall Study|Lost to Follow-up|1|||
30756473|NCT00091832|58766140|FG001|Overall Study|Lost to Follow-up|0|||
30756474|NCT00091832|58766141|FG002|Overall Study|Lost to Follow-up|3|||
30756475|NCT00091832|58766142|FG003|Overall Study|Lost to Follow-up|3|||
30756476|NCT00091832|58766143|FG004|Overall Study|Lost to Follow-up|2|||
30756477|NCT00091832|58766144|FG005|Overall Study|Lost to Follow-up|1|||
30756478|NCT00091832|58766139|FG000|Overall Study|Noncompliance|0|||
30756479|NCT00091832|58766140|FG001|Overall Study|Noncompliance|1|||
30756480|NCT00091832|58766141|FG002|Overall Study|Noncompliance|0|||
30756481|NCT00091832|58766142|FG003|Overall Study|Noncompliance|0|||
30756482|NCT00091832|58766143|FG004|Overall Study|Noncompliance|0|||
30925097|NCT01621490|58960468|FG005|Overall Study|Adverse event unrelated to study drug|0|||
30925098|NCT01621490|58960469|FG006|Overall Study|Adverse event unrelated to study drug|0|||
30925099|NCT01621490|58960470|FG007|Overall Study|Adverse event unrelated to study drug|2|||
30756483|NCT00091832|58766144|FG005|Overall Study|Noncompliance|0|||
30756484|NCT00091832|58766139|FG000|Overall Study|Other|0|||
30756485|NCT00091832|58766140|FG001|Overall Study|Other|1|||
30834436|NCT01329978|58858990|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
30834437|NCT01329978|58858991|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
30834438|NCT01329978|58858987|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
30834439|NCT01329978|58858988|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
30834440|NCT01329978|58858989|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
30834441|NCT01329978|58858990|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
30834442|NCT01329978|58858991|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
30834443|NCT01329978|58858987|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
30834444|NCT01329978|58858988|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
30834445|NCT01329978|58858989|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
30834446|NCT01329978|58858990|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
30834447|NCT01329978|58858991|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
30834448|NCT01338012|58859003|FG000|Overall Study|Death|4|||
30834449|NCT01338012|58859003|FG000|Overall Study|Study terminated|4|||
30834450|NCT04905498|58859009|FG000|Overall Study|Lost to Follow-up|0|||
30834451|NCT04905498|58859010|FG001|Overall Study|Lost to Follow-up|2|||
30834452|NCT04905498|58859009|FG000|Overall Study|COVID lockdown|1|||
30834453|NCT04905498|58859010|FG001|Overall Study|COVID lockdown|0|||
30834454|NCT02607280|58859018|FG000|Overall Study|Adverse Event|4|||
30834455|NCT02607280|58859019|FG001|Overall Study|Adverse Event|0|||
30834456|NCT02607280|58859018|FG000|Overall Study|Decrease in CrCl <15|0|||
30834457|NCT02607280|58859019|FG001|Overall Study|Decrease in CrCl <15|1|||
30834458|NCT02202434|58859029|FG000|Overall Study|Death|70|||
30834459|NCT02202434|58859030|FG001|Overall Study|Death|39|||
30925100|NCT01621490|58960471|FG008|Overall Study|Adverse event unrelated to study drug|1|||
30834460|NCT02202434|58859031|FG002|Overall Study|Death|13|||
30834461|NCT02202434|58859032|FG003|Overall Study|Death|27|||
30834462|NCT02202434|58859029|FG000|Overall Study|Lost to Follow-up|1|||
30756486|NCT00091832|58766141|FG002|Overall Study|Other|2|||
30756487|NCT00091832|58766142|FG003|Overall Study|Other|0|||
30756488|NCT00091832|58766143|FG004|Overall Study|Other|0|||
30756489|NCT00091832|58766144|FG005|Overall Study|Other|0|||
30756490|NCT00091832|58766139|FG000|Overall Study|Protocol Violation|0|||
30756491|NCT00091832|58766140|FG001|Overall Study|Protocol Violation|0|||
30756492|NCT00091832|58766141|FG002|Overall Study|Protocol Violation|1|||
30925101|NCT01621490|58960463|FG000|Overall Study|Disease progression|27|||
30925102|NCT01621490|58960464|FG001|Overall Study|Disease progression|28|||
30925103|NCT01621490|58960465|FG002|Overall Study|Disease progression|1|||
30925104|NCT01621490|58960466|FG003|Overall Study|Disease progression|5|||
30925105|NCT01621490|58960467|FG004|Overall Study|Disease progression|3|||
30925106|NCT01621490|58960468|FG005|Overall Study|Disease progression|8|||
30925107|NCT01621490|58960469|FG006|Overall Study|Disease progression|7|||
30834463|NCT02202434|58859030|FG001|Overall Study|Lost to Follow-up|1|||
30834464|NCT02202434|58859031|FG002|Overall Study|Lost to Follow-up|1|||
30834465|NCT02202434|58859032|FG003|Overall Study|Lost to Follow-up|0|||
30834466|NCT02202434|58859029|FG000|Overall Study|Physician Decision|2|||
30834467|NCT02202434|58859030|FG001|Overall Study|Physician Decision|3|||
30834468|NCT02202434|58859031|FG002|Overall Study|Physician Decision|0|||
30834469|NCT02202434|58859032|FG003|Overall Study|Physician Decision|0|||
30834470|NCT02202434|58859029|FG000|Overall Study|Withdrawal by Subject|13|||
30834471|NCT02202434|58859030|FG001|Overall Study|Withdrawal by Subject|14|||
30834472|NCT02202434|58859031|FG002|Overall Study|Withdrawal by Subject|1|||
30834473|NCT02202434|58859032|FG003|Overall Study|Withdrawal by Subject|4|||
30834474|NCT02202434|58859029|FG000|Overall Study|Completed Study|1|||
30834475|NCT02202434|58859030|FG001|Overall Study|Completed Study|0|||
30834476|NCT02202434|58859031|FG002|Overall Study|Completed Study|0|||
30834477|NCT02202434|58859032|FG003|Overall Study|Completed Study|0|||
30834478|NCT02202434|58859029|FG000|Overall Study|Visit Missed|21|||
30834479|NCT02202434|58859030|FG001|Overall Study|Visit Missed|12|||
30834480|NCT02202434|58859031|FG002|Overall Study|Visit Missed|0|||
30834481|NCT02202434|58859032|FG003|Overall Study|Visit Missed|5|||
30834482|NCT02202434|58859029|FG000|Overall Study|Other|1|||
30834483|NCT02202434|58859030|FG001|Overall Study|Other|0|||
30834484|NCT02202434|58859031|FG002|Overall Study|Other|0|||
30834485|NCT02202434|58859032|FG003|Overall Study|Other|1|||
30834486|NCT02784288|58859042|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
30834487|NCT01230242|58859047|FG000|Overall Study|Physician Decision|2|||
30834488|NCT01230242|58859047|FG000|Overall Study|Withdrawal by Subject|1|||
30834489|NCT02608450|58859053|FG000|Overall Study|Lost to Follow-up|39|||
30834490|NCT02608450|58859054|FG001|Overall Study|Lost to Follow-up|32|||
30834491|NCT02608450|58859053|FG000|Overall Study|Withdrawal by Subject|21|||
30834492|NCT02608450|58859054|FG001|Overall Study|Withdrawal by Subject|15|||
30834493|NCT02608450|58859053|FG000|Overall Study|Adverse Event|3|||
30834494|NCT02608450|58859054|FG001|Overall Study|Adverse Event|6|||
30834495|NCT02608450|58859053|FG000|Overall Study|Withdrawal by parent|2|||
30834496|NCT02608450|58859054|FG001|Overall Study|Withdrawal by parent|3|||
30834497|NCT02608450|58859053|FG000|Overall Study|Lack of Efficacy|0|||
30834498|NCT02608450|58859054|FG001|Overall Study|Lack of Efficacy|3|||
30834499|NCT02608450|58859053|FG000|Overall Study|Noncompliance with study drug|0|||
30834500|NCT02608450|58859054|FG001|Overall Study|Noncompliance with study drug|2|||
30834501|NCT02608450|58859053|FG000|Overall Study|Physician Decision|0|||
30834502|NCT02608450|58859054|FG001|Overall Study|Physician Decision|1|||
30834503|NCT02608450|58859053|FG000|Overall Study|Pregnancy|0|||
30834504|NCT02608450|58859054|FG001|Overall Study|Pregnancy|1|||
30834505|NCT02608450|58859053|FG000|Overall Study|Progressive disease|1|||
30834506|NCT02608450|58859054|FG001|Overall Study|Progressive disease|0|||
30834507|NCT02608450|58859053|FG000|Overall Study|Multiple reasons|0|||
30834508|NCT02608450|58859054|FG001|Overall Study|Multiple reasons|2|||
30834509|NCT01668004|58859060|FG000|Overall Study|Adverse Event|7|||
30834510|NCT01668004|58859060|FG000|Overall Study|Withdrawal by Subject|2|||
30834511|NCT01668004|58859060|FG000|Overall Study|Lost to Follow-up|5|||
30834512|NCT01668004|58859060|FG000|Overall Study|Lack of Efficacy|9|||
30834513|NCT01668004|58859060|FG000|Overall Study|Non-compliance with treatment|2|||
30834514|NCT01667926|58859068|FG000|Overall Study|Withdrawal by Subject|1|||
30834515|NCT01667926|58859069|FG001|Overall Study|Withdrawal by Subject|2|||
30834516|NCT01667926|58859070|FG002|Overall Study|Withdrawal by Subject|2|||
30834517|NCT01667926|58859068|FG000|Overall Study|Physician Decision|0|||
30834518|NCT01667926|58859069|FG001|Overall Study|Physician Decision|0|||
30834519|NCT01667926|58859070|FG002|Overall Study|Physician Decision|1|||
30834520|NCT01667926|58859068|FG000|Overall Study|Time committment|0|||
30834521|NCT01667926|58859069|FG001|Overall Study|Time committment|0|||
30834522|NCT01667926|58859070|FG002|Overall Study|Time committment|2|||
30834523|NCT01667926|58859068|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
30834524|NCT01667926|58859069|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
30834525|NCT01667926|58859070|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
30834526|NCT01667926|58859068|FG000|Overall Study|Lost to Follow-up|1|||
30834527|NCT01667926|58859069|FG001|Overall Study|Lost to Follow-up|2|||
30834528|NCT01667926|58859070|FG002|Overall Study|Lost to Follow-up|1|||
30834529|NCT01667926|58859068|FG000|Overall Study|Side effects|3|||
30834530|NCT01667926|58859069|FG001|Overall Study|Side effects|0|||
30834531|NCT01667926|58859070|FG002|Overall Study|Side effects|0|||
30834532|NCT02604160|58859078|FG000|Overall Study|Protocol Violation|0|||
30925108|NCT01621490|58960470|FG007|Overall Study|Disease progression|0|||
30925109|NCT01621490|58960471|FG008|Overall Study|Disease progression|4|||
30834533|NCT02604160|58859079|FG001|Overall Study|Protocol Violation|1|||
30834534|NCT02604160|58859078|FG000|Overall Study|Physician Decision|0|||
30834535|NCT02604160|58859079|FG001|Overall Study|Physician Decision|1|||
30834536|NCT01359904|58859089|FG000|Overall Study|Withdrawal by Subject|1|||
30834537|NCT01359904|58859090|FG001|Overall Study|Withdrawal by Subject|0|||
30834538|NCT00157248|58859119|FG000|Overall Study|Adverse Event|36|||
30834539|NCT00157248|58859120|FG001|Overall Study|Adverse Event|25|||
30834540|NCT00157248|58859121|FG002|Overall Study|Adverse Event|13|||
30834541|NCT00157248|58859122|FG003|Overall Study|Adverse Event|33|||
30834542|NCT00157248|58859119|FG000|Overall Study|Protocol Violation|4|||
30834543|NCT00157248|58859120|FG001|Overall Study|Protocol Violation|0|||
30834544|NCT00157248|58859121|FG002|Overall Study|Protocol Violation|2|||
30834545|NCT00157248|58859122|FG003|Overall Study|Protocol Violation|2|||
30834546|NCT00157248|58859119|FG000|Overall Study|Lost to Follow-up|0|||
30834547|NCT00157248|58859120|FG001|Overall Study|Lost to Follow-up|1|||
30834548|NCT00157248|58859121|FG002|Overall Study|Lost to Follow-up|0|||
30834549|NCT00157248|58859122|FG003|Overall Study|Lost to Follow-up|0|||
30834550|NCT00157248|58859119|FG000|Overall Study|Withdrawal by Subject|1|||
30834551|NCT00157248|58859120|FG001|Overall Study|Withdrawal by Subject|4|||
30834552|NCT00157248|58859121|FG002|Overall Study|Withdrawal by Subject|3|||
30834553|NCT00157248|58859122|FG003|Overall Study|Withdrawal by Subject|3|||
30834554|NCT00157248|58859119|FG000|Overall Study|site closures, subject moving|7|||
30834555|NCT00157248|58859120|FG001|Overall Study|site closures, subject moving|7|||
30834556|NCT00157248|58859121|FG002|Overall Study|site closures, subject moving|3|||
30834557|NCT00157248|58859122|FG003|Overall Study|site closures, subject moving|9|||
30834558|NCT01328756|58859136|FG000|Overall Study|Protocol Violation|4|||
30834559|NCT01328756|58859136|FG000|Overall Study|Adverse Event|39|||
30834560|NCT01328756|58859136|FG000|Overall Study|Lack of Efficacy|5|||
30834561|NCT01328756|58859136|FG000|Overall Study|Withdrawal by Subject|41|||
30834562|NCT01328756|58859136|FG000|Overall Study|Lost to Follow-up|5|||
30834563|NCT01328756|58859136|FG000|Overall Study|Other|29|||
30834564|NCT03922308|58859143|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
30834565|NCT03922308|58859144|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
30834566|NCT03922308|58859145|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
30834567|NCT03922308|58859143|FG000|Overall Study|Lost to Follow-up|1|||
30834568|NCT03922308|58859144|FG001|Overall Study|Lost to Follow-up|0|||
30834569|NCT03922308|58859145|FG002|Overall Study|Lost to Follow-up|0|||
30834570|NCT03922308|58859143|FG000|Overall Study|Reason not Specified|0|||
30834571|NCT03922308|58859144|FG001|Overall Study|Reason not Specified|2|||
30834572|NCT03922308|58859145|FG002|Overall Study|Reason not Specified|1|||
30834573|NCT02607930|58859158|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
30834574|NCT02607930|58859159|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
30834575|NCT02607930|58859160|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
30834576|NCT02607930|58859161|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
30834577|NCT02607930|58859158|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
30834578|NCT02607930|58859159|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
30834579|NCT02607930|58859160|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
30834580|NCT02607930|58859161|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
30834581|NCT02607930|58859158|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
30834582|NCT02607930|58859159|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
30834583|NCT02607930|58859160|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
30834584|NCT02607930|58859161|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
30834585|NCT02607930|58859158|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
30834586|NCT02607930|58859159|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
30834587|NCT02607930|58859160|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
30834588|NCT02607930|58859161|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
30834589|NCT02607930|58859158|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
30834590|NCT02607930|58859159|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
30834591|NCT02607930|58859160|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
30834592|NCT02607930|58859161|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
30834593|NCT02607930|58859158|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
30834594|NCT02607930|58859159|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
30834595|NCT02607930|58859160|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
30834596|NCT02607930|58859161|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
30623886|NCT00910000|58635854|FG002|Overall Study|Withdrawal by Subject|1|||
30834597|NCT02607930|58859158|FG000|Double-Blinded Treatment Phase|Death|2|||
30834598|NCT02607930|58859159|FG001|Double-Blinded Treatment Phase|Death|1|||
30834599|NCT02607930|58859160|FG002|Double-Blinded Treatment Phase|Death|0|||
30834600|NCT02607930|58859161|FG003|Double-Blinded Treatment Phase|Death|0|||
30834601|NCT02607930|58859158|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
30834602|NCT02607930|58859159|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
30834603|NCT02607930|58859160|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
30834604|NCT02607930|58859161|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
30834605|NCT02607930|58859158|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
30834606|NCT02607930|58859159|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
30834607|NCT02607930|58859160|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
30834608|NCT02607930|58859161|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
30834609|NCT02607930|58859158|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
30834610|NCT02607930|58859159|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
30834611|NCT02607930|58859160|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
30834612|NCT02607930|58859161|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
30834613|NCT02607930|58859158|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
30834614|NCT02607930|58859159|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
30834615|NCT02607930|58859160|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
30834616|NCT02607930|58859161|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
30834617|NCT02607930|58859158|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
30834618|NCT02607930|58859159|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
30834619|NCT02607930|58859160|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
30834620|NCT02607930|58859161|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
30834621|NCT02607930|58859158|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
30834622|NCT02607930|58859159|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
30834623|NCT02607930|58859160|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
30834624|NCT02607930|58859161|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
30834625|NCT02607930|58859158|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
30834626|NCT02607930|58859159|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
30834627|NCT02607930|58859160|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
30834628|NCT02607930|58859161|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
30834629|NCT02607930|58859158|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
30834630|NCT02607930|58859159|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
30834631|NCT02607930|58859160|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
30834632|NCT02607930|58859161|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
30834633|NCT02607930|58859158|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
30834634|NCT02607930|58859159|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
30834635|NCT02607930|58859160|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
30834636|NCT02607930|58859161|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
30834637|NCT02101034|58859180|FG000|Overall Study|Enrolled but did not start treatment|0|||
30834638|NCT02101034|58859181|FG001|Overall Study|Enrolled but did not start treatment|0|||
30834639|NCT02101034|58859182|FG002|Overall Study|Enrolled but did not start treatment|1|||
30834640|NCT02101034|58859183|FG003|Overall Study|Enrolled but did not start treatment|0|||
30834641|NCT02101034|58859184|FG004|Overall Study|Enrolled but did not start treatment|0|||
30834642|NCT02736188|58859219|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
30834643|NCT02736188|58859219|FG000|Overall Study|Adverse Event|1|||
30834644|NCT02736188|58859219|FG000|Overall Study|Withdrawal by Subject|1|||
30834645|NCT02736188|58859219|FG000|Overall Study|Other|6|||
30834646|NCT00154284|58859227|FG000|Overall Study|Adverse Event|6|||
30834647|NCT00154284|58859228|FG001|Overall Study|Adverse Event|9|||
30834648|NCT00154284|58859227|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30834649|NCT00154284|58859228|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30834650|NCT00154284|58859227|FG000|Overall Study|Lack of Efficacy|1|||
30834651|NCT00154284|58859228|FG001|Overall Study|Lack of Efficacy|2|||
30834652|NCT00154284|58859227|FG000|Overall Study|Protocol Violation|0|||
30756493|NCT00091832|58766142|FG003|Overall Study|Protocol Violation|0|||
30756494|NCT00091832|58766143|FG004|Overall Study|Protocol Violation|0|||
30756495|NCT00091832|58766144|FG005|Overall Study|Protocol Violation|1|||
30756496|NCT00391391|58766162|FG000|Overall Study|Adverse Event|0|||
30756497|NCT00391391|58766163|FG001|Overall Study|Adverse Event|0|||
30756498|NCT00391391|58766164|FG002|Overall Study|Adverse Event|0|||
30756499|NCT00391391|58766165|FG003|Overall Study|Adverse Event|1|||
30756500|NCT00391391|58766162|FG000|Overall Study|Lost to Follow-up|1|||
30756501|NCT00391391|58766163|FG001|Overall Study|Lost to Follow-up|3|||
30756502|NCT00391391|58766164|FG002|Overall Study|Lost to Follow-up|7|||
30756503|NCT00391391|58766165|FG003|Overall Study|Lost to Follow-up|4|||
30834653|NCT00154284|58859228|FG001|Overall Study|Protocol Violation|1|||
30834654|NCT02735096|58859236|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
30834655|NCT00905346|58859249|FG000|Period 1|Withdrawal by Subject|1|||
30834656|NCT00905346|58859250|FG001|Period 1|Withdrawal by Subject|0|||
30834657|NCT01328444|58859263|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
30834658|NCT01328444|58859264|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
30834659|NCT01328444|58859265|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
30834660|NCT01328444|58859266|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
30925110|NCT01621490|58960463|FG000|Overall Study|Study drug toxicity|1|||
30834661|NCT01328444|58859267|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
30834662|NCT01328444|58859268|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
30834663|NCT01328444|58859263|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
30834664|NCT01328444|58859264|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
30834665|NCT01328444|58859265|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
30834666|NCT01328444|58859266|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
30834667|NCT01328444|58859267|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
30834668|NCT01328444|58859268|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
30834669|NCT01328444|58859263|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
30834670|NCT01328444|58859264|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
30834671|NCT01328444|58859265|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
30834672|NCT01328444|58859266|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
30834673|NCT01328444|58859267|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
30834674|NCT01328444|58859268|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
30834675|NCT01328444|58859263|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
30834676|NCT01328444|58859264|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
30834677|NCT01328444|58859265|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
30834678|NCT01328444|58859266|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
30834679|NCT01328444|58859267|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
30834680|NCT01328444|58859268|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
30834681|NCT01328444|58859263|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
30834682|NCT01328444|58859264|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30834683|NCT01328444|58859265|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30834684|NCT01328444|58859266|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
30756504|NCT00391391|58766162|FG000|Overall Study|Protocol Violation|2|||
30756505|NCT00391391|58766163|FG001|Overall Study|Protocol Violation|3|||
30756506|NCT00391391|58766164|FG002|Overall Study|Protocol Violation|6|||
30756507|NCT00391391|58766165|FG003|Overall Study|Protocol Violation|7|||
30756508|NCT00391391|58766162|FG000|Overall Study|Withdrawal by Subject|6|||
30756509|NCT00391391|58766163|FG001|Overall Study|Withdrawal by Subject|4|||
30756510|NCT00391391|58766164|FG002|Overall Study|Withdrawal by Subject|10|||
30756511|NCT00391391|58766165|FG003|Overall Study|Withdrawal by Subject|7|||
30756512|NCT00091442|58766177|FG000|Overall Study|Progressive Disease|220|||
30756513|NCT00091442|58766178|FG001|Overall Study|Progressive Disease|189|||
30756514|NCT00091442|58766177|FG000|Overall Study|Physician Decision|61|||
30756515|NCT00091442|58766178|FG001|Overall Study|Physician Decision|58|||
30756516|NCT00091442|58766177|FG000|Overall Study|Withdrawal by Subject|38|||
30756517|NCT00091442|58766178|FG001|Overall Study|Withdrawal by Subject|46|||
30756518|NCT00091442|58766177|FG000|Overall Study|Adverse Event|29|||
30756519|NCT00091442|58766178|FG001|Overall Study|Adverse Event|48|||
30756520|NCT00091442|58766177|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
30756521|NCT00091442|58766178|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
30756522|NCT00091442|58766177|FG000|Overall Study|Death|9|||
30756523|NCT00091442|58766178|FG001|Overall Study|Death|7|||
30756524|NCT00091442|58766177|FG000|Overall Study|Lost to Follow-up|1|||
30756525|NCT00091442|58766178|FG001|Overall Study|Lost to Follow-up|3|||
30756526|NCT00091442|58766177|FG000|Overall Study|Other|2|||
30756527|NCT00091442|58766178|FG001|Overall Study|Other|6|||
30756528|NCT00390689|58766187|FG000|Overall Study|Adverse Event|2|||
30756529|NCT00390689|58766188|FG001|Overall Study|Adverse Event|5|||
30756530|NCT00390689|58766189|FG002|Overall Study|Adverse Event|2|||
30756531|NCT00390689|58766187|FG000|Overall Study|Lack of Efficacy|0|||
30756532|NCT00390689|58766188|FG001|Overall Study|Lack of Efficacy|0|||
30756533|NCT00390689|58766189|FG002|Overall Study|Lack of Efficacy|1|||
30756534|NCT00390689|58766187|FG000|Overall Study|Protocol Violation|1|||
30756535|NCT00390689|58766188|FG001|Overall Study|Protocol Violation|0|||
30756536|NCT00390689|58766189|FG002|Overall Study|Protocol Violation|0|||
30756537|NCT00390689|58766187|FG000|Overall Study|Investigator's judgement|2|||
30756538|NCT00390689|58766188|FG001|Overall Study|Investigator's judgement|0|||
30756539|NCT00390689|58766189|FG002|Overall Study|Investigator's judgement|0|||
30756540|NCT00121238|58766206|FG000|Overall Study|disease progression before intervention|1|||
30756541|NCT00121238|58766206|FG000|Overall Study|Protocol Violation|2|||
30756542|NCT00390455|58766212|FG000|Overall Study|Adverse Event|17|||
30756543|NCT00390455|58766213|FG001|Overall Study|Adverse Event|3|||
30756544|NCT00390455|58766212|FG000|Overall Study|Withdrawal by Subject|8|||
30834685|NCT01328444|58859267|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30834686|NCT01328444|58859268|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
30834687|NCT01328444|58859263|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
30834688|NCT01328444|58859264|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
30834689|NCT01328444|58859265|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
30834690|NCT01328444|58859266|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
30834691|NCT01328444|58859267|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
30756545|NCT00390455|58766213|FG001|Overall Study|Withdrawal by Subject|8|||
30834692|NCT01328444|58859268|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
30834693|NCT01328444|58859263|FG000|Washout Period (14 Days)|Adverse Event|1|||
30834694|NCT01328444|58859264|FG001|Washout Period (14 Days)|Adverse Event|1|||
30834695|NCT01328444|58859265|FG002|Washout Period (14 Days)|Adverse Event|0|||
30834696|NCT01328444|58859266|FG003|Washout Period (14 Days)|Adverse Event|1|||
30834697|NCT01328444|58859267|FG004|Washout Period (14 Days)|Adverse Event|1|||
30834698|NCT01328444|58859268|FG005|Washout Period (14 Days)|Adverse Event|2|||
30925111|NCT01621490|58960464|FG001|Overall Study|Study drug toxicity|4|||
30925112|NCT01621490|58960465|FG002|Overall Study|Study drug toxicity|5|||
30925113|NCT01621490|58960466|FG003|Overall Study|Study drug toxicity|3|||
30925114|NCT01621490|58960467|FG004|Overall Study|Study drug toxicity|1|||
30925115|NCT01621490|58960468|FG005|Overall Study|Study drug toxicity|10|||
30925116|NCT01621490|58960469|FG006|Overall Study|Study drug toxicity|1|||
30925117|NCT01621490|58960470|FG007|Overall Study|Study drug toxicity|4|||
30925118|NCT01621490|58960471|FG008|Overall Study|Study drug toxicity|1|||
30925119|NCT01621490|58960463|FG000|Overall Study|Death|0|||
30925120|NCT01621490|58960464|FG001|Overall Study|Death|0|||
30925121|NCT01621490|58960465|FG002|Overall Study|Death|0|||
30925122|NCT01621490|58960466|FG003|Overall Study|Death|0|||
30925123|NCT01621490|58960467|FG004|Overall Study|Death|0|||
30925124|NCT01621490|58960468|FG005|Overall Study|Death|0|||
30925125|NCT01621490|58960469|FG006|Overall Study|Death|0|||
30925126|NCT01621490|58960470|FG007|Overall Study|Death|1|||
30925127|NCT01621490|58960471|FG008|Overall Study|Death|0|||
30756546|NCT00390455|58766212|FG000|Overall Study|Alternate Treatment|0|||
30756547|NCT00390455|58766213|FG001|Overall Study|Alternate Treatment|1|||
30756548|NCT00390455|58766212|FG000|Overall Study|Other Medical Reasons|7|||
30756549|NCT00390455|58766213|FG001|Overall Study|Other Medical Reasons|11|||
30756550|NCT03812510|58766219|FG000|Overall Study|Lost to Follow-up|39|||
30756551|NCT03812510|58766219|FG000|Overall Study|Withdrawal by Subject|42|||
30756552|NCT03812510|58766219|FG000|Overall Study|Physician Decision|2|||
30756553|NCT03812510|58766219|FG000|Overall Study|Study Terminated by Sponsor|9|||
30756554|NCT03812510|58766219|FG000|Overall Study|Did Not Start Study Medication|55|||
30834699|NCT01328444|58859263|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
30834700|NCT01328444|58859264|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
30834701|NCT01328444|58859265|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
30834702|NCT01328444|58859266|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
30834703|NCT01328444|58859267|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
30834704|NCT01328444|58859268|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
30834705|NCT01328444|58859263|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
30834706|NCT01328444|58859264|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
30834707|NCT01328444|58859265|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
30834708|NCT01328444|58859266|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
30834709|NCT01328444|58859267|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
30834710|NCT01328444|58859268|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
30834711|NCT01328444|58859263|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
30834712|NCT01328444|58859264|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
30834713|NCT01328444|58859265|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
30834714|NCT01328444|58859266|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
30834715|NCT01328444|58859267|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
30834716|NCT01328444|58859268|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
30834717|NCT01328444|58859263|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
30834718|NCT01328444|58859264|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
30925128|NCT01621490|58960463|FG000|Overall Study|Grade 4 Lipase elevation|1|||
30925129|NCT01621490|58960464|FG001|Overall Study|Grade 4 Lipase elevation|0|||
30756555|NCT03812510|58766219|FG000|Overall Study|Adverse Event|5|||
30756556|NCT00390299|58766229|FG000|Overall Study|Cancellation|1|||
30756557|NCT00390299|58766230|FG001|Overall Study|Cancellation|0|||
30756558|NCT00390299|58766231|FG002|Overall Study|Cancellation|0|||
30756559|NCT00390299|58766232|FG003|Overall Study|Cancellation|0|||
30756560|NCT00390299|58766233|FG004|Overall Study|Cancellation|0|||
30756561|NCT00119678|58766249|FG000|Double-blind Treatment Period|Death|1|||
30756562|NCT00119678|58766250|FG001|Double-blind Treatment Period|Death|0|||
30756563|NCT00119678|58766249|FG000|Double-blind Treatment Period|Adverse Event|7|||
30756564|NCT00119678|58766250|FG001|Double-blind Treatment Period|Adverse Event|1|||
30756565|NCT00119678|58766249|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
30834719|NCT01328444|58859265|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
30834720|NCT01328444|58859266|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
30834721|NCT01328444|58859267|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
30834722|NCT01328444|58859268|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
30834723|NCT01328444|58859263|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
30925130|NCT01621490|58960465|FG002|Overall Study|Grade 4 Lipase elevation|0|||
30925131|NCT01621490|58960466|FG003|Overall Study|Grade 4 Lipase elevation|0|||
30925132|NCT01621490|58960467|FG004|Overall Study|Grade 4 Lipase elevation|0|||
30925133|NCT01621490|58960468|FG005|Overall Study|Grade 4 Lipase elevation|0|||
30925134|NCT01621490|58960469|FG006|Overall Study|Grade 4 Lipase elevation|0|||
30925135|NCT01621490|58960470|FG007|Overall Study|Grade 4 Lipase elevation|0|||
30925136|NCT01621490|58960471|FG008|Overall Study|Grade 4 Lipase elevation|0|||
30925137|NCT01621490|58960463|FG000|Overall Study|BMS informed of patient status|0|||
30925138|NCT01621490|58960464|FG001|Overall Study|BMS informed of patient status|0|||
30925139|NCT01621490|58960465|FG002|Overall Study|BMS informed of patient status|1|||
30925140|NCT01621490|58960466|FG003|Overall Study|BMS informed of patient status|0|||
30925141|NCT01621490|58960467|FG004|Overall Study|BMS informed of patient status|0|||
30925142|NCT01621490|58960468|FG005|Overall Study|BMS informed of patient status|0|||
30925143|NCT01621490|58960469|FG006|Overall Study|BMS informed of patient status|0|||
30925144|NCT01621490|58960470|FG007|Overall Study|BMS informed of patient status|0|||
30925145|NCT01621490|58960471|FG008|Overall Study|BMS informed of patient status|0|||
30925146|NCT01621490|58960463|FG000|Overall Study|Investigator decision|0|||
30925147|NCT01621490|58960464|FG001|Overall Study|Investigator decision|0|||
30925148|NCT01621490|58960465|FG002|Overall Study|Investigator decision|1|||
30925149|NCT01621490|58960466|FG003|Overall Study|Investigator decision|0|||
30925150|NCT01621490|58960467|FG004|Overall Study|Investigator decision|1|||
30925151|NCT01621490|58960468|FG005|Overall Study|Investigator decision|0|||
30925152|NCT01621490|58960469|FG006|Overall Study|Investigator decision|1|||
30925153|NCT01621490|58960470|FG007|Overall Study|Investigator decision|0|||
30925154|NCT01621490|58960471|FG008|Overall Study|Investigator decision|0|||
30925155|NCT01621490|58960463|FG000|Overall Study|Documented disease progression|0|||
30925156|NCT01621490|58960464|FG001|Overall Study|Documented disease progression|0|||
30925157|NCT01621490|58960465|FG002|Overall Study|Documented disease progression|1|||
30925158|NCT01621490|58960466|FG003|Overall Study|Documented disease progression|0|||
30925159|NCT01621490|58960467|FG004|Overall Study|Documented disease progression|0|||
30925160|NCT01621490|58960468|FG005|Overall Study|Documented disease progression|0|||
30925161|NCT01621490|58960469|FG006|Overall Study|Documented disease progression|0|||
30925162|NCT01621490|58960470|FG007|Overall Study|Documented disease progression|0|||
30925163|NCT01621490|58960471|FG008|Overall Study|Documented disease progression|0|||
30925164|NCT01621490|58960463|FG000|Overall Study|Patient reached treatment 2 yr limit|0|||
30925165|NCT01621490|58960464|FG001|Overall Study|Patient reached treatment 2 yr limit|1|||
30925166|NCT01621490|58960465|FG002|Overall Study|Patient reached treatment 2 yr limit|0|||
30925167|NCT01621490|58960466|FG003|Overall Study|Patient reached treatment 2 yr limit|0|||
30925168|NCT01621490|58960467|FG004|Overall Study|Patient reached treatment 2 yr limit|0|||
30925169|NCT01621490|58960468|FG005|Overall Study|Patient reached treatment 2 yr limit|0|||
30925170|NCT01621490|58960469|FG006|Overall Study|Patient reached treatment 2 yr limit|0|||
30925171|NCT01621490|58960470|FG007|Overall Study|Patient reached treatment 2 yr limit|0|||
30925172|NCT01621490|58960471|FG008|Overall Study|Patient reached treatment 2 yr limit|0|||
30925173|NCT01621490|58960463|FG000|Overall Study|Clinical deterioration|0|||
30925174|NCT01621490|58960464|FG001|Overall Study|Clinical deterioration|1|||
30925175|NCT01621490|58960465|FG002|Overall Study|Clinical deterioration|0|||
30925176|NCT01621490|58960466|FG003|Overall Study|Clinical deterioration|0|||
30925177|NCT01621490|58960467|FG004|Overall Study|Clinical deterioration|0|||
30925178|NCT01621490|58960468|FG005|Overall Study|Clinical deterioration|0|||
30925179|NCT01621490|58960469|FG006|Overall Study|Clinical deterioration|0|||
30925180|NCT01621490|58960470|FG007|Overall Study|Clinical deterioration|0|||
30925181|NCT01621490|58960471|FG008|Overall Study|Clinical deterioration|0|||
30756566|NCT00119678|58766250|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
30756567|NCT00119678|58766249|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
30756568|NCT00119678|58766250|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
30756569|NCT00119678|58766249|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
30756570|NCT00119678|58766250|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
30756571|NCT00119678|58766249|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
30756572|NCT00119678|58766250|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
30756573|NCT00119678|58766249|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
30756574|NCT00119678|58766250|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
30756575|NCT00119678|58766249|FG000|Double-blind Treatment Period|Pregnancy|0|||
30756576|NCT00119678|58766250|FG001|Double-blind Treatment Period|Pregnancy|2|||
30756577|NCT00119678|58766249|FG000|Double-blind Treatment Period|Not treated|1|||
30756578|NCT00119678|58766250|FG001|Double-blind Treatment Period|Not treated|2|||
30756579|NCT00119678|58766249|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
30756580|NCT00119678|58766250|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
30756581|NCT00119678|58766249|FG000|Open-label Treatment Period|Death|1|||
30756582|NCT00119678|58766250|FG001|Open-label Treatment Period|Death|0|||
30756583|NCT00119678|58766249|FG000|Open-label Treatment Period|Adverse Event|3|||
30756584|NCT00119678|58766250|FG001|Open-label Treatment Period|Adverse Event|0|||
30756585|NCT00119678|58766249|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
30925182|NCT01621490|58960463|FG000|Overall Study|Complete response|0|||
30925183|NCT01621490|58960464|FG001|Overall Study|Complete response|0|||
30925184|NCT01621490|58960465|FG002|Overall Study|Complete response|0|||
30925185|NCT01621490|58960466|FG003|Overall Study|Complete response|0|||
30925186|NCT01621490|58960467|FG004|Overall Study|Complete response|0|||
30925187|NCT01621490|58960468|FG005|Overall Study|Complete response|0|||
30925188|NCT01621490|58960469|FG006|Overall Study|Complete response|0|||
30925189|NCT01621490|58960470|FG007|Overall Study|Complete response|0|||
30925190|NCT01621490|58960471|FG008|Overall Study|Complete response|1|||
30925191|NCT01621490|58960463|FG000|Overall Study|Patient delayed due to toxicity|0|||
30834724|NCT01328444|58859264|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
30925192|NCT01621490|58960464|FG001|Overall Study|Patient delayed due to toxicity|0|||
30925193|NCT01621490|58960465|FG002|Overall Study|Patient delayed due to toxicity|0|||
30925194|NCT01621490|58960466|FG003|Overall Study|Patient delayed due to toxicity|0|||
30925195|NCT01621490|58960467|FG004|Overall Study|Patient delayed due to toxicity|0|||
30925196|NCT01621490|58960468|FG005|Overall Study|Patient delayed due to toxicity|1|||
30925197|NCT01621490|58960469|FG006|Overall Study|Patient delayed due to toxicity|0|||
30925198|NCT01621490|58960470|FG007|Overall Study|Patient delayed due to toxicity|0|||
30925199|NCT01621490|58960471|FG008|Overall Study|Patient delayed due to toxicity|0|||
30925200|NCT02018887|58960592|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
30925201|NCT02018887|58960593|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
30925202|NCT02018887|58960594|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
30925203|NCT02018887|58960595|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
30925204|NCT02018887|58960596|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
30925205|NCT02018887|58960597|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
30925206|NCT02018887|58960598|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
30925207|NCT02018887|58960599|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
30925208|NCT02018887|58960600|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
30925209|NCT02018887|58960601|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
30925210|NCT02018887|58960602|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
30925211|NCT02018887|58960592|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
30925212|NCT02018887|58960593|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
30925213|NCT02018887|58960594|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
30925214|NCT02018887|58960595|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
30925215|NCT02018887|58960596|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
30925216|NCT02018887|58960597|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
30925217|NCT02018887|58960598|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
30925218|NCT02018887|58960599|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
30925219|NCT02018887|58960600|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
30925220|NCT02018887|58960601|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
30925221|NCT02018887|58960602|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
30834725|NCT01328444|58859265|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
30834726|NCT01328444|58859266|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
30834727|NCT01328444|58859267|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
30834728|NCT01328444|58859268|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
30834729|NCT01328444|58859263|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
30834730|NCT01328444|58859264|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
30925222|NCT02018887|58960592|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
30925223|NCT02018887|58960593|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
30925224|NCT02018887|58960594|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
30925225|NCT02018887|58960595|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
30925226|NCT02018887|58960596|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
30925227|NCT02018887|58960597|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
30925228|NCT02018887|58960598|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
30925229|NCT02018887|58960599|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
30925230|NCT02018887|58960600|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
30756586|NCT00119678|58766250|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
30756587|NCT00119678|58766249|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
30756588|NCT00119678|58766250|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
30756589|NCT00119678|58766249|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
30756590|NCT00119678|58766250|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
30756591|NCT00119678|58766249|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
30756592|NCT00119678|58766250|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
30756593|NCT00119678|58766249|FG000|Open-label Treatment Period|Pregnancy|1|||
30756594|NCT00119678|58766250|FG001|Open-label Treatment Period|Pregnancy|0|||
30756595|NCT00119678|58766249|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
30834731|NCT01328444|58859265|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
30925231|NCT02018887|58960601|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
30925232|NCT02018887|58960602|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
30925233|NCT02018887|58960592|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
30925234|NCT02018887|58960593|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
30925235|NCT02018887|58960594|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
30925236|NCT02018887|58960595|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
30925237|NCT02018887|58960596|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
30925238|NCT02018887|58960597|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
30925239|NCT02018887|58960598|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
30925240|NCT02018887|58960599|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
30925241|NCT02018887|58960600|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
30925242|NCT02018887|58960601|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
30925243|NCT02018887|58960602|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
30925244|NCT02030041|58960671|FG000|Overall Study|Withdrawal by Subject|2|||
30925245|NCT02030041|58960672|FG001|Overall Study|Withdrawal by Subject|2|||
30925246|NCT02030041|58960673|FG002|Overall Study|Withdrawal by Subject|1|||
30925247|NCT01844505|58960684|FG000|Overall Study|Disease progression|170|||
30925248|NCT01844505|58960685|FG001|Overall Study|Disease progression|88|||
30925249|NCT01844505|58960686|FG002|Overall Study|Disease progression|224|||
30925250|NCT01844505|58960684|FG000|Overall Study|Study drug toxicity|40|||
30925251|NCT01844505|58960685|FG001|Overall Study|Study drug toxicity|131|||
30925252|NCT01844505|58960686|FG002|Overall Study|Study drug toxicity|50|||
30834732|NCT01328444|58859266|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
30834733|NCT01328444|58859267|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
30834734|NCT01328444|58859268|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
30834735|NCT01328444|58859263|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
30834736|NCT01328444|58859264|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
30834737|NCT01328444|58859265|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
30834738|NCT01328444|58859266|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
30834739|NCT01328444|58859267|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
30834740|NCT01328444|58859268|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
30834741|NCT01328444|58859263|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30834742|NCT01328444|58859264|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30834743|NCT01328444|58859265|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30834744|NCT01328444|58859266|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30834745|NCT01328444|58859267|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
30834746|NCT01328444|58859268|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
30834747|NCT00887250|58859285|FG000|Overall Study|Adverse Event|3|||
30834748|NCT00887250|58859286|FG001|Overall Study|Adverse Event|0|||
30834749|NCT00887250|58859287|FG002|Overall Study|Adverse Event|7|||
30834750|NCT00887250|58859285|FG000|Overall Study|Lack of Efficacy|9|||
30834751|NCT00887250|58859286|FG001|Overall Study|Lack of Efficacy|6|||
30834752|NCT00887250|58859287|FG002|Overall Study|Lack of Efficacy|1|||
30834753|NCT00887250|58859285|FG000|Overall Study|Lost to Follow-up|2|||
30834754|NCT00887250|58859286|FG001|Overall Study|Lost to Follow-up|3|||
30834755|NCT00887250|58859287|FG002|Overall Study|Lost to Follow-up|1|||
30834756|NCT00887250|58859285|FG000|Overall Study|Protocol Violation|2|||
30834757|NCT00887250|58859286|FG001|Overall Study|Protocol Violation|2|||
30834758|NCT00887250|58859287|FG002|Overall Study|Protocol Violation|1|||
30834759|NCT00887250|58859285|FG000|Overall Study|Withdrawal by Subject|2|||
30834760|NCT00887250|58859286|FG001|Overall Study|Withdrawal by Subject|1|||
30834761|NCT00887250|58859287|FG002|Overall Study|Withdrawal by Subject|2|||
30834762|NCT00887250|58859285|FG000|Overall Study|Patient uncooperative|0|||
30834763|NCT00887250|58859286|FG001|Overall Study|Patient uncooperative|0|||
30834764|NCT00887250|58859287|FG002|Overall Study|Patient uncooperative|1|||
30834765|NCT02599402|58859292|FG000|Overall Study|Disease progression|153|||
30834766|NCT02599402|58859292|FG000|Overall Study|Study drug toxicity|201|||
30834767|NCT02599402|58859292|FG000|Overall Study|Death|26|||
30834768|NCT02599402|58859292|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
30834769|NCT02599402|58859292|FG000|Overall Study|Participant request to discontinue study treatment|13|||
30834770|NCT02599402|58859292|FG000|Overall Study|Participant withdrew consent|5|||
30834771|NCT02599402|58859292|FG000|Overall Study|Lost to Follow-up|1|||
30834772|NCT02599402|58859292|FG000|Overall Study|Maximum Clinical Benefit|7|||
30834773|NCT02599402|58859292|FG000|Overall Study|Poor/non-compliance|1|||
30834774|NCT02599402|58859292|FG000|Overall Study|Pregnancy|1|||
30834775|NCT02599402|58859292|FG000|Overall Study|Participant no longer met study criteria|7|||
30834776|NCT02599402|58859292|FG000|Overall Study|Other Reasons|95|||
30834777|NCT02734862|58859332|FG000|Part A|Death|3|||
30834778|NCT02734862|58859333|FG001|Part A|Death|4|||
30834779|NCT02734862|58859334|FG002|Part A|Death|6|||
30834780|NCT02734862|58859332|FG000|Part A|Lost to Follow-up|2|||
30834781|NCT02734862|58859333|FG001|Part A|Lost to Follow-up|1|||
30834782|NCT02734862|58859334|FG002|Part A|Lost to Follow-up|1|||
30834783|NCT02734862|58859332|FG000|Part A|Withdrawal by Subject|1|||
30834784|NCT02734862|58859333|FG001|Part A|Withdrawal by Subject|1|||
30925253|NCT01844505|58960684|FG000|Overall Study|Death|1|||
30834785|NCT02734862|58859334|FG002|Part A|Withdrawal by Subject|2|||
30834786|NCT02734862|58859332|FG000|Part A|Physician Decision|2|||
30834787|NCT02734862|58859333|FG001|Part A|Physician Decision|0|||
30925254|NCT01844505|58960685|FG001|Overall Study|Death|3|||
30925255|NCT01844505|58960686|FG002|Overall Study|Death|1|||
30834788|NCT02734862|58859334|FG002|Part A|Physician Decision|1|||
30925256|NCT01844505|58960684|FG000|Overall Study|Adverse event unrelated to study drug|7|||
30834789|NCT02734862|58859332|FG000|Part A|Adverse Event|2|||
30834790|NCT02734862|58859333|FG001|Part A|Adverse Event|0|||
30834791|NCT02734862|58859334|FG002|Part A|Adverse Event|1|||
30834792|NCT02734862|58859332|FG000|Part A|Noncompliance|1|||
30834793|NCT02734862|58859333|FG001|Part A|Noncompliance|1|||
30834794|NCT02734862|58859334|FG002|Part A|Noncompliance|0|||
30834795|NCT02734862|58859332|FG000|Part A|Other|1|||
30834796|NCT02734862|58859333|FG001|Part A|Other|1|||
30834797|NCT02734862|58859334|FG002|Part A|Other|3|||
30834798|NCT02734862|58859332|FG000|Part B|Death|8|||
30834799|NCT02734862|58859333|FG001|Part B|Death|3|||
30834800|NCT02734862|58859334|FG002|Part B|Death|5|||
30834801|NCT02734862|58859332|FG000|Part B|Lost to Follow-up|2|||
30834802|NCT02734862|58859333|FG001|Part B|Lost to Follow-up|2|||
30834803|NCT02734862|58859334|FG002|Part B|Lost to Follow-up|0|||
30834804|NCT02734862|58859332|FG000|Part B|Withdrawal by Subject|3|||
30834805|NCT02734862|58859333|FG001|Part B|Withdrawal by Subject|1|||
30834806|NCT02734862|58859334|FG002|Part B|Withdrawal by Subject|0|||
30834807|NCT02734862|58859332|FG000|Part B|Other|0|||
30834808|NCT02734862|58859333|FG001|Part B|Other|1|||
30834809|NCT02734862|58859334|FG002|Part B|Other|0|||
30834810|NCT00858702|58859345|FG000|Overall Study|Lack of Efficacy|1|||
30834811|NCT00858702|58859346|FG001|Overall Study|Lack of Efficacy|0|||
30834812|NCT00858702|58859345|FG000|Overall Study|Protocol Violation|1|||
30834813|NCT00858702|58859346|FG001|Overall Study|Protocol Violation|1|||
30834814|NCT00858702|58859345|FG000|Overall Study|Other|2|||
30834815|NCT00858702|58859346|FG001|Overall Study|Other|1|||
30834816|NCT00858702|58859345|FG000|Overall Study|Withdrawal by Subject|1|||
30834817|NCT00858702|58859346|FG001|Overall Study|Withdrawal by Subject|0|||
30834818|NCT02598934|58859354|FG000|Overall Study|Adverse Event|11|||
30834819|NCT02598934|58859355|FG001|Overall Study|Adverse Event|13|||
30834820|NCT02598934|58859354|FG000|Overall Study|Failure to Return|3|||
30834821|NCT02598934|58859355|FG001|Overall Study|Failure to Return|3|||
30834822|NCT02598934|58859354|FG000|Overall Study|Withdrawal by Subject|2|||
30834823|NCT02598934|58859355|FG001|Overall Study|Withdrawal by Subject|3|||
30834824|NCT02598934|58859354|FG000|Overall Study|Administrative|2|||
30834825|NCT02598934|58859355|FG001|Overall Study|Administrative|1|||
30834826|NCT02598934|58859354|FG000|Overall Study|Protocol Violation|1|||
30834827|NCT02598934|58859355|FG001|Overall Study|Protocol Violation|2|||
30834828|NCT02598622|58859363|FG000|Overall Study|Withdrawal by Subject|3|||
30834829|NCT02598622|58859364|FG001|Overall Study|Withdrawal by Subject|0|||
30834830|NCT02598622|58859363|FG000|Overall Study|Physician Decision|3|||
30834831|NCT02598622|58859364|FG001|Overall Study|Physician Decision|0|||
30834832|NCT00841698|58859372|FG000|First Intervention|Withdrawal by Subject|1|||
30925257|NCT01844505|58960685|FG001|Overall Study|Adverse event unrelated to study drug|15|||
30925258|NCT01844505|58960686|FG002|Overall Study|Adverse event unrelated to study drug|6|||
30925259|NCT01844505|58960684|FG000|Overall Study|Subject request discontinue treatment|17|||
30925260|NCT01844505|58960685|FG001|Overall Study|Subject request discontinue treatment|14|||
30925261|NCT01844505|58960686|FG002|Overall Study|Subject request discontinue treatment|8|||
30925262|NCT01844505|58960684|FG000|Overall Study|Withdrawal by Subject|0|||
30925263|NCT01844505|58960685|FG001|Overall Study|Withdrawal by Subject|3|||
30925264|NCT01844505|58960686|FG002|Overall Study|Withdrawal by Subject|0|||
30925265|NCT01844505|58960684|FG000|Overall Study|Lost to Follow-up|1|||
30925266|NCT01844505|58960685|FG001|Overall Study|Lost to Follow-up|0|||
30925267|NCT01844505|58960686|FG002|Overall Study|Lost to Follow-up|0|||
30925268|NCT01844505|58960684|FG000|Overall Study|Maximum clinical benefit|8|||
30623887|NCT00910000|58635855|FG003|Overall Study|Withdrawal by Subject|0|||
30623888|NCT00910000|58635856|FG004|Overall Study|Withdrawal by Subject|1|||
30623889|NCT00910000|58635857|FG005|Overall Study|Withdrawal by Subject|0|||
30623890|NCT01119768|58635878|FG000|Treatment Period|Lack of Efficacy|18|||
30623891|NCT01119768|58635879|FG001|Treatment Period|Lack of Efficacy|25|||
30623892|NCT01165307|58635887|FG000|Overall Study|Lost to Follow-up|11|||
30623893|NCT01165307|58635888|FG001|Overall Study|Lost to Follow-up|3|||
30623894|NCT01165307|58635887|FG000|Overall Study|Withdrawal by Subject|2|||
30623895|NCT01165307|58635888|FG001|Overall Study|Withdrawal by Subject|0|||
30623896|NCT01165307|58635887|FG000|Overall Study|Subject not available for contact|1|||
30623897|NCT01165307|58635888|FG001|Overall Study|Subject not available for contact|0|||
30623898|NCT00960999|58635896|FG000|Overall Study|Withdrawal by Subject|1|||
30623899|NCT00960999|58635897|FG001|Overall Study|Withdrawal by Subject|0|||
30623900|NCT00960999|58635896|FG000|Overall Study|Protocol Violation|5|||
30834833|NCT00841698|58859373|FG001|First Intervention|Withdrawal by Subject|0|||
30834834|NCT00841542|58859379|FG000|Period 1|Adverse Event|1|||
30834835|NCT00841542|58859380|FG001|Period 1|Adverse Event|0|||
30834836|NCT00840216|58859402|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
30834837|NCT00840216|58859403|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
30834838|NCT00836706|58859413|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
30834839|NCT00836706|58859414|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
30834840|NCT00836472|58859420|FG000|Washout|Adverse Event|1|||
30834841|NCT00836472|58859421|FG001|Washout|Adverse Event|2|||
30834842|NCT00836472|58859420|FG000|Washout|Withdrawal by Subject|1|||
30925269|NCT01844505|58960685|FG001|Overall Study|Maximum clinical benefit|11|||
30925270|NCT01844505|58960686|FG002|Overall Study|Maximum clinical benefit|2|||
30925271|NCT01844505|58960684|FG000|Overall Study|Poor/non-compliance|1|||
30925272|NCT01844505|58960685|FG001|Overall Study|Poor/non-compliance|1|||
30925273|NCT01844505|58960686|FG002|Overall Study|Poor/non-compliance|1|||
30925274|NCT01844505|58960684|FG000|Overall Study|Subject no longer meets criteria|0|||
30834843|NCT00836472|58859421|FG001|Washout|Withdrawal by Subject|1|||
30834844|NCT02598388|58859437|FG000|Overall Study|Lost to Follow-up|1|||
30834845|NCT02598388|58859438|FG001|Overall Study|Lost to Follow-up|0|||
30834846|NCT02598388|58859439|FG002|Overall Study|Lost to Follow-up|1|||
30834847|NCT02598388|58859440|FG003|Overall Study|Lost to Follow-up|0|||
30834848|NCT02598388|58859441|FG004|Overall Study|Lost to Follow-up|5|||
30834849|NCT02598388|58859442|FG005|Overall Study|Lost to Follow-up|1|||
30925275|NCT01844505|58960685|FG001|Overall Study|Subject no longer meets criteria|1|||
30925276|NCT01844505|58960686|FG002|Overall Study|Subject no longer meets criteria|0|||
30925277|NCT01844505|58960684|FG000|Overall Study|Other Reasons|4|||
30925278|NCT01844505|58960685|FG001|Overall Study|Other Reasons|2|||
30925279|NCT01844505|58960686|FG002|Overall Study|Other Reasons|2|||
30925280|NCT01844505|58960684|FG000|Overall Study|Not Reported|0|||
30925281|NCT01844505|58960685|FG001|Overall Study|Not Reported|0|||
30925282|NCT01844505|58960686|FG002|Overall Study|Not Reported|1|||
30925283|NCT01994720|58960696|FG000|Overall Study|Withdrawal by Subject|46|||
30925284|NCT01994720|58960697|FG001|Overall Study|Withdrawal by Subject|56|||
30925285|NCT01814397|58960703|FG000|Overall Study|Adverse Event|7|||
30925286|NCT01814397|58960703|FG000|Overall Study|Withdrawal by Subject|7|||
30925287|NCT01814007|58960707|FG000|Overall Study|Withdrawal by Subject|1|||
30925288|NCT01844115|58960714|FG000|Overall Study|Adverse Event|4|||
30925289|NCT01844115|58960715|FG001|Overall Study|Adverse Event|22|||
30925290|NCT01844115|58960714|FG000|Overall Study|Lack of Efficacy|1|||
30925291|NCT01844115|58960715|FG001|Overall Study|Lack of Efficacy|4|||
30834850|NCT02598388|58859443|FG006|Overall Study|Lost to Follow-up|2|||
30834851|NCT02598388|58859444|FG007|Overall Study|Lost to Follow-up|1|||
30834852|NCT02598388|58859445|FG008|Overall Study|Lost to Follow-up|0|||
30834853|NCT02598388|58859446|FG009|Overall Study|Lost to Follow-up|0|||
30834854|NCT02598388|58859447|FG010|Overall Study|Lost to Follow-up|1|||
30834855|NCT02598388|58859448|FG011|Overall Study|Lost to Follow-up|0|||
30834856|NCT02598388|58859437|FG000|Overall Study|Withdrawal by Subject|0|||
30834857|NCT02598388|58859438|FG001|Overall Study|Withdrawal by Subject|0|||
30834858|NCT02598388|58859439|FG002|Overall Study|Withdrawal by Subject|0|||
30834859|NCT02598388|58859440|FG003|Overall Study|Withdrawal by Subject|0|||
30834860|NCT02598388|58859441|FG004|Overall Study|Withdrawal by Subject|2|||
30834861|NCT02598388|58859442|FG005|Overall Study|Withdrawal by Subject|0|||
30834862|NCT02598388|58859443|FG006|Overall Study|Withdrawal by Subject|2|||
30834863|NCT02598388|58859444|FG007|Overall Study|Withdrawal by Subject|0|||
30834864|NCT02598388|58859445|FG008|Overall Study|Withdrawal by Subject|0|||
30834865|NCT02598388|58859446|FG009|Overall Study|Withdrawal by Subject|1|||
30834866|NCT02598388|58859447|FG010|Overall Study|Withdrawal by Subject|0|||
30834867|NCT02598388|58859448|FG011|Overall Study|Withdrawal by Subject|0|||
30834868|NCT02598388|58859437|FG000|Overall Study|Other|0|||
30834869|NCT02598388|58859438|FG001|Overall Study|Other|0|||
30834870|NCT02598388|58859439|FG002|Overall Study|Other|1|||
30834871|NCT02598388|58859440|FG003|Overall Study|Other|0|||
30834872|NCT02598388|58859441|FG004|Overall Study|Other|3|||
30834873|NCT02598388|58859442|FG005|Overall Study|Other|0|||
30834874|NCT02598388|58859443|FG006|Overall Study|Other|1|||
30834875|NCT02598388|58859444|FG007|Overall Study|Other|0|||
30834876|NCT02598388|58859445|FG008|Overall Study|Other|0|||
30834877|NCT02598388|58859446|FG009|Overall Study|Other|0|||
30834878|NCT02598388|58859447|FG010|Overall Study|Other|0|||
30834879|NCT02598388|58859448|FG011|Overall Study|Other|0|||
30834880|NCT00835692|58859488|FG000|First Intervention|Withdrawal by Subject|1|||
30834881|NCT00835692|58859489|FG001|First Intervention|Withdrawal by Subject|0|||
30834882|NCT00835536|58859502|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
30834883|NCT00835536|58859503|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
30834884|NCT03865316|58859507|FG000|Overall Study|Procedure Cancelled|4|||
30834885|NCT03865316|58859507|FG000|Overall Study|Equipment failure|4|||
30834886|NCT02598076|58859513|FG000|Overall Study|Lost to Follow-up|2|||
30834887|NCT02598076|58859514|FG001|Overall Study|Lost to Follow-up|3|||
30925292|NCT01844115|58960714|FG000|Overall Study|Protocol Violation|12|||
30925293|NCT01844115|58960715|FG001|Overall Study|Protocol Violation|10|||
30925294|NCT01844115|58960714|FG000|Overall Study|Withdrawal by Subject|11|||
30925295|NCT01844115|58960715|FG001|Overall Study|Withdrawal by Subject|11|||
30925296|NCT01844115|58960714|FG000|Overall Study|Lost to Follow-up|11|||
30925297|NCT01844115|58960715|FG001|Overall Study|Lost to Follow-up|10|||
30925298|NCT01844115|58960714|FG000|Overall Study|Pregnancy|0|||
30834888|NCT02602288|58859522|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
30834889|NCT02602288|58859523|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
30925299|NCT01844115|58960715|FG001|Overall Study|Pregnancy|1|||
30834890|NCT02602288|58859522|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
30834891|NCT02602288|58859523|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
30834892|NCT02602288|58859522|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
30834893|NCT02602288|58859523|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
30834894|NCT02602288|58859522|FG000|12 Month Follow-up|Lost to Follow-up|0|||
30834895|NCT02602288|58859523|FG001|12 Month Follow-up|Lost to Follow-up|4|||
30834896|NCT02602288|58859522|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
30834897|NCT02602288|58859523|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
30834898|NCT02601820|58859529|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
30834899|NCT02601820|58859529|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
30834900|NCT02601820|58859529|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
30834901|NCT02601820|58859529|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
30834902|NCT02807454|58859548|FG000|Overall Study|Adverse Event|1|||
30834903|NCT02807454|58859549|FG001|Overall Study|Adverse Event|0|||
30834904|NCT02807454|58859548|FG000|Overall Study|Withdrawal by Subject|0|||
30834905|NCT02807454|58859549|FG001|Overall Study|Withdrawal by Subject|1|||
30834906|NCT02807454|58859548|FG000|Overall Study|Progressive Disease|30|||
30834907|NCT02807454|58859549|FG001|Overall Study|Progressive Disease|3|||
30925300|NCT02018042|58960721|FG000|Overall Study|Withdrawal by Subject|1|||
30925301|NCT01813305|58960727|FG000|Overall Study|Withdrawal by Subject|12|||
30925302|NCT01813305|58960728|FG001|Overall Study|Withdrawal by Subject|5|||
30925303|NCT01813305|58960727|FG000|Overall Study|Safety Concern|4|||
30925304|NCT01813305|58960728|FG001|Overall Study|Safety Concern|0|||
30925305|NCT01813305|58960727|FG000|Overall Study|Ulcer became worse|4|||
30925306|NCT01813305|58960728|FG001|Overall Study|Ulcer became worse|0|||
30925307|NCT01813305|58960727|FG000|Overall Study|Physician Decision|4|||
30925308|NCT01813305|58960728|FG001|Overall Study|Physician Decision|0|||
30925309|NCT01813305|58960727|FG000|Overall Study|Lost to Follow-up|3|||
30834908|NCT02807454|58859548|FG000|Overall Study|Other Reasons|1|||
30834909|NCT02807454|58859549|FG001|Overall Study|Other Reasons|1|||
30834910|NCT02597920|58859564|FG000|Overall Study|Worsening of other pre-existing disease|0|||
30834911|NCT02597920|58859565|FG001|Overall Study|Worsening of other pre-existing disease|1|||
30834912|NCT02597920|58859566|FG002|Overall Study|Worsening of other pre-existing disease|0|||
30834913|NCT02597920|58859564|FG000|Overall Study|Other adverse event|20|||
30834914|NCT02597920|58859565|FG001|Overall Study|Other adverse event|30|||
30834915|NCT02597920|58859566|FG002|Overall Study|Other adverse event|0|||
30834916|NCT02597920|58859564|FG000|Overall Study|Lost to Follow-up|7|||
30834917|NCT02597920|58859565|FG001|Overall Study|Lost to Follow-up|9|||
30834918|NCT02597920|58859566|FG002|Overall Study|Lost to Follow-up|0|||
30834919|NCT02597920|58859564|FG000|Overall Study|Refuse to continue in the study|3|||
30834920|NCT02597920|58859565|FG001|Overall Study|Refuse to continue in the study|13|||
30834921|NCT02597920|58859566|FG002|Overall Study|Refuse to continue in the study|1|||
30834922|NCT02597920|58859564|FG000|Overall Study|Other than specified|10|||
30834923|NCT02597920|58859565|FG001|Overall Study|Other than specified|31|||
30834924|NCT02597920|58859566|FG002|Overall Study|Other than specified|5|||
30834925|NCT02597920|58859564|FG000|Overall Study|Other|1|||
30834926|NCT02597920|58859565|FG001|Overall Study|Other|0|||
30834927|NCT02597920|58859566|FG002|Overall Study|Other|0|||
30834928|NCT01235234|58859586|FG000|Overall Study|Adverse Event|2|||
30834929|NCT01235234|58859587|FG001|Overall Study|Adverse Event|2|||
30834930|NCT01235234|58859588|FG002|Overall Study|Adverse Event|1|||
30834931|NCT02597452|58859603|FG000|Overall Study|testing incomplete|30|||
30834932|NCT00834756|58859609|FG000|First Intervention|Adverse Event|1|||
30834933|NCT00834756|58859610|FG001|First Intervention|Adverse Event|0|||
30834934|NCT00834756|58859609|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
30834935|NCT00834756|58859610|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
30834936|NCT00828854|58859614|FG000|Overall Study|Disease Progression|17|||
30925310|NCT01813305|58960728|FG001|Overall Study|Lost to Follow-up|1|||
30925311|NCT01813305|58960727|FG000|Overall Study|Protocol Violation|1|||
30925312|NCT01813305|58960728|FG001|Overall Study|Protocol Violation|0|||
30925313|NCT01813305|58960727|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
30925314|NCT01813305|58960728|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
30925315|NCT01993940|58960738|FG000|Overall Study|Adverse Event|16|||
30925316|NCT01993940|58960739|FG001|Overall Study|Adverse Event|11|||
30925317|NCT01993940|58960738|FG000|Overall Study|Withdrawal by Subject|15|||
30623901|NCT00960999|58635897|FG001|Overall Study|Protocol Violation|2|||
30834937|NCT00828854|58859614|FG000|Overall Study|Adverse Event|9|||
30834938|NCT00828854|58859614|FG000|Overall Study|Reason not Specified|1|||
30834939|NCT00834522|58859620|FG000|Washout|Adverse Event|1|||
30834940|NCT00834522|58859621|FG001|Washout|Adverse Event|0|||
30834941|NCT00834522|58859620|FG000|Washout|Withdrawal by Subject|2|||
30834942|NCT00834522|58859621|FG001|Washout|Withdrawal by Subject|1|||
30834943|NCT00834444|58859627|FG000|First Intervention|Adverse Event|1|||
30834944|NCT00834444|58859628|FG001|First Intervention|Adverse Event|0|||
30925318|NCT01993940|58960739|FG001|Overall Study|Withdrawal by Subject|19|||
30925319|NCT01993940|58960738|FG000|Overall Study|Lost to Follow-up|2|||
30925320|NCT01993940|58960739|FG001|Overall Study|Lost to Follow-up|5|||
30925321|NCT01993940|58960738|FG000|Overall Study|Protocol Violation|5|||
30834945|NCT00834444|58859627|FG000|First Intervention|Intolerance to Venopuncture|0|||
30834946|NCT00834444|58859628|FG001|First Intervention|Intolerance to Venopuncture|1|||
30834947|NCT00834444|58859627|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
30834948|NCT00834444|58859628|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
30756596|NCT00119678|58766250|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
30834949|NCT00834444|58859627|FG000|Second Intervention|Adverse Event|1|||
30834950|NCT00834444|58859628|FG001|Second Intervention|Adverse Event|0|||
30834951|NCT02605954|58859648|FG000|Overall Study|Adverse Event|5|||
30834952|NCT02605954|58859649|FG001|Overall Study|Adverse Event|1|||
30834953|NCT02605954|58859648|FG000|Overall Study|Investigator's Discretion|1|||
30834954|NCT02605954|58859649|FG001|Overall Study|Investigator's Discretion|0|||
30834955|NCT02605954|58859648|FG000|Overall Study|Non-Compliance with Study Drug|1|||
30834956|NCT02605954|58859649|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30834957|NCT02605954|58859648|FG000|Overall Study|Withdrew Consent|2|||
30834958|NCT02605954|58859649|FG001|Overall Study|Withdrew Consent|2|||
30834959|NCT02605954|58859648|FG000|Overall Study|Lost to Follow-up|3|||
30834960|NCT02605954|58859649|FG001|Overall Study|Lost to Follow-up|0|||
30834961|NCT02605954|58859648|FG000|Overall Study|Randomized but not treated|0|||
30834962|NCT02605954|58859649|FG001|Overall Study|Randomized but not treated|1|||
30834963|NCT00724698|58859658|FG000|Overall Study|Adverse Event|9|||
30834964|NCT00724698|58859658|FG000|Overall Study|Failure of Therapy|4|||
30834965|NCT00724698|58859658|FG000|Overall Study|Poor Compliance|16|||
30834966|NCT00724698|58859658|FG000|Overall Study|Lost to Follow-up|36|||
30834967|NCT00724698|58859658|FG000|Overall Study|No Info|25|||
30834968|NCT00829998|58859663|FG000|Washout|Adverse Event|0|||
30834969|NCT00829998|58859664|FG001|Washout|Adverse Event|1|||
30834970|NCT00829764|58859675|FG000|First Intervention|Adverse Event|1|||
30834971|NCT00829764|58859676|FG001|First Intervention|Adverse Event|0|||
30834972|NCT00829764|58859675|FG000|First Intervention|Withdrawal by Subject|1|||
30834973|NCT00829764|58859676|FG001|First Intervention|Withdrawal by Subject|1|||
30834974|NCT00829530|58859698|FG000|First Intervention|Adverse Event|0|||
30834975|NCT00829530|58859699|FG001|First Intervention|Adverse Event|1|||
30834976|NCT00829530|58859698|FG000|First Intervention|Intolerance to Venopuncture|0|||
30834977|NCT00829530|58859699|FG001|First Intervention|Intolerance to Venopuncture|1|||
30834978|NCT00829530|58859698|FG000|Second Intervention|Intolerance to Venopuncture|1|||
30834979|NCT00829530|58859699|FG001|Second Intervention|Intolerance to Venopuncture|0|||
30834980|NCT01377194|58859706|FG000|Overall Study|Adverse Event|3|||
30834981|NCT01377194|58859707|FG001|Overall Study|Adverse Event|12|||
30834982|NCT01377194|58859708|FG002|Overall Study|Adverse Event|19|||
30834983|NCT01377194|58859706|FG000|Overall Study|Lack of Efficacy|3|||
30834984|NCT01377194|58859707|FG001|Overall Study|Lack of Efficacy|3|||
30834985|NCT01377194|58859708|FG002|Overall Study|Lack of Efficacy|3|||
30834986|NCT01377194|58859706|FG000|Overall Study|Protocol Violation|4|||
30834987|NCT01377194|58859707|FG001|Overall Study|Protocol Violation|10|||
30834988|NCT01377194|58859708|FG002|Overall Study|Protocol Violation|6|||
30834989|NCT01377194|58859706|FG000|Overall Study|Withdrawal by Subject|8|||
30834990|NCT01377194|58859707|FG001|Overall Study|Withdrawal by Subject|10|||
30756597|NCT00110084|58766258|FG000|Overall Study|Adverse Event|9|||
30756598|NCT00110084|58766258|FG000|Overall Study|Death|1|||
30756599|NCT00110084|58766258|FG000|Overall Study|Patient Refusal|10|||
30756600|NCT00110084|58766258|FG000|Overall Study|Alternate Therapy|5|||
30756601|NCT00110084|58766258|FG000|Overall Study|Intercurrent Illness|1|||
30756602|NCT00110084|58766258|FG000|Overall Study|Other|2|||
30756603|NCT00390221|58766265|FG000|Overall Study|Lost to Follow-up|0|||
30756604|NCT00390221|58766266|FG001|Overall Study|Lost to Follow-up|3|||
30756605|NCT00390221|58766267|FG002|Overall Study|Lost to Follow-up|0|||
30756606|NCT00390221|58766265|FG000|Overall Study|Adverse Event|1|||
30756607|NCT00390221|58766266|FG001|Overall Study|Adverse Event|4|||
30756608|NCT00390221|58766267|FG002|Overall Study|Adverse Event|3|||
30756609|NCT00390221|58766265|FG000|Overall Study|Investigator Decision|0|||
30756610|NCT00390221|58766266|FG001|Overall Study|Investigator Decision|0|||
30756611|NCT00390221|58766267|FG002|Overall Study|Investigator Decision|1|||
30756612|NCT00390221|58766265|FG000|Overall Study|Withdrawal by Subject|13|||
30756613|NCT00390221|58766266|FG001|Overall Study|Withdrawal by Subject|9|||
30834991|NCT01377194|58859708|FG002|Overall Study|Withdrawal by Subject|7|||
30834992|NCT01377194|58859706|FG000|Overall Study|Lost to Follow-up|14|||
30834993|NCT01377194|58859707|FG001|Overall Study|Lost to Follow-up|8|||
30834994|NCT01377194|58859708|FG002|Overall Study|Lost to Follow-up|11|||
30834995|NCT00829452|58859721|FG000|First Intervention|Withdrawal by Subject|0|||
30834996|NCT00829452|58859722|FG001|First Intervention|Withdrawal by Subject|1|||
30756614|NCT00390221|58766267|FG002|Overall Study|Withdrawal by Subject|7|||
30756615|NCT00390221|58766265|FG000|Overall Study|Subject Non-compliance|1|||
30834997|NCT00829452|58859721|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
30834998|NCT00829452|58859722|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
30834999|NCT00829452|58859721|FG000|Second Intervention|Physician Decision|0|||
30835000|NCT00829452|58859722|FG001|Second Intervention|Physician Decision|1|||
30835001|NCT04600076|58859726|FG000|Overall Study|Lost to Follow-up|3|||
30835002|NCT02064387|58859742|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
30835003|NCT02064387|58859743|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
30835004|NCT02064387|58859744|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
30835005|NCT02064387|58859745|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
30835006|NCT02064387|58859746|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
30835007|NCT02064387|58859747|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
30835008|NCT02064387|58859748|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
30835009|NCT02064387|58859749|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
30835010|NCT02064387|58859750|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
30835011|NCT02064387|58859751|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
30835012|NCT02064387|58859752|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
30835013|NCT02064387|58859753|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
30835014|NCT02064387|58859742|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
30835015|NCT02064387|58859743|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
30835016|NCT02064387|58859744|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
30835017|NCT02064387|58859745|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
30835018|NCT02064387|58859746|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
30835019|NCT02064387|58859747|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
30835020|NCT02064387|58859748|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
30835021|NCT02064387|58859749|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
30925322|NCT01993940|58960739|FG001|Overall Study|Protocol Violation|8|||
30925323|NCT01993940|58960738|FG000|Overall Study|Death|1|||
30925324|NCT01993940|58960739|FG001|Overall Study|Death|0|||
30925325|NCT01993940|58960738|FG000|Overall Study|Other - Miscellaneous|1|||
30835022|NCT02064387|58859750|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
30835023|NCT02064387|58859751|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
30835024|NCT02064387|58859752|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
30835025|NCT02064387|58859753|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
30835026|NCT02064387|58859742|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
30835027|NCT02064387|58859743|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
30835028|NCT02064387|58859744|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
30835029|NCT02064387|58859745|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
30835030|NCT02064387|58859746|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
30835031|NCT02064387|58859747|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
30835032|NCT02064387|58859748|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
30835033|NCT02064387|58859749|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
30835034|NCT02064387|58859750|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
30925326|NCT01993940|58960739|FG001|Overall Study|Other - Miscellaneous|1|||
30925327|NCT01843803|58960747|FG000|Overall Study|not a Veteran, did not see provider|1|||
30925328|NCT01843803|58960748|FG001|Overall Study|not a Veteran, did not see provider|3|||
30925329|NCT02017171|58960756|FG000|Overall Study|Death|10|||
30925330|NCT02017171|58960757|FG001|Overall Study|Death|4|||
30925331|NCT02017171|58960756|FG000|Overall Study|Withdrawal by Subject|23|||
30925332|NCT02017171|58960757|FG001|Overall Study|Withdrawal by Subject|17|||
30925333|NCT02017171|58960756|FG000|Overall Study|Lost to Follow-up|21|||
30925334|NCT02017171|58960757|FG001|Overall Study|Lost to Follow-up|20|||
30925335|NCT02017171|58960756|FG000|Overall Study|ESKD|6|||
30925336|NCT02017171|58960757|FG001|Overall Study|ESKD|2|||
30925337|NCT02017171|58960756|FG000|Overall Study|Miscellaneous|2|||
30925338|NCT02017171|58960757|FG001|Overall Study|Miscellaneous|3|||
30925339|NCT02029417|58960764|FG000|Overall Study|Death|1|||
30925340|NCT02029417|58960764|FG000|Overall Study|Adverse Event|1|||
30925341|NCT02016716|58960771|FG000|Overall Study|Withdrawal by Subject|5|||
30925342|NCT02016716|58960772|FG001|Overall Study|Withdrawal by Subject|5|||
30925343|NCT02016716|58960773|FG002|Overall Study|Withdrawal by Subject|5|||
30925344|NCT02016716|58960771|FG000|Overall Study|Protocol-specified Criteria|0|||
30925345|NCT02016716|58960772|FG001|Overall Study|Protocol-specified Criteria|1|||
30925346|NCT02016716|58960773|FG002|Overall Study|Protocol-specified Criteria|0|||
30925347|NCT02016716|58960771|FG000|Overall Study|Lost to Follow-up|1|||
30925348|NCT02016716|58960772|FG001|Overall Study|Lost to Follow-up|2|||
30925349|NCT02016716|58960773|FG002|Overall Study|Lost to Follow-up|1|||
30835035|NCT02064387|58859751|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
30925350|NCT02050321|58960782|FG000|Overall Study|Withdrawal by Subject|1|||
30925351|NCT02050321|58960782|FG000|Overall Study|Adverse Event|1|||
30925352|NCT02039414|58960788|FG000|Overall Study|Delivered|1|||
30925353|NCT02039414|58960789|FG001|Overall Study|Delivered|1|||
30925354|NCT02039414|58960788|FG000|Overall Study|Lost to Follow-up|2|||
30925355|NCT02039414|58960789|FG001|Overall Study|Lost to Follow-up|0|||
30925356|NCT02039414|58960788|FG000|Overall Study|Protocol Violation|3|||
30925357|NCT02039414|58960789|FG001|Overall Study|Protocol Violation|1|||
30925358|NCT02017015|58960795|FG000|Overall Study|Adverse Event|9|||
30925359|NCT02017015|58960795|FG000|Overall Study|Withdrawal by Subject|21|||
30925360|NCT02017015|58960795|FG000|Overall Study|Death|4|||
30925361|NCT02017015|58960795|FG000|Overall Study|Progressive Disease|31|||
30925362|NCT02017015|58960795|FG000|Overall Study|Non-compliance with study drug|2|||
30756616|NCT00390221|58766266|FG001|Overall Study|Subject Non-compliance|0|||
30756617|NCT00390221|58766267|FG002|Overall Study|Subject Non-compliance|2|||
30756618|NCT00390221|58766265|FG000|Overall Study|Other|3|||
30756619|NCT00390221|58766266|FG001|Overall Study|Other|4|||
30756620|NCT00390221|58766267|FG002|Overall Study|Other|2|||
30756621|NCT00389831|58766278|FG000|Overall Study|Lack of Efficacy|0|||
30756622|NCT00389831|58766279|FG001|Overall Study|Lack of Efficacy|2|||
30756623|NCT00389831|58766278|FG000|Overall Study|Did not receive treatment.|0|||
30756624|NCT00389831|58766279|FG001|Overall Study|Did not receive treatment.|2|||
30756625|NCT00389831|58766278|FG000|Overall Study|Other reasons|0|||
30756626|NCT00389831|58766279|FG001|Overall Study|Other reasons|2|||
30756627|NCT00389831|58766278|FG000|Overall Study|Lost to Follow-up|0|||
30756628|NCT00389831|58766279|FG001|Overall Study|Lost to Follow-up|1|||
30756629|NCT00389597|58766301|FG000|Overall Study|Lost to Follow-up|8|||
30835036|NCT02064387|58859752|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
30835037|NCT02064387|58859753|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
30835038|NCT02064387|58859742|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
30756630|NCT00389597|58766302|FG001|Overall Study|Lost to Follow-up|6|||
30756631|NCT00389597|58766303|FG002|Overall Study|Lost to Follow-up|4|||
30756632|NCT00389597|58766304|FG003|Overall Study|Lost to Follow-up|6|||
30756633|NCT00389519|58766318|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
30756634|NCT00389519|58766319|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
30756635|NCT00389519|58766320|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
30756636|NCT00389519|58766321|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
30756637|NCT00389519|58766318|FG000|Placebo Run-In|Withdrawal by Subject|19|||
30756638|NCT00389519|58766319|FG001|Placebo Run-In|Withdrawal by Subject|0|||
30756639|NCT00389519|58766320|FG002|Placebo Run-In|Withdrawal by Subject|0|||
30756640|NCT00389519|58766321|FG003|Placebo Run-In|Withdrawal by Subject|0|||
30756641|NCT00389519|58766318|FG000|Placebo Run-In|Reason not specified|40|||
30756642|NCT00389519|58766319|FG001|Placebo Run-In|Reason not specified|0|||
30756643|NCT00389519|58766320|FG002|Placebo Run-In|Reason not specified|0|||
30835039|NCT02064387|58859743|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
30835040|NCT02064387|58859744|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
30835041|NCT02064387|58859745|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
30835042|NCT02064387|58859746|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
30835043|NCT02064387|58859747|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
30835044|NCT02064387|58859748|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
30835045|NCT02064387|58859749|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
30835046|NCT02064387|58859750|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
30835047|NCT02064387|58859751|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
30835048|NCT02064387|58859752|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
30835049|NCT02064387|58859753|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
30835050|NCT02064387|58859742|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
30835051|NCT02064387|58859743|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
30835052|NCT02064387|58859744|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
30835053|NCT02064387|58859745|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
30835054|NCT02064387|58859746|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
30835055|NCT02064387|58859747|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
30835056|NCT02064387|58859748|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
30835057|NCT02064387|58859749|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
30835058|NCT02064387|58859750|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
30835059|NCT02064387|58859751|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
30835060|NCT02064387|58859752|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
30835061|NCT02064387|58859753|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
30835062|NCT01328366|58859792|FG000|Overall Study|Death|1|||
30835063|NCT01328366|58859792|FG000|Overall Study|Withdrawal by Subject|2|||
30835064|NCT01328366|58859792|FG000|Overall Study|Lost to Follow-up|7|||
30925363|NCT02017015|58960795|FG000|Overall Study|Physician Decision|2|||
30756644|NCT00389519|58766321|FG003|Placebo Run-In|Reason not specified|0|||
30756645|NCT00389519|58766318|FG000|Randomized|Did not receive study drug|2|||
30756646|NCT00389519|58766319|FG001|Randomized|Did not receive study drug|0|||
30835065|NCT03256344|58859798|FG000|Overall Study|Death|6|||
30835066|NCT03256344|58859799|FG001|Overall Study|Death|22|||
30835067|NCT03256344|58859798|FG000|Overall Study|Withdrawal by Subject|3|||
30925364|NCT02016625|58960802|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
30756647|NCT00389519|58766320|FG002|Randomized|Did not receive study drug|0|||
30925365|NCT02016625|58960803|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
30925366|NCT02016625|58960802|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
30925367|NCT02016625|58960803|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
30925368|NCT02016625|58960802|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
30925369|NCT02016625|58960803|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
30925370|NCT02016482|58960821|FG000|Period A|Adverse Event|3|||
30925371|NCT02016482|58960822|FG001|Period A|Adverse Event|5|||
30925372|NCT02016482|58960821|FG000|Period A|Withdrawal by Subject|3|||
30925373|NCT02016482|58960822|FG001|Period A|Withdrawal by Subject|4|||
30925374|NCT02016482|58960821|FG000|Period A|Lost to Follow-up|3|||
30925375|NCT02016482|58960822|FG001|Period A|Lost to Follow-up|3|||
30925376|NCT02016482|58960821|FG000|Period A|Lack of Efficacy|2|||
30925377|NCT02016482|58960822|FG001|Period A|Lack of Efficacy|1|||
30925378|NCT02016482|58960821|FG000|Period A|Other|3|||
30925379|NCT02016482|58960822|FG001|Period A|Other|0|||
30925380|NCT02016482|58960821|FG000|Period A|Protocol Violation|0|||
30925381|NCT02016482|58960822|FG001|Period A|Protocol Violation|1|||
30925382|NCT02016482|58960821|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
30925383|NCT02016482|58960822|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
30925384|NCT02016482|58960821|FG000|Period B|Withdrawal by Subject|1|||
30925385|NCT02016482|58960822|FG001|Period B|Withdrawal by Subject|1|||
30925386|NCT02016482|58960821|FG000|Period B|Lost to Follow-up|2|||
30925387|NCT02016482|58960822|FG001|Period B|Lost to Follow-up|0|||
30925388|NCT02016482|58960821|FG000|Period B|Lack of Efficacy|6|||
30925389|NCT02016482|58960822|FG001|Period B|Lack of Efficacy|4|||
30925390|NCT02016482|58960821|FG000|Period B|Other|4|||
30925391|NCT02016482|58960822|FG001|Period B|Other|0|||
30925392|NCT02016482|58960821|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
30835068|NCT03256344|58859799|FG001|Overall Study|Withdrawal by Subject|3|||
30835069|NCT03256344|58859798|FG000|Overall Study|Sponsor Decision|1|||
30835070|NCT03256344|58859799|FG001|Overall Study|Sponsor Decision|0|||
30835071|NCT01370499|58859807|FG000|Overall Study|Adverse Event|38|||
30835072|NCT01370499|58859808|FG001|Overall Study|Adverse Event|12|||
30835073|NCT01370499|58859807|FG000|Overall Study|Lack of Efficacy|4|||
30835074|NCT01370499|58859808|FG001|Overall Study|Lack of Efficacy|2|||
30835075|NCT01370499|58859807|FG000|Overall Study|Lost to Follow-up|2|||
30835076|NCT01370499|58859808|FG001|Overall Study|Lost to Follow-up|1|||
30835077|NCT01370499|58859807|FG000|Overall Study|Physician Decision|3|||
30835078|NCT01370499|58859808|FG001|Overall Study|Physician Decision|3|||
30835079|NCT01370499|58859807|FG000|Overall Study|Protocol Violation|5|||
30835080|NCT01370499|58859808|FG001|Overall Study|Protocol Violation|4|||
30925393|NCT02016482|58960822|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
30925394|NCT02028871|58960832|FG000|Overall Study|Positive urine drug screen|1|||
30925395|NCT02028871|58960833|FG001|Overall Study|Positive urine drug screen|1|||
30925396|NCT02028871|58960832|FG000|Overall Study|Withdrawal by Subject|1|||
30925397|NCT02028871|58960833|FG001|Overall Study|Withdrawal by Subject|2|||
30925398|NCT02028871|58960832|FG000|Overall Study|IV placement difficulty|1|||
30925399|NCT02028871|58960833|FG001|Overall Study|IV placement difficulty|0|||
30925400|NCT02028871|58960832|FG000|Overall Study|Current Illness|1|||
30925401|NCT02028871|58960833|FG001|Overall Study|Current Illness|0|||
30925402|NCT02028715|58960844|FG000|Overall Study|Adverse Event|2|||
30925403|NCT02028715|58960845|FG001|Overall Study|Adverse Event|2|||
30925404|NCT02028715|58960844|FG000|Overall Study|Physician Decision|1|||
30925405|NCT02028715|58960845|FG001|Overall Study|Physician Decision|0|||
30925406|NCT02028715|58960844|FG000|Overall Study|Did not complete satisfaction surveys|2|||
30925407|NCT02028715|58960845|FG001|Overall Study|Did not complete satisfaction surveys|2|||
30925408|NCT02016170|58960854|FG000|Overall Study|Adverse Event|1|||
30925409|NCT02016170|58960855|FG001|Overall Study|Adverse Event|1|||
30925410|NCT02016170|58960856|FG002|Overall Study|Adverse Event|0|||
30925411|NCT02016170|58960854|FG000|Overall Study|Protocol Violation|1|||
30925412|NCT02016170|58960855|FG001|Overall Study|Protocol Violation|0|||
30925413|NCT02016170|58960856|FG002|Overall Study|Protocol Violation|0|||
30925414|NCT02028169|58960863|FG000|Overall Study|Lost to Follow-up|21|||
30925415|NCT02028169|58960863|FG000|Overall Study|Lack of Efficacy|2|||
30925416|NCT02028169|58960863|FG000|Overall Study|Withdrawal by Subject|2|||
30835081|NCT01370499|58859807|FG000|Overall Study|Withdrawal by Subject|18|||
30925417|NCT02028169|58960863|FG000|Overall Study|Adverse Event|1|||
30925418|NCT02028169|58960863|FG000|Overall Study|Cessation of Drug|1|||
30835082|NCT01370499|58859808|FG001|Overall Study|Withdrawal by Subject|7|||
30925419|NCT02028169|58960863|FG000|Overall Study|Concomitant Medication Usage|1|||
30925420|NCT02015546|58960870|FG000|Overall Study|Withdrawal by Subject|1|||
30925421|NCT02015546|58960871|FG001|Overall Study|Withdrawal by Subject|1|||
30925422|NCT02015546|58960872|FG002|Overall Study|Withdrawal by Subject|1|||
30925423|NCT02015546|58960870|FG000|Overall Study|Screem Failure|2|||
30925424|NCT02015546|58960871|FG001|Overall Study|Screem Failure|1|||
30925425|NCT02015546|58960872|FG002|Overall Study|Screem Failure|3|||
30925426|NCT02027701|58960880|FG000|Overall Study|Adverse Event|3|||
30925427|NCT02027701|58960880|FG000|Overall Study|Lack of Efficacy|8|||
30835083|NCT01370499|58859807|FG000|Overall Study|Sponsor Decision|41|||
30925428|NCT02027701|58960880|FG000|Overall Study|Physician Decision|2|||
30925429|NCT02027701|58960880|FG000|Overall Study|Withdrawal by Subject|3|||
30925430|NCT02038790|58960886|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
30925431|NCT02038790|58960887|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
30925432|NCT02027623|58960896|FG000|Overall Study|Lost to Follow-up|3|||
30925433|NCT02027623|58960897|FG001|Overall Study|Lost to Follow-up|3|||
30835084|NCT01370499|58859808|FG001|Overall Study|Sponsor Decision|15|||
30835085|NCT01370265|58859816|FG000|First Intervention|Adverse Event|1|||
30835086|NCT01370265|58859817|FG001|First Intervention|Adverse Event|1|||
30835087|NCT02792829|58859838|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
30835088|NCT02792829|58859839|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
30835089|NCT02792829|58859840|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
30835090|NCT02792829|58859841|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
30925434|NCT02027623|58960896|FG000|Overall Study|Withdrawal by Subject|6|||
30925435|NCT02027623|58960897|FG001|Overall Study|Withdrawal by Subject|9|||
30925436|NCT02015221|58960906|FG000|Overall Study|Withdrawal by Subject|8|||
30925437|NCT02015221|58960907|FG001|Overall Study|Withdrawal by Subject|6|||
30925438|NCT02015221|58960906|FG000|Overall Study|Lost to Follow-up|1|||
30925439|NCT02015221|58960907|FG001|Overall Study|Lost to Follow-up|0|||
30925440|NCT02027311|58960915|FG000|Overall Study|Protocol Violation|3|||
30925441|NCT02027311|58960916|FG001|Overall Study|Protocol Violation|2|||
30835091|NCT02792829|58859842|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
30835092|NCT02792829|58859843|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
30835093|NCT02792829|58859844|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
30835094|NCT02792829|58859845|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
30835095|NCT02792829|58859838|FG000|Treatment Period 2|Adverse Event|0|||
30925442|NCT02047903|58960924|FG000|Overall Study|Adverse Event|14|||
30925443|NCT02047903|58960924|FG000|Overall Study|Serious adverse event|10|||
30925444|NCT02047903|58960924|FG000|Overall Study|Withdrawal by Subject|16|||
30925445|NCT02047903|58960924|FG000|Overall Study|Lost to Follow-up|4|||
30925446|NCT02047903|58960924|FG000|Overall Study|Reason not listed|6|||
30925447|NCT02047903|58960924|FG000|Overall Study|Not Treated|9|||
30623902|NCT00960999|58635896|FG000|Overall Study|RT dose constraints not met|2|||
30623903|NCT00960999|58635897|FG001|Overall Study|RT dose constraints not met|0|||
30756648|NCT00389519|58766321|FG003|Randomized|Did not receive study drug|0|||
30756649|NCT00389519|58766318|FG000|Treated|Adverse Event|1|||
30756650|NCT00389519|58766319|FG001|Treated|Adverse Event|0|||
30756651|NCT00389519|58766320|FG002|Treated|Adverse Event|0|||
30756652|NCT00389519|58766321|FG003|Treated|Adverse Event|2|||
30756653|NCT00389519|58766318|FG000|Treated|Reason not specified|1|||
30756654|NCT00389519|58766319|FG001|Treated|Reason not specified|1|||
30756655|NCT00389519|58766320|FG002|Treated|Reason not specified|0|||
30756656|NCT00389519|58766321|FG003|Treated|Reason not specified|2|||
30756657|NCT00389441|58766331|FG000|Overall Study|Adverse Event|7|||
30756658|NCT00389441|58766331|FG000|Overall Study|Death|4|||
30756659|NCT00389441|58766331|FG000|Overall Study|Lost to Follow-up|2|||
30756660|NCT00389441|58766331|FG000|Overall Study|Withdrawal by Subject|4|||
30756661|NCT00389441|58766331|FG000|Overall Study|Physician Decision|1|||
30756662|NCT00389441|58766331|FG000|Overall Study|Protocol Violation|1|||
30756663|NCT00389441|58766331|FG000|Overall Study|Global deterioration of health status|4|||
30756664|NCT00389441|58766331|FG000|Overall Study|Objective progression or relapse|26|||
30756665|NCT00389441|58766331|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
30756666|NCT00389441|58766331|FG000|Overall Study|Clinical progression|1|||
30925448|NCT02015065|58960931|FG000|Overall Study|Death on study|1|||
30925449|NCT02015065|58960932|FG001|Overall Study|Death on study|2|||
30835096|NCT02792829|58859839|FG001|Treatment Period 2|Adverse Event|0|||
30835097|NCT02792829|58859840|FG002|Treatment Period 2|Adverse Event|0|||
30835098|NCT02792829|58859841|FG003|Treatment Period 2|Adverse Event|0|||
30835099|NCT02792829|58859842|FG004|Treatment Period 2|Adverse Event|1|||
30835100|NCT02792829|58859843|FG005|Treatment Period 2|Adverse Event|0|||
30835101|NCT02792829|58859844|FG006|Treatment Period 2|Adverse Event|1|||
30835102|NCT02792829|58859845|FG007|Treatment Period 2|Adverse Event|1|||
30835103|NCT02792829|58859838|FG000|Treatment Period 2|Use of proscribed medications|0|||
30835104|NCT02792829|58859839|FG001|Treatment Period 2|Use of proscribed medications|0|||
30835105|NCT02792829|58859840|FG002|Treatment Period 2|Use of proscribed medications|0|||
30835106|NCT02792829|58859841|FG003|Treatment Period 2|Use of proscribed medications|0|||
30835107|NCT02792829|58859842|FG004|Treatment Period 2|Use of proscribed medications|0|||
30835108|NCT02792829|58859843|FG005|Treatment Period 2|Use of proscribed medications|0|||
30835109|NCT02792829|58859844|FG006|Treatment Period 2|Use of proscribed medications|0|||
30835110|NCT02792829|58859845|FG007|Treatment Period 2|Use of proscribed medications|1|||
30835111|NCT02867592|58859877|FG000|Overall Study|Adverse Event|3|||
30835112|NCT02867592|58859878|FG001|Overall Study|Adverse Event|0|||
30835113|NCT02867592|58859879|FG002|Overall Study|Adverse Event|2|||
30835114|NCT02867592|58859880|FG003|Overall Study|Adverse Event|1|||
30835115|NCT02867592|58859881|FG004|Overall Study|Adverse Event|1|||
30835116|NCT02867592|58859882|FG005|Overall Study|Adverse Event|5|||
30835117|NCT02867592|58859877|FG000|Overall Study|Death|0|||
30835118|NCT02867592|58859878|FG001|Overall Study|Death|0|||
30835119|NCT02867592|58859879|FG002|Overall Study|Death|0|||
30835120|NCT02867592|58859880|FG003|Overall Study|Death|1|||
30925450|NCT02015065|58960933|FG002|Overall Study|Death on study|1|||
30835121|NCT02867592|58859881|FG004|Overall Study|Death|0|||
30835122|NCT02867592|58859882|FG005|Overall Study|Death|1|||
30835123|NCT02867592|58859877|FG000|Overall Study|Lack of Efficacy|8|||
30835124|NCT02867592|58859878|FG001|Overall Study|Lack of Efficacy|10|||
30835125|NCT02867592|58859879|FG002|Overall Study|Lack of Efficacy|8|||
30835126|NCT02867592|58859880|FG003|Overall Study|Lack of Efficacy|8|||
30835127|NCT02867592|58859881|FG004|Overall Study|Lack of Efficacy|12|||
30835128|NCT02867592|58859882|FG005|Overall Study|Lack of Efficacy|17|||
30835129|NCT02867592|58859877|FG000|Overall Study|Physician Decision|1|||
30835130|NCT02867592|58859878|FG001|Overall Study|Physician Decision|2|||
30835131|NCT02867592|58859879|FG002|Overall Study|Physician Decision|2|||
30925451|NCT02026141|58960943|FG000|Overall Study|Protocol Violation|0|||
30925452|NCT02026141|58960944|FG001|Overall Study|Protocol Violation|1|||
30925453|NCT02026063|58960952|FG000|Overall Study|Physician Decision|0|||
30925454|NCT02026063|58960953|FG001|Overall Study|Physician Decision|10|||
30925455|NCT02026063|58960952|FG000|Overall Study|Noncompliance with Study Drug|1|||
30756667|NCT00118898|58766339|FG000|Overall Study|Death|6|||
30756668|NCT00118898|58766340|FG001|Overall Study|Death|11|||
30756669|NCT00118898|58766341|FG002|Overall Study|Death|6|||
30756670|NCT00118898|58766342|FG003|Overall Study|Death|8|||
30756671|NCT00118898|58766339|FG000|Overall Study|Lost to Follow-up|26|||
30756672|NCT00118898|58766340|FG001|Overall Study|Lost to Follow-up|34|||
30756673|NCT00118898|58766341|FG002|Overall Study|Lost to Follow-up|33|||
30756674|NCT00118898|58766342|FG003|Overall Study|Lost to Follow-up|33|||
30756675|NCT00118898|58766339|FG000|Overall Study|Withdrawal by Subject|10|||
30756676|NCT00118898|58766340|FG001|Overall Study|Withdrawal by Subject|5|||
30756677|NCT00118898|58766341|FG002|Overall Study|Withdrawal by Subject|8|||
30756678|NCT00118898|58766342|FG003|Overall Study|Withdrawal by Subject|8|||
30756679|NCT00118898|58766339|FG000|Overall Study|Site Closure|33|||
30835132|NCT02867592|58859880|FG003|Overall Study|Physician Decision|0|||
30835133|NCT02867592|58859881|FG004|Overall Study|Physician Decision|5|||
30835134|NCT02867592|58859882|FG005|Overall Study|Physician Decision|1|||
30835135|NCT02867592|58859877|FG000|Overall Study|Protocol Violation|0|||
30835136|NCT02867592|58859878|FG001|Overall Study|Protocol Violation|0|||
30835137|NCT02867592|58859879|FG002|Overall Study|Protocol Violation|0|||
30835138|NCT02867592|58859880|FG003|Overall Study|Protocol Violation|0|||
30835139|NCT02867592|58859881|FG004|Overall Study|Protocol Violation|1|||
30925456|NCT02026063|58960953|FG001|Overall Study|Noncompliance with Study Drug|1|||
30835140|NCT02867592|58859882|FG005|Overall Study|Protocol Violation|1|||
30835141|NCT02867592|58859877|FG000|Overall Study|Withdrawal by Subject|0|||
30835142|NCT02867592|58859878|FG001|Overall Study|Withdrawal by Subject|1|||
30835143|NCT02867592|58859879|FG002|Overall Study|Withdrawal by Subject|0|||
30835144|NCT02867592|58859880|FG003|Overall Study|Withdrawal by Subject|1|||
30835145|NCT02867592|58859881|FG004|Overall Study|Withdrawal by Subject|3|||
30835146|NCT02867592|58859882|FG005|Overall Study|Withdrawal by Subject|3|||
30835147|NCT02867592|58859877|FG000|Overall Study|Ineligible|1|||
30835148|NCT02867592|58859878|FG001|Overall Study|Ineligible|1|||
30835149|NCT02867592|58859879|FG002|Overall Study|Ineligible|0|||
30835150|NCT02867592|58859880|FG003|Overall Study|Ineligible|0|||
30835151|NCT02867592|58859881|FG004|Overall Study|Ineligible|2|||
30835152|NCT02867592|58859882|FG005|Overall Study|Ineligible|0|||
30925457|NCT02026063|58960952|FG000|Overall Study|Withdrawal of Consent|1|||
30925458|NCT02026063|58960953|FG001|Overall Study|Withdrawal of Consent|6|||
30925459|NCT02026063|58960952|FG000|Overall Study|Adverse Event|5|||
30925460|NCT02026063|58960953|FG001|Overall Study|Adverse Event|20|||
30925461|NCT02026063|58960952|FG000|Overall Study|Lack of Efficacy|0|||
30925462|NCT02026063|58960953|FG001|Overall Study|Lack of Efficacy|4|||
30925463|NCT02026063|58960952|FG000|Overall Study|Lost to Follow-up|0|||
30925464|NCT02026063|58960953|FG001|Overall Study|Lost to Follow-up|1|||
30925465|NCT02026063|58960952|FG000|Overall Study|Reason not Specified|2|||
30925466|NCT02026063|58960953|FG001|Overall Study|Reason not Specified|7|||
30925467|NCT02025907|58960962|FG000|Overall Study|Lack of Efficacy|1|||
30925468|NCT02025907|58960963|FG001|Overall Study|Lack of Efficacy|0|||
30925469|NCT02025907|58960962|FG000|Overall Study|Withdrawal by Subject|15|||
30925470|NCT02025907|58960963|FG001|Overall Study|Withdrawal by Subject|8|||
30925471|NCT02025907|58960962|FG000|Overall Study|Protocol Violation|2|||
30925472|NCT02025907|58960963|FG001|Overall Study|Protocol Violation|0|||
30925473|NCT02025907|58960962|FG000|Overall Study|Physician Decision|2|||
30925474|NCT02025907|58960963|FG001|Overall Study|Physician Decision|0|||
30925475|NCT02025907|58960962|FG000|Overall Study|Lost to Follow-up|2|||
30925476|NCT02025907|58960963|FG001|Overall Study|Lost to Follow-up|2|||
30835153|NCT02867592|58859877|FG000|Overall Study|No Treatment|1|||
30835154|NCT02867592|58859878|FG001|Overall Study|No Treatment|0|||
30925477|NCT02025907|58960962|FG000|Overall Study|Adverse Event|3|||
30925478|NCT02025907|58960963|FG001|Overall Study|Adverse Event|1|||
30925479|NCT02025907|58960962|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
30925480|NCT02025907|58960963|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
30925481|NCT01813071|58960978|FG000|Overall Study|Protocol Violation|0|||
30925482|NCT01813071|58960979|FG001|Overall Study|Protocol Violation|0|||
30925483|NCT01813071|58960980|FG002|Overall Study|Protocol Violation|0|||
30925484|NCT01813071|58960981|FG003|Overall Study|Protocol Violation|0|||
30925485|NCT01813071|58960982|FG004|Overall Study|Protocol Violation|1|||
30925486|NCT01813071|58960983|FG005|Overall Study|Protocol Violation|4|||
30925487|NCT01813071|58960984|FG006|Overall Study|Protocol Violation|2|||
30925488|NCT01813071|58960985|FG007|Overall Study|Protocol Violation|4|||
30835155|NCT02867592|58859879|FG002|Overall Study|No Treatment|0|||
30835156|NCT02867592|58859880|FG003|Overall Study|No Treatment|0|||
30835157|NCT02867592|58859881|FG004|Overall Study|No Treatment|0|||
30835158|NCT02867592|58859882|FG005|Overall Study|No Treatment|0|||
30835159|NCT02867592|58859877|FG000|Overall Study|Still on Therapy|0|||
30835160|NCT02867592|58859878|FG001|Overall Study|Still on Therapy|0|||
30925489|NCT01813071|58960986|FG008|Overall Study|Protocol Violation|2|||
30835161|NCT02867592|58859879|FG002|Overall Study|Still on Therapy|0|||
30835162|NCT02867592|58859880|FG003|Overall Study|Still on Therapy|0|||
30835163|NCT02867592|58859881|FG004|Overall Study|Still on Therapy|1|||
30835164|NCT02867592|58859882|FG005|Overall Study|Still on Therapy|0|||
30835165|NCT02867592|58859877|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
30835166|NCT02867592|58859878|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
30835167|NCT02867592|58859879|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
30835168|NCT02867592|58859880|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
30835169|NCT02867592|58859881|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
30925490|NCT01813071|58960978|FG000|Overall Study|Withdrawal by Subject|0|||
30835170|NCT02867592|58859882|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
30925491|NCT01813071|58960979|FG001|Overall Study|Withdrawal by Subject|0|||
30925492|NCT01813071|58960980|FG002|Overall Study|Withdrawal by Subject|0|||
30925493|NCT01813071|58960981|FG003|Overall Study|Withdrawal by Subject|0|||
30925494|NCT01813071|58960982|FG004|Overall Study|Withdrawal by Subject|0|||
30925495|NCT01813071|58960983|FG005|Overall Study|Withdrawal by Subject|1|||
30835171|NCT02867592|58859877|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
30835172|NCT02867592|58859878|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
30925496|NCT01813071|58960984|FG006|Overall Study|Withdrawal by Subject|0|||
30925497|NCT01813071|58960985|FG007|Overall Study|Withdrawal by Subject|0|||
30925498|NCT01813071|58960986|FG008|Overall Study|Withdrawal by Subject|0|||
30925499|NCT01813071|58960978|FG000|Overall Study|Adverse Event|0|||
30925500|NCT01813071|58960979|FG001|Overall Study|Adverse Event|0|||
30925501|NCT01813071|58960980|FG002|Overall Study|Adverse Event|0|||
30925502|NCT01813071|58960981|FG003|Overall Study|Adverse Event|0|||
30925503|NCT01813071|58960982|FG004|Overall Study|Adverse Event|0|||
30925504|NCT01813071|58960983|FG005|Overall Study|Adverse Event|1|||
30925505|NCT01813071|58960984|FG006|Overall Study|Adverse Event|0|||
30925506|NCT01813071|58960985|FG007|Overall Study|Adverse Event|0|||
30925507|NCT01813071|58960986|FG008|Overall Study|Adverse Event|0|||
30835173|NCT02867592|58859879|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
30835174|NCT02867592|58859880|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
30835175|NCT02867592|58859881|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
30756680|NCT00118898|58766340|FG001|Overall Study|Site Closure|31|||
30756681|NCT00118898|58766341|FG002|Overall Study|Site Closure|28|||
30756682|NCT00118898|58766342|FG003|Overall Study|Site Closure|37|||
30756683|NCT00118898|58766339|FG000|Overall Study|Severe debilitation|1|||
30756684|NCT00118898|58766340|FG001|Overall Study|Severe debilitation|4|||
30756685|NCT00118898|58766341|FG002|Overall Study|Severe debilitation|6|||
30756686|NCT00118898|58766342|FG003|Overall Study|Severe debilitation|4|||
30835176|NCT02867592|58859882|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
30835177|NCT00676494|58859898|FG000|Overall Study|Missed Visit|8|||
30835178|NCT00676494|58859898|FG000|Overall Study|Withdrawal by Subject|6|||
30835179|NCT02605642|58859903|FG000|Overall Study|Other|11|||
30835180|NCT02605642|58859904|FG001|Overall Study|Other|1|||
30835181|NCT02605642|58859903|FG000|Overall Study|Participant non-compliance|2|||
30835182|NCT02605642|58859904|FG001|Overall Study|Participant non-compliance|4|||
30756687|NCT00118898|58766339|FG000|Overall Study|Not compliant with requirements|11|||
30756688|NCT00118898|58766340|FG001|Overall Study|Not compliant with requirements|13|||
30756689|NCT00118898|58766341|FG002|Overall Study|Not compliant with requirements|11|||
30835183|NCT02605642|58859903|FG000|Overall Study|Physician Decision|10|||
30835184|NCT02605642|58859904|FG001|Overall Study|Physician Decision|0|||
30835185|NCT02605642|58859903|FG000|Overall Study|Lost to Follow-up|12|||
30835186|NCT02605642|58859904|FG001|Overall Study|Lost to Follow-up|1|||
30835187|NCT02605642|58859903|FG000|Overall Study|Adverse Event|14|||
30835188|NCT02605642|58859904|FG001|Overall Study|Adverse Event|2|||
30835189|NCT02605642|58859903|FG000|Overall Study|Withdrawal by Subject|23|||
30835190|NCT02605642|58859904|FG001|Overall Study|Withdrawal by Subject|2|||
30835191|NCT02605642|58859903|FG000|Overall Study|Lack of response|24|||
30835192|NCT02605642|58859904|FG001|Overall Study|Lack of response|11|||
30835193|NCT02253810|58859912|FG000|Overall Study|Withdrawal by Subject|2|||
30835194|NCT02253810|58859913|FG001|Overall Study|Withdrawal by Subject|1|||
30835195|NCT02253810|58859912|FG000|Overall Study|Unknown concomitant procedure|3|||
30835196|NCT02253810|58859913|FG001|Overall Study|Unknown concomitant procedure|2|||
30835197|NCT03915470|58859934|FG000|Overall Study|Death|3|||
30835198|NCT03915470|58859935|FG001|Overall Study|Death|1|||
30835199|NCT03915470|58859934|FG000|Overall Study|Adverse Event|1|||
30835200|NCT03915470|58859935|FG001|Overall Study|Adverse Event|0|||
30835201|NCT03915470|58859934|FG000|Overall Study|Physician Decision|1|||
30835202|NCT03915470|58859935|FG001|Overall Study|Physician Decision|0|||
30835203|NCT03915470|58859934|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
30835204|NCT03915470|58859935|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
30835205|NCT02732912|58859946|FG000|Overall Study|Discharged before night|2|||
30835206|NCT02732912|58859947|FG001|Overall Study|Discharged before night|6|||
30835207|NCT02732912|58859946|FG000|Overall Study|Incomplete completion of questionnaire|2|||
30835208|NCT02732912|58859947|FG001|Overall Study|Incomplete completion of questionnaire|3|||
30835209|NCT02732912|58859946|FG000|Overall Study|No outcome; discharged or refused|6|||
30835210|NCT02732912|58859947|FG001|Overall Study|No outcome; discharged or refused|9|||
30835211|NCT02792517|58859953|FG000|Overall Study|Withdrawal by Subject|10|||
30835212|NCT02792517|58859953|FG000|Overall Study|Decision by Sponsor|7|||
30835213|NCT02792517|58859953|FG000|Overall Study|Lost to Follow-up|3|||
30835214|NCT01369485|58859988|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
30835215|NCT01369485|58859989|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
30925508|NCT01813071|58960978|FG000|Overall Study|Physician Decision|0|||
30925509|NCT01813071|58960979|FG001|Overall Study|Physician Decision|0|||
30925510|NCT01813071|58960980|FG002|Overall Study|Physician Decision|0|||
30925511|NCT01813071|58960981|FG003|Overall Study|Physician Decision|0|||
30925512|NCT01813071|58960982|FG004|Overall Study|Physician Decision|0|||
30925513|NCT01813071|58960983|FG005|Overall Study|Physician Decision|0|||
30925514|NCT01813071|58960984|FG006|Overall Study|Physician Decision|1|||
30756690|NCT00118898|58766342|FG003|Overall Study|Not compliant with requirements|11|||
30756691|NCT00118898|58766339|FG000|Overall Study|Not able to get to clinic|34|||
30925515|NCT01813071|58960985|FG007|Overall Study|Physician Decision|0|||
30925516|NCT01813071|58960986|FG008|Overall Study|Physician Decision|0|||
30756692|NCT00118898|58766340|FG001|Overall Study|Not able to get to clinic|43|||
30756693|NCT00118898|58766341|FG002|Overall Study|Not able to get to clinic|31|||
30756694|NCT00118898|58766342|FG003|Overall Study|Not able to get to clinic|40|||
30756695|NCT00118430|58766355|FG000|Overall Study|Withdrawal by Subject|6|||
30756696|NCT00118430|58766356|FG001|Overall Study|Withdrawal by Subject|2|||
30756697|NCT00118430|58766357|FG002|Overall Study|Withdrawal by Subject|0|||
30756698|NCT00118430|58766355|FG000|Overall Study|Lost to Follow-up|15|||
30756699|NCT00118430|58766356|FG001|Overall Study|Lost to Follow-up|22|||
30756700|NCT00118430|58766357|FG002|Overall Study|Lost to Follow-up|28|||
30756701|NCT00090584|58766366|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
30756702|NCT00090584|58766367|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
30756703|NCT00090584|58766366|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
30756704|NCT00090584|58766367|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
30756705|NCT03670810|58766387|FG000|Main Study|Adverse Event|37|||
30756706|NCT03670810|58766388|FG001|Main Study|Adverse Event|38|||
30756707|NCT03670810|58766389|FG002|Main Study|Adverse Event|3|||
30756708|NCT03670810|58766390|FG003|Main Study|Adverse Event|4|||
30756709|NCT03670810|58766391|FG004|Main Study|Adverse Event|4|||
30756710|NCT03670810|58766392|FG005|Main Study|Adverse Event|5|||
30925517|NCT01813071|58960978|FG000|Overall Study|Met inc/exc criteria|0|||
30925518|NCT01813071|58960979|FG001|Overall Study|Met inc/exc criteria|0|||
30925519|NCT01813071|58960980|FG002|Overall Study|Met inc/exc criteria|0|||
30925520|NCT01813071|58960981|FG003|Overall Study|Met inc/exc criteria|0|||
30925521|NCT01813071|58960982|FG004|Overall Study|Met inc/exc criteria|0|||
30925522|NCT01813071|58960983|FG005|Overall Study|Met inc/exc criteria|1|||
30925523|NCT01813071|58960984|FG006|Overall Study|Met inc/exc criteria|0|||
30925524|NCT01813071|58960985|FG007|Overall Study|Met inc/exc criteria|1|||
30925525|NCT01813071|58960986|FG008|Overall Study|Met inc/exc criteria|1|||
30925526|NCT02025751|58961022|FG000|Overall Study|Lost to Follow-up|1|||
30925527|NCT02025751|58961023|FG001|Overall Study|Lost to Follow-up|0|||
30925528|NCT02025751|58961022|FG000|Overall Study|Adverse Event|0|||
30925529|NCT02025751|58961023|FG001|Overall Study|Adverse Event|1|||
30925530|NCT02025751|58961022|FG000|Overall Study|Physician Decision|0|||
30925531|NCT02025751|58961023|FG001|Overall Study|Physician Decision|1|||
30925532|NCT02025751|58961022|FG000|Overall Study|Withdrawal by Subject|0|||
30925533|NCT02025751|58961023|FG001|Overall Study|Withdrawal by Subject|1|||
30925534|NCT02025205|58961031|FG000|Overall Study|Withdrawal by Subject|1|||
30925535|NCT02025205|58961032|FG001|Overall Study|Withdrawal by Subject|1|||
30925536|NCT02025205|58961031|FG000|Overall Study|Protocol Violation|2|||
30925537|NCT02025205|58961032|FG001|Overall Study|Protocol Violation|1|||
30835216|NCT01369485|58859988|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
30835217|NCT01369485|58859989|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
30835218|NCT01369485|58859988|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
30835219|NCT01369485|58859989|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
30835220|NCT01369485|58859988|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
30925538|NCT02025205|58961031|FG000|Overall Study|Death|0|||
30925539|NCT02025205|58961032|FG001|Overall Study|Death|1|||
30925540|NCT01812837|58961041|FG000|Overall Study|Lost to Follow-up|1|||
30925541|NCT01812837|58961042|FG001|Overall Study|Lost to Follow-up|1|||
30925542|NCT01812837|58961043|FG002|Overall Study|Lost to Follow-up|0|||
30925543|NCT01812837|58961041|FG000|Overall Study|Protocol Violation|1|||
30925544|NCT01812837|58961042|FG001|Overall Study|Protocol Violation|0|||
30925545|NCT01812837|58961043|FG002|Overall Study|Protocol Violation|0|||
30925546|NCT02024971|58961051|FG000|Overall Study|Data Not Available|30|||
30925547|NCT02024971|58961051|FG000|Overall Study|Lost to Follow-up|6|||
30925548|NCT01843023|58961057|FG000|Overall Study|Death|1|||
30925549|NCT01843023|58961058|FG001|Overall Study|Death|0|||
30925550|NCT01843023|58961057|FG000|Overall Study|Lost to Follow-up|24|||
30925551|NCT01843023|58961058|FG001|Overall Study|Lost to Follow-up|29|||
30925552|NCT01843023|58961057|FG000|Overall Study|Withdrawal by Subject|8|||
30925553|NCT01843023|58961058|FG001|Overall Study|Withdrawal by Subject|6|||
30925554|NCT01812759|58961067|FG000|Overall Study|Physician Decision|0|||
30925555|NCT01812759|58961068|FG001|Overall Study|Physician Decision|0|||
30925556|NCT01812759|58961069|FG002|Overall Study|Physician Decision|1|||
30925557|NCT01812057|58961079|FG000|Overall Study|Protocol Violation|1|||
30925558|NCT01812057|58961080|FG001|Overall Study|Protocol Violation|0|||
30925559|NCT01812057|58961079|FG000|Overall Study|Physician Decision|1|||
30925560|NCT01812057|58961080|FG001|Overall Study|Physician Decision|0|||
30925561|NCT01842633|58961093|FG000|Overall Study|Screen Failure|1|||
30925562|NCT01842633|58961094|FG001|Overall Study|Screen Failure|0|||
30835221|NCT01369485|58859989|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
30835222|NCT01369485|58859988|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
30925563|NCT01842633|58961095|FG002|Overall Study|Screen Failure|0|||
30835223|NCT01369485|58859989|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
30835224|NCT01369485|58859988|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
30835225|NCT01369485|58859989|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
30835226|NCT01369485|58859988|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
30835227|NCT01369485|58859989|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
30925564|NCT01842633|58961093|FG000|Overall Study|Adverse Event|1|||
30925565|NCT01842633|58961094|FG001|Overall Study|Adverse Event|1|||
30925566|NCT01842633|58961095|FG002|Overall Study|Adverse Event|0|||
30925567|NCT01842633|58961093|FG000|Overall Study|Withdrawal by Subject|0|||
30925568|NCT01842633|58961094|FG001|Overall Study|Withdrawal by Subject|1|||
30623904|NCT01124838|58635905|FG000|Overall Study|Miscellaneous|4|||
30925569|NCT01842633|58961095|FG002|Overall Study|Withdrawal by Subject|0|||
30925570|NCT01842633|58961093|FG000|Overall Study|Technical issues|1|||
30925571|NCT01842633|58961094|FG001|Overall Study|Technical issues|0|||
30925572|NCT01842633|58961095|FG002|Overall Study|Technical issues|0|||
30925573|NCT01810263|58961107|FG000|Overall Study|Lost to Follow-up|8|||
30925574|NCT01810263|58961108|FG001|Overall Study|Lost to Follow-up|7|||
30925575|NCT01841697|58961116|FG000|Overall Study|Death|0|||
30925576|NCT01841697|58961117|FG001|Overall Study|Death|1|||
30835228|NCT01369485|58859988|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
30835229|NCT01369485|58859989|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
30835230|NCT01369485|58859988|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
30835231|NCT01369485|58859989|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
30835232|NCT01369485|58859988|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
30835233|NCT01369485|58859989|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
30835234|NCT02886572|58860016|FG000|Overall Study|Death|8|||
30835235|NCT02741700|58860029|FG000|Overall Study|Lost to Follow-up|17|||
30835236|NCT02741700|58860030|FG001|Overall Study|Lost to Follow-up|8|||
30835237|NCT02741700|58860029|FG000|Overall Study|Withdrawal by Subject|2|||
30925577|NCT01841697|58961116|FG000|Overall Study|Lost to Follow-up|4|||
30925578|NCT01841697|58961117|FG001|Overall Study|Lost to Follow-up|1|||
30925579|NCT01841697|58961116|FG000|Overall Study|Withdrawal by Subject|16|||
30925580|NCT01841697|58961117|FG001|Overall Study|Withdrawal by Subject|16|||
30925581|NCT01841073|58961125|FG000|Overall Study|Adverse Event|1|||
30925582|NCT01841073|58961126|FG001|Overall Study|Adverse Event|1|||
30925583|NCT01841073|58961125|FG000|Overall Study|Physician Decision|1|||
30925584|NCT01841073|58961126|FG001|Overall Study|Physician Decision|0|||
30925585|NCT01841073|58961125|FG000|Overall Study|Lost to Follow-up|0|||
30925586|NCT01841073|58961126|FG001|Overall Study|Lost to Follow-up|2|||
30925587|NCT01809327|58961139|FG000|Overall Study|Lost to Follow-up|5|||
30925588|NCT01809327|58961140|FG001|Overall Study|Lost to Follow-up|2|||
30925589|NCT01809327|58961141|FG002|Overall Study|Lost to Follow-up|4|||
30925590|NCT01809327|58961142|FG003|Overall Study|Lost to Follow-up|2|||
30925591|NCT01809327|58961143|FG004|Overall Study|Lost to Follow-up|3|||
30925592|NCT01809327|58961139|FG000|Overall Study|Withdrawal by Subject|6|||
30925593|NCT01809327|58961140|FG001|Overall Study|Withdrawal by Subject|4|||
30925594|NCT01809327|58961141|FG002|Overall Study|Withdrawal by Subject|4|||
30925595|NCT01809327|58961142|FG003|Overall Study|Withdrawal by Subject|2|||
30925596|NCT01809327|58961143|FG004|Overall Study|Withdrawal by Subject|5|||
30835238|NCT02741700|58860030|FG001|Overall Study|Withdrawal by Subject|5|||
30835239|NCT02741700|58860029|FG000|Overall Study|Physician Decision|3|||
30835240|NCT02741700|58860030|FG001|Overall Study|Physician Decision|0|||
30835241|NCT02741700|58860029|FG000|Overall Study|Moved out of State|0|||
30835242|NCT02741700|58860030|FG001|Overall Study|Moved out of State|1|||
30835243|NCT02741700|58860029|FG000|Overall Study|Death|4|||
30835244|NCT02741700|58860030|FG001|Overall Study|Death|5|||
30623905|NCT01124838|58635906|FG001|Overall Study|Miscellaneous|2|||
30756711|NCT03670810|58766393|FG006|Main Study|Adverse Event|0|||
30756712|NCT03670810|58766394|FG007|Main Study|Adverse Event|0|||
30756713|NCT03670810|58766395|FG008|Main Study|Adverse Event|0|||
30756714|NCT03670810|58766387|FG000|Main Study|Lack of Efficacy|8|||
30756715|NCT03670810|58766388|FG001|Main Study|Lack of Efficacy|9|||
30756716|NCT03670810|58766389|FG002|Main Study|Lack of Efficacy|3|||
30756717|NCT03670810|58766390|FG003|Main Study|Lack of Efficacy|4|||
30835245|NCT00430950|58860038|FG000|Overall Study|Adverse Event|7|||
30835246|NCT00430950|58860039|FG001|Overall Study|Adverse Event|6|||
30835247|NCT00430950|58860038|FG000|Overall Study|Withdrawal by Subject|1|||
30756718|NCT03670810|58766391|FG004|Main Study|Lack of Efficacy|0|||
30756719|NCT03670810|58766392|FG005|Main Study|Lack of Efficacy|0|||
30835248|NCT00430950|58860039|FG001|Overall Study|Withdrawal by Subject|0|||
30835249|NCT00430950|58860038|FG000|Overall Study|concomitant medication,etc.|5|||
30835250|NCT00430950|58860039|FG001|Overall Study|concomitant medication,etc.|7|||
30835251|NCT02081391|58860047|FG000|12-hour Treatment|Withdrawal by Subject|3|||
30835252|NCT02081391|58860048|FG001|12-hour Treatment|Withdrawal by Subject|2|||
30623906|NCT01124838|58635905|FG000|Overall Study|Adverse Event|7|||
30623907|NCT01124838|58635906|FG001|Overall Study|Adverse Event|11|||
30623908|NCT01124838|58635905|FG000|Overall Study|Lack of Efficacy|2|||
30835253|NCT02081391|58860049|FG002|12-hour Treatment|Withdrawal by Subject|0|||
30925597|NCT01809327|58961139|FG000|Overall Study|Adverse Event|4|||
30925598|NCT01809327|58961140|FG001|Overall Study|Adverse Event|3|||
30623909|NCT01124838|58635906|FG001|Overall Study|Lack of Efficacy|0|||
30756720|NCT03670810|58766393|FG006|Main Study|Lack of Efficacy|0|||
30756721|NCT03670810|58766394|FG007|Main Study|Lack of Efficacy|0|||
30925599|NCT01809327|58961141|FG002|Overall Study|Adverse Event|7|||
30925600|NCT01809327|58961142|FG003|Overall Study|Adverse Event|4|||
30835254|NCT02081391|58860050|FG003|12-hour Treatment|Withdrawal by Subject|0|||
30925601|NCT01809327|58961143|FG004|Overall Study|Adverse Event|8|||
30925602|NCT01809327|58961139|FG000|Overall Study|Death|1|||
30925603|NCT01809327|58961140|FG001|Overall Study|Death|0|||
30925604|NCT01809327|58961141|FG002|Overall Study|Death|0|||
30925605|NCT01809327|58961142|FG003|Overall Study|Death|0|||
30925606|NCT01809327|58961143|FG004|Overall Study|Death|0|||
30925607|NCT01809327|58961139|FG000|Overall Study|Protocol Violation|0|||
30925608|NCT01809327|58961140|FG001|Overall Study|Protocol Violation|1|||
30925609|NCT01809327|58961141|FG002|Overall Study|Protocol Violation|0|||
30925610|NCT01809327|58961142|FG003|Overall Study|Protocol Violation|0|||
30925611|NCT01809327|58961143|FG004|Overall Study|Protocol Violation|0|||
30925612|NCT01809327|58961139|FG000|Overall Study|Physician Decision|1|||
30835255|NCT02081391|58860047|FG000|12-hour Treatment|Physician Decision|4|||
30835256|NCT02081391|58860048|FG001|12-hour Treatment|Physician Decision|1|||
30835257|NCT02081391|58860049|FG002|12-hour Treatment|Physician Decision|0|||
30835258|NCT02081391|58860050|FG003|12-hour Treatment|Physician Decision|0|||
30835259|NCT02081391|58860047|FG000|12-hour Treatment|Lack of Efficacy|3|||
30835260|NCT02081391|58860048|FG001|12-hour Treatment|Lack of Efficacy|0|||
30835261|NCT02081391|58860049|FG002|12-hour Treatment|Lack of Efficacy|0|||
30835262|NCT02081391|58860050|FG003|12-hour Treatment|Lack of Efficacy|0|||
30835263|NCT02081391|58860047|FG000|12-hour Treatment|Adverse Event|4|||
30835264|NCT02081391|58860048|FG001|12-hour Treatment|Adverse Event|2|||
30835265|NCT02081391|58860049|FG002|12-hour Treatment|Adverse Event|0|||
30835266|NCT02081391|58860050|FG003|12-hour Treatment|Adverse Event|0|||
30835267|NCT02081391|58860047|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
30925613|NCT01809327|58961140|FG001|Overall Study|Physician Decision|1|||
30835268|NCT02081391|58860048|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
30835269|NCT02081391|58860049|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
30835270|NCT02081391|58860050|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
30835271|NCT02081391|58860047|FG000|12-hour Treatment|Further reasons|2|||
30835272|NCT02081391|58860048|FG001|12-hour Treatment|Further reasons|1|||
30835273|NCT02081391|58860049|FG002|12-hour Treatment|Further reasons|0|||
30835274|NCT02081391|58860050|FG003|12-hour Treatment|Further reasons|0|||
30835275|NCT02081391|58860047|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
30835276|NCT02081391|58860048|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
30835277|NCT02081391|58860049|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
30835278|NCT02081391|58860050|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
30835279|NCT02081391|58860047|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
30835280|NCT02081391|58860048|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
30835281|NCT02081391|58860049|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
30925614|NCT01809327|58961141|FG002|Overall Study|Physician Decision|0|||
30835282|NCT02081391|58860050|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
30835283|NCT02081391|58860047|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
30835284|NCT02081391|58860048|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
30835285|NCT02081391|58860049|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
30925615|NCT01809327|58961142|FG003|Overall Study|Physician Decision|0|||
30925616|NCT01809327|58961143|FG004|Overall Study|Physician Decision|0|||
30835286|NCT02081391|58860050|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
30835287|NCT02081391|58860047|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
30835288|NCT02081391|58860048|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
30835289|NCT02081391|58860049|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
30835290|NCT02081391|58860050|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
30835291|NCT02081391|58860047|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
30835292|NCT02081391|58860048|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
30925617|NCT01809327|58961139|FG000|Overall Study|Pregnancy|1|||
30925618|NCT01809327|58961140|FG001|Overall Study|Pregnancy|0|||
30925619|NCT01809327|58961141|FG002|Overall Study|Pregnancy|0|||
30925620|NCT01809327|58961142|FG003|Overall Study|Pregnancy|0|||
30925621|NCT01809327|58961143|FG004|Overall Study|Pregnancy|0|||
30925622|NCT01809327|58961139|FG000|Overall Study|Other|14|||
30925623|NCT01809327|58961140|FG001|Overall Study|Other|15|||
30925624|NCT01809327|58961141|FG002|Overall Study|Other|7|||
30925625|NCT01809327|58961142|FG003|Overall Study|Other|4|||
30925626|NCT01809327|58961143|FG004|Overall Study|Other|9|||
30925627|NCT01808313|58961164|FG000|Overall Study|Adverse Event|5|||
30925628|NCT01808313|58961164|FG000|Overall Study|Protocol Violation|2|||
30925629|NCT01808313|58961164|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
30925630|NCT01808313|58961164|FG000|Overall Study|Lost to Follow-up|1|||
30925631|NCT01808313|58961164|FG000|Overall Study|Physician Decision|1|||
30925632|NCT01840605|58961170|FG000|Overall Study|Adverse Event|0|||
30925633|NCT01840605|58961171|FG001|Overall Study|Adverse Event|1|||
30925634|NCT01840605|58961170|FG000|Overall Study|Physician Decision|2|||
30925635|NCT01840605|58961171|FG001|Overall Study|Physician Decision|1|||
30925636|NCT02023879|58961180|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
30925637|NCT02023879|58961181|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
30925638|NCT02023879|58961182|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
30925639|NCT02023879|58961180|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
30925640|NCT02023879|58961181|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
30925641|NCT02023879|58961182|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
30925642|NCT02023879|58961180|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
30925643|NCT02023879|58961181|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
30925644|NCT02023879|58961182|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
30925645|NCT02023879|58961180|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
30623910|NCT01124838|58635905|FG000|Overall Study|Withdrawal by Subject|3|||
30623911|NCT01124838|58635906|FG001|Overall Study|Withdrawal by Subject|2|||
30623912|NCT01124838|58635905|FG000|Overall Study|Lost to Follow-up|2|||
30623913|NCT01124838|58635906|FG001|Overall Study|Lost to Follow-up|0|||
30623914|NCT00959751|58635916|FG000|Overall Study|Lost to Follow-up|2|||
30835293|NCT02081391|58860049|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
30835294|NCT02081391|58860050|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
30835295|NCT02081391|58860047|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
30835296|NCT02081391|58860048|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
30835297|NCT02081391|58860049|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
30925646|NCT02023879|58961181|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
30925647|NCT02023879|58961182|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
30623915|NCT00959751|58635917|FG001|Overall Study|Lost to Follow-up|3|||
30623916|NCT00959751|58635916|FG000|Overall Study|Consent Withdrawn|0|||
30623917|NCT00959751|58635917|FG001|Overall Study|Consent Withdrawn|1|||
30623918|NCT00959751|58635916|FG000|Overall Study|Non-compliance to Study Procedures|0|||
30835298|NCT02081391|58860050|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
30925648|NCT02023879|58961180|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
30925649|NCT02023879|58961181|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
30925650|NCT02023879|58961182|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
30925651|NCT02023879|58961180|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
30925652|NCT02023879|58961181|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
30925653|NCT02023879|58961182|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
30925654|NCT02023879|58961180|FG000|Extension Open Label Treatment|Adverse Event|1|||
30925655|NCT02023879|58961181|FG001|Extension Open Label Treatment|Adverse Event|7|||
30925656|NCT02023879|58961182|FG002|Extension Open Label Treatment|Adverse Event|3|||
30623919|NCT00959751|58635917|FG001|Overall Study|Non-compliance to Study Procedures|1|||
30623920|NCT00959751|58635916|FG000|Overall Study|No migraine headache without aura|7|||
30623921|NCT00959751|58635917|FG001|Overall Study|No migraine headache without aura|7|||
30835299|NCT00430092|58860073|FG000|Overall Study|Adverse Event|0|||
30835300|NCT00430092|58860074|FG001|Overall Study|Adverse Event|0|||
30835301|NCT00430092|58860075|FG002|Overall Study|Adverse Event|1|||
30835302|NCT00430092|58860073|FG000|Overall Study|Lack of Efficacy|5|||
30835303|NCT00430092|58860074|FG001|Overall Study|Lack of Efficacy|2|||
30835304|NCT00430092|58860075|FG002|Overall Study|Lack of Efficacy|54|||
30835305|NCT00430092|58860073|FG000|Overall Study|Lost to Follow-up|1|||
30835306|NCT00430092|58860074|FG001|Overall Study|Lost to Follow-up|0|||
30835307|NCT00430092|58860075|FG002|Overall Study|Lost to Follow-up|0|||
30835308|NCT00430092|58860073|FG000|Overall Study|Protocol Violation|0|||
30835309|NCT00430092|58860074|FG001|Overall Study|Protocol Violation|1|||
30835310|NCT00430092|58860075|FG002|Overall Study|Protocol Violation|1|||
30835311|NCT00430092|58860073|FG000|Overall Study|Withdrawal by Subject|0|||
30835312|NCT00430092|58860074|FG001|Overall Study|Withdrawal by Subject|1|||
30835313|NCT00430092|58860075|FG002|Overall Study|Withdrawal by Subject|1|||
30835314|NCT00425100|58860080|FG000|Overall Study|Adverse Event|36|||
30835315|NCT00425100|58860080|FG000|Overall Study|Lack of Efficacy|4|||
30835316|NCT00425100|58860080|FG000|Overall Study|Lost to Follow-up|2|||
30835317|NCT00425100|58860080|FG000|Overall Study|Protocol Violation|4|||
30835318|NCT00425100|58860080|FG000|Overall Study|Withdrawal by Subject|7|||
30835319|NCT00412932|58860085|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
30835320|NCT00412932|58860085|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
30925657|NCT02023879|58961180|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
30925658|NCT02023879|58961181|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
30925659|NCT02023879|58961182|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
30925660|NCT02023879|58961180|FG000|Extension Open Label Treatment|Participant moved|1|||
30835321|NCT00412932|58860085|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
30835322|NCT00412932|58860085|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
30835323|NCT00412932|58860085|FG000|Olmesartan (Olm) 20 mg|Other|1|||
30835324|NCT00412932|58860085|FG000|Olmesartan 40 mg|Adverse Event|4|||
30835325|NCT00412932|58860085|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
30835326|NCT00412932|58860085|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
30835327|NCT00412932|58860085|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
30835328|NCT00412932|58860085|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
30835329|NCT00412932|58860085|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
30835330|NCT00412932|58860085|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
30835331|NCT02696031|58860091|FG000|Up to Week 24|Adverse Event|2|||
30835332|NCT02696031|58860092|FG001|Up to Week 24|Adverse Event|4|||
30835333|NCT02696031|58860093|FG002|Up to Week 24|Adverse Event|2|||
30925661|NCT02023879|58961181|FG001|Extension Open Label Treatment|Participant moved|2|||
30925662|NCT02023879|58961182|FG002|Extension Open Label Treatment|Participant moved|0|||
30925663|NCT02023879|58961180|FG000|Extension Open Label Treatment|Other than specified above|2|||
30925664|NCT02023879|58961181|FG001|Extension Open Label Treatment|Other than specified above|7|||
30925665|NCT02023879|58961182|FG002|Extension Open Label Treatment|Other than specified above|2|||
30925666|NCT02014441|58961197|FG000|Overall Study|Withdrawal by Subject|12|||
30925667|NCT02013817|58961203|FG000|Overall Study|Adverse Event|12|||
30925668|NCT02013817|58961203|FG000|Overall Study|Withdrawal by Subject|4|||
30925669|NCT02013817|58961203|FG000|Overall Study|Death|2|||
30925670|NCT02013817|58961203|FG000|Overall Study|Other|9|||
30925671|NCT01994863|58961207|FG000|Period 1|Adverse Event|4|||
30925672|NCT01994863|58961208|FG001|Period 1|Adverse Event|0|||
30925673|NCT01994863|58961207|FG000|Period 1|Withdrawal by Subject|1|||
30925674|NCT01994863|58961208|FG001|Period 1|Withdrawal by Subject|0|||
30925675|NCT01994863|58961207|FG000|Period 1|Trial stopped by sponsor|1|||
30756722|NCT03670810|58766395|FG008|Main Study|Lack of Efficacy|0|||
30756723|NCT03670810|58766387|FG000|Main Study|Lost to Follow-up|9|||
30756724|NCT03670810|58766388|FG001|Main Study|Lost to Follow-up|7|||
30756725|NCT03670810|58766389|FG002|Main Study|Lost to Follow-up|4|||
30756726|NCT03670810|58766390|FG003|Main Study|Lost to Follow-up|6|||
30756727|NCT03670810|58766391|FG004|Main Study|Lost to Follow-up|1|||
30756728|NCT03670810|58766392|FG005|Main Study|Lost to Follow-up|0|||
30756729|NCT03670810|58766393|FG006|Main Study|Lost to Follow-up|0|||
30756730|NCT03670810|58766394|FG007|Main Study|Lost to Follow-up|0|||
30756731|NCT03670810|58766395|FG008|Main Study|Lost to Follow-up|0|||
30756732|NCT03670810|58766387|FG000|Main Study|Non-compliance with Study Drug|0|||
30756733|NCT03670810|58766388|FG001|Main Study|Non-compliance with Study Drug|2|||
30756734|NCT03670810|58766389|FG002|Main Study|Non-compliance with Study Drug|3|||
30835334|NCT02696031|58860094|FG003|Up to Week 24|Adverse Event|0|||
30835335|NCT02696031|58860095|FG004|Up to Week 24|Adverse Event|0|||
30835336|NCT02696031|58860096|FG005|Up to Week 24|Adverse Event|0|||
30835337|NCT02696031|58860091|FG000|Up to Week 24|Lack of Efficacy|2|||
30835338|NCT02696031|58860092|FG001|Up to Week 24|Lack of Efficacy|1|||
30835339|NCT02696031|58860093|FG002|Up to Week 24|Lack of Efficacy|2|||
30835340|NCT02696031|58860094|FG003|Up to Week 24|Lack of Efficacy|0|||
30835341|NCT02696031|58860095|FG004|Up to Week 24|Lack of Efficacy|0|||
30835342|NCT02696031|58860096|FG005|Up to Week 24|Lack of Efficacy|0|||
30835343|NCT02696031|58860091|FG000|Up to Week 24|Lost to Follow-up|0|||
30835344|NCT02696031|58860092|FG001|Up to Week 24|Lost to Follow-up|1|||
30835345|NCT02696031|58860093|FG002|Up to Week 24|Lost to Follow-up|1|||
30835346|NCT02696031|58860094|FG003|Up to Week 24|Lost to Follow-up|0|||
30835347|NCT02696031|58860095|FG004|Up to Week 24|Lost to Follow-up|0|||
30835348|NCT02696031|58860096|FG005|Up to Week 24|Lost to Follow-up|0|||
30835349|NCT02696031|58860091|FG000|Up to Week 24|Physician Decision|1|||
30925676|NCT01994863|58961208|FG001|Period 1|Trial stopped by sponsor|3|||
30925677|NCT01994863|58961207|FG000|Period 1|Lack of Efficacy|1|||
30756735|NCT03670810|58766390|FG003|Main Study|Non-compliance with Study Drug|0|||
30756736|NCT03670810|58766391|FG004|Main Study|Non-compliance with Study Drug|0|||
30756737|NCT03670810|58766392|FG005|Main Study|Non-compliance with Study Drug|0|||
30756738|NCT03670810|58766393|FG006|Main Study|Non-compliance with Study Drug|0|||
30756739|NCT03670810|58766394|FG007|Main Study|Non-compliance with Study Drug|1|||
30756740|NCT03670810|58766395|FG008|Main Study|Non-compliance with Study Drug|0|||
30756741|NCT03670810|58766387|FG000|Main Study|Physician Decision|3|||
30756742|NCT03670810|58766388|FG001|Main Study|Physician Decision|0|||
30756743|NCT03670810|58766389|FG002|Main Study|Physician Decision|1|||
30756744|NCT03670810|58766390|FG003|Main Study|Physician Decision|0|||
30756745|NCT03670810|58766391|FG004|Main Study|Physician Decision|0|||
30756746|NCT03670810|58766392|FG005|Main Study|Physician Decision|0|||
30756747|NCT03670810|58766393|FG006|Main Study|Physician Decision|1|||
30756748|NCT03670810|58766394|FG007|Main Study|Physician Decision|1|||
30756749|NCT03670810|58766395|FG008|Main Study|Physician Decision|0|||
30756750|NCT03670810|58766387|FG000|Main Study|Pregnancy|1|||
30756751|NCT03670810|58766388|FG001|Main Study|Pregnancy|2|||
30756752|NCT03670810|58766389|FG002|Main Study|Pregnancy|0|||
30756753|NCT03670810|58766390|FG003|Main Study|Pregnancy|0|||
30756754|NCT03670810|58766391|FG004|Main Study|Pregnancy|0|||
30756755|NCT03670810|58766392|FG005|Main Study|Pregnancy|0|||
30756756|NCT03670810|58766393|FG006|Main Study|Pregnancy|0|||
30756757|NCT03670810|58766394|FG007|Main Study|Pregnancy|0|||
30756758|NCT03670810|58766395|FG008|Main Study|Pregnancy|0|||
30756759|NCT03670810|58766387|FG000|Main Study|Protocol Deviation|2|||
30756760|NCT03670810|58766388|FG001|Main Study|Protocol Deviation|12|||
30756761|NCT03670810|58766389|FG002|Main Study|Protocol Deviation|8|||
30925678|NCT01994863|58961208|FG001|Period 1|Lack of Efficacy|0|||
30756762|NCT03670810|58766390|FG003|Main Study|Protocol Deviation|4|||
30756763|NCT03670810|58766391|FG004|Main Study|Protocol Deviation|0|||
30756764|NCT03670810|58766392|FG005|Main Study|Protocol Deviation|0|||
30756765|NCT03670810|58766393|FG006|Main Study|Protocol Deviation|0|||
30756766|NCT03670810|58766394|FG007|Main Study|Protocol Deviation|0|||
30756767|NCT03670810|58766395|FG008|Main Study|Protocol Deviation|0|||
30835350|NCT02696031|58860092|FG001|Up to Week 24|Physician Decision|0|||
30835351|NCT02696031|58860093|FG002|Up to Week 24|Physician Decision|1|||
30925679|NCT01994863|58961207|FG000|Period 2|Adverse Event|0|||
30756768|NCT03670810|58766387|FG000|Main Study|Withdrawal by Subject|21|||
30756769|NCT03670810|58766388|FG001|Main Study|Withdrawal by Subject|21|||
30756770|NCT03670810|58766389|FG002|Main Study|Withdrawal by Subject|8|||
30756771|NCT03670810|58766390|FG003|Main Study|Withdrawal by Subject|9|||
30756772|NCT03670810|58766391|FG004|Main Study|Withdrawal by Subject|5|||
30756773|NCT03670810|58766392|FG005|Main Study|Withdrawal by Subject|2|||
30756774|NCT03670810|58766393|FG006|Main Study|Withdrawal by Subject|1|||
30756775|NCT03670810|58766394|FG007|Main Study|Withdrawal by Subject|1|||
30756776|NCT03670810|58766395|FG008|Main Study|Withdrawal by Subject|0|||
30756777|NCT03670810|58766387|FG000|Main Study|Participant did not want to take the three other treatments|1|||
30756778|NCT03670810|58766388|FG001|Main Study|Participant did not want to take the three other treatments|0|||
30835352|NCT02696031|58860094|FG003|Up to Week 24|Physician Decision|0|||
30835353|NCT02696031|58860095|FG004|Up to Week 24|Physician Decision|0|||
30835354|NCT02696031|58860096|FG005|Up to Week 24|Physician Decision|0|||
30835355|NCT02696031|58860091|FG000|Up to Week 24|Protocol Violation|1|||
30835356|NCT02696031|58860092|FG001|Up to Week 24|Protocol Violation|0|||
30835357|NCT02696031|58860093|FG002|Up to Week 24|Protocol Violation|0|||
30835358|NCT02696031|58860094|FG003|Up to Week 24|Protocol Violation|0|||
30835359|NCT02696031|58860095|FG004|Up to Week 24|Protocol Violation|0|||
30835360|NCT02696031|58860096|FG005|Up to Week 24|Protocol Violation|0|||
30756779|NCT03670810|58766389|FG002|Main Study|Participant did not want to take the three other treatments|0|||
30756780|NCT03670810|58766390|FG003|Main Study|Participant did not want to take the three other treatments|0|||
30756781|NCT03670810|58766391|FG004|Main Study|Participant did not want to take the three other treatments|0|||
30756782|NCT03670810|58766392|FG005|Main Study|Participant did not want to take the three other treatments|0|||
30756783|NCT03670810|58766393|FG006|Main Study|Participant did not want to take the three other treatments|0|||
30756784|NCT03670810|58766394|FG007|Main Study|Participant did not want to take the three other treatments|0|||
30756785|NCT03670810|58766395|FG008|Main Study|Participant did not want to take the three other treatments|0|||
30756786|NCT03670810|58766387|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
30756787|NCT03670810|58766388|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
30756788|NCT03670810|58766389|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
30835361|NCT02696031|58860091|FG000|Up to Week 24|Withdrawal by Subject|4|||
30835362|NCT02696031|58860092|FG001|Up to Week 24|Withdrawal by Subject|1|||
30835363|NCT02696031|58860093|FG002|Up to Week 24|Withdrawal by Subject|5|||
30835364|NCT02696031|58860094|FG003|Up to Week 24|Withdrawal by Subject|0|||
30835365|NCT02696031|58860095|FG004|Up to Week 24|Withdrawal by Subject|0|||
30835366|NCT02696031|58860096|FG005|Up to Week 24|Withdrawal by Subject|0|||
30835367|NCT02696031|58860091|FG000|Up to Week 52|Adverse Event|4|||
30835368|NCT02696031|58860092|FG001|Up to Week 52|Adverse Event|5|||
30835369|NCT02696031|58860093|FG002|Up to Week 52|Adverse Event|3|||
30835370|NCT02696031|58860094|FG003|Up to Week 52|Adverse Event|0|||
30835371|NCT02696031|58860095|FG004|Up to Week 52|Adverse Event|0|||
30835372|NCT02696031|58860096|FG005|Up to Week 52|Adverse Event|0|||
30835373|NCT02696031|58860091|FG000|Up to Week 52|Lack of Efficacy|10|||
30835374|NCT02696031|58860092|FG001|Up to Week 52|Lack of Efficacy|7|||
30835375|NCT02696031|58860093|FG002|Up to Week 52|Lack of Efficacy|11|||
30835376|NCT02696031|58860094|FG003|Up to Week 52|Lack of Efficacy|0|||
30835377|NCT02696031|58860095|FG004|Up to Week 52|Lack of Efficacy|0|||
30835378|NCT02696031|58860096|FG005|Up to Week 52|Lack of Efficacy|0|||
30835379|NCT02696031|58860091|FG000|Up to Week 52|Lost to Follow-up|1|||
30835380|NCT02696031|58860092|FG001|Up to Week 52|Lost to Follow-up|1|||
30835381|NCT02696031|58860093|FG002|Up to Week 52|Lost to Follow-up|1|||
30835382|NCT02696031|58860094|FG003|Up to Week 52|Lost to Follow-up|0|||
30835383|NCT02696031|58860095|FG004|Up to Week 52|Lost to Follow-up|0|||
30835384|NCT02696031|58860096|FG005|Up to Week 52|Lost to Follow-up|0|||
30835385|NCT02696031|58860091|FG000|Up to Week 52|Physician Decision|1|||
30835386|NCT02696031|58860092|FG001|Up to Week 52|Physician Decision|1|||
30835387|NCT02696031|58860093|FG002|Up to Week 52|Physician Decision|2|||
30835388|NCT02696031|58860094|FG003|Up to Week 52|Physician Decision|0|||
30835389|NCT02696031|58860095|FG004|Up to Week 52|Physician Decision|0|||
30835390|NCT02696031|58860096|FG005|Up to Week 52|Physician Decision|0|||
30835391|NCT02696031|58860091|FG000|Up to Week 52|Pregnancy|0|||
30835392|NCT02696031|58860092|FG001|Up to Week 52|Pregnancy|2|||
30835393|NCT02696031|58860093|FG002|Up to Week 52|Pregnancy|0|||
30835394|NCT02696031|58860094|FG003|Up to Week 52|Pregnancy|0|||
30835395|NCT02696031|58860095|FG004|Up to Week 52|Pregnancy|0|||
30835396|NCT02696031|58860096|FG005|Up to Week 52|Pregnancy|0|||
30835397|NCT02696031|58860091|FG000|Up to Week 52|Protocol Violation|1|||
30835398|NCT02696031|58860092|FG001|Up to Week 52|Protocol Violation|0|||
30835399|NCT02696031|58860093|FG002|Up to Week 52|Protocol Violation|0|||
30835400|NCT02696031|58860094|FG003|Up to Week 52|Protocol Violation|0|||
30835401|NCT02696031|58860095|FG004|Up to Week 52|Protocol Violation|0|||
30835402|NCT02696031|58860096|FG005|Up to Week 52|Protocol Violation|0|||
30835403|NCT02696031|58860091|FG000|Up to Week 52|Withdrawal by Subject|12|||
30835404|NCT02696031|58860092|FG001|Up to Week 52|Withdrawal by Subject|3|||
30835405|NCT02696031|58860093|FG002|Up to Week 52|Withdrawal by Subject|9|||
30835406|NCT02696031|58860094|FG003|Up to Week 52|Withdrawal by Subject|0|||
30835407|NCT02696031|58860095|FG004|Up to Week 52|Withdrawal by Subject|0|||
30835408|NCT02696031|58860096|FG005|Up to Week 52|Withdrawal by Subject|0|||
30835409|NCT02696031|58860091|FG000|Up to Week 104|Pregnancy|0|||
30835410|NCT02696031|58860092|FG001|Up to Week 104|Pregnancy|2|||
30835411|NCT02696031|58860093|FG002|Up to Week 104|Pregnancy|1|||
30835412|NCT02696031|58860094|FG003|Up to Week 104|Pregnancy|0|||
30835413|NCT02696031|58860095|FG004|Up to Week 104|Pregnancy|0|||
30925680|NCT01994863|58961208|FG001|Period 2|Adverse Event|1|||
30925681|NCT01994863|58961207|FG000|Period 2|Lack of Efficacy|0|||
30925682|NCT01994863|58961208|FG001|Period 2|Lack of Efficacy|2|||
30925683|NCT01994863|58961207|FG000|Period 2|Withdrawal by Subject|1|||
30925684|NCT01994863|58961208|FG001|Period 2|Withdrawal by Subject|1|||
30623922|NCT00910858|58635926|FG000|Pharmacokinetic Phase|Adverse Event|1|||
30835414|NCT02696031|58860096|FG005|Up to Week 104|Pregnancy|0|||
30835415|NCT02696031|58860091|FG000|Up to Week 104|Withdrawal by Subject|15|||
30925685|NCT02023099|58961217|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
30925686|NCT02023099|58961218|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
30925687|NCT02023099|58961219|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
30925688|NCT02023099|58961217|FG000|Overall Study|Withdrawn Consent|3|||
30925689|NCT02023099|58961218|FG001|Overall Study|Withdrawn Consent|0|||
30925690|NCT02023099|58961219|FG002|Overall Study|Withdrawn Consent|1|||
30925691|NCT02023099|58961217|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
30925692|NCT02023099|58961218|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
30835416|NCT02696031|58860092|FG001|Up to Week 104|Withdrawal by Subject|10|||
30835417|NCT02696031|58860093|FG002|Up to Week 104|Withdrawal by Subject|16|||
30835418|NCT02696031|58860094|FG003|Up to Week 104|Withdrawal by Subject|0|||
30835419|NCT02696031|58860095|FG004|Up to Week 104|Withdrawal by Subject|0|||
30835420|NCT02696031|58860096|FG005|Up to Week 104|Withdrawal by Subject|0|||
30835421|NCT02696031|58860091|FG000|Up to Week 104|Protocol Violation|1|||
30835422|NCT02696031|58860092|FG001|Up to Week 104|Protocol Violation|0|||
30835423|NCT02696031|58860093|FG002|Up to Week 104|Protocol Violation|0|||
30835424|NCT02696031|58860094|FG003|Up to Week 104|Protocol Violation|0|||
30835425|NCT02696031|58860095|FG004|Up to Week 104|Protocol Violation|0|||
30835426|NCT02696031|58860096|FG005|Up to Week 104|Protocol Violation|0|||
30835427|NCT02696031|58860091|FG000|Up to Week 104|Physician Decision|1|||
30835428|NCT02696031|58860092|FG001|Up to Week 104|Physician Decision|2|||
30835429|NCT02696031|58860093|FG002|Up to Week 104|Physician Decision|3|||
30835430|NCT02696031|58860094|FG003|Up to Week 104|Physician Decision|0|||
30835431|NCT02696031|58860095|FG004|Up to Week 104|Physician Decision|0|||
30835432|NCT02696031|58860096|FG005|Up to Week 104|Physician Decision|0|||
30835433|NCT02696031|58860091|FG000|Up to Week 104|Lost to Follow-up|2|||
30835434|NCT02696031|58860092|FG001|Up to Week 104|Lost to Follow-up|3|||
30835435|NCT02696031|58860093|FG002|Up to Week 104|Lost to Follow-up|1|||
30835436|NCT02696031|58860094|FG003|Up to Week 104|Lost to Follow-up|0|||
30835437|NCT02696031|58860095|FG004|Up to Week 104|Lost to Follow-up|0|||
30835438|NCT02696031|58860096|FG005|Up to Week 104|Lost to Follow-up|0|||
30835439|NCT02696031|58860091|FG000|Up to Week 104|Lack of Efficacy|13|||
30835440|NCT02696031|58860092|FG001|Up to Week 104|Lack of Efficacy|12|||
30835441|NCT02696031|58860093|FG002|Up to Week 104|Lack of Efficacy|11|||
30835442|NCT02696031|58860094|FG003|Up to Week 104|Lack of Efficacy|0|||
30835443|NCT02696031|58860095|FG004|Up to Week 104|Lack of Efficacy|0|||
30835444|NCT02696031|58860096|FG005|Up to Week 104|Lack of Efficacy|0|||
30925693|NCT02023099|58961219|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
30925694|NCT02013037|58961227|FG000|Overall Study|Death|6|||
30925695|NCT02013037|58961227|FG000|Overall Study|Withdrawal by Subject|1|||
30925696|NCT02013037|58961227|FG000|Overall Study|Awaiting Transplantation|7|||
30925697|NCT02013037|58961227|FG000|Overall Study|Transplanted without DSA|2|||
30925698|NCT01967719|58961234|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
30835445|NCT02696031|58860091|FG000|Up to Week 104|Adverse Event|7|||
30835446|NCT02696031|58860092|FG001|Up to Week 104|Adverse Event|11|||
30925699|NCT01967719|58961235|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
30925700|NCT01967719|58961236|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
30925701|NCT01967719|58961237|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
30835447|NCT02696031|58860093|FG002|Up to Week 104|Adverse Event|5|||
30835448|NCT02696031|58860094|FG003|Up to Week 104|Adverse Event|0|||
30835449|NCT02696031|58860095|FG004|Up to Week 104|Adverse Event|0|||
30835450|NCT02696031|58860096|FG005|Up to Week 104|Adverse Event|0|||
30835451|NCT02696031|58860091|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
30835452|NCT02696031|58860092|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
30835453|NCT02696031|58860093|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
30835454|NCT02696031|58860094|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
30835455|NCT02696031|58860095|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
30835456|NCT02696031|58860096|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
30835457|NCT02696031|58860091|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
30835458|NCT02696031|58860092|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
30835459|NCT02696031|58860093|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
30835460|NCT02696031|58860094|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
30835461|NCT02696031|58860095|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
30835462|NCT02696031|58860096|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
30835463|NCT02696031|58860091|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
30835464|NCT02696031|58860092|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
30835465|NCT02696031|58860093|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
30835466|NCT02696031|58860094|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
30835467|NCT02696031|58860095|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
30835468|NCT02696031|58860096|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
30835469|NCT02696031|58860091|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
30835470|NCT02696031|58860092|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
30835471|NCT02696031|58860093|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
30835472|NCT02696031|58860094|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
30835473|NCT02696031|58860095|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
30835474|NCT02696031|58860096|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
30835475|NCT02696031|58860091|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
30835476|NCT02696031|58860092|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
30835477|NCT02696031|58860093|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
30835478|NCT02696031|58860094|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
30835479|NCT02696031|58860095|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
30835480|NCT02696031|58860096|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
30835481|NCT02696031|58860091|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
30835482|NCT02696031|58860092|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
30835483|NCT02696031|58860093|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
30835484|NCT02696031|58860094|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
30835485|NCT02696031|58860095|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
30835486|NCT02696031|58860096|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
30835487|NCT02696031|58860091|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
30835488|NCT02696031|58860092|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
30835489|NCT02696031|58860093|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
30835490|NCT02696031|58860094|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
30835491|NCT02696031|58860095|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
30835492|NCT02696031|58860096|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
30835493|NCT00397254|58860105|FG000|Overall Study|Lost to Follow-up|2|||
30835494|NCT00397254|58860106|FG001|Overall Study|Lost to Follow-up|2|||
30756789|NCT03670810|58766390|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
30835495|NCT01369641|58860110|FG000|Overall Study|Withdrawal by Subject|1|||
30835496|NCT00529152|58860114|FG000|Overall Study|Adverse Event|2|||
30835497|NCT00529152|58860114|FG000|Overall Study|Withdrawal by Subject|2|||
30835498|NCT00529152|58860114|FG000|Overall Study|Lost to Follow-up|1|||
30835499|NCT02605174|58860121|FG000|Overall Study|Adverse Event|0|||
30835500|NCT02605174|58860122|FG001|Overall Study|Adverse Event|0|||
30835501|NCT02605174|58860123|FG002|Overall Study|Adverse Event|1|||
30835502|NCT02605174|58860124|FG003|Overall Study|Adverse Event|0|||
30835503|NCT02605174|58860125|FG004|Overall Study|Adverse Event|4|||
30835504|NCT02605174|58860126|FG005|Overall Study|Adverse Event|0|||
30835505|NCT02605174|58860127|FG006|Overall Study|Adverse Event|0|||
30835506|NCT02605174|58860121|FG000|Overall Study|Lost to Follow-up|20|||
30835507|NCT02605174|58860122|FG001|Overall Study|Lost to Follow-up|7|||
30835508|NCT02605174|58860123|FG002|Overall Study|Lost to Follow-up|27|||
30925702|NCT01967719|58961234|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
30925703|NCT01967719|58961235|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
30925704|NCT01967719|58961236|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
30925705|NCT01967719|58961237|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
30925706|NCT01967173|58961255|FG000|Overall Study|Lost to Follow-up|5|||
30925707|NCT01967173|58961256|FG001|Overall Study|Lost to Follow-up|3|||
30925708|NCT01967173|58961257|FG002|Overall Study|Lost to Follow-up|2|||
30925709|NCT01967173|58961258|FG003|Overall Study|Lost to Follow-up|4|||
30925710|NCT01967173|58961259|FG004|Overall Study|Lost to Follow-up|8|||
30925711|NCT01967173|58961260|FG005|Overall Study|Lost to Follow-up|12|||
30925712|NCT01967173|58961261|FG006|Overall Study|Lost to Follow-up|6|||
30925713|NCT01967173|58961262|FG007|Overall Study|Lost to Follow-up|8|||
30925714|NCT01967173|58961255|FG000|Overall Study|Physician Decision|2|||
30925715|NCT01967173|58961256|FG001|Overall Study|Physician Decision|0|||
30925716|NCT01967173|58961257|FG002|Overall Study|Physician Decision|2|||
30925717|NCT01967173|58961258|FG003|Overall Study|Physician Decision|1|||
30925718|NCT01967173|58961259|FG004|Overall Study|Physician Decision|1|||
30925719|NCT01967173|58961260|FG005|Overall Study|Physician Decision|1|||
30925720|NCT01967173|58961261|FG006|Overall Study|Physician Decision|1|||
30925721|NCT01967173|58961262|FG007|Overall Study|Physician Decision|0|||
30925722|NCT01967173|58961255|FG000|Overall Study|Lack of Efficacy|2|||
30925723|NCT01967173|58961256|FG001|Overall Study|Lack of Efficacy|0|||
30925724|NCT01967173|58961257|FG002|Overall Study|Lack of Efficacy|2|||
30925725|NCT01967173|58961258|FG003|Overall Study|Lack of Efficacy|2|||
30925726|NCT01967173|58961259|FG004|Overall Study|Lack of Efficacy|0|||
30925727|NCT01967173|58961260|FG005|Overall Study|Lack of Efficacy|1|||
30925728|NCT01967173|58961261|FG006|Overall Study|Lack of Efficacy|0|||
30756790|NCT03670810|58766391|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
30756791|NCT03670810|58766392|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
30756792|NCT03670810|58766393|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
30756793|NCT03670810|58766394|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
30756794|NCT03670810|58766395|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
30756795|NCT03670810|58766387|FG000|Main Study|Travel and Coronavirus issues|0|||
30756796|NCT03670810|58766388|FG001|Main Study|Travel and Coronavirus issues|0|||
30756797|NCT03670810|58766389|FG002|Main Study|Travel and Coronavirus issues|0|||
30756798|NCT03670810|58766390|FG003|Main Study|Travel and Coronavirus issues|1|||
30756799|NCT03670810|58766391|FG004|Main Study|Travel and Coronavirus issues|0|||
30756800|NCT03670810|58766392|FG005|Main Study|Travel and Coronavirus issues|0|||
30756801|NCT03670810|58766393|FG006|Main Study|Travel and Coronavirus issues|0|||
30756802|NCT03670810|58766394|FG007|Main Study|Travel and Coronavirus issues|0|||
30756803|NCT03670810|58766395|FG008|Main Study|Travel and Coronavirus issues|0|||
30756804|NCT03670810|58766387|FG000|Open Label Extension|Protocol Deviation|0|||
30756805|NCT03670810|58766388|FG001|Open Label Extension|Protocol Deviation|0|||
30835509|NCT02605174|58860124|FG003|Overall Study|Lost to Follow-up|10|||
30835510|NCT02605174|58860125|FG004|Overall Study|Lost to Follow-up|20|||
30835511|NCT02605174|58860126|FG005|Overall Study|Lost to Follow-up|10|||
30835512|NCT02605174|58860127|FG006|Overall Study|Lost to Follow-up|29|||
30925729|NCT01967173|58961262|FG007|Overall Study|Lack of Efficacy|2|||
30925730|NCT01967173|58961255|FG000|Overall Study|Pregnancy|0|||
30925731|NCT01967173|58961256|FG001|Overall Study|Pregnancy|0|||
30925732|NCT01967173|58961257|FG002|Overall Study|Pregnancy|0|||
30835513|NCT02605174|58860121|FG000|Overall Study|Protocol Violation|10|||
30835514|NCT02605174|58860122|FG001|Overall Study|Protocol Violation|4|||
30756806|NCT03670810|58766389|FG002|Open Label Extension|Protocol Deviation|0|||
30756807|NCT03670810|58766390|FG003|Open Label Extension|Protocol Deviation|0|||
30756808|NCT03670810|58766391|FG004|Open Label Extension|Protocol Deviation|0|||
30756809|NCT03670810|58766392|FG005|Open Label Extension|Protocol Deviation|0|||
30756810|NCT03670810|58766393|FG006|Open Label Extension|Protocol Deviation|0|||
30756811|NCT03670810|58766394|FG007|Open Label Extension|Protocol Deviation|0|||
30925733|NCT01967173|58961258|FG003|Overall Study|Pregnancy|0|||
30925734|NCT01967173|58961259|FG004|Overall Study|Pregnancy|0|||
30925735|NCT01967173|58961260|FG005|Overall Study|Pregnancy|0|||
30925736|NCT01967173|58961261|FG006|Overall Study|Pregnancy|1|||
30925737|NCT01967173|58961262|FG007|Overall Study|Pregnancy|1|||
30925738|NCT01967173|58961255|FG000|Overall Study|Adverse Event|0|||
30925739|NCT01967173|58961256|FG001|Overall Study|Adverse Event|0|||
30925740|NCT01967173|58961257|FG002|Overall Study|Adverse Event|0|||
30925741|NCT01967173|58961258|FG003|Overall Study|Adverse Event|0|||
30835515|NCT02605174|58860123|FG002|Overall Study|Protocol Violation|14|||
30835516|NCT02605174|58860124|FG003|Overall Study|Protocol Violation|6|||
30835517|NCT02605174|58860125|FG004|Overall Study|Protocol Violation|7|||
30835518|NCT02605174|58860126|FG005|Overall Study|Protocol Violation|7|||
30835519|NCT02605174|58860127|FG006|Overall Study|Protocol Violation|12|||
30835520|NCT02605174|58860121|FG000|Overall Study|Pregnancy|1|||
30835521|NCT02605174|58860122|FG001|Overall Study|Pregnancy|0|||
30835522|NCT02605174|58860123|FG002|Overall Study|Pregnancy|0|||
30835523|NCT02605174|58860124|FG003|Overall Study|Pregnancy|2|||
30835524|NCT02605174|58860125|FG004|Overall Study|Pregnancy|0|||
30835525|NCT02605174|58860126|FG005|Overall Study|Pregnancy|0|||
30835526|NCT02605174|58860127|FG006|Overall Study|Pregnancy|0|||
30835527|NCT02605174|58860121|FG000|Overall Study|Withdrawal by Subject|9|||
30835528|NCT02605174|58860122|FG001|Overall Study|Withdrawal by Subject|6|||
30835529|NCT02605174|58860123|FG002|Overall Study|Withdrawal by Subject|14|||
30835530|NCT02605174|58860124|FG003|Overall Study|Withdrawal by Subject|11|||
30835531|NCT02605174|58860125|FG004|Overall Study|Withdrawal by Subject|6|||
30835532|NCT02605174|58860126|FG005|Overall Study|Withdrawal by Subject|4|||
30835533|NCT02605174|58860127|FG006|Overall Study|Withdrawal by Subject|15|||
30623923|NCT00910858|58635927|FG001|Pharmacokinetic Phase|Adverse Event|0|||
30623924|NCT00910858|58635928|FG002|Pharmacokinetic Phase|Adverse Event|0|||
30623925|NCT00910858|58635926|FG000|Monotherapy Phase|Adverse Event|3|||
30623926|NCT00910858|58635927|FG001|Monotherapy Phase|Adverse Event|2|||
30623927|NCT00910858|58635928|FG002|Monotherapy Phase|Adverse Event|0|||
30623928|NCT00910858|58635926|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
30623929|NCT00910858|58635927|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
30623930|NCT00910858|58635928|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
30623931|NCT00910858|58635926|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
30623932|NCT00910858|58635927|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
30623933|NCT00910858|58635928|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
30835534|NCT02605174|58860121|FG000|Overall Study|Physician Decision|2|||
30835535|NCT02605174|58860122|FG001|Overall Study|Physician Decision|0|||
30835536|NCT02605174|58860123|FG002|Overall Study|Physician Decision|0|||
30835537|NCT02605174|58860124|FG003|Overall Study|Physician Decision|0|||
30835538|NCT02605174|58860125|FG004|Overall Study|Physician Decision|0|||
30835539|NCT02605174|58860126|FG005|Overall Study|Physician Decision|0|||
30835540|NCT02605174|58860127|FG006|Overall Study|Physician Decision|3|||
30835541|NCT02605174|58860121|FG000|Overall Study|Randomization Failure|22|||
30835542|NCT02605174|58860122|FG001|Overall Study|Randomization Failure|6|||
30835543|NCT02605174|58860123|FG002|Overall Study|Randomization Failure|20|||
30835544|NCT02605174|58860124|FG003|Overall Study|Randomization Failure|7|||
30925742|NCT01967173|58961259|FG004|Overall Study|Adverse Event|0|||
30925743|NCT01967173|58961260|FG005|Overall Study|Adverse Event|0|||
30623934|NCT00910858|58635926|FG000|Monotherapy Phase|Protocol Violation|1|||
30623935|NCT00910858|58635927|FG001|Monotherapy Phase|Protocol Violation|0|||
30623936|NCT00910858|58635928|FG002|Monotherapy Phase|Protocol Violation|0|||
30756812|NCT03670810|58766395|FG008|Open Label Extension|Protocol Deviation|5|||
30756813|NCT03670810|58766387|FG000|Open Label Extension|Death|0|||
30756814|NCT03670810|58766388|FG001|Open Label Extension|Death|0|||
30756815|NCT03670810|58766389|FG002|Open Label Extension|Death|0|||
30756816|NCT03670810|58766390|FG003|Open Label Extension|Death|0|||
30756817|NCT03670810|58766391|FG004|Open Label Extension|Death|0|||
30756818|NCT03670810|58766392|FG005|Open Label Extension|Death|0|||
30756819|NCT03670810|58766393|FG006|Open Label Extension|Death|0|||
30756820|NCT03670810|58766394|FG007|Open Label Extension|Death|0|||
30756821|NCT03670810|58766395|FG008|Open Label Extension|Death|1|||
30756822|NCT03670810|58766387|FG000|Open Label Extension|COVID-19|0|||
30756823|NCT03670810|58766388|FG001|Open Label Extension|COVID-19|0|||
30756824|NCT03670810|58766389|FG002|Open Label Extension|COVID-19|0|||
30835545|NCT02605174|58860125|FG004|Overall Study|Randomization Failure|16|||
30623937|NCT00910858|58635926|FG000|Monotherapy Phase|Other|3|||
30756825|NCT03670810|58766390|FG003|Open Label Extension|COVID-19|0|||
30756826|NCT03670810|58766391|FG004|Open Label Extension|COVID-19|0|||
30756827|NCT03670810|58766392|FG005|Open Label Extension|COVID-19|0|||
30925744|NCT01967173|58961261|FG006|Overall Study|Adverse Event|0|||
30925745|NCT01967173|58961262|FG007|Overall Study|Adverse Event|1|||
30925746|NCT01967173|58961255|FG000|Overall Study|Withdrawal by Subject|15|||
30925747|NCT01967173|58961256|FG001|Overall Study|Withdrawal by Subject|14|||
30925748|NCT01967173|58961257|FG002|Overall Study|Withdrawal by Subject|10|||
30835546|NCT02605174|58860126|FG005|Overall Study|Randomization Failure|11|||
30835547|NCT02605174|58860127|FG006|Overall Study|Randomization Failure|30|||
30835548|NCT02604550|58860155|FG000|Overall Study|Lost to Follow-up|7|||
30835549|NCT02604550|58860156|FG001|Overall Study|Lost to Follow-up|6|||
30835550|NCT02604550|58860155|FG000|Overall Study|Withdrawal by Subject|0|||
30835551|NCT02604550|58860156|FG001|Overall Study|Withdrawal by Subject|1|||
30835552|NCT02604550|58860155|FG000|Overall Study|Incomplete data using paper journal|18|||
30925749|NCT01967173|58961258|FG003|Overall Study|Withdrawal by Subject|7|||
30925750|NCT01967173|58961259|FG004|Overall Study|Withdrawal by Subject|8|||
30925751|NCT01967173|58961260|FG005|Overall Study|Withdrawal by Subject|9|||
30925752|NCT01967173|58961261|FG006|Overall Study|Withdrawal by Subject|10|||
30925753|NCT01967173|58961262|FG007|Overall Study|Withdrawal by Subject|12|||
30925754|NCT01994629|58961276|FG000|Overall Study|Withdrawal by Subject|1|||
30925755|NCT01994629|58961277|FG001|Overall Study|Withdrawal by Subject|0|||
30925756|NCT01994629|58961276|FG000|Overall Study|Lost to Follow-up|0|||
30925757|NCT01994629|58961277|FG001|Overall Study|Lost to Follow-up|3|||
30925758|NCT01994395|58961285|FG000|Overall Study|Withdrawal by Subject|1|||
30925759|NCT01994395|58961286|FG001|Overall Study|Withdrawal by Subject|2|||
30925760|NCT01992536|58961302|FG000|Overall Study|Administrative Reason|0|||
30925761|NCT01992536|58961303|FG001|Overall Study|Administrative Reason|0|||
30925762|NCT01992536|58961304|FG002|Overall Study|Administrative Reason|0|||
30925763|NCT01992536|58961305|FG003|Overall Study|Administrative Reason|0|||
30925764|NCT01992536|58961306|FG004|Overall Study|Administrative Reason|0|||
30925765|NCT01992536|58961307|FG005|Overall Study|Administrative Reason|0|||
30925766|NCT01992536|58961308|FG006|Overall Study|Administrative Reason|7|||
30925767|NCT01992536|58961309|FG007|Overall Study|Administrative Reason|0|||
30925768|NCT01992536|58961310|FG008|Overall Study|Administrative Reason|0|||
30925769|NCT01992536|58961311|FG009|Overall Study|Administrative Reason|0|||
30925770|NCT01992536|58961302|FG000|Overall Study|Lost to Follow-up|4|||
30925771|NCT01992536|58961303|FG001|Overall Study|Lost to Follow-up|2|||
30925772|NCT01992536|58961304|FG002|Overall Study|Lost to Follow-up|1|||
30925773|NCT01992536|58961305|FG003|Overall Study|Lost to Follow-up|0|||
30925774|NCT01992536|58961306|FG004|Overall Study|Lost to Follow-up|0|||
30925775|NCT01992536|58961307|FG005|Overall Study|Lost to Follow-up|1|||
30925776|NCT01992536|58961308|FG006|Overall Study|Lost to Follow-up|0|||
30925777|NCT01992536|58961309|FG007|Overall Study|Lost to Follow-up|0|||
30925778|NCT01992536|58961310|FG008|Overall Study|Lost to Follow-up|1|||
30925779|NCT01992536|58961311|FG009|Overall Study|Lost to Follow-up|1|||
30925780|NCT01992536|58961302|FG000|Overall Study|Withdrawal by Subject|0|||
30925781|NCT01992536|58961303|FG001|Overall Study|Withdrawal by Subject|1|||
30925782|NCT01992536|58961304|FG002|Overall Study|Withdrawal by Subject|0|||
30925783|NCT01992536|58961305|FG003|Overall Study|Withdrawal by Subject|2|||
30925784|NCT01992536|58961306|FG004|Overall Study|Withdrawal by Subject|0|||
30756828|NCT03670810|58766393|FG006|Open Label Extension|COVID-19|0|||
30756829|NCT03670810|58766394|FG007|Open Label Extension|COVID-19|0|||
30756830|NCT03670810|58766395|FG008|Open Label Extension|COVID-19|1|||
30756831|NCT03670810|58766387|FG000|Open Label Extension|Lack of Efficacy|0|||
30756832|NCT03670810|58766388|FG001|Open Label Extension|Lack of Efficacy|0|||
30756833|NCT03670810|58766389|FG002|Open Label Extension|Lack of Efficacy|0|||
30925785|NCT01992536|58961307|FG005|Overall Study|Withdrawal by Subject|0|||
30623938|NCT00910858|58635927|FG001|Monotherapy Phase|Other|4|||
30623939|NCT00910858|58635928|FG002|Monotherapy Phase|Other|2|||
30623940|NCT00910858|58635926|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
30756834|NCT03670810|58766390|FG003|Open Label Extension|Lack of Efficacy|0|||
30835553|NCT02604550|58860156|FG001|Overall Study|Incomplete data using paper journal|19|||
30925786|NCT01992536|58961308|FG006|Overall Study|Withdrawal by Subject|0|||
30925787|NCT01992536|58961309|FG007|Overall Study|Withdrawal by Subject|0|||
30925788|NCT01992536|58961310|FG008|Overall Study|Withdrawal by Subject|0|||
30925789|NCT01992536|58961311|FG009|Overall Study|Withdrawal by Subject|0|||
30925790|NCT01993927|58961353|FG000|Overall Study|Case Report Forms Uncollected|18|||
30925791|NCT01993927|58961353|FG000|Overall Study|Protocol Violation|11|||
30925792|NCT02015390|58961359|FG000|Overall Study|Lost to Follow-up|1|||
30756835|NCT03670810|58766391|FG004|Open Label Extension|Lack of Efficacy|0|||
30756836|NCT03670810|58766392|FG005|Open Label Extension|Lack of Efficacy|0|||
30925793|NCT02015390|58961360|FG001|Overall Study|Lost to Follow-up|0|||
30925794|NCT02015390|58961359|FG000|Overall Study|Adverse Event|0|||
30925795|NCT02015390|58961360|FG001|Overall Study|Adverse Event|3|||
30925796|NCT02015390|58961359|FG000|Overall Study|Physician Decision|0|||
30835554|NCT02591290|58860162|FG000|Overall Study|Withdrawal by Subject|2|||
30835555|NCT02791893|58860168|FG000|Blinded Phase|Lost to Follow-up|2|||
30835556|NCT02791893|58860169|FG001|Blinded Phase|Lost to Follow-up|2|||
30835557|NCT02791893|58860168|FG000|Blinded Phase|Withdrawal by Subject|1|||
30835558|NCT02791893|58860169|FG001|Blinded Phase|Withdrawal by Subject|2|||
30835559|NCT02791893|58860168|FG000|Open Label Phase|Lost to Follow-up|3|||
30835560|NCT02791893|58860169|FG001|Open Label Phase|Lost to Follow-up|0|||
30835561|NCT02791893|58860168|FG000|Open Label Phase|Withdrawal by Subject|0|||
30835562|NCT02791893|58860169|FG001|Open Label Phase|Withdrawal by Subject|2|||
30835563|NCT00120042|58860178|FG000|Overall Study|all completed protocl|0|||
30835564|NCT00120042|58860179|FG001|Overall Study|all completed protocl|0|||
30835565|NCT00120042|58860180|FG002|Overall Study|all completed protocl|0|||
30835566|NCT02476851|58860187|FG000|Overall Study|Protocol Violation|1|||
30835567|NCT02476851|58860188|FG001|Overall Study|Protocol Violation|1|||
30835568|NCT02595970|58860194|FG000|Overall Study|Withdrawal by Subject|2|||
30835569|NCT02595970|58860194|FG000|Overall Study|Physician Decision|2|||
30835570|NCT02595970|58860194|FG000|Overall Study|Protocol Violation|4|||
30835571|NCT02595970|58860194|FG000|Overall Study|Adverse Event|5|||
30835572|NCT02595970|58860194|FG000|Overall Study|Lack of Efficacy|7|||
30835573|NCT01866111|58860202|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
30835574|NCT01866111|58860203|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
30835575|NCT01866111|58860204|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
30835576|NCT01866111|58860205|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
30835577|NCT01866111|58860202|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
30835578|NCT01866111|58860203|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
30835579|NCT01866111|58860204|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
30835580|NCT01866111|58860205|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
30835581|NCT02595502|58860215|FG000|Period 1|Adverse Event|0|||
30835582|NCT02595502|58860216|FG001|Period 1|Adverse Event|1|||
30835583|NCT02595502|58860215|FG000|Period 1|Withdrawal by Subject|1|||
30835584|NCT02595502|58860216|FG001|Period 1|Withdrawal by Subject|0|||
30835585|NCT02595502|58860215|FG000|Period 1|Lost to Follow-up|0|||
30835586|NCT02595502|58860216|FG001|Period 1|Lost to Follow-up|1|||
30835587|NCT02595502|58860215|FG000|Period 2|Adverse Event|1|||
30835588|NCT02595502|58860216|FG001|Period 2|Adverse Event|1|||
30835589|NCT02595502|58860215|FG000|Period 2|Received incorrect lens at Period 1|0|||
30835590|NCT02595502|58860216|FG001|Period 2|Received incorrect lens at Period 1|1|||
30835591|NCT02595502|58860215|FG000|Period 3|Protocol Violation|0|||
30835592|NCT02595502|58860216|FG001|Period 3|Protocol Violation|1|||
30835593|NCT02595502|58860215|FG000|Period 3|Lost to Follow-up|1|||
30835594|NCT02595502|58860216|FG001|Period 3|Lost to Follow-up|0|||
30835595|NCT02595502|58860215|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
30925797|NCT02015390|58961360|FG001|Overall Study|Physician Decision|1|||
30925798|NCT02012959|58961367|FG000|Treatment Phase A|Adverse Event|2|||
30835596|NCT02595502|58860216|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
30835597|NCT01369329|58860225|FG000|Overall Study|Withdrawal by Subject|8|||
30835598|NCT01369329|58860226|FG001|Overall Study|Withdrawal by Subject|6|||
30835599|NCT01369329|58860227|FG002|Overall Study|Withdrawal by Subject|10|||
30756837|NCT03670810|58766393|FG006|Open Label Extension|Lack of Efficacy|0|||
30756838|NCT03670810|58766394|FG007|Open Label Extension|Lack of Efficacy|0|||
30756839|NCT03670810|58766395|FG008|Open Label Extension|Lack of Efficacy|39|||
30756840|NCT03670810|58766387|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
30756841|NCT03670810|58766388|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
30756842|NCT03670810|58766389|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
30756843|NCT03670810|58766390|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
30756844|NCT03670810|58766391|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
30756845|NCT03670810|58766392|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
30756846|NCT03670810|58766393|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
30756847|NCT03670810|58766394|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
30756848|NCT03670810|58766395|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
30756849|NCT03670810|58766387|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
30756850|NCT03670810|58766388|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
30756851|NCT03670810|58766389|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
30756852|NCT03670810|58766390|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
30756853|NCT03670810|58766391|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
30756854|NCT03670810|58766392|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
30756855|NCT03670810|58766393|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
30756856|NCT03670810|58766394|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
30756857|NCT03670810|58766395|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
30756858|NCT03670810|58766387|FG000|Open Label Extension|Withdrawal by Subject|0|||
30756859|NCT03670810|58766388|FG001|Open Label Extension|Withdrawal by Subject|0|||
30756860|NCT03670810|58766389|FG002|Open Label Extension|Withdrawal by Subject|0|||
30835600|NCT01369329|58860225|FG000|Overall Study|Lost to Follow-up|2|||
30835601|NCT01369329|58860226|FG001|Overall Study|Lost to Follow-up|2|||
30835602|NCT01369329|58860227|FG002|Overall Study|Lost to Follow-up|2|||
30835603|NCT01369329|58860225|FG000|Overall Study|Other|2|||
30835604|NCT01369329|58860226|FG001|Overall Study|Other|3|||
30835605|NCT01369329|58860227|FG002|Overall Study|Other|2|||
30835606|NCT02791659|58860237|FG000|Overall Study|Protocol Violation|0|||
30835607|NCT02791659|58860238|FG001|Overall Study|Protocol Violation|1|||
30835608|NCT02594098|58860246|FG000|Overall Study|Lack of Efficacy|17|||
30835609|NCT02594098|58860247|FG001|Overall Study|Lack of Efficacy|6|||
30835610|NCT02594098|58860246|FG000|Overall Study|Withdrawal by Subject|1|||
30835611|NCT02594098|58860247|FG001|Overall Study|Withdrawal by Subject|3|||
30835612|NCT02594098|58860246|FG000|Overall Study|Terminated participation|6|||
30835613|NCT02594098|58860247|FG001|Overall Study|Terminated participation|2|||
30835614|NCT02594098|58860246|FG000|Overall Study|Seek alternative treatment|2|||
30835615|NCT02594098|58860247|FG001|Overall Study|Seek alternative treatment|1|||
30835616|NCT02594098|58860246|FG000|Overall Study|Other|0|||
30835617|NCT02594098|58860247|FG001|Overall Study|Other|1|||
30835618|NCT02593864|58860255|FG000|Overall Study|Withdrawal by Subject|3|||
30835619|NCT02593864|58860255|FG000|Overall Study|Lost to Follow-up|3|||
30623941|NCT00910858|58635927|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
30623942|NCT00910858|58635928|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
30756861|NCT03670810|58766390|FG003|Open Label Extension|Withdrawal by Subject|0|||
30756862|NCT03670810|58766391|FG004|Open Label Extension|Withdrawal by Subject|0|||
30756863|NCT03670810|58766392|FG005|Open Label Extension|Withdrawal by Subject|0|||
30756864|NCT03670810|58766393|FG006|Open Label Extension|Withdrawal by Subject|0|||
30756865|NCT03670810|58766394|FG007|Open Label Extension|Withdrawal by Subject|0|||
30756866|NCT03670810|58766395|FG008|Open Label Extension|Withdrawal by Subject|46|||
30756867|NCT03670810|58766387|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
30756868|NCT03670810|58766388|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
30756869|NCT03670810|58766389|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
30835620|NCT02590588|58860259|FG000|Overall Study|Adverse Event|1|||
30835621|NCT01434602|58860268|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
30835622|NCT01434602|58860269|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
30835623|NCT01434602|58860270|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
30835624|NCT01434602|58860271|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
30756870|NCT03670810|58766390|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
30756871|NCT03670810|58766391|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
30756872|NCT03670810|58766392|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
30756873|NCT03670810|58766393|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
30756874|NCT03670810|58766394|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
30756875|NCT03670810|58766395|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
30756876|NCT03670810|58766387|FG000|Open Label Extension|Physician Decision|0|||
30756877|NCT03670810|58766388|FG001|Open Label Extension|Physician Decision|0|||
30756878|NCT03670810|58766389|FG002|Open Label Extension|Physician Decision|0|||
30756879|NCT03670810|58766390|FG003|Open Label Extension|Physician Decision|0|||
30756880|NCT03670810|58766391|FG004|Open Label Extension|Physician Decision|0|||
30756881|NCT03670810|58766392|FG005|Open Label Extension|Physician Decision|0|||
30756882|NCT03670810|58766393|FG006|Open Label Extension|Physician Decision|0|||
30756883|NCT03670810|58766394|FG007|Open Label Extension|Physician Decision|0|||
30756884|NCT03670810|58766395|FG008|Open Label Extension|Physician Decision|2|||
30835625|NCT01434602|58860272|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
30835626|NCT01434602|58860268|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
30835627|NCT01434602|58860269|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
30835628|NCT01434602|58860270|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
30835629|NCT01434602|58860271|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
30835630|NCT01434602|58860272|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
30756885|NCT03670810|58766387|FG000|Open Label Extension|Non-compliance with study drug|0|||
30756886|NCT03670810|58766388|FG001|Open Label Extension|Non-compliance with study drug|0|||
30835631|NCT01434602|58860268|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
30835632|NCT01434602|58860269|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
30835633|NCT01434602|58860270|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
30835634|NCT01434602|58860271|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
30835635|NCT01434602|58860272|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
30835636|NCT01434602|58860268|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
30756887|NCT03670810|58766389|FG002|Open Label Extension|Non-compliance with study drug|0|||
30756888|NCT03670810|58766390|FG003|Open Label Extension|Non-compliance with study drug|0|||
30756889|NCT03670810|58766391|FG004|Open Label Extension|Non-compliance with study drug|0|||
30756890|NCT03670810|58766392|FG005|Open Label Extension|Non-compliance with study drug|0|||
30756891|NCT03670810|58766393|FG006|Open Label Extension|Non-compliance with study drug|0|||
30835637|NCT01434602|58860269|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
30835638|NCT01434602|58860270|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
30835639|NCT01434602|58860271|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
30835640|NCT01434602|58860272|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
30835641|NCT01434602|58860268|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
30835642|NCT01434602|58860269|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
30835643|NCT01434602|58860270|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
30835644|NCT01434602|58860271|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
30835645|NCT01434602|58860272|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
30835646|NCT01434602|58860268|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
30835647|NCT01434602|58860269|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
30835648|NCT01434602|58860270|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
30835649|NCT01434602|58860271|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
30835650|NCT01434602|58860272|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
30835651|NCT01434602|58860268|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
30835652|NCT01434602|58860269|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
30835653|NCT01434602|58860270|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
30835654|NCT01434602|58860271|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
30835655|NCT01434602|58860272|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
30623943|NCT00910858|58635926|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
30623944|NCT00910858|58635927|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
30623945|NCT00910858|58635928|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
30756892|NCT03670810|58766394|FG007|Open Label Extension|Non-compliance with study drug|0|||
30623946|NCT00910858|58635926|FG000|Combined Treatment Phase|Protocol Violation|1|||
30623947|NCT00910858|58635927|FG001|Combined Treatment Phase|Protocol Violation|0|||
30623948|NCT00910858|58635928|FG002|Combined Treatment Phase|Protocol Violation|0|||
30623949|NCT00910858|58635926|FG000|Combined Treatment Phase|Other|0|||
30623950|NCT00910858|58635927|FG001|Combined Treatment Phase|Other|2|||
30623951|NCT00910858|58635928|FG002|Combined Treatment Phase|Other|1|||
30623952|NCT00598975|58635946|FG000|Overall Study|Adverse Event|1|||
30623953|NCT00598975|58635947|FG001|Overall Study|Adverse Event|1|||
30623954|NCT00598975|58635946|FG000|Overall Study|Brain metastases|1|||
30623955|NCT00598975|58635947|FG001|Overall Study|Brain metastases|0|||
30623956|NCT00598975|58635946|FG000|Overall Study|Withdrawal by Subject|1|||
30623957|NCT00598975|58635947|FG001|Overall Study|Withdrawal by Subject|1|||
30623958|NCT00598975|58635946|FG000|Overall Study|Withdrawal of consent|0|||
30623959|NCT00598975|58635947|FG001|Overall Study|Withdrawal of consent|1|||
30623960|NCT00598975|58635946|FG000|Overall Study|Disease progression|8|||
30623961|NCT00598975|58635947|FG001|Overall Study|Disease progression|3|||
30623962|NCT00598975|58635946|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
30623963|NCT00598975|58635947|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
30623964|NCT00957021|58635955|FG000|Overall Study|Death|5|||
30623965|NCT00957021|58635955|FG000|Overall Study|Lost to Follow-up|8|||
30623966|NCT00957021|58635955|FG000|Overall Study|Withdrawal by Subject|34|||
30623967|NCT00957021|58635955|FG000|Overall Study|No 2 yr ROM data|35|||
30623968|NCT00957021|58635955|FG000|Overall Study|Revised study component by 2 yr visit|8|||
30623969|NCT00957021|58635955|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
30623970|NCT00957021|58635955|FG000|Overall Study|Surgery Cancelled|9|||
30623971|NCT00957021|58635955|FG000|Overall Study|Termination due to language issue|2|||
30623972|NCT01124604|58635962|FG000|Overall Study|Adverse Event|10|||
30623973|NCT01124604|58635963|FG001|Overall Study|Adverse Event|1|||
30623974|NCT01124604|58635962|FG000|Overall Study|Lack of Efficacy|1|||
30623975|NCT01124604|58635963|FG001|Overall Study|Lack of Efficacy|0|||
30835656|NCT01434602|58860268|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
30756893|NCT03670810|58766395|FG008|Open Label Extension|Non-compliance with study drug|5|||
30623976|NCT01124604|58635962|FG000|Overall Study|Withdrawal by Subject|4|||
30623977|NCT01124604|58635963|FG001|Overall Study|Withdrawal by Subject|0|||
30623978|NCT01124604|58635962|FG000|Overall Study|Disease Progression|0|||
30623979|NCT01124604|58635963|FG001|Overall Study|Disease Progression|1|||
30623980|NCT00909844|58635969|FG000|Overall Study|Adverse Event|1|||
30623981|NCT00909844|58635969|FG000|Overall Study|Withdrawal by Subject|1|||
30623982|NCT00909844|58635969|FG000|Overall Study|Lost to Follow-up|2|||
30623983|NCT01124448|58635976|FG000|Overall Study|Lost to Follow-up|0|||
30623984|NCT01124448|58635977|FG001|Overall Study|Lost to Follow-up|3|||
30623985|NCT01124448|58635976|FG000|Overall Study|Protocol Violation|2|||
30623986|NCT01124448|58635977|FG001|Overall Study|Protocol Violation|0|||
30623987|NCT01124292|58635986|FG000|Overall Study|Lost to Follow-up|2|||
30623988|NCT01124292|58635987|FG001|Overall Study|Lost to Follow-up|4|||
30756894|NCT03670810|58766387|FG000|Open Label Extension|Pregnancy|0|||
30756895|NCT03670810|58766388|FG001|Open Label Extension|Pregnancy|0|||
30756896|NCT03670810|58766389|FG002|Open Label Extension|Pregnancy|0|||
30756897|NCT03670810|58766390|FG003|Open Label Extension|Pregnancy|0|||
30756898|NCT03670810|58766391|FG004|Open Label Extension|Pregnancy|0|||
30756899|NCT03670810|58766392|FG005|Open Label Extension|Pregnancy|0|||
30756900|NCT03670810|58766393|FG006|Open Label Extension|Pregnancy|0|||
30756901|NCT03670810|58766394|FG007|Open Label Extension|Pregnancy|0|||
30756902|NCT03670810|58766395|FG008|Open Label Extension|Pregnancy|3|||
30756903|NCT03670810|58766387|FG000|Open Label Extension|Adverse Event|0|||
30756904|NCT03670810|58766388|FG001|Open Label Extension|Adverse Event|0|||
30756905|NCT03670810|58766389|FG002|Open Label Extension|Adverse Event|0|||
30756906|NCT03670810|58766390|FG003|Open Label Extension|Adverse Event|0|||
30756907|NCT03670810|58766391|FG004|Open Label Extension|Adverse Event|0|||
30756908|NCT03670810|58766392|FG005|Open Label Extension|Adverse Event|0|||
30756909|NCT03670810|58766393|FG006|Open Label Extension|Adverse Event|0|||
30756910|NCT03670810|58766394|FG007|Open Label Extension|Adverse Event|0|||
30756911|NCT03670810|58766395|FG008|Open Label Extension|Adverse Event|24|||
30756912|NCT03670810|58766387|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
30756913|NCT03670810|58766388|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
30756914|NCT03670810|58766389|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
30756915|NCT03670810|58766390|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
30756916|NCT03670810|58766391|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
30756917|NCT03670810|58766392|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
30756918|NCT03670810|58766393|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
30756919|NCT03670810|58766394|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
30756920|NCT03670810|58766395|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
30756921|NCT03670810|58766387|FG000|Open Label Extension|Lost to Follow-up|0|||
30756922|NCT03670810|58766388|FG001|Open Label Extension|Lost to Follow-up|0|||
30756923|NCT03670810|58766389|FG002|Open Label Extension|Lost to Follow-up|0|||
30756924|NCT03670810|58766390|FG003|Open Label Extension|Lost to Follow-up|0|||
30756925|NCT03670810|58766391|FG004|Open Label Extension|Lost to Follow-up|0|||
30756926|NCT03670810|58766392|FG005|Open Label Extension|Lost to Follow-up|0|||
30756927|NCT03670810|58766393|FG006|Open Label Extension|Lost to Follow-up|0|||
30756928|NCT03670810|58766394|FG007|Open Label Extension|Lost to Follow-up|0|||
30756929|NCT03670810|58766395|FG008|Open Label Extension|Lost to Follow-up|23|||
30756930|NCT00089648|58766409|FG000|Overall Study|Adverse Event|7|||
30756931|NCT00089648|58766409|FG000|Overall Study|Withdrawal by Subject|1|||
30756932|NCT00089648|58766409|FG000|Overall Study|Lack of Efficacy|33|||
30756933|NCT00118040|58766416|FG000|Overall Study|Adverse Event|0|||
30623989|NCT01124292|58635988|FG002|Overall Study|Lost to Follow-up|3|||
30623990|NCT01124292|58635986|FG000|Overall Study|Physician Decision|0|||
30756934|NCT00118040|58766417|FG001|Overall Study|Adverse Event|1|||
30756935|NCT00118040|58766418|FG002|Overall Study|Adverse Event|0|||
30756936|NCT00118040|58766416|FG000|Overall Study|Withdrawal by Subject|0|||
30756937|NCT00118040|58766417|FG001|Overall Study|Withdrawal by Subject|0|||
30756938|NCT00118040|58766418|FG002|Overall Study|Withdrawal by Subject|2|||
30756939|NCT00118040|58766416|FG000|Overall Study|Medical Contraindication|0|||
30756940|NCT00118040|58766417|FG001|Overall Study|Medical Contraindication|0|||
30756941|NCT00118040|58766418|FG002|Overall Study|Medical Contraindication|1|||
30623991|NCT01124292|58635987|FG001|Overall Study|Physician Decision|3|||
30623992|NCT01124292|58635988|FG002|Overall Study|Physician Decision|2|||
30756942|NCT00118040|58766416|FG000|Overall Study|Non-Compliant Participant|1|||
30756943|NCT00118040|58766417|FG001|Overall Study|Non-Compliant Participant|1|||
30756944|NCT00118040|58766418|FG002|Overall Study|Non-Compliant Participant|2|||
30623993|NCT01124292|58635986|FG000|Overall Study|Withdrawal by Subject|0|||
30756945|NCT00118040|58766416|FG000|Overall Study|Other|0|||
30756946|NCT00118040|58766417|FG001|Overall Study|Other|0|||
30756947|NCT00118040|58766418|FG002|Overall Study|Other|1|||
30756948|NCT00389207|58766434|FG000|Overall Study|Adverse Event|26|||
30756949|NCT00389207|58766435|FG001|Overall Study|Adverse Event|32|||
30756950|NCT00389207|58766436|FG002|Overall Study|Adverse Event|10|||
30623994|NCT01124292|58635987|FG001|Overall Study|Withdrawal by Subject|6|||
30623995|NCT01124292|58635988|FG002|Overall Study|Withdrawal by Subject|2|||
30623996|NCT01124292|58635986|FG000|Overall Study|medical issue unrelated to the study|0|||
30623997|NCT01124292|58635987|FG001|Overall Study|medical issue unrelated to the study|0|||
30623998|NCT01124292|58635988|FG002|Overall Study|medical issue unrelated to the study|2|||
30623999|NCT01124292|58635986|FG000|Overall Study|piercing track closed|0|||
30756951|NCT00389207|58766434|FG000|Overall Study|Protocol Violation|3|||
30835657|NCT01434602|58860269|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
30835658|NCT01434602|58860270|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
30835659|NCT01434602|58860271|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
30835660|NCT01434602|58860272|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
30835661|NCT01434602|58860268|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
30835662|NCT01434602|58860269|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
30835663|NCT01434602|58860270|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
30835664|NCT01434602|58860271|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
30835665|NCT01434602|58860272|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
30835666|NCT01434602|58860268|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
30835667|NCT01434602|58860269|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
30835668|NCT01434602|58860270|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
30835669|NCT01434602|58860271|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
30835670|NCT01434602|58860272|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
30835671|NCT01767129|58860294|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
30835672|NCT01767129|58860295|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
30835673|NCT02791269|58860304|FG000|Overall Study|Lost to Follow-up|0|||
30835674|NCT02791269|58860305|FG001|Overall Study|Lost to Follow-up|1|||
30835675|NCT02696564|58860315|FG000|Overall Study|Death|1|||
30925799|NCT02012959|58961368|FG001|Treatment Phase A|Adverse Event|0|||
30925800|NCT02012959|58961369|FG002|Treatment Phase A|Adverse Event|0|||
30925801|NCT02012959|58961370|FG003|Treatment Phase A|Adverse Event|0|||
30756952|NCT00389207|58766435|FG001|Overall Study|Protocol Violation|1|||
30756953|NCT00389207|58766436|FG002|Overall Study|Protocol Violation|4|||
30756954|NCT00389207|58766434|FG000|Overall Study|Lost to Follow-up|12|||
30756955|NCT00389207|58766435|FG001|Overall Study|Lost to Follow-up|9|||
30756956|NCT00389207|58766436|FG002|Overall Study|Lost to Follow-up|7|||
30756957|NCT00389207|58766434|FG000|Overall Study|Withdrawal by Subject|5|||
30756958|NCT00389207|58766435|FG001|Overall Study|Withdrawal by Subject|7|||
30756959|NCT00389207|58766436|FG002|Overall Study|Withdrawal by Subject|11|||
30835676|NCT02696564|58860316|FG001|Overall Study|Death|2|||
30835677|NCT02696564|58860315|FG000|Overall Study|Withdrawal by Subject|3|||
30925802|NCT02012959|58961371|FG004|Treatment Phase A|Adverse Event|0|||
30756960|NCT00389207|58766434|FG000|Overall Study|Other|17|||
30624000|NCT01124292|58635987|FG001|Overall Study|piercing track closed|2|||
30624001|NCT01124292|58635988|FG002|Overall Study|piercing track closed|1|||
30624002|NCT01136772|58636001|FG000|Overall Study|Adverse Event|15|||
30835678|NCT02696564|58860316|FG001|Overall Study|Withdrawal by Subject|2|||
30624003|NCT01136772|58636002|FG001|Overall Study|Adverse Event|14|||
30624004|NCT01136772|58636001|FG000|Overall Study|Lack of Efficacy|42|||
30624005|NCT01136772|58636002|FG001|Overall Study|Lack of Efficacy|39|||
30835679|NCT02696564|58860315|FG000|Overall Study|Lost to Follow-up|3|||
30835680|NCT02696564|58860316|FG001|Overall Study|Lost to Follow-up|3|||
30835681|NCT02696564|58860315|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
30835682|NCT02696564|58860316|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
30835683|NCT02696564|58860315|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
30835684|NCT02696564|58860316|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
30835685|NCT02696564|58860315|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
30835686|NCT02696564|58860316|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
30835687|NCT02696564|58860315|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
30835688|NCT02696564|58860316|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
30835689|NCT02696564|58860315|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
30835690|NCT02696564|58860316|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
30835691|NCT02640950|58860322|FG000|Overall Study|Adverse Event|1|||
30835692|NCT02640950|58860322|FG000|Overall Study|Withdrawal by Subject|1|||
30835693|NCT02593786|58860330|FG000|Overall Study|Disease progression|12|||
30835694|NCT02593786|58860331|FG001|Overall Study|Disease progression|16|||
30835695|NCT02593786|58860332|FG002|Overall Study|Disease progression|10|||
30835696|NCT02593786|58860333|FG003|Overall Study|Disease progression|7|||
30835697|NCT02593786|58860330|FG000|Overall Study|Study drug toxicity|1|||
30835698|NCT02593786|58860331|FG001|Overall Study|Study drug toxicity|0|||
30925803|NCT01990742|58961383|FG000|Overall Study|Withdrawal by facility|407|||
30925804|NCT01990742|58961384|FG001|Overall Study|Withdrawal by facility|1083|||
30925805|NCT01990742|58961383|FG000|Overall Study|Facility closed|0|||
30925806|NCT01990742|58961384|FG001|Overall Study|Facility closed|270|||
30835699|NCT02593786|58860332|FG002|Overall Study|Study drug toxicity|0|||
30835700|NCT02593786|58860333|FG003|Overall Study|Study drug toxicity|0|||
30835701|NCT02593786|58860330|FG000|Overall Study|Adverse event unrelated to study drug|1|||
30925807|NCT02012491|58961392|FG000|Overall Study|Lost to Follow-up|1|||
30925808|NCT02012491|58961393|FG001|Overall Study|Lost to Follow-up|0|||
30925809|NCT02012491|58961392|FG000|Overall Study|Protocol Violation|0|||
30925810|NCT02012491|58961393|FG001|Overall Study|Protocol Violation|1|||
30925811|NCT02012491|58961392|FG000|Overall Study|Withdrawal by Subject|1|||
30925812|NCT02012491|58961393|FG001|Overall Study|Withdrawal by Subject|0|||
30624006|NCT01136772|58636001|FG000|Overall Study|Administrative|14|||
30925813|NCT01990664|58961401|FG000|Overall Study|Lost to Follow-up|2|||
30925814|NCT01990664|58961402|FG001|Overall Study|Lost to Follow-up|6|||
30925815|NCT01990664|58961401|FG000|Overall Study|Withdrawal by Subject|2|||
30925816|NCT01990664|58961402|FG001|Overall Study|Withdrawal by Subject|3|||
30925817|NCT01990664|58961401|FG000|Overall Study|Protocol Violation|1|||
30925818|NCT01990664|58961402|FG001|Overall Study|Protocol Violation|0|||
30925819|NCT01990664|58961401|FG000|Overall Study|Lens Discomfort|1|||
30835702|NCT02593786|58860331|FG001|Overall Study|Adverse event unrelated to study drug|1|||
30835703|NCT02593786|58860332|FG002|Overall Study|Adverse event unrelated to study drug|1|||
30925820|NCT01990664|58961402|FG001|Overall Study|Lens Discomfort|1|||
30925821|NCT01990664|58961401|FG000|Overall Study|Lens Handling Difficulties|1|||
30925822|NCT01990664|58961402|FG001|Overall Study|Lens Handling Difficulties|0|||
30925823|NCT01990664|58961401|FG000|Overall Study|Unsatisfactory Visual Response|0|||
30925824|NCT01990664|58961402|FG001|Overall Study|Unsatisfactory Visual Response|1|||
30925825|NCT02038010|58961408|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
30925826|NCT02038010|58961409|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
30925827|NCT02038010|58961410|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
30925828|NCT02038010|58961411|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
30925829|NCT02038010|58961408|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
30925830|NCT02038010|58961409|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
30925831|NCT02038010|58961410|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
30925832|NCT02038010|58961411|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
30925833|NCT02038010|58961408|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
30925834|NCT02038010|58961409|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
30925835|NCT02038010|58961410|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
30925836|NCT02038010|58961411|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
30925837|NCT02038010|58961408|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
30925838|NCT02038010|58961409|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
30925839|NCT02038010|58961410|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
30925840|NCT02038010|58961411|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
30925841|NCT02038010|58961408|FG000|Follow Up|Death|4|||
30925842|NCT02038010|58961409|FG001|Follow Up|Death|3|||
30925843|NCT02038010|58961410|FG002|Follow Up|Death|0|||
30835704|NCT02593786|58860333|FG003|Overall Study|Adverse event unrelated to study drug|0|||
30925844|NCT02038010|58961411|FG003|Follow Up|Death|0|||
30925845|NCT02038010|58961408|FG000|Follow Up|Other|3|||
30925846|NCT02038010|58961409|FG001|Follow Up|Other|0|||
30925847|NCT02038010|58961410|FG002|Follow Up|Other|0|||
30925848|NCT02038010|58961411|FG003|Follow Up|Other|0|||
30925849|NCT01989572|58961425|FG000|Overall Study|Lack of Efficacy|35|||
30925850|NCT01989572|58961426|FG001|Overall Study|Lack of Efficacy|48|||
30925851|NCT01989572|58961427|FG002|Overall Study|Lack of Efficacy|48|||
30925852|NCT01989572|58961428|FG003|Overall Study|Lack of Efficacy|43|||
30925853|NCT01989572|58961429|FG004|Overall Study|Lack of Efficacy|71|||
30925854|NCT01989572|58961430|FG005|Overall Study|Lack of Efficacy|79|||
30925855|NCT01989572|58961425|FG000|Overall Study|Adverse Event|2|||
30925856|NCT01989572|58961426|FG001|Overall Study|Adverse Event|1|||
30925857|NCT01989572|58961427|FG002|Overall Study|Adverse Event|3|||
30624007|NCT01136772|58636002|FG001|Overall Study|Administrative|12|||
30835705|NCT02593786|58860330|FG000|Overall Study|Participant request to discontinue study therapy|0|||
30835706|NCT02593786|58860331|FG001|Overall Study|Participant request to discontinue study therapy|2|||
30835707|NCT02593786|58860332|FG002|Overall Study|Participant request to discontinue study therapy|0|||
30835708|NCT02593786|58860333|FG003|Overall Study|Participant request to discontinue study therapy|0|||
30835709|NCT02593786|58860330|FG000|Overall Study|Other reasons|1|||
30835710|NCT02593786|58860331|FG001|Overall Study|Other reasons|1|||
30835711|NCT02593786|58860332|FG002|Overall Study|Other reasons|0|||
30835712|NCT02593786|58860333|FG003|Overall Study|Other reasons|5|||
30835713|NCT04829331|58860372|FG000|Overall Study|Lost to Follow-up|1|||
30835714|NCT04829331|58860373|FG001|Overall Study|Lost to Follow-up|0|||
30925858|NCT01989572|58961428|FG003|Overall Study|Adverse Event|0|||
30925859|NCT01989572|58961429|FG004|Overall Study|Adverse Event|3|||
30925860|NCT01989572|58961430|FG005|Overall Study|Adverse Event|0|||
30925861|NCT01989572|58961425|FG000|Overall Study|Death|0|||
30835715|NCT04602546|58860388|FG000|Overall Study|Training|2|||
30925862|NCT01989572|58961426|FG001|Overall Study|Death|0|||
30925863|NCT01989572|58961427|FG002|Overall Study|Death|0|||
30925864|NCT01989572|58961428|FG003|Overall Study|Death|0|||
30624008|NCT01136772|58636001|FG000|Overall Study|Withdrawal by Subject|33|||
30624009|NCT01136772|58636002|FG001|Overall Study|Withdrawal by Subject|36|||
30756961|NCT00389207|58766435|FG001|Overall Study|Other|23|||
30756962|NCT00389207|58766436|FG002|Overall Study|Other|9|||
30756963|NCT00388973|58766451|FG000|Overall Study|Adverse Event|16|||
30756964|NCT00388973|58766452|FG001|Overall Study|Adverse Event|6|||
30756965|NCT00388973|58766451|FG000|Overall Study|Lack of Efficacy|1|||
30835716|NCT04602546|58860389|FG001|Overall Study|Training|2|||
30835717|NCT04602546|58860390|FG002|Overall Study|Training|1|||
30835718|NCT04602546|58860391|FG003|Overall Study|Training|2|||
30835719|NCT04602546|58860392|FG004|Overall Study|Training|0|||
30835720|NCT04602546|58860388|FG000|Overall Study|Randomized with disqualified data|2|||
30756966|NCT00388973|58766452|FG001|Overall Study|Lack of Efficacy|12|||
30756967|NCT00388973|58766451|FG000|Overall Study|Protocol Violation|3|||
30756968|NCT00388973|58766452|FG001|Overall Study|Protocol Violation|0|||
30756969|NCT00388973|58766451|FG000|Overall Study|Withdrawal by Subject|14|||
30756970|NCT00388973|58766452|FG001|Overall Study|Withdrawal by Subject|17|||
30756971|NCT00388973|58766451|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
30756972|NCT00388973|58766452|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
30756973|NCT00388973|58766451|FG000|Overall Study|Did not complete 61 days of treatment|5|||
30756974|NCT00388973|58766452|FG001|Overall Study|Did not complete 61 days of treatment|4|||
30756975|NCT00388973|58766451|FG000|Overall Study|Left region|0|||
30756976|NCT00388973|58766452|FG001|Overall Study|Left region|1|||
30756977|NCT00388973|58766451|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
30756978|NCT00388973|58766452|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
30756979|NCT00388583|58766460|FG000|Overall Study|Protocol Violation|1|||
30756980|NCT00388583|58766461|FG001|Overall Study|Protocol Violation|0|||
30756981|NCT00388583|58766460|FG000|Overall Study|Withdrawal by Subject|3|||
30756982|NCT00388583|58766461|FG001|Overall Study|Withdrawal by Subject|3|||
30756983|NCT00388583|58766460|FG000|Overall Study|Serious Adverse Event|2|||
30756984|NCT00388583|58766461|FG001|Overall Study|Serious Adverse Event|0|||
30756985|NCT00388583|58766460|FG000|Overall Study|Did not receive vaccine|0|||
30756986|NCT00388583|58766461|FG001|Overall Study|Did not receive vaccine|1|||
30756987|NCT00117572|58766469|FG000|Overall Study|Site withdrew before starting treatment|2|||
30756988|NCT00117572|58766470|FG001|Overall Study|Site withdrew before starting treatment|3|||
30756989|NCT00117572|58766469|FG000|Overall Study|Withdrawal by Subject|3|||
30756990|NCT00117572|58766470|FG001|Overall Study|Withdrawal by Subject|3|||
30756991|NCT00117572|58766469|FG000|Overall Study|Protocol Violation|1|||
30756992|NCT00117572|58766470|FG001|Overall Study|Protocol Violation|0|||
30756993|NCT00388505|58766478|FG000|Overall Study|Adverse Event or Death|43|||
30756994|NCT00388505|58766479|FG001|Overall Study|Adverse Event or Death|17|||
30756995|NCT00388505|58766478|FG000|Overall Study|Withdrawal by Subject|24|||
30756996|NCT00388505|58766479|FG001|Overall Study|Withdrawal by Subject|9|||
30756997|NCT00388505|58766478|FG000|Overall Study|Lost to Follow-up|5|||
30835721|NCT04602546|58860389|FG001|Overall Study|Randomized with disqualified data|0|||
30756998|NCT00388505|58766479|FG001|Overall Study|Lost to Follow-up|3|||
30756999|NCT00388505|58766478|FG000|Overall Study|Inappropriate Enrollment|0|||
30835722|NCT04602546|58860390|FG002|Overall Study|Randomized with disqualified data|2|||
30624010|NCT01136772|58636001|FG000|Overall Study|Did not receive injection|10|||
30757000|NCT00388505|58766479|FG001|Overall Study|Inappropriate Enrollment|1|||
30757001|NCT00388505|58766478|FG000|Overall Study|Administrative Reason|1|||
30757002|NCT00388505|58766479|FG001|Overall Study|Administrative Reason|0|||
30757003|NCT00388505|58766478|FG000|Overall Study|Protocol Violation|6|||
30757004|NCT00388505|58766479|FG001|Overall Study|Protocol Violation|5|||
30925865|NCT01989572|58961429|FG004|Overall Study|Death|1|||
30925866|NCT01989572|58961430|FG005|Overall Study|Death|0|||
30925867|NCT01989572|58961425|FG000|Overall Study|Withdrawal by Subject|4|||
30925868|NCT01989572|58961426|FG001|Overall Study|Withdrawal by Subject|1|||
30925869|NCT01989572|58961427|FG002|Overall Study|Withdrawal by Subject|5|||
30925870|NCT01989572|58961428|FG003|Overall Study|Withdrawal by Subject|1|||
30925871|NCT01989572|58961429|FG004|Overall Study|Withdrawal by Subject|12|||
30925872|NCT01989572|58961430|FG005|Overall Study|Withdrawal by Subject|4|||
30925873|NCT01989572|58961425|FG000|Overall Study|complicating disease|1|||
30925874|NCT01989572|58961426|FG001|Overall Study|complicating disease|1|||
30925875|NCT01989572|58961427|FG002|Overall Study|complicating disease|2|||
30925876|NCT01989572|58961428|FG003|Overall Study|complicating disease|0|||
30925877|NCT01989572|58961429|FG004|Overall Study|complicating disease|1|||
30925878|NCT01989572|58961430|FG005|Overall Study|complicating disease|0|||
30925879|NCT01989572|58961425|FG000|Overall Study|error|2|||
30925880|NCT01989572|58961426|FG001|Overall Study|error|1|||
30925881|NCT01989572|58961427|FG002|Overall Study|error|1|||
30925882|NCT01989572|58961428|FG003|Overall Study|error|1|||
30925883|NCT01989572|58961429|FG004|Overall Study|error|1|||
30925884|NCT01989572|58961430|FG005|Overall Study|error|1|||
30925885|NCT01989572|58961425|FG000|Overall Study|maximum dose reached|0|||
30925886|NCT01989572|58961426|FG001|Overall Study|maximum dose reached|1|||
30925887|NCT01989572|58961427|FG002|Overall Study|maximum dose reached|0|||
30925888|NCT01989572|58961428|FG003|Overall Study|maximum dose reached|0|||
30925889|NCT01989572|58961429|FG004|Overall Study|maximum dose reached|1|||
30925890|NCT01989572|58961430|FG005|Overall Study|maximum dose reached|0|||
30925891|NCT01989572|58961425|FG000|Overall Study|unknown/not specify|3|||
30925892|NCT01989572|58961426|FG001|Overall Study|unknown/not specify|4|||
30925893|NCT01989572|58961427|FG002|Overall Study|unknown/not specify|1|||
30925894|NCT01989572|58961428|FG003|Overall Study|unknown/not specify|3|||
30925895|NCT01989572|58961429|FG004|Overall Study|unknown/not specify|3|||
30925896|NCT01989572|58961430|FG005|Overall Study|unknown/not specify|5|||
30925897|NCT01989572|58961425|FG000|Overall Study|not start protocol therapy|5|||
30925898|NCT01989572|58961426|FG001|Overall Study|not start protocol therapy|1|||
30925899|NCT01989572|58961427|FG002|Overall Study|not start protocol therapy|2|||
30835723|NCT04602546|58860391|FG003|Overall Study|Randomized with disqualified data|5|||
30835724|NCT04602546|58860392|FG004|Overall Study|Randomized with disqualified data|3|||
30835725|NCT04102189|58860422|FG000|Overall Study|Withdrawal by Subject|1|||
30835726|NCT04102189|58860423|FG001|Overall Study|Withdrawal by Subject|2|||
30835727|NCT04102189|58860422|FG000|Overall Study|Withdrawal by parent/guardian|0|||
30835728|NCT04102189|58860423|FG001|Overall Study|Withdrawal by parent/guardian|1|||
30925900|NCT01989572|58961428|FG003|Overall Study|not start protocol therapy|3|||
30925901|NCT01989572|58961429|FG004|Overall Study|not start protocol therapy|4|||
30835729|NCT04102189|58860422|FG000|Overall Study|Lost to Follow-up|1|||
30835730|NCT04102189|58860423|FG001|Overall Study|Lost to Follow-up|0|||
30835731|NCT04004988|58860438|FG000|Period 1|Physician Decision|2|||
30835732|NCT04004988|58860439|FG001|Period 1|Physician Decision|0|||
30835733|NCT04004988|58860438|FG000|Period 1|Withdrawal by Subject|0|||
30835734|NCT04004988|58860439|FG001|Period 1|Withdrawal by Subject|1|||
30835735|NCT04004988|58860438|FG000|Period 1|Adverse Event|1|||
30835736|NCT04004988|58860439|FG001|Period 1|Adverse Event|2|||
30835737|NCT03898700|58860446|FG000|Overall Study|Withdrawal by Subject|2|||
30925902|NCT01989572|58961430|FG005|Overall Study|not start protocol therapy|18|||
30925903|NCT01989572|58961425|FG000|Overall Study|alternative therapy|3|||
30925904|NCT01989572|58961426|FG001|Overall Study|alternative therapy|0|||
30925905|NCT01989572|58961427|FG002|Overall Study|alternative therapy|0|||
30925906|NCT01989572|58961428|FG003|Overall Study|alternative therapy|0|||
30925907|NCT01989572|58961429|FG004|Overall Study|alternative therapy|1|||
30925908|NCT01989572|58961430|FG005|Overall Study|alternative therapy|3|||
30925909|NCT02036294|58961450|FG000|Overall Study|Death|7|||
30925910|NCT02036294|58961451|FG001|Overall Study|Death|8|||
30925911|NCT02036294|58961450|FG000|Overall Study|Withdrawal by Subject|2|||
30925912|NCT02036294|58961451|FG001|Overall Study|Withdrawal by Subject|3|||
30925913|NCT02035748|58961457|FG000|Overall Study|Adverse Event|5|||
30835738|NCT03693300|58860452|FG000|Overall Study|Patients ongoing study|43|||
30925914|NCT02035748|58961457|FG000|Overall Study|Death|3|||
30835739|NCT03693300|58860453|FG001|Overall Study|Patients ongoing study|1|||
30835740|NCT03586973|58860472|FG000|Overall Study|Death|15|||
30835741|NCT03586973|58860473|FG001|Overall Study|Death|8|||
30835742|NCT03586973|58860472|FG000|Overall Study|Site Terminated by Sponsor|3|||
30835743|NCT03586973|58860473|FG001|Overall Study|Site Terminated by Sponsor|6|||
30835744|NCT03586973|58860472|FG000|Overall Study|Withdrawal by Subject|1|||
30835745|NCT03586973|58860473|FG001|Overall Study|Withdrawal by Subject|0|||
30835746|NCT03586973|58860472|FG000|Overall Study|Lost to Follow-up|1|||
30835747|NCT03586973|58860473|FG001|Overall Study|Lost to Follow-up|0|||
30835748|NCT03383692|58860481|FG000|Overall Study|Progressive disease as per RECIST|3|||
30835749|NCT03383692|58860482|FG001|Overall Study|Progressive disease as per RECIST|3|||
30835750|NCT03383692|58860481|FG000|Overall Study|Clinical progression|0|||
30835751|NCT03383692|58860482|FG001|Overall Study|Clinical progression|1|||
30835752|NCT03383692|58860481|FG000|Overall Study|Adverse Event|3|||
30835753|NCT03383692|58860482|FG001|Overall Study|Adverse Event|0|||
30835754|NCT02968849|58860492|FG000|Overall Study|Death|8|||
30835755|NCT02968849|58860493|FG001|Overall Study|Death|10|||
30835756|NCT02968849|58860492|FG000|Overall Study|Lost to Follow-up|31|||
30835757|NCT02968849|58860493|FG001|Overall Study|Lost to Follow-up|29|||
30835758|NCT02968849|58860492|FG000|Overall Study|Withdrawal by Subject|73|||
30835759|NCT02968849|58860493|FG001|Overall Study|Withdrawal by Subject|64|||
30835760|NCT02968849|58860492|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
30835761|NCT02968849|58860493|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
30835762|NCT02968849|58860492|FG000|Overall Study|Physician Decision|6|||
30835763|NCT02968849|58860493|FG001|Overall Study|Physician Decision|9|||
30757005|NCT00388505|58766478|FG000|Overall Study|Unable to classify|4|||
30757006|NCT00388505|58766479|FG001|Overall Study|Unable to classify|3|||
30757007|NCT00388349|58766485|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
30757008|NCT00388349|58766486|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
30757009|NCT00117338|58766496|FG000|Overall Study|Adverse Event|0|||
30757010|NCT00117338|58766497|FG001|Overall Study|Adverse Event|1|||
30757011|NCT00117338|58766496|FG000|Overall Study|Protocol Violation|3|||
30757012|NCT00117338|58766497|FG001|Overall Study|Protocol Violation|2|||
30835764|NCT02968849|58860492|FG000|Overall Study|Other|16|||
30835765|NCT02968849|58860493|FG001|Overall Study|Other|10|||
30835766|NCT02669212|58860504|FG000|Overall Study|Lost to Follow-up|1|||
30624011|NCT01136772|58636002|FG001|Overall Study|Did not receive injection|7|||
30757013|NCT00117338|58766496|FG000|Overall Study|Withdrawal by Subject|1|||
30757014|NCT00117338|58766497|FG001|Overall Study|Withdrawal by Subject|0|||
30835767|NCT02669212|58860505|FG001|Overall Study|Lost to Follow-up|0|||
30835768|NCT02669212|58860504|FG000|Overall Study|Medical Condition|3|||
30835769|NCT02669212|58860505|FG001|Overall Study|Medical Condition|4|||
30835770|NCT02669212|58860504|FG000|Overall Study|Withdrawal by Subject|0|||
30835771|NCT02669212|58860505|FG001|Overall Study|Withdrawal by Subject|2|||
30835772|NCT02669212|58860504|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
30835773|NCT02669212|58860505|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
30757015|NCT00117338|58766496|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
30757016|NCT00117338|58766497|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
30757017|NCT00117338|58766496|FG000|Overall Study|Lack of Efficacy|0|||
30757018|NCT00117338|58766497|FG001|Overall Study|Lack of Efficacy|1|||
30757019|NCT00388037|58766503|FG000|Overall Study|Protocol Violation|1|||
30757020|NCT00387881|58766509|FG000|Overall Study|Lost to Follow-up|23|||
30757021|NCT00387881|58766510|FG001|Overall Study|Lost to Follow-up|23|||
30757022|NCT00387881|58766509|FG000|Overall Study|Protocol Violation|2|||
30835774|NCT02536664|58860527|FG000|Overall Study|Inadequate completion of documentation|2|||
30835775|NCT02536664|58860528|FG001|Overall Study|Inadequate completion of documentation|4|||
30835776|NCT02536664|58860527|FG000|Overall Study|Progression|13|||
30835777|NCT02536664|58860528|FG001|Overall Study|Progression|18|||
30624012|NCT01136772|58636001|FG000|Overall Study|Did not follow up after first injection|2|||
30757023|NCT00387881|58766510|FG001|Overall Study|Protocol Violation|12|||
30757024|NCT00387881|58766509|FG000|Overall Study|Withdrawal by Subject|15|||
30835778|NCT02536664|58860527|FG000|Overall Study|Death due to lymphoma|2|||
30835779|NCT02536664|58860528|FG001|Overall Study|Death due to lymphoma|1|||
30835780|NCT02536664|58860527|FG000|Overall Study|Death due to other reason|3|||
30925915|NCT02035748|58961457|FG000|Overall Study|Lost to Follow-up|2|||
30925916|NCT02035748|58961457|FG000|Overall Study|Physician Decision|3|||
30925917|NCT02035748|58961457|FG000|Overall Study|Withdrawal by Subject|6|||
30925918|NCT02035748|58961457|FG000|Overall Study|Progressive Disease|1|||
30925919|NCT02014376|58961465|FG000|Overall Study|Adverse Event|1|||
30925920|NCT02014376|58961466|FG001|Overall Study|Adverse Event|1|||
30925921|NCT02014376|58961467|FG002|Overall Study|Adverse Event|0|||
30757025|NCT00387881|58766510|FG001|Overall Study|Withdrawal by Subject|18|||
30757026|NCT00387881|58766509|FG000|Overall Study|Sponsor terminated Study|0|||
30757027|NCT00387881|58766510|FG001|Overall Study|Sponsor terminated Study|1|||
30757028|NCT00387881|58766509|FG000|Overall Study|Not eligible|6|||
30757029|NCT00387881|58766510|FG001|Overall Study|Not eligible|7|||
30757030|NCT00387881|58766509|FG000|Overall Study|No opportunity to treat headache|32|||
30757031|NCT00387881|58766510|FG001|Overall Study|No opportunity to treat headache|34|||
30757032|NCT00387881|58766509|FG000|Overall Study|Not otherwise specified|11|||
30757033|NCT00387881|58766510|FG001|Overall Study|Not otherwise specified|7|||
30757034|NCT00084656|58766519|FG000|Overall Study|Other reasons|0|||
30835781|NCT02536664|58860528|FG001|Overall Study|Death due to other reason|2|||
30835782|NCT02536664|58860527|FG000|Overall Study|Intolerability|8|||
30835783|NCT02536664|58860528|FG001|Overall Study|Intolerability|6|||
30835784|NCT02536664|58860527|FG000|Overall Study|Withdrawal by Subject|8|||
30835785|NCT02536664|58860528|FG001|Overall Study|Withdrawal by Subject|5|||
30835786|NCT02536664|58860527|FG000|Overall Study|Other|18|||
30835787|NCT02536664|58860528|FG001|Overall Study|Other|24|||
30835788|NCT02536664|58860527|FG000|Overall Study|Missing|53|||
30835789|NCT02536664|58860528|FG001|Overall Study|Missing|20|||
30835790|NCT02426892|58860534|FG000|Overall Study|Adverse Event|2|||
30835791|NCT02426892|58860534|FG000|Overall Study|Lack of Efficacy|17|||
30835792|NCT02426892|58860534|FG000|Overall Study|Withdrawal by Subject|1|||
30835793|NCT02312687|58860538|FG000|Overall Study|Other, Not Specified|1|||
30835794|NCT02304367|58860542|FG000|Overall Study|Lack of Response to Bruosumab|1|||
30835795|NCT02304367|58860542|FG000|Overall Study|Sponsor Decision|3|||
30835796|NCT02304367|58860542|FG000|Overall Study|Death|2|||
30835797|NCT02304367|58860542|FG000|Overall Study|Physician Decision|1|||
30925922|NCT02014376|58961465|FG000|Overall Study|Lost to Follow-up|2|||
30757035|NCT00084656|58766520|FG001|Overall Study|Other reasons|12|||
30757036|NCT00084656|58766521|FG002|Overall Study|Other reasons|11|||
30757037|NCT00084656|58766519|FG000|Overall Study|Withdrawal by Subject|15|||
30757038|NCT00084656|58766520|FG001|Overall Study|Withdrawal by Subject|4|||
30757039|NCT00084656|58766521|FG002|Overall Study|Withdrawal by Subject|4|||
30757040|NCT00084656|58766519|FG000|Overall Study|Disease relapse|0|||
30757041|NCT00084656|58766520|FG001|Overall Study|Disease relapse|9|||
30757042|NCT00084656|58766521|FG002|Overall Study|Disease relapse|10|||
30757043|NCT00084656|58766519|FG000|Overall Study|Disease progression|9|||
30757044|NCT00084656|58766520|FG001|Overall Study|Disease progression|0|||
30757045|NCT00084656|58766521|FG002|Overall Study|Disease progression|0|||
30757046|NCT00084656|58766519|FG000|Overall Study|Lost to Follow-up|1|||
30835798|NCT02304367|58860542|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
30835799|NCT02107703|58860555|FG000|Overall Study|Withdrawal by Subject|36|||
30835800|NCT02107703|58860556|FG001|Overall Study|Withdrawal by Subject|19|||
30835801|NCT02107703|58860555|FG000|Overall Study|Lost to Follow-up|6|||
30835802|NCT02107703|58860556|FG001|Overall Study|Lost to Follow-up|4|||
30835803|NCT02107703|58860555|FG000|Overall Study|On study treatment/follow up|319|||
30835804|NCT02107703|58860556|FG001|Overall Study|On study treatment/follow up|152|||
30925923|NCT02014376|58961466|FG001|Overall Study|Lost to Follow-up|0|||
30925924|NCT02014376|58961467|FG002|Overall Study|Lost to Follow-up|0|||
30925925|NCT02035202|58961478|FG000|Overall Study|Lost to Follow-up|8|||
30925926|NCT02035202|58961479|FG001|Overall Study|Lost to Follow-up|16|||
30925927|NCT02035202|58961480|FG002|Overall Study|Lost to Follow-up|2|||
30925928|NCT01988402|58961490|FG000|Overall Study|Adverse Event|1|||
30925929|NCT01988402|58961491|FG001|Overall Study|Adverse Event|2|||
30925930|NCT01988402|58961490|FG000|Overall Study|Withdrawal by Subject|1|||
30757047|NCT00084656|58766520|FG001|Overall Study|Lost to Follow-up|0|||
30757048|NCT00084656|58766521|FG002|Overall Study|Lost to Follow-up|1|||
30757049|NCT00387725|58766535|FG000|Overall Study|Adverse Event|0|||
30757050|NCT00387725|58766536|FG001|Overall Study|Adverse Event|0|||
30835805|NCT02054520|58860571|FG000|Overall Study|Adverse Event|1|||
30757051|NCT00387725|58766537|FG002|Overall Study|Adverse Event|0|||
30925931|NCT01988402|58961491|FG001|Overall Study|Withdrawal by Subject|0|||
30925932|NCT01988090|58961499|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
30925933|NCT01988090|58961500|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
30925934|NCT01988090|58961499|FG000|Start Treament After Randomization|Protocol Violation|0|||
30925935|NCT01988090|58961500|FG001|Start Treament After Randomization|Protocol Violation|1|||
30925936|NCT01988090|58961499|FG000|Complete Study After Start|Withdrawal by Subject|2|||
30925937|NCT01988090|58961500|FG001|Complete Study After Start|Withdrawal by Subject|0|||
30925938|NCT01988090|58961499|FG000|Complete Study After Start|Protocol Violation|1|||
30925939|NCT01988090|58961500|FG001|Complete Study After Start|Protocol Violation|1|||
30925940|NCT01988012|58961506|FG000|Overall Study|Adverse Event|5|||
30925941|NCT01988012|58961506|FG000|Overall Study|Insufficient Therapeutic Response|3|||
30925942|NCT01988012|58961506|FG000|Overall Study|Patient Withdrawal of Consent|4|||
30925943|NCT01988012|58961506|FG000|Overall Study|Lost to Follow-up|1|||
30925944|NCT01988012|58961506|FG000|Overall Study|Physician Decision|1|||
30925945|NCT01988012|58961506|FG000|Overall Study|Protocol Violation|1|||
30925946|NCT02011945|58961513|FG000|Overall Study|Participant requested to Discontinue|0|||
30925947|NCT02011945|58961514|FG001|Overall Study|Participant requested to Discontinue|1|||
30925948|NCT02011945|58961515|FG002|Overall Study|Participant requested to Discontinue|1|||
30925949|NCT02011945|58961513|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
30925950|NCT02011945|58961514|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
30925951|NCT02011945|58961515|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
30925952|NCT02011945|58961513|FG000|Overall Study|Study Drug Toxicity|0|||
30925953|NCT02011945|58961514|FG001|Overall Study|Study Drug Toxicity|0|||
30925954|NCT02011945|58961515|FG002|Overall Study|Study Drug Toxicity|1|||
30925955|NCT02011945|58961513|FG000|Overall Study|Treatment Failure|0|||
30925956|NCT02011945|58961514|FG001|Overall Study|Treatment Failure|7|||
30925957|NCT02011945|58961515|FG002|Overall Study|Treatment Failure|6|||
30925958|NCT02011945|58961513|FG000|Overall Study|No Longer Meets Study Criteria|1|||
30925959|NCT02011945|58961514|FG001|Overall Study|No Longer Meets Study Criteria|0|||
30925960|NCT02011945|58961515|FG002|Overall Study|No Longer Meets Study Criteria|0|||
30925961|NCT02011945|58961513|FG000|Overall Study|Proceeded to stem cell transplant|0|||
30925962|NCT02011945|58961514|FG001|Overall Study|Proceeded to stem cell transplant|0|||
30925963|NCT02011945|58961515|FG002|Overall Study|Proceeded to stem cell transplant|1|||
30925964|NCT02011945|58961513|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
30925965|NCT02011945|58961514|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
30925966|NCT02011945|58961515|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
30925967|NCT02013830|58961523|FG000|Overall Study|Adverse Event|3|||
30925968|NCT02013830|58961523|FG000|Overall Study|Death|1|||
30925969|NCT02013830|58961523|FG000|Overall Study|Insufficient therapeutic response|25|||
30925970|NCT02013830|58961523|FG000|Overall Study|Refused treatment|1|||
30925971|NCT02010775|58961532|FG000|Overall Study|Adverse Event|0|||
30925972|NCT02010775|58961533|FG001|Overall Study|Adverse Event|0|||
30925973|NCT02010775|58961534|FG002|Overall Study|Adverse Event|0|||
30925974|NCT02010775|58961535|FG003|Overall Study|Adverse Event|0|||
30925975|NCT02010775|58961536|FG004|Overall Study|Adverse Event|1|||
30925976|NCT02010775|58961532|FG000|Overall Study|Pregnancy|0|||
30925977|NCT02010775|58961533|FG001|Overall Study|Pregnancy|0|||
30925978|NCT02010775|58961534|FG002|Overall Study|Pregnancy|2|||
30925979|NCT02010775|58961535|FG003|Overall Study|Pregnancy|0|||
30925980|NCT02010775|58961536|FG004|Overall Study|Pregnancy|0|||
30925981|NCT02010775|58961532|FG000|Overall Study|Lost to Follow-up|2|||
30925982|NCT02010775|58961533|FG001|Overall Study|Lost to Follow-up|0|||
30925983|NCT02010775|58961534|FG002|Overall Study|Lost to Follow-up|0|||
30925984|NCT02010775|58961535|FG003|Overall Study|Lost to Follow-up|1|||
30925985|NCT02010775|58961536|FG004|Overall Study|Lost to Follow-up|1|||
30925986|NCT02010775|58961532|FG000|Overall Study|Personal Reasons|3|||
30925987|NCT02010775|58961533|FG001|Overall Study|Personal Reasons|3|||
30925988|NCT02010775|58961534|FG002|Overall Study|Personal Reasons|1|||
30925989|NCT02010775|58961535|FG003|Overall Study|Personal Reasons|2|||
30925990|NCT02010775|58961536|FG004|Overall Study|Personal Reasons|4|||
30925991|NCT01993615|58961550|FG000|Overall Study|Death|1|||
30925992|NCT01993615|58961551|FG001|Overall Study|Death|0|||
30925993|NCT01619059|58961559|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
30925994|NCT01619059|58961560|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
30925995|NCT01619059|58961559|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
30925996|NCT01619059|58961560|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
30925997|NCT01619059|58961559|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
30925998|NCT01619059|58961560|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
30925999|NCT01619059|58961559|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
30926000|NCT01619059|58961560|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
30926001|NCT01619059|58961559|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
30926002|NCT01619059|58961560|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
30926003|NCT01619059|58961559|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
30926004|NCT01619059|58961560|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
30926005|NCT01619059|58961559|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
30835806|NCT02054520|58860572|FG001|Overall Study|Adverse Event|4|||
30835807|NCT02054520|58860573|FG002|Overall Study|Adverse Event|2|||
30835808|NCT02054520|58860574|FG003|Overall Study|Adverse Event|1|||
30835809|NCT02054520|58860575|FG004|Overall Study|Adverse Event|1|||
30835810|NCT02054520|58860576|FG005|Overall Study|Adverse Event|0|||
30835811|NCT02054520|58860571|FG000|Overall Study|Lack of Efficacy|7|||
30926006|NCT01619059|58961560|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
30926007|NCT01619059|58961559|FG000|Long-Term (LT) Treatment Period|Death|1|||
30926008|NCT01619059|58961560|FG001|Long-Term (LT) Treatment Period|Death|0|||
30926009|NCT01619059|58961559|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
30926010|NCT01619059|58961560|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
30926011|NCT01619059|58961559|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
30926012|NCT01619059|58961560|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
30926013|NCT02013206|58961568|FG000|Overall Study|Progressive disease (PD)|14|||
30926014|NCT02013206|58961569|FG001|Overall Study|Progressive disease (PD)|17|||
30926015|NCT02013206|58961568|FG000|Overall Study|Symptomatic deterioration|3|||
30926016|NCT02013206|58961569|FG001|Overall Study|Symptomatic deterioration|1|||
30926017|NCT02013206|58961568|FG000|Overall Study|Adverse Event|1|||
30926018|NCT02013206|58961569|FG001|Overall Study|Adverse Event|0|||
30835812|NCT02054520|58860572|FG001|Overall Study|Lack of Efficacy|0|||
30835813|NCT02054520|58860573|FG002|Overall Study|Lack of Efficacy|2|||
30926019|NCT02013206|58961568|FG000|Overall Study|Patient refusal|2|||
30926020|NCT02013206|58961569|FG001|Overall Study|Patient refusal|0|||
30926021|NCT02013206|58961568|FG000|Overall Study|Patient non-compliance|1|||
30926022|NCT02013206|58961569|FG001|Overall Study|Patient non-compliance|0|||
30926023|NCT02013206|58961568|FG000|Overall Study|Death|1|||
30926024|NCT02013206|58961569|FG001|Overall Study|Death|2|||
30926025|NCT02013206|58961568|FG000|Overall Study|Other reasons off treatment|5|||
30926026|NCT02013206|58961569|FG001|Overall Study|Other reasons off treatment|2|||
30835814|NCT02054520|58860574|FG003|Overall Study|Lack of Efficacy|1|||
30835815|NCT02054520|58860575|FG004|Overall Study|Lack of Efficacy|3|||
30835816|NCT02054520|58860576|FG005|Overall Study|Lack of Efficacy|2|||
30835817|NCT02054520|58860571|FG000|Overall Study|Withdrawal by Subject|1|||
30835818|NCT02054520|58860572|FG001|Overall Study|Withdrawal by Subject|0|||
30835819|NCT02054520|58860573|FG002|Overall Study|Withdrawal by Subject|0|||
30835820|NCT02054520|58860574|FG003|Overall Study|Withdrawal by Subject|2|||
30926027|NCT01807923|58961578|FG000|Overall Study|Adverse Event|2|||
30926028|NCT01807923|58961579|FG001|Overall Study|Adverse Event|1|||
30926029|NCT01807923|58961580|FG002|Overall Study|Adverse Event|2|||
30926030|NCT01807923|58961578|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
30926031|NCT01807923|58961579|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
30926032|NCT01807923|58961580|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
30835821|NCT02054520|58860575|FG004|Overall Study|Withdrawal by Subject|1|||
30835822|NCT02054520|58860576|FG005|Overall Study|Withdrawal by Subject|0|||
30835823|NCT02054520|58860571|FG000|Overall Study|Physician Decision|0|||
30835824|NCT02054520|58860572|FG001|Overall Study|Physician Decision|1|||
30835825|NCT02054520|58860573|FG002|Overall Study|Physician Decision|0|||
30835826|NCT02054520|58860574|FG003|Overall Study|Physician Decision|1|||
30835827|NCT02054520|58860575|FG004|Overall Study|Physician Decision|0|||
30926033|NCT01807923|58961578|FG000|Overall Study|Physician Decision|0|||
30926034|NCT01807923|58961579|FG001|Overall Study|Physician Decision|0|||
30926035|NCT01807923|58961580|FG002|Overall Study|Physician Decision|1|||
30926036|NCT01807923|58961578|FG000|Overall Study|Not Eligible (Genotype)|0|||
30926037|NCT01807923|58961579|FG001|Overall Study|Not Eligible (Genotype)|0|||
30926038|NCT01807923|58961580|FG002|Overall Study|Not Eligible (Genotype)|1|||
30926039|NCT01807923|58961578|FG000|Overall Study|Randomized But Not Treated|3|||
30926040|NCT01807923|58961579|FG001|Overall Study|Randomized But Not Treated|2|||
30926041|NCT01807923|58961580|FG002|Overall Study|Randomized But Not Treated|5|||
30926042|NCT01966003|58961592|FG000|Overall Study|Death|43|||
30926043|NCT01966003|58961593|FG001|Overall Study|Death|36|||
30926044|NCT01966003|58961592|FG000|Overall Study|Protocol Violation|6|||
30926045|NCT01966003|58961593|FG001|Overall Study|Protocol Violation|4|||
30926046|NCT01966003|58961592|FG000|Overall Study|Lost to Follow-up|4|||
30926047|NCT01966003|58961593|FG001|Overall Study|Lost to Follow-up|3|||
30926048|NCT01966003|58961592|FG000|Overall Study|Physician Decision|12|||
30926049|NCT01966003|58961593|FG001|Overall Study|Physician Decision|13|||
30926050|NCT01966003|58961592|FG000|Overall Study|Withdrawal by Subject|29|||
30926051|NCT01966003|58961593|FG001|Overall Study|Withdrawal by Subject|19|||
30926052|NCT01966003|58961592|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
30926053|NCT01966003|58961593|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
30926054|NCT01966003|58961592|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
30926055|NCT01966003|58961593|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
30926056|NCT01966003|58961592|FG000|Overall Study|Other|1|||
30926057|NCT01966003|58961593|FG001|Overall Study|Other|1|||
30926058|NCT01839279|58961602|FG000|Overall Study|Adverse Event|4|||
30926059|NCT01839279|58961603|FG001|Overall Study|Adverse Event|1|||
30926060|NCT01839279|58961604|FG002|Overall Study|Adverse Event|1|||
30926061|NCT01839279|58961602|FG000|Overall Study|Withdrawal by Subject|4|||
30926062|NCT01839279|58961603|FG001|Overall Study|Withdrawal by Subject|1|||
30926063|NCT01839279|58961604|FG002|Overall Study|Withdrawal by Subject|1|||
30926064|NCT01839279|58961602|FG000|Overall Study|Classified as 'Other'|5|||
30926065|NCT01839279|58961603|FG001|Overall Study|Classified as 'Other'|0|||
30926066|NCT01839279|58961604|FG002|Overall Study|Classified as 'Other'|0|||
30926067|NCT01807299|58961623|FG000|Overall Study|Protocol Violation|3|||
30926068|NCT01807299|58961624|FG001|Overall Study|Protocol Violation|1|||
30926069|NCT01807299|58961625|FG002|Overall Study|Protocol Violation|0|||
30926070|NCT01807299|58961626|FG003|Overall Study|Protocol Violation|2|||
30926071|NCT01965535|58961638|FG000|Overall Study|Lack of Efficacy|2|||
30926072|NCT01965535|58961639|FG001|Overall Study|Lack of Efficacy|1|||
30926073|NCT01964755|58961645|FG000|Overall Study|Death|2|||
30926074|NCT01964521|58961649|FG000|Overall Study|Lost to Follow-up|4|||
30926075|NCT01992757|58961654|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
30926076|NCT01991743|58961663|FG000|Overall Study|external cephalic version not performed|0|||
30926077|NCT01991743|58961664|FG001|Overall Study|external cephalic version not performed|0|||
30926078|NCT01991743|58961665|FG002|Overall Study|external cephalic version not performed|1|||
30926079|NCT01991743|58961666|FG003|Overall Study|external cephalic version not performed|0|||
30926080|NCT01991197|58961678|FG000|Overall Study|Lost to Follow-up|1|||
30926081|NCT01991197|58961679|FG001|Overall Study|Lost to Follow-up|1|||
30926082|NCT01991197|58961678|FG000|Overall Study|Physician Decision|0|||
30926083|NCT01991197|58961679|FG001|Overall Study|Physician Decision|2|||
30926084|NCT01991197|58961678|FG000|Overall Study|Withdrawal by Subject|2|||
30926085|NCT01991197|58961679|FG001|Overall Study|Withdrawal by Subject|0|||
30926086|NCT01990573|58961693|FG000|Overall Study|Physician Decision|0|||
30926087|NCT01990573|58961694|FG001|Overall Study|Physician Decision|0|||
30926088|NCT01990573|58961695|FG002|Overall Study|Physician Decision|1|||
30926089|NCT01990495|58961705|FG000|Overall Study|Physician Decision|5|||
30926090|NCT01990495|58961706|FG001|Overall Study|Physician Decision|4|||
30926091|NCT01990339|58961714|FG000|Overall Study|Data Not Available|49|||
30926092|NCT01990339|58961714|FG000|Overall Study|Voluntary Withdrawal|1402|||
30926093|NCT01990339|58961714|FG000|Overall Study|Lost to Follow-up|861|||
30926094|NCT02007577|58961720|FG000|Overall Study|Adverse Event|1|||
30926095|NCT02007577|58961721|FG001|Overall Study|Adverse Event|0|||
30926096|NCT02007577|58961720|FG000|Overall Study|Withdrawal by Subject|0|||
30926097|NCT02007577|58961721|FG001|Overall Study|Withdrawal by Subject|1|||
30926098|NCT01990261|58961727|FG000|Overall Study|Death Before Treatment Start|2|||
30926099|NCT01990261|58961727|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
30926100|NCT01990261|58961727|FG000|Overall Study|Death From other Causes|1|||
30624013|NCT01136772|58636002|FG001|Overall Study|Did not follow up after first injection|2|||
30624014|NCT00909532|58636010|FG000|Overall Study|Adverse Event|4|||
30926101|NCT01990261|58961727|FG000|Overall Study|Disease Progression (PD)|8|||
30926102|NCT01990261|58961727|FG000|Overall Study|PD Before Treatment Start|1|||
30926103|NCT01990261|58961727|FG000|Overall Study|Dossier not Approved|1|||
30926104|NCT01990261|58961727|FG000|Overall Study|Lost to Follow-up|2|||
30926105|NCT01963117|58961731|FG000|Overall Study|Death|1|||
30926106|NCT02007109|58961735|FG000|Overall Study|Diary not returned or excluded|102|||
30926107|NCT02007109|58961735|FG000|Overall Study|Excluded - Age<7yo|9|||
30926108|NCT02006719|58961744|FG000|Overall Study|Withdrawal by Subject|10|||
30926109|NCT02006719|58961745|FG001|Overall Study|Withdrawal by Subject|2|||
30926110|NCT02006719|58961744|FG000|Overall Study|Lost to Follow-up|5|||
30926111|NCT02006719|58961745|FG001|Overall Study|Lost to Follow-up|1|||
30835828|NCT02054520|58860576|FG005|Overall Study|Physician Decision|1|||
30835829|NCT02054520|58860571|FG000|Overall Study|Study terminated by Sponsor|0|||
30835830|NCT02054520|58860572|FG001|Overall Study|Study terminated by Sponsor|0|||
30835831|NCT02054520|58860573|FG002|Overall Study|Study terminated by Sponsor|2|||
30926112|NCT02006719|58961744|FG000|Overall Study|Protocol Violation|2|||
30926113|NCT02006719|58961745|FG001|Overall Study|Protocol Violation|0|||
30926114|NCT02006719|58961744|FG000|Overall Study|Adverse Event|1|||
30926115|NCT02006719|58961745|FG001|Overall Study|Adverse Event|1|||
30926116|NCT02006719|58961744|FG000|Overall Study|Other/Unknown|0|||
30926117|NCT02006719|58961745|FG001|Overall Study|Other/Unknown|1|||
30835832|NCT02054520|58860574|FG003|Overall Study|Study terminated by Sponsor|1|||
30835833|NCT02054520|58860575|FG004|Overall Study|Study terminated by Sponsor|0|||
30835834|NCT02054520|58860576|FG005|Overall Study|Study terminated by Sponsor|0|||
30835835|NCT01546987|58860605|FG000|Overall Study|Protocol Violation|3|||
30835836|NCT01546987|58860606|FG001|Overall Study|Protocol Violation|4|||
30835837|NCT00261443|58860629|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
30835838|NCT00261443|58860630|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
30835839|NCT00261443|58860631|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
30835840|NCT00261443|58860629|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
30835841|NCT00261443|58860630|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
30835842|NCT00261443|58860631|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
30835843|NCT00261443|58860629|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
30835844|NCT00261443|58860630|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
30835845|NCT00261443|58860631|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
30926118|NCT01962493|58961753|FG000|Overall Study|Adverse Event|1|||
30926119|NCT01962493|58961754|FG001|Overall Study|Adverse Event|2|||
30926120|NCT01962493|58961753|FG000|Overall Study|Protocol Violation|0|||
30926121|NCT01962493|58961754|FG001|Overall Study|Protocol Violation|1|||
30926122|NCT01962493|58961753|FG000|Overall Study|Withdrawal by Subject|4|||
30926123|NCT01962493|58961754|FG001|Overall Study|Withdrawal by Subject|2|||
30926124|NCT01989169|58961762|FG000|Period 2|Adverse Event|0|||
30926125|NCT01989169|58961763|FG001|Period 2|Adverse Event|1|||
30926126|NCT01988779|58961771|FG000|Overall Study|Withdrawal by Subject|2|||
30926127|NCT01988779|58961772|FG001|Overall Study|Withdrawal by Subject|2|||
30926128|NCT01988779|58961771|FG000|Overall Study|Protocol Violation|1|||
30926129|NCT01988779|58961772|FG001|Overall Study|Protocol Violation|0|||
30926130|NCT01988233|58961780|FG000|Overall Study|Lost to Follow-up|64|||
30926131|NCT01988233|58961781|FG001|Overall Study|Lost to Follow-up|51|||
30926132|NCT01987765|58961787|FG000|Overall Study|Protocol Violation|65|||
30926133|NCT01987765|58961787|FG000|Overall Study|Lost to Follow-up|37|||
30926134|NCT01987609|58961791|FG000|Overall Study|Adverse Event|1|||
30926135|NCT02013674|58961807|FG000|Overall Study|Death|0|||
30926136|NCT02013674|58961808|FG001|Overall Study|Death|1|||
30926137|NCT02013674|58961807|FG000|Overall Study|Lost to Follow-up|1|||
30926138|NCT02013674|58961808|FG001|Overall Study|Lost to Follow-up|0|||
30926139|NCT01987232|58961819|FG000|Overall Study|Ongoing in Study|0|||
30926140|NCT01987232|58961820|FG001|Overall Study|Ongoing in Study|0|||
30926141|NCT01987232|58961821|FG002|Overall Study|Ongoing in Study|0|||
30926142|NCT01987232|58961822|FG003|Overall Study|Ongoing in Study|1|||
30926143|NCT01987232|58961823|FG004|Overall Study|Ongoing in Study|0|||
30926144|NCT01986920|58961837|FG000|A- 101 25%|Withdrawal by Subject|1|||
30926145|NCT01986920|58961838|FG001|A- 101 25%|Withdrawal by Subject|0|||
30835846|NCT00261443|58860629|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
30926146|NCT01986920|58961839|FG002|A- 101 25%|Withdrawal by Subject|0|||
30926147|NCT01986920|58961840|FG003|A- 101 25%|Withdrawal by Subject|0|||
30926148|NCT01986920|58961837|FG000|A-101 32.5%|Withdrawal by Subject|0|||
30926149|NCT01986920|58961838|FG001|A-101 32.5%|Withdrawal by Subject|1|||
30926150|NCT01986920|58961839|FG002|A-101 32.5%|Withdrawal by Subject|0|||
30926151|NCT01986920|58961840|FG003|A-101 32.5%|Withdrawal by Subject|0|||
30926152|NCT01986920|58961837|FG000|A-101 40%|Withdrawal by Subject|0|||
30926153|NCT01986920|58961838|FG001|A-101 40%|Withdrawal by Subject|0|||
30624015|NCT00909532|58636011|FG001|Overall Study|Adverse Event|1|||
30926154|NCT01986920|58961839|FG002|A-101 40%|Withdrawal by Subject|1|||
30926155|NCT01986920|58961840|FG003|A-101 40%|Withdrawal by Subject|0|||
30926156|NCT01986920|58961837|FG000|Placebo|Withdrawal by Subject|0|||
30926157|NCT01986920|58961838|FG001|Placebo|Withdrawal by Subject|0|||
30926158|NCT01986920|58961839|FG002|Placebo|Withdrawal by Subject|0|||
30926159|NCT01986920|58961840|FG003|Placebo|Withdrawal by Subject|1|||
30926160|NCT02010632|58961850|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
30926161|NCT02010632|58961851|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
30926162|NCT01986140|58961859|FG000|Overall Study|Withdrawal by Subject|31|||
30926163|NCT01986140|58961860|FG001|Overall Study|Withdrawal by Subject|25|||
30926164|NCT01986140|58961859|FG000|Overall Study|alternative treatment|1|||
30926165|NCT01986140|58961860|FG001|Overall Study|alternative treatment|1|||
30926166|NCT01986140|58961859|FG000|Overall Study|found not eligible|3|||
30926167|NCT01986140|58961860|FG001|Overall Study|found not eligible|0|||
30926168|NCT01986140|58961859|FG000|Overall Study|Adverse Event|0|||
30926169|NCT01986140|58961860|FG001|Overall Study|Adverse Event|1|||
30926170|NCT01986140|58961859|FG000|Overall Study|progression disease|0|||
30926171|NCT01986140|58961860|FG001|Overall Study|progression disease|1|||
30926172|NCT01986062|58961868|FG000|Overall Study|Lost to Follow-up|1|||
30926173|NCT01986062|58961869|FG001|Overall Study|Lost to Follow-up|0|||
30926174|NCT01986062|58961868|FG000|Overall Study|Withdrawal by Subject|0|||
30926175|NCT01986062|58961869|FG001|Overall Study|Withdrawal by Subject|1|||
30926176|NCT01985360|58961877|FG000|Overall Study|Withdrawal by Subject|4|||
30926177|NCT01985360|58961878|FG001|Overall Study|Withdrawal by Subject|0|||
30926178|NCT01985360|58961877|FG000|Overall Study|Lost to Follow-up|5|||
30926179|NCT01985360|58961878|FG001|Overall Study|Lost to Follow-up|3|||
30926180|NCT02032706|58961884|FG000|Overall Study|Did not qualify|5|||
30926181|NCT02032706|58961884|FG000|Overall Study|Protocol Violation|1|||
30926182|NCT02032238|58961890|FG000|Overall Study|Lost to Follow-up|2|||
30926183|NCT02032238|58961891|FG001|Overall Study|Lost to Follow-up|0|||
30926184|NCT02009930|58961897|FG000|Overall Study|withdrawn|5|||
30926185|NCT01985126|58961910|FG000|Overall Study|Death|15|||
30926186|NCT01985126|58961911|FG001|Overall Study|Death|69|||
30926187|NCT01985126|58961910|FG000|Overall Study|Lost to Follow-up|0|||
30926188|NCT01985126|58961911|FG001|Overall Study|Lost to Follow-up|8|||
30835847|NCT00261443|58860630|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
30835848|NCT00261443|58860631|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
30835849|NCT00261443|58860629|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
30835850|NCT00261443|58860630|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
30835851|NCT00261443|58860631|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
30835852|NCT00261443|58860629|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
30835853|NCT00261443|58860630|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
30835854|NCT00261443|58860631|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
30835855|NCT00261443|58860629|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
30835856|NCT00261443|58860630|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
30835857|NCT00261443|58860631|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
30835858|NCT00261443|58860629|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
30835859|NCT00261443|58860630|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
30835860|NCT00261443|58860631|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
30835861|NCT00261443|58860629|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
30835862|NCT00261443|58860630|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
30835863|NCT00261443|58860631|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
30835864|NCT00261443|58860629|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
30835865|NCT00261443|58860630|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
30835866|NCT00261443|58860631|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
30835867|NCT00261443|58860629|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
30835868|NCT00261443|58860630|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
30835869|NCT00261443|58860631|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
30835870|NCT00261443|58860629|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
30835871|NCT00261443|58860630|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
30835872|NCT00261443|58860631|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
30926189|NCT01985126|58961910|FG000|Overall Study|Study Terminated By Sponsor|1|||
30926190|NCT01985126|58961911|FG001|Overall Study|Study Terminated By Sponsor|22|||
30926191|NCT01985126|58961910|FG000|Overall Study|Withdrawal by Subject|2|||
30926192|NCT01985126|58961911|FG001|Overall Study|Withdrawal by Subject|7|||
30926193|NCT01984892|58961917|FG000|Overall Study|Progressive disease|7|||
30926194|NCT01807221|58961927|FG000|Overall Study|Progressive disease|1|||
30926195|NCT01807221|58961928|FG001|Overall Study|Progressive disease|0|||
30926196|NCT01807221|58961929|FG002|Overall Study|Progressive disease|1|||
30926197|NCT01807221|58961930|FG003|Overall Study|Progressive disease|0|||
30926198|NCT01807221|58961931|FG004|Overall Study|Progressive disease|0|||
30926199|NCT01807221|58961932|FG005|Overall Study|Progressive disease|0|||
30926200|NCT01807221|58961927|FG000|Overall Study|Death|7|||
30926201|NCT01807221|58961928|FG001|Overall Study|Death|9|||
30926202|NCT01807221|58961929|FG002|Overall Study|Death|4|||
30926203|NCT01807221|58961930|FG003|Overall Study|Death|2|||
30624016|NCT00909532|58636010|FG000|Overall Study|Pregnancy|0|||
30757052|NCT00387725|58766538|FG003|Overall Study|Adverse Event|1|||
30757053|NCT00387725|58766535|FG000|Overall Study|Protocol Violation|0|||
30926204|NCT01807221|58961931|FG004|Overall Study|Death|1|||
30926205|NCT01807221|58961932|FG005|Overall Study|Death|6|||
30926206|NCT01807221|58961927|FG000|Overall Study|Physician Decision|2|||
30926207|NCT01807221|58961928|FG001|Overall Study|Physician Decision|1|||
30926208|NCT01807221|58961929|FG002|Overall Study|Physician Decision|0|||
30926209|NCT01807221|58961930|FG003|Overall Study|Physician Decision|0|||
30926210|NCT01807221|58961931|FG004|Overall Study|Physician Decision|0|||
30926211|NCT01807221|58961932|FG005|Overall Study|Physician Decision|0|||
30926212|NCT01807221|58961927|FG000|Overall Study|Adverse Event|33|||
30926213|NCT01807221|58961928|FG001|Overall Study|Adverse Event|22|||
30757054|NCT00387725|58766536|FG001|Overall Study|Protocol Violation|1|||
30757055|NCT00387725|58766537|FG002|Overall Study|Protocol Violation|0|||
30757056|NCT00387725|58766538|FG003|Overall Study|Protocol Violation|0|||
30757057|NCT00387725|58766535|FG000|Overall Study|Withdrawal by Subject|1|||
30757058|NCT00387725|58766536|FG001|Overall Study|Withdrawal by Subject|0|||
30757059|NCT00387725|58766537|FG002|Overall Study|Withdrawal by Subject|1|||
30757060|NCT00387725|58766538|FG003|Overall Study|Withdrawal by Subject|0|||
30757061|NCT00387725|58766535|FG000|Overall Study|Parent/legal guardian request|0|||
30757062|NCT00387725|58766536|FG001|Overall Study|Parent/legal guardian request|0|||
30757063|NCT00387725|58766537|FG002|Overall Study|Parent/legal guardian request|1|||
30757064|NCT00387725|58766538|FG003|Overall Study|Parent/legal guardian request|1|||
30926214|NCT01807221|58961929|FG002|Overall Study|Adverse Event|26|||
30926215|NCT01807221|58961930|FG003|Overall Study|Adverse Event|25|||
30926216|NCT01807221|58961931|FG004|Overall Study|Adverse Event|18|||
30926217|NCT01807221|58961932|FG005|Overall Study|Adverse Event|21|||
30926218|NCT01807221|58961927|FG000|Overall Study|Protocol Violation|0|||
30926219|NCT01807221|58961928|FG001|Overall Study|Protocol Violation|2|||
30926220|NCT01807221|58961929|FG002|Overall Study|Protocol Violation|1|||
30926221|NCT01807221|58961930|FG003|Overall Study|Protocol Violation|2|||
30926222|NCT01807221|58961931|FG004|Overall Study|Protocol Violation|0|||
30926223|NCT01807221|58961932|FG005|Overall Study|Protocol Violation|1|||
30926224|NCT01807221|58961927|FG000|Overall Study|Non-compliance|1|||
30926225|NCT01807221|58961928|FG001|Overall Study|Non-compliance|2|||
30926226|NCT01807221|58961929|FG002|Overall Study|Non-compliance|0|||
30926227|NCT01807221|58961930|FG003|Overall Study|Non-compliance|1|||
30835873|NCT00261443|58860629|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
30835874|NCT00261443|58860630|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
30835875|NCT00261443|58860631|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
30835876|NCT00261443|58860629|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
30835877|NCT00261443|58860630|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
30835878|NCT00261443|58860631|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
30835879|NCT00261443|58860629|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
30926228|NCT01807221|58961931|FG004|Overall Study|Non-compliance|0|||
30926229|NCT01807221|58961932|FG005|Overall Study|Non-compliance|0|||
30926230|NCT01807221|58961927|FG000|Overall Study|Logistical difficulties|0|||
30926231|NCT01807221|58961928|FG001|Overall Study|Logistical difficulties|1|||
30926232|NCT01807221|58961929|FG002|Overall Study|Logistical difficulties|0|||
30835880|NCT00261443|58860630|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
30926233|NCT01807221|58961930|FG003|Overall Study|Logistical difficulties|0|||
30624017|NCT00909532|58636011|FG001|Overall Study|Pregnancy|1|||
30757065|NCT00102596|58766548|FG000|Part A|Screen failures|6|||
30757066|NCT00102596|58766549|FG001|Part A|Screen failures|0|||
30757067|NCT00102596|58766548|FG000|Part A|Adverse Event|1|||
30757068|NCT00102596|58766549|FG001|Part A|Adverse Event|0|||
30757069|NCT00387647|58766556|FG000|Overall Study|Death|18|||
30835881|NCT00261443|58860631|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
30835882|NCT00261443|58860629|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
30757070|NCT00386009|58766562|FG000|Overall Study|Adverse Event|0|||
30757071|NCT00386009|58766563|FG001|Overall Study|Adverse Event|2|||
30757072|NCT00386009|58766562|FG000|Overall Study|Death|1|||
30757073|NCT00386009|58766563|FG001|Overall Study|Death|0|||
30757074|NCT00386009|58766562|FG000|Overall Study|Entry Criteria Not Met|0|||
30757075|NCT00386009|58766563|FG001|Overall Study|Entry Criteria Not Met|2|||
30835883|NCT00261443|58860630|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
30835884|NCT00261443|58860631|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
30835885|NCT00261443|58860629|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
30835886|NCT00261443|58860630|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
30835887|NCT00261443|58860631|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
30835888|NCT00261443|58860629|FG000|3: Assessment of Relapse|Adverse Event|0|||
30926234|NCT01807221|58961931|FG004|Overall Study|Logistical difficulties|1|||
30926235|NCT01807221|58961932|FG005|Overall Study|Logistical difficulties|0|||
30926236|NCT01807221|58961927|FG000|Overall Study|Withdrawal by Subject|33|||
30926237|NCT01807221|58961928|FG001|Overall Study|Withdrawal by Subject|15|||
30926238|NCT01807221|58961929|FG002|Overall Study|Withdrawal by Subject|8|||
30926239|NCT01807221|58961930|FG003|Overall Study|Withdrawal by Subject|14|||
30926240|NCT01807221|58961931|FG004|Overall Study|Withdrawal by Subject|16|||
30926241|NCT01807221|58961932|FG005|Overall Study|Withdrawal by Subject|13|||
30926242|NCT01807221|58961927|FG000|Overall Study|Sponsor decision|2|||
30926243|NCT01807221|58961928|FG001|Overall Study|Sponsor decision|0|||
30926244|NCT01807221|58961929|FG002|Overall Study|Sponsor decision|1|||
30926245|NCT01807221|58961930|FG003|Overall Study|Sponsor decision|1|||
30926246|NCT01807221|58961931|FG004|Overall Study|Sponsor decision|0|||
30926247|NCT01807221|58961932|FG005|Overall Study|Sponsor decision|0|||
30926248|NCT01807221|58961927|FG000|Overall Study|Lost to Follow-up|1|||
30926249|NCT01807221|58961928|FG001|Overall Study|Lost to Follow-up|0|||
30926250|NCT01807221|58961929|FG002|Overall Study|Lost to Follow-up|2|||
30926251|NCT01807221|58961930|FG003|Overall Study|Lost to Follow-up|1|||
30926252|NCT01807221|58961931|FG004|Overall Study|Lost to Follow-up|0|||
30926253|NCT01807221|58961932|FG005|Overall Study|Lost to Follow-up|0|||
30926254|NCT01838499|58961948|FG000|Overall Study|Protocol Violation|0|||
30926255|NCT01838499|58961949|FG001|Overall Study|Protocol Violation|1|||
30926256|NCT01838499|58961948|FG000|Overall Study|Lost to Follow-up|2|||
30926257|NCT01838499|58961949|FG001|Overall Study|Lost to Follow-up|4|||
30926258|NCT01838499|58961948|FG000|Overall Study|Lack of Efficacy|1|||
30926259|NCT01838499|58961949|FG001|Overall Study|Lack of Efficacy|2|||
30926260|NCT01838499|58961948|FG000|Overall Study|Adverse Event|2|||
30926261|NCT01838499|58961949|FG001|Overall Study|Adverse Event|1|||
30926262|NCT01838499|58961948|FG000|Overall Study|Withdrawal by Subject|19|||
30926263|NCT01838499|58961949|FG001|Overall Study|Withdrawal by Subject|9|||
30926264|NCT01807065|58961957|FG000|Overall Study|Receive no sip-T due to IV access|1|||
30926265|NCT01807065|58961958|FG001|Overall Study|Receive no sip-T due to IV access|1|||
30926266|NCT02031458|58961971|FG000|May 8, 2015 to January 11, 2019|Death|89|||
30926267|NCT02031458|58961972|FG001|May 8, 2015 to January 11, 2019|Death|193|||
30926268|NCT02031458|58961973|FG002|May 8, 2015 to January 11, 2019|Death|198|||
30926269|NCT02031458|58961971|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
30926270|NCT02031458|58961972|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
30926271|NCT02031458|58961973|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
30926272|NCT02031458|58961971|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
30926273|NCT02031458|58961972|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
30926274|NCT02031458|58961973|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
30926275|NCT02031458|58961971|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
30926276|NCT02031458|58961972|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
30926277|NCT02031458|58961973|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
30926278|NCT02031458|58961971|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
30926279|NCT02031458|58961972|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
30926280|NCT02031458|58961973|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
30926281|NCT02031458|58961971|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
30926282|NCT02031458|58961972|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
30926283|NCT02031458|58961973|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
30757076|NCT00386009|58766562|FG000|Overall Study|Lost to Follow-up|1|||
30757077|NCT00386009|58766563|FG001|Overall Study|Lost to Follow-up|1|||
30757078|NCT00386009|58766562|FG000|Overall Study|Protocol Violation|1|||
30835889|NCT00261443|58860630|FG001|3: Assessment of Relapse|Adverse Event|15|||
30835890|NCT00261443|58860631|FG002|3: Assessment of Relapse|Adverse Event|19|||
30835891|NCT00261443|58860629|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
30835892|NCT00261443|58860630|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
30835893|NCT00261443|58860631|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
30835894|NCT00261443|58860629|FG000|3: Assessment of Relapse|Death|0|||
30757079|NCT00386009|58766563|FG001|Overall Study|Protocol Violation|0|||
30757080|NCT00386009|58766562|FG000|Overall Study|Sponsor Decision|1|||
30757081|NCT00386009|58766563|FG001|Overall Study|Sponsor Decision|1|||
30757082|NCT00386009|58766562|FG000|Overall Study|Withdrawal by Subject|5|||
30757083|NCT00386009|58766563|FG001|Overall Study|Withdrawal by Subject|4|||
30757084|NCT00373685|58766571|FG000|Overall Study|Death|2|||
30757085|NCT00373685|58766572|FG001|Overall Study|Death|1|||
30757086|NCT00373685|58766571|FG000|Overall Study|Adverse Event|278|||
30757087|NCT00373685|58766572|FG001|Overall Study|Adverse Event|253|||
30757088|NCT00373685|58766571|FG000|Overall Study|Insufficient clinical response|169|||
30926284|NCT02031458|58961971|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
30926285|NCT02031458|58961972|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
30926286|NCT02031458|58961973|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
30926287|NCT02031458|58961971|FG000|Baseline to May 8, 2015|Death|36|||
30926288|NCT02031458|58961972|FG001|Baseline to May 8, 2015|Death|87|||
30926289|NCT02031458|58961973|FG002|Baseline to May 8, 2015|Death|100|||
30926290|NCT02031458|58961971|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
30926291|NCT02031458|58961972|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
30835895|NCT00261443|58860630|FG001|3: Assessment of Relapse|Death|0|||
30835896|NCT00261443|58860631|FG002|3: Assessment of Relapse|Death|1|||
30835897|NCT00261443|58860629|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
30835898|NCT00261443|58860630|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
30835899|NCT00261443|58860631|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
30835900|NCT00261443|58860629|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
30835901|NCT00261443|58860630|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
30835902|NCT00261443|58860631|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
30835903|NCT00261443|58860629|FG000|3: Assessment of Relapse|Pregnancy|0|||
30835904|NCT00261443|58860630|FG001|3: Assessment of Relapse|Pregnancy|2|||
30835905|NCT00261443|58860631|FG002|3: Assessment of Relapse|Pregnancy|1|||
30835906|NCT00261443|58860629|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
30835907|NCT00261443|58860630|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
30835908|NCT00261443|58860631|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
30835909|NCT00261443|58860629|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
30835910|NCT00261443|58860630|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
30835911|NCT00261443|58860631|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
30835912|NCT00261443|58860629|FG000|3: Assessment of Relapse|Other Reasons|0|||
30835913|NCT00261443|58860630|FG001|3: Assessment of Relapse|Other Reasons|4|||
30835914|NCT00261443|58860631|FG002|3: Assessment of Relapse|Other Reasons|3|||
30835915|NCT00261443|58860629|FG000|4: Extension Phase|Adverse Event|0|||
30835916|NCT00261443|58860630|FG001|4: Extension Phase|Adverse Event|1|||
30835917|NCT00261443|58860631|FG002|4: Extension Phase|Adverse Event|0|||
30926292|NCT02031458|58961973|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
30926293|NCT02031458|58961971|FG000|Baseline to May 8, 2015|Physician Decision|0|||
30835918|NCT00261443|58860629|FG000|4: Extension Phase|Withdrawal by Subject|0|||
30835919|NCT00261443|58860630|FG001|4: Extension Phase|Withdrawal by Subject|1|||
30926294|NCT02031458|58961972|FG001|Baseline to May 8, 2015|Physician Decision|1|||
30926295|NCT02031458|58961973|FG002|Baseline to May 8, 2015|Physician Decision|0|||
30926296|NCT02031458|58961971|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
30926297|NCT02031458|58961972|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
30926298|NCT02031458|58961973|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
30926299|NCT02031458|58961971|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
30926300|NCT02031458|58961972|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
30926301|NCT02031458|58961973|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
30926302|NCT02031458|58961971|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
30926303|NCT02031458|58961972|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
30926304|NCT02031458|58961973|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
30926305|NCT02031458|58961971|FG000|Baseline to May 8, 2015|On Treatment|43|||
30926306|NCT02031458|58961972|FG001|Baseline to May 8, 2015|On Treatment|81|||
30926307|NCT02031458|58961973|FG002|Baseline to May 8, 2015|On Treatment|73|||
30926308|NCT02031458|58961971|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
30926309|NCT02031458|58961972|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
30926310|NCT02031458|58961973|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
30926311|NCT02009696|58961983|FG000|Overall Study|Withdrawal by Subject|2|||
30926312|NCT01806597|58961990|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
30926313|NCT01806597|58961991|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
30926314|NCT01806597|58961992|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
30926315|NCT01806597|58961993|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
30926316|NCT01806597|58961994|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
30926317|NCT01806597|58961995|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
30926318|NCT01806597|58961990|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
30926319|NCT01806597|58961991|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
30926320|NCT01806597|58961992|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
30926321|NCT01806597|58961993|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
30926322|NCT01806597|58961994|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
30757089|NCT00373685|58766572|FG001|Overall Study|Insufficient clinical response|119|||
30757090|NCT00373685|58766571|FG000|Overall Study|Did not meet entrance criteria|167|||
30757091|NCT00373685|58766572|FG001|Overall Study|Did not meet entrance criteria|184|||
30757092|NCT00373685|58766571|FG000|Overall Study|Lost to follow up|83|||
30757093|NCT00373685|58766572|FG001|Overall Study|Lost to follow up|103|||
30757094|NCT00373685|58766571|FG000|Overall Study|No longer willing to participate|337|||
30757095|NCT00373685|58766572|FG001|Overall Study|No longer willing to participate|352|||
30757096|NCT00373685|58766571|FG000|Overall Study|Other|149|||
30757097|NCT00373685|58766572|FG001|Overall Study|Other|146|||
30757098|NCT00373685|58766571|FG000|Overall Study|Protocol Violation|191|||
30757099|NCT00373685|58766572|FG001|Overall Study|Protocol Violation|182|||
30757100|NCT00373685|58766571|FG000|Overall Study|Final Status Unknown|12|||
30757101|NCT00373685|58766572|FG001|Overall Study|Final Status Unknown|4|||
30757102|NCT00373685|58766571|FG000|Overall Study|Randomized, not treated|51|||
30757103|NCT00373685|58766572|FG001|Overall Study|Randomized, not treated|77|||
30926323|NCT01806597|58961995|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
30926324|NCT01806597|58961990|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
30926325|NCT01806597|58961991|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
30926326|NCT01806597|58961992|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
30926327|NCT01806597|58961993|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
30926328|NCT01806597|58961994|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
30926329|NCT01806597|58961995|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
30926330|NCT01806597|58961990|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
30926331|NCT01806597|58961991|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
30926332|NCT01806597|58961992|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
30926333|NCT01806597|58961993|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
30926334|NCT01806597|58961994|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
30926335|NCT01806597|58961995|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
30926336|NCT01806597|58961990|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
30926337|NCT01806597|58961991|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
30926338|NCT01806597|58961992|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
30926339|NCT01806597|58961993|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
30926340|NCT01806597|58961994|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
30926341|NCT01806597|58961995|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
30926342|NCT01806597|58961990|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
30926343|NCT01806597|58961991|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
30926344|NCT01806597|58961992|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
30926345|NCT01806597|58961993|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
30926346|NCT01806597|58961994|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
30926347|NCT01806597|58961995|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
30926348|NCT01806597|58961990|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
30835920|NCT00261443|58860631|FG002|4: Extension Phase|Withdrawal by Subject|2|||
30835921|NCT00261443|58860629|FG000|4: Extension Phase|Lost to Follow-up|0|||
30835922|NCT00261443|58860630|FG001|4: Extension Phase|Lost to Follow-up|1|||
30835923|NCT00261443|58860631|FG002|4: Extension Phase|Lost to Follow-up|0|||
30835924|NCT02593318|58860648|FG000|Overall Study|Withdrawal by Subject|1|||
30835925|NCT02593318|58860649|FG001|Overall Study|Withdrawal by Subject|1|||
30835926|NCT02343302|58860663|FG000|Overall Study|Physician Decision|1|||
30835927|NCT02343302|58860664|FG001|Overall Study|Physician Decision|1|||
30835928|NCT02590432|58860672|FG000|Open-label Treatment Period|Adverse Event|97|||
30835929|NCT02590432|58860673|FG001|Open-label Treatment Period|Adverse Event|79|||
30835930|NCT02590432|58860674|FG002|Open-label Treatment Period|Adverse Event|0|||
30835931|NCT02590432|58860675|FG003|Open-label Treatment Period|Adverse Event|0|||
30835932|NCT02590432|58860676|FG004|Open-label Treatment Period|Adverse Event|0|||
30835933|NCT02590432|58860677|FG005|Open-label Treatment Period|Adverse Event|0|||
30835934|NCT02590432|58860678|FG006|Open-label Treatment Period|Adverse Event|0|||
30835935|NCT02590432|58860679|FG007|Open-label Treatment Period|Adverse Event|0|||
30926349|NCT01806597|58961991|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
30835936|NCT02590432|58860680|FG008|Open-label Treatment Period|Adverse Event|0|||
30835937|NCT02590432|58860672|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
30835938|NCT02590432|58860673|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
30835939|NCT02590432|58860674|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
30835940|NCT02590432|58860675|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
30926350|NCT01806597|58961992|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
30926351|NCT01806597|58961993|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
30926352|NCT01806597|58961994|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
30926353|NCT01806597|58961995|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
30926354|NCT01806597|58961990|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
30926355|NCT01806597|58961991|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
30926356|NCT01806597|58961992|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
30926357|NCT01806597|58961993|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
30926358|NCT01806597|58961994|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
30926359|NCT01806597|58961995|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
30835941|NCT02590432|58860676|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
30835942|NCT02590432|58860677|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
30835943|NCT02590432|58860678|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
30835944|NCT02590432|58860679|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
30835945|NCT02590432|58860680|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
30926360|NCT01806597|58961990|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
30926361|NCT01806597|58961991|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
30835946|NCT02590432|58860672|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
30835947|NCT02590432|58860673|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
30835948|NCT02590432|58860674|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
30926362|NCT01806597|58961992|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
30926363|NCT01806597|58961993|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
30926364|NCT01806597|58961994|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
30926365|NCT01806597|58961995|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
30926366|NCT01806597|58961990|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
30926367|NCT01806597|58961991|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
30926368|NCT01806597|58961992|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
30926369|NCT01806597|58961993|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
30926370|NCT01806597|58961994|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
30926371|NCT01806597|58961995|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
30926372|NCT01806597|58961990|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
30926373|NCT01806597|58961991|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
30926374|NCT01806597|58961992|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
30926375|NCT01806597|58961993|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
30926376|NCT01806597|58961994|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
30926377|NCT01806597|58961995|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
30926378|NCT01806597|58961990|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
30926379|NCT01806597|58961991|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
30926380|NCT01806597|58961992|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
30926381|NCT01806597|58961993|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
30926382|NCT01806597|58961994|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
30926383|NCT01806597|58961995|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
30926384|NCT01806597|58961990|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
30926385|NCT01806597|58961991|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
30926386|NCT01806597|58961992|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
30926387|NCT01806597|58961993|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
30926388|NCT01806597|58961994|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
30926389|NCT01806597|58961995|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
30926390|NCT01806597|58961990|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
30926391|NCT01806597|58961991|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
30926392|NCT01806597|58961992|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
30926393|NCT01806597|58961993|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
30926394|NCT01806597|58961994|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
30926395|NCT01806597|58961995|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
30926396|NCT01806597|58961990|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
30926397|NCT01806597|58961991|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
30926398|NCT01806597|58961992|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
30926399|NCT01806597|58961993|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
30926400|NCT01806597|58961994|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
30926401|NCT01806597|58961995|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
30757104|NCT00373529|58766578|FG000|Overall Study|Physician Decision|19|||
30757105|NCT00373529|58766578|FG000|Overall Study|Withdrawal by Subject|7|||
30757106|NCT00373529|58766578|FG000|Overall Study|Adverse Event|7|||
30757107|NCT00373529|58766578|FG000|Overall Study|Treatment failure|36|||
30757108|NCT00373529|58766578|FG000|Overall Study|Disease recurrence|10|||
30757109|NCT00373529|58766578|FG000|Overall Study|Death|16|||
30757110|NCT00373529|58766578|FG000|Overall Study|Need for treatment prohibited by study|1|||
30757111|NCT00373529|58766578|FG000|Overall Study|Other|8|||
30757112|NCT00373529|58766578|FG000|Overall Study|Failed independent confirmation of AML|3|||
30757113|NCT00373529|58766578|FG000|Overall Study|Consent violation|1|||
30757114|NCT00373295|58766582|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
30757115|NCT00373295|58766583|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
30926402|NCT01806597|58961990|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
30926403|NCT01806597|58961991|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
30926404|NCT01806597|58961992|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
30926405|NCT01806597|58961993|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
30926406|NCT01806597|58961994|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
30835949|NCT02590432|58860675|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
30835950|NCT02590432|58860676|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
30624018|NCT00909532|58636010|FG000|Overall Study|Prohibited Medication|2|||
30835951|NCT02590432|58860677|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
30835952|NCT02590432|58860678|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
30835953|NCT02590432|58860679|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
30835954|NCT02590432|58860680|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
30835955|NCT02590432|58860672|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
30835956|NCT02590432|58860673|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
30835957|NCT02590432|58860674|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
30926407|NCT01806597|58961995|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
30926408|NCT01806597|58961990|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
30926409|NCT01806597|58961991|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
30926410|NCT01806597|58961992|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
30926411|NCT01806597|58961993|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
30926412|NCT01806597|58961994|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
30926413|NCT01806597|58961995|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
30926414|NCT01806597|58961990|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
30926415|NCT01806597|58961991|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
30926416|NCT01806597|58961992|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
30926417|NCT01806597|58961993|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
30926418|NCT01806597|58961994|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
30926419|NCT01806597|58961995|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
30926420|NCT01806597|58961990|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
30926421|NCT01806597|58961991|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
30926422|NCT01806597|58961992|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
30926423|NCT01806597|58961993|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
30624019|NCT00909532|58636011|FG001|Overall Study|Prohibited Medication|1|||
30624020|NCT00909532|58636010|FG000|Overall Study|Withdrawal of Consent|1|||
30835958|NCT02590432|58860675|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
30835959|NCT02590432|58860676|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
30835960|NCT02590432|58860677|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
30835961|NCT02590432|58860678|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
30835962|NCT02590432|58860679|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
30835963|NCT02590432|58860680|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
30835964|NCT02590432|58860672|FG000|Open-label Treatment Period|Protocol Violation|10|||
30835965|NCT02590432|58860673|FG001|Open-label Treatment Period|Protocol Violation|4|||
30926424|NCT01806597|58961994|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
30926425|NCT01806597|58961995|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
30926426|NCT02031302|58962011|FG000|Overall Study|Death|115|||
30926427|NCT02031302|58962012|FG001|Overall Study|Death|0|||
30926428|NCT02031302|58962011|FG000|Overall Study|Not treated with study valve system|18|||
30926429|NCT02031302|58962012|FG001|Overall Study|Not treated with study valve system|0|||
30835966|NCT02590432|58860674|FG002|Open-label Treatment Period|Protocol Violation|0|||
30835967|NCT02590432|58860675|FG003|Open-label Treatment Period|Protocol Violation|0|||
30835968|NCT02590432|58860676|FG004|Open-label Treatment Period|Protocol Violation|0|||
30835969|NCT02590432|58860677|FG005|Open-label Treatment Period|Protocol Violation|0|||
30835970|NCT02590432|58860678|FG006|Open-label Treatment Period|Protocol Violation|0|||
30926430|NCT02031302|58962011|FG000|Overall Study|Missed Follow Up|27|||
30926431|NCT02031302|58962012|FG001|Overall Study|Missed Follow Up|0|||
30757116|NCT00373295|58766584|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
30757117|NCT00373295|58766585|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
30835971|NCT02590432|58860679|FG007|Open-label Treatment Period|Protocol Violation|0|||
30835972|NCT02590432|58860680|FG008|Open-label Treatment Period|Protocol Violation|0|||
30835973|NCT02590432|58860672|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
30835974|NCT02590432|58860673|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
30835975|NCT02590432|58860674|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
30835976|NCT02590432|58860675|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
30835977|NCT02590432|58860676|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
30835978|NCT02590432|58860677|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
30835979|NCT02590432|58860678|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
30835980|NCT02590432|58860679|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
30835981|NCT02590432|58860680|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
30835982|NCT02590432|58860672|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
30835983|NCT02590432|58860673|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
30835984|NCT02590432|58860674|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
30835985|NCT02590432|58860675|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
30926432|NCT02031302|58962011|FG000|Overall Study|Lost to Follow-up|4|||
30926433|NCT02031302|58962012|FG001|Overall Study|Lost to Follow-up|0|||
30926434|NCT01610037|58962022|FG000|All Patients|Adverse Event|27|||
30757118|NCT00373295|58766586|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
30757119|NCT00373295|58766587|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
30757120|NCT00385541|58766597|FG000|Overall Study|severe pain, clinician requested unblind|0|||
30757121|NCT00385541|58766598|FG001|Overall Study|severe pain, clinician requested unblind|1|||
30757122|NCT00392015|58766610|FG000|Overall Study|Lost to Follow-up|2|||
30757123|NCT00392015|58766611|FG001|Overall Study|Lost to Follow-up|0|||
30757124|NCT00392015|58766612|FG002|Overall Study|Lost to Follow-up|2|||
30757125|NCT00392015|58766613|FG003|Overall Study|Lost to Follow-up|1|||
30757126|NCT00392015|58766614|FG004|Overall Study|Lost to Follow-up|1|||
30757127|NCT00392015|58766615|FG005|Overall Study|Lost to Follow-up|0|||
30757128|NCT00392015|58766610|FG000|Overall Study|Withdrawal by Subject|0|||
30757129|NCT00392015|58766611|FG001|Overall Study|Withdrawal by Subject|0|||
30757130|NCT00392015|58766612|FG002|Overall Study|Withdrawal by Subject|2|||
30757131|NCT00392015|58766613|FG003|Overall Study|Withdrawal by Subject|0|||
30757132|NCT00392015|58766614|FG004|Overall Study|Withdrawal by Subject|0|||
30757133|NCT00392015|58766615|FG005|Overall Study|Withdrawal by Subject|0|||
30757134|NCT00392015|58766610|FG000|Overall Study|Adverse Event|0|||
30757135|NCT00392015|58766611|FG001|Overall Study|Adverse Event|0|||
30624021|NCT00909532|58636011|FG001|Overall Study|Withdrawal of Consent|1|||
30624022|NCT00909532|58636010|FG000|Overall Study|Noncompliance with Study Requirements|0|||
30624023|NCT00909532|58636011|FG001|Overall Study|Noncompliance with Study Requirements|2|||
30624024|NCT00909532|58636010|FG000|Overall Study|Physician Decision|1|||
30926435|NCT01610037|58962023|FG001|All Patients|Adverse Event|22|||
30926436|NCT01610037|58962024|FG002|All Patients|Adverse Event|26|||
30926437|NCT01610037|58962022|FG000|All Patients|Withdrawal by Subject|12|||
30926438|NCT01610037|58962023|FG001|All Patients|Withdrawal by Subject|10|||
30926439|NCT01610037|58962024|FG002|All Patients|Withdrawal by Subject|20|||
30624025|NCT00909532|58636011|FG001|Overall Study|Physician Decision|0|||
30624026|NCT00909532|58636010|FG000|Overall Study|Wrong Genotype|1|||
30624027|NCT00909532|58636011|FG001|Overall Study|Wrong Genotype|0|||
30624028|NCT00909532|58636010|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
30835986|NCT02590432|58860676|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
30835987|NCT02590432|58860677|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
30835988|NCT02590432|58860678|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
30835989|NCT02590432|58860679|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
30835990|NCT02590432|58860680|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
30835991|NCT02590432|58860672|FG000|Double-blind Treatment Period|Adverse Event|0|||
30835992|NCT02590432|58860673|FG001|Double-blind Treatment Period|Adverse Event|0|||
30835993|NCT02590432|58860674|FG002|Double-blind Treatment Period|Adverse Event|14|||
30835994|NCT02590432|58860675|FG003|Double-blind Treatment Period|Adverse Event|12|||
30835995|NCT02590432|58860676|FG004|Double-blind Treatment Period|Adverse Event|6|||
30926440|NCT01610037|58962022|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
30926441|NCT01610037|58962023|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
30926442|NCT01610037|58962024|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
30926443|NCT01610037|58962022|FG000|All Patients|Death|4|||
30926444|NCT01610037|58962023|FG001|All Patients|Death|2|||
30926445|NCT01610037|58962024|FG002|All Patients|Death|1|||
30926446|NCT01610037|58962022|FG000|All Patients|Protocol deviation|4|||
30926447|NCT01610037|58962023|FG001|All Patients|Protocol deviation|3|||
30926448|NCT01610037|58962024|FG002|All Patients|Protocol deviation|3|||
30926449|NCT01610037|58962022|FG000|All Patients|Abnormal laboratory value|1|||
30926450|NCT01610037|58962023|FG001|All Patients|Abnormal laboratory value|1|||
30926451|NCT01610037|58962024|FG002|All Patients|Abnormal laboratory value|0|||
30926452|NCT01610037|58962022|FG000|All Patients|Administrative problems|1|||
30926453|NCT01610037|58962023|FG001|All Patients|Administrative problems|4|||
30926454|NCT01610037|58962024|FG002|All Patients|Administrative problems|4|||
30926455|NCT01610037|58962022|FG000|All Patients|Lost to Follow-up|1|||
30926456|NCT01610037|58962023|FG001|All Patients|Lost to Follow-up|0|||
30926457|NCT01610037|58962024|FG002|All Patients|Lost to Follow-up|0|||
30926458|NCT01610037|58962022|FG000|All Patients|Abnormal test procedure result(s)|0|||
30926459|NCT01610037|58962023|FG001|All Patients|Abnormal test procedure result(s)|1|||
30926460|NCT01610037|58962024|FG002|All Patients|Abnormal test procedure result(s)|3|||
30926461|NCT01610037|58962022|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
30926462|NCT01610037|58962023|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
30926463|NCT01610037|58962024|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
30926464|NCT01610037|58962022|FG000|Treatment and Follow up Period|Death|10|||
30926465|NCT01610037|58962023|FG001|Treatment and Follow up Period|Death|5|||
30926466|NCT01610037|58962024|FG002|Treatment and Follow up Period|Death|4|||
30926467|NCT01610037|58962022|FG000|Treatment and Follow up Period|Administrative problems|1|||
30926468|NCT01610037|58962023|FG001|Treatment and Follow up Period|Administrative problems|3|||
30926469|NCT01610037|58962024|FG002|Treatment and Follow up Period|Administrative problems|2|||
30926470|NCT01610037|58962022|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
30926471|NCT01610037|58962023|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
30926472|NCT01610037|58962024|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
30926473|NCT01806051|58962032|FG000|Overall Study|Withdrawal by Subject|6|||
30926474|NCT01837797|58962041|FG000|Period 1|Adverse Event|9|||
30926475|NCT01837797|58962042|FG001|Period 1|Adverse Event|0|||
30757136|NCT00392015|58766612|FG002|Overall Study|Adverse Event|0|||
30757137|NCT00392015|58766613|FG003|Overall Study|Adverse Event|0|||
30757138|NCT00392015|58766614|FG004|Overall Study|Adverse Event|1|||
30757139|NCT00392015|58766615|FG005|Overall Study|Adverse Event|0|||
30757140|NCT00392015|58766610|FG000|Overall Study|Previous trial recipient|0|||
30757141|NCT00392015|58766611|FG001|Overall Study|Previous trial recipient|0|||
30757142|NCT00392015|58766612|FG002|Overall Study|Previous trial recipient|0|||
30757143|NCT00392015|58766613|FG003|Overall Study|Previous trial recipient|0|||
30757144|NCT00392015|58766614|FG004|Overall Study|Previous trial recipient|1|||
30835996|NCT02590432|58860677|FG005|Double-blind Treatment Period|Adverse Event|22|||
30835997|NCT02590432|58860678|FG006|Double-blind Treatment Period|Adverse Event|20|||
30835998|NCT02590432|58860679|FG007|Double-blind Treatment Period|Adverse Event|0|||
30835999|NCT02590432|58860680|FG008|Double-blind Treatment Period|Adverse Event|0|||
30836000|NCT02590432|58860672|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
30836001|NCT02590432|58860673|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
30836002|NCT02590432|58860674|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
30836003|NCT02590432|58860675|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
30926476|NCT01837797|58962043|FG002|Period 1|Adverse Event|0|||
30926477|NCT01837797|58962044|FG003|Period 1|Adverse Event|0|||
30926478|NCT01837797|58962045|FG004|Period 1|Adverse Event|0|||
30926479|NCT01837797|58962041|FG000|Period 1|Withdrawal by Subject|6|||
30926480|NCT01837797|58962042|FG001|Period 1|Withdrawal by Subject|0|||
30926481|NCT01837797|58962043|FG002|Period 1|Withdrawal by Subject|0|||
30926482|NCT01837797|58962044|FG003|Period 1|Withdrawal by Subject|0|||
30757145|NCT00392015|58766615|FG005|Overall Study|Previous trial recipient|0|||
30926483|NCT01837797|58962045|FG004|Period 1|Withdrawal by Subject|0|||
30757146|NCT00094302|58766636|FG000|Overall Study|Lost to Follow-up|43|||
30926484|NCT01837797|58962041|FG000|Period 1|Administrative reasons|76|||
30926485|NCT01837797|58962042|FG001|Period 1|Administrative reasons|0|||
30926486|NCT01837797|58962043|FG002|Period 1|Administrative reasons|0|||
30926487|NCT01837797|58962044|FG003|Period 1|Administrative reasons|0|||
30926488|NCT01837797|58962045|FG004|Period 1|Administrative reasons|0|||
30926489|NCT01837797|58962041|FG000|Period 1|Withdrawal of consent before treatment|1|||
30926490|NCT01837797|58962042|FG001|Period 1|Withdrawal of consent before treatment|0|||
30926491|NCT01837797|58962043|FG002|Period 1|Withdrawal of consent before treatment|0|||
30926492|NCT01837797|58962044|FG003|Period 1|Withdrawal of consent before treatment|0|||
30926493|NCT01837797|58962045|FG004|Period 1|Withdrawal of consent before treatment|0|||
30926494|NCT01837797|58962041|FG000|Period 1|Other|10|||
30926495|NCT01837797|58962042|FG001|Period 1|Other|0|||
30926496|NCT01837797|58962043|FG002|Period 1|Other|0|||
30926497|NCT01837797|58962044|FG003|Period 1|Other|0|||
30926498|NCT01837797|58962045|FG004|Period 1|Other|0|||
30926499|NCT01837797|58962041|FG000|Period 2|Administrative or other reasons|0|||
30926500|NCT01837797|58962042|FG001|Period 2|Administrative or other reasons|5|||
30926501|NCT01837797|58962043|FG002|Period 2|Administrative or other reasons|2|||
30926502|NCT01837797|58962044|FG003|Period 2|Administrative or other reasons|4|||
30926503|NCT01837797|58962045|FG004|Period 2|Administrative or other reasons|0|||
30926504|NCT01837797|58962041|FG000|Period 2|Adverse Event|0|||
30926505|NCT01837797|58962042|FG001|Period 2|Adverse Event|0|||
30926506|NCT01837797|58962043|FG002|Period 2|Adverse Event|0|||
30926507|NCT01837797|58962044|FG003|Period 2|Adverse Event|1|||
30926508|NCT01837797|58962045|FG004|Period 2|Adverse Event|0|||
30926509|NCT01837797|58962041|FG000|Period 3|Adverse Event|0|||
30926510|NCT01837797|58962042|FG001|Period 3|Adverse Event|0|||
30926511|NCT01837797|58962043|FG002|Period 3|Adverse Event|0|||
30926512|NCT01837797|58962044|FG003|Period 3|Adverse Event|0|||
30926513|NCT01837797|58962045|FG004|Period 3|Adverse Event|1|||
30926514|NCT01837797|58962041|FG000|Period 3|Administrative reasons|0|||
30836004|NCT02590432|58860676|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
30836005|NCT02590432|58860677|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
30836006|NCT02590432|58860678|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
30836007|NCT02590432|58860679|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
30836008|NCT02590432|58860680|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
30757147|NCT00094302|58766637|FG001|Overall Study|Lost to Follow-up|41|||
30757148|NCT00094302|58766636|FG000|Overall Study|Physician Decision|5|||
30757149|NCT00094302|58766637|FG001|Overall Study|Physician Decision|8|||
30757150|NCT00094302|58766636|FG000|Overall Study|Withdrawal by Subject|103|||
30757151|NCT00094302|58766637|FG001|Overall Study|Withdrawal by Subject|111|||
30757152|NCT00094302|58766636|FG000|Overall Study|Death|266|||
30757153|NCT00094302|58766637|FG001|Overall Study|Death|246|||
30757154|NCT00372905|58766643|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
30757155|NCT00372905|58766644|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
30757156|NCT00372905|58766645|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
30757157|NCT00372905|58766646|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
30757158|NCT00372905|58766643|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
30757159|NCT00372905|58766644|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
30757160|NCT00372905|58766645|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
30757161|NCT00372905|58766646|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
30757162|NCT00372905|58766643|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
30757163|NCT00372905|58766644|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
30757164|NCT00372905|58766645|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
30757165|NCT00372905|58766646|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
30757166|NCT00372905|58766643|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
30757167|NCT00372905|58766644|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
30757168|NCT00372905|58766645|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
30757169|NCT00372905|58766646|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
30836009|NCT02590432|58860672|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
30836010|NCT02590432|58860673|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
30836011|NCT02590432|58860674|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
30926515|NCT01837797|58962042|FG001|Period 3|Administrative reasons|0|||
30757170|NCT00372905|58766643|FG000|Follow up Until Relapse or Progression|Study closed|0|||
30926516|NCT01837797|58962043|FG002|Period 3|Administrative reasons|0|||
30926517|NCT01837797|58962044|FG003|Period 3|Administrative reasons|0|||
30926518|NCT01837797|58962045|FG004|Period 3|Administrative reasons|20|||
30926519|NCT01837797|58962041|FG000|Period 3|Other|0|||
30926520|NCT01837797|58962042|FG001|Period 3|Other|0|||
30926521|NCT01837797|58962043|FG002|Period 3|Other|0|||
30926522|NCT01837797|58962044|FG003|Period 3|Other|0|||
30926523|NCT01837797|58962045|FG004|Period 3|Other|2|||
30926524|NCT01984424|58962055|FG000|Overall Study|Withdrawal by Subject|3|||
30926525|NCT01984424|58962056|FG001|Overall Study|Withdrawal by Subject|5|||
30926526|NCT01984424|58962055|FG000|Overall Study|Sponsor Decision|0|||
30926527|NCT01984424|58962056|FG001|Overall Study|Sponsor Decision|1|||
30926528|NCT01984424|58962055|FG000|Overall Study|Lost to Follow-up|0|||
30926529|NCT01984424|58962056|FG001|Overall Study|Lost to Follow-up|1|||
30926530|NCT01837719|58962062|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
30926531|NCT01837719|58962062|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
30926532|NCT01984268|58962077|FG000|Overall Study|Study Terminated|15|||
30926533|NCT02031146|58962083|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
30926534|NCT02031146|58962084|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
30926535|NCT02031146|58962085|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
30926536|NCT02031146|58962086|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
30926537|NCT02031146|58962087|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
30926538|NCT02031146|58962088|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
30926539|NCT02031146|58962089|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
30926540|NCT02009384|58962099|FG000|Overall Study|Death|2|||
30926541|NCT01805037|58962103|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
30836012|NCT02590432|58860675|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
30836013|NCT02590432|58860676|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
30836014|NCT02590432|58860677|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
30836015|NCT02590432|58860678|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
30836016|NCT02590432|58860679|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
30836017|NCT02590432|58860680|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
30836018|NCT02590432|58860672|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
30757171|NCT00372905|58766644|FG001|Follow up Until Relapse or Progression|Study closed|0|||
30757172|NCT00372905|58766645|FG002|Follow up Until Relapse or Progression|Study closed|0|||
30757173|NCT00372905|58766646|FG003|Follow up Until Relapse or Progression|Study closed|3|||
30836019|NCT02590432|58860673|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
30836020|NCT02590432|58860674|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
30836021|NCT02590432|58860675|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
30836022|NCT02590432|58860676|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
30836023|NCT02590432|58860677|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
30836024|NCT02590432|58860678|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
30836025|NCT02590432|58860679|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
30836026|NCT02590432|58860680|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
30836027|NCT02590432|58860672|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
30836028|NCT02590432|58860673|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
30836029|NCT02590432|58860674|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
30836030|NCT02590432|58860675|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
30836031|NCT02590432|58860676|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
30836032|NCT02590432|58860677|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
30836033|NCT02590432|58860678|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
30836034|NCT02590432|58860679|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
30757174|NCT00372905|58766643|FG000|Follow up Until Relapse or Progression|Other|0|||
30757175|NCT00372905|58766644|FG001|Follow up Until Relapse or Progression|Other|1|||
30757176|NCT00372905|58766645|FG002|Follow up Until Relapse or Progression|Other|0|||
30757177|NCT00372905|58766646|FG003|Follow up Until Relapse or Progression|Other|0|||
30757178|NCT00384839|58766656|FG000|Overall Study|Adverse Event|4|||
30757179|NCT00384839|58766656|FG000|Overall Study|Investigator Request|1|||
30757180|NCT00384839|58766656|FG000|Overall Study|Patient Request|1|||
30757181|NCT00384839|58766656|FG000|Overall Study|Ineligible|2|||
30757182|NCT00384293|58766662|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
30757183|NCT00384293|58766663|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
30757184|NCT00384293|58766664|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
30757185|NCT00384293|58766662|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
30757186|NCT00384293|58766663|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
30757187|NCT00384293|58766664|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
30757188|NCT00384293|58766662|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
30757189|NCT00384293|58766663|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
30757190|NCT00384293|58766664|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
30757191|NCT00384293|58766662|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
30757192|NCT00384293|58766663|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
30757193|NCT00384293|58766664|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
30757194|NCT00384293|58766662|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
30757195|NCT00384293|58766663|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
30757196|NCT00384293|58766664|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
30757197|NCT00384293|58766662|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
30757198|NCT00384293|58766663|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
30757199|NCT00384293|58766664|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
30836035|NCT02590432|58860680|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
30926542|NCT01805037|58962104|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
30926543|NCT01805037|58962103|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
30926544|NCT01805037|58962104|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
30926545|NCT01805037|58962103|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
30926546|NCT01805037|58962104|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
30926547|NCT01805037|58962103|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
30926548|NCT01805037|58962104|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
30836036|NCT02590432|58860672|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
30836037|NCT02590432|58860673|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
30836038|NCT02590432|58860674|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
30836039|NCT02590432|58860675|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
30836040|NCT02590432|58860676|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
30836041|NCT02590432|58860677|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
30836042|NCT02590432|58860678|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
30836043|NCT02590432|58860679|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
30836044|NCT02590432|58860680|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
30836045|NCT02590432|58860672|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
30836046|NCT02590432|58860673|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
30836047|NCT02590432|58860674|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
30836048|NCT02590432|58860675|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
30836049|NCT02590432|58860676|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
30836050|NCT02590432|58860677|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
30836051|NCT02590432|58860678|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
30836052|NCT02590432|58860679|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
30836053|NCT02590432|58860680|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
30836054|NCT02590432|58860672|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
30836055|NCT02590432|58860673|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
30836056|NCT02590432|58860674|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
30926549|NCT01805037|58962103|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
30926550|NCT01805037|58962104|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
30926551|NCT01805037|58962103|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
30926552|NCT01805037|58962104|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
30926553|NCT01805037|58962103|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
30926554|NCT01805037|58962104|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
30926555|NCT01805037|58962103|FG000|Follow Up (up to 3 Years)|Death|0|||
30926556|NCT01805037|58962104|FG001|Follow Up (up to 3 Years)|Death|2|||
30926557|NCT01805037|58962103|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
30926558|NCT01805037|58962104|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
30926559|NCT01805037|58962103|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
30926560|NCT01805037|58962104|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
30757200|NCT00384293|58766662|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
30757201|NCT00384293|58766663|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
30757202|NCT00384293|58766664|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
30757203|NCT00384293|58766662|FG000|Post-randomization Period|Adverse Event|0|||
30757204|NCT00384293|58766663|FG001|Post-randomization Period|Adverse Event|23|||
30757205|NCT00384293|58766664|FG002|Post-randomization Period|Adverse Event|7|||
30757206|NCT00384293|58766662|FG000|Post-randomization Period|Lost to Follow-up|0|||
30757207|NCT00384293|58766663|FG001|Post-randomization Period|Lost to Follow-up|2|||
30757208|NCT00384293|58766664|FG002|Post-randomization Period|Lost to Follow-up|1|||
30926561|NCT01803711|58962110|FG000|Overall Study|Adverse Event|1|||
30926562|NCT01803711|58962111|FG001|Overall Study|Adverse Event|1|||
30926563|NCT01836549|58962125|FG000|Overall Study|Did not receive study drug|0|||
30926564|NCT01836549|58962126|FG001|Overall Study|Did not receive study drug|0|||
30757209|NCT00384293|58766662|FG000|Post-randomization Period|Protocol Violation|0|||
30757210|NCT00384293|58766663|FG001|Post-randomization Period|Protocol Violation|1|||
30757211|NCT00384293|58766664|FG002|Post-randomization Period|Protocol Violation|0|||
30757212|NCT00384293|58766662|FG000|Post-randomization Period|Withdrawal by Subject|0|||
30757213|NCT00384293|58766663|FG001|Post-randomization Period|Withdrawal by Subject|8|||
30757214|NCT00384293|58766664|FG002|Post-randomization Period|Withdrawal by Subject|6|||
30624029|NCT00909532|58636011|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
30624030|NCT01136382|58636020|FG000|Overall Study|Other|8|||
30624031|NCT01136382|58636021|FG001|Overall Study|Other|3|||
30757215|NCT00384293|58766662|FG000|Post-randomization Period|Trial Termination|0|||
30757216|NCT00384293|58766663|FG001|Post-randomization Period|Trial Termination|180|||
30757217|NCT00384293|58766664|FG002|Post-randomization Period|Trial Termination|204|||
30757218|NCT00384293|58766662|FG000|Post-randomization Period|Patient Randomized in Error|0|||
30757219|NCT00384293|58766663|FG001|Post-randomization Period|Patient Randomized in Error|0|||
30757220|NCT00384293|58766664|FG002|Post-randomization Period|Patient Randomized in Error|1|||
30757221|NCT00067002|58766674|FG000|Overall Study|Early Death|1|||
30757222|NCT00067002|58766675|FG001|Overall Study|Early Death|2|||
30757223|NCT00067002|58766674|FG000|Overall Study|Delayed|1|||
30757224|NCT00067002|58766675|FG001|Overall Study|Delayed|1|||
30757225|NCT00067002|58766674|FG000|Overall Study|Graft Failure|5|||
30757226|NCT00067002|58766675|FG001|Overall Study|Graft Failure|6|||
30757227|NCT00091572|58766683|FG000|Overall Study|Lost to Follow-up|1|||
30757228|NCT00091572|58766684|FG001|Overall Study|Lost to Follow-up|1|||
30757229|NCT00091572|58766683|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
30757230|NCT00091572|58766684|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
30757231|NCT00091572|58766683|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
30757232|NCT00091572|58766684|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
30926565|NCT01836549|58962127|FG002|Overall Study|Did not receive study drug|1|||
30926566|NCT01836549|58962128|FG003|Overall Study|Did not receive study drug|0|||
30836057|NCT02590432|58860675|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
30836058|NCT02590432|58860676|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
30836059|NCT02590432|58860677|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
30836060|NCT02590432|58860678|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
30836061|NCT02590432|58860679|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
30836062|NCT02590432|58860680|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
30836063|NCT02590432|58860672|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
30836064|NCT02590432|58860673|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
30836065|NCT02590432|58860674|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
30836066|NCT02590432|58860675|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
30836067|NCT02590432|58860676|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
30836068|NCT02590432|58860677|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
30836069|NCT02590432|58860678|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
30836070|NCT02590432|58860679|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
30836071|NCT02590432|58860680|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
30836072|NCT02590432|58860672|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
30757233|NCT00091572|58766683|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
30757234|NCT00091572|58766684|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
30757235|NCT00091572|58766683|FG000|Overall Study|Other Reason|6|||
30757236|NCT00091572|58766684|FG001|Overall Study|Other Reason|13|||
30757237|NCT00091572|58766683|FG000|Overall Study|Ongoing (still on treatment)|8|||
30757238|NCT00091572|58766684|FG001|Overall Study|Ongoing (still on treatment)|12|||
30757239|NCT00091572|58766683|FG000|Overall Study|Major Protocol Violation|2|||
30757240|NCT00091572|58766684|FG001|Overall Study|Major Protocol Violation|0|||
30757241|NCT00091572|58766683|FG000|Overall Study|Toxicity (Related AE)|53|||
30757242|NCT00091572|58766684|FG001|Overall Study|Toxicity (Related AE)|9|||
30757243|NCT00084266|58766692|FG000|Overall Study|Death|42|||
30757244|NCT00084266|58766693|FG001|Overall Study|Death|39|||
30757245|NCT00084266|58766692|FG000|Overall Study|Adverse Event|8|||
30757246|NCT00084266|58766693|FG001|Overall Study|Adverse Event|5|||
30757247|NCT00084266|58766692|FG000|Overall Study|Lack of Efficacy|2|||
30757248|NCT00084266|58766693|FG001|Overall Study|Lack of Efficacy|4|||
30757249|NCT00084266|58766692|FG000|Overall Study|Lost to Follow-up|5|||
30757250|NCT00084266|58766693|FG001|Overall Study|Lost to Follow-up|3|||
30757251|NCT00084266|58766692|FG000|Overall Study|Participant not willing to participate|3|||
30757252|NCT00084266|58766693|FG001|Overall Study|Participant not willing to participate|8|||
30757253|NCT00084266|58766692|FG000|Overall Study|Other|360|||
30757254|NCT00084266|58766693|FG001|Overall Study|Other|344|||
30757255|NCT00084266|58766692|FG000|Overall Study|Randomized not treated|21|||
30757256|NCT00084266|58766693|FG001|Overall Study|Randomized not treated|20|||
30757257|NCT00091026|58766701|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
30757258|NCT00091026|58766702|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
30757259|NCT00091026|58766701|FG000|Overall Study|Patient withdrew and never received trea|0|||
30757260|NCT00091026|58766702|FG001|Overall Study|Patient withdrew and never received trea|2|||
30757261|NCT00091026|58766701|FG000|Overall Study|Unknown-never received treatment|0|||
30757262|NCT00091026|58766702|FG001|Overall Study|Unknown-never received treatment|1|||
30757263|NCT00116558|58766711|FG000|Overall Study|Death|11|||
30757264|NCT00116558|58766712|FG001|Overall Study|Death|5|||
30757265|NCT00116558|58766713|FG002|Overall Study|Death|3|||
30757266|NCT00116558|58766711|FG000|Overall Study|Withdrawal by Subject|17|||
30757267|NCT00116558|58766712|FG001|Overall Study|Withdrawal by Subject|3|||
30757268|NCT00116558|58766713|FG002|Overall Study|Withdrawal by Subject|12|||
30757269|NCT00116558|58766711|FG000|Overall Study|disease progression|3|||
30757270|NCT00116558|58766712|FG001|Overall Study|disease progression|7|||
30757271|NCT00116558|58766713|FG002|Overall Study|disease progression|18|||
30757272|NCT00116168|58766724|FG000|Overall Study|Lost to Follow-up|6|||
30757273|NCT00116168|58766725|FG001|Overall Study|Lost to Follow-up|5|||
30757274|NCT00116168|58766726|FG002|Overall Study|Lost to Follow-up|0|||
30757275|NCT00116168|58766727|FG003|Overall Study|Lost to Follow-up|0|||
30757276|NCT00115934|58766739|FG000|Overall Study|Lost to Follow-up|1|||
30757277|NCT00115934|58766740|FG001|Overall Study|Lost to Follow-up|0|||
30757278|NCT00115934|58766739|FG000|Overall Study|Did not receive intervention|3|||
30926567|NCT01836549|58962129|FG004|Overall Study|Did not receive study drug|0|||
30926568|NCT01836549|58962130|FG005|Overall Study|Did not receive study drug|0|||
30757279|NCT00115934|58766740|FG001|Overall Study|Did not receive intervention|2|||
30757280|NCT00115778|58766746|FG000|Overall Study|Withdrawal by Subject|0|||
30757281|NCT00115778|58766747|FG001|Overall Study|Withdrawal by Subject|1|||
30757282|NCT00100178|58766756|FG000|Overall Study|Lost to Follow-up|0|||
30757283|NCT00100178|58766757|FG001|Overall Study|Lost to Follow-up|6|||
30757284|NCT00100178|58766758|FG002|Overall Study|Lost to Follow-up|5|||
30757285|NCT00100178|58766756|FG000|Overall Study|Adverse Event|2|||
30836073|NCT02590432|58860673|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
30836074|NCT02590432|58860674|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
30836075|NCT02590432|58860675|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
30836076|NCT02590432|58860676|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
30836077|NCT02590432|58860677|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
30836078|NCT02590432|58860678|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
30836079|NCT02590432|58860679|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
30836080|NCT02590432|58860680|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
30836081|NCT02590432|58860672|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
30836082|NCT02590432|58860673|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
30836083|NCT02590432|58860674|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
30836084|NCT02590432|58860675|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
30836085|NCT02590432|58860676|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
30836086|NCT02590432|58860677|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
30926569|NCT01836549|58962131|FG006|Overall Study|Did not receive study drug|0|||
30624032|NCT01136382|58636020|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
30757286|NCT00100178|58766757|FG001|Overall Study|Adverse Event|2|||
30624033|NCT01136382|58636021|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
30757287|NCT00100178|58766758|FG002|Overall Study|Adverse Event|1|||
30757288|NCT00100178|58766756|FG000|Overall Study|Withdrawal by Subject|1|||
30757289|NCT00100178|58766757|FG001|Overall Study|Withdrawal by Subject|1|||
30757290|NCT00100178|58766758|FG002|Overall Study|Withdrawal by Subject|1|||
30757291|NCT00100178|58766756|FG000|Overall Study|Physician Decision|6|||
30757292|NCT00100178|58766757|FG001|Overall Study|Physician Decision|1|||
30757293|NCT00100178|58766758|FG002|Overall Study|Physician Decision|3|||
30757294|NCT00099632|58766772|FG000|Overall Study|Lost to Follow-up|1|||
30757295|NCT00099632|58766773|FG001|Overall Study|Lost to Follow-up|0|||
30757296|NCT00099632|58766774|FG002|Overall Study|Lost to Follow-up|3|||
30757297|NCT00099632|58766775|FG003|Overall Study|Lost to Follow-up|1|||
30757298|NCT00099632|58766776|FG004|Overall Study|Lost to Follow-up|1|||
30757299|NCT00099632|58766777|FG005|Overall Study|Lost to Follow-up|0|||
30757300|NCT00099632|58766772|FG000|Overall Study|Withdrawal by Subject|0|||
30757301|NCT00099632|58766773|FG001|Overall Study|Withdrawal by Subject|1|||
30757302|NCT00099632|58766774|FG002|Overall Study|Withdrawal by Subject|0|||
30757303|NCT00099632|58766775|FG003|Overall Study|Withdrawal by Subject|0|||
30757304|NCT00099632|58766776|FG004|Overall Study|Withdrawal by Subject|0|||
30757305|NCT00099632|58766777|FG005|Overall Study|Withdrawal by Subject|1|||
30757306|NCT00099632|58766772|FG000|Overall Study|Protocol Violation|0|||
30757307|NCT00099632|58766773|FG001|Overall Study|Protocol Violation|0|||
30757308|NCT00099632|58766774|FG002|Overall Study|Protocol Violation|0|||
30757309|NCT00099632|58766775|FG003|Overall Study|Protocol Violation|0|||
30757310|NCT00099632|58766776|FG004|Overall Study|Protocol Violation|0|||
30757311|NCT00099632|58766777|FG005|Overall Study|Protocol Violation|1|||
30757312|NCT00098774|58766791|FG000|Overall Study|Adverse Event|2|||
30757313|NCT00098774|58766791|FG000|Overall Study|Disease Progression|9|||
30757314|NCT00098774|58766791|FG000|Overall Study|Withdrawal by Subject|1|||
30757315|NCT00098774|58766791|FG000|Overall Study|Failed (to respond) during induction|4|||
30757316|NCT00098774|58766791|FG000|Overall Study|Physician Decision|2|||
30757317|NCT00384059|58766797|FG000|Infant Series|Not consented|2|||
30757318|NCT00384059|58766798|FG001|Infant Series|Not consented|6|||
30757319|NCT00384059|58766797|FG000|Infant Series|Withdrawal by Subject|2|||
30757320|NCT00384059|58766798|FG001|Infant Series|Withdrawal by Subject|2|||
30757321|NCT00384059|58766797|FG000|Infant Series|Adverse Event|1|||
30757322|NCT00384059|58766798|FG001|Infant Series|Adverse Event|2|||
30757323|NCT00384059|58766797|FG000|Infant Series|Protocol Violation|1|||
30757324|NCT00384059|58766798|FG001|Infant Series|Protocol Violation|2|||
30757325|NCT00384059|58766797|FG000|Infant Series|Lost to Follow-up|0|||
30757326|NCT00384059|58766798|FG001|Infant Series|Lost to Follow-up|1|||
30757327|NCT00384059|58766797|FG000|After Infant Series|Protocol Violation|2|||
30757328|NCT00384059|58766798|FG001|After Infant Series|Protocol Violation|3|||
30757329|NCT00384059|58766797|FG000|After Infant Series|Withdrawal by Subject|2|||
30757330|NCT00384059|58766798|FG001|After Infant Series|Withdrawal by Subject|2|||
30757331|NCT00384059|58766797|FG000|After Infant Series|Failed to Return|0|||
30624034|NCT01136382|58636020|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
30757332|NCT00384059|58766798|FG001|After Infant Series|Failed to Return|2|||
30757333|NCT00384059|58766797|FG000|After Infant Series|Adverse Event|0|||
30757334|NCT00384059|58766798|FG001|After Infant Series|Adverse Event|1|||
30757335|NCT00384059|58766797|FG000|After Infant Series|Physician Decision|0|||
30757336|NCT00384059|58766798|FG001|After Infant Series|Physician Decision|1|||
30757337|NCT00384059|58766797|FG000|After Infant Series|Lost to Follow-up|0|||
30757338|NCT00384059|58766798|FG001|After Infant Series|Lost to Follow-up|1|||
30757339|NCT00384059|58766797|FG000|Toddler Dose|Lost to Follow-up|1|||
30757340|NCT00384059|58766798|FG001|Toddler Dose|Lost to Follow-up|1|||
30926570|NCT01836549|58962125|FG000|Overall Study|Patient declared ineligible|0|||
30926571|NCT01836549|58962126|FG001|Overall Study|Patient declared ineligible|0|||
30926572|NCT01836549|58962127|FG002|Overall Study|Patient declared ineligible|0|||
30926573|NCT01836549|58962128|FG003|Overall Study|Patient declared ineligible|1|||
30926574|NCT01836549|58962129|FG004|Overall Study|Patient declared ineligible|0|||
30926575|NCT01836549|58962130|FG005|Overall Study|Patient declared ineligible|0|||
30836087|NCT02590432|58860678|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
30836088|NCT02590432|58860679|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
30836089|NCT02590432|58860680|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
30836090|NCT02590432|58860672|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
30836091|NCT02590432|58860673|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
30836092|NCT02590432|58860674|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
30836093|NCT02590432|58860675|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
30836094|NCT02590432|58860676|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
30836095|NCT02590432|58860677|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
30836096|NCT02590432|58860678|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
30836097|NCT02590432|58860679|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
30926576|NCT01836549|58962131|FG006|Overall Study|Patient declared ineligible|0|||
30836098|NCT02590432|58860680|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
30836099|NCT02590354|58860692|FG000|Phase 1|Active hepatitis B or C infection|1|||
30836100|NCT02590354|58860692|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
30836101|NCT02590354|58860692|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
30836102|NCT02590354|58860692|FG000|Phase 1|Subject does not want to participate|20|||
30836103|NCT02590354|58860692|FG000|Phase 1|Lost to Follow-up|1|||
30836104|NCT02590354|58860692|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
30836105|NCT01667224|58860699|FG000|Overall Study|Withdrawal by Subject|3|||
30836106|NCT01667224|58860700|FG001|Overall Study|Withdrawal by Subject|1|||
30836107|NCT01667224|58860699|FG000|Overall Study|Protocol Violation|1|||
30836108|NCT01667224|58860700|FG001|Overall Study|Protocol Violation|1|||
30836109|NCT03923738|58860708|FG000|Period 1|Adverse Event|1|||
30836110|NCT03923738|58860708|FG000|Period 1|Withdrawal by Subject|1|||
30836111|NCT02588248|58860716|FG000|Overall Study|Physician Decision|4|||
30836112|NCT02588248|58860717|FG001|Overall Study|Physician Decision|3|||
30836113|NCT01328054|58860728|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
30836114|NCT01328054|58860729|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
30836115|NCT01328054|58860728|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
30836116|NCT01328054|58860729|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
30836117|NCT01328054|58860728|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
30757341|NCT00384059|58766797|FG000|Toddler Dose|Failed to return|0|||
30757342|NCT00384059|58766798|FG001|Toddler Dose|Failed to return|1|||
30757343|NCT00383123|58766827|FG000|Overall Study|Adverse Event|1|||
30757344|NCT00383123|58766828|FG001|Overall Study|Adverse Event|0|||
30757345|NCT00383123|58766827|FG000|Overall Study|Lost to Follow-up|68|||
30757346|NCT00383123|58766828|FG001|Overall Study|Lost to Follow-up|61|||
30757347|NCT00383123|58766827|FG000|Overall Study|Protocol Violation|5|||
30757348|NCT00383123|58766828|FG001|Overall Study|Protocol Violation|1|||
30757349|NCT00383123|58766827|FG000|Overall Study|Withdrawal by Subject|27|||
30757350|NCT00383123|58766828|FG001|Overall Study|Withdrawal by Subject|18|||
30757351|NCT00383123|58766827|FG000|Overall Study|Other reason|10|||
30757352|NCT00383123|58766828|FG001|Overall Study|Other reason|6|||
30757353|NCT00382967|58766836|FG000|Overall Study|Protocol Violation|1|||
30757354|NCT00382967|58766837|FG001|Overall Study|Protocol Violation|1|||
30757355|NCT00858364|58766845|FG000|Overall Study|Administrative Decision|3|||
30757356|NCT00858364|58766846|FG001|Overall Study|Administrative Decision|2|||
30757357|NCT00858364|58766845|FG000|Overall Study|Adverse Event|5|||
30757358|NCT00858364|58766846|FG001|Overall Study|Adverse Event|2|||
30757359|NCT00858364|58766845|FG000|Overall Study|Withdrawal by Subject|44|||
30757360|NCT00858364|58766846|FG001|Overall Study|Withdrawal by Subject|118|||
30757361|NCT00858364|58766845|FG000|Overall Study|Ineligibility Determined|1|||
30757362|NCT00858364|58766846|FG001|Overall Study|Ineligibility Determined|10|||
30757363|NCT00858364|58766845|FG000|Overall Study|Lost to Follow-up|24|||
30757364|NCT00858364|58766846|FG001|Overall Study|Lost to Follow-up|54|||
30757365|NCT00858364|58766845|FG000|Overall Study|Noncompliance|3|||
30757366|NCT00858364|58766846|FG001|Overall Study|Noncompliance|4|||
30757367|NCT00858364|58766845|FG000|Overall Study|Protocol Deviation|0|||
30757368|NCT00858364|58766846|FG001|Overall Study|Protocol Deviation|2|||
30757369|NCT00858364|58766845|FG000|Overall Study|Other|9|||
30757370|NCT00858364|58766846|FG001|Overall Study|Other|17|||
30757371|NCT00858364|58766845|FG000|Overall Study|Missing|1|||
30757372|NCT00858364|58766846|FG001|Overall Study|Missing|1|||
30757373|NCT00858364|58766845|FG000|Overall Study|Still on-study|114|||
30757374|NCT00858364|58766846|FG001|Overall Study|Still on-study|247|||
30757375|NCT00382733|58766852|FG000|Overall Study|Withdrawal by Subject|0|||
30757376|NCT00382733|58766853|FG001|Overall Study|Withdrawal by Subject|1|||
30757377|NCT00382733|58766854|FG002|Overall Study|Withdrawal by Subject|0|||
30757378|NCT00382733|58766855|FG003|Overall Study|Withdrawal by Subject|0|||
30757379|NCT00382733|58766856|FG004|Overall Study|Withdrawal by Subject|0|||
30757380|NCT03631732|58766871|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
30757381|NCT03631732|58766872|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
30757382|NCT03631732|58766871|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
30757383|NCT03631732|58766872|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
30757384|NCT03631732|58766871|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
30757385|NCT03631732|58766872|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
30757386|NCT03631732|58766871|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
30757387|NCT03631732|58766872|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
30836118|NCT01328054|58860729|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
30836119|NCT01849250|58860752|FG000|Overall Study|Withdrawal by Subject|1|||
30836120|NCT01849250|58860753|FG001|Overall Study|Withdrawal by Subject|0|||
30757388|NCT03631732|58766871|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
30757389|NCT03631732|58766872|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
30757390|NCT03631732|58766871|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
30757391|NCT03631732|58766872|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
30757392|NCT03631732|58766871|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
30836121|NCT01849250|58860752|FG000|Overall Study|Not Evaluable|5|||
30836122|NCT01849250|58860753|FG001|Overall Study|Not Evaluable|3|||
30757393|NCT03631732|58766872|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
30757394|NCT03631732|58766871|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
30757395|NCT03631732|58766872|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
30757396|NCT03631732|58766871|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
30926577|NCT01836549|58962125|FG000|Overall Study|Patient inevaluable to start therapy|0|||
30926578|NCT01836549|58962126|FG001|Overall Study|Patient inevaluable to start therapy|0|||
30926579|NCT01836549|58962127|FG002|Overall Study|Patient inevaluable to start therapy|0|||
30926580|NCT01836549|58962128|FG003|Overall Study|Patient inevaluable to start therapy|0|||
30926581|NCT01836549|58962129|FG004|Overall Study|Patient inevaluable to start therapy|0|||
30926582|NCT01836549|58962130|FG005|Overall Study|Patient inevaluable to start therapy|0|||
30926583|NCT01836549|58962131|FG006|Overall Study|Patient inevaluable to start therapy|1|||
30926584|NCT01836471|58962152|FG000|Overall Study|Pregnancy|1|||
30926585|NCT01836471|58962153|FG001|Overall Study|Pregnancy|0|||
30836123|NCT01849250|58860752|FG000|Overall Study|Screen Failure|1|||
30836124|NCT01849250|58860753|FG001|Overall Study|Screen Failure|0|||
30836125|NCT02791191|58860763|FG000|Overall Study|Adverse Event|2|||
30836126|NCT02791191|58860764|FG001|Overall Study|Adverse Event|4|||
30836127|NCT02791191|58860765|FG002|Overall Study|Adverse Event|5|||
30836128|NCT02791191|58860763|FG000|Overall Study|Lack of Efficacy|0|||
30836129|NCT02791191|58860764|FG001|Overall Study|Lack of Efficacy|1|||
30836130|NCT02791191|58860765|FG002|Overall Study|Lack of Efficacy|0|||
30836131|NCT02791191|58860763|FG000|Overall Study|Study Drug Non-Compliance|0|||
30836132|NCT02791191|58860764|FG001|Overall Study|Study Drug Non-Compliance|2|||
30836133|NCT02791191|58860765|FG002|Overall Study|Study Drug Non-Compliance|0|||
30836134|NCT02791191|58860763|FG000|Overall Study|Site Closed by Sponsor|1|||
30836135|NCT02791191|58860764|FG001|Overall Study|Site Closed by Sponsor|1|||
30836136|NCT02791191|58860765|FG002|Overall Study|Site Closed by Sponsor|3|||
30926586|NCT01836471|58962154|FG002|Overall Study|Pregnancy|0|||
30926587|NCT01836471|58962155|FG003|Overall Study|Pregnancy|0|||
30836137|NCT02791191|58860763|FG000|Overall Study|Progressive Disease|1|||
30926588|NCT01836471|58962156|FG004|Overall Study|Pregnancy|0|||
30926589|NCT01836471|58962152|FG000|Overall Study|Withdrawal by Subject|3|||
30836138|NCT02791191|58860764|FG001|Overall Study|Progressive Disease|0|||
30836139|NCT02791191|58860765|FG002|Overall Study|Progressive Disease|0|||
30926590|NCT01836471|58962153|FG001|Overall Study|Withdrawal by Subject|4|||
30926591|NCT01836471|58962154|FG002|Overall Study|Withdrawal by Subject|1|||
30926592|NCT01836471|58962155|FG003|Overall Study|Withdrawal by Subject|0|||
30926593|NCT01836471|58962156|FG004|Overall Study|Withdrawal by Subject|2|||
30926594|NCT01836471|58962152|FG000|Overall Study|Physician Decision|0|||
30926595|NCT01836471|58962153|FG001|Overall Study|Physician Decision|1|||
30926596|NCT01836471|58962154|FG002|Overall Study|Physician Decision|0|||
30926597|NCT01836471|58962155|FG003|Overall Study|Physician Decision|0|||
30926598|NCT01836471|58962156|FG004|Overall Study|Physician Decision|0|||
30926599|NCT01836471|58962152|FG000|Overall Study|Lost to Follow-up|0|||
30926600|NCT01836471|58962153|FG001|Overall Study|Lost to Follow-up|0|||
30926601|NCT01836471|58962154|FG002|Overall Study|Lost to Follow-up|0|||
30926602|NCT01836471|58962155|FG003|Overall Study|Lost to Follow-up|1|||
30624035|NCT01136382|58636021|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
30757397|NCT03631732|58766872|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
30757398|NCT03631732|58766871|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
30757399|NCT03631732|58766872|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
30757400|NCT03630016|58766882|FG000|Overall Study|Poor Sensor Placement|1|||
30757401|NCT03628924|58766889|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
30757402|NCT03628924|58766890|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
30757403|NCT03628924|58766891|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
30757404|NCT03628924|58766892|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
30757405|NCT03628924|58766893|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
30757406|NCT03628924|58766894|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
30757407|NCT03628924|58766895|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
30757408|NCT03628924|58766889|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
30836140|NCT02791191|58860763|FG000|Overall Study|Study Terminated by Sponsor|29|||
30836141|NCT02791191|58860764|FG001|Overall Study|Study Terminated by Sponsor|101|||
30836142|NCT02791191|58860765|FG002|Overall Study|Study Terminated by Sponsor|109|||
30836143|NCT02791191|58860763|FG000|Overall Study|Withdrawal by Subject|3|||
30836144|NCT02791191|58860764|FG001|Overall Study|Withdrawal by Subject|1|||
30836145|NCT02791191|58860765|FG002|Overall Study|Withdrawal by Subject|3|||
30836146|NCT02791191|58860763|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
30836147|NCT02791191|58860764|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
30836148|NCT02791191|58860765|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
30836149|NCT02114697|58860788|FG000|Overall Study|Study terminated|5|||
30836150|NCT02114697|58860789|FG001|Overall Study|Study terminated|4|||
30836151|NCT01330017|58860800|FG000|Overall Study|Adverse Event|0|||
30836152|NCT01330017|58860801|FG001|Overall Study|Adverse Event|1|||
30836153|NCT01330017|58860802|FG002|Overall Study|Adverse Event|1|||
30836154|NCT01330017|58860803|FG003|Overall Study|Adverse Event|4|||
30836155|NCT01330017|58860804|FG004|Overall Study|Adverse Event|0|||
30836156|NCT01330017|58860800|FG000|Overall Study|Withdrawal by Subject|0|||
30836157|NCT01330017|58860801|FG001|Overall Study|Withdrawal by Subject|0|||
30836158|NCT01330017|58860802|FG002|Overall Study|Withdrawal by Subject|1|||
30926603|NCT01836471|58962156|FG004|Overall Study|Lost to Follow-up|1|||
30926604|NCT01836471|58962152|FG000|Overall Study|Adverse Event|6|||
30926605|NCT01836471|58962153|FG001|Overall Study|Adverse Event|3|||
30836159|NCT01330017|58860803|FG003|Overall Study|Withdrawal by Subject|0|||
30836160|NCT01330017|58860804|FG004|Overall Study|Withdrawal by Subject|1|||
30836161|NCT01330017|58860800|FG000|Overall Study|Lost to Follow-up|0|||
30836162|NCT01330017|58860801|FG001|Overall Study|Lost to Follow-up|0|||
30836163|NCT01330017|58860802|FG002|Overall Study|Lost to Follow-up|1|||
30836164|NCT01330017|58860803|FG003|Overall Study|Lost to Follow-up|0|||
30836165|NCT01330017|58860804|FG004|Overall Study|Lost to Follow-up|0|||
30836166|NCT01330017|58860800|FG000|Overall Study|Protocol Violation|0|||
30836167|NCT01330017|58860801|FG001|Overall Study|Protocol Violation|0|||
30926606|NCT01836471|58962154|FG002|Overall Study|Adverse Event|1|||
30926607|NCT01836471|58962155|FG003|Overall Study|Adverse Event|1|||
30926608|NCT01836471|58962156|FG004|Overall Study|Adverse Event|2|||
30926609|NCT01836471|58962152|FG000|Overall Study|Non compliance with tx|1|||
30926610|NCT01836471|58962153|FG001|Overall Study|Non compliance with tx|1|||
30926611|NCT01836471|58962154|FG002|Overall Study|Non compliance with tx|0|||
30926612|NCT01836471|58962155|FG003|Overall Study|Non compliance with tx|0|||
30926613|NCT01836471|58962156|FG004|Overall Study|Non compliance with tx|0|||
30836168|NCT01330017|58860802|FG002|Overall Study|Protocol Violation|0|||
30926614|NCT02030600|58962171|FG000|Treatment Period 1|Adverse Event|5|||
30926615|NCT02030600|58962172|FG001|Treatment Period 1|Adverse Event|7|||
30926616|NCT02030600|58962171|FG000|Treatment Period 1|Lack of Efficacy|0|||
30926617|NCT02030600|58962172|FG001|Treatment Period 1|Lack of Efficacy|1|||
30926618|NCT02030600|58962171|FG000|Treatment Period 1|Lost to Follow-up|11|||
30926619|NCT02030600|58962172|FG001|Treatment Period 1|Lost to Follow-up|3|||
30926620|NCT02030600|58962171|FG000|Treatment Period 1|Protocol Violation|22|||
30926621|NCT02030600|58962172|FG001|Treatment Period 1|Protocol Violation|17|||
30926622|NCT02030600|58962171|FG000|Treatment Period 1|Withdrawal by Subject|13|||
30926623|NCT02030600|58962172|FG001|Treatment Period 1|Withdrawal by Subject|17|||
30926624|NCT02030600|58962171|FG000|Treatment Period 1|Casebook Unsigned|1|||
30926625|NCT02030600|58962172|FG001|Treatment Period 1|Casebook Unsigned|0|||
30926626|NCT02030600|58962171|FG000|Treatment Period 1|Unclassified|1|||
30926627|NCT02030600|58962172|FG001|Treatment Period 1|Unclassified|0|||
30926628|NCT02030600|58962171|FG000|Treatment Period 2|Adverse Event|4|||
30926629|NCT02030600|58962172|FG001|Treatment Period 2|Adverse Event|4|||
30926630|NCT02030600|58962171|FG000|Treatment Period 2|Lack of Efficacy|2|||
30836169|NCT01330017|58860803|FG003|Overall Study|Protocol Violation|1|||
30836170|NCT01330017|58860804|FG004|Overall Study|Protocol Violation|0|||
30836171|NCT01330017|58860800|FG000|Overall Study|Unknown Reason|5|||
30836172|NCT01330017|58860801|FG001|Overall Study|Unknown Reason|3|||
30836173|NCT01330017|58860802|FG002|Overall Study|Unknown Reason|5|||
30836174|NCT01330017|58860803|FG003|Overall Study|Unknown Reason|7|||
30836175|NCT01330017|58860804|FG004|Overall Study|Unknown Reason|2|||
30836176|NCT00150462|58860827|FG000|Overall Study|Disease Progression or Relapse|3|||
30926631|NCT02030600|58962172|FG001|Treatment Period 2|Lack of Efficacy|1|||
30926632|NCT02030600|58962171|FG000|Treatment Period 2|Lost to Follow-up|4|||
30836177|NCT00150462|58860828|FG001|Overall Study|Disease Progression or Relapse|1|||
30926633|NCT02030600|58962172|FG001|Treatment Period 2|Lost to Follow-up|2|||
30926634|NCT02030600|58962171|FG000|Treatment Period 2|Protocol Violation|1|||
30926635|NCT02030600|58962172|FG001|Treatment Period 2|Protocol Violation|2|||
30926636|NCT02030600|58962171|FG000|Treatment Period 2|Withdrawal by Subject|13|||
30926637|NCT02030600|58962172|FG001|Treatment Period 2|Withdrawal by Subject|9|||
30926638|NCT02030600|58962171|FG000|Treatment Period 2|Unclassified|1|||
30926639|NCT02030600|58962172|FG001|Treatment Period 2|Unclassified|0|||
30926640|NCT01802775|58962182|FG000|Overall Study|Death|0|||
30926641|NCT01802775|58962183|FG001|Overall Study|Death|3|||
30926642|NCT01802775|58962182|FG000|Overall Study|Reason not provided|0|||
30926643|NCT01802775|58962183|FG001|Overall Study|Reason not provided|1|||
30926644|NCT01802775|58962182|FG000|Overall Study|Physician Decision|1|||
30926645|NCT01802775|58962183|FG001|Overall Study|Physician Decision|0|||
30926646|NCT01802775|58962182|FG000|Overall Study|Adverse Event|1|||
30926647|NCT01802775|58962183|FG001|Overall Study|Adverse Event|1|||
30926648|NCT01802775|58962182|FG000|Overall Study|Withdrawal by Subject|3|||
30926649|NCT01802775|58962183|FG001|Overall Study|Withdrawal by Subject|5|||
30926650|NCT01802775|58962182|FG000|Overall Study|Lost to Follow-up|1|||
30926651|NCT01802775|58962183|FG001|Overall Study|Lost to Follow-up|2|||
30926652|NCT01802385|58962191|FG000|Overall Study|Death|106|||
30926653|NCT01802385|58962192|FG001|Overall Study|Death|120|||
30926654|NCT01773993|58962198|FG000|Overall Study|No Visit After Treatment|35|||
30926655|NCT01802073|58962204|FG000|Overall Study|Lost to Follow-up|0|||
30926656|NCT01802073|58962205|FG001|Overall Study|Lost to Follow-up|1|||
30926657|NCT01802073|58962204|FG000|Overall Study|Non-compliant|4|||
30926658|NCT01802073|58962205|FG001|Overall Study|Non-compliant|2|||
30926659|NCT01802073|58962204|FG000|Overall Study|Withdrawal by Subject|1|||
30926660|NCT01802073|58962205|FG001|Overall Study|Withdrawal by Subject|1|||
30926661|NCT01802073|58962204|FG000|Overall Study|Physician Decision|0|||
30926662|NCT01802073|58962205|FG001|Overall Study|Physician Decision|7|||
30926663|NCT01607073|58962211|FG000|Overall Study|Adverse Event|1|||
30926664|NCT01773291|58962221|FG000|Overall Study|Protocol Violation|1|||
30926665|NCT01773291|58962222|FG001|Overall Study|Protocol Violation|0|||
30926666|NCT01773291|58962223|FG002|Overall Study|Protocol Violation|0|||
30926667|NCT01773291|58962221|FG000|Overall Study|Withdrawal by Subject|0|||
30926668|NCT01773291|58962222|FG001|Overall Study|Withdrawal by Subject|0|||
30926669|NCT01773291|58962223|FG002|Overall Study|Withdrawal by Subject|1|||
30926670|NCT01801917|58962236|FG000|Period 1 - Randomized|Adverse Event|1|||
30926671|NCT01801917|58962237|FG001|Period 1 - Randomized|Adverse Event|0|||
30926672|NCT01801917|58962238|FG002|Period 1 - Randomized|Adverse Event|1|||
30926673|NCT01801917|58962239|FG003|Period 1 - Randomized|Adverse Event|0|||
30926674|NCT02008916|58962253|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
30926675|NCT02008916|58962254|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
30926676|NCT02008916|58962255|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
30926677|NCT02008916|58962253|FG000|Week 16 - 156|Adverse Event|4|||
30926678|NCT02008916|58962254|FG001|Week 16 - 156|Adverse Event|2|||
30624036|NCT01136382|58636020|FG000|Overall Study|Withdrawal by Subject|4|||
30757409|NCT03628924|58766890|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
30624037|NCT01136382|58636021|FG001|Overall Study|Withdrawal by Subject|1|||
30624038|NCT00912028|58636030|FG000|Overall Study|Lost to Follow-up|2|||
30757410|NCT03628924|58766891|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
30757411|NCT03628924|58766892|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
30757412|NCT03628924|58766893|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
30757413|NCT03628924|58766894|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
30757414|NCT03628924|58766895|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
30757415|NCT03628924|58766889|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
30757416|NCT03628924|58766890|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
30757417|NCT03628924|58766891|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
30757418|NCT03628924|58766892|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
30757419|NCT03628924|58766893|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
30624039|NCT00912028|58636031|FG001|Overall Study|Lost to Follow-up|3|||
30757420|NCT03628924|58766894|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
30926679|NCT02008916|58962255|FG002|Week 16 - 156|Adverse Event|3|||
30926680|NCT02008916|58962253|FG000|Week 16 - 156|Withdrawal by Subject|7|||
30926681|NCT02008916|58962254|FG001|Week 16 - 156|Withdrawal by Subject|3|||
30926682|NCT02008916|58962255|FG002|Week 16 - 156|Withdrawal by Subject|5|||
30926683|NCT02008916|58962253|FG000|Week 16 - 156|No longer requires treatment|0|||
30926684|NCT02008916|58962254|FG001|Week 16 - 156|No longer requires treatment|1|||
30926685|NCT02008916|58962255|FG002|Week 16 - 156|No longer requires treatment|0|||
30926686|NCT02008916|58962253|FG000|Week 16 - 156|Lost to Follow-up|5|||
30926687|NCT02008916|58962254|FG001|Week 16 - 156|Lost to Follow-up|0|||
30926688|NCT02008916|58962255|FG002|Week 16 - 156|Lost to Follow-up|0|||
30926689|NCT02008916|58962253|FG000|Week 16 - 156|Lack of Efficacy|3|||
30926690|NCT02008916|58962254|FG001|Week 16 - 156|Lack of Efficacy|5|||
30926691|NCT02008916|58962255|FG002|Week 16 - 156|Lack of Efficacy|2|||
30926692|NCT02008916|58962253|FG000|Week 16 - 156|Pregnancy|0|||
30926693|NCT02008916|58962254|FG001|Week 16 - 156|Pregnancy|1|||
30926694|NCT02008916|58962255|FG002|Week 16 - 156|Pregnancy|0|||
30926695|NCT02008916|58962253|FG000|Week 16 - 156|Physician Decision|0|||
30926696|NCT02008916|58962254|FG001|Week 16 - 156|Physician Decision|1|||
30926697|NCT02008916|58962255|FG002|Week 16 - 156|Physician Decision|0|||
30926698|NCT01772823|58962266|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
30926699|NCT01772823|58962267|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
30926700|NCT01772823|58962266|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
30926701|NCT01772823|58962267|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
30926702|NCT01772823|58962266|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
30926703|NCT01772823|58962267|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
30926704|NCT01772823|58962266|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
30926705|NCT01772823|58962267|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
30926706|NCT01772823|58962266|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
30926707|NCT01772823|58962267|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
30926708|NCT01772823|58962266|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
30926709|NCT01772823|58962267|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
30624040|NCT00912028|58636032|FG002|Overall Study|Lost to Follow-up|0|||
30624041|NCT00912028|58636033|FG003|Overall Study|Lost to Follow-up|1|||
30757421|NCT03628924|58766895|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
30757422|NCT03628924|58766889|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
30757423|NCT03628924|58766890|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
30757424|NCT03628924|58766891|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
30757425|NCT03628924|58766892|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
30757426|NCT03628924|58766893|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
30757427|NCT03628924|58766894|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
30757428|NCT03628924|58766895|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
30757429|NCT03628924|58766889|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
30757430|NCT03628924|58766890|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
30757431|NCT03628924|58766891|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
30757432|NCT03628924|58766892|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
30757433|NCT03628924|58766893|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
30757434|NCT03628924|58766894|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
30836178|NCT00150462|58860829|FG002|Overall Study|Disease Progression or Relapse|2|||
30836179|NCT00150462|58860830|FG003|Overall Study|Disease Progression or Relapse|1|||
30836180|NCT00150462|58860831|FG004|Overall Study|Disease Progression or Relapse|2|||
30836181|NCT00150462|58860832|FG005|Overall Study|Disease Progression or Relapse|2|||
30836182|NCT00150462|58860833|FG006|Overall Study|Disease Progression or Relapse|3|||
30836183|NCT00150462|58860834|FG007|Overall Study|Disease Progression or Relapse|5|||
30836184|NCT00150462|58860835|FG008|Overall Study|Disease Progression or Relapse|5|||
30836185|NCT00150462|58860836|FG009|Overall Study|Disease Progression or Relapse|3|||
30836186|NCT00150462|58860837|FG010|Overall Study|Disease Progression or Relapse|2|||
30836187|NCT00150462|58860827|FG000|Overall Study|Withdrawal by Subject|0|||
30836188|NCT00150462|58860828|FG001|Overall Study|Withdrawal by Subject|1|||
30836189|NCT00150462|58860829|FG002|Overall Study|Withdrawal by Subject|1|||
30836190|NCT00150462|58860830|FG003|Overall Study|Withdrawal by Subject|0|||
30836191|NCT00150462|58860831|FG004|Overall Study|Withdrawal by Subject|1|||
30624042|NCT00912028|58636034|FG004|Overall Study|Lost to Follow-up|3|||
30757435|NCT03628924|58766895|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
30836192|NCT00150462|58860832|FG005|Overall Study|Withdrawal by Subject|2|||
30926710|NCT01772823|58962266|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
30926711|NCT01772823|58962267|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
30926712|NCT01772823|58962266|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
30926713|NCT01772823|58962267|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
30926714|NCT01772823|58962266|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
30926715|NCT01772823|58962267|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
30926716|NCT01772823|58962266|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
30926717|NCT01772823|58962267|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
30926718|NCT01772823|58962266|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
30926719|NCT01772823|58962267|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
30926720|NCT01772823|58962266|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
30926721|NCT01772823|58962267|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
30926722|NCT01772823|58962266|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
30836193|NCT00150462|58860833|FG006|Overall Study|Withdrawal by Subject|0|||
30836194|NCT00150462|58860834|FG007|Overall Study|Withdrawal by Subject|1|||
30836195|NCT00150462|58860835|FG008|Overall Study|Withdrawal by Subject|0|||
30836196|NCT00150462|58860836|FG009|Overall Study|Withdrawal by Subject|1|||
30836197|NCT00150462|58860837|FG010|Overall Study|Withdrawal by Subject|0|||
30836198|NCT00150462|58860827|FG000|Overall Study|Death|0|||
30926723|NCT01772823|58962267|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
30926724|NCT01772823|58962266|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
30926725|NCT01772823|58962267|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
30926726|NCT01772823|58962266|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
30926727|NCT01772823|58962267|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
30926728|NCT01772823|58962266|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
30926729|NCT01772823|58962267|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
30926730|NCT02029976|58962280|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
30926731|NCT02029976|58962281|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
30757436|NCT03628924|58766889|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
30757437|NCT03628924|58766890|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
30757438|NCT03628924|58766891|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
30757439|NCT03628924|58766892|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
30757440|NCT03628924|58766893|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
30757441|NCT03628924|58766894|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
30757442|NCT03628924|58766895|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
30757443|NCT03628924|58766889|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
30836199|NCT00150462|58860828|FG001|Overall Study|Death|1|||
30836200|NCT00150462|58860829|FG002|Overall Study|Death|0|||
30836201|NCT00150462|58860830|FG003|Overall Study|Death|0|||
30836202|NCT00150462|58860831|FG004|Overall Study|Death|0|||
30836203|NCT00150462|58860832|FG005|Overall Study|Death|0|||
30836204|NCT00150462|58860833|FG006|Overall Study|Death|0|||
30836205|NCT00150462|58860834|FG007|Overall Study|Death|0|||
30836206|NCT00150462|58860835|FG008|Overall Study|Death|1|||
30836207|NCT00150462|58860836|FG009|Overall Study|Death|0|||
30926732|NCT02029976|58962280|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
30926733|NCT02029976|58962281|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
30926734|NCT02029976|58962280|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
30926735|NCT02029976|58962281|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
30926736|NCT02029976|58962280|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
30926737|NCT02029976|58962281|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
30926738|NCT01983254|58962289|FG000|Overall Study|Death|6|||
30926739|NCT01983254|58962290|FG001|Overall Study|Death|6|||
30926740|NCT01983254|58962289|FG000|Overall Study|Lost to Follow-up|17|||
30926741|NCT01983254|58962290|FG001|Overall Study|Lost to Follow-up|16|||
30926742|NCT01983254|58962289|FG000|Overall Study|too ill|11|||
30926743|NCT01983254|58962290|FG001|Overall Study|too ill|8|||
30926744|NCT01771809|58962298|FG000|Overall Study|Adverse Event|4|||
30926745|NCT01771809|58962299|FG001|Overall Study|Adverse Event|12|||
30926746|NCT01771809|58962298|FG000|Overall Study|Protocol Violation|0|||
30836208|NCT00150462|58860837|FG010|Overall Study|Death|0|||
30926747|NCT01771809|58962299|FG001|Overall Study|Protocol Violation|1|||
30926748|NCT01771809|58962298|FG000|Overall Study|Withdrawal by Subject|34|||
30926749|NCT01771809|58962299|FG001|Overall Study|Withdrawal by Subject|42|||
30926750|NCT01771809|58962298|FG000|Overall Study|Lost to Follow-up|1|||
30926751|NCT01771809|58962299|FG001|Overall Study|Lost to Follow-up|3|||
30926752|NCT01771809|58962298|FG000|Overall Study|Other (Insufficient clinical response)|22|||
30926753|NCT01771809|58962299|FG001|Overall Study|Other (Insufficient clinical response)|20|||
30926754|NCT01771809|58962298|FG000|Overall Study|Death|1|||
30836209|NCT00150462|58860827|FG000|Overall Study|Adverse Event|0|||
30836210|NCT00150462|58860828|FG001|Overall Study|Adverse Event|0|||
30926755|NCT01771809|58962299|FG001|Overall Study|Death|0|||
30926756|NCT01771809|58962298|FG000|Overall Study|Other (other)|9|||
30926757|NCT01771809|58962299|FG001|Overall Study|Other (other)|5|||
30926758|NCT01771731|58962307|FG000|Overall Study|Physician Decision|1|||
30926759|NCT01771731|58962308|FG001|Overall Study|Physician Decision|0|||
30926760|NCT01771731|58962307|FG000|Overall Study|Protocol Violation|0|||
30926761|NCT01771731|58962308|FG001|Overall Study|Protocol Violation|1|||
30926762|NCT01771731|58962307|FG000|Overall Study|Adverse event: Pain Crisis|1|||
30926763|NCT01771731|58962308|FG001|Overall Study|Adverse event: Pain Crisis|1|||
30926764|NCT01982942|58962316|FG000|Overall Study|Adverse Event|10|||
30926765|NCT01982942|58962317|FG001|Overall Study|Adverse Event|5|||
30926766|NCT01982942|58962316|FG000|Overall Study|Lost to Follow-up|4|||
30926767|NCT01982942|58962317|FG001|Overall Study|Lost to Follow-up|3|||
30926768|NCT01982942|58962316|FG000|Overall Study|Multiple sclerosis progression|3|||
30926769|NCT01982942|58962317|FG001|Overall Study|Multiple sclerosis progression|2|||
30926770|NCT01982942|58962316|FG000|Overall Study|Wanted to try therapy not permitted|1|||
30926771|NCT01982942|58962317|FG001|Overall Study|Wanted to try therapy not permitted|0|||
30926772|NCT01982942|58962316|FG000|Overall Study|Subject declined future visits|0|||
30926773|NCT01982942|58962317|FG001|Overall Study|Subject declined future visits|1|||
30926774|NCT01982942|58962316|FG000|Overall Study|Left geographical area|2|||
30926775|NCT01982942|58962317|FG001|Overall Study|Left geographical area|0|||
30926776|NCT01982942|58962316|FG000|Overall Study|Too many pills|1|||
30926777|NCT01982942|58962317|FG001|Overall Study|Too many pills|0|||
30926778|NCT01982942|58962316|FG000|Overall Study|MS Relapse|0|||
30926779|NCT01982942|58962317|FG001|Overall Study|MS Relapse|1|||
30926780|NCT01982942|58962316|FG000|Overall Study|Chose to join a stem cell trial|0|||
30926781|NCT01982942|58962317|FG001|Overall Study|Chose to join a stem cell trial|1|||
30926782|NCT01982942|58962316|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
30926783|NCT01982942|58962317|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
30926784|NCT01769469|58962323|FG000|Overall Study|Consent Withdrawn|5|||
30926785|NCT01769469|58962323|FG000|Overall Study|Moved Out Of Area|3|||
30926786|NCT01769469|58962323|FG000|Overall Study|Lost to Follow-up|17|||
30926787|NCT01769469|58962323|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
30926788|NCT01769469|58962323|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
30926789|NCT02008526|58962332|FG000|Overall Study|Death|0|||
30926790|NCT02008526|58962333|FG001|Overall Study|Death|2|||
30926791|NCT02008526|58962334|FG002|Overall Study|Death|1|||
30836211|NCT00150462|58860829|FG002|Overall Study|Adverse Event|0|||
30836212|NCT00150462|58860830|FG003|Overall Study|Adverse Event|1|||
30836213|NCT00150462|58860831|FG004|Overall Study|Adverse Event|0|||
30836214|NCT00150462|58860832|FG005|Overall Study|Adverse Event|0|||
30926792|NCT02008526|58962332|FG000|Overall Study|Withdrawal by Subject|3|||
30926793|NCT02008526|58962333|FG001|Overall Study|Withdrawal by Subject|3|||
30624043|NCT00912028|58636030|FG000|Overall Study|Withdrawal by Subject|3|||
30836215|NCT00150462|58860833|FG006|Overall Study|Adverse Event|0|||
30836216|NCT00150462|58860834|FG007|Overall Study|Adverse Event|2|||
30926794|NCT02008526|58962334|FG002|Overall Study|Withdrawal by Subject|2|||
30926795|NCT02008526|58962332|FG000|Overall Study|Lost to Follow-up|5|||
30926796|NCT02008526|58962333|FG001|Overall Study|Lost to Follow-up|9|||
30926797|NCT02008526|58962334|FG002|Overall Study|Lost to Follow-up|6|||
30926798|NCT01769391|58962344|FG000|Overall Study|Death|10|||
30926799|NCT01769391|58962345|FG001|Overall Study|Death|1|||
30926800|NCT01769391|58962344|FG000|Overall Study|Adverse Event|0|||
30926801|NCT01769391|58962345|FG001|Overall Study|Adverse Event|3|||
30926802|NCT01769391|58962344|FG000|Overall Study|Progressive Disease|1|||
30926803|NCT01769391|58962345|FG001|Overall Study|Progressive Disease|2|||
30926804|NCT01769391|58962344|FG000|Overall Study|Withdrawal by Subject|4|||
30926805|NCT01769391|58962345|FG001|Overall Study|Withdrawal by Subject|3|||
30926806|NCT01769391|58962344|FG000|Overall Study|Investigator Decision|2|||
30926807|NCT01769391|58962345|FG001|Overall Study|Investigator Decision|0|||
30926808|NCT01800903|58962357|FG000|Second Test Period|unable to catheterise|1|||
30926809|NCT01800903|58962358|FG001|Second Test Period|unable to catheterise|0|||
30836217|NCT00150462|58860835|FG008|Overall Study|Adverse Event|0|||
30836218|NCT00150462|58860836|FG009|Overall Study|Adverse Event|1|||
30836219|NCT00150462|58860837|FG010|Overall Study|Adverse Event|0|||
30836220|NCT00150462|58860827|FG000|Overall Study|Physician Decision|0|||
30836221|NCT00150462|58860828|FG001|Overall Study|Physician Decision|0|||
30836222|NCT00150462|58860829|FG002|Overall Study|Physician Decision|1|||
30836223|NCT00150462|58860830|FG003|Overall Study|Physician Decision|1|||
30836224|NCT00150462|58860831|FG004|Overall Study|Physician Decision|0|||
30836225|NCT00150462|58860832|FG005|Overall Study|Physician Decision|0|||
30836226|NCT00150462|58860833|FG006|Overall Study|Physician Decision|0|||
30836227|NCT00150462|58860834|FG007|Overall Study|Physician Decision|0|||
30836228|NCT00150462|58860835|FG008|Overall Study|Physician Decision|0|||
30836229|NCT00150462|58860836|FG009|Overall Study|Physician Decision|0|||
30836230|NCT00150462|58860837|FG010|Overall Study|Physician Decision|0|||
30836231|NCT00150462|58860827|FG000|Overall Study|Other|0|||
30836232|NCT00150462|58860828|FG001|Overall Study|Other|0|||
30836233|NCT00150462|58860829|FG002|Overall Study|Other|0|||
30836234|NCT00150462|58860830|FG003|Overall Study|Other|0|||
30836235|NCT00150462|58860831|FG004|Overall Study|Other|0|||
30836236|NCT00150462|58860832|FG005|Overall Study|Other|0|||
30836237|NCT00150462|58860833|FG006|Overall Study|Other|0|||
30836238|NCT00150462|58860834|FG007|Overall Study|Other|0|||
30836239|NCT00150462|58860835|FG008|Overall Study|Other|0|||
30836240|NCT00150462|58860836|FG009|Overall Study|Other|1|||
30836241|NCT00150462|58860837|FG010|Overall Study|Other|1|||
30836242|NCT01368081|58860877|FG000|Overall Study|Adverse Event|4|||
30836243|NCT01368081|58860878|FG001|Overall Study|Adverse Event|4|||
30836244|NCT01368081|58860879|FG002|Overall Study|Adverse Event|3|||
30836245|NCT01368081|58860880|FG003|Overall Study|Adverse Event|2|||
30836246|NCT01368081|58860881|FG004|Overall Study|Adverse Event|2|||
30836247|NCT01368081|58860882|FG005|Overall Study|Adverse Event|5|||
30836248|NCT01368081|58860883|FG006|Overall Study|Adverse Event|6|||
30836249|NCT01368081|58860884|FG007|Overall Study|Adverse Event|2|||
30836250|NCT01368081|58860885|FG008|Overall Study|Adverse Event|3|||
30836251|NCT01368081|58860886|FG009|Overall Study|Adverse Event|5|||
30836252|NCT01368081|58860887|FG010|Overall Study|Adverse Event|6|||
30836253|NCT01368081|58860888|FG011|Overall Study|Adverse Event|1|||
30836254|NCT01368081|58860889|FG012|Overall Study|Adverse Event|3|||
30836255|NCT01368081|58860877|FG000|Overall Study|Lack of Efficacy|0|||
30926810|NCT01800903|58962359|FG002|Second Test Period|unable to catheterise|0|||
30757444|NCT03628924|58766890|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
30757445|NCT03628924|58766891|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
30757446|NCT03628924|58766892|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
30757447|NCT03628924|58766893|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
30757448|NCT03628924|58766894|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
30757449|NCT03628924|58766895|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
30757450|NCT03628924|58766889|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
30757451|NCT03628924|58766890|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
30757452|NCT03628924|58766891|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
30757453|NCT03628924|58766892|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
30757454|NCT03628924|58766893|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
30757455|NCT03628924|58766894|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
30757456|NCT03628924|58766895|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
30757457|NCT03628924|58766889|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
30757458|NCT03628924|58766890|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
30757459|NCT03628924|58766891|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
30757460|NCT03628924|58766892|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
30757461|NCT03628924|58766893|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
30836256|NCT01368081|58860878|FG001|Overall Study|Lack of Efficacy|1|||
30836257|NCT01368081|58860879|FG002|Overall Study|Lack of Efficacy|0|||
30836258|NCT01368081|58860880|FG003|Overall Study|Lack of Efficacy|1|||
30836259|NCT01368081|58860881|FG004|Overall Study|Lack of Efficacy|0|||
30836260|NCT01368081|58860882|FG005|Overall Study|Lack of Efficacy|0|||
30836261|NCT01368081|58860883|FG006|Overall Study|Lack of Efficacy|0|||
30926811|NCT01800903|58962360|FG003|Second Test Period|unable to catheterise|0|||
30926812|NCT01800903|58962361|FG004|Second Test Period|unable to catheterise|0|||
30836262|NCT01368081|58860884|FG007|Overall Study|Lack of Efficacy|2|||
30836263|NCT01368081|58860885|FG008|Overall Study|Lack of Efficacy|0|||
30836264|NCT01368081|58860886|FG009|Overall Study|Lack of Efficacy|0|||
30836265|NCT01368081|58860887|FG010|Overall Study|Lack of Efficacy|0|||
30836266|NCT01368081|58860888|FG011|Overall Study|Lack of Efficacy|0|||
30836267|NCT01368081|58860889|FG012|Overall Study|Lack of Efficacy|0|||
30836268|NCT01368081|58860877|FG000|Overall Study|Protocol Violation|0|||
30836269|NCT01368081|58860878|FG001|Overall Study|Protocol Violation|0|||
30836270|NCT01368081|58860879|FG002|Overall Study|Protocol Violation|0|||
30836271|NCT01368081|58860880|FG003|Overall Study|Protocol Violation|0|||
30836272|NCT01368081|58860881|FG004|Overall Study|Protocol Violation|0|||
30836273|NCT01368081|58860882|FG005|Overall Study|Protocol Violation|1|||
30836274|NCT01368081|58860883|FG006|Overall Study|Protocol Violation|0|||
30836275|NCT01368081|58860884|FG007|Overall Study|Protocol Violation|1|||
30836276|NCT01368081|58860885|FG008|Overall Study|Protocol Violation|0|||
30836277|NCT01368081|58860886|FG009|Overall Study|Protocol Violation|0|||
30836278|NCT01368081|58860887|FG010|Overall Study|Protocol Violation|0|||
30836279|NCT01368081|58860888|FG011|Overall Study|Protocol Violation|0|||
30836280|NCT01368081|58860889|FG012|Overall Study|Protocol Violation|0|||
30836281|NCT01368081|58860877|FG000|Overall Study|Lost to Follow-up|0|||
30836282|NCT01368081|58860878|FG001|Overall Study|Lost to Follow-up|0|||
30836283|NCT01368081|58860879|FG002|Overall Study|Lost to Follow-up|0|||
30836284|NCT01368081|58860880|FG003|Overall Study|Lost to Follow-up|0|||
30836285|NCT01368081|58860881|FG004|Overall Study|Lost to Follow-up|0|||
30836286|NCT01368081|58860882|FG005|Overall Study|Lost to Follow-up|0|||
30836287|NCT01368081|58860883|FG006|Overall Study|Lost to Follow-up|0|||
30836288|NCT01368081|58860884|FG007|Overall Study|Lost to Follow-up|0|||
30836289|NCT01368081|58860885|FG008|Overall Study|Lost to Follow-up|0|||
30836290|NCT01368081|58860886|FG009|Overall Study|Lost to Follow-up|0|||
30836291|NCT01368081|58860887|FG010|Overall Study|Lost to Follow-up|0|||
30836292|NCT01368081|58860888|FG011|Overall Study|Lost to Follow-up|0|||
30836293|NCT01368081|58860889|FG012|Overall Study|Lost to Follow-up|1|||
30836294|NCT01368081|58860877|FG000|Overall Study|Withdrawal by Subject|4|||
30836295|NCT01368081|58860878|FG001|Overall Study|Withdrawal by Subject|4|||
30836296|NCT01368081|58860879|FG002|Overall Study|Withdrawal by Subject|1|||
30926813|NCT01800903|58962362|FG005|Second Test Period|unable to catheterise|0|||
30926814|NCT01767987|58962370|FG000|Overall Study|Physician Decision|4|||
30926815|NCT01767987|58962371|FG001|Overall Study|Physician Decision|1|||
30926816|NCT01800201|58962379|FG000|Overall Study|Withdrawal by Subject|2|||
30926817|NCT01800201|58962380|FG001|Overall Study|Withdrawal by Subject|0|||
30926818|NCT01800201|58962379|FG000|Overall Study|patient privacy concerns|1|||
30926819|NCT01800201|58962380|FG001|Overall Study|patient privacy concerns|1|||
30926820|NCT01800201|58962379|FG000|Overall Study|did not want to use device|0|||
30926821|NCT01800201|58962380|FG001|Overall Study|did not want to use device|1|||
30926822|NCT01800201|58962379|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
30926823|NCT01800201|58962380|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
30926824|NCT01767909|58962389|FG000|Overall Study|Withdrawal by Subject|4|||
30926825|NCT01767909|58962390|FG001|Overall Study|Withdrawal by Subject|7|||
30926826|NCT01767909|58962389|FG000|Overall Study|Adverse Event|3|||
30926827|NCT01767909|58962390|FG001|Overall Study|Adverse Event|1|||
30926828|NCT01767909|58962389|FG000|Overall Study|Withdrawal by Study Partner|3|||
30926829|NCT01767909|58962390|FG001|Overall Study|Withdrawal by Study Partner|1|||
30757462|NCT03628924|58766894|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
30757463|NCT03628924|58766895|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
30757464|NCT03628924|58766889|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
30757465|NCT03628924|58766890|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
30757466|NCT03628924|58766891|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
30757467|NCT03628924|58766892|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
30757468|NCT03628924|58766893|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
30757469|NCT03628924|58766894|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
30836297|NCT01368081|58860880|FG003|Overall Study|Withdrawal by Subject|1|||
30836298|NCT01368081|58860881|FG004|Overall Study|Withdrawal by Subject|0|||
30836299|NCT01368081|58860882|FG005|Overall Study|Withdrawal by Subject|3|||
30836300|NCT01368081|58860883|FG006|Overall Study|Withdrawal by Subject|4|||
30836301|NCT01368081|58860884|FG007|Overall Study|Withdrawal by Subject|2|||
30926830|NCT01767909|58962389|FG000|Overall Study|Non-Compliance|2|||
30926831|NCT01767909|58962390|FG001|Overall Study|Non-Compliance|0|||
30926832|NCT01767909|58962389|FG000|Overall Study|Perceived Lack of Efficacy|1|||
30836302|NCT01368081|58860885|FG008|Overall Study|Withdrawal by Subject|5|||
30926833|NCT01767909|58962390|FG001|Overall Study|Perceived Lack of Efficacy|0|||
30836303|NCT01368081|58860886|FG009|Overall Study|Withdrawal by Subject|4|||
30836304|NCT01368081|58860887|FG010|Overall Study|Withdrawal by Subject|3|||
30836305|NCT01368081|58860888|FG011|Overall Study|Withdrawal by Subject|2|||
30926834|NCT01767909|58962389|FG000|Overall Study|Investigator Recommendation|0|||
30926835|NCT01767909|58962390|FG001|Overall Study|Investigator Recommendation|1|||
30926836|NCT01767909|58962389|FG000|Overall Study|Lost to Follow-up|0|||
30926837|NCT01767909|58962390|FG001|Overall Study|Lost to Follow-up|1|||
30926838|NCT01767909|58962389|FG000|Overall Study|LP uncessessful|0|||
30926839|NCT01767909|58962390|FG001|Overall Study|LP uncessessful|1|||
30926840|NCT02029274|58962402|FG000|Overall Study|Adverse Event|1|||
30926841|NCT02029274|58962403|FG001|Overall Study|Adverse Event|0|||
30926842|NCT02029274|58962404|FG002|Overall Study|Adverse Event|2|||
30926843|NCT02029274|58962405|FG003|Overall Study|Adverse Event|2|||
30926844|NCT02008370|58962419|FG000|Overall Study|Lost to Follow-up|7|||
30926845|NCT01981616|58962425|FG000|Overall Study|Adverse Event|0|||
30926846|NCT01981616|58962426|FG001|Overall Study|Adverse Event|1|||
30926847|NCT01981616|58962425|FG000|Overall Study|Protocol Violation|1|||
30926848|NCT01981616|58962426|FG001|Overall Study|Protocol Violation|0|||
30926849|NCT02104817|58962434|FG000|Overall Study|Death|363|||
30926850|NCT02104817|58962435|FG001|Overall Study|Death|330|||
30926851|NCT02104817|58962434|FG000|Overall Study|Lost to Follow-up|3|||
30926852|NCT02104817|58962435|FG001|Overall Study|Lost to Follow-up|2|||
30926853|NCT02104817|58962434|FG000|Overall Study|Protocol Violation|0|||
30926854|NCT02104817|58962435|FG001|Overall Study|Protocol Violation|1|||
30926855|NCT02104817|58962434|FG000|Overall Study|Study terminated by sponsor|5854|||
30836306|NCT01368081|58860889|FG012|Overall Study|Withdrawal by Subject|0|||
30836307|NCT01368081|58860877|FG000|Overall Study|Other reason not defined above|2|||
30836308|NCT01368081|58860878|FG001|Overall Study|Other reason not defined above|0|||
30836309|NCT01368081|58860879|FG002|Overall Study|Other reason not defined above|0|||
30836310|NCT01368081|58860880|FG003|Overall Study|Other reason not defined above|1|||
30836311|NCT01368081|58860881|FG004|Overall Study|Other reason not defined above|0|||
30836312|NCT01368081|58860882|FG005|Overall Study|Other reason not defined above|1|||
30836313|NCT01368081|58860883|FG006|Overall Study|Other reason not defined above|2|||
30926856|NCT02104817|58962435|FG001|Overall Study|Study terminated by sponsor|5901|||
30926857|NCT02104817|58962434|FG000|Overall Study|Withdrawal by Subject|111|||
30926858|NCT02104817|58962435|FG001|Overall Study|Withdrawal by Subject|78|||
30926859|NCT02104817|58962434|FG000|Overall Study|Other reasons|128|||
30926860|NCT02104817|58962435|FG001|Overall Study|Other reasons|135|||
30926861|NCT01962103|58962450|FG000|Phase 1|Adverse Event|4|||
30926862|NCT01962103|58962451|FG001|Phase 1|Adverse Event|0|||
30926863|NCT01962103|58962452|FG002|Phase 1|Adverse Event|2|||
30926864|NCT01962103|58962453|FG003|Phase 1|Adverse Event|1|||
30926865|NCT01962103|58962454|FG004|Phase 1|Adverse Event|2|||
30926866|NCT01962103|58962455|FG005|Phase 1|Adverse Event|2|||
30926867|NCT01962103|58962456|FG006|Phase 1|Adverse Event|0|||
30926868|NCT01962103|58962457|FG007|Phase 1|Adverse Event|0|||
30926869|NCT01962103|58962458|FG008|Phase 1|Adverse Event|0|||
30926870|NCT01962103|58962450|FG000|Phase 1|Progressive Disease|8|||
30926871|NCT01962103|58962451|FG001|Phase 1|Progressive Disease|6|||
30926872|NCT01962103|58962452|FG002|Phase 1|Progressive Disease|8|||
30926873|NCT01962103|58962453|FG003|Phase 1|Progressive Disease|4|||
30926874|NCT01962103|58962454|FG004|Phase 1|Progressive Disease|5|||
30926875|NCT01962103|58962455|FG005|Phase 1|Progressive Disease|4|||
30926876|NCT01962103|58962456|FG006|Phase 1|Progressive Disease|0|||
30926877|NCT01962103|58962457|FG007|Phase 1|Progressive Disease|0|||
30926878|NCT01962103|58962458|FG008|Phase 1|Progressive Disease|0|||
30926879|NCT01962103|58962450|FG000|Phase 1|Withdrawal by Subject|0|||
30926880|NCT01962103|58962451|FG001|Phase 1|Withdrawal by Subject|0|||
30926881|NCT01962103|58962452|FG002|Phase 1|Withdrawal by Subject|0|||
30926882|NCT01962103|58962453|FG003|Phase 1|Withdrawal by Subject|2|||
30926883|NCT01962103|58962454|FG004|Phase 1|Withdrawal by Subject|0|||
30926884|NCT01962103|58962455|FG005|Phase 1|Withdrawal by Subject|0|||
30757470|NCT03628924|58766895|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
30757471|NCT03627832|58766909|FG000|Overall Study|Withdrawal by Subject|10|||
30757472|NCT03627832|58766910|FG001|Overall Study|Withdrawal by Subject|1|||
30757473|NCT00112437|58766921|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
30757474|NCT00112437|58766922|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
30757475|NCT00112437|58766923|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
30757476|NCT00112437|58766924|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
30836314|NCT01368081|58860884|FG007|Overall Study|Other reason not defined above|0|||
30836315|NCT01368081|58860885|FG008|Overall Study|Other reason not defined above|0|||
30836316|NCT01368081|58860886|FG009|Overall Study|Other reason not defined above|1|||
30926885|NCT01962103|58962456|FG006|Phase 1|Withdrawal by Subject|0|||
30926886|NCT01962103|58962457|FG007|Phase 1|Withdrawal by Subject|0|||
30926887|NCT01962103|58962458|FG008|Phase 1|Withdrawal by Subject|0|||
30926888|NCT01962103|58962450|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
30926889|NCT01962103|58962451|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
30836317|NCT01368081|58860887|FG010|Overall Study|Other reason not defined above|0|||
30926890|NCT01962103|58962452|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
30926891|NCT01962103|58962453|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
30926892|NCT01962103|58962454|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
30926893|NCT01962103|58962455|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
30926894|NCT01962103|58962456|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
30926895|NCT01962103|58962457|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
30926896|NCT01962103|58962458|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
30926897|NCT01962103|58962450|FG000|Phase 1|Physician Decision|0|||
30926898|NCT01962103|58962451|FG001|Phase 1|Physician Decision|0|||
30926899|NCT01962103|58962452|FG002|Phase 1|Physician Decision|0|||
30926900|NCT01962103|58962453|FG003|Phase 1|Physician Decision|1|||
30926901|NCT01962103|58962454|FG004|Phase 1|Physician Decision|0|||
30926902|NCT01962103|58962455|FG005|Phase 1|Physician Decision|0|||
30926903|NCT01962103|58962456|FG006|Phase 1|Physician Decision|0|||
30836318|NCT01368081|58860888|FG011|Overall Study|Other reason not defined above|0|||
30836319|NCT01368081|58860889|FG012|Overall Study|Other reason not defined above|3|||
30836320|NCT00303498|58860919|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
30836321|NCT00303498|58860920|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
30757477|NCT00112437|58766925|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
30757478|NCT00112437|58766926|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757479|NCT00112437|58766927|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757480|NCT00112437|58766928|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757481|NCT00112437|58766929|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757482|NCT00112437|58766930|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757483|NCT00112437|58766931|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
30926904|NCT01962103|58962457|FG007|Phase 1|Physician Decision|0|||
30926905|NCT01962103|58962458|FG008|Phase 1|Physician Decision|0|||
30926906|NCT01962103|58962450|FG000|Phase 1|Symptomatic Deterioration|3|||
30926907|NCT01962103|58962451|FG001|Phase 1|Symptomatic Deterioration|2|||
30926908|NCT01962103|58962452|FG002|Phase 1|Symptomatic Deterioration|2|||
30926909|NCT01962103|58962453|FG003|Phase 1|Symptomatic Deterioration|2|||
30926910|NCT01962103|58962454|FG004|Phase 1|Symptomatic Deterioration|1|||
30757484|NCT00112437|58766932|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
30836322|NCT00303498|58860919|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
30836323|NCT00303498|58860920|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
30836324|NCT00303498|58860919|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
30836325|NCT00303498|58860920|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
30836326|NCT00303498|58860919|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
30836327|NCT00303498|58860920|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
30836328|NCT00303498|58860919|FG000|Run-In-Phase (10 Weeks)|Other|4|||
30836329|NCT00303498|58860920|FG001|Run-In-Phase (10 Weeks)|Other|1|||
30836330|NCT00303498|58860919|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
30836331|NCT00303498|58860920|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
30836332|NCT00303498|58860919|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
30836333|NCT00303498|58860920|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
30836334|NCT00303498|58860919|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
30836335|NCT00303498|58860920|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
30836336|NCT00303498|58860919|FG000|Maintenance Phase (24 Weeks)|Death|1|||
30836337|NCT00303498|58860920|FG001|Maintenance Phase (24 Weeks)|Death|0|||
30836338|NCT00303498|58860919|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
30836339|NCT00303498|58860920|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
30836340|NCT00303498|58860919|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
30836341|NCT00303498|58860920|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
30836342|NCT00303498|58860919|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
30836343|NCT00303498|58860920|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
30836344|NCT00303498|58860919|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
30836345|NCT00303498|58860920|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
30836346|NCT00303498|58860919|FG000|Maintenance Phase (24 Weeks)|Other|1|||
30836347|NCT00303498|58860920|FG001|Maintenance Phase (24 Weeks)|Other|0|||
30836348|NCT00303498|58860919|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
30836349|NCT00303498|58860920|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
30836350|NCT00303498|58860919|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
30836351|NCT00303498|58860920|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
30836352|NCT02588092|58860936|FG000|Overall Study|Death|4|||
30836353|NCT02588092|58860937|FG001|Overall Study|Death|3|||
30836354|NCT02588092|58860938|FG002|Overall Study|Death|3|||
30836355|NCT02588092|58860939|FG003|Overall Study|Death|3|||
30836356|NCT02588092|58860940|FG004|Overall Study|Death|2|||
30836357|NCT02588092|58860941|FG005|Overall Study|Death|2|||
30836358|NCT02588092|58860942|FG006|Overall Study|Death|2|||
30836359|NCT02588092|58860943|FG007|Overall Study|Death|1|||
30836360|NCT02588092|58860944|FG008|Overall Study|Death|5|||
30836361|NCT02588092|58860945|FG009|Overall Study|Death|2|||
30836362|NCT02588092|58860936|FG000|Overall Study|Withdrawal by Subject|0|||
30836363|NCT02588092|58860937|FG001|Overall Study|Withdrawal by Subject|0|||
30836364|NCT02588092|58860938|FG002|Overall Study|Withdrawal by Subject|0|||
30926911|NCT01962103|58962455|FG005|Phase 1|Symptomatic Deterioration|1|||
30926912|NCT01962103|58962456|FG006|Phase 1|Symptomatic Deterioration|0|||
30926913|NCT01962103|58962457|FG007|Phase 1|Symptomatic Deterioration|0|||
30926914|NCT01962103|58962458|FG008|Phase 1|Symptomatic Deterioration|0|||
30926915|NCT01962103|58962450|FG000|Phase 1|Miscellaneous|1|||
30926916|NCT01962103|58962451|FG001|Phase 1|Miscellaneous|0|||
30926917|NCT01962103|58962452|FG002|Phase 1|Miscellaneous|0|||
30926918|NCT01962103|58962453|FG003|Phase 1|Miscellaneous|0|||
30926919|NCT01962103|58962454|FG004|Phase 1|Miscellaneous|0|||
30926920|NCT01962103|58962455|FG005|Phase 1|Miscellaneous|0|||
30926921|NCT01962103|58962456|FG006|Phase 1|Miscellaneous|0|||
30926922|NCT01962103|58962457|FG007|Phase 1|Miscellaneous|0|||
30926923|NCT01962103|58962458|FG008|Phase 1|Miscellaneous|0|||
30926924|NCT01962103|58962450|FG000|Phase 2|Adverse Event|0|||
30926925|NCT01962103|58962451|FG001|Phase 2|Adverse Event|0|||
30926926|NCT01962103|58962452|FG002|Phase 2|Adverse Event|0|||
30926927|NCT01962103|58962453|FG003|Phase 2|Adverse Event|0|||
30926928|NCT01962103|58962454|FG004|Phase 2|Adverse Event|0|||
30926929|NCT01962103|58962455|FG005|Phase 2|Adverse Event|0|||
30926930|NCT01962103|58962456|FG006|Phase 2|Adverse Event|1|||
30926931|NCT01962103|58962457|FG007|Phase 2|Adverse Event|0|||
30926932|NCT01962103|58962458|FG008|Phase 2|Adverse Event|3|||
30926933|NCT01962103|58962450|FG000|Phase 2|Progressive Disease|0|||
30926934|NCT01962103|58962451|FG001|Phase 2|Progressive Disease|0|||
30926935|NCT01962103|58962452|FG002|Phase 2|Progressive Disease|0|||
30926936|NCT01962103|58962453|FG003|Phase 2|Progressive Disease|0|||
30926937|NCT01962103|58962454|FG004|Phase 2|Progressive Disease|0|||
30926938|NCT01962103|58962455|FG005|Phase 2|Progressive Disease|0|||
30926939|NCT01962103|58962456|FG006|Phase 2|Progressive Disease|11|||
30926940|NCT01962103|58962457|FG007|Phase 2|Progressive Disease|12|||
30926941|NCT01962103|58962458|FG008|Phase 2|Progressive Disease|11|||
30757485|NCT00112437|58766933|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757486|NCT00112437|58766934|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757487|NCT00112437|58766935|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757488|NCT00112437|58766936|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757489|NCT00112437|58766937|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757490|NCT00112437|58766938|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
30836365|NCT02588092|58860939|FG003|Overall Study|Withdrawal by Subject|0|||
30836366|NCT02588092|58860940|FG004|Overall Study|Withdrawal by Subject|0|||
30836367|NCT02588092|58860941|FG005|Overall Study|Withdrawal by Subject|1|||
30836368|NCT02588092|58860942|FG006|Overall Study|Withdrawal by Subject|1|||
30836369|NCT02588092|58860943|FG007|Overall Study|Withdrawal by Subject|2|||
30836370|NCT02588092|58860944|FG008|Overall Study|Withdrawal by Subject|0|||
30836371|NCT02588092|58860945|FG009|Overall Study|Withdrawal by Subject|0|||
30836372|NCT02588092|58860936|FG000|Overall Study|Started Another Treatment|0|||
30836373|NCT02588092|58860937|FG001|Overall Study|Started Another Treatment|0|||
30836374|NCT02588092|58860938|FG002|Overall Study|Started Another Treatment|0|||
30836375|NCT02588092|58860939|FG003|Overall Study|Started Another Treatment|0|||
30836376|NCT02588092|58860940|FG004|Overall Study|Started Another Treatment|1|||
30836377|NCT02588092|58860941|FG005|Overall Study|Started Another Treatment|0|||
30836378|NCT02588092|58860942|FG006|Overall Study|Started Another Treatment|0|||
30836379|NCT02588092|58860943|FG007|Overall Study|Started Another Treatment|1|||
30836380|NCT02588092|58860944|FG008|Overall Study|Started Another Treatment|0|||
30836381|NCT02588092|58860945|FG009|Overall Study|Started Another Treatment|0|||
30836382|NCT02588092|58860936|FG000|Overall Study|Sponsor Decision|0|||
30836383|NCT02588092|58860937|FG001|Overall Study|Sponsor Decision|0|||
30836384|NCT02588092|58860938|FG002|Overall Study|Sponsor Decision|0|||
30836385|NCT02588092|58860939|FG003|Overall Study|Sponsor Decision|0|||
30836386|NCT02588092|58860940|FG004|Overall Study|Sponsor Decision|0|||
30836387|NCT02588092|58860941|FG005|Overall Study|Sponsor Decision|0|||
30836388|NCT02588092|58860942|FG006|Overall Study|Sponsor Decision|0|||
30836389|NCT02588092|58860943|FG007|Overall Study|Sponsor Decision|0|||
30836390|NCT02588092|58860944|FG008|Overall Study|Sponsor Decision|1|||
30836391|NCT02588092|58860945|FG009|Overall Study|Sponsor Decision|1|||
30836392|NCT01367847|58860973|FG000|Overall Study|Withdrawal by Subject|2|||
30836393|NCT01367847|58860974|FG001|Overall Study|Withdrawal by Subject|2|||
30926942|NCT01962103|58962450|FG000|Phase 2|Symptomatic Deterioration|0|||
30836394|NCT00150618|58860986|FG000|Overall Study|Adverse Event|2|||
30757491|NCT00112437|58766939|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757492|NCT00112437|58766940|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757493|NCT00112437|58766941|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
30836395|NCT00150618|58860987|FG001|Overall Study|Adverse Event|2|||
30836396|NCT00150618|58860988|FG002|Overall Study|Adverse Event|6|||
30836397|NCT00150618|58860989|FG003|Overall Study|Adverse Event|9|||
30836398|NCT00150618|58860990|FG004|Overall Study|Adverse Event|5|||
30836399|NCT00150618|58860986|FG000|Overall Study|Withdrawal by Subject|6|||
30926943|NCT01962103|58962451|FG001|Phase 2|Symptomatic Deterioration|0|||
30926944|NCT01962103|58962452|FG002|Phase 2|Symptomatic Deterioration|0|||
30926945|NCT01962103|58962453|FG003|Phase 2|Symptomatic Deterioration|0|||
30926946|NCT01962103|58962454|FG004|Phase 2|Symptomatic Deterioration|0|||
30926947|NCT01962103|58962455|FG005|Phase 2|Symptomatic Deterioration|0|||
30926948|NCT01962103|58962456|FG006|Phase 2|Symptomatic Deterioration|2|||
30926949|NCT01962103|58962457|FG007|Phase 2|Symptomatic Deterioration|2|||
30926950|NCT01962103|58962458|FG008|Phase 2|Symptomatic Deterioration|0|||
30926951|NCT01961323|58962478|FG000|Overall Study|Withdrawal by Subject|7|||
30926952|NCT01961323|58962478|FG000|Overall Study|Lost to Follow-up|8|||
30926953|NCT01961323|58962478|FG000|Overall Study|screen failure|34|||
30926954|NCT01960855|58962487|FG000|Overall Study|Subject noncompliant|1|||
30926955|NCT01960855|58962488|FG001|Overall Study|Subject noncompliant|0|||
30926956|NCT01960855|58962489|FG002|Overall Study|Subject noncompliant|0|||
30926957|NCT01960855|58962490|FG003|Overall Study|Subject noncompliant|0|||
30926958|NCT01960855|58962491|FG004|Overall Study|Subject noncompliant|0|||
30926959|NCT01960855|58962487|FG000|Overall Study|Adverse Event|2|||
30926960|NCT01960855|58962488|FG001|Overall Study|Adverse Event|0|||
30926961|NCT01960855|58962489|FG002|Overall Study|Adverse Event|6|||
30926962|NCT01960855|58962490|FG003|Overall Study|Adverse Event|2|||
30926963|NCT01960855|58962491|FG004|Overall Study|Adverse Event|2|||
30926964|NCT01960855|58962487|FG000|Overall Study|Lack of Efficacy|1|||
30926965|NCT01960855|58962488|FG001|Overall Study|Lack of Efficacy|1|||
30926966|NCT01960855|58962489|FG002|Overall Study|Lack of Efficacy|0|||
30926967|NCT01960855|58962490|FG003|Overall Study|Lack of Efficacy|0|||
30926968|NCT01960855|58962491|FG004|Overall Study|Lack of Efficacy|0|||
30926969|NCT01960855|58962487|FG000|Overall Study|Other|2|||
30926970|NCT01960855|58962488|FG001|Overall Study|Other|1|||
30926971|NCT01960855|58962489|FG002|Overall Study|Other|1|||
30926972|NCT01960855|58962490|FG003|Overall Study|Other|1|||
30926973|NCT01960855|58962491|FG004|Overall Study|Other|0|||
30926974|NCT01960855|58962487|FG000|Overall Study|Consent withdrawn by subject|3|||
30926975|NCT01960855|58962488|FG001|Overall Study|Consent withdrawn by subject|1|||
30926976|NCT01960855|58962489|FG002|Overall Study|Consent withdrawn by subject|2|||
30926977|NCT01960855|58962490|FG003|Overall Study|Consent withdrawn by subject|1|||
30926978|NCT01960855|58962491|FG004|Overall Study|Consent withdrawn by subject|1|||
30926979|NCT01960855|58962487|FG000|Overall Study|Lost to Follow-up|2|||
30926980|NCT01960855|58962488|FG001|Overall Study|Lost to Follow-up|1|||
30926981|NCT01960855|58962489|FG002|Overall Study|Lost to Follow-up|0|||
30926982|NCT01960855|58962490|FG003|Overall Study|Lost to Follow-up|0|||
30926983|NCT01960855|58962491|FG004|Overall Study|Lost to Follow-up|2|||
30926984|NCT02007434|58962511|FG000|Overall Study|Lost to Follow-up|0|||
30926985|NCT02007434|58962512|FG001|Overall Study|Lost to Follow-up|1|||
30926986|NCT02007434|58962513|FG002|Overall Study|Lost to Follow-up|0|||
30926987|NCT02007434|58962514|FG003|Overall Study|Lost to Follow-up|0|||
30926988|NCT02007434|58962515|FG004|Overall Study|Lost to Follow-up|0|||
30926989|NCT02007434|58962516|FG005|Overall Study|Lost to Follow-up|0|||
30926990|NCT02007434|58962517|FG006|Overall Study|Lost to Follow-up|0|||
30926991|NCT02007434|58962518|FG007|Overall Study|Lost to Follow-up|0|||
30926992|NCT02007434|58962511|FG000|Overall Study|Non-compliance|1|||
30926993|NCT02007434|58962512|FG001|Overall Study|Non-compliance|0|||
30926994|NCT02007434|58962513|FG002|Overall Study|Non-compliance|1|||
30926995|NCT02007434|58962514|FG003|Overall Study|Non-compliance|0|||
30926996|NCT02007434|58962515|FG004|Overall Study|Non-compliance|0|||
30926997|NCT02007434|58962516|FG005|Overall Study|Non-compliance|0|||
30926998|NCT02007434|58962517|FG006|Overall Study|Non-compliance|0|||
30926999|NCT02007434|58962518|FG007|Overall Study|Non-compliance|0|||
30927000|NCT01987453|58962540|FG000|Overall Study|Death|0|||
30927001|NCT01987453|58962541|FG001|Overall Study|Death|0|||
30927002|NCT01987453|58962542|FG002|Overall Study|Death|1|||
30927003|NCT01987453|58962540|FG000|Overall Study|Lack of Efficacy|1|||
30927004|NCT01987453|58962541|FG001|Overall Study|Lack of Efficacy|12|||
30927005|NCT01987453|58962542|FG002|Overall Study|Lack of Efficacy|0|||
30927006|NCT02006641|58962557|FG000|Overall Study|Withdrawal before treatment|2|||
30927007|NCT02006641|58962558|FG001|Overall Study|Withdrawal before treatment|5|||
30836400|NCT00150618|58860987|FG001|Overall Study|Withdrawal by Subject|8|||
30836401|NCT00150618|58860988|FG002|Overall Study|Withdrawal by Subject|8|||
30836402|NCT00150618|58860989|FG003|Overall Study|Withdrawal by Subject|4|||
30836403|NCT00150618|58860990|FG004|Overall Study|Withdrawal by Subject|5|||
30836404|NCT00150618|58860986|FG000|Overall Study|Lost to Follow-up|4|||
30836405|NCT00150618|58860987|FG001|Overall Study|Lost to Follow-up|1|||
30836406|NCT00150618|58860988|FG002|Overall Study|Lost to Follow-up|5|||
30836407|NCT00150618|58860989|FG003|Overall Study|Lost to Follow-up|8|||
30836408|NCT00150618|58860990|FG004|Overall Study|Lost to Follow-up|4|||
30836409|NCT00150618|58860986|FG000|Overall Study|Protocol Violation|1|||
30927008|NCT02006641|58962559|FG002|Overall Study|Withdrawal before treatment|3|||
30927009|NCT02006641|58962557|FG000|Overall Study|Adverse Event|15|||
30927010|NCT02006641|58962558|FG001|Overall Study|Adverse Event|11|||
30927011|NCT02006641|58962559|FG002|Overall Study|Adverse Event|15|||
30927012|NCT02006641|58962557|FG000|Overall Study|Protocol Violation|0|||
30927013|NCT02006641|58962558|FG001|Overall Study|Protocol Violation|2|||
30927014|NCT02006641|58962559|FG002|Overall Study|Protocol Violation|2|||
30927015|NCT02006641|58962557|FG000|Overall Study|Lost to Follow-up|0|||
30927016|NCT02006641|58962558|FG001|Overall Study|Lost to Follow-up|1|||
30927017|NCT02006641|58962559|FG002|Overall Study|Lost to Follow-up|0|||
30927018|NCT02006641|58962557|FG000|Overall Study|Withdrawal by Subject|7|||
30927019|NCT02006641|58962558|FG001|Overall Study|Withdrawal by Subject|12|||
30927020|NCT02006641|58962559|FG002|Overall Study|Withdrawal by Subject|11|||
30927021|NCT02006641|58962557|FG000|Overall Study|Other reason: patient didn't show up|1|||
30927022|NCT02006641|58962558|FG001|Overall Study|Other reason: patient didn't show up|0|||
30927023|NCT02006641|58962559|FG002|Overall Study|Other reason: patient didn't show up|0|||
30927024|NCT02006641|58962557|FG000|Overall Study|Other reason:patient didn't want to come|0|||
30927025|NCT02006641|58962558|FG001|Overall Study|Other reason:patient didn't want to come|0|||
30927026|NCT02006641|58962559|FG002|Overall Study|Other reason:patient didn't want to come|1|||
30927027|NCT02006641|58962557|FG000|Overall Study|Other reason: patient has moved|1|||
30927028|NCT02006641|58962558|FG001|Overall Study|Other reason: patient has moved|0|||
30927029|NCT02006641|58962559|FG002|Overall Study|Other reason: patient has moved|1|||
30927030|NCT02006641|58962557|FG000|Overall Study|Other reason: caregiver in hospital|0|||
30927031|NCT02006641|58962558|FG001|Overall Study|Other reason: caregiver in hospital|1|||
30927032|NCT02006641|58962559|FG002|Overall Study|Other reason: caregiver in hospital|0|||
30927033|NCT02006641|58962557|FG000|Overall Study|Other reason: patient's wife has died|0|||
30927034|NCT02006641|58962558|FG001|Overall Study|Other reason: patient's wife has died|0|||
30927035|NCT02006641|58962559|FG002|Overall Study|Other reason: patient's wife has died|1|||
30927036|NCT02006641|58962557|FG000|Overall Study|Other reason: hospitalisation|0|||
30927037|NCT02006641|58962558|FG001|Overall Study|Other reason: hospitalisation|1|||
30927038|NCT02006641|58962559|FG002|Overall Study|Other reason: hospitalisation|0|||
30927039|NCT02006641|58962557|FG000|Overall Study|Other reason: caregiver impossibility|0|||
30927040|NCT02006641|58962558|FG001|Overall Study|Other reason: caregiver impossibility|0|||
30927041|NCT02006641|58962559|FG002|Overall Study|Other reason: caregiver impossibility|1|||
30927042|NCT02006641|58962557|FG000|Overall Study|Other reason: protocol non-compliance|0|||
30927043|NCT02006641|58962558|FG001|Overall Study|Other reason: protocol non-compliance|0|||
30927044|NCT02006641|58962559|FG002|Overall Study|Other reason: protocol non-compliance|1|||
30927045|NCT01959919|58962567|FG000|Overall Study|Did not meet the eligibility criteria|2|||
30927046|NCT01986985|58962575|FG000|Overall Study|Withdrawal by Subject|4|||
30927047|NCT01986985|58962575|FG000|Overall Study|Scan not completed due to malfunction|3|||
30927048|NCT01986907|58962579|FG000|Overall Study|Adverse Event|11|||
30927049|NCT01986907|58962579|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
30927050|NCT01986907|58962579|FG000|Overall Study|Protocol Violation|4|||
30927051|NCT01986907|58962579|FG000|Overall Study|Withdrawal by Subject|76|||
30927052|NCT01986907|58962579|FG000|Overall Study|Lost to Follow-up|38|||
30927053|NCT01986907|58962579|FG000|Overall Study|Death|9|||
30927054|NCT01959841|58962589|FG000|Overall Study|Adverse Event|1|||
30927055|NCT01959841|58962590|FG001|Overall Study|Adverse Event|3|||
30927056|NCT01959841|58962591|FG002|Overall Study|Adverse Event|2|||
30927057|NCT01959841|58962589|FG000|Overall Study|Lack of Efficacy|5|||
30927058|NCT01959841|58962590|FG001|Overall Study|Lack of Efficacy|0|||
30927059|NCT01959841|58962591|FG002|Overall Study|Lack of Efficacy|0|||
30836410|NCT00150618|58860987|FG001|Overall Study|Protocol Violation|0|||
30836411|NCT00150618|58860988|FG002|Overall Study|Protocol Violation|0|||
30836412|NCT00150618|58860989|FG003|Overall Study|Protocol Violation|0|||
30836413|NCT00150618|58860990|FG004|Overall Study|Protocol Violation|1|||
30836414|NCT00150618|58860986|FG000|Overall Study|Lack of Efficacy|1|||
30836415|NCT00150618|58860987|FG001|Overall Study|Lack of Efficacy|4|||
30836416|NCT00150618|58860988|FG002|Overall Study|Lack of Efficacy|7|||
30836417|NCT00150618|58860989|FG003|Overall Study|Lack of Efficacy|4|||
30836418|NCT00150618|58860990|FG004|Overall Study|Lack of Efficacy|6|||
30836419|NCT00150618|58860986|FG000|Overall Study|No study meds|0|||
30836420|NCT00150618|58860987|FG001|Overall Study|No study meds|0|||
30836421|NCT00150618|58860988|FG002|Overall Study|No study meds|0|||
30836422|NCT00150618|58860989|FG003|Overall Study|No study meds|0|||
30836423|NCT00150618|58860990|FG004|Overall Study|No study meds|2|||
30836424|NCT00150618|58860986|FG000|Overall Study|Physician Decision|0|||
30836425|NCT00150618|58860987|FG001|Overall Study|Physician Decision|2|||
30836426|NCT00150618|58860988|FG002|Overall Study|Physician Decision|0|||
30836427|NCT00150618|58860989|FG003|Overall Study|Physician Decision|0|||
30836428|NCT00150618|58860990|FG004|Overall Study|Physician Decision|1|||
30836429|NCT00150618|58860986|FG000|Overall Study|Lack of compliance|2|||
30927060|NCT01959841|58962589|FG000|Overall Study|Lost to Follow-up|1|||
30927061|NCT01959841|58962590|FG001|Overall Study|Lost to Follow-up|1|||
30927062|NCT01959841|58962591|FG002|Overall Study|Lost to Follow-up|0|||
30927063|NCT01959841|58962589|FG000|Overall Study|Physician Decision|0|||
30836430|NCT00150618|58860987|FG001|Overall Study|Lack of compliance|1|||
30836431|NCT00150618|58860988|FG002|Overall Study|Lack of compliance|1|||
30927064|NCT01959841|58962590|FG001|Overall Study|Physician Decision|2|||
30927065|NCT01959841|58962591|FG002|Overall Study|Physician Decision|3|||
30927066|NCT01959841|58962589|FG000|Overall Study|Protocol Violation|16|||
30927067|NCT01959841|58962590|FG001|Overall Study|Protocol Violation|23|||
30927068|NCT01959841|58962591|FG002|Overall Study|Protocol Violation|16|||
30927069|NCT01959841|58962589|FG000|Overall Study|Withdrawal by Subject|7|||
30927070|NCT01959841|58962590|FG001|Overall Study|Withdrawal by Subject|7|||
30927071|NCT01959841|58962591|FG002|Overall Study|Withdrawal by Subject|5|||
30927072|NCT01959841|58962589|FG000|Overall Study|Clinical laboratory value|2|||
30927073|NCT01959841|58962590|FG001|Overall Study|Clinical laboratory value|6|||
30836432|NCT00150618|58860989|FG003|Overall Study|Lack of compliance|0|||
30836433|NCT00150618|58860990|FG004|Overall Study|Lack of compliance|1|||
30836434|NCT00150618|58860986|FG000|Overall Study|Abnormal ECG|1|||
30836435|NCT00150618|58860987|FG001|Overall Study|Abnormal ECG|0|||
30836436|NCT00150618|58860988|FG002|Overall Study|Abnormal ECG|0|||
30836437|NCT00150618|58860989|FG003|Overall Study|Abnormal ECG|0|||
30836438|NCT00150618|58860990|FG004|Overall Study|Abnormal ECG|0|||
30836439|NCT00150618|58860986|FG000|Overall Study|Sponsor's decision|0|||
30836440|NCT00150618|58860987|FG001|Overall Study|Sponsor's decision|0|||
30836441|NCT00150618|58860988|FG002|Overall Study|Sponsor's decision|0|||
30927074|NCT01959841|58962591|FG002|Overall Study|Clinical laboratory value|6|||
30927075|NCT01959841|58962589|FG000|Overall Study|Platelet count below on day1 or 4|11|||
30927076|NCT01959841|58962590|FG001|Overall Study|Platelet count below on day1 or 4|15|||
30927077|NCT01959841|58962591|FG002|Overall Study|Platelet count below on day1 or 4|11|||
30927078|NCT02005627|58962601|FG000|Overall Study|Lost to Follow-up|1|||
30927079|NCT02005627|58962602|FG001|Overall Study|Lost to Follow-up|2|||
30927080|NCT02005627|58962601|FG000|Overall Study|Withdrawal by Subject|1|||
30927081|NCT02005627|58962602|FG001|Overall Study|Withdrawal by Subject|2|||
30927082|NCT02104583|58962614|FG000|Overall Study|New ICD or CRT-D implanted|2|||
30927083|NCT02104583|58962615|FG001|Overall Study|New ICD or CRT-D implanted|0|||
30927084|NCT02104583|58962616|FG002|Overall Study|New ICD or CRT-D implanted|1|||
30927085|NCT02104583|58962617|FG003|Overall Study|New ICD or CRT-D implanted|0|||
30927086|NCT02104583|58962618|FG004|Overall Study|New ICD or CRT-D implanted|0|||
30927087|NCT02104583|58962614|FG000|Overall Study|Death|2|||
30927088|NCT02104583|58962615|FG001|Overall Study|Death|1|||
30927089|NCT02104583|58962616|FG002|Overall Study|Death|3|||
30927090|NCT02104583|58962617|FG003|Overall Study|Death|3|||
30927091|NCT02104583|58962618|FG004|Overall Study|Death|5|||
30927092|NCT02104583|58962614|FG000|Overall Study|Subject required cardiac ablation|6|||
30927093|NCT02104583|58962615|FG001|Overall Study|Subject required cardiac ablation|4|||
30927094|NCT02104583|58962616|FG002|Overall Study|Subject required cardiac ablation|4|||
30927095|NCT02104583|58962617|FG003|Overall Study|Subject required cardiac ablation|5|||
30927096|NCT02104583|58962618|FG004|Overall Study|Subject required cardiac ablation|4|||
30927097|NCT02104583|58962614|FG000|Overall Study|Subject required prohibited medication|0|||
30927098|NCT02104583|58962615|FG001|Overall Study|Subject required prohibited medication|1|||
30927099|NCT02104583|58962616|FG002|Overall Study|Subject required prohibited medication|1|||
30927100|NCT02104583|58962617|FG003|Overall Study|Subject required prohibited medication|0|||
30927101|NCT02104583|58962618|FG004|Overall Study|Subject required prohibited medication|1|||
30927102|NCT02104583|58962614|FG000|Overall Study|Withdrew Consent|3|||
30927103|NCT02104583|58962615|FG001|Overall Study|Withdrew Consent|2|||
30927104|NCT02104583|58962616|FG002|Overall Study|Withdrew Consent|0|||
30927105|NCT02104583|58962617|FG003|Overall Study|Withdrew Consent|2|||
30927106|NCT02104583|58962618|FG004|Overall Study|Withdrew Consent|1|||
30927107|NCT02104583|58962614|FG000|Overall Study|Investigator's Discretion|1|||
30927108|NCT02104583|58962615|FG001|Overall Study|Investigator's Discretion|0|||
30927109|NCT02104583|58962616|FG002|Overall Study|Investigator's Discretion|0|||
30927110|NCT02104583|58962617|FG003|Overall Study|Investigator's Discretion|0|||
30836442|NCT00150618|58860989|FG003|Overall Study|Sponsor's decision|1|||
30836443|NCT00150618|58860990|FG004|Overall Study|Sponsor's decision|0|||
30836444|NCT02587234|58861004|FG000|Overall Study|Withdrawal by Subject|1|||
30836445|NCT02587234|58861005|FG001|Overall Study|Withdrawal by Subject|1|||
30836446|NCT02587234|58861004|FG000|Overall Study|Lost to Follow-up|0|||
30836447|NCT02587234|58861005|FG001|Overall Study|Lost to Follow-up|2|||
30836448|NCT01359046|58861013|FG000|Overall Study|Did not receive allocated intervention|6|||
30836449|NCT01359046|58861014|FG001|Overall Study|Did not receive allocated intervention|6|||
30836450|NCT01359046|58861013|FG000|Overall Study|Physician Decision|1|||
30836451|NCT01359046|58861014|FG001|Overall Study|Physician Decision|11|||
30836452|NCT02741310|58861022|FG000|Overall Study|Sponsor Decision|2|||
30836453|NCT02741310|58861023|FG001|Overall Study|Sponsor Decision|2|||
30836454|NCT01367457|58861040|FG000|Overall Study|Death|2|||
30836455|NCT01367457|58861041|FG001|Overall Study|Death|0|||
30927111|NCT02104583|58962618|FG004|Overall Study|Investigator's Discretion|0|||
30927112|NCT02104583|58962614|FG000|Overall Study|Protocol Violation|0|||
30927113|NCT02104583|58962615|FG001|Overall Study|Protocol Violation|0|||
30927114|NCT02104583|58962616|FG002|Overall Study|Protocol Violation|1|||
30927115|NCT02104583|58962617|FG003|Overall Study|Protocol Violation|0|||
30927116|NCT02104583|58962618|FG004|Overall Study|Protocol Violation|0|||
30927117|NCT02104583|58962614|FG000|Overall Study|Adverse Event|3|||
30836456|NCT01367457|58861042|FG002|Overall Study|Death|0|||
30836457|NCT01367457|58861040|FG000|Overall Study|Investigator's decision|2|||
30927118|NCT02104583|58962615|FG001|Overall Study|Adverse Event|3|||
30927119|NCT02104583|58962616|FG002|Overall Study|Adverse Event|6|||
30836458|NCT01367457|58861041|FG001|Overall Study|Investigator's decision|0|||
30836459|NCT01367457|58861042|FG002|Overall Study|Investigator's decision|0|||
30836460|NCT01367457|58861040|FG000|Overall Study|Clinical decline (CD)|2|||
30927120|NCT02104583|58962617|FG003|Overall Study|Adverse Event|6|||
30927121|NCT02104583|58962618|FG004|Overall Study|Adverse Event|1|||
30927122|NCT02104583|58962614|FG000|Overall Study|Lost to Follow-up|1|||
30927123|NCT02104583|58962615|FG001|Overall Study|Lost to Follow-up|0|||
30927124|NCT02104583|58962616|FG002|Overall Study|Lost to Follow-up|0|||
30927125|NCT02104583|58962617|FG003|Overall Study|Lost to Follow-up|0|||
30927126|NCT02104583|58962618|FG004|Overall Study|Lost to Follow-up|0|||
30927127|NCT02104583|58962614|FG000|Overall Study|Randomized but Never Treated|0|||
30836461|NCT01367457|58861041|FG001|Overall Study|Clinical decline (CD)|0|||
30836462|NCT01367457|58861042|FG002|Overall Study|Clinical decline (CD)|0|||
30836463|NCT01367457|58861040|FG000|Overall Study|Progression and death|8|||
30836464|NCT01367457|58861041|FG001|Overall Study|Progression and death|0|||
30836465|NCT01367457|58861042|FG002|Overall Study|Progression and death|0|||
30836466|NCT01367457|58861040|FG000|Overall Study|Toxicity|16|||
30927128|NCT02104583|58962615|FG001|Overall Study|Randomized but Never Treated|0|||
30927129|NCT02104583|58962616|FG002|Overall Study|Randomized but Never Treated|0|||
30927130|NCT02104583|58962617|FG003|Overall Study|Randomized but Never Treated|1|||
30927131|NCT02104583|58962618|FG004|Overall Study|Randomized but Never Treated|0|||
30927132|NCT02074553|58962641|FG000|Intervention Period 1|Family Emergency|0|||
30927133|NCT02074553|58962642|FG001|Intervention Period 1|Family Emergency|0|||
30927134|NCT02074553|58962643|FG002|Intervention Period 1|Family Emergency|0|||
30927135|NCT02074553|58962644|FG003|Intervention Period 1|Family Emergency|1|||
30927136|NCT02074553|58962645|FG004|Intervention Period 1|Family Emergency|0|||
30927137|NCT02074553|58962646|FG005|Intervention Period 1|Family Emergency|0|||
30927138|NCT02074553|58962647|FG006|Intervention Period 1|Family Emergency|0|||
30927139|NCT02074553|58962648|FG007|Intervention Period 1|Family Emergency|0|||
30927140|NCT02074553|58962641|FG000|Washout Period 1|Adverse Event|1|||
30927141|NCT02074553|58962642|FG001|Washout Period 1|Adverse Event|0|||
30927142|NCT02074553|58962643|FG002|Washout Period 1|Adverse Event|0|||
30927143|NCT02074553|58962644|FG003|Washout Period 1|Adverse Event|0|||
30927144|NCT02074553|58962645|FG004|Washout Period 1|Adverse Event|0|||
30927145|NCT02074553|58962646|FG005|Washout Period 1|Adverse Event|0|||
30927146|NCT02074553|58962647|FG006|Washout Period 1|Adverse Event|0|||
30927147|NCT02074553|58962648|FG007|Washout Period 1|Adverse Event|0|||
30927148|NCT02074553|58962641|FG000|Washout Period 1|Physician Decision|0|||
30927149|NCT02074553|58962642|FG001|Washout Period 1|Physician Decision|0|||
30927150|NCT02074553|58962643|FG002|Washout Period 1|Physician Decision|0|||
30927151|NCT02074553|58962644|FG003|Washout Period 1|Physician Decision|1|||
30927152|NCT02074553|58962645|FG004|Washout Period 1|Physician Decision|0|||
30927153|NCT02074553|58962646|FG005|Washout Period 1|Physician Decision|0|||
30927154|NCT02074553|58962647|FG006|Washout Period 1|Physician Decision|0|||
30927155|NCT02074553|58962648|FG007|Washout Period 1|Physician Decision|0|||
30927156|NCT02074553|58962641|FG000|Washout Period 1|Other|0|||
30927157|NCT02074553|58962642|FG001|Washout Period 1|Other|0|||
30927158|NCT02074553|58962643|FG002|Washout Period 1|Other|0|||
30927159|NCT02074553|58962644|FG003|Washout Period 1|Other|0|||
30927160|NCT02074553|58962645|FG004|Washout Period 1|Other|0|||
30927161|NCT02074553|58962646|FG005|Washout Period 1|Other|1|||
30927162|NCT02074553|58962647|FG006|Washout Period 1|Other|0|||
30927163|NCT02074553|58962648|FG007|Washout Period 1|Other|0|||
30927164|NCT02074553|58962641|FG000|Washout Period 2|Adverse Event|0|||
30927165|NCT02074553|58962642|FG001|Washout Period 2|Adverse Event|0|||
30927166|NCT02074553|58962643|FG002|Washout Period 2|Adverse Event|0|||
30927167|NCT02074553|58962644|FG003|Washout Period 2|Adverse Event|0|||
30927168|NCT02074553|58962645|FG004|Washout Period 2|Adverse Event|0|||
30927169|NCT02074553|58962646|FG005|Washout Period 2|Adverse Event|0|||
30927170|NCT02074553|58962647|FG006|Washout Period 2|Adverse Event|1|||
30836467|NCT01367457|58861041|FG001|Overall Study|Toxicity|0|||
30836468|NCT01367457|58861042|FG002|Overall Study|Toxicity|0|||
30836469|NCT01367457|58861040|FG000|Overall Study|Progression|137|||
30836470|NCT01367457|58861041|FG001|Overall Study|Progression|0|||
30836471|NCT01367457|58861042|FG002|Overall Study|Progression|0|||
30836472|NCT01367457|58861040|FG000|Overall Study|Patient asks for rest + slow progression|1|||
30927171|NCT02074553|58962648|FG007|Washout Period 2|Adverse Event|0|||
30927172|NCT02074553|58962641|FG000|Washout Period 2|Physician Decision|0|||
30927173|NCT02074553|58962642|FG001|Washout Period 2|Physician Decision|0|||
30927174|NCT02074553|58962643|FG002|Washout Period 2|Physician Decision|0|||
30927175|NCT02074553|58962644|FG003|Washout Period 2|Physician Decision|0|||
30927176|NCT02074553|58962645|FG004|Washout Period 2|Physician Decision|0|||
30927177|NCT02074553|58962646|FG005|Washout Period 2|Physician Decision|1|||
30927178|NCT02074553|58962647|FG006|Washout Period 2|Physician Decision|0|||
30927179|NCT02074553|58962648|FG007|Washout Period 2|Physician Decision|0|||
30927180|NCT02074553|58962641|FG000|Washout Period 2|Lost to Follow-up|0|||
30927181|NCT02074553|58962642|FG001|Washout Period 2|Lost to Follow-up|0|||
30927182|NCT02074553|58962643|FG002|Washout Period 2|Lost to Follow-up|1|||
30927183|NCT02074553|58962644|FG003|Washout Period 2|Lost to Follow-up|0|||
30927184|NCT02074553|58962645|FG004|Washout Period 2|Lost to Follow-up|0|||
30927185|NCT02074553|58962646|FG005|Washout Period 2|Lost to Follow-up|0|||
30927186|NCT02074553|58962647|FG006|Washout Period 2|Lost to Follow-up|0|||
30927187|NCT02074553|58962648|FG007|Washout Period 2|Lost to Follow-up|0|||
30927188|NCT02074553|58962641|FG000|Washout Period 3|Physician Decision|0|||
30927189|NCT02074553|58962642|FG001|Washout Period 3|Physician Decision|0|||
30927190|NCT02074553|58962643|FG002|Washout Period 3|Physician Decision|0|||
30927191|NCT02074553|58962644|FG003|Washout Period 3|Physician Decision|0|||
30927192|NCT02074553|58962645|FG004|Washout Period 3|Physician Decision|0|||
30927193|NCT02074553|58962646|FG005|Washout Period 3|Physician Decision|0|||
30927194|NCT02074553|58962647|FG006|Washout Period 3|Physician Decision|0|||
30927195|NCT02074553|58962648|FG007|Washout Period 3|Physician Decision|1|||
30927196|NCT02073929|58962668|FG000|Overall Study|Lost to Follow-up|2|||
30927197|NCT02073929|58962669|FG001|Overall Study|Lost to Follow-up|1|||
30927198|NCT02073929|58962668|FG000|Overall Study|Adverse Event|2|||
30927199|NCT02073929|58962669|FG001|Overall Study|Adverse Event|1|||
30927200|NCT02073929|58962668|FG000|Overall Study|Withdrawal by Subject|0|||
30927201|NCT02073929|58962669|FG001|Overall Study|Withdrawal by Subject|1|||
30927202|NCT02113007|58962675|FG000|Overall Study|Progressive disease|2|||
30927203|NCT02005471|58962681|FG000|Overall Study|Ongoing in Study|144|||
30927204|NCT02005471|58962682|FG001|Overall Study|Ongoing in Study|171|||
30927205|NCT02005471|58962681|FG000|Overall Study|Adverse Event|1|||
30927206|NCT02005471|58962682|FG001|Overall Study|Adverse Event|0|||
30927207|NCT02005471|58962681|FG000|Overall Study|Death|26|||
30927208|NCT02005471|58962682|FG001|Overall Study|Death|15|||
30927209|NCT02005471|58962681|FG000|Overall Study|Lost to Follow-up|1|||
30927210|NCT02005471|58962682|FG001|Overall Study|Lost to Follow-up|0|||
30927211|NCT02005471|58962681|FG000|Overall Study|Physician Decision|2|||
30927212|NCT02005471|58962682|FG001|Overall Study|Physician Decision|1|||
30927213|NCT02005471|58962681|FG000|Overall Study|Progressive Disease|3|||
30927214|NCT02005471|58962682|FG001|Overall Study|Progressive Disease|0|||
30927215|NCT02005471|58962681|FG000|Overall Study|Withdrawal by Subject|18|||
30927216|NCT02005471|58962682|FG001|Overall Study|Withdrawal by Subject|7|||
30927217|NCT02104505|58962693|FG000|First Intervention (14 Days)|Adverse Event|2|||
30927218|NCT02104505|58962694|FG001|First Intervention (14 Days)|Adverse Event|0|||
30927219|NCT02104505|58962693|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
30927220|NCT02104505|58962694|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
30927221|NCT02104505|58962693|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
30927222|NCT02104505|58962694|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
30927223|NCT02104505|58962693|FG000|First Intervention (14 Days)|exclusionary condition|0|||
30927224|NCT02104505|58962694|FG001|First Intervention (14 Days)|exclusionary condition|1|||
30927225|NCT02104505|58962693|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
30927226|NCT02104505|58962694|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
30927227|NCT02104505|58962693|FG000|Second Intervention (14 Days)|Adverse Event|2|||
30927228|NCT02104505|58962694|FG001|Second Intervention (14 Days)|Adverse Event|0|||
30927229|NCT02111993|58962703|FG000|Overall Study|Physician Decision|5|||
30927230|NCT02111993|58962704|FG001|Overall Study|Physician Decision|4|||
30927231|NCT01959607|58962714|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
30927232|NCT01959607|58962715|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
30836473|NCT01367457|58861041|FG001|Overall Study|Patient asks for rest + slow progression|0|||
30836474|NCT01367457|58861042|FG002|Overall Study|Patient asks for rest + slow progression|0|||
30836475|NCT01367457|58861040|FG000|Overall Study|Investigator's opinion, stable disease|1|||
30836476|NCT01367457|58861041|FG001|Overall Study|Investigator's opinion, stable disease|0|||
30836477|NCT01367457|58861042|FG002|Overall Study|Investigator's opinion, stable disease|0|||
30836478|NCT01367457|58861040|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
30836479|NCT01367457|58861041|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
30836480|NCT01367457|58861042|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
30836481|NCT01367457|58861040|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
30836482|NCT01367457|58861041|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
30836483|NCT01367457|58861042|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
30836484|NCT01367457|58861040|FG000|Overall Study|low grade toxicities + stable disease|1|||
30836485|NCT01367457|58861041|FG001|Overall Study|low grade toxicities + stable disease|0|||
30836486|NCT01367457|58861042|FG002|Overall Study|low grade toxicities + stable disease|0|||
30836487|NCT01367457|58861040|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
30836488|NCT01367457|58861041|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
30927233|NCT01959607|58962716|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
30927234|NCT01959607|58962717|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
30927235|NCT02111603|58962726|FG000|Overall Study|Withdrawal by Subject|1|||
30927236|NCT02102399|58962732|FG000|Overall Study|Withdrawal by Subject|6|||
30927237|NCT02102399|58962733|FG001|Overall Study|Withdrawal by Subject|4|||
30927238|NCT02111369|58962744|FG000|Overall Study|Lost to Follow-up|2|||
30927239|NCT02111369|58962744|FG000|Overall Study|Withdrawal by Subject|1|||
30927240|NCT02111213|58962750|FG000|Overall Study|Withdrawal by Subject|3|||
30927241|NCT02111213|58962751|FG001|Overall Study|Withdrawal by Subject|2|||
30927242|NCT02111213|58962750|FG000|Overall Study|Lost to Follow-up|3|||
30927243|NCT02111213|58962751|FG001|Overall Study|Lost to Follow-up|4|||
30757494|NCT00112437|58766942|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757495|NCT00112437|58766943|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757496|NCT00112437|58766944|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757497|NCT00112437|58766945|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757498|NCT00112437|58766946|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
30757499|NCT00112437|58766921|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757500|NCT00112437|58766922|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
30757501|NCT00112437|58766923|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757502|NCT00112437|58766924|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30836489|NCT01367457|58861042|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
30836490|NCT01367457|58861040|FG000|Overall Study|Withdrawal by Subject|1|||
30836491|NCT01367457|58861041|FG001|Overall Study|Withdrawal by Subject|0|||
30836492|NCT01367457|58861042|FG002|Overall Study|Withdrawal by Subject|0|||
30836493|NCT01367457|58861040|FG000|Overall Study|CD, associated leukaemia|1|||
30836494|NCT01367457|58861041|FG001|Overall Study|CD, associated leukaemia|0|||
30836495|NCT01367457|58861042|FG002|Overall Study|CD, associated leukaemia|0|||
30836496|NCT01367457|58861040|FG000|Overall Study|Uncontrolled pain|1|||
30836497|NCT01367457|58861041|FG001|Overall Study|Uncontrolled pain|0|||
30836498|NCT01367457|58861042|FG002|Overall Study|Uncontrolled pain|0|||
30836499|NCT01367457|58861040|FG000|Overall Study|Overall status worsens to grade 4|1|||
30836500|NCT01367457|58861041|FG001|Overall Study|Overall status worsens to grade 4|0|||
30836501|NCT01367457|58861042|FG002|Overall Study|Overall status worsens to grade 4|0|||
30836502|NCT01367457|58861040|FG000|Overall Study|Stabilisation + frequent infections|1|||
30836503|NCT01367457|58861041|FG001|Overall Study|Stabilisation + frequent infections|0|||
30836504|NCT01367457|58861042|FG002|Overall Study|Stabilisation + frequent infections|0|||
30836505|NCT01367457|58861040|FG000|Overall Study|No clinical benefit|1|||
30836506|NCT01367457|58861041|FG001|Overall Study|No clinical benefit|0|||
30836507|NCT01367457|58861042|FG002|Overall Study|No clinical benefit|0|||
30836508|NCT01367457|58861040|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
30836509|NCT01367457|58861041|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
30836510|NCT01367457|58861042|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
30836511|NCT01367457|58861040|FG000|Overall Study|Overall decline|1|||
30836512|NCT01367457|58861041|FG001|Overall Study|Overall decline|0|||
30836513|NCT01367457|58861042|FG002|Overall Study|Overall decline|0|||
30836514|NCT01367457|58861040|FG000|Overall Study|Rejection of treatment|1|||
30836515|NCT01367457|58861041|FG001|Overall Study|Rejection of treatment|0|||
30836516|NCT01367457|58861042|FG002|Overall Study|Rejection of treatment|0|||
30836517|NCT01367457|58861040|FG000|Overall Study|Lost to Follow-up|1|||
30836518|NCT01367457|58861041|FG001|Overall Study|Lost to Follow-up|0|||
30836519|NCT01367457|58861042|FG002|Overall Study|Lost to Follow-up|0|||
30836520|NCT01367457|58861040|FG000|Overall Study|Death from septic shock|1|||
30836521|NCT01367457|58861041|FG001|Overall Study|Death from septic shock|0|||
30836522|NCT01367457|58861042|FG002|Overall Study|Death from septic shock|0|||
30836523|NCT01367457|58861040|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
30836524|NCT01367457|58861041|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
30836525|NCT01367457|58861042|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
30836526|NCT01367457|58861040|FG000|Overall Study|Patient's Wish|1|||
30836527|NCT01367457|58861041|FG001|Overall Study|Patient's Wish|0|||
30836528|NCT01367457|58861042|FG002|Overall Study|Patient's Wish|0|||
30836529|NCT01367457|58861040|FG000|Overall Study|Palliative. Overall decline|1|||
30836530|NCT01367457|58861041|FG001|Overall Study|Palliative. Overall decline|0|||
30836531|NCT01367457|58861042|FG002|Overall Study|Palliative. Overall decline|0|||
30836532|NCT01367457|58861040|FG000|Overall Study|Suspected DP/suspected active infection|1|||
30836533|NCT01367457|58861041|FG001|Overall Study|Suspected DP/suspected active infection|0|||
30836534|NCT01367457|58861042|FG002|Overall Study|Suspected DP/suspected active infection|0|||
30836535|NCT00235326|58861052|FG000|Overall Study|Lost to Follow-up|746|||
30836536|NCT00235326|58861053|FG001|Overall Study|Lost to Follow-up|1400|||
30836537|NCT00162942|58861063|FG000|Overall Study|Adverse Event|10|||
30836538|NCT00162942|58861064|FG001|Overall Study|Adverse Event|6|||
30836539|NCT00162942|58861063|FG000|Overall Study|Death|1|||
30836540|NCT00162942|58861064|FG001|Overall Study|Death|0|||
30836541|NCT00162942|58861063|FG000|Overall Study|Withdrawal by Subject|3|||
30836542|NCT00162942|58861064|FG001|Overall Study|Withdrawal by Subject|6|||
30836543|NCT00162942|58861063|FG000|Overall Study|Physician Decision|1|||
30836544|NCT00162942|58861064|FG001|Overall Study|Physician Decision|0|||
30836545|NCT00162942|58861063|FG000|Overall Study|Enter Open-Label Study|76|||
30836546|NCT00162942|58861064|FG001|Overall Study|Enter Open-Label Study|35|||
30836547|NCT00162942|58861063|FG000|Overall Study|Alternate Therapy|6|||
30836548|NCT00162942|58861064|FG001|Overall Study|Alternate Therapy|2|||
30836549|NCT00162942|58861063|FG000|Overall Study|Lack of Efficacy|1|||
30757503|NCT00112437|58766925|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30836550|NCT00162942|58861064|FG001|Overall Study|Lack of Efficacy|0|||
30836551|NCT00162942|58861063|FG000|Overall Study|Flare During Active Treatment|7|||
30836552|NCT00162942|58861064|FG001|Overall Study|Flare During Active Treatment|3|||
30927244|NCT02110901|58962759|FG000|Overall Study|Death|6|||
30927245|NCT02110901|58962760|FG001|Overall Study|Death|3|||
30927246|NCT02110901|58962759|FG000|Overall Study|Lost to Follow-up|12|||
30927247|NCT02110901|58962760|FG001|Overall Study|Lost to Follow-up|8|||
30927248|NCT02110901|58962759|FG000|Overall Study|Withdrawal by Subject|7|||
30927249|NCT02110901|58962760|FG001|Overall Study|Withdrawal by Subject|3|||
30927250|NCT02110901|58962759|FG000|Overall Study|received a kidney transplant|5|||
30927251|NCT02110901|58962760|FG001|Overall Study|received a kidney transplant|0|||
30927252|NCT02070965|58962770|FG000|Overall Study|Lost to Follow-up|0|||
30927253|NCT02070965|58962771|FG001|Overall Study|Lost to Follow-up|1|||
30927254|NCT02070965|58962772|FG002|Overall Study|Lost to Follow-up|0|||
30927255|NCT02070965|58962770|FG000|Overall Study|Withdrawal by Subject|1|||
30927256|NCT02070965|58962771|FG001|Overall Study|Withdrawal by Subject|1|||
30927257|NCT02070965|58962772|FG002|Overall Study|Withdrawal by Subject|1|||
30927258|NCT02070965|58962770|FG000|Overall Study|Subject moved|1|||
30927259|NCT02070965|58962771|FG001|Overall Study|Subject moved|0|||
30927260|NCT02070965|58962772|FG002|Overall Study|Subject moved|0|||
30927261|NCT02109107|58962780|FG000|Overall Study|Lost to Follow-up|2|||
30927262|NCT02100839|58962786|FG000|Multiple Ascending Dose|Adverse Event|2|||
30927263|NCT02100839|58962787|FG001|Multiple Ascending Dose|Adverse Event|0|||
30927264|NCT02100839|58962786|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
30927265|NCT02100839|58962787|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
30927266|NCT02069093|58962793|FG000|Overall Study|Disease progression|14|||
30927267|NCT02069093|58962793|FG000|Overall Study|New cancer therapy|1|||
30927268|NCT02069093|58962793|FG000|Overall Study|Death|1|||
30927269|NCT02069093|58962793|FG000|Overall Study|Administrative problems|1|||
30927270|NCT02069093|58962793|FG000|Overall Study|Withdrawal by Subject|2|||
30927271|NCT02069093|58962793|FG000|Overall Study|Abnormal laboratory values|1|||
30927272|NCT02069093|58962793|FG000|Overall Study|Adverse Event|10|||
30927273|NCT02109029|58962800|FG000|Part B|Adverse Event|0|||
30927274|NCT02109029|58962801|FG001|Part B|Adverse Event|0|||
30927275|NCT02109029|58962802|FG002|Part B|Adverse Event|0|||
30927276|NCT02109029|58962803|FG003|Part B|Adverse Event|0|||
30927277|NCT02109029|58962804|FG004|Part B|Adverse Event|1|||
30927278|NCT02109029|58962805|FG005|Part B|Adverse Event|1|||
30927279|NCT02069015|58962818|FG000|Overall Study|Lost to Follow-up|39|||
30927280|NCT02069015|58962819|FG001|Overall Study|Lost to Follow-up|32|||
30927281|NCT02069015|58962818|FG000|Overall Study|Withdrawal by Subject|1|||
30927282|NCT02069015|58962819|FG001|Overall Study|Withdrawal by Subject|1|||
30927283|NCT01598129|58962826|FG000|Overall Study|Disease progression|6|||
30927284|NCT01598129|58962826|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
30927285|NCT01598129|58962826|FG000|Overall Study|Withdrawal by Subject|1|||
30927286|NCT02068547|58962833|FG000|Overall Study|Lost to Follow-up|3|||
30927287|NCT02068547|58962834|FG001|Overall Study|Lost to Follow-up|3|||
30927288|NCT02068547|58962833|FG000|Overall Study|Physician Decision|1|||
30927289|NCT02068547|58962834|FG001|Overall Study|Physician Decision|0|||
30927290|NCT02108951|58962840|FG000|Overall Study|Lost to Follow-up|1|||
30927291|NCT02108951|58962840|FG000|Overall Study|Patient's/guardian's decision|1|||
30927292|NCT02108951|58962840|FG000|Overall Study|Study Terminated by Sponsor|14|||
30927293|NCT02107859|58962844|FG000|Overall Study|Withdrawal by Subject|14|||
30927294|NCT02107859|58962844|FG000|Overall Study|Adverse Event|3|||
30927295|NCT02107859|58962844|FG000|Overall Study|Study closure|41|||
30927296|NCT02107859|58962844|FG000|Overall Study|Other than specified|3|||
30927297|NCT02007278|58962850|FG000|Overall Study|Failure to comply with an eligibility|0|||
30927298|NCT02007278|58962851|FG001|Overall Study|Failure to comply with an eligibility|1|||
30927299|NCT02007278|58962850|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
30927300|NCT02007278|58962851|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
30927301|NCT02007278|58962850|FG000|Overall Study|Incorrect medication administration|1|||
30927302|NCT02007278|58962851|FG001|Overall Study|Incorrect medication administration|0|||
30927303|NCT02007278|58962850|FG000|Overall Study|Mis-randomization|1|||
30927304|NCT02007278|58962851|FG001|Overall Study|Mis-randomization|1|||
30927305|NCT02107313|58962857|FG000|Overall Study|One participant did not do the FED cohor|0|||
30927306|NCT02107313|58962858|FG001|Overall Study|One participant did not do the FED cohor|1|||
30927307|NCT02028338|58962866|FG000|Overall Study|Withdrawal by Subject|3|||
30927308|NCT02028338|58962867|FG001|Overall Study|Withdrawal by Subject|1|||
30927309|NCT02028338|58962866|FG000|Overall Study|Unable to contact participant|1|||
30927310|NCT02028338|58962867|FG001|Overall Study|Unable to contact participant|0|||
30927311|NCT01625897|58962875|FG000|Overall Study|Adverse Event|27|||
30927312|NCT01625897|58962876|FG001|Overall Study|Adverse Event|10|||
30927313|NCT01625897|58962875|FG000|Overall Study|Physician Decision|0|||
30927314|NCT01625897|58962876|FG001|Overall Study|Physician Decision|1|||
30927315|NCT01625897|58962875|FG000|Overall Study|Withdrawal by Subject|25|||
30927316|NCT01625897|58962876|FG001|Overall Study|Withdrawal by Subject|3|||
30927317|NCT02106923|58962885|FG000|Overall Study|Protocol Violation|0|||
30927318|NCT02106923|58962886|FG001|Overall Study|Protocol Violation|0|||
30927319|NCT02106923|58962887|FG002|Overall Study|Protocol Violation|0|||
30927320|NCT02106923|58962888|FG003|Overall Study|Protocol Violation|0|||
30927321|NCT02106923|58962889|FG004|Overall Study|Protocol Violation|0|||
30927322|NCT02106923|58962890|FG005|Overall Study|Protocol Violation|1|||
30927323|NCT02006732|58962908|FG000|Overall Study|Adverse Event|10|||
30927324|NCT02006732|58962909|FG001|Overall Study|Adverse Event|7|||
30927325|NCT02006732|58962910|FG002|Overall Study|Adverse Event|4|||
30927326|NCT02006732|58962911|FG003|Overall Study|Adverse Event|2|||
30927327|NCT02006732|58962908|FG000|Overall Study|Lack of Efficacy|6|||
30927328|NCT02006732|58962909|FG001|Overall Study|Lack of Efficacy|3|||
30927329|NCT02006732|58962910|FG002|Overall Study|Lack of Efficacy|1|||
30927330|NCT02006732|58962911|FG003|Overall Study|Lack of Efficacy|1|||
30927331|NCT02006732|58962908|FG000|Overall Study|Protocol Violation|1|||
30927332|NCT02006732|58962909|FG001|Overall Study|Protocol Violation|1|||
30927333|NCT02006732|58962910|FG002|Overall Study|Protocol Violation|0|||
30927334|NCT02006732|58962911|FG003|Overall Study|Protocol Violation|0|||
30927335|NCT02006732|58962908|FG000|Overall Study|Lost to Follow-up|0|||
30927336|NCT02006732|58962909|FG001|Overall Study|Lost to Follow-up|1|||
30927337|NCT02006732|58962910|FG002|Overall Study|Lost to Follow-up|0|||
30927338|NCT02006732|58962911|FG003|Overall Study|Lost to Follow-up|0|||
30927339|NCT02006732|58962908|FG000|Overall Study|Withdrawal by Subject|3|||
30927340|NCT02006732|58962909|FG001|Overall Study|Withdrawal by Subject|0|||
30927341|NCT02006732|58962910|FG002|Overall Study|Withdrawal by Subject|4|||
30927342|NCT02006732|58962911|FG003|Overall Study|Withdrawal by Subject|1|||
30927343|NCT02098733|58962921|FG000|Overall Study|Data Not Available|5|||
30927344|NCT02098733|58962921|FG000|Overall Study|Lost to Follow-up|5|||
30927345|NCT02028182|58962925|FG000|Overall Study|Protocol Violation|2|||
30927346|NCT02098109|58962932|FG000|Overall Study|Protocol Violation|3|||
30927347|NCT02098109|58962933|FG001|Overall Study|Protocol Violation|0|||
30927348|NCT02097719|58962941|FG000|Overall Study|Subject Withdrew Consent|1|||
30927349|NCT02097719|58962942|FG001|Overall Study|Subject Withdrew Consent|0|||
30927350|NCT02097719|58962941|FG000|Overall Study|Lost to Follow-up|0|||
30927351|NCT02097719|58962942|FG001|Overall Study|Lost to Follow-up|1|||
30927352|NCT02097719|58962941|FG000|Overall Study|Adverse Event|2|||
30927353|NCT02097719|58962942|FG001|Overall Study|Adverse Event|0|||
30927354|NCT01449370|58962973|FG000|Overall Study|Disease Progression|5|||
30927355|NCT01449370|58962974|FG001|Overall Study|Disease Progression|4|||
30927356|NCT01449370|58962975|FG002|Overall Study|Disease Progression|8|||
30927357|NCT01449370|58962976|FG003|Overall Study|Disease Progression|3|||
30927358|NCT01449370|58962977|FG004|Overall Study|Disease Progression|3|||
30927359|NCT01449370|58962978|FG005|Overall Study|Disease Progression|3|||
30927360|NCT01449370|58962979|FG006|Overall Study|Disease Progression|3|||
30927361|NCT01449370|58962980|FG007|Overall Study|Disease Progression|2|||
30927362|NCT01449370|58962981|FG008|Overall Study|Disease Progression|9|||
30836553|NCT00162942|58861063|FG000|Overall Study|2 or more consecutive treatments missed|1|||
30836554|NCT00162942|58861064|FG001|Overall Study|2 or more consecutive treatments missed|0|||
30836555|NCT02786901|58861094|FG000|Overall Study|Adverse Event|1|||
30927363|NCT01449370|58962982|FG009|Overall Study|Disease Progression|1|||
30927364|NCT01449370|58962983|FG010|Overall Study|Disease Progression|3|||
30836556|NCT02786901|58861095|FG001|Overall Study|Adverse Event|1|||
30836557|NCT02786901|58861096|FG002|Overall Study|Adverse Event|2|||
30836558|NCT02786901|58861094|FG000|Overall Study|Physician Decision|1|||
30836559|NCT02786901|58861095|FG001|Overall Study|Physician Decision|0|||
30836560|NCT02786901|58861096|FG002|Overall Study|Physician Decision|0|||
30927365|NCT01449370|58962984|FG011|Overall Study|Disease Progression|3|||
30927366|NCT01449370|58962985|FG012|Overall Study|Disease Progression|2|||
30927367|NCT01449370|58962986|FG013|Overall Study|Disease Progression|8|||
30927368|NCT01449370|58962987|FG014|Overall Study|Disease Progression|3|||
30927369|NCT01449370|58962988|FG015|Overall Study|Disease Progression|1|||
30927370|NCT01449370|58962989|FG016|Overall Study|Disease Progression|4|||
30757504|NCT00112437|58766926|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30927371|NCT01449370|58962990|FG017|Overall Study|Disease Progression|3|||
30757505|NCT00112437|58766927|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757506|NCT00112437|58766928|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757507|NCT00112437|58766929|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757508|NCT00112437|58766930|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757509|NCT00112437|58766931|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757510|NCT00112437|58766932|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757511|NCT00112437|58766933|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757512|NCT00112437|58766934|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757513|NCT00112437|58766935|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757514|NCT00112437|58766936|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30836561|NCT02786901|58861094|FG000|Overall Study|Rescue Therapy Use|71|||
30836562|NCT02786901|58861095|FG001|Overall Study|Rescue Therapy Use|49|||
30927372|NCT01449370|58962991|FG018|Overall Study|Disease Progression|1|||
30927373|NCT01449370|58962992|FG019|Overall Study|Disease Progression|2|||
30927374|NCT01449370|58962993|FG020|Overall Study|Disease Progression|5|||
30927375|NCT01449370|58962994|FG021|Overall Study|Disease Progression|2|||
30927376|NCT01449370|58962995|FG022|Overall Study|Disease Progression|3|||
30927377|NCT01449370|58962996|FG023|Overall Study|Disease Progression|7|||
30927378|NCT01449370|58962997|FG024|Overall Study|Disease Progression|3|||
30927379|NCT01449370|58962973|FG000|Overall Study|Adverse Event|1|||
30927380|NCT01449370|58962974|FG001|Overall Study|Adverse Event|2|||
30927381|NCT01449370|58962975|FG002|Overall Study|Adverse Event|0|||
30927382|NCT01449370|58962976|FG003|Overall Study|Adverse Event|1|||
30927383|NCT01449370|58962977|FG004|Overall Study|Adverse Event|0|||
30927384|NCT01449370|58962978|FG005|Overall Study|Adverse Event|0|||
30927385|NCT01449370|58962979|FG006|Overall Study|Adverse Event|0|||
30927386|NCT01449370|58962980|FG007|Overall Study|Adverse Event|0|||
30927387|NCT01449370|58962981|FG008|Overall Study|Adverse Event|1|||
30927388|NCT01449370|58962982|FG009|Overall Study|Adverse Event|1|||
30927389|NCT01449370|58962983|FG010|Overall Study|Adverse Event|0|||
30927390|NCT01449370|58962984|FG011|Overall Study|Adverse Event|0|||
30927391|NCT01449370|58962985|FG012|Overall Study|Adverse Event|0|||
30927392|NCT01449370|58962986|FG013|Overall Study|Adverse Event|2|||
30927393|NCT01449370|58962987|FG014|Overall Study|Adverse Event|0|||
30927394|NCT01449370|58962988|FG015|Overall Study|Adverse Event|1|||
30927395|NCT01449370|58962989|FG016|Overall Study|Adverse Event|0|||
30927396|NCT01449370|58962990|FG017|Overall Study|Adverse Event|0|||
30927397|NCT01449370|58962991|FG018|Overall Study|Adverse Event|1|||
30927398|NCT01449370|58962992|FG019|Overall Study|Adverse Event|1|||
30927399|NCT01449370|58962993|FG020|Overall Study|Adverse Event|0|||
30927400|NCT01449370|58962994|FG021|Overall Study|Adverse Event|1|||
30927401|NCT01449370|58962995|FG022|Overall Study|Adverse Event|0|||
30927402|NCT01449370|58962996|FG023|Overall Study|Adverse Event|1|||
30927403|NCT01449370|58962997|FG024|Overall Study|Adverse Event|3|||
30927404|NCT01449370|58962973|FG000|Overall Study|Participant Decision|0|||
30927405|NCT01449370|58962974|FG001|Overall Study|Participant Decision|0|||
30927406|NCT01449370|58962975|FG002|Overall Study|Participant Decision|0|||
30927407|NCT01449370|58962976|FG003|Overall Study|Participant Decision|0|||
30927408|NCT01449370|58962977|FG004|Overall Study|Participant Decision|0|||
30927409|NCT01449370|58962978|FG005|Overall Study|Participant Decision|0|||
30927410|NCT01449370|58962979|FG006|Overall Study|Participant Decision|0|||
30927411|NCT01449370|58962980|FG007|Overall Study|Participant Decision|1|||
30927412|NCT01449370|58962981|FG008|Overall Study|Participant Decision|1|||
30927413|NCT01449370|58962982|FG009|Overall Study|Participant Decision|0|||
30927414|NCT01449370|58962983|FG010|Overall Study|Participant Decision|0|||
30927415|NCT01449370|58962984|FG011|Overall Study|Participant Decision|0|||
30927416|NCT01449370|58962985|FG012|Overall Study|Participant Decision|1|||
30927417|NCT01449370|58962986|FG013|Overall Study|Participant Decision|1|||
30927418|NCT01449370|58962987|FG014|Overall Study|Participant Decision|0|||
30757515|NCT00112437|58766937|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757516|NCT00112437|58766938|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757517|NCT00112437|58766939|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757518|NCT00112437|58766940|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757519|NCT00112437|58766941|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757520|NCT00112437|58766942|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757521|NCT00112437|58766943|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757522|NCT00112437|58766944|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757523|NCT00112437|58766945|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757524|NCT00112437|58766946|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
30757525|NCT00112437|58766921|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757526|NCT00112437|58766922|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
30757527|NCT00112437|58766923|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30836563|NCT02786901|58861096|FG002|Overall Study|Rescue Therapy Use|33|||
30836564|NCT02786901|58861094|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
30836565|NCT02786901|58861095|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
30836566|NCT02786901|58861096|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
30836567|NCT02786901|58861094|FG000|Overall Study|Disallowed medication|1|||
30836568|NCT02786901|58861095|FG001|Overall Study|Disallowed medication|1|||
30836569|NCT02786901|58861096|FG002|Overall Study|Disallowed medication|0|||
30836570|NCT02786901|58861094|FG000|Overall Study|Randomized in error|2|||
30836571|NCT02786901|58861095|FG001|Overall Study|Randomized in error|0|||
30836572|NCT02786901|58861096|FG002|Overall Study|Randomized in error|1|||
30836573|NCT02137239|58861106|FG000|Overall Study|Discontinued Study Treatment|0|||
30836574|NCT02137239|58861107|FG001|Overall Study|Discontinued Study Treatment|3|||
30927419|NCT01449370|58962988|FG015|Overall Study|Participant Decision|1|||
30757528|NCT00112437|58766924|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30836575|NCT02137239|58861106|FG000|Overall Study|Withdrew Consent|1|||
30927420|NCT01449370|58962989|FG016|Overall Study|Participant Decision|3|||
30927421|NCT01449370|58962990|FG017|Overall Study|Participant Decision|0|||
30927422|NCT01449370|58962991|FG018|Overall Study|Participant Decision|1|||
30927423|NCT01449370|58962992|FG019|Overall Study|Participant Decision|0|||
30927424|NCT01449370|58962993|FG020|Overall Study|Participant Decision|0|||
30927425|NCT01449370|58962994|FG021|Overall Study|Participant Decision|1|||
30927426|NCT01449370|58962995|FG022|Overall Study|Participant Decision|0|||
30927427|NCT01449370|58962996|FG023|Overall Study|Participant Decision|0|||
30927428|NCT01449370|58962997|FG024|Overall Study|Participant Decision|1|||
30927429|NCT01449370|58962973|FG000|Overall Study|Lost to Follow-up|0|||
30927430|NCT01449370|58962974|FG001|Overall Study|Lost to Follow-up|0|||
30927431|NCT01449370|58962975|FG002|Overall Study|Lost to Follow-up|0|||
30927432|NCT01449370|58962976|FG003|Overall Study|Lost to Follow-up|0|||
30927433|NCT01449370|58962977|FG004|Overall Study|Lost to Follow-up|0|||
30927434|NCT01449370|58962978|FG005|Overall Study|Lost to Follow-up|0|||
30927435|NCT01449370|58962979|FG006|Overall Study|Lost to Follow-up|0|||
30927436|NCT01449370|58962980|FG007|Overall Study|Lost to Follow-up|0|||
30927437|NCT01449370|58962981|FG008|Overall Study|Lost to Follow-up|0|||
30927438|NCT01449370|58962982|FG009|Overall Study|Lost to Follow-up|0|||
30927439|NCT01449370|58962983|FG010|Overall Study|Lost to Follow-up|0|||
30927440|NCT01449370|58962984|FG011|Overall Study|Lost to Follow-up|0|||
30927441|NCT01449370|58962985|FG012|Overall Study|Lost to Follow-up|0|||
30927442|NCT01449370|58962986|FG013|Overall Study|Lost to Follow-up|0|||
30927443|NCT01449370|58962987|FG014|Overall Study|Lost to Follow-up|0|||
30927444|NCT01449370|58962988|FG015|Overall Study|Lost to Follow-up|0|||
30927445|NCT01449370|58962989|FG016|Overall Study|Lost to Follow-up|0|||
30927446|NCT01449370|58962990|FG017|Overall Study|Lost to Follow-up|0|||
30927447|NCT01449370|58962991|FG018|Overall Study|Lost to Follow-up|0|||
30927448|NCT01449370|58962992|FG019|Overall Study|Lost to Follow-up|0|||
30927449|NCT01449370|58962993|FG020|Overall Study|Lost to Follow-up|1|||
30927450|NCT01449370|58962994|FG021|Overall Study|Lost to Follow-up|0|||
30624044|NCT00912028|58636031|FG001|Overall Study|Withdrawal by Subject|0|||
30624045|NCT00912028|58636032|FG002|Overall Study|Withdrawal by Subject|0|||
30836576|NCT02137239|58861107|FG001|Overall Study|Withdrew Consent|1|||
30836577|NCT02137239|58861106|FG000|Overall Study|Adverse Event|2|||
30836578|NCT02137239|58861107|FG001|Overall Study|Adverse Event|2|||
30836579|NCT02741076|58861126|FG000|Overall Study|Adverse Event|0|||
30836580|NCT02741076|58861127|FG001|Overall Study|Adverse Event|1|||
30836581|NCT02741076|58861128|FG002|Overall Study|Adverse Event|1|||
30836582|NCT02741076|58861129|FG003|Overall Study|Adverse Event|0|||
30836583|NCT02741076|58861126|FG000|Overall Study|Lack of Efficacy|1|||
30836584|NCT02741076|58861127|FG001|Overall Study|Lack of Efficacy|0|||
30836585|NCT02741076|58861128|FG002|Overall Study|Lack of Efficacy|0|||
30836586|NCT02741076|58861129|FG003|Overall Study|Lack of Efficacy|0|||
30836587|NCT02741076|58861126|FG000|Overall Study|Withdrawal by Subject|0|||
30836588|NCT02741076|58861127|FG001|Overall Study|Withdrawal by Subject|1|||
30836589|NCT02741076|58861128|FG002|Overall Study|Withdrawal by Subject|0|||
30836590|NCT02741076|58861129|FG003|Overall Study|Withdrawal by Subject|0|||
30836591|NCT02741076|58861126|FG000|Overall Study|Sponsor Request|2|||
30836592|NCT02741076|58861127|FG001|Overall Study|Sponsor Request|3|||
30836593|NCT02741076|58861128|FG002|Overall Study|Sponsor Request|0|||
30836594|NCT02741076|58861129|FG003|Overall Study|Sponsor Request|1|||
30836595|NCT02741076|58861126|FG000|Overall Study|No additional information available|0|||
30927451|NCT01449370|58962995|FG022|Overall Study|Lost to Follow-up|0|||
30927452|NCT01449370|58962996|FG023|Overall Study|Lost to Follow-up|0|||
30927453|NCT01449370|58962997|FG024|Overall Study|Lost to Follow-up|0|||
30927454|NCT01449370|58962973|FG000|Overall Study|Other|0|||
30624046|NCT00912028|58636033|FG003|Overall Study|Withdrawal by Subject|0|||
30836596|NCT02741076|58861127|FG001|Overall Study|No additional information available|0|||
30836597|NCT02741076|58861128|FG002|Overall Study|No additional information available|1|||
30836598|NCT02741076|58861129|FG003|Overall Study|No additional information available|1|||
30836599|NCT01666444|58861142|FG000|Overall Study|Did not initiate treatment|2|||
30927455|NCT01449370|58962974|FG001|Overall Study|Other|0|||
30927456|NCT01449370|58962975|FG002|Overall Study|Other|0|||
30927457|NCT01449370|58962976|FG003|Overall Study|Other|0|||
30927458|NCT01449370|58962977|FG004|Overall Study|Other|0|||
30836600|NCT01666444|58861143|FG001|Overall Study|Did not initiate treatment|1|||
30836601|NCT05159622|58861151|FG000|Overall Study|Lost to Follow-up|4|||
30836602|NCT05159622|58861152|FG001|Overall Study|Lost to Follow-up|5|||
30836603|NCT01665430|58861164|FG000|Overall Study|Adverse Event|1|||
30836604|NCT01665430|58861164|FG000|Overall Study|Withdrawal by Subject|6|||
30836605|NCT01665430|58861164|FG000|Overall Study|Other Unspecified|2|||
30836606|NCT02739594|58861170|FG000|Overall Study|Undesired Event|3|||
30836607|NCT02739594|58861171|FG001|Overall Study|Undesired Event|4|||
30836608|NCT02739594|58861170|FG000|Overall Study|Violation of Eligibility Criteria|1|||
30836609|NCT02739594|58861171|FG001|Overall Study|Violation of Eligibility Criteria|2|||
30836610|NCT02739594|58861170|FG000|Overall Study|Protocol Violation|5|||
30836611|NCT02739594|58861171|FG001|Overall Study|Protocol Violation|6|||
30836612|NCT02739594|58861170|FG000|Overall Study|Death|4|||
30836613|NCT02739594|58861171|FG001|Overall Study|Death|2|||
30836614|NCT02739594|58861170|FG000|Overall Study|Renal Insufficiency|4|||
30836615|NCT02739594|58861171|FG001|Overall Study|Renal Insufficiency|6|||
30836616|NCT02739594|58861170|FG000|Overall Study|Administrative Reasons|1|||
30836617|NCT02739594|58861171|FG001|Overall Study|Administrative Reasons|3|||
30836618|NCT02739594|58861170|FG000|Overall Study|Withdrawal by Subject|1|||
30836619|NCT02739594|58861171|FG001|Overall Study|Withdrawal by Subject|1|||
30836620|NCT02739594|58861170|FG000|Overall Study|Lost to Follow-up|0|||
30836621|NCT02739594|58861171|FG001|Overall Study|Lost to Follow-up|1|||
30836622|NCT02739594|58861170|FG000|Overall Study|Elevated Serum Creatinine|0|||
30836623|NCT02739594|58861171|FG001|Overall Study|Elevated Serum Creatinine|1|||
30836624|NCT02739594|58861170|FG000|Overall Study|Other|6|||
30836625|NCT02739594|58861171|FG001|Overall Study|Other|2|||
30836626|NCT03989232|58861180|FG000|Overall Study|Lost to Follow-up|3|||
30836627|NCT03989232|58861181|FG001|Overall Study|Lost to Follow-up|10|||
30836628|NCT03989232|58861180|FG000|Overall Study|Withdrawal by Subject|6|||
30836629|NCT03989232|58861181|FG001|Overall Study|Withdrawal by Subject|6|||
30836630|NCT03989232|58861180|FG000|Overall Study|Death|1|||
30927459|NCT01449370|58962978|FG005|Overall Study|Other|0|||
30927460|NCT01449370|58962979|FG006|Overall Study|Other|0|||
30927461|NCT01449370|58962980|FG007|Overall Study|Other|0|||
30927462|NCT01449370|58962981|FG008|Overall Study|Other|1|||
30927463|NCT01449370|58962982|FG009|Overall Study|Other|1|||
30927464|NCT01449370|58962983|FG010|Overall Study|Other|0|||
30927465|NCT01449370|58962984|FG011|Overall Study|Other|0|||
30927466|NCT01449370|58962985|FG012|Overall Study|Other|0|||
30927467|NCT01449370|58962986|FG013|Overall Study|Other|0|||
30927468|NCT01449370|58962987|FG014|Overall Study|Other|0|||
30927469|NCT01449370|58962988|FG015|Overall Study|Other|0|||
30927470|NCT01449370|58962989|FG016|Overall Study|Other|0|||
30927471|NCT01449370|58962990|FG017|Overall Study|Other|0|||
30927472|NCT01449370|58962991|FG018|Overall Study|Other|0|||
30927473|NCT01449370|58962992|FG019|Overall Study|Other|0|||
30927474|NCT01449370|58962993|FG020|Overall Study|Other|0|||
30836631|NCT03989232|58861181|FG001|Overall Study|Death|2|||
30836632|NCT02585830|58861187|FG000|Overall Study|Withdrawal by Subject|3|||
30836633|NCT02584504|58861194|FG000|Double-blind Treatment|Participant withdrew consent|0|||
30836634|NCT02584504|58861195|FG001|Double-blind Treatment|Participant withdrew consent|0|||
30927475|NCT01449370|58962994|FG021|Overall Study|Other|0|||
30927476|NCT01449370|58962995|FG022|Overall Study|Other|1|||
30927477|NCT01449370|58962996|FG023|Overall Study|Other|1|||
30927478|NCT01449370|58962997|FG024|Overall Study|Other|0|||
30927479|NCT01449370|58962973|FG000|Overall Study|Medication Prohibited by Protocol|0|||
30927480|NCT01449370|58962974|FG001|Overall Study|Medication Prohibited by Protocol|0|||
30927481|NCT01449370|58962975|FG002|Overall Study|Medication Prohibited by Protocol|0|||
30927482|NCT01449370|58962976|FG003|Overall Study|Medication Prohibited by Protocol|0|||
30927483|NCT01449370|58962977|FG004|Overall Study|Medication Prohibited by Protocol|0|||
30927484|NCT01449370|58962978|FG005|Overall Study|Medication Prohibited by Protocol|0|||
30927485|NCT01449370|58962979|FG006|Overall Study|Medication Prohibited by Protocol|0|||
30927486|NCT01449370|58962980|FG007|Overall Study|Medication Prohibited by Protocol|0|||
30927487|NCT01449370|58962981|FG008|Overall Study|Medication Prohibited by Protocol|0|||
30927488|NCT01449370|58962982|FG009|Overall Study|Medication Prohibited by Protocol|0|||
30927489|NCT01449370|58962983|FG010|Overall Study|Medication Prohibited by Protocol|0|||
30927490|NCT01449370|58962984|FG011|Overall Study|Medication Prohibited by Protocol|0|||
30927491|NCT01449370|58962985|FG012|Overall Study|Medication Prohibited by Protocol|0|||
30927492|NCT01449370|58962986|FG013|Overall Study|Medication Prohibited by Protocol|0|||
30927493|NCT01449370|58962987|FG014|Overall Study|Medication Prohibited by Protocol|0|||
30927494|NCT01449370|58962988|FG015|Overall Study|Medication Prohibited by Protocol|0|||
30927495|NCT01449370|58962989|FG016|Overall Study|Medication Prohibited by Protocol|0|||
30927496|NCT01449370|58962990|FG017|Overall Study|Medication Prohibited by Protocol|0|||
30927497|NCT01449370|58962991|FG018|Overall Study|Medication Prohibited by Protocol|0|||
30927498|NCT01449370|58962992|FG019|Overall Study|Medication Prohibited by Protocol|0|||
30927499|NCT01449370|58962993|FG020|Overall Study|Medication Prohibited by Protocol|0|||
30927500|NCT01449370|58962994|FG021|Overall Study|Medication Prohibited by Protocol|0|||
30927501|NCT01449370|58962995|FG022|Overall Study|Medication Prohibited by Protocol|0|||
30927502|NCT01449370|58962996|FG023|Overall Study|Medication Prohibited by Protocol|1|||
30927503|NCT01449370|58962997|FG024|Overall Study|Medication Prohibited by Protocol|0|||
30927504|NCT01449370|58962973|FG000|Overall Study|Death|0|||
30927505|NCT01449370|58962974|FG001|Overall Study|Death|0|||
30927506|NCT01449370|58962975|FG002|Overall Study|Death|0|||
30927507|NCT01449370|58962976|FG003|Overall Study|Death|0|||
30927508|NCT01449370|58962977|FG004|Overall Study|Death|0|||
30927509|NCT01449370|58962978|FG005|Overall Study|Death|0|||
30927510|NCT01449370|58962979|FG006|Overall Study|Death|0|||
30927511|NCT01449370|58962980|FG007|Overall Study|Death|0|||
30927512|NCT01449370|58962981|FG008|Overall Study|Death|0|||
30927513|NCT01449370|58962982|FG009|Overall Study|Death|0|||
30927514|NCT01449370|58962983|FG010|Overall Study|Death|0|||
30927515|NCT01449370|58962984|FG011|Overall Study|Death|0|||
30757529|NCT00112437|58766925|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757530|NCT00112437|58766926|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757531|NCT00112437|58766927|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757532|NCT00112437|58766928|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757533|NCT00112437|58766929|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757534|NCT00112437|58766930|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757535|NCT00112437|58766931|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757536|NCT00112437|58766932|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757537|NCT00112437|58766933|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757538|NCT00112437|58766934|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757539|NCT00112437|58766935|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757540|NCT00112437|58766936|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757541|NCT00112437|58766937|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757542|NCT00112437|58766938|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757543|NCT00112437|58766939|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757544|NCT00112437|58766940|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757545|NCT00112437|58766941|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757546|NCT00112437|58766942|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30757547|NCT00112437|58766943|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30836635|NCT02584504|58861196|FG002|Double-blind Treatment|Participant withdrew consent|1|||
30836636|NCT02584504|58861194|FG000|Double-blind Treatment|Adverse Event|0|||
30836637|NCT02584504|58861195|FG001|Double-blind Treatment|Adverse Event|1|||
30836638|NCT02584504|58861196|FG002|Double-blind Treatment|Adverse Event|0|||
30836639|NCT02584504|58861194|FG000|Double-blind Treatment|Family Matter|0|||
30927516|NCT01449370|58962985|FG012|Overall Study|Death|0|||
30927517|NCT01449370|58962986|FG013|Overall Study|Death|0|||
30927518|NCT01449370|58962987|FG014|Overall Study|Death|0|||
30927519|NCT01449370|58962988|FG015|Overall Study|Death|0|||
30757548|NCT00112437|58766944|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30836640|NCT02584504|58861195|FG001|Double-blind Treatment|Family Matter|1|||
30836641|NCT02584504|58861196|FG002|Double-blind Treatment|Family Matter|0|||
30836642|NCT02584504|58861194|FG000|Open-label Treatment|Participant withdrew consent|0|||
30836643|NCT02584504|58861195|FG001|Open-label Treatment|Participant withdrew consent|0|||
30927520|NCT01449370|58962989|FG016|Overall Study|Death|0|||
30757549|NCT00112437|58766945|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30927521|NCT01449370|58962990|FG017|Overall Study|Death|0|||
30757550|NCT00112437|58766946|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
30927522|NCT01449370|58962991|FG018|Overall Study|Death|0|||
30927523|NCT01449370|58962992|FG019|Overall Study|Death|0|||
30927524|NCT01449370|58962993|FG020|Overall Study|Death|0|||
30927525|NCT01449370|58962994|FG021|Overall Study|Death|0|||
30927526|NCT01449370|58962995|FG022|Overall Study|Death|0|||
30927527|NCT01449370|58962996|FG023|Overall Study|Death|0|||
30927528|NCT01449370|58962997|FG024|Overall Study|Death|1|||
30927529|NCT02067533|58963072|FG000|Overall Study|Lost to Follow-up|4|||
30927530|NCT02067533|58963073|FG001|Overall Study|Lost to Follow-up|2|||
30927531|NCT02066129|58963081|FG000|Overall Study|Lost to Follow-up|13|||
30927532|NCT02066129|58963082|FG001|Overall Study|Lost to Follow-up|12|||
30927533|NCT02066129|58963081|FG000|Overall Study|Withdrawal by Subject|7|||
30927534|NCT02066129|58963082|FG001|Overall Study|Withdrawal by Subject|10|||
30927535|NCT02066129|58963081|FG000|Overall Study|Lack of Efficacy|8|||
30927536|NCT02066129|58963082|FG001|Overall Study|Lack of Efficacy|10|||
30927537|NCT02066129|58963081|FG000|Overall Study|Physician Decision|1|||
30927538|NCT02066129|58963082|FG001|Overall Study|Physician Decision|1|||
30927539|NCT02066051|58963088|FG000|Overall Study|Subject developed active GVHD|1|||
30927540|NCT01980992|58963094|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
30927541|NCT01980992|58963095|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
30927542|NCT01980992|58963094|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
30927543|NCT01980992|58963095|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
30927544|NCT01980992|58963094|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
30927545|NCT01980992|58963095|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
30927546|NCT01980992|58963094|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
30927547|NCT01980992|58963095|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
30927548|NCT01980992|58963094|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
30927549|NCT01980992|58963095|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
30927550|NCT01980992|58963094|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
30927551|NCT01980992|58963095|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
30927552|NCT02065895|58963108|FG000|Overall Study|Protocol Violation|1|||
30927553|NCT02065895|58963109|FG001|Overall Study|Protocol Violation|0|||
30927554|NCT02065895|58963110|FG002|Overall Study|Protocol Violation|0|||
30927555|NCT02065895|58963111|FG003|Overall Study|Protocol Violation|1|||
30927556|NCT02065895|58963112|FG004|Overall Study|Protocol Violation|0|||
30927557|NCT02065895|58963113|FG005|Overall Study|Protocol Violation|0|||
30927558|NCT02065895|58963108|FG000|Overall Study|Scheduling conflicts|0|||
30927559|NCT02065895|58963109|FG001|Overall Study|Scheduling conflicts|1|||
30927560|NCT02065895|58963110|FG002|Overall Study|Scheduling conflicts|0|||
30927561|NCT02065895|58963111|FG003|Overall Study|Scheduling conflicts|0|||
30927562|NCT02065895|58963112|FG004|Overall Study|Scheduling conflicts|0|||
30927563|NCT02065895|58963113|FG005|Overall Study|Scheduling conflicts|0|||
30927564|NCT02106455|58963130|FG000|Overall Study|Case Report Form Uncollected|6|||
30927565|NCT02106455|58963130|FG000|Overall Study|Protocol Deviation|2|||
30927566|NCT02006654|58963136|FG000|Overall Study|Withdrawal before treatment|4|||
30927567|NCT02006654|58963137|FG001|Overall Study|Withdrawal before treatment|2|||
30927568|NCT02006654|58963136|FG000|Overall Study|Adverse Event|16|||
30927569|NCT02006654|58963137|FG001|Overall Study|Adverse Event|17|||
30927570|NCT02006654|58963136|FG000|Overall Study|Death|1|||
30927571|NCT02006654|58963137|FG001|Overall Study|Death|0|||
30927572|NCT02006654|58963136|FG000|Overall Study|Withdrawal by Subject|14|||
30927573|NCT02006654|58963137|FG001|Overall Study|Withdrawal by Subject|12|||
30927574|NCT02006654|58963136|FG000|Overall Study|Protocol Violation|5|||
30927575|NCT02006654|58963137|FG001|Overall Study|Protocol Violation|8|||
30927576|NCT02006654|58963136|FG000|Overall Study|Lost to Follow-up|1|||
30927577|NCT02006654|58963137|FG001|Overall Study|Lost to Follow-up|0|||
30927578|NCT02006654|58963136|FG000|Overall Study|patient's will|2|||
30927579|NCT02006654|58963137|FG001|Overall Study|patient's will|1|||
30927580|NCT02006654|58963136|FG000|Overall Study|insufficient compliance|1|||
30927581|NCT02006654|58963137|FG001|Overall Study|insufficient compliance|0|||
30927582|NCT02006654|58963136|FG000|Overall Study|worsening cognitive condition|0|||
30927583|NCT02006654|58963137|FG001|Overall Study|worsening cognitive condition|1|||
30927584|NCT02006654|58963136|FG000|Overall Study|faecal incontinence|0|||
30927585|NCT02006654|58963137|FG001|Overall Study|faecal incontinence|1|||
30927586|NCT02006654|58963136|FG000|Overall Study|mood disorder|0|||
30927587|NCT02006654|58963137|FG001|Overall Study|mood disorder|1|||
30927588|NCT02006654|58963136|FG000|Overall Study|disallowed medication|1|||
30927589|NCT02006654|58963137|FG001|Overall Study|disallowed medication|0|||
30927590|NCT02006654|58963136|FG000|Overall Study|moving out of state|0|||
30927591|NCT02006654|58963137|FG001|Overall Study|moving out of state|1|||
30927592|NCT01980056|58963147|FG000|Overall Study|Death|1|||
30927593|NCT01980056|58963148|FG001|Overall Study|Death|1|||
30927594|NCT01980056|58963149|FG002|Overall Study|Death|0|||
30927595|NCT02027558|58963163|FG000|Overall Study|Death|0|||
30927596|NCT02027558|58963164|FG001|Overall Study|Death|1|||
30927597|NCT02027558|58963163|FG000|Overall Study|Withdrawal by Subject|2|||
30927598|NCT02027558|58963164|FG001|Overall Study|Withdrawal by Subject|0|||
30927599|NCT02027558|58963163|FG000|Overall Study|Lost to Follow-up|4|||
30927600|NCT02027558|58963164|FG001|Overall Study|Lost to Follow-up|1|||
30927601|NCT02027558|58963163|FG000|Overall Study|Refused assessment|3|||
30927602|NCT02027558|58963164|FG001|Overall Study|Refused assessment|0|||
30927603|NCT02006576|58963175|FG000|Overall Study|Withdrawal by Subject|4|||
30927604|NCT02006576|58963176|FG001|Overall Study|Withdrawal by Subject|6|||
30927605|NCT02006576|58963177|FG002|Overall Study|Withdrawal by Subject|2|||
30927606|NCT02006576|58963175|FG000|Overall Study|Death|0|||
30927607|NCT02006576|58963176|FG001|Overall Study|Death|0|||
30927608|NCT02006576|58963177|FG002|Overall Study|Death|1|||
30927609|NCT02006576|58963175|FG000|Overall Study|Lost to Follow-up|1|||
30836644|NCT02584504|58861196|FG002|Open-label Treatment|Participant withdrew consent|4|||
30836645|NCT02584504|58861194|FG000|Open-label Treatment|Adverse Event|2|||
30836646|NCT02584504|58861195|FG001|Open-label Treatment|Adverse Event|2|||
30836647|NCT02584504|58861196|FG002|Open-label Treatment|Adverse Event|3|||
30836648|NCT02584504|58861194|FG000|Open-label Treatment|Physician Decision|0|||
30836649|NCT02584504|58861195|FG001|Open-label Treatment|Physician Decision|1|||
30836650|NCT02584504|58861196|FG002|Open-label Treatment|Physician Decision|0|||
30836651|NCT02584504|58861194|FG000|Open-label Treatment|Entered but not treated|0|||
30836652|NCT02584504|58861195|FG001|Open-label Treatment|Entered but not treated|1|||
30836653|NCT02584504|58861196|FG002|Open-label Treatment|Entered but not treated|1|||
30836666|NCT04354155|58861231|FG000|Overall Study|Withdrawal by Subject|1|||
30836667|NCT04354155|58861231|FG000|Overall Study|Did not meet criteria for study intervention|1|||
30836668|NCT02586064|58861237|FG000|Overall Study|Other Obligations|6|||
30836669|NCT02586064|58861238|FG001|Overall Study|Other Obligations|6|||
30836670|NCT02586064|58861237|FG000|Overall Study|Other|3|||
30836671|NCT02586064|58861238|FG001|Overall Study|Other|7|||
30836672|NCT02586064|58861237|FG000|Overall Study|Never Started|3|||
30836673|NCT02586064|58861238|FG001|Overall Study|Never Started|3|||
30836674|NCT02586064|58861237|FG000|Overall Study|Lost Interest|1|||
30836675|NCT02586064|58861238|FG001|Overall Study|Lost Interest|4|||
30836676|NCT02586064|58861237|FG000|Overall Study|Miscellaneous Life Issues|0|||
30836677|NCT02586064|58861238|FG001|Overall Study|Miscellaneous Life Issues|5|||
30836678|NCT02586064|58861237|FG000|Overall Study|Infrequent Attendance|2|||
30836679|NCT02586064|58861238|FG001|Overall Study|Infrequent Attendance|1|||
30836680|NCT02586064|58861237|FG000|Overall Study|Timed Out|2|||
30836681|NCT02586064|58861238|FG001|Overall Study|Timed Out|0|||
30836682|NCT02586064|58861237|FG000|Overall Study|AUD relapse|0|||
30836683|NCT02586064|58861238|FG001|Overall Study|AUD relapse|2|||
30836684|NCT02586064|58861237|FG000|Overall Study|Legal Issue|1|||
30836685|NCT02586064|58861238|FG001|Overall Study|Legal Issue|0|||
30836686|NCT03810495|58861247|FG000|Overall Study|Lost to Follow-up|2|||
30836687|NCT03810495|58861247|FG000|Overall Study|Withdrawal by Subject|1|||
30836688|NCT02782923|58861251|FG000|Overall Study|Lost to Follow-up|15|||
30836689|NCT03760458|58861260|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
30836690|NCT03760458|58861261|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
30836691|NCT03760458|58861262|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
30836692|NCT03760458|58861263|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
30836693|NCT03760458|58861264|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
30836694|NCT02066415|58861279|FG000|Overall Study|Decision by Sponsor|5|||
30836695|NCT02066415|58861280|FG001|Overall Study|Decision by Sponsor|4|||
30836696|NCT02066415|58861281|FG002|Overall Study|Decision by Sponsor|2|||
30836697|NCT02066415|58861279|FG000|Overall Study|Withdrawal by Subject|9|||
30836698|NCT02066415|58861280|FG001|Overall Study|Withdrawal by Subject|1|||
30836699|NCT02066415|58861281|FG002|Overall Study|Withdrawal by Subject|4|||
30836700|NCT02066415|58861279|FG000|Overall Study|Lost to Follow-up|7|||
30836701|NCT02066415|58861280|FG001|Overall Study|Lost to Follow-up|2|||
30836702|NCT02066415|58861281|FG002|Overall Study|Lost to Follow-up|2|||
30836703|NCT02583256|58861293|FG000|Overall Study|Withdrawal by Subject|0|||
30836704|NCT02583256|58861294|FG001|Overall Study|Withdrawal by Subject|1|||
30836705|NCT02583256|58861295|FG002|Overall Study|Withdrawal by Subject|1|||
30836706|NCT02583256|58861296|FG003|Overall Study|Withdrawal by Subject|0|||
30927610|NCT02006576|58963176|FG001|Overall Study|Lost to Follow-up|0|||
30927611|NCT02006576|58963177|FG002|Overall Study|Lost to Follow-up|1|||
30927612|NCT02006576|58963175|FG000|Overall Study|Screen Failure, too sick, other|13|||
30927613|NCT02006576|58963176|FG001|Overall Study|Screen Failure, too sick, other|1|||
30927614|NCT02006576|58963177|FG002|Overall Study|Screen Failure, too sick, other|13|||
30927615|NCT02027402|58963187|FG000|Overall Study|Withdrawal by Subject|4|||
30927616|NCT02027402|58963188|FG001|Overall Study|Withdrawal by Subject|1|||
30927617|NCT01448824|58963204|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
30927618|NCT01448824|58963205|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
30927619|NCT01448824|58963206|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
30927620|NCT01448824|58963207|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
30927621|NCT01448824|58963208|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
30927622|NCT01448824|58963209|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
30927623|NCT01448824|58963210|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
30927624|NCT01448824|58963211|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
30927625|NCT01448824|58963204|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
30927626|NCT01448824|58963205|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
30927627|NCT01448824|58963206|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
30927628|NCT01448824|58963207|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
30927629|NCT01448824|58963208|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
30927630|NCT01448824|58963209|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
30927631|NCT01448824|58963210|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
30927632|NCT01448824|58963211|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
30927633|NCT01448824|58963204|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
30927634|NCT01448824|58963205|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
30927635|NCT01448824|58963206|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
30927636|NCT01448824|58963207|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
30927637|NCT01448824|58963208|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
30927638|NCT01448824|58963209|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
30927639|NCT01448824|58963210|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
30927640|NCT01448824|58963211|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
30927641|NCT01448824|58963204|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
30927642|NCT01448824|58963205|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
30927643|NCT01448824|58963206|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
30927644|NCT01448824|58963207|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
30927645|NCT01448824|58963208|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
30927646|NCT01448824|58963209|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
30927647|NCT01448824|58963210|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
30927648|NCT01448824|58963211|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
30927649|NCT01448824|58963204|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
30927650|NCT01448824|58963205|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
30927651|NCT01448824|58963206|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
30836707|NCT02583256|58861293|FG000|Overall Study|Lost to Follow-up|1|||
30836708|NCT02583256|58861294|FG001|Overall Study|Lost to Follow-up|1|||
30836709|NCT02583256|58861295|FG002|Overall Study|Lost to Follow-up|0|||
30836710|NCT02583256|58861296|FG003|Overall Study|Lost to Follow-up|1|||
30836711|NCT02583256|58861293|FG000|Overall Study|Administrative/Other|2|||
30836712|NCT02583256|58861294|FG001|Overall Study|Administrative/Other|0|||
30836713|NCT02583256|58861295|FG002|Overall Study|Administrative/Other|1|||
30836714|NCT02583256|58861296|FG003|Overall Study|Administrative/Other|2|||
30836715|NCT01981551|58861317|FG000|Overall Study|Refused further treatment|8|||
30836716|NCT01981551|58861317|FG000|Overall Study|Adverse Event|1|||
30836717|NCT02584660|58861323|FG000|Overall Study|Adverse Event|4|||
30836718|NCT02584660|58861324|FG001|Overall Study|Adverse Event|0|||
30836719|NCT02584660|58861323|FG000|Overall Study|Lost to Follow-up|3|||
30836720|NCT02584660|58861324|FG001|Overall Study|Lost to Follow-up|4|||
30836721|NCT02584660|58861323|FG000|Overall Study|Protocol Violation|0|||
30836722|NCT02584660|58861324|FG001|Overall Study|Protocol Violation|1|||
30836723|NCT02584660|58861323|FG000|Overall Study|Withdrawal by Subject|0|||
30836724|NCT02584660|58861324|FG001|Overall Study|Withdrawal by Subject|2|||
30836725|NCT02584660|58861323|FG000|Overall Study|Other|0|||
30836726|NCT02584660|58861324|FG001|Overall Study|Other|1|||
30836727|NCT02582632|58861346|FG000|Overall Study|Other|1|||
30836728|NCT02178722|58861355|FG000|Overall Study|Withdrawal by Subject|0|||
30836729|NCT02178722|58861356|FG001|Overall Study|Withdrawal by Subject|0|||
30836730|NCT02178722|58861357|FG002|Overall Study|Withdrawal by Subject|0|||
30836731|NCT02178722|58861358|FG003|Overall Study|Withdrawal by Subject|2|||
30836732|NCT02178722|58861359|FG004|Overall Study|Withdrawal by Subject|33|||
30836733|NCT02178722|58861355|FG000|Overall Study|Death|2|||
30836734|NCT02178722|58861356|FG001|Overall Study|Death|13|||
30836735|NCT02178722|58861357|FG002|Overall Study|Death|12|||
30836736|NCT02178722|58861358|FG003|Overall Study|Death|12|||
30836737|NCT02178722|58861359|FG004|Overall Study|Death|205|||
30836738|NCT02178722|58861355|FG000|Overall Study|Lost to Follow-up|0|||
30836739|NCT02178722|58861356|FG001|Overall Study|Lost to Follow-up|0|||
30836740|NCT02178722|58861357|FG002|Overall Study|Lost to Follow-up|0|||
30836741|NCT02178722|58861358|FG003|Overall Study|Lost to Follow-up|2|||
30836742|NCT02178722|58861359|FG004|Overall Study|Lost to Follow-up|11|||
30836743|NCT02178722|58861355|FG000|Overall Study|Study terminated by Sponsor|2|||
30836744|NCT02178722|58861356|FG001|Overall Study|Study terminated by Sponsor|7|||
30836745|NCT02178722|58861357|FG002|Overall Study|Study terminated by Sponsor|6|||
30836746|NCT02178722|58861358|FG003|Overall Study|Study terminated by Sponsor|4|||
30836747|NCT02178722|58861359|FG004|Overall Study|Study terminated by Sponsor|128|||
30836748|NCT02178722|58861355|FG000|Overall Study|Physician Decision|0|||
30836749|NCT02178722|58861356|FG001|Overall Study|Physician Decision|0|||
30836750|NCT02178722|58861357|FG002|Overall Study|Physician Decision|0|||
30836751|NCT02178722|58861358|FG003|Overall Study|Physician Decision|0|||
30836752|NCT02178722|58861359|FG004|Overall Study|Physician Decision|3|||
30836753|NCT02178722|58861355|FG000|Overall Study|Other|0|||
30836754|NCT02178722|58861356|FG001|Overall Study|Other|0|||
30836755|NCT02178722|58861357|FG002|Overall Study|Other|0|||
30836756|NCT02178722|58861358|FG003|Overall Study|Other|0|||
30836757|NCT02178722|58861359|FG004|Overall Study|Other|2|||
30836758|NCT00972309|58861376|FG000|Overall Study|Switched to alternative treatment|0|||
30836759|NCT00972309|58861377|FG001|Overall Study|Switched to alternative treatment|2|||
30836760|NCT00972309|58861376|FG000|Overall Study|Refused further treatment|0|||
30836761|NCT00972309|58861377|FG001|Overall Study|Refused further treatment|1|||
30836762|NCT00972309|58861376|FG000|Overall Study|Late determination of ineligibility|0|||
30836763|NCT00972309|58861377|FG001|Overall Study|Late determination of ineligibility|1|||
30836764|NCT00972309|58861376|FG000|Overall Study|Second malignancy|1|||
30836765|NCT00972309|58861377|FG001|Overall Study|Second malignancy|1|||
30836766|NCT00972309|58861376|FG000|Overall Study|Visa issues|0|||
30836767|NCT00972309|58861377|FG001|Overall Study|Visa issues|1|||
30836768|NCT00972309|58861376|FG000|Overall Study|Secondary cancer (SCC)|0|||
30836769|NCT00972309|58861377|FG001|Overall Study|Secondary cancer (SCC)|1|||
30836770|NCT00972309|58861376|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
30836771|NCT00972309|58861377|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
30836772|NCT00972309|58861376|FG000|Overall Study|Lost to Follow-up|1|||
30836773|NCT00972309|58861377|FG001|Overall Study|Lost to Follow-up|1|||
30836774|NCT00972309|58861376|FG000|Overall Study|Disease progression on study|10|||
30836775|NCT00972309|58861377|FG001|Overall Study|Disease progression on study|4|||
30836776|NCT02582242|58861396|FG000|Overall Study|Adverse Event|4|||
30836777|NCT02582242|58861397|FG001|Overall Study|Adverse Event|3|||
30836778|NCT02582242|58861396|FG000|Overall Study|Protocol Violation|3|||
30836779|NCT02582242|58861397|FG001|Overall Study|Protocol Violation|1|||
30836780|NCT02582242|58861396|FG000|Overall Study|Lost to Follow-up|0|||
30836781|NCT02582242|58861397|FG001|Overall Study|Lost to Follow-up|1|||
30836782|NCT02582242|58861396|FG000|Overall Study|Withdrawal by Subject|11|||
30836783|NCT02582242|58861397|FG001|Overall Study|Withdrawal by Subject|11|||
30836784|NCT02582242|58861396|FG000|Overall Study|Unclassified|2|||
30836785|NCT02582242|58861397|FG001|Overall Study|Unclassified|1|||
30836786|NCT00663351|58861405|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
30836787|NCT00663351|58861406|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
30836788|NCT00663351|58861405|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
30836789|NCT00663351|58861406|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
30836790|NCT00663351|58861405|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
30836791|NCT00663351|58861406|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
30836792|NCT00663351|58861405|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
30836793|NCT00663351|58861406|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
30836794|NCT00663351|58861405|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
30836795|NCT00663351|58861406|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
30836796|NCT00663351|58861405|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
30836797|NCT00663351|58861406|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
30836798|NCT00616941|58861415|FG000|Overall Study|Progressive Disease|1|||
30836799|NCT00616941|58861416|FG001|Overall Study|Progressive Disease|2|||
30836800|NCT00616941|58861417|FG002|Overall Study|Progressive Disease|1|||
30836801|NCT00616941|58861415|FG000|Overall Study|Adverse Event|0|||
30836802|NCT00616941|58861416|FG001|Overall Study|Adverse Event|1|||
30836803|NCT00616941|58861417|FG002|Overall Study|Adverse Event|1|||
30836804|NCT00616941|58861415|FG000|Overall Study|Subject Non-compliance|0|||
30836805|NCT00616941|58861416|FG001|Overall Study|Subject Non-compliance|0|||
30836806|NCT00616941|58861417|FG002|Overall Study|Subject Non-compliance|1|||
30836807|NCT00616941|58861415|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
30836808|NCT00616941|58861416|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
30927652|NCT01448824|58963207|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
30927653|NCT01448824|58963208|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
30927654|NCT01448824|58963209|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
30927655|NCT01448824|58963210|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
30927656|NCT01448824|58963211|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
30927657|NCT01448824|58963204|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
30927658|NCT01448824|58963205|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
30927659|NCT01448824|58963206|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
30927660|NCT01448824|58963207|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
30927661|NCT01448824|58963208|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
30927662|NCT01448824|58963209|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
30927663|NCT01448824|58963210|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
30927664|NCT01448824|58963211|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
30927665|NCT01448824|58963204|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
30927666|NCT01448824|58963205|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
30927667|NCT01448824|58963206|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
30927668|NCT01448824|58963207|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
30927669|NCT01448824|58963208|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
30927670|NCT01448824|58963209|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
30927671|NCT01448824|58963210|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
30927672|NCT01448824|58963211|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
30927673|NCT01448824|58963204|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
30927674|NCT01448824|58963205|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
30927675|NCT01448824|58963206|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
30927676|NCT01448824|58963207|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
30927677|NCT01448824|58963208|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
30927678|NCT01448824|58963209|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
30927679|NCT01448824|58963210|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
30927680|NCT01448824|58963211|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
30927681|NCT02005562|58963241|FG000|Overall Study|Death|2|||
30927682|NCT02005562|58963242|FG001|Overall Study|Death|2|||
30927683|NCT02005562|58963241|FG000|Overall Study|Graft loss|7|||
30927684|NCT02005562|58963242|FG001|Overall Study|Graft loss|6|||
30927685|NCT02005562|58963241|FG000|Overall Study|Withdrawal by Subject|2|||
30927686|NCT02005562|58963242|FG001|Overall Study|Withdrawal by Subject|2|||
30927687|NCT02005562|58963241|FG000|Overall Study|No transplant|1|||
30927688|NCT02005562|58963242|FG001|Overall Study|No transplant|4|||
30927689|NCT02005562|58963241|FG000|Overall Study|Physician Decision|0|||
30927690|NCT02005562|58963242|FG001|Overall Study|Physician Decision|1|||
30927691|NCT01448044|58963250|FG000|Treatment Period|Adverse Event|4|||
30927692|NCT01448044|58963251|FG001|Treatment Period|Adverse Event|3|||
30927693|NCT01448044|58963250|FG000|Treatment Period|Lack of Efficacy|5|||
30927694|NCT01448044|58963251|FG001|Treatment Period|Lack of Efficacy|12|||
30927695|NCT01448044|58963250|FG000|Treatment Period|Subject requested discontinue study drug|1|||
30927696|NCT01448044|58963251|FG001|Treatment Period|Subject requested discontinue study drug|0|||
30927697|NCT01448044|58963250|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
30927698|NCT01448044|58963251|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
30927699|NCT01448044|58963250|FG000|Treatment Period|Participant does not meet study criteria|1|||
30927700|NCT01448044|58963251|FG001|Treatment Period|Participant does not meet study criteria|0|||
30927701|NCT01448044|58963250|FG000|Treatment Period|Lost to Follow-up|2|||
30927702|NCT01448044|58963251|FG001|Treatment Period|Lost to Follow-up|1|||
30927703|NCT01448044|58963250|FG000|Treatment Period|Other reason|2|||
30927704|NCT01448044|58963251|FG001|Treatment Period|Other reason|0|||
30927705|NCT01448044|58963250|FG000|Follow Up Period|Withdrawal by Subject|1|||
30836809|NCT00616941|58861417|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
30836810|NCT00616941|58861415|FG000|Overall Study|Vaccination Suspended|0|||
30836811|NCT00616941|58861416|FG001|Overall Study|Vaccination Suspended|0|||
30836812|NCT00616941|58861417|FG002|Overall Study|Vaccination Suspended|3|||
30836813|NCT02581930|58861425|FG000|Overall Study|Withdrawal by Subject|1|||
30836814|NCT02581930|58861425|FG000|Overall Study|patient declined further treatment|1|||
30836815|NCT00105560|58861429|FG000|Overall Study|Lost to Follow-up|1|||
30836816|NCT02577718|58861442|FG000|Overall Study|Death|6|||
30836817|NCT02577718|58861442|FG000|Overall Study|Withdrawal by Subject|2|||
30836818|NCT00520533|58861448|FG000|Overall Study|Death|1|||
30927706|NCT01448044|58963251|FG001|Follow Up Period|Withdrawal by Subject|1|||
30927707|NCT01448044|58963250|FG000|Follow Up Period|Lost to Follow-up|6|||
30927708|NCT01448044|58963251|FG001|Follow Up Period|Lost to Follow-up|2|||
30927709|NCT01448044|58963250|FG000|Follow Up Period|Other|5|||
30927710|NCT01448044|58963251|FG001|Follow Up Period|Other|11|||
30927711|NCT02025530|58963259|FG000|Overall Study|No longer met elligibility criteria|5|||
30927712|NCT02025530|58963260|FG001|Overall Study|No longer met elligibility criteria|1|||
30927713|NCT01472380|58963266|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
30927714|NCT01472380|58963266|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
30927715|NCT01978262|58963273|FG000|Overall Study|Withdrawal by Subject|9|||
30927716|NCT01978262|58963273|FG000|Overall Study|Lost to Follow-up|2|||
30927717|NCT01447576|58963278|FG000|Overall Study|Lost to Follow-up|52|||
30927718|NCT01447576|58963278|FG000|Overall Study|Adverse Event|127|||
30927719|NCT01447576|58963278|FG000|Overall Study|Participant met withdrawal criteria|40|||
30927720|NCT01447576|58963278|FG000|Overall Study|Withdrawal by Subject|100|||
30927721|NCT01447576|58963278|FG000|Overall Study|Protocol deviation|83|||
30927722|NCT01447576|58963278|FG000|Overall Study|Lack of Efficacy|68|||
30927723|NCT01447576|58963278|FG000|Overall Study|Physician Decision|6|||
30927724|NCT01447420|58963285|FG000|Overall Study|Adverse Event|2|||
30927725|NCT01447420|58963286|FG001|Overall Study|Adverse Event|4|||
30927726|NCT01447420|58963287|FG002|Overall Study|Adverse Event|2|||
30927727|NCT01447420|58963285|FG000|Overall Study|Protocol Violation|3|||
30927728|NCT01447420|58963286|FG001|Overall Study|Protocol Violation|3|||
30927729|NCT01447420|58963287|FG002|Overall Study|Protocol Violation|0|||
30927730|NCT01447420|58963285|FG000|Overall Study|Withdrawal by Subject|4|||
30927731|NCT01447420|58963286|FG001|Overall Study|Withdrawal by Subject|1|||
30927732|NCT01447420|58963287|FG002|Overall Study|Withdrawal by Subject|0|||
30927733|NCT01447420|58963285|FG000|Overall Study|Lack of Efficacy|1|||
30836819|NCT00520533|58861448|FG000|Overall Study|Suspension of the study for safety reasons|1|||
30836820|NCT00520533|58861448|FG000|Overall Study|Withdrawal by Subject|1|||
30836821|NCT00520533|58861448|FG000|Overall Study|Physician Decision|1|||
30836822|NCT01664104|58861457|FG000|Overall Study|Adverse Event|6|||
30836823|NCT01664104|58861457|FG000|Overall Study|Lack of Efficacy|2|||
30836824|NCT01664104|58861457|FG000|Overall Study|Withdrawal by Subject|1|||
30836825|NCT01664104|58861457|FG000|Overall Study|Lost to Follow-up|4|||
30624047|NCT00912028|58636034|FG004|Overall Study|Withdrawal by Subject|0|||
30624048|NCT02731729|58636046|FG000|Overall Study|Death|2|||
30836826|NCT01664104|58861457|FG000|Overall Study|Other|1|||
30836827|NCT01664104|58861457|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
30836828|NCT02739984|58861465|FG000|Overall Study|Sponsor Decision|1|||
30836829|NCT02739984|58861466|FG001|Overall Study|Sponsor Decision|0|||
30836830|NCT02739984|58861465|FG000|Overall Study|Withdrawal by Subject|1|||
30836831|NCT02739984|58861466|FG001|Overall Study|Withdrawal by Subject|1|||
30836832|NCT02739984|58861465|FG000|Overall Study|Death|0|||
30836833|NCT02739984|58861466|FG001|Overall Study|Death|1|||
30836834|NCT02739984|58861465|FG000|Overall Study|Lost to Follow-up|3|||
30836835|NCT02739984|58861466|FG001|Overall Study|Lost to Follow-up|0|||
30836836|NCT00496730|58861474|FG000|Overall Study|Lost to Follow-up|4|||
30836837|NCT00496730|58861475|FG001|Overall Study|Lost to Follow-up|3|||
30836838|NCT00496730|58861474|FG000|Overall Study|Withdrawal by Subject|2|||
30836839|NCT00496730|58861475|FG001|Overall Study|Withdrawal by Subject|2|||
30836840|NCT02739828|58861481|FG000|Overall Study|Adverse Event|1|||
30836841|NCT02739828|58861481|FG000|Overall Study|Lost to Follow-up|4|||
30836842|NCT04435808|58861487|FG000|Overall Study|Study stopped by DSMB|0|||
30836843|NCT04435808|58861488|FG001|Overall Study|Study stopped by DSMB|1|||
30836844|NCT01664494|58861511|FG000|Overall Study|Withdrawal by Subject|27|||
30836845|NCT01664494|58861511|FG000|Overall Study|Death|18|||
30836846|NCT01664494|58861511|FG000|Overall Study|Other|49|||
30836847|NCT01664494|58861511|FG000|Overall Study|Lost to Follow-up|99|||
30836848|NCT02577016|58861517|FG000|Overall Study|Adverse Event|2|||
30836849|NCT02577016|58861518|FG001|Overall Study|Adverse Event|1|||
30836850|NCT02577016|58861517|FG000|Overall Study|Physician Decision|0|||
30836851|NCT02577016|58861518|FG001|Overall Study|Physician Decision|1|||
30836852|NCT05101252|58861526|FG000|Overall Study|Unsatisfactory Test Article|1|||
30836853|NCT05101252|58861527|FG001|Overall Study|Unsatisfactory Test Article|0|||
30836854|NCT05101252|58861526|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
30836855|NCT05101252|58861527|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
30836856|NCT05101252|58861526|FG000|Overall Study|Withdrew Consent during study|0|||
30836857|NCT05101252|58861527|FG001|Overall Study|Withdrew Consent during study|1|||
30836858|NCT05101252|58861526|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
30836859|NCT05101252|58861527|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
30836860|NCT03316586|58861533|FG000|Overall Study|Adverse Event|2|||
30836861|NCT03316586|58861533|FG000|Overall Study|Physician Decision|3|||
30836862|NCT03316586|58861533|FG000|Overall Study|Lack of Efficacy|10|||
30836863|NCT03316586|58861533|FG000|Overall Study|still on treatment|1|||
30836864|NCT03316586|58861533|FG000|Overall Study|Patient needed radiation therapy|1|||
30836865|NCT03316586|58861533|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
30836866|NCT02994927|58861539|FG000|Overall Study|Withdrawal by parent/guardian|0|||
30836867|NCT02994927|58861540|FG001|Overall Study|Withdrawal by parent/guardian|1|||
30836868|NCT02994927|58861539|FG000|Overall Study|Did not meet eligibility criteria|0|||
30927734|NCT01447420|58963286|FG001|Overall Study|Lack of Efficacy|19|||
30927735|NCT01447420|58963287|FG002|Overall Study|Lack of Efficacy|8|||
30927736|NCT01446874|58963297|FG000|Overall Study|Not eligible|1|||
30927737|NCT01446874|58963298|FG001|Overall Study|Not eligible|0|||
30927738|NCT01446874|58963299|FG002|Overall Study|Not eligible|0|||
30927739|NCT01446874|58963297|FG000|Overall Study|No surgery/No qualifying surgery|1|||
30927740|NCT01446874|58963298|FG001|Overall Study|No surgery/No qualifying surgery|0|||
30927741|NCT01446874|58963299|FG002|Overall Study|No surgery/No qualifying surgery|12|||
30927742|NCT01446874|58963297|FG000|Overall Study|Non-compliance|0|||
30757551|NCT00112437|58766921|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
30757552|NCT00112437|58766922|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757553|NCT00112437|58766923|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
30836869|NCT02994927|58861540|FG001|Overall Study|Did not meet eligibility criteria|1|||
30836870|NCT02994927|58861539|FG000|Overall Study|Physician Decision|4|||
30836871|NCT02994927|58861540|FG001|Overall Study|Physician Decision|3|||
30836872|NCT02994927|58861539|FG000|Overall Study|Death|4|||
30836873|NCT02994927|58861540|FG001|Overall Study|Death|2|||
30836874|NCT02994927|58861539|FG000|Overall Study|Adverse Event|2|||
30836875|NCT02994927|58861540|FG001|Overall Study|Adverse Event|1|||
30836876|NCT02994927|58861539|FG000|Overall Study|Withdrawal by Subject|3|||
30836877|NCT02994927|58861540|FG001|Overall Study|Withdrawal by Subject|6|||
30836878|NCT02994927|58861539|FG000|Overall Study|Lost to Follow-up|2|||
30836879|NCT02994927|58861540|FG001|Overall Study|Lost to Follow-up|1|||
30836880|NCT00107991|58861546|FG000|Eligibility Assessment|Disease not severe enough|7|||
30836881|NCT00107991|58861546|FG000|Eligibility Assessment|Unwilling to participate|7|||
30836882|NCT00107991|58861546|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
30836883|NCT00107991|58861546|FG000|Eligibility Assessment|Abnormal labs|2|||
30836884|NCT00107991|58861546|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
30836885|NCT00107991|58861546|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
30836886|NCT00107991|58861546|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
30836887|NCT00107991|58861546|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
30836888|NCT00107991|58861546|FG000|12 Week Treatment Period|Adverse Event|1|||
30757554|NCT00112437|58766924|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
30757555|NCT00112437|58766925|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
30757556|NCT00112437|58766926|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757557|NCT00112437|58766927|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757558|NCT00112437|58766928|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757559|NCT00112437|58766929|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757560|NCT00112437|58766930|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757561|NCT00112437|58766931|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757562|NCT00112437|58766932|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757563|NCT00112437|58766933|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757564|NCT00112437|58766934|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757565|NCT00112437|58766935|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757566|NCT00112437|58766936|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757567|NCT00112437|58766937|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757568|NCT00112437|58766938|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757569|NCT00112437|58766939|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757570|NCT00112437|58766940|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757571|NCT00112437|58766941|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757572|NCT00112437|58766942|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757573|NCT00112437|58766943|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757574|NCT00112437|58766944|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757575|NCT00112437|58766945|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757576|NCT00112437|58766946|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
30757577|NCT00112437|58766921|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
30757578|NCT00112437|58766922|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
30757579|NCT00112437|58766923|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
30757580|NCT00112437|58766924|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
30757581|NCT00112437|58766925|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
30757582|NCT00112437|58766926|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757583|NCT00112437|58766927|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30836889|NCT00107991|58861546|FG000|12 Week Treatment Period|Protocol Violation|1|||
30836890|NCT00107991|58861546|FG000|12 Week Treatment Period|Incarcerated|1|||
30836891|NCT00107991|58861546|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
30836892|NCT00492856|58861550|FG000|Induction|Adverse Event|2|||
30836893|NCT00492856|58861551|FG001|Induction|Adverse Event|0|||
30927743|NCT01446874|58963298|FG001|Overall Study|Non-compliance|4|||
30927744|NCT01446874|58963299|FG002|Overall Study|Non-compliance|0|||
30624049|NCT02731729|58636047|FG001|Overall Study|Death|2|||
30624050|NCT02731729|58636046|FG000|Overall Study|Study terminated by Sponsor|6|||
30836894|NCT00492856|58861552|FG002|Induction|Adverse Event|0|||
30836895|NCT00492856|58861553|FG003|Induction|Adverse Event|0|||
30836896|NCT00492856|58861550|FG000|Induction|Withdrawal by Subject|1|||
30836897|NCT00492856|58861551|FG001|Induction|Withdrawal by Subject|0|||
30927745|NCT01446874|58963297|FG000|Overall Study|Antibiotics for pre-op infection|0|||
30927746|NCT01446874|58963298|FG001|Overall Study|Antibiotics for pre-op infection|0|||
30927747|NCT01446874|58963299|FG002|Overall Study|Antibiotics for pre-op infection|2|||
30927748|NCT01446874|58963297|FG000|Overall Study|Withdrawal by Subject|0|||
30927749|NCT01446874|58963298|FG001|Overall Study|Withdrawal by Subject|0|||
30927750|NCT01446874|58963299|FG002|Overall Study|Withdrawal by Subject|4|||
30927751|NCT01446796|58963307|FG000|Overall Study|Withdrawal by Subject|1|||
30927752|NCT01446796|58963308|FG001|Overall Study|Withdrawal by Subject|0|||
30927753|NCT01439074|58963318|FG000|Overall Study|Lost to Follow-up|3|||
30927754|NCT01439074|58963319|FG001|Overall Study|Lost to Follow-up|4|||
30927755|NCT01439074|58963318|FG000|Overall Study|Subject shedding|1|||
30927756|NCT01439074|58963319|FG001|Overall Study|Subject shedding|0|||
30927757|NCT01439074|58963318|FG000|Overall Study|Withdrawal by Subject|1|||
30927758|NCT01439074|58963319|FG001|Overall Study|Withdrawal by Subject|5|||
30927759|NCT01439074|58963318|FG000|Overall Study|Other|4|||
30927760|NCT01439074|58963319|FG001|Overall Study|Other|4|||
30927761|NCT01438996|58963328|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
30927762|NCT01438996|58963329|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
30836898|NCT00492856|58861552|FG002|Induction|Withdrawal by Subject|0|||
30836899|NCT00492856|58861553|FG003|Induction|Withdrawal by Subject|0|||
30836900|NCT00492856|58861550|FG000|Induction|Death|3|||
30836901|NCT00492856|58861551|FG001|Induction|Death|0|||
30927763|NCT01438996|58963330|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
30927764|NCT01438840|58963340|FG000|Core Study|Adverse Event|0|||
30927765|NCT01438840|58963341|FG001|Core Study|Adverse Event|3|||
30927766|NCT01438840|58963342|FG002|Core Study|Adverse Event|0|||
30927767|NCT01438840|58963340|FG000|Core Study|Lack of Efficacy|15|||
30927768|NCT01438840|58963341|FG001|Core Study|Lack of Efficacy|7|||
30927769|NCT01438840|58963342|FG002|Core Study|Lack of Efficacy|0|||
30927770|NCT01438840|58963340|FG000|Core Study|Withdrawal of consent|1|||
30927771|NCT01438840|58963341|FG001|Core Study|Withdrawal of consent|0|||
30927772|NCT01438840|58963342|FG002|Core Study|Withdrawal of consent|0|||
30927773|NCT01438840|58963340|FG000|Extension Phase|Adverse Event|0|||
30927774|NCT01438840|58963341|FG001|Extension Phase|Adverse Event|0|||
30927775|NCT01438840|58963342|FG002|Extension Phase|Adverse Event|3|||
30927776|NCT01438840|58963340|FG000|Extension Phase|Lost to Follow-up|0|||
30927777|NCT01438840|58963341|FG001|Extension Phase|Lost to Follow-up|0|||
30927778|NCT01438840|58963342|FG002|Extension Phase|Lost to Follow-up|1|||
30927779|NCT01438840|58963340|FG000|Extension Phase|Withdrawal by Subject|0|||
30927780|NCT01438840|58963341|FG001|Extension Phase|Withdrawal by Subject|0|||
30927781|NCT01438840|58963342|FG002|Extension Phase|Withdrawal by Subject|3|||
30927782|NCT01438840|58963340|FG000|Extension Phase|Lack of Efficacy|0|||
30927783|NCT01438840|58963341|FG001|Extension Phase|Lack of Efficacy|0|||
30927784|NCT01438840|58963342|FG002|Extension Phase|Lack of Efficacy|2|||
30927785|NCT01438840|58963340|FG000|Extension Phase|Other|0|||
30927786|NCT01438840|58963341|FG001|Extension Phase|Other|0|||
30927787|NCT01438840|58963342|FG002|Extension Phase|Other|1|||
30927788|NCT01471054|58963351|FG000|Overall Study|Study terminated prematurely|4|||
30927789|NCT01471054|58963352|FG001|Overall Study|Study terminated prematurely|0|||
30927790|NCT01978184|58963370|FG000|Overall Study|Progressive disease|5|||
30927791|NCT01978184|58963371|FG001|Overall Study|Progressive disease|5|||
30927792|NCT01978184|58963370|FG000|Overall Study|Other than PDA|2|||
30757584|NCT00112437|58766928|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757585|NCT00112437|58766929|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757586|NCT00112437|58766930|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30927793|NCT01978184|58963371|FG001|Overall Study|Other than PDA|2|||
30757587|NCT00112437|58766931|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757588|NCT00112437|58766932|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757589|NCT00112437|58766933|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757590|NCT00112437|58766934|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757591|NCT00112437|58766935|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757592|NCT00112437|58766936|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30836902|NCT00492856|58861552|FG002|Induction|Death|0|||
30927794|NCT01978184|58963370|FG000|Overall Study|Physician Decision|0|||
30927795|NCT01978184|58963371|FG001|Overall Study|Physician Decision|3|||
30927796|NCT01978184|58963370|FG000|Overall Study|Noncompliance|1|||
30927797|NCT01978184|58963371|FG001|Overall Study|Noncompliance|2|||
30927798|NCT01978184|58963370|FG000|Overall Study|Death|1|||
30927799|NCT01978184|58963371|FG001|Overall Study|Death|0|||
30927800|NCT01978184|58963370|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
30927801|NCT01978184|58963371|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
30927802|NCT01445548|58963377|FG000|Overall Study|Adverse Event|1|||
30927803|NCT01977794|58963383|FG000|Overall Study|Adverse Event|2|||
30836903|NCT00492856|58861553|FG003|Induction|Death|0|||
30836904|NCT00492856|58861550|FG000|Consolidation|Adverse Event|6|||
30836905|NCT00492856|58861551|FG001|Consolidation|Adverse Event|0|||
30836906|NCT00492856|58861552|FG002|Consolidation|Adverse Event|0|||
30836907|NCT00492856|58861553|FG003|Consolidation|Adverse Event|0|||
30836908|NCT00492856|58861550|FG000|Consolidation|Not protocol specified|2|||
30836909|NCT00492856|58861551|FG001|Consolidation|Not protocol specified|0|||
30836910|NCT00492856|58861552|FG002|Consolidation|Not protocol specified|0|||
30836911|NCT00492856|58861553|FG003|Consolidation|Not protocol specified|0|||
30836912|NCT00492856|58861550|FG000|Consolidation|Lost to Follow-up|1|||
30836913|NCT00492856|58861551|FG001|Consolidation|Lost to Follow-up|0|||
30836914|NCT00492856|58861552|FG002|Consolidation|Lost to Follow-up|0|||
30836915|NCT00492856|58861553|FG003|Consolidation|Lost to Follow-up|0|||
30836916|NCT00492856|58861550|FG000|Post-consolidation|Adverse Event|0|||
30836917|NCT00492856|58861551|FG001|Post-consolidation|Adverse Event|4|||
30836918|NCT00492856|58861552|FG002|Post-consolidation|Adverse Event|0|||
30836919|NCT00492856|58861553|FG003|Post-consolidation|Adverse Event|1|||
30836920|NCT00492856|58861550|FG000|Post-consolidation|Withdrawal by Subject|0|||
30836921|NCT00492856|58861551|FG001|Post-consolidation|Withdrawal by Subject|4|||
30836922|NCT00492856|58861552|FG002|Post-consolidation|Withdrawal by Subject|0|||
30836923|NCT00492856|58861553|FG003|Post-consolidation|Withdrawal by Subject|0|||
30836924|NCT00492856|58861550|FG000|Post-consolidation|Death|0|||
30836925|NCT00492856|58861551|FG001|Post-consolidation|Death|1|||
30836926|NCT00492856|58861552|FG002|Post-consolidation|Death|0|||
30836927|NCT00492856|58861553|FG003|Post-consolidation|Death|0|||
30836928|NCT00492856|58861550|FG000|Post-consolidation|Not protocol specified|0|||
30836929|NCT00492856|58861551|FG001|Post-consolidation|Not protocol specified|1|||
30836930|NCT00492856|58861552|FG002|Post-consolidation|Not protocol specified|0|||
30836931|NCT00492856|58861553|FG003|Post-consolidation|Not protocol specified|0|||
30836932|NCT00492856|58861550|FG000|Post-consolidation|Lost to Follow-up|0|||
30836933|NCT00492856|58861551|FG001|Post-consolidation|Lost to Follow-up|2|||
30836934|NCT00492856|58861552|FG002|Post-consolidation|Lost to Follow-up|0|||
30836935|NCT00492856|58861553|FG003|Post-consolidation|Lost to Follow-up|0|||
30836936|NCT00492856|58861550|FG000|Post-consolidation|Observation Arm|0|||
30836937|NCT00492856|58861551|FG001|Post-consolidation|Observation Arm|0|||
30836938|NCT00492856|58861552|FG002|Post-consolidation|Observation Arm|27|||
30836939|NCT00492856|58861553|FG003|Post-consolidation|Observation Arm|0|||
30836940|NCT02782377|58861565|FG000|Overall Study|Physician Decision|5|||
30836941|NCT02410629|58861572|FG000|Overall Study|Family cannot commit to the study|2|||
30836942|NCT02410629|58861573|FG001|Overall Study|Family cannot commit to the study|1|||
30836943|NCT02410629|58861572|FG000|Overall Study|Subject returned to work|1|||
30836944|NCT02410629|58861573|FG001|Overall Study|Subject returned to work|0|||
30836945|NCT02410629|58861572|FG000|Overall Study|Subject moved back to home country|0|||
30836946|NCT02410629|58861573|FG001|Overall Study|Subject moved back to home country|1|||
30836947|NCT02410629|58861572|FG000|Overall Study|Subject underwent heart surgery|0|||
30836948|NCT02410629|58861573|FG001|Overall Study|Subject underwent heart surgery|1|||
30836949|NCT02252211|58861581|FG000|Overall Study|Adverse Event|0|||
30836950|NCT02252211|58861582|FG001|Overall Study|Adverse Event|1|||
30836951|NCT02252211|58861583|FG002|Overall Study|Adverse Event|0|||
30836952|NCT02252211|58861581|FG000|Overall Study|Progressive disease|3|||
30836953|NCT02252211|58861582|FG001|Overall Study|Progressive disease|2|||
30836954|NCT02252211|58861583|FG002|Overall Study|Progressive disease|0|||
30836955|NCT02252211|58861581|FG000|Overall Study|Withdrawal by Subject|1|||
30836956|NCT02252211|58861582|FG001|Overall Study|Withdrawal by Subject|0|||
30836957|NCT02252211|58861583|FG002|Overall Study|Withdrawal by Subject|0|||
30836958|NCT02252211|58861581|FG000|Overall Study|Serious Adverse Event During Screening|1|||
30836959|NCT02252211|58861582|FG001|Overall Study|Serious Adverse Event During Screening|0|||
30836960|NCT02252211|58861583|FG002|Overall Study|Serious Adverse Event During Screening|1|||
30836961|NCT02776683|58861590|FG000|Pre-switch Period|Protocol Violation|1|||
30836962|NCT02776683|58861591|FG001|Pre-switch Period|Protocol Violation|0|||
30836963|NCT02776683|58861590|FG000|Pre-switch Period|Adverse Event|21|||
30836964|NCT02776683|58861591|FG001|Pre-switch Period|Adverse Event|0|||
30836965|NCT02776683|58861590|FG000|Pre-switch Period|Withdrawal by Subject|9|||
30836966|NCT02776683|58861591|FG001|Pre-switch Period|Withdrawal by Subject|0|||
30836967|NCT02776683|58861590|FG000|Pre-switch Period|Physician Decision|7|||
30836968|NCT02776683|58861591|FG001|Pre-switch Period|Physician Decision|0|||
30836969|NCT02776683|58861590|FG000|Pre-switch Period|Progressive disease|39|||
30836970|NCT02776683|58861591|FG001|Pre-switch Period|Progressive disease|0|||
30836971|NCT02776683|58861590|FG000|Pre-switch Period|Other than listed|3|||
30836972|NCT02776683|58861591|FG001|Pre-switch Period|Other than listed|0|||
30836973|NCT02776683|58861590|FG000|Post-switch Period|Adverse Event|0|||
30836974|NCT02776683|58861591|FG001|Post-switch Period|Adverse Event|3|||
30836975|NCT02776683|58861590|FG000|Post-switch Period|Withdrawal by Subject|0|||
30836976|NCT02776683|58861591|FG001|Post-switch Period|Withdrawal by Subject|2|||
30836977|NCT02776683|58861590|FG000|Post-switch Period|Physician Decision|0|||
30836978|NCT02776683|58861591|FG001|Post-switch Period|Physician Decision|3|||
30836979|NCT02776683|58861590|FG000|Post-switch Period|Progressive disease|0|||
30927804|NCT01977794|58963384|FG001|Overall Study|Adverse Event|2|||
30927805|NCT01977794|58963383|FG000|Overall Study|Lost to Follow-up|2|||
30927806|NCT01977794|58963384|FG001|Overall Study|Lost to Follow-up|1|||
30927807|NCT01977794|58963383|FG000|Overall Study|Protocol Violation|1|||
30927808|NCT01977794|58963384|FG001|Overall Study|Protocol Violation|0|||
30927809|NCT01977794|58963383|FG000|Overall Study|Death|1|||
30927810|NCT01977794|58963384|FG001|Overall Study|Death|1|||
30927811|NCT01977794|58963383|FG000|Overall Study|Withdrew consent|2|||
30927812|NCT01977794|58963384|FG001|Overall Study|Withdrew consent|1|||
30927813|NCT01977794|58963383|FG000|Overall Study|Other|0|||
30927814|NCT01977794|58963384|FG001|Overall Study|Other|1|||
30927815|NCT02005484|58963390|FG000|Overall Study|Death|1|||
30927816|NCT02005484|58963390|FG000|Overall Study|Disease progression|1|||
30927817|NCT02005484|58963390|FG000|Overall Study|Changed to a Different Study|1|||
30927818|NCT02005484|58963390|FG000|Overall Study|Sponsor decision|1|||
30927819|NCT02005250|58963396|FG000|Overall Study|Lost to Follow-up|15|||
30927820|NCT02005250|58963397|FG001|Overall Study|Lost to Follow-up|5|||
30927821|NCT02024750|58963405|FG000|Overall Study|Withdrawal by Subject|2|||
30927822|NCT02024750|58963406|FG001|Overall Study|Withdrawal by Subject|1|||
30927823|NCT01597973|58963414|FG000|Overall Study|Found ineligible before study medication started|4|||
30927824|NCT01597973|58963415|FG001|Overall Study|Found ineligible before study medication started|2|||
30927825|NCT01597973|58963414|FG000|Overall Study|Eligible pathogen not confirmed|14|||
30927826|NCT01597973|58963415|FG001|Overall Study|Eligible pathogen not confirmed|15|||
30927827|NCT01597973|58963414|FG000|Overall Study|LAR not authorized to consent|0|||
30927828|NCT01597973|58963415|FG001|Overall Study|LAR not authorized to consent|1|||
30927829|NCT01597973|58963414|FG000|Overall Study|Ineligible due to early seizures|1|||
30927830|NCT01597973|58963415|FG001|Overall Study|Ineligible due to early seizures|0|||
30927831|NCT01597973|58963414|FG000|Overall Study|Ineligible due to non-target infection|1|||
30927832|NCT01597973|58963415|FG001|Overall Study|Ineligible due to non-target infection|1|||
30927833|NCT02023268|58963425|FG000|Overall Study|Lack of Efficacy|0|||
30927834|NCT02023268|58963426|FG001|Overall Study|Lack of Efficacy|1|||
30927835|NCT02023268|58963425|FG000|Overall Study|Adverse Event|0|||
30927836|NCT02023268|58963426|FG001|Overall Study|Adverse Event|2|||
30927837|NCT02023268|58963425|FG000|Overall Study|Withdrawal by Subject|0|||
30927838|NCT02023268|58963426|FG001|Overall Study|Withdrawal by Subject|1|||
30927839|NCT02047253|58963432|FG000|Overall Study|Lost to Follow-up|8|||
30927840|NCT02096705|58963438|FG000|Treatment|Adverse Event|6|||
30927841|NCT02096705|58963439|FG001|Treatment|Adverse Event|3|||
30927842|NCT02096705|58963438|FG000|Treatment|Subject request to discontinue treatment|1|||
30927843|NCT02096705|58963439|FG001|Treatment|Subject request to discontinue treatment|1|||
30927844|NCT02096705|58963438|FG000|Treatment|Withdrawal by Subject|1|||
30927845|NCT02096705|58963439|FG001|Treatment|Withdrawal by Subject|0|||
30927846|NCT02096705|58963438|FG000|Treatment|Other|1|||
30927847|NCT02096705|58963439|FG001|Treatment|Other|1|||
30927848|NCT02096705|58963438|FG000|Follow-up|Withdrawal by Subject|1|||
30927849|NCT02096705|58963439|FG001|Follow-up|Withdrawal by Subject|0|||
30927850|NCT02096705|58963438|FG000|Follow-up|Adverse Event|2|||
30927851|NCT02096705|58963439|FG001|Follow-up|Adverse Event|2|||
30927852|NCT02096705|58963438|FG000|Follow-up|Subjects not reporting status|1|||
30927853|NCT02096705|58963439|FG001|Follow-up|Subjects not reporting status|2|||
30927854|NCT02096471|58963445|FG000|Overall Study|Adverse Event|1|||
30624051|NCT02731729|58636047|FG001|Overall Study|Study terminated by Sponsor|6|||
30624052|NCT02731729|58636046|FG000|Overall Study|Withdrawal by Subject|1|||
30836980|NCT02776683|58861591|FG001|Post-switch Period|Progressive disease|20|||
30836981|NCT02776683|58861590|FG000|Post-switch Period|Other than listed|0|||
30836982|NCT02776683|58861591|FG001|Post-switch Period|Other than listed|15|||
30836983|NCT02731742|58861599|FG000|Overall Study|Death|1|||
30836984|NCT02731742|58861600|FG001|Overall Study|Death|2|||
30836985|NCT02731742|58861601|FG002|Overall Study|Death|5|||
30836986|NCT02731742|58861602|FG003|Overall Study|Death|0|||
30836987|NCT02731742|58861599|FG000|Overall Study|Physician Decision|0|||
30836988|NCT02731742|58861600|FG001|Overall Study|Physician Decision|0|||
30927855|NCT02096471|58963445|FG000|Overall Study|Lack of Efficacy|7|||
30927856|NCT02096471|58963445|FG000|Overall Study|Withdrawal by Subject|3|||
30927857|NCT02096471|58963445|FG000|Overall Study|Non-Compliant|2|||
30927858|NCT02096003|58963451|FG000|Overall Study|Protocol Violation|0|||
30927859|NCT02096003|58963452|FG001|Overall Study|Protocol Violation|2|||
30927860|NCT02096003|58963451|FG000|Overall Study|additional surgery|2|||
30927861|NCT02096003|58963452|FG001|Overall Study|additional surgery|1|||
30927862|NCT02062385|58963462|FG000|Overall Study|Adverse Event|19|||
30927863|NCT02062385|58963463|FG001|Overall Study|Adverse Event|13|||
30927864|NCT02062385|58963464|FG002|Overall Study|Adverse Event|1|||
30927865|NCT02062385|58963465|FG003|Overall Study|Adverse Event|0|||
30836989|NCT02731742|58861601|FG002|Overall Study|Physician Decision|0|||
30836990|NCT02731742|58861602|FG003|Overall Study|Physician Decision|1|||
30836991|NCT02731742|58861599|FG000|Overall Study|Study Terminated by Sponsor|2|||
30927866|NCT02062385|58963462|FG000|Overall Study|Protocol Violation|1|||
30927867|NCT02062385|58963463|FG001|Overall Study|Protocol Violation|0|||
30927868|NCT02062385|58963464|FG002|Overall Study|Protocol Violation|0|||
30927869|NCT02062385|58963465|FG003|Overall Study|Protocol Violation|0|||
30927870|NCT02062385|58963462|FG000|Overall Study|Incomplete EPI by database lock|2|||
30927871|NCT02062385|58963463|FG001|Overall Study|Incomplete EPI by database lock|0|||
30624053|NCT02731729|58636047|FG001|Overall Study|Withdrawal by Subject|0|||
30757593|NCT00112437|58766937|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757594|NCT00112437|58766938|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757595|NCT00112437|58766939|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757596|NCT00112437|58766940|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757597|NCT00112437|58766941|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757598|NCT00112437|58766942|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757599|NCT00112437|58766943|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757600|NCT00112437|58766944|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757601|NCT00112437|58766945|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757602|NCT00112437|58766946|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
30757603|NCT00112437|58766921|FG000|Year 1 (12-Month Base Study)|moved|0|||
30757604|NCT00112437|58766922|FG001|Year 1 (12-Month Base Study)|moved|1|||
30836992|NCT02731742|58861600|FG001|Overall Study|Study Terminated by Sponsor|1|||
30836993|NCT02731742|58861601|FG002|Overall Study|Study Terminated by Sponsor|1|||
30836994|NCT02731742|58861602|FG003|Overall Study|Study Terminated by Sponsor|1|||
30836995|NCT00104871|58861625|FG000|Overall Study|Not evaluable|1|||
30836996|NCT03487796|58861633|FG000|Overall Study|Lost to Follow-up|18|||
30836997|NCT03487796|58861634|FG001|Overall Study|Lost to Follow-up|6|||
30836998|NCT02148705|58861649|FG000|Overall Study|Death|2|||
30836999|NCT02148705|58861650|FG001|Overall Study|Death|0|||
30837000|NCT02148705|58861651|FG002|Overall Study|Death|0|||
30837001|NCT02148705|58861649|FG000|Overall Study|Lost to Follow-up|13|||
30837002|NCT02148705|58861650|FG001|Overall Study|Lost to Follow-up|4|||
30837003|NCT02148705|58861651|FG002|Overall Study|Lost to Follow-up|10|||
30837004|NCT02148705|58861649|FG000|Overall Study|Withdrawal by Subject|3|||
30837005|NCT02148705|58861650|FG001|Overall Study|Withdrawal by Subject|0|||
30837006|NCT02148705|58861651|FG002|Overall Study|Withdrawal by Subject|2|||
30837007|NCT02148705|58861649|FG000|Overall Study|Not Treated|0|||
30837008|NCT02148705|58861650|FG001|Overall Study|Not Treated|1|||
30837009|NCT02148705|58861651|FG002|Overall Study|Not Treated|5|||
30837010|NCT03446612|58861661|FG000|Overall Study|Protocol defined stopping criteria|0|||
30837011|NCT03446612|58861662|FG001|Overall Study|Protocol defined stopping criteria|1|||
30837012|NCT02730728|58861673|FG000|Overall Study|Withdrawal by Subject|0|||
30837013|NCT02730728|58861674|FG001|Overall Study|Withdrawal by Subject|1|||
30837014|NCT02730728|58861675|FG002|Overall Study|Withdrawal by Subject|0|||
30837015|NCT02730728|58861673|FG000|Overall Study|Lack of Efficacy|0|||
30837016|NCT02730728|58861674|FG001|Overall Study|Lack of Efficacy|1|||
30837017|NCT02730728|58861675|FG002|Overall Study|Lack of Efficacy|1|||
30837018|NCT00104637|58861683|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
30837019|NCT00104637|58861684|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
30837020|NCT02768103|58861693|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
30837021|NCT02767323|58861702|FG000|Overall Study|Withdrawal by Subject|17|||
30837022|NCT02767323|58861703|FG001|Overall Study|Withdrawal by Subject|5|||
30837023|NCT02767323|58861704|FG002|Overall Study|Withdrawal by Subject|13|||
30837024|NCT02767323|58861705|FG003|Overall Study|Withdrawal by Subject|0|||
30837025|NCT02767323|58861702|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
30837026|NCT02767323|58861703|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
30837027|NCT02767323|58861704|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
30837028|NCT02767323|58861705|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
30837029|NCT04304950|58861720|FG000|Overall Study|Lost to Follow-up|1|||
30837030|NCT04304950|58861721|FG001|Overall Study|Lost to Follow-up|1|||
30837031|NCT02780115|58861735|FG000|Overall Study|Withdrawal by Subject|0|||
30837032|NCT02780115|58861736|FG001|Overall Study|Withdrawal by Subject|1|||
30837033|NCT02780115|58861737|FG002|Overall Study|Withdrawal by Subject|1|||
30837034|NCT02780115|58861738|FG003|Overall Study|Withdrawal by Subject|0|||
30837035|NCT02780115|58861739|FG004|Overall Study|Withdrawal by Subject|0|||
30837036|NCT02780115|58861735|FG000|Overall Study|Adverse Event|0|||
30837037|NCT02780115|58861736|FG001|Overall Study|Adverse Event|0|||
30837038|NCT02780115|58861737|FG002|Overall Study|Adverse Event|0|||
30837039|NCT02780115|58861738|FG003|Overall Study|Adverse Event|1|||
30837040|NCT02780115|58861739|FG004|Overall Study|Adverse Event|1|||
30837041|NCT02766777|58861751|FG000|Overall Study|Adverse Event|12|||
30837042|NCT02766777|58861751|FG000|Overall Study|Lost to Follow-up|16|||
30837043|NCT02766777|58861751|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30837044|NCT02766777|58861751|FG000|Overall Study|Protocol Violation|1|||
30837045|NCT02766777|58861751|FG000|Overall Study|Withdrawal by Subject|4|||
30927872|NCT02062385|58963464|FG002|Overall Study|Incomplete EPI by database lock|0|||
30927873|NCT02062385|58963465|FG003|Overall Study|Incomplete EPI by database lock|0|||
30927874|NCT02062385|58963462|FG000|Overall Study|Moved|10|||
30927875|NCT02062385|58963463|FG001|Overall Study|Moved|11|||
30927876|NCT02062385|58963464|FG002|Overall Study|Moved|1|||
30927877|NCT02062385|58963465|FG003|Overall Study|Moved|0|||
30927878|NCT02062385|58963462|FG000|Overall Study|Withdrawn by parent/guardian|46|||
30927879|NCT02062385|58963463|FG001|Overall Study|Withdrawn by parent/guardian|41|||
30927880|NCT02062385|58963464|FG002|Overall Study|Withdrawn by parent/guardian|9|||
30757605|NCT00112437|58766923|FG002|Year 1 (12-Month Base Study)|moved|1|||
30757606|NCT00112437|58766924|FG003|Year 1 (12-Month Base Study)|moved|0|||
30757607|NCT00112437|58766925|FG004|Year 1 (12-Month Base Study)|moved|0|||
30757608|NCT00112437|58766926|FG005|Year 1 (12-Month Base Study)|moved|0|||
30757609|NCT00112437|58766927|FG006|Year 1 (12-Month Base Study)|moved|0|||
30757610|NCT00112437|58766928|FG007|Year 1 (12-Month Base Study)|moved|0|||
30757611|NCT00112437|58766929|FG008|Year 1 (12-Month Base Study)|moved|0|||
30757612|NCT00112437|58766930|FG009|Year 1 (12-Month Base Study)|moved|0|||
30757613|NCT00112437|58766931|FG010|Year 1 (12-Month Base Study)|moved|0|||
30837046|NCT00157014|58861759|FG000|Overall Study|Death|4|||
30837047|NCT00157014|58861760|FG001|Overall Study|Death|2|||
30837048|NCT00157014|58861761|FG002|Overall Study|Death|1|||
30837049|NCT00157014|58861762|FG003|Overall Study|Death|1|||
30837050|NCT00157014|58861759|FG000|Overall Study|Physician Decision|0|||
30837051|NCT00157014|58861760|FG001|Overall Study|Physician Decision|1|||
30837052|NCT00157014|58861761|FG002|Overall Study|Physician Decision|0|||
30837053|NCT00157014|58861762|FG003|Overall Study|Physician Decision|0|||
30837054|NCT00157014|58861759|FG000|Overall Study|Medications withdrawn on family request|0|||
30837055|NCT00157014|58861760|FG001|Overall Study|Medications withdrawn on family request|1|||
30837056|NCT00157014|58861761|FG002|Overall Study|Medications withdrawn on family request|0|||
30837057|NCT00157014|58861762|FG003|Overall Study|Medications withdrawn on family request|0|||
30837058|NCT00157014|58861759|FG000|Overall Study|Patient withdrawn by investigator|1|||
30837059|NCT00157014|58861760|FG001|Overall Study|Patient withdrawn by investigator|0|||
30837060|NCT00157014|58861761|FG002|Overall Study|Patient withdrawn by investigator|0|||
30837061|NCT00157014|58861762|FG003|Overall Study|Patient withdrawn by investigator|0|||
30837062|NCT00157014|58861759|FG000|Overall Study|Patient unable to return in nursing home|1|||
30837063|NCT00157014|58861760|FG001|Overall Study|Patient unable to return in nursing home|0|||
30837064|NCT00157014|58861761|FG002|Overall Study|Patient unable to return in nursing home|0|||
30837065|NCT00157014|58861762|FG003|Overall Study|Patient unable to return in nursing home|0|||
30837066|NCT00157014|58861759|FG000|Overall Study|Patient would not receive transplant|0|||
30837067|NCT00157014|58861760|FG001|Overall Study|Patient would not receive transplant|1|||
30837068|NCT00157014|58861761|FG002|Overall Study|Patient would not receive transplant|0|||
30837069|NCT00157014|58861762|FG003|Overall Study|Patient would not receive transplant|0|||
30837070|NCT00157014|58861759|FG000|Overall Study|Withdrawal by Subject|1|||
30837071|NCT00157014|58861760|FG001|Overall Study|Withdrawal by Subject|0|||
30837072|NCT00157014|58861761|FG002|Overall Study|Withdrawal by Subject|0|||
30837073|NCT00157014|58861762|FG003|Overall Study|Withdrawal by Subject|0|||
30837074|NCT02778867|58861774|FG000|Phase 1|Withdrawal by Subject|2|||
30837075|NCT02778867|58861775|FG001|Phase 1|Withdrawal by Subject|3|||
30837076|NCT02778867|58861776|FG002|Phase 1|Withdrawal by Subject|0|||
30837077|NCT02778867|58861777|FG003|Phase 1|Withdrawal by Subject|0|||
30837078|NCT02778867|58861774|FG000|Phase 2|Withdrawal by Subject|0|||
30837079|NCT02778867|58861775|FG001|Phase 2|Withdrawal by Subject|0|||
30837080|NCT02778867|58861776|FG002|Phase 2|Withdrawal by Subject|1|||
30837081|NCT02778867|58861777|FG003|Phase 2|Withdrawal by Subject|0|||
30837082|NCT02778867|58861774|FG000|Phase 2|Physician Decision|0|||
30837083|NCT02778867|58861775|FG001|Phase 2|Physician Decision|0|||
30837084|NCT02778867|58861776|FG002|Phase 2|Physician Decision|0|||
30837085|NCT02778867|58861777|FG003|Phase 2|Physician Decision|1|||
30837086|NCT02778867|58861774|FG000|Phase 2|Adverse Event|0|||
30837087|NCT02778867|58861775|FG001|Phase 2|Adverse Event|0|||
30837088|NCT02778867|58861776|FG002|Phase 2|Adverse Event|0|||
30837089|NCT02778867|58861777|FG003|Phase 2|Adverse Event|1|||
30837090|NCT02778555|58861790|FG000|Overall Study|Withdrawal by Subject|55|||
30837091|NCT02778555|58861791|FG001|Overall Study|Withdrawal by Subject|32|||
30927881|NCT02062385|58963465|FG003|Overall Study|Withdrawn by parent/guardian|8|||
30837092|NCT02778555|58861792|FG002|Overall Study|Withdrawal by Subject|107|||
30837093|NCT02778399|58861806|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
30837094|NCT02778399|58861807|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
30837095|NCT02778399|58861808|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
30837096|NCT02778399|58861809|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
30837097|NCT02778399|58861810|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
30837098|NCT02778399|58861811|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
30837099|NCT02778399|58861806|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
30927882|NCT02062385|58963462|FG000|Overall Study|Death|0|||
30927883|NCT02062385|58963463|FG001|Overall Study|Death|0|||
30927884|NCT02062385|58963464|FG002|Overall Study|Death|0|||
30927885|NCT02062385|58963465|FG003|Overall Study|Death|1|||
30927886|NCT02062385|58963462|FG000|Overall Study|Lost to Follow-up|0|||
30927887|NCT02062385|58963463|FG001|Overall Study|Lost to Follow-up|0|||
30927888|NCT02062385|58963464|FG002|Overall Study|Lost to Follow-up|1|||
30927889|NCT02062385|58963465|FG003|Overall Study|Lost to Follow-up|0|||
30837100|NCT02778399|58861807|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
30837101|NCT02778399|58861808|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
30837102|NCT02778399|58861809|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
30837103|NCT02778399|58861810|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
30837104|NCT02778399|58861811|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
30837105|NCT02778399|58861806|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
30837106|NCT02778399|58861807|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
30837107|NCT02778399|58861808|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
30837108|NCT02778399|58861809|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
30837109|NCT02778399|58861810|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
30837110|NCT02778399|58861811|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
30837111|NCT02778399|58861806|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
30837112|NCT02778399|58861807|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
30837113|NCT02778399|58861808|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
30837114|NCT02778399|58861809|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
30837115|NCT02778399|58861810|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
30837116|NCT02778399|58861811|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
30837117|NCT02778399|58861806|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
30837118|NCT02778399|58861807|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
30837119|NCT02778399|58861808|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
30837120|NCT02778399|58861809|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
30837121|NCT02778399|58861810|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
30837122|NCT02778399|58861811|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
30837123|NCT02778399|58861806|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
30837124|NCT02778399|58861807|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
30837125|NCT02778399|58861808|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
30837126|NCT02778399|58861809|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
30837127|NCT02778399|58861810|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
30837128|NCT02778399|58861811|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
30837129|NCT02778399|58861806|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
30837130|NCT02778399|58861807|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
30837131|NCT02778399|58861808|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
30837132|NCT02778399|58861809|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
30837133|NCT02778399|58861810|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
30837134|NCT02778399|58861811|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
30837135|NCT02778399|58861806|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
30837136|NCT02778399|58861807|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
30837137|NCT02778399|58861808|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
30837138|NCT02778399|58861809|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
30837139|NCT02778399|58861810|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
30837140|NCT02778399|58861811|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
30837141|NCT02778399|58861806|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
30837142|NCT02778399|58861807|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
30837143|NCT02778399|58861808|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
30837144|NCT02778399|58861809|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
30837145|NCT02778399|58861810|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
30837146|NCT02778399|58861811|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
30837147|NCT02778399|58861806|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
30837148|NCT02778399|58861807|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
30837149|NCT02778399|58861808|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
30837150|NCT02778399|58861809|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
30837151|NCT02778399|58861810|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
30837152|NCT02778399|58861811|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
30837153|NCT02778399|58861806|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
30837154|NCT02778399|58861807|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
30837155|NCT02778399|58861808|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
30837156|NCT02778399|58861809|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
30837157|NCT02778399|58861810|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
30837158|NCT02778399|58861811|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
30927890|NCT02062151|58963473|FG000|Overall Study|screen failure|1|||
30837159|NCT03656744|58861860|FG000|Overall Study|Adverse Event|1|||
30837160|NCT03656744|58861861|FG001|Overall Study|Adverse Event|4|||
30927891|NCT02060903|58963479|FG000|Overall Study|Lost to Follow-up|4|||
30927892|NCT02060903|58963480|FG001|Overall Study|Lost to Follow-up|0|||
30927893|NCT02060903|58963479|FG000|Overall Study|Withdrawal by Subject|0|||
30927894|NCT02060903|58963480|FG001|Overall Study|Withdrawal by Subject|7|||
30927895|NCT02095691|58963486|FG000|Overall Study|Physician Decision|1|||
30927896|NCT02095535|58963502|FG000|Recruitment|Protocol Violation|2|||
30927897|NCT02095223|58963508|FG000|Overall Study|Withdrawal by Subject|1|||
30927898|NCT02095223|58963509|FG001|Overall Study|Withdrawal by Subject|0|||
30927899|NCT02095145|58963517|FG000|Overall Study|Withdrawal by Subject|1|||
30927900|NCT02095145|58963518|FG001|Overall Study|Withdrawal by Subject|0|||
30927901|NCT02059187|58963528|FG000|Overall Study|Adverse Event|0|||
30927902|NCT02059187|58963529|FG001|Overall Study|Adverse Event|3|||
30927903|NCT02059187|58963528|FG000|Overall Study|Death|1|||
30927904|NCT02059187|58963529|FG001|Overall Study|Death|1|||
30927905|NCT02059187|58963528|FG000|Overall Study|Lost to Follow-up|9|||
30927906|NCT02059187|58963529|FG001|Overall Study|Lost to Follow-up|8|||
30927907|NCT02059187|58963528|FG000|Overall Study|Non-compliance with study drug|1|||
30927908|NCT02059187|58963529|FG001|Overall Study|Non-compliance with study drug|0|||
30927909|NCT02059187|58963528|FG000|Overall Study|Physician Decision|1|||
30927910|NCT02059187|58963529|FG001|Overall Study|Physician Decision|2|||
30927911|NCT02059187|58963528|FG000|Overall Study|Protocol Violation|1|||
30927912|NCT02059187|58963529|FG001|Overall Study|Protocol Violation|0|||
30927913|NCT02059187|58963528|FG000|Overall Study|Withdrawal by Subject|12|||
30927914|NCT02059187|58963529|FG001|Overall Study|Withdrawal by Subject|8|||
30927915|NCT02043899|58963535|FG000|Overall Study|Adverse Event|3|||
30927916|NCT02043899|58963535|FG000|Overall Study|Physician Decision|1|||
30927917|NCT02043899|58963535|FG000|Overall Study|Withdrawal by Subject|2|||
30927918|NCT02043899|58963535|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
30927919|NCT02043899|58963535|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
30927920|NCT02043899|58963535|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
30927921|NCT02043899|58963535|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
30927922|NCT02043899|58963535|FG000|Overall Study|Treatment delayed|1|||
30927923|NCT02043509|58963541|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
30927924|NCT02043509|58963542|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
30927925|NCT02043509|58963541|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
30927926|NCT02043509|58963542|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
30927927|NCT02043509|58963541|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
30927928|NCT02043509|58963542|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
30927929|NCT02043509|58963541|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
30927930|NCT02043509|58963542|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
30927931|NCT02058563|58963550|FG000|Overall Study|Lost to Follow-up|26|||
30927932|NCT02058563|58963551|FG001|Overall Study|Lost to Follow-up|22|||
30927933|NCT02058563|58963550|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
30927934|NCT02058563|58963551|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
30927935|NCT02058563|58963550|FG000|Overall Study|Consent Withdrawal|1|||
30927936|NCT02058563|58963551|FG001|Overall Study|Consent Withdrawal|1|||
30927937|NCT02058563|58963550|FG000|Overall Study|Other (patient incarcerated)|0|||
30927938|NCT02058563|58963551|FG001|Overall Study|Other (patient incarcerated)|1|||
30927939|NCT01622231|58963557|FG000|Overall Study|Physician Decision|1|||
30927940|NCT01622231|58963557|FG000|Overall Study|Withdrawal by Subject|1|||
30927941|NCT02042183|58963563|FG000|Overall Study|Physician Decision|7|||
30927942|NCT02042183|58963564|FG001|Overall Study|Physician Decision|2|||
30837161|NCT03656744|58861862|FG002|Overall Study|Adverse Event|1|||
30837162|NCT03656744|58861860|FG000|Overall Study|Protocol Violation|1|||
30837163|NCT03656744|58861861|FG001|Overall Study|Protocol Violation|0|||
30837164|NCT03656744|58861862|FG002|Overall Study|Protocol Violation|0|||
30837165|NCT03656744|58861860|FG000|Overall Study|Lost to Follow-up|2|||
30837166|NCT03656744|58861861|FG001|Overall Study|Lost to Follow-up|2|||
30837167|NCT03656744|58861862|FG002|Overall Study|Lost to Follow-up|0|||
30837168|NCT03656744|58861860|FG000|Overall Study|Withdrawal by Subject|0|||
30837169|NCT03656744|58861861|FG001|Overall Study|Withdrawal by Subject|1|||
30837170|NCT03656744|58861862|FG002|Overall Study|Withdrawal by Subject|0|||
30837171|NCT03656744|58861860|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
30837172|NCT03656744|58861861|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
30837173|NCT03656744|58861862|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
30837174|NCT02739360|58861870|FG000|Overall Study|Adverse Event|1|||
30927943|NCT02042183|58963563|FG000|Overall Study|Lack of Efficacy|4|||
30927944|NCT02042183|58963564|FG001|Overall Study|Lack of Efficacy|3|||
30927945|NCT02042183|58963563|FG000|Overall Study|Non-compliance with Study Drug|2|||
30927946|NCT02042183|58963564|FG001|Overall Study|Non-compliance with Study Drug|3|||
30927947|NCT02042183|58963563|FG000|Overall Study|Adverse Event|17|||
30927948|NCT02042183|58963564|FG001|Overall Study|Adverse Event|6|||
30927949|NCT02042183|58963563|FG000|Overall Study|Other|3|||
30927950|NCT02042183|58963564|FG001|Overall Study|Other|3|||
30837175|NCT02739360|58861870|FG000|Overall Study|Study terminated by Sponsor|2|||
30927951|NCT02042183|58963563|FG000|Overall Study|Withdrawal by Subject|21|||
30927952|NCT02042183|58963564|FG001|Overall Study|Withdrawal by Subject|16|||
30927953|NCT02042183|58963563|FG000|Overall Study|Site Terminated by Sponsor|2|||
30927954|NCT02042183|58963564|FG001|Overall Study|Site Terminated by Sponsor|1|||
30757614|NCT00112437|58766932|FG011|Year 1 (12-Month Base Study)|moved|0|||
30757615|NCT00112437|58766933|FG012|Year 1 (12-Month Base Study)|moved|0|||
30757616|NCT00112437|58766934|FG013|Year 1 (12-Month Base Study)|moved|0|||
30837176|NCT01822522|58861880|FG000|Overall Study|Adverse Event|1|||
30837177|NCT01822522|58861881|FG001|Overall Study|Adverse Event|1|||
30837178|NCT01822522|58861882|FG002|Overall Study|Adverse Event|1|||
30837179|NCT01822522|58861883|FG003|Overall Study|Adverse Event|0|||
30837180|NCT01822522|58861884|FG004|Overall Study|Adverse Event|0|||
30837181|NCT01822522|58861885|FG005|Overall Study|Adverse Event|1|||
30837182|NCT01822522|58861880|FG000|Overall Study|Death|3|||
30837183|NCT01822522|58861881|FG001|Overall Study|Death|0|||
30837184|NCT01822522|58861882|FG002|Overall Study|Death|2|||
30837185|NCT01822522|58861883|FG003|Overall Study|Death|0|||
30837186|NCT01822522|58861884|FG004|Overall Study|Death|0|||
30837187|NCT01822522|58861885|FG005|Overall Study|Death|0|||
30757617|NCT00112437|58766935|FG014|Year 1 (12-Month Base Study)|moved|0|||
30757618|NCT00112437|58766936|FG015|Year 1 (12-Month Base Study)|moved|0|||
30757619|NCT00112437|58766937|FG016|Year 1 (12-Month Base Study)|moved|0|||
30757620|NCT00112437|58766938|FG017|Year 1 (12-Month Base Study)|moved|0|||
30757621|NCT00112437|58766939|FG018|Year 1 (12-Month Base Study)|moved|0|||
30757622|NCT00112437|58766940|FG019|Year 1 (12-Month Base Study)|moved|0|||
30757623|NCT00112437|58766941|FG020|Year 1 (12-Month Base Study)|moved|0|||
30757624|NCT00112437|58766942|FG021|Year 1 (12-Month Base Study)|moved|0|||
30837188|NCT01822522|58861880|FG000|Overall Study|Lost to Follow-up|0|||
30837189|NCT01822522|58861881|FG001|Overall Study|Lost to Follow-up|0|||
30837190|NCT01822522|58861882|FG002|Overall Study|Lost to Follow-up|1|||
30837191|NCT01822522|58861883|FG003|Overall Study|Lost to Follow-up|1|||
30837192|NCT01822522|58861884|FG004|Overall Study|Lost to Follow-up|0|||
30837193|NCT01822522|58861885|FG005|Overall Study|Lost to Follow-up|1|||
30837194|NCT01822522|58861880|FG000|Overall Study|Withdrawal by Subject|0|||
30837195|NCT01822522|58861881|FG001|Overall Study|Withdrawal by Subject|0|||
30837196|NCT01822522|58861882|FG002|Overall Study|Withdrawal by Subject|0|||
30837197|NCT01822522|58861883|FG003|Overall Study|Withdrawal by Subject|1|||
30837198|NCT01822522|58861884|FG004|Overall Study|Withdrawal by Subject|0|||
30837199|NCT01822522|58861885|FG005|Overall Study|Withdrawal by Subject|0|||
30837200|NCT01822522|58861880|FG000|Overall Study|Lack of Efficacy|0|||
30837201|NCT01822522|58861881|FG001|Overall Study|Lack of Efficacy|0|||
30837202|NCT01822522|58861882|FG002|Overall Study|Lack of Efficacy|0|||
30837203|NCT01822522|58861883|FG003|Overall Study|Lack of Efficacy|0|||
30837204|NCT01822522|58861884|FG004|Overall Study|Lack of Efficacy|0|||
30837205|NCT01822522|58861885|FG005|Overall Study|Lack of Efficacy|2|||
30837206|NCT00102687|58861929|FG000|Initial Period|Withdrawal by Subject|6|||
30837207|NCT00102687|58861930|FG001|Initial Period|Withdrawal by Subject|3|||
30837208|NCT00102687|58861931|FG002|Initial Period|Withdrawal by Subject|5|||
30837209|NCT00102687|58861932|FG003|Initial Period|Withdrawal by Subject|0|||
30837210|NCT00102687|58861933|FG004|Initial Period|Withdrawal by Subject|0|||
30837211|NCT00102687|58861929|FG000|Initial Period|Adverse Event|4|||
30837212|NCT00102687|58861930|FG001|Initial Period|Adverse Event|7|||
30837213|NCT00102687|58861931|FG002|Initial Period|Adverse Event|9|||
30837214|NCT00102687|58861932|FG003|Initial Period|Adverse Event|0|||
30837215|NCT00102687|58861933|FG004|Initial Period|Adverse Event|0|||
30837216|NCT00102687|58861929|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
30837217|NCT00102687|58861930|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
30837218|NCT00102687|58861931|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
30837219|NCT00102687|58861932|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
30837220|NCT00102687|58861933|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
30837221|NCT00102687|58861929|FG000|Initial Period|Protocol Violation|0|||
30837222|NCT00102687|58861930|FG001|Initial Period|Protocol Violation|0|||
30837223|NCT00102687|58861931|FG002|Initial Period|Protocol Violation|2|||
30837224|NCT00102687|58861932|FG003|Initial Period|Protocol Violation|0|||
30837225|NCT00102687|58861933|FG004|Initial Period|Protocol Violation|0|||
30837226|NCT00102687|58861929|FG000|Initial Period|Physician Decision|2|||
30837227|NCT00102687|58861930|FG001|Initial Period|Physician Decision|9|||
30837228|NCT00102687|58861931|FG002|Initial Period|Physician Decision|6|||
30837229|NCT00102687|58861932|FG003|Initial Period|Physician Decision|0|||
30837230|NCT00102687|58861933|FG004|Initial Period|Physician Decision|0|||
30837231|NCT00102687|58861929|FG000|Initial Period|Sponsor's decision|0|||
30837232|NCT00102687|58861930|FG001|Initial Period|Sponsor's decision|1|||
30837233|NCT00102687|58861931|FG002|Initial Period|Sponsor's decision|1|||
30837234|NCT00102687|58861932|FG003|Initial Period|Sponsor's decision|0|||
30837235|NCT00102687|58861933|FG004|Initial Period|Sponsor's decision|0|||
30837236|NCT00102687|58861929|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
30837237|NCT00102687|58861930|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
30927955|NCT02042183|58963563|FG000|Overall Study|Lost to Follow-up|9|||
30927956|NCT02042183|58963564|FG001|Overall Study|Lost to Follow-up|2|||
30927957|NCT01977482|58963578|FG000|Overall Study|Adverse Event|0|||
30927958|NCT01977482|58963579|FG001|Overall Study|Adverse Event|1|||
30927959|NCT01977482|58963580|FG002|Overall Study|Adverse Event|1|||
30927960|NCT01977482|58963581|FG003|Overall Study|Adverse Event|0|||
30927961|NCT01977482|58963582|FG004|Overall Study|Adverse Event|2|||
30927962|NCT01977482|58963583|FG005|Overall Study|Adverse Event|0|||
30927963|NCT01977482|58963578|FG000|Overall Study|Lost to Follow-up|1|||
30927964|NCT01977482|58963579|FG001|Overall Study|Lost to Follow-up|0|||
30927965|NCT01977482|58963580|FG002|Overall Study|Lost to Follow-up|0|||
30927966|NCT01977482|58963581|FG003|Overall Study|Lost to Follow-up|0|||
30927967|NCT01977482|58963582|FG004|Overall Study|Lost to Follow-up|0|||
30927968|NCT01977482|58963583|FG005|Overall Study|Lost to Follow-up|0|||
30927969|NCT01977482|58963578|FG000|Overall Study|Physician Decision|0|||
30927970|NCT01977482|58963579|FG001|Overall Study|Physician Decision|1|||
30927971|NCT01977482|58963580|FG002|Overall Study|Physician Decision|0|||
30927972|NCT01977482|58963581|FG003|Overall Study|Physician Decision|0|||
30927973|NCT01977482|58963582|FG004|Overall Study|Physician Decision|0|||
30927974|NCT01977482|58963583|FG005|Overall Study|Physician Decision|0|||
30927975|NCT01977482|58963578|FG000|Overall Study|Protocol Violation|0|||
30927976|NCT01977482|58963579|FG001|Overall Study|Protocol Violation|0|||
30927977|NCT01977482|58963580|FG002|Overall Study|Protocol Violation|1|||
30927978|NCT01977482|58963581|FG003|Overall Study|Protocol Violation|0|||
30927979|NCT01977482|58963582|FG004|Overall Study|Protocol Violation|0|||
30927980|NCT01977482|58963583|FG005|Overall Study|Protocol Violation|0|||
30927981|NCT01977482|58963578|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
30927982|NCT01977482|58963579|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
30927983|NCT01977482|58963580|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
30927984|NCT01977482|58963581|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
30927985|NCT01977482|58963582|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
30927986|NCT01977482|58963583|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
30927987|NCT01977482|58963578|FG000|Overall Study|Withdrawal by Subject|2|||
30927988|NCT01977482|58963579|FG001|Overall Study|Withdrawal by Subject|4|||
30927989|NCT01977482|58963580|FG002|Overall Study|Withdrawal by Subject|1|||
30927990|NCT01977482|58963581|FG003|Overall Study|Withdrawal by Subject|3|||
30927991|NCT01977482|58963582|FG004|Overall Study|Withdrawal by Subject|1|||
30927992|NCT01977482|58963583|FG005|Overall Study|Withdrawal by Subject|5|||
30927993|NCT02058095|58963604|FG000|Overall Study|Adverse Event|1|||
30927994|NCT02058095|58963605|FG001|Overall Study|Adverse Event|0|||
30927995|NCT02023112|58963613|FG000|Overall Study|Withdrawal by Subject|2|||
30927996|NCT02023112|58963614|FG001|Overall Study|Withdrawal by Subject|1|||
30927997|NCT01977092|58963624|FG000|Overall Study|Death|3|||
30927998|NCT01977092|58963625|FG001|Overall Study|Death|4|||
30927999|NCT01977092|58963624|FG000|Overall Study|Lost to Follow-up|23|||
30837238|NCT00102687|58861931|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
30837239|NCT00102687|58861932|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
30837240|NCT00102687|58861933|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
30837241|NCT00102687|58861929|FG000|Initial Period|Death|1|||
30837242|NCT00102687|58861930|FG001|Initial Period|Death|1|||
30837243|NCT00102687|58861931|FG002|Initial Period|Death|1|||
30837244|NCT00102687|58861932|FG003|Initial Period|Death|0|||
30837245|NCT00102687|58861933|FG004|Initial Period|Death|0|||
30837246|NCT00102687|58861929|FG000|Maintenance Period|Withdrawal by Subject|4|||
30837247|NCT00102687|58861930|FG001|Maintenance Period|Withdrawal by Subject|0|||
30837248|NCT00102687|58861931|FG002|Maintenance Period|Withdrawal by Subject|2|||
30837249|NCT00102687|58861932|FG003|Maintenance Period|Withdrawal by Subject|3|||
30837250|NCT00102687|58861933|FG004|Maintenance Period|Withdrawal by Subject|1|||
30837251|NCT00102687|58861929|FG000|Maintenance Period|Adverse Event|1|||
30837252|NCT00102687|58861930|FG001|Maintenance Period|Adverse Event|0|||
30837253|NCT00102687|58861931|FG002|Maintenance Period|Adverse Event|0|||
30928000|NCT01977092|58963625|FG001|Overall Study|Lost to Follow-up|14|||
30624054|NCT01119066|58636057|FG000|Overall Study|Withdrawal by Subject|4|||
30837254|NCT00102687|58861932|FG003|Maintenance Period|Adverse Event|1|||
30837255|NCT00102687|58861933|FG004|Maintenance Period|Adverse Event|3|||
30837256|NCT00102687|58861929|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
30837257|NCT00102687|58861930|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
30928001|NCT01977092|58963624|FG000|Overall Study|Withdrawal by Subject|2|||
30928002|NCT01977092|58963625|FG001|Overall Study|Withdrawal by Subject|1|||
30928003|NCT01977092|58963624|FG000|Overall Study|In prison|3|||
30928004|NCT01977092|58963625|FG001|Overall Study|In prison|11|||
30928005|NCT01976624|58963631|FG000|Overall Study|Participants contraindicated|2|||
30928006|NCT01976624|58963631|FG000|Overall Study|Participants age less than 19 years|12|||
30928007|NCT02041091|58963637|FG000|Treatment|Adverse Event|3|||
30928008|NCT02041091|58963638|FG001|Treatment|Adverse Event|3|||
30928009|NCT02041091|58963637|FG000|Treatment|Withdrawal by Subject|2|||
30928010|NCT02041091|58963638|FG001|Treatment|Withdrawal by Subject|4|||
30928011|NCT02041091|58963637|FG000|Treatment|Physician Decision|1|||
30928012|NCT02041091|58963638|FG001|Treatment|Physician Decision|0|||
30928013|NCT02041091|58963637|FG000|Treatment|Sponsor Decision|15|||
30928014|NCT02041091|58963638|FG001|Treatment|Sponsor Decision|16|||
30928015|NCT02041091|58963637|FG000|Treatment|Lost to Follow-up|1|||
30928016|NCT02041091|58963638|FG001|Treatment|Lost to Follow-up|0|||
30624055|NCT01119066|58636058|FG001|Overall Study|Withdrawal by Subject|6|||
30837258|NCT00102687|58861931|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
30837259|NCT00102687|58861932|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
30837260|NCT00102687|58861933|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
30837261|NCT00102687|58861929|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
30837262|NCT00102687|58861930|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
30837263|NCT00102687|58861931|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
30837264|NCT00102687|58861932|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
30837265|NCT00102687|58861933|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
30837266|NCT00102687|58861929|FG000|Maintenance Period|Death|0|||
30837267|NCT00102687|58861930|FG001|Maintenance Period|Death|0|||
30837268|NCT00102687|58861931|FG002|Maintenance Period|Death|0|||
30837269|NCT00102687|58861932|FG003|Maintenance Period|Death|1|||
30837270|NCT00102687|58861933|FG004|Maintenance Period|Death|1|||
30837271|NCT00102687|58861929|FG000|Maintenance Period|Physician Decision|1|||
30837272|NCT00102687|58861930|FG001|Maintenance Period|Physician Decision|2|||
30837273|NCT00102687|58861931|FG002|Maintenance Period|Physician Decision|3|||
30837274|NCT00102687|58861932|FG003|Maintenance Period|Physician Decision|0|||
30837275|NCT00102687|58861933|FG004|Maintenance Period|Physician Decision|4|||
30624056|NCT01119066|58636059|FG002|Overall Study|Withdrawal by Subject|0|||
30624057|NCT01119066|58636060|FG003|Overall Study|Withdrawal by Subject|0|||
30624058|NCT01119066|58636057|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
30624059|NCT01119066|58636058|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
30837276|NCT00102531|58861951|FG000|Overall Study|Adverse Event|0|||
30928017|NCT02041091|58963637|FG000|Optional Safety Extension Period|Adverse Event|4|||
30928018|NCT02041091|58963638|FG001|Optional Safety Extension Period|Adverse Event|2|||
30928019|NCT02041091|58963637|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
30928020|NCT02041091|58963638|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
30928021|NCT02041091|58963637|FG000|Optional Safety Extension Period|Protocol Violation|2|||
30928022|NCT02041091|58963638|FG001|Optional Safety Extension Period|Protocol Violation|0|||
30928023|NCT02041091|58963637|FG000|Optional Safety Extension Period|Physician Decision|2|||
30928024|NCT02041091|58963638|FG001|Optional Safety Extension Period|Physician Decision|1|||
30928025|NCT02041091|58963637|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
30928026|NCT02041091|58963638|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
30928027|NCT02041091|58963637|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
30928028|NCT02041091|58963638|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
30928029|NCT02057549|58963652|FG000|Overall Study|Lost to Follow-up|1|||
30928030|NCT02057549|58963653|FG001|Overall Study|Lost to Follow-up|0|||
30928031|NCT02057549|58963652|FG000|Overall Study|Physician Decision|1|||
30928032|NCT02057549|58963653|FG001|Overall Study|Physician Decision|0|||
30928033|NCT02057549|58963652|FG000|Overall Study|Withdrawal by Subject|1|||
30928034|NCT02057549|58963653|FG001|Overall Study|Withdrawal by Subject|0|||
30928035|NCT02057393|58963659|FG000|Overall Study|Withdrawal by Subject|1|||
30928036|NCT02057393|58963659|FG000|Overall Study|Patient did not meet criteria|1|||
30928037|NCT02040779|58963666|FG000|Overall Study|Adverse Event|1|||
30928038|NCT02040779|58963667|FG001|Overall Study|Adverse Event|0|||
30928039|NCT02040779|58963668|FG002|Overall Study|Adverse Event|0|||
30928040|NCT02040779|58963666|FG000|Overall Study|Withdrawal by Subject|4|||
30928041|NCT02040779|58963667|FG001|Overall Study|Withdrawal by Subject|1|||
30928042|NCT02040779|58963668|FG002|Overall Study|Withdrawal by Subject|3|||
30928043|NCT02040779|58963666|FG000|Overall Study|Non-compliance|0|||
30928044|NCT02040779|58963667|FG001|Overall Study|Non-compliance|1|||
30837277|NCT00102531|58861952|FG001|Overall Study|Adverse Event|1|||
30837278|NCT00102531|58861951|FG000|Overall Study|Disease Progression|5|||
30837279|NCT00102531|58861952|FG001|Overall Study|Disease Progression|9|||
30928045|NCT02040779|58963668|FG002|Overall Study|Non-compliance|0|||
30928046|NCT02040779|58963666|FG000|Overall Study|Protocol Violation|2|||
30928047|NCT02040779|58963667|FG001|Overall Study|Protocol Violation|1|||
30928048|NCT02040779|58963668|FG002|Overall Study|Protocol Violation|0|||
30928049|NCT02040779|58963666|FG000|Overall Study|Lost to Follow-up|1|||
30837280|NCT00102531|58861951|FG000|Overall Study|Physician Decision|0|||
30837281|NCT00102531|58861952|FG001|Overall Study|Physician Decision|1|||
30928050|NCT02040779|58963667|FG001|Overall Study|Lost to Follow-up|2|||
30837282|NCT02771145|58861958|FG000|Overall Study|Adverse Event|3|||
30837283|NCT02771145|58861958|FG000|Overall Study|Lost to Follow-up|1|||
30837284|NCT02578186|58861978|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
30837285|NCT02578186|58861979|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
30837286|NCT02578186|58861978|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
30837287|NCT02578186|58861979|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
30837288|NCT00103311|58861987|FG000|Overall Study|Lost to Follow-up|1|||
30837289|NCT00103311|58861988|FG001|Overall Study|Lost to Follow-up|0|||
30837290|NCT00103311|58861987|FG000|Overall Study|Withdrawal by Subject|2|||
30928051|NCT02040779|58963668|FG002|Overall Study|Lost to Follow-up|1|||
30928052|NCT02040779|58963666|FG000|Overall Study|Lack of Efficacy|4|||
30928053|NCT02040779|58963667|FG001|Overall Study|Lack of Efficacy|2|||
30928054|NCT02040779|58963668|FG002|Overall Study|Lack of Efficacy|0|||
30837291|NCT00103311|58861988|FG001|Overall Study|Withdrawal by Subject|1|||
30837292|NCT00103311|58861987|FG000|Overall Study|Adverse Event|1|||
30837293|NCT00103311|58861988|FG001|Overall Study|Adverse Event|0|||
30837294|NCT02576938|58862001|FG000|Overall Study|Adverse Event|5|||
30837295|NCT02576938|58862002|FG001|Overall Study|Adverse Event|3|||
30837296|NCT02576938|58862003|FG002|Overall Study|Adverse Event|6|||
30837297|NCT02576938|58862001|FG000|Overall Study|Protocol Violation|1|||
30837298|NCT02576938|58862002|FG001|Overall Study|Protocol Violation|1|||
30837299|NCT02576938|58862003|FG002|Overall Study|Protocol Violation|1|||
30837300|NCT02576938|58862001|FG000|Overall Study|Withdrawal by Subject|3|||
30837301|NCT02576938|58862002|FG001|Overall Study|Withdrawal by Subject|2|||
30837302|NCT02576938|58862003|FG002|Overall Study|Withdrawal by Subject|4|||
30837303|NCT02576938|58862001|FG000|Overall Study|Lack of Efficacy|9|||
30837304|NCT02576938|58862002|FG001|Overall Study|Lack of Efficacy|4|||
30837305|NCT02576938|58862003|FG002|Overall Study|Lack of Efficacy|0|||
30837306|NCT02576938|58862001|FG000|Overall Study|Lost to Follow-up|2|||
30837307|NCT02576938|58862002|FG001|Overall Study|Lost to Follow-up|0|||
30837308|NCT02576938|58862003|FG002|Overall Study|Lost to Follow-up|1|||
30837309|NCT02576938|58862001|FG000|Overall Study|Physician Decision|0|||
30837310|NCT02576938|58862002|FG001|Overall Study|Physician Decision|1|||
30837311|NCT02576938|58862003|FG002|Overall Study|Physician Decision|0|||
30837312|NCT02576938|58862001|FG000|Overall Study|Met Exclusion Criteria|0|||
30837313|NCT02576938|58862002|FG001|Overall Study|Met Exclusion Criteria|1|||
30837314|NCT02576938|58862003|FG002|Overall Study|Met Exclusion Criteria|0|||
30837315|NCT02576860|58862015|FG000|Overall Study|Adverse Event|6|||
30837316|NCT02576860|58862016|FG001|Overall Study|Adverse Event|6|||
30837317|NCT02576860|58862015|FG000|Overall Study|Lost to Follow-up|5|||
30837318|NCT02576860|58862016|FG001|Overall Study|Lost to Follow-up|7|||
30837319|NCT02576860|58862015|FG000|Overall Study|Physician Decision|0|||
30837320|NCT02576860|58862016|FG001|Overall Study|Physician Decision|1|||
30837321|NCT02576860|58862015|FG000|Overall Study|Protocol Violation|0|||
30837322|NCT02576860|58862016|FG001|Overall Study|Protocol Violation|2|||
30837323|NCT02576860|58862015|FG000|Overall Study|Withdrawal by Subject|13|||
30837324|NCT02576860|58862016|FG001|Overall Study|Withdrawal by Subject|8|||
30837325|NCT02576860|58862015|FG000|Overall Study|Disallowed medication|1|||
30837326|NCT02576860|58862016|FG001|Overall Study|Disallowed medication|0|||
30837327|NCT02572570|58862023|FG000|Overall Study|Study Terminated|27|||
30837328|NCT00709202|58862032|FG000|Overall Study|Withdrawal by Subject|6|||
30837329|NCT00709202|58862033|FG001|Overall Study|Withdrawal by Subject|6|||
30837330|NCT00709124|58862042|FG000|Overall Study|Death|3|||
30837331|NCT00709124|58862043|FG001|Overall Study|Death|1|||
30837332|NCT00709124|58862042|FG000|Overall Study|encephalopathy; can't do assessment|1|||
30837333|NCT00709124|58862043|FG001|Overall Study|encephalopathy; can't do assessment|0|||
30837334|NCT02738580|58862055|FG000|Overall Study|Adverse Event|1|||
30837335|NCT02738580|58862056|FG001|Overall Study|Adverse Event|0|||
30837336|NCT02738580|58862055|FG000|Overall Study|Lack of Efficacy|3|||
30837337|NCT02738580|58862056|FG001|Overall Study|Lack of Efficacy|2|||
30837338|NCT02738580|58862055|FG000|Overall Study|Withdrawal by Subject|0|||
30837339|NCT02738580|58862056|FG001|Overall Study|Withdrawal by Subject|1|||
30928055|NCT02056301|58963678|FG000|Overall Study|Protocol Violation|1|||
30928056|NCT02056301|58963679|FG001|Overall Study|Protocol Violation|2|||
30837340|NCT02738580|58862055|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
30837341|NCT02738580|58862056|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
30837342|NCT02571244|58862064|FG000|Overall Study|Lost to Follow-up|0|||
30837343|NCT02571244|58862065|FG001|Overall Study|Lost to Follow-up|1|||
30837344|NCT02571244|58862064|FG000|Overall Study|Unable to reach out post discharge|3|||
30837345|NCT02571244|58862065|FG001|Overall Study|Unable to reach out post discharge|0|||
30837346|NCT02573350|58862076|FG000|Overall Study|Lost to Follow-up|2|||
30837347|NCT02573350|58862077|FG001|Overall Study|Lost to Follow-up|1|||
30837348|NCT02573350|58862076|FG000|Overall Study|Adverse Event|3|||
30837349|NCT02573350|58862077|FG001|Overall Study|Adverse Event|4|||
30837350|NCT02573350|58862076|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
30837351|NCT02573350|58862077|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
30928057|NCT02056301|58963678|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
30928058|NCT02056301|58963679|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
30928059|NCT02056301|58963678|FG000|Overall Study|Withdrawal by Subject|0|||
30928060|NCT02056301|58963679|FG001|Overall Study|Withdrawal by Subject|1|||
30928061|NCT02056301|58963678|FG000|Overall Study|Issues with epidural|0|||
30928062|NCT02056301|58963679|FG001|Overall Study|Issues with epidural|3|||
30928063|NCT01967732|58963687|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
30928064|NCT01967732|58963688|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
30928065|NCT01967732|58963689|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
30928066|NCT01967732|58963690|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
30928067|NCT01967732|58963687|FG000|First Intervention (Day 1)|Poor venous access|0|||
30928068|NCT01967732|58963688|FG001|First Intervention (Day 1)|Poor venous access|1|||
30928069|NCT01967732|58963689|FG002|First Intervention (Day 1)|Poor venous access|0|||
30928070|NCT01967732|58963690|FG003|First Intervention (Day 1)|Poor venous access|0|||
30928071|NCT01967576|58963698|FG000|Overall Study|Withdrawal by Subject|3|||
30928072|NCT01967576|58963698|FG000|Overall Study|Progressed/Removed from treatment|1|||
30928073|NCT01967576|58963698|FG000|Overall Study|Study closing at site|1|||
30928074|NCT01967576|58963698|FG000|Overall Study|Adverse Event|1|||
30928075|NCT01967576|58963698|FG000|Overall Study|Refused further treatment|1|||
30928076|NCT02039687|58963706|FG000|Overall Study|Adverse Event|0|||
30928077|NCT02039687|58963707|FG001|Overall Study|Adverse Event|0|||
30928078|NCT02039687|58963708|FG002|Overall Study|Adverse Event|1|||
30928079|NCT02039687|58963709|FG003|Overall Study|Adverse Event|0|||
30928080|NCT02039687|58963706|FG000|Overall Study|Withdrawal by Subject|0|||
30928081|NCT02039687|58963707|FG001|Overall Study|Withdrawal by Subject|1|||
30928082|NCT02039687|58963708|FG002|Overall Study|Withdrawal by Subject|0|||
30928083|NCT02039687|58963709|FG003|Overall Study|Withdrawal by Subject|0|||
30928084|NCT02039687|58963706|FG000|Overall Study|treatment assignment could not be confir|0|||
30928085|NCT02039687|58963707|FG001|Overall Study|treatment assignment could not be confir|0|||
30928086|NCT02039687|58963708|FG002|Overall Study|treatment assignment could not be confir|2|||
30928087|NCT02039687|58963709|FG003|Overall Study|treatment assignment could not be confir|0|||
30928088|NCT02003534|58963719|FG000|Overall Study|Lost to Follow-up|47|||
30928089|NCT02055365|58963723|FG000|Overall Study|Prematurely Withdrawn|1|||
30928090|NCT02039375|58963734|FG000|Overall Study|Lost to Follow-up|2|||
30928091|NCT02054897|58963741|FG000|Overall Study|Withdrawal by Subject|2|||
30928092|NCT02054897|58963742|FG001|Overall Study|Withdrawal by Subject|0|||
30928093|NCT02054897|58963743|FG002|Overall Study|Withdrawal by Subject|2|||
30928094|NCT02054897|58963741|FG000|Overall Study|Missing follow-up information|3|||
30928095|NCT02054897|58963742|FG001|Overall Study|Missing follow-up information|5|||
30928096|NCT02054897|58963743|FG002|Overall Study|Missing follow-up information|3|||
30928097|NCT02054897|58963741|FG000|Overall Study|Lost to Follow-up|4|||
30928098|NCT02054897|58963742|FG001|Overall Study|Lost to Follow-up|2|||
30928099|NCT02054897|58963743|FG002|Overall Study|Lost to Follow-up|7|||
30928100|NCT02054897|58963741|FG000|Overall Study|Randomized but not exposed|1|||
30928101|NCT02054897|58963742|FG001|Overall Study|Randomized but not exposed|0|||
30928102|NCT02054897|58963743|FG002|Overall Study|Randomized but not exposed|0|||
30928103|NCT01976312|58963753|FG000|Overall Study|Pregnancy|0|||
30928104|NCT01976312|58963754|FG001|Overall Study|Pregnancy|1|||
30928105|NCT01976312|58963753|FG000|Overall Study|Lost to Follow-up|2|||
30928106|NCT01976312|58963754|FG001|Overall Study|Lost to Follow-up|0|||
30928107|NCT01976312|58963753|FG000|Overall Study|Withdrawal by Subject|7|||
30928108|NCT01976312|58963754|FG001|Overall Study|Withdrawal by Subject|2|||
30928109|NCT01976312|58963753|FG000|Overall Study|Adverse Event|6|||
30928110|NCT01976312|58963754|FG001|Overall Study|Adverse Event|6|||
30928111|NCT01976312|58963753|FG000|Overall Study|Protocol Violation|2|||
30928112|NCT01976312|58963754|FG001|Overall Study|Protocol Violation|0|||
30928113|NCT02039219|58963763|FG000|Treatment|Withdrawal by Subject|1|||
30624060|NCT01119066|58636059|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
30624061|NCT01119066|58636060|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
30624062|NCT01119066|58636057|FG000|Overall Study|Relapse identified before transplant|1|||
30624063|NCT01119066|58636058|FG001|Overall Study|Relapse identified before transplant|0|||
30624064|NCT01119066|58636059|FG002|Overall Study|Relapse identified before transplant|0|||
30624065|NCT01119066|58636060|FG003|Overall Study|Relapse identified before transplant|0|||
30624066|NCT01119066|58636057|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
30624067|NCT01119066|58636058|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
30928114|NCT02039219|58963764|FG001|Treatment|Withdrawal by Subject|0|||
30928115|NCT02039219|58963763|FG000|Treatment|Adverse Event|0|||
30928116|NCT02039219|58963764|FG001|Treatment|Adverse Event|1|||
30928117|NCT02039219|58963763|FG000|Treatment|Physician Decision|1|||
30928118|NCT02039219|58963764|FG001|Treatment|Physician Decision|0|||
30928119|NCT02039219|58963763|FG000|Treatment|Lost to Follow-up|0|||
30928120|NCT02039219|58963764|FG001|Treatment|Lost to Follow-up|1|||
30928121|NCT02039219|58963763|FG000|Treatment|Protocol Violation|1|||
30928122|NCT02039219|58963764|FG001|Treatment|Protocol Violation|0|||
30928123|NCT02039219|58963763|FG000|Treatment|Death|1|||
30928124|NCT02039219|58963764|FG001|Treatment|Death|0|||
30928125|NCT02039219|58963763|FG000|Follow up|Adverse Event|0|||
30928126|NCT02039219|58963764|FG001|Follow up|Adverse Event|1|||
30837352|NCT02573350|58862076|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
30837353|NCT02573350|58862077|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
30928127|NCT02053493|58963772|FG000|Overall Study|Withdrawal by Subject|1|||
30928128|NCT02053493|58963773|FG001|Overall Study|Withdrawal by Subject|1|||
30757625|NCT00112437|58766943|FG022|Year 1 (12-Month Base Study)|moved|0|||
30757626|NCT00112437|58766944|FG023|Year 1 (12-Month Base Study)|moved|0|||
30757627|NCT00112437|58766945|FG024|Year 1 (12-Month Base Study)|moved|0|||
30757628|NCT00112437|58766946|FG025|Year 1 (12-Month Base Study)|moved|0|||
30757629|NCT00112437|58766921|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757630|NCT00112437|58766922|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757631|NCT00112437|58766923|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757632|NCT00112437|58766924|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
30757633|NCT00112437|58766925|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757634|NCT00112437|58766926|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757635|NCT00112437|58766927|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30837354|NCT02573350|58862076|FG000|Overall Study|Subject withdrew consent to participate|6|||
30837355|NCT02573350|58862077|FG001|Overall Study|Subject withdrew consent to participate|1|||
30837356|NCT02573350|58862076|FG000|Overall Study|Protocol Deviation|1|||
30837357|NCT02573350|58862077|FG001|Overall Study|Protocol Deviation|1|||
30837358|NCT01376804|58862086|FG000|Treatment Period|Withdrawal by Subject|1|||
30837359|NCT01376804|58862086|FG000|Treatment Period|Adverse Event|6|||
30837360|NCT01376804|58862086|FG000|Treatment Period|Patient did not receive study drug|1|||
30837361|NCT02574520|58862094|FG000|Overall Study|Not dosed|2|||
30837362|NCT02574520|58862095|FG001|Overall Study|Not dosed|0|||
30837363|NCT02574520|58862096|FG002|Overall Study|Not dosed|5|||
30837364|NCT02574520|58862097|FG003|Overall Study|Not dosed|4|||
30837365|NCT02574520|58862094|FG000|Overall Study|Adverse Event|0|||
30837366|NCT02574520|58862095|FG001|Overall Study|Adverse Event|0|||
30837367|NCT02574520|58862096|FG002|Overall Study|Adverse Event|0|||
30837368|NCT02574520|58862097|FG003|Overall Study|Adverse Event|1|||
30837369|NCT02574520|58862094|FG000|Overall Study|Withdrawal by Subject|0|||
30837370|NCT02574520|58862095|FG001|Overall Study|Withdrawal by Subject|0|||
30837371|NCT02574520|58862096|FG002|Overall Study|Withdrawal by Subject|0|||
30837372|NCT02574520|58862097|FG003|Overall Study|Withdrawal by Subject|1|||
30837373|NCT02574520|58862094|FG000|Overall Study|Other|0|||
30837374|NCT02574520|58862095|FG001|Overall Study|Other|0|||
30837375|NCT02574520|58862096|FG002|Overall Study|Other|0|||
30837376|NCT02574520|58862097|FG003|Overall Study|Other|2|||
30837377|NCT00709592|58862109|FG000|Overall Study|Unable to proceed to transplant|0|||
30837378|NCT00709592|58862110|FG001|Overall Study|Unable to proceed to transplant|1|||
30837379|NCT02570152|58862116|FG000|Overall Study|Protocol Violation|2|||
30837380|NCT02570152|58862116|FG000|Overall Study|Migrated/moved from study area|13|||
30837381|NCT02570074|58862122|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
30837382|NCT02570074|58862123|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
30837383|NCT02569996|58862141|FG000|Overall Study|Adverse Event|6|||
30837384|NCT02569996|58862141|FG000|Overall Study|Physician Decision|3|||
30837385|NCT02569996|58862141|FG000|Overall Study|Progression of the disease|18|||
30837386|NCT02569996|58862141|FG000|Overall Study|New anti-lymphoma treatment|1|||
30837387|NCT02569996|58862141|FG000|Overall Study|Non-compliance|9|||
30837388|NCT02569996|58862141|FG000|Overall Study|Withdrawal by Subject|5|||
30837389|NCT02569996|58862141|FG000|Overall Study|Lost to Follow-up|5|||
30837390|NCT02569996|58862141|FG000|Overall Study|Complete remission|7|||
30837391|NCT02569996|58862141|FG000|Overall Study|Unknown reason|1|||
30837392|NCT02572882|58862145|FG000|Overall Study|Withdrawal by Subject|1|||
30928129|NCT02003144|58963781|FG000|Open Label Maintenance Phase|Other than specified|2|||
30837393|NCT02572882|58862145|FG000|Overall Study|Participant received kidney transplant|1|||
30837394|NCT00708500|58862175|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
30837395|NCT00708500|58862176|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
30837396|NCT00708500|58862177|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
30928130|NCT02003144|58963782|FG001|Open Label Maintenance Phase|Other than specified|4|||
30928131|NCT02003144|58963781|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
30928132|NCT02003144|58963782|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
30928133|NCT02003144|58963781|FG000|Open Label Maintenance Phase|Pregnancy|0|||
30757636|NCT00112437|58766928|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757637|NCT00112437|58766929|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757638|NCT00112437|58766930|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757639|NCT00112437|58766931|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757640|NCT00112437|58766932|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757641|NCT00112437|58766933|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757642|NCT00112437|58766934|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757643|NCT00112437|58766935|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757644|NCT00112437|58766936|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30837397|NCT00708500|58862175|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
30837398|NCT00708500|58862176|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
30837399|NCT00708500|58862177|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
30837400|NCT00708500|58862175|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
30837401|NCT00708500|58862176|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
30837402|NCT00708500|58862177|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
30837403|NCT00708500|58862175|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
30837404|NCT00708500|58862176|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
30837405|NCT00708500|58862177|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
30837406|NCT00708500|58862175|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
30837407|NCT00708500|58862176|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
30837408|NCT00708500|58862177|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
30837409|NCT00708500|58862175|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
30837410|NCT00708500|58862176|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
30837411|NCT00708500|58862177|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
30837412|NCT00708500|58862175|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
30837413|NCT00708500|58862176|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
30837414|NCT00708500|58862177|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
30837415|NCT00708500|58862175|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
30837416|NCT00708500|58862176|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
30837417|NCT00708500|58862177|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
30837418|NCT00708500|58862175|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
30837419|NCT00708500|58862176|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
30837420|NCT00708500|58862177|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
30837421|NCT00708500|58862175|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
30837422|NCT00708500|58862176|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
30837423|NCT00708500|58862177|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
30837424|NCT00708500|58862175|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
30837425|NCT00708500|58862176|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
30837426|NCT00708500|58862177|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
30837427|NCT00708500|58862175|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
30837428|NCT00708500|58862176|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
30837429|NCT00708500|58862177|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
30837430|NCT00708500|58862175|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
30837431|NCT00708500|58862176|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
30837432|NCT00708500|58862177|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
30837433|NCT00708500|58862175|FG000|FOLLOWUP|Adverse Event|0|||
30837434|NCT00708500|58862176|FG001|FOLLOWUP|Adverse Event|1|||
30837435|NCT00708500|58862177|FG002|FOLLOWUP|Adverse Event|0|||
30837436|NCT00708500|58862175|FG000|FOLLOWUP|Lost to Follow-up|1|||
30837437|NCT00708500|58862176|FG001|FOLLOWUP|Lost to Follow-up|6|||
30837438|NCT00708500|58862177|FG002|FOLLOWUP|Lost to Follow-up|4|||
30837439|NCT00708500|58862175|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
30837440|NCT00708500|58862176|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
30837441|NCT00708500|58862177|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
30837442|NCT00708500|58862175|FG000|FOLLOWUP|Subject withdrew consent|31|||
30928134|NCT02003144|58963782|FG001|Open Label Maintenance Phase|Pregnancy|2|||
30928135|NCT02003144|58963781|FG000|Open Label Maintenance Phase|Physician Decision|1|||
30928136|NCT02003144|58963782|FG001|Open Label Maintenance Phase|Physician Decision|1|||
30928137|NCT02003144|58963781|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
30928138|NCT02003144|58963782|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
30928139|NCT02003144|58963781|FG000|Open Label Maintenance Phase|Adverse Event|2|||
30928140|NCT02003144|58963782|FG001|Open Label Maintenance Phase|Adverse Event|1|||
30928141|NCT02001194|58963793|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
30928142|NCT02001194|58963794|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
30928143|NCT02001194|58963795|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
30928144|NCT02001194|58963796|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
30928145|NCT02001194|58963793|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
30928146|NCT02001194|58963794|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
30928147|NCT02001194|58963795|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
30928148|NCT02001194|58963796|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
30928149|NCT02038907|58963820|FG000|Overall Study|Protocol Violation|0|||
30928150|NCT02038907|58963821|FG001|Overall Study|Protocol Violation|0|||
30928151|NCT02038907|58963822|FG002|Overall Study|Protocol Violation|0|||
30928152|NCT02038907|58963823|FG003|Overall Study|Protocol Violation|0|||
30928153|NCT02038907|58963824|FG004|Overall Study|Protocol Violation|0|||
30928154|NCT02038907|58963825|FG005|Overall Study|Protocol Violation|0|||
30928155|NCT02038907|58963826|FG006|Overall Study|Protocol Violation|0|||
30928156|NCT02038907|58963827|FG007|Overall Study|Protocol Violation|0|||
30928157|NCT02038907|58963828|FG008|Overall Study|Protocol Violation|0|||
30928158|NCT02038907|58963829|FG009|Overall Study|Protocol Violation|0|||
30928159|NCT02038907|58963830|FG010|Overall Study|Protocol Violation|1|||
30928160|NCT02038907|58963831|FG011|Overall Study|Protocol Violation|0|||
30928161|NCT02038907|58963832|FG012|Overall Study|Protocol Violation|0|||
30928162|NCT02038907|58963833|FG013|Overall Study|Protocol Violation|0|||
30928163|NCT02038907|58963820|FG000|Overall Study|Withdrawal by Subject|0|||
30928164|NCT02038907|58963821|FG001|Overall Study|Withdrawal by Subject|0|||
30928165|NCT02038907|58963822|FG002|Overall Study|Withdrawal by Subject|0|||
30928166|NCT02038907|58963823|FG003|Overall Study|Withdrawal by Subject|0|||
30928167|NCT02038907|58963824|FG004|Overall Study|Withdrawal by Subject|0|||
30928168|NCT02038907|58963825|FG005|Overall Study|Withdrawal by Subject|0|||
30928169|NCT02038907|58963826|FG006|Overall Study|Withdrawal by Subject|0|||
30928170|NCT02038907|58963827|FG007|Overall Study|Withdrawal by Subject|0|||
30928171|NCT02038907|58963828|FG008|Overall Study|Withdrawal by Subject|0|||
30928172|NCT02038907|58963829|FG009|Overall Study|Withdrawal by Subject|0|||
30928173|NCT02038907|58963830|FG010|Overall Study|Withdrawal by Subject|1|||
30928174|NCT02038907|58963831|FG011|Overall Study|Withdrawal by Subject|0|||
30928175|NCT02038907|58963832|FG012|Overall Study|Withdrawal by Subject|0|||
30928176|NCT02038907|58963833|FG013|Overall Study|Withdrawal by Subject|0|||
30928177|NCT02038829|58963865|FG000|Washout Period 1|Death|0|||
30928178|NCT02038829|58963866|FG001|Washout Period 1|Death|0|||
30928179|NCT02038829|58963867|FG002|Washout Period 1|Death|0|||
30928180|NCT02038829|58963868|FG003|Washout Period 1|Death|0|||
30928181|NCT02038829|58963869|FG004|Washout Period 1|Death|1|||
30928182|NCT02038829|58963870|FG005|Washout Period 1|Death|0|||
30928183|NCT02038829|58963871|FG006|Washout Period 1|Death|0|||
30928184|NCT02038829|58963872|FG007|Washout Period 1|Death|0|||
30928185|NCT02038829|58963873|FG008|Washout Period 1|Death|0|||
30928186|NCT02038829|58963874|FG009|Washout Period 1|Death|0|||
30928187|NCT02038829|58963875|FG010|Washout Period 1|Death|0|||
30928188|NCT02038829|58963876|FG011|Washout Period 1|Death|0|||
30928189|NCT02038829|58963865|FG000|Treatment Period 2|Adverse Event|0|||
30928190|NCT02038829|58963866|FG001|Treatment Period 2|Adverse Event|0|||
30928191|NCT02038829|58963867|FG002|Treatment Period 2|Adverse Event|0|||
30928192|NCT02038829|58963868|FG003|Treatment Period 2|Adverse Event|0|||
30928193|NCT02038829|58963869|FG004|Treatment Period 2|Adverse Event|0|||
30928194|NCT02038829|58963870|FG005|Treatment Period 2|Adverse Event|0|||
30928195|NCT02038829|58963871|FG006|Treatment Period 2|Adverse Event|0|||
30928196|NCT02038829|58963872|FG007|Treatment Period 2|Adverse Event|0|||
30928197|NCT02038829|58963873|FG008|Treatment Period 2|Adverse Event|0|||
30928198|NCT02038829|58963874|FG009|Treatment Period 2|Adverse Event|0|||
30928199|NCT02038829|58963875|FG010|Treatment Period 2|Adverse Event|1|||
30928200|NCT02038829|58963876|FG011|Treatment Period 2|Adverse Event|0|||
30928201|NCT02038829|58963865|FG000|Treatment Period 2|Withdrawal by Subject|1|||
30928202|NCT02038829|58963866|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30928203|NCT02038829|58963867|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30928204|NCT02038829|58963868|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30928205|NCT02038829|58963869|FG004|Treatment Period 2|Withdrawal by Subject|0|||
30928206|NCT02038829|58963870|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30928207|NCT02038829|58963871|FG006|Treatment Period 2|Withdrawal by Subject|0|||
30928208|NCT02038829|58963872|FG007|Treatment Period 2|Withdrawal by Subject|0|||
30928209|NCT02038829|58963873|FG008|Treatment Period 2|Withdrawal by Subject|0|||
30928210|NCT02038829|58963874|FG009|Treatment Period 2|Withdrawal by Subject|0|||
30928211|NCT02038829|58963875|FG010|Treatment Period 2|Withdrawal by Subject|0|||
30928212|NCT02038829|58963876|FG011|Treatment Period 2|Withdrawal by Subject|0|||
30928213|NCT02038829|58963865|FG000|Washout Period 2|Adverse Event|0|||
30928214|NCT02038829|58963866|FG001|Washout Period 2|Adverse Event|0|||
30928215|NCT02038829|58963867|FG002|Washout Period 2|Adverse Event|0|||
30928216|NCT02038829|58963868|FG003|Washout Period 2|Adverse Event|0|||
30928217|NCT02038829|58963869|FG004|Washout Period 2|Adverse Event|0|||
30928218|NCT02038829|58963870|FG005|Washout Period 2|Adverse Event|0|||
30928219|NCT02038829|58963871|FG006|Washout Period 2|Adverse Event|0|||
30837443|NCT00708500|58862176|FG001|FOLLOWUP|Subject withdrew consent|4|||
30837444|NCT00708500|58862177|FG002|FOLLOWUP|Subject withdrew consent|5|||
30837445|NCT00708500|58862175|FG000|FOLLOWUP|Non-compliance with protocol|5|||
30837446|NCT00708500|58862176|FG001|FOLLOWUP|Non-compliance with protocol|0|||
30837447|NCT00708500|58862177|FG002|FOLLOWUP|Non-compliance with protocol|1|||
30837448|NCT00708734|58862194|FG000|Overall Study|scheduling conflict|2|||
30837449|NCT00708734|58862194|FG000|Overall Study|moved|1|||
30837450|NCT00708734|58862194|FG000|Overall Study|leg injury|1|||
30837451|NCT00708734|58862194|FG000|Overall Study|knee replacement|1|||
30837452|NCT00708734|58862194|FG000|Overall Study|vertigo|1|||
30837453|NCT00708734|58862194|FG000|Overall Study|leg fracture|1|||
30837454|NCT04834362|58862200|FG000|Overall Study|Death|1|||
30837455|NCT04834362|58862201|FG001|Overall Study|Death|2|||
30928220|NCT02038829|58963872|FG007|Washout Period 2|Adverse Event|0|||
30928221|NCT02038829|58963873|FG008|Washout Period 2|Adverse Event|1|||
30928222|NCT02038829|58963874|FG009|Washout Period 2|Adverse Event|0|||
30928223|NCT02038829|58963875|FG010|Washout Period 2|Adverse Event|0|||
30928224|NCT02038829|58963876|FG011|Washout Period 2|Adverse Event|0|||
30928225|NCT02038829|58963865|FG000|Washout Period 2|Withdrawal by Subject|0|||
30928226|NCT02038829|58963866|FG001|Washout Period 2|Withdrawal by Subject|0|||
30928227|NCT02038829|58963867|FG002|Washout Period 2|Withdrawal by Subject|0|||
30928228|NCT02038829|58963868|FG003|Washout Period 2|Withdrawal by Subject|0|||
30928229|NCT02038829|58963869|FG004|Washout Period 2|Withdrawal by Subject|0|||
30928230|NCT02038829|58963870|FG005|Washout Period 2|Withdrawal by Subject|1|||
30928231|NCT02038829|58963871|FG006|Washout Period 2|Withdrawal by Subject|0|||
30928232|NCT02038829|58963872|FG007|Washout Period 2|Withdrawal by Subject|0|||
30928233|NCT02038829|58963873|FG008|Washout Period 2|Withdrawal by Subject|0|||
30928234|NCT02038829|58963874|FG009|Washout Period 2|Withdrawal by Subject|0|||
30928235|NCT02038829|58963875|FG010|Washout Period 2|Withdrawal by Subject|0|||
30928236|NCT02038829|58963876|FG011|Washout Period 2|Withdrawal by Subject|0|||
30928237|NCT02038829|58963865|FG000|Treatment Period 4|Adverse Event|0|||
30928238|NCT02038829|58963866|FG001|Treatment Period 4|Adverse Event|1|||
30928239|NCT02038829|58963867|FG002|Treatment Period 4|Adverse Event|0|||
30928240|NCT02038829|58963868|FG003|Treatment Period 4|Adverse Event|0|||
30928241|NCT02038829|58963869|FG004|Treatment Period 4|Adverse Event|0|||
30928242|NCT02038829|58963870|FG005|Treatment Period 4|Adverse Event|0|||
30928243|NCT02038829|58963871|FG006|Treatment Period 4|Adverse Event|0|||
30928244|NCT02038829|58963872|FG007|Treatment Period 4|Adverse Event|0|||
30928245|NCT02038829|58963873|FG008|Treatment Period 4|Adverse Event|0|||
30928246|NCT02038829|58963874|FG009|Treatment Period 4|Adverse Event|0|||
30928247|NCT02038829|58963875|FG010|Treatment Period 4|Adverse Event|0|||
30928248|NCT02038829|58963876|FG011|Treatment Period 4|Adverse Event|0|||
30928249|NCT02038829|58963865|FG000|Washout Period 4|Adverse Event|0|||
30928250|NCT02038829|58963866|FG001|Washout Period 4|Adverse Event|0|||
30928251|NCT02038829|58963867|FG002|Washout Period 4|Adverse Event|0|||
30928252|NCT02038829|58963868|FG003|Washout Period 4|Adverse Event|0|||
30928253|NCT02038829|58963869|FG004|Washout Period 4|Adverse Event|0|||
30928254|NCT02038829|58963870|FG005|Washout Period 4|Adverse Event|0|||
30928255|NCT02038829|58963871|FG006|Washout Period 4|Adverse Event|1|||
30928256|NCT02038829|58963872|FG007|Washout Period 4|Adverse Event|0|||
30928257|NCT02038829|58963873|FG008|Washout Period 4|Adverse Event|0|||
30928258|NCT02038829|58963874|FG009|Washout Period 4|Adverse Event|0|||
30928259|NCT02038829|58963875|FG010|Washout Period 4|Adverse Event|0|||
30928260|NCT02038829|58963876|FG011|Washout Period 4|Adverse Event|0|||
30837456|NCT00101907|58862213|FG000|Overall Study|Adverse Event|1|||
30837457|NCT00101907|58862214|FG001|Overall Study|Adverse Event|0|||
30837458|NCT00101907|58862215|FG002|Overall Study|Adverse Event|0|||
30928261|NCT02038829|58963865|FG000|Treatment Period 6|Adverse Event|0|||
30928262|NCT02038829|58963866|FG001|Treatment Period 6|Adverse Event|0|||
30928263|NCT02038829|58963867|FG002|Treatment Period 6|Adverse Event|1|||
30837459|NCT00101907|58862216|FG003|Overall Study|Adverse Event|0|||
30837460|NCT00101907|58862217|FG004|Overall Study|Adverse Event|0|||
30837461|NCT00101907|58862218|FG005|Overall Study|Adverse Event|0|||
30928264|NCT02038829|58963868|FG003|Treatment Period 6|Adverse Event|0|||
30928265|NCT02038829|58963869|FG004|Treatment Period 6|Adverse Event|0|||
30928266|NCT02038829|58963870|FG005|Treatment Period 6|Adverse Event|0|||
30928267|NCT02038829|58963871|FG006|Treatment Period 6|Adverse Event|0|||
30928268|NCT02038829|58963872|FG007|Treatment Period 6|Adverse Event|0|||
30928269|NCT02038829|58963873|FG008|Treatment Period 6|Adverse Event|0|||
30928270|NCT02038829|58963874|FG009|Treatment Period 6|Adverse Event|0|||
30928271|NCT02038829|58963875|FG010|Treatment Period 6|Adverse Event|0|||
30928272|NCT02038829|58963876|FG011|Treatment Period 6|Adverse Event|0|||
30928273|NCT02038049|58963893|FG000|Overall Study|Lost to Follow-up|1|||
30928274|NCT02038049|58963894|FG001|Overall Study|Lost to Follow-up|0|||
30928275|NCT02052011|58963906|FG000|Overall Study|Lost to Follow-up|3|||
30928276|NCT02052011|58963907|FG001|Overall Study|Lost to Follow-up|0|||
30928277|NCT02052011|58963906|FG000|Overall Study|Withdrawal by Subject|1|||
30928278|NCT02052011|58963907|FG001|Overall Study|Withdrawal by Subject|2|||
30928279|NCT02036645|58963925|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
30928280|NCT02036645|58963926|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
30928281|NCT02036645|58963927|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
30928282|NCT02036645|58963928|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
30928283|NCT02036645|58963929|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
30928284|NCT02036645|58963930|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
30928285|NCT02036645|58963931|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
30928286|NCT02036645|58963932|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
30928287|NCT02036645|58963933|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
30757645|NCT00112437|58766937|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757646|NCT00112437|58766938|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757647|NCT00112437|58766939|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757648|NCT00112437|58766940|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30837462|NCT00101907|58862213|FG000|Overall Study|Death|0|||
30837463|NCT00101907|58862214|FG001|Overall Study|Death|1|||
30837464|NCT00101907|58862215|FG002|Overall Study|Death|0|||
30837465|NCT00101907|58862216|FG003|Overall Study|Death|0|||
30837466|NCT00101907|58862217|FG004|Overall Study|Death|3|||
30837467|NCT00101907|58862218|FG005|Overall Study|Death|0|||
30837468|NCT00101907|58862213|FG000|Overall Study|Physician Decision|0|||
30837469|NCT00101907|58862214|FG001|Overall Study|Physician Decision|0|||
30837470|NCT00101907|58862215|FG002|Overall Study|Physician Decision|0|||
30757649|NCT00112437|58766941|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757650|NCT00112437|58766942|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757651|NCT00112437|58766943|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757652|NCT00112437|58766944|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30837471|NCT00101907|58862216|FG003|Overall Study|Physician Decision|1|||
30837472|NCT00101907|58862217|FG004|Overall Study|Physician Decision|1|||
30837473|NCT00101907|58862218|FG005|Overall Study|Physician Decision|0|||
30837474|NCT00101907|58862213|FG000|Overall Study|Withdrawal by Subject|1|||
30837475|NCT00101907|58862214|FG001|Overall Study|Withdrawal by Subject|0|||
30837476|NCT00101907|58862215|FG002|Overall Study|Withdrawal by Subject|1|||
30837477|NCT00101907|58862216|FG003|Overall Study|Withdrawal by Subject|0|||
30837478|NCT00101907|58862217|FG004|Overall Study|Withdrawal by Subject|1|||
30837479|NCT00101907|58862218|FG005|Overall Study|Withdrawal by Subject|0|||
30837480|NCT02565784|58862239|FG000|First Treatment|Adverse Event|1|||
30837481|NCT02565784|58862239|FG000|First Treatment|Withdrawal by Subject|1|||
30837482|NCT02565784|58862239|FG000|Second Treatment|Withdrawal by Subject|2|||
30837483|NCT04650204|58862273|FG000|Overall Study|Study was Terminated|2|||
30837484|NCT04650204|58862274|FG001|Overall Study|Study was Terminated|1|||
30837485|NCT02761629|58862282|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
30837486|NCT02761629|58862283|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
30837487|NCT02761629|58862282|FG000|Overall Study|Insufficient Therapeutic Response|2|||
30837488|NCT02761629|58862283|FG001|Overall Study|Insufficient Therapeutic Response|7|||
30837489|NCT02761629|58862282|FG000|Overall Study|Failure to Return|2|||
30837490|NCT02761629|58862283|FG001|Overall Study|Failure to Return|4|||
30837491|NCT02761629|58862282|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
30837492|NCT02761629|58862283|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
30837493|NCT02761629|58862282|FG000|Overall Study|Protocol Violation|2|||
30837494|NCT02761629|58862283|FG001|Overall Study|Protocol Violation|2|||
30837495|NCT02761629|58862282|FG000|Overall Study|Withdrawal by Subject|0|||
30837496|NCT02761629|58862283|FG001|Overall Study|Withdrawal by Subject|3|||
30837497|NCT02761629|58862282|FG000|Overall Study|Other|0|||
30837498|NCT02761629|58862283|FG001|Overall Study|Other|2|||
30837499|NCT02761629|58862282|FG000|Overall Study|Lost to Follow-up|4|||
30837500|NCT02761629|58862283|FG001|Overall Study|Lost to Follow-up|1|||
30837501|NCT02761629|58862282|FG000|Overall Study|Randomized But Not Treated|8|||
30837502|NCT02761629|58862283|FG001|Overall Study|Randomized But Not Treated|4|||
30837503|NCT02760927|58862289|FG000|Overall Study|Tube Slippage from Device|1|||
30837504|NCT00101439|58862295|FG000|Period 2|Withdrawal by Subject|0|||
30837505|NCT00101439|58862296|FG001|Period 2|Withdrawal by Subject|2|||
30928288|NCT02036645|58963934|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
30928289|NCT02036645|58963935|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
30928290|NCT02036645|58963936|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
30928291|NCT02036645|58963925|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
30928292|NCT02036645|58963926|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
30928293|NCT02036645|58963927|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
30928294|NCT02036645|58963928|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
30928295|NCT02036645|58963929|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
30928296|NCT02036645|58963930|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
30928297|NCT02036645|58963931|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
30837506|NCT04033068|58862306|FG000|Overall Study|Withdrawal by Subject|0|||
30837507|NCT04033068|58862307|FG001|Overall Study|Withdrawal by Subject|0|||
30837508|NCT04033068|58862308|FG002|Overall Study|Withdrawal by Subject|1|||
30928298|NCT02036645|58963932|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
30928299|NCT02036645|58963933|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
30928300|NCT02036645|58963934|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
30928301|NCT02036645|58963935|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
30928302|NCT02036645|58963936|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
30928303|NCT02051933|58963976|FG000|Overall Study|Physician Decision|0|||
30928304|NCT02051933|58963977|FG001|Overall Study|Physician Decision|1|||
30928305|NCT02050373|58963990|FG000|Overall Study|Adverse Event|4|||
30928306|NCT02050373|58963991|FG001|Overall Study|Adverse Event|7|||
30837509|NCT04033068|58862309|FG003|Overall Study|Withdrawal by Subject|0|||
30837510|NCT04033068|58862306|FG000|Overall Study|Lost to Follow-up|0|||
30837511|NCT04033068|58862307|FG001|Overall Study|Lost to Follow-up|1|||
30837512|NCT04033068|58862308|FG002|Overall Study|Lost to Follow-up|0|||
30837513|NCT04033068|58862309|FG003|Overall Study|Lost to Follow-up|0|||
30837514|NCT04033068|58862306|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
30837515|NCT04033068|58862307|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
30837516|NCT04033068|58862308|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
30837517|NCT04033068|58862309|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
30837518|NCT02762565|58862319|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
30837519|NCT02757963|58862332|FG000|Overall Study|Adverse Event|3|||
30837520|NCT02757963|58862332|FG000|Overall Study|Reached Stopping Criteria|1054|||
30837521|NCT02757963|58862332|FG000|Overall Study|Lost to Follow-up|5|||
30837522|NCT02757963|58862332|FG000|Overall Study|Physician Decision|1|||
30837523|NCT02757963|58862332|FG000|Overall Study|Withdrawal by Subject|34|||
30837524|NCT03111732|58862347|FG000|Overall Study|Enrolled in different study|1|||
30837525|NCT03111732|58862347|FG000|Overall Study|Progressive disease|3|||
30837526|NCT03111732|58862347|FG000|Overall Study|Withdrawal by Subject|1|||
30837527|NCT01663714|58862356|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
30837528|NCT01663714|58862356|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
30837529|NCT01663714|58862356|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
30837530|NCT01663714|58862356|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
30837531|NCT01663714|58862356|FG000|Long-Term Follow-Up|Death|4|||
30837532|NCT01663714|58862356|FG000|Long-Term Follow-Up|Non-compliance|1|||
30837533|NCT01663636|58862378|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
30837534|NCT01663636|58862379|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
30837535|NCT03065244|58862387|FG000|Overall Study|Lost to Follow-up|1|||
30837536|NCT03065244|58862388|FG001|Overall Study|Lost to Follow-up|1|||
30837537|NCT03065244|58862387|FG000|Overall Study|Diagnosed with a different disease|1|||
30837538|NCT03065244|58862388|FG001|Overall Study|Diagnosed with a different disease|1|||
30837539|NCT03065244|58862387|FG000|Overall Study|Protocol Violation|0|||
30837540|NCT03065244|58862388|FG001|Overall Study|Protocol Violation|1|||
30837541|NCT03065244|58862387|FG000|Overall Study|Withdrawal by Subject|1|||
30837542|NCT03065244|58862388|FG001|Overall Study|Withdrawal by Subject|1|||
30837543|NCT00100815|58862394|FG000|Overall Study|Progression|24|||
30837544|NCT00100815|58862394|FG000|Overall Study|Adverse Event|18|||
30837545|NCT00100815|58862394|FG000|Overall Study|Death|4|||
30837546|NCT00100815|58862394|FG000|Overall Study|Other|3|||
30837547|NCT00708422|58862400|FG000|Overall Study|Adverse Event|3|||
30837548|NCT00708422|58862401|FG001|Overall Study|Adverse Event|1|||
30837549|NCT00708422|58862400|FG000|Overall Study|Withdrawal by Subject|1|||
30837550|NCT00708422|58862401|FG001|Overall Study|Withdrawal by Subject|0|||
30837551|NCT02760069|58862410|FG000|Overall Study|Withdrawal by Subject|0|||
30837552|NCT02760069|58862411|FG001|Overall Study|Withdrawal by Subject|1|||
30837553|NCT02760069|58862412|FG002|Overall Study|Withdrawal by Subject|1|||
30837554|NCT00707486|58862420|FG000|Overall Study|Withdrawal by Subject|1|||
30837555|NCT02759055|58862428|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
30837556|NCT02759055|58862429|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
30837557|NCT00708032|58862437|FG000|Overall Study|Adverse Event|0|||
30837558|NCT00708032|58862438|FG001|Overall Study|Adverse Event|2|||
30837559|NCT00708032|58862437|FG000|Overall Study|Lost to Follow-up|1|||
30837560|NCT00708032|58862438|FG001|Overall Study|Lost to Follow-up|2|||
30837561|NCT00708032|58862437|FG000|Overall Study|Pregnancy|0|||
30837562|NCT00708032|58862438|FG001|Overall Study|Pregnancy|1|||
30928307|NCT02050373|58963990|FG000|Overall Study|Death|3|||
30928308|NCT02050373|58963991|FG001|Overall Study|Death|3|||
30928309|NCT02049437|58964000|FG000|Period 1|Adverse Event|1|||
30928310|NCT02049437|58964001|FG001|Period 1|Adverse Event|1|||
30928311|NCT02049437|58964000|FG000|Period 1|Adverse Event|1|||
30928312|NCT02049437|58964001|FG001|Period 1|Adverse Event|0|||
30928313|NCT02035553|58964009|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
30928314|NCT02035553|58964010|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
30928315|NCT02035553|58964009|FG000|Overall Study|Adverse Event|10|||
30928316|NCT02035553|58964010|FG001|Overall Study|Adverse Event|6|||
30928317|NCT02035553|58964009|FG000|Overall Study|Physician Decision|3|||
30928318|NCT02035553|58964010|FG001|Overall Study|Physician Decision|2|||
30928319|NCT02035553|58964009|FG000|Overall Study|Lack of Efficacy|1|||
30928320|NCT02035553|58964010|FG001|Overall Study|Lack of Efficacy|1|||
30928321|NCT02035553|58964009|FG000|Overall Study|Withdrawal by Subject|4|||
30928322|NCT02035553|58964010|FG001|Overall Study|Withdrawal by Subject|7|||
30928323|NCT02035553|58964009|FG000|Overall Study|Non-compliance with Study Drug|0|||
30928324|NCT02035553|58964010|FG001|Overall Study|Non-compliance with Study Drug|1|||
30928325|NCT02035553|58964009|FG000|Overall Study|Lost to Follow-up|0|||
30928326|NCT02035553|58964010|FG001|Overall Study|Lost to Follow-up|1|||
30928327|NCT02035553|58964009|FG000|Overall Study|Other Reason|0|||
30928328|NCT02035553|58964010|FG001|Overall Study|Other Reason|4|||
30928329|NCT01445080|58964025|FG000|Overall Study|Adverse Event|5|||
30928330|NCT01445080|58964026|FG001|Overall Study|Adverse Event|3|||
30928331|NCT01445080|58964027|FG002|Overall Study|Adverse Event|11|||
30928332|NCT01445080|58964028|FG003|Overall Study|Adverse Event|6|||
30928333|NCT01445080|58964029|FG004|Overall Study|Adverse Event|2|||
30928334|NCT01445080|58964030|FG005|Overall Study|Adverse Event|3|||
30928335|NCT01445080|58964031|FG006|Overall Study|Adverse Event|0|||
30928336|NCT01445080|58964032|FG007|Overall Study|Adverse Event|3|||
30928337|NCT01445080|58964033|FG008|Overall Study|Adverse Event|10|||
30928338|NCT01445080|58964025|FG000|Overall Study|Physician Decision|0|||
30928339|NCT01445080|58964026|FG001|Overall Study|Physician Decision|0|||
30928340|NCT01445080|58964027|FG002|Overall Study|Physician Decision|1|||
30928341|NCT01445080|58964028|FG003|Overall Study|Physician Decision|0|||
30928342|NCT01445080|58964029|FG004|Overall Study|Physician Decision|0|||
30928343|NCT01445080|58964030|FG005|Overall Study|Physician Decision|3|||
30928344|NCT01445080|58964031|FG006|Overall Study|Physician Decision|2|||
30928345|NCT01445080|58964032|FG007|Overall Study|Physician Decision|2|||
30928346|NCT01445080|58964033|FG008|Overall Study|Physician Decision|0|||
30928347|NCT01445080|58964025|FG000|Overall Study|Withdrawal by Subject|1|||
30928348|NCT01445080|58964026|FG001|Overall Study|Withdrawal by Subject|0|||
30928349|NCT01445080|58964027|FG002|Overall Study|Withdrawal by Subject|0|||
30928350|NCT01445080|58964028|FG003|Overall Study|Withdrawal by Subject|1|||
30928351|NCT01445080|58964029|FG004|Overall Study|Withdrawal by Subject|0|||
30928352|NCT01445080|58964030|FG005|Overall Study|Withdrawal by Subject|0|||
30928353|NCT01445080|58964031|FG006|Overall Study|Withdrawal by Subject|0|||
30928354|NCT01445080|58964032|FG007|Overall Study|Withdrawal by Subject|0|||
30928355|NCT01445080|58964033|FG008|Overall Study|Withdrawal by Subject|2|||
30928356|NCT01445080|58964025|FG000|Overall Study|Ineligible/Inevaluable|1|||
30928357|NCT01445080|58964026|FG001|Overall Study|Ineligible/Inevaluable|2|||
30928358|NCT01445080|58964027|FG002|Overall Study|Ineligible/Inevaluable|0|||
30928359|NCT01445080|58964028|FG003|Overall Study|Ineligible/Inevaluable|1|||
30928360|NCT01445080|58964029|FG004|Overall Study|Ineligible/Inevaluable|2|||
30928361|NCT01445080|58964030|FG005|Overall Study|Ineligible/Inevaluable|3|||
30928362|NCT01445080|58964031|FG006|Overall Study|Ineligible/Inevaluable|0|||
30928363|NCT01445080|58964032|FG007|Overall Study|Ineligible/Inevaluable|0|||
30928364|NCT01445080|58964033|FG008|Overall Study|Ineligible/Inevaluable|6|||
30928365|NCT02035475|58964068|FG000|Overall Study|Withdrawal by Subject|4|||
30928366|NCT02035475|58964068|FG000|Overall Study|Physician Decision|1|||
30928367|NCT02035475|58964068|FG000|Overall Study|Equipment Error|1|||
30928368|NCT01444456|58964074|FG000|Overall Study|Withdrawal by Subject|21|||
30928369|NCT01444456|58964074|FG000|Overall Study|Physician Decision|9|||
30928370|NCT01444456|58964074|FG000|Overall Study|Lost to Follow-up|37|||
30928371|NCT01444456|58964074|FG000|Overall Study|Death|73|||
30928372|NCT01444456|58964074|FG000|Overall Study|Ineligibility determined|23|||
30928373|NCT01444456|58964074|FG000|Overall Study|Other|18|||
30928374|NCT01444456|58964074|FG000|Overall Study|Not treated|104|||
30928375|NCT01438294|58964080|FG000|Overall Study|Lost to Follow-up|3|||
30928376|NCT01438294|58964081|FG001|Overall Study|Lost to Follow-up|7|||
30928377|NCT02033759|58964089|FG000|Overall Study|Withdrawal by Subject|2|||
30928378|NCT02033759|58964090|FG001|Overall Study|Withdrawal by Subject|1|||
30928379|NCT02033759|58964089|FG000|Overall Study|Protocol Violation|1|||
30928380|NCT02033759|58964090|FG001|Overall Study|Protocol Violation|1|||
30928381|NCT01959529|58964098|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
30928382|NCT01959529|58964099|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
30928383|NCT01959529|58964098|FG000|Overall Study|Lost to Follow-up|4|||
30928384|NCT01959529|58964099|FG001|Overall Study|Lost to Follow-up|1|||
30928385|NCT01959529|58964098|FG000|Overall Study|Other|70|||
30928386|NCT01959529|58964099|FG001|Overall Study|Other|68|||
30928387|NCT01959529|58964098|FG000|Overall Study|Hypoglycaemia|1|||
30928388|NCT01959529|58964099|FG001|Overall Study|Hypoglycaemia|1|||
30928389|NCT01959529|58964098|FG000|Overall Study|Lack of glycaemic control|1|||
30928390|NCT01959529|58964099|FG001|Overall Study|Lack of glycaemic control|1|||
30928391|NCT02033369|58964107|FG000|Overall Study|Physician Decision|1|||
30928392|NCT02033369|58964108|FG001|Overall Study|Physician Decision|2|||
30928393|NCT02033369|58964107|FG000|Overall Study|Not a good demographic match|0|||
30928394|NCT02033369|58964108|FG001|Overall Study|Not a good demographic match|2|||
30928395|NCT02033369|58964107|FG000|Overall Study|Withdrawal by Subject|1|||
30928396|NCT02033369|58964108|FG001|Overall Study|Withdrawal by Subject|1|||
30928397|NCT02033369|58964107|FG000|Overall Study|Lost to Follow-up|1|||
30928398|NCT02033369|58964108|FG001|Overall Study|Lost to Follow-up|0|||
30928399|NCT02033369|58964107|FG000|Overall Study|Protocol Violation|2|||
30928400|NCT02033369|58964108|FG001|Overall Study|Protocol Violation|0|||
30928401|NCT02032901|58964114|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
30928402|NCT02032901|58964115|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
30928403|NCT02032901|58964114|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
30928404|NCT02032901|58964115|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
30928405|NCT02020967|58964125|FG000|Overall Study|Withdrawal by Subject|51|||
30928406|NCT01986829|58964131|FG000|Overall Study|Death|1|||
30928407|NCT01986751|58964140|FG000|Overall Study|improperly consented|10|||
30928408|NCT01986751|58964141|FG001|Overall Study|improperly consented|2|||
30928409|NCT02004847|58964153|FG000|Overall Study|Protocol Violation|1|||
30928410|NCT02004847|58964154|FG001|Overall Study|Protocol Violation|1|||
30928411|NCT01438060|58964171|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
30928412|NCT01438060|58964172|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
30928413|NCT01438060|58964171|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
30928414|NCT01438060|58964172|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
30928415|NCT01438060|58964171|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
30928416|NCT01438060|58964172|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
30928417|NCT01438060|58964171|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
30928418|NCT01438060|58964172|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
30928419|NCT01438060|58964171|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
30928420|NCT01438060|58964172|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
30928421|NCT01438060|58964171|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
30928422|NCT01438060|58964172|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
30928423|NCT01438060|58964171|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
30928424|NCT01438060|58964172|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
30928425|NCT01438060|58964171|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
30928426|NCT01438060|58964172|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
30928427|NCT01438060|58964171|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
30928428|NCT01438060|58964172|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
30928429|NCT01438060|58964171|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
30928430|NCT01438060|58964172|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
30928431|NCT01438060|58964171|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
30928432|NCT01438060|58964172|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
30928433|NCT01438060|58964171|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
30928434|NCT01438060|58964172|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
30928435|NCT01438060|58964171|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
30928436|NCT01438060|58964172|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
30928437|NCT01438060|58964171|FG000|On Study Beyond Week 140|Adverse Event|0|||
30928438|NCT01438060|58964172|FG001|On Study Beyond Week 140|Adverse Event|2|||
30928439|NCT01438060|58964171|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
30928440|NCT01438060|58964172|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
30928441|NCT01438060|58964171|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
30928442|NCT01438060|58964172|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
30928443|NCT01438060|58964171|FG000|On Study Beyond Week 140|Death|0|||
30928444|NCT01438060|58964172|FG001|On Study Beyond Week 140|Death|1|||
30928445|NCT01438060|58964171|FG000|On Study Beyond Week 140|Other Reason|0|||
30928446|NCT01438060|58964172|FG001|On Study Beyond Week 140|Other Reason|3|||
30928447|NCT01469182|58964185|FG000|Overall Study|Adverse Event|21|||
30928448|NCT01469182|58964186|FG001|Overall Study|Adverse Event|3|||
30928449|NCT01469182|58964185|FG000|Overall Study|Lost to Follow-up|3|||
30928450|NCT01469182|58964186|FG001|Overall Study|Lost to Follow-up|0|||
30928451|NCT01469182|58964185|FG000|Overall Study|Withdrawal by Subject|4|||
30928452|NCT01469182|58964186|FG001|Overall Study|Withdrawal by Subject|1|||
30625655|NCT00595621|58637897|FG000|Randomization and Study|Withdrawal by Subject|0|||
30928453|NCT01469182|58964185|FG000|Overall Study|Protocol Violation|4|||
30928454|NCT01469182|58964186|FG001|Overall Study|Protocol Violation|2|||
30928455|NCT01469182|58964185|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
30928456|NCT01469182|58964186|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
30928457|NCT01444378|58964192|FG000|Overall Study|Lost to Follow-up|1|||
30928458|NCT01444378|58964192|FG000|Overall Study|Withdrawal by Subject|1|||
30928459|NCT01444378|58964192|FG000|Overall Study|Death|3|||
30928460|NCT01444378|58964192|FG000|Overall Study|Administrative Closure Of The Study|2|||
30928461|NCT01444378|58964192|FG000|Overall Study|Missed Visits|10|||
30928462|NCT02020889|58964201|FG000|Overall Study|Adverse Event|0|||
30928463|NCT02020889|58964202|FG001|Overall Study|Adverse Event|1|||
30928464|NCT02020889|58964201|FG000|Overall Study|Lack of Efficacy|1|||
30928465|NCT02020889|58964202|FG001|Overall Study|Lack of Efficacy|0|||
30928466|NCT02020889|58964201|FG000|Overall Study|Lost to Follow-up|1|||
30928467|NCT02020889|58964202|FG001|Overall Study|Lost to Follow-up|0|||
30928468|NCT02020889|58964201|FG000|Overall Study|Physician Decision|2|||
30928469|NCT02020889|58964202|FG001|Overall Study|Physician Decision|0|||
30928470|NCT02020889|58964201|FG000|Overall Study|Withdrawal by Subject|3|||
30928471|NCT02020889|58964202|FG001|Overall Study|Withdrawal by Subject|2|||
30928472|NCT01444300|58964210|FG000|Overall Study|Adverse Event|4|||
30928473|NCT01444300|58964211|FG001|Overall Study|Adverse Event|0|||
30928474|NCT01443364|58964218|FG000|Overall Study|Lack of Efficacy|14|||
30928475|NCT01443364|58964218|FG000|Overall Study|Lost to Follow-up|3|||
30928476|NCT01443364|58964218|FG000|Overall Study|Withdrawal by Subject|5|||
30928477|NCT01443364|58964218|FG000|Overall Study|Other Reason|4|||
30928478|NCT01443364|58964218|FG000|Overall Study|SAE, non-fatal|6|||
30928479|NCT01443364|58964218|FG000|Overall Study|AE, non-serious non-fatal|8|||
30928480|NCT01443364|58964218|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
30928481|NCT02020577|58964224|FG000|Overall Study|Progressive disease|3|||
30928482|NCT02020577|58964225|FG001|Overall Study|Progressive disease|38|||
30928483|NCT02020577|58964224|FG000|Overall Study|Other AE or clinical progression|0|||
30928484|NCT02020577|58964225|FG001|Overall Study|Other AE or clinical progression|15|||
30928485|NCT02020577|58964224|FG000|Overall Study|Withdrawal by Subject|0|||
30928486|NCT02020577|58964225|FG001|Overall Study|Withdrawal by Subject|1|||
30928487|NCT02020577|58964224|FG000|Overall Study|Other than stated above|0|||
30928488|NCT02020577|58964225|FG001|Overall Study|Other than stated above|1|||
30928489|NCT02020031|58964235|FG000|Overall Study|Physician Decision|1|||
30928490|NCT02020031|58964236|FG001|Overall Study|Physician Decision|1|||
30928491|NCT04179305|58964246|FG000|Overall Study|Death|1|||
30928492|NCT04179305|58964247|FG001|Overall Study|Death|1|||
30928493|NCT04179305|58964248|FG002|Overall Study|Death|0|||
30928494|NCT04179305|58964249|FG003|Overall Study|Death|0|||
30928495|NCT04179305|58964246|FG000|Overall Study|Lost to Follow-up|1|||
30928496|NCT04179305|58964247|FG001|Overall Study|Lost to Follow-up|1|||
30928497|NCT04179305|58964248|FG002|Overall Study|Lost to Follow-up|0|||
30928498|NCT04179305|58964249|FG003|Overall Study|Lost to Follow-up|0|||
30928499|NCT04179305|58964246|FG000|Overall Study|Withdrawal by Subject|0|||
30928500|NCT04179305|58964247|FG001|Overall Study|Withdrawal by Subject|1|||
30928501|NCT04179305|58964248|FG002|Overall Study|Withdrawal by Subject|0|||
30928502|NCT04179305|58964249|FG003|Overall Study|Withdrawal by Subject|0|||
30928503|NCT04179305|58964246|FG000|Overall Study|Did not have scan|1|||
30928504|NCT04179305|58964247|FG001|Overall Study|Did not have scan|0|||
30928505|NCT04179305|58964248|FG002|Overall Study|Did not have scan|0|||
30928506|NCT04179305|58964249|FG003|Overall Study|Did not have scan|0|||
30928507|NCT04179305|58964246|FG000|Overall Study|In hospice care|3|||
30928508|NCT04179305|58964247|FG001|Overall Study|In hospice care|0|||
30928509|NCT04179305|58964248|FG002|Overall Study|In hospice care|0|||
30928510|NCT04179305|58964249|FG003|Overall Study|In hospice care|0|||
30928511|NCT02019719|58964265|FG000|Overall Study|Adverse Event|1|||
30928512|NCT02019719|58964266|FG001|Overall Study|Adverse Event|0|||
30928513|NCT02019719|58964267|FG002|Overall Study|Adverse Event|0|||
30928514|NCT02019719|58964268|FG003|Overall Study|Adverse Event|1|||
30928515|NCT02019719|58964269|FG004|Overall Study|Adverse Event|1|||
30928516|NCT02019719|58964265|FG000|Overall Study|Protocol Violation|1|||
30928517|NCT02019719|58964266|FG001|Overall Study|Protocol Violation|1|||
30928518|NCT02019719|58964267|FG002|Overall Study|Protocol Violation|0|||
30928519|NCT02019719|58964268|FG003|Overall Study|Protocol Violation|0|||
30928520|NCT02019719|58964269|FG004|Overall Study|Protocol Violation|0|||
30928521|NCT02019719|58964265|FG000|Overall Study|Protocol defined stopping criteria|2|||
30928522|NCT02019719|58964266|FG001|Overall Study|Protocol defined stopping criteria|0|||
30928523|NCT02019719|58964267|FG002|Overall Study|Protocol defined stopping criteria|0|||
30928524|NCT02019719|58964268|FG003|Overall Study|Protocol defined stopping criteria|1|||
30928525|NCT02019719|58964269|FG004|Overall Study|Protocol defined stopping criteria|1|||
30928526|NCT02019719|58964265|FG000|Overall Study|Physician Decision|2|||
30928527|NCT02019719|58964266|FG001|Overall Study|Physician Decision|0|||
30928528|NCT02019719|58964267|FG002|Overall Study|Physician Decision|0|||
30928529|NCT02019719|58964268|FG003|Overall Study|Physician Decision|0|||
30928530|NCT02019719|58964269|FG004|Overall Study|Physician Decision|0|||
30928531|NCT02030405|58964288|FG000|Overall Study|Withdrawal by Subject|1|||
30928532|NCT02030405|58964288|FG000|Overall Study|Lost to Follow-up|1|||
30928533|NCT01975376|58964295|FG000|Overall Study|Adverse Event|5|||
30928534|NCT01975376|58964296|FG001|Overall Study|Adverse Event|5|||
30928535|NCT01975376|58964295|FG000|Overall Study|Death|65|||
30928536|NCT01975376|58964296|FG001|Overall Study|Death|72|||
30928537|NCT01975376|58964295|FG000|Overall Study|Lost to Follow-up|70|||
30928538|NCT01975376|58964296|FG001|Overall Study|Lost to Follow-up|66|||
30928539|NCT01975376|58964295|FG000|Overall Study|Withdrew consent|68|||
30928540|NCT01975376|58964296|FG001|Overall Study|Withdrew consent|62|||
30928541|NCT01975376|58964295|FG000|Overall Study|Other|2|||
30928542|NCT01975376|58964296|FG001|Overall Study|Other|4|||
30928543|NCT01975376|58964295|FG000|Overall Study|Randomized, Not Treated|16|||
30928544|NCT01975376|58964296|FG001|Overall Study|Randomized, Not Treated|8|||
30928545|NCT01443130|58964308|FG000|Overall Study|Lost to Follow-up|44|||
30928546|NCT01443130|58964309|FG001|Overall Study|Lost to Follow-up|42|||
30928547|NCT01443130|58964310|FG002|Overall Study|Lost to Follow-up|50|||
30928548|NCT01443130|58964311|FG003|Overall Study|Lost to Follow-up|23|||
30928549|NCT01443130|58964312|FG004|Overall Study|Lost to Follow-up|25|||
30928550|NCT01443130|58964313|FG005|Overall Study|Lost to Follow-up|21|||
30928551|NCT01443130|58964308|FG000|Overall Study|Death|0|||
30928552|NCT01443130|58964309|FG001|Overall Study|Death|1|||
30928553|NCT01443130|58964310|FG002|Overall Study|Death|0|||
30928554|NCT01443130|58964311|FG003|Overall Study|Death|7|||
30928555|NCT01443130|58964312|FG004|Overall Study|Death|10|||
30928556|NCT01443130|58964313|FG005|Overall Study|Death|8|||
30928557|NCT01443130|58964308|FG000|Overall Study|Adverse Event|2|||
30928558|NCT01443130|58964309|FG001|Overall Study|Adverse Event|1|||
30928559|NCT01443130|58964310|FG002|Overall Study|Adverse Event|1|||
30928560|NCT01443130|58964311|FG003|Overall Study|Adverse Event|0|||
30928561|NCT01443130|58964312|FG004|Overall Study|Adverse Event|0|||
30928562|NCT01443130|58964313|FG005|Overall Study|Adverse Event|0|||
30928563|NCT01443130|58964308|FG000|Overall Study|Protocol Violation|2|||
30928564|NCT01443130|58964309|FG001|Overall Study|Protocol Violation|1|||
30928565|NCT01443130|58964310|FG002|Overall Study|Protocol Violation|3|||
30928566|NCT01443130|58964311|FG003|Overall Study|Protocol Violation|2|||
30928567|NCT01443130|58964312|FG004|Overall Study|Protocol Violation|2|||
30928568|NCT01443130|58964313|FG005|Overall Study|Protocol Violation|3|||
30928569|NCT01443130|58964308|FG000|Overall Study|Withdrawal by Subject|15|||
30928570|NCT01443130|58964309|FG001|Overall Study|Withdrawal by Subject|14|||
30928571|NCT01443130|58964310|FG002|Overall Study|Withdrawal by Subject|12|||
30928572|NCT01443130|58964311|FG003|Overall Study|Withdrawal by Subject|7|||
30928573|NCT01443130|58964312|FG004|Overall Study|Withdrawal by Subject|7|||
30928574|NCT01443130|58964313|FG005|Overall Study|Withdrawal by Subject|2|||
30928575|NCT01443130|58964308|FG000|Overall Study|Death of Subject's Infant|5|||
30928576|NCT01443130|58964309|FG001|Overall Study|Death of Subject's Infant|10|||
30928577|NCT01443130|58964310|FG002|Overall Study|Death of Subject's Infant|11|||
30928578|NCT01443130|58964311|FG003|Overall Study|Death of Subject's Infant|0|||
30928579|NCT01443130|58964312|FG004|Overall Study|Death of Subject's Infant|0|||
30928580|NCT01443130|58964313|FG005|Overall Study|Death of Subject's Infant|0|||
30928581|NCT01436500|58964329|FG000|Overall Study|Death|1|||
30928582|NCT01436500|58964330|FG001|Overall Study|Death|0|||
30928583|NCT01436500|58964331|FG002|Overall Study|Death|0|||
30928584|NCT01436500|58964332|FG003|Overall Study|Death|0|||
30928585|NCT01436500|58964333|FG004|Overall Study|Death|0|||
30928586|NCT01436500|58964329|FG000|Overall Study|Adverse Event|0|||
30928587|NCT01436500|58964330|FG001|Overall Study|Adverse Event|2|||
30928588|NCT01436500|58964331|FG002|Overall Study|Adverse Event|2|||
30928589|NCT01436500|58964332|FG003|Overall Study|Adverse Event|0|||
30928590|NCT01436500|58964333|FG004|Overall Study|Adverse Event|1|||
30928591|NCT01436500|58964329|FG000|Overall Study|Withdrawal by Subject|0|||
30928592|NCT01436500|58964330|FG001|Overall Study|Withdrawal by Subject|0|||
30928593|NCT01436500|58964331|FG002|Overall Study|Withdrawal by Subject|2|||
30928594|NCT01436500|58964332|FG003|Overall Study|Withdrawal by Subject|0|||
30928595|NCT01436500|58964333|FG004|Overall Study|Withdrawal by Subject|2|||
30928596|NCT01436500|58964329|FG000|Overall Study|Physician Decision|0|||
30928597|NCT01436500|58964330|FG001|Overall Study|Physician Decision|0|||
30928598|NCT01436500|58964331|FG002|Overall Study|Physician Decision|1|||
30928599|NCT01436500|58964332|FG003|Overall Study|Physician Decision|0|||
30928600|NCT01436500|58964333|FG004|Overall Study|Physician Decision|0|||
30928601|NCT01436500|58964329|FG000|Overall Study|liver transplant|1|||
30928602|NCT01436500|58964330|FG001|Overall Study|liver transplant|0|||
30928603|NCT01436500|58964331|FG002|Overall Study|liver transplant|0|||
30928604|NCT01436500|58964332|FG003|Overall Study|liver transplant|0|||
30928605|NCT01436500|58964333|FG004|Overall Study|liver transplant|0|||
30928606|NCT01436500|58964329|FG000|Overall Study|initiation of dialysis|0|||
30928607|NCT01436500|58964330|FG001|Overall Study|initiation of dialysis|0|||
30928608|NCT01436500|58964331|FG002|Overall Study|initiation of dialysis|0|||
30928609|NCT01436500|58964332|FG003|Overall Study|initiation of dialysis|0|||
30928610|NCT01436500|58964333|FG004|Overall Study|initiation of dialysis|1|||
30928611|NCT01436500|58964329|FG000|Overall Study|discontinued study drug|1|||
30928612|NCT01436500|58964330|FG001|Overall Study|discontinued study drug|0|||
30928613|NCT01436500|58964331|FG002|Overall Study|discontinued study drug|0|||
30928614|NCT01436500|58964332|FG003|Overall Study|discontinued study drug|0|||
30928615|NCT01436500|58964333|FG004|Overall Study|discontinued study drug|0|||
30928616|NCT01436500|58964329|FG000|Overall Study|Other|0|||
30928617|NCT01436500|58964330|FG001|Overall Study|Other|1|||
30928618|NCT01436500|58964331|FG002|Overall Study|Other|0|||
30928619|NCT01436500|58964332|FG003|Overall Study|Other|1|||
30928620|NCT01436500|58964333|FG004|Overall Study|Other|0|||
30928621|NCT01958827|58964346|FG000|Overall Study|Adverse Event|3|||
30928622|NCT01958827|58964346|FG000|Overall Study|Lack of Efficacy|6|||
30928623|NCT01958827|58964346|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
30928624|NCT01620086|58964352|FG000|Overall Study|Withdrawal by Subject|3|||
30928625|NCT01620086|58964353|FG001|Overall Study|Withdrawal by Subject|3|||
30928626|NCT01620086|58964354|FG002|Overall Study|Withdrawal by Subject|0|||
30928627|NCT01620086|58964352|FG000|Overall Study|failed study criteria|1|||
30928628|NCT01620086|58964353|FG001|Overall Study|failed study criteria|4|||
30928629|NCT01620086|58964354|FG002|Overall Study|failed study criteria|0|||
30928630|NCT01620086|58964352|FG000|Overall Study|Physician Decision|1|||
30928631|NCT01620086|58964353|FG001|Overall Study|Physician Decision|0|||
30928632|NCT01620086|58964354|FG002|Overall Study|Physician Decision|0|||
30928633|NCT01436110|58964366|FG000|Overall Study|Lack of Efficacy|23|||
30837563|NCT00708032|58862437|FG000|Overall Study|Poor vision|0|||
30837564|NCT00708032|58862438|FG001|Overall Study|Poor vision|6|||
30837565|NCT00708032|58862437|FG000|Overall Study|Visit out of range at month 12|4|||
30837566|NCT00708032|58862438|FG001|Overall Study|Visit out of range at month 12|1|||
30837567|NCT00708032|58862437|FG000|Overall Study|Did not meet protocol criteria|1|||
30837568|NCT00708032|58862438|FG001|Overall Study|Did not meet protocol criteria|2|||
30837569|NCT00708032|58862437|FG000|Overall Study|Protocol Violation|4|||
30837570|NCT00708032|58862438|FG001|Overall Study|Protocol Violation|1|||
30837571|NCT00708032|58862437|FG000|Overall Study|Withdrawal by Subject|0|||
30928634|NCT01436110|58964367|FG001|Overall Study|Lack of Efficacy|14|||
30928635|NCT01436110|58964368|FG002|Overall Study|Lack of Efficacy|9|||
30928636|NCT01436110|58964366|FG000|Overall Study|Withdrawal by Subject|6|||
30624068|NCT01119066|58636059|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
30624069|NCT01119066|58636060|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
30624070|NCT01119066|58636057|FG000|Overall Study|Relapse identified before transplant|0|||
30624071|NCT01119066|58636058|FG001|Overall Study|Relapse identified before transplant|4|||
30624072|NCT01119066|58636059|FG002|Overall Study|Relapse identified before transplant|0|||
30624073|NCT01119066|58636060|FG003|Overall Study|Relapse identified before transplant|0|||
30624074|NCT00910624|58636074|FG000|Treatment Phase|Adverse Event|2|||
30624075|NCT00910624|58636075|FG001|Treatment Phase|Adverse Event|6|||
30624076|NCT00910624|58636076|FG002|Treatment Phase|Adverse Event|6|||
30624077|NCT00910624|58636077|FG003|Treatment Phase|Adverse Event|0|||
30928637|NCT01436110|58964367|FG001|Overall Study|Withdrawal by Subject|8|||
30928638|NCT01436110|58964368|FG002|Overall Study|Withdrawal by Subject|4|||
30928639|NCT01436110|58964366|FG000|Overall Study|Adverse Event|2|||
30928640|NCT01436110|58964367|FG001|Overall Study|Adverse Event|1|||
30928641|NCT01436110|58964368|FG002|Overall Study|Adverse Event|2|||
30928642|NCT01436110|58964366|FG000|Overall Study|Physician Decision|3|||
30928643|NCT01436110|58964367|FG001|Overall Study|Physician Decision|1|||
30928644|NCT01436110|58964368|FG002|Overall Study|Physician Decision|1|||
30928645|NCT01436110|58964366|FG000|Overall Study|Lost to Follow-up|1|||
30928646|NCT01436110|58964367|FG001|Overall Study|Lost to Follow-up|1|||
30928647|NCT01436110|58964368|FG002|Overall Study|Lost to Follow-up|3|||
30928648|NCT01436110|58964366|FG000|Overall Study|Protocol Violation|3|||
30928649|NCT01436110|58964367|FG001|Overall Study|Protocol Violation|1|||
30928650|NCT01436110|58964368|FG002|Overall Study|Protocol Violation|1|||
30928651|NCT01436110|58964366|FG000|Overall Study|Did Not Receive Trial Medication|1|||
30928652|NCT01436110|58964367|FG001|Overall Study|Did Not Receive Trial Medication|0|||
30928653|NCT01436110|58964368|FG002|Overall Study|Did Not Receive Trial Medication|3|||
30928654|NCT01619852|58964378|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
30928655|NCT01619852|58964379|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
30928656|NCT01619852|58964378|FG000|3 Month Follow up|Lost to Follow-up|31|||
30928657|NCT01619852|58964379|FG001|3 Month Follow up|Lost to Follow-up|34|||
30928658|NCT02000882|58964386|FG000|Overall Study|Adverse Event|3|||
30928659|NCT02000882|58964386|FG000|Overall Study|Physician Decision|2|||
30928660|NCT02000882|58964386|FG000|Overall Study|Withdrawal by Subject|1|||
30928661|NCT01965938|58964392|FG000|Overall Study|Withdrawal by Subject|1|||
30928662|NCT01965938|58964393|FG001|Overall Study|Withdrawal by Subject|0|||
30928663|NCT01965860|58964404|FG000|Overall Study|Pregnancy|1|||
30928664|NCT01965860|58964405|FG001|Overall Study|Pregnancy|0|||
30624078|NCT00910624|58636074|FG000|Treatment Phase|Treatment Failure|23|||
30624079|NCT00910624|58636075|FG001|Treatment Phase|Treatment Failure|10|||
30837572|NCT00708032|58862438|FG001|Overall Study|Withdrawal by Subject|1|||
30928665|NCT01965860|58964406|FG002|Overall Study|Pregnancy|1|||
30928666|NCT01965860|58964404|FG000|Overall Study|Logistics|1|||
30928667|NCT01965860|58964405|FG001|Overall Study|Logistics|0|||
30928668|NCT01965860|58964406|FG002|Overall Study|Logistics|0|||
30837573|NCT00707174|58862446|FG000|Overall Study|Adverse Event|1|||
30928669|NCT01965704|58964427|FG000|Overall Study|Withdrawal by Subject|2|||
30928670|NCT01965704|58964428|FG001|Overall Study|Withdrawal by Subject|2|||
30928671|NCT01965704|58964429|FG002|Overall Study|Withdrawal by Subject|1|||
30928672|NCT01965704|58964430|FG003|Overall Study|Withdrawal by Subject|1|||
30928673|NCT01965704|58964427|FG000|Overall Study|Delivered at home|1|||
30928674|NCT01965704|58964428|FG001|Overall Study|Delivered at home|1|||
30928675|NCT01965704|58964429|FG002|Overall Study|Delivered at home|0|||
30928676|NCT01965704|58964430|FG003|Overall Study|Delivered at home|0|||
30928677|NCT01965704|58964427|FG000|Overall Study|Experienced complications|0|||
30928678|NCT01965704|58964428|FG001|Overall Study|Experienced complications|0|||
30928679|NCT01965704|58964429|FG002|Overall Study|Experienced complications|2|||
30928680|NCT01965704|58964430|FG003|Overall Study|Experienced complications|2|||
30928681|NCT01965704|58964427|FG000|Overall Study|Adverse Event|0|||
30928682|NCT01965704|58964428|FG001|Overall Study|Adverse Event|0|||
30928683|NCT01965704|58964429|FG002|Overall Study|Adverse Event|1|||
30928684|NCT01965704|58964430|FG003|Overall Study|Adverse Event|1|||
30928685|NCT01965704|58964427|FG000|Overall Study|Did not meet inclusion criteria|0|||
30928686|NCT01965704|58964428|FG001|Overall Study|Did not meet inclusion criteria|0|||
30928687|NCT01965704|58964429|FG002|Overall Study|Did not meet inclusion criteria|1|||
30928688|NCT01965704|58964430|FG003|Overall Study|Did not meet inclusion criteria|1|||
30928689|NCT02003365|58964441|FG000|Overall Study|Lost to Follow-up|0|||
30928690|NCT02003365|58964442|FG001|Overall Study|Lost to Follow-up|0|||
30928691|NCT02003365|58964443|FG002|Overall Study|Lost to Follow-up|1|||
30928692|NCT01975220|58964454|FG000|Test Period 1|Not treated|0|||
30928693|NCT01975220|58964455|FG001|Test Period 1|Not treated|1|||
30928694|NCT01975220|58964456|FG002|Test Period 1|Not treated|0|||
30928695|NCT01975220|58964457|FG003|Test Period 1|Not treated|0|||
30928696|NCT01975220|58964458|FG004|Test Period 1|Not treated|0|||
30928697|NCT01975220|58964459|FG005|Test Period 1|Not treated|0|||
30928698|NCT01958437|58964476|FG000|Overall Study|Incidental MRI findings|0|||
30928699|NCT01958437|58964477|FG001|Overall Study|Incidental MRI findings|0|||
30928700|NCT01958437|58964478|FG002|Overall Study|Incidental MRI findings|1|||
30928701|NCT01958437|58964479|FG003|Overall Study|Incidental MRI findings|1|||
30928702|NCT01974752|58964498|FG000|Overall Study|Death|33|||
30928703|NCT01974752|58964499|FG001|Overall Study|Death|11|||
30928704|NCT01974752|58964498|FG000|Overall Study|Lost to Follow-up|2|||
30928705|NCT01974752|58964499|FG001|Overall Study|Lost to Follow-up|0|||
30928706|NCT01974752|58964498|FG000|Overall Study|Withdrawal by Subject|2|||
30928707|NCT01974752|58964499|FG001|Overall Study|Withdrawal by Subject|3|||
30928708|NCT01974752|58964498|FG000|Overall Study|Other Eligibility Criteria|0|||
30928709|NCT01974752|58964499|FG001|Overall Study|Other Eligibility Criteria|1|||
30928710|NCT01999946|58964508|FG000|Overall Study|Participant not released from jail|2|||
30928711|NCT01999946|58964509|FG001|Overall Study|Participant not released from jail|2|||
30928712|NCT01999946|58964510|FG002|Overall Study|Participant not released from jail|0|||
30928713|NCT01999946|58964508|FG000|Overall Study|Not included in primary outcome analysis|0|||
30928714|NCT01999946|58964509|FG001|Overall Study|Not included in primary outcome analysis|0|||
30928715|NCT01999946|58964510|FG002|Overall Study|Not included in primary outcome analysis|79|||
30928716|NCT01958281|58964520|FG000|Overall Study|Lack of Efficacy|5|||
30928717|NCT01958281|58964521|FG001|Overall Study|Lack of Efficacy|2|||
30928718|NCT01958281|58964522|FG002|Overall Study|Lack of Efficacy|0|||
30928719|NCT01958281|58964520|FG000|Overall Study|Adverse Event|0|||
30928720|NCT01958281|58964521|FG001|Overall Study|Adverse Event|2|||
30928721|NCT01958281|58964522|FG002|Overall Study|Adverse Event|0|||
30928722|NCT01958281|58964520|FG000|Overall Study|Withdrew Consent|1|||
30928723|NCT01958281|58964521|FG001|Overall Study|Withdrew Consent|0|||
30928724|NCT01958281|58964522|FG002|Overall Study|Withdrew Consent|0|||
30928725|NCT01958125|58964533|FG000|Overall Study|Missing diary data|2|||
30928726|NCT01958125|58964534|FG001|Overall Study|Missing diary data|6|||
30928727|NCT01958125|58964533|FG000|Overall Study|No headache attacks|0|||
30928728|NCT01958125|58964534|FG001|Overall Study|No headache attacks|2|||
30928729|NCT02002975|58964540|FG000|Overall Study|Case Report Forms Uncollected|135|||
30928730|NCT02002975|58964540|FG000|Overall Study|Protocol Deviation|437|||
30928731|NCT02001181|58964546|FG000|Overall Study|Adverse Event|0|||
30928732|NCT02001181|58964547|FG001|Overall Study|Adverse Event|2|||
30928733|NCT02001181|58964546|FG000|Overall Study|Lost to Follow-up|1|||
30928734|NCT02001181|58964547|FG001|Overall Study|Lost to Follow-up|0|||
30928735|NCT02001181|58964546|FG000|Overall Study|Withdrawal by Subject|0|||
30928736|NCT02001181|58964547|FG001|Overall Study|Withdrawal by Subject|1|||
30928737|NCT01999465|58964555|FG000|Overall Study|Lost to Follow-up|0|||
30928738|NCT01999465|58964556|FG001|Overall Study|Lost to Follow-up|2|||
30928739|NCT01999465|58964555|FG000|Overall Study|Protocol Violation|0|||
30928740|NCT01999465|58964556|FG001|Overall Study|Protocol Violation|1|||
30928741|NCT01982773|58964564|FG000|Overall Study|Withdrawal by Subject|1|||
30928742|NCT01982773|58964565|FG001|Overall Study|Withdrawal by Subject|3|||
30928743|NCT01982773|58964564|FG000|Overall Study|Lost to Follow-up|7|||
30928744|NCT01982773|58964565|FG001|Overall Study|Lost to Follow-up|1|||
30928745|NCT01974206|58964573|FG000|Overall Study|Did Not Take Study Drug|0|||
30928746|NCT01974206|58964574|FG001|Overall Study|Did Not Take Study Drug|1|||
30928747|NCT01974206|58964573|FG000|Overall Study|Physician Decision|1|||
30928748|NCT01974206|58964574|FG001|Overall Study|Physician Decision|0|||
30928749|NCT01974206|58964573|FG000|Overall Study|Withdrawal by Subject|3|||
30928750|NCT01974206|58964574|FG001|Overall Study|Withdrawal by Subject|0|||
30928751|NCT01974206|58964573|FG000|Overall Study|Lost to Follow-up|1|||
30837574|NCT00707174|58862447|FG001|Overall Study|Adverse Event|6|||
30837575|NCT00707174|58862446|FG000|Overall Study|Withdrawal by Subject|4|||
30837576|NCT00707174|58862447|FG001|Overall Study|Withdrawal by Subject|1|||
30837577|NCT02756403|58862457|FG000|Overall Study|Unable to swallow medication|0|||
30837578|NCT02756403|58862458|FG001|Overall Study|Unable to swallow medication|1|||
30837579|NCT02756403|58862459|FG002|Overall Study|Unable to swallow medication|1|||
30837580|NCT02756403|58862460|FG003|Overall Study|Unable to swallow medication|1|||
30837581|NCT02756403|58862457|FG000|Overall Study|Did not complete Procedure|0|||
30837582|NCT02756403|58862458|FG001|Overall Study|Did not complete Procedure|1|||
30837583|NCT02756403|58862459|FG002|Overall Study|Did not complete Procedure|0|||
30837584|NCT02756403|58862460|FG003|Overall Study|Did not complete Procedure|0|||
30837585|NCT02756403|58862457|FG000|Overall Study|Changed Mind About Procedure|0|||
30837586|NCT02756403|58862458|FG001|Overall Study|Changed Mind About Procedure|0|||
30837587|NCT02756403|58862459|FG002|Overall Study|Changed Mind About Procedure|1|||
30837588|NCT02756403|58862460|FG003|Overall Study|Changed Mind About Procedure|0|||
30837589|NCT02756403|58862457|FG000|Overall Study|Protocol Violation|0|||
30837590|NCT02756403|58862458|FG001|Overall Study|Protocol Violation|1|||
30837591|NCT02756403|58862459|FG002|Overall Study|Protocol Violation|0|||
30837592|NCT02756403|58862460|FG003|Overall Study|Protocol Violation|1|||
30837593|NCT02753595|58862472|FG000|Overall Study|Sponsor termination|2|||
30837594|NCT02753595|58862473|FG001|Overall Study|Sponsor termination|2|||
30837595|NCT00707954|58862496|FG000|Overall Study|Physician Decision|0|||
30837596|NCT00707954|58862497|FG001|Overall Study|Physician Decision|0|||
30837597|NCT00707954|58862498|FG002|Overall Study|Physician Decision|0|||
30837598|NCT00707954|58862499|FG003|Overall Study|Physician Decision|0|||
30837599|NCT00707954|58862500|FG004|Overall Study|Physician Decision|1|||
30837600|NCT02561962|58862521|FG000|Overall Study|Ongoing in study|1|||
30837601|NCT02561962|58862522|FG001|Overall Study|Ongoing in study|0|||
30837602|NCT02561962|58862523|FG002|Overall Study|Ongoing in study|0|||
30837603|NCT02561962|58862524|FG003|Overall Study|Ongoing in study|1|||
30837604|NCT02561962|58862525|FG004|Overall Study|Ongoing in study|0|||
30837605|NCT02561962|58862526|FG005|Overall Study|Ongoing in study|1|||
30837606|NCT02561962|58862527|FG006|Overall Study|Ongoing in study|0|||
30837607|NCT02561962|58862528|FG007|Overall Study|Ongoing in study|4|||
30837608|NCT02561962|58862529|FG008|Overall Study|Ongoing in study|1|||
30837609|NCT02561962|58862521|FG000|Overall Study|Withdrawal by Subject|1|||
30837610|NCT02561962|58862522|FG001|Overall Study|Withdrawal by Subject|0|||
30837611|NCT02561962|58862523|FG002|Overall Study|Withdrawal by Subject|0|||
30837612|NCT02561962|58862524|FG003|Overall Study|Withdrawal by Subject|0|||
30837613|NCT02561962|58862525|FG004|Overall Study|Withdrawal by Subject|1|||
30837614|NCT02561962|58862526|FG005|Overall Study|Withdrawal by Subject|1|||
30837615|NCT02561962|58862527|FG006|Overall Study|Withdrawal by Subject|2|||
30837616|NCT02561962|58862528|FG007|Overall Study|Withdrawal by Subject|1|||
30837617|NCT02561962|58862529|FG008|Overall Study|Withdrawal by Subject|0|||
30837618|NCT02561962|58862521|FG000|Overall Study|Decision by sponsor|0|||
30837619|NCT02561962|58862522|FG001|Overall Study|Decision by sponsor|0|||
30837620|NCT02561962|58862523|FG002|Overall Study|Decision by sponsor|0|||
30837621|NCT02561962|58862524|FG003|Overall Study|Decision by sponsor|0|||
30837622|NCT02561962|58862525|FG004|Overall Study|Decision by sponsor|1|||
30837623|NCT02561962|58862526|FG005|Overall Study|Decision by sponsor|1|||
30837624|NCT02561962|58862527|FG006|Overall Study|Decision by sponsor|0|||
30837625|NCT02561962|58862528|FG007|Overall Study|Decision by sponsor|3|||
30837626|NCT02561962|58862529|FG008|Overall Study|Decision by sponsor|0|||
30837627|NCT02561962|58862521|FG000|Overall Study|Lost to Follow-up|0|||
30837628|NCT02561962|58862522|FG001|Overall Study|Lost to Follow-up|0|||
30837629|NCT02561962|58862523|FG002|Overall Study|Lost to Follow-up|0|||
30837630|NCT02561962|58862524|FG003|Overall Study|Lost to Follow-up|0|||
30837631|NCT02561962|58862525|FG004|Overall Study|Lost to Follow-up|0|||
30837632|NCT02561962|58862526|FG005|Overall Study|Lost to Follow-up|1|||
30837633|NCT02561962|58862527|FG006|Overall Study|Lost to Follow-up|0|||
30837634|NCT02561962|58862528|FG007|Overall Study|Lost to Follow-up|0|||
30837635|NCT02561962|58862529|FG008|Overall Study|Lost to Follow-up|0|||
30837636|NCT02565706|58862553|FG000|Overall Study|Withdrawal by Subject|5|||
30837637|NCT02565706|58862554|FG001|Overall Study|Withdrawal by Subject|7|||
30837638|NCT02565706|58862555|FG002|Overall Study|Withdrawal by Subject|7|||
30837639|NCT02565706|58862556|FG003|Overall Study|Withdrawal by Subject|11|||
30837640|NCT02565706|58862553|FG000|Overall Study|Lost to Follow-up|72|||
30837641|NCT02565706|58862554|FG001|Overall Study|Lost to Follow-up|75|||
30837642|NCT02565706|58862555|FG002|Overall Study|Lost to Follow-up|82|||
30837643|NCT02565706|58862556|FG003|Overall Study|Lost to Follow-up|74|||
30837644|NCT00706628|58862575|FG000|Overall Study|Other Adverse Event|16|||
30928752|NCT01974206|58964574|FG001|Overall Study|Lost to Follow-up|0|||
30928753|NCT01974206|58964573|FG000|Overall Study|Death|1|||
30928754|NCT01974206|58964574|FG001|Overall Study|Death|0|||
30928755|NCT01999868|58964583|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
30928756|NCT01999868|58964584|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
30928757|NCT01999868|58964585|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
30928758|NCT01999868|58964583|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
30928759|NCT01999868|58964584|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
30928760|NCT01999868|58964585|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
30928761|NCT01999868|58964583|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
30928762|NCT01999868|58964584|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
30928763|NCT01999868|58964585|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
30928764|NCT01999868|58964583|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
30928765|NCT01999868|58964584|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
30928766|NCT01999868|58964585|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
30928767|NCT01999868|58964583|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
30928768|NCT01999868|58964584|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
30928769|NCT01999868|58964585|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
30928770|NCT01999868|58964583|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
30928771|NCT01999868|58964584|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
30928772|NCT01999868|58964585|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
30928773|NCT01999868|58964583|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
30928774|NCT01999868|58964584|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
30928775|NCT01999868|58964585|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
30928776|NCT01999868|58964583|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
30928777|NCT01999868|58964584|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
30928778|NCT01999868|58964585|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
30928779|NCT01999868|58964583|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
30928780|NCT01999868|58964584|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
30928781|NCT01999868|58964585|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
30928782|NCT01999868|58964583|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
30928783|NCT01999868|58964584|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
30928784|NCT01999868|58964585|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
30928785|NCT01999868|58964583|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
30928786|NCT01999868|58964584|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
30928787|NCT01999868|58964585|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
30928788|NCT01999868|58964583|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
30928789|NCT01999868|58964584|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
30928790|NCT01999868|58964585|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
30928791|NCT01999868|58964583|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
30928792|NCT01999868|58964584|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
30928793|NCT01999868|58964585|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
30928794|NCT01999868|58964583|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
30928795|NCT01999868|58964584|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
30928796|NCT01999868|58964585|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
30928797|NCT01999868|58964583|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
30928798|NCT01999868|58964584|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
30837645|NCT00706628|58862576|FG001|Overall Study|Other Adverse Event|5|||
30837646|NCT00706628|58862577|FG002|Overall Study|Other Adverse Event|5|||
30837647|NCT00706628|58862578|FG003|Overall Study|Other Adverse Event|2|||
30624080|NCT00910624|58636076|FG002|Treatment Phase|Treatment Failure|0|||
30837648|NCT00706628|58862575|FG000|Overall Study|Non compliant with protocol|0|||
30837649|NCT00706628|58862576|FG001|Overall Study|Non compliant with protocol|1|||
30837650|NCT00706628|58862577|FG002|Overall Study|Non compliant with protocol|0|||
30837651|NCT00706628|58862578|FG003|Overall Study|Non compliant with protocol|0|||
30837652|NCT00706628|58862575|FG000|Overall Study|Consent withdrawn|6|||
30837653|NCT00706628|58862576|FG001|Overall Study|Consent withdrawn|1|||
30837654|NCT00706628|58862577|FG002|Overall Study|Consent withdrawn|3|||
30837655|NCT00706628|58862578|FG003|Overall Study|Consent withdrawn|0|||
30837656|NCT00706628|58862575|FG000|Overall Study|Progressive disease|20|||
30837657|NCT00706628|58862576|FG001|Overall Study|Progressive disease|13|||
30837658|NCT00706628|58862577|FG002|Overall Study|Progressive disease|8|||
30837659|NCT00706628|58862578|FG003|Overall Study|Progressive disease|1|||
30928799|NCT01999868|58964585|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
30928800|NCT01957579|58964597|FG000|Overall Study|Withdrawal of concent|0|||
30928801|NCT01957579|58964598|FG001|Overall Study|Withdrawal of concent|1|||
30928802|NCT01957579|58964599|FG002|Overall Study|Withdrawal of concent|0|||
30928803|NCT01957579|58964600|FG003|Overall Study|Withdrawal of concent|0|||
30928804|NCT01957579|58964597|FG000|Overall Study|Death|0|||
30928805|NCT01957579|58964598|FG001|Overall Study|Death|0|||
30928806|NCT01957579|58964599|FG002|Overall Study|Death|2|||
30928807|NCT01957579|58964600|FG003|Overall Study|Death|0|||
30928808|NCT01999322|58964629|FG000|Overall Study|Adverse Event|1|||
30928809|NCT01999322|58964630|FG001|Overall Study|Adverse Event|0|||
30928810|NCT01996982|58964636|FG000|Overall Study|PI/team left institution|7|||
30928811|NCT01965158|58964642|FG000|Overall Study|Adverse Event|14|||
30928812|NCT01965158|58964643|FG001|Overall Study|Adverse Event|5|||
30928813|NCT01965158|58964642|FG000|Overall Study|Withdrawal by Subject|16|||
30928814|NCT01965158|58964643|FG001|Overall Study|Withdrawal by Subject|24|||
30928815|NCT01965158|58964642|FG000|Overall Study|Lost to Follow-up|7|||
30928816|NCT01965158|58964643|FG001|Overall Study|Lost to Follow-up|5|||
30928817|NCT01965158|58964642|FG000|Overall Study|Protocol Violation|1|||
30928818|NCT01965158|58964643|FG001|Overall Study|Protocol Violation|1|||
30928819|NCT01965158|58964642|FG000|Overall Study|Other - Miscellaneous|3|||
30928820|NCT01965158|58964643|FG001|Overall Study|Other - Miscellaneous|0|||
30624081|NCT00910624|58636077|FG003|Treatment Phase|Treatment Failure|0|||
30624082|NCT00910624|58636074|FG000|Treatment Phase|Lost to Follow-up|0|||
30624083|NCT00910624|58636075|FG001|Treatment Phase|Lost to Follow-up|0|||
30624084|NCT00910624|58636076|FG002|Treatment Phase|Lost to Follow-up|1|||
30624085|NCT00910624|58636077|FG003|Treatment Phase|Lost to Follow-up|0|||
30624086|NCT00910624|58636074|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
30624087|NCT00910624|58636075|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
30624088|NCT00910624|58636076|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
30624089|NCT00910624|58636077|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
30624090|NCT00910624|58636074|FG000|Treatment Phase|Withdrawal by Subject|2|||
30624091|NCT00910624|58636075|FG001|Treatment Phase|Withdrawal by Subject|1|||
30624092|NCT00910624|58636076|FG002|Treatment Phase|Withdrawal by Subject|0|||
30624093|NCT00910624|58636077|FG003|Treatment Phase|Withdrawal by Subject|0|||
30624094|NCT00910624|58636074|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
30624095|NCT00910624|58636075|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
30624096|NCT00910624|58636076|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
30624097|NCT00910624|58636077|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
30624098|NCT00910624|58636074|FG000|Follow-Up Phase|Adverse Event|0|||
30624099|NCT00910624|58636075|FG001|Follow-Up Phase|Adverse Event|0|||
30624100|NCT00910624|58636076|FG002|Follow-Up Phase|Adverse Event|1|||
30624101|NCT00910624|58636077|FG003|Follow-Up Phase|Adverse Event|0|||
30624102|NCT00910624|58636074|FG000|Follow-Up Phase|Lost to Follow-up|3|||
30624103|NCT00910624|58636075|FG001|Follow-Up Phase|Lost to Follow-up|1|||
30624104|NCT00910624|58636076|FG002|Follow-Up Phase|Lost to Follow-up|2|||
30624105|NCT00910624|58636077|FG003|Follow-Up Phase|Lost to Follow-up|0|||
30624106|NCT00910624|58636074|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
30624107|NCT00910624|58636075|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
30624108|NCT00910624|58636076|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
30624109|NCT00910624|58636077|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
30624110|NCT00910624|58636074|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
30624111|NCT00910624|58636075|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
30624112|NCT00910624|58636076|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
30624113|NCT00910624|58636077|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
30624114|NCT00910624|58636074|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
30624115|NCT00910624|58636075|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
30624116|NCT00910624|58636076|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
30624117|NCT00910624|58636077|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
30624118|NCT00910624|58636074|FG000|Follow-Up Phase|Administrative|0|||
30624119|NCT00910624|58636075|FG001|Follow-Up Phase|Administrative|1|||
30624120|NCT00910624|58636076|FG002|Follow-Up Phase|Administrative|1|||
30624121|NCT00910624|58636077|FG003|Follow-Up Phase|Administrative|0|||
30624122|NCT01123980|58636091|FG000|Overall Study|Adverse Event|1|||
30624123|NCT01123980|58636092|FG001|Overall Study|Adverse Event|1|||
30624124|NCT01123980|58636091|FG000|Overall Study|Lack of Efficacy|1|||
30624125|NCT01123980|58636092|FG001|Overall Study|Lack of Efficacy|0|||
30624126|NCT01123980|58636091|FG000|Overall Study|Physician Decision|0|||
30624127|NCT01123980|58636092|FG001|Overall Study|Physician Decision|1|||
30624128|NCT01123980|58636091|FG000|Overall Study|Lost to Follow-up|0|||
30624129|NCT01123980|58636092|FG001|Overall Study|Lost to Follow-up|6|||
30624130|NCT01123980|58636091|FG000|Overall Study|Protocol Violation|6|||
30624131|NCT01123980|58636092|FG001|Overall Study|Protocol Violation|6|||
30624132|NCT01123980|58636091|FG000|Overall Study|Withdrawal by Subject|5|||
30624133|NCT01123980|58636092|FG001|Overall Study|Withdrawal by Subject|3|||
30624134|NCT01123980|58636091|FG000|Overall Study|Unclassified|6|||
30624135|NCT01123980|58636092|FG001|Overall Study|Unclassified|7|||
30624136|NCT01118520|58636101|FG000|Overall Study|AAA repair|9|||
30928821|NCT01964924|58964649|FG000|Trametinib Monotherapy|Progression|19|||
30837660|NCT00706628|58862575|FG000|Overall Study|Other than those stated above|4|||
30837661|NCT00706628|58862576|FG001|Overall Study|Other than those stated above|0|||
30928822|NCT01964924|58964650|FG001|Trametinib Monotherapy|Progression|0|||
30928823|NCT01964378|58964661|FG000|Overall Study|Disc. due to death before first dosing|0|||
30928824|NCT01964378|58964662|FG001|Overall Study|Disc. due to death before first dosing|1|||
30928825|NCT01964378|58964661|FG000|Overall Study|Disc. due to AE before first dosing|1|||
30624137|NCT01118520|58636102|FG001|Overall Study|AAA repair|7|||
30624138|NCT01118520|58636103|FG002|Overall Study|AAA repair|9|||
30757653|NCT00112437|58766945|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757654|NCT00112437|58766946|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
30757655|NCT00112437|58766921|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757656|NCT00112437|58766922|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757657|NCT00112437|58766923|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757658|NCT00112437|58766924|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757659|NCT00112437|58766925|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
30757660|NCT00112437|58766926|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757661|NCT00112437|58766927|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757662|NCT00112437|58766928|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757663|NCT00112437|58766929|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757664|NCT00112437|58766930|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757665|NCT00112437|58766931|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30837662|NCT00706628|58862577|FG002|Overall Study|Other than those stated above|0|||
30837663|NCT00706628|58862578|FG003|Overall Study|Other than those stated above|0|||
30837664|NCT00706628|58862575|FG000|Overall Study|Not treated|1|||
30837665|NCT00706628|58862576|FG001|Overall Study|Not treated|1|||
30837666|NCT00706628|58862577|FG002|Overall Study|Not treated|0|||
30837667|NCT00706628|58862578|FG003|Overall Study|Not treated|0|||
30837668|NCT02561806|58862593|FG000|Induction Period|Adverse Event|0|||
30837669|NCT02561806|58862594|FG001|Induction Period|Adverse Event|2|||
30837670|NCT02561806|58862593|FG000|Induction Period|Lack of Efficacy|1|||
30837671|NCT02561806|58862594|FG001|Induction Period|Lack of Efficacy|0|||
30837672|NCT02561806|58862593|FG000|Induction Period|Withdrawal by Subject|0|||
30837673|NCT02561806|58862594|FG001|Induction Period|Withdrawal by Subject|2|||
30837674|NCT02561806|58862593|FG000|Induction Period|Site staff became unblinded|1|||
30624139|NCT01118520|58636101|FG000|Overall Study|Adverse Event|3|||
30837675|NCT02561806|58862594|FG001|Induction Period|Site staff became unblinded|0|||
30624140|NCT01118520|58636102|FG001|Overall Study|Adverse Event|3|||
30624141|NCT01118520|58636103|FG002|Overall Study|Adverse Event|3|||
30624142|NCT01118520|58636101|FG000|Overall Study|Withdrawal by Subject|8|||
30928826|NCT01964378|58964662|FG001|Overall Study|Disc. due to AE before first dosing|0|||
30757666|NCT00112437|58766932|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757667|NCT00112437|58766933|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757668|NCT00112437|58766934|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757669|NCT00112437|58766935|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757670|NCT00112437|58766936|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757671|NCT00112437|58766937|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757672|NCT00112437|58766938|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757673|NCT00112437|58766939|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757674|NCT00112437|58766940|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757675|NCT00112437|58766941|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757676|NCT00112437|58766942|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757677|NCT00112437|58766943|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757678|NCT00112437|58766944|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757679|NCT00112437|58766945|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757680|NCT00112437|58766946|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
30757681|NCT00112437|58766921|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
30757682|NCT00112437|58766922|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
30757683|NCT00112437|58766923|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
30757684|NCT00112437|58766924|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
30757685|NCT00112437|58766925|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
30757686|NCT00112437|58766926|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
30757687|NCT00112437|58766927|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
30757688|NCT00112437|58766928|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
30757689|NCT00112437|58766929|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
30757690|NCT00112437|58766930|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
30757691|NCT00112437|58766931|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
30757692|NCT00112437|58766932|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
30757693|NCT00112437|58766933|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
30757694|NCT00112437|58766934|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
30757695|NCT00112437|58766935|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
30757696|NCT00112437|58766936|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
30757697|NCT00112437|58766937|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
30757698|NCT00112437|58766938|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
30757699|NCT00112437|58766939|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
30757700|NCT00112437|58766940|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
30757701|NCT00112437|58766941|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
30757702|NCT00112437|58766942|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
30757703|NCT00112437|58766943|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
30757704|NCT00112437|58766944|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
30757705|NCT00112437|58766945|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
30757706|NCT00112437|58766946|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
30757707|NCT00112437|58766921|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757708|NCT00112437|58766922|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757709|NCT00112437|58766923|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757710|NCT00112437|58766924|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757711|NCT00112437|58766925|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757712|NCT00112437|58766926|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
30757713|NCT00112437|58766927|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
30757714|NCT00112437|58766928|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757715|NCT00112437|58766929|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757716|NCT00112437|58766930|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
30757717|NCT00112437|58766931|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757718|NCT00112437|58766932|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757719|NCT00112437|58766933|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757720|NCT00112437|58766934|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757721|NCT00112437|58766935|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757722|NCT00112437|58766936|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757723|NCT00112437|58766937|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757724|NCT00112437|58766938|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757725|NCT00112437|58766939|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757726|NCT00112437|58766940|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757727|NCT00112437|58766941|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30837676|NCT02561806|58862593|FG000|Induction Period|Randomized but not treated|0|||
30837677|NCT02561806|58862594|FG001|Induction Period|Randomized but not treated|1|||
30837678|NCT02561806|58862593|FG000|Maintenance Period|Adverse Event|2|||
30837679|NCT02561806|58862594|FG001|Maintenance Period|Adverse Event|1|||
30837680|NCT02561806|58862593|FG000|Maintenance Period|Lack of Efficacy|3|||
30837681|NCT02561806|58862594|FG001|Maintenance Period|Lack of Efficacy|1|||
30928827|NCT01964378|58964661|FG000|Overall Study|Death|3|||
30837682|NCT02561806|58862593|FG000|Maintenance Period|Lost to Follow-up|2|||
30837683|NCT02561806|58862594|FG001|Maintenance Period|Lost to Follow-up|2|||
30837684|NCT02561806|58862593|FG000|Maintenance Period|Protocol Violation|1|||
30837685|NCT02561806|58862594|FG001|Maintenance Period|Protocol Violation|0|||
30837686|NCT02561806|58862593|FG000|Maintenance Period|Withdrawal by Subject|5|||
30837687|NCT02561806|58862594|FG001|Maintenance Period|Withdrawal by Subject|3|||
30837688|NCT02561806|58862593|FG000|Maintenance Period|Site staff became unblinded|0|||
30837689|NCT02561806|58862594|FG001|Maintenance Period|Site staff became unblinded|1|||
30837690|NCT02561806|58862593|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
30837691|NCT02561806|58862594|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
30837692|NCT02561806|58862593|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
30837693|NCT02561806|58862594|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
30837694|NCT02561572|58862617|FG000|Overall Study|Inadequate time before surgery|2|||
30837695|NCT02561572|58862618|FG001|Overall Study|Inadequate time before surgery|1|||
30837696|NCT02561572|58862617|FG000|Overall Study|Protocol Violation|0|||
30837697|NCT02561572|58862618|FG001|Overall Study|Protocol Violation|1|||
30837698|NCT02180217|58862627|FG000|Overall Study|Adverse Event|3|||
30837699|NCT02180217|58862628|FG001|Overall Study|Adverse Event|2|||
30837700|NCT02180217|58862629|FG002|Overall Study|Adverse Event|22|||
30837701|NCT02180217|58862627|FG000|Overall Study|Death|1|||
30837702|NCT02180217|58862628|FG001|Overall Study|Death|1|||
30837703|NCT02180217|58862629|FG002|Overall Study|Death|0|||
30837704|NCT02180217|58862627|FG000|Overall Study|Withdrawal by Subject|1|||
30837705|NCT02180217|58862628|FG001|Overall Study|Withdrawal by Subject|1|||
30837706|NCT02180217|58862629|FG002|Overall Study|Withdrawal by Subject|4|||
30837707|NCT02180217|58862627|FG000|Overall Study|Subject/Guardian decision|5|||
30837708|NCT02180217|58862628|FG001|Overall Study|Subject/Guardian decision|3|||
30837709|NCT02180217|58862629|FG002|Overall Study|Subject/Guardian decision|6|||
30837710|NCT02180217|58862627|FG000|Overall Study|Physician Decision|1|||
30837711|NCT02180217|58862628|FG001|Overall Study|Physician Decision|1|||
30837712|NCT02180217|58862629|FG002|Overall Study|Physician Decision|6|||
30837713|NCT02180217|58862627|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30837714|NCT02180217|58862628|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30837715|NCT02180217|58862629|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
30837716|NCT02560558|58862646|FG000|Overall Study|Adverse Event|1|||
30837717|NCT02560558|58862647|FG001|Overall Study|Adverse Event|0|||
30837718|NCT02560558|58862646|FG000|Overall Study|Death|0|||
30837719|NCT02560558|58862647|FG001|Overall Study|Death|2|||
30837720|NCT02560558|58862646|FG000|Overall Study|Lost to Follow-up|0|||
30837721|NCT02560558|58862647|FG001|Overall Study|Lost to Follow-up|4|||
30837722|NCT02560558|58862646|FG000|Overall Study|Protocol Violation|3|||
30837723|NCT02560558|58862647|FG001|Overall Study|Protocol Violation|0|||
30837724|NCT02560558|58862646|FG000|Overall Study|Withdrawal by Subject|3|||
30837725|NCT02560558|58862647|FG001|Overall Study|Withdrawal by Subject|0|||
30837726|NCT02568046|58862655|FG000|Overall Study|Adverse Event|0|||
30837727|NCT02568046|58862656|FG001|Overall Study|Adverse Event|1|||
30837728|NCT02568046|58862655|FG000|Overall Study|Death|2|||
30837729|NCT02568046|58862656|FG001|Overall Study|Death|0|||
30624143|NCT01118520|58636102|FG001|Overall Study|Withdrawal by Subject|13|||
30624144|NCT01118520|58636103|FG002|Overall Study|Withdrawal by Subject|8|||
30624145|NCT01135992|58636111|FG000|Overall Study|Adverse Event|1|||
30624146|NCT01135992|58636111|FG000|Overall Study|Lack of Efficacy|1|||
30624147|NCT01135992|58636111|FG000|Overall Study|Protocol Violation|2|||
30624148|NCT01135992|58636111|FG000|Overall Study|Withdrawal criteria|10|||
30624149|NCT01135992|58636111|FG000|Overall Study|Unclassified|7|||
30624150|NCT00959049|58636121|FG000|Overall Study|Adverse Event|1|||
30624151|NCT00959049|58636122|FG001|Overall Study|Adverse Event|0|||
30624152|NCT00959049|58636123|FG002|Overall Study|Adverse Event|0|||
30757728|NCT00112437|58766942|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757729|NCT00112437|58766943|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757730|NCT00112437|58766944|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757731|NCT00112437|58766945|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757732|NCT00112437|58766946|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
30757733|NCT00112437|58766921|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757734|NCT00112437|58766922|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757735|NCT00112437|58766923|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757736|NCT00112437|58766924|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757737|NCT00112437|58766925|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30624153|NCT00959049|58636124|FG003|Overall Study|Adverse Event|0|||
30757738|NCT00112437|58766926|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30837730|NCT02568046|58862655|FG000|Overall Study|Progressive Disease|1|||
30837731|NCT02568046|58862656|FG001|Overall Study|Progressive Disease|0|||
30837732|NCT02568046|58862655|FG000|Overall Study|Withdrawal by Subject|2|||
30837733|NCT02568046|58862656|FG001|Overall Study|Withdrawal by Subject|1|||
30837734|NCT02568046|58862655|FG000|Overall Study|Other Events|0|||
30837735|NCT02568046|58862656|FG001|Overall Study|Other Events|1|||
30928828|NCT01964378|58964662|FG001|Overall Study|Death|2|||
30928829|NCT01964378|58964661|FG000|Overall Study|Adverse Event|12|||
30928830|NCT01964378|58964662|FG001|Overall Study|Adverse Event|5|||
30928831|NCT01964378|58964661|FG000|Overall Study|Lack of Efficacy|0|||
30928832|NCT01964378|58964662|FG001|Overall Study|Lack of Efficacy|1|||
30928833|NCT01964378|58964661|FG000|Overall Study|Protocol Violation|0|||
30928834|NCT01964378|58964662|FG001|Overall Study|Protocol Violation|1|||
30928835|NCT01964378|58964661|FG000|Overall Study|Lost to Follow-up|0|||
30928836|NCT01964378|58964662|FG001|Overall Study|Lost to Follow-up|1|||
30928837|NCT01964378|58964661|FG000|Overall Study|Withdrawal by Subject|7|||
30928838|NCT01964378|58964662|FG001|Overall Study|Withdrawal by Subject|5|||
30928839|NCT01964378|58964661|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
30928840|NCT01964378|58964662|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
30928841|NCT01964378|58964661|FG000|Overall Study|Other|1|||
30928842|NCT01964378|58964662|FG001|Overall Study|Other|2|||
30928843|NCT01442038|58964670|FG000|Overall Study|Death|35|||
30928844|NCT01442038|58964671|FG001|Overall Study|Death|29|||
30928845|NCT01442038|58964670|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
30928846|NCT01442038|58964671|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
30928847|NCT01442038|58964670|FG000|Overall Study|Participant Withdrew Consent|137|||
30928848|NCT01442038|58964671|FG001|Overall Study|Participant Withdrew Consent|102|||
30928849|NCT01442038|58964670|FG000|Overall Study|Lost to Follow-up|37|||
30928850|NCT01442038|58964671|FG001|Overall Study|Lost to Follow-up|51|||
30928851|NCT01442038|58964670|FG000|Overall Study|Adverse Event|26|||
30928852|NCT01442038|58964671|FG001|Overall Study|Adverse Event|15|||
30928853|NCT01442038|58964670|FG000|Overall Study|Protocol Deviation|9|||
30928854|NCT01442038|58964671|FG001|Overall Study|Protocol Deviation|20|||
30928855|NCT01442038|58964670|FG000|Overall Study|Investigator's Discretion|13|||
30928856|NCT01442038|58964671|FG001|Overall Study|Investigator's Discretion|16|||
30928857|NCT01442038|58964670|FG000|Overall Study|Study Terminated By Sponsor|2|||
30928858|NCT01442038|58964671|FG001|Overall Study|Study Terminated By Sponsor|3|||
30928859|NCT01998919|58964679|FG000|Overall Study|Death|2|||
30928860|NCT01998919|58964680|FG001|Overall Study|Death|2|||
30928861|NCT01998919|58964679|FG000|Overall Study|Adverse Event|0|||
30928862|NCT01998919|58964680|FG001|Overall Study|Adverse Event|5|||
30928863|NCT01998919|58964679|FG000|Overall Study|Disease progression|31|||
30928864|NCT01998919|58964680|FG001|Overall Study|Disease progression|22|||
30928865|NCT01998919|58964679|FG000|Overall Study|Withdrawal by Subject|2|||
30928866|NCT01998919|58964680|FG001|Overall Study|Withdrawal by Subject|4|||
30928867|NCT01998919|58964679|FG000|Overall Study|Lost to Follow-up|2|||
30928868|NCT01998919|58964680|FG001|Overall Study|Lost to Follow-up|0|||
30928869|NCT01998919|58964679|FG000|Overall Study|Other|5|||
30928870|NCT01998919|58964680|FG001|Overall Study|Other|2|||
30928871|NCT01957111|58964688|FG000|Overall Study|Withdrawal by Subject|1|||
30928872|NCT01957111|58964689|FG001|Overall Study|Withdrawal by Subject|1|||
30928873|NCT01964300|58964697|FG000|Overall Study|Ineligible after enrollment|0|||
30928874|NCT01964300|58964698|FG001|Overall Study|Ineligible after enrollment|1|||
30928875|NCT01964300|58964697|FG000|Overall Study|Adverse Event|1|||
30928876|NCT01964300|58964698|FG001|Overall Study|Adverse Event|1|||
30928877|NCT01964300|58964697|FG000|Overall Study|Lack of Efficacy|3|||
30928878|NCT01964300|58964698|FG001|Overall Study|Lack of Efficacy|5|||
30928879|NCT01964300|58964697|FG000|Overall Study|Withdrawal by Subject|0|||
30928880|NCT01964300|58964698|FG001|Overall Study|Withdrawal by Subject|1|||
30928881|NCT01964300|58964697|FG000|Overall Study|To receive alternative therapy|1|||
30928882|NCT01964300|58964698|FG001|Overall Study|To receive alternative therapy|2|||
30928883|NCT01964300|58964697|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
30928884|NCT01964300|58964698|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
30928885|NCT01964300|58964697|FG000|Overall Study|Weight criteria not met|0|||
30837736|NCT02567656|58862668|FG000|Overall Study|Premature discontinuation due to PD|1|||
30837737|NCT02567656|58862669|FG001|Overall Study|Premature discontinuation due to PD|1|||
30837738|NCT02567656|58862670|FG002|Overall Study|Premature discontinuation due to PD|2|||
30837739|NCT02567656|58862671|FG003|Overall Study|Premature discontinuation due to PD|0|||
30837740|NCT02567656|58862672|FG004|Overall Study|Premature discontinuation due to PD|0|||
30837741|NCT02567656|58862673|FG005|Overall Study|Premature discontinuation due to PD|0|||
30837742|NCT02560012|58862687|FG000|Overall Study|Study Terminated|2|||
30837743|NCT02567266|58862694|FG000|Overall Study|Withdrawal by Subject|10|||
30837744|NCT02567266|58862695|FG001|Overall Study|Withdrawal by Subject|7|||
30837745|NCT02567266|58862696|FG002|Overall Study|Withdrawal by Subject|6|||
30837746|NCT02567266|58862694|FG000|Overall Study|Lost to Follow-up|13|||
30837747|NCT02567266|58862695|FG001|Overall Study|Lost to Follow-up|8|||
30837748|NCT02567266|58862696|FG002|Overall Study|Lost to Follow-up|10|||
30837749|NCT02567188|58862704|FG000|Overall Study|Death|10|||
30928886|NCT01964300|58964698|FG001|Overall Study|Weight criteria not met|1|||
30928887|NCT01964222|58964706|FG000|Overall Study|Lost to Follow-up|7|||
30928888|NCT01964222|58964707|FG001|Overall Study|Lost to Follow-up|5|||
30928889|NCT01964222|58964706|FG000|Overall Study|Withdrawal by Subject|6|||
30928890|NCT01964222|58964707|FG001|Overall Study|Withdrawal by Subject|6|||
30928891|NCT01964222|58964706|FG000|Overall Study|Screening Failure|2|||
30928892|NCT01964222|58964707|FG001|Overall Study|Screening Failure|0|||
30928893|NCT01467700|58964717|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
30928894|NCT01467700|58964718|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
30928895|NCT01467700|58964719|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
30928896|NCT01467700|58964720|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
30928897|NCT01467700|58964717|FG000|Overall Study|Major Protocol Deviation|3|||
30928898|NCT01467700|58964718|FG001|Overall Study|Major Protocol Deviation|3|||
30928899|NCT01467700|58964719|FG002|Overall Study|Major Protocol Deviation|2|||
30928900|NCT01467700|58964720|FG003|Overall Study|Major Protocol Deviation|3|||
30928901|NCT01467700|58964717|FG000|Overall Study|Lost to Follow-up|6|||
30928902|NCT01467700|58964718|FG001|Overall Study|Lost to Follow-up|5|||
30928903|NCT01467700|58964719|FG002|Overall Study|Lost to Follow-up|2|||
30928904|NCT01467700|58964720|FG003|Overall Study|Lost to Follow-up|3|||
30928905|NCT01467700|58964717|FG000|Overall Study|Voluntary Withdrawal|5|||
30928906|NCT01467700|58964718|FG001|Overall Study|Voluntary Withdrawal|7|||
30928907|NCT01467700|58964719|FG002|Overall Study|Voluntary Withdrawal|6|||
30928908|NCT01467700|58964720|FG003|Overall Study|Voluntary Withdrawal|2|||
30928909|NCT01467700|58964717|FG000|Overall Study|Study Termination|6|||
30928910|NCT01467700|58964718|FG001|Overall Study|Study Termination|5|||
30928911|NCT01467700|58964719|FG002|Overall Study|Study Termination|10|||
30928912|NCT01467700|58964720|FG003|Overall Study|Study Termination|7|||
30928913|NCT01467700|58964717|FG000|Overall Study|Pregnancy|0|||
30928914|NCT01467700|58964718|FG001|Overall Study|Pregnancy|1|||
30928915|NCT01467700|58964719|FG002|Overall Study|Pregnancy|1|||
30928916|NCT01467700|58964720|FG003|Overall Study|Pregnancy|0|||
30928917|NCT01467700|58964717|FG000|Overall Study|Lack of Efficacy|2|||
30928918|NCT01467700|58964718|FG001|Overall Study|Lack of Efficacy|0|||
30928919|NCT01467700|58964719|FG002|Overall Study|Lack of Efficacy|2|||
30928920|NCT01467700|58964720|FG003|Overall Study|Lack of Efficacy|1|||
30928921|NCT01467700|58964717|FG000|Overall Study|Reason not Specified|1|||
30928922|NCT01467700|58964718|FG001|Overall Study|Reason not Specified|3|||
30928923|NCT01467700|58964719|FG002|Overall Study|Reason not Specified|2|||
30928924|NCT01467700|58964720|FG003|Overall Study|Reason not Specified|8|||
30928925|NCT01972724|58964733|FG000|Double-Blind|Rescue Criteria Met|1|||
30928926|NCT01972724|58964734|FG001|Double-Blind|Rescue Criteria Met|0|||
30837750|NCT02567188|58862704|FG000|Overall Study|Terminated Mircera Treatment|9|||
30837751|NCT02567188|58862704|FG000|Overall Study|Lost to Follow-up|5|||
30837752|NCT02567188|58862704|FG000|Overall Study|Adverse Event|1|||
30837753|NCT02567188|58862704|FG000|Overall Study|Withdrawal by Subject|1|||
30837754|NCT02567188|58862704|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
30837755|NCT02567188|58862704|FG000|Overall Study|Moved and Changed Clinic|1|||
30928927|NCT01972724|58964735|FG002|Double-Blind|Rescue Criteria Met|0|||
30928928|NCT01972724|58964733|FG000|Double-Blind|Adverse Event|1|||
30928929|NCT01972724|58964734|FG001|Double-Blind|Adverse Event|0|||
30928930|NCT01972724|58964735|FG002|Double-Blind|Adverse Event|0|||
30928931|NCT01972724|58964733|FG000|Double-Blind|Withdrawal of Consent|2|||
30928932|NCT01972724|58964734|FG001|Double-Blind|Withdrawal of Consent|1|||
30928933|NCT01972724|58964735|FG002|Double-Blind|Withdrawal of Consent|0|||
30928934|NCT01972724|58964733|FG000|Double-Blind|Significant Protocol Deviation|5|||
30928935|NCT01972724|58964734|FG001|Double-Blind|Significant Protocol Deviation|8|||
30928936|NCT01972724|58964735|FG002|Double-Blind|Significant Protocol Deviation|0|||
30928937|NCT01972724|58964733|FG000|Open-Label|Withdrew Consent|0|||
30837756|NCT02567188|58862704|FG000|Overall Study|Started Hemodialysis|2|||
30837757|NCT02567188|58862704|FG000|Overall Study|Protocol Violation|5|||
30837758|NCT00706238|58862709|FG000|Overall Study|Disease progression|4|||
30837759|NCT00706238|58862709|FG000|Overall Study|Other|1|||
30837760|NCT03321968|58862716|FG000|Overall Study|Withdrawal by Subject|1|||
30837761|NCT03321968|58862717|FG001|Overall Study|Withdrawal by Subject|2|||
30928938|NCT01972724|58964734|FG001|Open-Label|Withdrew Consent|0|||
30928939|NCT01972724|58964735|FG002|Open-Label|Withdrew Consent|3|||
30928940|NCT01972724|58964733|FG000|Open-Label|Significant Protocol Deviation|0|||
30928941|NCT01972724|58964734|FG001|Open-Label|Significant Protocol Deviation|0|||
30928942|NCT01972724|58964735|FG002|Open-Label|Significant Protocol Deviation|2|||
30928943|NCT01441960|58964743|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
30928944|NCT01441960|58964744|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
30928945|NCT01441960|58964743|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
30928946|NCT01441960|58964744|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
30928947|NCT01441960|58964743|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
30928948|NCT01441960|58964744|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
30928949|NCT01955707|58964756|FG000|Overall Study|Adverse Event|1|||
30624154|NCT00959049|58636125|FG004|Overall Study|Adverse Event|0|||
30624155|NCT00959049|58636126|FG005|Overall Study|Adverse Event|0|||
30837762|NCT03321968|58862718|FG002|Overall Study|Withdrawal by Subject|1|||
30837763|NCT03321968|58862716|FG000|Overall Study|Lost to Follow-up|2|||
30928950|NCT01955707|58964757|FG001|Overall Study|Adverse Event|2|||
30928951|NCT01955707|58964756|FG000|Overall Study|Lost to Follow-up|2|||
30928952|NCT01955707|58964757|FG001|Overall Study|Lost to Follow-up|1|||
30928953|NCT01955707|58964756|FG000|Overall Study|Withdrawal by Subject|0|||
30928954|NCT01955707|58964757|FG001|Overall Study|Withdrawal by Subject|3|||
30928955|NCT01955707|58964756|FG000|Overall Study|Death|13|||
30928956|NCT01955707|58964757|FG001|Overall Study|Death|14|||
30928957|NCT01955707|58964756|FG000|Overall Study|Other|4|||
30928958|NCT01955707|58964757|FG001|Overall Study|Other|2|||
30928959|NCT01435798|58964763|FG000|Overall Study|Withdrawal by Subject|1|||
30928960|NCT01972568|58964776|FG000|Overall Study|Other events|3|||
30928961|NCT01972568|58964777|FG001|Overall Study|Other events|0|||
30928962|NCT01972568|58964778|FG002|Overall Study|Other events|0|||
30928963|NCT01972568|58964776|FG000|Overall Study|Lack of Efficacy|0|||
30928964|NCT01972568|58964777|FG001|Overall Study|Lack of Efficacy|1|||
30928965|NCT01972568|58964778|FG002|Overall Study|Lack of Efficacy|2|||
30928966|NCT01972568|58964776|FG000|Overall Study|Protocol Violation|1|||
30928967|NCT01972568|58964777|FG001|Overall Study|Protocol Violation|2|||
30928968|NCT01972568|58964778|FG002|Overall Study|Protocol Violation|2|||
30624156|NCT00959049|58636121|FG000|Overall Study|Lost to Follow-up|17|||
30624157|NCT00959049|58636122|FG001|Overall Study|Lost to Follow-up|5|||
30624158|NCT00959049|58636123|FG002|Overall Study|Lost to Follow-up|1|||
30624159|NCT00959049|58636124|FG003|Overall Study|Lost to Follow-up|10|||
30624160|NCT00959049|58636125|FG004|Overall Study|Lost to Follow-up|9|||
30624161|NCT00959049|58636126|FG005|Overall Study|Lost to Follow-up|1|||
30624162|NCT00959049|58636121|FG000|Overall Study|Contraindicated medication|0|||
30757739|NCT00112437|58766927|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757740|NCT00112437|58766928|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757741|NCT00112437|58766929|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
30757742|NCT00112437|58766930|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757743|NCT00112437|58766931|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30837764|NCT03321968|58862717|FG001|Overall Study|Lost to Follow-up|0|||
30837765|NCT03321968|58862718|FG002|Overall Study|Lost to Follow-up|1|||
30837766|NCT03321968|58862716|FG000|Overall Study|Other than specified|0|||
30837767|NCT03321968|58862717|FG001|Overall Study|Other than specified|0|||
30837768|NCT03321968|58862718|FG002|Overall Study|Other than specified|1|||
30837769|NCT04649164|58862729|FG000|Overall Study|Withdrawal by Subject|1|||
30837770|NCT04649164|58862730|FG001|Overall Study|Withdrawal by Subject|1|||
30837771|NCT04649164|58862731|FG002|Overall Study|Withdrawal by Subject|2|||
30837772|NCT04649164|58862729|FG000|Overall Study|Participant's care recipient expired|0|||
30837773|NCT04649164|58862730|FG001|Overall Study|Participant's care recipient expired|0|||
30837774|NCT04649164|58862731|FG002|Overall Study|Participant's care recipient expired|2|||
30837775|NCT02753127|58862741|FG000|Overall Study|Lost to Follow-up|13|||
30837776|NCT02753127|58862742|FG001|Overall Study|Lost to Follow-up|11|||
30837777|NCT02753127|58862741|FG000|Overall Study|Withdrawal by Subject|37|||
30837778|NCT02753127|58862742|FG001|Overall Study|Withdrawal by Subject|47|||
30837779|NCT02753127|58862741|FG000|Overall Study|Other|3|||
30837780|NCT02753127|58862742|FG001|Overall Study|Other|8|||
30837781|NCT02753127|58862741|FG000|Overall Study|Hospice|0|||
30837782|NCT02753127|58862742|FG001|Overall Study|Hospice|2|||
30837783|NCT00706004|58862789|FG000|Overall Study|Did not meet eligibility criteria|2|||
30837784|NCT02724644|58862796|FG000|Overall Study|Adverse Event|7|||
30837785|NCT02724644|58862797|FG001|Overall Study|Adverse Event|1|||
30837786|NCT02724644|58862796|FG000|Overall Study|Lost to Follow-up|6|||
30837787|NCT02724644|58862797|FG001|Overall Study|Lost to Follow-up|2|||
30837788|NCT02724644|58862796|FG000|Overall Study|Withdrawal by Subject|7|||
30757744|NCT00112437|58766932|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757745|NCT00112437|58766933|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757746|NCT00112437|58766934|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757747|NCT00112437|58766935|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757748|NCT00112437|58766936|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30837789|NCT02724644|58862797|FG001|Overall Study|Withdrawal by Subject|1|||
30837790|NCT02724644|58862796|FG000|Overall Study|Administrative|1|||
30928969|NCT01972568|58964776|FG000|Overall Study|Withdrawal by Subject|6|||
30928970|NCT01972568|58964777|FG001|Overall Study|Withdrawal by Subject|3|||
30928971|NCT01972568|58964778|FG002|Overall Study|Withdrawal by Subject|7|||
30928972|NCT01972568|58964776|FG000|Overall Study|Lost to Follow-up|1|||
30928973|NCT01972568|58964777|FG001|Overall Study|Lost to Follow-up|0|||
30837791|NCT02724644|58862797|FG001|Overall Study|Administrative|0|||
30837792|NCT02725268|58862807|FG000|Overall Study|Death|58|||
30837793|NCT02725268|58862808|FG001|Overall Study|Death|59|||
30928974|NCT01972568|58964778|FG002|Overall Study|Lost to Follow-up|0|||
30928975|NCT01972568|58964776|FG000|Overall Study|Adverse Event|5|||
30928976|NCT01972568|58964777|FG001|Overall Study|Adverse Event|6|||
30928977|NCT01972568|58964778|FG002|Overall Study|Adverse Event|5|||
30928978|NCT01955161|58964789|FG000|Overall Study|Withdrawal before treatment|2|||
30928979|NCT01955161|58964790|FG001|Overall Study|Withdrawal before treatment|0|||
30928980|NCT01955161|58964791|FG002|Overall Study|Withdrawal before treatment|1|||
30928981|NCT01955161|58964789|FG000|Overall Study|Adverse Event|10|||
30928982|NCT01955161|58964790|FG001|Overall Study|Adverse Event|14|||
30928983|NCT01955161|58964791|FG002|Overall Study|Adverse Event|15|||
30928984|NCT01955161|58964789|FG000|Overall Study|Death|1|||
30928985|NCT01955161|58964790|FG001|Overall Study|Death|1|||
30928986|NCT01955161|58964791|FG002|Overall Study|Death|3|||
30928987|NCT01955161|58964789|FG000|Overall Study|Withdrawal by Subject|9|||
30928988|NCT01955161|58964790|FG001|Overall Study|Withdrawal by Subject|8|||
30928989|NCT01955161|58964791|FG002|Overall Study|Withdrawal by Subject|12|||
30928990|NCT01955161|58964789|FG000|Overall Study|Protocol Violation|2|||
30928991|NCT01955161|58964790|FG001|Overall Study|Protocol Violation|0|||
30928992|NCT01955161|58964791|FG002|Overall Study|Protocol Violation|0|||
30928993|NCT01955161|58964789|FG000|Overall Study|Other reason: physician decision|0|||
30928994|NCT01955161|58964790|FG001|Overall Study|Other reason: physician decision|1|||
30928995|NCT01955161|58964791|FG002|Overall Study|Other reason: physician decision|1|||
30928996|NCT01955161|58964789|FG000|Overall Study|Other reason: disallowed medication|1|||
30928997|NCT01955161|58964790|FG001|Overall Study|Other reason: disallowed medication|0|||
30928998|NCT01955161|58964791|FG002|Overall Study|Other reason: disallowed medication|1|||
30928999|NCT01955161|58964789|FG000|Overall Study|Other reason: caregiver unavailable|1|||
30929000|NCT01955161|58964790|FG001|Overall Study|Other reason: caregiver unavailable|0|||
30929001|NCT01955161|58964791|FG002|Overall Study|Other reason: caregiver unavailable|0|||
30929002|NCT01955161|58964789|FG000|Overall Study|Other reason: moved to nursing home|0|||
30929003|NCT01955161|58964790|FG001|Overall Study|Other reason: moved to nursing home|1|||
30929004|NCT01955161|58964791|FG002|Overall Study|Other reason: moved to nursing home|0|||
30929005|NCT01955161|58964789|FG000|Overall Study|Other reason: insufficient compliance|0|||
30929006|NCT01955161|58964790|FG001|Overall Study|Other reason: insufficient compliance|0|||
30929007|NCT01955161|58964791|FG002|Overall Study|Other reason: insufficient compliance|1|||
30929008|NCT01955161|58964789|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
30929009|NCT01955161|58964790|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
30929010|NCT01955161|58964791|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
30929011|NCT01955161|58964789|FG000|Overall Study|Other reason: patient's will|0|||
30929012|NCT01955161|58964790|FG001|Overall Study|Other reason: patient's will|0|||
30929013|NCT01955161|58964791|FG002|Overall Study|Other reason: patient's will|1|||
30929014|NCT01441414|58964799|FG000|Overall Study|Participant died|9|||
30929015|NCT01441414|58964799|FG000|Overall Study|Other reasons|3|||
30929016|NCT01441414|58964799|FG000|Overall Study|Study terminated by sponsor|2|||
30929017|NCT01441414|58964799|FG000|Overall Study|Subject refused further follow-up|1|||
30929018|NCT01971554|58964819|FG000|Overall Study|Lost to Follow-up|1|||
30929019|NCT01971554|58964820|FG001|Overall Study|Lost to Follow-up|0|||
30929020|NCT01971554|58964821|FG002|Overall Study|Lost to Follow-up|0|||
30929021|NCT01971554|58964822|FG003|Overall Study|Lost to Follow-up|0|||
30929022|NCT01955083|58964834|FG000|Overall Study|Lost to Follow-up|1|||
30929023|NCT01955083|58964835|FG001|Overall Study|Lost to Follow-up|1|||
30929024|NCT01955005|58964867|FG000|Overall Study|Withdrawal by Subject|3|||
30929025|NCT01955005|58964868|FG001|Overall Study|Withdrawal by Subject|5|||
30929026|NCT01954927|58964876|FG000|Overall Study|Withdrawal by Subject|3|||
30929027|NCT01954927|58964877|FG001|Overall Study|Withdrawal by Subject|1|||
30929028|NCT01954771|58964886|FG000|Overall Study|Missing HbA1c of end-point|1|||
30929029|NCT01954771|58964887|FG001|Overall Study|Missing HbA1c of end-point|1|||
30929030|NCT01954771|58964888|FG002|Overall Study|Missing HbA1c of end-point|0|||
30929031|NCT01954771|58964886|FG000|Overall Study|Missing CGMS of end-point|1|||
30929032|NCT01954771|58964887|FG001|Overall Study|Missing CGMS of end-point|1|||
30929033|NCT01954771|58964888|FG002|Overall Study|Missing CGMS of end-point|0|||
30929034|NCT01954771|58964886|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
30929035|NCT01954771|58964887|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
30929036|NCT01954771|58964888|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
30929037|NCT01997281|58964901|FG000|Overall Study|Withdrawal by Subject|1|||
30929038|NCT01997281|58964902|FG001|Overall Study|Withdrawal by Subject|0|||
30624163|NCT00959049|58636122|FG001|Overall Study|Contraindicated medication|0|||
30929039|NCT01996033|58964908|FG000|Overall Study|Death|1|||
30929040|NCT01996033|58964908|FG000|Overall Study|Physician Decision|1|||
30929041|NCT01996033|58964908|FG000|Overall Study|Withdrawal by Subject|4|||
30929042|NCT01996033|58964908|FG000|Overall Study|Lost to Follow-up|3|||
30929043|NCT01953913|58964912|FG000|Overall Study|Disease Progression|349|||
30929044|NCT01953913|58964912|FG000|Overall Study|Worsening of underlying cancer|22|||
30929045|NCT01953913|58964912|FG000|Overall Study|Adverse Event|20|||
30929046|NCT01953913|58964912|FG000|Overall Study|Protocol Violation|6|||
30929047|NCT01953913|58964912|FG000|Overall Study|Lost to Follow-up|4|||
30837794|NCT02725268|58862809|FG002|Overall Study|Death|30|||
30624164|NCT00959049|58636123|FG002|Overall Study|Contraindicated medication|0|||
30929048|NCT01953913|58964912|FG000|Overall Study|Withdrawal by Subject|32|||
30929049|NCT01953913|58964912|FG000|Overall Study|Other than listed|108|||
30929050|NCT01953913|58964912|FG000|Overall Study|Not Treated|1|||
30929051|NCT01971476|58964919|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
30929052|NCT01971476|58964920|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
30929053|NCT01971476|58964921|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
30929054|NCT01971476|58964919|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
30929055|NCT01971476|58964920|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
30837795|NCT02725268|58862810|FG003|Overall Study|Death|16|||
30837796|NCT02725268|58862807|FG000|Overall Study|Lost to Follow-up|4|||
30837797|NCT02725268|58862808|FG001|Overall Study|Lost to Follow-up|3|||
30837798|NCT02725268|58862809|FG002|Overall Study|Lost to Follow-up|0|||
30837799|NCT02725268|58862810|FG003|Overall Study|Lost to Follow-up|1|||
30837800|NCT02725268|58862807|FG000|Overall Study|Site Terminated by Sponsor|0|||
30837801|NCT02725268|58862808|FG001|Overall Study|Site Terminated by Sponsor|1|||
30837802|NCT02725268|58862809|FG002|Overall Study|Site Terminated by Sponsor|0|||
30837803|NCT02725268|58862810|FG003|Overall Study|Site Terminated by Sponsor|0|||
30837804|NCT02725268|58862807|FG000|Overall Study|Withdrawal by Subject|8|||
30837805|NCT02725268|58862808|FG001|Overall Study|Withdrawal by Subject|6|||
30837806|NCT02725268|58862809|FG002|Overall Study|Withdrawal by Subject|8|||
30837807|NCT02725268|58862810|FG003|Overall Study|Withdrawal by Subject|1|||
30837808|NCT02725268|58862807|FG000|Overall Study|Reason not Specified|2|||
30837809|NCT02725268|58862808|FG001|Overall Study|Reason not Specified|1|||
30837810|NCT02725268|58862809|FG002|Overall Study|Reason not Specified|0|||
30837811|NCT02725268|58862810|FG003|Overall Study|Reason not Specified|0|||
30837812|NCT02724956|58862822|FG000|Overall Study|Physician Decision|1|||
30837813|NCT02724956|58862823|FG001|Overall Study|Physician Decision|0|||
30837814|NCT02724956|58862822|FG000|Overall Study|Lack of Efficacy|0|||
30837815|NCT02724956|58862823|FG001|Overall Study|Lack of Efficacy|1|||
30837816|NCT02724956|58862822|FG000|Overall Study|Withdrawal by Subject|0|||
30837817|NCT02724956|58862823|FG001|Overall Study|Withdrawal by Subject|1|||
30837818|NCT00705536|58862831|FG000|Start Period 1|Withdrawal by Subject|0|||
30837819|NCT00705536|58862832|FG001|Start Period 1|Withdrawal by Subject|0|||
30837820|NCT00705536|58862833|FG002|Start Period 1|Withdrawal by Subject|0|||
30837821|NCT00705536|58862834|FG003|Start Period 1|Withdrawal by Subject|1|||
30837822|NCT02724020|58862856|FG000|Overall Study|Death|16|||
30837823|NCT02724020|58862857|FG001|Overall Study|Death|18|||
30837824|NCT02724020|58862858|FG002|Overall Study|Death|19|||
30837825|NCT02724020|58862856|FG000|Overall Study|Lost to Follow-up|0|||
30837826|NCT02724020|58862857|FG001|Overall Study|Lost to Follow-up|3|||
30837827|NCT02724020|58862858|FG002|Overall Study|Lost to Follow-up|0|||
30837828|NCT02724020|58862856|FG000|Overall Study|Site Terminated by Sponsor|15|||
30837829|NCT02724020|58862857|FG001|Overall Study|Site Terminated by Sponsor|8|||
30837830|NCT02724020|58862858|FG002|Overall Study|Site Terminated by Sponsor|8|||
30837831|NCT02724020|58862856|FG000|Overall Study|Withdrawal by Subject|1|||
30837832|NCT02724020|58862857|FG001|Overall Study|Withdrawal by Subject|3|||
30837833|NCT02724020|58862858|FG002|Overall Study|Withdrawal by Subject|5|||
30837834|NCT02660034|58862880|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
30837835|NCT02660034|58862881|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
30837836|NCT02660034|58862882|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
30837837|NCT02660034|58862883|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
30837838|NCT02660034|58862884|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
30837839|NCT02660034|58862885|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
30837840|NCT02660034|58862886|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
30837841|NCT02660034|58862887|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
30837842|NCT02660034|58862888|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
30837843|NCT02660034|58862889|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
30837844|NCT02660034|58862890|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
30837845|NCT02660034|58862891|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
30837846|NCT02660034|58862892|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
30837847|NCT02660034|58862893|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
30837848|NCT02660034|58862880|FG000|Overall Study|Progressive Disease (Clinical)|7|||
30837849|NCT02660034|58862881|FG001|Overall Study|Progressive Disease (Clinical)|8|||
30837850|NCT02660034|58862882|FG002|Overall Study|Progressive Disease (Clinical)|3|||
30837851|NCT02660034|58862883|FG003|Overall Study|Progressive Disease (Clinical)|9|||
30837852|NCT02660034|58862884|FG004|Overall Study|Progressive Disease (Clinical)|3|||
30837853|NCT02660034|58862885|FG005|Overall Study|Progressive Disease (Clinical)|0|||
30837854|NCT02660034|58862886|FG006|Overall Study|Progressive Disease (Clinical)|0|||
30837855|NCT02660034|58862887|FG007|Overall Study|Progressive Disease (Clinical)|0|||
30837856|NCT02660034|58862888|FG008|Overall Study|Progressive Disease (Clinical)|0|||
30929056|NCT01971476|58964921|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
30837857|NCT02660034|58862889|FG009|Overall Study|Progressive Disease (Clinical)|0|||
30929057|NCT01971476|58964919|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
30929058|NCT01971476|58964920|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
30929059|NCT01971476|58964921|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
30929060|NCT01996904|58964940|FG000|Overall Study|Lost to Follow-up|38|||
30929061|NCT01996904|58964941|FG001|Overall Study|Lost to Follow-up|27|||
30929062|NCT01970540|58964950|FG000|Overall Study|Non-treatment-related AE|0|||
30929063|NCT01970540|58964951|FG001|Overall Study|Non-treatment-related AE|0|||
30929064|NCT01970540|58964952|FG002|Overall Study|Non-treatment-related AE|1|||
30929065|NCT01970540|58964950|FG000|Overall Study|Progressive disease|55|||
30929066|NCT01970540|58964951|FG001|Overall Study|Progressive disease|23|||
30929067|NCT01970540|58964952|FG002|Overall Study|Progressive disease|10|||
30929068|NCT01970540|58964950|FG000|Overall Study|Treatment delay over protocol|0|||
30929069|NCT01970540|58964951|FG001|Overall Study|Treatment delay over protocol|0|||
30929070|NCT01970540|58964952|FG002|Overall Study|Treatment delay over protocol|1|||
30929071|NCT01970540|58964950|FG000|Overall Study|Physician Decision|7|||
30929072|NCT01970540|58964951|FG001|Overall Study|Physician Decision|2|||
30929073|NCT01970540|58964952|FG002|Overall Study|Physician Decision|0|||
30929074|NCT01970540|58964950|FG000|Overall Study|Clinical progression|0|||
30929075|NCT01970540|58964951|FG001|Overall Study|Clinical progression|1|||
30929076|NCT01970540|58964952|FG002|Overall Study|Clinical progression|1|||
30929077|NCT01970540|58964950|FG000|Overall Study|End of study|2|||
30929078|NCT01970540|58964951|FG001|Overall Study|End of study|0|||
30929079|NCT01970540|58964952|FG002|Overall Study|End of study|2|||
30929080|NCT01970540|58964950|FG000|Overall Study|Adverse Event|0|||
30929081|NCT01970540|58964951|FG001|Overall Study|Adverse Event|2|||
30929082|NCT01970540|58964952|FG002|Overall Study|Adverse Event|1|||
30929083|NCT01970540|58964950|FG000|Overall Study|Treatment-related AE|4|||
30929084|NCT01970540|58964951|FG001|Overall Study|Treatment-related AE|0|||
30929085|NCT01970540|58964952|FG002|Overall Study|Treatment-related AE|2|||
30929086|NCT01970540|58964950|FG000|Overall Study|Withdrawal by Subject|4|||
30929087|NCT01970540|58964951|FG001|Overall Study|Withdrawal by Subject|0|||
30929088|NCT01970540|58964952|FG002|Overall Study|Withdrawal by Subject|1|||
30624165|NCT00959049|58636124|FG003|Overall Study|Contraindicated medication|1|||
30837858|NCT02660034|58862890|FG010|Overall Study|Progressive Disease (Clinical)|0|||
30837859|NCT02660034|58862891|FG011|Overall Study|Progressive Disease (Clinical)|0|||
30837860|NCT02660034|58862892|FG012|Overall Study|Progressive Disease (Clinical)|0|||
30837861|NCT02660034|58862893|FG013|Overall Study|Progressive Disease (Clinical)|0|||
30837862|NCT02660034|58862880|FG000|Overall Study|Lost to Follow-up|0|||
30837863|NCT02660034|58862881|FG001|Overall Study|Lost to Follow-up|0|||
30837864|NCT02660034|58862882|FG002|Overall Study|Lost to Follow-up|1|||
30837865|NCT02660034|58862883|FG003|Overall Study|Lost to Follow-up|1|||
30837866|NCT02660034|58862884|FG004|Overall Study|Lost to Follow-up|0|||
30837867|NCT02660034|58862885|FG005|Overall Study|Lost to Follow-up|0|||
30837868|NCT02660034|58862886|FG006|Overall Study|Lost to Follow-up|0|||
30837869|NCT02660034|58862887|FG007|Overall Study|Lost to Follow-up|0|||
30837870|NCT02660034|58862888|FG008|Overall Study|Lost to Follow-up|0|||
30837871|NCT02660034|58862889|FG009|Overall Study|Lost to Follow-up|1|||
30837872|NCT02660034|58862890|FG010|Overall Study|Lost to Follow-up|1|||
30837873|NCT02660034|58862891|FG011|Overall Study|Lost to Follow-up|1|||
30837874|NCT02660034|58862892|FG012|Overall Study|Lost to Follow-up|0|||
30837875|NCT02660034|58862893|FG013|Overall Study|Lost to Follow-up|0|||
30837876|NCT02660034|58862880|FG000|Overall Study|Participant moved into special access scheme|1|||
30837877|NCT02660034|58862881|FG001|Overall Study|Participant moved into special access scheme|2|||
30837878|NCT02660034|58862882|FG002|Overall Study|Participant moved into special access scheme|0|||
30837879|NCT02660034|58862883|FG003|Overall Study|Participant moved into special access scheme|0|||
30837880|NCT02660034|58862884|FG004|Overall Study|Participant moved into special access scheme|0|||
30837881|NCT02660034|58862885|FG005|Overall Study|Participant moved into special access scheme|0|||
30837882|NCT02660034|58862886|FG006|Overall Study|Participant moved into special access scheme|0|||
30837883|NCT02660034|58862887|FG007|Overall Study|Participant moved into special access scheme|0|||
30837884|NCT02660034|58862888|FG008|Overall Study|Participant moved into special access scheme|0|||
30837885|NCT02660034|58862889|FG009|Overall Study|Participant moved into special access scheme|0|||
30837886|NCT02660034|58862890|FG010|Overall Study|Participant moved into special access scheme|0|||
30837887|NCT02660034|58862891|FG011|Overall Study|Participant moved into special access scheme|0|||
30837888|NCT02660034|58862892|FG012|Overall Study|Participant moved into special access scheme|0|||
30837889|NCT02660034|58862893|FG013|Overall Study|Participant moved into special access scheme|0|||
30837890|NCT02660034|58862880|FG000|Overall Study|Adverse Event|1|||
30929089|NCT01970540|58964950|FG000|Overall Study|Clinical deterioration|1|||
30929090|NCT01970540|58964951|FG001|Overall Study|Clinical deterioration|0|||
30929091|NCT01970540|58964952|FG002|Overall Study|Clinical deterioration|0|||
30929092|NCT01963676|58964973|FG000|Overall Study|Withdrawal by Subject|1|||
30929093|NCT01963676|58964974|FG001|Overall Study|Withdrawal by Subject|0|||
30929094|NCT01996826|58964982|FG000|Overall Study|Lost to Follow-up|6|||
30929095|NCT01996826|58964983|FG001|Overall Study|Lost to Follow-up|2|||
30929096|NCT01996826|58964982|FG000|Overall Study|Physician Decision|1|||
30929097|NCT01996826|58964983|FG001|Overall Study|Physician Decision|1|||
30929098|NCT01996748|58964991|FG000|Overall Study|Personal reason|1|||
30929099|NCT01996748|58964992|FG001|Overall Study|Personal reason|0|||
30929100|NCT01996748|58964991|FG000|Overall Study|Physician Decision|2|||
30929101|NCT01996748|58964992|FG001|Overall Study|Physician Decision|0|||
30929102|NCT01996748|58964991|FG000|Overall Study|Adverse Event|1|||
30929103|NCT01996748|58964992|FG001|Overall Study|Adverse Event|4|||
30929104|NCT01996748|58964991|FG000|Overall Study|Withdrawal by Subject|0|||
30929105|NCT01996748|58964992|FG001|Overall Study|Withdrawal by Subject|1|||
30929106|NCT01996748|58964991|FG000|Overall Study|Lost to Follow-up|4|||
30929107|NCT01996748|58964992|FG001|Overall Study|Lost to Follow-up|1|||
30929108|NCT01621178|58965003|FG000|Overall Study|Adverse Event|5|||
30929109|NCT01621178|58965004|FG001|Overall Study|Adverse Event|2|||
30929110|NCT01621178|58965005|FG002|Overall Study|Adverse Event|8|||
30757749|NCT00112437|58766937|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757750|NCT00112437|58766938|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757751|NCT00112437|58766939|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757752|NCT00112437|58766940|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757753|NCT00112437|58766941|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757754|NCT00112437|58766942|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757755|NCT00112437|58766943|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757756|NCT00112437|58766944|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757757|NCT00112437|58766945|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757758|NCT00112437|58766946|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
30757759|NCT00112437|58766921|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757760|NCT00112437|58766922|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757761|NCT00112437|58766923|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757762|NCT00112437|58766924|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757763|NCT00112437|58766925|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757764|NCT00112437|58766926|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757765|NCT00112437|58766927|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757766|NCT00112437|58766928|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
30837891|NCT02660034|58862881|FG001|Overall Study|Adverse Event|0|||
30837892|NCT02660034|58862882|FG002|Overall Study|Adverse Event|0|||
30837893|NCT02660034|58862883|FG003|Overall Study|Adverse Event|0|||
30837894|NCT02660034|58862884|FG004|Overall Study|Adverse Event|0|||
30837895|NCT02660034|58862885|FG005|Overall Study|Adverse Event|0|||
30837896|NCT02660034|58862886|FG006|Overall Study|Adverse Event|0|||
30837897|NCT02660034|58862887|FG007|Overall Study|Adverse Event|0|||
30837898|NCT02660034|58862888|FG008|Overall Study|Adverse Event|0|||
30837899|NCT02660034|58862889|FG009|Overall Study|Adverse Event|0|||
30837900|NCT02660034|58862890|FG010|Overall Study|Adverse Event|0|||
30837901|NCT02660034|58862891|FG011|Overall Study|Adverse Event|0|||
30837902|NCT02660034|58862892|FG012|Overall Study|Adverse Event|0|||
30837903|NCT02660034|58862893|FG013|Overall Study|Adverse Event|0|||
30837904|NCT02660034|58862880|FG000|Overall Study|Sponsor Decision|0|||
30837905|NCT02660034|58862881|FG001|Overall Study|Sponsor Decision|1|||
30837906|NCT02660034|58862882|FG002|Overall Study|Sponsor Decision|2|||
30837907|NCT02660034|58862883|FG003|Overall Study|Sponsor Decision|2|||
30837908|NCT02660034|58862884|FG004|Overall Study|Sponsor Decision|3|||
30837909|NCT02660034|58862885|FG005|Overall Study|Sponsor Decision|0|||
30837910|NCT02660034|58862886|FG006|Overall Study|Sponsor Decision|0|||
30837911|NCT02660034|58862887|FG007|Overall Study|Sponsor Decision|0|||
30837912|NCT02660034|58862888|FG008|Overall Study|Sponsor Decision|0|||
30837913|NCT02660034|58862889|FG009|Overall Study|Sponsor Decision|0|||
30837914|NCT02660034|58862890|FG010|Overall Study|Sponsor Decision|0|||
30837915|NCT02660034|58862891|FG011|Overall Study|Sponsor Decision|0|||
30837916|NCT02660034|58862892|FG012|Overall Study|Sponsor Decision|0|||
30837917|NCT02660034|58862893|FG013|Overall Study|Sponsor Decision|1|||
30837918|NCT02660034|58862880|FG000|Overall Study|Withdrawal by Subject|0|||
30837919|NCT02660034|58862881|FG001|Overall Study|Withdrawal by Subject|0|||
30837920|NCT02660034|58862882|FG002|Overall Study|Withdrawal by Subject|0|||
30837921|NCT02660034|58862883|FG003|Overall Study|Withdrawal by Subject|0|||
30929111|NCT01621178|58965003|FG000|Overall Study|Death|6|||
30929112|NCT01621178|58965004|FG001|Overall Study|Death|7|||
30929113|NCT01621178|58965005|FG002|Overall Study|Death|2|||
30929114|NCT01621178|58965003|FG000|Overall Study|Lost to Follow-up|1|||
30837922|NCT02660034|58862884|FG004|Overall Study|Withdrawal by Subject|0|||
30837923|NCT02660034|58862885|FG005|Overall Study|Withdrawal by Subject|0|||
30837924|NCT02660034|58862886|FG006|Overall Study|Withdrawal by Subject|1|||
30837925|NCT02660034|58862887|FG007|Overall Study|Withdrawal by Subject|1|||
30837926|NCT02660034|58862888|FG008|Overall Study|Withdrawal by Subject|1|||
30837927|NCT02660034|58862889|FG009|Overall Study|Withdrawal by Subject|0|||
30837928|NCT02660034|58862890|FG010|Overall Study|Withdrawal by Subject|0|||
30837929|NCT02660034|58862891|FG011|Overall Study|Withdrawal by Subject|1|||
30929115|NCT01621178|58965004|FG001|Overall Study|Lost to Follow-up|2|||
30929116|NCT01621178|58965005|FG002|Overall Study|Lost to Follow-up|1|||
30929117|NCT01621178|58965003|FG000|Overall Study|Withdrawal by Subject|14|||
30929118|NCT01621178|58965004|FG001|Overall Study|Withdrawal by Subject|17|||
30929119|NCT01621178|58965005|FG002|Overall Study|Withdrawal by Subject|18|||
30929120|NCT01621178|58965003|FG000|Overall Study|Physician Decision|5|||
30929121|NCT01621178|58965004|FG001|Overall Study|Physician Decision|2|||
30929122|NCT01621178|58965005|FG002|Overall Study|Physician Decision|7|||
30929123|NCT01962974|58965017|FG000|Overall Study|Study termination|7|||
30929124|NCT01996592|58965021|FG000|Overall Study|no response to text/no diary entry|32|||
30929125|NCT01996592|58965021|FG000|Overall Study|change in surgical date|4|||
30929126|NCT01996592|58965021|FG000|Overall Study|Withdrawal by Subject|5|||
30929127|NCT01996592|58965021|FG000|Overall Study|change in mode of delivery|4|||
30929128|NCT01962896|58965030|FG000|Overall Study|Lack of Efficacy|4|||
30929129|NCT01970462|58965037|FG000|Overall Study|Lost to Follow-up|0|||
30929130|NCT01970462|58965038|FG001|Overall Study|Lost to Follow-up|2|||
30929131|NCT01958671|58965047|FG000|Overall Study|Adverse Event|1|||
30929132|NCT01958671|58965048|FG001|Overall Study|Adverse Event|1|||
30929133|NCT01958671|58965049|FG002|Overall Study|Adverse Event|5|||
30929134|NCT01958671|58965047|FG000|Overall Study|Death|1|||
30929135|NCT01958671|58965048|FG001|Overall Study|Death|0|||
30929136|NCT01958671|58965049|FG002|Overall Study|Death|0|||
30929137|NCT01958671|58965047|FG000|Overall Study|Excluded medication|0|||
30929138|NCT01958671|58965048|FG001|Overall Study|Excluded medication|0|||
30929139|NCT01958671|58965049|FG002|Overall Study|Excluded medication|1|||
30929140|NCT01958671|58965047|FG000|Overall Study|Hyperglycemia|0|||
30929141|NCT01958671|58965048|FG001|Overall Study|Hyperglycemia|0|||
30929142|NCT01958671|58965049|FG002|Overall Study|Hyperglycemia|2|||
30929143|NCT01958671|58965047|FG000|Overall Study|Lost to Follow-up|7|||
30929144|NCT01958671|58965048|FG001|Overall Study|Lost to Follow-up|11|||
30929145|NCT01958671|58965049|FG002|Overall Study|Lost to Follow-up|7|||
30929146|NCT01958671|58965047|FG000|Overall Study|Non-compliance with study drug|1|||
30929147|NCT01958671|58965048|FG001|Overall Study|Non-compliance with study drug|1|||
30929148|NCT01958671|58965049|FG002|Overall Study|Non-compliance with study drug|1|||
30929149|NCT01958671|58965047|FG000|Overall Study|Pregnancy|0|||
30929150|NCT01958671|58965048|FG001|Overall Study|Pregnancy|0|||
30929151|NCT01958671|58965049|FG002|Overall Study|Pregnancy|1|||
30929152|NCT01958671|58965047|FG000|Overall Study|Protocol Violation|0|||
30929153|NCT01958671|58965048|FG001|Overall Study|Protocol Violation|1|||
30929154|NCT01958671|58965049|FG002|Overall Study|Protocol Violation|0|||
30929155|NCT01958671|58965047|FG000|Overall Study|Study site terminated by sponsor|1|||
30929156|NCT01958671|58965048|FG001|Overall Study|Study site terminated by sponsor|0|||
30929157|NCT01958671|58965049|FG002|Overall Study|Study site terminated by sponsor|1|||
30929158|NCT01958671|58965047|FG000|Overall Study|Participant moved|0|||
30929159|NCT01958671|58965048|FG001|Overall Study|Participant moved|0|||
30929160|NCT01958671|58965049|FG002|Overall Study|Participant moved|1|||
30929161|NCT01958671|58965047|FG000|Overall Study|Withdrawal by Subject|8|||
30929162|NCT01958671|58965048|FG001|Overall Study|Withdrawal by Subject|10|||
30757767|NCT00112437|58766929|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
30757768|NCT00112437|58766930|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757769|NCT00112437|58766931|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757770|NCT00112437|58766932|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757771|NCT00112437|58766933|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757772|NCT00112437|58766934|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
30837930|NCT02660034|58862892|FG012|Overall Study|Withdrawal by Subject|2|||
30837931|NCT02660034|58862893|FG013|Overall Study|Withdrawal by Subject|0|||
30837932|NCT02660034|58862880|FG000|Overall Study|Death|0|||
30837933|NCT02660034|58862881|FG001|Overall Study|Death|0|||
30837934|NCT02660034|58862882|FG002|Overall Study|Death|0|||
30837935|NCT02660034|58862883|FG003|Overall Study|Death|0|||
30757773|NCT00112437|58766935|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757774|NCT00112437|58766936|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
30837936|NCT02660034|58862884|FG004|Overall Study|Death|0|||
30837937|NCT02660034|58862885|FG005|Overall Study|Death|13|||
30837938|NCT02660034|58862886|FG006|Overall Study|Death|14|||
30929163|NCT01958671|58965049|FG002|Overall Study|Withdrawal by Subject|13|||
30929164|NCT01995266|58965061|FG000|Overall Study|Death|1|||
30929165|NCT01995266|58965061|FG000|Overall Study|Lack of Efficacy|6|||
30929166|NCT01995266|58965061|FG000|Overall Study|Adverse Event|2|||
30929167|NCT01969058|58965067|FG000|Overall Study|Withdrawal by Subject|2|||
30929168|NCT01969058|58965068|FG001|Overall Study|Withdrawal by Subject|0|||
30929169|NCT01969058|58965067|FG000|Overall Study|Adverse Event|1|||
30757775|NCT00112437|58766937|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
30929170|NCT01969058|58965068|FG001|Overall Study|Adverse Event|0|||
30757776|NCT00112437|58766938|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
30837939|NCT02660034|58862887|FG007|Overall Study|Death|10|||
30837940|NCT02660034|58862888|FG008|Overall Study|Death|9|||
30837941|NCT02660034|58862889|FG009|Overall Study|Death|21|||
30837942|NCT02660034|58862890|FG010|Overall Study|Death|17|||
30757777|NCT00112437|58766939|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
30837943|NCT02660034|58862891|FG011|Overall Study|Death|15|||
30837944|NCT02660034|58862892|FG012|Overall Study|Death|18|||
30837945|NCT02660034|58862893|FG013|Overall Study|Death|7|||
30837946|NCT02660034|58862880|FG000|Overall Study|Physician Decision|0|||
30837947|NCT02660034|58862881|FG001|Overall Study|Physician Decision|0|||
30837948|NCT02660034|58862882|FG002|Overall Study|Physician Decision|0|||
30837949|NCT02660034|58862883|FG003|Overall Study|Physician Decision|0|||
30837950|NCT02660034|58862884|FG004|Overall Study|Physician Decision|0|||
30837951|NCT02660034|58862885|FG005|Overall Study|Physician Decision|0|||
30837952|NCT02660034|58862886|FG006|Overall Study|Physician Decision|0|||
30837953|NCT02660034|58862887|FG007|Overall Study|Physician Decision|0|||
30837954|NCT02660034|58862888|FG008|Overall Study|Physician Decision|0|||
30837955|NCT02660034|58862889|FG009|Overall Study|Physician Decision|0|||
30837956|NCT02660034|58862890|FG010|Overall Study|Physician Decision|0|||
30837957|NCT02660034|58862891|FG011|Overall Study|Physician Decision|0|||
30837958|NCT02660034|58862892|FG012|Overall Study|Physician Decision|0|||
30837959|NCT02660034|58862893|FG013|Overall Study|Physician Decision|1|||
30837960|NCT02660034|58862880|FG000|Overall Study|Participants transferred to LTE|0|||
30837961|NCT02660034|58862881|FG001|Overall Study|Participants transferred to LTE|0|||
30837962|NCT02660034|58862882|FG002|Overall Study|Participants transferred to LTE|0|||
30837963|NCT02660034|58862883|FG003|Overall Study|Participants transferred to LTE|0|||
30837964|NCT02660034|58862884|FG004|Overall Study|Participants transferred to LTE|0|||
30837965|NCT02660034|58862885|FG005|Overall Study|Participants transferred to LTE|10|||
30837966|NCT02660034|58862886|FG006|Overall Study|Participants transferred to LTE|8|||
30837967|NCT02660034|58862887|FG007|Overall Study|Participants transferred to LTE|8|||
30837968|NCT02660034|58862888|FG008|Overall Study|Participants transferred to LTE|10|||
30837969|NCT02660034|58862889|FG009|Overall Study|Participants transferred to LTE|1|||
30837970|NCT02660034|58862890|FG010|Overall Study|Participants transferred to LTE|2|||
30837971|NCT02660034|58862891|FG011|Overall Study|Participants transferred to LTE|4|||
30837972|NCT02660034|58862892|FG012|Overall Study|Participants transferred to LTE|1|||
30837973|NCT02660034|58862893|FG013|Overall Study|Participants transferred to LTE|1|||
30837974|NCT02193867|58862936|FG000|Overall Study|Death|2|||
30837975|NCT02193867|58862936|FG000|Overall Study|Sponsor Study Termination|2|||
30837976|NCT02200770|58862964|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
30837977|NCT02200770|58862965|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
30837978|NCT02200770|58862964|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
30837979|NCT02200770|58862965|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
30837980|NCT02200770|58862964|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
30837981|NCT02200770|58862965|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
30837982|NCT02200770|58862964|FG000|Randomized-controlled Period (RCP)|Other|1|||
30837983|NCT02200770|58862965|FG001|Randomized-controlled Period (RCP)|Other|2|||
30837984|NCT02200770|58862964|FG000|Open-label Period (OLP)|Adverse Event|1|||
30837985|NCT02200770|58862965|FG001|Open-label Period (OLP)|Adverse Event|2|||
30837986|NCT02200770|58862964|FG000|Open-label Period (OLP)|Death|1|||
30837987|NCT02200770|58862965|FG001|Open-label Period (OLP)|Death|2|||
30837988|NCT02200770|58862964|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
30837989|NCT02200770|58862965|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
30837990|NCT02200770|58862964|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
30837991|NCT02200770|58862965|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
30837992|NCT02200770|58862964|FG000|Open-label Period (OLP)|Other|6|||
30837993|NCT02200770|58862965|FG001|Open-label Period (OLP)|Other|15|||
30837994|NCT01186848|58862987|FG000|Overall Study|Lost to Follow-up|4|||
30837995|NCT01186848|58862987|FG000|Overall Study|Withdrawal by Subject|2|||
30757778|NCT00112437|58766940|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757779|NCT00112437|58766941|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757780|NCT00112437|58766942|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757781|NCT00112437|58766943|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757782|NCT00112437|58766944|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757783|NCT00112437|58766945|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757784|NCT00112437|58766946|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
30757785|NCT00112437|58766921|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757786|NCT00112437|58766922|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757787|NCT00112437|58766923|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757788|NCT00112437|58766924|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757789|NCT00112437|58766925|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30837996|NCT01186848|58862987|FG000|Overall Study|Adverse Event|2|||
30837997|NCT01024608|58862995|FG000|Overall Study|Adverse Event|1|||
30837998|NCT01024608|58862996|FG001|Overall Study|Adverse Event|0|||
30837999|NCT01024608|58862995|FG000|Overall Study|Withdrawal by Subject|1|||
30838000|NCT01024608|58862996|FG001|Overall Study|Withdrawal by Subject|0|||
30757790|NCT00112437|58766926|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
30757791|NCT00112437|58766927|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
30757792|NCT00112437|58766928|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
30929171|NCT01968980|58965076|FG000|Overall Study|Death|0|||
30929172|NCT01968980|58965077|FG001|Overall Study|Death|1|||
30929173|NCT01968980|58965076|FG000|Overall Study|Adverse Event|1|||
30929174|NCT01968980|58965077|FG001|Overall Study|Adverse Event|3|||
30929175|NCT01968980|58965076|FG000|Overall Study|Does not meet entry criteria|1|||
30929176|NCT01968980|58965077|FG001|Overall Study|Does not meet entry criteria|3|||
30929177|NCT01968980|58965076|FG000|Overall Study|Withdrawal by Subject|13|||
30929178|NCT01968980|58965077|FG001|Overall Study|Withdrawal by Subject|5|||
30929179|NCT01968980|58965076|FG000|Overall Study|Other unspecified|1|||
30929180|NCT01968980|58965077|FG001|Overall Study|Other unspecified|2|||
30929181|NCT01961882|58965086|FG000|Overall Study|Adverse Event|3|||
30929182|NCT01961882|58965087|FG001|Overall Study|Adverse Event|2|||
30929183|NCT01961882|58965086|FG000|Overall Study|Physician Decision|1|||
30929184|NCT01961882|58965087|FG001|Overall Study|Physician Decision|0|||
30929185|NCT01961882|58965086|FG000|Overall Study|Withdrawal by Subject|4|||
30929186|NCT01961882|58965087|FG001|Overall Study|Withdrawal by Subject|1|||
30929187|NCT01961882|58965086|FG000|Overall Study|Relapse of AML|39|||
30929188|NCT01961882|58965087|FG001|Overall Study|Relapse of AML|37|||
30929189|NCT01961882|58965086|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
30929190|NCT01961882|58965087|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
30929191|NCT01961882|58965086|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
30929192|NCT01961882|58965087|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
30929193|NCT01968434|58965095|FG000|Overall Study|Lost to Follow-up|3|||
30929194|NCT01968434|58965096|FG001|Overall Study|Lost to Follow-up|6|||
30929195|NCT01946438|58965106|FG000|Overall Study|Adverse Event|0|||
30929196|NCT01946438|58965107|FG001|Overall Study|Adverse Event|0|||
30929197|NCT01946438|58965108|FG002|Overall Study|Adverse Event|0|||
30929198|NCT01946438|58965109|FG003|Overall Study|Adverse Event|1|||
30929199|NCT01946438|58965106|FG000|Overall Study|Serious Adverse event|1|||
30929200|NCT01946438|58965107|FG001|Overall Study|Serious Adverse event|0|||
30929201|NCT01946438|58965108|FG002|Overall Study|Serious Adverse event|0|||
30929202|NCT01946438|58965109|FG003|Overall Study|Serious Adverse event|0|||
30929203|NCT01946438|58965106|FG000|Overall Study|Protocol Violation|0|||
30929204|NCT01946438|58965107|FG001|Overall Study|Protocol Violation|0|||
30929205|NCT01946438|58965108|FG002|Overall Study|Protocol Violation|1|||
30929206|NCT01946438|58965109|FG003|Overall Study|Protocol Violation|0|||
30929207|NCT01946438|58965106|FG000|Overall Study|Withdrawal by Subject|1|||
30929208|NCT01946438|58965107|FG001|Overall Study|Withdrawal by Subject|0|||
30929209|NCT01946438|58965108|FG002|Overall Study|Withdrawal by Subject|0|||
30929210|NCT01946438|58965109|FG003|Overall Study|Withdrawal by Subject|0|||
30929211|NCT01946282|58965128|FG000|Year 1|Did not return FIT kit|4186|||
30929212|NCT01946282|58965129|FG001|Year 1|Did not return FIT kit|608|||
30929213|NCT01946282|58965130|FG002|Year 1|Did not return FIT kit|654|||
30838001|NCT01024608|58862995|FG000|Overall Study|Lost to Follow-up|0|||
30838002|NCT01024608|58862996|FG001|Overall Study|Lost to Follow-up|1|||
30838003|NCT01024608|58862995|FG000|Overall Study|Protocol Violation|0|||
30838004|NCT01024608|58862996|FG001|Overall Study|Protocol Violation|3|||
30838005|NCT01024608|58862995|FG000|Overall Study|Never received study treatment|2|||
30838006|NCT01024608|58862996|FG001|Overall Study|Never received study treatment|0|||
30838007|NCT00910650|58863002|FG000|Overall Study|Death|2|||
30838008|NCT03996876|58863037|FG000|Overall Study|Incomplete Data|2|||
30838009|NCT03996876|58863038|FG001|Overall Study|Incomplete Data|4|||
30838010|NCT01460160|58863045|FG000|Treatment Phase|Lack of Efficacy|3|||
30838011|NCT01460160|58863045|FG000|Treatment Phase|Study Drug Toxicity|2|||
30838012|NCT01460160|58863045|FG000|Treatment Phase|Adverse Event|8|||
30838013|NCT01460160|58863045|FG000|Treatment Phase|Withdrawal by Subject|4|||
30838014|NCT01460160|58863045|FG000|Treatment Phase|Death|2|||
30838015|NCT01460160|58863045|FG000|Treatment Phase|Other reasons|9|||
30838016|NCT01460160|58863045|FG000|Follow-up Phase|Withdrawal by Subject|4|||
30838017|NCT01460160|58863045|FG000|Follow-up Phase|Death|14|||
30838018|NCT01460160|58863045|FG000|Follow-up Phase|Lost to Follow-up|7|||
30838019|NCT01460160|58863045|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
30838020|NCT01460160|58863045|FG000|Follow-up Phase|Other and not reported reasons|5|||
30838021|NCT01170702|58863053|FG000|Overall Study|Exclusion criteria met after consent|1|||
30838022|NCT01170702|58863054|FG001|Overall Study|Exclusion criteria met after consent|2|||
30838023|NCT01170702|58863055|FG002|Overall Study|Exclusion criteria met after consent|0|||
30929214|NCT01946282|58965128|FG000|Year 2|Did not return FIT kit|803|||
30929215|NCT01946282|58965129|FG001|Year 2|Did not return FIT kit|131|||
30929216|NCT01946282|58965130|FG002|Year 2|Did not return FIT kit|115|||
30929217|NCT01946282|58965128|FG000|Year 3|Did not return FIT kit|288|||
30929218|NCT01946282|58965129|FG001|Year 3|Did not return FIT kit|43|||
30838024|NCT01170702|58863056|FG003|Overall Study|Exclusion criteria met after consent|2|||
30838025|NCT02723864|58863095|FG000|Overall Study|Refused further treatment|1|||
30838026|NCT02723864|58863096|FG001|Overall Study|Refused further treatment|0|||
30929219|NCT01946282|58965130|FG002|Year 3|Did not return FIT kit|30|||
30838027|NCT02723864|58863097|FG002|Overall Study|Refused further treatment|0|||
30929220|NCT01945580|58965142|FG000|Overall Study|Withdrawal by Subject|13|||
30929221|NCT01945580|58965143|FG001|Overall Study|Withdrawal by Subject|35|||
30929222|NCT01945580|58965142|FG000|Overall Study|Physician Decision|3|||
30929223|NCT01945580|58965143|FG001|Overall Study|Physician Decision|2|||
30929224|NCT01945580|58965142|FG000|Overall Study|Lost to Follow-up|26|||
30929225|NCT01945580|58965143|FG001|Overall Study|Lost to Follow-up|39|||
30929226|NCT01945580|58965142|FG000|Overall Study|Death|7|||
30929227|NCT01945580|58965143|FG001|Overall Study|Death|2|||
30929228|NCT01945580|58965142|FG000|Overall Study|Patient moved out of state|0|||
30929229|NCT01945580|58965143|FG001|Overall Study|Patient moved out of state|1|||
30929230|NCT01945580|58965142|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
30929231|NCT01945580|58965143|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
30929232|NCT01945580|58965142|FG000|Overall Study|Family illness - unable to return|0|||
30929233|NCT01945580|58965143|FG001|Overall Study|Family illness - unable to return|1|||
30929234|NCT01945580|58965142|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
30929235|NCT01945580|58965143|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
30929236|NCT01945580|58965142|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
30929237|NCT01945580|58965143|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
30929238|NCT01945580|58965142|FG000|Overall Study|Noncompliance with 36 month visit|1|||
30929239|NCT01945580|58965143|FG001|Overall Study|Noncompliance with 36 month visit|0|||
30929240|NCT01945580|58965142|FG000|Overall Study|The patient moved.|1|||
30929241|NCT01945580|58965143|FG001|Overall Study|The patient moved.|0|||
30929242|NCT01945580|58965142|FG000|Overall Study|No data available|0|||
30929243|NCT01945580|58965143|FG001|Overall Study|No data available|2|||
30929244|NCT01945034|58965156|FG000|Overall Study|Medication Error|0|||
30929245|NCT01945034|58965157|FG001|Overall Study|Medication Error|1|||
30929246|NCT01945034|58965158|FG002|Overall Study|Medication Error|0|||
30929247|NCT01945034|58965156|FG000|Overall Study|Withdrawal by Subject|0|||
30929248|NCT01945034|58965157|FG001|Overall Study|Withdrawal by Subject|3|||
30929249|NCT01945034|58965158|FG002|Overall Study|Withdrawal by Subject|1|||
30929250|NCT01945034|58965156|FG000|Overall Study|Other|0|||
30929251|NCT01945034|58965157|FG001|Overall Study|Other|1|||
30929252|NCT01945034|58965158|FG002|Overall Study|Other|3|||
30929253|NCT01945034|58965156|FG000|Overall Study|Lost to Follow-up|0|||
30929254|NCT01945034|58965157|FG001|Overall Study|Lost to Follow-up|0|||
30929255|NCT01945034|58965158|FG002|Overall Study|Lost to Follow-up|2|||
30929256|NCT01945034|58965156|FG000|Overall Study|Protocol Violation|1|||
30929257|NCT01945034|58965157|FG001|Overall Study|Protocol Violation|0|||
30929258|NCT01945034|58965158|FG002|Overall Study|Protocol Violation|1|||
30929259|NCT01960790|58965166|FG000|Overall Study|Survey forms could not be recovered|3|||
30929260|NCT01960790|58965166|FG000|Overall Study|Treat with Humira outside survey period|3|||
30929261|NCT01960790|58965166|FG000|Overall Study|Transferred to another hospital|4|||
30929262|NCT01960790|58965166|FG000|Overall Study|Unevaluable for safety|1|||
30929263|NCT01618214|58965172|FG000|Overall Study|Adverse Event|3|||
30929264|NCT01618214|58965173|FG001|Overall Study|Adverse Event|1|||
30929265|NCT01618214|58965172|FG000|Overall Study|Lack of Efficacy|1|||
30929266|NCT01618214|58965173|FG001|Overall Study|Lack of Efficacy|1|||
30929267|NCT01618214|58965172|FG000|Overall Study|Protocol Violation|1|||
30929268|NCT01618214|58965173|FG001|Overall Study|Protocol Violation|4|||
30929269|NCT01618214|58965172|FG000|Overall Study|Withdrawal Criteria|1|||
30929270|NCT01618214|58965173|FG001|Overall Study|Withdrawal Criteria|2|||
30929271|NCT01618214|58965172|FG000|Overall Study|Unclassified|4|||
30929272|NCT01618214|58965173|FG001|Overall Study|Unclassified|5|||
30929273|NCT01917968|58965181|FG000|Overall Study|Death|3|||
30929274|NCT01917968|58965182|FG001|Overall Study|Death|2|||
30929275|NCT01917968|58965181|FG000|Overall Study|Lost to Follow-up|21|||
30757793|NCT00112437|58766929|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
30757794|NCT00112437|58766930|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
30757795|NCT00112437|58766931|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757796|NCT00112437|58766932|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757797|NCT00112437|58766933|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757798|NCT00112437|58766934|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757799|NCT00112437|58766935|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757800|NCT00112437|58766936|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757801|NCT00112437|58766937|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757802|NCT00112437|58766938|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757803|NCT00112437|58766939|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757804|NCT00112437|58766940|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757805|NCT00112437|58766941|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757806|NCT00112437|58766942|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757807|NCT00112437|58766943|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757808|NCT00112437|58766944|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757809|NCT00112437|58766945|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30929276|NCT01917968|58965182|FG001|Overall Study|Lost to Follow-up|39|||
30929277|NCT01917968|58965181|FG000|Overall Study|Physician Decision|1|||
30929278|NCT01917968|58965182|FG001|Overall Study|Physician Decision|2|||
30929279|NCT01917968|58965181|FG000|Overall Study|Withdrawal by Subject|20|||
30929280|NCT01917968|58965182|FG001|Overall Study|Withdrawal by Subject|35|||
30929281|NCT01917968|58965181|FG000|Overall Study|Subject Relocation|5|||
30929282|NCT01917968|58965182|FG001|Overall Study|Subject Relocation|1|||
30929283|NCT01917968|58965181|FG000|Overall Study|36M Missed Visit|3|||
30929284|NCT01917968|58965182|FG001|Overall Study|36M Missed Visit|2|||
30757810|NCT00112437|58766946|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
30757811|NCT00112437|58766921|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757812|NCT00112437|58766922|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757813|NCT00112437|58766923|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757814|NCT00112437|58766924|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30929285|NCT01917968|58965181|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
30929286|NCT01917968|58965182|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
30929287|NCT01917968|58965181|FG000|Overall Study|Change in Family Circumstances|0|||
30929288|NCT01917968|58965182|FG001|Overall Study|Change in Family Circumstances|1|||
30929289|NCT01917968|58965181|FG000|Overall Study|No Data Available|0|||
30929290|NCT01917968|58965182|FG001|Overall Study|No Data Available|2|||
30929291|NCT01917656|58965197|FG000|Overall Study|Adverse Event|11|||
30929292|NCT01917656|58965198|FG001|Overall Study|Adverse Event|0|||
30929293|NCT01917656|58965197|FG000|Overall Study|Withdrawal criteria|8|||
30929294|NCT01917656|58965198|FG001|Overall Study|Withdrawal criteria|14|||
30929295|NCT01917656|58965197|FG000|Overall Study|Unclassified|0|||
30929296|NCT01917656|58965198|FG001|Overall Study|Unclassified|3|||
30929297|NCT01917656|58965197|FG000|Overall Study|Withdrawal by Subject|4|||
30929298|NCT01917656|58965198|FG001|Overall Study|Withdrawal by Subject|3|||
30929299|NCT01917656|58965197|FG000|Overall Study|Lost to Follow-up|3|||
30929300|NCT01917656|58965198|FG001|Overall Study|Lost to Follow-up|4|||
30929301|NCT02018861|58965214|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
30929302|NCT02018861|58965215|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
30929303|NCT02018861|58965216|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
30929304|NCT02018861|58965217|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
30929305|NCT02018861|58965218|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
30929306|NCT02018861|58965219|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
30929307|NCT02018861|58965220|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
30929308|NCT02018861|58965221|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
30929309|NCT02018861|58965222|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
30929310|NCT02018861|58965223|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
30929311|NCT02018861|58965214|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
30929312|NCT02018861|58965215|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
30929313|NCT02018861|58965216|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
30929314|NCT02018861|58965217|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
30929315|NCT02018861|58965218|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
30929316|NCT02018861|58965219|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
30929317|NCT02018861|58965220|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
30929318|NCT02018861|58965221|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
30929319|NCT02018861|58965222|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
30929320|NCT02018861|58965223|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
30929321|NCT02018861|58965214|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
30929322|NCT02018861|58965215|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
30929323|NCT02018861|58965216|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
30929324|NCT02018861|58965217|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
30929325|NCT02018861|58965218|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
30929326|NCT02018861|58965219|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
30929327|NCT02018861|58965220|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
30929328|NCT02018861|58965221|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
30929329|NCT02018861|58965222|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
30929330|NCT02018861|58965223|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
30929331|NCT02018861|58965214|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
30929332|NCT02018861|58965215|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
30929333|NCT02018861|58965216|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
30929334|NCT02018861|58965217|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
30929335|NCT02018861|58965218|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
30929336|NCT02018861|58965219|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
30929337|NCT02018861|58965220|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
30929338|NCT02018861|58965221|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
30838028|NCT02723864|58863098|FG003|Overall Study|Refused further treatment|0|||
30838029|NCT02723864|58863099|FG004|Overall Study|Refused further treatment|1|||
30838030|NCT02723864|58863100|FG005|Overall Study|Refused further treatment|2|||
30838031|NCT02723864|58863101|FG006|Overall Study|Refused further treatment|0|||
30838032|NCT02723864|58863095|FG000|Overall Study|Exceed treatment hold time|0|||
30838033|NCT02723864|58863096|FG001|Overall Study|Exceed treatment hold time|1|||
30838034|NCT02723864|58863097|FG002|Overall Study|Exceed treatment hold time|0|||
30838035|NCT02723864|58863098|FG003|Overall Study|Exceed treatment hold time|0|||
30838036|NCT02723864|58863099|FG004|Overall Study|Exceed treatment hold time|0|||
30838037|NCT02723864|58863100|FG005|Overall Study|Exceed treatment hold time|0|||
30838038|NCT02723864|58863101|FG006|Overall Study|Exceed treatment hold time|0|||
30838039|NCT02723864|58863095|FG000|Overall Study|Clinical progression|0|||
30838040|NCT02723864|58863096|FG001|Overall Study|Clinical progression|0|||
30838041|NCT02723864|58863097|FG002|Overall Study|Clinical progression|1|||
30838042|NCT02723864|58863098|FG003|Overall Study|Clinical progression|0|||
30929339|NCT02018861|58965222|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
30929340|NCT02018861|58965223|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
30929341|NCT02018861|58965214|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
30929342|NCT02018861|58965215|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
30929343|NCT02018861|58965216|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
30929344|NCT02018861|58965217|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
30929345|NCT02018861|58965218|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
30929346|NCT02018861|58965219|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
30929347|NCT02018861|58965220|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
30929348|NCT02018861|58965221|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
30929349|NCT02018861|58965222|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
30838043|NCT02723864|58863099|FG004|Overall Study|Clinical progression|0|||
30838044|NCT02723864|58863100|FG005|Overall Study|Clinical progression|3|||
30838045|NCT02723864|58863101|FG006|Overall Study|Clinical progression|1|||
30838046|NCT02723864|58863095|FG000|Overall Study|Physician Decision|0|||
30838047|NCT02723864|58863096|FG001|Overall Study|Physician Decision|0|||
30838048|NCT02723864|58863097|FG002|Overall Study|Physician Decision|0|||
30838049|NCT02723864|58863098|FG003|Overall Study|Physician Decision|0|||
30838050|NCT02723864|58863099|FG004|Overall Study|Physician Decision|0|||
30929350|NCT02018861|58965223|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
30929351|NCT02018861|58965214|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
30929352|NCT02018861|58965215|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
30929353|NCT02018861|58965216|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
30929354|NCT02018861|58965217|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
30929355|NCT02018861|58965218|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
30929356|NCT02018861|58965219|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
30929357|NCT02018861|58965220|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
30929358|NCT02018861|58965221|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
30929359|NCT02018861|58965222|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
30929360|NCT02018861|58965223|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
30838051|NCT02723864|58863100|FG005|Overall Study|Physician Decision|0|||
30838052|NCT02723864|58863101|FG006|Overall Study|Physician Decision|1|||
30838053|NCT02723864|58863095|FG000|Overall Study|Changes in patient condition|0|||
30929361|NCT02018861|58965214|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
30929362|NCT02018861|58965215|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
30929363|NCT02018861|58965216|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
30929364|NCT02018861|58965217|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
30929365|NCT02018861|58965218|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
30929366|NCT02018861|58965219|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
30929367|NCT02018861|58965220|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
30929368|NCT02018861|58965221|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
30929369|NCT02018861|58965222|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
30929370|NCT02018861|58965223|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
30929371|NCT02018861|58965214|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
30929372|NCT02018861|58965215|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
30929373|NCT02018861|58965216|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
30929374|NCT02018861|58965217|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
30929375|NCT02018861|58965218|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
30929376|NCT02018861|58965219|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
30929377|NCT02018861|58965220|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
30838054|NCT02723864|58863096|FG001|Overall Study|Changes in patient condition|0|||
30838055|NCT02723864|58863097|FG002|Overall Study|Changes in patient condition|0|||
30929378|NCT02018861|58965221|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
30929379|NCT02018861|58965222|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
30929380|NCT02018861|58965223|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
30929381|NCT02018861|58965214|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
30929382|NCT02018861|58965215|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
30929383|NCT02018861|58965216|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
30929384|NCT02018861|58965217|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
30929385|NCT02018861|58965218|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
30929386|NCT02018861|58965219|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
30929387|NCT02018861|58965220|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
30929388|NCT02018861|58965221|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
30929389|NCT02018861|58965222|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
30929390|NCT02018861|58965223|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
30929391|NCT02018861|58965214|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
30929392|NCT02018861|58965215|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
30929393|NCT02018861|58965216|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
30929394|NCT02018861|58965217|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
30929395|NCT02018861|58965218|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
30929396|NCT02018861|58965219|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
30929397|NCT02018861|58965220|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
30929398|NCT02018861|58965221|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
30929399|NCT02018861|58965222|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
30929400|NCT02018861|58965223|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
30929401|NCT02018861|58965214|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
30929402|NCT02018861|58965215|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
30929403|NCT02018861|58965216|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
30929404|NCT02018861|58965217|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
30838056|NCT02723864|58863098|FG003|Overall Study|Changes in patient condition|0|||
30838057|NCT02723864|58863099|FG004|Overall Study|Changes in patient condition|0|||
30838058|NCT02723864|58863100|FG005|Overall Study|Changes in patient condition|1|||
30838059|NCT02723864|58863101|FG006|Overall Study|Changes in patient condition|0|||
30838060|NCT02723864|58863095|FG000|Overall Study|Patient choice|0|||
30838061|NCT02723864|58863096|FG001|Overall Study|Patient choice|0|||
30838062|NCT02723864|58863097|FG002|Overall Study|Patient choice|0|||
30838063|NCT02723864|58863098|FG003|Overall Study|Patient choice|0|||
30929405|NCT02018861|58965218|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
30929406|NCT02018861|58965219|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
30929407|NCT02018861|58965220|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
30929408|NCT02018861|58965221|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
30929409|NCT02018861|58965222|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
30929410|NCT02018861|58965223|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
30929411|NCT02018861|58965214|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
30929412|NCT02018861|58965215|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
30929413|NCT02018861|58965216|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
30929414|NCT02018861|58965217|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
30929415|NCT02018861|58965218|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
30929416|NCT02018861|58965219|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
30929417|NCT02018861|58965220|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
30929418|NCT02018861|58965221|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
30929419|NCT02018861|58965222|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
30929420|NCT02018861|58965223|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
30929421|NCT02018861|58965214|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
30929422|NCT02018861|58965215|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
30838064|NCT02723864|58863099|FG004|Overall Study|Patient choice|0|||
30838065|NCT02723864|58863100|FG005|Overall Study|Patient choice|1|||
30757815|NCT00112437|58766925|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757816|NCT00112437|58766926|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757817|NCT00112437|58766927|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757818|NCT00112437|58766928|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757819|NCT00112437|58766929|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757820|NCT00112437|58766930|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
30757821|NCT00112437|58766931|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30838066|NCT02723864|58863101|FG006|Overall Study|Patient choice|0|||
30838067|NCT02723864|58863095|FG000|Overall Study|Adverse Event|0|||
30929423|NCT02018861|58965216|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
30929424|NCT02018861|58965217|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
30757822|NCT00112437|58766932|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757823|NCT00112437|58766933|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757824|NCT00112437|58766934|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757825|NCT00112437|58766935|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757826|NCT00112437|58766936|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757827|NCT00112437|58766937|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757828|NCT00112437|58766938|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757829|NCT00112437|58766939|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757830|NCT00112437|58766940|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757831|NCT00112437|58766941|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757832|NCT00112437|58766942|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757833|NCT00112437|58766943|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757834|NCT00112437|58766944|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757835|NCT00112437|58766945|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757836|NCT00112437|58766946|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
30757837|NCT00112437|58766921|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757838|NCT00112437|58766922|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757839|NCT00112437|58766923|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757840|NCT00112437|58766924|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757841|NCT00112437|58766925|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757842|NCT00112437|58766926|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757843|NCT00112437|58766927|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757844|NCT00112437|58766928|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757845|NCT00112437|58766929|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757846|NCT00112437|58766930|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
30757847|NCT00112437|58766931|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757848|NCT00112437|58766932|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757849|NCT00112437|58766933|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757850|NCT00112437|58766934|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757851|NCT00112437|58766935|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757852|NCT00112437|58766936|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757853|NCT00112437|58766937|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757854|NCT00112437|58766938|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757855|NCT00112437|58766939|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757856|NCT00112437|58766940|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757857|NCT00112437|58766941|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757858|NCT00112437|58766942|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757859|NCT00112437|58766943|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757860|NCT00112437|58766944|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757861|NCT00112437|58766945|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757862|NCT00112437|58766946|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
30757863|NCT00112437|58766921|FG000|Year 2 (12-Month Extension)|Moved|0|||
30757864|NCT00112437|58766922|FG001|Year 2 (12-Month Extension)|Moved|0|||
30757865|NCT00112437|58766923|FG002|Year 2 (12-Month Extension)|Moved|0|||
30757866|NCT00112437|58766924|FG003|Year 2 (12-Month Extension)|Moved|0|||
30757867|NCT00112437|58766925|FG004|Year 2 (12-Month Extension)|Moved|0|||
30757868|NCT00112437|58766926|FG005|Year 2 (12-Month Extension)|Moved|0|||
30757869|NCT00112437|58766927|FG006|Year 2 (12-Month Extension)|Moved|0|||
30757870|NCT00112437|58766928|FG007|Year 2 (12-Month Extension)|Moved|0|||
30757871|NCT00112437|58766929|FG008|Year 2 (12-Month Extension)|Moved|0|||
30757872|NCT00112437|58766930|FG009|Year 2 (12-Month Extension)|Moved|1|||
30757873|NCT00112437|58766931|FG010|Year 2 (12-Month Extension)|Moved|0|||
30757874|NCT00112437|58766932|FG011|Year 2 (12-Month Extension)|Moved|0|||
30757875|NCT00112437|58766933|FG012|Year 2 (12-Month Extension)|Moved|0|||
30757876|NCT00112437|58766934|FG013|Year 2 (12-Month Extension)|Moved|0|||
30757877|NCT00112437|58766935|FG014|Year 2 (12-Month Extension)|Moved|0|||
30757878|NCT00112437|58766936|FG015|Year 2 (12-Month Extension)|Moved|0|||
30757879|NCT00112437|58766937|FG016|Year 2 (12-Month Extension)|Moved|0|||
30757880|NCT00112437|58766938|FG017|Year 2 (12-Month Extension)|Moved|0|||
30838068|NCT02723864|58863096|FG001|Overall Study|Adverse Event|0|||
30838069|NCT02723864|58863097|FG002|Overall Study|Adverse Event|0|||
30838070|NCT02723864|58863098|FG003|Overall Study|Adverse Event|0|||
30838071|NCT02723864|58863099|FG004|Overall Study|Adverse Event|0|||
30757881|NCT00112437|58766939|FG018|Year 2 (12-Month Extension)|Moved|0|||
30838072|NCT02723864|58863100|FG005|Overall Study|Adverse Event|1|||
30838073|NCT02723864|58863101|FG006|Overall Study|Adverse Event|0|||
30838074|NCT02723864|58863095|FG000|Overall Study|Started new treatment|0|||
30838075|NCT02723864|58863096|FG001|Overall Study|Started new treatment|0|||
30929425|NCT02018861|58965218|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
30929426|NCT02018861|58965219|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
30929427|NCT02018861|58965220|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
30929428|NCT02018861|58965221|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
30929429|NCT02018861|58965222|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
30929430|NCT02018861|58965223|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
30929431|NCT01944722|58965254|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
30929432|NCT01944722|58965254|FG000|Overall Study|Specimen Shipping Issues|34|||
30929433|NCT01944722|58965254|FG000|Overall Study|Improper Storage/Transport|5|||
30929434|NCT01944722|58965254|FG000|Overall Study|Insufficient Volume for Test|1|||
30929435|NCT01944722|58965254|FG000|Overall Study|Missing Specimens|3|||
30929436|NCT01944722|58965254|FG000|Overall Study|Specimens Mislabeled|2|||
30929437|NCT01944722|58965254|FG000|Overall Study|Withdrawal by Subject|8|||
30929438|NCT01944722|58965254|FG000|Overall Study|NILM Subjects <30 years old|8106|||
30929439|NCT01944722|58965254|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
30929440|NCT01944722|58965254|FG000|Overall Study|>ASCUS Cytology|1122|||
30929441|NCT01917344|58965263|FG000|Overall Study|Withdrawal by Subject|1|||
30929442|NCT02017535|58965271|FG000|Overall Study|Withdrawal by Subject|1|||
30929443|NCT02017535|58965272|FG001|Overall Study|Withdrawal by Subject|0|||
30929444|NCT02017535|58965273|FG002|Overall Study|Withdrawal by Subject|0|||
30929445|NCT02017535|58965274|FG003|Overall Study|Withdrawal by Subject|0|||
30929446|NCT01944098|58965286|FG000|Overall Study|Physician Decision|1|||
30929447|NCT01944098|58965287|FG001|Overall Study|Physician Decision|0|||
30929448|NCT02017223|58965293|FG000|Overall Study|Algorithm problems|2|||
30929449|NCT01944020|58965299|FG000|Overall Study|Withdrawal by Subject|5|||
30929450|NCT01944020|58965300|FG001|Overall Study|Withdrawal by Subject|0|||
30929451|NCT01943552|58965308|FG000|Overall Study|Adverse Event|3|||
30929452|NCT01943552|58965309|FG001|Overall Study|Adverse Event|2|||
30929453|NCT01943552|58965308|FG000|Overall Study|Withdrawal by Subject|6|||
30929454|NCT01943552|58965309|FG001|Overall Study|Withdrawal by Subject|6|||
30929455|NCT01943552|58965308|FG000|Overall Study|Other Reasons|16|||
30929456|NCT01943552|58965309|FG001|Overall Study|Other Reasons|17|||
30929457|NCT01915940|58965317|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
30929458|NCT01915940|58965318|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
30838076|NCT02723864|58863097|FG002|Overall Study|Started new treatment|0|||
30929459|NCT01915940|58965319|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
30929460|NCT01915940|58965317|FG000|Treatment Period|Decision of Participant|0|||
30929461|NCT01915940|58965318|FG001|Treatment Period|Decision of Participant|1|||
30929462|NCT01915940|58965319|FG002|Treatment Period|Decision of Participant|3|||
30929463|NCT01915940|58965317|FG000|Treatment Period|Adverse Event|0|||
30929464|NCT01915940|58965318|FG001|Treatment Period|Adverse Event|9|||
30929465|NCT01915940|58965319|FG002|Treatment Period|Adverse Event|1|||
30929466|NCT01915940|58965317|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
30929467|NCT01915940|58965318|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
30929468|NCT01915940|58965319|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
30929469|NCT01914926|58965327|FG000|Overall Study|Adverse Event|1|||
30929470|NCT01914926|58965328|FG001|Overall Study|Adverse Event|0|||
30757882|NCT00112437|58766940|FG019|Year 2 (12-Month Extension)|Moved|0|||
30757883|NCT00112437|58766941|FG020|Year 2 (12-Month Extension)|Moved|0|||
30757884|NCT00112437|58766942|FG021|Year 2 (12-Month Extension)|Moved|0|||
30757885|NCT00112437|58766943|FG022|Year 2 (12-Month Extension)|Moved|0|||
30757886|NCT00112437|58766944|FG023|Year 2 (12-Month Extension)|Moved|0|||
30757887|NCT00112437|58766945|FG024|Year 2 (12-Month Extension)|Moved|0|||
30757888|NCT00112437|58766946|FG025|Year 2 (12-Month Extension)|Moved|0|||
30757889|NCT00112437|58766921|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
30757890|NCT00112437|58766922|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
30757891|NCT00112437|58766923|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
30757892|NCT00112437|58766924|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
30757893|NCT00112437|58766925|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
30838077|NCT02723864|58863098|FG003|Overall Study|Started new treatment|0|||
30838078|NCT02723864|58863099|FG004|Overall Study|Started new treatment|0|||
30838079|NCT02723864|58863100|FG005|Overall Study|Started new treatment|1|||
30838080|NCT02723864|58863101|FG006|Overall Study|Started new treatment|0|||
30838081|NCT02723864|58863095|FG000|Overall Study|Switched to alternative treatment|0|||
30838082|NCT02723864|58863096|FG001|Overall Study|Switched to alternative treatment|0|||
30838083|NCT02723864|58863097|FG002|Overall Study|Switched to alternative treatment|0|||
30929471|NCT01914926|58965327|FG000|Overall Study|uncooperative, agitated and removed|0|||
30929472|NCT01914926|58965328|FG001|Overall Study|uncooperative, agitated and removed|1|||
30929473|NCT02016755|58965334|FG000|Overall Study|Major amputation of index limb|2|||
30929474|NCT02016755|58965334|FG000|Overall Study|Adverse Event|2|||
30929475|NCT02016755|58965334|FG000|Overall Study|Physician Decision|1|||
30929476|NCT02016755|58965334|FG000|Overall Study|Death|2|||
30929477|NCT01942148|58965338|FG000|Overall Study|Adverse Event|4|||
30757894|NCT00112437|58766926|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
30757895|NCT00112437|58766927|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
30929478|NCT01942148|58965338|FG000|Overall Study|Lack of Efficacy|2|||
30929479|NCT01942148|58965338|FG000|Overall Study|Physician Decision|11|||
30929480|NCT01942148|58965338|FG000|Overall Study|Protocol Violation|1|||
30929481|NCT01942148|58965338|FG000|Overall Study|Withdrawal by Subject|8|||
30929482|NCT01942148|58965338|FG000|Overall Study|Use of the prohibition medicine|1|||
30929483|NCT02030015|58965342|FG000|Overall Study|Withdrawal by Subject|3|||
30929484|NCT02030015|58965342|FG000|Overall Study|Death|13|||
30929485|NCT02029235|58965348|FG000|Overall Study|Non-compliance with study meds or diary|4|||
30929486|NCT02029235|58965349|FG001|Overall Study|Non-compliance with study meds or diary|1|||
30929487|NCT01617434|58965357|FG000|Overall Study|Adverse Event|12|||
30929488|NCT01617434|58965358|FG001|Overall Study|Adverse Event|3|||
30929489|NCT01617434|58965357|FG000|Overall Study|Protocol Violation|8|||
30929490|NCT01617434|58965358|FG001|Overall Study|Protocol Violation|7|||
30929491|NCT01617434|58965357|FG000|Overall Study|Withdrawal Criteria|12|||
30929492|NCT01617434|58965358|FG001|Overall Study|Withdrawal Criteria|37|||
30929493|NCT01617434|58965357|FG000|Overall Study|Unclassified|3|||
30929494|NCT01617434|58965358|FG001|Overall Study|Unclassified|4|||
30929495|NCT01940900|58965366|FG000|Overall Study|Physician Decision|4|||
30929496|NCT01940900|58965367|FG001|Overall Study|Physician Decision|0|||
30929497|NCT01940900|58965366|FG000|Overall Study|Adverse Event|10|||
30929498|NCT01940900|58965367|FG001|Overall Study|Adverse Event|15|||
30929499|NCT01940900|58965366|FG000|Overall Study|Withdrawal by Subject|11|||
30929500|NCT01940900|58965367|FG001|Overall Study|Withdrawal by Subject|15|||
30929501|NCT01940900|58965366|FG000|Overall Study|Lost to Follow-up|1|||
30929502|NCT01940900|58965367|FG001|Overall Study|Lost to Follow-up|0|||
30929503|NCT01940900|58965366|FG000|Overall Study|Sponsor Decision|1|||
30929504|NCT01940900|58965367|FG001|Overall Study|Sponsor Decision|0|||
30929505|NCT01940900|58965366|FG000|Overall Study|subject non-compliance|1|||
30929506|NCT01940900|58965367|FG001|Overall Study|subject non-compliance|1|||
30929507|NCT01940900|58965366|FG000|Overall Study|other|1|||
30929508|NCT01940900|58965367|FG001|Overall Study|other|0|||
30929509|NCT01940354|58965375|FG000|Overall Study|Withdrawal by Subject|4|||
30929510|NCT01940354|58965376|FG001|Overall Study|Withdrawal by Subject|2|||
30929511|NCT01940120|58965382|FG000|Overall Study|Death|40|||
30929512|NCT01940120|58965382|FG000|Overall Study|Withdrawal by Subject|8|||
30929513|NCT01911260|58965391|FG000|Supplementation Period|transference or evasion of school|7|||
30929514|NCT01911260|58965392|FG001|Supplementation Period|transference or evasion of school|9|||
30929515|NCT01911260|58965393|FG002|Supplementation Period|transference or evasion of school|7|||
30929516|NCT01911260|58965394|FG003|Supplementation Period|transference or evasion of school|6|||
30929517|NCT01911260|58965391|FG000|Supplementation Period|Adverse Event|2|||
30929518|NCT01911260|58965392|FG001|Supplementation Period|Adverse Event|0|||
30929519|NCT01911260|58965393|FG002|Supplementation Period|Adverse Event|1|||
30929520|NCT01911260|58965394|FG003|Supplementation Period|Adverse Event|0|||
30929521|NCT01911260|58965391|FG000|Supplementation Period|refused to receive supplement|1|||
30929522|NCT01911260|58965392|FG001|Supplementation Period|refused to receive supplement|0|||
30929523|NCT01911260|58965393|FG002|Supplementation Period|refused to receive supplement|1|||
30929524|NCT01911260|58965394|FG003|Supplementation Period|refused to receive supplement|0|||
30929525|NCT01911260|58965391|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
30929526|NCT01911260|58965392|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
30929527|NCT01911260|58965393|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
30929528|NCT01911260|58965394|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
30929529|NCT01911260|58965391|FG000|Follow-up Period|transference or evasion of school|13|||
30929530|NCT01911260|58965392|FG001|Follow-up Period|transference or evasion of school|20|||
30929531|NCT01911260|58965393|FG002|Follow-up Period|transference or evasion of school|15|||
30929532|NCT01911260|58965394|FG003|Follow-up Period|transference or evasion of school|12|||
30929533|NCT02015819|58965408|FG000|Overall Study|Rickham catheter was misaligned|0|||
30929534|NCT02015819|58965409|FG001|Overall Study|Rickham catheter was misaligned|0|||
30757896|NCT00112437|58766928|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
30929535|NCT02015819|58965410|FG002|Overall Study|Rickham catheter was misaligned|0|||
30929536|NCT02015819|58965411|FG003|Overall Study|Rickham catheter was misaligned|1|||
30929537|NCT01939496|58965428|FG000|Overall Study|Adverse Event|2|||
30929538|NCT01939496|58965429|FG001|Overall Study|Adverse Event|0|||
30757897|NCT00112437|58766929|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
30757898|NCT00112437|58766930|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
30757899|NCT00112437|58766931|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
30757900|NCT00112437|58766932|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
30757901|NCT00112437|58766933|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
30757902|NCT00112437|58766934|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
30757903|NCT00112437|58766935|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
30757904|NCT00112437|58766936|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
30757905|NCT00112437|58766937|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
30757906|NCT00112437|58766938|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
30757907|NCT00112437|58766939|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
30757908|NCT00112437|58766940|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
30929539|NCT01939496|58965430|FG002|Overall Study|Adverse Event|0|||
30929540|NCT01939496|58965428|FG000|Overall Study|Lost to Follow-up|1|||
30929541|NCT01939496|58965429|FG001|Overall Study|Lost to Follow-up|1|||
30929542|NCT01939496|58965430|FG002|Overall Study|Lost to Follow-up|0|||
30929543|NCT01939496|58965428|FG000|Overall Study|Physician Decision|1|||
30929544|NCT01939496|58965429|FG001|Overall Study|Physician Decision|0|||
30929545|NCT01939496|58965430|FG002|Overall Study|Physician Decision|0|||
30929546|NCT01939496|58965428|FG000|Overall Study|Protocol Violation|3|||
30929547|NCT01939496|58965429|FG001|Overall Study|Protocol Violation|0|||
30929548|NCT01939496|58965430|FG002|Overall Study|Protocol Violation|0|||
30929549|NCT01939496|58965428|FG000|Overall Study|Withdrawal by Subject|0|||
30929550|NCT01939496|58965429|FG001|Overall Study|Withdrawal by Subject|1|||
30929551|NCT01939496|58965430|FG002|Overall Study|Withdrawal by Subject|1|||
30929552|NCT01939496|58965428|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
30929553|NCT01939496|58965429|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
30929554|NCT01939496|58965430|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
30929555|NCT01939496|58965428|FG000|Overall Study|Other|2|||
30929556|NCT01939496|58965429|FG001|Overall Study|Other|0|||
30929557|NCT01939496|58965430|FG002|Overall Study|Other|1|||
30929558|NCT01939028|58965438|FG000|Overall Study|Withdrawal by Subject|5|||
30929559|NCT01939028|58965438|FG000|Overall Study|Physician Decision|7|||
30929560|NCT01938716|58965442|FG000|Overall Study|Physician Decision|2|||
30929561|NCT01938716|58965442|FG000|Overall Study|Withdrawal by Subject|2|||
30929562|NCT01937390|58965446|FG000|Overall Study|Death|2|||
30929563|NCT01937390|58965446|FG000|Overall Study|Lost to Follow-up|7|||
30929564|NCT01937390|58965446|FG000|Overall Study|Withdrawal by Subject|5|||
30929565|NCT01937390|58965446|FG000|Overall Study|Fail to return|21|||
30929566|NCT02028767|58965450|FG000|Treatment Period 2|Non compliant with protocol|1|||
30929567|NCT02028767|58965451|FG001|Treatment Period 2|Non compliant with protocol|0|||
30929568|NCT02028767|58965450|FG000|Treatment Period 2|Reason other than those specified above|1|||
30929569|NCT02028767|58965451|FG001|Treatment Period 2|Reason other than those specified above|0|||
30929570|NCT01959932|58965460|FG000|Overall Study|Withdrawal by Subject|1|||
30929571|NCT01959932|58965461|FG001|Overall Study|Withdrawal by Subject|0|||
30929572|NCT01959932|58965462|FG002|Overall Study|Withdrawal by Subject|0|||
30929573|NCT02028065|58965474|FG000|Randomization Through Start Treatment|Not treated|1|||
30929574|NCT02028065|58965475|FG001|Randomization Through Start Treatment|Not treated|3|||
30929575|NCT02028065|58965476|FG002|Randomization Through Start Treatment|Not treated|3|||
30929576|NCT02028065|58965474|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
30929577|NCT02028065|58965475|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
30929578|NCT02028065|58965476|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
30929579|NCT02028065|58965474|FG000|Treatment Through Study Completion|Physician Decision|1|||
30929580|NCT02028065|58965475|FG001|Treatment Through Study Completion|Physician Decision|0|||
30929581|NCT02028065|58965476|FG002|Treatment Through Study Completion|Physician Decision|0|||
30929582|NCT02028065|58965474|FG000|Treatment Through Study Completion|Protocol Violation|1|||
30929583|NCT02028065|58965475|FG001|Treatment Through Study Completion|Protocol Violation|4|||
30929584|NCT02028065|58965476|FG002|Treatment Through Study Completion|Protocol Violation|0|||
30929585|NCT02028065|58965474|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
30929586|NCT02028065|58965475|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
30929587|NCT02028065|58965476|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
30929588|NCT02028065|58965474|FG000|Treatment Through Study Completion|Adverse Event|3|||
30929589|NCT02028065|58965475|FG001|Treatment Through Study Completion|Adverse Event|3|||
30929590|NCT02028065|58965476|FG002|Treatment Through Study Completion|Adverse Event|5|||
30929591|NCT02015195|58965491|FG000|Overall Study|Adverse Event|0|||
30929592|NCT02015195|58965492|FG001|Overall Study|Adverse Event|0|||
30929593|NCT02015195|58965493|FG002|Overall Study|Adverse Event|0|||
30929594|NCT02015195|58965494|FG003|Overall Study|Adverse Event|1|||
30929595|NCT02015195|58965495|FG004|Overall Study|Adverse Event|0|||
30929596|NCT02015195|58965496|FG005|Overall Study|Adverse Event|0|||
30929597|NCT02015195|58965497|FG006|Overall Study|Adverse Event|0|||
30929598|NCT02015039|58965514|FG000|Overall Study|Not eligible|0|||
30929599|NCT02015039|58965515|FG001|Overall Study|Not eligible|1|||
30624166|NCT00959049|58636125|FG004|Overall Study|Contraindicated medication|0|||
30624167|NCT00959049|58636126|FG005|Overall Study|Contraindicated medication|0|||
30624168|NCT00959049|58636121|FG000|Overall Study|Withdrawal by Subject|0|||
30757909|NCT00112437|58766941|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
30757910|NCT00112437|58766942|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
30757911|NCT00112437|58766943|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
30757912|NCT00112437|58766944|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
30757913|NCT00112437|58766945|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
30757914|NCT00112437|58766946|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
30757915|NCT00112437|58766921|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757916|NCT00112437|58766922|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30929600|NCT02025725|58965523|FG000|Overall Study|Adverse Event|5|||
30929601|NCT02025725|58965524|FG001|Overall Study|Adverse Event|0|||
30929602|NCT02025725|58965523|FG000|Overall Study|Lost to Follow-up|2|||
30929603|NCT02025725|58965524|FG001|Overall Study|Lost to Follow-up|0|||
30929604|NCT02025725|58965523|FG000|Overall Study|Protocol Violation|1|||
30929605|NCT02025725|58965524|FG001|Overall Study|Protocol Violation|1|||
30929606|NCT02025725|58965523|FG000|Overall Study|Withdrawal by Subject|3|||
30929607|NCT02025725|58965524|FG001|Overall Study|Withdrawal by Subject|2|||
30929608|NCT02025725|58965523|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
30929609|NCT02025725|58965524|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
30929610|NCT02025179|58965535|FG000|Overall Study|Lost to Follow-up|0|||
30929611|NCT02025179|58965536|FG001|Overall Study|Lost to Follow-up|0|||
30929612|NCT02025179|58965537|FG002|Overall Study|Lost to Follow-up|1|||
30929613|NCT02013791|58965554|FG000|Period 1|Lost to Follow-up|0|||
30929614|NCT02013791|58965555|FG001|Period 1|Lost to Follow-up|0|||
30929615|NCT02013791|58965556|FG002|Period 1|Lost to Follow-up|0|||
30929616|NCT02013791|58965557|FG003|Period 1|Lost to Follow-up|1|||
30929617|NCT02013791|58965558|FG004|Period 1|Lost to Follow-up|0|||
30929618|NCT02013791|58965559|FG005|Period 1|Lost to Follow-up|0|||
30929619|NCT02013791|58965560|FG006|Period 1|Lost to Follow-up|1|||
30929620|NCT02013791|58965561|FG007|Period 1|Lost to Follow-up|1|||
30929621|NCT02013791|58965562|FG008|Period 1|Lost to Follow-up|0|||
30929622|NCT02013791|58965554|FG000|Period 1|Other Miscellaneous Reasons|0|||
30929623|NCT02013791|58965555|FG001|Period 1|Other Miscellaneous Reasons|2|||
30929624|NCT02013791|58965556|FG002|Period 1|Other Miscellaneous Reasons|0|||
30929625|NCT02013791|58965557|FG003|Period 1|Other Miscellaneous Reasons|0|||
30929626|NCT02013791|58965558|FG004|Period 1|Other Miscellaneous Reasons|0|||
30929627|NCT02013791|58965559|FG005|Period 1|Other Miscellaneous Reasons|0|||
30929628|NCT02013791|58965560|FG006|Period 1|Other Miscellaneous Reasons|0|||
30929629|NCT02013791|58965561|FG007|Period 1|Other Miscellaneous Reasons|0|||
30929630|NCT02013791|58965562|FG008|Period 1|Other Miscellaneous Reasons|0|||
30929631|NCT02024867|58965585|FG000|Overall Study|Protocol Violation|3|||
30929632|NCT02024867|58965586|FG001|Overall Study|Protocol Violation|3|||
30929633|NCT02024867|58965585|FG000|Overall Study|Lost to Follow-up|6|||
30929634|NCT02024867|58965586|FG001|Overall Study|Lost to Follow-up|4|||
30929635|NCT01953601|58965595|FG000|Part 1 (Base Study)|Adverse Event|24|||
30929636|NCT01953601|58965596|FG001|Part 1 (Base Study)|Adverse Event|37|||
30929637|NCT01953601|58965597|FG002|Part 1 (Base Study)|Adverse Event|15|||
30929638|NCT01953601|58965595|FG000|Part 1 (Base Study)|Death|2|||
30929639|NCT01953601|58965596|FG001|Part 1 (Base Study)|Death|0|||
30929640|NCT01953601|58965597|FG002|Part 1 (Base Study)|Death|3|||
30929641|NCT01953601|58965595|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
30929642|NCT01953601|58965596|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
30929643|NCT01953601|58965597|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
30929644|NCT01953601|58965595|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
30929645|NCT01953601|58965596|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
30929646|NCT01953601|58965597|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
30929647|NCT01953601|58965595|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
30929648|NCT01953601|58965596|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
30929649|NCT01953601|58965597|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
30929650|NCT01953601|58965595|FG000|Part 1 (Base Study)|Physician Decision|3|||
30929651|NCT01953601|58965596|FG001|Part 1 (Base Study)|Physician Decision|7|||
30929652|NCT01953601|58965597|FG002|Part 1 (Base Study)|Physician Decision|4|||
30929653|NCT01953601|58965595|FG000|Part 1 (Base Study)|Screen failure|1|||
30929654|NCT01953601|58965596|FG001|Part 1 (Base Study)|Screen failure|0|||
30929655|NCT01953601|58965597|FG002|Part 1 (Base Study)|Screen failure|1|||
30929656|NCT01953601|58965595|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
30929657|NCT01953601|58965596|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
30929658|NCT01953601|58965597|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
30929659|NCT01953601|58965595|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
30929660|NCT01953601|58965596|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
30929661|NCT01953601|58965597|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
30929662|NCT01953601|58965595|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
30929663|NCT01953601|58965596|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
30929664|NCT01953601|58965597|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
30929665|NCT01953601|58965595|FG000|Part 1 (Base Study)|Subject moved|2|||
30929666|NCT01953601|58965596|FG001|Part 1 (Base Study)|Subject moved|2|||
30929667|NCT01953601|58965597|FG002|Part 1 (Base Study)|Subject moved|1|||
30929668|NCT01953601|58965595|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
30929669|NCT01953601|58965596|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
30929670|NCT01953601|58965597|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
30929671|NCT01953601|58965595|FG000|Part 2 (Extension Study)|Adverse Event|1|||
30929672|NCT01953601|58965596|FG001|Part 2 (Extension Study)|Adverse Event|1|||
30929673|NCT01953601|58965597|FG002|Part 2 (Extension Study)|Adverse Event|10|||
30929674|NCT01953601|58965595|FG000|Part 2 (Extension Study)|Death|0|||
30929675|NCT01953601|58965596|FG001|Part 2 (Extension Study)|Death|3|||
30929676|NCT01953601|58965597|FG002|Part 2 (Extension Study)|Death|0|||
30929677|NCT01953601|58965595|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
30929678|NCT01953601|58965596|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
30929679|NCT01953601|58965597|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
30929680|NCT01953601|58965595|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
30929681|NCT01953601|58965596|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
30929682|NCT01953601|58965597|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
30929683|NCT01953601|58965595|FG000|Part 2 (Extension Study)|Physician Decision|2|||
30929684|NCT01953601|58965596|FG001|Part 2 (Extension Study)|Physician Decision|0|||
30929685|NCT01953601|58965597|FG002|Part 2 (Extension Study)|Physician Decision|2|||
30929686|NCT01953601|58965595|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
30929687|NCT01953601|58965596|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
30929688|NCT01953601|58965597|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
30929689|NCT01953601|58965595|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
30929690|NCT01953601|58965596|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
30929691|NCT01953601|58965597|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
30929692|NCT01953601|58965595|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
30929693|NCT01953601|58965596|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
30929694|NCT01953601|58965597|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
30929695|NCT01953601|58965595|FG000|Part 2 (Extension Study)|Subject moved|0|||
30929696|NCT01953601|58965596|FG001|Part 2 (Extension Study)|Subject moved|0|||
30929697|NCT01953601|58965597|FG002|Part 2 (Extension Study)|Subject moved|1|||
30929698|NCT01953601|58965595|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
30929699|NCT01953601|58965596|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
30929700|NCT01953601|58965597|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
30929701|NCT01952665|58965610|FG000|Overall Study|Physician Decision|3|||
30929702|NCT01952665|58965611|FG001|Overall Study|Physician Decision|2|||
30929703|NCT01952665|58965610|FG000|Overall Study|Lost to Follow-up|1|||
30929704|NCT01952665|58965611|FG001|Overall Study|Lost to Follow-up|2|||
30929705|NCT01952665|58965610|FG000|Overall Study|Adverse Event|2|||
30929706|NCT01952665|58965611|FG001|Overall Study|Adverse Event|1|||
30929707|NCT01952665|58965610|FG000|Overall Study|Protocol Violation|0|||
30929708|NCT01952665|58965611|FG001|Overall Study|Protocol Violation|1|||
30929709|NCT01952041|58965622|FG000|Overall Study|Lost to Follow-up|9|||
30929710|NCT01952041|58965623|FG001|Overall Study|Lost to Follow-up|16|||
30929711|NCT01952041|58965622|FG000|Overall Study|Withdrawal by Subject|7|||
30929712|NCT01952041|58965623|FG001|Overall Study|Withdrawal by Subject|5|||
30929713|NCT01952041|58965622|FG000|Overall Study|Death|1|||
30929714|NCT01952041|58965623|FG001|Overall Study|Death|0|||
30929715|NCT01951573|58965629|FG000|Washout Period|Adverse Event|0|||
30929716|NCT01951573|58965630|FG001|Washout Period|Adverse Event|1|||
30929717|NCT02023697|58965639|FG000|Treatment Period|Radiological progression|13|||
30929718|NCT02023697|58965640|FG001|Treatment Period|Radiological progression|17|||
30929719|NCT02023697|58965641|FG002|Treatment Period|Radiological progression|26|||
30929720|NCT02023697|58965639|FG000|Treatment Period|Never Treated|5|||
30929721|NCT02023697|58965640|FG001|Treatment Period|Never Treated|6|||
30838084|NCT02723864|58863098|FG003|Overall Study|Switched to alternative treatment|0|||
30838085|NCT02723864|58863099|FG004|Overall Study|Switched to alternative treatment|0|||
30838086|NCT02723864|58863100|FG005|Overall Study|Switched to alternative treatment|1|||
30838087|NCT02723864|58863101|FG006|Overall Study|Switched to alternative treatment|0|||
30838088|NCT02723864|58863095|FG000|Overall Study|Late determination of ineligibility|0|||
30838089|NCT02723864|58863096|FG001|Overall Study|Late determination of ineligibility|0|||
30838090|NCT02723864|58863097|FG002|Overall Study|Late determination of ineligibility|0|||
30838091|NCT02723864|58863098|FG003|Overall Study|Late determination of ineligibility|0|||
30838092|NCT02723864|58863099|FG004|Overall Study|Late determination of ineligibility|0|||
30838093|NCT02723864|58863100|FG005|Overall Study|Late determination of ineligibility|1|||
30838094|NCT02723864|58863101|FG006|Overall Study|Late determination of ineligibility|0|||
30838095|NCT00705146|58863140|FG000|Overall Study|Lost to Follow-up|1|||
30838096|NCT00705146|58863141|FG001|Overall Study|Lost to Follow-up|1|||
30838097|NCT03203642|58863149|FG000|Overall Study|Adverse Event|3|||
30929722|NCT02023697|58965641|FG002|Treatment Period|Never Treated|10|||
30929723|NCT02023697|58965639|FG000|Treatment Period|Adverse Event|13|||
30838098|NCT03203642|58863150|FG001|Overall Study|Adverse Event|1|||
30929724|NCT02023697|58965640|FG001|Treatment Period|Adverse Event|25|||
30929725|NCT02023697|58965641|FG002|Treatment Period|Adverse Event|23|||
30929726|NCT02023697|58965639|FG000|Treatment Period|Logistical difficulties|1|||
30929727|NCT02023697|58965640|FG001|Treatment Period|Logistical difficulties|1|||
30929728|NCT02023697|58965641|FG002|Treatment Period|Logistical difficulties|1|||
30929729|NCT02023697|58965639|FG000|Treatment Period|Clinical progression|10|||
30929730|NCT02023697|58965640|FG001|Treatment Period|Clinical progression|8|||
30838099|NCT03203642|58863149|FG000|Overall Study|Withdrawal by Subject|6|||
30838100|NCT03203642|58863150|FG001|Overall Study|Withdrawal by Subject|6|||
30838101|NCT03203642|58863149|FG000|Overall Study|Lost to Follow-up|2|||
30838102|NCT03203642|58863150|FG001|Overall Study|Lost to Follow-up|1|||
30838103|NCT03203642|58863149|FG000|Overall Study|Termination of the study by sponsor|1|||
30838104|NCT03203642|58863150|FG001|Overall Study|Termination of the study by sponsor|1|||
30838105|NCT03203642|58863149|FG000|Overall Study|Participant moved|0|||
30838106|NCT03203642|58863150|FG001|Overall Study|Participant moved|1|||
30838107|NCT03203642|58863149|FG000|Overall Study|Investigator's decision|3|||
30838108|NCT03203642|58863150|FG001|Overall Study|Investigator's decision|0|||
30838109|NCT03203642|58863149|FG000|Overall Study|Other than above specified|0|||
30838110|NCT03203642|58863150|FG001|Overall Study|Other than above specified|1|||
30838111|NCT02737722|58863160|FG000|Overall Study|Physician Decision|0|||
30838112|NCT02737722|58863161|FG001|Overall Study|Physician Decision|0|||
30838113|NCT02737722|58863162|FG002|Overall Study|Physician Decision|1|||
30838114|NCT02737722|58863163|FG003|Overall Study|Physician Decision|0|||
30838115|NCT03792750|58863173|FG000|Overall Study|Death|3|||
30838116|NCT02750709|58863178|FG000|Treatment Period 1|Adverse Event|0|||
30929731|NCT02023697|58965641|FG002|Treatment Period|Clinical progression|28|||
30929732|NCT02023697|58965639|FG000|Treatment Period|Withdrawal by Subject|4|||
30929733|NCT02023697|58965640|FG001|Treatment Period|Withdrawal by Subject|5|||
30929734|NCT02023697|58965641|FG002|Treatment Period|Withdrawal by Subject|13|||
30929735|NCT02023697|58965639|FG000|Treatment Period|Safety outcome reached|0|||
30929736|NCT02023697|58965640|FG001|Treatment Period|Safety outcome reached|1|||
30929737|NCT02023697|58965641|FG002|Treatment Period|Safety outcome reached|0|||
30929738|NCT02023697|58965639|FG000|Treatment Period|Physician Decision|0|||
30929739|NCT02023697|58965640|FG001|Treatment Period|Physician Decision|0|||
30929740|NCT02023697|58965641|FG002|Treatment Period|Physician Decision|1|||
30929741|NCT02023697|58965639|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
30929742|NCT02023697|58965640|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
30929743|NCT02023697|58965641|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
30929744|NCT02023697|58965639|FG000|Active Follow-up Period|Lost to Follow-up|1|||
30929745|NCT02023697|58965640|FG001|Active Follow-up Period|Lost to Follow-up|1|||
30929746|NCT02023697|58965641|FG002|Active Follow-up Period|Lost to Follow-up|1|||
30929747|NCT02023697|58965639|FG000|Active Follow-up Period|Deterioration of general condition|1|||
30929748|NCT02023697|58965640|FG001|Active Follow-up Period|Deterioration of general condition|1|||
30929749|NCT02023697|58965641|FG002|Active Follow-up Period|Deterioration of general condition|1|||
30929750|NCT02023697|58965639|FG000|Active Follow-up Period|Other unspecified|2|||
30929751|NCT02023697|58965640|FG001|Active Follow-up Period|Other unspecified|0|||
30929752|NCT02023697|58965641|FG002|Active Follow-up Period|Other unspecified|1|||
30929753|NCT02023697|58965639|FG000|Active Follow-up Period|Clinical progression|0|||
30929754|NCT02023697|58965640|FG001|Active Follow-up Period|Clinical progression|2|||
30929755|NCT02023697|58965641|FG002|Active Follow-up Period|Clinical progression|1|||
30929756|NCT02023697|58965639|FG000|Active Follow-up Period|Radiological progression|0|||
30929757|NCT02023697|58965640|FG001|Active Follow-up Period|Radiological progression|0|||
30929758|NCT02023697|58965641|FG002|Active Follow-up Period|Radiological progression|1|||
30929759|NCT02023697|58965639|FG000|Active Follow-up Period|Death|83|||
30929760|NCT02023697|58965640|FG001|Active Follow-up Period|Death|82|||
30929761|NCT02023697|58965641|FG002|Active Follow-up Period|Death|87|||
30929762|NCT02023697|58965639|FG000|Long-term Follow-up Period|Death|9|||
30929763|NCT02023697|58965640|FG001|Long-term Follow-up Period|Death|6|||
30929764|NCT02023697|58965641|FG002|Long-term Follow-up Period|Death|4|||
30929765|NCT02023697|58965639|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
30929766|NCT02023697|58965640|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
30929767|NCT02023697|58965641|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
30929768|NCT02023697|58965639|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
30929769|NCT02023697|58965640|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
30757917|NCT00112437|58766923|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757918|NCT00112437|58766924|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757919|NCT00112437|58766925|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757920|NCT00112437|58766926|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757921|NCT00112437|58766927|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757922|NCT00112437|58766928|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757923|NCT00112437|58766929|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757924|NCT00112437|58766930|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757925|NCT00112437|58766931|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757926|NCT00112437|58766932|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
30757927|NCT00112437|58766933|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757928|NCT00112437|58766934|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
30838117|NCT02750709|58863179|FG001|Treatment Period 1|Adverse Event|0|||
30838118|NCT02750709|58863180|FG002|Treatment Period 1|Adverse Event|0|||
30838119|NCT02750709|58863181|FG003|Treatment Period 1|Adverse Event|0|||
30929770|NCT02023697|58965641|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
30929771|NCT02023697|58965639|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
30929772|NCT02023697|58965640|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
30757929|NCT00112437|58766935|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757930|NCT00112437|58766936|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
30929773|NCT02023697|58965641|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
30929774|NCT02023697|58965639|FG000|Long-term Follow-up Period|Technical problems|0|||
30929775|NCT02023697|58965640|FG001|Long-term Follow-up Period|Technical problems|0|||
30929776|NCT02023697|58965641|FG002|Long-term Follow-up Period|Technical problems|1|||
30929777|NCT02023697|58965639|FG000|Long-term Follow-up Period|Other unspecified|6|||
30929778|NCT02023697|58965640|FG001|Long-term Follow-up Period|Other unspecified|3|||
30929779|NCT02023697|58965641|FG002|Long-term Follow-up Period|Other unspecified|5|||
30929780|NCT01951417|58965656|FG000|Overall Study|Withdrawal by Subject|1|||
30929781|NCT01951417|58965656|FG000|Overall Study|Protocol Violation|2|||
30929782|NCT01951417|58965656|FG000|Overall Study|Lost to Follow-up|6|||
30929783|NCT01951261|58965666|FG000|Overall Study|Death|1|||
30929784|NCT01951261|58965667|FG001|Overall Study|Death|0|||
30929785|NCT01951261|58965666|FG000|Overall Study|Lost to Follow-up|4|||
30929786|NCT01951261|58965667|FG001|Overall Study|Lost to Follow-up|3|||
30929787|NCT01951261|58965666|FG000|Overall Study|Protocol Violation|4|||
30929788|NCT01951261|58965667|FG001|Overall Study|Protocol Violation|3|||
30929789|NCT02023151|58965673|FG000|Overall Study|Lost to Follow-up|4|||
30929790|NCT01979185|58965679|FG000|Period 2|Other|0|||
30929791|NCT01979185|58965680|FG001|Period 2|Other|1|||
30929792|NCT01946425|58965688|FG000|Overall Study|Protocol Violation|1|||
30929793|NCT01946425|58965689|FG001|Overall Study|Protocol Violation|0|||
30929794|NCT01946425|58965688|FG000|Overall Study|Withdrawal by Subject|1|||
30929795|NCT01946425|58965689|FG001|Overall Study|Withdrawal by Subject|0|||
30929796|NCT01946191|58965698|FG000|Allocation|Did not complete orientation|1|||
30929797|NCT01946191|58965699|FG001|Allocation|Did not complete orientation|1|||
30929798|NCT01946191|58965698|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
30929799|NCT01946191|58965699|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
30929800|NCT01946191|58965698|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
30929801|NCT01946191|58965699|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
30929802|NCT01946191|58965698|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
30929803|NCT01946191|58965699|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
30929804|NCT01937312|58965708|FG000|Overall Study|Adverse Event|10|||
30929805|NCT01937312|58965709|FG001|Overall Study|Adverse Event|1|||
30929806|NCT01937312|58965708|FG000|Overall Study|Lack of Efficacy|0|||
30929807|NCT01937312|58965709|FG001|Overall Study|Lack of Efficacy|1|||
30929808|NCT01937312|58965708|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
30838120|NCT02750709|58863182|FG004|Treatment Period 1|Adverse Event|0|||
30838121|NCT02750709|58863183|FG005|Treatment Period 1|Adverse Event|1|||
30929809|NCT01937312|58965709|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
30929810|NCT01909934|58965716|FG000|Overall Study|Ongoing|23|||
30929811|NCT01909934|58965716|FG000|Overall Study|Withdrawal by Subject|3|||
30929812|NCT01909934|58965716|FG000|Overall Study|Lost to Follow-up|1|||
30929813|NCT01909934|58965716|FG000|Overall Study|Withdrawal of Informed Consent|1|||
30757931|NCT00112437|58766937|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757932|NCT00112437|58766938|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757933|NCT00112437|58766939|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
30757934|NCT00112437|58766940|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757935|NCT00112437|58766941|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30838122|NCT02723786|58863191|FG000|Overall Study|Lost to Follow-up|1|||
30838123|NCT02723084|58863210|FG000|Overall Study|Withdrawal by Subject|1|||
30838124|NCT02723084|58863211|FG001|Overall Study|Withdrawal by Subject|1|||
30838125|NCT02723084|58863210|FG000|Overall Study|Lost to Follow-up|3|||
30838126|NCT02723084|58863211|FG001|Overall Study|Lost to Follow-up|0|||
30838127|NCT02750943|58863219|FG000|Overall Study|Lost to Follow-up|1|||
30838128|NCT02750943|58863220|FG001|Overall Study|Lost to Follow-up|2|||
30838129|NCT02750943|58863219|FG000|Overall Study|Withdrawal by Subject|5|||
30838130|NCT02750943|58863220|FG001|Overall Study|Withdrawal by Subject|7|||
30838131|NCT04730349|58863237|FG000|Overall Study|Participant withdrew consent|1|||
30757936|NCT00112437|58766942|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30838132|NCT04730349|58863238|FG001|Overall Study|Participant withdrew consent|0|||
30838133|NCT04730349|58863237|FG000|Overall Study|Disease progression|6|||
30838134|NCT04730349|58863238|FG001|Overall Study|Disease progression|4|||
30838135|NCT04730349|58863237|FG000|Overall Study|Study drug toxicity|0|||
30838136|NCT04730349|58863238|FG001|Overall Study|Study drug toxicity|1|||
30838137|NCT04307394|58863257|FG000|Overall Study|Lost to Follow-up|3|||
30838138|NCT04307394|58863257|FG000|Overall Study|Withdrawal by Subject|2|||
30929814|NCT01909934|58965716|FG000|Overall Study|Death|22|||
30929815|NCT01935128|58965720|FG000|Overall Study|Death|1|||
30929816|NCT01935128|58965720|FG000|Overall Study|Adverse Event|6|||
30929817|NCT01934972|58965726|FG000|Overall Study|Withdrawal by Subject|9|||
30929818|NCT01934972|58965727|FG001|Overall Study|Withdrawal by Subject|6|||
30929819|NCT01959230|58965735|FG000|Overall Study|Failure to follow study procedures|0|||
30929820|NCT01959230|58965736|FG001|Overall Study|Failure to follow study procedures|1|||
30929821|NCT01959230|58965735|FG000|Overall Study|Administrative reasons|2|||
30838139|NCT03940742|58863283|FG000|Overall Study|Lost to Follow-up|0|||
30838140|NCT03940742|58863284|FG001|Overall Study|Lost to Follow-up|0|||
30838141|NCT03940742|58863285|FG002|Overall Study|Lost to Follow-up|0|||
30838142|NCT03940742|58863286|FG003|Overall Study|Lost to Follow-up|1|||
30838143|NCT03917654|58863308|FG000|Year 1|Withdrawal by Subject|1|||
30838144|NCT03917654|58863309|FG001|Year 1|Withdrawal by Subject|0|||
30838145|NCT03917654|58863310|FG002|Year 1|Withdrawal by Subject|0|||
30838146|NCT03917654|58863311|FG003|Year 1|Withdrawal by Subject|0|||
30838147|NCT03917654|58863312|FG004|Year 1|Withdrawal by Subject|0|||
30838148|NCT03917654|58863313|FG005|Year 1|Withdrawal by Subject|1|||
30838149|NCT03917654|58863314|FG006|Year 1|Withdrawal by Subject|6|||
30929822|NCT01959230|58965736|FG001|Overall Study|Administrative reasons|0|||
30929823|NCT01959230|58965735|FG000|Overall Study|Withdrawal by Subject|2|||
30929824|NCT01959230|58965736|FG001|Overall Study|Withdrawal by Subject|0|||
30929825|NCT01909778|58965742|FG000|Overall Study|failed screening|1|||
30929826|NCT01977937|58965750|FG000|Overall Study|Withdrawal by Subject|2|||
30929827|NCT01977937|58965751|FG001|Overall Study|Withdrawal by Subject|1|||
30929828|NCT01977937|58965750|FG000|Overall Study|Adverse Event|1|||
30929829|NCT01977937|58965751|FG001|Overall Study|Adverse Event|0|||
30929830|NCT01977937|58965750|FG000|Overall Study|Physician Decision|0|||
30929831|NCT01977937|58965751|FG001|Overall Study|Physician Decision|1|||
30929832|NCT02015663|58965759|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
30929833|NCT02015663|58965760|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
30929834|NCT02015663|58965759|FG000|Overall Study|Withdrawal by Subject|1|||
30929835|NCT02015663|58965760|FG001|Overall Study|Withdrawal by Subject|0|||
30838150|NCT03917654|58863315|FG007|Year 1|Withdrawal by Subject|2|||
30838151|NCT03917654|58863316|FG008|Year 1|Withdrawal by Subject|5|||
30929836|NCT02015663|58965759|FG000|Overall Study|Protocol Violation|0|||
30929837|NCT02015663|58965760|FG001|Overall Study|Protocol Violation|1|||
30929838|NCT02015663|58965759|FG000|Overall Study|Adverse Event|3|||
30929839|NCT02015663|58965760|FG001|Overall Study|Adverse Event|0|||
30929840|NCT02015663|58965759|FG000|Overall Study|Administrative problems|10|||
30929841|NCT02015663|58965760|FG001|Overall Study|Administrative problems|11|||
30929842|NCT01978093|58965769|FG000|Overall Study|Death|1|||
30929843|NCT01978093|58965770|FG001|Overall Study|Death|0|||
30929844|NCT01978093|58965769|FG000|Overall Study|Adverse Event|0|||
30929845|NCT01978093|58965770|FG001|Overall Study|Adverse Event|5|||
30929846|NCT01978093|58965769|FG000|Overall Study|Protocol Violation|8|||
30929847|NCT01978093|58965770|FG001|Overall Study|Protocol Violation|2|||
30929848|NCT01978093|58965769|FG000|Overall Study|Withdrawal by Subject|29|||
30929849|NCT01978093|58965770|FG001|Overall Study|Withdrawal by Subject|25|||
30929850|NCT01978093|58965769|FG000|Overall Study|Lost to Follow-up|11|||
30929851|NCT01978093|58965770|FG001|Overall Study|Lost to Follow-up|15|||
30929852|NCT01978093|58965769|FG000|Overall Study|Migrated/moved from study area|11|||
30929853|NCT01978093|58965770|FG001|Overall Study|Migrated/moved from study area|13|||
30757937|NCT00112437|58766943|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757938|NCT00112437|58766944|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757939|NCT00112437|58766945|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757940|NCT00112437|58766946|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
30757941|NCT00112437|58766921|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757942|NCT00112437|58766922|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757943|NCT00112437|58766923|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757944|NCT00112437|58766924|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757945|NCT00112437|58766925|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757946|NCT00112437|58766926|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757947|NCT00112437|58766927|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757948|NCT00112437|58766928|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757949|NCT00112437|58766929|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757950|NCT00112437|58766930|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757951|NCT00112437|58766931|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30838152|NCT03917654|58863317|FG009|Year 1|Withdrawal by Subject|3|||
30838153|NCT03917654|58863318|FG010|Year 1|Withdrawal by Subject|1|||
30838154|NCT03917654|58863319|FG011|Year 1|Withdrawal by Subject|0|||
30838155|NCT03917654|58863308|FG000|Year 1|Travel|0|||
30838156|NCT03917654|58863309|FG001|Year 1|Travel|1|||
30838157|NCT03917654|58863310|FG002|Year 1|Travel|1|||
30838158|NCT03917654|58863311|FG003|Year 1|Travel|0|||
30838159|NCT03917654|58863312|FG004|Year 1|Travel|4|||
30838160|NCT03917654|58863313|FG005|Year 1|Travel|4|||
30838161|NCT03917654|58863314|FG006|Year 1|Travel|10|||
30929854|NCT01978093|58965769|FG000|Overall Study|Loss of kaiser coverage|4|||
30929855|NCT01978093|58965770|FG001|Overall Study|Loss of kaiser coverage|10|||
30929856|NCT01978093|58965769|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
30929857|NCT01978093|58965770|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
30929858|NCT01978093|58965769|FG000|Overall Study|Mother lost custody of child|0|||
30929859|NCT01978093|58965770|FG001|Overall Study|Mother lost custody of child|1|||
30929860|NCT01978093|58965769|FG000|Overall Study|Child was in care of grandmother|0|||
30929861|NCT01978093|58965770|FG001|Overall Study|Child was in care of grandmother|1|||
30929862|NCT01978093|58965769|FG000|Overall Study|N/A for vaccine administration|0|||
30929863|NCT01978093|58965770|FG001|Overall Study|N/A for vaccine administration|1|||
30929864|NCT01951105|58965782|FG000|Overall Study|Adverse Event|0|||
30929865|NCT01951105|58965783|FG001|Overall Study|Adverse Event|5|||
30929866|NCT01951105|58965784|FG002|Overall Study|Adverse Event|0|||
30929867|NCT01951105|58965782|FG000|Overall Study|Lost to Follow-up|0|||
30929868|NCT01951105|58965783|FG001|Overall Study|Lost to Follow-up|1|||
30929869|NCT01951105|58965784|FG002|Overall Study|Lost to Follow-up|0|||
30929870|NCT01951105|58965782|FG000|Overall Study|Protocol Violation|1|||
30929871|NCT01951105|58965783|FG001|Overall Study|Protocol Violation|1|||
30929872|NCT01951105|58965784|FG002|Overall Study|Protocol Violation|1|||
30929873|NCT01951105|58965782|FG000|Overall Study|Withdrawal by Subject|0|||
30929874|NCT01951105|58965783|FG001|Overall Study|Withdrawal by Subject|3|||
30929875|NCT01951105|58965784|FG002|Overall Study|Withdrawal by Subject|1|||
30929876|NCT01958918|58965800|FG000|Overall Study|Death|1|||
30929877|NCT01958918|58965801|FG001|Overall Study|Death|3|||
30929878|NCT01958918|58965800|FG000|Overall Study|Lost to Follow-up|4|||
30929879|NCT01958918|58965801|FG001|Overall Study|Lost to Follow-up|7|||
30929880|NCT01958918|58965800|FG000|Overall Study|Withdrawal by Subject|13|||
30929881|NCT01958918|58965801|FG001|Overall Study|Withdrawal by Subject|8|||
30929882|NCT01958918|58965800|FG000|Overall Study|Lack of Efficacy|13|||
30929883|NCT01958918|58965801|FG001|Overall Study|Lack of Efficacy|10|||
30929884|NCT01958918|58965800|FG000|Overall Study|Adverse Event|12|||
30929885|NCT01958918|58965801|FG001|Overall Study|Adverse Event|12|||
30929886|NCT01958918|58965800|FG000|Overall Study|administrative problems|0|||
30929887|NCT01958918|58965801|FG001|Overall Study|administrative problems|2|||
30929888|NCT01945489|58965809|FG000|Cycle 1|Adverse Event|2|||
30929889|NCT01945489|58965810|FG001|Cycle 1|Adverse Event|0|||
30929890|NCT01945489|58965809|FG000|Cycle 1|Lost to Follow-up|4|||
30929891|NCT01945489|58965810|FG001|Cycle 1|Lost to Follow-up|0|||
30929892|NCT01945489|58965809|FG000|Cycle 1|Personal Reasons|4|||
30929893|NCT01945489|58965810|FG001|Cycle 1|Personal Reasons|2|||
30929894|NCT01945489|58965809|FG000|Cycle 1|Protocol Violation|0|||
30929895|NCT01945489|58965810|FG001|Cycle 1|Protocol Violation|1|||
30929896|NCT01945489|58965809|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
30929897|NCT01945489|58965810|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
30929898|NCT01945489|58965809|FG000|Cycle 2|Adverse Event|1|||
30929899|NCT01945489|58965810|FG001|Cycle 2|Adverse Event|0|||
30929900|NCT01945489|58965809|FG000|Cycle 2|Lost to Follow-up|0|||
30929901|NCT01945489|58965810|FG001|Cycle 2|Lost to Follow-up|1|||
30838162|NCT03917654|58863315|FG007|Year 1|Travel|8|||
30838163|NCT03917654|58863316|FG008|Year 1|Travel|2|||
30838164|NCT03917654|58863317|FG009|Year 1|Travel|5|||
30838165|NCT03917654|58863318|FG010|Year 1|Travel|3|||
30838166|NCT03917654|58863319|FG011|Year 1|Travel|3|||
30838167|NCT03917654|58863308|FG000|Year 1|Subject moved away from site|0|||
30838168|NCT03917654|58863309|FG001|Year 1|Subject moved away from site|1|||
30838169|NCT03917654|58863310|FG002|Year 1|Subject moved away from site|0|||
30838170|NCT03917654|58863311|FG003|Year 1|Subject moved away from site|0|||
30929902|NCT01934894|58965819|FG000|Overall Study|Adverse Event|1|||
30929903|NCT01934894|58965820|FG001|Overall Study|Adverse Event|2|||
30929904|NCT01934894|58965819|FG000|Overall Study|Death|2|||
30929905|NCT01934894|58965820|FG001|Overall Study|Death|0|||
30929906|NCT01934894|58965819|FG000|Overall Study|Withdrawal by Subject|0|||
30929907|NCT01934894|58965820|FG001|Overall Study|Withdrawal by Subject|1|||
30929908|NCT01934894|58965819|FG000|Overall Study|Progressive Disease|3|||
30929909|NCT01934894|58965820|FG001|Overall Study|Progressive Disease|2|||
30929910|NCT01950169|58965832|FG000|Overall Study|Withdrawal by Subject|2|||
30929911|NCT01950169|58965833|FG001|Overall Study|Withdrawal by Subject|8|||
30929912|NCT01950169|58965834|FG002|Overall Study|Withdrawal by Subject|1|||
30929913|NCT01950169|58965832|FG000|Overall Study|Death|1|||
30929914|NCT01950169|58965833|FG001|Overall Study|Death|0|||
30929915|NCT01950169|58965834|FG002|Overall Study|Death|0|||
30929916|NCT01934504|58965847|FG000|Overall Study|Protocol Deviation|0|||
30929917|NCT01934504|58965848|FG001|Overall Study|Protocol Deviation|0|||
30929918|NCT01934504|58965849|FG002|Overall Study|Protocol Deviation|0|||
30929919|NCT01934504|58965850|FG003|Overall Study|Protocol Deviation|2|||
30929920|NCT01934504|58965847|FG000|Overall Study|Study Terminated by Sponsor|1|||
30838171|NCT03917654|58863312|FG004|Year 1|Subject moved away from site|0|||
30838172|NCT03917654|58863313|FG005|Year 1|Subject moved away from site|0|||
30838173|NCT03917654|58863314|FG006|Year 1|Subject moved away from site|1|||
30838174|NCT03917654|58863315|FG007|Year 1|Subject moved away from site|2|||
30838175|NCT03917654|58863316|FG008|Year 1|Subject moved away from site|1|||
30838176|NCT03917654|58863317|FG009|Year 1|Subject moved away from site|0|||
30838177|NCT03917654|58863318|FG010|Year 1|Subject moved away from site|0|||
30929921|NCT01934504|58965848|FG001|Overall Study|Study Terminated by Sponsor|0|||
30929922|NCT01934504|58965849|FG002|Overall Study|Study Terminated by Sponsor|5|||
30929923|NCT01934504|58965850|FG003|Overall Study|Study Terminated by Sponsor|5|||
30929924|NCT01950013|58965863|FG000|Overall Study|Withdrawal by Subject|0|||
30929925|NCT01950013|58965864|FG001|Overall Study|Withdrawal by Subject|2|||
30929926|NCT01950013|58965865|FG002|Overall Study|Withdrawal by Subject|0|||
30929927|NCT01949155|58965875|FG000|Overall Study|Lost to Follow-up|1|||
30929928|NCT01949155|58965876|FG001|Overall Study|Lost to Follow-up|0|||
30929929|NCT01949155|58965875|FG000|Overall Study|Protocol Violation|1|||
30929930|NCT01949155|58965876|FG001|Overall Study|Protocol Violation|0|||
30929931|NCT01909466|58965883|FG000|Overall Study|Lost to Follow-up|5|||
30929932|NCT01909466|58965884|FG001|Overall Study|Lost to Follow-up|7|||
30929933|NCT01909466|58965883|FG000|Overall Study|Adverse Event|3|||
30929934|NCT01909466|58965884|FG001|Overall Study|Adverse Event|4|||
30929935|NCT01909466|58965883|FG000|Overall Study|Met Withdrawal Criteria|0|||
30929936|NCT01909466|58965884|FG001|Overall Study|Met Withdrawal Criteria|3|||
30929937|NCT01909466|58965883|FG000|Overall Study|Physician Decision|2|||
30929938|NCT01909466|58965884|FG001|Overall Study|Physician Decision|0|||
30929939|NCT01909466|58965883|FG000|Overall Study|Withdrawal by Subject|11|||
30929940|NCT01909466|58965884|FG001|Overall Study|Withdrawal by Subject|9|||
30929941|NCT01909466|58965883|FG000|Overall Study|Lack of Efficacy|1|||
30929942|NCT01909466|58965884|FG001|Overall Study|Lack of Efficacy|0|||
30929943|NCT01977625|58965888|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
30929944|NCT01977625|58965889|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
30929945|NCT01977625|58965888|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
30929946|NCT01977625|58965889|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
30929947|NCT01944631|58965899|FG000|Overall Study|Adverse Event|1|||
30929948|NCT01944631|58965900|FG001|Overall Study|Adverse Event|0|||
30929949|NCT01944631|58965899|FG000|Overall Study|Lost to Follow-up|3|||
30929950|NCT01944631|58965900|FG001|Overall Study|Lost to Follow-up|1|||
30929951|NCT01944631|58965899|FG000|Overall Study|Withdrawal by Subject|0|||
30929952|NCT01944631|58965900|FG001|Overall Study|Withdrawal by Subject|1|||
30929953|NCT01948063|58965908|FG000|Overall Study|Boston MCI halted research protocol|0|||
30929954|NCT01948063|58965909|FG001|Overall Study|Boston MCI halted research protocol|1|||
30929955|NCT01948063|58965908|FG000|Overall Study|Discovered an enrollment in other study|0|||
30929956|NCT01948063|58965909|FG001|Overall Study|Discovered an enrollment in other study|1|||
30929957|NCT01948063|58965908|FG000|Overall Study|Blood samples were accidentally thawed|1|||
30929958|NCT01948063|58965909|FG001|Overall Study|Blood samples were accidentally thawed|0|||
30929959|NCT01995071|58965927|FG000|Overall Study|Adverse Event|0|||
30929960|NCT01995071|58965928|FG001|Overall Study|Adverse Event|0|||
30929961|NCT01995071|58965929|FG002|Overall Study|Adverse Event|0|||
30929962|NCT01995071|58965930|FG003|Overall Study|Adverse Event|0|||
30929963|NCT01995071|58965931|FG004|Overall Study|Adverse Event|0|||
30929964|NCT01995071|58965932|FG005|Overall Study|Adverse Event|0|||
30929965|NCT01995071|58965933|FG006|Overall Study|Adverse Event|1|||
30929966|NCT01995071|58965934|FG007|Overall Study|Adverse Event|0|||
30929967|NCT01995071|58965935|FG008|Overall Study|Adverse Event|0|||
30929968|NCT01995071|58965936|FG009|Overall Study|Adverse Event|0|||
30929969|NCT01995071|58965937|FG010|Overall Study|Adverse Event|0|||
30929970|NCT01995071|58965938|FG011|Overall Study|Adverse Event|0|||
30929971|NCT01995071|58965927|FG000|Overall Study|Moved|0|||
30929972|NCT01995071|58965928|FG001|Overall Study|Moved|0|||
30929973|NCT01995071|58965929|FG002|Overall Study|Moved|1|||
30929974|NCT01995071|58965930|FG003|Overall Study|Moved|0|||
30929975|NCT01995071|58965931|FG004|Overall Study|Moved|1|||
30929976|NCT01995071|58965932|FG005|Overall Study|Moved|0|||
30838178|NCT03917654|58863319|FG011|Year 1|Subject moved away from site|3|||
30838179|NCT03917654|58863308|FG000|Year 1|Spouse/Family member request|0|||
30838180|NCT03917654|58863309|FG001|Year 1|Spouse/Family member request|0|||
30838181|NCT03917654|58863310|FG002|Year 1|Spouse/Family member request|1|||
30838182|NCT03917654|58863311|FG003|Year 1|Spouse/Family member request|0|||
30838183|NCT03917654|58863312|FG004|Year 1|Spouse/Family member request|1|||
30929977|NCT01995071|58965933|FG006|Overall Study|Moved|0|||
30929978|NCT01995071|58965934|FG007|Overall Study|Moved|0|||
30929979|NCT01995071|58965935|FG008|Overall Study|Moved|0|||
30929980|NCT01995071|58965936|FG009|Overall Study|Moved|0|||
30929981|NCT01995071|58965937|FG010|Overall Study|Moved|1|||
30929982|NCT01995071|58965938|FG011|Overall Study|Moved|0|||
30838184|NCT03917654|58863313|FG005|Year 1|Spouse/Family member request|0|||
30838185|NCT03917654|58863314|FG006|Year 1|Spouse/Family member request|0|||
30838186|NCT03917654|58863315|FG007|Year 1|Spouse/Family member request|2|||
30838187|NCT03917654|58863316|FG008|Year 1|Spouse/Family member request|0|||
30929983|NCT01995071|58965927|FG000|Overall Study|Lost to Follow-up|1|||
30929984|NCT01995071|58965928|FG001|Overall Study|Lost to Follow-up|0|||
30929985|NCT01995071|58965929|FG002|Overall Study|Lost to Follow-up|0|||
30929986|NCT01995071|58965930|FG003|Overall Study|Lost to Follow-up|0|||
30929987|NCT01995071|58965931|FG004|Overall Study|Lost to Follow-up|0|||
30929988|NCT01995071|58965932|FG005|Overall Study|Lost to Follow-up|0|||
30929989|NCT01995071|58965933|FG006|Overall Study|Lost to Follow-up|0|||
30929990|NCT01995071|58965934|FG007|Overall Study|Lost to Follow-up|1|||
30929991|NCT01995071|58965935|FG008|Overall Study|Lost to Follow-up|1|||
30838188|NCT03917654|58863317|FG009|Year 1|Spouse/Family member request|0|||
30838189|NCT03917654|58863318|FG010|Year 1|Spouse/Family member request|0|||
30757952|NCT00112437|58766932|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757953|NCT00112437|58766933|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757954|NCT00112437|58766934|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757955|NCT00112437|58766935|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757956|NCT00112437|58766936|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
30838190|NCT03917654|58863319|FG011|Year 1|Spouse/Family member request|1|||
30838191|NCT03917654|58863308|FG000|Year 1|Death|0|||
30838192|NCT03917654|58863309|FG001|Year 1|Death|0|||
30838193|NCT03917654|58863310|FG002|Year 1|Death|0|||
30929992|NCT01995071|58965936|FG009|Overall Study|Lost to Follow-up|0|||
30929993|NCT01995071|58965937|FG010|Overall Study|Lost to Follow-up|0|||
30929994|NCT01995071|58965938|FG011|Overall Study|Lost to Follow-up|0|||
30929995|NCT01995071|58965927|FG000|Overall Study|Incarcerated|0|||
30929996|NCT01995071|58965928|FG001|Overall Study|Incarcerated|0|||
30929997|NCT01995071|58965929|FG002|Overall Study|Incarcerated|0|||
30929998|NCT01995071|58965930|FG003|Overall Study|Incarcerated|0|||
30929999|NCT01995071|58965931|FG004|Overall Study|Incarcerated|0|||
30930000|NCT01995071|58965932|FG005|Overall Study|Incarcerated|0|||
30930001|NCT01995071|58965933|FG006|Overall Study|Incarcerated|0|||
30930002|NCT01995071|58965934|FG007|Overall Study|Incarcerated|1|||
30930003|NCT01995071|58965935|FG008|Overall Study|Incarcerated|0|||
30930004|NCT01995071|58965936|FG009|Overall Study|Incarcerated|0|||
30930005|NCT01995071|58965937|FG010|Overall Study|Incarcerated|0|||
30930006|NCT01995071|58965938|FG011|Overall Study|Incarcerated|0|||
30930007|NCT01994837|58965970|FG000|Overall Study|Progressive disease per protocol|23|||
30930008|NCT01994837|58965970|FG000|Overall Study|Adv event related to progressive disease|3|||
30930009|NCT01994837|58965970|FG000|Overall Study|Fatal progressive disease|2|||
30930010|NCT01994837|58965970|FG000|Overall Study|Adverse event not related to progression|1|||
30930011|NCT01994837|58965970|FG000|Overall Study|Chose palliative care|1|||
30930012|NCT01994837|58965970|FG000|Overall Study|Proceeded to transplant|1|||
30930013|NCT01994837|58965970|FG000|Overall Study|Removed from study due to no response|1|||
30930014|NCT02010593|58965976|FG000|Overall Study|Lost to Follow-up|1|||
30930015|NCT02010593|58965977|FG001|Overall Study|Lost to Follow-up|0|||
30930016|NCT02010593|58965976|FG000|Overall Study|Physician Decision|1|||
30930017|NCT02010593|58965977|FG001|Overall Study|Physician Decision|0|||
30930018|NCT02010593|58965976|FG000|Overall Study|Unable to adhere to visit schedule|0|||
30930019|NCT02010593|58965977|FG001|Overall Study|Unable to adhere to visit schedule|2|||
30930020|NCT01994291|58965986|FG000|Overall Study|Adverse Event|4|||
30930021|NCT01994291|58965987|FG001|Overall Study|Adverse Event|1|||
30757957|NCT00112437|58766937|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757958|NCT00112437|58766938|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757959|NCT00112437|58766939|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757960|NCT00112437|58766940|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757961|NCT00112437|58766941|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30838194|NCT03917654|58863311|FG003|Year 1|Death|0|||
30838195|NCT03917654|58863312|FG004|Year 1|Death|0|||
30838196|NCT03917654|58863313|FG005|Year 1|Death|0|||
30838197|NCT03917654|58863314|FG006|Year 1|Death|0|||
30838198|NCT03917654|58863315|FG007|Year 1|Death|0|||
30838199|NCT03917654|58863316|FG008|Year 1|Death|1|||
30838200|NCT03917654|58863317|FG009|Year 1|Death|1|||
30838201|NCT03917654|58863318|FG010|Year 1|Death|0|||
30838202|NCT03917654|58863319|FG011|Year 1|Death|0|||
30838203|NCT03917654|58863308|FG000|Year 1|Lost to Follow-up|0|||
30838204|NCT03917654|58863309|FG001|Year 1|Lost to Follow-up|0|||
30838205|NCT03917654|58863310|FG002|Year 1|Lost to Follow-up|0|||
30838206|NCT03917654|58863311|FG003|Year 1|Lost to Follow-up|0|||
30838207|NCT03917654|58863312|FG004|Year 1|Lost to Follow-up|0|||
30838208|NCT03917654|58863313|FG005|Year 1|Lost to Follow-up|0|||
30930022|NCT01994291|58965988|FG002|Overall Study|Adverse Event|3|||
30930023|NCT01994291|58965986|FG000|Overall Study|Lost to Follow-up|1|||
30930024|NCT01994291|58965987|FG001|Overall Study|Lost to Follow-up|1|||
30930025|NCT01994291|58965988|FG002|Overall Study|Lost to Follow-up|0|||
30930026|NCT01994291|58965986|FG000|Overall Study|Does not meet entrance criteria|1|||
30930027|NCT01994291|58965987|FG001|Overall Study|Does not meet entrance criteria|0|||
30930028|NCT01994291|58965988|FG002|Overall Study|Does not meet entrance criteria|0|||
30757962|NCT00112437|58766942|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30838209|NCT03917654|58863314|FG006|Year 1|Lost to Follow-up|2|||
30838210|NCT03917654|58863315|FG007|Year 1|Lost to Follow-up|0|||
30838211|NCT03917654|58863316|FG008|Year 1|Lost to Follow-up|0|||
30930029|NCT01994291|58965986|FG000|Overall Study|Medication error without associated AE|1|||
30838212|NCT03917654|58863317|FG009|Year 1|Lost to Follow-up|0|||
30838213|NCT03917654|58863318|FG010|Year 1|Lost to Follow-up|0|||
30838214|NCT03917654|58863319|FG011|Year 1|Lost to Follow-up|0|||
30838215|NCT03917654|58863308|FG000|Year 1|Missed visits|0|||
30930030|NCT01994291|58965987|FG001|Overall Study|Medication error without associated AE|0|||
30930031|NCT01994291|58965988|FG002|Overall Study|Medication error without associated AE|1|||
30930032|NCT01994291|58965986|FG000|Overall Study|Protocol Violation|1|||
30757963|NCT00112437|58766943|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757964|NCT00112437|58766944|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757965|NCT00112437|58766945|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30930033|NCT01994291|58965987|FG001|Overall Study|Protocol Violation|0|||
30930034|NCT01994291|58965988|FG002|Overall Study|Protocol Violation|0|||
30930035|NCT01994291|58965986|FG000|Overall Study|Withdrawal by Subject|6|||
30930036|NCT01994291|58965987|FG001|Overall Study|Withdrawal by Subject|3|||
30930037|NCT01994291|58965988|FG002|Overall Study|Withdrawal by Subject|5|||
30930038|NCT01994291|58965986|FG000|Overall Study|Other|1|||
30930039|NCT01994291|58965987|FG001|Overall Study|Other|2|||
30930040|NCT01994291|58965988|FG002|Overall Study|Other|0|||
30930041|NCT02094677|58965999|FG000|Overall Study|Screening|3|||
30930042|NCT02094677|58966000|FG001|Overall Study|Screening|1|||
30930043|NCT01993823|58966015|FG000|Overall Study|Requested by the patient|6|||
30930044|NCT01993823|58966016|FG001|Overall Study|Requested by the patient|11|||
30930045|NCT01993823|58966015|FG000|Overall Study|Protocol Violation|0|||
30930046|NCT01993823|58966016|FG001|Overall Study|Protocol Violation|1|||
30930047|NCT01993823|58966015|FG000|Overall Study|Lost to Follow-up|1|||
30930048|NCT01993823|58966016|FG001|Overall Study|Lost to Follow-up|4|||
30930049|NCT01993667|58966024|FG000|Overall Study|Insufficient data to analyze|16|||
30930050|NCT01993667|58966025|FG001|Overall Study|Insufficient data to analyze|16|||
30930051|NCT01993667|58966024|FG000|Overall Study|Insufficient altitude reached|3|||
30930052|NCT01993667|58966025|FG001|Overall Study|Insufficient altitude reached|1|||
30930053|NCT01993667|58966024|FG000|Overall Study|Lost to Follow-up|2|||
30930054|NCT01993667|58966025|FG001|Overall Study|Lost to Follow-up|2|||
30930055|NCT01992107|58966034|FG000|Overall Study|Administrative reasons|2|||
30930056|NCT01992107|58966035|FG001|Overall Study|Administrative reasons|0|||
30930057|NCT01992107|58966036|FG002|Overall Study|Administrative reasons|0|||
30930058|NCT01992107|58966034|FG000|Overall Study|Adverse Event|0|||
30930059|NCT01992107|58966035|FG001|Overall Study|Adverse Event|1|||
30930060|NCT01992107|58966036|FG002|Overall Study|Adverse Event|0|||
30930061|NCT01992107|58966034|FG000|Overall Study|Lost to Follow-up|46|||
30930062|NCT01992107|58966035|FG001|Overall Study|Lost to Follow-up|22|||
30930063|NCT01992107|58966036|FG002|Overall Study|Lost to Follow-up|26|||
30930064|NCT01992107|58966034|FG000|Overall Study|noncompliance and were unavailable|7|||
30930065|NCT01992107|58966035|FG001|Overall Study|noncompliance and were unavailable|3|||
30930066|NCT01992107|58966036|FG002|Overall Study|noncompliance and were unavailable|2|||
30930067|NCT01992107|58966034|FG000|Overall Study|Withdrawal by Subject|13|||
30930068|NCT01992107|58966035|FG001|Overall Study|Withdrawal by Subject|7|||
30930069|NCT01992107|58966036|FG002|Overall Study|Withdrawal by Subject|8|||
30930070|NCT01934192|58966065|FG000|Overall Study|Protocol Violation|0|||
30930071|NCT01934192|58966066|FG001|Overall Study|Protocol Violation|0|||
30930072|NCT01934192|58966067|FG002|Overall Study|Protocol Violation|0|||
30930073|NCT01934192|58966068|FG003|Overall Study|Protocol Violation|1|||
30930074|NCT01934192|58966065|FG000|Overall Study|Other: reached stopping criteria|6|||
30930075|NCT01934192|58966066|FG001|Overall Study|Other: reached stopping criteria|5|||
30930076|NCT01934192|58966067|FG002|Overall Study|Other: reached stopping criteria|1|||
30930077|NCT01934192|58966068|FG003|Overall Study|Other: reached stopping criteria|0|||
30930078|NCT01934192|58966065|FG000|Overall Study|Physician Decision|3|||
30930079|NCT01934192|58966066|FG001|Overall Study|Physician Decision|2|||
30930080|NCT01934192|58966067|FG002|Overall Study|Physician Decision|0|||
30930081|NCT01934192|58966068|FG003|Overall Study|Physician Decision|0|||
30930082|NCT01933880|58966091|FG000|Overall Study|Withdrawal by Subject|5|||
30930083|NCT01933880|58966092|FG001|Overall Study|Withdrawal by Subject|0|||
30930084|NCT01933880|58966091|FG000|Overall Study|Lack of Efficacy|1|||
30930085|NCT01933880|58966092|FG001|Overall Study|Lack of Efficacy|0|||
30930086|NCT01933880|58966091|FG000|Overall Study|Concomitant medication Interference|0|||
30930087|NCT01933880|58966092|FG001|Overall Study|Concomitant medication Interference|1|||
30930088|NCT01933880|58966091|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
30930089|NCT01933880|58966092|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
30930090|NCT01933880|58966091|FG000|Overall Study|Other|4|||
30757966|NCT00112437|58766946|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
30757967|NCT00112437|58766921|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
30930091|NCT01933880|58966092|FG001|Overall Study|Other|0|||
30757968|NCT00112437|58766922|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757969|NCT00112437|58766923|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
30930092|NCT01933880|58966091|FG000|Overall Study|Protocol Violation|1|||
30930093|NCT01933880|58966092|FG001|Overall Study|Protocol Violation|0|||
30930094|NCT02008877|58966103|FG000|Overall Study|Inevaluable|0|||
30930095|NCT02008877|58966104|FG001|Overall Study|Inevaluable|1|||
30930096|NCT02008877|58966105|FG002|Overall Study|Inevaluable|0|||
30930097|NCT01933334|58966116|FG000|Overall Study|Adverse Event|5|||
30930098|NCT01933334|58966117|FG001|Overall Study|Adverse Event|1|||
30930099|NCT01933334|58966116|FG000|Overall Study|Withdrawal by Subject|0|||
30930100|NCT01933334|58966117|FG001|Overall Study|Withdrawal by Subject|1|||
30930101|NCT01908140|58966125|FG000|Overall Study|Other or Progressive Disease|5|||
30930102|NCT01908140|58966126|FG001|Overall Study|Other or Progressive Disease|12|||
30930103|NCT01908140|58966125|FG000|Overall Study|Lack of Efficacy|7|||
30930104|NCT01908140|58966126|FG001|Overall Study|Lack of Efficacy|5|||
30930105|NCT01908140|58966125|FG000|Overall Study|Withdrawal by Subject|23|||
30930106|NCT01908140|58966126|FG001|Overall Study|Withdrawal by Subject|24|||
30838216|NCT03917654|58863309|FG001|Year 1|Missed visits|0|||
30838217|NCT03917654|58863310|FG002|Year 1|Missed visits|0|||
30838218|NCT03917654|58863311|FG003|Year 1|Missed visits|0|||
30838219|NCT03917654|58863312|FG004|Year 1|Missed visits|0|||
30838220|NCT03917654|58863313|FG005|Year 1|Missed visits|0|||
30838221|NCT03917654|58863314|FG006|Year 1|Missed visits|0|||
30838222|NCT03917654|58863315|FG007|Year 1|Missed visits|0|||
30838223|NCT03917654|58863316|FG008|Year 1|Missed visits|0|||
30838224|NCT03917654|58863317|FG009|Year 1|Missed visits|0|||
30838225|NCT03917654|58863318|FG010|Year 1|Missed visits|1|||
30838226|NCT03917654|58863319|FG011|Year 1|Missed visits|1|||
30838227|NCT03917654|58863308|FG000|Year 1|Pregnancy|0|||
30838228|NCT03917654|58863309|FG001|Year 1|Pregnancy|0|||
30838229|NCT03917654|58863310|FG002|Year 1|Pregnancy|0|||
30838230|NCT03917654|58863311|FG003|Year 1|Pregnancy|0|||
30838231|NCT03917654|58863312|FG004|Year 1|Pregnancy|0|||
30930107|NCT01908140|58966125|FG000|Overall Study|Lost to Follow-up|1|||
30930108|NCT01908140|58966126|FG001|Overall Study|Lost to Follow-up|6|||
30930109|NCT01908140|58966125|FG000|Overall Study|Protocol Violation|8|||
30930110|NCT01908140|58966126|FG001|Overall Study|Protocol Violation|9|||
30930111|NCT01908140|58966125|FG000|Overall Study|Adverse Event|22|||
30930112|NCT01908140|58966126|FG001|Overall Study|Adverse Event|23|||
30930113|NCT02008565|58966136|FG000|Overall Study|Protocol Violation|1|||
30930114|NCT02008565|58966137|FG001|Overall Study|Protocol Violation|1|||
30930115|NCT02008565|58966138|FG002|Overall Study|Protocol Violation|2|||
30930116|NCT02008565|58966139|FG003|Overall Study|Protocol Violation|0|||
30930117|NCT01907906|58966153|FG000|Overall Study|Withdrawal by Subject|1|||
30930118|NCT01907906|58966154|FG001|Overall Study|Withdrawal by Subject|0|||
30930119|NCT01907906|58966153|FG000|Overall Study|Physician Decision|3|||
30930120|NCT01907906|58966154|FG001|Overall Study|Physician Decision|1|||
30930121|NCT01907828|58966164|FG000|Overall Study|Exclusion criteria not met|0|||
30930122|NCT01907828|58966165|FG001|Overall Study|Exclusion criteria not met|1|||
30930123|NCT01907828|58966164|FG000|Overall Study|Withdrawal by Subject|3|||
30930124|NCT01907828|58966165|FG001|Overall Study|Withdrawal by Subject|4|||
30930125|NCT01907828|58966164|FG000|Overall Study|Lost to Follow-up|3|||
30930126|NCT01907828|58966165|FG001|Overall Study|Lost to Follow-up|0|||
30930127|NCT01907828|58966164|FG000|Overall Study|Participant refused 24-month follow-up|1|||
30930128|NCT01907828|58966165|FG001|Overall Study|Participant refused 24-month follow-up|0|||
30930129|NCT01907828|58966164|FG000|Overall Study|Participant met exclusion criteria|0|||
30930130|NCT01907828|58966165|FG001|Overall Study|Participant met exclusion criteria|1|||
30930131|NCT01907516|58966173|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
30930132|NCT01907516|58966174|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
30930133|NCT01907516|58966173|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
30930134|NCT01907516|58966174|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
30930135|NCT01907516|58966173|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
30930136|NCT01907516|58966174|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
30930137|NCT01907516|58966173|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
30930138|NCT01907516|58966174|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
30930139|NCT01931462|58966181|FG000|Overall Study|Withdrawal by Subject|1|||
30930140|NCT01931150|58966187|FG000|Overall Study|Withdrawal by Subject|1|||
30930141|NCT01931150|58966188|FG001|Overall Study|Withdrawal by Subject|2|||
30930142|NCT01930214|58966197|FG000|Overall Study|Death|4|||
30930143|NCT01930214|58966198|FG001|Overall Study|Death|4|||
30930144|NCT01930214|58966199|FG002|Overall Study|Death|11|||
30930145|NCT01930214|58966197|FG000|Overall Study|Lost to Follow-up|12|||
30930146|NCT01930214|58966198|FG001|Overall Study|Lost to Follow-up|13|||
30930147|NCT01930214|58966199|FG002|Overall Study|Lost to Follow-up|12|||
30930148|NCT01930214|58966197|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
30930149|NCT01930214|58966198|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
30930150|NCT01930214|58966199|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
30838232|NCT03917654|58863313|FG005|Year 1|Pregnancy|0|||
30838233|NCT03917654|58863314|FG006|Year 1|Pregnancy|0|||
30838234|NCT03917654|58863315|FG007|Year 1|Pregnancy|1|||
30930151|NCT01930214|58966197|FG000|Overall Study|Physician Decision|2|||
30930152|NCT01930214|58966198|FG001|Overall Study|Physician Decision|0|||
30930153|NCT01930214|58966199|FG002|Overall Study|Physician Decision|0|||
30930154|NCT01958294|58966207|FG000|Overall Study|Clinical Circumstances|2|||
30930155|NCT01906346|58966211|FG000|Overall Study|AEs|1|||
30838235|NCT03917654|58863316|FG008|Year 1|Pregnancy|0|||
30838236|NCT03917654|58863317|FG009|Year 1|Pregnancy|1|||
30838237|NCT03917654|58863318|FG010|Year 1|Pregnancy|0|||
30838238|NCT03917654|58863319|FG011|Year 1|Pregnancy|0|||
30838239|NCT03917654|58863308|FG000|Year 2|Travel|1|||
30838240|NCT03917654|58863309|FG001|Year 2|Travel|0|||
30930156|NCT01958060|58966223|FG000|Overall Study|Not treated|2|||
30930157|NCT01958060|58966224|FG001|Overall Study|Not treated|0|||
30930158|NCT01958060|58966225|FG002|Overall Study|Not treated|0|||
30930159|NCT01958060|58966226|FG003|Overall Study|Not treated|0|||
30930160|NCT01958060|58966227|FG004|Overall Study|Not treated|1|||
30930161|NCT01958060|58966228|FG005|Overall Study|Not treated|0|||
30930162|NCT01929980|58966247|FG000|Overall Study|Physician Decision|1|||
30930163|NCT01363076|58966253|FG000|Overall Study|Withdrawal by Subject|0|||
30624169|NCT00959049|58636122|FG001|Overall Study|Withdrawal by Subject|2|||
30757970|NCT00112437|58766924|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
30838241|NCT03917654|58863310|FG002|Year 2|Travel|0|||
30838242|NCT03917654|58863311|FG003|Year 2|Travel|0|||
30838243|NCT03917654|58863312|FG004|Year 2|Travel|1|||
30838244|NCT03917654|58863313|FG005|Year 2|Travel|1|||
30838245|NCT03917654|58863314|FG006|Year 2|Travel|2|||
30838246|NCT03917654|58863315|FG007|Year 2|Travel|1|||
30838247|NCT03917654|58863316|FG008|Year 2|Travel|0|||
30838248|NCT03917654|58863317|FG009|Year 2|Travel|1|||
30838249|NCT03917654|58863318|FG010|Year 2|Travel|0|||
30838250|NCT03917654|58863319|FG011|Year 2|Travel|1|||
30757971|NCT00112437|58766925|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757972|NCT00112437|58766926|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757973|NCT00112437|58766927|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757974|NCT00112437|58766928|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757975|NCT00112437|58766929|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757976|NCT00112437|58766930|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757977|NCT00112437|58766931|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757978|NCT00112437|58766932|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757979|NCT00112437|58766933|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757980|NCT00112437|58766934|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
30838251|NCT03917654|58863308|FG000|Year 2|Married|1|||
30838252|NCT03917654|58863309|FG001|Year 2|Married|0|||
30838253|NCT03917654|58863310|FG002|Year 2|Married|0|||
30838254|NCT03917654|58863311|FG003|Year 2|Married|0|||
30838255|NCT03917654|58863312|FG004|Year 2|Married|0|||
30838256|NCT03917654|58863313|FG005|Year 2|Married|0|||
30838257|NCT03917654|58863314|FG006|Year 2|Married|1|||
30838258|NCT03917654|58863315|FG007|Year 2|Married|1|||
30838259|NCT03917654|58863316|FG008|Year 2|Married|0|||
30838260|NCT03917654|58863317|FG009|Year 2|Married|0|||
30838261|NCT03917654|58863318|FG010|Year 2|Married|0|||
30838262|NCT03917654|58863319|FG011|Year 2|Married|0|||
30838263|NCT03917654|58863308|FG000|Year 2|Subject moved away from site|1|||
30838264|NCT03917654|58863309|FG001|Year 2|Subject moved away from site|0|||
30838265|NCT03917654|58863310|FG002|Year 2|Subject moved away from site|0|||
30838266|NCT03917654|58863311|FG003|Year 2|Subject moved away from site|0|||
30838267|NCT03917654|58863312|FG004|Year 2|Subject moved away from site|1|||
30838268|NCT03917654|58863313|FG005|Year 2|Subject moved away from site|0|||
30838269|NCT03917654|58863314|FG006|Year 2|Subject moved away from site|2|||
30838270|NCT03917654|58863315|FG007|Year 2|Subject moved away from site|3|||
30838271|NCT03917654|58863316|FG008|Year 2|Subject moved away from site|0|||
30838272|NCT03917654|58863317|FG009|Year 2|Subject moved away from site|2|||
30838273|NCT03917654|58863318|FG010|Year 2|Subject moved away from site|0|||
30838274|NCT03917654|58863319|FG011|Year 2|Subject moved away from site|1|||
30838275|NCT03917654|58863308|FG000|Year 2|Year 2 Screening failure|0|||
30838276|NCT03917654|58863309|FG001|Year 2|Year 2 Screening failure|1|||
30838277|NCT03917654|58863310|FG002|Year 2|Year 2 Screening failure|0|||
30838278|NCT03917654|58863311|FG003|Year 2|Year 2 Screening failure|0|||
30838279|NCT03917654|58863312|FG004|Year 2|Year 2 Screening failure|2|||
30838280|NCT03917654|58863313|FG005|Year 2|Year 2 Screening failure|0|||
30838281|NCT03917654|58863314|FG006|Year 2|Year 2 Screening failure|4|||
30930164|NCT01363076|58966254|FG001|Overall Study|Withdrawal by Subject|1|||
30624170|NCT00959049|58636123|FG002|Overall Study|Withdrawal by Subject|0|||
30838282|NCT03917654|58863315|FG007|Year 2|Year 2 Screening failure|3|||
30838283|NCT03917654|58863316|FG008|Year 2|Year 2 Screening failure|10|||
30930165|NCT01929044|58966262|FG000|Overall Study|Adverse Event|1|||
30930166|NCT01929044|58966263|FG001|Overall Study|Adverse Event|0|||
30757981|NCT00112437|58766935|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757982|NCT00112437|58766936|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
30838284|NCT03917654|58863317|FG009|Year 2|Year 2 Screening failure|2|||
30838285|NCT03917654|58863318|FG010|Year 2|Year 2 Screening failure|1|||
30838286|NCT03917654|58863319|FG011|Year 2|Year 2 Screening failure|1|||
30838287|NCT03917654|58863308|FG000|Year 2|Death|0|||
30838288|NCT03917654|58863309|FG001|Year 2|Death|0|||
30838289|NCT03917654|58863310|FG002|Year 2|Death|0|||
30838290|NCT03917654|58863311|FG003|Year 2|Death|0|||
30838291|NCT03917654|58863312|FG004|Year 2|Death|0|||
30838292|NCT03917654|58863313|FG005|Year 2|Death|1|||
30838293|NCT03917654|58863314|FG006|Year 2|Death|0|||
30838294|NCT03917654|58863315|FG007|Year 2|Death|0|||
30838295|NCT03917654|58863316|FG008|Year 2|Death|1|||
30838296|NCT03917654|58863317|FG009|Year 2|Death|1|||
30838297|NCT03917654|58863318|FG010|Year 2|Death|0|||
30930167|NCT01929044|58966262|FG000|Overall Study|Protocol Violation|9|||
30838298|NCT03917654|58863319|FG011|Year 2|Death|0|||
30838299|NCT03917654|58863308|FG000|Year 2|Withdrawal by Subject|0|||
30838300|NCT03917654|58863309|FG001|Year 2|Withdrawal by Subject|0|||
30838301|NCT03917654|58863310|FG002|Year 2|Withdrawal by Subject|0|||
30838302|NCT03917654|58863311|FG003|Year 2|Withdrawal by Subject|0|||
30838303|NCT03917654|58863312|FG004|Year 2|Withdrawal by Subject|0|||
30838304|NCT03917654|58863313|FG005|Year 2|Withdrawal by Subject|0|||
30838305|NCT03917654|58863314|FG006|Year 2|Withdrawal by Subject|3|||
30838306|NCT03917654|58863315|FG007|Year 2|Withdrawal by Subject|0|||
30838307|NCT03917654|58863316|FG008|Year 2|Withdrawal by Subject|2|||
30838308|NCT03917654|58863317|FG009|Year 2|Withdrawal by Subject|5|||
30838309|NCT03917654|58863318|FG010|Year 2|Withdrawal by Subject|0|||
30930168|NCT01929044|58966263|FG001|Overall Study|Protocol Violation|14|||
30930169|NCT01929044|58966262|FG000|Overall Study|Not Treated|1|||
30930170|NCT01929044|58966263|FG001|Overall Study|Not Treated|3|||
30930171|NCT01903460|58966273|FG000|Overall Study|Adverse Event|0|||
30930172|NCT01903460|58966274|FG001|Overall Study|Adverse Event|0|||
30930173|NCT01903460|58966275|FG002|Overall Study|Adverse Event|0|||
30930174|NCT01903460|58966276|FG003|Overall Study|Adverse Event|1|||
30930175|NCT01957202|58966285|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930176|NCT01957202|58966286|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
30930177|NCT01957202|58966287|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930178|NCT01957202|58966288|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930179|NCT01957202|58966289|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930180|NCT01957202|58966290|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930181|NCT01957202|58966291|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30757983|NCT00112437|58766937|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757984|NCT00112437|58766938|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757985|NCT00112437|58766939|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757986|NCT00112437|58766940|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757987|NCT00112437|58766941|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757988|NCT00112437|58766942|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757989|NCT00112437|58766943|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757990|NCT00112437|58766944|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757991|NCT00112437|58766945|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757992|NCT00112437|58766946|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
30757993|NCT00112437|58766921|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30757994|NCT00112437|58766922|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30757995|NCT00112437|58766923|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30838310|NCT03917654|58863319|FG011|Year 2|Withdrawal by Subject|0|||
30838311|NCT03917654|58863308|FG000|Year 2|Spouse/family member request|0|||
30838312|NCT03917654|58863309|FG001|Year 2|Spouse/family member request|0|||
30838313|NCT03917654|58863310|FG002|Year 2|Spouse/family member request|0|||
30838314|NCT03917654|58863311|FG003|Year 2|Spouse/family member request|0|||
30838315|NCT03917654|58863312|FG004|Year 2|Spouse/family member request|0|||
30838316|NCT03917654|58863313|FG005|Year 2|Spouse/family member request|0|||
30838317|NCT03917654|58863314|FG006|Year 2|Spouse/family member request|1|||
30838318|NCT03917654|58863315|FG007|Year 2|Spouse/family member request|0|||
30838319|NCT03917654|58863316|FG008|Year 2|Spouse/family member request|0|||
30838320|NCT03917654|58863317|FG009|Year 2|Spouse/family member request|0|||
30838321|NCT03917654|58863318|FG010|Year 2|Spouse/family member request|0|||
30838322|NCT03917654|58863319|FG011|Year 2|Spouse/family member request|0|||
30838323|NCT03917654|58863308|FG000|Year 2|Lost to Follow-up|0|||
30838324|NCT03917654|58863309|FG001|Year 2|Lost to Follow-up|0|||
30838325|NCT03917654|58863310|FG002|Year 2|Lost to Follow-up|0|||
30838326|NCT03917654|58863311|FG003|Year 2|Lost to Follow-up|0|||
30838327|NCT03917654|58863312|FG004|Year 2|Lost to Follow-up|0|||
30838328|NCT03917654|58863313|FG005|Year 2|Lost to Follow-up|0|||
30838329|NCT03917654|58863314|FG006|Year 2|Lost to Follow-up|1|||
30838330|NCT03917654|58863315|FG007|Year 2|Lost to Follow-up|0|||
30838331|NCT03917654|58863316|FG008|Year 2|Lost to Follow-up|1|||
30838332|NCT03917654|58863317|FG009|Year 2|Lost to Follow-up|0|||
30838333|NCT03917654|58863318|FG010|Year 2|Lost to Follow-up|0|||
30838334|NCT03917654|58863319|FG011|Year 2|Lost to Follow-up|1|||
30838335|NCT03917654|58863308|FG000|Year 2|Adverse Event|0|||
30838336|NCT03917654|58863309|FG001|Year 2|Adverse Event|0|||
30930182|NCT01957202|58966292|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930183|NCT01957202|58966293|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930184|NCT01957202|58966294|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930185|NCT01957202|58966295|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30757996|NCT00112437|58766924|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30838337|NCT03917654|58863310|FG002|Year 2|Adverse Event|0|||
30838338|NCT03917654|58863311|FG003|Year 2|Adverse Event|0|||
30838339|NCT03917654|58863312|FG004|Year 2|Adverse Event|0|||
30838340|NCT03917654|58863313|FG005|Year 2|Adverse Event|0|||
30838341|NCT03917654|58863314|FG006|Year 2|Adverse Event|0|||
30838342|NCT03917654|58863315|FG007|Year 2|Adverse Event|0|||
30838343|NCT03917654|58863316|FG008|Year 2|Adverse Event|0|||
30930186|NCT01957202|58966296|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930187|NCT01957202|58966297|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930188|NCT01957202|58966298|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930189|NCT01957202|58966299|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930190|NCT01957202|58966300|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930191|NCT01957202|58966301|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
30930192|NCT01957202|58966302|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
30930193|NCT01957202|58966285|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930194|NCT01957202|58966286|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930195|NCT01957202|58966287|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930196|NCT01957202|58966288|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930197|NCT01957202|58966289|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930198|NCT01957202|58966290|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930199|NCT01957202|58966291|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930200|NCT01957202|58966292|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930201|NCT01957202|58966293|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930202|NCT01957202|58966294|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930203|NCT01957202|58966295|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930204|NCT01957202|58966296|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930205|NCT01957202|58966297|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930206|NCT01957202|58966298|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930207|NCT01957202|58966299|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930208|NCT01957202|58966300|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930209|NCT01957202|58966301|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
30930210|NCT01957202|58966302|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
30930211|NCT01616654|58966317|FG000|Overall Study|Lack of Efficacy|1|||
30930212|NCT01616654|58966318|FG001|Overall Study|Lack of Efficacy|0|||
30930213|NCT01616654|58966319|FG002|Overall Study|Lack of Efficacy|0|||
30930214|NCT01616654|58966320|FG003|Overall Study|Lack of Efficacy|0|||
30930215|NCT01616654|58966321|FG004|Overall Study|Lack of Efficacy|1|||
30930216|NCT01616654|58966317|FG000|Overall Study|Adverse Event|0|||
30930217|NCT01616654|58966318|FG001|Overall Study|Adverse Event|1|||
30930218|NCT01616654|58966319|FG002|Overall Study|Adverse Event|2|||
30930219|NCT01616654|58966320|FG003|Overall Study|Adverse Event|1|||
30930220|NCT01616654|58966321|FG004|Overall Study|Adverse Event|0|||
30930221|NCT01616654|58966317|FG000|Overall Study|Withdrawal by Subject|2|||
30930222|NCT01616654|58966318|FG001|Overall Study|Withdrawal by Subject|2|||
30930223|NCT01616654|58966319|FG002|Overall Study|Withdrawal by Subject|3|||
30930224|NCT01616654|58966320|FG003|Overall Study|Withdrawal by Subject|1|||
30930225|NCT01616654|58966321|FG004|Overall Study|Withdrawal by Subject|5|||
30930226|NCT01616654|58966317|FG000|Overall Study|Protocol Violation|0|||
30930227|NCT01616654|58966318|FG001|Overall Study|Protocol Violation|5|||
30930228|NCT01616654|58966319|FG002|Overall Study|Protocol Violation|2|||
30930229|NCT01616654|58966320|FG003|Overall Study|Protocol Violation|4|||
30930230|NCT01616654|58966321|FG004|Overall Study|Protocol Violation|4|||
30930231|NCT01616654|58966317|FG000|Overall Study|Lost to Follow-up|1|||
30757997|NCT00112437|58766925|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30757998|NCT00112437|58766926|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30757999|NCT00112437|58766927|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758000|NCT00112437|58766928|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758001|NCT00112437|58766929|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758002|NCT00112437|58766930|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758003|NCT00112437|58766931|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758004|NCT00112437|58766932|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
30758005|NCT00112437|58766933|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758006|NCT00112437|58766934|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758007|NCT00112437|58766935|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
30758008|NCT00112437|58766936|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758009|NCT00112437|58766937|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758010|NCT00112437|58766938|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758011|NCT00112437|58766939|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758012|NCT00112437|58766940|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30930232|NCT01616654|58966318|FG001|Overall Study|Lost to Follow-up|0|||
30930233|NCT01616654|58966319|FG002|Overall Study|Lost to Follow-up|3|||
30930234|NCT01616654|58966320|FG003|Overall Study|Lost to Follow-up|2|||
30930235|NCT01616654|58966321|FG004|Overall Study|Lost to Follow-up|1|||
30930236|NCT01616654|58966317|FG000|Overall Study|Pregnancy|1|||
30930237|NCT01616654|58966318|FG001|Overall Study|Pregnancy|0|||
30758013|NCT00112437|58766941|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758014|NCT00112437|58766942|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30930238|NCT01616654|58966319|FG002|Overall Study|Pregnancy|0|||
30930239|NCT01616654|58966320|FG003|Overall Study|Pregnancy|0|||
30930240|NCT01616654|58966321|FG004|Overall Study|Pregnancy|1|||
30930241|NCT01902290|58966336|FG000|Overall Study|Withdrawal by Subject|19|||
30930242|NCT01902290|58966337|FG001|Overall Study|Withdrawal by Subject|27|||
30930243|NCT01902290|58966336|FG000|Overall Study|Lost to Follow-up|2|||
30930244|NCT01902290|58966337|FG001|Overall Study|Lost to Follow-up|2|||
30930245|NCT01902290|58966336|FG000|Overall Study|Death|1|||
30930246|NCT01902290|58966337|FG001|Overall Study|Death|0|||
30930247|NCT01902290|58966336|FG000|Overall Study|Sponsor Decision|26|||
30930248|NCT01902290|58966337|FG001|Overall Study|Sponsor Decision|24|||
30930249|NCT01927562|58966344|FG000|Overall Study|Lost to Follow-up|30|||
30930250|NCT01927562|58966344|FG000|Overall Study|Withdrawal by Subject|3|||
30930251|NCT01927562|58966344|FG000|Overall Study|Physician Decision|5|||
30930252|NCT01467466|58966352|FG000|Overall Study|Withdrawal by Subject|15|||
30930253|NCT01467466|58966353|FG001|Overall Study|Withdrawal by Subject|18|||
30930254|NCT01467466|58966354|FG002|Overall Study|Withdrawal by Subject|13|||
30930255|NCT01467466|58966355|FG003|Overall Study|Withdrawal by Subject|11|||
30930256|NCT01467466|58966352|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
30930257|NCT01467466|58966353|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
30930258|NCT01467466|58966354|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
30930259|NCT01467466|58966355|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
30930260|NCT01467466|58966352|FG000|Overall Study|Procedure Cancelled|46|||
30930261|NCT01467466|58966353|FG001|Overall Study|Procedure Cancelled|45|||
30930262|NCT01467466|58966354|FG002|Overall Study|Procedure Cancelled|25|||
30838344|NCT03917654|58863317|FG009|Year 2|Adverse Event|1|||
30838345|NCT03917654|58863318|FG010|Year 2|Adverse Event|0|||
30838346|NCT03917654|58863319|FG011|Year 2|Adverse Event|0|||
30838347|NCT03060577|58863365|FG000|Overall Study|Withdrawal by Subject|25|||
30838348|NCT03060577|58863366|FG001|Overall Study|Withdrawal by Subject|5|||
30838349|NCT03060577|58863365|FG000|Overall Study|Physician Decision|4|||
30838350|NCT03060577|58863366|FG001|Overall Study|Physician Decision|3|||
30838351|NCT03060577|58863365|FG000|Overall Study|Lost to Follow-up|3|||
30838352|NCT03060577|58863366|FG001|Overall Study|Lost to Follow-up|0|||
30838353|NCT03060577|58863365|FG000|Overall Study|Death|7|||
30838354|NCT03060577|58863366|FG001|Overall Study|Death|1|||
30838355|NCT03060577|58863365|FG000|Overall Study|Adverse Event|9|||
30838356|NCT03060577|58863366|FG001|Overall Study|Adverse Event|1|||
30838357|NCT03060577|58863365|FG000|Overall Study|Inclusion/Exclusion|1|||
30838358|NCT03060577|58863366|FG001|Overall Study|Inclusion/Exclusion|0|||
30838359|NCT03060577|58863365|FG000|Overall Study|Other|8|||
30838360|NCT03060577|58863366|FG001|Overall Study|Other|2|||
30838361|NCT02872714|58863377|FG000|Overall Study|Progressive Disease|1|||
30838362|NCT02872714|58863378|FG001|Overall Study|Progressive Disease|2|||
30838363|NCT02872714|58863379|FG002|Overall Study|Progressive Disease|0|||
30838364|NCT02872714|58863380|FG003|Overall Study|Progressive Disease|0|||
30838365|NCT02872714|58863381|FG004|Overall Study|Progressive Disease|0|||
30838366|NCT02872714|58863377|FG000|Overall Study|Death|87|||
30838367|NCT02872714|58863378|FG001|Overall Study|Death|36|||
30838368|NCT02872714|58863379|FG002|Overall Study|Death|8|||
30838369|NCT02872714|58863380|FG003|Overall Study|Death|81|||
30838370|NCT02872714|58863381|FG004|Overall Study|Death|2|||
30838371|NCT02872714|58863377|FG000|Overall Study|Lost to Follow-up|2|||
30838372|NCT02872714|58863378|FG001|Overall Study|Lost to Follow-up|1|||
30838373|NCT02872714|58863379|FG002|Overall Study|Lost to Follow-up|0|||
30838374|NCT02872714|58863380|FG003|Overall Study|Lost to Follow-up|3|||
30838375|NCT02872714|58863381|FG004|Overall Study|Lost to Follow-up|0|||
30930263|NCT01467466|58966355|FG003|Overall Study|Procedure Cancelled|29|||
30838376|NCT02872714|58863377|FG000|Overall Study|Physician Decision|0|||
30838377|NCT02872714|58863378|FG001|Overall Study|Physician Decision|0|||
30838378|NCT02872714|58863379|FG002|Overall Study|Physician Decision|0|||
30838379|NCT02872714|58863380|FG003|Overall Study|Physician Decision|1|||
30838380|NCT02872714|58863381|FG004|Overall Study|Physician Decision|0|||
30838381|NCT02872714|58863377|FG000|Overall Study|Withdrawal by Subject|1|||
30838382|NCT02872714|58863378|FG001|Overall Study|Withdrawal by Subject|3|||
30838383|NCT02872714|58863379|FG002|Overall Study|Withdrawal by Subject|0|||
30838384|NCT02872714|58863380|FG003|Overall Study|Withdrawal by Subject|2|||
30838385|NCT02872714|58863381|FG004|Overall Study|Withdrawal by Subject|0|||
30838386|NCT02872714|58863377|FG000|Overall Study|Captured as Other|2|||
30838387|NCT02872714|58863378|FG001|Overall Study|Captured as Other|0|||
30930264|NCT01467466|58966352|FG000|Overall Study|No Endpoint Blood Draw|38|||
30838388|NCT02872714|58863379|FG002|Overall Study|Captured as Other|0|||
30930265|NCT01467466|58966353|FG001|Overall Study|No Endpoint Blood Draw|32|||
30930266|NCT01467466|58966354|FG002|Overall Study|No Endpoint Blood Draw|51|||
30930267|NCT01467466|58966355|FG003|Overall Study|No Endpoint Blood Draw|43|||
30930268|NCT01441180|58966368|FG000|Overall Study|Lost to Follow-up|1|||
30930269|NCT01441180|58966369|FG001|Overall Study|Lost to Follow-up|1|||
30930270|NCT01441180|58966370|FG002|Overall Study|Lost to Follow-up|1|||
30930271|NCT01441180|58966368|FG000|Overall Study|Discontinued|0|||
30930272|NCT01441180|58966369|FG001|Overall Study|Discontinued|0|||
30930273|NCT01441180|58966370|FG002|Overall Study|Discontinued|2|||
30930274|NCT01441102|58966381|FG000|Overall Study|Adverse Event|1|||
30930275|NCT01441102|58966381|FG000|Overall Study|Withdrawal by Subject|2|||
30930276|NCT01467076|58966388|FG000|Overall Study|Lost to Follow-up|1|||
30930277|NCT01467076|58966389|FG001|Overall Study|Lost to Follow-up|0|||
30930278|NCT01467076|58966390|FG002|Overall Study|Lost to Follow-up|0|||
30930279|NCT01466062|58966398|FG000|Overall Study|Adverse Event|1|||
30930280|NCT01466062|58966398|FG000|Overall Study|Withdrawal by Subject|1|||
30930281|NCT01435018|58966405|FG000|Overall Study|Death|37|||
30930282|NCT01435018|58966406|FG001|Overall Study|Death|18|||
30930283|NCT01435018|58966407|FG002|Overall Study|Death|25|||
30930284|NCT01435018|58966405|FG000|Overall Study|Site is closing|4|||
30930285|NCT01435018|58966406|FG001|Overall Study|Site is closing|9|||
30930286|NCT01435018|58966407|FG002|Overall Study|Site is closing|7|||
30930287|NCT01435018|58966405|FG000|Overall Study|Withdrew consent|0|||
30930288|NCT01435018|58966406|FG001|Overall Study|Withdrew consent|3|||
30930289|NCT01435018|58966407|FG002|Overall Study|Withdrew consent|1|||
30930290|NCT01435018|58966405|FG000|Overall Study|Not willing to adhere to requirements|0|||
30930291|NCT01435018|58966406|FG001|Overall Study|Not willing to adhere to requirements|2|||
30930292|NCT01435018|58966407|FG002|Overall Study|Not willing to adhere to requirements|3|||
30930293|NCT01435018|58966405|FG000|Overall Study|Not able to get to clinic|2|||
30930294|NCT01435018|58966406|FG001|Overall Study|Not able to get to clinic|0|||
30930295|NCT01435018|58966407|FG002|Overall Study|Not able to get to clinic|2|||
30930296|NCT01435018|58966405|FG000|Overall Study|Severe debilitation, unable to continue|0|||
30930297|NCT01435018|58966406|FG001|Overall Study|Severe debilitation, unable to continue|0|||
30930298|NCT01435018|58966407|FG002|Overall Study|Severe debilitation, unable to continue|1|||
30930299|NCT01435018|58966405|FG000|Overall Study|Unable to contact participant/parent|1|||
30930300|NCT01435018|58966406|FG001|Overall Study|Unable to contact participant/parent|1|||
30930301|NCT01435018|58966407|FG002|Overall Study|Unable to contact participant/parent|1|||
30930302|NCT01435018|58966405|FG000|Overall Study|Enrollment Violation|0|||
30930303|NCT01435018|58966406|FG001|Overall Study|Enrollment Violation|1|||
30930304|NCT01435018|58966407|FG002|Overall Study|Enrollment Violation|0|||
30930305|NCT01435018|58966405|FG000|Overall Study|Never started chemotherapy|3|||
30930306|NCT01435018|58966406|FG001|Overall Study|Never started chemotherapy|0|||
30930307|NCT01435018|58966407|FG002|Overall Study|Never started chemotherapy|1|||
30930308|NCT01419184|58966419|FG000|Overall Study|Site data not available|3|||
30930309|NCT01419184|58966420|FG001|Overall Study|Site data not available|2|||
30930310|NCT01419184|58966419|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
30930311|NCT01419184|58966420|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
30930312|NCT01419184|58966419|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
30930313|NCT01419184|58966420|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
30930314|NCT01419184|58966419|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
30930315|NCT01419184|58966420|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
30930316|NCT01419184|58966419|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
30930317|NCT01419184|58966420|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
30930318|NCT01419184|58966419|FG000|Overall Study|Participant randomized, not treated|1|||
30930319|NCT01419184|58966420|FG001|Overall Study|Participant randomized, not treated|0|||
30930320|NCT01417234|58966426|FG000|Overall Study|Subject non-compliant|3|||
30930321|NCT01417156|58966430|FG000|Overall Study|Adverse Event|12|||
30930322|NCT01417156|58966430|FG000|Overall Study|Protocol Violation|2|||
30758015|NCT00112437|58766943|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758016|NCT00112437|58766944|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758017|NCT00112437|58766945|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758018|NCT00112437|58766946|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
30758019|NCT00112437|58766921|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758020|NCT00112437|58766922|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758021|NCT00112437|58766923|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30930323|NCT01417078|58966434|FG000|Overall Study|Withdrawal by Subject|1|||
30930324|NCT01954394|58966442|FG000|Overall Study|Enrolled but not treated|1|||
30930325|NCT01954394|58966443|FG001|Overall Study|Enrolled but not treated|0|||
30930326|NCT01954394|58966442|FG000|Overall Study|Adverse Event|10|||
30930327|NCT01954394|58966443|FG001|Overall Study|Adverse Event|23|||
30930328|NCT01954394|58966442|FG000|Overall Study|Poor compliance to protocol|7|||
30930329|NCT01954394|58966443|FG001|Overall Study|Poor compliance to protocol|7|||
30930330|NCT01954394|58966442|FG000|Overall Study|Participant Moved|0|||
30930331|NCT01954394|58966443|FG001|Overall Study|Participant Moved|4|||
30930332|NCT01954394|58966442|FG000|Overall Study|Related to Study Drug administration|2|||
30930333|NCT01954394|58966443|FG001|Overall Study|Related to Study Drug administration|2|||
30930334|NCT01954394|58966442|FG000|Overall Study|Other than specified above|10|||
30930335|NCT01954394|58966443|FG001|Overall Study|Other than specified above|21|||
30930336|NCT01464424|58966451|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
30930337|NCT01464424|58966452|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
30930338|NCT01902134|58966464|FG000|Overall Study|Adverse Event|3|||
30930339|NCT01902134|58966465|FG001|Overall Study|Adverse Event|1|||
30930340|NCT01902134|58966466|FG002|Overall Study|Adverse Event|2|||
30930341|NCT01902134|58966467|FG003|Overall Study|Adverse Event|1|||
30930342|NCT01902134|58966468|FG004|Overall Study|Adverse Event|1|||
30930343|NCT01902134|58966469|FG005|Overall Study|Adverse Event|3|||
30930344|NCT01902134|58966464|FG000|Overall Study|Lack of Efficacy|0|||
30930345|NCT01902134|58966465|FG001|Overall Study|Lack of Efficacy|0|||
30930346|NCT01902134|58966466|FG002|Overall Study|Lack of Efficacy|2|||
30930347|NCT01902134|58966467|FG003|Overall Study|Lack of Efficacy|0|||
30930348|NCT01902134|58966468|FG004|Overall Study|Lack of Efficacy|0|||
30930349|NCT01902134|58966469|FG005|Overall Study|Lack of Efficacy|1|||
30930350|NCT01902134|58966464|FG000|Overall Study|Physician Decision|0|||
30930351|NCT01902134|58966465|FG001|Overall Study|Physician Decision|1|||
30930352|NCT01902134|58966466|FG002|Overall Study|Physician Decision|0|||
30930353|NCT01902134|58966467|FG003|Overall Study|Physician Decision|0|||
30930354|NCT01902134|58966468|FG004|Overall Study|Physician Decision|0|||
30930355|NCT01902134|58966469|FG005|Overall Study|Physician Decision|0|||
30930356|NCT01902134|58966464|FG000|Overall Study|Protocol Violation|0|||
30930357|NCT01902134|58966465|FG001|Overall Study|Protocol Violation|0|||
30930358|NCT01902134|58966466|FG002|Overall Study|Protocol Violation|0|||
30930359|NCT01902134|58966467|FG003|Overall Study|Protocol Violation|0|||
30930360|NCT01902134|58966468|FG004|Overall Study|Protocol Violation|0|||
30930361|NCT01902134|58966469|FG005|Overall Study|Protocol Violation|1|||
30930362|NCT01902134|58966464|FG000|Overall Study|Withdrawal by Subject|4|||
30930363|NCT01902134|58966465|FG001|Overall Study|Withdrawal by Subject|8|||
30930364|NCT01902134|58966466|FG002|Overall Study|Withdrawal by Subject|9|||
30930365|NCT01902134|58966467|FG003|Overall Study|Withdrawal by Subject|1|||
30930366|NCT01902134|58966468|FG004|Overall Study|Withdrawal by Subject|5|||
30930367|NCT01902134|58966469|FG005|Overall Study|Withdrawal by Subject|4|||
30930368|NCT01902134|58966464|FG000|Overall Study|no compliance|1|||
30930369|NCT01902134|58966465|FG001|Overall Study|no compliance|0|||
30930370|NCT01902134|58966466|FG002|Overall Study|no compliance|0|||
30930371|NCT01902134|58966467|FG003|Overall Study|no compliance|0|||
30930372|NCT01902134|58966468|FG004|Overall Study|no compliance|0|||
30930373|NCT01902134|58966469|FG005|Overall Study|no compliance|0|||
30838389|NCT02872714|58863380|FG003|Overall Study|Captured as Other|1|||
30838390|NCT02872714|58863381|FG004|Overall Study|Captured as Other|0|||
30838391|NCT02787005|58863401|FG000|Overall Study|Adverse Event|24|||
30838392|NCT02787005|58863402|FG001|Overall Study|Adverse Event|9|||
30838393|NCT02787005|58863403|FG002|Overall Study|Adverse Event|9|||
30838394|NCT02787005|58863404|FG003|Overall Study|Adverse Event|7|||
30838395|NCT02787005|58863405|FG004|Overall Study|Adverse Event|2|||
30838396|NCT02787005|58863401|FG000|Overall Study|Death|100|||
30838397|NCT02787005|58863402|FG001|Overall Study|Death|53|||
30838398|NCT02787005|58863403|FG002|Overall Study|Death|48|||
30838399|NCT02787005|58863404|FG003|Overall Study|Death|69|||
30838400|NCT02787005|58863405|FG004|Overall Study|Death|38|||
30838401|NCT02787005|58863401|FG000|Overall Study|Sponsor Decision|7|||
30838402|NCT02787005|58863402|FG001|Overall Study|Sponsor Decision|4|||
30838403|NCT02787005|58863403|FG002|Overall Study|Sponsor Decision|0|||
30838404|NCT02787005|58863404|FG003|Overall Study|Sponsor Decision|4|||
30838405|NCT02787005|58863405|FG004|Overall Study|Sponsor Decision|5|||
30838406|NCT02787005|58863401|FG000|Overall Study|Withdrawal by Subject|2|||
30838407|NCT02787005|58863402|FG001|Overall Study|Withdrawal by Subject|1|||
30838408|NCT02787005|58863403|FG002|Overall Study|Withdrawal by Subject|1|||
30838409|NCT02787005|58863404|FG003|Overall Study|Withdrawal by Subject|0|||
30930374|NCT01902134|58966464|FG000|Overall Study|Other|0|||
30930375|NCT01902134|58966465|FG001|Overall Study|Other|1|||
30838410|NCT02787005|58863405|FG004|Overall Study|Withdrawal by Subject|1|||
30838411|NCT02787005|58863401|FG000|Overall Study|Screen Failure|0|||
30838412|NCT02787005|58863402|FG001|Overall Study|Screen Failure|2|||
30838413|NCT02787005|58863403|FG002|Overall Study|Screen Failure|0|||
30838414|NCT02787005|58863404|FG003|Overall Study|Screen Failure|0|||
30838415|NCT02787005|58863405|FG004|Overall Study|Screen Failure|1|||
30838416|NCT02787005|58863401|FG000|Overall Study|Lost to Follow-up|0|||
30838417|NCT02787005|58863402|FG001|Overall Study|Lost to Follow-up|0|||
30838418|NCT02787005|58863403|FG002|Overall Study|Lost to Follow-up|0|||
30930376|NCT01902134|58966466|FG002|Overall Study|Other|2|||
30930377|NCT01902134|58966467|FG003|Overall Study|Other|0|||
30930378|NCT01902134|58966468|FG004|Overall Study|Other|1|||
30930379|NCT01902134|58966469|FG005|Overall Study|Other|0|||
30930380|NCT01954082|58966487|FG000|Overall Study|Study Suspension|42|||
30930381|NCT01954082|58966488|FG001|Overall Study|Study Suspension|36|||
30930382|NCT01954082|58966487|FG000|Overall Study|Adverse Event|10|||
30930383|NCT01954082|58966488|FG001|Overall Study|Adverse Event|4|||
30930384|NCT01954082|58966487|FG000|Overall Study|Intolerance|0|||
30930385|NCT01954082|58966488|FG001|Overall Study|Intolerance|1|||
30930386|NCT01954082|58966487|FG000|Overall Study|Non-compliance|6|||
30930387|NCT01954082|58966488|FG001|Overall Study|Non-compliance|4|||
30930388|NCT01954082|58966487|FG000|Overall Study|Physician Decision|2|||
30930389|NCT01954082|58966488|FG001|Overall Study|Physician Decision|0|||
30930390|NCT01954082|58966487|FG000|Overall Study|Parent Decision|1|||
30930391|NCT01954082|58966488|FG001|Overall Study|Parent Decision|0|||
30930392|NCT01954082|58966487|FG000|Overall Study|Withdrawal by Subject|0|||
30930393|NCT01954082|58966488|FG001|Overall Study|Withdrawal by Subject|1|||
30930394|NCT01954082|58966487|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
30930395|NCT01954082|58966488|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
30930396|NCT01954082|58966487|FG000|Overall Study|Redirection of Care|0|||
30930397|NCT01954082|58966488|FG001|Overall Study|Redirection of Care|2|||
30838419|NCT02787005|58863404|FG003|Overall Study|Lost to Follow-up|1|||
30930398|NCT01954082|58966487|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
30930399|NCT01954082|58966488|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
30930400|NCT01954082|58966487|FG000|Overall Study|Comfort Care|0|||
30930401|NCT01954082|58966488|FG001|Overall Study|Comfort Care|1|||
30930402|NCT01954082|58966487|FG000|Overall Study|Infant Moved|0|||
30930403|NCT01954082|58966488|FG001|Overall Study|Infant Moved|1|||
30838420|NCT02787005|58863405|FG004|Overall Study|Lost to Follow-up|0|||
30838421|NCT02601313|58863439|FG000|Overall Study|Death|2|||
30838422|NCT02601313|58863440|FG001|Overall Study|Death|16|||
30838423|NCT02601313|58863441|FG002|Overall Study|Death|4|||
30838424|NCT02601313|58863439|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
30838425|NCT02601313|58863440|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
30838426|NCT02601313|58863441|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
30838427|NCT02601313|58863439|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
30930404|NCT01954082|58966487|FG000|Overall Study|Randomized not Treated|4|||
30838428|NCT02601313|58863440|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
30838429|NCT02601313|58863441|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
30838430|NCT02601313|58863439|FG000|Overall Study|Still on study|0|||
30838431|NCT02601313|58863440|FG001|Overall Study|Still on study|52|||
30838432|NCT02601313|58863441|FG002|Overall Study|Still on study|10|||
30838433|NCT02601313|58863439|FG000|Overall Study|Enrolled, did not initiate AC|4|||
30838434|NCT02601313|58863440|FG001|Overall Study|Enrolled, did not initiate AC|0|||
30838435|NCT02601313|58863441|FG002|Overall Study|Enrolled, did not initiate AC|0|||
30838436|NCT02514083|58863449|FG000|Overall Study|Adverse Event|1|||
30838437|NCT02395848|58863453|FG000|Overall Study|Lost to Follow-up|2|||
30838438|NCT02061761|58863470|FG000|Overall Study|Disease progression|2|||
30838439|NCT02061761|58863471|FG001|Overall Study|Disease progression|8|||
30838440|NCT02061761|58863472|FG002|Overall Study|Disease progression|4|||
30838441|NCT02061761|58863473|FG003|Overall Study|Disease progression|5|||
30838442|NCT02061761|58863474|FG004|Overall Study|Disease progression|9|||
30838443|NCT02061761|58863475|FG005|Overall Study|Disease progression|3|||
30838444|NCT02061761|58863476|FG006|Overall Study|Disease progression|1|||
30838445|NCT02061761|58863477|FG007|Overall Study|Disease progression|2|||
30838446|NCT02061761|58863478|FG008|Overall Study|Disease progression|28|||
30838447|NCT02061761|58863470|FG000|Overall Study|Study Drug toxicity|0|||
30838448|NCT02061761|58863471|FG001|Overall Study|Study Drug toxicity|0|||
30838449|NCT02061761|58863472|FG002|Overall Study|Study Drug toxicity|0|||
30838450|NCT02061761|58863473|FG003|Overall Study|Study Drug toxicity|0|||
30838451|NCT02061761|58863474|FG004|Overall Study|Study Drug toxicity|0|||
30838452|NCT02061761|58863475|FG005|Overall Study|Study Drug toxicity|1|||
30838453|NCT02061761|58863476|FG006|Overall Study|Study Drug toxicity|0|||
30838454|NCT02061761|58863477|FG007|Overall Study|Study Drug toxicity|2|||
30838455|NCT02061761|58863478|FG008|Overall Study|Study Drug toxicity|6|||
30838456|NCT02061761|58863470|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
30838457|NCT02061761|58863471|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
30838458|NCT02061761|58863472|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
30930405|NCT01954082|58966488|FG001|Overall Study|Randomized not Treated|2|||
30930406|NCT01417000|58966496|FG000|Overall Study|Death|59|||
30930407|NCT01417000|58966497|FG001|Overall Study|Death|28|||
30930408|NCT01417000|58966496|FG000|Overall Study|Lost to Follow-up|1|||
30838459|NCT02061761|58863473|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
30838460|NCT02061761|58863474|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
30838461|NCT02061761|58863475|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
30838462|NCT02061761|58863476|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
30838463|NCT02061761|58863477|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
30838464|NCT02061761|58863478|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
30930409|NCT01417000|58966497|FG001|Overall Study|Lost to Follow-up|0|||
30930410|NCT01417000|58966496|FG000|Overall Study|Study Terminated by Sponsor|1|||
30930411|NCT01417000|58966497|FG001|Overall Study|Study Terminated by Sponsor|1|||
30930412|NCT01416610|58966503|FG000|Overall Study|Adverse Event|4|||
30930413|NCT01416610|58966503|FG000|Overall Study|Adverse Event -Patient decision|3|||
30930414|NCT01416610|58966503|FG000|Overall Study|Lack of Efficacy|4|||
30930415|NCT01416610|58966503|FG000|Overall Study|No reason given|5|||
30930416|NCT01416610|58966503|FG000|Overall Study|Withdrawal by Subject|13|||
30930417|NCT01416610|58966503|FG000|Overall Study|Lost to Follow-up|7|||
30930418|NCT01416610|58966503|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
30930419|NCT01416142|58966511|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
30930420|NCT01416142|58966512|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
30930421|NCT01416142|58966513|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
30930422|NCT01415986|58966521|FG000|Overall Study|Lost to Follow-up|1|||
30930423|NCT01415908|58966528|FG000|Overall Study|Withdrawal by Subject|1|||
30930424|NCT01415908|58966529|FG001|Overall Study|Withdrawal by Subject|0|||
30930425|NCT01415518|58966537|FG000|Overall Study|Withdrawal by Subject|2|||
30930426|NCT01415518|58966538|FG001|Overall Study|Withdrawal by Subject|12|||
30930427|NCT01415518|58966537|FG000|Overall Study|Protocol Violation|6|||
30930428|NCT01415518|58966538|FG001|Overall Study|Protocol Violation|8|||
30930429|NCT01415518|58966537|FG000|Overall Study|Lost to Follow-up|3|||
30930430|NCT01415518|58966538|FG001|Overall Study|Lost to Follow-up|5|||
30930431|NCT01415518|58966537|FG000|Overall Study|Adverse Event|3|||
30930432|NCT01415518|58966538|FG001|Overall Study|Adverse Event|4|||
30930433|NCT01415518|58966537|FG000|Overall Study|Death|1|||
30930434|NCT01415518|58966538|FG001|Overall Study|Death|1|||
30930435|NCT01415518|58966537|FG000|Overall Study|Condition under Investigation Worsened|1|||
30930436|NCT01415518|58966538|FG001|Overall Study|Condition under Investigation Worsened|1|||
30930437|NCT01393600|58966544|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
30930438|NCT01393600|58966545|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
30930439|NCT01393600|58966546|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
30930440|NCT01393600|58966547|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
30930441|NCT01393600|58966544|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
30930442|NCT01393600|58966545|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
30930443|NCT01393600|58966546|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
30930444|NCT01393600|58966547|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
30930445|NCT01393600|58966544|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
30930446|NCT01393600|58966545|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
30930447|NCT01393600|58966546|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
30838465|NCT02061761|58863470|FG000|Overall Study|Participant request to discontinue study treatment|0|||
30838466|NCT02061761|58863471|FG001|Overall Study|Participant request to discontinue study treatment|0|||
30838467|NCT02061761|58863472|FG002|Overall Study|Participant request to discontinue study treatment|2|||
30838468|NCT02061761|58863473|FG003|Overall Study|Participant request to discontinue study treatment|2|||
30838469|NCT02061761|58863474|FG004|Overall Study|Participant request to discontinue study treatment|0|||
30838470|NCT02061761|58863475|FG005|Overall Study|Participant request to discontinue study treatment|1|||
30838471|NCT02061761|58863476|FG006|Overall Study|Participant request to discontinue study treatment|0|||
30838472|NCT02061761|58863477|FG007|Overall Study|Participant request to discontinue study treatment|0|||
30838473|NCT02061761|58863478|FG008|Overall Study|Participant request to discontinue study treatment|2|||
30838474|NCT02061761|58863470|FG000|Overall Study|Withdrawal by Subject|0|||
30838475|NCT02061761|58863471|FG001|Overall Study|Withdrawal by Subject|0|||
30838476|NCT02061761|58863472|FG002|Overall Study|Withdrawal by Subject|0|||
30838477|NCT02061761|58863473|FG003|Overall Study|Withdrawal by Subject|0|||
30838478|NCT02061761|58863474|FG004|Overall Study|Withdrawal by Subject|0|||
30838479|NCT02061761|58863475|FG005|Overall Study|Withdrawal by Subject|0|||
30838480|NCT02061761|58863476|FG006|Overall Study|Withdrawal by Subject|0|||
30838481|NCT02061761|58863477|FG007|Overall Study|Withdrawal by Subject|0|||
30838482|NCT02061761|58863478|FG008|Overall Study|Withdrawal by Subject|2|||
30838483|NCT02061761|58863470|FG000|Overall Study|Maximum clinical benefit|0|||
30838484|NCT02061761|58863471|FG001|Overall Study|Maximum clinical benefit|0|||
30838485|NCT02061761|58863472|FG002|Overall Study|Maximum clinical benefit|0|||
30838486|NCT02061761|58863473|FG003|Overall Study|Maximum clinical benefit|1|||
30838487|NCT02061761|58863474|FG004|Overall Study|Maximum clinical benefit|0|||
30838488|NCT02061761|58863475|FG005|Overall Study|Maximum clinical benefit|0|||
30838489|NCT02061761|58863476|FG006|Overall Study|Maximum clinical benefit|0|||
30838490|NCT02061761|58863477|FG007|Overall Study|Maximum clinical benefit|0|||
30838491|NCT02061761|58863478|FG008|Overall Study|Maximum clinical benefit|6|||
30838492|NCT02061761|58863470|FG000|Overall Study|Participant no longer meets study criteria|0|||
30838493|NCT02061761|58863471|FG001|Overall Study|Participant no longer meets study criteria|0|||
30930448|NCT01393600|58966547|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
30838494|NCT02061761|58863472|FG002|Overall Study|Participant no longer meets study criteria|0|||
30838495|NCT02061761|58863473|FG003|Overall Study|Participant no longer meets study criteria|0|||
30838496|NCT02061761|58863474|FG004|Overall Study|Participant no longer meets study criteria|0|||
30838497|NCT02061761|58863475|FG005|Overall Study|Participant no longer meets study criteria|0|||
30838498|NCT02061761|58863476|FG006|Overall Study|Participant no longer meets study criteria|0|||
30930449|NCT01393600|58966544|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
30930450|NCT01393600|58966545|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
30930451|NCT01393600|58966546|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
30930452|NCT01393600|58966547|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
30930453|NCT01393600|58966544|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
30930454|NCT01393600|58966545|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
30930455|NCT01393600|58966546|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
30930456|NCT01393600|58966547|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
30930457|NCT01393600|58966544|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
30930458|NCT01393600|58966545|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
30930459|NCT01393600|58966546|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
30930460|NCT01393600|58966547|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
30930461|NCT01393600|58966544|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
30930462|NCT01393600|58966545|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
30930463|NCT01393600|58966546|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
30930464|NCT01393600|58966547|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
30930465|NCT01432756|58966563|FG000|Overall Study|Lost to Follow-up|1|||
30930466|NCT01432756|58966564|FG001|Overall Study|Lost to Follow-up|0|||
30930467|NCT01432756|58966565|FG002|Overall Study|Lost to Follow-up|2|||
30930468|NCT01432756|58966566|FG003|Overall Study|Lost to Follow-up|1|||
30930469|NCT01432600|58966577|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
30930470|NCT01432600|58966578|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
30930471|NCT01432600|58966579|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
30930472|NCT01432444|58966589|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
30930473|NCT01432444|58966590|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
30930474|NCT01432444|58966591|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
30930475|NCT01432444|58966589|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
30930476|NCT01432444|58966590|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
30930477|NCT01432444|58966591|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
30930478|NCT01432444|58966589|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
30930479|NCT01432444|58966590|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
30930480|NCT01432444|58966591|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
30930481|NCT01432444|58966589|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
30930482|NCT01432444|58966590|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
30930483|NCT01432444|58966591|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
30930484|NCT01432444|58966589|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
30930485|NCT01432444|58966590|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
30930486|NCT01432444|58966591|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
30930487|NCT01432444|58966589|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
30930488|NCT01432444|58966590|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
30930489|NCT01432444|58966591|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
30930490|NCT01432444|58966589|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
30930491|NCT01432444|58966590|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
30930492|NCT01432444|58966591|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
30930493|NCT01432444|58966589|FG000|Treatment Phase|Lost to Follow-up|0|||
30930494|NCT01432444|58966590|FG001|Treatment Phase|Lost to Follow-up|33|||
30930495|NCT01432444|58966591|FG002|Treatment Phase|Lost to Follow-up|0|||
30930496|NCT01432444|58966589|FG000|Treatment Phase|Adverse Event|0|||
30930497|NCT01432444|58966590|FG001|Treatment Phase|Adverse Event|37|||
30930498|NCT01432444|58966591|FG002|Treatment Phase|Adverse Event|0|||
30930499|NCT01432444|58966589|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
30930500|NCT01432444|58966590|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
30930501|NCT01432444|58966591|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
30930502|NCT01432444|58966589|FG000|Treatment Phase|Physician Decision|0|||
30930503|NCT01432444|58966590|FG001|Treatment Phase|Physician Decision|5|||
30930504|NCT01432444|58966591|FG002|Treatment Phase|Physician Decision|0|||
30930505|NCT01432444|58966589|FG000|Treatment Phase|Withdrawal by Subject|0|||
30930506|NCT01432444|58966590|FG001|Treatment Phase|Withdrawal by Subject|41|||
30930507|NCT01432444|58966591|FG002|Treatment Phase|Withdrawal by Subject|0|||
30930508|NCT01432444|58966589|FG000|Treatment Phase|Protocol Deviation|0|||
30930509|NCT01432444|58966590|FG001|Treatment Phase|Protocol Deviation|3|||
30930510|NCT01432444|58966591|FG002|Treatment Phase|Protocol Deviation|0|||
30930511|NCT01432444|58966589|FG000|Treatment Phase|Lack of Efficacy|0|||
30930512|NCT01432444|58966590|FG001|Treatment Phase|Lack of Efficacy|10|||
30930513|NCT01432444|58966591|FG002|Treatment Phase|Lack of Efficacy|0|||
30930514|NCT01432444|58966589|FG000|Extension Phase|Lost to Follow-up|0|||
30930515|NCT01432444|58966590|FG001|Extension Phase|Lost to Follow-up|0|||
30930516|NCT01432444|58966591|FG002|Extension Phase|Lost to Follow-up|17|||
30930517|NCT01432444|58966589|FG000|Extension Phase|Adverse Event|0|||
30930518|NCT01432444|58966590|FG001|Extension Phase|Adverse Event|0|||
30758022|NCT00112437|58766924|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30930519|NCT01432444|58966591|FG002|Extension Phase|Adverse Event|10|||
30930520|NCT01432444|58966589|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
30930521|NCT01432444|58966590|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
30930522|NCT01432444|58966591|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
30930523|NCT01432444|58966589|FG000|Extension Phase|Met Withdrawal Criteria|0|||
30930524|NCT01432444|58966590|FG001|Extension Phase|Met Withdrawal Criteria|0|||
30930525|NCT01432444|58966591|FG002|Extension Phase|Met Withdrawal Criteria|144|||
30930526|NCT01432444|58966589|FG000|Extension Phase|Physician Decision|0|||
30930527|NCT01432444|58966590|FG001|Extension Phase|Physician Decision|0|||
30930528|NCT01432444|58966591|FG002|Extension Phase|Physician Decision|1|||
30930529|NCT01432444|58966589|FG000|Extension Phase|Withdrawal by Subject|0|||
30930530|NCT01432444|58966590|FG001|Extension Phase|Withdrawal by Subject|0|||
30930531|NCT01432444|58966591|FG002|Extension Phase|Withdrawal by Subject|13|||
30930532|NCT01432366|58966596|FG000|Overall Study|Non-Responder|7|||
30930533|NCT01432366|58966596|FG000|Overall Study|Adverse Event|8|||
30930534|NCT01432366|58966596|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
30930535|NCT01432366|58966596|FG000|Overall Study|Pregnancy|1|||
30930536|NCT01432366|58966596|FG000|Overall Study|Lost to Follow-up|13|||
30930537|NCT01432366|58966596|FG000|Overall Study|Lack of Efficacy|1|||
30930538|NCT01432366|58966596|FG000|Overall Study|Site Closed|20|||
30930539|NCT01432366|58966596|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
30930540|NCT01432366|58966596|FG000|Overall Study|Other|14|||
30930541|NCT01415440|58966603|FG000|Overall Study|Lost to Follow-up|0|||
30930542|NCT01415440|58966604|FG001|Overall Study|Lost to Follow-up|1|||
30930543|NCT01415440|58966605|FG002|Overall Study|Lost to Follow-up|2|||
30930544|NCT01415440|58966603|FG000|Overall Study|Physician Decision|3|||
30930545|NCT01415440|58966604|FG001|Overall Study|Physician Decision|0|||
30930546|NCT01415440|58966605|FG002|Overall Study|Physician Decision|0|||
30930547|NCT01415440|58966603|FG000|Overall Study|Withdrawal by Subject|1|||
30930548|NCT01415440|58966604|FG001|Overall Study|Withdrawal by Subject|0|||
30930549|NCT01415440|58966605|FG002|Overall Study|Withdrawal by Subject|0|||
30930550|NCT01932788|58966623|FG000|Overall Study|Protocol Violation|18|||
30930551|NCT01932788|58966624|FG001|Overall Study|Protocol Violation|0|||
30930552|NCT01932788|58966623|FG000|Overall Study|Lost to Follow-up|18|||
30930553|NCT01932788|58966624|FG001|Overall Study|Lost to Follow-up|46|||
30930554|NCT01932788|58966623|FG000|Overall Study|Lack of Efficacy|2|||
30930555|NCT01932788|58966624|FG001|Overall Study|Lack of Efficacy|0|||
30930556|NCT01932788|58966623|FG000|Overall Study|Withdrawal by Subject|0|||
30838499|NCT02061761|58863477|FG007|Overall Study|Participant no longer meets study criteria|0|||
30838500|NCT02061761|58863478|FG008|Overall Study|Participant no longer meets study criteria|1|||
30930557|NCT01932788|58966624|FG001|Overall Study|Withdrawal by Subject|5|||
30930558|NCT01414738|58966630|FG000|Overall Study|Death|26|||
30930559|NCT01414738|58966630|FG000|Overall Study|Refused testing|5|||
30930560|NCT01414738|58966630|FG000|Overall Study|Lost to Follow-up|2|||
30930561|NCT01414738|58966630|FG000|Overall Study|Refused, disease progression|8|||
30930562|NCT01414738|58966630|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
30930563|NCT01414114|58966634|FG000|Overall Study|Adverse Event|2|||
30930564|NCT01414114|58966634|FG000|Overall Study|Withdrawal by Subject|1|||
30930565|NCT01414114|58966634|FG000|Overall Study|Other|2|||
30930566|NCT01393444|58966640|FG000|Overall Study|Withdrawal by Subject|1|||
30930567|NCT01393444|58966640|FG000|Overall Study|Determined ineligible during screening.|2|||
30930568|NCT01431976|58966644|FG000|Overall Study|Adverse Event|6|||
30930569|NCT01431976|58966644|FG000|Overall Study|Lack of Efficacy|2|||
30930570|NCT01431976|58966644|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
30758023|NCT00112437|58766925|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30838501|NCT02061761|58863470|FG000|Overall Study|Other reasons|0|||
30838502|NCT02061761|58863471|FG001|Overall Study|Other reasons|0|||
30838503|NCT02061761|58863472|FG002|Overall Study|Other reasons|0|||
30930571|NCT01431976|58966644|FG000|Overall Study|Physician Decision|1|||
30758024|NCT00112437|58766926|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758025|NCT00112437|58766927|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758026|NCT00112437|58766928|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758027|NCT00112437|58766929|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758028|NCT00112437|58766930|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758029|NCT00112437|58766931|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
30758030|NCT00112437|58766932|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
30838504|NCT02061761|58863473|FG003|Overall Study|Other reasons|0|||
30838505|NCT02061761|58863474|FG004|Overall Study|Other reasons|2|||
30930572|NCT01431976|58966644|FG000|Overall Study|Withdrawal by Subject|1|||
30930573|NCT01392742|58966648|FG000|Overall Study|Premature study termination|42|||
30930574|NCT01392742|58966648|FG000|Overall Study|Failure to return|35|||
30624171|NCT00959049|58636124|FG003|Overall Study|Withdrawal by Subject|0|||
30930575|NCT01392742|58966648|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
30930576|NCT01392742|58966648|FG000|Overall Study|Lost to Follow-up|34|||
30930577|NCT01392742|58966648|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
30838506|NCT02061761|58863475|FG005|Overall Study|Other reasons|0|||
30838507|NCT02061761|58863476|FG006|Overall Study|Other reasons|0|||
30838508|NCT02061761|58863477|FG007|Overall Study|Other reasons|0|||
30838509|NCT02061761|58863478|FG008|Overall Study|Other reasons|6|||
30838510|NCT01927068|58863506|FG000|Overall Study|Death|37|||
30838511|NCT01927068|58863507|FG001|Overall Study|Death|3|||
30838512|NCT01927068|58863506|FG000|Overall Study|Withdrawal by Subject|50|||
30838513|NCT01927068|58863507|FG001|Overall Study|Withdrawal by Subject|3|||
30838514|NCT01927068|58863506|FG000|Overall Study|Lost to Follow-up|10|||
30838515|NCT01927068|58863507|FG001|Overall Study|Lost to Follow-up|2|||
30838516|NCT01927068|58863506|FG000|Overall Study|Physician Decision|9|||
30838517|NCT01927068|58863507|FG001|Overall Study|Physician Decision|0|||
30838518|NCT01927068|58863506|FG000|Overall Study|Missed last follow-up visit|2|||
30838519|NCT01927068|58863507|FG001|Overall Study|Missed last follow-up visit|0|||
30930578|NCT01392742|58966648|FG000|Overall Study|ITR and Protocol deviation|1|||
30930579|NCT01392742|58966648|FG000|Overall Study|Adverse event/intercurrent illness|17|||
30930580|NCT01392742|58966648|FG000|Overall Study|Protocol Violation|14|||
30930581|NCT01392742|58966648|FG000|Overall Study|Other|3|||
30930582|NCT01392742|58966648|FG000|Overall Study|Missing information|13|||
30930583|NCT01413958|58966654|FG000|Overall Study|Lost to Follow-up|0|||
30930584|NCT01413958|58966655|FG001|Overall Study|Lost to Follow-up|1|||
30930585|NCT01413178|58966664|FG000|Overall Study|Toxicity|1|||
30930586|NCT01413178|58966665|FG001|Overall Study|Toxicity|0|||
30930587|NCT01413178|58966664|FG000|Overall Study|Ineligible|0|||
30930588|NCT01413178|58966665|FG001|Overall Study|Ineligible|2|||
30930589|NCT01799889|58966683|FG000|Overall Study|Adverse Event|4|||
30930590|NCT01799889|58966684|FG001|Overall Study|Adverse Event|4|||
30930591|NCT01799889|58966685|FG002|Overall Study|Adverse Event|5|||
30930592|NCT01799889|58966686|FG003|Overall Study|Adverse Event|1|||
30930593|NCT01799889|58966687|FG004|Overall Study|Adverse Event|11|||
30930594|NCT01799889|58966688|FG005|Overall Study|Adverse Event|1|||
30930595|NCT01799889|58966689|FG006|Overall Study|Adverse Event|5|||
30930596|NCT01799889|58966690|FG007|Overall Study|Adverse Event|2|||
30930597|NCT01799889|58966691|FG008|Overall Study|Adverse Event|3|||
30930598|NCT01799889|58966692|FG009|Overall Study|Adverse Event|1|||
30930599|NCT01799889|58966693|FG010|Overall Study|Adverse Event|1|||
30930600|NCT01799889|58966694|FG011|Overall Study|Adverse Event|0|||
30930601|NCT01799889|58966683|FG000|Overall Study|Death|1|||
30930602|NCT01799889|58966684|FG001|Overall Study|Death|0|||
30930603|NCT01799889|58966685|FG002|Overall Study|Death|5|||
30930604|NCT01799889|58966686|FG003|Overall Study|Death|3|||
30930605|NCT01799889|58966687|FG004|Overall Study|Death|1|||
30930606|NCT01799889|58966688|FG005|Overall Study|Death|0|||
30930607|NCT01799889|58966689|FG006|Overall Study|Death|0|||
30930608|NCT01799889|58966690|FG007|Overall Study|Death|0|||
30930609|NCT01799889|58966691|FG008|Overall Study|Death|1|||
30930610|NCT01799889|58966692|FG009|Overall Study|Death|0|||
30930611|NCT01799889|58966693|FG010|Overall Study|Death|1|||
30930612|NCT01799889|58966694|FG011|Overall Study|Death|0|||
30930613|NCT01799889|58966683|FG000|Overall Study|Lack of Efficacy|1|||
30930614|NCT01799889|58966684|FG001|Overall Study|Lack of Efficacy|1|||
30930615|NCT01799889|58966685|FG002|Overall Study|Lack of Efficacy|0|||
30930616|NCT01799889|58966686|FG003|Overall Study|Lack of Efficacy|1|||
30930617|NCT01799889|58966687|FG004|Overall Study|Lack of Efficacy|2|||
30930618|NCT01799889|58966688|FG005|Overall Study|Lack of Efficacy|2|||
30930619|NCT01799889|58966689|FG006|Overall Study|Lack of Efficacy|0|||
30930620|NCT01799889|58966690|FG007|Overall Study|Lack of Efficacy|0|||
30930621|NCT01799889|58966691|FG008|Overall Study|Lack of Efficacy|2|||
30930622|NCT01799889|58966692|FG009|Overall Study|Lack of Efficacy|0|||
30930623|NCT01799889|58966693|FG010|Overall Study|Lack of Efficacy|1|||
30930624|NCT01799889|58966694|FG011|Overall Study|Lack of Efficacy|0|||
30838520|NCT01309230|58863516|FG000|Overall Study|Withdrawal by Subject|0|||
30838521|NCT01309230|58863517|FG001|Overall Study|Withdrawal by Subject|2|||
30838522|NCT01309230|58863516|FG000|Overall Study|Observation arm closed|0|||
30838523|NCT01309230|58863517|FG001|Overall Study|Observation arm closed|2|||
30838524|NCT00819832|58863529|FG000|Overall Study|Sponsor Termination of Study|3|||
30838525|NCT00819832|58863530|FG001|Overall Study|Sponsor Termination of Study|0|||
30838526|NCT00819832|58863531|FG002|Overall Study|Sponsor Termination of Study|0|||
30930625|NCT01799889|58966683|FG000|Overall Study|Lost to Follow-up|0|||
30930626|NCT01799889|58966684|FG001|Overall Study|Lost to Follow-up|1|||
30930627|NCT01799889|58966685|FG002|Overall Study|Lost to Follow-up|0|||
30930628|NCT01799889|58966686|FG003|Overall Study|Lost to Follow-up|0|||
30930629|NCT01799889|58966687|FG004|Overall Study|Lost to Follow-up|0|||
30930630|NCT01799889|58966688|FG005|Overall Study|Lost to Follow-up|0|||
30930631|NCT01799889|58966689|FG006|Overall Study|Lost to Follow-up|0|||
30930632|NCT01799889|58966690|FG007|Overall Study|Lost to Follow-up|0|||
30930633|NCT01799889|58966691|FG008|Overall Study|Lost to Follow-up|0|||
30930634|NCT01799889|58966692|FG009|Overall Study|Lost to Follow-up|0|||
30930635|NCT01799889|58966693|FG010|Overall Study|Lost to Follow-up|0|||
30930636|NCT01799889|58966694|FG011|Overall Study|Lost to Follow-up|0|||
30930637|NCT01799889|58966683|FG000|Overall Study|Physician Decision|3|||
30930638|NCT01799889|58966684|FG001|Overall Study|Physician Decision|2|||
30930639|NCT01799889|58966685|FG002|Overall Study|Physician Decision|4|||
30930640|NCT01799889|58966686|FG003|Overall Study|Physician Decision|4|||
30930641|NCT01799889|58966687|FG004|Overall Study|Physician Decision|5|||
30624172|NCT00959049|58636125|FG004|Overall Study|Withdrawal by Subject|0|||
30624173|NCT00959049|58636126|FG005|Overall Study|Withdrawal by Subject|0|||
30624174|NCT00956943|58636153|FG000|Overall Study|Lost to Follow-up|9|||
30624175|NCT00956943|58636154|FG001|Overall Study|Lost to Follow-up|10|||
30624176|NCT00958893|58636160|FG000|Overall Study|Study prematurely terminated|4|||
30624177|NCT01135914|58636167|FG000|Overall Study|Withdrawal by Subject|1|||
30624178|NCT01135914|58636168|FG001|Overall Study|Withdrawal by Subject|3|||
30624179|NCT01135914|58636169|FG002|Overall Study|Withdrawal by Subject|6|||
30624180|NCT01135914|58636167|FG000|Overall Study|Lost to Follow-up|1|||
30838527|NCT00819832|58863532|FG003|Overall Study|Sponsor Termination of Study|0|||
30838528|NCT00819832|58863533|FG004|Overall Study|Sponsor Termination of Study|0|||
30838529|NCT00819832|58863534|FG005|Overall Study|Sponsor Termination of Study|0|||
30930642|NCT01799889|58966688|FG005|Overall Study|Physician Decision|5|||
30930643|NCT01799889|58966689|FG006|Overall Study|Physician Decision|5|||
30930644|NCT01799889|58966690|FG007|Overall Study|Physician Decision|2|||
30930645|NCT01799889|58966691|FG008|Overall Study|Physician Decision|6|||
30838530|NCT00704522|58863550|FG000|Overall Study|Lack of Efficacy|65|||
30838531|NCT00704522|58863551|FG001|Overall Study|Lack of Efficacy|17|||
30930646|NCT01799889|58966692|FG009|Overall Study|Physician Decision|0|||
30930647|NCT01799889|58966693|FG010|Overall Study|Physician Decision|0|||
30930648|NCT01799889|58966694|FG011|Overall Study|Physician Decision|1|||
30930649|NCT01799889|58966683|FG000|Overall Study|Progressive Disease|30|||
30930650|NCT01799889|58966684|FG001|Overall Study|Progressive Disease|26|||
30930651|NCT01799889|58966685|FG002|Overall Study|Progressive Disease|25|||
30930652|NCT01799889|58966686|FG003|Overall Study|Progressive Disease|30|||
30930653|NCT01799889|58966687|FG004|Overall Study|Progressive Disease|23|||
30930654|NCT01799889|58966688|FG005|Overall Study|Progressive Disease|9|||
30930655|NCT01799889|58966689|FG006|Overall Study|Progressive Disease|8|||
30930656|NCT01799889|58966690|FG007|Overall Study|Progressive Disease|13|||
30930657|NCT01799889|58966691|FG008|Overall Study|Progressive Disease|18|||
30930658|NCT01799889|58966692|FG009|Overall Study|Progressive Disease|5|||
30930659|NCT01799889|58966693|FG010|Overall Study|Progressive Disease|3|||
30930660|NCT01799889|58966694|FG011|Overall Study|Progressive Disease|1|||
30930661|NCT01799889|58966683|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
30930662|NCT01799889|58966684|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
30930663|NCT01799889|58966685|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
30930664|NCT01799889|58966686|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
30930665|NCT01799889|58966687|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
30930666|NCT01799889|58966688|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
30930667|NCT01799889|58966689|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
30930668|NCT01799889|58966690|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
30930669|NCT01799889|58966691|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
30930670|NCT01799889|58966692|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
30930671|NCT01799889|58966693|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
30930672|NCT01799889|58966694|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
30930673|NCT01799889|58966683|FG000|Overall Study|Study Terminated By Sponsor|1|||
30930674|NCT01799889|58966684|FG001|Overall Study|Study Terminated By Sponsor|0|||
30930675|NCT01799889|58966685|FG002|Overall Study|Study Terminated By Sponsor|0|||
30930676|NCT01799889|58966686|FG003|Overall Study|Study Terminated By Sponsor|0|||
30930677|NCT01799889|58966687|FG004|Overall Study|Study Terminated By Sponsor|2|||
30930678|NCT01799889|58966688|FG005|Overall Study|Study Terminated By Sponsor|1|||
30930679|NCT01799889|58966689|FG006|Overall Study|Study Terminated By Sponsor|0|||
30624181|NCT01135914|58636168|FG001|Overall Study|Lost to Follow-up|0|||
30624182|NCT01135914|58636169|FG002|Overall Study|Lost to Follow-up|1|||
30624183|NCT01135914|58636167|FG000|Overall Study|Protocol Violation|0|||
30758031|NCT00112437|58766933|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758032|NCT00112437|58766934|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758033|NCT00112437|58766935|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758034|NCT00112437|58766936|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758035|NCT00112437|58766937|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758036|NCT00112437|58766938|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758037|NCT00112437|58766939|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758038|NCT00112437|58766940|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30838532|NCT00704522|58863550|FG000|Overall Study|Failure to appear again at hospital|56|||
30930680|NCT01799889|58966690|FG007|Overall Study|Study Terminated By Sponsor|2|||
30930681|NCT01799889|58966691|FG008|Overall Study|Study Terminated By Sponsor|1|||
30930682|NCT01799889|58966692|FG009|Overall Study|Study Terminated By Sponsor|1|||
30930683|NCT01799889|58966693|FG010|Overall Study|Study Terminated By Sponsor|0|||
30930684|NCT01799889|58966694|FG011|Overall Study|Study Terminated By Sponsor|0|||
30930685|NCT01799889|58966683|FG000|Overall Study|Withdrawal by Subject|1|||
30930686|NCT01799889|58966684|FG001|Overall Study|Withdrawal by Subject|6|||
30930687|NCT01799889|58966685|FG002|Overall Study|Withdrawal by Subject|4|||
30930688|NCT01799889|58966686|FG003|Overall Study|Withdrawal by Subject|0|||
30930689|NCT01799889|58966687|FG004|Overall Study|Withdrawal by Subject|5|||
30838533|NCT00704522|58863551|FG001|Overall Study|Failure to appear again at hospital|10|||
30838534|NCT00704522|58863550|FG000|Overall Study|Withdrawal by Subject|17|||
30838535|NCT00704522|58863551|FG001|Overall Study|Withdrawal by Subject|8|||
30838536|NCT00704522|58863550|FG000|Overall Study|Adverse Event|9|||
30838537|NCT00704522|58863551|FG001|Overall Study|Adverse Event|1|||
30838538|NCT00704522|58863550|FG000|Overall Study|Undefined causes|9|||
30838539|NCT00704522|58863551|FG001|Overall Study|Undefined causes|7|||
30838540|NCT00704522|58863550|FG000|Overall Study|No information on therapy end|27|||
30838541|NCT00704522|58863551|FG001|Overall Study|No information on therapy end|2|||
30838542|NCT02723630|58863562|FG000|Intervention Period 1|Adverse Event|1|||
30838543|NCT02723630|58863563|FG001|Intervention Period 1|Adverse Event|0|||
30838544|NCT02723630|58863564|FG002|Intervention Period 1|Adverse Event|0|||
30838545|NCT02723630|58863565|FG003|Intervention Period 1|Adverse Event|0|||
30838546|NCT02723630|58863566|FG004|Intervention Period 1|Adverse Event|0|||
30838547|NCT02723630|58863567|FG005|Intervention Period 1|Adverse Event|0|||
30838548|NCT02723630|58863562|FG000|Intervention Period 3|consumption of restricted item|0|||
30838549|NCT02723630|58863563|FG001|Intervention Period 3|consumption of restricted item|1|||
30838550|NCT02723630|58863564|FG002|Intervention Period 3|consumption of restricted item|0|||
30838551|NCT02723630|58863565|FG003|Intervention Period 3|consumption of restricted item|0|||
30838552|NCT02723630|58863566|FG004|Intervention Period 3|consumption of restricted item|0|||
30838553|NCT02723630|58863567|FG005|Intervention Period 3|consumption of restricted item|0|||
30838554|NCT04089735|58863610|FG000|Overall Study|Adverse Event|1|||
30838555|NCT04089735|58863611|FG001|Overall Study|Adverse Event|0|||
30838556|NCT04089735|58863612|FG002|Overall Study|Adverse Event|1|||
30838557|NCT04089735|58863613|FG003|Overall Study|Adverse Event|1|||
30838558|NCT04089735|58863614|FG004|Overall Study|Adverse Event|0|||
30838559|NCT04089735|58863615|FG005|Overall Study|Adverse Event|0|||
30838560|NCT04089735|58863610|FG000|Overall Study|Physician Decision|0|||
30838561|NCT04089735|58863611|FG001|Overall Study|Physician Decision|3|||
30838562|NCT04089735|58863612|FG002|Overall Study|Physician Decision|0|||
30838563|NCT04089735|58863613|FG003|Overall Study|Physician Decision|0|||
30838564|NCT04089735|58863614|FG004|Overall Study|Physician Decision|0|||
30838565|NCT04089735|58863615|FG005|Overall Study|Physician Decision|0|||
30838566|NCT04089735|58863610|FG000|Overall Study|Withdrawal by Subject|0|||
30838567|NCT04089735|58863611|FG001|Overall Study|Withdrawal by Subject|0|||
30838568|NCT04089735|58863612|FG002|Overall Study|Withdrawal by Subject|1|||
30838569|NCT04089735|58863613|FG003|Overall Study|Withdrawal by Subject|0|||
30838570|NCT04089735|58863614|FG004|Overall Study|Withdrawal by Subject|0|||
30838571|NCT04089735|58863615|FG005|Overall Study|Withdrawal by Subject|0|||
30838572|NCT04089735|58863610|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
30838573|NCT04089735|58863611|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
30838574|NCT04089735|58863612|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
30838575|NCT04089735|58863613|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
30838576|NCT04089735|58863614|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
30838577|NCT04089735|58863615|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
30838578|NCT01876784|58863631|FG000|Overall Study|Withdrawal by Subject|17|||
30838579|NCT01876784|58863632|FG001|Overall Study|Withdrawal by Subject|2|||
30838580|NCT01876784|58863631|FG000|Overall Study|Adverse Event|15|||
30838581|NCT01876784|58863632|FG001|Overall Study|Adverse Event|2|||
30838582|NCT01876784|58863631|FG000|Overall Study|Protocol Violation|1|||
30838583|NCT01876784|58863632|FG001|Overall Study|Protocol Violation|0|||
30838584|NCT01876784|58863631|FG000|Overall Study|Disease progression|37|||
30838585|NCT01876784|58863632|FG001|Overall Study|Disease progression|67|||
30838586|NCT01876784|58863631|FG000|Overall Study|Lost to Follow-up|0|||
30838587|NCT01876784|58863632|FG001|Overall Study|Lost to Follow-up|1|||
30838588|NCT01876784|58863631|FG000|Overall Study|Death|1|||
30838589|NCT01876784|58863632|FG001|Overall Study|Death|0|||
30838590|NCT01876784|58863631|FG000|Overall Study|Randomized but not treated|2|||
30930690|NCT01799889|58966688|FG005|Overall Study|Withdrawal by Subject|1|||
30930691|NCT01799889|58966689|FG006|Overall Study|Withdrawal by Subject|3|||
30930692|NCT01799889|58966690|FG007|Overall Study|Withdrawal by Subject|1|||
30930693|NCT01799889|58966691|FG008|Overall Study|Withdrawal by Subject|2|||
30930694|NCT01799889|58966692|FG009|Overall Study|Withdrawal by Subject|1|||
30838591|NCT01876784|58863632|FG001|Overall Study|Randomized but not treated|1|||
30838592|NCT01876784|58863631|FG000|Overall Study|Other than specified above|5|||
30838593|NCT01876784|58863632|FG001|Overall Study|Other than specified above|6|||
30838594|NCT01876784|58863631|FG000|Overall Study|Ongoing|41|||
30838595|NCT01876784|58863632|FG001|Overall Study|Ongoing|40|||
30838596|NCT04205162|58863640|FG000|Overall Study|Lost to Follow-up|1|||
30838597|NCT04205162|58863641|FG001|Overall Study|Lost to Follow-up|0|||
30838598|NCT04205162|58863640|FG000|Overall Study|Withdrawal by Subject|2|||
30838599|NCT04205162|58863641|FG001|Overall Study|Withdrawal by Subject|0|||
30838600|NCT04205162|58863640|FG000|Overall Study|University closure due to COVID-19|1|||
30838601|NCT04205162|58863641|FG001|Overall Study|University closure due to COVID-19|0|||
30838602|NCT01329939|58863652|FG000|Overall Study|Lost to Follow-up|3|||
30838603|NCT01329939|58863653|FG001|Overall Study|Lost to Follow-up|0|||
30838604|NCT01329939|58863654|FG002|Overall Study|Lost to Follow-up|1|||
30838605|NCT01329939|58863655|FG003|Overall Study|Lost to Follow-up|2|||
30838606|NCT01329939|58863652|FG000|Overall Study|Withdrawal by Subject|0|||
30838607|NCT01329939|58863653|FG001|Overall Study|Withdrawal by Subject|1|||
30838608|NCT01329939|58863654|FG002|Overall Study|Withdrawal by Subject|0|||
30838609|NCT01329939|58863655|FG003|Overall Study|Withdrawal by Subject|0|||
30838610|NCT01329939|58863652|FG000|Overall Study|Adverse Event|0|||
30838611|NCT01329939|58863653|FG001|Overall Study|Adverse Event|0|||
30838612|NCT01329939|58863654|FG002|Overall Study|Adverse Event|0|||
30838613|NCT01329939|58863655|FG003|Overall Study|Adverse Event|3|||
30838614|NCT02499900|58863667|FG000|Core Study Period|Other|1|||
30838615|NCT02499900|58863668|FG001|Core Study Period|Other|4|||
30838616|NCT02499900|58863667|FG000|Core Study Period|Lost to Follow-up|1|||
30838617|NCT02499900|58863668|FG001|Core Study Period|Lost to Follow-up|2|||
30838618|NCT02499900|58863667|FG000|Core Study Period|Per sponsor request|0|||
30838619|NCT02499900|58863668|FG001|Core Study Period|Per sponsor request|1|||
30838620|NCT02499900|58863667|FG000|Core Study Period|Pregnancy|1|||
30838621|NCT02499900|58863668|FG001|Core Study Period|Pregnancy|0|||
30838622|NCT02499900|58863667|FG000|Core Study Period|Protocol Violation|3|||
30838623|NCT02499900|58863668|FG001|Core Study Period|Protocol Violation|0|||
30838624|NCT02499900|58863667|FG000|Core Study Period|Withdrawal by Subject|11|||
30838625|NCT02499900|58863668|FG001|Core Study Period|Withdrawal by Subject|10|||
30838626|NCT02499900|58863667|FG000|Core Study Period|Adverse Event|18|||
30838627|NCT02499900|58863668|FG001|Core Study Period|Adverse Event|14|||
30838628|NCT02499900|58863667|FG000|Core Study Period|Death|0|||
30838629|NCT02499900|58863668|FG001|Core Study Period|Death|1|||
30838630|NCT02499900|58863667|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
30838631|NCT02499900|58863668|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
30838632|NCT02499900|58863667|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
30838633|NCT02499900|58863668|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
30838634|NCT02499900|58863667|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
30758039|NCT00112437|58766941|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758040|NCT00112437|58766942|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758041|NCT00112437|58766943|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758042|NCT00112437|58766944|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758043|NCT00112437|58766945|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758044|NCT00112437|58766946|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
30758045|NCT00112437|58766921|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758046|NCT00112437|58766922|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758047|NCT00112437|58766923|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758048|NCT00112437|58766924|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758049|NCT00112437|58766925|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758050|NCT00112437|58766926|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758051|NCT00112437|58766927|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758052|NCT00112437|58766928|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758053|NCT00112437|58766929|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758054|NCT00112437|58766930|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758055|NCT00112437|58766931|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758056|NCT00112437|58766932|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758057|NCT00112437|58766933|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758058|NCT00112437|58766934|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758059|NCT00112437|58766935|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758060|NCT00112437|58766936|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30838635|NCT02499900|58863668|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
30838636|NCT02499900|58863667|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
30838637|NCT02499900|58863668|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
30838638|NCT02499900|58863667|FG000|Extension Study Period|Adverse Event|2|||
30838639|NCT02499900|58863668|FG001|Extension Study Period|Adverse Event|4|||
30838640|NCT02499900|58863667|FG000|Extension Study Period|Withdrawal by Subject|5|||
30838641|NCT02499900|58863668|FG001|Extension Study Period|Withdrawal by Subject|2|||
30838642|NCT02499900|58863667|FG000|Extension Study Period|Physician Decision|2|||
30758061|NCT00112437|58766937|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758062|NCT00112437|58766938|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30838643|NCT02499900|58863668|FG001|Extension Study Period|Physician Decision|5|||
30838644|NCT02499900|58863667|FG000|Extension Study Period|Pregnancy|1|||
30838645|NCT02499900|58863668|FG001|Extension Study Period|Pregnancy|2|||
30838646|NCT02499900|58863667|FG000|Extension Study Period|Lost to Follow-up|2|||
30838647|NCT02499900|58863668|FG001|Extension Study Period|Lost to Follow-up|5|||
30838648|NCT02499900|58863667|FG000|Extension Study Period|Other|0|||
30838649|NCT02499900|58863668|FG001|Extension Study Period|Other|2|||
30838650|NCT03505749|58863682|FG000|Overall Study|Lost to Follow-up|7|||
30838651|NCT03505749|58863683|FG001|Overall Study|Lost to Follow-up|11|||
30838652|NCT03505749|58863682|FG000|Overall Study|Withdrawal by Subject|6|||
30838653|NCT03505749|58863683|FG001|Overall Study|Withdrawal by Subject|0|||
30838654|NCT03505749|58863682|FG000|Overall Study|Discharged from treatment|3|||
30838655|NCT03505749|58863683|FG001|Overall Study|Discharged from treatment|6|||
30838656|NCT03710642|58863707|FG000|Overall Study|Adverse Event|5|||
30838657|NCT03710642|58863708|FG001|Overall Study|Adverse Event|1|||
30838658|NCT03710642|58863707|FG000|Overall Study|non-site physician recommendation|1|||
30838659|NCT03710642|58863708|FG001|Overall Study|non-site physician recommendation|0|||
30838660|NCT03710642|58863707|FG000|Overall Study|Participant unwilling or unable to participate|1|||
30838661|NCT03710642|58863708|FG001|Overall Study|Participant unwilling or unable to participate|1|||
30838662|NCT03710642|58863707|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
30838663|NCT03710642|58863708|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
30838664|NCT03710642|58863707|FG000|Overall Study|NA-no code provided|1|||
30838665|NCT03710642|58863708|FG001|Overall Study|NA-no code provided|0|||
30838666|NCT03710642|58863707|FG000|Overall Study|Withdrawal by Subject|1|||
30838667|NCT03710642|58863708|FG001|Overall Study|Withdrawal by Subject|0|||
30838668|NCT00705224|58863714|FG000|Overall Study|Adverse Event|1|||
30838669|NCT00705224|58863714|FG000|Overall Study|Lack of Efficacy|2|||
30838670|NCT00705224|58863714|FG000|Overall Study|Withdrawal by Subject|3|||
30838671|NCT00705224|58863714|FG000|Overall Study|Lost to Follow-up|5|||
30838672|NCT02722148|58863721|FG000|Overall Study|Lost to Follow-up|2|||
30838673|NCT02722148|58863721|FG000|Overall Study|Non compliant with treatment regimen|3|||
30838674|NCT00704132|58863727|FG000|Overall Study|Clinical Adverse Experience|1|||
30838675|NCT00704132|58863728|FG001|Overall Study|Clinical Adverse Experience|0|||
30838676|NCT00704132|58863727|FG000|Overall Study|Lack of Efficacy|0|||
30838677|NCT00704132|58863728|FG001|Overall Study|Lack of Efficacy|1|||
30838678|NCT00704132|58863727|FG000|Overall Study|Withdrawal by Subject|0|||
30838679|NCT00704132|58863728|FG001|Overall Study|Withdrawal by Subject|1|||
30838680|NCT01329549|58863743|FG000|Overall Study|Withdrawal by Subject|1|||
30838681|NCT01329549|58863743|FG000|Overall Study|Adverse Event|1|||
30838682|NCT02736474|58863749|FG000|Overall Study|Lost to Follow-up|0|||
30838683|NCT02736474|58863750|FG001|Overall Study|Lost to Follow-up|1|||
30838684|NCT00702650|58863772|FG000|Overall Study|Withdrawal by Subject|9|||
30838685|NCT00702650|58863772|FG000|Overall Study|Non-Compliance of Study Drug|3|||
30838686|NCT00702650|58863772|FG000|Overall Study|Lost to Follow-up|2|||
30838687|NCT00702650|58863772|FG000|Overall Study|Non-Compliance with Site Directives|1|||
30838688|NCT00702650|58863772|FG000|Overall Study|Sponsor Request|1|||
30838689|NCT00702650|58863772|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
30838690|NCT00702650|58863772|FG000|Overall Study|Adverse Event|3|||
30838691|NCT03230916|58863787|FG000|Overall Study|Withdrawal by Subject|0|||
30838692|NCT03230916|58863788|FG001|Overall Study|Withdrawal by Subject|0|||
30838693|NCT03230916|58863789|FG002|Overall Study|Withdrawal by Subject|0|||
30838694|NCT03230916|58863790|FG003|Overall Study|Withdrawal by Subject|0|||
30838695|NCT03230916|58863791|FG004|Overall Study|Withdrawal by Subject|0|||
30838696|NCT03230916|58863792|FG005|Overall Study|Withdrawal by Subject|1|||
30838697|NCT03230916|58863793|FG006|Overall Study|Withdrawal by Subject|0|||
30838698|NCT03230916|58863794|FG007|Overall Study|Withdrawal by Subject|0|||
30838699|NCT03230916|58863795|FG008|Overall Study|Withdrawal by Subject|0|||
30838700|NCT03230916|58863796|FG009|Overall Study|Withdrawal by Subject|0|||
30838701|NCT03230916|58863797|FG010|Overall Study|Withdrawal by Subject|0|||
30838702|NCT01337115|58863840|FG000|Overall Study|Protocol Violation|2|||
30838703|NCT01337115|58863841|FG001|Overall Study|Protocol Violation|0|||
30838704|NCT03761784|58863851|FG000|Overall Study|Adverse Event|4|||
30838705|NCT03761784|58863852|FG001|Overall Study|Adverse Event|0|||
30838706|NCT03761784|58863851|FG000|Overall Study|Lost to Follow-up|10|||
30838707|NCT03761784|58863852|FG001|Overall Study|Lost to Follow-up|7|||
30838708|NCT03761784|58863851|FG000|Overall Study|Pregnancy|1|||
30838709|NCT03761784|58863852|FG001|Overall Study|Pregnancy|0|||
30838710|NCT03761784|58863851|FG000|Overall Study|Protocol Violation|2|||
30838711|NCT03761784|58863852|FG001|Overall Study|Protocol Violation|0|||
30838712|NCT03761784|58863851|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
30838713|NCT03761784|58863852|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
30838714|NCT03761784|58863851|FG000|Overall Study|Withdrawal by Subject|9|||
30838715|NCT03761784|58863852|FG001|Overall Study|Withdrawal by Subject|4|||
30838716|NCT03761784|58863851|FG000|Overall Study|Physician Decision|1|||
30838717|NCT03761784|58863852|FG001|Overall Study|Physician Decision|0|||
30838718|NCT03761784|58863851|FG000|Overall Study|Other Than Specified|1|||
30838719|NCT03761784|58863852|FG001|Overall Study|Other Than Specified|0|||
30838720|NCT03195894|58863860|FG000|Overall Study|"An example is Started other treatment."|4|||
30838721|NCT03195894|58863861|FG001|Overall Study|"An example is Started other treatment."|5|||
30838722|NCT03195894|58863860|FG000|Overall Study|Withdrawal by Subject|15|||
30838723|NCT03195894|58863861|FG001|Overall Study|Withdrawal by Subject|4|||
30838724|NCT03195894|58863860|FG000|Overall Study|Lost to Follow-up|14|||
30838725|NCT03195894|58863861|FG001|Overall Study|Lost to Follow-up|19|||
30838726|NCT01337973|58863873|FG000|Overall Study|Lost to Follow-up|2|||
30838727|NCT01337973|58863874|FG001|Overall Study|Lost to Follow-up|4|||
30838728|NCT01337973|58863875|FG002|Overall Study|Lost to Follow-up|3|||
30838729|NCT01337973|58863873|FG000|Overall Study|Death|1|||
30838730|NCT01337973|58863874|FG001|Overall Study|Death|2|||
30838731|NCT01337973|58863875|FG002|Overall Study|Death|1|||
30838732|NCT01337973|58863873|FG000|Overall Study|Withdrawal by Subject|10|||
30838733|NCT01337973|58863874|FG001|Overall Study|Withdrawal by Subject|8|||
30838734|NCT01337973|58863875|FG002|Overall Study|Withdrawal by Subject|4|||
30838735|NCT01337973|58863873|FG000|Overall Study|missing data on primary outcome|3|||
30838736|NCT01337973|58863874|FG001|Overall Study|missing data on primary outcome|1|||
30838737|NCT01337973|58863875|FG002|Overall Study|missing data on primary outcome|3|||
30838738|NCT02929056|58863885|FG000|Overall Study|Lost to Follow-up|0|||
30838739|NCT02929056|58863886|FG001|Overall Study|Lost to Follow-up|1|||
30838740|NCT00157755|58863905|FG000|Overall Study|Death|2|||
30838741|NCT00157755|58863906|FG001|Overall Study|Death|3|||
30838742|NCT00157755|58863907|FG002|Overall Study|Death|3|||
30838743|NCT00157755|58863908|FG003|Overall Study|Death|2|||
30838744|NCT00157755|58863909|FG004|Overall Study|Death|0|||
30838745|NCT00157755|58863910|FG005|Overall Study|Death|0|||
30838746|NCT00157755|58863905|FG000|Overall Study|Lost to Follow-up|0|||
30838747|NCT00157755|58863906|FG001|Overall Study|Lost to Follow-up|0|||
30838748|NCT00157755|58863907|FG002|Overall Study|Lost to Follow-up|1|||
30838749|NCT00157755|58863908|FG003|Overall Study|Lost to Follow-up|0|||
30838750|NCT00157755|58863909|FG004|Overall Study|Lost to Follow-up|0|||
30838751|NCT00157755|58863910|FG005|Overall Study|Lost to Follow-up|0|||
30838752|NCT00157755|58863905|FG000|Overall Study|Withdrawal by Subject|0|||
30838753|NCT00157755|58863906|FG001|Overall Study|Withdrawal by Subject|0|||
30838754|NCT00157755|58863907|FG002|Overall Study|Withdrawal by Subject|1|||
30838755|NCT00157755|58863908|FG003|Overall Study|Withdrawal by Subject|1|||
30838756|NCT00157755|58863909|FG004|Overall Study|Withdrawal by Subject|1|||
30838757|NCT00157755|58863910|FG005|Overall Study|Withdrawal by Subject|2|||
30838758|NCT00157755|58863905|FG000|Overall Study|Explant due to infection|0|||
30838759|NCT00157755|58863906|FG001|Overall Study|Explant due to infection|0|||
30838760|NCT00157755|58863907|FG002|Overall Study|Explant due to infection|1|||
30838761|NCT00157755|58863908|FG003|Overall Study|Explant due to infection|0|||
30838762|NCT00157755|58863909|FG004|Overall Study|Explant due to infection|0|||
30838763|NCT00157755|58863910|FG005|Overall Study|Explant due to infection|0|||
30838764|NCT00157755|58863905|FG000|Overall Study|Medical reason|0|||
30838765|NCT00157755|58863906|FG001|Overall Study|Medical reason|0|||
30838766|NCT00157755|58863907|FG002|Overall Study|Medical reason|1|||
30838767|NCT00157755|58863908|FG003|Overall Study|Medical reason|1|||
30838768|NCT00157755|58863909|FG004|Overall Study|Medical reason|0|||
30838769|NCT00157755|58863910|FG005|Overall Study|Medical reason|0|||
30838770|NCT00157755|58863905|FG000|Overall Study|Study site closure|0|||
30838771|NCT00157755|58863906|FG001|Overall Study|Study site closure|1|||
30838772|NCT00157755|58863907|FG002|Overall Study|Study site closure|0|||
30838773|NCT00157755|58863908|FG003|Overall Study|Study site closure|0|||
30838774|NCT00157755|58863909|FG004|Overall Study|Study site closure|0|||
30838775|NCT00157755|58863910|FG005|Overall Study|Study site closure|0|||
30838776|NCT00157755|58863905|FG000|Overall Study|Subject non-compliance|0|||
30838777|NCT00157755|58863906|FG001|Overall Study|Subject non-compliance|0|||
30838778|NCT00157755|58863907|FG002|Overall Study|Subject non-compliance|0|||
30838779|NCT00157755|58863908|FG003|Overall Study|Subject non-compliance|0|||
30838780|NCT00157755|58863909|FG004|Overall Study|Subject non-compliance|0|||
30838781|NCT00157755|58863910|FG005|Overall Study|Subject non-compliance|1|||
30838782|NCT00157755|58863905|FG000|Overall Study|Study completion|0|||
30838783|NCT00157755|58863906|FG001|Overall Study|Study completion|0|||
30838784|NCT00157755|58863907|FG002|Overall Study|Study completion|0|||
30838785|NCT00157755|58863908|FG003|Overall Study|Study completion|0|||
30838786|NCT00157755|58863909|FG004|Overall Study|Study completion|1|||
30838787|NCT00157755|58863910|FG005|Overall Study|Study completion|2|||
30838788|NCT02723006|58863919|FG000|Overall Study|Withdrawal by Subject|0|||
30838789|NCT02723006|58863920|FG001|Overall Study|Withdrawal by Subject|1|||
30838790|NCT02723006|58863921|FG002|Overall Study|Withdrawal by Subject|1|||
30838791|NCT02723006|58863919|FG000|Overall Study|Study Terminated by Sponsor|1|||
30838792|NCT02723006|58863920|FG001|Overall Study|Study Terminated by Sponsor|6|||
30838793|NCT02723006|58863921|FG002|Overall Study|Study Terminated by Sponsor|6|||
30838794|NCT04003389|58863932|FG000|Overall Study|Adverse Event|27|||
30838795|NCT04003389|58863933|FG001|Overall Study|Adverse Event|34|||
30838796|NCT04003389|58863934|FG002|Overall Study|Adverse Event|28|||
30838797|NCT04003389|58863932|FG000|Overall Study|Lost to Follow-up|39|||
30838798|NCT04003389|58863933|FG001|Overall Study|Lost to Follow-up|30|||
30838799|NCT04003389|58863934|FG002|Overall Study|Lost to Follow-up|33|||
30838800|NCT04003389|58863932|FG000|Overall Study|Protocol Violation|1|||
30838801|NCT04003389|58863933|FG001|Overall Study|Protocol Violation|6|||
30838802|NCT04003389|58863934|FG002|Overall Study|Protocol Violation|5|||
30838803|NCT04003389|58863932|FG000|Overall Study|Withdrawal by Subject|119|||
30838804|NCT04003389|58863933|FG001|Overall Study|Withdrawal by Subject|79|||
30838805|NCT04003389|58863934|FG002|Overall Study|Withdrawal by Subject|85|||
30838806|NCT04003389|58863932|FG000|Overall Study|Miscellaneous|14|||
30838807|NCT04003389|58863933|FG001|Overall Study|Miscellaneous|11|||
30838808|NCT04003389|58863934|FG002|Overall Study|Miscellaneous|14|||
30838809|NCT04003389|58863932|FG000|Overall Study|Participant did not receive study drug|1|||
30838810|NCT04003389|58863933|FG001|Overall Study|Participant did not receive study drug|0|||
30838811|NCT04003389|58863934|FG002|Overall Study|Participant did not receive study drug|0|||
30838812|NCT00702962|58863944|FG000|Overall Study|Progressive disease|0|||
30838813|NCT00702962|58863945|FG001|Overall Study|Progressive disease|1|||
30838814|NCT00702962|58863944|FG000|Overall Study|Hospitalized for other health disorder|1|||
30838815|NCT00702962|58863945|FG001|Overall Study|Hospitalized for other health disorder|0|||
30838816|NCT01379508|58863957|FG000|Treatment to Week 104|Adverse Event|2|||
30838817|NCT01379508|58863958|FG001|Treatment to Week 104|Adverse Event|0|||
30838818|NCT01379508|58863959|FG002|Treatment to Week 104|Adverse Event|5|||
30838819|NCT01379508|58863960|FG003|Treatment to Week 104|Adverse Event|0|||
30838820|NCT01379508|58863957|FG000|Treatment to Week 104|Abnormal lab value|1|||
30838821|NCT01379508|58863958|FG001|Treatment to Week 104|Abnormal lab value|0|||
30838822|NCT01379508|58863959|FG002|Treatment to Week 104|Abnormal lab value|0|||
30838823|NCT01379508|58863960|FG003|Treatment to Week 104|Abnormal lab value|0|||
30838824|NCT01379508|58863957|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
30838825|NCT01379508|58863958|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
30838826|NCT01379508|58863959|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
30838827|NCT01379508|58863960|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
30838828|NCT01379508|58863957|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
30838829|NCT01379508|58863958|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
30838830|NCT01379508|58863959|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
30838831|NCT01379508|58863960|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
30838832|NCT01379508|58863957|FG000|Treatment to Week 104|Lost to Follow-up|5|||
30838833|NCT01379508|58863958|FG001|Treatment to Week 104|Lost to Follow-up|0|||
30838834|NCT01379508|58863959|FG002|Treatment to Week 104|Lost to Follow-up|3|||
30838835|NCT01379508|58863960|FG003|Treatment to Week 104|Lost to Follow-up|0|||
30838836|NCT01379508|58863957|FG000|Treatment to Week 104|Administrative problems|3|||
30838837|NCT01379508|58863958|FG001|Treatment to Week 104|Administrative problems|1|||
30838838|NCT01379508|58863959|FG002|Treatment to Week 104|Administrative problems|0|||
30838839|NCT01379508|58863960|FG003|Treatment to Week 104|Administrative problems|0|||
30838840|NCT01379508|58863957|FG000|Treatment to Week 104|Protocol Violation|1|||
30838841|NCT01379508|58863958|FG001|Treatment to Week 104|Protocol Violation|1|||
30838842|NCT01379508|58863959|FG002|Treatment to Week 104|Protocol Violation|1|||
30838843|NCT01379508|58863960|FG003|Treatment to Week 104|Protocol Violation|0|||
30838844|NCT01379508|58863957|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
30838845|NCT01379508|58863958|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
30838846|NCT01379508|58863959|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
30838847|NCT01379508|58863960|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
30838848|NCT01379508|58863957|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
30838849|NCT01379508|58863958|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
30838850|NCT01379508|58863959|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
30838851|NCT01379508|58863960|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
30838852|NCT01379508|58863957|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
30838853|NCT01379508|58863958|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
30838854|NCT01379508|58863959|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
30838855|NCT01379508|58863960|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
30838856|NCT01379508|58863957|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
30838857|NCT01379508|58863958|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
30838858|NCT01379508|58863959|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
30838859|NCT01379508|58863960|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
30838860|NCT02722928|58863976|FG000|Overall Study|Standard CT was not as required per prot|5|||
30838861|NCT02722928|58863977|FG001|Overall Study|Standard CT was not as required per prot|13|||
30838862|NCT02722928|58863976|FG000|Overall Study|Required Intraoperative MRI|5|||
30838863|NCT02722928|58863977|FG001|Overall Study|Required Intraoperative MRI|7|||
30838864|NCT02722304|58863992|FG000|Overall Study|Study Terminated by Sponsor|1|||
30838865|NCT02722304|58863993|FG001|Overall Study|Study Terminated by Sponsor|0|||
30838866|NCT02722304|58863994|FG002|Overall Study|Study Terminated by Sponsor|2|||
30838867|NCT02722304|58863995|FG003|Overall Study|Study Terminated by Sponsor|1|||
30838868|NCT02722304|58863996|FG004|Overall Study|Study Terminated by Sponsor|1|||
30838869|NCT02722304|58863992|FG000|Overall Study|Other|0|||
30838870|NCT02722304|58863993|FG001|Overall Study|Other|0|||
30838871|NCT02722304|58863994|FG002|Overall Study|Other|0|||
30838872|NCT02722304|58863995|FG003|Overall Study|Other|1|||
30838873|NCT02722304|58863996|FG004|Overall Study|Other|1|||
30838874|NCT00709956|58864012|FG000|Overall Study|Withdrawal by Subject|1|||
30838875|NCT00709956|58864013|FG001|Overall Study|Withdrawal by Subject|1|||
30838876|NCT00709956|58864012|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
30838877|NCT00709956|58864013|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
30838878|NCT02719028|58864043|FG000|Overall Study|Adverse Event|2|||
30838879|NCT02719028|58864044|FG001|Overall Study|Adverse Event|1|||
30838880|NCT02719028|58864045|FG002|Overall Study|Adverse Event|4|||
30838881|NCT02719028|58864046|FG003|Overall Study|Adverse Event|8|||
30838882|NCT02719028|58864043|FG000|Overall Study|Physician Decision|0|||
30838883|NCT02719028|58864044|FG001|Overall Study|Physician Decision|1|||
30838884|NCT02719028|58864045|FG002|Overall Study|Physician Decision|1|||
30838885|NCT02719028|58864046|FG003|Overall Study|Physician Decision|1|||
30838886|NCT02719028|58864043|FG000|Overall Study|Use of prohibited medication|0|||
30838887|NCT02719028|58864044|FG001|Overall Study|Use of prohibited medication|0|||
30838888|NCT02719028|58864045|FG002|Overall Study|Use of prohibited medication|1|||
30838889|NCT02719028|58864046|FG003|Overall Study|Use of prohibited medication|0|||
30838890|NCT02719028|58864043|FG000|Overall Study|Protocol Violation|0|||
30838891|NCT02719028|58864044|FG001|Overall Study|Protocol Violation|0|||
30838892|NCT02719028|58864045|FG002|Overall Study|Protocol Violation|0|||
30838893|NCT02719028|58864046|FG003|Overall Study|Protocol Violation|1|||
30838894|NCT02720510|58864058|FG000|Overall Study|Study Terminated by the sponsor|2|||
30838895|NCT02720510|58864059|FG001|Overall Study|Study Terminated by the sponsor|0|||
30838896|NCT02720510|58864058|FG000|Overall Study|Adverse Event|0|||
30838897|NCT02720510|58864059|FG001|Overall Study|Adverse Event|1|||
30838898|NCT02720510|58864058|FG000|Overall Study|Physician Decision|1|||
30838899|NCT02720510|58864059|FG001|Overall Study|Physician Decision|2|||
30838900|NCT02720198|58864067|FG000|Overall Study|Withdrawal by Subject|0|||
30838901|NCT02720198|58864068|FG001|Overall Study|Withdrawal by Subject|1|||
30838902|NCT00703118|58864090|FG000|Overall Study|Adverse Event|1|||
30838903|NCT00703118|58864091|FG001|Overall Study|Adverse Event|2|||
30838904|NCT00703118|58864092|FG002|Overall Study|Adverse Event|2|||
30838905|NCT00703118|58864090|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
30838906|NCT00703118|58864091|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
30838907|NCT00703118|58864092|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
30838908|NCT00703118|58864090|FG000|Overall Study|Lost to Follow-up|6|||
30838909|NCT00703118|58864091|FG001|Overall Study|Lost to Follow-up|4|||
30838910|NCT00703118|58864092|FG002|Overall Study|Lost to Follow-up|4|||
30838911|NCT00703118|58864090|FG000|Overall Study|Withdrawal by Subject|8|||
30838912|NCT00703118|58864091|FG001|Overall Study|Withdrawal by Subject|7|||
30838913|NCT00703118|58864092|FG002|Overall Study|Withdrawal by Subject|13|||
30838914|NCT00703118|58864090|FG000|Overall Study|Other|0|||
30838915|NCT00703118|58864091|FG001|Overall Study|Other|0|||
30838916|NCT00703118|58864092|FG002|Overall Study|Other|1|||
30838917|NCT00909753|58864114|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
30838918|NCT00909753|58864115|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
30838919|NCT00909753|58864114|FG000|Period: Second Intervention|Protocol Violation|1|||
30838920|NCT00909753|58864115|FG001|Period: Second Intervention|Protocol Violation|0|||
30838921|NCT03745638|58864122|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
30838922|NCT03745638|58864123|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
30624184|NCT01135914|58636168|FG001|Overall Study|Protocol Violation|0|||
30758063|NCT00112437|58766939|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758064|NCT00112437|58766940|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758065|NCT00112437|58766941|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
30758066|NCT00112437|58766942|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
30758067|NCT00112437|58766943|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758068|NCT00112437|58766944|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758069|NCT00112437|58766945|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758070|NCT00112437|58766946|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
30758071|NCT00112437|58766921|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30838923|NCT03745638|58864124|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
30838924|NCT03745638|58864125|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
30838925|NCT03745638|58864126|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
30838926|NCT03745638|58864127|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
30838927|NCT03745638|58864128|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
30838928|NCT03745638|58864122|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
30838929|NCT03745638|58864123|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30838930|NCT03745638|58864124|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30838931|NCT03745638|58864125|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30838932|NCT03745638|58864126|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30838933|NCT03745638|58864127|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30838934|NCT03745638|58864128|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30838935|NCT03745638|58864122|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
30838936|NCT03745638|58864123|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
30838937|NCT03745638|58864124|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
30838938|NCT03745638|58864125|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30838939|NCT03745638|58864126|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30838940|NCT03745638|58864127|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30838941|NCT03745638|58864128|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30838942|NCT03745638|58864122|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
30838943|NCT03745638|58864123|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
30838944|NCT03745638|58864124|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
30838945|NCT03745638|58864125|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
30838946|NCT03745638|58864126|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
30838947|NCT03745638|58864127|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
30838948|NCT03745638|58864128|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
30838949|NCT03745638|58864122|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
30838950|NCT03745638|58864123|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
30838951|NCT03745638|58864124|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
30838952|NCT03745638|58864125|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
30838953|NCT03745638|58864126|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
30838954|NCT03745638|58864127|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
30838955|NCT03745638|58864128|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
30838956|NCT03745638|58864122|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30838957|NCT03745638|58864123|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
30838958|NCT03745638|58864124|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30838959|NCT03745638|58864125|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30838960|NCT03745638|58864126|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30838961|NCT03745638|58864127|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30838962|NCT03745638|58864128|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30838963|NCT03745638|58864122|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
30838964|NCT03745638|58864123|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
30838965|NCT03745638|58864124|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
30838966|NCT03745638|58864125|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30838967|NCT03745638|58864126|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30838968|NCT03745638|58864127|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30838969|NCT03745638|58864128|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30838970|NCT03745638|58864122|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
30838971|NCT03745638|58864123|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
30838972|NCT03745638|58864124|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
30838973|NCT03745638|58864125|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
30838974|NCT03745638|58864126|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
30838975|NCT03745638|58864127|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
30838976|NCT03745638|58864128|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
30838977|NCT03745638|58864122|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
30838978|NCT03745638|58864123|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
30838979|NCT03745638|58864124|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
30838980|NCT03745638|58864125|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
30838981|NCT03745638|58864126|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
30838982|NCT03745638|58864127|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
30838983|NCT03745638|58864128|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
30838984|NCT03745638|58864122|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
30838985|NCT03745638|58864123|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
30758072|NCT00112437|58766922|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758073|NCT00112437|58766923|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758074|NCT00112437|58766924|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758075|NCT00112437|58766925|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758076|NCT00112437|58766926|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758077|NCT00112437|58766927|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758078|NCT00112437|58766928|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30838986|NCT03745638|58864124|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
30838987|NCT03745638|58864125|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
30838988|NCT03745638|58864126|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
30838989|NCT03745638|58864127|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
30838990|NCT03745638|58864128|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
30838991|NCT03745638|58864122|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
30838992|NCT03745638|58864123|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
30838993|NCT03745638|58864124|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
30838994|NCT03745638|58864125|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
30838995|NCT03745638|58864126|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
30838996|NCT03745638|58864127|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
30838997|NCT03745638|58864128|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
30838998|NCT03745638|58864122|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
30838999|NCT03745638|58864123|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
30839000|NCT03745638|58864124|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
30839001|NCT03745638|58864125|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
30839002|NCT03745638|58864126|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
30839003|NCT03745638|58864127|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
30839004|NCT03745638|58864128|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
30839005|NCT03745638|58864122|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30839006|NCT03745638|58864123|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30839007|NCT03745638|58864124|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30839008|NCT03745638|58864125|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30839009|NCT03745638|58864126|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30839010|NCT03745638|58864127|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
30839011|NCT03745638|58864128|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30839012|NCT03745638|58864122|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
30839013|NCT03745638|58864123|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
30839014|NCT03745638|58864124|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
30839015|NCT03745638|58864125|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
30930695|NCT01799889|58966693|FG010|Overall Study|Withdrawal by Subject|1|||
30930696|NCT01799889|58966694|FG011|Overall Study|Withdrawal by Subject|1|||
30930697|NCT01799889|58966683|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30930698|NCT01799889|58966684|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30930699|NCT01799889|58966685|FG002|Overall Study|Non-Compliance With Study Drug|0|||
30930700|NCT01799889|58966686|FG003|Overall Study|Non-Compliance With Study Drug|0|||
30930701|NCT01799889|58966687|FG004|Overall Study|Non-Compliance With Study Drug|0|||
30930702|NCT01799889|58966688|FG005|Overall Study|Non-Compliance With Study Drug|1|||
30930703|NCT01799889|58966689|FG006|Overall Study|Non-Compliance With Study Drug|0|||
30930704|NCT01799889|58966690|FG007|Overall Study|Non-Compliance With Study Drug|0|||
30930705|NCT01799889|58966691|FG008|Overall Study|Non-Compliance With Study Drug|0|||
30930706|NCT01799889|58966692|FG009|Overall Study|Non-Compliance With Study Drug|0|||
30930707|NCT01799889|58966693|FG010|Overall Study|Non-Compliance With Study Drug|0|||
30930708|NCT01799889|58966694|FG011|Overall Study|Non-Compliance With Study Drug|0|||
30930709|NCT01412944|58966733|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
30930710|NCT01412944|58966734|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
30930711|NCT01412944|58966735|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
30930712|NCT01412944|58966736|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
30930713|NCT01412944|58966737|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
30930714|NCT01412944|58966738|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
30930715|NCT01412944|58966733|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
30930716|NCT01412944|58966734|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
30930717|NCT01412944|58966735|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
30930718|NCT01412944|58966736|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
30930719|NCT01412944|58966737|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
30930720|NCT01412944|58966738|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
30930721|NCT01412944|58966733|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
30758079|NCT00112437|58766929|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758080|NCT00112437|58766930|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758081|NCT00112437|58766931|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758082|NCT00112437|58766932|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758083|NCT00112437|58766933|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758084|NCT00112437|58766934|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758085|NCT00112437|58766935|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30930722|NCT01412944|58966734|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
30930723|NCT01412944|58966735|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
30930724|NCT01412944|58966736|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
30930725|NCT01412944|58966737|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
30930726|NCT01412944|58966738|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
30930727|NCT01412944|58966733|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
30930728|NCT01412944|58966734|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
30930729|NCT01412944|58966735|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
30930730|NCT01412944|58966736|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
30930731|NCT01412944|58966737|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
30930732|NCT01412944|58966738|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
30930733|NCT01412944|58966733|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
30930734|NCT01412944|58966734|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
30930735|NCT01412944|58966735|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
30930736|NCT01412944|58966736|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
30930737|NCT01412944|58966737|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
30758086|NCT00112437|58766936|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758087|NCT00112437|58766937|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758088|NCT00112437|58766938|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30839016|NCT03745638|58864126|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
30839017|NCT03745638|58864127|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
30839018|NCT03745638|58864128|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
30839019|NCT03745638|58864122|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
30839020|NCT03745638|58864123|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
30839021|NCT03745638|58864124|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
30839022|NCT03745638|58864125|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
30839023|NCT03745638|58864126|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
30839024|NCT03745638|58864127|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
30839025|NCT03745638|58864128|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
30839026|NCT03715764|58864147|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
30839027|NCT03715764|58864148|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
30839028|NCT03715764|58864147|FG000|3 Month Follow-up|Lost to Follow-up|2|||
30839029|NCT03715764|58864148|FG001|3 Month Follow-up|Lost to Follow-up|2|||
30839030|NCT03715764|58864147|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
30839031|NCT03715764|58864148|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
30839032|NCT03715764|58864147|FG000|6 Month Follow-up|Lost to Follow-up|3|||
30839033|NCT03715764|58864148|FG001|6 Month Follow-up|Lost to Follow-up|0|||
30839034|NCT03715764|58864147|FG000|12 Month Follow-up|Lost to Follow-up|2|||
30839035|NCT03715764|58864148|FG001|12 Month Follow-up|Lost to Follow-up|3|||
30839036|NCT03715764|58864147|FG000|12 Month Follow-up|Pregnancy|0|||
30839037|NCT03715764|58864148|FG001|12 Month Follow-up|Pregnancy|1|||
30839038|NCT03715764|58864147|FG000|12 Month Follow-up|Surgery|2|||
30839039|NCT03715764|58864148|FG001|12 Month Follow-up|Surgery|0|||
30839040|NCT03715764|58864147|FG000|12 Month Follow-up|Wrong address|1|||
30839041|NCT03715764|58864148|FG001|12 Month Follow-up|Wrong address|0|||
30839042|NCT03715764|58864147|FG000|12 Month Follow-up|No symptoms|1|||
30839043|NCT03715764|58864148|FG001|12 Month Follow-up|No symptoms|0|||
30839044|NCT03715764|58864147|FG000|12 Month Follow-up|Changed primary care centre|0|||
30839045|NCT03715764|58864148|FG001|12 Month Follow-up|Changed primary care centre|1|||
30839046|NCT02718326|58864157|FG000|Overall Study|Adverse Event|4|||
30839047|NCT02718326|58864158|FG001|Overall Study|Adverse Event|9|||
30839048|NCT02718326|58864159|FG002|Overall Study|Adverse Event|0|||
30839049|NCT02718326|58864157|FG000|Overall Study|Death|8|||
30930738|NCT01412944|58966738|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
30930739|NCT01412944|58966733|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
30930740|NCT01412944|58966734|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
30758089|NCT00112437|58766939|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758090|NCT00112437|58766940|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758091|NCT00112437|58766941|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
30758092|NCT00112437|58766942|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758093|NCT00112437|58766943|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758094|NCT00112437|58766944|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758095|NCT00112437|58766945|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30839050|NCT02718326|58864158|FG001|Overall Study|Death|1|||
30839051|NCT02718326|58864159|FG002|Overall Study|Death|2|||
30839052|NCT02718326|58864157|FG000|Overall Study|Withdrawal by Subject|4|||
30839053|NCT02718326|58864158|FG001|Overall Study|Withdrawal by Subject|9|||
30839054|NCT02718326|58864159|FG002|Overall Study|Withdrawal by Subject|6|||
30839055|NCT02718326|58864157|FG000|Overall Study|Lost to Follow-up|18|||
30839056|NCT02718326|58864158|FG001|Overall Study|Lost to Follow-up|5|||
30839057|NCT02718326|58864159|FG002|Overall Study|Lost to Follow-up|14|||
30839058|NCT02718326|58864157|FG000|Overall Study|Protocol Deviation|1|||
30839059|NCT02718326|58864158|FG001|Overall Study|Protocol Deviation|0|||
30839060|NCT02718326|58864159|FG002|Overall Study|Protocol Deviation|0|||
30839061|NCT02718326|58864157|FG000|Overall Study|Pregnancy|1|||
30839062|NCT02718326|58864158|FG001|Overall Study|Pregnancy|0|||
30839063|NCT02718326|58864159|FG002|Overall Study|Pregnancy|0|||
30839064|NCT03600714|58864169|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
30839065|NCT02720042|58864208|FG000|Overall Study|Death|3|||
30839066|NCT02720042|58864208|FG000|Overall Study|Lost to Follow-up|4|||
30839067|NCT02720042|58864208|FG000|Overall Study|Withdrawal by Subject|1|||
30839068|NCT02720042|58864208|FG000|Overall Study|Physician Decision|3|||
30839069|NCT02720042|58864208|FG000|Overall Study|Phasix Mesh explanted|1|||
30839070|NCT02720042|58864208|FG000|Overall Study|unable due to non-study-related illness|3|||
30839071|NCT01352793|58864214|FG000|Overall Study|Lost to Follow-up|289|||
30839072|NCT01352793|58864215|FG001|Overall Study|Lost to Follow-up|125|||
30839073|NCT01352793|58864214|FG000|Overall Study|Withdrawal by Subject|120|||
30839074|NCT01352793|58864215|FG001|Overall Study|Withdrawal by Subject|55|||
30839075|NCT01352793|58864214|FG000|Overall Study|Protocol Violation|44|||
30839076|NCT01352793|58864215|FG001|Overall Study|Protocol Violation|23|||
30839077|NCT01352793|58864214|FG000|Overall Study|Adverse Event|44|||
30839078|NCT01352793|58864215|FG001|Overall Study|Adverse Event|10|||
30839079|NCT01352793|58864214|FG000|Overall Study|Physician Decision|1|||
30839080|NCT01352793|58864215|FG001|Overall Study|Physician Decision|0|||
30839081|NCT01352793|58864214|FG000|Overall Study|Pregnancy|26|||
30839082|NCT01352793|58864215|FG001|Overall Study|Pregnancy|8|||
30839083|NCT01352793|58864214|FG000|Overall Study|Other|25|||
30839084|NCT01352793|58864215|FG001|Overall Study|Other|7|||
30839085|NCT01352793|58864214|FG000|Overall Study|Medication error|2|||
30839086|NCT01352793|58864215|FG001|Overall Study|Medication error|2|||
30839087|NCT01352793|58864214|FG000|Overall Study|Death|1|||
30839088|NCT01352793|58864215|FG001|Overall Study|Death|0|||
30839089|NCT01352793|58864214|FG000|Overall Study|Randomized but not vaccinated|8|||
30839090|NCT01352793|58864215|FG001|Overall Study|Randomized but not vaccinated|0|||
30839091|NCT01352793|58864214|FG000|Overall Study|No longer meets eligibility criteria|25|||
30839092|NCT01352793|58864215|FG001|Overall Study|No longer meets eligibility criteria|15|||
30839093|NCT02717546|58864221|FG000|Overall Study|Lost to Follow-up|12|||
30839094|NCT01378962|58864225|FG000|Overall Study|Death|14|||
30930741|NCT01412944|58966735|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
30930742|NCT01412944|58966736|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
30930743|NCT01412944|58966737|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
30930744|NCT01412944|58966738|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
30930745|NCT01412944|58966733|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
30930746|NCT01412944|58966734|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
30930747|NCT01412944|58966735|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
30930748|NCT01412944|58966736|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
30930749|NCT01412944|58966737|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
30930750|NCT01412944|58966738|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
30930751|NCT01412944|58966733|FG000|Entire: IV + Maintenance|Adverse Event|0|||
30930752|NCT01412944|58966734|FG001|Entire: IV + Maintenance|Adverse Event|0|||
30930753|NCT01412944|58966735|FG002|Entire: IV + Maintenance|Adverse Event|0|||
30930754|NCT01412944|58966736|FG003|Entire: IV + Maintenance|Adverse Event|0|||
30930755|NCT01412944|58966737|FG004|Entire: IV + Maintenance|Adverse Event|1|||
30930756|NCT01412944|58966738|FG005|Entire: IV + Maintenance|Adverse Event|0|||
30930757|NCT01412944|58966733|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
30930758|NCT01412944|58966734|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
30930759|NCT01412944|58966735|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
30930760|NCT01412944|58966736|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
30930761|NCT01412944|58966737|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
30930762|NCT01412944|58966738|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
30624185|NCT01135914|58636169|FG002|Overall Study|Protocol Violation|3|||
30624186|NCT01135914|58636167|FG000|Overall Study|Lack of Efficacy|2|||
30839095|NCT01378962|58864225|FG000|Overall Study|Lost to Follow-up|1|||
30839096|NCT01378962|58864225|FG000|Overall Study|Other|2|||
30930763|NCT01412944|58966733|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
30930764|NCT01412944|58966734|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
30930765|NCT01412944|58966735|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
30839097|NCT00890409|58864231|FG000|Overall Study|Lost to Follow-up|20|||
30839098|NCT00890409|58864232|FG001|Overall Study|Lost to Follow-up|21|||
30839099|NCT04495478|58864243|FG000|Overall Study|Withdrawal by Subject|0|||
30839100|NCT04495478|58864244|FG001|Overall Study|Withdrawal by Subject|0|||
30839101|NCT04495478|58864245|FG002|Overall Study|Withdrawal by Subject|0|||
30839102|NCT04495478|58864246|FG003|Overall Study|Withdrawal by Subject|1|||
30839103|NCT04495478|58864247|FG004|Overall Study|Withdrawal by Subject|0|||
30930766|NCT01412944|58966736|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
30930767|NCT01412944|58966737|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
30930768|NCT01412944|58966738|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
30930769|NCT01412944|58966733|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
30930770|NCT01412944|58966734|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
30930771|NCT01412944|58966735|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
30930772|NCT01412944|58966736|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
30930773|NCT01412944|58966737|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
30930774|NCT01412944|58966738|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
30930775|NCT01412944|58966733|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
30930776|NCT01412944|58966734|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
30930777|NCT01412944|58966735|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
30930778|NCT01412944|58966736|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
30930779|NCT01412944|58966737|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
30930780|NCT01412944|58966738|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
30930781|NCT01412944|58966733|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
30930782|NCT01412944|58966734|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
30930783|NCT01412944|58966735|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
30930784|NCT01412944|58966736|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
30930785|NCT01412944|58966737|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
30930786|NCT01412944|58966738|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
30930787|NCT01412944|58966733|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
30930788|NCT01412944|58966734|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
30930789|NCT01412944|58966735|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
30930790|NCT01412944|58966736|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
30930791|NCT01412944|58966737|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
30930792|NCT01412944|58966738|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
30930793|NCT01412944|58966733|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
30930794|NCT01412944|58966734|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
30758096|NCT00112437|58766946|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
30758097|NCT00112437|58766921|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30930795|NCT01412944|58966735|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
30930796|NCT01412944|58966736|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
30930797|NCT01412944|58966737|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
30930798|NCT01412944|58966738|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
30930799|NCT01412944|58966733|FG000|Entire: IV + Maintenance|Adverse Event|0|||
30930800|NCT01412944|58966734|FG001|Entire: IV + Maintenance|Adverse Event|1|||
30930801|NCT01412944|58966735|FG002|Entire: IV + Maintenance|Adverse Event|0|||
30930802|NCT01412944|58966736|FG003|Entire: IV + Maintenance|Adverse Event|0|||
30758098|NCT00112437|58766922|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30930803|NCT01412944|58966737|FG004|Entire: IV + Maintenance|Adverse Event|0|||
30930804|NCT01412944|58966738|FG005|Entire: IV + Maintenance|Adverse Event|0|||
30930805|NCT01798485|58966756|FG000|Overall Study|Adverse Event|32|||
30930806|NCT01798485|58966757|FG001|Overall Study|Adverse Event|40|||
30758099|NCT00112437|58766923|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30930807|NCT01798485|58966756|FG000|Overall Study|Withdrawal by Subject|27|||
30930808|NCT01798485|58966757|FG001|Overall Study|Withdrawal by Subject|31|||
30930809|NCT01798485|58966756|FG000|Overall Study|Lost to Follow-up|0|||
30930810|NCT01798485|58966757|FG001|Overall Study|Lost to Follow-up|3|||
30930811|NCT01798485|58966756|FG000|Overall Study|Physician Decision|14|||
30930812|NCT01798485|58966757|FG001|Overall Study|Physician Decision|10|||
30930813|NCT01798485|58966756|FG000|Overall Study|Objective Disease Progression|152|||
30930814|NCT01798485|58966757|FG001|Overall Study|Objective Disease Progression|106|||
30930815|NCT01798485|58966756|FG000|Overall Study|Death|25|||
30930816|NCT01798485|58966757|FG001|Overall Study|Death|22|||
30930817|NCT01798485|58966756|FG000|Overall Study|Sponsor Decision|61|||
30930818|NCT01798485|58966757|FG001|Overall Study|Sponsor Decision|54|||
30930819|NCT01798485|58966756|FG000|Overall Study|Clinical Progression|35|||
30930820|NCT01798485|58966757|FG001|Overall Study|Clinical Progression|24|||
30930821|NCT01767597|58966765|FG000|Overall Study|Incomplete intervention|3|||
30930822|NCT01767597|58966766|FG001|Overall Study|Incomplete intervention|1|||
30930823|NCT01767597|58966765|FG000|Overall Study|Withdrawal by Subject|1|||
30930824|NCT01767597|58966766|FG001|Overall Study|Withdrawal by Subject|0|||
30930825|NCT01767519|58966775|FG000|Overall Study|Other Reasons|4|||
30930826|NCT01767519|58966776|FG001|Overall Study|Other Reasons|4|||
30930827|NCT01767519|58966777|FG002|Overall Study|Other Reasons|2|||
30930828|NCT01767519|58966775|FG000|Overall Study|Protocol Violation|0|||
30930829|NCT01767519|58966776|FG001|Overall Study|Protocol Violation|3|||
30930830|NCT01767519|58966777|FG002|Overall Study|Protocol Violation|0|||
30930831|NCT01767519|58966775|FG000|Overall Study|Personal Reasons|1|||
30930832|NCT01767519|58966776|FG001|Overall Study|Personal Reasons|0|||
30930833|NCT01767519|58966777|FG002|Overall Study|Personal Reasons|0|||
30930834|NCT01767519|58966775|FG000|Overall Study|Lost to Follow-up|3|||
30930835|NCT01767519|58966776|FG001|Overall Study|Lost to Follow-up|1|||
30930836|NCT01767519|58966777|FG002|Overall Study|Lost to Follow-up|2|||
30930837|NCT01767519|58966775|FG000|Overall Study|Lack of Efficacy|1|||
30930838|NCT01767519|58966776|FG001|Overall Study|Lack of Efficacy|0|||
30930839|NCT01767519|58966777|FG002|Overall Study|Lack of Efficacy|0|||
30930840|NCT01767519|58966775|FG000|Overall Study|Adverse Event|5|||
30930841|NCT01767519|58966776|FG001|Overall Study|Adverse Event|5|||
30930842|NCT01767519|58966777|FG002|Overall Study|Adverse Event|1|||
30930843|NCT01797783|58966787|FG000|Overall Study|Adverse Event|1|||
30930844|NCT01797783|58966788|FG001|Overall Study|Adverse Event|1|||
30930845|NCT01797783|58966787|FG000|Overall Study|Withdrawal by Subject|1|||
30930846|NCT01797783|58966788|FG001|Overall Study|Withdrawal by Subject|0|||
30758100|NCT00112437|58766924|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758101|NCT00112437|58766925|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758102|NCT00112437|58766926|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758103|NCT00112437|58766927|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30839104|NCT04495478|58864248|FG005|Overall Study|Withdrawal by Subject|0|||
30839105|NCT04495478|58864249|FG006|Overall Study|Withdrawal by Subject|0|||
30758104|NCT00112437|58766928|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758105|NCT00112437|58766929|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758106|NCT00112437|58766930|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758107|NCT00112437|58766931|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30839106|NCT04495478|58864243|FG000|Overall Study|Physician Decision|0|||
30839107|NCT04495478|58864244|FG001|Overall Study|Physician Decision|1|||
30839108|NCT04495478|58864245|FG002|Overall Study|Physician Decision|0|||
30839109|NCT04495478|58864246|FG003|Overall Study|Physician Decision|0|||
30839110|NCT04495478|58864247|FG004|Overall Study|Physician Decision|1|||
30839111|NCT04495478|58864248|FG005|Overall Study|Physician Decision|0|||
30839112|NCT04495478|58864249|FG006|Overall Study|Physician Decision|0|||
30930847|NCT01766817|58966805|FG000|Overall Study|Drug-related adverse event|1|||
30930848|NCT01766817|58966806|FG001|Overall Study|Drug-related adverse event|2|||
30930849|NCT01766817|58966807|FG002|Overall Study|Drug-related adverse event|1|||
30930850|NCT01766817|58966805|FG000|Overall Study|Drug-unrelated adverse event|3|||
30758108|NCT00112437|58766932|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30930851|NCT01766817|58966806|FG001|Overall Study|Drug-unrelated adverse event|3|||
30930852|NCT01766817|58966807|FG002|Overall Study|Drug-unrelated adverse event|3|||
30930853|NCT01766817|58966805|FG000|Overall Study|Death|1|||
30930854|NCT01766817|58966806|FG001|Overall Study|Death|1|||
30930855|NCT01766817|58966807|FG002|Overall Study|Death|0|||
30758109|NCT00112437|58766933|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758110|NCT00112437|58766934|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30930856|NCT01766817|58966805|FG000|Overall Study|Unable to take study drug|0|||
30930857|NCT01766817|58966806|FG001|Overall Study|Unable to take study drug|1|||
30930858|NCT01766817|58966807|FG002|Overall Study|Unable to take study drug|0|||
30930859|NCT01766817|58966805|FG000|Overall Study|Withdrawal by Subject|2|||
30930860|NCT01766817|58966806|FG001|Overall Study|Withdrawal by Subject|0|||
30930861|NCT01766817|58966807|FG002|Overall Study|Withdrawal by Subject|3|||
30930862|NCT01766817|58966805|FG000|Overall Study|Subject non-compliance|0|||
30930863|NCT01766817|58966806|FG001|Overall Study|Subject non-compliance|1|||
30930864|NCT01766817|58966807|FG002|Overall Study|Subject non-compliance|2|||
30930865|NCT01766817|58966805|FG000|Overall Study|Physician Decision|3|||
30930866|NCT01766817|58966806|FG001|Overall Study|Physician Decision|3|||
30930867|NCT01766817|58966807|FG002|Overall Study|Physician Decision|4|||
30930868|NCT01766817|58966805|FG000|Overall Study|Other|1|||
30930869|NCT01766817|58966806|FG001|Overall Study|Other|0|||
30930870|NCT01766817|58966807|FG002|Overall Study|Other|0|||
30930871|NCT01797705|58966815|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
30930872|NCT01797705|58966815|FG000|Overall Study|Withdrawal by Subject|1|||
30930873|NCT01797081|58966823|FG000|Overall Study|Adverse Event|1|||
30930874|NCT01797081|58966824|FG001|Overall Study|Adverse Event|0|||
30930875|NCT01797081|58966825|FG002|Overall Study|Adverse Event|1|||
30930876|NCT01797081|58966826|FG003|Overall Study|Adverse Event|0|||
30930877|NCT01797081|58966823|FG000|Overall Study|Pregnancy|1|||
30930878|NCT01797081|58966824|FG001|Overall Study|Pregnancy|0|||
30930879|NCT01797081|58966825|FG002|Overall Study|Pregnancy|0|||
30930880|NCT01797081|58966826|FG003|Overall Study|Pregnancy|0|||
30930881|NCT01797081|58966823|FG000|Overall Study|Personal Reasons|12|||
30930882|NCT01797081|58966824|FG001|Overall Study|Personal Reasons|4|||
30930883|NCT01797081|58966825|FG002|Overall Study|Personal Reasons|4|||
30930884|NCT01797081|58966826|FG003|Overall Study|Personal Reasons|8|||
30930885|NCT01797081|58966823|FG000|Overall Study|Protocol Violation|0|||
30930886|NCT01797081|58966824|FG001|Overall Study|Protocol Violation|0|||
30839113|NCT00152763|58864275|FG000|Overall Study|Death|4|||
30839114|NCT00152763|58864276|FG001|Overall Study|Death|1|||
30839115|NCT00152763|58864277|FG002|Overall Study|Death|2|||
30839116|NCT00152763|58864278|FG003|Overall Study|Death|1|||
30930887|NCT01797081|58966825|FG002|Overall Study|Protocol Violation|0|||
30930888|NCT01797081|58966826|FG003|Overall Study|Protocol Violation|1|||
30930889|NCT01794117|58966838|FG000|Overall Study|Adverse Event|1|||
30930890|NCT01794117|58966839|FG001|Overall Study|Adverse Event|0|||
30930891|NCT01794117|58966840|FG002|Overall Study|Adverse Event|0|||
30930892|NCT01794117|58966841|FG003|Overall Study|Adverse Event|0|||
30930893|NCT01794117|58966838|FG000|Overall Study|Participant noncompliance|0|||
30930894|NCT01794117|58966839|FG001|Overall Study|Participant noncompliance|1|||
30930895|NCT01794117|58966840|FG002|Overall Study|Participant noncompliance|0|||
30930896|NCT01794117|58966841|FG003|Overall Study|Participant noncompliance|0|||
30930897|NCT01794117|58966838|FG000|Overall Study|Refused further treatment|0|||
30930898|NCT01794117|58966839|FG001|Overall Study|Refused further treatment|2|||
30839117|NCT00152763|58864275|FG000|Overall Study|Lost to Follow-up|6|||
30839118|NCT00152763|58864276|FG001|Overall Study|Lost to Follow-up|4|||
30839119|NCT00152763|58864277|FG002|Overall Study|Lost to Follow-up|2|||
30930899|NCT01794117|58966840|FG002|Overall Study|Refused further treatment|0|||
30930900|NCT01794117|58966841|FG003|Overall Study|Refused further treatment|0|||
30930901|NCT01766037|58966854|FG000|Overall Study|Adverse Event|1|||
30930902|NCT01766037|58966855|FG001|Overall Study|Adverse Event|0|||
30930903|NCT01766037|58966854|FG000|Overall Study|Lack of Efficacy|1|||
30930904|NCT01766037|58966855|FG001|Overall Study|Lack of Efficacy|0|||
30930905|NCT01766037|58966854|FG000|Overall Study|Lost to Follow-up|0|||
30930906|NCT01766037|58966855|FG001|Overall Study|Lost to Follow-up|10|||
30930907|NCT01766037|58966854|FG000|Overall Study|Physician Decision|0|||
30930908|NCT01766037|58966855|FG001|Overall Study|Physician Decision|1|||
30930909|NCT01766037|58966854|FG000|Overall Study|Withdrawal by Subject|18|||
30930910|NCT01766037|58966855|FG001|Overall Study|Withdrawal by Subject|16|||
30930911|NCT01766037|58966854|FG000|Overall Study|Moved from area|5|||
30930912|NCT01766037|58966855|FG001|Overall Study|Moved from area|0|||
30930913|NCT01766037|58966854|FG000|Overall Study|medical - unrelated|1|||
30930914|NCT01766037|58966855|FG001|Overall Study|medical - unrelated|2|||
30930915|NCT01766037|58966854|FG000|Overall Study|nausea / discomfort|3|||
30930916|NCT01766037|58966855|FG001|Overall Study|nausea / discomfort|0|||
30930917|NCT01765569|58966861|FG000|Period B|Withdrawal by Subject|1|||
30930918|NCT01765569|58966861|FG000|Period C|Death|1|||
30930919|NCT01609257|58966870|FG000|Overall Study|Lost to Follow-up|2|||
30839120|NCT00152763|58864278|FG003|Overall Study|Lost to Follow-up|13|||
30930920|NCT01609257|58966871|FG001|Overall Study|Lost to Follow-up|1|||
30930921|NCT01609257|58966870|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
30930922|NCT01609257|58966871|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
30930923|NCT01609257|58966870|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
30930924|NCT01609257|58966871|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
30930925|NCT01609023|58966880|FG000|Overall Study|Lack of Efficacy|3|||
30930926|NCT01609023|58966880|FG000|Overall Study|Withdrawal by Subject|4|||
30930927|NCT01609023|58966880|FG000|Overall Study|Lost to Follow-up|8|||
30839121|NCT03181542|58864292|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
30930928|NCT01609023|58966880|FG000|Overall Study|Toxicity|3|||
30930929|NCT01609023|58966880|FG000|Overall Study|Disease progression|10|||
30930930|NCT01609023|58966880|FG000|Overall Study|Physician Decision|2|||
30930931|NCT01609023|58966880|FG000|Overall Study|Death|2|||
30930932|NCT01609023|58966880|FG000|Overall Study|Personal reasons|1|||
30930933|NCT01765179|58966884|FG000|Overall Study|Adverse Event|3|||
30930934|NCT01765179|58966884|FG000|Overall Study|Lost to Follow-up|5|||
30930935|NCT01765179|58966884|FG000|Overall Study|Non-compliance with study drug|2|||
30930936|NCT01765179|58966884|FG000|Overall Study|Protocol Violation|1|||
30930937|NCT01765179|58966884|FG000|Overall Study|Withdrawal by Subject|8|||
30930938|NCT01765179|58966884|FG000|Overall Study|Hematocrit >54%|3|||
30930939|NCT01765179|58966884|FG000|Overall Study|prohibited med|1|||
30930940|NCT01765179|58966884|FG000|Overall Study|Out of country unable to finish study|1|||
30930941|NCT01765179|58966884|FG000|Overall Study|lack of venous access|1|||
30930942|NCT01765179|58966884|FG000|Overall Study|work conflict|1|||
30930943|NCT01765179|58966884|FG000|Overall Study|Ca elevated 10.6|1|||
30930944|NCT01764945|58966896|FG000|Overall Study|Adverse Event|0|||
30930945|NCT01764945|58966897|FG001|Overall Study|Adverse Event|1|||
30930946|NCT01764945|58966898|FG002|Overall Study|Adverse Event|0|||
30930947|NCT01764945|58966899|FG003|Overall Study|Adverse Event|0|||
30930948|NCT01764945|58966900|FG004|Overall Study|Adverse Event|0|||
30930949|NCT01764945|58966901|FG005|Overall Study|Adverse Event|0|||
30930950|NCT01764945|58966902|FG006|Overall Study|Adverse Event|1|||
30930951|NCT01764945|58966903|FG007|Overall Study|Adverse Event|0|||
30930952|NCT01793883|58966924|FG000|Overall Study|Withdrawal by Subject|3|||
30930953|NCT01793883|58966925|FG001|Overall Study|Withdrawal by Subject|7|||
30930954|NCT01793883|58966926|FG002|Overall Study|Withdrawal by Subject|3|||
30930955|NCT01793883|58966924|FG000|Overall Study|Subject noncompliance|0|||
30930956|NCT01793883|58966925|FG001|Overall Study|Subject noncompliance|1|||
30930957|NCT01793883|58966926|FG002|Overall Study|Subject noncompliance|1|||
30930958|NCT01793883|58966924|FG000|Overall Study|Lost to Follow-up|5|||
30930959|NCT01793883|58966925|FG001|Overall Study|Lost to Follow-up|1|||
30930960|NCT01793883|58966926|FG002|Overall Study|Lost to Follow-up|3|||
30930961|NCT01793883|58966924|FG000|Overall Study|Randomized in error|1|||
30930962|NCT01793883|58966925|FG001|Overall Study|Randomized in error|0|||
30930963|NCT01793883|58966926|FG002|Overall Study|Randomized in error|0|||
30930964|NCT01793883|58966924|FG000|Overall Study|Unable to complete spriometry|1|||
30930965|NCT01793883|58966925|FG001|Overall Study|Unable to complete spriometry|0|||
30930966|NCT01793883|58966926|FG002|Overall Study|Unable to complete spriometry|0|||
30930967|NCT01793883|58966924|FG000|Overall Study|Unable to complete measurements|1|||
30930968|NCT01793883|58966925|FG001|Overall Study|Unable to complete measurements|0|||
30839122|NCT03181542|58864293|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
30839123|NCT00806403|58864301|FG000|Overall Study|Death|4|||
30839124|NCT00806403|58864302|FG001|Overall Study|Death|3|||
30839125|NCT00701558|58864319|FG000|Overall Study|Death|7|||
30839126|NCT00701558|58864319|FG000|Overall Study|Lost to Follow-up|8|||
30839127|NCT01663402|58864325|FG000|Overall Study|Randomized but not treated|19|||
30839128|NCT01663402|58864326|FG001|Overall Study|Randomized but not treated|11|||
30839129|NCT01663402|58864325|FG000|Overall Study|Adverse Event|347|||
30839130|NCT01663402|58864326|FG001|Overall Study|Adverse Event|362|||
30839131|NCT01663402|58864325|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
30839132|NCT01663402|58864326|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
30839133|NCT01663402|58864325|FG000|Overall Study|Poor compliance to protocol|529|||
30839134|NCT01663402|58864326|FG001|Overall Study|Poor compliance to protocol|454|||
30930969|NCT01793883|58966926|FG002|Overall Study|Unable to complete measurements|0|||
30930970|NCT01793883|58966924|FG000|Overall Study|Met exclusion criteria|1|||
30930971|NCT01793883|58966925|FG001|Overall Study|Met exclusion criteria|0|||
30930972|NCT01793883|58966926|FG002|Overall Study|Met exclusion criteria|0|||
30930973|NCT01793883|58966924|FG000|Overall Study|Dosing error|0|||
30930974|NCT01793883|58966925|FG001|Overall Study|Dosing error|1|||
30930975|NCT01793883|58966926|FG002|Overall Study|Dosing error|0|||
30930976|NCT01793883|58966924|FG000|Overall Study|Respiratory distress during spirometry|0|||
30930977|NCT01793883|58966925|FG001|Overall Study|Respiratory distress during spirometry|0|||
30930978|NCT01793883|58966926|FG002|Overall Study|Respiratory distress during spirometry|1|||
30930979|NCT01792635|58966937|FG000|Part B|Adverse Event|0|||
30930980|NCT01792635|58966938|FG001|Part B|Adverse Event|0|||
30930981|NCT01792635|58966939|FG002|Part B|Adverse Event|1|||
30930982|NCT01792635|58966937|FG000|Part B|Study terminated|0|||
30930983|NCT01792635|58966938|FG001|Part B|Study terminated|4|||
30930984|NCT01792635|58966939|FG002|Part B|Study terminated|3|||
30930985|NCT01953692|58966957|FG000|Overall Study|Adverse Event|5|||
30930986|NCT01953692|58966958|FG001|Overall Study|Adverse Event|2|||
30930987|NCT01953692|58966959|FG002|Overall Study|Adverse Event|4|||
30930988|NCT01953692|58966960|FG003|Overall Study|Adverse Event|2|||
30930989|NCT01953692|58966961|FG004|Overall Study|Adverse Event|1|||
30930990|NCT01953692|58966962|FG005|Overall Study|Adverse Event|2|||
30930991|NCT01953692|58966963|FG006|Overall Study|Adverse Event|0|||
30839135|NCT01663402|58864325|FG000|Overall Study|Physician Decision|77|||
30930992|NCT01953692|58966964|FG007|Overall Study|Adverse Event|0|||
30839136|NCT01663402|58864326|FG001|Overall Study|Physician Decision|62|||
30930993|NCT01953692|58966965|FG008|Overall Study|Adverse Event|0|||
30930994|NCT01953692|58966957|FG000|Overall Study|Clinical Progression|0|||
30930995|NCT01953692|58966958|FG001|Overall Study|Clinical Progression|15|||
30930996|NCT01953692|58966959|FG002|Overall Study|Clinical Progression|7|||
30930997|NCT01953692|58966960|FG003|Overall Study|Clinical Progression|5|||
30930998|NCT01953692|58966961|FG004|Overall Study|Clinical Progression|0|||
30930999|NCT01953692|58966962|FG005|Overall Study|Clinical Progression|7|||
30931000|NCT01953692|58966963|FG006|Overall Study|Clinical Progression|20|||
30931001|NCT01953692|58966964|FG007|Overall Study|Clinical Progression|3|||
30931002|NCT01953692|58966965|FG008|Overall Study|Clinical Progression|3|||
30931003|NCT01953692|58966957|FG000|Overall Study|Death|5|||
30931004|NCT01953692|58966958|FG001|Overall Study|Death|0|||
30931005|NCT01953692|58966959|FG002|Overall Study|Death|2|||
30931006|NCT01953692|58966960|FG003|Overall Study|Death|2|||
30931007|NCT01953692|58966961|FG004|Overall Study|Death|1|||
30931008|NCT01953692|58966962|FG005|Overall Study|Death|3|||
30931009|NCT01953692|58966963|FG006|Overall Study|Death|6|||
30931010|NCT01953692|58966964|FG007|Overall Study|Death|2|||
30839137|NCT01663402|58864325|FG000|Overall Study|Site terminated by sponsor|1|||
30839138|NCT01663402|58864326|FG001|Overall Study|Site terminated by sponsor|3|||
30839139|NCT01663402|58864325|FG000|Overall Study|Participant moved|139|||
30839140|NCT01663402|58864326|FG001|Overall Study|Participant moved|104|||
30839141|NCT01663402|58864325|FG000|Overall Study|Withdrawal by Subject|118|||
30839142|NCT01663402|58864326|FG001|Overall Study|Withdrawal by Subject|91|||
30839143|NCT01663402|58864325|FG000|Overall Study|Related to study drug administration|96|||
30839144|NCT01663402|58864326|FG001|Overall Study|Related to study drug administration|105|||
30839145|NCT01663402|58864325|FG000|Overall Study|Lost to Follow-up|17|||
30839146|NCT01663402|58864326|FG001|Overall Study|Lost to Follow-up|15|||
30839147|NCT01663402|58864325|FG000|Overall Study|Other than specified above|172|||
30839148|NCT01663402|58864326|FG001|Overall Study|Other than specified above|147|||
30839149|NCT00859521|58864343|FG000|Washout|Withdrawal by Subject|0|||
30839150|NCT00859521|58864344|FG001|Washout|Withdrawal by Subject|1|||
30839151|NCT00841815|58864359|FG000|Washout|Withdrawal by Subject|0|||
30839152|NCT00841815|58864360|FG001|Washout|Withdrawal by Subject|1|||
30839153|NCT00841659|58864367|FG000|Washout: 2 Weeks|Protocol Violation|1|||
30839154|NCT00841659|58864368|FG001|Washout: 2 Weeks|Protocol Violation|0|||
30839155|NCT02716298|58864372|FG000|First Intervention (1 Month)|Lens discomfort|1|||
30839156|NCT02716298|58864373|FG001|First Intervention (1 Month)|Lens discomfort|1|||
30839157|NCT00840879|58864386|FG000|Second Intervention|Withdrawal by Subject|1|||
30839158|NCT00840879|58864387|FG001|Second Intervention|Withdrawal by Subject|0|||
30839159|NCT00840411|58864402|FG000|First Intervention|Adverse Event|1|||
30839160|NCT00840411|58864403|FG001|First Intervention|Adverse Event|0|||
30839161|NCT00840411|58864402|FG000|Washout|Withdrawal by Subject|1|||
30839162|NCT00840411|58864403|FG001|Washout|Withdrawal by Subject|0|||
30839163|NCT00836901|58864416|FG000|First Intervention|Withdrawal by Subject|1|||
30839164|NCT00836901|58864417|FG001|First Intervention|Withdrawal by Subject|0|||
30839165|NCT04466384|58864421|FG000|First Phase|Protocol Violation|1|||
30839166|NCT04466384|58864422|FG001|First Phase|Protocol Violation|0|||
30839167|NCT04466384|58864421|FG000|First Phase|Missing data|1|||
30839168|NCT04466384|58864422|FG001|First Phase|Missing data|0|||
30839169|NCT04466384|58864421|FG000|Cross Over Phase|Physician Decision|1|||
30839170|NCT04466384|58864422|FG001|Cross Over Phase|Physician Decision|0|||
30839171|NCT04466384|58864421|FG000|Cross Over Phase|Withdrawal by Subject|0|||
30839172|NCT04466384|58864422|FG001|Cross Over Phase|Withdrawal by Subject|1|||
30839173|NCT03050814|58864433|FG000|Overall Study|Screen failures|0|||
30839174|NCT03050814|58864434|FG001|Overall Study|Screen failures|0|||
30839175|NCT03050814|58864435|FG002|Overall Study|Screen failures|4|||
30839176|NCT00835575|58864443|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
30839177|NCT00835575|58864444|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
30839178|NCT04601194|58864448|FG000|Overall Study|Lost to Follow-up|7|||
30931011|NCT01953692|58966965|FG008|Overall Study|Death|1|||
30839179|NCT00835263|58864461|FG000|Second Intervention|Adverse Event|1|||
30839180|NCT00835263|58864462|FG001|Second Intervention|Adverse Event|0|||
30839181|NCT01963208|58864500|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
30839182|NCT01963208|58864501|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
30931012|NCT01953692|58966957|FG000|Overall Study|Excluded Medication|1|||
30931013|NCT01953692|58966958|FG001|Overall Study|Excluded Medication|0|||
30931014|NCT01953692|58966959|FG002|Overall Study|Excluded Medication|0|||
30931015|NCT01953692|58966960|FG003|Overall Study|Excluded Medication|0|||
30839183|NCT01963208|58864502|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
30839184|NCT01963208|58864503|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
30931016|NCT01953692|58966961|FG004|Overall Study|Excluded Medication|0|||
30931017|NCT01953692|58966962|FG005|Overall Study|Excluded Medication|0|||
30931018|NCT01953692|58966963|FG006|Overall Study|Excluded Medication|0|||
30931019|NCT01953692|58966964|FG007|Overall Study|Excluded Medication|0|||
30839185|NCT01963208|58864504|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
30839186|NCT01963208|58864505|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
30931020|NCT01953692|58966965|FG008|Overall Study|Excluded Medication|0|||
30931021|NCT01953692|58966957|FG000|Overall Study|Lost to Follow-up|1|||
30931022|NCT01953692|58966958|FG001|Overall Study|Lost to Follow-up|0|||
30931023|NCT01953692|58966959|FG002|Overall Study|Lost to Follow-up|3|||
30839187|NCT01963208|58864500|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
30839188|NCT01963208|58864501|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
30839189|NCT01963208|58864502|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
30931024|NCT01953692|58966960|FG003|Overall Study|Lost to Follow-up|1|||
30931025|NCT01953692|58966961|FG004|Overall Study|Lost to Follow-up|0|||
30931026|NCT01953692|58966962|FG005|Overall Study|Lost to Follow-up|1|||
30931027|NCT01953692|58966963|FG006|Overall Study|Lost to Follow-up|0|||
30931028|NCT01953692|58966964|FG007|Overall Study|Lost to Follow-up|0|||
30931029|NCT01953692|58966965|FG008|Overall Study|Lost to Follow-up|0|||
30931030|NCT01953692|58966957|FG000|Overall Study|Physician Decision|11|||
30931031|NCT01953692|58966958|FG001|Overall Study|Physician Decision|4|||
30931032|NCT01953692|58966959|FG002|Overall Study|Physician Decision|2|||
30931033|NCT01953692|58966960|FG003|Overall Study|Physician Decision|2|||
30931034|NCT01953692|58966961|FG004|Overall Study|Physician Decision|1|||
30931035|NCT01953692|58966962|FG005|Overall Study|Physician Decision|2|||
30931036|NCT01953692|58966963|FG006|Overall Study|Physician Decision|4|||
30931037|NCT01953692|58966964|FG007|Overall Study|Physician Decision|1|||
30931038|NCT01953692|58966965|FG008|Overall Study|Physician Decision|0|||
30931039|NCT01953692|58966957|FG000|Overall Study|Protocol Violation|0|||
30931040|NCT01953692|58966958|FG001|Overall Study|Protocol Violation|2|||
30931041|NCT01953692|58966959|FG002|Overall Study|Protocol Violation|1|||
30931042|NCT01953692|58966960|FG003|Overall Study|Protocol Violation|0|||
30931043|NCT01953692|58966961|FG004|Overall Study|Protocol Violation|0|||
30931044|NCT01953692|58966962|FG005|Overall Study|Protocol Violation|0|||
30931045|NCT01953692|58966963|FG006|Overall Study|Protocol Violation|0|||
30931046|NCT01953692|58966964|FG007|Overall Study|Protocol Violation|1|||
30931047|NCT01953692|58966965|FG008|Overall Study|Protocol Violation|0|||
30931048|NCT01953692|58966957|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
30931049|NCT01953692|58966958|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
30931050|NCT01953692|58966959|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
30931051|NCT01953692|58966960|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
30931052|NCT01953692|58966961|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
30931053|NCT01953692|58966962|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
30931054|NCT01953692|58966963|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
30931055|NCT01953692|58966964|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
30931056|NCT01953692|58966965|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
30931057|NCT01953692|58966957|FG000|Overall Study|Withdrawal by Subject|4|||
30931058|NCT01953692|58966958|FG001|Overall Study|Withdrawal by Subject|2|||
30931059|NCT01953692|58966959|FG002|Overall Study|Withdrawal by Subject|1|||
30931060|NCT01953692|58966960|FG003|Overall Study|Withdrawal by Subject|2|||
30931061|NCT01953692|58966961|FG004|Overall Study|Withdrawal by Subject|0|||
30931062|NCT01953692|58966962|FG005|Overall Study|Withdrawal by Subject|3|||
30931063|NCT01953692|58966963|FG006|Overall Study|Withdrawal by Subject|2|||
30931064|NCT01953692|58966964|FG007|Overall Study|Withdrawal by Subject|1|||
30931065|NCT01953692|58966965|FG008|Overall Study|Withdrawal by Subject|1|||
30931066|NCT01791153|58966999|FG000|Part 1: Blinded Period|Adverse Event|7|||
30931067|NCT01791153|58967000|FG001|Part 1: Blinded Period|Adverse Event|3|||
30931068|NCT01791153|58967001|FG002|Part 1: Blinded Period|Adverse Event|2|||
30931069|NCT01791153|58967002|FG003|Part 1: Blinded Period|Adverse Event|0|||
30931070|NCT01791153|58967003|FG004|Part 1: Blinded Period|Adverse Event|0|||
30931071|NCT01791153|58967004|FG005|Part 1: Blinded Period|Adverse Event|0|||
30931072|NCT01791153|58967005|FG006|Part 1: Blinded Period|Adverse Event|0|||
30931073|NCT01791153|58967006|FG007|Part 1: Blinded Period|Adverse Event|0|||
30931074|NCT01791153|58966999|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
30931075|NCT01791153|58967000|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
30931076|NCT01791153|58967001|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
30931077|NCT01791153|58967002|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
30931078|NCT01791153|58967003|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
30931079|NCT01791153|58967004|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
30931080|NCT01791153|58967005|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
30931081|NCT01791153|58967006|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
30931082|NCT01791153|58966999|FG000|Part 1: Blinded Period|Non-Compliance|1|||
30931083|NCT01791153|58967000|FG001|Part 1: Blinded Period|Non-Compliance|0|||
30839190|NCT01963208|58864503|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
30839191|NCT01963208|58864504|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
30839192|NCT01963208|58864505|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
30839193|NCT01963208|58864500|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
30931084|NCT01791153|58967001|FG002|Part 1: Blinded Period|Non-Compliance|0|||
30931085|NCT01791153|58967002|FG003|Part 1: Blinded Period|Non-Compliance|0|||
30931086|NCT01791153|58967003|FG004|Part 1: Blinded Period|Non-Compliance|0|||
30931087|NCT01791153|58967004|FG005|Part 1: Blinded Period|Non-Compliance|0|||
30931088|NCT01791153|58967005|FG006|Part 1: Blinded Period|Non-Compliance|0|||
30931089|NCT01791153|58967006|FG007|Part 1: Blinded Period|Non-Compliance|0|||
30931090|NCT01791153|58966999|FG000|Part 1: Blinded Period|Physician Decision|0|||
30931091|NCT01791153|58967000|FG001|Part 1: Blinded Period|Physician Decision|0|||
30931092|NCT01791153|58967001|FG002|Part 1: Blinded Period|Physician Decision|0|||
30931093|NCT01791153|58967002|FG003|Part 1: Blinded Period|Physician Decision|1|||
30931094|NCT01791153|58967003|FG004|Part 1: Blinded Period|Physician Decision|0|||
30931095|NCT01791153|58967004|FG005|Part 1: Blinded Period|Physician Decision|0|||
30931096|NCT01791153|58967005|FG006|Part 1: Blinded Period|Physician Decision|0|||
30931097|NCT01791153|58967006|FG007|Part 1: Blinded Period|Physician Decision|0|||
30931098|NCT01791153|58966999|FG000|Part 1: Blinded Period|Protocol Violation|0|||
30931099|NCT01791153|58967000|FG001|Part 1: Blinded Period|Protocol Violation|0|||
30931100|NCT01791153|58967001|FG002|Part 1: Blinded Period|Protocol Violation|0|||
30931101|NCT01791153|58967002|FG003|Part 1: Blinded Period|Protocol Violation|1|||
30931102|NCT01791153|58967003|FG004|Part 1: Blinded Period|Protocol Violation|0|||
30931103|NCT01791153|58967004|FG005|Part 1: Blinded Period|Protocol Violation|0|||
30931104|NCT01791153|58967005|FG006|Part 1: Blinded Period|Protocol Violation|0|||
30931105|NCT01791153|58967006|FG007|Part 1: Blinded Period|Protocol Violation|0|||
30931106|NCT01791153|58966999|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
30931107|NCT01791153|58967000|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
30931108|NCT01791153|58967001|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
30931109|NCT01791153|58967002|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
30931110|NCT01791153|58967003|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
30931111|NCT01791153|58967004|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
30931112|NCT01791153|58967005|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
30931113|NCT01791153|58967006|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
30931114|NCT01791153|58966999|FG000|Part 2: Open-label Period|Adverse Event|0|||
30931115|NCT01791153|58967000|FG001|Part 2: Open-label Period|Adverse Event|0|||
30931116|NCT01791153|58967001|FG002|Part 2: Open-label Period|Adverse Event|0|||
30931117|NCT01791153|58967002|FG003|Part 2: Open-label Period|Adverse Event|0|||
30931118|NCT01791153|58967003|FG004|Part 2: Open-label Period|Adverse Event|0|||
30931119|NCT01791153|58967004|FG005|Part 2: Open-label Period|Adverse Event|1|||
30931120|NCT01791153|58967005|FG006|Part 2: Open-label Period|Adverse Event|1|||
30931121|NCT01791153|58967006|FG007|Part 2: Open-label Period|Adverse Event|2|||
30931122|NCT01791153|58966999|FG000|Part 2: Open-label Period|Death|0|||
30931123|NCT01791153|58967000|FG001|Part 2: Open-label Period|Death|0|||
30931124|NCT01791153|58967001|FG002|Part 2: Open-label Period|Death|0|||
30931125|NCT01791153|58967002|FG003|Part 2: Open-label Period|Death|0|||
30931126|NCT01791153|58967003|FG004|Part 2: Open-label Period|Death|0|||
30931127|NCT01791153|58967004|FG005|Part 2: Open-label Period|Death|1|||
30931128|NCT01791153|58967005|FG006|Part 2: Open-label Period|Death|1|||
30931129|NCT01791153|58967006|FG007|Part 2: Open-label Period|Death|1|||
30931130|NCT01791153|58966999|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
30931131|NCT01791153|58967000|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
30931132|NCT01791153|58967001|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
30931133|NCT01791153|58967002|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
30839194|NCT01963208|58864501|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
30839195|NCT01963208|58864502|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
30839196|NCT01963208|58864503|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
30839197|NCT01963208|58864504|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
30839198|NCT01963208|58864505|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
30839199|NCT01963208|58864500|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
30839200|NCT01963208|58864501|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
30839201|NCT01963208|58864502|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
30839202|NCT01963208|58864503|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
30839203|NCT01963208|58864504|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
30839204|NCT01963208|58864505|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
30839205|NCT01963208|58864500|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
30839206|NCT01963208|58864501|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
30839207|NCT01963208|58864502|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
30839208|NCT01963208|58864503|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
30839209|NCT01963208|58864504|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
30839210|NCT01963208|58864505|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
30839211|NCT01963208|58864500|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
30839212|NCT01963208|58864501|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
30839213|NCT01963208|58864502|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
30839214|NCT01963208|58864503|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
30931134|NCT01791153|58967003|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
30931135|NCT01791153|58967004|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
30931136|NCT01791153|58967005|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
30931137|NCT01791153|58967006|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
30931138|NCT01791153|58966999|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
30931139|NCT01791153|58967000|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
30839215|NCT01963208|58864504|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
30839216|NCT01963208|58864505|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
30931140|NCT01791153|58967001|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
30931141|NCT01791153|58967002|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
30931142|NCT01791153|58967003|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
30931143|NCT01791153|58967004|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
30931144|NCT01791153|58967005|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
30931145|NCT01791153|58967006|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
30931146|NCT01791153|58966999|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
30931147|NCT01791153|58967000|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
30931148|NCT01791153|58967001|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
30931149|NCT01791153|58967002|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
30839217|NCT01963208|58864500|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
30839218|NCT01963208|58864501|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
30839219|NCT01963208|58864502|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
30839220|NCT01963208|58864503|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
30839221|NCT01963208|58864504|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
30839222|NCT01963208|58864505|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
30839223|NCT01963208|58864500|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
30839224|NCT01963208|58864501|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
30839225|NCT01963208|58864502|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
30839226|NCT01963208|58864503|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
30839227|NCT01963208|58864504|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
30839228|NCT01963208|58864505|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
30839229|NCT01963208|58864500|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
30839230|NCT01963208|58864501|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
30839231|NCT01963208|58864502|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
30839232|NCT01963208|58864503|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
30839233|NCT01963208|58864504|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
30839234|NCT01963208|58864505|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
30839235|NCT01963208|58864500|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
30839236|NCT01963208|58864501|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
30839237|NCT01963208|58864502|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
30839238|NCT01963208|58864503|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
30839239|NCT01963208|58864504|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
30839240|NCT01963208|58864505|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
30839241|NCT01963208|58864500|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
30839242|NCT01963208|58864501|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
30839243|NCT01963208|58864502|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
30839244|NCT01963208|58864503|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
30839245|NCT01963208|58864504|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
30839246|NCT01963208|58864505|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
30839247|NCT01963208|58864500|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
30839248|NCT01963208|58864501|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
30839249|NCT01963208|58864502|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
30839250|NCT01963208|58864503|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
30839251|NCT01963208|58864504|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
30839252|NCT01963208|58864505|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
30839253|NCT01963208|58864500|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
30839254|NCT01963208|58864501|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
30839255|NCT01963208|58864502|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
30839256|NCT01963208|58864503|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
30839257|NCT01963208|58864504|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
30839258|NCT01963208|58864505|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
30839259|NCT01963208|58864500|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
30839260|NCT01963208|58864501|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
30839261|NCT01963208|58864502|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
30839262|NCT01963208|58864503|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
30839263|NCT01963208|58864504|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
30839264|NCT01963208|58864505|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
30839265|NCT00834873|58864517|FG000|First Intervention|Adverse Event|0|||
30931150|NCT01791153|58967003|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
30931151|NCT01791153|58967004|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
30931152|NCT01791153|58967005|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
30931153|NCT01791153|58967006|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
30839266|NCT00834873|58864518|FG001|First Intervention|Adverse Event|1|||
30839267|NCT01377480|58864526|FG000|Overall Study|Protocol Violation|0|||
30931154|NCT01791153|58966999|FG000|Part 2: Open-label Period|Physician Decision|0|||
30931155|NCT01791153|58967000|FG001|Part 2: Open-label Period|Physician Decision|0|||
30931156|NCT01791153|58967001|FG002|Part 2: Open-label Period|Physician Decision|0|||
30931157|NCT01791153|58967002|FG003|Part 2: Open-label Period|Physician Decision|0|||
30931158|NCT01791153|58967003|FG004|Part 2: Open-label Period|Physician Decision|1|||
30931159|NCT01791153|58967004|FG005|Part 2: Open-label Period|Physician Decision|1|||
30931160|NCT01791153|58967005|FG006|Part 2: Open-label Period|Physician Decision|0|||
30931161|NCT01791153|58967006|FG007|Part 2: Open-label Period|Physician Decision|0|||
30931162|NCT01926782|58967027|FG000|Overall Study|Participant moved|2|||
30931163|NCT01926782|58967028|FG001|Overall Study|Participant moved|0|||
30931164|NCT01926782|58967029|FG002|Overall Study|Participant moved|1|||
30931165|NCT01926782|58967030|FG003|Overall Study|Participant moved|1|||
30931166|NCT01926782|58967031|FG004|Overall Study|Participant moved|0|||
30931167|NCT01926782|58967032|FG005|Overall Study|Participant moved|3|||
30931168|NCT01926782|58967027|FG000|Overall Study|Physician Decision|0|||
30931169|NCT01926782|58967028|FG001|Overall Study|Physician Decision|2|||
30931170|NCT01926782|58967029|FG002|Overall Study|Physician Decision|1|||
30931171|NCT01926782|58967030|FG003|Overall Study|Physician Decision|1|||
30931172|NCT01926782|58967031|FG004|Overall Study|Physician Decision|0|||
30931173|NCT01926782|58967032|FG005|Overall Study|Physician Decision|0|||
30931174|NCT01926782|58967027|FG000|Overall Study|Other than specified|2|||
30931175|NCT01926782|58967028|FG001|Overall Study|Other than specified|3|||
30931176|NCT01926782|58967029|FG002|Overall Study|Other than specified|5|||
30931177|NCT01926782|58967030|FG003|Overall Study|Other than specified|12|||
30931178|NCT01926782|58967031|FG004|Overall Study|Other than specified|4|||
30931179|NCT01926782|58967032|FG005|Overall Study|Other than specified|11|||
30931180|NCT01926782|58967027|FG000|Overall Study|Adverse Event|13|||
30931181|NCT01926782|58967028|FG001|Overall Study|Adverse Event|4|||
30931182|NCT01926782|58967029|FG002|Overall Study|Adverse Event|17|||
30931183|NCT01926782|58967030|FG003|Overall Study|Adverse Event|4|||
30931184|NCT01926782|58967031|FG004|Overall Study|Adverse Event|3|||
30931185|NCT01926782|58967032|FG005|Overall Study|Adverse Event|14|||
30931186|NCT01926782|58967027|FG000|Overall Study|Poor compliance to protocol|5|||
30931187|NCT01926782|58967028|FG001|Overall Study|Poor compliance to protocol|3|||
30931188|NCT01926782|58967029|FG002|Overall Study|Poor compliance to protocol|8|||
30931189|NCT01926782|58967030|FG003|Overall Study|Poor compliance to protocol|0|||
30931190|NCT01926782|58967031|FG004|Overall Study|Poor compliance to protocol|1|||
30931191|NCT01926782|58967032|FG005|Overall Study|Poor compliance to protocol|6|||
30931192|NCT01926782|58967027|FG000|Overall Study|Randomized and not treated|0|||
30931193|NCT01926782|58967028|FG001|Overall Study|Randomized and not treated|0|||
30931194|NCT01926782|58967029|FG002|Overall Study|Randomized and not treated|0|||
30931195|NCT01926782|58967030|FG003|Overall Study|Randomized and not treated|1|||
30931196|NCT01926782|58967031|FG004|Overall Study|Randomized and not treated|0|||
30931197|NCT01926782|58967032|FG005|Overall Study|Randomized and not treated|0|||
30931198|NCT01926782|58967027|FG000|Overall Study|Withdrawal by Subject|6|||
30931199|NCT01926782|58967028|FG001|Overall Study|Withdrawal by Subject|1|||
30931200|NCT01926782|58967029|FG002|Overall Study|Withdrawal by Subject|8|||
30931201|NCT01926782|58967030|FG003|Overall Study|Withdrawal by Subject|1|||
30931202|NCT01926782|58967031|FG004|Overall Study|Withdrawal by Subject|0|||
30931203|NCT01926782|58967032|FG005|Overall Study|Withdrawal by Subject|5|||
30931204|NCT01926782|58967027|FG000|Overall Study|Related to study drug administration|0|||
30931205|NCT01926782|58967028|FG001|Overall Study|Related to study drug administration|0|||
30931206|NCT01926782|58967029|FG002|Overall Study|Related to study drug administration|0|||
30931207|NCT01926782|58967030|FG003|Overall Study|Related to study drug administration|0|||
30931208|NCT01926782|58967031|FG004|Overall Study|Related to study drug administration|0|||
30931209|NCT01926782|58967032|FG005|Overall Study|Related to study drug administration|2|||
30931210|NCT01926626|58967047|FG000|Overall Study|Withdrawal by Subject|15|||
30931211|NCT01926626|58967047|FG000|Overall Study|Lost to Follow-up|7|||
30931212|NCT01953224|58967053|FG000|Overall Study|Lost to Follow-up|1|||
30931213|NCT01953224|58967054|FG001|Overall Study|Lost to Follow-up|1|||
30931214|NCT01953224|58967053|FG000|Overall Study|Withdrawal by Subject|1|||
30931215|NCT01953224|58967054|FG001|Overall Study|Withdrawal by Subject|2|||
30931216|NCT01900730|58967062|FG000|Overall Study|Withdrawal by Subject|1|||
30931217|NCT01900730|58967063|FG001|Overall Study|Withdrawal by Subject|0|||
30931218|NCT01900730|58967062|FG000|Overall Study|Screen Failure|1|||
30931219|NCT01900730|58967063|FG001|Overall Study|Screen Failure|0|||
30931220|NCT01952834|58967069|FG000|Overall Study|Adverse Event|1|||
30931221|NCT01952366|58967074|FG000|Overall Study|Death|22|||
30931222|NCT01952366|58967074|FG000|Overall Study|Withdrawal by Subject|9|||
30931223|NCT01952054|58967081|FG000|Overall Study|Physician Decision|1|||
30931224|NCT01925768|58967087|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
30931225|NCT01925768|58967088|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30931226|NCT01925768|58967087|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
30931227|NCT01925768|58967088|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
30931228|NCT01925768|58967087|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
30931229|NCT01925768|58967088|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
30931230|NCT01925768|58967087|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
30931231|NCT01925768|58967088|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
30931232|NCT01925768|58967087|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
30931233|NCT01925768|58967088|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
30931234|NCT01925768|58967087|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
30931235|NCT01925768|58967088|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
30931236|NCT01925768|58967087|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
30931237|NCT01925768|58967088|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
30931238|NCT01925768|58967087|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
30931239|NCT01925768|58967088|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
30931240|NCT01925768|58967087|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
30931241|NCT01925768|58967088|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
30931242|NCT01925768|58967087|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
30931243|NCT01925768|58967088|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
30931244|NCT01925768|58967087|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
30931245|NCT01925768|58967088|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
30931246|NCT01431274|58967103|FG000|Overall Study|Adverse Event|51|||
30931247|NCT01431274|58967104|FG001|Overall Study|Adverse Event|37|||
30931248|NCT01431274|58967105|FG002|Overall Study|Adverse Event|43|||
30931249|NCT01431274|58967106|FG003|Overall Study|Adverse Event|30|||
30931250|NCT01431274|58967107|FG004|Overall Study|Adverse Event|37|||
30931251|NCT01431274|58967103|FG000|Overall Study|Consent withdrawn not due to AE|29|||
30931252|NCT01431274|58967104|FG001|Overall Study|Consent withdrawn not due to AE|20|||
30931253|NCT01431274|58967105|FG002|Overall Study|Consent withdrawn not due to AE|17|||
30931254|NCT01431274|58967106|FG003|Overall Study|Consent withdrawn not due to AE|20|||
30931255|NCT01431274|58967107|FG004|Overall Study|Consent withdrawn not due to AE|11|||
30931256|NCT01431274|58967103|FG000|Overall Study|Non compliant with protocol|5|||
30931257|NCT01431274|58967104|FG001|Overall Study|Non compliant with protocol|8|||
30931258|NCT01431274|58967105|FG002|Overall Study|Non compliant with protocol|4|||
30931259|NCT01431274|58967106|FG003|Overall Study|Non compliant with protocol|4|||
30931260|NCT01431274|58967107|FG004|Overall Study|Non compliant with protocol|4|||
30931261|NCT01431274|58967103|FG000|Overall Study|Lost to Follow-up|6|||
30931262|NCT01431274|58967104|FG001|Overall Study|Lost to Follow-up|7|||
30931263|NCT01431274|58967105|FG002|Overall Study|Lost to Follow-up|1|||
30931264|NCT01431274|58967106|FG003|Overall Study|Lost to Follow-up|4|||
30931265|NCT01431274|58967107|FG004|Overall Study|Lost to Follow-up|0|||
30931266|NCT01431274|58967103|FG000|Overall Study|Other reason not stated above|6|||
30931267|NCT01431274|58967104|FG001|Overall Study|Other reason not stated above|5|||
30931268|NCT01431274|58967105|FG002|Overall Study|Other reason not stated above|7|||
30931269|NCT01431274|58967106|FG003|Overall Study|Other reason not stated above|2|||
30839268|NCT01377480|58864527|FG001|Overall Study|Protocol Violation|0|||
30839269|NCT01377480|58864528|FG002|Overall Study|Protocol Violation|0|||
30839270|NCT01377480|58864529|FG003|Overall Study|Protocol Violation|4|||
30839271|NCT01377480|58864526|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
30839272|NCT01377480|58864527|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
30839273|NCT01377480|58864528|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
30839274|NCT01377480|58864529|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
30839275|NCT01377480|58864526|FG000|Overall Study|Withdrawal by Subject|0|||
30839276|NCT01377480|58864527|FG001|Overall Study|Withdrawal by Subject|0|||
30839277|NCT01377480|58864528|FG002|Overall Study|Withdrawal by Subject|1|||
30839278|NCT01377480|58864529|FG003|Overall Study|Withdrawal by Subject|0|||
30931270|NCT01431274|58967107|FG004|Overall Study|Other reason not stated above|4|||
30931271|NCT01991795|58967121|FG000|Overall Study|Lost to Follow-up|6|||
30931272|NCT01991795|58967122|FG001|Overall Study|Lost to Follow-up|4|||
30758111|NCT00112437|58766935|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758112|NCT00112437|58766936|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758113|NCT00112437|58766937|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758114|NCT00112437|58766938|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758115|NCT00112437|58766939|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758116|NCT00112437|58766940|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758117|NCT00112437|58766941|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758118|NCT00112437|58766942|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
30839279|NCT01377480|58864526|FG000|Overall Study|Serious adverse event|0|||
30839280|NCT01377480|58864527|FG001|Overall Study|Serious adverse event|0|||
30839281|NCT01377480|58864528|FG002|Overall Study|Serious adverse event|1|||
30931273|NCT01991795|58967121|FG000|Overall Study|Withdrawal by Subject|117|||
30931274|NCT01991795|58967122|FG001|Overall Study|Withdrawal by Subject|94|||
30931275|NCT01991795|58967121|FG000|Overall Study|Site prematurely closed by sponsor|26|||
30931276|NCT01991795|58967122|FG001|Overall Study|Site prematurely closed by sponsor|25|||
30931277|NCT01411852|58967163|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
30931278|NCT01411852|58967164|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
30931279|NCT01411852|58967163|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
30931280|NCT01411852|58967164|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
30931281|NCT01411852|58967163|FG000|Prehospital Intervention Phase|Found to be under age|0|||
30931282|NCT01411852|58967164|FG001|Prehospital Intervention Phase|Found to be under age|1|||
30931283|NCT01411852|58967163|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
30931284|NCT01411852|58967164|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
30931285|NCT01411852|58967163|FG000|Hospital Intervention Phase|Severe head injury|5|||
30931286|NCT01411852|58967164|FG001|Hospital Intervention Phase|Severe head injury|4|||
30839282|NCT01377480|58864529|FG003|Overall Study|Serious adverse event|1|||
30839283|NCT01377480|58864526|FG000|Overall Study|Other|0|||
30839284|NCT01377480|58864527|FG001|Overall Study|Other|0|||
30839285|NCT01377480|58864528|FG002|Overall Study|Other|7|||
30839286|NCT01377480|58864529|FG003|Overall Study|Other|6|||
30839287|NCT00834795|58864541|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
30839288|NCT00834795|58864542|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
30839289|NCT00834795|58864541|FG000|Second Intervention|Adverse Event|1|||
30839290|NCT00834795|58864542|FG001|Second Intervention|Adverse Event|0|||
30839291|NCT00834717|58864548|FG000|First Intervention|Adverse Event|1|||
30931287|NCT01411852|58967163|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
30931288|NCT01411852|58967164|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
30931289|NCT01411852|58967163|FG000|Hospital Intervention Phase|Miscommunication error|1|||
30931290|NCT01411852|58967164|FG001|Hospital Intervention Phase|Miscommunication error|2|||
30931291|NCT01411852|58967163|FG000|Hospital Intervention Phase|CPR administered|3|||
30931292|NCT01411852|58967164|FG001|Hospital Intervention Phase|CPR administered|1|||
30931293|NCT01411852|58967163|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
30931294|NCT01411852|58967164|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
30931295|NCT01411852|58967163|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
30931296|NCT01411852|58967164|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
30931297|NCT01411852|58967163|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
30931298|NCT01411852|58967164|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
30931299|NCT01411852|58967163|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
30931300|NCT01411852|58967164|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
30931301|NCT01411852|58967163|FG000|Hospital Intervention Phase|Other ineligible|2|||
30931302|NCT01411852|58967164|FG001|Hospital Intervention Phase|Other ineligible|2|||
30931303|NCT01411852|58967163|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
30931304|NCT01411852|58967164|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
30931305|NCT01411852|58967163|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
30931306|NCT01411852|58967164|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
30931307|NCT01411852|58967163|FG000|Hospital Intervention Phase|Vascular access failed|1|||
30931308|NCT01411852|58967164|FG001|Hospital Intervention Phase|Vascular access failed|0|||
30931309|NCT01411774|58967174|FG000|Overall Study|Withdrawal by Subject|0|||
30931310|NCT01411774|58967175|FG001|Overall Study|Withdrawal by Subject|3|||
30931311|NCT01411228|58967184|FG000|Overall Study|Lost to Follow-up|0|||
30931312|NCT01411228|58967185|FG001|Overall Study|Lost to Follow-up|0|||
30931313|NCT01411228|58967186|FG002|Overall Study|Lost to Follow-up|1|||
30931314|NCT01411228|58967184|FG000|Overall Study|Withdrawal by Subject|1|||
30931315|NCT01411228|58967185|FG001|Overall Study|Withdrawal by Subject|0|||
30931316|NCT01411228|58967186|FG002|Overall Study|Withdrawal by Subject|0|||
30931317|NCT01410604|58967196|FG000|Overall Study|Adverse Event|2|||
30839292|NCT00834717|58864549|FG001|First Intervention|Adverse Event|0|||
30839293|NCT00834717|58864548|FG000|First Intervention|Withdrawal by Subject|0|||
30931318|NCT01410604|58967197|FG001|Overall Study|Adverse Event|1|||
30931319|NCT01410604|58967196|FG000|Overall Study|Lost to Follow-up|1|||
30931320|NCT01410604|58967197|FG001|Overall Study|Lost to Follow-up|0|||
30931321|NCT01410604|58967196|FG000|Overall Study|Physician Decision|0|||
30931322|NCT01410604|58967197|FG001|Overall Study|Physician Decision|1|||
30931323|NCT01991483|58967207|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
30931324|NCT01991483|58967208|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
30931325|NCT01991483|58967209|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
30624187|NCT01135914|58636168|FG001|Overall Study|Lack of Efficacy|1|||
30931326|NCT01991483|58967210|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
30931327|NCT01991483|58967207|FG000|Dose Level 600 mg|Physician Decision|0|||
30624188|NCT01135914|58636169|FG002|Overall Study|Lack of Efficacy|10|||
30624189|NCT01135914|58636167|FG000|Overall Study|Adverse Event|0|||
30624190|NCT01135914|58636168|FG001|Overall Study|Adverse Event|1|||
30624191|NCT01135914|58636169|FG002|Overall Study|Adverse Event|2|||
30839294|NCT00834717|58864549|FG001|First Intervention|Withdrawal by Subject|1|||
30624192|NCT00907738|58636182|FG000|Overall Study|Adverse Event|2|||
30624193|NCT00907738|58636183|FG001|Overall Study|Adverse Event|0|||
30839295|NCT00834639|58864555|FG000|Second Intervention|Physician Decision|0|||
30931328|NCT01991483|58967208|FG001|Dose Level 600 mg|Physician Decision|0|||
30931329|NCT01991483|58967209|FG002|Dose Level 600 mg|Physician Decision|1|||
30931330|NCT01991483|58967210|FG003|Dose Level 600 mg|Physician Decision|0|||
30931331|NCT01991483|58967207|FG000|Dose Level 1000 mg|Protocol Violation|0|||
30931332|NCT01991483|58967208|FG001|Dose Level 1000 mg|Protocol Violation|0|||
30931333|NCT01991483|58967209|FG002|Dose Level 1000 mg|Protocol Violation|0|||
30931334|NCT01991483|58967210|FG003|Dose Level 1000 mg|Protocol Violation|1|||
30931335|NCT01410448|58967225|FG000|Overall Study|No conversion to everolimus|0|||
30931336|NCT01410448|58967226|FG001|Overall Study|No conversion to everolimus|24|||
30931337|NCT01410448|58967225|FG000|Overall Study|Graft loss|4|||
30931338|NCT01410448|58967226|FG001|Overall Study|Graft loss|1|||
30931339|NCT01410448|58967225|FG000|Overall Study|Administrative issues|2|||
30931340|NCT01410448|58967226|FG001|Overall Study|Administrative issues|1|||
30931341|NCT01410448|58967225|FG000|Overall Study|Lost to Follow-up|1|||
30931342|NCT01410448|58967226|FG001|Overall Study|Lost to Follow-up|0|||
30931343|NCT01410448|58967225|FG000|Overall Study|Withdrawal by Subject|3|||
30931344|NCT01410448|58967226|FG001|Overall Study|Withdrawal by Subject|2|||
30931345|NCT01410448|58967225|FG000|Overall Study|Protocol Violation|0|||
30931346|NCT01410448|58967226|FG001|Overall Study|Protocol Violation|4|||
30931347|NCT01410448|58967225|FG000|Overall Study|Death|2|||
30931348|NCT01410448|58967226|FG001|Overall Study|Death|3|||
30931349|NCT01943851|58967250|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30931350|NCT01943851|58967251|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30839296|NCT00834639|58864556|FG001|Second Intervention|Physician Decision|2|||
30931351|NCT01943851|58967252|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30931352|NCT01943851|58967253|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
30931353|NCT01943851|58967254|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30931354|NCT01943851|58967255|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30931355|NCT01943851|58967256|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
30931356|NCT01943851|58967257|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
30931357|NCT01943851|58967258|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
30624194|NCT00907738|58636184|FG002|Overall Study|Adverse Event|1|||
30624195|NCT00907738|58636185|FG003|Overall Study|Adverse Event|0|||
30624196|NCT00907738|58636186|FG004|Overall Study|Adverse Event|0|||
30839297|NCT00834249|58864576|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
30839298|NCT00834249|58864577|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
30839299|NCT00834249|58864576|FG000|Second Intervention|Adverse Event|1|||
30839300|NCT00834249|58864577|FG001|Second Intervention|Adverse Event|0|||
30839301|NCT00833937|58864583|FG000|Washout|Withdrawal by Subject|1|||
30839302|NCT00833937|58864584|FG001|Washout|Withdrawal by Subject|0|||
30839303|NCT00924170|58864590|FG000|Overall Study|Refused further treatment|0|||
30839304|NCT00924170|58864591|FG001|Overall Study|Refused further treatment|1|||
30839305|NCT00924170|58864590|FG000|Overall Study|Physician Decision|0|||
30839306|NCT00924170|58864591|FG001|Overall Study|Physician Decision|1|||
30839307|NCT00924170|58864590|FG000|Overall Study|Progressive disease|3|||
30839308|NCT00924170|58864591|FG001|Overall Study|Progressive disease|6|||
30839309|NCT00924170|58864590|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
30839310|NCT00924170|58864591|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
30839311|NCT00924170|58864590|FG000|Overall Study|Death|1|||
30839312|NCT00924170|58864591|FG001|Overall Study|Death|0|||
30839313|NCT00828321|58864605|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
30839314|NCT00828321|58864606|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
30839315|NCT00828321|58864605|FG000|Second Intervention|Protocol Violation|0|||
30839316|NCT00828321|58864606|FG001|Second Intervention|Protocol Violation|1|||
30839317|NCT01352715|58864612|FG000|Overall Study|Death|3|||
30839318|NCT01352715|58864613|FG001|Overall Study|Death|3|||
30839319|NCT01352715|58864612|FG000|Overall Study|Lost to Follow-up|5|||
30839320|NCT01352715|58864613|FG001|Overall Study|Lost to Follow-up|7|||
30839321|NCT01352715|58864612|FG000|Overall Study|Withdrawal by Subject|4|||
30839322|NCT01352715|58864613|FG001|Overall Study|Withdrawal by Subject|8|||
30839323|NCT01352715|58864612|FG000|Overall Study|site closure|16|||
30839324|NCT01352715|58864613|FG001|Overall Study|site closure|15|||
30839325|NCT01352715|58864612|FG000|Overall Study|no final visit in closeout period|15|||
30839326|NCT01352715|58864613|FG001|Overall Study|no final visit in closeout period|12|||
30839327|NCT01352715|58864612|FG000|Overall Study|major ineligibility|2|||
30839328|NCT01352715|58864613|FG001|Overall Study|major ineligibility|1|||
30839329|NCT00919893|58864624|FG000|Overall Study|Protocol Violation|19|||
30931358|NCT01943851|58967259|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30931359|NCT01943851|58967260|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30931360|NCT01943851|58967261|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30931361|NCT01943851|58967262|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30931362|NCT01943851|58967263|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30931363|NCT01943851|58967264|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30839330|NCT00919893|58864625|FG001|Overall Study|Protocol Violation|9|||
30931364|NCT01943851|58967265|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30839331|NCT02559622|58864633|FG000|Overall Study|Progressive disease|0|||
30839332|NCT02559622|58864634|FG001|Overall Study|Progressive disease|1|||
30839333|NCT02559622|58864635|FG002|Overall Study|Progressive disease|0|||
30839334|NCT02559622|58864636|FG003|Overall Study|Progressive disease|0|||
30839335|NCT02559622|58864633|FG000|Overall Study|Adverse Event|0|||
30839336|NCT02559622|58864634|FG001|Overall Study|Adverse Event|2|||
30839337|NCT02559622|58864635|FG002|Overall Study|Adverse Event|2|||
30839338|NCT02559622|58864636|FG003|Overall Study|Adverse Event|2|||
30839339|NCT02559622|58864633|FG000|Overall Study|Patient/guardian decision|1|||
30839340|NCT02559622|58864634|FG001|Overall Study|Patient/guardian decision|2|||
30839341|NCT02559622|58864635|FG002|Overall Study|Patient/guardian decision|0|||
30839342|NCT02559622|58864636|FG003|Overall Study|Patient/guardian decision|1|||
30839343|NCT02559310|58864652|FG000|Overall Study|Death|4|||
30839344|NCT02559310|58864653|FG001|Overall Study|Death|3|||
30839345|NCT02559310|58864652|FG000|Overall Study|Lost to Follow-up|5|||
30839346|NCT02559310|58864653|FG001|Overall Study|Lost to Follow-up|3|||
30839347|NCT02559310|58864652|FG000|Overall Study|Physician Decision|2|||
30839348|NCT02559310|58864653|FG001|Overall Study|Physician Decision|1|||
30931365|NCT01943851|58967266|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30931366|NCT01943851|58967267|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
30931367|NCT01943851|58967250|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931368|NCT01943851|58967251|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931369|NCT01943851|58967252|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931370|NCT01943851|58967253|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931371|NCT01943851|58967254|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
30931372|NCT01943851|58967255|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931373|NCT01943851|58967256|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931374|NCT01943851|58967257|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
30931375|NCT01943851|58967258|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931376|NCT01943851|58967259|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931377|NCT01943851|58967260|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931378|NCT01943851|58967261|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931379|NCT01943851|58967262|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931380|NCT01943851|58967263|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931381|NCT01943851|58967264|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30839349|NCT02559310|58864652|FG000|Overall Study|Withdrawal by Subject|13|||
30839350|NCT02559310|58864653|FG001|Overall Study|Withdrawal by Subject|9|||
30839351|NCT02559310|58864652|FG000|Overall Study|Sponsor Decision|0|||
30839352|NCT02559310|58864653|FG001|Overall Study|Sponsor Decision|1|||
30839353|NCT02559310|58864652|FG000|Overall Study|Randomized but not treated|3|||
30839354|NCT02559310|58864653|FG001|Overall Study|Randomized but not treated|2|||
30839355|NCT03517449|58864661|FG000|Overall Study|Death|184|||
30839356|NCT03517449|58864662|FG001|Overall Study|Death|236|||
30839357|NCT03517449|58864661|FG000|Overall Study|Lost to Follow-up|0|||
30839358|NCT03517449|58864662|FG001|Overall Study|Lost to Follow-up|2|||
30839359|NCT03517449|58864661|FG000|Overall Study|Withdrawal by Subject|7|||
30839360|NCT03517449|58864662|FG001|Overall Study|Withdrawal by Subject|26|||
30839361|NCT03517449|58864661|FG000|Overall Study|Participants Ongoing|220|||
30839362|NCT03517449|58864662|FG001|Overall Study|Participants Ongoing|152|||
30839363|NCT02555878|58864670|FG000|Overall Study|Lost to Follow-up|2|||
30931382|NCT01943851|58967265|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931383|NCT01943851|58967266|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931384|NCT01943851|58967267|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
30931385|NCT01943851|58967250|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931386|NCT01943851|58967251|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931387|NCT01943851|58967252|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931388|NCT01943851|58967253|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931389|NCT01943851|58967254|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931390|NCT01943851|58967255|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931391|NCT01943851|58967256|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931392|NCT01943851|58967257|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931393|NCT01943851|58967258|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931394|NCT01943851|58967259|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931395|NCT01943851|58967260|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931396|NCT01943851|58967261|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931397|NCT01943851|58967262|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931398|NCT01943851|58967263|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
30931399|NCT01943851|58967264|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931400|NCT01943851|58967265|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30839364|NCT02555878|58864671|FG001|Overall Study|Lost to Follow-up|3|||
30839365|NCT02555878|58864670|FG000|Overall Study|Withdrawal by Subject|48|||
30839366|NCT02555878|58864671|FG001|Overall Study|Withdrawal by Subject|48|||
30839367|NCT02555878|58864670|FG000|Overall Study|Adverse Event|12|||
30839368|NCT02555878|58864671|FG001|Overall Study|Adverse Event|8|||
30839369|NCT02555878|58864670|FG000|Overall Study|Death|74|||
30931401|NCT01943851|58967266|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931402|NCT01943851|58967267|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
30931403|NCT01943851|58967250|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931404|NCT01943851|58967251|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931405|NCT01943851|58967252|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931406|NCT01943851|58967253|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931407|NCT01943851|58967254|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931408|NCT01943851|58967255|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931409|NCT01943851|58967256|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931410|NCT01943851|58967257|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931411|NCT01943851|58967258|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931412|NCT01943851|58967259|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931413|NCT01943851|58967260|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931414|NCT01943851|58967261|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931415|NCT01943851|58967262|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931416|NCT01943851|58967263|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931417|NCT01943851|58967264|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931418|NCT01943851|58967265|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
30931419|NCT01943851|58967266|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931420|NCT01943851|58967267|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
30931421|NCT01943851|58967250|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931422|NCT01943851|58967251|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931423|NCT01943851|58967252|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931424|NCT01943851|58967253|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931425|NCT01943851|58967254|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931426|NCT01943851|58967255|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931427|NCT01943851|58967256|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931428|NCT01943851|58967257|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931429|NCT01943851|58967258|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931430|NCT01943851|58967259|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931431|NCT01943851|58967260|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931432|NCT01943851|58967261|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931433|NCT01943851|58967262|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931434|NCT01943851|58967263|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931435|NCT01943851|58967264|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
30931436|NCT01943851|58967265|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
30931437|NCT01943851|58967266|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
30931438|NCT01943851|58967267|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
30931439|NCT01430104|58967308|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
30931440|NCT01990859|58967315|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
30931441|NCT01990859|58967315|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
30931442|NCT02093897|58967320|FG000|Overall Study|Physician Decision|1|||
30931443|NCT02093897|58967320|FG000|Overall Study|Planned age group closure - no's reached|17|||
30931444|NCT02093897|58967320|FG000|Overall Study|Adverse event, non-fatal|1|||
30839370|NCT02555878|58864671|FG001|Overall Study|Death|59|||
30839371|NCT02555878|58864670|FG000|Overall Study|Protocol Violation|1|||
30839372|NCT02555878|58864671|FG001|Overall Study|Protocol Violation|2|||
30839373|NCT02555878|58864670|FG000|Overall Study|Physician Decision|12|||
30839374|NCT02555878|58864671|FG001|Overall Study|Physician Decision|13|||
30839375|NCT02555878|58864670|FG000|Overall Study|Other|17|||
30839376|NCT02555878|58864671|FG001|Overall Study|Other|17|||
30839377|NCT02555722|58864679|FG000|Week 2|Adverse Event|0|||
30839378|NCT02555722|58864680|FG001|Week 2|Adverse Event|1|||
30839379|NCT02555722|58864679|FG000|Week 2|Withdrawal by Subject|1|||
30839380|NCT02555722|58864680|FG001|Week 2|Withdrawal by Subject|0|||
30839381|NCT02555722|58864679|FG000|Month 1|Lens Discomfort|1|||
30839382|NCT02555722|58864680|FG001|Month 1|Lens Discomfort|0|||
30839383|NCT02555722|58864679|FG000|Month 2|Withdrawal by Subject|3|||
30839384|NCT02555722|58864680|FG001|Month 2|Withdrawal by Subject|0|||
30839385|NCT02555722|58864679|FG000|Month 2|Lost to Follow-up|1|||
30839386|NCT02555722|58864680|FG001|Month 2|Lost to Follow-up|0|||
30931445|NCT01990313|58967331|FG000|Overall Study|Lost to Follow-up|1|||
30931446|NCT01947517|58967337|FG000|Overall Study|Withdrawal by Subject|1|||
30931447|NCT01947517|58967338|FG001|Overall Study|Withdrawal by Subject|1|||
30931448|NCT02006927|58967344|FG000|Overall Study|Adverse Event|2|||
30931449|NCT02006927|58967344|FG000|Overall Study|Withdrawal by Subject|1|||
30839387|NCT03287960|58864732|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
30931450|NCT01947283|58967355|FG000|Overall Study|Death|1|||
30839388|NCT03287960|58864732|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
30839389|NCT02558296|58864739|FG000|Completed the Study Through Week 24|Adverse Event|9|||
30839390|NCT02558296|58864740|FG001|Completed the Study Through Week 24|Adverse Event|3|||
30931451|NCT01947283|58967356|FG001|Overall Study|Death|1|||
30931452|NCT01947283|58967357|FG002|Overall Study|Death|1|||
30931453|NCT01947283|58967358|FG003|Overall Study|Death|0|||
30931454|NCT01947283|58967359|FG004|Overall Study|Death|0|||
30931455|NCT01947283|58967360|FG005|Overall Study|Death|0|||
30931456|NCT01947283|58967361|FG006|Overall Study|Death|0|||
30931457|NCT01947283|58967355|FG000|Overall Study|Lost to Follow-up|4|||
30758119|NCT00112437|58766943|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758120|NCT00112437|58766944|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758121|NCT00112437|58766945|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758122|NCT00112437|58766946|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
30758123|NCT00112437|58766921|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758124|NCT00112437|58766922|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758125|NCT00112437|58766923|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758126|NCT00112437|58766924|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758127|NCT00112437|58766925|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758128|NCT00112437|58766926|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758129|NCT00112437|58766927|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758130|NCT00112437|58766928|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758131|NCT00112437|58766929|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758132|NCT00112437|58766930|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758133|NCT00112437|58766931|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758134|NCT00112437|58766932|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758135|NCT00112437|58766933|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758136|NCT00112437|58766934|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758137|NCT00112437|58766935|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758138|NCT00112437|58766936|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758139|NCT00112437|58766937|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758140|NCT00112437|58766938|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758141|NCT00112437|58766939|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758142|NCT00112437|58766940|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758143|NCT00112437|58766941|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758144|NCT00112437|58766942|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
30931458|NCT01947283|58967356|FG001|Overall Study|Lost to Follow-up|6|||
30931459|NCT01947283|58967357|FG002|Overall Study|Lost to Follow-up|5|||
30931460|NCT01947283|58967358|FG003|Overall Study|Lost to Follow-up|5|||
30931461|NCT01947283|58967359|FG004|Overall Study|Lost to Follow-up|0|||
30931462|NCT01947283|58967360|FG005|Overall Study|Lost to Follow-up|2|||
30931463|NCT01947283|58967361|FG006|Overall Study|Lost to Follow-up|5|||
30931464|NCT01947283|58967355|FG000|Overall Study|Withdrawal by Subject|10|||
30931465|NCT01947283|58967356|FG001|Overall Study|Withdrawal by Subject|8|||
30931466|NCT01947283|58967357|FG002|Overall Study|Withdrawal by Subject|4|||
30931467|NCT01947283|58967358|FG003|Overall Study|Withdrawal by Subject|1|||
30931468|NCT01947283|58967359|FG004|Overall Study|Withdrawal by Subject|0|||
30931469|NCT01947283|58967360|FG005|Overall Study|Withdrawal by Subject|0|||
30931470|NCT01947283|58967361|FG006|Overall Study|Withdrawal by Subject|2|||
30931471|NCT01947283|58967355|FG000|Overall Study|No Clinical Recording|12|||
30931472|NCT01947283|58967356|FG001|Overall Study|No Clinical Recording|6|||
30931473|NCT01947283|58967357|FG002|Overall Study|No Clinical Recording|8|||
30931474|NCT01947283|58967358|FG003|Overall Study|No Clinical Recording|10|||
30931475|NCT01947283|58967359|FG004|Overall Study|No Clinical Recording|0|||
30931476|NCT01947283|58967360|FG005|Overall Study|No Clinical Recording|0|||
30624197|NCT00907738|58636182|FG000|Overall Study|not specified or withdrew consent|3|||
30624198|NCT00907738|58636183|FG001|Overall Study|not specified or withdrew consent|0|||
30758145|NCT00112437|58766943|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758146|NCT00112437|58766944|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758147|NCT00112437|58766945|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758148|NCT00112437|58766946|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
30758149|NCT00112437|58766921|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758150|NCT00112437|58766922|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758151|NCT00112437|58766923|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758152|NCT00112437|58766924|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758153|NCT00112437|58766925|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30931477|NCT01947283|58967361|FG006|Overall Study|No Clinical Recording|0|||
30931478|NCT01947283|58967355|FG000|Overall Study|Non-coding Clinical Recording language|0|||
30931479|NCT01947283|58967356|FG001|Overall Study|Non-coding Clinical Recording language|0|||
30931480|NCT01947283|58967357|FG002|Overall Study|Non-coding Clinical Recording language|0|||
30931481|NCT01947283|58967358|FG003|Overall Study|Non-coding Clinical Recording language|1|||
30931482|NCT01947283|58967359|FG004|Overall Study|Non-coding Clinical Recording language|0|||
30931483|NCT01947283|58967360|FG005|Overall Study|Non-coding Clinical Recording language|0|||
30931484|NCT01947283|58967361|FG006|Overall Study|Non-coding Clinical Recording language|0|||
30931485|NCT01947283|58967355|FG000|Overall Study|Missing Follow-up Assessment|2|||
30931486|NCT01947283|58967356|FG001|Overall Study|Missing Follow-up Assessment|2|||
30931487|NCT01947283|58967357|FG002|Overall Study|Missing Follow-up Assessment|3|||
30931488|NCT01947283|58967358|FG003|Overall Study|Missing Follow-up Assessment|0|||
30931489|NCT01947283|58967359|FG004|Overall Study|Missing Follow-up Assessment|0|||
30758154|NCT00112437|58766926|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758155|NCT00112437|58766927|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758156|NCT00112437|58766928|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30931490|NCT01947283|58967360|FG005|Overall Study|Missing Follow-up Assessment|2|||
30931491|NCT01947283|58967361|FG006|Overall Study|Missing Follow-up Assessment|0|||
30931492|NCT01947283|58967355|FG000|Overall Study|No patients were enrolled in study|0|||
30931493|NCT01947283|58967356|FG001|Overall Study|No patients were enrolled in study|0|||
30931494|NCT01947283|58967357|FG002|Overall Study|No patients were enrolled in study|0|||
30931495|NCT01947283|58967358|FG003|Overall Study|No patients were enrolled in study|0|||
30931496|NCT01947283|58967359|FG004|Overall Study|No patients were enrolled in study|0|||
30931497|NCT01947283|58967360|FG005|Overall Study|No patients were enrolled in study|3|||
30931498|NCT01947283|58967361|FG006|Overall Study|No patients were enrolled in study|1|||
30931499|NCT02006693|58967380|FG000|Overall Study|No Reason Specified|6|||
30931500|NCT02006693|58967381|FG001|Overall Study|No Reason Specified|8|||
30931501|NCT02006693|58967380|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
30931502|NCT02006693|58967381|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
30931503|NCT02006693|58967380|FG000|Overall Study|XEN Implant Explantation|0|||
30931504|NCT02006693|58967381|FG001|Overall Study|XEN Implant Explantation|1|||
30931505|NCT02006693|58967380|FG000|Overall Study|Death|2|||
30931506|NCT02006693|58967381|FG001|Overall Study|Death|2|||
30931507|NCT02006693|58967380|FG000|Overall Study|Lost to Follow-up|4|||
30931508|NCT02006693|58967381|FG001|Overall Study|Lost to Follow-up|1|||
30931509|NCT02006693|58967380|FG000|Overall Study|Patient Decision|4|||
30931510|NCT02006693|58967381|FG001|Overall Study|Patient Decision|0|||
30931511|NCT01947127|58967389|FG000|Overall Study|Protocol Violation|18|||
30931512|NCT01947127|58967390|FG001|Overall Study|Protocol Violation|38|||
30931513|NCT01947127|58967389|FG000|Overall Study|Withdrawal by Subject|1|||
30931514|NCT01947127|58967390|FG001|Overall Study|Withdrawal by Subject|1|||
30931515|NCT01947127|58967389|FG000|Overall Study|Data loss|4|||
30931516|NCT01947127|58967390|FG001|Overall Study|Data loss|4|||
30931517|NCT01976845|58967399|FG000|Overall Study|Physician Decision|8|||
30931518|NCT01976845|58967400|FG001|Overall Study|Physician Decision|8|||
30931519|NCT01976845|58967401|FG002|Overall Study|Physician Decision|3|||
30931520|NCT01989689|58967411|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
30839391|NCT02558296|58864739|FG000|Completed the Study Through Week 24|Death|7|||
30839392|NCT02558296|58864740|FG001|Completed the Study Through Week 24|Death|7|||
30839393|NCT02558296|58864739|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
30931521|NCT01989689|58967412|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
30931522|NCT01989689|58967411|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
30931523|NCT01989689|58967412|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
30931524|NCT01943539|58967420|FG000|Overall Study|Non-compliance with at-home intervention|4|||
30758157|NCT00112437|58766929|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758158|NCT00112437|58766930|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758159|NCT00112437|58766931|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758160|NCT00112437|58766932|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758161|NCT00112437|58766933|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758162|NCT00112437|58766934|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30931525|NCT01943539|58967421|FG001|Overall Study|Non-compliance with at-home intervention|0|||
30931526|NCT01942993|58967428|FG000|Overall Study|Lost to Follow-up|1|||
30931527|NCT01942993|58967428|FG000|Overall Study|Physician Decision|1|||
30624199|NCT00907738|58636184|FG002|Overall Study|not specified or withdrew consent|0|||
30758163|NCT00112437|58766935|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30931528|NCT01989455|58967437|FG000|Overall Study|Adverse Event|0|||
30931529|NCT01989455|58967438|FG001|Overall Study|Adverse Event|1|||
30931530|NCT01989455|58967439|FG002|Overall Study|Adverse Event|0|||
30931531|NCT01989455|58967440|FG003|Overall Study|Adverse Event|0|||
30931532|NCT01989455|58967441|FG004|Overall Study|Adverse Event|0|||
30931533|NCT01989455|58967437|FG000|Overall Study|Withdrawal by Subject|0|||
30931534|NCT01989455|58967438|FG001|Overall Study|Withdrawal by Subject|1|||
30931535|NCT01989455|58967439|FG002|Overall Study|Withdrawal by Subject|0|||
30931536|NCT01989455|58967440|FG003|Overall Study|Withdrawal by Subject|0|||
30931537|NCT01989455|58967441|FG004|Overall Study|Withdrawal by Subject|0|||
30931538|NCT01989455|58967437|FG000|Overall Study|Technical problems with infusion|0|||
30931539|NCT01989455|58967438|FG001|Overall Study|Technical problems with infusion|0|||
30931540|NCT01989455|58967439|FG002|Overall Study|Technical problems with infusion|1|||
30931541|NCT01989455|58967440|FG003|Overall Study|Technical problems with infusion|0|||
30931542|NCT01989455|58967441|FG004|Overall Study|Technical problems with infusion|1|||
30931543|NCT01942837|58967457|FG000|Overall Study|Death|1|||
30931544|NCT01942837|58967457|FG000|Overall Study|Symptomatic or radiographic progression|49|||
30931545|NCT01942837|58967457|FG000|Overall Study|Adverse Event|6|||
30931546|NCT01942837|58967457|FG000|Overall Study|Physician Decision|3|||
30931547|NCT01942837|58967457|FG000|Overall Study|Withdrawal by Subject|2|||
30931548|NCT01942837|58967457|FG000|Overall Study|Intercurrent Illness|1|||
30931549|NCT01942837|58967457|FG000|Overall Study|On treatment|3|||
30931550|NCT01942837|58967457|FG000|Overall Study|Never initiate the treatment|2|||
30931551|NCT01987895|58967464|FG000|Overall Study|Withdrawal by Subject|12|||
30931552|NCT01987895|58967465|FG001|Overall Study|Withdrawal by Subject|7|||
30931553|NCT01987895|58967464|FG000|Overall Study|Physician Decision|8|||
30931554|NCT01987895|58967465|FG001|Overall Study|Physician Decision|10|||
30931555|NCT01987895|58967464|FG000|Overall Study|Death|7|||
30931556|NCT01987895|58967465|FG001|Overall Study|Death|7|||
30931557|NCT01987895|58967464|FG000|Overall Study|Lost to Follow-up|3|||
30931558|NCT01987895|58967465|FG001|Overall Study|Lost to Follow-up|5|||
30931559|NCT01987895|58967464|FG000|Overall Study|randomized before giving IC|0|||
30931560|NCT01987895|58967465|FG001|Overall Study|randomized before giving IC|1|||
30931561|NCT02005445|58967473|FG000|Overall Study|Dual study enrollment|0|||
30931562|NCT02005445|58967474|FG001|Overall Study|Dual study enrollment|1|||
30931563|NCT01618669|58967482|FG000|Overall Study|Lost to Follow-up|1|||
30931564|NCT01618669|58967483|FG001|Overall Study|Lost to Follow-up|1|||
30931565|NCT01618669|58967482|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
30931566|NCT01618669|58967483|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
30931567|NCT01618669|58967482|FG000|Overall Study|Adverse Event|16|||
30931568|NCT01618669|58967483|FG001|Overall Study|Adverse Event|7|||
30931569|NCT01618669|58967482|FG000|Overall Study|Protocol Violation|5|||
30931570|NCT01618669|58967483|FG001|Overall Study|Protocol Violation|3|||
30839394|NCT02558296|58864740|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
30931571|NCT01618669|58967482|FG000|Overall Study|Withdrawal by Subject|9|||
30931572|NCT01618669|58967483|FG001|Overall Study|Withdrawal by Subject|9|||
30931573|NCT01618669|58967482|FG000|Overall Study|Miscellaneous Reason|0|||
30931574|NCT01618669|58967483|FG001|Overall Study|Miscellaneous Reason|1|||
30931575|NCT01390948|58967504|FG000|Overall Study|End of Study|1|||
30931576|NCT01390948|58967505|FG001|Overall Study|End of Study|0|||
30931577|NCT01390948|58967506|FG002|Overall Study|End of Study|0|||
30931578|NCT01390948|58967504|FG000|Overall Study|Withdrew consent|2|||
30931579|NCT01390948|58967505|FG001|Overall Study|Withdrew consent|2|||
30839395|NCT02558296|58864739|FG000|Completed the Study Through Week 24|Physician Decision|1|||
30839396|NCT02558296|58864740|FG001|Completed the Study Through Week 24|Physician Decision|0|||
30931580|NCT01390948|58967506|FG002|Overall Study|Withdrew consent|0|||
30931581|NCT01390948|58967504|FG000|Overall Study|Progressive Disease|2|||
30931582|NCT01390948|58967505|FG001|Overall Study|Progressive Disease|5|||
30931583|NCT01390948|58967506|FG002|Overall Study|Progressive Disease|0|||
30931584|NCT01390948|58967504|FG000|Overall Study|Death during follow-up|10|||
30931585|NCT01390948|58967505|FG001|Overall Study|Death during follow-up|11|||
30931586|NCT01390948|58967506|FG002|Overall Study|Death during follow-up|1|||
30758164|NCT00112437|58766936|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758165|NCT00112437|58766937|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758166|NCT00112437|58766938|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758167|NCT00112437|58766939|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758168|NCT00112437|58766940|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758169|NCT00112437|58766941|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
30758170|NCT00112437|58766942|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
30758171|NCT00112437|58766943|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758172|NCT00112437|58766944|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758173|NCT00112437|58766945|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758174|NCT00112437|58766946|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
30758175|NCT00112437|58766921|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30931587|NCT02005211|58967520|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
30931588|NCT02005211|58967521|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
30931589|NCT02005211|58967522|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
30931590|NCT02005211|58967523|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
30931591|NCT02005211|58967524|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
30931592|NCT02005211|58967525|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
30931593|NCT02005211|58967526|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
30931594|NCT01429792|58967549|FG000|Overall Study|Other Reasons|67|||
30931595|NCT01429792|58967549|FG000|Overall Study|Unknown Disposition|94|||
30931596|NCT01429792|58967549|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
30931597|NCT01429792|58967549|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
30931598|NCT01429792|58967549|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
30931599|NCT01429792|58967549|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
30931600|NCT01429792|58967549|FG000|Overall Study|Withdrawal by Subject|70|||
30931601|NCT01429792|58967549|FG000|Overall Study|Lost to Follow-up|88|||
30931602|NCT01409434|58967553|FG000|Overall Study|Protocol Violation|4|||
30931603|NCT01940887|58967559|FG000|Year 1|Protocol Violation|0|||
30931604|NCT01940887|58967560|FG001|Year 1|Protocol Violation|1|||
30931605|NCT01940887|58967559|FG000|Year 1|Physician Decision|7|||
30931606|NCT01940887|58967560|FG001|Year 1|Physician Decision|3|||
30931607|NCT01940887|58967559|FG000|Year 1|Death|5|||
30931608|NCT01940887|58967560|FG001|Year 1|Death|3|||
30931609|NCT01940887|58967559|FG000|Year 1|Adverse Event|7|||
30931610|NCT01940887|58967560|FG001|Year 1|Adverse Event|6|||
30931611|NCT01940887|58967559|FG000|Year 1|Withdrawal by Subject|18|||
30931612|NCT01940887|58967560|FG001|Year 1|Withdrawal by Subject|9|||
30931613|NCT01940887|58967559|FG000|Year 1|Lost to Follow-up|2|||
30931614|NCT01940887|58967560|FG001|Year 1|Lost to Follow-up|1|||
30931615|NCT01940887|58967559|FG000|Year 2|Physician Decision|8|||
30931616|NCT01940887|58967560|FG001|Year 2|Physician Decision|1|||
30931617|NCT01940887|58967559|FG000|Year 2|Death|0|||
30931618|NCT01940887|58967560|FG001|Year 2|Death|2|||
30931619|NCT01940887|58967559|FG000|Year 2|Sponsor Decision, early termination|192|||
30931620|NCT01940887|58967560|FG001|Year 2|Sponsor Decision, early termination|203|||
30758176|NCT00112437|58766922|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758177|NCT00112437|58766923|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758178|NCT00112437|58766924|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758179|NCT00112437|58766925|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758180|NCT00112437|58766926|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758181|NCT00112437|58766927|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758182|NCT00112437|58766928|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758183|NCT00112437|58766929|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758184|NCT00112437|58766930|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758185|NCT00112437|58766931|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758186|NCT00112437|58766932|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758187|NCT00112437|58766933|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758188|NCT00112437|58766934|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758189|NCT00112437|58766935|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758190|NCT00112437|58766936|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758191|NCT00112437|58766937|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758192|NCT00112437|58766938|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758193|NCT00112437|58766939|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758194|NCT00112437|58766940|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758195|NCT00112437|58766941|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758196|NCT00112437|58766942|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30758197|NCT00112437|58766943|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
30758198|NCT00112437|58766944|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
30839397|NCT02558296|58864739|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
30839398|NCT02558296|58864740|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
30839399|NCT02558296|58864739|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
30839400|NCT02558296|58864740|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
30839401|NCT02558296|58864739|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
30839402|NCT02558296|58864740|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
30931621|NCT01940887|58967559|FG000|Year 2|Adverse Event|8|||
30931622|NCT01940887|58967560|FG001|Year 2|Adverse Event|2|||
30931623|NCT01940887|58967559|FG000|Year 2|Withdrawal by Subject|8|||
30758199|NCT00112437|58766945|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
30931624|NCT01940887|58967560|FG001|Year 2|Withdrawal by Subject|8|||
30931625|NCT01940887|58967559|FG000|Year 2|Lost to Follow-up|1|||
30931626|NCT01940887|58967560|FG001|Year 2|Lost to Follow-up|6|||
30931627|NCT01925612|58967571|FG000|Overall Study|Progressive Disease|1|||
30931628|NCT01925612|58967572|FG001|Overall Study|Progressive Disease|1|||
30931629|NCT01925612|58967573|FG002|Overall Study|Progressive Disease|1|||
30931630|NCT01925612|58967574|FG003|Overall Study|Progressive Disease|0|||
30931631|NCT01925612|58967575|FG004|Overall Study|Progressive Disease|0|||
30931632|NCT01925612|58967571|FG000|Overall Study|Adverse Event|3|||
30931633|NCT01925612|58967572|FG001|Overall Study|Adverse Event|3|||
30931634|NCT01925612|58967573|FG002|Overall Study|Adverse Event|0|||
30931635|NCT01925612|58967574|FG003|Overall Study|Adverse Event|1|||
30931636|NCT01925612|58967575|FG004|Overall Study|Adverse Event|2|||
30931637|NCT02093663|58967587|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
30839403|NCT02558296|58864739|FG000|Completed the Study|Adverse Event|14|||
30839404|NCT02558296|58864740|FG001|Completed the Study|Adverse Event|5|||
30839405|NCT02558296|58864739|FG000|Completed the Study|Death|39|||
30839406|NCT02558296|58864740|FG001|Completed the Study|Death|25|||
30839407|NCT02558296|58864739|FG000|Completed the Study|Lost to Follow-up|31|||
30839408|NCT02558296|58864740|FG001|Completed the Study|Lost to Follow-up|23|||
30839409|NCT02558296|58864739|FG000|Completed the Study|Physician Decision|6|||
30839410|NCT02558296|58864740|FG001|Completed the Study|Physician Decision|0|||
30839411|NCT02558296|58864739|FG000|Completed the Study|Protocol Violation|2|||
30839412|NCT02558296|58864740|FG001|Completed the Study|Protocol Violation|1|||
30839413|NCT02558296|58864739|FG000|Completed the Study|Withdrawal by Subject|53|||
30839414|NCT02558296|58864740|FG001|Completed the Study|Withdrawal by Subject|31|||
30839415|NCT02558296|58864739|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
30839416|NCT02558296|58864740|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
30839417|NCT02737475|58864777|FG000|Overall Study|Other reasons|0|||
30839418|NCT02737475|58864778|FG001|Overall Study|Other reasons|0|||
30839419|NCT02737475|58864779|FG002|Overall Study|Other reasons|0|||
30839420|NCT02737475|58864780|FG003|Overall Study|Other reasons|0|||
30839421|NCT02737475|58864781|FG004|Overall Study|Other reasons|1|||
30839422|NCT02737475|58864782|FG005|Overall Study|Other reasons|1|||
30839423|NCT02737475|58864783|FG006|Overall Study|Other reasons|0|||
30839424|NCT02737475|58864784|FG007|Overall Study|Other reasons|0|||
30839425|NCT02737475|58864785|FG008|Overall Study|Other reasons|1|||
30839426|NCT02737475|58864786|FG009|Overall Study|Other reasons|0|||
30839427|NCT02737475|58864787|FG010|Overall Study|Other reasons|1|||
30839428|NCT02737475|58864788|FG011|Overall Study|Other reasons|0|||
30839429|NCT02737475|58864789|FG012|Overall Study|Other reasons|0|||
30839430|NCT02737475|58864790|FG013|Overall Study|Other reasons|0|||
30839431|NCT02737475|58864791|FG014|Overall Study|Other reasons|0|||
30839432|NCT02737475|58864792|FG015|Overall Study|Other reasons|0|||
30839433|NCT02737475|58864793|FG016|Overall Study|Other reasons|0|||
30839434|NCT02737475|58864794|FG017|Overall Study|Other reasons|0|||
30839435|NCT02737475|58864795|FG018|Overall Study|Other reasons|0|||
30839436|NCT02737475|58864796|FG019|Overall Study|Other reasons|0|||
30839437|NCT02737475|58864797|FG020|Overall Study|Other reasons|0|||
30839438|NCT02737475|58864798|FG021|Overall Study|Other reasons|1|||
30839439|NCT02737475|58864799|FG022|Overall Study|Other reasons|0|||
30839440|NCT02737475|58864800|FG023|Overall Study|Other reasons|1|||
30839441|NCT02737475|58864801|FG024|Overall Study|Other reasons|1|||
30839442|NCT02737475|58864802|FG025|Overall Study|Other reasons|1|||
30839443|NCT02737475|58864803|FG026|Overall Study|Other reasons|0|||
30839444|NCT02737475|58864777|FG000|Overall Study|Death|1|||
30839445|NCT02737475|58864778|FG001|Overall Study|Death|0|||
30839446|NCT02737475|58864779|FG002|Overall Study|Death|0|||
30839447|NCT02737475|58864780|FG003|Overall Study|Death|1|||
30839448|NCT02737475|58864781|FG004|Overall Study|Death|0|||
30839449|NCT02737475|58864782|FG005|Overall Study|Death|0|||
30839450|NCT02737475|58864783|FG006|Overall Study|Death|0|||
30839451|NCT02737475|58864784|FG007|Overall Study|Death|2|||
30839452|NCT02737475|58864785|FG008|Overall Study|Death|0|||
30839453|NCT02737475|58864786|FG009|Overall Study|Death|0|||
30839454|NCT02737475|58864787|FG010|Overall Study|Death|0|||
30839455|NCT02737475|58864788|FG011|Overall Study|Death|4|||
30839456|NCT02737475|58864789|FG012|Overall Study|Death|2|||
30839457|NCT02737475|58864790|FG013|Overall Study|Death|2|||
30839458|NCT02737475|58864791|FG014|Overall Study|Death|0|||
30839459|NCT02737475|58864792|FG015|Overall Study|Death|2|||
30839460|NCT02737475|58864793|FG016|Overall Study|Death|2|||
30839461|NCT02737475|58864794|FG017|Overall Study|Death|2|||
30839462|NCT02737475|58864795|FG018|Overall Study|Death|1|||
30839463|NCT02737475|58864796|FG019|Overall Study|Death|0|||
30839464|NCT02737475|58864797|FG020|Overall Study|Death|0|||
30839465|NCT02737475|58864798|FG021|Overall Study|Death|0|||
30839466|NCT02737475|58864799|FG022|Overall Study|Death|0|||
30839467|NCT02737475|58864800|FG023|Overall Study|Death|0|||
30839468|NCT02737475|58864801|FG024|Overall Study|Death|0|||
30839469|NCT02737475|58864802|FG025|Overall Study|Death|0|||
30839470|NCT02737475|58864803|FG026|Overall Study|Death|0|||
30839471|NCT02737475|58864777|FG000|Overall Study|Participant withdrew consent|0|||
30839472|NCT02737475|58864778|FG001|Overall Study|Participant withdrew consent|0|||
30839473|NCT02737475|58864779|FG002|Overall Study|Participant withdrew consent|0|||
30931638|NCT02093663|58967588|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
30931639|NCT02093663|58967589|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
30931640|NCT02093663|58967590|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
30931641|NCT02093663|58967591|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
30931642|NCT02093663|58967587|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
30931643|NCT02093663|58967588|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
30931644|NCT02093663|58967589|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
30931645|NCT02093663|58967590|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
30931646|NCT02093663|58967591|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
30931647|NCT02093663|58967587|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
30931648|NCT02093663|58967588|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
30931649|NCT02093663|58967589|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
30931650|NCT02093663|58967590|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
30931651|NCT02093663|58967591|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
30931652|NCT02093663|58967587|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
30931653|NCT02093663|58967588|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
30931654|NCT02093663|58967589|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
30931655|NCT02093663|58967590|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
30931656|NCT02093663|58967591|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
30931657|NCT02093663|58967587|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
30931658|NCT02093663|58967588|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
30931659|NCT02093663|58967589|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
30931660|NCT02093663|58967590|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
30931661|NCT02093663|58967591|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
30931662|NCT02093663|58967587|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
30931663|NCT02093663|58967588|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
30931664|NCT02093663|58967589|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
30931665|NCT02093663|58967590|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
30931666|NCT02093663|58967591|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
30931667|NCT02093663|58967587|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
30931668|NCT02093663|58967588|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
30931669|NCT02093663|58967589|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
30931670|NCT02093663|58967590|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
30931671|NCT02093663|58967591|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
30931672|NCT02093663|58967587|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
30931673|NCT02093663|58967588|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
30931674|NCT02093663|58967589|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
30931675|NCT02093663|58967590|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
30931676|NCT02093663|58967591|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
30931677|NCT02093663|58967587|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
30931678|NCT02093663|58967588|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
30931679|NCT02093663|58967589|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
30931680|NCT02093663|58967590|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
30931681|NCT02093663|58967591|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
30839474|NCT02737475|58864780|FG003|Overall Study|Participant withdrew consent|0|||
30839475|NCT02737475|58864781|FG004|Overall Study|Participant withdrew consent|0|||
30839476|NCT02737475|58864782|FG005|Overall Study|Participant withdrew consent|2|||
30839477|NCT02737475|58864783|FG006|Overall Study|Participant withdrew consent|0|||
30839478|NCT02737475|58864784|FG007|Overall Study|Participant withdrew consent|0|||
30839479|NCT02737475|58864785|FG008|Overall Study|Participant withdrew consent|0|||
30839480|NCT02737475|58864786|FG009|Overall Study|Participant withdrew consent|0|||
30839481|NCT02737475|58864787|FG010|Overall Study|Participant withdrew consent|0|||
30839482|NCT02737475|58864788|FG011|Overall Study|Participant withdrew consent|0|||
30839483|NCT02737475|58864789|FG012|Overall Study|Participant withdrew consent|0|||
30839484|NCT02737475|58864790|FG013|Overall Study|Participant withdrew consent|0|||
30839485|NCT02737475|58864791|FG014|Overall Study|Participant withdrew consent|1|||
30839486|NCT02737475|58864792|FG015|Overall Study|Participant withdrew consent|0|||
30839487|NCT02737475|58864793|FG016|Overall Study|Participant withdrew consent|0|||
30839488|NCT02737475|58864794|FG017|Overall Study|Participant withdrew consent|2|||
30839489|NCT02737475|58864795|FG018|Overall Study|Participant withdrew consent|1|||
30839490|NCT02737475|58864796|FG019|Overall Study|Participant withdrew consent|0|||
30839491|NCT02737475|58864797|FG020|Overall Study|Participant withdrew consent|2|||
30839492|NCT02737475|58864798|FG021|Overall Study|Participant withdrew consent|0|||
30839493|NCT02737475|58864799|FG022|Overall Study|Participant withdrew consent|0|||
30839494|NCT02737475|58864800|FG023|Overall Study|Participant withdrew consent|0|||
30839495|NCT02737475|58864801|FG024|Overall Study|Participant withdrew consent|0|||
30839496|NCT02737475|58864802|FG025|Overall Study|Participant withdrew consent|0|||
30931682|NCT01408888|58967608|FG000|First Intervention|Adverse Event|0|||
30931683|NCT01408888|58967609|FG001|First Intervention|Adverse Event|1|||
30931684|NCT01408888|58967608|FG000|First Intervention|Withdrawal by Subject|0|||
30931685|NCT01408888|58967609|FG001|First Intervention|Withdrawal by Subject|2|||
30931686|NCT01408888|58967608|FG000|Second Intervention|Withdrawal by Subject|1|||
30931687|NCT01408888|58967609|FG001|Second Intervention|Withdrawal by Subject|0|||
30931688|NCT01408888|58967608|FG000|Second Intervention|Adverse Event|1|||
30931689|NCT01408888|58967609|FG001|Second Intervention|Adverse Event|0|||
30931690|NCT01918033|58967628|FG000|Overall Study|Adverse Event|1|||
30931691|NCT01918033|58967629|FG001|Overall Study|Adverse Event|0|||
30931692|NCT01918033|58967630|FG002|Overall Study|Adverse Event|2|||
30931693|NCT01918033|58967628|FG000|Overall Study|Lost to Follow-up|0|||
30931694|NCT01918033|58967629|FG001|Overall Study|Lost to Follow-up|1|||
30931695|NCT01918033|58967630|FG002|Overall Study|Lost to Follow-up|0|||
30931696|NCT01918033|58967628|FG000|Overall Study|Protocol Violation|2|||
30931697|NCT01918033|58967629|FG001|Overall Study|Protocol Violation|0|||
30931698|NCT01918033|58967630|FG002|Overall Study|Protocol Violation|1|||
30931699|NCT01918033|58967628|FG000|Overall Study|Withdrawal by Subject|2|||
30931700|NCT01918033|58967629|FG001|Overall Study|Withdrawal by Subject|1|||
30931701|NCT01918033|58967630|FG002|Overall Study|Withdrawal by Subject|0|||
30931702|NCT01408732|58967638|FG000|Overall Study|Withdrawal by Subject|2|||
30931703|NCT01408732|58967639|FG001|Overall Study|Withdrawal by Subject|2|||
30931704|NCT01390402|58967645|FG000|Overall Study|Death|1|||
30931705|NCT01390402|58967645|FG000|Overall Study|Disease Progression|4|||
30931706|NCT01976299|58967651|FG000|Overall Study|Withdrawal by Subject|3|||
30931707|NCT01976299|58967652|FG001|Overall Study|Withdrawal by Subject|1|||
30931708|NCT01976299|58967651|FG000|Overall Study|Death|4|||
30931709|NCT01976299|58967652|FG001|Overall Study|Death|2|||
30931710|NCT01976299|58967651|FG000|Overall Study|Lost to Follow-up|7|||
30931711|NCT01976299|58967652|FG001|Overall Study|Lost to Follow-up|1|||
30931712|NCT01976299|58967651|FG000|Overall Study|See clarification above in comments|9|||
30931713|NCT01976299|58967652|FG001|Overall Study|See clarification above in comments|2|||
30931714|NCT01428076|58967660|FG000|Overall Study|Adverse Event|0|||
30931715|NCT01428076|58967661|FG001|Overall Study|Adverse Event|1|||
30931716|NCT01900652|58967671|FG000|Overall Study|Progressive Disease|1|||
30931717|NCT01900652|58967672|FG001|Overall Study|Progressive Disease|0|||
30931718|NCT01900652|58967671|FG000|Overall Study|Consent withdrawn by subject|1|||
30931719|NCT01900652|58967672|FG001|Overall Study|Consent withdrawn by subject|1|||
30931720|NCT01900652|58967671|FG000|Overall Study|Death|3|||
30931721|NCT01900652|58967672|FG001|Overall Study|Death|0|||
30931722|NCT01900652|58967671|FG000|Overall Study|Adverse Event|2|||
30931723|NCT01900652|58967672|FG001|Overall Study|Adverse Event|1|||
30931724|NCT01900652|58967671|FG000|Overall Study|Physician Decision|1|||
30931725|NCT01900652|58967672|FG001|Overall Study|Physician Decision|1|||
30931726|NCT02093351|58967686|FG000|Part A|Adverse Event|0|||
30931727|NCT02093351|58967687|FG001|Part A|Adverse Event|1|||
30931728|NCT02093351|58967688|FG002|Part A|Adverse Event|1|||
30931729|NCT02093351|58967689|FG003|Part A|Adverse Event|0|||
30931730|NCT02093351|58967686|FG000|Part A|Condition under investigation worsened|2|||
30931731|NCT02093351|58967687|FG001|Part A|Condition under investigation worsened|0|||
30931732|NCT02093351|58967688|FG002|Part A|Condition under investigation worsened|2|||
30931733|NCT02093351|58967689|FG003|Part A|Condition under investigation worsened|0|||
30931734|NCT02093351|58967686|FG000|Part A|Death|0|||
30931735|NCT02093351|58967687|FG001|Part A|Death|1|||
30931736|NCT02093351|58967688|FG002|Part A|Death|0|||
30931737|NCT02093351|58967689|FG003|Part A|Death|0|||
30931738|NCT02093351|58967686|FG000|Part B|Patient decision|0|||
30931739|NCT02093351|58967687|FG001|Part B|Patient decision|0|||
30931740|NCT02093351|58967688|FG002|Part B|Patient decision|0|||
30931741|NCT02093351|58967689|FG003|Part B|Patient decision|3|||
30931742|NCT02093351|58967686|FG000|Part B|Disease progression|0|||
30931743|NCT02093351|58967687|FG001|Part B|Disease progression|0|||
30931744|NCT02093351|58967688|FG002|Part B|Disease progression|0|||
30931745|NCT02093351|58967689|FG003|Part B|Disease progression|4|||
30931746|NCT02093351|58967686|FG000|Part B|Complete response|0|||
30931747|NCT02093351|58967687|FG001|Part B|Complete response|0|||
30931748|NCT02093351|58967688|FG002|Part B|Complete response|0|||
30931749|NCT02093351|58967689|FG003|Part B|Complete response|1|||
30931750|NCT02093351|58967686|FG000|Part B|Adverse event + disease progression|0|||
30931751|NCT02093351|58967687|FG001|Part B|Adverse event + disease progression|0|||
30931752|NCT02093351|58967688|FG002|Part B|Adverse event + disease progression|0|||
30931753|NCT02093351|58967689|FG003|Part B|Adverse event + disease progression|1|||
30931754|NCT02093351|58967686|FG000|Part B|Lack of therapeutic response|0|||
30931755|NCT02093351|58967687|FG001|Part B|Lack of therapeutic response|0|||
30931756|NCT02093351|58967688|FG002|Part B|Lack of therapeutic response|0|||
30931757|NCT02093351|58967689|FG003|Part B|Lack of therapeutic response|12|||
30931758|NCT02093351|58967686|FG000|Part B|Condition under investigation worsened|0|||
30931759|NCT02093351|58967687|FG001|Part B|Condition under investigation worsened|0|||
30931760|NCT02093351|58967688|FG002|Part B|Condition under investigation worsened|0|||
30931761|NCT02093351|58967689|FG003|Part B|Condition under investigation worsened|39|||
30931762|NCT02093351|58967686|FG000|Part B|Adverse Event|0|||
30931763|NCT02093351|58967687|FG001|Part B|Adverse Event|0|||
30931764|NCT02093351|58967688|FG002|Part B|Adverse Event|0|||
30931765|NCT02093351|58967689|FG003|Part B|Adverse Event|2|||
30931766|NCT02093351|58967686|FG000|Part B|Death|0|||
30931767|NCT02093351|58967687|FG001|Part B|Death|0|||
30931768|NCT02093351|58967688|FG002|Part B|Death|0|||
30931769|NCT02093351|58967689|FG003|Part B|Death|1|||
30931770|NCT02092961|58967728|FG000|Overall Study|Not reported|1|||
30931771|NCT02092961|58967729|FG001|Overall Study|Not reported|0|||
30931772|NCT02092961|58967730|FG002|Overall Study|Not reported|1|||
30931773|NCT02092961|58967728|FG000|Overall Study|Study stopped|13|||
30931774|NCT02092961|58967729|FG001|Overall Study|Study stopped|9|||
30931775|NCT02092961|58967730|FG002|Overall Study|Study stopped|12|||
30931776|NCT02092961|58967728|FG000|Overall Study|Lack of therapeutic response|2|||
30839497|NCT02737475|58864803|FG026|Overall Study|Participant withdrew consent|0|||
30839498|NCT02737475|58864777|FG000|Overall Study|Lost to Follow-up|0|||
30839499|NCT02737475|58864778|FG001|Overall Study|Lost to Follow-up|0|||
30839500|NCT02737475|58864779|FG002|Overall Study|Lost to Follow-up|0|||
30839501|NCT02737475|58864780|FG003|Overall Study|Lost to Follow-up|0|||
30839502|NCT02737475|58864781|FG004|Overall Study|Lost to Follow-up|0|||
30839503|NCT02737475|58864782|FG005|Overall Study|Lost to Follow-up|0|||
30839504|NCT02737475|58864783|FG006|Overall Study|Lost to Follow-up|0|||
30839505|NCT02737475|58864784|FG007|Overall Study|Lost to Follow-up|0|||
30839506|NCT02737475|58864785|FG008|Overall Study|Lost to Follow-up|0|||
30839507|NCT02737475|58864786|FG009|Overall Study|Lost to Follow-up|0|||
30839508|NCT02737475|58864787|FG010|Overall Study|Lost to Follow-up|0|||
30839509|NCT02737475|58864788|FG011|Overall Study|Lost to Follow-up|0|||
30839510|NCT02737475|58864789|FG012|Overall Study|Lost to Follow-up|0|||
30839511|NCT02737475|58864790|FG013|Overall Study|Lost to Follow-up|0|||
30839512|NCT02737475|58864791|FG014|Overall Study|Lost to Follow-up|0|||
30931777|NCT02092961|58967729|FG001|Overall Study|Lack of therapeutic response|1|||
30931778|NCT02092961|58967730|FG002|Overall Study|Lack of therapeutic response|3|||
30931779|NCT02092961|58967728|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
30931780|NCT02092961|58967729|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
30931781|NCT02092961|58967730|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
30931782|NCT02092961|58967728|FG000|Overall Study|Adverse Event|2|||
30931783|NCT02092961|58967729|FG001|Overall Study|Adverse Event|4|||
30931784|NCT02092961|58967730|FG002|Overall Study|Adverse Event|0|||
30931785|NCT01898078|58967741|FG000|Overall Study|Progressive Disease|1|||
30931786|NCT01898078|58967742|FG001|Overall Study|Progressive Disease|5|||
30931787|NCT01898078|58967741|FG000|Overall Study|Adverse Event|2|||
30931788|NCT01898078|58967742|FG001|Overall Study|Adverse Event|1|||
30931789|NCT01898078|58967741|FG000|Overall Study|Withdrawal by Subject|1|||
30931790|NCT01898078|58967742|FG001|Overall Study|Withdrawal by Subject|1|||
30931791|NCT01898078|58967741|FG000|Overall Study|Symptomatic Deterioration|2|||
30839513|NCT02737475|58864792|FG015|Overall Study|Lost to Follow-up|1|||
30839514|NCT02737475|58864793|FG016|Overall Study|Lost to Follow-up|0|||
30839515|NCT02737475|58864794|FG017|Overall Study|Lost to Follow-up|0|||
30839516|NCT02737475|58864795|FG018|Overall Study|Lost to Follow-up|0|||
30839517|NCT02737475|58864796|FG019|Overall Study|Lost to Follow-up|0|||
30839518|NCT02737475|58864797|FG020|Overall Study|Lost to Follow-up|0|||
30839519|NCT02737475|58864798|FG021|Overall Study|Lost to Follow-up|0|||
30839520|NCT02737475|58864799|FG022|Overall Study|Lost to Follow-up|0|||
30839521|NCT02737475|58864800|FG023|Overall Study|Lost to Follow-up|0|||
30839522|NCT02737475|58864801|FG024|Overall Study|Lost to Follow-up|0|||
30839523|NCT02737475|58864802|FG025|Overall Study|Lost to Follow-up|0|||
30931792|NCT01898078|58967742|FG001|Overall Study|Symptomatic Deterioration|0|||
30931793|NCT01898078|58967741|FG000|Overall Study|Reason not Specified|0|||
30931794|NCT01898078|58967742|FG001|Overall Study|Reason not Specified|1|||
30931795|NCT01987817|58967752|FG000|Overall Study|Adverse Event|4|||
30931796|NCT01987817|58967753|FG001|Overall Study|Adverse Event|0|||
30931797|NCT01987817|58967752|FG000|Overall Study|Withdrawal by Subject|1|||
30931798|NCT01987817|58967753|FG001|Overall Study|Withdrawal by Subject|1|||
30931799|NCT01987817|58967752|FG000|Overall Study|Physician Decision|1|||
30931800|NCT01987817|58967753|FG001|Overall Study|Physician Decision|0|||
30624200|NCT00907738|58636185|FG003|Overall Study|not specified or withdrew consent|0|||
30624201|NCT00907738|58636186|FG004|Overall Study|not specified or withdrew consent|0|||
30624202|NCT00907738|58636182|FG000|Overall Study|Disease progression|8|||
30931801|NCT01940497|58967762|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
30931802|NCT01940497|58967763|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
30931803|NCT01940497|58967762|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
30931804|NCT01940497|58967763|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
30839524|NCT02737475|58864803|FG026|Overall Study|Lost to Follow-up|0|||
30839525|NCT02737475|58864777|FG000|Overall Study|Disease Progression|0|||
30839526|NCT02737475|58864778|FG001|Overall Study|Disease Progression|0|||
30839527|NCT02737475|58864779|FG002|Overall Study|Disease Progression|0|||
30839528|NCT02737475|58864780|FG003|Overall Study|Disease Progression|0|||
30839529|NCT02737475|58864781|FG004|Overall Study|Disease Progression|0|||
30931805|NCT01940497|58967762|FG000|Overall Study|Violation of Entry Criteria|1|||
30931806|NCT01940497|58967763|FG001|Overall Study|Violation of Entry Criteria|1|||
30931807|NCT01940497|58967762|FG000|Overall Study|Refused Treatment|1|||
30931808|NCT01940497|58967763|FG001|Overall Study|Refused Treatment|3|||
30931809|NCT01940497|58967762|FG000|Overall Study|Withdrew Consent|6|||
30931810|NCT01940497|58967763|FG001|Overall Study|Withdrew Consent|2|||
30931811|NCT01940497|58967762|FG000|Overall Study|Administrative/Other|1|||
30931812|NCT01940497|58967763|FG001|Overall Study|Administrative/Other|1|||
30931813|NCT01924754|58967783|FG000|Overall Study|Lost to Follow-up|1|||
30931814|NCT01924754|58967784|FG001|Overall Study|Lost to Follow-up|2|||
30931815|NCT01924754|58967785|FG002|Overall Study|Lost to Follow-up|1|||
30931816|NCT01924754|58967783|FG000|Overall Study|Pregnancy|0|||
30931817|NCT01924754|58967784|FG001|Overall Study|Pregnancy|1|||
30931818|NCT01924754|58967785|FG002|Overall Study|Pregnancy|2|||
30931819|NCT01924364|58967796|FG000|Overall Study|Physician Decision|3|||
30931820|NCT01987505|58967813|FG000|Overall Study|Other|9|||
30931821|NCT01987505|58967813|FG000|Overall Study|Withdrawal by Subject|2|||
30931822|NCT01987505|58967813|FG000|Overall Study|Other Reason|2|||
30931823|NCT01987505|58967813|FG000|Overall Study|Lost to Follow-up|15|||
30931824|NCT01987505|58967813|FG000|Overall Study|Investigator Decision|2|||
30931825|NCT01987505|58967813|FG000|Overall Study|Death|4|||
30931826|NCT01923896|58967821|FG000|Overall Study|Adverse Event|1|||
30931827|NCT01923896|58967822|FG001|Overall Study|Adverse Event|0|||
30948487|NCT01976741|58994462|FG009|Overall Study|Withdrawal by Subject|0|||
30948488|NCT01976741|58994453|FG000|Overall Study|Adverse Event|0|||
30948489|NCT01976741|58994454|FG001|Overall Study|Adverse Event|0|||
30948490|NCT01976741|58994455|FG002|Overall Study|Adverse Event|2|||
30948491|NCT01976741|58994456|FG003|Overall Study|Adverse Event|0|||
30948492|NCT01976741|58994457|FG004|Overall Study|Adverse Event|0|||
30948493|NCT01976741|58994458|FG005|Overall Study|Adverse Event|0|||
30948494|NCT01976741|58994459|FG006|Overall Study|Adverse Event|3|||
30948495|NCT01976741|58994460|FG007|Overall Study|Adverse Event|8|||
30948496|NCT01976741|58994461|FG008|Overall Study|Adverse Event|1|||
30948497|NCT01976741|58994462|FG009|Overall Study|Adverse Event|4|||
30948498|NCT01727713|58994496|FG000|Overall Study|Lost to Follow-up|5|||
30948499|NCT01727713|58994496|FG000|Overall Study|Adverse Event|10|||
30948500|NCT01727713|58994496|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
30839530|NCT02737475|58864782|FG005|Overall Study|Disease Progression|0|||
30839531|NCT02737475|58864783|FG006|Overall Study|Disease Progression|0|||
30839532|NCT02737475|58864784|FG007|Overall Study|Disease Progression|0|||
30839533|NCT02737475|58864785|FG008|Overall Study|Disease Progression|0|||
30839534|NCT02737475|58864786|FG009|Overall Study|Disease Progression|0|||
30839535|NCT02737475|58864787|FG010|Overall Study|Disease Progression|0|||
30839536|NCT02737475|58864788|FG011|Overall Study|Disease Progression|0|||
30839537|NCT02737475|58864789|FG012|Overall Study|Disease Progression|0|||
30839538|NCT02737475|58864790|FG013|Overall Study|Disease Progression|0|||
30839539|NCT02737475|58864791|FG014|Overall Study|Disease Progression|0|||
30839540|NCT02737475|58864792|FG015|Overall Study|Disease Progression|0|||
30839541|NCT02737475|58864793|FG016|Overall Study|Disease Progression|0|||
30948501|NCT01727713|58994496|FG000|Overall Study|Withdrawal by Subject|13|||
30948502|NCT01727713|58994496|FG000|Overall Study|Protocol Deviation|2|||
30948503|NCT01965431|58994500|FG000|Overall Study|Adverse Event|0|||
30948504|NCT01965431|58994501|FG001|Overall Study|Adverse Event|1|||
30948505|NCT01965431|58994502|FG002|Overall Study|Adverse Event|0|||
30948506|NCT01965431|58994503|FG003|Overall Study|Adverse Event|0|||
30948507|NCT01965431|58994504|FG004|Overall Study|Adverse Event|0|||
30948508|NCT01965431|58994505|FG005|Overall Study|Adverse Event|0|||
30948509|NCT01965431|58994500|FG000|Overall Study|Other than stated above|6|||
30948510|NCT01965431|58994501|FG001|Overall Study|Other than stated above|5|||
30948511|NCT01965431|58994502|FG002|Overall Study|Other than stated above|6|||
30948512|NCT01965431|58994503|FG003|Overall Study|Other than stated above|6|||
30948513|NCT01965431|58994504|FG004|Overall Study|Other than stated above|6|||
30948514|NCT01965431|58994505|FG005|Overall Study|Other than stated above|6|||
30948515|NCT01976663|58994515|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
30948516|NCT01976663|58994515|FG000|Overall Study|Personal Reasons|6|||
30839542|NCT02737475|58864794|FG017|Overall Study|Disease Progression|0|||
30839543|NCT02737475|58864795|FG018|Overall Study|Disease Progression|0|||
30839544|NCT02737475|58864796|FG019|Overall Study|Disease Progression|0|||
30948517|NCT01976663|58994515|FG000|Overall Study|Withdrawal by Subject|4|||
30948518|NCT01976663|58994515|FG000|Overall Study|Screen Failure|3|||
30948519|NCT01976663|58994515|FG000|Overall Study|Adverse Event|2|||
30948520|NCT01976663|58994515|FG000|Overall Study|Lost to Follow-up|3|||
30948521|NCT01775137|58994523|FG000|Overall Study|Death|1|||
30948522|NCT01775137|58994523|FG000|Overall Study|Protocol deviation|2|||
30948523|NCT01775137|58994523|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30948524|NCT01775137|58994523|FG000|Overall Study|Adverse Event|1|||
30948525|NCT01775137|58994523|FG000|Overall Study|Withdrawal by participants|5|||
30948526|NCT01976507|58994530|FG000|Overall Study|Adverse Event|6|||
30948527|NCT01976507|58994530|FG000|Overall Study|ablation not done, drug not given|1|||
30839545|NCT02737475|58864797|FG020|Overall Study|Disease Progression|0|||
30948528|NCT01964963|58994534|FG000|Overall Study|Case Report Forms Uncollected|888|||
30948529|NCT01964963|58994534|FG000|Overall Study|Protocol Deviation|50|||
30948530|NCT01964963|58994534|FG000|Overall Study|Data Reliability was not Assured|5|||
30931828|NCT02004353|58967828|FG000|Overall Study|Voluntary participation|1334|||
30931829|NCT01938625|58967834|FG000|Overall Study|Withdrawal by Subject|0|||
30931830|NCT01938625|58967835|FG001|Overall Study|Withdrawal by Subject|1|||
30931831|NCT01938625|58967834|FG000|Overall Study|Adverse Event|0|||
30931832|NCT01938625|58967835|FG001|Overall Study|Adverse Event|1|||
30931833|NCT01975675|58967845|FG000|Overall Study|Death|0|||
30931834|NCT01975675|58967846|FG001|Overall Study|Death|1|||
30931835|NCT01975675|58967847|FG002|Overall Study|Death|0|||
30931836|NCT01975675|58967848|FG003|Overall Study|Death|0|||
30931837|NCT01975285|58967860|FG000|Overall Study|Failed Block and follow up|2|||
30931838|NCT01975285|58967861|FG001|Overall Study|Failed Block and follow up|2|||
30931839|NCT01974895|58967869|FG000|Overall Study|Protocol Violation|1|||
30931840|NCT01974895|58967870|FG001|Overall Study|Protocol Violation|0|||
30931841|NCT01974895|58967869|FG000|Overall Study|Lost to Follow-up|4|||
30931842|NCT01974895|58967870|FG001|Overall Study|Lost to Follow-up|6|||
30931843|NCT01974895|58967869|FG000|Overall Study|Withdrawal by Subject|0|||
30931844|NCT01974895|58967870|FG001|Overall Study|Withdrawal by Subject|1|||
30931845|NCT01974895|58967869|FG000|Overall Study|Other (Missed Visit)|1|||
30931846|NCT01974895|58967870|FG001|Overall Study|Other (Missed Visit)|0|||
30931847|NCT01974895|58967869|FG000|Overall Study|Other (Reason unknown)|9|||
30931848|NCT01974895|58967870|FG001|Overall Study|Other (Reason unknown)|8|||
30931849|NCT01974817|58967876|FG000|Overall Study|Death|4|||
30931850|NCT01974817|58967876|FG000|Overall Study|Lost to Follow-up|2|||
30931851|NCT01974817|58967876|FG000|Overall Study|Protocol Violation|2|||
30931852|NCT01915849|58967884|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
30931853|NCT01915849|58967885|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
30931854|NCT01915849|58967886|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
30931855|NCT01915849|58967887|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
30931856|NCT01915849|58967884|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
30931857|NCT01915849|58967885|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
30931858|NCT01915849|58967886|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
30931859|NCT01915849|58967887|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
30931860|NCT01915771|58967897|FG000|Day 1|Withdrawal by Subject|1|||
30931861|NCT01915771|58967897|FG000|Day 15|Withdrawal by Subject|1|||
30931862|NCT01938391|58967905|FG000|6 Month Follow up|Withdrawal by Subject|1|||
30931863|NCT01938391|58967905|FG000|12 Month Follow up|Physician Decision|1|||
30931864|NCT01938391|58967905|FG000|12 Month Follow up|Withdrawal by Subject|1|||
30931865|NCT01915303|58967909|FG000|Core Phase|Adverse Event|7|||
30931866|NCT01915303|58967909|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
30931867|NCT01915303|58967909|FG000|Core Phase|Death|2|||
30931868|NCT01915303|58967909|FG000|Core Phase|Protocol Violation|2|||
30931869|NCT01915303|58967909|FG000|Core Phase|Abnormal lab value|1|||
30931870|NCT01915303|58967909|FG000|Core Phase|Withdrawal by Subject|1|||
30931871|NCT01915303|58967909|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
30931872|NCT01915303|58967909|FG000|Extension Phase|Withdrawal by Subject|4|||
30931873|NCT01915303|58967909|FG000|Extension Phase|Adverse Event|3|||
30931874|NCT01915303|58967909|FG000|Extension Phase|Death|1|||
30931875|NCT01915303|58967909|FG000|Extension Phase|Protocol Violation|1|||
30931876|NCT01987427|58967916|FG000|Overall Study|Adverse Event|4|||
30931877|NCT01987427|58967917|FG001|Overall Study|Adverse Event|2|||
30931878|NCT01987427|58967918|FG002|Overall Study|Adverse Event|8|||
30931879|NCT01987427|58967916|FG000|Overall Study|Lost to Follow-up|6|||
30931880|NCT01987427|58967917|FG001|Overall Study|Lost to Follow-up|6|||
30931881|NCT01987427|58967918|FG002|Overall Study|Lost to Follow-up|9|||
30931882|NCT01987427|58967916|FG000|Overall Study|Withdrawal by Subject|2|||
30931883|NCT01987427|58967917|FG001|Overall Study|Withdrawal by Subject|1|||
30931884|NCT01987427|58967918|FG002|Overall Study|Withdrawal by Subject|3|||
30931885|NCT01987427|58967916|FG000|Overall Study|Lack of Efficacy|1|||
30931886|NCT01987427|58967917|FG001|Overall Study|Lack of Efficacy|0|||
30931887|NCT01987427|58967918|FG002|Overall Study|Lack of Efficacy|0|||
30931888|NCT01987427|58967916|FG000|Overall Study|Other|1|||
30931889|NCT01987427|58967917|FG001|Overall Study|Other|1|||
30931890|NCT01987427|58967918|FG002|Overall Study|Other|0|||
30931891|NCT01937299|58967928|FG000|Overall Study|Adverse Event|13|||
30931892|NCT01937299|58967929|FG001|Overall Study|Adverse Event|0|||
30931893|NCT01937299|58967928|FG000|Overall Study|Lack of Efficacy|0|||
30931894|NCT01937299|58967929|FG001|Overall Study|Lack of Efficacy|4|||
30931895|NCT01937299|58967928|FG000|Overall Study|Withdrawal by Subject|1|||
30931896|NCT01937299|58967929|FG001|Overall Study|Withdrawal by Subject|0|||
30931897|NCT02003963|58967938|FG000|Overall Study|Lost to Follow-up|2|||
30931898|NCT02003963|58967939|FG001|Overall Study|Lost to Follow-up|1|||
30931899|NCT01606761|58967950|FG000|Prior to Week 24|Lost to Follow-up|0|||
30931900|NCT01606761|58967951|FG001|Prior to Week 24|Lost to Follow-up|3|||
30931901|NCT01606761|58967952|FG002|Prior to Week 24|Lost to Follow-up|2|||
30931902|NCT01606761|58967953|FG003|Prior to Week 24|Lost to Follow-up|0|||
30931903|NCT01606761|58967954|FG004|Prior to Week 24|Lost to Follow-up|0|||
30931904|NCT01606761|58967950|FG000|Prior to Week 24|Withdrawal by Subject|12|||
30931905|NCT01606761|58967951|FG001|Prior to Week 24|Withdrawal by Subject|10|||
30931906|NCT01606761|58967952|FG002|Prior to Week 24|Withdrawal by Subject|9|||
30931907|NCT01606761|58967953|FG003|Prior to Week 24|Withdrawal by Subject|0|||
30931908|NCT01606761|58967954|FG004|Prior to Week 24|Withdrawal by Subject|0|||
30931909|NCT01606761|58967950|FG000|Prior to Week 24|Adverse Event|11|||
30931910|NCT01606761|58967951|FG001|Prior to Week 24|Adverse Event|18|||
30931911|NCT01606761|58967952|FG002|Prior to Week 24|Adverse Event|22|||
30931912|NCT01606761|58967953|FG003|Prior to Week 24|Adverse Event|0|||
30931913|NCT01606761|58967954|FG004|Prior to Week 24|Adverse Event|0|||
30931914|NCT01606761|58967950|FG000|Prior to Week 24|Lack of Efficacy|15|||
30931915|NCT01606761|58967951|FG001|Prior to Week 24|Lack of Efficacy|14|||
30931916|NCT01606761|58967952|FG002|Prior to Week 24|Lack of Efficacy|8|||
30931917|NCT01606761|58967953|FG003|Prior to Week 24|Lack of Efficacy|0|||
30931918|NCT01606761|58967954|FG004|Prior to Week 24|Lack of Efficacy|0|||
30931919|NCT01606761|58967950|FG000|Prior to Week 24|Physician Decision|0|||
30931920|NCT01606761|58967951|FG001|Prior to Week 24|Physician Decision|3|||
30931921|NCT01606761|58967952|FG002|Prior to Week 24|Physician Decision|1|||
30931922|NCT01606761|58967953|FG003|Prior to Week 24|Physician Decision|0|||
30931923|NCT01606761|58967954|FG004|Prior to Week 24|Physician Decision|0|||
30931924|NCT01606761|58967950|FG000|Prior to Week 24|Other|4|||
30931925|NCT01606761|58967951|FG001|Prior to Week 24|Other|7|||
30931926|NCT01606761|58967952|FG002|Prior to Week 24|Other|5|||
30931927|NCT01606761|58967953|FG003|Prior to Week 24|Other|0|||
30931928|NCT01606761|58967954|FG004|Prior to Week 24|Other|0|||
30931929|NCT01606761|58967950|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
30931930|NCT01606761|58967951|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
30931931|NCT01606761|58967952|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
30931932|NCT01606761|58967953|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
30931933|NCT01606761|58967954|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
30931934|NCT01606761|58967950|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
30931935|NCT01606761|58967951|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
30931936|NCT01606761|58967952|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
30931937|NCT01606761|58967953|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
30931938|NCT01606761|58967954|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
30931939|NCT01606761|58967950|FG000|Week 24 to Week 52|Adverse Event|0|||
30931940|NCT01606761|58967951|FG001|Week 24 to Week 52|Adverse Event|11|||
30931941|NCT01606761|58967952|FG002|Week 24 to Week 52|Adverse Event|14|||
30931942|NCT01606761|58967953|FG003|Week 24 to Week 52|Adverse Event|3|||
30931943|NCT01606761|58967954|FG004|Week 24 to Week 52|Adverse Event|15|||
30931944|NCT01606761|58967950|FG000|Week 24 to Week 52|Death|0|||
30931945|NCT01606761|58967951|FG001|Week 24 to Week 52|Death|0|||
30931946|NCT01606761|58967952|FG002|Week 24 to Week 52|Death|2|||
30931947|NCT01606761|58967953|FG003|Week 24 to Week 52|Death|1|||
30931948|NCT01606761|58967954|FG004|Week 24 to Week 52|Death|0|||
30758200|NCT00112437|58766946|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
30839546|NCT02737475|58864798|FG021|Overall Study|Disease Progression|0|||
30839547|NCT02737475|58864799|FG022|Overall Study|Disease Progression|0|||
30839548|NCT02737475|58864800|FG023|Overall Study|Disease Progression|0|||
30839549|NCT02737475|58864801|FG024|Overall Study|Disease Progression|0|||
30839550|NCT02737475|58864802|FG025|Overall Study|Disease Progression|0|||
30839551|NCT02737475|58864803|FG026|Overall Study|Disease Progression|1|||
30758201|NCT00112437|58766921|FG000|Years 6-10 (60-Month Extension)|Death|0|||
30758202|NCT00112437|58766922|FG001|Years 6-10 (60-Month Extension)|Death|0|||
30758203|NCT00112437|58766923|FG002|Years 6-10 (60-Month Extension)|Death|0|||
30758204|NCT00112437|58766924|FG003|Years 6-10 (60-Month Extension)|Death|0|||
30758205|NCT00112437|58766925|FG004|Years 6-10 (60-Month Extension)|Death|0|||
30839552|NCT02557672|58864893|FG000|Overall Study|Withdrawal by Subject|4|||
30839553|NCT02557672|58864894|FG001|Overall Study|Withdrawal by Subject|2|||
30839554|NCT02714426|58864906|FG000|Overall Study|Withdrawal by Subject|2|||
30839555|NCT02714426|58864907|FG001|Overall Study|Withdrawal by Subject|2|||
30839556|NCT02925923|58864920|FG000|Overall Study|blood samples hemolyzed|0|||
30931949|NCT01606761|58967950|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
30758206|NCT00112437|58766926|FG005|Years 6-10 (60-Month Extension)|Death|0|||
30758207|NCT00112437|58766927|FG006|Years 6-10 (60-Month Extension)|Death|0|||
30758208|NCT00112437|58766928|FG007|Years 6-10 (60-Month Extension)|Death|0|||
30839557|NCT02925923|58864921|FG001|Overall Study|blood samples hemolyzed|2|||
30931950|NCT01606761|58967951|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
30931951|NCT01606761|58967952|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
30931952|NCT01606761|58967953|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
30931953|NCT01606761|58967954|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
30931954|NCT01606761|58967950|FG000|Week 24 to Week 52|Physician Decision|0|||
30931955|NCT01606761|58967951|FG001|Week 24 to Week 52|Physician Decision|1|||
30931956|NCT01606761|58967952|FG002|Week 24 to Week 52|Physician Decision|1|||
30931957|NCT01606761|58967953|FG003|Week 24 to Week 52|Physician Decision|0|||
30931958|NCT01606761|58967954|FG004|Week 24 to Week 52|Physician Decision|0|||
30758209|NCT00112437|58766929|FG008|Years 6-10 (60-Month Extension)|Death|0|||
30839558|NCT02410343|58864929|FG000|Core Period (24 Weeks)|Adverse Event|1|||
30931959|NCT01606761|58967950|FG000|Week 24 to Week 52|Other|0|||
30931960|NCT01606761|58967951|FG001|Week 24 to Week 52|Other|1|||
30931961|NCT01606761|58967952|FG002|Week 24 to Week 52|Other|5|||
30931962|NCT01606761|58967953|FG003|Week 24 to Week 52|Other|2|||
30931963|NCT01606761|58967954|FG004|Week 24 to Week 52|Other|2|||
30931964|NCT01606761|58967950|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
30931965|NCT01606761|58967951|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
30931966|NCT01606761|58967952|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
30931967|NCT01606761|58967953|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
30931968|NCT01606761|58967954|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
30931969|NCT01606761|58967950|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
30931970|NCT01606761|58967951|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
30931971|NCT01606761|58967952|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
30931972|NCT01606761|58967953|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
30931973|NCT01606761|58967954|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
30931974|NCT01606761|58967950|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
30931975|NCT01606761|58967951|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
30931976|NCT01606761|58967952|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
30931977|NCT01606761|58967953|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
30931978|NCT01606761|58967954|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
30931979|NCT01606761|58967950|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
30931980|NCT01606761|58967951|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
30931981|NCT01606761|58967952|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
30931982|NCT01606761|58967953|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
30931983|NCT01606761|58967954|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
30931984|NCT01790295|58967969|FG000|Overall Study|Adverse Event|1|||
30931985|NCT01790295|58967969|FG000|Overall Study|Death|4|||
30931986|NCT01790295|58967969|FG000|Overall Study|Lack of Efficacy|2|||
30931987|NCT01790295|58967969|FG000|Overall Study|Study closure|4|||
30931988|NCT01597557|58967976|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
30931989|NCT01597557|58967977|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
30931990|NCT01760733|58967983|FG000|Waiting List|Death|18|||
30931991|NCT01760733|58967983|FG000|Waiting List|Removed from waiting list|41|||
30931992|NCT01760733|58967983|FG000|Waiting List|Not received a transplant yet|13|||
30931993|NCT01760733|58967983|FG000|Transplanted|Not reached 10 years post transplant|184|||
30931994|NCT01760733|58967983|FG000|Transplanted|Death|26|||
30931995|NCT01760733|58967983|FG000|Transplanted|Graft loss|7|||
30931996|NCT01914757|58967991|FG000|Overall Study|Severe non-compliance to protocol|3|||
30931997|NCT01914757|58967992|FG001|Overall Study|Severe non-compliance to protocol|1|||
30931998|NCT01914757|58967993|FG002|Overall Study|Severe non-compliance to protocol|2|||
30931999|NCT01914757|58967991|FG000|Overall Study|Lost to Follow-up|5|||
30932000|NCT01914757|58967992|FG001|Overall Study|Lost to Follow-up|8|||
30932001|NCT01914757|58967993|FG002|Overall Study|Lost to Follow-up|6|||
30932002|NCT01914757|58967991|FG000|Overall Study|Withdrawal by Subject|15|||
30932003|NCT01914757|58967992|FG001|Overall Study|Withdrawal by Subject|27|||
30932004|NCT01914757|58967993|FG002|Overall Study|Withdrawal by Subject|19|||
30932005|NCT01914757|58967991|FG000|Overall Study|Death|2|||
30758210|NCT00112437|58766930|FG009|Years 6-10 (60-Month Extension)|Death|0|||
30758211|NCT00112437|58766931|FG010|Years 6-10 (60-Month Extension)|Death|0|||
30758212|NCT00112437|58766932|FG011|Years 6-10 (60-Month Extension)|Death|0|||
30758213|NCT00112437|58766933|FG012|Years 6-10 (60-Month Extension)|Death|0|||
30758214|NCT00112437|58766934|FG013|Years 6-10 (60-Month Extension)|Death|0|||
30932006|NCT01914757|58967992|FG001|Overall Study|Death|2|||
30932007|NCT01914757|58967993|FG002|Overall Study|Death|1|||
30932008|NCT01914757|58967991|FG000|Overall Study|Adverse Event|4|||
30932009|NCT01914757|58967992|FG001|Overall Study|Adverse Event|3|||
30932010|NCT01914757|58967993|FG002|Overall Study|Adverse Event|4|||
30932011|NCT01914757|58967991|FG000|Overall Study|Study specific withdrawal criteria|0|||
30932012|NCT01914757|58967992|FG001|Overall Study|Study specific withdrawal criteria|1|||
30932013|NCT01914757|58967993|FG002|Overall Study|Study specific withdrawal criteria|0|||
30932014|NCT01914757|58967991|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
30932015|NCT01914757|58967992|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30932016|NCT01914757|58967993|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
30932017|NCT01914757|58967991|FG000|Overall Study|Other reasons|5|||
30932018|NCT01914757|58967992|FG001|Overall Study|Other reasons|9|||
30932019|NCT01914757|58967993|FG002|Overall Study|Other reasons|4|||
30932020|NCT02003573|58968004|FG000|Overall Study|Progressive disease|2|||
30932021|NCT02003573|58968005|FG001|Overall Study|Progressive disease|0|||
30932022|NCT02003573|58968006|FG002|Overall Study|Progressive disease|1|||
30932023|NCT02003573|58968004|FG000|Overall Study|Other Adverse event|0|||
30932024|NCT02003573|58968005|FG001|Overall Study|Other Adverse event|1|||
30758215|NCT00112437|58766935|FG014|Years 6-10 (60-Month Extension)|Death|0|||
30758216|NCT00112437|58766936|FG015|Years 6-10 (60-Month Extension)|Death|0|||
30932025|NCT02003573|58968006|FG002|Overall Study|Other Adverse event|1|||
30932026|NCT02003573|58968004|FG000|Overall Study|Refuse to take trial medication|0|||
30624203|NCT00907738|58636183|FG001|Overall Study|Disease progression|1|||
30932027|NCT02003573|58968005|FG001|Overall Study|Refuse to take trial medication|1|||
30932028|NCT02003573|58968006|FG002|Overall Study|Refuse to take trial medication|1|||
30932029|NCT02003573|58968004|FG000|Overall Study|Other than specified|1|||
30932030|NCT02003573|58968005|FG001|Overall Study|Other than specified|2|||
30932031|NCT02003573|58968006|FG002|Overall Study|Other than specified|3|||
30932032|NCT01914679|58968016|FG000|Overall Study|Lack of Efficacy|1|||
30932033|NCT01914679|58968016|FG000|Overall Study|Sponsor terminated study|4|||
30932034|NCT01789281|58968022|FG000|Overall Study|Disease progression|15|||
30932035|NCT01789281|58968023|FG001|Overall Study|Disease progression|4|||
30932036|NCT01789281|58968022|FG000|Overall Study|Adverse Event|5|||
30932037|NCT01789281|58968023|FG001|Overall Study|Adverse Event|5|||
30932038|NCT01789281|58968022|FG000|Overall Study|Withdrawal by Subject|1|||
30932039|NCT01789281|58968023|FG001|Overall Study|Withdrawal by Subject|0|||
30932040|NCT01789281|58968022|FG000|Overall Study|Lost to Follow-up|1|||
30932041|NCT01789281|58968023|FG001|Overall Study|Lost to Follow-up|0|||
30932042|NCT01789281|58968022|FG000|Overall Study|Administrative problems|0|||
30932043|NCT01789281|58968023|FG001|Overall Study|Administrative problems|1|||
30932044|NCT01923740|58968032|FG000|Overall Study|Lost to Follow-up|4|||
30932045|NCT01923740|58968033|FG001|Overall Study|Lost to Follow-up|9|||
30932046|NCT01923740|58968032|FG000|Overall Study|Withdrawal by Subject|2|||
30932047|NCT01923740|58968033|FG001|Overall Study|Withdrawal by Subject|0|||
30932048|NCT01789203|58968041|FG000|Overall Study|Adverse Event|2|||
30932049|NCT01789203|58968042|FG001|Overall Study|Adverse Event|2|||
30932050|NCT01789203|58968041|FG000|Overall Study|Withdrawal by Subject|1|||
30932051|NCT01789203|58968042|FG001|Overall Study|Withdrawal by Subject|0|||
30932052|NCT01789203|58968041|FG000|Overall Study|Death|1|||
30932053|NCT01789203|58968042|FG001|Overall Study|Death|0|||
30932054|NCT01789203|58968041|FG000|Overall Study|Protocol Violation|2|||
30932055|NCT01789203|58968042|FG001|Overall Study|Protocol Violation|1|||
30932056|NCT01789203|58968041|FG000|Overall Study|Other|1|||
30932057|NCT01789203|58968042|FG001|Overall Study|Other|1|||
30932058|NCT01789203|58968041|FG000|Overall Study|patient non-adherent|2|||
30932059|NCT01789203|58968042|FG001|Overall Study|patient non-adherent|0|||
30932060|NCT01789047|58968052|FG000|Overall Study|Adverse Event|3|||
30932061|NCT01789047|58968053|FG001|Overall Study|Adverse Event|2|||
30932062|NCT01789047|58968052|FG000|Overall Study|Withdrawal by Subject|1|||
30932063|NCT01789047|58968053|FG001|Overall Study|Withdrawal by Subject|2|||
30932064|NCT01788423|58968062|FG000|Overall Study|See Comments in Completed (above)|0|||
30932065|NCT01788423|58968063|FG001|Overall Study|See Comments in Completed (above)|4|||
30932066|NCT01788423|58968064|FG002|Overall Study|See Comments in Completed (above)|5|||
30932067|NCT01617187|58968076|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
30932068|NCT01617187|58968077|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
30932069|NCT01617187|58968078|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
30932070|NCT01617187|58968079|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
30932071|NCT01617187|58968076|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
30932072|NCT01617187|58968077|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
30932073|NCT01617187|58968078|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
30932074|NCT01617187|58968079|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
30932075|NCT01617187|58968076|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
30932076|NCT01617187|58968077|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
30932077|NCT01617187|58968078|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
30932078|NCT01617187|58968079|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
30932079|NCT01617187|58968076|FG000|Treatment Through Study Completion|Adverse Event|1|||
30932080|NCT01617187|58968077|FG001|Treatment Through Study Completion|Adverse Event|1|||
30932081|NCT01617187|58968078|FG002|Treatment Through Study Completion|Adverse Event|0|||
30932082|NCT01617187|58968079|FG003|Treatment Through Study Completion|Adverse Event|1|||
30932083|NCT01617187|58968076|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
30932084|NCT01617187|58968077|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
30932085|NCT01617187|58968078|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
30932086|NCT01617187|58968079|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
30932087|NCT01617187|58968076|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
30624204|NCT00907738|58636184|FG002|Overall Study|Disease progression|6|||
30624205|NCT00907738|58636185|FG003|Overall Study|Disease progression|4|||
30932088|NCT01617187|58968077|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
30932089|NCT01617187|58968078|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
30932090|NCT01617187|58968079|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
30932091|NCT01617187|58968076|FG000|Treatment Through Study Completion|Protocol Violation|1|||
30932092|NCT01617187|58968077|FG001|Treatment Through Study Completion|Protocol Violation|0|||
30932093|NCT01617187|58968078|FG002|Treatment Through Study Completion|Protocol Violation|0|||
30932094|NCT01617187|58968079|FG003|Treatment Through Study Completion|Protocol Violation|1|||
30932095|NCT01759407|58968091|FG000|Overall Study|Protocol Violation|0|||
30932096|NCT01759407|58968092|FG001|Overall Study|Protocol Violation|2|||
30932097|NCT01787331|58968098|FG000|Overall Study|Physician Decision|1|||
30932098|NCT01787331|58968098|FG000|Overall Study|Withdrawal by Subject|1|||
30932099|NCT01757847|58968104|FG000|Overall Study|Withdrawal by Subject|3|||
30932100|NCT01757847|58968105|FG001|Overall Study|Withdrawal by Subject|4|||
30932101|NCT01787097|58968111|FG000|Overall Study|Withdrawal by Subject|1|||
30932102|NCT01787097|58968112|FG001|Overall Study|Withdrawal by Subject|0|||
30932103|NCT01787097|58968113|FG002|Overall Study|Withdrawal by Subject|0|||
30932104|NCT01787097|58968114|FG003|Overall Study|Withdrawal by Subject|0|||
30932105|NCT01757691|58968134|FG000|Overall Study|Administrative problems|2|||
30932106|NCT01757691|58968135|FG001|Overall Study|Administrative problems|0|||
30932107|NCT01786707|58968143|FG000|Overall Study|Lost to Follow-up|1|||
30932108|NCT01786707|58968144|FG001|Overall Study|Lost to Follow-up|1|||
30932109|NCT01786629|58968152|FG000|Overall Study|Lack of Efficacy|0|||
30932110|NCT01786629|58968153|FG001|Overall Study|Lack of Efficacy|4|||
30932111|NCT01786629|58968152|FG000|Overall Study|Adverse Event|0|||
30932112|NCT01786629|58968153|FG001|Overall Study|Adverse Event|1|||
30932113|NCT01786551|58968159|FG000|Overall Study|Participant withdrew consent|2|||
30932114|NCT01973569|58968166|FG000|Overall Study|Adverse Event|9|||
30932115|NCT01973569|58968167|FG001|Overall Study|Adverse Event|2|||
30932116|NCT01973569|58968168|FG002|Overall Study|Adverse Event|4|||
30932117|NCT01973569|58968166|FG000|Overall Study|Protocol Violation|2|||
30932118|NCT01973569|58968167|FG001|Overall Study|Protocol Violation|1|||
30932119|NCT01973569|58968168|FG002|Overall Study|Protocol Violation|3|||
30932120|NCT01973569|58968166|FG000|Overall Study|Withdrawal by Subject|7|||
30932121|NCT01973569|58968167|FG001|Overall Study|Withdrawal by Subject|5|||
30932122|NCT01973569|58968168|FG002|Overall Study|Withdrawal by Subject|2|||
30932123|NCT01973569|58968166|FG000|Overall Study|Invasive dental treatment|3|||
30932124|NCT01973569|58968167|FG001|Overall Study|Invasive dental treatment|5|||
30932125|NCT01973569|58968168|FG002|Overall Study|Invasive dental treatment|6|||
30932126|NCT01973569|58968166|FG000|Overall Study|Prohibited concomitant d|1|||
30932127|NCT01973569|58968167|FG001|Overall Study|Prohibited concomitant d|5|||
30932128|NCT01973569|58968168|FG002|Overall Study|Prohibited concomitant d|0|||
30932129|NCT01973569|58968166|FG000|Overall Study|Disease progression|0|||
30932130|NCT01973569|58968167|FG001|Overall Study|Disease progression|3|||
30932131|NCT01973569|58968168|FG002|Overall Study|Disease progression|0|||
30932132|NCT01973569|58968166|FG000|Overall Study|Other|1|||
30932133|NCT01973569|58968167|FG001|Overall Study|Other|1|||
30932134|NCT01973569|58968168|FG002|Overall Study|Other|0|||
30932135|NCT01973569|58968166|FG000|Overall Study|Did not receive study drug|6|||
30932136|NCT01973569|58968167|FG001|Overall Study|Did not receive study drug|3|||
30932137|NCT01973569|58968168|FG002|Overall Study|Did not receive study drug|3|||
30932138|NCT01973491|58968176|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
30932139|NCT01973491|58968176|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
30758217|NCT00112437|58766937|FG016|Years 6-10 (60-Month Extension)|Death|0|||
30758218|NCT00112437|58766938|FG017|Years 6-10 (60-Month Extension)|Death|0|||
30758219|NCT00112437|58766939|FG018|Years 6-10 (60-Month Extension)|Death|0|||
30758220|NCT00112437|58766940|FG019|Years 6-10 (60-Month Extension)|Death|0|||
30758221|NCT00112437|58766941|FG020|Years 6-10 (60-Month Extension)|Death|0|||
30758222|NCT00112437|58766942|FG021|Years 6-10 (60-Month Extension)|Death|0|||
30758223|NCT00112437|58766943|FG022|Years 6-10 (60-Month Extension)|Death|0|||
30758224|NCT00112437|58766944|FG023|Years 6-10 (60-Month Extension)|Death|2|||
30758225|NCT00112437|58766945|FG024|Years 6-10 (60-Month Extension)|Death|0|||
30758226|NCT00112437|58766946|FG025|Years 6-10 (60-Month Extension)|Death|0|||
30758227|NCT00112437|58766921|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758228|NCT00112437|58766922|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30932140|NCT01973491|58968176|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
30932141|NCT01951586|58968182|FG000|Overall Study|Death|61|||
30932142|NCT01951586|58968183|FG001|Overall Study|Death|120|||
30932143|NCT01951586|58968182|FG000|Overall Study|Withdrawal by Subject|8|||
30932144|NCT01951586|58968183|FG001|Overall Study|Withdrawal by Subject|17|||
30932145|NCT01951586|58968182|FG000|Overall Study|Lost to Follow-up|0|||
30932146|NCT01951586|58968183|FG001|Overall Study|Lost to Follow-up|1|||
30932147|NCT01951586|58968182|FG000|Overall Study|Sponsor Decision|9|||
30932148|NCT01951586|58968183|FG001|Overall Study|Sponsor Decision|10|||
30932149|NCT01785849|58968192|FG000|Overall Study|Death|7|||
30758229|NCT00112437|58766923|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30932150|NCT01785849|58968193|FG001|Overall Study|Death|9|||
30932151|NCT01785849|58968192|FG000|Overall Study|Protocol Specified Criteria|29|||
30932152|NCT01785849|58968193|FG001|Overall Study|Protocol Specified Criteria|1|||
30932153|NCT01785849|58968192|FG000|Overall Study|Withdrawal by Subject|15|||
30758230|NCT00112437|58766924|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758231|NCT00112437|58766925|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758232|NCT00112437|58766926|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758233|NCT00112437|58766927|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758234|NCT00112437|58766928|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758235|NCT00112437|58766929|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30839559|NCT02410343|58864930|FG001|Core Period (24 Weeks)|Adverse Event|0|||
30839560|NCT02410343|58864929|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
30839561|NCT02410343|58864930|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
30932154|NCT01785849|58968193|FG001|Overall Study|Withdrawal by Subject|12|||
30932155|NCT01785849|58968192|FG000|Overall Study|Sponsor Decision|0|||
30932156|NCT01785849|58968193|FG001|Overall Study|Sponsor Decision|1|||
30932157|NCT01785849|58968192|FG000|Overall Study|Lost to Follow-up|10|||
30932158|NCT01785849|58968193|FG001|Overall Study|Lost to Follow-up|11|||
30932159|NCT01756833|58968201|FG000|Overall Study|Withdrawal by Subject|4|||
30932160|NCT01756833|58968202|FG001|Overall Study|Withdrawal by Subject|3|||
30932161|NCT01617967|58968214|FG000|Overall Study|Protocol Violation|0|||
30932162|NCT01617967|58968215|FG001|Overall Study|Protocol Violation|0|||
30932163|NCT01617967|58968216|FG002|Overall Study|Protocol Violation|0|||
30932164|NCT01617967|58968217|FG003|Overall Study|Protocol Violation|1|||
30932165|NCT01617967|58968218|FG004|Overall Study|Protocol Violation|0|||
30932166|NCT01617967|58968219|FG005|Overall Study|Protocol Violation|0|||
30932167|NCT01617967|58968214|FG000|Overall Study|Withdrawal by Subject|0|||
30932168|NCT01617967|58968215|FG001|Overall Study|Withdrawal by Subject|0|||
30932169|NCT01617967|58968216|FG002|Overall Study|Withdrawal by Subject|0|||
30932170|NCT01617967|58968217|FG003|Overall Study|Withdrawal by Subject|0|||
30932171|NCT01617967|58968218|FG004|Overall Study|Withdrawal by Subject|0|||
30932172|NCT01617967|58968219|FG005|Overall Study|Withdrawal by Subject|1|||
30932173|NCT01617967|58968214|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
30932174|NCT01617967|58968215|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
30932175|NCT01617967|58968216|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
30932176|NCT01617967|58968217|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
30932177|NCT01617967|58968218|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
30932178|NCT01617967|58968219|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
30932179|NCT01785615|58968237|FG000|Dietary Phase|Lost to Follow-up|0|||
30932180|NCT01785615|58968238|FG001|Dietary Phase|Lost to Follow-up|0|||
30932181|NCT01785615|58968239|FG002|Dietary Phase|Lost to Follow-up|0|||
30932182|NCT01785615|58968240|FG003|Dietary Phase|Lost to Follow-up|24|||
30932183|NCT01913041|58968252|FG000|Overall Study|Protocol Violation|35|||
30932184|NCT01913041|58968252|FG000|Overall Study|Withdrawal by Subject|3|||
30932185|NCT01913041|58968252|FG000|Overall Study|Physician Decision|1|||
30932186|NCT01756053|58968256|FG000|Period 1 (10 Days)|Protocol Violation|1|||
30932187|NCT01756053|58968257|FG001|Period 1 (10 Days)|Protocol Violation|1|||
30932188|NCT01756053|58968256|FG000|Period 2 (10 Days)|Protocol Violation|0|||
30932189|NCT01756053|58968257|FG001|Period 2 (10 Days)|Protocol Violation|2|||
30932190|NCT01785069|58968267|FG000|Overall Study|Implanted with nonstudy device|1|||
30932191|NCT01785069|58968268|FG001|Overall Study|Implanted with nonstudy device|2|||
30932192|NCT01785069|58968269|FG002|Overall Study|Implanted with nonstudy device|1|||
30932193|NCT01785069|58968270|FG003|Overall Study|Implanted with nonstudy device|0|||
30932194|NCT01785069|58968267|FG000|Overall Study|Death|0|||
30932195|NCT01785069|58968268|FG001|Overall Study|Death|0|||
30932196|NCT01785069|58968269|FG002|Overall Study|Death|2|||
30932197|NCT01785069|58968270|FG003|Overall Study|Death|0|||
30932198|NCT01785069|58968267|FG000|Overall Study|Subject choice|2|||
30932199|NCT01785069|58968268|FG001|Overall Study|Subject choice|2|||
30932200|NCT01785069|58968269|FG002|Overall Study|Subject choice|0|||
30624206|NCT00907738|58636186|FG004|Overall Study|Disease progression|2|||
30839562|NCT02410343|58864929|FG000|Extension Period (12 Months)|Adverse Event|1|||
30839563|NCT02410343|58864930|FG001|Extension Period (12 Months)|Adverse Event|0|||
30839564|NCT02410343|58864929|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
30839565|NCT02410343|58864930|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
30839566|NCT03064841|58864937|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
30839567|NCT03064841|58864937|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
30932201|NCT01785069|58968270|FG003|Overall Study|Subject choice|1|||
30932202|NCT01785069|58968267|FG000|Overall Study|Lost to Follow-up|1|||
30758236|NCT00112437|58766930|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758237|NCT00112437|58766931|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30932203|NCT01785069|58968268|FG001|Overall Study|Lost to Follow-up|2|||
30932204|NCT01785069|58968269|FG002|Overall Study|Lost to Follow-up|4|||
30932205|NCT01785069|58968270|FG003|Overall Study|Lost to Follow-up|1|||
30932206|NCT01785069|58968267|FG000|Overall Study|Reason not Specified|1|||
30932207|NCT01785069|58968268|FG001|Overall Study|Reason not Specified|2|||
30932208|NCT01785069|58968269|FG002|Overall Study|Reason not Specified|1|||
30932209|NCT01785069|58968270|FG003|Overall Study|Reason not Specified|4|||
30932210|NCT01785069|58968267|FG000|Overall Study|Not evaluable|7|||
30932211|NCT01785069|58968268|FG001|Overall Study|Not evaluable|4|||
30932212|NCT01785069|58968269|FG002|Overall Study|Not evaluable|5|||
30932213|NCT01785069|58968270|FG003|Overall Study|Not evaluable|8|||
30932214|NCT01784523|58968282|FG000|Overall Study|Study closed early|7|||
30932215|NCT01784523|58968283|FG001|Overall Study|Study closed early|4|||
30932216|NCT01784211|58968291|FG000|Part A (Days 1-15)|Adverse Event|1|||
30932217|NCT01784211|58968292|FG001|Part A (Days 1-15)|Adverse Event|1|||
30932218|NCT01784211|58968293|FG002|Part A (Days 1-15)|Adverse Event|0|||
30932219|NCT01784211|58968294|FG003|Part A (Days 1-15)|Adverse Event|0|||
30932220|NCT01784211|58968295|FG004|Part A (Days 1-15)|Adverse Event|0|||
30932221|NCT01784211|58968296|FG005|Part A (Days 1-15)|Adverse Event|0|||
30932222|NCT01784211|58968291|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
30932223|NCT01784211|58968292|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
30932224|NCT01784211|58968293|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
30932225|NCT01784211|58968294|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
30932226|NCT01784211|58968295|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
30932227|NCT01784211|58968296|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
30932228|NCT01783821|58968310|FG000|Overall Study|Screen Failure|1|||
30932229|NCT01783821|58968311|FG001|Overall Study|Screen Failure|1|||
30932230|NCT01783743|58968319|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
30932231|NCT01783743|58968320|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
30932232|NCT01783743|58968319|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
30932233|NCT01783743|58968320|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
30932234|NCT01783743|58968319|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
30932235|NCT01783743|58968320|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
30932236|NCT01608321|58968328|FG000|Overall Study|Withdrawal by Subject|1|||
30932237|NCT01608321|58968329|FG001|Overall Study|Withdrawal by Subject|0|||
30932238|NCT01608087|58968338|FG000|Overall Study|Lost to Follow-up|0|||
30932239|NCT01608087|58968339|FG001|Overall Study|Lost to Follow-up|1|||
30932240|NCT01608087|58968340|FG002|Overall Study|Lost to Follow-up|0|||
30932241|NCT01608087|58968338|FG000|Overall Study|Other Reason|0|||
30932242|NCT01608087|58968339|FG001|Overall Study|Other Reason|1|||
30932243|NCT01608087|58968340|FG002|Overall Study|Other Reason|0|||
30932244|NCT01912963|58968351|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
30932245|NCT01912963|58968352|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
30932246|NCT01912963|58968353|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
30932247|NCT01912963|58968351|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
30932248|NCT01912963|58968352|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
30932249|NCT01912963|58968353|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
30932250|NCT01912963|58968351|FG000|Overall Study|Adverse Event|0|||
30932251|NCT01912963|58968352|FG001|Overall Study|Adverse Event|1|||
30932252|NCT01912963|58968353|FG002|Overall Study|Adverse Event|1|||
30839568|NCT03064841|58864937|FG000|Overall Study|Screen failure|2|||
30839569|NCT02045303|58864943|FG000|Overall Study|Protocol Violation|2|||
30839570|NCT02045303|58864944|FG001|Overall Study|Protocol Violation|1|||
30839571|NCT02045303|58864945|FG002|Overall Study|Protocol Violation|0|||
30839572|NCT02045303|58864943|FG000|Overall Study|Withdrawal by Subject|0|||
30839573|NCT02045303|58864944|FG001|Overall Study|Withdrawal by Subject|2|||
30839574|NCT02045303|58864945|FG002|Overall Study|Withdrawal by Subject|0|||
30839575|NCT03434379|58864956|FG000|Global Period|Lost to Follow-up|3|||
30839576|NCT03434379|58864957|FG001|Global Period|Lost to Follow-up|1|||
30839577|NCT03434379|58864958|FG002|Global Period|Lost to Follow-up|0|||
30839578|NCT03434379|58864959|FG003|Global Period|Lost to Follow-up|0|||
30839579|NCT03434379|58864956|FG000|Global Period|Death|99|||
30839580|NCT03434379|58864957|FG001|Global Period|Death|179|||
30839581|NCT03434379|58864958|FG002|Global Period|Death|0|||
30839582|NCT03434379|58864959|FG003|Global Period|Death|0|||
30839583|NCT03434379|58864956|FG000|Global Period|Withdrawal by Subject|20|||
30839584|NCT03434379|58864957|FG001|Global Period|Withdrawal by Subject|20|||
30839585|NCT03434379|58864958|FG002|Global Period|Withdrawal by Subject|0|||
30932253|NCT01912963|58968351|FG000|Overall Study|Withdrawal by Subject|0|||
30932254|NCT01912963|58968352|FG001|Overall Study|Withdrawal by Subject|1|||
30932255|NCT01912963|58968353|FG002|Overall Study|Withdrawal by Subject|0|||
30932256|NCT01912963|58968351|FG000|Overall Study|Sought treatment locally|0|||
30839586|NCT03434379|58864959|FG003|Global Period|Withdrawal by Subject|0|||
30839587|NCT03434379|58864956|FG000|Global Period|On Study|43|||
30839588|NCT03434379|58864957|FG001|Global Period|On Study|136|||
30839589|NCT03434379|58864958|FG002|Global Period|On Study|0|||
30839590|NCT03434379|58864959|FG003|Global Period|On Study|0|||
30932257|NCT01912963|58968352|FG001|Overall Study|Sought treatment locally|1|||
30932258|NCT01912963|58968353|FG002|Overall Study|Sought treatment locally|0|||
30932259|NCT01754727|58968361|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
30932260|NCT01912807|58968367|FG000|Overall Study|Did not meet elegibility criteria|6|||
30839591|NCT03434379|58864956|FG000|China Extension Period|Lost to Follow-up|0|||
30839592|NCT03434379|58864957|FG001|China Extension Period|Lost to Follow-up|0|||
30932261|NCT01912807|58968368|FG001|Overall Study|Did not meet elegibility criteria|4|||
30932262|NCT01912807|58968367|FG000|Overall Study|Lost to Follow-up|36|||
30932263|NCT01912807|58968368|FG001|Overall Study|Lost to Follow-up|37|||
30932264|NCT01782885|58968376|FG000|Overall Study|Lost to Follow-up|4|||
30932265|NCT01782885|58968377|FG001|Overall Study|Lost to Follow-up|6|||
30932266|NCT01912729|58968385|FG000|Overall Study|Withdrawal by Subject|0|||
30932267|NCT01912729|58968386|FG001|Overall Study|Withdrawal by Subject|1|||
30932268|NCT01754493|58968392|FG000|Overall Study|Adverse Event|1|||
30932269|NCT01754493|58968392|FG000|Overall Study|Lost to Follow-up|3|||
30932270|NCT01754493|58968392|FG000|Overall Study|Withdrawal by Subject|1|||
30932271|NCT01754493|58968392|FG000|Overall Study|Moved out of town|1|||
30932272|NCT01754493|58968392|FG000|Overall Study|Scheduling conflict|1|||
30932273|NCT01972789|58968398|FG000|Overall Study|Adverse Event|11|||
30932274|NCT01972789|58968399|FG001|Overall Study|Adverse Event|4|||
30932275|NCT01972789|58968398|FG000|Overall Study|Subject withdrew consent|14|||
30932276|NCT01972789|58968399|FG001|Overall Study|Subject withdrew consent|12|||
30932277|NCT01972789|58968398|FG000|Overall Study|Lost to Follow-up|4|||
30932278|NCT01972789|58968399|FG001|Overall Study|Lost to Follow-up|7|||
30932279|NCT01972789|58968398|FG000|Overall Study|Death|7|||
30932280|NCT01972789|58968399|FG001|Overall Study|Death|5|||
30932281|NCT01972789|58968398|FG000|Overall Study|Protocol deviation|1|||
30932282|NCT01972789|58968399|FG001|Overall Study|Protocol deviation|0|||
30932283|NCT01972789|58968398|FG000|Overall Study|Physician Decision|3|||
30932284|NCT01972789|58968399|FG001|Overall Study|Physician Decision|2|||
30932285|NCT01934335|58968407|FG000|Overall Study|Withdrawal by Subject|1|||
30932286|NCT01934335|58968408|FG001|Overall Study|Withdrawal by Subject|1|||
30932287|NCT01912339|58968416|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
30932288|NCT01912339|58968417|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
30932289|NCT01912339|58968418|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
30932290|NCT01912339|58968416|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
30932291|NCT01912339|58968417|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
30932292|NCT01912339|58968418|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
30932293|NCT01912339|58968416|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
30932294|NCT01912339|58968417|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
30932295|NCT01912339|58968418|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
30932296|NCT01912339|58968416|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
30932297|NCT01912339|58968417|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
30932298|NCT01912339|58968418|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
30932299|NCT01912339|58968416|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
30932300|NCT01912339|58968417|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
30932301|NCT01912339|58968418|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
30932302|NCT01912339|58968416|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
30932303|NCT01912339|58968417|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
30932304|NCT01912339|58968418|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
30932305|NCT01912339|58968416|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
30932306|NCT01912339|58968417|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
30932307|NCT01912339|58968418|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
30932308|NCT01912339|58968416|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
30932309|NCT01912339|58968417|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
30932310|NCT01912339|58968418|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
30932311|NCT01912339|58968416|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
30932312|NCT01912339|58968417|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
30932313|NCT01912339|58968418|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
30932314|NCT01912339|58968416|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
30932315|NCT01912339|58968417|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
30932316|NCT01912339|58968418|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
30932317|NCT01912339|58968416|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
30932318|NCT01912339|58968417|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
30932319|NCT01912339|58968418|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
30932320|NCT01912339|58968416|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
30932321|NCT01912339|58968417|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
30932322|NCT01912339|58968418|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
30932323|NCT01912339|58968416|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
30932324|NCT01912339|58968417|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
30932325|NCT01912339|58968418|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
30932326|NCT01911793|58968426|FG000|Overall Study|Physician Decision|1|||
30932327|NCT01911793|58968427|FG001|Overall Study|Physician Decision|5|||
30932328|NCT01933789|58968442|FG000|Overall Study|Death|0|||
30932329|NCT01933789|58968443|FG001|Overall Study|Death|0|||
30932330|NCT01933789|58968444|FG002|Overall Study|Death|0|||
30932331|NCT01933789|58968445|FG003|Overall Study|Death|0|||
30932332|NCT01933789|58968446|FG004|Overall Study|Death|21|||
30932333|NCT01933789|58968447|FG005|Overall Study|Death|32|||
30932334|NCT01933789|58968448|FG006|Overall Study|Death|0|||
30932335|NCT01933789|58968449|FG007|Overall Study|Death|0|||
30932336|NCT01933789|58968450|FG008|Overall Study|Death|0|||
30932337|NCT01933789|58968442|FG000|Overall Study|Lost to Follow-up|0|||
30932338|NCT01933789|58968443|FG001|Overall Study|Lost to Follow-up|0|||
30932339|NCT01933789|58968444|FG002|Overall Study|Lost to Follow-up|0|||
30932340|NCT01933789|58968445|FG003|Overall Study|Lost to Follow-up|1|||
30932341|NCT01933789|58968446|FG004|Overall Study|Lost to Follow-up|8|||
30932342|NCT01933789|58968447|FG005|Overall Study|Lost to Follow-up|9|||
30932343|NCT01933789|58968448|FG006|Overall Study|Lost to Follow-up|1|||
30932344|NCT01933789|58968449|FG007|Overall Study|Lost to Follow-up|4|||
30932345|NCT01933789|58968450|FG008|Overall Study|Lost to Follow-up|0|||
30932346|NCT01933789|58968442|FG000|Overall Study|Withdrawal by Subject|2|||
30932347|NCT01933789|58968443|FG001|Overall Study|Withdrawal by Subject|1|||
30932348|NCT01933789|58968444|FG002|Overall Study|Withdrawal by Subject|0|||
30932349|NCT01933789|58968445|FG003|Overall Study|Withdrawal by Subject|0|||
30932350|NCT01933789|58968446|FG004|Overall Study|Withdrawal by Subject|17|||
30932351|NCT01933789|58968447|FG005|Overall Study|Withdrawal by Subject|16|||
30932352|NCT01933789|58968448|FG006|Overall Study|Withdrawal by Subject|1|||
30932353|NCT01933789|58968449|FG007|Overall Study|Withdrawal by Subject|4|||
30932354|NCT01933789|58968450|FG008|Overall Study|Withdrawal by Subject|0|||
30932355|NCT01933789|58968442|FG000|Overall Study|Became Ineligible|4|||
30932356|NCT01933789|58968443|FG001|Overall Study|Became Ineligible|0|||
30932357|NCT01933789|58968444|FG002|Overall Study|Became Ineligible|0|||
30932358|NCT01933789|58968445|FG003|Overall Study|Became Ineligible|0|||
30932359|NCT01933789|58968446|FG004|Overall Study|Became Ineligible|13|||
30932360|NCT01933789|58968447|FG005|Overall Study|Became Ineligible|10|||
30932361|NCT01933789|58968448|FG006|Overall Study|Became Ineligible|13|||
30932362|NCT01933789|58968449|FG007|Overall Study|Became Ineligible|6|||
30624207|NCT01123356|58636202|FG000|Overall Study|Adverse Event|2|||
30624208|NCT01123356|58636202|FG000|Overall Study|Lack of Efficacy|4|||
30624209|NCT01123356|58636202|FG000|Overall Study|Withdrawal by Subject|1|||
30624210|NCT00908596|58636211|FG000|Overall Study|Other reasons|46|||
30624211|NCT00908596|58636212|FG001|Overall Study|Other reasons|6|||
30624212|NCT00908596|58636213|FG002|Overall Study|Other reasons|2|||
30624213|NCT00908596|58636214|FG003|Overall Study|Other reasons|0|||
30624214|NCT00908596|58636211|FG000|Overall Study|Lost to Follow-up|0|||
30624215|NCT00908596|58636212|FG001|Overall Study|Lost to Follow-up|1|||
30624216|NCT00908596|58636213|FG002|Overall Study|Lost to Follow-up|12|||
30624217|NCT00908596|58636214|FG003|Overall Study|Lost to Follow-up|4|||
30624218|NCT00908596|58636211|FG000|Overall Study|Death|0|||
30624219|NCT00908596|58636212|FG001|Overall Study|Death|5|||
30624220|NCT00908596|58636213|FG002|Overall Study|Death|57|||
30624221|NCT00908596|58636214|FG003|Overall Study|Death|32|||
30624222|NCT00908596|58636211|FG000|Overall Study|Protocol Violation|1|||
30624223|NCT00908596|58636212|FG001|Overall Study|Protocol Violation|0|||
30624224|NCT00908596|58636213|FG002|Overall Study|Protocol Violation|0|||
30624225|NCT00908596|58636214|FG003|Overall Study|Protocol Violation|0|||
30624226|NCT00908596|58636211|FG000|Overall Study|Withdrawal by Subject|0|||
30624227|NCT00908596|58636212|FG001|Overall Study|Withdrawal by Subject|1|||
30624228|NCT00908596|58636213|FG002|Overall Study|Withdrawal by Subject|3|||
30624229|NCT00908596|58636214|FG003|Overall Study|Withdrawal by Subject|1|||
30624230|NCT01118052|58636224|FG000|Overall Study|Never treated|2|||
30624231|NCT01123200|58636234|FG000|Overall Study|Withdrawal by Subject|1|||
30624232|NCT00955617|58636238|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
30624233|NCT00955617|58636239|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
30624234|NCT00955617|58636238|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
30624235|NCT00955617|58636239|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
30839593|NCT03434379|58864958|FG002|China Extension Period|Lost to Follow-up|1|||
30932363|NCT01933789|58968450|FG008|Overall Study|Became Ineligible|0|||
30932364|NCT01910389|58968472|FG000|Overall Study|Withdrawal by Subject|2|||
30932365|NCT01910389|58968473|FG001|Overall Study|Withdrawal by Subject|0|||
30932366|NCT01910389|58968472|FG000|Overall Study|Study Closed|13|||
30932367|NCT01910389|58968473|FG001|Overall Study|Study Closed|8|||
30932368|NCT01970995|58968482|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
30932369|NCT01970995|58968483|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
30932370|NCT01970995|58968484|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
30932371|NCT01970995|58968482|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
30624236|NCT00955617|58636238|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
30624237|NCT00955617|58636239|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
30624238|NCT00955617|58636238|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
30624239|NCT00955617|58636239|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
30932372|NCT01970995|58968483|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
30932373|NCT01970995|58968484|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
30948531|NCT01964105|58994541|FG000|Overall Study|Lost to Follow-up|2|||
30839594|NCT03434379|58864959|FG003|China Extension Period|Lost to Follow-up|0|||
30839595|NCT03434379|58864956|FG000|China Extension Period|Death|0|||
30839596|NCT03434379|58864957|FG001|China Extension Period|Death|0|||
30839597|NCT03434379|58864958|FG002|China Extension Period|Death|38|||
30932374|NCT01970527|58968494|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
30932375|NCT01970527|58968495|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
30932376|NCT01970527|58968494|FG000|Treatment|Disease progression|0|||
30932377|NCT01970527|58968495|FG001|Treatment|Disease progression|1|||
30932378|NCT01970527|58968494|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
30839598|NCT03434379|58864959|FG003|China Extension Period|Death|61|||
30839599|NCT03434379|58864956|FG000|China Extension Period|Withdrawal by Subject|0|||
30839600|NCT03434379|58864957|FG001|China Extension Period|Withdrawal by Subject|0|||
30932379|NCT01970527|58968495|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
30932380|NCT01970527|58968494|FG000|Treatment|Death|0|||
30932381|NCT01970527|58968495|FG001|Treatment|Death|1|||
30932382|NCT01970527|58968494|FG000|Follow-up Clinic Visit|Disease progression|1|||
30932383|NCT01970527|58968495|FG001|Follow-up Clinic Visit|Disease progression|1|||
30932384|NCT01970527|58968494|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
30932385|NCT01970527|58968495|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
30932386|NCT01970527|58968494|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
30932387|NCT01970527|58968495|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
30932388|NCT01931995|58968506|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
30932389|NCT01931995|58968507|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
30932390|NCT01931995|58968506|FG000|First Intervention (1 Day)|Physician Decision|1|||
30932391|NCT01931995|58968507|FG001|First Intervention (1 Day)|Physician Decision|1|||
30932392|NCT01931995|58968506|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
30932393|NCT01931995|58968507|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
30932394|NCT01408576|58968516|FG000|Overall Study|Lack of Efficacy|17|||
30932395|NCT01408576|58968517|FG001|Overall Study|Lack of Efficacy|30|||
30932396|NCT01408576|58968518|FG002|Overall Study|Lack of Efficacy|48|||
30932397|NCT01408576|58968516|FG000|Overall Study|Protocol Violation|1|||
30932398|NCT01408576|58968517|FG001|Overall Study|Protocol Violation|2|||
30932399|NCT01408576|58968518|FG002|Overall Study|Protocol Violation|2|||
30932400|NCT01408576|58968516|FG000|Overall Study|Lost to Follow-up|10|||
30932401|NCT01408576|58968517|FG001|Overall Study|Lost to Follow-up|9|||
30932402|NCT01408576|58968518|FG002|Overall Study|Lost to Follow-up|17|||
30932403|NCT01408576|58968516|FG000|Overall Study|Withdrawal by Subject|34|||
30932404|NCT01408576|58968517|FG001|Overall Study|Withdrawal by Subject|60|||
30932405|NCT01408576|58968518|FG002|Overall Study|Withdrawal by Subject|66|||
30932406|NCT01408576|58968516|FG000|Overall Study|Sponsor terminated study|89|||
30932407|NCT01408576|58968517|FG001|Overall Study|Sponsor terminated study|333|||
30932408|NCT01408576|58968518|FG002|Overall Study|Sponsor terminated study|330|||
30932409|NCT01408576|58968516|FG000|Overall Study|AE, serious fatal|4|||
30932410|NCT01408576|58968517|FG001|Overall Study|AE, serious fatal|4|||
30932411|NCT01408576|58968518|FG002|Overall Study|AE, serious fatal|1|||
30839601|NCT03434379|58864958|FG002|China Extension Period|Withdrawal by Subject|7|||
30839602|NCT03434379|58864959|FG003|China Extension Period|Withdrawal by Subject|6|||
30839603|NCT03434379|58864956|FG000|China Extension Period|On Study|0|||
30839604|NCT03434379|58864957|FG001|China Extension Period|On Study|0|||
30932412|NCT01408576|58968516|FG000|Overall Study|SAE, non-fatal|11|||
30932413|NCT01408576|58968517|FG001|Overall Study|SAE, non-fatal|23|||
30932414|NCT01408576|58968518|FG002|Overall Study|SAE, non-fatal|14|||
30932415|NCT01408576|58968516|FG000|Overall Study|AE, non-serious non-fatal|12|||
30932416|NCT01408576|58968517|FG001|Overall Study|AE, non-serious non-fatal|19|||
30839605|NCT03434379|58864958|FG002|China Extension Period|On Study|15|||
30839606|NCT03434379|58864959|FG003|China Extension Period|On Study|66|||
30839607|NCT03064451|58864975|FG000|Overall Study|Lost to Follow-up|1|||
30839608|NCT03064451|58864975|FG000|Overall Study|Mapping Failure|4|||
30839609|NCT03064451|58864975|FG000|Overall Study|Exited prior to procedure|8|||
30932417|NCT01408576|58968518|FG002|Overall Study|AE, non-serious non-fatal|11|||
30624240|NCT00958347|58636245|FG000|Overall Study|Death|43|||
30624241|NCT00958347|58636245|FG000|Overall Study|Withdrawal by Subject|23|||
30624242|NCT00958347|58636245|FG000|Overall Study|Lost to Follow-up|15|||
30839610|NCT03064451|58864975|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
30839611|NCT03058679|58864981|FG000|Baseline to Week 6|Lost to Follow-up|3|||
30839612|NCT03058679|58864982|FG001|Baseline to Week 6|Lost to Follow-up|2|||
30839613|NCT03058679|58864981|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
30932418|NCT01408576|58968516|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
30932419|NCT01408576|58968517|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
30932420|NCT01408576|58968518|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
30932421|NCT01408576|58968516|FG000|Overall Study|AE, unknown type|0|||
30932422|NCT01408576|58968517|FG001|Overall Study|AE, unknown type|1|||
30932423|NCT01408576|58968518|FG002|Overall Study|AE, unknown type|0|||
30932424|NCT01408576|58968516|FG000|Overall Study|Other|10|||
30932425|NCT01408576|58968517|FG001|Overall Study|Other|16|||
30932426|NCT01408576|58968518|FG002|Overall Study|Other|18|||
30932427|NCT01427920|58968540|FG000|Overall Study|Adverse Event|1|||
30932428|NCT01427920|58968541|FG001|Overall Study|Adverse Event|2|||
30932429|NCT01427920|58968540|FG000|Overall Study|Lack of Efficacy|1|||
30932430|NCT01427920|58968541|FG001|Overall Study|Lack of Efficacy|0|||
30932431|NCT01427920|58968540|FG000|Overall Study|Protocol Violation|1|||
30932432|NCT01427920|58968541|FG001|Overall Study|Protocol Violation|3|||
30932433|NCT01427920|58968540|FG000|Overall Study|Withdrawal Criteria|4|||
30932434|NCT01427920|58968541|FG001|Overall Study|Withdrawal Criteria|4|||
30932435|NCT01427920|58968540|FG000|Overall Study|Unclassified|2|||
30932436|NCT01427920|58968541|FG001|Overall Study|Unclassified|8|||
30932437|NCT01427608|58968549|FG000|Overall Study|Death|1|||
30932438|NCT01427608|58968550|FG001|Overall Study|Death|0|||
30932439|NCT01427608|58968549|FG000|Overall Study|Withdrawal by Subject|7|||
30932440|NCT01427608|58968550|FG001|Overall Study|Withdrawal by Subject|3|||
30932441|NCT01427608|58968549|FG000|Overall Study|Relapsed-all cause|13|||
30932442|NCT01427608|58968550|FG001|Overall Study|Relapsed-all cause|34|||
30932443|NCT01427608|58968549|FG000|Overall Study|Events not attributed to study meds|0|||
30932444|NCT01427608|58968550|FG001|Overall Study|Events not attributed to study meds|1|||
30932445|NCT01408030|58968562|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
30932446|NCT01408030|58968563|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
30932447|NCT01408030|58968564|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
30932448|NCT01408030|58968565|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
30932449|NCT01408030|58968562|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
30932450|NCT01408030|58968563|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
30932451|NCT01408030|58968564|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
30932452|NCT01408030|58968565|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
30932453|NCT01408030|58968562|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
30932454|NCT01408030|58968563|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
30932455|NCT01408030|58968564|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
30932456|NCT01408030|58968565|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
30932457|NCT01408030|58968562|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
30932458|NCT01408030|58968563|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
30932459|NCT01408030|58968564|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
30932460|NCT01408030|58968565|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
30932461|NCT01408030|58968562|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
30932462|NCT01408030|58968563|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
30932463|NCT01408030|58968564|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
30932464|NCT01408030|58968565|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
30932465|NCT01408030|58968562|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
30932466|NCT01408030|58968563|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
30932467|NCT01408030|58968564|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
30932468|NCT01408030|58968565|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
30932469|NCT01408030|58968562|FG000|Observation Phase (Off Drug)|Other|1|||
30932470|NCT01408030|58968563|FG001|Observation Phase (Off Drug)|Other|1|||
30932471|NCT01408030|58968564|FG002|Observation Phase (Off Drug)|Other|1|||
30932472|NCT01408030|58968565|FG003|Observation Phase (Off Drug)|Other|1|||
30932473|NCT01897532|58968577|FG000|Discontinuation From Treatment|Not Treated|7|||
30932474|NCT01897532|58968578|FG001|Discontinuation From Treatment|Not Treated|5|||
30932475|NCT01897532|58968577|FG000|Discontinuation From Treatment|Other reason than specified|196|||
30932476|NCT01897532|58968578|FG001|Discontinuation From Treatment|Other reason than specified|176|||
30932477|NCT01897532|58968577|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
30932478|NCT01897532|58968578|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
30932479|NCT01897532|58968577|FG000|Discontinuation From Treatment|Non compliance|24|||
30932480|NCT01897532|58968578|FG001|Discontinuation From Treatment|Non compliance|15|||
30932481|NCT01897532|58968577|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
30932482|NCT01897532|58968578|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
30932483|NCT01897532|58968577|FG000|Discontinuation From Trial|Not Treated|7|||
30932484|NCT01897532|58968578|FG001|Discontinuation From Trial|Not Treated|5|||
30758238|NCT00112437|58766932|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30932485|NCT01897532|58968577|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
30932486|NCT01897532|58968578|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
30932487|NCT01923428|58968588|FG000|Overall Study|Adverse Event|8|||
30932488|NCT01923428|58968589|FG001|Overall Study|Adverse Event|6|||
30932489|NCT01923428|58968590|FG002|Overall Study|Adverse Event|3|||
30932490|NCT01923428|58968591|FG003|Overall Study|Adverse Event|3|||
30932491|NCT01923428|58968588|FG000|Overall Study|Withdrawal by Subject|5|||
30932492|NCT01923428|58968589|FG001|Overall Study|Withdrawal by Subject|3|||
30932493|NCT01923428|58968590|FG002|Overall Study|Withdrawal by Subject|0|||
30932494|NCT01923428|58968591|FG003|Overall Study|Withdrawal by Subject|4|||
30932495|NCT01923428|58968588|FG000|Overall Study|Lost to Follow-up|2|||
30932496|NCT01923428|58968589|FG001|Overall Study|Lost to Follow-up|1|||
30932497|NCT01923428|58968590|FG002|Overall Study|Lost to Follow-up|5|||
30932498|NCT01923428|58968591|FG003|Overall Study|Lost to Follow-up|0|||
30932499|NCT01923428|58968588|FG000|Overall Study|Protocol Violation|3|||
30932500|NCT01923428|58968589|FG001|Overall Study|Protocol Violation|0|||
30932501|NCT01923428|58968590|FG002|Overall Study|Protocol Violation|2|||
30932502|NCT01923428|58968591|FG003|Overall Study|Protocol Violation|1|||
30932503|NCT01923428|58968588|FG000|Overall Study|Non Compliance to treatment|1|||
30932504|NCT01923428|58968589|FG001|Overall Study|Non Compliance to treatment|2|||
30932505|NCT01923428|58968590|FG002|Overall Study|Non Compliance to treatment|0|||
30932506|NCT01923428|58968591|FG003|Overall Study|Non Compliance to treatment|1|||
30932507|NCT01923428|58968588|FG000|Overall Study|Lack of Efficacy|0|||
30932508|NCT01923428|58968589|FG001|Overall Study|Lack of Efficacy|0|||
30932509|NCT01923428|58968590|FG002|Overall Study|Lack of Efficacy|1|||
30932510|NCT01923428|58968591|FG003|Overall Study|Lack of Efficacy|1|||
30932511|NCT01896986|58968603|FG000|Overall Study|samples lost|14|||
30932512|NCT01896986|58968604|FG001|Overall Study|samples lost|23|||
30932513|NCT01896128|58968612|FG000|Overall Study|Withdrawal by Subject|3|||
30932514|NCT01896128|58968613|FG001|Overall Study|Withdrawal by Subject|3|||
30932515|NCT01949870|58968619|FG000|Overall Study|Lack of Efficacy|2|||
30932516|NCT01949870|58968619|FG000|Overall Study|Adverse Event|1|||
30932517|NCT01949870|58968619|FG000|Overall Study|Study termination|1|||
30932518|NCT01949870|58968619|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
30932519|NCT01949480|58968625|FG000|Overall Study|Physician Decision|5|||
30932520|NCT01949480|58968626|FG001|Overall Study|Physician Decision|8|||
30932521|NCT01949090|58968637|FG000|Overall Study|Serious Adverse Event|0|||
30932522|NCT01949090|58968638|FG001|Overall Study|Serious Adverse Event|1|||
30932523|NCT01949090|58968639|FG002|Overall Study|Serious Adverse Event|2|||
30932524|NCT01949090|58968640|FG003|Overall Study|Serious Adverse Event|0|||
30932525|NCT01949090|58968641|FG004|Overall Study|Serious Adverse Event|1|||
30932526|NCT01949090|58968637|FG000|Overall Study|Withdrawal by Subject|2|||
30932527|NCT01949090|58968638|FG001|Overall Study|Withdrawal by Subject|0|||
30932528|NCT01949090|58968639|FG002|Overall Study|Withdrawal by Subject|0|||
30932529|NCT01949090|58968640|FG003|Overall Study|Withdrawal by Subject|0|||
30932530|NCT01949090|58968641|FG004|Overall Study|Withdrawal by Subject|1|||
30932531|NCT01949090|58968637|FG000|Overall Study|Protocol non-compliance|0|||
30932532|NCT01949090|58968638|FG001|Overall Study|Protocol non-compliance|0|||
30932533|NCT01949090|58968639|FG002|Overall Study|Protocol non-compliance|0|||
30932534|NCT01949090|58968640|FG003|Overall Study|Protocol non-compliance|0|||
30839614|NCT03058679|58864982|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
30839615|NCT03058679|58864981|FG000|Baseline to Week 6|Adverse Event|6|||
30839616|NCT03058679|58864982|FG001|Baseline to Week 6|Adverse Event|6|||
30839617|NCT03058679|58864981|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
30839618|NCT03058679|58864982|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
30839619|NCT03058679|58864981|FG000|Baseline to Week 6|Difficulty following the diet|0|||
30839620|NCT03058679|58864982|FG001|Baseline to Week 6|Difficulty following the diet|2|||
30839621|NCT03058679|58864981|FG000|Baseline to Week 6|Physician Decision|1|||
30839622|NCT03058679|58864982|FG001|Baseline to Week 6|Physician Decision|0|||
30839623|NCT03058679|58864981|FG000|Week 6 to Week 12|Change in medication|5|||
30839624|NCT03058679|58864982|FG001|Week 6 to Week 12|Change in medication|7|||
30839625|NCT03058679|58864981|FG000|Week 6 to Week 12|Adverse Event|4|||
30839626|NCT03058679|58864982|FG001|Week 6 to Week 12|Adverse Event|3|||
30839627|NCT03058679|58864981|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
30839628|NCT03058679|58864982|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
30839629|NCT03058679|58864981|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
30839630|NCT03058679|58864982|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
30839631|NCT03382821|58864990|FG000|Overall Study|Did not receive allocated intervention.|0|||
30839632|NCT03382821|58864991|FG001|Overall Study|Did not receive allocated intervention.|3|||
30839633|NCT02557516|58865002|FG000|Overall Study|Adverse Event|1|||
30839634|NCT02557516|58865003|FG001|Overall Study|Adverse Event|0|||
30839635|NCT02557516|58865004|FG002|Overall Study|Adverse Event|2|||
30932535|NCT01949090|58968641|FG004|Overall Study|Protocol non-compliance|1|||
30932536|NCT01949090|58968637|FG000|Overall Study|Lost to Follow-up|2|||
30932537|NCT01949090|58968638|FG001|Overall Study|Lost to Follow-up|1|||
30839636|NCT02557516|58865005|FG003|Overall Study|Adverse Event|1|||
30932538|NCT01949090|58968639|FG002|Overall Study|Lost to Follow-up|0|||
30932539|NCT01949090|58968640|FG003|Overall Study|Lost to Follow-up|1|||
30932540|NCT01949090|58968641|FG004|Overall Study|Lost to Follow-up|1|||
30932541|NCT01948076|58968656|FG000|Overall Study|Withdrawal by Subject|0|||
30932542|NCT01948076|58968657|FG001|Overall Study|Withdrawal by Subject|1|||
30839637|NCT02557516|58865002|FG000|Overall Study|Disease progression|0|||
30839638|NCT02557516|58865003|FG001|Overall Study|Disease progression|2|||
30839639|NCT02557516|58865004|FG002|Overall Study|Disease progression|0|||
30932543|NCT01922258|58968667|FG000|Overall Study|Lost to Follow-up|1|||
30932544|NCT01922258|58968668|FG001|Overall Study|Lost to Follow-up|1|||
30932545|NCT01922258|58968667|FG000|Overall Study|Adverse Event|9|||
30932546|NCT01922258|58968668|FG001|Overall Study|Adverse Event|2|||
30932547|NCT01922258|58968667|FG000|Overall Study|Met Withdrawal Criteria|0|||
30932548|NCT01922258|58968668|FG001|Overall Study|Met Withdrawal Criteria|4|||
30932549|NCT01922258|58968667|FG000|Overall Study|Withdrawn by the Investigator|1|||
30932550|NCT01922258|58968668|FG001|Overall Study|Withdrawn by the Investigator|4|||
30932551|NCT01922258|58968667|FG000|Overall Study|Withdrawal by participant|5|||
30932552|NCT01922258|58968668|FG001|Overall Study|Withdrawal by participant|5|||
30932553|NCT01406938|58968676|FG000|Induction Period|Subject/guardian decision|6|||
30932554|NCT01406938|58968677|FG001|Induction Period|Subject/guardian decision|8|||
30932555|NCT01406938|58968678|FG002|Induction Period|Subject/guardian decision|0|||
30932556|NCT01406938|58968679|FG003|Induction Period|Subject/guardian decision|0|||
30932557|NCT01406938|58968680|FG004|Induction Period|Subject/guardian decision|0|||
30932558|NCT01406938|58968681|FG005|Induction Period|Subject/guardian decision|0|||
30932559|NCT01406938|58968676|FG000|Induction Period|Protocol deviation|1|||
30932560|NCT01406938|58968677|FG001|Induction Period|Protocol deviation|0|||
30932561|NCT01406938|58968678|FG002|Induction Period|Protocol deviation|0|||
30932562|NCT01406938|58968679|FG003|Induction Period|Protocol deviation|0|||
30932563|NCT01406938|58968680|FG004|Induction Period|Protocol deviation|0|||
30932564|NCT01406938|58968681|FG005|Induction Period|Protocol deviation|0|||
30932565|NCT01406938|58968676|FG000|Induction Period|Adverse Event|8|||
30932566|NCT01406938|58968677|FG001|Induction Period|Adverse Event|9|||
30932567|NCT01406938|58968678|FG002|Induction Period|Adverse Event|0|||
30932568|NCT01406938|58968679|FG003|Induction Period|Adverse Event|0|||
30932569|NCT01406938|58968680|FG004|Induction Period|Adverse Event|0|||
30932570|NCT01406938|58968681|FG005|Induction Period|Adverse Event|0|||
30932571|NCT01406938|58968676|FG000|Induction Period|Lack of Efficacy|1|||
30932572|NCT01406938|58968677|FG001|Induction Period|Lack of Efficacy|0|||
30932573|NCT01406938|58968678|FG002|Induction Period|Lack of Efficacy|0|||
30932574|NCT01406938|58968679|FG003|Induction Period|Lack of Efficacy|0|||
30932575|NCT01406938|58968680|FG004|Induction Period|Lack of Efficacy|0|||
30932576|NCT01406938|58968681|FG005|Induction Period|Lack of Efficacy|0|||
30839640|NCT02557516|58865005|FG003|Overall Study|Disease progression|0|||
30839641|NCT02557516|58865002|FG000|Overall Study|Physician Decision|0|||
30839642|NCT02557516|58865003|FG001|Overall Study|Physician Decision|2|||
30839643|NCT02557516|58865004|FG002|Overall Study|Physician Decision|0|||
30932577|NCT01406938|58968676|FG000|Induction Period|Lost to Follow-up|2|||
30932578|NCT01406938|58968677|FG001|Induction Period|Lost to Follow-up|3|||
30932579|NCT01406938|58968678|FG002|Induction Period|Lost to Follow-up|0|||
30932580|NCT01406938|58968679|FG003|Induction Period|Lost to Follow-up|0|||
30932581|NCT01406938|58968680|FG004|Induction Period|Lost to Follow-up|0|||
30932582|NCT01406938|58968681|FG005|Induction Period|Lost to Follow-up|0|||
30932583|NCT01406938|58968676|FG000|Maintenance Period|Adverse Event|0|||
30932584|NCT01406938|58968677|FG001|Maintenance Period|Adverse Event|0|||
30932585|NCT01406938|58968678|FG002|Maintenance Period|Adverse Event|2|||
30932586|NCT01406938|58968679|FG003|Maintenance Period|Adverse Event|8|||
30932587|NCT01406938|58968680|FG004|Maintenance Period|Adverse Event|4|||
30932588|NCT01406938|58968681|FG005|Maintenance Period|Adverse Event|2|||
30932589|NCT01406938|58968676|FG000|Maintenance Period|Death|0|||
30932590|NCT01406938|58968677|FG001|Maintenance Period|Death|0|||
30932591|NCT01406938|58968678|FG002|Maintenance Period|Death|0|||
30932592|NCT01406938|58968679|FG003|Maintenance Period|Death|0|||
30932593|NCT01406938|58968680|FG004|Maintenance Period|Death|1|||
30932594|NCT01406938|58968681|FG005|Maintenance Period|Death|0|||
30932595|NCT01406938|58968676|FG000|Maintenance Period|Subject/guardian decision|0|||
30932596|NCT01406938|58968677|FG001|Maintenance Period|Subject/guardian decision|0|||
30932597|NCT01406938|58968678|FG002|Maintenance Period|Subject/guardian decision|11|||
30624243|NCT00958347|58636245|FG000|Overall Study|revision/removal|10|||
30839644|NCT02557516|58865005|FG003|Overall Study|Physician Decision|0|||
30932598|NCT01406938|58968679|FG003|Maintenance Period|Subject/guardian decision|7|||
30932599|NCT01406938|58968680|FG004|Maintenance Period|Subject/guardian decision|10|||
30932600|NCT01406938|58968681|FG005|Maintenance Period|Subject/guardian decision|7|||
30932601|NCT01406938|58968676|FG000|Maintenance Period|Protocol Violation|0|||
30932602|NCT01406938|58968677|FG001|Maintenance Period|Protocol Violation|0|||
30932603|NCT01406938|58968678|FG002|Maintenance Period|Protocol Violation|2|||
30932604|NCT01406938|58968679|FG003|Maintenance Period|Protocol Violation|2|||
30932605|NCT01406938|58968680|FG004|Maintenance Period|Protocol Violation|2|||
30932606|NCT01406938|58968681|FG005|Maintenance Period|Protocol Violation|2|||
30932607|NCT01406938|58968676|FG000|Maintenance Period|Pregnancy|0|||
30624244|NCT00958347|58636245|FG000|Overall Study|study termination|135|||
30839645|NCT02557516|58865002|FG000|Overall Study|Sponsor decision|0|||
30932608|NCT01406938|58968677|FG001|Maintenance Period|Pregnancy|0|||
30932609|NCT01406938|58968678|FG002|Maintenance Period|Pregnancy|0|||
30932610|NCT01406938|58968679|FG003|Maintenance Period|Pregnancy|0|||
30932611|NCT01406938|58968680|FG004|Maintenance Period|Pregnancy|1|||
30932612|NCT01406938|58968681|FG005|Maintenance Period|Pregnancy|0|||
30948532|NCT01964105|58994542|FG001|Overall Study|Lost to Follow-up|13|||
30932613|NCT01406938|58968676|FG000|Maintenance Period|Lost to Follow-up|0|||
30932614|NCT01406938|58968677|FG001|Maintenance Period|Lost to Follow-up|0|||
30932615|NCT01406938|58968678|FG002|Maintenance Period|Lost to Follow-up|0|||
30932616|NCT01406938|58968679|FG003|Maintenance Period|Lost to Follow-up|0|||
30932617|NCT01406938|58968680|FG004|Maintenance Period|Lost to Follow-up|4|||
30932618|NCT01406938|58968681|FG005|Maintenance Period|Lost to Follow-up|0|||
30932619|NCT01406938|58968676|FG000|Maintenance Period|Lack of Efficacy|0|||
30932620|NCT01406938|58968677|FG001|Maintenance Period|Lack of Efficacy|0|||
30932621|NCT01406938|58968678|FG002|Maintenance Period|Lack of Efficacy|2|||
30932622|NCT01406938|58968679|FG003|Maintenance Period|Lack of Efficacy|1|||
30932623|NCT01406938|58968680|FG004|Maintenance Period|Lack of Efficacy|3|||
30932624|NCT01406938|58968681|FG005|Maintenance Period|Lack of Efficacy|5|||
30932625|NCT01406938|58968676|FG000|Follow up|Lack of Efficacy|3|||
30932626|NCT01406938|58968677|FG001|Follow up|Lack of Efficacy|2|||
30932627|NCT01406938|58968678|FG002|Follow up|Lack of Efficacy|1|||
30932628|NCT01406938|58968679|FG003|Follow up|Lack of Efficacy|0|||
30932629|NCT01406938|58968680|FG004|Follow up|Lack of Efficacy|0|||
30932630|NCT01406938|58968681|FG005|Follow up|Lack of Efficacy|0|||
30932631|NCT01406938|58968676|FG000|Follow up|Patient/guardian decision|4|||
30932632|NCT01406938|58968677|FG001|Follow up|Patient/guardian decision|2|||
30932633|NCT01406938|58968678|FG002|Follow up|Patient/guardian decision|4|||
30932634|NCT01406938|58968679|FG003|Follow up|Patient/guardian decision|2|||
30932635|NCT01406938|58968680|FG004|Follow up|Patient/guardian decision|4|||
30932636|NCT01406938|58968681|FG005|Follow up|Patient/guardian decision|1|||
30932637|NCT01406938|58968676|FG000|Follow up|Protocol Violation|0|||
30932638|NCT01406938|58968677|FG001|Follow up|Protocol Violation|0|||
30932639|NCT01406938|58968678|FG002|Follow up|Protocol Violation|1|||
30932640|NCT01406938|58968679|FG003|Follow up|Protocol Violation|0|||
30932641|NCT01406938|58968680|FG004|Follow up|Protocol Violation|0|||
30932642|NCT01406938|58968681|FG005|Follow up|Protocol Violation|0|||
30932643|NCT01406938|58968676|FG000|Follow up|Physician Decision|0|||
30932644|NCT01406938|58968677|FG001|Follow up|Physician Decision|0|||
30932645|NCT01406938|58968678|FG002|Follow up|Physician Decision|2|||
30932646|NCT01406938|58968679|FG003|Follow up|Physician Decision|0|||
30932647|NCT01406938|58968680|FG004|Follow up|Physician Decision|3|||
30932648|NCT01406938|58968681|FG005|Follow up|Physician Decision|1|||
30932649|NCT01406938|58968676|FG000|Follow up|Lost to Follow-up|1|||
30932650|NCT01406938|58968677|FG001|Follow up|Lost to Follow-up|1|||
30932651|NCT01406938|58968678|FG002|Follow up|Lost to Follow-up|0|||
30932652|NCT01406938|58968679|FG003|Follow up|Lost to Follow-up|1|||
30932653|NCT01406938|58968680|FG004|Follow up|Lost to Follow-up|2|||
30932654|NCT01406938|58968681|FG005|Follow up|Lost to Follow-up|1|||
30932655|NCT01405924|58968701|FG000|Overall Study|Protocol Violation|8|||
30932656|NCT01405924|58968701|FG000|Overall Study|Missing/Incomplete Data|2|||
30932657|NCT01426438|58968709|FG000|Overall Study|Lost to Follow-up|1|||
30932658|NCT01426438|58968710|FG001|Overall Study|Lost to Follow-up|3|||
30839646|NCT02557516|58865003|FG001|Overall Study|Sponsor decision|1|||
30839647|NCT02557516|58865004|FG002|Overall Study|Sponsor decision|2|||
30932659|NCT01426438|58968709|FG000|Overall Study|Off study Treatment|9|||
30932660|NCT01426438|58968710|FG001|Overall Study|Off study Treatment|3|||
30839648|NCT02557516|58865005|FG003|Overall Study|Sponsor decision|8|||
30839649|NCT00711555|58865024|FG000|Overall Study|Adverse Event|3|||
30839650|NCT02713490|58865029|FG000|Overall Study|Withdrawal by Subject|2|||
30839651|NCT02713490|58865030|FG001|Overall Study|Withdrawal by Subject|1|||
30839652|NCT02713490|58865029|FG000|Overall Study|Did not receive study drug|1|||
30839653|NCT02713490|58865030|FG001|Overall Study|Did not receive study drug|0|||
30839654|NCT02713490|58865029|FG000|Overall Study|Met exclusion criteria|0|||
30839655|NCT02713490|58865030|FG001|Overall Study|Met exclusion criteria|1|||
30839656|NCT03772574|58865039|FG000|Overall Study|Protocol Violation|2|||
30839657|NCT03772574|58865040|FG001|Overall Study|Protocol Violation|0|||
30839658|NCT03772574|58865041|FG002|Overall Study|Protocol Violation|0|||
30839659|NCT03772574|58865039|FG000|Overall Study|Discomfort|0|||
30839660|NCT03772574|58865040|FG001|Overall Study|Discomfort|5|||
30839661|NCT03772574|58865041|FG002|Overall Study|Discomfort|4|||
30839662|NCT02743221|58865051|FG000|Overall Study|Progressive disease|29|||
30839663|NCT02743221|58865052|FG001|Overall Study|Progressive disease|38|||
30839664|NCT02743221|58865051|FG000|Overall Study|Adverse Event|17|||
30839665|NCT02743221|58865052|FG001|Overall Study|Adverse Event|14|||
30839666|NCT02743221|58865051|FG000|Overall Study|non medical reason|8|||
30932661|NCT01426438|58968709|FG000|Overall Study|Poor scan quality|3|||
30932662|NCT01426438|58968710|FG001|Overall Study|Poor scan quality|2|||
30932663|NCT01426438|58968709|FG000|Overall Study|Missed Scan|2|||
30932664|NCT01426438|58968710|FG001|Overall Study|Missed Scan|2|||
30932665|NCT01425814|58968716|FG000|Period 1|Stability criteria not fulfilled|0|||
30932666|NCT01425814|58968717|FG001|Period 1|Stability criteria not fulfilled|1|||
30932667|NCT01425814|58968718|FG002|Period 1|Stability criteria not fulfilled|0|||
30932668|NCT01425814|58968719|FG003|Period 1|Stability criteria not fulfilled|0|||
30839667|NCT02743221|58865052|FG001|Overall Study|non medical reason|2|||
30839668|NCT02743221|58865051|FG000|Overall Study|Physician Decision|2|||
30932669|NCT01425814|58968720|FG004|Period 1|Stability criteria not fulfilled|0|||
30932670|NCT01425814|58968721|FG005|Period 1|Stability criteria not fulfilled|0|||
30932671|NCT01425814|58968716|FG000|Period 2|Stability criteria not fulfilled|0|||
30932672|NCT01425814|58968717|FG001|Period 2|Stability criteria not fulfilled|1|||
30932673|NCT01425814|58968718|FG002|Period 2|Stability criteria not fulfilled|0|||
30932674|NCT01425814|58968719|FG003|Period 2|Stability criteria not fulfilled|0|||
30932675|NCT01425814|58968720|FG004|Period 2|Stability criteria not fulfilled|0|||
30932676|NCT01425814|58968721|FG005|Period 2|Stability criteria not fulfilled|0|||
30932677|NCT01425814|58968716|FG000|Period 3|Adverse Event|0|||
30932678|NCT01425814|58968717|FG001|Period 3|Adverse Event|0|||
30932679|NCT01425814|58968718|FG002|Period 3|Adverse Event|0|||
30932680|NCT01425814|58968719|FG003|Period 3|Adverse Event|0|||
30932681|NCT01425814|58968720|FG004|Period 3|Adverse Event|0|||
30932682|NCT01425814|58968721|FG005|Period 3|Adverse Event|1|||
30932683|NCT01425814|58968716|FG000|Period 4|Adverse Event|1|||
30932684|NCT01425814|58968717|FG001|Period 4|Adverse Event|0|||
30932685|NCT01425814|58968718|FG002|Period 4|Adverse Event|1|||
30932686|NCT01425814|58968719|FG003|Period 4|Adverse Event|0|||
30932687|NCT01425814|58968720|FG004|Period 4|Adverse Event|0|||
30932688|NCT01425814|58968721|FG005|Period 4|Adverse Event|0|||
30932689|NCT01425814|58968716|FG000|Period 5|Stability criteria not fulfilled|0|||
30932690|NCT01425814|58968717|FG001|Period 5|Stability criteria not fulfilled|0|||
30932691|NCT01425814|58968718|FG002|Period 5|Stability criteria not fulfilled|1|||
30932692|NCT01425814|58968719|FG003|Period 5|Stability criteria not fulfilled|0|||
30932693|NCT01425814|58968720|FG004|Period 5|Stability criteria not fulfilled|0|||
30932694|NCT01425814|58968721|FG005|Period 5|Stability criteria not fulfilled|1|||
30932695|NCT01782495|58968746|FG000|Overall Study|Adverse Event|0|||
30932696|NCT01782495|58968747|FG001|Overall Study|Adverse Event|0|||
30932697|NCT01782495|58968748|FG002|Overall Study|Adverse Event|0|||
30932698|NCT01782495|58968749|FG003|Overall Study|Adverse Event|0|||
30932699|NCT01782495|58968750|FG004|Overall Study|Adverse Event|0|||
30932700|NCT01782495|58968751|FG005|Overall Study|Adverse Event|0|||
30932701|NCT01782495|58968752|FG006|Overall Study|Adverse Event|0|||
30932702|NCT01782495|58968753|FG007|Overall Study|Adverse Event|2|||
30932703|NCT01782495|58968754|FG008|Overall Study|Adverse Event|0|||
30932704|NCT01782495|58968755|FG009|Overall Study|Adverse Event|0|||
30932705|NCT01782495|58968756|FG010|Overall Study|Adverse Event|0|||
30932706|NCT01782495|58968746|FG000|Overall Study|Withdrew Consent|0|||
30932707|NCT01782495|58968747|FG001|Overall Study|Withdrew Consent|1|||
30932708|NCT01782495|58968748|FG002|Overall Study|Withdrew Consent|0|||
30932709|NCT01782495|58968749|FG003|Overall Study|Withdrew Consent|0|||
30932710|NCT01782495|58968750|FG004|Overall Study|Withdrew Consent|0|||
30932711|NCT01782495|58968751|FG005|Overall Study|Withdrew Consent|0|||
30932712|NCT01782495|58968752|FG006|Overall Study|Withdrew Consent|0|||
30932713|NCT01782495|58968753|FG007|Overall Study|Withdrew Consent|1|||
30932714|NCT01782495|58968754|FG008|Overall Study|Withdrew Consent|0|||
30932715|NCT01782495|58968755|FG009|Overall Study|Withdrew Consent|0|||
30932716|NCT01782495|58968756|FG010|Overall Study|Withdrew Consent|0|||
30932717|NCT01922102|58968783|FG000|Overall Study|Withdrawal by Subject|7|||
30932718|NCT01922102|58968784|FG001|Overall Study|Withdrawal by Subject|3|||
30932719|NCT01922102|58968785|FG002|Overall Study|Withdrawal by Subject|7|||
30932720|NCT01922102|58968783|FG000|Overall Study|Physician Decision|0|||
30932721|NCT01922102|58968784|FG001|Overall Study|Physician Decision|2|||
30932722|NCT01922102|58968785|FG002|Overall Study|Physician Decision|1|||
30932723|NCT01922102|58968783|FG000|Overall Study|Adverse Event|1|||
30932724|NCT01922102|58968784|FG001|Overall Study|Adverse Event|2|||
30932725|NCT01922102|58968785|FG002|Overall Study|Adverse Event|0|||
30758239|NCT00112437|58766933|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758240|NCT00112437|58766934|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758241|NCT00112437|58766935|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30932726|NCT01922102|58968783|FG000|Overall Study|Lost to Follow-up|1|||
30932727|NCT01922102|58968784|FG001|Overall Study|Lost to Follow-up|0|||
30932728|NCT01922102|58968785|FG002|Overall Study|Lost to Follow-up|0|||
30932729|NCT01922102|58968783|FG000|Overall Study|Administrative problems|0|||
30932730|NCT01922102|58968784|FG001|Overall Study|Administrative problems|2|||
30932731|NCT01922102|58968785|FG002|Overall Study|Administrative problems|0|||
30932732|NCT01405768|58968799|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
30932733|NCT01405768|58968800|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
30932734|NCT01913353|58968808|FG000|Overall Study|Adverse Event|2|||
30758242|NCT00112437|58766936|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30932735|NCT01913353|58968809|FG001|Overall Study|Adverse Event|0|||
30932736|NCT01913353|58968808|FG000|Overall Study|Physician Decision|0|||
30932737|NCT01913353|58968809|FG001|Overall Study|Physician Decision|2|||
30932738|NCT01913353|58968808|FG000|Overall Study|Withdrawal by Subject|20|||
30932739|NCT01913353|58968809|FG001|Overall Study|Withdrawal by Subject|6|||
30932740|NCT01913353|58968808|FG000|Overall Study|multiple reasons|10|||
30932741|NCT01913353|58968809|FG001|Overall Study|multiple reasons|7|||
30932742|NCT01754259|58968824|FG000|Overall Study|Withdrawal by Subject|2|||
30932743|NCT01754259|58968825|FG001|Overall Study|Withdrawal by Subject|4|||
30932744|NCT01754259|58968824|FG000|Overall Study|Adverse Event|3|||
30932745|NCT01754259|58968825|FG001|Overall Study|Adverse Event|1|||
30932746|NCT01754259|58968824|FG000|Overall Study|Lost to Follow-up|0|||
30932747|NCT01754259|58968825|FG001|Overall Study|Lost to Follow-up|1|||
30932748|NCT01405456|58968833|FG000|Overall Study|Lost to Follow-up|2|||
30932749|NCT01405456|58968834|FG001|Overall Study|Lost to Follow-up|1|||
30932750|NCT01405456|58968833|FG000|Overall Study|Physician Decision|1|||
30932751|NCT01405456|58968834|FG001|Overall Study|Physician Decision|0|||
30932752|NCT01404988|58968843|FG000|Overall Study|Death|2|||
30932753|NCT01404988|58968844|FG001|Overall Study|Death|0|||
30932754|NCT01404988|58968845|FG002|Overall Study|Death|2|||
30932755|NCT01404988|58968843|FG000|Overall Study|Adverse Event|1|||
30932756|NCT01404988|58968844|FG001|Overall Study|Adverse Event|0|||
30932757|NCT01404988|58968845|FG002|Overall Study|Adverse Event|0|||
30932758|NCT01404988|58968843|FG000|Overall Study|Withdrawal by Subject|2|||
30932759|NCT01404988|58968844|FG001|Overall Study|Withdrawal by Subject|2|||
30932760|NCT01404988|58968845|FG002|Overall Study|Withdrawal by Subject|0|||
30932761|NCT01404988|58968843|FG000|Overall Study|Lost to Follow-up|1|||
30932762|NCT01404988|58968844|FG001|Overall Study|Lost to Follow-up|2|||
30932763|NCT01404988|58968845|FG002|Overall Study|Lost to Follow-up|1|||
30932764|NCT01389232|58968856|FG000|Overall Study|Had scaffold removed|15|||
30932765|NCT01389232|58968856|FG000|Overall Study|Personal reasons|2|||
30932766|NCT01389232|58968856|FG000|Overall Study|Adverse Event|1|||
30932767|NCT01389232|58968856|FG000|Overall Study|Death|1|||
30932768|NCT01404208|58968872|FG000|Overall Study|Discontinued|3|||
30932769|NCT01404208|58968873|FG001|Overall Study|Discontinued|0|||
30932770|NCT01617668|58968881|FG000|Overall Study|Adverse Event|7|||
30932771|NCT01617668|58968882|FG001|Overall Study|Adverse Event|0|||
30932772|NCT01617668|58968883|FG002|Overall Study|Adverse Event|12|||
30932773|NCT01617668|58968884|FG003|Overall Study|Adverse Event|5|||
30932774|NCT01617668|58968881|FG000|Overall Study|Physician Decision|1|||
30932775|NCT01617668|58968882|FG001|Overall Study|Physician Decision|2|||
30932776|NCT01617668|58968883|FG002|Overall Study|Physician Decision|3|||
30932777|NCT01617668|58968884|FG003|Overall Study|Physician Decision|0|||
30932778|NCT01617668|58968881|FG000|Overall Study|Progressive Disease|4|||
30932779|NCT01617668|58968882|FG001|Overall Study|Progressive Disease|4|||
30932780|NCT01617668|58968883|FG002|Overall Study|Progressive Disease|6|||
30932781|NCT01617668|58968884|FG003|Overall Study|Progressive Disease|9|||
30932782|NCT01617668|58968881|FG000|Overall Study|Subject/guardian decision|1|||
30932783|NCT01617668|58968882|FG001|Overall Study|Subject/guardian decision|3|||
30932784|NCT01617668|58968883|FG002|Overall Study|Subject/guardian decision|2|||
30932785|NCT01617668|58968884|FG003|Overall Study|Subject/guardian decision|1|||
30932786|NCT01425268|58968900|FG000|Overall Study|Withdrawal by Subject|2|||
30932787|NCT01425268|58968901|FG001|Overall Study|Withdrawal by Subject|0|||
30932788|NCT01425268|58968900|FG000|Overall Study|Sponsor Decision|5|||
30932789|NCT01425268|58968901|FG001|Overall Study|Sponsor Decision|0|||
30932790|NCT01425268|58968900|FG000|Overall Study|Physician Decision|1|||
30932791|NCT01425268|58968901|FG001|Overall Study|Physician Decision|0|||
30932792|NCT01425190|58968910|FG000|Overall Study|Full dose not consumed.|1|||
30932793|NCT01425190|58968911|FG001|Overall Study|Full dose not consumed.|0|||
30932794|NCT01425190|58968912|FG002|Overall Study|Full dose not consumed.|0|||
30839669|NCT02743221|58865052|FG001|Overall Study|Physician Decision|5|||
30839670|NCT02743221|58865051|FG000|Overall Study|Patient not eligible, not treated|0|||
30839671|NCT02743221|58865052|FG001|Overall Study|Patient not eligible, not treated|1|||
30839672|NCT03929757|58865060|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
30839673|NCT03929757|58865061|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
30839674|NCT03929757|58865062|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
30839675|NCT03929757|58865060|FG000|Main Study: Up to Day 365|Other|1|||
30839676|NCT03929757|58865061|FG001|Main Study: Up to Day 365|Other|0|||
30839677|NCT03929757|58865062|FG002|Main Study: Up to Day 365|Other|0|||
30839678|NCT03929757|58865060|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
30839679|NCT03929757|58865061|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
30839680|NCT03929757|58865062|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
30932795|NCT01388530|58968920|FG000|Overall Study|Lost to Follow-up|5|||
30932796|NCT01895270|58968926|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
30932797|NCT01895270|58968927|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
30839681|NCT03836625|58865071|FG000|Overall Study|Lost to Follow-up|9|||
30839682|NCT03836625|58865072|FG001|Overall Study|Lost to Follow-up|9|||
30932798|NCT01895270|58968926|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
30932799|NCT01895270|58968927|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
30932800|NCT01895270|58968926|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
30932801|NCT01895270|58968927|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
30932802|NCT01895270|58968926|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
30932803|NCT01895270|58968927|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
30932804|NCT01895270|58968926|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
30932805|NCT01895270|58968927|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
30932806|NCT01895270|58968926|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
30932807|NCT01895270|58968927|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
30932808|NCT01895270|58968926|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
30932809|NCT01895270|58968927|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
30932810|NCT01424722|58968933|FG000|Overall Study|Sponsor terminated investigation|2258|||
30932811|NCT01424644|58968939|FG000|Overall Study|Adverse Event|2|||
30932812|NCT01424644|58968940|FG001|Overall Study|Adverse Event|0|||
30932813|NCT01424644|58968939|FG000|Overall Study|Withdrawal by Subject|9|||
30932814|NCT01424644|58968940|FG001|Overall Study|Withdrawal by Subject|12|||
30932815|NCT01424644|58968939|FG000|Overall Study|Lost to Follow-up|16|||
30932816|NCT01424644|58968940|FG001|Overall Study|Lost to Follow-up|12|||
30932817|NCT01424644|58968939|FG000|Overall Study|Protocol Violation|4|||
30932818|NCT01424644|58968940|FG001|Overall Study|Protocol Violation|3|||
30932819|NCT01424644|58968939|FG000|Overall Study|Administrative Reason|1|||
30932820|NCT01424644|58968940|FG001|Overall Study|Administrative Reason|0|||
30932821|NCT01424644|58968939|FG000|Overall Study|Unable to Classify|1|||
30932822|NCT01424644|58968940|FG001|Overall Study|Unable to Classify|0|||
30932823|NCT01920854|58968953|FG000|Overall Study|Withdrawal by Subject|1|||
30932824|NCT01920854|58968954|FG001|Overall Study|Withdrawal by Subject|0|||
30932825|NCT01920854|58968955|FG002|Overall Study|Withdrawal by Subject|0|||
30932826|NCT01920854|58968956|FG003|Overall Study|Withdrawal by Subject|0|||
30932827|NCT01920854|58968957|FG004|Overall Study|Withdrawal by Subject|1|||
30932828|NCT01920854|58968958|FG005|Overall Study|Withdrawal by Subject|0|||
30932829|NCT01920854|58968959|FG006|Overall Study|Withdrawal by Subject|1|||
30932830|NCT01403194|58968994|FG000|Overall Study|Screen Failure|2|||
30932831|NCT01403194|58968994|FG000|Overall Study|Lost to Follow-up|8|||
30932832|NCT01403116|58969000|FG000|Overall Study|Adverse Event|7|||
30839683|NCT03836625|58865071|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
30839684|NCT03836625|58865072|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
30932833|NCT01403116|58969001|FG001|Overall Study|Adverse Event|4|||
30932834|NCT01403116|58969000|FG000|Overall Study|Lost to Follow-up|7|||
30932835|NCT01403116|58969001|FG001|Overall Study|Lost to Follow-up|5|||
30932836|NCT01403116|58969000|FG000|Overall Study|Withdrawal by Subject|12|||
30932837|NCT01403116|58969001|FG001|Overall Study|Withdrawal by Subject|15|||
30932838|NCT01403116|58969000|FG000|Overall Study|Non-compliance of study drug|3|||
30932839|NCT01403116|58969001|FG001|Overall Study|Non-compliance of study drug|0|||
30932840|NCT01403116|58969000|FG000|Overall Study|Protocol Violation|0|||
30932841|NCT01403116|58969001|FG001|Overall Study|Protocol Violation|1|||
30932842|NCT01403116|58969000|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
30932843|NCT01403116|58969001|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
30932844|NCT01403116|58969000|FG000|Overall Study|Hct >54%|2|||
30932845|NCT01403116|58969001|FG001|Overall Study|Hct >54%|0|||
30932846|NCT01403116|58969000|FG000|Overall Study|unable to keep appointments|0|||
30932847|NCT01403116|58969001|FG001|Overall Study|unable to keep appointments|2|||
30932848|NCT01402570|58969007|FG000|Overall Study|Adverse Event|1|||
30932849|NCT01753401|58969014|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
30932850|NCT01753401|58969015|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
30932851|NCT01753401|58969016|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
30932852|NCT01753401|58969017|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
30932853|NCT01753401|58969014|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
30932854|NCT01753401|58969015|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
30932855|NCT01753401|58969016|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
30932856|NCT01753401|58969017|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
30932857|NCT01753401|58969014|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
30932858|NCT01753401|58969015|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
30932859|NCT01753401|58969016|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
30932860|NCT01753401|58969017|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
30932861|NCT01753401|58969014|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
30839685|NCT03836625|58865071|FG000|Overall Study|Death|0|||
30839686|NCT03836625|58865072|FG001|Overall Study|Death|1|||
30839687|NCT03836625|58865071|FG000|Overall Study|Refused follow-up|0|||
30932862|NCT01753401|58969015|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
30932863|NCT01753401|58969016|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
30932864|NCT01753401|58969017|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
30839688|NCT03836625|58865072|FG001|Overall Study|Refused follow-up|1|||
30932865|NCT01753401|58969014|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
30932866|NCT01753401|58969015|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
30932867|NCT01753401|58969016|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
30932868|NCT01753401|58969017|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
30932869|NCT01753401|58969014|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
30932870|NCT01753401|58969015|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
30932871|NCT01753401|58969016|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
30932872|NCT01753401|58969017|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
30932873|NCT01753401|58969014|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
30932874|NCT01753401|58969015|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
30932875|NCT01753401|58969016|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
30932876|NCT01753401|58969017|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
30932877|NCT01618916|58969033|FG000|Overall Study|Adverse Event|1|||
30932878|NCT01618916|58969034|FG001|Overall Study|Adverse Event|0|||
30932879|NCT01618916|58969035|FG002|Overall Study|Adverse Event|0|||
30932880|NCT01618916|58969036|FG003|Overall Study|Adverse Event|0|||
30932881|NCT01618916|58969037|FG004|Overall Study|Adverse Event|0|||
30932882|NCT01618916|58969038|FG005|Overall Study|Adverse Event|0|||
30932883|NCT01618916|58969033|FG000|Overall Study|Withdrawal by Subject|0|||
30932884|NCT01618916|58969034|FG001|Overall Study|Withdrawal by Subject|1|||
30932885|NCT01618916|58969035|FG002|Overall Study|Withdrawal by Subject|1|||
30932886|NCT01618916|58969036|FG003|Overall Study|Withdrawal by Subject|0|||
30932887|NCT01618916|58969037|FG004|Overall Study|Withdrawal by Subject|1|||
30932888|NCT01618916|58969038|FG005|Overall Study|Withdrawal by Subject|0|||
30932889|NCT01618916|58969033|FG000|Overall Study|Lost to Follow-up|1|||
30932890|NCT01618916|58969034|FG001|Overall Study|Lost to Follow-up|0|||
30932891|NCT01618916|58969035|FG002|Overall Study|Lost to Follow-up|0|||
30932892|NCT01618916|58969036|FG003|Overall Study|Lost to Follow-up|2|||
30932893|NCT01618916|58969037|FG004|Overall Study|Lost to Follow-up|0|||
30932894|NCT01618916|58969038|FG005|Overall Study|Lost to Follow-up|0|||
30932895|NCT01753323|58969054|FG000|Overall Study|Lack of Efficacy|0|||
30932896|NCT01753323|58969055|FG001|Overall Study|Lack of Efficacy|0|||
30932897|NCT01753323|58969056|FG002|Overall Study|Lack of Efficacy|8|||
30932898|NCT01753323|58969054|FG000|Overall Study|Protocol deviation|1|||
30932899|NCT01753323|58969055|FG001|Overall Study|Protocol deviation|0|||
30932900|NCT01753323|58969056|FG002|Overall Study|Protocol deviation|0|||
30932901|NCT01753323|58969054|FG000|Overall Study|Adverse Event|0|||
30932902|NCT01753323|58969055|FG001|Overall Study|Adverse Event|0|||
30932903|NCT01753323|58969056|FG002|Overall Study|Adverse Event|1|||
30932904|NCT01894568|58969067|FG000|Overall Study|Adverse Event|2|||
30932905|NCT01894568|58969068|FG001|Overall Study|Adverse Event|3|||
30932906|NCT01894568|58969067|FG000|Overall Study|Protocol required discontinuation|2|||
30932907|NCT01894568|58969068|FG001|Overall Study|Protocol required discontinuation|1|||
30932908|NCT01894568|58969067|FG000|Overall Study|Withdrawal by Subject|5|||
30932909|NCT01894568|58969068|FG001|Overall Study|Withdrawal by Subject|5|||
30932910|NCT01894568|58969067|FG000|Overall Study|Physician Decision|1|||
30932911|NCT01894568|58969068|FG001|Overall Study|Physician Decision|0|||
30932912|NCT01894568|58969067|FG000|Overall Study|Lost to Follow-up|0|||
30758243|NCT00112437|58766937|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30839689|NCT01358968|58865078|FG000|Period 2|Adverse Event|0|||
30839690|NCT01358968|58865079|FG001|Period 2|Adverse Event|1|||
30839691|NCT01358968|58865080|FG002|Period 2|Adverse Event|0|||
30839692|NCT01358968|58865081|FG003|Period 2|Adverse Event|0|||
30839693|NCT01358968|58865078|FG000|Continued Access Phase|Progression of Disease|0|||
30839694|NCT01358968|58865079|FG001|Continued Access Phase|Progression of Disease|0|||
30839695|NCT01358968|58865080|FG002|Continued Access Phase|Progression of Disease|8|||
30839696|NCT01358968|58865081|FG003|Continued Access Phase|Progression of Disease|4|||
30839697|NCT01358968|58865078|FG000|Continued Access Phase|Protocol Violation|0|||
30839698|NCT01358968|58865079|FG001|Continued Access Phase|Protocol Violation|0|||
30839699|NCT01358968|58865080|FG002|Continued Access Phase|Protocol Violation|0|||
30839700|NCT01358968|58865081|FG003|Continued Access Phase|Protocol Violation|2|||
30839701|NCT01358968|58865078|FG000|Continued Access Phase|Withdrawal by Subject|0|||
30932913|NCT01894568|58969068|FG001|Overall Study|Lost to Follow-up|1|||
30932914|NCT01618838|58969075|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
30758244|NCT00112437|58766938|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758245|NCT00112437|58766939|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758246|NCT00112437|58766940|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758247|NCT00112437|58766941|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758248|NCT00112437|58766942|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758249|NCT00112437|58766943|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30932915|NCT01920152|58969082|FG000|Overall Study|Withdrawal by Subject|1|||
30932916|NCT01920152|58969083|FG001|Overall Study|Withdrawal by Subject|2|||
30839702|NCT01358968|58865079|FG001|Continued Access Phase|Withdrawal by Subject|0|||
30932917|NCT01752933|58969091|FG000|Treatment|Disease Progression|3|||
30932918|NCT01752933|58969092|FG001|Treatment|Disease Progression|29|||
30932919|NCT01752933|58969091|FG000|Treatment|Withdrawal by Subject|0|||
30932920|NCT01752933|58969092|FG001|Treatment|Withdrawal by Subject|5|||
30932921|NCT01752933|58969091|FG000|Treatment|Adverse Event|1|||
30839703|NCT01358968|58865080|FG002|Continued Access Phase|Withdrawal by Subject|3|||
30839704|NCT01358968|58865081|FG003|Continued Access Phase|Withdrawal by Subject|0|||
30932922|NCT01752933|58969092|FG001|Treatment|Adverse Event|4|||
30932923|NCT01752933|58969091|FG000|Treatment|Physician Decision|0|||
30932924|NCT01752933|58969092|FG001|Treatment|Physician Decision|3|||
30932925|NCT01752933|58969091|FG000|Treatment|Death|0|||
30932926|NCT01752933|58969092|FG001|Treatment|Death|2|||
30932927|NCT01752933|58969091|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
30932928|NCT01752933|58969092|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
30932929|NCT01752933|58969091|FG000|Treatment|Patient noncompliant|0|||
30932930|NCT01752933|58969092|FG001|Treatment|Patient noncompliant|1|||
30839705|NCT01358968|58865078|FG000|Continued Access Phase|Death|0|||
30839706|NCT01358968|58865079|FG001|Continued Access Phase|Death|0|||
30839707|NCT01358968|58865080|FG002|Continued Access Phase|Death|1|||
30839708|NCT01358968|58865081|FG003|Continued Access Phase|Death|1|||
30839709|NCT00701090|58865093|FG000|Overall Study|Adverse Event|11|||
30839710|NCT00701090|58865094|FG001|Overall Study|Adverse Event|2|||
30839711|NCT00701090|58865093|FG000|Overall Study|Death|0|||
30839712|NCT00701090|58865094|FG001|Overall Study|Death|1|||
30839713|NCT00701090|58865093|FG000|Overall Study|Lack of Efficacy|5|||
30839714|NCT00701090|58865094|FG001|Overall Study|Lack of Efficacy|4|||
30932931|NCT01752933|58969091|FG000|Treatment|Patient unable to travel to appointments|0|||
30932932|NCT01752933|58969092|FG001|Treatment|Patient unable to travel to appointments|1|||
30932933|NCT01752933|58969091|FG000|Overall Study and Follow-up|Death|4|||
30932934|NCT01752933|58969092|FG001|Overall Study and Follow-up|Death|34|||
30932935|NCT01752933|58969091|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
30932936|NCT01752933|58969092|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
30932937|NCT01752933|58969091|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
30932938|NCT01752933|58969092|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
30932939|NCT01752933|58969091|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
30932940|NCT01752933|58969092|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
30932941|NCT01752855|58969101|FG000|Overall Study|Adverse Event|1|||
30932942|NCT01752855|58969102|FG001|Overall Study|Adverse Event|0|||
30932943|NCT01752855|58969101|FG000|Overall Study|Withdrew Consent|0|||
30932944|NCT01752855|58969102|FG001|Overall Study|Withdrew Consent|2|||
30932945|NCT01752855|58969101|FG000|Overall Study|Lack of Efficacy|0|||
30932946|NCT01752855|58969102|FG001|Overall Study|Lack of Efficacy|2|||
30932947|NCT01402492|58969111|FG000|Overall Study|Withdrawal by Subject|17|||
30932948|NCT01402492|58969112|FG001|Overall Study|Withdrawal by Subject|11|||
30932949|NCT01402492|58969113|FG002|Overall Study|Withdrawal by Subject|11|||
30932950|NCT01402492|58969111|FG000|Overall Study|Adverse Event|2|||
30932951|NCT01402492|58969112|FG001|Overall Study|Adverse Event|3|||
30624245|NCT00958191|58636249|FG000|Overall Study|Death|4|||
30758250|NCT00112437|58766944|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30758251|NCT00112437|58766945|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
30839715|NCT00701090|58865093|FG000|Overall Study|Lost to Follow-up|9|||
30839716|NCT00701090|58865094|FG001|Overall Study|Lost to Follow-up|9|||
30839717|NCT00701090|58865093|FG000|Overall Study|Physician Decision|3|||
30758252|NCT00112437|58766946|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
30758253|NCT00112437|58766921|FG000|Years 6-10 (60-Month Extension)|Other|0|||
30758254|NCT00112437|58766922|FG001|Years 6-10 (60-Month Extension)|Other|0|||
30758255|NCT00112437|58766923|FG002|Years 6-10 (60-Month Extension)|Other|0|||
30758256|NCT00112437|58766924|FG003|Years 6-10 (60-Month Extension)|Other|0|||
30758257|NCT00112437|58766925|FG004|Years 6-10 (60-Month Extension)|Other|0|||
30758258|NCT00112437|58766926|FG005|Years 6-10 (60-Month Extension)|Other|0|||
30758259|NCT00112437|58766927|FG006|Years 6-10 (60-Month Extension)|Other|0|||
30758260|NCT00112437|58766928|FG007|Years 6-10 (60-Month Extension)|Other|0|||
30758261|NCT00112437|58766929|FG008|Years 6-10 (60-Month Extension)|Other|0|||
30758262|NCT00112437|58766930|FG009|Years 6-10 (60-Month Extension)|Other|0|||
30758263|NCT00112437|58766931|FG010|Years 6-10 (60-Month Extension)|Other|0|||
30758264|NCT00112437|58766932|FG011|Years 6-10 (60-Month Extension)|Other|0|||
30758265|NCT00112437|58766933|FG012|Years 6-10 (60-Month Extension)|Other|0|||
30758266|NCT00112437|58766934|FG013|Years 6-10 (60-Month Extension)|Other|0|||
30758267|NCT00112437|58766935|FG014|Years 6-10 (60-Month Extension)|Other|0|||
30758268|NCT00112437|58766936|FG015|Years 6-10 (60-Month Extension)|Other|0|||
30758269|NCT00112437|58766937|FG016|Years 6-10 (60-Month Extension)|Other|0|||
30839718|NCT00701090|58865094|FG001|Overall Study|Physician Decision|4|||
30839719|NCT00701090|58865093|FG000|Overall Study|Protocol Violation|2|||
30839720|NCT00701090|58865094|FG001|Overall Study|Protocol Violation|3|||
30932952|NCT01402492|58969113|FG002|Overall Study|Adverse Event|4|||
30932953|NCT01402492|58969111|FG000|Overall Study|Physician Decision|0|||
30932954|NCT01402492|58969112|FG001|Overall Study|Physician Decision|3|||
30932955|NCT01402492|58969113|FG002|Overall Study|Physician Decision|0|||
30932956|NCT01402492|58969111|FG000|Overall Study|Incarcerated (N=3)|2|||
30932957|NCT01402492|58969112|FG001|Overall Study|Incarcerated (N=3)|0|||
30839721|NCT00701090|58865093|FG000|Overall Study|Withdrawal by Subject|11|||
30839722|NCT00701090|58865094|FG001|Overall Study|Withdrawal by Subject|16|||
30839723|NCT00701090|58865093|FG000|Overall Study|Other|7|||
30839724|NCT00701090|58865094|FG001|Overall Study|Other|12|||
30932958|NCT01402492|58969113|FG002|Overall Study|Incarcerated (N=3)|1|||
30932959|NCT01402102|58969123|FG000|Overall Study|Protocol Violation|1|||
30932960|NCT01402102|58969124|FG001|Overall Study|Protocol Violation|0|||
30932961|NCT01402102|58969123|FG000|Overall Study|Insufficiency of compliance|1|||
30932962|NCT01402102|58969124|FG001|Overall Study|Insufficiency of compliance|1|||
30932963|NCT01402102|58969123|FG000|Overall Study|Withdrawal by Subject|0|||
30932964|NCT01402102|58969124|FG001|Overall Study|Withdrawal by Subject|2|||
30932965|NCT01423084|58969134|FG000|Overall Study|Adverse Event|0|||
30932966|NCT01423084|58969135|FG001|Overall Study|Adverse Event|1|||
30932967|NCT01423084|58969134|FG000|Overall Study|Withdrawal by Subject|2|||
30932968|NCT01423084|58969135|FG001|Overall Study|Withdrawal by Subject|3|||
30932969|NCT01894256|58969145|FG000|Part A|Adverse Event|0|||
30932970|NCT01894256|58969146|FG001|Part A|Adverse Event|1|||
30932971|NCT01894256|58969147|FG002|Part A|Adverse Event|0|||
30932972|NCT01894256|58969145|FG000|Part B|Death|0|||
30932973|NCT01894256|58969146|FG001|Part B|Death|1|||
30932974|NCT01894256|58969147|FG002|Part B|Death|1|||
30932975|NCT01894256|58969145|FG000|Part B|Withdrawal by Subject|0|||
30932976|NCT01894256|58969146|FG001|Part B|Withdrawal by Subject|1|||
30932977|NCT01894256|58969147|FG002|Part B|Withdrawal by Subject|0|||
30932978|NCT01894256|58969145|FG000|Part B|Lack of Efficacy|15|||
30932979|NCT01894256|58969146|FG001|Part B|Lack of Efficacy|12|||
30932980|NCT01894256|58969147|FG002|Part B|Lack of Efficacy|13|||
30932981|NCT01780935|58969160|FG000|Overall Study|Admin problems due to early termination|321|||
30932982|NCT01780935|58969161|FG001|Overall Study|Admin problems due to early termination|309|||
30932983|NCT01780935|58969160|FG000|Overall Study|Adverse Event|2|||
30932984|NCT01780935|58969161|FG001|Overall Study|Adverse Event|4|||
30932985|NCT01780935|58969160|FG000|Overall Study|Death|1|||
30932986|NCT01780935|58969161|FG001|Overall Study|Death|6|||
30932987|NCT01780935|58969160|FG000|Overall Study|Lost to Follow-up|2|||
30932988|NCT01780935|58969161|FG001|Overall Study|Lost to Follow-up|6|||
30932989|NCT01780935|58969160|FG000|Overall Study|Physician Decision|1|||
30932990|NCT01780935|58969161|FG001|Overall Study|Physician Decision|1|||
30932991|NCT01780935|58969160|FG000|Overall Study|Protocol deviation|0|||
30932992|NCT01780935|58969161|FG001|Overall Study|Protocol deviation|1|||
30932993|NCT01780935|58969160|FG000|Overall Study|Patient withdrew consent|8|||
30932994|NCT01780935|58969161|FG001|Overall Study|Patient withdrew consent|9|||
30932995|NCT01894100|58969169|FG000|Overall Study|Lost to Follow-up|0|||
30932996|NCT01894100|58969170|FG001|Overall Study|Lost to Follow-up|1|||
30932997|NCT01894100|58969169|FG000|Overall Study|Withdrawal by Subject|3|||
30932998|NCT01894100|58969170|FG001|Overall Study|Withdrawal by Subject|0|||
30932999|NCT01401478|58969216|FG000|Overall Study|Study drug not available|6|||
30933000|NCT01401478|58969216|FG000|Overall Study|Adverse Event|5|||
30933001|NCT01401478|58969216|FG000|Overall Study|Hyperphosphatemia|5|||
30933002|NCT01401478|58969216|FG000|Overall Study|Lost to Follow-up|5|||
30933003|NCT01401478|58969216|FG000|Overall Study|Kidney transplantation|3|||
30933004|NCT01401478|58969216|FG000|Overall Study|Withdrawal by Subject|3|||
30933005|NCT01401478|58969216|FG000|Overall Study|Blood samples not available|1|||
30933006|NCT01401478|58969216|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
30933007|NCT01401478|58969216|FG000|Overall Study|Low intact parathyroid hormone|1|||
30933008|NCT01401478|58969216|FG000|Overall Study|Serious adverse event|1|||
30933009|NCT01422850|58969220|FG000|Overall Study|Physician Decision|3|||
30933010|NCT01422538|58969229|FG000|Overall Study|Lost to Follow-up|0|||
30933011|NCT01422538|58969230|FG001|Overall Study|Lost to Follow-up|1|||
30933012|NCT01422538|58969231|FG002|Overall Study|Lost to Follow-up|1|||
30933013|NCT01422538|58969229|FG000|Overall Study|Missed visit|0|||
30933014|NCT01422538|58969230|FG001|Overall Study|Missed visit|1|||
30839725|NCT03057977|58865102|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
30839726|NCT03057977|58865103|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
30839727|NCT03057977|58865102|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
30933015|NCT01422538|58969231|FG002|Overall Study|Missed visit|1|||
30933016|NCT01422382|58969240|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
30933017|NCT01401322|58969244|FG000|Overall Study|Withdrawal by Subject|1|||
30933018|NCT01401322|58969244|FG000|Overall Study|Physician Decision|1|||
30933019|NCT01387594|58969250|FG000|Overall Study|Withdrawal by Subject|0|||
30933020|NCT01387594|58969251|FG001|Overall Study|Withdrawal by Subject|2|||
30933021|NCT01387594|58969250|FG000|Overall Study|Lost to Follow-up|0|||
30933022|NCT01387594|58969251|FG001|Overall Study|Lost to Follow-up|1|||
30933023|NCT01401010|58969262|FG000|Overall Study|Could not interpret assay results|1|||
30933024|NCT01401010|58969263|FG001|Overall Study|Could not interpret assay results|0|||
30933025|NCT01400932|58969276|FG000|Overall Study|Adverse Event|10|||
30933026|NCT01400932|58969277|FG001|Overall Study|Adverse Event|5|||
30933027|NCT01400932|58969276|FG000|Overall Study|Lack of Efficacy|0|||
30933028|NCT01400932|58969277|FG001|Overall Study|Lack of Efficacy|3|||
30933029|NCT01400932|58969276|FG000|Overall Study|Withdrawal by Subject|2|||
30933030|NCT01400932|58969277|FG001|Overall Study|Withdrawal by Subject|6|||
30933031|NCT01400932|58969276|FG000|Overall Study|Lost to Follow-up|1|||
30933032|NCT01400932|58969277|FG001|Overall Study|Lost to Follow-up|0|||
30933033|NCT01400932|58969276|FG000|Overall Study|Protocol Deviation|0|||
30933034|NCT01400932|58969277|FG001|Overall Study|Protocol Deviation|1|||
30933035|NCT01400932|58969276|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
30933036|NCT01400932|58969277|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
30933037|NCT01400698|58969287|FG000|Overall Study|Lost to Follow-up|2|||
30933038|NCT01400698|58969288|FG001|Overall Study|Lost to Follow-up|5|||
30933039|NCT01400698|58969289|FG002|Overall Study|Lost to Follow-up|2|||
30933040|NCT01400698|58969290|FG003|Overall Study|Lost to Follow-up|1|||
30933041|NCT01400698|58969291|FG004|Overall Study|Lost to Follow-up|4|||
30933042|NCT01400698|58969292|FG005|Overall Study|Lost to Follow-up|3|||
30933043|NCT01400698|58969287|FG000|Overall Study|Withdrawal by Subject|8|||
30933044|NCT01400698|58969288|FG001|Overall Study|Withdrawal by Subject|2|||
30933045|NCT01400698|58969289|FG002|Overall Study|Withdrawal by Subject|0|||
30933046|NCT01400698|58969290|FG003|Overall Study|Withdrawal by Subject|4|||
30933047|NCT01400698|58969291|FG004|Overall Study|Withdrawal by Subject|1|||
30933048|NCT01400698|58969292|FG005|Overall Study|Withdrawal by Subject|3|||
30933049|NCT01400698|58969287|FG000|Overall Study|Protocol Violation|0|||
30933050|NCT01400698|58969288|FG001|Overall Study|Protocol Violation|1|||
30933051|NCT01400698|58969289|FG002|Overall Study|Protocol Violation|0|||
30933052|NCT01400698|58969290|FG003|Overall Study|Protocol Violation|0|||
30933053|NCT01400698|58969291|FG004|Overall Study|Protocol Violation|1|||
30933054|NCT01400698|58969292|FG005|Overall Study|Protocol Violation|0|||
30933055|NCT01400698|58969287|FG000|Overall Study|Non-compliance|0|||
30933056|NCT01400698|58969288|FG001|Overall Study|Non-compliance|1|||
30933057|NCT01400698|58969289|FG002|Overall Study|Non-compliance|0|||
30933058|NCT01400698|58969290|FG003|Overall Study|Non-compliance|1|||
30933059|NCT01400698|58969291|FG004|Overall Study|Non-compliance|0|||
30933060|NCT01400698|58969292|FG005|Overall Study|Non-compliance|0|||
30933061|NCT01400698|58969287|FG000|Overall Study|Adverse Event|1|||
30933062|NCT01400698|58969288|FG001|Overall Study|Adverse Event|0|||
30933063|NCT01400698|58969289|FG002|Overall Study|Adverse Event|0|||
30933064|NCT01400698|58969290|FG003|Overall Study|Adverse Event|0|||
30933065|NCT01400698|58969291|FG004|Overall Study|Adverse Event|0|||
30933066|NCT01400698|58969292|FG005|Overall Study|Adverse Event|0|||
30933067|NCT01400698|58969287|FG000|Overall Study|Other|4|||
30933068|NCT01400698|58969288|FG001|Overall Study|Other|2|||
30933069|NCT01400698|58969289|FG002|Overall Study|Other|0|||
30933070|NCT01400698|58969290|FG003|Overall Study|Other|2|||
30933071|NCT01400698|58969291|FG004|Overall Study|Other|1|||
30933072|NCT01400698|58969292|FG005|Overall Study|Other|0|||
30933073|NCT01890746|58969304|FG000|Overall Study|Death|39|||
30933074|NCT01890746|58969305|FG001|Overall Study|Death|30|||
30933075|NCT01890746|58969304|FG000|Overall Study|Adverse Event|1|||
30933076|NCT01890746|58969305|FG001|Overall Study|Adverse Event|0|||
30933077|NCT01890746|58969304|FG000|Overall Study|Lost to Follow-up|4|||
30933078|NCT01890746|58969305|FG001|Overall Study|Lost to Follow-up|1|||
30933079|NCT01890746|58969304|FG000|Overall Study|Physician Decision|3|||
30933080|NCT01890746|58969305|FG001|Overall Study|Physician Decision|2|||
30933081|NCT01890746|58969304|FG000|Overall Study|Withdrawal by Subject|5|||
30933082|NCT01890746|58969305|FG001|Overall Study|Withdrawal by Subject|8|||
30933083|NCT01422304|58969313|FG000|Overall Study|Adverse Event|0|||
30933084|NCT01422304|58969314|FG001|Overall Study|Adverse Event|1|||
30933085|NCT01422304|58969313|FG000|Overall Study|Lost to Follow-up|14|||
30933086|NCT01422304|58969314|FG001|Overall Study|Lost to Follow-up|20|||
30933087|NCT01422304|58969313|FG000|Overall Study|Never Entered Follow-up|2|||
30933088|NCT01422304|58969314|FG001|Overall Study|Never Entered Follow-up|1|||
30933089|NCT01422304|58969313|FG000|Overall Study|Protocol Violation|1|||
30933090|NCT01422304|58969314|FG001|Overall Study|Protocol Violation|0|||
30933091|NCT01422304|58969313|FG000|Overall Study|Withdrawal by Subject|4|||
30933092|NCT01422304|58969314|FG001|Overall Study|Withdrawal by Subject|2|||
30933093|NCT01422304|58969313|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
30933094|NCT01422304|58969314|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
30933095|NCT01422304|58969313|FG000|Overall Study|Not Treated|3|||
30933096|NCT01422304|58969314|FG001|Overall Study|Not Treated|11|||
30933097|NCT01387516|58969324|FG000|Overall Study|Lost to Follow-up|4|||
30933098|NCT01387516|58969325|FG001|Overall Study|Lost to Follow-up|4|||
30933099|NCT01387516|58969326|FG002|Overall Study|Lost to Follow-up|2|||
30933100|NCT01387516|58969327|FG003|Overall Study|Lost to Follow-up|3|||
30933101|NCT01387516|58969324|FG000|Overall Study|Withdrawal by Subject|1|||
30933102|NCT01387516|58969325|FG001|Overall Study|Withdrawal by Subject|1|||
30933103|NCT01387516|58969326|FG002|Overall Study|Withdrawal by Subject|2|||
30933104|NCT01387516|58969327|FG003|Overall Study|Withdrawal by Subject|0|||
30933105|NCT01387516|58969324|FG000|Overall Study|Death|0|||
30933106|NCT01387516|58969325|FG001|Overall Study|Death|0|||
30933107|NCT01387516|58969326|FG002|Overall Study|Death|0|||
30933108|NCT01387516|58969327|FG003|Overall Study|Death|1|||
30624246|NCT00958191|58636249|FG000|Overall Study|Lost to Follow-up|5|||
30933109|NCT01421134|58969348|FG000|Overall Study|Adverse Event|3|||
30933110|NCT01421134|58969349|FG001|Overall Study|Adverse Event|5|||
30933111|NCT01421134|58969348|FG000|Overall Study|Lack of Efficacy|2|||
30933112|NCT01421134|58969349|FG001|Overall Study|Lack of Efficacy|4|||
30933113|NCT01421134|58969348|FG000|Overall Study|Protocol Violation|0|||
30933114|NCT01421134|58969349|FG001|Overall Study|Protocol Violation|3|||
30933115|NCT01421134|58969348|FG000|Overall Study|Withdrawal by Subject|1|||
30933116|NCT01421134|58969349|FG001|Overall Study|Withdrawal by Subject|1|||
30933117|NCT01421134|58969348|FG000|Overall Study|Administrative|0|||
30933118|NCT01421134|58969349|FG001|Overall Study|Administrative|1|||
30933119|NCT01421134|58969348|FG000|Overall Study|Lost to Follow-up|1|||
30933120|NCT01421134|58969349|FG001|Overall Study|Lost to Follow-up|1|||
30933121|NCT01894022|58969357|FG000|Overall Study|Death|1|||
30933122|NCT01894022|58969358|FG001|Overall Study|Death|0|||
30933123|NCT01894022|58969357|FG000|Overall Study|Adverse Event, non-fatal|1|||
30933124|NCT01894022|58969358|FG001|Overall Study|Adverse Event, non-fatal|0|||
30933125|NCT01894022|58969357|FG000|Overall Study|Study Closed/terminated|7|||
30933126|NCT01894022|58969358|FG001|Overall Study|Study Closed/terminated|10|||
30933127|NCT01615328|58969367|FG000|Overall Study|Lost to Follow-up|3|||
30933128|NCT01615328|58969368|FG001|Overall Study|Lost to Follow-up|5|||
30933129|NCT01890512|58969378|FG000|Overall Study|Physician Decision|1|||
30933130|NCT01890512|58969378|FG000|Overall Study|Withdrawal by Subject|1|||
30933131|NCT01890512|58969378|FG000|Overall Study|Protocol Violation|1|||
30933132|NCT01387282|58969384|FG000|Overall Study|Death|47|||
30933133|NCT01387282|58969385|FG001|Overall Study|Death|16|||
30933134|NCT01387282|58969384|FG000|Overall Study|Other|5|||
30933135|NCT01387282|58969385|FG001|Overall Study|Other|1|||
30933136|NCT01387282|58969384|FG000|Overall Study|Unrelated AE|6|||
30933137|NCT01387282|58969385|FG001|Overall Study|Unrelated AE|4|||
30933138|NCT01387282|58969384|FG000|Overall Study|Withdrawal by patient|33|||
30933139|NCT01387282|58969385|FG001|Overall Study|Withdrawal by patient|23|||
30933140|NCT01387282|58969384|FG000|Overall Study|Study drug-related AE|2|||
30933141|NCT01387282|58969385|FG001|Overall Study|Study drug-related AE|2|||
30933142|NCT01387282|58969384|FG000|Overall Study|Lost to Follow-up|4|||
30933143|NCT01387282|58969385|FG001|Overall Study|Lost to Follow-up|1|||
30933144|NCT01386970|58969393|FG000|Overall Study|Withdrawal by Subject|0|||
30933145|NCT01386970|58969394|FG001|Overall Study|Withdrawal by Subject|1|||
30933146|NCT01386970|58969393|FG000|Overall Study|Adverse Event|4|||
30933147|NCT01386970|58969394|FG001|Overall Study|Adverse Event|1|||
30933148|NCT01890434|58969402|FG000|Overall Study|Adverse Event|8|||
30933149|NCT01890434|58969402|FG000|Overall Study|PCI at external hospital|1|||
30933150|NCT01890434|58969402|FG000|Overall Study|Assessment discrepancy|1|||
30933151|NCT01890434|58969402|FG000|Overall Study|CRC didn't contact participant for FU|1|||
30933152|NCT01890434|58969402|FG000|Overall Study|Could not get whole set of images|1|||
30933153|NCT01890434|58969402|FG000|Overall Study|Decline to return for GSPECT|1|||
30933154|NCT01890434|58969402|FG000|Overall Study|GSPECT at rest was not done|1|||
30933155|NCT01890434|58969402|FG000|Overall Study|Participant didn't complete MRI|1|||
30933156|NCT01890434|58969402|FG000|Overall Study|Uncontactable by phone|1|||
30933157|NCT01890434|58969402|FG000|Overall Study|Moved out of position|1|||
30933158|NCT01890434|58969402|FG000|Overall Study|Unable to contact|1|||
30933159|NCT01890434|58969402|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
30933160|NCT01385566|58969412|FG000|Overall Study|Lost to Follow-up|1|||
30933161|NCT01385566|58969413|FG001|Overall Study|Lost to Follow-up|0|||
30933162|NCT01385566|58969414|FG002|Overall Study|Lost to Follow-up|0|||
30933163|NCT01385566|58969415|FG003|Overall Study|Lost to Follow-up|0|||
30933164|NCT01385566|58969416|FG004|Overall Study|Lost to Follow-up|0|||
30933165|NCT01385566|58969417|FG005|Overall Study|Lost to Follow-up|0|||
30933166|NCT01385566|58969412|FG000|Overall Study|Withdrawal by Subject|0|||
30933167|NCT01385566|58969413|FG001|Overall Study|Withdrawal by Subject|0|||
30933168|NCT01385566|58969414|FG002|Overall Study|Withdrawal by Subject|0|||
30933169|NCT01385566|58969415|FG003|Overall Study|Withdrawal by Subject|1|||
30933170|NCT01385566|58969416|FG004|Overall Study|Withdrawal by Subject|0|||
30933171|NCT01385566|58969417|FG005|Overall Study|Withdrawal by Subject|0|||
30933172|NCT01780545|58969435|FG000|Overall Study|Withdrawal by Subject|3|||
30933173|NCT01780545|58969436|FG001|Overall Study|Withdrawal by Subject|1|||
30933174|NCT01780545|58969435|FG000|Overall Study|Lost to Follow-up|1|||
30933175|NCT01780545|58969436|FG001|Overall Study|Lost to Follow-up|1|||
30933176|NCT01780389|58969445|FG000|Overall Study|Adverse Event|1|||
30933177|NCT01778985|58969452|FG000|Overall Study|Lost to Follow-up|1|||
30933178|NCT01778985|58969453|FG001|Overall Study|Lost to Follow-up|0|||
30933179|NCT01778985|58969452|FG000|Overall Study|Physician Decision|2|||
30933180|NCT01778985|58969453|FG001|Overall Study|Physician Decision|2|||
30933181|NCT01778985|58969452|FG000|Overall Study|Protocol Violation|4|||
30933182|NCT01778985|58969453|FG001|Overall Study|Protocol Violation|1|||
30933183|NCT01778751|58969461|FG000|Overall Study|Lost to Follow-up|1|||
30933184|NCT01778751|58969462|FG001|Overall Study|Lost to Follow-up|0|||
30933185|NCT01778751|58969461|FG000|Overall Study|Withdrawal by Subject|0|||
30933186|NCT01778751|58969462|FG001|Overall Study|Withdrawal by Subject|2|||
30933187|NCT01778751|58969461|FG000|Overall Study|Transfered care|1|||
30933188|NCT01778751|58969462|FG001|Overall Study|Transfered care|0|||
30933189|NCT01865084|58969471|FG000|Double Blind Period (DB)|Adverse Event|2|||
30933190|NCT01865084|58969472|FG001|Double Blind Period (DB)|Adverse Event|2|||
30933191|NCT01865084|58969473|FG002|Double Blind Period (DB)|Adverse Event|1|||
30933192|NCT01865084|58969471|FG000|Double Blind Period (DB)|Protocol Violation|0|||
30933193|NCT01865084|58969472|FG001|Double Blind Period (DB)|Protocol Violation|0|||
30933194|NCT01865084|58969473|FG002|Double Blind Period (DB)|Protocol Violation|1|||
30933195|NCT01865084|58969471|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
30933196|NCT01865084|58969472|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
30933197|NCT01865084|58969473|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
30933198|NCT01865084|58969471|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
30933199|NCT01865084|58969472|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
30933200|NCT01865084|58969473|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
30933201|NCT01865084|58969471|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
30933202|NCT01865084|58969472|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
30933203|NCT01865084|58969473|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
30933204|NCT01865084|58969471|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
30933205|NCT01865084|58969472|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
30933206|NCT01865084|58969473|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
30933207|NCT01865084|58969471|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
30933208|NCT01865084|58969472|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
30933209|NCT01865084|58969473|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
30933210|NCT01865084|58969471|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
30933211|NCT01865084|58969472|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
30933212|NCT01865084|58969473|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
30933213|NCT01865084|58969471|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
30933214|NCT01865084|58969472|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
30933215|NCT01865084|58969473|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
30933216|NCT01778127|58969488|FG000|Overall Study|Lost to Follow-up|5|||
30933217|NCT01778127|58969489|FG001|Overall Study|Lost to Follow-up|1|||
30933218|NCT01778127|58969490|FG002|Overall Study|Lost to Follow-up|2|||
30933219|NCT01778127|58969488|FG000|Overall Study|Withdrawal by Subject|3|||
30933220|NCT01778127|58969489|FG001|Overall Study|Withdrawal by Subject|1|||
30933221|NCT01778127|58969490|FG002|Overall Study|Withdrawal by Subject|4|||
30933222|NCT01892540|58969501|FG000|Overall Study|Did not complete PET/MRI|0|||
30933223|NCT01892540|58969502|FG001|Overall Study|Did not complete PET/MRI|0|||
30933224|NCT01892540|58969503|FG002|Overall Study|Did not complete PET/MRI|2|||
30933225|NCT01892540|58969501|FG000|Overall Study|Did not fit in scanner|0|||
30933226|NCT01892540|58969502|FG001|Overall Study|Did not fit in scanner|0|||
30933227|NCT01892540|58969503|FG002|Overall Study|Did not fit in scanner|1|||
30933228|NCT01385098|58969511|FG000|Overall Study|Adverse Event|10|||
30933229|NCT01385098|58969511|FG000|Overall Study|Lost to Follow-up|4|||
30933230|NCT01398514|58969519|FG000|Overall Study|Adverse Event|1|||
30933231|NCT01398514|58969520|FG001|Overall Study|Adverse Event|0|||
30933232|NCT01398514|58969519|FG000|Overall Study|Non-compliance with study procedures|2|||
30933233|NCT01398514|58969520|FG001|Overall Study|Non-compliance with study procedures|0|||
30933234|NCT01398514|58969519|FG000|Overall Study|Physiologic non-responsiveness|1|||
30933235|NCT01398514|58969520|FG001|Overall Study|Physiologic non-responsiveness|3|||
30933236|NCT01398514|58969519|FG000|Overall Study|Failure to show a conditioned response|4|||
30933237|NCT01398514|58969520|FG001|Overall Study|Failure to show a conditioned response|3|||
30933238|NCT01398358|58969531|FG000|Overall Study|Lost to Follow-up|11|||
30933239|NCT01398358|58969532|FG001|Overall Study|Lost to Follow-up|21|||
30933240|NCT01398358|58969533|FG002|Overall Study|Lost to Follow-up|18|||
30933241|NCT01398358|58969531|FG000|Overall Study|Withdrawal by Subject|3|||
30933242|NCT01398358|58969532|FG001|Overall Study|Withdrawal by Subject|2|||
30758270|NCT00112437|58766938|FG017|Years 6-10 (60-Month Extension)|Other|0|||
30933243|NCT01398358|58969533|FG002|Overall Study|Withdrawal by Subject|2|||
30933244|NCT01398358|58969531|FG000|Overall Study|no longer eligible|1|||
30933245|NCT01398358|58969532|FG001|Overall Study|no longer eligible|0|||
30933246|NCT01398358|58969533|FG002|Overall Study|no longer eligible|1|||
30933247|NCT01778049|58969543|FG000|Open Label Treatment Period|Adverse Event|5|||
30933248|NCT01778049|58969544|FG001|Open Label Treatment Period|Adverse Event|15|||
30933249|NCT01778049|58969545|FG002|Open Label Treatment Period|Adverse Event|0|||
30933250|NCT01778049|58969546|FG003|Open Label Treatment Period|Adverse Event|0|||
30933251|NCT01778049|58969547|FG004|Open Label Treatment Period|Adverse Event|0|||
30933252|NCT01778049|58969548|FG005|Open Label Treatment Period|Adverse Event|0|||
30933253|NCT01778049|58969543|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
30933254|NCT01778049|58969544|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
30758271|NCT00112437|58766939|FG018|Years 6-10 (60-Month Extension)|Other|0|||
30758272|NCT00112437|58766940|FG019|Years 6-10 (60-Month Extension)|Other|0|||
30933255|NCT01778049|58969545|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
30933256|NCT01778049|58969546|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
30933257|NCT01778049|58969547|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
30933258|NCT01778049|58969548|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
30933259|NCT01778049|58969543|FG000|Open Label Treatment Period|Protocol Violation|5|||
30933260|NCT01778049|58969544|FG001|Open Label Treatment Period|Protocol Violation|5|||
30933261|NCT01778049|58969545|FG002|Open Label Treatment Period|Protocol Violation|0|||
30933262|NCT01778049|58969546|FG003|Open Label Treatment Period|Protocol Violation|0|||
30933263|NCT01778049|58969547|FG004|Open Label Treatment Period|Protocol Violation|0|||
30933264|NCT01778049|58969548|FG005|Open Label Treatment Period|Protocol Violation|0|||
30933265|NCT01778049|58969543|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
30933266|NCT01778049|58969544|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
30933267|NCT01778049|58969545|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
30933268|NCT01778049|58969546|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
30933269|NCT01778049|58969547|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
30933270|NCT01778049|58969548|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
30933271|NCT01778049|58969543|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
30933272|NCT01778049|58969544|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
30933273|NCT01778049|58969545|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
30933274|NCT01778049|58969546|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
30933275|NCT01778049|58969547|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
30933276|NCT01778049|58969548|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
30933277|NCT01778049|58969543|FG000|Open Label Treatment Period|Not treated|2|||
30933278|NCT01778049|58969544|FG001|Open Label Treatment Period|Not treated|1|||
30933279|NCT01778049|58969545|FG002|Open Label Treatment Period|Not treated|0|||
30933280|NCT01778049|58969546|FG003|Open Label Treatment Period|Not treated|0|||
30933281|NCT01778049|58969547|FG004|Open Label Treatment Period|Not treated|0|||
30933282|NCT01778049|58969548|FG005|Open Label Treatment Period|Not treated|0|||
30933283|NCT01778049|58969543|FG000|Open Label Treatment Period|Other reason not defined above|77|||
30933284|NCT01778049|58969544|FG001|Open Label Treatment Period|Other reason not defined above|94|||
30933285|NCT01778049|58969545|FG002|Open Label Treatment Period|Other reason not defined above|0|||
30933286|NCT01778049|58969546|FG003|Open Label Treatment Period|Other reason not defined above|0|||
30933287|NCT01778049|58969547|FG004|Open Label Treatment Period|Other reason not defined above|0|||
30933288|NCT01778049|58969548|FG005|Open Label Treatment Period|Other reason not defined above|0|||
30933289|NCT01778049|58969543|FG000|Double Blind Treatment Period|Adverse Event|0|||
30933290|NCT01778049|58969544|FG001|Double Blind Treatment Period|Adverse Event|0|||
30839728|NCT03057977|58865103|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
30839729|NCT03057977|58865102|FG000|Discontinuation From Treatment|Protocol Violation|6|||
30839730|NCT03057977|58865103|FG001|Discontinuation From Treatment|Protocol Violation|5|||
30839731|NCT03057977|58865102|FG000|Discontinuation From Treatment|Not treated|4|||
30839732|NCT03057977|58865103|FG001|Discontinuation From Treatment|Not treated|0|||
30839733|NCT03057977|58865102|FG000|Discontinuation From Treatment|Adverse Event|343|||
30839734|NCT03057977|58865103|FG001|Discontinuation From Treatment|Adverse Event|337|||
30839735|NCT03057977|58865102|FG000|Discontinuation From Treatment|Reason Unknown|0|||
30839736|NCT03057977|58865103|FG001|Discontinuation From Treatment|Reason Unknown|1|||
30839737|NCT03057977|58865102|FG000|Discontinuation From Treatment|Personal Reasons|1|||
30839738|NCT03057977|58865103|FG001|Discontinuation From Treatment|Personal Reasons|1|||
30839739|NCT03057977|58865102|FG000|Discontinuation From Treatment|Unblinded medication|1|||
30839740|NCT03057977|58865103|FG001|Discontinuation From Treatment|Unblinded medication|0|||
30839741|NCT03057977|58865102|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
30839742|NCT03057977|58865103|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
30839743|NCT03057977|58865102|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
30839744|NCT03057977|58865103|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
30839745|NCT03057977|58865102|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
30839746|NCT03057977|58865103|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
30839747|NCT03057977|58865102|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
30839748|NCT03057977|58865103|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
30839749|NCT03057977|58865102|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
30839750|NCT03057977|58865103|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
30839751|NCT03057977|58865102|FG000|Discontinuation From Treatment|Not attending study visit|3|||
30839752|NCT03057977|58865103|FG001|Discontinuation From Treatment|Not attending study visit|10|||
30933291|NCT01778049|58969545|FG002|Double Blind Treatment Period|Adverse Event|4|||
30933292|NCT01778049|58969546|FG003|Double Blind Treatment Period|Adverse Event|5|||
30933293|NCT01778049|58969547|FG004|Double Blind Treatment Period|Adverse Event|3|||
30933294|NCT01778049|58969548|FG005|Double Blind Treatment Period|Adverse Event|2|||
30839753|NCT03057977|58865102|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
30839754|NCT03057977|58865103|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
30933295|NCT01778049|58969543|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
30933296|NCT01778049|58969544|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
30933297|NCT01778049|58969545|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
30933298|NCT01778049|58969546|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
30933299|NCT01778049|58969547|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
30933300|NCT01778049|58969548|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
30933301|NCT01778049|58969543|FG000|Double Blind Treatment Period|Protocol Violation|0|||
30933302|NCT01778049|58969544|FG001|Double Blind Treatment Period|Protocol Violation|0|||
30933303|NCT01778049|58969545|FG002|Double Blind Treatment Period|Protocol Violation|2|||
30933304|NCT01778049|58969546|FG003|Double Blind Treatment Period|Protocol Violation|0|||
30933305|NCT01778049|58969547|FG004|Double Blind Treatment Period|Protocol Violation|0|||
30933306|NCT01778049|58969548|FG005|Double Blind Treatment Period|Protocol Violation|0|||
30933307|NCT01778049|58969543|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
30933308|NCT01778049|58969544|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
30933309|NCT01778049|58969545|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
30933310|NCT01778049|58969546|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
30933311|NCT01778049|58969547|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
30933312|NCT01778049|58969548|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
30933313|NCT01778049|58969543|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
30933314|NCT01778049|58969544|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
30933315|NCT01778049|58969545|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
30933316|NCT01778049|58969546|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
30933317|NCT01778049|58969547|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
30933318|NCT01778049|58969548|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
30758273|NCT00112437|58766941|FG020|Years 6-10 (60-Month Extension)|Other|0|||
30758274|NCT00112437|58766942|FG021|Years 6-10 (60-Month Extension)|Other|0|||
30758275|NCT00112437|58766943|FG022|Years 6-10 (60-Month Extension)|Other|0|||
30758276|NCT00112437|58766944|FG023|Years 6-10 (60-Month Extension)|Other|0|||
30758277|NCT00112437|58766945|FG024|Years 6-10 (60-Month Extension)|Other|1|||
30758278|NCT00112437|58766946|FG025|Years 6-10 (60-Month Extension)|Other|0|||
30758279|NCT00112437|58766921|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758280|NCT00112437|58766922|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758281|NCT00112437|58766923|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758282|NCT00112437|58766924|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758283|NCT00112437|58766925|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758284|NCT00112437|58766926|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758285|NCT00112437|58766927|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758286|NCT00112437|58766928|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758287|NCT00112437|58766929|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758288|NCT00112437|58766930|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758289|NCT00112437|58766931|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758290|NCT00112437|58766932|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758291|NCT00112437|58766933|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758292|NCT00112437|58766934|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758293|NCT00112437|58766935|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758294|NCT00112437|58766936|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758295|NCT00112437|58766937|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758296|NCT00112437|58766938|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758297|NCT00112437|58766939|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758298|NCT00112437|58766940|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758299|NCT00112437|58766941|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758300|NCT00112437|58766942|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758301|NCT00112437|58766943|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758302|NCT00112437|58766944|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
30758303|NCT00112437|58766945|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758304|NCT00112437|58766946|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
30758305|NCT00112437|58766921|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758306|NCT00112437|58766922|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758307|NCT00112437|58766923|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758308|NCT00112437|58766924|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758309|NCT00112437|58766925|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758310|NCT00112437|58766926|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758311|NCT00112437|58766927|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758312|NCT00112437|58766928|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758313|NCT00112437|58766929|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30933319|NCT01778049|58969543|FG000|Double Blind Treatment Period|Not treated|0|||
30933320|NCT01778049|58969544|FG001|Double Blind Treatment Period|Not treated|0|||
30933321|NCT01778049|58969545|FG002|Double Blind Treatment Period|Not treated|0|||
30839755|NCT03057977|58865102|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
30839756|NCT03057977|58865103|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
30839757|NCT03057977|58865102|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
30839758|NCT03057977|58865103|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
30839759|NCT03057977|58865102|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
30839760|NCT03057977|58865103|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
30839761|NCT03057977|58865102|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
30839762|NCT03057977|58865103|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
30839763|NCT03062891|58865115|FG000|Overall Study|Withdrawal by Subject|2|||
30839764|NCT03062891|58865116|FG001|Overall Study|Withdrawal by Subject|0|||
30839765|NCT03062891|58865115|FG000|Overall Study|Lost to Follow-up|50|||
30839766|NCT03062891|58865116|FG001|Overall Study|Lost to Follow-up|38|||
30839767|NCT02552212|58865125|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
30839768|NCT02552212|58865126|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
30624247|NCT00958191|58636249|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
30624248|NCT00958191|58636249|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
30624249|NCT00958191|58636249|FG000|Overall Study|Revision of study device|4|||
30758314|NCT00112437|58766930|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758315|NCT00112437|58766931|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30933322|NCT01778049|58969546|FG003|Double Blind Treatment Period|Not treated|2|||
30933323|NCT01778049|58969547|FG004|Double Blind Treatment Period|Not treated|2|||
30933324|NCT01778049|58969548|FG005|Double Blind Treatment Period|Not treated|0|||
30933325|NCT01778049|58969543|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
30933326|NCT01778049|58969544|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
30933327|NCT01778049|58969545|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
30933328|NCT01778049|58969546|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
30933329|NCT01778049|58969547|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
30758316|NCT00112437|58766932|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758317|NCT00112437|58766933|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758318|NCT00112437|58766934|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758319|NCT00112437|58766935|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758320|NCT00112437|58766936|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758321|NCT00112437|58766937|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758322|NCT00112437|58766938|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758323|NCT00112437|58766939|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30839769|NCT02552212|58865127|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
30839770|NCT02552212|58865125|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
30839771|NCT02552212|58865126|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
30839772|NCT02552212|58865127|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
30839773|NCT02552212|58865125|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
30839774|NCT02552212|58865126|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
30839775|NCT02552212|58865127|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
30839776|NCT02552212|58865125|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
30839777|NCT02552212|58865126|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
30839778|NCT02552212|58865127|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
30839779|NCT02552212|58865125|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
30839780|NCT02552212|58865126|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
30839781|NCT02552212|58865127|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
30839782|NCT02552212|58865125|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
30839783|NCT02552212|58865126|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
30839784|NCT02552212|58865127|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
30839785|NCT02552212|58865125|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
30839786|NCT02552212|58865126|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
30839787|NCT02552212|58865127|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
30839788|NCT02552212|58865125|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
30839789|NCT02552212|58865126|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
30839790|NCT02552212|58865127|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
30839791|NCT02552212|58865125|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
30933330|NCT01778049|58969548|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
30933331|NCT01777581|58969562|FG000|Overall Study|Lost to Follow-up|1|||
30933332|NCT01777581|58969563|FG001|Overall Study|Lost to Follow-up|1|||
30933333|NCT01777581|58969562|FG000|Overall Study|Adverse Event|2|||
30933334|NCT01777581|58969563|FG001|Overall Study|Adverse Event|0|||
30933335|NCT01777581|58969562|FG000|Overall Study|Lack of Efficacy|0|||
30933336|NCT01777581|58969563|FG001|Overall Study|Lack of Efficacy|1|||
30933337|NCT01864148|58969574|FG000|Overall Study|Other|2|||
30933338|NCT01864148|58969575|FG001|Overall Study|Other|1|||
30933339|NCT01864148|58969576|FG002|Overall Study|Other|1|||
30933340|NCT01864148|58969577|FG003|Overall Study|Other|3|||
30933341|NCT01864148|58969578|FG004|Overall Study|Other|1|||
30933342|NCT01864148|58969574|FG000|Overall Study|Death|0|||
30933343|NCT01864148|58969575|FG001|Overall Study|Death|0|||
30933344|NCT01864148|58969576|FG002|Overall Study|Death|0|||
30758324|NCT00112437|58766940|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758325|NCT00112437|58766941|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758326|NCT00112437|58766942|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758327|NCT00112437|58766943|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
30758328|NCT00112437|58766944|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
30758329|NCT00112437|58766945|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
30758330|NCT00112437|58766946|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
30758331|NCT03653416|58767002|FG000|Overall Study|Protocol Violation|6|||
30758332|NCT03653416|58767003|FG001|Overall Study|Protocol Violation|1|||
30758333|NCT00112359|58767011|FG000|Overall Study|Unrelated adverse event|16|||
30758334|NCT00112359|58767012|FG001|Overall Study|Unrelated adverse event|8|||
30758335|NCT00112359|58767011|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
30758336|NCT00112359|58767012|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
30758337|NCT00112359|58767011|FG000|Overall Study|Related adverse event|5|||
30758338|NCT00112359|58767012|FG001|Overall Study|Related adverse event|3|||
30758339|NCT00112359|58767011|FG000|Overall Study|Lost to Follow-up|0|||
30758340|NCT00112359|58767012|FG001|Overall Study|Lost to Follow-up|1|||
30758341|NCT00112359|58767011|FG000|Overall Study|Personal/administrative|1|||
30758342|NCT00112359|58767012|FG001|Overall Study|Personal/administrative|1|||
30758343|NCT00112359|58767011|FG000|Overall Study|Other|3|||
30758344|NCT00112359|58767012|FG001|Overall Study|Other|0|||
30758345|NCT00119379|58767020|FG000|Overall Study|Adverse Event|4|||
30758346|NCT00119379|58767021|FG001|Overall Study|Adverse Event|1|||
30758347|NCT00118911|58767029|FG000|Overall Study|Withdrawal by Subject|2|||
30758348|NCT00118911|58767030|FG001|Overall Study|Withdrawal by Subject|5|||
30758349|NCT00131937|58767036|FG000|Overall Study|Adverse Event|3|||
30758350|NCT00131937|58767036|FG000|Overall Study|Withdrawal by Subject|2|||
30758351|NCT00131937|58767036|FG000|Overall Study|Physician Decision|1|||
30758352|NCT00131937|58767036|FG000|Overall Study|Disease Progression|7|||
30758353|NCT00131937|58767036|FG000|Overall Study|Alternative therapy|1|||
30758354|NCT00131469|58767042|FG000|Overall Study|Withdrawal by Subject|3|||
30758355|NCT00131469|58767043|FG001|Overall Study|Withdrawal by Subject|4|||
30758356|NCT00131469|58767042|FG000|Overall Study|Protocol Violation|3|||
30758357|NCT00131469|58767043|FG001|Overall Study|Protocol Violation|1|||
30758358|NCT00131469|58767042|FG000|Overall Study|Death|0|||
30758359|NCT00131469|58767043|FG001|Overall Study|Death|1|||
30933345|NCT01864148|58969577|FG003|Overall Study|Death|1|||
30933346|NCT01864148|58969578|FG004|Overall Study|Death|0|||
30758360|NCT00131469|58767042|FG000|Overall Study|Lost to Follow-up|0|||
30758361|NCT00131469|58767043|FG001|Overall Study|Lost to Follow-up|1|||
30758362|NCT00131469|58767042|FG000|Overall Study|scan not analyzable|3|||
30758363|NCT00131469|58767043|FG001|Overall Study|scan not analyzable|6|||
30933347|NCT01864148|58969574|FG000|Overall Study|Investigator Decision|5|||
30933348|NCT01864148|58969575|FG001|Overall Study|Investigator Decision|0|||
30933349|NCT01864148|58969576|FG002|Overall Study|Investigator Decision|0|||
30758364|NCT00372593|58767052|FG000|Overall Study|Adverse Event|43|||
30933350|NCT01864148|58969577|FG003|Overall Study|Investigator Decision|4|||
30933351|NCT01864148|58969578|FG004|Overall Study|Investigator Decision|6|||
30933352|NCT01864148|58969574|FG000|Overall Study|Withdrawal by Subject|9|||
30933353|NCT01864148|58969575|FG001|Overall Study|Withdrawal by Subject|2|||
30933354|NCT01864148|58969576|FG002|Overall Study|Withdrawal by Subject|6|||
30933355|NCT01864148|58969577|FG003|Overall Study|Withdrawal by Subject|8|||
30933356|NCT01864148|58969578|FG004|Overall Study|Withdrawal by Subject|8|||
30933357|NCT01864148|58969574|FG000|Overall Study|Lost to Follow-up|0|||
30933358|NCT01864148|58969575|FG001|Overall Study|Lost to Follow-up|0|||
30933359|NCT01864148|58969576|FG002|Overall Study|Lost to Follow-up|0|||
30933360|NCT01864148|58969577|FG003|Overall Study|Lost to Follow-up|2|||
30933361|NCT01864148|58969578|FG004|Overall Study|Lost to Follow-up|1|||
30933362|NCT01864148|58969574|FG000|Overall Study|Adverse Event|4|||
30933363|NCT01864148|58969575|FG001|Overall Study|Adverse Event|2|||
30933364|NCT01864148|58969576|FG002|Overall Study|Adverse Event|4|||
30933365|NCT01864148|58969577|FG003|Overall Study|Adverse Event|7|||
30933366|NCT01864148|58969578|FG004|Overall Study|Adverse Event|7|||
30933367|NCT01864148|58969574|FG000|Overall Study|Not Dosed|0|||
30933368|NCT01864148|58969575|FG001|Overall Study|Not Dosed|0|||
30933369|NCT01864148|58969576|FG002|Overall Study|Not Dosed|0|||
30933370|NCT01864148|58969577|FG003|Overall Study|Not Dosed|1|||
30933371|NCT01864148|58969578|FG004|Overall Study|Not Dosed|0|||
30933372|NCT01751139|58969595|FG000|Overall Study|Other|135|||
30933373|NCT01751139|58969595|FG000|Overall Study|Sponsor study termination|1609|||
30933374|NCT01751139|58969595|FG000|Overall Study|Lost to Follow-up|240|||
30933375|NCT01751139|58969595|FG000|Overall Study|Withdrawal by Subject|251|||
30933376|NCT01751139|58969595|FG000|Overall Study|Adverse Event|1|||
30933377|NCT01751139|58969595|FG000|Overall Study|Death|31|||
30933378|NCT01890122|58969603|FG000|Overall Study|Adverse Event|1|||
30933379|NCT01890122|58969604|FG001|Overall Study|Adverse Event|1|||
30933380|NCT01890122|58969605|FG002|Overall Study|Adverse Event|1|||
30933381|NCT01890122|58969606|FG003|Overall Study|Adverse Event|2|||
30933382|NCT01890122|58969603|FG000|Overall Study|Major Protocol Deviation|3|||
30933383|NCT01890122|58969604|FG001|Overall Study|Major Protocol Deviation|1|||
30933384|NCT01890122|58969605|FG002|Overall Study|Major Protocol Deviation|0|||
30933385|NCT01890122|58969606|FG003|Overall Study|Major Protocol Deviation|1|||
30933386|NCT01890122|58969603|FG000|Overall Study|Lost to Follow-up|0|||
30839792|NCT02552212|58865126|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
30839793|NCT02552212|58865127|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
30839794|NCT02552212|58865125|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
30839795|NCT02552212|58865126|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
30839796|NCT02552212|58865127|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
30839797|NCT02552212|58865125|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
30933387|NCT01890122|58969604|FG001|Overall Study|Lost to Follow-up|1|||
30933388|NCT01890122|58969605|FG002|Overall Study|Lost to Follow-up|2|||
30933389|NCT01890122|58969606|FG003|Overall Study|Lost to Follow-up|2|||
30933390|NCT01890122|58969603|FG000|Overall Study|Voluntary Withdrawal|8|||
30933391|NCT01890122|58969604|FG001|Overall Study|Voluntary Withdrawal|8|||
30933392|NCT01890122|58969605|FG002|Overall Study|Voluntary Withdrawal|2|||
30933393|NCT01890122|58969606|FG003|Overall Study|Voluntary Withdrawal|11|||
30933394|NCT01890122|58969603|FG000|Overall Study|Lack of Efficacy|14|||
30933395|NCT01890122|58969604|FG001|Overall Study|Lack of Efficacy|24|||
30933396|NCT01890122|58969605|FG002|Overall Study|Lack of Efficacy|7|||
30933397|NCT01890122|58969606|FG003|Overall Study|Lack of Efficacy|41|||
30933398|NCT01890122|58969603|FG000|Overall Study|Reason not Specified|0|||
30933399|NCT01890122|58969604|FG001|Overall Study|Reason not Specified|1|||
30933400|NCT01890122|58969605|FG002|Overall Study|Reason not Specified|1|||
30933401|NCT01890122|58969606|FG003|Overall Study|Reason not Specified|2|||
30933402|NCT01890122|58969603|FG000|Overall Study|Randomized but not Treated|1|||
30624250|NCT00958191|58636249|FG000|Overall Study|Site termination|11|||
30624251|NCT00958191|58636249|FG000|Overall Study|No 5 yr x-rays|56|||
30624252|NCT00960843|58636257|FG000|Overall Study|Lost to Follow-up|2|||
30624253|NCT00960843|58636258|FG001|Overall Study|Lost to Follow-up|0|||
30758365|NCT00372593|58767053|FG001|Overall Study|Adverse Event|45|||
30758366|NCT00372593|58767054|FG002|Overall Study|Adverse Event|0|||
30758367|NCT00372593|58767052|FG000|Overall Study|Death|16|||
30758368|NCT00372593|58767053|FG001|Overall Study|Death|20|||
30758369|NCT00372593|58767054|FG002|Overall Study|Death|1|||
30758370|NCT00372593|58767052|FG000|Overall Study|Lack of Efficacy|82|||
30758371|NCT00372593|58767053|FG001|Overall Study|Lack of Efficacy|71|||
30758372|NCT00372593|58767054|FG002|Overall Study|Lack of Efficacy|2|||
30839798|NCT02552212|58865126|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
30933403|NCT01890122|58969604|FG001|Overall Study|Randomized but not Treated|1|||
30933404|NCT01890122|58969605|FG002|Overall Study|Randomized but not Treated|0|||
30933405|NCT01890122|58969606|FG003|Overall Study|Randomized but not Treated|0|||
30624254|NCT00960843|58636257|FG000|Overall Study|Protocol Violation|0|||
30758373|NCT00372593|58767052|FG000|Overall Study|Lost to Follow-up|1|||
30758374|NCT00372593|58767053|FG001|Overall Study|Lost to Follow-up|0|||
30933406|NCT01397890|58969618|FG000|Overall Study|Withdrawal by Subject|7|||
30933407|NCT01397890|58969619|FG001|Overall Study|Withdrawal by Subject|11|||
30933408|NCT01397890|58969618|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
30624255|NCT00960843|58636258|FG001|Overall Study|Protocol Violation|4|||
30624256|NCT00960843|58636257|FG000|Overall Study|Repeated needle dislodgment|0|||
30624257|NCT00960843|58636258|FG001|Overall Study|Repeated needle dislodgment|1|||
30624258|NCT02396199|58636264|FG000|Overall Study|Lost to Follow-up|1|||
30624259|NCT02396199|58636264|FG000|Overall Study|Death|4|||
30624260|NCT01605253|58636270|FG000|Overall Study|Physician Decision|3|||
30624261|NCT01605253|58636271|FG001|Overall Study|Physician Decision|2|||
30624262|NCT01605253|58636270|FG000|Overall Study|Lost to Follow-up|3|||
30624263|NCT01605253|58636271|FG001|Overall Study|Lost to Follow-up|1|||
30624264|NCT00955305|58636281|FG000|Overall Study|Disease progression|39|||
30624265|NCT00955305|58636282|FG001|Overall Study|Disease progression|41|||
30624266|NCT00955305|58636281|FG000|Overall Study|Adverse Event|22|||
30624267|NCT00955305|58636282|FG001|Overall Study|Adverse Event|22|||
30624268|NCT00955305|58636281|FG000|Overall Study|Death|2|||
30624269|NCT00955305|58636282|FG001|Overall Study|Death|1|||
30624270|NCT00955305|58636281|FG000|Overall Study|Withdrawal by Subject|5|||
30624271|NCT00955305|58636282|FG001|Overall Study|Withdrawal by Subject|4|||
30624272|NCT00955305|58636281|FG000|Overall Study|Alternative therapy|4|||
30624273|NCT00955305|58636282|FG001|Overall Study|Alternative therapy|0|||
30624274|NCT00955305|58636281|FG000|Overall Study|Other complicating disease|2|||
30624275|NCT00955305|58636282|FG001|Overall Study|Other complicating disease|4|||
30933409|NCT01397890|58969619|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
30933410|NCT01397890|58969618|FG000|Overall Study|Death|2|||
30933411|NCT01397890|58969619|FG001|Overall Study|Death|3|||
30933412|NCT01397890|58969618|FG000|Overall Study|Lost to Follow-up|1|||
30933413|NCT01397890|58969619|FG001|Overall Study|Lost to Follow-up|4|||
30933414|NCT01397890|58969618|FG000|Overall Study|Condition under Investigation Worsened|1|||
30933415|NCT01397890|58969619|FG001|Overall Study|Condition under Investigation Worsened|3|||
30933416|NCT01397890|58969618|FG000|Overall Study|Adverse Event|1|||
30933417|NCT01397890|58969619|FG001|Overall Study|Adverse Event|2|||
30933418|NCT01397890|58969618|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
30933419|NCT01397890|58969619|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
30933420|NCT01397890|58969618|FG000|Overall Study|Others|2|||
30933421|NCT01397890|58969619|FG001|Overall Study|Others|1|||
30933422|NCT01777269|58969627|FG000|Overall Study|Adverse Event|24|||
30933423|NCT01777269|58969628|FG001|Overall Study|Adverse Event|33|||
30933424|NCT01777269|58969627|FG000|Overall Study|Lack of Efficacy|8|||
30933425|NCT01777269|58969628|FG001|Overall Study|Lack of Efficacy|10|||
30933426|NCT01777269|58969627|FG000|Overall Study|Protocol Violation|4|||
30933427|NCT01777269|58969628|FG001|Overall Study|Protocol Violation|4|||
30933428|NCT01777269|58969627|FG000|Overall Study|Participants reached stopping criteria|1|||
30933429|NCT01777269|58969628|FG001|Overall Study|Participants reached stopping criteria|1|||
30933430|NCT01777269|58969627|FG000|Overall Study|Lost to Follow-up|4|||
30933431|NCT01777269|58969628|FG001|Overall Study|Lost to Follow-up|0|||
30933432|NCT01777269|58969627|FG000|Overall Study|Physician Decision|5|||
30933433|NCT01777269|58969628|FG001|Overall Study|Physician Decision|2|||
30933434|NCT01777269|58969627|FG000|Overall Study|Withdrawal by Subject|9|||
30933435|NCT01777269|58969628|FG001|Overall Study|Withdrawal by Subject|9|||
30933436|NCT04016272|58969636|FG000|Overall Study|Withdrawal by Subject|1|||
30933437|NCT04016272|58969637|FG001|Overall Study|Withdrawal by Subject|2|||
30933438|NCT01751061|58969645|FG000|Overall Study|Death|1|||
30933439|NCT01751061|58969646|FG001|Overall Study|Death|0|||
30933440|NCT01751061|58969645|FG000|Overall Study|patient death|5|||
30933441|NCT01751061|58969646|FG001|Overall Study|patient death|0|||
30933442|NCT01751061|58969645|FG000|Overall Study|Lost to Follow-up|40|||
30933443|NCT01751061|58969646|FG001|Overall Study|Lost to Follow-up|25|||
30933444|NCT01751061|58969645|FG000|Overall Study|patient regained decisional capacity|4|||
30933445|NCT01751061|58969646|FG001|Overall Study|patient regained decisional capacity|8|||
30933446|NCT01751061|58969645|FG000|Overall Study|Withdrawal by Subject|4|||
30933447|NCT01751061|58969646|FG001|Overall Study|Withdrawal by Subject|1|||
30933448|NCT01751061|58969645|FG000|Overall Study|Physician Decision|2|||
30933449|NCT01751061|58969646|FG001|Overall Study|Physician Decision|0|||
30933450|NCT01777191|58969654|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
30933451|NCT01777191|58969655|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
30624276|NCT00955305|58636281|FG000|Overall Study|Physician Decision|1|||
30624277|NCT00955305|58636282|FG001|Overall Study|Physician Decision|0|||
30624278|NCT00955305|58636281|FG000|Overall Study|Continued presence of residual disease|0|||
30624279|NCT00955305|58636282|FG001|Overall Study|Continued presence of residual disease|1|||
30624280|NCT00955305|58636281|FG000|Overall Study|Functional decline|2|||
30624281|NCT00955305|58636282|FG001|Overall Study|Functional decline|0|||
30624282|NCT00955305|58636281|FG000|Overall Study|Maximum response achieved|0|||
30624283|NCT00955305|58636282|FG001|Overall Study|Maximum response achieved|1|||
30933452|NCT01777191|58969654|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
30933453|NCT01777191|58969655|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
30933454|NCT01777191|58969654|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
30624284|NCT00955305|58636281|FG000|Overall Study|Lost to Follow-up|0|||
30933455|NCT01777191|58969655|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
30933456|NCT01777191|58969654|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
30933457|NCT01777191|58969655|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
30933458|NCT01777191|58969654|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
30933459|NCT01777191|58969655|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
30933460|NCT01777191|58969654|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
30933461|NCT01777191|58969655|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
30933462|NCT01777191|58969654|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
30933463|NCT01777191|58969655|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
30933464|NCT01777191|58969654|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
30933465|NCT01777191|58969655|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
30933466|NCT01777191|58969654|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
30933467|NCT01777191|58969655|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
30933468|NCT01777191|58969654|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
30933469|NCT01777191|58969655|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
30933470|NCT01777191|58969654|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
30933471|NCT01777191|58969655|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
30933472|NCT01896050|58969666|FG000|Overall Study|Adverse Event|37|||
30933473|NCT01896050|58969667|FG001|Overall Study|Adverse Event|2|||
30933474|NCT01896050|58969666|FG000|Overall Study|Death|1|||
30933475|NCT01896050|58969667|FG001|Overall Study|Death|0|||
30933476|NCT01775787|58969675|FG000|First 7-10 Days|Adverse Event|0|||
30933477|NCT01775787|58969676|FG001|First 7-10 Days|Adverse Event|1|||
30933478|NCT01775787|58969675|FG000|First 7-10 Days|family emergency|0|||
30933479|NCT01775787|58969676|FG001|First 7-10 Days|family emergency|1|||
30933480|NCT01775787|58969675|FG000|First 7-10 Days|time commitment|0|||
30933481|NCT01775787|58969676|FG001|First 7-10 Days|time commitment|2|||
30933482|NCT01775787|58969675|FG000|First 7-10 Days|concerns with using IV|1|||
30933483|NCT01775787|58969676|FG001|First 7-10 Days|concerns with using IV|2|||
30933484|NCT01775787|58969675|FG000|Second 7-10 Days|time commitment|0|||
30933485|NCT01775787|58969676|FG001|Second 7-10 Days|time commitment|1|||
30933486|NCT01775787|58969675|FG000|Second 7-10 Days|concerns with using IV|0|||
30933487|NCT01775787|58969676|FG001|Second 7-10 Days|concerns with using IV|1|||
30933488|NCT01775553|58969684|FG000|Overall Study|Adverse Event|1|||
30933489|NCT01775553|58969684|FG000|Overall Study|Disease Progression|12|||
30933490|NCT01775475|58969690|FG000|Overall Study|Death|3|||
30933491|NCT01775475|58969691|FG001|Overall Study|Death|3|||
30933492|NCT01774929|58969697|FG000|Overall Study|Adverse Event|3|||
30933493|NCT01888874|58969708|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
30933494|NCT01888874|58969709|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
30933495|NCT01888874|58969710|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
30933496|NCT01888874|58969711|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
30933497|NCT01888874|58969712|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
30933498|NCT01888874|58969713|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
30933499|NCT01888874|58969714|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
30933500|NCT01888874|58969708|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
30933501|NCT01888874|58969709|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
30933502|NCT01888874|58969710|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
30933503|NCT01888874|58969711|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
30933504|NCT01888874|58969712|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
30933505|NCT01888874|58969713|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
30933506|NCT01888874|58969714|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
30933507|NCT01888874|58969708|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
30933508|NCT01888874|58969709|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
30933509|NCT01888874|58969710|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
30758375|NCT00372593|58767054|FG002|Overall Study|Lost to Follow-up|0|||
30758376|NCT00372593|58767052|FG000|Overall Study|Physician Decision|42|||
30758377|NCT00372593|58767053|FG001|Overall Study|Physician Decision|41|||
30758378|NCT00372593|58767054|FG002|Overall Study|Physician Decision|0|||
30758379|NCT00372593|58767052|FG000|Overall Study|Ineligible|20|||
30758380|NCT00372593|58767053|FG001|Overall Study|Ineligible|21|||
30758381|NCT00372593|58767054|FG002|Overall Study|Ineligible|1|||
30758382|NCT03666988|58767069|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
30758383|NCT03666988|58767070|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
30758384|NCT03666988|58767071|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
30758385|NCT03666988|58767072|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
30758386|NCT03666988|58767073|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
30758387|NCT03666988|58767074|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
30758388|NCT03666988|58767069|FG000|Part 1 (Up to 28 Months)|Other|0|||
30758389|NCT03666988|58767070|FG001|Part 1 (Up to 28 Months)|Other|1|||
30758390|NCT03666988|58767071|FG002|Part 1 (Up to 28 Months)|Other|1|||
30758391|NCT03666988|58767072|FG003|Part 1 (Up to 28 Months)|Other|0|||
30758392|NCT03666988|58767073|FG004|Part 1 (Up to 28 Months)|Other|0|||
30758393|NCT03666988|58767074|FG005|Part 1 (Up to 28 Months)|Other|0|||
30758394|NCT03666988|58767069|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
30933510|NCT01888874|58969711|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
30933511|NCT01888874|58969712|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
30933512|NCT01888874|58969713|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
30933513|NCT01888874|58969714|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
30933514|NCT01888874|58969708|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
30933515|NCT01888874|58969709|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
30933516|NCT01888874|58969710|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
30933517|NCT01888874|58969711|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
30933518|NCT01888874|58969712|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
30933519|NCT01888874|58969713|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
30933520|NCT01888874|58969714|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
30933521|NCT01888874|58969708|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
30933522|NCT01888874|58969709|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
30933523|NCT01888874|58969710|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
30933524|NCT01888874|58969711|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
30933525|NCT01888874|58969712|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
30933526|NCT01888874|58969713|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
30933527|NCT01888874|58969714|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
30933528|NCT01888874|58969708|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
30933529|NCT01888874|58969709|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
30933530|NCT01888874|58969710|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
30933531|NCT01888874|58969711|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
30933532|NCT01888874|58969712|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
30933533|NCT01888874|58969713|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
30933534|NCT01888874|58969714|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
30933535|NCT01888874|58969708|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
30933536|NCT01888874|58969709|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
30933537|NCT01888874|58969710|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
30933538|NCT01888874|58969711|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
30933539|NCT01888874|58969712|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
30933540|NCT01888874|58969713|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
30933541|NCT01888874|58969714|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
30933542|NCT01888874|58969708|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
30933543|NCT01888874|58969709|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
30933544|NCT01888874|58969710|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
30933545|NCT01888874|58969711|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
30933546|NCT01888874|58969712|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
30933547|NCT01888874|58969713|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
30933548|NCT01888874|58969714|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
30933549|NCT01888874|58969708|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
30933550|NCT01888874|58969709|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
30933551|NCT01888874|58969710|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
30933552|NCT01888874|58969711|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
30933553|NCT01888874|58969712|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
30933554|NCT01888874|58969713|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
30933555|NCT01888874|58969714|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
30933556|NCT01888874|58969708|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
30933557|NCT01888874|58969709|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
30933558|NCT01888874|58969710|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
30933559|NCT01888874|58969711|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
30933560|NCT01888874|58969712|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
30933561|NCT01888874|58969713|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
30933562|NCT01888874|58969714|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
30933563|NCT01888874|58969708|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
30933564|NCT01888874|58969709|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
30933565|NCT01888874|58969710|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
30933566|NCT01888874|58969711|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
30933567|NCT01888874|58969712|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
30933568|NCT01888874|58969713|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
30933569|NCT01888874|58969714|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
30933570|NCT01888874|58969708|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
30933571|NCT01888874|58969709|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
30933572|NCT01888874|58969710|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
30933573|NCT01888874|58969711|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
30933574|NCT01888874|58969712|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
30933575|NCT01888874|58969713|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
30933576|NCT01888874|58969714|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
30933577|NCT01888874|58969708|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
30933578|NCT01888874|58969709|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
30933579|NCT01888874|58969710|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
30933580|NCT01888874|58969711|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
30933581|NCT01888874|58969712|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
30933582|NCT01888874|58969713|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
30933583|NCT01888874|58969714|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
30933584|NCT01749735|58969733|FG000|Overall Study|Withdrawal by Subject|1|||
30933585|NCT01749735|58969734|FG001|Overall Study|Withdrawal by Subject|0|||
30933586|NCT01749033|58969743|FG000|Overall Study|Did not receive allocated intervention|3|||
30933587|NCT01749033|58969744|FG001|Overall Study|Did not receive allocated intervention|3|||
30933588|NCT01749033|58969745|FG002|Overall Study|Did not receive allocated intervention|0|||
30624285|NCT00955305|58636282|FG001|Overall Study|Lost to Follow-up|1|||
30839799|NCT02552212|58865127|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
30839800|NCT02552212|58865125|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
30933589|NCT01749033|58969743|FG000|Overall Study|Lost to Follow-up|0|||
30758395|NCT03666988|58767070|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
30758396|NCT03666988|58767071|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
30758397|NCT03666988|58767072|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
30758398|NCT03666988|58767073|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
30758399|NCT03666988|58767074|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
30758400|NCT03666988|58767069|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
30758401|NCT03666988|58767070|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
30758402|NCT03666988|58767071|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
30758403|NCT03666988|58767072|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
30758404|NCT03666988|58767073|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
30758405|NCT03666988|58767074|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
30758406|NCT03666988|58767069|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
30758407|NCT03666988|58767070|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
30758408|NCT03666988|58767071|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
30758409|NCT03666988|58767072|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
30758410|NCT03666988|58767073|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
30758411|NCT03666988|58767074|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
30758412|NCT00382109|58767094|FG000|Overall Study|Adverse Event|3|||
30758413|NCT00382109|58767095|FG001|Overall Study|Adverse Event|0|||
30758414|NCT00382109|58767094|FG000|Overall Study|Physician Decision|6|||
30758415|NCT00382109|58767095|FG001|Overall Study|Physician Decision|1|||
30758416|NCT00382109|58767094|FG000|Overall Study|Withdrawal by Subject|1|||
30758417|NCT00382109|58767095|FG001|Overall Study|Withdrawal by Subject|0|||
30758418|NCT00382109|58767094|FG000|Overall Study|ineligible|2|||
30758419|NCT00382109|58767095|FG001|Overall Study|ineligible|0|||
30758420|NCT00382109|58767094|FG000|Overall Study|Other|0|||
30758421|NCT00382109|58767095|FG001|Overall Study|Other|2|||
30758422|NCT00382109|58767094|FG000|Overall Study|consent withdrawal|0|||
30758423|NCT00382109|58767095|FG001|Overall Study|consent withdrawal|1|||
30758424|NCT03651622|58767107|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
30758425|NCT03651622|58767108|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
30758426|NCT03651622|58767109|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
30758427|NCT03651622|58767107|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
30758428|NCT03651622|58767108|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
30758429|NCT03651622|58767109|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
30758430|NCT03651622|58767107|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
30758431|NCT03651622|58767108|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
30758432|NCT03651622|58767109|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
30758433|NCT03651622|58767107|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
30758434|NCT03651622|58767108|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
30758435|NCT03651622|58767109|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
30758436|NCT03651622|58767107|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
30758437|NCT03651622|58767108|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
30758438|NCT03651622|58767109|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
30758439|NCT00381797|58767122|FG000|Overall Study|Withdrawal by Subject|1|||
30758440|NCT00381797|58767123|FG001|Overall Study|Withdrawal by Subject|1|||
30758441|NCT00381797|58767124|FG002|Overall Study|Withdrawal by Subject|0|||
30933590|NCT01749033|58969744|FG001|Overall Study|Lost to Follow-up|2|||
30933591|NCT01749033|58969745|FG002|Overall Study|Lost to Follow-up|1|||
30933592|NCT01774305|58969756|FG000|Overall Study|Physician Decision|1|||
30933593|NCT01774305|58969757|FG001|Overall Study|Physician Decision|0|||
30933594|NCT01737021|58969765|FG000|Overall Study|Lost to Follow-up|5|||
30933595|NCT01737021|58969766|FG001|Overall Study|Lost to Follow-up|3|||
30933596|NCT01397422|58969776|FG000|Overall Study|Adverse Event|0|||
30933597|NCT01397422|58969777|FG001|Overall Study|Adverse Event|3|||
30933598|NCT01397422|58969778|FG002|Overall Study|Adverse Event|3|||
30933599|NCT01397422|58969779|FG003|Overall Study|Adverse Event|8|||
30933600|NCT01397422|58969776|FG000|Overall Study|Withdrawal by Subject|1|||
30933601|NCT01397422|58969777|FG001|Overall Study|Withdrawal by Subject|0|||
30933602|NCT01397422|58969778|FG002|Overall Study|Withdrawal by Subject|0|||
30933603|NCT01397422|58969779|FG003|Overall Study|Withdrawal by Subject|0|||
30933604|NCT01397422|58969776|FG000|Overall Study|Increased bradykinesia related to PD|1|||
30933605|NCT01397422|58969777|FG001|Overall Study|Increased bradykinesia related to PD|0|||
30933606|NCT01397422|58969778|FG002|Overall Study|Increased bradykinesia related to PD|0|||
30933607|NCT01397422|58969779|FG003|Overall Study|Increased bradykinesia related to PD|0|||
30933608|NCT01736553|58969793|FG000|Overall Study|Death|12|||
30933609|NCT01736553|58969794|FG001|Overall Study|Death|0|||
30839801|NCT02552212|58865126|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
30839802|NCT02552212|58865127|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
30839803|NCT02552212|58865125|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
30839804|NCT02552212|58865126|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
30839805|NCT02552212|58865127|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
30933610|NCT01736553|58969793|FG000|Overall Study|Withdrawal by Subject|5|||
30933611|NCT01736553|58969794|FG001|Overall Study|Withdrawal by Subject|2|||
30933612|NCT01736553|58969793|FG000|Overall Study|Lost to Follow-up|2|||
30933613|NCT01736553|58969794|FG001|Overall Study|Lost to Follow-up|2|||
30933614|NCT01888640|58969821|FG000|Overall Study|Lost to Follow-up|1|||
30933615|NCT01888640|58969822|FG001|Overall Study|Lost to Follow-up|2|||
30933616|NCT01888640|58969823|FG002|Overall Study|Lost to Follow-up|0|||
30933617|NCT01888640|58969821|FG000|Overall Study|Withdrawal by Subject|15|||
30933618|NCT01888640|58969822|FG001|Overall Study|Withdrawal by Subject|11|||
30933619|NCT01888640|58969823|FG002|Overall Study|Withdrawal by Subject|4|||
30933620|NCT01888640|58969821|FG000|Overall Study|Minimum dose not met|10|||
30933621|NCT01888640|58969822|FG001|Overall Study|Minimum dose not met|16|||
30933622|NCT01888640|58969823|FG002|Overall Study|Minimum dose not met|0|||
30933623|NCT01888640|58969821|FG000|Overall Study|Given wrong unit (placebo)|1|||
30933624|NCT01888640|58969822|FG001|Overall Study|Given wrong unit (placebo)|0|||
30933625|NCT01888640|58969823|FG002|Overall Study|Given wrong unit (placebo)|0|||
30933626|NCT01888640|58969821|FG000|Overall Study|Excluded for prior TENS|0|||
30933627|NCT01888640|58969822|FG001|Overall Study|Excluded for prior TENS|1|||
30933628|NCT01888640|58969823|FG002|Overall Study|Excluded for prior TENS|0|||
30933629|NCT01888640|58969821|FG000|Overall Study|Researcher Termination of Participant|0|||
30933630|NCT01888640|58969822|FG001|Overall Study|Researcher Termination of Participant|1|||
30933631|NCT01888640|58969823|FG002|Overall Study|Researcher Termination of Participant|1|||
30933632|NCT01736475|58969836|FG000|Overall Study|Adverse Event|4|||
30933633|NCT01736475|58969837|FG001|Overall Study|Adverse Event|0|||
30933634|NCT01736475|58969836|FG000|Overall Study|Withdrawal by Subject|2|||
30933635|NCT01736475|58969837|FG001|Overall Study|Withdrawal by Subject|0|||
30933636|NCT01736475|58969836|FG000|Overall Study|Protocol Violation|4|||
30933637|NCT01736475|58969837|FG001|Overall Study|Protocol Violation|0|||
30933638|NCT01736475|58969836|FG000|Overall Study|Other - Screen failure|1|||
30933639|NCT01736475|58969837|FG001|Overall Study|Other - Screen failure|0|||
30933640|NCT01736475|58969836|FG000|Overall Study|Other - Surgical procedure|1|||
30933641|NCT01736475|58969837|FG001|Overall Study|Other - Surgical procedure|0|||
30933642|NCT01863758|58969854|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
30933643|NCT01863758|58969854|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
30933644|NCT01863680|58969858|FG000|Overall Study|Adverse Event|17|||
30933645|NCT01863680|58969858|FG000|Overall Study|Risk of OHSS|17|||
30933646|NCT01863680|58969858|FG000|Overall Study|Spontaneous pregnancy|2|||
30839806|NCT02552212|58865125|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
30839807|NCT02552212|58865126|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
30839808|NCT02552212|58865127|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
30839809|NCT02552212|58865125|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
30839810|NCT02552212|58865126|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
30839811|NCT02552212|58865127|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
30839812|NCT02552212|58865125|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
30933647|NCT01863680|58969858|FG000|Overall Study|Withdrawal by Subject|1|||
30933648|NCT01863680|58969858|FG000|Overall Study|Did not undergo IVF/ET|14|||
30839813|NCT02552212|58865126|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
30933649|NCT01863680|58969858|FG000|Overall Study|Other|6|||
30933650|NCT01747629|58969864|FG000|Overall Study|Adverse Event|1|||
30933651|NCT01747629|58969865|FG001|Overall Study|Adverse Event|2|||
30933652|NCT01747629|58969864|FG000|Overall Study|Withdrawal by Subject|2|||
30933653|NCT01747629|58969865|FG001|Overall Study|Withdrawal by Subject|2|||
30933654|NCT01747629|58969864|FG000|Overall Study|Noncompliance|1|||
30933655|NCT01747629|58969865|FG001|Overall Study|Noncompliance|1|||
30933656|NCT01747629|58969864|FG000|Overall Study|Inclusion criteria not met|1|||
30933657|NCT01747629|58969865|FG001|Overall Study|Inclusion criteria not met|0|||
30933658|NCT01747629|58969864|FG000|Overall Study|Not treated|1|||
30933659|NCT01747629|58969865|FG001|Overall Study|Not treated|0|||
30933660|NCT01747629|58969864|FG000|Overall Study|Other|2|||
30933661|NCT01747629|58969865|FG001|Overall Study|Other|1|||
30933662|NCT01863368|58969873|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
30933663|NCT01863368|58969874|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
30933664|NCT01863368|58969873|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
30933665|NCT01863368|58969874|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
30933666|NCT01863368|58969873|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
30933667|NCT01863368|58969874|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
30933668|NCT01863368|58969873|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
30933669|NCT01863368|58969874|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
30933670|NCT01863368|58969873|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
30933671|NCT01863368|58969874|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
30933672|NCT01863368|58969873|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
30933673|NCT01863368|58969874|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
30933674|NCT01886690|58969883|FG000|Overall Study|Protocol Violation|0|||
30933675|NCT01886690|58969884|FG001|Overall Study|Protocol Violation|1|||
30933676|NCT01886690|58969883|FG000|Overall Study|Personal Reasons|0|||
30933677|NCT01886690|58969884|FG001|Overall Study|Personal Reasons|1|||
30933678|NCT01886378|58969890|FG000|Overall Study|Adverse Event|1|||
30933679|NCT01886378|58969890|FG000|Overall Study|Withdrawal by Subject|4|||
30933680|NCT01886300|58969894|FG000|Overall Study|Trial terminated by sponsor|16|||
30933681|NCT01885208|58969900|FG000|Overall Study|Unclassified|32|||
30933682|NCT01885208|58969901|FG001|Overall Study|Unclassified|38|||
30933683|NCT01859702|58969907|FG000|Overall Study|Protocol deviation|3|||
30933684|NCT01859702|58969907|FG000|Overall Study|Adverse Event|2|||
30933685|NCT01835132|58969911|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
30933686|NCT01747551|58969917|FG000|Overall Study|Progressive Disease|24|||
30933687|NCT01747551|58969918|FG001|Overall Study|Progressive Disease|17|||
30933688|NCT01747551|58969917|FG000|Overall Study|Death|3|||
30933689|NCT01747551|58969918|FG001|Overall Study|Death|1|||
30933690|NCT01747551|58969917|FG000|Overall Study|Adverse Event|7|||
30933691|NCT01747551|58969918|FG001|Overall Study|Adverse Event|1|||
30933692|NCT01747551|58969917|FG000|Overall Study|Prolonged Treatment Delay|2|||
30933693|NCT01747551|58969918|FG001|Overall Study|Prolonged Treatment Delay|0|||
30933694|NCT01747551|58969917|FG000|Overall Study|Withdrawal by Subject|3|||
30933695|NCT01747551|58969918|FG001|Overall Study|Withdrawal by Subject|1|||
30933696|NCT01747551|58969917|FG000|Overall Study|Physician Decision|2|||
30933697|NCT01747551|58969918|FG001|Overall Study|Physician Decision|1|||
30933698|NCT01747551|58969917|FG000|Overall Study|Other|2|||
30933699|NCT01747551|58969918|FG001|Overall Study|Other|0|||
30933700|NCT01736397|58969926|FG000|Overall Study|Lack of Efficacy|1|||
30933701|NCT01736397|58969927|FG001|Overall Study|Lack of Efficacy|11|||
30933702|NCT01736397|58969926|FG000|Overall Study|Withdrawal by Subject|6|||
30933703|NCT01736397|58969927|FG001|Overall Study|Withdrawal by Subject|5|||
30933704|NCT01736397|58969926|FG000|Overall Study|Lost to Follow-up|0|||
30933705|NCT01736397|58969927|FG001|Overall Study|Lost to Follow-up|1|||
30933706|NCT01736397|58969926|FG000|Overall Study|Adverse Event|6|||
30933707|NCT01736397|58969927|FG001|Overall Study|Adverse Event|3|||
30933708|NCT01736397|58969926|FG000|Overall Study|Not stated|1|||
30839814|NCT02552212|58865127|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
30933709|NCT01736397|58969927|FG001|Overall Study|Not stated|4|||
30933710|NCT01859390|58969935|FG000|Overall Study|Insufficient Sputum Collected|1|||
30839815|NCT02552212|58865125|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
30933711|NCT01859390|58969936|FG001|Overall Study|Insufficient Sputum Collected|3|||
30933712|NCT01859390|58969935|FG000|Overall Study|Sample Missing Collection Date|0|||
30933713|NCT01859390|58969936|FG001|Overall Study|Sample Missing Collection Date|1|||
30933714|NCT01859390|58969935|FG000|Overall Study|Tube Cracked|0|||
30933715|NCT01859390|58969936|FG001|Overall Study|Tube Cracked|2|||
30933716|NCT01859390|58969935|FG000|Overall Study|Shipment Error|0|||
30933717|NCT01859390|58969936|FG001|Overall Study|Shipment Error|1|||
30933718|NCT01858766|58969961|FG000|Overall Study|Randomized but Never Treated|0|||
30933719|NCT01858766|58969962|FG001|Overall Study|Randomized but Never Treated|0|||
30933720|NCT01858766|58969963|FG002|Overall Study|Randomized but Never Treated|0|||
30933721|NCT01858766|58969964|FG003|Overall Study|Randomized but Never Treated|0|||
30933722|NCT01858766|58969965|FG004|Overall Study|Randomized but Never Treated|0|||
30933723|NCT01858766|58969966|FG005|Overall Study|Randomized but Never Treated|1|||
30933724|NCT01858766|58969967|FG006|Overall Study|Randomized but Never Treated|0|||
30933725|NCT01858766|58969968|FG007|Overall Study|Randomized but Never Treated|0|||
30933726|NCT01858766|58969969|FG008|Overall Study|Randomized but Never Treated|0|||
30933727|NCT01858766|58969970|FG009|Overall Study|Randomized but Never Treated|0|||
30933728|NCT01858766|58969971|FG010|Overall Study|Randomized but Never Treated|0|||
30933729|NCT01858766|58969972|FG011|Overall Study|Randomized but Never Treated|0|||
30933730|NCT01858766|58969973|FG012|Overall Study|Randomized but Never Treated|0|||
30933731|NCT01858766|58969974|FG013|Overall Study|Randomized but Never Treated|0|||
30933732|NCT01858766|58969975|FG014|Overall Study|Randomized but Never Treated|0|||
30933733|NCT01858766|58969976|FG015|Overall Study|Randomized but Never Treated|0|||
30933734|NCT01858766|58969977|FG016|Overall Study|Randomized but Never Treated|0|||
30933735|NCT01858766|58969978|FG017|Overall Study|Randomized but Never Treated|1|||
30933736|NCT01858766|58969979|FG018|Overall Study|Randomized but Never Treated|0|||
30933737|NCT01858766|58969961|FG000|Overall Study|Death|0|||
30933738|NCT01858766|58969962|FG001|Overall Study|Death|0|||
30933739|NCT01858766|58969963|FG002|Overall Study|Death|1|||
30933740|NCT01858766|58969964|FG003|Overall Study|Death|0|||
30839816|NCT02552212|58865126|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
30839817|NCT02552212|58865127|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
30839818|NCT02552212|58865125|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
30839819|NCT02552212|58865126|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
30839820|NCT02552212|58865127|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
30839821|NCT02552212|58865125|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
30839822|NCT02552212|58865126|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
30839823|NCT02552212|58865127|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
30839824|NCT02552212|58865125|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
30839825|NCT02552212|58865126|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
30839826|NCT02552212|58865127|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
30839827|NCT02552212|58865125|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
30839828|NCT02552212|58865126|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
30839829|NCT02552212|58865127|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
30839830|NCT00685919|58865147|FG000|Overall Study|Withdrawal by Subject|0|||
30839831|NCT00685919|58865148|FG001|Overall Study|Withdrawal by Subject|0|||
30839832|NCT00685919|58865149|FG002|Overall Study|Withdrawal by Subject|1|||
30839833|NCT00685919|58865150|FG003|Overall Study|Withdrawal by Subject|0|||
30839834|NCT00685919|58865147|FG000|Overall Study|Physician Decision|1|||
30839835|NCT00685919|58865148|FG001|Overall Study|Physician Decision|0|||
30839836|NCT00685919|58865149|FG002|Overall Study|Physician Decision|0|||
30839837|NCT00685919|58865150|FG003|Overall Study|Physician Decision|0|||
30839838|NCT03061331|58865162|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
30839839|NCT03061331|58865163|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
30839840|NCT00700778|58865169|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
30839841|NCT02551666|58865175|FG000|Overall Study|Withdrawal by Subject|1|||
30839842|NCT02551666|58865176|FG001|Overall Study|Withdrawal by Subject|3|||
30839843|NCT03061175|58865188|FG000|Baseline|Participant was deemed ineligible|1|||
30839844|NCT03061175|58865189|FG001|Baseline|Participant was deemed ineligible|0|||
30839845|NCT03061175|58865188|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
30839846|NCT03061175|58865189|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
30839847|NCT03061175|58865188|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
30839848|NCT03061175|58865189|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
30839849|NCT03061175|58865188|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
30839850|NCT03061175|58865189|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
30839851|NCT02554474|58865206|FG000|Overall Study|Protocol Violation|1|||
30839852|NCT02554474|58865207|FG001|Overall Study|Protocol Violation|1|||
30839853|NCT02554474|58865206|FG000|Overall Study|Health issue not related to the study|1|||
30839854|NCT02554474|58865207|FG001|Overall Study|Health issue not related to the study|0|||
30839855|NCT02554474|58865206|FG000|Overall Study|Withdrawal by Subject|1|||
30839856|NCT02554474|58865207|FG001|Overall Study|Withdrawal by Subject|1|||
30839857|NCT03061097|58865215|FG000|Overall Study|Withdrawal by Subject|0|||
30839858|NCT03061097|58865216|FG001|Overall Study|Withdrawal by Subject|3|||
30839859|NCT02554318|58865224|FG000|Overall Study|Withdrawal by Subject|10|||
30839860|NCT02554318|58865225|FG001|Overall Study|Withdrawal by Subject|8|||
30839861|NCT02550106|58865231|FG000|Overall Study|Adverse Event|1|||
30933741|NCT01858766|58969965|FG004|Overall Study|Death|0|||
30933742|NCT01858766|58969966|FG005|Overall Study|Death|0|||
30933743|NCT01858766|58969967|FG006|Overall Study|Death|0|||
30933744|NCT01858766|58969968|FG007|Overall Study|Death|0|||
30839862|NCT02550106|58865231|FG000|Overall Study|Lack of Efficacy|3|||
30839863|NCT02550106|58865231|FG000|Overall Study|Protocol Violation|6|||
30839864|NCT02550106|58865231|FG000|Overall Study|Withdrawal by Subject|2|||
30839865|NCT03060551|58865237|FG000|Overall Study|Withdrawal by Subject|1|||
30839866|NCT03060551|58865237|FG000|Overall Study|Adverse Event|1|||
30839867|NCT01662310|58865241|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
30839868|NCT01662310|58865242|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
30839869|NCT01662310|58865243|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
30839870|NCT01662310|58865244|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
30839871|NCT01662310|58865245|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
30839872|NCT01662310|58865241|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
30839873|NCT01662310|58865242|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
30839874|NCT01662310|58865243|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
30839875|NCT01662310|58865244|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
30839876|NCT01662310|58865245|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
30839877|NCT01662310|58865241|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
30839878|NCT01662310|58865242|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
30839879|NCT01662310|58865243|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
30839880|NCT01662310|58865244|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
30839881|NCT01662310|58865245|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
30933745|NCT01858766|58969969|FG008|Overall Study|Death|0|||
30933746|NCT01858766|58969970|FG009|Overall Study|Death|0|||
30933747|NCT01858766|58969971|FG010|Overall Study|Death|0|||
30933748|NCT01858766|58969972|FG011|Overall Study|Death|0|||
30933749|NCT01858766|58969973|FG012|Overall Study|Death|0|||
30933750|NCT01858766|58969974|FG013|Overall Study|Death|0|||
30933751|NCT01858766|58969975|FG014|Overall Study|Death|0|||
30933752|NCT01858766|58969976|FG015|Overall Study|Death|0|||
30933753|NCT01858766|58969977|FG016|Overall Study|Death|0|||
30933754|NCT01858766|58969978|FG017|Overall Study|Death|0|||
30933755|NCT01858766|58969979|FG018|Overall Study|Death|0|||
30933756|NCT01858766|58969961|FG000|Overall Study|Lack of Efficacy|1|||
30933757|NCT01858766|58969962|FG001|Overall Study|Lack of Efficacy|0|||
30933758|NCT01858766|58969963|FG002|Overall Study|Lack of Efficacy|0|||
30933759|NCT01858766|58969964|FG003|Overall Study|Lack of Efficacy|0|||
30933760|NCT01858766|58969965|FG004|Overall Study|Lack of Efficacy|1|||
30933761|NCT01858766|58969966|FG005|Overall Study|Lack of Efficacy|2|||
30933762|NCT01858766|58969967|FG006|Overall Study|Lack of Efficacy|0|||
30933763|NCT01858766|58969968|FG007|Overall Study|Lack of Efficacy|0|||
30933764|NCT01858766|58969969|FG008|Overall Study|Lack of Efficacy|0|||
30933765|NCT01858766|58969970|FG009|Overall Study|Lack of Efficacy|0|||
30933766|NCT01858766|58969971|FG010|Overall Study|Lack of Efficacy|0|||
30933767|NCT01858766|58969972|FG011|Overall Study|Lack of Efficacy|3|||
30933768|NCT01858766|58969973|FG012|Overall Study|Lack of Efficacy|5|||
30933769|NCT01858766|58969974|FG013|Overall Study|Lack of Efficacy|3|||
30933770|NCT01858766|58969975|FG014|Overall Study|Lack of Efficacy|5|||
30933771|NCT01858766|58969976|FG015|Overall Study|Lack of Efficacy|5|||
30933772|NCT01858766|58969977|FG016|Overall Study|Lack of Efficacy|2|||
30933773|NCT01858766|58969978|FG017|Overall Study|Lack of Efficacy|3|||
30933774|NCT01858766|58969979|FG018|Overall Study|Lack of Efficacy|3|||
30933775|NCT01858766|58969961|FG000|Overall Study|Lost to Follow-up|0|||
30933776|NCT01858766|58969962|FG001|Overall Study|Lost to Follow-up|0|||
30933777|NCT01858766|58969963|FG002|Overall Study|Lost to Follow-up|0|||
30933778|NCT01858766|58969964|FG003|Overall Study|Lost to Follow-up|0|||
30933779|NCT01858766|58969965|FG004|Overall Study|Lost to Follow-up|0|||
30933780|NCT01858766|58969966|FG005|Overall Study|Lost to Follow-up|1|||
30933781|NCT01858766|58969967|FG006|Overall Study|Lost to Follow-up|0|||
30933782|NCT01858766|58969968|FG007|Overall Study|Lost to Follow-up|2|||
30933783|NCT01858766|58969969|FG008|Overall Study|Lost to Follow-up|0|||
30933784|NCT01858766|58969970|FG009|Overall Study|Lost to Follow-up|0|||
30933785|NCT01858766|58969971|FG010|Overall Study|Lost to Follow-up|0|||
30933786|NCT01858766|58969972|FG011|Overall Study|Lost to Follow-up|1|||
30933787|NCT01858766|58969973|FG012|Overall Study|Lost to Follow-up|0|||
30839882|NCT01662310|58865241|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
30839883|NCT01662310|58865242|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
30839884|NCT01662310|58865243|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
30839885|NCT01662310|58865244|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
30839886|NCT01662310|58865245|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
30933788|NCT01858766|58969974|FG013|Overall Study|Lost to Follow-up|0|||
30933789|NCT01858766|58969975|FG014|Overall Study|Lost to Follow-up|3|||
30933790|NCT01858766|58969976|FG015|Overall Study|Lost to Follow-up|1|||
30933791|NCT01858766|58969977|FG016|Overall Study|Lost to Follow-up|1|||
30933792|NCT01858766|58969978|FG017|Overall Study|Lost to Follow-up|0|||
30933793|NCT01858766|58969979|FG018|Overall Study|Lost to Follow-up|1|||
30933794|NCT01858766|58969961|FG000|Overall Study|Withdrew Consent|0|||
30933795|NCT01858766|58969962|FG001|Overall Study|Withdrew Consent|0|||
30933796|NCT01858766|58969963|FG002|Overall Study|Withdrew Consent|0|||
30933797|NCT01858766|58969964|FG003|Overall Study|Withdrew Consent|0|||
30933798|NCT01858766|58969965|FG004|Overall Study|Withdrew Consent|0|||
30933799|NCT01858766|58969966|FG005|Overall Study|Withdrew Consent|0|||
30933800|NCT01858766|58969967|FG006|Overall Study|Withdrew Consent|0|||
30933801|NCT01858766|58969968|FG007|Overall Study|Withdrew Consent|0|||
30933802|NCT01858766|58969969|FG008|Overall Study|Withdrew Consent|0|||
30933803|NCT01858766|58969970|FG009|Overall Study|Withdrew Consent|0|||
30933804|NCT01858766|58969971|FG010|Overall Study|Withdrew Consent|0|||
30933805|NCT01858766|58969972|FG011|Overall Study|Withdrew Consent|1|||
30933806|NCT01858766|58969973|FG012|Overall Study|Withdrew Consent|0|||
30933807|NCT01858766|58969974|FG013|Overall Study|Withdrew Consent|0|||
30933808|NCT01858766|58969975|FG014|Overall Study|Withdrew Consent|0|||
30933809|NCT01858766|58969976|FG015|Overall Study|Withdrew Consent|0|||
30933810|NCT01858766|58969977|FG016|Overall Study|Withdrew Consent|0|||
30933811|NCT01858766|58969978|FG017|Overall Study|Withdrew Consent|0|||
30933812|NCT01858766|58969979|FG018|Overall Study|Withdrew Consent|0|||
30933813|NCT01734993|58970012|FG000|Overall Study|Adverse Event|1|||
30839887|NCT01662310|58865241|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
30839888|NCT01662310|58865242|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
30839889|NCT01662310|58865243|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
30839890|NCT01662310|58865244|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
30839891|NCT01662310|58865245|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
30839892|NCT01662310|58865241|FG000|Run-In or Stabilization Phase|Other|1|||
30839893|NCT01662310|58865242|FG001|Run-In or Stabilization Phase|Other|0|||
30839894|NCT01662310|58865243|FG002|Run-In or Stabilization Phase|Other|0|||
30839895|NCT01662310|58865244|FG003|Run-In or Stabilization Phase|Other|0|||
30839896|NCT01662310|58865245|FG004|Run-In or Stabilization Phase|Other|0|||
30839897|NCT01662310|58865241|FG000|Double-Blind Phase|Adverse Event|0|||
30839898|NCT01662310|58865242|FG001|Double-Blind Phase|Adverse Event|0|||
30839899|NCT01662310|58865243|FG002|Double-Blind Phase|Adverse Event|1|||
30839900|NCT01662310|58865244|FG003|Double-Blind Phase|Adverse Event|0|||
30839901|NCT01662310|58865245|FG004|Double-Blind Phase|Adverse Event|0|||
30933814|NCT01734993|58970012|FG000|Overall Study|Lack of Efficacy|1|||
30933815|NCT01745367|58970019|FG000|Overall Study|Death|1|||
30933816|NCT01745367|58970020|FG001|Overall Study|Death|0|||
30933817|NCT01745367|58970019|FG000|Overall Study|Withdrawal by Subject|1|||
30933818|NCT01745367|58970020|FG001|Overall Study|Withdrawal by Subject|2|||
30933819|NCT01745367|58970019|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
30933820|NCT01745367|58970020|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
30933821|NCT01745367|58970019|FG000|Overall Study|Other Reasons Unspecified|0|||
30933822|NCT01745367|58970020|FG001|Overall Study|Other Reasons Unspecified|2|||
30933823|NCT01733121|58970028|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
30933824|NCT01733121|58970029|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
30933825|NCT01733121|58970028|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
30933826|NCT01733121|58970029|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
30933827|NCT01733121|58970028|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
30933828|NCT01733121|58970029|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
30933829|NCT01733121|58970028|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
30933830|NCT01733121|58970029|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
30933831|NCT01744977|58970039|FG000|Overall Study|Withdrawal by Subject|1|||
30933832|NCT01744977|58970040|FG001|Overall Study|Withdrawal by Subject|2|||
30933833|NCT01744977|58970039|FG000|Overall Study|Death|2|||
30933834|NCT01744977|58970040|FG001|Overall Study|Death|3|||
30933835|NCT01744977|58970039|FG000|Overall Study|Lost to Follow-up|2|||
30933836|NCT01744977|58970040|FG001|Overall Study|Lost to Follow-up|0|||
30933837|NCT01744977|58970039|FG000|Overall Study|No longer meets inclusion|6|||
30933838|NCT01744977|58970040|FG001|Overall Study|No longer meets inclusion|0|||
30624286|NCT00955305|58636281|FG000|Overall Study|No off-treatment reason submitted|1|||
30624287|NCT00955305|58636282|FG001|Overall Study|No off-treatment reason submitted|0|||
30758442|NCT00381797|58767125|FG003|Overall Study|Withdrawal by Subject|0|||
30758443|NCT00381797|58767126|FG004|Overall Study|Withdrawal by Subject|2|||
30758444|NCT00381797|58767122|FG000|Overall Study|Ineligible|0|||
30758445|NCT00381797|58767123|FG001|Overall Study|Ineligible|0|||
30758446|NCT00381797|58767124|FG002|Overall Study|Ineligible|0|||
30758447|NCT00381797|58767125|FG003|Overall Study|Ineligible|1|||
30758448|NCT00381797|58767126|FG004|Overall Study|Ineligible|0|||
30758449|NCT03665038|58767162|FG000|Overall Study|Lost to Follow-up|0|||
30758450|NCT03665038|58767163|FG001|Overall Study|Lost to Follow-up|0|||
30758451|NCT03665038|58767164|FG002|Overall Study|Lost to Follow-up|1|||
30758452|NCT03664024|58767174|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
30758453|NCT03664024|58767174|FG000|Overall Study|Lost to Follow-up|2|||
30933839|NCT01383928|58970049|FG000|Overall Study|Initiation of ASCT|2|||
30933840|NCT01383928|58970050|FG001|Overall Study|Initiation of ASCT|1|||
30933841|NCT01383928|58970051|FG002|Overall Study|Initiation of ASCT|18|||
30758454|NCT03664024|58767174|FG000|Overall Study|Withdrawal by Subject|2|||
30933842|NCT01383928|58970049|FG000|Overall Study|Adverse Event|1|||
30758455|NCT03664024|58767174|FG000|Overall Study|Death|80|||
30758456|NCT00381563|58767183|FG000|Overall Study|Withdrawal by Subject|5|||
30758457|NCT00381563|58767184|FG001|Overall Study|Withdrawal by Subject|5|||
30933843|NCT01383928|58970050|FG001|Overall Study|Adverse Event|2|||
30933844|NCT01383928|58970051|FG002|Overall Study|Adverse Event|8|||
30933845|NCT01383928|58970049|FG000|Overall Study|Other|1|||
30933846|NCT01383928|58970050|FG001|Overall Study|Other|3|||
30933847|NCT01383928|58970051|FG002|Overall Study|Other|4|||
30933848|NCT01383928|58970049|FG000|Overall Study|Progressive Disease|1|||
30933849|NCT01383928|58970050|FG001|Overall Study|Progressive Disease|1|||
30933850|NCT01383928|58970051|FG002|Overall Study|Progressive Disease|5|||
30933851|NCT01383928|58970049|FG000|Overall Study|Withdrawal by Subject|0|||
30933852|NCT01383928|58970050|FG001|Overall Study|Withdrawal by Subject|0|||
30933853|NCT01383928|58970051|FG002|Overall Study|Withdrawal by Subject|4|||
30933854|NCT01383928|58970049|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
30933855|NCT01383928|58970050|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
30933856|NCT01383928|58970051|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
30933857|NCT01382602|58970063|FG000|Overall Study|Protocol Violation|0|||
30933858|NCT01382602|58970064|FG001|Overall Study|Protocol Violation|3|||
30933859|NCT01382602|58970063|FG000|Overall Study|Withdrawal by Subject|0|||
30933860|NCT01382602|58970064|FG001|Overall Study|Withdrawal by Subject|1|||
30933861|NCT04801420|58970073|FG000|Overall Study|Other|1|||
30933862|NCT04801420|58970074|FG001|Overall Study|Other|2|||
30933863|NCT04801420|58970075|FG002|Overall Study|Other|1|||
30933864|NCT04801420|58970073|FG000|Overall Study|Lost to Follow-up|7|||
30933865|NCT04801420|58970074|FG001|Overall Study|Lost to Follow-up|9|||
30933866|NCT04801420|58970075|FG002|Overall Study|Lost to Follow-up|10|||
30933867|NCT04801420|58970073|FG000|Overall Study|Moved from study area|0|||
30933868|NCT04801420|58970074|FG001|Overall Study|Moved from study area|1|||
30933869|NCT04801420|58970075|FG002|Overall Study|Moved from study area|1|||
30933870|NCT04801420|58970073|FG000|Overall Study|Withdrawal by Subject|5|||
30933871|NCT04801420|58970074|FG001|Overall Study|Withdrawal by Subject|1|||
30933872|NCT04801420|58970075|FG002|Overall Study|Withdrawal by Subject|4|||
30933873|NCT04801420|58970073|FG000|Overall Study|Individual stopping criteria reached|0|||
30933874|NCT04801420|58970074|FG001|Overall Study|Individual stopping criteria reached|1|||
30933875|NCT04801420|58970075|FG002|Overall Study|Individual stopping criteria reached|0|||
30933876|NCT04801420|58970073|FG000|Overall Study|Ongoing in the study|195|||
30933877|NCT04801420|58970074|FG001|Overall Study|Ongoing in the study|195|||
30933878|NCT04801420|58970075|FG002|Overall Study|Ongoing in the study|192|||
30839902|NCT01662310|58865241|FG000|Double-Blind Phase|Lost to Follow-up|0|||
30839903|NCT01662310|58865242|FG001|Double-Blind Phase|Lost to Follow-up|3|||
30839904|NCT01662310|58865243|FG002|Double-Blind Phase|Lost to Follow-up|0|||
30839905|NCT01662310|58865244|FG003|Double-Blind Phase|Lost to Follow-up|0|||
30839906|NCT01662310|58865245|FG004|Double-Blind Phase|Lost to Follow-up|0|||
30839907|NCT01662310|58865241|FG000|Double-Blind Phase|Pregnancy|0|||
30839908|NCT01662310|58865242|FG001|Double-Blind Phase|Pregnancy|2|||
30839909|NCT01662310|58865243|FG002|Double-Blind Phase|Pregnancy|0|||
30839910|NCT01662310|58865244|FG003|Double-Blind Phase|Pregnancy|0|||
30839911|NCT01662310|58865245|FG004|Double-Blind Phase|Pregnancy|0|||
30839912|NCT01662310|58865241|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
30933879|NCT04294472|58970090|FG000|Overall Study|Adverse Event|0|||
30933880|NCT04294472|58970091|FG001|Overall Study|Adverse Event|1|||
30933881|NCT04294472|58970092|FG002|Overall Study|Adverse Event|1|||
30933882|NCT04294472|58970090|FG000|Overall Study|Randomized but not treated|0|||
30933883|NCT04294472|58970091|FG001|Overall Study|Randomized but not treated|1|||
30933884|NCT04294472|58970092|FG002|Overall Study|Randomized but not treated|1|||
30933885|NCT04233918|58970102|FG000|Part C (Extension Period)|Ongoing in study|0|||
30933886|NCT04233918|58970103|FG001|Part C (Extension Period)|Ongoing in study|0|||
30933887|NCT04233918|58970104|FG002|Part C (Extension Period)|Ongoing in study|15|||
30933888|NCT04060251|58970116|FG000|Overall Study|Study terminated due to low enrollment.|7|||
30758458|NCT00381563|58767183|FG000|Overall Study|Lost to Follow-up|2|||
30758459|NCT00381563|58767184|FG001|Overall Study|Lost to Follow-up|0|||
30758460|NCT00381563|58767183|FG000|Overall Study|Protocol Violation|0|||
30758461|NCT00381563|58767184|FG001|Overall Study|Protocol Violation|1|||
30758462|NCT03624946|58767191|FG000|Overall Study|Lost to Follow-up|0|||
30758463|NCT03624946|58767192|FG001|Overall Study|Lost to Follow-up|1|||
30758464|NCT00381095|58767204|FG000|Overall Study|Death|3|||
30758465|NCT00381095|58767205|FG001|Overall Study|Death|4|||
30758466|NCT00381095|58767204|FG000|Overall Study|Lack of Efficacy|2|||
30758467|NCT00381095|58767205|FG001|Overall Study|Lack of Efficacy|4|||
30758468|NCT00381095|58767204|FG000|Overall Study|Other|2|||
30758469|NCT00381095|58767205|FG001|Overall Study|Other|2|||
30758470|NCT00381095|58767204|FG000|Overall Study|Protocol Violation|1|||
30758471|NCT00381095|58767205|FG001|Overall Study|Protocol Violation|1|||
30758472|NCT00381095|58767204|FG000|Overall Study|Withdrawal by Subject|3|||
30758473|NCT00381095|58767205|FG001|Overall Study|Withdrawal by Subject|3|||
30758474|NCT00381095|58767204|FG000|Overall Study|Adverse Event|2|||
30758475|NCT00381095|58767205|FG001|Overall Study|Adverse Event|7|||
30758476|NCT03619174|58767213|FG000|Overall Study|Lost to Follow-up|3|||
30758477|NCT03619174|58767214|FG001|Overall Study|Lost to Follow-up|0|||
30839913|NCT01662310|58865242|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
30758478|NCT03619174|58767213|FG000|Overall Study|Withdrawal by Subject|4|||
30758479|NCT03619174|58767214|FG001|Overall Study|Withdrawal by Subject|3|||
30758480|NCT03619174|58767213|FG000|Overall Study|Pregnancy|1|||
30758481|NCT03619174|58767214|FG001|Overall Study|Pregnancy|1|||
30758482|NCT03619174|58767213|FG000|Overall Study|Discomfort during treatment|1|||
30758483|NCT03619174|58767214|FG001|Overall Study|Discomfort during treatment|0|||
30758484|NCT00112047|58767222|FG000|Randomized Phase|Lost to Follow-up|26|||
30758485|NCT00112047|58767223|FG001|Randomized Phase|Lost to Follow-up|33|||
30758486|NCT00112047|58767222|FG000|Randomized Phase|Adverse Event|10|||
30758487|NCT00112047|58767223|FG001|Randomized Phase|Adverse Event|10|||
30758488|NCT00112047|58767222|FG000|Randomized Phase|Withrawal of consent|10|||
30758489|NCT00112047|58767223|FG001|Randomized Phase|Withrawal of consent|18|||
30758490|NCT00112047|58767222|FG000|Randomized Phase|Sub-optimal virological response|3|||
30758491|NCT00112047|58767223|FG001|Randomized Phase|Sub-optimal virological response|13|||
30758492|NCT00112047|58767222|FG000|Randomized Phase|Noncompliance|8|||
30758493|NCT00112047|58767223|FG001|Randomized Phase|Noncompliance|4|||
30758494|NCT00112047|58767222|FG000|Randomized Phase|Protocol Violation|2|||
30758495|NCT00112047|58767223|FG001|Randomized Phase|Protocol Violation|0|||
30758496|NCT00112047|58767222|FG000|Randomized Phase|Pregnancy|3|||
30758497|NCT00112047|58767223|FG001|Randomized Phase|Pregnancy|1|||
30758498|NCT00112047|58767222|FG000|Randomized Phase|Death|1|||
30758499|NCT00112047|58767223|FG001|Randomized Phase|Death|3|||
30839914|NCT01662310|58865243|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
30839915|NCT01662310|58865244|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
30839916|NCT01662310|58865245|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
30839917|NCT01662310|58865241|FG000|Double-Blind Phase|Other|0|||
30839918|NCT01662310|58865242|FG001|Double-Blind Phase|Other|0|||
30839919|NCT01662310|58865243|FG002|Double-Blind Phase|Other|1|||
30839920|NCT01662310|58865244|FG003|Double-Blind Phase|Other|0|||
30839921|NCT01662310|58865245|FG004|Double-Blind Phase|Other|0|||
30839922|NCT01662310|58865241|FG000|Double-Blind Phase|Randomized but not treated|0|||
30839923|NCT01662310|58865242|FG001|Double-Blind Phase|Randomized but not treated|1|||
30839924|NCT01662310|58865243|FG002|Double-Blind Phase|Randomized but not treated|0|||
30839925|NCT01662310|58865244|FG003|Double-Blind Phase|Randomized but not treated|0|||
30839926|NCT01662310|58865245|FG004|Double-Blind Phase|Randomized but not treated|0|||
30839927|NCT01662310|58865241|FG000|Open-Label Extension Phase|Adverse Event|0|||
30839928|NCT01662310|58865242|FG001|Open-Label Extension Phase|Adverse Event|0|||
30839929|NCT01662310|58865243|FG002|Open-Label Extension Phase|Adverse Event|0|||
30839930|NCT01662310|58865244|FG003|Open-Label Extension Phase|Adverse Event|3|||
30839931|NCT01662310|58865245|FG004|Open-Label Extension Phase|Adverse Event|0|||
30839932|NCT01662310|58865241|FG000|Open-Label Extension Phase|Death|0|||
30839933|NCT01662310|58865242|FG001|Open-Label Extension Phase|Death|0|||
30839934|NCT01662310|58865243|FG002|Open-Label Extension Phase|Death|0|||
30839935|NCT01662310|58865244|FG003|Open-Label Extension Phase|Death|1|||
30839936|NCT01662310|58865245|FG004|Open-Label Extension Phase|Death|0|||
30839937|NCT01662310|58865241|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
30839938|NCT01662310|58865242|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
30839939|NCT01662310|58865243|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
30933889|NCT04060251|58970117|FG001|Overall Study|Study terminated due to low enrollment.|5|||
30933890|NCT04060251|58970118|FG002|Overall Study|Study terminated due to low enrollment.|7|||
30933891|NCT04060251|58970116|FG000|Overall Study|Adverse Event|1|||
30933892|NCT04060251|58970117|FG001|Overall Study|Adverse Event|1|||
30933893|NCT04060251|58970118|FG002|Overall Study|Adverse Event|0|||
30933894|NCT04048876|58970130|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
30933895|NCT04048876|58970131|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
30933896|NCT04048876|58970132|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
30839940|NCT01662310|58865244|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
30839941|NCT01662310|58865245|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
30839942|NCT01662310|58865241|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
30839943|NCT01662310|58865242|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
30839944|NCT01662310|58865243|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
30839945|NCT01662310|58865244|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
30839946|NCT01662310|58865245|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
30933897|NCT04048876|58970133|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
30933898|NCT04048876|58970130|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
30933899|NCT04048876|58970131|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
30758500|NCT00112047|58767222|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
30758501|NCT00112047|58767223|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
30758502|NCT00112047|58767222|FG000|Randomized Phase|Inability to swallow pills|0|||
30758503|NCT00112047|58767223|FG001|Randomized Phase|Inability to swallow pills|1|||
30758504|NCT00112047|58767222|FG000|Randomized Phase|Incarceration|3|||
30839947|NCT01662310|58865241|FG000|Open-Label Extension Phase|Pregnancy|0|||
30758505|NCT00112047|58767223|FG001|Randomized Phase|Incarceration|2|||
30758506|NCT00112047|58767222|FG000|Randomized Phase|Moved out of State|0|||
30758507|NCT00112047|58767223|FG001|Randomized Phase|Moved out of State|1|||
30839948|NCT01662310|58865242|FG001|Open-Label Extension Phase|Pregnancy|0|||
30839949|NCT01662310|58865243|FG002|Open-Label Extension Phase|Pregnancy|0|||
30839950|NCT01662310|58865244|FG003|Open-Label Extension Phase|Pregnancy|1|||
30839951|NCT01662310|58865245|FG004|Open-Label Extension Phase|Pregnancy|0|||
30839952|NCT01662310|58865241|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
30839953|NCT01662310|58865242|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
30839954|NCT01662310|58865243|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
30839955|NCT01662310|58865244|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
30839956|NCT01662310|58865245|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
30839957|NCT00700622|58865259|FG000|Overall Study|Adverse Event|4|||
30839958|NCT00700622|58865260|FG001|Overall Study|Adverse Event|0|||
30839959|NCT00700622|58865259|FG000|Overall Study|Lost to Follow-up|0|||
30839960|NCT00700622|58865260|FG001|Overall Study|Lost to Follow-up|1|||
30839961|NCT00700622|58865259|FG000|Overall Study|Physician Decision|2|||
30839962|NCT00700622|58865260|FG001|Overall Study|Physician Decision|1|||
30839963|NCT00700622|58865259|FG000|Overall Study|Protocol Violation|0|||
30839964|NCT00700622|58865260|FG001|Overall Study|Protocol Violation|1|||
30839965|NCT00700622|58865259|FG000|Overall Study|Withdrawal by Subject|4|||
30839966|NCT00700622|58865260|FG001|Overall Study|Withdrawal by Subject|1|||
30839967|NCT00700622|58865259|FG000|Overall Study|Other|3|||
30839968|NCT00700622|58865260|FG001|Overall Study|Other|1|||
30839969|NCT02553928|58865268|FG000|Overall Study|Adverse Event|2|||
30839970|NCT02553928|58865269|FG001|Overall Study|Adverse Event|1|||
30839971|NCT02553928|58865268|FG000|Overall Study|Lost to Follow-up|0|||
30839972|NCT02553928|58865269|FG001|Overall Study|Lost to Follow-up|1|||
30839973|NCT02553928|58865268|FG000|Overall Study|Administrative reason(s)|0|||
30839974|NCT02553928|58865269|FG001|Overall Study|Administrative reason(s)|1|||
30839975|NCT03076775|58865278|FG000|Overall Study|Lost to Follow-up|1|||
30933900|NCT04048876|58970132|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
30933901|NCT04048876|58970133|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
30933902|NCT04048876|58970130|FG000|Placebo Controlled Phase|Adverse Event|0|||
30933903|NCT04048876|58970131|FG001|Placebo Controlled Phase|Adverse Event|1|||
30933904|NCT04048876|58970132|FG002|Placebo Controlled Phase|Adverse Event|0|||
30933905|NCT04048876|58970133|FG003|Placebo Controlled Phase|Adverse Event|0|||
30933906|NCT04048876|58970130|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
30933907|NCT04048876|58970131|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
30933908|NCT04048876|58970132|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
30933909|NCT04048876|58970133|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
30933910|NCT03921424|58970160|FG000|Overall Study|Lost to Follow-up|0|||
30839976|NCT03076775|58865279|FG001|Overall Study|Lost to Follow-up|0|||
30839977|NCT03058991|58865296|FG000|Overall Study|Lost to Follow-up|17|||
30839978|NCT03058991|58865297|FG001|Overall Study|Lost to Follow-up|12|||
30933911|NCT03921424|58970161|FG001|Overall Study|Lost to Follow-up|1|||
30933912|NCT03921424|58970160|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
30933913|NCT03921424|58970161|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
30933914|NCT03852628|58970184|FG000|Overall Study|Lost to Follow-up|7|||
30933915|NCT03852628|58970185|FG001|Overall Study|Lost to Follow-up|6|||
30933916|NCT03852628|58970184|FG000|Overall Study|Lack of Efficacy|6|||
30933917|NCT03852628|58970185|FG001|Overall Study|Lack of Efficacy|6|||
30933918|NCT03602976|58970191|FG000|Overall Study|Withdrawal by Subject|1|||
30933919|NCT03474107|58970200|FG000|Overall Study|Adverse Event|42|||
30758508|NCT00112047|58767222|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
30758509|NCT00112047|58767223|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
30758510|NCT00112047|58767222|FG000|Randomized Phase|High Hepatitis B DNA|0|||
30758511|NCT00112047|58767223|FG001|Randomized Phase|High Hepatitis B DNA|1|||
30758512|NCT00112047|58767222|FG000|Atripla Phase|Adverse Event|2|||
30758513|NCT00112047|58767223|FG001|Atripla Phase|Adverse Event|1|||
30758514|NCT00112047|58767222|FG000|Atripla Phase|Lost to Follow-up|5|||
30839979|NCT03058991|58865298|FG002|Overall Study|Lost to Follow-up|12|||
30839980|NCT03058991|58865296|FG000|Overall Study|Withdrawal by Subject|1|||
30839981|NCT03058991|58865297|FG001|Overall Study|Withdrawal by Subject|0|||
30839982|NCT03058991|58865298|FG002|Overall Study|Withdrawal by Subject|0|||
30933920|NCT03474107|58970201|FG001|Overall Study|Adverse Event|46|||
30933921|NCT03474107|58970200|FG000|Overall Study|Death|2|||
30933922|NCT03474107|58970201|FG001|Overall Study|Death|2|||
30933923|NCT03474107|58970200|FG000|Overall Study|Lost to Follow-up|0|||
30933924|NCT03474107|58970201|FG001|Overall Study|Lost to Follow-up|1|||
30933925|NCT03474107|58970200|FG000|Overall Study|Progressive Disease|177|||
30933926|NCT03474107|58970201|FG001|Overall Study|Progressive Disease|180|||
30933927|NCT03474107|58970200|FG000|Overall Study|Protocol Violation|1|||
30933928|NCT03474107|58970201|FG001|Overall Study|Protocol Violation|1|||
30933929|NCT03474107|58970200|FG000|Overall Study|Withdrawal by Subject|15|||
30933930|NCT03474107|58970201|FG001|Overall Study|Withdrawal by Subject|27|||
30933931|NCT03474107|58970200|FG000|Overall Study|Physician Decision|7|||
30933932|NCT03474107|58970201|FG001|Overall Study|Physician Decision|22|||
30933933|NCT03474107|58970200|FG000|Overall Study|Miscellaneous|1|||
30933934|NCT03474107|58970201|FG001|Overall Study|Miscellaneous|6|||
30933935|NCT03278106|58970216|FG000|Overall Study|No protocol treatment|1|||
30933936|NCT03214198|58970220|FG000|Overall Study|Case Report Forms Uncollected|18|||
30933937|NCT03214198|58970220|FG000|Overall Study|Protocol Deviation|18|||
30933938|NCT03052608|58970233|FG000|Treatment Phase|Adverse Event|10|||
30933939|NCT03052608|58970234|FG001|Treatment Phase|Adverse Event|12|||
30933940|NCT03052608|58970233|FG000|Treatment Phase|Death|6|||
30933941|NCT03052608|58970234|FG001|Treatment Phase|Death|4|||
30933942|NCT03052608|58970233|FG000|Treatment Phase|Withdrawal by Subject|4|||
30933943|NCT03052608|58970234|FG001|Treatment Phase|Withdrawal by Subject|12|||
30933944|NCT03052608|58970233|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
30758515|NCT00112047|58767223|FG001|Atripla Phase|Lost to Follow-up|7|||
30758516|NCT00112047|58767222|FG000|Atripla Phase|Pregnancy|0|||
30758517|NCT00112047|58767223|FG001|Atripla Phase|Pregnancy|1|||
30758518|NCT00112047|58767222|FG000|Atripla Phase|Death|0|||
30839983|NCT00700310|58865310|FG000|Overall Study|Adverse Event|6|||
30933945|NCT03052608|58970234|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
30933946|NCT03052608|58970233|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
30933947|NCT03052608|58970234|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
30933948|NCT03052608|58970233|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
30933949|NCT03052608|58970234|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
30933950|NCT03052608|58970233|FG000|Treatment Phase|Ongoing|103|||
30933951|NCT03052608|58970234|FG001|Treatment Phase|Ongoing|31|||
30758519|NCT00112047|58767223|FG001|Atripla Phase|Death|2|||
30758520|NCT00112047|58767222|FG000|Atripla Phase|Withdrew consent|7|||
30839984|NCT00700310|58865311|FG001|Overall Study|Adverse Event|10|||
30839985|NCT00700310|58865312|FG002|Overall Study|Adverse Event|5|||
30839986|NCT00700310|58865313|FG003|Overall Study|Adverse Event|11|||
30758521|NCT00112047|58767223|FG001|Atripla Phase|Withdrew consent|7|||
30758522|NCT00112047|58767222|FG000|Atripla Phase|Sub-optimal virological response|0|||
30839987|NCT00700310|58865310|FG000|Overall Study|Lost to Follow-up|4|||
30839988|NCT00700310|58865311|FG001|Overall Study|Lost to Follow-up|1|||
30839989|NCT00700310|58865312|FG002|Overall Study|Lost to Follow-up|0|||
30839990|NCT00700310|58865313|FG003|Overall Study|Lost to Follow-up|1|||
30839991|NCT00700310|58865310|FG000|Overall Study|Withdrawal by Subject|8|||
30839992|NCT00700310|58865311|FG001|Overall Study|Withdrawal by Subject|9|||
30839993|NCT00700310|58865312|FG002|Overall Study|Withdrawal by Subject|8|||
30839994|NCT00700310|58865313|FG003|Overall Study|Withdrawal by Subject|8|||
30839995|NCT00700310|58865310|FG000|Overall Study|Lack of Efficacy|0|||
30839996|NCT00700310|58865311|FG001|Overall Study|Lack of Efficacy|3|||
30839997|NCT00700310|58865312|FG002|Overall Study|Lack of Efficacy|0|||
30933952|NCT03052608|58970233|FG000|Long-Term Follow-up Phase|Death|23|||
30933953|NCT03052608|58970234|FG001|Long-Term Follow-up Phase|Death|28|||
30758523|NCT00112047|58767223|FG001|Atripla Phase|Sub-optimal virological response|1|||
30758524|NCT00112047|58767222|FG000|Atripla Phase|Non-compliance|1|||
30839998|NCT00700310|58865313|FG003|Overall Study|Lack of Efficacy|1|||
30839999|NCT00700310|58865310|FG000|Overall Study|Administrative/Other|1|||
30933954|NCT03052608|58970233|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
30933955|NCT03052608|58970234|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
30758525|NCT00112047|58767223|FG001|Atripla Phase|Non-compliance|0|||
30758526|NCT00112047|58767222|FG000|Atripla Phase|Other|3|||
30758527|NCT00112047|58767223|FG001|Atripla Phase|Other|1|||
30840000|NCT00700310|58865311|FG001|Overall Study|Administrative/Other|3|||
30840001|NCT00700310|58865312|FG002|Overall Study|Administrative/Other|1|||
30840002|NCT00700310|58865313|FG003|Overall Study|Administrative/Other|3|||
30758528|NCT03658876|58767236|FG000|Overall Study|Protocol Violation|3|||
30840003|NCT00700310|58865310|FG000|Overall Study|Randomized, Not Treated|2|||
30840004|NCT00700310|58865311|FG001|Overall Study|Randomized, Not Treated|0|||
30840005|NCT00700310|58865312|FG002|Overall Study|Randomized, Not Treated|2|||
30840006|NCT00700310|58865313|FG003|Overall Study|Randomized, Not Treated|2|||
30840007|NCT01575548|58865334|FG000|Overall Study|Adverse Event|15|||
30840008|NCT01575548|58865335|FG001|Overall Study|Adverse Event|2|||
30933956|NCT03052608|58970233|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
30933957|NCT03052608|58970234|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
30933958|NCT03052608|58970233|FG000|Long-Term Follow-up Phase|Ongoing|122|||
30933959|NCT03052608|58970234|FG001|Long-Term Follow-up Phase|Ongoing|99|||
30840009|NCT01575548|58865334|FG000|Overall Study|Disease progression|12|||
30840010|NCT01575548|58865335|FG001|Overall Study|Disease progression|25|||
30840011|NCT01575548|58865334|FG000|Overall Study|Death|1|||
30840012|NCT01575548|58865335|FG001|Overall Study|Death|0|||
30840013|NCT01575548|58865334|FG000|Overall Study|Other complicating disease|1|||
30840014|NCT01575548|58865335|FG001|Overall Study|Other complicating disease|0|||
30840015|NCT01575548|58865334|FG000|Overall Study|Withdrawal by Subject|7|||
30840016|NCT01575548|58865335|FG001|Overall Study|Withdrawal by Subject|3|||
30840017|NCT01575548|58865334|FG000|Overall Study|Noncompliance|1|||
30840018|NCT01575548|58865335|FG001|Overall Study|Noncompliance|0|||
30840019|NCT01575548|58865334|FG000|Overall Study|Anticipated surgery|0|||
30840020|NCT01575548|58865335|FG001|Overall Study|Anticipated surgery|1|||
30840021|NCT01575548|58865334|FG000|Overall Study|Never started protocol therapy|3|||
30840022|NCT01575548|58865335|FG001|Overall Study|Never started protocol therapy|2|||
30840023|NCT01750281|58865344|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
30840024|NCT01750281|58865345|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
30840025|NCT01750281|58865346|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
30840026|NCT01750281|58865344|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
30840027|NCT01750281|58865345|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
30840028|NCT01750281|58865346|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
30840029|NCT01750281|58865344|FG000|Overall Study|Did not receive treatment|0|||
30840030|NCT01750281|58865345|FG001|Overall Study|Did not receive treatment|1|||
30840031|NCT01750281|58865346|FG002|Overall Study|Did not receive treatment|0|||
30840032|NCT03000569|58865373|FG000|Overall Study|Withdrawal by Subject|1|||
30840033|NCT03000569|58865374|FG001|Overall Study|Withdrawal by Subject|0|||
30840034|NCT02554786|58865393|FG000|Overall Study|Subject/guardian decision|29|||
30840035|NCT02554786|58865394|FG001|Overall Study|Subject/guardian decision|17|||
30840036|NCT02554786|58865395|FG002|Overall Study|Subject/guardian decision|18|||
30840037|NCT02554786|58865396|FG003|Overall Study|Subject/guardian decision|30|||
30840038|NCT02554786|58865397|FG004|Overall Study|Subject/guardian decision|20|||
30840039|NCT02554786|58865393|FG000|Overall Study|Lost to Follow-up|4|||
30840040|NCT02554786|58865394|FG001|Overall Study|Lost to Follow-up|3|||
30840041|NCT02554786|58865395|FG002|Overall Study|Lost to Follow-up|4|||
30840042|NCT02554786|58865396|FG003|Overall Study|Lost to Follow-up|2|||
30840043|NCT02554786|58865397|FG004|Overall Study|Lost to Follow-up|2|||
30933960|NCT02914639|58970242|FG000|Overall Study|Withdrawal by Subject|0|||
30933961|NCT02914639|58970243|FG001|Overall Study|Withdrawal by Subject|2|||
30933962|NCT02865018|58970250|FG000|Overall Study|Withdrawal by Subject|1|||
30933963|NCT02704208|58970265|FG000|Overall Study|Lost to Follow-up|42|||
30933964|NCT02704208|58970266|FG001|Overall Study|Lost to Follow-up|37|||
30933965|NCT02618408|58970275|FG000|Overall Study|Withdrawal by Subject|1|||
30933966|NCT02618408|58970276|FG001|Overall Study|Withdrawal by Subject|0|||
30933967|NCT02618408|58970277|FG002|Overall Study|Withdrawal by Subject|4|||
30933968|NCT02618408|58970275|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
30933969|NCT02618408|58970276|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
30933970|NCT02618408|58970277|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
30933971|NCT02618408|58970275|FG000|Overall Study|Lost to Follow-up|4|||
30933972|NCT02618408|58970276|FG001|Overall Study|Lost to Follow-up|2|||
30933973|NCT02618408|58970277|FG002|Overall Study|Lost to Follow-up|6|||
30933974|NCT02618408|58970275|FG000|Overall Study|Adverse Event|4|||
30933975|NCT02618408|58970276|FG001|Overall Study|Adverse Event|0|||
30933976|NCT02618408|58970277|FG002|Overall Study|Adverse Event|10|||
30933977|NCT02618408|58970275|FG000|Overall Study|Physician Decision|1|||
30933978|NCT02618408|58970276|FG001|Overall Study|Physician Decision|1|||
30933979|NCT02618408|58970277|FG002|Overall Study|Physician Decision|2|||
30933980|NCT02618408|58970275|FG000|Overall Study|Protocol Violation|1|||
30933981|NCT02618408|58970276|FG001|Overall Study|Protocol Violation|1|||
30624288|NCT00955305|58636281|FG000|Overall Study|Never started protocol treatment|5|||
30933982|NCT02618408|58970277|FG002|Overall Study|Protocol Violation|2|||
30840044|NCT02554786|58865393|FG000|Overall Study|Protocol deviation|1|||
30840045|NCT02554786|58865394|FG001|Overall Study|Protocol deviation|3|||
30840046|NCT02554786|58865395|FG002|Overall Study|Protocol deviation|3|||
30840047|NCT02554786|58865396|FG003|Overall Study|Protocol deviation|4|||
30840048|NCT02554786|58865397|FG004|Overall Study|Protocol deviation|2|||
30840049|NCT02554786|58865393|FG000|Overall Study|Technical problems|1|||
30840050|NCT02554786|58865394|FG001|Overall Study|Technical problems|1|||
30840051|NCT02554786|58865395|FG002|Overall Study|Technical problems|0|||
30933983|NCT02618408|58970275|FG000|Overall Study|Other, Multiple Categories|0|||
30758529|NCT03658876|58767237|FG001|Overall Study|Protocol Violation|2|||
30758530|NCT03658876|58767236|FG000|Overall Study|Withdrawal by Subject|2|||
30758531|NCT03658876|58767237|FG001|Overall Study|Withdrawal by Subject|0|||
30840052|NCT02554786|58865396|FG003|Overall Study|Technical problems|2|||
30840053|NCT02554786|58865397|FG004|Overall Study|Technical problems|1|||
30840054|NCT02554786|58865393|FG000|Overall Study|Adverse Event|0|||
30840055|NCT02554786|58865394|FG001|Overall Study|Adverse Event|0|||
30840056|NCT02554786|58865395|FG002|Overall Study|Adverse Event|0|||
30840057|NCT02554786|58865396|FG003|Overall Study|Adverse Event|0|||
30840058|NCT02554786|58865397|FG004|Overall Study|Adverse Event|2|||
30840059|NCT02554786|58865393|FG000|Overall Study|Death|0|||
30840060|NCT02554786|58865394|FG001|Overall Study|Death|0|||
30840061|NCT02554786|58865395|FG002|Overall Study|Death|0|||
30840062|NCT02554786|58865396|FG003|Overall Study|Death|1|||
30840063|NCT02554786|58865397|FG004|Overall Study|Death|0|||
30840064|NCT02554786|58865393|FG000|Overall Study|Non-compliance with study treatment|0|||
30840065|NCT02554786|58865394|FG001|Overall Study|Non-compliance with study treatment|1|||
30840066|NCT02554786|58865395|FG002|Overall Study|Non-compliance with study treatment|1|||
30840067|NCT02554786|58865396|FG003|Overall Study|Non-compliance with study treatment|0|||
30840068|NCT02554786|58865397|FG004|Overall Study|Non-compliance with study treatment|1|||
30840069|NCT02554786|58865393|FG000|Overall Study|Physician Decision|0|||
30840070|NCT02554786|58865394|FG001|Overall Study|Physician Decision|1|||
30840071|NCT02554786|58865395|FG002|Overall Study|Physician Decision|4|||
30840072|NCT02554786|58865396|FG003|Overall Study|Physician Decision|1|||
30840073|NCT02554786|58865397|FG004|Overall Study|Physician Decision|1|||
30840074|NCT02554786|58865393|FG000|Overall Study|Pregnancy|0|||
30840075|NCT02554786|58865394|FG001|Overall Study|Pregnancy|0|||
30840076|NCT02554786|58865395|FG002|Overall Study|Pregnancy|0|||
30840077|NCT02554786|58865396|FG003|Overall Study|Pregnancy|1|||
30758532|NCT03658876|58767236|FG000|Overall Study|Death|0|||
30758533|NCT03658876|58767237|FG001|Overall Study|Death|1|||
30758534|NCT03658876|58767236|FG000|Overall Study|Intercurrent illness|6|||
30758535|NCT03658876|58767237|FG001|Overall Study|Intercurrent illness|4|||
30758536|NCT03658876|58767236|FG000|Overall Study|Transplantation/other operation|1|||
30758537|NCT03658876|58767237|FG001|Overall Study|Transplantation/other operation|5|||
30758538|NCT03618628|58767243|FG000|Overall Study|Death|1|||
30758539|NCT03618628|58767243|FG000|Overall Study|Lost to Follow-up|1|||
30758540|NCT03617770|58767249|FG000|Overall Study|Lost to Follow-up|1|||
30758541|NCT03617770|58767250|FG001|Overall Study|Lost to Follow-up|0|||
30758542|NCT03616600|58767258|FG000|Overall Study|Withdrawal by Subject|1|||
30758543|NCT03616600|58767259|FG001|Overall Study|Withdrawal by Subject|0|||
30758544|NCT00380393|58767268|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
30758545|NCT00380393|58767269|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
30758546|NCT00380393|58767268|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
30840078|NCT02554786|58865397|FG004|Overall Study|Pregnancy|1|||
30840079|NCT02893930|58865413|FG000|Overall Study|Adverse Event|3|||
30840080|NCT02893930|58865413|FG000|Overall Study|Death|1|||
30840081|NCT02893930|58865413|FG000|Overall Study|Disease progression|5|||
30840082|NCT02893930|58865413|FG000|Overall Study|Withdrawal by Subject|2|||
30840083|NCT02893930|58865413|FG000|Overall Study|Physician Decision|1|||
30840084|NCT02893930|58865413|FG000|Overall Study|Ineligible|1|||
30840085|NCT01347645|58865422|FG000|Overall Study|Death|1|||
30840086|NCT01347645|58865423|FG001|Overall Study|Death|5|||
30840087|NCT01347645|58865424|FG002|Overall Study|Death|2|||
30840088|NCT01347645|58865425|FG003|Overall Study|Death|7|||
30840089|NCT01347645|58865426|FG004|Overall Study|Death|7|||
30840090|NCT01347645|58865422|FG000|Overall Study|Lost to Follow-up|1|||
30840091|NCT01347645|58865423|FG001|Overall Study|Lost to Follow-up|1|||
30840092|NCT01347645|58865424|FG002|Overall Study|Lost to Follow-up|0|||
30840093|NCT01347645|58865425|FG003|Overall Study|Lost to Follow-up|1|||
30840094|NCT01347645|58865426|FG004|Overall Study|Lost to Follow-up|1|||
30624289|NCT00955305|58636282|FG001|Overall Study|Never started protocol treatment|5|||
30624290|NCT00955305|58636281|FG000|Overall Study|Ineligible|5|||
30758547|NCT00380393|58767269|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
30840095|NCT01347645|58865422|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
30840096|NCT01347645|58865423|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
30840097|NCT01347645|58865424|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
30758548|NCT00380393|58767268|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
30758549|NCT00380393|58767269|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
30758550|NCT00380393|58767268|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
30840098|NCT01347645|58865425|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
30840099|NCT01347645|58865426|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
30840100|NCT01347645|58865422|FG000|Overall Study|Other|1|||
30840101|NCT01347645|58865423|FG001|Overall Study|Other|0|||
30758551|NCT00380393|58767269|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
30840102|NCT01347645|58865424|FG002|Overall Study|Other|0|||
30840103|NCT01347645|58865425|FG003|Overall Study|Other|0|||
30933984|NCT02618408|58970276|FG001|Overall Study|Other, Multiple Categories|0|||
30933985|NCT02618408|58970277|FG002|Overall Study|Other, Multiple Categories|4|||
30933986|NCT02553460|58970288|FG000|Overall Study|Death|3|||
30933987|NCT02553460|58970288|FG000|Overall Study|Withdrawal by Subject|1|||
30933988|NCT02553460|58970288|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
30933989|NCT02553460|58970288|FG000|Overall Study|Relapse or Transplant|14|||
30933990|NCT02553460|58970288|FG000|Overall Study|No response to treatment|2|||
30933991|NCT02553460|58970288|FG000|Overall Study|Still on therapy|7|||
30933992|NCT02553460|58970288|FG000|Overall Study|CAR T cells|1|||
30933993|NCT02157883|58970301|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
30933994|NCT02157883|58970301|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
30933995|NCT02157883|58970301|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
30933996|NCT02157883|58970301|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
30933997|NCT02157883|58970301|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
30933998|NCT02071290|58970310|FG000|Overall Study|Death|1|||
30933999|NCT02071290|58970311|FG001|Overall Study|Death|0|||
30934000|NCT02071290|58970310|FG000|Overall Study|Withdrawal by Subject|0|||
30934001|NCT02071290|58970311|FG001|Overall Study|Withdrawal by Subject|1|||
30934002|NCT02071290|58970310|FG000|Overall Study|Protocol Violation|3|||
30934003|NCT02071290|58970311|FG001|Overall Study|Protocol Violation|5|||
30934004|NCT02071290|58970310|FG000|Overall Study|Physician Decision|0|||
30934005|NCT02071290|58970311|FG001|Overall Study|Physician Decision|1|||
30934006|NCT02066181|58970319|FG000|Overall Study|Withdrawal by Subject|1|||
30934007|NCT02066181|58970320|FG001|Overall Study|Withdrawal by Subject|1|||
30934008|NCT01972217|58970333|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
30934009|NCT01972217|58970334|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
30934010|NCT01972217|58970335|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
30934011|NCT01972217|58970336|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
30934012|NCT01972217|58970333|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
30934013|NCT01972217|58970334|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
30840104|NCT01347645|58865426|FG004|Overall Study|Other|1|||
30840105|NCT01347645|58865422|FG000|Overall Study|Withdrawal by Subject|0|||
30840106|NCT01347645|58865423|FG001|Overall Study|Withdrawal by Subject|0|||
30840107|NCT01347645|58865424|FG002|Overall Study|Withdrawal by Subject|0|||
30840108|NCT01347645|58865425|FG003|Overall Study|Withdrawal by Subject|3|||
30840109|NCT01347645|58865426|FG004|Overall Study|Withdrawal by Subject|3|||
30840110|NCT01347645|58865422|FG000|Overall Study|Physician Decision|0|||
30840111|NCT01347645|58865423|FG001|Overall Study|Physician Decision|0|||
30840112|NCT01347645|58865424|FG002|Overall Study|Physician Decision|0|||
30840113|NCT01347645|58865425|FG003|Overall Study|Physician Decision|0|||
30840114|NCT01347645|58865426|FG004|Overall Study|Physician Decision|1|||
30840115|NCT01347645|58865422|FG000|Overall Study|Adverse Event|0|||
30840116|NCT01347645|58865423|FG001|Overall Study|Adverse Event|0|||
30840117|NCT01347645|58865424|FG002|Overall Study|Adverse Event|0|||
30840118|NCT01347645|58865425|FG003|Overall Study|Adverse Event|1|||
30840119|NCT01347645|58865426|FG004|Overall Study|Adverse Event|1|||
30840120|NCT00484419|58865464|FG000|Overall Study|Adverse Event|3|||
30840121|NCT00484419|58865465|FG001|Overall Study|Adverse Event|0|||
30934014|NCT01972217|58970335|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
30934015|NCT01972217|58970336|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
30934016|NCT01972217|58970333|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
30934017|NCT01972217|58970334|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
30934018|NCT01972217|58970335|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
30934019|NCT01972217|58970336|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
30934020|NCT01972217|58970333|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
30934021|NCT01972217|58970334|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
30934022|NCT01972217|58970335|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
30934023|NCT01972217|58970336|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
30934024|NCT01972217|58970333|FG000|Part B Double-blind, Randomised Period|Death|0|||
30934025|NCT01972217|58970334|FG001|Part B Double-blind, Randomised Period|Death|0|||
30934026|NCT01972217|58970335|FG002|Part B Double-blind, Randomised Period|Death|43|||
30934027|NCT01972217|58970336|FG003|Part B Double-blind, Randomised Period|Death|44|||
30934028|NCT01972217|58970333|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
30934029|NCT01972217|58970334|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
30948533|NCT01964105|58994543|FG002|Overall Study|Lost to Follow-up|0|||
30840122|NCT00484419|58865466|FG002|Overall Study|Adverse Event|0|||
30840123|NCT00484419|58865464|FG000|Overall Study|Lost to Follow-up|1|||
30840124|NCT00484419|58865465|FG001|Overall Study|Lost to Follow-up|0|||
30840125|NCT00484419|58865466|FG002|Overall Study|Lost to Follow-up|2|||
30840126|NCT00484419|58865464|FG000|Overall Study|Withdrawal by Subject|3|||
30840127|NCT00484419|58865465|FG001|Overall Study|Withdrawal by Subject|1|||
30934030|NCT01972217|58970335|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
30934031|NCT01972217|58970336|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
30934032|NCT01972217|58970333|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
30934033|NCT01972217|58970334|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
30934034|NCT01972217|58970335|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
30934035|NCT01972217|58970336|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
30934036|NCT01972217|58970333|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
30934037|NCT01972217|58970334|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
30934038|NCT01972217|58970335|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
30934039|NCT01972217|58970336|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
30934040|NCT01972217|58970333|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
30934041|NCT01972217|58970334|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
30934042|NCT01972217|58970335|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
30934043|NCT01972217|58970336|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
30934044|NCT01970865|58970365|FG000|Overall Study|Death|3|||
30934045|NCT01970865|58970366|FG001|Overall Study|Death|1|||
30934046|NCT01970865|58970367|FG002|Overall Study|Death|3|||
30934047|NCT01970865|58970368|FG003|Overall Study|Death|4|||
30934048|NCT01970865|58970369|FG004|Overall Study|Death|6|||
30934049|NCT01970865|58970370|FG005|Overall Study|Death|3|||
30934050|NCT01970865|58970371|FG006|Overall Study|Death|1|||
30934051|NCT01970865|58970372|FG007|Overall Study|Death|3|||
30934052|NCT01970865|58970373|FG008|Overall Study|Death|2|||
30934053|NCT01970865|58970374|FG009|Overall Study|Death|1|||
30934054|NCT01970865|58970375|FG010|Overall Study|Death|1|||
30934055|NCT01970865|58970376|FG011|Overall Study|Death|4|||
30934056|NCT01970865|58970377|FG012|Overall Study|Death|14|||
30934057|NCT01970865|58970378|FG013|Overall Study|Death|19|||
30934058|NCT01970865|58970379|FG014|Overall Study|Death|15|||
30934059|NCT01970865|58970380|FG015|Overall Study|Death|10|||
30934060|NCT01970865|58970381|FG016|Overall Study|Death|1|||
30934061|NCT01970865|58970365|FG000|Overall Study|Lost to Follow-up|0|||
30934062|NCT01970865|58970366|FG001|Overall Study|Lost to Follow-up|0|||
30934063|NCT01970865|58970367|FG002|Overall Study|Lost to Follow-up|0|||
30934064|NCT01970865|58970368|FG003|Overall Study|Lost to Follow-up|1|||
30934065|NCT01970865|58970369|FG004|Overall Study|Lost to Follow-up|1|||
30934066|NCT01970865|58970370|FG005|Overall Study|Lost to Follow-up|0|||
30934067|NCT01970865|58970371|FG006|Overall Study|Lost to Follow-up|0|||
30934068|NCT01970865|58970372|FG007|Overall Study|Lost to Follow-up|0|||
30934069|NCT01970865|58970373|FG008|Overall Study|Lost to Follow-up|0|||
30934070|NCT01970865|58970374|FG009|Overall Study|Lost to Follow-up|0|||
30934071|NCT01970865|58970375|FG010|Overall Study|Lost to Follow-up|0|||
30934072|NCT01970865|58970376|FG011|Overall Study|Lost to Follow-up|0|||
30934073|NCT01970865|58970377|FG012|Overall Study|Lost to Follow-up|1|||
30934074|NCT01970865|58970378|FG013|Overall Study|Lost to Follow-up|0|||
30934075|NCT01970865|58970379|FG014|Overall Study|Lost to Follow-up|0|||
30934076|NCT01970865|58970380|FG015|Overall Study|Lost to Follow-up|0|||
30934077|NCT01970865|58970381|FG016|Overall Study|Lost to Follow-up|0|||
30758552|NCT00380393|58767268|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
30758553|NCT00380393|58767269|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
30840128|NCT00484419|58865466|FG002|Overall Study|Withdrawal by Subject|1|||
30840129|NCT00484419|58865464|FG000|Overall Study|subject met discontinuation criteria|2|||
30840130|NCT00484419|58865465|FG001|Overall Study|subject met discontinuation criteria|2|||
30840131|NCT00484419|58865466|FG002|Overall Study|subject met discontinuation criteria|4|||
30840132|NCT00484419|58865464|FG000|Overall Study|required restricted medication|1|||
30840133|NCT00484419|58865465|FG001|Overall Study|required restricted medication|0|||
30840134|NCT00484419|58865466|FG002|Overall Study|required restricted medication|1|||
30840135|NCT00484419|58865464|FG000|Overall Study|Physician Decision|1|||
30840136|NCT00484419|58865465|FG001|Overall Study|Physician Decision|1|||
30840137|NCT00484419|58865466|FG002|Overall Study|Physician Decision|1|||
30840138|NCT00484419|58865464|FG000|Overall Study|subject unable to receive medication|1|||
30758554|NCT00380393|58767268|FG000|Month 14|Withdrawal by Subject|9|||
30758555|NCT00380393|58767269|FG001|Month 14|Withdrawal by Subject|7|||
30758556|NCT00380393|58767268|FG000|Month 14|Death|1|||
30758557|NCT00380393|58767269|FG001|Month 14|Death|0|||
30758558|NCT00380393|58767268|FG000|Month 14|Lost to Follow-up|0|||
30758559|NCT00380393|58767269|FG001|Month 14|Lost to Follow-up|1|||
30758560|NCT00380393|58767268|FG000|Month 14|Migrated/moved from study area|39|||
30758561|NCT00380393|58767269|FG001|Month 14|Migrated/moved from study area|42|||
30840139|NCT00484419|58865465|FG001|Overall Study|subject unable to receive medication|0|||
30934078|NCT01970865|58970365|FG000|Overall Study|Withdrawal by Subject|0|||
30934079|NCT01970865|58970366|FG001|Overall Study|Withdrawal by Subject|0|||
30934080|NCT01970865|58970367|FG002|Overall Study|Withdrawal by Subject|0|||
30934081|NCT01970865|58970368|FG003|Overall Study|Withdrawal by Subject|1|||
30934082|NCT01970865|58970369|FG004|Overall Study|Withdrawal by Subject|2|||
30934083|NCT01970865|58970370|FG005|Overall Study|Withdrawal by Subject|0|||
30840140|NCT00484419|58865466|FG002|Overall Study|subject unable to receive medication|0|||
30840141|NCT00484419|58865464|FG000|Overall Study|subject relocated|0|||
30934084|NCT01970865|58970371|FG006|Overall Study|Withdrawal by Subject|0|||
30934085|NCT01970865|58970372|FG007|Overall Study|Withdrawal by Subject|0|||
30934086|NCT01970865|58970373|FG008|Overall Study|Withdrawal by Subject|0|||
30934087|NCT01970865|58970374|FG009|Overall Study|Withdrawal by Subject|0|||
30934088|NCT01970865|58970375|FG010|Overall Study|Withdrawal by Subject|0|||
30934089|NCT01970865|58970376|FG011|Overall Study|Withdrawal by Subject|1|||
30934090|NCT01970865|58970377|FG012|Overall Study|Withdrawal by Subject|2|||
30934091|NCT01970865|58970378|FG013|Overall Study|Withdrawal by Subject|5|||
30934092|NCT01970865|58970379|FG014|Overall Study|Withdrawal by Subject|2|||
30934093|NCT01970865|58970380|FG015|Overall Study|Withdrawal by Subject|7|||
30934094|NCT01970865|58970381|FG016|Overall Study|Withdrawal by Subject|0|||
30934095|NCT01970865|58970365|FG000|Overall Study|Other|0|||
30934096|NCT01970865|58970366|FG001|Overall Study|Other|0|||
30934097|NCT01970865|58970367|FG002|Overall Study|Other|0|||
30934098|NCT01970865|58970368|FG003|Overall Study|Other|1|||
30934099|NCT01970865|58970369|FG004|Overall Study|Other|0|||
30934100|NCT01970865|58970370|FG005|Overall Study|Other|0|||
30934101|NCT01970865|58970371|FG006|Overall Study|Other|0|||
30934102|NCT01970865|58970372|FG007|Overall Study|Other|0|||
30934103|NCT01970865|58970373|FG008|Overall Study|Other|0|||
30934104|NCT01970865|58970374|FG009|Overall Study|Other|0|||
30934105|NCT01970865|58970375|FG010|Overall Study|Other|0|||
30934106|NCT01970865|58970376|FG011|Overall Study|Other|0|||
30934107|NCT01970865|58970377|FG012|Overall Study|Other|0|||
30934108|NCT01970865|58970378|FG013|Overall Study|Other|1|||
30934109|NCT01970865|58970379|FG014|Overall Study|Other|0|||
30934110|NCT01970865|58970380|FG015|Overall Study|Other|1|||
30934111|NCT01970865|58970381|FG016|Overall Study|Other|0|||
30934112|NCT01970865|58970365|FG000|Overall Study|Study ongoing|0|||
30934113|NCT01970865|58970366|FG001|Overall Study|Study ongoing|2|||
30934114|NCT01970865|58970367|FG002|Overall Study|Study ongoing|0|||
30934115|NCT01970865|58970368|FG003|Overall Study|Study ongoing|6|||
30934116|NCT01970865|58970369|FG004|Overall Study|Study ongoing|8|||
30934117|NCT01970865|58970370|FG005|Overall Study|Study ongoing|0|||
30934118|NCT01970865|58970371|FG006|Overall Study|Study ongoing|2|||
30934119|NCT01970865|58970372|FG007|Overall Study|Study ongoing|0|||
30934120|NCT01970865|58970373|FG008|Overall Study|Study ongoing|1|||
30934121|NCT01970865|58970374|FG009|Overall Study|Study ongoing|3|||
30934122|NCT01970865|58970375|FG010|Overall Study|Study ongoing|29|||
30934123|NCT01970865|58970376|FG011|Overall Study|Study ongoing|22|||
30934124|NCT01970865|58970377|FG012|Overall Study|Study ongoing|43|||
30934125|NCT01970865|58970378|FG013|Overall Study|Study ongoing|41|||
30934126|NCT01970865|58970379|FG014|Overall Study|Study ongoing|29|||
30934127|NCT01970865|58970380|FG015|Overall Study|Study ongoing|29|||
30934128|NCT01970865|58970381|FG016|Overall Study|Study ongoing|2|||
30934129|NCT01711541|58970456|FG000|Overall Study|Cancel prior to treatment|0|||
30934130|NCT01711541|58970457|FG001|Overall Study|Cancel prior to treatment|0|||
30934131|NCT01711541|58970458|FG002|Overall Study|Cancel prior to treatment|0|||
30934132|NCT01711541|58970459|FG003|Overall Study|Cancel prior to treatment|1|||
30934133|NCT01711541|58970460|FG004|Overall Study|Cancel prior to treatment|0|||
30934134|NCT01711541|58970456|FG000|Overall Study|Ineligible|0|||
30934135|NCT01711541|58970457|FG001|Overall Study|Ineligible|1|||
30934136|NCT01711541|58970458|FG002|Overall Study|Ineligible|0|||
30934137|NCT01711541|58970459|FG003|Overall Study|Ineligible|0|||
30934138|NCT01711541|58970460|FG004|Overall Study|Ineligible|0|||
30934139|NCT01382446|58970496|FG000|Overall Study|Withdrawal by Subject|0|||
30934140|NCT01382446|58970497|FG001|Overall Study|Withdrawal by Subject|1|||
30934141|NCT01382446|58970496|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
30934142|NCT01382446|58970497|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
30934143|NCT01382212|58970503|FG000|Overall Study|Kidney transplant|1|||
30934144|NCT01382212|58970503|FG000|Overall Study|Withdrew consent|1|||
30934145|NCT01381900|58970510|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
30758562|NCT00380393|58767268|FG000|Month 14|Protocol Violation|2|||
30758563|NCT00380393|58767269|FG001|Month 14|Protocol Violation|0|||
30758564|NCT00380393|58767268|FG000|Month 14|Others|6|||
30758565|NCT00380393|58767269|FG001|Month 14|Others|6|||
30758566|NCT00380081|58767281|FG000|Overall Study|Withdrawal by Subject|0|||
30758567|NCT00380081|58767282|FG001|Overall Study|Withdrawal by Subject|0|||
30758568|NCT00380081|58767283|FG002|Overall Study|Withdrawal by Subject|0|||
30758569|NCT00380081|58767284|FG003|Overall Study|Withdrawal by Subject|0|||
30758570|NCT00380081|58767285|FG004|Overall Study|Withdrawal by Subject|1|||
30758571|NCT00380081|58767286|FG005|Overall Study|Withdrawal by Subject|0|||
30934146|NCT01381900|58970511|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
30934147|NCT01381900|58970512|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
30934148|NCT01381900|58970510|FG000|Overall Study|Adverse Event|4|||
30934149|NCT01381900|58970511|FG001|Overall Study|Adverse Event|6|||
30934150|NCT01381900|58970512|FG002|Overall Study|Adverse Event|7|||
30934151|NCT01381900|58970510|FG000|Overall Study|Noncompliance with study drug|0|||
30934152|NCT01381900|58970511|FG001|Overall Study|Noncompliance with study drug|0|||
30934153|NCT01381900|58970512|FG002|Overall Study|Noncompliance with study drug|1|||
30934154|NCT01381900|58970510|FG000|Overall Study|Physician Decision|0|||
30934155|NCT01381900|58970511|FG001|Overall Study|Physician Decision|1|||
30934156|NCT01381900|58970512|FG002|Overall Study|Physician Decision|1|||
30934157|NCT01381900|58970510|FG000|Overall Study|Protocol Violation|0|||
30934158|NCT01381900|58970511|FG001|Overall Study|Protocol Violation|1|||
30934159|NCT01381900|58970512|FG002|Overall Study|Protocol Violation|1|||
30934160|NCT01381900|58970510|FG000|Overall Study|Withdrawal by Subject|0|||
30934161|NCT01381900|58970511|FG001|Overall Study|Withdrawal by Subject|0|||
30934162|NCT01381900|58970512|FG002|Overall Study|Withdrawal by Subject|1|||
30934163|NCT01381900|58970510|FG000|Overall Study|Early withdraw|3|||
30934164|NCT01381900|58970511|FG001|Overall Study|Early withdraw|1|||
30934165|NCT01381900|58970512|FG002|Overall Study|Early withdraw|1|||
30934166|NCT01744665|58970520|FG000|Monitoring Phase|Adverse Event|4|||
30934167|NCT01744665|58970520|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
30934168|NCT01744665|58970520|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
30934169|NCT01744665|58970520|FG000|Monitoring Phase|Withdrawal by Subject|5|||
30934170|NCT01744665|58970520|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
30934171|NCT01744665|58970520|FG000|Consolidation Phase|Adverse Event|2|||
30934172|NCT01744665|58970520|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
30934173|NCT01744665|58970520|FG000|Consolidation Phase|Withdrawal by Subject|4|||
30934174|NCT01744665|58970520|FG000|Consolidation Phase|Administrative problems|9|||
30934175|NCT01744665|58970520|FG000|Re-initiation Phase|Administrative problems|10|||
30934176|NCT01744665|58970520|FG000|Re-initiation Phase|Adverse Event|1|||
30934177|NCT01744665|58970520|FG000|Re-initiation Phase|No longer required treatment|1|||
30934178|NCT01744665|58970520|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
30934179|NCT01744197|58970529|FG000|Overall Study|Received 1 patch|2|||
30934180|NCT01744197|58970530|FG001|Overall Study|Received 1 patch|1|||
30934181|NCT01744197|58970529|FG000|Overall Study|No patch received|2|||
30934182|NCT01744197|58970530|FG001|Overall Study|No patch received|2|||
30934183|NCT01732107|58970536|FG000|Overall Study|Adverse Event|2|||
30934184|NCT01732107|58970536|FG000|Overall Study|Disease Progression|8|||
30934185|NCT01732107|58970536|FG000|Overall Study|Physician Decision|1|||
30934186|NCT01732107|58970536|FG000|Overall Study|Withdrawal by Subject|2|||
30934187|NCT01743027|58970544|FG000|Overall Study|Adverse Event|2|||
30934188|NCT01743027|58970545|FG001|Overall Study|Adverse Event|0|||
30934189|NCT01743027|58970546|FG002|Overall Study|Adverse Event|0|||
30934190|NCT01743027|58970547|FG003|Overall Study|Adverse Event|0|||
30934191|NCT01743027|58970544|FG000|Overall Study|Lost to Follow-up|0|||
30934192|NCT01743027|58970545|FG001|Overall Study|Lost to Follow-up|0|||
30934193|NCT01743027|58970546|FG002|Overall Study|Lost to Follow-up|2|||
30934194|NCT01743027|58970547|FG003|Overall Study|Lost to Follow-up|0|||
30934195|NCT01743027|58970544|FG000|Overall Study|Progressive Disease|1|||
30934196|NCT01743027|58970545|FG001|Overall Study|Progressive Disease|4|||
30934197|NCT01743027|58970546|FG002|Overall Study|Progressive Disease|3|||
30934198|NCT01743027|58970547|FG003|Overall Study|Progressive Disease|0|||
30934199|NCT01743027|58970544|FG000|Overall Study|Protocol Violation|1|||
30934200|NCT01743027|58970545|FG001|Overall Study|Protocol Violation|1|||
30934201|NCT01743027|58970546|FG002|Overall Study|Protocol Violation|1|||
30934202|NCT01743027|58970547|FG003|Overall Study|Protocol Violation|0|||
30934203|NCT01743027|58970544|FG000|Overall Study|Withdrawal by Subject|1|||
30934204|NCT01743027|58970545|FG001|Overall Study|Withdrawal by Subject|0|||
30934205|NCT01743027|58970546|FG002|Overall Study|Withdrawal by Subject|3|||
30934206|NCT01743027|58970547|FG003|Overall Study|Withdrawal by Subject|1|||
30934207|NCT01380730|58970565|FG000|Overall Study|Death|0|||
30934208|NCT01380730|58970566|FG001|Overall Study|Death|0|||
30934209|NCT01380730|58970567|FG002|Overall Study|Death|0|||
30934210|NCT01380730|58970568|FG003|Overall Study|Death|0|||
30934211|NCT01380730|58970569|FG004|Overall Study|Death|1|||
30934212|NCT01380730|58970570|FG005|Overall Study|Death|0|||
30934213|NCT01380730|58970571|FG006|Overall Study|Death|0|||
30934214|NCT01380730|58970572|FG007|Overall Study|Death|0|||
30934215|NCT01395784|58970590|FG000|Overall Study|Lost to Follow-up|7|||
30934216|NCT01395784|58970590|FG000|Overall Study|Withdrawal by Subject|3|||
30934217|NCT01395784|58970590|FG000|Overall Study|Physician Decision|5|||
30934218|NCT01380184|58970594|FG000|Part 1 (19 Days)|Adverse Event|1|||
30934219|NCT01380184|58970594|FG000|Part 2|Adverse Event|5|||
30934220|NCT01380184|58970594|FG000|Part 2|Disease Progression|8|||
30934221|NCT01380184|58970594|FG000|Part 2|Lost to Follow-up|1|||
30934222|NCT01395394|58970601|FG000|Baseline Study Visit|Protocol Violation|1|||
30934223|NCT01395394|58970602|FG001|Baseline Study Visit|Protocol Violation|0|||
30934224|NCT01395394|58970603|FG002|Baseline Study Visit|Protocol Violation|0|||
30934225|NCT01395316|58970611|FG000|Overall Study|Lost to Follow-up|2|||
30934226|NCT01395316|58970611|FG000|Overall Study|poor MRI quality|1|||
30758572|NCT00380081|58767281|FG000|Overall Study|Family Emergency|0|||
30934227|NCT01742091|58970621|FG000|Overall Study|Adverse Event|0|||
30934228|NCT01742091|58970622|FG001|Overall Study|Adverse Event|0|||
30934229|NCT01742091|58970623|FG002|Overall Study|Adverse Event|0|||
30934230|NCT01742091|58970624|FG003|Overall Study|Adverse Event|0|||
30934231|NCT01742091|58970625|FG004|Overall Study|Adverse Event|1|||
30934232|NCT01742091|58970626|FG005|Overall Study|Adverse Event|0|||
30934233|NCT01742091|58970621|FG000|Overall Study|Physician Decision|0|||
30934234|NCT01742091|58970622|FG001|Overall Study|Physician Decision|0|||
30934235|NCT01742091|58970623|FG002|Overall Study|Physician Decision|0|||
30934236|NCT01742091|58970624|FG003|Overall Study|Physician Decision|0|||
30934237|NCT01742091|58970625|FG004|Overall Study|Physician Decision|0|||
30934238|NCT01742091|58970626|FG005|Overall Study|Physician Decision|1|||
30934239|NCT01742091|58970621|FG000|Overall Study|Withdrawal by Subject|0|||
30934240|NCT01742091|58970622|FG001|Overall Study|Withdrawal by Subject|0|||
30934241|NCT01742091|58970623|FG002|Overall Study|Withdrawal by Subject|0|||
30934242|NCT01742091|58970624|FG003|Overall Study|Withdrawal by Subject|1|||
30840142|NCT00484419|58865465|FG001|Overall Study|subject relocated|1|||
30840143|NCT00484419|58865466|FG002|Overall Study|subject relocated|0|||
30840144|NCT00484419|58865464|FG000|Overall Study|sponsor decision, randomized in error|0|||
30840145|NCT00484419|58865465|FG001|Overall Study|sponsor decision, randomized in error|0|||
30840146|NCT00484419|58865466|FG002|Overall Study|sponsor decision, randomized in error|2|||
30840147|NCT03220724|58865475|FG000|Overall Study|Lost to Follow-up|2|||
30840148|NCT03220724|58865476|FG001|Overall Study|Lost to Follow-up|1|||
30840149|NCT03220724|58865477|FG002|Overall Study|Lost to Follow-up|0|||
30934243|NCT01742091|58970625|FG004|Overall Study|Withdrawal by Subject|0|||
30934244|NCT01742091|58970626|FG005|Overall Study|Withdrawal by Subject|0|||
30934245|NCT01742091|58970621|FG000|Overall Study|Lost to Follow-up|0|||
30934246|NCT01742091|58970622|FG001|Overall Study|Lost to Follow-up|0|||
30934247|NCT01742091|58970623|FG002|Overall Study|Lost to Follow-up|0|||
30934248|NCT01742091|58970624|FG003|Overall Study|Lost to Follow-up|0|||
30934249|NCT01742091|58970625|FG004|Overall Study|Lost to Follow-up|0|||
30934250|NCT01742091|58970626|FG005|Overall Study|Lost to Follow-up|1|||
30840150|NCT03220724|58865478|FG003|Overall Study|Lost to Follow-up|3|||
30840151|NCT03220724|58865475|FG000|Overall Study|Withdrawal by Subject|1|||
30840152|NCT03220724|58865476|FG001|Overall Study|Withdrawal by Subject|1|||
30840153|NCT03220724|58865477|FG002|Overall Study|Withdrawal by Subject|1|||
30840154|NCT03220724|58865478|FG003|Overall Study|Withdrawal by Subject|0|||
30840155|NCT02549092|58865490|FG000|Treatment Period|Adverse Event|2|||
30840156|NCT02549092|58865491|FG001|Treatment Period|Adverse Event|2|||
30840157|NCT02549092|58865490|FG000|Treatment Period|Withdrawal by Subject|1|||
30840158|NCT02549092|58865491|FG001|Treatment Period|Withdrawal by Subject|3|||
30840159|NCT02549092|58865490|FG000|Treatment Period|Lack of Efficacy|0|||
30840160|NCT02549092|58865491|FG001|Treatment Period|Lack of Efficacy|2|||
30840161|NCT02549092|58865490|FG000|Extension/Transition Period|Still in Extension/Transition Period|4|||
30840162|NCT02549092|58865491|FG001|Extension/Transition Period|Still in Extension/Transition Period|8|||
30840163|NCT02549092|58865490|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
30840164|NCT02549092|58865491|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
30840165|NCT03056573|58865502|FG000|Overall Study|Death|2|||
30840166|NCT03056573|58865503|FG001|Overall Study|Death|4|||
30840167|NCT03056573|58865502|FG000|Overall Study|Withdrawal by Subject|2|||
30840168|NCT03056573|58865503|FG001|Overall Study|Withdrawal by Subject|0|||
30840169|NCT03056573|58865502|FG000|Overall Study|Lost to Follow-up|1|||
30840170|NCT03056573|58865503|FG001|Overall Study|Lost to Follow-up|1|||
30840171|NCT02553772|58865511|FG000|Overall Study|Adverse Event|2|||
30840172|NCT02553772|58865512|FG001|Overall Study|Adverse Event|3|||
30840173|NCT02553772|58865511|FG000|Overall Study|Lost to Follow-up|2|||
30840174|NCT02553772|58865512|FG001|Overall Study|Lost to Follow-up|1|||
30840175|NCT02553772|58865511|FG000|Overall Study|Withdrawal of Consent|1|||
30840176|NCT02553772|58865512|FG001|Overall Study|Withdrawal of Consent|1|||
30840177|NCT02553772|58865511|FG000|Overall Study|Lack of Efficacy|1|||
30840178|NCT02553772|58865512|FG001|Overall Study|Lack of Efficacy|0|||
30840179|NCT02553772|58865511|FG000|Overall Study|Other Miscellaneous Reasons|0|||
30840180|NCT02553772|58865512|FG001|Overall Study|Other Miscellaneous Reasons|1|||
30840181|NCT02553538|58865520|FG000|Overall Study|Could Not Reach by Telephone|133|||
30840182|NCT02553538|58865521|FG001|Overall Study|Could Not Reach by Telephone|0|||
30840183|NCT02553538|58865520|FG000|Overall Study|Died or Left Network|54|||
30840184|NCT02553538|58865521|FG001|Overall Study|Died or Left Network|56|||
30840185|NCT02548156|58865527|FG000|Washout Period 1|Lost to Follow-up|0|||
30934251|NCT01731951|58970646|FG000|Overall Study|Documented Disease Progression|1|||
30934252|NCT01731951|58970647|FG001|Overall Study|Documented Disease Progression|0|||
30934253|NCT01731951|58970648|FG002|Overall Study|Documented Disease Progression|0|||
30934254|NCT01731951|58970649|FG003|Overall Study|Documented Disease Progression|0|||
30934255|NCT01731951|58970650|FG004|Overall Study|Documented Disease Progression|0|||
30934256|NCT01731951|58970651|FG005|Overall Study|Documented Disease Progression|0|||
30934257|NCT01731951|58970646|FG000|Overall Study|Lost to Follow-up|2|||
30934258|NCT01731951|58970647|FG001|Overall Study|Lost to Follow-up|0|||
30934259|NCT01731951|58970648|FG002|Overall Study|Lost to Follow-up|0|||
30934260|NCT01731951|58970649|FG003|Overall Study|Lost to Follow-up|1|||
30840186|NCT02548156|58865528|FG001|Washout Period 1|Lost to Follow-up|0|||
30840187|NCT02548156|58865529|FG002|Washout Period 1|Lost to Follow-up|0|||
30840188|NCT02548156|58865530|FG003|Washout Period 1|Lost to Follow-up|0|||
30840189|NCT02548156|58865531|FG004|Washout Period 1|Lost to Follow-up|1|||
30840190|NCT02548156|58865532|FG005|Washout Period 1|Lost to Follow-up|0|||
30840191|NCT01503515|58865542|FG000|Overall Study|Adverse Event|4|||
30840192|NCT01503515|58865543|FG001|Overall Study|Adverse Event|5|||
30840193|NCT01503515|58865542|FG000|Overall Study|Death|0|||
30758573|NCT00380081|58767282|FG001|Overall Study|Family Emergency|0|||
30758574|NCT00380081|58767283|FG002|Overall Study|Family Emergency|0|||
30758575|NCT00380081|58767284|FG003|Overall Study|Family Emergency|0|||
30758576|NCT00380081|58767285|FG004|Overall Study|Family Emergency|0|||
30758577|NCT00380081|58767286|FG005|Overall Study|Family Emergency|1|||
30758578|NCT03579940|58767305|FG000|Period 2|Withdrawal by Subject|0|||
30758579|NCT03579940|58767306|FG001|Period 2|Withdrawal by Subject|0|||
30840194|NCT01503515|58865543|FG001|Overall Study|Death|1|||
30840195|NCT01503515|58865542|FG000|Overall Study|Physician Decision|14|||
30840196|NCT01503515|58865543|FG001|Overall Study|Physician Decision|23|||
30840197|NCT01503515|58865542|FG000|Overall Study|Withdrawal by Subject|0|||
30840198|NCT01503515|58865543|FG001|Overall Study|Withdrawal by Subject|1|||
30840199|NCT01503515|58865542|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
30840200|NCT01503515|58865543|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
30934261|NCT01731951|58970650|FG004|Overall Study|Lost to Follow-up|3|||
30934262|NCT01731951|58970651|FG005|Overall Study|Lost to Follow-up|1|||
30934263|NCT01731951|58970646|FG000|Overall Study|Withdrawal of Consent|1|||
30934264|NCT01731951|58970647|FG001|Overall Study|Withdrawal of Consent|0|||
30934265|NCT01731951|58970648|FG002|Overall Study|Withdrawal of Consent|0|||
30934266|NCT01731951|58970649|FG003|Overall Study|Withdrawal of Consent|0|||
30934267|NCT01731951|58970650|FG004|Overall Study|Withdrawal of Consent|0|||
30934268|NCT01731951|58970651|FG005|Overall Study|Withdrawal of Consent|2|||
30934269|NCT01731951|58970646|FG000|Overall Study|Death|13|||
30934270|NCT01731951|58970647|FG001|Overall Study|Death|15|||
30840201|NCT01503515|58865542|FG000|Overall Study|Ineligible|1|||
30840202|NCT01503515|58865543|FG001|Overall Study|Ineligible|1|||
30840203|NCT02742519|58865551|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
30934271|NCT01731951|58970648|FG002|Overall Study|Death|9|||
30934272|NCT01731951|58970649|FG003|Overall Study|Death|8|||
30934273|NCT01731951|58970650|FG004|Overall Study|Death|9|||
30934274|NCT01731951|58970651|FG005|Overall Study|Death|6|||
30934275|NCT01731171|58970671|FG000|Overall Study|Withdrawal by Subject|4|||
30934276|NCT01731171|58970672|FG001|Overall Study|Withdrawal by Subject|1|||
30934277|NCT01731171|58970671|FG000|Overall Study|Lost to Follow-up|3|||
30934278|NCT01731171|58970672|FG001|Overall Study|Lost to Follow-up|2|||
30934279|NCT01731171|58970671|FG000|Overall Study|Moved out of Area|0|||
30934280|NCT01731171|58970672|FG001|Overall Study|Moved out of Area|2|||
30934281|NCT01731171|58970671|FG000|Overall Study|Terminated for Lack of Adherence|0|||
30758580|NCT03579940|58767307|FG002|Period 2|Withdrawal by Subject|1|||
30840204|NCT02742519|58865552|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
30934282|NCT01731171|58970672|FG001|Overall Study|Terminated for Lack of Adherence|1|||
30758581|NCT03579940|58767308|FG003|Period 2|Withdrawal by Subject|0|||
30758582|NCT03579940|58767309|FG004|Period 2|Withdrawal by Subject|0|||
30758583|NCT03579940|58767310|FG005|Period 2|Withdrawal by Subject|0|||
30840205|NCT02742519|58865553|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
30758584|NCT03579940|58767311|FG006|Period 2|Withdrawal by Subject|0|||
30934283|NCT01731171|58970671|FG000|Overall Study|Terminated for Safety Reasons|0|||
30934284|NCT01731171|58970672|FG001|Overall Study|Terminated for Safety Reasons|1|||
30934285|NCT01741701|58970680|FG000|Overall Study|Adverse Event|5|||
30934286|NCT01741701|58970681|FG001|Overall Study|Adverse Event|1|||
30934287|NCT01741701|58970680|FG000|Overall Study|Withdrawal by Subject|0|||
30934288|NCT01741701|58970681|FG001|Overall Study|Withdrawal by Subject|1|||
30934289|NCT01741545|58970689|FG000|Treatment Period|Lack of Efficacy|0|||
30758585|NCT03579940|58767312|FG007|Period 2|Withdrawal by Subject|0|||
30934290|NCT01741545|58970690|FG001|Treatment Period|Lack of Efficacy|1|||
30934291|NCT01741545|58970689|FG000|Treatment Period|Adverse event, non-fatal|1|||
30934292|NCT01741545|58970690|FG001|Treatment Period|Adverse event, non-fatal|3|||
30934293|NCT01741545|58970689|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
30934294|NCT01741545|58970690|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
30934295|NCT01741545|58970689|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
30934296|NCT01741545|58970690|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
30934297|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
30934298|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
30934299|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
30934300|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
30934301|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
30934302|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
30934303|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
30934304|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
30934305|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
30934306|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
30934307|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
30934308|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
30934309|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
30934310|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
30934311|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
30934312|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
30934313|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
30934314|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
30934315|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
30934316|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
30934317|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
30934318|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
30934319|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
30934320|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
30934321|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
30934322|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
30934323|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
30934324|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
30934325|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
30934326|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
30934327|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
30934328|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
30934329|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
30934330|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
30934331|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
30934332|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
30934333|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
30934334|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
30934335|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
30934336|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
30934337|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
30934338|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
30934339|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
30934340|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
30934341|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
30934342|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
30934343|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
30934344|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
30934345|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
30934346|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
30934347|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
30934348|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
30934349|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
30934350|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
30934351|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
30948534|NCT01974323|58994553|FG000|Overall Study|Other Reasons|25|||
30934352|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
30934353|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
30934354|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
30934355|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
30934356|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
30934357|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
30934358|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
30934359|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
30934360|NCT01884350|58970698|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
30934361|NCT01884350|58970699|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
30934362|NCT01884350|58970700|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
30934363|NCT01614795|58970714|FG000|Overall Study|Adverse Event|0|||
30934364|NCT01614795|58970715|FG001|Overall Study|Adverse Event|0|||
30934365|NCT01614795|58970716|FG002|Overall Study|Adverse Event|1|||
30934366|NCT01614795|58970717|FG003|Overall Study|Adverse Event|1|||
30934367|NCT01614795|58970714|FG000|Overall Study|Lack of Efficacy|10|||
30934368|NCT01614795|58970715|FG001|Overall Study|Lack of Efficacy|10|||
30934369|NCT01614795|58970716|FG002|Overall Study|Lack of Efficacy|9|||
30934370|NCT01614795|58970717|FG003|Overall Study|Lack of Efficacy|8|||
30840206|NCT02742519|58865551|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
30840207|NCT02742519|58865552|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
30840208|NCT02742519|58865553|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
30840209|NCT02742519|58865551|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
30840210|NCT02742519|58865552|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
30840211|NCT02742519|58865553|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
30840212|NCT01375010|58865563|FG000|Overall Study|Lost to Follow-up|8|||
30840213|NCT01375010|58865564|FG001|Overall Study|Lost to Follow-up|2|||
30840214|NCT01375010|58865563|FG000|Overall Study|Withdrawal by Subject|4|||
30840215|NCT01375010|58865564|FG001|Overall Study|Withdrawal by Subject|2|||
30840216|NCT00659061|58865588|FG000|Overall Study|Migration due to political unrest|21|||
30840217|NCT00659061|58865589|FG001|Overall Study|Migration due to political unrest|15|||
30840218|NCT02548078|58865606|FG000|Overall Study|Serious adverse event/Adverse event|1|||
30840219|NCT02548078|58865607|FG001|Overall Study|Serious adverse event/Adverse event|0|||
30840220|NCT02548078|58865606|FG000|Overall Study|Moved from study area|3|||
30840221|NCT02548078|58865607|FG001|Overall Study|Moved from study area|3|||
30840222|NCT02548078|58865606|FG000|Overall Study|Lost to Follow-up|1|||
30840223|NCT02548078|58865607|FG001|Overall Study|Lost to Follow-up|3|||
30840224|NCT02671435|58865635|FG000|Overall Study|Death|1|||
30840225|NCT02671435|58865636|FG001|Overall Study|Death|3|||
30840226|NCT02671435|58865637|FG002|Overall Study|Death|0|||
30840227|NCT02671435|58865638|FG003|Overall Study|Death|16|||
30840228|NCT02671435|58865639|FG004|Overall Study|Death|14|||
30840229|NCT02671435|58865640|FG005|Overall Study|Death|29|||
30840230|NCT02671435|58865641|FG006|Overall Study|Death|34|||
30840231|NCT02671435|58865642|FG007|Overall Study|Death|28|||
30840232|NCT02671435|58865643|FG008|Overall Study|Death|19|||
30840233|NCT02671435|58865644|FG009|Overall Study|Death|10|||
30840234|NCT02671435|58865645|FG010|Overall Study|Death|8|||
30840235|NCT02671435|58865646|FG011|Overall Study|Death|29|||
30840236|NCT02671435|58865647|FG012|Overall Study|Death|29|||
30840237|NCT02671435|58865648|FG013|Overall Study|Death|29|||
30840238|NCT02671435|58865649|FG014|Overall Study|Death|27|||
30840239|NCT02671435|58865635|FG000|Overall Study|Lost to Follow-up|0|||
30840240|NCT02671435|58865636|FG001|Overall Study|Lost to Follow-up|0|||
30840241|NCT02671435|58865637|FG002|Overall Study|Lost to Follow-up|1|||
30840242|NCT02671435|58865638|FG003|Overall Study|Lost to Follow-up|0|||
30840243|NCT02671435|58865639|FG004|Overall Study|Lost to Follow-up|1|||
30840244|NCT02671435|58865640|FG005|Overall Study|Lost to Follow-up|1|||
30934371|NCT01614795|58970714|FG000|Overall Study|Physician Decision|1|||
30934372|NCT01614795|58970715|FG001|Overall Study|Physician Decision|0|||
30934373|NCT01614795|58970716|FG002|Overall Study|Physician Decision|1|||
30934374|NCT01614795|58970717|FG003|Overall Study|Physician Decision|1|||
30934375|NCT01614795|58970714|FG000|Overall Study|Withdrawal by Subject|0|||
30934376|NCT01614795|58970715|FG001|Overall Study|Withdrawal by Subject|1|||
30934377|NCT01614795|58970716|FG002|Overall Study|Withdrawal by Subject|0|||
30934378|NCT01614795|58970717|FG003|Overall Study|Withdrawal by Subject|2|||
30840245|NCT02671435|58865641|FG006|Overall Study|Lost to Follow-up|2|||
30840246|NCT02671435|58865642|FG007|Overall Study|Lost to Follow-up|2|||
30840247|NCT02671435|58865643|FG008|Overall Study|Lost to Follow-up|0|||
30840248|NCT02671435|58865644|FG009|Overall Study|Lost to Follow-up|2|||
30840249|NCT02671435|58865645|FG010|Overall Study|Lost to Follow-up|0|||
30840250|NCT02671435|58865646|FG011|Overall Study|Lost to Follow-up|3|||
30840251|NCT02671435|58865647|FG012|Overall Study|Lost to Follow-up|3|||
30840252|NCT02671435|58865648|FG013|Overall Study|Lost to Follow-up|2|||
30840253|NCT02671435|58865649|FG014|Overall Study|Lost to Follow-up|0|||
30934379|NCT01614795|58970714|FG000|Overall Study|Ineligible|0|||
30934380|NCT01614795|58970715|FG001|Overall Study|Ineligible|1|||
30934381|NCT01614795|58970716|FG002|Overall Study|Ineligible|0|||
30934382|NCT01614795|58970717|FG003|Overall Study|Ineligible|0|||
30934383|NCT01834586|58970728|FG000|Overall Study|Adverse Event|1|||
30934384|NCT01614249|58970734|FG000|Overall Study|Lost to Follow-up|11|||
30934385|NCT01614249|58970735|FG001|Overall Study|Lost to Follow-up|23|||
30934386|NCT01597778|58970743|FG000|Overall Study|Death|7|||
30934387|NCT01597778|58970744|FG001|Overall Study|Death|10|||
30934388|NCT01597778|58970743|FG000|Overall Study|Withdrawal by Subject|3|||
30934389|NCT01597778|58970744|FG001|Overall Study|Withdrawal by Subject|4|||
30934390|NCT01597778|58970743|FG000|Overall Study|Adverse Event|1|||
30934391|NCT01597778|58970744|FG001|Overall Study|Adverse Event|1|||
30934392|NCT01597778|58970743|FG000|Overall Study|Protocol Violation|1|||
30934393|NCT01597778|58970744|FG001|Overall Study|Protocol Violation|11|||
30934394|NCT01597778|58970743|FG000|Overall Study|Transplanted off protocol|2|||
30934395|NCT01597778|58970744|FG001|Overall Study|Transplanted off protocol|3|||
30934396|NCT01614093|58970750|FG000|Overall Study|Withdrawal by Subject|1|||
30934397|NCT01834274|58970757|FG000|Overall Study|Study Termination|41|||
30934398|NCT01834274|58970758|FG001|Overall Study|Study Termination|38|||
30934399|NCT01834274|58970757|FG000|Overall Study|Withdrawal by Subject|1|||
30934400|NCT01834274|58970758|FG001|Overall Study|Withdrawal by Subject|1|||
30934401|NCT01834274|58970757|FG000|Overall Study|Lost to Follow-up|3|||
30934402|NCT01834274|58970758|FG001|Overall Study|Lost to Follow-up|1|||
30934403|NCT01834274|58970757|FG000|Overall Study|Other|2|||
30934404|NCT01834274|58970758|FG001|Overall Study|Other|1|||
30934405|NCT01739595|58970767|FG000|Overall Study|Adverse Event|3|||
30934406|NCT01739595|58970768|FG001|Overall Study|Adverse Event|0|||
30934407|NCT01739595|58970769|FG002|Overall Study|Adverse Event|0|||
30934408|NCT01739595|58970767|FG000|Overall Study|Lost to Follow-up|2|||
30934409|NCT01739595|58970768|FG001|Overall Study|Lost to Follow-up|0|||
30934410|NCT01739595|58970769|FG002|Overall Study|Lost to Follow-up|0|||
30934411|NCT01739595|58970767|FG000|Overall Study|Withdrawal by Subject|2|||
30934412|NCT01739595|58970768|FG001|Overall Study|Withdrawal by Subject|1|||
30840254|NCT02671435|58865635|FG000|Overall Study|Withdrawal by Subject|2|||
30840255|NCT02671435|58865636|FG001|Overall Study|Withdrawal by Subject|0|||
30840256|NCT02671435|58865637|FG002|Overall Study|Withdrawal by Subject|2|||
30840257|NCT02671435|58865638|FG003|Overall Study|Withdrawal by Subject|2|||
30840258|NCT02671435|58865639|FG004|Overall Study|Withdrawal by Subject|2|||
30840259|NCT02671435|58865640|FG005|Overall Study|Withdrawal by Subject|7|||
30840260|NCT02671435|58865641|FG006|Overall Study|Withdrawal by Subject|2|||
30840261|NCT02671435|58865642|FG007|Overall Study|Withdrawal by Subject|7|||
30840262|NCT02671435|58865643|FG008|Overall Study|Withdrawal by Subject|1|||
30840263|NCT02671435|58865644|FG009|Overall Study|Withdrawal by Subject|1|||
30934413|NCT01739595|58970769|FG002|Overall Study|Withdrawal by Subject|2|||
30934414|NCT01739595|58970767|FG000|Overall Study|Eligibility issue|3|||
30934415|NCT01739595|58970768|FG001|Overall Study|Eligibility issue|0|||
30934416|NCT01739595|58970769|FG002|Overall Study|Eligibility issue|0|||
30934417|NCT01739595|58970767|FG000|Overall Study|Protocol Violation|1|||
30934418|NCT01739595|58970768|FG001|Overall Study|Protocol Violation|0|||
30934419|NCT01739595|58970769|FG002|Overall Study|Protocol Violation|0|||
30934420|NCT01739595|58970767|FG000|Overall Study|Lab assessment|1|||
30840264|NCT02671435|58865645|FG010|Overall Study|Withdrawal by Subject|2|||
30840265|NCT02671435|58865646|FG011|Overall Study|Withdrawal by Subject|4|||
30840266|NCT02671435|58865647|FG012|Overall Study|Withdrawal by Subject|4|||
30840267|NCT02671435|58865648|FG013|Overall Study|Withdrawal by Subject|4|||
30934421|NCT01739595|58970768|FG001|Overall Study|Lab assessment|0|||
30934422|NCT01739595|58970769|FG002|Overall Study|Lab assessment|0|||
30934423|NCT01739595|58970767|FG000|Overall Study|Drug discrepancy|1|||
30934424|NCT01739595|58970768|FG001|Overall Study|Drug discrepancy|0|||
30934425|NCT01739595|58970769|FG002|Overall Study|Drug discrepancy|0|||
30934426|NCT01833494|58970776|FG000|Overall Study|Adverse Event|24|||
30934427|NCT01833494|58970776|FG000|Overall Study|Physician Decision|6|||
30840268|NCT02671435|58865649|FG014|Overall Study|Withdrawal by Subject|2|||
30840269|NCT02671435|58865635|FG000|Overall Study|Un-specified|0|||
30840270|NCT02671435|58865636|FG001|Overall Study|Un-specified|0|||
30840271|NCT02671435|58865637|FG002|Overall Study|Un-specified|0|||
30934428|NCT01833494|58970776|FG000|Overall Study|Withdrawal by Subject|6|||
30934429|NCT01833494|58970776|FG000|Overall Study|Decrease in serum phosphorus|4|||
30934430|NCT01833494|58970776|FG000|Overall Study|Decrease in serum calcium|4|||
30934431|NCT01833494|58970776|FG000|Overall Study|Increase in serum ferritin|1|||
30934432|NCT01738971|58970783|FG000|Overall Study|Lost to Follow-up|19|||
30934433|NCT01738971|58970784|FG001|Overall Study|Lost to Follow-up|30|||
30934434|NCT01738971|58970785|FG002|Overall Study|Lost to Follow-up|17|||
30934435|NCT01738581|58970795|FG000|Overall Study|Lost to Follow-up|1|||
30934436|NCT01738581|58970796|FG001|Overall Study|Lost to Follow-up|0|||
30934437|NCT01738503|58970808|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
30934438|NCT01738503|58970809|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
30934439|NCT01738503|58970810|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
30934440|NCT01738503|58970811|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
30934441|NCT01738503|58970812|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
30934442|NCT01738503|58970813|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
30934443|NCT01738503|58970814|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
30758586|NCT03579940|58767313|FG008|Period 2|Withdrawal by Subject|0|||
30758587|NCT03579940|58767314|FG009|Period 2|Withdrawal by Subject|0|||
30840272|NCT02671435|58865638|FG003|Overall Study|Un-specified|0|||
30840273|NCT02671435|58865639|FG004|Overall Study|Un-specified|1|||
30840274|NCT02671435|58865640|FG005|Overall Study|Un-specified|3|||
30840275|NCT02671435|58865641|FG006|Overall Study|Un-specified|2|||
30840276|NCT02671435|58865642|FG007|Overall Study|Un-specified|3|||
30840277|NCT02671435|58865643|FG008|Overall Study|Un-specified|0|||
30840278|NCT02671435|58865644|FG009|Overall Study|Un-specified|5|||
30840279|NCT02671435|58865645|FG010|Overall Study|Un-specified|8|||
30840280|NCT02671435|58865646|FG011|Overall Study|Un-specified|4|||
30840281|NCT02671435|58865647|FG012|Overall Study|Un-specified|5|||
30840282|NCT02671435|58865648|FG013|Overall Study|Un-specified|9|||
30840283|NCT02671435|58865649|FG014|Overall Study|Un-specified|8|||
30840284|NCT02916433|58865704|FG000|Overall Study|Withdrawal by Subject|1|||
30840285|NCT02916433|58865705|FG001|Overall Study|Withdrawal by Subject|0|||
30840286|NCT02916433|58865704|FG000|Overall Study|Physician Decision|1|||
30840287|NCT02916433|58865705|FG001|Overall Study|Physician Decision|0|||
30840288|NCT00526227|58865714|FG000|Overall Study|Device not implanted|1|||
30840289|NCT00526227|58865714|FG000|Overall Study|Death|1|||
30840290|NCT02547922|58865722|FG000|Overall Study|Withdrawal by Subject|9|||
30840291|NCT02547922|58865723|FG001|Overall Study|Withdrawal by Subject|6|||
30840292|NCT02547922|58865724|FG002|Overall Study|Withdrawal by Subject|10|||
30840293|NCT02547922|58865722|FG000|Overall Study|Adverse Event|3|||
30840294|NCT02547922|58865723|FG001|Overall Study|Adverse Event|1|||
30840295|NCT02547922|58865724|FG002|Overall Study|Adverse Event|2|||
30840296|NCT02547922|58865722|FG000|Overall Study|Lost to Follow-up|1|||
30840297|NCT02547922|58865723|FG001|Overall Study|Lost to Follow-up|0|||
30840298|NCT02547922|58865724|FG002|Overall Study|Lost to Follow-up|0|||
30840299|NCT02547922|58865722|FG000|Overall Study|Lack of Efficacy|5|||
30840300|NCT02547922|58865723|FG001|Overall Study|Lack of Efficacy|7|||
30840301|NCT02547922|58865724|FG002|Overall Study|Lack of Efficacy|4|||
30840302|NCT02547922|58865722|FG000|Overall Study|Death|1|||
30840303|NCT02547922|58865723|FG001|Overall Study|Death|0|||
30840304|NCT02547922|58865724|FG002|Overall Study|Death|0|||
30840305|NCT02547922|58865722|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
30840306|NCT02547922|58865723|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
30840307|NCT02547922|58865724|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
30840308|NCT02547922|58865722|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
30840309|NCT02547922|58865723|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
30840310|NCT02547922|58865724|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
30840311|NCT02547922|58865722|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
30840312|NCT02547922|58865723|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
30840313|NCT02547922|58865724|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
30840314|NCT02547922|58865722|FG000|Overall Study|Physician Decision|2|||
30840315|NCT02547922|58865723|FG001|Overall Study|Physician Decision|1|||
30840316|NCT02547922|58865724|FG002|Overall Study|Physician Decision|2|||
30758588|NCT03579940|58767315|FG010|Period 2|Withdrawal by Subject|0|||
30758589|NCT00098306|58767350|FG000|Double Blind|Randomized, not treated|9|||
30758590|NCT00098306|58767351|FG001|Double Blind|Randomized, not treated|5|||
30758591|NCT00098306|58767352|FG002|Double Blind|Randomized, not treated|2|||
30758592|NCT00098306|58767353|FG003|Double Blind|Randomized, not treated|0|||
30758593|NCT00098306|58767354|FG004|Double Blind|Randomized, not treated|0|||
30758594|NCT00098306|58767355|FG005|Double Blind|Randomized, not treated|0|||
30758595|NCT00098306|58767356|FG006|Double Blind|Randomized, not treated|0|||
30758596|NCT00098306|58767350|FG000|Double Blind|Ongoing at cut-off date|151|||
30758597|NCT00098306|58767351|FG001|Double Blind|Ongoing at cut-off date|166|||
30758598|NCT00098306|58767352|FG002|Double Blind|Ongoing at cut-off date|72|||
30758599|NCT00098306|58767353|FG003|Double Blind|Ongoing at cut-off date|0|||
30758600|NCT00098306|58767354|FG004|Double Blind|Ongoing at cut-off date|0|||
30840317|NCT02547922|58865722|FG000|Overall Study|Patients did not receive IP|1|||
30840318|NCT02547922|58865723|FG001|Overall Study|Patients did not receive IP|1|||
30840319|NCT02547922|58865724|FG002|Overall Study|Patients did not receive IP|0|||
30840320|NCT02547766|58865738|FG000|Overall Study|Withdrawal by Subject|1|||
30840321|NCT02742441|58865751|FG000|Overall Study|Lost to Follow-up|4|||
30758601|NCT00098306|58767355|FG005|Double Blind|Ongoing at cut-off date|0|||
30840322|NCT02742441|58865752|FG001|Overall Study|Lost to Follow-up|4|||
30840323|NCT02742441|58865751|FG000|Overall Study|Withdrawal by Subject|2|||
30840324|NCT02742441|58865752|FG001|Overall Study|Withdrawal by Subject|2|||
30624291|NCT00955305|58636282|FG001|Overall Study|Ineligible|7|||
30934444|NCT01738503|58970808|FG000|Treatment Period|Adverse Event|0|||
30934445|NCT01738503|58970809|FG001|Treatment Period|Adverse Event|1|||
30934446|NCT01738503|58970810|FG002|Treatment Period|Adverse Event|0|||
30934447|NCT01738503|58970811|FG003|Treatment Period|Adverse Event|1|||
30934448|NCT01738503|58970812|FG004|Treatment Period|Adverse Event|2|||
30934449|NCT01738503|58970813|FG005|Treatment Period|Adverse Event|2|||
30934450|NCT01738503|58970814|FG006|Treatment Period|Adverse Event|2|||
30934451|NCT01738503|58970808|FG000|Treatment Period|Lost to Follow-up|0|||
30934452|NCT01738503|58970809|FG001|Treatment Period|Lost to Follow-up|0|||
30934453|NCT01738503|58970810|FG002|Treatment Period|Lost to Follow-up|3|||
30934454|NCT01738503|58970811|FG003|Treatment Period|Lost to Follow-up|4|||
30934455|NCT01738503|58970812|FG004|Treatment Period|Lost to Follow-up|1|||
30934456|NCT01738503|58970813|FG005|Treatment Period|Lost to Follow-up|1|||
30934457|NCT01738503|58970814|FG006|Treatment Period|Lost to Follow-up|5|||
30934458|NCT01738503|58970808|FG000|Treatment Period|Withdrawal by Subject|0|||
30934459|NCT01738503|58970809|FG001|Treatment Period|Withdrawal by Subject|1|||
30934460|NCT01738503|58970810|FG002|Treatment Period|Withdrawal by Subject|0|||
30934461|NCT01738503|58970811|FG003|Treatment Period|Withdrawal by Subject|1|||
30934462|NCT01738503|58970812|FG004|Treatment Period|Withdrawal by Subject|1|||
30934463|NCT01738503|58970813|FG005|Treatment Period|Withdrawal by Subject|1|||
30934464|NCT01738503|58970814|FG006|Treatment Period|Withdrawal by Subject|1|||
30934465|NCT01738503|58970808|FG000|Treatment Period|Protocol Violation|0|||
30934466|NCT01738503|58970809|FG001|Treatment Period|Protocol Violation|3|||
30934467|NCT01738503|58970810|FG002|Treatment Period|Protocol Violation|1|||
30934468|NCT01738503|58970811|FG003|Treatment Period|Protocol Violation|0|||
30934469|NCT01738503|58970812|FG004|Treatment Period|Protocol Violation|4|||
30934470|NCT01738503|58970813|FG005|Treatment Period|Protocol Violation|2|||
30934471|NCT01738503|58970814|FG006|Treatment Period|Protocol Violation|0|||
30934472|NCT01738503|58970808|FG000|Treatment Period|Other|0|||
30934473|NCT01738503|58970809|FG001|Treatment Period|Other|0|||
30934474|NCT01738503|58970810|FG002|Treatment Period|Other|1|||
30934475|NCT01738503|58970811|FG003|Treatment Period|Other|0|||
30934476|NCT01738503|58970812|FG004|Treatment Period|Other|0|||
30934477|NCT01738503|58970813|FG005|Treatment Period|Other|0|||
30934478|NCT01738503|58970814|FG006|Treatment Period|Other|0|||
30934479|NCT01738503|58970808|FG000|PET Imaging Sub-study|Adverse Event|0|||
30840325|NCT02742441|58865751|FG000|Overall Study|Adverse Event|0|||
30840326|NCT02742441|58865752|FG001|Overall Study|Adverse Event|2|||
30840327|NCT02547220|58865760|FG000|Overall Study|Withdrawal by Subject|1|||
30840328|NCT02547220|58865761|FG001|Overall Study|Withdrawal by Subject|0|||
30840329|NCT02547220|58865760|FG000|Overall Study|Study terminated by sponsor|18|||
30840330|NCT02547220|58865761|FG001|Overall Study|Study terminated by sponsor|20|||
30934480|NCT01738503|58970809|FG001|PET Imaging Sub-study|Adverse Event|0|||
30934481|NCT01738503|58970810|FG002|PET Imaging Sub-study|Adverse Event|0|||
30934482|NCT01738503|58970811|FG003|PET Imaging Sub-study|Adverse Event|0|||
30934483|NCT01738503|58970812|FG004|PET Imaging Sub-study|Adverse Event|0|||
30934484|NCT01738503|58970813|FG005|PET Imaging Sub-study|Adverse Event|1|||
30934485|NCT01738503|58970814|FG006|PET Imaging Sub-study|Adverse Event|0|||
30934486|NCT01738503|58970808|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
30934487|NCT01738503|58970809|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
30934488|NCT01738503|58970810|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
30934489|NCT01738503|58970811|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
30934490|NCT01738503|58970812|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
30934491|NCT01738503|58970813|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
30934492|NCT01738503|58970814|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
30934493|NCT01738191|58970838|FG000|Overall Study|Withdrawal by Subject|4|||
30934494|NCT01738191|58970839|FG001|Overall Study|Withdrawal by Subject|1|||
30934495|NCT01737879|58970845|FG000|Overall Study|Death|1|||
30934496|NCT01737879|58970845|FG000|Overall Study|Sponsor decision|40|||
30934497|NCT01879683|58970849|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
30934498|NCT01605825|58970855|FG000|Overall Study|Adverse Event|4|||
30934499|NCT01605825|58970856|FG001|Overall Study|Adverse Event|2|||
30840331|NCT02542072|58865769|FG000|First Intervention (1 Month)|Adverse Event|1|||
30934500|NCT01605825|58970855|FG000|Overall Study|Withdrawal by Subject|0|||
30840332|NCT02542072|58865770|FG001|First Intervention (1 Month)|Adverse Event|1|||
30934501|NCT01605825|58970856|FG001|Overall Study|Withdrawal by Subject|1|||
30934502|NCT01605825|58970855|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
30934503|NCT01605825|58970856|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
30934504|NCT01605825|58970855|FG000|Overall Study|Non-Compliance with Protocol|3|||
30934505|NCT01605825|58970856|FG001|Overall Study|Non-Compliance with Protocol|0|||
30934506|NCT01727505|58970862|FG000|First 24 Hours|Adverse Event|0|||
30934507|NCT01727505|58970863|FG001|First 24 Hours|Adverse Event|1|||
30934508|NCT01727505|58970862|FG000|Second 24 Hours|Missing data|0|||
30934509|NCT01727505|58970863|FG001|Second 24 Hours|Missing data|1|||
30934510|NCT01726803|58970871|FG000|Overall Study|Lost to Follow-up|6|||
30934511|NCT01726803|58970872|FG001|Overall Study|Lost to Follow-up|1|||
30934512|NCT01726803|58970871|FG000|Overall Study|Withdrawal by Subject|1|||
30934513|NCT01726803|58970872|FG001|Overall Study|Withdrawal by Subject|0|||
30934514|NCT01726335|58970878|FG000|Overall Study|Lost to Follow-up|2|||
30934515|NCT01726335|58970878|FG000|Overall Study|Withdrawal by Subject|15|||
30934516|NCT01726335|58970878|FG000|Overall Study|Adverse Event|4|||
30934517|NCT01726335|58970878|FG000|Overall Study|Lost to Follow-up|2|||
30934518|NCT01726335|58970878|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
30934519|NCT01877421|58970914|FG000|Phase 2|Lost to Follow-up|0|||
30840333|NCT02542072|58865769|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
30934520|NCT01877421|58970915|FG001|Phase 2|Lost to Follow-up|0|||
30934521|NCT01877421|58970916|FG002|Phase 2|Lost to Follow-up|0|||
30934522|NCT01877421|58970917|FG003|Phase 2|Lost to Follow-up|0|||
30934523|NCT01877421|58970918|FG004|Phase 2|Lost to Follow-up|0|||
30934524|NCT01877421|58970919|FG005|Phase 2|Lost to Follow-up|0|||
30934525|NCT01877421|58970920|FG006|Phase 2|Lost to Follow-up|1|||
30934526|NCT01877421|58970921|FG007|Phase 2|Lost to Follow-up|0|||
30934527|NCT01877421|58970922|FG008|Phase 2|Lost to Follow-up|0|||
30934528|NCT01877421|58970923|FG009|Phase 2|Lost to Follow-up|0|||
30934529|NCT01877421|58970924|FG010|Phase 2|Lost to Follow-up|0|||
30934530|NCT01877421|58970925|FG011|Phase 2|Lost to Follow-up|0|||
30934531|NCT01877421|58970926|FG012|Phase 2|Lost to Follow-up|0|||
30934532|NCT01877421|58970927|FG013|Phase 2|Lost to Follow-up|0|||
30934533|NCT01877421|58970928|FG014|Phase 2|Lost to Follow-up|0|||
30934534|NCT01877421|58970929|FG015|Phase 2|Lost to Follow-up|0|||
30934535|NCT01877421|58970930|FG016|Phase 2|Lost to Follow-up|0|||
30934536|NCT01877421|58970931|FG017|Phase 2|Lost to Follow-up|0|||
30934537|NCT01877421|58970914|FG000|Phase 2|Withdrawal by Subject|0|||
30934538|NCT01877421|58970915|FG001|Phase 2|Withdrawal by Subject|0|||
30934539|NCT01877421|58970916|FG002|Phase 2|Withdrawal by Subject|0|||
30934540|NCT01877421|58970917|FG003|Phase 2|Withdrawal by Subject|0|||
30934541|NCT01877421|58970918|FG004|Phase 2|Withdrawal by Subject|0|||
30934542|NCT01877421|58970919|FG005|Phase 2|Withdrawal by Subject|0|||
30934543|NCT01877421|58970920|FG006|Phase 2|Withdrawal by Subject|0|||
30934544|NCT01877421|58970921|FG007|Phase 2|Withdrawal by Subject|0|||
30934545|NCT01877421|58970922|FG008|Phase 2|Withdrawal by Subject|1|||
30934546|NCT01877421|58970923|FG009|Phase 2|Withdrawal by Subject|0|||
30934547|NCT01877421|58970924|FG010|Phase 2|Withdrawal by Subject|1|||
30934548|NCT01877421|58970925|FG011|Phase 2|Withdrawal by Subject|0|||
30934549|NCT01877421|58970926|FG012|Phase 2|Withdrawal by Subject|1|||
30934550|NCT01877421|58970927|FG013|Phase 2|Withdrawal by Subject|0|||
30934551|NCT01877421|58970928|FG014|Phase 2|Withdrawal by Subject|0|||
30934552|NCT01877421|58970929|FG015|Phase 2|Withdrawal by Subject|1|||
30934553|NCT01877421|58970930|FG016|Phase 2|Withdrawal by Subject|0|||
30934554|NCT01877421|58970931|FG017|Phase 2|Withdrawal by Subject|0|||
30934555|NCT01877421|58970914|FG000|Phase 2|Protocol Violation|0|||
30934556|NCT01877421|58970915|FG001|Phase 2|Protocol Violation|0|||
30934557|NCT01877421|58970916|FG002|Phase 2|Protocol Violation|0|||
30934558|NCT01877421|58970917|FG003|Phase 2|Protocol Violation|0|||
30624292|NCT00598585|58636290|FG000|Overall Study|Lost to Follow-up|1|||
30624293|NCT00598585|58636291|FG001|Overall Study|Lost to Follow-up|0|||
30624294|NCT00953667|58636297|FG000|Overall Study|Lost to Follow-up|11|||
30624295|NCT00953667|58636297|FG000|Overall Study|Physician Decision|35|||
30758602|NCT00098306|58767356|FG006|Double Blind|Ongoing at cut-off date|0|||
30758603|NCT00098306|58767350|FG000|Double Blind|Adverse Event|11|||
30758604|NCT00098306|58767351|FG001|Double Blind|Adverse Event|10|||
30758605|NCT00098306|58767352|FG002|Double Blind|Adverse Event|6|||
30758606|NCT00098306|58767353|FG003|Double Blind|Adverse Event|0|||
30758607|NCT00098306|58767354|FG004|Double Blind|Adverse Event|0|||
30758608|NCT00098306|58767355|FG005|Double Blind|Adverse Event|0|||
30758609|NCT00098306|58767356|FG006|Double Blind|Adverse Event|0|||
30758610|NCT00098306|58767350|FG000|Double Blind|Lack of Efficacy|43|||
30758611|NCT00098306|58767351|FG001|Double Blind|Lack of Efficacy|34|||
30758612|NCT00098306|58767352|FG002|Double Blind|Lack of Efficacy|17|||
30934559|NCT01877421|58970918|FG004|Phase 2|Protocol Violation|0|||
30758613|NCT00098306|58767353|FG003|Double Blind|Lack of Efficacy|0|||
30758614|NCT00098306|58767354|FG004|Double Blind|Lack of Efficacy|0|||
30934560|NCT01877421|58970919|FG005|Phase 2|Protocol Violation|0|||
30624296|NCT00953667|58636297|FG000|Overall Study|Withdrawal by Subject|63|||
30934561|NCT01877421|58970920|FG006|Phase 2|Protocol Violation|0|||
30934562|NCT01877421|58970921|FG007|Phase 2|Protocol Violation|0|||
30934563|NCT01877421|58970922|FG008|Phase 2|Protocol Violation|0|||
30934564|NCT01877421|58970923|FG009|Phase 2|Protocol Violation|0|||
30934565|NCT01877421|58970924|FG010|Phase 2|Protocol Violation|1|||
30934566|NCT01877421|58970925|FG011|Phase 2|Protocol Violation|0|||
30934567|NCT01877421|58970926|FG012|Phase 2|Protocol Violation|0|||
30934568|NCT01877421|58970927|FG013|Phase 2|Protocol Violation|0|||
30934569|NCT01877421|58970928|FG014|Phase 2|Protocol Violation|0|||
30934570|NCT01877421|58970929|FG015|Phase 2|Protocol Violation|0|||
30934571|NCT01877421|58970930|FG016|Phase 2|Protocol Violation|0|||
30934572|NCT01877421|58970931|FG017|Phase 2|Protocol Violation|0|||
30934573|NCT01726023|58971013|FG000|Overall Study|Death|1|||
30758615|NCT00098306|58767355|FG005|Double Blind|Lack of Efficacy|0|||
30934574|NCT01726023|58971014|FG001|Overall Study|Death|1|||
30934575|NCT01726023|58971013|FG000|Overall Study|Lost to Follow-up|5|||
30934576|NCT01726023|58971014|FG001|Overall Study|Lost to Follow-up|10|||
30934577|NCT01726023|58971013|FG000|Overall Study|Other Eligibility criteria|7|||
30934578|NCT01726023|58971014|FG001|Overall Study|Other Eligibility criteria|7|||
30934579|NCT01726023|58971013|FG000|Overall Study|Withdrawal by Subject|16|||
30934580|NCT01726023|58971014|FG001|Overall Study|Withdrawal by Subject|8|||
30934581|NCT01877265|58971027|FG000|Treatment Period 1|Sponsor Decision|0|||
30934582|NCT01877265|58971028|FG001|Treatment Period 1|Sponsor Decision|0|||
30934583|NCT01877265|58971029|FG002|Treatment Period 1|Sponsor Decision|1|||
30934584|NCT01877265|58971030|FG003|Treatment Period 1|Sponsor Decision|0|||
30934585|NCT01877265|58971031|FG004|Treatment Period 1|Sponsor Decision|0|||
30934586|NCT01877265|58971032|FG005|Treatment Period 1|Sponsor Decision|0|||
30934587|NCT01877265|58971027|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
30934588|NCT01877265|58971028|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
30934589|NCT01877265|58971029|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
30934590|NCT01877265|58971030|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
30840334|NCT02542072|58865770|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
30934591|NCT01877265|58971031|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
30934592|NCT01877265|58971032|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
30934593|NCT01877265|58971027|FG000|Treatment Period 3|Lost to Follow-up|1|||
30934594|NCT01877265|58971028|FG001|Treatment Period 3|Lost to Follow-up|0|||
30934595|NCT01877265|58971029|FG002|Treatment Period 3|Lost to Follow-up|0|||
30934596|NCT01877265|58971030|FG003|Treatment Period 3|Lost to Follow-up|0|||
30934597|NCT01877265|58971031|FG004|Treatment Period 3|Lost to Follow-up|0|||
30934598|NCT01877265|58971032|FG005|Treatment Period 3|Lost to Follow-up|0|||
30934599|NCT01877187|58971043|FG000|Overall Study|Death|2|||
30934600|NCT01877187|58971043|FG000|Overall Study|Withdrawal by Subject|4|||
30934601|NCT01877187|58971043|FG000|Overall Study|Lost to Follow-up|3|||
30934602|NCT01877187|58971043|FG000|Overall Study|Declining clinical status|11|||
30934603|NCT01877187|58971043|FG000|Overall Study|Liver transplant|2|||
30934604|NCT01858532|58971054|FG000|Overall Study|Adverse Event|58|||
30934605|NCT01858532|58971055|FG001|Overall Study|Adverse Event|50|||
30934606|NCT01858532|58971056|FG002|Overall Study|Adverse Event|23|||
30934607|NCT01858532|58971057|FG003|Overall Study|Adverse Event|28|||
30934608|NCT01858532|58971054|FG000|Overall Study|Withdrew consent|71|||
30934609|NCT01858532|58971055|FG001|Overall Study|Withdrew consent|93|||
30934610|NCT01858532|58971056|FG002|Overall Study|Withdrew consent|46|||
30934611|NCT01858532|58971057|FG003|Overall Study|Withdrew consent|27|||
30934612|NCT01858532|58971054|FG000|Overall Study|Lost to Follow-up|17|||
30934613|NCT01858532|58971055|FG001|Overall Study|Lost to Follow-up|26|||
30934614|NCT01858532|58971056|FG002|Overall Study|Lost to Follow-up|11|||
30934615|NCT01858532|58971057|FG003|Overall Study|Lost to Follow-up|14|||
30934616|NCT01858532|58971054|FG000|Overall Study|Deterioration of medical status|3|||
30934617|NCT01858532|58971055|FG001|Overall Study|Deterioration of medical status|4|||
30934618|NCT01858532|58971056|FG002|Overall Study|Deterioration of medical status|3|||
30934619|NCT01858532|58971057|FG003|Overall Study|Deterioration of medical status|7|||
30934620|NCT01858532|58971054|FG000|Overall Study|Investigator request|3|||
30934621|NCT01858532|58971055|FG001|Overall Study|Investigator request|4|||
30934622|NCT01858532|58971056|FG002|Overall Study|Investigator request|2|||
30934623|NCT01858532|58971057|FG003|Overall Study|Investigator request|6|||
30934624|NCT01858532|58971054|FG000|Overall Study|Other, not specified|29|||
30934625|NCT01858532|58971055|FG001|Overall Study|Other, not specified|15|||
30934626|NCT01858532|58971056|FG002|Overall Study|Other, not specified|13|||
30934627|NCT01858532|58971057|FG003|Overall Study|Other, not specified|11|||
30934628|NCT01883492|58971069|FG000|Overall Study|Lost to Follow-up|3|||
30934629|NCT01883492|58971070|FG001|Overall Study|Lost to Follow-up|4|||
30758616|NCT00098306|58767356|FG006|Double Blind|Lack of Efficacy|0|||
30758617|NCT00098306|58767350|FG000|Double Blind|Death|1|||
30758618|NCT00098306|58767351|FG001|Double Blind|Death|4|||
30758619|NCT00098306|58767352|FG002|Double Blind|Death|1|||
30758620|NCT00098306|58767353|FG003|Double Blind|Death|0|||
30758621|NCT00098306|58767354|FG004|Double Blind|Death|0|||
30758622|NCT00098306|58767355|FG005|Double Blind|Death|0|||
30758623|NCT00098306|58767356|FG006|Double Blind|Death|0|||
30758624|NCT00098306|58767350|FG000|Double Blind|Participant defaulted|19|||
30934630|NCT01883492|58971069|FG000|Overall Study|Surgery on contra-lateral hip|0|||
30934631|NCT01883492|58971070|FG001|Overall Study|Surgery on contra-lateral hip|1|||
30934632|NCT01883492|58971069|FG000|Overall Study|Poor X-ray quality|7|||
30934633|NCT01883492|58971070|FG001|Overall Study|Poor X-ray quality|4|||
30934634|NCT01883492|58971069|FG000|Overall Study|Withdrawal by Subject|1|||
30934635|NCT01883492|58971070|FG001|Overall Study|Withdrawal by Subject|0|||
30934636|NCT01883492|58971069|FG000|Overall Study|inappropriate implant used|1|||
30934637|NCT01883492|58971070|FG001|Overall Study|inappropriate implant used|1|||
30934638|NCT01883492|58971069|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
30934639|NCT01883492|58971070|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
30934640|NCT01832480|58971078|FG000|Overall Study|Lost to Follow-up|33|||
30934641|NCT01832480|58971079|FG001|Overall Study|Lost to Follow-up|30|||
30934642|NCT01832480|58971078|FG000|Overall Study|Withdrawal by Subject|0|||
30934643|NCT01832480|58971079|FG001|Overall Study|Withdrawal by Subject|2|||
30934644|NCT01832480|58971078|FG000|Overall Study|post randomization ineligible|8|||
30934645|NCT01832480|58971079|FG001|Overall Study|post randomization ineligible|10|||
30934646|NCT01858376|58971085|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
30934647|NCT01831856|58971091|FG000|Overall Study|Adverse Event|5|||
30934648|NCT01831856|58971092|FG001|Overall Study|Adverse Event|8|||
30934649|NCT01831856|58971091|FG000|Overall Study|Lack of Efficacy|13|||
30934650|NCT01831856|58971092|FG001|Overall Study|Lack of Efficacy|11|||
30934651|NCT01831856|58971091|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
30934652|NCT01831856|58971092|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
30934653|NCT01831544|58971098|FG000|Overall Study|Death|1|||
30934654|NCT01831544|58971098|FG000|Overall Study|Still on original MVAD device|2|||
30934655|NCT01857206|58971104|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
30934656|NCT01857206|58971105|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
30934657|NCT01857206|58971104|FG000|Overall Study|Lost to Follow-up|9|||
30934658|NCT01857206|58971105|FG001|Overall Study|Lost to Follow-up|6|||
30934659|NCT01857206|58971104|FG000|Overall Study|Unclassified|3|||
30934660|NCT01857206|58971105|FG001|Overall Study|Unclassified|3|||
30934661|NCT01857206|58971104|FG000|Overall Study|Withdrawal by Subject|1|||
30934662|NCT01857206|58971105|FG001|Overall Study|Withdrawal by Subject|0|||
30934663|NCT01882088|58971115|FG000|Overall Study|Intolerance of esophageal manometry|1|||
30934664|NCT01882088|58971115|FG000|Overall Study|no possibility to place the catheter|1|||
30934665|NCT01882088|58971115|FG000|Overall Study|Protocol Violation|1|||
30934666|NCT01882088|58971115|FG000|Overall Study|inadequate pH-impedance tracings|2|||
30934667|NCT01881776|58971122|FG000|Overall Study|Lost to Follow-up|1|||
30934668|NCT01881776|58971123|FG001|Overall Study|Lost to Follow-up|2|||
30934669|NCT01881776|58971124|FG002|Overall Study|Lost to Follow-up|1|||
30934670|NCT01881776|58971122|FG000|Overall Study|Protocol Violation|0|||
30934671|NCT01881776|58971123|FG001|Overall Study|Protocol Violation|2|||
30934672|NCT01881776|58971124|FG002|Overall Study|Protocol Violation|1|||
30934673|NCT01708161|58971138|FG000|Overall Study|Adverse Event|1|||
30934674|NCT01708161|58971139|FG001|Overall Study|Adverse Event|3|||
30934675|NCT01708161|58971140|FG002|Overall Study|Adverse Event|4|||
30934676|NCT01708161|58971141|FG003|Overall Study|Adverse Event|2|||
30934677|NCT01708161|58971142|FG004|Overall Study|Adverse Event|3|||
30934678|NCT01708161|58971143|FG005|Overall Study|Adverse Event|0|||
30934679|NCT01708161|58971138|FG000|Overall Study|Death|0|||
30934680|NCT01708161|58971139|FG001|Overall Study|Death|0|||
30934681|NCT01708161|58971140|FG002|Overall Study|Death|0|||
30934682|NCT01708161|58971141|FG003|Overall Study|Death|1|||
30934683|NCT01708161|58971142|FG004|Overall Study|Death|0|||
30758625|NCT00098306|58767351|FG001|Double Blind|Participant defaulted|18|||
30758626|NCT00098306|58767352|FG002|Double Blind|Participant defaulted|11|||
30758627|NCT00098306|58767353|FG003|Double Blind|Participant defaulted|0|||
30758628|NCT00098306|58767354|FG004|Double Blind|Participant defaulted|0|||
30758629|NCT00098306|58767355|FG005|Double Blind|Participant defaulted|0|||
30758630|NCT00098306|58767356|FG006|Double Blind|Participant defaulted|0|||
30758631|NCT00098306|58767350|FG000|Double Blind|Un-specified|7|||
30758632|NCT00098306|58767351|FG001|Double Blind|Un-specified|3|||
30758633|NCT00098306|58767352|FG002|Double Blind|Un-specified|11|||
30758634|NCT00098306|58767353|FG003|Double Blind|Un-specified|0|||
30758635|NCT00098306|58767354|FG004|Double Blind|Un-specified|0|||
30758636|NCT00098306|58767355|FG005|Double Blind|Un-specified|0|||
30758637|NCT00098306|58767356|FG006|Double Blind|Un-specified|0|||
30758638|NCT00098306|58767350|FG000|Open Label|Lack of Efficacy|0|||
30758639|NCT00098306|58767351|FG001|Open Label|Lack of Efficacy|0|||
30758640|NCT00098306|58767352|FG002|Open Label|Lack of Efficacy|0|||
30758641|NCT00098306|58767353|FG003|Open Label|Lack of Efficacy|13|||
30934684|NCT01708161|58971143|FG005|Overall Study|Death|1|||
30934685|NCT01708161|58971138|FG000|Overall Study|Withdrawal by Subject|0|||
30934686|NCT01708161|58971139|FG001|Overall Study|Withdrawal by Subject|1|||
30934687|NCT01708161|58971140|FG002|Overall Study|Withdrawal by Subject|1|||
30934688|NCT01708161|58971141|FG003|Overall Study|Withdrawal by Subject|0|||
30934689|NCT01708161|58971142|FG004|Overall Study|Withdrawal by Subject|0|||
30934690|NCT01708161|58971143|FG005|Overall Study|Withdrawal by Subject|0|||
30934691|NCT01708161|58971138|FG000|Overall Study|Administrative problems|0|||
30934692|NCT01708161|58971139|FG001|Overall Study|Administrative problems|1|||
30934693|NCT01708161|58971140|FG002|Overall Study|Administrative problems|0|||
30934694|NCT01708161|58971141|FG003|Overall Study|Administrative problems|0|||
30934695|NCT01708161|58971142|FG004|Overall Study|Administrative problems|0|||
30934696|NCT01708161|58971143|FG005|Overall Study|Administrative problems|0|||
30934697|NCT01708161|58971138|FG000|Overall Study|Disease progression|3|||
30934698|NCT01708161|58971139|FG001|Overall Study|Disease progression|5|||
30934699|NCT01708161|58971140|FG002|Overall Study|Disease progression|5|||
30934700|NCT01708161|58971141|FG003|Overall Study|Disease progression|13|||
30934701|NCT01708161|58971142|FG004|Overall Study|Disease progression|3|||
30934702|NCT01708161|58971143|FG005|Overall Study|Disease progression|0|||
30934703|NCT01707693|58971159|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
30934704|NCT01707693|58971160|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
30934705|NCT01707693|58971159|FG000|Overall Study Allocation|Protocol Violation|4|||
30934706|NCT01707693|58971160|FG001|Overall Study Allocation|Protocol Violation|3|||
30934707|NCT01707693|58971159|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
30934708|NCT01707693|58971160|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
30934709|NCT01707693|58971159|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
30934710|NCT01707693|58971160|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
30934711|NCT01722669|58971173|FG000|Overall Study|Withdrawal by Subject|0|||
30934712|NCT01722669|58971174|FG001|Overall Study|Withdrawal by Subject|0|||
30934713|NCT01722669|58971175|FG002|Overall Study|Withdrawal by Subject|0|||
30934714|NCT01722669|58971176|FG003|Overall Study|Withdrawal by Subject|0|||
30934715|NCT01722669|58971177|FG004|Overall Study|Withdrawal by Subject|0|||
30934716|NCT01722669|58971178|FG005|Overall Study|Withdrawal by Subject|2|||
30934717|NCT01707147|58971198|FG000|Overall Study|Administered Trajenta prior to contract|5|||
30934718|NCT01707147|58971198|FG000|Overall Study|Patients who have not taken Trajenta|1|||
30934719|NCT01707147|58971198|FG000|Overall Study|Follow-up failure|17|||
30934720|NCT01707147|58971198|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
30934721|NCT01876251|58971205|FG000|Overall Study|Clinical progression|1|||
30934722|NCT01876251|58971206|FG001|Overall Study|Clinical progression|0|||
30934723|NCT01876251|58971207|FG002|Overall Study|Clinical progression|0|||
30934724|NCT01876251|58971205|FG000|Overall Study|Death|2|||
30934725|NCT01876251|58971206|FG001|Overall Study|Death|0|||
30934726|NCT01876251|58971207|FG002|Overall Study|Death|1|||
30934727|NCT01876251|58971205|FG000|Overall Study|Participant started new treatment|1|||
30934728|NCT01876251|58971206|FG001|Overall Study|Participant started new treatment|0|||
30934729|NCT01876251|58971207|FG002|Overall Study|Participant started new treatment|1|||
30934730|NCT01876251|58971205|FG000|Overall Study|Participant refused further follow-up|0|||
30934731|NCT01876251|58971206|FG001|Overall Study|Participant refused further follow-up|0|||
30934732|NCT01876251|58971207|FG002|Overall Study|Participant refused further follow-up|1|||
30934733|NCT01876251|58971205|FG000|Overall Study|Study terminated|1|||
30934734|NCT01876251|58971206|FG001|Overall Study|Study terminated|0|||
30934735|NCT01876251|58971207|FG002|Overall Study|Study terminated|0|||
30934736|NCT01876251|58971205|FG000|Overall Study|Objective progression or relapse|10|||
30934737|NCT01876251|58971206|FG001|Overall Study|Objective progression or relapse|3|||
30934738|NCT01876251|58971207|FG002|Overall Study|Objective progression or relapse|8|||
30934739|NCT01875471|58971218|FG000|Overall Study|Adverse Event|0|||
30934740|NCT01875471|58971219|FG001|Overall Study|Adverse Event|1|||
30934741|NCT01875471|58971218|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
30934742|NCT01875471|58971219|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
30934743|NCT01875237|58971227|FG000|Overall Study|GVDH before DLI|1|||
30934744|NCT01875237|58971228|FG001|Overall Study|GVDH before DLI|0|||
30934745|NCT01875237|58971227|FG000|Overall Study|DLI cells could not be produced|1|||
30934746|NCT01875237|58971228|FG001|Overall Study|DLI cells could not be produced|0|||
30840335|NCT02542072|58865769|FG000|First Intervention (1 Month)|Lens discomfort|1|||
30840336|NCT02542072|58865770|FG001|First Intervention (1 Month)|Lens discomfort|2|||
30840337|NCT02542072|58865769|FG000|First Intervention (1 Month)|Protocol Violation|1|||
30840338|NCT02542072|58865770|FG001|First Intervention (1 Month)|Protocol Violation|0|||
30840339|NCT02542072|58865769|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
30840340|NCT02542072|58865770|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
30840341|NCT02542072|58865769|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
30840342|NCT02542072|58865770|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
30840343|NCT02547454|58865796|FG000|Overall Study|Due to hemodialysis|53|||
30840344|NCT02547454|58865796|FG000|Overall Study|Due to transplantation|1|||
30840345|NCT02547454|58865796|FG000|Overall Study|Due to no further need to treat|4|||
30840346|NCT02547454|58865796|FG000|Overall Study|Death|38|||
30840347|NCT02547454|58865796|FG000|Overall Study|Lost to Follow-up|26|||
30840348|NCT02547454|58865796|FG000|Overall Study|Other|39|||
30840349|NCT02547454|58865796|FG000|Overall Study|No data|11|||
30840350|NCT00415623|58865827|FG000|Overall Study|Adverse Event|3|||
30840351|NCT00415623|58865828|FG001|Overall Study|Adverse Event|4|||
30624297|NCT00953667|58636297|FG000|Overall Study|Adverse Event|10|||
30934747|NCT01874535|58971238|FG000|Overall Study|Lost to Follow-up|10|||
30934748|NCT01874535|58971239|FG001|Overall Study|Lost to Follow-up|9|||
30934749|NCT01874535|58971238|FG000|Overall Study|incomplete symptom resolution|45|||
30934750|NCT01874535|58971239|FG001|Overall Study|incomplete symptom resolution|35|||
30934751|NCT01722045|58971245|FG000|Overall Study|Adverse Event|8|||
30934752|NCT01722045|58971245|FG000|Overall Study|Death|3|||
30934753|NCT01722045|58971245|FG000|Overall Study|Withdrawal by Subject|8|||
30934754|NCT01722045|58971245|FG000|Overall Study|Lost to Follow-up|4|||
30934755|NCT01722045|58971245|FG000|Overall Study|Protocol Deviation|1|||
30934756|NCT01722045|58971245|FG000|Overall Study|Physician Decision|3|||
30934757|NCT01722045|58971245|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
30934758|NCT01721109|58971249|FG000|Overall Study|Lack of Efficacy|1|||
30934759|NCT01721109|58971249|FG000|Overall Study|Non- Compliance with Study Drug|3|||
30934760|NCT01721109|58971249|FG000|Overall Study|Withdrew Consent|1|||
30934761|NCT01721109|58971249|FG000|Overall Study|Lost to Follow-up|2|||
30934762|NCT01874145|58971255|FG000|Core Period|Non-compliance|1|||
30934763|NCT01874145|58971256|FG001|Core Period|Non-compliance|0|||
30934764|NCT01874145|58971255|FG000|Core Period|Protocol Violation|1|||
30934765|NCT01874145|58971256|FG001|Core Period|Protocol Violation|1|||
30934766|NCT01874145|58971255|FG000|Core Period|Physician Decision|1|||
30934767|NCT01874145|58971256|FG001|Core Period|Physician Decision|1|||
30934768|NCT01874145|58971255|FG000|Core Period|Adverse Event|0|||
30934769|NCT01874145|58971256|FG001|Core Period|Adverse Event|1|||
30934770|NCT01874145|58971255|FG000|Core Period|Withdrawal by Subject|0|||
30840352|NCT00415623|58865827|FG000|Overall Study|Death|1|||
30840353|NCT00415623|58865828|FG001|Overall Study|Death|0|||
30840354|NCT00415623|58865827|FG000|Overall Study|Withdrawal by Subject|1|||
30840355|NCT00415623|58865828|FG001|Overall Study|Withdrawal by Subject|1|||
30840356|NCT01969409|58865837|FG000|Overall Study|Death|2|||
30840357|NCT01969409|58865838|FG001|Overall Study|Death|2|||
30840358|NCT01969409|58865837|FG000|Overall Study|Transplant|1|||
30840359|NCT01969409|58865838|FG001|Overall Study|Transplant|1|||
30840360|NCT01969409|58865837|FG000|Overall Study|Withdrawal by Subject|0|||
30840361|NCT01969409|58865838|FG001|Overall Study|Withdrawal by Subject|1|||
30840362|NCT00150813|58865844|FG000|Overall Study|Adverse Event|1|||
30840363|NCT00150813|58865844|FG000|Overall Study|Lack of Efficacy|1|||
30840364|NCT00150813|58865844|FG000|Overall Study|Lost to Follow-up|5|||
30840365|NCT00150813|58865844|FG000|Overall Study|Withdrawal by Subject|5|||
30840366|NCT00150813|58865844|FG000|Overall Study|Remission|3|||
30840367|NCT00150813|58865844|FG000|Overall Study|Planned pregancy|1|||
30840368|NCT00150813|58865844|FG000|Overall Study|Switch to commercially available LEV|2|||
30934771|NCT01874145|58971256|FG001|Core Period|Withdrawal by Subject|4|||
30934772|NCT01874145|58971255|FG000|Extension Period|Adverse Event|3|||
30934773|NCT01874145|58971256|FG001|Extension Period|Adverse Event|2|||
30934774|NCT01874145|58971255|FG000|Extension Period|Withdrawal by Subject|2|||
30934775|NCT01874145|58971256|FG001|Extension Period|Withdrawal by Subject|1|||
30934776|NCT01874145|58971255|FG000|Extension Period|Lost to Follow-up|1|||
30934777|NCT01874145|58971256|FG001|Extension Period|Lost to Follow-up|1|||
30934778|NCT01720797|58971268|FG000|Overall Study|Withdrawal by Subject|3|||
30934779|NCT01720797|58971269|FG001|Overall Study|Withdrawal by Subject|0|||
30934780|NCT01831466|58971287|FG000|Overall Study|Protocol Violation|1|||
30934781|NCT01831466|58971288|FG001|Overall Study|Protocol Violation|1|||
30934782|NCT01831466|58971289|FG002|Overall Study|Protocol Violation|2|||
30934783|NCT01831466|58971290|FG003|Overall Study|Protocol Violation|0|||
30934784|NCT01831466|58971291|FG004|Overall Study|Protocol Violation|0|||
30934785|NCT01831466|58971292|FG005|Overall Study|Protocol Violation|1|||
30934786|NCT01831466|58971293|FG006|Overall Study|Protocol Violation|0|||
30934787|NCT01831466|58971294|FG007|Overall Study|Protocol Violation|0|||
30934788|NCT01831466|58971295|FG008|Overall Study|Protocol Violation|0|||
30934789|NCT01831466|58971296|FG009|Overall Study|Protocol Violation|0|||
30934790|NCT01831466|58971297|FG010|Overall Study|Protocol Violation|0|||
30934791|NCT01831466|58971298|FG011|Overall Study|Protocol Violation|0|||
30934792|NCT01831466|58971287|FG000|Overall Study|Other|2|||
30934793|NCT01831466|58971288|FG001|Overall Study|Other|3|||
30934794|NCT01831466|58971289|FG002|Overall Study|Other|2|||
30934795|NCT01831466|58971290|FG003|Overall Study|Other|2|||
30934796|NCT01831466|58971291|FG004|Overall Study|Other|2|||
30934797|NCT01831466|58971292|FG005|Overall Study|Other|1|||
30934798|NCT01831466|58971293|FG006|Overall Study|Other|0|||
30934799|NCT01831466|58971294|FG007|Overall Study|Other|0|||
30624298|NCT00953667|58636297|FG000|Overall Study|poor venous access,unable to draw blood|4|||
30934800|NCT01831466|58971295|FG008|Overall Study|Other|0|||
30934801|NCT01831466|58971296|FG009|Overall Study|Other|0|||
30934802|NCT01831466|58971297|FG010|Overall Study|Other|0|||
30934803|NCT01831466|58971298|FG011|Overall Study|Other|0|||
30934804|NCT01831466|58971287|FG000|Overall Study|Non-compliance with study treatment|2|||
30934805|NCT01831466|58971288|FG001|Overall Study|Non-compliance with study treatment|1|||
30934806|NCT01831466|58971289|FG002|Overall Study|Non-compliance with study treatment|1|||
30840369|NCT02712788|58865850|FG000|Overall Study|Physician Decision|1|||
30840370|NCT02712788|58865851|FG001|Overall Study|Physician Decision|0|||
30840371|NCT02712788|58865850|FG000|Overall Study|Protocol Violation|1|||
30934807|NCT01831466|58971290|FG003|Overall Study|Non-compliance with study treatment|0|||
30934808|NCT01831466|58971291|FG004|Overall Study|Non-compliance with study treatment|0|||
30934809|NCT01831466|58971292|FG005|Overall Study|Non-compliance with study treatment|1|||
30934810|NCT01831466|58971293|FG006|Overall Study|Non-compliance with study treatment|0|||
30934811|NCT01831466|58971294|FG007|Overall Study|Non-compliance with study treatment|0|||
30934812|NCT01831466|58971295|FG008|Overall Study|Non-compliance with study treatment|0|||
30934813|NCT01831466|58971296|FG009|Overall Study|Non-compliance with study treatment|0|||
30934814|NCT01831466|58971297|FG010|Overall Study|Non-compliance with study treatment|0|||
30934815|NCT01831466|58971298|FG011|Overall Study|Non-compliance with study treatment|0|||
30934816|NCT01831466|58971287|FG000|Overall Study|Death|0|||
30934817|NCT01831466|58971288|FG001|Overall Study|Death|1|||
30934818|NCT01831466|58971289|FG002|Overall Study|Death|0|||
30934819|NCT01831466|58971290|FG003|Overall Study|Death|0|||
30934820|NCT01831466|58971291|FG004|Overall Study|Death|0|||
30934821|NCT01831466|58971292|FG005|Overall Study|Death|0|||
30934822|NCT01831466|58971293|FG006|Overall Study|Death|0|||
30934823|NCT01831466|58971294|FG007|Overall Study|Death|0|||
30934824|NCT01831466|58971295|FG008|Overall Study|Death|0|||
30934825|NCT01831466|58971296|FG009|Overall Study|Death|0|||
30934826|NCT01831466|58971297|FG010|Overall Study|Death|0|||
30934827|NCT01831466|58971298|FG011|Overall Study|Death|0|||
30934828|NCT01831466|58971287|FG000|Overall Study|Withdrawal by Subject|6|||
30934829|NCT01831466|58971288|FG001|Overall Study|Withdrawal by Subject|3|||
30934830|NCT01831466|58971289|FG002|Overall Study|Withdrawal by Subject|3|||
30934831|NCT01831466|58971290|FG003|Overall Study|Withdrawal by Subject|3|||
30934832|NCT01831466|58971291|FG004|Overall Study|Withdrawal by Subject|3|||
30934833|NCT01831466|58971292|FG005|Overall Study|Withdrawal by Subject|5|||
30934834|NCT01831466|58971293|FG006|Overall Study|Withdrawal by Subject|0|||
30758642|NCT00098306|58767354|FG004|Open Label|Lack of Efficacy|0|||
30840372|NCT02712788|58865851|FG001|Overall Study|Protocol Violation|0|||
30840373|NCT02308111|58865859|FG000|Overall Study|Adverse Event|31|||
30840374|NCT02308111|58865860|FG001|Overall Study|Adverse Event|19|||
30840375|NCT02308111|58865859|FG000|Overall Study|Death|9|||
30840376|NCT02308111|58865860|FG001|Overall Study|Death|6|||
30840377|NCT02308111|58865859|FG000|Overall Study|Lost to Follow-up|2|||
30840378|NCT02308111|58865860|FG001|Overall Study|Lost to Follow-up|7|||
30840379|NCT02308111|58865859|FG000|Overall Study|Physician Decision|6|||
30840380|NCT02308111|58865860|FG001|Overall Study|Physician Decision|17|||
30840381|NCT02308111|58865859|FG000|Overall Study|Protocol Violation|0|||
30840382|NCT02308111|58865860|FG001|Overall Study|Protocol Violation|1|||
30840383|NCT02308111|58865859|FG000|Overall Study|Withdrawal by Subject|28|||
30758643|NCT00098306|58767355|FG005|Open Label|Lack of Efficacy|0|||
30840384|NCT02308111|58865860|FG001|Overall Study|Withdrawal by Subject|38|||
30840385|NCT02308111|58865859|FG000|Overall Study|Study Terminated by Sponsor|72|||
30840386|NCT02308111|58865860|FG001|Overall Study|Study Terminated by Sponsor|61|||
30758644|NCT00098306|58767356|FG006|Open Label|Lack of Efficacy|0|||
30758645|NCT00098306|58767350|FG000|Open Label|Adverse Event|0|||
30758646|NCT00098306|58767351|FG001|Open Label|Adverse Event|0|||
30758647|NCT00098306|58767352|FG002|Open Label|Adverse Event|0|||
30758648|NCT00098306|58767353|FG003|Open Label|Adverse Event|2|||
30758649|NCT00098306|58767354|FG004|Open Label|Adverse Event|0|||
30758650|NCT00098306|58767355|FG005|Open Label|Adverse Event|0|||
30758651|NCT00098306|58767356|FG006|Open Label|Adverse Event|0|||
30758652|NCT00098306|58767350|FG000|Open Label|Death|0|||
30758653|NCT00098306|58767351|FG001|Open Label|Death|0|||
30758654|NCT00098306|58767352|FG002|Open Label|Death|0|||
30758655|NCT00098306|58767353|FG003|Open Label|Death|4|||
30758656|NCT00098306|58767354|FG004|Open Label|Death|0|||
30758657|NCT00098306|58767355|FG005|Open Label|Death|0|||
30758658|NCT00098306|58767356|FG006|Open Label|Death|0|||
30758659|NCT00098306|58767350|FG000|Open Label|Participant defaulted|0|||
30758660|NCT00098306|58767351|FG001|Open Label|Participant defaulted|0|||
30758661|NCT00098306|58767352|FG002|Open Label|Participant defaulted|0|||
30758662|NCT00098306|58767353|FG003|Open Label|Participant defaulted|24|||
30758663|NCT00098306|58767354|FG004|Open Label|Participant defaulted|0|||
30758664|NCT00098306|58767355|FG005|Open Label|Participant defaulted|0|||
30758665|NCT00098306|58767356|FG006|Open Label|Participant defaulted|0|||
30758666|NCT00098306|58767350|FG000|Open Label|Un-specified|0|||
30758667|NCT00098306|58767351|FG001|Open Label|Un-specified|0|||
30840387|NCT02308111|58865859|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
30840388|NCT02308111|58865860|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
30840389|NCT02308111|58865859|FG000|Overall Study|Site Closure|3|||
30934835|NCT01831466|58971294|FG007|Overall Study|Withdrawal by Subject|0|||
30934836|NCT01831466|58971295|FG008|Overall Study|Withdrawal by Subject|0|||
30758668|NCT00098306|58767352|FG002|Open Label|Un-specified|0|||
30758669|NCT00098306|58767353|FG003|Open Label|Un-specified|15|||
30758670|NCT00098306|58767354|FG004|Open Label|Un-specified|0|||
30758671|NCT00098306|58767355|FG005|Open Label|Un-specified|0|||
30758672|NCT00098306|58767356|FG006|Open Label|Un-specified|0|||
30758673|NCT00098306|58767350|FG000|Open Label|Ongoing at cut-off date|0|||
30758674|NCT00098306|58767351|FG001|Open Label|Ongoing at cut-off date|0|||
30758675|NCT00098306|58767352|FG002|Open Label|Ongoing at cut-off date|0|||
30758676|NCT00098306|58767353|FG003|Open Label|Ongoing at cut-off date|269|||
30840390|NCT02308111|58865860|FG001|Overall Study|Site Closure|3|||
30934837|NCT01831466|58971296|FG009|Overall Study|Withdrawal by Subject|1|||
30934838|NCT01831466|58971297|FG010|Overall Study|Withdrawal by Subject|0|||
30934839|NCT01831466|58971298|FG011|Overall Study|Withdrawal by Subject|1|||
30934840|NCT01831466|58971287|FG000|Overall Study|Lost to Follow-up|0|||
30934841|NCT01831466|58971288|FG001|Overall Study|Lost to Follow-up|1|||
30934842|NCT01831466|58971289|FG002|Overall Study|Lost to Follow-up|4|||
30934843|NCT01831466|58971290|FG003|Overall Study|Lost to Follow-up|2|||
30840391|NCT02308111|58865859|FG000|Overall Study|Non-compliance with Study Drug|3|||
30840392|NCT02308111|58865860|FG001|Overall Study|Non-compliance with Study Drug|1|||
30840393|NCT02308111|58865859|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
30840394|NCT02308111|58865860|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
30934844|NCT01831466|58971291|FG004|Overall Study|Lost to Follow-up|0|||
30934845|NCT01831466|58971292|FG005|Overall Study|Lost to Follow-up|3|||
30934846|NCT01831466|58971293|FG006|Overall Study|Lost to Follow-up|0|||
30934847|NCT01831466|58971294|FG007|Overall Study|Lost to Follow-up|0|||
30934848|NCT01831466|58971295|FG008|Overall Study|Lost to Follow-up|0|||
30934849|NCT01831466|58971296|FG009|Overall Study|Lost to Follow-up|1|||
30934850|NCT01831466|58971297|FG010|Overall Study|Lost to Follow-up|0|||
30934851|NCT01831466|58971298|FG011|Overall Study|Lost to Follow-up|1|||
30934852|NCT01831466|58971287|FG000|Overall Study|Lack of Efficacy|5|||
30934853|NCT01831466|58971288|FG001|Overall Study|Lack of Efficacy|8|||
30934854|NCT01831466|58971289|FG002|Overall Study|Lack of Efficacy|7|||
30934855|NCT01831466|58971290|FG003|Overall Study|Lack of Efficacy|6|||
30934856|NCT01831466|58971291|FG004|Overall Study|Lack of Efficacy|9|||
30934857|NCT01831466|58971292|FG005|Overall Study|Lack of Efficacy|8|||
30934858|NCT01831466|58971293|FG006|Overall Study|Lack of Efficacy|1|||
30934859|NCT01831466|58971294|FG007|Overall Study|Lack of Efficacy|1|||
30934860|NCT01831466|58971295|FG008|Overall Study|Lack of Efficacy|2|||
30934861|NCT01831466|58971296|FG009|Overall Study|Lack of Efficacy|2|||
30934862|NCT01831466|58971297|FG010|Overall Study|Lack of Efficacy|2|||
30934863|NCT01831466|58971298|FG011|Overall Study|Lack of Efficacy|0|||
30934864|NCT01831466|58971287|FG000|Overall Study|Adverse Event|0|||
30934865|NCT01831466|58971288|FG001|Overall Study|Adverse Event|0|||
30934866|NCT01831466|58971289|FG002|Overall Study|Adverse Event|4|||
30934867|NCT01831466|58971290|FG003|Overall Study|Adverse Event|6|||
30934868|NCT01831466|58971291|FG004|Overall Study|Adverse Event|3|||
30934869|NCT01831466|58971292|FG005|Overall Study|Adverse Event|7|||
30934870|NCT01831466|58971293|FG006|Overall Study|Adverse Event|0|||
30934871|NCT01831466|58971294|FG007|Overall Study|Adverse Event|1|||
30934872|NCT01831466|58971295|FG008|Overall Study|Adverse Event|1|||
30934873|NCT01831466|58971296|FG009|Overall Study|Adverse Event|1|||
30934874|NCT01831466|58971297|FG010|Overall Study|Adverse Event|0|||
30934875|NCT01831466|58971298|FG011|Overall Study|Adverse Event|2|||
30934876|NCT01881620|58971318|FG000|Overall Study|Protocol Violation|4|||
30934877|NCT01830920|58971327|FG000|Overall Study|Adverse Event|1|||
30934878|NCT01830920|58971328|FG001|Overall Study|Adverse Event|0|||
30934879|NCT01830920|58971329|FG002|Overall Study|Adverse Event|1|||
30934880|NCT01830920|58971330|FG003|Overall Study|Adverse Event|0|||
30934881|NCT01830920|58971331|FG004|Overall Study|Adverse Event|0|||
30934882|NCT01830920|58971327|FG000|Overall Study|Withdrawal by Subject|2|||
30934883|NCT01830920|58971328|FG001|Overall Study|Withdrawal by Subject|2|||
30934884|NCT01830920|58971329|FG002|Overall Study|Withdrawal by Subject|1|||
30934885|NCT01830920|58971330|FG003|Overall Study|Withdrawal by Subject|7|||
30934886|NCT01830920|58971331|FG004|Overall Study|Withdrawal by Subject|1|||
30934887|NCT01830920|58971327|FG000|Overall Study|Death|3|||
30934888|NCT01830920|58971328|FG001|Overall Study|Death|3|||
30934889|NCT01830920|58971329|FG002|Overall Study|Death|5|||
30934890|NCT01830920|58971330|FG003|Overall Study|Death|4|||
30934891|NCT01830920|58971331|FG004|Overall Study|Death|4|||
30934892|NCT01830920|58971327|FG000|Overall Study|Other|15|||
30934893|NCT01830920|58971328|FG001|Overall Study|Other|1|||
30934894|NCT01830920|58971329|FG002|Overall Study|Other|1|||
30934895|NCT01830920|58971330|FG003|Overall Study|Other|5|||
30840395|NCT02308111|58865859|FG000|Overall Study|Liver Transplant|3|||
30840396|NCT02308111|58865860|FG001|Overall Study|Liver Transplant|3|||
30840397|NCT02308111|58865859|FG000|Overall Study|Liver Transplant Waitlist|2|||
30840398|NCT02308111|58865860|FG001|Overall Study|Liver Transplant Waitlist|2|||
30840399|NCT02308111|58865859|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
30840400|NCT02308111|58865860|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
30840401|NCT01346189|58865871|FG000|Overall Study|Withdrawal by Subject|7|||
30840402|NCT01346189|58865872|FG001|Overall Study|Withdrawal by Subject|5|||
30840403|NCT01346189|58865873|FG002|Overall Study|Withdrawal by Subject|3|||
30934896|NCT01830920|58971331|FG004|Overall Study|Other|3|||
30934897|NCT01881230|58971346|FG000|Overall Study|Death|2|||
30934898|NCT01881230|58971347|FG001|Overall Study|Death|0|||
30934899|NCT01881230|58971348|FG002|Overall Study|Death|1|||
30934900|NCT01881230|58971346|FG000|Overall Study|Adverse Event|9|||
30934901|NCT01881230|58971347|FG001|Overall Study|Adverse Event|13|||
30934902|NCT01881230|58971348|FG002|Overall Study|Adverse Event|12|||
30934903|NCT01881230|58971346|FG000|Overall Study|Progressive Disease|31|||
30934904|NCT01881230|58971347|FG001|Overall Study|Progressive Disease|35|||
30934905|NCT01881230|58971348|FG002|Overall Study|Progressive Disease|36|||
30934906|NCT01881230|58971346|FG000|Overall Study|Symptomatic Deterioration|3|||
30934907|NCT01881230|58971347|FG001|Overall Study|Symptomatic Deterioration|3|||
30934908|NCT01881230|58971348|FG002|Overall Study|Symptomatic Deterioration|1|||
30934909|NCT01881230|58971346|FG000|Overall Study|Withdrawal by Subject|6|||
30934910|NCT01881230|58971347|FG001|Overall Study|Withdrawal by Subject|4|||
30934911|NCT01881230|58971348|FG002|Overall Study|Withdrawal by Subject|6|||
30934912|NCT01881230|58971346|FG000|Overall Study|Physician Decision|4|||
30934913|NCT01881230|58971347|FG001|Overall Study|Physician Decision|3|||
30934914|NCT01881230|58971348|FG002|Overall Study|Physician Decision|6|||
30934915|NCT01881230|58971346|FG000|Overall Study|Non-Compliance with Study Drug|1|||
30934916|NCT01881230|58971347|FG001|Overall Study|Non-Compliance with Study Drug|2|||
30934917|NCT01881230|58971348|FG002|Overall Study|Non-Compliance with Study Drug|0|||
30934918|NCT01881230|58971346|FG000|Overall Study|Given Commercially Available Drug|0|||
30934919|NCT01881230|58971347|FG001|Overall Study|Given Commercially Available Drug|0|||
30934920|NCT01881230|58971348|FG002|Overall Study|Given Commercially Available Drug|2|||
30934921|NCT01881230|58971346|FG000|Overall Study|Protocol Violation|1|||
30934922|NCT01881230|58971347|FG001|Overall Study|Protocol Violation|1|||
30934923|NCT01881230|58971348|FG002|Overall Study|Protocol Violation|0|||
30934924|NCT01881230|58971346|FG000|Overall Study|Miscellaneous|3|||
30934925|NCT01881230|58971347|FG001|Overall Study|Miscellaneous|3|||
30934926|NCT01881230|58971348|FG002|Overall Study|Miscellaneous|0|||
30934927|NCT01881230|58971346|FG000|Overall Study|Untreated: Other|0|||
30934928|NCT01881230|58971347|FG001|Overall Study|Untreated: Other|0|||
30934929|NCT01881230|58971348|FG002|Overall Study|Untreated: Other|1|||
30934930|NCT01881230|58971346|FG000|Overall Study|Untreated: Death|0|||
30934931|NCT01881230|58971347|FG001|Overall Study|Untreated: Death|0|||
30934932|NCT01881230|58971348|FG002|Overall Study|Untreated: Death|1|||
30934933|NCT01881230|58971346|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
30934934|NCT01881230|58971347|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
30934935|NCT01881230|58971348|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
30934936|NCT01856582|58971356|FG000|Overall Study|Died prior to Boost infusion|1|||
30934937|NCT01829360|58971364|FG000|Overall Study|Protocol Violation|0|||
30934938|NCT01829360|58971365|FG001|Overall Study|Protocol Violation|0|||
30934939|NCT01829360|58971366|FG002|Overall Study|Protocol Violation|1|||
30934940|NCT01829360|58971367|FG003|Overall Study|Protocol Violation|0|||
30934941|NCT01856114|58971383|FG000|Overall Study|Withdrawal by Subject|1|||
30934942|NCT01856114|58971384|FG001|Overall Study|Withdrawal by Subject|0|||
30934943|NCT01856114|58971383|FG000|Overall Study|Adverse Event|1|||
30934944|NCT01856114|58971384|FG001|Overall Study|Adverse Event|0|||
30934945|NCT01855958|58971392|FG000|Overall Study|Withdrawal by Subject|1|||
30934946|NCT01855958|58971393|FG001|Overall Study|Withdrawal by Subject|0|||
30934947|NCT01855412|58971404|FG000|Overall Study|Death|77|||
30934948|NCT01855412|58971405|FG001|Overall Study|Death|123|||
30934949|NCT01855412|58971406|FG002|Overall Study|Death|30|||
30934950|NCT01855412|58971404|FG000|Overall Study|Lost to Follow-up|28|||
30934951|NCT01855412|58971405|FG001|Overall Study|Lost to Follow-up|46|||
30624299|NCT00883129|58636303|FG000|Overall Study|Adverse Event|7|||
30758677|NCT00098306|58767354|FG004|Open Label|Ongoing at cut-off date|62|||
30758678|NCT00098306|58767355|FG005|Open Label|Ongoing at cut-off date|0|||
30758679|NCT00098306|58767356|FG006|Open Label|Ongoing at cut-off date|0|||
30758680|NCT00098306|58767350|FG000|Observational Phase|Death|0|||
30758681|NCT00098306|58767351|FG001|Observational Phase|Death|0|||
30758682|NCT00098306|58767352|FG002|Observational Phase|Death|0|||
30758683|NCT00098306|58767353|FG003|Observational Phase|Death|0|||
30758684|NCT00098306|58767354|FG004|Observational Phase|Death|0|||
30758685|NCT00098306|58767355|FG005|Observational Phase|Death|5|||
30758686|NCT00098306|58767356|FG006|Observational Phase|Death|4|||
30758687|NCT00098306|58767350|FG000|Observational Phase|Participant defaulted|0|||
30758688|NCT00098306|58767351|FG001|Observational Phase|Participant defaulted|0|||
30758689|NCT00098306|58767352|FG002|Observational Phase|Participant defaulted|0|||
30758690|NCT00098306|58767353|FG003|Observational Phase|Participant defaulted|0|||
30758691|NCT00098306|58767354|FG004|Observational Phase|Participant defaulted|0|||
30758692|NCT00098306|58767355|FG005|Observational Phase|Participant defaulted|34|||
30758693|NCT00098306|58767356|FG006|Observational Phase|Participant defaulted|18|||
30758694|NCT00098306|58767350|FG000|Observational Phase|Un-specified|0|||
30758695|NCT00098306|58767351|FG001|Observational Phase|Un-specified|0|||
30758696|NCT00098306|58767352|FG002|Observational Phase|Un-specified|0|||
30758697|NCT00098306|58767353|FG003|Observational Phase|Un-specified|0|||
30758698|NCT00098306|58767354|FG004|Observational Phase|Un-specified|0|||
30758699|NCT00098306|58767355|FG005|Observational Phase|Un-specified|7|||
30934952|NCT01855412|58971406|FG002|Overall Study|Lost to Follow-up|15|||
30934953|NCT01855412|58971404|FG000|Overall Study|Withdrawal by Subject|77|||
30934954|NCT01855412|58971405|FG001|Overall Study|Withdrawal by Subject|123|||
30934955|NCT01855412|58971406|FG002|Overall Study|Withdrawal by Subject|24|||
30934956|NCT01855412|58971404|FG000|Overall Study|Physician Decision|25|||
30934957|NCT01855412|58971405|FG001|Overall Study|Physician Decision|31|||
30934958|NCT01855412|58971406|FG002|Overall Study|Physician Decision|3|||
30934959|NCT01855412|58971404|FG000|Overall Study|Site Closure|4|||
30934960|NCT01855412|58971405|FG001|Overall Study|Site Closure|18|||
30934961|NCT01855412|58971406|FG002|Overall Study|Site Closure|1|||
30934962|NCT01855412|58971404|FG000|Overall Study|Reason not Specified|1|||
30934963|NCT01855412|58971405|FG001|Overall Study|Reason not Specified|2|||
30934964|NCT01855412|58971406|FG002|Overall Study|Reason not Specified|3|||
30934965|NCT01614470|58971422|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
30934966|NCT01614470|58971423|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
30934967|NCT01614470|58971424|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
30934968|NCT01614470|58971422|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
30934969|NCT01614470|58971423|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
30934970|NCT01614470|58971424|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
30934971|NCT01880528|58971435|FG000|Overall Study|Other|1|||
30934972|NCT01880528|58971436|FG001|Overall Study|Other|1|||
30934973|NCT01854944|58971445|FG000|Overall Study|Withdrawal by Subject|0|||
30934974|NCT01854944|58971446|FG001|Overall Study|Withdrawal by Subject|0|||
30934975|NCT01854944|58971447|FG002|Overall Study|Withdrawal by Subject|1|||
30934976|NCT01829048|58971474|FG000|Overall Study|Withdrawal by Subject|0|||
30934977|NCT01829048|58971475|FG001|Overall Study|Withdrawal by Subject|0|||
30934978|NCT01829048|58971476|FG002|Overall Study|Withdrawal by Subject|0|||
30934979|NCT01829048|58971477|FG003|Overall Study|Withdrawal by Subject|2|||
30934980|NCT01829048|58971478|FG004|Overall Study|Withdrawal by Subject|0|||
30934981|NCT01854710|58971491|FG000|Overall Study|Withdrawal by Subject|2|||
30934982|NCT01854710|58971492|FG001|Overall Study|Withdrawal by Subject|1|||
30934983|NCT01854710|58971493|FG002|Overall Study|Withdrawal by Subject|0|||
30934984|NCT01854710|58971494|FG003|Overall Study|Withdrawal by Subject|0|||
30934985|NCT01854710|58971495|FG004|Overall Study|Withdrawal by Subject|0|||
30934986|NCT01854710|58971496|FG005|Overall Study|Withdrawal by Subject|0|||
30934987|NCT01854710|58971491|FG000|Overall Study|CRI procedural error|2|||
30934988|NCT01854710|58971492|FG001|Overall Study|CRI procedural error|2|||
30934989|NCT01854710|58971493|FG002|Overall Study|CRI procedural error|2|||
30934990|NCT01854710|58971494|FG003|Overall Study|CRI procedural error|2|||
30934991|NCT01854710|58971495|FG004|Overall Study|CRI procedural error|2|||
30840404|NCT01346189|58865874|FG003|Overall Study|Withdrawal by Subject|5|||
30840405|NCT01346189|58865871|FG000|Overall Study|Physician Decision|4|||
30840406|NCT01346189|58865872|FG001|Overall Study|Physician Decision|0|||
30840407|NCT01346189|58865873|FG002|Overall Study|Physician Decision|0|||
30840408|NCT01346189|58865874|FG003|Overall Study|Physician Decision|0|||
30840409|NCT01346189|58865871|FG000|Overall Study|Moved|3|||
30840410|NCT01346189|58865872|FG001|Overall Study|Moved|0|||
30840411|NCT01346189|58865873|FG002|Overall Study|Moved|4|||
30840412|NCT01346189|58865874|FG003|Overall Study|Moved|0|||
30840413|NCT01346189|58865871|FG000|Overall Study|Other|2|||
30840414|NCT01346189|58865872|FG001|Overall Study|Other|4|||
30840415|NCT01346189|58865873|FG002|Overall Study|Other|7|||
30840416|NCT01346189|58865874|FG003|Overall Study|Other|3|||
30840417|NCT01346189|58865871|FG000|Overall Study|Death|0|||
30840418|NCT01346189|58865872|FG001|Overall Study|Death|3|||
30840419|NCT01346189|58865873|FG002|Overall Study|Death|0|||
30840420|NCT01346189|58865874|FG003|Overall Study|Death|0|||
30840421|NCT01346189|58865871|FG000|Overall Study|Non-health system primary care physician|0|||
30840422|NCT01346189|58865872|FG001|Overall Study|Non-health system primary care physician|5|||
30840423|NCT01346189|58865873|FG002|Overall Study|Non-health system primary care physician|0|||
30840424|NCT01346189|58865874|FG003|Overall Study|Non-health system primary care physician|0|||
30840425|NCT01346189|58865871|FG000|Overall Study|Travel|0|||
30840426|NCT01346189|58865872|FG001|Overall Study|Travel|0|||
30840427|NCT01346189|58865873|FG002|Overall Study|Travel|0|||
30840428|NCT01346189|58865874|FG003|Overall Study|Travel|3|||
30840429|NCT00369317|58865884|FG000|Overall Study|Adverse Event|3|||
30934992|NCT01854710|58971496|FG005|Overall Study|CRI procedural error|2|||
30948535|NCT01974323|58994554|FG001|Overall Study|Other Reasons|28|||
30840430|NCT00369317|58865884|FG000|Overall Study|Death|1|||
30840431|NCT00369317|58865884|FG000|Overall Study|Lack of Efficacy|5|||
30840432|NCT00369317|58865884|FG000|Overall Study|Physician Decision|2|||
30840433|NCT00369317|58865884|FG000|Overall Study|Withdrawal by Subject|8|||
30840434|NCT00369317|58865884|FG000|Overall Study|Ineligible|1|||
30840435|NCT03193021|58865891|FG000|Overall Study|Lost to Follow-up|1|||
30840436|NCT03193021|58865892|FG001|Overall Study|Lost to Follow-up|1|||
30840437|NCT03913091|58865900|FG000|Overall Study|Lost to Follow-up|18|||
30840438|NCT03913091|58865901|FG001|Overall Study|Lost to Follow-up|11|||
30840439|NCT03913091|58865900|FG000|Overall Study|Required additional meds/surgery|1|||
30840440|NCT03913091|58865901|FG001|Overall Study|Required additional meds/surgery|2|||
30840441|NCT03913091|58865900|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
30840442|NCT03913091|58865901|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
30840443|NCT01318499|58865925|FG000|Overall Study|Adverse Event|16|||
30840444|NCT01318499|58865926|FG001|Overall Study|Adverse Event|11|||
30840445|NCT01318499|58865927|FG002|Overall Study|Adverse Event|6|||
30840446|NCT01318499|58865925|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
30840447|NCT01318499|58865926|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
30840448|NCT01318499|58865927|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
30840449|NCT01318499|58865925|FG000|Overall Study|Noncompliance|2|||
30624300|NCT00883129|58636304|FG001|Overall Study|Adverse Event|15|||
30840450|NCT01318499|58865926|FG001|Overall Study|Noncompliance|3|||
30840451|NCT01318499|58865927|FG002|Overall Study|Noncompliance|0|||
30840452|NCT01318499|58865925|FG000|Overall Study|Treatment Failure|19|||
30840453|NCT01318499|58865926|FG001|Overall Study|Treatment Failure|19|||
30840454|NCT01318499|58865927|FG002|Overall Study|Treatment Failure|101|||
30840455|NCT01318499|58865925|FG000|Overall Study|Protocol Violation|2|||
30840456|NCT01318499|58865926|FG001|Overall Study|Protocol Violation|4|||
30840457|NCT01318499|58865927|FG002|Overall Study|Protocol Violation|2|||
30840458|NCT01318499|58865925|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
30840459|NCT01318499|58865926|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
30840460|NCT01318499|58865927|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
30840461|NCT01318499|58865925|FG000|Overall Study|Other|7|||
30840462|NCT01318499|58865926|FG001|Overall Study|Other|10|||
30840463|NCT01318499|58865927|FG002|Overall Study|Other|22|||
30840464|NCT02285595|58865961|FG000|Overall Study|Lost to Follow-up|14|||
30840465|NCT02285595|58865961|FG000|Overall Study|Withdrawal by Subject|1|||
30840466|NCT02712398|58865984|FG000|Overall Study|Withdrawal by Subject|6|||
30840467|NCT02712398|58865984|FG000|Overall Study|Lost to Follow-up|6|||
30840468|NCT02712398|58865984|FG000|Overall Study|Sponsor Decision|1|||
30840469|NCT02712398|58865984|FG000|Overall Study|Physician Decision|1|||
30840470|NCT02712398|58865984|FG000|Overall Study|Death|2|||
30840471|NCT02712398|58865984|FG000|Overall Study|Re-operation|21|||
30840472|NCT00282867|58865991|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
30840473|NCT00282867|58865992|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
30840474|NCT00282867|58865993|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
30840475|NCT00151281|58865998|FG000|Overall Study|Not evaluable|3|||
30840476|NCT01318109|58866013|FG000|Overall Study|Adverse Event|0|||
30840477|NCT01318109|58866014|FG001|Overall Study|Adverse Event|2|||
30840478|NCT01318109|58866015|FG002|Overall Study|Adverse Event|0|||
30840479|NCT01318109|58866013|FG000|Overall Study|Withdrawal by Subject|1|||
30840480|NCT01318109|58866014|FG001|Overall Study|Withdrawal by Subject|0|||
30840481|NCT01318109|58866015|FG002|Overall Study|Withdrawal by Subject|0|||
30840482|NCT01318109|58866013|FG000|Overall Study|Schedule Conflict|0|||
30840483|NCT01318109|58866014|FG001|Overall Study|Schedule Conflict|1|||
30840484|NCT01318109|58866015|FG002|Overall Study|Schedule Conflict|0|||
30840485|NCT02712554|58866025|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
30840486|NCT02712554|58866026|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
30840487|NCT02712554|58866025|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
30840488|NCT02712554|58866026|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
30840489|NCT02712554|58866025|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
30840490|NCT02712554|58866026|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
30840491|NCT02712554|58866025|FG000|Part B: Qualification Phase|Adverse Event|0|||
30840492|NCT02712554|58866026|FG001|Part B: Qualification Phase|Adverse Event|1|||
30840493|NCT02712554|58866025|FG000|Part B: Treatment Phase|Adverse Event|0|||
30840494|NCT02712554|58866026|FG001|Part B: Treatment Phase|Adverse Event|1|||
30758700|NCT00098306|58767356|FG006|Observational Phase|Un-specified|4|||
30758701|NCT03615040|58767371|FG000|Overall Study|Withdrawal by Subject|2|||
30758702|NCT03615040|58767372|FG001|Overall Study|Withdrawal by Subject|1|||
30758703|NCT03615040|58767371|FG000|Overall Study|Physician Decision|2|||
30758704|NCT03615040|58767372|FG001|Overall Study|Physician Decision|2|||
30758705|NCT03615040|58767371|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
30758706|NCT03615040|58767372|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
30758707|NCT03615040|58767371|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
30758708|NCT03615040|58767372|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
30758709|NCT03615040|58767371|FG000|Overall Study|Death|0|||
30758710|NCT03615040|58767372|FG001|Overall Study|Death|2|||
30840495|NCT02712554|58866025|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
30948536|NCT01974323|58994553|FG000|Overall Study|Protocol Violation|2|||
30840496|NCT02712554|58866026|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
30840497|NCT02712554|58866025|FG000|Part B: Treatment Phase|Other|0|||
30840498|NCT02712554|58866026|FG001|Part B: Treatment Phase|Other|1|||
30840499|NCT02712320|58866049|FG000|Overall Study|Lost to Follow-up|1|||
30840500|NCT02712320|58866049|FG000|Overall Study|Withdrawal by Subject|1|||
30840501|NCT02712320|58866049|FG000|Overall Study|Transferred to another facility|1|||
30840502|NCT02712320|58866049|FG000|Overall Study|Treating with the prohibited medications|2|||
30840503|NCT03052751|58866055|FG000|Dosing Period 1|Adverse Event|0|||
30840504|NCT03052751|58866056|FG001|Dosing Period 1|Adverse Event|1|||
30840505|NCT03052751|58866057|FG002|Dosing Period 1|Adverse Event|0|||
30840506|NCT03052751|58866058|FG003|Dosing Period 1|Adverse Event|0|||
30840507|NCT03052751|58866059|FG004|Dosing Period 1|Adverse Event|0|||
30840508|NCT03052751|58866060|FG005|Dosing Period 1|Adverse Event|0|||
30840509|NCT03052751|58866055|FG000|Dosing Period 2|Adverse Event|0|||
30840510|NCT03052751|58866056|FG001|Dosing Period 2|Adverse Event|0|||
30840511|NCT03052751|58866057|FG002|Dosing Period 2|Adverse Event|3|||
30840512|NCT03052751|58866058|FG003|Dosing Period 2|Adverse Event|0|||
30840513|NCT03052751|58866059|FG004|Dosing Period 2|Adverse Event|0|||
30840514|NCT03052751|58866060|FG005|Dosing Period 2|Adverse Event|0|||
30840515|NCT03052751|58866055|FG000|Observation Period|Adverse Event|0|||
30840516|NCT03052751|58866056|FG001|Observation Period|Adverse Event|0|||
30840517|NCT03052751|58866057|FG002|Observation Period|Adverse Event|0|||
30840518|NCT03052751|58866058|FG003|Observation Period|Adverse Event|0|||
30840519|NCT03052751|58866059|FG004|Observation Period|Adverse Event|1|||
30840520|NCT03052751|58866060|FG005|Observation Period|Adverse Event|0|||
30840521|NCT01317797|58866073|FG000|Overall Study|Other|0|||
30840522|NCT01317797|58866074|FG001|Overall Study|Other|1|||
30840523|NCT01317797|58866075|FG002|Overall Study|Other|0|||
30840524|NCT01317797|58866073|FG000|Overall Study|Withdrawal of Patient|0|||
30840525|NCT01317797|58866074|FG001|Overall Study|Withdrawal of Patient|0|||
30840526|NCT01317797|58866075|FG002|Overall Study|Withdrawal of Patient|1|||
30840527|NCT01343693|58866083|FG000|Overall Study|Lost to Follow-up|9|||
30840528|NCT02712008|58866090|FG000|Baseline (Day 1) up to Week 12|Death|3|||
30840529|NCT02712008|58866091|FG001|Baseline (Day 1) up to Week 12|Death|0|||
30840530|NCT02712008|58866092|FG002|Baseline (Day 1) up to Week 12|Death|0|||
30840531|NCT02712008|58866093|FG003|Baseline (Day 1) up to Week 12|Death|0|||
30840532|NCT02712008|58866094|FG004|Baseline (Day 1) up to Week 12|Death|0|||
30840533|NCT02712008|58866095|FG005|Baseline (Day 1) up to Week 12|Death|0|||
30840534|NCT02712008|58866096|FG006|Baseline (Day 1) up to Week 12|Death|0|||
30840535|NCT02712008|58866097|FG007|Baseline (Day 1) up to Week 12|Death|0|||
30840536|NCT02712008|58866090|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30840537|NCT02712008|58866091|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
30840538|NCT02712008|58866092|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
30840539|NCT02712008|58866093|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30840540|NCT02712008|58866094|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30840541|NCT02712008|58866095|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30840542|NCT02712008|58866096|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30840543|NCT02712008|58866097|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
30840544|NCT02712008|58866090|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
30840545|NCT02712008|58866091|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30840546|NCT02712008|58866092|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
30840547|NCT02712008|58866093|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30840548|NCT02712008|58866094|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30840549|NCT02712008|58866095|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30840550|NCT02712008|58866096|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30934993|NCT01828034|58971510|FG000|Overall Study|Withdrawal by Subject|0|||
30934994|NCT01828034|58971511|FG001|Overall Study|Withdrawal by Subject|0|||
30934995|NCT01828034|58971512|FG002|Overall Study|Withdrawal by Subject|0|||
30934996|NCT01828034|58971513|FG003|Overall Study|Withdrawal by Subject|1|||
30934997|NCT01853696|58971522|FG000|Overall Study|Withdrawal by Subject|1|||
30934998|NCT01853696|58971523|FG001|Overall Study|Withdrawal by Subject|1|||
30934999|NCT01853696|58971522|FG000|Overall Study|Lost to Follow-up|5|||
30935000|NCT01853696|58971523|FG001|Overall Study|Lost to Follow-up|4|||
30935001|NCT01871805|58971535|FG000|Phase I|Death|7|||
30935002|NCT01871805|58971536|FG001|Phase I|Death|4|||
30935003|NCT01871805|58971537|FG002|Phase I|Death|6|||
30935004|NCT01871805|58971538|FG003|Phase I|Death|2|||
30935005|NCT01871805|58971539|FG004|Phase I|Death|9|||
30935006|NCT01871805|58971540|FG005|Phase I|Death|0|||
30935007|NCT01871805|58971535|FG000|Phase I|Alive in Survival Follow-up|0|||
30840551|NCT02712008|58866097|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
30840552|NCT02712008|58866090|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
30935008|NCT01871805|58971536|FG001|Phase I|Alive in Survival Follow-up|2|||
30840553|NCT02712008|58866091|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
30935009|NCT01871805|58971537|FG002|Phase I|Alive in Survival Follow-up|4|||
30935010|NCT01871805|58971538|FG003|Phase I|Alive in Survival Follow-up|5|||
30948537|NCT01974323|58994554|FG001|Overall Study|Protocol Violation|2|||
30935011|NCT01871805|58971539|FG004|Phase I|Alive in Survival Follow-up|4|||
30758711|NCT00068822|58767380|FG000|First Randomized Intervention|Lost to Follow-up|1|||
30840554|NCT02712008|58866092|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
30840555|NCT02712008|58866093|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
30840556|NCT02712008|58866094|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
30840557|NCT02712008|58866095|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
30840558|NCT02712008|58866096|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
30840559|NCT02712008|58866097|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
30840560|NCT02712008|58866090|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
30840561|NCT02712008|58866091|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
30840562|NCT02712008|58866092|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
30840563|NCT02712008|58866093|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
30840564|NCT02712008|58866094|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
30840565|NCT02712008|58866095|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
30840566|NCT02712008|58866096|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
30840567|NCT02712008|58866097|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
30840568|NCT02712008|58866090|FG000|From Week 12 up to Week 36|Adverse Event|0|||
30840569|NCT02712008|58866091|FG001|From Week 12 up to Week 36|Adverse Event|0|||
30840570|NCT02712008|58866092|FG002|From Week 12 up to Week 36|Adverse Event|0|||
30840571|NCT02712008|58866093|FG003|From Week 12 up to Week 36|Adverse Event|0|||
30840572|NCT02712008|58866094|FG004|From Week 12 up to Week 36|Adverse Event|1|||
30840573|NCT02712008|58866095|FG005|From Week 12 up to Week 36|Adverse Event|0|||
30840574|NCT02712008|58866096|FG006|From Week 12 up to Week 36|Adverse Event|0|||
30840575|NCT02712008|58866097|FG007|From Week 12 up to Week 36|Adverse Event|2|||
30840576|NCT02712008|58866090|FG000|From Week 12 up to Week 36|Death|1|||
30840577|NCT02712008|58866091|FG001|From Week 12 up to Week 36|Death|0|||
30840578|NCT02712008|58866092|FG002|From Week 12 up to Week 36|Death|0|||
30840579|NCT02712008|58866093|FG003|From Week 12 up to Week 36|Death|0|||
30840580|NCT02712008|58866094|FG004|From Week 12 up to Week 36|Death|0|||
30840581|NCT02712008|58866095|FG005|From Week 12 up to Week 36|Death|0|||
30840582|NCT02712008|58866096|FG006|From Week 12 up to Week 36|Death|1|||
30840583|NCT02712008|58866097|FG007|From Week 12 up to Week 36|Death|0|||
30840584|NCT02712008|58866090|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
30840585|NCT02712008|58866091|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
30840586|NCT02712008|58866092|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
30840587|NCT02712008|58866093|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
30840588|NCT02712008|58866094|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
30840589|NCT02712008|58866095|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
30840590|NCT02712008|58866096|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
30840591|NCT02712008|58866097|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
30840592|NCT02712008|58866090|FG000|From Week 12 up to Week 36|Physician Decision|0|||
30840593|NCT02712008|58866091|FG001|From Week 12 up to Week 36|Physician Decision|0|||
30840594|NCT02712008|58866092|FG002|From Week 12 up to Week 36|Physician Decision|0|||
30840595|NCT02712008|58866093|FG003|From Week 12 up to Week 36|Physician Decision|1|||
30840596|NCT02712008|58866094|FG004|From Week 12 up to Week 36|Physician Decision|1|||
30840597|NCT02712008|58866095|FG005|From Week 12 up to Week 36|Physician Decision|0|||
30840598|NCT02712008|58866096|FG006|From Week 12 up to Week 36|Physician Decision|0|||
30935012|NCT01871805|58971540|FG005|Phase I|Alive in Survival Follow-up|0|||
30758712|NCT00068822|58767381|FG001|First Randomized Intervention|Lost to Follow-up|2|||
30758713|NCT00068588|58767390|FG000|Overall Study|Adverse Event|0|||
30758714|NCT00068588|58767391|FG001|Overall Study|Adverse Event|0|||
30758715|NCT00068588|58767392|FG002|Overall Study|Adverse Event|2|||
30758716|NCT00068588|58767390|FG000|Overall Study|Withdrawal by Subject|0|||
30758717|NCT00068588|58767391|FG001|Overall Study|Withdrawal by Subject|0|||
30758718|NCT00068588|58767392|FG002|Overall Study|Withdrawal by Subject|1|||
30758719|NCT00068588|58767390|FG000|Overall Study|Poor KPS|0|||
30758720|NCT00068588|58767391|FG001|Overall Study|Poor KPS|0|||
30758721|NCT00068588|58767392|FG002|Overall Study|Poor KPS|1|||
30758722|NCT03650452|58767401|FG000|Overall Study|Physician Decision|1|||
30758723|NCT03650452|58767402|FG001|Overall Study|Physician Decision|0|||
30758724|NCT03650452|58767401|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
30758725|NCT03650452|58767402|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
30758726|NCT03650452|58767401|FG000|Overall Study|Adverse Event|3|||
30758727|NCT03650452|58767402|FG001|Overall Study|Adverse Event|4|||
30758728|NCT03650452|58767401|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
30758729|NCT03650452|58767402|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
30758730|NCT03575806|58767410|FG000|Overall Study|Withdrawal by Subject|0|||
30758731|NCT03575806|58767411|FG001|Overall Study|Withdrawal by Subject|2|||
30758732|NCT03575806|58767410|FG000|Overall Study|Protocol Violation|0|||
30758733|NCT03575806|58767411|FG001|Overall Study|Protocol Violation|2|||
30758734|NCT03610048|58767417|FG000|Overall Study|Study terminated by sponsor|84|||
30758735|NCT03610048|58767417|FG000|Overall Study|Adverse Event|32|||
30758736|NCT03610048|58767417|FG000|Overall Study|Withdrawal by Subject|31|||
30840599|NCT02712008|58866097|FG007|From Week 12 up to Week 36|Physician Decision|0|||
30840600|NCT02712008|58866090|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
30840601|NCT02712008|58866091|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
30935013|NCT01871805|58971535|FG000|Phase I|Lost to Follow-up|0|||
30935014|NCT01871805|58971536|FG001|Phase I|Lost to Follow-up|1|||
30935015|NCT01871805|58971537|FG002|Phase I|Lost to Follow-up|3|||
30935016|NCT01871805|58971538|FG003|Phase I|Lost to Follow-up|0|||
30935017|NCT01871805|58971539|FG004|Phase I|Lost to Follow-up|0|||
30935018|NCT01871805|58971540|FG005|Phase I|Lost to Follow-up|0|||
30935019|NCT01871805|58971535|FG000|Phase II|Death|0|||
30935020|NCT01871805|58971536|FG001|Phase II|Death|0|||
30935021|NCT01871805|58971537|FG002|Phase II|Death|0|||
30935022|NCT01871805|58971538|FG003|Phase II|Death|0|||
30935023|NCT01871805|58971539|FG004|Phase II|Death|0|||
30935024|NCT01871805|58971540|FG005|Phase II|Death|45|||
30935025|NCT01871805|58971535|FG000|Phase II|Alive in Survival Follow-up|0|||
30935026|NCT01871805|58971536|FG001|Phase II|Alive in Survival Follow-up|0|||
30935027|NCT01871805|58971537|FG002|Phase II|Alive in Survival Follow-up|0|||
30935028|NCT01871805|58971538|FG003|Phase II|Alive in Survival Follow-up|0|||
30935029|NCT01871805|58971539|FG004|Phase II|Alive in Survival Follow-up|0|||
30935030|NCT01871805|58971540|FG005|Phase II|Alive in Survival Follow-up|29|||
30935031|NCT01871805|58971535|FG000|Phase II|Lost to Follow-up|0|||
30935032|NCT01871805|58971536|FG001|Phase II|Lost to Follow-up|0|||
30935033|NCT01871805|58971537|FG002|Phase II|Lost to Follow-up|0|||
30935034|NCT01871805|58971538|FG003|Phase II|Lost to Follow-up|0|||
30840602|NCT02712008|58866092|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
30840603|NCT02712008|58866093|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
30840604|NCT02712008|58866094|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
30840605|NCT02712008|58866095|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
30840606|NCT02712008|58866096|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
30840607|NCT02712008|58866097|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
30840608|NCT04238481|58866115|FG000|Overall Study|Miscellaneous|0|||
30840609|NCT04238481|58866116|FG001|Overall Study|Miscellaneous|1|||
30840610|NCT04238481|58866117|FG002|Overall Study|Miscellaneous|0|||
30840611|NCT04238481|58866118|FG003|Overall Study|Miscellaneous|0|||
30840612|NCT02711306|58866134|FG000|Overall Study|Withdrawal by Subject|2|||
30840613|NCT02711306|58866135|FG001|Overall Study|Withdrawal by Subject|2|||
30935035|NCT01871805|58971539|FG004|Phase II|Lost to Follow-up|0|||
30935036|NCT01871805|58971540|FG005|Phase II|Lost to Follow-up|13|||
30935037|NCT01719861|58971571|FG000|Cycle 1|Death|4|||
30935038|NCT01719861|58971571|FG000|Cycle 2|Death|1|||
30935039|NCT01853618|58971581|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
30935040|NCT01853618|58971582|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
30935041|NCT01853618|58971583|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
30935042|NCT01853618|58971584|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
30935043|NCT01853618|58971585|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
30935044|NCT01853618|58971581|FG000|Overall Study|Progressive disease|1|||
30935045|NCT01853618|58971582|FG001|Overall Study|Progressive disease|1|||
30935046|NCT01853618|58971583|FG002|Overall Study|Progressive disease|1|||
30935047|NCT01853618|58971584|FG003|Overall Study|Progressive disease|1|||
30935048|NCT01853618|58971585|FG004|Overall Study|Progressive disease|2|||
30935049|NCT01853618|58971581|FG000|Overall Study|Physician Decision|0|||
30935050|NCT01853618|58971582|FG001|Overall Study|Physician Decision|1|||
30935051|NCT01853618|58971583|FG002|Overall Study|Physician Decision|1|||
30758737|NCT03610048|58767417|FG000|Overall Study|Lost to Follow-up|8|||
30758738|NCT03610048|58767417|FG000|Overall Study|Other|4|||
30758739|NCT03610048|58767417|FG000|Overall Study|Physician Decision|1|||
30758740|NCT03610048|58767417|FG000|Overall Study|Pregnancy|1|||
30758741|NCT03608254|58767421|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
30758742|NCT03608254|58767421|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
30758743|NCT03606460|58767427|FG000|Overall Study|Lost to Follow-up|1|||
30758744|NCT03606460|58767428|FG001|Overall Study|Lost to Follow-up|8|||
30758745|NCT03605836|58767439|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
30840614|NCT02710292|58866141|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
30840615|NCT02710292|58866142|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
30935052|NCT01853618|58971584|FG003|Overall Study|Physician Decision|0|||
30935053|NCT01853618|58971585|FG004|Overall Study|Physician Decision|0|||
30935054|NCT01853618|58971581|FG000|Overall Study|Refused further treatment|0|||
30935055|NCT01853618|58971582|FG001|Overall Study|Refused further treatment|0|||
30935056|NCT01853618|58971583|FG002|Overall Study|Refused further treatment|0|||
30935057|NCT01853618|58971584|FG003|Overall Study|Refused further treatment|0|||
30935058|NCT01853618|58971585|FG004|Overall Study|Refused further treatment|1|||
30758746|NCT03605836|58767440|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
30840616|NCT02710292|58866141|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
30840617|NCT02710292|58866142|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
30840618|NCT02710214|58866151|FG000|Overall Study|Lost to Follow-up|1|||
30935059|NCT01853462|58971600|FG000|Overall Study|Withdrawal by Subject|1|||
30935060|NCT01853462|58971601|FG001|Overall Study|Withdrawal by Subject|1|||
30935061|NCT01719783|58971611|FG000|Dose 2|Physician Decision|1|||
30935062|NCT01719783|58971612|FG001|Dose 2|Physician Decision|0|||
30935063|NCT01853384|58971640|FG000|Randomized|Adverse Event|5|||
30935064|NCT01853384|58971641|FG001|Randomized|Adverse Event|3|||
30935065|NCT01853384|58971640|FG000|Randomized|Death|1|||
30935066|NCT01853384|58971641|FG001|Randomized|Death|2|||
30935067|NCT01853384|58971640|FG000|Randomized|Lost to Follow-up|1|||
30935068|NCT01853384|58971641|FG001|Randomized|Lost to Follow-up|1|||
30935069|NCT01853384|58971640|FG000|Randomized|Withdrawal by Subject|5|||
30935070|NCT01853384|58971641|FG001|Randomized|Withdrawal by Subject|3|||
30935071|NCT01853384|58971640|FG000|Randomized|Sponsor Decision|47|||
30935072|NCT01853384|58971641|FG001|Randomized|Sponsor Decision|34|||
30935073|NCT01853384|58971640|FG000|Randomized|Other|3|||
30935074|NCT01853384|58971641|FG001|Randomized|Other|3|||
30935075|NCT01853384|58971640|FG000|Completed Follow up Visit 1|Early Termination|13|||
30935076|NCT01853384|58971641|FG001|Completed Follow up Visit 1|Early Termination|9|||
30935077|NCT01853384|58971640|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
30935078|NCT01853384|58971641|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
30935079|NCT01853384|58971640|FG000|Completed Follow up Visit 2|Adverse Event|1|||
30935080|NCT01853384|58971641|FG001|Completed Follow up Visit 2|Adverse Event|0|||
30935081|NCT01853384|58971640|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
30935082|NCT01853384|58971641|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
30935083|NCT01853384|58971640|FG000|Completed Follow up Visit 2|Death|1|||
30935084|NCT01853384|58971641|FG001|Completed Follow up Visit 2|Death|0|||
30935085|NCT01853384|58971640|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
30935086|NCT01853384|58971641|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
30935087|NCT01878890|58971651|FG000|Overall Study|Protocol Violation|0|||
30935088|NCT01878890|58971652|FG001|Overall Study|Protocol Violation|1|||
30935089|NCT01878890|58971653|FG002|Overall Study|Protocol Violation|0|||
30935090|NCT01878890|58971654|FG003|Overall Study|Protocol Violation|0|||
30935091|NCT01827332|58971667|FG000|Overall Study|Lost to Follow-up|2|||
30935092|NCT01827332|58971668|FG001|Overall Study|Lost to Follow-up|1|||
30935093|NCT01719003|58971682|FG000|Overall Study|Non compliant with protocol|1|||
30935094|NCT01719003|58971683|FG001|Overall Study|Non compliant with protocol|1|||
30935095|NCT01719003|58971684|FG002|Overall Study|Non compliant with protocol|0|||
30935096|NCT01719003|58971685|FG003|Overall Study|Non compliant with protocol|1|||
30935097|NCT01719003|58971686|FG004|Overall Study|Non compliant with protocol|2|||
30840619|NCT02710214|58866152|FG001|Overall Study|Lost to Follow-up|0|||
30840620|NCT02710214|58866151|FG000|Overall Study|Lack of Efficacy|0|||
30840621|NCT02710214|58866152|FG001|Overall Study|Lack of Efficacy|1|||
30840622|NCT02710214|58866151|FG000|Overall Study|Death|0|||
30840623|NCT02710214|58866152|FG001|Overall Study|Death|1|||
30840624|NCT03052517|58866161|FG000|Overall Study|Study Terminated By Sponsor|928|||
30840625|NCT03052517|58866162|FG001|Overall Study|Study Terminated By Sponsor|938|||
30840626|NCT03052517|58866163|FG002|Overall Study|Study Terminated By Sponsor|296|||
30840627|NCT03052517|58866161|FG000|Overall Study|Subject/Guardian Decision|50|||
30840628|NCT03052517|58866162|FG001|Overall Study|Subject/Guardian Decision|45|||
30840629|NCT03052517|58866163|FG002|Overall Study|Subject/Guardian Decision|22|||
30840630|NCT03052517|58866161|FG000|Overall Study|Lack of Efficacy|23|||
30935098|NCT01719003|58971687|FG005|Overall Study|Non compliant with protocol|1|||
30935099|NCT01719003|58971688|FG006|Overall Study|Non compliant with protocol|2|||
30935100|NCT01719003|58971689|FG007|Overall Study|Non compliant with protocol|3|||
30935101|NCT01719003|58971690|FG008|Overall Study|Non compliant with protocol|0|||
30935102|NCT01719003|58971682|FG000|Overall Study|Adverse Event|6|||
30935103|NCT01719003|58971683|FG001|Overall Study|Adverse Event|5|||
30935104|NCT01719003|58971684|FG002|Overall Study|Adverse Event|4|||
30935105|NCT01719003|58971685|FG003|Overall Study|Adverse Event|3|||
30935106|NCT01719003|58971686|FG004|Overall Study|Adverse Event|4|||
30935107|NCT01719003|58971687|FG005|Overall Study|Adverse Event|3|||
30935108|NCT01719003|58971688|FG006|Overall Study|Adverse Event|6|||
30935109|NCT01719003|58971689|FG007|Overall Study|Adverse Event|5|||
30935110|NCT01719003|58971690|FG008|Overall Study|Adverse Event|0|||
30935111|NCT01719003|58971682|FG000|Overall Study|Lost to Follow-up|0|||
30935112|NCT01719003|58971683|FG001|Overall Study|Lost to Follow-up|6|||
30935113|NCT01719003|58971684|FG002|Overall Study|Lost to Follow-up|7|||
30840631|NCT03052517|58866162|FG001|Overall Study|Lack of Efficacy|14|||
30840632|NCT03052517|58866163|FG002|Overall Study|Lack of Efficacy|7|||
30935114|NCT01719003|58971685|FG003|Overall Study|Lost to Follow-up|2|||
30935115|NCT01719003|58971686|FG004|Overall Study|Lost to Follow-up|3|||
30935116|NCT01719003|58971687|FG005|Overall Study|Lost to Follow-up|4|||
30935117|NCT01719003|58971688|FG006|Overall Study|Lost to Follow-up|3|||
30840633|NCT03052517|58866161|FG000|Overall Study|Adverse Event|6|||
30840634|NCT03052517|58866162|FG001|Overall Study|Adverse Event|5|||
30935118|NCT01719003|58971689|FG007|Overall Study|Lost to Follow-up|2|||
30935119|NCT01719003|58971690|FG008|Overall Study|Lost to Follow-up|2|||
30948538|NCT01974323|58994553|FG000|Overall Study|Personal Reasons|15|||
30840635|NCT03052517|58866163|FG002|Overall Study|Adverse Event|0|||
30840636|NCT03052517|58866161|FG000|Overall Study|Physician Decision|4|||
30840637|NCT03052517|58866162|FG001|Overall Study|Physician Decision|5|||
30840638|NCT03052517|58866163|FG002|Overall Study|Physician Decision|1|||
30840639|NCT03052517|58866161|FG000|Overall Study|Death|3|||
30840640|NCT03052517|58866162|FG001|Overall Study|Death|0|||
30840641|NCT03052517|58866163|FG002|Overall Study|Death|1|||
30840642|NCT03052517|58866161|FG000|Overall Study|Lost to Follow-up|2|||
30840643|NCT03052517|58866162|FG001|Overall Study|Lost to Follow-up|4|||
30840644|NCT03052517|58866163|FG002|Overall Study|Lost to Follow-up|0|||
30840645|NCT03052517|58866161|FG000|Overall Study|Pregnancy|1|||
30840646|NCT03052517|58866162|FG001|Overall Study|Pregnancy|0|||
30935120|NCT01719003|58971682|FG000|Overall Study|Refusal to continue, not due to AE|2|||
30935121|NCT01719003|58971683|FG001|Overall Study|Refusal to continue, not due to AE|5|||
30935122|NCT01719003|58971684|FG002|Overall Study|Refusal to continue, not due to AE|4|||
30935123|NCT01719003|58971685|FG003|Overall Study|Refusal to continue, not due to AE|4|||
30935124|NCT01719003|58971686|FG004|Overall Study|Refusal to continue, not due to AE|4|||
30935125|NCT01719003|58971687|FG005|Overall Study|Refusal to continue, not due to AE|3|||
30840647|NCT03052517|58866163|FG002|Overall Study|Pregnancy|1|||
30840648|NCT03052517|58866161|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
30935126|NCT01719003|58971688|FG006|Overall Study|Refusal to continue, not due to AE|8|||
30935127|NCT01719003|58971689|FG007|Overall Study|Refusal to continue, not due to AE|7|||
30935128|NCT01719003|58971690|FG008|Overall Study|Refusal to continue, not due to AE|1|||
30935129|NCT01719003|58971682|FG000|Overall Study|Reason other than those specified|0|||
30935130|NCT01719003|58971683|FG001|Overall Study|Reason other than those specified|0|||
30935131|NCT01719003|58971684|FG002|Overall Study|Reason other than those specified|2|||
30935132|NCT01719003|58971685|FG003|Overall Study|Reason other than those specified|3|||
30935133|NCT01719003|58971686|FG004|Overall Study|Reason other than those specified|4|||
30935134|NCT01719003|58971687|FG005|Overall Study|Reason other than those specified|1|||
30935135|NCT01719003|58971688|FG006|Overall Study|Reason other than those specified|0|||
30935136|NCT01719003|58971689|FG007|Overall Study|Reason other than those specified|3|||
30935137|NCT01719003|58971690|FG008|Overall Study|Reason other than those specified|1|||
30935138|NCT01719003|58971682|FG000|Overall Study|Lack of Efficacy|0|||
30935139|NCT01719003|58971683|FG001|Overall Study|Lack of Efficacy|0|||
30935140|NCT01719003|58971684|FG002|Overall Study|Lack of Efficacy|0|||
30935141|NCT01719003|58971685|FG003|Overall Study|Lack of Efficacy|0|||
30935142|NCT01719003|58971686|FG004|Overall Study|Lack of Efficacy|0|||
30935143|NCT01719003|58971687|FG005|Overall Study|Lack of Efficacy|0|||
30935144|NCT01719003|58971688|FG006|Overall Study|Lack of Efficacy|1|||
30935145|NCT01719003|58971689|FG007|Overall Study|Lack of Efficacy|0|||
30935146|NCT01719003|58971690|FG008|Overall Study|Lack of Efficacy|0|||
30935147|NCT01853228|58971709|FG000|Phase 1|Lack of Efficacy|8|||
30935148|NCT01853228|58971710|FG001|Phase 1|Lack of Efficacy|0|||
30935149|NCT01853228|58971709|FG000|Phase 1|Other|1|||
30935150|NCT01853228|58971710|FG001|Phase 1|Other|0|||
30935151|NCT01853228|58971709|FG000|Phase 2|Physician Decision|0|||
30935152|NCT01853228|58971710|FG001|Phase 2|Physician Decision|1|||
30935153|NCT01853228|58971709|FG000|Phase 2|Proceed To Transplant|0|||
30935154|NCT01853228|58971710|FG001|Phase 2|Proceed To Transplant|3|||
30935155|NCT01853228|58971709|FG000|Phase 2|Lack of Efficacy|0|||
30935156|NCT01853228|58971710|FG001|Phase 2|Lack of Efficacy|4|||
30935157|NCT01705587|58971717|FG000|Overall Study|Withdrawal by Subject|0|||
30935158|NCT01705587|58971718|FG001|Overall Study|Withdrawal by Subject|1|||
30935159|NCT01718535|58971734|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
30935160|NCT01718535|58971735|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
30935161|NCT01718535|58971736|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
30935162|NCT01718535|58971737|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
30935163|NCT01718535|58971738|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
30935164|NCT01718535|58971739|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
30935165|NCT01718535|58971740|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
30935166|NCT01718535|58971741|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
30935167|NCT01718535|58971742|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
30935168|NCT01718535|58971743|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
30935169|NCT01717989|58971765|FG000|Overall Study|Ineligibility determined|6|||
30935170|NCT01717989|58971765|FG000|Overall Study|Protocol deviation|6|||
30935171|NCT01717989|58971765|FG000|Overall Study|Withdrawal by Subject|11|||
30840649|NCT03052517|58866162|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
30840650|NCT03052517|58866163|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
30840651|NCT03052517|58866161|FG000|Overall Study|Technical Problems|0|||
30840652|NCT03052517|58866162|FG001|Overall Study|Technical Problems|1|||
30840653|NCT03052517|58866163|FG002|Overall Study|Technical Problems|0|||
30840654|NCT02708498|58866179|FG000|Overall Study|Death|20|||
30935172|NCT01717989|58971765|FG000|Overall Study|Physician Decision|2|||
30935173|NCT01717989|58971765|FG000|Overall Study|Lost to Follow-up|11|||
30935174|NCT01717989|58971765|FG000|Overall Study|Death|439|||
30935175|NCT01717989|58971765|FG000|Overall Study|Protocol-specified criteria|551|||
30935176|NCT01717989|58971765|FG000|Overall Study|Other|40|||
30935177|NCT01705509|58971784|FG000|Inclusion CPET|Screen Failure|5|||
30935178|NCT01705509|58971784|FG000|Inclusion CPET|Withdrawal by Subject|2|||
30935179|NCT01705509|58971784|FG000|CPET w/ Ranexa|Screen Failure|2|||
30935180|NCT01853072|58971790|FG000|Overall Study|Adverse event prior to treatment|0|||
30935181|NCT01853072|58971791|FG001|Overall Study|Adverse event prior to treatment|1|||
30935182|NCT01853072|58971790|FG000|Overall Study|Adverse Event|0|||
30935183|NCT01853072|58971791|FG001|Overall Study|Adverse Event|3|||
30935184|NCT01853072|58971790|FG000|Overall Study|Death|1|||
30935185|NCT01853072|58971791|FG001|Overall Study|Death|4|||
30935186|NCT01853072|58971790|FG000|Overall Study|Lost to Follow-up|0|||
30935187|NCT01853072|58971791|FG001|Overall Study|Lost to Follow-up|3|||
30935188|NCT01853072|58971790|FG000|Overall Study|Non-compliance with study drug|0|||
30935189|NCT01853072|58971791|FG001|Overall Study|Non-compliance with study drug|1|||
30935190|NCT01853072|58971790|FG000|Overall Study|Physician Decision|1|||
30935191|NCT01853072|58971791|FG001|Overall Study|Physician Decision|1|||
30935192|NCT01853072|58971790|FG000|Overall Study|Withdrawal by Subject|1|||
30935193|NCT01853072|58971791|FG001|Overall Study|Withdrawal by Subject|2|||
30935194|NCT01853072|58971790|FG000|Overall Study|Reason not specified|9|||
30935195|NCT01853072|58971791|FG001|Overall Study|Reason not specified|6|||
30935196|NCT01877720|58971799|FG000|Overall Study|Adverse Event|1|||
30935197|NCT01877720|58971800|FG001|Overall Study|Adverse Event|0|||
30935198|NCT01870869|58971810|FG000|Overall Study|Implanted with nonstudy device|1|||
30935199|NCT01870869|58971811|FG001|Overall Study|Implanted with nonstudy device|3|||
30935200|NCT01870869|58971812|FG002|Overall Study|Implanted with nonstudy device|14|||
30935201|NCT01870869|58971813|FG003|Overall Study|Implanted with nonstudy device|4|||
30935202|NCT01870869|58971810|FG000|Overall Study|Death|0|||
30935203|NCT01870869|58971811|FG001|Overall Study|Death|0|||
30935204|NCT01870869|58971812|FG002|Overall Study|Death|7|||
30935205|NCT01870869|58971813|FG003|Overall Study|Death|1|||
30935206|NCT01870869|58971810|FG000|Overall Study|Subject choice|6|||
30935207|NCT01870869|58971811|FG001|Overall Study|Subject choice|2|||
30935208|NCT01870869|58971812|FG002|Overall Study|Subject choice|22|||
30935209|NCT01870869|58971813|FG003|Overall Study|Subject choice|8|||
30935210|NCT01870869|58971810|FG000|Overall Study|Lost to Follow-up|10|||
30935211|NCT01870869|58971811|FG001|Overall Study|Lost to Follow-up|2|||
30935212|NCT01870869|58971812|FG002|Overall Study|Lost to Follow-up|25|||
30935213|NCT01870869|58971813|FG003|Overall Study|Lost to Follow-up|3|||
30935214|NCT01870869|58971810|FG000|Overall Study|Reason not Specified|1|||
30935215|NCT01870869|58971811|FG001|Overall Study|Reason not Specified|2|||
30935216|NCT01870869|58971812|FG002|Overall Study|Reason not Specified|20|||
30935217|NCT01870869|58971813|FG003|Overall Study|Reason not Specified|4|||
30935218|NCT01870869|58971810|FG000|Overall Study|Not evaluable|10|||
30935219|NCT01870869|58971811|FG001|Overall Study|Not evaluable|5|||
30935220|NCT01870869|58971812|FG002|Overall Study|Not evaluable|42|||
30935221|NCT01870869|58971813|FG003|Overall Study|Not evaluable|10|||
30935222|NCT01877408|58971825|FG000|Overall Study|Lost to Follow-up|0|||
30935223|NCT01877408|58971826|FG001|Overall Study|Lost to Follow-up|2|||
30935224|NCT01717287|58971835|FG000|Overall Study|Lost to Follow-up|0|||
30935225|NCT01717287|58971836|FG001|Overall Study|Lost to Follow-up|2|||
30935226|NCT01717287|58971835|FG000|Overall Study|Protocol Violation|0|||
30758747|NCT03605836|58767441|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
30758748|NCT03605836|58767442|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
30758749|NCT03605836|58767439|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
30758750|NCT03605836|58767440|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
30840655|NCT02708498|58866180|FG001|Overall Study|Death|19|||
30935227|NCT01717287|58971836|FG001|Overall Study|Protocol Violation|1|||
30758751|NCT03605836|58767441|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
30758752|NCT03605836|58767442|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
30758753|NCT03605836|58767439|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
30758754|NCT03605836|58767440|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
30758755|NCT03605836|58767441|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
30840656|NCT02708498|58866181|FG002|Overall Study|Death|0|||
30840657|NCT02708498|58866182|FG003|Overall Study|Death|0|||
30840658|NCT02708498|58866183|FG004|Overall Study|Death|1|||
30840659|NCT02708498|58866184|FG005|Overall Study|Death|0|||
30935228|NCT01827254|58971842|FG000|Overall Study|Death|10|||
30935229|NCT01827254|58971842|FG000|Overall Study|Case report form not completed|4|||
30935230|NCT01827254|58971842|FG000|Overall Study|Invalidated centre|3|||
30935231|NCT01827254|58971842|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
30935232|NCT01827254|58971842|FG000|Overall Study|Did not complete re-challenge|1|||
30935233|NCT01827254|58971842|FG000|Overall Study|Disease progression|36|||
30935234|NCT01827254|58971842|FG000|Overall Study|Intolerance to treatment|4|||
30935235|NCT01824602|58971854|FG000|Overall Study|Withdrawal by Subject|0|||
30935236|NCT01824602|58971855|FG001|Overall Study|Withdrawal by Subject|0|||
30935237|NCT01824602|58971856|FG002|Overall Study|Withdrawal by Subject|1|||
30935238|NCT01824602|58971857|FG003|Overall Study|Withdrawal by Subject|2|||
30935239|NCT01824602|58971854|FG000|Overall Study|Patient non-compliance|0|||
30935240|NCT01824602|58971855|FG001|Overall Study|Patient non-compliance|0|||
30935241|NCT01824602|58971856|FG002|Overall Study|Patient non-compliance|1|||
30935242|NCT01824602|58971857|FG003|Overall Study|Patient non-compliance|0|||
30935243|NCT01824602|58971854|FG000|Overall Study|Adverse Event|1|||
30935244|NCT01824602|58971855|FG001|Overall Study|Adverse Event|0|||
30935245|NCT01824602|58971856|FG002|Overall Study|Adverse Event|2|||
30935246|NCT01824602|58971857|FG003|Overall Study|Adverse Event|2|||
30935247|NCT01824602|58971854|FG000|Overall Study|Treatment failure|0|||
30935248|NCT01824602|58971855|FG001|Overall Study|Treatment failure|0|||
30935249|NCT01824602|58971856|FG002|Overall Study|Treatment failure|0|||
30935250|NCT01824602|58971857|FG003|Overall Study|Treatment failure|1|||
30935251|NCT01704651|58971869|FG000|Overall Study|Pre-op withdrawal by subject|1|||
30935252|NCT01704651|58971870|FG001|Overall Study|Pre-op withdrawal by subject|1|||
30935253|NCT01704651|58971869|FG000|Overall Study|Pre-op change in treatment plan|1|||
30935254|NCT01704651|58971870|FG001|Overall Study|Pre-op change in treatment plan|4|||
30935255|NCT01704651|58971869|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
30935256|NCT01704651|58971870|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
30935257|NCT01704651|58971869|FG000|Overall Study|Post-op did not have laparotomy|2|||
30935258|NCT01704651|58971870|FG001|Overall Study|Post-op did not have laparotomy|1|||
30935259|NCT01876706|58971876|FG000|Overall Study|BPH Intervention|9|||
30935260|NCT01876706|58971876|FG000|Overall Study|Lost to Follow-up|7|||
30935261|NCT01876706|58971876|FG000|Overall Study|Withdrawals|6|||
30935262|NCT01876706|58971876|FG000|Overall Study|Death|3|||
30840660|NCT02708498|58866185|FG006|Overall Study|Death|0|||
30840661|NCT02708498|58866186|FG007|Overall Study|Death|0|||
30840662|NCT02708498|58866179|FG000|Overall Study|Unknown reason, missing data|0|||
30840663|NCT02708498|58866180|FG001|Overall Study|Unknown reason, missing data|0|||
30840664|NCT02708498|58866181|FG002|Overall Study|Unknown reason, missing data|62|||
30840665|NCT02708498|58866182|FG003|Overall Study|Unknown reason, missing data|51|||
30840666|NCT02708498|58866183|FG004|Overall Study|Unknown reason, missing data|195|||
30840667|NCT02708498|58866184|FG005|Overall Study|Unknown reason, missing data|132|||
30840668|NCT02708498|58866185|FG006|Overall Study|Unknown reason, missing data|0|||
30840669|NCT02708498|58866186|FG007|Overall Study|Unknown reason, missing data|0|||
30840670|NCT02710136|58866204|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
30840671|NCT02710136|58866205|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
30840672|NCT03702231|58866215|FG000|Overall Study|Withdrawal by Subject|1|||
30840673|NCT03702231|58866216|FG001|Overall Study|Withdrawal by Subject|0|||
30840674|NCT03702231|58866217|FG002|Overall Study|Withdrawal by Subject|0|||
30840675|NCT03702231|58866215|FG000|Overall Study|Protocol Violation|0|||
30840676|NCT03702231|58866216|FG001|Overall Study|Protocol Violation|0|||
30840677|NCT03702231|58866217|FG002|Overall Study|Protocol Violation|1|||
30840678|NCT03702231|58866215|FG000|Overall Study|Change in CLL Treatment|0|||
30935263|NCT01876082|58971882|FG000|Overall Study|Withdrawal by Subject|0|||
30935264|NCT01876082|58971883|FG001|Overall Study|Withdrawal by Subject|2|||
30935265|NCT01876082|58971882|FG000|Overall Study|Protocol Violation|1|||
30935266|NCT01876082|58971883|FG001|Overall Study|Protocol Violation|0|||
30758756|NCT03605836|58767442|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
30758757|NCT03605836|58767439|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
30758758|NCT03605836|58767440|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
30758759|NCT03605836|58767441|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
30758760|NCT03605836|58767442|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
30758761|NCT03605836|58767439|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
30758762|NCT03605836|58767440|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
30758763|NCT03605836|58767441|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
30758764|NCT03605836|58767442|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
30758765|NCT03605836|58767439|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
30758766|NCT03605836|58767440|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
30758767|NCT03605836|58767441|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
30840679|NCT03702231|58866216|FG001|Overall Study|Change in CLL Treatment|0|||
30840680|NCT03702231|58866217|FG002|Overall Study|Change in CLL Treatment|1|||
30840681|NCT03702231|58866215|FG000|Overall Study|COVID Pandemic|1|||
30840682|NCT03702231|58866216|FG001|Overall Study|COVID Pandemic|4|||
30935267|NCT01876082|58971882|FG000|Overall Study|Adverse Event|1|||
30935268|NCT01876082|58971883|FG001|Overall Study|Adverse Event|1|||
30935269|NCT01876082|58971882|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
30935270|NCT01876082|58971883|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
30935271|NCT01704495|58971893|FG000|Subjects Randomized|Other Reason|3|||
30935272|NCT01704495|58971894|FG001|Subjects Randomized|Other Reason|2|||
30935273|NCT01704495|58971895|FG002|Subjects Randomized|Other Reason|3|||
30935274|NCT01704495|58971896|FG003|Subjects Randomized|Other Reason|2|||
30935275|NCT01704495|58971893|FG000|Subjects Randomized|Discontinuation criteria met|4|||
30935276|NCT01704495|58971894|FG001|Subjects Randomized|Discontinuation criteria met|2|||
30840683|NCT03702231|58866217|FG002|Overall Study|COVID Pandemic|1|||
30840684|NCT03702231|58866215|FG000|Overall Study|Non-compliance|0|||
30840685|NCT03702231|58866216|FG001|Overall Study|Non-compliance|0|||
30840686|NCT03702231|58866217|FG002|Overall Study|Non-compliance|1|||
30840687|NCT02741271|58866227|FG000|Overall Study|Lost to Follow-up|2|||
30935277|NCT01704495|58971895|FG002|Subjects Randomized|Discontinuation criteria met|2|||
30935278|NCT01704495|58971896|FG003|Subjects Randomized|Discontinuation criteria met|0|||
30935279|NCT01704495|58971893|FG000|Subjects Randomized|Adverse Event|8|||
30935280|NCT01704495|58971894|FG001|Subjects Randomized|Adverse Event|2|||
30935281|NCT01704495|58971895|FG002|Subjects Randomized|Adverse Event|0|||
30935282|NCT01704495|58971896|FG003|Subjects Randomized|Adverse Event|7|||
30935283|NCT01704495|58971893|FG000|Subjects Randomized|Withdrawal by Subject|5|||
30935284|NCT01704495|58971894|FG001|Subjects Randomized|Withdrawal by Subject|5|||
30935285|NCT01704495|58971895|FG002|Subjects Randomized|Withdrawal by Subject|5|||
30935286|NCT01704495|58971896|FG003|Subjects Randomized|Withdrawal by Subject|5|||
30935287|NCT01704495|58971893|FG000|Subjects Randomized|Protocol Violation|1|||
30935288|NCT01704495|58971894|FG001|Subjects Randomized|Protocol Violation|1|||
30935289|NCT01704495|58971895|FG002|Subjects Randomized|Protocol Violation|2|||
30840688|NCT02741271|58866228|FG001|Overall Study|Lost to Follow-up|0|||
30840689|NCT02741271|58866227|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30840690|NCT02741271|58866228|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
30840691|NCT02709746|58866241|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
30840692|NCT02709746|58866242|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
30840693|NCT02709746|58866243|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
30840694|NCT02709746|58866244|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
30935290|NCT01704495|58971896|FG003|Subjects Randomized|Protocol Violation|0|||
30935291|NCT01704495|58971893|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
30935292|NCT01704495|58971894|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
30935293|NCT01704495|58971895|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
30935294|NCT01704495|58971896|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
30935295|NCT01704495|58971893|FG000|Optional Safety Extension|Adverse Event|0|||
30935296|NCT01704495|58971894|FG001|Optional Safety Extension|Adverse Event|4|||
30935297|NCT01704495|58971895|FG002|Optional Safety Extension|Adverse Event|0|||
30935298|NCT01704495|58971896|FG003|Optional Safety Extension|Adverse Event|1|||
30935299|NCT01704495|58971893|FG000|Optional Safety Extension|Other reason|27|||
30935300|NCT01704495|58971894|FG001|Optional Safety Extension|Other reason|29|||
30935301|NCT01704495|58971895|FG002|Optional Safety Extension|Other reason|30|||
30935302|NCT01704495|58971896|FG003|Optional Safety Extension|Other reason|28|||
30935303|NCT01704495|58971893|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
30758768|NCT03605836|58767442|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
30758769|NCT03605836|58767439|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
30840695|NCT02709746|58866245|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
30840696|NCT02709746|58866241|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
30840697|NCT02709746|58866242|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
30840698|NCT02709746|58866243|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
30840699|NCT02709746|58866244|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
30840700|NCT02709746|58866245|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
30840701|NCT02709746|58866241|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
30840702|NCT02709746|58866242|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
30840703|NCT02709746|58866243|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
30840704|NCT02709746|58866244|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
30840705|NCT02709746|58866245|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
30935304|NCT01704495|58971894|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
30935305|NCT01704495|58971895|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
30758770|NCT03605836|58767440|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
30758771|NCT03605836|58767441|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
30758772|NCT03605836|58767442|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
30758773|NCT03605836|58767439|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
30758774|NCT03605836|58767440|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
30758775|NCT03605836|58767441|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
30758776|NCT03605836|58767442|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
30758777|NCT03605836|58767439|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
30840706|NCT02709746|58866241|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
30840707|NCT02709746|58866242|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
30935306|NCT01704495|58971896|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
30935307|NCT01716663|58971906|FG000|Overall Study|Withdrawn prior to procedure|4|||
30935308|NCT01716663|58971906|FG000|Overall Study|Treated with non-study catheter|2|||
30935309|NCT01716585|58971912|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
30935310|NCT01716585|58971913|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
30935311|NCT01716585|58971912|FG000|Double-blind Treatment|Adverse Event|2|||
30935312|NCT01716585|58971913|FG001|Double-blind Treatment|Adverse Event|1|||
30935313|NCT01716585|58971912|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
30935314|NCT01716585|58971913|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
30935315|NCT01716585|58971912|FG000|Double-blind Treatment|Lost to Follow-up|2|||
30935316|NCT01716585|58971913|FG001|Double-blind Treatment|Lost to Follow-up|0|||
30935317|NCT01716585|58971912|FG000|Double-blind Treatment|Subject Noncompliant|1|||
30935318|NCT01716585|58971913|FG001|Double-blind Treatment|Subject Noncompliant|0|||
30935319|NCT01716585|58971912|FG000|Double-blind Treatment|Other|1|||
30935320|NCT01716585|58971913|FG001|Double-blind Treatment|Other|0|||
30935321|NCT01716585|58971912|FG000|Open-label Treatment|Adverse Event|0|||
30935322|NCT01716585|58971913|FG001|Open-label Treatment|Adverse Event|2|||
30935323|NCT01716585|58971912|FG000|Open-label Treatment|Virologic Failure|0|||
30935324|NCT01716585|58971913|FG001|Open-label Treatment|Virologic Failure|2|||
30935325|NCT01716585|58971912|FG000|Open-label Treatment|Withdrawal by Subject|0|||
30935326|NCT01716585|58971913|FG001|Open-label Treatment|Withdrawal by Subject|3|||
30935327|NCT01852292|58971922|FG000|Overall Study|Untreated - did not receive study drug|3|||
30935328|NCT01852292|58971923|FG001|Overall Study|Untreated - did not receive study drug|1|||
30935329|NCT01852292|58971922|FG000|Overall Study|Death|9|||
30935330|NCT01852292|58971923|FG001|Overall Study|Death|8|||
30935331|NCT01852292|58971922|FG000|Overall Study|Patient/guardian decision|8|||
30935332|NCT01852292|58971923|FG001|Overall Study|Patient/guardian decision|4|||
30935333|NCT01852292|58971922|FG000|Overall Study|Adverse Event|8|||
30935334|NCT01852292|58971923|FG001|Overall Study|Adverse Event|11|||
30935335|NCT01852292|58971922|FG000|Overall Study|Physician Decision|6|||
30840708|NCT02709746|58866243|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
30840709|NCT02709746|58866244|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
30840710|NCT02709746|58866245|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
30840711|NCT02709746|58866241|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
30840712|NCT02709746|58866242|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
30840713|NCT02709746|58866243|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
30840714|NCT02709746|58866244|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
30840715|NCT02709746|58866245|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
30840716|NCT02709746|58866241|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
30840717|NCT02709746|58866242|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
30840718|NCT02709746|58866243|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
30840719|NCT02709746|58866244|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
30840720|NCT02709746|58866245|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
30840721|NCT02709746|58866241|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
30840722|NCT02709746|58866242|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
30840723|NCT02709746|58866243|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
30840724|NCT02709746|58866244|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
30840725|NCT02709746|58866245|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
30840726|NCT02709746|58866241|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
30840727|NCT02709746|58866242|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
30840728|NCT02709746|58866243|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
30840729|NCT02709746|58866244|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
30840730|NCT02709746|58866245|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
30840731|NCT02709746|58866241|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
30840732|NCT02709746|58866242|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
30840733|NCT02709746|58866243|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
30840734|NCT02709746|58866244|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
30840735|NCT02709746|58866245|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
30840736|NCT02709746|58866241|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
30840737|NCT02709746|58866242|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
30935336|NCT01852292|58971923|FG001|Overall Study|Physician Decision|2|||
30624301|NCT00883129|58636303|FG000|Overall Study|Withdrawal by Subject|8|||
30624302|NCT00883129|58636304|FG001|Overall Study|Withdrawal by Subject|9|||
30840738|NCT02709746|58866243|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
30840739|NCT02709746|58866244|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
30935337|NCT01852292|58971922|FG000|Overall Study|Protocol Violation|2|||
30935338|NCT01852292|58971923|FG001|Overall Study|Protocol Violation|0|||
30935339|NCT01852292|58971922|FG000|Overall Study|Non-compliance with study treatment|1|||
30935340|NCT01852292|58971923|FG001|Overall Study|Non-compliance with study treatment|0|||
30935341|NCT01852292|58971922|FG000|Overall Study|Study terminated by Sponsor|0|||
30840740|NCT02709746|58866245|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
30840741|NCT02709746|58866241|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
30840742|NCT02709746|58866242|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
30935342|NCT01852292|58971923|FG001|Overall Study|Study terminated by Sponsor|1|||
30935343|NCT01852292|58971922|FG000|Overall Study|Progressive disease|42|||
30935344|NCT01852292|58971923|FG001|Overall Study|Progressive disease|52|||
30935345|NCT01715805|58971929|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
30935346|NCT01715805|58971930|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
30935347|NCT01715805|58971931|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
30935348|NCT01715805|58971932|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
30935349|NCT01715805|58971929|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
30935350|NCT01715805|58971930|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
30935351|NCT01715805|58971931|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
30935352|NCT01715805|58971932|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
30935353|NCT01715805|58971929|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
30935354|NCT01715805|58971930|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
30935355|NCT01715805|58971931|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
30935356|NCT01715805|58971932|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
30935357|NCT01715805|58971929|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
30935358|NCT01715805|58971930|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
30935359|NCT01715805|58971931|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
30935360|NCT01715805|58971932|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
30758778|NCT03605836|58767440|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
30758779|NCT03605836|58767441|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
30758780|NCT03605836|58767442|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
30758781|NCT03605836|58767439|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
30758782|NCT03605836|58767440|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
30758783|NCT03605836|58767441|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
30758784|NCT03605836|58767442|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
30840743|NCT02709746|58866243|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
30840744|NCT02709746|58866244|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
30840745|NCT02709746|58866245|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
30840746|NCT02709746|58866241|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
30840747|NCT02709746|58866242|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
30840748|NCT02709746|58866243|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
30840749|NCT02709746|58866244|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
30840750|NCT02709746|58866245|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
30840751|NCT02709746|58866241|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
30840752|NCT02709746|58866242|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
30840753|NCT02709746|58866243|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
30840754|NCT02709746|58866244|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
30840755|NCT02709746|58866245|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
30840756|NCT02709746|58866241|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
30840757|NCT02709746|58866242|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
30840758|NCT02709746|58866243|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
30840759|NCT02709746|58866244|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
30840760|NCT02709746|58866245|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
30840761|NCT02709746|58866241|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
30935361|NCT01715805|58971929|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
30935362|NCT01715805|58971930|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
30935363|NCT01715805|58971931|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
30935364|NCT01715805|58971932|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
30935365|NCT01715805|58971929|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
30935366|NCT01715805|58971930|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
30935367|NCT01715805|58971931|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
30935368|NCT01715805|58971932|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
30935369|NCT01715805|58971929|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
30935370|NCT01715805|58971930|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
30935371|NCT01715805|58971931|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
30935372|NCT01715805|58971932|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
30935373|NCT01715805|58971929|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
30935374|NCT01715805|58971930|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
30758785|NCT03605836|58767439|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
30840762|NCT02709746|58866242|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
30624303|NCT00883129|58636303|FG000|Overall Study|Non-compliance|3|||
30935375|NCT01715805|58971931|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
30935376|NCT01715805|58971932|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
30935377|NCT01715805|58971929|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
30935378|NCT01715805|58971930|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
30935379|NCT01715805|58971931|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
30935380|NCT01715805|58971932|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
30935381|NCT01715805|58971929|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
30935382|NCT01715805|58971930|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
30935383|NCT01715805|58971931|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
30935384|NCT01715805|58971932|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
30935385|NCT01715805|58971929|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
30935386|NCT01715805|58971930|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
30935387|NCT01715805|58971931|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
30935388|NCT01715805|58971932|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
30935389|NCT01715805|58971929|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
30935390|NCT01715805|58971930|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
30935391|NCT01715805|58971931|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
30935392|NCT01715805|58971932|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
30935393|NCT01715805|58971929|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
30935394|NCT01715805|58971930|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
30935395|NCT01715805|58971931|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
30935396|NCT01715805|58971932|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
30935397|NCT01715805|58971929|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
30935398|NCT01715805|58971930|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
30935399|NCT01715805|58971931|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
30935400|NCT01715805|58971932|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
30935401|NCT01852214|58971940|FG000|Period 1|Adverse Event|1|||
30935402|NCT01852214|58971941|FG001|Period 1|Adverse Event|2|||
30935403|NCT01852214|58971940|FG000|Period 1|Withdrawal by Subject|0|||
30935404|NCT01852214|58971941|FG001|Period 1|Withdrawal by Subject|1|||
30935405|NCT01852214|58971940|FG000|Washout Period|Withdrawal by Subject|0|||
30935406|NCT01852214|58971941|FG001|Washout Period|Withdrawal by Subject|1|||
30935407|NCT01393990|58971966|FG000|Overall Study|Adverse Event|0|||
30935408|NCT01393990|58971967|FG001|Overall Study|Adverse Event|0|||
30935409|NCT01393990|58971968|FG002|Overall Study|Adverse Event|0|||
30935410|NCT01393990|58971969|FG003|Overall Study|Adverse Event|0|||
30935411|NCT01393990|58971970|FG004|Overall Study|Adverse Event|0|||
30935412|NCT01393990|58971971|FG005|Overall Study|Adverse Event|0|||
30935413|NCT01393990|58971972|FG006|Overall Study|Adverse Event|0|||
30935414|NCT01393990|58971973|FG007|Overall Study|Adverse Event|0|||
30935415|NCT01393990|58971974|FG008|Overall Study|Adverse Event|0|||
30935416|NCT01393990|58971975|FG009|Overall Study|Adverse Event|0|||
30935417|NCT01393990|58971976|FG010|Overall Study|Adverse Event|0|||
30935418|NCT01393990|58971977|FG011|Overall Study|Adverse Event|0|||
30935419|NCT01393990|58971978|FG012|Overall Study|Adverse Event|0|||
30935420|NCT01393990|58971979|FG013|Overall Study|Adverse Event|0|||
30935421|NCT01393990|58971980|FG014|Overall Study|Adverse Event|1|||
30935422|NCT01393990|58971981|FG015|Overall Study|Adverse Event|1|||
30935423|NCT01393990|58971982|FG016|Overall Study|Adverse Event|0|||
30935424|NCT01393990|58971983|FG017|Overall Study|Adverse Event|0|||
30935425|NCT01393990|58971966|FG000|Overall Study|Progressive Disease|1|||
30935426|NCT01393990|58971967|FG001|Overall Study|Progressive Disease|0|||
30935427|NCT01393990|58971968|FG002|Overall Study|Progressive Disease|0|||
30935428|NCT01393990|58971969|FG003|Overall Study|Progressive Disease|1|||
30935429|NCT01393990|58971970|FG004|Overall Study|Progressive Disease|1|||
30935430|NCT01393990|58971971|FG005|Overall Study|Progressive Disease|1|||
30935431|NCT01393990|58971972|FG006|Overall Study|Progressive Disease|1|||
30935432|NCT01393990|58971973|FG007|Overall Study|Progressive Disease|1|||
30935433|NCT01393990|58971974|FG008|Overall Study|Progressive Disease|3|||
30935434|NCT01393990|58971975|FG009|Overall Study|Progressive Disease|1|||
30935435|NCT01393990|58971976|FG010|Overall Study|Progressive Disease|0|||
30935436|NCT01393990|58971977|FG011|Overall Study|Progressive Disease|0|||
30624304|NCT00883129|58636304|FG001|Overall Study|Non-compliance|6|||
30935437|NCT01393990|58971978|FG012|Overall Study|Progressive Disease|0|||
30935438|NCT01393990|58971979|FG013|Overall Study|Progressive Disease|1|||
30935439|NCT01393990|58971980|FG014|Overall Study|Progressive Disease|6|||
30624305|NCT00883129|58636303|FG000|Overall Study|Lost to Follow-up|1|||
30758786|NCT03605836|58767440|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
30935440|NCT01393990|58971981|FG015|Overall Study|Progressive Disease|1|||
30935441|NCT01393990|58971982|FG016|Overall Study|Progressive Disease|0|||
30935442|NCT01393990|58971983|FG017|Overall Study|Progressive Disease|0|||
30935443|NCT01393990|58971966|FG000|Overall Study|Death|0|||
30935444|NCT01393990|58971967|FG001|Overall Study|Death|0|||
30935445|NCT01393990|58971968|FG002|Overall Study|Death|0|||
30935446|NCT01393990|58971969|FG003|Overall Study|Death|0|||
30935447|NCT01393990|58971970|FG004|Overall Study|Death|1|||
30935448|NCT01393990|58971971|FG005|Overall Study|Death|0|||
30935449|NCT01393990|58971972|FG006|Overall Study|Death|0|||
30935450|NCT01393990|58971973|FG007|Overall Study|Death|0|||
30840763|NCT02709746|58866243|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
30840764|NCT02709746|58866244|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
30840765|NCT02709746|58866245|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
30840766|NCT02709746|58866241|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
30840767|NCT02709746|58866242|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
30840768|NCT02709746|58866243|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
30840769|NCT02709746|58866244|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
30840770|NCT02709746|58866245|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
30840771|NCT02709746|58866241|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
30840772|NCT02709746|58866242|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
30840773|NCT02709746|58866243|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
30840774|NCT02709746|58866244|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
30840775|NCT02709746|58866245|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
30840776|NCT01317641|58866266|FG000|Overall Study|Not treated|0|||
30840777|NCT01317641|58866267|FG001|Overall Study|Not treated|0|||
30840778|NCT01317641|58866268|FG002|Overall Study|Not treated|0|||
30935451|NCT01393990|58971974|FG008|Overall Study|Death|0|||
30935452|NCT01393990|58971975|FG009|Overall Study|Death|0|||
30935453|NCT01393990|58971976|FG010|Overall Study|Death|0|||
30935454|NCT01393990|58971977|FG011|Overall Study|Death|0|||
30935455|NCT01393990|58971978|FG012|Overall Study|Death|0|||
30935456|NCT01393990|58971979|FG013|Overall Study|Death|1|||
30935457|NCT01393990|58971980|FG014|Overall Study|Death|1|||
30935458|NCT01393990|58971981|FG015|Overall Study|Death|0|||
30935459|NCT01393990|58971982|FG016|Overall Study|Death|0|||
30935460|NCT01393990|58971983|FG017|Overall Study|Death|0|||
30935461|NCT01393990|58971966|FG000|Overall Study|Withdrawal by Subject|0|||
30935462|NCT01393990|58971967|FG001|Overall Study|Withdrawal by Subject|0|||
30840779|NCT01317641|58866269|FG003|Overall Study|Not treated|0|||
30935463|NCT01393990|58971968|FG002|Overall Study|Withdrawal by Subject|0|||
30935464|NCT01393990|58971969|FG003|Overall Study|Withdrawal by Subject|0|||
30935465|NCT01393990|58971970|FG004|Overall Study|Withdrawal by Subject|0|||
30935466|NCT01393990|58971971|FG005|Overall Study|Withdrawal by Subject|0|||
30935467|NCT01393990|58971972|FG006|Overall Study|Withdrawal by Subject|0|||
30935468|NCT01393990|58971973|FG007|Overall Study|Withdrawal by Subject|0|||
30935469|NCT01393990|58971974|FG008|Overall Study|Withdrawal by Subject|0|||
30935470|NCT01393990|58971975|FG009|Overall Study|Withdrawal by Subject|0|||
30935471|NCT01393990|58971976|FG010|Overall Study|Withdrawal by Subject|0|||
30935472|NCT01393990|58971977|FG011|Overall Study|Withdrawal by Subject|0|||
30935473|NCT01393990|58971978|FG012|Overall Study|Withdrawal by Subject|0|||
30935474|NCT01393990|58971979|FG013|Overall Study|Withdrawal by Subject|0|||
30935475|NCT01393990|58971980|FG014|Overall Study|Withdrawal by Subject|1|||
30935476|NCT01393990|58971981|FG015|Overall Study|Withdrawal by Subject|1|||
30935477|NCT01393990|58971982|FG016|Overall Study|Withdrawal by Subject|0|||
30935478|NCT01393990|58971983|FG017|Overall Study|Withdrawal by Subject|0|||
30935479|NCT00210184|58972032|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
30935480|NCT00210106|58972036|FG000|Overall Study|Death|1|||
30935481|NCT00210106|58972036|FG000|Overall Study|Protocol Violation|13|||
30935482|NCT01851590|58972044|FG000|Overall Study|Withdrawal by Subject|0|||
30935483|NCT01851590|58972045|FG001|Overall Study|Withdrawal by Subject|0|||
30935484|NCT01851590|58972046|FG002|Overall Study|Withdrawal by Subject|1|||
30935485|NCT01851590|58972044|FG000|Overall Study|Adverse Event|0|||
30935486|NCT01851590|58972045|FG001|Overall Study|Adverse Event|0|||
30935487|NCT01851590|58972046|FG002|Overall Study|Adverse Event|2|||
30935488|NCT01851590|58972044|FG000|Overall Study|Lack of Efficacy|0|||
30840780|NCT01317641|58866270|FG004|Overall Study|Not treated|0|||
30840781|NCT01317641|58866271|FG005|Overall Study|Not treated|0|||
30840782|NCT01317641|58866272|FG006|Overall Study|Not treated|0|||
30840783|NCT01317641|58866273|FG007|Overall Study|Not treated|1|||
30935489|NCT01851590|58972045|FG001|Overall Study|Lack of Efficacy|1|||
30935490|NCT01851590|58972046|FG002|Overall Study|Lack of Efficacy|0|||
30935491|NCT01852058|58972061|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
30935492|NCT01852058|58972062|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
30935493|NCT01852058|58972063|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
30935494|NCT01852058|58972064|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
30935495|NCT01852058|58972065|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
30935496|NCT01852058|58972066|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
30935497|NCT01852058|58972067|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
30758787|NCT03605836|58767441|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
30758788|NCT03605836|58767442|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
30758789|NCT03605836|58767439|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
30758790|NCT03605836|58767440|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
30758791|NCT03605836|58767441|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
30758792|NCT03605836|58767442|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
30758793|NCT03605836|58767439|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
30758794|NCT03605836|58767440|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
30758795|NCT03605836|58767441|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
30758796|NCT03605836|58767442|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
30758797|NCT03605836|58767439|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
30758798|NCT03605836|58767440|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
30758799|NCT03605836|58767441|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
30758800|NCT03605836|58767442|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
30758801|NCT03605836|58767439|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
30758802|NCT03605836|58767440|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
30758803|NCT03605836|58767441|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
30758804|NCT03605836|58767442|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
30758805|NCT03605836|58767439|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
30758806|NCT03605836|58767440|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
30758807|NCT03605836|58767441|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
30840784|NCT01317641|58866274|FG008|Overall Study|Not treated|1|||
30840785|NCT01317641|58866266|FG000|Overall Study|Adverse Event|0|||
30840786|NCT01317641|58866267|FG001|Overall Study|Adverse Event|1|||
30840787|NCT01317641|58866268|FG002|Overall Study|Adverse Event|0|||
30840788|NCT01317641|58866269|FG003|Overall Study|Adverse Event|1|||
30840789|NCT01317641|58866270|FG004|Overall Study|Adverse Event|0|||
30840790|NCT01317641|58866271|FG005|Overall Study|Adverse Event|0|||
30935498|NCT01852058|58972068|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
30935499|NCT01852058|58972069|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
30935500|NCT01852058|58972070|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
30935501|NCT01852058|58972071|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
30935502|NCT01852058|58972072|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
30935503|NCT01852058|58972061|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
30935504|NCT01852058|58972062|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
30935505|NCT01852058|58972063|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
30935506|NCT01852058|58972064|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
30935507|NCT01852058|58972065|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
30935508|NCT01852058|58972066|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
30935509|NCT01852058|58972067|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
30935510|NCT01852058|58972068|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
30935511|NCT01852058|58972069|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
30935512|NCT01852058|58972070|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
30935513|NCT01852058|58972071|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
30935514|NCT01852058|58972072|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
30935515|NCT01852058|58972061|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
30935516|NCT01852058|58972062|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
30935517|NCT01852058|58972063|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
30935518|NCT01852058|58972064|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
30840791|NCT01317641|58866272|FG006|Overall Study|Adverse Event|2|||
30840792|NCT01317641|58866273|FG007|Overall Study|Adverse Event|1|||
30840793|NCT01317641|58866274|FG008|Overall Study|Adverse Event|0|||
30840794|NCT01317641|58866266|FG000|Overall Study|Protocol Violation|1|||
30840795|NCT01317641|58866267|FG001|Overall Study|Protocol Violation|0|||
30840796|NCT01317641|58866268|FG002|Overall Study|Protocol Violation|0|||
30840797|NCT01317641|58866269|FG003|Overall Study|Protocol Violation|0|||
30840798|NCT01317641|58866270|FG004|Overall Study|Protocol Violation|0|||
30935519|NCT01852058|58972065|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
30935520|NCT01852058|58972066|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
30935521|NCT01852058|58972067|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
30935522|NCT01852058|58972068|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
30840799|NCT01317641|58866271|FG005|Overall Study|Protocol Violation|0|||
30840800|NCT01317641|58866272|FG006|Overall Study|Protocol Violation|0|||
30935523|NCT01852058|58972069|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
30935524|NCT01852058|58972070|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
30840801|NCT01317641|58866273|FG007|Overall Study|Protocol Violation|0|||
30840802|NCT01317641|58866274|FG008|Overall Study|Protocol Violation|0|||
30840803|NCT01317641|58866266|FG000|Overall Study|Disease progression|0|||
30840804|NCT01317641|58866267|FG001|Overall Study|Disease progression|0|||
30840805|NCT01317641|58866268|FG002|Overall Study|Disease progression|0|||
30840806|NCT01317641|58866269|FG003|Overall Study|Disease progression|0|||
30840807|NCT01317641|58866270|FG004|Overall Study|Disease progression|0|||
30840808|NCT01317641|58866271|FG005|Overall Study|Disease progression|0|||
30840809|NCT01317641|58866272|FG006|Overall Study|Disease progression|0|||
30935525|NCT01852058|58972071|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
30935526|NCT01852058|58972072|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
30935527|NCT01852058|58972061|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
30935528|NCT01852058|58972062|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
30840810|NCT01317641|58866273|FG007|Overall Study|Disease progression|3|||
30840811|NCT01317641|58866274|FG008|Overall Study|Disease progression|4|||
30840812|NCT01317641|58866266|FG000|Overall Study|Withdrawal by Subject|0|||
30840813|NCT01317641|58866267|FG001|Overall Study|Withdrawal by Subject|0|||
30935529|NCT01852058|58972063|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
30758808|NCT03605836|58767442|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
30758809|NCT03605836|58767439|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
30758810|NCT03605836|58767440|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
30758811|NCT03605836|58767441|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
30758812|NCT03605836|58767442|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
30758813|NCT03605836|58767439|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
30758814|NCT03605836|58767440|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
30758815|NCT03605836|58767441|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
30758816|NCT03605836|58767442|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
30758817|NCT03605836|58767439|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
30758818|NCT03605836|58767440|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
30758819|NCT03605836|58767441|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
30758820|NCT03605836|58767442|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
30758821|NCT03605836|58767439|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
30758822|NCT03605836|58767440|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
30758823|NCT03605836|58767441|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
30758824|NCT03605836|58767442|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
30758825|NCT03605836|58767439|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
30758826|NCT03605836|58767440|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
30758827|NCT03605836|58767441|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
30758828|NCT03605836|58767442|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
30758829|NCT03605836|58767439|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
30758830|NCT03605836|58767440|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
30758831|NCT03605836|58767441|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
30758832|NCT03605836|58767442|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
30758833|NCT03605680|58767455|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
30758834|NCT03605680|58767456|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
30758835|NCT03605680|58767457|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
30758836|NCT03605680|58767458|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
30758837|NCT03605680|58767455|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
30758838|NCT03605680|58767456|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
30758839|NCT03605680|58767457|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
30758840|NCT03605680|58767458|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
30758841|NCT03605680|58767455|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
30758842|NCT03605680|58767456|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
30758843|NCT03605680|58767457|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
30758844|NCT03605680|58767458|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
30758845|NCT03605680|58767455|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
30840814|NCT01317641|58866268|FG002|Overall Study|Withdrawal by Subject|0|||
30840815|NCT01317641|58866269|FG003|Overall Study|Withdrawal by Subject|0|||
30840816|NCT01317641|58866270|FG004|Overall Study|Withdrawal by Subject|0|||
30840817|NCT01317641|58866271|FG005|Overall Study|Withdrawal by Subject|0|||
30840818|NCT01317641|58866272|FG006|Overall Study|Withdrawal by Subject|1|||
30840819|NCT01317641|58866273|FG007|Overall Study|Withdrawal by Subject|0|||
30840820|NCT01317641|58866274|FG008|Overall Study|Withdrawal by Subject|0|||
30840821|NCT03186794|58866310|FG000|Overall Study|Physician Decision|2|||
30840822|NCT03186794|58866310|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
30840823|NCT02290431|58866315|FG000|Overall Study|Adverse Event|20|||
30935530|NCT01852058|58972064|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
30935531|NCT01852058|58972065|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
30935532|NCT01852058|58972066|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
30935533|NCT01852058|58972067|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
30935534|NCT01852058|58972068|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
30935535|NCT01852058|58972069|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
30935536|NCT01852058|58972070|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
30935537|NCT01852058|58972071|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
30935538|NCT01852058|58972072|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
30935539|NCT01852058|58972061|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
30935540|NCT01852058|58972062|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
30935541|NCT01852058|58972063|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
30935542|NCT01852058|58972064|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
30935543|NCT01852058|58972065|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
30935544|NCT01852058|58972066|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
30935545|NCT01852058|58972067|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
30935546|NCT01852058|58972068|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
30935547|NCT01852058|58972069|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
30935548|NCT01852058|58972070|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
30935549|NCT01852058|58972071|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
30935550|NCT01852058|58972072|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
30935551|NCT01852058|58972061|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
30935552|NCT01852058|58972062|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
30935553|NCT01852058|58972063|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
30935554|NCT01852058|58972064|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
30935555|NCT01852058|58972065|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
30935556|NCT01852058|58972066|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
30935557|NCT01852058|58972067|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
30935558|NCT01852058|58972068|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
30935559|NCT01852058|58972069|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
30935560|NCT01852058|58972070|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
30935561|NCT01852058|58972071|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
30935562|NCT01852058|58972072|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
30935563|NCT01852058|58972061|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
30935564|NCT01852058|58972062|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
30935565|NCT01852058|58972063|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
30935566|NCT01852058|58972064|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
30935567|NCT01852058|58972065|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
30935568|NCT01852058|58972066|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
30935569|NCT01852058|58972067|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
30935570|NCT01852058|58972068|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
30935571|NCT01852058|58972069|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
30935572|NCT01852058|58972070|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
30935573|NCT01852058|58972071|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
30935574|NCT01852058|58972072|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
30935575|NCT01852058|58972061|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
30935576|NCT01852058|58972062|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
30935577|NCT01852058|58972063|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
30935578|NCT01852058|58972064|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
30935579|NCT01852058|58972065|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
30935580|NCT01852058|58972066|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
30935581|NCT01852058|58972067|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
30935582|NCT01852058|58972068|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
30935583|NCT01852058|58972069|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
30935584|NCT01852058|58972070|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
30935585|NCT01852058|58972071|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
30935586|NCT01852058|58972072|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
30935587|NCT01852058|58972061|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
30935588|NCT01852058|58972062|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
30935589|NCT01852058|58972063|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
30840824|NCT02290431|58866315|FG000|Overall Study|Progressive disease|4|||
30935590|NCT01852058|58972064|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
30935591|NCT01852058|58972065|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
30935592|NCT01852058|58972066|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
30935593|NCT01852058|58972067|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
30935594|NCT01852058|58972068|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
30935595|NCT01852058|58972069|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
30935596|NCT01852058|58972070|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
30935597|NCT01852058|58972071|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
30935598|NCT01852058|58972072|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
30935599|NCT00218296|58972109|FG000|Overall Study|Lost to Follow-up|9|||
30935600|NCT00218296|58972110|FG001|Overall Study|Lost to Follow-up|7|||
30935601|NCT00218296|58972109|FG000|Overall Study|Withdrawal by Subject|36|||
30935602|NCT00218296|58972110|FG001|Overall Study|Withdrawal by Subject|47|||
30935603|NCT00218296|58972109|FG000|Overall Study|Randomized but did not enter treatment|66|||
30935604|NCT00218296|58972110|FG001|Overall Study|Randomized but did not enter treatment|67|||
30840825|NCT02290431|58866315|FG000|Overall Study|Study terminated by Sponsor|1|||
30840826|NCT02290431|58866315|FG000|Overall Study|Physician Decision|2|||
30840827|NCT02707952|58866323|FG000|Overall Study|Adverse Event|1|||
30935605|NCT00217672|58972118|FG000|Allocation|Ineligible|2|||
30935606|NCT00217672|58972119|FG001|Allocation|Ineligible|0|||
30935607|NCT00217672|58972118|FG000|Treatment|disease progression|33|||
30935608|NCT00217672|58972119|FG001|Treatment|disease progression|4|||
30935609|NCT00217672|58972118|FG000|Treatment|Adverse Event|18|||
30935610|NCT00217672|58972119|FG001|Treatment|Adverse Event|2|||
30935611|NCT00217672|58972118|FG000|Treatment|reqd treatment not permitted by protocol|6|||
30935612|NCT00217672|58972119|FG001|Treatment|reqd treatment not permitted by protocol|0|||
30935613|NCT00217672|58972118|FG000|Treatment|Physician Decision|6|||
30935614|NCT00217672|58972119|FG001|Treatment|Physician Decision|0|||
30935615|NCT00217672|58972118|FG000|Treatment|insurance issues|1|||
30935616|NCT00217672|58972119|FG001|Treatment|insurance issues|1|||
30935617|NCT00217672|58972118|FG000|Treatment|Death|2|||
30935618|NCT00217672|58972119|FG001|Treatment|Death|0|||
30935619|NCT00217672|58972118|FG000|Treatment|secondary malignancy|1|||
30935620|NCT00217672|58972119|FG001|Treatment|secondary malignancy|0|||
30935621|NCT00217672|58972118|FG000|Follow-up|Withdrawal by Subject|4|||
30935622|NCT00217672|58972119|FG001|Follow-up|Withdrawal by Subject|0|||
30935623|NCT00217672|58972118|FG000|Follow-up|Lost to Follow-up|1|||
30935624|NCT00217672|58972119|FG001|Follow-up|Lost to Follow-up|0|||
30935625|NCT00216736|58972125|FG000|Overall Study|Lost to Follow-up|1|||
30935626|NCT00216736|58972126|FG001|Overall Study|Lost to Follow-up|1|||
30935627|NCT01850030|58972134|FG000|Overall Study|Adverse Event|64|||
30935628|NCT01850030|58972135|FG001|Overall Study|Adverse Event|82|||
30935629|NCT01850030|58972134|FG000|Overall Study|Lack of Efficacy|3|||
30935630|NCT01850030|58972135|FG001|Overall Study|Lack of Efficacy|1|||
30935631|NCT01850030|58972134|FG000|Overall Study|Lost to Follow-up|5|||
30935632|NCT01850030|58972135|FG001|Overall Study|Lost to Follow-up|5|||
30935633|NCT01850030|58972134|FG000|Overall Study|Withdrawal by Subject|3|||
30935634|NCT01850030|58972135|FG001|Overall Study|Withdrawal by Subject|4|||
30935635|NCT01850030|58972134|FG000|Overall Study|Protocol Violation|24|||
30935636|NCT01850030|58972135|FG001|Overall Study|Protocol Violation|28|||
30758846|NCT03605680|58767456|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
30758847|NCT03605680|58767457|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
30935637|NCT01850030|58972134|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
30935638|NCT01850030|58972135|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
30935639|NCT00215644|58972143|FG000|Overall Study|Disease Progression|28|||
30758848|NCT03605680|58767458|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
30758849|NCT03605680|58767455|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
30758850|NCT03605680|58767456|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
30758851|NCT03605680|58767457|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
30758852|NCT03605680|58767458|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
30758853|NCT03605680|58767455|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
30758854|NCT03605680|58767456|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
30758855|NCT03605680|58767457|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
30758856|NCT03605680|58767458|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
30840828|NCT02707952|58866324|FG001|Overall Study|Adverse Event|0|||
30840829|NCT02707952|58866325|FG002|Overall Study|Adverse Event|0|||
30935640|NCT00215644|58972144|FG001|Overall Study|Disease Progression|10|||
30935641|NCT00215644|58972143|FG000|Overall Study|Adverse Event|2|||
30935642|NCT00215644|58972144|FG001|Overall Study|Adverse Event|9|||
30935643|NCT00215644|58972143|FG000|Overall Study|Death|1|||
30935644|NCT00215644|58972144|FG001|Overall Study|Death|2|||
30935645|NCT00215644|58972143|FG000|Overall Study|Withdrawal by Subject|1|||
30935646|NCT00215644|58972144|FG001|Overall Study|Withdrawal by Subject|0|||
30935647|NCT00215644|58972143|FG000|Overall Study|Other|3|||
30935648|NCT00215644|58972144|FG001|Overall Study|Other|15|||
30935649|NCT00215644|58972143|FG000|Overall Study|Randomized but Not Treated|1|||
30935650|NCT00215644|58972144|FG001|Overall Study|Randomized but Not Treated|0|||
30935651|NCT01870401|58972152|FG000|Overall Study|Death|48|||
30935652|NCT01870401|58972153|FG001|Overall Study|Death|24|||
30935653|NCT01870401|58972152|FG000|Overall Study|Withdrawal by Subject|39|||
30935654|NCT01870401|58972153|FG001|Overall Study|Withdrawal by Subject|26|||
30935655|NCT01870401|58972152|FG000|Overall Study|Lost to Follow-up|19|||
30935656|NCT01870401|58972153|FG001|Overall Study|Lost to Follow-up|14|||
30935657|NCT01870401|58972152|FG000|Overall Study|Other|9|||
30935658|NCT01870401|58972153|FG001|Overall Study|Other|7|||
30935659|NCT01870401|58972152|FG000|Overall Study|On-going in the Study|35|||
30935660|NCT01870401|58972153|FG001|Overall Study|On-going in the Study|25|||
30935661|NCT00213148|58972165|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
30935662|NCT00213148|58972166|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
30935663|NCT00213148|58972167|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
30935664|NCT00213148|58972168|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
30935665|NCT00213148|58972169|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
30935666|NCT00213148|58972165|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
30935667|NCT00213148|58972166|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
30935668|NCT00213148|58972167|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
30935669|NCT00213148|58972168|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
30935670|NCT00213148|58972169|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
30935671|NCT00213148|58972165|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
30935672|NCT00213148|58972166|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
30935673|NCT00213148|58972167|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
30935674|NCT00213148|58972168|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
30935675|NCT00213148|58972169|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
30935676|NCT00213148|58972165|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
30935677|NCT00213148|58972166|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
30935678|NCT00213148|58972167|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
30935679|NCT00213148|58972168|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
30935680|NCT00213148|58972169|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
30935681|NCT00213148|58972165|FG000|Cycle 1 (1 Month)|Other|3|||
30935682|NCT00213148|58972166|FG001|Cycle 1 (1 Month)|Other|0|||
30935683|NCT00213148|58972167|FG002|Cycle 1 (1 Month)|Other|2|||
30935684|NCT00213148|58972168|FG003|Cycle 1 (1 Month)|Other|2|||
30935685|NCT00213148|58972169|FG004|Cycle 1 (1 Month)|Other|7|||
30935686|NCT00213148|58972165|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
30935687|NCT00213148|58972166|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
30935688|NCT00213148|58972167|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
30935689|NCT00213148|58972168|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
30935690|NCT00213148|58972169|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
30935691|NCT00213148|58972165|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
30935692|NCT00213148|58972166|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
30935693|NCT00213148|58972167|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
30935694|NCT00213148|58972168|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
30935695|NCT00213148|58972169|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
30935696|NCT00213148|58972165|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
30935697|NCT00213148|58972166|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
30935698|NCT00213148|58972167|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
30935699|NCT00213148|58972168|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
30935700|NCT00213148|58972169|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
30935701|NCT00213148|58972165|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
30935702|NCT00213148|58972166|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
30935703|NCT00213148|58972167|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
30935704|NCT00213148|58972168|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
30935705|NCT00213148|58972169|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
30935706|NCT00213148|58972165|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
30935707|NCT00213148|58972166|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
30935708|NCT00213148|58972167|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
30935709|NCT00213148|58972168|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
30935710|NCT00213148|58972169|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
30935711|NCT00213148|58972165|FG000|Cycle 2 (1 Month)|Other|2|||
30935712|NCT00213148|58972166|FG001|Cycle 2 (1 Month)|Other|1|||
30935713|NCT00213148|58972167|FG002|Cycle 2 (1 Month)|Other|2|||
30935714|NCT00213148|58972168|FG003|Cycle 2 (1 Month)|Other|8|||
30935715|NCT00213148|58972169|FG004|Cycle 2 (1 Month)|Other|7|||
30935716|NCT00213148|58972165|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
30935717|NCT00213148|58972166|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
30935718|NCT00213148|58972167|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
30935719|NCT00213148|58972168|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
30935720|NCT00213148|58972169|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
30935721|NCT00213148|58972165|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
30935722|NCT00213148|58972166|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
30935723|NCT00213148|58972167|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
30935724|NCT00213148|58972168|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
30935725|NCT00213148|58972169|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
30935726|NCT00213148|58972165|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
30935727|NCT00213148|58972166|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
30935728|NCT00213148|58972167|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
30840830|NCT02707952|58866326|FG003|Overall Study|Adverse Event|0|||
30840831|NCT02707952|58866323|FG000|Overall Study|Lost to Follow-up|1|||
30840832|NCT02707952|58866324|FG001|Overall Study|Lost to Follow-up|0|||
30840833|NCT02707952|58866325|FG002|Overall Study|Lost to Follow-up|0|||
30840834|NCT02707952|58866326|FG003|Overall Study|Lost to Follow-up|0|||
30840835|NCT02707952|58866323|FG000|Overall Study|Withdrawal by Subject|0|||
30935729|NCT00213148|58972168|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
30935730|NCT00213148|58972169|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
30935731|NCT00213148|58972165|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
30935732|NCT00213148|58972166|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
30935733|NCT00213148|58972167|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
30935734|NCT00213148|58972168|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
30935735|NCT00213148|58972169|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
30935736|NCT00213148|58972165|FG000|Cycle 3 (1 Month)|Other|0|||
30935737|NCT00213148|58972166|FG001|Cycle 3 (1 Month)|Other|0|||
30935738|NCT00213148|58972167|FG002|Cycle 3 (1 Month)|Other|1|||
30935739|NCT00213148|58972168|FG003|Cycle 3 (1 Month)|Other|1|||
30935740|NCT00213148|58972169|FG004|Cycle 3 (1 Month)|Other|0|||
30935741|NCT01704261|58972191|FG000|Overall Study|Withdrawal by Subject|12|||
30935742|NCT01704261|58972192|FG001|Overall Study|Withdrawal by Subject|15|||
30935743|NCT01704261|58972191|FG000|Overall Study|Lost to Follow-up|1|||
30624306|NCT00883129|58636304|FG001|Overall Study|Lost to Follow-up|2|||
30624307|NCT00883129|58636303|FG000|Overall Study|Death|1|||
30758857|NCT03605680|58767455|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
30758858|NCT03605680|58767456|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
30840836|NCT02707952|58866324|FG001|Overall Study|Withdrawal by Subject|1|||
30840837|NCT02707952|58866325|FG002|Overall Study|Withdrawal by Subject|2|||
30840838|NCT02707952|58866326|FG003|Overall Study|Withdrawal by Subject|0|||
30840839|NCT03050801|58866344|FG000|Experiment 1|Lost to Follow-up|0|||
30840840|NCT03050801|58866345|FG001|Experiment 1|Lost to Follow-up|1|||
30840841|NCT03050801|58866346|FG002|Experiment 1|Lost to Follow-up|0|||
30840842|NCT03050801|58866347|FG003|Experiment 1|Lost to Follow-up|0|||
30840843|NCT03050801|58866348|FG004|Experiment 1|Lost to Follow-up|0|||
30840844|NCT03050801|58866349|FG005|Experiment 1|Lost to Follow-up|0|||
30840845|NCT03050801|58866344|FG000|Experiment 1|Physician Decision|0|||
30840846|NCT03050801|58866345|FG001|Experiment 1|Physician Decision|3|||
30840847|NCT03050801|58866346|FG002|Experiment 1|Physician Decision|0|||
30840848|NCT03050801|58866347|FG003|Experiment 1|Physician Decision|0|||
30840849|NCT03050801|58866348|FG004|Experiment 1|Physician Decision|0|||
30758859|NCT03605680|58767457|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
30758860|NCT03605680|58767458|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
30758861|NCT03605680|58767455|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
30758862|NCT03605680|58767456|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
30758863|NCT03605680|58767457|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
30758864|NCT03605680|58767458|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
30758865|NCT03605680|58767455|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
30758866|NCT03605680|58767456|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
30758867|NCT03605680|58767457|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
30758868|NCT03605680|58767458|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
30758869|NCT03605680|58767455|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
30758870|NCT03605680|58767456|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
30758871|NCT03605680|58767457|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
30758872|NCT03605680|58767458|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
30758873|NCT03605680|58767455|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
30840850|NCT03050801|58866349|FG005|Experiment 1|Physician Decision|0|||
30840851|NCT03050801|58866344|FG000|Experiment 1|Change of experimental design|0|||
30840852|NCT03050801|58866345|FG001|Experiment 1|Change of experimental design|3|||
30840853|NCT03050801|58866346|FG002|Experiment 1|Change of experimental design|0|||
30840854|NCT03050801|58866347|FG003|Experiment 1|Change of experimental design|0|||
30840855|NCT03050801|58866348|FG004|Experiment 1|Change of experimental design|0|||
30840856|NCT03050801|58866349|FG005|Experiment 1|Change of experimental design|0|||
30840857|NCT03050801|58866344|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
30840858|NCT03050801|58866345|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
30935744|NCT01704261|58972192|FG001|Overall Study|Lost to Follow-up|0|||
30935745|NCT01715571|58972198|FG000|Overall Study|Lost to Follow-up|8|||
30935746|NCT00212758|58972202|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
30935747|NCT00212758|58972203|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
30935748|NCT00212758|58972202|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
30935749|NCT00212758|58972203|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
30935750|NCT01824290|58972211|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
30935751|NCT01824290|58972212|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
30935752|NCT01824290|58972213|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
30935753|NCT01824290|58972214|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
30935754|NCT01824290|58972211|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
30935755|NCT01824290|58972212|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
30935756|NCT01824290|58972213|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
30935757|NCT01824290|58972214|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
30935758|NCT01824290|58972211|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
30935759|NCT01824290|58972212|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
30935760|NCT01824290|58972213|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
30935761|NCT01824290|58972214|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
30935762|NCT01824290|58972211|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
30935763|NCT01824290|58972212|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
30935764|NCT01824290|58972213|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
30935765|NCT01824290|58972214|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
30935766|NCT01824290|58972211|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
30935767|NCT01824290|58972212|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
30935768|NCT01824290|58972213|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
30935769|NCT01824290|58972214|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
30935770|NCT01824290|58972211|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
30935771|NCT01824290|58972212|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
30935772|NCT01824290|58972213|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
30935773|NCT01824290|58972214|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
30935774|NCT01715415|58972228|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
30935775|NCT01715415|58972229|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
30935776|NCT01715415|58972228|FG000|Double-blind Treatment|Adverse Event|3|||
30935777|NCT01715415|58972229|FG001|Double-blind Treatment|Adverse Event|0|||
30935778|NCT01715415|58972228|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
30935779|NCT01715415|58972229|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
30935780|NCT01715415|58972228|FG000|Double-blind Treatment|Other|1|||
30935781|NCT01715415|58972229|FG001|Double-blind Treatment|Other|0|||
30935782|NCT01715415|58972228|FG000|Open-label Treatment|Adverse Event|0|||
30935783|NCT01715415|58972229|FG001|Open-label Treatment|Adverse Event|1|||
30935784|NCT01715415|58972228|FG000|Open-label Treatment|Subject Noncompliant|0|||
30935785|NCT01715415|58972229|FG001|Open-label Treatment|Subject Noncompliant|1|||
30935786|NCT00211510|58972238|FG000|Overall Study|Physician Decision|3|||
30935787|NCT00211510|58972239|FG001|Overall Study|Physician Decision|1|||
30935788|NCT00211510|58972238|FG000|Overall Study|Withdrawal by Subject|3|||
30935789|NCT00211510|58972239|FG001|Overall Study|Withdrawal by Subject|1|||
30935790|NCT01869777|58972248|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
30935791|NCT01714947|58972252|FG000|Part B|Progressive Disease|3|||
30935792|NCT01869699|58972258|FG000|Overall Study|Withdrawal by Subject|1|||
30935793|NCT01869699|58972259|FG001|Overall Study|Withdrawal by Subject|0|||
30935794|NCT01714635|58972268|FG000|Overall Study|Discontinued|1|||
30935795|NCT01714635|58972269|FG001|Overall Study|Discontinued|0|||
30935796|NCT01714635|58972270|FG002|Overall Study|Discontinued|2|||
30935797|NCT01714635|58972268|FG000|Overall Study|Missed 6-month exam|1|||
30935798|NCT01714635|58972269|FG001|Overall Study|Missed 6-month exam|0|||
30935799|NCT01714635|58972270|FG002|Overall Study|Missed 6-month exam|0|||
30935800|NCT01849874|58972280|FG000|Overall Study|Death|34|||
30935801|NCT01849874|58972281|FG001|Overall Study|Death|16|||
30935802|NCT01849874|58972280|FG000|Overall Study|Withdrawal by Subject|4|||
30935803|NCT01849874|58972281|FG001|Overall Study|Withdrawal by Subject|8|||
30935804|NCT01849874|58972280|FG000|Overall Study|Lost to Follow-up|0|||
30935805|NCT01849874|58972281|FG001|Overall Study|Lost to Follow-up|1|||
30935806|NCT01849874|58972280|FG000|Overall Study|Randomized but Never Treated|1|||
30935807|NCT01849874|58972281|FG001|Overall Study|Randomized but Never Treated|8|||
30758874|NCT03605680|58767456|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
30758875|NCT03605680|58767457|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
30758876|NCT03605680|58767458|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
30758877|NCT03605680|58767455|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
30758878|NCT03605680|58767456|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
30758879|NCT03605680|58767457|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
30758880|NCT03605680|58767458|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
30758881|NCT03605680|58767455|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
30758882|NCT03605680|58767456|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
30758883|NCT03605680|58767457|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
30758884|NCT03605680|58767458|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
30840859|NCT03050801|58866346|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
30840860|NCT03050801|58866347|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
30840861|NCT03050801|58866348|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
30840862|NCT03050801|58866349|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
30840863|NCT03050801|58866344|FG000|Experiment 2|Lost to Follow-up|0|||
30840864|NCT03050801|58866345|FG001|Experiment 2|Lost to Follow-up|0|||
30840865|NCT03050801|58866346|FG002|Experiment 2|Lost to Follow-up|0|||
30840866|NCT03050801|58866347|FG003|Experiment 2|Lost to Follow-up|1|||
30840867|NCT03050801|58866348|FG004|Experiment 2|Lost to Follow-up|1|||
30840868|NCT03050801|58866349|FG005|Experiment 2|Lost to Follow-up|0|||
30840869|NCT03050801|58866344|FG000|Experiment 2|Physician Decision|0|||
30840870|NCT03050801|58866345|FG001|Experiment 2|Physician Decision|0|||
30840871|NCT03050801|58866346|FG002|Experiment 2|Physician Decision|0|||
30840872|NCT03050801|58866347|FG003|Experiment 2|Physician Decision|0|||
30840873|NCT03050801|58866348|FG004|Experiment 2|Physician Decision|1|||
30840874|NCT03050801|58866349|FG005|Experiment 2|Physician Decision|0|||
30840875|NCT03050801|58866344|FG000|Experiment 2|Pregnancy|0|||
30840876|NCT03050801|58866345|FG001|Experiment 2|Pregnancy|0|||
30840877|NCT03050801|58866346|FG002|Experiment 2|Pregnancy|0|||
30840878|NCT03050801|58866347|FG003|Experiment 2|Pregnancy|0|||
30840879|NCT03050801|58866348|FG004|Experiment 2|Pregnancy|1|||
30840880|NCT03050801|58866349|FG005|Experiment 2|Pregnancy|0|||
30840881|NCT03050801|58866344|FG000|Experiment 2|Withdrawal by Subject|0|||
30840882|NCT03050801|58866345|FG001|Experiment 2|Withdrawal by Subject|0|||
30840883|NCT03050801|58866346|FG002|Experiment 2|Withdrawal by Subject|0|||
30840884|NCT03050801|58866347|FG003|Experiment 2|Withdrawal by Subject|1|||
30840885|NCT03050801|58866348|FG004|Experiment 2|Withdrawal by Subject|0|||
30840886|NCT03050801|58866349|FG005|Experiment 2|Withdrawal by Subject|0|||
30840887|NCT03050801|58866344|FG000|Experiment 2|Poor data quality|0|||
30840888|NCT03050801|58866345|FG001|Experiment 2|Poor data quality|0|||
30935808|NCT01849874|58972280|FG000|Overall Study|Ongoing|162|||
30935809|NCT01849874|58972281|FG001|Overall Study|Ongoing|69|||
30935810|NCT01713933|58972287|FG000|Overall Study|Lost to Follow-up|2|||
30935811|NCT01713933|58972287|FG000|Overall Study|Withdrawal by Subject|3|||
30935812|NCT01713933|58972287|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
30935813|NCT01868997|58972293|FG000|Overall Study|Adverse Event|2|||
30935814|NCT01868997|58972294|FG001|Overall Study|Adverse Event|5|||
30935815|NCT01868997|58972293|FG000|Overall Study|Lack of Efficacy|2|||
30935816|NCT01868997|58972294|FG001|Overall Study|Lack of Efficacy|0|||
30935817|NCT01868997|58972293|FG000|Overall Study|Other|3|||
30935818|NCT01868997|58972294|FG001|Overall Study|Other|1|||
30935819|NCT01875848|58972302|FG000|Overall Study|Withdrawal by Subject|2|||
30935820|NCT01875848|58972303|FG001|Overall Study|Withdrawal by Subject|0|||
30935821|NCT04191382|58972312|FG000|Overall Study|Withdrawal by Subject|1|||
30935822|NCT04191382|58972313|FG001|Overall Study|Withdrawal by Subject|0|||
30935823|NCT04191382|58972314|FG002|Overall Study|Withdrawal by Subject|0|||
30935824|NCT01703091|58972324|FG000|Overall Study|Adverse Event|5|||
30935825|NCT01703091|58972325|FG001|Overall Study|Adverse Event|3|||
30935826|NCT01703091|58972324|FG000|Overall Study|Physician Decision|2|||
30935827|NCT01703091|58972325|FG001|Overall Study|Physician Decision|1|||
30935828|NCT01703091|58972324|FG000|Overall Study|Withdrawal by Subject|1|||
30935829|NCT01703091|58972325|FG001|Overall Study|Withdrawal by Subject|0|||
30935830|NCT01703091|58972324|FG000|Overall Study|Sponsor Decision|1|||
30935831|NCT01703091|58972325|FG001|Overall Study|Sponsor Decision|0|||
30935832|NCT01712685|58972331|FG000|Overall Study|pt declined to participate before trmt|1|||
30935833|NCT01867671|58972337|FG000|Overall Study|Adverse Event|5|||
30935834|NCT01867671|58972338|FG001|Overall Study|Adverse Event|3|||
30935835|NCT01867671|58972337|FG000|Overall Study|Anaphylaxis|0|||
30935836|NCT01867671|58972338|FG001|Overall Study|Anaphylaxis|1|||
30935837|NCT01867671|58972337|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
30935838|NCT01867671|58972338|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
30935839|NCT01867671|58972337|FG000|Overall Study|Lost to Follow-up|0|||
30935840|NCT01867671|58972338|FG001|Overall Study|Lost to Follow-up|1|||
30840889|NCT03050801|58866346|FG002|Experiment 2|Poor data quality|0|||
30840890|NCT03050801|58866347|FG003|Experiment 2|Poor data quality|4|||
30935841|NCT01867671|58972337|FG000|Overall Study|Non-compliance with Study Drug|1|||
30935842|NCT01867671|58972338|FG001|Overall Study|Non-compliance with Study Drug|2|||
30935843|NCT01867671|58972337|FG000|Overall Study|Withdrawal by Subject|21|||
30935844|NCT01867671|58972338|FG001|Overall Study|Withdrawal by Subject|21|||
30935845|NCT01702311|58972346|FG000|Overall Study|Withdrawal by Subject|3|||
30840891|NCT03050801|58866348|FG004|Experiment 2|Poor data quality|1|||
30840892|NCT03050801|58866349|FG005|Experiment 2|Poor data quality|0|||
30840893|NCT03050801|58866344|FG000|Experiment 2|Discomfort during stimulation|0|||
30840894|NCT03050801|58866345|FG001|Experiment 2|Discomfort during stimulation|0|||
30840895|NCT03050801|58866346|FG002|Experiment 2|Discomfort during stimulation|0|||
30935846|NCT01702311|58972347|FG001|Overall Study|Withdrawal by Subject|2|||
30840896|NCT03050801|58866347|FG003|Experiment 2|Discomfort during stimulation|0|||
30935847|NCT01702311|58972346|FG000|Overall Study|Discharge less than 24 hours|10|||
30935848|NCT01702311|58972347|FG001|Overall Study|Discharge less than 24 hours|7|||
30935849|NCT01702311|58972346|FG000|Overall Study|Physician Decision|3|||
30935850|NCT01702311|58972347|FG001|Overall Study|Physician Decision|4|||
30935851|NCT01712061|58972363|FG000|Overall Study|Adverse Event|4|||
30935852|NCT01712061|58972364|FG001|Overall Study|Adverse Event|9|||
30935853|NCT01712061|58972365|FG002|Overall Study|Adverse Event|5|||
30935854|NCT01712061|58972363|FG000|Overall Study|Death|0|||
30935855|NCT01712061|58972364|FG001|Overall Study|Death|0|||
30935856|NCT01712061|58972365|FG002|Overall Study|Death|1|||
30935857|NCT01712061|58972363|FG000|Overall Study|Lost to Follow-up|1|||
30935858|NCT01712061|58972364|FG001|Overall Study|Lost to Follow-up|0|||
30935859|NCT01712061|58972365|FG002|Overall Study|Lost to Follow-up|1|||
30935860|NCT01712061|58972363|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
30935861|NCT01712061|58972364|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
30935862|NCT01712061|58972365|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
30935863|NCT01712061|58972363|FG000|Overall Study|Medication Error Without Associated AE|0|||
30935864|NCT01712061|58972364|FG001|Overall Study|Medication Error Without Associated AE|1|||
30935865|NCT01712061|58972365|FG002|Overall Study|Medication Error Without Associated AE|0|||
30935866|NCT01712061|58972363|FG000|Overall Study|Withdrawal by Subject|1|||
30935867|NCT01712061|58972364|FG001|Overall Study|Withdrawal by Subject|7|||
30935868|NCT01712061|58972365|FG002|Overall Study|Withdrawal by Subject|1|||
30935869|NCT01712061|58972363|FG000|Overall Study|Other|0|||
30935870|NCT01712061|58972364|FG001|Overall Study|Other|3|||
30935871|NCT01712061|58972365|FG002|Overall Study|Other|0|||
30935872|NCT03592186|58972376|FG000|Overall Study|Withdrawal by Subject|1|||
30935873|NCT03592186|58972377|FG001|Overall Study|Withdrawal by Subject|0|||
30935874|NCT03592186|58972376|FG000|Overall Study|Lost to Follow-up|16|||
30935875|NCT03592186|58972377|FG001|Overall Study|Lost to Follow-up|11|||
30935876|NCT03598114|58972385|FG000|Overall Study|Staff turnover/left the program|3|||
30935877|NCT03598114|58972386|FG001|Overall Study|Staff turnover/left the program|39|||
30935878|NCT01711983|58972413|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
30935879|NCT01711983|58972413|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
30935880|NCT01711983|58972413|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
30935881|NCT01711983|58972413|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
30935882|NCT01874288|58972427|FG000|Overall Study|Withdrawal by Subject|1|||
30935883|NCT01874288|58972428|FG001|Overall Study|Withdrawal by Subject|0|||
30935884|NCT01874288|58972429|FG002|Overall Study|Withdrawal by Subject|2|||
30935885|NCT01874288|58972430|FG003|Overall Study|Withdrawal by Subject|1|||
30935886|NCT01874288|58972431|FG004|Overall Study|Withdrawal by Subject|1|||
30935887|NCT01874288|58972427|FG000|Overall Study|Physician Decision|0|||
30935888|NCT01874288|58972428|FG001|Overall Study|Physician Decision|0|||
30935889|NCT01874288|58972429|FG002|Overall Study|Physician Decision|0|||
30935890|NCT01874288|58972430|FG003|Overall Study|Physician Decision|1|||
30935891|NCT01874288|58972431|FG004|Overall Study|Physician Decision|0|||
30935892|NCT01874288|58972427|FG000|Overall Study|Progressive disease|2|||
30935893|NCT01874288|58972428|FG001|Overall Study|Progressive disease|0|||
30935894|NCT01874288|58972429|FG002|Overall Study|Progressive disease|3|||
30935895|NCT01874288|58972430|FG003|Overall Study|Progressive disease|5|||
30935896|NCT01874288|58972431|FG004|Overall Study|Progressive disease|1|||
30935897|NCT01874054|58972460|FG000|Overall Study|Withdrawal by Subject|3|||
30935898|NCT01874054|58972460|FG000|Overall Study|Study Termination by Sponsor|42|||
30935899|NCT01874054|58972460|FG000|Overall Study|Lost to Follow-up|5|||
30935900|NCT01874054|58972460|FG000|Overall Study|Death|5|||
30935901|NCT01873742|58972466|FG000|Overall Study|Lost to Follow-up|68|||
30935902|NCT01873742|58972467|FG001|Overall Study|Lost to Follow-up|76|||
30935903|NCT01873586|58972473|FG000|Overall Study|Lost to Follow-up|3|||
30935904|NCT04027348|58972507|FG000|Overall Study|Adverse Event|2|||
30935905|NCT04196686|58972520|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
30935906|NCT04196686|58972521|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
30935907|NCT01611974|58972530|FG000|Overall Study|Death|10|||
30935908|NCT01611974|58972531|FG001|Overall Study|Death|12|||
30935909|NCT01611974|58972532|FG002|Overall Study|Death|10|||
30935910|NCT01611974|58972530|FG000|Overall Study|Lost to Follow-up|0|||
30935911|NCT01611974|58972531|FG001|Overall Study|Lost to Follow-up|1|||
30935912|NCT01611974|58972532|FG002|Overall Study|Lost to Follow-up|0|||
30758885|NCT03605680|58767455|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
30935913|NCT01611974|58972530|FG000|Overall Study|Physician Decision|5|||
30758886|NCT03605680|58767456|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
30758887|NCT03605680|58767457|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
30935914|NCT01611974|58972531|FG001|Overall Study|Physician Decision|1|||
30935915|NCT01611974|58972532|FG002|Overall Study|Physician Decision|2|||
30935916|NCT01611974|58972530|FG000|Overall Study|Withdrawal by Subject|0|||
30935917|NCT01611974|58972531|FG001|Overall Study|Withdrawal by Subject|1|||
30935918|NCT01611974|58972532|FG002|Overall Study|Withdrawal by Subject|4|||
30935919|NCT01848938|58972542|FG000|Overall Study|Lost to Follow-up|1|||
30935920|NCT01848938|58972543|FG001|Overall Study|Lost to Follow-up|1|||
30935921|NCT01871870|58972549|FG000|Overall Study|Hardware issues|7|||
30935922|NCT01871870|58972549|FG000|Overall Study|hyperglycemia|2|||
30935923|NCT01871558|58972562|FG000|Overall Study|Other reason|0|||
30935924|NCT01871558|58972563|FG001|Overall Study|Other reason|1|||
30840897|NCT03050801|58866348|FG004|Experiment 2|Discomfort during stimulation|0|||
30840898|NCT03050801|58866349|FG005|Experiment 2|Discomfort during stimulation|2|||
30840899|NCT02707640|58866368|FG000|Overall Study|Adverse Event|4|||
30840900|NCT02707640|58866369|FG001|Overall Study|Adverse Event|2|||
30840901|NCT02707640|58866368|FG000|Overall Study|Death|1|||
30840902|NCT02707640|58866369|FG001|Overall Study|Death|2|||
30840903|NCT02707640|58866368|FG000|Overall Study|Physician Decision|2|||
30840904|NCT02707640|58866369|FG001|Overall Study|Physician Decision|0|||
30840905|NCT02707640|58866368|FG000|Overall Study|Withdrawal by Subject|0|||
30840906|NCT02707640|58866369|FG001|Overall Study|Withdrawal by Subject|1|||
30840907|NCT02707640|58866368|FG000|Overall Study|Participant's Personal Decision|1|||
30840908|NCT02707640|58866369|FG001|Overall Study|Participant's Personal Decision|2|||
30840909|NCT02707640|58866368|FG000|Overall Study|Sponsor Discretion|1|||
30840910|NCT02707640|58866369|FG001|Overall Study|Sponsor Discretion|0|||
30840911|NCT02708966|58866377|FG000|Overall Study|Lost to Follow-up|2|||
30840912|NCT02708966|58866378|FG001|Overall Study|Lost to Follow-up|2|||
30840913|NCT02706938|58866386|FG000|First Period, 6 Weeks|Adverse Event|8|||
30840914|NCT02706938|58866387|FG001|First Period, 6 Weeks|Adverse Event|0|||
30840915|NCT02706938|58866386|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
30840916|NCT02706938|58866387|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
30840917|NCT02706938|58866386|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
30840918|NCT02706938|58866387|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
30840919|NCT02706938|58866386|FG000|Second Period, 6 Weeks|Adverse Event|0|||
30840920|NCT02706938|58866387|FG001|Second Period, 6 Weeks|Adverse Event|7|||
30840921|NCT02706938|58866386|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
30840922|NCT02706938|58866387|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
30840923|NCT03053063|58866397|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
30840924|NCT03053063|58866398|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
30840925|NCT03053063|58866399|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
30840926|NCT03053063|58866400|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
30840927|NCT03053063|58866397|FG000|Randomized Phase|Withdrew consent|8|||
30935925|NCT01871558|58972562|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
30935926|NCT01871558|58972563|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
30935927|NCT01871558|58972562|FG000|Overall Study|Withdrawal by Subject|2|||
30935928|NCT01871558|58972563|FG001|Overall Study|Withdrawal by Subject|0|||
30935929|NCT01711359|58972572|FG000|Treatment Period|Withdrawal by Subject|18|||
30935930|NCT01711359|58972573|FG001|Treatment Period|Withdrawal by Subject|7|||
30935931|NCT01711359|58972574|FG002|Treatment Period|Withdrawal by Subject|13|||
30935932|NCT01711359|58972572|FG000|Treatment Period|Lack of Efficacy|13|||
30935933|NCT01711359|58972573|FG001|Treatment Period|Lack of Efficacy|2|||
30935934|NCT01711359|58972574|FG002|Treatment Period|Lack of Efficacy|2|||
30935935|NCT01711359|58972572|FG000|Treatment Period|Adverse Event|8|||
30935936|NCT01711359|58972573|FG001|Treatment Period|Adverse Event|10|||
30935937|NCT01711359|58972574|FG002|Treatment Period|Adverse Event|24|||
30935938|NCT01711359|58972572|FG000|Treatment Period|Physician Decision|4|||
30935939|NCT01711359|58972573|FG001|Treatment Period|Physician Decision|3|||
30935940|NCT01711359|58972574|FG002|Treatment Period|Physician Decision|2|||
30935941|NCT01711359|58972572|FG000|Treatment Period|Death|3|||
30935942|NCT01711359|58972573|FG001|Treatment Period|Death|0|||
30935943|NCT01711359|58972574|FG002|Treatment Period|Death|0|||
30935944|NCT01711359|58972572|FG000|Treatment Period|Entry Criteria Not Met|1|||
30935945|NCT01711359|58972573|FG001|Treatment Period|Entry Criteria Not Met|0|||
30935946|NCT01711359|58972574|FG002|Treatment Period|Entry Criteria Not Met|0|||
30935947|NCT01711359|58972572|FG000|Treatment Period|Sponsor Decision|1|||
30935948|NCT01711359|58972573|FG001|Treatment Period|Sponsor Decision|0|||
30935949|NCT01711359|58972574|FG002|Treatment Period|Sponsor Decision|0|||
30935950|NCT01711359|58972572|FG000|Treatment Period|Lost to Follow-up|1|||
30935951|NCT01711359|58972573|FG001|Treatment Period|Lost to Follow-up|1|||
30935952|NCT01711359|58972574|FG002|Treatment Period|Lost to Follow-up|1|||
30935953|NCT01711359|58972572|FG000|Treatment Period|Randomized, Not Treated|3|||
30935954|NCT01711359|58972573|FG001|Treatment Period|Randomized, Not Treated|1|||
30840928|NCT03053063|58866398|FG001|Randomized Phase|Withdrew consent|11|||
30840929|NCT03053063|58866399|FG002|Randomized Phase|Withdrew consent|5|||
30840930|NCT03053063|58866400|FG003|Randomized Phase|Withdrew consent|0|||
30840931|NCT03053063|58866397|FG000|Randomized Phase|Investigator's Discretion|8|||
30840932|NCT03053063|58866398|FG001|Randomized Phase|Investigator's Discretion|6|||
30840933|NCT03053063|58866399|FG002|Randomized Phase|Investigator's Discretion|2|||
30935955|NCT01711359|58972574|FG002|Treatment Period|Randomized, Not Treated|0|||
30935956|NCT01710657|58972601|FG000|Overall Study|Lost to Follow-up|2|||
30935957|NCT01710657|58972602|FG001|Overall Study|Lost to Follow-up|0|||
30935958|NCT01710657|58972603|FG002|Overall Study|Lost to Follow-up|1|||
30935959|NCT01710657|58972601|FG000|Overall Study|Protocol Violation|2|||
30935960|NCT01710657|58972602|FG001|Overall Study|Protocol Violation|2|||
30935961|NCT01710657|58972603|FG002|Overall Study|Protocol Violation|0|||
30935962|NCT01710657|58972601|FG000|Overall Study|Adverse Event|14|||
30935963|NCT01710657|58972602|FG001|Overall Study|Adverse Event|8|||
30935964|NCT01710657|58972603|FG002|Overall Study|Adverse Event|28|||
30935965|NCT01710657|58972601|FG000|Overall Study|Withdrawal by Subject|0|||
30935966|NCT01710657|58972602|FG001|Overall Study|Withdrawal by Subject|1|||
30935967|NCT01710657|58972603|FG002|Overall Study|Withdrawal by Subject|2|||
30935968|NCT01710657|58972601|FG000|Overall Study|Lack of Efficacy|0|||
30935969|NCT01710657|58972602|FG001|Overall Study|Lack of Efficacy|1|||
30935970|NCT01710657|58972603|FG002|Overall Study|Lack of Efficacy|1|||
30935971|NCT01701063|58972614|FG000|Overall Study|Lost to Follow-up|0|||
30935972|NCT01701063|58972615|FG001|Overall Study|Lost to Follow-up|1|||
30935973|NCT01701063|58972616|FG002|Overall Study|Lost to Follow-up|0|||
30935974|NCT01701063|58972614|FG000|Overall Study|Withdrawal by Subject|0|||
30935975|NCT01701063|58972615|FG001|Overall Study|Withdrawal by Subject|0|||
30935976|NCT01701063|58972616|FG002|Overall Study|Withdrawal by Subject|1|||
30935977|NCT01701063|58972614|FG000|Overall Study|Other|0|||
30935978|NCT01701063|58972615|FG001|Overall Study|Other|0|||
30935979|NCT01701063|58972616|FG002|Overall Study|Other|1|||
30935980|NCT01700985|58972627|FG000|Overall Study|Incarcerated|0|||
30935981|NCT01700985|58972628|FG001|Overall Study|Incarcerated|1|||
30935982|NCT01710501|58972637|FG000|Overall Study|Lost to Follow-up|2|||
30935983|NCT01710501|58972638|FG001|Overall Study|Lost to Follow-up|0|||
30935984|NCT01710501|58972639|FG002|Overall Study|Lost to Follow-up|0|||
30935985|NCT01700829|58972649|FG000|Overall Study|Withdrawal by Subject|1|||
30935986|NCT01700829|58972650|FG001|Overall Study|Withdrawal by Subject|1|||
30935987|NCT01710345|58972659|FG000|Overall Study|Adverse Event|0|||
30935988|NCT01710345|58972660|FG001|Overall Study|Adverse Event|2|||
30935989|NCT01710345|58972661|FG002|Overall Study|Adverse Event|0|||
30935990|NCT01710345|58972659|FG000|Overall Study|Lack of Efficacy|2|||
30935991|NCT01710345|58972660|FG001|Overall Study|Lack of Efficacy|3|||
30935992|NCT01710345|58972661|FG002|Overall Study|Lack of Efficacy|1|||
30935993|NCT01710345|58972659|FG000|Overall Study|Drug Dosing Error|1|||
30935994|NCT01710345|58972660|FG001|Overall Study|Drug Dosing Error|0|||
30935995|NCT01710345|58972661|FG002|Overall Study|Drug Dosing Error|0|||
30935996|NCT01710033|58972677|FG000|Stage 2|Adverse Event|0|||
30935997|NCT01710033|58972678|FG001|Stage 2|Adverse Event|0|||
30935998|NCT01710033|58972679|FG002|Stage 2|Adverse Event|0|||
30935999|NCT01710033|58972680|FG003|Stage 2|Adverse Event|0|||
30936000|NCT01710033|58972681|FG004|Stage 2|Adverse Event|1|||
30936001|NCT01822496|58972698|FG000|Overall Study|Protocol Violation|2|||
30936002|NCT01822496|58972699|FG001|Overall Study|Protocol Violation|2|||
30936003|NCT01822496|58972700|FG002|Overall Study|Protocol Violation|0|||
30936004|NCT01822496|58972701|FG003|Overall Study|Protocol Violation|1|||
30936005|NCT01822496|58972698|FG000|Overall Study|Withdrawal by Subject|0|||
30936006|NCT01822496|58972699|FG001|Overall Study|Withdrawal by Subject|0|||
30936007|NCT01822496|58972700|FG002|Overall Study|Withdrawal by Subject|0|||
30936008|NCT01822496|58972701|FG003|Overall Study|Withdrawal by Subject|3|||
30936009|NCT01867047|58972713|FG000|Overall Study|Lost to Follow-up|3|||
30936010|NCT01867047|58972714|FG001|Overall Study|Lost to Follow-up|3|||
30936011|NCT01867047|58972713|FG000|Overall Study|Withdrawal by Subject|2|||
30936012|NCT01867047|58972714|FG001|Overall Study|Withdrawal by Subject|0|||
30936013|NCT01867047|58972713|FG000|Overall Study|Physician Decision|2|||
30936014|NCT01867047|58972714|FG001|Overall Study|Physician Decision|0|||
30936015|NCT01867047|58972713|FG000|Overall Study|surgery not indicated in protocol|1|||
30936016|NCT01867047|58972714|FG001|Overall Study|surgery not indicated in protocol|2|||
30936017|NCT01821560|58972726|FG000|Overall Study|Lost to Follow-up|5|||
30936018|NCT01821560|58972727|FG001|Overall Study|Lost to Follow-up|5|||
30936019|NCT01821560|58972726|FG000|Overall Study|Withdrawal by Subject|1|||
30936020|NCT01821560|58972727|FG001|Overall Study|Withdrawal by Subject|1|||
30936021|NCT01821560|58972726|FG000|Overall Study|Protocol Violation|0|||
30936022|NCT01821560|58972727|FG001|Overall Study|Protocol Violation|1|||
30936023|NCT01871402|58972735|FG000|Overall Study|Lost to Follow-up|1|||
30936024|NCT01871402|58972736|FG001|Overall Study|Lost to Follow-up|0|||
30936025|NCT01871402|58972735|FG000|Overall Study|Withdrawal by Subject|0|||
30936026|NCT01871402|58972736|FG001|Overall Study|Withdrawal by Subject|2|||
30936027|NCT01871402|58972735|FG000|Overall Study|Non-compliance|0|||
30936028|NCT01871402|58972736|FG001|Overall Study|Non-compliance|1|||
30936029|NCT01846442|58972755|FG000|Overall Study|Adverse Event|2|||
30936030|NCT01846442|58972756|FG001|Overall Study|Adverse Event|4|||
30936031|NCT01846442|58972757|FG002|Overall Study|Adverse Event|2|||
30936032|NCT01846442|58972758|FG003|Overall Study|Adverse Event|1|||
30936033|NCT01846442|58972755|FG000|Overall Study|Lost to Follow-up|0|||
30936034|NCT01846442|58972756|FG001|Overall Study|Lost to Follow-up|0|||
30936035|NCT01846442|58972757|FG002|Overall Study|Lost to Follow-up|1|||
30936036|NCT01846442|58972758|FG003|Overall Study|Lost to Follow-up|0|||
30936037|NCT01846442|58972755|FG000|Overall Study|Withdrawal by Subject|3|||
30936038|NCT01846442|58972756|FG001|Overall Study|Withdrawal by Subject|2|||
30936039|NCT01846442|58972757|FG002|Overall Study|Withdrawal by Subject|0|||
30936040|NCT01846442|58972758|FG003|Overall Study|Withdrawal by Subject|1|||
30936041|NCT01846442|58972755|FG000|Overall Study|Left the city/Lost medication|1|||
30624308|NCT00883129|58636304|FG001|Overall Study|Death|2|||
30624309|NCT00883129|58636303|FG000|Overall Study|Defined Treatment Failure|0|||
30624310|NCT00883129|58636304|FG001|Overall Study|Defined Treatment Failure|2|||
30624311|NCT00905632|58636335|FG000|Overall Study|Adverse Event|0|||
30624312|NCT00905632|58636336|FG001|Overall Study|Adverse Event|0|||
30624313|NCT00905632|58636337|FG002|Overall Study|Adverse Event|0|||
30624314|NCT00905632|58636338|FG003|Overall Study|Adverse Event|0|||
30624315|NCT00905632|58636339|FG004|Overall Study|Adverse Event|0|||
30624316|NCT00905632|58636340|FG005|Overall Study|Adverse Event|1|||
30624317|NCT00905632|58636341|FG006|Overall Study|Adverse Event|4|||
30624318|NCT00954447|58636366|FG000|Overall Study|Adverse Event|33|||
30840934|NCT03053063|58866400|FG003|Randomized Phase|Investigator's Discretion|0|||
30840935|NCT03053063|58866397|FG000|Randomized Phase|Lost to Follow-up|3|||
30840936|NCT03053063|58866398|FG001|Randomized Phase|Lost to Follow-up|5|||
30840937|NCT03053063|58866399|FG002|Randomized Phase|Lost to Follow-up|1|||
30840938|NCT03053063|58866400|FG003|Randomized Phase|Lost to Follow-up|0|||
30840939|NCT03053063|58866397|FG000|Randomized Phase|Adverse Event|0|||
30840940|NCT03053063|58866398|FG001|Randomized Phase|Adverse Event|1|||
30840941|NCT03053063|58866399|FG002|Randomized Phase|Adverse Event|0|||
30840942|NCT03053063|58866400|FG003|Randomized Phase|Adverse Event|0|||
30840943|NCT03053063|58866397|FG000|Randomized Phase|Randomized but Never Treated|1|||
30840944|NCT03053063|58866398|FG001|Randomized Phase|Randomized but Never Treated|3|||
30840945|NCT03053063|58866399|FG002|Randomized Phase|Randomized but Never Treated|2|||
30840946|NCT03053063|58866400|FG003|Randomized Phase|Randomized but Never Treated|0|||
30840947|NCT03053063|58866397|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
30840948|NCT03053063|58866398|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
30936042|NCT01846442|58972756|FG001|Overall Study|Left the city/Lost medication|0|||
30624319|NCT00954447|58636367|FG001|Overall Study|Adverse Event|25|||
30624320|NCT00954447|58636366|FG000|Overall Study|Lack of Efficacy|17|||
30936043|NCT01846442|58972757|FG002|Overall Study|Left the city/Lost medication|1|||
30936044|NCT01846442|58972758|FG003|Overall Study|Left the city/Lost medication|1|||
30936045|NCT01709721|58972771|FG000|Open Label Phase|Withdrawal by Subject|0|||
30936046|NCT01709721|58972772|FG001|Open Label Phase|Withdrawal by Subject|0|||
30936047|NCT01709721|58972773|FG002|Open Label Phase|Withdrawal by Subject|5|||
30936048|NCT01709721|58972771|FG000|Open Label Phase|Adverse Event|0|||
30936049|NCT01709721|58972772|FG001|Open Label Phase|Adverse Event|0|||
30936050|NCT01709721|58972773|FG002|Open Label Phase|Adverse Event|8|||
30936051|NCT01709721|58972771|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
30624321|NCT00954447|58636367|FG001|Overall Study|Lack of Efficacy|3|||
30624322|NCT00954447|58636366|FG000|Overall Study|Protocol Violation|5|||
30624323|NCT00954447|58636367|FG001|Overall Study|Protocol Violation|7|||
30624324|NCT00954447|58636366|FG000|Overall Study|Lost to Follow-up|8|||
30624325|NCT00954447|58636367|FG001|Overall Study|Lost to Follow-up|14|||
30624326|NCT00954447|58636366|FG000|Overall Study|Withdrawal by Subject|26|||
30624327|NCT00954447|58636367|FG001|Overall Study|Withdrawal by Subject|21|||
30624328|NCT00954447|58636366|FG000|Overall Study|Other|21|||
30624329|NCT00954447|58636367|FG001|Overall Study|Other|18|||
30624330|NCT00904150|58636375|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
30624331|NCT00904150|58636376|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
30624332|NCT00904150|58636375|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
30624333|NCT00904150|58636376|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
30840949|NCT03053063|58866399|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
30936052|NCT01709721|58972772|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
30936053|NCT01709721|58972773|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
30936054|NCT01709721|58972771|FG000|Open Label Phase|Investigator Decision|0|||
30624334|NCT00903760|58636384|FG000|Overall Study|Disease Progression/Death|8|||
30624335|NCT00903760|58636385|FG001|Overall Study|Disease Progression/Death|6|||
30624336|NCT00903760|58636384|FG000|Overall Study|Stem Cell Transplant|8|||
30624337|NCT00903760|58636385|FG001|Overall Study|Stem Cell Transplant|4|||
30624338|NCT00903760|58636384|FG000|Overall Study|Physician Decision|1|||
30624339|NCT00903760|58636385|FG001|Overall Study|Physician Decision|2|||
30624340|NCT00903760|58636384|FG000|Overall Study|Death|0|||
30624341|NCT00903760|58636385|FG001|Overall Study|Death|1|||
30624342|NCT00903760|58636384|FG000|Overall Study|Lost to Follow-up|1|||
30840950|NCT03053063|58866400|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
30840951|NCT03053063|58866397|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
30840952|NCT03053063|58866398|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
30624343|NCT00903760|58636385|FG001|Overall Study|Lost to Follow-up|0|||
30624344|NCT00903760|58636384|FG000|Overall Study|Withdrawal by Subject|1|||
30624345|NCT00903760|58636385|FG001|Overall Study|Withdrawal by Subject|2|||
30936055|NCT01709721|58972772|FG001|Open Label Phase|Investigator Decision|0|||
30936056|NCT01709721|58972773|FG002|Open Label Phase|Investigator Decision|1|||
30936057|NCT01709721|58972771|FG000|Open Label Phase|Sponsor Decision|0|||
30936058|NCT01709721|58972772|FG001|Open Label Phase|Sponsor Decision|0|||
30936059|NCT01709721|58972773|FG002|Open Label Phase|Sponsor Decision|2|||
30936060|NCT01709721|58972771|FG000|Open Label Phase|Protocol Violation|0|||
30936061|NCT01709721|58972772|FG001|Open Label Phase|Protocol Violation|0|||
30936062|NCT01709721|58972773|FG002|Open Label Phase|Protocol Violation|1|||
30936063|NCT01709721|58972771|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
30936064|NCT01709721|58972772|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
30936065|NCT01709721|58972773|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
30936066|NCT01709721|58972771|FG000|Open Label Phase|Inadequate Pain Control|0|||
30936067|NCT01709721|58972772|FG001|Open Label Phase|Inadequate Pain Control|0|||
30936068|NCT01709721|58972773|FG002|Open Label Phase|Inadequate Pain Control|37|||
30840953|NCT03053063|58866399|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
30840954|NCT03053063|58866400|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
30840955|NCT03053063|58866397|FG000|Open-Label Phase|Death|0|||
30840956|NCT03053063|58866398|FG001|Open-Label Phase|Death|0|||
30840957|NCT03053063|58866399|FG002|Open-Label Phase|Death|0|||
30840958|NCT03053063|58866400|FG003|Open-Label Phase|Death|2|||
30936069|NCT01709721|58972771|FG000|Open Label Phase|Other, Specify in text field in database|0|||
30936070|NCT01709721|58972772|FG001|Open Label Phase|Other, Specify in text field in database|0|||
30936071|NCT01709721|58972773|FG002|Open Label Phase|Other, Specify in text field in database|14|||
30840959|NCT03053063|58866397|FG000|Open-Label Phase|Investigator's discretion|0|||
30840960|NCT03053063|58866398|FG001|Open-Label Phase|Investigator's discretion|0|||
30840961|NCT03053063|58866399|FG002|Open-Label Phase|Investigator's discretion|0|||
30840962|NCT03053063|58866400|FG003|Open-Label Phase|Investigator's discretion|2|||
30840963|NCT01316939|58866422|FG000|Overall Study|Study closed/terminated|26|||
30840964|NCT01316939|58866423|FG001|Overall Study|Study closed/terminated|25|||
30840965|NCT01316939|58866424|FG002|Overall Study|Study closed/terminated|23|||
30840966|NCT01316939|58866422|FG000|Overall Study|Lack of Efficacy|24|||
30840967|NCT01316939|58866423|FG001|Overall Study|Lack of Efficacy|25|||
30840968|NCT01316939|58866424|FG002|Overall Study|Lack of Efficacy|25|||
30840969|NCT01316939|58866422|FG000|Overall Study|Adverse Event|9|||
30840970|NCT01316939|58866423|FG001|Overall Study|Adverse Event|12|||
30840971|NCT01316939|58866424|FG002|Overall Study|Adverse Event|11|||
30840972|NCT01316939|58866422|FG000|Overall Study|Withdrawal by Subject|1|||
30840973|NCT01316939|58866423|FG001|Overall Study|Withdrawal by Subject|3|||
30840974|NCT01316939|58866424|FG002|Overall Study|Withdrawal by Subject|6|||
30840975|NCT01316939|58866422|FG000|Overall Study|Physician Decision|2|||
30840976|NCT01316939|58866423|FG001|Overall Study|Physician Decision|2|||
30840977|NCT01316939|58866424|FG002|Overall Study|Physician Decision|1|||
30840978|NCT01316939|58866422|FG000|Overall Study|Lost to Follow-up|0|||
30840979|NCT01316939|58866423|FG001|Overall Study|Lost to Follow-up|0|||
30840980|NCT01316939|58866424|FG002|Overall Study|Lost to Follow-up|2|||
30840981|NCT01316939|58866422|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
30840982|NCT01316939|58866423|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
30840983|NCT01316939|58866424|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
30840984|NCT01316939|58866422|FG000|Overall Study|Protocol Violation|0|||
30840985|NCT01316939|58866423|FG001|Overall Study|Protocol Violation|1|||
30840986|NCT01316939|58866424|FG002|Overall Study|Protocol Violation|0|||
30840987|NCT03044249|58866434|FG000|Overall Study|Adverse Event|4|||
30840988|NCT03044249|58866435|FG001|Overall Study|Adverse Event|9|||
30840989|NCT03044249|58866434|FG000|Overall Study|Lost to Follow-up|1|||
30840990|NCT03044249|58866435|FG001|Overall Study|Lost to Follow-up|0|||
30840991|NCT03044249|58866434|FG000|Overall Study|Non-compliance with Study Drug|1|||
30840992|NCT03044249|58866435|FG001|Overall Study|Non-compliance with Study Drug|0|||
30840993|NCT03044249|58866434|FG000|Overall Study|Study Terminated by Sponsor|2|||
30840994|NCT03044249|58866435|FG001|Overall Study|Study Terminated by Sponsor|0|||
30840995|NCT03044249|58866434|FG000|Overall Study|Withdrawal by Subject|2|||
30840996|NCT03044249|58866435|FG001|Overall Study|Withdrawal by Subject|5|||
30840997|NCT02704130|58866448|FG000|Overall Study|Physician Decision|5|||
30840998|NCT02704130|58866449|FG001|Overall Study|Physician Decision|3|||
30840999|NCT03740009|58866455|FG000|Overall Study|Physician Decision|9|||
30841000|NCT03740009|58866455|FG000|Overall Study|Lost to Follow-up|1|||
30841001|NCT03649217|58866459|FG000|Overall Study|subject had severe ataxia not initially found|1|||
30841002|NCT03649217|58866459|FG000|Overall Study|subject had cognitive issues not initially found|1|||
30841003|NCT03138889|58866488|FG000|Overall Study|Withdrawal by Subject|5|||
30841004|NCT03138889|58866489|FG001|Overall Study|Withdrawal by Subject|5|||
30936072|NCT01709721|58972771|FG000|Randomized Phase|Adverse Event|0|||
30841005|NCT03138889|58866490|FG002|Overall Study|Withdrawal by Subject|0|||
30841006|NCT03138889|58866491|FG003|Overall Study|Withdrawal by Subject|2|||
30936073|NCT01709721|58972772|FG001|Randomized Phase|Adverse Event|1|||
30936074|NCT01709721|58972773|FG002|Randomized Phase|Adverse Event|0|||
30936075|NCT01709721|58972771|FG000|Randomized Phase|Lost to Follow-up|1|||
30936076|NCT01709721|58972772|FG001|Randomized Phase|Lost to Follow-up|0|||
30936077|NCT01709721|58972773|FG002|Randomized Phase|Lost to Follow-up|0|||
30936078|NCT01709721|58972771|FG000|Randomized Phase|Inadequate Pain Control|1|||
30936079|NCT01709721|58972772|FG001|Randomized Phase|Inadequate Pain Control|2|||
30936080|NCT01709721|58972773|FG002|Randomized Phase|Inadequate Pain Control|0|||
30936081|NCT01709721|58972771|FG000|Randomized Phase|Other, Specify text field in database|1|||
30936082|NCT01709721|58972772|FG001|Randomized Phase|Other, Specify text field in database|3|||
30936083|NCT01709721|58972773|FG002|Randomized Phase|Other, Specify text field in database|0|||
30936084|NCT01866657|58972783|FG000|Overall Study|Surgery canceled|2|||
30936085|NCT01866657|58972784|FG001|Overall Study|Surgery canceled|0|||
30936086|NCT01700205|58972792|FG000|Overall Study|Withdrawal by Subject|13|||
30936087|NCT01700205|58972793|FG001|Overall Study|Withdrawal by Subject|13|||
30936088|NCT01700205|58972792|FG000|Overall Study|Protocol Violation|2|||
30936089|NCT01700205|58972793|FG001|Overall Study|Protocol Violation|2|||
30936090|NCT01700049|58972799|FG000|Overall Study|Withdrawal by Subject|1|||
30936091|NCT01699815|58972806|FG000|Overall Study|Protocol Violation|4|||
30936092|NCT01699815|58972807|FG001|Overall Study|Protocol Violation|7|||
30936093|NCT01699815|58972806|FG000|Overall Study|record could not be located|1|||
30936094|NCT01699815|58972807|FG001|Overall Study|record could not be located|0|||
30936095|NCT01699815|58972806|FG000|Overall Study|Adverse Event|0|||
30936096|NCT01699815|58972807|FG001|Overall Study|Adverse Event|1|||
30936097|NCT01866423|58972813|FG000|Overall Study|Lack of Efficacy|3|||
30936098|NCT01866423|58972813|FG000|Overall Study|Sponsor Decision|1|||
30936099|NCT01846208|58972820|FG000|Overall Study|Withdrew prior to treatment|1|||
30936100|NCT01846208|58972821|FG001|Overall Study|Withdrew prior to treatment|1|||
30936101|NCT01846208|58972822|FG002|Overall Study|Withdrew prior to treatment|1|||
30936102|NCT01846208|58972820|FG000|Overall Study|Dosing Symptoms|1|||
30936103|NCT01846208|58972821|FG001|Overall Study|Dosing Symptoms|2|||
30936104|NCT01846208|58972822|FG002|Overall Study|Dosing Symptoms|6|||
30936105|NCT01846208|58972820|FG000|Overall Study|Withdrawal by Subject|5|||
30936106|NCT01846208|58972821|FG001|Overall Study|Withdrawal by Subject|0|||
30936107|NCT01846208|58972822|FG002|Overall Study|Withdrawal by Subject|0|||
30936108|NCT01846208|58972820|FG000|Overall Study|Non-compliance|1|||
30936109|NCT01846208|58972821|FG001|Overall Study|Non-compliance|1|||
30936110|NCT01846208|58972822|FG002|Overall Study|Non-compliance|0|||
30936111|NCT01846208|58972820|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
30936112|NCT01846208|58972821|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
30936113|NCT01846208|58972822|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
30936114|NCT01846208|58972820|FG000|Overall Study|Refused SU OFC|0|||
30936115|NCT01846208|58972821|FG001|Overall Study|Refused SU OFC|0|||
30936116|NCT01846208|58972822|FG002|Overall Study|Refused SU OFC|1|||
30936117|NCT01845974|58972832|FG000|Overall Study|screen failure|1|||
30936118|NCT01845974|58972833|FG001|Overall Study|screen failure|0|||
30936119|NCT01865487|58972845|FG000|Overall Study|Lost to Follow-up|0|||
30936120|NCT01865487|58972846|FG001|Overall Study|Lost to Follow-up|0|||
30936121|NCT01865487|58972847|FG002|Overall Study|Lost to Follow-up|0|||
30936122|NCT01865487|58972848|FG003|Overall Study|Lost to Follow-up|1|||
30936123|NCT01865487|58972849|FG004|Overall Study|Lost to Follow-up|0|||
30936124|NCT01865487|58972850|FG005|Overall Study|Lost to Follow-up|0|||
30936125|NCT01865487|58972851|FG006|Overall Study|Lost to Follow-up|1|||
30936126|NCT01865487|58972852|FG007|Overall Study|Lost to Follow-up|0|||
30936127|NCT01865487|58972853|FG008|Overall Study|Lost to Follow-up|0|||
30936128|NCT01865487|58972854|FG009|Overall Study|Lost to Follow-up|0|||
30936129|NCT01865487|58972845|FG000|Overall Study|Withdrawal by Subject|0|||
30936130|NCT01865487|58972846|FG001|Overall Study|Withdrawal by Subject|0|||
30936131|NCT01865487|58972847|FG002|Overall Study|Withdrawal by Subject|0|||
30936132|NCT01865487|58972848|FG003|Overall Study|Withdrawal by Subject|0|||
30936133|NCT01865487|58972849|FG004|Overall Study|Withdrawal by Subject|1|||
30936134|NCT01865487|58972850|FG005|Overall Study|Withdrawal by Subject|0|||
30936135|NCT01865487|58972851|FG006|Overall Study|Withdrawal by Subject|0|||
30936136|NCT01865487|58972852|FG007|Overall Study|Withdrawal by Subject|0|||
30936137|NCT01865487|58972853|FG008|Overall Study|Withdrawal by Subject|0|||
30936138|NCT01865487|58972854|FG009|Overall Study|Withdrawal by Subject|0|||
30936139|NCT01699503|58972884|FG000|Overall Study|Death|31|||
30936140|NCT01699503|58972885|FG001|Overall Study|Death|40|||
30758888|NCT03605680|58767458|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
30936141|NCT01699503|58972884|FG000|Overall Study|Withdrawal by Subject|65|||
30936142|NCT01699503|58972885|FG001|Overall Study|Withdrawal by Subject|57|||
30936143|NCT01699503|58972884|FG000|Overall Study|Lost to Follow-up|121|||
30936144|NCT01699503|58972885|FG001|Overall Study|Lost to Follow-up|117|||
30936145|NCT01699503|58972884|FG000|Overall Study|Excluded due to quality|783|||
30936146|NCT01699503|58972885|FG001|Overall Study|Excluded due to quality|791|||
30936147|NCT01709409|58972893|FG000|Overall Study|Protocol Violation|1|||
30936148|NCT01709409|58972894|FG001|Overall Study|Protocol Violation|0|||
30936149|NCT01698879|58972903|FG000|Overall Study|Withdrawal by Subject|1|||
30936150|NCT01698879|58972904|FG001|Overall Study|Withdrawal by Subject|0|||
30936151|NCT01698879|58972905|FG002|Overall Study|Withdrawal by Subject|0|||
30936152|NCT01698801|58972944|FG000|Treatment Phase|Adverse Event|4|||
30936153|NCT01698801|58972944|FG000|Treatment Phase|Protocol Violation|1|||
30936154|NCT01698801|58972944|FG000|Treatment Phase|Other|4|||
30936155|NCT01698801|58972944|FG000|Treatment Phase|Withdrawal by Subject|1|||
30936156|NCT01698801|58972944|FG000|Treatment Phase|Disease progression|1|||
30936157|NCT01698801|58972944|FG000|Follow Up Phase|Withdrawal by Subject|1|||
30936158|NCT01698801|58972944|FG000|Follow Up Phase|Death|4|||
30936159|NCT01682811|58972956|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
30936160|NCT01682811|58972957|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
30936161|NCT01682811|58972958|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
30936162|NCT01682811|58972959|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
30936163|NCT01682811|58972960|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
30936164|NCT01682811|58972961|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
30936165|NCT01682811|58972962|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
30936166|NCT01682811|58972956|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
30936167|NCT01682811|58972957|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
30936168|NCT01682811|58972958|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
30936169|NCT01682811|58972959|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
30936170|NCT01682811|58972960|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
30936171|NCT01682811|58972961|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
30841007|NCT03138889|58866492|FG004|Overall Study|Withdrawal by Subject|1|||
30841008|NCT03138889|58866493|FG005|Overall Study|Withdrawal by Subject|3|||
30841009|NCT03138889|58866494|FG006|Overall Study|Withdrawal by Subject|0|||
30841010|NCT03138889|58866495|FG007|Overall Study|Withdrawal by Subject|1|||
30841011|NCT02706392|58866547|FG000|Overall Study|Death|1|||
30841012|NCT02706392|58866548|FG001|Overall Study|Death|0|||
30841013|NCT02706392|58866549|FG002|Overall Study|Death|2|||
30841014|NCT02706392|58866550|FG003|Overall Study|Death|2|||
30841015|NCT02706392|58866551|FG004|Overall Study|Death|5|||
30841016|NCT02706392|58866552|FG005|Overall Study|Death|2|||
30841017|NCT03042767|58866568|FG000|Overall Study|Lost to Follow-up|1|||
30841018|NCT03042767|58866569|FG001|Overall Study|Lost to Follow-up|2|||
30936172|NCT01682811|58972962|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
30936173|NCT01682811|58972956|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
30936174|NCT01682811|58972957|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
30936175|NCT01682811|58972958|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
30936176|NCT01682811|58972959|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
30936177|NCT01682811|58972960|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
30936178|NCT01682811|58972961|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
30936179|NCT01682811|58972962|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
30936180|NCT01682811|58972956|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
30936181|NCT01682811|58972957|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
30936182|NCT01682811|58972958|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
30936183|NCT01682811|58972959|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
30936184|NCT01682811|58972960|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
30624346|NCT00903760|58636384|FG000|Overall Study|Off treatment for long period|0|||
30841019|NCT00703820|58866577|FG000|Overall Study|Adverse Event|12|||
30841020|NCT00703820|58866578|FG001|Overall Study|Adverse Event|17|||
30841021|NCT00703820|58866577|FG000|Overall Study|Death|5|||
30841022|NCT00703820|58866578|FG001|Overall Study|Death|0|||
30841023|NCT00703820|58866577|FG000|Overall Study|Lack of Efficacy|11|||
30841024|NCT00703820|58866578|FG001|Overall Study|Lack of Efficacy|11|||
30841025|NCT00703820|58866577|FG000|Overall Study|Received non-protocol therapy|1|||
30936185|NCT01682811|58972961|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
30936186|NCT01682811|58972962|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
30936187|NCT01682031|58972983|FG000|Overall Study|Withdrawal by Subject|0|||
30936188|NCT01682031|58972984|FG001|Overall Study|Withdrawal by Subject|1|||
30936189|NCT01682031|58972983|FG000|Overall Study|Adverse Event|0|||
30936190|NCT01682031|58972984|FG001|Overall Study|Adverse Event|2|||
30936191|NCT01682031|58972983|FG000|Overall Study|MRI results indicate increased nodul|0|||
30936192|NCT01682031|58972984|FG001|Overall Study|MRI results indicate increased nodul|1|||
30624347|NCT00903760|58636385|FG001|Overall Study|Off treatment for long period|1|||
30624348|NCT00883051|58636396|FG000|Overall Study|Lost to Follow-up|0|||
30841026|NCT00703820|58866578|FG001|Overall Study|Received non-protocol therapy|0|||
30841027|NCT00703820|58866577|FG000|Overall Study|Physician Decision|4|||
30841028|NCT00703820|58866578|FG001|Overall Study|Physician Decision|5|||
30841029|NCT00703820|58866577|FG000|Overall Study|Withdrawal by Subject|2|||
30936193|NCT01682031|58972983|FG000|Overall Study|Patient could not swallow tablets|1|||
30936194|NCT01682031|58972984|FG001|Overall Study|Patient could not swallow tablets|0|||
30936195|NCT01682031|58972983|FG000|Overall Study|Patient stopped selenium on his own|0|||
30624349|NCT00883051|58636397|FG001|Overall Study|Lost to Follow-up|0|||
30841030|NCT00703820|58866578|FG001|Overall Study|Withdrawal by Subject|1|||
30841031|NCT03045887|58866596|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
30841032|NCT03045887|58866597|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
30841033|NCT03045887|58866598|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
30841034|NCT03045887|58866599|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
30841035|NCT03045887|58866600|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
30841036|NCT03045887|58866601|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
30841037|NCT03045887|58866602|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
30841038|NCT03045887|58866603|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
30841039|NCT03045887|58866604|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
30841040|NCT03045887|58866605|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
30841041|NCT03045887|58866596|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
30841042|NCT03045887|58866597|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
30841043|NCT03045887|58866598|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
30841044|NCT03045887|58866599|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
30841045|NCT03045887|58866600|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
30841046|NCT03045887|58866601|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
30841047|NCT03045887|58866602|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
30841048|NCT03045887|58866603|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
30841049|NCT03045887|58866604|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
30841050|NCT03045887|58866605|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
30841051|NCT03045887|58866596|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
30841052|NCT03045887|58866597|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
30841053|NCT03045887|58866598|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
30841054|NCT03045887|58866599|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
30841055|NCT03045887|58866600|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
30841056|NCT03045887|58866601|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
30841057|NCT03045887|58866602|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
30841058|NCT03045887|58866603|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
30841059|NCT03045887|58866604|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
30936196|NCT01682031|58972984|FG001|Overall Study|Patient stopped selenium on his own|1|||
30936197|NCT01567527|58973005|FG000|Conversion Phase.|Protocol deviation|3|||
30841060|NCT03045887|58866605|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
30841061|NCT03045887|58866596|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
30841062|NCT03045887|58866597|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
30841063|NCT03045887|58866598|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
30936198|NCT01567527|58973006|FG001|Conversion Phase.|Protocol deviation|0|||
30936199|NCT01567527|58973007|FG002|Conversion Phase.|Protocol deviation|0|||
30936200|NCT01567527|58973008|FG003|Conversion Phase.|Protocol deviation|0|||
30936201|NCT01567527|58973009|FG004|Conversion Phase.|Protocol deviation|0|||
30936202|NCT01567527|58973005|FG000|Conversion Phase.|Met withdrawal criteria|10|||
30936203|NCT01567527|58973006|FG001|Conversion Phase.|Met withdrawal criteria|0|||
30936204|NCT01567527|58973007|FG002|Conversion Phase.|Met withdrawal criteria|0|||
30936205|NCT01567527|58973008|FG003|Conversion Phase.|Met withdrawal criteria|0|||
30936206|NCT01567527|58973009|FG004|Conversion Phase.|Met withdrawal criteria|0|||
30936207|NCT01567527|58973005|FG000|Conversion Phase.|Withdrawal by Subject|32|||
30936208|NCT01567527|58973006|FG001|Conversion Phase.|Withdrawal by Subject|0|||
30936209|NCT01567527|58973007|FG002|Conversion Phase.|Withdrawal by Subject|0|||
30936210|NCT01567527|58973008|FG003|Conversion Phase.|Withdrawal by Subject|0|||
30936211|NCT01567527|58973009|FG004|Conversion Phase.|Withdrawal by Subject|0|||
30936212|NCT01567527|58973005|FG000|Conversion Phase.|Lost to Follow-up|16|||
30936213|NCT01567527|58973006|FG001|Conversion Phase.|Lost to Follow-up|0|||
30936214|NCT01567527|58973007|FG002|Conversion Phase.|Lost to Follow-up|0|||
30936215|NCT01567527|58973008|FG003|Conversion Phase.|Lost to Follow-up|0|||
30936216|NCT01567527|58973009|FG004|Conversion Phase.|Lost to Follow-up|0|||
30936217|NCT01567527|58973005|FG000|Conversion Phase.|Lack of Efficacy|2|||
30841064|NCT03045887|58866599|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
30841065|NCT03045887|58866600|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
30936218|NCT01567527|58973006|FG001|Conversion Phase.|Lack of Efficacy|0|||
30936219|NCT01567527|58973007|FG002|Conversion Phase.|Lack of Efficacy|0|||
30841066|NCT03045887|58866601|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
30841067|NCT03045887|58866602|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
30841068|NCT03045887|58866603|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
30841069|NCT03045887|58866604|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
30841070|NCT03045887|58866605|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
30841071|NCT03045887|58866596|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30841072|NCT03045887|58866597|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30841073|NCT03045887|58866598|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30841074|NCT03045887|58866599|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
30936220|NCT01567527|58973008|FG003|Conversion Phase.|Lack of Efficacy|0|||
30936221|NCT01567527|58973009|FG004|Conversion Phase.|Lack of Efficacy|0|||
30936222|NCT01567527|58973005|FG000|Conversion Phase.|Adverse Event|33|||
30841075|NCT03045887|58866600|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30841076|NCT03045887|58866601|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30841077|NCT03045887|58866602|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30841078|NCT03045887|58866603|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30841079|NCT03045887|58866604|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30841080|NCT03045887|58866605|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
30841081|NCT01564537|58866634|FG000|Overall Study|Site Terminated by Sponsor|1|||
30841082|NCT01564537|58866635|FG001|Overall Study|Site Terminated by Sponsor|0|||
30841083|NCT01564537|58866634|FG000|Overall Study|Withdrawal by Subject|12|||
30841084|NCT01564537|58866635|FG001|Overall Study|Withdrawal by Subject|14|||
30841085|NCT01564537|58866634|FG000|Overall Study|Lost to Follow-up|7|||
30841086|NCT01564537|58866635|FG001|Overall Study|Lost to Follow-up|3|||
30841087|NCT01564537|58866634|FG000|Overall Study|Reason not specified|81|||
30841088|NCT01564537|58866635|FG001|Overall Study|Reason not specified|82|||
30841089|NCT03042611|58866646|FG000|Core Phase|Withdrawal by Subject|13|||
30841090|NCT03042611|58866647|FG001|Core Phase|Withdrawal by Subject|4|||
30841091|NCT03042611|58866648|FG002|Core Phase|Withdrawal by Subject|0|||
30841092|NCT03042611|58866649|FG003|Core Phase|Withdrawal by Subject|0|||
30841093|NCT03042611|58866646|FG000|Core Phase|Death|232|||
30841094|NCT03042611|58866647|FG001|Core Phase|Death|110|||
30841095|NCT03042611|58866648|FG002|Core Phase|Death|0|||
30841096|NCT03042611|58866649|FG003|Core Phase|Death|0|||
30841097|NCT03042611|58866646|FG000|Core Phase|Lost to Follow-up|4|||
30841098|NCT03042611|58866647|FG001|Core Phase|Lost to Follow-up|7|||
30841099|NCT03042611|58866648|FG002|Core Phase|Lost to Follow-up|0|||
30841100|NCT03042611|58866649|FG003|Core Phase|Lost to Follow-up|0|||
30936223|NCT01567527|58973006|FG001|Conversion Phase.|Adverse Event|0|||
30936224|NCT01567527|58973007|FG002|Conversion Phase.|Adverse Event|0|||
30936225|NCT01567527|58973008|FG003|Conversion Phase.|Adverse Event|0|||
30936226|NCT01567527|58973009|FG004|Conversion Phase.|Adverse Event|0|||
30936227|NCT01567527|58973005|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
30936228|NCT01567527|58973006|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
30936229|NCT01567527|58973007|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
30936230|NCT01567527|58973008|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
30936231|NCT01567527|58973009|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
30936232|NCT01567527|58973005|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
30936233|NCT01567527|58973006|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
30936234|NCT01567527|58973007|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
30841101|NCT03042611|58866646|FG000|Core Phase|Physician Decision|7|||
30841102|NCT03042611|58866647|FG001|Core Phase|Physician Decision|2|||
30841103|NCT03042611|58866648|FG002|Core Phase|Physician Decision|0|||
30841104|NCT03042611|58866649|FG003|Core Phase|Physician Decision|0|||
30841105|NCT03042611|58866646|FG000|Core Phase|Study Closed|0|||
30841106|NCT03042611|58866647|FG001|Core Phase|Study Closed|1|||
30841107|NCT03042611|58866648|FG002|Core Phase|Study Closed|0|||
30841108|NCT03042611|58866649|FG003|Core Phase|Study Closed|0|||
30841109|NCT03042611|58866646|FG000|Extension Phase|Death|0|||
30841110|NCT03042611|58866647|FG001|Extension Phase|Death|0|||
30841111|NCT03042611|58866648|FG002|Extension Phase|Death|34|||
30841112|NCT03042611|58866649|FG003|Extension Phase|Death|16|||
30841113|NCT03042611|58866646|FG000|Extension Phase|Lost to Follow-up|0|||
30841114|NCT03042611|58866647|FG001|Extension Phase|Lost to Follow-up|0|||
30841115|NCT03042611|58866648|FG002|Extension Phase|Lost to Follow-up|1|||
30841116|NCT03042611|58866649|FG003|Extension Phase|Lost to Follow-up|1|||
30841117|NCT03042611|58866646|FG000|Extension Phase|Study Closed|0|||
30841118|NCT03042611|58866647|FG001|Extension Phase|Study Closed|0|||
30841119|NCT03042611|58866648|FG002|Extension Phase|Study Closed|17|||
30841120|NCT03042611|58866649|FG003|Extension Phase|Study Closed|11|||
30841121|NCT02701634|58866657|FG000|Overall Study|Adverse Event|2|||
30841122|NCT02701634|58866658|FG001|Overall Study|Adverse Event|3|||
30841123|NCT02701634|58866657|FG000|Overall Study|Death|1|||
30841124|NCT02701634|58866658|FG001|Overall Study|Death|0|||
30841125|NCT02701634|58866657|FG000|Overall Study|Investigator's Discretion|7|||
30841126|NCT02701634|58866658|FG001|Overall Study|Investigator's Discretion|4|||
30936235|NCT01567527|58973008|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
30936236|NCT01567527|58973009|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
30841127|NCT02701634|58866657|FG000|Overall Study|Study terminated by Sponsor|15|||
30841128|NCT02701634|58866658|FG001|Overall Study|Study terminated by Sponsor|17|||
30841129|NCT02701634|58866657|FG000|Overall Study|Withdrew Consent|6|||
30841130|NCT02701634|58866658|FG001|Overall Study|Withdrew Consent|7|||
30841131|NCT02701634|58866657|FG000|Overall Study|Randomized but not treated|1|||
30841132|NCT02701634|58866658|FG001|Overall Study|Randomized but not treated|0|||
30841133|NCT02442765|58866668|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
30841134|NCT02442765|58866669|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
30841135|NCT02442765|58866670|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
30841136|NCT02442765|58866671|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
30841137|NCT02442765|58866672|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
30841138|NCT02442765|58866673|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
30841139|NCT02442765|58866674|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
30841140|NCT02442765|58866675|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
30841141|NCT02442765|58866668|FG000|Stage 2- (Days 43 to 85)|Death|0|||
30841142|NCT02442765|58866669|FG001|Stage 2- (Days 43 to 85)|Death|0|||
30841143|NCT02442765|58866670|FG002|Stage 2- (Days 43 to 85)|Death|0|||
30936237|NCT01567527|58973005|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
30936238|NCT01567527|58973006|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
30936239|NCT01567527|58973007|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
30936240|NCT01567527|58973008|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
30936241|NCT01567527|58973009|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
30936242|NCT01567527|58973005|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
30841144|NCT02442765|58866671|FG003|Stage 2- (Days 43 to 85)|Death|1|||
30841145|NCT02442765|58866672|FG004|Stage 2- (Days 43 to 85)|Death|1|||
30841146|NCT02442765|58866673|FG005|Stage 2- (Days 43 to 85)|Death|0|||
30936243|NCT01567527|58973006|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
30936244|NCT01567527|58973007|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
30758889|NCT03605680|58767455|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
30758890|NCT03605680|58767456|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
30758891|NCT03605680|58767457|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
30758892|NCT03605680|58767458|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
30758893|NCT03605680|58767455|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
30758894|NCT03605680|58767456|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
30841147|NCT02442765|58866674|FG006|Stage 2- (Days 43 to 85)|Death|2|||
30841148|NCT02442765|58866675|FG007|Stage 2- (Days 43 to 85)|Death|0|||
30841149|NCT02442765|58866668|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
30841150|NCT02442765|58866669|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
30841151|NCT02442765|58866670|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
30841152|NCT02442765|58866671|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
30841153|NCT02442765|58866672|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
30841154|NCT02442765|58866673|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
30841155|NCT02442765|58866674|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
30758895|NCT03605680|58767457|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
30758896|NCT03605680|58767458|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
30758897|NCT03605680|58767455|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
30758898|NCT03605680|58767456|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
30758899|NCT03605680|58767457|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
30758900|NCT03605680|58767458|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
30758901|NCT03605680|58767455|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
30758902|NCT03605680|58767456|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
30758903|NCT03605680|58767457|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
30758904|NCT03605680|58767458|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
30758905|NCT03605680|58767455|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
30758906|NCT03605680|58767456|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
30758907|NCT03605680|58767457|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
30758908|NCT03605680|58767458|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
30758909|NCT03572218|58767469|FG000|Overall Study|Lost to Follow-up|3|||
30758910|NCT03572218|58767470|FG001|Overall Study|Lost to Follow-up|2|||
30758911|NCT03572218|58767469|FG000|Overall Study|No longer available for study visits|2|||
30841156|NCT02442765|58866675|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
30841157|NCT02442765|58866668|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
30841158|NCT02442765|58866669|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
30841159|NCT02442765|58866670|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
30936245|NCT01567527|58973008|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
30936246|NCT01567527|58973009|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
30936247|NCT01567527|58973005|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
30936248|NCT01567527|58973006|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
30936249|NCT01567527|58973007|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
30936250|NCT01567527|58973008|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
30841160|NCT02442765|58866671|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
30841161|NCT02442765|58866672|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
30841162|NCT02442765|58866673|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
30758912|NCT03572218|58767470|FG001|Overall Study|No longer available for study visits|1|||
30758913|NCT03572218|58767469|FG000|Overall Study|No longer interested|1|||
30758914|NCT03572218|58767470|FG001|Overall Study|No longer interested|2|||
30841163|NCT02442765|58866674|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
30841164|NCT02442765|58866675|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
30841165|NCT02442765|58866668|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
30936251|NCT01567527|58973009|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
30936252|NCT01567527|58973005|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
30936253|NCT01567527|58973006|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
30936254|NCT01567527|58973007|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
30936255|NCT01567527|58973008|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
30936256|NCT01567527|58973009|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
30936257|NCT01567527|58973005|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
30936258|NCT01567527|58973006|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
30936259|NCT01567527|58973007|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
30936260|NCT01567527|58973008|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
30936261|NCT01567527|58973009|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
30936262|NCT01567527|58973005|FG000|IM Depot Stabilization.|Protocol deviation|0|||
30936263|NCT01567527|58973006|FG001|IM Depot Stabilization.|Protocol deviation|0|||
30936264|NCT01567527|58973007|FG002|IM Depot Stabilization.|Protocol deviation|5|||
30936265|NCT01567527|58973008|FG003|IM Depot Stabilization.|Protocol deviation|0|||
30936266|NCT01567527|58973009|FG004|IM Depot Stabilization.|Protocol deviation|0|||
30936267|NCT01567527|58973005|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
30841166|NCT02442765|58866669|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
30841167|NCT02442765|58866670|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
30841168|NCT02442765|58866671|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
30841169|NCT02442765|58866672|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
30841170|NCT02442765|58866673|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
30841171|NCT02442765|58866674|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
30841172|NCT02442765|58866675|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
30841173|NCT02442765|58866668|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
30841174|NCT02442765|58866669|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
30841175|NCT02442765|58866670|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
30841176|NCT02442765|58866671|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
30841177|NCT02442765|58866672|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
30841178|NCT02442765|58866673|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
30841179|NCT02442765|58866674|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
30841180|NCT02442765|58866675|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
30841181|NCT02442765|58866668|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
30841182|NCT02442765|58866669|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
30841183|NCT02442765|58866670|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
30841184|NCT02442765|58866671|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
30841185|NCT02442765|58866672|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
30841186|NCT02442765|58866673|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
30841187|NCT02442765|58866674|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
30841188|NCT02442765|58866675|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
30841189|NCT02442765|58866668|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
30841190|NCT02442765|58866669|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
30841191|NCT02442765|58866670|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
30841192|NCT02442765|58866671|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
30841193|NCT02442765|58866672|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
30841194|NCT02442765|58866673|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
30841195|NCT02442765|58866674|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
30841196|NCT02442765|58866675|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
30841197|NCT02699684|58866706|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
30841198|NCT02699684|58866707|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
30841199|NCT02700698|58866716|FG000|Overall Study|Withdrawal by Subject|1|||
30841200|NCT02700698|58866717|FG001|Overall Study|Withdrawal by Subject|0|||
30841201|NCT01774721|58866725|FG000|Overall Study|Death|76|||
30841202|NCT01774721|58866726|FG001|Overall Study|Death|91|||
30841203|NCT01774721|58866725|FG000|Overall Study|Withdrawal by Subject|14|||
30841204|NCT01774721|58866726|FG001|Overall Study|Withdrawal by Subject|10|||
30841205|NCT01774721|58866725|FG000|Overall Study|Lost to Follow-up|1|||
30841206|NCT01774721|58866726|FG001|Overall Study|Lost to Follow-up|1|||
30841207|NCT01774721|58866725|FG000|Overall Study|Did not meet eligibility criteria|0|||
30841208|NCT01774721|58866726|FG001|Overall Study|Did not meet eligibility criteria|3|||
30841209|NCT01774721|58866725|FG000|Overall Study|Ongoing in study|136|||
30841210|NCT01774721|58866726|FG001|Overall Study|Ongoing in study|120|||
30936268|NCT01567527|58973006|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
30841211|NCT02699450|58866737|FG000|Overall Study|Death|2|||
30841212|NCT02699450|58866738|FG001|Overall Study|Death|1|||
30841213|NCT02699450|58866739|FG002|Overall Study|Death|2|||
30936269|NCT01567527|58973007|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
30948539|NCT01974323|58994554|FG001|Overall Study|Personal Reasons|19|||
30841214|NCT02699450|58866737|FG000|Overall Study|Met Criteria for Study Exit|0|||
30841215|NCT02699450|58866738|FG001|Overall Study|Met Criteria for Study Exit|0|||
30841216|NCT02699450|58866739|FG002|Overall Study|Met Criteria for Study Exit|1|||
30841217|NCT02699450|58866737|FG000|Overall Study|Protocol Violation|4|||
30841218|NCT02699450|58866738|FG001|Overall Study|Protocol Violation|3|||
30841219|NCT02699450|58866739|FG002|Overall Study|Protocol Violation|5|||
30841220|NCT02699450|58866737|FG000|Overall Study|Lost to Follow-up|3|||
30841221|NCT02699450|58866738|FG001|Overall Study|Lost to Follow-up|0|||
30841222|NCT02699450|58866739|FG002|Overall Study|Lost to Follow-up|5|||
30841223|NCT02699450|58866737|FG000|Overall Study|Physician Decision|2|||
30841224|NCT02699450|58866738|FG001|Overall Study|Physician Decision|0|||
30841225|NCT02699450|58866739|FG002|Overall Study|Physician Decision|0|||
30936270|NCT01567527|58973008|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
30936271|NCT01567527|58973009|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
30936272|NCT01567527|58973005|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
30936273|NCT01567527|58973006|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
30936274|NCT01567527|58973007|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
30936275|NCT01567527|58973008|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
30936276|NCT01567527|58973009|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
30936277|NCT01567527|58973005|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
30841226|NCT02699450|58866737|FG000|Overall Study|Withdrawal by Subject|3|||
30841227|NCT02699450|58866738|FG001|Overall Study|Withdrawal by Subject|1|||
30841228|NCT02699450|58866739|FG002|Overall Study|Withdrawal by Subject|2|||
30841229|NCT02699450|58866737|FG000|Overall Study|Adverse Event|1|||
30841230|NCT02699450|58866738|FG001|Overall Study|Adverse Event|0|||
30841231|NCT02699450|58866739|FG002|Overall Study|Adverse Event|0|||
30841232|NCT02699996|58866750|FG000|Overall Study|Withdrawal by Subject|5|||
30841233|NCT02699996|58866751|FG001|Overall Study|Withdrawal by Subject|2|||
30841234|NCT02739321|58866760|FG000|Overall Study|Lack of Efficacy|1|||
30841235|NCT02739321|58866761|FG001|Overall Study|Lack of Efficacy|1|||
30841236|NCT02739321|58866760|FG000|Overall Study|Lost to Follow-up|1|||
30841237|NCT02739321|58866761|FG001|Overall Study|Lost to Follow-up|1|||
30841238|NCT02739321|58866760|FG000|Overall Study|Withdrawal by Subject|1|||
30841239|NCT02739321|58866761|FG001|Overall Study|Withdrawal by Subject|2|||
30841240|NCT02696798|58866779|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
30841241|NCT02696798|58866780|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
30841242|NCT02696798|58866781|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
30841243|NCT02696798|58866779|FG000|Blinded Treatment Dosing Period|Death|0|||
30841244|NCT02696798|58866780|FG001|Blinded Treatment Dosing Period|Death|0|||
30841245|NCT02696798|58866781|FG002|Blinded Treatment Dosing Period|Death|1|||
30841246|NCT02696798|58866779|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
30841247|NCT02696798|58866780|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
30841248|NCT02696798|58866781|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
30841249|NCT02696798|58866779|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
30841250|NCT02696798|58866780|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
30841251|NCT02696798|58866781|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
30841252|NCT02696798|58866779|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
30841253|NCT02696798|58866780|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
30841254|NCT02696798|58866781|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
30841255|NCT02696798|58866779|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
30841256|NCT02696798|58866780|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
30841257|NCT02696798|58866781|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
30841258|NCT02696798|58866779|FG000|Extended Treatment Period|Adverse Event|1|||
30948540|NCT01974323|58994553|FG000|Overall Study|Lost to Follow-up|45|||
30758915|NCT00111813|58767476|FG000|Overall Study|Adverse Event|1|||
30758916|NCT00111813|58767477|FG001|Overall Study|Adverse Event|2|||
30758917|NCT00111813|58767478|FG002|Overall Study|Adverse Event|4|||
30758918|NCT00111813|58767479|FG003|Overall Study|Adverse Event|2|||
30758919|NCT00111813|58767480|FG004|Overall Study|Adverse Event|2|||
30758920|NCT00111813|58767481|FG005|Overall Study|Adverse Event|2|||
30758921|NCT00111813|58767476|FG000|Overall Study|Progressive disease|2|||
30758922|NCT00111813|58767477|FG001|Overall Study|Progressive disease|1|||
30758923|NCT00111813|58767478|FG002|Overall Study|Progressive disease|5|||
30758924|NCT00111813|58767479|FG003|Overall Study|Progressive disease|3|||
30758925|NCT00111813|58767480|FG004|Overall Study|Progressive disease|4|||
30758926|NCT00111813|58767481|FG005|Overall Study|Progressive disease|3|||
30758927|NCT00111813|58767476|FG000|Overall Study|Lack of Efficacy|0|||
30841259|NCT02696798|58866780|FG001|Extended Treatment Period|Adverse Event|4|||
30936278|NCT01567527|58973006|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
30936279|NCT01567527|58973007|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
30936280|NCT01567527|58973008|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
30936281|NCT01567527|58973009|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
30936282|NCT01567527|58973005|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
30936283|NCT01567527|58973006|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
30936284|NCT01567527|58973007|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
30936285|NCT01567527|58973008|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
30936286|NCT01567527|58973009|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
30841260|NCT02696798|58866781|FG002|Extended Treatment Period|Adverse Event|5|||
30841261|NCT02696798|58866779|FG000|Extended Treatment Period|Lack of Efficacy|7|||
30841262|NCT02696798|58866780|FG001|Extended Treatment Period|Lack of Efficacy|2|||
30841263|NCT02696798|58866781|FG002|Extended Treatment Period|Lack of Efficacy|2|||
30936287|NCT01567527|58973005|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
30936288|NCT01567527|58973006|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
30936289|NCT01567527|58973007|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
30936290|NCT01567527|58973008|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
30936291|NCT01567527|58973009|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
30936292|NCT01567527|58973005|FG000|IM Depot Stabilization.|Adverse Event|0|||
30936293|NCT01567527|58973006|FG001|IM Depot Stabilization.|Adverse Event|0|||
30936294|NCT01567527|58973007|FG002|IM Depot Stabilization.|Adverse Event|37|||
30936295|NCT01567527|58973008|FG003|IM Depot Stabilization.|Adverse Event|0|||
30936296|NCT01567527|58973009|FG004|IM Depot Stabilization.|Adverse Event|0|||
30936297|NCT01567527|58973005|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
30936298|NCT01567527|58973006|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
30936299|NCT01567527|58973007|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
30936300|NCT01567527|58973008|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
30936301|NCT01567527|58973009|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
30936302|NCT01567527|58973005|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
30936303|NCT01567527|58973006|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
30936304|NCT01567527|58973007|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
30936305|NCT01567527|58973008|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
30936306|NCT01567527|58973009|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
30936307|NCT01567527|58973005|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
30936308|NCT01567527|58973006|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
30936309|NCT01567527|58973007|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
30936310|NCT01567527|58973008|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
30936311|NCT01567527|58973009|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
30936312|NCT01567527|58973005|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
30936313|NCT01567527|58973006|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
30936314|NCT01567527|58973007|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
30936315|NCT01567527|58973008|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
30936316|NCT01567527|58973009|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
30936317|NCT01567527|58973005|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
30936318|NCT01567527|58973006|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
30936319|NCT01567527|58973007|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
30936320|NCT01567527|58973008|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
30936321|NCT01567527|58973009|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
30948541|NCT01974323|58994554|FG001|Overall Study|Lost to Follow-up|40|||
30758928|NCT00111813|58767477|FG001|Overall Study|Lack of Efficacy|0|||
30758929|NCT00111813|58767478|FG002|Overall Study|Lack of Efficacy|0|||
30758930|NCT00111813|58767479|FG003|Overall Study|Lack of Efficacy|0|||
30758931|NCT00111813|58767480|FG004|Overall Study|Lack of Efficacy|0|||
30758932|NCT00111813|58767481|FG005|Overall Study|Lack of Efficacy|1|||
30758933|NCT00111813|58767476|FG000|Overall Study|Other|0|||
30758934|NCT00111813|58767477|FG001|Overall Study|Other|0|||
30758935|NCT00111813|58767478|FG002|Overall Study|Other|1|||
30758936|NCT00111813|58767479|FG003|Overall Study|Other|0|||
30936322|NCT01567527|58973005|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
30936323|NCT01567527|58973006|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
30936324|NCT01567527|58973007|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
30936325|NCT01567527|58973008|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
30936326|NCT01567527|58973009|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
30936327|NCT01567527|58973005|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
30936328|NCT01567527|58973006|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
30936329|NCT01567527|58973007|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
30936330|NCT01567527|58973008|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
30936331|NCT01567527|58973009|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
30936332|NCT01567527|58973005|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
30936333|NCT01567527|58973006|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
30936334|NCT01567527|58973007|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
30936335|NCT01567527|58973008|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
30936336|NCT01567527|58973009|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
30936337|NCT01567527|58973005|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
30936338|NCT01567527|58973006|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
30936339|NCT01567527|58973007|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
30841264|NCT02696798|58866779|FG000|Extended Treatment Period|Lost to Follow-up|1|||
30841265|NCT02696798|58866780|FG001|Extended Treatment Period|Lost to Follow-up|0|||
30841266|NCT02696798|58866781|FG002|Extended Treatment Period|Lost to Follow-up|0|||
30841267|NCT02696798|58866779|FG000|Extended Treatment Period|Physician Decision|0|||
30841268|NCT02696798|58866780|FG001|Extended Treatment Period|Physician Decision|1|||
30841269|NCT02696798|58866781|FG002|Extended Treatment Period|Physician Decision|0|||
30841270|NCT02696798|58866779|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
30841271|NCT02696798|58866780|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
30841272|NCT02696798|58866781|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
30841273|NCT02696798|58866779|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
30841274|NCT02696798|58866780|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
30841275|NCT02696798|58866781|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
30841276|NCT02696798|58866779|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
30841277|NCT02696798|58866780|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
30841278|NCT02696798|58866781|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
30758937|NCT00111813|58767480|FG004|Overall Study|Other|0|||
30841279|NCT02696798|58866779|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
30841280|NCT02696798|58866780|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
30841281|NCT02696798|58866781|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
30841282|NCT02696798|58866779|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
30841283|NCT02696798|58866780|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
30841284|NCT02696798|58866781|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
30841285|NCT02696798|58866779|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
30841286|NCT02696798|58866780|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
30841287|NCT02696798|58866781|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
30841288|NCT02696798|58866779|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
30841289|NCT02696798|58866780|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
30758938|NCT00111813|58767481|FG005|Overall Study|Other|0|||
30758939|NCT00118287|58767496|FG000|Overall Study|Intracranial haemorrhage|1|||
30758940|NCT00118287|58767496|FG000|Overall Study|Muscle pain|1|||
30758941|NCT00130689|58767500|FG000|Overall Study|Progressive Disease|29|||
30758942|NCT00130689|58767500|FG000|Overall Study|Death|1|||
30758943|NCT00130689|58767500|FG000|Overall Study|Clinical Deterioration|4|||
30758944|NCT00130689|58767500|FG000|Overall Study|Withdrawal by Subject|3|||
30758945|NCT00130689|58767500|FG000|Overall Study|Ineligible|6|||
30758946|NCT03605212|58767509|FG000|Treatment Period|Adverse Event|1|||
30758947|NCT03605212|58767510|FG001|Treatment Period|Adverse Event|0|||
30758948|NCT03605212|58767511|FG002|Treatment Period|Adverse Event|0|||
30758949|NCT03605212|58767512|FG003|Treatment Period|Adverse Event|0|||
30841290|NCT02696798|58866781|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
30841291|NCT02698826|58866803|FG000|Overall Study|Death|13|||
30841292|NCT02698826|58866803|FG000|Overall Study|Adverse Event|1|||
30841293|NCT02541604|58866821|FG000|Overall Study|Death|6|||
30841294|NCT02541604|58866822|FG001|Overall Study|Death|5|||
30841295|NCT02541604|58866823|FG002|Overall Study|Death|7|||
30841296|NCT02541604|58866824|FG003|Overall Study|Death|2|||
30841297|NCT02541604|58866825|FG004|Overall Study|Death|9|||
30841298|NCT02541604|58866826|FG005|Overall Study|Death|8|||
30841299|NCT02541604|58866827|FG006|Overall Study|Death|9|||
30841300|NCT02541604|58866828|FG007|Overall Study|Death|9|||
30841301|NCT02541604|58866829|FG008|Overall Study|Death|3|||
30841302|NCT02541604|58866830|FG009|Overall Study|Death|4|||
30841303|NCT02541604|58866831|FG010|Overall Study|Death|2|||
30841304|NCT02541604|58866832|FG011|Overall Study|Death|3|||
30841305|NCT02541604|58866821|FG000|Overall Study|Lost to Follow-up|2|||
30841306|NCT02541604|58866822|FG001|Overall Study|Lost to Follow-up|0|||
30841307|NCT02541604|58866823|FG002|Overall Study|Lost to Follow-up|1|||
30841308|NCT02541604|58866824|FG003|Overall Study|Lost to Follow-up|0|||
30841309|NCT02541604|58866825|FG004|Overall Study|Lost to Follow-up|0|||
30841310|NCT02541604|58866826|FG005|Overall Study|Lost to Follow-up|1|||
30841311|NCT02541604|58866827|FG006|Overall Study|Lost to Follow-up|1|||
30841312|NCT02541604|58866828|FG007|Overall Study|Lost to Follow-up|0|||
30841313|NCT02541604|58866829|FG008|Overall Study|Lost to Follow-up|0|||
30841314|NCT02541604|58866830|FG009|Overall Study|Lost to Follow-up|0|||
30841315|NCT02541604|58866831|FG010|Overall Study|Lost to Follow-up|0|||
30841316|NCT02541604|58866832|FG011|Overall Study|Lost to Follow-up|0|||
30841317|NCT02541604|58866821|FG000|Overall Study|Withdrawal by Subject|2|||
30841318|NCT02541604|58866822|FG001|Overall Study|Withdrawal by Subject|0|||
30841319|NCT02541604|58866823|FG002|Overall Study|Withdrawal by Subject|1|||
30841320|NCT02541604|58866824|FG003|Overall Study|Withdrawal by Subject|0|||
30841321|NCT02541604|58866825|FG004|Overall Study|Withdrawal by Subject|1|||
30841322|NCT02541604|58866826|FG005|Overall Study|Withdrawal by Subject|1|||
30841323|NCT02541604|58866827|FG006|Overall Study|Withdrawal by Subject|0|||
30841324|NCT02541604|58866828|FG007|Overall Study|Withdrawal by Subject|0|||
30841325|NCT02541604|58866829|FG008|Overall Study|Withdrawal by Subject|1|||
30841326|NCT02541604|58866830|FG009|Overall Study|Withdrawal by Subject|0|||
30841327|NCT02541604|58866831|FG010|Overall Study|Withdrawal by Subject|0|||
30841328|NCT02541604|58866832|FG011|Overall Study|Withdrawal by Subject|0|||
30841329|NCT02541604|58866821|FG000|Overall Study|Study Terminated by Sponsor|1|||
30841330|NCT02541604|58866822|FG001|Overall Study|Study Terminated by Sponsor|4|||
30841331|NCT02541604|58866823|FG002|Overall Study|Study Terminated by Sponsor|2|||
30841332|NCT02541604|58866824|FG003|Overall Study|Study Terminated by Sponsor|1|||
30841333|NCT02541604|58866825|FG004|Overall Study|Study Terminated by Sponsor|0|||
30841334|NCT02541604|58866826|FG005|Overall Study|Study Terminated by Sponsor|0|||
30841335|NCT02541604|58866827|FG006|Overall Study|Study Terminated by Sponsor|0|||
30841336|NCT02541604|58866828|FG007|Overall Study|Study Terminated by Sponsor|0|||
30841337|NCT02541604|58866829|FG008|Overall Study|Study Terminated by Sponsor|0|||
30936340|NCT01567527|58973008|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
30936341|NCT01567527|58973009|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
30936342|NCT01818752|58973020|FG000|Overall Study|Adverse Event|64|||
30936343|NCT01818752|58973021|FG001|Overall Study|Adverse Event|74|||
30936344|NCT01818752|58973020|FG000|Overall Study|Death|14|||
30936345|NCT01818752|58973021|FG001|Overall Study|Death|18|||
30936346|NCT01818752|58973020|FG000|Overall Study|Non-compliance|16|||
30758950|NCT03605212|58767513|FG004|Treatment Period|Adverse Event|0|||
30758951|NCT03605212|58767509|FG000|Treatment Period|Physician Decision|0|||
30758952|NCT03605212|58767510|FG001|Treatment Period|Physician Decision|0|||
30758953|NCT03605212|58767511|FG002|Treatment Period|Physician Decision|0|||
30758954|NCT03605212|58767512|FG003|Treatment Period|Physician Decision|0|||
30758955|NCT03605212|58767513|FG004|Treatment Period|Physician Decision|1|||
30758956|NCT03603652|58767526|FG000|Overall Study|Death|2|||
30758957|NCT00117507|58767530|FG000|Overall Study|Adverse Event|4|||
30758958|NCT00117507|58767530|FG000|Overall Study|Abnormal laboratory values|3|||
30758959|NCT00117507|58767530|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30841338|NCT02541604|58866830|FG009|Overall Study|Study Terminated by Sponsor|0|||
30841339|NCT02541604|58866831|FG010|Overall Study|Study Terminated by Sponsor|0|||
30841340|NCT02541604|58866832|FG011|Overall Study|Study Terminated by Sponsor|0|||
30841341|NCT02541604|58866821|FG000|Overall Study|Medical condition may jeopardize safety|0|||
30841342|NCT02541604|58866822|FG001|Overall Study|Medical condition may jeopardize safety|0|||
30841343|NCT02541604|58866823|FG002|Overall Study|Medical condition may jeopardize safety|0|||
30841344|NCT02541604|58866824|FG003|Overall Study|Medical condition may jeopardize safety|0|||
30841345|NCT02541604|58866825|FG004|Overall Study|Medical condition may jeopardize safety|0|||
30841346|NCT02541604|58866826|FG005|Overall Study|Medical condition may jeopardize safety|0|||
30841347|NCT02541604|58866827|FG006|Overall Study|Medical condition may jeopardize safety|0|||
30841348|NCT02541604|58866828|FG007|Overall Study|Medical condition may jeopardize safety|1|||
30936347|NCT01818752|58973021|FG001|Overall Study|Non-compliance|20|||
30841349|NCT02541604|58866829|FG008|Overall Study|Medical condition may jeopardize safety|0|||
30841350|NCT02541604|58866830|FG009|Overall Study|Medical condition may jeopardize safety|0|||
30841351|NCT02541604|58866831|FG010|Overall Study|Medical condition may jeopardize safety|0|||
30936348|NCT01818752|58973020|FG000|Overall Study|Withdrawal by Subject|15|||
30936349|NCT01818752|58973021|FG001|Overall Study|Withdrawal by Subject|14|||
30936350|NCT01818752|58973020|FG000|Overall Study|Physician Decision|9|||
30936351|NCT01818752|58973021|FG001|Overall Study|Physician Decision|8|||
30936352|NCT01818752|58973020|FG000|Overall Study|Disease Progression|54|||
30936353|NCT01818752|58973021|FG001|Overall Study|Disease Progression|48|||
30936354|NCT01818752|58973020|FG000|Overall Study|Other|7|||
30936355|NCT01818752|58973021|FG001|Overall Study|Other|8|||
30936356|NCT01818752|58973020|FG000|Overall Study|Continuing Treatment|1|||
30936357|NCT01818752|58973021|FG001|Overall Study|Continuing Treatment|4|||
30936358|NCT01818752|58973020|FG000|Overall Study|Randomized but not Dosed|7|||
30936359|NCT01818752|58973021|FG001|Overall Study|Randomized but not Dosed|4|||
30936360|NCT01845818|58973029|FG000|Overall Study|Withdrawal by Subject|0|||
30936361|NCT01845818|58973030|FG001|Overall Study|Withdrawal by Subject|1|||
30936362|NCT01845818|58973029|FG000|Overall Study|Lost to Follow-up|7|||
30936363|NCT01845818|58973030|FG001|Overall Study|Lost to Follow-up|5|||
30936364|NCT01845818|58973029|FG000|Overall Study|Administrative Reasons|3|||
30936365|NCT01845818|58973030|FG001|Overall Study|Administrative Reasons|1|||
30936366|NCT01845818|58973029|FG000|Overall Study|Serious Adverse Event|1|||
30936367|NCT01845818|58973030|FG001|Overall Study|Serious Adverse Event|1|||
30936368|NCT01845818|58973029|FG000|Overall Study|Other|25|||
30936369|NCT01845818|58973030|FG001|Overall Study|Other|8|||
30936370|NCT01845818|58973029|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
30936371|NCT01845818|58973030|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
30936372|NCT01845818|58973029|FG000|Overall Study|No Follow-Up Data Available|4|||
30758960|NCT00117507|58767530|FG000|Overall Study|Patient withdrew consent|4|||
30758961|NCT00117507|58767530|FG000|Overall Study|Death|3|||
30841352|NCT02541604|58866832|FG011|Overall Study|Medical condition may jeopardize safety|0|||
30841353|NCT02546674|58866881|FG000|Overall Study|Adverse Event|19|||
30758962|NCT03603496|58767537|FG000|Overall Study|Death|19|||
30758963|NCT03603496|58767538|FG001|Overall Study|Death|24|||
30758964|NCT03603496|58767537|FG000|Overall Study|Lost to Follow-up|141|||
30758965|NCT03603496|58767538|FG001|Overall Study|Lost to Follow-up|141|||
30758966|NCT03603496|58767537|FG000|Overall Study|Withdrawal by Subject|26|||
30758967|NCT03603496|58767538|FG001|Overall Study|Withdrawal by Subject|20|||
30758968|NCT03603028|58767544|FG000|Overall Study|Withdrawal by Subject|1|||
30758969|NCT03602482|58767550|FG000|Overall Study|Withdrawal by Subject|6|||
30841354|NCT02546674|58866881|FG000|Overall Study|Death|1|||
30841355|NCT02546674|58866881|FG000|Overall Study|Lost to Follow-up|1|||
30841356|NCT02546674|58866881|FG000|Overall Study|Physician Decision|13|||
30841357|NCT02546674|58866881|FG000|Overall Study|Pregnancy|1|||
30841358|NCT02546674|58866881|FG000|Overall Study|Progressive Disease|2|||
30841359|NCT02546674|58866881|FG000|Overall Study|Protocol Deviation|2|||
30841360|NCT02546674|58866881|FG000|Overall Study|Subject/Guardian Decision|6|||
30841361|NCT02546674|58866881|FG000|Overall Study|Withdrawal of Informed Consent|3|||
30841362|NCT02546362|58866886|FG000|4-week Treatment Period|Lost to Follow-up|1|||
30841363|NCT02546362|58866886|FG000|4-week Treatment Period|Change in medication|2|||
30841364|NCT02546362|58866886|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
30841365|NCT02546362|58866886|FG000|12-week Treatment Period|Lost to Follow-up|2|||
30841366|NCT02546362|58866886|FG000|12-week Treatment Period|Change in medication|1|||
30841367|NCT02698436|58866892|FG000|Overall Study|Adverse Event|1|||
30841368|NCT02698436|58866893|FG001|Overall Study|Adverse Event|0|||
30841369|NCT02698436|58866892|FG000|Overall Study|Withdrawal by Subject|3|||
30841370|NCT02698436|58866893|FG001|Overall Study|Withdrawal by Subject|3|||
30841371|NCT02698436|58866892|FG000|Overall Study|Lost to Follow-up|2|||
30841372|NCT02698436|58866893|FG001|Overall Study|Lost to Follow-up|4|||
30841373|NCT02698436|58866892|FG000|Overall Study|Non-compliance with study regimen|1|||
30841374|NCT02698436|58866893|FG001|Overall Study|Non-compliance with study regimen|0|||
30841375|NCT02694536|58866899|FG000|Overall Study|Progressive Disease|40|||
30841376|NCT02694536|58866899|FG000|Overall Study|Lost to Follow-up|1|||
30841377|NCT02694536|58866899|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
30841378|NCT02694536|58866899|FG000|Overall Study|Withdrawal by Subject|8|||
30841379|NCT02694536|58866899|FG000|Overall Study|Death|8|||
30936373|NCT01845818|58973030|FG001|Overall Study|No Follow-Up Data Available|1|||
30936374|NCT01362608|58973040|FG000|Overall Study|Protocol Violation|0|||
30758970|NCT03602482|58767551|FG001|Overall Study|Withdrawal by Subject|7|||
30841380|NCT02694536|58866899|FG000|Overall Study|Other|22|||
30841381|NCT01661686|58866905|FG000|Overall Study|Lost to Follow-up|2|||
30841382|NCT01661686|58866906|FG001|Overall Study|Lost to Follow-up|1|||
30936375|NCT01362608|58973041|FG001|Overall Study|Protocol Violation|1|||
30936376|NCT01362608|58973040|FG000|Overall Study|Lost to Follow-up|3|||
30936377|NCT01362608|58973041|FG001|Overall Study|Lost to Follow-up|1|||
30936378|NCT01362608|58973040|FG000|Overall Study|Withdrawal by Subject|1|||
30936379|NCT01362608|58973041|FG001|Overall Study|Withdrawal by Subject|2|||
30841383|NCT01661686|58866905|FG000|Overall Study|did not receive allocated intervention|0|||
30841384|NCT01661686|58866906|FG001|Overall Study|did not receive allocated intervention|1|||
30841385|NCT02696096|58866912|FG000|Overall Study|ruled out at screening|1|||
30841386|NCT02696096|58866912|FG000|Overall Study|did not attend second fMRI|1|||
30841387|NCT02695628|58866920|FG000|Overall Study|Withdrawal by Subject|1|||
30841388|NCT02693834|58866924|FG000|Baseline Measurement|Withdrawal by Subject|1|||
30841389|NCT02693834|58866925|FG001|Baseline Measurement|Withdrawal by Subject|0|||
30841390|NCT02693834|58866924|FG000|Baseline Measurement|Adverse Event|1|||
30841391|NCT02693834|58866925|FG001|Baseline Measurement|Adverse Event|0|||
30841392|NCT02693834|58866924|FG000|Week 2 Practice|Adverse Event|0|||
30841393|NCT02693834|58866925|FG001|Week 2 Practice|Adverse Event|1|||
30841394|NCT02545504|58866933|FG000|Overall Study|Death|174|||
30841395|NCT02545504|58866934|FG001|Overall Study|Death|168|||
30841396|NCT02545504|58866933|FG000|Overall Study|Unknown reason|30|||
30841397|NCT02545504|58866934|FG001|Overall Study|Unknown reason|32|||
30841398|NCT02545504|58866933|FG000|Overall Study|Withdrew consent|9|||
30841399|NCT02545504|58866934|FG001|Overall Study|Withdrew consent|11|||
30841400|NCT02545504|58866933|FG000|Overall Study|Investigator's discretion|3|||
30841401|NCT02545504|58866934|FG001|Overall Study|Investigator's discretion|1|||
30841402|NCT02545504|58866933|FG000|Overall Study|Lost to Follow-up|2|||
30841403|NCT02545504|58866934|FG001|Overall Study|Lost to Follow-up|2|||
30841404|NCT02545270|58866947|FG000|Overall Study|technical difficulties|0|||
30841405|NCT02545270|58866948|FG001|Overall Study|technical difficulties|1|||
30841406|NCT02545270|58866949|FG002|Overall Study|technical difficulties|0|||
30841407|NCT02545270|58866947|FG000|Overall Study|Videos being too similar to other|0|||
30841408|NCT02545270|58866948|FG001|Overall Study|Videos being too similar to other|0|||
30841409|NCT02545270|58866949|FG002|Overall Study|Videos being too similar to other|2|||
30841410|NCT02540668|58866958|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
30841411|NCT02540668|58866959|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
30841412|NCT02339740|58866968|FG000|Overall Study|Death|1|||
30841413|NCT02339740|58866969|FG001|Overall Study|Death|0|||
30841414|NCT02339740|58866968|FG000|Overall Study|Physician Decision|0|||
30624350|NCT00883051|58636398|FG002|Overall Study|Lost to Follow-up|0|||
30624351|NCT00883051|58636399|FG003|Overall Study|Lost to Follow-up|0|||
30624352|NCT00883051|58636400|FG004|Overall Study|Lost to Follow-up|1|||
30624353|NCT00883051|58636396|FG000|Overall Study|Did not use study medication|24|||
30624354|NCT00883051|58636397|FG001|Overall Study|Did not use study medication|22|||
30624355|NCT00883051|58636398|FG002|Overall Study|Did not use study medication|29|||
30624356|NCT00883051|58636399|FG003|Overall Study|Did not use study medication|29|||
30624357|NCT00883051|58636400|FG004|Overall Study|Did not use study medication|17|||
30624358|NCT00903682|58636414|FG000|Overall Study|Adverse Event|6|||
30624359|NCT00903682|58636415|FG001|Overall Study|Adverse Event|13|||
30624360|NCT00903682|58636414|FG000|Overall Study|Lost to Follow-up|1|||
30624361|NCT00903682|58636415|FG001|Overall Study|Lost to Follow-up|0|||
30624362|NCT00903682|58636414|FG000|Overall Study|Withdrawal by Subject|5|||
30624363|NCT00903682|58636415|FG001|Overall Study|Withdrawal by Subject|0|||
30624364|NCT00903682|58636414|FG000|Overall Study|Pregnancy|0|||
30624365|NCT00903682|58636415|FG001|Overall Study|Pregnancy|1|||
30624366|NCT00903682|58636414|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
30624367|NCT00903682|58636415|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
30624368|NCT00903682|58636414|FG000|Overall Study|Subject Non-Compliant|1|||
30624369|NCT00903682|58636415|FG001|Overall Study|Subject Non-Compliant|0|||
30624370|NCT00903682|58636414|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
30624371|NCT00903682|58636415|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
30624372|NCT00903682|58636414|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
30624373|NCT00903682|58636415|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
30624374|NCT01117428|58636427|FG000|Overall Study|Lack of Efficacy|1|||
30624375|NCT01117428|58636428|FG001|Overall Study|Lack of Efficacy|0|||
30624376|NCT01117428|58636429|FG002|Overall Study|Lack of Efficacy|0|||
30624377|NCT01117428|58636430|FG003|Overall Study|Lack of Efficacy|0|||
30841415|NCT02339740|58866969|FG001|Overall Study|Physician Decision|2|||
30841416|NCT02339740|58866968|FG000|Overall Study|Withdrawal by Subject|5|||
30841417|NCT02339740|58866969|FG001|Overall Study|Withdrawal by Subject|1|||
30841418|NCT02339740|58866968|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
30841419|NCT02339740|58866969|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
30624378|NCT01117428|58636431|FG004|Overall Study|Lack of Efficacy|0|||
30624379|NCT01117428|58636432|FG005|Overall Study|Lack of Efficacy|0|||
30624380|NCT01117428|58636427|FG000|Overall Study|Adverse Event|4|||
30624381|NCT01117428|58636428|FG001|Overall Study|Adverse Event|0|||
30841420|NCT02535364|58866992|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
30841421|NCT02535364|58866992|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
30841422|NCT02535364|58866992|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
30624382|NCT01117428|58636429|FG002|Overall Study|Adverse Event|0|||
30841423|NCT02535364|58866992|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
30758971|NCT03602482|58767552|FG002|Overall Study|Withdrawal by Subject|0|||
30936380|NCT01362608|58973040|FG000|Overall Study|Lack of Efficacy|0|||
30936381|NCT01362608|58973041|FG001|Overall Study|Lack of Efficacy|2|||
30936382|NCT01362608|58973040|FG000|Overall Study|Adverse Event|0|||
30936383|NCT01362608|58973041|FG001|Overall Study|Adverse Event|2|||
30936384|NCT01871090|58973049|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
30936385|NCT01871090|58973050|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
30936386|NCT01871090|58973049|FG000|Overall Study|Interrogation not completed correctly|1|||
30936387|NCT01871090|58973050|FG001|Overall Study|Interrogation not completed correctly|0|||
30936388|NCT01871090|58973049|FG000|Overall Study|Subject Non-Compliance|0|||
30936389|NCT01871090|58973050|FG001|Overall Study|Subject Non-Compliance|1|||
30936390|NCT01818596|58973058|FG000|Overall Study|Enrolled but Not Treated|4|||
30936391|NCT01818596|58973059|FG001|Overall Study|Enrolled but Not Treated|0|||
30936392|NCT01818596|58973058|FG000|Overall Study|Adverse Event|7|||
30936393|NCT01818596|58973059|FG001|Overall Study|Adverse Event|0|||
30936394|NCT01818596|58973058|FG000|Overall Study|Death|3|||
30936395|NCT01818596|58973059|FG001|Overall Study|Death|0|||
30936396|NCT01818596|58973058|FG000|Overall Study|Investigator's Discretion|4|||
30936397|NCT01818596|58973059|FG001|Overall Study|Investigator's Discretion|0|||
30936398|NCT01818596|58973058|FG000|Overall Study|Protocol Violation|1|||
30936399|NCT01818596|58973059|FG001|Overall Study|Protocol Violation|0|||
30936400|NCT01818596|58973058|FG000|Overall Study|Withdrew Consent|5|||
30936401|NCT01818596|58973059|FG001|Overall Study|Withdrew Consent|0|||
30936402|NCT01818596|58973058|FG000|Overall Study|Lost to Follow-up|7|||
30758972|NCT03602482|58767553|FG003|Overall Study|Withdrawal by Subject|0|||
30758973|NCT00096135|58767568|FG000|Overall Study|Physician Decision|20|||
30936403|NCT01818596|58973059|FG001|Overall Study|Lost to Follow-up|0|||
30936404|NCT04577794|58973072|FG000|Overall Study|Adverse Event|1|||
30936405|NCT04577794|58973073|FG001|Overall Study|Adverse Event|1|||
30936406|NCT01594281|58973090|FG000|Interventional Core Phase|Protocol Deviation|1|||
30936407|NCT01594281|58973091|FG001|Interventional Core Phase|Protocol Deviation|0|||
30936408|NCT01594281|58973092|FG002|Interventional Core Phase|Protocol Deviation|0|||
30936409|NCT01594281|58973090|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
30936410|NCT01594281|58973091|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
30936411|NCT01594281|58973092|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
30936412|NCT01594281|58973090|FG000|Interventional Core Phase|Death|1|||
30936413|NCT01594281|58973091|FG001|Interventional Core Phase|Death|1|||
30936414|NCT01594281|58973092|FG002|Interventional Core Phase|Death|2|||
30936415|NCT01594281|58973090|FG000|Interventional Core Phase|Lost to Follow-up|1|||
30936416|NCT01594281|58973091|FG001|Interventional Core Phase|Lost to Follow-up|4|||
30936417|NCT01594281|58973092|FG002|Interventional Core Phase|Lost to Follow-up|1|||
30936418|NCT01594281|58973090|FG000|Interventional Core Phase|Adverse Event|4|||
30936419|NCT01594281|58973091|FG001|Interventional Core Phase|Adverse Event|4|||
30936420|NCT01594281|58973092|FG002|Interventional Core Phase|Adverse Event|4|||
30936421|NCT01594281|58973090|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
30936422|NCT01594281|58973091|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
30936423|NCT01594281|58973092|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
30936424|NCT01594281|58973090|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
30936425|NCT01594281|58973091|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
30936426|NCT01594281|58973092|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
30936427|NCT01594281|58973090|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
30936428|NCT01594281|58973091|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
30758974|NCT00096135|58767569|FG001|Overall Study|Physician Decision|4|||
30758975|NCT00096135|58767568|FG000|Overall Study|Refusal of further protocol therapy|4|||
30758976|NCT00096135|58767569|FG001|Overall Study|Refusal of further protocol therapy|1|||
30758977|NCT00096135|58767568|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
30758978|NCT00096135|58767569|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
30758979|NCT00096135|58767568|FG000|Overall Study|Other, specify|15|||
30758980|NCT00096135|58767569|FG001|Overall Study|Other, specify|3|||
30936429|NCT01594281|58973092|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
30936430|NCT01566981|58973105|FG000|Overall Study|Lost to Follow-up|5|||
30936431|NCT01566981|58973106|FG001|Overall Study|Lost to Follow-up|8|||
30936432|NCT01870778|58973116|FG000|Overall Study|Withdrawal by Subject|8|||
30936433|NCT01870778|58973117|FG001|Overall Study|Withdrawal by Subject|7|||
30936434|NCT01870778|58973116|FG000|Overall Study|Lost to Follow-up|0|||
30936435|NCT01870778|58973117|FG001|Overall Study|Lost to Follow-up|2|||
30936436|NCT01818284|58973130|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
30936437|NCT01818284|58973131|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
30936438|NCT01818284|58973130|FG000|Overall Study|Death|0|||
30936439|NCT01818284|58973131|FG001|Overall Study|Death|2|||
30936440|NCT01610492|58973167|FG000|Overall Study|Adverse Event|1|||
30936441|NCT01610492|58973167|FG000|Overall Study|Lack of Efficacy|3|||
30936442|NCT01610492|58973167|FG000|Overall Study|Other: Reached stopping criteria|1|||
30936443|NCT01610492|58973167|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
30936444|NCT01817582|58973174|FG000|Overall Study|Withdrawal by Subject|0|||
30936445|NCT01817582|58973175|FG001|Overall Study|Withdrawal by Subject|1|||
30936446|NCT01817582|58973176|FG002|Overall Study|Withdrawal by Subject|0|||
30936447|NCT01817582|58973174|FG000|Overall Study|Participant revealed masked treatment|1|||
30936448|NCT01817582|58973175|FG001|Overall Study|Participant revealed masked treatment|0|||
30936449|NCT01817582|58973176|FG002|Overall Study|Participant revealed masked treatment|0|||
30936450|NCT01817582|58973174|FG000|Overall Study|Randomized but exclusion criteria met|1|||
30936451|NCT01817582|58973175|FG001|Overall Study|Randomized but exclusion criteria met|0|||
30936452|NCT01817582|58973176|FG002|Overall Study|Randomized but exclusion criteria met|0|||
30936453|NCT01594125|58973189|FG000|Overall Study|Withdrawal by Subject|1|||
30936454|NCT01594125|58973190|FG001|Overall Study|Withdrawal by Subject|0|||
30936455|NCT01594125|58973191|FG002|Overall Study|Withdrawal by Subject|0|||
30936456|NCT01594125|58973192|FG003|Overall Study|Withdrawal by Subject|1|||
30936457|NCT01594125|58973193|FG004|Overall Study|Withdrawal by Subject|0|||
30936458|NCT01594125|58973189|FG000|Overall Study|Progressive Disease|3|||
30936459|NCT01594125|58973190|FG001|Overall Study|Progressive Disease|12|||
30936460|NCT01594125|58973191|FG002|Overall Study|Progressive Disease|3|||
30936461|NCT01594125|58973192|FG003|Overall Study|Progressive Disease|3|||
30936462|NCT01594125|58973193|FG004|Overall Study|Progressive Disease|7|||
30936463|NCT01870076|58973209|FG000|Overall Study|Withdrawal by Subject|1|||
30936464|NCT01870076|58973210|FG001|Overall Study|Withdrawal by Subject|0|||
30936465|NCT01870076|58973211|FG002|Overall Study|Withdrawal by Subject|1|||
30936466|NCT01870076|58973212|FG003|Overall Study|Withdrawal by Subject|0|||
30936467|NCT01592721|58973222|FG000|Long-term Follow-up|Death|1|||
30936468|NCT01613378|58973226|FG000|Overall Study|Lack of Efficacy|13|||
30936469|NCT01613378|58973226|FG000|Overall Study|Adverse Event|11|||
30936470|NCT01613378|58973226|FG000|Overall Study|Withdrawal by Subject|8|||
30936471|NCT01613378|58973226|FG000|Overall Study|Death|2|||
30936472|NCT01613378|58973226|FG000|Overall Study|Lost to Follow-up|1|||
30936473|NCT01613378|58973226|FG000|Overall Study|Other Reason|4|||
30758981|NCT00096135|58767568|FG000|Overall Study|Ineligible|2|||
30758982|NCT00096135|58767569|FG001|Overall Study|Ineligible|0|||
30936474|NCT01592409|58973232|FG000|Overall Study|Withdrawal by Subject|0|||
30936475|NCT01592409|58973233|FG001|Overall Study|Withdrawal by Subject|1|||
30936476|NCT01697319|58973252|FG000|Primary Phase|Withdrawal by Subject|1|||
30936477|NCT01697319|58973252|FG000|Extension Phase|Terminated by Sponsor|15|||
30936478|NCT01566435|58973267|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
30936479|NCT01696929|58973275|FG000|Overall Study|Physician Decision|1|||
30936480|NCT01696773|58973285|FG000|Days 15-27, Washout|Adverse Event|1|||
30936481|NCT01696773|58973286|FG001|Days 15-27, Washout|Adverse Event|0|||
30936482|NCT01696695|58973292|FG000|Overall Study|Disease progression|373|||
30936483|NCT01696695|58973292|FG000|Overall Study|Death|29|||
30936484|NCT01696695|58973292|FG000|Overall Study|Adverse Event|74|||
30936485|NCT01696695|58973292|FG000|Overall Study|Withdrawal by Subject|92|||
30936486|NCT01696695|58973292|FG000|Overall Study|Lost to Follow-up|48|||
30936487|NCT01696695|58973292|FG000|Overall Study|Other|74|||
30936488|NCT01696695|58973292|FG000|Overall Study|Major Protocol Violation|192|||
30936489|NCT01565889|58973311|FG000|Part A|Withdrawal by Subject|1|||
30936490|NCT01565889|58973312|FG001|Part A|Withdrawal by Subject|0|||
30936491|NCT01565889|58973313|FG002|Part A|Withdrawal by Subject|0|||
30936492|NCT01565889|58973314|FG003|Part A|Withdrawal by Subject|0|||
30936493|NCT01565889|58973315|FG004|Part A|Withdrawal by Subject|0|||
30936494|NCT01565889|58973316|FG005|Part A|Withdrawal by Subject|0|||
30936495|NCT01565889|58973311|FG000|Part B|Withdrawal by Subject|0|||
30936496|NCT01565889|58973312|FG001|Part B|Withdrawal by Subject|0|||
30936497|NCT01565889|58973313|FG002|Part B|Withdrawal by Subject|0|||
30936498|NCT01565889|58973314|FG003|Part B|Withdrawal by Subject|0|||
30936499|NCT01565889|58973315|FG004|Part B|Withdrawal by Subject|0|||
30936500|NCT01565889|58973316|FG005|Part B|Withdrawal by Subject|1|||
30936501|NCT01565889|58973311|FG000|Part B|Lack of Efficacy|0|||
30936502|NCT01565889|58973312|FG001|Part B|Lack of Efficacy|0|||
30624383|NCT01117428|58636430|FG003|Overall Study|Adverse Event|0|||
30758983|NCT00116805|58767577|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
30758984|NCT00116805|58767578|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
30758985|NCT00116805|58767577|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
30758986|NCT00116805|58767578|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
30936503|NCT01565889|58973313|FG002|Part B|Lack of Efficacy|0|||
30936504|NCT01565889|58973314|FG003|Part B|Lack of Efficacy|0|||
30936505|NCT01565889|58973315|FG004|Part B|Lack of Efficacy|0|||
30936506|NCT01565889|58973316|FG005|Part B|Lack of Efficacy|2|||
30936507|NCT01565889|58973311|FG000|Part B|Lost to Follow-up|0|||
30936508|NCT01565889|58973312|FG001|Part B|Lost to Follow-up|0|||
30936509|NCT01565889|58973313|FG002|Part B|Lost to Follow-up|0|||
30936510|NCT01565889|58973314|FG003|Part B|Lost to Follow-up|0|||
30936511|NCT01565889|58973315|FG004|Part B|Lost to Follow-up|0|||
30936512|NCT01565889|58973316|FG005|Part B|Lost to Follow-up|1|||
30936513|NCT01696071|58973331|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
30936514|NCT01696071|58973332|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
30936515|NCT01591863|58973343|FG000|Overall Study|Adverse Event|3|||
30936516|NCT01591863|58973343|FG000|Overall Study|Withdrawal by Subject|1|||
30936517|NCT01591863|58973343|FG000|Overall Study|recurrence|9|||
30936518|NCT01591863|58973343|FG000|Overall Study|Lack of Efficacy|1|||
30936519|NCT01591785|58973349|FG000|Overall Study|worsening condition|1|||
30936520|NCT01591785|58973350|FG001|Overall Study|worsening condition|2|||
30936521|NCT01591785|58973349|FG000|Overall Study|Protocol Violation|2|||
30936522|NCT01591785|58973350|FG001|Overall Study|Protocol Violation|0|||
30841424|NCT02535364|58866992|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
30841425|NCT02535364|58866992|FG000|Part B Screening|Death|2|||
30841426|NCT02535364|58866992|FG000|Part B Screening|Physician Decision|1|||
30841427|NCT02535364|58866992|FG000|Part B Screening|Withdrawal by Subject|1|||
30841428|NCT02535364|58866992|FG000|Part B Screening|Adverse Event|1|||
30841429|NCT02535364|58866992|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
30841430|NCT02535364|58866992|FG000|Study Treatment|Death|1|||
30841431|NCT02535364|58866992|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
30936523|NCT01591785|58973349|FG000|Overall Study|Lost to Follow-up|1|||
30936524|NCT01591785|58973350|FG001|Overall Study|Lost to Follow-up|0|||
30936525|NCT01695993|58973359|FG000|Overall Study|Lost to Follow-up|2|||
30936526|NCT01695993|58973360|FG001|Overall Study|Lost to Follow-up|1|||
30936527|NCT01695993|58973361|FG002|Overall Study|Lost to Follow-up|3|||
30936528|NCT01695993|58973359|FG000|Overall Study|Withdrawal by Subject|2|||
30936529|NCT01695993|58973360|FG001|Overall Study|Withdrawal by Subject|2|||
30936530|NCT01695993|58973361|FG002|Overall Study|Withdrawal by Subject|2|||
30936531|NCT01695993|58973359|FG000|Overall Study|To ill to continue|1|||
30936532|NCT01695993|58973360|FG001|Overall Study|To ill to continue|2|||
30936533|NCT01695993|58973361|FG002|Overall Study|To ill to continue|0|||
30936534|NCT01695993|58973359|FG000|Overall Study|Changed Medical Facility|0|||
30936535|NCT01695993|58973360|FG001|Overall Study|Changed Medical Facility|0|||
30936536|NCT01695993|58973361|FG002|Overall Study|Changed Medical Facility|1|||
30936537|NCT01565343|58973372|FG000|Overall Study|Administrative decision/technical issues|1|||
30936538|NCT01565343|58973373|FG001|Overall Study|Administrative decision/technical issues|0|||
30936539|NCT01565343|58973374|FG002|Overall Study|Administrative decision/technical issues|0|||
30936540|NCT01695135|58973399|FG000|Double-blind Treatment Phase|Progressive disease|50|||
30758987|NCT00116805|58767577|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
30758988|NCT00116805|58767578|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
30758989|NCT00116805|58767577|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
30758990|NCT00116805|58767578|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
30758991|NCT00116805|58767577|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
30758992|NCT00116805|58767578|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
30758993|NCT00116805|58767577|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
30758994|NCT00116805|58767578|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
30758995|NCT00116805|58767577|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
30758996|NCT00116805|58767578|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
30758997|NCT00116805|58767577|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
30758998|NCT00116805|58767578|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
30758999|NCT00116805|58767577|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
30759000|NCT00116805|58767578|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
30759001|NCT00116805|58767577|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
30759002|NCT00116805|58767578|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
30759003|NCT00116805|58767577|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
30759004|NCT00116805|58767578|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
30759005|NCT00116805|58767577|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
30759006|NCT00116805|58767578|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
30759007|NCT00116805|58767577|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
30759008|NCT00116805|58767578|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
30759009|NCT00116805|58767577|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
30936541|NCT01695135|58973400|FG001|Double-blind Treatment Phase|Progressive disease|110|||
30841432|NCT02535364|58866992|FG000|12-Month Follow-up Period|Disease progression|22|||
30841433|NCT02535364|58866992|FG000|12-Month Follow-up Period|Death|5|||
30841434|NCT02535364|58866992|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
30841435|NCT02535364|58866992|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
30841436|NCT02535364|58866992|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
30841437|NCT02540356|58866998|FG000|Overall Study|Terminated due to disease progression|1|||
30841438|NCT02540356|58866999|FG001|Overall Study|Terminated due to disease progression|0|||
30841439|NCT02534896|58867007|FG000|Overall Study|Adverse Event|2|||
30841440|NCT02534896|58867008|FG001|Overall Study|Adverse Event|1|||
30841441|NCT02534896|58867009|FG002|Overall Study|Adverse Event|1|||
30841442|NCT02534896|58867007|FG000|Overall Study|Insufficient therapeutic response|2|||
30841443|NCT02534896|58867008|FG001|Overall Study|Insufficient therapeutic response|0|||
30841444|NCT02534896|58867009|FG002|Overall Study|Insufficient therapeutic response|0|||
30841445|NCT02697734|58867019|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
30841446|NCT02697734|58867020|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
30841447|NCT02697734|58867019|FG000|Core Phase - up to Week 48|Adverse Event|1|||
30841448|NCT02697734|58867020|FG001|Core Phase - up to Week 48|Adverse Event|2|||
30841449|NCT02697734|58867019|FG000|Core Phase - up to Week 48|Physician Decision|1|||
30841450|NCT02697734|58867020|FG001|Core Phase - up to Week 48|Physician Decision|0|||
30936542|NCT01695135|58973401|FG002|Double-blind Treatment Phase|Progressive disease|0|||
30936543|NCT01695135|58973402|FG003|Double-blind Treatment Phase|Progressive disease|0|||
30936544|NCT01695135|58973399|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
30936545|NCT01695135|58973400|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
30759010|NCT00116805|58767578|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
30841451|NCT02697734|58867019|FG000|Optional Extension Phase|Adverse Event|5|||
30841452|NCT02697734|58867020|FG001|Optional Extension Phase|Adverse Event|1|||
30841453|NCT02697734|58867019|FG000|Optional Extension Phase|Physician Decision|0|||
30841454|NCT02697734|58867020|FG001|Optional Extension Phase|Physician Decision|1|||
30841455|NCT02692586|58867034|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
30841456|NCT02692586|58867034|FG000|Overall Study|Received adjunctive thrombolytics|2|||
30841457|NCT02534350|58867040|FG000|Overall Study|Randomized But Not Treated|1|||
30841458|NCT02534350|58867041|FG001|Overall Study|Randomized But Not Treated|0|||
30841459|NCT02534350|58867040|FG000|Overall Study|Protocol Violation|1|||
30841460|NCT02534350|58867041|FG001|Overall Study|Protocol Violation|0|||
30841461|NCT02534350|58867040|FG000|Overall Study|Withdrew Consent|2|||
30841462|NCT02534350|58867041|FG001|Overall Study|Withdrew Consent|0|||
30841463|NCT02688764|58867049|FG000|Overall Study|Adverse Event|3|||
30841464|NCT02688764|58867050|FG001|Overall Study|Adverse Event|3|||
30841465|NCT02688764|58867049|FG000|Overall Study|AE/Kidney transplant|1|||
30841466|NCT02688764|58867050|FG001|Overall Study|AE/Kidney transplant|0|||
30841467|NCT02688764|58867049|FG000|Overall Study|AE/Lack of efficacy|1|||
30841468|NCT02688764|58867050|FG001|Overall Study|AE/Lack of efficacy|0|||
30841469|NCT02688764|58867049|FG000|Overall Study|AE/Non-compl.|1|||
30841470|NCT02688764|58867050|FG001|Overall Study|AE/Non-compl.|0|||
30841471|NCT02688764|58867049|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
30841472|NCT02688764|58867050|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
30841473|NCT02688764|58867049|FG000|Overall Study|AE/Other|0|||
30936546|NCT01695135|58973401|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
30936547|NCT01695135|58973402|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
30936548|NCT01695135|58973399|FG000|Double-blind Treatment Phase|Adverse Event|7|||
30936549|NCT01695135|58973400|FG001|Double-blind Treatment Phase|Adverse Event|7|||
30936550|NCT01695135|58973401|FG002|Double-blind Treatment Phase|Adverse Event|0|||
30936551|NCT01695135|58973402|FG003|Double-blind Treatment Phase|Adverse Event|0|||
30759011|NCT00116805|58767577|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
30759012|NCT00116805|58767578|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
30759013|NCT00116805|58767577|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
30759014|NCT00116805|58767578|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
30759015|NCT00116805|58767577|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
30759016|NCT00116805|58767578|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
30759017|NCT00116805|58767577|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
30759018|NCT00116805|58767578|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
30759019|NCT00116805|58767577|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
30841474|NCT02688764|58867050|FG001|Overall Study|AE/Other|1|||
30841475|NCT02688764|58867049|FG000|Overall Study|AE/Physician decision|1|||
30841476|NCT02688764|58867050|FG001|Overall Study|AE/Physician decision|0|||
30841477|NCT02688764|58867049|FG000|Overall Study|AE/Withd. parent|3|||
30841478|NCT02688764|58867050|FG001|Overall Study|AE/Withd. parent|0|||
30759020|NCT00116805|58767578|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
30936552|NCT01695135|58973399|FG000|Double-blind Treatment Phase|Other|1|||
30936553|NCT01695135|58973400|FG001|Double-blind Treatment Phase|Other|3|||
30936554|NCT01695135|58973401|FG002|Double-blind Treatment Phase|Other|0|||
30936555|NCT01695135|58973402|FG003|Double-blind Treatment Phase|Other|0|||
30936556|NCT01695135|58973399|FG000|Double-blind Treatment Phase|Physician Decision|6|||
30936557|NCT01695135|58973400|FG001|Double-blind Treatment Phase|Physician Decision|3|||
30936558|NCT01695135|58973401|FG002|Double-blind Treatment Phase|Physician Decision|0|||
30936559|NCT01695135|58973402|FG003|Double-blind Treatment Phase|Physician Decision|0|||
30936560|NCT01695135|58973399|FG000|Double-blind Treatment Phase|Death|1|||
30936561|NCT01695135|58973400|FG001|Double-blind Treatment Phase|Death|1|||
30936562|NCT01695135|58973401|FG002|Double-blind Treatment Phase|Death|0|||
30936563|NCT01695135|58973402|FG003|Double-blind Treatment Phase|Death|0|||
30936564|NCT01695135|58973399|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
30936565|NCT01695135|58973400|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
30936566|NCT01695135|58973401|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
30936567|NCT01695135|58973402|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
30936568|NCT01695135|58973399|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
30936569|NCT01695135|58973400|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
30936570|NCT01695135|58973401|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
30936571|NCT01695135|58973402|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
30936572|NCT01695135|58973399|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
30936573|NCT01695135|58973400|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
30936574|NCT01695135|58973401|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
30936575|NCT01695135|58973402|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
30936576|NCT01695135|58973399|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
30936577|NCT01695135|58973400|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
30936578|NCT01695135|58973401|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
30936579|NCT01695135|58973402|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
30936580|NCT01695135|58973399|FG000|Open Label Extension Treatment Phase|Other|0|||
30936581|NCT01695135|58973400|FG001|Open Label Extension Treatment Phase|Other|0|||
30936582|NCT01695135|58973401|FG002|Open Label Extension Treatment Phase|Other|4|||
30936583|NCT01695135|58973402|FG003|Open Label Extension Treatment Phase|Other|7|||
30936584|NCT01695135|58973399|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
30936585|NCT01695135|58973400|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
30936586|NCT01695135|58973401|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
30936587|NCT01695135|58973402|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
30936588|NCT01695135|58973399|FG000|Open Label Extension Treatment Phase|Death|0|||
30936589|NCT01695135|58973400|FG001|Open Label Extension Treatment Phase|Death|0|||
30936590|NCT01695135|58973401|FG002|Open Label Extension Treatment Phase|Death|2|||
30936591|NCT01695135|58973402|FG003|Open Label Extension Treatment Phase|Death|7|||
30936592|NCT01695135|58973399|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
30936593|NCT01695135|58973400|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
30936594|NCT01695135|58973401|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
30936595|NCT01695135|58973402|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
30936596|NCT01610414|58973412|FG000|Study Start - Month 13|Serious Adverse Event|65|||
30936597|NCT01610414|58973413|FG001|Study Start - Month 13|Serious Adverse Event|67|||
30936598|NCT01610414|58973412|FG000|Study Start - Month 13|Adverse Event|14|||
30936599|NCT01610414|58973413|FG001|Study Start - Month 13|Adverse Event|14|||
30936600|NCT01610414|58973412|FG000|Study Start - Month 13|Protocol Violation|3|||
30936601|NCT01610414|58973413|FG001|Study Start - Month 13|Protocol Violation|1|||
30936602|NCT01610414|58973412|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
30936603|NCT01610414|58973413|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
30936604|NCT01610414|58973412|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
30936605|NCT01610414|58973413|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
30936606|NCT01610414|58973412|FG000|Study Start - Month 13|Lost to Follow-up|4|||
30936607|NCT01610414|58973413|FG001|Study Start - Month 13|Lost to Follow-up|6|||
30936608|NCT01610414|58973412|FG000|Study Start - Month 13|Suspected HZ episode|1|||
30936609|NCT01610414|58973413|FG001|Study Start - Month 13|Suspected HZ episode|3|||
30936610|NCT01610414|58973412|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
30759021|NCT00116805|58767577|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
30759022|NCT00116805|58767578|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
30936611|NCT01610414|58973413|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
30936612|NCT01610414|58973412|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
30936613|NCT01610414|58973413|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
30936614|NCT01610414|58973412|FG000|Month 13 - Month 25|Adverse Event|8|||
30936615|NCT01610414|58973413|FG001|Month 13 - Month 25|Adverse Event|4|||
30936616|NCT01610414|58973412|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
30936617|NCT01610414|58973413|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
30936618|NCT01610414|58973412|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
30936619|NCT01610414|58973413|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
30936620|NCT01610414|58973412|FG000|Month 13 - Month 25|Protocol Violation|0|||
30936621|NCT01610414|58973413|FG001|Month 13 - Month 25|Protocol Violation|2|||
30936622|NCT01610414|58973412|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
30936623|NCT01610414|58973413|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
30936624|NCT01610414|58973412|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
30936625|NCT01610414|58973413|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
30936626|NCT01610414|58973412|FG000|After Month 25|Study end not reached|48|||
30936627|NCT01610414|58973413|FG001|After Month 25|Study end not reached|53|||
30936628|NCT01564407|58973441|FG000|Overall Study|Lost to Follow-up|0|||
30936629|NCT01564407|58973442|FG001|Overall Study|Lost to Follow-up|1|||
30936630|NCT01564407|58973443|FG002|Overall Study|Lost to Follow-up|0|||
30936631|NCT01564407|58973444|FG003|Overall Study|Lost to Follow-up|0|||
30936632|NCT01564407|58973445|FG004|Overall Study|Lost to Follow-up|0|||
30936633|NCT01564407|58973441|FG000|Overall Study|Withdrawal by Subject|0|||
30936634|NCT01564407|58973442|FG001|Overall Study|Withdrawal by Subject|1|||
30936635|NCT01564407|58973443|FG002|Overall Study|Withdrawal by Subject|0|||
30936636|NCT01564407|58973444|FG003|Overall Study|Withdrawal by Subject|0|||
30936637|NCT01564407|58973445|FG004|Overall Study|Withdrawal by Subject|0|||
30936638|NCT01564407|58973441|FG000|Overall Study|funding lost, study ended|0|||
30936639|NCT01564407|58973442|FG001|Overall Study|funding lost, study ended|0|||
30936640|NCT01564407|58973443|FG002|Overall Study|funding lost, study ended|0|||
30936641|NCT01564407|58973444|FG003|Overall Study|funding lost, study ended|1|||
30936642|NCT01564407|58973445|FG004|Overall Study|funding lost, study ended|0|||
30936643|NCT01590771|58973468|FG000|Overall Study|Other Protocol Specified Criteria|5|||
30936644|NCT01590771|58973469|FG001|Overall Study|Other Protocol Specified Criteria|14|||
30936645|NCT01590771|58973468|FG000|Overall Study|Withdrawal by Subject|8|||
30936646|NCT01590771|58973469|FG001|Overall Study|Withdrawal by Subject|15|||
30936647|NCT01590771|58973468|FG000|Overall Study|Protocol Violation|1|||
30936648|NCT01590771|58973469|FG001|Overall Study|Protocol Violation|2|||
30936649|NCT01590771|58973468|FG000|Overall Study|Lost to Follow-up|1|||
30936650|NCT01590771|58973469|FG001|Overall Study|Lost to Follow-up|1|||
30936651|NCT01590771|58973468|FG000|Overall Study|Lack of Efficacy|1|||
30936652|NCT01590771|58973469|FG001|Overall Study|Lack of Efficacy|0|||
30936653|NCT01590771|58973468|FG000|Overall Study|Adverse Event|3|||
30936654|NCT01590771|58973469|FG001|Overall Study|Adverse Event|7|||
30936655|NCT01563237|58973475|FG000|Overall Study|Lost to Follow-up|6|||
30936656|NCT01563237|58973476|FG001|Overall Study|Lost to Follow-up|0|||
30936657|NCT01563237|58973475|FG000|Overall Study|Withdrawal by Subject|1|||
30936658|NCT01563237|58973476|FG001|Overall Study|Withdrawal by Subject|0|||
30936659|NCT01563237|58973475|FG000|Overall Study|Adverse Event|1|||
30936660|NCT01563237|58973476|FG001|Overall Study|Adverse Event|0|||
30936661|NCT01563237|58973475|FG000|Overall Study|Medical Reasons|1|||
30936662|NCT01563237|58973476|FG001|Overall Study|Medical Reasons|0|||
30936663|NCT01563237|58973475|FG000|Overall Study|Death|1|||
30936664|NCT01563237|58973476|FG001|Overall Study|Death|0|||
30936665|NCT01694433|58973492|FG000|Overall Study|Adverse Event|7|||
30936666|NCT01694433|58973493|FG001|Overall Study|Adverse Event|0|||
30936667|NCT01694433|58973492|FG000|Overall Study|Physician Decision|1|||
30936668|NCT01694433|58973493|FG001|Overall Study|Physician Decision|0|||
30936669|NCT01694433|58973492|FG000|Overall Study|Withdrawal by Subject|3|||
30936670|NCT01694433|58973493|FG001|Overall Study|Withdrawal by Subject|4|||
30841479|NCT02688764|58867049|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
30936671|NCT01694121|58973501|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
30936672|NCT01694121|58973502|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
30936673|NCT01562613|58973508|FG000|Overall Study|Lost to Follow-up|2|||
30936674|NCT01562613|58973508|FG000|Overall Study|Withdrawal by Subject|2|||
30936675|NCT01693185|58973514|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
30936676|NCT01693185|58973515|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
30759023|NCT00116805|58767577|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
30759024|NCT00116805|58767578|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
30759025|NCT00116805|58767577|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
30759026|NCT00116805|58767578|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
30759027|NCT00116805|58767577|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
30759028|NCT00116805|58767578|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
30759029|NCT00116805|58767577|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
30759030|NCT00116805|58767578|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
30759031|NCT00116805|58767577|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
30759032|NCT00116805|58767578|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
30759033|NCT00116805|58767577|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
30936677|NCT01693029|58973530|FG000|Overall Study|Withdrawal by Subject|15|||
30936678|NCT01693029|58973531|FG001|Overall Study|Withdrawal by Subject|22|||
30936679|NCT01693029|58973530|FG000|Overall Study|Kidney transplantation|7|||
30936680|NCT01693029|58973531|FG001|Overall Study|Kidney transplantation|7|||
30841480|NCT02688764|58867050|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
30841481|NCT02688764|58867049|FG000|Overall Study|AE/Withd. subject|1|||
30841482|NCT02688764|58867050|FG001|Overall Study|AE/Withd. subject|0|||
30841483|NCT02688764|58867049|FG000|Overall Study|Kidney transplant|10|||
30841484|NCT02688764|58867050|FG001|Overall Study|Kidney transplant|4|||
30841485|NCT02688764|58867049|FG000|Overall Study|Lack of Efficacy|3|||
30841486|NCT02688764|58867050|FG001|Overall Study|Lack of Efficacy|2|||
30841487|NCT02688764|58867049|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
30841488|NCT02688764|58867050|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
30841489|NCT02688764|58867049|FG000|Overall Study|Non-compliance with study drug|4|||
30841490|NCT02688764|58867050|FG001|Overall Study|Non-compliance with study drug|0|||
30841491|NCT02688764|58867049|FG000|Overall Study|Non-compl./Physician decision|2|||
30841492|NCT02688764|58867050|FG001|Overall Study|Non-compl./Physician decision|0|||
30841493|NCT02688764|58867049|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
30841494|NCT02688764|58867050|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
30841495|NCT02688764|58867049|FG000|Overall Study|Non-compl./Withd. subject|0|||
30841496|NCT02688764|58867050|FG001|Overall Study|Non-compl./Withd. subject|2|||
30841497|NCT02688764|58867049|FG000|Overall Study|Phosphorus level outside safe range|0|||
30841498|NCT02688764|58867050|FG001|Overall Study|Phosphorus level outside safe range|1|||
30841499|NCT02688764|58867049|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
30841500|NCT02688764|58867050|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
30841501|NCT02688764|58867049|FG000|Overall Study|Study drug taste/Withd. parent|1|||
30841502|NCT02688764|58867050|FG001|Overall Study|Study drug taste/Withd. parent|0|||
30841503|NCT02688764|58867049|FG000|Overall Study|Subject moving out|2|||
30841504|NCT02688764|58867050|FG001|Overall Study|Subject moving out|0|||
30841505|NCT02688764|58867049|FG000|Overall Study|Subject taken off dialysis|1|||
30841506|NCT02688764|58867050|FG001|Overall Study|Subject taken off dialysis|0|||
30841507|NCT02688764|58867049|FG000|Overall Study|Withdrawal by parent|3|||
30841508|NCT02688764|58867050|FG001|Overall Study|Withdrawal by parent|0|||
30841509|NCT02688608|58867059|FG000|Overall Study|Lost to Follow-up|1|||
30841510|NCT02688530|58867067|FG000|Overall Study|Withdrawal by Subject|0|||
30841511|NCT02688530|58867068|FG001|Overall Study|Withdrawal by Subject|1|||
30841512|NCT02688530|58867069|FG002|Overall Study|Withdrawal by Subject|0|||
30841513|NCT02688530|58867070|FG003|Overall Study|Withdrawal by Subject|0|||
30841514|NCT02688530|58867067|FG000|Overall Study|Lost to Follow-up|0|||
30841515|NCT02688530|58867068|FG001|Overall Study|Lost to Follow-up|0|||
30841516|NCT02688530|58867069|FG002|Overall Study|Lost to Follow-up|2|||
30841517|NCT02688530|58867070|FG003|Overall Study|Lost to Follow-up|0|||
30841518|NCT02467270|58867087|FG000|Overall Study|Participants Never Treated|0|||
30841519|NCT02467270|58867088|FG001|Overall Study|Participants Never Treated|1|||
30841520|NCT02467270|58867089|FG002|Overall Study|Participants Never Treated|0|||
30841521|NCT02467270|58867087|FG000|Overall Study|Ongoing|50|||
30841522|NCT02467270|58867088|FG001|Overall Study|Ongoing|41|||
30841523|NCT02467270|58867089|FG002|Overall Study|Ongoing|43|||
30841524|NCT02467270|58867087|FG000|Overall Study|Adverse Event|16|||
30841525|NCT02467270|58867088|FG001|Overall Study|Adverse Event|15|||
30841526|NCT02467270|58867089|FG002|Overall Study|Adverse Event|14|||
30841527|NCT02467270|58867087|FG000|Overall Study|Progressive Disease|7|||
30841528|NCT02467270|58867088|FG001|Overall Study|Progressive Disease|7|||
30841529|NCT02467270|58867089|FG002|Overall Study|Progressive Disease|4|||
30841530|NCT02467270|58867087|FG000|Overall Study|Death|2|||
30841531|NCT02467270|58867088|FG001|Overall Study|Death|0|||
30841532|NCT02467270|58867089|FG002|Overall Study|Death|2|||
30841533|NCT02467270|58867087|FG000|Overall Study|Lack of Efficacy|12|||
30841534|NCT02467270|58867088|FG001|Overall Study|Lack of Efficacy|18|||
30841535|NCT02467270|58867089|FG002|Overall Study|Lack of Efficacy|23|||
30841536|NCT02467270|58867087|FG000|Overall Study|Non-compliance With Study Drug|0|||
30841537|NCT02467270|58867088|FG001|Overall Study|Non-compliance With Study Drug|2|||
30841538|NCT02467270|58867089|FG002|Overall Study|Non-compliance With Study Drug|1|||
30841539|NCT02467270|58867087|FG000|Overall Study|Lost to Follow-up|2|||
30841540|NCT02467270|58867088|FG001|Overall Study|Lost to Follow-up|1|||
30841541|NCT02467270|58867089|FG002|Overall Study|Lost to Follow-up|0|||
30841542|NCT02467270|58867087|FG000|Overall Study|Pregnancy|0|||
30841543|NCT02467270|58867088|FG001|Overall Study|Pregnancy|1|||
30841544|NCT02467270|58867089|FG002|Overall Study|Pregnancy|0|||
30841545|NCT02467270|58867087|FG000|Overall Study|Physician Decision|0|||
30841546|NCT02467270|58867088|FG001|Overall Study|Physician Decision|4|||
30841547|NCT02467270|58867089|FG002|Overall Study|Physician Decision|1|||
30841548|NCT02467270|58867087|FG000|Overall Study|Withdrawal by Subject|4|||
30841549|NCT02467270|58867088|FG001|Overall Study|Withdrawal by Subject|3|||
30841550|NCT02467270|58867089|FG002|Overall Study|Withdrawal by Subject|5|||
30841551|NCT02467270|58867087|FG000|Overall Study|Reason not Specified|1|||
30841552|NCT02467270|58867088|FG001|Overall Study|Reason not Specified|2|||
30841553|NCT02467270|58867089|FG002|Overall Study|Reason not Specified|1|||
30841554|NCT05083559|58867099|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
30841555|NCT05083559|58867100|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
30841556|NCT05083559|58867099|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
30841557|NCT05083559|58867100|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
30841558|NCT05083559|58867099|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
30841559|NCT05083559|58867100|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
30841560|NCT03037307|58867106|FG000|Period 1|Did Not Meet Study Criteria|0|||
30841561|NCT03037307|58867107|FG001|Period 1|Did Not Meet Study Criteria|0|||
30841562|NCT03037307|58867108|FG002|Period 1|Did Not Meet Study Criteria|0|||
30841563|NCT03037307|58867109|FG003|Period 1|Did Not Meet Study Criteria|1|||
30841564|NCT03037307|58867110|FG004|Period 1|Did Not Meet Study Criteria|0|||
30841565|NCT03037307|58867111|FG005|Period 1|Did Not Meet Study Criteria|0|||
30841566|NCT02538094|58867120|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
30841567|NCT02538094|58867121|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
30841568|NCT02538094|58867120|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
30841569|NCT02538094|58867121|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
30841570|NCT02686034|58867129|FG000|Run-In Period 1|Eligibility|12|||
30841571|NCT02686034|58867130|FG001|Run-In Period 1|Eligibility|10|||
30841572|NCT02686034|58867129|FG000|Run-In Period 1|Withdrawal by Subject|4|||
30841573|NCT02686034|58867130|FG001|Run-In Period 1|Withdrawal by Subject|3|||
30841574|NCT02686034|58867129|FG000|Run-In Period 1|Lost to Follow-up|4|||
30841575|NCT02686034|58867130|FG001|Run-In Period 1|Lost to Follow-up|4|||
30841576|NCT02686034|58867129|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
30841577|NCT02686034|58867130|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
30841578|NCT02686034|58867129|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
30841579|NCT02686034|58867130|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
30841580|NCT02686034|58867129|FG000|Randomized Controlled Period 2|Adverse Event|0|||
30841581|NCT02686034|58867130|FG001|Randomized Controlled Period 2|Adverse Event|2|||
30841582|NCT02686034|58867129|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
30841583|NCT02686034|58867130|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
30841584|NCT02686034|58867129|FG000|Open Label Period 3|Lost to Follow-up|0|||
30841585|NCT02686034|58867130|FG001|Open Label Period 3|Lost to Follow-up|1|||
30841586|NCT02685488|58867138|FG000|Overall Study|Withdrawal by Subject|0|||
30841587|NCT02685488|58867139|FG001|Overall Study|Withdrawal by Subject|1|||
30841588|NCT02533570|58867148|FG000|Overall Study|Adverse Event|0|||
30841589|NCT02533570|58867149|FG001|Overall Study|Adverse Event|1|||
30841590|NCT02533570|58867150|FG002|Overall Study|Adverse Event|1|||
30841591|NCT03036839|58867161|FG000|Overall Study|Adverse Event|0|||
30841592|NCT03036839|58867162|FG001|Overall Study|Adverse Event|0|||
30841593|NCT03036839|58867163|FG002|Overall Study|Adverse Event|1|||
30841594|NCT03036839|58867161|FG000|Overall Study|Death|3|||
30841595|NCT03036839|58867162|FG001|Overall Study|Death|0|||
30841596|NCT03036839|58867163|FG002|Overall Study|Death|3|||
30841597|NCT03036839|58867161|FG000|Overall Study|Withdrew Consent|0|||
30841598|NCT03036839|58867162|FG001|Overall Study|Withdrew Consent|0|||
30841599|NCT03036839|58867163|FG002|Overall Study|Withdrew Consent|1|||
30841600|NCT01286207|58867174|FG000|Overall Study|Adverse Event|27|||
30841601|NCT01286207|58867175|FG001|Overall Study|Adverse Event|41|||
30841602|NCT01286207|58867176|FG002|Overall Study|Adverse Event|8|||
30841603|NCT01286207|58867174|FG000|Overall Study|Lost to Follow-up|49|||
30841604|NCT01286207|58867175|FG001|Overall Study|Lost to Follow-up|43|||
30841605|NCT01286207|58867176|FG002|Overall Study|Lost to Follow-up|20|||
30841606|NCT01286207|58867174|FG000|Overall Study|Withdrawal by Subject|93|||
30841607|NCT01286207|58867175|FG001|Overall Study|Withdrawal by Subject|79|||
30841608|NCT01286207|58867176|FG002|Overall Study|Withdrawal by Subject|41|||
30841609|NCT01286207|58867174|FG000|Overall Study|Lack of Response|92|||
30841610|NCT01286207|58867175|FG001|Overall Study|Lack of Response|38|||
30841611|NCT01286207|58867176|FG002|Overall Study|Lack of Response|8|||
30841612|NCT01286207|58867174|FG000|Overall Study|Other|37|||
30841613|NCT01286207|58867175|FG001|Overall Study|Other|47|||
30841614|NCT01286207|58867176|FG002|Overall Study|Other|13|||
30841615|NCT00968201|58867213|FG000|Base Study - (Period II)|Adverse Event|8|||
30841616|NCT00968201|58867214|FG001|Base Study - (Period II)|Adverse Event|0|||
30841617|NCT00968201|58867215|FG002|Base Study - (Period II)|Adverse Event|16|||
30841618|NCT00968201|58867213|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
30841619|NCT00968201|58867214|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
30841620|NCT00968201|58867215|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
30841621|NCT00968201|58867213|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
30841622|NCT00968201|58867214|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
30841623|NCT00968201|58867215|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
30841624|NCT00968201|58867213|FG000|Base Study - (Period II)|Protocol Violation|12|||
30841625|NCT00968201|58867214|FG001|Base Study - (Period II)|Protocol Violation|0|||
30936681|NCT01693029|58973530|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
30936682|NCT01693029|58973531|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
30841626|NCT00968201|58867215|FG002|Base Study - (Period II)|Protocol Violation|12|||
30841627|NCT00968201|58867213|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
30841628|NCT00968201|58867214|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
30936683|NCT01693029|58973530|FG000|Overall Study|Protocol Violation|6|||
30936684|NCT01693029|58973531|FG001|Overall Study|Protocol Violation|7|||
30936685|NCT01693029|58973530|FG000|Overall Study|Change in dialysis modality|2|||
30936686|NCT01693029|58973531|FG001|Overall Study|Change in dialysis modality|1|||
30936687|NCT01693029|58973530|FG000|Overall Study|Physician Decision|0|||
30936688|NCT01693029|58973531|FG001|Overall Study|Physician Decision|2|||
30936689|NCT01693029|58973530|FG000|Overall Study|Lost to Follow-up|0|||
30936690|NCT01693029|58973531|FG001|Overall Study|Lost to Follow-up|1|||
30936691|NCT01693029|58973530|FG000|Overall Study|Adverse Event|1|||
30936692|NCT01693029|58973531|FG001|Overall Study|Adverse Event|6|||
30936693|NCT01693029|58973530|FG000|Overall Study|Death|5|||
30936694|NCT01693029|58973531|FG001|Overall Study|Death|8|||
30936695|NCT01693029|58973530|FG000|Overall Study|Non-compliance|2|||
30936696|NCT01693029|58973531|FG001|Overall Study|Non-compliance|1|||
30936697|NCT01589445|58973537|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
30936698|NCT01589445|58973537|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
30936699|NCT01589445|58973537|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
30936700|NCT01589445|58973537|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
30936701|NCT01589445|58973537|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
30936702|NCT01589445|58973537|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
30936703|NCT01589445|58973537|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
30936704|NCT01589445|58973537|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
30936705|NCT01589445|58973537|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
30936706|NCT01589445|58973537|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
30936707|NCT01588509|58973547|FG000|Overall Study|Lost to Follow-up|1|||
30936708|NCT01588509|58973548|FG001|Overall Study|Lost to Follow-up|0|||
30936709|NCT01588353|58973557|FG000|Step2|Withdrawal by Subject|0|||
30936710|NCT01588353|58973558|FG001|Step2|Withdrawal by Subject|1|||
30936711|NCT01588353|58973559|FG002|Step2|Withdrawal by Subject|0|||
30936712|NCT01588353|58973557|FG000|Step3|Adverse Event|0|||
30936713|NCT01588353|58973558|FG001|Step3|Adverse Event|0|||
30936714|NCT01588353|58973559|FG002|Step3|Adverse Event|2|||
30936715|NCT01588197|58973568|FG000|Overall Study|Lack of Efficacy|0|||
30936716|NCT01588197|58973569|FG001|Overall Study|Lack of Efficacy|1|||
30936717|NCT01588197|58973568|FG000|Overall Study|No MRI|1|||
30936718|NCT01588197|58973569|FG001|Overall Study|No MRI|0|||
30936719|NCT01561989|58973577|FG000|Overall Study|accural target not met.|5|||
30936720|NCT01561989|58973578|FG001|Overall Study|accural target not met.|6|||
30936721|NCT01587885|58973593|FG000|Treatment Period 1|Failure to Return|0|||
30936722|NCT01587885|58973594|FG001|Treatment Period 1|Failure to Return|1|||
30936723|NCT01587885|58973593|FG000|Treatment Period 1|Protocol Violation|0|||
30936724|NCT01587885|58973594|FG001|Treatment Period 1|Protocol Violation|2|||
30936725|NCT01587651|58973604|FG000|Overall Study|Adverse Event|0|||
30936726|NCT01587651|58973605|FG001|Overall Study|Adverse Event|1|||
30936727|NCT01587651|58973606|FG002|Overall Study|Adverse Event|0|||
30936728|NCT01587651|58973604|FG000|Overall Study|Protocol Violation|0|||
30624384|NCT01117428|58636431|FG004|Overall Study|Adverse Event|1|||
30624385|NCT01117428|58636432|FG005|Overall Study|Adverse Event|2|||
30624386|NCT01117428|58636427|FG000|Overall Study|Death|0|||
30624387|NCT01117428|58636428|FG001|Overall Study|Death|1|||
30624388|NCT01117428|58636429|FG002|Overall Study|Death|2|||
30759034|NCT00116805|58767578|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
30759035|NCT00116805|58767577|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
30759036|NCT00116805|58767578|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
30759037|NCT00116805|58767577|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
30759038|NCT00116805|58767578|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
30759039|NCT00116805|58767577|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
30759040|NCT00116805|58767578|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
30759041|NCT00116805|58767577|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
30759042|NCT00116805|58767578|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
30759043|NCT00116805|58767577|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
30759044|NCT00116805|58767578|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
30759045|NCT00116805|58767577|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
30759046|NCT00116805|58767578|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
30759047|NCT00116805|58767577|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
30936729|NCT01587651|58973605|FG001|Overall Study|Protocol Violation|1|||
30936730|NCT01587651|58973606|FG002|Overall Study|Protocol Violation|1|||
30936731|NCT01587651|58973604|FG000|Overall Study|Withdrawal by Subject|0|||
30936732|NCT01587651|58973605|FG001|Overall Study|Withdrawal by Subject|1|||
30936733|NCT01587651|58973606|FG002|Overall Study|Withdrawal by Subject|0|||
30936734|NCT01691859|58973628|FG000|Overall Study|Adverse Event|19|||
30624389|NCT01117428|58636430|FG003|Overall Study|Death|0|||
30936735|NCT01691859|58973628|FG000|Overall Study|Lack of Efficacy|11|||
30936736|NCT01691859|58973628|FG000|Overall Study|Protocol Violation|4|||
30624390|NCT01117428|58636431|FG004|Overall Study|Death|0|||
30759048|NCT00116805|58767578|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
30624391|NCT01117428|58636432|FG005|Overall Study|Death|1|||
30624392|NCT01117428|58636427|FG000|Overall Study|Physician Decision|0|||
30624393|NCT01117428|58636428|FG001|Overall Study|Physician Decision|1|||
30624394|NCT01117428|58636429|FG002|Overall Study|Physician Decision|0|||
30759049|NCT00116805|58767577|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
30936737|NCT01691859|58973628|FG000|Overall Study|Product commercially available|221|||
30936738|NCT01691859|58973628|FG000|Overall Study|Study closed/terminated|50|||
30936739|NCT01691859|58973628|FG000|Overall Study|Lost to Follow-up|5|||
30936740|NCT01691859|58973628|FG000|Overall Study|Physician Decision|6|||
30936741|NCT01691859|58973628|FG000|Overall Study|Withdrawal by Subject|31|||
30936742|NCT01691781|58973672|FG000|Overall Study|Withdrawal by Subject|4|||
30936743|NCT01691781|58973673|FG001|Overall Study|Withdrawal by Subject|3|||
30936744|NCT01691781|58973672|FG000|Overall Study|Physician Decision|1|||
30936745|NCT01691781|58973673|FG001|Overall Study|Physician Decision|1|||
30936746|NCT01691781|58973672|FG000|Overall Study|Protocol Violation|2|||
30936747|NCT01691781|58973673|FG001|Overall Study|Protocol Violation|2|||
30936748|NCT01691781|58973672|FG000|Overall Study|Adverse Event|0|||
30936749|NCT01691781|58973673|FG001|Overall Study|Adverse Event|1|||
30936750|NCT01561755|58973681|FG000|Overall Study|Lost to Follow-up|0|||
30936751|NCT01561755|58973682|FG001|Overall Study|Lost to Follow-up|1|||
30936752|NCT01585155|58973702|FG000|Overall Study|Adverse Event|1|||
30936753|NCT01585155|58973702|FG000|Overall Study|Lack of Efficacy|2|||
30936754|NCT01585155|58973702|FG000|Overall Study|Worsening ulcerative colitis|2|||
30936755|NCT01560507|58973709|FG000|Overall Study|Lost to Follow-up|3|||
30936756|NCT01560507|58973710|FG001|Overall Study|Lost to Follow-up|1|||
30936757|NCT01560507|58973711|FG002|Overall Study|Lost to Follow-up|2|||
30936758|NCT01560507|58973709|FG000|Overall Study|Withdrawal by Subject|1|||
30936759|NCT01560507|58973710|FG001|Overall Study|Withdrawal by Subject|1|||
30936760|NCT01560507|58973711|FG002|Overall Study|Withdrawal by Subject|0|||
30936761|NCT01584843|58973726|FG000|First Treatment Period|Adverse Event|0|||
30936762|NCT01584843|58973727|FG001|First Treatment Period|Adverse Event|0|||
30936763|NCT01584843|58973728|FG002|First Treatment Period|Adverse Event|1|||
30936764|NCT01584843|58973729|FG003|First Treatment Period|Adverse Event|0|||
30936765|NCT01584843|58973730|FG004|First Treatment Period|Adverse Event|0|||
30936766|NCT01584843|58973731|FG005|First Treatment Period|Adverse Event|0|||
30936767|NCT01584843|58973726|FG000|First Treatment Period|Protocol Violation|0|||
30936768|NCT01584843|58973727|FG001|First Treatment Period|Protocol Violation|0|||
30936769|NCT01584843|58973728|FG002|First Treatment Period|Protocol Violation|0|||
30936770|NCT01584843|58973729|FG003|First Treatment Period|Protocol Violation|0|||
30936771|NCT01584843|58973730|FG004|First Treatment Period|Protocol Violation|0|||
30936772|NCT01584843|58973731|FG005|First Treatment Period|Protocol Violation|1|||
30936773|NCT01584843|58973726|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
30936774|NCT01584843|58973727|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
30936775|NCT01584843|58973728|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
30936776|NCT01584843|58973729|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
30936777|NCT01584843|58973730|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
30936778|NCT01584843|58973731|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
30936779|NCT01584843|58973726|FG000|Second Treatment Period|Withdrawal by Subject|0|||
30936780|NCT01584843|58973727|FG001|Second Treatment Period|Withdrawal by Subject|0|||
30936781|NCT01584843|58973728|FG002|Second Treatment Period|Withdrawal by Subject|0|||
30936782|NCT01584843|58973729|FG003|Second Treatment Period|Withdrawal by Subject|0|||
30936783|NCT01584843|58973730|FG004|Second Treatment Period|Withdrawal by Subject|0|||
30936784|NCT01584843|58973731|FG005|Second Treatment Period|Withdrawal by Subject|1|||
30936785|NCT01560429|58973749|FG000|Overall Study|Protocol Violation|3|||
30936786|NCT01560429|58973750|FG001|Overall Study|Protocol Violation|6|||
30936787|NCT01582971|58973760|FG000|Overall Study|Death|2|||
30936788|NCT01582971|58973761|FG001|Overall Study|Death|1|||
30936789|NCT01582971|58973760|FG000|Overall Study|Lost to Follow-up|18|||
30936790|NCT01582971|58973761|FG001|Overall Study|Lost to Follow-up|21|||
30936791|NCT01582971|58973760|FG000|Overall Study|Withdrawal by Subject|4|||
30624395|NCT01117428|58636430|FG003|Overall Study|Physician Decision|0|||
30936792|NCT01582971|58973761|FG001|Overall Study|Withdrawal by Subject|2|||
30936793|NCT01582971|58973760|FG000|Overall Study|Other|15|||
30936794|NCT01582971|58973761|FG001|Overall Study|Other|13|||
30936795|NCT01690299|58973776|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
30936796|NCT01690299|58973777|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
30936797|NCT01690299|58973778|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
30936798|NCT01690299|58973779|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
30936799|NCT01690299|58973780|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
30624396|NCT01117428|58636431|FG004|Overall Study|Physician Decision|0|||
30936800|NCT01690299|58973781|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
30936801|NCT01690299|58973776|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
30936802|NCT01690299|58973777|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30936803|NCT01690299|58973778|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30936804|NCT01690299|58973779|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30936805|NCT01690299|58973780|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30936806|NCT01690299|58973781|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30936807|NCT01690299|58973776|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
30936808|NCT01690299|58973777|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
30936809|NCT01690299|58973778|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30936810|NCT01690299|58973779|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30936811|NCT01690299|58973780|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30936812|NCT01690299|58973781|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30936813|NCT01690299|58973776|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
30624397|NCT01117428|58636432|FG005|Overall Study|Physician Decision|0|||
30936814|NCT01690299|58973777|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
30936815|NCT01690299|58973778|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
30936816|NCT01690299|58973779|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
30936817|NCT01690299|58973780|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
30936818|NCT01690299|58973781|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
30936819|NCT01690299|58973776|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
30936820|NCT01690299|58973777|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
30936821|NCT01690299|58973778|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
30936822|NCT01690299|58973779|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
30936823|NCT01690299|58973780|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
30936824|NCT01690299|58973781|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
30936825|NCT01690299|58973776|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
30936826|NCT01690299|58973777|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
30936827|NCT01690299|58973778|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
30936828|NCT01690299|58973779|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
30936829|NCT01690299|58973780|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
30936830|NCT01690299|58973781|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
30936831|NCT01690299|58973776|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
30936832|NCT01690299|58973777|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
30936833|NCT01690299|58973778|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
30936834|NCT01690299|58973779|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
30936835|NCT01690299|58973780|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
30936836|NCT01690299|58973781|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
30936837|NCT01690299|58973776|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
30936838|NCT01690299|58973777|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
30936839|NCT01690299|58973778|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
30936840|NCT01690299|58973779|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
30936841|NCT01690299|58973780|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
30936842|NCT01690299|58973781|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
30936843|NCT01690299|58973776|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
30936844|NCT01690299|58973777|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
30936845|NCT01690299|58973778|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
30936846|NCT01690299|58973779|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
30936847|NCT01690299|58973780|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
30936848|NCT01690299|58973781|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
30936849|NCT01690299|58973776|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
30936850|NCT01690299|58973777|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
30936851|NCT01690299|58973778|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
30936852|NCT01690299|58973779|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
30936853|NCT01690299|58973780|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
30936854|NCT01690299|58973781|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
30936855|NCT01690143|58973810|FG000|Overall Study|Withdrawal by Subject|1|||
30936856|NCT01559259|58973829|FG000|Overall Study|Withdrawal by Subject|0|||
30936857|NCT01559259|58973830|FG001|Overall Study|Withdrawal by Subject|0|||
30936858|NCT01559259|58973831|FG002|Overall Study|Withdrawal by Subject|0|||
30936859|NCT01559259|58973832|FG003|Overall Study|Withdrawal by Subject|1|||
30936860|NCT01559259|58973833|FG004|Overall Study|Withdrawal by Subject|0|||
30936861|NCT01559259|58973829|FG000|Overall Study|Adverse Event|0|||
30936862|NCT01559259|58973830|FG001|Overall Study|Adverse Event|1|||
30936863|NCT01559259|58973831|FG002|Overall Study|Adverse Event|1|||
30936864|NCT01559259|58973832|FG003|Overall Study|Adverse Event|0|||
30936865|NCT01559259|58973833|FG004|Overall Study|Adverse Event|0|||
30936866|NCT01670500|58973857|FG000|Overall Study|Withdrawal by Subject|1|||
30936867|NCT01670500|58973858|FG001|Overall Study|Withdrawal by Subject|0|||
30936868|NCT02400736|58973866|FG000|Overall Study|Lost to Follow-up|6|||
30936869|NCT02400736|58973867|FG001|Overall Study|Lost to Follow-up|6|||
30936870|NCT02400736|58973866|FG000|Overall Study|Withdrawal by Subject|2|||
30936871|NCT02400736|58973867|FG001|Overall Study|Withdrawal by Subject|1|||
30936872|NCT02400736|58973866|FG000|Overall Study|Moved from the area|3|||
30936873|NCT02400736|58973867|FG001|Overall Study|Moved from the area|1|||
30936874|NCT01689519|58973879|FG000|Intent to Treat|Death|157|||
30936875|NCT01689519|58973880|FG001|Intent to Treat|Death|167|||
30936876|NCT01689519|58973879|FG000|Intent to Treat|Lost to Follow-up|4|||
30936877|NCT01689519|58973880|FG001|Intent to Treat|Lost to Follow-up|8|||
30936878|NCT01689519|58973879|FG000|Intent to Treat|Other|2|||
30936879|NCT01689519|58973880|FG001|Intent to Treat|Other|4|||
30936880|NCT01689519|58973879|FG000|Intent to Treat|Physician Decision|4|||
30936881|NCT01689519|58973880|FG001|Intent to Treat|Physician Decision|1|||
30936882|NCT01689519|58973879|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
30936883|NCT01689519|58973880|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
30936884|NCT01689519|58973879|FG000|Intent to Treat|Withdrawal by Subject|21|||
30936885|NCT01689519|58973880|FG001|Intent to Treat|Withdrawal by Subject|20|||
30936886|NCT01689519|58973879|FG000|Safety Population|Death|158|||
30936887|NCT01689519|58973880|FG001|Safety Population|Death|165|||
30936888|NCT01689519|58973879|FG000|Safety Population|Lost to Follow-up|4|||
30936889|NCT01689519|58973880|FG001|Safety Population|Lost to Follow-up|8|||
30936890|NCT01689519|58973879|FG000|Safety Population|Other|2|||
30936891|NCT01689519|58973880|FG001|Safety Population|Other|4|||
30936892|NCT01689519|58973879|FG000|Safety Population|Physician Decision|4|||
30936893|NCT01689519|58973880|FG001|Safety Population|Physician Decision|1|||
30936894|NCT01689519|58973879|FG000|Safety Population|Study Terminated By Sponsor|60|||
30936895|NCT01689519|58973880|FG001|Safety Population|Study Terminated By Sponsor|47|||
30936896|NCT01689519|58973879|FG000|Safety Population|Withdrawal by Subject|20|||
30936897|NCT01689519|58973880|FG001|Safety Population|Withdrawal by Subject|20|||
30936898|NCT01689363|58973886|FG000|Overall Study|Protocol Violation|0|||
30936899|NCT01689363|58973887|FG001|Overall Study|Protocol Violation|1|||
30936900|NCT01689363|58973888|FG002|Overall Study|Protocol Violation|0|||
30936901|NCT01689363|58973889|FG003|Overall Study|Protocol Violation|0|||
30936902|NCT01689363|58973890|FG004|Overall Study|Protocol Violation|0|||
30936903|NCT01689363|58973891|FG005|Overall Study|Protocol Violation|0|||
30936904|NCT01689363|58973892|FG006|Overall Study|Protocol Violation|0|||
30936905|NCT01689363|58973893|FG007|Overall Study|Protocol Violation|0|||
30936906|NCT01558635|58973909|FG000|Overall Study|Death|1|||
30936907|NCT01558635|58973909|FG000|Overall Study|Withdrawal by Subject|2|||
30936908|NCT01558635|58973909|FG000|Overall Study|Physician Decision|1|||
30936909|NCT01558635|58973909|FG000|Overall Study|Subject received other treatment|1|||
30936910|NCT01558635|58973909|FG000|Overall Study|Reveal XT was explanted|1|||
30936911|NCT00089986|58973923|FG000|Overall Study|Adverse Event|6|||
30936912|NCT00089986|58973924|FG001|Overall Study|Adverse Event|9|||
30936913|NCT00089986|58973925|FG002|Overall Study|Adverse Event|6|||
30936914|NCT00089986|58973923|FG000|Overall Study|Lost to Follow-up|3|||
30936915|NCT00089986|58973924|FG001|Overall Study|Lost to Follow-up|1|||
30936916|NCT00089986|58973925|FG002|Overall Study|Lost to Follow-up|1|||
30936917|NCT00089986|58973923|FG000|Overall Study|Protocol Violation|0|||
30936918|NCT00089986|58973924|FG001|Overall Study|Protocol Violation|1|||
30936919|NCT00089986|58973925|FG002|Overall Study|Protocol Violation|0|||
30936920|NCT00089986|58973923|FG000|Overall Study|Patient transferred to another hospital|2|||
30936921|NCT00089986|58973924|FG001|Overall Study|Patient transferred to another hospital|1|||
30936922|NCT00089986|58973925|FG002|Overall Study|Patient transferred to another hospital|0|||
30936923|NCT00089986|58973923|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
30936924|NCT00089986|58973924|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
30936925|NCT00089986|58973925|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
30936926|NCT00089986|58973923|FG000|Overall Study|Hemohlobin stopping rule|0|||
30936927|NCT00089986|58973924|FG001|Overall Study|Hemohlobin stopping rule|1|||
30936928|NCT00089986|58973925|FG002|Overall Study|Hemohlobin stopping rule|0|||
30936929|NCT00089986|58973923|FG000|Overall Study|Investigator decision to withdrew|0|||
30936930|NCT00089986|58973924|FG001|Overall Study|Investigator decision to withdrew|1|||
30936931|NCT00089986|58973925|FG002|Overall Study|Investigator decision to withdrew|0|||
30936932|NCT00089986|58973923|FG000|Overall Study|Enrollment in another study|0|||
30759050|NCT00116805|58767578|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
30936933|NCT00089986|58973924|FG001|Overall Study|Enrollment in another study|1|||
30936934|NCT00089986|58973925|FG002|Overall Study|Enrollment in another study|0|||
30936935|NCT00089986|58973923|FG000|Overall Study|Family decision|0|||
30936936|NCT00089986|58973924|FG001|Overall Study|Family decision|1|||
30759051|NCT00116805|58767577|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
30759052|NCT00116805|58767578|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
30936937|NCT00089986|58973925|FG002|Overall Study|Family decision|0|||
30936938|NCT00089986|58973923|FG000|Overall Study|Do not resuscitate (DNR)|0|||
30936939|NCT00089986|58973924|FG001|Overall Study|Do not resuscitate (DNR)|0|||
30936940|NCT00089986|58973925|FG002|Overall Study|Do not resuscitate (DNR)|1|||
30936941|NCT00089986|58973923|FG000|Overall Study|Withdrawal by Subject|3|||
30936942|NCT00089986|58973924|FG001|Overall Study|Withdrawal by Subject|6|||
30936943|NCT00089986|58973925|FG002|Overall Study|Withdrawal by Subject|2|||
30936944|NCT01689207|58973948|FG000|Overall Study|Adverse Event|0|||
30936945|NCT01689207|58973949|FG001|Overall Study|Adverse Event|1|||
30936946|NCT01689207|58973950|FG002|Overall Study|Adverse Event|0|||
30936947|NCT01689207|58973951|FG003|Overall Study|Adverse Event|0|||
30936948|NCT01689207|58973952|FG004|Overall Study|Adverse Event|2|||
30936949|NCT01689207|58973953|FG005|Overall Study|Adverse Event|1|||
30936950|NCT01689207|58973954|FG006|Overall Study|Adverse Event|0|||
30936951|NCT01689207|58973955|FG007|Overall Study|Adverse Event|0|||
30936952|NCT01689207|58973956|FG008|Overall Study|Adverse Event|1|||
30936953|NCT01689207|58973957|FG009|Overall Study|Adverse Event|0|||
30936954|NCT01689207|58973958|FG010|Overall Study|Adverse Event|0|||
30936955|NCT00089284|58973993|FG000|Overall Study|Adverse event before starting treatment|0|||
30936956|NCT00089284|58973994|FG001|Overall Study|Adverse event before starting treatment|0|||
30936957|NCT00089284|58973995|FG002|Overall Study|Adverse event before starting treatment|0|||
30936958|NCT00089284|58973996|FG003|Overall Study|Adverse event before starting treatment|0|||
30936959|NCT00089284|58973997|FG004|Overall Study|Adverse event before starting treatment|0|||
30936960|NCT00089284|58973998|FG005|Overall Study|Adverse event before starting treatment|0|||
30936961|NCT00089284|58973999|FG006|Overall Study|Adverse event before starting treatment|1|||
30936962|NCT01688973|58974023|FG000|Overall Study|Ineligible|2|||
30936963|NCT01688973|58974024|FG001|Overall Study|Ineligible|3|||
30936964|NCT00087646|58974035|FG000|Overall Study|Adverse Event|37|||
30936965|NCT00087646|58974036|FG001|Overall Study|Adverse Event|6|||
30936966|NCT00087646|58974037|FG002|Overall Study|Adverse Event|18|||
30936967|NCT00087646|58974038|FG003|Overall Study|Adverse Event|20|||
30936968|NCT00087646|58974035|FG000|Overall Study|Death|0|||
30936969|NCT00087646|58974036|FG001|Overall Study|Death|1|||
30936970|NCT00087646|58974037|FG002|Overall Study|Death|0|||
30936971|NCT00087646|58974038|FG003|Overall Study|Death|0|||
30936972|NCT00087646|58974035|FG000|Overall Study|Withdrawal by Subject|6|||
30936973|NCT00087646|58974036|FG001|Overall Study|Withdrawal by Subject|1|||
30936974|NCT00087646|58974037|FG002|Overall Study|Withdrawal by Subject|2|||
30936975|NCT00087646|58974038|FG003|Overall Study|Withdrawal by Subject|2|||
30936976|NCT00087646|58974035|FG000|Overall Study|Insufficient therapeutic response|64|||
30936977|NCT00087646|58974036|FG001|Overall Study|Insufficient therapeutic response|24|||
30936978|NCT00087646|58974037|FG002|Overall Study|Insufficient therapeutic response|38|||
30936979|NCT00087646|58974038|FG003|Overall Study|Insufficient therapeutic response|51|||
30936980|NCT00087646|58974035|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
30936981|NCT00087646|58974036|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
30936982|NCT00087646|58974037|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
30936983|NCT00087646|58974038|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
30936984|NCT00087646|58974035|FG000|Overall Study|Failure to Return|5|||
30936985|NCT00087646|58974036|FG001|Overall Study|Failure to Return|2|||
30936986|NCT00087646|58974037|FG002|Overall Study|Failure to Return|2|||
30936987|NCT00087646|58974038|FG003|Overall Study|Failure to Return|3|||
30936988|NCT00087646|58974035|FG000|Overall Study|Administrative/Other|6|||
30936989|NCT00087646|58974036|FG001|Overall Study|Administrative/Other|1|||
30936990|NCT00087646|58974037|FG002|Overall Study|Administrative/Other|1|||
30624398|NCT01117428|58636427|FG000|Overall Study|Withdrawal by Subject|0|||
30624399|NCT01117428|58636428|FG001|Overall Study|Withdrawal by Subject|0|||
30624400|NCT01117428|58636429|FG002|Overall Study|Withdrawal by Subject|1|||
30624401|NCT01117428|58636430|FG003|Overall Study|Withdrawal by Subject|0|||
30624402|NCT01117428|58636431|FG004|Overall Study|Withdrawal by Subject|0|||
30624403|NCT01117428|58636432|FG005|Overall Study|Withdrawal by Subject|0|||
30624404|NCT01117428|58636427|FG000|Overall Study|Progressive disease|15|||
30624405|NCT01117428|58636428|FG001|Overall Study|Progressive disease|27|||
30624406|NCT01117428|58636429|FG002|Overall Study|Progressive disease|10|||
30624407|NCT01117428|58636430|FG003|Overall Study|Progressive disease|12|||
30624408|NCT01117428|58636431|FG004|Overall Study|Progressive disease|16|||
30624409|NCT01117428|58636432|FG005|Overall Study|Progressive disease|17|||
30624410|NCT00655681|58636450|FG000|Overall Study|Lost to Follow-up|1|||
30624411|NCT00655681|58636451|FG001|Overall Study|Lost to Follow-up|1|||
30624412|NCT01135524|58636470|FG000|Overall Study|Withdrawal by Subject|14|||
30624413|NCT01135524|58636470|FG000|Overall Study|Adverse Event|20|||
30624414|NCT01135524|58636470|FG000|Overall Study|Lost to Follow-up|3|||
30624415|NCT01135524|58636470|FG000|Overall Study|Administrative|151|||
30624416|NCT01135524|58636470|FG000|Overall Study|Lack of Efficacy|8|||
30624417|NCT00948675|58636476|FG000|Overall Study|Lost to Follow-up|1|||
30624418|NCT00948675|58636477|FG001|Overall Study|Lost to Follow-up|0|||
30936991|NCT00087646|58974038|FG003|Overall Study|Administrative/Other|2|||
30936992|NCT00087646|58974035|FG000|Overall Study|Other Protocol Violation|3|||
30936993|NCT00087646|58974036|FG001|Overall Study|Other Protocol Violation|1|||
30936994|NCT00087646|58974037|FG002|Overall Study|Other Protocol Violation|0|||
30936995|NCT00087646|58974038|FG003|Overall Study|Other Protocol Violation|0|||
30624419|NCT00903370|58636485|FG000|Overall Study|Death|13|||
30624420|NCT00903370|58636486|FG001|Overall Study|Death|10|||
30624421|NCT00903370|58636485|FG000|Overall Study|Withdrawal by Subject|9|||
30624422|NCT00903370|58636486|FG001|Overall Study|Withdrawal by Subject|6|||
30624423|NCT00903370|58636485|FG000|Overall Study|Lost to Follow-up|6|||
30624424|NCT00903370|58636486|FG001|Overall Study|Lost to Follow-up|8|||
30936996|NCT00087646|58974035|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
30936997|NCT00087646|58974036|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
30936998|NCT00087646|58974037|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
30936999|NCT00087646|58974038|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
30937000|NCT00087568|58974055|FG000|Overall Study|Adverse Event|4|||
30937001|NCT00087568|58974056|FG001|Overall Study|Adverse Event|0|||
30937002|NCT00087568|58974055|FG000|Overall Study|Withdrawal by Subject|1|||
30937003|NCT00087568|58974056|FG001|Overall Study|Withdrawal by Subject|1|||
30937004|NCT00087568|58974055|FG000|Overall Study|Lost to Follow-up|1|||
30937005|NCT00087568|58974056|FG001|Overall Study|Lost to Follow-up|0|||
30937006|NCT00087568|58974055|FG000|Overall Study|Lack of Efficacy|24|||
30937007|NCT00087568|58974056|FG001|Overall Study|Lack of Efficacy|1|||
30937008|NCT00085540|58974064|FG000|Overall Study|Withdrawal by Subject|0|||
30937009|NCT00085540|58974065|FG001|Overall Study|Withdrawal by Subject|1|||
30937010|NCT00085540|58974064|FG000|Overall Study|Protocol Violation|0|||
30937011|NCT00085540|58974065|FG001|Overall Study|Protocol Violation|1|||
30937012|NCT01688739|58974081|FG000|Overall Study|Administrative Decision|1|||
30937013|NCT01688739|58974082|FG001|Overall Study|Administrative Decision|0|||
30937014|NCT01688739|58974083|FG002|Overall Study|Administrative Decision|0|||
30937015|NCT01688739|58974084|FG003|Overall Study|Administrative Decision|0|||
30937016|NCT01688739|58974085|FG004|Overall Study|Administrative Decision|0|||
30937017|NCT01688739|58974086|FG005|Overall Study|Administrative Decision|0|||
30937018|NCT01688739|58974087|FG006|Overall Study|Administrative Decision|0|||
30937019|NCT01688739|58974088|FG007|Overall Study|Administrative Decision|0|||
30937020|NCT01688739|58974089|FG008|Overall Study|Administrative Decision|0|||
30937021|NCT01688739|58974090|FG009|Overall Study|Administrative Decision|0|||
30937022|NCT00084838|58974120|FG000|Overall Study|Death|1|||
30937023|NCT00084838|58974120|FG000|Overall Study|Adverse Event|2|||
30937024|NCT00084838|58974120|FG000|Overall Study|Withdrawal by Subject|1|||
30937025|NCT00084838|58974120|FG000|Overall Study|Progressive Disease|4|||
30937026|NCT00084838|58974120|FG000|Overall Study|Pt Non-Compliance|1|||
30937027|NCT00084838|58974120|FG000|Overall Study|Ineligible|4|||
30937028|NCT01558089|58974126|FG000|Overall Study|Adverse Event|1|||
30937029|NCT01558089|58974126|FG000|Overall Study|Lack of Efficacy|1|||
30937030|NCT01558089|58974126|FG000|Overall Study|Lost to Follow-up|5|||
30937031|NCT01558089|58974126|FG000|Overall Study|Withdrawal by Subject|6|||
30937032|NCT01581021|58974132|FG000|Overall Study|Lost to Follow-up|4|||
30937033|NCT01581021|58974133|FG001|Overall Study|Lost to Follow-up|6|||
30937034|NCT01581021|58974132|FG000|Overall Study|More than 2 hooks in thoracic|3|||
30937035|NCT01581021|58974133|FG001|Overall Study|More than 2 hooks in thoracic|0|||
30937036|NCT01581021|58974132|FG000|Overall Study|Neuromuscular|2|||
30937037|NCT01581021|58974133|FG001|Overall Study|Neuromuscular|1|||
30937038|NCT01581021|58974132|FG000|Overall Study|Not Randomized|1|||
30937039|NCT01581021|58974133|FG001|Overall Study|Not Randomized|2|||
30937040|NCT01581021|58974132|FG000|Overall Study|Lenke 6 Classification|0|||
30937041|NCT01581021|58974133|FG001|Overall Study|Lenke 6 Classification|1|||
30937042|NCT01581021|58974132|FG000|Overall Study|Lack of Efficacy|0|||
30937043|NCT01581021|58974133|FG001|Overall Study|Lack of Efficacy|1|||
30937044|NCT00084682|58974139|FG000|Overall Study|Withdrawal by Subject|1|||
30937045|NCT01556997|58974147|FG000|Overall Study|Adverse Event|10|||
30937046|NCT01556997|58974148|FG001|Overall Study|Adverse Event|12|||
30937047|NCT01556997|58974149|FG002|Overall Study|Adverse Event|12|||
30937048|NCT01556997|58974147|FG000|Overall Study|Lost to Follow-up|6|||
30937049|NCT01556997|58974148|FG001|Overall Study|Lost to Follow-up|6|||
30937050|NCT01556997|58974149|FG002|Overall Study|Lost to Follow-up|4|||
30937051|NCT01556997|58974147|FG000|Overall Study|Physician Decision|1|||
30937052|NCT01556997|58974148|FG001|Overall Study|Physician Decision|1|||
30937053|NCT01556997|58974149|FG002|Overall Study|Physician Decision|1|||
30937054|NCT01556997|58974147|FG000|Overall Study|Withdrawal by Subject|7|||
30937055|NCT01556997|58974148|FG001|Overall Study|Withdrawal by Subject|6|||
30937056|NCT01556997|58974149|FG002|Overall Study|Withdrawal by Subject|8|||
30937057|NCT01556997|58974147|FG000|Overall Study|Other|2|||
30937058|NCT01556997|58974148|FG001|Overall Study|Other|3|||
30624425|NCT01110408|58636494|FG000|Overall Study|Protocol Violation|1|||
30937059|NCT01556997|58974149|FG002|Overall Study|Other|7|||
30937060|NCT00082888|58974160|FG000|Overall Study|Ineligible|1|||
30937061|NCT00082888|58974161|FG001|Overall Study|Ineligible|0|||
30937062|NCT00082888|58974162|FG002|Overall Study|Ineligible|0|||
30624426|NCT01110408|58636495|FG001|Overall Study|Protocol Violation|0|||
30937063|NCT00082810|58974171|FG000|Overall Study|Adverse Event|3|||
30937064|NCT00082810|58974171|FG000|Overall Study|Progressive disease|24|||
30937065|NCT00082810|58974171|FG000|Overall Study|Withdrawal by Subject|4|||
30937066|NCT01577745|58974182|FG000|Overall Study|Withdrawal by Subject|0|||
30937067|NCT01577745|58974183|FG001|Overall Study|Withdrawal by Subject|1|||
30937068|NCT01577745|58974184|FG002|Overall Study|Withdrawal by Subject|0|||
30937069|NCT01577745|58974185|FG003|Overall Study|Withdrawal by Subject|3|||
30937070|NCT01577745|58974186|FG004|Overall Study|Withdrawal by Subject|2|||
30937071|NCT01577745|58974187|FG005|Overall Study|Withdrawal by Subject|0|||
30937072|NCT01577745|58974182|FG000|Overall Study|Death|3|||
30937073|NCT01577745|58974183|FG001|Overall Study|Death|2|||
30937074|NCT01577745|58974184|FG002|Overall Study|Death|2|||
30937075|NCT01577745|58974185|FG003|Overall Study|Death|1|||
30937076|NCT01577745|58974186|FG004|Overall Study|Death|1|||
30937077|NCT01577745|58974187|FG005|Overall Study|Death|3|||
30937078|NCT01577745|58974182|FG000|Overall Study|Physician Decision|0|||
30937079|NCT01577745|58974183|FG001|Overall Study|Physician Decision|0|||
30937080|NCT01577745|58974184|FG002|Overall Study|Physician Decision|0|||
30937081|NCT01577745|58974185|FG003|Overall Study|Physician Decision|1|||
30937082|NCT01577745|58974186|FG004|Overall Study|Physician Decision|1|||
30937083|NCT01577745|58974187|FG005|Overall Study|Physician Decision|0|||
30937084|NCT01577745|58974182|FG000|Overall Study|Lost to Follow-up|0|||
30937085|NCT01577745|58974183|FG001|Overall Study|Lost to Follow-up|0|||
30937086|NCT01577745|58974184|FG002|Overall Study|Lost to Follow-up|0|||
30937087|NCT01577745|58974185|FG003|Overall Study|Lost to Follow-up|0|||
30937088|NCT01577745|58974186|FG004|Overall Study|Lost to Follow-up|0|||
30937089|NCT01577745|58974187|FG005|Overall Study|Lost to Follow-up|1|||
30937090|NCT01577745|58974182|FG000|Overall Study|Alternative Therapy|0|||
30937091|NCT01577745|58974183|FG001|Overall Study|Alternative Therapy|0|||
30937092|NCT01577745|58974184|FG002|Overall Study|Alternative Therapy|0|||
30937093|NCT01577745|58974185|FG003|Overall Study|Alternative Therapy|1|||
30937094|NCT01577745|58974186|FG004|Overall Study|Alternative Therapy|1|||
30937095|NCT01577745|58974187|FG005|Overall Study|Alternative Therapy|0|||
30937096|NCT01688037|58974209|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
30937097|NCT01688037|58974210|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
30937098|NCT01688037|58974211|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
30937099|NCT01688037|58974209|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
30937100|NCT01688037|58974210|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
30937101|NCT01688037|58974211|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
30937102|NCT01688037|58974209|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
30937103|NCT01688037|58974210|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
30937104|NCT01688037|58974211|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
30937105|NCT01688037|58974209|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
30937106|NCT01688037|58974210|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
30937107|NCT01688037|58974211|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
30937108|NCT01688037|58974209|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
30937109|NCT01688037|58974210|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
30937110|NCT01688037|58974211|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
30937111|NCT01688037|58974209|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
30937112|NCT01688037|58974210|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
30937113|NCT01688037|58974211|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
30937114|NCT01688037|58974209|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
30937115|NCT01688037|58974210|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
30937116|NCT01688037|58974211|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
30937117|NCT01688037|58974209|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
30937118|NCT01688037|58974210|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
30937119|NCT01688037|58974211|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
30937120|NCT01688037|58974209|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
30937121|NCT01688037|58974210|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
30937122|NCT01688037|58974211|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
30937123|NCT01688037|58974209|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
30937124|NCT01688037|58974210|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
30937125|NCT01688037|58974211|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
30937126|NCT01610336|58974244|FG000|Overall Study|Progressive Disease|4|||
30759053|NCT00116805|58767577|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
30759054|NCT00116805|58767578|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
30759055|NCT00116805|58767577|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
30759056|NCT00116805|58767578|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
30759057|NCT00116805|58767577|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
30759058|NCT00116805|58767578|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
30759059|NCT00116805|58767577|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
30937127|NCT01610336|58974245|FG001|Overall Study|Progressive Disease|6|||
30937128|NCT01610336|58974246|FG002|Overall Study|Progressive Disease|6|||
30937129|NCT01610336|58974247|FG003|Overall Study|Progressive Disease|5|||
30937130|NCT01610336|58974248|FG004|Overall Study|Progressive Disease|3|||
30937131|NCT01610336|58974249|FG005|Overall Study|Progressive Disease|10|||
30937132|NCT01610336|58974250|FG006|Overall Study|Progressive Disease|1|||
30937133|NCT01610336|58974251|FG007|Overall Study|Progressive Disease|6|||
30937134|NCT01610336|58974252|FG008|Overall Study|Progressive Disease|6|||
30937135|NCT01610336|58974253|FG009|Overall Study|Progressive Disease|40|||
30937136|NCT01610336|58974254|FG010|Overall Study|Progressive Disease|36|||
30937137|NCT01610336|58974244|FG000|Overall Study|Adverse Event|0|||
30937138|NCT01610336|58974245|FG001|Overall Study|Adverse Event|0|||
30937139|NCT01610336|58974246|FG002|Overall Study|Adverse Event|0|||
30937140|NCT01610336|58974247|FG003|Overall Study|Adverse Event|1|||
30937141|NCT01610336|58974248|FG004|Overall Study|Adverse Event|1|||
30937142|NCT01610336|58974249|FG005|Overall Study|Adverse Event|1|||
30937143|NCT01610336|58974250|FG006|Overall Study|Adverse Event|0|||
30937144|NCT01610336|58974251|FG007|Overall Study|Adverse Event|0|||
30937145|NCT01610336|58974252|FG008|Overall Study|Adverse Event|2|||
30937146|NCT01610336|58974253|FG009|Overall Study|Adverse Event|8|||
30937147|NCT01610336|58974254|FG010|Overall Study|Adverse Event|6|||
30937148|NCT01610336|58974244|FG000|Overall Study|Subject/Guardian decision|1|||
30937149|NCT01610336|58974245|FG001|Overall Study|Subject/Guardian decision|1|||
30937150|NCT01610336|58974246|FG002|Overall Study|Subject/Guardian decision|0|||
30937151|NCT01610336|58974247|FG003|Overall Study|Subject/Guardian decision|1|||
30937152|NCT01610336|58974248|FG004|Overall Study|Subject/Guardian decision|0|||
30937153|NCT01610336|58974249|FG005|Overall Study|Subject/Guardian decision|0|||
30937154|NCT01610336|58974250|FG006|Overall Study|Subject/Guardian decision|0|||
30937155|NCT01610336|58974251|FG007|Overall Study|Subject/Guardian decision|1|||
30937156|NCT01610336|58974252|FG008|Overall Study|Subject/Guardian decision|0|||
30937157|NCT01610336|58974253|FG009|Overall Study|Subject/Guardian decision|2|||
30937158|NCT01610336|58974254|FG010|Overall Study|Subject/Guardian decision|2|||
30937159|NCT01610336|58974244|FG000|Overall Study|Death|0|||
30937160|NCT01610336|58974245|FG001|Overall Study|Death|0|||
30937161|NCT01610336|58974246|FG002|Overall Study|Death|0|||
30937162|NCT01610336|58974247|FG003|Overall Study|Death|0|||
30937163|NCT01610336|58974248|FG004|Overall Study|Death|0|||
30937164|NCT01610336|58974249|FG005|Overall Study|Death|1|||
30937165|NCT01610336|58974250|FG006|Overall Study|Death|3|||
30937166|NCT01610336|58974251|FG007|Overall Study|Death|0|||
30937167|NCT01610336|58974252|FG008|Overall Study|Death|0|||
30937168|NCT01610336|58974253|FG009|Overall Study|Death|1|||
30937169|NCT01610336|58974254|FG010|Overall Study|Death|2|||
30937170|NCT01610336|58974244|FG000|Overall Study|Non-Compliance with study treatment|0|||
30937171|NCT01610336|58974245|FG001|Overall Study|Non-Compliance with study treatment|0|||
30937172|NCT01610336|58974246|FG002|Overall Study|Non-Compliance with study treatment|0|||
30937173|NCT01610336|58974247|FG003|Overall Study|Non-Compliance with study treatment|0|||
30937174|NCT01610336|58974248|FG004|Overall Study|Non-Compliance with study treatment|0|||
30937175|NCT01610336|58974249|FG005|Overall Study|Non-Compliance with study treatment|0|||
30937176|NCT01610336|58974250|FG006|Overall Study|Non-Compliance with study treatment|0|||
30937177|NCT01610336|58974251|FG007|Overall Study|Non-Compliance with study treatment|0|||
30937178|NCT01610336|58974252|FG008|Overall Study|Non-Compliance with study treatment|0|||
30937179|NCT01610336|58974253|FG009|Overall Study|Non-Compliance with study treatment|1|||
30937180|NCT01610336|58974254|FG010|Overall Study|Non-Compliance with study treatment|0|||
30841629|NCT00968201|58867215|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
30841630|NCT00968201|58867213|FG000|Base Study - (Period II)|Site Error|0|||
30841631|NCT00968201|58867214|FG001|Base Study - (Period II)|Site Error|0|||
30841632|NCT00968201|58867215|FG002|Base Study - (Period II)|Site Error|1|||
30841633|NCT00968201|58867213|FG000|Extension Study - (Period III)|Adverse Event|0|||
30841634|NCT00968201|58867214|FG001|Extension Study - (Period III)|Adverse Event|5|||
30841635|NCT00968201|58867215|FG002|Extension Study - (Period III)|Adverse Event|22|||
30841636|NCT00968201|58867213|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
30841637|NCT00968201|58867214|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
30937181|NCT01610336|58974244|FG000|Overall Study|Physician Decision|0|||
30937182|NCT01610336|58974245|FG001|Overall Study|Physician Decision|0|||
30841638|NCT00968201|58867215|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
30937183|NCT01610336|58974246|FG002|Overall Study|Physician Decision|0|||
30937184|NCT01610336|58974247|FG003|Overall Study|Physician Decision|0|||
30937185|NCT01610336|58974248|FG004|Overall Study|Physician Decision|0|||
30937186|NCT01610336|58974249|FG005|Overall Study|Physician Decision|0|||
30937187|NCT01610336|58974250|FG006|Overall Study|Physician Decision|1|||
30937188|NCT01610336|58974251|FG007|Overall Study|Physician Decision|0|||
30937189|NCT01610336|58974252|FG008|Overall Study|Physician Decision|0|||
30937190|NCT01610336|58974253|FG009|Overall Study|Physician Decision|0|||
30937191|NCT01610336|58974254|FG010|Overall Study|Physician Decision|0|||
30937192|NCT01610336|58974244|FG000|Overall Study|Protocol Deviation|0|||
30937193|NCT01610336|58974245|FG001|Overall Study|Protocol Deviation|0|||
30937194|NCT01610336|58974246|FG002|Overall Study|Protocol Deviation|0|||
30937195|NCT01610336|58974247|FG003|Overall Study|Protocol Deviation|0|||
30937196|NCT01610336|58974248|FG004|Overall Study|Protocol Deviation|0|||
30937197|NCT01610336|58974249|FG005|Overall Study|Protocol Deviation|0|||
30937198|NCT01610336|58974250|FG006|Overall Study|Protocol Deviation|0|||
30937199|NCT01610336|58974251|FG007|Overall Study|Protocol Deviation|0|||
30937200|NCT01610336|58974252|FG008|Overall Study|Protocol Deviation|0|||
30937201|NCT01610336|58974253|FG009|Overall Study|Protocol Deviation|1|||
30937202|NCT01610336|58974254|FG010|Overall Study|Protocol Deviation|0|||
30937203|NCT01610336|58974244|FG000|Overall Study|Transfer to another trial|0|||
30937204|NCT01610336|58974245|FG001|Overall Study|Transfer to another trial|0|||
30937205|NCT01610336|58974246|FG002|Overall Study|Transfer to another trial|0|||
30937206|NCT01610336|58974247|FG003|Overall Study|Transfer to another trial|0|||
30937207|NCT01610336|58974248|FG004|Overall Study|Transfer to another trial|0|||
30937208|NCT01610336|58974249|FG005|Overall Study|Transfer to another trial|0|||
30937209|NCT01610336|58974250|FG006|Overall Study|Transfer to another trial|0|||
30937210|NCT01610336|58974251|FG007|Overall Study|Transfer to another trial|0|||
30937211|NCT01610336|58974252|FG008|Overall Study|Transfer to another trial|0|||
30937212|NCT01610336|58974253|FG009|Overall Study|Transfer to another trial|0|||
30937213|NCT01610336|58974254|FG010|Overall Study|Transfer to another trial|1|||
30937214|NCT01613222|58974282|FG000|Overall Study|Physician Decision|1|||
30937215|NCT01613222|58974282|FG000|Overall Study|Unable to place arterial line|1|||
30937216|NCT01613222|58974282|FG000|Overall Study|Reused disposable sensors|10|||
30937217|NCT01612676|58974329|FG000|Overall Study|Adverse Event|2|||
30937218|NCT01612676|58974330|FG001|Overall Study|Adverse Event|3|||
30937219|NCT01612676|58974331|FG002|Overall Study|Adverse Event|1|||
30937220|NCT01612676|58974332|FG003|Overall Study|Adverse Event|3|||
30937221|NCT01612676|58974329|FG000|Overall Study|Protocol Violation|0|||
30937222|NCT01612676|58974330|FG001|Overall Study|Protocol Violation|1|||
30937223|NCT01612676|58974331|FG002|Overall Study|Protocol Violation|0|||
30937224|NCT01612676|58974332|FG003|Overall Study|Protocol Violation|0|||
30937225|NCT01869764|58974346|FG000|Overall Study|Withdrawal by Subject|0|||
30937226|NCT01869764|58974347|FG001|Overall Study|Withdrawal by Subject|2|||
30937227|NCT01842620|58974353|FG000|Period 1|Withdrawal by Subject|1|||
30937228|NCT01842620|58974354|FG001|Period 1|Withdrawal by Subject|0|||
30937229|NCT01931839|58974380|FG000|Overall Study|Death|0|||
30937230|NCT01931839|58974381|FG001|Overall Study|Death|1|||
30937231|NCT01931839|58974382|FG002|Overall Study|Death|2|||
30937232|NCT01931839|58974383|FG003|Overall Study|Death|0|||
30937233|NCT01931839|58974384|FG004|Overall Study|Death|0|||
30937234|NCT01931839|58974385|FG005|Overall Study|Death|0|||
30937235|NCT01931839|58974386|FG006|Overall Study|Death|0|||
30937236|NCT01931839|58974380|FG000|Overall Study|Physician Decision|1|||
30937237|NCT01931839|58974381|FG001|Overall Study|Physician Decision|0|||
30937238|NCT01931839|58974382|FG002|Overall Study|Physician Decision|1|||
30937239|NCT01931839|58974383|FG003|Overall Study|Physician Decision|0|||
30937240|NCT01931839|58974384|FG004|Overall Study|Physician Decision|0|||
30937241|NCT01931839|58974385|FG005|Overall Study|Physician Decision|0|||
30937242|NCT01931839|58974386|FG006|Overall Study|Physician Decision|1|||
30937243|NCT01931839|58974380|FG000|Overall Study|Withdrawal of consent|0|||
30937244|NCT01931839|58974381|FG001|Overall Study|Withdrawal of consent|0|||
30759060|NCT00116805|58767578|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
30759061|NCT00116805|58767577|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
30759062|NCT00116805|58767578|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
30759063|NCT00116805|58767577|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
30759064|NCT00116805|58767578|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
30937245|NCT01931839|58974382|FG002|Overall Study|Withdrawal of consent|0|||
30841639|NCT00968201|58867213|FG000|Extension Study - (Period III)|Protocol Violation|0|||
30841640|NCT00968201|58867214|FG001|Extension Study - (Period III)|Protocol Violation|17|||
30841641|NCT00968201|58867215|FG002|Extension Study - (Period III)|Protocol Violation|14|||
30841642|NCT00968201|58867213|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
30841643|NCT00968201|58867214|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
30937246|NCT01931839|58974383|FG003|Overall Study|Withdrawal of consent|0|||
30937247|NCT01931839|58974384|FG004|Overall Study|Withdrawal of consent|1|||
30759065|NCT00116805|58767577|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
30759066|NCT00116805|58767578|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
30759067|NCT00116805|58767577|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
30759068|NCT00116805|58767578|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
30759069|NCT00116805|58767577|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
30937248|NCT01931839|58974385|FG005|Overall Study|Withdrawal of consent|0|||
30937249|NCT01931839|58974386|FG006|Overall Study|Withdrawal of consent|0|||
30937250|NCT01931839|58974380|FG000|Overall Study|Adverse Event|9|||
30937251|NCT01931839|58974381|FG001|Overall Study|Adverse Event|4|||
30937252|NCT01931839|58974382|FG002|Overall Study|Adverse Event|1|||
30937253|NCT01931839|58974383|FG003|Overall Study|Adverse Event|3|||
30937254|NCT01931839|58974384|FG004|Overall Study|Adverse Event|0|||
30937255|NCT01931839|58974385|FG005|Overall Study|Adverse Event|0|||
30937256|NCT01931839|58974386|FG006|Overall Study|Adverse Event|1|||
30937257|NCT01931839|58974380|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
30841644|NCT00968201|58867215|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
30841645|NCT00968201|58867213|FG000|Extension Study - (Period III)|Patient Relocated|0|||
30841646|NCT00968201|58867214|FG001|Extension Study - (Period III)|Patient Relocated|1|||
30841647|NCT00968201|58867215|FG002|Extension Study - (Period III)|Patient Relocated|1|||
30841648|NCT00968201|58867213|FG000|Extension Study - (Period III)|Noncompliance|0|||
30841649|NCT00968201|58867214|FG001|Extension Study - (Period III)|Noncompliance|0|||
30937258|NCT01931839|58974381|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
30937259|NCT01931839|58974382|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
30937260|NCT01931839|58974383|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
30937261|NCT01931839|58974384|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
30937262|NCT01931839|58974385|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
30937263|NCT01931839|58974386|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
30937264|NCT01931839|58974380|FG000|Overall Study|Other non-compliance|15|||
30937265|NCT01931839|58974381|FG001|Overall Study|Other non-compliance|9|||
30937266|NCT01931839|58974382|FG002|Overall Study|Other non-compliance|12|||
30937267|NCT01931839|58974383|FG003|Overall Study|Other non-compliance|3|||
30937268|NCT01931839|58974384|FG004|Overall Study|Other non-compliance|0|||
30937269|NCT01931839|58974385|FG005|Overall Study|Other non-compliance|3|||
30937270|NCT01931839|58974386|FG006|Overall Study|Other non-compliance|0|||
30937271|NCT01931839|58974380|FG000|Overall Study|Lost to Follow-up|1|||
30937272|NCT01931839|58974381|FG001|Overall Study|Lost to Follow-up|2|||
30937273|NCT01931839|58974382|FG002|Overall Study|Lost to Follow-up|4|||
30937274|NCT01931839|58974383|FG003|Overall Study|Lost to Follow-up|5|||
30937275|NCT01931839|58974384|FG004|Overall Study|Lost to Follow-up|0|||
30937276|NCT01931839|58974385|FG005|Overall Study|Lost to Follow-up|0|||
30937277|NCT01931839|58974386|FG006|Overall Study|Lost to Follow-up|0|||
30937278|NCT01931839|58974380|FG000|Overall Study|Other|4|||
30937279|NCT01931839|58974381|FG001|Overall Study|Other|2|||
30937280|NCT01931839|58974382|FG002|Overall Study|Other|6|||
30937281|NCT01931839|58974383|FG003|Overall Study|Other|0|||
30937282|NCT01931839|58974384|FG004|Overall Study|Other|0|||
30937283|NCT01931839|58974385|FG005|Overall Study|Other|0|||
30937284|NCT01931839|58974386|FG006|Overall Study|Other|0|||
30937285|NCT01842308|58974411|FG000|Overall Study|Withdrawal by Subject|0|||
30937286|NCT01842308|58974412|FG001|Overall Study|Withdrawal by Subject|0|||
30937287|NCT01842308|58974413|FG002|Overall Study|Withdrawal by Subject|0|||
30937288|NCT01842308|58974414|FG003|Overall Study|Withdrawal by Subject|0|||
30937289|NCT01842308|58974415|FG004|Overall Study|Withdrawal by Subject|1|||
30937290|NCT01931059|58974430|FG000|Day 1|Pregnancy|0|||
30937291|NCT01931059|58974431|FG001|Day 1|Pregnancy|1|||
30937292|NCT01931059|58974430|FG000|Day3|Lost to Follow-up|1|||
30937293|NCT01931059|58974431|FG001|Day3|Lost to Follow-up|0|||
30937294|NCT01841762|58974443|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
30937295|NCT01841762|58974443|FG000|Treatment Period|Adverse Event|16|||
30937296|NCT01841762|58974443|FG000|Treatment Period|Death|1|||
30937297|NCT01841762|58974443|FG000|Treatment Period|Withdrawal by Subject|7|||
30937298|NCT01841762|58974443|FG000|Treatment Period|Lost to Follow-up|1|||
30937299|NCT01841762|58974443|FG000|Treatment Period|Physician Decision|2|||
30937300|NCT01841762|58974443|FG000|Treatment Period|Other, including non-compliance|5|||
30937301|NCT01841762|58974443|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
30937302|NCT01841762|58974443|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
30937303|NCT01841762|58974443|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
30937304|NCT01841762|58974443|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
30937305|NCT01841060|58974460|FG000|Overall Study|Protocol Violation|10|||
30937306|NCT01814696|58974466|FG000|Overall Study|Withdrawal by Subject|1|||
30759070|NCT00116805|58767578|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
30759071|NCT00116805|58767577|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
30759072|NCT00116805|58767578|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
30759073|NCT00116649|58767593|FG000|Overall Study|Adverse Event|20|||
30759074|NCT00116649|58767593|FG000|Overall Study|Lack of Efficacy|1|||
30759075|NCT00116649|58767593|FG000|Overall Study|Lost to Follow-up|32|||
30759076|NCT00116649|58767593|FG000|Overall Study|Withdrawal by Subject|68|||
30759077|NCT00116649|58767593|FG000|Overall Study|Local Skin Reaction|9|||
30759078|NCT00116649|58767593|FG000|Overall Study|Various Reasons|18|||
30759079|NCT00116649|58767593|FG000|Overall Study|Protocol Specified|7|||
30841650|NCT00968201|58867215|FG002|Extension Study - (Period III)|Noncompliance|3|||
30937307|NCT01814696|58974467|FG001|Overall Study|Withdrawal by Subject|0|||
30759080|NCT00083889|58767599|FG000|Overall Study|Adverse Event|76|||
30841651|NCT00968201|58867213|FG000|Extension Study - (Period III)|Other|0|||
30937308|NCT01814696|58974466|FG000|Overall Study|Randomized to wrong group|1|||
30937309|NCT01814696|58974467|FG001|Overall Study|Randomized to wrong group|0|||
30937310|NCT01970371|58974476|FG000|Overall Study|Death|8|||
30937311|NCT01970371|58974477|FG001|Overall Study|Death|13|||
30937312|NCT01970371|58974478|FG002|Overall Study|Death|12|||
30937313|NCT01970371|58974476|FG000|Overall Study|Lost to Follow-up|0|||
30937314|NCT01970371|58974477|FG001|Overall Study|Lost to Follow-up|0|||
30624427|NCT00953043|58636503|FG000|Overall Study|Withdrawal by Subject|4|||
30624428|NCT00953043|58636504|FG001|Overall Study|Withdrawal by Subject|0|||
30624429|NCT00953043|58636503|FG000|Overall Study|Physician Decision|0|||
30937315|NCT01970371|58974478|FG002|Overall Study|Lost to Follow-up|1|||
30937316|NCT01868594|58974499|FG000|Overall Study|Do not meet inclusion criteria|4|||
30937317|NCT01868594|58974500|FG001|Overall Study|Do not meet inclusion criteria|3|||
30937318|NCT01616953|58974510|FG000|Overall Study|Lost to Follow-up|1|||
30937319|NCT01616953|58974511|FG001|Overall Study|Lost to Follow-up|0|||
30937320|NCT01616953|58974510|FG000|Overall Study|lack of bone and soft tissue|1|||
30937321|NCT01616953|58974511|FG001|Overall Study|lack of bone and soft tissue|0|||
30937322|NCT01867658|58974517|FG000|Overall Study|Withdrawal by Subject|6|||
30937323|NCT01867658|58974517|FG000|Overall Study|Death|2|||
30937324|NCT01867658|58974517|FG000|Overall Study|Subject could not be contacted|1|||
30937325|NCT01867580|58974523|FG000|Overall Study|Withdrawal by Subject|2|||
30937326|NCT01867580|58974524|FG001|Overall Study|Withdrawal by Subject|3|||
30937327|NCT01867580|58974523|FG000|Overall Study|Physician Decision|17|||
30937328|NCT01867580|58974524|FG001|Overall Study|Physician Decision|12|||
30841652|NCT00968201|58867214|FG001|Extension Study - (Period III)|Other|0|||
30841653|NCT00968201|58867215|FG002|Extension Study - (Period III)|Other|2|||
30841654|NCT00968201|58867213|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
30841655|NCT00968201|58867214|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
30841656|NCT00968201|58867215|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
30841657|NCT00943397|58867226|FG000|Overall Study|Adverse Event|0|||
30841658|NCT00943397|58867227|FG001|Overall Study|Adverse Event|6|||
30841659|NCT00943397|58867226|FG000|Overall Study|Lost to Follow-up|0|||
30841660|NCT00943397|58867227|FG001|Overall Study|Lost to Follow-up|4|||
30841661|NCT00943397|58867226|FG000|Overall Study|Protocol Violation|2|||
30841662|NCT00943397|58867227|FG001|Overall Study|Protocol Violation|5|||
30841663|NCT00943397|58867226|FG000|Overall Study|Withdrawal by Subject|1|||
30841664|NCT00943397|58867227|FG001|Overall Study|Withdrawal by Subject|1|||
30841665|NCT00943397|58867226|FG000|Overall Study|Site terminated and other|12|||
30841666|NCT00943397|58867227|FG001|Overall Study|Site terminated and other|56|||
30841667|NCT00702845|58867235|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
30841668|NCT00702845|58867236|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
30841669|NCT00702845|58867235|FG000|Overall Study|Too high ovarian response|5|||
30841670|NCT00702845|58867236|FG001|Overall Study|Too high ovarian response|1|||
30937329|NCT01867580|58974523|FG000|Overall Study|Lost to Follow-up|3|||
30937330|NCT01867580|58974524|FG001|Overall Study|Lost to Follow-up|5|||
30937331|NCT01867580|58974523|FG000|Overall Study|Sponsor terminated study|1|||
30937332|NCT01867580|58974524|FG001|Overall Study|Sponsor terminated study|0|||
30624430|NCT00953043|58636504|FG001|Overall Study|Physician Decision|2|||
30624431|NCT01135134|58636512|FG000|Overall Study|Adverse Event|1|||
30624432|NCT01135134|58636513|FG001|Overall Study|Adverse Event|1|||
30624433|NCT01135134|58636512|FG000|Overall Study|Did not meet protocol eligibility|1|||
30624434|NCT01135134|58636513|FG001|Overall Study|Did not meet protocol eligibility|0|||
30624435|NCT00948441|58636521|FG000|Overall Study|no longer meet inclusion criteria|1|||
30624436|NCT00948441|58636522|FG001|Overall Study|no longer meet inclusion criteria|4|||
30624437|NCT01117350|58636532|FG000|Comparative Period|Not Treated|5|||
30624438|NCT01117350|58636533|FG001|Comparative Period|Not Treated|8|||
30624439|NCT01117350|58636532|FG000|Comparative Period|Adverse Event|6|||
30624440|NCT01117350|58636533|FG001|Comparative Period|Adverse Event|33|||
30624441|NCT01117350|58636532|FG000|Comparative Period|Lost to Follow-up|11|||
30624442|NCT01117350|58636533|FG001|Comparative Period|Lost to Follow-up|7|||
30624443|NCT01117350|58636532|FG000|Comparative Period|Withdrawal by Subject|9|||
30624444|NCT01117350|58636533|FG001|Comparative Period|Withdrawal by Subject|13|||
30759081|NCT00083889|58767600|FG001|Overall Study|Adverse Event|86|||
30759082|NCT00083889|58767599|FG000|Overall Study|Protocol Violation|2|||
30759083|NCT00083889|58767600|FG001|Overall Study|Protocol Violation|2|||
30759084|NCT00083889|58767599|FG000|Overall Study|Withdrawal by Subject|22|||
30759085|NCT00083889|58767600|FG001|Overall Study|Withdrawal by Subject|24|||
30759086|NCT00083889|58767599|FG000|Overall Study|Lack of Efficacy|240|||
30759087|NCT00083889|58767600|FG001|Overall Study|Lack of Efficacy|219|||
30759088|NCT00083889|58767599|FG000|Overall Study|Decision of sponsor|32|||
30759089|NCT00083889|58767600|FG001|Overall Study|Decision of sponsor|4|||
30759090|NCT00083889|58767599|FG000|Overall Study|Randomized: did not take study drug|0|||
30759091|NCT00083889|58767600|FG001|Overall Study|Randomized: did not take study drug|15|||
30759092|NCT00083889|58767599|FG000|Overall Study|Completed on marketed sunitinub|3|||
30759093|NCT00083889|58767600|FG001|Overall Study|Completed on marketed sunitinub|0|||
30759094|NCT00083889|58767599|FG000|Overall Study|Crossover to SU011248|0|||
30841671|NCT00702845|58867235|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
30841672|NCT00702845|58867236|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
30937333|NCT01867580|58974523|FG000|Overall Study|Missed follow-up assessment|2|||
30937334|NCT01867580|58974524|FG001|Overall Study|Missed follow-up assessment|1|||
30937335|NCT01867580|58974523|FG000|Overall Study|Interruption to therapy|3|||
30841673|NCT00702845|58867235|FG000|Overall Study|Insufficient ovarian response|1|||
30841674|NCT00702845|58867236|FG001|Overall Study|Insufficient ovarian response|0|||
30841675|NCT00702845|58867235|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
30841676|NCT00702845|58867236|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
30841677|NCT00702845|58867235|FG000|Overall Study|No or abnormal fertilization|4|||
30937336|NCT01867580|58974524|FG001|Overall Study|Interruption to therapy|0|||
30937337|NCT01867580|58974523|FG000|Overall Study|Osteomyelitis|0|||
30937338|NCT01867580|58974524|FG001|Overall Study|Osteomyelitis|1|||
30937339|NCT01867580|58974523|FG000|Overall Study|Continuation of therapy|0|||
30937340|NCT01867580|58974524|FG001|Overall Study|Continuation of therapy|1|||
30937341|NCT01867580|58974523|FG000|Overall Study|Wound recurrence|0|||
30937342|NCT01867580|58974524|FG001|Overall Study|Wound recurrence|1|||
30937343|NCT01839656|58974538|FG000|Overall Study|Withdrawal by Subject|1|||
30937344|NCT01839656|58974539|FG001|Overall Study|Withdrawal by Subject|1|||
30937345|NCT01839656|58974538|FG000|Overall Study|Adverse event, serious fatal|1|||
30937346|NCT01839656|58974539|FG001|Overall Study|Adverse event, serious fatal|4|||
30937347|NCT01839656|58974538|FG000|Overall Study|Early study closure|0|||
30937348|NCT01839656|58974539|FG001|Overall Study|Early study closure|11|||
30937349|NCT01839656|58974538|FG000|Overall Study|Adverse Event|1|||
30937350|NCT01839656|58974539|FG001|Overall Study|Adverse Event|0|||
30937351|NCT01839188|58974545|FG000|Overall Study|Withdrawal by Subject|1|||
30937352|NCT01838876|58974554|FG000|Overall Study|Adverse Event|49|||
30937353|NCT01838876|58974554|FG000|Overall Study|Insufficient Therapeutic Response|10|||
30937354|NCT01838876|58974554|FG000|Overall Study|Protocol Violation|34|||
30937355|NCT01838876|58974554|FG000|Overall Study|Withdrawal of Consent|33|||
30937356|NCT01838876|58974554|FG000|Overall Study|Lost to Follow-up|21|||
30937357|NCT01838876|58974554|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
30937358|NCT01838876|58974554|FG000|Overall Study|Reason not Specified|7|||
30937359|NCT01838876|58974554|FG000|Overall Study|Did not meet eligibility criteria|78|||
30841678|NCT00702845|58867236|FG001|Overall Study|No or abnormal fertilization|2|||
30841679|NCT00702845|58867235|FG000|Overall Study|Patient's decision|2|||
30841680|NCT00702845|58867236|FG001|Overall Study|Patient's decision|1|||
30937360|NCT01838642|58974569|FG000|Overall Study|Died on study|1|||
30937361|NCT01611194|58974576|FG000|Overall Study|Lost to Follow-up|0|||
30937362|NCT01611194|58974577|FG001|Overall Study|Lost to Follow-up|1|||
30937363|NCT01611194|58974576|FG000|Overall Study|Withdrawal by Subject|0|||
30937364|NCT01611194|58974577|FG001|Overall Study|Withdrawal by Subject|1|||
30937365|NCT01611194|58974576|FG000|Overall Study|drug use|0|||
30937366|NCT01611194|58974577|FG001|Overall Study|drug use|1|||
30937367|NCT01813058|58974585|FG000|Overall Study|Withdrawal by Subject|5|||
30937368|NCT01813058|58974586|FG001|Overall Study|Withdrawal by Subject|4|||
30937369|NCT01867424|58974594|FG000|Overall Study|Patient noncompliance|2|||
30937370|NCT01867424|58974595|FG001|Overall Study|Patient noncompliance|1|||
30937371|NCT01811732|58974603|FG000|Overall Study|Lost to Follow-up|24|||
30937372|NCT01811732|58974604|FG001|Overall Study|Lost to Follow-up|30|||
30937373|NCT01811732|58974603|FG000|Overall Study|Withdrawal by Subject|16|||
30937374|NCT01811732|58974604|FG001|Overall Study|Withdrawal by Subject|10|||
30937375|NCT01811732|58974603|FG000|Overall Study|Adverse Event|3|||
30841681|NCT00702845|58867235|FG000|Overall Study|Not randomized|0|||
30937376|NCT01811732|58974604|FG001|Overall Study|Adverse Event|9|||
30937377|NCT01811732|58974603|FG000|Overall Study|Lack of Efficacy|3|||
30937378|NCT01811732|58974604|FG001|Overall Study|Lack of Efficacy|1|||
30937379|NCT01811732|58974603|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
30937380|NCT01811732|58974604|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
30937381|NCT01811732|58974603|FG000|Overall Study|Physician Decision|2|||
30937382|NCT01811732|58974604|FG001|Overall Study|Physician Decision|0|||
30937383|NCT01811732|58974603|FG000|Overall Study|Death|1|||
30937384|NCT01811732|58974604|FG001|Overall Study|Death|1|||
30937385|NCT01811732|58974603|FG000|Overall Study|Insufficient venous access|0|||
30937386|NCT01811732|58974604|FG001|Overall Study|Insufficient venous access|1|||
30937387|NCT01811732|58974603|FG000|Overall Study|Protocol Violation|0|||
30937388|NCT01811732|58974604|FG001|Overall Study|Protocol Violation|1|||
30841682|NCT00702845|58867236|FG001|Overall Study|Not randomized|1|||
30841683|NCT01302847|58867250|FG000|Overall Study|Ongoing|0|||
30841684|NCT01302847|58867251|FG001|Overall Study|Ongoing|0|||
30841685|NCT01302847|58867252|FG002|Overall Study|Ongoing|0|||
30841686|NCT01302847|58867253|FG003|Overall Study|Ongoing|0|||
30937389|NCT01811732|58974603|FG000|Overall Study|Subject incarcerated|1|||
30937390|NCT01811732|58974604|FG001|Overall Study|Subject incarcerated|2|||
30937391|NCT01811732|58974603|FG000|Overall Study|Admitted to another facility|1|||
30937392|NCT01811732|58974604|FG001|Overall Study|Admitted to another facility|0|||
30937393|NCT01811732|58974603|FG000|Overall Study|Correct study drug not available on site|1|||
30937394|NCT01811732|58974604|FG001|Overall Study|Correct study drug not available on site|0|||
30937395|NCT01836458|58974615|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
30937396|NCT01836458|58974616|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30937397|NCT01836458|58974617|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
30948542|NCT01974323|58994553|FG000|Overall Study|Pregnancy|2|||
30937398|NCT01836458|58974618|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
30841687|NCT01302847|58867254|FG004|Overall Study|Ongoing|0|||
30841688|NCT01302847|58867255|FG005|Overall Study|Ongoing|27|||
30841689|NCT01302847|58867256|FG006|Overall Study|Ongoing|22|||
30841690|NCT01302847|58867257|FG007|Overall Study|Ongoing|17|||
30937399|NCT01811186|58974630|FG000|Overall Study|Adverse Event|54|||
30937400|NCT01811186|58974631|FG001|Overall Study|Adverse Event|38|||
30937401|NCT01811186|58974630|FG000|Overall Study|Protocol Violation|5|||
30937402|NCT01811186|58974631|FG001|Overall Study|Protocol Violation|6|||
30937403|NCT01811186|58974630|FG000|Overall Study|Withdrawal by Subject|5|||
30937404|NCT01811186|58974631|FG001|Overall Study|Withdrawal by Subject|10|||
30937405|NCT01811186|58974630|FG000|Overall Study|Lack of Efficacy|3|||
30937406|NCT01811186|58974631|FG001|Overall Study|Lack of Efficacy|6|||
30937407|NCT01811186|58974630|FG000|Overall Study|Lost to Follow-up|4|||
30937408|NCT01811186|58974631|FG001|Overall Study|Lost to Follow-up|2|||
30841691|NCT01302847|58867250|FG000|Overall Study|Death|0|||
30841692|NCT01302847|58867251|FG001|Overall Study|Death|1|||
30841693|NCT01302847|58867252|FG002|Overall Study|Death|0|||
30841694|NCT01302847|58867253|FG003|Overall Study|Death|0|||
30841695|NCT01302847|58867254|FG004|Overall Study|Death|0|||
30841696|NCT01302847|58867255|FG005|Overall Study|Death|1|||
30841697|NCT01302847|58867256|FG006|Overall Study|Death|1|||
30841698|NCT01302847|58867257|FG007|Overall Study|Death|0|||
30841699|NCT01302847|58867250|FG000|Overall Study|Pregnancy|2|||
30841700|NCT01302847|58867251|FG001|Overall Study|Pregnancy|0|||
30841701|NCT01302847|58867252|FG002|Overall Study|Pregnancy|0|||
30841702|NCT01302847|58867253|FG003|Overall Study|Pregnancy|0|||
30841703|NCT01302847|58867254|FG004|Overall Study|Pregnancy|0|||
30841704|NCT01302847|58867255|FG005|Overall Study|Pregnancy|0|||
30841705|NCT01302847|58867256|FG006|Overall Study|Pregnancy|0|||
30841706|NCT01302847|58867257|FG007|Overall Study|Pregnancy|0|||
30841707|NCT01302847|58867250|FG000|Overall Study|Virologic failure|0|||
30841708|NCT01302847|58867251|FG001|Overall Study|Virologic failure|2|||
30841709|NCT01302847|58867252|FG002|Overall Study|Virologic failure|2|||
30841710|NCT01302847|58867253|FG003|Overall Study|Virologic failure|0|||
30841711|NCT01302847|58867254|FG004|Overall Study|Virologic failure|1|||
30841712|NCT01302847|58867255|FG005|Overall Study|Virologic failure|1|||
30841713|NCT01302847|58867256|FG006|Overall Study|Virologic failure|0|||
30841714|NCT01302847|58867257|FG007|Overall Study|Virologic failure|2|||
30841715|NCT01302847|58867250|FG000|Overall Study|Severe debilitation, unable to continue|0|||
30841716|NCT01302847|58867251|FG001|Overall Study|Severe debilitation, unable to continue|0|||
30841717|NCT01302847|58867252|FG002|Overall Study|Severe debilitation, unable to continue|0|||
30841718|NCT01302847|58867253|FG003|Overall Study|Severe debilitation, unable to continue|0|||
30841719|NCT01302847|58867254|FG004|Overall Study|Severe debilitation, unable to continue|0|||
30841720|NCT01302847|58867255|FG005|Overall Study|Severe debilitation, unable to continue|1|||
30841721|NCT01302847|58867256|FG006|Overall Study|Severe debilitation, unable to continue|1|||
30841722|NCT01302847|58867257|FG007|Overall Study|Severe debilitation, unable to continue|0|||
30841723|NCT01302847|58867250|FG000|Overall Study|Not able to get to clinic|1|||
30841724|NCT01302847|58867251|FG001|Overall Study|Not able to get to clinic|1|||
30841725|NCT01302847|58867252|FG002|Overall Study|Not able to get to clinic|0|||
30841726|NCT01302847|58867253|FG003|Overall Study|Not able to get to clinic|0|||
30841727|NCT01302847|58867254|FG004|Overall Study|Not able to get to clinic|0|||
30841728|NCT01302847|58867255|FG005|Overall Study|Not able to get to clinic|0|||
30841729|NCT01302847|58867256|FG006|Overall Study|Not able to get to clinic|0|||
30841730|NCT01302847|58867257|FG007|Overall Study|Not able to get to clinic|0|||
30841731|NCT01302847|58867250|FG000|Overall Study|Site closing|2|||
30841732|NCT01302847|58867251|FG001|Overall Study|Site closing|2|||
30841733|NCT01302847|58867252|FG002|Overall Study|Site closing|0|||
30841734|NCT01302847|58867253|FG003|Overall Study|Site closing|0|||
30841735|NCT01302847|58867254|FG004|Overall Study|Site closing|0|||
30841736|NCT01302847|58867255|FG005|Overall Study|Site closing|0|||
30841737|NCT01302847|58867256|FG006|Overall Study|Site closing|0|||
30841738|NCT01302847|58867257|FG007|Overall Study|Site closing|0|||
30841739|NCT01302847|58867250|FG000|Overall Study|Withdrawal by Subject|1|||
30841740|NCT01302847|58867251|FG001|Overall Study|Withdrawal by Subject|0|||
30841741|NCT01302847|58867252|FG002|Overall Study|Withdrawal by Subject|0|||
30841742|NCT01302847|58867253|FG003|Overall Study|Withdrawal by Subject|0|||
30841743|NCT01302847|58867254|FG004|Overall Study|Withdrawal by Subject|1|||
30841744|NCT01302847|58867255|FG005|Overall Study|Withdrawal by Subject|0|||
30841745|NCT01302847|58867256|FG006|Overall Study|Withdrawal by Subject|0|||
30841746|NCT01302847|58867257|FG007|Overall Study|Withdrawal by Subject|1|||
30841747|NCT01302847|58867250|FG000|Overall Study|Not willing to adhere to requirements|5|||
30937409|NCT01866098|58974644|FG000|Overall Study|Lost to Follow-up|11|||
30937410|NCT01866098|58974645|FG001|Overall Study|Lost to Follow-up|18|||
30937411|NCT01866098|58974646|FG002|Overall Study|Lost to Follow-up|13|||
30937412|NCT01866098|58974644|FG000|Overall Study|Physician Decision|0|||
30841748|NCT01302847|58867251|FG001|Overall Study|Not willing to adhere to requirements|0|||
30841749|NCT01302847|58867252|FG002|Overall Study|Not willing to adhere to requirements|0|||
30841750|NCT01302847|58867253|FG003|Overall Study|Not willing to adhere to requirements|1|||
30841751|NCT01302847|58867254|FG004|Overall Study|Not willing to adhere to requirements|0|||
30841752|NCT01302847|58867255|FG005|Overall Study|Not willing to adhere to requirements|0|||
30841753|NCT01302847|58867256|FG006|Overall Study|Not willing to adhere to requirements|0|||
30841754|NCT01302847|58867257|FG007|Overall Study|Not willing to adhere to requirements|2|||
30841755|NCT01302847|58867250|FG000|Overall Study|Site unable to contact participant|2|||
30841756|NCT01302847|58867251|FG001|Overall Study|Site unable to contact participant|1|||
30841757|NCT01302847|58867252|FG002|Overall Study|Site unable to contact participant|0|||
30841758|NCT01302847|58867253|FG003|Overall Study|Site unable to contact participant|0|||
30841759|NCT01302847|58867254|FG004|Overall Study|Site unable to contact participant|0|||
30841760|NCT01302847|58867255|FG005|Overall Study|Site unable to contact participant|0|||
30841761|NCT01302847|58867256|FG006|Overall Study|Site unable to contact participant|2|||
30841762|NCT01302847|58867257|FG007|Overall Study|Site unable to contact participant|0|||
30841763|NCT03039569|58867286|FG000|Overall Study|Lost to Follow-up|5|||
30841764|NCT03039569|58867287|FG001|Overall Study|Lost to Follow-up|4|||
30841765|NCT01272037|58867296|FG000|Overall Study|Death|30|||
30841766|NCT01272037|58867297|FG001|Overall Study|Death|30|||
30841767|NCT01272037|58867296|FG000|Overall Study|Adverse Event|12|||
30841768|NCT01272037|58867297|FG001|Overall Study|Adverse Event|7|||
30841769|NCT01272037|58867296|FG000|Overall Study|Withdrawal by Subject|158|||
30841770|NCT01272037|58867297|FG001|Overall Study|Withdrawal by Subject|83|||
30841771|NCT01272037|58867296|FG000|Overall Study|Disease progression|85|||
30841772|NCT01272037|58867297|FG001|Overall Study|Disease progression|125|||
30841773|NCT01272037|58867296|FG000|Overall Study|Other reason|49|||
30841774|NCT01272037|58867297|FG001|Overall Study|Other reason|45|||
30841775|NCT01272037|58867296|FG000|Overall Study|Delinquent data|6|||
30841776|NCT01272037|58867297|FG001|Overall Study|Delinquent data|4|||
30841777|NCT01272037|58867296|FG000|Overall Study|Reason under review|107|||
30841778|NCT01272037|58867297|FG001|Overall Study|Reason under review|136|||
30841779|NCT01272037|58867296|FG000|Overall Study|On treatment|173|||
30841780|NCT01272037|58867297|FG001|Overall Study|On treatment|185|||
30841781|NCT02738775|58867309|FG000|Overall Study|Withdrawal by Subject|0|||
30841782|NCT02738775|58867310|FG001|Overall Study|Withdrawal by Subject|1|||
30841783|NCT02738775|58867311|FG002|Overall Study|Withdrawal by Subject|0|||
30937413|NCT01866098|58974645|FG001|Overall Study|Physician Decision|1|||
30937414|NCT01866098|58974646|FG002|Overall Study|Physician Decision|2|||
30937415|NCT01866098|58974644|FG000|Overall Study|Adverse Event|1|||
30937416|NCT01866098|58974645|FG001|Overall Study|Adverse Event|5|||
30937417|NCT01866098|58974646|FG002|Overall Study|Adverse Event|4|||
30937418|NCT01866098|58974644|FG000|Overall Study|Protocol Violation|1|||
30937419|NCT01866098|58974645|FG001|Overall Study|Protocol Violation|0|||
30937420|NCT01866098|58974646|FG002|Overall Study|Protocol Violation|0|||
30937421|NCT01866098|58974644|FG000|Overall Study|Withdrawal by Subject|1|||
30937422|NCT01866098|58974645|FG001|Overall Study|Withdrawal by Subject|2|||
30937423|NCT01866098|58974646|FG002|Overall Study|Withdrawal by Subject|0|||
30937424|NCT01866098|58974644|FG000|Overall Study|Unrelated Hospitalization|2|||
30937425|NCT01866098|58974645|FG001|Overall Study|Unrelated Hospitalization|0|||
30937426|NCT01866098|58974646|FG002|Overall Study|Unrelated Hospitalization|1|||
30937427|NCT01866098|58974644|FG000|Overall Study|Non-compliance|1|||
30937428|NCT01866098|58974645|FG001|Overall Study|Non-compliance|0|||
30937429|NCT01866098|58974646|FG002|Overall Study|Non-compliance|1|||
30937430|NCT01866098|58974644|FG000|Overall Study|Pregnancy|2|||
30937431|NCT01866098|58974645|FG001|Overall Study|Pregnancy|0|||
30937432|NCT01866098|58974646|FG002|Overall Study|Pregnancy|0|||
30937433|NCT01866098|58974644|FG000|Overall Study|Death|0|||
30937434|NCT01866098|58974645|FG001|Overall Study|Death|1|||
30937435|NCT01866098|58974646|FG002|Overall Study|Death|0|||
30937436|NCT01865552|58974660|FG000|Period 1|Adverse Event|1|||
30937437|NCT01865552|58974661|FG001|Period 1|Adverse Event|0|||
30937438|NCT01865552|58974662|FG002|Period 1|Adverse Event|0|||
30937439|NCT01865552|58974663|FG003|Period 1|Adverse Event|1|||
30937440|NCT01865552|58974664|FG004|Period 1|Adverse Event|1|||
30937441|NCT01865552|58974665|FG005|Period 1|Adverse Event|1|||
30841784|NCT02738775|58867312|FG003|Overall Study|Withdrawal by Subject|0|||
30841785|NCT02738775|58867313|FG004|Overall Study|Withdrawal by Subject|0|||
30841786|NCT02738775|58867314|FG005|Overall Study|Withdrawal by Subject|0|||
30841787|NCT02738775|58867309|FG000|Overall Study|Adverse Event|0|||
30841788|NCT02738775|58867310|FG001|Overall Study|Adverse Event|0|||
30841789|NCT02738775|58867311|FG002|Overall Study|Adverse Event|0|||
30841790|NCT02738775|58867312|FG003|Overall Study|Adverse Event|1|||
30937442|NCT01865552|58974660|FG000|Period 1|Pathological lab|0|||
30937443|NCT01865552|58974661|FG001|Period 1|Pathological lab|0|||
30624445|NCT01117350|58636532|FG000|Comparative Period|Protocol Violation|8|||
30937444|NCT01865552|58974662|FG002|Period 1|Pathological lab|0|||
30937445|NCT01865552|58974663|FG003|Period 1|Pathological lab|0|||
30937446|NCT01865552|58974664|FG004|Period 1|Pathological lab|1|||
30937447|NCT01865552|58974665|FG005|Period 1|Pathological lab|0|||
30937448|NCT01865552|58974660|FG000|Period 1|Other|0|||
30937449|NCT01865552|58974661|FG001|Period 1|Other|0|||
30937450|NCT01865552|58974662|FG002|Period 1|Other|0|||
30937451|NCT01865552|58974663|FG003|Period 1|Other|0|||
30937452|NCT01865552|58974664|FG004|Period 1|Other|1|||
30937453|NCT01865552|58974665|FG005|Period 1|Other|0|||
30937454|NCT01809314|58974679|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
30937455|NCT01809314|58974679|FG000|Overall Study|Adverse Event|6|||
30937456|NCT01809314|58974679|FG000|Overall Study|Insufficient Therapeutic Response|14|||
30937457|NCT01809314|58974679|FG000|Overall Study|Lost to Follow-up|724|||
30937458|NCT01803464|58974687|FG000|Overall Study|Incomplete data|0|||
30937459|NCT01803464|58974688|FG001|Overall Study|Incomplete data|0|||
30937460|NCT01803464|58974689|FG002|Overall Study|Incomplete data|4|||
30937461|NCT01803464|58974690|FG003|Overall Study|Incomplete data|0|||
30937462|NCT01803464|58974687|FG000|Overall Study|Withdrawal by Subject|1|||
30937463|NCT01803464|58974688|FG001|Overall Study|Withdrawal by Subject|0|||
30937464|NCT01803464|58974689|FG002|Overall Study|Withdrawal by Subject|0|||
30937465|NCT01803464|58974690|FG003|Overall Study|Withdrawal by Subject|0|||
30937466|NCT01808690|58974706|FG000|Overall Study|Withdrawal by Subject|1|||
30937467|NCT01808690|58974707|FG001|Overall Study|Withdrawal by Subject|2|||
30937468|NCT01363297|58974718|FG000|Overall Study|Other|0|||
30937469|NCT01363297|58974719|FG001|Overall Study|Other|0|||
30937470|NCT01363297|58974720|FG002|Overall Study|Other|0|||
30937471|NCT01363297|58974721|FG003|Overall Study|Other|0|||
30937472|NCT01363297|58974722|FG004|Overall Study|Other|1|||
30937473|NCT01363297|58974718|FG000|Overall Study|Death|3|||
30937474|NCT01363297|58974719|FG001|Overall Study|Death|6|||
30937475|NCT01363297|58974720|FG002|Overall Study|Death|6|||
30937476|NCT01363297|58974721|FG003|Overall Study|Death|10|||
30937477|NCT01363297|58974722|FG004|Overall Study|Death|30|||
30937478|NCT01908907|58974741|FG000|Overall Study|Physician Decision|1|||
30937479|NCT01908907|58974742|FG001|Overall Study|Physician Decision|0|||
30937480|NCT01908907|58974741|FG000|Overall Study|Protocol Violation|1|||
30937481|NCT01908907|58974742|FG001|Overall Study|Protocol Violation|0|||
30937482|NCT01808612|58974755|FG000|Treatment Period|Adverse Event|8|||
30937483|NCT01808612|58974756|FG001|Treatment Period|Adverse Event|4|||
30937484|NCT01808612|58974757|FG002|Treatment Period|Adverse Event|3|||
30937485|NCT01808612|58974755|FG000|Treatment Period|Lost to Follow-up|2|||
30937486|NCT01808612|58974756|FG001|Treatment Period|Lost to Follow-up|2|||
30937487|NCT01808612|58974757|FG002|Treatment Period|Lost to Follow-up|1|||
30937488|NCT01808612|58974755|FG000|Treatment Period|Protocol Violation|1|||
30937489|NCT01808612|58974756|FG001|Treatment Period|Protocol Violation|0|||
30937490|NCT01808612|58974757|FG002|Treatment Period|Protocol Violation|0|||
30937491|NCT01808612|58974755|FG000|Treatment Period|Withdrawal by Subject|1|||
30937492|NCT01808612|58974756|FG001|Treatment Period|Withdrawal by Subject|0|||
30937493|NCT01808612|58974757|FG002|Treatment Period|Withdrawal by Subject|4|||
30937494|NCT01808612|58974755|FG000|Treatment Period|Physician Decision|1|||
30937495|NCT01808612|58974756|FG001|Treatment Period|Physician Decision|0|||
30937496|NCT01808612|58974757|FG002|Treatment Period|Physician Decision|4|||
30937497|NCT01808612|58974755|FG000|Treatment Period|Sponsor Decision|1|||
30759095|NCT00083889|58767600|FG001|Overall Study|Crossover to SU011248|25|||
30759096|NCT03572062|58767619|FG000|Overall Study|Adverse Event|0|||
30759097|NCT03572062|58767620|FG001|Overall Study|Adverse Event|0|||
30759098|NCT03572062|58767621|FG002|Overall Study|Adverse Event|0|||
30759099|NCT03572062|58767622|FG003|Overall Study|Adverse Event|0|||
30759100|NCT03572062|58767623|FG004|Overall Study|Adverse Event|0|||
30759101|NCT03572062|58767624|FG005|Overall Study|Adverse Event|0|||
30759102|NCT03572062|58767625|FG006|Overall Study|Adverse Event|0|||
30759103|NCT03572062|58767626|FG007|Overall Study|Adverse Event|0|||
30759104|NCT03572062|58767627|FG008|Overall Study|Adverse Event|1|||
30759105|NCT03572062|58767628|FG009|Overall Study|Adverse Event|3|||
30759106|NCT03572062|58767619|FG000|Overall Study|Death|0|||
30759107|NCT03572062|58767620|FG001|Overall Study|Death|0|||
30759108|NCT03572062|58767621|FG002|Overall Study|Death|0|||
30937498|NCT01808612|58974756|FG001|Treatment Period|Sponsor Decision|0|||
30937499|NCT01808612|58974757|FG002|Treatment Period|Sponsor Decision|0|||
30937500|NCT01808612|58974755|FG000|Treatment Period|Lack of Efficacy|1|||
30937501|NCT01808612|58974756|FG001|Treatment Period|Lack of Efficacy|1|||
30937502|NCT01808612|58974757|FG002|Treatment Period|Lack of Efficacy|2|||
30937503|NCT01808612|58974755|FG000|Discontinuation Period|Adverse Event|1|||
30937504|NCT01808612|58974756|FG001|Discontinuation Period|Adverse Event|0|||
30937505|NCT01808612|58974757|FG002|Discontinuation Period|Adverse Event|0|||
30937506|NCT01808612|58974755|FG000|Discontinuation Period|Physician Decision|1|||
30759109|NCT03572062|58767622|FG003|Overall Study|Death|0|||
30937507|NCT01808612|58974756|FG001|Discontinuation Period|Physician Decision|0|||
30937508|NCT01808612|58974757|FG002|Discontinuation Period|Physician Decision|0|||
30937509|NCT01808612|58974755|FG000|Discontinuation Period|Lost to Follow-up|0|||
30937510|NCT01808612|58974756|FG001|Discontinuation Period|Lost to Follow-up|1|||
30937511|NCT01808612|58974757|FG002|Discontinuation Period|Lost to Follow-up|0|||
30937512|NCT01908829|58974771|FG000|Overall Study|Adverse Event|13|||
30937513|NCT01908829|58974772|FG001|Overall Study|Adverse Event|11|||
30937514|NCT01908829|58974773|FG002|Overall Study|Adverse Event|13|||
30937515|NCT01908829|58974771|FG000|Overall Study|Lost to Follow-up|4|||
30937516|NCT01908829|58974772|FG001|Overall Study|Lost to Follow-up|2|||
30937517|NCT01908829|58974773|FG002|Overall Study|Lost to Follow-up|1|||
30937518|NCT01908829|58974771|FG000|Overall Study|Randomized no double-blind drug received|1|||
30937519|NCT01908829|58974772|FG001|Overall Study|Randomized no double-blind drug received|0|||
30937520|NCT01908829|58974773|FG002|Overall Study|Randomized no double-blind drug received|1|||
30937521|NCT01908829|58974771|FG000|Overall Study|Discontinued (no EoT page)|2|||
30937522|NCT01908829|58974772|FG001|Overall Study|Discontinued (no EoT page)|0|||
30937523|NCT01908829|58974773|FG002|Overall Study|Discontinued (no EoT page)|0|||
30937524|NCT01908829|58974771|FG000|Overall Study|Miscellaneous|0|||
30937525|NCT01908829|58974772|FG001|Overall Study|Miscellaneous|2|||
30937526|NCT01908829|58974773|FG002|Overall Study|Miscellaneous|0|||
30937527|NCT01908829|58974771|FG000|Overall Study|Protocol Violation|2|||
30937528|NCT01908829|58974772|FG001|Overall Study|Protocol Violation|2|||
30937529|NCT01908829|58974773|FG002|Overall Study|Protocol Violation|0|||
30937530|NCT01908829|58974771|FG000|Overall Study|Lack of Efficacy|1|||
30937531|NCT01908829|58974772|FG001|Overall Study|Lack of Efficacy|3|||
30937532|NCT01908829|58974773|FG002|Overall Study|Lack of Efficacy|2|||
30937533|NCT01908829|58974771|FG000|Overall Study|Withdrawal by Subject|26|||
30937534|NCT01908829|58974772|FG001|Overall Study|Withdrawal by Subject|29|||
30937535|NCT01908829|58974773|FG002|Overall Study|Withdrawal by Subject|22|||
30937536|NCT01773122|58974785|FG000|Overall Study|Due to amended age eligibility criteria|3|||
30937537|NCT01773122|58974786|FG001|Overall Study|Due to amended age eligibility criteria|1|||
30937538|NCT01773122|58974787|FG002|Overall Study|Due to amended age eligibility criteria|0|||
30937539|NCT01773122|58974788|FG003|Overall Study|Due to amended age eligibility criteria|1|||
30937540|NCT01808534|58974798|FG000|Overall Study|Disease progression|3|||
30937541|NCT01808534|58974798|FG000|Overall Study|Physician Decision|1|||
30937542|NCT01808222|58974802|FG000|Overall Study|mpMR scan was not performed|1|||
30937543|NCT01772576|58974806|FG000|Overall Study|Death|15|||
30937544|NCT01772576|58974806|FG000|Overall Study|Protocol Violation|1|||
30937545|NCT01772576|58974806|FG000|Overall Study|Lost to Follow-up|3|||
30937546|NCT01772576|58974806|FG000|Overall Study|Study device not used|3|||
30937547|NCT01772576|58974806|FG000|Overall Study|Adverse Event|6|||
30937548|NCT01772576|58974806|FG000|Overall Study|Withdrawal by Subject|6|||
30937549|NCT01802216|58974833|FG000|4 Month Visit|Participant did not show to visit|3|||
30937550|NCT01802216|58974834|FG001|4 Month Visit|Participant did not show to visit|4|||
30937551|NCT01802216|58974833|FG000|8 Month Visit|Participant did not show to visit|3|||
30937552|NCT01802216|58974834|FG001|8 Month Visit|Participant did not show to visit|5|||
30759110|NCT03572062|58767623|FG004|Overall Study|Death|0|||
30841791|NCT02738775|58867313|FG004|Overall Study|Adverse Event|0|||
30841792|NCT02738775|58867314|FG005|Overall Study|Adverse Event|0|||
30841793|NCT02738775|58867309|FG000|Overall Study|Pregnancy|0|||
30841794|NCT02738775|58867310|FG001|Overall Study|Pregnancy|1|||
30841795|NCT02738775|58867311|FG002|Overall Study|Pregnancy|0|||
30841796|NCT02738775|58867312|FG003|Overall Study|Pregnancy|0|||
30841797|NCT02738775|58867313|FG004|Overall Study|Pregnancy|0|||
30841798|NCT02738775|58867314|FG005|Overall Study|Pregnancy|0|||
30841799|NCT02738775|58867309|FG000|Overall Study|Missing|0|||
30841800|NCT02738775|58867310|FG001|Overall Study|Missing|0|||
30841801|NCT02738775|58867311|FG002|Overall Study|Missing|0|||
30841802|NCT02738775|58867312|FG003|Overall Study|Missing|0|||
30841803|NCT02738775|58867313|FG004|Overall Study|Missing|0|||
30841804|NCT02738775|58867314|FG005|Overall Study|Missing|1|||
30843680|NCT01915498|58869663|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
30843681|NCT01915498|58869664|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
30937553|NCT01802216|58974833|FG000|12 Month Visit|Participant did not show to visit|3|||
30937554|NCT01802216|58974834|FG001|12 Month Visit|Participant did not show to visit|4|||
30937555|NCT01808144|58974842|FG000|Overall Study|Death|1|||
30937556|NCT01808144|58974843|FG001|Overall Study|Death|0|||
30937557|NCT01808144|58974842|FG000|Overall Study|Withdrawal by Subject|16|||
30937558|NCT01808144|58974843|FG001|Overall Study|Withdrawal by Subject|23|||
30937559|NCT01808144|58974842|FG000|Overall Study|Lost to Follow-up|6|||
30843682|NCT01915498|58869665|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
30937560|NCT01808144|58974843|FG001|Overall Study|Lost to Follow-up|3|||
30937561|NCT01808144|58974842|FG000|Overall Study|Protocol Violation|6|||
30937562|NCT01808144|58974843|FG001|Overall Study|Protocol Violation|6|||
30843683|NCT01915498|58869647|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
30843684|NCT01915498|58869648|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
30843685|NCT01915498|58869649|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
30843686|NCT01915498|58869650|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
30937563|NCT01808144|58974842|FG000|Overall Study|Gout flare|0|||
30937564|NCT01808144|58974843|FG001|Overall Study|Gout flare|1|||
30843687|NCT01915498|58869651|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
30937565|NCT01808144|58974842|FG000|Overall Study|Adverse Event|11|||
30937566|NCT01808144|58974843|FG001|Overall Study|Adverse Event|15|||
30937567|NCT01801982|58974849|FG000|Overall Study|Lost to Follow-up|1|||
30937568|NCT01808066|58974862|FG000|Overall Study|Withdrawal by Subject|15|||
30937569|NCT01604343|58974870|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
30937570|NCT01604343|58974871|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
30937571|NCT01604343|58974872|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
30841805|NCT02314923|58867351|FG000|Overall Study|Death|0|||
30841806|NCT02314923|58867352|FG001|Overall Study|Death|0|||
30841807|NCT02314923|58867353|FG002|Overall Study|Death|0|||
30841808|NCT02314923|58867354|FG003|Overall Study|Death|1|||
30841809|NCT02314923|58867355|FG004|Overall Study|Death|0|||
30841810|NCT02314923|58867356|FG005|Overall Study|Death|0|||
30841811|NCT02314923|58867357|FG006|Overall Study|Death|0|||
30841812|NCT02314923|58867358|FG007|Overall Study|Death|0|||
30841813|NCT02314923|58867359|FG008|Overall Study|Death|0|||
30841814|NCT02314923|58867360|FG009|Overall Study|Death|0|||
30841815|NCT02314923|58867351|FG000|Overall Study|Lost to Follow-up|2|||
30841816|NCT02314923|58867352|FG001|Overall Study|Lost to Follow-up|3|||
30841817|NCT02314923|58867353|FG002|Overall Study|Lost to Follow-up|1|||
30841818|NCT02314923|58867354|FG003|Overall Study|Lost to Follow-up|0|||
30841819|NCT02314923|58867355|FG004|Overall Study|Lost to Follow-up|0|||
30841820|NCT02314923|58867356|FG005|Overall Study|Lost to Follow-up|0|||
30841821|NCT02314923|58867357|FG006|Overall Study|Lost to Follow-up|3|||
30841822|NCT02314923|58867358|FG007|Overall Study|Lost to Follow-up|4|||
30841823|NCT02314923|58867359|FG008|Overall Study|Lost to Follow-up|2|||
30937572|NCT01604343|58974873|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
30937573|NCT01604343|58974874|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
30937574|NCT01604343|58974870|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
30937575|NCT01604343|58974871|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
30937576|NCT01604343|58974872|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
30937577|NCT01604343|58974873|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
30937578|NCT01604343|58974874|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
30937579|NCT01604343|58974870|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
30937580|NCT01604343|58974871|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
30937581|NCT01604343|58974872|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
30937582|NCT01604343|58974873|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
30759111|NCT03572062|58767624|FG005|Overall Study|Death|1|||
30759112|NCT03572062|58767625|FG006|Overall Study|Death|0|||
30937583|NCT01604343|58974874|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
30937584|NCT01604343|58974870|FG000|Prior to W52 Administration(Through W52)|Death|5|||
30759113|NCT03572062|58767626|FG007|Overall Study|Death|0|||
30759114|NCT03572062|58767627|FG008|Overall Study|Death|0|||
30937585|NCT01604343|58974871|FG001|Prior to W52 Administration(Through W52)|Death|0|||
30759115|NCT03572062|58767628|FG009|Overall Study|Death|0|||
30759116|NCT03572062|58767619|FG000|Overall Study|Lost to Follow-up|0|||
30759117|NCT03572062|58767620|FG001|Overall Study|Lost to Follow-up|0|||
30759118|NCT03572062|58767621|FG002|Overall Study|Lost to Follow-up|0|||
30759119|NCT03572062|58767622|FG003|Overall Study|Lost to Follow-up|0|||
30759120|NCT03572062|58767623|FG004|Overall Study|Lost to Follow-up|0|||
30937586|NCT01604343|58974872|FG002|Prior to W52 Administration(Through W52)|Death|2|||
30937587|NCT01604343|58974873|FG003|Prior to W52 Administration(Through W52)|Death|0|||
30937588|NCT01604343|58974874|FG004|Prior to W52 Administration(Through W52)|Death|4|||
30937589|NCT01604343|58974870|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
30937590|NCT01604343|58974871|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
30937591|NCT01604343|58974872|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
30937592|NCT01604343|58974873|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
30937593|NCT01604343|58974874|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
30937594|NCT01604343|58974870|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
30759121|NCT03572062|58767624|FG005|Overall Study|Lost to Follow-up|1|||
30759122|NCT03572062|58767625|FG006|Overall Study|Lost to Follow-up|1|||
30841824|NCT02314923|58867360|FG009|Overall Study|Lost to Follow-up|0|||
30841825|NCT02314923|58867351|FG000|Overall Study|Withdrawal by Subject|0|||
30841826|NCT02314923|58867352|FG001|Overall Study|Withdrawal by Subject|0|||
30841827|NCT02314923|58867353|FG002|Overall Study|Withdrawal by Subject|1|||
30841828|NCT02314923|58867354|FG003|Overall Study|Withdrawal by Subject|0|||
30841829|NCT02314923|58867355|FG004|Overall Study|Withdrawal by Subject|1|||
30841830|NCT02314923|58867356|FG005|Overall Study|Withdrawal by Subject|0|||
30841831|NCT02314923|58867357|FG006|Overall Study|Withdrawal by Subject|1|||
30841832|NCT02314923|58867358|FG007|Overall Study|Withdrawal by Subject|0|||
30759123|NCT03572062|58767626|FG007|Overall Study|Lost to Follow-up|0|||
30759124|NCT03572062|58767627|FG008|Overall Study|Lost to Follow-up|0|||
30759125|NCT03572062|58767628|FG009|Overall Study|Lost to Follow-up|0|||
30759126|NCT03572062|58767619|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
30841833|NCT02314923|58867359|FG008|Overall Study|Withdrawal by Subject|0|||
30937595|NCT01604343|58974871|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
30759127|NCT03572062|58767620|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
30759128|NCT03572062|58767621|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
30759129|NCT03572062|58767622|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
30759130|NCT03572062|58767623|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
30841834|NCT02314923|58867360|FG009|Overall Study|Withdrawal by Subject|0|||
30937596|NCT01604343|58974872|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
30937597|NCT01604343|58974873|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
30937598|NCT01604343|58974874|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
30937599|NCT01604343|58974870|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
30937600|NCT01604343|58974871|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
30937601|NCT01604343|58974872|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
30937602|NCT01604343|58974873|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
30937603|NCT01604343|58974874|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
30937604|NCT01604343|58974870|FG000|Prior to W52 Administration(Through W52)|Other|15|||
30937605|NCT01604343|58974871|FG001|Prior to W52 Administration(Through W52)|Other|0|||
30937606|NCT01604343|58974872|FG002|Prior to W52 Administration(Through W52)|Other|10|||
30937607|NCT01604343|58974873|FG003|Prior to W52 Administration(Through W52)|Other|0|||
30937608|NCT01604343|58974874|FG004|Prior to W52 Administration(Through W52)|Other|6|||
30937609|NCT01604343|58974870|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
30937610|NCT01604343|58974871|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
30937611|NCT01604343|58974872|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
30937612|NCT01604343|58974873|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
30937613|NCT01604343|58974874|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
30937614|NCT01604343|58974870|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
30937615|NCT01604343|58974871|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
30937616|NCT01604343|58974872|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
30937617|NCT01604343|58974873|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
30937618|NCT01604343|58974874|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
30937619|NCT01604343|58974870|FG000|Week 52 to Week 104|Adverse Event|0|||
30937620|NCT01604343|58974871|FG001|Week 52 to Week 104|Adverse Event|12|||
30937621|NCT01604343|58974872|FG002|Week 52 to Week 104|Adverse Event|26|||
30937622|NCT01604343|58974873|FG003|Week 52 to Week 104|Adverse Event|21|||
30937623|NCT01604343|58974874|FG004|Week 52 to Week 104|Adverse Event|27|||
30937624|NCT01604343|58974870|FG000|Week 52 to Week 104|Death|0|||
30937625|NCT01604343|58974871|FG001|Week 52 to Week 104|Death|4|||
30937626|NCT01604343|58974872|FG002|Week 52 to Week 104|Death|2|||
30937627|NCT01604343|58974873|FG003|Week 52 to Week 104|Death|5|||
30937628|NCT01604343|58974874|FG004|Week 52 to Week 104|Death|0|||
30937629|NCT01604343|58974870|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
30937630|NCT01604343|58974871|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
30937631|NCT01604343|58974872|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
30937632|NCT01604343|58974873|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
30937633|NCT01604343|58974874|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
30937634|NCT01604343|58974870|FG000|Week 52 to Week 104|Physician Decision|0|||
30937635|NCT01604343|58974871|FG001|Week 52 to Week 104|Physician Decision|1|||
30937636|NCT01604343|58974872|FG002|Week 52 to Week 104|Physician Decision|0|||
30937637|NCT01604343|58974873|FG003|Week 52 to Week 104|Physician Decision|0|||
30937638|NCT01604343|58974874|FG004|Week 52 to Week 104|Physician Decision|2|||
30937639|NCT01604343|58974870|FG000|Week 52 to Week 104|Pregnancy|0|||
30937640|NCT01604343|58974871|FG001|Week 52 to Week 104|Pregnancy|0|||
30937641|NCT01604343|58974872|FG002|Week 52 to Week 104|Pregnancy|1|||
30937642|NCT01604343|58974873|FG003|Week 52 to Week 104|Pregnancy|2|||
30937643|NCT01604343|58974874|FG004|Week 52 to Week 104|Pregnancy|1|||
30937644|NCT01604343|58974870|FG000|Week 52 to Week 104|Other|0|||
30937645|NCT01604343|58974871|FG001|Week 52 to Week 104|Other|11|||
30937646|NCT01604343|58974872|FG002|Week 52 to Week 104|Other|11|||
30937647|NCT01604343|58974873|FG003|Week 52 to Week 104|Other|6|||
30937648|NCT01604343|58974874|FG004|Week 52 to Week 104|Other|3|||
30937649|NCT01604343|58974870|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
30937650|NCT01604343|58974871|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
30937651|NCT01604343|58974872|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
30948543|NCT01974323|58994554|FG001|Overall Study|Pregnancy|1|||
30624446|NCT01117350|58636533|FG001|Comparative Period|Protocol Violation|12|||
30759131|NCT03572062|58767624|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
30759132|NCT03572062|58767625|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
30759133|NCT03572062|58767626|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
30759134|NCT03572062|58767627|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
30759135|NCT03572062|58767628|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
30759136|NCT03572062|58767619|FG000|Overall Study|Study Terminated By Sponsor|0|||
30624447|NCT01117350|58636532|FG000|Comparative Period|Lack of Efficacy|1|||
30759137|NCT03572062|58767620|FG001|Overall Study|Study Terminated By Sponsor|0|||
30759138|NCT03572062|58767621|FG002|Overall Study|Study Terminated By Sponsor|0|||
30841835|NCT02314923|58867351|FG000|Overall Study|Physician Decision|0|||
30937652|NCT01604343|58974873|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
30937653|NCT01604343|58974874|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
30937654|NCT01604343|58974870|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
30937655|NCT01604343|58974871|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
30937656|NCT01604343|58974872|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
30937657|NCT01604343|58974873|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
30937658|NCT01604343|58974874|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
30841836|NCT02314923|58867352|FG001|Overall Study|Physician Decision|1|||
30937659|NCT01604343|58974870|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
30937660|NCT01604343|58974871|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
30937661|NCT01604343|58974872|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
30937662|NCT01604343|58974873|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
30937663|NCT01604343|58974874|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
30937664|NCT01801436|58974884|FG000|Overall Study|Withdrawal by Subject|3|||
30937665|NCT01801436|58974884|FG000|Overall Study|Adverse Event|2|||
30937666|NCT01801436|58974884|FG000|Overall Study|Progressive disease|4|||
30937667|NCT01771250|58974888|FG000|Period 1|Met exclusion criteria|1|||
30937668|NCT01771250|58974889|FG001|Period 1|Met exclusion criteria|0|||
30937669|NCT01770860|58974895|FG000|Overall Study|Withdrawal by Subject|4|||
30937670|NCT01770860|58974895|FG000|Overall Study|Lost to Follow-up|1|||
30937671|NCT01770860|58974895|FG000|Overall Study|Administrative decision made by the PI|1|||
30937672|NCT01603875|58974906|FG000|Overall Study|Preexisting rabies antibody|3|||
30937673|NCT01603875|58974907|FG001|Overall Study|Preexisting rabies antibody|4|||
30937674|NCT01603875|58974908|FG002|Overall Study|Preexisting rabies antibody|3|||
30937675|NCT01603875|58974906|FG000|Overall Study|Lost to Follow-up|4|||
30937676|NCT01603875|58974907|FG001|Overall Study|Lost to Follow-up|3|||
30937677|NCT01603875|58974908|FG002|Overall Study|Lost to Follow-up|6|||
30937678|NCT01603875|58974906|FG000|Overall Study|Protocol Violation|0|||
30937679|NCT01603875|58974907|FG001|Overall Study|Protocol Violation|1|||
30937680|NCT01603875|58974908|FG002|Overall Study|Protocol Violation|0|||
30937681|NCT01770392|58974916|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
30937682|NCT01603641|58974926|FG000|Overall Study|Did not Receive Treatment|3|||
30624448|NCT01117350|58636533|FG001|Comparative Period|Lack of Efficacy|0|||
30841837|NCT02314923|58867353|FG002|Overall Study|Physician Decision|0|||
30841838|NCT02314923|58867354|FG003|Overall Study|Physician Decision|0|||
30841839|NCT02314923|58867355|FG004|Overall Study|Physician Decision|0|||
30841840|NCT02314923|58867356|FG005|Overall Study|Physician Decision|0|||
30841841|NCT02314923|58867357|FG006|Overall Study|Physician Decision|0|||
30841842|NCT02314923|58867358|FG007|Overall Study|Physician Decision|0|||
30841843|NCT02314923|58867359|FG008|Overall Study|Physician Decision|0|||
30841844|NCT02314923|58867360|FG009|Overall Study|Physician Decision|0|||
30841845|NCT02314923|58867351|FG000|Overall Study|Participant unavailable|0|||
30841846|NCT02314923|58867352|FG001|Overall Study|Participant unavailable|0|||
30841847|NCT02314923|58867353|FG002|Overall Study|Participant unavailable|0|||
30841848|NCT02314923|58867354|FG003|Overall Study|Participant unavailable|0|||
30841849|NCT02314923|58867355|FG004|Overall Study|Participant unavailable|0|||
30841850|NCT02314923|58867356|FG005|Overall Study|Participant unavailable|1|||
30841851|NCT02314923|58867357|FG006|Overall Study|Participant unavailable|0|||
30841852|NCT02314923|58867358|FG007|Overall Study|Participant unavailable|0|||
30841853|NCT02314923|58867359|FG008|Overall Study|Participant unavailable|0|||
30841854|NCT02314923|58867360|FG009|Overall Study|Participant unavailable|0|||
30841855|NCT02314923|58867351|FG000|Overall Study|Screen failure|0|||
30841856|NCT02314923|58867352|FG001|Overall Study|Screen failure|0|||
30841857|NCT02314923|58867353|FG002|Overall Study|Screen failure|0|||
30841858|NCT02314923|58867354|FG003|Overall Study|Screen failure|0|||
30841859|NCT02314923|58867355|FG004|Overall Study|Screen failure|0|||
30841860|NCT02314923|58867356|FG005|Overall Study|Screen failure|0|||
30841861|NCT02314923|58867357|FG006|Overall Study|Screen failure|1|||
30841862|NCT02314923|58867358|FG007|Overall Study|Screen failure|0|||
30841863|NCT02314923|58867359|FG008|Overall Study|Screen failure|0|||
30841864|NCT02314923|58867360|FG009|Overall Study|Screen failure|0|||
30937683|NCT01603641|58974926|FG000|Overall Study|Adverse Event|1|||
30624449|NCT01117350|58636532|FG000|Comparative Period|Physician Decision|0|||
30841865|NCT02314923|58867351|FG000|Overall Study|Participant relocation|1|||
30841866|NCT02314923|58867352|FG001|Overall Study|Participant relocation|0|||
30841867|NCT02314923|58867353|FG002|Overall Study|Participant relocation|0|||
30841868|NCT02314923|58867354|FG003|Overall Study|Participant relocation|0|||
30841869|NCT02314923|58867355|FG004|Overall Study|Participant relocation|0|||
30841870|NCT02314923|58867356|FG005|Overall Study|Participant relocation|0|||
30841871|NCT02314923|58867357|FG006|Overall Study|Participant relocation|0|||
30841872|NCT02314923|58867358|FG007|Overall Study|Participant relocation|1|||
30937684|NCT01603641|58974926|FG000|Overall Study|Lack of Efficacy|1|||
30937685|NCT01603641|58974926|FG000|Overall Study|Lost to Follow-up|6|||
30937686|NCT01603641|58974926|FG000|Overall Study|Personal Reasons|18|||
30937687|NCT01603641|58974926|FG000|Overall Study|Other Miscellaneous Reasons|6|||
30937688|NCT01556763|58974933|FG000|Overall Study|Withdrawal by Subject|0|||
30841873|NCT02314923|58867359|FG008|Overall Study|Participant relocation|0|||
30841874|NCT02314923|58867360|FG009|Overall Study|Participant relocation|0|||
30841875|NCT03023137|58867385|FG000|Overall Study|Multiple pregnancy|2|||
30841876|NCT03023137|58867386|FG001|Overall Study|Multiple pregnancy|4|||
30841877|NCT03023137|58867385|FG000|Overall Study|Lost to Follow-up|1|||
30841878|NCT03023137|58867386|FG001|Overall Study|Lost to Follow-up|1|||
30841879|NCT03023137|58867385|FG000|Overall Study|Protocol Violation|0|||
30841880|NCT03023137|58867386|FG001|Overall Study|Protocol Violation|4|||
30841881|NCT03023137|58867385|FG000|Overall Study|Lost the baby in a car accident|1|||
30841882|NCT03023137|58867386|FG001|Overall Study|Lost the baby in a car accident|0|||
30937689|NCT01556763|58974934|FG001|Overall Study|Withdrawal by Subject|1|||
30937690|NCT01556763|58974935|FG002|Overall Study|Withdrawal by Subject|0|||
30937691|NCT01576575|58974945|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
30937692|NCT01576575|58974945|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
30937693|NCT01576575|58974945|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
30937694|NCT01555983|58974955|FG000|Overall Study|Withdrawal by Subject|1|||
30937695|NCT01555983|58974956|FG001|Overall Study|Withdrawal by Subject|0|||
30937696|NCT01555983|58974957|FG002|Overall Study|Withdrawal by Subject|0|||
30841883|NCT03049813|58867397|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
30841884|NCT03049813|58867398|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
30841885|NCT03049813|58867399|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
30841886|NCT03049813|58867400|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
30841887|NCT03049813|58867397|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
30841888|NCT03049813|58867398|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
30841889|NCT03049813|58867399|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
30841890|NCT03049813|58867400|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
30841891|NCT03049813|58867397|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
30841892|NCT03049813|58867398|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
30841893|NCT03049813|58867399|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
30841894|NCT03049813|58867400|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
30841895|NCT03049813|58867397|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
30841896|NCT03049813|58867398|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
30841897|NCT03049813|58867399|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
30841898|NCT03049813|58867400|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
30841899|NCT03022981|58867411|FG000|Overall Study|Adverse Event|0|||
30841900|NCT03022981|58867412|FG001|Overall Study|Adverse Event|1|||
30841901|NCT03022981|58867413|FG002|Overall Study|Adverse Event|0|||
30937697|NCT01555983|58974958|FG003|Overall Study|Withdrawal by Subject|0|||
30937698|NCT01555983|58974959|FG004|Overall Study|Withdrawal by Subject|1|||
30937699|NCT01555983|58974960|FG005|Overall Study|Withdrawal by Subject|1|||
30937700|NCT01576341|58974968|FG000|Overall Study|Withdrawal by Subject|24|||
30937701|NCT01576341|58974968|FG000|Overall Study|Adverse Event|10|||
30937702|NCT01576341|58974968|FG000|Overall Study|Death|21|||
30937703|NCT01576341|58974968|FG000|Overall Study|Physician Decision|2|||
30937704|NCT01576341|58974968|FG000|Overall Study|Lost to Follow-up|2|||
30937705|NCT01576341|58974968|FG000|Overall Study|Kidney transplantation|10|||
30937706|NCT01576341|58974968|FG000|Overall Study|Protocol Violation|12|||
30937707|NCT01576341|58974968|FG000|Overall Study|Other|12|||
30937708|NCT01687413|58974986|FG000|Overall Study|Withdrawal by Subject|0|||
30937709|NCT01687413|58974987|FG001|Overall Study|Withdrawal by Subject|2|||
30937710|NCT01687413|58974986|FG000|Overall Study|Not eligible|0|||
30937711|NCT01687413|58974987|FG001|Overall Study|Not eligible|2|||
30937712|NCT01687413|58974986|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
30841902|NCT03022981|58867411|FG000|Overall Study|Investigator's Discretion|0|||
30841903|NCT03022981|58867412|FG001|Overall Study|Investigator's Discretion|1|||
30841904|NCT03022981|58867413|FG002|Overall Study|Investigator's Discretion|2|||
30841905|NCT03022981|58867411|FG000|Overall Study|Lost to Follow-up|6|||
30841906|NCT03022981|58867412|FG001|Overall Study|Lost to Follow-up|2|||
30841907|NCT03022981|58867413|FG002|Overall Study|Lost to Follow-up|1|||
30937713|NCT01687413|58974987|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
30937714|NCT01555671|58975013|FG000|Overall Study|Physician Decision|20|||
30937715|NCT01555671|58975014|FG001|Overall Study|Physician Decision|25|||
30937716|NCT01801358|58975028|FG000|Overall Study|Adverse Event|0|||
30937717|NCT01801358|58975029|FG001|Overall Study|Adverse Event|2|||
30937718|NCT01801358|58975030|FG002|Overall Study|Adverse Event|1|||
30937719|NCT01801358|58975031|FG003|Overall Study|Adverse Event|0|||
30937720|NCT01801358|58975032|FG004|Overall Study|Adverse Event|0|||
30937721|NCT01801358|58975033|FG005|Overall Study|Adverse Event|1|||
30937722|NCT01801358|58975028|FG000|Overall Study|Physician Decision|0|||
30937723|NCT01801358|58975029|FG001|Overall Study|Physician Decision|0|||
30937724|NCT01801358|58975030|FG002|Overall Study|Physician Decision|1|||
30937725|NCT01801358|58975031|FG003|Overall Study|Physician Decision|0|||
30937726|NCT01801358|58975032|FG004|Overall Study|Physician Decision|0|||
30937727|NCT01801358|58975033|FG005|Overall Study|Physician Decision|0|||
30937728|NCT01801358|58975028|FG000|Overall Study|Progressive Disease|6|||
30937729|NCT01801358|58975029|FG001|Overall Study|Progressive Disease|4|||
30841908|NCT03022981|58867411|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30841909|NCT03022981|58867412|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30841910|NCT03022981|58867413|FG002|Overall Study|Non-Compliance With Study Drug|2|||
30841911|NCT03022981|58867411|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
30841912|NCT03022981|58867412|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
30841913|NCT03022981|58867413|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
30841914|NCT03377699|58867433|FG000|Overall Study|Withdrawal by Subject|2|||
30841915|NCT03377699|58867434|FG001|Overall Study|Withdrawal by Subject|9|||
30841916|NCT03377699|58867433|FG000|Overall Study|Lost to Follow-up|1|||
30841917|NCT03377699|58867434|FG001|Overall Study|Lost to Follow-up|1|||
30841918|NCT03377699|58867433|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
30841919|NCT03377699|58867434|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
30841920|NCT03377699|58867433|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
30841921|NCT03377699|58867434|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
30841922|NCT03377699|58867433|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
30841923|NCT03377699|58867434|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
30841924|NCT03377699|58867433|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
30841925|NCT03377699|58867434|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
30841926|NCT01314443|58867446|FG000|Overall Study|Withdrawal by Subject|2|||
30841927|NCT01314443|58867447|FG001|Overall Study|Withdrawal by Subject|1|||
30841928|NCT01314443|58867448|FG002|Overall Study|Withdrawal by Subject|1|||
30841929|NCT01314443|58867449|FG003|Overall Study|Withdrawal by Subject|1|||
30841930|NCT01314443|58867446|FG000|Overall Study|Protocol Violation|2|||
30841931|NCT01314443|58867447|FG001|Overall Study|Protocol Violation|2|||
30841932|NCT01314443|58867448|FG002|Overall Study|Protocol Violation|1|||
30841933|NCT01314443|58867449|FG003|Overall Study|Protocol Violation|1|||
30841934|NCT02923921|58867461|FG000|Overall Study|Sponsor Decision|39|||
30841935|NCT02923921|58867462|FG001|Overall Study|Sponsor Decision|38|||
30937730|NCT01801358|58975030|FG002|Overall Study|Progressive Disease|4|||
30937731|NCT01801358|58975031|FG003|Overall Study|Progressive Disease|5|||
30937732|NCT01801358|58975032|FG004|Overall Study|Progressive Disease|6|||
30937733|NCT01801358|58975033|FG005|Overall Study|Progressive Disease|5|||
30937734|NCT01801358|58975028|FG000|Overall Study|Withdrawal by Subject|0|||
30937735|NCT01801358|58975029|FG001|Overall Study|Withdrawal by Subject|0|||
30937736|NCT01801358|58975030|FG002|Overall Study|Withdrawal by Subject|0|||
30937737|NCT01801358|58975031|FG003|Overall Study|Withdrawal by Subject|1|||
30937738|NCT01801358|58975032|FG004|Overall Study|Withdrawal by Subject|0|||
30937739|NCT01801358|58975033|FG005|Overall Study|Withdrawal by Subject|2|||
30937740|NCT01807598|58975068|FG000|Overall Study|Withdrawal by Subject|4|||
30937741|NCT01807598|58975068|FG000|Overall Study|Adverse Event|1|||
30937742|NCT01807598|58975068|FG000|Overall Study|Other Physician Decision|1|||
30937743|NCT01801280|58975076|FG000|Period 1|Withdrawal by Subject|0|||
30937744|NCT01801280|58975077|FG001|Period 1|Withdrawal by Subject|1|||
30937745|NCT01801280|58975078|FG002|Period 1|Withdrawal by Subject|0|||
30937746|NCT01801280|58975079|FG003|Period 1|Withdrawal by Subject|0|||
30937747|NCT01801280|58975076|FG000|Period 2|Withdrawal by Subject|1|||
30937748|NCT01801280|58975077|FG001|Period 2|Withdrawal by Subject|0|||
30841936|NCT02923921|58867461|FG000|Overall Study|Lost to Follow-up|1|||
30841937|NCT02923921|58867462|FG001|Overall Study|Lost to Follow-up|0|||
30841938|NCT02923921|58867461|FG000|Overall Study|Withdrawal by Subject|6|||
30841939|NCT02923921|58867462|FG001|Overall Study|Withdrawal by Subject|13|||
30937749|NCT01801280|58975078|FG002|Period 2|Withdrawal by Subject|0|||
30937750|NCT01801280|58975079|FG003|Period 2|Withdrawal by Subject|0|||
30841940|NCT02923921|58867461|FG000|Overall Study|Unknown, Not Collected|7|||
30937751|NCT01801280|58975076|FG000|Period 4|Protocol Violation|0|||
30937752|NCT01801280|58975077|FG001|Period 4|Protocol Violation|0|||
30937753|NCT01801280|58975078|FG002|Period 4|Protocol Violation|1|||
30937754|NCT01801280|58975079|FG003|Period 4|Protocol Violation|0|||
30937755|NCT01769456|58975089|FG000|Overall Study|Lost to Follow-up|19|||
30937756|NCT01769456|58975089|FG000|Overall Study|Withdrawal by Subject|3|||
30937757|NCT01769456|58975089|FG000|Overall Study|Did not receive PCC intervention|6|||
30937758|NCT01769456|58975089|FG000|Overall Study|Moved out of the area|3|||
30841941|NCT02923921|58867462|FG001|Overall Study|Unknown, Not Collected|6|||
30841942|NCT03039023|58867473|FG000|Overall Study|Withdrawal by Subject|1|||
30841943|NCT03039023|58867474|FG001|Overall Study|Withdrawal by Subject|0|||
30841944|NCT03039023|58867475|FG002|Overall Study|Withdrawal by Subject|1|||
30841945|NCT03039023|58867476|FG003|Overall Study|Withdrawal by Subject|1|||
30841946|NCT03039023|58867477|FG004|Overall Study|Withdrawal by Subject|0|||
30841947|NCT03039023|58867473|FG000|Overall Study|Physician Decision|0|||
30841948|NCT03039023|58867474|FG001|Overall Study|Physician Decision|0|||
30841949|NCT03039023|58867475|FG002|Overall Study|Physician Decision|0|||
30841950|NCT03039023|58867476|FG003|Overall Study|Physician Decision|1|||
30841951|NCT03039023|58867477|FG004|Overall Study|Physician Decision|0|||
30841952|NCT03022045|58867491|FG000|Overall Study|Adverse Event|0|||
30841953|NCT03022045|58867492|FG001|Overall Study|Adverse Event|1|||
30841954|NCT03022045|58867491|FG000|Overall Study|Withdrawal by Subject|1|||
30841955|NCT03022045|58867492|FG001|Overall Study|Withdrawal by Subject|1|||
30841956|NCT03037619|58867504|FG000|Overall Study|Lost to Follow-up|0|||
30841957|NCT03037619|58867505|FG001|Overall Study|Lost to Follow-up|1|||
30841958|NCT04771013|58867513|FG000|Overall Study|Withdrawal by Subject|2|||
30841959|NCT04771013|58867514|FG001|Overall Study|Withdrawal by Subject|0|||
30841960|NCT04771013|58867513|FG000|Overall Study|Death|0|||
30841961|NCT04771013|58867514|FG001|Overall Study|Death|5|||
30841962|NCT04771013|58867513|FG000|Overall Study|Referred to another hospital before day 20|0|||
30841963|NCT04771013|58867514|FG001|Overall Study|Referred to another hospital before day 20|1|||
30841964|NCT03021265|58867520|FG000|Overall Study|Adverse Event|29|||
30841965|NCT03021265|58867520|FG000|Overall Study|Lack of Efficacy|3|||
30841966|NCT03021265|58867520|FG000|Overall Study|Improved|17|||
30841967|NCT03021265|58867520|FG000|Overall Study|Lost to Follow-up|67|||
30841968|NCT03021265|58867520|FG000|Overall Study|No reason given|2|||
30841969|NCT03021265|58867520|FG000|Overall Study|No visit since the first visit|4|||
30841970|NCT04611789|58867527|FG000|Overall Study|Lost to Follow-up|1|||
30841971|NCT04611789|58867528|FG001|Overall Study|Lost to Follow-up|0|||
30841972|NCT04611789|58867529|FG002|Overall Study|Lost to Follow-up|0|||
30841973|NCT03561597|58867545|FG000|Overall Study|Lost to Follow-up|20|||
30841974|NCT03034967|58867568|FG000|Overall Study|Withdrawal by Subject|9|||
30841975|NCT03034967|58867569|FG001|Overall Study|Withdrawal by Subject|2|||
30841976|NCT03034967|58867570|FG002|Overall Study|Withdrawal by Subject|6|||
30841977|NCT03034967|58867571|FG003|Overall Study|Withdrawal by Subject|6|||
30841978|NCT03034967|58867572|FG004|Overall Study|Withdrawal by Subject|9|||
30841979|NCT03034967|58867573|FG005|Overall Study|Withdrawal by Subject|2|||
30841980|NCT03034967|58867568|FG000|Overall Study|Physician Decision|1|||
30841981|NCT03034967|58867569|FG001|Overall Study|Physician Decision|0|||
30841982|NCT03034967|58867570|FG002|Overall Study|Physician Decision|1|||
30841983|NCT03034967|58867571|FG003|Overall Study|Physician Decision|1|||
30841984|NCT03034967|58867572|FG004|Overall Study|Physician Decision|1|||
30841985|NCT03034967|58867573|FG005|Overall Study|Physician Decision|0|||
30841986|NCT03034967|58867568|FG000|Overall Study|Lost to Follow-up|0|||
30841987|NCT03034967|58867569|FG001|Overall Study|Lost to Follow-up|0|||
30841988|NCT03034967|58867570|FG002|Overall Study|Lost to Follow-up|0|||
30841989|NCT03034967|58867571|FG003|Overall Study|Lost to Follow-up|1|||
30841990|NCT03034967|58867572|FG004|Overall Study|Lost to Follow-up|0|||
30841991|NCT03034967|58867573|FG005|Overall Study|Lost to Follow-up|2|||
30841992|NCT03034967|58867568|FG000|Overall Study|Liver function test abnormality|0|||
30841993|NCT03034967|58867569|FG001|Overall Study|Liver function test abnormality|0|||
30841994|NCT03034967|58867570|FG002|Overall Study|Liver function test abnormality|1|||
30841995|NCT03034967|58867571|FG003|Overall Study|Liver function test abnormality|0|||
30841996|NCT03034967|58867572|FG004|Overall Study|Liver function test abnormality|0|||
30841997|NCT03034967|58867573|FG005|Overall Study|Liver function test abnormality|0|||
30841998|NCT03034967|58867568|FG000|Overall Study|Protocol Violation|1|||
30841999|NCT03034967|58867569|FG001|Overall Study|Protocol Violation|0|||
30842000|NCT03034967|58867570|FG002|Overall Study|Protocol Violation|0|||
30842001|NCT03034967|58867571|FG003|Overall Study|Protocol Violation|0|||
30842002|NCT03034967|58867572|FG004|Overall Study|Protocol Violation|0|||
30842003|NCT03034967|58867573|FG005|Overall Study|Protocol Violation|2|||
30842004|NCT03034967|58867568|FG000|Overall Study|Lack of Efficacy|0|||
30842005|NCT03034967|58867569|FG001|Overall Study|Lack of Efficacy|1|||
30842006|NCT03034967|58867570|FG002|Overall Study|Lack of Efficacy|2|||
30842007|NCT03034967|58867571|FG003|Overall Study|Lack of Efficacy|1|||
30842008|NCT03034967|58867572|FG004|Overall Study|Lack of Efficacy|1|||
30842009|NCT03034967|58867573|FG005|Overall Study|Lack of Efficacy|0|||
30842010|NCT03034967|58867568|FG000|Overall Study|Adverse Event, non-fatal|3|||
30842011|NCT03034967|58867569|FG001|Overall Study|Adverse Event, non-fatal|1|||
30842012|NCT03034967|58867570|FG002|Overall Study|Adverse Event, non-fatal|2|||
30842013|NCT03034967|58867571|FG003|Overall Study|Adverse Event, non-fatal|0|||
30842014|NCT03034967|58867572|FG004|Overall Study|Adverse Event, non-fatal|2|||
30842015|NCT03034967|58867573|FG005|Overall Study|Adverse Event, non-fatal|8|||
30842016|NCT03034967|58867568|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
30842017|NCT03034967|58867569|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
30842018|NCT03034967|58867570|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
30842019|NCT03034967|58867571|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
30842020|NCT03034967|58867572|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
30842021|NCT03034967|58867573|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
30842022|NCT03021187|58867596|FG000|Overall Study|Death|0|||
30842023|NCT03021187|58867597|FG001|Overall Study|Death|0|||
30842024|NCT03021187|58867598|FG002|Overall Study|Death|3|||
30842025|NCT03021187|58867599|FG003|Overall Study|Death|0|||
30842026|NCT03021187|58867596|FG000|Overall Study|Withdrawal by Subject|0|||
30842027|NCT03021187|58867597|FG001|Overall Study|Withdrawal by Subject|6|||
30842028|NCT03021187|58867598|FG002|Overall Study|Withdrawal by Subject|2|||
30842029|NCT03021187|58867599|FG003|Overall Study|Withdrawal by Subject|5|||
30842030|NCT03021187|58867596|FG000|Overall Study|Lost to Follow-up|10|||
30842031|NCT03021187|58867597|FG001|Overall Study|Lost to Follow-up|3|||
30937759|NCT01769456|58975089|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
30937760|NCT01769456|58975089|FG000|Overall Study|Parental request to youth to withdraw|1|||
30937761|NCT01769378|58975096|FG000|Overall Study|Adverse Event|10|||
30937762|NCT01769378|58975097|FG001|Overall Study|Adverse Event|0|||
30937763|NCT01769378|58975096|FG000|Overall Study|Entry criteria not met|1|||
30937764|NCT01769378|58975097|FG001|Overall Study|Entry criteria not met|0|||
30937765|NCT01769378|58975096|FG000|Overall Study|Protocol Violation|1|||
30937766|NCT01769378|58975097|FG001|Overall Study|Protocol Violation|1|||
30937767|NCT01769378|58975096|FG000|Overall Study|Withdrawal by Subject|10|||
30937768|NCT01769378|58975097|FG001|Overall Study|Withdrawal by Subject|3|||
30937769|NCT01769378|58975096|FG000|Overall Study|Sponsor Decision|1|||
30937770|NCT01769378|58975097|FG001|Overall Study|Sponsor Decision|0|||
30937771|NCT01769378|58975096|FG000|Overall Study|Lost to Follow-up|2|||
30842032|NCT03021187|58867598|FG002|Overall Study|Lost to Follow-up|1|||
30842033|NCT03021187|58867599|FG003|Overall Study|Lost to Follow-up|4|||
30842034|NCT03014479|58867611|FG000|Overall Study|Adverse Event|0|||
30842035|NCT03014479|58867612|FG001|Overall Study|Adverse Event|1|||
30842036|NCT03014479|58867611|FG000|Overall Study|Voluntary Withdrawal|0|||
30842037|NCT03014479|58867612|FG001|Overall Study|Voluntary Withdrawal|2|||
30842038|NCT03014479|58867611|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
30842039|NCT03014479|58867612|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
30842040|NCT04766333|58867620|FG000|Overall Study|Lost to Follow-up|40|||
30842041|NCT04766333|58867621|FG001|Overall Study|Lost to Follow-up|826|||
30842042|NCT03020641|58867629|FG000|Overall Study|Lost to Follow-up|0|||
30842043|NCT03020641|58867630|FG001|Overall Study|Lost to Follow-up|1|||
30842044|NCT03020641|58867629|FG000|Overall Study|Converted to open surgery|2|||
30842045|NCT03020641|58867630|FG001|Overall Study|Converted to open surgery|1|||
30842046|NCT03020641|58867629|FG000|Overall Study|for surgery not performed|0|||
30842047|NCT03020641|58867630|FG001|Overall Study|for surgery not performed|1|||
30842048|NCT03020407|58867641|FG000|Overall Study|Withdrawal by Subject|2|||
30842049|NCT03020407|58867642|FG001|Overall Study|Withdrawal by Subject|1|||
30842050|NCT03020407|58867641|FG000|Overall Study|Lost to Follow-up|2|||
30842051|NCT03020407|58867642|FG001|Overall Study|Lost to Follow-up|3|||
30842052|NCT03020407|58867641|FG000|Overall Study|Protocol Violation|0|||
30842053|NCT03020407|58867642|FG001|Overall Study|Protocol Violation|1|||
30842054|NCT02536846|58867648|FG000|Overall Study|Withdrawal by Subject|1|||
30842055|NCT03014011|58867653|FG000|First Intervention|Withdrawal by Subject|1|||
30842056|NCT03014011|58867654|FG001|First Intervention|Withdrawal by Subject|0|||
30842057|NCT03014011|58867653|FG000|Washout|Withdrawal by Subject|1|||
30842058|NCT03014011|58867654|FG001|Washout|Withdrawal by Subject|0|||
30842059|NCT03012841|58867669|FG000|Overall Study|Protocol Violation|0|||
30842060|NCT03012841|58867670|FG001|Overall Study|Protocol Violation|10|||
30842061|NCT03012841|58867669|FG000|Overall Study|Lost to Follow-up|6|||
30842062|NCT03012841|58867670|FG001|Overall Study|Lost to Follow-up|1|||
30842063|NCT03012841|58867669|FG000|Overall Study|Withdrawal by Subject|6|||
30842064|NCT03012841|58867670|FG001|Overall Study|Withdrawal by Subject|0|||
30842065|NCT03012841|58867669|FG000|Overall Study|Unable to complete 12 month visit|6|||
30842066|NCT03012841|58867670|FG001|Overall Study|Unable to complete 12 month visit|0|||
30842067|NCT03012841|58867669|FG000|Overall Study|Subject relocation|1|||
30842068|NCT03012841|58867670|FG001|Overall Study|Subject relocation|0|||
30842069|NCT03012841|58867669|FG000|Overall Study|Seasonal winter travel|1|||
30937772|NCT01769378|58975097|FG001|Overall Study|Lost to Follow-up|0|||
30937773|NCT01807520|58975106|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
30937774|NCT01807520|58975107|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
30624450|NCT01117350|58636533|FG001|Comparative Period|Physician Decision|1|||
30948544|NCT01974323|58994553|FG000|Overall Study|Lack of Efficacy|1|||
30842070|NCT03012841|58867670|FG001|Overall Study|Seasonal winter travel|0|||
30842071|NCT03012841|58867669|FG000|Overall Study|Physician Decision|0|||
30842072|NCT03012841|58867670|FG001|Overall Study|Physician Decision|2|||
30842073|NCT03012841|58867669|FG000|Overall Study|No ablation performed|0|||
30842074|NCT03012841|58867670|FG001|Overall Study|No ablation performed|2|||
30842075|NCT03012841|58867669|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
30937775|NCT01807520|58975108|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
30937776|NCT01807520|58975109|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
30937777|NCT01807520|58975110|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
30937778|NCT01807520|58975111|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
30937779|NCT01807520|58975112|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
30937780|NCT01807520|58975106|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
30937781|NCT01807520|58975107|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
30937782|NCT01807520|58975108|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
30937783|NCT01807520|58975109|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
30937784|NCT01807520|58975110|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
30937785|NCT01807520|58975111|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
30937786|NCT01807520|58975112|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
30937787|NCT01807520|58975106|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
30937788|NCT01807520|58975107|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
30937789|NCT01807520|58975108|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
30937790|NCT01807520|58975109|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
30937791|NCT01807520|58975110|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
30937792|NCT01807520|58975111|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
30937793|NCT01807520|58975112|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
30937794|NCT01807520|58975106|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
30937795|NCT01807520|58975107|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
30937796|NCT01807520|58975108|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
30937797|NCT01807520|58975109|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
30937798|NCT01807520|58975110|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
30937799|NCT01807520|58975111|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
30937800|NCT01807520|58975112|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
30937801|NCT01807520|58975106|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
30937802|NCT01807520|58975107|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
30937803|NCT01807520|58975108|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
30937804|NCT01807520|58975109|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
30937805|NCT01807520|58975110|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
30937806|NCT01807520|58975111|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
30937807|NCT01807520|58975112|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
30937808|NCT01807520|58975106|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
30937809|NCT01807520|58975107|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
30937810|NCT01807520|58975108|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
30937811|NCT01807520|58975109|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
30937812|NCT01807520|58975110|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
30937813|NCT01807520|58975111|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
30937814|NCT01807520|58975112|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
30937815|NCT01807520|58975106|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
30937816|NCT01807520|58975107|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
30937817|NCT01807520|58975108|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
30937818|NCT01807520|58975109|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
30937819|NCT01807520|58975110|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
30937820|NCT01807520|58975111|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
30937821|NCT01807520|58975112|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
30937822|NCT01807520|58975106|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
30937823|NCT01807520|58975107|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
30759139|NCT03572062|58767622|FG003|Overall Study|Study Terminated By Sponsor|0|||
30759140|NCT03572062|58767623|FG004|Overall Study|Study Terminated By Sponsor|0|||
30759141|NCT03572062|58767624|FG005|Overall Study|Study Terminated By Sponsor|0|||
30842076|NCT03012841|58867670|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
30759142|NCT03572062|58767625|FG006|Overall Study|Study Terminated By Sponsor|0|||
30759143|NCT03572062|58767626|FG007|Overall Study|Study Terminated By Sponsor|0|||
30759144|NCT03572062|58767627|FG008|Overall Study|Study Terminated By Sponsor|29|||
30759145|NCT03572062|58767628|FG009|Overall Study|Study Terminated By Sponsor|27|||
30759146|NCT03572062|58767619|FG000|Overall Study|Physician Decision|0|||
30759147|NCT03572062|58767620|FG001|Overall Study|Physician Decision|0|||
30759148|NCT03572062|58767621|FG002|Overall Study|Physician Decision|0|||
30759149|NCT03572062|58767622|FG003|Overall Study|Physician Decision|0|||
30759150|NCT03572062|58767623|FG004|Overall Study|Physician Decision|0|||
30842077|NCT03012841|58867669|FG000|Overall Study|Insurance change|0|||
30937824|NCT01807520|58975108|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
30624451|NCT01117350|58636532|FG000|Comparative Period|Move to another city/country|2|||
30759151|NCT03572062|58767624|FG005|Overall Study|Physician Decision|0|||
30759152|NCT03572062|58767625|FG006|Overall Study|Physician Decision|0|||
30759153|NCT03572062|58767626|FG007|Overall Study|Physician Decision|0|||
30842078|NCT03012841|58867670|FG001|Overall Study|Insurance change|1|||
30937825|NCT01807520|58975109|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
30937826|NCT01807520|58975110|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
30937827|NCT01807520|58975111|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
30937828|NCT01807520|58975112|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
30937829|NCT01807520|58975106|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
30937830|NCT01807520|58975107|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
30937831|NCT01807520|58975108|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
30937832|NCT01807520|58975109|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
30937833|NCT01807520|58975110|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
30937834|NCT01807520|58975111|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
30937835|NCT01807520|58975112|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
30937836|NCT01807520|58975106|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
30937837|NCT01807520|58975107|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
30937838|NCT01807520|58975108|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
30937839|NCT01807520|58975109|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
30937840|NCT01807520|58975110|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
30937841|NCT01807520|58975111|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
30937842|NCT01807520|58975112|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
30937843|NCT01807520|58975106|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
30937844|NCT01807520|58975107|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
30937845|NCT01807520|58975108|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
30937846|NCT01807520|58975109|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
30937847|NCT01807520|58975110|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
30937848|NCT01807520|58975111|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
30937849|NCT01807520|58975112|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
30937850|NCT01807520|58975106|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
30937851|NCT01807520|58975107|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
30937852|NCT01807520|58975108|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
30937853|NCT01807520|58975109|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
30937854|NCT01807520|58975110|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
30937855|NCT01807520|58975111|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
30937856|NCT01807520|58975112|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
30937857|NCT01807520|58975106|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
30937858|NCT01807520|58975107|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
30937859|NCT01807520|58975108|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
30937860|NCT01807520|58975109|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
30937861|NCT01807520|58975110|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
30937862|NCT01807520|58975111|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
30937863|NCT01807520|58975112|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
30937864|NCT01807520|58975106|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
30937865|NCT01807520|58975107|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
30937866|NCT01807520|58975108|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
30937867|NCT01807520|58975109|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
30937868|NCT01807520|58975110|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
30937869|NCT01807520|58975111|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
30937870|NCT01807520|58975112|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
30937871|NCT01807520|58975106|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
30937872|NCT01807520|58975107|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
30937873|NCT01807520|58975108|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
30937874|NCT01807520|58975109|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
30937875|NCT01807520|58975110|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
30937876|NCT01807520|58975111|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
30937877|NCT01807520|58975112|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
30937878|NCT01807520|58975106|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
30937879|NCT01807520|58975107|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
30937880|NCT01807520|58975108|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
30937881|NCT01807520|58975109|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
30937882|NCT01807520|58975110|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
30937883|NCT01807520|58975111|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
30937884|NCT01807520|58975112|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
30937885|NCT01807520|58975106|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
30759154|NCT03572062|58767627|FG008|Overall Study|Physician Decision|1|||
30937886|NCT01807520|58975107|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
30937887|NCT01807520|58975108|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
30937888|NCT01807520|58975109|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
30937889|NCT01807520|58975110|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
30937890|NCT01807520|58975111|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
30937891|NCT01807520|58975112|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
30937892|NCT01806896|58975125|FG000|Overall Study|Adverse Event|2|||
30937893|NCT01806896|58975126|FG001|Overall Study|Adverse Event|0|||
30937894|NCT01806896|58975125|FG000|Overall Study|Other|1|||
30937895|NCT01806896|58975126|FG001|Overall Study|Other|0|||
30937896|NCT01768676|58975134|FG000|Overall Study|Adverse Event|3|||
30759155|NCT03572062|58767628|FG009|Overall Study|Physician Decision|0|||
30759156|NCT03572062|58767619|FG000|Overall Study|Withdrawal by Subject|0|||
30759157|NCT03572062|58767620|FG001|Overall Study|Withdrawal by Subject|0|||
30759158|NCT03572062|58767621|FG002|Overall Study|Withdrawal by Subject|0|||
30759159|NCT03572062|58767622|FG003|Overall Study|Withdrawal by Subject|0|||
30759160|NCT03572062|58767623|FG004|Overall Study|Withdrawal by Subject|0|||
30759161|NCT03572062|58767624|FG005|Overall Study|Withdrawal by Subject|0|||
30759162|NCT03572062|58767625|FG006|Overall Study|Withdrawal by Subject|0|||
30759163|NCT03572062|58767626|FG007|Overall Study|Withdrawal by Subject|0|||
30842079|NCT02359864|58867677|FG000|Overall Study|Withdrawal by Subject|1|||
30937897|NCT01768676|58975135|FG001|Overall Study|Adverse Event|3|||
30937898|NCT01768676|58975134|FG000|Overall Study|Lost to Follow-up|13|||
30937899|NCT01768676|58975135|FG001|Overall Study|Lost to Follow-up|16|||
30937900|NCT01768676|58975134|FG000|Overall Study|Protocol Violation|1|||
30937901|NCT01768676|58975135|FG001|Overall Study|Protocol Violation|1|||
30937902|NCT01768676|58975134|FG000|Overall Study|Physician Decision|4|||
30937903|NCT01768676|58975135|FG001|Overall Study|Physician Decision|1|||
30937904|NCT01768676|58975134|FG000|Overall Study|Withdrawal by Subject|3|||
30937905|NCT01768676|58975135|FG001|Overall Study|Withdrawal by Subject|10|||
30937906|NCT01555125|58975144|FG000|Induction Period|Lost to Follow-up|0|||
30937907|NCT01555125|58975145|FG001|Induction Period|Lost to Follow-up|2|||
30937908|NCT01555125|58975146|FG002|Induction Period|Lost to Follow-up|0|||
30937909|NCT01555125|58975147|FG003|Induction Period|Lost to Follow-up|0|||
30937910|NCT01555125|58975148|FG004|Induction Period|Lost to Follow-up|0|||
30937911|NCT01555125|58975144|FG000|Induction Period|Adverse Event|0|||
30937912|NCT01555125|58975145|FG001|Induction Period|Adverse Event|1|||
30937913|NCT01555125|58975146|FG002|Induction Period|Adverse Event|0|||
30937914|NCT01555125|58975147|FG003|Induction Period|Adverse Event|0|||
30937915|NCT01555125|58975148|FG004|Induction Period|Adverse Event|1|||
30937916|NCT01555125|58975144|FG000|Induction Period|Subject / guardian decision|0|||
30937917|NCT01555125|58975145|FG001|Induction Period|Subject / guardian decision|0|||
30937918|NCT01555125|58975146|FG002|Induction Period|Subject / guardian decision|0|||
30937919|NCT01555125|58975147|FG003|Induction Period|Subject / guardian decision|0|||
30937920|NCT01555125|58975148|FG004|Induction Period|Subject / guardian decision|2|||
30937921|NCT01555125|58975144|FG000|Induction Period|Death|1|||
30937922|NCT01555125|58975145|FG001|Induction Period|Death|0|||
30937923|NCT01555125|58975146|FG002|Induction Period|Death|0|||
30937924|NCT01555125|58975147|FG003|Induction Period|Death|0|||
30937925|NCT01555125|58975148|FG004|Induction Period|Death|0|||
30937926|NCT01555125|58975144|FG000|Maintenance Period|Adverse Event|1|||
30937927|NCT01555125|58975145|FG001|Maintenance Period|Adverse Event|1|||
30937928|NCT01555125|58975146|FG002|Maintenance Period|Adverse Event|0|||
30937929|NCT01555125|58975147|FG003|Maintenance Period|Adverse Event|0|||
30937930|NCT01555125|58975148|FG004|Maintenance Period|Adverse Event|0|||
30937931|NCT01555125|58975144|FG000|Maintenance Period|Subject / guardian decision|1|||
30937932|NCT01555125|58975145|FG001|Maintenance Period|Subject / guardian decision|2|||
30937933|NCT01555125|58975146|FG002|Maintenance Period|Subject / guardian decision|0|||
30937934|NCT01555125|58975147|FG003|Maintenance Period|Subject / guardian decision|0|||
30937935|NCT01555125|58975148|FG004|Maintenance Period|Subject / guardian decision|0|||
30937936|NCT01555125|58975144|FG000|Maintenance Period|Lost to Follow-up|2|||
30937937|NCT01555125|58975145|FG001|Maintenance Period|Lost to Follow-up|0|||
30937938|NCT01555125|58975146|FG002|Maintenance Period|Lost to Follow-up|0|||
30759164|NCT03572062|58767627|FG008|Overall Study|Withdrawal by Subject|0|||
30759165|NCT03572062|58767628|FG009|Overall Study|Withdrawal by Subject|1|||
30759166|NCT03572062|58767619|FG000|Overall Study|Randomized But Not Treated|0|||
30937939|NCT01555125|58975147|FG003|Maintenance Period|Lost to Follow-up|1|||
30937940|NCT01555125|58975148|FG004|Maintenance Period|Lost to Follow-up|0|||
30937941|NCT01555125|58975144|FG000|Maintenance Period|Lack of Efficacy|6|||
30937942|NCT01555125|58975145|FG001|Maintenance Period|Lack of Efficacy|1|||
30937943|NCT01555125|58975146|FG002|Maintenance Period|Lack of Efficacy|3|||
30937944|NCT01555125|58975147|FG003|Maintenance Period|Lack of Efficacy|0|||
30937945|NCT01555125|58975148|FG004|Maintenance Period|Lack of Efficacy|0|||
30937946|NCT01555125|58975144|FG000|Maintenance Period|Physician Decision|0|||
30937947|NCT01555125|58975145|FG001|Maintenance Period|Physician Decision|0|||
30937948|NCT01555125|58975146|FG002|Maintenance Period|Physician Decision|1|||
30937949|NCT01555125|58975147|FG003|Maintenance Period|Physician Decision|0|||
30937950|NCT01555125|58975148|FG004|Maintenance Period|Physician Decision|0|||
30937951|NCT01555125|58975144|FG000|Maintenance Period|Death|0|||
30937952|NCT01555125|58975145|FG001|Maintenance Period|Death|0|||
30937953|NCT01555125|58975146|FG002|Maintenance Period|Death|0|||
30937954|NCT01555125|58975147|FG003|Maintenance Period|Death|1|||
30937955|NCT01555125|58975148|FG004|Maintenance Period|Death|0|||
30937956|NCT01555125|58975144|FG000|Extension|Adverse Event|1|||
30937957|NCT01555125|58975145|FG001|Extension|Adverse Event|2|||
30937958|NCT01555125|58975146|FG002|Extension|Adverse Event|1|||
30937959|NCT01555125|58975147|FG003|Extension|Adverse Event|1|||
30937960|NCT01555125|58975148|FG004|Extension|Adverse Event|0|||
30937961|NCT01555125|58975144|FG000|Extension|Protocol deviation|1|||
30937962|NCT01555125|58975145|FG001|Extension|Protocol deviation|0|||
30937963|NCT01555125|58975146|FG002|Extension|Protocol deviation|0|||
30937964|NCT01555125|58975147|FG003|Extension|Protocol deviation|0|||
30937965|NCT01555125|58975148|FG004|Extension|Protocol deviation|0|||
30937966|NCT01555125|58975144|FG000|Extension|Lack of Efficacy|7|||
30937967|NCT01555125|58975145|FG001|Extension|Lack of Efficacy|6|||
30937968|NCT01555125|58975146|FG002|Extension|Lack of Efficacy|3|||
30937969|NCT01555125|58975147|FG003|Extension|Lack of Efficacy|0|||
30937970|NCT01555125|58975148|FG004|Extension|Lack of Efficacy|0|||
30937971|NCT01555125|58975144|FG000|Extension|Lost to Follow-up|2|||
30937972|NCT01555125|58975145|FG001|Extension|Lost to Follow-up|1|||
30937973|NCT01555125|58975146|FG002|Extension|Lost to Follow-up|2|||
30937974|NCT01555125|58975147|FG003|Extension|Lost to Follow-up|0|||
30937975|NCT01555125|58975148|FG004|Extension|Lost to Follow-up|0|||
30937976|NCT01555125|58975144|FG000|Extension|Study terminated by sponsor|32|||
30937977|NCT01555125|58975145|FG001|Extension|Study terminated by sponsor|33|||
30937978|NCT01555125|58975146|FG002|Extension|Study terminated by sponsor|16|||
30937979|NCT01555125|58975147|FG003|Extension|Study terminated by sponsor|20|||
30937980|NCT01555125|58975148|FG004|Extension|Study terminated by sponsor|0|||
30937981|NCT01555125|58975144|FG000|Extension|Subject/guardian decision|1|||
30937982|NCT01555125|58975145|FG001|Extension|Subject/guardian decision|9|||
30937983|NCT01555125|58975146|FG002|Extension|Subject/guardian decision|1|||
30937984|NCT01555125|58975147|FG003|Extension|Subject/guardian decision|0|||
30937985|NCT01555125|58975148|FG004|Extension|Subject/guardian decision|0|||
30937986|NCT01555125|58975144|FG000|Extension|Technical Problems|1|||
30937987|NCT01555125|58975145|FG001|Extension|Technical Problems|0|||
30937988|NCT01555125|58975146|FG002|Extension|Technical Problems|0|||
30937989|NCT01555125|58975147|FG003|Extension|Technical Problems|1|||
30937990|NCT01555125|58975148|FG004|Extension|Technical Problems|0|||
30937991|NCT01555125|58975144|FG000|Follow-Up Period|Lost to Follow-up|1|||
30937992|NCT01555125|58975145|FG001|Follow-Up Period|Lost to Follow-up|0|||
30937993|NCT01555125|58975146|FG002|Follow-Up Period|Lost to Follow-up|0|||
30937994|NCT01555125|58975147|FG003|Follow-Up Period|Lost to Follow-up|0|||
30937995|NCT01555125|58975148|FG004|Follow-Up Period|Lost to Follow-up|0|||
30937996|NCT01555125|58975144|FG000|Follow-Up Period|Subject / guardian decision|3|||
30937997|NCT01555125|58975145|FG001|Follow-Up Period|Subject / guardian decision|1|||
30937998|NCT01555125|58975146|FG002|Follow-Up Period|Subject / guardian decision|1|||
30937999|NCT01555125|58975147|FG003|Follow-Up Period|Subject / guardian decision|1|||
30938000|NCT01555125|58975148|FG004|Follow-Up Period|Subject / guardian decision|0|||
30938001|NCT01768286|58975167|FG000|Overall Study|Randomized But Not Treated|0|||
30938002|NCT01768286|58975168|FG001|Overall Study|Randomized But Not Treated|0|||
30938003|NCT01768286|58975169|FG002|Overall Study|Randomized But Not Treated|1|||
30938004|NCT01768286|58975170|FG003|Overall Study|Randomized But Not Treated|0|||
30938005|NCT01768286|58975167|FG000|Overall Study|Lack of Efficacy|7|||
30938006|NCT01768286|58975168|FG001|Overall Study|Lack of Efficacy|4|||
30938007|NCT01768286|58975169|FG002|Overall Study|Lack of Efficacy|0|||
30938008|NCT01768286|58975170|FG003|Overall Study|Lack of Efficacy|1|||
30938009|NCT01768286|58975167|FG000|Overall Study|Withdrew Consent|0|||
30938010|NCT01768286|58975168|FG001|Overall Study|Withdrew Consent|0|||
30938011|NCT01768286|58975169|FG002|Overall Study|Withdrew Consent|1|||
30938012|NCT01768286|58975170|FG003|Overall Study|Withdrew Consent|0|||
30759167|NCT03572062|58767620|FG001|Overall Study|Randomized But Not Treated|0|||
30759168|NCT03572062|58767621|FG002|Overall Study|Randomized But Not Treated|0|||
30938013|NCT01800968|58975182|FG000|Overall Study|Death|23|||
30938014|NCT01800968|58975183|FG001|Overall Study|Death|16|||
30938015|NCT01800968|58975182|FG000|Overall Study|Lost to Follow-up|5|||
30938016|NCT01800968|58975183|FG001|Overall Study|Lost to Follow-up|7|||
30938017|NCT01800968|58975182|FG000|Overall Study|Withdrawal by Subject|7|||
30938018|NCT01800968|58975183|FG001|Overall Study|Withdrawal by Subject|9|||
30938019|NCT01800968|58975182|FG000|Overall Study|Physician Decision|1|||
30938020|NCT01800968|58975183|FG001|Overall Study|Physician Decision|0|||
30938021|NCT01799720|58975192|FG000|Overall Study|Withdrawal by Subject|3|||
30938022|NCT01799720|58975193|FG001|Overall Study|Withdrawal by Subject|0|||
30938023|NCT01799720|58975194|FG002|Overall Study|Withdrawal by Subject|0|||
30938024|NCT01799720|58975192|FG000|Overall Study|Protocol Violation|0|||
30938025|NCT01799720|58975193|FG001|Overall Study|Protocol Violation|1|||
30938026|NCT01799720|58975194|FG002|Overall Study|Protocol Violation|0|||
30938027|NCT01799720|58975192|FG000|Overall Study|Pregnancy|0|||
30938028|NCT01799720|58975193|FG001|Overall Study|Pregnancy|0|||
30938029|NCT01799720|58975194|FG002|Overall Study|Pregnancy|1|||
30938030|NCT01687257|58975204|FG000|Overall Study|Efficacy Failure|6|||
30938031|NCT01687257|58975205|FG001|Overall Study|Efficacy Failure|0|||
30938032|NCT01687257|58975206|FG002|Overall Study|Efficacy Failure|5|||
30938033|NCT01687257|58975204|FG000|Overall Study|Subject Withdrew Consent|1|||
30938034|NCT01687257|58975205|FG001|Overall Study|Subject Withdrew Consent|1|||
30938035|NCT01687257|58975206|FG002|Overall Study|Subject Withdrew Consent|1|||
30938036|NCT01687257|58975204|FG000|Overall Study|Adverse Event|1|||
30938037|NCT01687257|58975205|FG001|Overall Study|Adverse Event|0|||
30938038|NCT01687257|58975206|FG002|Overall Study|Adverse Event|0|||
30938039|NCT01687257|58975204|FG000|Overall Study|Investigator's Discretion|0|||
30938040|NCT01687257|58975205|FG001|Overall Study|Investigator's Discretion|3|||
30938041|NCT01687257|58975206|FG002|Overall Study|Investigator's Discretion|0|||
30938042|NCT01806740|58975220|FG000|Overall Study|Withdrawal by Subject|4|||
30938043|NCT01806740|58975220|FG000|Overall Study|Physician Decision|1|||
30938044|NCT01806740|58975220|FG000|Overall Study|Patient's refusal of treatment|1|||
30938045|NCT01687101|58975227|FG000|Overall Study|Lost to Follow-up|7|||
30938046|NCT01968967|58975233|FG000|Treatment Period|Other|22|||
30938047|NCT01968967|58975234|FG001|Treatment Period|Other|22|||
30938048|NCT01968967|58975235|FG002|Treatment Period|Other|0|||
30938049|NCT01968967|58975236|FG003|Treatment Period|Other|0|||
30938050|NCT01968967|58975237|FG004|Treatment Period|Other|0|||
30938051|NCT01968967|58975233|FG000|Treatment Period|Withdrawal by Subject|71|||
30938052|NCT01968967|58975234|FG001|Treatment Period|Withdrawal by Subject|61|||
30938053|NCT01968967|58975235|FG002|Treatment Period|Withdrawal by Subject|0|||
30938054|NCT01968967|58975236|FG003|Treatment Period|Withdrawal by Subject|0|||
30938055|NCT01968967|58975237|FG004|Treatment Period|Withdrawal by Subject|0|||
30938056|NCT01968967|58975233|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
30938057|NCT01968967|58975234|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
30938058|NCT01968967|58975235|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
30938059|NCT01968967|58975236|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
30938060|NCT01968967|58975237|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
30938061|NCT01968967|58975233|FG000|Treatment Period|Lost to Follow-up|26|||
30938062|NCT01968967|58975234|FG001|Treatment Period|Lost to Follow-up|31|||
30938063|NCT01968967|58975235|FG002|Treatment Period|Lost to Follow-up|0|||
30938064|NCT01968967|58975236|FG003|Treatment Period|Lost to Follow-up|0|||
30938065|NCT01968967|58975237|FG004|Treatment Period|Lost to Follow-up|0|||
30938066|NCT01968967|58975233|FG000|Treatment Period|Protocol Violation|1|||
30938067|NCT01968967|58975234|FG001|Treatment Period|Protocol Violation|2|||
30938068|NCT01968967|58975235|FG002|Treatment Period|Protocol Violation|0|||
30938069|NCT01968967|58975236|FG003|Treatment Period|Protocol Violation|0|||
30938070|NCT01968967|58975237|FG004|Treatment Period|Protocol Violation|0|||
30938071|NCT01968967|58975233|FG000|Treatment Period|Adverse Event|9|||
30938072|NCT01968967|58975234|FG001|Treatment Period|Adverse Event|8|||
30938073|NCT01968967|58975235|FG002|Treatment Period|Adverse Event|0|||
30938074|NCT01968967|58975236|FG003|Treatment Period|Adverse Event|0|||
30938075|NCT01968967|58975237|FG004|Treatment Period|Adverse Event|0|||
30938076|NCT01968967|58975233|FG000|Treatment Period|Death|9|||
30938077|NCT01968967|58975234|FG001|Treatment Period|Death|2|||
30938078|NCT01968967|58975235|FG002|Treatment Period|Death|0|||
30938079|NCT01968967|58975236|FG003|Treatment Period|Death|0|||
30938080|NCT01968967|58975237|FG004|Treatment Period|Death|0|||
30938081|NCT01968967|58975233|FG000|Treatment Period|Randomized Not Treated|6|||
30938082|NCT01968967|58975234|FG001|Treatment Period|Randomized Not Treated|5|||
30938083|NCT01968967|58975235|FG002|Treatment Period|Randomized Not Treated|0|||
30938084|NCT01968967|58975236|FG003|Treatment Period|Randomized Not Treated|0|||
30938085|NCT01968967|58975237|FG004|Treatment Period|Randomized Not Treated|0|||
30938086|NCT01968967|58975233|FG000|Extension Period|Withdrew Consent|0|||
30938087|NCT01968967|58975234|FG001|Extension Period|Withdrew Consent|0|||
30938088|NCT01968967|58975235|FG002|Extension Period|Withdrew Consent|2|||
30938089|NCT01968967|58975236|FG003|Extension Period|Withdrew Consent|0|||
30938090|NCT01968967|58975237|FG004|Extension Period|Withdrew Consent|5|||
30938091|NCT01554579|58975253|FG000|Overall Study|Adverse Event|6|||
30938092|NCT01554579|58975254|FG001|Overall Study|Adverse Event|25|||
30938093|NCT01554579|58975253|FG000|Overall Study|Lack of Efficacy|2|||
30938094|NCT01554579|58975254|FG001|Overall Study|Lack of Efficacy|1|||
30938095|NCT01554579|58975253|FG000|Overall Study|Withdrawal by Subject|2|||
30938096|NCT01554579|58975254|FG001|Overall Study|Withdrawal by Subject|1|||
30938097|NCT01806662|58975261|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
30938098|NCT01806662|58975262|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
30938099|NCT01806662|58975261|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
30938100|NCT01806662|58975262|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
30938101|NCT01806662|58975261|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
30938102|NCT01806662|58975262|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
30842080|NCT02359864|58867678|FG001|Overall Study|Withdrawal by Subject|0|||
30842081|NCT02533258|58867684|FG000|Overall Study|Adverse Event|1|||
30842082|NCT02533258|58867684|FG000|Overall Study|Death|2|||
30842083|NCT02533258|58867684|FG000|Overall Study|Other|1|||
30842084|NCT02533258|58867684|FG000|Overall Study|Economic factor|1|||
30842085|NCT02533258|58867684|FG000|Overall Study|Progression of pleural effusion|1|||
30842086|NCT02533258|58867684|FG000|Overall Study|Lack of Efficacy|2|||
30842087|NCT03019627|58867703|FG000|Overall Study|Adverse Event|8|||
30842088|NCT03019627|58867704|FG001|Overall Study|Adverse Event|0|||
30842089|NCT03019627|58867703|FG000|Overall Study|Unrelated to adverse event|1|||
30842090|NCT03019627|58867704|FG001|Overall Study|Unrelated to adverse event|3|||
30842091|NCT03019627|58867703|FG000|Overall Study|Lost to Follow-up|2|||
30842092|NCT03019627|58867704|FG001|Overall Study|Lost to Follow-up|1|||
30842093|NCT03019627|58867703|FG000|Overall Study|not compliance|2|||
30842094|NCT03019627|58867704|FG001|Overall Study|not compliance|2|||
30842095|NCT03019627|58867703|FG000|Overall Study|Other|2|||
30842096|NCT03019627|58867704|FG001|Overall Study|Other|2|||
30842097|NCT01661140|58867710|FG000|Open-Label Period|Adverse Event|44|||
30842098|NCT01661140|58867711|FG001|Open-Label Period|Adverse Event|0|||
30842099|NCT01661140|58867712|FG002|Open-Label Period|Adverse Event|0|||
30842100|NCT01661140|58867710|FG000|Open-Label Period|Protocol Violation|3|||
30842101|NCT01661140|58867711|FG001|Open-Label Period|Protocol Violation|0|||
30842102|NCT01661140|58867712|FG002|Open-Label Period|Protocol Violation|0|||
30842103|NCT01661140|58867710|FG000|Open-Label Period|Withdrawal by Subject|5|||
30842104|NCT01661140|58867711|FG001|Open-Label Period|Withdrawal by Subject|0|||
30842105|NCT01661140|58867712|FG002|Open-Label Period|Withdrawal by Subject|0|||
30842106|NCT01661140|58867710|FG000|Open-Label Period|Investigator Decision|3|||
30842107|NCT01661140|58867711|FG001|Open-Label Period|Investigator Decision|0|||
30842108|NCT01661140|58867712|FG002|Open-Label Period|Investigator Decision|0|||
30842109|NCT01661140|58867710|FG000|Open-Label Period|Death|1|||
30842110|NCT01661140|58867711|FG001|Open-Label Period|Death|0|||
30842111|NCT01661140|58867712|FG002|Open-Label Period|Death|0|||
30842112|NCT01661140|58867710|FG000|Open-Label Period|Administrative/Other|1|||
30842113|NCT01661140|58867711|FG001|Open-Label Period|Administrative/Other|0|||
30842114|NCT01661140|58867712|FG002|Open-Label Period|Administrative/Other|0|||
30842115|NCT01661140|58867710|FG000|Open-Label Period|Sponsor termination|16|||
30842116|NCT01661140|58867711|FG001|Open-Label Period|Sponsor termination|0|||
30842117|NCT01661140|58867712|FG002|Open-Label Period|Sponsor termination|0|||
30842118|NCT01661140|58867710|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
30842119|NCT01661140|58867711|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
30842120|NCT01661140|58867712|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
30842121|NCT01661140|58867710|FG000|Open-Label Period|Lost to Follow-up|2|||
30842122|NCT01661140|58867711|FG001|Open-Label Period|Lost to Follow-up|0|||
30842123|NCT01661140|58867712|FG002|Open-Label Period|Lost to Follow-up|0|||
30842124|NCT01661140|58867710|FG000|Double-Blind Period|Refused Treatment|0|||
30842125|NCT01661140|58867711|FG001|Double-Blind Period|Refused Treatment|0|||
30842126|NCT01661140|58867712|FG002|Double-Blind Period|Refused Treatment|1|||
30842127|NCT01661140|58867710|FG000|Double-Blind Period|Adverse Event|0|||
30842128|NCT01661140|58867711|FG001|Double-Blind Period|Adverse Event|16|||
30842129|NCT01661140|58867712|FG002|Double-Blind Period|Adverse Event|18|||
30842130|NCT01661140|58867710|FG000|Double-Blind Period|Protocol Violation|0|||
30842131|NCT01661140|58867711|FG001|Double-Blind Period|Protocol Violation|2|||
30842132|NCT01661140|58867712|FG002|Double-Blind Period|Protocol Violation|3|||
30842133|NCT01661140|58867710|FG000|Double-Blind Period|Withdrawal by Subject|0|||
30842134|NCT01661140|58867711|FG001|Double-Blind Period|Withdrawal by Subject|1|||
30842135|NCT01661140|58867712|FG002|Double-Blind Period|Withdrawal by Subject|3|||
30842136|NCT01661140|58867710|FG000|Double-Blind Period|Investigator's Decision|0|||
30842137|NCT01661140|58867711|FG001|Double-Blind Period|Investigator's Decision|1|||
30842138|NCT01661140|58867712|FG002|Double-Blind Period|Investigator's Decision|2|||
30842139|NCT01661140|58867710|FG000|Double-Blind Period|Sponsor Termination|0|||
30842140|NCT01661140|58867711|FG001|Double-Blind Period|Sponsor Termination|14|||
30842141|NCT01661140|58867712|FG002|Double-Blind Period|Sponsor Termination|17|||
30842142|NCT01661140|58867710|FG000|Double-Blind Period|Administrative/Other|0|||
30842143|NCT01661140|58867711|FG001|Double-Blind Period|Administrative/Other|7|||
30842144|NCT01661140|58867712|FG002|Double-Blind Period|Administrative/Other|6|||
30842145|NCT03019549|58867720|FG000|Washout|DId not meet genotype criteria|11|||
30842146|NCT03019549|58867720|FG000|Period 2|Adverse Event|2|||
30842147|NCT03019549|58867720|FG000|Period 2|Physician Decision|2|||
30842148|NCT03019549|58867720|FG000|Period 2|Withdrawal by Subject|1|||
30842149|NCT01661062|58867729|FG000|Overall Study|Completed Treatment Off Study|3|||
30842150|NCT01661062|58867729|FG000|Overall Study|Withdrawal by Subject|2|||
30842151|NCT02536378|58867735|FG000|Overall Study|Physician Decision|0|||
30842152|NCT02536378|58867736|FG001|Overall Study|Physician Decision|2|||
30842153|NCT02536378|58867735|FG000|Overall Study|Withdrawal by Subject|0|||
30842154|NCT02536378|58867736|FG001|Overall Study|Withdrawal by Subject|1|||
30842155|NCT02536378|58867735|FG000|Overall Study|Death|1|||
30842156|NCT02536378|58867736|FG001|Overall Study|Death|2|||
30948545|NCT01974323|58994554|FG001|Overall Study|Lack of Efficacy|1|||
30938103|NCT01806662|58975261|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
30938104|NCT01806662|58975262|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
30938105|NCT01930123|58975270|FG000|Overall Study|Adverse Event|1|||
30938106|NCT01930123|58975271|FG001|Overall Study|Adverse Event|0|||
30938107|NCT01930123|58975270|FG000|Overall Study|Physician Decision|21|||
30938108|NCT01930123|58975271|FG001|Overall Study|Physician Decision|8|||
30938109|NCT01930123|58975270|FG000|Overall Study|Withdrawal by Subject|1|||
30938110|NCT01930123|58975271|FG001|Overall Study|Withdrawal by Subject|0|||
30938111|NCT01930045|58975277|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
30938112|NCT01930045|58975278|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
30938113|NCT01930045|58975279|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
30938114|NCT01930045|58975280|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
30938115|NCT01930045|58975281|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
30938116|NCT01930045|58975282|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
30938117|NCT01930045|58975277|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
30938118|NCT01930045|58975278|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
30938119|NCT01930045|58975279|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
30938120|NCT01930045|58975280|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
30938121|NCT01930045|58975281|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
30938122|NCT01930045|58975282|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
30938123|NCT01929343|58975297|FG000|Overall Study|Physician Decision|0|||
30938124|NCT01929343|58975298|FG001|Overall Study|Physician Decision|2|||
30938125|NCT01929343|58975299|FG002|Overall Study|Physician Decision|0|||
30938126|NCT01929343|58975297|FG000|Overall Study|Withdrawal by Subject|1|||
30938127|NCT01929343|58975298|FG001|Overall Study|Withdrawal by Subject|0|||
30938128|NCT01929343|58975299|FG002|Overall Study|Withdrawal by Subject|0|||
30938129|NCT01968811|58975307|FG000|Overall Study|Protocol Violation|4|||
30938130|NCT01968811|58975307|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
30938131|NCT01806584|58975313|FG000|Overall Study|Adverse Event|2|||
30938132|NCT01806584|58975314|FG001|Overall Study|Adverse Event|1|||
30938133|NCT01806584|58975313|FG000|Overall Study|Death|1|||
30938134|NCT01806584|58975314|FG001|Overall Study|Death|0|||
30938135|NCT01806584|58975313|FG000|Overall Study|Lost to Follow-up|0|||
30938136|NCT01806584|58975314|FG001|Overall Study|Lost to Follow-up|2|||
30938137|NCT01806584|58975313|FG000|Overall Study|Study terminated by sponsor|9|||
30938138|NCT01806584|58975314|FG001|Overall Study|Study terminated by sponsor|14|||
30938139|NCT01806584|58975313|FG000|Overall Study|Withdrawal by Subject|1|||
30938140|NCT01806584|58975314|FG001|Overall Study|Withdrawal by Subject|1|||
30938141|NCT01806584|58975313|FG000|Overall Study|Other unspecified|1|||
30938142|NCT01806584|58975314|FG001|Overall Study|Other unspecified|0|||
30938143|NCT01798706|58975322|FG000|Overall Study|Adverse Event|15|||
30938144|NCT01798706|58975323|FG001|Overall Study|Adverse Event|10|||
30938145|NCT01798706|58975322|FG000|Overall Study|Lack of Efficacy|0|||
30938146|NCT01798706|58975323|FG001|Overall Study|Lack of Efficacy|2|||
30938147|NCT01798706|58975322|FG000|Overall Study|Poor compliance to protocol|1|||
30938148|NCT01798706|58975323|FG001|Overall Study|Poor compliance to protocol|0|||
30938149|NCT01798706|58975322|FG000|Overall Study|Other than specified above|5|||
30938150|NCT01798706|58975323|FG001|Overall Study|Other than specified above|9|||
30938151|NCT01767194|58975331|FG000|Overall Study|Adverse Event|1|||
30938152|NCT01767194|58975332|FG001|Overall Study|Adverse Event|1|||
30938153|NCT01767194|58975331|FG000|Overall Study|Death|0|||
30938154|NCT01767194|58975332|FG001|Overall Study|Death|1|||
30938155|NCT01767194|58975331|FG000|Overall Study|Lack of Efficacy|12|||
30938156|NCT01767194|58975332|FG001|Overall Study|Lack of Efficacy|11|||
30938157|NCT01767194|58975331|FG000|Overall Study|Physician Decision|2|||
30938158|NCT01767194|58975332|FG001|Overall Study|Physician Decision|23|||
30938159|NCT01767194|58975331|FG000|Overall Study|Withdrawal by Subject|0|||
30938160|NCT01767194|58975332|FG001|Overall Study|Withdrawal by Subject|1|||
30938161|NCT01767194|58975331|FG000|Overall Study|Ineligible|1|||
30938162|NCT01767194|58975332|FG001|Overall Study|Ineligible|1|||
30938163|NCT01767194|58975331|FG000|Overall Study|Refusal by patient/parent|2|||
30938164|NCT01767194|58975332|FG001|Overall Study|Refusal by patient/parent|4|||
30938165|NCT01767194|58975331|FG000|Overall Study|Criteria not met on time for next cycle|0|||
30938166|NCT01767194|58975332|FG001|Overall Study|Criteria not met on time for next cycle|1|||
30938167|NCT01575873|58975343|FG000|Overall Study|Withdrawal by Subject|15|||
30938168|NCT01575873|58975344|FG001|Overall Study|Withdrawal by Subject|20|||
30624452|NCT01117350|58636533|FG001|Comparative Period|Move to another city/country|1|||
30938169|NCT01575873|58975345|FG002|Overall Study|Withdrawal by Subject|34|||
30938170|NCT01575873|58975346|FG003|Overall Study|Withdrawal by Subject|34|||
30938171|NCT01575873|58975343|FG000|Overall Study|Adverse Event|7|||
30938172|NCT01575873|58975344|FG001|Overall Study|Adverse Event|7|||
30938173|NCT01575873|58975345|FG002|Overall Study|Adverse Event|9|||
30938174|NCT01575873|58975346|FG003|Overall Study|Adverse Event|12|||
30938175|NCT01575873|58975343|FG000|Overall Study|Lost to Follow-up|1|||
30938176|NCT01575873|58975344|FG001|Overall Study|Lost to Follow-up|3|||
30938177|NCT01575873|58975345|FG002|Overall Study|Lost to Follow-up|13|||
30938178|NCT01575873|58975346|FG003|Overall Study|Lost to Follow-up|5|||
30938179|NCT01575873|58975343|FG000|Overall Study|Death|3|||
30938180|NCT01575873|58975344|FG001|Overall Study|Death|2|||
30938181|NCT01575873|58975345|FG002|Overall Study|Death|8|||
30938182|NCT01575873|58975346|FG003|Overall Study|Death|9|||
30938183|NCT01575873|58975343|FG000|Overall Study|Noncompliance|1|||
30938184|NCT01575873|58975344|FG001|Overall Study|Noncompliance|2|||
30938185|NCT01575873|58975345|FG002|Overall Study|Noncompliance|4|||
30938186|NCT01575873|58975346|FG003|Overall Study|Noncompliance|3|||
30938187|NCT01575873|58975343|FG000|Overall Study|Administrative decision|1|||
30938188|NCT01575873|58975344|FG001|Overall Study|Administrative decision|1|||
30938189|NCT01575873|58975345|FG002|Overall Study|Administrative decision|1|||
30938190|NCT01575873|58975346|FG003|Overall Study|Administrative decision|0|||
30938191|NCT01575873|58975343|FG000|Overall Study|Protocol deviation|0|||
30938192|NCT01575873|58975344|FG001|Overall Study|Protocol deviation|1|||
30938193|NCT01575873|58975345|FG002|Overall Study|Protocol deviation|0|||
30938194|NCT01575873|58975346|FG003|Overall Study|Protocol deviation|1|||
30938195|NCT01575873|58975343|FG000|Overall Study|Requirement for Alternative Therapy|0|||
30938196|NCT01575873|58975344|FG001|Overall Study|Requirement for Alternative Therapy|0|||
30938197|NCT01575873|58975345|FG002|Overall Study|Requirement for Alternative Therapy|1|||
30938198|NCT01575873|58975346|FG003|Overall Study|Requirement for Alternative Therapy|1|||
30938199|NCT01575873|58975343|FG000|Overall Study|Other|0|||
30938200|NCT01575873|58975344|FG001|Overall Study|Other|0|||
30938201|NCT01575873|58975345|FG002|Overall Study|Other|4|||
30938202|NCT01575873|58975346|FG003|Overall Study|Other|2|||
30938203|NCT01575561|58975354|FG000|Overall Study|Adverse Event|9|||
30938204|NCT01575561|58975354|FG000|Overall Study|Lack of Efficacy|8|||
30938205|NCT01575561|58975354|FG000|Overall Study|Lost to Follow-up|6|||
30938206|NCT01575561|58975354|FG000|Overall Study|Protocol Violation|4|||
30938207|NCT01575561|58975354|FG000|Overall Study|Withdrawal by Subject|11|||
30938208|NCT01575561|58975354|FG000|Overall Study|administration|1|||
30938209|NCT01609790|58975361|FG000|Overall Study|Protocol Violation|1|||
30938210|NCT01609790|58975362|FG001|Overall Study|Protocol Violation|7|||
30938211|NCT01609790|58975363|FG002|Overall Study|Protocol Violation|8|||
30938212|NCT01767116|58975373|FG000|Overall Study|Lost to Follow-up|2|||
30938213|NCT01767116|58975374|FG001|Overall Study|Lost to Follow-up|2|||
30938214|NCT01574703|58975384|FG000|Overall Study|Adverse Event|0|||
30938215|NCT01574703|58975385|FG001|Overall Study|Adverse Event|2|||
30938216|NCT01574703|58975386|FG002|Overall Study|Adverse Event|1|||
30938217|NCT01574703|58975387|FG003|Overall Study|Adverse Event|1|||
30938218|NCT01574703|58975384|FG000|Overall Study|Protocol Violation|0|||
30938219|NCT01574703|58975385|FG001|Overall Study|Protocol Violation|0|||
30938220|NCT01574703|58975386|FG002|Overall Study|Protocol Violation|0|||
30938221|NCT01574703|58975387|FG003|Overall Study|Protocol Violation|1|||
30938222|NCT01574703|58975384|FG000|Overall Study|Unspecified Reason|27|||
30938223|NCT01574703|58975385|FG001|Overall Study|Unspecified Reason|15|||
30938224|NCT01574703|58975386|FG002|Overall Study|Unspecified Reason|20|||
30938225|NCT01574703|58975387|FG003|Overall Study|Unspecified Reason|16|||
30938226|NCT01574703|58975384|FG000|Overall Study|Withdrawal by Subject|53|||
30938227|NCT01574703|58975385|FG001|Overall Study|Withdrawal by Subject|52|||
30938228|NCT01574703|58975386|FG002|Overall Study|Withdrawal by Subject|36|||
30938229|NCT01574703|58975387|FG003|Overall Study|Withdrawal by Subject|61|||
30938230|NCT01574703|58975384|FG000|Overall Study|Met Withdrawal Criteria|0|||
30938231|NCT01574703|58975385|FG001|Overall Study|Met Withdrawal Criteria|1|||
30938232|NCT01574703|58975386|FG002|Overall Study|Met Withdrawal Criteria|1|||
30938233|NCT01574703|58975387|FG003|Overall Study|Met Withdrawal Criteria|0|||
30938234|NCT01574703|58975384|FG000|Overall Study|Lost to Follow-up|43|||
30938235|NCT01574703|58975385|FG001|Overall Study|Lost to Follow-up|41|||
30938236|NCT01574703|58975386|FG002|Overall Study|Lost to Follow-up|46|||
30938237|NCT01574703|58975387|FG003|Overall Study|Lost to Follow-up|35|||
30938238|NCT01574703|58975384|FG000|Overall Study|Death|2|||
30624453|NCT01117350|58636532|FG000|Extension Period|Not included in extension, not treated|0|||
30759169|NCT03572062|58767622|FG003|Overall Study|Randomized But Not Treated|0|||
30759170|NCT03572062|58767623|FG004|Overall Study|Randomized But Not Treated|1|||
30842157|NCT02536378|58867735|FG000|Overall Study|Patient refused further follow up|6|||
30938239|NCT01574703|58975385|FG001|Overall Study|Death|1|||
30938240|NCT01574703|58975386|FG002|Overall Study|Death|1|||
30938241|NCT01574703|58975387|FG003|Overall Study|Death|0|||
30938242|NCT01686633|58975400|FG000|Overall Study|Lack of Efficacy|33|||
30938243|NCT01686633|58975401|FG001|Overall Study|Lack of Efficacy|13|||
30938244|NCT01686633|58975402|FG002|Overall Study|Lack of Efficacy|11|||
30938245|NCT01686633|58975400|FG000|Overall Study|Withdrawal by Subject|8|||
30938246|NCT01686633|58975401|FG001|Overall Study|Withdrawal by Subject|8|||
30938247|NCT01686633|58975402|FG002|Overall Study|Withdrawal by Subject|5|||
30938248|NCT01686633|58975400|FG000|Overall Study|Physician Decision|3|||
30938249|NCT01686633|58975401|FG001|Overall Study|Physician Decision|4|||
30938250|NCT01686633|58975402|FG002|Overall Study|Physician Decision|4|||
30938251|NCT01686633|58975400|FG000|Overall Study|Adverse Event|4|||
30938252|NCT01686633|58975401|FG001|Overall Study|Adverse Event|3|||
30938253|NCT01686633|58975402|FG002|Overall Study|Adverse Event|3|||
30938254|NCT01686633|58975400|FG000|Overall Study|Protocol Violation|2|||
30938255|NCT01686633|58975401|FG001|Overall Study|Protocol Violation|3|||
30938256|NCT01686633|58975402|FG002|Overall Study|Protocol Violation|0|||
30938257|NCT01686633|58975400|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
30938258|NCT01686633|58975401|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
30938259|NCT01686633|58975402|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
30938260|NCT01686633|58975400|FG000|Overall Study|Lost to Follow-up|0|||
30938261|NCT01686633|58975401|FG001|Overall Study|Lost to Follow-up|1|||
30938262|NCT01686633|58975402|FG002|Overall Study|Lost to Follow-up|1|||
30938263|NCT01685697|58975412|FG000|Overall Study|Protocol Violation|3|||
30938264|NCT01685697|58975413|FG001|Overall Study|Protocol Violation|3|||
30938265|NCT02395120|58975424|FG000|Overall Study|Missed follow-up dental exam|57|||
30938266|NCT02395120|58975425|FG001|Overall Study|Missed follow-up dental exam|62|||
30938267|NCT02395120|58975426|FG002|Overall Study|Missed follow-up dental exam|6|||
30938268|NCT02395120|58975427|FG003|Overall Study|Missed follow-up dental exam|6|||
30938269|NCT02395120|58975428|FG004|Overall Study|Missed follow-up dental exam|51|||
30938270|NCT01685229|58975442|FG000|Overall Study|Subjects missing Study Exit form|3|||
30938271|NCT01685229|58975443|FG001|Overall Study|Subjects missing Study Exit form|1|||
30938272|NCT01685229|58975442|FG000|Overall Study|Lost to Follow-up|16|||
30938273|NCT01685229|58975443|FG001|Overall Study|Lost to Follow-up|10|||
30938274|NCT01685229|58975442|FG000|Overall Study|Withdrawal by Subject|6|||
30938275|NCT01685229|58975443|FG001|Overall Study|Withdrawal by Subject|5|||
30938276|NCT01685229|58975442|FG000|Overall Study|Death|1|||
30938277|NCT01685229|58975443|FG001|Overall Study|Death|0|||
30938278|NCT01551693|58975454|FG000|Overall Study|Disease Progression|1|||
30938279|NCT01551693|58975455|FG001|Overall Study|Disease Progression|0|||
30938280|NCT01551693|58975454|FG000|Overall Study|Adverse Event|0|||
30938281|NCT01551693|58975455|FG001|Overall Study|Adverse Event|1|||
30938282|NCT01551693|58975454|FG000|Overall Study|Withdrawal by Subject|0|||
30938283|NCT01551693|58975455|FG001|Overall Study|Withdrawal by Subject|1|||
30938284|NCT01574157|58975463|FG000|Overall Study|Withdrawal by Subject|4|||
30938285|NCT01574157|58975464|FG001|Overall Study|Withdrawal by Subject|5|||
30938286|NCT01574157|58975463|FG000|Overall Study|Lost to Follow-up|0|||
30938287|NCT01574157|58975464|FG001|Overall Study|Lost to Follow-up|3|||
30938288|NCT01574079|58975476|FG000|Overall Study|Physician Decision|0|||
30938289|NCT01574079|58975477|FG001|Overall Study|Physician Decision|2|||
30938290|NCT01574079|58975476|FG000|Overall Study|Lost to Follow-up|1|||
30938291|NCT01574079|58975477|FG001|Overall Study|Lost to Follow-up|0|||
30938292|NCT01573767|58975487|FG000|Overall Study|Adverse Event|0|||
30938293|NCT01573767|58975488|FG001|Overall Study|Adverse Event|1|||
30938294|NCT01573767|58975489|FG002|Overall Study|Adverse Event|0|||
30938295|NCT01573767|58975490|FG003|Overall Study|Adverse Event|1|||
30938296|NCT01573767|58975487|FG000|Overall Study|Lack of Efficacy|18|||
30938297|NCT01573767|58975488|FG001|Overall Study|Lack of Efficacy|15|||
30938298|NCT01573767|58975489|FG002|Overall Study|Lack of Efficacy|12|||
30938299|NCT01573767|58975490|FG003|Overall Study|Lack of Efficacy|17|||
30938300|NCT01573767|58975487|FG000|Overall Study|Protocol Violation|3|||
30938301|NCT01573767|58975488|FG001|Overall Study|Protocol Violation|1|||
30938302|NCT01573767|58975489|FG002|Overall Study|Protocol Violation|1|||
30938303|NCT01573767|58975490|FG003|Overall Study|Protocol Violation|3|||
30938304|NCT01573767|58975487|FG000|Overall Study|Lost to Follow-up|0|||
30938305|NCT01573767|58975488|FG001|Overall Study|Lost to Follow-up|1|||
30938306|NCT01573767|58975489|FG002|Overall Study|Lost to Follow-up|1|||
30938307|NCT01573767|58975490|FG003|Overall Study|Lost to Follow-up|1|||
30938308|NCT01573767|58975487|FG000|Overall Study|Physician Decision|1|||
30938309|NCT01573767|58975488|FG001|Overall Study|Physician Decision|2|||
30938310|NCT01573767|58975489|FG002|Overall Study|Physician Decision|0|||
30938311|NCT01573767|58975490|FG003|Overall Study|Physician Decision|2|||
30938312|NCT01573767|58975487|FG000|Overall Study|Withdrawal by Subject|0|||
30938313|NCT01573767|58975488|FG001|Overall Study|Withdrawal by Subject|1|||
30938314|NCT01573767|58975489|FG002|Overall Study|Withdrawal by Subject|0|||
30938315|NCT01573767|58975490|FG003|Overall Study|Withdrawal by Subject|0|||
30938316|NCT01551303|58975502|FG000|Overall Study|failed awareness check on vision test|4|||
30938317|NCT01551303|58975503|FG001|Overall Study|failed awareness check on vision test|7|||
30938318|NCT00638404|58975511|FG000|Overall Study|Physician Decision|8|||
30938319|NCT00638404|58975512|FG001|Overall Study|Physician Decision|0|||
30938320|NCT01550757|58975526|FG000|Overall Study|Lost to Follow-up|21|||
30938321|NCT01550757|58975527|FG001|Overall Study|Lost to Follow-up|14|||
30938322|NCT01550757|58975528|FG002|Overall Study|Lost to Follow-up|42|||
30938323|NCT01550757|58975529|FG003|Overall Study|Lost to Follow-up|53|||
30938324|NCT01550757|58975526|FG000|Overall Study|Withdrawal by Subject|2|||
30938325|NCT01550757|58975527|FG001|Overall Study|Withdrawal by Subject|0|||
30938326|NCT01550757|58975528|FG002|Overall Study|Withdrawal by Subject|3|||
30938327|NCT01550757|58975529|FG003|Overall Study|Withdrawal by Subject|1|||
30938328|NCT01685073|58975541|FG000|Overall Study|Lost to Follow-up|6|||
30938329|NCT01685073|58975542|FG001|Overall Study|Lost to Follow-up|8|||
30938330|NCT01685073|58975541|FG000|Overall Study|Withdrawal by Subject|24|||
30938331|NCT01685073|58975542|FG001|Overall Study|Withdrawal by Subject|24|||
30938332|NCT01572909|58975550|FG000|Overall Study|Adverse Event|7|||
30938333|NCT01572909|58975551|FG001|Overall Study|Adverse Event|2|||
30938334|NCT01572909|58975550|FG000|Overall Study|Death|3|||
30938335|NCT01572909|58975551|FG001|Overall Study|Death|1|||
30938336|NCT01572909|58975550|FG000|Overall Study|Lost to Follow-up|8|||
30938337|NCT01572909|58975551|FG001|Overall Study|Lost to Follow-up|7|||
30938338|NCT01572909|58975550|FG000|Overall Study|Physician Decision|1|||
30938339|NCT01572909|58975551|FG001|Overall Study|Physician Decision|1|||
30938340|NCT01572909|58975550|FG000|Overall Study|Technical Issues|1|||
30938341|NCT01572909|58975551|FG001|Overall Study|Technical Issues|0|||
30938342|NCT01572909|58975550|FG000|Overall Study|Withdrawal by Subject|12|||
30938343|NCT01572909|58975551|FG001|Overall Study|Withdrawal by Subject|11|||
30938344|NCT01572909|58975550|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
30938345|NCT01572909|58975551|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
30938346|NCT01572675|58975561|FG000|Overall Study|End of prescribed treatment|140|||
30938347|NCT01572675|58975562|FG001|Overall Study|End of prescribed treatment|118|||
30938348|NCT01572675|58975561|FG000|Overall Study|Recovery|16|||
30938349|NCT01572675|58975562|FG001|Overall Study|Recovery|23|||
30938350|NCT01572675|58975561|FG000|Overall Study|Lack of Efficacy|31|||
30938351|NCT01572675|58975562|FG001|Overall Study|Lack of Efficacy|31|||
30938352|NCT01572675|58975561|FG000|Overall Study|Intolerance|6|||
30938353|NCT01572675|58975562|FG001|Overall Study|Intolerance|5|||
30938354|NCT01572675|58975561|FG000|Overall Study|Improved symptoms|8|||
30938355|NCT01572675|58975562|FG001|Overall Study|Improved symptoms|2|||
30938356|NCT01572675|58975561|FG000|Overall Study|Surgical intervention|3|||
30938357|NCT01572675|58975562|FG001|Overall Study|Surgical intervention|6|||
30938358|NCT01572675|58975561|FG000|Overall Study|Withdrawal by Subject|5|||
30938359|NCT01572675|58975562|FG001|Overall Study|Withdrawal by Subject|1|||
30938360|NCT01572675|58975561|FG000|Overall Study|Physician Decision|2|||
30938361|NCT01572675|58975562|FG001|Overall Study|Physician Decision|2|||
30938362|NCT01572675|58975561|FG000|Overall Study|Death unrelated to coxibs|1|||
30938363|NCT01572675|58975562|FG001|Overall Study|Death unrelated to coxibs|1|||
30938364|NCT01572675|58975561|FG000|Overall Study|Other disease detected|1|||
30938365|NCT01572675|58975562|FG001|Overall Study|Other disease detected|1|||
30938366|NCT01572675|58975561|FG000|Overall Study|Unknown reason|1|||
30938367|NCT01572675|58975562|FG001|Overall Study|Unknown reason|1|||
30938368|NCT01572675|58975561|FG000|Overall Study|Rheumatologist new evaluation|0|||
30938369|NCT01572675|58975562|FG001|Overall Study|Rheumatologist new evaluation|1|||
30938370|NCT01572675|58975561|FG000|Overall Study|Missing data|1|||
30938371|NCT01572675|58975562|FG001|Overall Study|Missing data|4|||
30938372|NCT01572675|58975561|FG000|Overall Study|Lost to Follow-up|22|||
30938373|NCT01572675|58975562|FG001|Overall Study|Lost to Follow-up|27|||
30938374|NCT05065983|58975581|FG000|Overall Study|Lost to Follow-up|2|||
30938375|NCT04797650|58975588|FG000|Overall Study|Reason Not Specified|5|||
30938376|NCT04797650|58975589|FG001|Overall Study|Reason Not Specified|12|||
30938377|NCT04797650|58975590|FG002|Overall Study|Reason Not Specified|5|||
30938378|NCT04797650|58975588|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
30938379|NCT04797650|58975589|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
30938380|NCT04797650|58975590|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
30938381|NCT04797650|58975588|FG000|Overall Study|Lack of Efficacy|1|||
30938382|NCT04797650|58975589|FG001|Overall Study|Lack of Efficacy|0|||
30938383|NCT04797650|58975590|FG002|Overall Study|Lack of Efficacy|1|||
30938384|NCT04797650|58975588|FG000|Overall Study|Non-compliance with Study Drug|0|||
30938385|NCT04797650|58975589|FG001|Overall Study|Non-compliance with Study Drug|0|||
30938386|NCT04797650|58975590|FG002|Overall Study|Non-compliance with Study Drug|2|||
30938387|NCT04797650|58975588|FG000|Overall Study|Lost to Follow-up|4|||
30938388|NCT04797650|58975589|FG001|Overall Study|Lost to Follow-up|6|||
30938389|NCT04797650|58975590|FG002|Overall Study|Lost to Follow-up|1|||
30938390|NCT04705597|58975602|FG000|Overall Study|Death|16|||
30938391|NCT04705597|58975603|FG001|Overall Study|Death|9|||
30938392|NCT04705597|58975602|FG000|Overall Study|Lost to Follow-up|1|||
30938393|NCT04705597|58975603|FG001|Overall Study|Lost to Follow-up|0|||
30938394|NCT04705597|58975602|FG000|Overall Study|Withdrawal by Subject|1|||
30938395|NCT04705597|58975603|FG001|Overall Study|Withdrawal by Subject|2|||
30938396|NCT04534114|58975617|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
30938397|NCT04534114|58975618|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
30938398|NCT04534114|58975619|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
30938399|NCT04534114|58975620|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
30938400|NCT04534114|58975617|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
30938401|NCT04534114|58975618|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
30938402|NCT04534114|58975619|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
30938403|NCT04534114|58975620|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
30938404|NCT04534114|58975617|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
30938405|NCT04534114|58975618|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
30938406|NCT04534114|58975619|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
30938407|NCT04534114|58975620|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
30938408|NCT04534114|58975617|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
30938409|NCT04534114|58975618|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
30938410|NCT04534114|58975619|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
30938411|NCT04534114|58975620|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
30938412|NCT04534114|58975617|FG000|Main Treatment Period|Physician Decision|0|||
30938413|NCT04534114|58975618|FG001|Main Treatment Period|Physician Decision|0|||
30938414|NCT04534114|58975619|FG002|Main Treatment Period|Physician Decision|0|||
30938415|NCT04534114|58975620|FG003|Main Treatment Period|Physician Decision|1|||
30938416|NCT04534114|58975617|FG000|Main Treatment Period|Death|1|||
30938417|NCT04534114|58975618|FG001|Main Treatment Period|Death|0|||
30938418|NCT04534114|58975619|FG002|Main Treatment Period|Death|0|||
30938419|NCT04534114|58975620|FG003|Main Treatment Period|Death|1|||
30938420|NCT04534114|58975617|FG000|Main Treatment Period|Other reason|1|||
30938421|NCT04534114|58975618|FG001|Main Treatment Period|Other reason|1|||
30938422|NCT04534114|58975619|FG002|Main Treatment Period|Other reason|0|||
30938423|NCT04534114|58975620|FG003|Main Treatment Period|Other reason|0|||
30938424|NCT04534114|58975617|FG000|Main Treatment Period|Participant decision|1|||
30938425|NCT04534114|58975618|FG001|Main Treatment Period|Participant decision|3|||
30938426|NCT04534114|58975619|FG002|Main Treatment Period|Participant decision|3|||
30938427|NCT04534114|58975620|FG003|Main Treatment Period|Participant decision|1|||
30938428|NCT04534114|58975617|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
30938429|NCT04534114|58975618|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
30938430|NCT04534114|58975619|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
30938431|NCT04534114|58975620|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
30938432|NCT04534114|58975617|FG000|Main Treatment Period|Adverse Event|4|||
30938433|NCT04534114|58975618|FG001|Main Treatment Period|Adverse Event|2|||
30938434|NCT04534114|58975619|FG002|Main Treatment Period|Adverse Event|1|||
30938435|NCT04534114|58975620|FG003|Main Treatment Period|Adverse Event|2|||
30938436|NCT04534114|58975617|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
30938437|NCT04534114|58975618|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
30938438|NCT04534114|58975619|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
30938439|NCT04534114|58975620|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
30938440|NCT04534114|58975617|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
30938441|NCT04534114|58975618|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
30938442|NCT04534114|58975619|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
30938443|NCT04534114|58975620|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
30938444|NCT04534114|58975617|FG000|Extension Treatment Period|Other reason|0|||
30938445|NCT04534114|58975618|FG001|Extension Treatment Period|Other reason|1|||
30938446|NCT04534114|58975619|FG002|Extension Treatment Period|Other reason|0|||
30938447|NCT04534114|58975620|FG003|Extension Treatment Period|Other reason|0|||
30938448|NCT04534114|58975617|FG000|Extension Treatment Period|Death|0|||
30938449|NCT04534114|58975618|FG001|Extension Treatment Period|Death|0|||
30938450|NCT04534114|58975619|FG002|Extension Treatment Period|Death|1|||
30938451|NCT04534114|58975620|FG003|Extension Treatment Period|Death|2|||
30938452|NCT04534114|58975617|FG000|Extension Treatment Period|Adverse Event|0|||
30938453|NCT04534114|58975618|FG001|Extension Treatment Period|Adverse Event|1|||
30938454|NCT04534114|58975619|FG002|Extension Treatment Period|Adverse Event|0|||
30938455|NCT04534114|58975620|FG003|Extension Treatment Period|Adverse Event|1|||
30938456|NCT04534114|58975617|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
30938457|NCT04534114|58975618|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
30938458|NCT04534114|58975619|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
30938459|NCT04534114|58975620|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
30938460|NCT04474366|58975641|FG000|Overall Study|Lost to Follow-up|2|||
30938461|NCT04474366|58975642|FG001|Overall Study|Lost to Follow-up|5|||
30938462|NCT04422431|58975648|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
30938463|NCT04422431|58975648|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
30938464|NCT04422431|58975648|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
30938465|NCT04422431|58975648|FG000|Extension Period (48 Weeks)|ongoing in the Extension Period|25|||
30938466|NCT04115488|58975659|FG000|Overall Study|Adverse Event|8|||
30938467|NCT04115488|58975660|FG001|Overall Study|Adverse Event|4|||
30624454|NCT01117350|58636533|FG001|Extension Period|Not included in extension, not treated|50|||
30938468|NCT04115488|58975659|FG000|Overall Study|Withdrawal by Subject|3|||
30938469|NCT04115488|58975660|FG001|Overall Study|Withdrawal by Subject|6|||
30938470|NCT04115488|58975659|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
30938471|NCT04115488|58975660|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
30938472|NCT04115488|58975659|FG000|Overall Study|Patient 's location change|1|||
30938473|NCT04115488|58975660|FG001|Overall Study|Patient 's location change|0|||
30948546|NCT01974323|58994553|FG000|Overall Study|Adverse Event|2|||
30938474|NCT04115488|58975659|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
30938475|NCT04115488|58975660|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
30938476|NCT04080752|58975684|FG000|Overall Study|Adverse Event|2|||
30938477|NCT04080752|58975685|FG001|Overall Study|Adverse Event|3|||
30938478|NCT04080752|58975684|FG000|Overall Study|Lack of Efficacy|1|||
30938479|NCT04080752|58975685|FG001|Overall Study|Lack of Efficacy|0|||
30938480|NCT04080752|58975684|FG000|Overall Study|Lost to Follow-up|1|||
30938481|NCT04080752|58975685|FG001|Overall Study|Lost to Follow-up|0|||
30938482|NCT04080752|58975684|FG000|Overall Study|Pregnancy|0|||
30938483|NCT04080752|58975685|FG001|Overall Study|Pregnancy|1|||
30938484|NCT04080752|58975684|FG000|Overall Study|Withdrawal by Subject|7|||
30938485|NCT04080752|58975685|FG001|Overall Study|Withdrawal by Subject|0|||
30938486|NCT04080752|58975684|FG000|Overall Study|Non-Compliance with Study Drug|0|||
30938487|NCT04080752|58975685|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30938488|NCT04080752|58975684|FG000|Overall Study|Other|2|||
30938489|NCT04080752|58975685|FG001|Overall Study|Other|1|||
30938490|NCT03968419|58975695|FG000|Treatment Period|Adverse Event|0|||
30938491|NCT03968419|58975696|FG001|Treatment Period|Adverse Event|0|||
30938492|NCT03968419|58975697|FG002|Treatment Period|Adverse Event|1|||
30938493|NCT03968419|58975695|FG000|Safety Follow-up Period|Death|3|||
30938494|NCT03968419|58975696|FG001|Safety Follow-up Period|Death|2|||
30938495|NCT03968419|58975697|FG002|Safety Follow-up Period|Death|1|||
30938496|NCT03968419|58975695|FG000|Safety Follow-up Period|Subject Decision|2|||
30938497|NCT03968419|58975696|FG001|Safety Follow-up Period|Subject Decision|1|||
30938498|NCT03968419|58975697|FG002|Safety Follow-up Period|Subject Decision|0|||
30938499|NCT03816332|58975717|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
30938500|NCT03816332|58975717|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
30938501|NCT03784846|58975726|FG000|Pre-COVID Study|Lost to Follow-up|3|||
30938502|NCT03784846|58975727|FG001|Pre-COVID Study|Lost to Follow-up|3|||
30938503|NCT03784846|58975728|FG002|Pre-COVID Study|Lost to Follow-up|2|||
30938504|NCT03784846|58975726|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
30938505|NCT03784846|58975727|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
30938506|NCT03784846|58975728|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
30938507|NCT03784846|58975726|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
30938508|NCT03784846|58975727|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
30938509|NCT03784846|58975728|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
30938510|NCT03784846|58975726|FG000|Post-COVID Study|Lost to Follow-up|3|||
30938511|NCT03784846|58975727|FG001|Post-COVID Study|Lost to Follow-up|5|||
30938512|NCT03784846|58975728|FG002|Post-COVID Study|Lost to Follow-up|1|||
30938513|NCT03784846|58975726|FG000|Post-COVID Study|Withdrawal by Subject|1|||
30938514|NCT03784846|58975727|FG001|Post-COVID Study|Withdrawal by Subject|2|||
30938515|NCT03784846|58975728|FG002|Post-COVID Study|Withdrawal by Subject|0|||
30938516|NCT03756350|58975736|FG000|Overall Study|Lost to Follow-up|1|||
30938517|NCT03648996|58975758|FG000|Overall Study|Withdrawal by Subject|0|||
30938518|NCT03648996|58975759|FG001|Overall Study|Withdrawal by Subject|2|||
30938519|NCT03648996|58975760|FG002|Overall Study|Withdrawal by Subject|2|||
30938520|NCT03648996|58975758|FG000|Overall Study|Physician Decision|2|||
30938521|NCT03648996|58975759|FG001|Overall Study|Physician Decision|0|||
30938522|NCT03648996|58975760|FG002|Overall Study|Physician Decision|0|||
30938523|NCT03483961|58975785|FG000|Overall Study|Lost to Follow-up|7|||
30938524|NCT03483961|58975786|FG001|Overall Study|Lost to Follow-up|6|||
30938525|NCT03483961|58975787|FG002|Overall Study|Lost to Follow-up|6|||
30938526|NCT03483961|58975788|FG003|Overall Study|Lost to Follow-up|6|||
30938527|NCT03483961|58975789|FG004|Overall Study|Lost to Follow-up|6|||
30938528|NCT03483961|58975790|FG005|Overall Study|Lost to Follow-up|4|||
30938529|NCT03483961|58975791|FG006|Overall Study|Lost to Follow-up|4|||
30938530|NCT03483961|58975792|FG007|Overall Study|Lost to Follow-up|11|||
30938531|NCT03483961|58975793|FG008|Overall Study|Lost to Follow-up|1|||
30938532|NCT03483961|58975794|FG009|Overall Study|Lost to Follow-up|0|||
30938533|NCT03483961|58975785|FG000|Overall Study|Withdrawal by Subject|3|||
30938534|NCT03483961|58975786|FG001|Overall Study|Withdrawal by Subject|4|||
30938535|NCT03483961|58975787|FG002|Overall Study|Withdrawal by Subject|5|||
30938536|NCT03483961|58975788|FG003|Overall Study|Withdrawal by Subject|3|||
30938537|NCT03483961|58975789|FG004|Overall Study|Withdrawal by Subject|4|||
30938538|NCT03483961|58975790|FG005|Overall Study|Withdrawal by Subject|2|||
30938539|NCT03483961|58975791|FG006|Overall Study|Withdrawal by Subject|1|||
30938540|NCT03483961|58975792|FG007|Overall Study|Withdrawal by Subject|2|||
30938541|NCT03483961|58975793|FG008|Overall Study|Withdrawal by Subject|1|||
30938542|NCT03483961|58975794|FG009|Overall Study|Withdrawal by Subject|0|||
30938543|NCT03483961|58975785|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
30938544|NCT03483961|58975786|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
30938545|NCT03483961|58975787|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
30938546|NCT03483961|58975788|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
30938547|NCT03483961|58975789|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
30938548|NCT03483961|58975790|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
30938549|NCT03483961|58975791|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
30938550|NCT03483961|58975792|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
30938551|NCT03483961|58975793|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
30938552|NCT03483961|58975794|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
30938553|NCT03483961|58975785|FG000|Overall Study|Adverse Event|0|||
30938554|NCT03483961|58975786|FG001|Overall Study|Adverse Event|0|||
30938555|NCT03483961|58975787|FG002|Overall Study|Adverse Event|1|||
30938556|NCT03483961|58975788|FG003|Overall Study|Adverse Event|0|||
30938557|NCT03483961|58975789|FG004|Overall Study|Adverse Event|0|||
30938558|NCT03483961|58975790|FG005|Overall Study|Adverse Event|0|||
30938559|NCT03483961|58975791|FG006|Overall Study|Adverse Event|0|||
30938560|NCT03483961|58975792|FG007|Overall Study|Adverse Event|0|||
30938561|NCT03483961|58975793|FG008|Overall Study|Adverse Event|0|||
30938562|NCT03483961|58975794|FG009|Overall Study|Adverse Event|0|||
30938563|NCT03459807|58975821|FG000|Overall Study|Withdrawal due to transplant|0|||
30938564|NCT03459807|58975822|FG001|Overall Study|Withdrawal due to transplant|1|||
30938565|NCT03439293|58975835|FG000|Overall Study|Ongoing on Treatment|15|||
30938566|NCT03439293|58975835|FG000|Overall Study|Ongoing off Treatment|19|||
30938567|NCT03439293|58975835|FG000|Overall Study|Death|18|||
30938568|NCT03439293|58975835|FG000|Overall Study|Withdrawal by Subject|7|||
30938569|NCT03439293|58975835|FG000|Overall Study|Lost to Follow-up|2|||
30938570|NCT03423979|58975840|FG000|Overall Study|Death|1|||
30938571|NCT03239210|58975846|FG000|Overall Study|Lost to Follow-up|2|||
30938572|NCT03239210|58975847|FG001|Overall Study|Lost to Follow-up|2|||
30938573|NCT03239210|58975846|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
30938574|NCT03239210|58975847|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
30938575|NCT03239210|58975846|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
30938576|NCT03239210|58975847|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
30938577|NCT03227224|58975857|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
30938578|NCT03227224|58975858|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
30938579|NCT03227224|58975859|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
30938580|NCT03227224|58975860|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
30938581|NCT03227224|58975857|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
30938582|NCT03227224|58975858|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
30938583|NCT03227224|58975859|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
30938584|NCT03227224|58975860|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
30938585|NCT03227224|58975857|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
30938586|NCT03227224|58975858|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
30938587|NCT03227224|58975859|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
30938588|NCT03227224|58975860|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
30938589|NCT03227224|58975857|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
30938590|NCT03227224|58975858|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
30938591|NCT03227224|58975859|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
30938592|NCT03227224|58975860|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
30938593|NCT03227224|58975857|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
30938594|NCT03227224|58975858|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
30938595|NCT03227224|58975859|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
30938596|NCT03227224|58975860|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
30938597|NCT03227224|58975857|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
30938598|NCT03227224|58975858|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
30938599|NCT03227224|58975859|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
30938600|NCT03227224|58975860|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
30938601|NCT03227224|58975857|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
30938602|NCT03227224|58975858|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
30938603|NCT03227224|58975859|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
30938604|NCT03227224|58975860|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
30938605|NCT03227224|58975857|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
30938606|NCT03227224|58975858|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
30938607|NCT03227224|58975859|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
30842158|NCT02536378|58867736|FG001|Overall Study|Patient refused further follow up|2|||
30938608|NCT03227224|58975860|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
30938609|NCT03227224|58975857|FG000|Follow-up Phase (2 Weeks)|Other|4|||
30938610|NCT03227224|58975858|FG001|Follow-up Phase (2 Weeks)|Other|4|||
30938611|NCT03227224|58975859|FG002|Follow-up Phase (2 Weeks)|Other|6|||
30938612|NCT03227224|58975860|FG003|Follow-up Phase (2 Weeks)|Other|3|||
30938613|NCT03086343|58975879|FG000|Overall Study|Adverse Event|7|||
30938614|NCT03086343|58975880|FG001|Overall Study|Adverse Event|7|||
30938615|NCT03086343|58975879|FG000|Overall Study|Withdrawal by Subject|10|||
30938616|NCT03086343|58975880|FG001|Overall Study|Withdrawal by Subject|6|||
30938617|NCT03086343|58975879|FG000|Overall Study|Lost to Follow-up|3|||
30938618|NCT03086343|58975880|FG001|Overall Study|Lost to Follow-up|1|||
30938619|NCT03086343|58975879|FG000|Overall Study|Lack of Efficacy|4|||
30938620|NCT03086343|58975880|FG001|Overall Study|Lack of Efficacy|6|||
30938621|NCT03086343|58975879|FG000|Overall Study|Other, not specified|8|||
30938622|NCT03086343|58975880|FG001|Overall Study|Other, not specified|4|||
30938623|NCT03086343|58975879|FG000|Overall Study|Missing|0|||
30938624|NCT03086343|58975880|FG001|Overall Study|Missing|1|||
30938625|NCT02788045|58975924|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
30938626|NCT02788045|58975925|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
30938627|NCT02788045|58975926|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
30938628|NCT02788045|58975924|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
30938629|NCT02788045|58975925|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
30938630|NCT02788045|58975926|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
30938631|NCT02788045|58975924|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
30938632|NCT02788045|58975925|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
30938633|NCT02788045|58975926|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
30938634|NCT02788045|58975924|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
30938635|NCT02788045|58975925|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
30938636|NCT02788045|58975926|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
30938637|NCT02788045|58975924|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
30938638|NCT02788045|58975925|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
30938639|NCT02788045|58975926|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
30938640|NCT02788045|58975924|FG000|Main Study (Up to Week 72)|Other|3|||
30938641|NCT02788045|58975925|FG001|Main Study (Up to Week 72)|Other|0|||
30938642|NCT02788045|58975926|FG002|Main Study (Up to Week 72)|Other|0|||
30938643|NCT02788045|58975924|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
30938644|NCT02788045|58975925|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
30938645|NCT02788045|58975926|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
30938646|NCT02788045|58975924|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
30938647|NCT02788045|58975925|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
30938648|NCT02788045|58975926|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
30938649|NCT02788045|58975924|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
30938650|NCT02788045|58975925|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
30938651|NCT02788045|58975926|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
30938652|NCT02466685|58975954|FG000|Overall Study|Adverse Event|6|||
30938653|NCT02466685|58975955|FG001|Overall Study|Adverse Event|2|||
30938654|NCT02466685|58975954|FG000|Overall Study|Lost to Follow-up|0|||
30938655|NCT02466685|58975955|FG001|Overall Study|Lost to Follow-up|2|||
30938656|NCT02466685|58975954|FG000|Overall Study|Withdrawal by Subject|1|||
30938657|NCT02466685|58975955|FG001|Overall Study|Withdrawal by Subject|1|||
30938658|NCT02453282|58975967|FG000|Overall Study|Death|275|||
30938659|NCT02453282|58975968|FG001|Overall Study|Death|277|||
30938660|NCT02453282|58975969|FG002|Overall Study|Death|296|||
30938661|NCT02453282|58975967|FG000|Overall Study|Lost to Follow-up|1|||
30938662|NCT02453282|58975968|FG001|Overall Study|Lost to Follow-up|0|||
30938663|NCT02453282|58975969|FG002|Overall Study|Lost to Follow-up|2|||
30938664|NCT02453282|58975967|FG000|Overall Study|Withdrawal by Subject|12|||
30938665|NCT02453282|58975968|FG001|Overall Study|Withdrawal by Subject|10|||
30938666|NCT02453282|58975969|FG002|Overall Study|Withdrawal by Subject|11|||
30938667|NCT02453282|58975967|FG000|Overall Study|Participants ongoing at data cut-off|85|||
30938668|NCT02453282|58975968|FG001|Overall Study|Participants ongoing at data cut-off|84|||
30938669|NCT02453282|58975969|FG002|Overall Study|Participants ongoing at data cut-off|62|||
30938670|NCT02453282|58975967|FG000|Overall Study|Other|1|||
30938671|NCT02453282|58975968|FG001|Overall Study|Other|1|||
30938672|NCT02453282|58975969|FG002|Overall Study|Other|1|||
30938673|NCT02437318|58975981|FG000|Overall Study|Progressive disease|173|||
30938674|NCT02437318|58975982|FG001|Overall Study|Progressive disease|208|||
30938675|NCT02437318|58975981|FG000|Overall Study|Subject/guardian decision|22|||
30938676|NCT02437318|58975982|FG001|Overall Study|Subject/guardian decision|10|||
30938677|NCT02437318|58975981|FG000|Overall Study|Physician Decision|11|||
30938678|NCT02437318|58975982|FG001|Overall Study|Physician Decision|10|||
30938679|NCT02437318|58975981|FG000|Overall Study|Adverse Event|14|||
30938680|NCT02437318|58975982|FG001|Overall Study|Adverse Event|3|||
30938681|NCT02437318|58975981|FG000|Overall Study|Death|4|||
30938682|NCT02437318|58975982|FG001|Overall Study|Death|4|||
30938683|NCT02437318|58975981|FG000|Overall Study|Protocol Violation|5|||
30938684|NCT02437318|58975982|FG001|Overall Study|Protocol Violation|6|||
30938685|NCT02437318|58975981|FG000|Overall Study|Untreated|0|||
30938686|NCT02437318|58975982|FG001|Overall Study|Untreated|1|||
30938687|NCT02315703|58975996|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
30938688|NCT02315703|58975997|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
30938689|NCT02315703|58975998|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
30938690|NCT02315703|58975999|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
30938691|NCT02315703|58976000|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
30938692|NCT02315703|58976001|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
30938693|NCT02315703|58976002|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
30938694|NCT02315703|58976003|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
30938695|NCT02315703|58975996|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
30938696|NCT02315703|58975997|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
30938697|NCT02315703|58975998|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
30938698|NCT02315703|58975999|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
30938699|NCT02315703|58976000|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
30938700|NCT02315703|58976001|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
30938701|NCT02315703|58976002|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
30938702|NCT02315703|58976003|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
30938703|NCT02315703|58975996|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
30938704|NCT02315703|58975997|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
30938705|NCT02315703|58975998|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
30938706|NCT02315703|58975999|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
30938707|NCT02315703|58976000|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
30938708|NCT02315703|58976001|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
30938709|NCT02315703|58976002|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
30938710|NCT02315703|58976003|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
30938711|NCT02315703|58975996|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
30938712|NCT02315703|58975997|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
30938713|NCT02315703|58975998|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
30938714|NCT02315703|58975999|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
30938715|NCT02315703|58976000|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
30938716|NCT02315703|58976001|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
30938717|NCT02315703|58976002|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
30938718|NCT02315703|58976003|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
30938719|NCT02315703|58975996|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
30938720|NCT02315703|58975997|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
30938721|NCT02315703|58975998|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
30938722|NCT02315703|58975999|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
30938723|NCT02315703|58976000|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
30938724|NCT02315703|58976001|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
30938725|NCT02315703|58976002|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
30938726|NCT02315703|58976003|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
30938727|NCT02315703|58975996|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
30938728|NCT02315703|58975997|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
30938729|NCT02315703|58975998|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
30938730|NCT02315703|58975999|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
30938731|NCT02315703|58976000|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
30938732|NCT02315703|58976001|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
30938733|NCT02315703|58976002|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
30938734|NCT02315703|58976003|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
30938735|NCT02315703|58975996|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
30938736|NCT02315703|58975997|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
30938737|NCT02315703|58975998|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
30938738|NCT02315703|58975999|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
30938739|NCT02315703|58976000|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
30938740|NCT02315703|58976001|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
30938741|NCT02315703|58976002|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
30938742|NCT02315703|58976003|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
30938743|NCT02315703|58975996|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
30938744|NCT02315703|58975997|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
30938745|NCT02315703|58975998|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
30938746|NCT02315703|58975999|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
30938747|NCT02315703|58976000|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
30938748|NCT02315703|58976001|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
30938749|NCT02315703|58976002|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
30948547|NCT01974323|58994554|FG001|Overall Study|Adverse Event|2|||
30938750|NCT02315703|58976003|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
30938751|NCT02315703|58975996|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
30938752|NCT02315703|58975997|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
30938753|NCT02315703|58975998|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
30938754|NCT02315703|58975999|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
30938755|NCT02315703|58976000|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
30938756|NCT02315703|58976001|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
30938757|NCT02315703|58976002|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
30938758|NCT02315703|58976003|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
30938759|NCT02125461|58976023|FG000|Overall Study|Withdrawal by Subject|30|||
30938760|NCT02125461|58976024|FG001|Overall Study|Withdrawal by Subject|16|||
30938761|NCT02125461|58976023|FG000|Overall Study|Lost to Follow-up|8|||
30938762|NCT02125461|58976024|FG001|Overall Study|Lost to Follow-up|3|||
30938763|NCT02125461|58976023|FG000|Overall Study|Death|260|||
30938764|NCT02125461|58976024|FG001|Overall Study|Death|149|||
30938765|NCT02125461|58976023|FG000|Overall Study|Missing Termination Reason|0|||
30938766|NCT02125461|58976024|FG001|Overall Study|Missing Termination Reason|1|||
30938767|NCT02049359|58976032|FG000|Overall Study|Lost to Follow-up|26|||
30938768|NCT02049359|58976033|FG001|Overall Study|Lost to Follow-up|19|||
30938769|NCT01933932|58976061|FG000|Overall Study|Death|173|||
30938770|NCT01933932|58976062|FG001|Overall Study|Death|163|||
30938771|NCT01933932|58976061|FG000|Overall Study|Withdrawal by Subject|11|||
30938772|NCT01933932|58976062|FG001|Overall Study|Withdrawal by Subject|14|||
30938773|NCT01933932|58976061|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30938774|NCT01933932|58976062|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
30938775|NCT01698905|58976072|FG000|Overall Study|Adverse Event|4|||
30938776|NCT01698905|58976072|FG000|Overall Study|Physician Decision|2|||
30938777|NCT01698905|58976072|FG000|Overall Study|Pregnancy|1|||
30938778|NCT01698905|58976072|FG000|Overall Study|Protocol Violation|1|||
30938779|NCT01698905|58976072|FG000|Overall Study|Subject/guardian decision|2|||
30938780|NCT01698905|58976072|FG000|Overall Study|Death|1|||
30938781|NCT01466686|58976083|FG000|Overall Study|Withdrawal by Subject|1|||
30938782|NCT01550289|58976089|FG000|Overall Study|Protocol Violation|1|||
30938783|NCT01550289|58976090|FG001|Overall Study|Protocol Violation|0|||
30938784|NCT01550289|58976089|FG000|Overall Study|Lost to Follow-up|1|||
30938785|NCT01550289|58976090|FG001|Overall Study|Lost to Follow-up|1|||
30938786|NCT01550289|58976089|FG000|Overall Study|Withdrawal by Subject|11|||
30938787|NCT01550289|58976090|FG001|Overall Study|Withdrawal by Subject|3|||
30938788|NCT01968031|58976101|FG000|Overall Study|Adverse Event|13|||
30938789|NCT01968031|58976102|FG001|Overall Study|Adverse Event|10|||
30938790|NCT01968031|58976103|FG002|Overall Study|Adverse Event|22|||
30938791|NCT01968031|58976101|FG000|Overall Study|Withdrawal by Subject|3|||
30938792|NCT01968031|58976102|FG001|Overall Study|Withdrawal by Subject|7|||
30938793|NCT01968031|58976103|FG002|Overall Study|Withdrawal by Subject|3|||
30938794|NCT01968031|58976101|FG000|Overall Study|Did not meet entry criteria|1|||
30938795|NCT01968031|58976102|FG001|Overall Study|Did not meet entry criteria|1|||
30938796|NCT01968031|58976103|FG002|Overall Study|Did not meet entry criteria|1|||
30938797|NCT01968031|58976101|FG000|Overall Study|Noncompliance|0|||
30938798|NCT01968031|58976102|FG001|Overall Study|Noncompliance|0|||
30938799|NCT01968031|58976103|FG002|Overall Study|Noncompliance|2|||
30938800|NCT01968031|58976101|FG000|Overall Study|Failed inclusion criteria|0|||
30938801|NCT01968031|58976102|FG001|Overall Study|Failed inclusion criteria|2|||
30938802|NCT01968031|58976103|FG002|Overall Study|Failed inclusion criteria|0|||
30938803|NCT01968031|58976101|FG000|Overall Study|Death|0|||
30938804|NCT01968031|58976102|FG001|Overall Study|Death|0|||
30938805|NCT01968031|58976103|FG002|Overall Study|Death|1|||
30938806|NCT01968031|58976101|FG000|Overall Study|Prohibited concomitant medication|1|||
30938807|NCT01968031|58976102|FG001|Overall Study|Prohibited concomitant medication|0|||
30938808|NCT01968031|58976103|FG002|Overall Study|Prohibited concomitant medication|0|||
30938809|NCT01684215|58976115|FG000|Phase 1, Part 1|Adverse Event|1|||
30938810|NCT01684215|58976116|FG001|Phase 1, Part 1|Adverse Event|0|||
30938811|NCT01684215|58976117|FG002|Phase 1, Part 1|Adverse Event|0|||
30938812|NCT01684215|58976118|FG003|Phase 1, Part 1|Adverse Event|0|||
30938813|NCT01684215|58976115|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
30938814|NCT01684215|58976116|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
30938815|NCT01684215|58976117|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
30938816|NCT01684215|58976118|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
30938817|NCT01684215|58976115|FG000|Phase 1, Part 2|Adverse Event|0|||
30938818|NCT01684215|58976116|FG001|Phase 1, Part 2|Adverse Event|0|||
30938819|NCT01684215|58976117|FG002|Phase 1, Part 2|Adverse Event|1|||
30938820|NCT01684215|58976118|FG003|Phase 1, Part 2|Adverse Event|0|||
30938821|NCT01684215|58976115|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
30938822|NCT01684215|58976116|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
30938823|NCT01684215|58976117|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
30938824|NCT01684215|58976118|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
30938825|NCT01684215|58976115|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
30938826|NCT01684215|58976116|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
30938827|NCT01684215|58976117|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
30938828|NCT01684215|58976118|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
30938829|NCT01684215|58976115|FG000|Phase 2|Death|0|||
30938830|NCT01684215|58976116|FG001|Phase 2|Death|0|||
30938831|NCT01684215|58976117|FG002|Phase 2|Death|0|||
30938832|NCT01684215|58976118|FG003|Phase 2|Death|8|||
30938833|NCT01684215|58976115|FG000|Phase 2|Study terminated by sponsor|0|||
30938834|NCT01684215|58976116|FG001|Phase 2|Study terminated by sponsor|0|||
30938835|NCT01684215|58976117|FG002|Phase 2|Study terminated by sponsor|0|||
30938836|NCT01684215|58976118|FG003|Phase 2|Study terminated by sponsor|30|||
30938837|NCT01684215|58976115|FG000|Phase 2|Enrolled but not treated|0|||
30938838|NCT01684215|58976116|FG001|Phase 2|Enrolled but not treated|0|||
30938839|NCT01684215|58976117|FG002|Phase 2|Enrolled but not treated|0|||
30938840|NCT01684215|58976118|FG003|Phase 2|Enrolled but not treated|1|||
30938841|NCT01684215|58976115|FG000|Phase 2|Lost to Follow-up|0|||
30938842|NCT01684215|58976116|FG001|Phase 2|Lost to Follow-up|0|||
30938843|NCT01684215|58976117|FG002|Phase 2|Lost to Follow-up|0|||
30938844|NCT01684215|58976118|FG003|Phase 2|Lost to Follow-up|4|||
30938845|NCT01549275|58976133|FG000|Overall Study|Lost to Follow-up|1|||
30938846|NCT01549275|58976134|FG001|Overall Study|Lost to Follow-up|0|||
30938847|NCT01908205|58976146|FG000|Overall Study|Lost to Follow-up|2|||
30938848|NCT01908205|58976147|FG001|Overall Study|Lost to Follow-up|0|||
30938849|NCT01908205|58976146|FG000|Overall Study|Withdrawal by Subject|3|||
30938850|NCT01908205|58976147|FG001|Overall Study|Withdrawal by Subject|1|||
30938851|NCT01549041|58976168|FG000|Overall Study|Lack of Efficacy|2|||
30938852|NCT01549041|58976169|FG001|Overall Study|Lack of Efficacy|4|||
30938853|NCT01549041|58976168|FG000|Overall Study|Adverse Event|0|||
30938854|NCT01549041|58976169|FG001|Overall Study|Adverse Event|4|||
30938855|NCT01907815|58976177|FG000|Overall Study|Withdrawal by Subject|1|||
30938856|NCT01907815|58976178|FG001|Overall Study|Withdrawal by Subject|0|||
30938857|NCT01548573|58976186|FG000|Overall Study|Death|3|||
30938858|NCT01548573|58976186|FG000|Overall Study|Withdrawal by Subject|2|||
30938859|NCT01907737|58976191|FG000|Overall Study|Withdrawal by Subject|1|||
30938860|NCT01570491|58976203|FG000|Overall Study|Lost to Follow-up|3|||
30938861|NCT01570491|58976204|FG001|Overall Study|Lost to Follow-up|1|||
30938862|NCT01570491|58976203|FG000|Overall Study|treatment: not given or discontinued|2|||
30938863|NCT01570491|58976204|FG001|Overall Study|treatment: not given or discontinued|0|||
30938864|NCT01929109|58976215|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
30938865|NCT01929109|58976216|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
30938866|NCT01929109|58976217|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
30938867|NCT01929109|58976218|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
30938868|NCT01929109|58976219|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
30938869|NCT01518153|58976234|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
30938870|NCT01518153|58976235|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
30938871|NCT01518153|58976236|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
30938872|NCT01518153|58976234|FG000|Stem Cell Transplant|Death|2|||
30938873|NCT01518153|58976235|FG001|Stem Cell Transplant|Death|0|||
30938874|NCT01518153|58976236|FG002|Stem Cell Transplant|Death|0|||
30938875|NCT01518153|58976234|FG000|Stem Cell Transplant|Secondary graft failure|1|||
30938876|NCT01518153|58976235|FG001|Stem Cell Transplant|Secondary graft failure|0|||
30938877|NCT01518153|58976236|FG002|Stem Cell Transplant|Secondary graft failure|0|||
30938878|NCT01518153|58976234|FG000|Stem Cell Transplant|Adverse Event|1|||
30938879|NCT01518153|58976235|FG001|Stem Cell Transplant|Adverse Event|0|||
30938880|NCT01518153|58976236|FG002|Stem Cell Transplant|Adverse Event|0|||
30938881|NCT01518153|58976234|FG000|Donor Lymphocyte Infusion|Death|0|||
30938882|NCT01518153|58976235|FG001|Donor Lymphocyte Infusion|Death|2|||
30938883|NCT01518153|58976236|FG002|Donor Lymphocyte Infusion|Death|1|||
30938884|NCT01906489|58976246|FG000|Overall Study|Adverse Event|10|||
30938885|NCT01906489|58976247|FG001|Overall Study|Adverse Event|3|||
30938886|NCT01906489|58976246|FG000|Overall Study|Worsening of CKD|6|||
30938887|NCT01906489|58976247|FG001|Overall Study|Worsening of CKD|4|||
30938888|NCT01906489|58976246|FG000|Overall Study|Withdrawal by Subject|5|||
30938889|NCT01906489|58976247|FG001|Overall Study|Withdrawal by Subject|0|||
30938890|NCT01906489|58976246|FG000|Overall Study|Worsening of Anemia|1|||
30938891|NCT01906489|58976247|FG001|Overall Study|Worsening of Anemia|0|||
30759171|NCT03572062|58767624|FG005|Overall Study|Randomized But Not Treated|2|||
30759172|NCT03572062|58767625|FG006|Overall Study|Randomized But Not Treated|0|||
30938892|NCT01906489|58976246|FG000|Overall Study|Protocol Violation|0|||
30759173|NCT03572062|58767626|FG007|Overall Study|Randomized But Not Treated|1|||
30938893|NCT01906489|58976247|FG001|Overall Study|Protocol Violation|1|||
30938894|NCT01906489|58976246|FG000|Overall Study|Non- Compliance|1|||
30938895|NCT01906489|58976247|FG001|Overall Study|Non- Compliance|0|||
30938896|NCT01906489|58976246|FG000|Overall Study|Sponsor Decision|1|||
30938897|NCT01906489|58976247|FG001|Overall Study|Sponsor Decision|0|||
30938898|NCT01906489|58976246|FG000|Overall Study|Lost to Follow-up|1|||
30938899|NCT01906489|58976247|FG001|Overall Study|Lost to Follow-up|1|||
30938900|NCT01906489|58976246|FG000|Overall Study|Other|1|||
30938901|NCT01906489|58976247|FG001|Overall Study|Other|0|||
30938902|NCT01517373|58976258|FG000|Run-in Period|Death|1|||
30938903|NCT01517373|58976259|FG001|Run-in Period|Death|0|||
30938904|NCT01517373|58976260|FG002|Run-in Period|Death|0|||
30938905|NCT01517373|58976261|FG003|Run-in Period|Death|0|||
30938906|NCT01517373|58976262|FG004|Run-in Period|Death|0|||
30938907|NCT01517373|58976263|FG005|Run-in Period|Death|0|||
30938908|NCT01517373|58976258|FG000|Run-in Period|Adverse Event|5|||
30938909|NCT01517373|58976259|FG001|Run-in Period|Adverse Event|0|||
30938910|NCT01517373|58976260|FG002|Run-in Period|Adverse Event|0|||
30938911|NCT01517373|58976261|FG003|Run-in Period|Adverse Event|0|||
30938912|NCT01517373|58976262|FG004|Run-in Period|Adverse Event|0|||
30938913|NCT01517373|58976263|FG005|Run-in Period|Adverse Event|0|||
30938914|NCT01517373|58976258|FG000|Run-in Period|Did not meet eligibility criteria|34|||
30938915|NCT01517373|58976259|FG001|Run-in Period|Did not meet eligibility criteria|0|||
30938916|NCT01517373|58976260|FG002|Run-in Period|Did not meet eligibility criteria|0|||
30938917|NCT01517373|58976261|FG003|Run-in Period|Did not meet eligibility criteria|0|||
30938918|NCT01517373|58976262|FG004|Run-in Period|Did not meet eligibility criteria|0|||
30938919|NCT01517373|58976263|FG005|Run-in Period|Did not meet eligibility criteria|0|||
30938920|NCT01517373|58976258|FG000|Run-in Period|Lost to Follow-up|1|||
30938921|NCT01517373|58976259|FG001|Run-in Period|Lost to Follow-up|0|||
30938922|NCT01517373|58976260|FG002|Run-in Period|Lost to Follow-up|0|||
30938923|NCT01517373|58976261|FG003|Run-in Period|Lost to Follow-up|0|||
30938924|NCT01517373|58976262|FG004|Run-in Period|Lost to Follow-up|0|||
30938925|NCT01517373|58976263|FG005|Run-in Period|Lost to Follow-up|0|||
30938926|NCT01517373|58976258|FG000|Run-in Period|Withdrawal by Subject|12|||
30938927|NCT01517373|58976259|FG001|Run-in Period|Withdrawal by Subject|0|||
30938928|NCT01517373|58976260|FG002|Run-in Period|Withdrawal by Subject|0|||
30938929|NCT01517373|58976261|FG003|Run-in Period|Withdrawal by Subject|0|||
30938930|NCT01517373|58976262|FG004|Run-in Period|Withdrawal by Subject|0|||
30938931|NCT01517373|58976263|FG005|Run-in Period|Withdrawal by Subject|0|||
30938932|NCT01517373|58976258|FG000|Run-in Period|Sponsor Decision|3|||
30938933|NCT01517373|58976259|FG001|Run-in Period|Sponsor Decision|0|||
30938934|NCT01517373|58976260|FG002|Run-in Period|Sponsor Decision|0|||
30938935|NCT01517373|58976261|FG003|Run-in Period|Sponsor Decision|0|||
30938936|NCT01517373|58976262|FG004|Run-in Period|Sponsor Decision|0|||
30938937|NCT01517373|58976263|FG005|Run-in Period|Sponsor Decision|0|||
30938938|NCT01517373|58976258|FG000|Run-in Period|Other|1|||
30938939|NCT01517373|58976259|FG001|Run-in Period|Other|0|||
30938940|NCT01517373|58976260|FG002|Run-in Period|Other|0|||
30938941|NCT01517373|58976261|FG003|Run-in Period|Other|0|||
30938942|NCT01517373|58976262|FG004|Run-in Period|Other|0|||
30938943|NCT01517373|58976263|FG005|Run-in Period|Other|0|||
30938944|NCT01517373|58976258|FG000|Treatment Period|Adverse Event|0|||
30938945|NCT01517373|58976259|FG001|Treatment Period|Adverse Event|0|||
30938946|NCT01517373|58976260|FG002|Treatment Period|Adverse Event|0|||
30938947|NCT01517373|58976261|FG003|Treatment Period|Adverse Event|0|||
30938948|NCT01517373|58976262|FG004|Treatment Period|Adverse Event|0|||
30938949|NCT01517373|58976263|FG005|Treatment Period|Adverse Event|2|||
30938950|NCT01517373|58976258|FG000|Treatment Period|Lost to Follow-up|0|||
30938951|NCT01517373|58976259|FG001|Treatment Period|Lost to Follow-up|0|||
30938952|NCT01517373|58976260|FG002|Treatment Period|Lost to Follow-up|1|||
30938953|NCT01517373|58976261|FG003|Treatment Period|Lost to Follow-up|1|||
30938954|NCT01517373|58976262|FG004|Treatment Period|Lost to Follow-up|0|||
30938955|NCT01517373|58976263|FG005|Treatment Period|Lost to Follow-up|0|||
30938956|NCT01517373|58976258|FG000|Treatment Period|Withdrawal by Subject|0|||
30938957|NCT01517373|58976259|FG001|Treatment Period|Withdrawal by Subject|3|||
30938958|NCT01517373|58976260|FG002|Treatment Period|Withdrawal by Subject|2|||
30938959|NCT01517373|58976261|FG003|Treatment Period|Withdrawal by Subject|2|||
30938960|NCT01517373|58976262|FG004|Treatment Period|Withdrawal by Subject|2|||
30938961|NCT01517373|58976263|FG005|Treatment Period|Withdrawal by Subject|3|||
30938962|NCT01517373|58976258|FG000|Treatment Period|Other|0|||
30938963|NCT01517373|58976259|FG001|Treatment Period|Other|0|||
30938964|NCT01517373|58976260|FG002|Treatment Period|Other|0|||
30938965|NCT01517373|58976261|FG003|Treatment Period|Other|0|||
30938966|NCT01517373|58976262|FG004|Treatment Period|Other|1|||
30938967|NCT01517373|58976263|FG005|Treatment Period|Other|0|||
30938968|NCT01517373|58976258|FG000|Treatment Period|Protocol Violation|0|||
30938969|NCT01517373|58976259|FG001|Treatment Period|Protocol Violation|0|||
30938970|NCT01517373|58976260|FG002|Treatment Period|Protocol Violation|0|||
30938971|NCT01517373|58976261|FG003|Treatment Period|Protocol Violation|0|||
30938972|NCT01517373|58976262|FG004|Treatment Period|Protocol Violation|1|||
30938973|NCT01517373|58976263|FG005|Treatment Period|Protocol Violation|0|||
30938974|NCT01517373|58976258|FG000|Treatment Period|Lack of Efficacy|0|||
30938975|NCT01517373|58976259|FG001|Treatment Period|Lack of Efficacy|1|||
30938976|NCT01517373|58976260|FG002|Treatment Period|Lack of Efficacy|1|||
30938977|NCT01517373|58976261|FG003|Treatment Period|Lack of Efficacy|3|||
30938978|NCT01517373|58976262|FG004|Treatment Period|Lack of Efficacy|2|||
30938979|NCT01517373|58976263|FG005|Treatment Period|Lack of Efficacy|0|||
30938980|NCT01517373|58976258|FG000|Treatment Period|Medication error without AEs|0|||
30938981|NCT01517373|58976259|FG001|Treatment Period|Medication error without AEs|0|||
30938982|NCT01517373|58976260|FG002|Treatment Period|Medication error without AEs|2|||
30938983|NCT01517373|58976261|FG003|Treatment Period|Medication error without AEs|1|||
30938984|NCT01517373|58976262|FG004|Treatment Period|Medication error without AEs|0|||
30938985|NCT01517373|58976263|FG005|Treatment Period|Medication error without AEs|2|||
30938986|NCT01517295|58976278|FG000|Overall Study|Physician Decision|1|||
30938987|NCT01517295|58976279|FG001|Overall Study|Physician Decision|0|||
30938988|NCT01541865|58976285|FG000|Overall Study|Lost to Follow-up|11|||
30938989|NCT01541865|58976285|FG000|Overall Study|Withdrawal by Subject|9|||
30938990|NCT01541865|58976285|FG000|Overall Study|Adverse Event|1|||
30938991|NCT01541865|58976285|FG000|Overall Study|Protocol Violation|1|||
30938992|NCT01541397|58976291|FG000|Overall Study|Study ended prior to data collection|4|||
30938993|NCT01541397|58976292|FG001|Overall Study|Study ended prior to data collection|2|||
30938994|NCT01548417|58976300|FG000|Overall Study|Withdrawal by Subject|0|||
30938995|NCT01548417|58976301|FG001|Overall Study|Withdrawal by Subject|2|||
30938996|NCT01546857|58976309|FG000|Overall Study|Withdrawal by Subject|2|||
30938997|NCT01546857|58976310|FG001|Overall Study|Withdrawal by Subject|3|||
30938998|NCT01540851|58976319|FG000|Overall Study|Lost to Follow-up|14|||
30938999|NCT01540851|58976320|FG001|Overall Study|Lost to Follow-up|15|||
30939000|NCT01540851|58976319|FG000|Overall Study|Withdrawal by Subject|7|||
30939001|NCT01540851|58976320|FG001|Overall Study|Withdrawal by Subject|3|||
30939002|NCT01516749|58976328|FG000|Active Therapy|Lost to Follow-up|1|||
30939003|NCT01516749|58976328|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
30939004|NCT01516437|58976336|FG000|Overall Study|Reason not specified|0|||
30939005|NCT01516437|58976337|FG001|Overall Study|Reason not specified|0|||
30939006|NCT01516437|58976338|FG002|Overall Study|Reason not specified|1|||
30939007|NCT01516437|58976339|FG003|Overall Study|Reason not specified|1|||
30939008|NCT01515423|58976353|FG000|Open Label Phase|Adverse Event|57|||
30939009|NCT01515423|58976354|FG001|Open Label Phase|Adverse Event|0|||
30939010|NCT01515423|58976355|FG002|Open Label Phase|Adverse Event|0|||
30939011|NCT01515423|58976353|FG000|Open Label Phase|Death|2|||
30939012|NCT01515423|58976354|FG001|Open Label Phase|Death|0|||
30939013|NCT01515423|58976355|FG002|Open Label Phase|Death|0|||
30939014|NCT01515423|58976353|FG000|Open Label Phase|Lack of Efficacy|117|||
30939015|NCT01515423|58976354|FG001|Open Label Phase|Lack of Efficacy|0|||
30939016|NCT01515423|58976355|FG002|Open Label Phase|Lack of Efficacy|0|||
30939017|NCT01515423|58976353|FG000|Open Label Phase|Lost to Follow-up|21|||
30939018|NCT01515423|58976354|FG001|Open Label Phase|Lost to Follow-up|0|||
30939019|NCT01515423|58976355|FG002|Open Label Phase|Lost to Follow-up|0|||
30939020|NCT01515423|58976353|FG000|Open Label Phase|Withdrawal by Subject|118|||
30939021|NCT01515423|58976354|FG001|Open Label Phase|Withdrawal by Subject|0|||
30939022|NCT01515423|58976355|FG002|Open Label Phase|Withdrawal by Subject|0|||
30939023|NCT01515423|58976353|FG000|Open Label Phase|excluded from DB Phase|70|||
30939024|NCT01515423|58976354|FG001|Open Label Phase|excluded from DB Phase|0|||
30939025|NCT01515423|58976355|FG002|Open Label Phase|excluded from DB Phase|0|||
30939026|NCT01515423|58976353|FG000|Open Label Phase|Other|28|||
30939027|NCT01515423|58976354|FG001|Open Label Phase|Other|0|||
30939028|NCT01515423|58976355|FG002|Open Label Phase|Other|0|||
30939029|NCT01515423|58976353|FG000|DOUBLE BLIND|Adverse Event|0|||
30939030|NCT01515423|58976354|FG001|DOUBLE BLIND|Adverse Event|15|||
30939031|NCT01515423|58976355|FG002|DOUBLE BLIND|Adverse Event|13|||
30939032|NCT01515423|58976353|FG000|DOUBLE BLIND|Death|0|||
30939033|NCT01515423|58976354|FG001|DOUBLE BLIND|Death|1|||
30939034|NCT01515423|58976355|FG002|DOUBLE BLIND|Death|2|||
30939035|NCT01515423|58976353|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
30939036|NCT01515423|58976354|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
30939037|NCT01515423|58976355|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
30939038|NCT01515423|58976353|FG000|DOUBLE BLIND|Pregnancy|0|||
30939039|NCT01515423|58976354|FG001|DOUBLE BLIND|Pregnancy|2|||
30939040|NCT01515423|58976355|FG002|DOUBLE BLIND|Pregnancy|0|||
30939041|NCT01515423|58976353|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
30939042|NCT01515423|58976354|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
30939043|NCT01515423|58976355|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
30939044|NCT01515423|58976353|FG000|DOUBLE BLIND|Other|0|||
30842159|NCT01373151|58867751|FG000|Period 1|Lack of Efficacy|3|||
30842160|NCT01373151|58867752|FG001|Period 1|Lack of Efficacy|0|||
30939045|NCT01515423|58976354|FG001|DOUBLE BLIND|Other|6|||
30939046|NCT01515423|58976355|FG002|DOUBLE BLIND|Other|12|||
30939047|NCT01515423|58976353|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
30939048|NCT01515423|58976354|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
30939049|NCT01515423|58976355|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
30939050|NCT00637156|58976364|FG000|Overall Study|Withdrawal by Subject|0|||
30939051|NCT00637156|58976365|FG001|Overall Study|Withdrawal by Subject|7|||
30939052|NCT00637156|58976364|FG000|Overall Study|Death|0|||
30939053|NCT00637156|58976365|FG001|Overall Study|Death|1|||
30939054|NCT00637156|58976364|FG000|Overall Study|Lost to Follow-up|10|||
30939055|NCT00637156|58976365|FG001|Overall Study|Lost to Follow-up|16|||
30939056|NCT00637000|58976373|FG000|Overall Study|Withdrawal by Subject|4|||
30939057|NCT00637000|58976374|FG001|Overall Study|Withdrawal by Subject|3|||
30939058|NCT01515189|58976382|FG000|Induction|Disease Progression|109|||
30939059|NCT01515189|58976383|FG001|Induction|Disease Progression|155|||
30939060|NCT01515189|58976382|FG000|Induction|Study drug toxicity|86|||
30939061|NCT01515189|58976383|FG001|Induction|Study drug toxicity|36|||
30939062|NCT01515189|58976382|FG000|Induction|Death|24|||
30939063|NCT01515189|58976383|FG001|Induction|Death|17|||
30939064|NCT01515189|58976382|FG000|Induction|Adverse Event|14|||
30939065|NCT01515189|58976383|FG001|Induction|Adverse Event|9|||
30939066|NCT01515189|58976382|FG000|Induction|Withdrawal by Subject|3|||
30939067|NCT01515189|58976383|FG001|Induction|Withdrawal by Subject|9|||
30939068|NCT01515189|58976382|FG000|Induction|No longer meets study criteria|0|||
30939069|NCT01515189|58976383|FG001|Induction|No longer meets study criteria|2|||
30939070|NCT01515189|58976382|FG000|Induction|Lost to Follow-up|1|||
30939071|NCT01515189|58976383|FG001|Induction|Lost to Follow-up|0|||
30939072|NCT01515189|58976382|FG000|Induction|Other|0|||
30939073|NCT01515189|58976383|FG001|Induction|Other|4|||
30939074|NCT01515189|58976382|FG000|First Re-Induction Phase|Disease progression|6|||
30939075|NCT01515189|58976383|FG001|First Re-Induction Phase|Disease progression|14|||
30939076|NCT01515189|58976382|FG000|First Re-Induction Phase|Study drug toxicity|5|||
30939077|NCT01515189|58976383|FG001|First Re-Induction Phase|Study drug toxicity|0|||
30939078|NCT01515189|58976382|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
30939079|NCT01515189|58976383|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
30939080|NCT01515189|58976382|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
30939081|NCT01515189|58976383|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
30939082|NCT01515189|58976382|FG000|First Re-Induction Phase|Other|1|||
30939083|NCT01515189|58976383|FG001|First Re-Induction Phase|Other|0|||
30939084|NCT01546623|58976391|FG000|Overall Study|Adverse Event|2|||
30939085|NCT01546623|58976392|FG001|Overall Study|Adverse Event|3|||
30939086|NCT01546623|58976391|FG000|Overall Study|Major Protocol Deviation|1|||
30939087|NCT01546623|58976392|FG001|Overall Study|Major Protocol Deviation|1|||
30939088|NCT01546623|58976391|FG000|Overall Study|High Prostate specific antigen|2|||
30939089|NCT01546623|58976392|FG001|Overall Study|High Prostate specific antigen|1|||
30939090|NCT01546623|58976391|FG000|Overall Study|Did Not Receive Study Drug|1|||
30939091|NCT01546623|58976392|FG001|Overall Study|Did Not Receive Study Drug|1|||
30939092|NCT01546155|58976398|FG000|Overall Study|could not tolerate long scan duration|3|||
30939093|NCT00636610|58976404|FG000|Overall Study|Adverse Event|4|||
30939094|NCT00636610|58976405|FG001|Overall Study|Adverse Event|4|||
30939095|NCT00636610|58976404|FG000|Overall Study|Death|6|||
30939096|NCT00636610|58976405|FG001|Overall Study|Death|3|||
30939097|NCT00636610|58976404|FG000|Overall Study|Physician decision to withdraw patient|15|||
30939098|NCT00636610|58976405|FG001|Overall Study|Physician decision to withdraw patient|9|||
30939099|NCT00636610|58976404|FG000|Overall Study|Subject decision to withdraw|15|||
30939100|NCT00636610|58976405|FG001|Overall Study|Subject decision to withdraw|11|||
30939101|NCT00636610|58976404|FG000|Overall Study|Disease progression - radiographic|41|||
30939102|NCT00636610|58976405|FG001|Overall Study|Disease progression - radiographic|51|||
30939103|NCT00636610|58976404|FG000|Overall Study|Disease progression - clinical|8|||
30939104|NCT00636610|58976405|FG001|Overall Study|Disease progression - clinical|3|||
30939105|NCT00636610|58976404|FG000|Overall Study|Reason for discontinuation not available|3|||
30759174|NCT03572062|58767627|FG008|Overall Study|Randomized But Not Treated|0|||
30759175|NCT03572062|58767628|FG009|Overall Study|Randomized But Not Treated|0|||
30939106|NCT00636610|58976405|FG001|Overall Study|Reason for discontinuation not available|2|||
30939107|NCT00635050|58976413|FG000|Overall Study|Withdrawal by Subject|1|||
30939108|NCT00634504|58976422|FG000|Overall Study|Protocol Violation|1|||
30939109|NCT00634504|58976423|FG001|Overall Study|Protocol Violation|0|||
30939110|NCT00634114|58976432|FG000|Overall Study|Adverse Event|6|||
30939111|NCT00634114|58976433|FG001|Overall Study|Adverse Event|8|||
30939112|NCT00634114|58976434|FG002|Overall Study|Adverse Event|3|||
30939113|NCT00634114|58976432|FG000|Overall Study|Withdrawal by Subject|9|||
30939114|NCT00634114|58976433|FG001|Overall Study|Withdrawal by Subject|6|||
30939115|NCT00634114|58976434|FG002|Overall Study|Withdrawal by Subject|11|||
30939116|NCT00634114|58976432|FG000|Overall Study|Lost to Follow-up|0|||
30939117|NCT00634114|58976433|FG001|Overall Study|Lost to Follow-up|0|||
30939118|NCT00634114|58976434|FG002|Overall Study|Lost to Follow-up|1|||
30939119|NCT00634114|58976432|FG000|Overall Study|Protocol Violation|3|||
30939120|NCT00634114|58976433|FG001|Overall Study|Protocol Violation|3|||
30939121|NCT00634114|58976434|FG002|Overall Study|Protocol Violation|1|||
30939122|NCT00634114|58976432|FG000|Overall Study|Pregnancy|1|||
30939123|NCT00634114|58976433|FG001|Overall Study|Pregnancy|0|||
30939124|NCT00634114|58976434|FG002|Overall Study|Pregnancy|0|||
30939125|NCT00634114|58976432|FG000|Overall Study|Incorrect enrolment|0|||
30939126|NCT00634114|58976433|FG001|Overall Study|Incorrect enrolment|1|||
30939127|NCT00634114|58976434|FG002|Overall Study|Incorrect enrolment|0|||
30939128|NCT00634114|58976432|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
30939129|NCT00634114|58976433|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
30939130|NCT00634114|58976434|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
30939131|NCT00634114|58976432|FG000|Overall Study|Difficult to continue|3|||
30939132|NCT00634114|58976433|FG001|Overall Study|Difficult to continue|1|||
30939133|NCT00634114|58976434|FG002|Overall Study|Difficult to continue|1|||
30939134|NCT00634114|58976432|FG000|Overall Study|Other reason|1|||
30939135|NCT00634114|58976433|FG001|Overall Study|Other reason|1|||
30939136|NCT00634114|58976434|FG002|Overall Study|Other reason|1|||
30939137|NCT00634036|58976444|FG000|Overall Study|Lost to Follow-up|1|||
30939138|NCT00634036|58976445|FG001|Overall Study|Lost to Follow-up|1|||
30939139|NCT00634036|58976444|FG000|Overall Study|Withdrawal by Subject|1|||
30939140|NCT00634036|58976445|FG001|Overall Study|Withdrawal by Subject|1|||
30939141|NCT01545375|58976453|FG000|Overall Study|Adverse Event|2|||
30939142|NCT01545375|58976454|FG001|Overall Study|Adverse Event|1|||
30939143|NCT01545375|58976453|FG000|Overall Study|Lost to Follow-up|34|||
30939144|NCT01545375|58976454|FG001|Overall Study|Lost to Follow-up|31|||
30939145|NCT01545375|58976453|FG000|Overall Study|Protocol Violation|3|||
30939146|NCT01545375|58976454|FG001|Overall Study|Protocol Violation|3|||
30939147|NCT01545375|58976453|FG000|Overall Study|Withdrawal by Subject|58|||
30939148|NCT01545375|58976454|FG001|Overall Study|Withdrawal by Subject|55|||
30939149|NCT01539837|58976463|FG000|Overall Study|reduce neutrophil level|0|||
30939150|NCT01539837|58976464|FG001|Overall Study|reduce neutrophil level|1|||
30939151|NCT01539837|58976465|FG002|Overall Study|reduce neutrophil level|1|||
30939152|NCT01539837|58976463|FG000|Overall Study|bad compliance|0|||
30939153|NCT01539837|58976464|FG001|Overall Study|bad compliance|0|||
30939154|NCT01539837|58976465|FG002|Overall Study|bad compliance|1|||
30939155|NCT01539759|58976475|FG000|Overall Study|Lost to Follow-up|6|||
30939156|NCT01539759|58976476|FG001|Overall Study|Lost to Follow-up|8|||
30939157|NCT00633022|58976485|FG000|Overall Study|Adverse Event|1|||
30939158|NCT00633022|58976486|FG001|Overall Study|Adverse Event|0|||
30624455|NCT01117350|58636532|FG000|Extension Period|Adverse Event|0|||
30842161|NCT01373151|58867753|FG002|Period 1|Lack of Efficacy|0|||
30842162|NCT01373151|58867754|FG003|Period 1|Lack of Efficacy|0|||
30842163|NCT01373151|58867755|FG004|Period 1|Lack of Efficacy|1|||
30842164|NCT01373151|58867756|FG005|Period 1|Lack of Efficacy|0|||
30842165|NCT01373151|58867757|FG006|Period 1|Lack of Efficacy|0|||
30842166|NCT01373151|58867751|FG000|Period 1|Adverse Event|0|||
30842167|NCT01373151|58867752|FG001|Period 1|Adverse Event|0|||
30842168|NCT01373151|58867753|FG002|Period 1|Adverse Event|1|||
30842169|NCT01373151|58867754|FG003|Period 1|Adverse Event|0|||
30842170|NCT01373151|58867755|FG004|Period 1|Adverse Event|4|||
30842171|NCT01373151|58867756|FG005|Period 1|Adverse Event|3|||
30842172|NCT01373151|58867757|FG006|Period 1|Adverse Event|0|||
30842173|NCT01373151|58867751|FG000|Period 1|Withdrawal by Subject|2|||
30842174|NCT01373151|58867752|FG001|Period 1|Withdrawal by Subject|0|||
30842175|NCT01373151|58867753|FG002|Period 1|Withdrawal by Subject|3|||
30842176|NCT01373151|58867754|FG003|Period 1|Withdrawal by Subject|1|||
30842177|NCT01373151|58867755|FG004|Period 1|Withdrawal by Subject|0|||
30842178|NCT01373151|58867756|FG005|Period 1|Withdrawal by Subject|1|||
30842179|NCT01373151|58867757|FG006|Period 1|Withdrawal by Subject|0|||
30842180|NCT01373151|58867751|FG000|Period 2|Lack of Efficacy|9|||
30842181|NCT01373151|58867752|FG001|Period 2|Lack of Efficacy|0|||
30842182|NCT01373151|58867753|FG002|Period 2|Lack of Efficacy|0|||
30939159|NCT00633022|58976487|FG002|Overall Study|Adverse Event|5|||
30939160|NCT00633022|58976485|FG000|Overall Study|Physician Decision|0|||
30939161|NCT00633022|58976486|FG001|Overall Study|Physician Decision|1|||
30939162|NCT00633022|58976487|FG002|Overall Study|Physician Decision|0|||
30939163|NCT00630994|58976495|FG000|Overall Study|Adverse Event|1|||
30939164|NCT00630994|58976495|FG000|Overall Study|Disease Progression|1|||
30939165|NCT00630994|58976495|FG000|Overall Study|Lack of Efficacy|1|||
30939166|NCT00630994|58976495|FG000|Overall Study|Other|1|||
30939167|NCT00630838|58976501|FG000|Overall Study|Death|0|||
30842183|NCT01373151|58867754|FG003|Period 2|Lack of Efficacy|1|||
30842184|NCT01373151|58867755|FG004|Period 2|Lack of Efficacy|2|||
30842185|NCT01373151|58867756|FG005|Period 2|Lack of Efficacy|0|||
30939168|NCT00630838|58976502|FG001|Overall Study|Death|1|||
30939169|NCT00630838|58976501|FG000|Overall Study|Lost to Follow-up|0|||
30939170|NCT00630838|58976502|FG001|Overall Study|Lost to Follow-up|1|||
30939171|NCT00630058|58976512|FG000|Overall Study|Adverse Event|1|||
30842186|NCT01373151|58867757|FG006|Period 2|Lack of Efficacy|3|||
30842187|NCT01373151|58867751|FG000|Period 2|Adverse Event|0|||
30842188|NCT01373151|58867752|FG001|Period 2|Adverse Event|0|||
30842189|NCT01373151|58867753|FG002|Period 2|Adverse Event|3|||
30842190|NCT01373151|58867754|FG003|Period 2|Adverse Event|3|||
30842191|NCT01373151|58867755|FG004|Period 2|Adverse Event|0|||
30842192|NCT01373151|58867756|FG005|Period 2|Adverse Event|0|||
30842193|NCT01373151|58867757|FG006|Period 2|Adverse Event|1|||
30842194|NCT01373151|58867751|FG000|Period 2|subject request to discontinue|0|||
30842195|NCT01373151|58867752|FG001|Period 2|subject request to discontinue|1|||
30842196|NCT01373151|58867753|FG002|Period 2|subject request to discontinue|0|||
30939172|NCT00630058|58976513|FG001|Overall Study|Adverse Event|1|||
30939173|NCT00630058|58976512|FG000|Overall Study|Withdrawal by Subject|0|||
30939174|NCT00630058|58976513|FG001|Overall Study|Withdrawal by Subject|1|||
30939175|NCT00630058|58976512|FG000|Overall Study|stopping criteria|3|||
30939176|NCT00630058|58976513|FG001|Overall Study|stopping criteria|2|||
30939177|NCT01925794|58976519|FG000|180 Days|Death|2|||
30624456|NCT01117350|58636533|FG001|Extension Period|Adverse Event|2|||
30624457|NCT01117350|58636532|FG000|Extension Period|Protocol Violation|0|||
30624458|NCT01117350|58636533|FG001|Extension Period|Protocol Violation|2|||
30624459|NCT01117350|58636532|FG000|Extension Period|Lost to Follow-up|0|||
30624460|NCT01117350|58636533|FG001|Extension Period|Lost to Follow-up|2|||
30624461|NCT01117350|58636532|FG000|Extension Period|Withdrawal by Subject|0|||
30624462|NCT01117350|58636533|FG001|Extension Period|Withdrawal by Subject|3|||
30624463|NCT01117350|58636532|FG000|Extension Period|Lack of Efficacy|0|||
30624464|NCT01117350|58636533|FG001|Extension Period|Lack of Efficacy|2|||
30624465|NCT01117350|58636532|FG000|Extension Period|Inclusion criteria not respected|0|||
30624466|NCT01117350|58636533|FG001|Extension Period|Inclusion criteria not respected|1|||
30624467|NCT01117350|58636532|FG000|Extension Period|Prohibited medication|0|||
30939178|NCT01925794|58976519|FG000|180 Days|Withdrawal by Subject|2|||
30939179|NCT01925794|58976519|FG000|270 Days|Death|2|||
30939180|NCT01925794|58976519|FG000|270 Days|Protocol Violation|3|||
30939181|NCT00989950|58976531|FG000|Randomized Phase|Protocol Violation|1|||
30939182|NCT00989950|58976532|FG001|Randomized Phase|Protocol Violation|0|||
30939183|NCT00989950|58976533|FG002|Randomized Phase|Protocol Violation|0|||
30939184|NCT00989950|58976534|FG003|Randomized Phase|Protocol Violation|0|||
30939185|NCT00989950|58976531|FG000|Randomized Phase|Adverse Event|0|||
30939186|NCT00989950|58976532|FG001|Randomized Phase|Adverse Event|1|||
30939187|NCT00989950|58976533|FG002|Randomized Phase|Adverse Event|0|||
30939188|NCT00989950|58976534|FG003|Randomized Phase|Adverse Event|0|||
30939189|NCT01905943|58976544|FG000|Overall Study|Withdrawal of consent|90|||
30939190|NCT01905943|58976544|FG000|Overall Study|Lost to Follow-up|16|||
30939191|NCT01905943|58976544|FG000|Overall Study|Investigator discretion|7|||
30939192|NCT01905943|58976544|FG000|Overall Study|Death|186|||
30939193|NCT01905943|58976544|FG000|Overall Study|Adverse Event|3|||
30939194|NCT01905943|58976544|FG000|Overall Study|Other|12|||
30939195|NCT01905553|58976565|FG000|Period 2|Adverse Event|1|||
30939196|NCT01905553|58976566|FG001|Period 2|Adverse Event|0|||
30939197|NCT01929031|58976576|FG000|Overall Study|Adverse Event|3|||
30842197|NCT01373151|58867754|FG003|Period 2|subject request to discontinue|0|||
30842198|NCT01373151|58867755|FG004|Period 2|subject request to discontinue|0|||
30842199|NCT01373151|58867756|FG005|Period 2|subject request to discontinue|0|||
30842200|NCT01373151|58867757|FG006|Period 2|subject request to discontinue|0|||
30842201|NCT01373151|58867751|FG000|Period 2|Withdrawal by Subject|0|||
30842202|NCT01373151|58867752|FG001|Period 2|Withdrawal by Subject|0|||
30842203|NCT01373151|58867753|FG002|Period 2|Withdrawal by Subject|0|||
30842204|NCT01373151|58867754|FG003|Period 2|Withdrawal by Subject|1|||
30939198|NCT01929031|58976577|FG001|Overall Study|Adverse Event|1|||
30939199|NCT01929031|58976578|FG002|Overall Study|Adverse Event|1|||
30939200|NCT01929031|58976579|FG003|Overall Study|Adverse Event|0|||
30939201|NCT01929031|58976580|FG004|Overall Study|Adverse Event|0|||
30939202|NCT01929031|58976581|FG005|Overall Study|Adverse Event|0|||
30939203|NCT01929031|58976576|FG000|Overall Study|Protocol Violation|1|||
30939204|NCT01929031|58976577|FG001|Overall Study|Protocol Violation|0|||
30842205|NCT01373151|58867755|FG004|Period 2|Withdrawal by Subject|0|||
30842206|NCT01373151|58867756|FG005|Period 2|Withdrawal by Subject|0|||
30842207|NCT01373151|58867757|FG006|Period 2|Withdrawal by Subject|0|||
30842208|NCT01373151|58867751|FG000|Period 2|Other|0|||
30842209|NCT01373151|58867752|FG001|Period 2|Other|0|||
30939205|NCT01929031|58976578|FG002|Overall Study|Protocol Violation|0|||
30939206|NCT01929031|58976579|FG003|Overall Study|Protocol Violation|0|||
30939207|NCT01929031|58976580|FG004|Overall Study|Protocol Violation|0|||
30939208|NCT01929031|58976581|FG005|Overall Study|Protocol Violation|1|||
30939209|NCT01929031|58976576|FG000|Overall Study|Reason other than specified above|0|||
30939210|NCT01929031|58976577|FG001|Overall Study|Reason other than specified above|1|||
30939211|NCT01929031|58976578|FG002|Overall Study|Reason other than specified above|0|||
30939212|NCT01929031|58976579|FG003|Overall Study|Reason other than specified above|0|||
30939213|NCT01929031|58976580|FG004|Overall Study|Reason other than specified above|1|||
30939214|NCT01929031|58976581|FG005|Overall Study|Reason other than specified above|0|||
30842210|NCT01373151|58867753|FG002|Period 2|Other|1|||
30842211|NCT01373151|58867754|FG003|Period 2|Other|0|||
30939215|NCT00989092|58976593|FG000|Overall Study|Physician Decision|9|||
30939216|NCT00989092|58976594|FG001|Overall Study|Physician Decision|6|||
30939217|NCT00989092|58976593|FG000|Overall Study|Adverse Event|20|||
30939218|NCT00989092|58976594|FG001|Overall Study|Adverse Event|1|||
30939219|NCT00989092|58976593|FG000|Overall Study|Chemotherapy initiated|12|||
30939220|NCT00989092|58976594|FG001|Overall Study|Chemotherapy initiated|4|||
30939221|NCT00989092|58976593|FG000|Overall Study|Withdrawal by Subject|17|||
30939222|NCT00989092|58976594|FG001|Overall Study|Withdrawal by Subject|9|||
30939223|NCT00989092|58976593|FG000|Overall Study|Death|14|||
30939224|NCT00989092|58976594|FG001|Overall Study|Death|2|||
30939225|NCT00989092|58976593|FG000|Overall Study|Ineligibility determined|3|||
30939226|NCT00989092|58976594|FG001|Overall Study|Ineligibility determined|3|||
30939227|NCT00989092|58976593|FG000|Overall Study|Lost to Follow-up|6|||
30939228|NCT00989092|58976594|FG001|Overall Study|Lost to Follow-up|2|||
30939229|NCT00989092|58976593|FG000|Overall Study|Other|3|||
30939230|NCT00989092|58976594|FG001|Overall Study|Other|1|||
30939231|NCT00989092|58976593|FG000|Overall Study|Protocol deviation|2|||
30939232|NCT00989092|58976594|FG001|Overall Study|Protocol deviation|0|||
30939233|NCT00989092|58976593|FG000|Overall Study|Erythropoietin therapy initiated|2|||
30939234|NCT00989092|58976594|FG001|Overall Study|Erythropoietin therapy initiated|0|||
30939235|NCT00989092|58976593|FG000|Overall Study|Did not receive study drug|2|||
30939236|NCT00989092|58976594|FG001|Overall Study|Did not receive study drug|0|||
30939237|NCT00988858|58976601|FG000|Overall Study|Adverse Event|7|||
30939238|NCT00988858|58976601|FG000|Overall Study|Death|1|||
30939239|NCT00988858|58976601|FG000|Overall Study|Physician Decision|1|||
30939240|NCT00988858|58976601|FG000|Overall Study|Sponsor Decision|1|||
30939241|NCT00986986|58976607|FG000|Overall Study|Lost to Follow-up|0|||
30939242|NCT00986986|58976608|FG001|Overall Study|Lost to Follow-up|1|||
30939243|NCT01904773|58976615|FG000|Screen|Screen failure|3|||
30939244|NCT01904773|58976616|FG001|Screen|Screen failure|0|||
30939245|NCT01904773|58976617|FG002|Screen|Screen failure|0|||
30939246|NCT01904773|58976618|FG003|Screen|Screen failure|0|||
30939247|NCT01904773|58976619|FG004|Screen|Screen failure|0|||
30939248|NCT01904773|58976620|FG005|Screen|Screen failure|0|||
30939249|NCT01904773|58976621|FG006|Screen|Screen failure|0|||
30939250|NCT01904773|58976622|FG007|Screen|Screen failure|0|||
30939251|NCT01904773|58976623|FG008|Screen|Screen failure|0|||
30939252|NCT01904773|58976615|FG000|Screen|Withdrawal by Subject|1|||
30939253|NCT01904773|58976616|FG001|Screen|Withdrawal by Subject|0|||
30939254|NCT01904773|58976617|FG002|Screen|Withdrawal by Subject|0|||
30939255|NCT01904773|58976618|FG003|Screen|Withdrawal by Subject|0|||
30939256|NCT01904773|58976619|FG004|Screen|Withdrawal by Subject|0|||
30939257|NCT01904773|58976620|FG005|Screen|Withdrawal by Subject|0|||
30939258|NCT01904773|58976621|FG006|Screen|Withdrawal by Subject|0|||
30939259|NCT01904773|58976622|FG007|Screen|Withdrawal by Subject|0|||
30939260|NCT01904773|58976623|FG008|Screen|Withdrawal by Subject|0|||
30939261|NCT01904773|58976615|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
30939262|NCT01904773|58976616|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
30939263|NCT01904773|58976617|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
30939264|NCT01904773|58976618|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
30939265|NCT01904773|58976619|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
30939266|NCT01904773|58976620|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
30939267|NCT01904773|58976621|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
30939268|NCT01904773|58976622|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
30939269|NCT01904773|58976623|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
30939270|NCT01904773|58976615|FG000|First Intervention|Adverse Event|0|||
30939271|NCT01904773|58976616|FG001|First Intervention|Adverse Event|0|||
30939272|NCT01904773|58976617|FG002|First Intervention|Adverse Event|0|||
30939273|NCT01904773|58976618|FG003|First Intervention|Adverse Event|0|||
30939274|NCT01904773|58976619|FG004|First Intervention|Adverse Event|0|||
30939275|NCT01904773|58976620|FG005|First Intervention|Adverse Event|0|||
30939276|NCT01904773|58976621|FG006|First Intervention|Adverse Event|1|||
30939277|NCT01904773|58976622|FG007|First Intervention|Adverse Event|0|||
30939278|NCT01904773|58976623|FG008|First Intervention|Adverse Event|0|||
30939279|NCT01904773|58976615|FG000|Placebo Washout First Intervention|Condition worsened|0|||
30939280|NCT01904773|58976616|FG001|Placebo Washout First Intervention|Condition worsened|1|||
30939281|NCT01904773|58976617|FG002|Placebo Washout First Intervention|Condition worsened|0|||
30939282|NCT01904773|58976618|FG003|Placebo Washout First Intervention|Condition worsened|0|||
30939283|NCT01904773|58976619|FG004|Placebo Washout First Intervention|Condition worsened|0|||
30939284|NCT01904773|58976620|FG005|Placebo Washout First Intervention|Condition worsened|0|||
30939285|NCT01904773|58976621|FG006|Placebo Washout First Intervention|Condition worsened|0|||
30939286|NCT01904773|58976622|FG007|Placebo Washout First Intervention|Condition worsened|0|||
30939287|NCT01904773|58976623|FG008|Placebo Washout First Intervention|Condition worsened|0|||
30939288|NCT01904773|58976615|FG000|Fifth Intervention|Adverse Event|0|||
30939289|NCT01904773|58976616|FG001|Fifth Intervention|Adverse Event|0|||
30939290|NCT01904773|58976617|FG002|Fifth Intervention|Adverse Event|0|||
30939291|NCT01904773|58976618|FG003|Fifth Intervention|Adverse Event|0|||
30939292|NCT01904773|58976619|FG004|Fifth Intervention|Adverse Event|0|||
30939293|NCT01904773|58976620|FG005|Fifth Intervention|Adverse Event|0|||
30939294|NCT01904773|58976621|FG006|Fifth Intervention|Adverse Event|0|||
30939295|NCT01904773|58976622|FG007|Fifth Intervention|Adverse Event|1|||
30939296|NCT01904773|58976623|FG008|Fifth Intervention|Adverse Event|0|||
30939297|NCT01904773|58976615|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
30939298|NCT01904773|58976616|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
30939299|NCT01904773|58976617|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
30939300|NCT01904773|58976618|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
30939301|NCT01904773|58976619|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
30939302|NCT01904773|58976620|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
30939303|NCT01904773|58976621|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
30939304|NCT01904773|58976622|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
30939305|NCT01904773|58976623|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
30939306|NCT01928719|58976637|FG000|Overall Study|Lost to Follow-up|26|||
30939307|NCT01928719|58976638|FG001|Overall Study|Lost to Follow-up|11|||
30939308|NCT01928719|58976637|FG000|Overall Study|Withdrawal by Subject|22|||
30939309|NCT01928719|58976638|FG001|Overall Study|Withdrawal by Subject|7|||
30939310|NCT01928719|58976637|FG000|Overall Study|Protocol Violation|3|||
30939311|NCT01928719|58976638|FG001|Overall Study|Protocol Violation|1|||
30939312|NCT01928719|58976637|FG000|Overall Study|Adverse Event|1|||
30939313|NCT01928719|58976638|FG001|Overall Study|Adverse Event|0|||
30939314|NCT00986674|58976649|FG000|Overall Study|Lack of Efficacy|28|||
30939315|NCT00986674|58976650|FG001|Overall Study|Lack of Efficacy|25|||
30939316|NCT00986674|58976651|FG002|Overall Study|Lack of Efficacy|23|||
30939317|NCT00986674|58976649|FG000|Overall Study|Adverse Event|4|||
30939318|NCT00986674|58976650|FG001|Overall Study|Adverse Event|8|||
30939319|NCT00986674|58976651|FG002|Overall Study|Adverse Event|9|||
30939320|NCT00986674|58976649|FG000|Overall Study|Death|5|||
30939321|NCT00986674|58976650|FG001|Overall Study|Death|0|||
30939322|NCT00986674|58976651|FG002|Overall Study|Death|4|||
30939323|NCT00986674|58976649|FG000|Overall Study|Withdrawal by Subject|6|||
30939324|NCT00986674|58976650|FG001|Overall Study|Withdrawal by Subject|2|||
30939325|NCT00986674|58976651|FG002|Overall Study|Withdrawal by Subject|1|||
30939326|NCT00986674|58976649|FG000|Overall Study|alternative therapy|0|||
30939327|NCT00986674|58976650|FG001|Overall Study|alternative therapy|0|||
30939328|NCT00986674|58976651|FG002|Overall Study|alternative therapy|1|||
30939329|NCT00986674|58976649|FG000|Overall Study|not start protocol therapy|4|||
30939330|NCT00986674|58976650|FG001|Overall Study|not start protocol therapy|3|||
30842212|NCT01373151|58867755|FG004|Period 2|Other|0|||
30842213|NCT01373151|58867756|FG005|Period 2|Other|0|||
30842214|NCT01373151|58867757|FG006|Period 2|Other|1|||
30842215|NCT01660906|58867773|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
30842216|NCT03015181|58867793|FG000|Overall Study|Enrolled, but product never administered|1|||
30842217|NCT03015181|58867794|FG001|Overall Study|Enrolled, but product never administered|0|||
30842218|NCT03015181|58867795|FG002|Overall Study|Enrolled, but product never administered|0|||
30842219|NCT03015181|58867796|FG003|Overall Study|Enrolled, but product never administered|0|||
30842220|NCT03015181|58867797|FG004|Overall Study|Enrolled, but product never administered|0|||
30842221|NCT03015181|58867798|FG005|Overall Study|Enrolled, but product never administered|0|||
30842222|NCT03015181|58867799|FG006|Overall Study|Enrolled, but product never administered|0|||
30842223|NCT03015181|58867793|FG000|Overall Study|Withdrawal by Subject|0|||
30842224|NCT03015181|58867794|FG001|Overall Study|Withdrawal by Subject|0|||
30842225|NCT03015181|58867795|FG002|Overall Study|Withdrawal by Subject|0|||
30842226|NCT03015181|58867796|FG003|Overall Study|Withdrawal by Subject|0|||
30842227|NCT03015181|58867797|FG004|Overall Study|Withdrawal by Subject|0|||
30842228|NCT03015181|58867798|FG005|Overall Study|Withdrawal by Subject|1|||
30842229|NCT03015181|58867799|FG006|Overall Study|Withdrawal by Subject|0|||
30842230|NCT03015181|58867793|FG000|Overall Study|Physician Decision|0|||
30842231|NCT03015181|58867794|FG001|Overall Study|Physician Decision|0|||
30842232|NCT03015181|58867795|FG002|Overall Study|Physician Decision|0|||
30842233|NCT03015181|58867796|FG003|Overall Study|Physician Decision|0|||
30842234|NCT03015181|58867797|FG004|Overall Study|Physician Decision|0|||
30842235|NCT03015181|58867798|FG005|Overall Study|Physician Decision|0|||
30842236|NCT03015181|58867799|FG006|Overall Study|Physician Decision|1|||
30842237|NCT00960297|58867848|FG000|Overall Study|Physician Decision|1|||
30842238|NCT00960297|58867848|FG000|Overall Study|Venous port infection|1|||
30939331|NCT00986674|58976651|FG002|Overall Study|not start protocol therapy|1|||
30842239|NCT00960297|58867848|FG000|Overall Study|Disease progression|1|||
30842240|NCT03018691|58867855|FG000|Overall Study|Adverse Event|1|||
30939332|NCT00986674|58976649|FG000|Overall Study|unknown/not specify|0|||
30939333|NCT00986674|58976650|FG001|Overall Study|unknown/not specify|7|||
30939334|NCT00986674|58976651|FG002|Overall Study|unknown/not specify|9|||
30939335|NCT00986440|58976661|FG000|Overall Study|Progressive disease|27|||
30939336|NCT00986440|58976662|FG001|Overall Study|Progressive disease|37|||
30842241|NCT03018691|58867856|FG001|Overall Study|Adverse Event|1|||
30842242|NCT03018691|58867857|FG002|Overall Study|Adverse Event|4|||
30842243|NCT03018691|58867855|FG000|Overall Study|Lack of Efficacy|0|||
30842244|NCT03018691|58867856|FG001|Overall Study|Lack of Efficacy|0|||
30842245|NCT03018691|58867857|FG002|Overall Study|Lack of Efficacy|1|||
30842246|NCT03018691|58867855|FG000|Overall Study|Withdrawal by Subject|0|||
30842247|NCT03018691|58867856|FG001|Overall Study|Withdrawal by Subject|0|||
30842248|NCT03018691|58867857|FG002|Overall Study|Withdrawal by Subject|1|||
30842249|NCT03018691|58867855|FG000|Overall Study|Withdrawal by parent/guardian|1|||
30842250|NCT03018691|58867856|FG001|Overall Study|Withdrawal by parent/guardian|0|||
30842251|NCT03018691|58867857|FG002|Overall Study|Withdrawal by parent/guardian|1|||
30842252|NCT03012061|58867870|FG000|Overall Study|Withdrawal by Subject|1|||
30842253|NCT03012061|58867871|FG001|Overall Study|Withdrawal by Subject|5|||
30842254|NCT03012061|58867872|FG002|Overall Study|Withdrawal by Subject|4|||
30842255|NCT03012061|58867870|FG000|Overall Study|Investigator Site Closed|1|||
30842256|NCT03012061|58867871|FG001|Overall Study|Investigator Site Closed|2|||
30842257|NCT03012061|58867872|FG002|Overall Study|Investigator Site Closed|0|||
30842258|NCT03012061|58867870|FG000|Overall Study|Lost to Follow-up|2|||
30842259|NCT03012061|58867871|FG001|Overall Study|Lost to Follow-up|1|||
30842260|NCT03012061|58867872|FG002|Overall Study|Lost to Follow-up|0|||
30939337|NCT00986440|58976661|FG000|Overall Study|Serious adverse event or adverse event|9|||
30842261|NCT03012061|58867870|FG000|Overall Study|Study closed/ Terminated|0|||
30842262|NCT03012061|58867871|FG001|Overall Study|Study closed/ Terminated|0|||
30842263|NCT03012061|58867872|FG002|Overall Study|Study closed/ Terminated|1|||
30842264|NCT03012061|58867870|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
30842265|NCT03012061|58867871|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
30842266|NCT03012061|58867872|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
30842267|NCT03012061|58867870|FG000|Overall Study|Protocol Violation|0|||
30939338|NCT00986440|58976662|FG001|Overall Study|Serious adverse event or adverse event|2|||
30939339|NCT00986440|58976661|FG000|Overall Study|Withdrawal by Subject|1|||
30939340|NCT00986440|58976662|FG001|Overall Study|Withdrawal by Subject|2|||
30939341|NCT00986440|58976661|FG000|Overall Study|Screen failure (not dosed)|4|||
30939342|NCT00986440|58976662|FG001|Overall Study|Screen failure (not dosed)|2|||
30939343|NCT01904383|58976668|FG000|Overall Study|CRF not collected|117|||
30939344|NCT01904383|58976668|FG000|Overall Study|Reason not listed|147|||
30939345|NCT01904383|58976668|FG000|Overall Study|Lost to Follow-up|674|||
30939346|NCT01904383|58976668|FG000|Overall Study|Lack of Efficacy|370|||
30939347|NCT01904383|58976668|FG000|Overall Study|Improvement|141|||
30939348|NCT01904383|58976668|FG000|Overall Study|Adverse Event|271|||
30939349|NCT01904383|58976668|FG000|Overall Study|No patient visit after entry|54|||
30939350|NCT01904149|58976678|FG000|Overall Study|Adverse Event|3|||
30939351|NCT01904149|58976679|FG001|Overall Study|Adverse Event|4|||
30939352|NCT01904149|58976680|FG002|Overall Study|Adverse Event|0|||
30939353|NCT01904149|58976681|FG003|Overall Study|Adverse Event|1|||
30939354|NCT01904149|58976682|FG004|Overall Study|Adverse Event|1|||
30939355|NCT01904149|58976683|FG005|Overall Study|Adverse Event|2|||
30939356|NCT01904149|58976678|FG000|Overall Study|Lack of Efficacy|0|||
30939357|NCT01904149|58976679|FG001|Overall Study|Lack of Efficacy|3|||
30939358|NCT01904149|58976680|FG002|Overall Study|Lack of Efficacy|1|||
30939359|NCT01904149|58976681|FG003|Overall Study|Lack of Efficacy|3|||
30939360|NCT01904149|58976682|FG004|Overall Study|Lack of Efficacy|3|||
30939361|NCT01904149|58976683|FG005|Overall Study|Lack of Efficacy|1|||
30939362|NCT01904149|58976678|FG000|Overall Study|Withdrawal by Subject|1|||
30939363|NCT01904149|58976679|FG001|Overall Study|Withdrawal by Subject|3|||
30939364|NCT01904149|58976680|FG002|Overall Study|Withdrawal by Subject|1|||
30939365|NCT01904149|58976681|FG003|Overall Study|Withdrawal by Subject|0|||
30939366|NCT01904149|58976682|FG004|Overall Study|Withdrawal by Subject|1|||
30939367|NCT01904149|58976683|FG005|Overall Study|Withdrawal by Subject|0|||
30939368|NCT01904149|58976678|FG000|Overall Study|Protocol Violation|0|||
30939369|NCT01904149|58976679|FG001|Overall Study|Protocol Violation|1|||
30939370|NCT01904149|58976680|FG002|Overall Study|Protocol Violation|0|||
30842268|NCT03012061|58867871|FG001|Overall Study|Protocol Violation|0|||
30939371|NCT01904149|58976681|FG003|Overall Study|Protocol Violation|0|||
30939372|NCT01904149|58976682|FG004|Overall Study|Protocol Violation|0|||
30939373|NCT01904149|58976683|FG005|Overall Study|Protocol Violation|0|||
30842269|NCT03012061|58867872|FG002|Overall Study|Protocol Violation|2|||
30939374|NCT01904149|58976678|FG000|Overall Study|non compliance with study drug|1|||
30939375|NCT01904149|58976679|FG001|Overall Study|non compliance with study drug|0|||
30939376|NCT01904149|58976680|FG002|Overall Study|non compliance with study drug|0|||
30939377|NCT01904149|58976681|FG003|Overall Study|non compliance with study drug|0|||
30939378|NCT01904149|58976682|FG004|Overall Study|non compliance with study drug|0|||
30939379|NCT01904149|58976683|FG005|Overall Study|non compliance with study drug|0|||
30939380|NCT00986362|58976701|FG000|Overall Study|Death|2|||
30939381|NCT00986362|58976702|FG001|Overall Study|Death|0|||
30939382|NCT00986362|58976701|FG000|Overall Study|Lost to Follow-up|0|||
30939383|NCT00986362|58976702|FG001|Overall Study|Lost to Follow-up|1|||
30939384|NCT01890421|58976708|FG000|Overall Study|Adverse Event|1|||
30939385|NCT01890421|58976708|FG000|Overall Study|Other reason|10|||
30939386|NCT00985738|58976714|FG000|Overall Study|Study closed prematurely|8|||
30939387|NCT00985738|58976715|FG001|Overall Study|Study closed prematurely|8|||
30939388|NCT01928485|58976723|FG000|Overall Study|Physician Decision|0|||
30939389|NCT01928485|58976724|FG001|Overall Study|Physician Decision|1|||
30939390|NCT00985504|58976732|FG000|Acute Treatment Period|Adverse Event|3|||
30939391|NCT00985504|58976733|FG001|Acute Treatment Period|Adverse Event|4|||
30939392|NCT00985504|58976732|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
30939393|NCT00985504|58976733|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
30939394|NCT00985504|58976732|FG000|Acute Treatment Period|Protocol Violation|2|||
30939395|NCT00985504|58976733|FG001|Acute Treatment Period|Protocol Violation|0|||
30939396|NCT00985504|58976732|FG000|Acute Treatment Period|Sponsor Decision|0|||
30939397|NCT00985504|58976733|FG001|Acute Treatment Period|Sponsor Decision|1|||
30939398|NCT00985504|58976732|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
30939399|NCT00985504|58976733|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
30939400|NCT00985504|58976732|FG000|Optimization Period|Adverse Event|7|||
30939401|NCT00985504|58976733|FG001|Optimization Period|Adverse Event|9|||
30939402|NCT00985504|58976732|FG000|Optimization Period|Death|0|||
30939403|NCT00985504|58976733|FG001|Optimization Period|Death|1|||
30939404|NCT00985504|58976732|FG000|Optimization Period|Lack of Efficacy|5|||
30939405|NCT00985504|58976733|FG001|Optimization Period|Lack of Efficacy|3|||
30939406|NCT00985504|58976732|FG000|Optimization Period|Lost to Follow-up|0|||
30939407|NCT00985504|58976733|FG001|Optimization Period|Lost to Follow-up|1|||
30939408|NCT00985504|58976732|FG000|Optimization Period|Physician Decision|1|||
30939409|NCT00985504|58976733|FG001|Optimization Period|Physician Decision|0|||
30939410|NCT00985504|58976732|FG000|Optimization Period|Protocol Violation|3|||
30939411|NCT00985504|58976733|FG001|Optimization Period|Protocol Violation|1|||
30939412|NCT00985504|58976732|FG000|Optimization Period|Withdrawal by Subject|10|||
30939413|NCT00985504|58976733|FG001|Optimization Period|Withdrawal by Subject|8|||
30939414|NCT00985426|58976741|FG000|Overall Study|Adverse Event|0|||
30939415|NCT00985426|58976742|FG001|Overall Study|Adverse Event|1|||
30939416|NCT00985426|58976741|FG000|Overall Study|Subject Non-Compliance|3|||
30842270|NCT03012061|58867870|FG000|Overall Study|Lack of Efficacy|0|||
30842271|NCT03012061|58867871|FG001|Overall Study|Lack of Efficacy|1|||
30939417|NCT00985426|58976742|FG001|Overall Study|Subject Non-Compliance|3|||
30759176|NCT03571516|58767650|FG000|Overall Study|Severe diarrhea|1|||
30842272|NCT03012061|58867872|FG002|Overall Study|Lack of Efficacy|0|||
30842273|NCT03012061|58867870|FG000|Overall Study|Adverse Event|2|||
30842274|NCT03012061|58867871|FG001|Overall Study|Adverse Event|0|||
30842275|NCT03012061|58867872|FG002|Overall Study|Adverse Event|0|||
30842276|NCT03010501|58867880|FG000|Study Week 1|Withdrawal by Subject|2|||
30842277|NCT03010501|58867881|FG001|Study Week 1|Withdrawal by Subject|1|||
30842278|NCT03010501|58867882|FG002|Study Week 1|Withdrawal by Subject|0|||
30842279|NCT03010501|58867883|FG003|Study Week 1|Withdrawal by Subject|2|||
30842280|NCT03010501|58867884|FG004|Study Week 1|Withdrawal by Subject|0|||
30842281|NCT03010501|58867885|FG005|Study Week 1|Withdrawal by Subject|0|||
30842282|NCT03010501|58867880|FG000|Study Week 3|Withdrawal by Subject|0|||
30842283|NCT03010501|58867881|FG001|Study Week 3|Withdrawal by Subject|0|||
30842284|NCT03010501|58867882|FG002|Study Week 3|Withdrawal by Subject|0|||
30842285|NCT03010501|58867883|FG003|Study Week 3|Withdrawal by Subject|1|||
30842286|NCT03010501|58867884|FG004|Study Week 3|Withdrawal by Subject|0|||
30842287|NCT03010501|58867885|FG005|Study Week 3|Withdrawal by Subject|0|||
30842288|NCT03002623|58867895|FG000|Overall Study|Lost to Follow-up|1|||
30842289|NCT03002623|58867896|FG001|Overall Study|Lost to Follow-up|0|||
30842290|NCT03002623|58867895|FG000|Overall Study|Physician Decision|1|||
30842291|NCT03002623|58867896|FG001|Overall Study|Physician Decision|1|||
30842292|NCT03010423|58867904|FG000|Overall Study|Study termination|8|||
30842293|NCT03002311|58867910|FG000|Overall Study|Lost to Follow-up|13|||
30939418|NCT00985426|58976741|FG000|Overall Study|Withdrawal by Subject|12|||
30939419|NCT00985426|58976742|FG001|Overall Study|Withdrawal by Subject|16|||
30939420|NCT00985426|58976741|FG000|Overall Study|Lost to Follow-up|8|||
30939421|NCT00985426|58976742|FG001|Overall Study|Lost to Follow-up|10|||
30939422|NCT00985426|58976741|FG000|Overall Study|Death|7|||
30939423|NCT00985426|58976742|FG001|Overall Study|Death|3|||
30939424|NCT00985426|58976741|FG000|Overall Study|Protocol Violation|2|||
30939425|NCT00985426|58976742|FG001|Overall Study|Protocol Violation|0|||
30939426|NCT00985426|58976741|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
30759177|NCT03571516|58767651|FG001|Overall Study|Severe diarrhea|0|||
30759178|NCT03571516|58767650|FG000|Overall Study|Withdrawal by Subject|0|||
30759179|NCT03571516|58767651|FG001|Overall Study|Withdrawal by Subject|1|||
30759180|NCT03600376|58767659|FG000|Overall Study|Adverse Event|1|||
30759181|NCT03600376|58767660|FG001|Overall Study|Adverse Event|1|||
30759182|NCT03600376|58767659|FG000|Overall Study|Transferred to other facility|1|||
30759183|NCT03600376|58767660|FG001|Overall Study|Transferred to other facility|0|||
30939427|NCT00985426|58976742|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
30939428|NCT00985192|58976748|FG000|Overall Study|Withdrawal by Subject|1|||
30939429|NCT00985192|58976748|FG000|Overall Study|Disease Progression|1|||
30939430|NCT00985192|58976748|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
30939431|NCT00985114|58976754|FG000|Overall Study|Adverse Event|1|||
30939432|NCT00985114|58976755|FG001|Overall Study|Adverse Event|0|||
30939433|NCT00985114|58976754|FG000|Overall Study|Withdrawal by Subject|0|||
30939434|NCT00985114|58976755|FG001|Overall Study|Withdrawal by Subject|2|||
30939435|NCT00984568|58976763|FG000|Overall Study|Withdrawal by Subject|1|||
30939436|NCT00984568|58976764|FG001|Overall Study|Withdrawal by Subject|2|||
30939437|NCT00984568|58976763|FG000|Overall Study|Lack of Efficacy|2|||
30939438|NCT00984568|58976764|FG001|Overall Study|Lack of Efficacy|0|||
30939439|NCT00984568|58976763|FG000|Overall Study|Adverse Event|2|||
30939440|NCT00984568|58976764|FG001|Overall Study|Adverse Event|0|||
30939441|NCT00984568|58976763|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
30939442|NCT00984568|58976764|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
30939443|NCT00984568|58976763|FG000|Overall Study|Lost to Follow-up|0|||
30939444|NCT00984568|58976764|FG001|Overall Study|Lost to Follow-up|1|||
30939445|NCT00984568|58976763|FG000|Overall Study|Opportunistic Infection|1|||
30939446|NCT00984568|58976764|FG001|Overall Study|Opportunistic Infection|0|||
30939447|NCT00984568|58976763|FG000|Overall Study|Unknown Reason|1|||
30939448|NCT00984568|58976764|FG001|Overall Study|Unknown Reason|3|||
30939449|NCT00984256|58976772|FG000|Overall Study|Withdrawal by Subject|0|||
30939450|NCT00984256|58976773|FG001|Overall Study|Withdrawal by Subject|1|||
30939451|NCT00984022|58976790|FG000|Overall Study|Lost to Follow-up|10|||
30939452|NCT00984022|58976791|FG001|Overall Study|Lost to Follow-up|14|||
30939453|NCT01890265|58976803|FG000|Overall Study|Other (Unspecified reason)|0|||
30939454|NCT01890265|58976804|FG001|Overall Study|Other (Unspecified reason)|1|||
30939455|NCT01890265|58976805|FG002|Overall Study|Other (Unspecified reason)|0|||
30939456|NCT01890265|58976806|FG003|Overall Study|Other (Unspecified reason)|0|||
30939457|NCT01890265|58976807|FG004|Overall Study|Other (Unspecified reason)|0|||
30939458|NCT01890265|58976808|FG005|Overall Study|Other (Unspecified reason)|0|||
30939459|NCT01890265|58976803|FG000|Overall Study|Progressive disease|6|||
30939460|NCT01890265|58976804|FG001|Overall Study|Progressive disease|6|||
30939461|NCT01890265|58976805|FG002|Overall Study|Progressive disease|0|||
30939462|NCT01890265|58976806|FG003|Overall Study|Progressive disease|0|||
30939463|NCT01890265|58976807|FG004|Overall Study|Progressive disease|0|||
30939464|NCT01890265|58976808|FG005|Overall Study|Progressive disease|0|||
30939465|NCT01890265|58976803|FG000|Overall Study|Adverse Event|2|||
30939466|NCT01890265|58976804|FG001|Overall Study|Adverse Event|1|||
30939467|NCT01890265|58976805|FG002|Overall Study|Adverse Event|0|||
30939468|NCT01890265|58976806|FG003|Overall Study|Adverse Event|0|||
30939469|NCT01890265|58976807|FG004|Overall Study|Adverse Event|0|||
30939470|NCT01890265|58976808|FG005|Overall Study|Adverse Event|0|||
30939471|NCT01890265|58976803|FG000|Overall Study|Death|2|||
30939472|NCT01890265|58976804|FG001|Overall Study|Death|3|||
30939473|NCT01890265|58976805|FG002|Overall Study|Death|1|||
30939474|NCT01890265|58976806|FG003|Overall Study|Death|0|||
30939475|NCT01890265|58976807|FG004|Overall Study|Death|0|||
30939476|NCT01890265|58976808|FG005|Overall Study|Death|0|||
30939477|NCT01890265|58976803|FG000|Overall Study|Withdrawal by Subject|0|||
30624468|NCT01117350|58636533|FG001|Extension Period|Prohibited medication|1|||
30624469|NCT00952731|58636544|FG000|Overall Study|Drug supply expired|1|||
30939478|NCT01890265|58976804|FG001|Overall Study|Withdrawal by Subject|2|||
30939479|NCT01890265|58976805|FG002|Overall Study|Withdrawal by Subject|3|||
30939480|NCT01890265|58976806|FG003|Overall Study|Withdrawal by Subject|0|||
30939481|NCT01890265|58976807|FG004|Overall Study|Withdrawal by Subject|2|||
30939482|NCT01890265|58976808|FG005|Overall Study|Withdrawal by Subject|0|||
30939483|NCT01928329|58976829|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
30939484|NCT01928329|58976830|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
30939485|NCT01928329|58976829|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
30842294|NCT03002311|58867911|FG001|Overall Study|Lost to Follow-up|26|||
30939486|NCT01928329|58976830|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
30939487|NCT01928329|58976829|FG000|Overall Study|Adverse Event|5|||
30939488|NCT01928329|58976830|FG001|Overall Study|Adverse Event|3|||
30939489|NCT01928329|58976829|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
30939490|NCT01928329|58976830|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
30939491|NCT01928329|58976829|FG000|Overall Study|Withdrawal by Subject|1|||
30939492|NCT01928329|58976830|FG001|Overall Study|Withdrawal by Subject|5|||
30939493|NCT01928329|58976829|FG000|Overall Study|Physician Decision|1|||
30939494|NCT01928329|58976830|FG001|Overall Study|Physician Decision|1|||
30939495|NCT01890109|58976838|FG000|Overall Study|Withdrawal by Subject|0|||
30939496|NCT01890109|58976839|FG001|Overall Study|Withdrawal by Subject|3|||
30939497|NCT01890109|58976838|FG000|Overall Study|Lost to Follow-up|1|||
30624470|NCT00952731|58636545|FG001|Overall Study|Drug supply expired|0|||
30939498|NCT01890109|58976839|FG001|Overall Study|Lost to Follow-up|2|||
30939499|NCT00982930|58976846|FG000|Overall Study|Adverse Event|1|||
30939500|NCT00982930|58976846|FG000|Overall Study|Withdrawal by Subject|1|||
30939501|NCT00982930|58976846|FG000|Overall Study|Administrative Problems|2|||
30939502|NCT00981682|58976850|FG000|Overall Study|Adverse Event|48|||
30939503|NCT00981682|58976850|FG000|Overall Study|Withdrawal by Subject|52|||
30939504|NCT00981682|58976850|FG000|Overall Study|Lost to Follow-up|14|||
30939505|NCT00981682|58976850|FG000|Overall Study|Lack of Efficacy|13|||
30939506|NCT00981682|58976850|FG000|Overall Study|Protocol Violation|6|||
30939507|NCT00981682|58976850|FG000|Overall Study|administrative|9|||
30939508|NCT01903993|58976856|FG000|Overall Study|Death|118|||
30939509|NCT01903993|58976857|FG001|Overall Study|Death|121|||
30939510|NCT01903993|58976856|FG000|Overall Study|Withdrawal by Subject|15|||
30939511|NCT01903993|58976857|FG001|Overall Study|Withdrawal by Subject|4|||
30939512|NCT01903993|58976856|FG000|Overall Study|Lost to Follow-up|2|||
30939513|NCT01903993|58976857|FG001|Overall Study|Lost to Follow-up|3|||
30939514|NCT01903993|58976856|FG000|Overall Study|Study Terminated by Sponsor|8|||
30939515|NCT01903993|58976857|FG001|Overall Study|Study Terminated by Sponsor|14|||
30939516|NCT01903993|58976856|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
30939517|NCT01903993|58976857|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
30939518|NCT00981292|58976870|FG000|Day 1|Protocol Violation|1|||
30939519|NCT00981292|58976871|FG001|Day 1|Protocol Violation|0|||
30939520|NCT00981292|58976872|FG002|Day 1|Protocol Violation|0|||
30939521|NCT00981292|58976873|FG003|Day 1|Protocol Violation|0|||
30939522|NCT00981292|58976874|FG004|Day 1|Protocol Violation|0|||
30939523|NCT00981292|58976875|FG005|Day 1|Protocol Violation|2|||
30939524|NCT00981292|58976870|FG000|Day 2|Protocol Violation|2|||
30939525|NCT00981292|58976871|FG001|Day 2|Protocol Violation|0|||
30939526|NCT00981292|58976872|FG002|Day 2|Protocol Violation|0|||
30939527|NCT00981292|58976873|FG003|Day 2|Protocol Violation|0|||
30939528|NCT00981292|58976874|FG004|Day 2|Protocol Violation|0|||
30939529|NCT00981292|58976875|FG005|Day 2|Protocol Violation|0|||
30939530|NCT00981292|58976870|FG000|Day 3|Protocol Violation|0|||
30939531|NCT00981292|58976871|FG001|Day 3|Protocol Violation|0|||
30939532|NCT00981292|58976872|FG002|Day 3|Protocol Violation|0|||
30939533|NCT00981292|58976873|FG003|Day 3|Protocol Violation|0|||
30939534|NCT00981292|58976874|FG004|Day 3|Protocol Violation|0|||
30939535|NCT00981292|58976875|FG005|Day 3|Protocol Violation|1|||
30939536|NCT00980044|58976890|FG000|Overall Study|Withdrawal by Subject|5|||
30939537|NCT00980044|58976891|FG001|Overall Study|Withdrawal by Subject|7|||
30939538|NCT00980044|58976892|FG002|Overall Study|Withdrawal by Subject|3|||
30939539|NCT00980044|58976890|FG000|Overall Study|Protocol Violation|0|||
30939540|NCT00980044|58976891|FG001|Overall Study|Protocol Violation|0|||
30939541|NCT00980044|58976892|FG002|Overall Study|Protocol Violation|2|||
30939542|NCT01903837|58976907|FG000|Part A|Withdrawal by Subject|4|||
30939543|NCT01903837|58976908|FG001|Part A|Withdrawal by Subject|9|||
30939544|NCT01903837|58976909|FG002|Part A|Withdrawal by Subject|8|||
30939545|NCT01903837|58976910|FG003|Part A|Withdrawal by Subject|5|||
30939546|NCT01903837|58976907|FG000|Part A|Adverse Event|3|||
30939547|NCT01903837|58976908|FG001|Part A|Adverse Event|6|||
30939548|NCT01903837|58976909|FG002|Part A|Adverse Event|9|||
30939549|NCT01903837|58976910|FG003|Part A|Adverse Event|6|||
30939550|NCT01903837|58976907|FG000|Part A|Lost to Follow-up|9|||
30939551|NCT01903837|58976908|FG001|Part A|Lost to Follow-up|7|||
30939552|NCT01903837|58976909|FG002|Part A|Lost to Follow-up|7|||
30939553|NCT01903837|58976910|FG003|Part A|Lost to Follow-up|2|||
30939554|NCT01903837|58976907|FG000|Part A|Non-compliance with study drug|1|||
30939555|NCT01903837|58976908|FG001|Part A|Non-compliance with study drug|4|||
30939556|NCT01903837|58976909|FG002|Part A|Non-compliance with study drug|4|||
30939557|NCT01903837|58976910|FG003|Part A|Non-compliance with study drug|0|||
30939558|NCT01903837|58976907|FG000|Part A|Physician Decision|1|||
30939559|NCT01903837|58976908|FG001|Part A|Physician Decision|1|||
30939560|NCT01903837|58976909|FG002|Part A|Physician Decision|0|||
30939561|NCT01903837|58976910|FG003|Part A|Physician Decision|0|||
30939562|NCT01903837|58976907|FG000|Part A|Protocol Violation|1|||
30939563|NCT01903837|58976908|FG001|Part A|Protocol Violation|1|||
30939564|NCT01903837|58976909|FG002|Part A|Protocol Violation|0|||
30939565|NCT01903837|58976910|FG003|Part A|Protocol Violation|0|||
30939566|NCT01903837|58976907|FG000|Part B|Lost to Follow-up|0|||
30939567|NCT01903837|58976908|FG001|Part B|Lost to Follow-up|3|||
30939568|NCT01903837|58976909|FG002|Part B|Lost to Follow-up|3|||
30939569|NCT01903837|58976910|FG003|Part B|Lost to Follow-up|4|||
30939570|NCT01903837|58976907|FG000|Part B|Withdrawal by Subject|1|||
30939571|NCT01903837|58976908|FG001|Part B|Withdrawal by Subject|2|||
30939572|NCT01903837|58976909|FG002|Part B|Withdrawal by Subject|0|||
30939573|NCT01903837|58976910|FG003|Part B|Withdrawal by Subject|3|||
30939574|NCT01903837|58976907|FG000|Part B|Adverse Event|3|||
30939575|NCT01903837|58976908|FG001|Part B|Adverse Event|0|||
30939576|NCT01903837|58976909|FG002|Part B|Adverse Event|2|||
30939577|NCT01903837|58976910|FG003|Part B|Adverse Event|0|||
30939578|NCT01903837|58976907|FG000|Part B|Non-compliance with study drug|2|||
30939579|NCT01903837|58976908|FG001|Part B|Non-compliance with study drug|0|||
30939580|NCT01903837|58976909|FG002|Part B|Non-compliance with study drug|0|||
30939581|NCT01903837|58976910|FG003|Part B|Non-compliance with study drug|1|||
30939582|NCT01903837|58976907|FG000|Part B|Incarceration|2|||
30939583|NCT01903837|58976908|FG001|Part B|Incarceration|0|||
30939584|NCT01903837|58976909|FG002|Part B|Incarceration|0|||
30939585|NCT01903837|58976910|FG003|Part B|Incarceration|1|||
30939586|NCT01903837|58976907|FG000|Part B|Physician Decision|1|||
30939587|NCT01903837|58976908|FG001|Part B|Physician Decision|0|||
30939588|NCT01903837|58976909|FG002|Part B|Physician Decision|0|||
30939589|NCT01903837|58976910|FG003|Part B|Physician Decision|2|||
30939590|NCT01903837|58976907|FG000|Part B|Lack of Efficacy|0|||
30939591|NCT01903837|58976908|FG001|Part B|Lack of Efficacy|1|||
30939592|NCT01903837|58976909|FG002|Part B|Lack of Efficacy|0|||
30939593|NCT01903837|58976910|FG003|Part B|Lack of Efficacy|0|||
30939594|NCT01903525|58976943|FG000|Overall Study|Lost to Follow-up|5|||
30939595|NCT01903525|58976944|FG001|Overall Study|Lost to Follow-up|9|||
30939596|NCT01903525|58976943|FG000|Overall Study|Adverse Event|0|||
30939597|NCT01903525|58976944|FG001|Overall Study|Adverse Event|1|||
30939598|NCT00981526|58976952|FG000|Overall Study|Withdrawal by Subject|0|||
30939599|NCT00981526|58976953|FG001|Overall Study|Withdrawal by Subject|2|||
30939600|NCT00981526|58976952|FG000|Overall Study|Physician Decision|4|||
30939601|NCT00981526|58976953|FG001|Overall Study|Physician Decision|4|||
30939602|NCT01927861|58976963|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
30939603|NCT01927861|58976964|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
30939604|NCT01927861|58976963|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
30939605|NCT01927861|58976964|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
30939606|NCT01927627|58976970|FG000|Overall Study|Adverse Event|3|||
30939607|NCT01927627|58976970|FG000|Overall Study|Lack of Efficacy|1|||
30939608|NCT01927627|58976970|FG000|Overall Study|Financial Concerns|1|||
30939609|NCT01889251|58976976|FG000|Overall Study|Adverse Event|1|||
30939610|NCT01889251|58976977|FG001|Overall Study|Adverse Event|0|||
30939611|NCT01616563|58976983|FG000|Overall Study|Lost to Follow-up|40|||
30939612|NCT01616173|58976991|FG000|Overall Study|Lost to Follow-up|0|||
30939613|NCT01616173|58976992|FG001|Overall Study|Lost to Follow-up|2|||
30939614|NCT01616173|58976993|FG002|Overall Study|Lost to Follow-up|0|||
30939615|NCT01544595|58977007|FG000|Status at Week 68|Adverse Event|3|||
30939616|NCT01544595|58977008|FG001|Status at Week 68|Adverse Event|2|||
30939617|NCT01544595|58977009|FG002|Status at Week 68|Adverse Event|1|||
30939618|NCT01544595|58977010|FG003|Status at Week 68|Adverse Event|0|||
30939619|NCT01544595|58977011|FG004|Status at Week 68|Adverse Event|0|||
30939620|NCT01544595|58977012|FG005|Status at Week 68|Adverse Event|0|||
30939621|NCT01544595|58977007|FG000|Status at Week 68|Lack of Efficacy|1|||
30939622|NCT01544595|58977008|FG001|Status at Week 68|Lack of Efficacy|0|||
30939623|NCT01544595|58977009|FG002|Status at Week 68|Lack of Efficacy|0|||
30939624|NCT01544595|58977010|FG003|Status at Week 68|Lack of Efficacy|0|||
30939625|NCT01544595|58977011|FG004|Status at Week 68|Lack of Efficacy|0|||
30939626|NCT01544595|58977012|FG005|Status at Week 68|Lack of Efficacy|0|||
30939627|NCT01544595|58977007|FG000|Status at Week 68|Lost to Follow-up|1|||
30939628|NCT01544595|58977008|FG001|Status at Week 68|Lost to Follow-up|1|||
30939629|NCT01544595|58977009|FG002|Status at Week 68|Lost to Follow-up|0|||
30939630|NCT01544595|58977010|FG003|Status at Week 68|Lost to Follow-up|0|||
30939631|NCT01544595|58977011|FG004|Status at Week 68|Lost to Follow-up|0|||
30939632|NCT01544595|58977012|FG005|Status at Week 68|Lost to Follow-up|0|||
30939633|NCT01544595|58977007|FG000|Status at Week 68|Non-compliance with study treatment|1|||
30939634|NCT01544595|58977008|FG001|Status at Week 68|Non-compliance with study treatment|0|||
30939635|NCT01544595|58977009|FG002|Status at Week 68|Non-compliance with study treatment|0|||
30939636|NCT01544595|58977010|FG003|Status at Week 68|Non-compliance with study treatment|1|||
30939637|NCT01544595|58977011|FG004|Status at Week 68|Non-compliance with study treatment|0|||
30939638|NCT01544595|58977012|FG005|Status at Week 68|Non-compliance with study treatment|0|||
30939639|NCT01544595|58977007|FG000|Status at Week 68|Protocol Violation|2|||
30939640|NCT01544595|58977008|FG001|Status at Week 68|Protocol Violation|0|||
30939641|NCT01544595|58977009|FG002|Status at Week 68|Protocol Violation|1|||
30939642|NCT01544595|58977010|FG003|Status at Week 68|Protocol Violation|1|||
30939643|NCT01544595|58977011|FG004|Status at Week 68|Protocol Violation|0|||
30939644|NCT01544595|58977012|FG005|Status at Week 68|Protocol Violation|0|||
30939645|NCT01544595|58977007|FG000|Status at Week 68|Technical problems|1|||
30939646|NCT01544595|58977008|FG001|Status at Week 68|Technical problems|0|||
30939647|NCT01544595|58977009|FG002|Status at Week 68|Technical problems|0|||
30939648|NCT01544595|58977010|FG003|Status at Week 68|Technical problems|1|||
30939649|NCT01544595|58977011|FG004|Status at Week 68|Technical problems|0|||
30939650|NCT01544595|58977012|FG005|Status at Week 68|Technical problems|0|||
30939651|NCT01544595|58977007|FG000|Status at Week 68|Withdrawal by Subject|0|||
30939652|NCT01544595|58977008|FG001|Status at Week 68|Withdrawal by Subject|1|||
30939653|NCT01544595|58977009|FG002|Status at Week 68|Withdrawal by Subject|1|||
30939654|NCT01544595|58977010|FG003|Status at Week 68|Withdrawal by Subject|2|||
30939655|NCT01544595|58977011|FG004|Status at Week 68|Withdrawal by Subject|0|||
30939656|NCT01544595|58977012|FG005|Status at Week 68|Withdrawal by Subject|0|||
30939657|NCT01544595|58977007|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
30939658|NCT01544595|58977008|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
30939659|NCT01544595|58977009|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
30939660|NCT01544595|58977010|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
30939661|NCT01544595|58977011|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
30939662|NCT01544595|58977012|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
30939663|NCT01544595|58977007|FG000|Status at Week 156|Withdrawal by Subject|9|||
30939664|NCT01544595|58977008|FG001|Status at Week 156|Withdrawal by Subject|10|||
30939665|NCT01544595|58977009|FG002|Status at Week 156|Withdrawal by Subject|4|||
30939666|NCT01544595|58977010|FG003|Status at Week 156|Withdrawal by Subject|9|||
30939667|NCT01544595|58977011|FG004|Status at Week 156|Withdrawal by Subject|20|||
30939668|NCT01544595|58977012|FG005|Status at Week 156|Withdrawal by Subject|6|||
30939669|NCT01544595|58977007|FG000|Status at Week 156|Adverse Event|9|||
30939670|NCT01544595|58977008|FG001|Status at Week 156|Adverse Event|11|||
30939671|NCT01544595|58977009|FG002|Status at Week 156|Adverse Event|1|||
30939672|NCT01544595|58977010|FG003|Status at Week 156|Adverse Event|3|||
30939673|NCT01544595|58977011|FG004|Status at Week 156|Adverse Event|4|||
30939674|NCT01544595|58977012|FG005|Status at Week 156|Adverse Event|2|||
30939675|NCT01544595|58977007|FG000|Status at Week 156|Lost to Follow-up|4|||
30939676|NCT01544595|58977008|FG001|Status at Week 156|Lost to Follow-up|4|||
30939677|NCT01544595|58977009|FG002|Status at Week 156|Lost to Follow-up|0|||
30939678|NCT01544595|58977010|FG003|Status at Week 156|Lost to Follow-up|1|||
30939679|NCT01544595|58977011|FG004|Status at Week 156|Lost to Follow-up|4|||
30939680|NCT01544595|58977012|FG005|Status at Week 156|Lost to Follow-up|1|||
30939681|NCT01544595|58977007|FG000|Status at Week 156|Non-compliance with study treatement|0|||
30939682|NCT01544595|58977008|FG001|Status at Week 156|Non-compliance with study treatement|1|||
30939683|NCT01544595|58977009|FG002|Status at Week 156|Non-compliance with study treatement|0|||
30939684|NCT01544595|58977010|FG003|Status at Week 156|Non-compliance with study treatement|1|||
30939685|NCT01544595|58977011|FG004|Status at Week 156|Non-compliance with study treatement|0|||
30842295|NCT03002311|58867910|FG000|Overall Study|Referral provider called to schedule app|3|||
30842296|NCT03002311|58867911|FG001|Overall Study|Referral provider called to schedule app|3|||
30939686|NCT01544595|58977012|FG005|Status at Week 156|Non-compliance with study treatement|1|||
30939687|NCT01544595|58977007|FG000|Status at Week 156|Physician Decision|0|||
30939688|NCT01544595|58977008|FG001|Status at Week 156|Physician Decision|3|||
30939689|NCT01544595|58977009|FG002|Status at Week 156|Physician Decision|1|||
30939690|NCT01544595|58977010|FG003|Status at Week 156|Physician Decision|0|||
30939691|NCT01544595|58977011|FG004|Status at Week 156|Physician Decision|0|||
30939692|NCT01544595|58977012|FG005|Status at Week 156|Physician Decision|0|||
30939693|NCT01544595|58977007|FG000|Status at Week 156|Pregnancy|2|||
30939694|NCT01544595|58977008|FG001|Status at Week 156|Pregnancy|3|||
30939695|NCT01544595|58977009|FG002|Status at Week 156|Pregnancy|0|||
30939696|NCT01544595|58977010|FG003|Status at Week 156|Pregnancy|0|||
30939697|NCT01544595|58977011|FG004|Status at Week 156|Pregnancy|0|||
30939698|NCT01544595|58977012|FG005|Status at Week 156|Pregnancy|0|||
30939699|NCT01544595|58977007|FG000|Status at Week 156|Protocol Violation|3|||
30939700|NCT01544595|58977008|FG001|Status at Week 156|Protocol Violation|1|||
30939701|NCT01544595|58977009|FG002|Status at Week 156|Protocol Violation|2|||
30939702|NCT01544595|58977010|FG003|Status at Week 156|Protocol Violation|2|||
30939703|NCT01544595|58977011|FG004|Status at Week 156|Protocol Violation|0|||
30939704|NCT01544595|58977012|FG005|Status at Week 156|Protocol Violation|0|||
30939705|NCT01544595|58977007|FG000|Status at Week 156|Technical problems|3|||
30939706|NCT01544595|58977008|FG001|Status at Week 156|Technical problems|1|||
30939707|NCT01544595|58977009|FG002|Status at Week 156|Technical problems|0|||
30939708|NCT01544595|58977010|FG003|Status at Week 156|Technical problems|1|||
30939709|NCT01544595|58977011|FG004|Status at Week 156|Technical problems|0|||
30939710|NCT01544595|58977012|FG005|Status at Week 156|Technical problems|0|||
30939711|NCT01544595|58977007|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
30939712|NCT01544595|58977008|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
30939713|NCT01544595|58977009|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
30939714|NCT01544595|58977010|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
30939715|NCT01544595|58977011|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
30939716|NCT01544595|58977012|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
30939717|NCT01544595|58977007|FG000|Status at Week 156|Lack of Efficacy|1|||
30939718|NCT01544595|58977008|FG001|Status at Week 156|Lack of Efficacy|0|||
30939719|NCT01544595|58977009|FG002|Status at Week 156|Lack of Efficacy|1|||
30939720|NCT01544595|58977010|FG003|Status at Week 156|Lack of Efficacy|4|||
30939721|NCT01544595|58977011|FG004|Status at Week 156|Lack of Efficacy|10|||
30939722|NCT01544595|58977012|FG005|Status at Week 156|Lack of Efficacy|5|||
30939723|NCT01539525|58977033|FG000|Overall Study|Lost to Follow-up|19|||
30939724|NCT01539525|58977034|FG001|Overall Study|Lost to Follow-up|12|||
30939725|NCT01539525|58977035|FG002|Overall Study|Lost to Follow-up|11|||
30939726|NCT01539525|58977033|FG000|Overall Study|Withdrawal by Subject|0|||
30939727|NCT01539525|58977034|FG001|Overall Study|Withdrawal by Subject|3|||
30939728|NCT01539525|58977035|FG002|Overall Study|Withdrawal by Subject|2|||
30939729|NCT01539525|58977033|FG000|Overall Study|Protocol Violation|1|||
30939730|NCT01539525|58977034|FG001|Overall Study|Protocol Violation|1|||
30939731|NCT01539525|58977035|FG002|Overall Study|Protocol Violation|4|||
30939732|NCT01513551|58977049|FG000|Overall Study|Death|0|||
30939733|NCT01513551|58977050|FG001|Overall Study|Death|1|||
30939734|NCT01513551|58977051|FG002|Overall Study|Death|0|||
30939735|NCT01513551|58977049|FG000|Overall Study|Lost to Follow-up|3|||
30939736|NCT01513551|58977050|FG001|Overall Study|Lost to Follow-up|5|||
30939737|NCT01513551|58977051|FG002|Overall Study|Lost to Follow-up|2|||
30939738|NCT01513551|58977049|FG000|Overall Study|Withdrawal by Subject|1|||
30939739|NCT01513551|58977050|FG001|Overall Study|Withdrawal by Subject|0|||
30939740|NCT01513551|58977051|FG002|Overall Study|Withdrawal by Subject|2|||
30939741|NCT01513551|58977049|FG000|Overall Study|Randomized but not vaccinated|0|||
30939742|NCT01513551|58977050|FG001|Overall Study|Randomized but not vaccinated|0|||
30939743|NCT01513551|58977051|FG002|Overall Study|Randomized but not vaccinated|1|||
30939744|NCT01513473|58977061|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
30939745|NCT01513473|58977062|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
30939746|NCT01513473|58977061|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
30939747|NCT01513473|58977062|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
30939748|NCT01513473|58977061|FG000|Main Trial (26 Weeks)|Unclassified|0|||
30939749|NCT01513473|58977062|FG001|Main Trial (26 Weeks)|Unclassified|2|||
30939750|NCT01513473|58977061|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
30939751|NCT01513473|58977062|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
30939752|NCT01513473|58977061|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
30939753|NCT01513473|58977062|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
30939754|NCT01513317|58977070|FG000|Overall Study|Withdrawal by Subject|15|||
30939755|NCT01513317|58977071|FG001|Overall Study|Withdrawal by Subject|4|||
30939756|NCT01513317|58977070|FG000|Overall Study|Death|1|||
30939757|NCT01513317|58977071|FG001|Overall Study|Death|1|||
30939758|NCT01513317|58977070|FG000|Overall Study|Study terminated by sponsor|18|||
30939759|NCT01513317|58977071|FG001|Overall Study|Study terminated by sponsor|18|||
30939760|NCT01513317|58977070|FG000|Overall Study|Other|0|||
30939761|NCT01513317|58977071|FG001|Overall Study|Other|1|||
30939762|NCT03824392|58977081|FG000|Overall Study|Adverse Event|1|||
30939763|NCT03824392|58977082|FG001|Overall Study|Adverse Event|0|||
30939764|NCT03824392|58977083|FG002|Overall Study|Adverse Event|0|||
30939765|NCT03824392|58977084|FG003|Overall Study|Adverse Event|0|||
30939766|NCT03824392|58977081|FG000|Overall Study|Investigator Decision|0|||
30939767|NCT03824392|58977082|FG001|Overall Study|Investigator Decision|1|||
30939768|NCT03824392|58977083|FG002|Overall Study|Investigator Decision|0|||
30939769|NCT03824392|58977084|FG003|Overall Study|Investigator Decision|0|||
30939770|NCT03824392|58977081|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
30939771|NCT03824392|58977082|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
30939772|NCT03824392|58977083|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
30939773|NCT03824392|58977084|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
30939774|NCT01901653|58977107|FG000|Overall Study|Death|2|||
30939775|NCT01901653|58977108|FG001|Overall Study|Death|1|||
30939776|NCT01901653|58977109|FG002|Overall Study|Death|8|||
30939777|NCT01901653|58977110|FG003|Overall Study|Death|3|||
30939778|NCT01901653|58977111|FG004|Overall Study|Death|2|||
30939779|NCT01901653|58977112|FG005|Overall Study|Death|2|||
30939780|NCT01901653|58977113|FG006|Overall Study|Death|6|||
30939781|NCT01901653|58977114|FG007|Overall Study|Death|9|||
30842297|NCT03002311|58867910|FG000|Overall Study|Physician Decision|3|||
30939782|NCT01901653|58977115|FG008|Overall Study|Death|1|||
30939783|NCT01901653|58977116|FG009|Overall Study|Death|16|||
30939784|NCT01901653|58977117|FG010|Overall Study|Death|2|||
30939785|NCT01901653|58977118|FG011|Overall Study|Death|15|||
30939786|NCT01901653|58977119|FG012|Overall Study|Death|4|||
30939787|NCT01901653|58977107|FG000|Overall Study|Lost to Follow-up|1|||
30939788|NCT01901653|58977108|FG001|Overall Study|Lost to Follow-up|0|||
30939789|NCT01901653|58977109|FG002|Overall Study|Lost to Follow-up|2|||
30939790|NCT01901653|58977110|FG003|Overall Study|Lost to Follow-up|0|||
30939791|NCT01901653|58977111|FG004|Overall Study|Lost to Follow-up|0|||
30939792|NCT01901653|58977112|FG005|Overall Study|Lost to Follow-up|1|||
30939793|NCT01901653|58977113|FG006|Overall Study|Lost to Follow-up|0|||
30939794|NCT01901653|58977114|FG007|Overall Study|Lost to Follow-up|1|||
30939795|NCT01901653|58977115|FG008|Overall Study|Lost to Follow-up|0|||
30939796|NCT01901653|58977116|FG009|Overall Study|Lost to Follow-up|0|||
30939797|NCT01901653|58977117|FG010|Overall Study|Lost to Follow-up|0|||
30939798|NCT01901653|58977118|FG011|Overall Study|Lost to Follow-up|0|||
30939799|NCT01901653|58977119|FG012|Overall Study|Lost to Follow-up|0|||
30939800|NCT01901653|58977107|FG000|Overall Study|Withdrawal by Subject|0|||
30939801|NCT01901653|58977108|FG001|Overall Study|Withdrawal by Subject|0|||
30939802|NCT01901653|58977109|FG002|Overall Study|Withdrawal by Subject|0|||
30939803|NCT01901653|58977110|FG003|Overall Study|Withdrawal by Subject|0|||
30939804|NCT01901653|58977111|FG004|Overall Study|Withdrawal by Subject|0|||
30939805|NCT01901653|58977112|FG005|Overall Study|Withdrawal by Subject|0|||
30939806|NCT01901653|58977113|FG006|Overall Study|Withdrawal by Subject|1|||
30939807|NCT01901653|58977114|FG007|Overall Study|Withdrawal by Subject|0|||
30939808|NCT01901653|58977115|FG008|Overall Study|Withdrawal by Subject|0|||
30939809|NCT01901653|58977116|FG009|Overall Study|Withdrawal by Subject|0|||
30939810|NCT01901653|58977117|FG010|Overall Study|Withdrawal by Subject|0|||
30939811|NCT01901653|58977118|FG011|Overall Study|Withdrawal by Subject|0|||
30939812|NCT01901653|58977119|FG012|Overall Study|Withdrawal by Subject|0|||
30939813|NCT01901653|58977107|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
30939814|NCT01901653|58977108|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
30939815|NCT01901653|58977109|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
30939816|NCT01901653|58977110|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
30939817|NCT01901653|58977111|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
30939818|NCT01901653|58977112|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
30939819|NCT01901653|58977113|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
30939820|NCT01901653|58977114|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
30939821|NCT01901653|58977115|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
30939822|NCT01901653|58977116|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
30939823|NCT01901653|58977117|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
30939824|NCT01901653|58977118|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
30939825|NCT01901653|58977119|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
30939826|NCT01925989|58977147|FG000|Period 1|Sponsor Decision|1|||
30939827|NCT01925989|58977148|FG001|Period 1|Sponsor Decision|1|||
30939828|NCT01925989|58977149|FG002|Period 1|Sponsor Decision|0|||
30939829|NCT01925989|58977147|FG000|Period 1|Withdrawal by Subject|0|||
30939830|NCT01925989|58977148|FG001|Period 1|Withdrawal by Subject|1|||
30939831|NCT01925989|58977149|FG002|Period 1|Withdrawal by Subject|0|||
30939832|NCT01901419|58977163|FG000|Overall Study|Protocol Violation|2|||
30939833|NCT01901419|58977164|FG001|Overall Study|Protocol Violation|6|||
30939834|NCT01901419|58977163|FG000|Overall Study|unavailable researchers|6|||
30939835|NCT01901419|58977164|FG001|Overall Study|unavailable researchers|3|||
30939836|NCT01901341|58977191|FG000|Overall Study|Adverse Event|4|||
30939837|NCT01901341|58977192|FG001|Overall Study|Adverse Event|2|||
30939838|NCT01901341|58977191|FG000|Overall Study|Lack of Efficacy|0|||
30939839|NCT01901341|58977192|FG001|Overall Study|Lack of Efficacy|2|||
30939840|NCT01901341|58977191|FG000|Overall Study|Lost to Follow-up|0|||
30939841|NCT01901341|58977192|FG001|Overall Study|Lost to Follow-up|1|||
30939842|NCT01901341|58977191|FG000|Overall Study|Protocol Violation|2|||
30939843|NCT01901341|58977192|FG001|Overall Study|Protocol Violation|0|||
30939844|NCT01901341|58977191|FG000|Overall Study|Study Terminated by Sponsor|13|||
30939845|NCT01901341|58977192|FG001|Overall Study|Study Terminated by Sponsor|15|||
30939846|NCT01901341|58977191|FG000|Overall Study|Withdrawal by Subject|1|||
30939847|NCT01901341|58977192|FG001|Overall Study|Withdrawal by Subject|1|||
30939848|NCT01615939|58977201|FG000|Overall Study|Lost to Follow-up|5|||
30939849|NCT01615939|58977202|FG001|Overall Study|Lost to Follow-up|0|||
30939850|NCT01901185|58977208|FG000|Overall Study|Withdrawal by Subject|2|||
30939851|NCT01888003|58977215|FG000|Overall Study|Study Terminated|5|||
30939852|NCT01888003|58977216|FG001|Overall Study|Study Terminated|6|||
30939853|NCT01888003|58977217|FG002|Overall Study|Study Terminated|40|||
30939854|NCT01925209|58977283|FG000|Treatment Epoch|Physician Decision|1|||
30939855|NCT01925209|58977284|FG001|Treatment Epoch|Physician Decision|0|||
30939856|NCT01925209|58977285|FG002|Treatment Epoch|Physician Decision|0|||
30939857|NCT01925209|58977286|FG003|Treatment Epoch|Physician Decision|0|||
30939858|NCT01925209|58977283|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
30939859|NCT01925209|58977284|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
30939860|NCT01925209|58977285|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
30939861|NCT01925209|58977286|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
30939862|NCT01925209|58977283|FG000|Treatment Epoch|Death|1|||
30939863|NCT01925209|58977284|FG001|Treatment Epoch|Death|0|||
30939864|NCT01925209|58977285|FG002|Treatment Epoch|Death|0|||
30939865|NCT01925209|58977286|FG003|Treatment Epoch|Death|0|||
30939866|NCT01925209|58977283|FG000|Treatment Epoch|Protocol deviation|0|||
30939867|NCT01925209|58977284|FG001|Treatment Epoch|Protocol deviation|0|||
30939868|NCT01925209|58977285|FG002|Treatment Epoch|Protocol deviation|1|||
30939869|NCT01925209|58977286|FG003|Treatment Epoch|Protocol deviation|1|||
30939870|NCT01925209|58977283|FG000|Treatment Epoch|Withdrawal by Subject|4|||
30939871|NCT01925209|58977284|FG001|Treatment Epoch|Withdrawal by Subject|3|||
30939872|NCT01925209|58977285|FG002|Treatment Epoch|Withdrawal by Subject|3|||
30939873|NCT01925209|58977286|FG003|Treatment Epoch|Withdrawal by Subject|2|||
30939874|NCT01925209|58977283|FG000|Treatment Epoch|Adverse Event|3|||
30939875|NCT01925209|58977284|FG001|Treatment Epoch|Adverse Event|5|||
30939876|NCT01925209|58977285|FG002|Treatment Epoch|Adverse Event|3|||
30939877|NCT01925209|58977286|FG003|Treatment Epoch|Adverse Event|1|||
30939878|NCT01925209|58977283|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
30939879|NCT01925209|58977284|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
30939880|NCT01925209|58977285|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
30939881|NCT01925209|58977286|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
30939882|NCT01925209|58977283|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
30939883|NCT01925209|58977284|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
30939884|NCT01925209|58977285|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
30939885|NCT01925209|58977286|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
30939886|NCT01925209|58977283|FG000|Follow-up|Adverse Event|1|||
30939887|NCT01925209|58977284|FG001|Follow-up|Adverse Event|4|||
30939888|NCT01925209|58977285|FG002|Follow-up|Adverse Event|0|||
30939889|NCT01925209|58977286|FG003|Follow-up|Adverse Event|1|||
30939890|NCT01925209|58977283|FG000|Follow-up|Physician Decision|0|||
30939891|NCT01925209|58977284|FG001|Follow-up|Physician Decision|0|||
30939892|NCT01925209|58977285|FG002|Follow-up|Physician Decision|1|||
30939893|NCT01925209|58977286|FG003|Follow-up|Physician Decision|0|||
30939894|NCT01925209|58977283|FG000|Follow-up|Non-compliance with study treatment|0|||
30939895|NCT01925209|58977284|FG001|Follow-up|Non-compliance with study treatment|0|||
30939896|NCT01925209|58977285|FG002|Follow-up|Non-compliance with study treatment|0|||
30939897|NCT01925209|58977286|FG003|Follow-up|Non-compliance with study treatment|1|||
30939898|NCT01925209|58977283|FG000|Follow-up|Withdrawal by Subject|0|||
30939899|NCT01925209|58977284|FG001|Follow-up|Withdrawal by Subject|2|||
30939900|NCT01925209|58977285|FG002|Follow-up|Withdrawal by Subject|0|||
30939901|NCT01925209|58977286|FG003|Follow-up|Withdrawal by Subject|2|||
30939902|NCT01614925|58977298|FG000|Overall Study|Withdrawal by Subject|1|||
30939903|NCT01614925|58977299|FG001|Overall Study|Withdrawal by Subject|0|||
30939904|NCT01614925|58977298|FG000|Overall Study|Protocol Violation|3|||
30939905|NCT01614925|58977299|FG001|Overall Study|Protocol Violation|2|||
30939906|NCT01886833|58977305|FG000|Overall Study|IgA not available from both periods|204|||
30939907|NCT01898923|58977314|FG000|Overall Study|Lack of Efficacy|5|||
30939908|NCT01898923|58977315|FG001|Overall Study|Lack of Efficacy|6|||
30939909|NCT01898923|58977314|FG000|Overall Study|Adverse Event|3|||
30939910|NCT01898923|58977315|FG001|Overall Study|Adverse Event|1|||
30939911|NCT01898923|58977314|FG000|Overall Study|Lost to Follow-up|0|||
30939912|NCT01898923|58977315|FG001|Overall Study|Lost to Follow-up|1|||
30939913|NCT01898923|58977314|FG000|Overall Study|Withdrawal by Subject|4|||
30939914|NCT01898923|58977315|FG001|Overall Study|Withdrawal by Subject|7|||
30939915|NCT01898923|58977314|FG000|Overall Study|Physician Decision|3|||
30939916|NCT01898923|58977315|FG001|Overall Study|Physician Decision|4|||
30939917|NCT01898923|58977314|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
30939918|NCT01898923|58977315|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
30939919|NCT01924429|58977323|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
30939920|NCT01924429|58977324|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
30939921|NCT01898299|58977334|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
30939922|NCT01898299|58977335|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
30939923|NCT01886287|58977341|FG000|Overall Study|Radiographic disease progression|1|||
30939924|NCT01886287|58977341|FG000|Overall Study|Clinical progression due to disease|1|||
30939925|NCT01885195|58977345|FG000|Overall Study|Adverse Event|29|||
30939926|NCT01885195|58977345|FG000|Overall Study|Death|1|||
30939927|NCT01885195|58977345|FG000|Overall Study|Disease Progression|67|||
30939928|NCT01885195|58977345|FG000|Overall Study|Protocol Deviation|2|||
30939929|NCT01885195|58977345|FG000|Overall Study|Physician Decision|3|||
30939930|NCT01885195|58977345|FG000|Overall Study|Patient/guardian decision|8|||
30759184|NCT03600376|58767659|FG000|Overall Study|Investigator Decision|0|||
30939931|NCT01896895|58977352|FG000|Double-blind MP|Physician Decision|0|||
30939932|NCT01896895|58977353|FG001|Double-blind MP|Physician Decision|0|||
30939933|NCT01896895|58977354|FG002|Double-blind MP|Physician Decision|1|||
30939934|NCT01896895|58977355|FG003|Double-blind MP|Physician Decision|0|||
30939935|NCT01896895|58977352|FG000|Double-blind MP|Withdrawal by Subject|0|||
30939936|NCT01896895|58977353|FG001|Double-blind MP|Withdrawal by Subject|2|||
30939937|NCT01896895|58977354|FG002|Double-blind MP|Withdrawal by Subject|1|||
30939938|NCT01896895|58977355|FG003|Double-blind MP|Withdrawal by Subject|0|||
30939939|NCT01896895|58977352|FG000|Double-blind MP|Lost to Follow-up|1|||
30939940|NCT01896895|58977353|FG001|Double-blind MP|Lost to Follow-up|0|||
30939941|NCT01896895|58977354|FG002|Double-blind MP|Lost to Follow-up|1|||
30939942|NCT01896895|58977355|FG003|Double-blind MP|Lost to Follow-up|0|||
30939943|NCT01923181|58977398|FG000|Overall Study|Protocol Violation|2|||
30939944|NCT01923181|58977399|FG001|Overall Study|Protocol Violation|2|||
30939945|NCT01923181|58977400|FG002|Overall Study|Protocol Violation|0|||
30939946|NCT01923181|58977401|FG003|Overall Study|Protocol Violation|2|||
30939947|NCT01923181|58977402|FG004|Overall Study|Protocol Violation|2|||
30939948|NCT01923181|58977403|FG005|Overall Study|Protocol Violation|1|||
30939949|NCT01923181|58977404|FG006|Overall Study|Protocol Violation|1|||
30939950|NCT01923181|58977405|FG007|Overall Study|Protocol Violation|2|||
30939951|NCT01923181|58977406|FG008|Overall Study|Protocol Violation|1|||
30939952|NCT01923181|58977398|FG000|Overall Study|Withdrawal by Subject|0|||
30939953|NCT01923181|58977399|FG001|Overall Study|Withdrawal by Subject|1|||
30939954|NCT01923181|58977400|FG002|Overall Study|Withdrawal by Subject|0|||
30939955|NCT01923181|58977401|FG003|Overall Study|Withdrawal by Subject|1|||
30939956|NCT01923181|58977402|FG004|Overall Study|Withdrawal by Subject|4|||
30939957|NCT01923181|58977403|FG005|Overall Study|Withdrawal by Subject|2|||
30939958|NCT01923181|58977404|FG006|Overall Study|Withdrawal by Subject|4|||
30939959|NCT01923181|58977405|FG007|Overall Study|Withdrawal by Subject|3|||
30939960|NCT01923181|58977406|FG008|Overall Study|Withdrawal by Subject|1|||
30939961|NCT01923181|58977398|FG000|Overall Study|Other|1|||
30939962|NCT01923181|58977399|FG001|Overall Study|Other|0|||
30939963|NCT01923181|58977400|FG002|Overall Study|Other|0|||
30939964|NCT01923181|58977401|FG003|Overall Study|Other|1|||
30939965|NCT01923181|58977402|FG004|Overall Study|Other|0|||
30939966|NCT01923181|58977403|FG005|Overall Study|Other|0|||
30939967|NCT01923181|58977404|FG006|Overall Study|Other|0|||
30939968|NCT01923181|58977405|FG007|Overall Study|Other|0|||
30939969|NCT01923181|58977406|FG008|Overall Study|Other|0|||
30939970|NCT01923181|58977398|FG000|Overall Study|Lost to Follow-up|0|||
30939971|NCT01923181|58977399|FG001|Overall Study|Lost to Follow-up|3|||
30939972|NCT01923181|58977400|FG002|Overall Study|Lost to Follow-up|2|||
30939973|NCT01923181|58977401|FG003|Overall Study|Lost to Follow-up|1|||
30939974|NCT01923181|58977402|FG004|Overall Study|Lost to Follow-up|2|||
30939975|NCT01923181|58977403|FG005|Overall Study|Lost to Follow-up|1|||
30939976|NCT01923181|58977404|FG006|Overall Study|Lost to Follow-up|3|||
30939977|NCT01923181|58977405|FG007|Overall Study|Lost to Follow-up|3|||
30939978|NCT01923181|58977406|FG008|Overall Study|Lost to Follow-up|1|||
30939979|NCT01896271|58977429|FG000|Overall Study|Physician Decision|10|||
30939980|NCT01884571|58977442|FG000|Overall Study|Adverse Event|1|||
30939981|NCT01884571|58977442|FG000|Overall Study|Death|2|||
30939982|NCT01884571|58977442|FG000|Overall Study|Withdrawal by Subject|2|||
30939983|NCT01884571|58977442|FG000|Overall Study|Disease progression|3|||
30939984|NCT01884337|58977448|FG000|Treatment|Adverse Event|2|||
30939985|NCT01884337|58977449|FG001|Treatment|Adverse Event|2|||
30939986|NCT01884337|58977448|FG000|Treatment|Subj. request to discont. treatment|2|||
30939987|NCT01884337|58977449|FG001|Treatment|Subj. request to discont. treatment|0|||
30939988|NCT01884337|58977448|FG000|Follow-up Period|Lost to Follow-up|1|||
30939989|NCT01884337|58977449|FG001|Follow-up Period|Lost to Follow-up|1|||
30939990|NCT01922089|58977457|FG000|Overall Study|Adverse Event|18|||
30939991|NCT01922089|58977458|FG001|Overall Study|Adverse Event|13|||
30939992|NCT01922089|58977457|FG000|Overall Study|Protocol Deviation|10|||
30939993|NCT01922089|58977458|FG001|Overall Study|Protocol Deviation|7|||
30939994|NCT01922089|58977457|FG000|Overall Study|Withdrawal by Subject|3|||
30939995|NCT01922089|58977458|FG001|Overall Study|Withdrawal by Subject|4|||
30939996|NCT01922089|58977457|FG000|Overall Study|administrative problems|4|||
30939997|NCT01922089|58977458|FG001|Overall Study|administrative problems|1|||
30939998|NCT01922089|58977457|FG000|Overall Study|Physician Decision|2|||
30939999|NCT01922089|58977458|FG001|Overall Study|Physician Decision|3|||
30940000|NCT01922089|58977457|FG000|Overall Study|Death|2|||
30940001|NCT01922089|58977458|FG001|Overall Study|Death|1|||
30940002|NCT01922089|58977457|FG000|Overall Study|Lost to Follow-up|0|||
30940003|NCT01922089|58977458|FG001|Overall Study|Lost to Follow-up|1|||
30940004|NCT01884025|58977466|FG000|Overall Study|Lost to Follow-up|3|||
30940005|NCT01884025|58977467|FG001|Overall Study|Lost to Follow-up|4|||
30940006|NCT01896193|58977477|FG000|Overall Study|Lack of Efficacy|20|||
30940007|NCT01896193|58977478|FG001|Overall Study|Lack of Efficacy|11|||
30940008|NCT01896193|58977477|FG000|Overall Study|Protocol Violation|0|||
30940009|NCT01896193|58977478|FG001|Overall Study|Protocol Violation|1|||
30940010|NCT01896193|58977477|FG000|Overall Study|Withdrew Consent|1|||
30940011|NCT01896193|58977478|FG001|Overall Study|Withdrew Consent|0|||
30940012|NCT01922011|58977488|FG000|Overall Study|Protocol Violation|0|||
30940013|NCT01922011|58977489|FG001|Overall Study|Protocol Violation|1|||
30940014|NCT01922011|58977488|FG000|Overall Study|Physician Decision|0|||
30940015|NCT01922011|58977489|FG001|Overall Study|Physician Decision|1|||
30940016|NCT01922011|58977488|FG000|Overall Study|Parent/Guardian Decision|3|||
30940017|NCT01922011|58977489|FG001|Overall Study|Parent/Guardian Decision|0|||
30940018|NCT01922011|58977488|FG000|Overall Study|Lost to Follow-up|0|||
30940019|NCT01922011|58977489|FG001|Overall Study|Lost to Follow-up|1|||
30940020|NCT01922011|58977488|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
30940021|NCT01922011|58977489|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
30940022|NCT01922011|58977488|FG000|Overall Study|Not Treated|1|||
30940023|NCT01922011|58977489|FG001|Overall Study|Not Treated|0|||
30940024|NCT01922011|58977488|FG000|Overall Study|Lack of willing home health agency|1|||
30940025|NCT01922011|58977489|FG001|Overall Study|Lack of willing home health agency|0|||
30940026|NCT01922011|58977488|FG000|Overall Study|Randomized in error|1|||
30940027|NCT01922011|58977489|FG001|Overall Study|Randomized in error|0|||
30940028|NCT01883635|58977503|FG000|Overall Study|Withdrawal by Subject|4|||
30940029|NCT01883635|58977504|FG001|Overall Study|Withdrawal by Subject|0|||
30940030|NCT01921387|58977512|FG000|Overall Study|Adverse Event|1|||
30940031|NCT01895335|58977516|FG000|Overall Study|Adverse Event|106|||
30940032|NCT01895335|58977516|FG000|Overall Study|Lack of Efficacy|53|||
30940033|NCT01895335|58977516|FG000|Overall Study|Poor Compliance to Protocol|11|||
30940034|NCT01895335|58977516|FG000|Overall Study|Included But Not treated|1|||
30940035|NCT01895335|58977516|FG000|Overall Study|Other than Specified Above|44|||
30940036|NCT01617655|58977522|FG000|Overall Study|Adverse Event|2|||
30940037|NCT01617655|58977523|FG001|Overall Study|Adverse Event|3|||
30940038|NCT01617655|58977522|FG000|Overall Study|Poor compliance to protocol|1|||
30940039|NCT01617655|58977523|FG001|Overall Study|Poor compliance to protocol|4|||
30940040|NCT01617655|58977522|FG000|Overall Study|Participants moved|0|||
30940041|NCT01617655|58977523|FG001|Overall Study|Participants moved|4|||
30940042|NCT01617655|58977522|FG000|Overall Study|Consent withdrawn by participant|1|||
30940043|NCT01617655|58977523|FG001|Overall Study|Consent withdrawn by participant|1|||
30940044|NCT01617655|58977522|FG000|Overall Study|Last visit outside protocol visit window|1|||
30940045|NCT01617655|58977523|FG001|Overall Study|Last visit outside protocol visit window|10|||
30940046|NCT01617655|58977522|FG000|Overall Study|Site closure|3|||
30940047|NCT01617655|58977523|FG001|Overall Study|Site closure|5|||
30940048|NCT01617655|58977522|FG000|Overall Study|Other than specified above|1|||
30940049|NCT01617655|58977523|FG001|Overall Study|Other than specified above|2|||
30940050|NCT01895101|58977534|FG000|Overall Study|OPCAB procedure|1|||
30940051|NCT01895101|58977535|FG001|Overall Study|OPCAB procedure|1|||
30940052|NCT01895101|58977536|FG002|Overall Study|OPCAB procedure|3|||
30940053|NCT01895101|58977534|FG000|Overall Study|Withdrawal by Subject|0|||
30940054|NCT01895101|58977535|FG001|Overall Study|Withdrawal by Subject|1|||
30940055|NCT01895101|58977536|FG002|Overall Study|Withdrawal by Subject|2|||
30940056|NCT01895101|58977534|FG000|Overall Study|another study, enrolled in other study|0|||
30940057|NCT01895101|58977535|FG001|Overall Study|another study, enrolled in other study|1|||
30940058|NCT01895101|58977536|FG002|Overall Study|another study, enrolled in other study|0|||
30940059|NCT01895101|58977534|FG000|Overall Study|Death|0|||
30940060|NCT01895101|58977535|FG001|Overall Study|Death|1|||
30940061|NCT01895101|58977536|FG002|Overall Study|Death|0|||
30940062|NCT01895101|58977534|FG000|Overall Study|coagulation disorder|0|||
30940063|NCT01895101|58977535|FG001|Overall Study|coagulation disorder|1|||
30940064|NCT01895101|58977536|FG002|Overall Study|coagulation disorder|0|||
30940065|NCT01894477|58977546|FG000|Overall Study|Protocol Violation|0|||
30940066|NCT01894477|58977547|FG001|Overall Study|Protocol Violation|1|||
30940067|NCT01894477|58977546|FG000|Overall Study|protocol changed due SC changed to cord|0|||
30940068|NCT01894477|58977547|FG001|Overall Study|protocol changed due SC changed to cord|1|||
30940069|NCT01894243|58977556|FG000|Overall Study|Adverse Event|0|||
30940070|NCT01894243|58977557|FG001|Overall Study|Adverse Event|1|||
30842298|NCT03002311|58867911|FG001|Overall Study|Physician Decision|1|||
30842299|NCT03002077|58867917|FG000|Overall Study|Non-compliance with Study Drug|4|||
30842300|NCT03002077|58867917|FG000|Overall Study|Non-compliance w/Background ADT|1|||
30842301|NCT03002077|58867917|FG000|Overall Study|Study Terminated by Sponsor|257|||
30842302|NCT03002077|58867917|FG000|Overall Study|Site Terminated by Sponsor|5|||
30842303|NCT03002077|58867917|FG000|Overall Study|Miscellaneous Reasons|10|||
30842304|NCT03002077|58867917|FG000|Overall Study|Adverse Event|23|||
30842305|NCT03002077|58867917|FG000|Overall Study|Lack of Efficacy|20|||
30842306|NCT03002077|58867917|FG000|Overall Study|Withdrawal by Subject|72|||
30842307|NCT03002077|58867917|FG000|Overall Study|Lost to Follow-up|21|||
30842308|NCT03002077|58867917|FG000|Overall Study|Pregnancy|4|||
30842309|NCT03002077|58867917|FG000|Overall Study|Protocol Violation|21|||
30842310|NCT03008005|58867924|FG000|Overall Study|Physician Decision|1|||
30842311|NCT03008005|58867925|FG001|Overall Study|Physician Decision|0|||
30940071|NCT01894243|58977558|FG002|Overall Study|Adverse Event|2|||
30940072|NCT01894243|58977556|FG000|Overall Study|Death|0|||
30842312|NCT03008005|58867926|FG002|Overall Study|Physician Decision|0|||
30842313|NCT03008005|58867924|FG000|Overall Study|Withdrawal by Subject|1|||
30842314|NCT03008005|58867925|FG001|Overall Study|Withdrawal by Subject|0|||
30842315|NCT03008005|58867926|FG002|Overall Study|Withdrawal by Subject|0|||
30940073|NCT01894243|58977557|FG001|Overall Study|Death|0|||
30940074|NCT01894243|58977558|FG002|Overall Study|Death|3|||
30940075|NCT01894243|58977556|FG000|Overall Study|Lack of Efficacy|3|||
30940076|NCT01894243|58977557|FG001|Overall Study|Lack of Efficacy|3|||
30940077|NCT01894243|58977558|FG002|Overall Study|Lack of Efficacy|1|||
30940078|NCT01894243|58977556|FG000|Overall Study|Condition under investigation worsened|8|||
30940079|NCT01894243|58977557|FG001|Overall Study|Condition under investigation worsened|6|||
30940080|NCT01894243|58977558|FG002|Overall Study|Condition under investigation worsened|2|||
30940081|NCT01894243|58977556|FG000|Overall Study|Subject decision|1|||
30940082|NCT01894243|58977557|FG001|Overall Study|Subject decision|0|||
30940083|NCT01894243|58977558|FG002|Overall Study|Subject decision|0|||
30940084|NCT01894243|58977556|FG000|Overall Study|Other|1|||
30940085|NCT01894243|58977557|FG001|Overall Study|Other|0|||
30940086|NCT01894243|58977558|FG002|Overall Study|Other|0|||
30940087|NCT03822832|58977575|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
30940088|NCT03822832|58977576|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
30940089|NCT03822832|58977575|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
30940090|NCT03822832|58977576|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
30940091|NCT03822832|58977575|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
30940092|NCT03822832|58977576|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
30940093|NCT03822832|58977575|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
30940094|NCT03822832|58977576|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
30940095|NCT03822832|58977575|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
30940096|NCT03822832|58977576|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
30940097|NCT03822832|58977575|FG000|Re-allocation|Not re-allocated to open label period|2|||
30940098|NCT03822832|58977576|FG001|Re-allocation|Not re-allocated to open label period|6|||
30940099|NCT03822832|58977575|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
30940100|NCT03822832|58977576|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
30940101|NCT03822832|58977575|FG000|Period 2 - Open Label Period|Adverse Event|0|||
30940102|NCT03822832|58977576|FG001|Period 2 - Open Label Period|Adverse Event|3|||
30940103|NCT01513239|58977586|FG000|Period 1: Main Phase|Adverse Event|1|||
30940104|NCT01513239|58977587|FG001|Period 1: Main Phase|Adverse Event|1|||
30940105|NCT01513239|58977588|FG002|Period 1: Main Phase|Adverse Event|2|||
30940106|NCT01513239|58977589|FG003|Period 1: Main Phase|Adverse Event|0|||
30940107|NCT01513239|58977590|FG004|Period 1: Main Phase|Adverse Event|0|||
30940108|NCT01513239|58977591|FG005|Period 1: Main Phase|Adverse Event|0|||
30940109|NCT01513239|58977586|FG000|Period 1: Main Phase|Death|29|||
30940110|NCT01513239|58977587|FG001|Period 1: Main Phase|Death|22|||
30940111|NCT01513239|58977588|FG002|Period 1: Main Phase|Death|32|||
30940112|NCT01513239|58977589|FG003|Period 1: Main Phase|Death|0|||
30940113|NCT01513239|58977590|FG004|Period 1: Main Phase|Death|0|||
30940114|NCT01513239|58977591|FG005|Period 1: Main Phase|Death|0|||
30940115|NCT01513239|58977586|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
30940116|NCT01513239|58977587|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
30940117|NCT01513239|58977588|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
30940118|NCT01513239|58977589|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
30940119|NCT01513239|58977590|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
30940120|NCT01513239|58977591|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
30940121|NCT01513239|58977586|FG000|Period 1: Main Phase|Physician Decision|4|||
30940122|NCT01513239|58977587|FG001|Period 1: Main Phase|Physician Decision|4|||
30940123|NCT01513239|58977588|FG002|Period 1: Main Phase|Physician Decision|4|||
30940124|NCT01513239|58977589|FG003|Period 1: Main Phase|Physician Decision|0|||
30940125|NCT01513239|58977590|FG004|Period 1: Main Phase|Physician Decision|0|||
30940126|NCT01513239|58977591|FG005|Period 1: Main Phase|Physician Decision|0|||
30940127|NCT01513239|58977586|FG000|Period 1: Main Phase|Protocol Violation|2|||
30940128|NCT01513239|58977587|FG001|Period 1: Main Phase|Protocol Violation|2|||
30940129|NCT01513239|58977588|FG002|Period 1: Main Phase|Protocol Violation|2|||
30940130|NCT01513239|58977589|FG003|Period 1: Main Phase|Protocol Violation|0|||
30624471|NCT00947427|58636553|FG000|Overall Study|Withdrawal by Subject|1|||
30624472|NCT00947427|58636554|FG001|Overall Study|Withdrawal by Subject|3|||
30624473|NCT00947427|58636553|FG000|Overall Study|Protocol Violation|0|||
30624474|NCT00947427|58636554|FG001|Overall Study|Protocol Violation|1|||
30624475|NCT01116882|58636562|FG000|30-day|Lost to Follow-up|50|||
30940131|NCT01513239|58977590|FG004|Period 1: Main Phase|Protocol Violation|0|||
30940132|NCT01513239|58977591|FG005|Period 1: Main Phase|Protocol Violation|0|||
30940133|NCT01513239|58977586|FG000|Period 1: Main Phase|Technical Problems|1|||
30940134|NCT01513239|58977587|FG001|Period 1: Main Phase|Technical Problems|2|||
30940135|NCT01513239|58977588|FG002|Period 1: Main Phase|Technical Problems|0|||
30940136|NCT01513239|58977589|FG003|Period 1: Main Phase|Technical Problems|0|||
30940137|NCT01513239|58977590|FG004|Period 1: Main Phase|Technical Problems|0|||
30940138|NCT01513239|58977591|FG005|Period 1: Main Phase|Technical Problems|0|||
30940139|NCT01513239|58977586|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
30624476|NCT01116882|58636563|FG001|30-day|Lost to Follow-up|21|||
30624477|NCT01116882|58636562|FG000|30-day|Withdrawal by Subject|2|||
30940140|NCT01513239|58977587|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
30940141|NCT01513239|58977588|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
30624478|NCT01116882|58636563|FG001|30-day|Withdrawal by Subject|4|||
30624479|NCT01116882|58636562|FG000|30-day|Other Reasons|16|||
30624480|NCT01116882|58636563|FG001|30-day|Other Reasons|6|||
30759185|NCT03600376|58767660|FG001|Overall Study|Investigator Decision|4|||
30940142|NCT01513239|58977589|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
30940143|NCT01513239|58977590|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
30940144|NCT01513239|58977591|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
30940145|NCT01513239|58977586|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
30940146|NCT01513239|58977587|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
30759186|NCT03600376|58767659|FG000|Overall Study|Determined to be ineligible for study|0|||
30759187|NCT03600376|58767660|FG001|Overall Study|Determined to be ineligible for study|1|||
30940147|NCT01513239|58977588|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
30940148|NCT01513239|58977589|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
30940149|NCT01513239|58977590|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
30940150|NCT01513239|58977591|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
30940151|NCT01513239|58977586|FG000|Period 2: 9 Month Extension Phase|Death|0|||
30940152|NCT01513239|58977587|FG001|Period 2: 9 Month Extension Phase|Death|0|||
30940153|NCT01513239|58977588|FG002|Period 2: 9 Month Extension Phase|Death|0|||
30940154|NCT01513239|58977589|FG003|Period 2: 9 Month Extension Phase|Death|2|||
30940155|NCT01513239|58977590|FG004|Period 2: 9 Month Extension Phase|Death|5|||
30940156|NCT01513239|58977591|FG005|Period 2: 9 Month Extension Phase|Death|2|||
30940157|NCT01513239|58977586|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
30940158|NCT01513239|58977587|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
30940159|NCT01513239|58977588|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
30940160|NCT01513239|58977589|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
30940161|NCT01513239|58977590|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
30940162|NCT01513239|58977591|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
30940163|NCT01513239|58977586|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
30940164|NCT01513239|58977587|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
30940165|NCT01513239|58977588|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
30940166|NCT01513239|58977589|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
30940167|NCT01513239|58977590|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
30940168|NCT01513239|58977591|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
30940169|NCT01513239|58977586|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
30940170|NCT01513239|58977587|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
30940171|NCT01513239|58977588|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
30940172|NCT01513239|58977589|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
30940173|NCT01513239|58977590|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
30940174|NCT01513239|58977591|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
30940175|NCT01544127|58977606|FG000|Overall Study|Lost to Follow-up|4|||
30940176|NCT01544127|58977607|FG001|Overall Study|Lost to Follow-up|2|||
30940177|NCT01544127|58977608|FG002|Overall Study|Lost to Follow-up|9|||
30940178|NCT01544127|58977606|FG000|Overall Study|Withdrawal by Subject|2|||
30940179|NCT01544127|58977607|FG001|Overall Study|Withdrawal by Subject|2|||
30940180|NCT01544127|58977608|FG002|Overall Study|Withdrawal by Subject|1|||
30940181|NCT01544127|58977606|FG000|Overall Study|Discharged out of catchment area|1|||
30940182|NCT01544127|58977607|FG001|Overall Study|Discharged out of catchment area|1|||
30940183|NCT01544127|58977608|FG002|Overall Study|Discharged out of catchment area|1|||
30940184|NCT01544127|58977606|FG000|Overall Study|Death|1|||
30940185|NCT01544127|58977607|FG001|Overall Study|Death|0|||
30624481|NCT01116882|58636562|FG000|12-month|Lost to Follow-up|111|||
30759188|NCT03599362|58767666|FG000|Overall Study|Screen Failure|3|||
30759189|NCT03598036|58767672|FG000|Overall Study|Withdrawal by Subject|1|||
30759190|NCT03598036|58767673|FG001|Overall Study|Withdrawal by Subject|0|||
30759191|NCT00082407|58767683|FG000|Overall Study|Adverse Event|20|||
30759192|NCT00082407|58767684|FG001|Overall Study|Adverse Event|0|||
30842316|NCT03008005|58867924|FG000|Overall Study|Ineligible|0|||
30842317|NCT03008005|58867925|FG001|Overall Study|Ineligible|1|||
30842318|NCT03008005|58867926|FG002|Overall Study|Ineligible|0|||
30624482|NCT01116882|58636563|FG001|12-month|Lost to Follow-up|42|||
30759193|NCT00082407|58767683|FG000|Overall Study|Protocol Violation|14|||
30759194|NCT00082407|58767684|FG001|Overall Study|Protocol Violation|12|||
30624483|NCT01116882|58636562|FG000|12-month|Other Reasons|151|||
30842319|NCT02440425|58867943|FG000|Overall Study|Death likely due to disease progression|1|||
30842320|NCT02440425|58867943|FG000|Overall Study|Withdrawal by Subject|2|||
30842321|NCT02440425|58867943|FG000|Overall Study|Adverse Event|1|||
30842322|NCT02440425|58867943|FG000|Overall Study|Adverse Event/Ineligible|1|||
30842323|NCT03001219|58867958|FG000|Proof of Concept|Study Termination by Sponsor|0|||
30842324|NCT03001219|58867959|FG001|Proof of Concept|Study Termination by Sponsor|1|||
30842325|NCT03001219|58867958|FG000|Proof of Concept|Withdrawal by Subject|0|||
30842326|NCT03001219|58867959|FG001|Proof of Concept|Withdrawal by Subject|4|||
30940186|NCT01544127|58977608|FG002|Overall Study|Death|0|||
30940187|NCT01544127|58977606|FG000|Overall Study|Jail or Prison|1|||
30940188|NCT01544127|58977607|FG001|Overall Study|Jail or Prison|1|||
30940189|NCT01544127|58977608|FG002|Overall Study|Jail or Prison|2|||
30940190|NCT01544127|58977606|FG000|Overall Study|Became Psychotic|1|||
30940191|NCT01544127|58977607|FG001|Overall Study|Became Psychotic|0|||
30940192|NCT01544127|58977608|FG002|Overall Study|Became Psychotic|0|||
30940193|NCT01544127|58977606|FG000|Overall Study|Researcher withdrew|1|||
30940194|NCT01544127|58977607|FG001|Overall Study|Researcher withdrew|0|||
30940195|NCT01544127|58977608|FG002|Overall Study|Researcher withdrew|0|||
30940196|NCT01544127|58977606|FG000|Overall Study|Went active duty|0|||
30940197|NCT01544127|58977607|FG001|Overall Study|Went active duty|0|||
30940198|NCT01544127|58977608|FG002|Overall Study|Went active duty|1|||
30940199|NCT01512693|58977619|FG000|Overall Study|Withdrawal by Subject|0|||
30940200|NCT01512693|58977620|FG001|Overall Study|Withdrawal by Subject|1|||
30940201|NCT01458340|58977629|FG000|Overall Study|Adverse Event|5|||
30940202|NCT01458340|58977630|FG001|Overall Study|Adverse Event|4|||
30940203|NCT01458340|58977631|FG002|Overall Study|Adverse Event|2|||
30940204|NCT01458340|58977629|FG000|Overall Study|Lost to Follow-up|3|||
30940205|NCT01458340|58977630|FG001|Overall Study|Lost to Follow-up|3|||
30940206|NCT01458340|58977631|FG002|Overall Study|Lost to Follow-up|10|||
30940207|NCT01458340|58977629|FG000|Overall Study|Miscellaneous|0|||
30940208|NCT01458340|58977630|FG001|Overall Study|Miscellaneous|1|||
30940209|NCT01458340|58977631|FG002|Overall Study|Miscellaneous|0|||
30940210|NCT01458340|58977629|FG000|Overall Study|Physician Decision|1|||
30940211|NCT01458340|58977630|FG001|Overall Study|Physician Decision|1|||
30940212|NCT01458340|58977631|FG002|Overall Study|Physician Decision|2|||
30940213|NCT01458340|58977629|FG000|Overall Study|Protocol Violation|6|||
30940214|NCT01458340|58977630|FG001|Overall Study|Protocol Violation|6|||
30940215|NCT01458340|58977631|FG002|Overall Study|Protocol Violation|5|||
30940216|NCT01458340|58977629|FG000|Overall Study|Withdrawal by Subject|12|||
30940217|NCT01458340|58977630|FG001|Overall Study|Withdrawal by Subject|6|||
30940218|NCT01458340|58977631|FG002|Overall Study|Withdrawal by Subject|4|||
30940219|NCT01539291|58977686|FG000|Study GS-US-312-0116|Adverse Event|9|||
30940220|NCT01539291|58977687|FG001|Study GS-US-312-0116|Adverse Event|0|||
30940221|NCT01539291|58977688|FG002|Study GS-US-312-0116|Adverse Event|0|||
30940222|NCT01539291|58977689|FG003|Study GS-US-312-0116|Adverse Event|0|||
30940223|NCT01539291|58977686|FG000|Study GS-US-312-0116|Physician Decision|1|||
30940224|NCT01539291|58977687|FG001|Study GS-US-312-0116|Physician Decision|0|||
30940225|NCT01539291|58977688|FG002|Study GS-US-312-0116|Physician Decision|0|||
30940226|NCT01539291|58977689|FG003|Study GS-US-312-0116|Physician Decision|0|||
30940227|NCT01539291|58977686|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
30940228|NCT01539291|58977687|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
30940229|NCT01539291|58977688|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
30940230|NCT01539291|58977689|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
30940231|NCT01539291|58977686|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
30940232|NCT01539291|58977687|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
30940233|NCT01539291|58977688|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
30940234|NCT01539291|58977689|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
30940235|NCT01539291|58977686|FG000|Study GS-US-312-0116|Other|1|||
30940236|NCT01539291|58977687|FG001|Study GS-US-312-0116|Other|0|||
30940237|NCT01539291|58977688|FG002|Study GS-US-312-0116|Other|0|||
30940238|NCT01539291|58977689|FG003|Study GS-US-312-0116|Other|0|||
30940239|NCT01539291|58977686|FG000|Study GS-US-312-0117|Adverse Event|22|||
30940240|NCT01539291|58977687|FG001|Study GS-US-312-0117|Adverse Event|1|||
30940241|NCT01539291|58977688|FG002|Study GS-US-312-0117|Adverse Event|9|||
30842327|NCT03001219|58867958|FG000|Proof of Concept|Protocol Deviation|0|||
30842328|NCT03001219|58867959|FG001|Proof of Concept|Protocol Deviation|1|||
30842329|NCT03001219|58867958|FG000|Proof of Concept|Adverse Event|1|||
30842330|NCT03001219|58867959|FG001|Proof of Concept|Adverse Event|1|||
30842331|NCT03001219|58867958|FG000|Proof of Concept|Physician Decision|1|||
30842332|NCT03001219|58867959|FG001|Proof of Concept|Physician Decision|0|||
30842333|NCT03001219|58867958|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
30842334|NCT03001219|58867959|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
30940242|NCT01539291|58977689|FG003|Study GS-US-312-0117|Adverse Event|12|||
30940243|NCT01539291|58977686|FG000|Study GS-US-312-0117|Physician Decision|9|||
30940244|NCT01539291|58977687|FG001|Study GS-US-312-0117|Physician Decision|0|||
30940245|NCT01539291|58977688|FG002|Study GS-US-312-0117|Physician Decision|6|||
30940246|NCT01539291|58977689|FG003|Study GS-US-312-0117|Physician Decision|4|||
30940247|NCT01539291|58977686|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
30940248|NCT01539291|58977687|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
30940249|NCT01539291|58977688|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
30940250|NCT01539291|58977689|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
30940251|NCT01539291|58977686|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
30940252|NCT01539291|58977687|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
30940253|NCT01539291|58977688|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
30940254|NCT01539291|58977689|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
30940255|NCT01539291|58977686|FG000|Study GS-US-312-0117|Other|2|||
30940256|NCT01539291|58977687|FG001|Study GS-US-312-0117|Other|1|||
30940257|NCT01539291|58977688|FG002|Study GS-US-312-0117|Other|1|||
30940258|NCT01539291|58977689|FG003|Study GS-US-312-0117|Other|1|||
30940259|NCT01538199|58977712|FG000|Overall Study|Lost to Follow-up|1|||
30940260|NCT01538199|58977713|FG001|Overall Study|Lost to Follow-up|2|||
30940261|NCT01538199|58977714|FG002|Overall Study|Lost to Follow-up|1|||
30940262|NCT01538199|58977715|FG003|Overall Study|Lost to Follow-up|0|||
30940263|NCT01538199|58977712|FG000|Overall Study|participant did not have time|1|||
30940264|NCT01538199|58977713|FG001|Overall Study|participant did not have time|0|||
30940265|NCT01538199|58977714|FG002|Overall Study|participant did not have time|0|||
30940266|NCT01538199|58977715|FG003|Overall Study|participant did not have time|2|||
30940267|NCT01538199|58977712|FG000|Overall Study|Lack of Efficacy|0|||
30940268|NCT01538199|58977713|FG001|Overall Study|Lack of Efficacy|1|||
30940269|NCT01538199|58977714|FG002|Overall Study|Lack of Efficacy|0|||
30940270|NCT01538199|58977715|FG003|Overall Study|Lack of Efficacy|0|||
30940271|NCT01511445|58977734|FG000|Overall Study|Lost to Follow-up|3|||
30940272|NCT01511445|58977735|FG001|Overall Study|Lost to Follow-up|1|||
30940273|NCT01511445|58977734|FG000|Overall Study|Protocol Violation|1|||
30940274|NCT01511445|58977735|FG001|Overall Study|Protocol Violation|3|||
30940275|NCT01511445|58977734|FG000|Overall Study|Protocol Violation|1|||
30940276|NCT01511445|58977735|FG001|Overall Study|Protocol Violation|0|||
30940277|NCT01543503|58977743|FG000|Overall Study|Lost to Follow-up|32|||
30940278|NCT01543503|58977744|FG001|Overall Study|Lost to Follow-up|36|||
30940279|NCT01543503|58977743|FG000|Overall Study|Adverse Event|9|||
30940280|NCT01543503|58977744|FG001|Overall Study|Adverse Event|13|||
30940281|NCT01543503|58977743|FG000|Overall Study|Lack of Efficacy|4|||
30940282|NCT01543503|58977744|FG001|Overall Study|Lack of Efficacy|16|||
30940283|NCT01543503|58977743|FG000|Overall Study|Participant withdrew informed consent|8|||
30940284|NCT01543503|58977744|FG001|Overall Study|Participant withdrew informed consent|10|||
30940285|NCT01543503|58977743|FG000|Overall Study|Change of jobs|0|||
30940286|NCT01543503|58977744|FG001|Overall Study|Change of jobs|1|||
30842335|NCT03001219|58867958|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
30842336|NCT03001219|58867959|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
30842337|NCT03001219|58867958|FG000|Extension Period Analysis|Physician Decision|0|||
30842338|NCT03001219|58867959|FG001|Extension Period Analysis|Physician Decision|1|||
30842339|NCT03001219|58867958|FG000|Extension Period Analysis|Adverse Event|1|||
30842340|NCT03001219|58867959|FG001|Extension Period Analysis|Adverse Event|1|||
30842341|NCT03001219|58867958|FG000|Extension Period Analysis|Protocol Deviation|0|||
30842342|NCT03001219|58867959|FG001|Extension Period Analysis|Protocol Deviation|1|||
30842343|NCT03001219|58867958|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
30842344|NCT03001219|58867959|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
30842345|NCT03000673|58867974|FG000|Overall Study|Withdrawal by Subject|1|||
30842346|NCT03000673|58867975|FG001|Overall Study|Withdrawal by Subject|0|||
30842347|NCT03000673|58867976|FG002|Overall Study|Withdrawal by Subject|0|||
30842348|NCT03000673|58867977|FG003|Overall Study|Withdrawal by Subject|0|||
30842349|NCT02912455|58867990|FG000|Overall Study|Withdrawal by Subject|0|||
30842350|NCT02912455|58867991|FG001|Overall Study|Withdrawal by Subject|1|||
30842351|NCT02912455|58867990|FG000|Overall Study|Lack of Efficacy|0|||
30940287|NCT01543503|58977743|FG000|Overall Study|Intolerance to the biologic treatment|0|||
30940288|NCT01543503|58977744|FG001|Overall Study|Intolerance to the biologic treatment|1|||
30940289|NCT01543503|58977743|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
30940290|NCT01543503|58977744|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
30940291|NCT01543503|58977743|FG000|Overall Study|Participant did not complete last visit|0|||
30940292|NCT01543503|58977744|FG001|Overall Study|Participant did not complete last visit|2|||
30940293|NCT01543503|58977743|FG000|Overall Study|Refused to continue treatment|7|||
30940294|NCT01543503|58977744|FG001|Overall Study|Refused to continue treatment|0|||
30940295|NCT01543503|58977743|FG000|Overall Study|Incorrect medication received|1|||
30940296|NCT01543503|58977744|FG001|Overall Study|Incorrect medication received|0|||
30842352|NCT02912455|58867991|FG001|Overall Study|Lack of Efficacy|1|||
30842353|NCT02912455|58867990|FG000|Overall Study|Lost to Follow-up|2|||
30842354|NCT02912455|58867991|FG001|Overall Study|Lost to Follow-up|1|||
30940297|NCT01543503|58977743|FG000|Overall Study|Participant moved to another city|2|||
30948548|NCT01963403|58994562|FG000|Overall Study|Lost to Follow-up|2|||
30842355|NCT04524507|58867999|FG000|Overall Study|Lost to Follow-up|2|||
30842356|NCT04524507|58868000|FG001|Overall Study|Lost to Follow-up|4|||
30842357|NCT04524507|58867999|FG000|Overall Study|Withdrawal by Subject|2|||
30940298|NCT01543503|58977744|FG001|Overall Study|Participant moved to another city|0|||
30940299|NCT01543503|58977743|FG000|Overall Study|Participant will not return for visits|0|||
30940300|NCT01543503|58977744|FG001|Overall Study|Participant will not return for visits|2|||
30940301|NCT01543503|58977743|FG000|Overall Study|Participant transferred to another city|1|||
30940302|NCT01543503|58977744|FG001|Overall Study|Participant transferred to another city|0|||
30940303|NCT01543503|58977743|FG000|Overall Study|Participant moved to Scotland|1|||
30940304|NCT01543503|58977744|FG001|Overall Study|Participant moved to Scotland|0|||
30940305|NCT01543503|58977743|FG000|Overall Study|Participant decision to stop treatment|1|||
30940306|NCT01543503|58977744|FG001|Overall Study|Participant decision to stop treatment|0|||
30940307|NCT01543503|58977743|FG000|Overall Study|Investigator did not wish to participate|1|||
30940308|NCT01543503|58977744|FG001|Overall Study|Investigator did not wish to participate|1|||
30940309|NCT01543503|58977743|FG000|Overall Study|Participant recruited after closing date|0|||
30940310|NCT01543503|58977744|FG001|Overall Study|Participant recruited after closing date|1|||
30940311|NCT01543503|58977743|FG000|Overall Study|Site stopped participation|5|||
30940312|NCT01543503|58977744|FG001|Overall Study|Site stopped participation|1|||
30940313|NCT01543503|58977743|FG000|Overall Study|Participant did not attend a visit|1|||
30940314|NCT01543503|58977744|FG001|Overall Study|Participant did not attend a visit|0|||
30940315|NCT01543503|58977743|FG000|Overall Study|Moved to other rheumatologic site|0|||
30940316|NCT01543503|58977744|FG001|Overall Study|Moved to other rheumatologic site|1|||
30940317|NCT01543503|58977743|FG000|Overall Study|Participant consented to another study|0|||
30940318|NCT01543503|58977744|FG001|Overall Study|Participant consented to another study|2|||
30940319|NCT01543503|58977743|FG000|Overall Study|Participant went to United States|1|||
30940320|NCT01543503|58977744|FG001|Overall Study|Participant went to United States|0|||
30940321|NCT01543503|58977743|FG000|Overall Study|Screen failure|1|||
30940322|NCT01543503|58977744|FG001|Overall Study|Screen failure|0|||
30940323|NCT01511055|58977750|FG000|Overall Study|Withdrawal by Subject|6|||
30940324|NCT01537887|58977754|FG000|Period 1|Physician Decision|0|||
30940325|NCT01537887|58977755|FG001|Period 1|Physician Decision|0|||
30940326|NCT01537887|58977756|FG002|Period 1|Physician Decision|0|||
30940327|NCT01537887|58977757|FG003|Period 1|Physician Decision|0|||
30940328|NCT01537887|58977758|FG004|Period 1|Physician Decision|1|||
30940329|NCT01537887|58977759|FG005|Period 1|Physician Decision|1|||
30940330|NCT01537887|58977754|FG000|Period 1|Did not receive treatment|0|||
30940331|NCT01537887|58977755|FG001|Period 1|Did not receive treatment|0|||
30940332|NCT01537887|58977756|FG002|Period 1|Did not receive treatment|1|||
30940333|NCT01537887|58977757|FG003|Period 1|Did not receive treatment|0|||
30940334|NCT01537887|58977758|FG004|Period 1|Did not receive treatment|0|||
30940335|NCT01537887|58977759|FG005|Period 1|Did not receive treatment|0|||
30940336|NCT01537887|58977754|FG000|Period 2|Withdrawal by Subject|0|||
30940337|NCT01537887|58977755|FG001|Period 2|Withdrawal by Subject|1|||
30940338|NCT01537887|58977756|FG002|Period 2|Withdrawal by Subject|0|||
30940339|NCT01537887|58977757|FG003|Period 2|Withdrawal by Subject|0|||
30940340|NCT01537887|58977758|FG004|Period 2|Withdrawal by Subject|0|||
30940341|NCT01537887|58977759|FG005|Period 2|Withdrawal by Subject|0|||
30940342|NCT01537887|58977754|FG000|Period 3|Adverse Event|0|||
30940343|NCT01537887|58977755|FG001|Period 3|Adverse Event|0|||
30940344|NCT01537887|58977756|FG002|Period 3|Adverse Event|1|||
30940345|NCT01537887|58977757|FG003|Period 3|Adverse Event|0|||
30940346|NCT01537887|58977758|FG004|Period 3|Adverse Event|0|||
30940347|NCT01537887|58977759|FG005|Period 3|Adverse Event|0|||
30940348|NCT01537887|58977754|FG000|Period 3|Withdrawal by Subject|0|||
30940349|NCT01537887|58977755|FG001|Period 3|Withdrawal by Subject|1|||
30940350|NCT01537887|58977756|FG002|Period 3|Withdrawal by Subject|0|||
30940351|NCT01537887|58977757|FG003|Period 3|Withdrawal by Subject|0|||
30940352|NCT01537887|58977758|FG004|Period 3|Withdrawal by Subject|0|||
30940353|NCT01537887|58977759|FG005|Period 3|Withdrawal by Subject|0|||
30940354|NCT01489527|58977769|FG000|Overall Study|Pregnancy|9|||
30940355|NCT01489527|58977770|FG001|Overall Study|Pregnancy|14|||
30940356|NCT01489527|58977769|FG000|Overall Study|Participant moved|6|||
30940357|NCT01489527|58977770|FG001|Overall Study|Participant moved|7|||
30940358|NCT01489527|58977769|FG000|Overall Study|Withdrawal by Subject|0|||
30940359|NCT01489527|58977770|FG001|Overall Study|Withdrawal by Subject|4|||
30940360|NCT01489527|58977769|FG000|Overall Study|Lost to Follow-up|5|||
30940361|NCT01489527|58977770|FG001|Overall Study|Lost to Follow-up|1|||
30940362|NCT01489527|58977769|FG000|Overall Study|Procedures|1|||
30940363|NCT01489527|58977770|FG001|Overall Study|Procedures|0|||
30940364|NCT01489527|58977769|FG000|Overall Study|Not compliant|1|||
30940365|NCT01489527|58977770|FG001|Overall Study|Not compliant|0|||
30940366|NCT01487577|58977783|FG000|Overall Study|Became ineligible after signing consent|1|||
30940367|NCT01536951|58977789|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
30624484|NCT01116882|58636563|FG001|12-month|Other Reasons|49|||
30940368|NCT01536951|58977790|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
30940369|NCT01536951|58977791|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
30940370|NCT01536951|58977792|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
30940371|NCT01536951|58977793|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
30940372|NCT01536951|58977794|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
30940373|NCT01536951|58977795|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
30940374|NCT01536951|58977796|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
30940375|NCT01536951|58977797|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
30940376|NCT01536951|58977789|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
30940377|NCT01536951|58977790|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
30940378|NCT01536951|58977791|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
30940379|NCT01536951|58977792|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
30940380|NCT01536951|58977793|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
30940381|NCT01536951|58977794|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
30940382|NCT01536951|58977795|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
30940383|NCT01536951|58977796|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
30940384|NCT01536951|58977797|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
30940385|NCT01536795|58977822|FG000|Overall Study|Lost to Follow-up|0|||
30940386|NCT01536795|58977823|FG001|Overall Study|Lost to Follow-up|2|||
30940387|NCT01536795|58977822|FG000|Overall Study|Lack of Efficacy|1|||
30940388|NCT01536795|58977823|FG001|Overall Study|Lack of Efficacy|0|||
30940389|NCT01536561|58977833|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
30940390|NCT01536561|58977833|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
30940391|NCT01536561|58977833|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
30940392|NCT01536561|58977833|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
30940393|NCT01536561|58977833|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
30940394|NCT01536561|58977833|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
30940395|NCT01536405|58977851|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
30940396|NCT01536405|58977852|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
30940397|NCT01536405|58977851|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
30940398|NCT01536405|58977852|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
30940399|NCT01536405|58977851|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
30940400|NCT01536405|58977852|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
30940401|NCT01536405|58977851|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
30940402|NCT01536405|58977852|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
30940403|NCT01536405|58977851|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
30940404|NCT01536405|58977852|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
30940405|NCT01536405|58977851|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
30940406|NCT01536405|58977852|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
30940407|NCT01536405|58977851|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
30940408|NCT01536405|58977852|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
30940409|NCT01536405|58977851|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
30940410|NCT01536405|58977852|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
30940411|NCT01536405|58977851|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
30940412|NCT01536405|58977852|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
30940413|NCT01536405|58977851|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
30940414|NCT01536405|58977852|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
30940415|NCT01536405|58977851|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
30940416|NCT01536405|58977852|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
30940417|NCT01536405|58977851|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
30940418|NCT01536405|58977852|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
30940419|NCT01536405|58977851|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
30940420|NCT01536405|58977852|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
30940421|NCT01487265|58977858|FG000|Overall Study|Adverse Event|8|||
30940422|NCT01487265|58977858|FG000|Overall Study|Withdrawal by Subject|5|||
30940423|NCT01487265|58977858|FG000|Overall Study|Disease Progression|21|||
30940424|NCT01487265|58977858|FG000|Overall Study|Death|2|||
30940425|NCT01487265|58977858|FG000|Overall Study|Still on Treatment|1|||
30940426|NCT01485627|58977864|FG000|Overall Study|Patient withdrew|6|||
30940427|NCT01485627|58977865|FG001|Overall Study|Patient withdrew|5|||
30940428|NCT01485627|58977864|FG000|Overall Study|Patient died|3|||
30940429|NCT01485627|58977865|FG001|Overall Study|Patient died|1|||
30940430|NCT01485627|58977864|FG000|Overall Study|Patient lost to followup|0|||
30940431|NCT01485627|58977865|FG001|Overall Study|Patient lost to followup|1|||
30940432|NCT01485627|58977864|FG000|Overall Study|Caregiver withdrew|3|||
30940433|NCT01485627|58977865|FG001|Overall Study|Caregiver withdrew|3|||
30940434|NCT01485627|58977864|FG000|Overall Study|Caregiver lost to follow up|11|||
30940435|NCT01485627|58977865|FG001|Overall Study|Caregiver lost to follow up|12|||
30940436|NCT01485627|58977864|FG000|Overall Study|Caregiver died|1|||
30940437|NCT01485627|58977865|FG001|Overall Study|Caregiver died|0|||
30940438|NCT01485627|58977864|FG000|Overall Study|caregiver was not bereaved|42|||
30940439|NCT01485627|58977865|FG001|Overall Study|caregiver was not bereaved|35|||
30940440|NCT01508325|58977888|FG000|Overall Study|Withdrawal by Subject|8|||
30940441|NCT01508325|58977889|FG001|Overall Study|Withdrawal by Subject|9|||
30940442|NCT01508325|58977888|FG000|Overall Study|Protocol Violation|0|||
30940443|NCT01508325|58977889|FG001|Overall Study|Protocol Violation|3|||
30940444|NCT01508325|58977888|FG000|Overall Study|Physician Decision|2|||
30940445|NCT01508325|58977889|FG001|Overall Study|Physician Decision|1|||
30940446|NCT01508325|58977888|FG000|Overall Study|Adverse Event|1|||
30940447|NCT01508325|58977889|FG001|Overall Study|Adverse Event|0|||
30940448|NCT01508325|58977888|FG000|Overall Study|Lost to Follow-up|5|||
30940449|NCT01508325|58977889|FG001|Overall Study|Lost to Follow-up|6|||
30940450|NCT01508325|58977888|FG000|Overall Study|Other|2|||
30940451|NCT01508325|58977889|FG001|Overall Study|Other|2|||
30940452|NCT01508169|58977897|FG000|Overall Study|Adverse Event|1|||
30940453|NCT01508169|58977898|FG001|Overall Study|Adverse Event|0|||
30940454|NCT01508169|58977897|FG000|Overall Study|Withdrawal by Subject|1|||
30940455|NCT01508169|58977898|FG001|Overall Study|Withdrawal by Subject|0|||
30940456|NCT01508169|58977897|FG000|Overall Study|Lost to Follow-up|1|||
30940457|NCT01508169|58977898|FG001|Overall Study|Lost to Follow-up|2|||
30940458|NCT01536171|58977910|FG000|Overall Study|Withdrawal by Subject|1|||
30940459|NCT01536093|58977917|FG000|Overall Study|Death|1|||
30940460|NCT01536093|58977918|FG001|Overall Study|Death|2|||
30940461|NCT01536093|58977917|FG000|Overall Study|absence of maternal colostrum|2|||
30940462|NCT01536093|58977918|FG001|Overall Study|absence of maternal colostrum|0|||
30940463|NCT01536093|58977917|FG000|Overall Study|Withdrawal by Subject|0|||
30940464|NCT01536093|58977918|FG001|Overall Study|Withdrawal by Subject|1|||
30940465|NCT01536015|58977926|FG000|Overall Study|Adverse Event|1|||
30940466|NCT01536015|58977927|FG001|Overall Study|Adverse Event|4|||
30940467|NCT01536015|58977926|FG000|Overall Study|Lost to Follow-up|0|||
30940468|NCT01536015|58977927|FG001|Overall Study|Lost to Follow-up|1|||
30940469|NCT01536015|58977926|FG000|Overall Study|Inclusion Criterion not met|2|||
30940470|NCT01536015|58977927|FG001|Overall Study|Inclusion Criterion not met|0|||
30940471|NCT01536015|58977926|FG000|Overall Study|Study closure|5|||
30940472|NCT01536015|58977927|FG001|Overall Study|Study closure|5|||
30940473|NCT01484691|58977936|FG000|Overall Study|Withdrawal by Subject|1|||
30940474|NCT01484691|58977937|FG001|Overall Study|Withdrawal by Subject|1|||
30940475|NCT01484691|58977938|FG002|Overall Study|Withdrawal by Subject|1|||
30940476|NCT01484691|58977936|FG000|Overall Study|Physician Decision|0|||
30940477|NCT01484691|58977937|FG001|Overall Study|Physician Decision|2|||
30940478|NCT01484691|58977938|FG002|Overall Study|Physician Decision|1|||
30940479|NCT01535235|58977949|FG000|Overall Study|Adverse Event|1|||
30940480|NCT01535235|58977950|FG001|Overall Study|Adverse Event|0|||
30940481|NCT01483599|58977994|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
30940482|NCT01483599|58977995|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
30940483|NCT01483599|58977996|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
30940484|NCT01483599|58977997|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
30940485|NCT01483599|58977998|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
30842358|NCT04524507|58868000|FG001|Overall Study|Withdrawal by Subject|9|||
30842359|NCT04524507|58867999|FG000|Overall Study|Death|2|||
30842360|NCT04524507|58868000|FG001|Overall Study|Death|10|||
30842361|NCT02999191|58868009|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
30842362|NCT02999191|58868010|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
30842363|NCT02999191|58868011|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
30842364|NCT02531698|58868021|FG000|Overall Study|Adverse Event|2|||
30842365|NCT02531698|58868022|FG001|Overall Study|Adverse Event|1|||
30842366|NCT02531698|58868021|FG000|Overall Study|Withdrawal by Subject|6|||
30842367|NCT02531698|58868022|FG001|Overall Study|Withdrawal by Subject|1|||
30842368|NCT02531698|58868021|FG000|Overall Study|Protocol Violation|2|||
30842369|NCT02531698|58868022|FG001|Overall Study|Protocol Violation|0|||
30842370|NCT02531698|58868021|FG000|Overall Study|Lost to Follow-up|1|||
30842371|NCT02531698|58868022|FG001|Overall Study|Lost to Follow-up|0|||
30842372|NCT02998021|58868039|FG000|Overall Study|Withdrawal by Subject|3|||
30842373|NCT02998021|58868040|FG001|Overall Study|Withdrawal by Subject|1|||
30842374|NCT02998021|58868039|FG000|Overall Study|unsafe home|0|||
30842375|NCT02998021|58868040|FG001|Overall Study|unsafe home|1|||
30842376|NCT03034577|58868054|FG000|Overall Study|Withdrawal by Subject|6|||
30842377|NCT03034577|58868055|FG001|Overall Study|Withdrawal by Subject|9|||
30842378|NCT03034577|58868054|FG000|Overall Study|Lost to Follow-up|25|||
30842379|NCT03034577|58868055|FG001|Overall Study|Lost to Follow-up|26|||
30940486|NCT01483599|58977999|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
30940487|NCT01483599|58978000|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
30940488|NCT01483599|58978001|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
30940489|NCT01483599|58978002|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
30940490|NCT01483599|58978003|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
30940491|NCT01483599|58978004|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
30940492|NCT01483599|58978005|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
30940493|NCT01483599|58978006|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
30940494|NCT01483599|58978007|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
30940495|NCT01483599|58977994|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
30940496|NCT01483599|58977995|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
30940497|NCT01483599|58977996|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
30940498|NCT01483599|58977997|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
30940499|NCT01483599|58977998|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
30940500|NCT01483599|58977999|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
30940501|NCT01483599|58978000|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
30940502|NCT01483599|58978001|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
30940503|NCT01483599|58978002|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
30940504|NCT01483599|58978003|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
30940505|NCT01483599|58978004|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
30940506|NCT01483599|58978005|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
30940507|NCT01483599|58978006|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
30940508|NCT01483599|58978007|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
30940509|NCT01483599|58977994|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
30940510|NCT01483599|58977995|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940511|NCT01483599|58977996|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940512|NCT01483599|58977997|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940513|NCT01483599|58977998|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940514|NCT01483599|58977999|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940515|NCT01483599|58978000|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940516|NCT01483599|58978001|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940517|NCT01483599|58978002|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940518|NCT01483599|58978003|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940519|NCT01483599|58978004|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940520|NCT01483599|58978005|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940521|NCT01483599|58978006|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940522|NCT01483599|58978007|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
30940523|NCT01483599|58977994|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
30940524|NCT01483599|58977995|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
30940525|NCT01483599|58977996|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
30940526|NCT01483599|58977997|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
30940527|NCT01483599|58977998|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
30940528|NCT01483599|58977999|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
30940529|NCT01483599|58978000|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
30940530|NCT01483599|58978001|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
30940531|NCT01483599|58978002|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
30940532|NCT01483599|58978003|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
30940533|NCT01483599|58978004|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
30940534|NCT01483599|58978005|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
30940535|NCT01483599|58978006|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
30940536|NCT01483599|58978007|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
30940537|NCT01483599|58977994|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
30940538|NCT01483599|58977995|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
30940539|NCT01483599|58977996|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
30940540|NCT01483599|58977997|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
30940541|NCT01483599|58977998|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
30940542|NCT01483599|58977999|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
30940543|NCT01483599|58978000|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
30940544|NCT01483599|58978001|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
30940545|NCT01483599|58978002|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
30940546|NCT01483599|58978003|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
30940547|NCT01483599|58978004|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
30940548|NCT01483599|58978005|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
30940549|NCT01483599|58978006|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
30940550|NCT01483599|58978007|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
30940551|NCT01483599|58977994|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
30940552|NCT01483599|58977995|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
30940553|NCT01483599|58977996|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
30940554|NCT01483599|58977997|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
30940555|NCT01483599|58977998|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
30940556|NCT01483599|58977999|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
30940557|NCT01483599|58978000|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
30940558|NCT01483599|58978001|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
30940559|NCT01483599|58978002|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
30940560|NCT01483599|58978003|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
30940561|NCT01483599|58978004|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
30940562|NCT01483599|58978005|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
30940563|NCT01483599|58978006|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
30940564|NCT01483599|58978007|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
30940565|NCT01483599|58977994|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
30940566|NCT01483599|58977995|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
30940567|NCT01483599|58977996|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
30940568|NCT01483599|58977997|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
30940569|NCT01483599|58977998|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
30940570|NCT01483599|58977999|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
30940571|NCT01483599|58978000|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
30940572|NCT01483599|58978001|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
30940573|NCT01483599|58978002|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
30940574|NCT01483599|58978003|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
30940575|NCT01483599|58978004|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
30940576|NCT01483599|58978005|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
30940577|NCT01483599|58978006|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
30940578|NCT01483599|58978007|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
30940579|NCT01483599|58977994|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
30940580|NCT01483599|58977995|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
30940581|NCT01483599|58977996|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
30940582|NCT01483599|58977997|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
30940583|NCT01483599|58977998|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
30940584|NCT01483599|58977999|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
30940585|NCT01483599|58978000|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
30940586|NCT01483599|58978001|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
30940587|NCT01483599|58978002|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
30940588|NCT01483599|58978003|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
30940589|NCT01483599|58978004|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
30940590|NCT01483599|58978005|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
30940591|NCT01483599|58978006|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
30940592|NCT01483599|58978007|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
30940593|NCT01483599|58977994|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
30940594|NCT01483599|58977995|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
30940595|NCT01483599|58977996|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
30940596|NCT01483599|58977997|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
30940597|NCT01483599|58977998|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
30940598|NCT01483599|58977999|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
30940599|NCT01483599|58978000|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
30940600|NCT01483599|58978001|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
30940601|NCT01483599|58978002|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
30940602|NCT01483599|58978003|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
30940603|NCT01483599|58978004|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
30940604|NCT01483599|58978005|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
30940605|NCT01483599|58978006|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
30940606|NCT01483599|58978007|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
30940607|NCT01483599|58977994|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
30940608|NCT01483599|58977995|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
30940609|NCT01483599|58977996|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
30940610|NCT01483599|58977997|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
30940611|NCT01483599|58977998|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
30940612|NCT01483599|58977999|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
30940613|NCT01483599|58978000|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
30940614|NCT01483599|58978001|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
30940615|NCT01483599|58978002|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
30940616|NCT01483599|58978003|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
30940617|NCT01483599|58978004|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
30940618|NCT01483599|58978005|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
30940619|NCT01483599|58978006|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
30940620|NCT01483599|58978007|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
30940621|NCT01507545|58978083|FG000|Overall Study|Withdrawal by Subject|6|||
30940622|NCT01507545|58978084|FG001|Overall Study|Withdrawal by Subject|2|||
30940623|NCT01507545|58978083|FG000|Overall Study|Lost to Follow-up|1|||
30940624|NCT01507545|58978084|FG001|Overall Study|Lost to Follow-up|0|||
30940625|NCT01507545|58978083|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
30940626|NCT01507545|58978084|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
30940627|NCT01507545|58978083|FG000|Overall Study|Progressive disease|60|||
30940628|NCT01507545|58978084|FG001|Overall Study|Progressive disease|27|||
30940629|NCT01507545|58978083|FG000|Overall Study|Other|6|||
30940630|NCT01507545|58978084|FG001|Overall Study|Other|4|||
30940631|NCT01482819|58978090|FG000|Overall Study|Lost to Follow-up|2|||
30940632|NCT01534533|58978102|FG000|Overall Study|Lost to Follow-up|3|||
30940633|NCT01534533|58978103|FG001|Overall Study|Lost to Follow-up|0|||
30940634|NCT01534533|58978104|FG002|Overall Study|Lost to Follow-up|4|||
30940635|NCT01534533|58978105|FG003|Overall Study|Lost to Follow-up|3|||
30940636|NCT01534533|58978102|FG000|Overall Study|Withdrawal by Subject|5|||
30940637|NCT01534533|58978103|FG001|Overall Study|Withdrawal by Subject|3|||
30940638|NCT01534533|58978104|FG002|Overall Study|Withdrawal by Subject|4|||
30940639|NCT01534533|58978105|FG003|Overall Study|Withdrawal by Subject|1|||
30940640|NCT01506609|58978239|FG000|Overall Study|Adverse Event Related to Progression|0|||
30940641|NCT01506609|58978240|FG001|Overall Study|Adverse Event Related to Progression|0|||
30940642|NCT01506609|58978241|FG002|Overall Study|Adverse Event Related to Progression|0|||
30940643|NCT01506609|58978242|FG003|Overall Study|Adverse Event Related to Progression|3|||
30940644|NCT01506609|58978243|FG004|Overall Study|Adverse Event Related to Progression|7|||
30940645|NCT01506609|58978244|FG005|Overall Study|Adverse Event Related to Progression|3|||
30940646|NCT01506609|58978239|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
30940647|NCT01506609|58978240|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
30940648|NCT01506609|58978241|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
30940649|NCT01506609|58978242|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
30940650|NCT01506609|58978243|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
30940651|NCT01506609|58978244|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
30940652|NCT01506609|58978239|FG000|Overall Study|Withdrawal by Subject|0|||
30940653|NCT01506609|58978240|FG001|Overall Study|Withdrawal by Subject|0|||
30940654|NCT01506609|58978241|FG002|Overall Study|Withdrawal by Subject|0|||
30940655|NCT01506609|58978242|FG003|Overall Study|Withdrawal by Subject|9|||
30940656|NCT01506609|58978243|FG004|Overall Study|Withdrawal by Subject|7|||
30940657|NCT01506609|58978244|FG005|Overall Study|Withdrawal by Subject|7|||
30940658|NCT01506609|58978239|FG000|Overall Study|Lost to Follow-up|0|||
30940659|NCT01506609|58978240|FG001|Overall Study|Lost to Follow-up|0|||
30940660|NCT01506609|58978241|FG002|Overall Study|Lost to Follow-up|0|||
30842380|NCT01659736|58868065|FG000|Treatment Period|Adverse Event|1|||
30940661|NCT01506609|58978242|FG003|Overall Study|Lost to Follow-up|1|||
30940662|NCT01506609|58978243|FG004|Overall Study|Lost to Follow-up|2|||
30940663|NCT01506609|58978244|FG005|Overall Study|Lost to Follow-up|0|||
30940664|NCT01506609|58978239|FG000|Overall Study|Sponsor Discontinued Study|0|||
30940665|NCT01506609|58978240|FG001|Overall Study|Sponsor Discontinued Study|0|||
30940666|NCT01506609|58978241|FG002|Overall Study|Sponsor Discontinued Study|0|||
30940667|NCT01506609|58978242|FG003|Overall Study|Sponsor Discontinued Study|2|||
30842381|NCT01659736|58868066|FG001|Treatment Period|Adverse Event|1|||
30940668|NCT01506609|58978243|FG004|Overall Study|Sponsor Discontinued Study|2|||
30940669|NCT01506609|58978244|FG005|Overall Study|Sponsor Discontinued Study|0|||
30940670|NCT01506609|58978239|FG000|Overall Study|Progressive Disease per Protocol|1|||
30940671|NCT01506609|58978240|FG001|Overall Study|Progressive Disease per Protocol|0|||
30940672|NCT01506609|58978241|FG002|Overall Study|Progressive Disease per Protocol|0|||
30940673|NCT01506609|58978242|FG003|Overall Study|Progressive Disease per Protocol|64|||
30940674|NCT01506609|58978243|FG004|Overall Study|Progressive Disease per Protocol|57|||
30940675|NCT01506609|58978244|FG005|Overall Study|Progressive Disease per Protocol|74|||
30940676|NCT01506609|58978239|FG000|Overall Study|Other, Not Specified|0|||
30940677|NCT01506609|58978240|FG001|Overall Study|Other, Not Specified|0|||
30940678|NCT01506609|58978241|FG002|Overall Study|Other, Not Specified|0|||
30940679|NCT01506609|58978242|FG003|Overall Study|Other, Not Specified|10|||
30940680|NCT01506609|58978243|FG004|Overall Study|Other, Not Specified|7|||
30940681|NCT01506609|58978244|FG005|Overall Study|Other, Not Specified|3|||
30940682|NCT01506609|58978239|FG000|Overall Study|Missing / Unknown Reason|1|||
30940683|NCT01506609|58978240|FG001|Overall Study|Missing / Unknown Reason|0|||
30940684|NCT01506609|58978241|FG002|Overall Study|Missing / Unknown Reason|1|||
30940685|NCT01506609|58978242|FG003|Overall Study|Missing / Unknown Reason|4|||
30940686|NCT01506609|58978243|FG004|Overall Study|Missing / Unknown Reason|4|||
30940687|NCT01506609|58978244|FG005|Overall Study|Missing / Unknown Reason|2|||
30940688|NCT01506453|58978268|FG000|Overall Study|Withdrawal prior to treatment|0|||
30940689|NCT01506453|58978269|FG001|Overall Study|Withdrawal prior to treatment|2|||
30940690|NCT01482429|58978277|FG000|Care Usual|Protocol Violation|0|||
30940691|NCT01482429|58978278|FG001|Care Usual|Protocol Violation|172|||
30940692|NCT01482429|58978277|FG000|Care Usual|Lost to Follow-up|0|||
30940693|NCT01482429|58978278|FG001|Care Usual|Lost to Follow-up|1|||
30940694|NCT01482429|58978277|FG000|Protocol|Protocol Violation|275|||
30940695|NCT01482429|58978278|FG001|Protocol|Protocol Violation|0|||
30940696|NCT01504971|58978284|FG000|Overall Study|Physician Decision|13|||
30940697|NCT01479777|58978292|FG000|Overall Study|Physician Decision|2|||
30940698|NCT01479621|58978302|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
30940699|NCT01479621|58978303|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30940700|NCT01479621|58978304|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30940701|NCT01479621|58978305|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30940702|NCT01479621|58978306|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30940703|NCT01479621|58978307|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30940704|NCT01479621|58978308|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30940705|NCT01479621|58978302|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
30940706|NCT01479621|58978303|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30940707|NCT01479621|58978304|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30940708|NCT01479621|58978305|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30940709|NCT01479621|58978306|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30940710|NCT01479621|58978307|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30940711|NCT01479621|58978308|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30940712|NCT01479621|58978302|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
30940713|NCT01479621|58978303|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30940714|NCT01479621|58978304|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30940715|NCT01479621|58978305|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30940716|NCT01479621|58978306|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30940717|NCT01479621|58978307|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30940718|NCT01479621|58978308|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30940719|NCT01479621|58978302|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
30940720|NCT01479621|58978303|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30940721|NCT01479621|58978304|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30940722|NCT01479621|58978305|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30940723|NCT01479621|58978306|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30940724|NCT01479621|58978307|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30940725|NCT01479621|58978308|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30940726|NCT01479621|58978302|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
30940727|NCT01479621|58978303|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30940728|NCT01479621|58978304|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30940729|NCT01479621|58978305|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30940730|NCT01479621|58978306|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30940731|NCT01479621|58978307|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30940732|NCT01479621|58978308|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30842382|NCT01659736|58868065|FG000|Treatment Period|Protocol Violation|3|||
30940733|NCT01479621|58978302|FG000|Treatment Period|Adverse Event|0|||
30940734|NCT01479621|58978303|FG001|Treatment Period|Adverse Event|0|||
30940735|NCT01479621|58978304|FG002|Treatment Period|Adverse Event|0|||
30940736|NCT01479621|58978305|FG003|Treatment Period|Adverse Event|0|||
30940737|NCT01479621|58978306|FG004|Treatment Period|Adverse Event|1|||
30940738|NCT01479621|58978307|FG005|Treatment Period|Adverse Event|2|||
30940739|NCT01479621|58978308|FG006|Treatment Period|Adverse Event|2|||
30940740|NCT01479621|58978302|FG000|Treatment Period|Withdrawal by Subject|0|||
30940741|NCT01479621|58978303|FG001|Treatment Period|Withdrawal by Subject|4|||
30940742|NCT01479621|58978304|FG002|Treatment Period|Withdrawal by Subject|2|||
30940743|NCT01479621|58978305|FG003|Treatment Period|Withdrawal by Subject|2|||
30940744|NCT01479621|58978306|FG004|Treatment Period|Withdrawal by Subject|5|||
30940745|NCT01479621|58978307|FG005|Treatment Period|Withdrawal by Subject|5|||
30940746|NCT01479621|58978308|FG006|Treatment Period|Withdrawal by Subject|1|||
30940747|NCT01479621|58978302|FG000|Treatment Period|Physician Decision|0|||
30940748|NCT01479621|58978303|FG001|Treatment Period|Physician Decision|0|||
30940749|NCT01479621|58978304|FG002|Treatment Period|Physician Decision|0|||
30940750|NCT01479621|58978305|FG003|Treatment Period|Physician Decision|0|||
30940751|NCT01479621|58978306|FG004|Treatment Period|Physician Decision|1|||
30940752|NCT01479621|58978307|FG005|Treatment Period|Physician Decision|1|||
30940753|NCT01479621|58978308|FG006|Treatment Period|Physician Decision|0|||
30940754|NCT01479621|58978302|FG000|Treatment Period|Non-compliance to study drug|0|||
30940755|NCT01479621|58978303|FG001|Treatment Period|Non-compliance to study drug|1|||
30940756|NCT01479621|58978304|FG002|Treatment Period|Non-compliance to study drug|0|||
30940757|NCT01479621|58978305|FG003|Treatment Period|Non-compliance to study drug|0|||
30940758|NCT01479621|58978306|FG004|Treatment Period|Non-compliance to study drug|0|||
30940759|NCT01479621|58978307|FG005|Treatment Period|Non-compliance to study drug|0|||
30940760|NCT01479621|58978308|FG006|Treatment Period|Non-compliance to study drug|1|||
30940761|NCT01479621|58978302|FG000|Treatment Period|Protocol Violation|0|||
30940762|NCT01479621|58978303|FG001|Treatment Period|Protocol Violation|9|||
30940763|NCT01479621|58978304|FG002|Treatment Period|Protocol Violation|6|||
30940764|NCT01479621|58978305|FG003|Treatment Period|Protocol Violation|5|||
30940765|NCT01479621|58978306|FG004|Treatment Period|Protocol Violation|2|||
30940766|NCT01479621|58978307|FG005|Treatment Period|Protocol Violation|10|||
30940767|NCT01479621|58978308|FG006|Treatment Period|Protocol Violation|6|||
30940768|NCT01479621|58978302|FG000|Treatment Period|Pregnancy|0|||
30940769|NCT01479621|58978303|FG001|Treatment Period|Pregnancy|0|||
30940770|NCT01479621|58978304|FG002|Treatment Period|Pregnancy|2|||
30940771|NCT01479621|58978305|FG003|Treatment Period|Pregnancy|0|||
30940772|NCT01479621|58978306|FG004|Treatment Period|Pregnancy|0|||
30940773|NCT01479621|58978307|FG005|Treatment Period|Pregnancy|0|||
30940774|NCT01479621|58978308|FG006|Treatment Period|Pregnancy|0|||
30940775|NCT01479621|58978302|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
30940776|NCT01479621|58978303|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
30940777|NCT01479621|58978304|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
30940778|NCT01479621|58978305|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
30940779|NCT01479621|58978306|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
30940780|NCT01479621|58978307|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
30940781|NCT01479621|58978308|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
30940782|NCT01479621|58978302|FG000|Treatment Period|Lost to Follow-up|0|||
30940783|NCT01479621|58978303|FG001|Treatment Period|Lost to Follow-up|0|||
30940784|NCT01479621|58978304|FG002|Treatment Period|Lost to Follow-up|1|||
30940785|NCT01479621|58978305|FG003|Treatment Period|Lost to Follow-up|0|||
30940786|NCT01479621|58978306|FG004|Treatment Period|Lost to Follow-up|2|||
30940787|NCT01479621|58978307|FG005|Treatment Period|Lost to Follow-up|2|||
30940788|NCT01479621|58978308|FG006|Treatment Period|Lost to Follow-up|1|||
30940789|NCT01479621|58978302|FG000|Treatment Period|Met stopping criteria|0|||
30940790|NCT01479621|58978303|FG001|Treatment Period|Met stopping criteria|8|||
30940791|NCT01479621|58978304|FG002|Treatment Period|Met stopping criteria|7|||
30940792|NCT01479621|58978305|FG003|Treatment Period|Met stopping criteria|4|||
30940793|NCT01479621|58978306|FG004|Treatment Period|Met stopping criteria|9|||
30940794|NCT01479621|58978307|FG005|Treatment Period|Met stopping criteria|20|||
30940795|NCT01479621|58978308|FG006|Treatment Period|Met stopping criteria|6|||
30940796|NCT01479465|58978356|FG000|Overall Study|Disease Progression|9|||
30940797|NCT01479465|58978357|FG001|Overall Study|Disease Progression|61|||
30940798|NCT01479465|58978358|FG002|Overall Study|Disease Progression|65|||
30940799|NCT01479465|58978359|FG003|Overall Study|Disease Progression|70|||
30940800|NCT01479465|58978356|FG000|Overall Study|Study Discontinued by Sponsor|0|||
30940801|NCT01479465|58978357|FG001|Overall Study|Study Discontinued by Sponsor|7|||
30940802|NCT01479465|58978358|FG002|Overall Study|Study Discontinued by Sponsor|5|||
30940803|NCT01479465|58978359|FG003|Overall Study|Study Discontinued by Sponsor|3|||
30940804|NCT01479465|58978356|FG000|Overall Study|Adverse Event|0|||
30940805|NCT01479465|58978357|FG001|Overall Study|Adverse Event|3|||
30940806|NCT01479465|58978358|FG002|Overall Study|Adverse Event|6|||
30940807|NCT01479465|58978359|FG003|Overall Study|Adverse Event|4|||
30940808|NCT01479465|58978356|FG000|Overall Study|Investigator Discretion|1|||
30940809|NCT01479465|58978357|FG001|Overall Study|Investigator Discretion|4|||
30940810|NCT01479465|58978358|FG002|Overall Study|Investigator Discretion|2|||
30940811|NCT01479465|58978359|FG003|Overall Study|Investigator Discretion|4|||
30940812|NCT01479465|58978356|FG000|Overall Study|Subject Request|1|||
30940813|NCT01479465|58978357|FG001|Overall Study|Subject Request|3|||
30940814|NCT01479465|58978358|FG002|Overall Study|Subject Request|4|||
30940815|NCT01479465|58978359|FG003|Overall Study|Subject Request|2|||
30940816|NCT01479465|58978356|FG000|Overall Study|Subject Withdrew Consent|0|||
30940817|NCT01479465|58978357|FG001|Overall Study|Subject Withdrew Consent|5|||
30940818|NCT01479465|58978358|FG002|Overall Study|Subject Withdrew Consent|2|||
30940819|NCT01479465|58978359|FG003|Overall Study|Subject Withdrew Consent|1|||
30940820|NCT01479465|58978356|FG000|Overall Study|Protocol Violation|0|||
30940821|NCT01479465|58978357|FG001|Overall Study|Protocol Violation|1|||
30940822|NCT01479465|58978358|FG002|Overall Study|Protocol Violation|1|||
30940823|NCT01479465|58978359|FG003|Overall Study|Protocol Violation|0|||
30940824|NCT01479465|58978356|FG000|Overall Study|Death|0|||
30940825|NCT01479465|58978357|FG001|Overall Study|Death|0|||
30940826|NCT01479465|58978358|FG002|Overall Study|Death|0|||
30940827|NCT01479465|58978359|FG003|Overall Study|Death|1|||
30940828|NCT01479465|58978356|FG000|Overall Study|Lost to Follow-up|0|||
30940829|NCT01479465|58978357|FG001|Overall Study|Lost to Follow-up|0|||
30940830|NCT01479465|58978358|FG002|Overall Study|Lost to Follow-up|1|||
30940831|NCT01479465|58978359|FG003|Overall Study|Lost to Follow-up|0|||
30940832|NCT01503021|58978423|FG000|Overall Study|Adverse Event|7|||
30940833|NCT01503021|58978424|FG001|Overall Study|Adverse Event|6|||
30940834|NCT01503021|58978423|FG000|Overall Study|Death|0|||
30940835|NCT01503021|58978424|FG001|Overall Study|Death|2|||
30940836|NCT01503021|58978423|FG000|Overall Study|Lost to Follow-up|2|||
30940837|NCT01503021|58978424|FG001|Overall Study|Lost to Follow-up|0|||
30940838|NCT01503021|58978423|FG000|Overall Study|Physician Decision|3|||
30940839|NCT01503021|58978424|FG001|Overall Study|Physician Decision|0|||
30940840|NCT01503021|58978423|FG000|Overall Study|Protocol Violation|1|||
30940841|NCT01503021|58978424|FG001|Overall Study|Protocol Violation|3|||
30940842|NCT01503021|58978423|FG000|Overall Study|Withdrawal by Subject|9|||
30940843|NCT01503021|58978424|FG001|Overall Study|Withdrawal by Subject|8|||
30940844|NCT01503021|58978423|FG000|Overall Study|Moved, received transplant, etc.|5|||
30940845|NCT01503021|58978424|FG001|Overall Study|Moved, received transplant, etc.|7|||
30940846|NCT01531725|58978435|FG000|Overall Study|Protocol Violation|5|||
30940847|NCT01478373|58978439|FG000|Treatment Phase|Protocol Violation|1|||
30940848|NCT01478373|58978439|FG000|Survival Phase|Adverse Event|8|||
30759195|NCT00082407|58767683|FG000|Overall Study|Patient Decision|13|||
30759196|NCT00082407|58767684|FG001|Overall Study|Patient Decision|6|||
30759197|NCT00082407|58767683|FG000|Overall Study|Physician Decision|5|||
30759198|NCT00082407|58767684|FG001|Overall Study|Physician Decision|3|||
30759199|NCT00082407|58767683|FG000|Overall Study|Loss of Glucose Control|2|||
30759200|NCT00082407|58767684|FG001|Overall Study|Loss of Glucose Control|2|||
30759201|NCT00082407|58767683|FG000|Overall Study|Death|2|||
30759202|NCT00082407|58767684|FG001|Overall Study|Death|1|||
30759203|NCT00082407|58767683|FG000|Overall Study|Lost to Follow-up|0|||
30759204|NCT00082407|58767684|FG001|Overall Study|Lost to Follow-up|3|||
30759205|NCT03643432|58767692|FG000|Overall Study|Lost to Follow-up|1|||
30759206|NCT03643432|58767693|FG001|Overall Study|Lost to Follow-up|0|||
30759207|NCT03810183|58767701|FG000|Overall Study|Study terminated by Sponsor|2|||
30759208|NCT03810183|58767702|FG001|Overall Study|Study terminated by Sponsor|1|||
30759209|NCT03597022|58767712|FG000|Overall Study|Premature termination of the study|7|||
30759210|NCT03597022|58767713|FG001|Overall Study|Premature termination of the study|7|||
30759211|NCT03597022|58767714|FG002|Overall Study|Premature termination of the study|8|||
30759212|NCT03597022|58767712|FG000|Overall Study|Serious adverse event|1|||
30940849|NCT01478373|58978439|FG000|Survival Phase|Protocol Violation|1|||
30940850|NCT01478373|58978439|FG000|Survival Phase|crossover to another study|2|||
30940851|NCT01478373|58978439|FG000|Survival Phase|Progressive Disease|27|||
30940852|NCT01502709|58978445|FG000|Overall Study|Lost to Follow-up|4|||
30940853|NCT01502709|58978446|FG001|Overall Study|Lost to Follow-up|0|||
30940854|NCT01477749|58978453|FG000|Overall Study|Physician Decision|4|||
30940855|NCT01502631|58978483|FG000|Overall Study|Adverse Event|5|||
30940856|NCT01502631|58978484|FG001|Overall Study|Adverse Event|8|||
30940857|NCT01502631|58978483|FG000|Overall Study|Lost to Follow-up|2|||
30940858|NCT01502631|58978484|FG001|Overall Study|Lost to Follow-up|2|||
30940859|NCT01502631|58978483|FG000|Overall Study|Participant withdrew consent|2|||
30759213|NCT03597022|58767713|FG001|Overall Study|Serious adverse event|1|||
30759214|NCT03597022|58767714|FG002|Overall Study|Serious adverse event|0|||
30759215|NCT03571204|58767725|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
30940860|NCT01502631|58978484|FG001|Overall Study|Participant withdrew consent|4|||
30940861|NCT01502631|58978483|FG000|Overall Study|Participant non-compliant|1|||
30940862|NCT01502631|58978484|FG001|Overall Study|Participant non-compliant|0|||
30940863|NCT01502631|58978483|FG000|Overall Study|Investigator's decision|0|||
30759216|NCT03571204|58767726|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
30948549|NCT01963403|58994563|FG001|Overall Study|Lost to Follow-up|3|||
30940864|NCT01502631|58978484|FG001|Overall Study|Investigator's decision|1|||
30940865|NCT01502631|58978483|FG000|Overall Study|Other|10|||
30940866|NCT01502631|58978484|FG001|Overall Study|Other|5|||
30940867|NCT01475721|58978540|FG000|Overall Study|Death|3|||
30940868|NCT01475721|58978541|FG001|Overall Study|Death|6|||
30940869|NCT01475721|58978540|FG000|Overall Study|Withdrawal by Subject|8|||
30940870|NCT01475721|58978541|FG001|Overall Study|Withdrawal by Subject|8|||
30940871|NCT01530087|58978565|FG000|Overall Study|Physician Decision|2|||
30940872|NCT01475487|58978583|FG000|Overall Study|had to leave early for personal reasons|2|||
30940873|NCT01475487|58978584|FG001|Overall Study|had to leave early for personal reasons|1|||
30940874|NCT01475331|58978592|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
30940875|NCT01475331|58978593|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
30940876|NCT01475331|58978592|FG000|Overall Study|excessive main duct communication|1|||
30940877|NCT01475331|58978593|FG001|Overall Study|excessive main duct communication|1|||
30940878|NCT01475331|58978592|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
30940879|NCT01475331|58978593|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
30940880|NCT01475331|58978592|FG000|Overall Study|Sign of malignancy during the procedure|2|||
30940881|NCT01475331|58978593|FG001|Overall Study|Sign of malignancy during the procedure|0|||
30940882|NCT01475331|58978592|FG000|Overall Study|cyst found to be prohibitively small|0|||
30940883|NCT01475331|58978593|FG001|Overall Study|cyst found to be prohibitively small|1|||
30940884|NCT01500213|58978601|FG000|Overall Study|Adverse Event|35|||
30940885|NCT01500213|58978602|FG001|Overall Study|Adverse Event|35|||
30940886|NCT01500213|58978601|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
30940887|NCT01500213|58978602|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
30940888|NCT01500213|58978601|FG000|Overall Study|Withdrawal by Subject|28|||
30940889|NCT01500213|58978602|FG001|Overall Study|Withdrawal by Subject|37|||
30940890|NCT01500213|58978601|FG000|Overall Study|Death|7|||
30940891|NCT01500213|58978602|FG001|Overall Study|Death|3|||
30940892|NCT01500213|58978601|FG000|Overall Study|Disease Progression|13|||
30940893|NCT01500213|58978602|FG001|Overall Study|Disease Progression|21|||
30940894|NCT01500213|58978601|FG000|Overall Study|Protocol Violation|19|||
30940895|NCT01500213|58978602|FG001|Overall Study|Protocol Violation|19|||
30940896|NCT01500213|58978601|FG000|Overall Study|Physician Decision|12|||
30940897|NCT01500213|58978602|FG001|Overall Study|Physician Decision|10|||
30940898|NCT01500213|58978601|FG000|Overall Study|Lack of Efficacy|9|||
30940899|NCT01500213|58978602|FG001|Overall Study|Lack of Efficacy|7|||
30940900|NCT01500213|58978601|FG000|Overall Study|Lost to Follow-up|3|||
30940901|NCT01500213|58978602|FG001|Overall Study|Lost to Follow-up|6|||
30940902|NCT01500213|58978601|FG000|Overall Study|Other Reasons|7|||
30940903|NCT01500213|58978602|FG001|Overall Study|Other Reasons|5|||
30940904|NCT01475253|58978632|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
30940905|NCT01475253|58978633|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
30940906|NCT01475253|58978634|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
30940907|NCT01475253|58978635|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
30940908|NCT01475253|58978632|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
30940909|NCT01475253|58978633|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
30940910|NCT01475253|58978634|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
30940911|NCT01475253|58978635|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
30940912|NCT01500135|58978693|FG000|Overall Study|Withdrawal of Consent|4|||
30940913|NCT01500135|58978694|FG001|Overall Study|Withdrawal of Consent|0|||
30940914|NCT01500135|58978693|FG000|Overall Study|Lost to Follow-up|6|||
30940915|NCT01500135|58978694|FG001|Overall Study|Lost to Follow-up|4|||
30940916|NCT01500135|58978693|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
30940917|NCT01500135|58978694|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
30940918|NCT01500135|58978693|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
30940919|NCT01500135|58978694|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
30940920|NCT01500135|58978693|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
30940921|NCT01500135|58978694|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
30940922|NCT01500135|58978693|FG000|Overall Study|Participant was a Safety Concern|1|||
30940923|NCT01500135|58978694|FG001|Overall Study|Participant was a Safety Concern|0|||
30940924|NCT01500135|58978693|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
30940925|NCT01500135|58978694|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
30940926|NCT01475097|58978706|FG000|Overall Study|Protocol Violation|1|||
30940927|NCT01475097|58978707|FG001|Overall Study|Protocol Violation|1|||
30940928|NCT01529385|58978715|FG000|Overall Study|Lost to Follow-up|2|||
30940929|NCT01529385|58978716|FG001|Overall Study|Lost to Follow-up|1|||
30940930|NCT01474551|58978722|FG000|Overall Study|Death|1|||
30940931|NCT01500057|58978757|FG000|Overall Study|Lost to Follow-up|6|||
30940932|NCT01500057|58978758|FG001|Overall Study|Lost to Follow-up|4|||
30940933|NCT01499667|58978776|FG000|Overall Study|administrative problems|4|||
30940934|NCT01499667|58978777|FG001|Overall Study|administrative problems|5|||
30940935|NCT01499667|58978778|FG002|Overall Study|administrative problems|5|||
30940936|NCT01499667|58978776|FG000|Overall Study|Protocol Violation|1|||
30940937|NCT01499667|58978777|FG001|Overall Study|Protocol Violation|3|||
30940938|NCT01499667|58978778|FG002|Overall Study|Protocol Violation|2|||
30940939|NCT01499667|58978776|FG000|Overall Study|Adverse Event|0|||
30940940|NCT01499667|58978777|FG001|Overall Study|Adverse Event|2|||
30940941|NCT01499667|58978778|FG002|Overall Study|Adverse Event|2|||
30940942|NCT01499667|58978776|FG000|Overall Study|Withdrawal by Subject|2|||
30940943|NCT01499667|58978777|FG001|Overall Study|Withdrawal by Subject|1|||
30940944|NCT01499667|58978778|FG002|Overall Study|Withdrawal by Subject|1|||
30940945|NCT01499667|58978776|FG000|Overall Study|Lack of Efficacy|2|||
30940946|NCT01499667|58978777|FG001|Overall Study|Lack of Efficacy|0|||
30940947|NCT01499667|58978778|FG002|Overall Study|Lack of Efficacy|0|||
30940948|NCT01499511|58978788|FG000|Overall Study|Death|1|||
30940949|NCT01499511|58978789|FG001|Overall Study|Death|0|||
30940950|NCT01474317|58978809|FG000|Overall Study|Adverse Event|1|||
30940951|NCT01474317|58978809|FG000|Overall Study|Subject ineligible for study|1|||
30940952|NCT01499355|58978905|FG000|Run-In Period|Study Termination|15|||
30940953|NCT01499355|58978906|FG001|Run-In Period|Study Termination|0|||
30940954|NCT01499355|58978907|FG002|Run-In Period|Study Termination|0|||
30940955|NCT01499355|58978908|FG003|Run-In Period|Study Termination|0|||
30940956|NCT01499355|58978905|FG000|Run-In Period|Other|3|||
30940957|NCT01499355|58978906|FG001|Run-In Period|Other|0|||
30940958|NCT01499355|58978907|FG002|Run-In Period|Other|0|||
30940959|NCT01499355|58978908|FG003|Run-In Period|Other|0|||
30940960|NCT01499355|58978905|FG000|Run-In Period|Death|2|||
30940961|NCT01499355|58978906|FG001|Run-In Period|Death|0|||
30940962|NCT01499355|58978907|FG002|Run-In Period|Death|0|||
30940963|NCT01499355|58978908|FG003|Run-In Period|Death|0|||
30940964|NCT01499355|58978905|FG000|Run-In Period|Investigator Decision|2|||
30940965|NCT01499355|58978906|FG001|Run-In Period|Investigator Decision|0|||
30940966|NCT01499355|58978907|FG002|Run-In Period|Investigator Decision|0|||
30940967|NCT01499355|58978908|FG003|Run-In Period|Investigator Decision|0|||
30940968|NCT01499355|58978905|FG000|Run-In Period|Consent Withdrawn|1|||
30940969|NCT01499355|58978906|FG001|Run-In Period|Consent Withdrawn|0|||
30940970|NCT01499355|58978907|FG002|Run-In Period|Consent Withdrawn|0|||
30940971|NCT01499355|58978908|FG003|Run-In Period|Consent Withdrawn|0|||
30940972|NCT01499355|58978905|FG000|Run-In Period|Adverse Event|8|||
30940973|NCT01499355|58978906|FG001|Run-In Period|Adverse Event|0|||
30940974|NCT01499355|58978907|FG002|Run-In Period|Adverse Event|0|||
30940975|NCT01499355|58978908|FG003|Run-In Period|Adverse Event|0|||
30940976|NCT01499355|58978905|FG000|Double-Blind Period|Adverse Event|0|||
30940977|NCT01499355|58978906|FG001|Double-Blind Period|Adverse Event|2|||
30940978|NCT01499355|58978907|FG002|Double-Blind Period|Adverse Event|3|||
30940979|NCT01499355|58978908|FG003|Double-Blind Period|Adverse Event|2|||
30940980|NCT01499355|58978905|FG000|Double-Blind Period|Study Termination|0|||
30940981|NCT01499355|58978906|FG001|Double-Blind Period|Study Termination|18|||
30940982|NCT01499355|58978907|FG002|Double-Blind Period|Study Termination|16|||
30940983|NCT01499355|58978908|FG003|Double-Blind Period|Study Termination|14|||
30940984|NCT01499355|58978905|FG000|Double-Blind Period|Other|0|||
30940985|NCT01499355|58978906|FG001|Double-Blind Period|Other|1|||
30940986|NCT01499355|58978907|FG002|Double-Blind Period|Other|2|||
30940987|NCT01499355|58978908|FG003|Double-Blind Period|Other|2|||
30940988|NCT01499355|58978905|FG000|Double-Blind Period|Death|0|||
30940989|NCT01499355|58978906|FG001|Double-Blind Period|Death|1|||
30940990|NCT01499355|58978907|FG002|Double-Blind Period|Death|0|||
30940991|NCT01499355|58978908|FG003|Double-Blind Period|Death|0|||
30940992|NCT01499355|58978905|FG000|Double-Blind Period|Investigator Decision|0|||
30940993|NCT01499355|58978906|FG001|Double-Blind Period|Investigator Decision|0|||
30940994|NCT01499355|58978907|FG002|Double-Blind Period|Investigator Decision|3|||
30940995|NCT01499355|58978908|FG003|Double-Blind Period|Investigator Decision|3|||
30940996|NCT01499355|58978905|FG000|Double-Blind Period|Consent Withdrawn|0|||
30940997|NCT01499355|58978906|FG001|Double-Blind Period|Consent Withdrawn|0|||
30940998|NCT01499355|58978907|FG002|Double-Blind Period|Consent Withdrawn|1|||
30940999|NCT01499355|58978908|FG003|Double-Blind Period|Consent Withdrawn|2|||
30941000|NCT01499355|58978905|FG000|Double-Blind Period|Lost to Follow-up|0|||
30941001|NCT01499355|58978906|FG001|Double-Blind Period|Lost to Follow-up|1|||
30941002|NCT01499355|58978907|FG002|Double-Blind Period|Lost to Follow-up|0|||
30941003|NCT01499355|58978908|FG003|Double-Blind Period|Lost to Follow-up|0|||
30941004|NCT01474239|58978929|FG000|Overall Study|Disease Progression|37|||
30941005|NCT01474239|58978930|FG001|Overall Study|Disease Progression|25|||
30941006|NCT01474239|58978929|FG000|Overall Study|Adverse Event|12|||
30941007|NCT01474239|58978930|FG001|Overall Study|Adverse Event|3|||
30941008|NCT01474239|58978929|FG000|Overall Study|Withdrawal by Subject|1|||
30941009|NCT01474239|58978930|FG001|Overall Study|Withdrawal by Subject|2|||
30941010|NCT01474239|58978929|FG000|Overall Study|Death|1|||
30941011|NCT01474239|58978930|FG001|Overall Study|Death|1|||
30941012|NCT01474239|58978929|FG000|Overall Study|Clinical Disease Progression|7|||
30941013|NCT01474239|58978930|FG001|Overall Study|Clinical Disease Progression|1|||
30941014|NCT01474239|58978929|FG000|Overall Study|Withdrawal for Economic Reason|1|||
30941015|NCT01474239|58978930|FG001|Overall Study|Withdrawal for Economic Reason|0|||
30941016|NCT01473381|58978940|FG000|Overall Study|Adverse Event|8|||
30941017|NCT01473381|58978941|FG001|Overall Study|Adverse Event|20|||
30941018|NCT01473381|58978942|FG002|Overall Study|Adverse Event|25|||
30941019|NCT01473381|58978943|FG003|Overall Study|Adverse Event|17|||
30941020|NCT01473381|58978940|FG000|Overall Study|Insufficient Therapeutic Response|10|||
30941021|NCT01473381|58978941|FG001|Overall Study|Insufficient Therapeutic Response|1|||
30941022|NCT01473381|58978942|FG002|Overall Study|Insufficient Therapeutic Response|2|||
30941023|NCT01473381|58978943|FG003|Overall Study|Insufficient Therapeutic Response|3|||
30941024|NCT01473381|58978940|FG000|Overall Study|Protocol Violation|17|||
30941025|NCT01473381|58978941|FG001|Overall Study|Protocol Violation|23|||
30941026|NCT01473381|58978942|FG002|Overall Study|Protocol Violation|19|||
30941027|NCT01473381|58978943|FG003|Overall Study|Protocol Violation|17|||
30941028|NCT01473381|58978940|FG000|Overall Study|Withdrawal of Consent|20|||
30941029|NCT01473381|58978941|FG001|Overall Study|Withdrawal of Consent|21|||
30941030|NCT01473381|58978942|FG002|Overall Study|Withdrawal of Consent|20|||
30941031|NCT01473381|58978943|FG003|Overall Study|Withdrawal of Consent|26|||
30941032|NCT01473381|58978940|FG000|Overall Study|Lost to Follow-up|25|||
30941033|NCT01473381|58978941|FG001|Overall Study|Lost to Follow-up|28|||
30941034|NCT01473381|58978942|FG002|Overall Study|Lost to Follow-up|35|||
30941035|NCT01473381|58978943|FG003|Overall Study|Lost to Follow-up|23|||
30941036|NCT01473381|58978940|FG000|Overall Study|Other Reasons|0|||
30941037|NCT01473381|58978941|FG001|Overall Study|Other Reasons|0|||
30941038|NCT01473381|58978942|FG002|Overall Study|Other Reasons|1|||
30941039|NCT01473381|58978943|FG003|Overall Study|Other Reasons|3|||
30941040|NCT01499277|58978985|FG000|Overall Study|Adverse Event|3|||
30941041|NCT01499277|58978986|FG001|Overall Study|Adverse Event|6|||
30941042|NCT01499277|58978985|FG000|Overall Study|Death|3|||
30941043|NCT01499277|58978986|FG001|Overall Study|Death|2|||
30941044|NCT01499277|58978985|FG000|Overall Study|Lost to Follow-up|15|||
30941045|NCT01499277|58978986|FG001|Overall Study|Lost to Follow-up|8|||
30941046|NCT01499277|58978985|FG000|Overall Study|Protocol Violation|2|||
30941047|NCT01499277|58978986|FG001|Overall Study|Protocol Violation|3|||
30941048|NCT01499277|58978985|FG000|Overall Study|Withdrawal by Subject|16|||
30941049|NCT01499277|58978986|FG001|Overall Study|Withdrawal by Subject|6|||
30941050|NCT01499277|58978985|FG000|Overall Study|Lack of therapeutic response and other|8|||
30941051|NCT01499277|58978986|FG001|Overall Study|Lack of therapeutic response and other|7|||
30941052|NCT01499199|58979011|FG000|Overall Study|Adverse Event|1|||
30941053|NCT01499199|58979011|FG000|Overall Study|Lack of Efficacy|1|||
30941054|NCT01499043|58979015|FG000|Overall Study|Progressive disease (radiographic)|2|||
30941055|NCT01499043|58979015|FG000|Overall Study|Progressive disease (clinical)|1|||
30941056|NCT01499043|58979015|FG000|Overall Study|Withdrawal by Subject|2|||
30941057|NCT01499043|58979015|FG000|Overall Study|Adverse Event|1|||
30941058|NCT01498887|58979089|FG000|Overall Study|Administrative problems|1|||
30941059|NCT01498887|58979090|FG001|Overall Study|Administrative problems|0|||
30941060|NCT01498887|58979089|FG000|Overall Study|Lost to Follow-up|1|||
30941061|NCT01498887|58979090|FG001|Overall Study|Lost to Follow-up|1|||
30941062|NCT01498887|58979089|FG000|Overall Study|Withdrawal by Subject|1|||
30941063|NCT01498887|58979090|FG001|Overall Study|Withdrawal by Subject|0|||
30941064|NCT01498887|58979089|FG000|Overall Study|Protocol Violation|1|||
30941065|NCT01498887|58979090|FG001|Overall Study|Protocol Violation|3|||
30941066|NCT01498887|58979089|FG000|Overall Study|Lack of Efficacy|5|||
30941067|NCT01498887|58979090|FG001|Overall Study|Lack of Efficacy|3|||
30759217|NCT03571204|58767727|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
30759218|NCT03571204|58767725|FG000|Overall Study|Physician Decision|0|||
30759219|NCT03571204|58767726|FG001|Overall Study|Physician Decision|1|||
30759220|NCT03571204|58767727|FG002|Overall Study|Physician Decision|0|||
30759221|NCT03569098|58767739|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
30941068|NCT01498887|58979089|FG000|Overall Study|Abnormal result from test procedure|1|||
30941069|NCT01498887|58979090|FG001|Overall Study|Abnormal result from test procedure|1|||
30941070|NCT01498887|58979089|FG000|Overall Study|Abnormal laboratory value|2|||
30941071|NCT01498887|58979090|FG001|Overall Study|Abnormal laboratory value|2|||
30941072|NCT01498887|58979089|FG000|Overall Study|Adverse Event|4|||
30941073|NCT01498887|58979090|FG001|Overall Study|Adverse Event|1|||
30941074|NCT01498653|58979099|FG000|Overall Study|Adverse Event|2|||
30941075|NCT01498653|58979100|FG001|Overall Study|Adverse Event|2|||
30941076|NCT01498653|58979099|FG000|Overall Study|Lack of Efficacy|12|||
30941077|NCT01498653|58979100|FG001|Overall Study|Lack of Efficacy|26|||
30941078|NCT01498653|58979099|FG000|Overall Study|Protocol Violation|0|||
30759222|NCT03569098|58767740|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
30759223|NCT03569098|58767741|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
30759224|NCT03569098|58767739|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
30759225|NCT03569098|58767740|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
30759226|NCT03569098|58767741|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
30759227|NCT03569098|58767739|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
30759228|NCT03569098|58767740|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
30759229|NCT03569098|58767741|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
30759230|NCT03569098|58767739|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
30759231|NCT03569098|58767740|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
30941079|NCT01498653|58979100|FG001|Overall Study|Protocol Violation|4|||
30941080|NCT01498653|58979099|FG000|Overall Study|Lost to Follow-up|1|||
30941081|NCT01498653|58979100|FG001|Overall Study|Lost to Follow-up|0|||
30941082|NCT01498653|58979099|FG000|Overall Study|Physician Decision|2|||
30941083|NCT01498653|58979100|FG001|Overall Study|Physician Decision|0|||
30941084|NCT01498653|58979099|FG000|Overall Study|Withdrawal by Subject|2|||
30941085|NCT01498653|58979100|FG001|Overall Study|Withdrawal by Subject|3|||
30941086|NCT01498575|58979108|FG000|Overall Sample|Withdrawal by Subject|60|||
30941087|NCT01498575|58979109|FG001|Overall Sample|Withdrawal by Subject|14|||
30941088|NCT01498575|58979108|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
30941089|NCT01498575|58979109|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
30941090|NCT01498575|58979108|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
30941091|NCT01498575|58979109|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
30941092|NCT01498185|58979120|FG000|Overall Study|Adverse Event|0|||
30941093|NCT01498185|58979121|FG001|Overall Study|Adverse Event|0|||
30941094|NCT01498185|58979122|FG002|Overall Study|Adverse Event|0|||
30941095|NCT01498185|58979123|FG003|Overall Study|Adverse Event|1|||
30941096|NCT01498185|58979124|FG004|Overall Study|Adverse Event|0|||
30941097|NCT01498185|58979120|FG000|Overall Study|Withdrawal by Subject|1|||
30941098|NCT01498185|58979121|FG001|Overall Study|Withdrawal by Subject|1|||
30941099|NCT01498185|58979122|FG002|Overall Study|Withdrawal by Subject|0|||
30941100|NCT01498185|58979123|FG003|Overall Study|Withdrawal by Subject|2|||
30941101|NCT01498185|58979124|FG004|Overall Study|Withdrawal by Subject|1|||
30941102|NCT01498185|58979120|FG000|Overall Study|No longer met criteria, etc|0|||
30941103|NCT01498185|58979121|FG001|Overall Study|No longer met criteria, etc|0|||
30941104|NCT01498185|58979122|FG002|Overall Study|No longer met criteria, etc|0|||
30941105|NCT01498185|58979123|FG003|Overall Study|No longer met criteria, etc|0|||
30941106|NCT01498185|58979124|FG004|Overall Study|No longer met criteria, etc|2|||
30941107|NCT01528605|58979146|FG000|Overall Study|Lost to Follow-up|1|||
30941108|NCT01528605|58979147|FG001|Overall Study|Lost to Follow-up|0|||
30941109|NCT01528605|58979148|FG002|Overall Study|Lost to Follow-up|1|||
30941110|NCT01528605|58979149|FG003|Overall Study|Lost to Follow-up|1|||
30941111|NCT01528605|58979150|FG004|Overall Study|Lost to Follow-up|0|||
30941112|NCT01528605|58979151|FG005|Overall Study|Lost to Follow-up|0|||
30941113|NCT01528605|58979146|FG000|Overall Study|Death|1|||
30941114|NCT01528605|58979147|FG001|Overall Study|Death|0|||
30941115|NCT01528605|58979148|FG002|Overall Study|Death|0|||
30941116|NCT01528605|58979149|FG003|Overall Study|Death|0|||
30941117|NCT01528605|58979150|FG004|Overall Study|Death|0|||
30941118|NCT01528605|58979151|FG005|Overall Study|Death|0|||
30941119|NCT01528215|58979167|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
30941120|NCT01528215|58979168|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
30941121|NCT01528215|58979167|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
30941122|NCT01528215|58979168|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
30941123|NCT01528215|58979167|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
30941124|NCT01528215|58979168|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
30941125|NCT01528215|58979167|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
30941126|NCT01528215|58979168|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
30941127|NCT01527357|58979176|FG000|Overall Study|Death|8|||
30941128|NCT01527357|58979177|FG001|Overall Study|Death|2|||
30941129|NCT01527357|58979176|FG000|Overall Study|Lost to Follow-up|6|||
30941130|NCT01527357|58979177|FG001|Overall Study|Lost to Follow-up|4|||
30941131|NCT01527357|58979176|FG000|Overall Study|Withdrew Consent|1|||
30941132|NCT01527357|58979177|FG001|Overall Study|Withdrew Consent|1|||
30941133|NCT01527357|58979176|FG000|Overall Study|Non-compliance|0|||
30941134|NCT01527357|58979177|FG001|Overall Study|Non-compliance|1|||
30941135|NCT01527357|58979176|FG000|Overall Study|No Day 29 Visit|0|||
30941136|NCT01527357|58979177|FG001|Overall Study|No Day 29 Visit|1|||
30941137|NCT01527357|58979176|FG000|Overall Study|Did Not Receive Treatment|2|||
30941138|NCT01527357|58979177|FG001|Overall Study|Did Not Receive Treatment|0|||
30941139|NCT01526889|58979196|FG000|Treatment Period|Adverse Event|2|||
30941140|NCT01526889|58979197|FG001|Treatment Period|Adverse Event|0|||
30941141|NCT01526889|58979196|FG000|Treatment Extension Period|Administrative problems|1|||
30941142|NCT01526889|58979197|FG001|Treatment Extension Period|Administrative problems|0|||
30941143|NCT01472835|58979209|FG000|Overall Study|Lost to Follow-up|2|||
30941144|NCT01472835|58979210|FG001|Overall Study|Lost to Follow-up|0|||
30941145|NCT01526733|58979223|FG000|Phase 1|Protocol Violation|1|||
30941146|NCT01526733|58979224|FG001|Phase 1|Protocol Violation|0|||
30941147|NCT01526733|58979223|FG000|Phase 1|Withdrawal by Subject|1|||
30941148|NCT01526733|58979224|FG001|Phase 1|Withdrawal by Subject|1|||
30941149|NCT01472757|58979269|FG000|Overall Study|Withdrawal by Subject|1|||
30941150|NCT01472757|58979270|FG001|Overall Study|Withdrawal by Subject|2|||
30941151|NCT01472757|58979271|FG002|Overall Study|Withdrawal by Subject|2|||
30941152|NCT01472757|58979272|FG003|Overall Study|Withdrawal by Subject|0|||
30941153|NCT01472757|58979269|FG000|Overall Study|Asthma exacerbation|4|||
30941154|NCT01472757|58979270|FG001|Overall Study|Asthma exacerbation|1|||
30759232|NCT03569098|58767741|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
30759233|NCT03569098|58767739|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
30759234|NCT03569098|58767740|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
30759235|NCT03569098|58767741|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
30759236|NCT03569098|58767739|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
30759237|NCT03569098|58767740|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
30759238|NCT03569098|58767741|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
30759239|NCT03569098|58767739|FG000|Double-Blind Treatment Cycle 1|Other|1|||
30759240|NCT03569098|58767740|FG001|Double-Blind Treatment Cycle 1|Other|0|||
30759241|NCT03569098|58767741|FG002|Double-Blind Treatment Cycle 1|Other|1|||
30759242|NCT03569098|58767739|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
30759243|NCT03569098|58767740|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
30759244|NCT03569098|58767741|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
30759245|NCT03569098|58767739|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
30759246|NCT03569098|58767740|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
30759247|NCT03569098|58767741|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
30759248|NCT03569098|58767739|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
30759249|NCT03569098|58767740|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
30759250|NCT03569098|58767741|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
30759251|NCT03569098|58767739|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
30759252|NCT03569098|58767740|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
30759253|NCT03569098|58767741|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
30759254|NCT03569098|58767739|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
30759255|NCT03569098|58767740|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
30759256|NCT03569098|58767741|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
30759257|NCT03569098|58767739|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
30759258|NCT03569098|58767740|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
30759259|NCT03569098|58767741|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
30759260|NCT03568942|58767752|FG000|Overall Study|Family emergency|1|||
30759261|NCT03568942|58767752|FG000|Overall Study|Lost to Follow-up|1|||
30759262|NCT00110019|58767758|FG000|Overall Study|Lack of Efficacy|253|||
30759263|NCT00110019|58767759|FG001|Overall Study|Lack of Efficacy|285|||
30759264|NCT00110019|58767758|FG000|Overall Study|Adverse Event|61|||
30759265|NCT00110019|58767759|FG001|Overall Study|Adverse Event|40|||
30759266|NCT00110019|58767758|FG000|Overall Study|Death|13|||
30759267|NCT00110019|58767759|FG001|Overall Study|Death|15|||
30759268|NCT00110019|58767758|FG000|Overall Study|Withdrawal by Subject|21|||
30759269|NCT00110019|58767759|FG001|Overall Study|Withdrawal by Subject|9|||
30759270|NCT00110019|58767758|FG000|Overall Study|alternative therapy|5|||
30759271|NCT00110019|58767759|FG001|Overall Study|alternative therapy|1|||
30759272|NCT00110019|58767758|FG000|Overall Study|complicating disease|1|||
30759273|NCT00110019|58767759|FG001|Overall Study|complicating disease|1|||
30759274|NCT00110019|58767758|FG000|Overall Study|symptom deterioration|13|||
30759275|NCT00110019|58767759|FG001|Overall Study|symptom deterioration|16|||
30759276|NCT00110019|58767758|FG000|Overall Study|Not start protocol therapy|17|||
30759277|NCT00110019|58767759|FG001|Overall Study|Not start protocol therapy|16|||
30759278|NCT00110019|58767758|FG000|Overall Study|other reasons|22|||
30759279|NCT00110019|58767759|FG001|Overall Study|other reasons|30|||
30759280|NCT03595618|58767769|FG000|Overall Study|Adverse Event|16|||
30759281|NCT03595618|58767770|FG001|Overall Study|Adverse Event|17|||
30759282|NCT03595618|58767771|FG002|Overall Study|Adverse Event|20|||
30759283|NCT03595618|58767772|FG003|Overall Study|Adverse Event|8|||
30941155|NCT01472757|58979271|FG002|Overall Study|Asthma exacerbation|2|||
30759284|NCT03595618|58767769|FG000|Overall Study|Withdrawal by Subject|12|||
30759285|NCT03595618|58767770|FG001|Overall Study|Withdrawal by Subject|14|||
30759286|NCT03595618|58767771|FG002|Overall Study|Withdrawal by Subject|14|||
30759287|NCT03595618|58767772|FG003|Overall Study|Withdrawal by Subject|10|||
30759288|NCT03595618|58767769|FG000|Overall Study|Lost to Follow-up|6|||
30941156|NCT01472757|58979272|FG003|Overall Study|Asthma exacerbation|1|||
30941157|NCT01472757|58979269|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
30759289|NCT03595618|58767770|FG001|Overall Study|Lost to Follow-up|4|||
30941158|NCT01472757|58979270|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
30941159|NCT01472757|58979271|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
30759290|NCT03595618|58767771|FG002|Overall Study|Lost to Follow-up|5|||
30759291|NCT03595618|58767772|FG003|Overall Study|Lost to Follow-up|6|||
30759292|NCT03595618|58767769|FG000|Overall Study|Protocol Violation|2|||
30759293|NCT03595618|58767770|FG001|Overall Study|Protocol Violation|0|||
30941160|NCT01472757|58979272|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
30941161|NCT01472757|58979269|FG000|Overall Study|Protocol Violation|3|||
30941162|NCT01472757|58979270|FG001|Overall Study|Protocol Violation|2|||
30941163|NCT01472757|58979271|FG002|Overall Study|Protocol Violation|4|||
30941164|NCT01472757|58979272|FG003|Overall Study|Protocol Violation|4|||
30941165|NCT01472757|58979269|FG000|Overall Study|Other reasons|1|||
30941166|NCT01472757|58979270|FG001|Overall Study|Other reasons|0|||
30941167|NCT01472757|58979271|FG002|Overall Study|Other reasons|2|||
30941168|NCT01472757|58979272|FG003|Overall Study|Other reasons|2|||
30941169|NCT01472289|58979291|FG000|Overall Study|Death|2|||
30941170|NCT01525875|58979310|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
30941171|NCT01525875|58979311|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
30941172|NCT01525875|58979310|FG000|Open-label Period|Lost to Follow-up|0|||
30941173|NCT01525875|58979311|FG001|Open-label Period|Lost to Follow-up|2|||
30941174|NCT01525641|58979317|FG000|Overall Study|Case report form not collected|25|||
30941175|NCT01525641|58979317|FG000|Overall Study|No visit since the first visit|16|||
30941176|NCT01525641|58979317|FG000|Overall Study|Adverse Event|73|||
30941177|NCT01525641|58979317|FG000|Overall Study|Lack of Efficacy|24|||
30941178|NCT01525641|58979317|FG000|Overall Study|Improvement|5|||
30941179|NCT01525641|58979317|FG000|Overall Study|Lost to follow-up (relocation)|1|||
30941180|NCT01525641|58979317|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
30941181|NCT01525641|58979317|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
30941182|NCT01525641|58979317|FG000|Overall Study|Other than stated above|7|||
30941183|NCT01496469|58979332|FG000|Overall Study|Adverse Event|1|||
30941184|NCT01496469|58979333|FG001|Overall Study|Adverse Event|0|||
30941185|NCT01496469|58979332|FG000|Overall Study|Protocol Violation|2|||
30941186|NCT01496469|58979333|FG001|Overall Study|Protocol Violation|0|||
30941187|NCT01496469|58979332|FG000|Overall Study|Lost to Follow-up|1|||
30941188|NCT01496469|58979333|FG001|Overall Study|Lost to Follow-up|1|||
30941189|NCT01496469|58979332|FG000|Overall Study|Withdrawal by Subject|4|||
30941190|NCT01496469|58979333|FG001|Overall Study|Withdrawal by Subject|4|||
30941191|NCT01496469|58979332|FG000|Overall Study|BP exceeds protocol limits|1|||
30941192|NCT01496469|58979333|FG001|Overall Study|BP exceeds protocol limits|2|||
30941193|NCT01496469|58979332|FG000|Overall Study|Other|1|||
30941194|NCT01496469|58979333|FG001|Overall Study|Other|1|||
30941195|NCT01471353|58979348|FG000|Overall Study|remain on study|3|||
30941196|NCT01525407|58979354|FG000|Overall Study|Change in recipient treatment plan|2|||
30759294|NCT03595618|58767771|FG002|Overall Study|Protocol Violation|6|||
30759295|NCT03595618|58767772|FG003|Overall Study|Protocol Violation|2|||
30759296|NCT03595618|58767769|FG000|Overall Study|Physician Decision|0|||
30759297|NCT03595618|58767770|FG001|Overall Study|Physician Decision|0|||
30759298|NCT03595618|58767771|FG002|Overall Study|Physician Decision|1|||
30759299|NCT03595618|58767772|FG003|Overall Study|Physician Decision|2|||
30759300|NCT03595618|58767769|FG000|Overall Study|Miscellaneous|7|||
30759301|NCT03595618|58767770|FG001|Overall Study|Miscellaneous|5|||
30759302|NCT03595618|58767771|FG002|Overall Study|Miscellaneous|10|||
30624485|NCT01116882|58636562|FG000|12-month|Withdrawal by Subject|5|||
30941197|NCT01525407|58979355|FG001|Overall Study|Change in recipient treatment plan|2|||
30941198|NCT01525407|58979354|FG000|Overall Study|Withdrawal by Subject|0|||
30624486|NCT01116882|58636563|FG001|12-month|Withdrawal by Subject|8|||
30624487|NCT00953745|58636574|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
30624488|NCT00953745|58636575|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
30624489|NCT00953745|58636574|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
30624490|NCT00953745|58636575|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
30759303|NCT03595618|58767772|FG003|Overall Study|Miscellaneous|6|||
30759304|NCT02954848|58767784|FG000|Overall Study|Randomized but Not Treated|0|||
30759305|NCT02954848|58767785|FG001|Overall Study|Randomized but Not Treated|1|||
30759306|NCT02954848|58767784|FG000|Overall Study|Adverse Event|2|||
30941199|NCT01525407|58979355|FG001|Overall Study|Withdrawal by Subject|1|||
30941200|NCT01525407|58979354|FG000|Overall Study|Transplant was delayed|0|||
30941201|NCT01525407|58979355|FG001|Overall Study|Transplant was delayed|1|||
30624491|NCT00953745|58636574|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
30941202|NCT01525407|58979354|FG000|Overall Study|Delay in Transplant|1|||
30941203|NCT01525407|58979355|FG001|Overall Study|Delay in Transplant|0|||
30941204|NCT01471197|58979363|FG000|Overall Study|Disease Progression|4|||
30759307|NCT02954848|58767785|FG001|Overall Study|Adverse Event|3|||
30759308|NCT02954848|58767784|FG000|Overall Study|Withdrawal by Participant|0|||
30759309|NCT02954848|58767785|FG001|Overall Study|Withdrawal by Participant|1|||
30759310|NCT03642262|58767791|FG000|Period 1|Withdrawal by Subject|1|||
30759311|NCT03642262|58767792|FG001|Period 1|Withdrawal by Subject|1|||
30941205|NCT01471197|58979364|FG001|Overall Study|Disease Progression|2|||
30941206|NCT01471197|58979363|FG000|Overall Study|Death|1|||
30941207|NCT01471197|58979364|FG001|Overall Study|Death|0|||
30941208|NCT01471197|58979363|FG000|Overall Study|Study Drug Toxicity|1|||
30941209|NCT01471197|58979364|FG001|Overall Study|Study Drug Toxicity|0|||
30941210|NCT01524783|58979398|FG000|Blinded Period|Adverse Event|64|||
30941211|NCT01524783|58979399|FG001|Blinded Period|Adverse Event|7|||
30941212|NCT01524783|58979400|FG002|Blinded Period|Adverse Event|0|||
30941213|NCT01524783|58979398|FG000|Blinded Period|Disease Progression|89|||
30941214|NCT01524783|58979399|FG001|Blinded Period|Disease Progression|75|||
30941215|NCT01524783|58979400|FG002|Blinded Period|Disease Progression|0|||
30941216|NCT01524783|58979398|FG000|Blinded Period|Withdrawal by Subject|19|||
30941217|NCT01524783|58979399|FG001|Blinded Period|Withdrawal by Subject|6|||
30941218|NCT01524783|58979400|FG002|Blinded Period|Withdrawal by Subject|0|||
30941219|NCT01524783|58979398|FG000|Blinded Period|Protocol deviation|2|||
30941220|NCT01524783|58979399|FG001|Blinded Period|Protocol deviation|1|||
30941221|NCT01524783|58979400|FG002|Blinded Period|Protocol deviation|0|||
30941222|NCT01524783|58979398|FG000|Blinded Period|Death|5|||
30941223|NCT01524783|58979399|FG001|Blinded Period|Death|2|||
30941224|NCT01524783|58979400|FG002|Blinded Period|Death|0|||
30941225|NCT01524783|58979398|FG000|Open-label Period|Disease progression|13|||
30941226|NCT01524783|58979399|FG001|Open-label Period|Disease progression|0|||
30941227|NCT01524783|58979400|FG002|Open-label Period|Disease progression|2|||
30941228|NCT01524783|58979398|FG000|Open-label Period|Administrative problems|5|||
30941229|NCT01524783|58979399|FG001|Open-label Period|Administrative problems|0|||
30941230|NCT01524783|58979400|FG002|Open-label Period|Administrative problems|2|||
30941231|NCT01524783|58979398|FG000|Open-label Period|Adverse Event|5|||
30941232|NCT01524783|58979399|FG001|Open-label Period|Adverse Event|0|||
30941233|NCT01524783|58979400|FG002|Open-label Period|Adverse Event|1|||
30941234|NCT01524783|58979398|FG000|Open-label Period|Withdrawal by Subject|2|||
30941235|NCT01524783|58979399|FG001|Open-label Period|Withdrawal by Subject|0|||
30941236|NCT01524783|58979400|FG002|Open-label Period|Withdrawal by Subject|1|||
30941237|NCT01524783|58979398|FG000|Open-label Period|Protocol deviation|1|||
30941238|NCT01524783|58979399|FG001|Open-label Period|Protocol deviation|0|||
30941239|NCT01524783|58979400|FG002|Open-label Period|Protocol deviation|0|||
30941240|NCT01494987|58979414|FG000|Overall Study|Adverse Event|6|||
30941241|NCT01494987|58979415|FG001|Overall Study|Adverse Event|5|||
30941242|NCT01494987|58979414|FG000|Overall Study|Hyperglycemia|6|||
30941243|NCT01494987|58979415|FG001|Overall Study|Hyperglycemia|4|||
30941244|NCT01494987|58979414|FG000|Overall Study|Investigator's Discretion|1|||
30759312|NCT03642262|58767791|FG000|Period 1|Adverse Event|0|||
30759313|NCT03642262|58767792|FG001|Period 1|Adverse Event|1|||
30759314|NCT00109707|58767802|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
30759315|NCT00109707|58767803|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
30759316|NCT00109707|58767804|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
30759317|NCT00109707|58767802|FG000|Overall Study|Abnormal laboratory values|1|||
30759318|NCT00109707|58767803|FG001|Overall Study|Abnormal laboratory values|0|||
30759319|NCT00109707|58767804|FG002|Overall Study|Abnormal laboratory values|0|||
30759320|NCT00109707|58767802|FG000|Overall Study|Administrative problems|2|||
30759321|NCT00109707|58767803|FG001|Overall Study|Administrative problems|0|||
30759322|NCT00109707|58767804|FG002|Overall Study|Administrative problems|1|||
30759323|NCT00109707|58767802|FG000|Overall Study|Adverse Event|10|||
30759324|NCT00109707|58767803|FG001|Overall Study|Adverse Event|2|||
30759325|NCT00109707|58767804|FG002|Overall Study|Adverse Event|3|||
30759326|NCT00109707|58767802|FG000|Overall Study|Death|4|||
30759327|NCT00109707|58767803|FG001|Overall Study|Death|0|||
30759328|NCT00109707|58767804|FG002|Overall Study|Death|0|||
30759329|NCT00109707|58767802|FG000|Overall Study|Disease progression|12|||
30759330|NCT00109707|58767803|FG001|Overall Study|Disease progression|4|||
30759331|NCT00109707|58767804|FG002|Overall Study|Disease progression|3|||
30759332|NCT00109707|58767802|FG000|Overall Study|Lost to Follow-up|3|||
30759333|NCT00109707|58767803|FG001|Overall Study|Lost to Follow-up|0|||
30842383|NCT01659736|58868066|FG001|Treatment Period|Protocol Violation|1|||
30842384|NCT01659736|58868065|FG000|Treatment Period|Withdrawal by Subject|1|||
30941245|NCT01494987|58979415|FG001|Overall Study|Investigator's Discretion|2|||
30941246|NCT01494987|58979414|FG000|Overall Study|Lost to Follow-up|1|||
30941247|NCT01494987|58979415|FG001|Overall Study|Lost to Follow-up|1|||
30941248|NCT01494987|58979414|FG000|Overall Study|Protocol Violation|3|||
30941249|NCT01494987|58979415|FG001|Overall Study|Protocol Violation|3|||
30941250|NCT01494987|58979414|FG000|Overall Study|Subject Non-Compliance|9|||
30759334|NCT00109707|58767804|FG002|Overall Study|Lost to Follow-up|0|||
30759335|NCT00109707|58767802|FG000|Overall Study|Protocol Violation|1|||
30759336|NCT00109707|58767803|FG001|Overall Study|Protocol Violation|0|||
30759337|NCT00109707|58767804|FG002|Overall Study|Protocol Violation|0|||
30941251|NCT01494987|58979415|FG001|Overall Study|Subject Non-Compliance|10|||
30941252|NCT01494987|58979414|FG000|Overall Study|Subject Withdrew Consent|2|||
30941253|NCT01494987|58979415|FG001|Overall Study|Subject Withdrew Consent|3|||
30941254|NCT01524627|58979423|FG000|Overall Study|Physician Decision|0|||
30941255|NCT01524627|58979424|FG001|Overall Study|Physician Decision|1|||
30941256|NCT01524627|58979423|FG000|Overall Study|Lost to Follow-up|1|||
30941257|NCT01524627|58979424|FG001|Overall Study|Lost to Follow-up|1|||
30941258|NCT01469637|58979432|FG000|First Intervention|Unacceptable behavior|0|||
30941259|NCT01469637|58979433|FG001|First Intervention|Unacceptable behavior|1|||
30941260|NCT01469637|58979432|FG000|Second Intervention|Incarcerated|1|||
30941261|NCT01469637|58979433|FG001|Second Intervention|Incarcerated|0|||
30941262|NCT04842747|58979853|FG000|Overall Study|Withdrawal by Subject|6|||
30941263|NCT04842747|58979854|FG001|Overall Study|Withdrawal by Subject|2|||
30941264|NCT04842747|58979853|FG000|Overall Study|Lost to Follow-up|1|||
30941265|NCT04842747|58979854|FG001|Overall Study|Lost to Follow-up|2|||
30941266|NCT04842747|58979853|FG000|Overall Study|Physician Decision|1|||
30941267|NCT04842747|58979854|FG001|Overall Study|Physician Decision|0|||
30941268|NCT04842747|58979853|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
30941269|NCT04842747|58979854|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
30941270|NCT04810481|58979862|FG000|Overall Study|Disqualified data sets|10|||
30941271|NCT04810481|58979863|FG001|Overall Study|Disqualified data sets|28|||
30941272|NCT04664400|58979882|FG000|Overall Study|Withdrawal by Subject|2|||
30941273|NCT04657770|58979887|FG000|Overall Study|Withdrawal by Subject|3|||
30941274|NCT04657770|58979887|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
30941275|NCT04496453|58979891|FG000|Overall Study|Lost to Follow-up|6|||
30941276|NCT04482647|58979895|FG000|Overall Study|Time constraints|2|||
30941277|NCT04482647|58979895|FG000|Overall Study|Health issues|1|||
30941278|NCT04482647|58979895|FG000|Overall Study|Death in the family|1|||
30941279|NCT04482647|58979895|FG000|Overall Study|Disliked the intervention|1|||
30941280|NCT04482647|58979895|FG000|Overall Study|No reasons specified|7|||
30941281|NCT04440163|58979907|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
30941282|NCT04440163|58979908|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
30941283|NCT04440163|58979909|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
30941284|NCT04440163|58979910|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
30941285|NCT04440163|58979911|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
30941286|NCT04440163|58979912|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
30941287|NCT04440163|58979913|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
30941288|NCT04440163|58979914|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
30941289|NCT04440163|58979907|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
30941290|NCT04440163|58979908|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
30941291|NCT04440163|58979909|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
30941292|NCT04440163|58979910|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
30941293|NCT04440163|58979911|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
30941294|NCT04440163|58979912|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
30941295|NCT04440163|58979913|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
30941296|NCT04440163|58979914|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
30941297|NCT04440163|58979907|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
30941298|NCT04440163|58979908|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
30941299|NCT04440163|58979909|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
30941300|NCT04440163|58979910|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
30941301|NCT04440163|58979911|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
30759338|NCT00109707|58767802|FG000|Overall Study|Patient withdrew consent|6|||
30759339|NCT00109707|58767803|FG001|Overall Study|Patient withdrew consent|1|||
30759340|NCT00109707|58767804|FG002|Overall Study|Patient withdrew consent|0|||
30759341|NCT00095979|58767816|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
30759342|NCT00082173|58767827|FG000|Overall Study|Withdrawal by Subject|3|||
30759343|NCT00082173|58767828|FG001|Overall Study|Withdrawal by Subject|5|||
30759344|NCT00082173|58767827|FG000|Overall Study|Lost to Follow-up|1|||
30759345|NCT00082173|58767828|FG001|Overall Study|Lost to Follow-up|0|||
30759346|NCT00082173|58767827|FG000|Overall Study|Adverse Event|1|||
30759347|NCT00082173|58767828|FG001|Overall Study|Adverse Event|0|||
30759348|NCT00082173|58767827|FG000|Overall Study|Culture negative or resistant at baselin|5|||
30759349|NCT00082173|58767828|FG001|Overall Study|Culture negative or resistant at baselin|6|||
30759350|NCT00108069|58767836|FG000|Overall Study|Never rec'd study drug|0|||
30759351|NCT00108069|58767837|FG001|Overall Study|Never rec'd study drug|1|||
30759352|NCT00108069|58767836|FG000|Overall Study|Adverse Event|1|||
30759353|NCT00108069|58767837|FG001|Overall Study|Adverse Event|1|||
30759354|NCT00108069|58767836|FG000|Overall Study|Withdrawal by Subject|1|||
30948550|NCT01963403|58994562|FG000|Overall Study|Implant removal|0|||
30759355|NCT00108069|58767837|FG001|Overall Study|Withdrawal by Subject|0|||
30759356|NCT00108069|58767836|FG000|Overall Study|Death|1|||
30941302|NCT04440163|58979912|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
30941303|NCT04440163|58979913|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
30941304|NCT04440163|58979914|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
30941305|NCT04440163|58979907|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
30941306|NCT04440163|58979908|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
30941307|NCT04440163|58979909|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
30941308|NCT04440163|58979910|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
30941309|NCT04440163|58979911|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
30941310|NCT04440163|58979912|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
30941311|NCT04440163|58979913|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
30941312|NCT04440163|58979914|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
30941313|NCT04440163|58979907|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
30941314|NCT04440163|58979908|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
30941315|NCT04440163|58979909|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
30941316|NCT04440163|58979910|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
30941317|NCT04440163|58979911|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
30941318|NCT04440163|58979912|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
30941319|NCT04440163|58979913|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
30941320|NCT04440163|58979914|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
30941321|NCT04440163|58979907|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
30941322|NCT04440163|58979908|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
30941323|NCT04440163|58979909|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
30941324|NCT04440163|58979910|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
30941325|NCT04440163|58979911|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
30941326|NCT04440163|58979912|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
30941327|NCT04440163|58979913|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
30941328|NCT04440163|58979914|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
30941329|NCT04440163|58979907|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
30941330|NCT04440163|58979908|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
30941331|NCT04440163|58979909|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
30941332|NCT04440163|58979910|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
30941333|NCT04440163|58979911|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
30941334|NCT04440163|58979912|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
30941335|NCT04440163|58979913|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
30941336|NCT04440163|58979914|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
30941337|NCT04440163|58979907|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
30941338|NCT04440163|58979908|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
30941339|NCT04440163|58979909|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
30941340|NCT04440163|58979910|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
30941341|NCT04440163|58979911|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
30941342|NCT04440163|58979912|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
30941343|NCT04440163|58979913|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
30941344|NCT04440163|58979914|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
30941345|NCT04440163|58979907|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
30941346|NCT04440163|58979908|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
30941347|NCT04440163|58979909|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
30941348|NCT04440163|58979910|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
30941349|NCT04440163|58979911|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
30941350|NCT04440163|58979912|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
30941351|NCT04440163|58979913|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
30941352|NCT04440163|58979914|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
30941353|NCT04440163|58979907|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
30941354|NCT04440163|58979908|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
30941355|NCT04440163|58979909|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
30941356|NCT04440163|58979910|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
30941357|NCT04440163|58979911|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
30941358|NCT04440163|58979912|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
30941359|NCT04440163|58979913|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
30941360|NCT04440163|58979914|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
30941361|NCT04440163|58979907|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
30948551|NCT01963403|58994563|FG001|Overall Study|Implant removal|1|||
30842385|NCT01659736|58868066|FG001|Treatment Period|Withdrawal by Subject|0|||
30842386|NCT01659736|58868065|FG000|3-month Follow-up|Lost to Follow-up|0|||
30759357|NCT00108069|58767837|FG001|Overall Study|Death|0|||
30941362|NCT04440163|58979908|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
30941363|NCT04440163|58979909|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
30941364|NCT04440163|58979910|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
30941365|NCT04440163|58979911|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
30941366|NCT04440163|58979912|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
30941367|NCT04440163|58979913|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
30941368|NCT04440163|58979914|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
30941369|NCT04440163|58979907|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
30941370|NCT04440163|58979908|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
30941371|NCT04440163|58979909|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
30941372|NCT04440163|58979910|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
30941373|NCT04440163|58979911|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
30941374|NCT04440163|58979912|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
30941375|NCT04440163|58979913|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
30941376|NCT04440163|58979914|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
30941377|NCT04304508|58979945|FG000|Overall Study|Subject Decision|29|||
30941378|NCT04304508|58979946|FG001|Overall Study|Subject Decision|39|||
30941379|NCT04304508|58979947|FG002|Overall Study|Subject Decision|37|||
30941380|NCT04304508|58979948|FG003|Overall Study|Subject Decision|48|||
30941381|NCT04304508|58979945|FG000|Overall Study|Death|6|||
30941382|NCT04304508|58979946|FG001|Overall Study|Death|1|||
30941383|NCT04304508|58979947|FG002|Overall Study|Death|8|||
30941384|NCT04304508|58979948|FG003|Overall Study|Death|5|||
30941385|NCT04304508|58979945|FG000|Overall Study|Non-compliance With Study Drug|3|||
30941386|NCT04304508|58979946|FG001|Overall Study|Non-compliance With Study Drug|1|||
30941387|NCT04304508|58979947|FG002|Overall Study|Non-compliance With Study Drug|2|||
30941388|NCT04304508|58979948|FG003|Overall Study|Non-compliance With Study Drug|0|||
30941389|NCT04304508|58979945|FG000|Overall Study|Switching To Other Therapy|1|||
30941390|NCT04304508|58979946|FG001|Overall Study|Switching To Other Therapy|1|||
30941391|NCT04304508|58979947|FG002|Overall Study|Switching To Other Therapy|1|||
30941392|NCT04304508|58979948|FG003|Overall Study|Switching To Other Therapy|2|||
30941393|NCT04304508|58979945|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
30941394|NCT04304508|58979946|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
30941395|NCT04304508|58979947|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
30941396|NCT04304508|58979948|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
30941397|NCT04304508|58979945|FG000|Overall Study|Withdrawal by Subject|7|||
30941398|NCT04304508|58979946|FG001|Overall Study|Withdrawal by Subject|5|||
30941399|NCT04304508|58979947|FG002|Overall Study|Withdrawal by Subject|11|||
30941400|NCT04304508|58979948|FG003|Overall Study|Withdrawal by Subject|6|||
30941401|NCT04304508|58979945|FG000|Overall Study|Logistical Difficulties|2|||
30941402|NCT04304508|58979946|FG001|Overall Study|Logistical Difficulties|2|||
30941403|NCT04304508|58979947|FG002|Overall Study|Logistical Difficulties|3|||
30941404|NCT04304508|58979948|FG003|Overall Study|Logistical Difficulties|2|||
30941405|NCT04304508|58979945|FG000|Overall Study|Missing Information|1|||
30941406|NCT04304508|58979946|FG001|Overall Study|Missing Information|2|||
30941407|NCT04304508|58979947|FG002|Overall Study|Missing Information|1|||
30941408|NCT04304508|58979948|FG003|Overall Study|Missing Information|3|||
30941409|NCT04304508|58979945|FG000|Overall Study|Other|7|||
30941410|NCT04304508|58979946|FG001|Overall Study|Other|6|||
30941411|NCT04304508|58979947|FG002|Overall Study|Other|5|||
30941412|NCT04304508|58979948|FG003|Overall Study|Other|4|||
30941413|NCT04304508|58979945|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
30941414|NCT04304508|58979946|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
30941415|NCT04304508|58979947|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
30941416|NCT04304508|58979948|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
30941417|NCT04304508|58979945|FG000|Overall Study|Physician Decision|3|||
30941418|NCT04304508|58979946|FG001|Overall Study|Physician Decision|4|||
30941419|NCT04304508|58979947|FG002|Overall Study|Physician Decision|9|||
30941420|NCT04304508|58979948|FG003|Overall Study|Physician Decision|7|||
30941421|NCT04304508|58979945|FG000|Overall Study|Study drug never administered|10|||
30941422|NCT04304508|58979946|FG001|Overall Study|Study drug never administered|4|||
30941423|NCT04304508|58979947|FG002|Overall Study|Study drug never administered|4|||
30941424|NCT04304508|58979948|FG003|Overall Study|Study drug never administered|4|||
30941425|NCT04304508|58979945|FG000|Overall Study|Adverse Event|49|||
30941426|NCT04304508|58979946|FG001|Overall Study|Adverse Event|50|||
30941427|NCT04304508|58979947|FG002|Overall Study|Adverse Event|51|||
30941428|NCT04304508|58979948|FG003|Overall Study|Adverse Event|56|||
30941429|NCT04304508|58979945|FG000|Overall Study|Lost to Follow-up|1|||
30941430|NCT04304508|58979946|FG001|Overall Study|Lost to Follow-up|5|||
30941431|NCT04304508|58979947|FG002|Overall Study|Lost to Follow-up|2|||
30941432|NCT04304508|58979948|FG003|Overall Study|Lost to Follow-up|3|||
30941433|NCT04206332|58979977|FG000|Part A|Lost to Follow-up|0|||
30941434|NCT04206332|58979978|FG001|Part A|Lost to Follow-up|1|||
30941435|NCT04206332|58979979|FG002|Part A|Lost to Follow-up|0|||
30941436|NCT04206332|58979980|FG003|Part A|Lost to Follow-up|0|||
30941437|NCT04206332|58979981|FG004|Part A|Lost to Follow-up|0|||
30941438|NCT04206332|58979982|FG005|Part A|Lost to Follow-up|0|||
30941439|NCT04206332|58979983|FG006|Part A|Lost to Follow-up|0|||
30941440|NCT04206332|58979984|FG007|Part A|Lost to Follow-up|0|||
30941441|NCT04206332|58979985|FG008|Part A|Lost to Follow-up|0|||
30941442|NCT04206332|58979986|FG009|Part A|Lost to Follow-up|0|||
30941443|NCT04206332|58979987|FG010|Part A|Lost to Follow-up|0|||
30941444|NCT04206332|58979988|FG011|Part A|Lost to Follow-up|0|||
30941445|NCT04206332|58979989|FG012|Part A|Lost to Follow-up|0|||
30941446|NCT04206332|58979990|FG013|Part A|Lost to Follow-up|0|||
30941447|NCT04206332|58979991|FG014|Part A|Lost to Follow-up|0|||
30941448|NCT04206332|58979992|FG015|Part A|Lost to Follow-up|0|||
30941449|NCT04206332|58979993|FG016|Part A|Lost to Follow-up|0|||
30941450|NCT04206332|58979977|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941451|NCT04206332|58979978|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941452|NCT04206332|58979979|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941453|NCT04206332|58979980|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941454|NCT04206332|58979981|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941455|NCT04206332|58979982|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
30941456|NCT04206332|58979983|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941457|NCT04206332|58979984|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941458|NCT04206332|58979985|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941459|NCT04206332|58979986|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941460|NCT04206332|58979987|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941461|NCT04206332|58979988|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941462|NCT04206332|58979989|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941463|NCT04206332|58979990|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941464|NCT04206332|58979991|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941465|NCT04206332|58979992|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941466|NCT04206332|58979993|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
30941467|NCT04206332|58979977|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30842387|NCT01659736|58868066|FG001|3-month Follow-up|Lost to Follow-up|1|||
30842388|NCT02997163|58868078|FG000|Overall Study|Adverse Event|1|||
30842389|NCT02997163|58868079|FG001|Overall Study|Adverse Event|0|||
30842390|NCT02997163|58868080|FG002|Overall Study|Adverse Event|0|||
30842391|NCT02997163|58868081|FG003|Overall Study|Adverse Event|1|||
30842392|NCT00458536|58868091|FG000|Overall Study|Disease progression prior to treatment|7|||
30842393|NCT00458536|58868091|FG000|Overall Study|Unable to make vaccine|3|||
30842394|NCT00458536|58868091|FG000|Overall Study|No measurable disease after surgery|2|||
30842395|NCT00458536|58868091|FG000|Overall Study|Did not have renal cell carcinoma|2|||
30842396|NCT00458536|58868091|FG000|Overall Study|Patient did not have surgery|1|||
30842397|NCT00458536|58868091|FG000|Overall Study|Ineligible due to toxicity|1|||
30842398|NCT00458536|58868091|FG000|Overall Study|Withdrawal by Subject|1|||
30842399|NCT00458536|58868091|FG000|Overall Study|Progressive disease during treatment|2|||
30842400|NCT02526550|58868095|FG000|Overall Study|Lost to Follow-up|1|||
30842401|NCT03030989|58868110|FG000|Overall Study|Fever|2|||
30842402|NCT03030989|58868111|FG001|Overall Study|Fever|2|||
30842403|NCT03030989|58868110|FG000|Overall Study|Rash|2|||
30842404|NCT03030989|58868111|FG001|Overall Study|Rash|1|||
30842405|NCT03030989|58868110|FG000|Overall Study|Fatigue/Overwhelmed|1|||
30842406|NCT03030989|58868111|FG001|Overall Study|Fatigue/Overwhelmed|5|||
30842407|NCT03030989|58868110|FG000|Overall Study|Positive Blood Cultures|2|||
30842408|NCT03030989|58868111|FG001|Overall Study|Positive Blood Cultures|1|||
30842409|NCT03030989|58868110|FG000|Overall Study|Line Removed|0|||
30842410|NCT03030989|58868111|FG001|Overall Study|Line Removed|2|||
30842411|NCT03030989|58868110|FG000|Overall Study|No longer interested|5|||
30842412|NCT03030989|58868111|FG001|Overall Study|No longer interested|3|||
30842413|NCT03030599|58868117|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
30941468|NCT04206332|58979978|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941469|NCT04206332|58979979|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30842414|NCT03030599|58868118|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
30842415|NCT03030599|58868119|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
30842416|NCT03030599|58868117|FG000|Open Label Treatment and Titration|Other|1|||
30842417|NCT03030599|58868118|FG001|Open Label Treatment and Titration|Other|0|||
30842418|NCT03030599|58868119|FG002|Open Label Treatment and Titration|Other|0|||
30842419|NCT03030599|58868117|FG000|Open Label Treatment and Titration|Physician Decision|3|||
30941470|NCT04206332|58979980|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941471|NCT04206332|58979981|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941472|NCT04206332|58979982|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941473|NCT04206332|58979983|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941474|NCT04206332|58979984|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
30941475|NCT04206332|58979985|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941476|NCT04206332|58979986|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941477|NCT04206332|58979987|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
30941478|NCT04206332|58979988|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941479|NCT04206332|58979989|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941480|NCT04206332|58979990|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941481|NCT04206332|58979991|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941482|NCT04206332|58979992|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941483|NCT04206332|58979993|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941484|NCT04206332|58979977|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941485|NCT04206332|58979978|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941486|NCT04206332|58979979|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941487|NCT04206332|58979980|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941488|NCT04206332|58979981|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941489|NCT04206332|58979982|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941490|NCT04206332|58979983|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941491|NCT04206332|58979984|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941492|NCT04206332|58979985|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941493|NCT04206332|58979986|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941494|NCT04206332|58979987|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941495|NCT04206332|58979988|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941496|NCT04206332|58979989|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941497|NCT04206332|58979990|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941498|NCT04206332|58979991|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941499|NCT04206332|58979992|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
30941500|NCT04206332|58979993|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
30941501|NCT04206332|58979977|FG000|Part C|Withdrawal by Subject|0|||
30941502|NCT04206332|58979978|FG001|Part C|Withdrawal by Subject|0|||
30941503|NCT04206332|58979979|FG002|Part C|Withdrawal by Subject|0|||
30941504|NCT04206332|58979980|FG003|Part C|Withdrawal by Subject|0|||
30941505|NCT04206332|58979981|FG004|Part C|Withdrawal by Subject|0|||
30941506|NCT04206332|58979982|FG005|Part C|Withdrawal by Subject|0|||
30941507|NCT04206332|58979983|FG006|Part C|Withdrawal by Subject|0|||
30941508|NCT04206332|58979984|FG007|Part C|Withdrawal by Subject|0|||
30941509|NCT04206332|58979985|FG008|Part C|Withdrawal by Subject|0|||
30941510|NCT04206332|58979986|FG009|Part C|Withdrawal by Subject|0|||
30941511|NCT04206332|58979987|FG010|Part C|Withdrawal by Subject|0|||
30941512|NCT04206332|58979988|FG011|Part C|Withdrawal by Subject|0|||
30941513|NCT04206332|58979989|FG012|Part C|Withdrawal by Subject|0|||
30941514|NCT04206332|58979990|FG013|Part C|Withdrawal by Subject|0|||
30941515|NCT04206332|58979991|FG014|Part C|Withdrawal by Subject|2|||
30941516|NCT04206332|58979992|FG015|Part C|Withdrawal by Subject|0|||
30941517|NCT04206332|58979993|FG016|Part C|Withdrawal by Subject|0|||
30941518|NCT03790111|58980076|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
30941519|NCT03780543|58980083|FG000|Overall Study|Adverse Event|1|||
30941520|NCT03780543|58980084|FG001|Overall Study|Adverse Event|0|||
30941521|NCT03780543|58980085|FG002|Overall Study|Adverse Event|2|||
30941522|NCT03780543|58980083|FG000|Overall Study|Lost to Follow-up|2|||
30941523|NCT03780543|58980084|FG001|Overall Study|Lost to Follow-up|0|||
30941524|NCT03780543|58980085|FG002|Overall Study|Lost to Follow-up|1|||
30941525|NCT03780543|58980083|FG000|Overall Study|Study terminated by Sponsor|8|||
30941526|NCT03780543|58980084|FG001|Overall Study|Study terminated by Sponsor|7|||
30941527|NCT03780543|58980085|FG002|Overall Study|Study terminated by Sponsor|13|||
30941528|NCT03780543|58980083|FG000|Overall Study|Withdrawal by Subject|1|||
30941529|NCT03780543|58980084|FG001|Overall Study|Withdrawal by Subject|8|||
30941530|NCT03780543|58980085|FG002|Overall Study|Withdrawal by Subject|1|||
30941531|NCT03780543|58980083|FG000|Overall Study|Noncompliance with study drug|1|||
30941532|NCT03780543|58980084|FG001|Overall Study|Noncompliance with study drug|0|||
30941533|NCT03780543|58980085|FG002|Overall Study|Noncompliance with study drug|0|||
30941534|NCT03745820|58980098|FG000|Overall Study|Adverse Event|0|||
30941535|NCT03745820|58980099|FG001|Overall Study|Adverse Event|3|||
30941536|NCT03745820|58980100|FG002|Overall Study|Adverse Event|2|||
30941537|NCT03745820|58980098|FG000|Overall Study|Non-Compliance with Study Drug|4|||
30941538|NCT03745820|58980099|FG001|Overall Study|Non-Compliance with Study Drug|3|||
30941539|NCT03745820|58980100|FG002|Overall Study|Non-Compliance with Study Drug|0|||
30941540|NCT03745820|58980098|FG000|Overall Study|Withdrawal by Subject|4|||
30941541|NCT03745820|58980099|FG001|Overall Study|Withdrawal by Subject|4|||
30941542|NCT03745820|58980100|FG002|Overall Study|Withdrawal by Subject|4|||
30941543|NCT03745820|58980098|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
30941544|NCT03745820|58980099|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
30941545|NCT03745820|58980100|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
30941546|NCT03745820|58980098|FG000|Overall Study|Lost to Follow-up|2|||
30941547|NCT03745820|58980099|FG001|Overall Study|Lost to Follow-up|0|||
30941548|NCT03745820|58980100|FG002|Overall Study|Lost to Follow-up|3|||
30941549|NCT03745820|58980098|FG000|Overall Study|Reason not Specified|2|||
30941550|NCT03745820|58980099|FG001|Overall Study|Reason not Specified|4|||
30941551|NCT03745820|58980100|FG002|Overall Study|Reason not Specified|1|||
30941552|NCT03699631|58980108|FG000|Overall Study|Adverse Event|3|||
30941553|NCT03686150|58980122|FG000|Overall Study|Withdrawal by Subject|1|||
30941554|NCT03686150|58980123|FG001|Overall Study|Withdrawal by Subject|1|||
30941555|NCT03686150|58980124|FG002|Overall Study|Withdrawal by Subject|1|||
30941556|NCT03686150|58980125|FG003|Overall Study|Withdrawal by Subject|0|||
30941557|NCT03686150|58980126|FG004|Overall Study|Withdrawal by Subject|1|||
30941558|NCT03686150|58980127|FG005|Overall Study|Withdrawal by Subject|2|||
30941559|NCT03686150|58980122|FG000|Overall Study|Physician Decision|1|||
30941560|NCT03686150|58980123|FG001|Overall Study|Physician Decision|0|||
30941561|NCT03686150|58980124|FG002|Overall Study|Physician Decision|0|||
30941562|NCT03686150|58980125|FG003|Overall Study|Physician Decision|0|||
30941563|NCT03686150|58980126|FG004|Overall Study|Physician Decision|0|||
30941564|NCT03686150|58980127|FG005|Overall Study|Physician Decision|1|||
30941565|NCT03686150|58980122|FG000|Overall Study|Lost to Follow-up|0|||
30941566|NCT03686150|58980123|FG001|Overall Study|Lost to Follow-up|1|||
30941567|NCT03686150|58980124|FG002|Overall Study|Lost to Follow-up|0|||
30941568|NCT03686150|58980125|FG003|Overall Study|Lost to Follow-up|0|||
30941569|NCT03686150|58980126|FG004|Overall Study|Lost to Follow-up|0|||
30941570|NCT03686150|58980127|FG005|Overall Study|Lost to Follow-up|0|||
30941571|NCT03604172|58980144|FG000|Overall Study|Lost to Follow-up|1|||
30941572|NCT03604172|58980145|FG001|Overall Study|Lost to Follow-up|2|||
30941573|NCT03530124|58980153|FG000|Overall Study|Withdrawal by Subject|0|||
30941574|NCT03530124|58980154|FG001|Overall Study|Withdrawal by Subject|1|||
30941575|NCT03530124|58980153|FG000|Overall Study|Protocol Violation|1|||
30941576|NCT03530124|58980154|FG001|Overall Study|Protocol Violation|0|||
30941577|NCT03530124|58980153|FG000|Overall Study|Discharged prior to study completion|1|||
30941578|NCT03530124|58980154|FG001|Overall Study|Discharged prior to study completion|0|||
30941579|NCT03496207|58980163|FG000|Base Study|Adverse Event|0|||
30941580|NCT03496207|58980164|FG001|Base Study|Adverse Event|0|||
30941581|NCT03496207|58980165|FG002|Base Study|Adverse Event|1|||
30941582|NCT03496207|58980166|FG003|Base Study|Adverse Event|1|||
30941583|NCT03496207|58980167|FG004|Base Study|Adverse Event|4|||
30941584|NCT03496207|58980163|FG000|Base Study|Death|0|||
30941585|NCT03496207|58980164|FG001|Base Study|Death|0|||
30941586|NCT03496207|58980165|FG002|Base Study|Death|0|||
30941587|NCT03496207|58980166|FG003|Base Study|Death|0|||
30842420|NCT03030599|58868118|FG001|Open Label Treatment and Titration|Physician Decision|0|||
30941588|NCT03496207|58980167|FG004|Base Study|Death|1|||
30941589|NCT03496207|58980163|FG000|Base Study|Withdrawal by Subject|0|||
30941590|NCT03496207|58980164|FG001|Base Study|Withdrawal by Subject|0|||
30941591|NCT03496207|58980165|FG002|Base Study|Withdrawal by Subject|1|||
30941592|NCT03496207|58980166|FG003|Base Study|Withdrawal by Subject|0|||
30941593|NCT03496207|58980167|FG004|Base Study|Withdrawal by Subject|1|||
30941594|NCT03496207|58980163|FG000|Extension Period|Adverse Event|0|||
30941595|NCT03496207|58980164|FG001|Extension Period|Adverse Event|0|||
30941596|NCT03496207|58980165|FG002|Extension Period|Adverse Event|0|||
30941597|NCT03496207|58980166|FG003|Extension Period|Adverse Event|1|||
30941598|NCT03496207|58980167|FG004|Extension Period|Adverse Event|1|||
30941599|NCT03496207|58980163|FG000|Extension Period|Death|1|||
30941600|NCT03496207|58980164|FG001|Extension Period|Death|0|||
30941601|NCT03496207|58980165|FG002|Extension Period|Death|0|||
30941602|NCT03496207|58980166|FG003|Extension Period|Death|1|||
30941603|NCT03496207|58980167|FG004|Extension Period|Death|2|||
30941604|NCT03496207|58980163|FG000|Extension Period|Withdrawal by Subject|1|||
30941605|NCT03496207|58980164|FG001|Extension Period|Withdrawal by Subject|0|||
30941606|NCT03496207|58980165|FG002|Extension Period|Withdrawal by Subject|0|||
30941607|NCT03496207|58980166|FG003|Extension Period|Withdrawal by Subject|1|||
30941608|NCT03496207|58980167|FG004|Extension Period|Withdrawal by Subject|1|||
30941609|NCT03496207|58980163|FG000|Extension Period|Elevated hemoglobin levels|0|||
30941610|NCT03496207|58980164|FG001|Extension Period|Elevated hemoglobin levels|0|||
30941611|NCT03496207|58980165|FG002|Extension Period|Elevated hemoglobin levels|0|||
30941612|NCT03496207|58980166|FG003|Extension Period|Elevated hemoglobin levels|0|||
30941613|NCT03496207|58980167|FG004|Extension Period|Elevated hemoglobin levels|1|||
30941614|NCT03204188|58980197|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
30941615|NCT03204188|58980197|FG000|Immunotherapy Phase (1 Year)|Death|1|||
30941616|NCT03204188|58980197|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
30941617|NCT03204188|58980197|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
30941618|NCT03112590|58980204|FG000|Overall Study|Adverse Event|0|||
30941619|NCT03112590|58980205|FG001|Overall Study|Adverse Event|1|||
30941620|NCT03112590|58980206|FG002|Overall Study|Adverse Event|0|||
30941621|NCT03060629|58980216|FG000|Overall Study|Death|4|||
30941622|NCT03060629|58980217|FG001|Overall Study|Death|5|||
30941623|NCT03060629|58980216|FG000|Overall Study|Withdrawal by Subject|50|||
30941624|NCT03060629|58980217|FG001|Overall Study|Withdrawal by Subject|35|||
30941625|NCT03060629|58980216|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
30941626|NCT03060629|58980217|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
30941627|NCT03060629|58980216|FG000|Overall Study|Participant Relocate|15|||
30941628|NCT03060629|58980217|FG001|Overall Study|Participant Relocate|15|||
30941629|NCT03060629|58980216|FG000|Overall Study|Unable to Contact Participant|34|||
30941630|NCT03060629|58980217|FG001|Overall Study|Unable to Contact Participant|23|||
30941631|NCT03060629|58980216|FG000|Overall Study|Investigator Decision|7|||
30941632|NCT03060629|58980217|FG001|Overall Study|Investigator Decision|7|||
30941633|NCT03060629|58980216|FG000|Overall Study|Study Terminated by Sponsor|1100|||
30941634|NCT03060629|58980217|FG001|Overall Study|Study Terminated by Sponsor|1123|||
30941635|NCT03060629|58980216|FG000|Overall Study|Other|4|||
30941636|NCT03060629|58980217|FG001|Overall Study|Other|4|||
30941637|NCT03021486|58980226|FG000|Overall Study|Withdrawal by Subject|1|||
30941638|NCT03021486|58980227|FG001|Overall Study|Withdrawal by Subject|1|||
30941639|NCT03021486|58980228|FG002|Overall Study|Withdrawal by Subject|3|||
30941640|NCT03021486|58980226|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
30941641|NCT03021486|58980227|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
30941642|NCT03021486|58980228|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
30941643|NCT02999789|58980240|FG000|Overall Study|Withdrawal by Subject|0|||
30941644|NCT02999789|58980241|FG001|Overall Study|Withdrawal by Subject|1|||
30941645|NCT02999789|58980240|FG000|Overall Study|Became ineligible|1|||
30941646|NCT02999789|58980241|FG001|Overall Study|Became ineligible|2|||
30941647|NCT02949128|58980248|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2|||
30941648|NCT02949128|58980248|FG000|Initial Evaluation Period|Adverse Event|3|||
30941649|NCT02949128|58980248|FG000|Initial Evaluation Period|Death|2|||
30941650|NCT02949128|58980248|FG000|Initial Evaluation Period|Physician Decision|1|||
30941651|NCT02949128|58980248|FG000|Initial Evaluation Period|Protocol Violation|1|||
30941652|NCT02949128|58980248|FG000|Extension Period|Withdrawal by Subject|5|||
30941653|NCT02949128|58980248|FG000|Extension Period|Protocol Violation|1|||
30941654|NCT02949128|58980248|FG000|Extension Period|Physician Decision|2|||
30941655|NCT02949128|58980248|FG000|Extension Period|Ongoing in Extension Period as of 07/02/2019|41|||
30941656|NCT02923115|58980267|FG000|Overall Study|Lost to Follow-up|0|||
30941657|NCT02923115|58980268|FG001|Overall Study|Lost to Follow-up|0|||
30941658|NCT02923115|58980269|FG002|Overall Study|Lost to Follow-up|0|||
30941659|NCT02923115|58980270|FG003|Overall Study|Lost to Follow-up|1|||
30941660|NCT02923115|58980271|FG004|Overall Study|Lost to Follow-up|0|||
30941661|NCT02923115|58980272|FG005|Overall Study|Lost to Follow-up|0|||
30941662|NCT02923115|58980267|FG000|Overall Study|Withdrawal by Subject|0|||
30941663|NCT02923115|58980268|FG001|Overall Study|Withdrawal by Subject|1|||
30941664|NCT02923115|58980269|FG002|Overall Study|Withdrawal by Subject|0|||
30941665|NCT02923115|58980270|FG003|Overall Study|Withdrawal by Subject|0|||
30941666|NCT02923115|58980271|FG004|Overall Study|Withdrawal by Subject|0|||
30941667|NCT02923115|58980272|FG005|Overall Study|Withdrawal by Subject|0|||
30941668|NCT02923115|58980267|FG000|Overall Study|Randomized, but not dosed|0|||
30941669|NCT02923115|58980268|FG001|Overall Study|Randomized, but not dosed|0|||
30941670|NCT02923115|58980269|FG002|Overall Study|Randomized, but not dosed|3|||
30941671|NCT02923115|58980270|FG003|Overall Study|Randomized, but not dosed|1|||
30941672|NCT02923115|58980271|FG004|Overall Study|Randomized, but not dosed|5|||
30941673|NCT02923115|58980272|FG005|Overall Study|Randomized, but not dosed|0|||
30941674|NCT02910583|58980288|FG000|Overall Study|Withdrawal by Subject|6|||
30941675|NCT02910583|58980289|FG001|Overall Study|Withdrawal by Subject|7|||
30941676|NCT02910583|58980288|FG000|Overall Study|Other, Not Specified|1|||
30941677|NCT02910583|58980289|FG001|Overall Study|Other, Not Specified|0|||
30941678|NCT02779855|58980326|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
30941679|NCT02779855|58980327|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
30941680|NCT02779855|58980328|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
30941681|NCT02487394|58980348|FG000|Phase 1|Withdrawal by Subject|0|||
30941682|NCT02487394|58980349|FG001|Phase 1|Withdrawal by Subject|1|||
30941683|NCT02063724|58980368|FG000|Overall Study|Disease progression|1|||
30941684|NCT02029846|58980374|FG000|Overall Study|n=1 each arm|1|||
30941685|NCT02029846|58980375|FG001|Overall Study|n=1 each arm|1|||
30941686|NCT05419908|58980383|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
30941687|NCT05419908|58980384|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
30941688|NCT05419908|58980383|FG000|Overall Study|Serious Adverse Event|0|||
30941689|NCT05419908|58980384|FG001|Overall Study|Serious Adverse Event|2|||
30941690|NCT05419908|58980383|FG000|Overall Study|Withdrawal by Subject|2|||
30941691|NCT05419908|58980384|FG001|Overall Study|Withdrawal by Subject|0|||
30941692|NCT05419908|58980383|FG000|Overall Study|Miscellaneous|1|||
30941693|NCT05419908|58980384|FG001|Overall Study|Miscellaneous|1|||
30941694|NCT05091060|58980390|FG000|Overall Study|Lost to Follow-up|1|||
30941695|NCT05056311|58980394|FG000|Overall Study|Lost to Follow-up|14|||
30941696|NCT05056311|58980394|FG000|Overall Study|Withdrawal by Subject|1|||
30941697|NCT05056311|58980394|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
30941698|NCT04806503|58980432|FG000|Overall Study|Lost to Follow-up|0|||
30941699|NCT04806503|58980433|FG001|Overall Study|Lost to Follow-up|0|||
30941700|NCT04806503|58980434|FG002|Overall Study|Lost to Follow-up|1|||
30941701|NCT04806503|58980435|FG003|Overall Study|Lost to Follow-up|0|||
30941702|NCT04806503|58980436|FG004|Overall Study|Lost to Follow-up|0|||
30941703|NCT04806503|58980432|FG000|Overall Study|Withdrawal by Subject|1|||
30941704|NCT04806503|58980433|FG001|Overall Study|Withdrawal by Subject|0|||
30941705|NCT04806503|58980434|FG002|Overall Study|Withdrawal by Subject|1|||
30941706|NCT04806503|58980435|FG003|Overall Study|Withdrawal by Subject|1|||
30941707|NCT04806503|58980436|FG004|Overall Study|Withdrawal by Subject|1|||
30941708|NCT04806503|58980432|FG000|Overall Study|Adverse Event|1|||
30941709|NCT04806503|58980433|FG001|Overall Study|Adverse Event|1|||
30941710|NCT04806503|58980434|FG002|Overall Study|Adverse Event|0|||
30941711|NCT04806503|58980435|FG003|Overall Study|Adverse Event|1|||
30941712|NCT04806503|58980436|FG004|Overall Study|Adverse Event|0|||
30941713|NCT04508751|58980452|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
30941714|NCT04508751|58980453|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
30941715|NCT04508751|58980454|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
30941716|NCT04473482|58980464|FG000|Overall Study|Death|0|||
30941717|NCT04473482|58980465|FG001|Overall Study|Death|3|||
30941718|NCT04473482|58980464|FG000|Overall Study|Lost to Follow-up|9|||
30941719|NCT04473482|58980465|FG001|Overall Study|Lost to Follow-up|7|||
30941720|NCT04473482|58980464|FG000|Overall Study|Withdrawal by Subject|2|||
30941721|NCT04473482|58980465|FG001|Overall Study|Withdrawal by Subject|1|||
30941722|NCT04439318|58980472|FG000|Overall Study|Ineligible|1|||
30941723|NCT04439318|58980472|FG000|Overall Study|Never Started Treatment|3|||
30941724|NCT04439318|58980472|FG000|Overall Study|Adverse Event|10|||
30941725|NCT04439318|58980472|FG000|Overall Study|Death|2|||
30941726|NCT04439318|58980472|FG000|Overall Study|Disease Progression|25|||
30941727|NCT04439318|58980472|FG000|Overall Study|Other Complicating Disease|2|||
30941728|NCT04439318|58980472|FG000|Overall Study|Withdrawal by Subject|4|||
30941729|NCT04439318|58980472|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
30941730|NCT04439318|58980472|FG000|Overall Study|Non-Compliance|1|||
30941731|NCT04439318|58980472|FG000|Overall Study|Still on Treatment|1|||
30941732|NCT03919799|58980479|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
30941733|NCT03919799|58980480|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
30941734|NCT03919799|58980481|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
30941735|NCT03919799|58980482|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
30941736|NCT03919799|58980483|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
30941737|NCT03919799|58980479|FG000|DB Period (28 Weeks)|Adverse Event|1|||
30941738|NCT03919799|58980480|FG001|DB Period (28 Weeks)|Adverse Event|1|||
30941739|NCT03919799|58980481|FG002|DB Period (28 Weeks)|Adverse Event|1|||
30941740|NCT03919799|58980482|FG003|DB Period (28 Weeks)|Adverse Event|0|||
30941741|NCT03919799|58980483|FG004|DB Period (28 Weeks)|Adverse Event|0|||
30941742|NCT03919799|58980479|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
30941743|NCT03919799|58980480|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
30941744|NCT03919799|58980481|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
30941745|NCT03919799|58980482|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
30941746|NCT03919799|58980483|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
30941747|NCT03919799|58980479|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
30941748|NCT03919799|58980480|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
30941749|NCT03919799|58980481|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
30941750|NCT03919799|58980482|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
30941751|NCT03919799|58980483|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
30941752|NCT03919799|58980479|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
30941753|NCT03919799|58980480|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
30941754|NCT03919799|58980481|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
30941755|NCT03919799|58980482|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
30941756|NCT03919799|58980483|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
30941757|NCT03621735|58980528|FG000|Overall Study|Withdrawal by Subject|13|||
30941758|NCT03621735|58980529|FG001|Overall Study|Withdrawal by Subject|13|||
30941759|NCT03547908|58980553|FG000|Overall Study|Still On Study|115|||
30941760|NCT03547908|58980554|FG001|Overall Study|Still On Study|118|||
30941761|NCT03547908|58980553|FG000|Overall Study|Lost to Follow-up|2|||
30941762|NCT03547908|58980554|FG001|Overall Study|Lost to Follow-up|2|||
30941763|NCT03547908|58980553|FG000|Overall Study|Withdrew Consent|2|||
30941764|NCT03547908|58980554|FG001|Overall Study|Withdrew Consent|1|||
30941765|NCT03547908|58980553|FG000|Overall Study|Adverse Event|1|||
30941766|NCT03547908|58980554|FG001|Overall Study|Adverse Event|0|||
30941767|NCT03547908|58980553|FG000|Overall Study|Death|1|||
30941768|NCT03547908|58980554|FG001|Overall Study|Death|0|||
30941769|NCT03547908|58980553|FG000|Overall Study|Investigator's Discretion|0|||
30941770|NCT03547908|58980554|FG001|Overall Study|Investigator's Discretion|1|||
30941771|NCT03547908|58980553|FG000|Overall Study|Randomized But Never Treated|1|||
30941772|NCT03547908|58980554|FG001|Overall Study|Randomized But Never Treated|0|||
30941773|NCT03462719|58980577|FG000|Overall Study|Withdrawal by Subject|4|||
30941774|NCT03462719|58980578|FG001|Overall Study|Withdrawal by Subject|3|||
30941775|NCT03462719|58980577|FG000|Overall Study|Ongoing|87|||
30941776|NCT03462719|58980578|FG001|Overall Study|Ongoing|72|||
30941777|NCT03245151|58980607|FG000|Overall Study|Withdrawal by Subject|2|||
30941778|NCT03245151|58980608|FG001|Overall Study|Withdrawal by Subject|0|||
30941779|NCT03245151|58980609|FG002|Overall Study|Withdrawal by Subject|0|||
30941780|NCT03245151|58980610|FG003|Overall Study|Withdrawal by Subject|2|||
30941781|NCT03245151|58980611|FG004|Overall Study|Withdrawal by Subject|1|||
30941782|NCT03245151|58980607|FG000|Overall Study|Death|3|||
30941783|NCT03245151|58980608|FG001|Overall Study|Death|14|||
30941784|NCT03245151|58980609|FG002|Overall Study|Death|9|||
30941785|NCT03245151|58980610|FG003|Overall Study|Death|16|||
30941786|NCT03245151|58980611|FG004|Overall Study|Death|7|||
30941787|NCT03245151|58980607|FG000|Overall Study|Sponsor's decision|0|||
30941788|NCT03245151|58980608|FG001|Overall Study|Sponsor's decision|1|||
30941789|NCT03245151|58980609|FG002|Overall Study|Sponsor's decision|0|||
30941790|NCT03245151|58980610|FG003|Overall Study|Sponsor's decision|0|||
30941791|NCT03245151|58980611|FG004|Overall Study|Sponsor's decision|0|||
30941792|NCT03075527|58980628|FG000|Overall Study|Ongoing treatment|2|||
30941793|NCT02421939|58980652|FG000|Overall Study|Progressive disease|70|||
30941794|NCT02421939|58980653|FG001|Overall Study|Progressive disease|16|||
30941795|NCT02421939|58980652|FG000|Overall Study|Lack of Efficacy|21|||
30941796|NCT02421939|58980653|FG001|Overall Study|Lack of Efficacy|31|||
30941797|NCT02421939|58980652|FG000|Overall Study|Death|36|||
30941798|NCT02421939|58980653|FG001|Overall Study|Death|10|||
30941799|NCT02421939|58980652|FG000|Overall Study|Disease relapse|33|||
30941800|NCT02421939|58980653|FG001|Overall Study|Disease relapse|2|||
30941801|NCT02421939|58980652|FG000|Overall Study|Adverse Event|28|||
30941802|NCT02421939|58980653|FG001|Overall Study|Adverse Event|5|||
30941803|NCT02421939|58980652|FG000|Overall Study|Withdrawal by Subject|5|||
30941804|NCT02421939|58980653|FG001|Overall Study|Withdrawal by Subject|24|||
30941805|NCT02421939|58980652|FG000|Overall Study|Physician Decision|11|||
30941806|NCT02421939|58980653|FG001|Overall Study|Physician Decision|11|||
30941807|NCT02421939|58980652|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
30941808|NCT02421939|58980653|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
30941809|NCT02421939|58980652|FG000|Overall Study|Miscellaneous|4|||
30941810|NCT02421939|58980653|FG001|Overall Study|Miscellaneous|5|||
30941811|NCT02421939|58980652|FG000|Overall Study|Protocol deviation|1|||
30941812|NCT02421939|58980653|FG001|Overall Study|Protocol deviation|1|||
30941813|NCT02227199|58980662|FG000|Overall Study|Physician Decision|0|||
30941814|NCT02227199|58980663|FG001|Overall Study|Physician Decision|0|||
30941815|NCT02227199|58980664|FG002|Overall Study|Physician Decision|1|||
30941816|NCT02227199|58980662|FG000|Overall Study|Adverse Event|0|||
30941817|NCT02227199|58980663|FG001|Overall Study|Adverse Event|0|||
30941818|NCT02227199|58980664|FG002|Overall Study|Adverse Event|3|||
30941819|NCT02087865|58980679|FG000|Overall Study|Withdrawal by Subject|6|||
30941820|NCT02087865|58980680|FG001|Overall Study|Withdrawal by Subject|0|||
30941821|NCT02087865|58980681|FG002|Overall Study|Withdrawal by Subject|1|||
30941822|NCT02087865|58980679|FG000|Overall Study|Lost to Follow-up|0|||
30941823|NCT02087865|58980680|FG001|Overall Study|Lost to Follow-up|0|||
30941824|NCT02087865|58980681|FG002|Overall Study|Lost to Follow-up|1|||
30941825|NCT02087865|58980679|FG000|Overall Study|Drug Non-compliance|0|||
30941826|NCT02087865|58980680|FG001|Overall Study|Drug Non-compliance|2|||
30941827|NCT02087865|58980681|FG002|Overall Study|Drug Non-compliance|0|||
30941828|NCT02087865|58980679|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
30941829|NCT02087865|58980680|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
30941830|NCT02087865|58980681|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
30941831|NCT01682083|58980701|FG000|Overall Study|Lost to Follow-up|11|||
30941832|NCT01682083|58980702|FG001|Overall Study|Lost to Follow-up|18|||
30941833|NCT01682083|58980701|FG000|Overall Study|Withdrawal by Subject|31|||
30941834|NCT01682083|58980702|FG001|Overall Study|Withdrawal by Subject|40|||
30941835|NCT01682083|58980701|FG000|Overall Study|Death|60|||
30941836|NCT01682083|58980702|FG001|Overall Study|Death|93|||
30941837|NCT01682083|58980701|FG000|Overall Study|Physician Decision|5|||
30941838|NCT01682083|58980702|FG001|Overall Study|Physician Decision|4|||
30941839|NCT01180790|58980719|FG000|Overall Study|Adverse Event|1|||
30941840|NCT01180790|58980720|FG001|Overall Study|Adverse Event|1|||
30941841|NCT01180790|58980721|FG002|Overall Study|Adverse Event|2|||
30941842|NCT01180790|58980722|FG003|Overall Study|Adverse Event|0|||
30941843|NCT01180790|58980723|FG004|Overall Study|Adverse Event|1|||
30941844|NCT01180790|58980724|FG005|Overall Study|Adverse Event|3|||
30941845|NCT01180790|58980725|FG006|Overall Study|Adverse Event|0|||
30941846|NCT01180790|58980719|FG000|Overall Study|Withdrawal by Subject|3|||
30941847|NCT01180790|58980720|FG001|Overall Study|Withdrawal by Subject|0|||
30941848|NCT01180790|58980721|FG002|Overall Study|Withdrawal by Subject|5|||
30941849|NCT01180790|58980722|FG003|Overall Study|Withdrawal by Subject|0|||
30941850|NCT01180790|58980723|FG004|Overall Study|Withdrawal by Subject|2|||
30941851|NCT01180790|58980724|FG005|Overall Study|Withdrawal by Subject|1|||
30941852|NCT01180790|58980725|FG006|Overall Study|Withdrawal by Subject|0|||
30941853|NCT01180790|58980719|FG000|Overall Study|Lost to Follow-up|3|||
30941854|NCT01180790|58980720|FG001|Overall Study|Lost to Follow-up|1|||
30941855|NCT01180790|58980721|FG002|Overall Study|Lost to Follow-up|0|||
30941856|NCT01180790|58980722|FG003|Overall Study|Lost to Follow-up|2|||
30941857|NCT01180790|58980723|FG004|Overall Study|Lost to Follow-up|1|||
30941858|NCT01180790|58980724|FG005|Overall Study|Lost to Follow-up|0|||
30941859|NCT01180790|58980725|FG006|Overall Study|Lost to Follow-up|1|||
30941860|NCT01180790|58980719|FG000|Overall Study|Physician Decision|1|||
30941861|NCT01180790|58980720|FG001|Overall Study|Physician Decision|0|||
30941862|NCT01180790|58980721|FG002|Overall Study|Physician Decision|0|||
30941863|NCT01180790|58980722|FG003|Overall Study|Physician Decision|1|||
30941864|NCT01180790|58980723|FG004|Overall Study|Physician Decision|0|||
30941865|NCT01180790|58980724|FG005|Overall Study|Physician Decision|0|||
30941866|NCT01180790|58980725|FG006|Overall Study|Physician Decision|0|||
30941867|NCT01180790|58980719|FG000|Overall Study|Lack of Efficacy|1|||
30941868|NCT01180790|58980720|FG001|Overall Study|Lack of Efficacy|2|||
30941869|NCT01180790|58980721|FG002|Overall Study|Lack of Efficacy|5|||
30941870|NCT01180790|58980722|FG003|Overall Study|Lack of Efficacy|6|||
30941871|NCT01180790|58980723|FG004|Overall Study|Lack of Efficacy|1|||
30941872|NCT01180790|58980724|FG005|Overall Study|Lack of Efficacy|3|||
30941873|NCT01180790|58980725|FG006|Overall Study|Lack of Efficacy|0|||
30941874|NCT01180790|58980719|FG000|Overall Study|compliance|0|||
30941875|NCT01180790|58980720|FG001|Overall Study|compliance|1|||
30941876|NCT01180790|58980721|FG002|Overall Study|compliance|0|||
30941877|NCT01180790|58980722|FG003|Overall Study|compliance|0|||
30941878|NCT01180790|58980723|FG004|Overall Study|compliance|0|||
30941879|NCT01180790|58980724|FG005|Overall Study|compliance|0|||
30941880|NCT01180790|58980725|FG006|Overall Study|compliance|0|||
30941881|NCT01180790|58980719|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
30941882|NCT01180790|58980720|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
30941883|NCT01180790|58980721|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
30941884|NCT01180790|58980722|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
30941885|NCT01180790|58980723|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
30941886|NCT01180790|58980724|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
30941887|NCT01180790|58980725|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
30941888|NCT01112306|58980770|FG000|Overall Study|Death|175|||
30941889|NCT01112306|58980770|FG000|Overall Study|Lost to Follow-up|9|||
30941890|NCT01112306|58980770|FG000|Overall Study|Withdrawal by Subject|31|||
30941891|NCT01112306|58980770|FG000|Overall Study|Other|70|||
30941892|NCT00679042|58980778|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
30941893|NCT00679042|58980778|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
30759358|NCT00108069|58767836|FG000|Overall Study|Progessive disease|27|||
30941894|NCT00679042|58980778|FG000|5-Year Follow Up|Death|1|||
30941895|NCT00679042|58980778|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
30941896|NCT00679042|58980778|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
30941897|NCT00569127|58980808|FG000|Overall Study|Adverse Event|57|||
30941898|NCT00569127|58980809|FG001|Overall Study|Adverse Event|47|||
30941899|NCT00569127|58980808|FG000|Overall Study|Withdrawal by Subject|13|||
30941900|NCT00569127|58980809|FG001|Overall Study|Withdrawal by Subject|27|||
30941901|NCT00569127|58980808|FG000|Overall Study|Progression|99|||
30941902|NCT00569127|58980809|FG001|Overall Study|Progression|100|||
30941903|NCT00569127|58980808|FG000|Overall Study|Death|4|||
30941904|NCT00569127|58980809|FG001|Overall Study|Death|3|||
30941905|NCT00569127|58980808|FG000|Overall Study|Other|20|||
30941906|NCT00569127|58980809|FG001|Overall Study|Other|19|||
30941907|NCT00569127|58980808|FG000|Overall Study|Lost to Follow-up|0|||
30941908|NCT00569127|58980809|FG001|Overall Study|Lost to Follow-up|3|||
30941909|NCT00569127|58980808|FG000|Overall Study|Not Eligible|14|||
30941910|NCT00569127|58980809|FG001|Overall Study|Not Eligible|11|||
30941911|NCT00569127|58980808|FG000|Overall Study|Still on Treatment|7|||
30941912|NCT00569127|58980809|FG001|Overall Study|Still on Treatment|3|||
30941913|NCT00350272|58980817|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
30941914|NCT00350272|58980818|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
30941915|NCT00350272|58980817|FG000|Blinded 12-Week Treatment|Death|1|||
30941916|NCT00350272|58980818|FG001|Blinded 12-Week Treatment|Death|0|||
30941917|NCT00350272|58980817|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
30941918|NCT00350272|58980818|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
30941919|NCT00350272|58980817|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
30941920|NCT00350272|58980818|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
30941921|NCT00350272|58980817|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
30941922|NCT00350272|58980818|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
30941923|NCT00350272|58980817|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
30941924|NCT00350272|58980818|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
30941925|NCT00350272|58980817|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
30941926|NCT00350272|58980818|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
30941927|NCT00350272|58980817|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
30941928|NCT00350272|58980818|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
30941929|NCT00350272|58980817|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
30941930|NCT00350272|58980818|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
30941931|NCT00350272|58980817|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
30941932|NCT00350272|58980818|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
30941933|NCT00350272|58980817|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
30941934|NCT00350272|58980818|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
30948552|NCT01973387|58994573|FG000|Overall Study|Adverse Event|14|||
30948553|NCT01973387|58994574|FG001|Overall Study|Adverse Event|4|||
30948554|NCT01973387|58994573|FG000|Overall Study|Withdrawal by Subject|7|||
30948555|NCT01973387|58994574|FG001|Overall Study|Withdrawal by Subject|4|||
30948556|NCT01973387|58994573|FG000|Overall Study|Study terminated by sponsor|63|||
30948557|NCT01973387|58994574|FG001|Overall Study|Study terminated by sponsor|0|||
30948558|NCT01973387|58994573|FG000|Overall Study|Progressive disease or relapse|16|||
30948559|NCT01973387|58994574|FG001|Overall Study|Progressive disease or relapse|5|||
30948560|NCT01973387|58994573|FG000|Overall Study|Death|4|||
30948561|NCT01973387|58994574|FG001|Overall Study|Death|3|||
30759359|NCT00108069|58767837|FG001|Overall Study|Progessive disease|11|||
30759360|NCT00079274|58767856|FG000|Overall Study|Withdrawal by Subject|111|||
30759361|NCT00079274|58767857|FG001|Overall Study|Withdrawal by Subject|10|||
30759362|NCT00079274|58767858|FG002|Overall Study|Withdrawal by Subject|12|||
30759363|NCT00079274|58767859|FG003|Overall Study|Withdrawal by Subject|163|||
30759364|NCT00079274|58767860|FG004|Overall Study|Withdrawal by Subject|7|||
30759365|NCT00079274|58767861|FG005|Overall Study|Withdrawal by Subject|8|||
30759366|NCT00079274|58767862|FG006|Overall Study|Withdrawal by Subject|0|||
30759367|NCT00079274|58767856|FG000|Overall Study|Adverse Event|130|||
30759368|NCT00079274|58767857|FG001|Overall Study|Adverse Event|8|||
30842421|NCT03030599|58868119|FG002|Open Label Treatment and Titration|Physician Decision|0|||
30842422|NCT03030599|58868117|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
30842423|NCT03030599|58868118|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
30842424|NCT03030599|58868119|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
30842425|NCT03030599|58868117|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
30842426|NCT03030599|58868118|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
30842427|NCT03030599|58868119|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
30842428|NCT03030599|58868117|FG000|Open Label Treatment and Titration|Adverse Event|18|||
30842429|NCT03030599|58868118|FG001|Open Label Treatment and Titration|Adverse Event|0|||
30842430|NCT03030599|58868119|FG002|Open Label Treatment and Titration|Adverse Event|0|||
30842431|NCT03030599|58868117|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
30842432|NCT03030599|58868118|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
30842433|NCT03030599|58868119|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
30842434|NCT03030599|58868117|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
30842435|NCT03030599|58868118|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
30842436|NCT03030599|58868119|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
30842437|NCT03030599|58868117|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
30842438|NCT03030599|58868118|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
30948562|NCT01973387|58994573|FG000|Overall Study|Randomized, not treated|2|||
30948563|NCT01973387|58994574|FG001|Overall Study|Randomized, not treated|2|||
30948564|NCT01973231|58994582|FG000|Overall Study|Protocol Violation|1|||
30759369|NCT00079274|58767858|FG002|Overall Study|Adverse Event|8|||
30842439|NCT03030599|58868119|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
30941935|NCT02028884|58980829|FG000|Double-blind Period|Adverse Event|5|||
30941936|NCT02028884|58980830|FG001|Double-blind Period|Adverse Event|3|||
30941937|NCT02028884|58980831|FG002|Double-blind Period|Adverse Event|0|||
30941938|NCT02028884|58980829|FG000|Double-blind Period|Eligibility Violation|1|||
30941939|NCT02028884|58980830|FG001|Double-blind Period|Eligibility Violation|0|||
30941940|NCT02028884|58980831|FG002|Double-blind Period|Eligibility Violation|0|||
30941941|NCT02028884|58980829|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
30941942|NCT02028884|58980830|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
30941943|NCT02028884|58980831|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
30941944|NCT02028884|58980829|FG000|Double-blind Period|Withdrawal by Subject|2|||
30941945|NCT02028884|58980830|FG001|Double-blind Period|Withdrawal by Subject|0|||
30941946|NCT02028884|58980831|FG002|Double-blind Period|Withdrawal by Subject|0|||
30941947|NCT02028884|58980829|FG000|Open-label Extension Period|Adverse Event|3|||
30941948|NCT02028884|58980830|FG001|Open-label Extension Period|Adverse Event|1|||
30941949|NCT02028884|58980831|FG002|Open-label Extension Period|Adverse Event|0|||
30941950|NCT02028884|58980829|FG000|Open-label Extension Period|Lack of Efficacy|3|||
30941951|NCT02028884|58980830|FG001|Open-label Extension Period|Lack of Efficacy|0|||
30941952|NCT02028884|58980831|FG002|Open-label Extension Period|Lack of Efficacy|0|||
30941953|NCT02028884|58980829|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
30941954|NCT02028884|58980830|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
30941955|NCT02028884|58980831|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
30941956|NCT02028884|58980829|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
30941957|NCT02028884|58980830|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
30941958|NCT02028884|58980831|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
30941959|NCT02028884|58980829|FG000|Open-label Extension Period|Switched to another treatment option|3|||
30941960|NCT02028884|58980830|FG001|Open-label Extension Period|Switched to another treatment option|0|||
30941961|NCT02028884|58980831|FG002|Open-label Extension Period|Switched to another treatment option|0|||
30941962|NCT01701674|58980866|FG000|Overall Study|Unable to safely complete treatment|1|||
30941963|NCT01467427|58980887|FG000|Overall Study|Withdrawal by Subject|1|||
30941964|NCT01467427|58980888|FG001|Overall Study|Withdrawal by Subject|0|||
30941965|NCT01467427|58980887|FG000|Overall Study|Entered extension phase|11|||
30941966|NCT01467427|58980888|FG001|Overall Study|Entered extension phase|11|||
30941967|NCT01467427|58980887|FG000|Overall Study|Not continuing in extension phase|0|||
30941968|NCT01467427|58980888|FG001|Overall Study|Not continuing in extension phase|2|||
30941969|NCT01422187|58980897|FG000|Overall Study|Personal reason|1|||
30941970|NCT01422187|58980898|FG001|Overall Study|Personal reason|0|||
30941971|NCT01422187|58980899|FG002|Overall Study|Personal reason|0|||
30941972|NCT01422187|58980897|FG000|Overall Study|Lost to Follow-up|0|||
30941973|NCT01422187|58980898|FG001|Overall Study|Lost to Follow-up|1|||
30941974|NCT01422187|58980899|FG002|Overall Study|Lost to Follow-up|0|||
30941975|NCT00472212|58980909|FG000|Overall Study|Lost to Follow-up|6|||
30941976|NCT00472212|58980910|FG001|Overall Study|Lost to Follow-up|4|||
30941977|NCT00378105|58980918|FG000|Overall Study|Adverse Event|3|||
30941978|NCT00378105|58980919|FG001|Overall Study|Adverse Event|1|||
30941979|NCT00378105|58980918|FG000|Overall Study|Withdrawal by Subject|3|||
30941980|NCT00378105|58980919|FG001|Overall Study|Withdrawal by Subject|3|||
30941981|NCT00378105|58980918|FG000|Overall Study|Death|1|||
30941982|NCT00378105|58980919|FG001|Overall Study|Death|0|||
30941983|NCT00378105|58980918|FG000|Overall Study|Going to transplant|7|||
30941984|NCT00378105|58980919|FG001|Overall Study|Going to transplant|8|||
30941985|NCT00378105|58980918|FG000|Overall Study|Progressive disease|3|||
30941986|NCT00378105|58980919|FG001|Overall Study|Progressive disease|3|||
30941987|NCT00378105|58980918|FG000|Overall Study|remain on study|3|||
30941988|NCT00378105|58980919|FG001|Overall Study|remain on study|11|||
30941989|NCT00378105|58980918|FG000|Overall Study|Physician Decision|0|||
30941990|NCT00378105|58980919|FG001|Overall Study|Physician Decision|2|||
30941991|NCT00378105|58980918|FG000|Overall Study|Going non-protocol therapy|0|||
30941992|NCT00378105|58980919|FG001|Overall Study|Going non-protocol therapy|1|||
30941993|NCT00378105|58980918|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
30941994|NCT00378105|58980919|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
30941995|NCT00139477|58980928|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
30941996|NCT00139477|58980929|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
30941997|NCT00139477|58980928|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
30941998|NCT00139477|58980929|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
30941999|NCT00139477|58980928|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
30942000|NCT00139477|58980929|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
30942001|NCT00139477|58980928|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
30942002|NCT00139477|58980929|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
30942003|NCT00139477|58980928|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
30942004|NCT00139477|58980929|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
30942005|NCT00139477|58980928|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
30942006|NCT00139477|58980929|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
30942007|NCT00139477|58980928|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
30942008|NCT00139477|58980929|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
30942009|NCT01469013|58981249|FG000|Part A (Treatment Period)|Adverse Event|1|||
30942010|NCT01469013|58981250|FG001|Part A (Treatment Period)|Adverse Event|0|||
30942011|NCT01469013|58981251|FG002|Part A (Treatment Period)|Adverse Event|0|||
30942012|NCT01469013|58981252|FG003|Part A (Treatment Period)|Adverse Event|0|||
30942013|NCT01469013|58981253|FG004|Part A (Treatment Period)|Adverse Event|1|||
30942014|NCT01469013|58981254|FG005|Part A (Treatment Period)|Adverse Event|0|||
30942015|NCT01469013|58981255|FG006|Part A (Treatment Period)|Adverse Event|0|||
30942016|NCT01469013|58981256|FG007|Part A (Treatment Period)|Adverse Event|0|||
30942017|NCT01469013|58981257|FG008|Part A (Treatment Period)|Adverse Event|0|||
30942018|NCT01469013|58981258|FG009|Part A (Treatment Period)|Adverse Event|0|||
30942019|NCT01469013|58981259|FG010|Part A (Treatment Period)|Adverse Event|0|||
30942020|NCT01469013|58981260|FG011|Part A (Treatment Period)|Adverse Event|0|||
30942021|NCT01469013|58981261|FG012|Part A (Treatment Period)|Adverse Event|0|||
30942022|NCT01469013|58981249|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
30942023|NCT01469013|58981250|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
30942024|NCT01469013|58981251|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
30942025|NCT01469013|58981252|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
30942026|NCT01469013|58981253|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
30942027|NCT01469013|58981254|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
30942028|NCT01469013|58981255|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
30942029|NCT01469013|58981256|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
30942030|NCT01469013|58981257|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
30759370|NCT00079274|58767859|FG003|Overall Study|Adverse Event|184|||
30759371|NCT00079274|58767860|FG004|Overall Study|Adverse Event|7|||
30759372|NCT00079274|58767861|FG005|Overall Study|Adverse Event|8|||
30759373|NCT00079274|58767862|FG006|Overall Study|Adverse Event|0|||
30759374|NCT00079274|58767856|FG000|Overall Study|Recurrence|21|||
30759375|NCT00079274|58767857|FG001|Overall Study|Recurrence|0|||
30759376|NCT00079274|58767858|FG002|Overall Study|Recurrence|1|||
30759377|NCT00079274|58767859|FG003|Overall Study|Recurrence|15|||
30759378|NCT00079274|58767860|FG004|Overall Study|Recurrence|0|||
30759379|NCT00079274|58767861|FG005|Overall Study|Recurrence|2|||
30759380|NCT00079274|58767862|FG006|Overall Study|Recurrence|0|||
30759381|NCT00079274|58767856|FG000|Overall Study|Alternate Treatment|6|||
30759382|NCT00079274|58767857|FG001|Overall Study|Alternate Treatment|1|||
30759383|NCT00079274|58767858|FG002|Overall Study|Alternate Treatment|0|||
30759384|NCT00079274|58767859|FG003|Overall Study|Alternate Treatment|3|||
30759385|NCT00079274|58767860|FG004|Overall Study|Alternate Treatment|0|||
30759386|NCT00079274|58767861|FG005|Overall Study|Alternate Treatment|0|||
30759387|NCT00079274|58767862|FG006|Overall Study|Alternate Treatment|0|||
30759388|NCT00079274|58767856|FG000|Overall Study|Other Medical Problems|6|||
30759389|NCT00079274|58767857|FG001|Overall Study|Other Medical Problems|1|||
30842440|NCT03030599|58868117|FG000|Stable Dose|Protocol deviation|3|||
30842441|NCT03030599|58868118|FG001|Stable Dose|Protocol deviation|0|||
30842442|NCT03030599|58868119|FG002|Stable Dose|Protocol deviation|0|||
30842443|NCT03030599|58868117|FG000|Stable Dose|Adverse Event|1|||
30842444|NCT03030599|58868118|FG001|Stable Dose|Adverse Event|0|||
30842445|NCT03030599|58868119|FG002|Stable Dose|Adverse Event|0|||
30842446|NCT03030599|58868117|FG000|Stable Dose|Lost to Follow-up|1|||
30842447|NCT03030599|58868118|FG001|Stable Dose|Lost to Follow-up|0|||
30842448|NCT03030599|58868119|FG002|Stable Dose|Lost to Follow-up|0|||
30842449|NCT03030599|58868117|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
30842450|NCT03030599|58868118|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
30842451|NCT03030599|58868119|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
30842452|NCT03030599|58868117|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
30842453|NCT03030599|58868118|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
30842454|NCT03030599|58868119|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
30842455|NCT03030599|58868117|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
30842456|NCT03030599|58868118|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
30942031|NCT01469013|58981258|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
30759390|NCT00079274|58767858|FG002|Overall Study|Other Medical Problems|0|||
30842457|NCT03030599|58868119|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
30759391|NCT00079274|58767859|FG003|Overall Study|Other Medical Problems|7|||
30759392|NCT00079274|58767860|FG004|Overall Study|Other Medical Problems|0|||
30759393|NCT00079274|58767861|FG005|Overall Study|Other Medical Problems|0|||
30759394|NCT00079274|58767862|FG006|Overall Study|Other Medical Problems|0|||
30759395|NCT00079274|58767856|FG000|Overall Study|Death|4|||
30842458|NCT03030599|58868117|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
30942032|NCT01469013|58981259|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
30759396|NCT00079274|58767857|FG001|Overall Study|Death|0|||
30842459|NCT03030599|58868118|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
30842460|NCT03030599|58868119|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
30942033|NCT01469013|58981260|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
30942034|NCT01469013|58981261|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
30942035|NCT01469013|58981249|FG000|Part B (Extension Period)|Adverse Event|0|||
30942036|NCT01469013|58981250|FG001|Part B (Extension Period)|Adverse Event|0|||
30942037|NCT01469013|58981251|FG002|Part B (Extension Period)|Adverse Event|0|||
30942038|NCT01469013|58981252|FG003|Part B (Extension Period)|Adverse Event|0|||
30942039|NCT01469013|58981253|FG004|Part B (Extension Period)|Adverse Event|0|||
30942040|NCT01469013|58981254|FG005|Part B (Extension Period)|Adverse Event|2|||
30942041|NCT01469013|58981255|FG006|Part B (Extension Period)|Adverse Event|5|||
30942042|NCT01469013|58981256|FG007|Part B (Extension Period)|Adverse Event|5|||
30942043|NCT01469013|58981257|FG008|Part B (Extension Period)|Adverse Event|3|||
30942044|NCT01469013|58981258|FG009|Part B (Extension Period)|Adverse Event|3|||
30942045|NCT01469013|58981259|FG010|Part B (Extension Period)|Adverse Event|1|||
30942046|NCT01469013|58981260|FG011|Part B (Extension Period)|Adverse Event|6|||
30942047|NCT01469013|58981261|FG012|Part B (Extension Period)|Adverse Event|3|||
30942048|NCT01469013|58981249|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
30942049|NCT01469013|58981250|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
30942050|NCT01469013|58981251|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
30942051|NCT01469013|58981252|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
30942052|NCT01469013|58981253|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
30942053|NCT01469013|58981254|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
30942054|NCT01469013|58981255|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
30942055|NCT01469013|58981256|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
30942056|NCT01469013|58981257|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
30942057|NCT01469013|58981258|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
30942058|NCT01469013|58981259|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
30942059|NCT01469013|58981260|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
30942060|NCT01469013|58981261|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
30942061|NCT01493427|58981288|FG000|Overall Study|Adverse Event|10|||
30942062|NCT01493427|58981288|FG000|Overall Study|Personal Reasons|4|||
30942063|NCT01493427|58981288|FG000|Overall Study|Lost to Follow-up|2|||
30942064|NCT01493427|58981288|FG000|Overall Study|Inability to Follow Instructions|2|||
30942065|NCT01493427|58981288|FG000|Overall Study|Other|2|||
30942066|NCT01523457|58981294|FG000|Overall Study|Withdrawal by Subject|7|||
30942067|NCT01523457|58981295|FG001|Overall Study|Withdrawal by Subject|2|||
30942068|NCT01523301|58981303|FG000|Overall Study|Adverse Event|25|||
30942069|NCT01523301|58981304|FG001|Overall Study|Adverse Event|16|||
30942070|NCT01523301|58981303|FG000|Overall Study|Lack of Efficacy|0|||
30942071|NCT01523301|58981304|FG001|Overall Study|Lack of Efficacy|2|||
30942072|NCT01523301|58981303|FG000|Overall Study|Protocol Violation|3|||
30942073|NCT01523301|58981304|FG001|Overall Study|Protocol Violation|4|||
30942074|NCT01523301|58981303|FG000|Overall Study|Lost to Follow-up|1|||
30942075|NCT01523301|58981304|FG001|Overall Study|Lost to Follow-up|0|||
30942076|NCT01523301|58981303|FG000|Overall Study|Withdrawal by Subject|6|||
30942077|NCT01523301|58981304|FG001|Overall Study|Withdrawal by Subject|8|||
30942078|NCT01523301|58981303|FG000|Overall Study|Other Reason|0|||
30942079|NCT01523301|58981304|FG001|Overall Study|Other Reason|2|||
30942080|NCT01806506|58981312|FG000|Overall Study|Lost to Follow-up|2|||
30942081|NCT01806506|58981313|FG001|Overall Study|Lost to Follow-up|1|||
30942082|NCT01766336|58981321|FG000|Overall Study|Adverse Event|11|||
30942083|NCT01766336|58981322|FG001|Overall Study|Adverse Event|8|||
30942084|NCT01766336|58981321|FG000|Overall Study|Death|4|||
30842461|NCT03030599|58868117|FG000|Open-label Extension|Adverse Event|3|||
30842462|NCT03030599|58868118|FG001|Open-label Extension|Adverse Event|0|||
30842463|NCT03030599|58868119|FG002|Open-label Extension|Adverse Event|0|||
30842464|NCT03030599|58868117|FG000|Open-label Extension|Lost to Follow-up|2|||
30842465|NCT03030599|58868118|FG001|Open-label Extension|Lost to Follow-up|0|||
30842466|NCT03030599|58868119|FG002|Open-label Extension|Lost to Follow-up|0|||
30842467|NCT03030599|58868117|FG000|Open-label Extension|Lack of Efficacy|1|||
30842468|NCT03030599|58868118|FG001|Open-label Extension|Lack of Efficacy|0|||
30942085|NCT01766336|58981322|FG001|Overall Study|Death|3|||
30942086|NCT01766336|58981321|FG000|Overall Study|Lost to Follow-up|1|||
30942087|NCT01766336|58981322|FG001|Overall Study|Lost to Follow-up|3|||
30942088|NCT01766336|58981321|FG000|Overall Study|Physician Decision|4|||
30942089|NCT01766336|58981322|FG001|Overall Study|Physician Decision|2|||
30942090|NCT01766336|58981321|FG000|Overall Study|Protocol Violation|0|||
30942091|NCT01766336|58981322|FG001|Overall Study|Protocol Violation|1|||
30842469|NCT03030599|58868119|FG002|Open-label Extension|Lack of Efficacy|0|||
30942092|NCT01766336|58981321|FG000|Overall Study|Sponsor Decision|52|||
30942093|NCT01766336|58981322|FG001|Overall Study|Sponsor Decision|43|||
30942094|NCT01766336|58981321|FG000|Overall Study|Withdrawal by Subject|18|||
30842470|NCT03030599|58868117|FG000|Open-label Extension|Other Reason|1|||
30942095|NCT01766336|58981322|FG001|Overall Study|Withdrawal by Subject|15|||
30942096|NCT01797536|58981332|FG000|Overall Study|Adverse Event|0|||
30942097|NCT01797536|58981333|FG001|Overall Study|Adverse Event|1|||
30942098|NCT01797536|58981334|FG002|Overall Study|Adverse Event|0|||
30942099|NCT01797536|58981335|FG003|Overall Study|Adverse Event|0|||
30942100|NCT01797302|58981348|FG000|Overall Study|Lost to Follow-up|16|||
30942101|NCT01797302|58981349|FG001|Overall Study|Lost to Follow-up|23|||
30942102|NCT01797302|58981350|FG002|Overall Study|Lost to Follow-up|22|||
30942103|NCT01797302|58981348|FG000|Overall Study|Withdrawal by Subject|1|||
30942104|NCT01797302|58981349|FG001|Overall Study|Withdrawal by Subject|3|||
30942105|NCT01797302|58981350|FG002|Overall Study|Withdrawal by Subject|4|||
30942106|NCT01805180|58981360|FG000|Lead-in Donor Phase|screen failure|1|||
30942107|NCT01805180|58981361|FG001|Lead-in Donor Phase|screen failure|0|||
30942108|NCT01805180|58981362|FG002|Lead-in Donor Phase|screen failure|0|||
30942109|NCT01804946|58981372|FG000|Overall Study|Protocol Violation|1|||
30942110|NCT01804946|58981373|FG001|Overall Study|Protocol Violation|0|||
30942111|NCT01804946|58981372|FG000|Overall Study|Adverse Event|0|||
30759397|NCT00079274|58767858|FG002|Overall Study|Death|1|||
30759398|NCT00079274|58767859|FG003|Overall Study|Death|15|||
30759399|NCT00079274|58767860|FG004|Overall Study|Death|0|||
30759400|NCT00079274|58767861|FG005|Overall Study|Death|0|||
30759401|NCT00079274|58767862|FG006|Overall Study|Death|0|||
30759402|NCT00079274|58767856|FG000|Overall Study|Cytogenetic resistance|0|||
30759403|NCT00079274|58767857|FG001|Overall Study|Cytogenetic resistance|0|||
30759404|NCT00079274|58767858|FG002|Overall Study|Cytogenetic resistance|0|||
30759405|NCT00079274|58767859|FG003|Overall Study|Cytogenetic resistance|2|||
30759406|NCT00079274|58767860|FG004|Overall Study|Cytogenetic resistance|0|||
30759407|NCT00079274|58767861|FG005|Overall Study|Cytogenetic resistance|0|||
30759408|NCT00079274|58767862|FG006|Overall Study|Cytogenetic resistance|0|||
30759409|NCT00079274|58767856|FG000|Overall Study|Other|43|||
30759410|NCT00079274|58767857|FG001|Overall Study|Other|7|||
30759411|NCT00079274|58767858|FG002|Overall Study|Other|5|||
30759412|NCT00079274|58767859|FG003|Overall Study|Other|55|||
30759413|NCT00079274|58767860|FG004|Overall Study|Other|1|||
30759414|NCT00079274|58767861|FG005|Overall Study|Other|2|||
30759415|NCT00079274|58767862|FG006|Overall Study|Other|0|||
30759416|NCT00079040|58767875|FG000|Overall Study|Withdrew before treatment|1|||
30759417|NCT00079040|58767875|FG000|Overall Study|Ineligible|1|||
30759418|NCT00078806|58767879|FG000|Part 1A|Adverse Event|2|||
30759419|NCT00078806|58767880|FG001|Part 1A|Adverse Event|0|||
30759420|NCT00078806|58767881|FG002|Part 1A|Adverse Event|0|||
30759421|NCT00078806|58767882|FG003|Part 1A|Adverse Event|0|||
30759422|NCT00078806|58767879|FG000|Part 1A|Lack of Efficacy|7|||
30759423|NCT00078806|58767880|FG001|Part 1A|Lack of Efficacy|0|||
30759424|NCT00078806|58767881|FG002|Part 1A|Lack of Efficacy|0|||
30759425|NCT00078806|58767882|FG003|Part 1A|Lack of Efficacy|0|||
30759426|NCT00078806|58767879|FG000|Part 1A|Other|1|||
30759427|NCT00078806|58767880|FG001|Part 1A|Other|0|||
30759428|NCT00078806|58767881|FG002|Part 1A|Other|0|||
30759429|NCT00078806|58767882|FG003|Part 1A|Other|0|||
30759430|NCT00078806|58767879|FG000|Part 1B|Adverse Event|1|||
30759431|NCT00078806|58767880|FG001|Part 1B|Adverse Event|0|||
30759432|NCT00078806|58767881|FG002|Part 1B|Adverse Event|0|||
30759433|NCT00078806|58767882|FG003|Part 1B|Adverse Event|0|||
30759434|NCT00078806|58767879|FG000|Part 1B|Lack of Efficacy|7|||
30759435|NCT00078806|58767880|FG001|Part 1B|Lack of Efficacy|0|||
30759436|NCT00078806|58767881|FG002|Part 1B|Lack of Efficacy|0|||
30759437|NCT00078806|58767882|FG003|Part 1B|Lack of Efficacy|0|||
30759438|NCT00078806|58767879|FG000|Part 2|Adverse Event|0|||
30759439|NCT00078806|58767880|FG001|Part 2|Adverse Event|1|||
30759440|NCT00078806|58767881|FG002|Part 2|Adverse Event|0|||
30759441|NCT00078806|58767882|FG003|Part 2|Adverse Event|0|||
30759442|NCT00078338|58767899|FG000|Overall Study|Adverse Event|31|||
30759443|NCT00078338|58767900|FG001|Overall Study|Adverse Event|24|||
30759444|NCT00078338|58767899|FG000|Overall Study|Lost to Follow-up|17|||
30759445|NCT00078338|58767900|FG001|Overall Study|Lost to Follow-up|2|||
30759446|NCT00078338|58767899|FG000|Overall Study|Protocol Violation|2|||
30942112|NCT01804946|58981373|FG001|Overall Study|Adverse Event|1|||
30942113|NCT01804946|58981372|FG000|Overall Study|Insufficient data available|0|||
30759447|NCT00078338|58767900|FG001|Overall Study|Protocol Violation|2|||
30759448|NCT00078338|58767899|FG000|Overall Study|Disease Progression|4|||
30759449|NCT00078338|58767900|FG001|Overall Study|Disease Progression|7|||
30759450|NCT00078338|58767899|FG000|Overall Study|Other|28|||
30759451|NCT00078338|58767900|FG001|Overall Study|Other|16|||
30759452|NCT00078338|58767899|FG000|Overall Study|Subjects randomized, but not treated|3|||
30759453|NCT00078338|58767900|FG001|Overall Study|Subjects randomized, but not treated|3|||
30942114|NCT01804946|58981373|FG001|Overall Study|Insufficient data available|1|||
30759454|NCT03808688|58767908|FG000|Overall Study|Adverse Event|13|||
30759455|NCT03808688|58767909|FG001|Overall Study|Adverse Event|17|||
30759456|NCT03808688|58767908|FG000|Overall Study|Lack of Efficacy|2|||
30759457|NCT03808688|58767909|FG001|Overall Study|Lack of Efficacy|0|||
30759458|NCT03808688|58767908|FG000|Overall Study|Lost to Follow-up|0|||
30759459|NCT03808688|58767909|FG001|Overall Study|Lost to Follow-up|2|||
30942115|NCT01804946|58981372|FG000|Overall Study|Do not meet inclusion criteria|1|||
30942116|NCT01804946|58981373|FG001|Overall Study|Do not meet inclusion criteria|2|||
30942117|NCT01737398|58981383|FG000|Overall Study|Adverse event or SAE|16|||
30942118|NCT01737398|58981384|FG001|Overall Study|Adverse event or SAE|1|||
30942119|NCT01737398|58981383|FG000|Overall Study|Stopping rule met|2|||
30942120|NCT01737398|58981384|FG001|Overall Study|Stopping rule met|1|||
30942121|NCT01737398|58981383|FG000|Overall Study|Voluntary withdrawal|2|||
30942122|NCT01737398|58981384|FG001|Overall Study|Voluntary withdrawal|3|||
30942123|NCT01737398|58981383|FG000|Overall Study|Ineligibility|1|||
30942124|NCT01737398|58981384|FG001|Overall Study|Ineligibility|0|||
30942125|NCT01737398|58981383|FG000|Overall Study|Liver transplant|1|||
30942126|NCT01737398|58981384|FG001|Overall Study|Liver transplant|0|||
30942127|NCT01737398|58981383|FG000|Overall Study|Disease progression|2|||
30942128|NCT01737398|58981384|FG001|Overall Study|Disease progression|3|||
30942129|NCT01737398|58981383|FG000|Overall Study|Sponsor's decision|2|||
30942130|NCT01737398|58981384|FG001|Overall Study|Sponsor's decision|0|||
30942131|NCT01795898|58981393|FG000|Overall Study|Adverse Event|27|||
30942132|NCT01795898|58981393|FG000|Overall Study|Lost to Follow-up|20|||
30942133|NCT01795898|58981393|FG000|Overall Study|Withdrawal of consent|6|||
30942134|NCT01795898|58981393|FG000|Overall Study|Diagnosed with metastasis|1|||
30942135|NCT01795898|58981393|FG000|Overall Study|No pain|1|||
30942136|NCT01795898|58981393|FG000|Overall Study|Death|1|||
30942137|NCT01795898|58981393|FG000|Overall Study|Withdrew consent & had adverse events|3|||
30942138|NCT01795898|58981393|FG000|Overall Study|Physician Decision|1|||
30942139|NCT01736696|58981404|FG000|Overall Study|Withdrawal by Subject|0|||
30942140|NCT01736696|58981405|FG001|Overall Study|Withdrawal by Subject|0|||
30942141|NCT01736696|58981406|FG002|Overall Study|Withdrawal by Subject|1|||
30942142|NCT01736696|58981407|FG003|Overall Study|Withdrawal by Subject|0|||
30942143|NCT01736696|58981408|FG004|Overall Study|Withdrawal by Subject|0|||
30942144|NCT01736696|58981409|FG005|Overall Study|Withdrawal by Subject|0|||
30942145|NCT01736696|58981410|FG006|Overall Study|Withdrawal by Subject|0|||
30942146|NCT01736540|58981434|FG000|Overall Study|Did not complete scan within 45 days|2|||
30942147|NCT01736540|58981434|FG000|Overall Study|Death|1|||
30942148|NCT01736540|58981434|FG000|Overall Study|Abnormal test procedure|1|||
30942149|NCT01736540|58981434|FG000|Overall Study|Withdrawal by Subject|5|||
30942150|NCT01736540|58981434|FG000|Overall Study|Protocol Violation|1|||
30942151|NCT01736540|58981434|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
30942152|NCT01736540|58981434|FG000|Overall Study|No show for MRI appointment|1|||
30942153|NCT01736540|58981434|FG000|Overall Study|Unable to make MRI appointment|3|||
30942154|NCT01794338|58981447|FG000|Overall Study|Death|2|||
30942155|NCT01794338|58981448|FG001|Overall Study|Death|0|||
30942156|NCT01794338|58981447|FG000|Overall Study|Lost to Follow-up|6|||
30942157|NCT01794338|58981448|FG001|Overall Study|Lost to Follow-up|9|||
30942158|NCT01609478|58981457|FG000|Overall Study|Adverse Event|3|||
30942159|NCT01609478|58981458|FG001|Overall Study|Adverse Event|1|||
30942160|NCT01609478|58981459|FG002|Overall Study|Adverse Event|5|||
30759460|NCT03808688|58767908|FG000|Overall Study|Withdrawal by Subject|1|||
30942161|NCT01609478|58981457|FG000|Overall Study|Protocol Deviation|0|||
30942162|NCT01609478|58981458|FG001|Overall Study|Protocol Deviation|1|||
30942163|NCT01609478|58981459|FG002|Overall Study|Protocol Deviation|1|||
30942164|NCT01609478|58981457|FG000|Overall Study|Non-Compliance with study treatment|1|||
30942165|NCT01609478|58981458|FG001|Overall Study|Non-Compliance with study treatment|0|||
30759461|NCT03808688|58767909|FG001|Overall Study|Withdrawal by Subject|0|||
30942166|NCT01609478|58981459|FG002|Overall Study|Non-Compliance with study treatment|0|||
30942167|NCT01609478|58981457|FG000|Overall Study|Physician Decision|1|||
30942168|NCT01609478|58981458|FG001|Overall Study|Physician Decision|0|||
30759462|NCT03808688|58767908|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
30942169|NCT01609478|58981459|FG002|Overall Study|Physician Decision|1|||
30942170|NCT01609478|58981457|FG000|Overall Study|Withdrawal by Subject|2|||
30942171|NCT01609478|58981458|FG001|Overall Study|Withdrawal by Subject|0|||
30942172|NCT01609478|58981459|FG002|Overall Study|Withdrawal by Subject|2|||
30942173|NCT01764854|58981471|FG000|Overall Study|Adverse Event|0|||
30942174|NCT01764854|58981472|FG001|Overall Study|Adverse Event|0|||
30942175|NCT01764854|58981473|FG002|Overall Study|Adverse Event|2|||
30942176|NCT01764854|58981474|FG003|Overall Study|Adverse Event|0|||
30759463|NCT03808688|58767909|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
30759464|NCT03808688|58767908|FG000|Overall Study|IOP Too High|1|||
30759465|NCT03808688|58767909|FG001|Overall Study|IOP Too High|1|||
30759466|NCT03808688|58767908|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
30759467|NCT03808688|58767909|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
30942177|NCT01764854|58981471|FG000|Overall Study|Withdrawal by Subject|0|||
30942178|NCT01764854|58981472|FG001|Overall Study|Withdrawal by Subject|0|||
30942179|NCT01764854|58981473|FG002|Overall Study|Withdrawal by Subject|1|||
30759468|NCT03808688|58767908|FG000|Overall Study|Visit Out of Window|0|||
30942180|NCT01764854|58981474|FG003|Overall Study|Withdrawal by Subject|0|||
30942181|NCT01764854|58981471|FG000|Overall Study|relocation|0|||
30942182|NCT01764854|58981472|FG001|Overall Study|relocation|0|||
30942183|NCT01764854|58981473|FG002|Overall Study|relocation|2|||
30942184|NCT01764854|58981474|FG003|Overall Study|relocation|0|||
30942185|NCT01764854|58981471|FG000|Overall Study|Protocol Violation|0|||
30759469|NCT03808688|58767909|FG001|Overall Study|Visit Out of Window|1|||
30842471|NCT03030599|58868118|FG001|Open-label Extension|Other Reason|0|||
30842472|NCT03030599|58868119|FG002|Open-label Extension|Other Reason|0|||
30842473|NCT03031847|58868129|FG000|Overall Study|Death|1|||
30842474|NCT03031847|58868130|FG001|Overall Study|Death|1|||
30842475|NCT03031847|58868131|FG002|Overall Study|Death|2|||
30842476|NCT03031847|58868132|FG003|Overall Study|Death|3|||
30842477|NCT03031847|58868129|FG000|Overall Study|Lost to Follow-up|1|||
30842478|NCT03031847|58868130|FG001|Overall Study|Lost to Follow-up|1|||
30842479|NCT03031847|58868131|FG002|Overall Study|Lost to Follow-up|2|||
30842480|NCT03031847|58868132|FG003|Overall Study|Lost to Follow-up|3|||
30842481|NCT03028415|58868144|FG000|Overall Study|Lost to Follow-up|6|||
30842482|NCT03028415|58868145|FG001|Overall Study|Lost to Follow-up|3|||
30842483|NCT03028415|58868144|FG000|Overall Study|Withdrawal by Subject|1|||
30842484|NCT03028415|58868145|FG001|Overall Study|Withdrawal by Subject|0|||
30842485|NCT03028415|58868144|FG000|Overall Study|Discontinued due to COVID-19|1|||
30842486|NCT03028415|58868145|FG001|Overall Study|Discontinued due to COVID-19|0|||
30842487|NCT02692040|58868169|FG000|Overall Study|Protocol Violation|0|||
30842488|NCT02692040|58868170|FG001|Overall Study|Protocol Violation|0|||
30842489|NCT02692040|58868171|FG002|Overall Study|Protocol Violation|0|||
30842490|NCT02692040|58868172|FG003|Overall Study|Protocol Violation|0|||
30842491|NCT02692040|58868173|FG004|Overall Study|Protocol Violation|0|||
30842492|NCT02692040|58868174|FG005|Overall Study|Protocol Violation|0|||
30842493|NCT02692040|58868175|FG006|Overall Study|Protocol Violation|0|||
30842494|NCT02692040|58868176|FG007|Overall Study|Protocol Violation|0|||
30842495|NCT02692040|58868177|FG008|Overall Study|Protocol Violation|0|||
30842496|NCT02692040|58868178|FG009|Overall Study|Protocol Violation|0|||
30842497|NCT02692040|58868179|FG010|Overall Study|Protocol Violation|0|||
30842498|NCT02692040|58868180|FG011|Overall Study|Protocol Violation|0|||
30842499|NCT02692040|58868181|FG012|Overall Study|Protocol Violation|1|||
30842500|NCT02692040|58868182|FG013|Overall Study|Protocol Violation|0|||
30842501|NCT02692040|58868183|FG014|Overall Study|Protocol Violation|0|||
30842502|NCT02692040|58868184|FG015|Overall Study|Protocol Violation|0|||
30842503|NCT02692040|58868185|FG016|Overall Study|Protocol Violation|0|||
30759470|NCT03808688|58767908|FG000|Overall Study|Medication Non-Compliance|0|||
30842504|NCT02692040|58868169|FG000|Overall Study|Adverse Event|0|||
30842505|NCT02692040|58868170|FG001|Overall Study|Adverse Event|0|||
30842506|NCT02692040|58868171|FG002|Overall Study|Adverse Event|0|||
30842507|NCT02692040|58868172|FG003|Overall Study|Adverse Event|0|||
30842508|NCT02692040|58868173|FG004|Overall Study|Adverse Event|0|||
30842509|NCT02692040|58868174|FG005|Overall Study|Adverse Event|0|||
30842510|NCT02692040|58868175|FG006|Overall Study|Adverse Event|0|||
30842511|NCT02692040|58868176|FG007|Overall Study|Adverse Event|0|||
30942186|NCT01764854|58981472|FG001|Overall Study|Protocol Violation|0|||
30842512|NCT02692040|58868177|FG008|Overall Study|Adverse Event|0|||
30842513|NCT02692040|58868178|FG009|Overall Study|Adverse Event|0|||
30942187|NCT01764854|58981473|FG002|Overall Study|Protocol Violation|1|||
30942188|NCT01764854|58981474|FG003|Overall Study|Protocol Violation|2|||
30942189|NCT01764464|58981486|FG000|First Intervention|Withdrawal by Subject|1|||
30942190|NCT01764464|58981487|FG001|First Intervention|Withdrawal by Subject|0|||
30942191|NCT01764464|58981486|FG000|First Intervention|Lost to Follow-up|1|||
30942192|NCT01764464|58981487|FG001|First Intervention|Lost to Follow-up|0|||
30942193|NCT01764464|58981486|FG000|First Intervention|Adverse Event|0|||
30942194|NCT01764464|58981487|FG001|First Intervention|Adverse Event|2|||
30942195|NCT01764464|58981486|FG000|First Intervention|did not receive study drug|0|||
30942196|NCT01764464|58981487|FG001|First Intervention|did not receive study drug|1|||
30942197|NCT01764464|58981486|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
30942198|NCT01764464|58981487|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
30942199|NCT01764386|58981495|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
30942200|NCT01764386|58981496|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
30942201|NCT01764386|58981495|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
30942202|NCT01764386|58981496|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
30942203|NCT01764386|58981495|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
30942204|NCT01764386|58981496|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
30942205|NCT01764386|58981495|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
30942206|NCT01764386|58981496|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
30942207|NCT01764386|58981495|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
30942208|NCT01764386|58981496|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
30942209|NCT01764386|58981495|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
30942210|NCT01764386|58981496|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
30942211|NCT01764386|58981495|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
30942212|NCT01764386|58981496|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
30942213|NCT01764386|58981495|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
30942214|NCT01764386|58981496|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
30942215|NCT01763918|58981507|FG000|Overall Study|Withdrawal by Subject|2|||
30942216|NCT01763918|58981508|FG001|Overall Study|Withdrawal by Subject|1|||
30942217|NCT01763918|58981509|FG002|Overall Study|Withdrawal by Subject|1|||
30942218|NCT01763918|58981510|FG003|Overall Study|Withdrawal by Subject|2|||
30942219|NCT01763918|58981507|FG000|Overall Study|Sponsor Decision|4|||
30942220|NCT01763918|58981508|FG001|Overall Study|Sponsor Decision|0|||
30942221|NCT01763918|58981509|FG002|Overall Study|Sponsor Decision|9|||
30942222|NCT01763918|58981510|FG003|Overall Study|Sponsor Decision|0|||
30942223|NCT01763684|58981522|FG000|Overall Study|Study terminated early due to low enrollment|126|||
30942224|NCT01763684|58981523|FG001|Overall Study|Study terminated early due to low enrollment|127|||
30942225|NCT01763684|58981522|FG000|Overall Study|Study surgery not performed|7|||
30942226|NCT01763684|58981523|FG001|Overall Study|Study surgery not performed|6|||
30942227|NCT01606748|58981531|FG000|Overall Study|Adverse Event|1|||
30942228|NCT01606748|58981532|FG001|Overall Study|Adverse Event|0|||
30942229|NCT01606748|58981531|FG000|Overall Study|Progressive Disease|1|||
30942230|NCT01606748|58981532|FG001|Overall Study|Progressive Disease|0|||
30942231|NCT01606748|58981531|FG000|Overall Study|Withdrawal by Subject|1|||
30942232|NCT01606748|58981532|FG001|Overall Study|Withdrawal by Subject|0|||
30942233|NCT01597622|58981550|FG000|Overall Study|Adverse Event|7|||
30942234|NCT01597622|58981550|FG000|Overall Study|Lack of Efficacy|3|||
30942235|NCT01597622|58981550|FG000|Overall Study|Protocol Violation|1|||
30942236|NCT01597622|58981550|FG000|Overall Study|Lost to Follow-up|1|||
30942237|NCT01597622|58981550|FG000|Overall Study|Investigator Discretion|5|||
30942238|NCT01597622|58981550|FG000|Overall Study|Withdrawal by Subject|20|||
30942239|NCT01597622|58981550|FG000|Overall Study|Death|1|||
30942240|NCT01761266|58981556|FG000|Overall Study|Death|415|||
30942241|NCT01761266|58981557|FG001|Overall Study|Death|402|||
30942242|NCT01761266|58981556|FG000|Overall Study|Lost to Follow-up|8|||
30942243|NCT01761266|58981557|FG001|Overall Study|Lost to Follow-up|12|||
30942244|NCT01761266|58981556|FG000|Overall Study|Withdrawal by Subject|14|||
30942245|NCT01761266|58981557|FG001|Overall Study|Withdrawal by Subject|10|||
30942246|NCT01761266|58981556|FG000|Overall Study|Sponsor Decision|41|||
30942247|NCT01761266|58981557|FG001|Overall Study|Sponsor Decision|52|||
30942248|NCT01760954|58981570|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
30759471|NCT03808688|58767909|FG001|Overall Study|Medication Non-Compliance|1|||
30759472|NCT03808298|58767917|FG000|Overall Study|Adverse Event|3|||
30759473|NCT03808298|58767917|FG000|Overall Study|Physician Decision|1|||
30759474|NCT03808298|58767917|FG000|Overall Study|Withdrawal by Subject|1|||
30842514|NCT02692040|58868179|FG010|Overall Study|Adverse Event|0|||
30942249|NCT01760954|58981571|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
30942250|NCT01760954|58981572|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
30942251|NCT01760954|58981573|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
30942252|NCT01760954|58981570|FG000|Treatment Period (6 Months)|Adverse Event|5|||
30942253|NCT01760954|58981571|FG001|Treatment Period (6 Months)|Adverse Event|3|||
30942254|NCT01760954|58981572|FG002|Treatment Period (6 Months)|Adverse Event|4|||
30942255|NCT01760954|58981573|FG003|Treatment Period (6 Months)|Adverse Event|10|||
30942256|NCT01760954|58981570|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
30942257|NCT01760954|58981571|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
30942258|NCT01760954|58981572|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
30942259|NCT01760954|58981573|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
30942260|NCT01760954|58981570|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
30942261|NCT01760954|58981571|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
30942262|NCT01760954|58981572|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
30942263|NCT01760954|58981573|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
30942264|NCT01760954|58981570|FG000|Treatment Period (6 Months)|Pregnancy|5|||
30942265|NCT01760954|58981571|FG001|Treatment Period (6 Months)|Pregnancy|0|||
30942266|NCT01760954|58981572|FG002|Treatment Period (6 Months)|Pregnancy|3|||
30942267|NCT01760954|58981573|FG003|Treatment Period (6 Months)|Pregnancy|2|||
30942268|NCT01760954|58981570|FG000|Treatment Period (6 Months)|Non-compliance|1|||
30942269|NCT01760954|58981571|FG001|Treatment Period (6 Months)|Non-compliance|4|||
30942270|NCT01760954|58981572|FG002|Treatment Period (6 Months)|Non-compliance|0|||
30942271|NCT01760954|58981573|FG003|Treatment Period (6 Months)|Non-compliance|3|||
30942272|NCT01760954|58981570|FG000|Treatment Period (6 Months)|Other|0|||
30942273|NCT01760954|58981571|FG001|Treatment Period (6 Months)|Other|3|||
30942274|NCT01760954|58981572|FG002|Treatment Period (6 Months)|Other|3|||
30942275|NCT01760954|58981573|FG003|Treatment Period (6 Months)|Other|1|||
30942276|NCT01760954|58981570|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
30942277|NCT01760954|58981571|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
30942278|NCT01760954|58981572|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
30942279|NCT01760954|58981573|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
30942280|NCT01760954|58981570|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
30942281|NCT01760954|58981571|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
30942282|NCT01760954|58981572|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
30942283|NCT01760954|58981573|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
30942284|NCT01760954|58981570|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
30942285|NCT01760954|58981571|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
30942286|NCT01760954|58981572|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
30942287|NCT01760954|58981573|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
30942288|NCT01760954|58981570|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
30942289|NCT01760954|58981571|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
30942290|NCT01760954|58981572|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
30942291|NCT01760954|58981573|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
30942292|NCT01760954|58981570|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
30942293|NCT01760954|58981571|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
30942294|NCT01760954|58981572|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
30942295|NCT01760954|58981573|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
30942296|NCT01760954|58981570|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
30942297|NCT01760954|58981571|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
30942298|NCT01760954|58981572|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
30942299|NCT01760954|58981573|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
30942300|NCT01760954|58981570|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
30942301|NCT01760954|58981571|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
30942302|NCT01760954|58981572|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
30942303|NCT01760954|58981573|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
30942304|NCT01760954|58981570|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
30942305|NCT01760954|58981571|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
30942306|NCT01760954|58981572|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
30942307|NCT01760954|58981573|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
30942308|NCT01760876|58981583|FG000|Overall Study|Non-cardiac death (head injury)|1|||
30942309|NCT01760876|58981583|FG000|Overall Study|Carcinoma of prostate|1|||
30942310|NCT01760876|58981583|FG000|Overall Study|Impaired renal function|1|||
30942311|NCT01760876|58981583|FG000|Overall Study|Major depression|1|||
30942312|NCT01760876|58981583|FG000|Overall Study|Very poor baseline OCT quality|2|||
30942313|NCT01759862|58981589|FG000|Overall Study|Physician Decision|3|||
30942314|NCT01759862|58981590|FG001|Overall Study|Physician Decision|1|||
30942315|NCT01759862|58981589|FG000|Overall Study|Adverse Event|0|||
30942316|NCT01759862|58981590|FG001|Overall Study|Adverse Event|1|||
30942317|NCT01606670|58981596|FG000|Overall Study|Adverse Event|6|||
30942318|NCT01606670|58981596|FG000|Overall Study|Lack of Efficacy|2|||
30942319|NCT01606670|58981596|FG000|Overall Study|Lost to Follow-up|3|||
30942320|NCT01606670|58981596|FG000|Overall Study|Withdrawal by Subject|3|||
30942321|NCT01606670|58981596|FG000|Overall Study|Other Reason|2|||
30942322|NCT01793792|58981600|FG000|Overall Study|Death|5|||
30942323|NCT01793792|58981600|FG000|Overall Study|Lost to Follow-up|5|||
30942324|NCT01793792|58981600|FG000|Overall Study|Withdrawal by Subject|1|||
30942325|NCT01793792|58981600|FG000|Overall Study|Device Not Implanted|1|||
30942326|NCT01790984|58981606|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
30942327|NCT01790984|58981607|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
30942328|NCT01790984|58981608|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
30942329|NCT01790984|58981609|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
30942330|NCT01735994|58981634|FG000|Overall Study|Withdrawal by Subject|6|||
30942331|NCT01735994|58981635|FG001|Overall Study|Withdrawal by Subject|4|||
30942332|NCT01735994|58981634|FG000|Overall Study|Injury|2|||
30942333|NCT01735994|58981635|FG001|Overall Study|Injury|0|||
30942334|NCT01735994|58981634|FG000|Overall Study|Kicked off team|5|||
30942335|NCT01735994|58981635|FG001|Overall Study|Kicked off team|0|||
30942336|NCT01735994|58981634|FG000|Overall Study|Lost to Follow-up|50|||
30942337|NCT01735994|58981635|FG001|Overall Study|Lost to Follow-up|62|||
30942338|NCT01790828|58981641|FG000|Overall Study|Other|34|||
30942339|NCT01790594|58981647|FG000|Overall Study|Death|1|||
30942340|NCT01790594|58981648|FG001|Overall Study|Death|0|||
30942341|NCT01790594|58981649|FG002|Overall Study|Death|0|||
30942342|NCT01790594|58981647|FG000|Overall Study|Physician Decision|2|||
30942343|NCT01790594|58981648|FG001|Overall Study|Physician Decision|1|||
30942344|NCT01790594|58981649|FG002|Overall Study|Physician Decision|0|||
30942345|NCT01790594|58981647|FG000|Overall Study|Withdrawal by Subject|2|||
30942346|NCT01790594|58981648|FG001|Overall Study|Withdrawal by Subject|0|||
30942347|NCT01790594|58981649|FG002|Overall Study|Withdrawal by Subject|0|||
30942348|NCT01790594|58981647|FG000|Overall Study|Transplant was not done|0|||
30942349|NCT01790594|58981648|FG001|Overall Study|Transplant was not done|0|||
30942350|NCT01790594|58981649|FG002|Overall Study|Transplant was not done|3|||
30942351|NCT01790594|58981647|FG000|Overall Study|Terminated prior to week 76|0|||
30942352|NCT01790594|58981648|FG001|Overall Study|Terminated prior to week 76|2|||
30942353|NCT01790594|58981649|FG002|Overall Study|Terminated prior to week 76|0|||
30942354|NCT01790516|58981658|FG000|Overall Study|Physician Decision|1|||
30942355|NCT01790516|58981659|FG001|Overall Study|Physician Decision|0|||
30942356|NCT01790438|58981667|FG000|Overall Study|Adverse Event|3|||
30942357|NCT01790438|58981668|FG001|Overall Study|Adverse Event|2|||
30942358|NCT01790438|58981667|FG000|Overall Study|Death|4|||
30942359|NCT01790438|58981668|FG001|Overall Study|Death|0|||
30942360|NCT01790438|58981667|FG000|Overall Study|Lost to Follow-up|5|||
30942361|NCT01790438|58981668|FG001|Overall Study|Lost to Follow-up|2|||
30942362|NCT01790438|58981667|FG000|Overall Study|Withdrawal by Subject|13|||
30942363|NCT01790438|58981668|FG001|Overall Study|Withdrawal by Subject|2|||
30942364|NCT01790438|58981667|FG000|Overall Study|Physician Decision|3|||
30942365|NCT01790438|58981668|FG001|Overall Study|Physician Decision|1|||
30942366|NCT01790438|58981667|FG000|Overall Study|Sponsor Decision|0|||
30942367|NCT01790438|58981668|FG001|Overall Study|Sponsor Decision|3|||
30942368|NCT01790438|58981667|FG000|Overall Study|Protocol Required Discontinuation|7|||
30942369|NCT01790438|58981668|FG001|Overall Study|Protocol Required Discontinuation|1|||
30942370|NCT01735916|58981679|FG000|Overall Study|Subject not eligible to be randomized|11|||
30942371|NCT01735916|58981680|FG001|Overall Study|Subject not eligible to be randomized|0|||
30942372|NCT01735916|58981681|FG002|Overall Study|Subject not eligible to be randomized|0|||
30942373|NCT01735916|58981679|FG000|Overall Study|Early termination of study by sponsor|4|||
30942374|NCT01735916|58981680|FG001|Overall Study|Early termination of study by sponsor|19|||
30942375|NCT01735916|58981681|FG002|Overall Study|Early termination of study by sponsor|7|||
30942376|NCT01735916|58981679|FG000|Overall Study|Withdrawal by Subject|3|||
30942377|NCT01735916|58981680|FG001|Overall Study|Withdrawal by Subject|0|||
30942378|NCT01735916|58981681|FG002|Overall Study|Withdrawal by Subject|0|||
30942379|NCT01790126|58981691|FG000|Overall Study|PSA Progression|12|||
30942380|NCT01790126|58981692|FG001|Overall Study|PSA Progression|16|||
30942381|NCT01790126|58981693|FG002|Overall Study|PSA Progression|16|||
30942382|NCT01790126|58981691|FG000|Overall Study|Other|5|||
30942383|NCT01790126|58981692|FG001|Overall Study|Other|4|||
30942384|NCT01790126|58981693|FG002|Overall Study|Other|8|||
30942385|NCT01790126|58981691|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
30942386|NCT01790126|58981692|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
30942387|NCT01790126|58981693|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
30942388|NCT01790126|58981691|FG000|Overall Study|Withdrawal by Physician|1|||
30942389|NCT01790126|58981692|FG001|Overall Study|Withdrawal by Physician|1|||
30942390|NCT01790126|58981693|FG002|Overall Study|Withdrawal by Physician|2|||
30942391|NCT01790126|58981691|FG000|Overall Study|Withdrawal by Subject|3|||
30942392|NCT01790126|58981692|FG001|Overall Study|Withdrawal by Subject|1|||
30942393|NCT01790126|58981693|FG002|Overall Study|Withdrawal by Subject|2|||
30942394|NCT01790126|58981691|FG000|Overall Study|Lost to Follow-up|1|||
30942395|NCT01790126|58981692|FG001|Overall Study|Lost to Follow-up|0|||
30942396|NCT01790126|58981693|FG002|Overall Study|Lost to Follow-up|1|||
30942397|NCT01790126|58981691|FG000|Overall Study|Adverse Event|0|||
30942398|NCT01790126|58981692|FG001|Overall Study|Adverse Event|2|||
30942399|NCT01790126|58981693|FG002|Overall Study|Adverse Event|0|||
30942400|NCT01790126|58981691|FG000|Overall Study|Death|2|||
30942401|NCT01790126|58981692|FG001|Overall Study|Death|0|||
30942402|NCT01790126|58981693|FG002|Overall Study|Death|0|||
30942403|NCT01790126|58981691|FG000|Overall Study|Radiographic Progression|3|||
30942404|NCT01790126|58981692|FG001|Overall Study|Radiographic Progression|1|||
30942405|NCT01790126|58981693|FG002|Overall Study|Radiographic Progression|0|||
30942406|NCT01734902|58981704|FG000|Overall Study|Other than listed|0|||
30942407|NCT01734902|58981705|FG001|Overall Study|Other than listed|2|||
30942408|NCT01790048|58981713|FG000|Overall Study|Incorrect Age|9|||
30942409|NCT01790048|58981714|FG001|Overall Study|Incorrect Age|14|||
30942410|NCT01790048|58981713|FG000|Overall Study|data entry error|0|||
30942411|NCT01790048|58981714|FG001|Overall Study|data entry error|1|||
30942412|NCT01790048|58981713|FG000|Overall Study|Other|0|||
30942413|NCT01790048|58981714|FG001|Overall Study|Other|2|||
30942414|NCT01790048|58981713|FG000|Overall Study|SAM at Enrollment|2|||
30942415|NCT01790048|58981714|FG001|Overall Study|SAM at Enrollment|0|||
30942416|NCT01790048|58981713|FG000|Overall Study|Measurement error|1|||
30942417|NCT01790048|58981714|FG001|Overall Study|Measurement error|0|||
30942418|NCT01789970|58981724|FG000|Open-label Titration Period|Adverse Event|68|||
30942419|NCT01789970|58981725|FG001|Open-label Titration Period|Adverse Event|0|||
30942420|NCT01789970|58981726|FG002|Open-label Titration Period|Adverse Event|0|||
30942421|NCT01789970|58981724|FG000|Open-label Titration Period|Lack of Efficacy|31|||
30942422|NCT01789970|58981725|FG001|Open-label Titration Period|Lack of Efficacy|0|||
30942423|NCT01789970|58981726|FG002|Open-label Titration Period|Lack of Efficacy|0|||
30942424|NCT01789970|58981724|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
30942425|NCT01789970|58981725|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
30942426|NCT01789970|58981726|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
30942427|NCT01789970|58981724|FG000|Open-label Titration Period|Protocol Violation|18|||
30942428|NCT01789970|58981725|FG001|Open-label Titration Period|Protocol Violation|0|||
30942429|NCT01789970|58981726|FG002|Open-label Titration Period|Protocol Violation|0|||
30942430|NCT01789970|58981724|FG000|Open-label Titration Period|Lost to Follow-up|5|||
30942431|NCT01789970|58981725|FG001|Open-label Titration Period|Lost to Follow-up|0|||
30942432|NCT01789970|58981726|FG002|Open-label Titration Period|Lost to Follow-up|0|||
30942433|NCT01789970|58981724|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
30942434|NCT01789970|58981725|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
30942435|NCT01789970|58981726|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
30942436|NCT01789970|58981724|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
30942437|NCT01789970|58981725|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
30942438|NCT01789970|58981726|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
30942439|NCT01789970|58981724|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
30942440|NCT01789970|58981725|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
30942441|NCT01789970|58981726|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
30942442|NCT01789970|58981724|FG000|Open-label Titration Period|Pregnancy|2|||
30942443|NCT01789970|58981725|FG001|Open-label Titration Period|Pregnancy|0|||
30942444|NCT01789970|58981726|FG002|Open-label Titration Period|Pregnancy|0|||
30942445|NCT01789970|58981724|FG000|Open-label Titration Period|Other|76|||
30942446|NCT01789970|58981725|FG001|Open-label Titration Period|Other|0|||
30942447|NCT01789970|58981726|FG002|Open-label Titration Period|Other|0|||
30942448|NCT01789970|58981724|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
30942449|NCT01789970|58981725|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
30942450|NCT01789970|58981726|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
30942451|NCT01789970|58981724|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
30942452|NCT01789970|58981725|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
30942453|NCT01789970|58981726|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
30942454|NCT01789970|58981724|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
30942455|NCT01789970|58981725|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
30942456|NCT01789970|58981726|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
30942457|NCT01789970|58981724|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
30942458|NCT01789970|58981725|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
30942459|NCT01789970|58981726|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
30942460|NCT01789970|58981724|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
30942461|NCT01789970|58981725|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
30942462|NCT01789970|58981726|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
30948565|NCT01973231|58994583|FG001|Overall Study|Protocol Violation|1|||
30942463|NCT01789970|58981724|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
30942464|NCT01789970|58981725|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
30942465|NCT01789970|58981726|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
30942466|NCT01789970|58981724|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
30942467|NCT01789970|58981725|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
30942468|NCT01789970|58981726|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
30942469|NCT01789970|58981724|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
30942470|NCT01789970|58981725|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
30942471|NCT01789970|58981726|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
30942472|NCT01789970|58981724|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
30942473|NCT01789970|58981725|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
30942474|NCT01789970|58981726|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
30942475|NCT01789970|58981724|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
30942476|NCT01789970|58981725|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
30942477|NCT01789970|58981726|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
30942478|NCT01789970|58981724|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
30942479|NCT01789970|58981725|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
30942480|NCT01789970|58981726|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
30942481|NCT01734434|58981744|FG000|Overall Study|Death Infant|3|||
30942482|NCT01734434|58981745|FG001|Overall Study|Death Infant|1|||
30942483|NCT01734434|58981746|FG002|Overall Study|Death Infant|17|||
30942484|NCT01734434|58981747|FG003|Overall Study|Death Infant|5|||
30942485|NCT01734434|58981744|FG000|Overall Study|Lost to Follow-up|2|||
30942486|NCT01734434|58981745|FG001|Overall Study|Lost to Follow-up|9|||
30942487|NCT01734434|58981746|FG002|Overall Study|Lost to Follow-up|67|||
30942488|NCT01734434|58981747|FG003|Overall Study|Lost to Follow-up|11|||
30942489|NCT01734434|58981744|FG000|Overall Study|No Live Birth|1|||
30942490|NCT01734434|58981745|FG001|Overall Study|No Live Birth|2|||
30942491|NCT01734434|58981746|FG002|Overall Study|No Live Birth|32|||
30942492|NCT01734434|58981747|FG003|Overall Study|No Live Birth|6|||
30942493|NCT01734434|58981744|FG000|Overall Study|Withdrawal by Subject|4|||
30942494|NCT01734434|58981745|FG001|Overall Study|Withdrawal by Subject|0|||
30942495|NCT01734434|58981746|FG002|Overall Study|Withdrawal by Subject|8|||
30942496|NCT01734434|58981747|FG003|Overall Study|Withdrawal by Subject|1|||
30942497|NCT01734434|58981744|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
30942498|NCT01734434|58981745|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
30942499|NCT01734434|58981746|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
30942500|NCT01734434|58981747|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
30942501|NCT01734434|58981744|FG000|Overall Study|Subject Not Reachable|0|||
30942502|NCT01734434|58981745|FG001|Overall Study|Subject Not Reachable|0|||
30942503|NCT01734434|58981746|FG002|Overall Study|Subject Not Reachable|1|||
30942504|NCT01734434|58981747|FG003|Overall Study|Subject Not Reachable|0|||
30942505|NCT01734434|58981744|FG000|Overall Study|Treatment Defaulter|0|||
30942506|NCT01734434|58981745|FG001|Overall Study|Treatment Defaulter|0|||
30942507|NCT01734434|58981746|FG002|Overall Study|Treatment Defaulter|1|||
30942508|NCT01734434|58981747|FG003|Overall Study|Treatment Defaulter|0|||
30942509|NCT01734434|58981744|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
30942510|NCT01734434|58981745|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
30942511|NCT01734434|58981746|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
30942512|NCT01734434|58981747|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
30942513|NCT01734434|58981744|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
30942514|NCT01734434|58981745|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
30942515|NCT01734434|58981746|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
30942516|NCT01734434|58981747|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
30942517|NCT01788566|58981765|FG000|Overall Study|Death|4|||
30942518|NCT01788566|58981765|FG000|Overall Study|Adverse Event|1|||
30942519|NCT01788566|58981765|FG000|Overall Study|Clinical Progressive Disease|3|||
30942520|NCT01733732|58981771|FG000|Overall Study|Adverse Event|1|||
30942521|NCT01733732|58981772|FG001|Overall Study|Adverse Event|0|||
30942522|NCT01733732|58981771|FG000|Overall Study|Did not attend all study visits|1|||
30942523|NCT01733732|58981772|FG001|Overall Study|Did not attend all study visits|0|||
30942524|NCT01732874|58981790|FG000|Overall Study|Withdrawal by Subject|5|||
30942525|NCT01732874|58981791|FG001|Overall Study|Withdrawal by Subject|1|||
30942526|NCT01732874|58981790|FG000|Overall Study|Death of Infant|3|||
30942527|NCT01732874|58981791|FG001|Overall Study|Death of Infant|2|||
30942528|NCT01732796|58981800|FG000|Overall Study|Adverse Event|16|||
30942529|NCT01732796|58981801|FG001|Overall Study|Adverse Event|16|||
30942530|NCT01732796|58981802|FG002|Overall Study|Adverse Event|4|||
30942531|NCT01732796|58981800|FG000|Overall Study|Lack of Efficacy|21|||
30942532|NCT01732796|58981801|FG001|Overall Study|Lack of Efficacy|18|||
30942533|NCT01732796|58981802|FG002|Overall Study|Lack of Efficacy|5|||
30942534|NCT01732796|58981800|FG000|Overall Study|Lost to Follow-up|2|||
30942535|NCT01732796|58981801|FG001|Overall Study|Lost to Follow-up|0|||
30942536|NCT01732796|58981802|FG002|Overall Study|Lost to Follow-up|0|||
30942537|NCT01732796|58981800|FG000|Overall Study|Withdrawal by Subject|6|||
30942538|NCT01732796|58981801|FG001|Overall Study|Withdrawal by Subject|8|||
30942539|NCT01732796|58981802|FG002|Overall Study|Withdrawal by Subject|2|||
30942540|NCT01732796|58981800|FG000|Overall Study|Other reason not defined above|1|||
30942541|NCT01732796|58981801|FG001|Overall Study|Other reason not defined above|0|||
30942542|NCT01732796|58981802|FG002|Overall Study|Other reason not defined above|2|||
30942543|NCT01732640|58981812|FG000|Overall Study|Adverse Event|0|||
30942544|NCT01732640|58981813|FG001|Overall Study|Adverse Event|1|||
30942545|NCT01732640|58981812|FG000|Overall Study|Death|0|||
30942546|NCT01732640|58981813|FG001|Overall Study|Death|1|||
30942547|NCT01732484|58981823|FG000|Overall Study|Death|7|||
30942548|NCT01732484|58981823|FG000|Overall Study|Lost to Follow-up|14|||
30942549|NCT01732484|58981823|FG000|Overall Study|chronical illness|5|||
30942550|NCT01786148|58981831|FG000|Overall Study|Lost to Follow-up|21|||
30942551|NCT01786148|58981832|FG001|Overall Study|Lost to Follow-up|13|||
30942552|NCT01786148|58981831|FG000|Overall Study|Death|0|||
30942553|NCT01786148|58981832|FG001|Overall Study|Death|1|||
30942554|NCT01786148|58981831|FG000|Overall Study|Withdrawal by Subject|0|||
30942555|NCT01786148|58981832|FG001|Overall Study|Withdrawal by Subject|7|||
30942556|NCT01786148|58981831|FG000|Overall Study|Incarceration|1|||
30942557|NCT01786148|58981832|FG001|Overall Study|Incarceration|1|||
30624492|NCT00953745|58636575|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
30624493|NCT00953745|58636574|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
30624494|NCT00953745|58636575|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
30842515|NCT02692040|58868180|FG011|Overall Study|Adverse Event|0|||
30842516|NCT02692040|58868181|FG012|Overall Study|Adverse Event|0|||
30842517|NCT02692040|58868182|FG013|Overall Study|Adverse Event|3|||
30842518|NCT02692040|58868183|FG014|Overall Study|Adverse Event|1|||
30842519|NCT02692040|58868184|FG015|Overall Study|Adverse Event|1|||
30842520|NCT02692040|58868185|FG016|Overall Study|Adverse Event|0|||
30842521|NCT03029819|58868264|FG000|Overall Study|Lost to Follow-up|3|||
30842522|NCT03029819|58868265|FG001|Overall Study|Lost to Follow-up|5|||
30842523|NCT03029819|58868264|FG000|Overall Study|Removed due to disruptive behavior|0|||
30842524|NCT03029819|58868265|FG001|Overall Study|Removed due to disruptive behavior|1|||
30842525|NCT02678390|58868276|FG000|AE (1 Day)|Withdrawal by Subject|0|||
30842526|NCT02678390|58868277|FG001|AE (1 Day)|Withdrawal by Subject|1|||
30842527|NCT03027557|58868286|FG000|Overall Study|Adverse Event|1|||
30842528|NCT03027557|58868287|FG001|Overall Study|Adverse Event|0|||
30842529|NCT03027557|58868288|FG002|Overall Study|Adverse Event|0|||
30842530|NCT03029585|58868298|FG000|Overall Study|Death|1|||
30842531|NCT03029585|58868299|FG001|Overall Study|Death|1|||
30842532|NCT03029585|58868298|FG000|Overall Study|Withdrawal by Subject|1|||
30842533|NCT03029585|58868299|FG001|Overall Study|Withdrawal by Subject|0|||
30842534|NCT02678000|58868310|FG000|PART 2|Adverse Event|0|||
30842535|NCT02678000|58868311|FG001|PART 2|Adverse Event|0|||
30842536|NCT02678000|58868312|FG002|PART 2|Adverse Event|2|||
30842537|NCT02678000|58868313|FG003|PART 2|Adverse Event|1|||
30624495|NCT00953745|58636574|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
30624496|NCT00953745|58636575|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
30624497|NCT00953745|58636574|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
30624498|NCT00953745|58636575|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
30624499|NCT00902746|58636592|FG000|Overall Study|Protocol Violation|7|||
30624500|NCT00902746|58636592|FG000|Overall Study|Withdrawal by Subject|16|||
30624501|NCT00902746|58636592|FG000|Overall Study|Adverse Event|8|||
30624502|NCT00902746|58636592|FG000|Overall Study|Lost to Follow-up|3|||
30624503|NCT00902746|58636592|FG000|Overall Study|Physician Decision|2|||
30624504|NCT00902668|58636605|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
30624505|NCT00947349|58636613|FG000|Triple Treatment Combination Period|Adverse Event|0|||
30624506|NCT00947349|58636614|FG001|Triple Treatment Combination Period|Adverse Event|1|||
30624507|NCT00947349|58636615|FG002|Triple Treatment Combination Period|Adverse Event|0|||
30624508|NCT00947349|58636616|FG003|Triple Treatment Combination Period|Adverse Event|0|||
30842538|NCT02678000|58868314|FG004|PART 2|Adverse Event|0|||
30842539|NCT02678000|58868310|FG000|PART 2|Withdrawal by Subject|0|||
30842540|NCT02678000|58868311|FG001|PART 2|Withdrawal by Subject|0|||
30842541|NCT02678000|58868312|FG002|PART 2|Withdrawal by Subject|1|||
30942558|NCT01785602|58981844|FG000|Overall Study|Withdrawal by Subject|2|||
30942559|NCT01785602|58981845|FG001|Overall Study|Withdrawal by Subject|0|||
30942560|NCT01785602|58981844|FG000|Overall Study|Lost to Follow-up|1|||
30942561|NCT01785602|58981845|FG001|Overall Study|Lost to Follow-up|1|||
30942562|NCT01785602|58981844|FG000|Overall Study|Adverse Event|3|||
30942563|NCT01785602|58981845|FG001|Overall Study|Adverse Event|5|||
30942564|NCT01785602|58981844|FG000|Overall Study|Administrative problems|7|||
30942565|NCT01785602|58981845|FG001|Overall Study|Administrative problems|3|||
30942566|NCT01785524|58981853|FG000|Overall Study|Withdrawal by Subject|2|||
30942567|NCT01785524|58981854|FG001|Overall Study|Withdrawal by Subject|2|||
30942568|NCT01757288|58981863|FG000|Overall Study|Consent withdrawal|0|||
30942569|NCT01757288|58981864|FG001|Overall Study|Consent withdrawal|4|||
30942570|NCT01757288|58981865|FG002|Overall Study|Consent withdrawal|4|||
30942571|NCT01757288|58981863|FG000|Overall Study|Patient off study, IRB hold.|0|||
30942572|NCT01757288|58981864|FG001|Overall Study|Patient off study, IRB hold.|0|||
30942573|NCT01757288|58981865|FG002|Overall Study|Patient off study, IRB hold.|1|||
30942574|NCT01757288|58981863|FG000|Overall Study|Patient death prior to starting treatment|0|||
30942575|NCT01757288|58981864|FG001|Overall Study|Patient death prior to starting treatment|0|||
30942576|NCT01757288|58981865|FG002|Overall Study|Patient death prior to starting treatment|1|||
30942577|NCT01757288|58981863|FG000|Overall Study|Wrong medication administered|0|||
30942578|NCT01757288|58981864|FG001|Overall Study|Wrong medication administered|1|||
30942579|NCT01757288|58981865|FG002|Overall Study|Wrong medication administered|0|||
30942580|NCT01757288|58981863|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
30942581|NCT01757288|58981864|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
30942582|NCT01757288|58981865|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
30942583|NCT01757288|58981863|FG000|Overall Study|Not meeting protocol constraints|0|||
30942584|NCT01757288|58981864|FG001|Overall Study|Not meeting protocol constraints|1|||
30942585|NCT01757288|58981865|FG002|Overall Study|Not meeting protocol constraints|1|||
30942586|NCT01757288|58981863|FG000|Overall Study|Multiple missed appointments|0|||
30942587|NCT01757288|58981864|FG001|Overall Study|Multiple missed appointments|1|||
30942588|NCT01757288|58981865|FG002|Overall Study|Multiple missed appointments|0|||
30942589|NCT01757288|58981863|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
30942590|NCT01757288|58981864|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
30942591|NCT01757288|58981865|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
30942592|NCT01757288|58981863|FG000|Overall Study|>2 weeks treatment break|0|||
30942593|NCT01757288|58981864|FG001|Overall Study|>2 weeks treatment break|0|||
30942594|NCT01757288|58981865|FG002|Overall Study|>2 weeks treatment break|1|||
30942595|NCT01756898|58981878|FG000|Overall Study|Adverse Event|7|||
30942596|NCT01756898|58981879|FG001|Overall Study|Adverse Event|1|||
30942597|NCT01756898|58981880|FG002|Overall Study|Adverse Event|0|||
30942598|NCT01756898|58981881|FG003|Overall Study|Adverse Event|0|||
30942599|NCT01756898|58981878|FG000|Overall Study|Lack of Efficacy|4|||
30942600|NCT01756898|58981879|FG001|Overall Study|Lack of Efficacy|7|||
30942601|NCT01756898|58981880|FG002|Overall Study|Lack of Efficacy|6|||
30942602|NCT01756898|58981881|FG003|Overall Study|Lack of Efficacy|6|||
30942603|NCT01756898|58981878|FG000|Overall Study|Lost to Follow-up|2|||
30942604|NCT01756898|58981879|FG001|Overall Study|Lost to Follow-up|4|||
30942605|NCT01756898|58981880|FG002|Overall Study|Lost to Follow-up|2|||
30942606|NCT01756898|58981881|FG003|Overall Study|Lost to Follow-up|3|||
30942607|NCT01756898|58981878|FG000|Overall Study|Protocol Violation|1|||
30942608|NCT01756898|58981879|FG001|Overall Study|Protocol Violation|2|||
30942609|NCT01756898|58981880|FG002|Overall Study|Protocol Violation|2|||
30942610|NCT01756898|58981881|FG003|Overall Study|Protocol Violation|1|||
30942611|NCT01756898|58981878|FG000|Overall Study|Withdrew Consent|5|||
30942612|NCT01756898|58981879|FG001|Overall Study|Withdrew Consent|3|||
30942613|NCT01756898|58981880|FG002|Overall Study|Withdrew Consent|5|||
30942614|NCT01756898|58981881|FG003|Overall Study|Withdrew Consent|6|||
30942615|NCT01756898|58981878|FG000|Overall Study|Other|0|||
30942616|NCT01756898|58981879|FG001|Overall Study|Other|2|||
30942617|NCT01756898|58981880|FG002|Overall Study|Other|2|||
30942618|NCT01756898|58981881|FG003|Overall Study|Other|0|||
30942619|NCT01731938|58981898|FG000|Preliminary Part I|Withdrawal by Subject|2|||
30942620|NCT01731938|58981899|FG001|Preliminary Part I|Withdrawal by Subject|2|||
30842542|NCT02678000|58868313|FG003|PART 2|Withdrawal by Subject|0|||
30842543|NCT02678000|58868314|FG004|PART 2|Withdrawal by Subject|0|||
30842544|NCT02691572|58868341|FG000|Overall Study|Withdrawal by Subject|1|||
30842545|NCT02691572|58868342|FG001|Overall Study|Withdrawal by Subject|0|||
30842546|NCT02691572|58868341|FG000|Overall Study|Protocol Violation|0|||
30842547|NCT02691572|58868342|FG001|Overall Study|Protocol Violation|1|||
30842548|NCT02677844|58868350|FG000|Period 3|Withdrawal by Subject|0|||
30842549|NCT02677844|58868351|FG001|Period 3|Withdrawal by Subject|0|||
30842550|NCT02677844|58868352|FG002|Period 3|Withdrawal by Subject|0|||
30842551|NCT02677844|58868353|FG003|Period 3|Withdrawal by Subject|1|||
30942621|NCT01731938|58981898|FG000|Preliminary Part I|Physician Decision|1|||
30942622|NCT01731938|58981899|FG001|Preliminary Part I|Physician Decision|0|||
30942623|NCT01731938|58981898|FG000|Preliminary Part I|Lost to Follow-up|0|||
30942624|NCT01731938|58981899|FG001|Preliminary Part I|Lost to Follow-up|3|||
30942625|NCT01731938|58981898|FG000|Preliminary Part I|Missed Week 6 visit|0|||
30942626|NCT01731938|58981899|FG001|Preliminary Part I|Missed Week 6 visit|3|||
30942627|NCT01731938|58981898|FG000|Primary Part II|Withdrawal by Subject|5|||
30942628|NCT01731938|58981899|FG001|Primary Part II|Withdrawal by Subject|4|||
30942629|NCT01731938|58981898|FG000|Primary Part II|Lost to Follow-up|4|||
30942630|NCT01731938|58981899|FG001|Primary Part II|Lost to Follow-up|5|||
30942631|NCT01731938|58981898|FG000|Primary Part II|Death|2|||
30942632|NCT01731938|58981899|FG001|Primary Part II|Death|1|||
30942633|NCT01731938|58981898|FG000|Primary Part II|Missed Week 6 visit|2|||
30942634|NCT01731938|58981899|FG001|Primary Part II|Missed Week 6 visit|3|||
30942635|NCT01731470|58981906|FG000|Overall Study|Withdrawal by Subject|1|||
30942636|NCT01731470|58981906|FG000|Overall Study|Did not meet study criteria|1|||
30942637|NCT01756352|58981910|FG000|Overall Study|moved away and lost to followup|1|||
30942638|NCT01756274|58981914|FG000|Overall Study|Protocol Violation|2|||
30942639|NCT01756274|58981914|FG000|Overall Study|Laboratory error|1|||
30942640|NCT01731002|58981922|FG000|Overall Study|Adverse Event|0|||
30942641|NCT01731002|58981923|FG001|Overall Study|Adverse Event|2|||
30942642|NCT01731002|58981924|FG002|Overall Study|Adverse Event|2|||
30942643|NCT01731002|58981922|FG000|Overall Study|Non-Compliant|0|||
30942644|NCT01731002|58981923|FG001|Overall Study|Non-Compliant|1|||
30942645|NCT01731002|58981924|FG002|Overall Study|Non-Compliant|0|||
30942646|NCT01731002|58981922|FG000|Overall Study|Lost to Follow-up|1|||
30942647|NCT01731002|58981923|FG001|Overall Study|Lost to Follow-up|0|||
30942648|NCT01731002|58981924|FG002|Overall Study|Lost to Follow-up|0|||
30942649|NCT01731002|58981922|FG000|Overall Study|Test Agent Discontinuation|0|||
30942650|NCT01731002|58981923|FG001|Overall Study|Test Agent Discontinuation|1|||
30942651|NCT01731002|58981924|FG002|Overall Study|Test Agent Discontinuation|0|||
30942652|NCT01731002|58981922|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
30942653|NCT01731002|58981923|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
30942654|NCT01731002|58981924|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
30942655|NCT01731002|58981922|FG000|Overall Study|Elevated IOP|1|||
30942656|NCT01731002|58981923|FG001|Overall Study|Elevated IOP|0|||
30942657|NCT01731002|58981924|FG002|Overall Study|Elevated IOP|0|||
30942658|NCT01731002|58981922|FG000|Overall Study|Inappropriate use of study medications|0|||
30942659|NCT01731002|58981923|FG001|Overall Study|Inappropriate use of study medications|0|||
30942660|NCT01731002|58981924|FG002|Overall Study|Inappropriate use of study medications|1|||
30942661|NCT01783886|58981935|FG000|Overall Study|Lost to Follow-up|0|||
30942662|NCT01783886|58981936|FG001|Overall Study|Lost to Follow-up|3|||
30942663|NCT01783886|58981937|FG002|Overall Study|Lost to Follow-up|0|||
30942664|NCT01783886|58981935|FG000|Overall Study|Protocol deviation|0|||
30942665|NCT01783886|58981936|FG001|Overall Study|Protocol deviation|0|||
30942666|NCT01783886|58981937|FG002|Overall Study|Protocol deviation|2|||
30942667|NCT01783886|58981935|FG000|Overall Study|Withdrawal of consent by participant|1|||
30942668|NCT01783886|58981936|FG001|Overall Study|Withdrawal of consent by participant|3|||
30942669|NCT01783886|58981937|FG002|Overall Study|Withdrawal of consent by participant|4|||
30942670|NCT01783886|58981935|FG000|Overall Study|Adverse Event|4|||
30942671|NCT01783886|58981936|FG001|Overall Study|Adverse Event|5|||
30942672|NCT01783886|58981937|FG002|Overall Study|Adverse Event|4|||
30942673|NCT01609556|58981961|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
30942674|NCT01609556|58981962|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
30942675|NCT01609556|58981963|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
30942676|NCT01609556|58981964|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
30942677|NCT01609556|58981965|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
30942678|NCT01609556|58981966|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
30942679|NCT01609556|58981967|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
30942680|NCT01609556|58981968|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
30942681|NCT01609556|58981969|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
30942682|NCT01609556|58981970|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
30942683|NCT01609556|58981971|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
30942684|NCT01609556|58981972|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
30942685|NCT01609556|58981973|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
30942686|NCT01609556|58981974|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
30942687|NCT01609556|58981975|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
30942688|NCT01609556|58981976|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
30942689|NCT01609556|58981961|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
30842552|NCT02677844|58868354|FG004|Period 3|Withdrawal by Subject|0|||
30842553|NCT02677844|58868355|FG005|Period 3|Withdrawal by Subject|0|||
30842554|NCT02677844|58868356|FG006|Period 3|Withdrawal by Subject|0|||
30842555|NCT02691494|58868378|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
30842556|NCT02691494|58868379|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
30842557|NCT02691494|58868380|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
30842558|NCT02691494|58868378|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
30842559|NCT02691494|58868379|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
30942690|NCT01609556|58981962|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
30942691|NCT01609556|58981963|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
30942692|NCT01609556|58981964|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
30842560|NCT02691494|58868380|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
30942693|NCT01609556|58981965|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
30942694|NCT01609556|58981966|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
30942695|NCT01609556|58981967|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
30942696|NCT01609556|58981968|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
30942697|NCT01609556|58981969|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
30942698|NCT01609556|58981970|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
30942699|NCT01609556|58981971|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
30942700|NCT01609556|58981972|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
30942701|NCT01609556|58981973|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
30942702|NCT01609556|58981974|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
30942703|NCT01609556|58981975|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
30942704|NCT01609556|58981976|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
30942705|NCT01609556|58981961|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
30942706|NCT01609556|58981962|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
30942707|NCT01609556|58981963|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
30942708|NCT01609556|58981964|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
30942709|NCT01609556|58981965|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
30942710|NCT01609556|58981966|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
30942711|NCT01609556|58981967|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
30942712|NCT01609556|58981968|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
30942713|NCT01609556|58981969|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
30942714|NCT01609556|58981970|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
30942715|NCT01609556|58981971|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
30942716|NCT01609556|58981972|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
30942717|NCT01609556|58981973|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
30942718|NCT01609556|58981974|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
30942719|NCT01609556|58981975|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
30942720|NCT01609556|58981976|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
30942721|NCT01609556|58981961|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942722|NCT01609556|58981962|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942723|NCT01609556|58981963|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942724|NCT01609556|58981964|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942725|NCT01609556|58981965|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942726|NCT01609556|58981966|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
30942727|NCT01609556|58981967|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942728|NCT01609556|58981968|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942729|NCT01609556|58981969|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942730|NCT01609556|58981970|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942731|NCT01609556|58981971|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942732|NCT01609556|58981972|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
30942733|NCT01609556|58981973|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942734|NCT01609556|58981974|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942735|NCT01609556|58981975|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942736|NCT01609556|58981976|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
30942737|NCT01609556|58981961|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942738|NCT01609556|58981962|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942739|NCT01609556|58981963|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942740|NCT01609556|58981964|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942741|NCT01609556|58981965|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942742|NCT01609556|58981966|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
30942743|NCT01609556|58981967|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942744|NCT01609556|58981968|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942745|NCT01609556|58981969|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942746|NCT01609556|58981970|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942747|NCT01609556|58981971|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942748|NCT01609556|58981972|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942749|NCT01609556|58981973|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942750|NCT01609556|58981974|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942751|NCT01609556|58981975|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942752|NCT01609556|58981976|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
30942753|NCT01609556|58981961|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942754|NCT01609556|58981962|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942755|NCT01609556|58981963|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942756|NCT01609556|58981964|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942757|NCT01609556|58981965|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942758|NCT01609556|58981966|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942759|NCT01609556|58981967|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942760|NCT01609556|58981968|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942761|NCT01609556|58981969|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
30942762|NCT01609556|58981970|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942763|NCT01609556|58981971|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942764|NCT01609556|58981972|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942765|NCT01609556|58981973|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942766|NCT01609556|58981974|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942767|NCT01609556|58981975|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942768|NCT01609556|58981976|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
30942769|NCT01609556|58981961|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
30942770|NCT01609556|58981962|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942771|NCT01609556|58981963|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942772|NCT01609556|58981964|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942773|NCT01609556|58981965|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942774|NCT01609556|58981966|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
30942775|NCT01609556|58981967|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942776|NCT01609556|58981968|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942777|NCT01609556|58981969|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942778|NCT01609556|58981970|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942779|NCT01609556|58981971|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
30942780|NCT01609556|58981972|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942781|NCT01609556|58981973|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942782|NCT01609556|58981974|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942783|NCT01609556|58981975|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942784|NCT01609556|58981976|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
30942785|NCT01609556|58981961|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942786|NCT01609556|58981962|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942787|NCT01609556|58981963|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942788|NCT01609556|58981964|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942789|NCT01609556|58981965|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942790|NCT01609556|58981966|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942791|NCT01609556|58981967|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942792|NCT01609556|58981968|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942793|NCT01609556|58981969|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942794|NCT01609556|58981970|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942795|NCT01609556|58981971|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942796|NCT01609556|58981972|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
30942797|NCT01609556|58981973|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
30942798|NCT01609556|58981974|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
30942799|NCT01609556|58981975|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
30942800|NCT01609556|58981976|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
30942801|NCT01609556|58981961|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942802|NCT01609556|58981962|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942803|NCT01609556|58981963|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942804|NCT01609556|58981964|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942805|NCT01609556|58981965|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942806|NCT01609556|58981966|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942807|NCT01609556|58981967|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942808|NCT01609556|58981968|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942809|NCT01609556|58981969|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942810|NCT01609556|58981970|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942811|NCT01609556|58981971|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942812|NCT01609556|58981972|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
30942813|NCT01609556|58981973|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
30942814|NCT01609556|58981974|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
30942815|NCT01609556|58981975|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
30942816|NCT01609556|58981976|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
30942817|NCT01609556|58981961|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30942818|NCT01609556|58981962|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30942819|NCT01609556|58981963|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30942820|NCT01609556|58981964|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30942821|NCT01609556|58981965|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30842561|NCT02691494|58868378|FG000|Post-Treatment Follow-Up Period|Other|2|||
30842562|NCT02691494|58868379|FG001|Post-Treatment Follow-Up Period|Other|1|||
30842563|NCT02691494|58868380|FG002|Post-Treatment Follow-Up Period|Other|1|||
30942822|NCT01609556|58981966|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30942823|NCT01609556|58981967|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30942824|NCT01609556|58981968|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30942825|NCT01609556|58981969|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30942826|NCT01609556|58981970|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30942827|NCT01609556|58981971|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30942828|NCT01609556|58981972|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
30942829|NCT01609556|58981973|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
30942830|NCT01609556|58981974|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
30942831|NCT01609556|58981975|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
30942832|NCT01609556|58981976|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
30942833|NCT01609556|58981961|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942834|NCT01609556|58981962|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942835|NCT01609556|58981963|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942836|NCT01609556|58981964|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942837|NCT01609556|58981965|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942838|NCT01609556|58981966|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942839|NCT01609556|58981967|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942840|NCT01609556|58981968|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942841|NCT01609556|58981969|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942842|NCT01609556|58981970|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942843|NCT01609556|58981971|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942844|NCT01609556|58981972|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942845|NCT01609556|58981973|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
30942846|NCT01609556|58981974|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942847|NCT01609556|58981975|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942848|NCT01609556|58981976|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
30942849|NCT01609556|58981961|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942850|NCT01609556|58981962|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942851|NCT01609556|58981963|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942852|NCT01609556|58981964|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942853|NCT01609556|58981965|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942854|NCT01609556|58981966|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942855|NCT01609556|58981967|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942856|NCT01609556|58981968|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942857|NCT01609556|58981969|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942858|NCT01609556|58981970|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942859|NCT01609556|58981971|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942860|NCT01609556|58981972|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
30942861|NCT01609556|58981973|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
30942862|NCT01609556|58981974|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
30942863|NCT01609556|58981975|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
30942864|NCT01609556|58981976|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
30942865|NCT01609556|58981961|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942866|NCT01609556|58981962|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942867|NCT01609556|58981963|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942868|NCT01609556|58981964|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942869|NCT01609556|58981965|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942870|NCT01609556|58981966|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942871|NCT01609556|58981967|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942872|NCT01609556|58981968|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942873|NCT01609556|58981969|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942874|NCT01609556|58981970|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942875|NCT01609556|58981971|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942876|NCT01609556|58981972|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942877|NCT01609556|58981973|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942878|NCT01609556|58981974|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942879|NCT01609556|58981975|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
30942880|NCT01609556|58981976|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
30942881|NCT01609556|58981961|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942882|NCT01609556|58981962|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942883|NCT01609556|58981963|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942884|NCT01609556|58981964|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942885|NCT01609556|58981965|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942886|NCT01609556|58981966|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942887|NCT01609556|58981967|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942888|NCT01609556|58981968|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942889|NCT01609556|58981969|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942890|NCT01609556|58981970|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942891|NCT01609556|58981971|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942892|NCT01609556|58981972|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942893|NCT01609556|58981973|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
30942894|NCT01609556|58981974|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
30942895|NCT01609556|58981975|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
30942896|NCT01609556|58981976|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
30942897|NCT01609556|58981961|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942898|NCT01609556|58981962|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942899|NCT01609556|58981963|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942900|NCT01609556|58981964|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942901|NCT01609556|58981965|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942902|NCT01609556|58981966|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942903|NCT01609556|58981967|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942904|NCT01609556|58981968|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942905|NCT01609556|58981969|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942906|NCT01609556|58981970|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942907|NCT01609556|58981971|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942908|NCT01609556|58981972|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942909|NCT01609556|58981973|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
30942910|NCT01609556|58981974|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942911|NCT01609556|58981975|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942912|NCT01609556|58981976|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
30942913|NCT01763996|58982350|FG000|Treatment Period 2|Adverse Event|0|||
30942914|NCT01763996|58982351|FG001|Treatment Period 2|Adverse Event|1|||
30942915|NCT01468701|58982794|FG000|Overall Study|Not eligible|91|||
30942916|NCT01468701|58982795|FG001|Overall Study|Not eligible|140|||
30942917|NCT01468701|58982796|FG002|Overall Study|Not eligible|29|||
30942918|NCT01468701|58982797|FG003|Overall Study|Not eligible|12|||
30942919|NCT01468701|58982798|FG004|Overall Study|Not eligible|22|||
30942920|NCT01468701|58982799|FG005|Overall Study|Not eligible|2|||
30942921|NCT01468701|58982800|FG006|Overall Study|Not eligible|39|||
30942922|NCT01468701|58982801|FG007|Overall Study|Not eligible|1|||
30942923|NCT01468701|58982802|FG008|Overall Study|Not eligible|40|||
30942924|NCT01468701|58982803|FG009|Overall Study|Not eligible|126|||
30942925|NCT01468701|58982804|FG010|Overall Study|Not eligible|39|||
30942926|NCT01468701|58982805|FG011|Overall Study|Not eligible|33|||
30942927|NCT01468701|58982806|FG012|Overall Study|Not eligible|1|||
30942928|NCT01468701|58982807|FG013|Overall Study|Not eligible|19|||
30942929|NCT01468701|58982808|FG014|Overall Study|Not eligible|1|||
30942930|NCT01468701|58982809|FG015|Overall Study|Not eligible|32|||
30942931|NCT01468701|58982810|FG016|Overall Study|Not eligible|0|||
30942932|NCT01468701|58982794|FG000|Overall Study|Lost to Follow-up|306|||
30942933|NCT01468701|58982795|FG001|Overall Study|Lost to Follow-up|0|||
30942934|NCT01468701|58982796|FG002|Overall Study|Lost to Follow-up|0|||
30942935|NCT01468701|58982797|FG003|Overall Study|Lost to Follow-up|0|||
30942936|NCT01468701|58982798|FG004|Overall Study|Lost to Follow-up|0|||
30942937|NCT01468701|58982799|FG005|Overall Study|Lost to Follow-up|0|||
30842564|NCT02691494|58868378|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
30842565|NCT02691494|58868379|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
30942938|NCT01468701|58982800|FG006|Overall Study|Lost to Follow-up|0|||
30942939|NCT01468701|58982801|FG007|Overall Study|Lost to Follow-up|0|||
30942940|NCT01468701|58982802|FG008|Overall Study|Lost to Follow-up|215|||
30942941|NCT01468701|58982803|FG009|Overall Study|Lost to Follow-up|309|||
30942942|NCT01468701|58982804|FG010|Overall Study|Lost to Follow-up|224|||
30842566|NCT02691494|58868380|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
30942943|NCT01468701|58982805|FG011|Overall Study|Lost to Follow-up|212|||
30942944|NCT01468701|58982806|FG012|Overall Study|Lost to Follow-up|11|||
30942945|NCT01468701|58982807|FG013|Overall Study|Lost to Follow-up|164|||
30942946|NCT01468701|58982808|FG014|Overall Study|Lost to Follow-up|17|||
30942947|NCT01468701|58982809|FG015|Overall Study|Lost to Follow-up|127|||
30942948|NCT01468701|58982810|FG016|Overall Study|Lost to Follow-up|1|||
30942949|NCT01468701|58982794|FG000|Overall Study|Withdrawal by Subject|165|||
30942950|NCT01468701|58982795|FG001|Overall Study|Withdrawal by Subject|0|||
30942951|NCT01468701|58982796|FG002|Overall Study|Withdrawal by Subject|0|||
30942952|NCT01468701|58982797|FG003|Overall Study|Withdrawal by Subject|0|||
30942953|NCT01468701|58982798|FG004|Overall Study|Withdrawal by Subject|0|||
30942954|NCT01468701|58982799|FG005|Overall Study|Withdrawal by Subject|0|||
30942955|NCT01468701|58982800|FG006|Overall Study|Withdrawal by Subject|0|||
30942956|NCT01468701|58982801|FG007|Overall Study|Withdrawal by Subject|0|||
30942957|NCT01468701|58982802|FG008|Overall Study|Withdrawal by Subject|83|||
30942958|NCT01468701|58982803|FG009|Overall Study|Withdrawal by Subject|88|||
30942959|NCT01468701|58982804|FG010|Overall Study|Withdrawal by Subject|100|||
30942960|NCT01468701|58982805|FG011|Overall Study|Withdrawal by Subject|114|||
30942961|NCT01468701|58982806|FG012|Overall Study|Withdrawal by Subject|9|||
30942962|NCT01468701|58982807|FG013|Overall Study|Withdrawal by Subject|47|||
30942963|NCT01468701|58982808|FG014|Overall Study|Withdrawal by Subject|6|||
30942964|NCT01468701|58982809|FG015|Overall Study|Withdrawal by Subject|31|||
30942965|NCT01468701|58982810|FG016|Overall Study|Withdrawal by Subject|0|||
30942966|NCT01468701|58982794|FG000|Overall Study|Other reasons than listed|437|||
30942967|NCT01468701|58982795|FG001|Overall Study|Other reasons than listed|0|||
30942968|NCT01468701|58982796|FG002|Overall Study|Other reasons than listed|0|||
30942969|NCT01468701|58982797|FG003|Overall Study|Other reasons than listed|0|||
30942970|NCT01468701|58982798|FG004|Overall Study|Other reasons than listed|0|||
30942971|NCT01468701|58982799|FG005|Overall Study|Other reasons than listed|0|||
30942972|NCT01468701|58982800|FG006|Overall Study|Other reasons than listed|0|||
30942973|NCT01468701|58982801|FG007|Overall Study|Other reasons than listed|0|||
30942974|NCT01468701|58982802|FG008|Overall Study|Other reasons than listed|318|||
30942975|NCT01468701|58982803|FG009|Overall Study|Other reasons than listed|658|||
30942976|NCT01468701|58982804|FG010|Overall Study|Other reasons than listed|433|||
30942977|NCT01468701|58982805|FG011|Overall Study|Other reasons than listed|504|||
30942978|NCT01468701|58982806|FG012|Overall Study|Other reasons than listed|28|||
30942979|NCT01468701|58982807|FG013|Overall Study|Other reasons than listed|239|||
30942980|NCT01468701|58982808|FG014|Overall Study|Other reasons than listed|39|||
30942981|NCT01468701|58982809|FG015|Overall Study|Other reasons than listed|172|||
30942982|NCT01468701|58982810|FG016|Overall Study|Other reasons than listed|0|||
30942983|NCT01468701|58982794|FG000|Overall Study|No end of study case report form|0|||
30942984|NCT01468701|58982795|FG001|Overall Study|No end of study case report form|0|||
30942985|NCT01468701|58982796|FG002|Overall Study|No end of study case report form|0|||
30942986|NCT01468701|58982797|FG003|Overall Study|No end of study case report form|0|||
30942987|NCT01468701|58982798|FG004|Overall Study|No end of study case report form|0|||
30942988|NCT01468701|58982799|FG005|Overall Study|No end of study case report form|0|||
30942989|NCT01468701|58982800|FG006|Overall Study|No end of study case report form|0|||
30942990|NCT01468701|58982801|FG007|Overall Study|No end of study case report form|0|||
30942991|NCT01468701|58982802|FG008|Overall Study|No end of study case report form|4|||
30942992|NCT01468701|58982803|FG009|Overall Study|No end of study case report form|1|||
30942993|NCT01468701|58982804|FG010|Overall Study|No end of study case report form|2|||
30942994|NCT01468701|58982805|FG011|Overall Study|No end of study case report form|3|||
30942995|NCT01468701|58982806|FG012|Overall Study|No end of study case report form|0|||
30942996|NCT01468701|58982807|FG013|Overall Study|No end of study case report form|1|||
30942997|NCT01468701|58982808|FG014|Overall Study|No end of study case report form|0|||
30942998|NCT01468701|58982809|FG015|Overall Study|No end of study case report form|0|||
30942999|NCT01468701|58982810|FG016|Overall Study|No end of study case report form|0|||
30943000|NCT01468701|58982794|FG000|Overall Study|Not being followed up|0|||
30943001|NCT01468701|58982795|FG001|Overall Study|Not being followed up|4963|||
30943002|NCT01468701|58982796|FG002|Overall Study|Not being followed up|1755|||
30943003|NCT01468701|58982797|FG003|Overall Study|Not being followed up|703|||
30943004|NCT01468701|58982798|FG004|Overall Study|Not being followed up|1714|||
30943005|NCT01468701|58982799|FG005|Overall Study|Not being followed up|126|||
30943006|NCT01468701|58982800|FG006|Overall Study|Not being followed up|1170|||
30943007|NCT01468701|58982801|FG007|Overall Study|Not being followed up|4|||
30943008|NCT01468701|58982802|FG008|Overall Study|Not being followed up|0|||
30943009|NCT01468701|58982803|FG009|Overall Study|Not being followed up|0|||
30943010|NCT01468701|58982804|FG010|Overall Study|Not being followed up|0|||
30943011|NCT01468701|58982805|FG011|Overall Study|Not being followed up|0|||
30943012|NCT01468701|58982806|FG012|Overall Study|Not being followed up|0|||
30943013|NCT01468701|58982807|FG013|Overall Study|Not being followed up|0|||
30943014|NCT01468701|58982808|FG014|Overall Study|Not being followed up|0|||
30943015|NCT01468701|58982809|FG015|Overall Study|Not being followed up|0|||
30943016|NCT01468701|58982810|FG016|Overall Study|Not being followed up|0|||
30943017|NCT01492101|58982825|FG000|Overall Study|Death|323|||
30943018|NCT01492101|58982826|FG001|Overall Study|Death|322|||
30943019|NCT01492101|58982825|FG000|Overall Study|Withdrawal by Subject|14|||
30943020|NCT01492101|58982826|FG001|Overall Study|Withdrawal by Subject|18|||
30943021|NCT01492101|58982825|FG000|Overall Study|Lost to Follow-up|0|||
30943022|NCT01492101|58982826|FG001|Overall Study|Lost to Follow-up|2|||
30943023|NCT01468311|58982832|FG000|Overall Study|mobilization failure|1|||
30943024|NCT01468311|58982832|FG000|Overall Study|Withdrawal by Subject|1|||
30943025|NCT01730534|58982943|FG000|Overall Study|Withdrawal by Subject|97|||
30943026|NCT01730534|58982944|FG001|Overall Study|Withdrawal by Subject|127|||
30943027|NCT01730534|58982943|FG000|Overall Study|Lost to Follow-up|12|||
30943028|NCT01730534|58982944|FG001|Overall Study|Lost to Follow-up|18|||
30943029|NCT01783730|58982964|FG000|Overall Study|Failed to meet inclusion criteria|6|||
30943030|NCT01730378|58982970|FG000|Overall Study|Lost to Follow-up|1|||
30943031|NCT01730378|58982971|FG001|Overall Study|Lost to Follow-up|0|||
30943032|NCT01783496|58982984|FG000|Overall Study|Lost to Follow-up|0|||
30943033|NCT01783496|58982985|FG001|Overall Study|Lost to Follow-up|0|||
30943034|NCT01783496|58982986|FG002|Overall Study|Lost to Follow-up|0|||
30943035|NCT01783496|58982987|FG003|Overall Study|Lost to Follow-up|2|||
30943036|NCT01783496|58982988|FG004|Overall Study|Lost to Follow-up|0|||
30943037|NCT01783496|58982989|FG005|Overall Study|Lost to Follow-up|1|||
30943038|NCT01783496|58982984|FG000|Overall Study|Withdrawal by Subject|1|||
30943039|NCT01783496|58982985|FG001|Overall Study|Withdrawal by Subject|0|||
30943040|NCT01783496|58982986|FG002|Overall Study|Withdrawal by Subject|0|||
30943041|NCT01783496|58982987|FG003|Overall Study|Withdrawal by Subject|0|||
30943042|NCT01783496|58982988|FG004|Overall Study|Withdrawal by Subject|0|||
30943043|NCT01783496|58982989|FG005|Overall Study|Withdrawal by Subject|0|||
30943044|NCT01729208|58983014|FG000|Baseline|Physician Decision|5|||
30943045|NCT01729208|58983015|FG001|Baseline|Physician Decision|4|||
30943046|NCT01729208|58983014|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
30943047|NCT01729208|58983015|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
30943048|NCT01729208|58983014|FG000|12 Months Follow-up|Lost to Follow-up|3|||
30943049|NCT01729208|58983015|FG001|12 Months Follow-up|Lost to Follow-up|3|||
30943050|NCT01729208|58983014|FG000|24 Months Follow-up|Lost to Follow-up|3|||
30943051|NCT01729208|58983015|FG001|24 Months Follow-up|Lost to Follow-up|0|||
30943052|NCT01729208|58983014|FG000|36 Months Follow-up|Physician Decision|1|||
30943053|NCT01729208|58983015|FG001|36 Months Follow-up|Physician Decision|0|||
30943054|NCT01729208|58983014|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
30943055|NCT01729208|58983015|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
30943056|NCT01609010|58983032|FG000|Overall Study|Stable disease (SD)|22|||
30943057|NCT01609010|58983033|FG001|Overall Study|Stable disease (SD)|16|||
30943058|NCT01609010|58983032|FG000|Overall Study|Progressive disease (PD)|8|||
30943059|NCT01609010|58983033|FG001|Overall Study|Progressive disease (PD)|10|||
30943060|NCT01609010|58983032|FG000|Overall Study|Adverse Event|3|||
30943061|NCT01609010|58983033|FG001|Overall Study|Adverse Event|6|||
30943062|NCT01609010|58983032|FG000|Overall Study|Withdrawal by Subject|2|||
30943063|NCT01609010|58983033|FG001|Overall Study|Withdrawal by Subject|2|||
30943064|NCT01609010|58983032|FG000|Overall Study|Other|2|||
30943065|NCT01609010|58983033|FG001|Overall Study|Other|0|||
30943066|NCT01609010|58983032|FG000|Overall Study|Other malignancy|1|||
30943067|NCT01609010|58983033|FG001|Overall Study|Other malignancy|0|||
30943068|NCT01609010|58983032|FG000|Overall Study|Pathology review|2|||
30943069|NCT01609010|58983033|FG001|Overall Study|Pathology review|1|||
30943070|NCT01609010|58983032|FG000|Overall Study|Protocol Violation|1|||
30943071|NCT01609010|58983033|FG001|Overall Study|Protocol Violation|1|||
30943072|NCT01609010|58983032|FG000|Overall Study|New cancer|1|||
30943073|NCT01609010|58983033|FG001|Overall Study|New cancer|0|||
30943074|NCT01609010|58983032|FG000|Overall Study|Lost to Follow-up|1|||
30943075|NCT01609010|58983033|FG001|Overall Study|Lost to Follow-up|1|||
30943076|NCT01608308|58983041|FG000|Overall Study|pretreatment medical and billing reasons|0|||
30943077|NCT01608308|58983042|FG001|Overall Study|pretreatment medical and billing reasons|2|||
30943078|NCT01755416|58983073|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
30943079|NCT01755416|58983074|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
30943080|NCT01755026|58983082|FG000|Overall Study|Adverse Event|1|||
30943081|NCT01755026|58983083|FG001|Overall Study|Adverse Event|0|||
30943082|NCT01755026|58983082|FG000|Overall Study|Withdrawal by Subject|1|||
30943083|NCT01755026|58983083|FG001|Overall Study|Withdrawal by Subject|1|||
30943084|NCT01491945|58983098|FG000|Overall Study|Death|30|||
30943085|NCT01491945|58983098|FG000|Overall Study|Withdrwan/LTF|16|||
30943086|NCT01491945|58983098|FG000|Overall Study|Conversion|4|||
30943087|NCT01491945|58983098|FG000|Overall Study|Missed Visit|1|||
30943088|NCT01728584|58983120|FG000|Overall Study|Adverse Event|1|||
30943089|NCT01728584|58983121|FG001|Overall Study|Adverse Event|0|||
30943090|NCT01728584|58983122|FG002|Overall Study|Adverse Event|0|||
30943091|NCT01728584|58983123|FG003|Overall Study|Adverse Event|0|||
30943092|NCT01728584|58983120|FG000|Overall Study|Physician Decision|4|||
30943093|NCT01728584|58983121|FG001|Overall Study|Physician Decision|0|||
30943094|NCT01728584|58983122|FG002|Overall Study|Physician Decision|1|||
30943095|NCT01728584|58983123|FG003|Overall Study|Physician Decision|0|||
30943096|NCT01728584|58983120|FG000|Overall Study|Withdrawal by Subject|1|||
30943097|NCT01728584|58983121|FG001|Overall Study|Withdrawal by Subject|0|||
30943098|NCT01728584|58983122|FG002|Overall Study|Withdrawal by Subject|0|||
30943099|NCT01728584|58983123|FG003|Overall Study|Withdrawal by Subject|0|||
30943100|NCT01728584|58983120|FG000|Overall Study|Screen failure|1|||
30943101|NCT01728584|58983121|FG001|Overall Study|Screen failure|0|||
30943102|NCT01728584|58983122|FG002|Overall Study|Screen failure|0|||
30943103|NCT01728584|58983123|FG003|Overall Study|Screen failure|0|||
30943104|NCT01728584|58983120|FG000|Overall Study|Other reason (not specified)|1|||
30943105|NCT01728584|58983121|FG001|Overall Study|Other reason (not specified)|0|||
30943106|NCT01728584|58983122|FG002|Overall Study|Other reason (not specified)|0|||
30943107|NCT01728584|58983123|FG003|Overall Study|Other reason (not specified)|1|||
30943108|NCT01522443|58983156|FG000|Overall Study|No longer receiving clinical benefit|36|||
30943109|NCT01522443|58983157|FG001|Overall Study|No longer receiving clinical benefit|28|||
30943110|NCT01522443|58983156|FG000|Overall Study|Adverse Event|10|||
30943111|NCT01522443|58983157|FG001|Overall Study|Adverse Event|15|||
30943112|NCT01522443|58983156|FG000|Overall Study|Withdrawal by Subject|5|||
30943113|NCT01522443|58983157|FG001|Overall Study|Withdrawal by Subject|8|||
30943114|NCT01522443|58983156|FG000|Overall Study|No study treatment given|1|||
30943115|NCT01522443|58983157|FG001|Overall Study|No study treatment given|1|||
30943116|NCT01522443|58983156|FG000|Overall Study|Other|1|||
30943117|NCT01522443|58983157|FG001|Overall Study|Other|3|||
30943118|NCT01468233|58983178|FG000|Treatment Period 1|Adverse Event|5|||
30943119|NCT01468233|58983179|FG001|Treatment Period 1|Adverse Event|3|||
30943120|NCT01468233|58983180|FG002|Treatment Period 1|Adverse Event|0|||
30943121|NCT01468233|58983181|FG003|Treatment Period 1|Adverse Event|0|||
30943122|NCT01468233|58983182|FG004|Treatment Period 1|Adverse Event|0|||
30943123|NCT01468233|58983183|FG005|Treatment Period 1|Adverse Event|0|||
30943124|NCT01468233|58983178|FG000|Treatment Period 1|Withdrawal by Subject|3|||
30943125|NCT01468233|58983179|FG001|Treatment Period 1|Withdrawal by Subject|4|||
30943126|NCT01468233|58983180|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30943127|NCT01468233|58983181|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30943128|NCT01468233|58983182|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30943129|NCT01468233|58983183|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30943130|NCT01468233|58983178|FG000|Treatment Period 1|Lost to Follow-up|3|||
30943131|NCT01468233|58983179|FG001|Treatment Period 1|Lost to Follow-up|0|||
30943132|NCT01468233|58983180|FG002|Treatment Period 1|Lost to Follow-up|0|||
30943133|NCT01468233|58983181|FG003|Treatment Period 1|Lost to Follow-up|0|||
30943134|NCT01468233|58983182|FG004|Treatment Period 1|Lost to Follow-up|0|||
30943135|NCT01468233|58983183|FG005|Treatment Period 1|Lost to Follow-up|0|||
30943136|NCT01468233|58983178|FG000|Treatment Period 1|Other|1|||
30943137|NCT01468233|58983179|FG001|Treatment Period 1|Other|1|||
30943138|NCT01468233|58983180|FG002|Treatment Period 1|Other|0|||
30943139|NCT01468233|58983181|FG003|Treatment Period 1|Other|0|||
30943140|NCT01468233|58983182|FG004|Treatment Period 1|Other|0|||
30943141|NCT01468233|58983183|FG005|Treatment Period 1|Other|0|||
30943142|NCT01468233|58983178|FG000|Treatment Period 2|Adverse Event|0|||
30943143|NCT01468233|58983179|FG001|Treatment Period 2|Adverse Event|0|||
30943144|NCT01468233|58983180|FG002|Treatment Period 2|Adverse Event|3|||
30943145|NCT01468233|58983181|FG003|Treatment Period 2|Adverse Event|0|||
30943146|NCT01468233|58983182|FG004|Treatment Period 2|Adverse Event|2|||
30943147|NCT01468233|58983183|FG005|Treatment Period 2|Adverse Event|1|||
30943148|NCT01468233|58983178|FG000|Treatment Period 2|Lack of Efficacy|0|||
30943149|NCT01468233|58983179|FG001|Treatment Period 2|Lack of Efficacy|0|||
30759475|NCT03808298|58767917|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
30759476|NCT00077636|58767948|FG000|Overall Study|Refused Treatment|9|||
30759477|NCT00077636|58767949|FG001|Overall Study|Refused Treatment|31|||
30759478|NCT00077636|58767948|FG000|Overall Study|Admin|3|||
30759479|NCT00077636|58767949|FG001|Overall Study|Admin|3|||
30759480|NCT00077636|58767948|FG000|Overall Study|Withdrawal by Subject|2|||
30759481|NCT00077636|58767949|FG001|Overall Study|Withdrawal by Subject|2|||
30759482|NCT00077636|58767948|FG000|Overall Study|Adverse Event|17|||
30759483|NCT00077636|58767949|FG001|Overall Study|Adverse Event|34|||
30759484|NCT00077636|58767948|FG000|Overall Study|Protocol Violation|0|||
30943150|NCT01468233|58983180|FG002|Treatment Period 2|Lack of Efficacy|9|||
30943151|NCT01468233|58983181|FG003|Treatment Period 2|Lack of Efficacy|2|||
30759485|NCT00077636|58767949|FG001|Overall Study|Protocol Violation|2|||
30759486|NCT00077636|58767948|FG000|Overall Study|Lost to Follow-up|10|||
30943152|NCT01468233|58983182|FG004|Treatment Period 2|Lack of Efficacy|0|||
30943153|NCT01468233|58983183|FG005|Treatment Period 2|Lack of Efficacy|1|||
30943154|NCT01468233|58983178|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30943155|NCT01468233|58983179|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30943156|NCT01468233|58983180|FG002|Treatment Period 2|Withdrawal by Subject|9|||
30943157|NCT01468233|58983181|FG003|Treatment Period 2|Withdrawal by Subject|1|||
30943158|NCT01468233|58983182|FG004|Treatment Period 2|Withdrawal by Subject|1|||
30943159|NCT01468233|58983183|FG005|Treatment Period 2|Withdrawal by Subject|1|||
30943160|NCT01468233|58983178|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
30943161|NCT01468233|58983179|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
30943162|NCT01468233|58983180|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
30943163|NCT01468233|58983181|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
30943164|NCT01468233|58983182|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
30943165|NCT01468233|58983183|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
30943166|NCT01468233|58983178|FG000|Treatment Period 2|Lost to Follow-up|0|||
30943167|NCT01468233|58983179|FG001|Treatment Period 2|Lost to Follow-up|0|||
30943168|NCT01468233|58983180|FG002|Treatment Period 2|Lost to Follow-up|3|||
30943169|NCT01468233|58983181|FG003|Treatment Period 2|Lost to Follow-up|0|||
30943170|NCT01468233|58983182|FG004|Treatment Period 2|Lost to Follow-up|2|||
30943171|NCT01468233|58983183|FG005|Treatment Period 2|Lost to Follow-up|0|||
30943172|NCT01468233|58983178|FG000|Treatment Period 2|Other|0|||
30943173|NCT01468233|58983179|FG001|Treatment Period 2|Other|0|||
30943174|NCT01468233|58983180|FG002|Treatment Period 2|Other|3|||
30943175|NCT01468233|58983181|FG003|Treatment Period 2|Other|0|||
30943176|NCT01468233|58983182|FG004|Treatment Period 2|Other|1|||
30943177|NCT01468233|58983183|FG005|Treatment Period 2|Other|0|||
30943178|NCT01468077|58983203|FG000|Overall Study|Adverse Event|2|||
30943179|NCT01468077|58983204|FG001|Overall Study|Adverse Event|2|||
30943180|NCT01468077|58983203|FG000|Overall Study|Lack of Efficacy|1|||
30943181|NCT01468077|58983204|FG001|Overall Study|Lack of Efficacy|1|||
30943182|NCT01468077|58983203|FG000|Overall Study|Physician Decision|1|||
30943183|NCT01468077|58983204|FG001|Overall Study|Physician Decision|0|||
30943184|NCT01522365|58983212|FG000|Overall Study|Withdrawal by Subject|1|||
30943185|NCT01522365|58983213|FG001|Overall Study|Withdrawal by Subject|1|||
30943186|NCT01522365|58983212|FG000|Overall Study|Lost to Follow-up|1|||
30943187|NCT01522365|58983213|FG001|Overall Study|Lost to Follow-up|1|||
30943188|NCT01754402|58983223|FG000|Overall Study|Death|0|||
30943189|NCT01754402|58983224|FG001|Overall Study|Death|0|||
30943190|NCT01754402|58983225|FG002|Overall Study|Death|1|||
30943191|NCT01754402|58983223|FG000|Overall Study|Adverse Event|2|||
30943192|NCT01754402|58983224|FG001|Overall Study|Adverse Event|2|||
30943193|NCT01754402|58983225|FG002|Overall Study|Adverse Event|1|||
30943194|NCT01754402|58983223|FG000|Overall Study|Withdrawal by Subject|0|||
30943195|NCT01754402|58983224|FG001|Overall Study|Withdrawal by Subject|0|||
30943196|NCT01754402|58983225|FG002|Overall Study|Withdrawal by Subject|1|||
30943197|NCT01754402|58983223|FG000|Overall Study|Lack of Efficacy|0|||
30943198|NCT01754402|58983224|FG001|Overall Study|Lack of Efficacy|0|||
30943199|NCT01754402|58983225|FG002|Overall Study|Lack of Efficacy|1|||
30759487|NCT00077636|58767949|FG001|Overall Study|Lost to Follow-up|18|||
30759488|NCT00077636|58767948|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
30759489|NCT00077636|58767949|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
30759490|NCT00095199|58767960|FG000|Overall Study|Adverse Event|40|||
30759491|NCT00095199|58767961|FG001|Overall Study|Adverse Event|22|||
30759492|NCT00095199|58767962|FG002|Overall Study|Adverse Event|26|||
30759493|NCT00095199|58767963|FG003|Overall Study|Adverse Event|11|||
30759494|NCT00095199|58767960|FG000|Overall Study|Progressive disease|213|||
30759495|NCT00095199|58767961|FG001|Overall Study|Progressive disease|179|||
30759496|NCT00095199|58767962|FG002|Overall Study|Progressive disease|105|||
30759497|NCT00095199|58767963|FG003|Overall Study|Progressive disease|98|||
30759498|NCT00095199|58767960|FG000|Overall Study|Death|10|||
30759499|NCT00095199|58767961|FG001|Overall Study|Death|6|||
30759500|NCT00095199|58767962|FG002|Overall Study|Death|11|||
30759501|NCT00095199|58767963|FG003|Overall Study|Death|9|||
30759502|NCT00095199|58767960|FG000|Overall Study|Withdrawal by Subject|21|||
30759503|NCT00095199|58767961|FG001|Overall Study|Withdrawal by Subject|16|||
30759504|NCT00095199|58767962|FG002|Overall Study|Withdrawal by Subject|13|||
30759505|NCT00095199|58767963|FG003|Overall Study|Withdrawal by Subject|22|||
30759506|NCT00095199|58767960|FG000|Overall Study|Protocol Violation|4|||
30943200|NCT01783418|58983236|FG000|Overall Study|Withdrawal by Subject|1|||
30943201|NCT01783418|58983237|FG001|Overall Study|Withdrawal by Subject|0|||
30943202|NCT01521897|58983243|FG000|Overall Study|Protocol Violation|18|||
30943203|NCT01521897|58983243|FG000|Overall Study|Lost to Follow-up|5|||
30943204|NCT01782872|58983251|FG000|Overall Study|Protocol Violation|0|||
30943205|NCT01782872|58983252|FG001|Overall Study|Protocol Violation|0|||
30943206|NCT01782872|58983253|FG002|Overall Study|Protocol Violation|0|||
30759507|NCT00095199|58767961|FG001|Overall Study|Protocol Violation|4|||
30759508|NCT00095199|58767962|FG002|Overall Study|Protocol Violation|2|||
30759509|NCT00095199|58767963|FG003|Overall Study|Protocol Violation|0|||
30759510|NCT00095199|58767960|FG000|Overall Study|Liver function test results elevated|0|||
30943207|NCT01782872|58983254|FG003|Overall Study|Protocol Violation|1|||
30943208|NCT01782872|58983251|FG000|Overall Study|Withdrawal by Subject|0|||
30759511|NCT00095199|58767961|FG001|Overall Study|Liver function test results elevated|0|||
30943209|NCT01782872|58983252|FG001|Overall Study|Withdrawal by Subject|1|||
30943210|NCT01782872|58983253|FG002|Overall Study|Withdrawal by Subject|0|||
30943211|NCT01782872|58983254|FG003|Overall Study|Withdrawal by Subject|0|||
30943212|NCT01490697|58983266|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
30943213|NCT01490697|58983267|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
30943214|NCT01728194|58983275|FG000|Overall Study|Lost to Follow-up|4|||
30943215|NCT01728194|58983276|FG001|Overall Study|Lost to Follow-up|3|||
30943216|NCT01728194|58983275|FG000|Overall Study|Physician Decision|4|||
30943217|NCT01728194|58983276|FG001|Overall Study|Physician Decision|0|||
30943218|NCT01728194|58983275|FG000|Overall Study|Withdrawal by Subject|7|||
30943219|NCT01728194|58983276|FG001|Overall Study|Withdrawal by Subject|3|||
30943220|NCT01728194|58983275|FG000|Overall Study|Perceived Medication Side Effects|4|||
30943221|NCT01728194|58983276|FG001|Overall Study|Perceived Medication Side Effects|0|||
30943222|NCT01728194|58983275|FG000|Overall Study|Family Member Request|1|||
30943223|NCT01728194|58983276|FG001|Overall Study|Family Member Request|0|||
30943224|NCT01782482|58983284|FG000|Overall Study|Adverse Event|2|||
30943225|NCT01782482|58983285|FG001|Overall Study|Adverse Event|1|||
30943226|NCT01782482|58983284|FG000|Overall Study|Lost to Follow-up|2|||
30943227|NCT01782482|58983285|FG001|Overall Study|Lost to Follow-up|3|||
30943228|NCT01782482|58983284|FG000|Overall Study|Physician Decision|1|||
30943229|NCT01782482|58983285|FG001|Overall Study|Physician Decision|0|||
30943230|NCT01782482|58983284|FG000|Overall Study|Protocol Violation|1|||
30943231|NCT01782482|58983285|FG001|Overall Study|Protocol Violation|0|||
30943232|NCT01782482|58983284|FG000|Overall Study|Withdrawal by Subject|2|||
30943233|NCT01782482|58983285|FG001|Overall Study|Withdrawal by Subject|3|||
30943234|NCT01782482|58983284|FG000|Overall Study|Randomized in Error|2|||
30943235|NCT01782482|58983285|FG001|Overall Study|Randomized in Error|2|||
30943236|NCT01782482|58983284|FG000|Overall Study|Habitually wearing toric lens OS|0|||
30943237|NCT01782482|58983285|FG001|Overall Study|Habitually wearing toric lens OS|1|||
30943238|NCT01466673|58983293|FG000|Overall Study|Non-compliance with study treatment|2|||
30943239|NCT01466673|58983294|FG001|Overall Study|Non-compliance with study treatment|0|||
30624509|NCT00947349|58636613|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
30624510|NCT00947349|58636614|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
30624511|NCT00947349|58636615|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
30624512|NCT00947349|58636616|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
30842567|NCT02691494|58868378|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
30842568|NCT02691494|58868379|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
30943240|NCT01466673|58983293|FG000|Overall Study|Lost to Follow-up|3|||
30943241|NCT01466673|58983294|FG001|Overall Study|Lost to Follow-up|5|||
30943242|NCT01466673|58983293|FG000|Overall Study|Adverse Event|2|||
30943243|NCT01466673|58983294|FG001|Overall Study|Adverse Event|1|||
30943244|NCT01753856|58983302|FG000|Overall Study|Adverse Event|1|||
30943245|NCT01753856|58983303|FG001|Overall Study|Adverse Event|0|||
30943246|NCT01753856|58983302|FG000|Overall Study|Withdrawal by Subject|0|||
30943247|NCT01753856|58983303|FG001|Overall Study|Withdrawal by Subject|2|||
30943248|NCT01753856|58983302|FG000|Overall Study|Sponsor Decision|2|||
30943249|NCT01753856|58983303|FG001|Overall Study|Sponsor Decision|0|||
30943250|NCT01464333|58983312|FG000|Overall Study|Adverse Event|34|||
30943251|NCT01464333|58983312|FG000|Overall Study|Lack of Efficacy|72|||
30943252|NCT01464333|58983312|FG000|Overall Study|Withdrawal by Subject|11|||
30943253|NCT01464333|58983312|FG000|Overall Study|Other|4|||
30943254|NCT01464333|58983312|FG000|Overall Study|No Hospital Visit|42|||
30943255|NCT01464255|58983318|FG000|Overall Study|unresolve corneal staining|0|||
30943256|NCT01464255|58983319|FG001|Overall Study|unresolve corneal staining|1|||
30943257|NCT01464021|58983326|FG000|Overall Study|Withdrawal by Subject|13|||
30943258|NCT01464021|58983326|FG000|Overall Study|Lost to Follow-up|1|||
30943259|NCT01464021|58983326|FG000|Overall Study|Lack of Efficacy|1|||
30943260|NCT01464021|58983326|FG000|Overall Study|various|11|||
30943261|NCT01753310|58983332|FG000|Overall Study|Entered into open label extension study|25|||
30943262|NCT01753310|58983333|FG001|Overall Study|Entered into open label extension study|22|||
30943263|NCT01753310|58983332|FG000|Overall Study|Adverse Event|1|||
30943264|NCT01753310|58983333|FG001|Overall Study|Adverse Event|0|||
30943265|NCT01753310|58983332|FG000|Overall Study|Lost to Follow-up|2|||
30943266|NCT01753310|58983333|FG001|Overall Study|Lost to Follow-up|0|||
30943267|NCT01753310|58983332|FG000|Overall Study|Subject decision|2|||
30943268|NCT01753310|58983333|FG001|Overall Study|Subject decision|2|||
30943269|NCT01753310|58983332|FG000|Overall Study|Sponsor decision|1|||
30943270|NCT01753310|58983333|FG001|Overall Study|Sponsor decision|0|||
30943271|NCT01753310|58983332|FG000|Overall Study|Withdrawal by Subject|1|||
30943272|NCT01753310|58983333|FG001|Overall Study|Withdrawal by Subject|0|||
30943273|NCT01463631|58983343|FG000|Overall Study|Withdrawal by Subject|0|||
30943274|NCT01463631|58983344|FG001|Overall Study|Withdrawal by Subject|0|||
30624513|NCT00947349|58636613|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
30943275|NCT01463631|58983345|FG002|Overall Study|Withdrawal by Subject|0|||
30943276|NCT01463631|58983346|FG003|Overall Study|Withdrawal by Subject|1|||
30943277|NCT01463631|58983343|FG000|Overall Study|Death|0|||
30943278|NCT01463631|58983344|FG001|Overall Study|Death|0|||
30943279|NCT01463631|58983345|FG002|Overall Study|Death|1|||
30943280|NCT01463631|58983346|FG003|Overall Study|Death|0|||
30943281|NCT01463631|58983343|FG000|Overall Study|Progressive Disease|0|||
30943282|NCT01463631|58983344|FG001|Overall Study|Progressive Disease|0|||
30943283|NCT01463631|58983345|FG002|Overall Study|Progressive Disease|0|||
30943284|NCT01463631|58983346|FG003|Overall Study|Progressive Disease|5|||
30943285|NCT01521507|58983360|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
30943286|NCT01521507|58983361|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
30943287|NCT01521507|58983360|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
30943288|NCT01521507|58983361|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
30943289|NCT01521507|58983360|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
30943290|NCT01521507|58983361|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
30943291|NCT01521507|58983360|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
30943292|NCT01521507|58983361|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
30943293|NCT01521507|58983360|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
30943294|NCT01521507|58983361|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
30943295|NCT01521507|58983360|FG000|Stage 2: Observational Design|Physician Decision|1|||
30943296|NCT01521507|58983361|FG001|Stage 2: Observational Design|Physician Decision|0|||
30943297|NCT01521117|58983374|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
30943298|NCT01521117|58983375|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
30943299|NCT01521117|58983374|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
30943300|NCT01521117|58983375|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
30943301|NCT01521117|58983374|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
30943302|NCT01521117|58983375|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
30943303|NCT01466595|58983383|FG000|Overall Study|Withdrawal by Subject|0|||
30943304|NCT01466595|58983384|FG001|Overall Study|Withdrawal by Subject|1|||
30943305|NCT01728116|58983401|FG000|Overall Study|Sponsor Terminated Study|106|||
30943306|NCT01728116|58983402|FG001|Overall Study|Sponsor Terminated Study|35|||
30943307|NCT01728116|58983401|FG000|Overall Study|Withdrawal by Subject|16|||
30943308|NCT01728116|58983402|FG001|Overall Study|Withdrawal by Subject|9|||
30943309|NCT01728116|58983401|FG000|Overall Study|Adverse Event|13|||
30943310|NCT01728116|58983402|FG001|Overall Study|Adverse Event|0|||
30943311|NCT01728116|58983401|FG000|Overall Study|Procedure/device failure|7|||
30943312|NCT01728116|58983402|FG001|Overall Study|Procedure/device failure|0|||
30943313|NCT01728116|58983401|FG000|Overall Study|Lost to Follow-up|9|||
30943314|NCT01728116|58983402|FG001|Overall Study|Lost to Follow-up|2|||
30943315|NCT01728116|58983401|FG000|Overall Study|Physician Decision|2|||
30943316|NCT01728116|58983402|FG001|Overall Study|Physician Decision|0|||
30943317|NCT01728116|58983401|FG000|Overall Study|Subject Non-Compliance|2|||
30943318|NCT01728116|58983402|FG001|Overall Study|Subject Non-Compliance|0|||
30943319|NCT01728116|58983401|FG000|Overall Study|Inter-current finding at procedure|1|||
30943320|NCT01728116|58983402|FG001|Overall Study|Inter-current finding at procedure|0|||
30943321|NCT01728116|58983401|FG000|Overall Study|Incorrectly enrolled in Study|0|||
30943322|NCT01728116|58983402|FG001|Overall Study|Incorrectly enrolled in Study|1|||
30943323|NCT01728116|58983401|FG000|Overall Study|various not noted previously|5|||
30943324|NCT01728116|58983402|FG001|Overall Study|various not noted previously|0|||
30943325|NCT01465659|58983413|FG000|Completed 1 Cycle of Treatment|Death|0|||
30943326|NCT01465659|58983414|FG001|Completed 1 Cycle of Treatment|Death|1|||
30943327|NCT01465659|58983415|FG002|Completed 1 Cycle of Treatment|Death|0|||
30943328|NCT01465659|58983416|FG003|Completed 1 Cycle of Treatment|Death|0|||
30943329|NCT01465659|58983413|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
30943330|NCT01465659|58983414|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
30943331|NCT01465659|58983415|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
30943332|NCT01465659|58983416|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
30943333|NCT01465659|58983413|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
30943334|NCT01465659|58983414|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
30943335|NCT01465659|58983415|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
30943336|NCT01465659|58983416|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
30943337|NCT01465659|58983413|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
30943338|NCT01465659|58983414|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
30943339|NCT01465659|58983415|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
30943340|NCT01465659|58983416|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
30943341|NCT01465659|58983413|FG000|Completed Follow for 1 Year|Death|6|||
30943342|NCT01465659|58983414|FG001|Completed Follow for 1 Year|Death|3|||
30943343|NCT01465659|58983415|FG002|Completed Follow for 1 Year|Death|2|||
30943344|NCT01465659|58983416|FG003|Completed Follow for 1 Year|Death|4|||
30943345|NCT01753076|58983431|FG000|Overall Study|Adverse Event|17|||
30943346|NCT01753076|58983432|FG001|Overall Study|Adverse Event|18|||
30943347|NCT01753076|58983431|FG000|Overall Study|Lack of Efficacy|3|||
30943348|NCT01753076|58983432|FG001|Overall Study|Lack of Efficacy|1|||
30943349|NCT01753076|58983431|FG000|Overall Study|Lost to Follow-up|2|||
30943350|NCT01753076|58983432|FG001|Overall Study|Lost to Follow-up|1|||
30943351|NCT01753076|58983431|FG000|Overall Study|Physician Decision|4|||
30943352|NCT01753076|58983432|FG001|Overall Study|Physician Decision|2|||
30943353|NCT01753076|58983431|FG000|Overall Study|Withdrawal by Subject|14|||
30943354|NCT01753076|58983432|FG001|Overall Study|Withdrawal by Subject|24|||
30943355|NCT01753076|58983431|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
30943356|NCT01753076|58983432|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
30943357|NCT01463007|58983440|FG000|Overall Study|Physician Decision|1|||
30943358|NCT01462929|58983448|FG000|Overall Study|Adverse Event|3|||
30943359|NCT01462929|58983449|FG001|Overall Study|Adverse Event|3|||
30943360|NCT01462929|58983450|FG002|Overall Study|Adverse Event|4|||
30943361|NCT01462929|58983448|FG000|Overall Study|Withdrawal by Subject|2|||
30943362|NCT01462929|58983449|FG001|Overall Study|Withdrawal by Subject|1|||
30943363|NCT01462929|58983450|FG002|Overall Study|Withdrawal by Subject|0|||
30943364|NCT01462929|58983448|FG000|Overall Study|Lack of Efficacy|0|||
30943365|NCT01462929|58983449|FG001|Overall Study|Lack of Efficacy|0|||
30943366|NCT01462929|58983450|FG002|Overall Study|Lack of Efficacy|1|||
30943367|NCT01462695|58983460|FG000|Overall Study|Adverse Event|1|||
30943368|NCT01462695|58983461|FG001|Overall Study|Adverse Event|1|||
30943369|NCT01462695|58983460|FG000|Overall Study|Death|2|||
30943370|NCT01462695|58983461|FG001|Overall Study|Death|0|||
30943371|NCT01462695|58983460|FG000|Overall Study|Lack of Efficacy|6|||
30943372|NCT01462695|58983461|FG001|Overall Study|Lack of Efficacy|12|||
30943373|NCT01462695|58983460|FG000|Overall Study|Physician Decision|5|||
30943374|NCT01462695|58983461|FG001|Overall Study|Physician Decision|0|||
30943375|NCT01462695|58983460|FG000|Overall Study|Withdrawal by Subject|2|||
30943376|NCT01462695|58983461|FG001|Overall Study|Withdrawal by Subject|0|||
30943377|NCT01462695|58983460|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
30943378|NCT01462695|58983461|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
30943379|NCT01465347|58983467|FG000|Overall Study|Withdrawal by Subject|1|||
30943380|NCT01465347|58983468|FG001|Overall Study|Withdrawal by Subject|1|||
30943381|NCT01465347|58983467|FG000|Overall Study|Physician Decision|0|||
30943382|NCT01465347|58983468|FG001|Overall Study|Physician Decision|1|||
30943383|NCT01465347|58983467|FG000|Overall Study|Admitted to hospice|0|||
30943384|NCT01465347|58983468|FG001|Overall Study|Admitted to hospice|1|||
30943385|NCT01465191|58983480|FG000|Overall Study|Protocol Violation|6|||
30943386|NCT01465191|58983481|FG001|Overall Study|Protocol Violation|3|||
30943387|NCT01465191|58983482|FG002|Overall Study|Protocol Violation|3|||
30943388|NCT01465191|58983480|FG000|Overall Study|Lost to Follow-up|3|||
30943389|NCT01465191|58983481|FG001|Overall Study|Lost to Follow-up|6|||
30943390|NCT01465191|58983482|FG002|Overall Study|Lost to Follow-up|4|||
30943391|NCT01519947|58983497|FG000|Overall Study|Death|0|||
30943392|NCT01519947|58983498|FG001|Overall Study|Death|0|||
30943393|NCT01519947|58983499|FG002|Overall Study|Death|0|||
30943394|NCT01519947|58983500|FG003|Overall Study|Death|1|||
30943395|NCT01519947|58983497|FG000|Overall Study|Protocol Violation|0|||
30943396|NCT01519947|58983498|FG001|Overall Study|Protocol Violation|0|||
30943397|NCT01519947|58983499|FG002|Overall Study|Protocol Violation|2|||
30943398|NCT01519947|58983500|FG003|Overall Study|Protocol Violation|1|||
30943399|NCT01519947|58983497|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
30943400|NCT01519947|58983498|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
30943401|NCT01519947|58983499|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
30943402|NCT01519947|58983500|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
30943403|NCT01519947|58983497|FG000|Overall Study|Development of Anemia|0|||
30943404|NCT01519947|58983498|FG001|Overall Study|Development of Anemia|1|||
30943405|NCT01519947|58983499|FG002|Overall Study|Development of Anemia|0|||
30943406|NCT01519947|58983500|FG003|Overall Study|Development of Anemia|1|||
30943407|NCT01519947|58983497|FG000|Overall Study|Blood Transfusion|0|||
30943408|NCT01519947|58983498|FG001|Overall Study|Blood Transfusion|1|||
30943409|NCT01519947|58983499|FG002|Overall Study|Blood Transfusion|1|||
30943410|NCT01519947|58983500|FG003|Overall Study|Blood Transfusion|0|||
30943411|NCT01519947|58983497|FG000|Overall Study|Withdrawal by Subject|0|||
30943412|NCT01519947|58983498|FG001|Overall Study|Withdrawal by Subject|1|||
30943413|NCT01519947|58983499|FG002|Overall Study|Withdrawal by Subject|0|||
30943414|NCT01519947|58983500|FG003|Overall Study|Withdrawal by Subject|1|||
30943415|NCT01519947|58983497|FG000|Overall Study|Lost to Follow-up|0|||
30943416|NCT01519947|58983498|FG001|Overall Study|Lost to Follow-up|0|||
30943417|NCT01519947|58983499|FG002|Overall Study|Lost to Follow-up|3|||
30943418|NCT01519947|58983500|FG003|Overall Study|Lost to Follow-up|2|||
30943419|NCT01519947|58983497|FG000|Overall Study|Poor Response|1|||
30943420|NCT01519947|58983498|FG001|Overall Study|Poor Response|0|||
30943421|NCT01519947|58983499|FG002|Overall Study|Poor Response|0|||
30943422|NCT01519947|58983500|FG003|Overall Study|Poor Response|1|||
30943423|NCT01519947|58983497|FG000|Overall Study|Adverse Event|1|||
30943424|NCT01519947|58983498|FG001|Overall Study|Adverse Event|0|||
30943425|NCT01519947|58983499|FG002|Overall Study|Adverse Event|1|||
30943426|NCT01519947|58983500|FG003|Overall Study|Adverse Event|1|||
30943427|NCT01462227|58983512|FG000|Second Assignment|Lost to Follow-up|1|||
30943428|NCT01462227|58983513|FG001|Second Assignment|Lost to Follow-up|0|||
30943429|NCT01462227|58983514|FG002|Second Assignment|Lost to Follow-up|0|||
30943430|NCT01462227|58983515|FG003|Second Assignment|Lost to Follow-up|0|||
30943431|NCT01462227|58983512|FG000|Second Assignment|Protocol Violation|0|||
30943432|NCT01462227|58983513|FG001|Second Assignment|Protocol Violation|1|||
30943433|NCT01462227|58983514|FG002|Second Assignment|Protocol Violation|1|||
30943434|NCT01462227|58983515|FG003|Second Assignment|Protocol Violation|0|||
30943435|NCT01464879|58983523|FG000|Overall Study|Physician Decision|1|||
30943436|NCT01464879|58983523|FG000|Overall Study|Non-compliance|1|||
30943437|NCT01519869|58983533|FG000|Overall Study|Lost to Follow-up|1|||
30943438|NCT01519791|58983539|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
30943439|NCT01519791|58983540|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
30943440|NCT01519791|58983539|FG000|Overall Study|Protocol Violation|6|||
30943441|NCT01519791|58983540|FG001|Overall Study|Protocol Violation|19|||
30943442|NCT01519791|58983539|FG000|Overall Study|Other Reason|87|||
30943443|NCT01519791|58983540|FG001|Overall Study|Other Reason|222|||
30943444|NCT01519791|58983539|FG000|Overall Study|subjects randomized in error|2|||
30943445|NCT01519791|58983540|FG001|Overall Study|subjects randomized in error|0|||
30943446|NCT01519791|58983539|FG000|Overall Study|Lack of Efficacy|16|||
30759512|NCT00095199|58767962|FG002|Overall Study|Liver function test results elevated|1|||
30759513|NCT00095199|58767963|FG003|Overall Study|Liver function test results elevated|1|||
30943447|NCT01519791|58983540|FG001|Overall Study|Lack of Efficacy|20|||
30943448|NCT01519791|58983539|FG000|Overall Study|SAE, non-fatal|6|||
30943449|NCT01519791|58983540|FG001|Overall Study|SAE, non-fatal|22|||
30943450|NCT01519791|58983539|FG000|Overall Study|AE, serious fatal|0|||
30943451|NCT01519791|58983540|FG001|Overall Study|AE, serious fatal|1|||
30943452|NCT01519791|58983539|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
30943453|NCT01519791|58983540|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
30943454|NCT01519791|58983539|FG000|Overall Study|AE, non-serious non-fatal|12|||
30943455|NCT01519791|58983540|FG001|Overall Study|AE, non-serious non-fatal|31|||
30943456|NCT01519791|58983539|FG000|Overall Study|Withdrawal by Subject|15|||
30943457|NCT01519791|58983540|FG001|Overall Study|Withdrawal by Subject|37|||
30943458|NCT01519791|58983539|FG000|Overall Study|Lost to Follow-up|6|||
30943459|NCT01519791|58983540|FG001|Overall Study|Lost to Follow-up|14|||
30943460|NCT01461993|58983551|FG000|Overall Study|Withdrawal by Subject|60|||
30943461|NCT01461993|58983552|FG001|Overall Study|Withdrawal by Subject|53|||
30943462|NCT01461993|58983553|FG002|Overall Study|Withdrawal by Subject|16|||
30943463|NCT01461993|58983551|FG000|Overall Study|Lost to Follow-up|44|||
30943464|NCT01461993|58983552|FG001|Overall Study|Lost to Follow-up|48|||
30943465|NCT01461993|58983553|FG002|Overall Study|Lost to Follow-up|22|||
30943466|NCT01461993|58983551|FG000|Overall Study|Protocol Violation|10|||
30943467|NCT01461993|58983552|FG001|Overall Study|Protocol Violation|9|||
30943468|NCT01461993|58983553|FG002|Overall Study|Protocol Violation|7|||
30943469|NCT01461993|58983551|FG000|Overall Study|Adverse Event|9|||
30943470|NCT01461993|58983552|FG001|Overall Study|Adverse Event|11|||
30943471|NCT01461993|58983553|FG002|Overall Study|Adverse Event|3|||
30943472|NCT01461993|58983551|FG000|Overall Study|No longer met eligibility criteria|13|||
30943473|NCT01461993|58983552|FG001|Overall Study|No longer met eligibility criteria|18|||
30943474|NCT01461993|58983553|FG002|Overall Study|No longer met eligibility criteria|10|||
30943475|NCT01461993|58983551|FG000|Overall Study|Did not meet entrance criteria|2|||
30943476|NCT01461993|58983552|FG001|Overall Study|Did not meet entrance criteria|3|||
30943477|NCT01461993|58983553|FG002|Overall Study|Did not meet entrance criteria|0|||
30943478|NCT01461993|58983551|FG000|Overall Study|Other|13|||
30943479|NCT01461993|58983552|FG001|Overall Study|Other|15|||
30943480|NCT01461993|58983553|FG002|Overall Study|Other|6|||
30943481|NCT01782326|58983564|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
30943482|NCT01782326|58983565|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
30943483|NCT01782326|58983564|FG000|Planned Treatment Epoch|Death|29|||
30943484|NCT01782326|58983565|FG001|Planned Treatment Epoch|Death|30|||
30759514|NCT00095199|58767960|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
30759515|NCT00095199|58767961|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
30943485|NCT01782326|58983564|FG000|Planned Treatment Epoch|Physician Decision|18|||
30943486|NCT01782326|58983565|FG001|Planned Treatment Epoch|Physician Decision|16|||
30943487|NCT01782326|58983564|FG000|Planned Treatment Epoch|Protocol deviation|2|||
30943488|NCT01782326|58983565|FG001|Planned Treatment Epoch|Protocol deviation|3|||
30943489|NCT01782326|58983564|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
30943490|NCT01782326|58983565|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
30943491|NCT01782326|58983564|FG000|Planned Treatment Epoch|Technical problems|0|||
30759516|NCT00095199|58767962|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
30943492|NCT01782326|58983565|FG001|Planned Treatment Epoch|Technical problems|4|||
30943493|NCT01782326|58983564|FG000|Double-blind Treatment|Adverse Event|129|||
30943494|NCT01782326|58983565|FG001|Double-blind Treatment|Adverse Event|145|||
30943495|NCT01782326|58983564|FG000|Double-blind Treatment|Subject/guardian decision|111|||
30943496|NCT01782326|58983565|FG001|Double-blind Treatment|Subject/guardian decision|125|||
30943497|NCT01782326|58983564|FG000|Double-blind Treatment|Lack of Efficacy|17|||
30943498|NCT01782326|58983565|FG001|Double-blind Treatment|Lack of Efficacy|22|||
30943499|NCT01782326|58983564|FG000|Double-blind Treatment|Physician Decision|13|||
30943500|NCT01782326|58983565|FG001|Double-blind Treatment|Physician Decision|16|||
30943501|NCT01782326|58983564|FG000|Double-blind Treatment|Protocol deviation|8|||
30943502|NCT01782326|58983565|FG001|Double-blind Treatment|Protocol deviation|7|||
30943503|NCT01782326|58983564|FG000|Double-blind Treatment|Technical problems|0|||
30943504|NCT01782326|58983565|FG001|Double-blind Treatment|Technical problems|5|||
30943505|NCT01439373|58983573|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
30943506|NCT01439373|58983574|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
30943507|NCT01439373|58983573|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
30943508|NCT01439373|58983574|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
30943509|NCT01461369|58983587|FG000|Overall Study|Lack of Efficacy|2|||
30943510|NCT01461369|58983588|FG001|Overall Study|Lack of Efficacy|0|||
30943511|NCT01461369|58983589|FG002|Overall Study|Lack of Efficacy|6|||
30943512|NCT01461369|58983587|FG000|Overall Study|Lost to Follow-up|0|||
30943513|NCT01461369|58983588|FG001|Overall Study|Lost to Follow-up|0|||
30943514|NCT01461369|58983589|FG002|Overall Study|Lost to Follow-up|3|||
30943515|NCT01461369|58983587|FG000|Overall Study|Adverse Event|9|||
30943516|NCT01461369|58983588|FG001|Overall Study|Adverse Event|12|||
30943517|NCT01461369|58983589|FG002|Overall Study|Adverse Event|4|||
30943518|NCT01461369|58983587|FG000|Overall Study|Protocol Violation|1|||
30943519|NCT01461369|58983588|FG001|Overall Study|Protocol Violation|2|||
30943520|NCT01461369|58983589|FG002|Overall Study|Protocol Violation|2|||
30943521|NCT01461369|58983587|FG000|Overall Study|Withdrawal by Subject|1|||
30943522|NCT01461369|58983588|FG001|Overall Study|Withdrawal by Subject|3|||
30943523|NCT01461369|58983589|FG002|Overall Study|Withdrawal by Subject|2|||
30943524|NCT01727258|58983600|FG000|Overall Study|Adverse Event|0|||
30943525|NCT01727258|58983601|FG001|Overall Study|Adverse Event|2|||
30943526|NCT01727258|58983602|FG002|Overall Study|Adverse Event|0|||
30943527|NCT01727258|58983600|FG000|Overall Study|Noncompliance with Study Drug|0|||
30943528|NCT01727258|58983601|FG001|Overall Study|Noncompliance with Study Drug|0|||
30943529|NCT01727258|58983602|FG002|Overall Study|Noncompliance with Study Drug|1|||
30943530|NCT01727258|58983600|FG000|Overall Study|Withdrawal by Subject|1|||
30943531|NCT01727258|58983601|FG001|Overall Study|Withdrawal by Subject|1|||
30943532|NCT01727258|58983602|FG002|Overall Study|Withdrawal by Subject|0|||
30943533|NCT01727258|58983600|FG000|Overall Study|Lost to Follow-up|1|||
30943534|NCT01727258|58983601|FG001|Overall Study|Lost to Follow-up|0|||
30943535|NCT01727258|58983602|FG002|Overall Study|Lost to Follow-up|0|||
30943536|NCT01781390|58983613|FG000|Overall Study|Withdrawal of Consent|0|||
30943537|NCT01781390|58983614|FG001|Overall Study|Withdrawal of Consent|3|||
30943538|NCT01781390|58983615|FG002|Overall Study|Withdrawal of Consent|1|||
30943539|NCT01781390|58983613|FG000|Overall Study|Lost to Follow-up|1|||
30943540|NCT01781390|58983614|FG001|Overall Study|Lost to Follow-up|1|||
30943541|NCT01781390|58983615|FG002|Overall Study|Lost to Follow-up|1|||
30943542|NCT01781390|58983613|FG000|Overall Study|Adverse Event|1|||
30943543|NCT01781390|58983614|FG001|Overall Study|Adverse Event|2|||
30943544|NCT01781390|58983615|FG002|Overall Study|Adverse Event|1|||
30943545|NCT01781390|58983613|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
30943546|NCT01781390|58983614|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
30943547|NCT01781390|58983615|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
30943548|NCT01781234|58983625|FG000|Overall Study|Adverse Event|2|||
30943549|NCT01781234|58983626|FG001|Overall Study|Adverse Event|0|||
30943550|NCT01781234|58983625|FG000|Overall Study|Protocol Violation|3|||
30943551|NCT01781234|58983626|FG001|Overall Study|Protocol Violation|0|||
30943552|NCT01781234|58983625|FG000|Overall Study|Withdrawal by Subject|4|||
30943553|NCT01781234|58983626|FG001|Overall Study|Withdrawal by Subject|3|||
30943554|NCT01752842|58983636|FG000|Overall Study|Adverse Event|3|||
30943555|NCT01752842|58983637|FG001|Overall Study|Adverse Event|0|||
30943556|NCT01752842|58983636|FG000|Overall Study|Withdrawal by Subject|0|||
30943557|NCT01752842|58983637|FG001|Overall Study|Withdrawal by Subject|2|||
30943558|NCT01461057|58983645|FG000|Overall Study|Death|10|||
30943559|NCT01461057|58983646|FG001|Overall Study|Death|9|||
30943560|NCT01461057|58983645|FG000|Overall Study|Withdrawal by Subject|2|||
30943561|NCT01461057|58983646|FG001|Overall Study|Withdrawal by Subject|3|||
30943562|NCT01461057|58983645|FG000|Overall Study|Physician Decision|0|||
30943563|NCT01461057|58983646|FG001|Overall Study|Physician Decision|2|||
30943564|NCT01461057|58983645|FG000|Overall Study|Adverse Event|0|||
30943565|NCT01461057|58983646|FG001|Overall Study|Adverse Event|1|||
30943566|NCT01461057|58983645|FG000|Overall Study|Progression of Disease|1|||
30943567|NCT01461057|58983646|FG001|Overall Study|Progression of Disease|0|||
30943568|NCT01461057|58983645|FG000|Overall Study|Study Terminated by Sponsor|2|||
30943569|NCT01461057|58983646|FG001|Overall Study|Study Terminated by Sponsor|0|||
30943570|NCT01460901|58983652|FG000|Overall Study|Withdrawal by Subject|2|||
30759517|NCT00095199|58767963|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
30759518|NCT00095199|58767960|FG000|Overall Study|Physician Decision|5|||
30842569|NCT02691494|58868380|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
30842570|NCT02677220|58868388|FG000|Overall Study|Adverse Event|1|||
30842571|NCT02682602|58868395|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
30842572|NCT02682602|58868396|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
30842573|NCT02682602|58868395|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
30842574|NCT02682602|58868396|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
30842575|NCT02681510|58868406|FG000|Overall Study|Withdrawal by Subject|1|||
30842576|NCT02681510|58868406|FG000|Overall Study|Lost to Follow-up|9|||
30842577|NCT02690714|58868410|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
30842578|NCT02690714|58868410|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
30759519|NCT00095199|58767961|FG001|Overall Study|Physician Decision|6|||
30759520|NCT00095199|58767962|FG002|Overall Study|Physician Decision|1|||
30759521|NCT00095199|58767963|FG003|Overall Study|Physician Decision|1|||
30759522|NCT00095199|58767960|FG000|Overall Study|Not eligible|1|||
30759523|NCT00095199|58767961|FG001|Overall Study|Not eligible|7|||
30759524|NCT00095199|58767962|FG002|Overall Study|Not eligible|0|||
30759525|NCT00095199|58767963|FG003|Overall Study|Not eligible|1|||
30759526|NCT00095199|58767960|FG000|Overall Study|Started Palliative Radiotherapy|1|||
30759527|NCT00095199|58767961|FG001|Overall Study|Started Palliative Radiotherapy|0|||
30842579|NCT01898793|58868425|FG000|Overall Study|Death|2|||
30842580|NCT01898793|58868426|FG001|Overall Study|Death|1|||
30842581|NCT01898793|58868427|FG002|Overall Study|Death|4|||
30842582|NCT01898793|58868428|FG003|Overall Study|Death|0|||
30759528|NCT00095199|58767962|FG002|Overall Study|Started Palliative Radiotherapy|0|||
30842583|NCT01898793|58868429|FG004|Overall Study|Death|0|||
30842584|NCT01898793|58868430|FG005|Overall Study|Death|0|||
30759529|NCT00095199|58767963|FG003|Overall Study|Started Palliative Radiotherapy|0|||
30759530|NCT00095199|58767960|FG000|Overall Study|Started radiotherapy regimen|0|||
30759531|NCT00095199|58767961|FG001|Overall Study|Started radiotherapy regimen|1|||
30759532|NCT00095199|58767962|FG002|Overall Study|Started radiotherapy regimen|0|||
30759533|NCT00095199|58767963|FG003|Overall Study|Started radiotherapy regimen|0|||
30759534|NCT00095199|58767960|FG000|Overall Study|Primary tumor removed in other surgery|0|||
30759535|NCT00095199|58767961|FG001|Overall Study|Primary tumor removed in other surgery|1|||
30759536|NCT00095199|58767962|FG002|Overall Study|Primary tumor removed in other surgery|0|||
30842585|NCT01898793|58868431|FG006|Overall Study|Death|0|||
30842586|NCT01791543|58868450|FG000|Overall Study|Lost to Follow-up|1|||
30842587|NCT01791543|58868450|FG000|Overall Study|Adverse Event|1|||
30842588|NCT02925455|58868457|FG000|Overall Study|Withdrawal by Subject|2|||
30842589|NCT02925455|58868458|FG001|Overall Study|Withdrawal by Subject|0|||
30842590|NCT03033069|58868468|FG000|Overall Study|Adverse Event|6|||
30842591|NCT03033069|58868469|FG001|Overall Study|Adverse Event|7|||
30842592|NCT03033069|58868470|FG002|Overall Study|Adverse Event|4|||
30842593|NCT03033069|58868471|FG003|Overall Study|Adverse Event|6|||
30842594|NCT03033069|58868468|FG000|Overall Study|Lack of Efficacy|0|||
30842595|NCT03033069|58868469|FG001|Overall Study|Lack of Efficacy|0|||
30759537|NCT00095199|58767963|FG003|Overall Study|Primary tumor removed in other surgery|0|||
30759538|NCT00095199|58767960|FG000|Overall Study|Data inadvertently lost by site|1|||
30842596|NCT03033069|58868470|FG002|Overall Study|Lack of Efficacy|1|||
30842597|NCT03033069|58868471|FG003|Overall Study|Lack of Efficacy|0|||
30842598|NCT03033069|58868468|FG000|Overall Study|Lost to Follow-up|6|||
30842599|NCT03033069|58868469|FG001|Overall Study|Lost to Follow-up|5|||
30842600|NCT03033069|58868470|FG002|Overall Study|Lost to Follow-up|5|||
30842601|NCT03033069|58868471|FG003|Overall Study|Lost to Follow-up|6|||
30842602|NCT03033069|58868468|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30842603|NCT03033069|58868469|FG001|Overall Study|Non-Compliance With Study Drug|1|||
30842604|NCT03033069|58868470|FG002|Overall Study|Non-Compliance With Study Drug|1|||
30842605|NCT03033069|58868471|FG003|Overall Study|Non-Compliance With Study Drug|0|||
30842606|NCT03033069|58868468|FG000|Overall Study|Protocol Deviation|0|||
30943571|NCT01519635|58983661|FG000|Overall Study|Withdrawal by Subject|0|||
30943572|NCT01519635|58983662|FG001|Overall Study|Withdrawal by Subject|1|||
30943573|NCT01519635|58983661|FG000|Overall Study|No possibility to put a catheter|1|||
30943574|NCT01519635|58983662|FG001|Overall Study|No possibility to put a catheter|2|||
30759539|NCT00095199|58767961|FG001|Overall Study|Data inadvertently lost by site|0|||
30759540|NCT00095199|58767962|FG002|Overall Study|Data inadvertently lost by site|0|||
30759541|NCT00095199|58767963|FG003|Overall Study|Data inadvertently lost by site|0|||
30759542|NCT00075764|58767980|FG000|Overall Study|Adverse Event|5|||
30842607|NCT03033069|58868469|FG001|Overall Study|Protocol Deviation|1|||
30842608|NCT03033069|58868470|FG002|Overall Study|Protocol Deviation|0|||
30842609|NCT03033069|58868471|FG003|Overall Study|Protocol Deviation|0|||
30842610|NCT03033069|58868468|FG000|Overall Study|Withdrawal by Subject|10|||
30943575|NCT01519323|58983668|FG000|Overall Study|Death|3|||
30943576|NCT01519323|58983669|FG001|Overall Study|Death|2|||
30943577|NCT01519323|58983668|FG000|Overall Study|Study terminated by sponsor|0|||
30943578|NCT01519323|58983669|FG001|Overall Study|Study terminated by sponsor|1|||
30943579|NCT01519245|58983677|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
30943580|NCT01519245|58983678|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
30943581|NCT01519167|58983688|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
30943582|NCT01519167|58983689|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
30943583|NCT01519167|58983688|FG000|Overall Study|Adverse Event|0|||
30943584|NCT01519167|58983689|FG001|Overall Study|Adverse Event|1|||
30943585|NCT01519167|58983688|FG000|Overall Study|Lack of Efficacy|0|||
30943586|NCT01519167|58983689|FG001|Overall Study|Lack of Efficacy|1|||
30943587|NCT01519167|58983688|FG000|Overall Study|Medical condition changes&deep sedation|0|||
30943588|NCT01519167|58983689|FG001|Overall Study|Medical condition changes&deep sedation|2|||
30943589|NCT01519167|58983688|FG000|Overall Study|Physician Decision|0|||
30943590|NCT01519167|58983689|FG001|Overall Study|Physician Decision|1|||
30943591|NCT01519089|58983930|FG000|Overall Study|Adverse Event|4|||
30943592|NCT01519089|58983931|FG001|Overall Study|Adverse Event|4|||
30943593|NCT01519089|58983930|FG000|Overall Study|Lack of Efficacy|0|||
30943594|NCT01519089|58983931|FG001|Overall Study|Lack of Efficacy|2|||
30943595|NCT01519089|58983930|FG000|Overall Study|Lost to Follow-up|1|||
30943596|NCT01519089|58983931|FG001|Overall Study|Lost to Follow-up|0|||
30943597|NCT01519089|58983930|FG000|Overall Study|Withdrawal by Subject|0|||
30943598|NCT01519089|58983931|FG001|Overall Study|Withdrawal by Subject|2|||
30943599|NCT01519089|58983930|FG000|Overall Study|Other|2|||
30943600|NCT01519089|58983931|FG001|Overall Study|Other|6|||
30943601|NCT01519089|58983930|FG000|Overall Study|Not received study drug|0|||
30943602|NCT01519089|58983931|FG001|Overall Study|Not received study drug|1|||
30943603|NCT01518699|58983953|FG000|Period 2|Protocol Violation|1|||
30943604|NCT01518699|58983954|FG001|Period 2|Protocol Violation|1|||
30943605|NCT01518699|58983955|FG002|Period 2|Protocol Violation|0|||
30943606|NCT01518699|58983956|FG003|Period 2|Protocol Violation|0|||
30943607|NCT01518699|58983957|FG004|Period 2|Protocol Violation|0|||
30943608|NCT01518699|58983958|FG005|Period 2|Protocol Violation|0|||
30943609|NCT01518699|58983953|FG000|Period 2|Lost to Follow-up|0|||
30943610|NCT01518699|58983954|FG001|Period 2|Lost to Follow-up|1|||
30943611|NCT01518699|58983955|FG002|Period 2|Lost to Follow-up|0|||
30943612|NCT01518699|58983956|FG003|Period 2|Lost to Follow-up|0|||
30943613|NCT01518699|58983957|FG004|Period 2|Lost to Follow-up|0|||
30943614|NCT01518699|58983958|FG005|Period 2|Lost to Follow-up|0|||
30943615|NCT01518699|58983953|FG000|Period 2|Adverse Event|1|||
30943616|NCT01518699|58983954|FG001|Period 2|Adverse Event|0|||
30943617|NCT01518699|58983955|FG002|Period 2|Adverse Event|0|||
30943618|NCT01518699|58983956|FG003|Period 2|Adverse Event|0|||
30943619|NCT01518699|58983957|FG004|Period 2|Adverse Event|0|||
30943620|NCT01518699|58983958|FG005|Period 2|Adverse Event|0|||
30943621|NCT01518309|58983966|FG000|Overall Study|Adverse Event|6|||
30943622|NCT01518309|58983966|FG000|Overall Study|Death|6|||
30943623|NCT01518309|58983966|FG000|Overall Study|Lack of Efficacy|7|||
30943624|NCT01518309|58983966|FG000|Overall Study|Withdrawal by Subject|6|||
30943625|NCT01518309|58983966|FG000|Overall Study|Physician Decision|3|||
30943626|NCT01518309|58983966|FG000|Overall Study|Sponsor Decision|2|||
30943627|NCT01518309|58983966|FG000|Overall Study|Not in Predefined Categories|9|||
30943628|NCT01419717|58983970|FG000|Overall Study|Protocol-specified Criteria|62|||
30943629|NCT01419717|58983970|FG000|Overall Study|Adverse Event|19|||
30943630|NCT01419717|58983970|FG000|Overall Study|Death|17|||
30943631|NCT01419717|58983970|FG000|Overall Study|Withdrawal by Subject|10|||
30943632|NCT01419717|58983970|FG000|Overall Study|Disease Progression|9|||
30943633|NCT01419717|58983970|FG000|Overall Study|Other|4|||
30943634|NCT01419717|58983970|FG000|Overall Study|Lost to Follow-up|2|||
30943635|NCT01419717|58983970|FG000|Overall Study|Administrative Decision|1|||
30943636|NCT01419717|58983970|FG000|Overall Study|Noncompliance|1|||
30943637|NCT01458951|58983977|FG000|Overall Study|Other|1|||
30943638|NCT01458951|58983978|FG001|Overall Study|Other|0|||
30943639|NCT01458951|58983979|FG002|Overall Study|Other|0|||
30943640|NCT01458951|58983977|FG000|Overall Study|Protocol Violation|5|||
30943641|NCT01458951|58983978|FG001|Overall Study|Protocol Violation|1|||
30943642|NCT01458951|58983979|FG002|Overall Study|Protocol Violation|0|||
30943643|NCT01458951|58983977|FG000|Overall Study|Withdrawal by Subject|2|||
30943644|NCT01458951|58983978|FG001|Overall Study|Withdrawal by Subject|0|||
30943645|NCT01458951|58983979|FG002|Overall Study|Withdrawal by Subject|2|||
30943646|NCT01458951|58983977|FG000|Overall Study|Adverse Event|7|||
30943647|NCT01458951|58983978|FG001|Overall Study|Adverse Event|0|||
30943648|NCT01458951|58983979|FG002|Overall Study|Adverse Event|2|||
30943649|NCT01458951|58983977|FG000|Overall Study|Insufficient Clinical Response|17|||
30943650|NCT01458951|58983978|FG001|Overall Study|Insufficient Clinical Response|0|||
30943651|NCT01458951|58983979|FG002|Overall Study|Insufficient Clinical Response|11|||
30943652|NCT01458639|58983986|FG000|Overall Study|Physician Decision|4|||
30943653|NCT01458639|58983986|FG000|Overall Study|Equipment issue|1|||
30943654|NCT01458639|58983986|FG000|Overall Study|Inability to obtain subject blood sample|1|||
30943655|NCT01437423|58983990|FG000|Overall Study|Lost to Follow-up|12|||
30943656|NCT01437423|58983990|FG000|Overall Study|Off label usage|3|||
30943657|NCT01458249|58984021|FG000|Overall Study|Not treated|1|||
30943658|NCT01458249|58984021|FG000|Overall Study|Adverse Event|4|||
30943659|NCT01458249|58984021|FG000|Overall Study|Other|2|||
30943660|NCT01458249|58984021|FG000|Overall Study|Ongoing|1|||
30943661|NCT01458171|58984037|FG000|Overall Study|Adverse Event|1|||
30943662|NCT01457703|58984054|FG000|Overall Study|Screen Failure|5|||
30943663|NCT01457703|58984055|FG001|Overall Study|Screen Failure|7|||
30943664|NCT01457703|58984054|FG000|Overall Study|Withdrawal by Subject|1|||
30943665|NCT01457703|58984055|FG001|Overall Study|Withdrawal by Subject|4|||
30943666|NCT01419015|58984073|FG000|Overall Study|Death|2|||
30943667|NCT01418937|58984094|FG000|Overall Study|Lost to Follow-up|5|||
30943668|NCT01418937|58984094|FG000|Overall Study|Protocol Violation|1|||
30943669|NCT01418937|58984094|FG000|Overall Study|Pregnancy|1|||
30943670|NCT01418937|58984094|FG000|Overall Study|Withdrawal by Subject|1|||
30943671|NCT01417377|58984107|FG000|Overall Study|Lost to Follow-up|12|||
30943672|NCT01417377|58984107|FG000|Overall Study|Enrolled, but not treated|1|||
30943673|NCT01437267|58984154|FG000|Overall Study|Withdrawal by Subject|0|||
30943674|NCT01437267|58984155|FG001|Overall Study|Withdrawal by Subject|0|||
30943675|NCT01437267|58984156|FG002|Overall Study|Withdrawal by Subject|0|||
30943676|NCT01437267|58984157|FG003|Overall Study|Withdrawal by Subject|1|||
30943677|NCT01437267|58984158|FG004|Overall Study|Withdrawal by Subject|0|||
30943678|NCT01437267|58984159|FG005|Overall Study|Withdrawal by Subject|0|||
30943679|NCT01437267|58984154|FG000|Overall Study|Protocol Violation|0|||
30943680|NCT01437267|58984155|FG001|Overall Study|Protocol Violation|1|||
30943681|NCT01437267|58984156|FG002|Overall Study|Protocol Violation|0|||
30943682|NCT01437267|58984157|FG003|Overall Study|Protocol Violation|0|||
30943683|NCT01437267|58984158|FG004|Overall Study|Protocol Violation|0|||
30943684|NCT01437267|58984159|FG005|Overall Study|Protocol Violation|0|||
30943685|NCT01456221|58984188|FG000|Overall Study|Withdrawal by Subject|56|||
30943686|NCT01456221|58984189|FG001|Overall Study|Withdrawal by Subject|49|||
30943687|NCT01456221|58984188|FG000|Overall Study|Lost to Follow-up|1|||
30943688|NCT01456221|58984189|FG001|Overall Study|Lost to Follow-up|4|||
30943689|NCT01456221|58984188|FG000|Overall Study|Received medication|3|||
30943690|NCT01456221|58984189|FG001|Overall Study|Received medication|2|||
30943691|NCT01456221|58984188|FG000|Overall Study|Incomplete data|4|||
30943692|NCT01456221|58984189|FG001|Overall Study|Incomplete data|2|||
30943693|NCT01437111|58984195|FG000|Overall Study|Adverse Event|2|||
30943694|NCT01437111|58984195|FG000|Overall Study|Withdrawal by Subject|4|||
30943695|NCT01437111|58984195|FG000|Overall Study|Not reported|5|||
30943696|NCT01437111|58984195|FG000|Overall Study|Physician Decision|1|||
30943697|NCT01437111|58984195|FG000|Overall Study|Lost to Follow-up|5|||
30943698|NCT01437111|58984195|FG000|Overall Study|Protocol Violation|1|||
30943699|NCT01436643|58984243|FG000|2-week Pre-treatment|Abnormal test result|0|||
30943700|NCT01436643|58984244|FG001|2-week Pre-treatment|Abnormal test result|0|||
30943701|NCT01436643|58984245|FG002|2-week Pre-treatment|Abnormal test result|0|||
30943702|NCT01436643|58984246|FG003|2-week Pre-treatment|Abnormal test result|1|||
30943703|NCT01436643|58984243|FG000|2-week Pre-treatment|Adverse Event|0|||
30943704|NCT01436643|58984244|FG001|2-week Pre-treatment|Adverse Event|0|||
30943705|NCT01436643|58984245|FG002|2-week Pre-treatment|Adverse Event|0|||
30943706|NCT01436643|58984246|FG003|2-week Pre-treatment|Adverse Event|5|||
30842611|NCT03033069|58868469|FG001|Overall Study|Withdrawal by Subject|10|||
30943707|NCT01436643|58984243|FG000|2-week Pre-treatment|Protocol Violation|0|||
30943708|NCT01436643|58984244|FG001|2-week Pre-treatment|Protocol Violation|0|||
30943709|NCT01436643|58984245|FG002|2-week Pre-treatment|Protocol Violation|0|||
30943710|NCT01436643|58984246|FG003|2-week Pre-treatment|Protocol Violation|4|||
30943711|NCT01436643|58984243|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
30943712|NCT01436643|58984244|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
30943713|NCT01436643|58984245|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
30943714|NCT01436643|58984246|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
30943715|NCT01436643|58984243|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
30943716|NCT01436643|58984244|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
30943717|NCT01436643|58984245|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
30943718|NCT01436643|58984246|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
30943719|NCT01436643|58984243|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
30943720|NCT01436643|58984244|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
30759543|NCT00075764|58767981|FG001|Overall Study|Adverse Event|12|||
30759544|NCT00075764|58767980|FG000|Overall Study|Death|4|||
30759545|NCT00075764|58767981|FG001|Overall Study|Death|8|||
30759546|NCT00075764|58767980|FG000|Overall Study|Withdrawal by Subject|28|||
30759547|NCT00075764|58767981|FG001|Overall Study|Withdrawal by Subject|18|||
30759548|NCT00075764|58767980|FG000|Overall Study|Progression|269|||
30759549|NCT00075764|58767981|FG001|Overall Study|Progression|274|||
30759550|NCT00075764|58767980|FG000|Overall Study|Still on treatment|8|||
30759551|NCT00075764|58767981|FG001|Overall Study|Still on treatment|15|||
30759552|NCT00075764|58767980|FG000|Overall Study|Delinquent|4|||
30943721|NCT01436643|58984245|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
30943722|NCT01436643|58984246|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
30943723|NCT01454739|58984344|FG000|Overall Study|Protocol Violation|2|||
30943724|NCT01454739|58984345|FG001|Overall Study|Protocol Violation|3|||
30943725|NCT01454739|58984344|FG000|Overall Study|Withdrawal by Subject|2|||
30943726|NCT01454739|58984345|FG001|Overall Study|Withdrawal by Subject|6|||
30943727|NCT01454739|58984344|FG000|Overall Study|Other|3|||
30943728|NCT01454739|58984345|FG001|Overall Study|Other|5|||
30943729|NCT01454739|58984344|FG000|Overall Study|Physician Decision|0|||
30943730|NCT01454739|58984345|FG001|Overall Study|Physician Decision|5|||
30943731|NCT01454739|58984344|FG000|Overall Study|Lost to Follow-up|0|||
30943732|NCT01454739|58984345|FG001|Overall Study|Lost to Follow-up|1|||
30943733|NCT01454739|58984344|FG000|Overall Study|Adverse Event|0|||
30943734|NCT01454739|58984345|FG001|Overall Study|Adverse Event|1|||
30943735|NCT01416441|58984383|FG000|Overall Study|Lost to Follow-up|5|||
30943736|NCT01416441|58984383|FG000|Overall Study|Adverse Event|6|||
30943737|NCT01416441|58984383|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
30943738|NCT01416441|58984383|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
30943739|NCT01416441|58984383|FG000|Overall Study|Investigator Withdrew Subject|2|||
30943740|NCT01416441|58984383|FG000|Overall Study|Subject Withdrew Consent|12|||
30943741|NCT01416441|58984383|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
30943742|NCT01436253|58984392|FG000|Overall Study|Lost to Follow-up|182|||
30943743|NCT01436253|58984392|FG000|Overall Study|Not meeting all eligibility criteria|117|||
30943744|NCT01454583|58985305|FG000|1st Year|Lost to Follow-up|1057|||
30943745|NCT01454583|58985306|FG001|1st Year|Lost to Follow-up|318|||
30943746|NCT01454583|58985307|FG002|1st Year|Lost to Follow-up|180|||
30943747|NCT01454583|58985305|FG000|2nd Year|Lost to Follow-up|3965|||
30943748|NCT01454583|58985306|FG001|2nd Year|Lost to Follow-up|1049|||
30943749|NCT01454583|58985307|FG002|2nd Year|Lost to Follow-up|737|||
30943750|NCT01454583|58985305|FG000|3rd Year|Lost to Follow-up|1959|||
30943751|NCT01454583|58985306|FG001|3rd Year|Lost to Follow-up|512|||
30943752|NCT01454583|58985307|FG002|3rd Year|Lost to Follow-up|297|||
30943753|NCT01436175|58985330|FG000|Overall Study|Adverse Event|111|||
30943754|NCT01436175|58985330|FG000|Overall Study|Protocol Violation|49|||
30943755|NCT01436175|58985330|FG000|Overall Study|Withdrawal by Subject|108|||
30943756|NCT01436175|58985330|FG000|Overall Study|Lost to Follow-up|89|||
30943757|NCT01436175|58985330|FG000|Overall Study|Lack of Efficacy|24|||
30943758|NCT01436175|58985330|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
30943759|NCT01436175|58985330|FG000|Overall Study|Other|826|||
30943760|NCT01453725|58985358|FG000|Overall Study|Adverse Event|3|||
30943761|NCT01453725|58985359|FG001|Overall Study|Adverse Event|3|||
30943762|NCT01453725|58985358|FG000|Overall Study|Lost to Follow-up|4|||
30943763|NCT01453725|58985359|FG001|Overall Study|Lost to Follow-up|0|||
30943764|NCT01453725|58985358|FG000|Overall Study|Non-compliance With Protocol|1|||
30943765|NCT01453725|58985359|FG001|Overall Study|Non-compliance With Protocol|2|||
30943766|NCT01453725|58985358|FG000|Overall Study|Protocol Violation|1|||
30943767|NCT01453725|58985359|FG001|Overall Study|Protocol Violation|0|||
30943768|NCT01453725|58985358|FG000|Overall Study|Withdrawal by Subject|2|||
30943769|NCT01453725|58985359|FG001|Overall Study|Withdrawal by Subject|3|||
30943770|NCT01453725|58985358|FG000|Overall Study|Pregnancy Wish|0|||
30943771|NCT01453725|58985359|FG001|Overall Study|Pregnancy Wish|2|||
30943772|NCT01453725|58985358|FG000|Overall Study|Pregnancy|1|||
30943773|NCT01453725|58985359|FG001|Overall Study|Pregnancy|0|||
30943774|NCT01453725|58985358|FG000|Overall Study|Physician Decision|1|||
30943775|NCT01453725|58985359|FG001|Overall Study|Physician Decision|1|||
30943776|NCT01415349|58985398|FG000|Treatment Period 1|Adverse Event|0|||
30943777|NCT01415349|58985399|FG001|Treatment Period 1|Adverse Event|1|||
30943778|NCT01415349|58985398|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30943779|NCT01415349|58985399|FG001|Treatment Period 1|Withdrawal by Subject|1|||
30943780|NCT01453023|58985453|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
30943781|NCT01453023|58985454|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
30943782|NCT01453023|58985453|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
30943783|NCT01453023|58985454|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
30943784|NCT01453023|58985453|FG000|Treatment Period 2|Protocol Violation|0|||
30943785|NCT01453023|58985454|FG001|Treatment Period 2|Protocol Violation|1|||
30943786|NCT01452789|58985462|FG000|Overall Study|Withdrawal by Subject|3|||
30943787|NCT01452789|58985463|FG001|Overall Study|Withdrawal by Subject|2|||
30943788|NCT01451931|58985472|FG000|Overall Study|Lost to Follow-up|17|||
30943789|NCT01451931|58985473|FG001|Overall Study|Lost to Follow-up|36|||
30943790|NCT01451931|58985474|FG002|Overall Study|Lost to Follow-up|21|||
30943791|NCT01451931|58985472|FG000|Overall Study|Withdrawal by Subject|16|||
30943792|NCT01451931|58985473|FG001|Overall Study|Withdrawal by Subject|22|||
30943793|NCT01451931|58985474|FG002|Overall Study|Withdrawal by Subject|22|||
30943794|NCT01414257|58985497|FG000|Overall Study|No Visit After First Day of Treatment|12|||
30943795|NCT01414257|58985497|FG000|Overall Study|Protocol Violation|10|||
30943796|NCT01434693|58985540|FG000|Overall Study|Adverse Event|1|||
30943797|NCT01434693|58985541|FG001|Overall Study|Adverse Event|0|||
30943798|NCT01434693|58985542|FG002|Overall Study|Adverse Event|0|||
30943799|NCT01434693|58985543|FG003|Overall Study|Adverse Event|0|||
30943800|NCT01434693|58985540|FG000|Overall Study|Withdrawal by Subject|1|||
30943801|NCT01434693|58985541|FG001|Overall Study|Withdrawal by Subject|0|||
30943802|NCT01434693|58985542|FG002|Overall Study|Withdrawal by Subject|1|||
30943803|NCT01434693|58985543|FG003|Overall Study|Withdrawal by Subject|1|||
30943804|NCT01434693|58985540|FG000|Overall Study|Lost to Follow-up|1|||
30943805|NCT01434693|58985541|FG001|Overall Study|Lost to Follow-up|0|||
30943806|NCT01434693|58985542|FG002|Overall Study|Lost to Follow-up|0|||
30943807|NCT01434693|58985543|FG003|Overall Study|Lost to Follow-up|0|||
30943808|NCT01451541|58985560|FG000|Overall Study|Adverse Event|4|||
30943809|NCT01451541|58985561|FG001|Overall Study|Adverse Event|3|||
30943810|NCT01451541|58985562|FG002|Overall Study|Adverse Event|6|||
30943811|NCT01451541|58985560|FG000|Overall Study|Lack of Efficacy|2|||
30943812|NCT01451541|58985561|FG001|Overall Study|Lack of Efficacy|0|||
30943813|NCT01451541|58985562|FG002|Overall Study|Lack of Efficacy|0|||
30943814|NCT01451541|58985560|FG000|Overall Study|Lost to Follow-up|4|||
30943815|NCT01451541|58985561|FG001|Overall Study|Lost to Follow-up|4|||
30943816|NCT01451541|58985562|FG002|Overall Study|Lost to Follow-up|7|||
30943817|NCT01451541|58985560|FG000|Overall Study|Withdrawal by Subject|15|||
30943818|NCT01451541|58985561|FG001|Overall Study|Withdrawal by Subject|8|||
30943819|NCT01451541|58985562|FG002|Overall Study|Withdrawal by Subject|6|||
30943820|NCT01451541|58985560|FG000|Overall Study|randomization error, noncompliance|11|||
30943821|NCT01451541|58985561|FG001|Overall Study|randomization error, noncompliance|10|||
30943822|NCT01451541|58985562|FG002|Overall Study|randomization error, noncompliance|8|||
30943823|NCT01450761|58985690|FG000|Randomization|Subject no longer meets study criteria|1|||
30943824|NCT01450761|58985691|FG001|Randomization|Subject no longer meets study criteria|2|||
30943825|NCT01450761|58985690|FG000|Randomization|Withdrawal by Subject|2|||
30943826|NCT01450761|58985691|FG001|Randomization|Withdrawal by Subject|0|||
30943827|NCT01450761|58985690|FG000|Randomization|Disease progression|0|||
30943828|NCT01450761|58985691|FG001|Randomization|Disease progression|2|||
30943829|NCT01450761|58985690|FG000|Randomization|Adverse Event unrelated to study drug|1|||
30943830|NCT01450761|58985691|FG001|Randomization|Adverse Event unrelated to study drug|0|||
30943831|NCT01450761|58985690|FG000|Randomization|Other|0|||
30943832|NCT01450761|58985691|FG001|Randomization|Other|1|||
30943833|NCT01450761|58985690|FG000|Lead-in Chemotherapy|Disease progression|33|||
30943834|NCT01450761|58985691|FG001|Lead-in Chemotherapy|Disease progression|32|||
30943835|NCT01450761|58985690|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
30943836|NCT01450761|58985691|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
30943837|NCT01450761|58985690|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
30943838|NCT01450761|58985691|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
30943839|NCT01450761|58985690|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
30943840|NCT01450761|58985691|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
30943841|NCT01450761|58985690|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
30943842|NCT01450761|58985691|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
30943843|NCT01450761|58985690|FG000|Lead-in Chemotherapy|Death|3|||
30943844|NCT01450761|58985691|FG001|Lead-in Chemotherapy|Death|3|||
30943845|NCT01450761|58985690|FG000|Lead-in Chemotherapy|Other|2|||
30943846|NCT01450761|58985691|FG001|Lead-in Chemotherapy|Other|2|||
30943847|NCT01450761|58985690|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
30943848|NCT01450761|58985691|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
30624514|NCT00947349|58636614|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
30624515|NCT00947349|58636615|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
30624516|NCT00947349|58636616|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
30842612|NCT03033069|58868470|FG002|Overall Study|Withdrawal by Subject|11|||
30842613|NCT03033069|58868471|FG003|Overall Study|Withdrawal by Subject|6|||
30842614|NCT03033069|58868468|FG000|Overall Study|Withdrawal By Caregiver|1|||
30943849|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
30943850|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
30943851|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
30943852|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
30943853|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
30943854|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
30943855|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
30943856|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
30943857|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
30943858|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
30943859|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Death|5|||
30943860|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Death|6|||
30943861|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
30943862|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
30943863|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
30943864|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
30943865|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
30943866|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
30943867|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
30943868|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
30943869|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
30943870|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
30943871|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
30943872|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
30943873|NCT01450761|58985690|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
30943874|NCT01450761|58985691|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
30943875|NCT01433991|58985741|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
30943876|NCT01433991|58985742|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
30943877|NCT01433991|58985743|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
30943878|NCT01433991|58985744|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
30943879|NCT01433991|58985741|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
30943880|NCT01433991|58985742|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
30943881|NCT01433991|58985743|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
30943882|NCT01433991|58985744|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
30943883|NCT01433991|58985741|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
30943884|NCT01433991|58985742|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
30943885|NCT01433991|58985743|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
30943886|NCT01433991|58985744|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
30943887|NCT01433991|58985741|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
30943888|NCT01433991|58985742|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
30943889|NCT01433991|58985743|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
30943890|NCT01433991|58985744|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
30943891|NCT01433991|58985741|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
30943892|NCT01433991|58985742|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
30943893|NCT01433991|58985743|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
30943894|NCT01433991|58985744|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
30943895|NCT01433991|58985741|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
30943896|NCT01433991|58985742|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
30943897|NCT01433991|58985743|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
30943898|NCT01433991|58985744|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
30943899|NCT01433991|58985741|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
30943900|NCT01433991|58985742|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
30943901|NCT01433991|58985743|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
30943902|NCT01433991|58985744|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
30943903|NCT01450683|58985760|FG000|Overall Study|Adverse Event|2|||
30943904|NCT01433055|58985766|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
30943905|NCT01433055|58985767|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
30943906|NCT01433055|58985766|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
30943907|NCT01433055|58985767|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
30943908|NCT01450137|58985775|FG000|Up to Week 12|Adverse Event|2|||
30943909|NCT01450137|58985776|FG001|Up to Week 12|Adverse Event|1|||
30943910|NCT01450137|58985775|FG000|Up to Week 12|Withdrawal by Subject|0|||
30943911|NCT01450137|58985776|FG001|Up to Week 12|Withdrawal by Subject|2|||
30943912|NCT01450137|58985775|FG000|Week 12 to Study End|Death|0|||
30943913|NCT01450137|58985776|FG001|Week 12 to Study End|Death|1|||
30943914|NCT01450137|58985775|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
30943915|NCT01450137|58985776|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
30943916|NCT01412229|58985782|FG000|Overall Study|Physician Decision|1|||
30943917|NCT01412151|58985787|FG000|Week 0 - 306 - Treatment Period|Death|1|||
30943918|NCT01412151|58985787|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
30943919|NCT01412151|58985787|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
30943920|NCT01412151|58985787|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
30943921|NCT01432275|58985793|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
30943922|NCT01432275|58985794|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
30943923|NCT01432275|58985793|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
30943924|NCT01432275|58985794|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
30943925|NCT01432275|58985793|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
30943926|NCT01432275|58985794|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
30943927|NCT01432275|58985793|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
30943928|NCT01432275|58985794|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
30943929|NCT01432275|58985793|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
30943930|NCT01432275|58985794|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
30943931|NCT01432275|58985793|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
30943932|NCT01432275|58985794|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
30943933|NCT01432275|58985793|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
30943934|NCT01432275|58985794|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
30943935|NCT01432275|58985793|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
30943936|NCT01432275|58985794|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
30943937|NCT01432275|58985793|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
30943938|NCT01432275|58985794|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
30943939|NCT01411995|58985802|FG000|Overall Study|Failed IUD insertion|0|||
30943940|NCT01411995|58985803|FG001|Overall Study|Failed IUD insertion|1|||
30943941|NCT01411917|58985811|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
30943942|NCT01411917|58985812|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
30759553|NCT00075764|58767981|FG001|Overall Study|Delinquent|2|||
30759554|NCT00075764|58767980|FG000|Overall Study|Not protocol specified|27|||
30759555|NCT00075764|58767981|FG001|Overall Study|Not protocol specified|19|||
30759556|NCT00075764|58767980|FG000|Overall Study|Under review|0|||
30842615|NCT03033069|58868469|FG001|Overall Study|Withdrawal By Caregiver|0|||
30842616|NCT03033069|58868470|FG002|Overall Study|Withdrawal By Caregiver|0|||
30842617|NCT03033069|58868471|FG003|Overall Study|Withdrawal By Caregiver|0|||
30842618|NCT03033069|58868468|FG000|Overall Study|Reason not Specified|0|||
30842619|NCT03033069|58868469|FG001|Overall Study|Reason not Specified|1|||
30842620|NCT03033069|58868470|FG002|Overall Study|Reason not Specified|0|||
30842621|NCT03033069|58868471|FG003|Overall Study|Reason not Specified|1|||
30842622|NCT02917265|58868483|FG000|Overall Study|Physician Decision|1|||
30842623|NCT02917265|58868484|FG001|Overall Study|Physician Decision|0|||
30842624|NCT02917265|58868483|FG000|Overall Study|Withdrawal by Subject|1|||
30842625|NCT02917265|58868484|FG001|Overall Study|Withdrawal by Subject|0|||
30842626|NCT02136069|58868494|FG000|Overall Study|UC flare-up|1|||
30842627|NCT02136069|58868495|FG001|Overall Study|UC flare-up|0|||
30842628|NCT02136069|58868494|FG000|Overall Study|Adverse Event|6|||
30842629|NCT02136069|58868495|FG001|Overall Study|Adverse Event|8|||
30759557|NCT00075764|58767981|FG001|Overall Study|Under review|1|||
30759558|NCT03568162|58767995|FG000|Overall Study|Adverse Event|0|||
30759559|NCT03568162|58767996|FG001|Overall Study|Adverse Event|1|||
30759560|NCT03568162|58767997|FG002|Overall Study|Adverse Event|2|||
30759561|NCT03568162|58767998|FG003|Overall Study|Adverse Event|0|||
30759562|NCT03568162|58767999|FG004|Overall Study|Adverse Event|0|||
30759563|NCT03568162|58768000|FG005|Overall Study|Adverse Event|1|||
30759564|NCT03568162|58767995|FG000|Overall Study|Death|0|||
30759565|NCT03568162|58767996|FG001|Overall Study|Death|0|||
30759566|NCT03568162|58767997|FG002|Overall Study|Death|0|||
30759567|NCT03568162|58767998|FG003|Overall Study|Death|0|||
30759568|NCT03568162|58767999|FG004|Overall Study|Death|1|||
30759569|NCT03568162|58768000|FG005|Overall Study|Death|0|||
30759570|NCT03568162|58767995|FG000|Overall Study|Lost to Follow-up|3|||
30759571|NCT03568162|58767996|FG001|Overall Study|Lost to Follow-up|2|||
30759572|NCT03568162|58767997|FG002|Overall Study|Lost to Follow-up|4|||
30759573|NCT03568162|58767998|FG003|Overall Study|Lost to Follow-up|2|||
30759574|NCT03568162|58767999|FG004|Overall Study|Lost to Follow-up|3|||
30759575|NCT03568162|58768000|FG005|Overall Study|Lost to Follow-up|2|||
30759576|NCT03568162|58767995|FG000|Overall Study|Physician Decision|0|||
30759577|NCT03568162|58767996|FG001|Overall Study|Physician Decision|1|||
30759578|NCT03568162|58767997|FG002|Overall Study|Physician Decision|1|||
30759579|NCT03568162|58767998|FG003|Overall Study|Physician Decision|0|||
30759580|NCT03568162|58767999|FG004|Overall Study|Physician Decision|1|||
30842630|NCT02136069|58868494|FG000|Overall Study|Death|0|||
30842631|NCT02136069|58868495|FG001|Overall Study|Death|1|||
30943943|NCT01411839|58985820|FG000|Overall Study|Lost to Follow-up|4|||
30943944|NCT01411839|58985821|FG001|Overall Study|Lost to Follow-up|3|||
30943945|NCT01411215|58985829|FG000|Overall Study|Adverse Event|1|||
30943946|NCT01411215|58985830|FG001|Overall Study|Adverse Event|2|||
30759581|NCT03568162|58768000|FG005|Overall Study|Physician Decision|0|||
30759582|NCT03568162|58767995|FG000|Overall Study|Pregnancy|0|||
30759583|NCT03568162|58767996|FG001|Overall Study|Pregnancy|0|||
30759584|NCT03568162|58767997|FG002|Overall Study|Pregnancy|0|||
30759585|NCT03568162|58767998|FG003|Overall Study|Pregnancy|1|||
30759586|NCT03568162|58767999|FG004|Overall Study|Pregnancy|0|||
30759587|NCT03568162|58768000|FG005|Overall Study|Pregnancy|0|||
30759588|NCT03568162|58767995|FG000|Overall Study|Protocol Violation|1|||
30759589|NCT03568162|58767996|FG001|Overall Study|Protocol Violation|0|||
30759590|NCT03568162|58767997|FG002|Overall Study|Protocol Violation|1|||
30943947|NCT01411215|58985829|FG000|Overall Study|Lack of Efficacy|2|||
30943948|NCT01411215|58985830|FG001|Overall Study|Lack of Efficacy|4|||
30943949|NCT01411215|58985829|FG000|Overall Study|Lost to Follow-up|12|||
30943950|NCT01411215|58985830|FG001|Overall Study|Lost to Follow-up|18|||
30943951|NCT01411215|58985829|FG000|Overall Study|Did not meet entrance criteria|0|||
30943952|NCT01411215|58985830|FG001|Overall Study|Did not meet entrance criteria|1|||
30943953|NCT01411215|58985829|FG000|Overall Study|Study terminated by sponsor|2|||
30943954|NCT01411215|58985830|FG001|Overall Study|Study terminated by sponsor|15|||
30943955|NCT01411215|58985829|FG000|Overall Study|Protocol Violation|3|||
30943956|NCT01411215|58985830|FG001|Overall Study|Protocol Violation|5|||
30943957|NCT01411215|58985829|FG000|Overall Study|Withdrawal by Subject|34|||
30943958|NCT01411215|58985830|FG001|Overall Study|Withdrawal by Subject|21|||
30943959|NCT01411215|58985829|FG000|Overall Study|Other|12|||
30943960|NCT01411215|58985830|FG001|Overall Study|Other|17|||
30943961|NCT01411215|58985829|FG000|Overall Study|Screen failure|0|||
30943962|NCT01411215|58985830|FG001|Overall Study|Screen failure|1|||
30943963|NCT01449279|58985836|FG000|Overall Study|Lack of Efficacy|5|||
30943964|NCT01449279|58985836|FG000|Overall Study|Toxicity|2|||
30943965|NCT01447719|58985840|FG000|Overall Study|Image acquisition failure|2|||
30943966|NCT01447719|58985840|FG000|Overall Study|Invalid image or not imaged|3|||
30943967|NCT01447719|58985840|FG000|Overall Study|Subject still living at end of study|79|||
30943968|NCT01447719|58985840|FG000|Overall Study|Withdrawal by Subject|2|||
30943969|NCT01447719|58985840|FG000|Overall Study|Family withdrew autopsy consent|7|||
30943970|NCT01431963|58985849|FG000|Overall Study|Adverse Event|18|||
30943971|NCT01431963|58985849|FG000|Overall Study|Lack of Efficacy|7|||
30943972|NCT01431963|58985849|FG000|Overall Study|Protocol Violation|1|||
30943973|NCT01431963|58985849|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
30943974|NCT01431963|58985849|FG000|Overall Study|Physician Decision|4|||
30943975|NCT01431963|58985849|FG000|Overall Study|Withdrawal by Subject|3|||
30943976|NCT01447407|58985857|FG000|Overall Study|Withdrawal by Subject|2|||
30943977|NCT01447407|58985858|FG001|Overall Study|Withdrawal by Subject|0|||
30943978|NCT01447407|58985859|FG002|Overall Study|Withdrawal by Subject|0|||
30943979|NCT01447407|58985860|FG003|Overall Study|Withdrawal by Subject|1|||
30943980|NCT01447407|58985857|FG000|Overall Study|Physician Decision|0|||
30943981|NCT01447407|58985858|FG001|Overall Study|Physician Decision|0|||
30943982|NCT01447407|58985859|FG002|Overall Study|Physician Decision|1|||
30943983|NCT01447407|58985860|FG003|Overall Study|Physician Decision|1|||
30943984|NCT01446237|58985870|FG000|Overall Study|Adverse Event|1|||
30943985|NCT01446237|58985870|FG000|Overall Study|Lost to Follow-up|2|||
30943986|NCT01446237|58985870|FG000|Overall Study|Withdrawal by Subject|7|||
30943987|NCT01446159|58986014|FG000|Overall Study|Withdrawal by Subject|1|||
30943988|NCT01446159|58986015|FG001|Overall Study|Withdrawal by Subject|0|||
30943989|NCT01446159|58986016|FG002|Overall Study|Withdrawal by Subject|14|||
30943990|NCT01446159|58986017|FG003|Overall Study|Withdrawal by Subject|11|||
30943991|NCT01446159|58986014|FG000|Overall Study|Lost to Follow-up|0|||
30943992|NCT01446159|58986015|FG001|Overall Study|Lost to Follow-up|0|||
30943993|NCT01446159|58986016|FG002|Overall Study|Lost to Follow-up|1|||
30943994|NCT01446159|58986017|FG003|Overall Study|Lost to Follow-up|2|||
30943995|NCT01446159|58986014|FG000|Overall Study|Death|2|||
30943996|NCT01446159|58986015|FG001|Overall Study|Death|3|||
30943997|NCT01446159|58986016|FG002|Overall Study|Death|43|||
30943998|NCT01446159|58986017|FG003|Overall Study|Death|36|||
30943999|NCT01446159|58986014|FG000|Overall Study|Other|0|||
30944000|NCT01446159|58986015|FG001|Overall Study|Other|0|||
30944001|NCT01446159|58986016|FG002|Overall Study|Other|13|||
30944002|NCT01446159|58986017|FG003|Overall Study|Other|13|||
30944003|NCT01446003|58986053|FG000|Period 1|Protocol Violation|2|||
30944004|NCT01446003|58986054|FG001|Period 1|Protocol Violation|0|||
30944005|NCT01446003|58986053|FG000|Period 2|Adverse Event|1|||
30944006|NCT01446003|58986054|FG001|Period 2|Adverse Event|0|||
30944007|NCT01430559|58986071|FG000|Overall Study|Adverse Event|7|||
30944008|NCT01430559|58986072|FG001|Overall Study|Adverse Event|3|||
30944009|NCT01430559|58986071|FG000|Overall Study|Entry criteria not met|1|||
30944010|NCT01430559|58986072|FG001|Overall Study|Entry criteria not met|1|||
30944011|NCT01430559|58986071|FG000|Overall Study|Lost to Follow-up|1|||
30944012|NCT01430559|58986072|FG001|Overall Study|Lost to Follow-up|0|||
30944013|NCT01430559|58986071|FG000|Overall Study|Medication error|1|||
30944014|NCT01430559|58986072|FG001|Overall Study|Medication error|0|||
30944015|NCT01430559|58986071|FG000|Overall Study|Withdrawal by Subject|3|||
30944016|NCT01430559|58986072|FG001|Overall Study|Withdrawal by Subject|2|||
30944017|NCT01430559|58986071|FG000|Overall Study|Protocol Violation|1|||
30944018|NCT01430559|58986072|FG001|Overall Study|Protocol Violation|0|||
30944019|NCT01430559|58986071|FG000|Overall Study|Other|3|||
30944020|NCT01430559|58986072|FG001|Overall Study|Other|3|||
30944021|NCT01430559|58986071|FG000|Overall Study|Randomized, Not Treated|3|||
30944022|NCT01430559|58986072|FG001|Overall Study|Randomized, Not Treated|3|||
30944023|NCT01410357|58986085|FG000|Overall Study|Death|2|||
30944024|NCT01410357|58986086|FG001|Overall Study|Death|1|||
30944025|NCT01410357|58986085|FG000|Overall Study|Withdrawal by Subject|1|||
30944026|NCT01410357|58986086|FG001|Overall Study|Withdrawal by Subject|2|||
30944027|NCT01410357|58986085|FG000|Overall Study|Lost to Follow-up|23|||
30944028|NCT01410357|58986086|FG001|Overall Study|Lost to Follow-up|21|||
30944029|NCT01409811|58986111|FG000|Overall Study|Insurance denial|1|||
30944030|NCT01445847|58986117|FG000|Overall Study|Protocol Violation|13|||
30944031|NCT01445847|58986118|FG001|Overall Study|Protocol Violation|14|||
30944032|NCT01445847|58986117|FG000|Overall Study|Missed Data|1|||
30944033|NCT01445847|58986118|FG001|Overall Study|Missed Data|0|||
30944034|NCT01445769|58986137|FG000|Overall Study|Consent Withdrawn|2|||
30944035|NCT01445769|58986137|FG000|Overall Study|Disease Progression|1|||
30944036|NCT01445769|58986137|FG000|Overall Study|Lost to Follow-up|5|||
30944037|NCT01445613|58986219|FG000|30-day Follow-up|Withdrawal by Subject|6|||
30944038|NCT01445613|58986219|FG000|30-day Follow-up|Physician Decision|3|||
30944039|NCT01445613|58986219|FG000|30-day Follow-up|Missed visit|23|||
30944040|NCT01445613|58986219|FG000|30-day Follow-up|Death|3|||
30944041|NCT01445613|58986219|FG000|1-year Follow-up|Withdrawal by Subject|12|||
30944042|NCT01445613|58986219|FG000|1-year Follow-up|Missed visit|29|||
30944043|NCT01445613|58986219|FG000|1-year Follow-up|Lost to Follow-up|2|||
30944044|NCT01445613|58986219|FG000|1-year Follow-up|Death|30|||
30944045|NCT01445613|58986219|FG000|1-year Follow-up|Physician Decision|2|||
30944046|NCT01445613|58986219|FG000|1-year Follow-up|Received a non-study stent|2|||
30944047|NCT01445535|58986323|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
30944048|NCT01445535|58986324|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
30944049|NCT01445535|58986325|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
30944050|NCT01445535|58986326|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
30944051|NCT01445535|58986323|FG000|Overall Study|Disease progression|1|||
30944052|NCT01445535|58986324|FG001|Overall Study|Disease progression|0|||
30944053|NCT01445535|58986325|FG002|Overall Study|Disease progression|1|||
30944054|NCT01445535|58986326|FG003|Overall Study|Disease progression|0|||
30944055|NCT01445535|58986323|FG000|Overall Study|PI discretion|0|||
30944056|NCT01445535|58986324|FG001|Overall Study|PI discretion|0|||
30944057|NCT01445535|58986325|FG002|Overall Study|PI discretion|0|||
30944058|NCT01445535|58986326|FG003|Overall Study|PI discretion|1|||
30944059|NCT01445301|58986340|FG000|Overall Study|Adverse Event|15|||
30944060|NCT01445301|58986341|FG001|Overall Study|Adverse Event|25|||
30944061|NCT01445301|58986342|FG002|Overall Study|Adverse Event|4|||
30944062|NCT01445301|58986340|FG000|Overall Study|Lack of Efficacy|0|||
30944063|NCT01445301|58986341|FG001|Overall Study|Lack of Efficacy|1|||
30944064|NCT01445301|58986342|FG002|Overall Study|Lack of Efficacy|0|||
30944065|NCT01445301|58986340|FG000|Overall Study|Protocol Violation|1|||
30944066|NCT01445301|58986341|FG001|Overall Study|Protocol Violation|0|||
30944067|NCT01445301|58986342|FG002|Overall Study|Protocol Violation|0|||
30944068|NCT01445301|58986340|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
30944069|NCT01445301|58986341|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
30944070|NCT01445301|58986342|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
30944071|NCT01445301|58986340|FG000|Overall Study|Physician Decision|0|||
30944072|NCT01445301|58986341|FG001|Overall Study|Physician Decision|2|||
30944073|NCT01445301|58986342|FG002|Overall Study|Physician Decision|0|||
30944074|NCT01445301|58986340|FG000|Overall Study|Withdrawal by Subject|5|||
30944075|NCT01445301|58986341|FG001|Overall Study|Withdrawal by Subject|6|||
30944076|NCT01445301|58986342|FG002|Overall Study|Withdrawal by Subject|4|||
30944077|NCT01409031|58986352|FG000|Overall Study|transferred to other hosp|1|||
30944078|NCT01409031|58986353|FG001|Overall Study|transferred to other hosp|0|||
30944079|NCT01430403|58986362|FG000|Overall Study|Lost to Follow-up|5|||
30944080|NCT01430403|58986363|FG001|Overall Study|Lost to Follow-up|5|||
30944081|NCT01430403|58986364|FG002|Overall Study|Lost to Follow-up|3|||
30944082|NCT01430403|58986362|FG000|Overall Study|Physician Decision|1|||
30944083|NCT01430403|58986363|FG001|Overall Study|Physician Decision|0|||
30944084|NCT01430403|58986364|FG002|Overall Study|Physician Decision|0|||
30944085|NCT01430403|58986362|FG000|Overall Study|Protocol Violation|2|||
30944086|NCT01430403|58986363|FG001|Overall Study|Protocol Violation|3|||
30944087|NCT01430403|58986364|FG002|Overall Study|Protocol Violation|2|||
30944088|NCT01430403|58986362|FG000|Overall Study|Withdrawal by Subject|9|||
30944089|NCT01430403|58986363|FG001|Overall Study|Withdrawal by Subject|1|||
30944090|NCT01430403|58986364|FG002|Overall Study|Withdrawal by Subject|3|||
30944091|NCT01429623|58986379|FG000|Overall Study|Death|1|||
30944092|NCT01429623|58986380|FG001|Overall Study|Death|0|||
30944093|NCT01429623|58986379|FG000|Overall Study|Adverse Event|7|||
30944094|NCT01429623|58986380|FG001|Overall Study|Adverse Event|14|||
30944095|NCT01429623|58986379|FG000|Overall Study|Withdrawal by Subject|19|||
30944096|NCT01429623|58986380|FG001|Overall Study|Withdrawal by Subject|13|||
30944097|NCT01429623|58986379|FG000|Overall Study|Physician Decision|2|||
30944098|NCT01429623|58986380|FG001|Overall Study|Physician Decision|3|||
30944099|NCT01429623|58986379|FG000|Overall Study|Protocol Violation|3|||
30944100|NCT01429623|58986380|FG001|Overall Study|Protocol Violation|2|||
30759591|NCT03568162|58767998|FG003|Overall Study|Protocol Violation|1|||
30944101|NCT01429623|58986379|FG000|Overall Study|Assorted|1|||
30944102|NCT01429623|58986380|FG001|Overall Study|Assorted|2|||
30944103|NCT01429623|58986379|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
30944104|NCT01429623|58986380|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
30944105|NCT01429623|58986379|FG000|Overall Study|No post baseline data|4|||
30944106|NCT01429623|58986380|FG001|Overall Study|No post baseline data|4|||
30944107|NCT01408641|58986388|FG000|Overall Study|Physician Decision|1|||
30944108|NCT01408641|58986389|FG001|Overall Study|Physician Decision|0|||
30944109|NCT01429077|58986397|FG000|Overall Study|Lost to Follow-up|0|||
30944110|NCT01429077|58986398|FG001|Overall Study|Lost to Follow-up|3|||
30944111|NCT01428453|58986406|FG000|Overall Study|Adverse Event|2|||
30944112|NCT01428453|58986407|FG001|Overall Study|Adverse Event|7|||
30944113|NCT01428453|58986406|FG000|Overall Study|Protocol Violation|1|||
30944114|NCT01428453|58986407|FG001|Overall Study|Protocol Violation|0|||
30944115|NCT01428453|58986406|FG000|Overall Study|Lost to Follow-up|0|||
30944116|NCT01428453|58986407|FG001|Overall Study|Lost to Follow-up|1|||
30944117|NCT01428453|58986406|FG000|Overall Study|Withdrawal by Subject|3|||
30944118|NCT01428453|58986407|FG001|Overall Study|Withdrawal by Subject|1|||
30944119|NCT01408563|58986415|FG000|Overall Study|Ineligible after consent/ registration|2|||
30944120|NCT01442493|58986421|FG000|Overall Study|withdrawn from study|3|||
30944121|NCT01442493|58986422|FG001|Overall Study|withdrawn from study|2|||
30944122|NCT01442181|58986430|FG000|Overall Study|patient refused surgery|1|||
30944123|NCT01442181|58986431|FG001|Overall Study|patient refused surgery|0|||
30944124|NCT01442181|58986430|FG000|Overall Study|no insurance for surgery|1|||
30944125|NCT01442181|58986431|FG001|Overall Study|no insurance for surgery|0|||
30944126|NCT01442181|58986430|FG000|Overall Study|low ejection factor|0|||
30944127|NCT01442181|58986431|FG001|Overall Study|low ejection factor|1|||
30944128|NCT01442181|58986430|FG000|Overall Study|Lost to Follow-up|1|||
30944129|NCT01442181|58986431|FG001|Overall Study|Lost to Follow-up|1|||
30944130|NCT01442181|58986430|FG000|Overall Study|patient in an additional study|1|||
30944131|NCT01442181|58986431|FG001|Overall Study|patient in an additional study|0|||
30944132|NCT01442181|58986430|FG000|Overall Study|atrial fibrillation not noted|0|||
30944133|NCT01442181|58986431|FG001|Overall Study|atrial fibrillation not noted|1|||
30944134|NCT01442103|58986438|FG000|Overall Study|Lost to Follow-up|2|||
30944135|NCT01428219|58986442|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
30944136|NCT01428063|58986449|FG000|Overall Study|Lack of Efficacy|8|||
30944137|NCT01428063|58986450|FG001|Overall Study|Lack of Efficacy|4|||
30944138|NCT01428063|58986451|FG002|Overall Study|Lack of Efficacy|1|||
30944139|NCT01428063|58986449|FG000|Overall Study|Adverse Event|2|||
30944140|NCT01428063|58986450|FG001|Overall Study|Adverse Event|3|||
30944141|NCT01428063|58986451|FG002|Overall Study|Adverse Event|0|||
30944142|NCT01428063|58986449|FG000|Overall Study|Lost to Follow-up|0|||
30944143|NCT01428063|58986450|FG001|Overall Study|Lost to Follow-up|2|||
30944144|NCT01428063|58986451|FG002|Overall Study|Lost to Follow-up|0|||
30944145|NCT01428063|58986449|FG000|Overall Study|No longer meets study criteria|0|||
30944146|NCT01428063|58986450|FG001|Overall Study|No longer meets study criteria|1|||
30944147|NCT01428063|58986451|FG002|Overall Study|No longer meets study criteria|0|||
30944148|NCT01441635|58986615|FG000|Overall Study|Adverse Event|4|||
30944149|NCT01441635|58986616|FG001|Overall Study|Adverse Event|3|||
30944150|NCT01441635|58986617|FG002|Overall Study|Adverse Event|1|||
30944151|NCT01441635|58986618|FG003|Overall Study|Adverse Event|5|||
30944152|NCT01441635|58986619|FG004|Overall Study|Adverse Event|1|||
30944153|NCT01441635|58986620|FG005|Overall Study|Adverse Event|2|||
30944154|NCT01441635|58986621|FG006|Overall Study|Adverse Event|2|||
30944155|NCT01441635|58986622|FG007|Overall Study|Adverse Event|2|||
30944156|NCT01441635|58986623|FG008|Overall Study|Adverse Event|1|||
30944157|NCT01441635|58986624|FG009|Overall Study|Adverse Event|0|||
30944158|NCT01441635|58986615|FG000|Overall Study|Withdrawal by Subject|1|||
30944159|NCT01441635|58986616|FG001|Overall Study|Withdrawal by Subject|1|||
30944160|NCT01441635|58986617|FG002|Overall Study|Withdrawal by Subject|0|||
30944161|NCT01441635|58986618|FG003|Overall Study|Withdrawal by Subject|1|||
30944162|NCT01441635|58986619|FG004|Overall Study|Withdrawal by Subject|0|||
30944163|NCT01441635|58986620|FG005|Overall Study|Withdrawal by Subject|0|||
30944164|NCT01441635|58986621|FG006|Overall Study|Withdrawal by Subject|2|||
30944165|NCT01441635|58986622|FG007|Overall Study|Withdrawal by Subject|0|||
30944166|NCT01441635|58986623|FG008|Overall Study|Withdrawal by Subject|1|||
30944167|NCT01441635|58986624|FG009|Overall Study|Withdrawal by Subject|1|||
30944168|NCT01441635|58986615|FG000|Overall Study|Lost to Follow-up|0|||
30944169|NCT01441635|58986616|FG001|Overall Study|Lost to Follow-up|1|||
30944170|NCT01441635|58986617|FG002|Overall Study|Lost to Follow-up|1|||
30944171|NCT01441635|58986618|FG003|Overall Study|Lost to Follow-up|1|||
30944172|NCT01441635|58986619|FG004|Overall Study|Lost to Follow-up|1|||
30759592|NCT03568162|58767999|FG004|Overall Study|Protocol Violation|1|||
30759593|NCT03568162|58768000|FG005|Overall Study|Protocol Violation|1|||
30759594|NCT03568162|58767995|FG000|Overall Study|Withdrawal by Subject|15|||
30759595|NCT03568162|58767996|FG001|Overall Study|Withdrawal by Subject|15|||
30842632|NCT02136069|58868494|FG000|Overall Study|Lack of Efficacy|10|||
30944173|NCT01441635|58986620|FG005|Overall Study|Lost to Follow-up|3|||
30944174|NCT01441635|58986621|FG006|Overall Study|Lost to Follow-up|1|||
30944175|NCT01441635|58986622|FG007|Overall Study|Lost to Follow-up|1|||
30944176|NCT01441635|58986623|FG008|Overall Study|Lost to Follow-up|0|||
30944177|NCT01441635|58986624|FG009|Overall Study|Lost to Follow-up|1|||
30944178|NCT01441635|58986615|FG000|Overall Study|Noncompliance|0|||
30944179|NCT01441635|58986616|FG001|Overall Study|Noncompliance|1|||
30944180|NCT01441635|58986617|FG002|Overall Study|Noncompliance|0|||
30944181|NCT01441635|58986618|FG003|Overall Study|Noncompliance|0|||
30944182|NCT01441635|58986619|FG004|Overall Study|Noncompliance|0|||
30944183|NCT01441635|58986620|FG005|Overall Study|Noncompliance|0|||
30944184|NCT01441635|58986621|FG006|Overall Study|Noncompliance|1|||
30944185|NCT01441635|58986622|FG007|Overall Study|Noncompliance|0|||
30944186|NCT01441635|58986623|FG008|Overall Study|Noncompliance|0|||
30944187|NCT01441635|58986624|FG009|Overall Study|Noncompliance|0|||
30944188|NCT01441635|58986615|FG000|Overall Study|Surgery or Invasive Intervention|0|||
30944189|NCT01441635|58986616|FG001|Overall Study|Surgery or Invasive Intervention|0|||
30944190|NCT01441635|58986617|FG002|Overall Study|Surgery or Invasive Intervention|1|||
30944191|NCT01441635|58986618|FG003|Overall Study|Surgery or Invasive Intervention|0|||
30944192|NCT01441635|58986619|FG004|Overall Study|Surgery or Invasive Intervention|0|||
30944193|NCT01441635|58986620|FG005|Overall Study|Surgery or Invasive Intervention|0|||
30944194|NCT01441635|58986621|FG006|Overall Study|Surgery or Invasive Intervention|0|||
30944195|NCT01441635|58986622|FG007|Overall Study|Surgery or Invasive Intervention|0|||
30944196|NCT01441635|58986623|FG008|Overall Study|Surgery or Invasive Intervention|0|||
30944197|NCT01441635|58986624|FG009|Overall Study|Surgery or Invasive Intervention|0|||
30944198|NCT01441635|58986615|FG000|Overall Study|Received Exclusionary Medication|1|||
30944199|NCT01441635|58986616|FG001|Overall Study|Received Exclusionary Medication|0|||
30944200|NCT01441635|58986617|FG002|Overall Study|Received Exclusionary Medication|0|||
30944201|NCT01441635|58986618|FG003|Overall Study|Received Exclusionary Medication|0|||
30944202|NCT01441635|58986619|FG004|Overall Study|Received Exclusionary Medication|0|||
30944203|NCT01441635|58986620|FG005|Overall Study|Received Exclusionary Medication|0|||
30944204|NCT01441635|58986621|FG006|Overall Study|Received Exclusionary Medication|0|||
30944205|NCT01441635|58986622|FG007|Overall Study|Received Exclusionary Medication|0|||
30944206|NCT01441635|58986623|FG008|Overall Study|Received Exclusionary Medication|0|||
30944207|NCT01441635|58986624|FG009|Overall Study|Received Exclusionary Medication|0|||
30944208|NCT01441635|58986615|FG000|Overall Study|Other|0|||
30944209|NCT01441635|58986616|FG001|Overall Study|Other|0|||
30944210|NCT01441635|58986617|FG002|Overall Study|Other|0|||
30944211|NCT01441635|58986618|FG003|Overall Study|Other|0|||
30944212|NCT01441635|58986619|FG004|Overall Study|Other|0|||
30944213|NCT01441635|58986620|FG005|Overall Study|Other|0|||
30944214|NCT01441635|58986621|FG006|Overall Study|Other|0|||
30944215|NCT01441635|58986622|FG007|Overall Study|Other|1|||
30944216|NCT01441635|58986623|FG008|Overall Study|Other|0|||
30944217|NCT01441635|58986624|FG009|Overall Study|Other|0|||
30944218|NCT01408485|58986646|FG000|Overall Study|Withdrawal by Subject|21|||
30944219|NCT01427907|58986652|FG000|Overall Study|Withdrawal by Subject|3|||
30944220|NCT01427907|58986653|FG001|Overall Study|Withdrawal by Subject|4|||
30944221|NCT01427751|58986661|FG000|Overall Study|Adverse Event|18|||
30944222|NCT01427751|58986662|FG001|Overall Study|Adverse Event|2|||
30944223|NCT01427751|58986661|FG000|Overall Study|No further treatment benefit expected|5|||
30944224|NCT01427751|58986662|FG001|Overall Study|No further treatment benefit expected|1|||
30944225|NCT01427751|58986661|FG000|Overall Study|Lost to Follow-up|3|||
30944226|NCT01427751|58986662|FG001|Overall Study|Lost to Follow-up|1|||
30944227|NCT01427751|58986661|FG000|Overall Study|Withdrawal of consent|2|||
30944228|NCT01427751|58986662|FG001|Overall Study|Withdrawal of consent|2|||
30944229|NCT01427751|58986661|FG000|Overall Study|Protocol Violation|6|||
30944230|NCT01427751|58986662|FG001|Overall Study|Protocol Violation|4|||
30944231|NCT01427751|58986661|FG000|Overall Study|Death|2|||
30944232|NCT01427751|58986662|FG001|Overall Study|Death|0|||
30944233|NCT01427751|58986661|FG000|Overall Study|Other miscellaneous reasons|6|||
30944234|NCT01427751|58986662|FG001|Overall Study|Other miscellaneous reasons|4|||
30944235|NCT01920061|58986688|FG000|Overall Study|Death|1|||
30944236|NCT01920061|58986689|FG001|Overall Study|Death|1|||
30944237|NCT01920061|58986690|FG002|Overall Study|Death|0|||
30944238|NCT01920061|58986691|FG003|Overall Study|Death|1|||
30944239|NCT01920061|58986692|FG004|Overall Study|Death|1|||
30944240|NCT01920061|58986693|FG005|Overall Study|Death|0|||
30944241|NCT01920061|58986694|FG006|Overall Study|Death|0|||
30944242|NCT01920061|58986695|FG007|Overall Study|Death|1|||
30944243|NCT01920061|58986696|FG008|Overall Study|Death|0|||
30944244|NCT01920061|58986697|FG009|Overall Study|Death|1|||
30944245|NCT01920061|58986698|FG010|Overall Study|Death|0|||
30944246|NCT01920061|58986699|FG011|Overall Study|Death|1|||
30944247|NCT01920061|58986700|FG012|Overall Study|Death|0|||
30944248|NCT01920061|58986701|FG013|Overall Study|Death|2|||
30944249|NCT01920061|58986702|FG014|Overall Study|Death|0|||
30944250|NCT01920061|58986703|FG015|Overall Study|Death|0|||
30944251|NCT01920061|58986704|FG016|Overall Study|Death|0|||
30944252|NCT01920061|58986705|FG017|Overall Study|Death|0|||
30842633|NCT02136069|58868495|FG001|Overall Study|Lack of Efficacy|4|||
30944253|NCT01920061|58986706|FG018|Overall Study|Death|1|||
30944254|NCT01920061|58986707|FG019|Overall Study|Death|0|||
30944255|NCT01920061|58986688|FG000|Overall Study|Lost to Follow-up|0|||
30944256|NCT01920061|58986689|FG001|Overall Study|Lost to Follow-up|2|||
30944257|NCT01920061|58986690|FG002|Overall Study|Lost to Follow-up|0|||
30944258|NCT01920061|58986691|FG003|Overall Study|Lost to Follow-up|0|||
30944259|NCT01920061|58986692|FG004|Overall Study|Lost to Follow-up|0|||
30944260|NCT01920061|58986693|FG005|Overall Study|Lost to Follow-up|0|||
30944261|NCT01920061|58986694|FG006|Overall Study|Lost to Follow-up|1|||
30944262|NCT01920061|58986695|FG007|Overall Study|Lost to Follow-up|0|||
30944263|NCT01920061|58986696|FG008|Overall Study|Lost to Follow-up|0|||
30944264|NCT01920061|58986697|FG009|Overall Study|Lost to Follow-up|0|||
30944265|NCT01920061|58986698|FG010|Overall Study|Lost to Follow-up|3|||
30944266|NCT01920061|58986699|FG011|Overall Study|Lost to Follow-up|0|||
30944267|NCT01920061|58986700|FG012|Overall Study|Lost to Follow-up|0|||
30944268|NCT01920061|58986701|FG013|Overall Study|Lost to Follow-up|0|||
30944269|NCT01920061|58986702|FG014|Overall Study|Lost to Follow-up|0|||
30944270|NCT01920061|58986703|FG015|Overall Study|Lost to Follow-up|0|||
30944271|NCT01920061|58986704|FG016|Overall Study|Lost to Follow-up|0|||
30944272|NCT01920061|58986705|FG017|Overall Study|Lost to Follow-up|1|||
30944273|NCT01920061|58986706|FG018|Overall Study|Lost to Follow-up|4|||
30944274|NCT01920061|58986707|FG019|Overall Study|Lost to Follow-up|3|||
30944275|NCT01920061|58986688|FG000|Overall Study|Other|1|||
30944276|NCT01920061|58986689|FG001|Overall Study|Other|1|||
30944277|NCT01920061|58986690|FG002|Overall Study|Other|2|||
30944278|NCT01920061|58986691|FG003|Overall Study|Other|1|||
30944279|NCT01920061|58986692|FG004|Overall Study|Other|0|||
30944280|NCT01920061|58986693|FG005|Overall Study|Other|1|||
30944281|NCT01920061|58986694|FG006|Overall Study|Other|0|||
30944282|NCT01920061|58986695|FG007|Overall Study|Other|0|||
30944283|NCT01920061|58986696|FG008|Overall Study|Other|0|||
30944284|NCT01920061|58986697|FG009|Overall Study|Other|1|||
30944285|NCT01920061|58986698|FG010|Overall Study|Other|1|||
30944286|NCT01920061|58986699|FG011|Overall Study|Other|2|||
30944287|NCT01920061|58986700|FG012|Overall Study|Other|1|||
30944288|NCT01920061|58986701|FG013|Overall Study|Other|4|||
30944289|NCT01920061|58986702|FG014|Overall Study|Other|0|||
30944290|NCT01920061|58986703|FG015|Overall Study|Other|1|||
30944291|NCT01920061|58986704|FG016|Overall Study|Other|1|||
30944292|NCT01920061|58986705|FG017|Overall Study|Other|0|||
30944293|NCT01920061|58986706|FG018|Overall Study|Other|1|||
30944294|NCT01920061|58986707|FG019|Overall Study|Other|1|||
30944295|NCT01920061|58986688|FG000|Overall Study|Participant refused further follow-up|0|||
30944296|NCT01920061|58986689|FG001|Overall Study|Participant refused further follow-up|0|||
30944297|NCT01920061|58986690|FG002|Overall Study|Participant refused further follow-up|0|||
30944298|NCT01920061|58986691|FG003|Overall Study|Participant refused further follow-up|0|||
30944299|NCT01920061|58986692|FG004|Overall Study|Participant refused further follow-up|1|||
30944300|NCT01920061|58986693|FG005|Overall Study|Participant refused further follow-up|1|||
30944301|NCT01920061|58986694|FG006|Overall Study|Participant refused further follow-up|0|||
30944302|NCT01920061|58986695|FG007|Overall Study|Participant refused further follow-up|0|||
30944303|NCT01920061|58986696|FG008|Overall Study|Participant refused further follow-up|1|||
30944304|NCT01920061|58986697|FG009|Overall Study|Participant refused further follow-up|0|||
30944305|NCT01920061|58986698|FG010|Overall Study|Participant refused further follow-up|1|||
30944306|NCT01920061|58986699|FG011|Overall Study|Participant refused further follow-up|0|||
30759596|NCT03568162|58767997|FG002|Overall Study|Withdrawal by Subject|26|||
30759597|NCT03568162|58767998|FG003|Overall Study|Withdrawal by Subject|22|||
30759598|NCT03568162|58767999|FG004|Overall Study|Withdrawal by Subject|6|||
30759599|NCT03568162|58768000|FG005|Overall Study|Withdrawal by Subject|9|||
30944307|NCT01920061|58986700|FG012|Overall Study|Participant refused further follow-up|1|||
30944308|NCT01920061|58986701|FG013|Overall Study|Participant refused further follow-up|0|||
30944309|NCT01920061|58986702|FG014|Overall Study|Participant refused further follow-up|1|||
30944310|NCT01920061|58986703|FG015|Overall Study|Participant refused further follow-up|2|||
30944311|NCT01920061|58986704|FG016|Overall Study|Participant refused further follow-up|1|||
30944312|NCT01920061|58986705|FG017|Overall Study|Participant refused further follow-up|1|||
30759600|NCT03568162|58767995|FG000|Overall Study|Others|3|||
30759601|NCT03568162|58767996|FG001|Overall Study|Others|4|||
30944313|NCT01920061|58986706|FG018|Overall Study|Participant refused further follow-up|0|||
30944314|NCT01920061|58986707|FG019|Overall Study|Participant refused further follow-up|0|||
30944315|NCT01426425|58986770|FG000|Overall Study|Exited prior to EP study|22|||
30944316|NCT01426425|58986770|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
30944317|NCT01426425|58986770|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
30759602|NCT03568162|58767997|FG002|Overall Study|Others|1|||
30759603|NCT03568162|58767998|FG003|Overall Study|Others|4|||
30759604|NCT03568162|58767999|FG004|Overall Study|Others|2|||
30944318|NCT01426347|58986783|FG000|Overall Study|Lost to Follow-up|0|||
30944319|NCT01426347|58986784|FG001|Overall Study|Lost to Follow-up|3|||
30944320|NCT01426347|58986783|FG000|Overall Study|Protocol Violation|2|||
30944321|NCT01426347|58986784|FG001|Overall Study|Protocol Violation|0|||
30944322|NCT01426347|58986783|FG000|Overall Study|Withdrawal by Subject|5|||
30944323|NCT01426347|58986784|FG001|Overall Study|Withdrawal by Subject|0|||
30944324|NCT01882465|58986790|FG000|Period 1|Lens Discomfort|0|||
30944325|NCT01882465|58986791|FG001|Period 1|Lens Discomfort|0|||
30944326|NCT01882465|58986792|FG002|Period 1|Lens Discomfort|0|||
30944327|NCT01882465|58986793|FG003|Period 1|Lens Discomfort|1|||
30944328|NCT01882465|58986794|FG004|Period 1|Lens Discomfort|0|||
30944329|NCT01882465|58986795|FG005|Period 1|Lens Discomfort|0|||
30944330|NCT01882465|58986796|FG006|Period 1|Lens Discomfort|0|||
30944331|NCT01882465|58986790|FG000|Period 1|Withdrawal by Subject|0|||
30944332|NCT01882465|58986791|FG001|Period 1|Withdrawal by Subject|0|||
30944333|NCT01882465|58986792|FG002|Period 1|Withdrawal by Subject|0|||
30944334|NCT01882465|58986793|FG003|Period 1|Withdrawal by Subject|0|||
30944335|NCT01882465|58986794|FG004|Period 1|Withdrawal by Subject|0|||
30944336|NCT01882465|58986795|FG005|Period 1|Withdrawal by Subject|0|||
30944337|NCT01882465|58986796|FG006|Period 1|Withdrawal by Subject|1|||
30944338|NCT01882465|58986790|FG000|Period 2|Protocol Violation|0|||
30944339|NCT01882465|58986791|FG001|Period 2|Protocol Violation|0|||
30944340|NCT01882465|58986792|FG002|Period 2|Protocol Violation|0|||
30944341|NCT01882465|58986793|FG003|Period 2|Protocol Violation|0|||
30944342|NCT01882465|58986794|FG004|Period 2|Protocol Violation|1|||
30944343|NCT01882465|58986795|FG005|Period 2|Protocol Violation|0|||
30944344|NCT01882465|58986796|FG006|Period 2|Protocol Violation|0|||
30944345|NCT01426269|58986804|FG000|Period 1: 12 Weeks|Adverse Event|5|||
30944346|NCT01426269|58986805|FG001|Period 1: 12 Weeks|Adverse Event|0|||
30944347|NCT01426269|58986806|FG002|Period 1: 12 Weeks|Adverse Event|0|||
30944348|NCT01426269|58986804|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
30944349|NCT01426269|58986805|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
30944350|NCT01426269|58986806|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
30944351|NCT01426269|58986804|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
30944352|NCT01426269|58986805|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
30944353|NCT01426269|58986806|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
30944354|NCT01426269|58986804|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
30944355|NCT01426269|58986805|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
30944356|NCT01426269|58986806|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
30944357|NCT01426269|58986804|FG000|Period 1: 12 Weeks|Pregnancy|1|||
30944358|NCT01426269|58986805|FG001|Period 1: 12 Weeks|Pregnancy|0|||
30944359|NCT01426269|58986806|FG002|Period 1: 12 Weeks|Pregnancy|0|||
30944360|NCT01426269|58986804|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
30944361|NCT01426269|58986805|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
30944362|NCT01426269|58986806|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
30944363|NCT01426269|58986804|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
30944364|NCT01426269|58986805|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
30944365|NCT01426269|58986806|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
30944366|NCT01426269|58986804|FG000|Period 2: 40 Weeks|Adverse Event|0|||
30944367|NCT01426269|58986805|FG001|Period 2: 40 Weeks|Adverse Event|1|||
30944368|NCT01426269|58986806|FG002|Period 2: 40 Weeks|Adverse Event|2|||
30944369|NCT01426269|58986804|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
30944370|NCT01426269|58986805|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
30944371|NCT01426269|58986806|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
30944372|NCT01426269|58986804|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
30944373|NCT01426269|58986805|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
30944374|NCT01426269|58986806|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
30944375|NCT01426269|58986804|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
30944376|NCT01426269|58986805|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
30944377|NCT01426269|58986806|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
30944378|NCT01426269|58986804|FG000|Period 2: 40 Weeks|Site closed|0|||
30944379|NCT01426269|58986805|FG001|Period 2: 40 Weeks|Site closed|6|||
30944380|NCT01426269|58986806|FG002|Period 2: 40 Weeks|Site closed|5|||
30944381|NCT01426269|58986804|FG000|Period 2: 40 Weeks|Relapsed|0|||
30944382|NCT01426269|58986805|FG001|Period 2: 40 Weeks|Relapsed|9|||
30944383|NCT01426269|58986806|FG002|Period 2: 40 Weeks|Relapsed|18|||
30944384|NCT01426113|58986819|FG000|Overall Study|Study Discontinued|1|||
30944385|NCT01426113|58986820|FG001|Overall Study|Study Discontinued|1|||
30944386|NCT01426113|58986819|FG000|Overall Study|Adverse Event|0|||
30944387|NCT01426113|58986820|FG001|Overall Study|Adverse Event|1|||
30944388|NCT01864603|58986828|FG000|Stage 2|DSMB design modification|86056|||
30944389|NCT01864603|58986829|FG001|Stage 2|DSMB design modification|92558|||
30944390|NCT01892293|58986840|FG000|Overall Study|Apheresed but not treated|4|||
30944391|NCT01393899|58986847|FG000|Overall Study|Study terminated by sponsor|1|||
30944392|NCT01393899|58986848|FG001|Overall Study|Study terminated by sponsor|0|||
30944393|NCT01393899|58986849|FG002|Overall Study|Study terminated by sponsor|1|||
30944394|NCT01393899|58986847|FG000|Overall Study|Other|1|||
30944395|NCT01393899|58986848|FG001|Overall Study|Other|0|||
30842634|NCT02136069|58868494|FG000|Overall Study|Lost to Follow-up|1|||
30944396|NCT01393899|58986849|FG002|Overall Study|Other|0|||
30944397|NCT01393899|58986847|FG000|Overall Study|Withdrawal by Subject|2|||
30944398|NCT01393899|58986848|FG001|Overall Study|Withdrawal by Subject|2|||
30944399|NCT01393899|58986849|FG002|Overall Study|Withdrawal by Subject|1|||
30944400|NCT01393899|58986847|FG000|Overall Study|Lost to Follow-up|0|||
30944401|NCT01393899|58986848|FG001|Overall Study|Lost to Follow-up|0|||
30944402|NCT01393899|58986849|FG002|Overall Study|Lost to Follow-up|1|||
30944403|NCT01393899|58986847|FG000|Overall Study|Does not meet entrance criteria|1|||
30944404|NCT01393899|58986848|FG001|Overall Study|Does not meet entrance criteria|0|||
30944405|NCT01393899|58986849|FG002|Overall Study|Does not meet entrance criteria|1|||
30944406|NCT01393899|58986847|FG000|Overall Study|Lack of Efficacy|26|||
30944407|NCT01393899|58986848|FG001|Overall Study|Lack of Efficacy|21|||
30944408|NCT01393899|58986849|FG002|Overall Study|Lack of Efficacy|16|||
30944409|NCT01393899|58986847|FG000|Overall Study|Adverse Event|1|||
30944410|NCT01393899|58986848|FG001|Overall Study|Adverse Event|5|||
30944411|NCT01393899|58986849|FG002|Overall Study|Adverse Event|3|||
30944412|NCT01393743|58986861|FG000|Core Study|Adverse Event|5|||
30944413|NCT01393743|58986862|FG001|Core Study|Adverse Event|9|||
30944414|NCT01393743|58986863|FG002|Core Study|Adverse Event|0|||
30944415|NCT01393743|58986861|FG000|Core Study|Lost to Follow-up|1|||
30944416|NCT01393743|58986862|FG001|Core Study|Lost to Follow-up|1|||
30944417|NCT01393743|58986863|FG002|Core Study|Lost to Follow-up|0|||
30944418|NCT01393743|58986861|FG000|Core Study|Participant's Choice|2|||
30944419|NCT01393743|58986862|FG001|Core Study|Participant's Choice|3|||
30944420|NCT01393743|58986863|FG002|Core Study|Participant's Choice|0|||
30944421|NCT01393743|58986861|FG000|Core Study|Inadequate therapeutic effect|2|||
30944422|NCT01393743|58986862|FG001|Core Study|Inadequate therapeutic effect|0|||
30944423|NCT01393743|58986863|FG002|Core Study|Inadequate therapeutic effect|0|||
30944424|NCT01393743|58986861|FG000|Extension Phase|Adverse Event|0|||
30944425|NCT01393743|58986862|FG001|Extension Phase|Adverse Event|0|||
30944426|NCT01393743|58986863|FG002|Extension Phase|Adverse Event|12|||
30944427|NCT01393743|58986861|FG000|Extension Phase|Lost to Follow-up|0|||
30944428|NCT01393743|58986862|FG001|Extension Phase|Lost to Follow-up|0|||
30944429|NCT01393743|58986863|FG002|Extension Phase|Lost to Follow-up|2|||
30944430|NCT01393743|58986861|FG000|Extension Phase|Participant choice|0|||
30944431|NCT01393743|58986862|FG001|Extension Phase|Participant choice|0|||
30944432|NCT01393743|58986863|FG002|Extension Phase|Participant choice|16|||
30944433|NCT01393743|58986861|FG000|Extension Phase|Inadequate therapeutic effect|0|||
30944434|NCT01393743|58986862|FG001|Extension Phase|Inadequate therapeutic effect|0|||
30944435|NCT01393743|58986863|FG002|Extension Phase|Inadequate therapeutic effect|7|||
30944436|NCT01393743|58986861|FG000|Extension Phase|Withdrawal by Subject|0|||
30944437|NCT01393743|58986862|FG001|Extension Phase|Withdrawal by Subject|0|||
30944438|NCT01393743|58986863|FG002|Extension Phase|Withdrawal by Subject|8|||
30944439|NCT01393743|58986861|FG000|Extension Phase|Pregnancy|0|||
30944440|NCT01393743|58986862|FG001|Extension Phase|Pregnancy|0|||
30944441|NCT01393743|58986863|FG002|Extension Phase|Pregnancy|1|||
30944442|NCT01393743|58986861|FG000|Extension Phase|Other|0|||
30944443|NCT01393743|58986862|FG001|Extension Phase|Other|0|||
30944444|NCT01393743|58986863|FG002|Extension Phase|Other|14|||
30944445|NCT01405911|58986882|FG000|Overall Study|Pre-treatment lab AE|0|||
30944446|NCT01405911|58986883|FG001|Overall Study|Pre-treatment lab AE|1|||
30944447|NCT01405911|58986884|FG002|Overall Study|Pre-treatment lab AE|0|||
30944448|NCT01405911|58986882|FG000|Overall Study|Lost to Follow-up|0|||
30944449|NCT01405911|58986883|FG001|Overall Study|Lost to Follow-up|1|||
30944450|NCT01405911|58986884|FG002|Overall Study|Lost to Follow-up|0|||
30944451|NCT01405911|58986882|FG000|Overall Study|Protocol Violation|1|||
30944452|NCT01405911|58986883|FG001|Overall Study|Protocol Violation|0|||
30944453|NCT01405911|58986884|FG002|Overall Study|Protocol Violation|0|||
30944454|NCT01405911|58986882|FG000|Overall Study|Withdrawal by Subject|3|||
30944455|NCT01405911|58986883|FG001|Overall Study|Withdrawal by Subject|1|||
30944456|NCT01405911|58986884|FG002|Overall Study|Withdrawal by Subject|1|||
30944457|NCT01425801|58986892|FG000|Period 1|Withdrawal by Subject|0|||
30944458|NCT01425801|58986893|FG001|Period 1|Withdrawal by Subject|0|||
30944459|NCT01425801|58986894|FG002|Period 1|Withdrawal by Subject|0|||
30944460|NCT01425801|58986895|FG003|Period 1|Withdrawal by Subject|0|||
30944461|NCT01425801|58986896|FG004|Period 1|Withdrawal by Subject|1|||
30944462|NCT01425801|58986897|FG005|Period 1|Withdrawal by Subject|0|||
30944463|NCT01425801|58986892|FG000|Period 2|Withdrawal by Subject|0|||
30944464|NCT01425801|58986893|FG001|Period 2|Withdrawal by Subject|0|||
30624517|NCT00947349|58636613|FG000|Overall Study Standard of Care|Other|0|||
30944465|NCT01425801|58986894|FG002|Period 2|Withdrawal by Subject|0|||
30944466|NCT01425801|58986895|FG003|Period 2|Withdrawal by Subject|0|||
30944467|NCT01425801|58986896|FG004|Period 2|Withdrawal by Subject|1|||
30944468|NCT01425801|58986897|FG005|Period 2|Withdrawal by Subject|0|||
30842635|NCT02136069|58868495|FG001|Overall Study|Lost to Follow-up|0|||
30944469|NCT01425801|58986892|FG000|Period 3|Stability criteria not fullfilled|0|||
30944470|NCT01425801|58986893|FG001|Period 3|Stability criteria not fullfilled|0|||
30944471|NCT01425801|58986894|FG002|Period 3|Stability criteria not fullfilled|1|||
30944472|NCT01425801|58986895|FG003|Period 3|Stability criteria not fullfilled|0|||
30944473|NCT01425801|58986896|FG004|Period 3|Stability criteria not fullfilled|0|||
30944474|NCT01425801|58986897|FG005|Period 3|Stability criteria not fullfilled|0|||
30944475|NCT01425801|58986892|FG000|Period 4|Not able to maintain visit schedule|0|||
30944476|NCT01425801|58986893|FG001|Period 4|Not able to maintain visit schedule|0|||
30944477|NCT01425801|58986894|FG002|Period 4|Not able to maintain visit schedule|1|||
30944478|NCT01425801|58986895|FG003|Period 4|Not able to maintain visit schedule|0|||
30944479|NCT01425801|58986896|FG004|Period 4|Not able to maintain visit schedule|0|||
30944480|NCT01425801|58986897|FG005|Period 4|Not able to maintain visit schedule|0|||
30944481|NCT01425723|58986922|FG000|Overall Study|Lack of Efficacy|0|||
30944482|NCT01425723|58986923|FG001|Overall Study|Lack of Efficacy|1|||
30944483|NCT01425723|58986922|FG000|Overall Study|Withdrawal by Subject|1|||
30944484|NCT01425723|58986923|FG001|Overall Study|Withdrawal by Subject|4|||
30944485|NCT01425723|58986922|FG000|Overall Study|Lost to Follow-up|0|||
30944486|NCT01425723|58986923|FG001|Overall Study|Lost to Follow-up|3|||
30944487|NCT01425723|58986922|FG000|Overall Study|Physician Decision|2|||
30944488|NCT01425723|58986923|FG001|Overall Study|Physician Decision|0|||
30944489|NCT01425723|58986922|FG000|Overall Study|Other|1|||
30944490|NCT01425723|58986923|FG001|Overall Study|Other|10|||
30944491|NCT01424397|58986954|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
30944492|NCT01424397|58986955|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
30944493|NCT01424397|58986956|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
30944494|NCT01424397|58986957|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
30944495|NCT01424397|58986958|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
30944496|NCT01424397|58986959|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
30944497|NCT01424397|58986960|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
30944498|NCT01424397|58986961|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
30944499|NCT01424397|58986962|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
30944500|NCT01424397|58986963|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
30944501|NCT01424397|58986964|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
30944502|NCT01424397|58986965|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
30944503|NCT01392963|58986981|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
30944504|NCT01392963|58986982|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
30944505|NCT01392963|58986981|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
30944506|NCT01392963|58986982|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
30944507|NCT01392963|58986981|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
30944508|NCT01392963|58986982|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
30944509|NCT01392573|58986992|FG000|Overall Study|Adverse Event|1|||
30944510|NCT01392573|58986993|FG001|Overall Study|Adverse Event|3|||
30944511|NCT01392573|58986992|FG000|Overall Study|Lack of Efficacy|1|||
30944512|NCT01392573|58986993|FG001|Overall Study|Lack of Efficacy|2|||
30944513|NCT01392573|58986992|FG000|Overall Study|Protocol Violation|0|||
30944514|NCT01392573|58986993|FG001|Overall Study|Protocol Violation|2|||
30944515|NCT01392573|58986992|FG000|Overall Study|Withdrawal Criteria|13|||
30944516|NCT01392573|58986993|FG001|Overall Study|Withdrawal Criteria|15|||
30944517|NCT01392573|58986992|FG000|Overall Study|Site closure|8|||
30944518|NCT01392573|58986993|FG001|Overall Study|Site closure|7|||
30944519|NCT01392573|58986992|FG000|Overall Study|Unclassified|9|||
30944520|NCT01392573|58986993|FG001|Overall Study|Unclassified|6|||
30944521|NCT01392495|58986999|FG000|Overall Study|Death|3|||
30944522|NCT01392495|58986999|FG000|Overall Study|Administrative problems|8|||
30944523|NCT01392495|58986999|FG000|Overall Study|Withdrawal by Subject|2|||
30944524|NCT01392495|58986999|FG000|Overall Study|Adverse Event|3|||
30944525|NCT01405053|58987007|FG000|Overall Study|Adverse Event|3|||
30944526|NCT01405053|58987008|FG001|Overall Study|Adverse Event|0|||
30944527|NCT01405053|58987007|FG000|Overall Study|Lost to Follow-up|0|||
30944528|NCT01405053|58987008|FG001|Overall Study|Lost to Follow-up|1|||
30944529|NCT01405053|58987007|FG000|Overall Study|Participant choice|2|||
30944530|NCT01405053|58987008|FG001|Overall Study|Participant choice|1|||
30944531|NCT01405053|58987007|FG000|Overall Study|Inadequate therapeutic effect|2|||
30944532|NCT01405053|58987008|FG001|Overall Study|Inadequate therapeutic effect|1|||
30944533|NCT01405053|58987007|FG000|Overall Study|Withdrawal by Subject|3|||
30944534|NCT01405053|58987008|FG001|Overall Study|Withdrawal by Subject|4|||
30944535|NCT01405053|58987007|FG000|Overall Study|Other|0|||
30944536|NCT01405053|58987008|FG001|Overall Study|Other|1|||
30944537|NCT01403805|58987016|FG000|Overall Study|Withdrawal by Subject|0|||
30944538|NCT01403805|58987017|FG001|Overall Study|Withdrawal by Subject|4|||
30944539|NCT01403805|58987016|FG000|Overall Study|Lost to Follow-up|0|||
30944540|NCT01403805|58987017|FG001|Overall Study|Lost to Follow-up|2|||
30944541|NCT01403805|58987016|FG000|Overall Study|Death|0|||
30944542|NCT01403805|58987017|FG001|Overall Study|Death|1|||
30944543|NCT01423617|58987029|FG000|Overall Study|Lost to Follow-up|0|||
30944544|NCT01423617|58987030|FG001|Overall Study|Lost to Follow-up|1|||
30944545|NCT01392183|58987038|FG000|First Drug Administration|Adverse Event|3|||
30944546|NCT01392183|58987039|FG001|First Drug Administration|Adverse Event|2|||
30944547|NCT01392183|58987038|FG000|First Drug Administration|Death|1|||
30944548|NCT01392183|58987039|FG001|First Drug Administration|Death|0|||
30944549|NCT01392183|58987038|FG000|First Drug Administration|Withdrawal by Subject|10|||
30944550|NCT01392183|58987039|FG001|First Drug Administration|Withdrawal by Subject|17|||
30944551|NCT01751906|58987049|FG000|Overall Study|Lost to Follow-up|151|||
30944552|NCT01751906|58987050|FG001|Overall Study|Lost to Follow-up|68|||
30944553|NCT01751906|58987049|FG000|Overall Study|Withdrawal by Subject|22|||
30944554|NCT01751906|58987050|FG001|Overall Study|Withdrawal by Subject|18|||
30944555|NCT01751906|58987049|FG000|Overall Study|Physician Decision|5|||
30944556|NCT01751906|58987050|FG001|Overall Study|Physician Decision|2|||
30944557|NCT01751906|58987049|FG000|Overall Study|Death|84|||
30944558|NCT01751906|58987050|FG001|Overall Study|Death|43|||
30944559|NCT01751906|58987049|FG000|Overall Study|Denied on premises for follow-up by law|1|||
30944560|NCT01751906|58987050|FG001|Overall Study|Denied on premises for follow-up by law|0|||
30944561|NCT01402947|58987058|FG000|First Intervention|Adverse Event|0|||
30944562|NCT01402947|58987059|FG001|First Intervention|Adverse Event|1|||
30944563|NCT01402869|58987068|FG000|Overall Study|Required Tooth Extraction|0|||
30944564|NCT01402869|58987069|FG001|Overall Study|Required Tooth Extraction|0|||
30944565|NCT01402869|58987070|FG002|Overall Study|Required Tooth Extraction|1|||
30944566|NCT01391793|58987080|FG000|Overall Study|Ineligible|3|||
30944567|NCT01391793|58987081|FG001|Overall Study|Ineligible|0|||
30944568|NCT01391793|58987080|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
30944569|NCT01391793|58987081|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
30944570|NCT01391793|58987080|FG000|Overall Study|No DMSA|73|||
30944571|NCT01391793|58987081|FG001|Overall Study|No DMSA|57|||
30944572|NCT01422915|58987087|FG000|Overall Study|Adverse Event|1|||
30944573|NCT01727024|58987092|FG000|Period 1|Lost to Follow-up|1|||
30944574|NCT01727024|58987093|FG001|Period 1|Lost to Follow-up|1|||
30944575|NCT01727024|58987092|FG000|Period 1|Withdrawal by Subject|2|||
30759605|NCT03568162|58768000|FG005|Overall Study|Others|1|||
30759606|NCT03567616|58768019|FG000|Overall Study|Disease progression|4|||
30759607|NCT03567616|58768019|FG000|Overall Study|Withdrawal by Subject|1|||
30759608|NCT03567616|58768019|FG000|Overall Study|Physician Decision|1|||
30759609|NCT03567616|58768019|FG000|Overall Study|Death|1|||
30759610|NCT03567616|58768019|FG000|Overall Study|Adverse Event|1|||
30759611|NCT03567382|58768028|FG000|Overall Study|Lost to Follow-up|1|||
30842636|NCT02136069|58868494|FG000|Overall Study|Non-Compliance|1|||
30842637|NCT02136069|58868495|FG001|Overall Study|Non-Compliance|0|||
30842638|NCT02136069|58868494|FG000|Overall Study|Physician Decision|5|||
30842639|NCT02136069|58868495|FG001|Overall Study|Physician Decision|4|||
30842640|NCT02136069|58868494|FG000|Overall Study|Withdrawal by Subject|10|||
30842641|NCT02136069|58868495|FG001|Overall Study|Withdrawal by Subject|11|||
30842642|NCT02917031|58868504|FG000|Overall Study|Reason not specified|7|||
30842643|NCT02917031|58868505|FG001|Overall Study|Reason not specified|5|||
30842644|NCT02917031|58868506|FG002|Overall Study|Reason not specified|6|||
30842645|NCT02917031|58868504|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
30842646|NCT02917031|58868505|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
30842647|NCT02917031|58868506|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
30842648|NCT02917031|58868504|FG000|Overall Study|Withdrawal by Subject|3|||
30842649|NCT02917031|58868505|FG001|Overall Study|Withdrawal by Subject|3|||
30842650|NCT02917031|58868506|FG002|Overall Study|Withdrawal by Subject|0|||
30842651|NCT02917031|58868504|FG000|Overall Study|Physician Decision|1|||
30842652|NCT02917031|58868505|FG001|Overall Study|Physician Decision|0|||
30842653|NCT02917031|58868506|FG002|Overall Study|Physician Decision|0|||
30842654|NCT02917031|58868504|FG000|Overall Study|Adverse Event|4|||
30842655|NCT02917031|58868505|FG001|Overall Study|Adverse Event|1|||
30842656|NCT02917031|58868506|FG002|Overall Study|Adverse Event|5|||
30842657|NCT02917031|58868504|FG000|Overall Study|Death|2|||
30759612|NCT03567382|58768029|FG001|Overall Study|Lost to Follow-up|21|||
30759613|NCT03567382|58768030|FG002|Overall Study|Lost to Follow-up|1|||
30759614|NCT03567382|58768031|FG003|Overall Study|Lost to Follow-up|21|||
30759615|NCT03567382|58768028|FG000|Overall Study|Withdrawal by Subject|2|||
30944576|NCT01727024|58987093|FG001|Period 1|Withdrawal by Subject|3|||
30944577|NCT01422213|58987102|FG000|Overall Study|Adverse Event|8|||
30944578|NCT01422213|58987103|FG001|Overall Study|Adverse Event|7|||
30944579|NCT01422213|58987104|FG002|Overall Study|Adverse Event|11|||
30944580|NCT01422213|58987102|FG000|Overall Study|Lack of Efficacy|10|||
30944581|NCT01422213|58987103|FG001|Overall Study|Lack of Efficacy|2|||
30842658|NCT02917031|58868505|FG001|Overall Study|Death|3|||
30944582|NCT01422213|58987104|FG002|Overall Study|Lack of Efficacy|2|||
30842659|NCT02917031|58868506|FG002|Overall Study|Death|4|||
30842660|NCT01018563|58868515|FG000|Overall Study|Termination of the study by Sponsor|2|||
30759616|NCT03567382|58768029|FG001|Overall Study|Withdrawal by Subject|14|||
30759617|NCT03567382|58768030|FG002|Overall Study|Withdrawal by Subject|1|||
30759618|NCT03567382|58768031|FG003|Overall Study|Withdrawal by Subject|12|||
30759619|NCT03595384|58768042|FG000|Overall Study|Other time commitments|8|||
30759620|NCT03595384|58768042|FG000|Overall Study|Changes to session time|7|||
30759621|NCT03595384|58768042|FG000|Overall Study|Relocation out of country|1|||
30759622|NCT03591874|58768048|FG000|Overall Study|Adverse Event|4|||
30759623|NCT03591874|58768049|FG001|Overall Study|Adverse Event|0|||
30759624|NCT03591874|58768048|FG000|Overall Study|Withdrawal by Subject|2|||
30759625|NCT03591874|58768049|FG001|Overall Study|Withdrawal by Subject|1|||
30759626|NCT03591874|58768048|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
30842661|NCT01018563|58868516|FG001|Overall Study|Termination of the study by Sponsor|1|||
30842662|NCT02528188|58868529|FG000|Overall Study|Adverse Event|23|||
30842663|NCT02528188|58868530|FG001|Overall Study|Adverse Event|22|||
30842664|NCT02528188|58868531|FG002|Overall Study|Adverse Event|8|||
30842665|NCT02528188|58868529|FG000|Overall Study|Protocol Violation|4|||
30842666|NCT02528188|58868530|FG001|Overall Study|Protocol Violation|6|||
30842667|NCT02528188|58868531|FG002|Overall Study|Protocol Violation|4|||
30842668|NCT02528188|58868529|FG000|Overall Study|Lack of Efficacy|19|||
30842669|NCT02528188|58868530|FG001|Overall Study|Lack of Efficacy|21|||
30842670|NCT02528188|58868531|FG002|Overall Study|Lack of Efficacy|22|||
30842671|NCT02528188|58868529|FG000|Overall Study|Withdrawal by Subject|97|||
30842672|NCT02528188|58868530|FG001|Overall Study|Withdrawal by Subject|104|||
30842673|NCT02528188|58868531|FG002|Overall Study|Withdrawal by Subject|100|||
30842674|NCT02528188|58868529|FG000|Overall Study|Lost to Follow-up|25|||
30842675|NCT02528188|58868530|FG001|Overall Study|Lost to Follow-up|21|||
30842676|NCT02528188|58868531|FG002|Overall Study|Lost to Follow-up|31|||
30842677|NCT02528188|58868529|FG000|Overall Study|Death|4|||
30842678|NCT02528188|58868530|FG001|Overall Study|Death|4|||
30842679|NCT02528188|58868531|FG002|Overall Study|Death|0|||
30842680|NCT02528188|58868529|FG000|Overall Study|Other|89|||
30842681|NCT02528188|58868530|FG001|Overall Study|Other|91|||
30842682|NCT02528188|58868531|FG002|Overall Study|Other|74|||
30842683|NCT02528188|58868529|FG000|Overall Study|Randomized but not treated|6|||
30842684|NCT02528188|58868530|FG001|Overall Study|Randomized but not treated|7|||
30842685|NCT02528188|58868531|FG002|Overall Study|Randomized but not treated|12|||
30842686|NCT03896165|58868539|FG000|Overall Study|Withdrawal by Subject|2|||
30842687|NCT05361304|58868552|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
30842688|NCT05361304|58868553|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
30759627|NCT03591874|58768049|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
30759628|NCT03591874|58768048|FG000|Overall Study|On Study at Time of Study Termination|12|||
30759629|NCT03591874|58768049|FG001|Overall Study|On Study at Time of Study Termination|6|||
30759630|NCT03566680|58768055|FG000|Overall Study|Pregnancy|1|||
30759631|NCT03566680|58768055|FG000|Overall Study|Lost to Follow-up|13|||
30759632|NCT03566680|58768055|FG000|Overall Study|Withdrawal by Subject|3|||
30759633|NCT00106353|58768061|FG000|Part 1|Disease progression|3|||
30759634|NCT00106353|58768062|FG001|Part 1|Disease progression|4|||
30759635|NCT00106353|58768063|FG002|Part 1|Disease progression|1|||
30759636|NCT00106353|58768064|FG003|Part 1|Disease progression|3|||
30759637|NCT00106353|58768065|FG004|Part 1|Disease progression|0|||
30842689|NCT05361304|58868552|FG000|Overall Study|COVID-19 Related|1|||
30842690|NCT05361304|58868553|FG001|Overall Study|COVID-19 Related|2|||
30842691|NCT05361304|58868552|FG000|Overall Study|Withdrawal by Subject|1|||
30842692|NCT05361304|58868553|FG001|Overall Study|Withdrawal by Subject|0|||
30842693|NCT02269917|58868576|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
30842694|NCT02269917|58868577|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
30624518|NCT00947349|58636614|FG001|Overall Study Standard of Care|Other|0|||
30624519|NCT00947349|58636615|FG002|Overall Study Standard of Care|Other|0|||
30842695|NCT02269917|58868578|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
30842696|NCT02269917|58868576|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
30842697|NCT02269917|58868577|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
30842698|NCT02269917|58868578|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
30842699|NCT02269917|58868576|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
30842700|NCT02269917|58868577|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
30624520|NCT00947349|58636616|FG003|Overall Study Standard of Care|Other|1|||
30624521|NCT00947193|58636644|FG000|Overall Study|Lost to Follow-up|1|||
30624522|NCT00947193|58636645|FG001|Overall Study|Lost to Follow-up|0|||
30624523|NCT00947193|58636644|FG000|Overall Study|Withdrawal by Subject|1|||
30624524|NCT00947193|58636645|FG001|Overall Study|Withdrawal by Subject|0|||
30944583|NCT01422213|58987102|FG000|Overall Study|Non-compliance with study drug|0|||
30624525|NCT00947193|58636644|FG000|Overall Study|Factor VIII >1%|1|||
30842701|NCT02269917|58868578|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
30759638|NCT00106353|58768066|FG005|Part 1|Disease progression|0|||
30624526|NCT00947193|58636645|FG001|Overall Study|Factor VIII >1%|0|||
30759639|NCT00106353|58768067|FG006|Part 1|Disease progression|0|||
30759640|NCT00106353|58768061|FG000|Part 1|Withdrawal by Subject|0|||
30944584|NCT01422213|58987103|FG001|Overall Study|Non-compliance with study drug|1|||
30944585|NCT01422213|58987104|FG002|Overall Study|Non-compliance with study drug|0|||
30944586|NCT01422213|58987102|FG000|Overall Study|Protocol Violation|0|||
30944587|NCT01422213|58987103|FG001|Overall Study|Protocol Violation|2|||
30944588|NCT01422213|58987104|FG002|Overall Study|Protocol Violation|4|||
30944589|NCT01422213|58987102|FG000|Overall Study|Withdrawal of Consent|7|||
30944590|NCT01422213|58987103|FG001|Overall Study|Withdrawal of Consent|3|||
30944591|NCT01422213|58987104|FG002|Overall Study|Withdrawal of Consent|5|||
30944592|NCT01422213|58987102|FG000|Overall Study|Lost to Follow-up|3|||
30944593|NCT01422213|58987103|FG001|Overall Study|Lost to Follow-up|3|||
30944594|NCT01422213|58987104|FG002|Overall Study|Lost to Follow-up|5|||
30944595|NCT01422213|58987102|FG000|Overall Study|Administrative or Other Reason(s)|5|||
30944596|NCT01422213|58987103|FG001|Overall Study|Administrative or Other Reason(s)|4|||
30944597|NCT01422213|58987104|FG002|Overall Study|Administrative or Other Reason(s)|2|||
30944598|NCT01390857|58987112|FG000|Overall Study|Protocol Violation|2|||
30944599|NCT01390857|58987112|FG000|Overall Study|Lost to Follow-up|1|||
30944600|NCT01390857|58987112|FG000|Overall Study|No Visit after the First Visit|7|||
30944601|NCT01725386|58987118|FG000|Overall Study|Death|84|||
30944602|NCT01725386|58987119|FG001|Overall Study|Death|40|||
30944603|NCT01725386|58987118|FG000|Overall Study|Lost to Follow-up|81|||
30944604|NCT01725386|58987119|FG001|Overall Study|Lost to Follow-up|6|||
30944605|NCT01725386|58987118|FG000|Overall Study|Withdrawal by Subject|10|||
30944606|NCT01725386|58987119|FG001|Overall Study|Withdrawal by Subject|0|||
30944607|NCT01402011|58987128|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
30944608|NCT01402011|58987129|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
30944609|NCT01402011|58987130|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
30944610|NCT01402011|58987128|FG000|Active Treatment Period|Withdrawal by Subject|1|||
30944611|NCT01402011|58987129|FG001|Active Treatment Period|Withdrawal by Subject|3|||
30944612|NCT01402011|58987130|FG002|Active Treatment Period|Withdrawal by Subject|0|||
30944613|NCT01402011|58987128|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
30944614|NCT01402011|58987129|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
30944615|NCT01402011|58987130|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
30944616|NCT01421667|58987145|FG000|Overall Study|Withdrawal by Subject|0|||
30944617|NCT01421667|58987146|FG001|Overall Study|Withdrawal by Subject|1|||
30944618|NCT01421667|58987147|FG002|Overall Study|Withdrawal by Subject|2|||
30944619|NCT01421667|58987148|FG003|Overall Study|Withdrawal by Subject|1|||
30944620|NCT01421667|58987145|FG000|Overall Study|Lost to Follow-up|0|||
30944621|NCT01421667|58987146|FG001|Overall Study|Lost to Follow-up|1|||
30944622|NCT01421667|58987147|FG002|Overall Study|Lost to Follow-up|0|||
30944623|NCT01421667|58987148|FG003|Overall Study|Lost to Follow-up|0|||
30944624|NCT01390779|58987166|FG000|Overall Study|Physician Decision|1|||
30944625|NCT01891669|58987180|FG000|Overall Study|Death|0|||
30944626|NCT01891669|58987181|FG001|Overall Study|Death|0|||
30944627|NCT01891669|58987182|FG002|Overall Study|Death|0|||
30944628|NCT01891669|58987183|FG003|Overall Study|Death|0|||
30944629|NCT01891669|58987184|FG004|Overall Study|Death|0|||
30944630|NCT01891669|58987185|FG005|Overall Study|Death|0|||
30944631|NCT01891669|58987186|FG006|Overall Study|Death|0|||
30944632|NCT01891669|58987187|FG007|Overall Study|Death|1|||
30944633|NCT01891669|58987188|FG008|Overall Study|Death|0|||
30944634|NCT01891669|58987189|FG009|Overall Study|Death|1|||
30944635|NCT01891669|58987180|FG000|Overall Study|Withdrawal by Subject|1|||
30944636|NCT01891669|58987181|FG001|Overall Study|Withdrawal by Subject|1|||
30944637|NCT01891669|58987182|FG002|Overall Study|Withdrawal by Subject|0|||
30944638|NCT01891669|58987183|FG003|Overall Study|Withdrawal by Subject|0|||
30944639|NCT01891669|58987184|FG004|Overall Study|Withdrawal by Subject|0|||
30944640|NCT01891669|58987185|FG005|Overall Study|Withdrawal by Subject|0|||
30944641|NCT01891669|58987186|FG006|Overall Study|Withdrawal by Subject|1|||
30944642|NCT01891669|58987187|FG007|Overall Study|Withdrawal by Subject|2|||
30944643|NCT01891669|58987188|FG008|Overall Study|Withdrawal by Subject|1|||
30944644|NCT01891669|58987189|FG009|Overall Study|Withdrawal by Subject|1|||
30944645|NCT01891669|58987180|FG000|Overall Study|Other|1|||
30944646|NCT01891669|58987181|FG001|Overall Study|Other|0|||
30944647|NCT01891669|58987182|FG002|Overall Study|Other|0|||
30944648|NCT01891669|58987183|FG003|Overall Study|Other|0|||
30944649|NCT01891669|58987184|FG004|Overall Study|Other|0|||
30944650|NCT01891669|58987185|FG005|Overall Study|Other|0|||
30944651|NCT01891669|58987186|FG006|Overall Study|Other|0|||
30944652|NCT01891669|58987187|FG007|Overall Study|Other|1|||
30944653|NCT01891669|58987188|FG008|Overall Study|Other|0|||
30944654|NCT01891669|58987189|FG009|Overall Study|Other|0|||
30944655|NCT01421511|58987222|FG000|Overall Study|Lost to Follow-up|11|||
30944656|NCT01421511|58987223|FG001|Overall Study|Lost to Follow-up|14|||
30944657|NCT01421511|58987222|FG000|Overall Study|Randomized but didn't receive study drug|1|||
30944658|NCT01421511|58987223|FG001|Overall Study|Randomized but didn't receive study drug|7|||
30944659|NCT01421511|58987222|FG000|Overall Study|Physician Decision|0|||
30944660|NCT01421511|58987223|FG001|Overall Study|Physician Decision|1|||
30944661|NCT01421511|58987222|FG000|Overall Study|Withdrawal by Subject|6|||
30944662|NCT01421511|58987223|FG001|Overall Study|Withdrawal by Subject|5|||
30944663|NCT01421511|58987222|FG000|Overall Study|Death|1|||
30944664|NCT01421511|58987223|FG001|Overall Study|Death|1|||
30944665|NCT01864525|58987232|FG000|Overall Study|Adverse Event|1|||
30944666|NCT01864525|58987233|FG001|Overall Study|Adverse Event|0|||
30944667|NCT01421277|58987241|FG000|Overall Study|Lack of qualifying event|0|||
30944668|NCT01421277|58987242|FG001|Overall Study|Lack of qualifying event|61|||
30944669|NCT01421277|58987241|FG000|Overall Study|Incomplete baseline data|0|||
30944670|NCT01421277|58987242|FG001|Overall Study|Incomplete baseline data|31|||
30944671|NCT01891357|58987248|FG000|Overall Study|Protocol Violation|3|||
30944672|NCT01420965|58987255|FG000|Overall Study|Withdrawal by Subject|1|||
30842702|NCT02269917|58868576|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
30842703|NCT02269917|58868577|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
30944673|NCT01420965|58987256|FG001|Overall Study|Withdrawal by Subject|0|||
30944674|NCT01420965|58987257|FG002|Overall Study|Withdrawal by Subject|0|||
30944675|NCT01420965|58987255|FG000|Overall Study|Adverse Event|0|||
30944676|NCT01420965|58987256|FG001|Overall Study|Adverse Event|1|||
30944677|NCT01420965|58987257|FG002|Overall Study|Adverse Event|0|||
30944678|NCT01390389|58987267|FG000|Overall Study|Withdrawal by Subject|2|||
30944679|NCT01390389|58987268|FG001|Overall Study|Withdrawal by Subject|0|||
30944680|NCT01390389|58987267|FG000|Overall Study|Screen Fail|2|||
30944681|NCT01390389|58987268|FG001|Overall Study|Screen Fail|1|||
30944682|NCT01401465|58987280|FG000|Treatment Period 1|Adverse Event|4|||
30944683|NCT01401465|58987281|FG001|Treatment Period 1|Adverse Event|1|||
30944684|NCT01401465|58987280|FG000|Treatment Period 1|Pregnancy|0|||
30944685|NCT01401465|58987281|FG001|Treatment Period 1|Pregnancy|1|||
30944686|NCT01401465|58987280|FG000|Treatment Period 1|Protocol Violation|5|||
30944687|NCT01401465|58987281|FG001|Treatment Period 1|Protocol Violation|0|||
30944688|NCT01401465|58987280|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30842704|NCT02269917|58868578|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
30842705|NCT02269917|58868576|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
30842706|NCT02269917|58868577|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
30842707|NCT02269917|58868578|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
30842708|NCT02269917|58868576|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
30842709|NCT02269917|58868577|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
30842710|NCT02269917|58868578|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
30842711|NCT02269917|58868576|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
30842712|NCT02269917|58868577|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
30842713|NCT02269917|58868578|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
30842714|NCT02269917|58868576|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
30842715|NCT02269917|58868577|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
30842716|NCT02269917|58868578|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
30842717|NCT02269917|58868576|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
30842718|NCT02269917|58868577|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
30842719|NCT02269917|58868578|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
30842720|NCT02269917|58868576|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
30842721|NCT02269917|58868577|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
30842722|NCT02269917|58868578|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
30842723|NCT02269917|58868576|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
30842724|NCT02269917|58868577|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
30842725|NCT02269917|58868578|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
30842726|NCT02269917|58868576|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
30842727|NCT02269917|58868577|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
30842728|NCT02269917|58868578|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
30842729|NCT02269917|58868576|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
30842730|NCT02269917|58868577|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
30944689|NCT01401465|58987281|FG001|Treatment Period 1|Withdrawal by Subject|4|||
30944690|NCT01401465|58987280|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
30944691|NCT01401465|58987281|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
30944692|NCT01401465|58987280|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
30944693|NCT01401465|58987281|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
30944694|NCT01401465|58987280|FG000|Treatment Period 1|Scheduling Difficulties|1|||
30944695|NCT01401465|58987281|FG001|Treatment Period 1|Scheduling Difficulties|1|||
30944696|NCT01401465|58987280|FG000|Treatment Period 2|Lost to Follow-up|0|||
30944697|NCT01401465|58987281|FG001|Treatment Period 2|Lost to Follow-up|1|||
30944698|NCT01401465|58987280|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30944699|NCT01401465|58987281|FG001|Treatment Period 2|Withdrawal by Subject|1|||
30944700|NCT01401153|58987292|FG000|First Test Day|Learning disabilities; illness|1|||
30944701|NCT01401153|58987293|FG001|First Test Day|Learning disabilities; illness|10|||
30944702|NCT01401153|58987292|FG000|Second Test Day|illness|0|||
30944703|NCT01401153|58987293|FG001|Second Test Day|illness|5|||
30944704|NCT01890967|58987306|FG000|Overall Study|Adverse Event|3|||
30944705|NCT01890967|58987307|FG001|Overall Study|Adverse Event|3|||
30944706|NCT01890967|58987308|FG002|Overall Study|Adverse Event|3|||
30944707|NCT01890967|58987309|FG003|Overall Study|Adverse Event|2|||
30944708|NCT01890967|58987310|FG004|Overall Study|Adverse Event|1|||
30944709|NCT01890967|58987311|FG005|Overall Study|Adverse Event|7|||
30944710|NCT01890967|58987306|FG000|Overall Study|Death|1|||
30944711|NCT01890967|58987307|FG001|Overall Study|Death|0|||
30944712|NCT01890967|58987308|FG002|Overall Study|Death|0|||
30944713|NCT01890967|58987309|FG003|Overall Study|Death|0|||
30944714|NCT01890967|58987310|FG004|Overall Study|Death|0|||
30944715|NCT01890967|58987311|FG005|Overall Study|Death|0|||
30944716|NCT01890967|58987306|FG000|Overall Study|Lost to Follow-up|1|||
30944717|NCT01890967|58987307|FG001|Overall Study|Lost to Follow-up|1|||
30944718|NCT01890967|58987308|FG002|Overall Study|Lost to Follow-up|1|||
30944719|NCT01890967|58987309|FG003|Overall Study|Lost to Follow-up|1|||
30944720|NCT01890967|58987310|FG004|Overall Study|Lost to Follow-up|0|||
30944721|NCT01890967|58987311|FG005|Overall Study|Lost to Follow-up|1|||
30944722|NCT01890967|58987306|FG000|Overall Study|Protocol Violation|0|||
30944723|NCT01890967|58987307|FG001|Overall Study|Protocol Violation|3|||
30944724|NCT01890967|58987308|FG002|Overall Study|Protocol Violation|3|||
30944725|NCT01890967|58987309|FG003|Overall Study|Protocol Violation|2|||
30944726|NCT01890967|58987310|FG004|Overall Study|Protocol Violation|4|||
30944727|NCT01890967|58987311|FG005|Overall Study|Protocol Violation|1|||
30944728|NCT01890967|58987306|FG000|Overall Study|Sponsor Decision|2|||
30944729|NCT01890967|58987307|FG001|Overall Study|Sponsor Decision|0|||
30944730|NCT01890967|58987308|FG002|Overall Study|Sponsor Decision|1|||
30944731|NCT01890967|58987309|FG003|Overall Study|Sponsor Decision|3|||
30944732|NCT01890967|58987310|FG004|Overall Study|Sponsor Decision|2|||
30944733|NCT01890967|58987311|FG005|Overall Study|Sponsor Decision|3|||
30944734|NCT01890967|58987306|FG000|Overall Study|Withdrawal by Subject|3|||
30944735|NCT01890967|58987307|FG001|Overall Study|Withdrawal by Subject|4|||
30944736|NCT01890967|58987308|FG002|Overall Study|Withdrawal by Subject|2|||
30944737|NCT01890967|58987309|FG003|Overall Study|Withdrawal by Subject|3|||
30944738|NCT01890967|58987310|FG004|Overall Study|Withdrawal by Subject|3|||
30944739|NCT01890967|58987311|FG005|Overall Study|Withdrawal by Subject|1|||
30944740|NCT01400919|58987330|FG000|Overall Study|Withdrawal by Subject|4|||
30944741|NCT01400919|58987330|FG000|Overall Study|Lost to Follow-up|2|||
30944742|NCT01400919|58987330|FG000|Overall Study|Missed visit|2|||
30944743|NCT01864291|58987334|FG000|Overall Study|need for revision surgery|2|||
30944744|NCT01400841|58987338|FG000|Initial Study Phase (6 Months)|Death|1|||
30944745|NCT01400841|58987338|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
30944746|NCT01863667|58987344|FG000|Overall Study|Adverse Event|1|||
30944747|NCT01863667|58987345|FG001|Overall Study|Adverse Event|0|||
30944748|NCT01863667|58987344|FG000|Overall Study|Study terminated by Sponsor|30|||
30944749|NCT01863667|58987345|FG001|Overall Study|Study terminated by Sponsor|30|||
30944750|NCT01863667|58987344|FG000|Overall Study|Withdrawal by Subject|2|||
30944751|NCT01863667|58987345|FG001|Overall Study|Withdrawal by Subject|2|||
30944752|NCT01614769|58987351|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
30944753|NCT01614769|58987352|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
30944754|NCT01614769|58987353|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
30944755|NCT01614769|58987354|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
30944756|NCT01614769|58987355|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
30944757|NCT01614769|58987356|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
30944758|NCT01614769|58987351|FG000|Period 1|Protocol Violation|0|||
30944759|NCT01614769|58987352|FG001|Period 1|Protocol Violation|0|||
30944760|NCT01614769|58987353|FG002|Period 1|Protocol Violation|0|||
30624527|NCT00947115|58636653|FG000|Overall Study|Missed reporting interval|3|||
30944761|NCT01614769|58987354|FG003|Period 1|Protocol Violation|1|||
30944762|NCT01614769|58987355|FG004|Period 1|Protocol Violation|0|||
30944763|NCT01614769|58987356|FG005|Period 1|Protocol Violation|0|||
30944764|NCT01614769|58987351|FG000|Period 1|Withdrawal by Subject|1|||
30944765|NCT01614769|58987352|FG001|Period 1|Withdrawal by Subject|0|||
30944766|NCT01614769|58987353|FG002|Period 1|Withdrawal by Subject|0|||
30944767|NCT01614769|58987354|FG003|Period 1|Withdrawal by Subject|0|||
30944768|NCT01614769|58987355|FG004|Period 1|Withdrawal by Subject|0|||
30944769|NCT01614769|58987356|FG005|Period 1|Withdrawal by Subject|0|||
30944770|NCT01614769|58987351|FG000|Period 3|Withdrawal by Subject|0|||
30624528|NCT00947115|58636654|FG001|Overall Study|Missed reporting interval|4|||
30944771|NCT01614769|58987352|FG001|Period 3|Withdrawal by Subject|0|||
30944772|NCT01614769|58987353|FG002|Period 3|Withdrawal by Subject|1|||
30944773|NCT01614769|58987354|FG003|Period 3|Withdrawal by Subject|0|||
30944774|NCT01614769|58987355|FG004|Period 3|Withdrawal by Subject|0|||
30944775|NCT01614769|58987356|FG005|Period 3|Withdrawal by Subject|0|||
30944776|NCT01614457|58987366|FG000|Overall Study|Non-Compliance|1|||
30944777|NCT01614457|58987367|FG001|Overall Study|Non-Compliance|0|||
30944778|NCT01614457|58987366|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
30944779|NCT01614457|58987367|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
30759641|NCT00106353|58768062|FG001|Part 1|Withdrawal by Subject|0|||
30759642|NCT00106353|58768063|FG002|Part 1|Withdrawal by Subject|1|||
30759643|NCT00106353|58768064|FG003|Part 1|Withdrawal by Subject|2|||
30759644|NCT00106353|58768065|FG004|Part 1|Withdrawal by Subject|0|||
30759645|NCT00106353|58768066|FG005|Part 1|Withdrawal by Subject|0|||
30759646|NCT00106353|58768067|FG006|Part 1|Withdrawal by Subject|0|||
30759647|NCT00106353|58768061|FG000|Part 1|Symptomatic deterioration|0|||
30759648|NCT00106353|58768062|FG001|Part 1|Symptomatic deterioration|0|||
30759649|NCT00106353|58768063|FG002|Part 1|Symptomatic deterioration|1|||
30759650|NCT00106353|58768064|FG003|Part 1|Symptomatic deterioration|0|||
30759651|NCT00106353|58768065|FG004|Part 1|Symptomatic deterioration|0|||
30759652|NCT00106353|58768066|FG005|Part 1|Symptomatic deterioration|0|||
30759653|NCT00106353|58768067|FG006|Part 1|Symptomatic deterioration|0|||
30759654|NCT00106353|58768061|FG000|Part 1|Entered follow-up phase|1|||
30759655|NCT00106353|58768062|FG001|Part 1|Entered follow-up phase|1|||
30759656|NCT00106353|58768063|FG002|Part 1|Entered follow-up phase|0|||
30759657|NCT00106353|58768064|FG003|Part 1|Entered follow-up phase|1|||
30759658|NCT00106353|58768065|FG004|Part 1|Entered follow-up phase|0|||
30759659|NCT00106353|58768066|FG005|Part 1|Entered follow-up phase|0|||
30759660|NCT00106353|58768067|FG006|Part 1|Entered follow-up phase|0|||
30759661|NCT00106353|58768061|FG000|Part 1|Adverse Event|0|||
30759662|NCT00106353|58768062|FG001|Part 1|Adverse Event|0|||
30759663|NCT00106353|58768063|FG002|Part 1|Adverse Event|0|||
30759664|NCT00106353|58768064|FG003|Part 1|Adverse Event|1|||
30759665|NCT00106353|58768065|FG004|Part 1|Adverse Event|0|||
30759666|NCT00106353|58768066|FG005|Part 1|Adverse Event|0|||
30759667|NCT00106353|58768067|FG006|Part 1|Adverse Event|0|||
30759668|NCT00106353|58768061|FG000|Part 2|Disease progression|0|||
30759669|NCT00106353|58768062|FG001|Part 2|Disease progression|0|||
30759670|NCT00106353|58768063|FG002|Part 2|Disease progression|0|||
30759671|NCT00106353|58768064|FG003|Part 2|Disease progression|0|||
30759672|NCT00106353|58768065|FG004|Part 2|Disease progression|8|||
30759673|NCT00106353|58768066|FG005|Part 2|Disease progression|14|||
30759674|NCT00106353|58768067|FG006|Part 2|Disease progression|13|||
30759675|NCT00106353|58768061|FG000|Part 2|Death|0|||
30759676|NCT00106353|58768062|FG001|Part 2|Death|0|||
30759677|NCT00106353|58768063|FG002|Part 2|Death|0|||
30759678|NCT00106353|58768064|FG003|Part 2|Death|0|||
30759679|NCT00106353|58768065|FG004|Part 2|Death|3|||
30759680|NCT00106353|58768066|FG005|Part 2|Death|0|||
30759681|NCT00106353|58768067|FG006|Part 2|Death|1|||
30759682|NCT00106353|58768061|FG000|Part 2|Symptomatic deterioration|0|||
30759683|NCT00106353|58768062|FG001|Part 2|Symptomatic deterioration|0|||
30759684|NCT00106353|58768063|FG002|Part 2|Symptomatic deterioration|0|||
30759685|NCT00106353|58768064|FG003|Part 2|Symptomatic deterioration|0|||
30759686|NCT00106353|58768065|FG004|Part 2|Symptomatic deterioration|3|||
30759687|NCT00106353|58768066|FG005|Part 2|Symptomatic deterioration|0|||
30759688|NCT00106353|58768067|FG006|Part 2|Symptomatic deterioration|0|||
30759689|NCT00106353|58768061|FG000|Part 2|Adverse Event|0|||
30759690|NCT00106353|58768062|FG001|Part 2|Adverse Event|0|||
30759691|NCT00106353|58768063|FG002|Part 2|Adverse Event|0|||
30624529|NCT00947115|58636655|FG002|Overall Study|Missed reporting interval|2|||
30624530|NCT00947115|58636653|FG000|Overall Study|Physician Decision|0|||
30759692|NCT00106353|58768064|FG003|Part 2|Adverse Event|0|||
30944780|NCT01863433|58987373|FG000|Overall Study|Protocol Violation|1|||
30944781|NCT01862029|58987377|FG000|Overall Study|Physician Decision|1|||
30759693|NCT00106353|58768065|FG004|Part 2|Adverse Event|0|||
30759694|NCT00106353|58768066|FG005|Part 2|Adverse Event|2|||
30759695|NCT00106353|58768067|FG006|Part 2|Adverse Event|1|||
30759696|NCT00106353|58768061|FG000|Part 2|Other|0|||
30759697|NCT00106353|58768062|FG001|Part 2|Other|0|||
30759698|NCT00106353|58768063|FG002|Part 2|Other|0|||
30759699|NCT00106353|58768064|FG003|Part 2|Other|0|||
30759700|NCT00106353|58768065|FG004|Part 2|Other|1|||
30944782|NCT01835431|58987384|FG000|Overall Study|Adverse Event|1|||
30944783|NCT01835431|58987385|FG001|Overall Study|Adverse Event|0|||
30944784|NCT01835431|58987384|FG000|Overall Study|other|0|||
30944785|NCT01835431|58987385|FG001|Overall Study|other|2|||
30944786|NCT01835431|58987384|FG000|Overall Study|Withdrawal by Subject|6|||
30944787|NCT01835431|58987385|FG001|Overall Study|Withdrawal by Subject|10|||
30944788|NCT01835431|58987384|FG000|Overall Study|Protocol Violation|1|||
30944789|NCT01835431|58987385|FG001|Overall Study|Protocol Violation|0|||
30944790|NCT01880593|58987393|FG000|Overall Study|Adverse Event|1|||
30944791|NCT01880593|58987394|FG001|Overall Study|Adverse Event|0|||
30944792|NCT01880593|58987393|FG000|Overall Study|Lack of Efficacy|1|||
30944793|NCT01880593|58987394|FG001|Overall Study|Lack of Efficacy|5|||
30944794|NCT01880593|58987393|FG000|Overall Study|Withdrawal by Subject|6|||
30944795|NCT01880593|58987394|FG001|Overall Study|Withdrawal by Subject|1|||
30944796|NCT01400451|58987403|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
30944797|NCT01400451|58987404|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
30944798|NCT01400451|58987405|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
30944799|NCT01400451|58987403|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
30944800|NCT01400451|58987404|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
30944801|NCT01400451|58987405|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
30944802|NCT01400451|58987403|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
30944803|NCT01400451|58987404|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
30944804|NCT01400451|58987405|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
30944805|NCT01400451|58987403|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
30944806|NCT01400451|58987404|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
30944807|NCT01400451|58987405|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
30944808|NCT01400451|58987403|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
30944809|NCT01400451|58987404|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
30944810|NCT01400451|58987405|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
30944811|NCT01400139|58987418|FG000|HYD Core Study|Adverse Event|210|||
30944812|NCT01400139|58987418|FG000|HYD Core Study|Lack of Efficacy|59|||
30944813|NCT01400139|58987418|FG000|HYD Core Study|Withdrawal by Subject|114|||
30944814|NCT01400139|58987418|FG000|HYD Core Study|Lost to Follow-up|39|||
30944815|NCT01400139|58987418|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
30944816|NCT01400139|58987418|FG000|HYD Core Study|Administrative|56|||
30944817|NCT01400139|58987418|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
30944818|NCT01400139|58987418|FG000|HYD Extension Period|Adverse Event|8|||
30944819|NCT01400139|58987418|FG000|HYD Extension Period|Withdrawal by Subject|5|||
30944820|NCT01400139|58987418|FG000|HYD Extension Period|Administrative|10|||
30944821|NCT01399905|58987426|FG000|Overall Study|Withdrawal by Subject|1|||
30944822|NCT01399905|58987427|FG001|Overall Study|Withdrawal by Subject|1|||
30944823|NCT01725308|58987441|FG000|Treatment Period I|Did Not Receive Drug|1|||
30944824|NCT01725308|58987442|FG001|Treatment Period I|Did Not Receive Drug|0|||
30944825|NCT01725308|58987443|FG002|Treatment Period I|Did Not Receive Drug|0|||
30944826|NCT01725308|58987441|FG000|Treatment Period I|Adverse Event|5|||
30944827|NCT01725308|58987442|FG001|Treatment Period I|Adverse Event|4|||
30944828|NCT01725308|58987443|FG002|Treatment Period I|Adverse Event|21|||
30944829|NCT01725308|58987441|FG000|Treatment Period I|Insufficient Response|7|||
30944830|NCT01725308|58987442|FG001|Treatment Period I|Insufficient Response|0|||
30944831|NCT01725308|58987443|FG002|Treatment Period I|Insufficient Response|5|||
30944832|NCT01725308|58987441|FG000|Treatment Period I|Worsening of the Target Disease|8|||
30944833|NCT01725308|58987442|FG001|Treatment Period I|Worsening of the Target Disease|0|||
30944834|NCT01725308|58987443|FG002|Treatment Period I|Worsening of the Target Disease|2|||
30944835|NCT01725308|58987441|FG000|Treatment Period I|Changes in the Episodes|3|||
30944836|NCT01725308|58987442|FG001|Treatment Period I|Changes in the Episodes|0|||
30944837|NCT01725308|58987443|FG002|Treatment Period I|Changes in the Episodes|2|||
30944838|NCT01725308|58987441|FG000|Treatment Period I|Withdrawal of Consent|12|||
30944839|NCT01725308|58987442|FG001|Treatment Period I|Withdrawal of Consent|7|||
30944840|NCT01725308|58987443|FG002|Treatment Period I|Withdrawal of Consent|5|||
30944841|NCT01725308|58987441|FG000|Treatment Period I|Lost to Follow-up|3|||
30944842|NCT01725308|58987442|FG001|Treatment Period I|Lost to Follow-up|2|||
30944843|NCT01725308|58987443|FG002|Treatment Period I|Lost to Follow-up|2|||
30944844|NCT01725308|58987441|FG000|Treatment Period I|Protocol Deviations|3|||
30944845|NCT01725308|58987442|FG001|Treatment Period I|Protocol Deviations|1|||
30944846|NCT01725308|58987443|FG002|Treatment Period I|Protocol Deviations|1|||
30944847|NCT01725308|58987441|FG000|Treatment Period I|Miscellaneous|2|||
30944848|NCT01725308|58987442|FG001|Treatment Period I|Miscellaneous|0|||
30944849|NCT01725308|58987443|FG002|Treatment Period I|Miscellaneous|3|||
30944850|NCT01725308|58987441|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
30944851|NCT01725308|58987442|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
30944852|NCT01725308|58987443|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
30944853|NCT01725308|58987441|FG000|Treatment Period II|Did Not Receive Drug|4|||
30944854|NCT01725308|58987442|FG001|Treatment Period II|Did Not Receive Drug|0|||
30944855|NCT01725308|58987443|FG002|Treatment Period II|Did Not Receive Drug|0|||
30944856|NCT01725308|58987441|FG000|Treatment Period II|Adverse Event|13|||
30944857|NCT01725308|58987442|FG001|Treatment Period II|Adverse Event|8|||
30944858|NCT01725308|58987443|FG002|Treatment Period II|Adverse Event|20|||
30944859|NCT01725308|58987441|FG000|Treatment Period II|Insufficient Response|2|||
30944860|NCT01725308|58987442|FG001|Treatment Period II|Insufficient Response|4|||
30944861|NCT01725308|58987443|FG002|Treatment Period II|Insufficient Response|6|||
30944862|NCT01725308|58987441|FG000|Treatment Period II|Worsening of the Target Disease|1|||
30944863|NCT01725308|58987442|FG001|Treatment Period II|Worsening of the Target Disease|4|||
30944864|NCT01725308|58987443|FG002|Treatment Period II|Worsening of the Target Disease|2|||
30944865|NCT01725308|58987441|FG000|Treatment Period II|Changes in the Episodes|1|||
30944866|NCT01725308|58987442|FG001|Treatment Period II|Changes in the Episodes|0|||
30944867|NCT01725308|58987443|FG002|Treatment Period II|Changes in the Episodes|5|||
30944868|NCT01725308|58987441|FG000|Treatment Period II|Withdrawal of Consent|28|||
30944869|NCT01725308|58987442|FG001|Treatment Period II|Withdrawal of Consent|2|||
30944870|NCT01725308|58987443|FG002|Treatment Period II|Withdrawal of Consent|16|||
30944871|NCT01725308|58987441|FG000|Treatment Period II|Lost to Follow-up|1|||
30944872|NCT01725308|58987442|FG001|Treatment Period II|Lost to Follow-up|5|||
30944873|NCT01725308|58987443|FG002|Treatment Period II|Lost to Follow-up|3|||
30944874|NCT01725308|58987441|FG000|Treatment Period II|Protocol Deviations|0|||
30944875|NCT01725308|58987442|FG001|Treatment Period II|Protocol Deviations|0|||
30944876|NCT01725308|58987443|FG002|Treatment Period II|Protocol Deviations|1|||
30944877|NCT01725308|58987441|FG000|Treatment Period II|Miscellaneous|5|||
30944878|NCT01725308|58987442|FG001|Treatment Period II|Miscellaneous|3|||
30944879|NCT01725308|58987443|FG002|Treatment Period II|Miscellaneous|7|||
30944880|NCT01724528|58987460|FG000|Overall Study|Death|3|||
30944881|NCT01724528|58987461|FG001|Overall Study|Death|0|||
30944882|NCT01724528|58987460|FG000|Overall Study|Withdrawal by Subject|0|||
30944883|NCT01724528|58987461|FG001|Overall Study|Withdrawal by Subject|2|||
30944884|NCT01724528|58987460|FG000|Overall Study|Protocol Violation|0|||
30842731|NCT02269917|58868578|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
30842732|NCT02269917|58868576|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
30842733|NCT02269917|58868577|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
30842734|NCT02269917|58868578|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
30842735|NCT02269917|58868576|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
30842736|NCT02269917|58868577|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
30842737|NCT02269917|58868578|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
30842738|NCT02269917|58868576|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
30842739|NCT02269917|58868577|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
30944885|NCT01724528|58987461|FG001|Overall Study|Protocol Violation|1|||
30944886|NCT01724528|58987460|FG000|Overall Study|Patient refused to attend last visit|1|||
30944887|NCT01724528|58987461|FG001|Overall Study|Patient refused to attend last visit|0|||
30944888|NCT01779440|58987469|FG000|Overall Study|Withdrawal by Subject|3|||
30944889|NCT01779440|58987470|FG001|Overall Study|Withdrawal by Subject|5|||
30944890|NCT01750346|58987479|FG000|Overall Study|Adverse Event|1|||
30944891|NCT01750346|58987480|FG001|Overall Study|Adverse Event|0|||
30842740|NCT02269917|58868578|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
30944892|NCT01750346|58987481|FG002|Overall Study|Adverse Event|0|||
30944893|NCT01750268|58987491|FG000|Overall Study|Lost to Follow-up|0|||
30944894|NCT01750268|58987492|FG001|Overall Study|Lost to Follow-up|2|||
30944895|NCT01750268|58987491|FG000|Overall Study|Physician Decision|0|||
30944896|NCT01750268|58987492|FG001|Overall Study|Physician Decision|3|||
30944897|NCT01750268|58987491|FG000|Overall Study|Withdrawal by Subject|2|||
30944898|NCT01750268|58987492|FG001|Overall Study|Withdrawal by Subject|0|||
30944899|NCT01880437|58987501|FG000|Overall Study|Death|12|||
30944900|NCT01880437|58987502|FG001|Overall Study|Death|4|||
30944901|NCT01880437|58987503|FG002|Overall Study|Death|17|||
30944902|NCT01880437|58987501|FG000|Overall Study|Study terminated by Sponsor|3|||
30944903|NCT01880437|58987502|FG001|Overall Study|Study terminated by Sponsor|0|||
30944904|NCT01880437|58987503|FG002|Overall Study|Study terminated by Sponsor|2|||
30944905|NCT01861717|58987513|FG000|Overall Study|Lost to Follow-up|1|||
30944906|NCT01861717|58987513|FG000|Overall Study|Withdrawal by Subject|1|||
30944907|NCT01834729|58987522|FG000|Overall Study|Did not return bowel diaries|0|||
30944908|NCT01834729|58987523|FG001|Overall Study|Did not return bowel diaries|0|||
30944909|NCT01834729|58987524|FG002|Overall Study|Did not return bowel diaries|3|||
30944910|NCT01834729|58987525|FG003|Overall Study|Did not return bowel diaries|0|||
30944911|NCT01834729|58987522|FG000|Overall Study|Withdrawal by Subject|1|||
30944912|NCT01834729|58987523|FG001|Overall Study|Withdrawal by Subject|1|||
30944913|NCT01834729|58987524|FG002|Overall Study|Withdrawal by Subject|0|||
30944914|NCT01834729|58987525|FG003|Overall Study|Withdrawal by Subject|0|||
30944915|NCT01834729|58987522|FG000|Overall Study|Adverse Event|0|||
30944916|NCT01834729|58987523|FG001|Overall Study|Adverse Event|0|||
30944917|NCT01834729|58987524|FG002|Overall Study|Adverse Event|0|||
30842741|NCT02522494|58868589|FG000|Overall Study|Lost to Follow-up|6|||
30944918|NCT01834729|58987525|FG003|Overall Study|Adverse Event|2|||
30944919|NCT01860703|58987536|FG000|Overall Study|Adverse Event|1|||
30944920|NCT01860703|58987537|FG001|Overall Study|Adverse Event|4|||
30944921|NCT01860703|58987538|FG002|Overall Study|Adverse Event|0|||
30944922|NCT01860703|58987539|FG003|Overall Study|Adverse Event|2|||
30944923|NCT01860703|58987536|FG000|Overall Study|Withdrawal by Subject|0|||
30944924|NCT01860703|58987537|FG001|Overall Study|Withdrawal by Subject|1|||
30944925|NCT01860703|58987538|FG002|Overall Study|Withdrawal by Subject|0|||
30944926|NCT01860703|58987539|FG003|Overall Study|Withdrawal by Subject|0|||
30944927|NCT01860703|58987536|FG000|Overall Study|Personal reason|1|||
30944928|NCT01860703|58987537|FG001|Overall Study|Personal reason|0|||
30944929|NCT01860703|58987538|FG002|Overall Study|Personal reason|1|||
30944930|NCT01860703|58987539|FG003|Overall Study|Personal reason|0|||
30944931|NCT01399593|58987557|FG000|Overall Study|Physician Decision|1|||
30944932|NCT01399593|58987558|FG001|Overall Study|Physician Decision|0|||
30944933|NCT01399593|58987557|FG000|Overall Study|Adverse Event|1|||
30944934|NCT01399593|58987558|FG001|Overall Study|Adverse Event|0|||
30944935|NCT01399593|58987557|FG000|Overall Study|Death|1|||
30944936|NCT01399593|58987558|FG001|Overall Study|Death|1|||
30944937|NCT01399593|58987557|FG000|Overall Study|Transplantectomy|0|||
30944938|NCT01399593|58987558|FG001|Overall Study|Transplantectomy|1|||
30944939|NCT01833169|58987564|FG000|Overall Study|Disease Progression|99|||
30944940|NCT01833169|58987564|FG000|Overall Study|Adverse Event|33|||
30944941|NCT01833169|58987564|FG000|Overall Study|Withdrawal by Subject|9|||
30944942|NCT01833169|58987564|FG000|Overall Study|Death|3|||
30944943|NCT01833169|58987564|FG000|Overall Study|Physician Decision|2|||
30944944|NCT01860079|58987570|FG000|Overall Study|Physician Decision|14|||
30944945|NCT01860079|58987571|FG001|Overall Study|Physician Decision|22|||
30944946|NCT01388985|58987579|FG000|Overall Study|Death|0|||
30944947|NCT01388985|58987580|FG001|Overall Study|Death|1|||
30944948|NCT01388985|58987579|FG000|Overall Study|Lost to Follow-up|30|||
30944949|NCT01388985|58987580|FG001|Overall Study|Lost to Follow-up|30|||
30944950|NCT01388985|58987579|FG000|Overall Study|Withdrawal by Subject|13|||
30944951|NCT01388985|58987580|FG001|Overall Study|Withdrawal by Subject|4|||
30842742|NCT02522494|58868590|FG001|Overall Study|Lost to Follow-up|2|||
30944952|NCT01388985|58987579|FG000|Overall Study|Subject unavailable|1|||
30944953|NCT01388985|58987580|FG001|Overall Study|Subject unavailable|1|||
30944954|NCT01388985|58987579|FG000|Overall Study|Other (no reason)|0|||
30944955|NCT01388985|58987580|FG001|Overall Study|Other (no reason)|1|||
30944956|NCT01388985|58987579|FG000|Overall Study|Error of nurse|5|||
30944957|NCT01388985|58987580|FG001|Overall Study|Error of nurse|1|||
30944958|NCT01388907|58987588|FG000|Overall Study|Adverse Event|2|||
30944959|NCT01388907|58987589|FG001|Overall Study|Adverse Event|0|||
30944960|NCT01388361|58987600|FG000|Overall Study|Adverse Event|0|||
30944961|NCT01388361|58987601|FG001|Overall Study|Adverse Event|5|||
30944962|NCT01388361|58987602|FG002|Overall Study|Adverse Event|1|||
30944963|NCT01388361|58987600|FG000|Overall Study|Protocol Violation|0|||
30944964|NCT01388361|58987601|FG001|Overall Study|Protocol Violation|0|||
30944965|NCT01388361|58987602|FG002|Overall Study|Protocol Violation|2|||
30944966|NCT01388361|58987600|FG000|Overall Study|Withdrawal criteria|12|||
30944967|NCT01388361|58987601|FG001|Overall Study|Withdrawal criteria|7|||
30944968|NCT01388361|58987602|FG002|Overall Study|Withdrawal criteria|10|||
30944969|NCT01388361|58987600|FG000|Overall Study|Unclassified|0|||
30944970|NCT01388361|58987601|FG001|Overall Study|Unclassified|0|||
30944971|NCT01388361|58987602|FG002|Overall Study|Unclassified|1|||
30944972|NCT01399125|58987612|FG000|Overall Study|Adverse Event|32|||
30944973|NCT01399125|58987613|FG001|Overall Study|Adverse Event|30|||
30944974|NCT01399125|58987612|FG000|Overall Study|Abnormal Lab values|0|||
30944975|NCT01399125|58987613|FG001|Overall Study|Abnormal Lab values|1|||
30944976|NCT01399125|58987612|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
30944977|NCT01399125|58987613|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
30944978|NCT01399125|58987612|FG000|Overall Study|Withdrawal by Subject|5|||
30944979|NCT01399125|58987613|FG001|Overall Study|Withdrawal by Subject|8|||
30944980|NCT01399125|58987612|FG000|Overall Study|Lost to Follow-up|2|||
30944981|NCT01399125|58987613|FG001|Overall Study|Lost to Follow-up|3|||
30944982|NCT01399125|58987612|FG000|Overall Study|Administrative Problems|7|||
30944983|NCT01399125|58987613|FG001|Overall Study|Administrative Problems|11|||
30944984|NCT01399125|58987612|FG000|Overall Study|Death|0|||
30944985|NCT01399125|58987613|FG001|Overall Study|Death|1|||
30944986|NCT01399125|58987612|FG000|Overall Study|Protocol Deviation|5|||
30944987|NCT01399125|58987613|FG001|Overall Study|Protocol Deviation|2|||
30944988|NCT01399047|58987621|FG000|Overall Study|Withdrawal by Subject|0|||
30944989|NCT01399047|58987622|FG001|Overall Study|Withdrawal by Subject|1|||
30944990|NCT01387737|58987632|FG000|Overall Study|Adverse Event|20|||
30944991|NCT01387737|58987633|FG001|Overall Study|Adverse Event|30|||
30944992|NCT01387737|58987632|FG000|Overall Study|Lack of Efficacy|1|||
30944993|NCT01387737|58987633|FG001|Overall Study|Lack of Efficacy|0|||
30944994|NCT01387737|58987632|FG000|Overall Study|Physician Decision|3|||
30944995|NCT01387737|58987633|FG001|Overall Study|Physician Decision|10|||
30944996|NCT01387737|58987632|FG000|Overall Study|Withdrawal by Subject|27|||
30944997|NCT01387737|58987633|FG001|Overall Study|Withdrawal by Subject|31|||
30944998|NCT01387737|58987632|FG000|Overall Study|Clearly not eligible for the study|1|||
30944999|NCT01387737|58987633|FG001|Overall Study|Clearly not eligible for the study|3|||
30945000|NCT01387347|58987641|FG000|Overall Study|Lost to Follow-up|2|||
30945001|NCT01387347|58987642|FG001|Overall Study|Lost to Follow-up|1|||
30945002|NCT01859923|58987656|FG000|Overall Study|Adverse Event|0|||
30945003|NCT01859923|58987657|FG001|Overall Study|Adverse Event|0|||
30945004|NCT01859923|58987658|FG002|Overall Study|Adverse Event|1|||
30945005|NCT01859923|58987659|FG003|Overall Study|Adverse Event|1|||
30945006|NCT01832155|58987674|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
30945007|NCT01832155|58987675|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
30945008|NCT01832155|58987674|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
30945009|NCT01832155|58987675|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
30945010|NCT01879579|58987689|FG000|Overall Study|Phone incompatible with texting platform|3|||
30945011|NCT01879579|58987690|FG001|Overall Study|Phone incompatible with texting platform|0|||
30945012|NCT01879579|58987689|FG000|Overall Study|Did not enroll in texting platform|1|||
30945013|NCT01879579|58987690|FG001|Overall Study|Did not enroll in texting platform|0|||
30945014|NCT01879579|58987689|FG000|Overall Study|Did not initiate insulin treatment|1|||
30945015|NCT01879579|58987690|FG001|Overall Study|Did not initiate insulin treatment|0|||
30945016|NCT01879579|58987689|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
30945017|NCT01879579|58987690|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
30945018|NCT01879579|58987689|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
30945019|NCT01879579|58987690|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
30945020|NCT01386645|58987702|FG000|Overall Study|Physician Decision|0|||
30945021|NCT01386645|58987703|FG001|Overall Study|Physician Decision|0|||
30945022|NCT01386645|58987704|FG002|Overall Study|Physician Decision|1|||
30945023|NCT01386645|58987702|FG000|Overall Study|Withdrawal by Subject|0|||
30945024|NCT01386645|58987703|FG001|Overall Study|Withdrawal by Subject|1|||
30945025|NCT01386645|58987704|FG002|Overall Study|Withdrawal by Subject|1|||
30945026|NCT01387269|58987714|FG000|Overall Study|Death|38|||
30945027|NCT01387269|58987715|FG001|Overall Study|Death|20|||
30945028|NCT01387269|58987714|FG000|Overall Study|Other|8|||
30945029|NCT01387269|58987715|FG001|Overall Study|Other|7|||
30945030|NCT01387269|58987714|FG000|Overall Study|Unrelated AE|12|||
30945031|NCT01387269|58987715|FG001|Overall Study|Unrelated AE|3|||
30945032|NCT01387269|58987714|FG000|Overall Study|Withdrawal by patient|32|||
30945033|NCT01387269|58987715|FG001|Overall Study|Withdrawal by patient|10|||
30945034|NCT01387269|58987714|FG000|Overall Study|Study drug-related AE|1|||
30945035|NCT01387269|58987715|FG001|Overall Study|Study drug-related AE|0|||
30945036|NCT01387269|58987714|FG000|Overall Study|Lost to Follow-up|1|||
30945037|NCT01387269|58987715|FG001|Overall Study|Lost to Follow-up|0|||
30945038|NCT01859143|58987723|FG000|Overall Study|Lost to Follow-up|2|||
30945039|NCT01859143|58987724|FG001|Overall Study|Lost to Follow-up|0|||
30945040|NCT01878253|58987731|FG000|Overall Study|Death|1|||
30945041|NCT01878253|58987731|FG000|Overall Study|SIdus System Removal|3|||
30945042|NCT01878253|58987731|FG000|Overall Study|Withdrawal by Subject|1|||
30945043|NCT01878253|58987731|FG000|Overall Study|Lost to Follow-up|2|||
30945044|NCT01878253|58987731|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
30945045|NCT01878175|58987740|FG000|Overall Study|Developed contraindicated health problem|2|||
30945046|NCT01878097|58987747|FG000|Baseline|Surveys not fully completed|2497|||
30945047|NCT01878097|58987748|FG001|Baseline|Surveys not fully completed|1800|||
30945048|NCT01878097|58987747|FG000|Implementation Year 1|Surveys not fully completed|3202|||
30945049|NCT01878097|58987748|FG001|Implementation Year 1|Surveys not fully completed|2549|||
30945050|NCT01878097|58987747|FG000|Implementation Year 2|Surveys not fully completed|3281|||
30945051|NCT01878097|58987748|FG001|Implementation Year 2|Surveys not fully completed|2841|||
30945052|NCT01878097|58987747|FG000|Implementation Year 3|Surveys not fully completed|3494|||
30945053|NCT01878097|58987748|FG001|Implementation Year 3|Surveys not fully completed|2980|||
30945054|NCT01878097|58987747|FG000|Implementation Year 4|Surveys not fully completed|3604|||
30945055|NCT01878097|58987748|FG001|Implementation Year 4|Surveys not fully completed|3007|||
30945056|NCT01750190|58987756|FG000|Overall Study|Adverse Event|47|||
30945057|NCT01750190|58987757|FG001|Overall Study|Adverse Event|19|||
30945058|NCT01750190|58987756|FG000|Overall Study|Death|38|||
30945059|NCT01750190|58987757|FG001|Overall Study|Death|11|||
30945060|NCT01750190|58987756|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
30945061|NCT01750190|58987757|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
30945062|NCT01750190|58987756|FG000|Overall Study|Lost to Follow-up|28|||
30945063|NCT01750190|58987757|FG001|Overall Study|Lost to Follow-up|7|||
30945064|NCT01750190|58987756|FG000|Overall Study|Physician Decision|16|||
30945065|NCT01750190|58987757|FG001|Overall Study|Physician Decision|17|||
30945066|NCT01750190|58987756|FG000|Overall Study|Protocol Violation|6|||
30945067|NCT01750190|58987757|FG001|Overall Study|Protocol Violation|5|||
30945068|NCT01750190|58987756|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
30945069|NCT01750190|58987757|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
30945070|NCT01750190|58987756|FG000|Overall Study|Withdrawal by Subject|83|||
30945071|NCT01750190|58987757|FG001|Overall Study|Withdrawal by Subject|89|||
30945072|NCT01750190|58987756|FG000|Overall Study|Kidney Transplant|8|||
30945073|NCT01750190|58987757|FG001|Overall Study|Kidney Transplant|4|||
30945074|NCT01750190|58987756|FG000|Overall Study|Dialysis|22|||
30945075|NCT01750190|58987757|FG001|Overall Study|Dialysis|8|||
30945076|NCT01750190|58987756|FG000|Overall Study|Other than Specified|13|||
30945077|NCT01750190|58987757|FG001|Overall Study|Other than Specified|4|||
30945078|NCT01831765|58987766|FG000|Overall Study|Lack of Efficacy|1|||
30945079|NCT01831765|58987767|FG001|Overall Study|Lack of Efficacy|0|||
30945080|NCT01831765|58987768|FG002|Overall Study|Lack of Efficacy|0|||
30945081|NCT01831765|58987766|FG000|Overall Study|Other, sponsor withdrew subject|0|||
30945082|NCT01831765|58987767|FG001|Overall Study|Other, sponsor withdrew subject|1|||
30945083|NCT01831765|58987768|FG002|Overall Study|Other, sponsor withdrew subject|0|||
30945084|NCT01831765|58987766|FG000|Overall Study|Pregnancy|1|||
30945085|NCT01831765|58987767|FG001|Overall Study|Pregnancy|1|||
30945086|NCT01831765|58987768|FG002|Overall Study|Pregnancy|2|||
30945087|NCT01831765|58987766|FG000|Overall Study|Death|0|||
30945088|NCT01831765|58987767|FG001|Overall Study|Death|1|||
30945089|NCT01831765|58987768|FG002|Overall Study|Death|1|||
30945090|NCT01831765|58987766|FG000|Overall Study|Other, site closed|1|||
30945091|NCT01831765|58987767|FG001|Overall Study|Other, site closed|1|||
30945092|NCT01831765|58987768|FG002|Overall Study|Other, site closed|0|||
30945093|NCT01831765|58987766|FG000|Overall Study|Adverse Event|5|||
30945094|NCT01831765|58987767|FG001|Overall Study|Adverse Event|3|||
30945095|NCT01831765|58987768|FG002|Overall Study|Adverse Event|3|||
30945096|NCT01831765|58987766|FG000|Overall Study|Withdrawal by Subject|22|||
30945097|NCT01831765|58987767|FG001|Overall Study|Withdrawal by Subject|7|||
30945098|NCT01831765|58987768|FG002|Overall Study|Withdrawal by Subject|17|||
30945099|NCT01831765|58987766|FG000|Overall Study|Withdrawal criteria|12|||
30945100|NCT01831765|58987767|FG001|Overall Study|Withdrawal criteria|10|||
30945101|NCT01831765|58987768|FG002|Overall Study|Withdrawal criteria|16|||
30945102|NCT01831765|58987766|FG000|Overall Study|Lost to Follow-up|2|||
30945103|NCT01831765|58987767|FG001|Overall Study|Lost to Follow-up|3|||
30945104|NCT01831765|58987768|FG002|Overall Study|Lost to Follow-up|3|||
30945105|NCT01749800|58987781|FG000|Overall Study|not meeting inclusion criteria|3|||
30945106|NCT01749800|58987782|FG001|Overall Study|not meeting inclusion criteria|0|||
30945107|NCT01749800|58987783|FG002|Overall Study|not meeting inclusion criteria|0|||
30945108|NCT01749800|58987781|FG000|Overall Study|Withdrawal by Subject|0|||
30945109|NCT01749800|58987782|FG001|Overall Study|Withdrawal by Subject|1|||
30945110|NCT01749800|58987783|FG002|Overall Study|Withdrawal by Subject|0|||
30945111|NCT01830595|58987791|FG000|First Period|Withdrawal by Subject|1|||
30945112|NCT01830595|58987792|FG001|First Period|Withdrawal by Subject|3|||
30945113|NCT01830595|58987791|FG000|Washout|Withdrawal by Subject|2|||
30945114|NCT01830595|58987792|FG001|Washout|Withdrawal by Subject|2|||
30945115|NCT01748552|58987810|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
30945116|NCT01748552|58987811|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
30945117|NCT01748552|58987812|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
30945118|NCT01748552|58987813|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
30945119|NCT01748552|58987814|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
30945120|NCT01748552|58987815|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
30945121|NCT01748552|58987816|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
30945122|NCT01748552|58987817|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
30945123|NCT01748552|58987818|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
30945124|NCT01748552|58987819|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
30945125|NCT01748552|58987820|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
30945126|NCT01748552|58987821|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
30945127|NCT01748552|58987810|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
30945128|NCT01748552|58987811|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
30945129|NCT01748552|58987812|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
30945130|NCT01748552|58987813|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
30945131|NCT01748552|58987814|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
30945132|NCT01748552|58987815|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
30945133|NCT01748552|58987816|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
30945134|NCT01748552|58987817|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
30945135|NCT01748552|58987818|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
30759701|NCT00106353|58768066|FG005|Part 2|Other|1|||
30759702|NCT00106353|58768067|FG006|Part 2|Other|1|||
30759703|NCT00106353|58768061|FG000|Part 2|Withdrawal by Subject|0|||
30759704|NCT00106353|58768062|FG001|Part 2|Withdrawal by Subject|0|||
30759705|NCT00106353|58768063|FG002|Part 2|Withdrawal by Subject|0|||
30759706|NCT00106353|58768064|FG003|Part 2|Withdrawal by Subject|0|||
30759707|NCT00106353|58768065|FG004|Part 2|Withdrawal by Subject|1|||
30759708|NCT00106353|58768066|FG005|Part 2|Withdrawal by Subject|0|||
30842743|NCT02522494|58868589|FG000|Overall Study|Withdrawal by Subject|1|||
30842744|NCT02522494|58868590|FG001|Overall Study|Withdrawal by Subject|0|||
30842745|NCT02522494|58868589|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
30842746|NCT02522494|58868590|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
30759709|NCT00106353|58768067|FG006|Part 2|Withdrawal by Subject|0|||
30759710|NCT00106353|58768061|FG000|Part 2|Physician Decision|0|||
30759711|NCT00106353|58768062|FG001|Part 2|Physician Decision|0|||
30759712|NCT00106353|58768063|FG002|Part 2|Physician Decision|0|||
30759713|NCT00106353|58768064|FG003|Part 2|Physician Decision|0|||
30759714|NCT00106353|58768065|FG004|Part 2|Physician Decision|0|||
30759715|NCT00106353|58768066|FG005|Part 2|Physician Decision|1|||
30759716|NCT00106353|58768067|FG006|Part 2|Physician Decision|0|||
30759717|NCT00080301|58768090|FG000|Overall Study|Randomized but Never Treated|5|||
30759718|NCT00080301|58768091|FG001|Overall Study|Randomized but Never Treated|10|||
30759719|NCT00080301|58768090|FG000|Overall Study|Still on Treatment as of CSR date|0|||
30759720|NCT00080301|58768091|FG001|Overall Study|Still on Treatment as of CSR date|1|||
30842747|NCT02522494|58868589|FG000|Overall Study|Participant did not watch the video|1|||
30842748|NCT02522494|58868590|FG001|Overall Study|Participant did not watch the video|0|||
30842749|NCT02522494|58868589|FG000|Overall Study|Death|0|||
30842750|NCT02522494|58868590|FG001|Overall Study|Death|1|||
30842751|NCT01658020|58868598|FG000|Overall Study|Adverse Event|3|||
30842752|NCT01658020|58868599|FG001|Overall Study|Adverse Event|3|||
30842753|NCT01658020|58868598|FG000|Overall Study|Lost to Follow-up|1|||
30842754|NCT01658020|58868599|FG001|Overall Study|Lost to Follow-up|0|||
30842755|NCT01658020|58868598|FG000|Overall Study|Withdrawal by Subject|4|||
30842756|NCT01658020|58868599|FG001|Overall Study|Withdrawal by Subject|5|||
30842757|NCT01658020|58868598|FG000|Overall Study|Protocol Violation|0|||
30842758|NCT01658020|58868599|FG001|Overall Study|Protocol Violation|1|||
30759721|NCT00079677|58768100|FG000|Overall Study|Adverse Event|5|||
30759722|NCT00079677|58768101|FG001|Overall Study|Adverse Event|6|||
30759723|NCT00079677|58768100|FG000|Overall Study|Lack of Efficacy|1|||
30759724|NCT00079677|58768101|FG001|Overall Study|Lack of Efficacy|0|||
30842759|NCT03389477|58868617|FG000|Step 1|Withdrawal by Subject|1|||
30842760|NCT03389477|58868618|FG001|Step 1|Withdrawal by Subject|0|||
30842761|NCT03389477|58868617|FG000|Step 2|Withdrawal by Subject|1|||
30842762|NCT03389477|58868618|FG001|Step 2|Withdrawal by Subject|2|||
30842763|NCT03389477|58868617|FG000|Step 2|Disease progression|1|||
30759725|NCT00079677|58768100|FG000|Overall Study|Lost to Follow-up|2|||
30759726|NCT00079677|58768101|FG001|Overall Study|Lost to Follow-up|2|||
30759727|NCT00079677|58768100|FG000|Overall Study|Physician Decision|3|||
30842764|NCT03389477|58868618|FG001|Step 2|Disease progression|0|||
30842765|NCT03389477|58868617|FG000|Step 2|Death|0|||
30842766|NCT03389477|58868618|FG001|Step 2|Death|1|||
30842767|NCT03389477|58868617|FG000|Step 2|Poor performance status and nutrition|0|||
30842768|NCT03389477|58868618|FG001|Step 2|Poor performance status and nutrition|1|||
30945136|NCT01748552|58987819|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
30945137|NCT01748552|58987820|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
30945138|NCT01748552|58987821|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
30945139|NCT01748162|58987863|FG000|Overall Study|no additional croup episodes to evaluate|2|||
30945140|NCT01748162|58987864|FG001|Overall Study|no additional croup episodes to evaluate|2|||
30945141|NCT01748162|58987863|FG000|Overall Study|participant consented but did not begin|0|||
30945142|NCT01748162|58987864|FG001|Overall Study|participant consented but did not begin|1|||
30945143|NCT01748162|58987863|FG000|Overall Study|reasons not available|3|||
30945144|NCT01748162|58987864|FG001|Overall Study|reasons not available|2|||
30945145|NCT01724216|58987870|FG000|Overall Study|Scan was not completed|1|||
30945146|NCT01723904|58987874|FG000|Overall Study|Noncompliant|3|||
30945147|NCT01723904|58987874|FG000|Overall Study|Adverse Event|5|||
30759728|NCT00079677|58768101|FG001|Overall Study|Physician Decision|0|||
30842769|NCT03389477|58868617|FG000|Step 3|Withdrawal after 3 cycles|0|||
30842770|NCT03389477|58868618|FG001|Step 3|Withdrawal after 3 cycles|1|||
30842771|NCT03389477|58868617|FG000|Step 3|Still receiving active treatment|4|||
30842772|NCT03389477|58868618|FG001|Step 3|Still receiving active treatment|0|||
30842773|NCT03389477|58868617|FG000|Step 3|Progressive disease after 2 cycles|1|||
30842774|NCT03389477|58868618|FG001|Step 3|Progressive disease after 2 cycles|0|||
30842775|NCT02680574|58868628|FG000|Overall Study|Death|137|||
30842776|NCT02680574|58868629|FG001|Overall Study|Death|137|||
30842777|NCT02680574|58868628|FG000|Overall Study|Withdrawal by Subject|17|||
30842778|NCT02680574|58868629|FG001|Overall Study|Withdrawal by Subject|9|||
30842779|NCT02680574|58868628|FG000|Overall Study|Lost to Follow-up|4|||
30842780|NCT02680574|58868629|FG001|Overall Study|Lost to Follow-up|6|||
30842781|NCT02522884|58868635|FG000|Overall Study|Withdrawal by Subject|6|||
30842782|NCT02522884|58868635|FG000|Overall Study|Death|3|||
30842783|NCT02522884|58868635|FG000|Overall Study|Missed 12-month Follow-up|9|||
30842784|NCT02674568|58868652|FG000|Overall Study|Withdrawal by Subject|5|||
30842785|NCT02674568|58868652|FG000|Overall Study|Death|303|||
30842786|NCT02674568|58868652|FG000|Overall Study|Physician Decision|2|||
30842787|NCT02674568|58868652|FG000|Overall Study|Lost to Follow-up|9|||
30842788|NCT02674568|58868652|FG000|Overall Study|Other, Not Specified|20|||
30842789|NCT03022799|58868681|FG000|Overall Study|Adverse Event|0|||
30842790|NCT03022799|58868682|FG001|Overall Study|Adverse Event|0|||
30842791|NCT03022799|58868683|FG002|Overall Study|Adverse Event|0|||
30842792|NCT03022799|58868684|FG003|Overall Study|Adverse Event|0|||
30945148|NCT01723904|58987874|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
30945149|NCT01747772|58987878|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
30759729|NCT00079677|58768100|FG000|Overall Study|Protocol Violation|2|||
30759730|NCT00079677|58768101|FG001|Overall Study|Protocol Violation|3|||
30759731|NCT00079677|58768100|FG000|Overall Study|Withdrawal by Subject|5|||
30759732|NCT00079677|58768101|FG001|Overall Study|Withdrawal by Subject|3|||
30759733|NCT00079677|58768100|FG000|Overall Study|Miscellaneous|2|||
30759734|NCT00079677|58768101|FG001|Overall Study|Miscellaneous|0|||
30945150|NCT01830127|58987888|FG000|Overall Study|Adverse Event|1|||
30759735|NCT00095121|58768109|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
30759736|NCT00095121|58768110|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
30759737|NCT00095121|58768109|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
30759738|NCT00095121|58768110|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
30759739|NCT00094809|58768128|FG000|Overall Study|Protocol deviation|2|||
30759740|NCT00094809|58768129|FG001|Overall Study|Protocol deviation|2|||
30759741|NCT00094809|58768128|FG000|Overall Study|Noncompliance|1|||
30759742|NCT00094809|58768129|FG001|Overall Study|Noncompliance|0|||
30759743|NCT00094809|58768128|FG000|Overall Study|Adverse Event|3|||
30759744|NCT00094809|58768129|FG001|Overall Study|Adverse Event|1|||
30759745|NCT00094809|58768128|FG000|Overall Study|Withdrawal by Subject|8|||
30759746|NCT00094809|58768129|FG001|Overall Study|Withdrawal by Subject|9|||
30759747|NCT00094809|58768128|FG000|Overall Study|Disease progression|3|||
30842793|NCT03022799|58868685|FG004|Overall Study|Adverse Event|0|||
30842794|NCT03022799|58868686|FG005|Overall Study|Adverse Event|0|||
30842795|NCT03022799|58868687|FG006|Overall Study|Adverse Event|0|||
30842796|NCT03022799|58868688|FG007|Overall Study|Adverse Event|0|||
30842797|NCT03022799|58868689|FG008|Overall Study|Adverse Event|0|||
30842798|NCT03022799|58868690|FG009|Overall Study|Adverse Event|1|||
30842799|NCT03022799|58868691|FG010|Overall Study|Adverse Event|1|||
30842800|NCT03022799|58868692|FG011|Overall Study|Adverse Event|0|||
30842801|NCT03022799|58868693|FG012|Overall Study|Adverse Event|0|||
30842802|NCT02674334|58868740|FG000|Overall Study|Lost to Follow-up|5|||
30945151|NCT01830127|58987889|FG001|Overall Study|Adverse Event|6|||
30759748|NCT00094809|58768129|FG001|Overall Study|Disease progression|3|||
30759749|NCT00094809|58768128|FG000|Overall Study|Physician Decision|3|||
30945152|NCT01830127|58987888|FG000|Overall Study|Lack of Efficacy|3|||
30945153|NCT01830127|58987889|FG001|Overall Study|Lack of Efficacy|0|||
30945154|NCT01830127|58987888|FG000|Overall Study|Withdrawal by Subject|1|||
30945155|NCT01830127|58987889|FG001|Overall Study|Withdrawal by Subject|1|||
30945156|NCT01830127|58987888|FG000|Overall Study|Other reason not defined above|0|||
30945157|NCT01830127|58987889|FG001|Overall Study|Other reason not defined above|2|||
30945158|NCT01614067|58987897|FG000|Overall Study|Pregnancy|1|||
30945159|NCT01614067|58987898|FG001|Overall Study|Pregnancy|0|||
30945160|NCT01614067|58987897|FG000|Overall Study|Physician Decision|6|||
30945161|NCT01614067|58987898|FG001|Overall Study|Physician Decision|5|||
30945162|NCT01614067|58987897|FG000|Overall Study|Withdrawal by Subject|0|||
30945163|NCT01614067|58987898|FG001|Overall Study|Withdrawal by Subject|1|||
30945164|NCT01614067|58987897|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
30945165|NCT01614067|58987898|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
30945166|NCT01777490|58987908|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
30945167|NCT01777490|58987909|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
30945168|NCT01777490|58987910|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
30945169|NCT01777490|58987911|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
30842803|NCT02674334|58868741|FG001|Overall Study|Lost to Follow-up|3|||
30842804|NCT02674334|58868740|FG000|Overall Study|participant difficulty breathing|1|||
30842805|NCT02674334|58868741|FG001|Overall Study|participant difficulty breathing|0|||
30842806|NCT02674334|58868740|FG000|Overall Study|NIRS not recording|1|||
30842807|NCT02674334|58868741|FG001|Overall Study|NIRS not recording|0|||
30842808|NCT03026075|58868747|FG000|Overall Study|Physician Decision|1|||
30842809|NCT01373918|58868753|FG000|Overall Study|Physician Decision|0|||
30842810|NCT01373918|58868754|FG001|Overall Study|Physician Decision|1|||
30842811|NCT02667626|58868762|FG000|Overall Study|Withdrawal by Subject|0|||
30842812|NCT02667626|58868763|FG001|Overall Study|Withdrawal by Subject|1|||
30842813|NCT02522728|58868774|FG000|Overall Study|Withdrawal by Subject|6|||
30842814|NCT02522728|58868775|FG001|Overall Study|Withdrawal by Subject|6|||
30842815|NCT02522728|58868774|FG000|Overall Study|Death|4|||
30945170|NCT01397409|58987933|FG000|Stage 2|Adverse Event|0|||
30945171|NCT01397409|58987934|FG001|Stage 2|Adverse Event|0|||
30945172|NCT01397409|58987935|FG002|Stage 2|Adverse Event|0|||
30945173|NCT01397409|58987936|FG003|Stage 2|Adverse Event|0|||
30945174|NCT01397409|58987937|FG004|Stage 2|Adverse Event|6|||
30945175|NCT01397409|58987938|FG005|Stage 2|Adverse Event|3|||
30945176|NCT01397409|58987939|FG006|Stage 2|Adverse Event|0|||
30945177|NCT01397409|58987940|FG007|Stage 2|Adverse Event|0|||
30945178|NCT01397409|58987941|FG008|Stage 2|Adverse Event|0|||
30945179|NCT01397409|58987942|FG009|Stage 2|Adverse Event|0|||
30945180|NCT01397409|58987933|FG000|Stage 2|Personal Reasons|0|||
30945181|NCT01397409|58987934|FG001|Stage 2|Personal Reasons|0|||
30945182|NCT01397409|58987935|FG002|Stage 2|Personal Reasons|0|||
30945183|NCT01397409|58987936|FG003|Stage 2|Personal Reasons|0|||
30945184|NCT01397409|58987937|FG004|Stage 2|Personal Reasons|1|||
30945185|NCT01397409|58987938|FG005|Stage 2|Personal Reasons|0|||
30945186|NCT01397409|58987939|FG006|Stage 2|Personal Reasons|0|||
30945187|NCT01397409|58987940|FG007|Stage 2|Personal Reasons|0|||
30945188|NCT01397409|58987941|FG008|Stage 2|Personal Reasons|0|||
30945189|NCT01397409|58987942|FG009|Stage 2|Personal Reasons|0|||
30945190|NCT01397409|58987933|FG000|Stage 2|Other Miscellaneous Reasons|0|||
30759750|NCT00094809|58768129|FG001|Overall Study|Physician Decision|5|||
30759751|NCT00094809|58768128|FG000|Overall Study|Lost to Follow-up|6|||
30759752|NCT00094809|58768129|FG001|Overall Study|Lost to Follow-up|6|||
30759753|NCT00094809|58768128|FG000|Overall Study|Death|19|||
30759754|NCT00094809|58768129|FG001|Overall Study|Death|25|||
30759755|NCT00094809|58768128|FG000|Overall Study|Protocol-specified criteria|1|||
30759756|NCT00094809|58768129|FG001|Overall Study|Protocol-specified criteria|1|||
30759757|NCT00094809|58768128|FG000|Overall Study|Other|2|||
30759758|NCT00094809|58768129|FG001|Overall Study|Other|4|||
30842816|NCT02522728|58868775|FG001|Overall Study|Death|3|||
30842817|NCT02522728|58868774|FG000|Overall Study|Adverse Event|2|||
30945191|NCT01397409|58987934|FG001|Stage 2|Other Miscellaneous Reasons|0|||
30945192|NCT01397409|58987935|FG002|Stage 2|Other Miscellaneous Reasons|0|||
30945193|NCT01397409|58987936|FG003|Stage 2|Other Miscellaneous Reasons|0|||
30945194|NCT01397409|58987937|FG004|Stage 2|Other Miscellaneous Reasons|1|||
30945195|NCT01397409|58987938|FG005|Stage 2|Other Miscellaneous Reasons|1|||
30945196|NCT01397409|58987939|FG006|Stage 2|Other Miscellaneous Reasons|0|||
30945197|NCT01397409|58987940|FG007|Stage 2|Other Miscellaneous Reasons|0|||
30945198|NCT01397409|58987941|FG008|Stage 2|Other Miscellaneous Reasons|0|||
30759759|NCT00094809|58768128|FG000|Overall Study|Informed consent signed after treatment|1|||
30842818|NCT02522728|58868775|FG001|Overall Study|Adverse Event|1|||
30842819|NCT02522728|58868774|FG000|Overall Study|Did not receive randomized study device|0|||
30842820|NCT02522728|58868775|FG001|Overall Study|Did not receive randomized study device|1|||
30842821|NCT03025217|58868790|FG000|Overall Study|Pregnancy|1|||
30842822|NCT03025217|58868790|FG000|Overall Study|Lost to Follow-up|1|||
30948566|NCT01973231|58994582|FG000|Overall Study|Lost to Follow-up|1|||
30759760|NCT00094809|58768129|FG001|Overall Study|Informed consent signed after treatment|0|||
30759761|NCT00094809|58768128|FG000|Overall Study|Study drug not received|2|||
30759762|NCT00094809|58768129|FG001|Overall Study|Study drug not received|8|||
30759763|NCT00094809|58768128|FG000|Overall Study|Other|1|||
30759764|NCT00094809|58768129|FG001|Overall Study|Other|1|||
30759765|NCT00075218|58768137|FG000|Double-Blind Treatment|Adverse Event|23|||
30759766|NCT00075218|58768138|FG001|Double-Blind Treatment|Adverse Event|4|||
30759767|NCT00075218|58768139|FG002|Double-Blind Treatment|Adverse Event|0|||
30759768|NCT00075218|58768137|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
30759769|NCT00075218|58768138|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
30945199|NCT01397409|58987942|FG009|Stage 2|Other Miscellaneous Reasons|0|||
30945200|NCT01397409|58987933|FG000|Stage 3|Adverse Event|0|||
30945201|NCT01397409|58987934|FG001|Stage 3|Adverse Event|0|||
30945202|NCT01397409|58987935|FG002|Stage 3|Adverse Event|0|||
30945203|NCT01397409|58987936|FG003|Stage 3|Adverse Event|0|||
30759770|NCT00075218|58768139|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
30759771|NCT00075218|58768137|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
30759772|NCT00075218|58768138|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
30759773|NCT00075218|58768139|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
30759774|NCT00075218|58768137|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
30759775|NCT00075218|58768138|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
30759776|NCT00075218|58768139|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
30759777|NCT00075218|58768137|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
30759778|NCT00075218|58768138|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
30759779|NCT00075218|58768139|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
30759780|NCT00075218|58768137|FG000|Double-Blind Treatment|No study medication taken|2|||
30759781|NCT00075218|58768138|FG001|Double-Blind Treatment|No study medication taken|0|||
30759782|NCT00075218|58768139|FG002|Double-Blind Treatment|No study medication taken|0|||
30759783|NCT00075218|58768137|FG000|Open-Label Treatment|Lack of Efficacy|0|||
30759784|NCT00075218|58768138|FG001|Open-Label Treatment|Lack of Efficacy|0|||
30759785|NCT00075218|58768139|FG002|Open-Label Treatment|Lack of Efficacy|174|||
30759786|NCT00075218|58768137|FG000|Open-Label Treatment|Adverse Event|0|||
30759787|NCT00075218|58768138|FG001|Open-Label Treatment|Adverse Event|0|||
30759788|NCT00075218|58768139|FG002|Open-Label Treatment|Adverse Event|51|||
30759789|NCT00075218|58768137|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
30759790|NCT00075218|58768138|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
30759791|NCT00075218|58768139|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
30759792|NCT00075218|58768137|FG000|Open-Label Treatment|Decision of Sponsor|0|||
30759793|NCT00075218|58768138|FG001|Open-Label Treatment|Decision of Sponsor|0|||
30759794|NCT00075218|58768139|FG002|Open-Label Treatment|Decision of Sponsor|8|||
30759795|NCT00075218|58768137|FG000|Open-Label Treatment|Protocol Violation|0|||
30759796|NCT00075218|58768138|FG001|Open-Label Treatment|Protocol Violation|0|||
30759797|NCT00075218|58768139|FG002|Open-Label Treatment|Protocol Violation|1|||
30759798|NCT00075218|58768137|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
30759799|NCT00075218|58768138|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
30759800|NCT00075218|58768139|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
30759801|NCT00094653|58768149|FG000|Overall Study|Death|306|||
30759802|NCT00094653|58768150|FG001|Overall Study|Death|100|||
30759803|NCT00094653|58768151|FG002|Overall Study|Death|119|||
30759804|NCT00094653|58768149|FG000|Overall Study|Subject Withdrew Consent|10|||
30759805|NCT00094653|58768150|FG001|Overall Study|Subject Withdrew Consent|2|||
30759806|NCT00094653|58768151|FG002|Overall Study|Subject Withdrew Consent|3|||
30759807|NCT00094653|58768149|FG000|Overall Study|Other|2|||
30759808|NCT00094653|58768150|FG001|Overall Study|Other|2|||
30759809|NCT00094653|58768151|FG002|Overall Study|Other|2|||
30759810|NCT00094653|58768149|FG000|Overall Study|Lost to Follow-up|3|||
30759811|NCT00094653|58768150|FG001|Overall Study|Lost to Follow-up|2|||
30759812|NCT00094653|58768151|FG002|Overall Study|Lost to Follow-up|1|||
30759813|NCT00094653|58768149|FG000|Overall Study|Protocol Violation|0|||
30759814|NCT00094653|58768150|FG001|Overall Study|Protocol Violation|0|||
30759815|NCT00094653|58768151|FG002|Overall Study|Protocol Violation|1|||
30759816|NCT00104247|58768162|FG000|Overall Study|Withdrawal by Subject|1|||
30759817|NCT00104247|58768163|FG001|Overall Study|Withdrawal by Subject|0|||
30759818|NCT00104247|58768162|FG000|Overall Study|Noncompliant with dosing|0|||
30759819|NCT00104247|58768163|FG001|Overall Study|Noncompliant with dosing|1|||
30759820|NCT03591406|58768171|FG000|Overall Study|Adverse Event|5|||
30759821|NCT03591406|58768172|FG001|Overall Study|Adverse Event|3|||
30759822|NCT03591406|58768171|FG000|Overall Study|Protocol Violation|2|||
30759823|NCT03591406|58768172|FG001|Overall Study|Protocol Violation|1|||
30759824|NCT03591406|58768171|FG000|Overall Study|Withdrawal by Subject|0|||
30842823|NCT03025217|58868790|FG000|Overall Study|Not eligible, poor English|2|||
30842824|NCT03023813|58868797|FG000|Overall Study|Lost to Follow-up|1|||
30945204|NCT01397409|58987937|FG004|Stage 3|Adverse Event|0|||
30759825|NCT03591406|58768172|FG001|Overall Study|Withdrawal by Subject|5|||
30759826|NCT03560986|58768180|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
30759827|NCT03560986|58768181|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
30759828|NCT03560986|58768180|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
30759829|NCT03560986|58768181|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
30759830|NCT03560986|58768180|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
30759831|NCT03560986|58768181|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
30759832|NCT03560986|58768180|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
30759833|NCT03560986|58768181|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
30759834|NCT03560986|58768180|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
30759835|NCT03560986|58768181|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
30759836|NCT03560986|58768180|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
30759837|NCT03560986|58768181|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
30759838|NCT03560986|58768180|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
30759839|NCT03560986|58768181|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
30759840|NCT03560518|58768196|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
30759841|NCT03560518|58768197|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
30759842|NCT03560518|58768198|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
30759843|NCT03560518|58768196|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
30759844|NCT03560518|58768197|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
30759845|NCT03560518|58768198|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
30759846|NCT03560518|58768196|FG000|Double Blind Treatment Period|Protocol Violation|1|||
30759847|NCT03560518|58768197|FG001|Double Blind Treatment Period|Protocol Violation|2|||
30759848|NCT03560518|58768198|FG002|Double Blind Treatment Period|Protocol Violation|0|||
30759849|NCT03560518|58768196|FG000|Double Blind Treatment Period|Pregnancy|0|||
30759850|NCT03560518|58768197|FG001|Double Blind Treatment Period|Pregnancy|2|||
30759851|NCT03560518|58768198|FG002|Double Blind Treatment Period|Pregnancy|0|||
30759852|NCT03560518|58768196|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
30759853|NCT03560518|58768197|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
30759854|NCT03560518|58768198|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
30842825|NCT03023813|58868798|FG001|Overall Study|Lost to Follow-up|2|||
30842826|NCT03023813|58868799|FG002|Overall Study|Lost to Follow-up|0|||
30842827|NCT01365130|58868808|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
30842828|NCT01657162|58868814|FG000|Overall Study|Adverse Event|26|||
30842829|NCT01657162|58868815|FG001|Overall Study|Adverse Event|36|||
30842830|NCT01657162|58868814|FG000|Overall Study|Withdrawal by Subject|13|||
30842831|NCT01657162|58868815|FG001|Overall Study|Withdrawal by Subject|13|||
30842832|NCT01657162|58868814|FG000|Overall Study|Continuing Significant Deterioration|9|||
30842833|NCT01657162|58868815|FG001|Overall Study|Continuing Significant Deterioration|3|||
30842834|NCT01657162|58868814|FG000|Overall Study|Refusal of Treatment|4|||
30842835|NCT01657162|58868815|FG001|Overall Study|Refusal of Treatment|6|||
30842836|NCT01657162|58868814|FG000|Overall Study|Lost to Follow-up|3|||
30945205|NCT01397409|58987938|FG005|Stage 3|Adverse Event|0|||
30945206|NCT01397409|58987939|FG006|Stage 3|Adverse Event|0|||
30945207|NCT01397409|58987940|FG007|Stage 3|Adverse Event|1|||
30945208|NCT01397409|58987941|FG008|Stage 3|Adverse Event|0|||
30945209|NCT01397409|58987942|FG009|Stage 3|Adverse Event|0|||
30945210|NCT01397409|58987933|FG000|Stage 3|Other Miscellaneous Reasons|0|||
30945211|NCT01397409|58987934|FG001|Stage 3|Other Miscellaneous Reasons|0|||
30945212|NCT01397409|58987935|FG002|Stage 3|Other Miscellaneous Reasons|0|||
30945213|NCT01397409|58987936|FG003|Stage 3|Other Miscellaneous Reasons|0|||
30945214|NCT01397409|58987937|FG004|Stage 3|Other Miscellaneous Reasons|0|||
30945215|NCT01397409|58987938|FG005|Stage 3|Other Miscellaneous Reasons|0|||
30945216|NCT01397409|58987939|FG006|Stage 3|Other Miscellaneous Reasons|0|||
30945217|NCT01397409|58987940|FG007|Stage 3|Other Miscellaneous Reasons|1|||
30945218|NCT01397409|58987941|FG008|Stage 3|Other Miscellaneous Reasons|0|||
30945219|NCT01397409|58987942|FG009|Stage 3|Other Miscellaneous Reasons|0|||
30945220|NCT01397253|58987967|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
30945221|NCT01397253|58987968|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
30945222|NCT01777334|58987976|FG000|Overall Study|Adverse Event|18|||
30945223|NCT01777334|58987977|FG001|Overall Study|Adverse Event|14|||
30759855|NCT03560518|58768196|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
30945224|NCT01777334|58987976|FG000|Overall Study|Lack of Efficacy|15|||
30759856|NCT03560518|58768197|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
30759857|NCT03560518|58768198|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
30759858|NCT03560518|58768196|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
30759859|NCT03560518|58768197|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
30842837|NCT01657162|58868815|FG001|Overall Study|Lost to Follow-up|4|||
30842838|NCT01657162|58868814|FG000|Overall Study|Death|2|||
30842839|NCT01657162|58868815|FG001|Overall Study|Death|3|||
30842840|NCT01657162|58868814|FG000|Overall Study|Inability to Complete Study Procedures|1|||
30945225|NCT01777334|58987977|FG001|Overall Study|Lack of Efficacy|29|||
30945226|NCT01777334|58987976|FG000|Overall Study|Protocol Violation|3|||
30945227|NCT01777334|58987977|FG001|Overall Study|Protocol Violation|7|||
30945228|NCT01777334|58987976|FG000|Overall Study|Lost to Follow-up|3|||
30945229|NCT01777334|58987977|FG001|Overall Study|Lost to Follow-up|2|||
30945230|NCT01777334|58987976|FG000|Overall Study|Withdrawal by Subject|14|||
30945231|NCT01777334|58987977|FG001|Overall Study|Withdrawal by Subject|11|||
30945232|NCT01383993|58987986|FG000|Overall Study|Adverse Event|1|||
30945233|NCT01383993|58987987|FG001|Overall Study|Adverse Event|1|||
30945234|NCT01383993|58987988|FG002|Overall Study|Adverse Event|0|||
30945235|NCT01383993|58987986|FG000|Overall Study|Withdrawal by Subject|0|||
30945236|NCT01383993|58987987|FG001|Overall Study|Withdrawal by Subject|0|||
30945237|NCT01383993|58987988|FG002|Overall Study|Withdrawal by Subject|1|||
30945238|NCT01383993|58987986|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
30945239|NCT01383993|58987987|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
30945240|NCT01383993|58987988|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
30945241|NCT01396395|58987999|FG000|Overall Study|Withdrawal by Subject|10|||
30945242|NCT01396395|58988000|FG001|Overall Study|Withdrawal by Subject|12|||
30945243|NCT01396395|58987999|FG000|Overall Study|Protocol Violation|3|||
30945244|NCT01396395|58988000|FG001|Overall Study|Protocol Violation|1|||
30945245|NCT01396395|58987999|FG000|Overall Study|Adverse Event|10|||
30945246|NCT01396395|58988000|FG001|Overall Study|Adverse Event|2|||
30945247|NCT01396395|58987999|FG000|Overall Study|Lost to Follow-up|17|||
30945248|NCT01396395|58988000|FG001|Overall Study|Lost to Follow-up|11|||
30945249|NCT01396395|58987999|FG000|Overall Study|Other|0|||
30945250|NCT01396395|58988000|FG001|Overall Study|Other|1|||
30945251|NCT01396317|58988010|FG000|Overall Study|Adverse Event|1|||
30945252|NCT01396317|58988011|FG001|Overall Study|Adverse Event|0|||
30945253|NCT01396161|58988026|FG000|Overall Study|Withdrawal by Subject|0|||
30945254|NCT01396161|58988027|FG001|Overall Study|Withdrawal by Subject|0|||
30945255|NCT01396161|58988028|FG002|Overall Study|Withdrawal by Subject|0|||
30945256|NCT01396161|58988029|FG003|Overall Study|Withdrawal by Subject|0|||
30945257|NCT01396161|58988030|FG004|Overall Study|Withdrawal by Subject|1|||
30945258|NCT01396161|58988031|FG005|Overall Study|Withdrawal by Subject|0|||
30945259|NCT01396161|58988032|FG006|Overall Study|Withdrawal by Subject|0|||
30945260|NCT01396161|58988026|FG000|Overall Study|Other|0|||
30945261|NCT01396161|58988027|FG001|Overall Study|Other|0|||
30945262|NCT01396161|58988028|FG002|Overall Study|Other|0|||
30945263|NCT01396161|58988029|FG003|Overall Study|Other|0|||
30945264|NCT01396161|58988030|FG004|Overall Study|Other|0|||
30945265|NCT01396161|58988031|FG005|Overall Study|Other|0|||
30945266|NCT01396161|58988032|FG006|Overall Study|Other|1|||
30945267|NCT01396083|58988055|FG000|Overall Study|Adverse Event|2|||
30945268|NCT01396083|58988056|FG001|Overall Study|Adverse Event|28|||
30945269|NCT01396083|58988055|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30945270|NCT01396083|58988056|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
30945271|NCT01396083|58988055|FG000|Overall Study|Consent withdrawn|4|||
30945272|NCT01396083|58988056|FG001|Overall Study|Consent withdrawn|5|||
30945273|NCT01396083|58988055|FG000|Overall Study|Protocol deviation(s)|0|||
30945274|NCT01396083|58988056|FG001|Overall Study|Protocol deviation(s)|1|||
30945275|NCT01396083|58988055|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30945276|NCT01396083|58988056|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30945277|NCT01396083|58988055|FG000|Overall Study|Administrative problems|1|||
30945278|NCT01396083|58988056|FG001|Overall Study|Administrative problems|0|||
30945279|NCT01396083|58988055|FG000|Overall Study|Lost to Follow-up|1|||
30945280|NCT01396083|58988056|FG001|Overall Study|Lost to Follow-up|0|||
30945281|NCT01723826|58988066|FG000|Overall Study|Adverse Event|4|||
30945282|NCT01723826|58988067|FG001|Overall Study|Adverse Event|1|||
30945283|NCT01723826|58988068|FG002|Overall Study|Adverse Event|4|||
30945284|NCT01723826|58988069|FG003|Overall Study|Adverse Event|5|||
30945285|NCT01723826|58988066|FG000|Overall Study|Death according to AE eCRF|2|||
30945286|NCT01723826|58988067|FG001|Overall Study|Death according to AE eCRF|3|||
30945287|NCT01723826|58988068|FG002|Overall Study|Death according to AE eCRF|3|||
30945288|NCT01723826|58988069|FG003|Overall Study|Death according to AE eCRF|7|||
30945289|NCT01723826|58988066|FG000|Overall Study|Lost to Follow-up|1|||
30945290|NCT01723826|58988067|FG001|Overall Study|Lost to Follow-up|3|||
30945291|NCT01723826|58988068|FG002|Overall Study|Lost to Follow-up|1|||
30945292|NCT01723826|58988069|FG003|Overall Study|Lost to Follow-up|1|||
30945293|NCT01723826|58988066|FG000|Overall Study|Non-compliance|0|||
30945294|NCT01723826|58988067|FG001|Overall Study|Non-compliance|1|||
30945295|NCT01723826|58988068|FG002|Overall Study|Non-compliance|3|||
30945296|NCT01723826|58988069|FG003|Overall Study|Non-compliance|3|||
30945297|NCT01723826|58988066|FG000|Overall Study|Non-compliance With Study Drug|0|||
30945298|NCT01723826|58988067|FG001|Overall Study|Non-compliance With Study Drug|1|||
30945299|NCT01723826|58988068|FG002|Overall Study|Non-compliance With Study Drug|0|||
30945300|NCT01723826|58988069|FG003|Overall Study|Non-compliance With Study Drug|0|||
30945301|NCT01723826|58988066|FG000|Overall Study|Other Reason|8|||
30945302|NCT01723826|58988067|FG001|Overall Study|Other Reason|6|||
30945303|NCT01723826|58988068|FG002|Overall Study|Other Reason|12|||
30945304|NCT01723826|58988069|FG003|Overall Study|Other Reason|14|||
30945305|NCT01723826|58988066|FG000|Overall Study|Physician Decision|1|||
30945306|NCT01723826|58988067|FG001|Overall Study|Physician Decision|3|||
30945307|NCT01723826|58988068|FG002|Overall Study|Physician Decision|4|||
30945308|NCT01723826|58988069|FG003|Overall Study|Physician Decision|11|||
30945309|NCT01723826|58988066|FG000|Overall Study|Protocol Violation|1|||
30945310|NCT01723826|58988067|FG001|Overall Study|Protocol Violation|1|||
30945311|NCT01723826|58988068|FG002|Overall Study|Protocol Violation|3|||
30945312|NCT01723826|58988069|FG003|Overall Study|Protocol Violation|1|||
30945313|NCT01723826|58988066|FG000|Overall Study|Withdrawal by Subject|10|||
30945314|NCT01723826|58988067|FG001|Overall Study|Withdrawal by Subject|17|||
30945315|NCT01723826|58988068|FG002|Overall Study|Withdrawal by Subject|27|||
30945316|NCT01723826|58988069|FG003|Overall Study|Withdrawal by Subject|48|||
30945317|NCT01721954|58988081|FG000|Overall Study|Death|58|||
30945318|NCT01721954|58988082|FG001|Overall Study|Death|64|||
30945319|NCT01721954|58988081|FG000|Overall Study|Withdrawal by Subject|8|||
30945320|NCT01721954|58988082|FG001|Overall Study|Withdrawal by Subject|4|||
30945321|NCT01721954|58988081|FG000|Overall Study|Adverse Event|2|||
30945322|NCT01721954|58988082|FG001|Overall Study|Adverse Event|0|||
30945323|NCT01721954|58988081|FG000|Overall Study|Lost to Follow-up|2|||
30945324|NCT01721954|58988082|FG001|Overall Study|Lost to Follow-up|1|||
30945325|NCT01776554|58988090|FG000|Overall Study|Adverse Event|1|||
30945326|NCT01776554|58988091|FG001|Overall Study|Adverse Event|0|||
30945327|NCT01776554|58988090|FG000|Overall Study|Withdrawal by Subject|3|||
30624531|NCT00947115|58636654|FG001|Overall Study|Physician Decision|2|||
30624532|NCT00947115|58636655|FG002|Overall Study|Physician Decision|0|||
30624533|NCT00947115|58636653|FG000|Overall Study|Death|0|||
30624534|NCT00947115|58636654|FG001|Overall Study|Death|1|||
30624535|NCT00947115|58636655|FG002|Overall Study|Death|1|||
30624536|NCT00947115|58636653|FG000|Overall Study|Migrated from study area|2|||
30624537|NCT00947115|58636654|FG001|Overall Study|Migrated from study area|0|||
30624538|NCT00947115|58636655|FG002|Overall Study|Migrated from study area|0|||
30624539|NCT00947115|58636653|FG000|Overall Study|Withdrawal by Subject|1|||
30624540|NCT00947115|58636654|FG001|Overall Study|Withdrawal by Subject|3|||
30624541|NCT00947115|58636655|FG002|Overall Study|Withdrawal by Subject|4|||
30624542|NCT00947115|58636653|FG000|Overall Study|Lost to Follow-up|11|||
30624543|NCT00947115|58636654|FG001|Overall Study|Lost to Follow-up|12|||
30624544|NCT00947115|58636655|FG002|Overall Study|Lost to Follow-up|8|||
30624545|NCT00952419|58636666|FG000|Overall Study|Adverse Event|2|||
30624546|NCT00952419|58636667|FG001|Overall Study|Adverse Event|0|||
30624547|NCT00952419|58636668|FG002|Overall Study|Adverse Event|0|||
30624548|NCT00952419|58636666|FG000|Overall Study|Protocol Violation|3|||
30624549|NCT00952419|58636667|FG001|Overall Study|Protocol Violation|7|||
30624550|NCT00952419|58636668|FG002|Overall Study|Protocol Violation|0|||
30624551|NCT00952419|58636666|FG000|Overall Study|Withdrawal by Subject|1|||
30624552|NCT00952419|58636667|FG001|Overall Study|Withdrawal by Subject|3|||
30624553|NCT00952419|58636668|FG002|Overall Study|Withdrawal by Subject|0|||
30624554|NCT00902278|58636681|FG000|Overall Study|Physician Decision|1|||
30624555|NCT00902278|58636682|FG001|Overall Study|Physician Decision|0|||
30624556|NCT00902278|58636683|FG002|Overall Study|Physician Decision|2|||
30945328|NCT01776554|58988091|FG001|Overall Study|Withdrawal by Subject|8|||
30945329|NCT01776554|58988090|FG000|Overall Study|Lost to Follow-up|6|||
30945330|NCT01776554|58988091|FG001|Overall Study|Lost to Follow-up|9|||
30945331|NCT01776554|58988090|FG000|Overall Study|Administrative Reason|2|||
30945332|NCT01776554|58988091|FG001|Overall Study|Administrative Reason|5|||
30945333|NCT01776554|58988090|FG000|Overall Study|Protocol Violation|1|||
30945334|NCT01776554|58988091|FG001|Overall Study|Protocol Violation|0|||
30624557|NCT00902278|58636684|FG003|Overall Study|Physician Decision|0|||
30624558|NCT00902278|58636685|FG004|Overall Study|Physician Decision|1|||
30945335|NCT01776554|58988090|FG000|Overall Study|Unclassified|4|||
30945336|NCT01776554|58988091|FG001|Overall Study|Unclassified|1|||
30945337|NCT01776008|58988098|FG000|Overall Study|ineligible|2|||
30624559|NCT00902278|58636681|FG000|Overall Study|Lost to Follow-up|3|||
30624560|NCT00902278|58636682|FG001|Overall Study|Lost to Follow-up|2|||
30624561|NCT00902278|58636683|FG002|Overall Study|Lost to Follow-up|3|||
30624562|NCT00902278|58636684|FG003|Overall Study|Lost to Follow-up|0|||
30624563|NCT00902278|58636685|FG004|Overall Study|Lost to Follow-up|1|||
30945338|NCT01746368|58988104|FG000|Overall Study|Lost to Follow-up|2|||
30945339|NCT01746368|58988105|FG001|Overall Study|Lost to Follow-up|0|||
30945340|NCT01746368|58988104|FG000|Overall Study|Withdrawal by Subject|0|||
30945341|NCT01746368|58988105|FG001|Overall Study|Withdrawal by Subject|1|||
30945342|NCT01381575|58988114|FG000|Overall Study|Serious Adverse Event|1|||
30945343|NCT01381575|58988115|FG001|Overall Study|Serious Adverse Event|0|||
30945344|NCT01381575|58988116|FG002|Overall Study|Serious Adverse Event|0|||
30945345|NCT01381575|58988114|FG000|Overall Study|Non-Serious Adverse Event|0|||
30945346|NCT01381575|58988115|FG001|Overall Study|Non-Serious Adverse Event|0|||
30945347|NCT01381575|58988116|FG002|Overall Study|Non-Serious Adverse Event|1|||
30945348|NCT01381575|58988114|FG000|Overall Study|Protocol Violation|0|||
30945349|NCT01381575|58988115|FG001|Overall Study|Protocol Violation|1|||
30945350|NCT01381575|58988116|FG002|Overall Study|Protocol Violation|1|||
30945351|NCT01381575|58988114|FG000|Overall Study|Withdrawal by Subject|15|||
30945352|NCT01381575|58988115|FG001|Overall Study|Withdrawal by Subject|9|||
30945353|NCT01381575|58988116|FG002|Overall Study|Withdrawal by Subject|7|||
30945354|NCT01381575|58988114|FG000|Overall Study|Migrated/moved from study area|2|||
30945355|NCT01381575|58988115|FG001|Overall Study|Migrated/moved from study area|12|||
30945356|NCT01381575|58988116|FG002|Overall Study|Migrated/moved from study area|2|||
30945357|NCT01381575|58988114|FG000|Overall Study|Lost to Follow-up|8|||
30945358|NCT01381575|58988115|FG001|Overall Study|Lost to Follow-up|17|||
30945359|NCT01381575|58988116|FG002|Overall Study|Lost to Follow-up|9|||
30945360|NCT01858363|58988127|FG000|Overall Study|Death|35|||
30945361|NCT01858363|58988128|FG001|Overall Study|Death|9|||
30945362|NCT01858363|58988127|FG000|Overall Study|Withdrawal by Subject|28|||
30945363|NCT01858363|58988128|FG001|Overall Study|Withdrawal by Subject|14|||
30945364|NCT01858363|58988127|FG000|Overall Study|Lost to Follow-up|13|||
30945365|NCT01858363|58988128|FG001|Overall Study|Lost to Follow-up|3|||
30945366|NCT01877551|58988136|FG000|Overall Study|Physician Decision|0|||
30945367|NCT01877551|58988137|FG001|Overall Study|Physician Decision|1|||
30945368|NCT01396005|58988145|FG000|Overall Study|Withdrawal by Subject|0|||
30945369|NCT01396005|58988146|FG001|Overall Study|Withdrawal by Subject|1|||
30945370|NCT01396005|58988145|FG000|Overall Study|Non-compliance with protocol|0|||
30945371|NCT01396005|58988146|FG001|Overall Study|Non-compliance with protocol|1|||
30945372|NCT01877239|58988154|FG000|Overall Study|Adverse Event|4|||
30945373|NCT01877239|58988154|FG000|Overall Study|Disease Remission|1|||
30945374|NCT01877239|58988154|FG000|Overall Study|Withdrawal by Subject|4|||
30945375|NCT01877239|58988154|FG000|Overall Study|Other|2|||
30945376|NCT01877239|58988154|FG000|Overall Study|Lack of Efficacy|4|||
30945377|NCT01877239|58988154|FG000|Overall Study|Data not available|35|||
30945378|NCT01877083|58988158|FG000|Treatment Phase|Disease Progression|10|||
30945379|NCT01877083|58988158|FG000|Treatment Phase|Clinical Progression|1|||
30945380|NCT01877083|58988158|FG000|Treatment Phase|Adverse Event|6|||
30945381|NCT01877083|58988158|FG000|Treatment Phase|Withdrawal by Subject|2|||
30945382|NCT01877083|58988158|FG000|Treatment Phase|Lost to Follow-up|1|||
30945383|NCT01877083|58988158|FG000|Extension Phase|Disease Progression|3|||
30945384|NCT01877083|58988158|FG000|Extension Phase|Adverse Event|2|||
30945385|NCT01380327|58988165|FG000|Overall Study|Lost to Follow-up|0|||
30945386|NCT01380327|58988166|FG001|Overall Study|Lost to Follow-up|1|||
30945387|NCT01380327|58988167|FG002|Overall Study|Lost to Follow-up|1|||
30945388|NCT01380327|58988165|FG000|Overall Study|Protocol Violation|3|||
30945389|NCT01380327|58988166|FG001|Overall Study|Protocol Violation|2|||
30945390|NCT01380327|58988167|FG002|Overall Study|Protocol Violation|3|||
30945391|NCT01380327|58988165|FG000|Overall Study|Withdrawal by Subject|0|||
30945392|NCT01380327|58988166|FG001|Overall Study|Withdrawal by Subject|0|||
30945393|NCT01380327|58988167|FG002|Overall Study|Withdrawal by Subject|1|||
30945394|NCT01380327|58988165|FG000|Overall Study|Housing situation precluded ability to k|0|||
30945395|NCT01380327|58988166|FG001|Overall Study|Housing situation precluded ability to k|0|||
30945396|NCT01380327|58988167|FG002|Overall Study|Housing situation precluded ability to k|1|||
30945397|NCT01380327|58988165|FG000|Overall Study|Questionable onset of epilepsy|0|||
30945398|NCT01380327|58988166|FG001|Overall Study|Questionable onset of epilepsy|0|||
30945399|NCT01380327|58988167|FG002|Overall Study|Questionable onset of epilepsy|1|||
30945400|NCT01829425|58988177|FG000|Overall Study|Withdrawal by Subject|4|||
30945401|NCT01829425|58988178|FG001|Overall Study|Withdrawal by Subject|3|||
30945402|NCT01829425|58988177|FG000|Overall Study|Lost to Follow-up|2|||
30945403|NCT01829425|58988178|FG001|Overall Study|Lost to Follow-up|1|||
30945404|NCT01394991|58988195|FG000|Overall Study|Adverse Event|0|||
30945405|NCT01394991|58988196|FG001|Overall Study|Adverse Event|4|||
30624564|NCT01998633|58636699|FG000|Overall Study|Death|1|||
30624565|NCT00952341|58636709|FG000|Cycle 1|Adverse Event|4|||
30624566|NCT00952341|58636710|FG001|Cycle 1|Adverse Event|1|||
30945406|NCT01394991|58988195|FG000|Overall Study|Lack of Efficacy|5|||
30624567|NCT00952341|58636709|FG000|Cycle 1|Withdrawal by Subject|3|||
30945407|NCT01394991|58988196|FG001|Overall Study|Lack of Efficacy|7|||
30945408|NCT01394991|58988195|FG000|Overall Study|Lost to Follow-up|6|||
30945409|NCT01394991|58988196|FG001|Overall Study|Lost to Follow-up|8|||
30945410|NCT01394991|58988195|FG000|Overall Study|Physician Decision|1|||
30945411|NCT01394991|58988196|FG001|Overall Study|Physician Decision|3|||
30945412|NCT01394991|58988195|FG000|Overall Study|Protocol Violation|1|||
30945413|NCT01394991|58988196|FG001|Overall Study|Protocol Violation|1|||
30945414|NCT01394991|58988195|FG000|Overall Study|Withdrawal by Subject|20|||
30945415|NCT01394991|58988196|FG001|Overall Study|Withdrawal by Subject|17|||
30945416|NCT01394991|58988195|FG000|Overall Study|Chemotherapy Termination|10|||
30842841|NCT01657162|58868815|FG001|Overall Study|Inability to Complete Study Procedures|7|||
30842842|NCT01657162|58868814|FG000|Overall Study|Protocol Violation|1|||
30842843|NCT01657162|58868815|FG001|Overall Study|Protocol Violation|0|||
30842844|NCT01657162|58868814|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
30842845|NCT01657162|58868815|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
30842846|NCT01657162|58868814|FG000|Overall Study|Other than Specified|0|||
30842847|NCT01657162|58868815|FG001|Overall Study|Other than Specified|2|||
30842848|NCT01373294|58868849|FG000|Overall Study|Adverse Event|1|||
30842849|NCT01373294|58868850|FG001|Overall Study|Adverse Event|0|||
30842850|NCT01656304|58868856|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
30842851|NCT03023423|58868863|FG000|Overall Study|Death|5|||
30842852|NCT03023423|58868864|FG001|Overall Study|Death|12|||
30842853|NCT03023423|58868865|FG002|Overall Study|Death|20|||
30842854|NCT03023423|58868863|FG000|Overall Study|Other|0|||
30842855|NCT03023423|58868864|FG001|Overall Study|Other|2|||
30842856|NCT03023423|58868865|FG002|Overall Study|Other|2|||
30842857|NCT03023423|58868863|FG000|Overall Study|Ongoing|2|||
30842858|NCT03023423|58868864|FG001|Overall Study|Ongoing|32|||
30842859|NCT03023423|58868865|FG002|Overall Study|Ongoing|24|||
30842860|NCT03185741|58868880|FG000|Baseline|Withdrawal by Subject|1|||
30842861|NCT03185741|58868881|FG001|Baseline|Withdrawal by Subject|3|||
30842862|NCT03185741|58868882|FG002|Baseline|Withdrawal by Subject|2|||
30842863|NCT03185741|58868880|FG000|Baseline|Lost to Follow-up|1|||
30842864|NCT03185741|58868881|FG001|Baseline|Lost to Follow-up|2|||
30842865|NCT03185741|58868882|FG002|Baseline|Lost to Follow-up|3|||
30842866|NCT03185741|58868880|FG000|3Month|Death|1|||
30842867|NCT03185741|58868881|FG001|3Month|Death|1|||
30842868|NCT03185741|58868882|FG002|3Month|Death|2|||
30842869|NCT03185741|58868880|FG000|3Month|Withdrawal by Subject|1|||
30842870|NCT03185741|58868881|FG001|3Month|Withdrawal by Subject|5|||
30842871|NCT03185741|58868882|FG002|3Month|Withdrawal by Subject|1|||
30842872|NCT03185741|58868880|FG000|3Month|Lost to Follow-up|7|||
30842873|NCT03185741|58868881|FG001|3Month|Lost to Follow-up|9|||
30842874|NCT03185741|58868882|FG002|3Month|Lost to Follow-up|8|||
30842875|NCT03185741|58868880|FG000|3Month|Unavailable for 3Month|11|||
30842876|NCT03185741|58868881|FG001|3Month|Unavailable for 3Month|10|||
30842877|NCT03185741|58868882|FG002|3Month|Unavailable for 3Month|11|||
30842878|NCT03185741|58868880|FG000|3Month|Protocol Violation|0|||
30842879|NCT03185741|58868881|FG001|3Month|Protocol Violation|0|||
30842880|NCT03185741|58868882|FG002|3Month|Protocol Violation|3|||
30842881|NCT03185741|58868880|FG000|6Month|Death|1|||
30842882|NCT03185741|58868881|FG001|6Month|Death|1|||
30842883|NCT03185741|58868882|FG002|6Month|Death|2|||
30842884|NCT03185741|58868880|FG000|6Month|Withdrawal by Subject|2|||
30842885|NCT03185741|58868881|FG001|6Month|Withdrawal by Subject|3|||
30842886|NCT03185741|58868882|FG002|6Month|Withdrawal by Subject|1|||
30842887|NCT03185741|58868880|FG000|6Month|Lost to Follow-up|16|||
30842888|NCT03185741|58868881|FG001|6Month|Lost to Follow-up|15|||
30842889|NCT03185741|58868882|FG002|6Month|Lost to Follow-up|16|||
30842890|NCT02672852|58868892|FG000|Part A1|Disease Worsening|1|||
30842891|NCT02672852|58868893|FG001|Part A1|Disease Worsening|0|||
30842892|NCT02672852|58868894|FG002|Part A1|Disease Worsening|0|||
30842893|NCT02672852|58868895|FG003|Part A1|Disease Worsening|0|||
30842894|NCT02672852|58868896|FG004|Part A1|Disease Worsening|0|||
30842895|NCT02672852|58868897|FG005|Part A1|Disease Worsening|0|||
30842896|NCT02672852|58868898|FG006|Part A1|Disease Worsening|0|||
30945417|NCT01394991|58988196|FG001|Overall Study|Chemotherapy Termination|15|||
30759860|NCT03560518|58768198|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
30759861|NCT03560518|58768196|FG000|Double Blind Treatment Period|Adverse Event|0|||
30759862|NCT03560518|58768197|FG001|Double Blind Treatment Period|Adverse Event|3|||
30759863|NCT03560518|58768198|FG002|Double Blind Treatment Period|Adverse Event|1|||
30759864|NCT03560206|58768208|FG000|Overall Study|Lost to Follow-up|19|||
30759865|NCT03560206|58768209|FG001|Overall Study|Lost to Follow-up|11|||
30759866|NCT03560206|58768208|FG000|Overall Study|Withdrawal by Subject|2|||
30759867|NCT03560206|58768209|FG001|Overall Study|Withdrawal by Subject|4|||
30945418|NCT01394991|58988195|FG000|Overall Study|Disease Progression|7|||
30945419|NCT01394991|58988196|FG001|Overall Study|Disease Progression|7|||
30842897|NCT02672852|58868892|FG000|Part A1|Adverse Event|0|||
30842898|NCT02672852|58868893|FG001|Part A1|Adverse Event|1|||
30842899|NCT02672852|58868894|FG002|Part A1|Adverse Event|0|||
30842900|NCT02672852|58868895|FG003|Part A1|Adverse Event|0|||
30842901|NCT02672852|58868896|FG004|Part A1|Adverse Event|0|||
30842902|NCT02672852|58868897|FG005|Part A1|Adverse Event|0|||
30842903|NCT02672852|58868898|FG006|Part A1|Adverse Event|0|||
30842904|NCT02672852|58868892|FG000|Part A1|Lost to Follow-up|1|||
30842905|NCT02672852|58868893|FG001|Part A1|Lost to Follow-up|2|||
30842906|NCT02672852|58868894|FG002|Part A1|Lost to Follow-up|0|||
30842907|NCT02672852|58868895|FG003|Part A1|Lost to Follow-up|0|||
30842908|NCT02672852|58868896|FG004|Part A1|Lost to Follow-up|0|||
30842909|NCT02672852|58868897|FG005|Part A1|Lost to Follow-up|0|||
30842910|NCT02672852|58868898|FG006|Part A1|Lost to Follow-up|0|||
30842911|NCT02672852|58868892|FG000|Part A1|Withdrawal by Subject|1|||
30945420|NCT01394991|58988195|FG000|Overall Study|Prematurely Termination of Trial|9|||
30945421|NCT01394991|58988196|FG001|Overall Study|Prematurely Termination of Trial|10|||
30945422|NCT01829347|58988204|FG000|VTI-210|Death|5|||
30945423|NCT01829347|58988205|FG001|VTI-210|Death|3|||
30945424|NCT01829347|58988204|FG000|VTI-210|Withdrawal by Subject|1|||
30945425|NCT01829347|58988205|FG001|VTI-210|Withdrawal by Subject|0|||
30945426|NCT01829347|58988204|FG000|VTI-210E|Death|2|||
30945427|NCT01829347|58988205|FG001|VTI-210E|Death|1|||
30945428|NCT01829347|58988204|FG000|VTI-210E|Study terminated prematurely|1|||
30945429|NCT01829347|58988205|FG001|VTI-210E|Study terminated prematurely|5|||
30945430|NCT01394523|58988214|FG000|Overall Study|Unable to place block|1|||
30945431|NCT01394523|58988215|FG001|Overall Study|Unable to place block|0|||
30945432|NCT01394523|58988216|FG002|Overall Study|Unable to place block|0|||
30945433|NCT01857973|58988224|FG000|Overall Study|Subject did not meet required BG range|3|||
30945434|NCT01857973|58988224|FG000|Overall Study|drop out after 3 failed attempts|1|||
30945435|NCT01857973|58988224|FG000|Overall Study|Physician Decision|1|||
30945436|NCT01857583|58988232|FG000|Overall Study|Adverse Event|0|||
30945437|NCT01857583|58988233|FG001|Overall Study|Adverse Event|0|||
30945438|NCT01857583|58988234|FG002|Overall Study|Adverse Event|1|||
30945439|NCT01857583|58988235|FG003|Overall Study|Adverse Event|1|||
30945440|NCT01857583|58988232|FG000|Overall Study|Death|0|||
30945441|NCT01857583|58988233|FG001|Overall Study|Death|1|||
30945442|NCT01857583|58988234|FG002|Overall Study|Death|1|||
30945443|NCT01857583|58988235|FG003|Overall Study|Death|0|||
30945444|NCT01857583|58988232|FG000|Overall Study|Physician Decision|0|||
30945445|NCT01857583|58988233|FG001|Overall Study|Physician Decision|0|||
30945446|NCT01857583|58988234|FG002|Overall Study|Physician Decision|0|||
30945447|NCT01857583|58988235|FG003|Overall Study|Physician Decision|1|||
30945448|NCT01857583|58988232|FG000|Overall Study|Withdrawal by Subject|1|||
30945449|NCT01857583|58988233|FG001|Overall Study|Withdrawal by Subject|0|||
30945450|NCT01857583|58988234|FG002|Overall Study|Withdrawal by Subject|1|||
30945451|NCT01857583|58988235|FG003|Overall Study|Withdrawal by Subject|2|||
30945452|NCT01829191|58988247|FG000|Overall Study|Relocation|0|||
30945453|NCT01829191|58988248|FG001|Overall Study|Relocation|1|||
30945454|NCT01829191|58988247|FG000|Overall Study|Lens discomfort|0|||
30945455|NCT01829191|58988248|FG001|Overall Study|Lens discomfort|3|||
30945456|NCT01829191|58988247|FG000|Overall Study|Lens handling difficulty|1|||
30945457|NCT01829191|58988248|FG001|Overall Study|Lens handling difficulty|4|||
30945458|NCT01829191|58988247|FG000|Overall Study|Protocol Violation|4|||
30945459|NCT01829191|58988248|FG001|Overall Study|Protocol Violation|1|||
30945460|NCT01829191|58988247|FG000|Overall Study|Withdrawal by Subject|2|||
30945461|NCT01829191|58988248|FG001|Overall Study|Withdrawal by Subject|3|||
30945462|NCT01829191|58988247|FG000|Overall Study|Lost to Follow-up|0|||
30945463|NCT01829191|58988248|FG001|Overall Study|Lost to Follow-up|1|||
30945464|NCT01829191|58988247|FG000|Overall Study|Subject was fit for ortho - k|0|||
30945465|NCT01829191|58988248|FG001|Overall Study|Subject was fit for ortho - k|1|||
30945466|NCT00211185|58988253|FG000|Overall Study|Death|2|||
30945467|NCT00211185|58988253|FG000|Overall Study|Disease progression|7|||
30945468|NCT00211185|58988253|FG000|Overall Study|Withdrawal by Subject|6|||
30945469|NCT00211185|58988253|FG000|Overall Study|Physician Decision|5|||
30945470|NCT00210639|58988259|FG000|Overall Study|Lost to Follow-up|37|||
30945471|NCT00210639|58988260|FG001|Overall Study|Lost to Follow-up|29|||
30945472|NCT00210639|58988259|FG000|Overall Study|Withdrawal by Subject|8|||
30945473|NCT00210639|58988260|FG001|Overall Study|Withdrawal by Subject|1|||
30945474|NCT00210639|58988259|FG000|Overall Study|Other|18|||
30945475|NCT00210639|58988260|FG001|Overall Study|Other|12|||
30945476|NCT01829113|58988268|FG000|Overall Study|Disease Progression|37|||
30945477|NCT01829113|58988269|FG001|Overall Study|Disease Progression|48|||
30945478|NCT01829113|58988268|FG000|Overall Study|Adverse Event|14|||
30945479|NCT01829113|58988269|FG001|Overall Study|Adverse Event|10|||
30945480|NCT01829113|58988268|FG000|Overall Study|Withdrawal by Subject|17|||
30945481|NCT01829113|58988269|FG001|Overall Study|Withdrawal by Subject|10|||
30945482|NCT01829113|58988268|FG000|Overall Study|Death|4|||
30945483|NCT01829113|58988269|FG001|Overall Study|Death|6|||
30945484|NCT01829113|58988268|FG000|Overall Study|Sponsor Decision|1|||
30945485|NCT01829113|58988269|FG001|Overall Study|Sponsor Decision|1|||
30945486|NCT01829113|58988268|FG000|Overall Study|No Study Treatment Received|3|||
30945487|NCT01829113|58988269|FG001|Overall Study|No Study Treatment Received|2|||
30945488|NCT01829113|58988268|FG000|Overall Study|Physician Decision|1|||
30945489|NCT01829113|58988269|FG001|Overall Study|Physician Decision|1|||
30945490|NCT01857271|58988277|FG000|Overall Study|Lost to Follow-up|1|||
30945491|NCT01745120|58988283|FG000|Overall Study|Investigator decision|1|||
30945492|NCT01745120|58988284|FG001|Overall Study|Investigator decision|0|||
30945493|NCT01828567|58988295|FG000|Overall Study|Lost to Follow-up|27|||
30945494|NCT01828567|58988296|FG001|Overall Study|Lost to Follow-up|9|||
30945495|NCT01828567|58988295|FG000|Overall Study|Excluded - did not meet criteria|4|||
30945496|NCT01828567|58988296|FG001|Overall Study|Excluded - did not meet criteria|1|||
30945497|NCT01721486|58988304|FG000|Overall Study|Protocol Violation|1|||
30945498|NCT01721486|58988305|FG001|Overall Study|Protocol Violation|0|||
30945499|NCT01721486|58988304|FG000|Overall Study|Physician Decision|0|||
30945500|NCT01721486|58988305|FG001|Overall Study|Physician Decision|1|||
30945501|NCT01775930|58988311|FG000|Overall Study|Futility stopping boundary met|1|||
30945502|NCT01856569|58988315|FG000|Overall Study|Other|1|||
30945503|NCT01856569|58988315|FG000|Overall Study|Changed Site/Structure|1|||
30945504|NCT01856569|58988315|FG000|Overall Study|Lost to Follow-up|3|||
30945505|NCT01856569|58988315|FG000|Overall Study|Did not met inclusion criteria|8|||
30945506|NCT01721408|58988321|FG000|Overall Study|Adverse Event|6|||
30945507|NCT01721408|58988322|FG001|Overall Study|Adverse Event|1|||
30945508|NCT01721408|58988321|FG000|Overall Study|Death|1|||
30945509|NCT01721408|58988322|FG001|Overall Study|Death|0|||
30945510|NCT01721408|58988321|FG000|Overall Study|Insufficient clinical response|15|||
30945511|NCT01721408|58988322|FG001|Overall Study|Insufficient clinical response|6|||
30945512|NCT01721408|58988321|FG000|Overall Study|No longer willing to participate study|9|||
30945513|NCT01721408|58988322|FG001|Overall Study|No longer willing to participate study|10|||
30945514|NCT01721408|58988321|FG000|Overall Study|Protocol Violation|0|||
30945515|NCT01721408|58988322|FG001|Overall Study|Protocol Violation|2|||
30945516|NCT01721408|58988321|FG000|Overall Study|Other|3|||
30945517|NCT01721408|58988322|FG001|Overall Study|Other|3|||
30945518|NCT01721408|58988321|FG000|Overall Study|Lost to Follow-up|1|||
30945519|NCT01721408|58988322|FG001|Overall Study|Lost to Follow-up|2|||
30945520|NCT01721408|58988321|FG000|Overall Study|Does not meet entrance criteria|1|||
30945521|NCT01721408|58988322|FG001|Overall Study|Does not meet entrance criteria|0|||
30945522|NCT01744496|58988330|FG000|Titration Period|Adverse Event|2|||
30945523|NCT01744496|58988331|FG001|Titration Period|Adverse Event|1|||
30945524|NCT01744496|58988330|FG000|Titration Period|Personal reasons|0|||
30945525|NCT01744496|58988331|FG001|Titration Period|Personal reasons|1|||
30945526|NCT01744496|58988330|FG000|Maintenance Period|Adverse Event|1|||
30945527|NCT01744496|58988331|FG001|Maintenance Period|Adverse Event|3|||
30945528|NCT01744496|58988330|FG000|Maintenance Period|Protocol Violation|1|||
30945529|NCT01744496|58988331|FG001|Maintenance Period|Protocol Violation|0|||
30945530|NCT01744496|58988330|FG000|Maintenance Period|Withdrawal by Subject|1|||
30945531|NCT01744496|58988331|FG001|Maintenance Period|Withdrawal by Subject|1|||
30945532|NCT01744496|58988330|FG000|Maintenance Period|Subject left town|1|||
30945533|NCT01744496|58988331|FG001|Maintenance Period|Subject left town|0|||
30945534|NCT01721330|58988339|FG000|Overall Study|Withdrawal by Subject|0|||
30945535|NCT01721330|58988340|FG001|Overall Study|Withdrawal by Subject|1|||
30945536|NCT01828021|58988356|FG000|Overall Study|Adverse Event|5|||
30945537|NCT01828021|58988356|FG000|Overall Study|Lack of Efficacy|17|||
30945538|NCT01828021|58988356|FG000|Overall Study|Withdrawal by Subject|2|||
30945539|NCT01828021|58988356|FG000|Overall Study|Ileal obstruction, unrelated|1|||
30945540|NCT01827943|58988360|FG000|Overall Study|Protocol Violation|8|||
30945541|NCT01827943|58988360|FG000|Overall Study|Never treated because of an rapid progression|1|||
30945542|NCT00217971|58988366|FG000|Overall Study|Adverse Event|1|||
30945543|NCT00217971|58988367|FG001|Overall Study|Adverse Event|1|||
30945544|NCT00217971|58988366|FG000|Overall Study|Lost to Follow-up|15|||
30945545|NCT00217971|58988367|FG001|Overall Study|Lost to Follow-up|19|||
30945546|NCT00217971|58988366|FG000|Overall Study|Physician Decision|0|||
30945547|NCT00217971|58988367|FG001|Overall Study|Physician Decision|1|||
30945548|NCT00217971|58988366|FG000|Overall Study|Withdrawal by Subject|7|||
30945549|NCT00217971|58988367|FG001|Overall Study|Withdrawal by Subject|12|||
30945550|NCT00217971|58988366|FG000|Overall Study|non compliant|1|||
30945551|NCT00217971|58988367|FG001|Overall Study|non compliant|0|||
30945552|NCT00217581|58988373|FG000|Overall Study|Withdrawal by Subject|1|||
30945553|NCT01856257|58988381|FG000|Overall Study|Death|2|||
30945554|NCT01856257|58988382|FG001|Overall Study|Death|0|||
30945555|NCT01856257|58988383|FG002|Overall Study|Death|0|||
30945556|NCT01856257|58988384|FG003|Overall Study|Death|0|||
30945557|NCT01856257|58988381|FG000|Overall Study|Physician Decision|0|||
30945558|NCT01856257|58988382|FG001|Overall Study|Physician Decision|0|||
30945559|NCT01856257|58988383|FG002|Overall Study|Physician Decision|0|||
30945560|NCT01856257|58988384|FG003|Overall Study|Physician Decision|1|||
30945561|NCT01856257|58988381|FG000|Overall Study|Withdrawal by Subject|1|||
30945562|NCT01856257|58988382|FG001|Overall Study|Withdrawal by Subject|1|||
30945563|NCT01856257|58988383|FG002|Overall Study|Withdrawal by Subject|0|||
30945564|NCT01856257|58988384|FG003|Overall Study|Withdrawal by Subject|0|||
30945565|NCT01856257|58988381|FG000|Overall Study|Donor complication|0|||
30945566|NCT01856257|58988382|FG001|Overall Study|Donor complication|0|||
30624568|NCT00952341|58636710|FG001|Cycle 1|Withdrawal by Subject|8|||
30760682|NCT02899195|58769157|FG000|Maintenance Durvalumab|Physician Decision|1|||
30945567|NCT01856257|58988383|FG002|Overall Study|Donor complication|0|||
30945568|NCT01856257|58988384|FG003|Overall Study|Donor complication|1|||
30945569|NCT00215943|58988395|FG000|Overall Study|Disease Progression|3|||
30945570|NCT00215943|58988396|FG001|Overall Study|Disease Progression|5|||
30945571|NCT00215943|58988395|FG000|Overall Study|Alternate therapy|0|||
30945572|NCT00215943|58988396|FG001|Overall Study|Alternate therapy|1|||
30945573|NCT00215943|58988395|FG000|Overall Study|Adverse Event|3|||
30945574|NCT00215943|58988396|FG001|Overall Study|Adverse Event|6|||
30945575|NCT00215943|58988395|FG000|Overall Study|Other disease|0|||
30945576|NCT00215943|58988396|FG001|Overall Study|Other disease|1|||
30945577|NCT00215943|58988395|FG000|Overall Study|Other complications|3|||
30945578|NCT00215943|58988396|FG001|Overall Study|Other complications|1|||
30945579|NCT01827319|58988402|FG000|Overall Study|Lost to Follow-up|3|||
30945580|NCT01827163|58988406|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
30945581|NCT01827163|58988406|FG000|Overall Study|Adverse Event|9|||
30945582|NCT00215553|58988417|FG000|Overall Study|Adverse Event|0|||
30945583|NCT00215553|58988418|FG001|Overall Study|Adverse Event|1|||
30945584|NCT00215553|58988419|FG002|Overall Study|Adverse Event|2|||
30945585|NCT00215553|58988420|FG003|Overall Study|Adverse Event|1|||
30945586|NCT00215553|58988421|FG004|Overall Study|Adverse Event|2|||
30945587|NCT00215553|58988422|FG005|Overall Study|Adverse Event|6|||
30945588|NCT00215553|58988423|FG006|Overall Study|Adverse Event|0|||
30945589|NCT00214461|58988443|FG000|Overall Study|Adverse Event|0|||
30945590|NCT00214461|58988444|FG001|Overall Study|Adverse Event|0|||
30945591|NCT00214461|58988445|FG002|Overall Study|Adverse Event|1|||
30945592|NCT00214461|58988446|FG003|Overall Study|Adverse Event|1|||
30945593|NCT00214461|58988443|FG000|Overall Study|Withdrawal by Subject|0|||
30945594|NCT00214461|58988444|FG001|Overall Study|Withdrawal by Subject|0|||
30945595|NCT00214461|58988445|FG002|Overall Study|Withdrawal by Subject|1|||
30945596|NCT00214461|58988446|FG003|Overall Study|Withdrawal by Subject|0|||
30945597|NCT00214383|58988458|FG000|Overall Study|Lost to Follow-up|16|||
30945598|NCT00214383|58988459|FG001|Overall Study|Lost to Follow-up|26|||
30945599|NCT00212355|58988465|FG000|Overall Study|Adverse Event|1|||
30945600|NCT00212355|58988465|FG000|Overall Study|Withdrawal by Subject|1|||
30945601|NCT00212355|58988465|FG000|Overall Study|A change of address|1|||
30945602|NCT00211887|58988472|FG000|Overall Study|Adverse Event|8|||
30945603|NCT00211887|58988473|FG001|Overall Study|Adverse Event|4|||
30945604|NCT00211887|58988474|FG002|Overall Study|Adverse Event|6|||
30945605|NCT00211887|58988472|FG000|Overall Study|Death|1|||
30945606|NCT00211887|58988473|FG001|Overall Study|Death|1|||
30945607|NCT00211887|58988474|FG002|Overall Study|Death|1|||
30945608|NCT00211887|58988472|FG000|Overall Study|Lost to Follow-up|28|||
30945609|NCT00211887|58988473|FG001|Overall Study|Lost to Follow-up|13|||
30945610|NCT00211887|58988474|FG002|Overall Study|Lost to Follow-up|9|||
30945611|NCT00211887|58988472|FG000|Overall Study|Non-medical reason|31|||
30945612|NCT00211887|58988473|FG001|Overall Study|Non-medical reason|14|||
30945613|NCT00211887|58988474|FG002|Overall Study|Non-medical reason|8|||
30945614|NCT00211887|58988472|FG000|Overall Study|Other medical reason|15|||
30945615|NCT00211887|58988473|FG001|Overall Study|Other medical reason|11|||
30945616|NCT00211887|58988474|FG002|Overall Study|Other medical reason|7|||
30945617|NCT00211887|58988472|FG000|Overall Study|Side effects|19|||
30945618|NCT00211887|58988473|FG001|Overall Study|Side effects|13|||
30945619|NCT00211887|58988474|FG002|Overall Study|Side effects|5|||
30945620|NCT01855945|58988494|FG000|Overall Study|Adverse Event|0|||
30945621|NCT01855945|58988495|FG001|Overall Study|Adverse Event|0|||
30945622|NCT01855945|58988496|FG002|Overall Study|Adverse Event|0|||
30945623|NCT01855945|58988497|FG003|Overall Study|Adverse Event|0|||
30945624|NCT01855945|58988498|FG004|Overall Study|Adverse Event|0|||
30945625|NCT01855945|58988499|FG005|Overall Study|Adverse Event|0|||
30945626|NCT01855945|58988500|FG006|Overall Study|Adverse Event|1|||
30945627|NCT01855945|58988501|FG007|Overall Study|Adverse Event|0|||
30945628|NCT01855945|58988502|FG008|Overall Study|Adverse Event|0|||
30945629|NCT01855945|58988503|FG009|Overall Study|Adverse Event|0|||
30945630|NCT01855945|58988504|FG010|Overall Study|Adverse Event|0|||
30945631|NCT01855945|58988505|FG011|Overall Study|Adverse Event|0|||
30945632|NCT01855945|58988494|FG000|Overall Study|Death|0|||
30945633|NCT01855945|58988495|FG001|Overall Study|Death|0|||
30945634|NCT01855945|58988496|FG002|Overall Study|Death|0|||
30945635|NCT01855945|58988497|FG003|Overall Study|Death|0|||
30945636|NCT01855945|58988498|FG004|Overall Study|Death|0|||
30945637|NCT01855945|58988499|FG005|Overall Study|Death|0|||
30945638|NCT01855945|58988500|FG006|Overall Study|Death|2|||
30945639|NCT01855945|58988501|FG007|Overall Study|Death|0|||
30945640|NCT01855945|58988502|FG008|Overall Study|Death|0|||
30945641|NCT01855945|58988503|FG009|Overall Study|Death|0|||
30945642|NCT01855945|58988504|FG010|Overall Study|Death|0|||
30945643|NCT01855945|58988505|FG011|Overall Study|Death|0|||
30945644|NCT01855945|58988494|FG000|Overall Study|Lost to Follow-up|11|||
30945645|NCT01855945|58988495|FG001|Overall Study|Lost to Follow-up|10|||
30945646|NCT01855945|58988496|FG002|Overall Study|Lost to Follow-up|7|||
30945647|NCT01855945|58988497|FG003|Overall Study|Lost to Follow-up|3|||
30945648|NCT01855945|58988498|FG004|Overall Study|Lost to Follow-up|0|||
30759868|NCT03560206|58768208|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
30945649|NCT01855945|58988499|FG005|Overall Study|Lost to Follow-up|3|||
30945650|NCT01855945|58988500|FG006|Overall Study|Lost to Follow-up|4|||
30945651|NCT01855945|58988501|FG007|Overall Study|Lost to Follow-up|7|||
30945652|NCT01855945|58988502|FG008|Overall Study|Lost to Follow-up|2|||
30945653|NCT01855945|58988503|FG009|Overall Study|Lost to Follow-up|0|||
30945654|NCT01855945|58988504|FG010|Overall Study|Lost to Follow-up|0|||
30945655|NCT01855945|58988505|FG011|Overall Study|Lost to Follow-up|2|||
30945656|NCT01855945|58988494|FG000|Overall Study|Other - Unclassified|1|||
30945657|NCT01855945|58988495|FG001|Overall Study|Other - Unclassified|1|||
30945658|NCT01855945|58988496|FG002|Overall Study|Other - Unclassified|1|||
30945659|NCT01855945|58988497|FG003|Overall Study|Other - Unclassified|0|||
30945660|NCT01855945|58988498|FG004|Overall Study|Other - Unclassified|0|||
30945661|NCT01855945|58988499|FG005|Overall Study|Other - Unclassified|0|||
30945662|NCT01855945|58988500|FG006|Overall Study|Other - Unclassified|2|||
30945663|NCT01855945|58988501|FG007|Overall Study|Other - Unclassified|1|||
30945664|NCT01855945|58988502|FG008|Overall Study|Other - Unclassified|0|||
30945665|NCT01855945|58988503|FG009|Overall Study|Other - Unclassified|0|||
30945666|NCT01855945|58988504|FG010|Overall Study|Other - Unclassified|1|||
30945667|NCT01855945|58988505|FG011|Overall Study|Other - Unclassified|0|||
30945668|NCT01855945|58988494|FG000|Overall Study|Withdrawal by Subject|4|||
30945669|NCT01855945|58988495|FG001|Overall Study|Withdrawal by Subject|0|||
30945670|NCT01855945|58988496|FG002|Overall Study|Withdrawal by Subject|4|||
30945671|NCT01855945|58988497|FG003|Overall Study|Withdrawal by Subject|1|||
30945672|NCT01855945|58988498|FG004|Overall Study|Withdrawal by Subject|1|||
30945673|NCT01855945|58988499|FG005|Overall Study|Withdrawal by Subject|0|||
30945674|NCT01855945|58988500|FG006|Overall Study|Withdrawal by Subject|1|||
30945675|NCT01855945|58988501|FG007|Overall Study|Withdrawal by Subject|0|||
30945676|NCT01855945|58988502|FG008|Overall Study|Withdrawal by Subject|0|||
30945677|NCT01855945|58988503|FG009|Overall Study|Withdrawal by Subject|2|||
30945678|NCT01855945|58988504|FG010|Overall Study|Withdrawal by Subject|4|||
30945679|NCT01855945|58988505|FG011|Overall Study|Withdrawal by Subject|1|||
30945680|NCT01855789|58988568|FG000|1) Baseline up to Week 24|Adverse Event|37|||
30945681|NCT01855789|58988569|FG001|1) Baseline up to Week 24|Adverse Event|0|||
30945682|NCT01855789|58988570|FG002|1) Baseline up to Week 24|Adverse Event|0|||
30945683|NCT01855789|58988571|FG003|1) Baseline up to Week 24|Adverse Event|0|||
30945684|NCT01855789|58988568|FG000|1) Baseline up to Week 24|Death|2|||
30945685|NCT01855789|58988569|FG001|1) Baseline up to Week 24|Death|0|||
30945686|NCT01855789|58988570|FG002|1) Baseline up to Week 24|Death|0|||
30945687|NCT01855789|58988571|FG003|1) Baseline up to Week 24|Death|0|||
30945688|NCT01855789|58988568|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
30945689|NCT01855789|58988569|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
30945690|NCT01855789|58988570|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
30945691|NCT01855789|58988571|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
30945692|NCT01855789|58988568|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
30945693|NCT01855789|58988569|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
30945694|NCT01855789|58988570|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
30945695|NCT01855789|58988571|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
30945696|NCT01855789|58988568|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
30945697|NCT01855789|58988569|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
30945698|NCT01855789|58988570|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
30945699|NCT01855789|58988571|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
30945700|NCT01855789|58988568|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
30945701|NCT01855789|58988569|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
30945702|NCT01855789|58988570|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
30945703|NCT01855789|58988571|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
30945704|NCT01855789|58988568|FG000|1) Baseline up to Week 24|Physician Decision|4|||
30945705|NCT01855789|58988569|FG001|1) Baseline up to Week 24|Physician Decision|0|||
30945706|NCT01855789|58988570|FG002|1) Baseline up to Week 24|Physician Decision|0|||
30945707|NCT01855789|58988571|FG003|1) Baseline up to Week 24|Physician Decision|0|||
30945708|NCT01855789|58988568|FG000|1) Baseline up to Week 24|Pregnancy|1|||
30945709|NCT01855789|58988569|FG001|1) Baseline up to Week 24|Pregnancy|0|||
30945710|NCT01855789|58988570|FG002|1) Baseline up to Week 24|Pregnancy|0|||
30945711|NCT01855789|58988571|FG003|1) Baseline up to Week 24|Pregnancy|0|||
30945712|NCT01855789|58988568|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
30945713|NCT01855789|58988569|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
30945714|NCT01855789|58988570|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
30945715|NCT01855789|58988571|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
30945716|NCT01855789|58988568|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
30945717|NCT01855789|58988569|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
30945718|NCT01855789|58988570|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
30945719|NCT01855789|58988571|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
30945720|NCT01855789|58988568|FG000|1) Baseline up to Week 24|Other|4|||
30945721|NCT01855789|58988569|FG001|1) Baseline up to Week 24|Other|0|||
30945722|NCT01855789|58988570|FG002|1) Baseline up to Week 24|Other|0|||
30945723|NCT01855789|58988571|FG003|1) Baseline up to Week 24|Other|0|||
30945724|NCT01855789|58988568|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
30945725|NCT01855789|58988569|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
30948567|NCT01973231|58994583|FG001|Overall Study|Lost to Follow-up|1|||
30945726|NCT01855789|58988570|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
30945727|NCT01855789|58988571|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
30945728|NCT01855789|58988568|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
30945729|NCT01855789|58988569|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
30945730|NCT01855789|58988570|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
30945731|NCT01855789|58988571|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
30945732|NCT01855789|58988568|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
30945733|NCT01855789|58988569|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
30945734|NCT01855789|58988570|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
30945735|NCT01855789|58988571|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
30945736|NCT01855789|58988568|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
30945737|NCT01855789|58988569|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
30945738|NCT01855789|58988570|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
30945739|NCT01855789|58988571|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
30945740|NCT01855789|58988568|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
30945741|NCT01855789|58988569|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
30945742|NCT01855789|58988570|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
30945743|NCT01855789|58988571|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
30945744|NCT01855789|58988568|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
30945745|NCT01855789|58988569|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
30945746|NCT01855789|58988570|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
30945747|NCT01855789|58988571|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
30945748|NCT01855789|58988568|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
30945749|NCT01855789|58988569|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
30945750|NCT01855789|58988570|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
30945751|NCT01855789|58988571|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
30945752|NCT01855789|58988568|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
30945753|NCT01855789|58988569|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
30945754|NCT01855789|58988570|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
30945755|NCT01855789|58988571|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
30945756|NCT01855789|58988568|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
30945757|NCT01855789|58988569|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
30945758|NCT01855789|58988570|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
30945759|NCT01855789|58988571|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
30945760|NCT01855789|58988568|FG000|2) Week 24 up to End of Study|Other|0|||
30945761|NCT01855789|58988569|FG001|2) Week 24 up to End of Study|Other|0|||
30945762|NCT01855789|58988570|FG002|2) Week 24 up to End of Study|Other|0|||
30945763|NCT01855789|58988571|FG003|2) Week 24 up to End of Study|Other|1|||
30945764|NCT01610791|58988577|FG000|Overall Study|Lost to Follow-up|7|||
30945765|NCT01610791|58988577|FG000|Overall Study|Adverse Event|6|||
30945766|NCT01610791|58988577|FG000|Overall Study|Physician Decision|1|||
30945767|NCT01610791|58988577|FG000|Overall Study|Adverse event and Investigator decision|1|||
30945768|NCT01610791|58988577|FG000|Overall Study|Death|1|||
30945769|NCT01610791|58988577|FG000|Overall Study|Not determined|5|||
30945770|NCT01876381|58988581|FG000|Overall Study|Lack of Efficacy|5|||
30945771|NCT01876381|58988581|FG000|Overall Study|Physician Decision|1|||
30945772|NCT01876381|58988581|FG000|Overall Study|Withdrawal by Subject|1|||
30945773|NCT01855399|58988596|FG000|6 Month|Lost to Follow-up|12|||
30945774|NCT01855399|58988597|FG001|6 Month|Lost to Follow-up|9|||
30945775|NCT01855399|58988596|FG000|6 Month|Withdrawal by Subject|8|||
30945776|NCT01855399|58988597|FG001|6 Month|Withdrawal by Subject|6|||
30945777|NCT01855399|58988596|FG000|12 Month|Lost to Follow-up|7|||
30945778|NCT01855399|58988597|FG001|12 Month|Lost to Follow-up|11|||
30945779|NCT01875991|58988605|FG000|Overall Study|Withdrawal by Subject|6|||
30945780|NCT01875991|58988606|FG001|Overall Study|Withdrawal by Subject|6|||
30945781|NCT01875991|58988605|FG000|Overall Study|Sponsor Decision|1|||
30945782|NCT01875991|58988606|FG001|Overall Study|Sponsor Decision|0|||
30945783|NCT01855243|58988618|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
30945784|NCT01855243|58988619|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
30624569|NCT00952341|58636709|FG000|Cycle 1|Protocol Violation|2|||
30945785|NCT01855243|58988620|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
30945786|NCT01825837|58988632|FG000|PART I|Withdrawal by Subject|0|||
30624570|NCT00952341|58636710|FG001|Cycle 1|Protocol Violation|1|||
30945787|NCT01825837|58988633|FG001|PART I|Withdrawal by Subject|0|||
30945788|NCT01825837|58988634|FG002|PART I|Withdrawal by Subject|0|||
30945789|NCT01825837|58988635|FG003|PART I|Withdrawal by Subject|6|||
30945790|NCT01825837|58988632|FG000|PART I|Patient non-compliance|0|||
30945791|NCT01825837|58988633|FG001|PART I|Patient non-compliance|0|||
30945792|NCT01825837|58988634|FG002|PART I|Patient non-compliance|0|||
30945793|NCT01825837|58988635|FG003|PART I|Patient non-compliance|1|||
30945794|NCT01825837|58988632|FG000|PART I|Treatment failure|0|||
30945795|NCT01825837|58988633|FG001|PART I|Treatment failure|0|||
30945796|NCT01825837|58988634|FG002|PART I|Treatment failure|0|||
30945797|NCT01825837|58988635|FG003|PART I|Treatment failure|7|||
30945798|NCT01825837|58988632|FG000|PART I|reason unspecified|0|||
30945799|NCT01825837|58988633|FG001|PART I|reason unspecified|0|||
30945800|NCT01825837|58988634|FG002|PART I|reason unspecified|0|||
30945801|NCT01825837|58988635|FG003|PART I|reason unspecified|3|||
30945802|NCT01825837|58988632|FG000|PART II|Withdrawal by Subject|3|||
30945803|NCT01825837|58988633|FG001|PART II|Withdrawal by Subject|3|||
30945804|NCT01825837|58988634|FG002|PART II|Withdrawal by Subject|7|||
30945805|NCT01825837|58988635|FG003|PART II|Withdrawal by Subject|0|||
30945806|NCT01825837|58988632|FG000|PART II|Patient non-compliance|5|||
30945807|NCT01825837|58988633|FG001|PART II|Patient non-compliance|2|||
30945808|NCT01825837|58988634|FG002|PART II|Patient non-compliance|4|||
30945809|NCT01825837|58988635|FG003|PART II|Patient non-compliance|0|||
30945810|NCT01825837|58988632|FG000|PART II|Adverse Event|3|||
30945811|NCT01825837|58988633|FG001|PART II|Adverse Event|3|||
30945812|NCT01825837|58988634|FG002|PART II|Adverse Event|1|||
30945813|NCT01825837|58988635|FG003|PART II|Adverse Event|0|||
30945814|NCT01825837|58988632|FG000|PART II|Treatment failure|6|||
30945815|NCT01825837|58988633|FG001|PART II|Treatment failure|4|||
30945816|NCT01825837|58988634|FG002|PART II|Treatment failure|5|||
30945817|NCT01825837|58988635|FG003|PART II|Treatment failure|0|||
30945818|NCT01825837|58988632|FG000|PART II|reason unspecified|2|||
30945819|NCT01825837|58988633|FG001|PART II|reason unspecified|2|||
30945820|NCT01825837|58988634|FG002|PART II|reason unspecified|2|||
30945821|NCT01825837|58988635|FG003|PART II|reason unspecified|0|||
30945822|NCT01854697|58988648|FG000|Overall Study|Adverse Event|1|||
30945823|NCT01854697|58988649|FG001|Overall Study|Adverse Event|0|||
30945824|NCT01854697|58988650|FG002|Overall Study|Adverse Event|0|||
30945825|NCT01854697|58988651|FG003|Overall Study|Adverse Event|0|||
30945826|NCT01854697|58988652|FG004|Overall Study|Adverse Event|1|||
30945827|NCT01854697|58988648|FG000|Overall Study|Lost to Follow-up|4|||
30945828|NCT01854697|58988649|FG001|Overall Study|Lost to Follow-up|1|||
30945829|NCT01854697|58988650|FG002|Overall Study|Lost to Follow-up|1|||
30945830|NCT01854697|58988651|FG003|Overall Study|Lost to Follow-up|2|||
30945831|NCT01854697|58988652|FG004|Overall Study|Lost to Follow-up|0|||
30945832|NCT01854697|58988648|FG000|Overall Study|To enter another AbbVie study|1|||
30945833|NCT01854697|58988649|FG001|Overall Study|To enter another AbbVie study|0|||
30945834|NCT01854697|58988650|FG002|Overall Study|To enter another AbbVie study|0|||
30945835|NCT01854697|58988651|FG003|Overall Study|To enter another AbbVie study|0|||
30945836|NCT01854697|58988652|FG004|Overall Study|To enter another AbbVie study|1|||
30945837|NCT01854697|58988648|FG000|Overall Study|Withdrew Consent|0|||
30945838|NCT01854697|58988649|FG001|Overall Study|Withdrew Consent|1|||
30945839|NCT01854697|58988650|FG002|Overall Study|Withdrew Consent|0|||
30945840|NCT01854697|58988651|FG003|Overall Study|Withdrew Consent|1|||
30945841|NCT01854697|58988652|FG004|Overall Study|Withdrew Consent|0|||
30945842|NCT01854697|58988648|FG000|Overall Study|Other|0|||
30945843|NCT01854697|58988649|FG001|Overall Study|Other|1|||
30945844|NCT01854697|58988650|FG002|Overall Study|Other|1|||
30945845|NCT01854697|58988651|FG003|Overall Study|Other|0|||
30945846|NCT01854697|58988652|FG004|Overall Study|Other|0|||
30945847|NCT01824979|58988664|FG000|Overall Study|Withdrawal by Subject|5|||
30945848|NCT01824979|58988665|FG001|Overall Study|Withdrawal by Subject|0|||
30945849|NCT01824979|58988664|FG000|Overall Study|Physician Decision|2|||
30945850|NCT01824979|58988665|FG001|Overall Study|Physician Decision|0|||
30945851|NCT01824979|58988664|FG000|Overall Study|Protocol Violation|6|||
30945852|NCT01824979|58988665|FG001|Overall Study|Protocol Violation|13|||
30945853|NCT01824823|58988673|FG000|Overall Study|Lack of Efficacy|1|||
30624571|NCT00952341|58636709|FG000|Cycle 1|Lost to Follow-up|11|||
30945854|NCT01824823|58988674|FG001|Overall Study|Lack of Efficacy|1|||
30945855|NCT01824823|58988673|FG000|Overall Study|Off-treatment reason not submitted|1|||
30945856|NCT01824823|58988674|FG001|Overall Study|Off-treatment reason not submitted|0|||
30945857|NCT01875367|58988682|FG000|Overall Study|Not complete at least 2 questionaries|4|||
30945858|NCT01875367|58988683|FG001|Overall Study|Not complete at least 2 questionaries|2|||
30945859|NCT01875367|58988682|FG000|Overall Study|Not receive study treatment|1|||
30945860|NCT01875367|58988683|FG001|Overall Study|Not receive study treatment|0|||
30945861|NCT01853839|58988693|FG000|Overall Study|Violated inclusion criteria|2|||
30945862|NCT01853839|58988693|FG000|Overall Study|Not meet ITT population definition|58|||
30945863|NCT01853839|58988693|FG000|Overall Study|End of treatment visit too early|33|||
30945864|NCT01853839|58988693|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
30945865|NCT01874665|58988703|FG000|Overall Study|Adverse Event|6|||
30945866|NCT01874665|58988704|FG001|Overall Study|Adverse Event|2|||
30945867|NCT01874665|58988703|FG000|Overall Study|Withdrawal by Subject|4|||
30945868|NCT01874665|58988704|FG001|Overall Study|Withdrawal by Subject|1|||
30945869|NCT01874665|58988703|FG000|Overall Study|Physician Decision|3|||
30945870|NCT01874665|58988704|FG001|Overall Study|Physician Decision|0|||
30945871|NCT01874665|58988703|FG000|Overall Study|Clinical Progressive Disease|4|||
30945872|NCT01874665|58988704|FG001|Overall Study|Clinical Progressive Disease|3|||
30945873|NCT01874665|58988703|FG000|Overall Study|Study Terminated by Sponsor|0|||
30945874|NCT01874665|58988704|FG001|Overall Study|Study Terminated by Sponsor|2|||
30945875|NCT01874665|58988703|FG000|Overall Study|Documented Progressive Disease|11|||
30945876|NCT01874665|58988704|FG001|Overall Study|Documented Progressive Disease|7|||
30945877|NCT01874665|58988703|FG000|Overall Study|Other|2|||
30945878|NCT01874665|58988704|FG001|Overall Study|Other|0|||
30945879|NCT01874431|58988719|FG000|Overall Study|Physician Decision|0|||
30945880|NCT01874431|58988720|FG001|Overall Study|Physician Decision|0|||
30945881|NCT01874431|58988721|FG002|Overall Study|Physician Decision|1|||
30945882|NCT01874431|58988722|FG003|Overall Study|Physician Decision|0|||
30945883|NCT01874431|58988723|FG004|Overall Study|Physician Decision|0|||
30945884|NCT01874431|58988724|FG005|Overall Study|Physician Decision|0|||
30945885|NCT01874431|58988725|FG006|Overall Study|Physician Decision|0|||
30945886|NCT01874431|58988726|FG007|Overall Study|Physician Decision|0|||
30945887|NCT01874431|58988719|FG000|Overall Study|Adverse Event|5|||
30945888|NCT01874431|58988720|FG001|Overall Study|Adverse Event|4|||
30945889|NCT01874431|58988721|FG002|Overall Study|Adverse Event|6|||
30945890|NCT01874431|58988722|FG003|Overall Study|Adverse Event|5|||
30945891|NCT01874431|58988723|FG004|Overall Study|Adverse Event|2|||
30945892|NCT01874431|58988724|FG005|Overall Study|Adverse Event|8|||
30945893|NCT01874431|58988725|FG006|Overall Study|Adverse Event|2|||
30945894|NCT01874431|58988726|FG007|Overall Study|Adverse Event|3|||
30945895|NCT01874431|58988719|FG000|Overall Study|Protocol Violation|1|||
30945896|NCT01874431|58988720|FG001|Overall Study|Protocol Violation|1|||
30945897|NCT01874431|58988721|FG002|Overall Study|Protocol Violation|1|||
30945898|NCT01874431|58988722|FG003|Overall Study|Protocol Violation|0|||
30945899|NCT01874431|58988723|FG004|Overall Study|Protocol Violation|3|||
30945900|NCT01874431|58988724|FG005|Overall Study|Protocol Violation|2|||
30945901|NCT01874431|58988725|FG006|Overall Study|Protocol Violation|1|||
30945902|NCT01874431|58988726|FG007|Overall Study|Protocol Violation|1|||
30945903|NCT01874431|58988719|FG000|Overall Study|Non-compliance|0|||
30945904|NCT01874431|58988720|FG001|Overall Study|Non-compliance|0|||
30945905|NCT01874431|58988721|FG002|Overall Study|Non-compliance|0|||
30945906|NCT01874431|58988722|FG003|Overall Study|Non-compliance|0|||
30945907|NCT01874431|58988723|FG004|Overall Study|Non-compliance|1|||
30945908|NCT01874431|58988724|FG005|Overall Study|Non-compliance|0|||
30945909|NCT01874431|58988725|FG006|Overall Study|Non-compliance|1|||
30945910|NCT01874431|58988726|FG007|Overall Study|Non-compliance|0|||
30945911|NCT01874431|58988719|FG000|Overall Study|Logistical difficulties|0|||
30945912|NCT01874431|58988720|FG001|Overall Study|Logistical difficulties|0|||
30945913|NCT01874431|58988721|FG002|Overall Study|Logistical difficulties|0|||
30945914|NCT01874431|58988722|FG003|Overall Study|Logistical difficulties|0|||
30945915|NCT01874431|58988723|FG004|Overall Study|Logistical difficulties|0|||
30945916|NCT01874431|58988724|FG005|Overall Study|Logistical difficulties|0|||
30945917|NCT01874431|58988725|FG006|Overall Study|Logistical difficulties|1|||
30945918|NCT01874431|58988726|FG007|Overall Study|Logistical difficulties|0|||
30945919|NCT01874431|58988719|FG000|Overall Study|Withdrawal by Subject|0|||
30945920|NCT01874431|58988720|FG001|Overall Study|Withdrawal by Subject|0|||
30945921|NCT01874431|58988721|FG002|Overall Study|Withdrawal by Subject|1|||
30945922|NCT01874431|58988722|FG003|Overall Study|Withdrawal by Subject|2|||
30945923|NCT01874431|58988723|FG004|Overall Study|Withdrawal by Subject|1|||
30945924|NCT01874431|58988724|FG005|Overall Study|Withdrawal by Subject|1|||
30945925|NCT01874431|58988725|FG006|Overall Study|Withdrawal by Subject|3|||
30945926|NCT01874431|58988726|FG007|Overall Study|Withdrawal by Subject|0|||
30945927|NCT01874431|58988719|FG000|Overall Study|Sponsor decision|0|||
30945928|NCT01874431|58988720|FG001|Overall Study|Sponsor decision|0|||
30945929|NCT01874431|58988721|FG002|Overall Study|Sponsor decision|0|||
30945930|NCT01874431|58988722|FG003|Overall Study|Sponsor decision|0|||
30945931|NCT01874431|58988723|FG004|Overall Study|Sponsor decision|1|||
30945932|NCT01874431|58988724|FG005|Overall Study|Sponsor decision|0|||
30945933|NCT01874431|58988725|FG006|Overall Study|Sponsor decision|0|||
30945934|NCT01874431|58988726|FG007|Overall Study|Sponsor decision|0|||
30945935|NCT01874431|58988719|FG000|Overall Study|Lost to Follow-up|0|||
30945936|NCT01874431|58988720|FG001|Overall Study|Lost to Follow-up|0|||
30945937|NCT01874431|58988721|FG002|Overall Study|Lost to Follow-up|1|||
30945938|NCT01874431|58988722|FG003|Overall Study|Lost to Follow-up|0|||
30945939|NCT01874431|58988723|FG004|Overall Study|Lost to Follow-up|0|||
30945940|NCT01874431|58988724|FG005|Overall Study|Lost to Follow-up|0|||
30945941|NCT01874431|58988725|FG006|Overall Study|Lost to Follow-up|0|||
30945942|NCT01874431|58988726|FG007|Overall Study|Lost to Follow-up|0|||
30945943|NCT01824355|58988744|FG000|Overall Study|Adverse Event|2|||
30945944|NCT01824355|58988744|FG000|Overall Study|unevaluable reference method results per|1|||
30945945|NCT01823341|58988752|FG000|Overall Study|Failed run-in|7|||
30945946|NCT01823341|58988752|FG000|Overall Study|Withdrawal by Subject|7|||
30945947|NCT01823341|58988752|FG000|Overall Study|Adverse Event|1|||
30945948|NCT01853137|58988761|FG000|Overall Study|Lost to Follow-up|4|||
30945949|NCT01853137|58988762|FG001|Overall Study|Lost to Follow-up|1|||
30945950|NCT01823107|58988769|FG000|Overall Study|Withdrawal by Subject|1|||
30945951|NCT01874275|58988775|FG000|Overall Study|Lost to Follow-up|1|||
30945952|NCT01874275|58988776|FG001|Overall Study|Lost to Follow-up|0|||
30945953|NCT01873729|58988788|FG000|Overall Study|Withdrawal by Subject|1|||
30945954|NCT01873495|58988792|FG000|Overall Study|Withdrawal by Subject|1|||
30945955|NCT01873495|58988792|FG000|Overall Study|Physician Decision|3|||
30945956|NCT01873495|58988792|FG000|Overall Study|Adverse Event|1|||
30945957|NCT01873495|58988792|FG000|Overall Study|Removed for Transplantation|1|||
30945958|NCT01873495|58988792|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
30945959|NCT01852825|58988799|FG000|Overall Study|Withdrawal by Subject|2|||
30945960|NCT01852825|58988800|FG001|Overall Study|Withdrawal by Subject|0|||
30945961|NCT01852825|58988801|FG002|Overall Study|Withdrawal by Subject|0|||
30945962|NCT01822561|58988809|FG000|Overall Study|Withdrawal by Subject|2|||
30945963|NCT01852591|58988834|FG000|Overall Study|Withdrawal by Subject|2|||
30945964|NCT01852591|58988834|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
30945965|NCT01852045|58988841|FG000|Overall Study|Adverse Event|1|||
30945966|NCT01852045|58988842|FG001|Overall Study|Adverse Event|0|||
30945967|NCT01852045|58988843|FG002|Overall Study|Adverse Event|0|||
30945968|NCT01852045|58988841|FG000|Overall Study|Lack of Efficacy|3|||
30945969|NCT01852045|58988842|FG001|Overall Study|Lack of Efficacy|0|||
30945970|NCT01852045|58988843|FG002|Overall Study|Lack of Efficacy|0|||
30945971|NCT01852045|58988841|FG000|Overall Study|Lost to Follow-up|0|||
30945972|NCT01852045|58988842|FG001|Overall Study|Lost to Follow-up|1|||
30945973|NCT01852045|58988843|FG002|Overall Study|Lost to Follow-up|1|||
30945974|NCT01852045|58988841|FG000|Overall Study|Withdrawal by Subject|1|||
30945975|NCT01852045|58988842|FG001|Overall Study|Withdrawal by Subject|0|||
30945976|NCT01852045|58988843|FG002|Overall Study|Withdrawal by Subject|1|||
30945977|NCT01852045|58988841|FG000|Overall Study|Other Miscellaneous Reasons|1|||
30945978|NCT01852045|58988842|FG001|Overall Study|Other Miscellaneous Reasons|3|||
30945979|NCT01852045|58988843|FG002|Overall Study|Other Miscellaneous Reasons|2|||
30945980|NCT01821937|58988862|FG000|Overall Study|Adverse Event|0|||
30945981|NCT01821937|58988863|FG001|Overall Study|Adverse Event|3|||
30945982|NCT01821625|58988871|FG000|Overall Study|Withdrawal by Subject|2|||
30945983|NCT01821625|58988871|FG000|Overall Study|Lack of Efficacy|2|||
30945984|NCT01821625|58988871|FG000|Overall Study|Adverse Event|1|||
30945985|NCT01821625|58988871|FG000|Overall Study|Medical contraindication|1|||
30945986|NCT01821391|58988877|FG000|Overall Study|Adverse Event|1|||
30945987|NCT01821391|58988878|FG001|Overall Study|Adverse Event|0|||
30945988|NCT01873417|58988886|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
30945989|NCT01873417|58988886|FG000|Overall Study|Adverse Event|24|||
30945990|NCT01873417|58988886|FG000|Overall Study|Lost to Follow-up|2|||
30945991|NCT01873417|58988886|FG000|Overall Study|Withdrawal by Subject|2|||
30945992|NCT01873417|58988886|FG000|Overall Study|Physician Decision|3|||
30945993|NCT01872715|58988890|FG000|Overall Study|Adverse Event|1|||
30945994|NCT01872715|58988890|FG000|Overall Study|Protocol Violation|1|||
30945995|NCT01872715|58988890|FG000|Overall Study|Withdrawal by Subject|2|||
30842912|NCT02672852|58868893|FG001|Part A1|Withdrawal by Subject|1|||
30945996|NCT01871545|58988906|FG000|Overall Study|Death|2|||
30945997|NCT01871545|58988907|FG001|Overall Study|Death|0|||
30945998|NCT01871545|58988906|FG000|Overall Study|Lack of Efficacy|11|||
30945999|NCT01871545|58988907|FG001|Overall Study|Lack of Efficacy|2|||
30946000|NCT01871545|58988906|FG000|Overall Study|Physician Decision|4|||
30946001|NCT01871545|58988907|FG001|Overall Study|Physician Decision|0|||
30946002|NCT01871545|58988906|FG000|Overall Study|Withdrawal by Subject|0|||
30946003|NCT01871545|58988907|FG001|Overall Study|Withdrawal by Subject|1|||
30946004|NCT01613599|58988916|FG000|Overall Study|Death|9|||
30946005|NCT01613599|58988916|FG000|Overall Study|Lost to Follow-up|5|||
30946006|NCT01613599|58988916|FG000|Overall Study|Withdrawal by Subject|8|||
30946007|NCT01613599|58988916|FG000|Overall Study|Reason not specified|3|||
30946008|NCT01850641|58988920|FG000|Overall Study|Physician Decision|1|||
30948568|NCT01973231|58994582|FG000|Overall Study|unclassified|2|||
30946009|NCT01850641|58988920|FG000|Overall Study|Decrease in serum phosphorus|1|||
30946010|NCT01850641|58988920|FG000|Overall Study|Decrease in serum calcium|2|||
30946011|NCT01850641|58988920|FG000|Overall Study|Increase in serum ferritin|1|||
30946012|NCT01850563|58988926|FG000|Overall Study|Not eligible|3|||
30946013|NCT01850563|58988927|FG001|Overall Study|Not eligible|0|||
30946014|NCT01819129|58988940|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
30946015|NCT01819129|58988941|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
30946016|NCT01819129|58988940|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
30946017|NCT01819129|58988941|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
30946018|NCT01819129|58988940|FG000|Overall Study|Other, Subject moved out of the country|0|||
30946019|NCT01819129|58988941|FG001|Overall Study|Other, Subject moved out of the country|1|||
30946020|NCT01819129|58988940|FG000|Overall Study|Withdrawal by Subject|15|||
30946021|NCT01819129|58988941|FG001|Overall Study|Withdrawal by Subject|15|||
30946022|NCT01819129|58988940|FG000|Overall Study|Lost to Follow-up|5|||
30946023|NCT01819129|58988941|FG001|Overall Study|Lost to Follow-up|2|||
30946024|NCT01819129|58988940|FG000|Overall Study|Lack of Efficacy|0|||
30946025|NCT01819129|58988941|FG001|Overall Study|Lack of Efficacy|1|||
30946026|NCT01819129|58988940|FG000|Overall Study|Adverse Event|1|||
30946027|NCT01819129|58988941|FG001|Overall Study|Adverse Event|4|||
30946028|NCT01819129|58988940|FG000|Overall Study|Death|1|||
30946029|NCT01819129|58988941|FG001|Overall Study|Death|1|||
30946030|NCT01819129|58988940|FG000|Overall Study|Withdrawal Criteria|20|||
30946031|NCT01819129|58988941|FG001|Overall Study|Withdrawal Criteria|15|||
30946032|NCT04022889|58988949|FG000|Stage 1: Period 1|Adverse Event|1|||
30946033|NCT04022889|58988950|FG001|Stage 1: Period 1|Adverse Event|0|||
30946034|NCT04022889|58988951|FG002|Stage 1: Period 1|Adverse Event|0|||
30946035|NCT04022889|58988949|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
30946036|NCT04022889|58988950|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
30946037|NCT04022889|58988951|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
30946038|NCT04022889|58988949|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
30946039|NCT04022889|58988950|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
30946040|NCT04022889|58988951|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
30946041|NCT04022889|58988949|FG000|Stage 2|Screen Failure|0|||
30946042|NCT04022889|58988950|FG001|Stage 2|Screen Failure|0|||
30946043|NCT04022889|58988951|FG002|Stage 2|Screen Failure|3|||
30946044|NCT04022889|58988949|FG000|Stage 2|Ineligible for apheresis donation|0|||
30946045|NCT04022889|58988950|FG001|Stage 2|Ineligible for apheresis donation|0|||
30946046|NCT04022889|58988951|FG002|Stage 2|Ineligible for apheresis donation|2|||
30946047|NCT04022889|58988949|FG000|Stage 2|Adverse Event|0|||
30946048|NCT04022889|58988950|FG001|Stage 2|Adverse Event|0|||
30946049|NCT04022889|58988951|FG002|Stage 2|Adverse Event|2|||
30946050|NCT04022889|58988949|FG000|Stage 2|Protocol Violation|0|||
30946051|NCT04022889|58988950|FG001|Stage 2|Protocol Violation|0|||
30946052|NCT04022889|58988951|FG002|Stage 2|Protocol Violation|1|||
30946053|NCT04022889|58988949|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
30946054|NCT04022889|58988950|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
30946055|NCT04022889|58988951|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
30946056|NCT01849783|58988983|FG000|Overall Study|Adverse Event|5|||
30946057|NCT01849783|58988983|FG000|Overall Study|Death|2|||
30946058|NCT01849783|58988983|FG000|Overall Study|Physician Decision|1|||
30946059|NCT01849783|58988983|FG000|Overall Study|Withdrawal by Subject|1|||
30946060|NCT01849783|58988983|FG000|Overall Study|Unable to comply|2|||
30946061|NCT01849783|58988983|FG000|Overall Study|Disease progression|11|||
30946062|NCT01611883|58988995|FG000|Overall Study|Adverse Event|1|||
30946063|NCT01611883|58988996|FG001|Overall Study|Adverse Event|1|||
30946064|NCT01848457|58989006|FG000|Overall Study|Death|1|||
30946065|NCT01848457|58989007|FG001|Overall Study|Death|0|||
30946066|NCT01848457|58989008|FG002|Overall Study|Death|0|||
30946067|NCT01848457|58989009|FG003|Overall Study|Death|0|||
30946068|NCT01817959|58989029|FG000|Overall Study|Graft loss|1|||
30946069|NCT01817959|58989030|FG001|Overall Study|Graft loss|1|||
30946070|NCT01817959|58989029|FG000|Overall Study|forbidden medication|1|||
30946071|NCT01817959|58989030|FG001|Overall Study|forbidden medication|1|||
30624572|NCT00952341|58636710|FG001|Cycle 1|Lost to Follow-up|2|||
30624573|NCT00952341|58636709|FG000|Cycle 1|Physician Decision|0|||
30624574|NCT00952341|58636710|FG001|Cycle 1|Physician Decision|1|||
30946072|NCT01817959|58989029|FG000|Overall Study|Adverse Event|1|||
30946073|NCT01817959|58989030|FG001|Overall Study|Adverse Event|0|||
30946074|NCT01817959|58989029|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
30946075|NCT01817959|58989030|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
30946076|NCT01817725|58989036|FG000|Overall Study|Withdrawal by Subject|1|||
30946077|NCT01870999|58989043|FG000|Overall Study|Adverse Event|0|||
30946078|NCT01870999|58989044|FG001|Overall Study|Adverse Event|4|||
30946079|NCT01870999|58989045|FG002|Overall Study|Adverse Event|1|||
30946080|NCT01870999|58989043|FG000|Overall Study|Subject met withdrawal criteria|3|||
30946081|NCT01870999|58989044|FG001|Overall Study|Subject met withdrawal criteria|2|||
30946082|NCT01870999|58989045|FG002|Overall Study|Subject met withdrawal criteria|0|||
30946083|NCT01870999|58989043|FG000|Overall Study|Subject withdrawn by Investigator|1|||
30946084|NCT01870999|58989044|FG001|Overall Study|Subject withdrawn by Investigator|0|||
30946085|NCT01870999|58989045|FG002|Overall Study|Subject withdrawn by Investigator|0|||
30946086|NCT01870999|58989043|FG000|Overall Study|Withdrawal by Subject|0|||
30946087|NCT01870999|58989044|FG001|Overall Study|Withdrawal by Subject|2|||
30946088|NCT01870999|58989045|FG002|Overall Study|Withdrawal by Subject|5|||
30946089|NCT01870999|58989043|FG000|Overall Study|Protocol Violation|0|||
30946090|NCT01870999|58989044|FG001|Overall Study|Protocol Violation|0|||
30946091|NCT01870999|58989045|FG002|Overall Study|Protocol Violation|1|||
30946092|NCT01870921|58989053|FG000|Overall Study|Subject decision|80|||
30946093|NCT01870921|58989053|FG000|Overall Study|Severe non-compliance to protocol|7|||
30946094|NCT01870921|58989053|FG000|Overall Study|Subject Lost to Follow up|2|||
30946095|NCT01870921|58989053|FG000|Overall Study|Other|1|||
30946096|NCT01848145|58989066|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
30946097|NCT01848145|58989066|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
30946098|NCT01848145|58989066|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
30946099|NCT01848145|58989066|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
30946100|NCT01848145|58989066|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
30946101|NCT01848145|58989066|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
30946102|NCT01848145|58989066|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
30946103|NCT01847755|58989070|FG000|Overall Study|Adverse Event|2|||
30946104|NCT01847755|58989070|FG000|Overall Study|Withdrawal by Subject|2|||
30946105|NCT01847755|58989070|FG000|Overall Study|Physician Decision|1|||
30946106|NCT01847443|58989101|FG000|Study Period 1|Withdrawal by Subject|0|||
30946107|NCT01847443|58989102|FG001|Study Period 1|Withdrawal by Subject|1|||
30946108|NCT01847443|58989103|FG002|Study Period 1|Withdrawal by Subject|0|||
30946109|NCT01847443|58989104|FG003|Study Period 1|Withdrawal by Subject|0|||
30946110|NCT01847443|58989101|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
30946111|NCT01847443|58989102|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
30946112|NCT01847443|58989103|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
30946113|NCT01847443|58989104|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
30946114|NCT01847443|58989101|FG000|Washout Period Before Study Period 2|Other reason|1|||
30624575|NCT00952341|58636709|FG000|Cycle 2|Withdrawal by Subject|1|||
30946115|NCT01847443|58989102|FG001|Washout Period Before Study Period 2|Other reason|0|||
30946116|NCT01847443|58989103|FG002|Washout Period Before Study Period 2|Other reason|0|||
30946117|NCT01847443|58989104|FG003|Washout Period Before Study Period 2|Other reason|0|||
30946118|NCT01847443|58989101|FG000|Washout Period Before Study Period 3|Other reason|1|||
30946119|NCT01847443|58989102|FG001|Washout Period Before Study Period 3|Other reason|0|||
30946120|NCT01847443|58989103|FG002|Washout Period Before Study Period 3|Other reason|0|||
30946121|NCT01847443|58989104|FG003|Washout Period Before Study Period 3|Other reason|0|||
30946122|NCT01847443|58989101|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
30946123|NCT01847443|58989102|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
30946124|NCT01847443|58989103|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
30946125|NCT01847443|58989104|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
30946126|NCT01847443|58989101|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
30946127|NCT01847443|58989102|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
30946128|NCT01847443|58989103|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
30946129|NCT01847443|58989104|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
30946130|NCT01847209|58989123|FG000|Overall Study|Withdrawal by Subject|1|||
30946131|NCT01847209|58989123|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
30946132|NCT01846741|58989127|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
30946133|NCT01870843|58989166|FG000|Overall Study|Adverse Event|10|||
30946134|NCT01870843|58989166|FG000|Overall Study|Lost to Follow-up|24|||
30946135|NCT01870843|58989166|FG000|Overall Study|Death|1|||
30946136|NCT01870843|58989166|FG000|Overall Study|Withdrawal by Subject|18|||
30946137|NCT01816477|58989172|FG000|Overall Study|Withdrawal by Subject|13|||
30946138|NCT01816477|58989173|FG001|Overall Study|Withdrawal by Subject|1|||
30946139|NCT01816477|58989172|FG000|Overall Study|Unable to tolerate catheter placement|3|||
30946140|NCT01816477|58989173|FG001|Overall Study|Unable to tolerate catheter placement|0|||
30946141|NCT01846507|58989179|FG000|Overall Study|Lost to Follow-up|4|||
30946142|NCT01846507|58989179|FG000|Overall Study|Protocol Violation|1|||
30946143|NCT01846507|58989179|FG000|Overall Study|Missing data|2|||
30946144|NCT01846039|58989185|FG000|Overall Study|Protocol Violation|1|||
30946145|NCT01846039|58989185|FG000|Overall Study|Subject Withdrew Consent|1|||
30946146|NCT01610167|58989192|FG000|Overall Study|Scheduling conflict.|0|||
30946147|NCT01610167|58989193|FG001|Overall Study|Scheduling conflict.|0|||
30946148|NCT01610167|58989194|FG002|Overall Study|Scheduling conflict.|2|||
30946149|NCT01816243|58989202|FG000|Overall Study|Adverse Event|6|||
30946150|NCT01816243|58989202|FG000|Overall Study|Lost to Follow-up|1|||
30946151|NCT01816243|58989202|FG000|Overall Study|Lack of Efficacy|1|||
30946152|NCT01816243|58989202|FG000|Overall Study|Not eligible for the study|1|||
30946153|NCT01816243|58989202|FG000|Overall Study|Amputation|3|||
30946154|NCT01845805|58989208|FG000|Overall Study|Withdrawal by Subject|1|||
30946155|NCT01845805|58989209|FG001|Overall Study|Withdrawal by Subject|2|||
30946156|NCT01845805|58989208|FG000|Overall Study|Disease Progression|13|||
30946157|NCT01845805|58989209|FG001|Overall Study|Disease Progression|14|||
30946158|NCT01845805|58989208|FG000|Overall Study|Drug-related Toxicity|4|||
30946159|NCT01845805|58989209|FG001|Overall Study|Drug-related Toxicity|0|||
30946160|NCT01845025|58989217|FG000|Overall Study|Adverse Event|6|||
30946161|NCT01845025|58989218|FG001|Overall Study|Adverse Event|3|||
30946162|NCT01845025|58989217|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
30946163|NCT01845025|58989218|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30946164|NCT01845025|58989217|FG000|Overall Study|Withdrawal by Subject|48|||
30624576|NCT00952341|58636710|FG001|Cycle 2|Withdrawal by Subject|1|||
30624577|NCT00952341|58636709|FG000|Cycle 2|Protocol Violation|1|||
30946165|NCT01845025|58989218|FG001|Overall Study|Withdrawal by Subject|44|||
30946166|NCT01845025|58989217|FG000|Overall Study|Lost to Follow-up|13|||
30946167|NCT01845025|58989218|FG001|Overall Study|Lost to Follow-up|13|||
30946168|NCT01845025|58989217|FG000|Overall Study|Administrative problems|8|||
30946169|NCT01845025|58989218|FG001|Overall Study|Administrative problems|8|||
30946170|NCT01845025|58989217|FG000|Overall Study|Death|2|||
30946171|NCT01845025|58989218|FG001|Overall Study|Death|0|||
30946172|NCT01845025|58989217|FG000|Overall Study|Protocol deviation|3|||
30946173|NCT01845025|58989218|FG001|Overall Study|Protocol deviation|6|||
30946174|NCT01845025|58989217|FG000|Overall Study|Missing|1|||
30946175|NCT01845025|58989218|FG001|Overall Study|Missing|1|||
30946176|NCT01870297|58989259|FG000|Overall Study|Adverse Event|0|||
30946177|NCT01870297|58989260|FG001|Overall Study|Adverse Event|0|||
30946178|NCT01870297|58989261|FG002|Overall Study|Adverse Event|0|||
30946179|NCT01870297|58989262|FG003|Overall Study|Adverse Event|0|||
30946180|NCT01870297|58989263|FG004|Overall Study|Adverse Event|2|||
30946181|NCT01870297|58989264|FG005|Overall Study|Adverse Event|0|||
30946182|NCT01870297|58989265|FG006|Overall Study|Adverse Event|0|||
30946183|NCT01870297|58989259|FG000|Overall Study|Lost to Follow-up|0|||
30946184|NCT01870297|58989260|FG001|Overall Study|Lost to Follow-up|1|||
30946185|NCT01870297|58989261|FG002|Overall Study|Lost to Follow-up|1|||
30946186|NCT01870297|58989262|FG003|Overall Study|Lost to Follow-up|0|||
30946187|NCT01870297|58989263|FG004|Overall Study|Lost to Follow-up|0|||
30624578|NCT00952341|58636710|FG001|Cycle 2|Protocol Violation|0|||
30624579|NCT00952341|58636709|FG000|Cycle 2|Lost to Follow-up|6|||
30624580|NCT00952341|58636710|FG001|Cycle 2|Lost to Follow-up|9|||
30624581|NCT00952341|58636709|FG000|Cycle 2|Physician Decision|1|||
30624582|NCT00952341|58636710|FG001|Cycle 2|Physician Decision|1|||
30946188|NCT01870297|58989264|FG005|Overall Study|Lost to Follow-up|0|||
30946189|NCT01870297|58989265|FG006|Overall Study|Lost to Follow-up|0|||
30946190|NCT01870297|58989259|FG000|Overall Study|Withdrawal by Subject|0|||
30946191|NCT01870297|58989260|FG001|Overall Study|Withdrawal by Subject|0|||
30946192|NCT01870297|58989261|FG002|Overall Study|Withdrawal by Subject|0|||
30946193|NCT01870297|58989262|FG003|Overall Study|Withdrawal by Subject|0|||
30946194|NCT01870297|58989263|FG004|Overall Study|Withdrawal by Subject|1|||
30946195|NCT01870297|58989264|FG005|Overall Study|Withdrawal by Subject|1|||
30946196|NCT01870297|58989265|FG006|Overall Study|Withdrawal by Subject|1|||
30946197|NCT01870297|58989259|FG000|Overall Study|Sponsor Decision|0|||
30624583|NCT00952341|58636709|FG000|Cycle 2|Progressive Disease|0|||
30624584|NCT00952341|58636710|FG001|Cycle 2|Progressive Disease|1|||
30624585|NCT00946881|58636716|FG000|First Treatment|Withdrawal by Subject|1|||
30624586|NCT00946881|58636716|FG000|First Treatment|Patient relocated to another state|1|||
30624587|NCT00946881|58636716|FG000|Retreatment|Withdrawal by Subject|1|||
30624588|NCT01214642|58636753|FG000|Overall Study|Progressive Disease|3|||
30624589|NCT01214642|58636754|FG001|Overall Study|Progressive Disease|2|||
30624590|NCT01214642|58636755|FG002|Overall Study|Progressive Disease|3|||
30624591|NCT01214642|58636756|FG003|Overall Study|Progressive Disease|5|||
30624592|NCT01214642|58636757|FG004|Overall Study|Progressive Disease|5|||
30946198|NCT01870297|58989260|FG001|Overall Study|Sponsor Decision|6|||
30946199|NCT01870297|58989261|FG002|Overall Study|Sponsor Decision|0|||
30946200|NCT01870297|58989262|FG003|Overall Study|Sponsor Decision|0|||
30946201|NCT01870297|58989263|FG004|Overall Study|Sponsor Decision|0|||
30946202|NCT01870297|58989264|FG005|Overall Study|Sponsor Decision|0|||
30946203|NCT01870297|58989265|FG006|Overall Study|Sponsor Decision|1|||
30946204|NCT01814761|58989292|FG000|Overall Study|Other Reasons|1|||
30946205|NCT01814761|58989293|FG001|Overall Study|Other Reasons|10|||
30946206|NCT01814761|58989292|FG000|Overall Study|Ocular Adverse Event|6|||
30946207|NCT01814761|58989293|FG001|Overall Study|Ocular Adverse Event|15|||
30946208|NCT01814761|58989292|FG000|Overall Study|Lost to Follow-up|1|||
30946209|NCT01814761|58989293|FG001|Overall Study|Lost to Follow-up|5|||
30946210|NCT01843933|58989301|FG000|Overall Study|Data lost|6|||
30946211|NCT01843933|58989302|FG001|Overall Study|Data lost|4|||
30624593|NCT01214642|58636758|FG005|Overall Study|Progressive Disease|3|||
30624594|NCT01214642|58636759|FG006|Overall Study|Progressive Disease|5|||
30624595|NCT01214642|58636760|FG007|Overall Study|Progressive Disease|3|||
30624596|NCT01214642|58636761|FG008|Overall Study|Progressive Disease|10|||
30624597|NCT01214642|58636762|FG009|Overall Study|Progressive Disease|2|||
30624598|NCT01214642|58636763|FG010|Overall Study|Progressive Disease|1|||
30624599|NCT01214642|58636764|FG011|Overall Study|Progressive Disease|4|||
30624600|NCT01214642|58636753|FG000|Overall Study|Adverse Event|0|||
30624601|NCT01214642|58636754|FG001|Overall Study|Adverse Event|1|||
30624602|NCT01214642|58636755|FG002|Overall Study|Adverse Event|0|||
30624603|NCT01214642|58636756|FG003|Overall Study|Adverse Event|0|||
30624604|NCT01214642|58636757|FG004|Overall Study|Adverse Event|0|||
30946212|NCT01814371|58989310|FG000|Overall Study|Lost to Follow-up|30|||
30946213|NCT01814371|58989311|FG001|Overall Study|Lost to Follow-up|27|||
30946214|NCT01814137|58989385|FG000|Overall Study|Adverse Event|0|||
30946215|NCT01814137|58989386|FG001|Overall Study|Adverse Event|1|||
30624605|NCT01214642|58636758|FG005|Overall Study|Adverse Event|0|||
30624606|NCT01214642|58636759|FG006|Overall Study|Adverse Event|1|||
30946216|NCT01814137|58989385|FG000|Overall Study|Withdrawal by Subject|2|||
30946217|NCT01814137|58989386|FG001|Overall Study|Withdrawal by Subject|2|||
30946218|NCT01814137|58989385|FG000|Overall Study|Physician Decision|1|||
30946219|NCT01814137|58989386|FG001|Overall Study|Physician Decision|1|||
30946220|NCT01814137|58989385|FG000|Overall Study|Unclassified|2|||
30946221|NCT01814137|58989386|FG001|Overall Study|Unclassified|1|||
30946222|NCT01813435|58989403|FG000|Overall Study|did not finish experimental regimen|1902|||
30946223|NCT01813435|58989404|FG001|Overall Study|did not finish experimental regimen|770|||
30624607|NCT01214642|58636760|FG007|Overall Study|Adverse Event|0|||
30624608|NCT01214642|58636761|FG008|Overall Study|Adverse Event|0|||
30624609|NCT01214642|58636762|FG009|Overall Study|Adverse Event|1|||
30624610|NCT01214642|58636763|FG010|Overall Study|Adverse Event|1|||
30624611|NCT01214642|58636764|FG011|Overall Study|Adverse Event|0|||
30624612|NCT01214642|58636753|FG000|Overall Study|Death|0|||
30624613|NCT01214642|58636754|FG001|Overall Study|Death|0|||
30624614|NCT01214642|58636755|FG002|Overall Study|Death|1|||
30624615|NCT01214642|58636756|FG003|Overall Study|Death|0|||
30624616|NCT01214642|58636757|FG004|Overall Study|Death|0|||
30624617|NCT01214642|58636758|FG005|Overall Study|Death|0|||
30624618|NCT01214642|58636759|FG006|Overall Study|Death|0|||
30624619|NCT01214642|58636760|FG007|Overall Study|Death|0|||
30624620|NCT01214642|58636761|FG008|Overall Study|Death|0|||
30624621|NCT01214642|58636762|FG009|Overall Study|Death|0|||
30624622|NCT01214642|58636763|FG010|Overall Study|Death|1|||
30624623|NCT01214642|58636764|FG011|Overall Study|Death|0|||
30624624|NCT01214642|58636753|FG000|Overall Study|Withdrawal by Subject|0|||
30624625|NCT01214642|58636754|FG001|Overall Study|Withdrawal by Subject|0|||
30624626|NCT01214642|58636755|FG002|Overall Study|Withdrawal by Subject|1|||
30624627|NCT01214642|58636756|FG003|Overall Study|Withdrawal by Subject|0|||
30624628|NCT01214642|58636757|FG004|Overall Study|Withdrawal by Subject|0|||
30624629|NCT01214642|58636758|FG005|Overall Study|Withdrawal by Subject|0|||
30624630|NCT01214642|58636759|FG006|Overall Study|Withdrawal by Subject|0|||
30624631|NCT01214642|58636760|FG007|Overall Study|Withdrawal by Subject|0|||
30624632|NCT01214642|58636761|FG008|Overall Study|Withdrawal by Subject|3|||
30624633|NCT01214642|58636762|FG009|Overall Study|Withdrawal by Subject|1|||
30624634|NCT01214642|58636763|FG010|Overall Study|Withdrawal by Subject|1|||
30624635|NCT01214642|58636764|FG011|Overall Study|Withdrawal by Subject|0|||
30624636|NCT01214642|58636753|FG000|Overall Study|Physician Decision|0|||
30624637|NCT01214642|58636754|FG001|Overall Study|Physician Decision|0|||
30624638|NCT01214642|58636755|FG002|Overall Study|Physician Decision|1|||
30624639|NCT01214642|58636756|FG003|Overall Study|Physician Decision|1|||
30624640|NCT01214642|58636757|FG004|Overall Study|Physician Decision|1|||
30624641|NCT01214642|58636758|FG005|Overall Study|Physician Decision|0|||
30624642|NCT01214642|58636759|FG006|Overall Study|Physician Decision|0|||
30624643|NCT01214642|58636760|FG007|Overall Study|Physician Decision|0|||
30624644|NCT01214642|58636761|FG008|Overall Study|Physician Decision|0|||
30624645|NCT01214642|58636762|FG009|Overall Study|Physician Decision|0|||
30624646|NCT01214642|58636763|FG010|Overall Study|Physician Decision|0|||
30842913|NCT02672852|58868894|FG002|Part A1|Withdrawal by Subject|0|||
30842914|NCT02672852|58868895|FG003|Part A1|Withdrawal by Subject|0|||
30842915|NCT02672852|58868896|FG004|Part A1|Withdrawal by Subject|0|||
30842916|NCT02672852|58868897|FG005|Part A1|Withdrawal by Subject|0|||
30842917|NCT02672852|58868898|FG006|Part A1|Withdrawal by Subject|0|||
30842918|NCT02672852|58868892|FG000|Part A2|Disease worsening|0|||
30842919|NCT02672852|58868893|FG001|Part A2|Disease worsening|0|||
30842920|NCT02672852|58868894|FG002|Part A2|Disease worsening|1|||
30842921|NCT02672852|58868895|FG003|Part A2|Disease worsening|0|||
30842922|NCT02672852|58868896|FG004|Part A2|Disease worsening|0|||
30842923|NCT02672852|58868897|FG005|Part A2|Disease worsening|0|||
30842924|NCT02672852|58868898|FG006|Part A2|Disease worsening|0|||
30842925|NCT02672852|58868892|FG000|Part A2|Adverse Event|0|||
30842926|NCT02672852|58868893|FG001|Part A2|Adverse Event|0|||
30842927|NCT02672852|58868894|FG002|Part A2|Adverse Event|3|||
30842928|NCT02672852|58868895|FG003|Part A2|Adverse Event|0|||
30842929|NCT02672852|58868896|FG004|Part A2|Adverse Event|0|||
30842930|NCT02672852|58868897|FG005|Part A2|Adverse Event|0|||
30842931|NCT02672852|58868898|FG006|Part A2|Adverse Event|0|||
30842932|NCT02672852|58868892|FG000|Part A2|Lost to Follow-up|0|||
30842933|NCT02672852|58868893|FG001|Part A2|Lost to Follow-up|0|||
30842934|NCT02672852|58868894|FG002|Part A2|Lost to Follow-up|2|||
30842935|NCT02672852|58868895|FG003|Part A2|Lost to Follow-up|0|||
30842936|NCT02672852|58868896|FG004|Part A2|Lost to Follow-up|0|||
30624647|NCT01214642|58636764|FG011|Overall Study|Physician Decision|2|||
30624648|NCT01214252|58636807|FG000|Overall Study|Not eligible per protocol|82|||
30624649|NCT01214174|58636815|FG000|Overall Study|Withdrawal by Subject|0|||
30624650|NCT01214174|58636816|FG001|Overall Study|Withdrawal by Subject|0|||
30624651|NCT01214174|58636817|FG002|Overall Study|Withdrawal by Subject|1|||
30624652|NCT00901342|58636825|FG000|Overall Study|Adverse Event|1|||
30624653|NCT00901342|58636825|FG000|Overall Study|Death|4|||
30624654|NCT00901342|58636825|FG000|Overall Study|Disease progression|1|||
30624655|NCT00901342|58636825|FG000|Overall Study|Withdrawal by Subject|9|||
30624656|NCT00901186|58636831|FG000|Overall Study|Lack of Efficacy|0|||
30624657|NCT00901186|58636832|FG001|Overall Study|Lack of Efficacy|1|||
30624658|NCT00901186|58636831|FG000|Overall Study|Abnormal laboratory values|0|||
30842937|NCT02672852|58868897|FG005|Part A2|Lost to Follow-up|0|||
30946224|NCT01813435|58989403|FG000|Overall Study|Lost to Follow-up|268|||
30624659|NCT00901186|58636832|FG001|Overall Study|Abnormal laboratory values|1|||
30842938|NCT02672852|58868898|FG006|Part A2|Lost to Follow-up|0|||
30842939|NCT02672852|58868892|FG000|Part A2|Withdrawal by Subject|0|||
30842940|NCT02672852|58868893|FG001|Part A2|Withdrawal by Subject|0|||
30842941|NCT02672852|58868894|FG002|Part A2|Withdrawal by Subject|1|||
30624660|NCT00901186|58636831|FG000|Overall Study|Lost to Follow-up|2|||
30624661|NCT00901186|58636832|FG001|Overall Study|Lost to Follow-up|0|||
30624662|NCT00901186|58636831|FG000|Overall Study|Adverse Event|2|||
30624663|NCT00901186|58636832|FG001|Overall Study|Adverse Event|4|||
30624664|NCT00901186|58636831|FG000|Overall Study|Administration problems|0|||
30624665|NCT00901186|58636832|FG001|Overall Study|Administration problems|1|||
30624666|NCT00901186|58636831|FG000|Overall Study|Protocol deviations|5|||
30624667|NCT00901186|58636832|FG001|Overall Study|Protocol deviations|4|||
30624668|NCT01213472|58636838|FG000|Overall Study|Recurrence/Progressive disease|25|||
30624669|NCT01213472|58636838|FG000|Overall Study|Withdrawal by Subject|1|||
30624670|NCT01213472|58636838|FG000|Overall Study|Physician Decision|1|||
30624671|NCT00900796|58636842|FG000|Phase 1|Lacked sufficient information|4|||
30624672|NCT00900796|58636842|FG000|Phase 1|Missing information at Week 16|7|||
30624673|NCT00900796|58636842|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
30624674|NCT00900796|58636842|FG000|Phase 2|Lost to Follow-up|5|||
30624675|NCT01213082|58636850|FG000|Overall Study|Lost to Follow-up|6|||
30624676|NCT01213082|58636851|FG001|Overall Study|Lost to Follow-up|7|||
30624677|NCT01213082|58636852|FG002|Overall Study|Lost to Follow-up|4|||
30624678|NCT01213082|58636850|FG000|Overall Study|Physician Decision|0|||
30624679|NCT01213082|58636851|FG001|Overall Study|Physician Decision|0|||
30624680|NCT01213082|58636852|FG002|Overall Study|Physician Decision|1|||
30624681|NCT00885703|58636867|FG000|Overall Study|Death|9|||
30624682|NCT00885703|58636868|FG001|Overall Study|Death|7|||
30624683|NCT00885703|58636869|FG002|Overall Study|Death|8|||
30624684|NCT00885703|58636870|FG003|Overall Study|Death|7|||
30624685|NCT00885703|58636871|FG004|Overall Study|Death|7|||
30624686|NCT00885703|58636872|FG005|Overall Study|Death|8|||
30946225|NCT01813435|58989404|FG001|Overall Study|Lost to Follow-up|237|||
30946226|NCT01813357|58989412|FG000|Overall Study|Lost to Follow-up|5|||
30946227|NCT01813357|58989413|FG001|Overall Study|Lost to Follow-up|6|||
30946228|NCT01812655|58989422|FG000|Overall Study|Protocol Violation|1|||
30946229|NCT01812655|58989423|FG001|Overall Study|Protocol Violation|1|||
30946230|NCT01812655|58989424|FG002|Overall Study|Protocol Violation|0|||
30946231|NCT01812109|58989445|FG000|Overall Study|research personnel delay|16|||
30946232|NCT01812109|58989445|FG000|Overall Study|NIRS Unattainable|17|||
30946233|NCT01811953|58989455|FG000|Overall Study|Adverse Event|0|||
30946234|NCT01811953|58989456|FG001|Overall Study|Adverse Event|0|||
30946235|NCT01811953|58989457|FG002|Overall Study|Adverse Event|0|||
30946236|NCT01811953|58989458|FG003|Overall Study|Adverse Event|1|||
30946237|NCT01811953|58989459|FG004|Overall Study|Adverse Event|0|||
30946238|NCT01811953|58989460|FG005|Overall Study|Adverse Event|1|||
30946239|NCT01811953|58989455|FG000|Overall Study|Protocol Violation|0|||
30946240|NCT01811953|58989456|FG001|Overall Study|Protocol Violation|0|||
30946241|NCT01811953|58989457|FG002|Overall Study|Protocol Violation|0|||
30624687|NCT00885703|58636873|FG006|Overall Study|Death|4|||
30624688|NCT00885703|58636867|FG000|Overall Study|Lost to Follow-up|0|||
30624689|NCT00885703|58636868|FG001|Overall Study|Lost to Follow-up|0|||
30624690|NCT00885703|58636869|FG002|Overall Study|Lost to Follow-up|1|||
30624691|NCT00885703|58636870|FG003|Overall Study|Lost to Follow-up|0|||
30624692|NCT00885703|58636871|FG004|Overall Study|Lost to Follow-up|0|||
30624693|NCT00885703|58636872|FG005|Overall Study|Lost to Follow-up|1|||
30624694|NCT00885703|58636873|FG006|Overall Study|Lost to Follow-up|0|||
30624695|NCT00885703|58636867|FG000|Overall Study|Withdrawal by Subject|0|||
30624696|NCT00885703|58636868|FG001|Overall Study|Withdrawal by Subject|0|||
30624697|NCT00885703|58636869|FG002|Overall Study|Withdrawal by Subject|0|||
30624698|NCT00885703|58636870|FG003|Overall Study|Withdrawal by Subject|1|||
30624699|NCT00885703|58636871|FG004|Overall Study|Withdrawal by Subject|3|||
30624700|NCT00885703|58636872|FG005|Overall Study|Withdrawal by Subject|1|||
30946242|NCT01811953|58989458|FG003|Overall Study|Protocol Violation|0|||
30946243|NCT01811953|58989459|FG004|Overall Study|Protocol Violation|1|||
30946244|NCT01811953|58989460|FG005|Overall Study|Protocol Violation|0|||
30946245|NCT01811563|58989476|FG000|Overall Study|Lost to Follow-up|5|||
30624701|NCT00885703|58636873|FG006|Overall Study|Withdrawal by Subject|1|||
30624702|NCT00885703|58636867|FG000|Overall Study|Ineligible (no CM)|1|||
30624703|NCT00885703|58636868|FG001|Overall Study|Ineligible (no CM)|3|||
30624704|NCT00885703|58636869|FG002|Overall Study|Ineligible (no CM)|2|||
30842942|NCT02672852|58868895|FG003|Part A2|Withdrawal by Subject|0|||
30624705|NCT00885703|58636870|FG003|Overall Study|Ineligible (no CM)|1|||
30624706|NCT00885703|58636871|FG004|Overall Study|Ineligible (no CM)|2|||
30624707|NCT00885703|58636872|FG005|Overall Study|Ineligible (no CM)|3|||
30624708|NCT00885703|58636873|FG006|Overall Study|Ineligible (no CM)|1|||
30624709|NCT00901576|58636899|FG000|Second Intervention|Withdrawal by Subject|0|||
30946246|NCT01811563|58989477|FG001|Overall Study|Lost to Follow-up|2|||
30624710|NCT00901576|58636900|FG001|Second Intervention|Withdrawal by Subject|0|||
30624711|NCT00901576|58636901|FG002|Second Intervention|Withdrawal by Subject|0|||
30624712|NCT00901576|58636902|FG003|Second Intervention|Withdrawal by Subject|1|||
30946247|NCT01811563|58989476|FG000|Overall Study|Incorrect Randomization procedure|0|||
30946248|NCT01811563|58989477|FG001|Overall Study|Incorrect Randomization procedure|1|||
30624713|NCT00901576|58636903|FG004|Second Intervention|Withdrawal by Subject|0|||
30624714|NCT00901576|58636904|FG005|Second Intervention|Withdrawal by Subject|1|||
30624715|NCT00901576|58636899|FG000|Second Intervention|Physician Decision|1|||
30624716|NCT00901576|58636900|FG001|Second Intervention|Physician Decision|0|||
30624717|NCT00901576|58636901|FG002|Second Intervention|Physician Decision|0|||
30946249|NCT01811485|58989486|FG000|Overall Study|Adverse Event|1|||
30946250|NCT01811485|58989487|FG001|Overall Study|Adverse Event|3|||
30946251|NCT01811485|58989488|FG002|Overall Study|Adverse Event|2|||
30946252|NCT01811485|58989486|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30946253|NCT01811485|58989487|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30624718|NCT00901576|58636902|FG003|Second Intervention|Physician Decision|0|||
30624719|NCT00901576|58636903|FG004|Second Intervention|Physician Decision|0|||
30624720|NCT00901576|58636904|FG005|Second Intervention|Physician Decision|0|||
30624721|NCT00882583|58636914|FG000|Overall Study|Physician Decision|1|||
30624722|NCT00882583|58636915|FG001|Overall Study|Physician Decision|0|||
30624723|NCT00882583|58636914|FG000|Overall Study|Adverse Event|0|||
30624724|NCT00882583|58636915|FG001|Overall Study|Adverse Event|1|||
30624725|NCT00900562|58636923|FG000|Overall Study|Progressive disease|9|||
30624726|NCT00900562|58636924|FG001|Overall Study|Progressive disease|5|||
30624727|NCT00900562|58636923|FG000|Overall Study|Toxicity|1|||
30624728|NCT00900562|58636924|FG001|Overall Study|Toxicity|0|||
30624729|NCT00900562|58636923|FG000|Overall Study|Death|1|||
30624730|NCT00900562|58636924|FG001|Overall Study|Death|1|||
30624731|NCT00900562|58636923|FG000|Overall Study|Withdrawal by Subject|0|||
30624732|NCT00900562|58636924|FG001|Overall Study|Withdrawal by Subject|1|||
30624733|NCT00900562|58636923|FG000|Overall Study|Unrelated adverse event|1|||
30624734|NCT00900562|58636924|FG001|Overall Study|Unrelated adverse event|0|||
30624735|NCT00599521|58636933|FG000|Overall Study|Lack of Efficacy|4|||
30624736|NCT00599521|58636934|FG001|Overall Study|Lack of Efficacy|8|||
30624737|NCT00599521|58636933|FG000|Overall Study|Adverse Event|4|||
30624738|NCT00599521|58636934|FG001|Overall Study|Adverse Event|1|||
30624739|NCT00599521|58636933|FG000|Overall Study|Withdrawal by Subject|28|||
30624740|NCT00599521|58636934|FG001|Overall Study|Withdrawal by Subject|34|||
30624741|NCT00599521|58636933|FG000|Overall Study|Protocol Violation|1|||
30624742|NCT00599521|58636934|FG001|Overall Study|Protocol Violation|1|||
30624743|NCT00599521|58636933|FG000|Overall Study|Lost to Follow-up|23|||
30624744|NCT00599521|58636934|FG001|Overall Study|Lost to Follow-up|23|||
30624745|NCT00599521|58636933|FG000|Overall Study|Pregnancy|0|||
30624746|NCT00599521|58636934|FG001|Overall Study|Pregnancy|2|||
30624747|NCT00882115|58636940|FG000|Overall Study|Withdrawal by Subject|3|||
30624748|NCT00882115|58636940|FG000|Overall Study|did not respond to DEP challe|6|||
30624749|NCT00881959|58636946|FG000|Overall Study|Lost to Follow-up|2|||
30624750|NCT00881959|58636947|FG001|Overall Study|Lost to Follow-up|4|||
30624751|NCT00884377|58636955|FG000|Overall Study|Withdrawal by Subject|1|||
30624752|NCT00884377|58636956|FG001|Overall Study|Withdrawal by Subject|0|||
30624753|NCT00884377|58636955|FG000|Overall Study|Could not confirm diagnosis|1|||
30624754|NCT00884377|58636956|FG001|Overall Study|Could not confirm diagnosis|0|||
30624755|NCT00884377|58636955|FG000|Overall Study|Physician Decision|0|||
30624756|NCT00884377|58636956|FG001|Overall Study|Physician Decision|1|||
30624757|NCT00884221|58636970|FG000|Overall Study|Withdrawal by Subject|0|||
30624758|NCT00884221|58636971|FG001|Overall Study|Withdrawal by Subject|3|||
30624759|NCT00884221|58636970|FG000|Overall Study|Adverse Event|6|||
30624760|NCT00884221|58636971|FG001|Overall Study|Adverse Event|3|||
30624761|NCT00884221|58636970|FG000|Overall Study|Protocol Violation|16|||
30624762|NCT00884221|58636971|FG001|Overall Study|Protocol Violation|13|||
30624763|NCT00884221|58636970|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
30624764|NCT00884221|58636971|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
30624765|NCT00899548|58636992|FG000|Overall Study|Physician Decision|3|||
30624766|NCT00899392|58637002|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
30624767|NCT00899392|58637003|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
30624768|NCT00690898|58637009|FG000|SCREENING|Screen failure|18|||
30624769|NCT00690898|58637009|FG000|TREATMENT|Adverse Event|3|||
30624770|NCT00690898|58637009|FG000|TREATMENT|Lack of Efficacy|18|||
30624771|NCT00690898|58637009|FG000|TREATMENT|Withdrawal by Subject|4|||
30624772|NCT00690898|58637009|FG000|TREATMENT|Other (not otherwise specified)|1|||
30624773|NCT00895414|58637013|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
30624774|NCT00895414|58637014|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
30624775|NCT00895414|58637013|FG000|First Intervention (14 Days)|Physician Decision|0|||
30624776|NCT00895414|58637014|FG001|First Intervention (14 Days)|Physician Decision|1|||
30624777|NCT01212770|58637023|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
30624778|NCT01212770|58637024|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
30624779|NCT01212770|58637025|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
30624780|NCT01212770|58637026|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30624781|NCT01212770|58637027|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30624782|NCT01212770|58637028|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30842943|NCT02672852|58868896|FG004|Part A2|Withdrawal by Subject|0|||
30624783|NCT01212770|58637029|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30624784|NCT01212770|58637030|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30624785|NCT01212770|58637031|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30624786|NCT01212770|58637023|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
30624787|NCT01212770|58637024|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
30624788|NCT01212770|58637025|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
30624789|NCT01212770|58637026|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30624790|NCT01212770|58637027|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30624791|NCT01212770|58637028|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30624792|NCT01212770|58637029|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30624793|NCT01212770|58637030|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30624794|NCT01212770|58637031|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30624795|NCT01212770|58637023|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
30624796|NCT01212770|58637024|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
30624797|NCT01212770|58637025|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
30624798|NCT01212770|58637026|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30624799|NCT01212770|58637027|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30624800|NCT01212770|58637028|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30759869|NCT03560206|58768209|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
30759870|NCT03560206|58768208|FG000|Overall Study|Busy schedule|14|||
30946254|NCT01811485|58989488|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
30946255|NCT01811485|58989486|FG000|Overall Study|Administrative problems|1|||
30946256|NCT01811485|58989487|FG001|Overall Study|Administrative problems|0|||
30946257|NCT01811485|58989488|FG002|Overall Study|Administrative problems|0|||
30946258|NCT01811485|58989486|FG000|Overall Study|Protocol Deviation|0|||
30946259|NCT01811485|58989487|FG001|Overall Study|Protocol Deviation|1|||
30946260|NCT01811485|58989488|FG002|Overall Study|Protocol Deviation|0|||
30946261|NCT01810939|58989499|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
30946262|NCT01810939|58989500|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
30946263|NCT01810939|58989501|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
30946264|NCT01810939|58989499|FG000|Part A Treatment Period|Protocol Violation|2|||
30946265|NCT01810939|58989500|FG001|Part A Treatment Period|Protocol Violation|0|||
30946266|NCT01810939|58989501|FG002|Part A Treatment Period|Protocol Violation|0|||
30946267|NCT01810939|58989499|FG000|Part A Treatment Period|Adverse Event|10|||
30946268|NCT01810939|58989500|FG001|Part A Treatment Period|Adverse Event|0|||
30946269|NCT01810939|58989501|FG002|Part A Treatment Period|Adverse Event|0|||
30946270|NCT01810939|58989499|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
30946271|NCT01810939|58989500|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
30946272|NCT01810939|58989501|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
30946273|NCT01810939|58989499|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
30946274|NCT01810939|58989500|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
30946275|NCT01810939|58989501|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
30946276|NCT01810939|58989499|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
30759871|NCT03560206|58768209|FG001|Overall Study|Busy schedule|2|||
30759872|NCT03560206|58768208|FG000|Overall Study|patients' new health condition such as cancer|10|||
30759873|NCT03560206|58768209|FG001|Overall Study|patients' new health condition such as cancer|1|||
30759874|NCT02892760|58768215|FG000|Overall Study|Withdrawal by Subject|3|||
30759875|NCT03635086|58768224|FG000|Overall Study|Withdrawal of consent|0|||
30759876|NCT03635086|58768225|FG001|Overall Study|Withdrawal of consent|0|||
30759877|NCT03635086|58768226|FG002|Overall Study|Withdrawal of consent|1|||
30759878|NCT03635086|58768227|FG003|Overall Study|Withdrawal of consent|0|||
30759879|NCT03635086|58768228|FG004|Overall Study|Withdrawal of consent|0|||
30759880|NCT03635086|58768224|FG000|Overall Study|Adverse Event|0|||
30759881|NCT03635086|58768225|FG001|Overall Study|Adverse Event|1|||
30842944|NCT02672852|58868897|FG005|Part A2|Withdrawal by Subject|0|||
30842945|NCT02672852|58868898|FG006|Part A2|Withdrawal by Subject|0|||
30946277|NCT01810939|58989500|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
30946278|NCT01810939|58989501|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
30946279|NCT01810939|58989499|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
30946280|NCT01810939|58989500|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
30946281|NCT01810939|58989501|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
30946282|NCT01810939|58989499|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
30946283|NCT01810939|58989500|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
30946284|NCT01810939|58989501|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
30624801|NCT01212770|58637029|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30946285|NCT01810939|58989499|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
30946286|NCT01810939|58989500|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
30946287|NCT01810939|58989501|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
30946288|NCT01810939|58989499|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
30946289|NCT01810939|58989500|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
30946290|NCT01810939|58989501|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
30946291|NCT01810939|58989499|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
30946292|NCT01810939|58989500|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
30946293|NCT01810939|58989501|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
30946294|NCT01810939|58989499|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
30946295|NCT01810939|58989500|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
30946296|NCT01810939|58989501|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
30946297|NCT01810939|58989499|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
30946298|NCT01810939|58989500|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
30946299|NCT01810939|58989501|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
30946300|NCT01810939|58989499|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
30624802|NCT01212770|58637030|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30624803|NCT01212770|58637031|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30624804|NCT01212770|58637023|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
30946301|NCT01810939|58989500|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
30946302|NCT01810939|58989501|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
30946303|NCT01810939|58989499|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
30946304|NCT01810939|58989500|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
30946305|NCT01810939|58989501|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
30946306|NCT01810939|58989499|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
30946307|NCT01810939|58989500|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
30946308|NCT01810939|58989501|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
30946309|NCT01810939|58989499|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
30624805|NCT01212770|58637024|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30624806|NCT01212770|58637025|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
30624807|NCT01212770|58637026|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30624808|NCT01212770|58637027|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30624809|NCT01212770|58637028|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30759882|NCT03635086|58768226|FG002|Overall Study|Adverse Event|0|||
30759883|NCT03635086|58768227|FG003|Overall Study|Adverse Event|0|||
30759884|NCT03635086|58768228|FG004|Overall Study|Adverse Event|0|||
30759885|NCT03635086|58768224|FG000|Overall Study|Lost to Follow-up|1|||
30759886|NCT03635086|58768225|FG001|Overall Study|Lost to Follow-up|0|||
30759887|NCT03635086|58768226|FG002|Overall Study|Lost to Follow-up|0|||
30759888|NCT03635086|58768227|FG003|Overall Study|Lost to Follow-up|0|||
30759889|NCT03635086|58768228|FG004|Overall Study|Lost to Follow-up|0|||
30624810|NCT01212770|58637029|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30759890|NCT03588910|58768243|FG000|Overall Study|Withdrawal by Subject|1|||
30842946|NCT02672852|58868892|FG000|Part A2|Other|0|||
30842947|NCT02672852|58868893|FG001|Part A2|Other|0|||
30842948|NCT02672852|58868894|FG002|Part A2|Other|3|||
30842949|NCT02672852|58868895|FG003|Part A2|Other|0|||
30842950|NCT02672852|58868896|FG004|Part A2|Other|0|||
30842951|NCT02672852|58868897|FG005|Part A2|Other|0|||
30842952|NCT02672852|58868898|FG006|Part A2|Other|0|||
30842953|NCT02672852|58868892|FG000|Part A2|Not entered in Part B|0|||
30759891|NCT03588910|58768244|FG001|Overall Study|Withdrawal by Subject|0|||
30946310|NCT01810939|58989500|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
30946311|NCT01810939|58989501|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
30946312|NCT01810783|58989520|FG000|Overall Study|Adverse Event|32|||
30946313|NCT01810783|58989520|FG000|Overall Study|Withdrawal by Subject|22|||
30946314|NCT01810783|58989520|FG000|Overall Study|Lack of Efficacy|12|||
30946315|NCT01810783|58989520|FG000|Overall Study|Lost to Follow-up|10|||
30946316|NCT01810783|58989520|FG000|Overall Study|Protocol Violation|5|||
30946317|NCT01810783|58989520|FG000|Overall Study|Non-compliance with IMP|4|||
30946318|NCT01810783|58989520|FG000|Overall Study|Adminstrative or other reason(s)|23|||
30842954|NCT02672852|58868893|FG001|Part A2|Not entered in Part B|0|||
30842955|NCT02672852|58868894|FG002|Part A2|Not entered in Part B|0|||
30842956|NCT02672852|58868895|FG003|Part A2|Not entered in Part B|4|||
30946319|NCT01810783|58989520|FG000|Overall Study|Enrolled, not treated|1|||
30946320|NCT01808209|58989541|FG000|Overall Study|Lost to Follow-up|0|||
30946321|NCT01808209|58989542|FG001|Overall Study|Lost to Follow-up|1|||
30946322|NCT01807117|58989552|FG000|Overall Study|Physician Decision|2|||
30946323|NCT01807117|58989552|FG000|Overall Study|Disease diagnosis not a study disease|1|||
30946324|NCT01806961|58989558|FG000|Overall Study|sponsor decision|16|||
30946325|NCT01613131|58989564|FG000|Overall Study|Withdrawal by Subject|3|||
30946326|NCT01613131|58989565|FG001|Overall Study|Withdrawal by Subject|5|||
30946327|NCT01868893|58989571|FG000|Overall Study|Adverse Event|2|||
30946328|NCT01868893|58989571|FG000|Overall Study|Commercial availability of study drug|17|||
30946329|NCT01868893|58989571|FG000|Overall Study|Neutropenia|1|||
30946330|NCT01868503|58989577|FG000|Overall Study|Withdrawal by Subject|1|||
30946331|NCT01868503|58989577|FG000|Overall Study|Protocol Violation|1|||
30946332|NCT01868035|58989587|FG000|Overall Study|Lost to Follow-up|3|||
30946333|NCT01868035|58989587|FG000|Overall Study|Withdrawal by Subject|1|||
30946334|NCT01868035|58989587|FG000|Overall Study|Progressive Disease|2|||
30946335|NCT01868035|58989587|FG000|Overall Study|Non-compliance|1|||
30946336|NCT01609933|58989591|FG000|Overall Study|Adverse Event|1|||
30946337|NCT01609933|58989591|FG000|Overall Study|Withdrawal by Subject|3|||
30946338|NCT01843777|58989599|FG000|Overall Study|Withdrawal by Subject|1|||
30946339|NCT01843777|58989600|FG001|Overall Study|Withdrawal by Subject|0|||
30624811|NCT01212770|58637030|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30624812|NCT01212770|58637031|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30624813|NCT01212770|58637023|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30624814|NCT01212770|58637024|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30624815|NCT01212770|58637025|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
30624816|NCT01212770|58637026|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30624817|NCT01212770|58637027|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30624818|NCT01212770|58637028|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30624819|NCT01212770|58637029|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30624820|NCT01212770|58637030|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30624821|NCT01212770|58637031|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30624822|NCT01212770|58637023|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
30946340|NCT01842607|58989606|FG000|Overall Study|Adverse Event|11|||
30946341|NCT01842607|58989606|FG000|Overall Study|Lack of Efficacy|19|||
30946342|NCT01842607|58989606|FG000|Overall Study|Protocol Violation|8|||
30946343|NCT01842607|58989606|FG000|Overall Study|Protocol defined stopping criteria|2|||
30946344|NCT01842607|58989606|FG000|Overall Study|Lost to Follow-up|3|||
30624823|NCT01212770|58637024|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
30624824|NCT01212770|58637025|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
30624825|NCT01212770|58637026|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
30624826|NCT01212770|58637027|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
30624827|NCT01212770|58637028|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
30624828|NCT01212770|58637029|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
30624829|NCT01212770|58637030|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
30624830|NCT01212770|58637031|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
30624831|NCT01212770|58637023|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
30624832|NCT01212770|58637024|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
30624833|NCT01212770|58637025|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
30759892|NCT03588910|58768243|FG000|Overall Study|Allergy|2|||
30759893|NCT03588910|58768244|FG001|Overall Study|Allergy|0|||
30759894|NCT03588910|58768243|FG000|Overall Study|Protocol Violation|0|||
30946345|NCT01842607|58989606|FG000|Overall Study|Physician Decision|9|||
30946346|NCT01842607|58989606|FG000|Overall Study|Withdrawal by Subject|14|||
30946347|NCT01803607|58989612|FG000|Overall Study|Adverse Event|5|||
30946348|NCT01803607|58989613|FG001|Overall Study|Adverse Event|3|||
30946349|NCT01803607|58989612|FG000|Overall Study|Lack of Efficacy|0|||
30946350|NCT01803607|58989613|FG001|Overall Study|Lack of Efficacy|1|||
30946351|NCT01803607|58989612|FG000|Overall Study|Protocol Violation|3|||
30946352|NCT01803607|58989613|FG001|Overall Study|Protocol Violation|2|||
30946353|NCT01803607|58989612|FG000|Overall Study|Study terminated by sponsor|54|||
30759895|NCT03588910|58768244|FG001|Overall Study|Protocol Violation|3|||
30759896|NCT03588910|58768243|FG000|Overall Study|Did not complete Day 1 Survey|5|||
30759897|NCT03588910|58768244|FG001|Overall Study|Did not complete Day 1 Survey|10|||
30759898|NCT03588910|58768243|FG000|Overall Study|Did not complete Day 7 Survey|5|||
30842957|NCT02672852|58868896|FG004|Part A2|Not entered in Part B|0|||
30624834|NCT01212770|58637026|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
30624835|NCT01212770|58637027|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
30624836|NCT01212770|58637028|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
30624837|NCT01212770|58637029|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
30624838|NCT01212770|58637030|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
30624839|NCT01212770|58637031|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
30624840|NCT01212770|58637023|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
30624841|NCT01212770|58637024|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
30624842|NCT01212770|58637025|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
30624843|NCT01212770|58637026|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
30624844|NCT01212770|58637027|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
30624845|NCT01212770|58637028|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
30624846|NCT01212770|58637029|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
30624847|NCT01212770|58637030|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
30624848|NCT01212770|58637031|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
30624849|NCT01212770|58637023|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
30624850|NCT01212770|58637024|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
30624851|NCT01212770|58637025|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
30624852|NCT01212770|58637026|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
30624853|NCT01212770|58637027|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
30759899|NCT03588910|58768244|FG001|Overall Study|Did not complete Day 7 Survey|2|||
30759900|NCT03587974|58768252|FG000|Overall Study|caregiver demented, care recipient died|3|||
30759901|NCT03587974|58768253|FG001|Overall Study|caregiver demented, care recipient died|3|||
30759902|NCT03587974|58768252|FG000|Overall Study|Withdrawal by Subject|2|||
30759903|NCT03587974|58768253|FG001|Overall Study|Withdrawal by Subject|1|||
30759904|NCT00103857|58768266|FG000|54-Week Base Study|Adverse Event|12|||
30842958|NCT02672852|58868897|FG005|Part A2|Not entered in Part B|0|||
30842959|NCT02672852|58868898|FG006|Part A2|Not entered in Part B|0|||
30842960|NCT02672852|58868892|FG000|Part B|Disease worsening|0|||
30842961|NCT02672852|58868893|FG001|Part B|Disease worsening|0|||
30842962|NCT02672852|58868894|FG002|Part B|Disease worsening|0|||
30842963|NCT02672852|58868895|FG003|Part B|Disease worsening|0|||
30842964|NCT02672852|58868896|FG004|Part B|Disease worsening|1|||
30842965|NCT02672852|58868897|FG005|Part B|Disease worsening|0|||
30842966|NCT02672852|58868898|FG006|Part B|Disease worsening|1|||
30842967|NCT02672852|58868892|FG000|Part B|Worsening pre-existing condition|0|||
30842968|NCT02672852|58868893|FG001|Part B|Worsening pre-existing condition|0|||
30842969|NCT02672852|58868894|FG002|Part B|Worsening pre-existing condition|0|||
30842970|NCT02672852|58868895|FG003|Part B|Worsening pre-existing condition|0|||
30842971|NCT02672852|58868896|FG004|Part B|Worsening pre-existing condition|0|||
30842972|NCT02672852|58868897|FG005|Part B|Worsening pre-existing condition|1|||
30842973|NCT02672852|58868898|FG006|Part B|Worsening pre-existing condition|0|||
30842974|NCT02672852|58868892|FG000|Part B|Other adverse event|0|||
30842975|NCT02672852|58868893|FG001|Part B|Other adverse event|0|||
30842976|NCT02672852|58868894|FG002|Part B|Other adverse event|0|||
30759905|NCT00103857|58768267|FG001|54-Week Base Study|Adverse Event|9|||
30759906|NCT00103857|58768268|FG002|54-Week Base Study|Adverse Event|11|||
30759907|NCT00103857|58768269|FG003|54-Week Base Study|Adverse Event|6|||
30759908|NCT00103857|58768270|FG004|54-Week Base Study|Adverse Event|5|||
30759909|NCT00103857|58768271|FG005|54-Week Base Study|Adverse Event|11|||
30759910|NCT00103857|58768272|FG006|54-Week Base Study|Adverse Event|3|||
30759911|NCT00103857|58768266|FG000|54-Week Base Study|Death|0|||
30759912|NCT00103857|58768267|FG001|54-Week Base Study|Death|0|||
30842977|NCT02672852|58868895|FG003|Part B|Other adverse event|0|||
30842978|NCT02672852|58868896|FG004|Part B|Other adverse event|3|||
30759913|NCT00103857|58768268|FG002|54-Week Base Study|Death|0|||
30842979|NCT02672852|58868897|FG005|Part B|Other adverse event|5|||
30842980|NCT02672852|58868898|FG006|Part B|Other adverse event|1|||
30842981|NCT02672852|58868892|FG000|Part B|Lost to Follow-up|0|||
30842982|NCT02672852|58868893|FG001|Part B|Lost to Follow-up|0|||
30842983|NCT02672852|58868894|FG002|Part B|Lost to Follow-up|0|||
30842984|NCT02672852|58868895|FG003|Part B|Lost to Follow-up|0|||
30842985|NCT02672852|58868896|FG004|Part B|Lost to Follow-up|3|||
30946354|NCT01803607|58989613|FG001|Overall Study|Study terminated by sponsor|56|||
30946355|NCT01803607|58989612|FG000|Overall Study|Withdrawal by Subject|6|||
30946356|NCT01803607|58989613|FG001|Overall Study|Withdrawal by Subject|5|||
30946357|NCT01867021|58989621|FG000|Overall Study|Adverse Event|0|||
30946358|NCT01867021|58989622|FG001|Overall Study|Adverse Event|1|||
30946359|NCT01867021|58989621|FG000|Overall Study|Not Eligible|0|||
30946360|NCT01867021|58989622|FG001|Overall Study|Not Eligible|1|||
30946361|NCT01867021|58989621|FG000|Overall Study|Death|1|||
30946362|NCT01867021|58989622|FG001|Overall Study|Death|0|||
30946363|NCT01867021|58989621|FG000|Overall Study|Lost to Follow-up|0|||
30946364|NCT01867021|58989622|FG001|Overall Study|Lost to Follow-up|2|||
30946365|NCT01867021|58989621|FG000|Overall Study|Withdrawal by Subject|1|||
30946366|NCT01867021|58989622|FG001|Overall Study|Withdrawal by Subject|6|||
30624854|NCT01212770|58637028|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
30624855|NCT01212770|58637029|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
30624856|NCT01212770|58637030|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
30624857|NCT01212770|58637031|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
30624858|NCT01212770|58637023|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
30624859|NCT01212770|58637024|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
30624860|NCT01212770|58637025|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
30624861|NCT01212770|58637026|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
30624862|NCT01212770|58637027|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
30624863|NCT01212770|58637028|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
30624864|NCT01212770|58637029|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
30624865|NCT01212770|58637030|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
30624866|NCT01212770|58637031|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
30624867|NCT01212770|58637023|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
30624868|NCT01212770|58637024|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
30624869|NCT01212770|58637025|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
30624870|NCT01212770|58637026|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
30624871|NCT01212770|58637027|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
30624872|NCT01212770|58637028|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
30842986|NCT02672852|58868897|FG005|Part B|Lost to Follow-up|4|||
30842987|NCT02672852|58868898|FG006|Part B|Lost to Follow-up|1|||
30842988|NCT02672852|58868892|FG000|Part B|Withdrawal by Subject|0|||
30946367|NCT01866709|58989635|FG000|Overall Study|Adverse Event|1|||
30946368|NCT01866709|58989636|FG001|Overall Study|Adverse Event|0|||
30946369|NCT01841593|58989644|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
30946370|NCT01841593|58989645|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
30946371|NCT01841593|58989644|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
30946372|NCT01841593|58989645|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
30946373|NCT01866319|58989913|FG000|Overall Study|Adverse Event|12|||
30946374|NCT01866319|58989914|FG001|Overall Study|Adverse Event|5|||
30946375|NCT01866319|58989915|FG002|Overall Study|Adverse Event|9|||
30946376|NCT01866319|58989913|FG000|Overall Study|Clinical progression|3|||
30946377|NCT01866319|58989914|FG001|Overall Study|Clinical progression|2|||
30946378|NCT01866319|58989915|FG002|Overall Study|Clinical progression|2|||
30946379|NCT01866319|58989913|FG000|Overall Study|Death|153|||
30946380|NCT01866319|58989914|FG001|Overall Study|Death|154|||
30946381|NCT01866319|58989915|FG002|Overall Study|Death|147|||
30946382|NCT01866319|58989913|FG000|Overall Study|Lost to Follow-up|6|||
30946383|NCT01866319|58989914|FG001|Overall Study|Lost to Follow-up|3|||
30946384|NCT01866319|58989915|FG002|Overall Study|Lost to Follow-up|8|||
30946385|NCT01866319|58989913|FG000|Overall Study|Physician Decision|1|||
30946386|NCT01866319|58989914|FG001|Overall Study|Physician Decision|0|||
30946387|NCT01866319|58989915|FG002|Overall Study|Physician Decision|1|||
30946388|NCT01866319|58989913|FG000|Overall Study|Protocol Violation|0|||
30946389|NCT01866319|58989914|FG001|Overall Study|Protocol Violation|0|||
30946390|NCT01866319|58989915|FG002|Overall Study|Protocol Violation|1|||
30946391|NCT01866319|58989913|FG000|Overall Study|Withdrawal by Subject|32|||
30946392|NCT01866319|58989914|FG001|Overall Study|Withdrawal by Subject|14|||
30946393|NCT01866319|58989915|FG002|Overall Study|Withdrawal by Subject|12|||
30946394|NCT01802515|58989942|FG000|Overall Study|Withdrawal by Subject|3|||
30946395|NCT01802515|58989943|FG001|Overall Study|Withdrawal by Subject|0|||
30946396|NCT01802515|58989944|FG002|Overall Study|Withdrawal by Subject|0|||
30759914|NCT00103857|58768269|FG003|54-Week Base Study|Death|0|||
30759915|NCT00103857|58768270|FG004|54-Week Base Study|Death|1|||
30759916|NCT00103857|58768271|FG005|54-Week Base Study|Death|1|||
30759917|NCT00103857|58768272|FG006|54-Week Base Study|Death|0|||
30759918|NCT00103857|58768266|FG000|54-Week Base Study|Lack of Efficacy|11|||
30759919|NCT00103857|58768267|FG001|54-Week Base Study|Lack of Efficacy|14|||
30759920|NCT00103857|58768268|FG002|54-Week Base Study|Lack of Efficacy|8|||
30759921|NCT00103857|58768269|FG003|54-Week Base Study|Lack of Efficacy|4|||
30759922|NCT00103857|58768270|FG004|54-Week Base Study|Lack of Efficacy|3|||
30759923|NCT00103857|58768271|FG005|54-Week Base Study|Lack of Efficacy|14|||
30759924|NCT00103857|58768272|FG006|54-Week Base Study|Lack of Efficacy|19|||
30759925|NCT00103857|58768266|FG000|54-Week Base Study|Lost to Follow-up|5|||
30759926|NCT00103857|58768267|FG001|54-Week Base Study|Lost to Follow-up|4|||
30759927|NCT00103857|58768268|FG002|54-Week Base Study|Lost to Follow-up|7|||
30759928|NCT00103857|58768269|FG003|54-Week Base Study|Lost to Follow-up|5|||
30759929|NCT00103857|58768270|FG004|54-Week Base Study|Lost to Follow-up|10|||
30759930|NCT00103857|58768271|FG005|54-Week Base Study|Lost to Follow-up|9|||
30759931|NCT00103857|58768272|FG006|54-Week Base Study|Lost to Follow-up|3|||
30759932|NCT00103857|58768266|FG000|54-Week Base Study|Physician Decision|1|||
30759933|NCT00103857|58768267|FG001|54-Week Base Study|Physician Decision|1|||
30842989|NCT02672852|58868893|FG001|Part B|Withdrawal by Subject|0|||
30842990|NCT02672852|58868894|FG002|Part B|Withdrawal by Subject|0|||
30842991|NCT02672852|58868895|FG003|Part B|Withdrawal by Subject|0|||
30842992|NCT02672852|58868896|FG004|Part B|Withdrawal by Subject|5|||
30842993|NCT02672852|58868897|FG005|Part B|Withdrawal by Subject|0|||
30842994|NCT02672852|58868898|FG006|Part B|Withdrawal by Subject|7|||
30842995|NCT02672852|58868892|FG000|Part B|Other|0|||
30759934|NCT00103857|58768268|FG002|54-Week Base Study|Physician Decision|0|||
30759935|NCT00103857|58768269|FG003|54-Week Base Study|Physician Decision|0|||
30759936|NCT00103857|58768270|FG004|54-Week Base Study|Physician Decision|1|||
30759937|NCT00103857|58768271|FG005|54-Week Base Study|Physician Decision|0|||
30759938|NCT00103857|58768272|FG006|54-Week Base Study|Physician Decision|0|||
30759939|NCT00103857|58768266|FG000|54-Week Base Study|Pregnancy|1|||
30759940|NCT00103857|58768267|FG001|54-Week Base Study|Pregnancy|0|||
30759941|NCT00103857|58768268|FG002|54-Week Base Study|Pregnancy|0|||
30759942|NCT00103857|58768269|FG003|54-Week Base Study|Pregnancy|0|||
30759943|NCT00103857|58768270|FG004|54-Week Base Study|Pregnancy|1|||
30759944|NCT00103857|58768271|FG005|54-Week Base Study|Pregnancy|0|||
30946397|NCT01802437|58989954|FG000|Overall Study|Lost to Follow-up|1|||
30946398|NCT01802437|58989955|FG001|Overall Study|Lost to Follow-up|0|||
30842996|NCT02672852|58868893|FG001|Part B|Other|0|||
30842997|NCT02672852|58868894|FG002|Part B|Other|0|||
30842998|NCT02672852|58868895|FG003|Part B|Other|0|||
30946399|NCT01802437|58989954|FG000|Overall Study|Withdrawal by Subject|3|||
30624873|NCT01212770|58637029|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
30624874|NCT01212770|58637030|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
30624875|NCT01212770|58637031|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
30624876|NCT01212770|58637023|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
30624877|NCT01212770|58637024|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
30624878|NCT01212770|58637025|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
30624879|NCT01212770|58637026|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
30624880|NCT01212770|58637027|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
30624881|NCT01212770|58637028|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
30624882|NCT01212770|58637029|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
30624883|NCT01212770|58637030|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
30624884|NCT01212770|58637031|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
30624885|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
30624886|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
30624887|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
30624888|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
30624889|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
30624890|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
30624891|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
30624892|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
30624893|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
30624894|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
30624895|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
30624896|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
30624897|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
30624898|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
30624899|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
30624900|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
30624901|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
30624902|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
30624903|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
30624904|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
30624905|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
30624906|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
30624907|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
30624908|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
30624909|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
30624910|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
30624911|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
30624912|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30624913|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
30624914|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
30624915|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30624916|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30624917|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30624918|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30624919|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
30624920|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
30624921|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
30624922|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
30624923|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
30624924|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
30624925|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
30624926|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
30624927|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
30624928|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
30624929|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
30624930|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30759945|NCT00103857|58768272|FG006|54-Week Base Study|Pregnancy|1|||
30759946|NCT00103857|58768266|FG000|54-Week Base Study|Protocol Violation|6|||
30759947|NCT00103857|58768267|FG001|54-Week Base Study|Protocol Violation|4|||
30759948|NCT00103857|58768268|FG002|54-Week Base Study|Protocol Violation|2|||
30759949|NCT00103857|58768269|FG003|54-Week Base Study|Protocol Violation|4|||
30759950|NCT00103857|58768270|FG004|54-Week Base Study|Protocol Violation|0|||
30759951|NCT00103857|58768271|FG005|54-Week Base Study|Protocol Violation|3|||
30759952|NCT00103857|58768272|FG006|54-Week Base Study|Protocol Violation|3|||
30842999|NCT02672852|58868896|FG004|Part B|Other|4|||
30843000|NCT02672852|58868897|FG005|Part B|Other|1|||
30843001|NCT02672852|58868898|FG006|Part B|Other|2|||
30624931|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
30624932|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
30624933|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30624934|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30624935|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30624936|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30624937|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
30624938|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
30624939|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
30624940|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
30624941|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
30624942|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
30624943|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
30624944|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
30624945|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
30624946|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
30624947|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
30624948|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
30624949|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
30624950|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
30624951|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
30624952|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
30624953|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
30624954|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
30624955|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
30624956|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
30624957|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30624958|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
30624959|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
30624960|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30624961|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30624962|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30624963|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30624964|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
30624965|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
30624966|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30624967|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
30624968|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30624969|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30624970|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30624971|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30624972|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30624973|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30624974|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
30624975|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
30624976|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
30624977|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
30624978|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
30624979|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
30759953|NCT00103857|58768266|FG000|54-Week Base Study|Withdrawal by Subject|17|||
30946400|NCT01802437|58989955|FG001|Overall Study|Withdrawal by Subject|4|||
30946401|NCT01801735|58990062|FG000|Overall Study|Adverse Event|79|||
30624980|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
30624981|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
30624982|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
30624983|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
30624984|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30624985|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
30624986|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
30624987|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30624988|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30624989|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30624990|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
30624991|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
30624992|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
30624993|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30624994|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
30624995|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
30624996|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30624997|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30624998|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30624999|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30625000|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
30625001|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
30625002|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30625003|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
30625004|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
30625005|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30625006|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30625007|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30625008|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30625009|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
30625010|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
30625011|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
30625012|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
30625013|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
30625014|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
30625015|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
30625016|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
30625017|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
30625018|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
30625019|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
30625020|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30625021|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
30625022|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
30625023|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30625024|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30625025|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30625026|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30625027|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30625028|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30625029|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30625030|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30625031|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
30625032|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30625033|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30625034|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30625035|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30625036|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30625037|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
30625038|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30625039|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
30625040|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30625041|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30625042|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30625043|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30625044|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30625045|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
30625046|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
30625047|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
30625048|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
30625049|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
30625050|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
30625051|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
30625052|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
30625053|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
30625054|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
30625055|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
30625056|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30625057|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30759954|NCT00103857|58768267|FG001|54-Week Base Study|Withdrawal by Subject|16|||
30946402|NCT01801735|58990062|FG000|Overall Study|Lack of Efficacy|28|||
30946403|NCT01801735|58990062|FG000|Overall Study|Withdrawal by Subject|27|||
30946404|NCT01801735|58990062|FG000|Overall Study|Protocol Violation|25|||
30946405|NCT01801735|58990062|FG000|Overall Study|Lost to Follow-up|15|||
30946406|NCT01801735|58990062|FG000|Overall Study|Non-compliance with Trial Drug|13|||
30946407|NCT01801735|58990062|FG000|Overall Study|Physician Decision|3|||
30946408|NCT01801735|58990062|FG000|Overall Study|Death|1|||
30946409|NCT01801735|58990062|FG000|Overall Study|Other, including site closure|19|||
30946410|NCT01840579|58990828|FG000|Overall Study|Status not recorded|0|||
30946411|NCT01840579|58990829|FG001|Overall Study|Status not recorded|0|||
30946412|NCT01840579|58990830|FG002|Overall Study|Status not recorded|2|||
30946413|NCT01840579|58990831|FG003|Overall Study|Status not recorded|3|||
30946414|NCT01840579|58990832|FG004|Overall Study|Status not recorded|4|||
30946415|NCT01840579|58990833|FG005|Overall Study|Status not recorded|3|||
30946416|NCT01840579|58990834|FG006|Overall Study|Status not recorded|0|||
30946417|NCT01840579|58990835|FG007|Overall Study|Status not recorded|3|||
30946418|NCT01840579|58990836|FG008|Overall Study|Status not recorded|3|||
30946419|NCT01840579|58990837|FG009|Overall Study|Status not recorded|3|||
30946420|NCT01840579|58990828|FG000|Overall Study|Progressive disease|3|||
30946421|NCT01840579|58990829|FG001|Overall Study|Progressive disease|5|||
30946422|NCT01840579|58990830|FG002|Overall Study|Progressive disease|0|||
30946423|NCT01840579|58990831|FG003|Overall Study|Progressive disease|0|||
30946424|NCT01840579|58990832|FG004|Overall Study|Progressive disease|0|||
30946425|NCT01840579|58990833|FG005|Overall Study|Progressive disease|0|||
30946426|NCT01840579|58990834|FG006|Overall Study|Progressive disease|0|||
30946427|NCT01840579|58990835|FG007|Overall Study|Progressive disease|0|||
30946428|NCT01840579|58990836|FG008|Overall Study|Progressive disease|0|||
30946429|NCT01840579|58990837|FG009|Overall Study|Progressive disease|0|||
30946430|NCT01840579|58990828|FG000|Overall Study|Ongoing in study|0|||
30946431|NCT01840579|58990829|FG001|Overall Study|Ongoing in study|1|||
30946432|NCT01840579|58990830|FG002|Overall Study|Ongoing in study|0|||
30946433|NCT01840579|58990831|FG003|Overall Study|Ongoing in study|0|||
30946434|NCT01840579|58990832|FG004|Overall Study|Ongoing in study|0|||
30946435|NCT01840579|58990833|FG005|Overall Study|Ongoing in study|0|||
30946436|NCT01840579|58990834|FG006|Overall Study|Ongoing in study|0|||
30946437|NCT01840579|58990835|FG007|Overall Study|Ongoing in study|0|||
30946438|NCT01840579|58990836|FG008|Overall Study|Ongoing in study|0|||
30946439|NCT01840579|58990837|FG009|Overall Study|Ongoing in study|0|||
30946440|NCT01840579|58990828|FG000|Overall Study|Death|0|||
30946441|NCT01840579|58990829|FG001|Overall Study|Death|0|||
30946442|NCT01840579|58990830|FG002|Overall Study|Death|0|||
30946443|NCT01840579|58990831|FG003|Overall Study|Death|0|||
30946444|NCT01840579|58990832|FG004|Overall Study|Death|0|||
30946445|NCT01840579|58990833|FG005|Overall Study|Death|1|||
30946446|NCT01840579|58990834|FG006|Overall Study|Death|0|||
30946447|NCT01840579|58990835|FG007|Overall Study|Death|0|||
30946448|NCT01840579|58990836|FG008|Overall Study|Death|0|||
30946449|NCT01840579|58990837|FG009|Overall Study|Death|0|||
30625058|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
30625059|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30759955|NCT00103857|58768268|FG002|54-Week Base Study|Withdrawal by Subject|16|||
30946450|NCT01840579|58990828|FG000|Overall Study|Adverse Event|0|||
30946451|NCT01840579|58990829|FG001|Overall Study|Adverse Event|1|||
30946452|NCT01840579|58990830|FG002|Overall Study|Adverse Event|0|||
30946453|NCT01840579|58990831|FG003|Overall Study|Adverse Event|0|||
30946454|NCT01840579|58990832|FG004|Overall Study|Adverse Event|0|||
30946455|NCT01840579|58990833|FG005|Overall Study|Adverse Event|0|||
30946456|NCT01840579|58990834|FG006|Overall Study|Adverse Event|0|||
30946457|NCT01840579|58990835|FG007|Overall Study|Adverse Event|0|||
30946458|NCT01840579|58990836|FG008|Overall Study|Adverse Event|0|||
30946459|NCT01840579|58990837|FG009|Overall Study|Adverse Event|0|||
30946460|NCT01840579|58990828|FG000|Overall Study|Follow-up ended by Sponsor|0|||
30946461|NCT01840579|58990829|FG001|Overall Study|Follow-up ended by Sponsor|0|||
30946462|NCT01840579|58990830|FG002|Overall Study|Follow-up ended by Sponsor|0|||
30946463|NCT01840579|58990831|FG003|Overall Study|Follow-up ended by Sponsor|0|||
30946464|NCT01840579|58990832|FG004|Overall Study|Follow-up ended by Sponsor|0|||
30946465|NCT01840579|58990833|FG005|Overall Study|Follow-up ended by Sponsor|0|||
30946466|NCT01840579|58990834|FG006|Overall Study|Follow-up ended by Sponsor|2|||
30946467|NCT01840579|58990835|FG007|Overall Study|Follow-up ended by Sponsor|0|||
30946468|NCT01840579|58990836|FG008|Overall Study|Follow-up ended by Sponsor|0|||
30946469|NCT01840579|58990837|FG009|Overall Study|Follow-up ended by Sponsor|0|||
30946470|NCT01801111|58990916|FG000|Overall Study|Adverse Event|12|||
30946471|NCT01801111|58990916|FG000|Overall Study|Death|8|||
30946472|NCT01801111|58990916|FG000|Overall Study|Physician Decision|5|||
30946473|NCT01801111|58990916|FG000|Overall Study|Other|1|||
30946474|NCT01801111|58990916|FG000|Overall Study|Withdrawal by Subject|4|||
30946475|NCT01801111|58990916|FG000|Overall Study|Study Terminated by Sponsor|27|||
30946476|NCT01801111|58990916|FG000|Overall Study|Progressive Disease|81|||
30946477|NCT01773967|58990948|FG000|Overall Study|Lost to Follow-up|15|||
30946478|NCT01773967|58990949|FG001|Overall Study|Lost to Follow-up|13|||
30946479|NCT01773889|58990959|FG000|Overall Study|lack of funding|2|||
30946480|NCT01839487|58991137|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
30946481|NCT01839487|58991138|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
30946482|NCT01839487|58991139|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
30946483|NCT01839487|58991140|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
30946484|NCT01839487|58991141|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
30946485|NCT01839487|58991142|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
30946486|NCT01839487|58991137|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
30946487|NCT01839487|58991138|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
30946488|NCT01839487|58991139|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
30946489|NCT01839487|58991140|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
30946490|NCT01839487|58991141|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
30946491|NCT01839487|58991142|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
30946492|NCT01839487|58991137|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
30946493|NCT01839487|58991138|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
30946494|NCT01839487|58991139|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
30946495|NCT01839487|58991140|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
30946496|NCT01839487|58991141|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
30946497|NCT01839487|58991142|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
30946498|NCT01839487|58991137|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
30946499|NCT01839487|58991138|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
30946500|NCT01839487|58991139|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
30946501|NCT01839487|58991140|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
30946502|NCT01839487|58991141|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
30946503|NCT01839487|58991142|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
30946504|NCT01839487|58991137|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
30946505|NCT01839487|58991138|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
30946506|NCT01839487|58991139|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
30946507|NCT01839487|58991140|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
30946508|NCT01839487|58991141|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
30946509|NCT01839487|58991142|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
30946510|NCT01839487|58991137|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
30946511|NCT01839487|58991138|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
30625060|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30625061|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30625062|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30625063|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30625064|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
30625065|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30625066|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30625067|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
30625068|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30625069|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30625070|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30625071|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30625072|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
30625073|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
30625074|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30625075|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30625076|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
30625077|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30625078|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30625079|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30625080|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30625081|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30625082|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
30625083|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30625084|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
30625085|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
30625086|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30625087|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30625088|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30625089|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30625090|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
30625091|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30625092|NCT01212770|58637023|FG000|Long-term Safety Phase (Year 5)|Death|0|||
30625093|NCT01212770|58637024|FG001|Long-term Safety Phase (Year 5)|Death|0|||
30625094|NCT01212770|58637025|FG002|Long-term Safety Phase (Year 5)|Death|0|||
30625095|NCT01212770|58637026|FG003|Long-term Safety Phase (Year 5)|Death|0|||
30625096|NCT01212770|58637027|FG004|Long-term Safety Phase (Year 5)|Death|0|||
30625097|NCT01212770|58637028|FG005|Long-term Safety Phase (Year 5)|Death|0|||
30625098|NCT01212770|58637029|FG006|Long-term Safety Phase (Year 5)|Death|0|||
30625099|NCT01212770|58637030|FG007|Long-term Safety Phase (Year 5)|Death|1|||
30625100|NCT01212770|58637031|FG008|Long-term Safety Phase (Year 5)|Death|0|||
30625101|NCT00598273|58637056|FG000|Overall Study|Adverse Event|4|||
30625102|NCT00598273|58637057|FG001|Overall Study|Adverse Event|5|||
30625103|NCT00598273|58637058|FG002|Overall Study|Adverse Event|2|||
30625104|NCT00598273|58637056|FG000|Overall Study|Death|6|||
30625105|NCT00598273|58637057|FG001|Overall Study|Death|12|||
30625106|NCT00598273|58637058|FG002|Overall Study|Death|8|||
30625107|NCT00598273|58637056|FG000|Overall Study|Lost to Follow-up|8|||
30625108|NCT00598273|58637057|FG001|Overall Study|Lost to Follow-up|3|||
30625109|NCT00598273|58637058|FG002|Overall Study|Lost to Follow-up|5|||
30625110|NCT00598273|58637056|FG000|Overall Study|Physician Decision|0|||
30625111|NCT00598273|58637057|FG001|Overall Study|Physician Decision|0|||
30946512|NCT01839487|58991139|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
30946513|NCT01839487|58991140|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
30946514|NCT01839487|58991141|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
30946515|NCT01839487|58991142|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
30946516|NCT01839487|58991137|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
30946517|NCT01839487|58991138|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
30625112|NCT00598273|58637058|FG002|Overall Study|Physician Decision|1|||
30625113|NCT00598273|58637056|FG000|Overall Study|Withdrawal by Subject|12|||
30625114|NCT00598273|58637057|FG001|Overall Study|Withdrawal by Subject|10|||
30625115|NCT00598273|58637058|FG002|Overall Study|Withdrawal by Subject|10|||
30625116|NCT00598273|58637056|FG000|Overall Study|Noncompliance|3|||
30625117|NCT00598273|58637057|FG001|Overall Study|Noncompliance|2|||
30625118|NCT00598273|58637058|FG002|Overall Study|Noncompliance|3|||
30625119|NCT00598273|58637056|FG000|Overall Study|Relocation|0|||
30625120|NCT00598273|58637057|FG001|Overall Study|Relocation|2|||
30625121|NCT00598273|58637058|FG002|Overall Study|Relocation|4|||
30625122|NCT00598273|58637056|FG000|Overall Study|Renal transplant|1|||
30625123|NCT00598273|58637057|FG001|Overall Study|Renal transplant|0|||
30625124|NCT00598273|58637058|FG002|Overall Study|Renal transplant|1|||
30625125|NCT00598273|58637056|FG000|Overall Study|Site elected to close|1|||
30625126|NCT00598273|58637057|FG001|Overall Study|Site elected to close|0|||
30625127|NCT00598273|58637058|FG002|Overall Study|Site elected to close|0|||
30625128|NCT00598273|58637056|FG000|Overall Study|Started dialysis|6|||
30625129|NCT00598273|58637057|FG001|Overall Study|Started dialysis|4|||
30625130|NCT00598273|58637058|FG002|Overall Study|Started dialysis|5|||
30625131|NCT01211522|58637069|FG000|Overall Study|Withdrawal by Subject|3|||
30625132|NCT01211522|58637070|FG001|Overall Study|Withdrawal by Subject|7|||
30625133|NCT01211522|58637071|FG002|Overall Study|Withdrawal by Subject|5|||
30625134|NCT01211288|58637081|FG000|Overall Study|Lost to Follow-up|1|||
30625135|NCT01211288|58637082|FG001|Overall Study|Lost to Follow-up|1|||
30625136|NCT00883753|58637090|FG000|Overall Study|Adverse Event|37|||
30946518|NCT01839487|58991139|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
30625137|NCT00883753|58637090|FG000|Overall Study|Death|2|||
30625138|NCT00883753|58637090|FG000|Overall Study|Insufficient therapeutic response|16|||
30625139|NCT00883753|58637090|FG000|Overall Study|Lost to Follow-up|4|||
30625140|NCT00883753|58637090|FG000|Overall Study|Violation of selection criteria at entry|7|||
30625141|NCT00883753|58637090|FG000|Overall Study|Protocol Violation|2|||
30625142|NCT00883753|58637090|FG000|Overall Study|Refused treatment|4|||
30625143|NCT00883753|58637090|FG000|Overall Study|Withdrew consent|10|||
30625144|NCT00883753|58637090|FG000|Overall Study|Investigator's decision|17|||
30625145|NCT00883753|58637090|FG000|Overall Study|Administrative/Other|8|||
30625146|NCT01210664|58637097|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
30625147|NCT01210664|58637098|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
30625148|NCT01210664|58637099|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
30625149|NCT01210664|58637100|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
30625150|NCT01210664|58637097|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
30625151|NCT01210664|58637098|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
30625152|NCT01210664|58637099|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
30625153|NCT01210664|58637100|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
30625154|NCT01210664|58637097|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
30625155|NCT01210664|58637098|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
30625156|NCT01210664|58637099|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
30625157|NCT01210664|58637100|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
30625158|NCT00881569|58637112|FG000|Overall Study|Disease progression|1|||
30625159|NCT00881569|58637113|FG001|Overall Study|Disease progression|1|||
30625160|NCT00881335|58637121|FG000|Overall Study|Lost to Follow-up|3|||
30625161|NCT00881335|58637122|FG001|Overall Study|Lost to Follow-up|2|||
30625162|NCT00879775|58637139|FG000|Overall Study|Lost to Follow-up|2|||
30625163|NCT00879775|58637140|FG001|Overall Study|Lost to Follow-up|1|||
30625164|NCT00894790|58637148|FG000|Overall Study|Protocol Violation|0|||
30625165|NCT00894790|58637149|FG001|Overall Study|Protocol Violation|1|||
30946519|NCT01839487|58991140|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
30946520|NCT01839487|58991141|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
30625166|NCT00894790|58637148|FG000|Overall Study|Lost to Follow-up|0|||
30625167|NCT00894790|58637149|FG001|Overall Study|Lost to Follow-up|1|||
30625168|NCT00894790|58637148|FG000|Overall Study|Did not meet entrance criteria|1|||
30625169|NCT00894790|58637149|FG001|Overall Study|Did not meet entrance criteria|0|||
30625170|NCT00879229|58637157|FG000|Overall Study|Study terminated by Sponsor|13|||
30625171|NCT00879229|58637158|FG001|Overall Study|Study terminated by Sponsor|12|||
30625172|NCT00879229|58637157|FG000|Overall Study|Death|4|||
30625173|NCT00879229|58637158|FG001|Overall Study|Death|2|||
30625174|NCT00879229|58637157|FG000|Overall Study|Adverse Event|2|||
30625175|NCT00879229|58637158|FG001|Overall Study|Adverse Event|0|||
30946521|NCT01839487|58991142|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
30946522|NCT01839487|58991137|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
30946523|NCT01839487|58991138|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
30946524|NCT01839487|58991139|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
30946525|NCT01839487|58991140|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
30946526|NCT01839487|58991141|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
30625176|NCT00879229|58637157|FG000|Overall Study|Withdrawal by Subject|1|||
30625177|NCT00879229|58637158|FG001|Overall Study|Withdrawal by Subject|0|||
30625178|NCT00879229|58637157|FG000|Overall Study|Clinical status did not improve|1|||
30625179|NCT00879229|58637158|FG001|Overall Study|Clinical status did not improve|0|||
30946527|NCT01839487|58991142|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
30946528|NCT01839487|58991137|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
30946529|NCT01839487|58991138|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
30946530|NCT01839487|58991139|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
30946531|NCT01839487|58991140|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
30946532|NCT01839487|58991141|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
30946533|NCT01839487|58991142|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
30946534|NCT01799941|58991169|FG000|Overall Study|Adverse Event|34|||
30946535|NCT01799941|58991169|FG000|Overall Study|Withdrawal by Subject|21|||
30946536|NCT01799941|58991169|FG000|Overall Study|Death|2|||
30625180|NCT00879229|58637157|FG000|Overall Study|Other|1|||
30625181|NCT00879229|58637158|FG001|Overall Study|Other|0|||
30625182|NCT00878995|58637166|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
30625183|NCT00878995|58637167|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
30625184|NCT00879697|58637175|FG000|Overall Study|Physician Decision|2|||
30625185|NCT00879697|58637176|FG001|Overall Study|Physician Decision|2|||
30843002|NCT02671760|58868909|FG000|Overall Study|Lost to Follow-up|0|||
30946537|NCT01799941|58991169|FG000|Overall Study|Investigator Decision|4|||
30946538|NCT01799941|58991169|FG000|Overall Study|Lack of Efficacy|3|||
30625186|NCT00894556|58637185|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
30625187|NCT00894556|58637186|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
30625188|NCT00894556|58637187|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
30625189|NCT00894556|58637188|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
30625190|NCT00894556|58637185|FG000|Treatment Phase|Lost to Follow-up|2|||
30625191|NCT00894556|58637186|FG001|Treatment Phase|Lost to Follow-up|3|||
30625192|NCT00894556|58637187|FG002|Treatment Phase|Lost to Follow-up|1|||
30625193|NCT00894556|58637188|FG003|Treatment Phase|Lost to Follow-up|0|||
30625194|NCT00894556|58637185|FG000|Treatment Phase|Lack of Qualifying Event|2|||
30625195|NCT00894556|58637186|FG001|Treatment Phase|Lack of Qualifying Event|1|||
30625196|NCT00894556|58637187|FG002|Treatment Phase|Lack of Qualifying Event|0|||
30625197|NCT00894556|58637188|FG003|Treatment Phase|Lack of Qualifying Event|0|||
30625198|NCT01210352|58637204|FG000|Overall Study|Adverse Event|0|||
30625199|NCT01210352|58637205|FG001|Overall Study|Adverse Event|0|||
30625200|NCT01210352|58637206|FG002|Overall Study|Adverse Event|0|||
30625201|NCT01210352|58637207|FG003|Overall Study|Adverse Event|0|||
30625202|NCT01210352|58637208|FG004|Overall Study|Adverse Event|0|||
30625203|NCT01210352|58637209|FG005|Overall Study|Adverse Event|0|||
30625204|NCT01210352|58637210|FG006|Overall Study|Adverse Event|0|||
30625205|NCT01210352|58637211|FG007|Overall Study|Adverse Event|2|||
30625206|NCT01210352|58637212|FG008|Overall Study|Adverse Event|1|||
30625207|NCT01210352|58637204|FG000|Overall Study|Lack of Efficacy|0|||
30625208|NCT01210352|58637205|FG001|Overall Study|Lack of Efficacy|0|||
30625209|NCT01210352|58637206|FG002|Overall Study|Lack of Efficacy|0|||
30625210|NCT01210352|58637207|FG003|Overall Study|Lack of Efficacy|0|||
30625211|NCT01210352|58637208|FG004|Overall Study|Lack of Efficacy|0|||
30625212|NCT01210352|58637209|FG005|Overall Study|Lack of Efficacy|0|||
30625213|NCT01210352|58637210|FG006|Overall Study|Lack of Efficacy|1|||
30625214|NCT01210352|58637211|FG007|Overall Study|Lack of Efficacy|0|||
30625215|NCT01210352|58637212|FG008|Overall Study|Lack of Efficacy|0|||
30625216|NCT01210352|58637204|FG000|Overall Study|Physician Decision|0|||
30625217|NCT01210352|58637205|FG001|Overall Study|Physician Decision|0|||
30625218|NCT01210352|58637206|FG002|Overall Study|Physician Decision|0|||
30625219|NCT01210352|58637207|FG003|Overall Study|Physician Decision|0|||
30625220|NCT01210352|58637208|FG004|Overall Study|Physician Decision|0|||
30625221|NCT01210352|58637209|FG005|Overall Study|Physician Decision|0|||
30625222|NCT01210352|58637210|FG006|Overall Study|Physician Decision|0|||
30625223|NCT01210352|58637211|FG007|Overall Study|Physician Decision|1|||
30625224|NCT01210352|58637212|FG008|Overall Study|Physician Decision|2|||
30625225|NCT01210352|58637204|FG000|Overall Study|Withdrawal by Subject|0|||
30625226|NCT01210352|58637205|FG001|Overall Study|Withdrawal by Subject|0|||
30625227|NCT01210352|58637206|FG002|Overall Study|Withdrawal by Subject|1|||
30625228|NCT01210352|58637207|FG003|Overall Study|Withdrawal by Subject|0|||
30625229|NCT01210352|58637208|FG004|Overall Study|Withdrawal by Subject|0|||
30625230|NCT01210352|58637209|FG005|Overall Study|Withdrawal by Subject|0|||
30625231|NCT01210352|58637210|FG006|Overall Study|Withdrawal by Subject|1|||
30625232|NCT01210352|58637211|FG007|Overall Study|Withdrawal by Subject|0|||
30625233|NCT01210352|58637212|FG008|Overall Study|Withdrawal by Subject|1|||
30625234|NCT01210352|58637204|FG000|Overall Study|Patient Discharged Early|0|||
30625235|NCT01210352|58637205|FG001|Overall Study|Patient Discharged Early|0|||
30625236|NCT01210352|58637206|FG002|Overall Study|Patient Discharged Early|1|||
30625237|NCT01210352|58637207|FG003|Overall Study|Patient Discharged Early|0|||
30625238|NCT01210352|58637208|FG004|Overall Study|Patient Discharged Early|0|||
30625239|NCT01210352|58637209|FG005|Overall Study|Patient Discharged Early|0|||
30625240|NCT01210352|58637210|FG006|Overall Study|Patient Discharged Early|0|||
30625241|NCT01210352|58637211|FG007|Overall Study|Patient Discharged Early|0|||
30625242|NCT01210352|58637212|FG008|Overall Study|Patient Discharged Early|0|||
30625243|NCT01210118|58637319|FG000|Overall Study|Lost to Follow-up|1|||
30625244|NCT01210118|58637320|FG001|Overall Study|Lost to Follow-up|1|||
30625245|NCT01210118|58637319|FG000|Overall Study|Protocol Violation|1|||
30625246|NCT01210118|58637320|FG001|Overall Study|Protocol Violation|1|||
30625247|NCT01210118|58637319|FG000|Overall Study|Spontaneous abortion|1|||
30625248|NCT01210118|58637320|FG001|Overall Study|Spontaneous abortion|3|||
30625249|NCT01208870|58637331|FG000|Overall Study|Lost to Follow-up|2|||
30625250|NCT01208870|58637332|FG001|Overall Study|Lost to Follow-up|8|||
30625251|NCT00880555|58637343|FG000|Overall Study|Physician Decision|0|||
30625252|NCT00880555|58637344|FG001|Overall Study|Physician Decision|8|||
30625253|NCT00880555|58637345|FG002|Overall Study|Physician Decision|0|||
30625254|NCT00880555|58637346|FG003|Overall Study|Physician Decision|2|||
30625255|NCT00880555|58637347|FG004|Overall Study|Physician Decision|1|||
30625256|NCT00880555|58637348|FG005|Overall Study|Physician Decision|0|||
30625257|NCT00880555|58637343|FG000|Overall Study|Withdrawal by Subject|1|||
30946539|NCT01799941|58991169|FG000|Overall Study|Lost to Follow-up|17|||
30625258|NCT00880555|58637344|FG001|Overall Study|Withdrawal by Subject|1|||
30625259|NCT00880555|58637345|FG002|Overall Study|Withdrawal by Subject|0|||
30625260|NCT00880555|58637346|FG003|Overall Study|Withdrawal by Subject|0|||
30625261|NCT00880555|58637347|FG004|Overall Study|Withdrawal by Subject|0|||
30625262|NCT00880555|58637348|FG005|Overall Study|Withdrawal by Subject|0|||
30625263|NCT00880555|58637343|FG000|Overall Study|Lack of resources (hired rater)|9|||
30625264|NCT00880555|58637344|FG001|Overall Study|Lack of resources (hired rater)|7|||
30625265|NCT00880555|58637345|FG002|Overall Study|Lack of resources (hired rater)|5|||
30625266|NCT00880555|58637346|FG003|Overall Study|Lack of resources (hired rater)|0|||
30625267|NCT00880555|58637347|FG004|Overall Study|Lack of resources (hired rater)|0|||
30625268|NCT00880555|58637348|FG005|Overall Study|Lack of resources (hired rater)|0|||
30625269|NCT00880555|58637343|FG000|Overall Study|Death|0|||
30625270|NCT00880555|58637344|FG001|Overall Study|Death|0|||
30625271|NCT00880555|58637345|FG002|Overall Study|Death|0|||
30625272|NCT00880555|58637346|FG003|Overall Study|Death|0|||
30625273|NCT00880555|58637347|FG004|Overall Study|Death|0|||
30625274|NCT00880555|58637348|FG005|Overall Study|Death|1|||
30625275|NCT00880555|58637343|FG000|Overall Study|Lost to Follow-up|0|||
30625276|NCT00880555|58637344|FG001|Overall Study|Lost to Follow-up|1|||
30625277|NCT00880555|58637345|FG002|Overall Study|Lost to Follow-up|0|||
30625278|NCT00880555|58637346|FG003|Overall Study|Lost to Follow-up|0|||
30625279|NCT00880555|58637347|FG004|Overall Study|Lost to Follow-up|0|||
30625280|NCT00880555|58637348|FG005|Overall Study|Lost to Follow-up|0|||
30625281|NCT01208402|58637361|FG000|Overall Study|Withdrawal by Subject|1|||
30625282|NCT01208402|58637362|FG001|Overall Study|Withdrawal by Subject|0|||
30625283|NCT01208324|58637372|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
30625284|NCT01208324|58637373|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
30625285|NCT01208324|58637374|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
30625286|NCT01208324|58637375|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
30625287|NCT00880399|58637388|FG000|Overall Study|Adverse Event|4|||
30625288|NCT00880399|58637389|FG001|Overall Study|Adverse Event|6|||
30625289|NCT00880399|58637390|FG002|Overall Study|Adverse Event|5|||
30625290|NCT00880399|58637388|FG000|Overall Study|Lack of Efficacy|1|||
30625291|NCT00880399|58637389|FG001|Overall Study|Lack of Efficacy|4|||
30625292|NCT00880399|58637390|FG002|Overall Study|Lack of Efficacy|2|||
30625293|NCT00880399|58637388|FG000|Overall Study|Protocol Violation|4|||
30625294|NCT00880399|58637389|FG001|Overall Study|Protocol Violation|4|||
30625295|NCT00880399|58637390|FG002|Overall Study|Protocol Violation|6|||
30625296|NCT00880399|58637388|FG000|Overall Study|Study closed/terminated|3|||
30625297|NCT00880399|58637389|FG001|Overall Study|Study closed/terminated|7|||
30625298|NCT00880399|58637390|FG002|Overall Study|Study closed/terminated|4|||
30843003|NCT02671760|58868910|FG001|Overall Study|Lost to Follow-up|1|||
30843004|NCT02671760|58868911|FG002|Overall Study|Lost to Follow-up|0|||
30946540|NCT01799941|58991169|FG000|Overall Study|Other|15|||
30946541|NCT01799239|58991197|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
30946542|NCT01799239|58991198|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
30946543|NCT01799239|58991197|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
30946544|NCT01799239|58991198|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
30946545|NCT01799239|58991197|FG000|Period 1 (7 Days)|Protocol Violation|0|||
30946546|NCT01799239|58991198|FG001|Period 1 (7 Days)|Protocol Violation|1|||
30946547|NCT01799239|58991197|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
30946548|NCT01799239|58991198|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
30946549|NCT01799239|58991197|FG000|Period 2 (7 Days)|Protocol Violation|1|||
30946550|NCT01799239|58991198|FG001|Period 2 (7 Days)|Protocol Violation|0|||
30946551|NCT02999854|58991214|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
30946552|NCT02999854|58991215|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
30946553|NCT02999854|58991214|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
30946554|NCT02999854|58991215|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
30946555|NCT02999854|58991214|FG000|Active Study Phase (up to 18 Months)|Death|7|||
30946556|NCT02999854|58991215|FG001|Active Study Phase (up to 18 Months)|Death|5|||
30946557|NCT02999854|58991214|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
30946558|NCT02999854|58991215|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
30946559|NCT02999854|58991214|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
30946560|NCT02999854|58991215|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
30946561|NCT02999854|58991214|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
30946562|NCT02999854|58991215|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
30946563|NCT02999854|58991214|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
30946564|NCT02999854|58991215|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
30946565|NCT02999854|58991214|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
30946566|NCT02999854|58991215|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
30946567|NCT04146363|58991348|FG000|Induction Period|Adverse Event|1|||
30625299|NCT00880399|58637388|FG000|Overall Study|Lost to Follow-up|8|||
30625300|NCT00880399|58637389|FG001|Overall Study|Lost to Follow-up|5|||
30625301|NCT00880399|58637390|FG002|Overall Study|Lost to Follow-up|3|||
30625302|NCT00880399|58637388|FG000|Overall Study|Physician Decision|5|||
30625303|NCT00880399|58637389|FG001|Overall Study|Physician Decision|0|||
30843005|NCT02667236|58868921|FG000|Overall Study|Adverse Event|1|||
30946568|NCT04146363|58991349|FG001|Induction Period|Adverse Event|2|||
30946569|NCT04146363|58991350|FG002|Induction Period|Adverse Event|0|||
30946570|NCT04146363|58991351|FG003|Induction Period|Adverse Event|0|||
30946571|NCT04146363|58991352|FG004|Induction Period|Adverse Event|0|||
30946572|NCT04146363|58991353|FG005|Induction Period|Adverse Event|0|||
30946573|NCT04146363|58991354|FG006|Induction Period|Adverse Event|0|||
30946574|NCT04146363|58991355|FG007|Induction Period|Adverse Event|0|||
30946575|NCT04146363|58991356|FG008|Induction Period|Adverse Event|0|||
30946576|NCT04146363|58991357|FG009|Induction Period|Adverse Event|0|||
30946577|NCT04146363|58991358|FG010|Induction Period|Adverse Event|0|||
30946578|NCT04146363|58991348|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
30946579|NCT04146363|58991349|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
30946580|NCT04146363|58991350|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
30946581|NCT04146363|58991351|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
30946582|NCT04146363|58991352|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
30946583|NCT04146363|58991353|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
30946584|NCT04146363|58991354|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
30946585|NCT04146363|58991355|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
30946586|NCT04146363|58991356|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
30946587|NCT04146363|58991357|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
30946588|NCT04146363|58991358|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
30946589|NCT04146363|58991348|FG000|Induction Period|Lack of Efficacy|7|||
30946590|NCT04146363|58991349|FG001|Induction Period|Lack of Efficacy|2|||
30946591|NCT04146363|58991350|FG002|Induction Period|Lack of Efficacy|0|||
30946592|NCT04146363|58991351|FG003|Induction Period|Lack of Efficacy|0|||
30946593|NCT04146363|58991352|FG004|Induction Period|Lack of Efficacy|0|||
30946594|NCT04146363|58991353|FG005|Induction Period|Lack of Efficacy|0|||
30946595|NCT04146363|58991354|FG006|Induction Period|Lack of Efficacy|0|||
30946596|NCT04146363|58991355|FG007|Induction Period|Lack of Efficacy|0|||
30946597|NCT04146363|58991356|FG008|Induction Period|Lack of Efficacy|0|||
30946598|NCT04146363|58991357|FG009|Induction Period|Lack of Efficacy|0|||
30946599|NCT04146363|58991358|FG010|Induction Period|Lack of Efficacy|0|||
30946600|NCT04146363|58991348|FG000|Induction Period|Lost to Follow-up|1|||
30946601|NCT04146363|58991349|FG001|Induction Period|Lost to Follow-up|4|||
30946602|NCT04146363|58991350|FG002|Induction Period|Lost to Follow-up|0|||
30946603|NCT04146363|58991351|FG003|Induction Period|Lost to Follow-up|0|||
30946604|NCT04146363|58991352|FG004|Induction Period|Lost to Follow-up|0|||
30946605|NCT04146363|58991353|FG005|Induction Period|Lost to Follow-up|0|||
30946606|NCT04146363|58991354|FG006|Induction Period|Lost to Follow-up|0|||
30946607|NCT04146363|58991355|FG007|Induction Period|Lost to Follow-up|0|||
30946608|NCT04146363|58991356|FG008|Induction Period|Lost to Follow-up|0|||
30946609|NCT04146363|58991357|FG009|Induction Period|Lost to Follow-up|0|||
30946610|NCT04146363|58991358|FG010|Induction Period|Lost to Follow-up|0|||
30946611|NCT04146363|58991348|FG000|Induction Period|Positive quantiferon test|0|||
30946612|NCT04146363|58991349|FG001|Induction Period|Positive quantiferon test|1|||
30946613|NCT04146363|58991350|FG002|Induction Period|Positive quantiferon test|0|||
30946614|NCT04146363|58991351|FG003|Induction Period|Positive quantiferon test|0|||
30946615|NCT04146363|58991352|FG004|Induction Period|Positive quantiferon test|0|||
30946616|NCT04146363|58991353|FG005|Induction Period|Positive quantiferon test|0|||
30946617|NCT04146363|58991354|FG006|Induction Period|Positive quantiferon test|0|||
30946618|NCT04146363|58991355|FG007|Induction Period|Positive quantiferon test|0|||
30946619|NCT04146363|58991356|FG008|Induction Period|Positive quantiferon test|0|||
30946620|NCT04146363|58991357|FG009|Induction Period|Positive quantiferon test|0|||
30946621|NCT04146363|58991358|FG010|Induction Period|Positive quantiferon test|0|||
30946622|NCT04146363|58991348|FG000|Induction Period|Protocol Deviation|5|||
30946623|NCT04146363|58991349|FG001|Induction Period|Protocol Deviation|6|||
30946624|NCT04146363|58991350|FG002|Induction Period|Protocol Deviation|0|||
30946625|NCT04146363|58991351|FG003|Induction Period|Protocol Deviation|0|||
30946626|NCT04146363|58991352|FG004|Induction Period|Protocol Deviation|0|||
30946627|NCT04146363|58991353|FG005|Induction Period|Protocol Deviation|0|||
30946628|NCT04146363|58991354|FG006|Induction Period|Protocol Deviation|0|||
30946629|NCT04146363|58991355|FG007|Induction Period|Protocol Deviation|0|||
30946630|NCT04146363|58991356|FG008|Induction Period|Protocol Deviation|0|||
30946631|NCT04146363|58991357|FG009|Induction Period|Protocol Deviation|0|||
30946632|NCT04146363|58991358|FG010|Induction Period|Protocol Deviation|0|||
30946633|NCT04146363|58991348|FG000|Induction Period|Withdrawal by Subject|6|||
30946634|NCT04146363|58991349|FG001|Induction Period|Withdrawal by Subject|3|||
30946635|NCT04146363|58991350|FG002|Induction Period|Withdrawal by Subject|0|||
30625304|NCT00880399|58637390|FG002|Overall Study|Physician Decision|3|||
30946636|NCT04146363|58991351|FG003|Induction Period|Withdrawal by Subject|0|||
30946637|NCT04146363|58991352|FG004|Induction Period|Withdrawal by Subject|0|||
30946638|NCT04146363|58991353|FG005|Induction Period|Withdrawal by Subject|0|||
30946639|NCT04146363|58991354|FG006|Induction Period|Withdrawal by Subject|0|||
30946640|NCT04146363|58991355|FG007|Induction Period|Withdrawal by Subject|0|||
30946641|NCT04146363|58991356|FG008|Induction Period|Withdrawal by Subject|0|||
30946642|NCT04146363|58991357|FG009|Induction Period|Withdrawal by Subject|0|||
30946643|NCT04146363|58991358|FG010|Induction Period|Withdrawal by Subject|0|||
30946644|NCT04146363|58991348|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
30946645|NCT04146363|58991349|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
30946646|NCT04146363|58991350|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
30946647|NCT04146363|58991351|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
30946648|NCT04146363|58991352|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
30946649|NCT04146363|58991353|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
30946650|NCT04146363|58991354|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
30946651|NCT04146363|58991355|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
30946652|NCT04146363|58991356|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
30946653|NCT04146363|58991357|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
30946654|NCT04146363|58991358|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
30946655|NCT04146363|58991348|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30946656|NCT04146363|58991349|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30946657|NCT04146363|58991350|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30946658|NCT04146363|58991351|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30946659|NCT04146363|58991352|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30946660|NCT04146363|58991353|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30946661|NCT04146363|58991354|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30946662|NCT04146363|58991355|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
30946663|NCT04146363|58991356|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30946664|NCT04146363|58991357|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30946665|NCT04146363|58991358|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
30946666|NCT04146363|58991348|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30946667|NCT04146363|58991349|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30946668|NCT04146363|58991350|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30946669|NCT04146363|58991351|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30946670|NCT04146363|58991352|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30946671|NCT04146363|58991353|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30946672|NCT04146363|58991354|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
30946673|NCT04146363|58991355|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
30946674|NCT04146363|58991356|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30946675|NCT04146363|58991357|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30946676|NCT04146363|58991358|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
30946677|NCT04146363|58991348|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
30946678|NCT04146363|58991349|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
30946679|NCT04146363|58991350|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
30946680|NCT04146363|58991351|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
30946681|NCT04146363|58991352|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
30946682|NCT04146363|58991353|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
30946683|NCT04146363|58991354|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
30946684|NCT04146363|58991355|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
30946685|NCT04146363|58991356|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
30946686|NCT04146363|58991357|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
30946687|NCT04146363|58991358|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
30946688|NCT04146363|58991348|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30946689|NCT04146363|58991349|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30946690|NCT04146363|58991350|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30946691|NCT04146363|58991351|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30946692|NCT04146363|58991352|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
30946693|NCT04146363|58991353|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
30946694|NCT04146363|58991354|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
30946695|NCT04146363|58991355|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
30946696|NCT04146363|58991356|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30946697|NCT04146363|58991357|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30946698|NCT04146363|58991358|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
30946699|NCT04146363|58991348|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30946700|NCT04146363|58991349|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30759956|NCT00103857|58768269|FG003|54-Week Base Study|Withdrawal by Subject|15|||
30759957|NCT00103857|58768270|FG004|54-Week Base Study|Withdrawal by Subject|10|||
30946701|NCT04146363|58991350|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
30946702|NCT04146363|58991351|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30946703|NCT04146363|58991352|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30946704|NCT04146363|58991353|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
30946705|NCT04146363|58991354|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
30946706|NCT04146363|58991355|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
30946707|NCT04146363|58991356|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30946708|NCT04146363|58991357|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30946709|NCT04146363|58991358|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
30946710|NCT04146363|58991348|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
30946711|NCT04146363|58991349|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
30946712|NCT04146363|58991350|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
30946713|NCT04146363|58991351|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
30759958|NCT00103857|58768271|FG005|54-Week Base Study|Withdrawal by Subject|15|||
30759959|NCT00103857|58768272|FG006|54-Week Base Study|Withdrawal by Subject|4|||
30759960|NCT00103857|58768266|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
30759961|NCT00103857|58768267|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
30759962|NCT00103857|58768268|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
30759963|NCT00103857|58768269|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
30759964|NCT00103857|58768270|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
30759965|NCT00103857|58768271|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
30759966|NCT00103857|58768272|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
30759967|NCT00103857|58768266|FG000|54-Week Base Study|patient moved|0|||
30759968|NCT00103857|58768267|FG001|54-Week Base Study|patient moved|1|||
30759969|NCT00103857|58768268|FG002|54-Week Base Study|patient moved|1|||
30759970|NCT00103857|58768269|FG003|54-Week Base Study|patient moved|2|||
30759971|NCT00103857|58768270|FG004|54-Week Base Study|patient moved|3|||
30759972|NCT00103857|58768271|FG005|54-Week Base Study|patient moved|1|||
30759973|NCT00103857|58768272|FG006|54-Week Base Study|patient moved|0|||
30759974|NCT00103857|58768266|FG000|54-Week Base Study|non-compliance with study procedures|1|||
30759975|NCT00103857|58768267|FG001|54-Week Base Study|non-compliance with study procedures|2|||
30759976|NCT00103857|58768268|FG002|54-Week Base Study|non-compliance with study procedures|0|||
30759977|NCT00103857|58768269|FG003|54-Week Base Study|non-compliance with study procedures|0|||
30759978|NCT00103857|58768270|FG004|54-Week Base Study|non-compliance with study procedures|0|||
30759979|NCT00103857|58768271|FG005|54-Week Base Study|non-compliance with study procedures|2|||
30759980|NCT00103857|58768272|FG006|54-Week Base Study|non-compliance with study procedures|0|||
30759981|NCT00103857|58768266|FG000|54-Week Base Study|patient incarcerated|0|||
30759982|NCT00103857|58768267|FG001|54-Week Base Study|patient incarcerated|0|||
30759983|NCT00103857|58768268|FG002|54-Week Base Study|patient incarcerated|0|||
30759984|NCT00103857|58768269|FG003|54-Week Base Study|patient incarcerated|0|||
30759985|NCT00103857|58768270|FG004|54-Week Base Study|patient incarcerated|1|||
30759986|NCT00103857|58768271|FG005|54-Week Base Study|patient incarcerated|1|||
30759987|NCT00103857|58768272|FG006|54-Week Base Study|patient incarcerated|0|||
30759988|NCT00103857|58768266|FG000|54-Week Base Study|laboratory reporting error|0|||
30759989|NCT00103857|58768267|FG001|54-Week Base Study|laboratory reporting error|0|||
30759990|NCT00103857|58768268|FG002|54-Week Base Study|laboratory reporting error|0|||
30759991|NCT00103857|58768269|FG003|54-Week Base Study|laboratory reporting error|0|||
30759992|NCT00103857|58768270|FG004|54-Week Base Study|laboratory reporting error|1|||
30759993|NCT00103857|58768271|FG005|54-Week Base Study|laboratory reporting error|0|||
30759994|NCT00103857|58768272|FG006|54-Week Base Study|laboratory reporting error|0|||
30759995|NCT00103857|58768266|FG000|54-Week Base Study|site error|0|||
30759996|NCT00103857|58768267|FG001|54-Week Base Study|site error|0|||
30759997|NCT00103857|58768268|FG002|54-Week Base Study|site error|0|||
30759998|NCT00103857|58768269|FG003|54-Week Base Study|site error|0|||
30759999|NCT00103857|58768270|FG004|54-Week Base Study|site error|0|||
30760000|NCT00103857|58768271|FG005|54-Week Base Study|site error|1|||
30760001|NCT00103857|58768272|FG006|54-Week Base Study|site error|0|||
30760002|NCT00103857|58768266|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
30760003|NCT00103857|58768267|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
30760004|NCT00103857|58768268|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
30760005|NCT00103857|58768269|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
30760006|NCT00103857|58768270|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
30760007|NCT00103857|58768271|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
30760008|NCT00103857|58768272|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
30760009|NCT00103857|58768266|FG000|50-Week Extension Study|Adverse Event|2|||
30760010|NCT00103857|58768267|FG001|50-Week Extension Study|Adverse Event|3|||
30760011|NCT00103857|58768268|FG002|50-Week Extension Study|Adverse Event|2|||
30760012|NCT00103857|58768269|FG003|50-Week Extension Study|Adverse Event|0|||
30843006|NCT02667236|58868922|FG001|Overall Study|Adverse Event|1|||
30946714|NCT04146363|58991352|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
30946715|NCT04146363|58991353|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
30946716|NCT04146363|58991354|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
30946717|NCT04146363|58991355|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
30946718|NCT04146363|58991356|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
30946719|NCT04146363|58991357|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
30946720|NCT04146363|58991358|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
30946721|NCT04146363|58991348|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30946722|NCT04146363|58991349|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30946723|NCT04146363|58991350|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30946724|NCT04146363|58991351|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30946725|NCT04146363|58991352|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30946726|NCT04146363|58991353|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30946727|NCT04146363|58991354|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30946728|NCT04146363|58991355|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30946729|NCT04146363|58991356|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
30946730|NCT04146363|58991357|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
30946731|NCT04146363|58991358|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
30946732|NCT04146363|58991348|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30946733|NCT04146363|58991349|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30946734|NCT04146363|58991350|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30946735|NCT04146363|58991351|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30946736|NCT04146363|58991352|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30946737|NCT04146363|58991353|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30946738|NCT04146363|58991354|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30946739|NCT04146363|58991355|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30946740|NCT04146363|58991356|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
30946741|NCT04146363|58991357|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
30946742|NCT04146363|58991358|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30946743|NCT04146363|58991348|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
30946744|NCT04146363|58991349|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
30946745|NCT04146363|58991350|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
30946746|NCT04146363|58991351|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
30946747|NCT04146363|58991352|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
30946748|NCT04146363|58991353|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
30946749|NCT04146363|58991354|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
30946750|NCT04146363|58991355|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
30946751|NCT04146363|58991356|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
30946752|NCT04146363|58991357|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
30946753|NCT04146363|58991358|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
30946754|NCT04146363|58991348|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30946755|NCT04146363|58991349|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30946756|NCT04146363|58991350|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30946757|NCT04146363|58991351|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30946758|NCT04146363|58991352|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30946759|NCT04146363|58991353|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30946760|NCT04146363|58991354|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30946761|NCT04146363|58991355|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30946762|NCT04146363|58991356|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
30946763|NCT04146363|58991357|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
30946764|NCT04146363|58991358|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
30946765|NCT04146363|58991348|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
30946766|NCT04146363|58991349|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
30946767|NCT04146363|58991350|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
30946768|NCT04146363|58991351|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
30946769|NCT04146363|58991352|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
30946770|NCT04146363|58991353|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
30946771|NCT04146363|58991354|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
30946772|NCT04146363|58991355|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
30946773|NCT04146363|58991356|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
30946774|NCT04146363|58991357|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
30946775|NCT04146363|58991358|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
30946776|NCT04146363|58991348|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
30946777|NCT04146363|58991349|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
30946778|NCT04146363|58991350|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
30946779|NCT04146363|58991351|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
30946780|NCT04146363|58991352|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
30946781|NCT04146363|58991353|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
30946782|NCT04146363|58991354|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
30946783|NCT04146363|58991355|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
30946784|NCT04146363|58991356|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
30946785|NCT04146363|58991357|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
30946786|NCT04146363|58991358|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
30946787|NCT01838941|58991383|FG000|Overall Study|Adverse Event|1|||
30946788|NCT01838941|58991383|FG000|Overall Study|Withdrawal by Subject|1|||
30946789|NCT01773109|58991388|FG000|Overall Study|Symptomatic Progression|2|||
30946790|NCT01773109|58991388|FG000|Overall Study|Death|1|||
30946791|NCT01772719|58991392|FG000|Overall Study|Withdrawal by Subject|3|||
30946792|NCT01772719|58991392|FG000|Overall Study|Adverse Event|2|||
30946793|NCT01772719|58991392|FG000|Overall Study|Protocol Violation|1|||
30946794|NCT01772719|58991392|FG000|Overall Study|Lost to Follow-up|1|||
30946795|NCT01798927|58991399|FG000|Overall Study|Withdrawal by Subject|1|||
30946796|NCT01276288|58991468|FG000|Overall Study|Adverse Event|1|||
30946797|NCT01276288|58991469|FG001|Overall Study|Adverse Event|1|||
30946798|NCT01276288|58991470|FG002|Overall Study|Adverse Event|0|||
30946799|NCT01276288|58991471|FG003|Overall Study|Adverse Event|0|||
30946800|NCT01276288|58991468|FG000|Overall Study|not treated|1|||
30946801|NCT01276288|58991469|FG001|Overall Study|not treated|0|||
30946802|NCT01276288|58991470|FG002|Overall Study|not treated|0|||
30946803|NCT01276288|58991471|FG003|Overall Study|not treated|0|||
30946804|NCT02702271|58991495|FG000|Overall Study|Death|36|||
30946805|NCT02702271|58991496|FG001|Overall Study|Death|7|||
30946806|NCT02702271|58991495|FG000|Overall Study|Lost to Follow-up|12|||
30946807|NCT02702271|58991496|FG001|Overall Study|Lost to Follow-up|0|||
30946808|NCT02702271|58991495|FG000|Overall Study|Withdrawal by Subject|8|||
30946809|NCT02702271|58991496|FG001|Overall Study|Withdrawal by Subject|1|||
30946810|NCT02702271|58991495|FG000|Overall Study|Physician Decision|2|||
30946811|NCT02702271|58991496|FG001|Overall Study|Physician Decision|0|||
30946812|NCT02702271|58991495|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
30843007|NCT02667236|58868921|FG000|Overall Study|Withdrawal by Subject|2|||
30946813|NCT02702271|58991496|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
30946814|NCT01276054|58991581|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
30946815|NCT01276054|58991582|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
30946816|NCT01798849|58991591|FG000|Overall Study|Physician Decision|0|||
30946817|NCT01798849|58991592|FG001|Overall Study|Physician Decision|0|||
30946818|NCT01798849|58991593|FG002|Overall Study|Physician Decision|1|||
30946819|NCT01797835|58991673|FG000|Overall Study|Lost to Follow-up|31|||
30946820|NCT01797835|58991674|FG001|Overall Study|Lost to Follow-up|27|||
30946821|NCT01275430|58991680|FG000|Overall Study|Adverse Event|1|||
30946822|NCT01275430|58991680|FG000|Overall Study|No Contrast Injection|6|||
30946823|NCT01275430|58991680|FG000|Overall Study|Device Malfunction|1|||
30946824|NCT01275430|58991680|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
30946825|NCT01838551|58991685|FG000|Overall Study|Adverse Event|16|||
30946826|NCT01838551|58991685|FG000|Overall Study|Death|1|||
30946827|NCT01838551|58991685|FG000|Overall Study|Lack of Efficacy|10|||
30946828|NCT01838551|58991685|FG000|Overall Study|Physician Decision|4|||
30946829|NCT01838551|58991685|FG000|Overall Study|Withdrawal by Subject|10|||
30946830|NCT01838551|58991685|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
30946831|NCT01797445|58991691|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
30946832|NCT01797445|58991692|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
30946833|NCT01797445|58991691|FG000|Double-Blind Phase|Adverse Event|3|||
30946834|NCT01797445|58991692|FG001|Double-Blind Phase|Adverse Event|0|||
30946835|NCT01797445|58991691|FG000|Double-Blind Phase|Death|5|||
30946836|NCT01797445|58991692|FG001|Double-Blind Phase|Death|4|||
30946837|NCT01797445|58991691|FG000|Double-Blind Phase|Pregnancy|0|||
30946838|NCT01797445|58991692|FG001|Double-Blind Phase|Pregnancy|1|||
30946839|NCT01797445|58991691|FG000|Double-Blind Phase|Lack of Efficacy|1|||
30946840|NCT01797445|58991692|FG001|Double-Blind Phase|Lack of Efficacy|2|||
30946841|NCT01797445|58991691|FG000|Double-Blind Phase|Investigator's Discretion|15|||
30946842|NCT01797445|58991692|FG001|Double-Blind Phase|Investigator's Discretion|17|||
30946843|NCT01797445|58991691|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
30946844|NCT01797445|58991692|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
30760013|NCT00103857|58768270|FG004|50-Week Extension Study|Adverse Event|1|||
30946845|NCT01797445|58991691|FG000|Double-Blind Phase|Protocol Violation|0|||
30946846|NCT01797445|58991692|FG001|Double-Blind Phase|Protocol Violation|1|||
30946847|NCT01797445|58991691|FG000|Double-Blind Phase|Withdrew Consent|20|||
30946848|NCT01797445|58991692|FG001|Double-Blind Phase|Withdrew Consent|35|||
30946849|NCT01797445|58991691|FG000|Double-Blind Phase|Lost to Follow-up|34|||
30946850|NCT01797445|58991692|FG001|Double-Blind Phase|Lost to Follow-up|26|||
30946851|NCT01797445|58991691|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
30946852|NCT01797445|58991692|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
30946853|NCT01611259|58991700|FG000|Overall Study|Physician Decision|1|||
30946854|NCT01611259|58991700|FG000|Overall Study|Lack of Efficacy|2|||
30946855|NCT01611259|58991700|FG000|Overall Study|Adverse Event|4|||
30946856|NCT01611259|58991700|FG000|Overall Study|Withdrawal by Subject|7|||
30946857|NCT01795495|58991707|FG000|Overall Study|Protocol Violation|1|||
30946858|NCT01795495|58991708|FG001|Overall Study|Protocol Violation|0|||
30946859|NCT01795495|58991709|FG002|Overall Study|Protocol Violation|1|||
30946860|NCT01795495|58991707|FG000|Overall Study|Physician Decision|0|||
30946861|NCT01795495|58991708|FG001|Overall Study|Physician Decision|0|||
30946862|NCT01795495|58991709|FG002|Overall Study|Physician Decision|1|||
30946863|NCT01794949|58991719|FG000|Overall Study|Lost to Follow-up|1|||
30946864|NCT01794949|58991720|FG001|Overall Study|Lost to Follow-up|0|||
30946865|NCT01770379|58991729|FG000|Overall Study|Technical issues|1|||
30946866|NCT01770379|58991730|FG001|Overall Study|Technical issues|0|||
30946867|NCT01770379|58991731|FG002|Overall Study|Technical issues|0|||
30946868|NCT01770379|58991729|FG000|Overall Study|Withdrawal by Subject|7|||
30946869|NCT01770379|58991730|FG001|Overall Study|Withdrawal by Subject|10|||
30946870|NCT01770379|58991731|FG002|Overall Study|Withdrawal by Subject|7|||
30946871|NCT01770379|58991729|FG000|Overall Study|study terminated by sponsor|22|||
30946872|NCT01770379|58991730|FG001|Overall Study|study terminated by sponsor|23|||
30946873|NCT01770379|58991731|FG002|Overall Study|study terminated by sponsor|22|||
30946874|NCT01770379|58991729|FG000|Overall Study|Protocol Violation|0|||
30946875|NCT01770379|58991730|FG001|Overall Study|Protocol Violation|1|||
30946876|NCT01770379|58991731|FG002|Overall Study|Protocol Violation|1|||
30946877|NCT01770379|58991729|FG000|Overall Study|Physician Decision|0|||
30946878|NCT01770379|58991730|FG001|Overall Study|Physician Decision|1|||
30946879|NCT01770379|58991731|FG002|Overall Study|Physician Decision|2|||
30946880|NCT01770379|58991729|FG000|Overall Study|Lost to Follow-up|0|||
30946881|NCT01770379|58991730|FG001|Overall Study|Lost to Follow-up|0|||
30946882|NCT01770379|58991731|FG002|Overall Study|Lost to Follow-up|2|||
30946883|NCT01770379|58991729|FG000|Overall Study|Lack of Efficacy|8|||
30946884|NCT01770379|58991730|FG001|Overall Study|Lack of Efficacy|6|||
30946885|NCT01770379|58991731|FG002|Overall Study|Lack of Efficacy|6|||
30946886|NCT01770379|58991729|FG000|Overall Study|Adverse Event|1|||
30946887|NCT01770379|58991730|FG001|Overall Study|Adverse Event|3|||
30946888|NCT01770379|58991731|FG002|Overall Study|Adverse Event|2|||
30946889|NCT01986881|58991744|FG000|Overall Study|Death|228|||
30760014|NCT00103857|58768271|FG005|50-Week Extension Study|Adverse Event|1|||
30760015|NCT00103857|58768272|FG006|50-Week Extension Study|Adverse Event|0|||
30760016|NCT00103857|58768266|FG000|50-Week Extension Study|Death|0|||
30760017|NCT00103857|58768267|FG001|50-Week Extension Study|Death|0|||
30760018|NCT00103857|58768268|FG002|50-Week Extension Study|Death|0|||
30760019|NCT00103857|58768269|FG003|50-Week Extension Study|Death|1|||
30760020|NCT00103857|58768270|FG004|50-Week Extension Study|Death|0|||
30760021|NCT00103857|58768271|FG005|50-Week Extension Study|Death|1|||
30760022|NCT00103857|58768272|FG006|50-Week Extension Study|Death|0|||
30760023|NCT00103857|58768266|FG000|50-Week Extension Study|Lack of Efficacy|26|||
30760024|NCT00103857|58768267|FG001|50-Week Extension Study|Lack of Efficacy|15|||
30760025|NCT00103857|58768268|FG002|50-Week Extension Study|Lack of Efficacy|13|||
30760026|NCT00103857|58768269|FG003|50-Week Extension Study|Lack of Efficacy|16|||
30760027|NCT00103857|58768270|FG004|50-Week Extension Study|Lack of Efficacy|8|||
30760028|NCT00103857|58768271|FG005|50-Week Extension Study|Lack of Efficacy|8|||
30760029|NCT00103857|58768272|FG006|50-Week Extension Study|Lack of Efficacy|0|||
30760030|NCT00103857|58768266|FG000|50-Week Extension Study|Lost to Follow-up|4|||
30760031|NCT00103857|58768267|FG001|50-Week Extension Study|Lost to Follow-up|0|||
30760032|NCT00103857|58768268|FG002|50-Week Extension Study|Lost to Follow-up|1|||
30760033|NCT00103857|58768269|FG003|50-Week Extension Study|Lost to Follow-up|4|||
30760034|NCT00103857|58768270|FG004|50-Week Extension Study|Lost to Follow-up|3|||
30760035|NCT00103857|58768271|FG005|50-Week Extension Study|Lost to Follow-up|3|||
30760036|NCT00103857|58768272|FG006|50-Week Extension Study|Lost to Follow-up|0|||
30760037|NCT00103857|58768266|FG000|50-Week Extension Study|Physician Decision|0|||
30760038|NCT00103857|58768267|FG001|50-Week Extension Study|Physician Decision|1|||
30760039|NCT00103857|58768268|FG002|50-Week Extension Study|Physician Decision|1|||
30760040|NCT00103857|58768269|FG003|50-Week Extension Study|Physician Decision|0|||
30760041|NCT00103857|58768270|FG004|50-Week Extension Study|Physician Decision|0|||
30946890|NCT01986881|58991745|FG001|Overall Study|Death|233|||
30760042|NCT00103857|58768271|FG005|50-Week Extension Study|Physician Decision|0|||
30760043|NCT00103857|58768272|FG006|50-Week Extension Study|Physician Decision|0|||
30760044|NCT00103857|58768266|FG000|50-Week Extension Study|Pregnancy|0|||
30760045|NCT00103857|58768267|FG001|50-Week Extension Study|Pregnancy|0|||
30760046|NCT00103857|58768268|FG002|50-Week Extension Study|Pregnancy|1|||
30946891|NCT01986881|58991746|FG002|Overall Study|Death|247|||
30946892|NCT01986881|58991744|FG000|Overall Study|Lost to Follow-up|51|||
30946893|NCT01986881|58991745|FG001|Overall Study|Lost to Follow-up|44|||
30946894|NCT01986881|58991746|FG002|Overall Study|Lost to Follow-up|55|||
30946895|NCT01986881|58991744|FG000|Overall Study|Physician Decision|7|||
30946896|NCT01986881|58991745|FG001|Overall Study|Physician Decision|4|||
30946897|NCT01986881|58991746|FG002|Overall Study|Physician Decision|6|||
30946898|NCT01986881|58991744|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
30946899|NCT01986881|58991745|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
30946900|NCT01986881|58991746|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
30946901|NCT01986881|58991744|FG000|Overall Study|Withdrawal by Subject|41|||
30946902|NCT01986881|58991745|FG001|Overall Study|Withdrawal by Subject|60|||
30946903|NCT01986881|58991746|FG002|Overall Study|Withdrawal by Subject|45|||
30946904|NCT01986881|58991744|FG000|Overall Study|Subject Moved|0|||
30946905|NCT01986881|58991745|FG001|Overall Study|Subject Moved|1|||
30946906|NCT01986881|58991746|FG002|Overall Study|Subject Moved|0|||
30946907|NCT01986881|58991744|FG000|Overall Study|Other|1|||
30946908|NCT01986881|58991745|FG001|Overall Study|Other|2|||
30946909|NCT01986881|58991746|FG002|Overall Study|Other|2|||
30946910|NCT01609543|58991777|FG000|Overall Study|Disease Progression|28|||
30946911|NCT01609543|58991777|FG000|Overall Study|Adverse Event|5|||
30946912|NCT01609543|58991777|FG000|Overall Study|Withdrawal by Subject|1|||
30946913|NCT01609543|58991777|FG000|Overall Study|Protocol Violation|1|||
30946914|NCT01609543|58991777|FG000|Overall Study|Death|7|||
30946915|NCT02003183|58991784|FG000|Overall Study|Lost to Follow-up|0|||
30946916|NCT02003183|58991785|FG001|Overall Study|Lost to Follow-up|2|||
30946917|NCT01986647|58991795|FG000|Overall Study|Lost to Follow-up|4|||
30946918|NCT01986647|58991796|FG001|Overall Study|Lost to Follow-up|1|||
30946919|NCT01986647|58991797|FG002|Overall Study|Lost to Follow-up|4|||
30946920|NCT01986647|58991798|FG003|Overall Study|Lost to Follow-up|4|||
30946921|NCT01986647|58991795|FG000|Overall Study|Withdrawal by Subject|1|||
30946922|NCT01986647|58991796|FG001|Overall Study|Withdrawal by Subject|3|||
30760047|NCT00103857|58768269|FG003|50-Week Extension Study|Pregnancy|0|||
30760048|NCT00103857|58768270|FG004|50-Week Extension Study|Pregnancy|1|||
30760049|NCT00103857|58768271|FG005|50-Week Extension Study|Pregnancy|0|||
30760050|NCT00103857|58768272|FG006|50-Week Extension Study|Pregnancy|0|||
30760051|NCT00103857|58768266|FG000|50-Week Extension Study|Protocol Violation|1|||
30760052|NCT00103857|58768267|FG001|50-Week Extension Study|Protocol Violation|1|||
30760053|NCT00103857|58768268|FG002|50-Week Extension Study|Protocol Violation|1|||
30760054|NCT00103857|58768269|FG003|50-Week Extension Study|Protocol Violation|2|||
30760055|NCT00103857|58768270|FG004|50-Week Extension Study|Protocol Violation|0|||
30760056|NCT00103857|58768271|FG005|50-Week Extension Study|Protocol Violation|1|||
30760057|NCT00103857|58768272|FG006|50-Week Extension Study|Protocol Violation|0|||
30760058|NCT00103857|58768266|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
30760059|NCT00103857|58768267|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
30760060|NCT00103857|58768268|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
30760061|NCT00103857|58768269|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
30760062|NCT00103857|58768270|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
30760063|NCT00103857|58768271|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
30760064|NCT00103857|58768272|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
30760065|NCT00103857|58768266|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
30760066|NCT00103857|58768267|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
30760067|NCT00103857|58768268|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
30946923|NCT01986647|58991797|FG002|Overall Study|Withdrawal by Subject|2|||
30946924|NCT01986647|58991798|FG003|Overall Study|Withdrawal by Subject|3|||
30946925|NCT01986647|58991795|FG000|Overall Study|Health|5|||
30946926|NCT01986647|58991796|FG001|Overall Study|Health|3|||
30946927|NCT01986647|58991797|FG002|Overall Study|Health|6|||
30946928|NCT01986647|58991798|FG003|Overall Study|Health|4|||
30760068|NCT00103857|58768269|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
30946929|NCT02002091|58991814|FG000|Screening|Lost to Follow-up|10|||
30946930|NCT02002091|58991815|FG001|Screening|Lost to Follow-up|12|||
30946931|NCT02002091|58991814|FG000|Screening|Death|3|||
30946932|NCT02002091|58991815|FG001|Screening|Death|2|||
30946933|NCT01985321|58991852|FG000|Overall Study|Protocol Violation|4|||
30946934|NCT01985321|58991853|FG001|Overall Study|Protocol Violation|3|||
30946935|NCT01985321|58991852|FG000|Overall Study|Withdrawal by Subject|1|||
30946936|NCT01985321|58991853|FG001|Overall Study|Withdrawal by Subject|0|||
30946937|NCT01985321|58991852|FG000|Overall Study|Lost to Follow-up|5|||
30946938|NCT01985321|58991853|FG001|Overall Study|Lost to Follow-up|2|||
30946939|NCT01985321|58991852|FG000|Overall Study|Subject treated wrong type of sore|1|||
30946940|NCT01985321|58991853|FG001|Overall Study|Subject treated wrong type of sore|0|||
30946941|NCT02000921|58991862|FG000|Overall Study|Withdrawal by Subject|3|||
30946942|NCT02000921|58991863|FG001|Overall Study|Withdrawal by Subject|10|||
30946943|NCT02000921|58991864|FG002|Overall Study|Withdrawal by Subject|5|||
30946944|NCT02000921|58991862|FG000|Overall Study|Lost to Follow-up|2|||
30946945|NCT02000921|58991863|FG001|Overall Study|Lost to Follow-up|4|||
30946946|NCT02000921|58991864|FG002|Overall Study|Lost to Follow-up|5|||
30946947|NCT02000921|58991862|FG000|Overall Study|Physician Decision|0|||
30946948|NCT02000921|58991863|FG001|Overall Study|Physician Decision|2|||
30946949|NCT02000921|58991864|FG002|Overall Study|Physician Decision|0|||
30946950|NCT01836523|58991910|FG000|Overall Study|Adverse Event|15|||
30946951|NCT01836523|58991911|FG001|Overall Study|Adverse Event|41|||
30946952|NCT01836523|58991912|FG002|Overall Study|Adverse Event|49|||
30946953|NCT01836523|58991913|FG003|Overall Study|Adverse Event|14|||
30946954|NCT01836523|58991910|FG000|Overall Study|Protocol Violation|6|||
30946955|NCT01836523|58991911|FG001|Overall Study|Protocol Violation|3|||
30946956|NCT01836523|58991912|FG002|Overall Study|Protocol Violation|2|||
30946957|NCT01836523|58991913|FG003|Overall Study|Protocol Violation|4|||
30946958|NCT01836523|58991910|FG000|Overall Study|Met Withdrawal Criteria|13|||
30946959|NCT01836523|58991911|FG001|Overall Study|Met Withdrawal Criteria|13|||
30946960|NCT01836523|58991912|FG002|Overall Study|Met Withdrawal Criteria|21|||
30946961|NCT01836523|58991913|FG003|Overall Study|Met Withdrawal Criteria|27|||
30946962|NCT01836523|58991910|FG000|Overall Study|Unclassified|17|||
30946963|NCT01836523|58991911|FG001|Overall Study|Unclassified|28|||
30946964|NCT01836523|58991912|FG002|Overall Study|Unclassified|19|||
30946965|NCT01836523|58991913|FG003|Overall Study|Unclassified|29|||
30946966|NCT01275196|58991925|FG000|Overall Study|Adverse Event|3|||
30946967|NCT01275196|58991926|FG001|Overall Study|Adverse Event|5|||
30946968|NCT01275196|58991925|FG000|Overall Study|Withdrawal by Subject|4|||
30946969|NCT01275196|58991926|FG001|Overall Study|Withdrawal by Subject|5|||
30946970|NCT01275196|58991925|FG000|Overall Study|Lost to Follow-up|1|||
30946971|NCT01275196|58991926|FG001|Overall Study|Lost to Follow-up|0|||
30946972|NCT01275196|58991925|FG000|Overall Study|Disease Progression|6|||
30946973|NCT01275196|58991926|FG001|Overall Study|Disease Progression|5|||
30946974|NCT01275196|58991925|FG000|Overall Study|Protocol Violation|1|||
30946975|NCT01275196|58991926|FG001|Overall Study|Protocol Violation|0|||
30946976|NCT01275196|58991925|FG000|Overall Study|Suboptimal response/treatment failure|5|||
30946977|NCT01275196|58991926|FG001|Overall Study|Suboptimal response/treatment failure|6|||
30946978|NCT01984697|58991939|FG000|Overall Study|Adverse Event|0|||
30946979|NCT01984697|58991940|FG001|Overall Study|Adverse Event|0|||
30946980|NCT01984697|58991941|FG002|Overall Study|Adverse Event|2|||
30946981|NCT01984697|58991942|FG003|Overall Study|Adverse Event|0|||
30946982|NCT01984697|58991943|FG004|Overall Study|Adverse Event|0|||
30946983|NCT01984697|58991939|FG000|Overall Study|Lost to Follow-up|14|||
30946984|NCT01984697|58991940|FG001|Overall Study|Lost to Follow-up|5|||
30946985|NCT01984697|58991941|FG002|Overall Study|Lost to Follow-up|10|||
30946986|NCT01984697|58991942|FG003|Overall Study|Lost to Follow-up|6|||
30946987|NCT01984697|58991943|FG004|Overall Study|Lost to Follow-up|21|||
30946988|NCT01984697|58991939|FG000|Overall Study|Physician Decision|3|||
30946989|NCT01984697|58991940|FG001|Overall Study|Physician Decision|0|||
30946990|NCT01984697|58991941|FG002|Overall Study|Physician Decision|0|||
30946991|NCT01984697|58991942|FG003|Overall Study|Physician Decision|1|||
30946992|NCT01984697|58991943|FG004|Overall Study|Physician Decision|0|||
30946993|NCT01984697|58991939|FG000|Overall Study|Protocol Violation|8|||
30946994|NCT01984697|58991940|FG001|Overall Study|Protocol Violation|5|||
30946995|NCT01984697|58991941|FG002|Overall Study|Protocol Violation|3|||
30946996|NCT01984697|58991942|FG003|Overall Study|Protocol Violation|2|||
30946997|NCT01984697|58991943|FG004|Overall Study|Protocol Violation|0|||
30946998|NCT01984697|58991939|FG000|Overall Study|Withdrawal by Subject|15|||
30946999|NCT01984697|58991940|FG001|Overall Study|Withdrawal by Subject|21|||
30947000|NCT01984697|58991941|FG002|Overall Study|Withdrawal by Subject|13|||
30947001|NCT01984697|58991942|FG003|Overall Study|Withdrawal by Subject|11|||
30947002|NCT01984697|58991943|FG004|Overall Study|Withdrawal by Subject|13|||
30947003|NCT01984697|58991939|FG000|Overall Study|Missed last follow-up visit|1|||
30947004|NCT01984697|58991940|FG001|Overall Study|Missed last follow-up visit|0|||
30947005|NCT01984697|58991941|FG002|Overall Study|Missed last follow-up visit|0|||
30947006|NCT01984697|58991942|FG003|Overall Study|Missed last follow-up visit|0|||
30947007|NCT01984697|58991943|FG004|Overall Study|Missed last follow-up visit|0|||
30947008|NCT01984697|58991939|FG000|Overall Study|Death|0|||
30947009|NCT01984697|58991940|FG001|Overall Study|Death|0|||
30843008|NCT02667236|58868922|FG001|Overall Study|Withdrawal by Subject|0|||
30947010|NCT01984697|58991941|FG002|Overall Study|Death|0|||
30947011|NCT01984697|58991942|FG003|Overall Study|Death|1|||
30947012|NCT01984697|58991943|FG004|Overall Study|Death|0|||
30947013|NCT01984697|58991939|FG000|Overall Study|Pregnancy|2|||
30947014|NCT01984697|58991940|FG001|Overall Study|Pregnancy|0|||
30947015|NCT01984697|58991941|FG002|Overall Study|Pregnancy|1|||
30947016|NCT01984697|58991942|FG003|Overall Study|Pregnancy|0|||
30947017|NCT01984697|58991943|FG004|Overall Study|Pregnancy|1|||
30947018|NCT02000531|58991957|FG000|Overall Study|Lost to Follow-up|1|||
30947019|NCT02000531|58991958|FG001|Overall Study|Lost to Follow-up|0|||
30947020|NCT02000531|58991957|FG000|Overall Study|Discontinued due to data cut-off|3|||
30947021|NCT02000531|58991958|FG001|Overall Study|Discontinued due to data cut-off|8|||
30947022|NCT01609231|58991966|FG000|Overall Study|Adverse Event|1|||
30947023|NCT01609231|58991967|FG001|Overall Study|Adverse Event|3|||
30947024|NCT01609231|58991966|FG000|Overall Study|Physician Decision|1|||
30947025|NCT01609231|58991967|FG001|Overall Study|Physician Decision|0|||
30947026|NCT01609231|58991966|FG000|Overall Study|Withdrawal by Subject|1|||
30947027|NCT01609231|58991967|FG001|Overall Study|Withdrawal by Subject|0|||
30947028|NCT01793935|58991975|FG000|Overall Study|Pregnancy|1|||
30947029|NCT01793935|58991976|FG001|Overall Study|Pregnancy|0|||
30947030|NCT01793935|58991975|FG000|Overall Study|Protocol Violation|2|||
30947031|NCT01793935|58991976|FG001|Overall Study|Protocol Violation|1|||
30947032|NCT01793935|58991975|FG000|Overall Study|Adverse Event|2|||
30947033|NCT01793935|58991976|FG001|Overall Study|Adverse Event|0|||
30947034|NCT01793935|58991975|FG000|Overall Study|Patient did not take study medication|1|||
30947035|NCT01793935|58991976|FG001|Overall Study|Patient did not take study medication|1|||
30947036|NCT01793935|58991975|FG000|Overall Study|Lost to Follow-up|0|||
30947037|NCT01793935|58991976|FG001|Overall Study|Lost to Follow-up|1|||
30947038|NCT02092025|58991982|FG000|Overall Study|Case Report Forms Uncollected|44|||
30947039|NCT02092025|58991982|FG000|Overall Study|Protocol Deviation|24|||
30947040|NCT01769443|58991988|FG000|Overall Study|Study closure|1|||
30947041|NCT01769443|58991989|FG001|Overall Study|Study closure|0|||
30947042|NCT01768117|58991996|FG000|Overall Study|Lost to Follow-up|1|||
30947043|NCT01768117|58991996|FG000|Overall Study|Withdrawal by Subject|2|||
30947044|NCT01768117|58991996|FG000|Overall Study|Protocol Violation|3|||
30947045|NCT01767493|58992000|FG000|Overall Study|screen failures|3|||
30947046|NCT01274182|58992007|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
30947047|NCT01274182|58992008|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
30947048|NCT01274182|58992009|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
30947049|NCT01274182|58992007|FG000|Overall Study|Adverse Event|4|||
30947050|NCT01274182|58992008|FG001|Overall Study|Adverse Event|5|||
30947051|NCT01274182|58992009|FG002|Overall Study|Adverse Event|3|||
30947052|NCT01274182|58992007|FG000|Overall Study|Withdrawal by Subject|5|||
30947053|NCT01274182|58992008|FG001|Overall Study|Withdrawal by Subject|5|||
30947054|NCT01274182|58992009|FG002|Overall Study|Withdrawal by Subject|3|||
30947055|NCT01274182|58992007|FG000|Overall Study|Lost to Follow-up|2|||
30947056|NCT01274182|58992008|FG001|Overall Study|Lost to Follow-up|3|||
30947057|NCT01274182|58992009|FG002|Overall Study|Lost to Follow-up|1|||
30947058|NCT01274182|58992007|FG000|Overall Study|Protocol Violation|3|||
30947059|NCT01274182|58992008|FG001|Overall Study|Protocol Violation|2|||
30947060|NCT01274182|58992009|FG002|Overall Study|Protocol Violation|0|||
30947061|NCT01274182|58992007|FG000|Overall Study|Death|1|||
30947062|NCT01274182|58992008|FG001|Overall Study|Death|0|||
30947063|NCT01274182|58992009|FG002|Overall Study|Death|1|||
30947064|NCT01984229|58992023|FG000|Safety Follow-up Period|Adverse Event|1|||
30947065|NCT01984229|58992024|FG001|Safety Follow-up Period|Adverse Event|1|||
30947066|NCT01984229|58992023|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
30947067|NCT01984229|58992024|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
30947068|NCT01835899|58992039|FG000|Overall Study|Adverse Event|0|||
30947069|NCT01835899|58992040|FG001|Overall Study|Adverse Event|0|||
30947070|NCT01835899|58992041|FG002|Overall Study|Adverse Event|1|||
30947071|NCT01835899|58992039|FG000|Overall Study|Other than stated above|0|||
30947072|NCT01835899|58992040|FG001|Overall Study|Other than stated above|1|||
30947073|NCT01835899|58992041|FG002|Overall Study|Other than stated above|0|||
30947074|NCT01766401|58992053|FG000|Overall Study|Adverse Event|7|||
30947075|NCT01766401|58992054|FG001|Overall Study|Adverse Event|22|||
30947076|NCT01766401|58992053|FG000|Overall Study|Lack of Efficacy|1|||
30760069|NCT00103857|58768270|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
30947077|NCT01766401|58992054|FG001|Overall Study|Lack of Efficacy|2|||
30947078|NCT01766401|58992053|FG000|Overall Study|Protocol Violation|3|||
30947079|NCT01766401|58992054|FG001|Overall Study|Protocol Violation|8|||
30947080|NCT01766401|58992053|FG000|Overall Study|Withdrawal by Subject|15|||
30947081|NCT01766401|58992054|FG001|Overall Study|Withdrawal by Subject|12|||
30947082|NCT01766401|58992053|FG000|Overall Study|Lost to Follow-up|10|||
30947083|NCT01766401|58992054|FG001|Overall Study|Lost to Follow-up|11|||
30947084|NCT01766401|58992053|FG000|Overall Study|Pregnancy|1|||
30947085|NCT01766401|58992054|FG001|Overall Study|Pregnancy|1|||
30947086|NCT01272934|58992062|FG000|Overall Study|Adverse Event|0|||
30947087|NCT01272934|58992063|FG001|Overall Study|Adverse Event|1|||
30947088|NCT01272934|58992062|FG000|Overall Study|Abnormal Laboratory Value|0|||
30947089|NCT01272934|58992063|FG001|Overall Study|Abnormal Laboratory Value|1|||
30947090|NCT01983683|58992081|FG000|Overall Study|Withdrawal by Subject|14|||
30947091|NCT01983683|58992082|FG001|Overall Study|Withdrawal by Subject|18|||
30947092|NCT01983683|58992081|FG000|Overall Study|Death|11|||
30947093|NCT01983683|58992082|FG001|Overall Study|Death|15|||
30947094|NCT01983683|58992081|FG000|Overall Study|Physician Decision|8|||
30947095|NCT01983683|58992082|FG001|Overall Study|Physician Decision|9|||
30947096|NCT01983683|58992081|FG000|Overall Study|Lost to Follow-up|4|||
30947097|NCT01983683|58992082|FG001|Overall Study|Lost to Follow-up|8|||
30947098|NCT01983683|58992081|FG000|Overall Study|Sponsor Decision|1|||
30947099|NCT01983683|58992082|FG001|Overall Study|Sponsor Decision|1|||
30947100|NCT01998893|58992088|FG000|Overall Study|Adverse Event|2|||
30947101|NCT01998893|58992088|FG000|Overall Study|Death|1|||
30947102|NCT01998893|58992088|FG000|Overall Study|Lost to Follow-up|8|||
30947103|NCT01998893|58992088|FG000|Overall Study|Physician Decision|2|||
30947104|NCT01998893|58992088|FG000|Overall Study|Protocol Violation|2|||
30947105|NCT01998893|58992088|FG000|Overall Study|Withdrawal by Subject|1|||
30947106|NCT01998893|58992088|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
30947107|NCT01791985|58992092|FG000|Overall Study|Adverse Event|7|||
30947108|NCT01791985|58992092|FG000|Overall Study|Withdrawal by Subject|1|||
30947109|NCT01998737|58992099|FG000|Overall Study|Corrupted database|23|||
30947110|NCT01998737|58992100|FG001|Overall Study|Corrupted database|0|||
30947111|NCT01791517|58992109|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
30947112|NCT01791517|58992110|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
30947113|NCT01791517|58992111|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
30947114|NCT01791517|58992112|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
30947115|NCT01791517|58992113|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
30947116|NCT01791517|58992114|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
30947117|NCT01791517|58992115|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
30947118|NCT01791517|58992116|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
30947119|NCT01791517|58992117|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
30947120|NCT01791517|58992118|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
30947121|NCT01791517|58992119|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
30947122|NCT01791517|58992120|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
30947123|NCT01791517|58992109|FG000|Phase I: Period 1|Adverse Event|0|||
30947124|NCT01791517|58992110|FG001|Phase I: Period 1|Adverse Event|0|||
30947125|NCT01791517|58992111|FG002|Phase I: Period 1|Adverse Event|1|||
30947126|NCT01791517|58992112|FG003|Phase I: Period 1|Adverse Event|1|||
30947127|NCT01791517|58992113|FG004|Phase I: Period 1|Adverse Event|0|||
30947128|NCT01791517|58992114|FG005|Phase I: Period 1|Adverse Event|0|||
30947129|NCT01791517|58992115|FG006|Phase I: Period 1|Adverse Event|0|||
30947130|NCT01791517|58992116|FG007|Phase I: Period 1|Adverse Event|0|||
30947131|NCT01791517|58992117|FG008|Phase I: Period 1|Adverse Event|0|||
30947132|NCT01791517|58992118|FG009|Phase I: Period 1|Adverse Event|0|||
30947133|NCT01791517|58992119|FG010|Phase I: Period 1|Adverse Event|0|||
30947134|NCT01791517|58992120|FG011|Phase I: Period 1|Adverse Event|0|||
30625305|NCT00880399|58637388|FG000|Overall Study|Withdrawal by Subject|6|||
30625306|NCT00880399|58637389|FG001|Overall Study|Withdrawal by Subject|3|||
30625307|NCT00880399|58637390|FG002|Overall Study|Withdrawal by Subject|3|||
30625308|NCT01207388|58637398|FG000|Overall Study|Death|67|||
30625309|NCT01207388|58637398|FG000|Overall Study|Withdrawal by Subject|1|||
30625310|NCT01206764|58637410|FG000|Overall Study|Adverse Event|20|||
30625311|NCT01206764|58637410|FG000|Overall Study|Abnormal laboratory value|2|||
30625312|NCT01206764|58637410|FG000|Overall Study|Abnormal test procedure result|1|||
30625313|NCT01206764|58637410|FG000|Overall Study|Patient withdrew consent|5|||
30625314|NCT01206764|58637410|FG000|Overall Study|Lost to Follow-up|6|||
30625315|NCT01206764|58637410|FG000|Overall Study|Death|11|||
30625316|NCT01206764|58637410|FG000|Overall Study|New cancer therapy|2|||
30625317|NCT01206764|58637410|FG000|Overall Study|Disease progression|88|||
30625318|NCT01206764|58637410|FG000|Overall Study|Protocol deviation|3|||
30625319|NCT00894322|58637417|FG000|Overall Study|Withdrawal by Subject|1|||
30625320|NCT00894322|58637418|FG001|Overall Study|Withdrawal by Subject|0|||
30625321|NCT00894322|58637419|FG002|Overall Study|Withdrawal by Subject|0|||
30625322|NCT00596635|58637432|FG000|Overall Study|Lost to Follow-up|0|||
30625323|NCT00596635|58637433|FG001|Overall Study|Lost to Follow-up|2|||
30843009|NCT01126749|58868932|FG000|Phase 1b|Other|0|||
30843010|NCT01126749|58868933|FG001|Phase 1b|Other|1|||
30843011|NCT01126749|58868934|FG002|Phase 1b|Other|0|||
30843012|NCT01126749|58868935|FG003|Phase 1b|Other|0|||
30947135|NCT01791517|58992109|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
30947136|NCT01791517|58992110|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
30947137|NCT01791517|58992111|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
30947138|NCT01791517|58992112|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
30947139|NCT01791517|58992113|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
30947140|NCT01791517|58992114|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
30947141|NCT01791517|58992115|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
30947142|NCT01791517|58992116|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
30625324|NCT00596635|58637434|FG002|Overall Study|Lost to Follow-up|0|||
30625325|NCT00596635|58637432|FG000|Overall Study|Treatment for symptomatic UTI|4|||
30843013|NCT01126749|58868932|FG000|Phase 1b|Withdrawal by Subject|0|||
30947143|NCT01791517|58992117|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
30625326|NCT00596635|58637433|FG001|Overall Study|Treatment for symptomatic UTI|6|||
30625327|NCT00596635|58637434|FG002|Overall Study|Treatment for symptomatic UTI|3|||
30625328|NCT00596635|58637432|FG000|Overall Study|Hip fracture|2|||
30625329|NCT00596635|58637433|FG001|Overall Study|Hip fracture|3|||
30625330|NCT00596635|58637434|FG002|Overall Study|Hip fracture|3|||
30625331|NCT00596635|58637432|FG000|Overall Study|Could not provide urine specimen|1|||
30625332|NCT00596635|58637433|FG001|Overall Study|Could not provide urine specimen|2|||
30625333|NCT00596635|58637434|FG002|Overall Study|Could not provide urine specimen|2|||
30625334|NCT00894166|58637450|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
30760070|NCT00103857|58768271|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
30760071|NCT00103857|58768272|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
30760072|NCT00103857|58768266|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
30947144|NCT01791517|58992118|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
30947145|NCT01791517|58992119|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
30947146|NCT01791517|58992120|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
30947147|NCT01791517|58992109|FG000|Phase I: Period 1|Protocol Violation|0|||
30947148|NCT01791517|58992110|FG001|Phase I: Period 1|Protocol Violation|1|||
30947149|NCT01791517|58992111|FG002|Phase I: Period 1|Protocol Violation|0|||
30947150|NCT01791517|58992112|FG003|Phase I: Period 1|Protocol Violation|0|||
30947151|NCT01791517|58992113|FG004|Phase I: Period 1|Protocol Violation|0|||
30947152|NCT01791517|58992114|FG005|Phase I: Period 1|Protocol Violation|0|||
30947153|NCT01791517|58992115|FG006|Phase I: Period 1|Protocol Violation|0|||
30947154|NCT01791517|58992116|FG007|Phase I: Period 1|Protocol Violation|0|||
30947155|NCT01791517|58992117|FG008|Phase I: Period 1|Protocol Violation|0|||
30947156|NCT01791517|58992118|FG009|Phase I: Period 1|Protocol Violation|0|||
30947157|NCT01791517|58992119|FG010|Phase I: Period 1|Protocol Violation|0|||
30947158|NCT01791517|58992120|FG011|Phase I: Period 1|Protocol Violation|0|||
30947159|NCT01791517|58992109|FG000|Phase I: Period 1|Lost to Follow-up|0|||
30947160|NCT01791517|58992110|FG001|Phase I: Period 1|Lost to Follow-up|0|||
30947161|NCT01791517|58992111|FG002|Phase I: Period 1|Lost to Follow-up|0|||
30947162|NCT01791517|58992112|FG003|Phase I: Period 1|Lost to Follow-up|1|||
30947163|NCT01791517|58992113|FG004|Phase I: Period 1|Lost to Follow-up|0|||
30843014|NCT01126749|58868933|FG001|Phase 1b|Withdrawal by Subject|1|||
30843015|NCT01126749|58868934|FG002|Phase 1b|Withdrawal by Subject|0|||
30843016|NCT01126749|58868935|FG003|Phase 1b|Withdrawal by Subject|0|||
30843017|NCT01126749|58868932|FG000|Phase 1b|Death|3|||
30947164|NCT01791517|58992114|FG005|Phase I: Period 1|Lost to Follow-up|0|||
30947165|NCT01791517|58992115|FG006|Phase I: Period 1|Lost to Follow-up|1|||
30947166|NCT01791517|58992116|FG007|Phase I: Period 1|Lost to Follow-up|0|||
30947167|NCT01791517|58992117|FG008|Phase I: Period 1|Lost to Follow-up|1|||
30947168|NCT01791517|58992118|FG009|Phase I: Period 1|Lost to Follow-up|1|||
30947169|NCT01791517|58992119|FG010|Phase I: Period 1|Lost to Follow-up|0|||
30947170|NCT01791517|58992120|FG011|Phase I: Period 1|Lost to Follow-up|0|||
30947171|NCT01791517|58992109|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
30947172|NCT01791517|58992110|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
30947173|NCT01791517|58992111|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
30947174|NCT01791517|58992112|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
30947175|NCT01791517|58992113|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
30947176|NCT01791517|58992114|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
30947177|NCT01791517|58992115|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
30947178|NCT01791517|58992116|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
30625335|NCT00894166|58637451|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
30760073|NCT00103857|58768267|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
30760074|NCT00103857|58768268|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
30760075|NCT00103857|58768269|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
30760076|NCT00103857|58768270|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
30760077|NCT00103857|58768271|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
30760078|NCT00103857|58768272|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
30760079|NCT00103857|58768266|FG000|50-Week Extension Study|patient moved|0|||
30760080|NCT00103857|58768267|FG001|50-Week Extension Study|patient moved|0|||
30760081|NCT00103857|58768268|FG002|50-Week Extension Study|patient moved|1|||
30843018|NCT01126749|58868933|FG001|Phase 1b|Death|4|||
30843019|NCT01126749|58868934|FG002|Phase 1b|Death|0|||
30947179|NCT01791517|58992117|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
30947180|NCT01791517|58992118|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
30947181|NCT01791517|58992119|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
30947182|NCT01791517|58992120|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
30947183|NCT01791517|58992109|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
30947184|NCT01791517|58992110|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
30947185|NCT01791517|58992111|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
30947186|NCT01791517|58992112|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
30843020|NCT01126749|58868935|FG003|Phase 1b|Death|0|||
30947187|NCT01791517|58992113|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
30947188|NCT01791517|58992114|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
30947189|NCT01791517|58992115|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
30947190|NCT01791517|58992116|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
30947191|NCT01791517|58992117|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
30947192|NCT01791517|58992118|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
30947193|NCT01791517|58992119|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
30947194|NCT01791517|58992120|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
30947195|NCT01791517|58992109|FG000|Phase I: Period 2|Protocol Violation|0|||
30947196|NCT01791517|58992110|FG001|Phase I: Period 2|Protocol Violation|0|||
30947197|NCT01791517|58992111|FG002|Phase I: Period 2|Protocol Violation|0|||
30947198|NCT01791517|58992112|FG003|Phase I: Period 2|Protocol Violation|1|||
30947199|NCT01791517|58992113|FG004|Phase I: Period 2|Protocol Violation|0|||
30947200|NCT01791517|58992114|FG005|Phase I: Period 2|Protocol Violation|0|||
30947201|NCT01791517|58992115|FG006|Phase I: Period 2|Protocol Violation|0|||
30947202|NCT01791517|58992116|FG007|Phase I: Period 2|Protocol Violation|0|||
30947203|NCT01791517|58992117|FG008|Phase I: Period 2|Protocol Violation|0|||
30947204|NCT01791517|58992118|FG009|Phase I: Period 2|Protocol Violation|0|||
30947205|NCT01791517|58992119|FG010|Phase I: Period 2|Protocol Violation|0|||
30947206|NCT01791517|58992120|FG011|Phase I: Period 2|Protocol Violation|0|||
30947207|NCT01791517|58992109|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
30947208|NCT01791517|58992110|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
30947209|NCT01791517|58992111|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
30947210|NCT01791517|58992112|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
30947211|NCT01791517|58992113|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
30947212|NCT01791517|58992114|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
30947213|NCT01791517|58992115|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
30947214|NCT01791517|58992116|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
30947215|NCT01791517|58992117|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
30947216|NCT01791517|58992118|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
30947217|NCT01791517|58992119|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
30947218|NCT01791517|58992120|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
30947219|NCT01791517|58992109|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
30947220|NCT01791517|58992110|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
30947221|NCT01791517|58992111|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
30947222|NCT01791517|58992112|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
30947223|NCT01791517|58992113|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
30947224|NCT01791517|58992114|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
30947225|NCT01791517|58992115|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
30947226|NCT01791517|58992116|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
30947227|NCT01791517|58992117|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
30947228|NCT01791517|58992118|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
30947229|NCT01791517|58992119|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
30947230|NCT01791517|58992120|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
30947231|NCT01791517|58992109|FG000|Phase I: Period 2|Lens Discomfort|0|||
30947232|NCT01791517|58992110|FG001|Phase I: Period 2|Lens Discomfort|0|||
30947233|NCT01791517|58992111|FG002|Phase I: Period 2|Lens Discomfort|0|||
30947234|NCT01791517|58992112|FG003|Phase I: Period 2|Lens Discomfort|0|||
30947235|NCT01791517|58992113|FG004|Phase I: Period 2|Lens Discomfort|0|||
30947236|NCT01791517|58992114|FG005|Phase I: Period 2|Lens Discomfort|1|||
30947237|NCT01791517|58992115|FG006|Phase I: Period 2|Lens Discomfort|0|||
30947238|NCT01791517|58992116|FG007|Phase I: Period 2|Lens Discomfort|0|||
30947239|NCT01791517|58992117|FG008|Phase I: Period 2|Lens Discomfort|0|||
30947240|NCT01791517|58992118|FG009|Phase I: Period 2|Lens Discomfort|0|||
30947241|NCT01791517|58992119|FG010|Phase I: Period 2|Lens Discomfort|0|||
30947242|NCT01791517|58992120|FG011|Phase I: Period 2|Lens Discomfort|0|||
30947243|NCT01791517|58992109|FG000|Phase I: Period 2|Lost to Follow-up|0|||
30947244|NCT01791517|58992110|FG001|Phase I: Period 2|Lost to Follow-up|3|||
30947245|NCT01791517|58992111|FG002|Phase I: Period 2|Lost to Follow-up|2|||
30947246|NCT01791517|58992112|FG003|Phase I: Period 2|Lost to Follow-up|0|||
30947247|NCT01791517|58992113|FG004|Phase I: Period 2|Lost to Follow-up|0|||
30947248|NCT01791517|58992114|FG005|Phase I: Period 2|Lost to Follow-up|0|||
30947249|NCT01791517|58992115|FG006|Phase I: Period 2|Lost to Follow-up|0|||
30947250|NCT01791517|58992116|FG007|Phase I: Period 2|Lost to Follow-up|0|||
30947251|NCT01791517|58992117|FG008|Phase I: Period 2|Lost to Follow-up|0|||
30947252|NCT01791517|58992118|FG009|Phase I: Period 2|Lost to Follow-up|0|||
30947253|NCT01791517|58992119|FG010|Phase I: Period 2|Lost to Follow-up|0|||
30947254|NCT01791517|58992120|FG011|Phase I: Period 2|Lost to Follow-up|0|||
30947255|NCT01791517|58992109|FG000|Phase I: Period 3|Lens Discomfort|0|||
30947256|NCT01791517|58992110|FG001|Phase I: Period 3|Lens Discomfort|0|||
30947257|NCT01791517|58992111|FG002|Phase I: Period 3|Lens Discomfort|0|||
30947258|NCT01791517|58992112|FG003|Phase I: Period 3|Lens Discomfort|0|||
30947259|NCT01791517|58992113|FG004|Phase I: Period 3|Lens Discomfort|0|||
30947260|NCT01791517|58992114|FG005|Phase I: Period 3|Lens Discomfort|0|||
30947261|NCT01791517|58992115|FG006|Phase I: Period 3|Lens Discomfort|0|||
30947262|NCT01791517|58992116|FG007|Phase I: Period 3|Lens Discomfort|0|||
30947263|NCT01791517|58992117|FG008|Phase I: Period 3|Lens Discomfort|0|||
30947264|NCT01791517|58992118|FG009|Phase I: Period 3|Lens Discomfort|0|||
30947265|NCT01791517|58992119|FG010|Phase I: Period 3|Lens Discomfort|0|||
30947266|NCT01791517|58992120|FG011|Phase I: Period 3|Lens Discomfort|1|||
30947267|NCT01791517|58992109|FG000|Phase I: Period 3|Lost to Follow-up|0|||
30947268|NCT01791517|58992110|FG001|Phase I: Period 3|Lost to Follow-up|1|||
30947269|NCT01791517|58992111|FG002|Phase I: Period 3|Lost to Follow-up|0|||
30947270|NCT01791517|58992112|FG003|Phase I: Period 3|Lost to Follow-up|0|||
30947271|NCT01791517|58992113|FG004|Phase I: Period 3|Lost to Follow-up|1|||
30947272|NCT01791517|58992114|FG005|Phase I: Period 3|Lost to Follow-up|0|||
30947273|NCT01791517|58992115|FG006|Phase I: Period 3|Lost to Follow-up|0|||
30947274|NCT01791517|58992116|FG007|Phase I: Period 3|Lost to Follow-up|0|||
30947275|NCT01791517|58992117|FG008|Phase I: Period 3|Lost to Follow-up|0|||
30947276|NCT01791517|58992118|FG009|Phase I: Period 3|Lost to Follow-up|0|||
30947277|NCT01791517|58992119|FG010|Phase I: Period 3|Lost to Follow-up|0|||
30947278|NCT01791517|58992120|FG011|Phase I: Period 3|Lost to Follow-up|0|||
30947279|NCT01791517|58992109|FG000|Phase I: Period 3|Adverse Event|0|||
30947280|NCT01791517|58992110|FG001|Phase I: Period 3|Adverse Event|0|||
30947281|NCT01791517|58992111|FG002|Phase I: Period 3|Adverse Event|0|||
30947282|NCT01791517|58992112|FG003|Phase I: Period 3|Adverse Event|1|||
30947283|NCT01791517|58992113|FG004|Phase I: Period 3|Adverse Event|0|||
30947284|NCT01791517|58992114|FG005|Phase I: Period 3|Adverse Event|0|||
30947285|NCT01791517|58992115|FG006|Phase I: Period 3|Adverse Event|0|||
30947286|NCT01791517|58992116|FG007|Phase I: Period 3|Adverse Event|0|||
30947287|NCT01791517|58992117|FG008|Phase I: Period 3|Adverse Event|0|||
30947288|NCT01791517|58992118|FG009|Phase I: Period 3|Adverse Event|0|||
30947289|NCT01791517|58992119|FG010|Phase I: Period 3|Adverse Event|0|||
30947290|NCT01791517|58992120|FG011|Phase I: Period 3|Adverse Event|0|||
30947291|NCT01791517|58992109|FG000|Phase II|Lost to Follow-up|1|||
30947292|NCT01791517|58992110|FG001|Phase II|Lost to Follow-up|0|||
30947293|NCT01791517|58992111|FG002|Phase II|Lost to Follow-up|1|||
30947294|NCT01791517|58992112|FG003|Phase II|Lost to Follow-up|0|||
30947295|NCT01791517|58992113|FG004|Phase II|Lost to Follow-up|1|||
30947296|NCT01791517|58992114|FG005|Phase II|Lost to Follow-up|2|||
30947297|NCT01791517|58992115|FG006|Phase II|Lost to Follow-up|0|||
30947298|NCT01791517|58992116|FG007|Phase II|Lost to Follow-up|1|||
30947299|NCT01791517|58992117|FG008|Phase II|Lost to Follow-up|1|||
30947300|NCT01791517|58992118|FG009|Phase II|Lost to Follow-up|1|||
30947301|NCT01791517|58992119|FG010|Phase II|Lost to Follow-up|0|||
30947302|NCT01791517|58992120|FG011|Phase II|Lost to Follow-up|0|||
30947303|NCT01791517|58992109|FG000|Phase II|Withdrawal by Subject|1|||
30947304|NCT01791517|58992110|FG001|Phase II|Withdrawal by Subject|0|||
30947305|NCT01791517|58992111|FG002|Phase II|Withdrawal by Subject|0|||
30947306|NCT01791517|58992112|FG003|Phase II|Withdrawal by Subject|0|||
30947307|NCT01791517|58992113|FG004|Phase II|Withdrawal by Subject|0|||
30947308|NCT01791517|58992114|FG005|Phase II|Withdrawal by Subject|2|||
30947309|NCT01791517|58992115|FG006|Phase II|Withdrawal by Subject|0|||
30947310|NCT01791517|58992116|FG007|Phase II|Withdrawal by Subject|1|||
30947311|NCT01791517|58992117|FG008|Phase II|Withdrawal by Subject|0|||
30947312|NCT01791517|58992118|FG009|Phase II|Withdrawal by Subject|0|||
30947313|NCT01791517|58992119|FG010|Phase II|Withdrawal by Subject|1|||
30947314|NCT01791517|58992120|FG011|Phase II|Withdrawal by Subject|0|||
30947315|NCT01791517|58992109|FG000|Phase II|Lack of Efficacy|0|||
30947316|NCT01791517|58992110|FG001|Phase II|Lack of Efficacy|0|||
30947317|NCT01791517|58992111|FG002|Phase II|Lack of Efficacy|0|||
30947318|NCT01791517|58992112|FG003|Phase II|Lack of Efficacy|0|||
30843021|NCT01126749|58868932|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
30843022|NCT01126749|58868933|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
30843023|NCT01126749|58868934|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
30843024|NCT01126749|58868935|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
30843025|NCT01126749|58868932|FG000|Phase 2|Study Termination by Sponsor|0|||
30843026|NCT01126749|58868933|FG001|Phase 2|Study Termination by Sponsor|0|||
30843027|NCT01126749|58868934|FG002|Phase 2|Study Termination by Sponsor|12|||
30843028|NCT01126749|58868935|FG003|Phase 2|Study Termination by Sponsor|6|||
30843029|NCT01126749|58868932|FG000|Phase 2|Other|0|||
30947319|NCT01791517|58992113|FG004|Phase II|Lack of Efficacy|1|||
30947320|NCT01791517|58992114|FG005|Phase II|Lack of Efficacy|0|||
30947321|NCT01791517|58992115|FG006|Phase II|Lack of Efficacy|0|||
30947322|NCT01791517|58992116|FG007|Phase II|Lack of Efficacy|0|||
30947323|NCT01791517|58992117|FG008|Phase II|Lack of Efficacy|0|||
30947324|NCT01791517|58992118|FG009|Phase II|Lack of Efficacy|0|||
30947325|NCT01791517|58992119|FG010|Phase II|Lack of Efficacy|0|||
30947326|NCT01791517|58992120|FG011|Phase II|Lack of Efficacy|0|||
30947327|NCT01791517|58992109|FG000|Phase II|Adverse Event|0|||
30947328|NCT01791517|58992110|FG001|Phase II|Adverse Event|0|||
30947329|NCT01791517|58992111|FG002|Phase II|Adverse Event|0|||
30947330|NCT01791517|58992112|FG003|Phase II|Adverse Event|0|||
30947331|NCT01791517|58992113|FG004|Phase II|Adverse Event|0|||
30947332|NCT01791517|58992114|FG005|Phase II|Adverse Event|0|||
30947333|NCT01791517|58992115|FG006|Phase II|Adverse Event|2|||
30947334|NCT01791517|58992116|FG007|Phase II|Adverse Event|1|||
30947335|NCT01791517|58992117|FG008|Phase II|Adverse Event|0|||
30947336|NCT01791517|58992118|FG009|Phase II|Adverse Event|1|||
30947337|NCT01791517|58992119|FG010|Phase II|Adverse Event|0|||
30947338|NCT01791517|58992120|FG011|Phase II|Adverse Event|0|||
30947339|NCT01791517|58992109|FG000|Phase II|Lens Handling Difficulties|0|||
30947340|NCT01791517|58992110|FG001|Phase II|Lens Handling Difficulties|0|||
30947341|NCT01791517|58992111|FG002|Phase II|Lens Handling Difficulties|0|||
30947342|NCT01791517|58992112|FG003|Phase II|Lens Handling Difficulties|0|||
30947343|NCT01791517|58992113|FG004|Phase II|Lens Handling Difficulties|0|||
30947344|NCT01791517|58992114|FG005|Phase II|Lens Handling Difficulties|0|||
30947345|NCT01791517|58992115|FG006|Phase II|Lens Handling Difficulties|0|||
30947346|NCT01791517|58992116|FG007|Phase II|Lens Handling Difficulties|0|||
30947347|NCT01791517|58992117|FG008|Phase II|Lens Handling Difficulties|1|||
30947348|NCT01791517|58992118|FG009|Phase II|Lens Handling Difficulties|0|||
30947349|NCT01791517|58992119|FG010|Phase II|Lens Handling Difficulties|0|||
30947350|NCT01791517|58992120|FG011|Phase II|Lens Handling Difficulties|0|||
30947351|NCT01791517|58992109|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
30947352|NCT01791517|58992110|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
30947353|NCT01791517|58992111|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
30947354|NCT01791517|58992112|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
30947355|NCT01791517|58992113|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
30947356|NCT01791517|58992114|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
30947357|NCT01791517|58992115|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
30947358|NCT01791517|58992116|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
30947359|NCT01791517|58992117|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
30947360|NCT01791517|58992118|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
30947361|NCT01791517|58992119|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
30947362|NCT01791517|58992120|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
30947363|NCT01791517|58992109|FG000|Phase II|Pre-Existing Ocular Issue|0|||
30947364|NCT01791517|58992110|FG001|Phase II|Pre-Existing Ocular Issue|0|||
30947365|NCT01791517|58992111|FG002|Phase II|Pre-Existing Ocular Issue|0|||
30947366|NCT01791517|58992112|FG003|Phase II|Pre-Existing Ocular Issue|0|||
30947367|NCT01791517|58992113|FG004|Phase II|Pre-Existing Ocular Issue|0|||
30947368|NCT01791517|58992114|FG005|Phase II|Pre-Existing Ocular Issue|0|||
30947369|NCT01791517|58992115|FG006|Phase II|Pre-Existing Ocular Issue|0|||
30947370|NCT01791517|58992116|FG007|Phase II|Pre-Existing Ocular Issue|0|||
30947371|NCT01791517|58992117|FG008|Phase II|Pre-Existing Ocular Issue|0|||
30947372|NCT01791517|58992118|FG009|Phase II|Pre-Existing Ocular Issue|0|||
30947373|NCT01791517|58992119|FG010|Phase II|Pre-Existing Ocular Issue|0|||
30947374|NCT01791517|58992120|FG011|Phase II|Pre-Existing Ocular Issue|1|||
30947375|NCT01998581|58992140|FG000|Overall Study|Refused repeat treatment|20|||
30947376|NCT01998581|58992141|FG001|Overall Study|Refused repeat treatment|4|||
30947377|NCT01998581|58992140|FG000|Overall Study|Protocol Violation|1|||
30947378|NCT01998581|58992141|FG001|Overall Study|Protocol Violation|0|||
30947379|NCT01998581|58992140|FG000|Overall Study|Withdrawal by Subject|8|||
30947380|NCT01998581|58992141|FG001|Overall Study|Withdrawal by Subject|1|||
30947381|NCT01998581|58992140|FG000|Overall Study|Lost to Follow-up|12|||
30947382|NCT01998581|58992141|FG001|Overall Study|Lost to Follow-up|4|||
30947383|NCT01998581|58992140|FG000|Overall Study|Adverse Event|1|||
30947384|NCT01998581|58992141|FG001|Overall Study|Adverse Event|1|||
30947385|NCT01998581|58992140|FG000|Overall Study|Other reasons|3|||
30947386|NCT01998581|58992141|FG001|Overall Study|Other reasons|2|||
30947387|NCT01998581|58992140|FG000|Overall Study|Randomized but withdrew before treatment|1|||
30947388|NCT01998581|58992141|FG001|Overall Study|Randomized but withdrew before treatment|0|||
30947389|NCT01983293|58992150|FG000|Overall Study|Withdrawal by Subject|29|||
30947390|NCT01983293|58992151|FG001|Overall Study|Withdrawal by Subject|15|||
30947391|NCT01983293|58992150|FG000|Overall Study|Missing 12-month visit|3|||
30947392|NCT01983293|58992151|FG001|Overall Study|Missing 12-month visit|3|||
30947393|NCT01983293|58992150|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
30947394|NCT01983293|58992151|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
30947395|NCT01791205|58992159|FG000|Phase II|Lack of Efficacy|6|||
30947396|NCT01791205|58992160|FG001|Phase II|Lack of Efficacy|0|||
30947397|NCT01791205|58992159|FG000|Phase II|Adverse Event|2|||
30947398|NCT01791205|58992160|FG001|Phase II|Adverse Event|0|||
30947399|NCT01791205|58992159|FG000|Phase II|Safety|1|||
30947400|NCT01791205|58992160|FG001|Phase II|Safety|0|||
30947401|NCT01791205|58992159|FG000|Phase II|Lost to Follow-up|1|||
30947402|NCT01791205|58992160|FG001|Phase II|Lost to Follow-up|0|||
30947403|NCT01791205|58992159|FG000|Phase II|Remission of disease|1|||
30947404|NCT01791205|58992160|FG001|Phase II|Remission of disease|0|||
30947405|NCT01791205|58992159|FG000|Phase II|Physician's decision|1|||
30947406|NCT01791205|58992160|FG001|Phase II|Physician's decision|0|||
30947407|NCT01272232|58992169|FG000|Weeks 0-56|Adverse Event|39|||
30947408|NCT01272232|58992170|FG001|Weeks 0-56|Adverse Event|18|||
30947409|NCT01272232|58992171|FG002|Weeks 0-56|Adverse Event|7|||
30947410|NCT01272232|58992169|FG000|Weeks 0-56|Lack of Efficacy|0|||
30947411|NCT01272232|58992170|FG001|Weeks 0-56|Lack of Efficacy|0|||
30947412|NCT01272232|58992171|FG002|Weeks 0-56|Lack of Efficacy|3|||
30947413|NCT01272232|58992169|FG000|Weeks 0-56|Protocol Violation|12|||
30947414|NCT01272232|58992170|FG001|Weeks 0-56|Protocol Violation|8|||
30947415|NCT01272232|58992171|FG002|Weeks 0-56|Protocol Violation|13|||
30947416|NCT01272232|58992169|FG000|Weeks 0-56|Withdrawal criteria|32|||
30947417|NCT01272232|58992170|FG001|Weeks 0-56|Withdrawal criteria|14|||
30947418|NCT01272232|58992171|FG002|Weeks 0-56|Withdrawal criteria|37|||
30947419|NCT01272232|58992169|FG000|Weeks 0-56|Unclassified|16|||
30947420|NCT01272232|58992170|FG001|Weeks 0-56|Unclassified|7|||
30947421|NCT01272232|58992171|FG002|Weeks 0-56|Unclassified|12|||
30947422|NCT01272232|58992169|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
30947423|NCT01272232|58992170|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
30947424|NCT01272232|58992171|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
30947425|NCT01272232|58992169|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
30947426|NCT01272232|58992170|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
30947427|NCT01272232|58992171|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
30947428|NCT01272232|58992169|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
30947429|NCT01272232|58992170|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
30947430|NCT01272232|58992171|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
30947431|NCT01272232|58992169|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
30947432|NCT01272232|58992170|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
30947433|NCT01272232|58992171|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
30947434|NCT01272232|58992169|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
30947435|NCT01272232|58992170|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
30947436|NCT01272232|58992171|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
30947437|NCT01791127|58992179|FG000|Overall Study|Death|356|||
30947438|NCT01791127|58992179|FG000|Overall Study|Patient has withdrawn from study|293|||
30947439|NCT01791127|58992179|FG000|Overall Study|Lost to Follow-up|42|||
30947440|NCT01791127|58992179|FG000|Overall Study|All Siello leads are explanted|31|||
30947441|NCT01791127|58992179|FG000|Overall Study|Completion of 30 day safety registry|1|||
30947442|NCT01791127|58992179|FG000|Overall Study|Study terminated for EP Passion|749|||
30947443|NCT01997333|58992210|FG000|Randomization and Treatment|Disease Progression|70|||
30947444|NCT01997333|58992211|FG001|Randomization and Treatment|Disease Progression|159|||
30947445|NCT01997333|58992210|FG000|Randomization and Treatment|Adverse Event|10|||
30947446|NCT01997333|58992211|FG001|Randomization and Treatment|Adverse Event|32|||
30947447|NCT01997333|58992210|FG000|Randomization and Treatment|Physician Decision|0|||
30947448|NCT01997333|58992211|FG001|Randomization and Treatment|Physician Decision|4|||
30947449|NCT01997333|58992210|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
30947450|NCT01997333|58992211|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
30947451|NCT01997333|58992210|FG000|Randomization and Treatment|Did not receive treatment|17|||
30947452|NCT01997333|58992211|FG001|Randomization and Treatment|Did not receive treatment|5|||
30947453|NCT01997333|58992210|FG000|Survival Follow up|Withdrawal by Subject|15|||
30947454|NCT01997333|58992211|FG001|Survival Follow up|Withdrawal by Subject|6|||
30947455|NCT01997333|58992210|FG000|Survival Follow up|Lost to Follow-up|0|||
30947456|NCT01997333|58992211|FG001|Survival Follow up|Lost to Follow-up|6|||
30947457|NCT01997333|58992210|FG000|Survival Follow up|Various|1|||
30947458|NCT01997333|58992211|FG001|Survival Follow up|Various|2|||
30947459|NCT01982435|58992275|FG000|Overall Study|Adverse Event|1|||
30947460|NCT01982435|58992276|FG001|Overall Study|Adverse Event|0|||
30947461|NCT01620983|58992316|FG000|Overall Study|Lost to Follow-up|8|||
30947462|NCT01620983|58992317|FG001|Overall Study|Lost to Follow-up|4|||
30947463|NCT01620983|58992318|FG002|Overall Study|Lost to Follow-up|9|||
30947464|NCT01620983|58992316|FG000|Overall Study|Withdrawal by Subject|6|||
30947465|NCT01620983|58992317|FG001|Overall Study|Withdrawal by Subject|8|||
30947466|NCT01620983|58992318|FG002|Overall Study|Withdrawal by Subject|1|||
30947467|NCT01620983|58992316|FG000|Overall Study|Death|2|||
30947468|NCT01620983|58992317|FG001|Overall Study|Death|0|||
30947469|NCT01620983|58992318|FG002|Overall Study|Death|0|||
30947470|NCT01620983|58992316|FG000|Overall Study|Physician Decision|3|||
30947471|NCT01620983|58992317|FG001|Overall Study|Physician Decision|10|||
30947472|NCT01620983|58992318|FG002|Overall Study|Physician Decision|5|||
30947473|NCT01996709|58992328|FG000|Overall Study|Withdrawal by Subject|1|||
30947474|NCT01996709|58992329|FG001|Overall Study|Withdrawal by Subject|0|||
30625336|NCT00894166|58637452|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
30625337|NCT00894166|58637453|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
30625338|NCT00894166|58637454|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
30947475|NCT01996709|58992328|FG000|Overall Study|Lost to Follow-up|3|||
30947476|NCT01996709|58992329|FG001|Overall Study|Lost to Follow-up|0|||
30947477|NCT01996709|58992328|FG000|Overall Study|Subject Non-Compliant|1|||
30947478|NCT01996709|58992329|FG001|Overall Study|Subject Non-Compliant|0|||
30947479|NCT01996709|58992328|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
30947480|NCT01996709|58992329|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
30947481|NCT01996319|58992354|FG000|Overall Study|Protocol Violation|1|||
30947482|NCT01996319|58992355|FG001|Overall Study|Protocol Violation|0|||
30947483|NCT01996319|58992354|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
30947484|NCT01996319|58992355|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
30947485|NCT01996319|58992354|FG000|Overall Study|Adverse Event|2|||
30947486|NCT01996319|58992355|FG001|Overall Study|Adverse Event|2|||
30947487|NCT01279486|58992361|FG000|Overall Study|Lost to Follow-up|1|||
30947488|NCT01279954|58992367|FG000|Overall Study|Lack of Efficacy|3|||
30947489|NCT01279954|58992368|FG001|Overall Study|Lack of Efficacy|4|||
30947490|NCT01278862|58992379|FG000|Overall Study|Lost to Follow-up|1|||
30947491|NCT01278862|58992380|FG001|Overall Study|Lost to Follow-up|1|||
30947492|NCT01278394|58992395|FG000|Overall Study|Lost to Follow-up|1|||
30947493|NCT01981187|58992399|FG000|Overall Study|Participant/guardian decision|2|||
30947494|NCT01981187|58992399|FG000|Overall Study|Physician Decision|1|||
30947495|NCT01981187|58992399|FG000|Overall Study|Disease progression|2|||
30947496|NCT01981187|58992399|FG000|Overall Study|Adverse Event|7|||
30947497|NCT01278160|58992405|FG000|Overall Study|Adverse Event|1|||
30947498|NCT01278160|58992406|FG001|Overall Study|Adverse Event|1|||
30947499|NCT01278160|58992405|FG000|Overall Study|Lost to Follow-up|0|||
30947500|NCT01278160|58992406|FG001|Overall Study|Lost to Follow-up|1|||
30947501|NCT01278160|58992405|FG000|Overall Study|Withdrawal by Subject|3|||
30947502|NCT01278160|58992406|FG001|Overall Study|Withdrawal by Subject|2|||
30947503|NCT01278160|58992405|FG000|Overall Study|Unclassified|1|||
30947504|NCT01278160|58992406|FG001|Overall Study|Unclassified|2|||
30947505|NCT01996241|58992414|FG000|Overall Study|Lost to Follow-up|252|||
30947506|NCT01996241|58992415|FG001|Overall Study|Lost to Follow-up|235|||
30947507|NCT02091869|58992425|FG000|Overall Study|Withdrawal by Subject|0|||
30947508|NCT02091869|58992426|FG001|Overall Study|Withdrawal by Subject|3|||
30947509|NCT01981109|58992441|FG000|Overall Study|Death|36|||
30947510|NCT01981109|58992441|FG000|Overall Study|Withdrawal by Subject|40|||
30947511|NCT01981109|58992441|FG000|Overall Study|Lost to Follow-up|9|||
30947512|NCT01981109|58992441|FG000|Overall Study|No Discontinuation Documentation|37|||
30947513|NCT01981109|58992441|FG000|Overall Study|Study Termination|100|||
30947514|NCT01981109|58992441|FG000|Overall Study|No data available|2|||
30947515|NCT00248794|58992449|FG000|Overall Study|Lost to Follow-up|6|||
30947516|NCT00248794|58992450|FG001|Overall Study|Lost to Follow-up|8|||
30947517|NCT00248794|58992451|FG002|Overall Study|Lost to Follow-up|3|||
30947518|NCT01995539|58992465|FG000|Overall Study|Screening Failure|1|||
30947519|NCT01995539|58992465|FG000|Overall Study|Withdrawal by Investigator|15|||
30947520|NCT01995539|58992465|FG000|Overall Study|Withdrawal by Subject|11|||
30947521|NCT01995539|58992465|FG000|Overall Study|Lost to Follow-up|5|||
30947522|NCT01995539|58992465|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
30947523|NCT01835587|58992473|FG000|Overall Study|Disease Recurrence or Relapse|0|||
30947524|NCT01835587|58992474|FG001|Overall Study|Disease Recurrence or Relapse|3|||
30947525|NCT01835587|58992475|FG002|Overall Study|Disease Recurrence or Relapse|0|||
30947526|NCT01835587|58992476|FG003|Overall Study|Disease Recurrence or Relapse|3|||
30947527|NCT01835587|58992473|FG000|Overall Study|Withdrawal by Subject|2|||
30947528|NCT01835587|58992474|FG001|Overall Study|Withdrawal by Subject|0|||
30947529|NCT01835587|58992475|FG002|Overall Study|Withdrawal by Subject|0|||
30947530|NCT01835587|58992476|FG003|Overall Study|Withdrawal by Subject|3|||
30947531|NCT01835587|58992473|FG000|Overall Study|Adverse Event|0|||
30947532|NCT01835587|58992474|FG001|Overall Study|Adverse Event|0|||
30947533|NCT01835587|58992475|FG002|Overall Study|Adverse Event|2|||
30947534|NCT01835587|58992476|FG003|Overall Study|Adverse Event|2|||
30947535|NCT01835587|58992473|FG000|Overall Study|Death|0|||
30947536|NCT01835587|58992474|FG001|Overall Study|Death|0|||
30947537|NCT01835587|58992475|FG002|Overall Study|Death|0|||
30947538|NCT01835587|58992476|FG003|Overall Study|Death|1|||
30947539|NCT01835587|58992473|FG000|Overall Study|Miscellaneous|0|||
30947540|NCT01835587|58992474|FG001|Overall Study|Miscellaneous|1|||
30947541|NCT01835587|58992475|FG002|Overall Study|Miscellaneous|0|||
30947542|NCT01835587|58992476|FG003|Overall Study|Miscellaneous|0|||
30947543|NCT01736917|58992493|FG000|Overall Study|Adverse Event|1|||
30947544|NCT01736917|58992493|FG000|Overall Study|Protocol Violation|10|||
30947545|NCT01277302|58992502|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
30947546|NCT01277302|58992503|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
30947547|NCT01277302|58992504|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
30947548|NCT01277302|58992502|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
30947549|NCT01277302|58992503|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
30947550|NCT01277302|58992504|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
30947551|NCT01277302|58992502|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
30947552|NCT01277302|58992503|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
30947553|NCT01277302|58992504|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
30947554|NCT01277302|58992502|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
30947555|NCT01277302|58992503|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
30947556|NCT01277302|58992504|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
30948569|NCT01973231|58994583|FG001|Overall Study|unclassified|1|||
30947557|NCT01277302|58992502|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
30947558|NCT01277302|58992503|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
30947559|NCT01277302|58992504|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
30947560|NCT01277302|58992502|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
30947561|NCT01277302|58992503|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
30947562|NCT01277302|58992504|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
30947563|NCT01277302|58992502|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
30947564|NCT01277302|58992503|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
30947565|NCT01277302|58992504|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
30947566|NCT01277302|58992502|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
30947567|NCT01277302|58992503|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
30947568|NCT01277302|58992504|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
30947569|NCT01277302|58992502|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
30947570|NCT01277302|58992503|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
30947571|NCT01277302|58992504|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
30947572|NCT01980875|58992515|FG000|Overall Study|Withdrew Consent|1|||
30947573|NCT01980875|58992516|FG001|Overall Study|Withdrew Consent|1|||
30947574|NCT01980875|58992517|FG002|Overall Study|Withdrew Consent|1|||
30947575|NCT01980875|58992515|FG000|Overall Study|Study Terminated by Sponsor|7|||
30947576|NCT01980875|58992516|FG001|Overall Study|Study Terminated by Sponsor|24|||
30947577|NCT01980875|58992517|FG002|Overall Study|Study Terminated by Sponsor|22|||
30947578|NCT01980875|58992515|FG000|Overall Study|Lost to Follow-up|0|||
30947579|NCT01980875|58992516|FG001|Overall Study|Lost to Follow-up|0|||
30947580|NCT01980875|58992517|FG002|Overall Study|Lost to Follow-up|1|||
30947581|NCT01995461|58992525|FG000|Overall Study|Death|1|||
30947582|NCT01995461|58992525|FG000|Overall Study|Lost to Follow-up|2|||
30947583|NCT01995461|58992525|FG000|Overall Study|Withdrawal by Subject|2|||
30947584|NCT01980095|58992531|FG000|Overall Study|Lost to Follow-up|6|||
30947585|NCT01980095|58992532|FG001|Overall Study|Lost to Follow-up|7|||
30947586|NCT01980095|58992531|FG000|Overall Study|Withdrawal by Subject|2|||
30947587|NCT01980095|58992532|FG001|Overall Study|Withdrawal by Subject|3|||
30947588|NCT01980095|58992531|FG000|Overall Study|Poor compliance|5|||
30947589|NCT01980095|58992532|FG001|Overall Study|Poor compliance|0|||
30947590|NCT01980095|58992531|FG000|Overall Study|Safety issue|0|||
30947591|NCT01980095|58992532|FG001|Overall Study|Safety issue|1|||
30947592|NCT01980095|58992531|FG000|Overall Study|Study drug discontinued|1|||
30947593|NCT01980095|58992532|FG001|Overall Study|Study drug discontinued|0|||
30947594|NCT01980095|58992531|FG000|Overall Study|Randomized by mistake|1|||
30947595|NCT01980095|58992532|FG001|Overall Study|Randomized by mistake|0|||
30947596|NCT01980017|58992542|FG000|Overall Study|Lost to Follow-up|30|||
30947597|NCT01980017|58992543|FG001|Overall Study|Lost to Follow-up|21|||
30947598|NCT01980017|58992542|FG000|Overall Study|Death|0|||
30947599|NCT01980017|58992543|FG001|Overall Study|Death|1|||
30947600|NCT01978145|58992552|FG000|Treatment Period 1|Adverse Event|1|||
30947601|NCT01978145|58992553|FG001|Treatment Period 1|Adverse Event|9|||
30947602|NCT01978145|58992552|FG000|Treatment Period 1|Physician Decision|1|||
30947603|NCT01978145|58992553|FG001|Treatment Period 1|Physician Decision|0|||
30947604|NCT01978145|58992552|FG000|Treatment Period 1|Withdrawal by Subject|5|||
30947605|NCT01978145|58992553|FG001|Treatment Period 1|Withdrawal by Subject|4|||
30947606|NCT01978145|58992552|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
30947607|NCT01978145|58992553|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
30947608|NCT01978145|58992552|FG000|Washout Period 1|Adverse Event|0|||
30947609|NCT01978145|58992553|FG001|Washout Period 1|Adverse Event|1|||
30947610|NCT01978145|58992552|FG000|Washout Period 1|Withdrawal by Subject|1|||
30947611|NCT01978145|58992553|FG001|Washout Period 1|Withdrawal by Subject|1|||
30947612|NCT01978145|58992552|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
30947613|NCT01978145|58992553|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
30947614|NCT01978145|58992552|FG000|Treatment Period 2|Adverse Event|3|||
30947615|NCT01978145|58992553|FG001|Treatment Period 2|Adverse Event|3|||
30947616|NCT01978145|58992552|FG000|Treatment Period 2|Protocol Violation|0|||
30947617|NCT01978145|58992553|FG001|Treatment Period 2|Protocol Violation|1|||
30947618|NCT01978145|58992552|FG000|Treatment Period 2|Lost to Follow-up|1|||
30947619|NCT01978145|58992553|FG001|Treatment Period 2|Lost to Follow-up|1|||
30947620|NCT01978145|58992552|FG000|Treatment Period 2|Withdrawal by Subject|7|||
30947621|NCT01978145|58992553|FG001|Treatment Period 2|Withdrawal by Subject|4|||
30947622|NCT01978145|58992552|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
30947623|NCT01978145|58992553|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
30947624|NCT01967537|58992559|FG000|Overall Study|Withdrawal by Subject|52|||
30947625|NCT01967537|58992559|FG000|Overall Study|Refuse treatment|2|||
30947626|NCT01967537|58992559|FG000|Overall Study|Lost to Follow-up|6|||
30947627|NCT01967225|58992567|FG000|Overall Study|Adverse Event|3|||
30947628|NCT01967225|58992568|FG001|Overall Study|Adverse Event|1|||
30947629|NCT01967225|58992567|FG000|Overall Study|Withdrawal by Subject|2|||
30947630|NCT01967225|58992568|FG001|Overall Study|Withdrawal by Subject|1|||
30947631|NCT01967225|58992567|FG000|Overall Study|Lack of Efficacy|1|||
30947632|NCT01967225|58992568|FG001|Overall Study|Lack of Efficacy|1|||
30947633|NCT01967225|58992567|FG000|Overall Study|Switching to other therapy|2|||
30947634|NCT01967225|58992568|FG001|Overall Study|Switching to other therapy|0|||
30947635|NCT01967225|58992567|FG000|Overall Study|Protocol driven decision point|1|||
30947636|NCT01967225|58992568|FG001|Overall Study|Protocol driven decision point|0|||
30947637|NCT01967225|58992567|FG000|Overall Study|Logistical difficulties|1|||
30947638|NCT01967225|58992568|FG001|Overall Study|Logistical difficulties|0|||
30947639|NCT01967225|58992567|FG000|Overall Study|Protocol Violation|2|||
30947640|NCT01967225|58992568|FG001|Overall Study|Protocol Violation|0|||
30947641|NCT01967147|58992578|FG000|Overall Study|Adverse Event|5|||
30947642|NCT01967147|58992579|FG001|Overall Study|Adverse Event|2|||
30947643|NCT01967147|58992578|FG000|Overall Study|Lack of Efficacy|1|||
30947644|NCT01967147|58992579|FG001|Overall Study|Lack of Efficacy|4|||
30947645|NCT01967147|58992578|FG000|Overall Study|Lost to Follow-up|1|||
30947646|NCT01967147|58992579|FG001|Overall Study|Lost to Follow-up|2|||
30947647|NCT01967147|58992578|FG000|Overall Study|Withdrawal by Subject|2|||
30947648|NCT01967147|58992579|FG001|Overall Study|Withdrawal by Subject|4|||
30947649|NCT01967147|58992578|FG000|Overall Study|Non-compliance with Study Drug|0|||
30947650|NCT01967147|58992579|FG001|Overall Study|Non-compliance with Study Drug|3|||
30947651|NCT01967147|58992578|FG000|Overall Study|Other|4|||
30947652|NCT01967147|58992579|FG001|Overall Study|Other|5|||
30947653|NCT01967069|58992588|FG000|Overall Study|Adverse Event|2|||
30947654|NCT01967069|58992589|FG001|Overall Study|Adverse Event|2|||
30947655|NCT01967069|58992588|FG000|Overall Study|Lost to Follow-up|5|||
30947656|NCT01967069|58992589|FG001|Overall Study|Lost to Follow-up|2|||
30947657|NCT01967069|58992588|FG000|Overall Study|Withdrawal by Subject|1|||
30947658|NCT01967069|58992589|FG001|Overall Study|Withdrawal by Subject|3|||
30947659|NCT01967069|58992588|FG000|Overall Study|Lack of Efficacy|0|||
30947660|NCT01967069|58992589|FG001|Overall Study|Lack of Efficacy|1|||
30947661|NCT01790503|58992606|FG000|Overall Study|Adverse Event|1|||
30947662|NCT01790503|58992607|FG001|Overall Study|Adverse Event|0|||
30947663|NCT01790503|58992608|FG002|Overall Study|Adverse Event|0|||
30947664|NCT01790503|58992609|FG003|Overall Study|Adverse Event|0|||
30947665|NCT01790503|58992610|FG004|Overall Study|Adverse Event|0|||
30947666|NCT01790503|58992611|FG005|Overall Study|Adverse Event|2|||
30947667|NCT01790503|58992612|FG006|Overall Study|Adverse Event|0|||
30947668|NCT01790503|58992613|FG007|Overall Study|Adverse Event|0|||
30947669|NCT01790503|58992614|FG008|Overall Study|Adverse Event|2|||
30947670|NCT01790503|58992615|FG009|Overall Study|Adverse Event|4|||
30947671|NCT01790503|58992616|FG010|Overall Study|Adverse Event|7|||
30947672|NCT01790503|58992606|FG000|Overall Study|Withdrawal by Subject|0|||
30947673|NCT01790503|58992607|FG001|Overall Study|Withdrawal by Subject|0|||
30947674|NCT01790503|58992608|FG002|Overall Study|Withdrawal by Subject|1|||
30947675|NCT01790503|58992609|FG003|Overall Study|Withdrawal by Subject|1|||
30947676|NCT01790503|58992610|FG004|Overall Study|Withdrawal by Subject|1|||
30947677|NCT01790503|58992611|FG005|Overall Study|Withdrawal by Subject|2|||
30947678|NCT01790503|58992612|FG006|Overall Study|Withdrawal by Subject|1|||
30947679|NCT01790503|58992613|FG007|Overall Study|Withdrawal by Subject|0|||
30947680|NCT01790503|58992614|FG008|Overall Study|Withdrawal by Subject|0|||
30947681|NCT01790503|58992615|FG009|Overall Study|Withdrawal by Subject|0|||
30947682|NCT01790503|58992616|FG010|Overall Study|Withdrawal by Subject|1|||
30947683|NCT01790503|58992606|FG000|Overall Study|Disease progression|2|||
30947684|NCT01790503|58992607|FG001|Overall Study|Disease progression|1|||
30947685|NCT01790503|58992608|FG002|Overall Study|Disease progression|0|||
30947686|NCT01790503|58992609|FG003|Overall Study|Disease progression|1|||
30947687|NCT01790503|58992610|FG004|Overall Study|Disease progression|2|||
30947688|NCT01790503|58992611|FG005|Overall Study|Disease progression|1|||
30947689|NCT01790503|58992612|FG006|Overall Study|Disease progression|0|||
30947690|NCT01790503|58992613|FG007|Overall Study|Disease progression|1|||
30947691|NCT01790503|58992614|FG008|Overall Study|Disease progression|0|||
30947692|NCT01790503|58992615|FG009|Overall Study|Disease progression|17|||
30947693|NCT01790503|58992616|FG010|Overall Study|Disease progression|7|||
30947694|NCT01790503|58992606|FG000|Overall Study|Protocol Violation|0|||
30947695|NCT01790503|58992607|FG001|Overall Study|Protocol Violation|0|||
30947696|NCT01790503|58992608|FG002|Overall Study|Protocol Violation|0|||
30947697|NCT01790503|58992609|FG003|Overall Study|Protocol Violation|0|||
30947698|NCT01790503|58992610|FG004|Overall Study|Protocol Violation|0|||
30947699|NCT01790503|58992611|FG005|Overall Study|Protocol Violation|0|||
30947700|NCT01790503|58992612|FG006|Overall Study|Protocol Violation|0|||
30947701|NCT01790503|58992613|FG007|Overall Study|Protocol Violation|0|||
30947702|NCT01790503|58992614|FG008|Overall Study|Protocol Violation|0|||
30947703|NCT01790503|58992615|FG009|Overall Study|Protocol Violation|1|||
30947704|NCT01790503|58992616|FG010|Overall Study|Protocol Violation|0|||
30947705|NCT01790503|58992606|FG000|Overall Study|Physician Decision|0|||
30947706|NCT01790503|58992607|FG001|Overall Study|Physician Decision|0|||
30947707|NCT01790503|58992608|FG002|Overall Study|Physician Decision|0|||
30947708|NCT01790503|58992609|FG003|Overall Study|Physician Decision|0|||
30947709|NCT01790503|58992610|FG004|Overall Study|Physician Decision|0|||
30947710|NCT01790503|58992611|FG005|Overall Study|Physician Decision|0|||
30947711|NCT01790503|58992612|FG006|Overall Study|Physician Decision|0|||
30947712|NCT01790503|58992613|FG007|Overall Study|Physician Decision|0|||
30947713|NCT01790503|58992614|FG008|Overall Study|Physician Decision|0|||
30947714|NCT01790503|58992615|FG009|Overall Study|Physician Decision|1|||
30947715|NCT01790503|58992616|FG010|Overall Study|Physician Decision|1|||
30947716|NCT01790503|58992606|FG000|Overall Study|Death|0|||
30947717|NCT01790503|58992607|FG001|Overall Study|Death|0|||
30947718|NCT01790503|58992608|FG002|Overall Study|Death|0|||
30947719|NCT01790503|58992609|FG003|Overall Study|Death|0|||
30947720|NCT01790503|58992610|FG004|Overall Study|Death|0|||
30947721|NCT01790503|58992611|FG005|Overall Study|Death|0|||
30947722|NCT01790503|58992612|FG006|Overall Study|Death|0|||
30947723|NCT01790503|58992613|FG007|Overall Study|Death|0|||
30947724|NCT01790503|58992614|FG008|Overall Study|Death|0|||
30947725|NCT01790503|58992615|FG009|Overall Study|Death|1|||
30947726|NCT01790503|58992616|FG010|Overall Study|Death|0|||
30947727|NCT01790503|58992606|FG000|Overall Study|Non Compliance|0|||
30947728|NCT01790503|58992607|FG001|Overall Study|Non Compliance|0|||
30947729|NCT01790503|58992608|FG002|Overall Study|Non Compliance|0|||
30947730|NCT01790503|58992609|FG003|Overall Study|Non Compliance|0|||
30947731|NCT01790503|58992610|FG004|Overall Study|Non Compliance|1|||
30947732|NCT01790503|58992611|FG005|Overall Study|Non Compliance|0|||
30947733|NCT01790503|58992612|FG006|Overall Study|Non Compliance|0|||
30947734|NCT01790503|58992613|FG007|Overall Study|Non Compliance|0|||
30947735|NCT01790503|58992614|FG008|Overall Study|Non Compliance|0|||
30947736|NCT01790503|58992615|FG009|Overall Study|Non Compliance|0|||
30947737|NCT01790503|58992616|FG010|Overall Study|Non Compliance|0|||
30947738|NCT01790503|58992606|FG000|Overall Study|Other|0|||
30947739|NCT01790503|58992607|FG001|Overall Study|Other|0|||
30947740|NCT01790503|58992608|FG002|Overall Study|Other|0|||
30947741|NCT01790503|58992609|FG003|Overall Study|Other|0|||
30947742|NCT01790503|58992610|FG004|Overall Study|Other|1|||
30947743|NCT01790503|58992611|FG005|Overall Study|Other|0|||
30947744|NCT01790503|58992612|FG006|Overall Study|Other|0|||
30947745|NCT01790503|58992613|FG007|Overall Study|Other|0|||
30947746|NCT01790503|58992614|FG008|Overall Study|Other|1|||
30947747|NCT01790503|58992615|FG009|Overall Study|Other|2|||
30947748|NCT01790503|58992616|FG010|Overall Study|Other|0|||
30947749|NCT01790113|58992655|FG000|Overall Study|Adverse Event|2|||
30947750|NCT01790113|58992656|FG001|Overall Study|Adverse Event|7|||
30947751|NCT01790113|58992655|FG000|Overall Study|Study ended due to FDA clearance|1|||
30947752|NCT01790113|58992656|FG001|Overall Study|Study ended due to FDA clearance|68|||
30947753|NCT01789567|58992662|FG000|Overall Study|Death|6|||
30947754|NCT01765543|58992666|FG000|Overall Study|Death|1|||
30947755|NCT01765543|58992666|FG000|Overall Study|Withdrawal by Subject|2|||
30947756|NCT01765153|58992676|FG000|Training Phase 1|Format of intervention differed|1|||
30947757|NCT01765153|58992677|FG001|Training Phase 1|Format of intervention differed|0|||
30947758|NCT01765153|58992676|FG000|Training Phase 1|Poor participation in intervention|0|||
30947759|NCT01765153|58992677|FG001|Training Phase 1|Poor participation in intervention|1|||
30947760|NCT01765153|58992676|FG000|Rest Phase 1|Withdrawal by Subject|0|||
30947761|NCT01765153|58992677|FG001|Rest Phase 1|Withdrawal by Subject|1|||
30625339|NCT00894166|58637455|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
30947762|NCT01765153|58992676|FG000|Training Phase 2|Withdrawal by Subject|0|||
30947763|NCT01765153|58992677|FG001|Training Phase 2|Withdrawal by Subject|1|||
30947764|NCT01765153|58992676|FG000|Rest Phase 2|Lost to Follow-up|2|||
30947765|NCT01765153|58992677|FG001|Rest Phase 2|Lost to Follow-up|1|||
30947766|NCT00248170|58992689|FG000|Overall Study|Withdrawal by Subject|71|||
30947767|NCT00248170|58992690|FG001|Overall Study|Withdrawal by Subject|79|||
30947768|NCT00248170|58992689|FG000|Overall Study|Protocol Violation|35|||
30947769|NCT00248170|58992690|FG001|Overall Study|Protocol Violation|30|||
30947770|NCT00248170|58992689|FG000|Overall Study|Lost to Follow-up|28|||
30625340|NCT00894166|58637456|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
30947771|NCT00248170|58992690|FG001|Overall Study|Lost to Follow-up|35|||
30947772|NCT00248170|58992689|FG000|Overall Study|Disease progression|196|||
30947773|NCT00248170|58992690|FG001|Overall Study|Disease progression|216|||
30947774|NCT00248170|58992689|FG000|Overall Study|Death|28|||
30947775|NCT00248170|58992690|FG001|Overall Study|Death|47|||
30947776|NCT00248170|58992689|FG000|Overall Study|Adverse Event|311|||
30947777|NCT00248170|58992690|FG001|Overall Study|Adverse Event|296|||
30947778|NCT00248170|58992689|FG000|Overall Study|Administrative problems|22|||
30947779|NCT00248170|58992690|FG001|Overall Study|Administrative problems|25|||
30947780|NCT00248170|58992689|FG000|Overall Study|Abnormal test procedure(s) result|49|||
30947781|NCT00248170|58992690|FG001|Overall Study|Abnormal test procedure(s) result|61|||
30947782|NCT00248170|58992689|FG000|Overall Study|Abnormal laboratory values|4|||
30947783|NCT00248170|58992690|FG001|Overall Study|Abnormal laboratory values|0|||
30947784|NCT00248170|58992689|FG000|Overall Study|Protocol deviation|17|||
30947785|NCT00248170|58992690|FG001|Overall Study|Protocol deviation|19|||
30947786|NCT01764997|58992701|FG000|Run-in Period|Adverse Event|15|||
30947787|NCT01764997|58992702|FG001|Run-in Period|Adverse Event|0|||
30947788|NCT01764997|58992703|FG002|Run-in Period|Adverse Event|0|||
30947789|NCT01764997|58992704|FG003|Run-in Period|Adverse Event|0|||
30947790|NCT01764997|58992705|FG004|Run-in Period|Adverse Event|0|||
30947791|NCT01764997|58992701|FG000|Run-in Period|Lack of Efficacy|5|||
30947792|NCT01764997|58992702|FG001|Run-in Period|Lack of Efficacy|0|||
30947793|NCT01764997|58992703|FG002|Run-in Period|Lack of Efficacy|0|||
30947794|NCT01764997|58992704|FG003|Run-in Period|Lack of Efficacy|0|||
30947795|NCT01764997|58992705|FG004|Run-in Period|Lack of Efficacy|0|||
30947796|NCT01764997|58992701|FG000|Run-in Period|Poor compliance to protocol|1|||
30947797|NCT01764997|58992702|FG001|Run-in Period|Poor compliance to protocol|0|||
30947798|NCT01764997|58992703|FG002|Run-in Period|Poor compliance to protocol|0|||
30947799|NCT01764997|58992704|FG003|Run-in Period|Poor compliance to protocol|0|||
30947800|NCT01764997|58992705|FG004|Run-in Period|Poor compliance to protocol|0|||
30947801|NCT01764997|58992701|FG000|Run-in Period|Other than specified above|17|||
30947802|NCT01764997|58992702|FG001|Run-in Period|Other than specified above|0|||
30947803|NCT01764997|58992703|FG002|Run-in Period|Other than specified above|0|||
30947804|NCT01764997|58992704|FG003|Run-in Period|Other than specified above|0|||
30947805|NCT01764997|58992705|FG004|Run-in Period|Other than specified above|0|||
30947806|NCT01764997|58992701|FG000|Study Drug Treatment Period|Adverse Event|0|||
30947807|NCT01764997|58992702|FG001|Study Drug Treatment Period|Adverse Event|1|||
30947808|NCT01764997|58992703|FG002|Study Drug Treatment Period|Adverse Event|0|||
30947809|NCT01764997|58992704|FG003|Study Drug Treatment Period|Adverse Event|0|||
30947810|NCT01764997|58992705|FG004|Study Drug Treatment Period|Adverse Event|24|||
30947811|NCT01764997|58992701|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
30947812|NCT01764997|58992702|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
30947813|NCT01764997|58992703|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
30947814|NCT01764997|58992704|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
30947815|NCT01764997|58992705|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
30947816|NCT01764997|58992701|FG000|Study Drug Treatment Period|Other than specified above|0|||
30947817|NCT01764997|58992702|FG001|Study Drug Treatment Period|Other than specified above|0|||
30947818|NCT01764997|58992703|FG002|Study Drug Treatment Period|Other than specified above|0|||
30947819|NCT01764997|58992704|FG003|Study Drug Treatment Period|Other than specified above|0|||
30947820|NCT01764997|58992705|FG004|Study Drug Treatment Period|Other than specified above|10|||
30947821|NCT01276756|58992717|FG000|Overall Study|Lost to Follow-up|2|||
30947822|NCT01276756|58992718|FG001|Overall Study|Lost to Follow-up|0|||
30947823|NCT01276756|58992717|FG000|Overall Study|Adverse Event|3|||
30947824|NCT01276756|58992718|FG001|Overall Study|Adverse Event|2|||
30947825|NCT00246376|58992729|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
30947826|NCT00246376|58992730|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
30947827|NCT00246376|58992731|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
30947828|NCT00246376|58992732|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
30947829|NCT00246376|58992733|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
30947830|NCT00246376|58992729|FG000|Overall Study|Adverse Event|2|||
30947831|NCT00246376|58992730|FG001|Overall Study|Adverse Event|3|||
30947832|NCT00246376|58992731|FG002|Overall Study|Adverse Event|1|||
30947833|NCT00246376|58992732|FG003|Overall Study|Adverse Event|3|||
30947834|NCT00246376|58992733|FG004|Overall Study|Adverse Event|1|||
30947835|NCT00246376|58992729|FG000|Overall Study|Lost to Follow-up|2|||
30947836|NCT00246376|58992730|FG001|Overall Study|Lost to Follow-up|11|||
30947837|NCT00246376|58992731|FG002|Overall Study|Lost to Follow-up|11|||
30947838|NCT00246376|58992732|FG003|Overall Study|Lost to Follow-up|16|||
30947839|NCT00246376|58992733|FG004|Overall Study|Lost to Follow-up|13|||
30625341|NCT00894166|58637457|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
30760082|NCT00103857|58768269|FG003|50-Week Extension Study|patient moved|2|||
30760083|NCT00103857|58768270|FG004|50-Week Extension Study|patient moved|0|||
30947840|NCT01764841|58992791|FG000|Overall Study|Logistical Difficulties|0|||
30947841|NCT01764841|58992792|FG001|Overall Study|Logistical Difficulties|1|||
30947842|NCT01764841|58992793|FG002|Overall Study|Logistical Difficulties|0|||
30947843|NCT01764841|58992794|FG003|Overall Study|Logistical Difficulties|0|||
30947844|NCT01764841|58992791|FG000|Overall Study|Death|3|||
30947845|NCT01764841|58992792|FG001|Overall Study|Death|0|||
30947846|NCT01764841|58992793|FG002|Overall Study|Death|1|||
30947847|NCT01764841|58992794|FG003|Overall Study|Death|4|||
30947848|NCT01764841|58992791|FG000|Overall Study|No Follow Up|1|||
30947849|NCT01764841|58992792|FG001|Overall Study|No Follow Up|0|||
30947850|NCT01764841|58992793|FG002|Overall Study|No Follow Up|1|||
30947851|NCT01764841|58992794|FG003|Overall Study|No Follow Up|0|||
30947852|NCT01764841|58992791|FG000|Overall Study|Protocol Violation|0|||
30947853|NCT01764841|58992792|FG001|Overall Study|Protocol Violation|1|||
30947854|NCT01764841|58992793|FG002|Overall Study|Protocol Violation|0|||
30947855|NCT01764841|58992794|FG003|Overall Study|Protocol Violation|0|||
30947856|NCT01764841|58992791|FG000|Overall Study|Withdrawal by Subject|16|||
30947857|NCT01764841|58992792|FG001|Overall Study|Withdrawal by Subject|24|||
30947858|NCT01764841|58992793|FG002|Overall Study|Withdrawal by Subject|11|||
30947859|NCT01764841|58992794|FG003|Overall Study|Withdrawal by Subject|15|||
30947860|NCT01764841|58992791|FG000|Overall Study|Lost to Follow-up|3|||
30947861|NCT01764841|58992792|FG001|Overall Study|Lost to Follow-up|0|||
30947862|NCT01764841|58992793|FG002|Overall Study|Lost to Follow-up|1|||
30947863|NCT01764841|58992794|FG003|Overall Study|Lost to Follow-up|0|||
30947864|NCT00245050|58992806|FG000|Overall Study|Adverse Event|3|||
30947865|NCT00245050|58992807|FG001|Overall Study|Adverse Event|2|||
30947866|NCT00243412|58992845|FG000|Overall Study|Death|0|||
30947867|NCT00243412|58992846|FG001|Overall Study|Death|1|||
30947868|NCT00243412|58992845|FG000|Overall Study|Adverse Event|4|||
30947869|NCT00243412|58992846|FG001|Overall Study|Adverse Event|2|||
30947870|NCT00243412|58992845|FG000|Overall Study|Lost to Follow-up|0|||
30947871|NCT00243412|58992846|FG001|Overall Study|Lost to Follow-up|1|||
30947872|NCT00243412|58992845|FG000|Overall Study|Physician Decision|1|||
30760084|NCT00103857|58768271|FG005|50-Week Extension Study|patient moved|0|||
30760085|NCT00103857|58768272|FG006|50-Week Extension Study|patient moved|0|||
30760086|NCT00103857|58768266|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
30760087|NCT00103857|58768267|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
30760088|NCT00103857|58768268|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
30760089|NCT00103857|58768269|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
30760090|NCT00103857|58768270|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
30760091|NCT00103857|58768271|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
30760092|NCT00103857|58768272|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
30760093|NCT00103857|58768266|FG000|50-Week Extension Study|reason unspecified|0|||
30760094|NCT00103857|58768267|FG001|50-Week Extension Study|reason unspecified|0|||
30760095|NCT00103857|58768268|FG002|50-Week Extension Study|reason unspecified|0|||
30760096|NCT00103857|58768269|FG003|50-Week Extension Study|reason unspecified|0|||
30760097|NCT00103857|58768270|FG004|50-Week Extension Study|reason unspecified|1|||
30760098|NCT00103857|58768271|FG005|50-Week Extension Study|reason unspecified|0|||
30760099|NCT00103857|58768272|FG006|50-Week Extension Study|reason unspecified|0|||
30760100|NCT03587584|58768289|FG000|Overall Study|SOC deviations|4|||
30760101|NCT03587584|58768290|FG001|Overall Study|SOC deviations|6|||
30947873|NCT00243412|58992846|FG001|Overall Study|Physician Decision|1|||
30947874|NCT00243412|58992845|FG000|Overall Study|Withdrawal by Subject|4|||
30947875|NCT00243412|58992846|FG001|Overall Study|Withdrawal by Subject|5|||
30947876|NCT00243412|58992845|FG000|Overall Study|Other|1|||
30947877|NCT00243412|58992846|FG001|Overall Study|Other|1|||
30947878|NCT03805750|58992861|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
30947879|NCT03805750|58992862|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
30947880|NCT03804268|58992870|FG000|Overall Study|Adverse Event|2|||
30947881|NCT03804268|58992871|FG001|Overall Study|Adverse Event|2|||
30947882|NCT03804268|58992870|FG000|Overall Study|Withdrawal by Subject|2|||
30947883|NCT03804268|58992871|FG001|Overall Study|Withdrawal by Subject|0|||
30947884|NCT03804268|58992870|FG000|Overall Study|Lost to Follow-up|1|||
30947885|NCT03804268|58992871|FG001|Overall Study|Lost to Follow-up|0|||
30947886|NCT03804268|58992870|FG000|Overall Study|Physician Decision|2|||
30947887|NCT03804268|58992871|FG001|Overall Study|Physician Decision|0|||
30947888|NCT00243022|58992896|FG000|Overall Study|Withdrawal by Subject|1|||
30947889|NCT00243022|58992897|FG001|Overall Study|Withdrawal by Subject|0|||
30947890|NCT00243022|58992896|FG000|Overall Study|Death|1|||
30947891|NCT00243022|58992897|FG001|Overall Study|Death|0|||
30947892|NCT00243022|58992896|FG000|Overall Study|Difficult Travel Distance|0|||
30843030|NCT01126749|58868933|FG001|Phase 2|Other|0|||
30843031|NCT01126749|58868934|FG002|Phase 2|Other|4|||
30843032|NCT01126749|58868935|FG003|Phase 2|Other|2|||
30843033|NCT01126749|58868932|FG000|Phase 2|Withdrawal by Subject|0|||
30843034|NCT01126749|58868933|FG001|Phase 2|Withdrawal by Subject|0|||
30843035|NCT01126749|58868934|FG002|Phase 2|Withdrawal by Subject|0|||
30843036|NCT01126749|58868935|FG003|Phase 2|Withdrawal by Subject|2|||
30843037|NCT01126749|58868932|FG000|Phase 2|Lost to Follow-up|0|||
30843038|NCT01126749|58868933|FG001|Phase 2|Lost to Follow-up|0|||
30843039|NCT01126749|58868934|FG002|Phase 2|Lost to Follow-up|0|||
30947893|NCT00243022|58992897|FG001|Overall Study|Difficult Travel Distance|1|||
30760102|NCT03587584|58768289|FG000|Overall Study|Incomplete data|0|||
30760103|NCT03587584|58768290|FG001|Overall Study|Incomplete data|3|||
30760104|NCT03586726|58768296|FG000|Overall Study|Withdrawal by Subject|1|||
30843040|NCT01126749|58868935|FG003|Phase 2|Lost to Follow-up|1|||
30843041|NCT01126749|58868932|FG000|Phase 2|Death|0|||
30843042|NCT01126749|58868933|FG001|Phase 2|Death|0|||
30843043|NCT01126749|58868934|FG002|Phase 2|Death|22|||
30947894|NCT01736683|58992982|FG000|Overall Study|Disease Relapse|0|||
30947895|NCT01736683|58992983|FG001|Overall Study|Disease Relapse|0|||
30947896|NCT01736683|58992984|FG002|Overall Study|Disease Relapse|2|||
30947897|NCT01736683|58992985|FG003|Overall Study|Disease Relapse|1|||
30947898|NCT01736683|58992986|FG004|Overall Study|Disease Relapse|0|||
30947899|NCT01736683|58992982|FG000|Overall Study|Adverse Event|0|||
30947900|NCT01736683|58992983|FG001|Overall Study|Adverse Event|2|||
30947901|NCT01736683|58992984|FG002|Overall Study|Adverse Event|2|||
30947902|NCT01736683|58992985|FG003|Overall Study|Adverse Event|3|||
30947903|NCT01736683|58992986|FG004|Overall Study|Adverse Event|2|||
30947904|NCT01736683|58992982|FG000|Overall Study|Withdrawal by Subject|0|||
30947905|NCT01736683|58992983|FG001|Overall Study|Withdrawal by Subject|0|||
30947906|NCT01736683|58992984|FG002|Overall Study|Withdrawal by Subject|3|||
30947907|NCT01736683|58992985|FG003|Overall Study|Withdrawal by Subject|1|||
30947908|NCT01736683|58992986|FG004|Overall Study|Withdrawal by Subject|1|||
30947909|NCT01736683|58992982|FG000|Overall Study|Lack of Therapeutic Effect|7|||
30947910|NCT01736683|58992983|FG001|Overall Study|Lack of Therapeutic Effect|4|||
30947911|NCT01736683|58992984|FG002|Overall Study|Lack of Therapeutic Effect|13|||
30947912|NCT01736683|58992985|FG003|Overall Study|Lack of Therapeutic Effect|20|||
30947913|NCT01736683|58992986|FG004|Overall Study|Lack of Therapeutic Effect|1|||
30947914|NCT01736683|58992982|FG000|Overall Study|Progressive Disease|0|||
30947915|NCT01736683|58992983|FG001|Overall Study|Progressive Disease|0|||
30947916|NCT01736683|58992984|FG002|Overall Study|Progressive Disease|0|||
30947917|NCT01736683|58992985|FG003|Overall Study|Progressive Disease|1|||
30947918|NCT01736683|58992986|FG004|Overall Study|Progressive Disease|0|||
30947919|NCT01736683|58992982|FG000|Overall Study|Other|0|||
30843044|NCT01126749|58868935|FG003|Phase 2|Death|22|||
30843045|NCT01126749|58868932|FG000|Phase 2|Adverse Event|0|||
30843046|NCT01126749|58868933|FG001|Phase 2|Adverse Event|0|||
30843047|NCT01126749|58868934|FG002|Phase 2|Adverse Event|0|||
30843048|NCT01126749|58868935|FG003|Phase 2|Adverse Event|1|||
30843049|NCT02521948|58868945|FG000|Overall Study|Adverse Event|2|||
30843050|NCT02521948|58868945|FG000|Overall Study|Death|4|||
30843051|NCT02521948|58868945|FG000|Overall Study|Lost to Follow-up|1|||
30843052|NCT02521948|58868945|FG000|Overall Study|Did not attend one or both follow-ups|6|||
30843053|NCT04446429|58868954|FG000|Overall Study|Lost to Follow-up|6|||
30843054|NCT04446429|58868955|FG001|Overall Study|Lost to Follow-up|0|||
30843055|NCT02832687|58868963|FG000|Overall Study|Adverse Event|0|||
30843056|NCT02832687|58868964|FG001|Overall Study|Adverse Event|2|||
30843057|NCT01656850|58868989|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
30843058|NCT01656850|58868990|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
30843059|NCT03116685|58869002|FG000|Overall Study|Physician Decision|0|||
30843060|NCT03116685|58869003|FG001|Overall Study|Physician Decision|1|||
30843061|NCT02666222|58869023|FG000|Overall Study|Death|2|||
30843062|NCT00739401|58869027|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
30843063|NCT00739401|58869027|FG000|Overall Study|Death|3|||
30843064|NCT00739401|58869027|FG000|Overall Study|Withdrawal by Subject|4|||
30843065|NCT01365052|58869033|FG000|Overall Study|Adverse Event|4|||
30843066|NCT01365052|58869034|FG001|Overall Study|Adverse Event|4|||
30843067|NCT01372748|58869042|FG000|Overall Study|Lost to Follow-up|16|||
30843068|NCT01372748|58869043|FG001|Overall Study|Lost to Follow-up|34|||
30843069|NCT01372748|58869042|FG000|Overall Study|Withdrawal by Subject|7|||
30843070|NCT01372748|58869043|FG001|Overall Study|Withdrawal by Subject|5|||
30843071|NCT02268851|58869055|FG000|Overall Study|Death|0|||
30843072|NCT02268851|58869056|FG001|Overall Study|Death|0|||
30843073|NCT02268851|58869057|FG002|Overall Study|Death|0|||
30843074|NCT02268851|58869058|FG003|Overall Study|Death|1|||
30843075|NCT02268851|58869059|FG004|Overall Study|Death|2|||
30843076|NCT02268851|58869060|FG005|Overall Study|Death|1|||
30843077|NCT02268851|58869055|FG000|Overall Study|Adverse Event|0|||
30843078|NCT02268851|58869056|FG001|Overall Study|Adverse Event|0|||
30843079|NCT02268851|58869057|FG002|Overall Study|Adverse Event|0|||
30843080|NCT02268851|58869058|FG003|Overall Study|Adverse Event|0|||
30843081|NCT02268851|58869059|FG004|Overall Study|Adverse Event|2|||
30843082|NCT02268851|58869060|FG005|Overall Study|Adverse Event|2|||
30843083|NCT02268851|58869055|FG000|Overall Study|Withdrawal by Subject|0|||
30843084|NCT02268851|58869056|FG001|Overall Study|Withdrawal by Subject|0|||
30843085|NCT02268851|58869057|FG002|Overall Study|Withdrawal by Subject|0|||
30843086|NCT02268851|58869058|FG003|Overall Study|Withdrawal by Subject|2|||
30843087|NCT02268851|58869059|FG004|Overall Study|Withdrawal by Subject|0|||
30843088|NCT02268851|58869060|FG005|Overall Study|Withdrawal by Subject|1|||
30843089|NCT02268851|58869055|FG000|Overall Study|Progressive Disease|1|||
30843090|NCT02268851|58869056|FG001|Overall Study|Progressive Disease|3|||
30843091|NCT02268851|58869057|FG002|Overall Study|Progressive Disease|0|||
30843092|NCT02268851|58869058|FG003|Overall Study|Progressive Disease|0|||
30843093|NCT02268851|58869059|FG004|Overall Study|Progressive Disease|1|||
30843094|NCT02268851|58869060|FG005|Overall Study|Progressive Disease|4|||
30843095|NCT02268851|58869055|FG000|Overall Study|Physician Decision|0|||
30843096|NCT02268851|58869056|FG001|Overall Study|Physician Decision|0|||
30843097|NCT02268851|58869057|FG002|Overall Study|Physician Decision|1|||
30843098|NCT02268851|58869058|FG003|Overall Study|Physician Decision|0|||
30843099|NCT02268851|58869059|FG004|Overall Study|Physician Decision|0|||
30947920|NCT01736683|58992983|FG001|Overall Study|Other|0|||
30947921|NCT01736683|58992984|FG002|Overall Study|Other|1|||
30947922|NCT01736683|58992985|FG003|Overall Study|Other|9|||
30947923|NCT01736683|58992986|FG004|Overall Study|Other|1|||
30843100|NCT02268851|58869060|FG005|Overall Study|Physician Decision|1|||
30843101|NCT02268851|58869055|FG000|Overall Study|Patient Compliance|0|||
30843102|NCT02268851|58869056|FG001|Overall Study|Patient Compliance|0|||
30843103|NCT02268851|58869057|FG002|Overall Study|Patient Compliance|0|||
30843104|NCT02268851|58869058|FG003|Overall Study|Patient Compliance|0|||
30843105|NCT02268851|58869059|FG004|Overall Study|Patient Compliance|1|||
30843106|NCT02268851|58869060|FG005|Overall Study|Patient Compliance|1|||
30843107|NCT02268851|58869055|FG000|Overall Study|Co-Morbid Condition|0|||
30843108|NCT02268851|58869056|FG001|Overall Study|Co-Morbid Condition|0|||
30843109|NCT02268851|58869057|FG002|Overall Study|Co-Morbid Condition|0|||
30843110|NCT02268851|58869058|FG003|Overall Study|Co-Morbid Condition|0|||
30843111|NCT02268851|58869059|FG004|Overall Study|Co-Morbid Condition|1|||
30843112|NCT02268851|58869060|FG005|Overall Study|Co-Morbid Condition|1|||
30843113|NCT02736825|58869076|FG000|Overall Study|Lost to Follow-up|10|||
30843114|NCT02736825|58869077|FG001|Overall Study|Lost to Follow-up|11|||
30843115|NCT02736825|58869076|FG000|Overall Study|Early Termination|0|||
30843116|NCT02736825|58869077|FG001|Overall Study|Early Termination|1|||
30843117|NCT02670122|58869084|FG000|Overall Study|Lost to Follow-up|4|||
30843118|NCT03283371|58869097|FG000|Placebo-controlled|Adverse Event|1|||
30843119|NCT03283371|58869098|FG001|Placebo-controlled|Adverse Event|1|||
30843120|NCT03283371|58869099|FG002|Placebo-controlled|Adverse Event|0|||
30843121|NCT03283371|58869100|FG003|Placebo-controlled|Adverse Event|0|||
30843122|NCT03283371|58869097|FG000|Placebo-controlled|Lack of Efficacy|1|||
30843123|NCT03283371|58869098|FG001|Placebo-controlled|Lack of Efficacy|0|||
30843124|NCT03283371|58869099|FG002|Placebo-controlled|Lack of Efficacy|0|||
30843125|NCT03283371|58869100|FG003|Placebo-controlled|Lack of Efficacy|0|||
30843126|NCT03283371|58869097|FG000|Placebo-controlled|Withdrawal by Subject|1|||
30843127|NCT03283371|58869098|FG001|Placebo-controlled|Withdrawal by Subject|1|||
30843128|NCT03283371|58869099|FG002|Placebo-controlled|Withdrawal by Subject|0|||
30843129|NCT03283371|58869100|FG003|Placebo-controlled|Withdrawal by Subject|0|||
30843130|NCT03283371|58869097|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
30843131|NCT03283371|58869098|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
30947924|NCT01788943|58993002|FG000|Overall Study|Withdrawal by Subject|1|||
30947925|NCT01788943|58993003|FG001|Overall Study|Withdrawal by Subject|0|||
30947926|NCT01788163|58993030|FG000|Overall Study|Other|53|||
30947927|NCT01788163|58993031|FG001|Overall Study|Other|0|||
30947928|NCT01788163|58993032|FG002|Overall Study|Other|0|||
30947929|NCT01788163|58993033|FG003|Overall Study|Other|0|||
30947930|NCT01788163|58993034|FG004|Overall Study|Other|0|||
30947931|NCT01788163|58993035|FG005|Overall Study|Other|7|||
30947932|NCT01788163|58993036|FG006|Overall Study|Other|1|||
30947933|NCT01788163|58993037|FG007|Overall Study|Other|48|||
30947934|NCT01788163|58993038|FG008|Overall Study|Other|15|||
30947935|NCT01788163|58993030|FG000|Overall Study|Withdrawal by Subject|2|||
30947936|NCT01788163|58993031|FG001|Overall Study|Withdrawal by Subject|0|||
30947937|NCT01788163|58993032|FG002|Overall Study|Withdrawal by Subject|0|||
30947938|NCT01788163|58993033|FG003|Overall Study|Withdrawal by Subject|0|||
30947939|NCT01788163|58993034|FG004|Overall Study|Withdrawal by Subject|0|||
30947940|NCT01788163|58993035|FG005|Overall Study|Withdrawal by Subject|0|||
30947941|NCT01788163|58993036|FG006|Overall Study|Withdrawal by Subject|0|||
30947942|NCT01788163|58993037|FG007|Overall Study|Withdrawal by Subject|0|||
30947943|NCT01788163|58993038|FG008|Overall Study|Withdrawal by Subject|1|||
30947944|NCT01787461|58993174|FG000|Overall Study|Adverse Event|4|||
30947945|NCT01787461|58993175|FG001|Overall Study|Adverse Event|3|||
30947946|NCT01787461|58993174|FG000|Overall Study|Lost to Follow-up|3|||
30947947|NCT01787461|58993175|FG001|Overall Study|Lost to Follow-up|2|||
30947948|NCT01787461|58993174|FG000|Overall Study|No longer met eligibility criteria|1|||
30947949|NCT01787461|58993175|FG001|Overall Study|No longer met eligibility criteria|0|||
30947950|NCT01787461|58993174|FG000|Overall Study|Withdrawal by Subject|3|||
30947951|NCT01787461|58993175|FG001|Overall Study|Withdrawal by Subject|4|||
30947952|NCT01787461|58993174|FG000|Overall Study|Protocol Violation|3|||
30947953|NCT01787461|58993175|FG001|Overall Study|Protocol Violation|0|||
30947954|NCT01786993|58993200|FG000|Overall Study|Death|6|||
30947955|NCT01786993|58993201|FG001|Overall Study|Death|7|||
30947956|NCT01786993|58993200|FG000|Overall Study|Withdrawal by Subject|3|||
30947957|NCT01786993|58993201|FG001|Overall Study|Withdrawal by Subject|2|||
30947958|NCT01786993|58993200|FG000|Overall Study|Lost to Follow-up|0|||
30947959|NCT01786993|58993201|FG001|Overall Study|Lost to Follow-up|1|||
30947960|NCT01786993|58993200|FG000|Overall Study|Subject Non-Compliance|1|||
30947961|NCT01786993|58993201|FG001|Overall Study|Subject Non-Compliance|0|||
30947962|NCT01786993|58993200|FG000|Overall Study|System Explant|1|||
30947963|NCT01786993|58993201|FG001|Overall Study|System Explant|0|||
30947964|NCT01786993|58993200|FG000|Overall Study|Hospice Admission|1|||
30947965|NCT01786993|58993201|FG001|Overall Study|Hospice Admission|0|||
30947966|NCT01966445|58993226|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
30947967|NCT01966445|58993227|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
30947968|NCT01966445|58993228|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
30947969|NCT01966445|58993229|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
30947970|NCT01966445|58993230|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
30947971|NCT01966445|58993231|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
30947972|NCT01966445|58993232|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
30947973|NCT01966445|58993226|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
30947974|NCT01966445|58993227|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
30947975|NCT01966445|58993228|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
30947976|NCT01966445|58993229|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
30947977|NCT01966445|58993230|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
30947978|NCT01966445|58993231|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
30947979|NCT01966445|58993232|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
30947980|NCT01966445|58993226|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
30947981|NCT01966445|58993227|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
30947982|NCT01966445|58993228|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
30947983|NCT01966445|58993229|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
30947984|NCT01966445|58993230|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
30947985|NCT01966445|58993231|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
30947986|NCT01966445|58993232|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
30947987|NCT01966445|58993226|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
30947988|NCT01966445|58993227|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
30947989|NCT01966445|58993228|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
30947990|NCT01966445|58993229|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
30947991|NCT01966445|58993230|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
30947992|NCT01966445|58993231|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
30947993|NCT01966445|58993232|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
30947994|NCT01966445|58993226|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
30947995|NCT01966445|58993227|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
30947996|NCT01966445|58993228|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
30947997|NCT01966445|58993229|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
30947998|NCT01966445|58993230|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
30947999|NCT01966445|58993231|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
30948000|NCT01966445|58993232|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
30948001|NCT01763905|58993252|FG000|Overall Study|Withdrawal by Subject|1|||
30948002|NCT01763905|58993253|FG001|Overall Study|Withdrawal by Subject|1|||
30948003|NCT01763905|58993254|FG002|Overall Study|Withdrawal by Subject|0|||
30948004|NCT01763905|58993255|FG003|Overall Study|Withdrawal by Subject|1|||
30948005|NCT01763905|58993252|FG000|Overall Study|Decision by sponsor|5|||
30948006|NCT01763905|58993253|FG001|Overall Study|Decision by sponsor|0|||
30948007|NCT01763905|58993254|FG002|Overall Study|Decision by sponsor|8|||
30948008|NCT01763905|58993255|FG003|Overall Study|Decision by sponsor|0|||
30948009|NCT01763905|58993252|FG000|Overall Study|Lost to Follow-up|0|||
30948010|NCT01763905|58993253|FG001|Overall Study|Lost to Follow-up|0|||
30948011|NCT01763905|58993254|FG002|Overall Study|Lost to Follow-up|1|||
30843132|NCT03283371|58869099|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
30843133|NCT03283371|58869100|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
30843134|NCT03283371|58869097|FG000|Open-label Phase|Adverse Event|0|||
30843135|NCT03283371|58869098|FG001|Open-label Phase|Adverse Event|0|||
30843136|NCT03283371|58869099|FG002|Open-label Phase|Adverse Event|2|||
30843137|NCT03283371|58869100|FG003|Open-label Phase|Adverse Event|0|||
30843138|NCT03283371|58869097|FG000|Open-label Phase|Withdrawal by Subject|0|||
30843139|NCT03283371|58869098|FG001|Open-label Phase|Withdrawal by Subject|0|||
30843140|NCT03283371|58869099|FG002|Open-label Phase|Withdrawal by Subject|1|||
30843141|NCT03283371|58869100|FG003|Open-label Phase|Withdrawal by Subject|0|||
30843142|NCT03283371|58869097|FG000|Open-label Phase|Other|0|||
30843143|NCT03283371|58869098|FG001|Open-label Phase|Other|0|||
30843144|NCT03283371|58869099|FG002|Open-label Phase|Other|1|||
30843145|NCT03283371|58869100|FG003|Open-label Phase|Other|1|||
30843146|NCT03069417|58869112|FG000|Overall Study|Lost to Follow-up|2|||
30843147|NCT03069417|58869113|FG001|Overall Study|Lost to Follow-up|0|||
30843148|NCT03069417|58869112|FG000|Overall Study|Reason Unknown|4|||
30843149|NCT03069417|58869113|FG001|Overall Study|Reason Unknown|7|||
30843150|NCT04930263|58869122|FG000|Overall Study|Withdrawal by Subject|3|||
30843151|NCT04930263|58869123|FG001|Overall Study|Withdrawal by Subject|5|||
30948012|NCT01763905|58993255|FG003|Overall Study|Lost to Follow-up|0|||
30948013|NCT02091167|58993267|FG000|Overall Study|Lost to Follow-up|0|||
30948014|NCT02091167|58993268|FG001|Overall Study|Lost to Follow-up|2|||
30948015|NCT02091089|58993274|FG000|Overall Study|Lost to Follow-up|2|||
30948016|NCT01763203|58993289|FG000|Overall Study|Death|4|||
30948017|NCT01763203|58993290|FG001|Overall Study|Death|7|||
30948018|NCT01763203|58993289|FG000|Overall Study|Lost to Follow-up|12|||
30948019|NCT01763203|58993290|FG001|Overall Study|Lost to Follow-up|12|||
30948020|NCT01763203|58993289|FG000|Overall Study|Withdrawal by Subject|8|||
30948021|NCT01763203|58993290|FG001|Overall Study|Withdrawal by Subject|12|||
30948022|NCT01763203|58993289|FG000|Overall Study|Moved out of study region|7|||
30948023|NCT01763203|58993290|FG001|Overall Study|Moved out of study region|10|||
30948024|NCT01763203|58993289|FG000|Overall Study|Physician Decision|2|||
30948025|NCT01763203|58993290|FG001|Overall Study|Physician Decision|1|||
30948026|NCT01763047|58993307|FG000|Period 1|Test Article Not Available|4|||
30948027|NCT01763047|58993308|FG001|Period 1|Test Article Not Available|1|||
30948028|NCT01763047|58993307|FG000|Period 1|Protocol Violation|4|||
30948029|NCT01763047|58993308|FG001|Period 1|Protocol Violation|4|||
30948030|NCT01763047|58993307|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
30948031|NCT01763047|58993308|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
30948032|NCT01763047|58993307|FG000|Period 1|Adverse Event|0|||
30948033|NCT01763047|58993308|FG001|Period 1|Adverse Event|1|||
30948034|NCT01763047|58993307|FG000|Period 1|Unsatisfactory Visual Response|0|||
30948035|NCT01763047|58993308|FG001|Period 1|Unsatisfactory Visual Response|3|||
30948036|NCT01763047|58993307|FG000|Period 1|Lens Power Not Available|0|||
30948037|NCT01763047|58993308|FG001|Period 1|Lens Power Not Available|1|||
30948038|NCT01763047|58993307|FG000|Period 1|Study Site office Closed|0|||
30948039|NCT01763047|58993308|FG001|Period 1|Study Site office Closed|1|||
30948040|NCT01763047|58993307|FG000|Period 2|Lens Discomfort|1|||
30948041|NCT01763047|58993308|FG001|Period 2|Lens Discomfort|0|||
30948042|NCT01763047|58993307|FG000|Period 2|No longer meets Eligibility Criteria|1|||
30948043|NCT01763047|58993308|FG001|Period 2|No longer meets Eligibility Criteria|0|||
30948044|NCT01763047|58993307|FG000|Period 2|Study Site office Closed|1|||
30948045|NCT01763047|58993308|FG001|Period 2|Study Site office Closed|1|||
30948046|NCT01763047|58993307|FG000|Period 2|Unsatisfactory Visual Response|1|||
30948047|NCT01763047|58993308|FG001|Period 2|Unsatisfactory Visual Response|1|||
30948048|NCT01763047|58993307|FG000|Period 2|Protocol Violation|0|||
30948049|NCT01763047|58993308|FG001|Period 2|Protocol Violation|2|||
30948050|NCT01763047|58993307|FG000|Period 2|Unsatisfactory lens Fitting|0|||
30948051|NCT01763047|58993308|FG001|Period 2|Unsatisfactory lens Fitting|1|||
30948052|NCT01977677|58993320|FG000|Overall Study|Unrelated Adverse Event|0|||
30948053|NCT01977677|58993321|FG001|Overall Study|Unrelated Adverse Event|0|||
30948054|NCT01977677|58993322|FG002|Overall Study|Unrelated Adverse Event|1|||
30948055|NCT01762345|58993330|FG000|Overall Study|Adverse Event|5|||
30948056|NCT01762345|58993330|FG000|Overall Study|Protocol Violation|2|||
30948057|NCT02090855|58993335|FG000|Overall Study|no evaluable Standard of Truth results|2|||
30948058|NCT01761565|58993342|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
30948059|NCT01619579|58993352|FG000|Overall Study|Withdrawal by Subject|0|||
30948060|NCT01619579|58993353|FG001|Overall Study|Withdrawal by Subject|3|||
30948061|NCT01736215|58993359|FG000|Overall Study|Early termination of erythropoietin use|1|||
30948062|NCT01736215|58993359|FG000|Overall Study|Adverse Event|4|||
30948063|NCT01736215|58993359|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
30948064|NCT01736215|58993359|FG000|Overall Study|Insufficient data to perform analysis|8|||
30948065|NCT01786603|58993365|FG000|Overall Study|Death|5|||
30948066|NCT01786603|58993366|FG001|Overall Study|Death|1|||
30948067|NCT01786603|58993365|FG000|Overall Study|Adverse Event|6|||
30948068|NCT01786603|58993366|FG001|Overall Study|Adverse Event|2|||
30948069|NCT01786603|58993365|FG000|Overall Study|Physician decision to withdraw|6|||
30948070|NCT01786603|58993366|FG001|Overall Study|Physician decision to withdraw|7|||
30948071|NCT01786603|58993365|FG000|Overall Study|Lost to Follow-up|1|||
30948072|NCT01786603|58993366|FG001|Overall Study|Lost to Follow-up|2|||
30948073|NCT01619423|58993389|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
30948074|NCT01619423|58993390|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
30948075|NCT01619423|58993391|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
30948076|NCT01619423|58993392|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
30948077|NCT01735279|58993405|FG000|Overall Study|Lost to Follow-up|11|||
30948078|NCT01735279|58993406|FG001|Overall Study|Lost to Follow-up|8|||
30948079|NCT01759381|58993414|FG000|Overall Study|Death|1|||
30948080|NCT01759381|58993415|FG001|Overall Study|Death|0|||
30948081|NCT01758523|58993434|FG000|Overall Study|Adverse Event|2|||
30948082|NCT01758523|58993435|FG001|Overall Study|Adverse Event|1|||
30948083|NCT01758523|58993434|FG000|Overall Study|Lack of Efficacy|4|||
30948084|NCT01758523|58993435|FG001|Overall Study|Lack of Efficacy|2|||
30948085|NCT01758523|58993434|FG000|Overall Study|Lost to Follow-up|3|||
30948086|NCT01758523|58993435|FG001|Overall Study|Lost to Follow-up|4|||
30948087|NCT01758523|58993434|FG000|Overall Study|Withdrawal by Subject|12|||
30948088|NCT01758523|58993435|FG001|Overall Study|Withdrawal by Subject|7|||
30948089|NCT01758289|58993458|FG000|Overall Study|Premature Study Termination|44|||
30948090|NCT01758289|58993458|FG000|Overall Study|Adverse Event|9|||
30948091|NCT01757821|58993482|FG000|Overall Study|Adverse Event|1|||
30948092|NCT01735201|58993511|FG000|Overall Study|Adverse Event|1|||
30948093|NCT01735201|58993512|FG001|Overall Study|Adverse Event|1|||
30948094|NCT01735201|58993513|FG002|Overall Study|Adverse Event|0|||
30948095|NCT01735201|58993514|FG003|Overall Study|Adverse Event|1|||
30948096|NCT01735201|58993515|FG004|Overall Study|Adverse Event|1|||
30948097|NCT01735201|58993516|FG005|Overall Study|Adverse Event|3|||
30948098|NCT01735201|58993517|FG006|Overall Study|Adverse Event|2|||
30948099|NCT01735201|58993518|FG007|Overall Study|Adverse Event|1|||
30948100|NCT01735201|58993511|FG000|Overall Study|Personal Reasons|1|||
30948101|NCT01735201|58993512|FG001|Overall Study|Personal Reasons|0|||
30948102|NCT01735201|58993513|FG002|Overall Study|Personal Reasons|0|||
30760105|NCT03586648|58768300|FG000|Period 1|Withdrawal by Subject|0|||
30760106|NCT03586648|58768301|FG001|Period 1|Withdrawal by Subject|1|||
30760107|NCT03586648|58768300|FG000|Period 1|Lost to Follow-up|1|||
30760108|NCT03586648|58768301|FG001|Period 1|Lost to Follow-up|1|||
30843152|NCT02665286|58869132|FG000|Overall Study|Lost to Follow-up|3|||
30843153|NCT02665286|58869133|FG001|Overall Study|Lost to Follow-up|2|||
30843154|NCT02665286|58869134|FG002|Overall Study|Lost to Follow-up|1|||
30843155|NCT02134925|58869144|FG000|Overall Study|Withdrawal by Subject|1|||
30760109|NCT03586648|58768300|FG000|Period 1|Adverse Event|1|||
30760110|NCT03586648|58768301|FG001|Period 1|Adverse Event|0|||
30760111|NCT03586648|58768300|FG000|Period 1|Study related symptoms or complaints|2|||
30760112|NCT03586648|58768301|FG001|Period 1|Study related symptoms or complaints|1|||
30760113|NCT03586648|58768300|FG000|Period 1|Physician Decision|0|||
30760114|NCT03586648|58768301|FG001|Period 1|Physician Decision|1|||
30760115|NCT03586648|58768300|FG000|Period 2|Adverse Event|1|||
30760116|NCT03586648|58768301|FG001|Period 2|Adverse Event|0|||
30760117|NCT02892448|58768310|FG000|Overall Study|Screening failure|2|||
30760118|NCT02892448|58768311|FG001|Overall Study|Screening failure|2|||
30760119|NCT02892448|58768312|FG002|Overall Study|Screening failure|1|||
30760120|NCT03585712|58768320|FG000|Treatment Period 1|Protocol Violation|1|||
30760121|NCT03585712|58768321|FG001|Treatment Period 1|Protocol Violation|0|||
30760122|NCT03585712|58768322|FG002|Treatment Period 1|Protocol Violation|0|||
30760123|NCT03585712|58768320|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
30760124|NCT03585712|58768321|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
30760125|NCT03585712|58768322|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
30760126|NCT03585712|58768320|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
30760127|NCT03585712|58768321|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
30760128|NCT03585712|58768322|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
30760129|NCT03585712|58768320|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
30760130|NCT03585712|58768321|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
30843156|NCT02134925|58869145|FG001|Overall Study|Withdrawal by Subject|0|||
30843157|NCT02134925|58869144|FG000|Overall Study|Cancel|1|||
30843158|NCT02134925|58869145|FG001|Overall Study|Cancel|6|||
30843159|NCT02911519|58869153|FG000|Overall Study|Lost to Follow-up|2|||
30843160|NCT02911519|58869154|FG001|Overall Study|Lost to Follow-up|2|||
30843161|NCT02911519|58869153|FG000|Overall Study|Death|0|||
30843162|NCT02911519|58869154|FG001|Overall Study|Death|2|||
30843163|NCT02911285|58869162|FG000|Overall Study|Lost to Follow-up|8|||
30843164|NCT02911285|58869163|FG001|Overall Study|Lost to Follow-up|5|||
30948103|NCT01735201|58993514|FG003|Overall Study|Personal Reasons|0|||
30760131|NCT03585712|58768322|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
30760132|NCT03585244|58768339|FG000|Overall Study|Withdrawal by Subject|15|||
30760133|NCT00074984|58768345|FG000|Overall Study|Death|1|||
30760134|NCT00074984|58768346|FG001|Overall Study|Death|2|||
30760135|NCT00074984|58768345|FG000|Overall Study|Withdrawal by Subject|2|||
30948104|NCT01735201|58993515|FG004|Overall Study|Personal Reasons|0|||
30760136|NCT00074984|58768346|FG001|Overall Study|Withdrawal by Subject|3|||
30843165|NCT02911285|58869162|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
30843166|NCT02911285|58869163|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
30948105|NCT01735201|58993516|FG005|Overall Study|Personal Reasons|0|||
30948106|NCT01735201|58993517|FG006|Overall Study|Personal Reasons|0|||
30948107|NCT01735201|58993518|FG007|Overall Study|Personal Reasons|0|||
30760137|NCT00074984|58768345|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
30760138|NCT00074984|58768346|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
30760139|NCT03583606|58768356|FG000|Overall Study|Lost to Follow-up|0|||
30760140|NCT03583606|58768357|FG001|Overall Study|Lost to Follow-up|1|||
30760141|NCT03583606|58768358|FG002|Overall Study|Lost to Follow-up|0|||
30760142|NCT03583606|58768356|FG000|Overall Study|Ineligible at baseline|1|||
30760143|NCT03583606|58768357|FG001|Overall Study|Ineligible at baseline|0|||
30760144|NCT03583606|58768358|FG002|Overall Study|Ineligible at baseline|0|||
30843167|NCT02910739|58869175|FG000|Overall Study|Adverse Event|1|||
30843168|NCT02910739|58869176|FG001|Overall Study|Adverse Event|0|||
30948108|NCT01735201|58993511|FG000|Overall Study|Protocol Violation|1|||
30948109|NCT01735201|58993512|FG001|Overall Study|Protocol Violation|0|||
30948110|NCT01735201|58993513|FG002|Overall Study|Protocol Violation|0|||
30948111|NCT01735201|58993514|FG003|Overall Study|Protocol Violation|0|||
30948112|NCT01735201|58993515|FG004|Overall Study|Protocol Violation|0|||
30948113|NCT01735201|58993516|FG005|Overall Study|Protocol Violation|0|||
30948114|NCT01735201|58993517|FG006|Overall Study|Protocol Violation|0|||
30948115|NCT01735201|58993518|FG007|Overall Study|Protocol Violation|0|||
30948116|NCT01735201|58993511|FG000|Overall Study|Other Miscellaneous Reasons|0|||
30948117|NCT01735201|58993512|FG001|Overall Study|Other Miscellaneous Reasons|0|||
30948118|NCT01735201|58993513|FG002|Overall Study|Other Miscellaneous Reasons|0|||
30948119|NCT01735201|58993514|FG003|Overall Study|Other Miscellaneous Reasons|1|||
30948120|NCT01735201|58993515|FG004|Overall Study|Other Miscellaneous Reasons|0|||
30948121|NCT01735201|58993516|FG005|Overall Study|Other Miscellaneous Reasons|2|||
30948122|NCT01735201|58993517|FG006|Overall Study|Other Miscellaneous Reasons|1|||
30948123|NCT01735201|58993518|FG007|Overall Study|Other Miscellaneous Reasons|1|||
30948124|NCT01734811|58993538|FG000|Overall Study|Lost to Follow-up|2|||
30948125|NCT01734811|58993539|FG001|Overall Study|Lost to Follow-up|3|||
30948126|NCT01734811|58993538|FG000|Overall Study|Withdrawal by Subject|2|||
30948127|NCT01734811|58993539|FG001|Overall Study|Withdrawal by Subject|0|||
30948128|NCT01757275|58993547|FG000|Overall Study|Lost to Follow-up|1|||
30948129|NCT01757275|58993548|FG001|Overall Study|Lost to Follow-up|2|||
30948130|NCT01757275|58993547|FG000|Overall Study|Adverse Event|3|||
30948131|NCT01757275|58993548|FG001|Overall Study|Adverse Event|3|||
30948132|NCT01757275|58993547|FG000|Overall Study|Withdrawal by Subject|2|||
30948133|NCT01757275|58993548|FG001|Overall Study|Withdrawal by Subject|4|||
30948134|NCT01757275|58993547|FG000|Overall Study|Not treated|3|||
30948135|NCT01757275|58993548|FG001|Overall Study|Not treated|4|||
30948136|NCT01757197|58993563|FG000|Overall Study|Death|2|||
30948137|NCT01784965|58993587|FG000|Overall Study|Withdrawal by Subject|6|||
30948138|NCT01784965|58993588|FG001|Overall Study|Withdrawal by Subject|3|||
30948139|NCT01784965|58993587|FG000|Overall Study|Adverse Event|0|||
30948140|NCT01784965|58993588|FG001|Overall Study|Adverse Event|8|||
30948141|NCT01784419|58993596|FG000|Overall Study|Adverse Event|3|||
30948142|NCT01784029|58993603|FG000|Overall Study|Lost to Follow-up|19|||
30948143|NCT01784029|58993604|FG001|Overall Study|Lost to Follow-up|20|||
30948144|NCT01784029|58993605|FG002|Overall Study|Lost to Follow-up|22|||
30948145|NCT01733329|58993627|FG000|Overall Study|Protocol Violation|1|||
30948146|NCT01733329|58993628|FG001|Overall Study|Protocol Violation|1|||
30948147|NCT01733329|58993627|FG000|Overall Study|Uterine artery injury|1|||
30948148|NCT01733329|58993628|FG001|Overall Study|Uterine artery injury|0|||
30948149|NCT01783483|58993636|FG000|Overall Study|Death|3|||
30948150|NCT01783483|58993637|FG001|Overall Study|Death|3|||
30948151|NCT01783483|58993636|FG000|Overall Study|Lost to Follow-up|14|||
30948152|NCT01783483|58993637|FG001|Overall Study|Lost to Follow-up|10|||
30948153|NCT01783483|58993636|FG000|Overall Study|Withdrawal by Subject|2|||
30948154|NCT01783483|58993637|FG001|Overall Study|Withdrawal by Subject|1|||
30948155|NCT01783483|58993636|FG000|Overall Study|Physician Decision|1|||
30948156|NCT01783483|58993637|FG001|Overall Study|Physician Decision|1|||
30948157|NCT01607593|58993656|FG000|Overall Study|Adverse Event|15|||
30948158|NCT01607593|58993656|FG000|Overall Study|Lack of Efficacy|16|||
30948159|NCT01607593|58993656|FG000|Overall Study|Lost to Follow-up|25|||
30948160|NCT01607593|58993656|FG000|Overall Study|Continuation|33|||
30948161|NCT01607593|58993656|FG000|Overall Study|Other|4|||
30948162|NCT01755637|58993669|FG000|Period 1|Adverse Event|0|||
30948163|NCT01755637|58993670|FG001|Period 1|Adverse Event|1|||
30948164|NCT01732549|58993688|FG000|Overall Study|Adverse Event|13|||
30948165|NCT01732549|58993689|FG001|Overall Study|Adverse Event|3|||
30948166|NCT01732549|58993688|FG000|Overall Study|Consent withdrawn|13|||
30948167|NCT01732549|58993689|FG001|Overall Study|Consent withdrawn|6|||
30625342|NCT00894166|58637450|FG000|Overall Study|Death|0|||
30625343|NCT00894166|58637451|FG001|Overall Study|Death|0|||
30625344|NCT00894166|58637452|FG002|Overall Study|Death|0|||
30625345|NCT00894166|58637453|FG003|Overall Study|Death|1|||
30843169|NCT02910739|58869177|FG002|Overall Study|Adverse Event|0|||
30625346|NCT00894166|58637454|FG004|Overall Study|Death|0|||
30625347|NCT00894166|58637455|FG005|Overall Study|Death|0|||
30843170|NCT02910739|58869178|FG003|Overall Study|Adverse Event|0|||
30843171|NCT01069939|58869186|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
30843172|NCT01069939|58869187|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
30843173|NCT01069939|58869186|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
30843174|NCT01069939|58869187|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
30843175|NCT01069939|58869186|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
30843176|NCT01069939|58869187|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
30843177|NCT01069939|58869186|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
30843178|NCT01069939|58869187|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
30843179|NCT01069939|58869186|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
30843180|NCT01069939|58869187|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
30843181|NCT01069939|58869186|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
30843182|NCT01069939|58869187|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
30843183|NCT01069939|58869186|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
30843184|NCT01069939|58869187|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
30843185|NCT01069939|58869186|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
30760145|NCT03583450|58768369|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
30760146|NCT03583450|58768370|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
30760147|NCT03583372|58768382|FG000|Overall Study|Withdrawal by Subject|6|||
30625348|NCT00894166|58637456|FG006|Overall Study|Death|0|||
30843186|NCT01069939|58869187|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
30843187|NCT01069939|58869186|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
30843188|NCT01069939|58869187|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
30843189|NCT01069939|58869186|FG000|Randomised and Included in the Analyses|Removal|1|||
30843190|NCT01069939|58869187|FG001|Randomised and Included in the Analyses|Removal|0|||
30843191|NCT01069705|58869193|FG000|Overall Study|Adverse Event|1|||
30843192|NCT01069705|58869193|FG000|Overall Study|Withdrawal by Subject|2|||
30843193|NCT01069627|58869197|FG000|Overall Study|Disease progression|7|||
30843194|NCT01069627|58869197|FG000|Overall Study|Adverse Event|12|||
30843195|NCT01069627|58869197|FG000|Overall Study|Protocol Violation|1|||
30843196|NCT02422797|58869203|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
30843197|NCT02422797|58869204|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
30843198|NCT02422797|58869203|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
30843199|NCT02422797|58869204|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
30843200|NCT02422797|58869203|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
30843201|NCT02422797|58869204|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
30843202|NCT02422797|58869203|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
30843203|NCT02422797|58869204|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
30843204|NCT02422797|58869203|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
30843205|NCT02422797|58869204|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
30843206|NCT02422797|58869203|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
30843207|NCT02422797|58869204|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
30843208|NCT02422797|58869203|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
30843209|NCT02422797|58869204|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
30843210|NCT02422797|58869203|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
30843211|NCT02422797|58869204|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
30843212|NCT02422797|58869203|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
30843213|NCT02422797|58869204|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
30843214|NCT02422797|58869203|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
30843215|NCT02422797|58869204|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
30948168|NCT01732549|58993688|FG000|Overall Study|Disease progression|37|||
30843216|NCT02422797|58869203|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
30843217|NCT02422797|58869204|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
30843218|NCT02422797|58869203|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
30948169|NCT01732549|58993689|FG001|Overall Study|Disease progression|50|||
30625349|NCT00894166|58637457|FG007|Overall Study|Death|0|||
30760148|NCT03583372|58768383|FG001|Overall Study|Withdrawal by Subject|11|||
30843219|NCT02422797|58869204|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
30760149|NCT03583372|58768384|FG002|Overall Study|Withdrawal by Subject|7|||
30760150|NCT03583372|58768385|FG003|Overall Study|Withdrawal by Subject|8|||
30760151|NCT03583372|58768382|FG000|Overall Study|Lost to Follow-up|4|||
30760152|NCT03583372|58768383|FG001|Overall Study|Lost to Follow-up|6|||
30948170|NCT01732549|58993688|FG000|Overall Study|Other|8|||
30948171|NCT01732549|58993689|FG001|Overall Study|Other|14|||
30948172|NCT01755091|58993708|FG000|Overall Study|Withdrawal by Subject|6|||
30948173|NCT01755091|58993709|FG001|Overall Study|Withdrawal by Subject|1|||
30948174|NCT01755091|58993710|FG002|Overall Study|Withdrawal by Subject|3|||
30948175|NCT01755091|58993708|FG000|Overall Study|Adverse Event|1|||
30948176|NCT01755091|58993709|FG001|Overall Study|Adverse Event|1|||
30948177|NCT01755091|58993710|FG002|Overall Study|Adverse Event|1|||
30948178|NCT01755091|58993708|FG000|Overall Study|Lost to Follow-up|1|||
30948179|NCT01755091|58993709|FG001|Overall Study|Lost to Follow-up|0|||
30948180|NCT01755091|58993710|FG002|Overall Study|Lost to Follow-up|1|||
30948181|NCT01755091|58993708|FG000|Overall Study|Physician Decision|1|||
30948182|NCT01755091|58993709|FG001|Overall Study|Physician Decision|1|||
30948183|NCT01755091|58993710|FG002|Overall Study|Physician Decision|2|||
30948184|NCT01754467|58993743|FG000|Overall Study|Lost to Follow-up|1|||
30948185|NCT01753999|58993747|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
30948186|NCT01753999|58993748|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
30948187|NCT01753999|58993747|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
30948188|NCT01753999|58993748|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
30948189|NCT01753999|58993747|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
30948190|NCT01753999|58993748|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
30948191|NCT01753999|58993747|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
30948192|NCT01753999|58993748|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
30948193|NCT01753999|58993747|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
30948194|NCT01753999|58993748|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
30948195|NCT01753999|58993747|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
30948196|NCT01753999|58993748|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
30948197|NCT01783015|58993768|FG000|Blinded Treatment|Adverse Event|0|||
30948198|NCT01783015|58993769|FG001|Blinded Treatment|Adverse Event|1|||
30760153|NCT03583372|58768384|FG002|Overall Study|Lost to Follow-up|3|||
30760154|NCT03583372|58768385|FG003|Overall Study|Lost to Follow-up|2|||
30760155|NCT03583372|58768382|FG000|Overall Study|Adverse Event|1|||
30760156|NCT03583372|58768383|FG001|Overall Study|Adverse Event|3|||
30760157|NCT03583372|58768384|FG002|Overall Study|Adverse Event|4|||
30760158|NCT03583372|58768385|FG003|Overall Study|Adverse Event|4|||
30760159|NCT03583372|58768382|FG000|Overall Study|Physician Decision|0|||
30843220|NCT02422797|58869203|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
30948199|NCT01783015|58993770|FG002|Blinded Treatment|Adverse Event|0|||
30948200|NCT01783015|58993768|FG000|Blinded Treatment|Protocol Violation|0|||
30760160|NCT03583372|58768383|FG001|Overall Study|Physician Decision|1|||
30760161|NCT03583372|58768384|FG002|Overall Study|Physician Decision|1|||
30948201|NCT01783015|58993769|FG001|Blinded Treatment|Protocol Violation|1|||
30760162|NCT03583372|58768385|FG003|Overall Study|Physician Decision|1|||
30760163|NCT03583372|58768382|FG000|Overall Study|Lack of Efficacy|0|||
30760164|NCT03583372|58768383|FG001|Overall Study|Lack of Efficacy|1|||
30760165|NCT03583372|58768384|FG002|Overall Study|Lack of Efficacy|0|||
30760166|NCT03583372|58768385|FG003|Overall Study|Lack of Efficacy|1|||
30760167|NCT03583372|58768382|FG000|Overall Study|Death|1|||
30760168|NCT03583372|58768383|FG001|Overall Study|Death|0|||
30760169|NCT03583372|58768384|FG002|Overall Study|Death|0|||
30760170|NCT03583372|58768385|FG003|Overall Study|Death|0|||
30760171|NCT03583372|58768382|FG000|Overall Study|Protocol Violation|0|||
30760172|NCT03583372|58768383|FG001|Overall Study|Protocol Violation|1|||
30760173|NCT03583372|58768384|FG002|Overall Study|Protocol Violation|0|||
30760174|NCT03583372|58768385|FG003|Overall Study|Protocol Violation|0|||
30843221|NCT02422797|58869204|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
30843222|NCT02422797|58869203|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
30843223|NCT02422797|58869204|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
30843224|NCT03021551|58869220|FG000|Overall Study|Equipment Issues|2|||
30843225|NCT03021551|58869220|FG000|Overall Study|Protocol Violation|1|||
30843226|NCT01585025|58869227|FG000|Overall Study|Withdrawal by Subject|0|||
30843227|NCT01585025|58869228|FG001|Overall Study|Withdrawal by Subject|3|||
30760175|NCT03583372|58768382|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
30760176|NCT03583372|58768383|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
30760177|NCT03583372|58768384|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
30760178|NCT03583372|58768385|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
30760179|NCT03583372|58768382|FG000|Overall Study|Did Not Receive Study Drug|0|||
30760180|NCT03583372|58768383|FG001|Overall Study|Did Not Receive Study Drug|1|||
30843228|NCT01585025|58869229|FG002|Overall Study|Withdrawal by Subject|4|||
30843229|NCT01068769|58869237|FG000|Overall Study|Ineligible|1|||
30625350|NCT00880165|58637482|FG000|Overall Study|Withdrawal by Subject|27|||
30760181|NCT03583372|58768384|FG002|Overall Study|Did Not Receive Study Drug|0|||
30760182|NCT03583372|58768385|FG003|Overall Study|Did Not Receive Study Drug|0|||
30843230|NCT05114564|58869256|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
30843688|NCT01915498|58869652|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
30843231|NCT05114564|58869257|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
30843232|NCT05114564|58869256|FG000|First Intervention|Adverse Event|0|||
30843233|NCT05114564|58869257|FG001|First Intervention|Adverse Event|1|||
30843234|NCT04706416|58869265|FG000|Overall Study|Lost to Follow-up|2|||
30843235|NCT04706416|58869266|FG001|Overall Study|Lost to Follow-up|0|||
30843236|NCT04683926|58869279|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
30843237|NCT04683926|58869280|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
30843238|NCT04683926|58869281|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
30843239|NCT04683926|58869282|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
30843240|NCT04285346|58869294|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
30843241|NCT04285346|58869295|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
30843242|NCT04285346|58869294|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
30843243|NCT04285346|58869295|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
30843244|NCT04285346|58869294|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
30843245|NCT04285346|58869295|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
30843246|NCT04148287|58869310|FG000|Overall Study|Death|2|||
30843247|NCT03772613|58869338|FG000|Overall Study|Lost to Follow-up|0|||
30843248|NCT03772613|58869339|FG001|Overall Study|Lost to Follow-up|1|||
30843249|NCT03772613|58869340|FG002|Overall Study|Lost to Follow-up|1|||
30843250|NCT03739437|58869350|FG000|Overall Study|Lost to Follow-up|2|||
30843251|NCT03739437|58869351|FG001|Overall Study|Lost to Follow-up|5|||
30843252|NCT03730194|58869359|FG000|First Stage Treatment|Withdrawal by Subject|1|||
30843253|NCT03730194|58869360|FG001|First Stage Treatment|Withdrawal by Subject|1|||
30843254|NCT03730194|58869361|FG002|First Stage Treatment|Withdrawal by Subject|0|||
30843255|NCT03730194|58869362|FG003|First Stage Treatment|Withdrawal by Subject|0|||
30843256|NCT03730194|58869363|FG004|First Stage Treatment|Withdrawal by Subject|0|||
30843257|NCT03730194|58869364|FG005|First Stage Treatment|Withdrawal by Subject|0|||
30843258|NCT03730194|58869359|FG000|First Stage Treatment|Protocol Violation|3|||
30843259|NCT03730194|58869360|FG001|First Stage Treatment|Protocol Violation|3|||
30625351|NCT00880165|58637483|FG001|Overall Study|Withdrawal by Subject|23|||
30625352|NCT00880165|58637482|FG000|Overall Study|Not diagnosed with OSA|14|||
30625353|NCT00880165|58637483|FG001|Overall Study|Not diagnosed with OSA|8|||
30760183|NCT03583372|58768382|FG000|Overall Study|Captured as Other in the Database|1|||
30760184|NCT03583372|58768383|FG001|Overall Study|Captured as Other in the Database|2|||
30760185|NCT03583372|58768384|FG002|Overall Study|Captured as Other in the Database|4|||
30948202|NCT01783015|58993770|FG002|Blinded Treatment|Protocol Violation|0|||
30948203|NCT01783015|58993768|FG000|Blinded Treatment|Withdrawal by Subject|0|||
30948204|NCT01783015|58993769|FG001|Blinded Treatment|Withdrawal by Subject|1|||
30948205|NCT01783015|58993770|FG002|Blinded Treatment|Withdrawal by Subject|0|||
30948206|NCT01783015|58993768|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
30948207|NCT01783015|58993769|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
30948208|NCT01783015|58993770|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
30948209|NCT01783015|58993768|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
30948210|NCT01783015|58993769|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
30948211|NCT01783015|58993770|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
30948212|NCT01782859|58993780|FG000|Overall Study|Protocol Violation|6|||
30948213|NCT01782859|58993781|FG001|Overall Study|Protocol Violation|6|||
30760186|NCT03583372|58768385|FG003|Overall Study|Captured as Other in the Database|1|||
30760187|NCT03582826|58768397|FG000|Overall Study|Lost to Follow-up|39|||
30760188|NCT03582826|58768398|FG001|Overall Study|Lost to Follow-up|0|||
30760189|NCT03582826|58768397|FG000|Overall Study|Withdrawal by Subject|2|||
30760190|NCT03582826|58768398|FG001|Overall Study|Withdrawal by Subject|0|||
30760191|NCT03518008|58768413|FG000|Period 2, Second Week of Wear|Family emergency|0|||
30760192|NCT03518008|58768414|FG001|Period 2, Second Week of Wear|Family emergency|1|||
30760193|NCT03810014|58768424|FG000|Overall Study|Pregnancy|2|||
30760194|NCT03810014|58768425|FG001|Overall Study|Pregnancy|2|||
30760195|NCT03810014|58768426|FG002|Overall Study|Pregnancy|0|||
30760196|NCT03810014|58768427|FG003|Overall Study|Pregnancy|2|||
30760197|NCT04978363|58768448|FG000|Overall Study|Other medical issues unrelated to the study|0|||
30760198|NCT04978363|58768449|FG001|Overall Study|Other medical issues unrelated to the study|0|||
30760199|NCT04978363|58768450|FG002|Overall Study|Other medical issues unrelated to the study|0|||
30760200|NCT04978363|58768451|FG003|Overall Study|Other medical issues unrelated to the study|0|||
30760201|NCT04978363|58768452|FG004|Overall Study|Other medical issues unrelated to the study|1|||
30760202|NCT04978363|58768453|FG005|Overall Study|Other medical issues unrelated to the study|0|||
30760203|NCT04978363|58768454|FG006|Overall Study|Other medical issues unrelated to the study|0|||
30760204|NCT04978363|58768455|FG007|Overall Study|Other medical issues unrelated to the study|0|||
30760205|NCT04978363|58768456|FG008|Overall Study|Other medical issues unrelated to the study|0|||
30760206|NCT04978363|58768457|FG009|Overall Study|Other medical issues unrelated to the study|0|||
30760207|NCT04978363|58768458|FG010|Overall Study|Other medical issues unrelated to the study|0|||
30760208|NCT04978363|58768448|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
30760209|NCT04978363|58768449|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
30760210|NCT04978363|58768450|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
30760211|NCT04978363|58768451|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
30760212|NCT04978363|58768452|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
30760213|NCT04978363|58768453|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
30760214|NCT04978363|58768454|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
30760215|NCT04978363|58768455|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
30760216|NCT04978363|58768456|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
30760217|NCT04978363|58768457|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
30760218|NCT04978363|58768458|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
30760219|NCT04978363|58768448|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
30760220|NCT04978363|58768449|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
30760221|NCT04978363|58768450|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
30760222|NCT04978363|58768451|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
30760223|NCT04978363|58768452|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
30948214|NCT01782859|58993780|FG000|Overall Study|Withdrawal by Subject|0|||
30948215|NCT01782859|58993781|FG001|Overall Study|Withdrawal by Subject|1|||
30948216|NCT01782469|58993788|FG000|Overall Study|Lost to Follow-up|1|||
30948217|NCT01782313|58993792|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
30760224|NCT04978363|58768453|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
30760225|NCT04978363|58768454|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
30760226|NCT04978363|58768455|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
30760227|NCT04978363|58768456|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
30948218|NCT01782313|58993792|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
30948219|NCT01782313|58993792|FG000|Treated Cycle 3|Progressive Disease|21|||
30843260|NCT03730194|58869361|FG002|First Stage Treatment|Protocol Violation|0|||
30843261|NCT03730194|58869362|FG003|First Stage Treatment|Protocol Violation|0|||
30843262|NCT03730194|58869363|FG004|First Stage Treatment|Protocol Violation|0|||
30843263|NCT03730194|58869364|FG005|First Stage Treatment|Protocol Violation|0|||
30843264|NCT03701555|58869407|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
30843265|NCT03701555|58869408|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
30843266|NCT03701555|58869409|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
30843267|NCT03701555|58869410|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
30843268|NCT03701555|58869411|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
30843269|NCT03701555|58869412|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
30843270|NCT03701555|58869413|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
30843271|NCT03701555|58869414|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
30843272|NCT03701555|58869415|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
30843273|NCT03701555|58869416|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
30843274|NCT03701555|58869417|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
30843275|NCT03701555|58869418|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
30843276|NCT03701555|58869419|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
30843277|NCT03701555|58869420|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
30843278|NCT03701555|58869421|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
30843279|NCT03701555|58869422|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
30843280|NCT03701555|58869423|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
30843281|NCT03701555|58869424|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
30843282|NCT03701555|58869425|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
30843283|NCT03701555|58869426|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
30760228|NCT04978363|58768457|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
30760229|NCT04978363|58768458|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
30760230|NCT04101422|58768538|FG000|Overall Study|Ineligible|1|||
30760231|NCT04101422|58768539|FG001|Overall Study|Ineligible|0|||
30760232|NCT04101422|58768540|FG002|Overall Study|Ineligible|9|||
30760233|NCT04101422|58768541|FG003|Overall Study|Ineligible|0|||
30760234|NCT04101422|58768538|FG000|Overall Study|Withdrawal by Subject|0|||
30760235|NCT04101422|58768539|FG001|Overall Study|Withdrawal by Subject|0|||
30760236|NCT04101422|58768540|FG002|Overall Study|Withdrawal by Subject|1|||
30760237|NCT04101422|58768541|FG003|Overall Study|Withdrawal by Subject|0|||
30760238|NCT04101422|58768538|FG000|Overall Study|Not attending to the stimuli|0|||
30760239|NCT04101422|58768539|FG001|Overall Study|Not attending to the stimuli|0|||
30843284|NCT03701555|58869427|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
30760240|NCT04101422|58768540|FG002|Overall Study|Not attending to the stimuli|4|||
30760241|NCT04101422|58768541|FG003|Overall Study|Not attending to the stimuli|0|||
30760242|NCT04101422|58768538|FG000|Overall Study|Did not download app|0|||
30760243|NCT04101422|58768539|FG001|Overall Study|Did not download app|0|||
30843285|NCT03701555|58869428|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
30760244|NCT04101422|58768540|FG002|Overall Study|Did not download app|0|||
30760245|NCT04101422|58768541|FG003|Overall Study|Did not download app|17|||
30760246|NCT04101422|58768538|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
30760247|NCT04101422|58768539|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
30843286|NCT03701555|58869429|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
30843287|NCT03701555|58869430|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
30843288|NCT03701555|58869431|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
30760248|NCT04101422|58768540|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
30843289|NCT03701555|58869432|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
30843290|NCT03701555|58869433|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
30760249|NCT04101422|58768541|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
30760250|NCT03841604|58768553|FG000|Overall Study|Withdrawal by Subject|3|||
30760251|NCT03841604|58768554|FG001|Overall Study|Withdrawal by Subject|1|||
30843291|NCT03701555|58869434|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
30760252|NCT03841604|58768553|FG000|Overall Study|Adverse Event|4|||
30843292|NCT03701555|58869435|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
30760253|NCT03841604|58768554|FG001|Overall Study|Adverse Event|2|||
30760254|NCT03841604|58768553|FG000|Overall Study|Physician Decision|1|||
30843293|NCT03701555|58869436|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
30843294|NCT03701555|58869437|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
30760255|NCT03841604|58768554|FG001|Overall Study|Physician Decision|0|||
30760256|NCT03541187|58768571|FG000|Overall Study|Lost to Follow-up|2|||
30760257|NCT03541187|58768572|FG001|Overall Study|Lost to Follow-up|6|||
30760258|NCT03541187|58768571|FG000|Overall Study|Pregnancy|0|||
30843295|NCT03701555|58869438|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
30843296|NCT03701555|58869439|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
30843297|NCT03701555|58869440|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
30843298|NCT03701555|58869441|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
30843299|NCT03701555|58869442|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
30843300|NCT03701555|58869407|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
30843301|NCT03701555|58869408|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
30843302|NCT03701555|58869409|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
30760259|NCT03541187|58768572|FG001|Overall Study|Pregnancy|1|||
30760260|NCT03541187|58768571|FG000|Overall Study|Withdrawal by Subject|6|||
30760261|NCT03541187|58768572|FG001|Overall Study|Withdrawal by Subject|2|||
30843303|NCT03701555|58869410|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
30843304|NCT03701555|58869411|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
30843305|NCT03701555|58869412|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
30843306|NCT03701555|58869413|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
30843307|NCT03701555|58869414|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
30843308|NCT03701555|58869415|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
30948220|NCT01782313|58993792|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
30948221|NCT01782313|58993792|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
30948222|NCT01782313|58993792|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
30948223|NCT01782313|58993792|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
30948224|NCT01782313|58993792|FG000|Survival Follow up|Lost to Follow-up|1|||
30948225|NCT01781611|58993815|FG000|Overall Study|Adverse Event|4|||
30948226|NCT01781611|58993816|FG001|Overall Study|Adverse Event|0|||
30948227|NCT01781299|58993833|FG000|Overall Study|Withdrawal by Subject|0|||
30948228|NCT01781299|58993834|FG001|Overall Study|Withdrawal by Subject|1|||
30948229|NCT01732471|58993840|FG000|Overall Study|Withdrawal by Subject|1|||
30948230|NCT01780987|58993859|FG000|Overall Study|Adverse Event|0|||
30948231|NCT01780987|58993860|FG001|Overall Study|Adverse Event|4|||
30948232|NCT01780987|58993859|FG000|Overall Study|Withdrawal by Subject|2|||
30948233|NCT01780987|58993860|FG001|Overall Study|Withdrawal by Subject|0|||
30948234|NCT01780987|58993859|FG000|Overall Study|Request of Changing Hospital|0|||
30948235|NCT01780987|58993860|FG001|Overall Study|Request of Changing Hospital|1|||
30948236|NCT01780987|58993859|FG000|Overall Study|Changing Residence|1|||
30948237|NCT01780987|58993860|FG001|Overall Study|Changing Residence|0|||
30948238|NCT01780987|58993859|FG000|Overall Study|Not Receiving any Study Medication|0|||
30948239|NCT01780987|58993860|FG001|Overall Study|Not Receiving any Study Medication|1|||
30948240|NCT01730053|58993949|FG000|Overall Study|Participant moved|0|||
30948241|NCT01730053|58993950|FG001|Overall Study|Participant moved|0|||
30948242|NCT01730053|58993951|FG002|Overall Study|Participant moved|1|||
30948243|NCT01730053|58993952|FG003|Overall Study|Participant moved|0|||
30948244|NCT01730053|58993953|FG004|Overall Study|Participant moved|0|||
30948245|NCT01730053|58993954|FG005|Overall Study|Participant moved|0|||
30948246|NCT01730053|58993949|FG000|Overall Study|Physician Decision|0|||
30843309|NCT03701555|58869416|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
30843310|NCT03701555|58869417|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
30948247|NCT01730053|58993950|FG001|Overall Study|Physician Decision|0|||
30948248|NCT01730053|58993951|FG002|Overall Study|Physician Decision|0|||
30948249|NCT01730053|58993952|FG003|Overall Study|Physician Decision|1|||
30948250|NCT01730053|58993953|FG004|Overall Study|Physician Decision|0|||
30948251|NCT01730053|58993954|FG005|Overall Study|Physician Decision|0|||
30948252|NCT01730053|58993949|FG000|Overall Study|Adverse Event|2|||
30948253|NCT01730053|58993950|FG001|Overall Study|Adverse Event|6|||
30760262|NCT03541187|58768571|FG000|Overall Study|Moved out of town|1|||
30843311|NCT03701555|58869418|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
30948254|NCT01730053|58993951|FG002|Overall Study|Adverse Event|3|||
30948255|NCT01730053|58993952|FG003|Overall Study|Adverse Event|3|||
30843312|NCT03701555|58869419|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
30760263|NCT03541187|58768572|FG001|Overall Study|Moved out of town|0|||
30760264|NCT03541187|58768571|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
30760265|NCT03541187|58768572|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
30760266|NCT03541187|58768571|FG000|Overall Study|Did not meet randomization criteria|1|||
30625354|NCT00880165|58637482|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
30760267|NCT03541187|58768572|FG001|Overall Study|Did not meet randomization criteria|1|||
30760268|NCT03541187|58768571|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
30760269|NCT03541187|58768572|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
30760270|NCT03541187|58768571|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
30760271|NCT03541187|58768572|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
30760272|NCT03240081|58768593|FG000|Overall Study|Withdrawal by Subject|0|||
30760273|NCT03240081|58768594|FG001|Overall Study|Withdrawal by Subject|2|||
30760274|NCT03240081|58768593|FG000|Overall Study|Lost to Follow-up|0|||
30760275|NCT03240081|58768594|FG001|Overall Study|Lost to Follow-up|1|||
30760276|NCT03003520|58768615|FG000|Overall Study|Adverse Event|9|||
30760277|NCT03003520|58768616|FG001|Overall Study|Adverse Event|0|||
30760278|NCT03003520|58768615|FG000|Overall Study|Death|1|||
30760279|NCT03003520|58768616|FG001|Overall Study|Death|0|||
30760280|NCT03003520|58768615|FG000|Overall Study|Other reasons|4|||
30843313|NCT03701555|58869420|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
30760281|NCT03003520|58768616|FG001|Overall Study|Other reasons|0|||
30843314|NCT03701555|58869421|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
30760282|NCT03003520|58768615|FG000|Overall Study|Withdrawal by Subject|6|||
30625355|NCT00880165|58637483|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
30625356|NCT00880165|58637482|FG000|Overall Study|Lost to follow|9|||
30625357|NCT00880165|58637483|FG001|Overall Study|Lost to follow|15|||
30760283|NCT03003520|58768616|FG001|Overall Study|Withdrawal by Subject|0|||
30760284|NCT03003520|58768615|FG000|Overall Study|Progressive disease|9|||
30843315|NCT03701555|58869422|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
30760285|NCT03003520|58768616|FG001|Overall Study|Progressive disease|1|||
30760286|NCT02958527|58768639|FG000|Overall Study|Not collected CRFs|12|||
30843316|NCT03701555|58869423|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
30843317|NCT03701555|58869424|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
30625358|NCT01165229|58637491|FG000|Overall Study|Serious Adverse Event|456|||
30625359|NCT01165229|58637492|FG001|Overall Study|Serious Adverse Event|487|||
30625360|NCT01165229|58637491|FG000|Overall Study|Non-Serious Adverse Event|47|||
30625361|NCT01165229|58637492|FG001|Overall Study|Non-Serious Adverse Event|15|||
30625362|NCT01165229|58637491|FG000|Overall Study|Protocol Violation|6|||
30625363|NCT01165229|58637492|FG001|Overall Study|Protocol Violation|8|||
30760287|NCT02586025|58768661|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
30760288|NCT02586025|58768662|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
30760289|NCT02586025|58768661|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
30843318|NCT03701555|58869425|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
30948256|NCT01730053|58993953|FG004|Overall Study|Adverse Event|2|||
30948257|NCT01730053|58993954|FG005|Overall Study|Adverse Event|2|||
30760290|NCT02586025|58768662|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
30760291|NCT02586025|58768661|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
30625364|NCT01165229|58637491|FG000|Overall Study|Withdrawal by Subject|387|||
30625365|NCT01165229|58637492|FG001|Overall Study|Withdrawal by Subject|396|||
30625366|NCT01165229|58637491|FG000|Overall Study|Migrated/moved from study area|51|||
30625367|NCT01165229|58637492|FG001|Overall Study|Migrated/moved from study area|46|||
30625368|NCT01165229|58637491|FG000|Overall Study|Lost to Follow-up|123|||
30625369|NCT01165229|58637492|FG001|Overall Study|Lost to Follow-up|133|||
30625370|NCT01165229|58637491|FG000|Overall Study|Suspected HZ Episode|2|||
30625371|NCT01165229|58637492|FG001|Overall Study|Suspected HZ Episode|2|||
30625372|NCT01165229|58637491|FG000|Overall Study|No reason from the subject|108|||
30625373|NCT01165229|58637492|FG001|Overall Study|No reason from the subject|102|||
30625374|NCT01165229|58637491|FG000|Overall Study|Unknown completion status|0|||
30625375|NCT01165229|58637492|FG001|Overall Study|Unknown completion status|1|||
30760292|NCT02586025|58768662|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
30760293|NCT02586025|58768661|FG000|Neoadjuvant Treatment|Death|1|||
30760294|NCT02586025|58768662|FG001|Neoadjuvant Treatment|Death|0|||
30760295|NCT02586025|58768661|FG000|Neoadjuvant Treatment|Adverse Event|1|||
30760296|NCT02586025|58768662|FG001|Neoadjuvant Treatment|Adverse Event|0|||
30760297|NCT02586025|58768661|FG000|Neoadjuvant Treatment|Physician Decision|2|||
30760298|NCT02586025|58768662|FG001|Neoadjuvant Treatment|Physician Decision|1|||
30760299|NCT02586025|58768661|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
30760300|NCT02586025|58768662|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
30843319|NCT03701555|58869426|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
30843320|NCT03701555|58869427|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
30843321|NCT03701555|58869428|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
30843322|NCT03701555|58869429|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
30843323|NCT03701555|58869430|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
30843324|NCT03701555|58869431|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
30948258|NCT01730053|58993949|FG000|Overall Study|Poor compliance to protocol|1|||
30760301|NCT02586025|58768661|FG000|Adjuvant Treatment|Recurrent Disease|4|||
30760302|NCT02586025|58768662|FG001|Adjuvant Treatment|Recurrent Disease|5|||
30760303|NCT02586025|58768661|FG000|Adjuvant Treatment|Physician Decision|0|||
30760304|NCT02586025|58768662|FG001|Adjuvant Treatment|Physician Decision|1|||
30760305|NCT02586025|58768661|FG000|Adjuvant Treatment|Pregnancy|1|||
30760306|NCT02586025|58768662|FG001|Adjuvant Treatment|Pregnancy|0|||
30760307|NCT02586025|58768661|FG000|Treatment-Free Follow-Up|Death|11|||
30760308|NCT02586025|58768662|FG001|Treatment-Free Follow-Up|Death|11|||
30760309|NCT02586025|58768661|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
30760310|NCT02586025|58768662|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
30760311|NCT02586025|58768661|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
30760312|NCT02586025|58768662|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
30760313|NCT02586025|58768661|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
30760314|NCT02586025|58768662|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
30760315|NCT02586025|58768661|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
30760316|NCT02586025|58768662|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
30760317|NCT02446600|58768682|FG000|Overall Study|Never treated|20|||
30760318|NCT02446600|58768683|FG001|Overall Study|Never treated|2|||
30760319|NCT02446600|58768684|FG002|Overall Study|Never treated|6|||
30843325|NCT03701555|58869432|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
30843326|NCT03701555|58869433|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
30843327|NCT03701555|58869434|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
30843328|NCT03701555|58869435|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
30843329|NCT03701555|58869436|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
30843330|NCT03701555|58869437|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
30843331|NCT03701555|58869438|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
30843332|NCT03701555|58869439|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
30843333|NCT03701555|58869440|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
30948259|NCT01730053|58993950|FG001|Overall Study|Poor compliance to protocol|2|||
30948260|NCT01730053|58993951|FG002|Overall Study|Poor compliance to protocol|2|||
30948261|NCT01730053|58993952|FG003|Overall Study|Poor compliance to protocol|0|||
30948262|NCT01730053|58993953|FG004|Overall Study|Poor compliance to protocol|0|||
30948263|NCT01730053|58993954|FG005|Overall Study|Poor compliance to protocol|2|||
30948264|NCT01730053|58993949|FG000|Overall Study|Other than specified|2|||
30948265|NCT01730053|58993950|FG001|Overall Study|Other than specified|6|||
30948266|NCT01730053|58993951|FG002|Overall Study|Other than specified|5|||
30948267|NCT01730053|58993952|FG003|Overall Study|Other than specified|4|||
30843334|NCT03701555|58869441|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
30948268|NCT01730053|58993953|FG004|Overall Study|Other than specified|7|||
30760320|NCT02446600|58768685|FG003|Overall Study|Never treated|0|||
30760321|NCT02446600|58768682|FG000|Overall Study|Withdrawal by Subject|19|||
30760322|NCT02446600|58768683|FG001|Overall Study|Withdrawal by Subject|5|||
30760323|NCT02446600|58768684|FG002|Overall Study|Withdrawal by Subject|17|||
30843335|NCT03701555|58869442|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
30948269|NCT01730053|58993954|FG005|Overall Study|Other than specified|9|||
30760324|NCT02446600|58768685|FG003|Overall Study|Withdrawal by Subject|0|||
30625376|NCT00596011|58637530|FG000|Overall Study|Withdrawal by Subject|2|||
30625377|NCT00596011|58637531|FG001|Overall Study|Withdrawal by Subject|3|||
30948270|NCT01752985|58993989|FG000|Treatment Period|Subject request to discontinue treatment|1|||
30625378|NCT00596011|58637530|FG000|Overall Study|Adverse Event|11|||
30760325|NCT02446600|58768682|FG000|Overall Study|Ineligible|1|||
30760326|NCT02446600|58768683|FG001|Overall Study|Ineligible|4|||
30760327|NCT02446600|58768684|FG002|Overall Study|Ineligible|4|||
30760328|NCT02446600|58768685|FG003|Overall Study|Ineligible|1|||
30760329|NCT02446600|58768682|FG000|Overall Study|Duplicate Enrollment|0|||
30760330|NCT02446600|58768683|FG001|Overall Study|Duplicate Enrollment|1|||
30625379|NCT00596011|58637531|FG001|Overall Study|Adverse Event|7|||
30948271|NCT01752985|58993990|FG001|Treatment Period|Subject request to discontinue treatment|0|||
30625380|NCT01163747|58637539|FG000|Overall Study|Adverse Event|0|||
30625381|NCT01163747|58637540|FG001|Overall Study|Adverse Event|5|||
30625382|NCT01163747|58637539|FG000|Overall Study|Insufficient Therapeutic Response|0|||
30625383|NCT01163747|58637540|FG001|Overall Study|Insufficient Therapeutic Response|1|||
30760331|NCT02446600|58768684|FG002|Overall Study|Duplicate Enrollment|0|||
30843336|NCT03701555|58869407|FG000|Part 2 (Day 1)|Other|0|||
30843337|NCT03701555|58869408|FG001|Part 2 (Day 1)|Other|0|||
30843338|NCT03701555|58869409|FG002|Part 2 (Day 1)|Other|0|||
30843339|NCT03701555|58869410|FG003|Part 2 (Day 1)|Other|0|||
30760332|NCT02446600|58768685|FG003|Overall Study|Duplicate Enrollment|0|||
30760333|NCT02285114|58768698|FG000|Overall Study|Investigator's Discretion|0|||
30760334|NCT02285114|58768699|FG001|Overall Study|Investigator's Discretion|2|||
30760335|NCT02285114|58768700|FG002|Overall Study|Investigator's Discretion|0|||
30760336|NCT02285114|58768698|FG000|Overall Study|Withdrew Consent|0|||
30760337|NCT02285114|58768699|FG001|Overall Study|Withdrew Consent|0|||
30843340|NCT03701555|58869411|FG004|Part 2 (Day 1)|Other|0|||
30760338|NCT02285114|58768700|FG002|Overall Study|Withdrew Consent|1|||
30760339|NCT02285114|58768698|FG000|Overall Study|Enrolled but not treated|1|||
30843341|NCT03701555|58869412|FG005|Part 2 (Day 1)|Other|0|||
30843342|NCT03701555|58869413|FG006|Part 2 (Day 1)|Other|0|||
30843343|NCT03701555|58869414|FG007|Part 2 (Day 1)|Other|0|||
30843344|NCT03701555|58869415|FG008|Part 2 (Day 1)|Other|0|||
30843345|NCT03701555|58869416|FG009|Part 2 (Day 1)|Other|0|||
30625384|NCT01163747|58637539|FG000|Overall Study|Protocol Violation|0|||
30625385|NCT01163747|58637540|FG001|Overall Study|Protocol Violation|1|||
30625386|NCT01163747|58637539|FG000|Overall Study|Refused Treatment|6|||
30625387|NCT01163747|58637540|FG001|Overall Study|Refused Treatment|4|||
30625388|NCT01163279|58637548|FG000|Overall Study|Withdrawal by Subject|2|||
30625389|NCT01163279|58637549|FG001|Overall Study|Withdrawal by Subject|0|||
30625390|NCT01162499|58637556|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
30625391|NCT01162499|58637557|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
30625392|NCT01206140|58637567|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
30625393|NCT01206140|58637568|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
30625394|NCT01162421|58637576|FG000|Overall Study|Did not receive study drug|2|||
30625395|NCT01162421|58637577|FG001|Overall Study|Did not receive study drug|1|||
30625396|NCT01162421|58637576|FG000|Overall Study|Adverse Event|2|||
30625397|NCT01162421|58637577|FG001|Overall Study|Adverse Event|5|||
30625398|NCT01162421|58637576|FG000|Overall Study|Lost to Follow-up|0|||
30625399|NCT01162421|58637577|FG001|Overall Study|Lost to Follow-up|2|||
30625400|NCT01162421|58637576|FG000|Overall Study|Lack of Efficacy|2|||
30625401|NCT01162421|58637577|FG001|Overall Study|Lack of Efficacy|2|||
30625402|NCT01162421|58637576|FG000|Overall Study|Other|2|||
30625403|NCT01162421|58637577|FG001|Overall Study|Other|3|||
30625404|NCT01162343|58637583|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
30625405|NCT01162343|58637583|FG000|Overall Study|Refused psychiatrist assessment|12|||
30625406|NCT01188551|58637591|FG000|Overall Study|Pharmacy issues|1|||
30625407|NCT01188551|58637592|FG001|Overall Study|Pharmacy issues|0|||
30625408|NCT01188551|58637593|FG002|Overall Study|Pharmacy issues|0|||
30625409|NCT01188551|58637594|FG003|Overall Study|Pharmacy issues|0|||
30625410|NCT01161407|58637606|FG000|Overall Study|Protocol Violation|3|||
30625411|NCT01161407|58637607|FG001|Overall Study|Protocol Violation|1|||
30625412|NCT01161173|58637613|FG000|Overall Study|Protocol Violation|13|||
30625413|NCT01161173|58637613|FG000|Overall Study|Lost to Follow-up|7|||
30625414|NCT01161173|58637613|FG000|Overall Study|Progressive Disease|82|||
30625415|NCT01161173|58637613|FG000|Overall Study|Withdrawal of Consent|5|||
30625416|NCT01161173|58637613|FG000|Overall Study|Unacceptable Toxicity|21|||
30625417|NCT01161173|58637613|FG000|Overall Study|Death|194|||
30625418|NCT01161173|58637613|FG000|Overall Study|End of Study|2|||
30625419|NCT01161173|58637613|FG000|Overall Study|Reasons Not Specified|23|||
30625420|NCT01159769|58637617|FG000|Overall Study|Adverse Event|1|||
30625421|NCT01159691|58637621|FG000|Overall Study|Lost to Follow-up|2|||
30625422|NCT01159691|58637621|FG000|Overall Study|Unknown reasons|1|||
30625423|NCT01159691|58637621|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
30625424|NCT01159691|58637621|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
30625425|NCT01159691|58637621|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
30625426|NCT01159691|58637621|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
30625427|NCT01159691|58637621|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
30625428|NCT01159691|58637621|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
30625429|NCT01157897|58637629|FG000|Overall Study|Lost to Follow-up|2|||
30625430|NCT01157897|58637630|FG001|Overall Study|Lost to Follow-up|0|||
30625431|NCT01157897|58637631|FG002|Overall Study|Lost to Follow-up|0|||
30625432|NCT01157897|58637632|FG003|Overall Study|Lost to Follow-up|1|||
30625433|NCT01157897|58637629|FG000|Overall Study|Relocated|0|||
30625434|NCT01157897|58637630|FG001|Overall Study|Relocated|2|||
30625435|NCT01157897|58637631|FG002|Overall Study|Relocated|0|||
30625436|NCT01157897|58637632|FG003|Overall Study|Relocated|0|||
30625437|NCT01185821|58637647|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30625438|NCT01185821|58637648|FG001|Overall Study|Abnormal laboratory value(s)|2|||
30625439|NCT01185821|58637649|FG002|Overall Study|Abnormal laboratory value(s)|1|||
30625440|NCT01185821|58637650|FG003|Overall Study|Abnormal laboratory value(s)|0|||
30625441|NCT01185821|58637651|FG004|Overall Study|Abnormal laboratory value(s)|0|||
30625442|NCT01185821|58637647|FG000|Overall Study|Protocol Violation|0|||
30625443|NCT01185821|58637648|FG001|Overall Study|Protocol Violation|0|||
30625444|NCT01185821|58637649|FG002|Overall Study|Protocol Violation|0|||
30625445|NCT01185821|58637650|FG003|Overall Study|Protocol Violation|1|||
30625446|NCT01185821|58637651|FG004|Overall Study|Protocol Violation|1|||
30625447|NCT01185821|58637647|FG000|Overall Study|Abnormal test procedure result|0|||
30625448|NCT01185821|58637648|FG001|Overall Study|Abnormal test procedure result|0|||
30625449|NCT01185821|58637649|FG002|Overall Study|Abnormal test procedure result|0|||
30625450|NCT01185821|58637650|FG003|Overall Study|Abnormal test procedure result|0|||
30625451|NCT01185821|58637651|FG004|Overall Study|Abnormal test procedure result|1|||
30625452|NCT01185821|58637647|FG000|Overall Study|Death|0|||
30625453|NCT01185821|58637648|FG001|Overall Study|Death|1|||
30625454|NCT01185821|58637649|FG002|Overall Study|Death|0|||
30625455|NCT01185821|58637650|FG003|Overall Study|Death|0|||
30625456|NCT01185821|58637651|FG004|Overall Study|Death|0|||
30625457|NCT01185821|58637647|FG000|Overall Study|Condition no longer required study drug|0|||
30948272|NCT01752985|58993991|FG002|Treatment Period|Subject request to discontinue treatment|1|||
30625458|NCT01185821|58637648|FG001|Overall Study|Condition no longer required study drug|0|||
30948273|NCT01752985|58993989|FG000|Treatment Period|Subject no longer meets study criteria|0|||
30948274|NCT01752985|58993990|FG001|Treatment Period|Subject no longer meets study criteria|1|||
30625459|NCT01185821|58637649|FG002|Overall Study|Condition no longer required study drug|0|||
30625460|NCT01185821|58637650|FG003|Overall Study|Condition no longer required study drug|0|||
30625461|NCT01185821|58637651|FG004|Overall Study|Condition no longer required study drug|1|||
30625462|NCT01185821|58637647|FG000|Overall Study|Adverse Event|2|||
30625463|NCT01185821|58637648|FG001|Overall Study|Adverse Event|3|||
30625464|NCT01185821|58637649|FG002|Overall Study|Adverse Event|1|||
30625465|NCT01185821|58637650|FG003|Overall Study|Adverse Event|2|||
30625466|NCT01185821|58637651|FG004|Overall Study|Adverse Event|5|||
30760340|NCT02285114|58768699|FG001|Overall Study|Enrolled but not treated|0|||
30760341|NCT02285114|58768700|FG002|Overall Study|Enrolled but not treated|0|||
30948275|NCT01752985|58993991|FG002|Treatment Period|Subject no longer meets study criteria|1|||
30948276|NCT01752985|58993989|FG000|Treatment Period|Adverse Event|2|||
30948277|NCT01752985|58993990|FG001|Treatment Period|Adverse Event|1|||
30948278|NCT01752985|58993991|FG002|Treatment Period|Adverse Event|2|||
30948279|NCT01752985|58993989|FG000|Treatment Period|Withdrawal by Subject|1|||
30760342|NCT02285114|58768698|FG000|Overall Study|Still on study|21|||
30948280|NCT01752985|58993990|FG001|Treatment Period|Withdrawal by Subject|1|||
30948281|NCT01752985|58993991|FG002|Treatment Period|Withdrawal by Subject|0|||
30948282|NCT01752985|58993989|FG000|Treatment Period|Lost to Follow-up|0|||
30948283|NCT01752985|58993990|FG001|Treatment Period|Lost to Follow-up|0|||
30948284|NCT01752985|58993991|FG002|Treatment Period|Lost to Follow-up|1|||
30948285|NCT01751113|58993999|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
30948286|NCT01751113|58994000|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
30948287|NCT01751113|58994001|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
30948288|NCT01751113|58994002|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
30948289|NCT01751113|58994003|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
30760343|NCT02285114|58768699|FG001|Overall Study|Still on study|5|||
30760344|NCT02285114|58768700|FG002|Overall Study|Still on study|2|||
30843346|NCT03701555|58869417|FG010|Part 2 (Day 1)|Other|3|||
30843347|NCT03701555|58869418|FG011|Part 2 (Day 1)|Other|1|||
30843348|NCT03701555|58869419|FG012|Part 2 (Day 1)|Other|0|||
30843349|NCT03701555|58869420|FG013|Part 2 (Day 1)|Other|1|||
30843350|NCT03701555|58869421|FG014|Part 2 (Day 1)|Other|0|||
30843351|NCT03701555|58869422|FG015|Part 2 (Day 1)|Other|2|||
30843352|NCT03701555|58869423|FG016|Part 2 (Day 1)|Other|2|||
30843353|NCT03701555|58869424|FG017|Part 2 (Day 1)|Other|0|||
30843354|NCT03701555|58869425|FG018|Part 2 (Day 1)|Other|0|||
30843355|NCT03701555|58869426|FG019|Part 2 (Day 1)|Other|0|||
30843356|NCT03701555|58869427|FG020|Part 2 (Day 1)|Other|0|||
30843357|NCT03701555|58869428|FG021|Part 2 (Day 1)|Other|0|||
30843358|NCT03701555|58869429|FG022|Part 2 (Day 1)|Other|0|||
30843359|NCT03701555|58869430|FG023|Part 2 (Day 1)|Other|0|||
30843360|NCT03701555|58869431|FG024|Part 2 (Day 1)|Other|0|||
30843361|NCT03701555|58869432|FG025|Part 2 (Day 1)|Other|0|||
30843362|NCT03701555|58869433|FG026|Part 2 (Day 1)|Other|0|||
30843363|NCT03701555|58869434|FG027|Part 2 (Day 1)|Other|0|||
30843364|NCT03701555|58869435|FG028|Part 2 (Day 1)|Other|0|||
30843365|NCT03701555|58869436|FG029|Part 2 (Day 1)|Other|0|||
30843366|NCT03701555|58869437|FG030|Part 2 (Day 1)|Other|0|||
30843367|NCT03701555|58869438|FG031|Part 2 (Day 1)|Other|0|||
30843368|NCT03701555|58869439|FG032|Part 2 (Day 1)|Other|0|||
30843369|NCT03701555|58869440|FG033|Part 2 (Day 1)|Other|0|||
30843370|NCT03701555|58869441|FG034|Part 2 (Day 1)|Other|0|||
30843371|NCT03701555|58869442|FG035|Part 2 (Day 1)|Other|0|||
30843372|NCT03701555|58869407|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
30843373|NCT03701555|58869408|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
30843374|NCT03701555|58869409|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
30843375|NCT03701555|58869410|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
30843376|NCT03701555|58869411|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
30843377|NCT03701555|58869412|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
30760345|NCT02094261|58768714|FG000|Overall Study|Death|24|||
30760346|NCT02094261|58768714|FG000|Overall Study|Lost to Follow-up|1|||
30760347|NCT02094261|58768714|FG000|Overall Study|Withdrawal by Subject|4|||
30760348|NCT02094261|58768714|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
30760349|NCT01721577|58768720|FG000|Overall Study|Lack of Efficacy|1|||
30760350|NCT01721577|58768721|FG001|Overall Study|Lack of Efficacy|0|||
30760351|NCT01721577|58768720|FG000|Overall Study|Death|1|||
30760352|NCT01721577|58768721|FG001|Overall Study|Death|0|||
30760353|NCT01721577|58768720|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
30760354|NCT01721577|58768721|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
30948290|NCT01751113|58994004|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
30760355|NCT01721577|58768720|FG000|Overall Study|Adverse Event|0|||
30760356|NCT01721577|58768721|FG001|Overall Study|Adverse Event|2|||
30760357|NCT01411332|58768738|FG000|Enrollment|Protocol Violation|0|||
30760358|NCT01411332|58768739|FG001|Enrollment|Protocol Violation|1|||
30843378|NCT03701555|58869413|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
30843379|NCT03701555|58869414|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
30843380|NCT03701555|58869415|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
30843381|NCT03701555|58869416|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
30843382|NCT03701555|58869417|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
30843383|NCT03701555|58869418|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
30843384|NCT03701555|58869419|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
30948291|NCT01751113|58993999|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
30760359|NCT01411332|58768738|FG000|Enrollment|Withdrawal by Subject|0|||
30760360|NCT01411332|58768739|FG001|Enrollment|Withdrawal by Subject|1|||
30760361|NCT01411332|58768738|FG000|Treatment|Lost to Follow-up|1|||
30760362|NCT01411332|58768739|FG001|Treatment|Lost to Follow-up|0|||
30843385|NCT03701555|58869420|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
30625467|NCT01185821|58637647|FG000|Overall Study|Lack of Efficacy|0|||
30760363|NCT01194570|58768748|FG000|Overall Study|Death|1|||
30625468|NCT01185821|58637648|FG001|Overall Study|Lack of Efficacy|0|||
30625469|NCT01185821|58637649|FG002|Overall Study|Lack of Efficacy|3|||
30625470|NCT01185821|58637650|FG003|Overall Study|Lack of Efficacy|0|||
30625471|NCT01185821|58637651|FG004|Overall Study|Lack of Efficacy|9|||
30625472|NCT01185821|58637647|FG000|Overall Study|Withdrawal by Subject|3|||
30625473|NCT01185821|58637648|FG001|Overall Study|Withdrawal by Subject|2|||
30625474|NCT01185821|58637649|FG002|Overall Study|Withdrawal by Subject|2|||
30760364|NCT01194570|58768749|FG001|Overall Study|Death|3|||
30760365|NCT01194570|58768748|FG000|Overall Study|Ongoing at CCOD|162|||
30760366|NCT01194570|58768749|FG001|Overall Study|Ongoing at CCOD|387|||
30760367|NCT01194570|58768748|FG000|Overall Study|Physician Decision|2|||
30760368|NCT01194570|58768749|FG001|Overall Study|Physician Decision|6|||
30760369|NCT01194570|58768748|FG000|Overall Study|Reason not specified|13|||
30760370|NCT01194570|58768749|FG001|Overall Study|Reason not specified|20|||
30760371|NCT01194570|58768748|FG000|Overall Study|Protocol Violation|0|||
30760372|NCT01194570|58768749|FG001|Overall Study|Protocol Violation|2|||
30760373|NCT01194570|58768748|FG000|Overall Study|Non-compliance with study drug|2|||
30760374|NCT01194570|58768749|FG001|Overall Study|Non-compliance with study drug|2|||
30760375|NCT01194570|58768748|FG000|Overall Study|Adverse Event|12|||
30760376|NCT01194570|58768749|FG001|Overall Study|Adverse Event|18|||
30760377|NCT01194570|58768748|FG000|Overall Study|Non-compliance|2|||
30760378|NCT01194570|58768749|FG001|Overall Study|Non-compliance|2|||
30760379|NCT01194570|58768748|FG000|Overall Study|Lack of Efficacy|27|||
30760380|NCT01194570|58768749|FG001|Overall Study|Lack of Efficacy|21|||
30760381|NCT01194570|58768748|FG000|Overall Study|Withdrawal by Subject|21|||
30760382|NCT01194570|58768749|FG001|Overall Study|Withdrawal by Subject|22|||
30760383|NCT01194570|58768748|FG000|Overall Study|Pregnancy|1|||
30760384|NCT01194570|58768749|FG001|Overall Study|Pregnancy|1|||
30760385|NCT01194570|58768748|FG000|Overall Study|Lost to Follow-up|1|||
30760386|NCT01194570|58768749|FG001|Overall Study|Lost to Follow-up|4|||
30760387|NCT04881747|58768775|FG000|Period 2 Washout|Adverse Event|1|||
30625475|NCT01185821|58637650|FG003|Overall Study|Withdrawal by Subject|1|||
30625476|NCT01185821|58637651|FG004|Overall Study|Withdrawal by Subject|3|||
30625477|NCT01185821|58637647|FG000|Overall Study|Lost to Follow-up|1|||
30625478|NCT01185821|58637648|FG001|Overall Study|Lost to Follow-up|1|||
30760388|NCT04881747|58768776|FG001|Period 2 Washout|Adverse Event|0|||
30760389|NCT04881747|58768777|FG002|Period 2 Washout|Adverse Event|0|||
30625479|NCT01185821|58637649|FG002|Overall Study|Lost to Follow-up|2|||
30760390|NCT04881747|58768778|FG003|Period 2 Washout|Adverse Event|0|||
30760391|NCT04881747|58768779|FG004|Period 2 Washout|Adverse Event|1|||
30760392|NCT04881747|58768780|FG005|Period 2 Washout|Adverse Event|0|||
30760393|NCT04881747|58768775|FG000|Period 2 Washout|Withdrawal by Subject|1|||
30760394|NCT04881747|58768776|FG001|Period 2 Washout|Withdrawal by Subject|0|||
30760395|NCT04881747|58768777|FG002|Period 2 Washout|Withdrawal by Subject|0|||
30843386|NCT03701555|58869421|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
30843387|NCT03701555|58869422|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
30843388|NCT03701555|58869423|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
30843389|NCT03701555|58869424|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
30948292|NCT01751113|58994000|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
30948293|NCT01751113|58994001|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
30843390|NCT03701555|58869425|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
30948294|NCT01751113|58994002|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
30843391|NCT03701555|58869426|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
30843392|NCT03701555|58869427|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
30843393|NCT03701555|58869428|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
30843394|NCT03701555|58869429|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
30843395|NCT03701555|58869430|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
30843396|NCT03701555|58869431|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
30843397|NCT03701555|58869432|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
30843398|NCT03701555|58869433|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
30843399|NCT03701555|58869434|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
30843400|NCT03701555|58869435|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
30843401|NCT03701555|58869436|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
30843402|NCT03701555|58869437|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
30843403|NCT03701555|58869438|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
30843404|NCT03701555|58869439|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
30843405|NCT03701555|58869440|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
30843406|NCT03701555|58869441|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
30843407|NCT03701555|58869442|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
30843408|NCT03701555|58869407|FG000|Part 3 (Day 1)|Subject Decision|0|||
30843409|NCT03701555|58869408|FG001|Part 3 (Day 1)|Subject Decision|0|||
30625480|NCT01185821|58637650|FG003|Overall Study|Lost to Follow-up|1|||
30625481|NCT01185821|58637651|FG004|Overall Study|Lost to Follow-up|2|||
30625482|NCT01185821|58637647|FG000|Overall Study|Administrative problems|0|||
30625483|NCT01185821|58637648|FG001|Overall Study|Administrative problems|0|||
30843410|NCT03701555|58869409|FG002|Part 3 (Day 1)|Subject Decision|0|||
30843411|NCT03701555|58869410|FG003|Part 3 (Day 1)|Subject Decision|0|||
30843412|NCT03701555|58869411|FG004|Part 3 (Day 1)|Subject Decision|0|||
30843413|NCT03701555|58869412|FG005|Part 3 (Day 1)|Subject Decision|0|||
30843414|NCT03701555|58869413|FG006|Part 3 (Day 1)|Subject Decision|0|||
30843415|NCT03701555|58869414|FG007|Part 3 (Day 1)|Subject Decision|0|||
30843416|NCT03701555|58869415|FG008|Part 3 (Day 1)|Subject Decision|0|||
30843417|NCT03701555|58869416|FG009|Part 3 (Day 1)|Subject Decision|0|||
30843418|NCT03701555|58869417|FG010|Part 3 (Day 1)|Subject Decision|0|||
30843419|NCT03701555|58869418|FG011|Part 3 (Day 1)|Subject Decision|0|||
30625484|NCT01185821|58637649|FG002|Overall Study|Administrative problems|1|||
30948295|NCT01751113|58994003|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
30948296|NCT01751113|58994004|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
30948297|NCT01750879|58994015|FG000|Overall Study|Adverse Event|8|||
30843420|NCT03701555|58869419|FG012|Part 3 (Day 1)|Subject Decision|0|||
30843421|NCT03701555|58869420|FG013|Part 3 (Day 1)|Subject Decision|0|||
30843422|NCT03701555|58869421|FG014|Part 3 (Day 1)|Subject Decision|0|||
30760396|NCT04881747|58768778|FG003|Period 2 Washout|Withdrawal by Subject|1|||
30760397|NCT04881747|58768779|FG004|Period 2 Washout|Withdrawal by Subject|0|||
30760398|NCT04881747|58768780|FG005|Period 2 Washout|Withdrawal by Subject|0|||
30760399|NCT04795622|58768790|FG000|Overall Study|Adverse Event|1|||
30760400|NCT04795622|58768791|FG001|Overall Study|Adverse Event|0|||
30760401|NCT04795622|58768790|FG000|Overall Study|Withdrawal by Subject|3|||
30760402|NCT04795622|58768791|FG001|Overall Study|Withdrawal by Subject|3|||
30760403|NCT04795622|58768790|FG000|Overall Study|Protocol Violation|0|||
30760404|NCT04795622|58768791|FG001|Overall Study|Protocol Violation|2|||
30760405|NCT04795622|58768790|FG000|Overall Study|Lost to Follow-up|2|||
30760406|NCT04795622|58768791|FG001|Overall Study|Lost to Follow-up|3|||
30760407|NCT04795622|58768790|FG000|Overall Study|Other|7|||
30760408|NCT04795622|58768791|FG001|Overall Study|Other|8|||
30760409|NCT04652245|58768812|FG000|Wash-Out Period|Adverse Event|0|||
30760410|NCT04652245|58768813|FG001|Wash-Out Period|Adverse Event|2|||
30760411|NCT04652245|58768812|FG000|Wash-Out Period|Withdrawal by Subject|0|||
30760412|NCT04652245|58768813|FG001|Wash-Out Period|Withdrawal by Subject|2|||
30760413|NCT04405739|58768830|FG000|Overall Study|Adverse Event|0|||
30760414|NCT04405739|58768831|FG001|Overall Study|Adverse Event|1|||
30760415|NCT04405739|58768832|FG002|Overall Study|Adverse Event|0|||
30760416|NCT04405739|58768833|FG003|Overall Study|Adverse Event|0|||
30760417|NCT04405739|58768830|FG000|Overall Study|Lost to Follow-up|0|||
30760418|NCT04405739|58768831|FG001|Overall Study|Lost to Follow-up|2|||
30760419|NCT04405739|58768832|FG002|Overall Study|Lost to Follow-up|1|||
30760420|NCT04405739|58768833|FG003|Overall Study|Lost to Follow-up|3|||
30760421|NCT04405739|58768830|FG000|Overall Study|Withdrawal by Subject|0|||
30760422|NCT04405739|58768831|FG001|Overall Study|Withdrawal by Subject|2|||
30760423|NCT04405739|58768832|FG002|Overall Study|Withdrawal by Subject|1|||
30760424|NCT04405739|58768833|FG003|Overall Study|Withdrawal by Subject|1|||
30760425|NCT04405739|58768830|FG000|Overall Study|Death|0|||
30760426|NCT04405739|58768831|FG001|Overall Study|Death|0|||
30760427|NCT04405739|58768832|FG002|Overall Study|Death|1|||
30760428|NCT04405739|58768833|FG003|Overall Study|Death|0|||
30760429|NCT04405739|58768830|FG000|Overall Study|Transferred to rehab|0|||
30760430|NCT04405739|58768831|FG001|Overall Study|Transferred to rehab|0|||
30760431|NCT04405739|58768832|FG002|Overall Study|Transferred to rehab|0|||
30760432|NCT04405739|58768833|FG003|Overall Study|Transferred to rehab|1|||
30760433|NCT04405739|58768830|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
30760434|NCT04405739|58768831|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
30760435|NCT04405739|58768832|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
30760436|NCT04405739|58768833|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
30948298|NCT01750879|58994016|FG001|Overall Study|Adverse Event|0|||
30948299|NCT01750879|58994015|FG000|Overall Study|Lack of Efficacy|1|||
30948300|NCT01750879|58994016|FG001|Overall Study|Lack of Efficacy|0|||
30760437|NCT04954326|58768866|FG000|Overall Study|Protocol Violation|0|||
30760438|NCT04954326|58768867|FG001|Overall Study|Protocol Violation|1|||
30760439|NCT04954326|58768866|FG000|Overall Study|Death|0|||
30625485|NCT01185821|58637650|FG003|Overall Study|Administrative problems|1|||
30625486|NCT01185821|58637651|FG004|Overall Study|Administrative problems|2|||
30625487|NCT00893464|58637673|FG000|Overall Study|Did not complete therapy/experience PD|0|||
30625488|NCT00893464|58637674|FG001|Overall Study|Did not complete therapy/experience PD|0|||
30625489|NCT00893464|58637675|FG002|Overall Study|Did not complete therapy/experience PD|0|||
30625490|NCT00893464|58637676|FG003|Overall Study|Did not complete therapy/experience PD|0|||
30625491|NCT00893464|58637677|FG004|Overall Study|Did not complete therapy/experience PD|0|||
30625492|NCT00893464|58637678|FG005|Overall Study|Did not complete therapy/experience PD|0|||
30625493|NCT00893464|58637679|FG006|Overall Study|Did not complete therapy/experience PD|2|||
30625494|NCT00893464|58637680|FG007|Overall Study|Did not complete therapy/experience PD|2|||
30760440|NCT04954326|58768867|FG001|Overall Study|Death|2|||
30760441|NCT04954326|58768866|FG000|Overall Study|Physician Decision|0|||
30760442|NCT04954326|58768867|FG001|Overall Study|Physician Decision|1|||
30760443|NCT04914819|58768875|FG000|Overall Study|Pregnancy|3|||
30760444|NCT04914819|58768876|FG001|Overall Study|Pregnancy|1|||
30760445|NCT04914819|58768875|FG000|Overall Study|Discontinued study|4|||
30843423|NCT03701555|58869422|FG015|Part 3 (Day 1)|Subject Decision|0|||
30843424|NCT03701555|58869423|FG016|Part 3 (Day 1)|Subject Decision|0|||
30760446|NCT04914819|58768876|FG001|Overall Study|Discontinued study|1|||
30843425|NCT03701555|58869424|FG017|Part 3 (Day 1)|Subject Decision|0|||
30843426|NCT03701555|58869425|FG018|Part 3 (Day 1)|Subject Decision|0|||
30843427|NCT03701555|58869426|FG019|Part 3 (Day 1)|Subject Decision|0|||
30843428|NCT03701555|58869427|FG020|Part 3 (Day 1)|Subject Decision|0|||
30625495|NCT00891904|58637703|FG000|Overall Study|Death|1|||
30760447|NCT04914819|58768875|FG000|Overall Study|Lost to Follow-up|7|||
30760448|NCT04914819|58768876|FG001|Overall Study|Lost to Follow-up|0|||
30843429|NCT03701555|58869428|FG021|Part 3 (Day 1)|Subject Decision|0|||
30843430|NCT03701555|58869429|FG022|Part 3 (Day 1)|Subject Decision|0|||
30948301|NCT01750879|58994015|FG000|Overall Study|Withdrawal by Subject|1|||
30948302|NCT01750879|58994016|FG001|Overall Study|Withdrawal by Subject|0|||
30948303|NCT01750879|58994015|FG000|Overall Study|Did not complete per protocol|0|||
30948304|NCT01750879|58994016|FG001|Overall Study|Did not complete per protocol|3|||
30948305|NCT01719380|58994042|FG000|Overall Study|Adverse Event|0|||
30948306|NCT01719380|58994043|FG001|Overall Study|Adverse Event|0|||
30948307|NCT01719380|58994044|FG002|Overall Study|Adverse Event|1|||
30948308|NCT01719380|58994045|FG003|Overall Study|Adverse Event|2|||
30948309|NCT01719380|58994046|FG004|Overall Study|Adverse Event|0|||
30948310|NCT01719380|58994047|FG005|Overall Study|Adverse Event|1|||
30948311|NCT01719380|58994048|FG006|Overall Study|Adverse Event|0|||
30948312|NCT01719380|58994049|FG007|Overall Study|Adverse Event|1|||
30948313|NCT01719380|58994050|FG008|Overall Study|Adverse Event|4|||
30948314|NCT01719380|58994051|FG009|Overall Study|Adverse Event|3|||
30843431|NCT03701555|58869430|FG023|Part 3 (Day 1)|Subject Decision|0|||
30843432|NCT03701555|58869431|FG024|Part 3 (Day 1)|Subject Decision|0|||
30843433|NCT03701555|58869432|FG025|Part 3 (Day 1)|Subject Decision|0|||
30843434|NCT03701555|58869433|FG026|Part 3 (Day 1)|Subject Decision|1|||
30843435|NCT03701555|58869434|FG027|Part 3 (Day 1)|Subject Decision|0|||
30843436|NCT03701555|58869435|FG028|Part 3 (Day 1)|Subject Decision|0|||
30843437|NCT03701555|58869436|FG029|Part 3 (Day 1)|Subject Decision|0|||
30843438|NCT03701555|58869437|FG030|Part 3 (Day 1)|Subject Decision|0|||
30625496|NCT00891904|58637703|FG000|Overall Study|Adverse Event|1|||
30843439|NCT03701555|58869438|FG031|Part 3 (Day 1)|Subject Decision|2|||
30843440|NCT03701555|58869439|FG032|Part 3 (Day 1)|Subject Decision|1|||
30843441|NCT03701555|58869440|FG033|Part 3 (Day 1)|Subject Decision|1|||
30843442|NCT03701555|58869441|FG034|Part 3 (Day 1)|Subject Decision|0|||
30843443|NCT03701555|58869442|FG035|Part 3 (Day 1)|Subject Decision|0|||
30843444|NCT03701555|58869407|FG000|Part 3 (Day 1)|Other|0|||
30843445|NCT03701555|58869408|FG001|Part 3 (Day 1)|Other|0|||
30843446|NCT03701555|58869409|FG002|Part 3 (Day 1)|Other|0|||
30843447|NCT03701555|58869410|FG003|Part 3 (Day 1)|Other|0|||
30948315|NCT01719380|58994042|FG000|Overall Study|Death|0|||
30843448|NCT03701555|58869411|FG004|Part 3 (Day 1)|Other|0|||
30843449|NCT03701555|58869412|FG005|Part 3 (Day 1)|Other|0|||
30843450|NCT03701555|58869413|FG006|Part 3 (Day 1)|Other|0|||
30760449|NCT04818346|58768891|FG000|24-Week Placebo-Controlled Period|Adverse Event|1|||
30760450|NCT04818346|58768892|FG001|24-Week Placebo-Controlled Period|Adverse Event|2|||
30760451|NCT04818346|58768893|FG002|24-Week Placebo-Controlled Period|Adverse Event|0|||
30760452|NCT04818346|58768894|FG003|24-Week Placebo-Controlled Period|Adverse Event|3|||
30625497|NCT01157351|58637709|FG000|Overall Study|Adverse Event|5|||
30948316|NCT01719380|58994043|FG001|Overall Study|Death|1|||
30948317|NCT01719380|58994044|FG002|Overall Study|Death|0|||
30948318|NCT01719380|58994045|FG003|Overall Study|Death|0|||
30948319|NCT01719380|58994046|FG004|Overall Study|Death|0|||
30948320|NCT01719380|58994047|FG005|Overall Study|Death|0|||
30948321|NCT01719380|58994048|FG006|Overall Study|Death|0|||
30948322|NCT01719380|58994049|FG007|Overall Study|Death|0|||
30760453|NCT04818346|58768891|FG000|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
30760454|NCT04818346|58768892|FG001|24-Week Placebo-Controlled Period|Lost to Follow-up|2|||
30760455|NCT04818346|58768893|FG002|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
30760456|NCT04818346|58768894|FG003|24-Week Placebo-Controlled Period|Lost to Follow-up|1|||
30760457|NCT04818346|58768891|FG000|24-Week Placebo-Controlled Period|Physician Decision|1|||
30760458|NCT04818346|58768892|FG001|24-Week Placebo-Controlled Period|Physician Decision|0|||
30760459|NCT04818346|58768893|FG002|24-Week Placebo-Controlled Period|Physician Decision|0|||
30760460|NCT04818346|58768894|FG003|24-Week Placebo-Controlled Period|Physician Decision|0|||
30760461|NCT04818346|58768891|FG000|24-Week Placebo-Controlled Period|Protocol Violation|0|||
30760462|NCT04818346|58768892|FG001|24-Week Placebo-Controlled Period|Protocol Violation|0|||
30760463|NCT04818346|58768893|FG002|24-Week Placebo-Controlled Period|Protocol Violation|1|||
30760464|NCT04818346|58768894|FG003|24-Week Placebo-Controlled Period|Protocol Violation|1|||
30760465|NCT04818346|58768891|FG000|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
30760466|NCT04818346|58768892|FG001|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
30760467|NCT04818346|58768893|FG002|24-Week Placebo-Controlled Period|Withdrawal by Subject|6|||
30760468|NCT04818346|58768894|FG003|24-Week Placebo-Controlled Period|Withdrawal by Subject|2|||
30760469|NCT04818346|58768891|FG000|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|1|||
30760470|NCT04818346|58768892|FG001|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
30760471|NCT04818346|58768893|FG002|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
30760472|NCT04818346|58768894|FG003|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
30760473|NCT04818346|58768891|FG000|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
30760474|NCT04818346|58768892|FG001|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
30760475|NCT04818346|58768893|FG002|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
30760476|NCT04818346|58768894|FG003|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
30760477|NCT04818346|58768891|FG000|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
30760478|NCT04818346|58768892|FG001|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
30760479|NCT04818346|58768893|FG002|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|1|||
30760480|NCT04818346|58768894|FG003|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
30760481|NCT04818346|58768891|FG000|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
30948323|NCT01719380|58994050|FG008|Overall Study|Death|3|||
30948324|NCT01719380|58994051|FG009|Overall Study|Death|3|||
30760482|NCT04818346|58768892|FG001|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
30760483|NCT04818346|58768893|FG002|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
30948325|NCT01719380|58994042|FG000|Overall Study|Participant/Guardian Decision|0|||
30760484|NCT04818346|58768894|FG003|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
30625498|NCT01157351|58637710|FG001|Overall Study|Adverse Event|4|||
30760485|NCT04723394|58768906|FG000|Overall Study|Adverse Event|0|||
30843451|NCT03701555|58869414|FG007|Part 3 (Day 1)|Other|0|||
30843452|NCT03701555|58869415|FG008|Part 3 (Day 1)|Other|0|||
30843453|NCT03701555|58869416|FG009|Part 3 (Day 1)|Other|0|||
30843454|NCT03701555|58869417|FG010|Part 3 (Day 1)|Other|0|||
30843455|NCT03701555|58869418|FG011|Part 3 (Day 1)|Other|0|||
30843456|NCT03701555|58869419|FG012|Part 3 (Day 1)|Other|0|||
30625499|NCT01157351|58637709|FG000|Overall Study|Death|1|||
30625500|NCT01157351|58637710|FG001|Overall Study|Death|0|||
30625501|NCT01157351|58637709|FG000|Overall Study|Lost to Follow-up|53|||
30625502|NCT01157351|58637710|FG001|Overall Study|Lost to Follow-up|55|||
30625503|NCT01157351|58637709|FG000|Overall Study|Withdrawal by Subject|37|||
30625504|NCT01157351|58637710|FG001|Overall Study|Withdrawal by Subject|27|||
30625505|NCT01157351|58637709|FG000|Overall Study|Physician Decision|5|||
30625506|NCT01157351|58637710|FG001|Overall Study|Physician Decision|4|||
30625507|NCT01157351|58637709|FG000|Overall Study|Protocol Violation|0|||
30625508|NCT01157351|58637710|FG001|Overall Study|Protocol Violation|1|||
30625509|NCT01157351|58637709|FG000|Overall Study|Other|32|||
30625510|NCT01157351|58637710|FG001|Overall Study|Other|36|||
30625511|NCT01157351|58637709|FG000|Overall Study|Noncompliance with Study Drug|0|||
30625512|NCT01157351|58637710|FG001|Overall Study|Noncompliance with Study Drug|3|||
30625513|NCT01157351|58637709|FG000|Overall Study|Randomized but not Treated|4|||
30625514|NCT01157351|58637710|FG001|Overall Study|Randomized but not Treated|2|||
30625515|NCT01157117|58637719|FG000|Overall Study|Dosing Symptoms|0|||
30625516|NCT01157117|58637720|FG001|Overall Study|Dosing Symptoms|4|||
30625517|NCT01157117|58637721|FG002|Overall Study|Dosing Symptoms|0|||
30625518|NCT01157117|58637719|FG000|Overall Study|Withdrawal by Subject|4|||
30625519|NCT01157117|58637720|FG001|Overall Study|Withdrawal by Subject|1|||
30625520|NCT01157117|58637721|FG002|Overall Study|Withdrawal by Subject|1|||
30625521|NCT01157117|58637719|FG000|Overall Study|Lack of Efficacy|1|||
30625522|NCT01157117|58637720|FG001|Overall Study|Lack of Efficacy|1|||
30625523|NCT01157117|58637721|FG002|Overall Study|Lack of Efficacy|0|||
30625524|NCT01157117|58637719|FG000|Overall Study|Lost to Follow-up|0|||
30625525|NCT01157117|58637720|FG001|Overall Study|Lost to Follow-up|0|||
30625526|NCT01157117|58637721|FG002|Overall Study|Lost to Follow-up|1|||
30625527|NCT01157117|58637719|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
30625528|NCT01157117|58637720|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
30760486|NCT04723394|58768907|FG001|Overall Study|Adverse Event|3|||
30760487|NCT04723394|58768906|FG000|Overall Study|Death|8|||
30760488|NCT04723394|58768907|FG001|Overall Study|Death|8|||
30760489|NCT04723394|58768906|FG000|Overall Study|Lost to Follow-up|20|||
30760490|NCT04723394|58768907|FG001|Overall Study|Lost to Follow-up|17|||
30760491|NCT04723394|58768906|FG000|Overall Study|Physician Decision|1|||
30760492|NCT04723394|58768907|FG001|Overall Study|Physician Decision|0|||
30760493|NCT04723394|58768906|FG000|Overall Study|Withdrawal by Subject|20|||
30760494|NCT04723394|58768907|FG001|Overall Study|Withdrawal by Subject|34|||
30760495|NCT04723394|58768906|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
30760496|NCT04723394|58768907|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
30760497|NCT04478266|58768919|FG000|Overall Study|Adverse Event|17|||
30760498|NCT04478266|58768920|FG001|Overall Study|Adverse Event|18|||
30760499|NCT04478266|58768919|FG000|Overall Study|Progressive disease|99|||
30760500|NCT04478266|58768920|FG001|Overall Study|Progressive disease|118|||
30760501|NCT04478266|58768919|FG000|Overall Study|Poor compliance to protocol|1|||
30760502|NCT04478266|58768920|FG001|Overall Study|Poor compliance to protocol|0|||
30760503|NCT04478266|58768919|FG000|Overall Study|Withdrawal by Subject|14|||
30760504|NCT04478266|58768920|FG001|Overall Study|Withdrawal by Subject|16|||
30760505|NCT04478266|58768919|FG000|Overall Study|Other: unspecified|5|||
30760506|NCT04478266|58768920|FG001|Overall Study|Other: unspecified|4|||
30760507|NCT04478266|58768919|FG000|Overall Study|Randomized not treated|1|||
30760508|NCT04478266|58768920|FG001|Overall Study|Randomized not treated|1|||
30760509|NCT04478266|58768919|FG000|Overall Study|Ongoing|397|||
30760510|NCT04478266|58768920|FG001|Overall Study|Ongoing|377|||
30760511|NCT04409002|58768928|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
30760512|NCT04325828|58768932|FG000|Overall Study|Ongoing|26|||
30760513|NCT04289363|58768938|FG000|Overall Study|Lost to Follow-up|14|||
30760514|NCT04289363|58768939|FG001|Overall Study|Lost to Follow-up|0|||
30760515|NCT04235959|58768948|FG000|Overall Study|Protocol Violation|0|||
30760516|NCT04235959|58768949|FG001|Overall Study|Protocol Violation|1|||
30760517|NCT04235959|58768950|FG002|Overall Study|Protocol Violation|0|||
30760518|NCT04235959|58768948|FG000|Overall Study|Adverse Event|1|||
30760519|NCT04235959|58768949|FG001|Overall Study|Adverse Event|0|||
30760520|NCT04235959|58768950|FG002|Overall Study|Adverse Event|0|||
30760521|NCT03735121|58768991|FG000|Overall Study|Death|3|||
30760522|NCT03735121|58768992|FG001|Overall Study|Death|6|||
30760523|NCT03735121|58768993|FG002|Overall Study|Death|8|||
30760524|NCT03735121|58768994|FG003|Overall Study|Death|37|||
30760525|NCT03735121|58768995|FG004|Overall Study|Death|86|||
30760526|NCT03735121|58768991|FG000|Overall Study|Withdrawal by Subject|1|||
30760527|NCT03735121|58768992|FG001|Overall Study|Withdrawal by Subject|1|||
30760528|NCT03735121|58768993|FG002|Overall Study|Withdrawal by Subject|3|||
30760529|NCT03735121|58768994|FG003|Overall Study|Withdrawal by Subject|4|||
30948326|NCT01719380|58994043|FG001|Overall Study|Participant/Guardian Decision|0|||
30948327|NCT01719380|58994044|FG002|Overall Study|Participant/Guardian Decision|1|||
30948328|NCT01719380|58994045|FG003|Overall Study|Participant/Guardian Decision|0|||
30625529|NCT01157117|58637721|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
30760530|NCT03735121|58768995|FG004|Overall Study|Withdrawal by Subject|2|||
30760531|NCT03735121|58768991|FG000|Overall Study|Progressive Disease|0|||
30760532|NCT03735121|58768992|FG001|Overall Study|Progressive Disease|0|||
30760533|NCT03735121|58768993|FG002|Overall Study|Progressive Disease|1|||
30760534|NCT03735121|58768994|FG003|Overall Study|Progressive Disease|0|||
30843457|NCT03701555|58869420|FG013|Part 3 (Day 1)|Other|0|||
30843458|NCT03701555|58869421|FG014|Part 3 (Day 1)|Other|0|||
30760535|NCT03735121|58768995|FG004|Overall Study|Progressive Disease|0|||
30760536|NCT03735121|58768991|FG000|Overall Study|Lost to Follow-up|0|||
30843459|NCT03701555|58869422|FG015|Part 3 (Day 1)|Other|0|||
30625530|NCT00891202|58637731|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
30625531|NCT00891202|58637732|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
30625532|NCT00891202|58637733|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
30760537|NCT03735121|58768992|FG001|Overall Study|Lost to Follow-up|0|||
30760538|NCT03735121|58768993|FG002|Overall Study|Lost to Follow-up|0|||
30760539|NCT03735121|58768994|FG003|Overall Study|Lost to Follow-up|0|||
30760540|NCT03735121|58768995|FG004|Overall Study|Lost to Follow-up|1|||
30760541|NCT03735121|58768991|FG000|Overall Study|Ongoing|3|||
30760542|NCT03735121|58768992|FG001|Overall Study|Ongoing|3|||
30760543|NCT03735121|58768993|FG002|Overall Study|Ongoing|26|||
30760544|NCT03735121|58768994|FG003|Overall Study|Ongoing|83|||
30843460|NCT03701555|58869423|FG016|Part 3 (Day 1)|Other|0|||
30843461|NCT03701555|58869424|FG017|Part 3 (Day 1)|Other|0|||
30760545|NCT03735121|58768995|FG004|Overall Study|Ongoing|158|||
30760546|NCT03525613|58769022|FG000|Overall Study|Adverse Event|11|||
30760547|NCT03525613|58769023|FG001|Overall Study|Adverse Event|8|||
30760548|NCT03525613|58769024|FG002|Overall Study|Adverse Event|3|||
30760549|NCT03525613|58769025|FG003|Overall Study|Adverse Event|3|||
30760550|NCT03525613|58769022|FG000|Overall Study|Lost to Follow-up|4|||
30760551|NCT03525613|58769023|FG001|Overall Study|Lost to Follow-up|5|||
30948329|NCT01719380|58994046|FG004|Overall Study|Participant/Guardian Decision|0|||
30843462|NCT03701555|58869425|FG018|Part 3 (Day 1)|Other|0|||
30760552|NCT03525613|58769024|FG002|Overall Study|Lost to Follow-up|3|||
30948330|NCT01719380|58994047|FG005|Overall Study|Participant/Guardian Decision|0|||
30948331|NCT01719380|58994048|FG006|Overall Study|Participant/Guardian Decision|0|||
30948332|NCT01719380|58994049|FG007|Overall Study|Participant/Guardian Decision|0|||
30948333|NCT01719380|58994050|FG008|Overall Study|Participant/Guardian Decision|2|||
30948334|NCT01719380|58994051|FG009|Overall Study|Participant/Guardian Decision|2|||
30843463|NCT03701555|58869426|FG019|Part 3 (Day 1)|Other|0|||
30843464|NCT03701555|58869427|FG020|Part 3 (Day 1)|Other|0|||
30948335|NCT01719380|58994042|FG000|Overall Study|Physician Decision|0|||
30948336|NCT01719380|58994043|FG001|Overall Study|Physician Decision|0|||
30948337|NCT01719380|58994044|FG002|Overall Study|Physician Decision|2|||
30948338|NCT01719380|58994045|FG003|Overall Study|Physician Decision|0|||
30948339|NCT01719380|58994046|FG004|Overall Study|Physician Decision|0|||
30948340|NCT01719380|58994047|FG005|Overall Study|Physician Decision|0|||
30948341|NCT01719380|58994048|FG006|Overall Study|Physician Decision|0|||
30948342|NCT01719380|58994049|FG007|Overall Study|Physician Decision|0|||
30843465|NCT03701555|58869428|FG021|Part 3 (Day 1)|Other|0|||
30948343|NCT01719380|58994050|FG008|Overall Study|Physician Decision|1|||
30948344|NCT01719380|58994051|FG009|Overall Study|Physician Decision|1|||
30948345|NCT01719380|58994042|FG000|Overall Study|Lack of Efficacy|2|||
30948346|NCT01719380|58994043|FG001|Overall Study|Lack of Efficacy|6|||
30948347|NCT01719380|58994044|FG002|Overall Study|Lack of Efficacy|5|||
30625533|NCT00891202|58637734|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
30625534|NCT00891202|58637731|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
30625535|NCT00891202|58637732|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
30625536|NCT00891202|58637733|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
30948348|NCT01719380|58994045|FG003|Overall Study|Lack of Efficacy|6|||
30948349|NCT01719380|58994046|FG004|Overall Study|Lack of Efficacy|3|||
30625537|NCT00891202|58637734|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
30625538|NCT00891202|58637731|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
30625539|NCT00891202|58637732|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
30948350|NCT01719380|58994047|FG005|Overall Study|Lack of Efficacy|7|||
30948351|NCT01719380|58994048|FG006|Overall Study|Lack of Efficacy|10|||
30625540|NCT00891202|58637733|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
30625541|NCT00891202|58637734|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
30625542|NCT00891202|58637731|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
30625543|NCT00891202|58637732|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
30625544|NCT00891202|58637733|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
30843466|NCT03701555|58869429|FG022|Part 3 (Day 1)|Other|0|||
30625545|NCT00891202|58637734|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
30948352|NCT01719380|58994049|FG007|Overall Study|Lack of Efficacy|6|||
30948353|NCT01719380|58994050|FG008|Overall Study|Lack of Efficacy|39|||
30760553|NCT03525613|58769025|FG003|Overall Study|Lost to Follow-up|2|||
30760554|NCT03525613|58769022|FG000|Overall Study|Physician Decision|0|||
30760555|NCT03525613|58769023|FG001|Overall Study|Physician Decision|1|||
30948354|NCT01719380|58994051|FG009|Overall Study|Lack of Efficacy|42|||
30948355|NCT01719380|58994042|FG000|Overall Study|Progressive Disease|0|||
30948356|NCT01719380|58994043|FG001|Overall Study|Progressive Disease|0|||
30948357|NCT01719380|58994044|FG002|Overall Study|Progressive Disease|0|||
30948358|NCT01719380|58994045|FG003|Overall Study|Progressive Disease|0|||
30948359|NCT01719380|58994046|FG004|Overall Study|Progressive Disease|0|||
30948360|NCT01719380|58994047|FG005|Overall Study|Progressive Disease|0|||
30948361|NCT01719380|58994048|FG006|Overall Study|Progressive Disease|0|||
30948362|NCT01719380|58994049|FG007|Overall Study|Progressive Disease|0|||
30948363|NCT01719380|58994050|FG008|Overall Study|Progressive Disease|1|||
30760556|NCT03525613|58769024|FG002|Overall Study|Physician Decision|0|||
30760557|NCT03525613|58769025|FG003|Overall Study|Physician Decision|1|||
30948364|NCT01719380|58994051|FG009|Overall Study|Progressive Disease|0|||
30948365|NCT01743560|58994101|FG000|Overall Study|Disease progression|26|||
30948366|NCT01743560|58994101|FG000|Overall Study|Adverse Event|8|||
30948367|NCT01743560|58994101|FG000|Overall Study|Death|3|||
30760558|NCT03525613|58769022|FG000|Overall Study|Consent Withdrawal|25|||
30948368|NCT01743560|58994101|FG000|Overall Study|Withdrawal by Subject|2|||
30948369|NCT01743560|58994101|FG000|Overall Study|Protocol Violation|1|||
30760559|NCT03525613|58769023|FG001|Overall Study|Consent Withdrawal|16|||
30625546|NCT01185509|58637744|FG000|Overall Study|Progression/Relapse|9|||
30760560|NCT03525613|58769024|FG002|Overall Study|Consent Withdrawal|12|||
30760561|NCT03525613|58769025|FG003|Overall Study|Consent Withdrawal|9|||
30760562|NCT03525613|58769022|FG000|Overall Study|Death|20|||
30760563|NCT03525613|58769023|FG001|Overall Study|Death|9|||
30760564|NCT03525613|58769024|FG002|Overall Study|Death|7|||
30760565|NCT03525613|58769025|FG003|Overall Study|Death|1|||
30760566|NCT03525613|58769022|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
30760567|NCT03525613|58769023|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
30760568|NCT03525613|58769024|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
30760569|NCT03525613|58769025|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
30760570|NCT03500692|58769039|FG000|Overall Study|Death|163|||
30760571|NCT03500692|58769039|FG000|Overall Study|Lost to Follow-up|76|||
30760572|NCT03500692|58769039|FG000|Overall Study|Termination Reasons|3|||
30760573|NCT03404960|58769058|FG000|Overall Study|Adverse Event|0|||
30760574|NCT03404960|58769059|FG001|Overall Study|Adverse Event|2|||
30760575|NCT03404960|58769058|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
30760576|NCT03404960|58769059|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
30760577|NCT03404960|58769058|FG000|Overall Study|Bowel obstruction|0|||
30760578|NCT03404960|58769059|FG001|Overall Study|Bowel obstruction|1|||
30843467|NCT03701555|58869430|FG023|Part 3 (Day 1)|Other|0|||
30843468|NCT03701555|58869431|FG024|Part 3 (Day 1)|Other|1|||
30843469|NCT03701555|58869432|FG025|Part 3 (Day 1)|Other|1|||
30843470|NCT03701555|58869433|FG026|Part 3 (Day 1)|Other|0|||
30843471|NCT03701555|58869434|FG027|Part 3 (Day 1)|Other|0|||
30843472|NCT03701555|58869435|FG028|Part 3 (Day 1)|Other|0|||
30843473|NCT03701555|58869436|FG029|Part 3 (Day 1)|Other|1|||
30843474|NCT03701555|58869437|FG030|Part 3 (Day 1)|Other|1|||
30843475|NCT03701555|58869438|FG031|Part 3 (Day 1)|Other|0|||
30843476|NCT03701555|58869439|FG032|Part 3 (Day 1)|Other|1|||
30843477|NCT03701555|58869440|FG033|Part 3 (Day 1)|Other|1|||
30843478|NCT03701555|58869441|FG034|Part 3 (Day 1)|Other|0|||
30843479|NCT03701555|58869442|FG035|Part 3 (Day 1)|Other|0|||
30625547|NCT01185509|58637745|FG001|Overall Study|Progression/Relapse|15|||
30625548|NCT01185509|58637744|FG000|Overall Study|Physician Decision|2|||
30760579|NCT03404960|58769058|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
30760580|NCT03404960|58769059|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
30843480|NCT02484443|58869576|FG000|Overall Study|Lack of Efficacy|28|||
30843481|NCT02484443|58869576|FG000|Overall Study|Physician Decision|2|||
30843482|NCT02484443|58869576|FG000|Overall Study|Ineligible|2|||
30843483|NCT02306161|58869582|FG000|Overall Study|Death|1|||
30843484|NCT02306161|58869583|FG001|Overall Study|Death|3|||
30948370|NCT01743560|58994101|FG000|Overall Study|>1 dose of study drug|3|||
30948371|NCT01743092|58994131|FG000|Overall Study|Lost to Follow-up|14|||
30948372|NCT01743092|58994132|FG001|Overall Study|Lost to Follow-up|15|||
30948373|NCT01780831|58994165|FG000|Overall Study|Withdrawal by Subject|0|||
30948374|NCT01780831|58994166|FG001|Overall Study|Withdrawal by Subject|0|||
30948375|NCT01780831|58994167|FG002|Overall Study|Withdrawal by Subject|4|||
30948376|NCT01780831|58994168|FG003|Overall Study|Withdrawal by Subject|0|||
30760581|NCT03381274|58769070|FG000|Overall Study|Death|2|||
30760582|NCT03381274|58769071|FG001|Overall Study|Death|9|||
30948377|NCT01780831|58994165|FG000|Overall Study|Lost to Follow-up|0|||
30843485|NCT02306161|58869582|FG000|Overall Study|Lack of Efficacy|20|||
30843486|NCT02306161|58869583|FG001|Overall Study|Lack of Efficacy|43|||
30948378|NCT01780831|58994166|FG001|Overall Study|Lost to Follow-up|0|||
30625549|NCT01185509|58637745|FG001|Overall Study|Physician Decision|2|||
30760583|NCT03381274|58769072|FG002|Overall Study|Death|3|||
30948379|NCT01780831|58994167|FG002|Overall Study|Lost to Follow-up|0|||
30948380|NCT01780831|58994168|FG003|Overall Study|Lost to Follow-up|1|||
30948381|NCT01778023|58994227|FG000|Overall Study|Withdrawal by Subject|0|||
30948382|NCT01778023|58994228|FG001|Overall Study|Withdrawal by Subject|3|||
30948383|NCT01753297|58994236|FG000|Overall Study|Lost to Follow-up|7|||
30948384|NCT01753297|58994237|FG001|Overall Study|Lost to Follow-up|2|||
30948385|NCT01753297|58994236|FG000|Overall Study|Withdrawal by Subject|26|||
30948386|NCT01753297|58994237|FG001|Overall Study|Withdrawal by Subject|23|||
30948387|NCT01753297|58994236|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
30948388|NCT01753297|58994237|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
30948389|NCT01753297|58994236|FG000|Overall Study|Death|0|||
30948390|NCT01753297|58994237|FG001|Overall Study|Death|2|||
30948391|NCT01753297|58994236|FG000|Overall Study|Did not attend end of study visit|7|||
30948392|NCT01753297|58994237|FG001|Overall Study|Did not attend end of study visit|8|||
30948393|NCT01777321|58994247|FG000|Overall Study|Withdrawal by Subject|0|||
30948394|NCT01777321|58994248|FG001|Overall Study|Withdrawal by Subject|1|||
30948395|NCT01729819|58994256|FG000|Overall Study|Adverse Event|2|||
30948396|NCT01729819|58994257|FG001|Overall Study|Adverse Event|4|||
30760584|NCT03381274|58769073|FG003|Overall Study|Death|2|||
30948397|NCT01729819|58994256|FG000|Overall Study|Lack of Efficacy|1|||
30948398|NCT01729819|58994257|FG001|Overall Study|Lack of Efficacy|0|||
30948399|NCT01729819|58994256|FG000|Overall Study|Lost to Follow-up|2|||
30948570|NCT01973231|58994582|FG000|Overall Study|Withdrawal by Subject|7|||
30948571|NCT01973231|58994583|FG001|Overall Study|Withdrawal by Subject|9|||
30843719|NCT01915498|58869664|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843720|NCT01915498|58869665|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
30843721|NCT01915498|58869647|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
30843722|NCT01915498|58869648|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
30843723|NCT01915498|58869649|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
30760683|NCT02899195|58769157|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
30760684|NCT02899195|58769157|FG000|Maintenance Durvalumab|Progressive Disease|31|||
30760685|NCT02562235|58769243|FG000|Overall Study|Adverse Event|3|||
30760686|NCT02527200|58769256|FG000|Overall Study|Withdrawal by Subject|3|||
30760687|NCT02527200|58769257|FG001|Overall Study|Withdrawal by Subject|2|||
30760688|NCT02527200|58769258|FG002|Overall Study|Withdrawal by Subject|1|||
30760689|NCT02527200|58769259|FG003|Overall Study|Withdrawal by Subject|0|||
30760690|NCT02527200|58769256|FG000|Overall Study|Unclassified|0|||
30760691|NCT02527200|58769257|FG001|Overall Study|Unclassified|1|||
30760692|NCT02527200|58769258|FG002|Overall Study|Unclassified|0|||
30760693|NCT02527200|58769259|FG003|Overall Study|Unclassified|0|||
30760694|NCT02527200|58769256|FG000|Overall Study|Lost to Follow-up|0|||
30843724|NCT01915498|58869650|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
30843725|NCT01915498|58869651|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
30843726|NCT01915498|58869652|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
30843727|NCT01915498|58869653|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
30843728|NCT01915498|58869654|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
30843729|NCT01915498|58869655|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
30843730|NCT01915498|58869656|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
30843731|NCT01915498|58869657|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
30843732|NCT01915498|58869658|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
30843733|NCT01915498|58869659|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
30843734|NCT01915498|58869660|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
30843735|NCT01915498|58869661|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
30843736|NCT01915498|58869662|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
30843737|NCT01915498|58869663|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
30843738|NCT01915498|58869664|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
30843739|NCT01915498|58869665|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
30843740|NCT01915498|58869647|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843741|NCT01915498|58869648|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843742|NCT01915498|58869649|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843743|NCT01915498|58869650|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843744|NCT01915498|58869651|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
30843745|NCT01915498|58869652|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843746|NCT01915498|58869653|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843747|NCT01915498|58869654|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843748|NCT01915498|58869655|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843749|NCT01915498|58869656|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
30843750|NCT01915498|58869657|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843751|NCT01915498|58869658|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843752|NCT01915498|58869659|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843753|NCT01915498|58869660|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843754|NCT01915498|58869661|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30760695|NCT02527200|58769257|FG001|Overall Study|Lost to Follow-up|0|||
30760696|NCT02527200|58769258|FG002|Overall Study|Lost to Follow-up|1|||
30760697|NCT02527200|58769259|FG003|Overall Study|Lost to Follow-up|0|||
30760698|NCT02510040|58769276|FG000|Overall Study|Deemed no longer eligible|18|||
30877136|NCT03330405|58908692|FG009|Overall Study|Physician Decision|0|||
30877137|NCT03330405|58908693|FG010|Overall Study|Physician Decision|0|||
30877138|NCT03174782|58908738|FG000|Overall Study|Protocol Violation|1|||
30877139|NCT03174782|58908739|FG001|Overall Study|Protocol Violation|0|||
30877140|NCT03174782|58908738|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
30760699|NCT02510040|58769277|FG001|Overall Study|Deemed no longer eligible|3|||
30760700|NCT02510040|58769278|FG002|Overall Study|Deemed no longer eligible|1|||
30877141|NCT03174782|58908739|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
30877142|NCT02919969|58908745|FG000|Overall Study|Lack of Efficacy|22|||
30877143|NCT02919969|58908745|FG000|Overall Study|Death|4|||
30877144|NCT02919969|58908745|FG000|Overall Study|Physician Decision|3|||
30877145|NCT02919969|58908745|FG000|Overall Study|Withdrawal by Subject|2|||
30877146|NCT02003209|58908765|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
30877147|NCT02003209|58908766|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
30877148|NCT01891344|58908776|FG000|Overall Study|Ongoing|6|||
30877149|NCT01891344|58908777|FG001|Overall Study|Ongoing|2|||
30877150|NCT01891344|58908778|FG002|Overall Study|Ongoing|0|||
30877151|NCT01891344|58908779|FG003|Overall Study|Ongoing|1|||
30843755|NCT01915498|58869662|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843756|NCT01915498|58869663|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30760701|NCT02296125|58769302|FG000|Overall Study|Withdrawal by Subject|18|||
30843757|NCT01915498|58869664|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843758|NCT01915498|58869665|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
30843759|NCT01915498|58869647|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
30843760|NCT01915498|58869648|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
30843761|NCT01915498|58869649|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
30843762|NCT01915498|58869650|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
30843763|NCT01915498|58869651|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
30843764|NCT01915498|58869652|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
30843765|NCT01915498|58869653|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
30843766|NCT01915498|58869654|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
30843767|NCT01915498|58869655|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
30843768|NCT01915498|58869656|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
30843769|NCT01915498|58869657|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
30843770|NCT01915498|58869658|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
30843771|NCT01915498|58869659|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
30843772|NCT01915498|58869660|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
30843773|NCT01915498|58869661|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
30843774|NCT01915498|58869662|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
30843775|NCT01915498|58869663|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
30843776|NCT01915498|58869664|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
30843777|NCT01915498|58869665|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
30843778|NCT01915498|58869647|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
30843779|NCT01915498|58869648|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
30843780|NCT01915498|58869649|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
30843781|NCT01915498|58869650|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
30843782|NCT01915498|58869651|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
30843783|NCT01915498|58869652|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
30843784|NCT01915498|58869653|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
30843785|NCT01915498|58869654|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
30843786|NCT01915498|58869655|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
30843787|NCT01915498|58869656|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
30843788|NCT01915498|58869657|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
30843789|NCT01915498|58869658|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
30843790|NCT01915498|58869659|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
30843791|NCT01915498|58869660|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
30843792|NCT01915498|58869661|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
30843793|NCT01915498|58869662|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
30843794|NCT01915498|58869663|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
30843795|NCT01915498|58869664|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
30843796|NCT01915498|58869665|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
30877152|NCT01891344|58908780|FG004|Overall Study|Ongoing|4|||
30760702|NCT02296125|58769303|FG001|Overall Study|Withdrawal by Subject|8|||
30760703|NCT02296125|58769304|FG002|Overall Study|Withdrawal by Subject|6|||
30760704|NCT02296125|58769305|FG003|Overall Study|Withdrawal by Subject|2|||
30760705|NCT02296125|58769302|FG000|Overall Study|Adverse Event|41|||
30760706|NCT02296125|58769303|FG001|Overall Study|Adverse Event|52|||
30760707|NCT02296125|58769304|FG002|Overall Study|Adverse Event|9|||
30760708|NCT02296125|58769305|FG003|Overall Study|Adverse Event|4|||
30760709|NCT02296125|58769302|FG000|Overall Study|Severe non-compliance to protocol|0|||
30760710|NCT02296125|58769303|FG001|Overall Study|Severe non-compliance to protocol|1|||
30760711|NCT02296125|58769304|FG002|Overall Study|Severe non-compliance to protocol|0|||
30760712|NCT02296125|58769305|FG003|Overall Study|Severe non-compliance to protocol|0|||
30760713|NCT02296125|58769302|FG000|Overall Study|Condition under investigation worsened|153|||
30760714|NCT02296125|58769303|FG001|Overall Study|Condition under investigation worsened|199|||
30760715|NCT02296125|58769304|FG002|Overall Study|Condition under investigation worsened|39|||
30760716|NCT02296125|58769305|FG003|Overall Study|Condition under investigation worsened|56|||
30843797|NCT01915498|58869647|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843798|NCT01915498|58869648|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843799|NCT01915498|58869649|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843800|NCT01915498|58869650|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843801|NCT01915498|58869651|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843802|NCT01915498|58869652|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843803|NCT01915498|58869653|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843804|NCT01915498|58869654|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843805|NCT01915498|58869655|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843806|NCT01915498|58869656|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843807|NCT01915498|58869657|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
30843808|NCT01915498|58869658|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843809|NCT01915498|58869659|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843810|NCT01915498|58869660|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
30843811|NCT01915498|58869661|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843812|NCT01915498|58869662|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843813|NCT01915498|58869663|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
30843814|NCT01915498|58869664|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
30843815|NCT01915498|58869665|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
30843816|NCT01915498|58869647|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
30843817|NCT01915498|58869648|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843818|NCT01915498|58869649|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843819|NCT01915498|58869650|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843820|NCT01915498|58869651|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843821|NCT01915498|58869652|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
30843822|NCT01915498|58869653|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843823|NCT01915498|58869654|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843824|NCT01915498|58869655|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843825|NCT01915498|58869656|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843826|NCT01915498|58869657|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843827|NCT01915498|58869658|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843828|NCT01915498|58869659|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843829|NCT01915498|58869660|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843830|NCT01915498|58869661|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
30843831|NCT01915498|58869662|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843832|NCT01915498|58869663|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843833|NCT01915498|58869664|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
30843834|NCT01915498|58869665|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
30843835|NCT01915498|58869647|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30843836|NCT01915498|58869648|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30843837|NCT01915498|58869649|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30843838|NCT01915498|58869650|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30760717|NCT02296125|58769302|FG000|Overall Study|Any reason not specifically recorded|6|||
30760718|NCT02296125|58769303|FG001|Overall Study|Any reason not specifically recorded|4|||
30760719|NCT02296125|58769304|FG002|Overall Study|Any reason not specifically recorded|2|||
30843839|NCT01915498|58869651|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30843840|NCT01915498|58869652|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
30843841|NCT01915498|58869653|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30760720|NCT02296125|58769305|FG003|Overall Study|Any reason not specifically recorded|0|||
30760721|NCT01935089|58769320|FG000|Overall Study|Adverse Event|2|||
30760722|NCT01935089|58769320|FG000|Overall Study|Withdrawal by Subject|1|||
30843842|NCT01915498|58869654|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30843843|NCT01915498|58869655|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30843844|NCT01915498|58869656|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
30843845|NCT01915498|58869657|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30843846|NCT01915498|58869658|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30760723|NCT00770809|58769359|FG000|Overall Study|Adverse Event|9|||
30760724|NCT00770809|58769360|FG001|Overall Study|Adverse Event|1|||
30760725|NCT00770809|58769361|FG002|Overall Study|Adverse Event|12|||
30760726|NCT00770809|58769359|FG000|Overall Study|Death|1|||
30843847|NCT01915498|58869659|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30843848|NCT01915498|58869660|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
30843849|NCT01915498|58869661|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
30843850|NCT01915498|58869662|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
30843851|NCT01915498|58869663|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
30843852|NCT01915498|58869664|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
30843853|NCT01915498|58869665|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
30843854|NCT01915498|58869647|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843855|NCT01915498|58869648|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843856|NCT01915498|58869649|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843857|NCT01915498|58869650|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843858|NCT01915498|58869651|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843859|NCT01915498|58869652|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843860|NCT01915498|58869653|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843861|NCT01915498|58869654|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843862|NCT01915498|58869655|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843863|NCT01915498|58869656|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843864|NCT01915498|58869657|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843865|NCT01915498|58869658|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843866|NCT01915498|58869659|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843867|NCT01915498|58869660|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30760727|NCT00770809|58769360|FG001|Overall Study|Death|0|||
30760728|NCT00770809|58769361|FG002|Overall Study|Death|0|||
30760729|NCT00770809|58769359|FG000|Overall Study|Withdrawal by Subject|3|||
30843868|NCT01915498|58869661|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843869|NCT01915498|58869662|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843870|NCT01915498|58869663|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843871|NCT01915498|58869664|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
30843872|NCT01915498|58869665|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
30843873|NCT01798004|58869757|FG000|Overall Study|Death|2|||
30843874|NCT01798004|58869757|FG000|Overall Study|Lack of Efficacy|8|||
30843875|NCT01798004|58869757|FG000|Overall Study|Physician Decision|25|||
30843876|NCT01798004|58869757|FG000|Overall Study|Withdrawal by Subject|4|||
30843877|NCT01798004|58869757|FG000|Overall Study|Ineligible|4|||
30843878|NCT01798004|58869757|FG000|Overall Study|Patient/parent refusal|7|||
30843879|NCT01798004|58869757|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
30843880|NCT01798004|58869757|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
30843881|NCT01630434|58869763|FG000|Overall Study|Donor lungs turned down|1|||
30843882|NCT01630434|58869764|FG001|Overall Study|Donor lungs turned down|0|||
30843883|NCT01630434|58869763|FG000|Overall Study|Protocol Violation|9|||
30843884|NCT01630434|58869764|FG001|Overall Study|Protocol Violation|4|||
30843885|NCT01630434|58869763|FG000|Overall Study|Death|20|||
30843886|NCT01630434|58869764|FG001|Overall Study|Death|26|||
30843887|NCT01256398|58869774|FG000|Overall Study|Withdrawal by Subject|1|||
30843888|NCT01175356|58869780|FG000|Overall Study|Death|1|||
30843889|NCT01175356|58869780|FG000|Overall Study|Lack of Efficacy|12|||
30843890|NCT01175356|58869780|FG000|Overall Study|Lost to Follow-up|1|||
30843891|NCT01175356|58869780|FG000|Overall Study|Physician Decision|23|||
30843892|NCT01175356|58869780|FG000|Overall Study|Ineligible|1|||
30843893|NCT01175356|58869780|FG000|Overall Study|Treatment Slot Not Available|18|||
30843894|NCT01175356|58869780|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
30843895|NCT01175356|58869780|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
30843896|NCT01175356|58869780|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
30843897|NCT01175356|58869780|FG000|Overall Study|Inadequate stem cell for transplant|1|||
30843898|NCT01175356|58869780|FG000|Overall Study|Initiation other tx prior to completion|9|||
30843899|NCT01151423|58869786|FG000|Overall Study|Study terminated by Sponsor|9|||
30843900|NCT01151423|58869787|FG001|Overall Study|Study terminated by Sponsor|10|||
30843901|NCT01151423|58869786|FG000|Overall Study|Protocol Violation|0|||
30843902|NCT01151423|58869787|FG001|Overall Study|Protocol Violation|1|||
30843903|NCT01151423|58869786|FG000|Overall Study|Physician Decision|1|||
30948572|NCT01961687|58994589|FG000|Overall Study|Lost to Follow-up|19|||
30760730|NCT00770809|58769360|FG001|Overall Study|Withdrawal by Subject|3|||
30760731|NCT00770809|58769361|FG002|Overall Study|Withdrawal by Subject|7|||
30760732|NCT00770809|58769359|FG000|Overall Study|Progression|2|||
30760733|NCT00770809|58769360|FG001|Overall Study|Progression|2|||
30760734|NCT00770809|58769361|FG002|Overall Study|Progression|0|||
30760735|NCT00770809|58769359|FG000|Overall Study|Complicating illness|0|||
30760736|NCT00770809|58769360|FG001|Overall Study|Complicating illness|0|||
30760737|NCT00770809|58769361|FG002|Overall Study|Complicating illness|1|||
30843904|NCT01151423|58869787|FG001|Overall Study|Physician Decision|1|||
30843905|NCT01151423|58869786|FG000|Overall Study|Pregnancy|0|||
30843906|NCT01151423|58869787|FG001|Overall Study|Pregnancy|1|||
30843907|NCT01151423|58869786|FG000|Overall Study|Death|0|||
30843908|NCT01151423|58869787|FG001|Overall Study|Death|1|||
30843909|NCT01151423|58869786|FG000|Overall Study|Adverse Event|3|||
30625656|NCT00595621|58637898|FG001|Randomization and Study|Withdrawal by Subject|1|||
30625657|NCT00888238|58637905|FG000|Washout Period After Period 2|Adverse Event|0|||
30843910|NCT01151423|58869787|FG001|Overall Study|Adverse Event|0|||
30843911|NCT01151423|58869786|FG000|Overall Study|Withdrawal by Subject|1|||
30843912|NCT01151423|58869787|FG001|Overall Study|Withdrawal by Subject|3|||
30843913|NCT01151423|58869786|FG000|Overall Study|Lost to Follow-up|1|||
30843914|NCT01151423|58869787|FG001|Overall Study|Lost to Follow-up|0|||
30843915|NCT01151423|58869786|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
30843916|NCT01151423|58869787|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
30843917|NCT01151423|58869786|FG000|Overall Study|Participated in other clinical trial|1|||
30843918|NCT01151423|58869787|FG001|Overall Study|Participated in other clinical trial|0|||
30843919|NCT00565617|58869819|FG000|Overall Study|Withdrawal by Subject|1|||
30843920|NCT00453154|58869826|FG000|Double BIind Maintenance|Adverse Event|0|||
30843921|NCT00453154|58869827|FG001|Double BIind Maintenance|Adverse Event|0|||
30843922|NCT00453154|58869828|FG002|Double BIind Maintenance|Adverse Event|3|||
30843923|NCT00453154|58869829|FG003|Double BIind Maintenance|Adverse Event|12|||
30843924|NCT00453154|58869826|FG000|Double BIind Maintenance|Death|0|||
30760738|NCT00770809|58769359|FG000|Overall Study|Other Medical Reasons|2|||
30760739|NCT00770809|58769360|FG001|Overall Study|Other Medical Reasons|4|||
30760740|NCT00770809|58769361|FG002|Overall Study|Other Medical Reasons|3|||
30760741|NCT00571727|58769369|FG000|Overall Study|Did not enter in this study|1|||
30760742|NCT00571727|58769369|FG000|Overall Study|Non-compliance|4|||
30760743|NCT00571727|58769369|FG000|Overall Study|Lost to Follow-up|30|||
30760744|NCT00571727|58769369|FG000|Overall Study|Poor growth|1|||
30760745|NCT00571727|58769369|FG000|Overall Study|Parent/patient decision|2|||
30760746|NCT00571727|58769369|FG000|Overall Study|Participant transferred to commercial drug|14|||
30760747|NCT00571727|58769369|FG000|Overall Study|Unable to provide study drug|6|||
30760748|NCT00571727|58769369|FG000|Overall Study|On-treatment at end of study|8|||
30843925|NCT00453154|58869827|FG001|Double BIind Maintenance|Death|0|||
30843926|NCT00453154|58869828|FG002|Double BIind Maintenance|Death|2|||
30843927|NCT00453154|58869829|FG003|Double BIind Maintenance|Death|1|||
30843928|NCT00453154|58869826|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
30843929|NCT00453154|58869827|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
30948573|NCT01961687|58994589|FG000|Overall Study|Re-operation|17|||
30948574|NCT01961687|58994589|FG000|Overall Study|Death|7|||
30948575|NCT01961687|58994589|FG000|Overall Study|Withdrawal by Subject|6|||
30948576|NCT01961687|58994589|FG000|Overall Study|Adverse Event|6|||
30948577|NCT01961687|58994589|FG000|Overall Study|Moved to area without study site|2|||
30843930|NCT00453154|58869828|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
30948578|NCT01961687|58994589|FG000|Overall Study|Sponsor decision|2|||
30625658|NCT00888238|58637906|FG001|Washout Period After Period 2|Adverse Event|0|||
30625659|NCT00888238|58637907|FG002|Washout Period After Period 2|Adverse Event|1|||
30625660|NCT00595465|58637916|FG000|Overall Study|Adverse Event|4|||
30625661|NCT00595465|58637917|FG001|Overall Study|Adverse Event|3|||
30625662|NCT00595465|58637918|FG002|Overall Study|Adverse Event|3|||
30625663|NCT00595465|58637916|FG000|Overall Study|Pregnancy|0|||
30625664|NCT00595465|58637917|FG001|Overall Study|Pregnancy|0|||
30625665|NCT00595465|58637918|FG002|Overall Study|Pregnancy|1|||
30625666|NCT00595465|58637916|FG000|Overall Study|Protocol Violation|2|||
30760749|NCT00489307|58769375|FG000|Overall Study|Death|1|||
30760750|NCT00489307|58769376|FG001|Overall Study|Death|1|||
30760751|NCT00489307|58769375|FG000|Overall Study|Lost to Follow-up|2|||
30760752|NCT00489307|58769376|FG001|Overall Study|Lost to Follow-up|2|||
30760753|NCT00489307|58769375|FG000|Overall Study|Physician Decision|1|||
30760754|NCT00489307|58769376|FG001|Overall Study|Physician Decision|0|||
30760755|NCT00489307|58769375|FG000|Overall Study|Withdrawal by Subject|2|||
30760756|NCT00489307|58769376|FG001|Overall Study|Withdrawal by Subject|4|||
30625667|NCT00595465|58637917|FG001|Overall Study|Protocol Violation|1|||
30760757|NCT00489307|58769375|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
30948579|NCT01961687|58994589|FG000|Overall Study|Physician Decision|1|||
30843931|NCT00453154|58869829|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
30843932|NCT00453154|58869826|FG000|Double BIind Maintenance|Progression|0|||
30843933|NCT00453154|58869827|FG001|Double BIind Maintenance|Progression|0|||
30843934|NCT00453154|58869828|FG002|Double BIind Maintenance|Progression|29|||
30843935|NCT00453154|58869829|FG003|Double BIind Maintenance|Progression|26|||
30843936|NCT00453154|58869826|FG000|Double BIind Maintenance|Medical Issues|0|||
30843937|NCT00453154|58869827|FG001|Double BIind Maintenance|Medical Issues|0|||
30843938|NCT00453154|58869828|FG002|Double BIind Maintenance|Medical Issues|3|||
30843939|NCT00453154|58869829|FG003|Double BIind Maintenance|Medical Issues|1|||
30843940|NCT00453154|58869826|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
30843941|NCT00453154|58869827|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
30843942|NCT00453154|58869828|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
30843943|NCT00453154|58869829|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
30843944|NCT00334815|58869840|FG000|Overall Study|Adverse Event|3|||
30843945|NCT00334815|58869841|FG001|Overall Study|Adverse Event|2|||
30843946|NCT00334815|58869840|FG000|Overall Study|Death|0|||
30843947|NCT00334815|58869841|FG001|Overall Study|Death|2|||
30843948|NCT00334815|58869840|FG000|Overall Study|Progression|1|||
30843949|NCT00334815|58869841|FG001|Overall Study|Progression|0|||
30843950|NCT00334815|58869840|FG000|Overall Study|ineligible|1|||
30843951|NCT00334815|58869841|FG001|Overall Study|ineligible|1|||
30843952|NCT00334815|58869840|FG000|Overall Study|patient refused treatment|0|||
30843953|NCT00334815|58869841|FG001|Overall Study|patient refused treatment|1|||
30843954|NCT00334815|58869840|FG000|Overall Study|Physician Decision|2|||
30625668|NCT00595465|58637918|FG002|Overall Study|Protocol Violation|0|||
30625669|NCT00595465|58637916|FG000|Overall Study|Lost to Follow-up|0|||
30625670|NCT00595465|58637917|FG001|Overall Study|Lost to Follow-up|0|||
30625671|NCT00595465|58637918|FG002|Overall Study|Lost to Follow-up|2|||
30625672|NCT00595465|58637916|FG000|Overall Study|administrative reason|0|||
30625673|NCT00595465|58637917|FG001|Overall Study|administrative reason|0|||
30625674|NCT00595465|58637918|FG002|Overall Study|administrative reason|1|||
30625675|NCT01205438|58637929|FG000|Overall Study|Adverse Event|19|||
30625676|NCT01205438|58637930|FG001|Overall Study|Adverse Event|17|||
30625677|NCT01205438|58637931|FG002|Overall Study|Adverse Event|24|||
30625678|NCT01205438|58637929|FG000|Overall Study|Death|1|||
30625679|NCT01205438|58637930|FG001|Overall Study|Death|1|||
30625680|NCT01205438|58637931|FG002|Overall Study|Death|3|||
30625681|NCT01205438|58637929|FG000|Overall Study|Entry Criteria Not Met|16|||
30625682|NCT01205438|58637930|FG001|Overall Study|Entry Criteria Not Met|15|||
30625683|NCT01205438|58637931|FG002|Overall Study|Entry Criteria Not Met|13|||
30625684|NCT01205438|58637929|FG000|Overall Study|Lack of Efficacy|14|||
30625685|NCT01205438|58637930|FG001|Overall Study|Lack of Efficacy|11|||
30625686|NCT01205438|58637931|FG002|Overall Study|Lack of Efficacy|14|||
30625687|NCT01205438|58637929|FG000|Overall Study|Lost to Follow-up|6|||
30625688|NCT01205438|58637930|FG001|Overall Study|Lost to Follow-up|7|||
30625689|NCT01205438|58637931|FG002|Overall Study|Lost to Follow-up|8|||
30625690|NCT01205438|58637929|FG000|Overall Study|Withdrawal by Subject|19|||
30625691|NCT01205438|58637930|FG001|Overall Study|Withdrawal by Subject|25|||
30625692|NCT01205438|58637931|FG002|Overall Study|Withdrawal by Subject|19|||
30625693|NCT01205438|58637929|FG000|Overall Study|Physician Decision|0|||
30625694|NCT01205438|58637930|FG001|Overall Study|Physician Decision|3|||
30625695|NCT01205438|58637931|FG002|Overall Study|Physician Decision|2|||
30625696|NCT01205438|58637929|FG000|Overall Study|Protocol Violation|2|||
30625697|NCT01205438|58637930|FG001|Overall Study|Protocol Violation|7|||
30625698|NCT01205438|58637931|FG002|Overall Study|Protocol Violation|4|||
30625699|NCT01205438|58637929|FG000|Overall Study|Sponsor Decision|0|||
30625700|NCT01205438|58637930|FG001|Overall Study|Sponsor Decision|1|||
30625701|NCT01205438|58637931|FG002|Overall Study|Sponsor Decision|1|||
30625702|NCT01104870|58637945|FG000|Overall Study|Adverse Event|1|||
30625703|NCT01104870|58637946|FG001|Overall Study|Adverse Event|1|||
30625704|NCT01104870|58637947|FG002|Overall Study|Adverse Event|0|||
30625705|NCT01104870|58637945|FG000|Overall Study|Death|0|||
30625706|NCT01104870|58637946|FG001|Overall Study|Death|0|||
30843955|NCT00334815|58869841|FG001|Overall Study|Physician Decision|4|||
30843956|NCT00258960|58869849|FG000|Overall Study|Death|2|||
30625707|NCT01104870|58637947|FG002|Overall Study|Death|1|||
30625708|NCT01104870|58637945|FG000|Overall Study|Withdrawal by Subject|0|||
30625709|NCT01104870|58637946|FG001|Overall Study|Withdrawal by Subject|0|||
30625710|NCT01104870|58637947|FG002|Overall Study|Withdrawal by Subject|1|||
30625711|NCT01104792|58637955|FG000|Overall Study|Adverse Event|77|||
30843957|NCT00258960|58869849|FG000|Overall Study|Disease Progression|7|||
30625712|NCT01104792|58637955|FG000|Overall Study|Insufficient Therapeutic Response|22|||
30625713|NCT01104792|58637955|FG000|Overall Study|Protocol Violation|45|||
30625714|NCT01104792|58637955|FG000|Overall Study|Withdrawal of Consent|179|||
30625715|NCT01104792|58637955|FG000|Overall Study|Lost to Follow-up|43|||
30843958|NCT00258960|58869849|FG000|Overall Study|Adverse Event|4|||
30843959|NCT00258960|58869849|FG000|Overall Study|Physician Decision|1|||
30843960|NCT00258960|58869849|FG000|Overall Study|Withdrawal by Subject|1|||
30843961|NCT00258960|58869849|FG000|Overall Study|Mistake|2|||
30760758|NCT00489307|58769376|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
30760759|NCT00489307|58769375|FG000|Overall Study|Surgery after assignment|1|||
30760760|NCT00489307|58769376|FG001|Overall Study|Surgery after assignment|0|||
30760761|NCT00489307|58769375|FG000|Overall Study|Did not fill up the forms|2|||
30760762|NCT00489307|58769376|FG001|Overall Study|Did not fill up the forms|1|||
30760763|NCT00489307|58769375|FG000|Overall Study|Patient or family refusal|5|||
30948580|NCT01961687|58994589|FG000|Overall Study|Unable to meet follow-up requirements|1|||
30948581|NCT01961609|58994651|FG000|Initiation|Missing|3|||
30843962|NCT00121992|58869855|FG000|Overall Study|Treatment not received|2|||
30843963|NCT00121992|58869856|FG001|Overall Study|Treatment not received|11|||
30843964|NCT00070564|58869868|FG000|Overall Study|Progression|2|||
30843965|NCT00070564|58869869|FG001|Overall Study|Progression|4|||
30843966|NCT00070564|58869870|FG002|Overall Study|Progression|7|||
30843967|NCT00070564|58869871|FG003|Overall Study|Progression|7|||
30843968|NCT00070564|58869872|FG004|Overall Study|Progression|1|||
30843969|NCT00070564|58869873|FG005|Overall Study|Progression|0|||
30760764|NCT00489307|58769376|FG001|Overall Study|Patient or family refusal|9|||
30760765|NCT00427349|58769382|FG000|Overall Study|Lack of Efficacy|23|||
30760766|NCT00427349|58769382|FG000|Overall Study|Adverse Event|14|||
30760767|NCT00427349|58769382|FG000|Overall Study|Death|1|||
30760768|NCT00427349|58769382|FG000|Overall Study|Withdrawal by Subject|3|||
30760769|NCT00427349|58769382|FG000|Overall Study|Alternative therapy|1|||
30760770|NCT00427349|58769382|FG000|Overall Study|Other|2|||
30760771|NCT00427349|58769382|FG000|Overall Study|Ineligible|1|||
30760772|NCT00427349|58769382|FG000|Overall Study|Never started therapy|1|||
30760773|NCT00309985|58769388|FG000|Overall Study|Disease progression|12|||
30760774|NCT00309985|58769389|FG001|Overall Study|Disease progression|0|||
30760775|NCT00309985|58769388|FG000|Overall Study|Adverse Event|30|||
30760776|NCT00309985|58769389|FG001|Overall Study|Adverse Event|0|||
30760777|NCT00309985|58769388|FG000|Overall Study|Death|2|||
30843970|NCT00070564|58869868|FG000|Overall Study|Delinquent|1|||
30843971|NCT00070564|58869869|FG001|Overall Study|Delinquent|4|||
30843972|NCT00070564|58869870|FG002|Overall Study|Delinquent|2|||
30843973|NCT00070564|58869871|FG003|Overall Study|Delinquent|0|||
30843974|NCT00070564|58869872|FG004|Overall Study|Delinquent|0|||
30843975|NCT00070564|58869873|FG005|Overall Study|Delinquent|0|||
30843976|NCT00070564|58869868|FG000|Overall Study|Adverse Event|150|||
30843977|NCT00070564|58869869|FG001|Overall Study|Adverse Event|142|||
30843978|NCT00070564|58869870|FG002|Overall Study|Adverse Event|120|||
30843979|NCT00070564|58869871|FG003|Overall Study|Adverse Event|108|||
30843980|NCT00070564|58869872|FG004|Overall Study|Adverse Event|63|||
30843981|NCT00070564|58869873|FG005|Overall Study|Adverse Event|36|||
30843982|NCT00070564|58869868|FG000|Overall Study|Death|4|||
30843983|NCT00070564|58869869|FG001|Overall Study|Death|1|||
30843984|NCT00070564|58869870|FG002|Overall Study|Death|5|||
30843985|NCT00070564|58869871|FG003|Overall Study|Death|3|||
30843986|NCT00070564|58869872|FG004|Overall Study|Death|0|||
30843987|NCT00070564|58869873|FG005|Overall Study|Death|1|||
30843988|NCT00070564|58869868|FG000|Overall Study|Other, not protocol specified|17|||
30843989|NCT00070564|58869869|FG001|Overall Study|Other, not protocol specified|15|||
30843990|NCT00070564|58869870|FG002|Overall Study|Other, not protocol specified|14|||
30843991|NCT00070564|58869871|FG003|Overall Study|Other, not protocol specified|19|||
30843992|NCT00070564|58869872|FG004|Overall Study|Other, not protocol specified|6|||
30843993|NCT00070564|58869873|FG005|Overall Study|Other, not protocol specified|7|||
30843994|NCT00070564|58869868|FG000|Overall Study|Withdrawal by Subject|26|||
30843995|NCT00070564|58869869|FG001|Overall Study|Withdrawal by Subject|37|||
30843996|NCT00070564|58869870|FG002|Overall Study|Withdrawal by Subject|23|||
30843997|NCT00070564|58869871|FG003|Overall Study|Withdrawal by Subject|30|||
30843998|NCT00070564|58869872|FG004|Overall Study|Withdrawal by Subject|8|||
30843999|NCT00070564|58869873|FG005|Overall Study|Withdrawal by Subject|8|||
30844000|NCT00070564|58869868|FG000|Overall Study|Not reported|0|||
30844001|NCT00070564|58869869|FG001|Overall Study|Not reported|0|||
30760778|NCT00309985|58769389|FG001|Overall Study|Death|0|||
30844002|NCT00070564|58869870|FG002|Overall Study|Not reported|0|||
30760779|NCT00309985|58769388|FG000|Overall Study|Withdrawal by Subject|5|||
30844003|NCT00070564|58869871|FG003|Overall Study|Not reported|0|||
30844004|NCT00070564|58869872|FG004|Overall Study|Not reported|1|||
30844005|NCT00070564|58869873|FG005|Overall Study|Not reported|0|||
30844006|NCT02738151|58869899|FG000|Overall Study|Randomized but not treated|4|||
30948582|NCT01961609|58994652|FG001|Initiation|Missing|2|||
30760780|NCT00309985|58769389|FG001|Overall Study|Withdrawal by Subject|1|||
30844007|NCT02738151|58869900|FG001|Overall Study|Randomized but not treated|1|||
30844008|NCT02738151|58869899|FG000|Overall Study|Adverse Event|4|||
30844009|NCT02738151|58869900|FG001|Overall Study|Adverse Event|5|||
30844010|NCT02738151|58869899|FG000|Overall Study|Hypoglycemia|0|||
30844011|NCT02738151|58869900|FG001|Overall Study|Hypoglycemia|1|||
30760781|NCT00309985|58769388|FG000|Overall Study|Physician Decision|3|||
30844012|NCT02738151|58869899|FG000|Overall Study|Poor Compliance to Protocol|4|||
30844013|NCT02738151|58869900|FG001|Overall Study|Poor Compliance to Protocol|3|||
30844014|NCT02738151|58869899|FG000|Overall Study|Other than specified above|11|||
30844015|NCT02738151|58869900|FG001|Overall Study|Other than specified above|21|||
30844016|NCT02993731|58869908|FG000|Overall Study|Study Termination|101|||
30844017|NCT02993731|58869909|FG001|Overall Study|Study Termination|105|||
30844018|NCT02915159|58869927|FG000|Overall Study|Participant no longer meets criteria|2|||
30844019|NCT02915159|58869928|FG001|Overall Study|Participant no longer meets criteria|0|||
30844020|NCT02915159|58869927|FG000|Overall Study|poor/non-compliance|1|||
30844021|NCT02915159|58869928|FG001|Overall Study|poor/non-compliance|0|||
30844022|NCT02915159|58869927|FG000|Overall Study|Participant withdrew consent|5|||
30844023|NCT02915159|58869928|FG001|Overall Study|Participant withdrew consent|1|||
30844024|NCT02915159|58869927|FG000|Overall Study|Request to discontinue treatment|1|||
30844025|NCT02915159|58869928|FG001|Overall Study|Request to discontinue treatment|2|||
30844026|NCT02915159|58869927|FG000|Overall Study|Adverse Event|2|||
30844027|NCT02915159|58869928|FG001|Overall Study|Adverse Event|2|||
30844028|NCT02915159|58869927|FG000|Overall Study|Lack of Efficacy|0|||
30844029|NCT02915159|58869928|FG001|Overall Study|Lack of Efficacy|3|||
30844030|NCT02924051|58869940|FG000|Overall Study|Withdrawal by Subject|1|||
30844031|NCT02924051|58869941|FG001|Overall Study|Withdrawal by Subject|9|||
30844032|NCT02923427|58869955|FG000|Overall Study|convert to laparatomy|2|||
30844033|NCT02923427|58869956|FG001|Overall Study|convert to laparatomy|2|||
30844034|NCT02923427|58869955|FG000|Overall Study|destaturation|1|||
30844035|NCT02923427|58869956|FG001|Overall Study|destaturation|0|||
30844036|NCT02923427|58869955|FG000|Overall Study|can not replace LMA|1|||
30844037|NCT02923427|58869956|FG001|Overall Study|can not replace LMA|0|||
30844038|NCT02669264|58869969|FG000|Overall Study|Death|5|||
30844039|NCT02669264|58869970|FG001|Overall Study|Death|5|||
30844040|NCT02669264|58869971|FG002|Overall Study|Death|3|||
30844041|NCT02669264|58869972|FG003|Overall Study|Death|3|||
30844042|NCT02669264|58869973|FG004|Overall Study|Death|3|||
30844043|NCT02669264|58869974|FG005|Overall Study|Death|6|||
30844044|NCT02669264|58869975|FG006|Overall Study|Death|3|||
30844045|NCT02669264|58869969|FG000|Overall Study|Withdrawal by Subject|0|||
30844046|NCT02669264|58869970|FG001|Overall Study|Withdrawal by Subject|1|||
30844047|NCT02669264|58869971|FG002|Overall Study|Withdrawal by Subject|0|||
30844048|NCT02669264|58869972|FG003|Overall Study|Withdrawal by Subject|0|||
30844049|NCT02669264|58869973|FG004|Overall Study|Withdrawal by Subject|1|||
30844050|NCT02669264|58869974|FG005|Overall Study|Withdrawal by Subject|0|||
30844051|NCT02669264|58869975|FG006|Overall Study|Withdrawal by Subject|0|||
30844052|NCT02669264|58869969|FG000|Overall Study|Lost to Follow-up|0|||
30844053|NCT02669264|58869970|FG001|Overall Study|Lost to Follow-up|0|||
30844054|NCT02669264|58869971|FG002|Overall Study|Lost to Follow-up|0|||
30844055|NCT02669264|58869972|FG003|Overall Study|Lost to Follow-up|0|||
30844056|NCT02669264|58869973|FG004|Overall Study|Lost to Follow-up|1|||
30844057|NCT02669264|58869974|FG005|Overall Study|Lost to Follow-up|0|||
30844058|NCT02669264|58869975|FG006|Overall Study|Lost to Follow-up|0|||
30844059|NCT02669264|58869969|FG000|Overall Study|Miscellaneous|0|||
30844060|NCT02669264|58869970|FG001|Overall Study|Miscellaneous|0|||
30844061|NCT02669264|58869971|FG002|Overall Study|Miscellaneous|0|||
30844062|NCT02669264|58869972|FG003|Overall Study|Miscellaneous|0|||
30844063|NCT02669264|58869973|FG004|Overall Study|Miscellaneous|0|||
30844064|NCT02669264|58869974|FG005|Overall Study|Miscellaneous|0|||
30844065|NCT02669264|58869975|FG006|Overall Study|Miscellaneous|2|||
30844066|NCT02521870|58870001|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
30844067|NCT02521870|58870002|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
30844068|NCT02521870|58870003|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
30844069|NCT02521870|58870004|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
30844070|NCT02521870|58870005|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
30844071|NCT02521870|58870006|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
30844072|NCT02521870|58870007|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
30844073|NCT02521870|58870008|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
30844074|NCT02521870|58870009|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
30625716|NCT01104792|58637955|FG000|Overall Study|Reasons Not Specified|27|||
30844075|NCT02521870|58870010|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
30844076|NCT02521870|58870011|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
30844077|NCT02521870|58870012|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
30844078|NCT02521870|58870001|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
30844079|NCT02521870|58870002|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
30844080|NCT02521870|58870003|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
30844081|NCT02521870|58870004|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
30844082|NCT02521870|58870005|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
30844083|NCT02521870|58870006|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
30844084|NCT02521870|58870007|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
30844085|NCT02521870|58870008|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
30844086|NCT02521870|58870009|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
30844087|NCT02521870|58870010|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
30844088|NCT02521870|58870011|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
30844089|NCT02521870|58870012|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
30844090|NCT02521870|58870001|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
30844091|NCT02521870|58870002|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
30844092|NCT02521870|58870003|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
30844093|NCT02521870|58870004|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
30844094|NCT02521870|58870005|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
30844095|NCT02521870|58870006|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
30844096|NCT02521870|58870007|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
30844097|NCT02521870|58870008|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
30844098|NCT02521870|58870009|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
30844099|NCT02521870|58870010|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
30844100|NCT02521870|58870011|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
30844101|NCT02521870|58870012|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
30844102|NCT02521870|58870001|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
30844103|NCT02521870|58870002|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
30844104|NCT02521870|58870003|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
30844105|NCT02521870|58870004|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
30844106|NCT02521870|58870005|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
30844107|NCT02521870|58870006|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
30844108|NCT02521870|58870007|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
30844109|NCT02521870|58870008|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
30844110|NCT02521870|58870009|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
30844111|NCT02521870|58870010|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
30844112|NCT02521870|58870011|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
30844113|NCT02521870|58870012|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
30844114|NCT02521870|58870001|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
30844115|NCT02521870|58870002|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
30844116|NCT02521870|58870003|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
30844117|NCT02521870|58870004|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
30844118|NCT02521870|58870005|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
30844119|NCT02521870|58870006|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
30844120|NCT02521870|58870007|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
30844121|NCT02521870|58870008|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
30844122|NCT02521870|58870009|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
30844123|NCT02521870|58870010|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
30844124|NCT02521870|58870011|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
30844125|NCT02521870|58870012|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
30844126|NCT02521870|58870001|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
30844127|NCT02521870|58870002|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
30844128|NCT02521870|58870003|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
30844129|NCT02521870|58870004|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
30844130|NCT02521870|58870005|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
30844131|NCT02521870|58870006|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
30844132|NCT02521870|58870007|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
30844133|NCT02521870|58870008|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
30844134|NCT02521870|58870009|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
30844135|NCT02521870|58870010|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
30844136|NCT02521870|58870011|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
30844137|NCT02521870|58870012|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
30844138|NCT02521870|58870001|FG000|Phase 2: Dose Expansion|Death|0|||
30844139|NCT02521870|58870002|FG001|Phase 2: Dose Expansion|Death|0|||
30844140|NCT02521870|58870003|FG002|Phase 2: Dose Expansion|Death|0|||
30844141|NCT02521870|58870004|FG003|Phase 2: Dose Expansion|Death|0|||
30844142|NCT02521870|58870005|FG004|Phase 2: Dose Expansion|Death|1|||
30844143|NCT02521870|58870006|FG005|Phase 2: Dose Expansion|Death|1|||
30844144|NCT02521870|58870007|FG006|Phase 2: Dose Expansion|Death|3|||
30844145|NCT02521870|58870008|FG007|Phase 2: Dose Expansion|Death|1|||
30844146|NCT02521870|58870009|FG008|Phase 2: Dose Expansion|Death|1|||
30844147|NCT02521870|58870010|FG009|Phase 2: Dose Expansion|Death|5|||
30844148|NCT02521870|58870011|FG010|Phase 2: Dose Expansion|Death|2|||
30844149|NCT02521870|58870012|FG011|Phase 2: Dose Expansion|Death|2|||
30844150|NCT02521870|58870001|FG000|Phase 2: Dose Expansion|Other|0|||
30844151|NCT02521870|58870002|FG001|Phase 2: Dose Expansion|Other|0|||
30844152|NCT02521870|58870003|FG002|Phase 2: Dose Expansion|Other|0|||
30844153|NCT02521870|58870004|FG003|Phase 2: Dose Expansion|Other|0|||
30844154|NCT02521870|58870005|FG004|Phase 2: Dose Expansion|Other|10|||
30844155|NCT02521870|58870006|FG005|Phase 2: Dose Expansion|Other|3|||
30844156|NCT02521870|58870007|FG006|Phase 2: Dose Expansion|Other|2|||
30844157|NCT02521870|58870008|FG007|Phase 2: Dose Expansion|Other|0|||
30760782|NCT00309985|58769389|FG001|Overall Study|Physician Decision|0|||
30844158|NCT02521870|58870009|FG008|Phase 2: Dose Expansion|Other|10|||
30844159|NCT02521870|58870010|FG009|Phase 2: Dose Expansion|Other|5|||
30844160|NCT02521870|58870011|FG010|Phase 2: Dose Expansion|Other|1|||
30844161|NCT02521870|58870012|FG011|Phase 2: Dose Expansion|Other|7|||
30844162|NCT02521870|58870001|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
30844163|NCT02521870|58870002|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
30844164|NCT02521870|58870003|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
30844165|NCT02521870|58870004|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
30844166|NCT02521870|58870005|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
30844167|NCT02521870|58870006|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
30844168|NCT02521870|58870007|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
30844169|NCT02521870|58870008|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
30844170|NCT02521870|58870009|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
30844171|NCT02521870|58870010|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
30844172|NCT02521870|58870011|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
30844173|NCT02521870|58870012|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
30844174|NCT02521870|58870001|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
30844175|NCT02521870|58870002|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
30844176|NCT02521870|58870003|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
30844177|NCT02521870|58870004|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
30844178|NCT02521870|58870005|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
30844179|NCT02521870|58870006|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
30844180|NCT02521870|58870007|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
30844181|NCT02521870|58870008|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
30844182|NCT02521870|58870009|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
30844183|NCT02521870|58870010|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
30844184|NCT02521870|58870011|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
30844185|NCT02521870|58870012|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
30844186|NCT02923349|58870049|FG000|Overall Study|Other|1|||
30844187|NCT02923349|58870050|FG001|Overall Study|Other|2|||
30844188|NCT02923349|58870051|FG002|Overall Study|Other|4|||
30844189|NCT02923349|58870052|FG003|Overall Study|Other|1|||
30844190|NCT02923349|58870053|FG004|Overall Study|Other|3|||
30844191|NCT02923349|58870054|FG005|Overall Study|Other|0|||
30844192|NCT02923349|58870055|FG006|Overall Study|Other|1|||
30844193|NCT02923349|58870049|FG000|Overall Study|Withdrawal by Subject|2|||
30844194|NCT02923349|58870050|FG001|Overall Study|Withdrawal by Subject|2|||
30760783|NCT00309985|58769388|FG000|Overall Study|Never started treatment|7|||
30760784|NCT00309985|58769389|FG001|Overall Study|Never started treatment|0|||
30760785|NCT00309985|58769388|FG000|Overall Study|Complicating disease|1|||
30760786|NCT00309985|58769389|FG001|Overall Study|Complicating disease|0|||
30760787|NCT00309985|58769388|FG000|Overall Study|Non-compliance|1|||
30760788|NCT00309985|58769389|FG001|Overall Study|Non-compliance|0|||
30760789|NCT00309985|58769388|FG000|Overall Study|Chemotherapy discontinued only|1|||
30760790|NCT00309985|58769389|FG001|Overall Study|Chemotherapy discontinued only|0|||
30760791|NCT00098787|58769411|FG000|Overall Study|Never started treatment|3|||
30760792|NCT00098787|58769412|FG001|Overall Study|Never started treatment|2|||
30760793|NCT00098787|58769413|FG002|Overall Study|Never started treatment|1|||
30760794|NCT00098787|58769411|FG000|Overall Study|Ineligible|9|||
30760795|NCT00098787|58769412|FG001|Overall Study|Ineligible|7|||
30760796|NCT00098787|58769413|FG002|Overall Study|Ineligible|3|||
30760797|NCT00098787|58769411|FG000|Overall Study|Disease progression|28|||
30760798|NCT00098787|58769412|FG001|Overall Study|Disease progression|17|||
30760799|NCT00098787|58769413|FG002|Overall Study|Disease progression|23|||
30760800|NCT00098787|58769411|FG000|Overall Study|Adverse Event|8|||
30844195|NCT02923349|58870051|FG002|Overall Study|Withdrawal by Subject|8|||
30844196|NCT02923349|58870052|FG003|Overall Study|Withdrawal by Subject|10|||
30844197|NCT02923349|58870053|FG004|Overall Study|Withdrawal by Subject|12|||
30844198|NCT02923349|58870054|FG005|Overall Study|Withdrawal by Subject|3|||
30844199|NCT02923349|58870055|FG006|Overall Study|Withdrawal by Subject|0|||
30844200|NCT02923349|58870049|FG000|Overall Study|Physician Decision|0|||
30844201|NCT02923349|58870050|FG001|Overall Study|Physician Decision|0|||
30760801|NCT00098787|58769412|FG001|Overall Study|Adverse Event|17|||
30760802|NCT00098787|58769413|FG002|Overall Study|Adverse Event|8|||
30844202|NCT02923349|58870051|FG002|Overall Study|Physician Decision|0|||
30760803|NCT00098787|58769411|FG000|Overall Study|Death|6|||
30760804|NCT00098787|58769412|FG001|Overall Study|Death|1|||
30760805|NCT00098787|58769413|FG002|Overall Study|Death|0|||
30844203|NCT02923349|58870052|FG003|Overall Study|Physician Decision|1|||
30844204|NCT02923349|58870053|FG004|Overall Study|Physician Decision|1|||
30844205|NCT02923349|58870054|FG005|Overall Study|Physician Decision|0|||
30844206|NCT02923349|58870055|FG006|Overall Study|Physician Decision|2|||
30844207|NCT02923349|58870049|FG000|Overall Study|Lost to Follow-up|0|||
30844208|NCT02923349|58870050|FG001|Overall Study|Lost to Follow-up|0|||
30844209|NCT02923349|58870051|FG002|Overall Study|Lost to Follow-up|3|||
30760806|NCT00098787|58769411|FG000|Overall Study|Withdrawal by Subject|4|||
30760807|NCT00098787|58769412|FG001|Overall Study|Withdrawal by Subject|12|||
30760808|NCT00098787|58769413|FG002|Overall Study|Withdrawal by Subject|6|||
30760809|NCT00098787|58769411|FG000|Overall Study|Alternative therapy|8|||
30760810|NCT00098787|58769412|FG001|Overall Study|Alternative therapy|13|||
30760811|NCT00098787|58769413|FG002|Overall Study|Alternative therapy|13|||
30760812|NCT00098787|58769411|FG000|Overall Study|Other|7|||
30760813|NCT00098787|58769412|FG001|Overall Study|Other|6|||
30948583|NCT01961609|58994653|FG002|Initiation|Missing|0|||
30948584|NCT01961609|58994654|FG003|Initiation|Missing|0|||
30948585|NCT01961609|58994651|FG000|Initiation|Protocol deviation|1|||
30625717|NCT01104792|58637955|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
30625718|NCT01205126|58637961|FG000|Titration Phase|Adverse Event|5|||
30625719|NCT01205126|58637962|FG001|Titration Phase|Adverse Event|3|||
30625720|NCT01205126|58637961|FG000|Titration Phase|Withdrawal by Subject|5|||
30625721|NCT01205126|58637962|FG001|Titration Phase|Withdrawal by Subject|5|||
30625722|NCT01205126|58637961|FG000|Titration Phase|Lost to Follow-up|2|||
30625723|NCT01205126|58637962|FG001|Titration Phase|Lost to Follow-up|2|||
30625724|NCT01205126|58637961|FG000|Titration Phase|No stable titration dose|1|||
30625725|NCT01205126|58637962|FG001|Titration Phase|No stable titration dose|0|||
30625726|NCT01205126|58637961|FG000|Titration Phase|More than maximum dosage required|2|||
30760814|NCT00098787|58769413|FG002|Overall Study|Other|9|||
30760815|NCT00091169|58769423|FG000|Overall Study|Disease progression|3|||
30760816|NCT00091169|58769424|FG001|Overall Study|Disease progression|1|||
30760817|NCT00091169|58769423|FG000|Overall Study|Adverse Event|11|||
30760818|NCT00091169|58769424|FG001|Overall Study|Adverse Event|17|||
30760819|NCT00091169|58769423|FG000|Overall Study|Death|4|||
30760820|NCT00091169|58769424|FG001|Overall Study|Death|1|||
30760821|NCT00091169|58769423|FG000|Overall Study|Withdrawal by Subject|10|||
30760822|NCT00091169|58769424|FG001|Overall Study|Withdrawal by Subject|13|||
30760823|NCT00091169|58769423|FG000|Overall Study|Other|3|||
30844210|NCT02923349|58870052|FG003|Overall Study|Lost to Follow-up|0|||
30844211|NCT02923349|58870053|FG004|Overall Study|Lost to Follow-up|1|||
30844212|NCT02923349|58870054|FG005|Overall Study|Lost to Follow-up|1|||
30844213|NCT02923349|58870055|FG006|Overall Study|Lost to Follow-up|0|||
30844214|NCT02923349|58870049|FG000|Overall Study|Death|1|||
30844215|NCT02923349|58870050|FG001|Overall Study|Death|0|||
30844216|NCT02923349|58870051|FG002|Overall Study|Death|2|||
30844217|NCT02923349|58870052|FG003|Overall Study|Death|4|||
30844218|NCT02923349|58870053|FG004|Overall Study|Death|2|||
30844219|NCT02923349|58870054|FG005|Overall Study|Death|3|||
30844220|NCT02923349|58870055|FG006|Overall Study|Death|0|||
30844221|NCT02521792|58870071|FG000|Overall Study|Study Terminated|6|||
30844222|NCT03020615|58870078|FG000|Overall Study|Physician Decision|3|||
30948586|NCT01961609|58994652|FG001|Initiation|Protocol deviation|0|||
30948587|NCT01961609|58994653|FG002|Initiation|Protocol deviation|0|||
30948588|NCT01961609|58994654|FG003|Initiation|Protocol deviation|0|||
30948589|NCT01961609|58994651|FG000|Initiation|Death|0|||
30625727|NCT01205126|58637962|FG001|Titration Phase|More than maximum dosage required|3|||
30625728|NCT01205126|58637961|FG000|Titration Phase|Other|8|||
30760824|NCT00091169|58769424|FG001|Overall Study|Other|4|||
30760825|NCT00091169|58769423|FG000|Overall Study|Not start protocol therapy|26|||
30760826|NCT00091169|58769424|FG001|Overall Study|Not start protocol therapy|17|||
30948590|NCT01961609|58994652|FG001|Initiation|Death|1|||
30948591|NCT01961609|58994653|FG002|Initiation|Death|0|||
30948592|NCT01961609|58994654|FG003|Initiation|Death|0|||
30948593|NCT01961609|58994651|FG000|Initiation|Administrative problems|1|||
30948594|NCT01961609|58994652|FG001|Initiation|Administrative problems|0|||
30948595|NCT01961609|58994653|FG002|Initiation|Administrative problems|0|||
30948596|NCT01961609|58994654|FG003|Initiation|Administrative problems|0|||
30625729|NCT01205126|58637962|FG001|Titration Phase|Other|6|||
30625730|NCT01205126|58637961|FG000|Between Titration & Maintenance Phase|Other|0|||
30625731|NCT01205126|58637962|FG001|Between Titration & Maintenance Phase|Other|4|||
30760827|NCT00075946|58769436|FG000|Overall Study|Path ineligible: undetermined histology|0|||
30625732|NCT01205126|58637961|FG000|Maintenance Phase|Adverse Event|3|||
30844223|NCT03020615|58870079|FG001|Overall Study|Physician Decision|1|||
30844224|NCT03020615|58870080|FG002|Overall Study|Physician Decision|2|||
30844225|NCT03020615|58870078|FG000|Overall Study|Parent/guardian/patient choice|3|||
30844226|NCT03020615|58870079|FG001|Overall Study|Parent/guardian/patient choice|0|||
30760828|NCT00075946|58769437|FG001|Overall Study|Path ineligible: undetermined histology|0|||
30844227|NCT03020615|58870080|FG002|Overall Study|Parent/guardian/patient choice|4|||
30948597|NCT01961609|58994651|FG000|Initiation|Withdrawal by Subject|1|||
30948598|NCT01961609|58994652|FG001|Initiation|Withdrawal by Subject|2|||
30844228|NCT03020615|58870078|FG000|Overall Study|Screen failure|0|||
30844229|NCT03020615|58870079|FG001|Overall Study|Screen failure|0|||
30844230|NCT03020615|58870080|FG002|Overall Study|Screen failure|1|||
30844231|NCT03020615|58870078|FG000|Overall Study|Death|1|||
30844232|NCT03020615|58870079|FG001|Overall Study|Death|0|||
30844233|NCT03020615|58870080|FG002|Overall Study|Death|0|||
30844234|NCT03020615|58870078|FG000|Overall Study|Lost to Follow-up|0|||
30844235|NCT03020615|58870079|FG001|Overall Study|Lost to Follow-up|1|||
30844236|NCT03020615|58870080|FG002|Overall Study|Lost to Follow-up|0|||
30844237|NCT03020069|58870093|FG000|Overall Study|Lost to Follow-up|0|||
30844238|NCT03020069|58870094|FG001|Overall Study|Lost to Follow-up|1|||
30844239|NCT03693170|58870100|FG000|Overall Study|Disease Progression|48|||
30844240|NCT03693170|58870100|FG000|Overall Study|Adverse Event|16|||
30844241|NCT03693170|58870100|FG000|Overall Study|Physician Decision|6|||
30844242|NCT03693170|58870100|FG000|Overall Study|Protocol Violation|2|||
30844243|NCT03693170|58870100|FG000|Overall Study|Death|1|||
30844244|NCT03693170|58870100|FG000|Overall Study|Non compliance with study drug|1|||
30844245|NCT03693170|58870100|FG000|Overall Study|Withdrawal by Subject|1|||
30844246|NCT03021005|58870107|FG000|Overall Study|Lost to Follow-up|39|||
30844247|NCT03021005|58870108|FG001|Overall Study|Lost to Follow-up|26|||
30844248|NCT02914457|58870114|FG000|Overall Study|Withdrawal by Subject|1|||
30844249|NCT02914457|58870114|FG000|Overall Study|Physician Decision|1|||
30844250|NCT02914457|58870114|FG000|Overall Study|No veins available for lead placement|1|||
30844251|NCT02914457|58870114|FG000|Overall Study|Electrical instability of patient|1|||
30844252|NCT02914457|58870114|FG000|Overall Study|ECG acquisition error due to sweating|1|||
30844253|NCT02914457|58870114|FG000|Overall Study|Protocol Violation|1|||
30844254|NCT02665052|58870122|FG000|Overall Study|Lost to Follow-up|1|||
30844255|NCT02665052|58870123|FG001|Overall Study|Lost to Follow-up|0|||
30844256|NCT02665052|58870124|FG002|Overall Study|Lost to Follow-up|0|||
30844257|NCT02665052|58870125|FG003|Overall Study|Lost to Follow-up|0|||
30844258|NCT02665052|58870122|FG000|Overall Study|Withdrawal by Subject|1|||
30844259|NCT02665052|58870123|FG001|Overall Study|Withdrawal by Subject|1|||
30844260|NCT02665052|58870124|FG002|Overall Study|Withdrawal by Subject|0|||
30844261|NCT02665052|58870125|FG003|Overall Study|Withdrawal by Subject|5|||
30844262|NCT02665052|58870122|FG000|Overall Study|Adverse Event|1|||
30844263|NCT02665052|58870123|FG001|Overall Study|Adverse Event|1|||
30844264|NCT02665052|58870124|FG002|Overall Study|Adverse Event|0|||
30844265|NCT02665052|58870125|FG003|Overall Study|Adverse Event|0|||
30844266|NCT03019289|58870145|FG000|Overall Study|Adverse Event|1|||
30844267|NCT03019289|58870146|FG001|Overall Study|Adverse Event|0|||
30844268|NCT03019289|58870147|FG002|Overall Study|Adverse Event|0|||
30844269|NCT03019289|58870148|FG003|Overall Study|Adverse Event|0|||
30844270|NCT03019289|58870149|FG004|Overall Study|Adverse Event|0|||
30844271|NCT03019289|58870150|FG005|Overall Study|Adverse Event|0|||
30844272|NCT03019289|58870151|FG006|Overall Study|Adverse Event|0|||
30844273|NCT03019289|58870152|FG007|Overall Study|Adverse Event|0|||
30844274|NCT03019289|58870153|FG008|Overall Study|Adverse Event|1|||
30844275|NCT03019289|58870145|FG000|Overall Study|Other|1|||
30844276|NCT03019289|58870146|FG001|Overall Study|Other|0|||
30844277|NCT03019289|58870147|FG002|Overall Study|Other|0|||
30844278|NCT03019289|58870148|FG003|Overall Study|Other|0|||
30844279|NCT03019289|58870149|FG004|Overall Study|Other|0|||
30844280|NCT03019289|58870150|FG005|Overall Study|Other|0|||
30844281|NCT03019289|58870151|FG006|Overall Study|Other|0|||
30844282|NCT03019289|58870152|FG007|Overall Study|Other|0|||
30844283|NCT03019289|58870153|FG008|Overall Study|Other|0|||
30844284|NCT02520388|58870176|FG000|Overall Study|Physician Decision|1|||
30844285|NCT02520388|58870177|FG001|Overall Study|Physician Decision|0|||
30844286|NCT02520388|58870176|FG000|Overall Study|Subject or parent/guardian request|0|||
30844287|NCT02520388|58870177|FG001|Overall Study|Subject or parent/guardian request|6|||
30844288|NCT02520388|58870176|FG000|Overall Study|Adverse Event|1|||
30844289|NCT02520388|58870177|FG001|Overall Study|Adverse Event|4|||
30844290|NCT02520388|58870176|FG000|Overall Study|Lost to Follow-up|3|||
30844291|NCT02520388|58870177|FG001|Overall Study|Lost to Follow-up|2|||
30844292|NCT02520388|58870176|FG000|Overall Study|Other (reason not defined)|4|||
30844293|NCT02520388|58870177|FG001|Overall Study|Other (reason not defined)|4|||
30844294|NCT02924129|58870185|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
30844295|NCT02924129|58870186|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
30844296|NCT02924129|58870185|FG000|Overall Study|Withdrawal by Subject|2|||
30844297|NCT02924129|58870186|FG001|Overall Study|Withdrawal by Subject|2|||
30844298|NCT02924129|58870185|FG000|Overall Study|Physician Decision|1|||
30844299|NCT02924129|58870186|FG001|Overall Study|Physician Decision|0|||
30844300|NCT02924129|58870185|FG000|Overall Study|Missed Visit|0|||
30844301|NCT02924129|58870186|FG001|Overall Study|Missed Visit|1|||
30844302|NCT02668640|58870192|FG000|Overall Study|Lost to Follow-up|13|||
30844303|NCT02668640|58870192|FG000|Overall Study|Other, not specified|1|||
30844304|NCT03014453|58870196|FG000|Overall Study|Lost to Follow-up|12|||
30844305|NCT03014453|58870196|FG000|Overall Study|Discontinued GER|3|||
30844306|NCT03014453|58870196|FG000|Overall Study|Excluded|19|||
30844307|NCT03014453|58870196|FG000|Overall Study|Refused to take part in|37|||
30844308|NCT02664272|58870200|FG000|Overall Study|Fluoroscopic images not made available|2|||
30844309|NCT02663882|58870206|FG000|Overall Study|Lost to Follow-up|4|||
30844310|NCT02663882|58870207|FG001|Overall Study|Lost to Follow-up|2|||
30844311|NCT03011333|58870220|FG000|Overall Study|Lost to Follow-up|0|||
30844312|NCT03011333|58870221|FG001|Overall Study|Lost to Follow-up|1|||
30844313|NCT03011333|58870222|FG002|Overall Study|Lost to Follow-up|0|||
30844314|NCT03011333|58870223|FG003|Overall Study|Lost to Follow-up|1|||
30844315|NCT03011333|58870224|FG004|Overall Study|Lost to Follow-up|4|||
30844316|NCT03011333|58870225|FG005|Overall Study|Lost to Follow-up|4|||
30844317|NCT03011333|58870226|FG006|Overall Study|Lost to Follow-up|5|||
30844318|NCT03011099|58870244|FG000|Overall Study|Withdrawal by Subject|0|||
30844319|NCT03011099|58870245|FG001|Overall Study|Withdrawal by Subject|2|||
30844320|NCT03013985|58870255|FG000|Overall Study|Protocol Violation|2|||
30844321|NCT03013985|58870256|FG001|Overall Study|Protocol Violation|2|||
30844322|NCT03013985|58870255|FG000|Overall Study|Withdrawal by Subject|14|||
30844323|NCT03013985|58870256|FG001|Overall Study|Withdrawal by Subject|17|||
30844324|NCT03016403|58870266|FG000|Baseline|Death|5|||
30844325|NCT03016403|58870267|FG001|Baseline|Death|8|||
30844326|NCT03016403|58870268|FG002|Baseline|Death|1|||
30844327|NCT03016403|58870269|FG003|Baseline|Death|0|||
30844328|NCT03016403|58870266|FG000|Baseline|Withdrawal by Subject|2|||
30844329|NCT03016403|58870267|FG001|Baseline|Withdrawal by Subject|8|||
30844330|NCT03016403|58870268|FG002|Baseline|Withdrawal by Subject|4|||
30844331|NCT03016403|58870269|FG003|Baseline|Withdrawal by Subject|10|||
30844332|NCT03016403|58870266|FG000|Baseline|Lost to Follow-up|9|||
30844333|NCT03016403|58870267|FG001|Baseline|Lost to Follow-up|11|||
30844334|NCT03016403|58870268|FG002|Baseline|Lost to Follow-up|6|||
30844335|NCT03016403|58870269|FG003|Baseline|Lost to Follow-up|24|||
30844336|NCT03016403|58870266|FG000|6-week Follow-up|Death|1|||
30844337|NCT03016403|58870267|FG001|6-week Follow-up|Death|4|||
30844338|NCT03016403|58870268|FG002|6-week Follow-up|Death|0|||
30844339|NCT03016403|58870269|FG003|6-week Follow-up|Death|0|||
30625733|NCT01205126|58637962|FG001|Maintenance Phase|Adverse Event|7|||
30844340|NCT03016403|58870266|FG000|6-week Follow-up|Lost to Follow-up|2|||
30844341|NCT03016403|58870267|FG001|6-week Follow-up|Lost to Follow-up|7|||
30844342|NCT03016403|58870268|FG002|6-week Follow-up|Lost to Follow-up|4|||
30844343|NCT03016403|58870269|FG003|6-week Follow-up|Lost to Follow-up|8|||
30844344|NCT03016403|58870266|FG000|6-week Follow-up|Withdrawal by Subject|0|||
30844345|NCT03016403|58870267|FG001|6-week Follow-up|Withdrawal by Subject|2|||
30844346|NCT03016403|58870268|FG002|6-week Follow-up|Withdrawal by Subject|0|||
30844347|NCT03016403|58870269|FG003|6-week Follow-up|Withdrawal by Subject|1|||
30844348|NCT03016403|58870266|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
30844349|NCT03016403|58870267|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
30844350|NCT03016403|58870268|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
30844351|NCT03016403|58870269|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
30844352|NCT03016403|58870266|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
30844353|NCT03016403|58870267|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
30844354|NCT03016403|58870268|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
30844355|NCT03016403|58870269|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
30844356|NCT03016403|58870266|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
30844357|NCT03016403|58870267|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
30844358|NCT03016403|58870268|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
30844359|NCT03016403|58870269|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
30844360|NCT02520310|58870281|FG000|At 6 Months Clinical Follow-up|Death|1|||
30844361|NCT02520310|58870281|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
30844362|NCT02520310|58870281|FG000|AT 3 Year Clinical Follow-up|Death|2|||
30844363|NCT02520310|58870281|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
30844364|NCT02520310|58870281|FG000|AT 4 Year Clinical Follow-up|Death|1|||
30844365|NCT02520310|58870281|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
30844366|NCT02662556|58870287|FG000|Overall Study|Adverse Event|4|||
30844367|NCT02662556|58870287|FG000|Overall Study|Lack of Efficacy|4|||
30844368|NCT02516098|58870294|FG000|Period 1|Protocol Violation|1|||
30844369|NCT02516098|58870295|FG001|Period 1|Protocol Violation|0|||
30844370|NCT02516098|58870294|FG000|Washout After Period 1|Adverse Event|0|||
30844371|NCT02516098|58870295|FG001|Washout After Period 1|Adverse Event|1|||
30844372|NCT02516098|58870294|FG000|Period 2|Withdrawal by Subject|0|||
30844373|NCT02516098|58870295|FG001|Period 2|Withdrawal by Subject|1|||
30844374|NCT01364428|58870303|FG000|Overall Study|Adverse Event|1|||
30844375|NCT01364428|58870304|FG001|Overall Study|Adverse Event|2|||
30844376|NCT01364428|58870303|FG000|Overall Study|Protocol Violation|2|||
30844377|NCT01364428|58870304|FG001|Overall Study|Protocol Violation|0|||
30844378|NCT01364428|58870303|FG000|Overall Study|Withdrawal Criteria|14|||
30844379|NCT01364428|58870304|FG001|Overall Study|Withdrawal Criteria|10|||
30844380|NCT01364428|58870303|FG000|Overall Study|Other|3|||
30844381|NCT01364428|58870304|FG001|Overall Study|Other|3|||
30844382|NCT02515942|58870313|FG000|Overall Study|Adverse Event|5|||
30844383|NCT02515942|58870314|FG001|Overall Study|Adverse Event|0|||
30844384|NCT02515942|58870315|FG002|Overall Study|Adverse Event|0|||
30844385|NCT02515942|58870313|FG000|Overall Study|Death|0|||
30844386|NCT02515942|58870314|FG001|Overall Study|Death|0|||
30844387|NCT02515942|58870315|FG002|Overall Study|Death|1|||
30844388|NCT02515942|58870313|FG000|Overall Study|Lack of Efficacy|0|||
30844389|NCT02515942|58870314|FG001|Overall Study|Lack of Efficacy|0|||
30844390|NCT02515942|58870315|FG002|Overall Study|Lack of Efficacy|1|||
30844391|NCT02515942|58870313|FG000|Overall Study|Lost to Follow-up|2|||
30844392|NCT02515942|58870314|FG001|Overall Study|Lost to Follow-up|0|||
30844393|NCT02515942|58870315|FG002|Overall Study|Lost to Follow-up|0|||
30844394|NCT02515942|58870313|FG000|Overall Study|Withdrawal by Subject|0|||
30844395|NCT02515942|58870314|FG001|Overall Study|Withdrawal by Subject|3|||
30844396|NCT02515942|58870315|FG002|Overall Study|Withdrawal by Subject|2|||
30844397|NCT02991859|58870342|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844398|NCT02991859|58870343|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
30844399|NCT02991859|58870344|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844400|NCT02991859|58870345|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844401|NCT02991859|58870346|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
30844402|NCT02991859|58870347|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30625734|NCT01205126|58637961|FG000|Maintenance Phase|Death|4|||
30844403|NCT02991859|58870348|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844404|NCT02991859|58870349|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844405|NCT02991859|58870350|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844406|NCT02991859|58870351|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844407|NCT02991859|58870352|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844408|NCT02991859|58870353|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30625735|NCT01205126|58637962|FG001|Maintenance Phase|Death|4|||
30625736|NCT01205126|58637961|FG000|Maintenance Phase|More than the maximum dosage required|5|||
30625737|NCT01205126|58637962|FG001|Maintenance Phase|More than the maximum dosage required|5|||
30760829|NCT00075946|58769438|FG002|Overall Study|Path ineligible: undetermined histology|0|||
30760830|NCT00075946|58769439|FG003|Overall Study|Path ineligible: undetermined histology|0|||
30760831|NCT00075946|58769440|FG004|Overall Study|Path ineligible: undetermined histology|6|||
30760832|NCT00075946|58769436|FG000|Overall Study|Did not achieve response after induction|0|||
30760833|NCT00075946|58769437|FG001|Overall Study|Did not achieve response after induction|0|||
30760834|NCT00075946|58769438|FG002|Overall Study|Did not achieve response after induction|0|||
30844409|NCT02991859|58870354|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844410|NCT02991859|58870355|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30760835|NCT00075946|58769439|FG003|Overall Study|Did not achieve response after induction|0|||
30760836|NCT00075946|58769440|FG004|Overall Study|Did not achieve response after induction|182|||
30760837|NCT00075946|58769436|FG000|Overall Study|Incorrectly randomized (no response)|5|||
30760838|NCT00075946|58769437|FG001|Overall Study|Incorrectly randomized (no response)|5|||
30760839|NCT00075946|58769438|FG002|Overall Study|Incorrectly randomized (no response)|5|||
30760840|NCT00075946|58769439|FG003|Overall Study|Incorrectly randomized (no response)|1|||
30760841|NCT00075946|58769440|FG004|Overall Study|Incorrectly randomized (no response)|0|||
30760842|NCT00075946|58769436|FG000|Overall Study|Still on treatment at time of analysis|52|||
30760843|NCT00075946|58769437|FG001|Overall Study|Still on treatment at time of analysis|19|||
30760844|NCT00075946|58769438|FG002|Overall Study|Still on treatment at time of analysis|3|||
30760845|NCT00075946|58769439|FG003|Overall Study|Still on treatment at time of analysis|9|||
30760846|NCT00075946|58769440|FG004|Overall Study|Still on treatment at time of analysis|0|||
30760847|NCT00075946|58769436|FG000|Overall Study|Adverse Event|2|||
30760848|NCT00075946|58769437|FG001|Overall Study|Adverse Event|10|||
30760849|NCT00075946|58769438|FG002|Overall Study|Adverse Event|0|||
30760850|NCT00075946|58769439|FG003|Overall Study|Adverse Event|2|||
30760851|NCT00075946|58769440|FG004|Overall Study|Adverse Event|0|||
30760852|NCT00075946|58769436|FG000|Overall Study|Death|0|||
30760853|NCT00075946|58769437|FG001|Overall Study|Death|1|||
30760854|NCT00075946|58769438|FG002|Overall Study|Death|0|||
30760855|NCT00075946|58769439|FG003|Overall Study|Death|0|||
30760856|NCT00075946|58769440|FG004|Overall Study|Death|0|||
30760857|NCT00075946|58769436|FG000|Overall Study|Withdrawal by Subject|23|||
30760858|NCT00075946|58769437|FG001|Overall Study|Withdrawal by Subject|58|||
30760859|NCT00075946|58769438|FG002|Overall Study|Withdrawal by Subject|4|||
30760860|NCT00075946|58769439|FG003|Overall Study|Withdrawal by Subject|9|||
30760861|NCT00075946|58769440|FG004|Overall Study|Withdrawal by Subject|0|||
30760862|NCT00075946|58769436|FG000|Overall Study|Alternative therapy|16|||
30760863|NCT00075946|58769437|FG001|Overall Study|Alternative therapy|2|||
30760864|NCT00075946|58769438|FG002|Overall Study|Alternative therapy|5|||
30760865|NCT00075946|58769439|FG003|Overall Study|Alternative therapy|0|||
30760866|NCT00075946|58769440|FG004|Overall Study|Alternative therapy|0|||
30760867|NCT00075946|58769436|FG000|Overall Study|Other complicating disease|7|||
30760868|NCT00075946|58769437|FG001|Overall Study|Other complicating disease|13|||
30760869|NCT00075946|58769438|FG002|Overall Study|Other complicating disease|1|||
30760870|NCT00075946|58769439|FG003|Overall Study|Other complicating disease|4|||
30760871|NCT00075946|58769440|FG004|Overall Study|Other complicating disease|0|||
30760872|NCT00075946|58769436|FG000|Overall Study|No response to retreatment|23|||
30760873|NCT00075946|58769437|FG001|Overall Study|No response to retreatment|0|||
30760874|NCT00075946|58769438|FG002|Overall Study|No response to retreatment|2|||
30760875|NCT00075946|58769439|FG003|Overall Study|No response to retreatment|0|||
30760876|NCT00075946|58769440|FG004|Overall Study|No response to retreatment|0|||
30760877|NCT00075946|58769436|FG000|Overall Study|Time to progression less than 6 months|15|||
30760878|NCT00075946|58769437|FG001|Overall Study|Time to progression less than 6 months|30|||
30760879|NCT00075946|58769438|FG002|Overall Study|Time to progression less than 6 months|8|||
30760880|NCT00075946|58769439|FG003|Overall Study|Time to progression less than 6 months|3|||
30760881|NCT00075946|58769440|FG004|Overall Study|Time to progression less than 6 months|0|||
30844411|NCT02991859|58870356|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844412|NCT02991859|58870357|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844413|NCT02991859|58870358|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
30844414|NCT02991859|58870342|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30844415|NCT02991859|58870343|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30844416|NCT02991859|58870344|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30625738|NCT01205126|58637961|FG000|Maintenance Phase|Prohibited drugs used|1|||
30625739|NCT01205126|58637962|FG001|Maintenance Phase|Prohibited drugs used|0|||
30625740|NCT01205126|58637961|FG000|Maintenance Phase|Other|11|||
30625741|NCT01205126|58637962|FG001|Maintenance Phase|Other|8|||
30625742|NCT01205126|58637961|FG000|Maintenance Phase|Lost to Follow-up|5|||
30625743|NCT01205126|58637962|FG001|Maintenance Phase|Lost to Follow-up|5|||
30625744|NCT01205126|58637961|FG000|Maintenance Phase|Withdrawal by Subject|8|||
30625745|NCT01205126|58637962|FG001|Maintenance Phase|Withdrawal by Subject|11|||
30625746|NCT00946647|58637973|FG000|Phase 1 Part|Adverse Event|2|||
30625747|NCT00946647|58637974|FG001|Phase 1 Part|Adverse Event|5|||
30625748|NCT00946647|58637975|FG002|Phase 1 Part|Adverse Event|3|||
30625749|NCT00946647|58637976|FG003|Phase 1 Part|Adverse Event|0|||
30625750|NCT00946647|58637977|FG004|Phase 1 Part|Adverse Event|0|||
30625751|NCT00946647|58637973|FG000|Phase 1 Part|Disease progression|3|||
30625752|NCT00946647|58637974|FG001|Phase 1 Part|Disease progression|6|||
30625753|NCT00946647|58637975|FG002|Phase 1 Part|Disease progression|1|||
30625754|NCT00946647|58637976|FG003|Phase 1 Part|Disease progression|0|||
30625755|NCT00946647|58637977|FG004|Phase 1 Part|Disease progression|0|||
30625756|NCT00946647|58637973|FG000|Phase 1 Part|Withdrawal by Subject|1|||
30625757|NCT00946647|58637974|FG001|Phase 1 Part|Withdrawal by Subject|4|||
30760882|NCT00075946|58769436|FG000|Overall Study|Other|5|||
30760883|NCT00075946|58769437|FG001|Overall Study|Other|13|||
30760884|NCT00075946|58769438|FG002|Overall Study|Other|0|||
30760885|NCT00075946|58769439|FG003|Overall Study|Other|2|||
30760886|NCT00075946|58769440|FG004|Overall Study|Other|0|||
30760887|NCT00057876|58769457|FG000|Overall Study|Adverse Event|8|||
30760888|NCT00057876|58769458|FG001|Overall Study|Adverse Event|8|||
30760889|NCT00057876|58769457|FG000|Overall Study|Death|2|||
30760890|NCT00057876|58769458|FG001|Overall Study|Death|1|||
30760891|NCT00057876|58769457|FG000|Overall Study|Withdrawal by Subject|5|||
30760892|NCT00057876|58769458|FG001|Overall Study|Withdrawal by Subject|6|||
30760893|NCT00057876|58769457|FG000|Overall Study|Lack of Efficacy|10|||
30760894|NCT00057876|58769458|FG001|Overall Study|Lack of Efficacy|8|||
30760895|NCT00057876|58769457|FG000|Overall Study|Ineligible|1|||
30760896|NCT00057876|58769458|FG001|Overall Study|Ineligible|2|||
30760897|NCT00057876|58769457|FG000|Overall Study|other reason|2|||
30760898|NCT00057876|58769458|FG001|Overall Study|other reason|2|||
30844417|NCT02991859|58870345|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30625758|NCT00946647|58637975|FG002|Phase 1 Part|Withdrawal by Subject|3|||
30625759|NCT00946647|58637976|FG003|Phase 1 Part|Withdrawal by Subject|0|||
30625760|NCT00946647|58637977|FG004|Phase 1 Part|Withdrawal by Subject|0|||
30625761|NCT00946647|58637973|FG000|Phase 1 Part|Abnormal values|0|||
30625762|NCT00946647|58637974|FG001|Phase 1 Part|Abnormal values|2|||
30625763|NCT00946647|58637975|FG002|Phase 1 Part|Abnormal values|0|||
30625764|NCT00946647|58637976|FG003|Phase 1 Part|Abnormal values|0|||
30625765|NCT00946647|58637977|FG004|Phase 1 Part|Abnormal values|0|||
30625766|NCT00946647|58637973|FG000|Phase 1 Part|Reason missing|0|||
30625767|NCT00946647|58637974|FG001|Phase 1 Part|Reason missing|1|||
30625768|NCT00946647|58637975|FG002|Phase 1 Part|Reason missing|0|||
30625769|NCT00946647|58637976|FG003|Phase 1 Part|Reason missing|0|||
30625770|NCT00946647|58637977|FG004|Phase 1 Part|Reason missing|0|||
30625771|NCT00946647|58637973|FG000|Phase ll Part|Untreated|0|||
30625772|NCT00946647|58637974|FG001|Phase ll Part|Untreated|0|||
30625773|NCT00946647|58637975|FG002|Phase ll Part|Untreated|0|||
30625774|NCT00946647|58637976|FG003|Phase ll Part|Untreated|0|||
30625775|NCT00946647|58637977|FG004|Phase ll Part|Untreated|2|||
30625776|NCT00946647|58637973|FG000|Phase ll Part|Adverse Event|0|||
30625777|NCT00946647|58637974|FG001|Phase ll Part|Adverse Event|0|||
30760899|NCT00057876|58769457|FG000|Overall Study|other complicating disease|1|||
30760900|NCT00057876|58769458|FG001|Overall Study|other complicating disease|0|||
30844418|NCT02991859|58870346|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30844419|NCT02991859|58870347|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30625778|NCT00946647|58637975|FG002|Phase ll Part|Adverse Event|0|||
30625779|NCT00946647|58637976|FG003|Phase ll Part|Adverse Event|10|||
30625780|NCT00946647|58637977|FG004|Phase ll Part|Adverse Event|6|||
30760901|NCT00057837|58769466|FG000|Overall Study|Progression/relapse|12|||
30760902|NCT00057837|58769467|FG001|Overall Study|Progression/relapse|14|||
30760903|NCT00057837|58769466|FG000|Overall Study|Adverse Event|2|||
30760904|NCT00057837|58769467|FG001|Overall Study|Adverse Event|12|||
30625781|NCT00946647|58637973|FG000|Phase ll Part|Withdrawal by Subject|0|||
30760905|NCT00057837|58769466|FG000|Overall Study|Death|5|||
30760906|NCT00057837|58769467|FG001|Overall Study|Death|4|||
30760907|NCT00057837|58769466|FG000|Overall Study|Withdrawal by Subject|5|||
30760908|NCT00057837|58769467|FG001|Overall Study|Withdrawal by Subject|3|||
30760909|NCT00057837|58769466|FG000|Overall Study|Alternative therapy|0|||
30760910|NCT00057837|58769467|FG001|Overall Study|Alternative therapy|1|||
30760911|NCT00057837|58769466|FG000|Overall Study|Other complicating disease|2|||
30760912|NCT00057837|58769467|FG001|Overall Study|Other complicating disease|1|||
30760913|NCT00057837|58769466|FG000|Overall Study|Physician Decision|1|||
30760914|NCT00057837|58769467|FG001|Overall Study|Physician Decision|0|||
30760915|NCT00057837|58769466|FG000|Overall Study|Ineligible|3|||
30760916|NCT00057837|58769467|FG001|Overall Study|Ineligible|3|||
30760917|NCT00057837|58769466|FG000|Overall Study|Never started treatment|1|||
30760918|NCT00057837|58769467|FG001|Overall Study|Never started treatment|1|||
30760919|NCT00046930|58769475|FG000|Overall Study|Ineligible|12|||
30760920|NCT00046930|58769476|FG001|Overall Study|Ineligible|4|||
30760921|NCT00042939|58769487|FG000|Overall Study|Adverse Event|6|||
30760922|NCT00042939|58769488|FG001|Overall Study|Adverse Event|7|||
30760923|NCT00042939|58769487|FG000|Overall Study|Death|3|||
30760924|NCT00042939|58769488|FG001|Overall Study|Death|2|||
30760925|NCT00042939|58769487|FG000|Overall Study|Withdrawal by Subject|3|||
30760926|NCT00042939|58769488|FG001|Overall Study|Withdrawal by Subject|4|||
30760927|NCT00042939|58769487|FG000|Overall Study|Other disease|1|||
30760928|NCT00042939|58769488|FG001|Overall Study|Other disease|0|||
30760929|NCT00042939|58769487|FG000|Overall Study|Ineligible|2|||
30760930|NCT00042939|58769488|FG001|Overall Study|Ineligible|2|||
30760931|NCT00042939|58769487|FG000|Overall Study|Deterioration of health|3|||
30760932|NCT00042939|58769488|FG001|Overall Study|Deterioration of health|4|||
30760933|NCT00042939|58769487|FG000|Overall Study|QOL diminished|1|||
30760934|NCT00042939|58769488|FG001|Overall Study|QOL diminished|0|||
30760935|NCT00042939|58769487|FG000|Overall Study|Rising ca 19-9|1|||
30760936|NCT00042939|58769488|FG001|Overall Study|Rising ca 19-9|0|||
30760937|NCT00042939|58769487|FG000|Overall Study|Patient non-compliance|1|||
30760938|NCT00042939|58769488|FG001|Overall Study|Patient non-compliance|0|||
30760939|NCT00042939|58769487|FG000|Overall Study|Still on treatment|1|||
30760940|NCT00042939|58769488|FG001|Overall Study|Still on treatment|0|||
30760941|NCT00042939|58769487|FG000|Overall Study|Treatment break > 4 weeks|0|||
30760942|NCT00042939|58769488|FG001|Overall Study|Treatment break > 4 weeks|1|||
30760943|NCT00042939|58769487|FG000|Overall Study|Did not start treatment|2|||
30760944|NCT00042939|58769488|FG001|Overall Study|Did not start treatment|1|||
30844420|NCT02991859|58870348|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30844421|NCT02991859|58870349|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30844422|NCT02991859|58870350|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30844423|NCT02991859|58870351|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30844424|NCT02991859|58870352|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30844425|NCT02991859|58870353|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30844426|NCT02991859|58870354|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
30948599|NCT01961609|58994653|FG002|Initiation|Withdrawal by Subject|0|||
30948600|NCT01961609|58994654|FG003|Initiation|Withdrawal by Subject|0|||
30948601|NCT01961609|58994651|FG000|Initiation|Lack of Efficacy|2|||
30948602|NCT01961609|58994652|FG001|Initiation|Lack of Efficacy|1|||
30625782|NCT00946647|58637974|FG001|Phase ll Part|Withdrawal by Subject|0|||
30625783|NCT00946647|58637975|FG002|Phase ll Part|Withdrawal by Subject|0|||
30625784|NCT00946647|58637976|FG003|Phase ll Part|Withdrawal by Subject|8|||
30625785|NCT00946647|58637977|FG004|Phase ll Part|Withdrawal by Subject|6|||
30625786|NCT00946647|58637973|FG000|Phase ll Part|Administrative problems|0|||
30625787|NCT00946647|58637974|FG001|Phase ll Part|Administrative problems|0|||
30625788|NCT00946647|58637975|FG002|Phase ll Part|Administrative problems|0|||
30625789|NCT00946647|58637976|FG003|Phase ll Part|Administrative problems|3|||
30625790|NCT00946647|58637977|FG004|Phase ll Part|Administrative problems|8|||
30625791|NCT00946647|58637973|FG000|Phase ll Part|Death|0|||
30625792|NCT00946647|58637974|FG001|Phase ll Part|Death|0|||
30625793|NCT00946647|58637975|FG002|Phase ll Part|Death|0|||
30625794|NCT00946647|58637976|FG003|Phase ll Part|Death|7|||
30625795|NCT00946647|58637977|FG004|Phase ll Part|Death|4|||
30625796|NCT00946647|58637973|FG000|Phase ll Part|Disease progression|0|||
30625797|NCT00946647|58637974|FG001|Phase ll Part|Disease progression|0|||
30625798|NCT00946647|58637975|FG002|Phase ll Part|Disease progression|0|||
30760945|NCT00008385|58769496|FG000|Overall Study|Off treatment reasons not reported|79|||
30760946|NCT00008385|58769497|FG001|Overall Study|Off treatment reasons not reported|70|||
30760947|NCT00008385|58769496|FG000|Overall Study|Progressive disease|52|||
30760948|NCT00008385|58769497|FG001|Overall Study|Progressive disease|117|||
30760949|NCT00008385|58769496|FG000|Overall Study|Adverse Event|8|||
30760950|NCT00008385|58769497|FG001|Overall Study|Adverse Event|20|||
30760951|NCT00008385|58769496|FG000|Overall Study|Death|12|||
30760952|NCT00008385|58769497|FG001|Overall Study|Death|18|||
30760953|NCT00008385|58769496|FG000|Overall Study|Withdrawal by Subject|67|||
30625799|NCT00946647|58637976|FG003|Phase ll Part|Disease progression|6|||
30760954|NCT00008385|58769497|FG001|Overall Study|Withdrawal by Subject|157|||
30760955|NCT00008385|58769496|FG000|Overall Study|Start non-protocol therapy|3|||
30760956|NCT00008385|58769497|FG001|Overall Study|Start non-protocol therapy|1|||
30760957|NCT00008385|58769496|FG000|Overall Study|Other complicating disease|17|||
30760958|NCT00008385|58769497|FG001|Overall Study|Other complicating disease|30|||
30760959|NCT00008385|58769496|FG000|Overall Study|Maximum dose reached|0|||
30760960|NCT00008385|58769497|FG001|Overall Study|Maximum dose reached|2|||
30760961|NCT00008385|58769496|FG000|Overall Study|Other|105|||
30760962|NCT00008385|58769497|FG001|Overall Study|Other|212|||
30844427|NCT02991859|58870355|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
30844428|NCT02991859|58870356|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30844429|NCT02991859|58870357|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30625800|NCT00946647|58637977|FG004|Phase ll Part|Disease progression|14|||
30625801|NCT00946647|58637973|FG000|Phase ll Part|Protocol Violation|0|||
30625802|NCT00946647|58637974|FG001|Phase ll Part|Protocol Violation|0|||
30625803|NCT00946647|58637975|FG002|Phase ll Part|Protocol Violation|0|||
30625804|NCT00946647|58637976|FG003|Phase ll Part|Protocol Violation|4|||
30625805|NCT00946647|58637977|FG004|Phase ll Part|Protocol Violation|2|||
30625806|NCT00946647|58637973|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
30625807|NCT00946647|58637974|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
30625808|NCT00946647|58637975|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
30625809|NCT00946647|58637976|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
30625810|NCT00946647|58637977|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
30625811|NCT00946101|58637992|FG000|Overall Study|Lost to Follow-up|2|||
30625812|NCT00946101|58637993|FG001|Overall Study|Lost to Follow-up|1|||
30625813|NCT00946101|58637992|FG000|Overall Study|Withdrawal of consent|2|||
30625814|NCT00946101|58637993|FG001|Overall Study|Withdrawal of consent|0|||
30625815|NCT00946101|58637992|FG000|Overall Study|Physician Decision|0|||
30625816|NCT00946101|58637993|FG001|Overall Study|Physician Decision|1|||
30625817|NCT01109940|58638007|FG000|Overall Study|Administrative problems|2|||
30625818|NCT01109940|58638008|FG001|Overall Study|Administrative problems|0|||
30625819|NCT01109940|58638009|FG002|Overall Study|Administrative problems|0|||
30625820|NCT01109940|58638010|FG003|Overall Study|Administrative problems|0|||
30625821|NCT01109940|58638007|FG000|Overall Study|Serious Adverse Event|2|||
30625822|NCT01109940|58638008|FG001|Overall Study|Serious Adverse Event|1|||
30625823|NCT01109940|58638009|FG002|Overall Study|Serious Adverse Event|0|||
30625824|NCT01109940|58638010|FG003|Overall Study|Serious Adverse Event|0|||
30625825|NCT01109940|58638007|FG000|Overall Study|Lost to Follow-up|1|||
30760963|NCT00008385|58769496|FG000|Overall Study|Not start protocol therapy|44|||
30877153|NCT01891344|58908781|FG005|Overall Study|Ongoing|1|||
30948603|NCT01961609|58994653|FG002|Initiation|Lack of Efficacy|0|||
30948604|NCT01961609|58994654|FG003|Initiation|Lack of Efficacy|0|||
30948605|NCT01961609|58994651|FG000|Initiation|Abnormal lab values|0|||
30948606|NCT01961609|58994652|FG001|Initiation|Abnormal lab values|1|||
30625826|NCT01109940|58638008|FG001|Overall Study|Lost to Follow-up|0|||
30625827|NCT01109940|58638009|FG002|Overall Study|Lost to Follow-up|0|||
30625828|NCT01109940|58638010|FG003|Overall Study|Lost to Follow-up|0|||
30625829|NCT01109940|58638007|FG000|Overall Study|Patient withdrew consent|1|||
30625830|NCT01109940|58638008|FG001|Overall Study|Patient withdrew consent|1|||
30625831|NCT01109940|58638009|FG002|Overall Study|Patient withdrew consent|0|||
30760964|NCT00008385|58769497|FG001|Overall Study|Not start protocol therapy|175|||
30948607|NCT01961609|58994653|FG002|Initiation|Abnormal lab values|0|||
30625832|NCT01109940|58638010|FG003|Overall Study|Patient withdrew consent|0|||
30625833|NCT01109940|58638007|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30625834|NCT01109940|58638008|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30625835|NCT01109940|58638009|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
30625836|NCT01109940|58638010|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
30625837|NCT00595309|58638020|FG000|Overall Study|Lost to Follow-up|1|||
30625838|NCT00595309|58638020|FG000|Overall Study|planned vaccination against yellow fever|1|||
30625839|NCT00595309|58638020|FG000|Overall Study|acute infection after V0|1|||
30625840|NCT00595309|58638020|FG000|Overall Study|personal reason|1|||
30625841|NCT00595075|58638026|FG000|Overall Study|Withdrawal by Subject|1|||
30625842|NCT00595075|58638027|FG001|Overall Study|Withdrawal by Subject|0|||
30625843|NCT00887224|58638036|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
30625844|NCT00887224|58638037|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
30625845|NCT00887224|58638038|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
30625846|NCT00887224|58638036|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
30625847|NCT00887224|58638037|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
30625848|NCT00887224|58638038|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
30625849|NCT00887224|58638036|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
30625850|NCT00887224|58638037|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
30625851|NCT00887224|58638038|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
30625852|NCT00887224|58638036|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
30625853|NCT00887224|58638037|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
30625854|NCT00887224|58638038|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
30625855|NCT00887224|58638036|FG000|Open-label Response (OLR) Phase|Other|1|||
30625856|NCT00887224|58638037|FG001|Open-label Response (OLR) Phase|Other|0|||
30625857|NCT00887224|58638038|FG002|Open-label Response (OLR) Phase|Other|0|||
30625858|NCT00887224|58638036|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
30625859|NCT00887224|58638037|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
30625860|NCT00887224|58638038|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
30625861|NCT00887224|58638036|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
30625862|NCT00887224|58638037|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
30625863|NCT00887224|58638038|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
30625864|NCT00887224|58638036|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
30625865|NCT00887224|58638037|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
30625866|NCT00887224|58638038|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
30625867|NCT00887224|58638036|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
30625868|NCT00887224|58638037|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
30625869|NCT00887224|58638038|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
30625870|NCT00887224|58638036|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
30625871|NCT00887224|58638037|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
30625872|NCT00887224|58638038|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
30625873|NCT00887224|58638036|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
30625874|NCT00887224|58638037|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
30625875|NCT00887224|58638038|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
30625876|NCT00887224|58638036|FG000|Open-label Stability (OLS) Phase|Other|1|||
30625877|NCT00887224|58638037|FG001|Open-label Stability (OLS) Phase|Other|0|||
30625878|NCT00887224|58638038|FG002|Open-label Stability (OLS) Phase|Other|0|||
30625879|NCT00887224|58638036|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
30625880|NCT00887224|58638037|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
30625881|NCT00887224|58638038|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
30625882|NCT00887224|58638036|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
30625883|NCT00887224|58638037|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
30625884|NCT00887224|58638038|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
30625885|NCT00887224|58638036|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
30625886|NCT00887224|58638037|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
30625887|NCT00887224|58638038|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
30625888|NCT00887224|58638036|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
30625889|NCT00887224|58638037|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
30625890|NCT00887224|58638038|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
30625891|NCT00887224|58638036|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
30625892|NCT00887224|58638037|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
30625893|NCT00887224|58638038|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
30625894|NCT00887224|58638036|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
30625895|NCT00887224|58638037|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
30625896|NCT00887224|58638038|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
30844430|NCT02991859|58870358|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
30948608|NCT01961609|58994654|FG003|Initiation|Abnormal lab values|0|||
30948609|NCT01961609|58994651|FG000|Initiation|Adverse Event|3|||
30625897|NCT00887224|58638036|FG000|OL Taper Phase / OL Follow Up|Other|30|||
30625898|NCT00887224|58638037|FG001|OL Taper Phase / OL Follow Up|Other|0|||
30625899|NCT00887224|58638038|FG002|OL Taper Phase / OL Follow Up|Other|0|||
30625900|NCT00887224|58638036|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
30625901|NCT00887224|58638037|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
30625902|NCT00887224|58638038|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
30625903|NCT00887224|58638036|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
30625904|NCT00887224|58638037|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
30625905|NCT00887224|58638038|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
30625906|NCT00887224|58638036|FG000|Double-blind (DB) Phase|Adverse Event|0|||
30625907|NCT00887224|58638037|FG001|Double-blind (DB) Phase|Adverse Event|7|||
30760965|NCT00003907|58769512|FG000|Overall Study|Adverse Event|2|||
30844431|NCT02991859|58870342|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844432|NCT02991859|58870343|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844433|NCT02991859|58870344|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844434|NCT02991859|58870345|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844435|NCT02991859|58870346|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844436|NCT02991859|58870347|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
30844437|NCT02991859|58870348|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844438|NCT02991859|58870349|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844439|NCT02991859|58870350|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844440|NCT02991859|58870351|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844441|NCT02991859|58870352|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844442|NCT02991859|58870353|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844443|NCT02991859|58870354|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844444|NCT02991859|58870355|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844445|NCT02991859|58870356|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844446|NCT02991859|58870357|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844447|NCT02991859|58870358|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
30844448|NCT02991859|58870342|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844449|NCT02991859|58870343|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844450|NCT02991859|58870344|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844451|NCT02991859|58870345|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844452|NCT02991859|58870346|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844453|NCT02991859|58870347|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844454|NCT02991859|58870348|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844455|NCT02991859|58870349|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844456|NCT02991859|58870350|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844457|NCT02991859|58870351|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
30844458|NCT02991859|58870352|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844459|NCT02991859|58870353|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844460|NCT02991859|58870354|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844461|NCT02991859|58870355|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844462|NCT02991859|58870356|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844463|NCT02991859|58870357|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844464|NCT02991859|58870358|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
30844465|NCT02991859|58870342|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844466|NCT02991859|58870343|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844467|NCT02991859|58870344|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844468|NCT02991859|58870345|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844469|NCT02991859|58870346|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844470|NCT02991859|58870347|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844471|NCT02991859|58870348|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844472|NCT02991859|58870349|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844473|NCT02991859|58870350|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
30844474|NCT02991859|58870351|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844475|NCT02991859|58870352|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30625908|NCT00887224|58638038|FG002|Double-blind (DB) Phase|Adverse Event|2|||
30625909|NCT00887224|58638036|FG000|Double-blind (DB) Phase|Failed to return|0|||
30625910|NCT00887224|58638037|FG001|Double-blind (DB) Phase|Failed to return|2|||
30760966|NCT00003907|58769513|FG001|Overall Study|Adverse Event|11|||
30760967|NCT00003907|58769512|FG000|Overall Study|Death|2|||
30760968|NCT00003907|58769513|FG001|Overall Study|Death|0|||
30760969|NCT00003907|58769512|FG000|Overall Study|Withdrawal by Subject|1|||
30760970|NCT00003907|58769513|FG001|Overall Study|Withdrawal by Subject|3|||
30760971|NCT00003907|58769512|FG000|Overall Study|Progressive disease|4|||
30760972|NCT00003907|58769513|FG001|Overall Study|Progressive disease|4|||
30760973|NCT00003907|58769512|FG000|Overall Study|Complicating disease|1|||
30760974|NCT00003907|58769513|FG001|Overall Study|Complicating disease|0|||
30760975|NCT00003907|58769512|FG000|Overall Study|Other|1|||
30760976|NCT00003907|58769513|FG001|Overall Study|Other|3|||
30760977|NCT00003907|58769512|FG000|Overall Study|ineligible or not treated|2|||
30760978|NCT00003907|58769513|FG001|Overall Study|ineligible or not treated|2|||
30760979|NCT04241315|58769521|FG000|Overall Study|Withdrawal by Subject|0|||
30760980|NCT04241315|58769522|FG001|Overall Study|Withdrawal by Subject|1|||
30760981|NCT04225026|58769528|FG000|Overall Study|Withdrawal by Subject|4|||
30760982|NCT04225026|58769528|FG000|Overall Study|Adverse Event|1|||
30760983|NCT04225026|58769528|FG000|Overall Study|Other|1|||
30760984|NCT04225026|58769528|FG000|Overall Study|Death|11|||
30760985|NCT04225026|58769528|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
30760986|NCT03493958|58769934|FG000|Overall Study|Withdrawal by Subject|6|||
30760987|NCT03493958|58769934|FG000|Overall Study|Lost to Follow-up|7|||
30760988|NCT03493958|58769934|FG000|Overall Study|Did not complete all required study procedures|2|||
30844476|NCT02991859|58870353|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844477|NCT02991859|58870354|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844478|NCT02991859|58870355|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844479|NCT02991859|58870356|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844480|NCT02991859|58870357|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844481|NCT02991859|58870358|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
30844482|NCT03016325|58870441|FG000|Treatment Period|Participant withdrew consent|0|||
30844483|NCT03016325|58870442|FG001|Treatment Period|Participant withdrew consent|1|||
30844484|NCT03016325|58870443|FG002|Treatment Period|Participant withdrew consent|0|||
30844485|NCT03016325|58870444|FG003|Treatment Period|Participant withdrew consent|0|||
30844486|NCT03016325|58870445|FG004|Treatment Period|Participant withdrew consent|0|||
30844487|NCT03016325|58870446|FG005|Treatment Period|Participant withdrew consent|0|||
30844488|NCT03016325|58870447|FG006|Treatment Period|Participant withdrew consent|0|||
30844489|NCT03016325|58870448|FG007|Treatment Period|Participant withdrew consent|0|||
30844490|NCT03016325|58870441|FG000|Treatment Period|Death|0|||
30844491|NCT03016325|58870442|FG001|Treatment Period|Death|0|||
30844492|NCT03016325|58870443|FG002|Treatment Period|Death|0|||
30844493|NCT03016325|58870444|FG003|Treatment Period|Death|0|||
30844494|NCT03016325|58870445|FG004|Treatment Period|Death|2|||
30844495|NCT03016325|58870446|FG005|Treatment Period|Death|0|||
30844496|NCT03016325|58870447|FG006|Treatment Period|Death|0|||
30844497|NCT03016325|58870448|FG007|Treatment Period|Death|0|||
30844498|NCT03016325|58870441|FG000|Treatment Period|Participant refuses assessments|0|||
30844499|NCT03016325|58870442|FG001|Treatment Period|Participant refuses assessments|0|||
30844500|NCT03016325|58870443|FG002|Treatment Period|Participant refuses assessments|1|||
30844501|NCT03016325|58870444|FG003|Treatment Period|Participant refuses assessments|0|||
30844502|NCT03016325|58870445|FG004|Treatment Period|Participant refuses assessments|0|||
30844503|NCT03016325|58870446|FG005|Treatment Period|Participant refuses assessments|0|||
30844504|NCT03016325|58870447|FG006|Treatment Period|Participant refuses assessments|0|||
30844505|NCT03016325|58870448|FG007|Treatment Period|Participant refuses assessments|0|||
30844506|NCT03016325|58870441|FG000|32-Day Follow-Up Period|Death|2|||
30844507|NCT03016325|58870442|FG001|32-Day Follow-Up Period|Death|0|||
30844508|NCT03016325|58870443|FG002|32-Day Follow-Up Period|Death|5|||
30844509|NCT03016325|58870444|FG003|32-Day Follow-Up Period|Death|6|||
30844510|NCT03016325|58870445|FG004|32-Day Follow-Up Period|Death|3|||
30844511|NCT03016325|58870446|FG005|32-Day Follow-Up Period|Death|0|||
30844512|NCT03016325|58870447|FG006|32-Day Follow-Up Period|Death|0|||
30844513|NCT03016325|58870448|FG007|32-Day Follow-Up Period|Death|0|||
30844514|NCT03016325|58870441|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
30844515|NCT03016325|58870442|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
30760989|NCT03486223|58769940|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
30844516|NCT03016325|58870443|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
30844517|NCT03016325|58870444|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
30844518|NCT03016325|58870445|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
30844519|NCT03016325|58870446|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
30948610|NCT01961609|58994652|FG001|Initiation|Adverse Event|5|||
30948611|NCT01961609|58994653|FG002|Initiation|Adverse Event|0|||
30948612|NCT01961609|58994654|FG003|Initiation|Adverse Event|0|||
30948613|NCT01961609|58994651|FG000|Initiation|Randomized but not treated|1|||
30948614|NCT01961609|58994652|FG001|Initiation|Randomized but not treated|1|||
30948615|NCT01961609|58994653|FG002|Initiation|Randomized but not treated|0|||
30948616|NCT01961609|58994654|FG003|Initiation|Randomized but not treated|0|||
30948617|NCT01961609|58994651|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
30948618|NCT01961609|58994652|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
30948619|NCT01961609|58994653|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
30948620|NCT01961609|58994654|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
30948621|NCT01961609|58994651|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
30948622|NCT01961609|58994652|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
30948623|NCT01961609|58994653|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
30948624|NCT01961609|58994654|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
30948625|NCT01961609|58994651|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
30948626|NCT01961609|58994652|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
30948627|NCT01961609|58994653|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
30948628|NCT01961609|58994654|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
30948629|NCT01961609|58994651|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
30948630|NCT01961609|58994652|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
30948631|NCT01961609|58994653|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
30948632|NCT01961609|58994654|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
30948633|NCT01961609|58994651|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
30948634|NCT01961609|58994652|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
30948635|NCT01961609|58994653|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
30948636|NCT01961609|58994654|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
30948637|NCT01961609|58994651|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
30948638|NCT01961609|58994652|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
30948639|NCT01961609|58994653|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
30948640|NCT01961609|58994654|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
30948641|NCT01961609|58994651|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
30948642|NCT01961609|58994652|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
30948643|NCT01961609|58994653|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
30948644|NCT01961609|58994654|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
30948645|NCT01961609|58994651|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
30948646|NCT01961609|58994652|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
30948647|NCT01961609|58994653|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
30948648|NCT01961609|58994654|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
30948649|NCT01961609|58994651|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
30948650|NCT01961609|58994652|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
30948651|NCT01961609|58994653|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
30948652|NCT01961609|58994654|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
30948653|NCT01961609|58994651|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
30948654|NCT01961609|58994652|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
30948655|NCT01961609|58994653|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
30948656|NCT01961609|58994654|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
30948657|NCT01961609|58994651|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
30948658|NCT01961609|58994652|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
30948659|NCT01961609|58994653|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
30948660|NCT01961609|58994654|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
30948661|NCT01961609|58994651|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
30948662|NCT01961609|58994652|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
30948663|NCT01961609|58994653|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
30948664|NCT01961609|58994654|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
30948665|NCT01774981|58994763|FG000|Overall Study|Adverse Event|0|||
30948666|NCT01774981|58994764|FG001|Overall Study|Adverse Event|0|||
30948667|NCT01774981|58994765|FG002|Overall Study|Adverse Event|0|||
30948668|NCT01774981|58994766|FG003|Overall Study|Adverse Event|0|||
30948669|NCT01774981|58994767|FG004|Overall Study|Adverse Event|0|||
30948670|NCT01774981|58994768|FG005|Overall Study|Adverse Event|1|||
30948671|NCT01774981|58994769|FG006|Overall Study|Adverse Event|0|||
30948672|NCT01774981|58994770|FG007|Overall Study|Adverse Event|0|||
30948673|NCT01774981|58994763|FG000|Overall Study|Withdrawal by Subject|0|||
30948674|NCT01774981|58994764|FG001|Overall Study|Withdrawal by Subject|0|||
30948675|NCT01774981|58994765|FG002|Overall Study|Withdrawal by Subject|0|||
30948676|NCT01774981|58994766|FG003|Overall Study|Withdrawal by Subject|0|||
30948677|NCT01774981|58994767|FG004|Overall Study|Withdrawal by Subject|0|||
30948678|NCT01774981|58994768|FG005|Overall Study|Withdrawal by Subject|0|||
30948679|NCT01774981|58994769|FG006|Overall Study|Withdrawal by Subject|0|||
30948680|NCT01774981|58994770|FG007|Overall Study|Withdrawal by Subject|1|||
30948681|NCT01774981|58994763|FG000|Overall Study|Death|0|||
30948682|NCT01774981|58994764|FG001|Overall Study|Death|0|||
30948683|NCT01774981|58994765|FG002|Overall Study|Death|0|||
30948684|NCT01774981|58994766|FG003|Overall Study|Death|0|||
30948685|NCT01774981|58994767|FG004|Overall Study|Death|1|||
30948686|NCT01774981|58994768|FG005|Overall Study|Death|0|||
30948687|NCT01774981|58994769|FG006|Overall Study|Death|0|||
30948688|NCT01774981|58994770|FG007|Overall Study|Death|0|||
30948689|NCT01972841|58994799|FG000|Overall Study|Randomized but Never Received Treatment|2|||
30948690|NCT01972841|58994800|FG001|Overall Study|Randomized but Never Received Treatment|5|||
30948691|NCT01972841|58994801|FG002|Overall Study|Randomized but Never Received Treatment|4|||
30948692|NCT01972841|58994802|FG003|Overall Study|Randomized but Never Received Treatment|2|||
30948693|NCT01972841|58994803|FG004|Overall Study|Randomized but Never Received Treatment|6|||
30948694|NCT01972841|58994804|FG005|Overall Study|Randomized but Never Received Treatment|13|||
30948695|NCT01972841|58994799|FG000|Overall Study|Adverse Event|13|||
30948696|NCT01972841|58994800|FG001|Overall Study|Adverse Event|8|||
30948697|NCT01972841|58994801|FG002|Overall Study|Adverse Event|12|||
30948698|NCT01972841|58994802|FG003|Overall Study|Adverse Event|9|||
30948699|NCT01972841|58994803|FG004|Overall Study|Adverse Event|21|||
30948700|NCT01972841|58994804|FG005|Overall Study|Adverse Event|26|||
30948701|NCT01972841|58994799|FG000|Overall Study|Lack of Efficacy|1|||
30948702|NCT01972841|58994800|FG001|Overall Study|Lack of Efficacy|0|||
30948703|NCT01972841|58994801|FG002|Overall Study|Lack of Efficacy|0|||
30948704|NCT01972841|58994802|FG003|Overall Study|Lack of Efficacy|2|||
30948705|NCT01972841|58994803|FG004|Overall Study|Lack of Efficacy|4|||
30948706|NCT01972841|58994804|FG005|Overall Study|Lack of Efficacy|1|||
30948707|NCT01972841|58994799|FG000|Overall Study|Lost to Follow-up|4|||
30948708|NCT01972841|58994800|FG001|Overall Study|Lost to Follow-up|2|||
30948709|NCT01972841|58994801|FG002|Overall Study|Lost to Follow-up|4|||
30948710|NCT01972841|58994802|FG003|Overall Study|Lost to Follow-up|2|||
30948711|NCT01972841|58994803|FG004|Overall Study|Lost to Follow-up|9|||
30948712|NCT01972841|58994804|FG005|Overall Study|Lost to Follow-up|3|||
30948713|NCT01972841|58994799|FG000|Overall Study|Protocol Violation|2|||
30948714|NCT01972841|58994800|FG001|Overall Study|Protocol Violation|2|||
30948715|NCT01972841|58994801|FG002|Overall Study|Protocol Violation|3|||
30948716|NCT01972841|58994802|FG003|Overall Study|Protocol Violation|5|||
30948717|NCT01972841|58994803|FG004|Overall Study|Protocol Violation|9|||
30948718|NCT01972841|58994804|FG005|Overall Study|Protocol Violation|4|||
30948719|NCT01972841|58994799|FG000|Overall Study|Withdrawal by participants|21|||
30948720|NCT01972841|58994800|FG001|Overall Study|Withdrawal by participants|27|||
30948721|NCT01972841|58994801|FG002|Overall Study|Withdrawal by participants|23|||
30948722|NCT01972841|58994802|FG003|Overall Study|Withdrawal by participants|16|||
30948723|NCT01972841|58994803|FG004|Overall Study|Withdrawal by participants|33|||
30948724|NCT01972841|58994804|FG005|Overall Study|Withdrawal by participants|34|||
30948725|NCT01972841|58994799|FG000|Overall Study|Miscellaneous|0|||
30948726|NCT01972841|58994800|FG001|Overall Study|Miscellaneous|0|||
30948727|NCT01972841|58994801|FG002|Overall Study|Miscellaneous|4|||
30844520|NCT03016325|58870447|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
30948728|NCT01972841|58994802|FG003|Overall Study|Miscellaneous|1|||
30948729|NCT01972841|58994803|FG004|Overall Study|Miscellaneous|0|||
30948730|NCT01972841|58994804|FG005|Overall Study|Miscellaneous|4|||
30948731|NCT01972841|58994799|FG000|Overall Study|Did not have end of treatment page|0|||
30948732|NCT01972841|58994800|FG001|Overall Study|Did not have end of treatment page|0|||
30948733|NCT01972841|58994801|FG002|Overall Study|Did not have end of treatment page|0|||
30948734|NCT01972841|58994802|FG003|Overall Study|Did not have end of treatment page|0|||
30948735|NCT01972841|58994803|FG004|Overall Study|Did not have end of treatment page|1|||
30948736|NCT01972841|58994804|FG005|Overall Study|Did not have end of treatment page|0|||
30948737|NCT01774903|58994818|FG000|Overall Study|Adverse Event|7|||
30948738|NCT01774903|58994818|FG000|Overall Study|Withdrawal by Subject|2|||
30948739|NCT01774903|58994818|FG000|Overall Study|Lack of Efficacy|1|||
30948740|NCT01774903|58994818|FG000|Overall Study|Ineligible to continue the trial|1|||
30948741|NCT01774591|58994825|FG000|Overall Study|Physician Decision|1|||
30948742|NCT01774591|58994826|FG001|Overall Study|Physician Decision|1|||
30948743|NCT01774591|58994825|FG000|Overall Study|Withdrawal by Subject|0|||
30948744|NCT01774591|58994826|FG001|Overall Study|Withdrawal by Subject|1|||
30948745|NCT01774591|58994825|FG000|Overall Study|Adverse Event|0|||
30948746|NCT01774591|58994826|FG001|Overall Study|Adverse Event|2|||
30844521|NCT03016325|58870448|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
30844522|NCT03016325|58870441|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
30844523|NCT03016325|58870442|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
30844524|NCT03016325|58870443|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
30844525|NCT03016325|58870444|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
30844526|NCT03016325|58870445|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
30844527|NCT03016325|58870446|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
30844528|NCT03016325|58870447|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
30844529|NCT03016325|58870448|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
30844530|NCT03016325|58870441|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
30844531|NCT03016325|58870442|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
30844532|NCT03016325|58870443|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
30844533|NCT03016325|58870444|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
30844534|NCT03016325|58870445|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
30844535|NCT03016325|58870446|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
30844536|NCT03016325|58870447|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
30844537|NCT03016325|58870448|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
30844538|NCT03016325|58870441|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
30844539|NCT03016325|58870442|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
30844540|NCT03016325|58870443|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
30844541|NCT03016325|58870444|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
30844542|NCT03016325|58870445|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
30844543|NCT03016325|58870446|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
30844544|NCT03016325|58870447|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
30844545|NCT03016325|58870448|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
30844546|NCT03016325|58870441|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
30844547|NCT03016325|58870442|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
30844548|NCT03016325|58870443|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
30844549|NCT03016325|58870444|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
30844550|NCT03016325|58870445|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
30844551|NCT03016325|58870446|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
30844552|NCT03016325|58870447|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
30844553|NCT03016325|58870448|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
30844554|NCT03016325|58870441|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
30844555|NCT03016325|58870442|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
30844556|NCT03016325|58870443|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
30844557|NCT03016325|58870444|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
30844558|NCT03016325|58870445|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
30844559|NCT03016325|58870446|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
30844560|NCT03016325|58870447|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
30844561|NCT03016325|58870448|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
30844562|NCT03016325|58870441|FG000|182-Day Follow-Up Period|Death|3|||
30844563|NCT03016325|58870442|FG001|182-Day Follow-Up Period|Death|3|||
30844564|NCT03016325|58870443|FG002|182-Day Follow-Up Period|Death|11|||
30844565|NCT03016325|58870444|FG003|182-Day Follow-Up Period|Death|12|||
30844566|NCT03016325|58870445|FG004|182-Day Follow-Up Period|Death|9|||
30844567|NCT03016325|58870446|FG005|182-Day Follow-Up Period|Death|0|||
30844568|NCT03016325|58870447|FG006|182-Day Follow-Up Period|Death|0|||
30844569|NCT03016325|58870448|FG007|182-Day Follow-Up Period|Death|1|||
30844570|NCT03016325|58870441|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
30844571|NCT03016325|58870442|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
30844572|NCT03016325|58870443|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
30844573|NCT03016325|58870444|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
30844574|NCT03016325|58870445|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
30844575|NCT03016325|58870446|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
30948747|NCT01708915|58994836|FG000|Overall Study|Adverse Event|1|||
30844576|NCT03016325|58870447|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
30844577|NCT03016325|58870448|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
30844578|NCT03016325|58870441|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
30844579|NCT03016325|58870442|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
30844580|NCT03016325|58870443|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
30948748|NCT01708915|58994837|FG001|Overall Study|Adverse Event|0|||
30948749|NCT01708915|58994838|FG002|Overall Study|Adverse Event|9|||
30948750|NCT01708915|58994839|FG003|Overall Study|Adverse Event|13|||
30948751|NCT01708915|58994836|FG000|Overall Study|Lack of Efficacy|84|||
30948752|NCT01708915|58994837|FG001|Overall Study|Lack of Efficacy|60|||
30948753|NCT01708915|58994838|FG002|Overall Study|Lack of Efficacy|35|||
30948754|NCT01708915|58994839|FG003|Overall Study|Lack of Efficacy|15|||
30948755|NCT01708915|58994836|FG000|Overall Study|Protocol Violation|0|||
30948756|NCT01708915|58994837|FG001|Overall Study|Protocol Violation|0|||
30948757|NCT01708915|58994838|FG002|Overall Study|Protocol Violation|0|||
30948758|NCT01708915|58994839|FG003|Overall Study|Protocol Violation|1|||
30948759|NCT01708915|58994836|FG000|Overall Study|Withdrawal by Subject|0|||
30844581|NCT03016325|58870444|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
30844582|NCT03016325|58870445|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
30844583|NCT03016325|58870446|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
30844584|NCT03016325|58870447|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
30948760|NCT01708915|58994837|FG001|Overall Study|Withdrawal by Subject|1|||
30948761|NCT01708915|58994838|FG002|Overall Study|Withdrawal by Subject|2|||
30948762|NCT01708915|58994839|FG003|Overall Study|Withdrawal by Subject|2|||
30948763|NCT01708915|58994836|FG000|Overall Study|Other reasons than stated above|1|||
30948764|NCT01708915|58994837|FG001|Overall Study|Other reasons than stated above|1|||
30625911|NCT00887224|58638038|FG002|Double-blind (DB) Phase|Failed to return|2|||
30760990|NCT03486223|58769941|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
30760991|NCT03482024|58769952|FG000|Overall Study|Physician Decision|1|||
30760992|NCT03482024|58769953|FG001|Overall Study|Physician Decision|0|||
30760993|NCT03482024|58769954|FG002|Overall Study|Physician Decision|0|||
30625912|NCT00887224|58638036|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
30625913|NCT00887224|58638037|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
30625914|NCT00887224|58638038|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
30625915|NCT00887224|58638036|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
30625916|NCT00887224|58638037|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
30625917|NCT00887224|58638038|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
30625918|NCT00887224|58638036|FG000|Double-blind (DB) Phase|Other|0|||
30625919|NCT00887224|58638037|FG001|Double-blind (DB) Phase|Other|2|||
30625920|NCT00887224|58638038|FG002|Double-blind (DB) Phase|Other|0|||
30625921|NCT00887224|58638036|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
30625922|NCT00887224|58638037|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
30625923|NCT00887224|58638038|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
30625924|NCT00887224|58638036|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
30625925|NCT00887224|58638037|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
30625926|NCT00887224|58638038|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
30625927|NCT00887224|58638036|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
30625928|NCT00887224|58638037|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
30625929|NCT00887224|58638038|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
30625930|NCT00887224|58638036|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
30625931|NCT00887224|58638037|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
30625932|NCT00887224|58638038|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
30625933|NCT00887224|58638036|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
30625934|NCT00887224|58638037|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
30625935|NCT00887224|58638038|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
30625936|NCT00887224|58638036|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
30625937|NCT00887224|58638037|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
30625938|NCT00887224|58638038|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
30625939|NCT00887224|58638036|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
30625940|NCT00887224|58638037|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
30625941|NCT00887224|58638038|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
30625942|NCT00887224|58638036|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
30625943|NCT00887224|58638037|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
30625944|NCT00887224|58638038|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
30625945|NCT00887224|58638036|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
30625946|NCT00887224|58638037|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
30625947|NCT00887224|58638038|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
30625948|NCT01109316|58638056|FG000|Study Period 1|Adverse Event|0|||
30625949|NCT01109316|58638057|FG001|Study Period 1|Adverse Event|0|||
30625950|NCT01109316|58638058|FG002|Study Period 1|Adverse Event|1|||
30625951|NCT01109316|58638059|FG003|Study Period 1|Adverse Event|0|||
30625952|NCT01109316|58638060|FG004|Study Period 1|Adverse Event|0|||
30760994|NCT03482024|58769955|FG003|Overall Study|Physician Decision|0|||
30760995|NCT03482024|58769956|FG004|Overall Study|Physician Decision|0|||
30760996|NCT03468309|58769968|FG000|Overall Study|Lost to Follow-up|4|||
30760997|NCT03468309|58769968|FG000|Overall Study|Withdrawal by Subject|2|||
30760998|NCT03423147|58769974|FG000|Overall Study|Lost to Follow-up|5|||
30948765|NCT01708915|58994838|FG002|Overall Study|Other reasons than stated above|0|||
30948766|NCT01708915|58994839|FG003|Overall Study|Other reasons than stated above|2|||
30948767|NCT01708291|58994851|FG000|Overall Study|fighting|2|||
30948768|NCT01708291|58994852|FG001|Overall Study|fighting|1|||
30948769|NCT01708057|58994858|FG000|Overall Study|Withdrawal due to study termination.|1|||
30948770|NCT01708057|58994859|FG001|Overall Study|Withdrawal due to study termination.|1|||
30948771|NCT01708057|58994860|FG002|Overall Study|Withdrawal due to study termination.|1|||
30948772|NCT01748071|58994877|FG000|Overall Study|Adverse Event|2|||
30948773|NCT01748071|58994878|FG001|Overall Study|Adverse Event|2|||
30948774|NCT01748071|58994879|FG002|Overall Study|Adverse Event|0|||
30948775|NCT01972529|58994891|FG000|Overall Study|Adverse Event|0|||
30948776|NCT01972529|58994892|FG001|Overall Study|Adverse Event|1|||
30948777|NCT01972529|58994893|FG002|Overall Study|Adverse Event|0|||
30948778|NCT01972529|58994894|FG003|Overall Study|Adverse Event|0|||
30948779|NCT01972529|58994891|FG000|Overall Study|Lost to Follow-up|1|||
30948780|NCT01972529|58994892|FG001|Overall Study|Lost to Follow-up|0|||
30948781|NCT01972529|58994893|FG002|Overall Study|Lost to Follow-up|0|||
30948782|NCT01972529|58994894|FG003|Overall Study|Lost to Follow-up|0|||
30948783|NCT01972529|58994891|FG000|Overall Study|Participant Choice|0|||
30948784|NCT01972529|58994892|FG001|Overall Study|Participant Choice|1|||
30948785|NCT01972529|58994893|FG002|Overall Study|Participant Choice|0|||
30948786|NCT01972529|58994894|FG003|Overall Study|Participant Choice|0|||
30948787|NCT01972529|58994891|FG000|Overall Study|Withdrawl of Consent|1|||
30948788|NCT01972529|58994892|FG001|Overall Study|Withdrawl of Consent|2|||
30948789|NCT01972529|58994893|FG002|Overall Study|Withdrawl of Consent|0|||
30948790|NCT01972529|58994894|FG003|Overall Study|Withdrawl of Consent|1|||
30948791|NCT01972529|58994891|FG000|Overall Study|Other|0|||
30948792|NCT01972529|58994892|FG001|Overall Study|Other|0|||
30948793|NCT01972529|58994893|FG002|Overall Study|Other|0|||
30948794|NCT01972529|58994894|FG003|Overall Study|Other|2|||
30948795|NCT01972529|58994891|FG000|Overall Study|Not treated|0|||
30948796|NCT01972529|58994892|FG001|Overall Study|Not treated|1|||
30948797|NCT01972529|58994893|FG002|Overall Study|Not treated|2|||
30948798|NCT01972529|58994894|FG003|Overall Study|Not treated|1|||
30948799|NCT01747915|58994908|FG000|Overall Study|Other|1|||
30948800|NCT01747915|58994909|FG001|Overall Study|Other|1|||
30948801|NCT01747915|58994910|FG002|Overall Study|Other|1|||
30948802|NCT01747915|58994908|FG000|Overall Study|Adverse Event|8|||
30948803|NCT01747915|58994909|FG001|Overall Study|Adverse Event|5|||
30948804|NCT01747915|58994910|FG002|Overall Study|Adverse Event|2|||
30948805|NCT01747915|58994908|FG000|Overall Study|Death|0|||
30948806|NCT01747915|58994909|FG001|Overall Study|Death|0|||
30948807|NCT01747915|58994910|FG002|Overall Study|Death|1|||
30948808|NCT01747915|58994908|FG000|Overall Study|Lack of Efficacy|0|||
30948809|NCT01747915|58994909|FG001|Overall Study|Lack of Efficacy|1|||
30948810|NCT01747915|58994910|FG002|Overall Study|Lack of Efficacy|0|||
30948811|NCT01747915|58994908|FG000|Overall Study|Lost to Follow-up|1|||
30948812|NCT01747915|58994909|FG001|Overall Study|Lost to Follow-up|0|||
30948813|NCT01747915|58994910|FG002|Overall Study|Lost to Follow-up|0|||
30948814|NCT01747915|58994908|FG000|Overall Study|Withdrawal by Subject|4|||
30625953|NCT01109316|58638061|FG005|Study Period 1|Adverse Event|0|||
30625954|NCT01109316|58638056|FG000|Study Period 1|Lost to Follow-up|0|||
30760999|NCT03423147|58769975|FG001|Overall Study|Lost to Follow-up|8|||
30761000|NCT03423147|58769974|FG000|Overall Study|Withdrawal by Subject|1|||
30761001|NCT03423147|58769975|FG001|Overall Study|Withdrawal by Subject|0|||
30761002|NCT03423147|58769974|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
30761003|NCT03423147|58769975|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
30761004|NCT03423147|58769974|FG000|Overall Study|Age < 18|1|||
30761005|NCT03423147|58769975|FG001|Overall Study|Age < 18|0|||
30844585|NCT03016325|58870448|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
30844586|NCT03016325|58870441|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
30948815|NCT01747915|58994909|FG001|Overall Study|Withdrawal by Subject|4|||
30761006|NCT03423147|58769974|FG000|Overall Study|No Trial of Labor|0|||
30761007|NCT03423147|58769975|FG001|Overall Study|No Trial of Labor|1|||
30761008|NCT03322631|58769985|FG000|Overall Study|Withdrawal by Subject|0|||
30761009|NCT03322631|58769986|FG001|Overall Study|Withdrawal by Subject|1|||
30948816|NCT01747915|58994910|FG002|Overall Study|Withdrawal by Subject|1|||
30625955|NCT01109316|58638057|FG001|Study Period 1|Lost to Follow-up|0|||
30625956|NCT01109316|58638058|FG002|Study Period 1|Lost to Follow-up|1|||
30761010|NCT03322631|58769987|FG002|Overall Study|Withdrawal by Subject|0|||
30948817|NCT01747915|58994908|FG000|Overall Study|Protocol Violation|1|||
30948818|NCT01747915|58994909|FG001|Overall Study|Protocol Violation|0|||
30948819|NCT01747915|58994910|FG002|Overall Study|Protocol Violation|0|||
30948820|NCT01747915|58994908|FG000|Overall Study|Pregnancy|0|||
30948821|NCT01747915|58994909|FG001|Overall Study|Pregnancy|0|||
30948822|NCT01747915|58994910|FG002|Overall Study|Pregnancy|1|||
30948823|NCT01961297|58994920|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
30948824|NCT01961297|58994921|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
30948825|NCT01960907|58994929|FG000|Overall Study|Death|4|||
30948826|NCT01960907|58994930|FG001|Overall Study|Death|3|||
30844587|NCT03016325|58870442|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
30844588|NCT03016325|58870443|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
30844589|NCT03016325|58870444|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
30844590|NCT03016325|58870445|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
30844591|NCT03016325|58870446|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
30844592|NCT03016325|58870447|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
30844593|NCT03016325|58870448|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
30844594|NCT03016325|58870441|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
30844595|NCT03016325|58870442|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
30844596|NCT03016325|58870443|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
30844597|NCT03016325|58870444|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
30844598|NCT03016325|58870445|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
30844599|NCT03016325|58870446|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
30844600|NCT03016325|58870447|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
30844601|NCT03016325|58870448|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
30844602|NCT03016325|58870441|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
30844603|NCT03016325|58870442|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
30844604|NCT03016325|58870443|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
30844605|NCT03016325|58870444|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
30844606|NCT03016325|58870445|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
30844607|NCT03016325|58870446|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
30844608|NCT03016325|58870447|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
30844609|NCT03016325|58870448|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
30844610|NCT03016325|58870441|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
30844611|NCT03016325|58870442|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
30844612|NCT03016325|58870443|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
30844613|NCT03016325|58870444|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
30844614|NCT03016325|58870445|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
30948827|NCT01960907|58994929|FG000|Overall Study|Withdrawal by Subject|32|||
30948828|NCT01960907|58994930|FG001|Overall Study|Withdrawal by Subject|42|||
30948829|NCT01747837|58994941|FG000|Overall Study|Lost to Follow-up|5|||
30948830|NCT01747837|58994942|FG001|Overall Study|Lost to Follow-up|2|||
30844615|NCT03016325|58870446|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
30844616|NCT03016325|58870447|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
30844617|NCT03016325|58870448|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
30844618|NCT03016325|58870441|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
30844619|NCT03016325|58870442|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
30844620|NCT03016325|58870443|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
30844621|NCT03016325|58870444|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
30844622|NCT03016325|58870445|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
30844623|NCT03016325|58870446|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
30844624|NCT03016325|58870447|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
30844625|NCT03016325|58870448|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
30844626|NCT02988115|58870471|FG000|Overall Study|Adverse Event|6|||
30844627|NCT02988115|58870472|FG001|Overall Study|Adverse Event|1|||
30844628|NCT02988115|58870471|FG000|Overall Study|Sponsor Decision|5|||
30844629|NCT02988115|58870472|FG001|Overall Study|Sponsor Decision|2|||
30844630|NCT02988115|58870471|FG000|Overall Study|Withdrawal by Subject|1|||
30844631|NCT02988115|58870472|FG001|Overall Study|Withdrawal by Subject|1|||
30844632|NCT02988115|58870471|FG000|Overall Study|Withdrawn by Mistake|1|||
30948831|NCT01747837|58994941|FG000|Overall Study|Death|4|||
30948832|NCT01747837|58994942|FG001|Overall Study|Death|4|||
30948833|NCT01971203|58994950|FG000|Overall Study|Protocol Violation|3|||
30625957|NCT01109316|58638059|FG003|Study Period 1|Lost to Follow-up|1|||
30625958|NCT01109316|58638060|FG004|Study Period 1|Lost to Follow-up|0|||
30625959|NCT01109316|58638061|FG005|Study Period 1|Lost to Follow-up|0|||
30625960|NCT01109316|58638056|FG000|Study Period 1|Withdrawal by Subject|0|||
30625961|NCT01109316|58638057|FG001|Study Period 1|Withdrawal by Subject|0|||
30625962|NCT01109316|58638058|FG002|Study Period 1|Withdrawal by Subject|1|||
30625963|NCT01109316|58638059|FG003|Study Period 1|Withdrawal by Subject|0|||
30625964|NCT01109316|58638060|FG004|Study Period 1|Withdrawal by Subject|2|||
30625965|NCT01109316|58638061|FG005|Study Period 1|Withdrawal by Subject|0|||
30625966|NCT01109316|58638056|FG000|Study Period 1|Sponsor Decision|0|||
30625967|NCT01109316|58638057|FG001|Study Period 1|Sponsor Decision|0|||
30625968|NCT01109316|58638058|FG002|Study Period 1|Sponsor Decision|0|||
30625969|NCT01109316|58638059|FG003|Study Period 1|Sponsor Decision|0|||
30625970|NCT01109316|58638060|FG004|Study Period 1|Sponsor Decision|0|||
30625971|NCT01109316|58638061|FG005|Study Period 1|Sponsor Decision|2|||
30625972|NCT01109316|58638056|FG000|Study Period 2|Entry Criteria Not Met|0|||
30625973|NCT01109316|58638057|FG001|Study Period 2|Entry Criteria Not Met|1|||
30625974|NCT01109316|58638058|FG002|Study Period 2|Entry Criteria Not Met|0|||
30948834|NCT01971203|58994951|FG001|Overall Study|Protocol Violation|2|||
30948835|NCT01971203|58994950|FG000|Overall Study|Withdrawal by Subject|5|||
30948836|NCT01971203|58994951|FG001|Overall Study|Withdrawal by Subject|6|||
30948837|NCT01971203|58994950|FG000|Overall Study|Adverse Event|1|||
30948838|NCT01971203|58994951|FG001|Overall Study|Adverse Event|0|||
30948839|NCT01605877|58994957|FG000|Overall Study|Withdrawal by Subject|1|||
30948840|NCT01970501|58994981|FG000|Overall Study|Discontinuation of study by sponsor|16|||
30948841|NCT01970501|58994982|FG001|Overall Study|Discontinuation of study by sponsor|14|||
30948842|NCT01970501|58994981|FG000|Overall Study|Withdrawal by Subject|6|||
30948843|NCT01970501|58994982|FG001|Overall Study|Withdrawal by Subject|7|||
30625975|NCT01109316|58638059|FG003|Study Period 2|Entry Criteria Not Met|0|||
30761011|NCT03322631|58769988|FG003|Overall Study|Withdrawal by Subject|0|||
30761012|NCT03322631|58769985|FG000|Overall Study|Adverse Event|0|||
30761013|NCT03322631|58769986|FG001|Overall Study|Adverse Event|0|||
30761014|NCT03322631|58769987|FG002|Overall Study|Adverse Event|1|||
30761015|NCT03322631|58769988|FG003|Overall Study|Adverse Event|0|||
30761016|NCT03018704|58770007|FG000|Overall Study|Lost to Follow-up|1|||
30761017|NCT03018704|58770008|FG001|Overall Study|Lost to Follow-up|1|||
30761018|NCT02663349|58770014|FG000|Overall Study|Withdrawal by Subject|6|||
30761019|NCT02558491|58770018|FG000|First Invention|Withdrawal by Subject|3|||
30761020|NCT02558491|58770019|FG001|First Invention|Withdrawal by Subject|1|||
30761021|NCT02558491|58770018|FG000|First Invention|Data collection issues|1|||
30761022|NCT02558491|58770019|FG001|First Invention|Data collection issues|0|||
30761023|NCT02558491|58770018|FG000|First Invention|Stopping criteria|0|||
30761024|NCT02558491|58770019|FG001|First Invention|Stopping criteria|1|||
30761025|NCT02558491|58770018|FG000|First Invention|Changed parameters during trial|1|||
30761026|NCT02558491|58770019|FG001|First Invention|Changed parameters during trial|0|||
30761027|NCT02558491|58770018|FG000|Second Intervention|Withdrawal by Subject|1|||
30761028|NCT02558491|58770019|FG001|Second Intervention|Withdrawal by Subject|0|||
30761029|NCT02558491|58770018|FG000|Second Intervention|Stopping Criteria|1|||
30761030|NCT02558491|58770019|FG001|Second Intervention|Stopping Criteria|0|||
30761031|NCT02490878|58770028|FG000|Overall Study|deemed ineligible|0|||
30761032|NCT02490878|58770029|FG001|Overall Study|deemed ineligible|1|||
30761033|NCT02490878|58770028|FG000|Overall Study|progression prior to treatment|0|||
30625976|NCT01109316|58638060|FG004|Study Period 2|Entry Criteria Not Met|0|||
30625977|NCT01109316|58638061|FG005|Study Period 2|Entry Criteria Not Met|0|||
30625978|NCT01109316|58638056|FG000|Study Period 2|Physician Decision|0|||
30625979|NCT01109316|58638057|FG001|Study Period 2|Physician Decision|0|||
30625980|NCT01109316|58638058|FG002|Study Period 2|Physician Decision|0|||
30625981|NCT01109316|58638059|FG003|Study Period 2|Physician Decision|1|||
30625982|NCT01109316|58638060|FG004|Study Period 2|Physician Decision|0|||
30625983|NCT01109316|58638061|FG005|Study Period 2|Physician Decision|0|||
30625984|NCT01109316|58638056|FG000|Study Period 2|Protocol Violation|1|||
30625985|NCT01109316|58638057|FG001|Study Period 2|Protocol Violation|0|||
30625986|NCT01109316|58638058|FG002|Study Period 2|Protocol Violation|0|||
30625987|NCT01109316|58638059|FG003|Study Period 2|Protocol Violation|0|||
30625988|NCT01109316|58638060|FG004|Study Period 2|Protocol Violation|0|||
30625989|NCT01109316|58638061|FG005|Study Period 2|Protocol Violation|0|||
30625990|NCT01109316|58638056|FG000|Study Period 2|Withdrawal by Subject|0|||
30625991|NCT01109316|58638057|FG001|Study Period 2|Withdrawal by Subject|0|||
30625992|NCT01109316|58638058|FG002|Study Period 2|Withdrawal by Subject|1|||
30625993|NCT01109316|58638059|FG003|Study Period 2|Withdrawal by Subject|0|||
30625994|NCT01109316|58638060|FG004|Study Period 2|Withdrawal by Subject|0|||
30625995|NCT01109316|58638061|FG005|Study Period 2|Withdrawal by Subject|1|||
30625996|NCT01109316|58638056|FG000|Study Period 3|Lost to Follow-up|0|||
30625997|NCT01109316|58638057|FG001|Study Period 3|Lost to Follow-up|0|||
30625998|NCT01109316|58638058|FG002|Study Period 3|Lost to Follow-up|0|||
30625999|NCT01109316|58638059|FG003|Study Period 3|Lost to Follow-up|0|||
30626000|NCT01109316|58638060|FG004|Study Period 3|Lost to Follow-up|1|||
30626001|NCT01109316|58638061|FG005|Study Period 3|Lost to Follow-up|0|||
30626002|NCT01109316|58638056|FG000|Study Period 3|Withdrawal by Subject|1|||
30626003|NCT01109316|58638057|FG001|Study Period 3|Withdrawal by Subject|0|||
30626004|NCT01109316|58638058|FG002|Study Period 3|Withdrawal by Subject|0|||
30626005|NCT01109316|58638059|FG003|Study Period 3|Withdrawal by Subject|0|||
30626006|NCT01109316|58638060|FG004|Study Period 3|Withdrawal by Subject|1|||
30626007|NCT01109316|58638061|FG005|Study Period 3|Withdrawal by Subject|0|||
30626008|NCT00887068|58638071|FG000|Overall Study|Withdrawal by Subject|2|||
30626009|NCT00887068|58638072|FG001|Overall Study|Withdrawal by Subject|0|||
30761034|NCT02490878|58770029|FG001|Overall Study|progression prior to treatment|1|||
30948844|NCT01970501|58994981|FG000|Overall Study|Adverse Event|2|||
30761035|NCT02490878|58770028|FG000|Overall Study|only submitted baseline QOL|0|||
30761036|NCT02490878|58770029|FG001|Overall Study|only submitted baseline QOL|1|||
30761037|NCT02421601|58770035|FG000|Overall Study|Adverse Event|4|||
30761038|NCT02421601|58770035|FG000|Overall Study|Lack of Efficacy|5|||
30948845|NCT01970501|58994982|FG001|Overall Study|Adverse Event|4|||
30948846|NCT01970501|58994981|FG000|Overall Study|Death|1|||
30626010|NCT00887068|58638071|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
30626011|NCT00887068|58638072|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
30626012|NCT00941031|58638082|FG000|Induction Period|Lack of Efficacy|2|||
30626013|NCT00941031|58638083|FG001|Induction Period|Lack of Efficacy|1|||
30626014|NCT00941031|58638084|FG002|Induction Period|Lack of Efficacy|0|||
30626015|NCT00941031|58638085|FG003|Induction Period|Lack of Efficacy|5|||
30761039|NCT02421601|58770035|FG000|Overall Study|Physician Decision|1|||
30844633|NCT02988115|58870472|FG001|Overall Study|Withdrawn by Mistake|0|||
30844634|NCT02988115|58870471|FG000|Overall Study|Lost to Follow-up|1|||
30844635|NCT02988115|58870472|FG001|Overall Study|Lost to Follow-up|0|||
30844636|NCT02921425|58870478|FG000|Overall Study|Protocol Violation|9|||
30844637|NCT03008915|58870482|FG000|Treatment 1|Withdrawal by Subject|0|||
30844638|NCT03008915|58870483|FG001|Treatment 1|Withdrawal by Subject|1|||
30844639|NCT02920957|58870494|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
30844640|NCT02920957|58870495|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
30844641|NCT02920957|58870494|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
30844642|NCT02920957|58870495|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
30844643|NCT02920957|58870494|FG000|First Intervention : 1 Month|Adverse Event|1|||
30844644|NCT02920957|58870495|FG001|First Intervention : 1 Month|Adverse Event|0|||
30844645|NCT02920957|58870494|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
30844646|NCT02920957|58870495|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
30844647|NCT03006887|58870512|FG000|Overall Study|Adverse Event|1|||
30844648|NCT02514772|58870518|FG000|Overall Study|Adverse Event|1|||
30844649|NCT02514772|58870519|FG001|Overall Study|Adverse Event|0|||
30844650|NCT02514772|58870518|FG000|Overall Study|Death|0|||
30844651|NCT02514772|58870519|FG001|Overall Study|Death|1|||
30844652|NCT02514772|58870518|FG000|Overall Study|Withdrawal by Subject|2|||
30844653|NCT02514772|58870519|FG001|Overall Study|Withdrawal by Subject|1|||
30844654|NCT03000179|58870527|FG000|Overall Study|Lost to Follow-up|2|||
30844655|NCT02920177|58870533|FG000|Overall Study|Withdrawal by Subject|1|||
30844656|NCT02920177|58870534|FG001|Overall Study|Withdrawal by Subject|1|||
30844657|NCT02920177|58870533|FG000|Overall Study|Physician Decision|1|||
30948847|NCT01970501|58994982|FG001|Overall Study|Death|3|||
30948848|NCT01970501|58994981|FG000|Overall Study|Physician Decision|2|||
30948849|NCT01970501|58994982|FG001|Overall Study|Physician Decision|0|||
30948850|NCT01969799|58994990|FG000|Overall Study|Adverse Event|0|||
30948851|NCT01969799|58994991|FG001|Overall Study|Adverse Event|1|||
30948852|NCT01969799|58994990|FG000|Overall Study|Death|16|||
30948853|NCT01969799|58994991|FG001|Overall Study|Death|11|||
30948854|NCT01969799|58994990|FG000|Overall Study|Lost to Follow-up|0|||
30948855|NCT01969799|58994991|FG001|Overall Study|Lost to Follow-up|2|||
30844658|NCT02920177|58870534|FG001|Overall Study|Physician Decision|0|||
30844659|NCT02920177|58870533|FG000|Overall Study|Lost to Follow-up|0|||
30844660|NCT02920177|58870534|FG001|Overall Study|Lost to Follow-up|1|||
30844661|NCT03006341|58870544|FG000|Overall Study|Not linked in the EMR|25069|||
30844662|NCT03006341|58870545|FG001|Overall Study|Not linked in the EMR|67505|||
30844663|NCT03006341|58870546|FG002|Overall Study|Not linked in the EMR|30993|||
30844664|NCT03006341|58870547|FG003|Overall Study|Not linked in the EMR|10685|||
30844665|NCT03935594|58870555|FG000|Overall Study|Physician Decision|3|||
30844666|NCT02512042|58870563|FG000|Overall Study|Adverse Event|0|||
30948856|NCT01969799|58994990|FG000|Overall Study|Physician Decision|1|||
30948857|NCT01969799|58994991|FG001|Overall Study|Physician Decision|0|||
30948858|NCT01969721|58994997|FG000|Overall Study|Adverse Event|3|||
30948859|NCT01969721|58994998|FG001|Overall Study|Adverse Event|8|||
30761040|NCT02421601|58770035|FG000|Overall Study|Withdrawal by Subject|31|||
30761041|NCT02421601|58770035|FG000|Overall Study|Others|41|||
30761042|NCT01934218|58770041|FG000|Double-blind Phase|Adverse Event|8|||
30761043|NCT01934218|58770042|FG001|Double-blind Phase|Adverse Event|8|||
30761044|NCT01934218|58770041|FG000|Double-blind Phase|Lack of Efficacy|6|||
30761045|NCT01934218|58770042|FG001|Double-blind Phase|Lack of Efficacy|7|||
30761046|NCT01934218|58770041|FG000|Double-blind Phase|Lost to Follow-up|7|||
30761047|NCT01934218|58770042|FG001|Double-blind Phase|Lost to Follow-up|14|||
30761048|NCT01934218|58770041|FG000|Double-blind Phase|Physician Decision|1|||
30761049|NCT01934218|58770042|FG001|Double-blind Phase|Physician Decision|2|||
30761050|NCT01934218|58770041|FG000|Double-blind Phase|Protocol Violation|4|||
30948860|NCT01969721|58994999|FG002|Overall Study|Adverse Event|3|||
30948861|NCT01969721|58995000|FG003|Overall Study|Adverse Event|2|||
30626016|NCT00941031|58638086|FG004|Induction Period|Lack of Efficacy|0|||
30761051|NCT01934218|58770042|FG001|Double-blind Phase|Protocol Violation|0|||
30761052|NCT01934218|58770041|FG000|Double-blind Phase|Withdrawal by Subject|16|||
30844667|NCT02512042|58870564|FG001|Overall Study|Adverse Event|4|||
30844668|NCT02512042|58870563|FG000|Overall Study|Withdrawal by Subject|6|||
30844669|NCT02512042|58870564|FG001|Overall Study|Withdrawal by Subject|6|||
30844670|NCT02512042|58870563|FG000|Overall Study|Non-compliance with study drug|1|||
30844671|NCT02512042|58870564|FG001|Overall Study|Non-compliance with study drug|2|||
30844672|NCT02512042|58870563|FG000|Overall Study|Lost to Follow-up|5|||
30844673|NCT02512042|58870564|FG001|Overall Study|Lost to Follow-up|2|||
30948862|NCT01969721|58994997|FG000|Overall Study|Lack of Efficacy|0|||
30626017|NCT00941031|58638087|FG005|Induction Period|Lack of Efficacy|0|||
30844674|NCT02512042|58870563|FG000|Overall Study|Other|11|||
30844675|NCT02512042|58870564|FG001|Overall Study|Other|11|||
30844676|NCT02911025|58870570|FG000|Overall Study|Lost to Follow-up|3|||
30844677|NCT02919475|58870579|FG000|Overall Study|Adverse Event|3|||
30844678|NCT02919475|58870580|FG001|Overall Study|Adverse Event|3|||
30844679|NCT02919475|58870581|FG002|Overall Study|Adverse Event|3|||
30844680|NCT02919475|58870582|FG003|Overall Study|Adverse Event|9|||
30844681|NCT02919475|58870583|FG004|Overall Study|Adverse Event|2|||
30844682|NCT02919475|58870579|FG000|Overall Study|Death|0|||
30844683|NCT02919475|58870580|FG001|Overall Study|Death|1|||
30844684|NCT02919475|58870581|FG002|Overall Study|Death|0|||
30844685|NCT02919475|58870582|FG003|Overall Study|Death|0|||
30844686|NCT02919475|58870583|FG004|Overall Study|Death|0|||
30844687|NCT02919475|58870579|FG000|Overall Study|Lost to Follow-up|0|||
30844688|NCT02919475|58870580|FG001|Overall Study|Lost to Follow-up|0|||
30844689|NCT02919475|58870581|FG002|Overall Study|Lost to Follow-up|0|||
30844690|NCT02919475|58870582|FG003|Overall Study|Lost to Follow-up|1|||
30844691|NCT02919475|58870583|FG004|Overall Study|Lost to Follow-up|0|||
30948863|NCT01969721|58994998|FG001|Overall Study|Lack of Efficacy|0|||
30626018|NCT00941031|58638088|FG006|Induction Period|Lack of Efficacy|0|||
30761053|NCT01934218|58770042|FG001|Double-blind Phase|Withdrawal by Subject|13|||
30761054|NCT01934218|58770041|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
30761055|NCT01934218|58770042|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
30761056|NCT01934218|58770041|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
30761057|NCT01934218|58770042|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
30761058|NCT01934218|58770041|FG000|Open-Label Phase|Adverse Event|2|||
30761059|NCT01934218|58770042|FG001|Open-Label Phase|Adverse Event|4|||
30761060|NCT01934218|58770041|FG000|Open-Label Phase|Lack of Efficacy|1|||
30761061|NCT01934218|58770042|FG001|Open-Label Phase|Lack of Efficacy|4|||
30761062|NCT01934218|58770041|FG000|Open-Label Phase|Lost to Follow-up|4|||
30761063|NCT01934218|58770042|FG001|Open-Label Phase|Lost to Follow-up|2|||
30761064|NCT01934218|58770041|FG000|Open-Label Phase|Physician Decision|1|||
30761065|NCT01934218|58770042|FG001|Open-Label Phase|Physician Decision|0|||
30761066|NCT01934218|58770041|FG000|Open-Label Phase|Protocol Violation|1|||
30761067|NCT01934218|58770042|FG001|Open-Label Phase|Protocol Violation|0|||
30761068|NCT01934218|58770041|FG000|Open-Label Phase|Withdrawal by Subject|13|||
30761069|NCT01934218|58770042|FG001|Open-Label Phase|Withdrawal by Subject|11|||
30761070|NCT01934218|58770041|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
30761071|NCT01934218|58770042|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
30761072|NCT01934218|58770041|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
30761073|NCT01934218|58770042|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
30761074|NCT01702805|58770050|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
30761075|NCT01702805|58770051|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
30761076|NCT01702805|58770050|FG000|Overall Study|Incomplete Follow-up|18|||
30761077|NCT01702805|58770051|FG001|Overall Study|Incomplete Follow-up|15|||
30761078|NCT01702805|58770050|FG000|Overall Study|Vital Status Assessment Only|40|||
30761079|NCT01702805|58770051|FG001|Overall Study|Vital Status Assessment Only|39|||
30761080|NCT01702805|58770050|FG000|Overall Study|Lost to Follow-up|5|||
30761081|NCT01702805|58770051|FG001|Overall Study|Lost to Follow-up|5|||
30761082|NCT00097370|58770074|FG000|Stage 1|Adverse Event|3|||
30761083|NCT00097370|58770074|FG000|Stage 1|Withdrawal by Subject|1|||
30761084|NCT00097370|58770074|FG000|Stage 1|Lack of Efficacy|2|||
30761085|NCT00097370|58770074|FG000|Stage 2|Adverse Event|5|||
30761086|NCT00097370|58770074|FG000|Stage 2|Withdrawal by Subject|1|||
30761087|NCT00097370|58770074|FG000|Stage 2|Lack of Efficacy|3|||
30761088|NCT00097370|58770074|FG000|Stage 2|Pregnancy|1|||
30761089|NCT00097370|58770074|FG000|Stage 2|Sponsor Terminated Study|2|||
30761090|NCT00097370|58770074|FG000|Stage 2|Lost to Follow-up|1|||
30761091|NCT00097370|58770074|FG000|Stage 3|Adverse Event|2|||
30761092|NCT00097370|58770074|FG000|Stage 3|Withdrawal by Subject|3|||
30761093|NCT00097370|58770074|FG000|Stage 3|Lack of Efficacy|1|||
30761094|NCT00097370|58770074|FG000|Stage 3|Sponsor Terminated Study|52|||
30761095|NCT00097370|58770074|FG000|Stage 3|Lost to Follow-up|1|||
30761096|NCT03515824|58770090|FG000|Overall Study|Death|3|||
30761097|NCT03515824|58770091|FG001|Overall Study|Death|2|||
30761098|NCT03515824|58770092|FG002|Overall Study|Death|6|||
30761099|NCT03515824|58770093|FG003|Overall Study|Death|0|||
30761100|NCT03515824|58770090|FG000|Overall Study|Lost to Follow-up|0|||
30761101|NCT03515824|58770091|FG001|Overall Study|Lost to Follow-up|1|||
30761102|NCT03515824|58770092|FG002|Overall Study|Lost to Follow-up|1|||
30844692|NCT02919475|58870579|FG000|Overall Study|Withdrawal by Subject|2|||
30844693|NCT02919475|58870580|FG001|Overall Study|Withdrawal by Subject|3|||
30844694|NCT02919475|58870581|FG002|Overall Study|Withdrawal by Subject|1|||
30844695|NCT02919475|58870582|FG003|Overall Study|Withdrawal by Subject|2|||
30844696|NCT02919475|58870583|FG004|Overall Study|Withdrawal by Subject|2|||
30844697|NCT02919475|58870579|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
30844698|NCT02919475|58870580|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
30844699|NCT02919475|58870581|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
30948864|NCT01969721|58994999|FG002|Overall Study|Lack of Efficacy|1|||
30948865|NCT01969721|58995000|FG003|Overall Study|Lack of Efficacy|0|||
30948866|NCT01969721|58994997|FG000|Overall Study|Non compliant with protocol|1|||
30948867|NCT01969721|58994998|FG001|Overall Study|Non compliant with protocol|1|||
30948868|NCT01969721|58994999|FG002|Overall Study|Non compliant with protocol|0|||
30948869|NCT01969721|58995000|FG003|Overall Study|Non compliant with protocol|2|||
30948870|NCT01969721|58994997|FG000|Overall Study|Other not defined above|0|||
30948871|NCT01969721|58994998|FG001|Overall Study|Other not defined above|2|||
30948872|NCT01969721|58994999|FG002|Overall Study|Other not defined above|0|||
30948873|NCT01969721|58995000|FG003|Overall Study|Other not defined above|0|||
30948874|NCT01969721|58994997|FG000|Overall Study|Discontinued during washout periods.|0|||
30948875|NCT01969721|58994998|FG001|Overall Study|Discontinued during washout periods.|1|||
30948876|NCT01969721|58994999|FG002|Overall Study|Discontinued during washout periods.|1|||
30948877|NCT01969721|58995000|FG003|Overall Study|Discontinued during washout periods.|2|||
30948878|NCT01969565|58995010|FG000|Overall Study|Withdrawal by Subject|1|||
30948879|NCT01968707|58995023|FG000|Overall Study|Did not meet treatment day baseline|49|||
30948880|NCT01968707|58995024|FG001|Overall Study|Did not meet treatment day baseline|12|||
30948881|NCT01968707|58995025|FG002|Overall Study|Did not meet treatment day baseline|41|||
30948882|NCT01968707|58995026|FG003|Overall Study|Did not meet treatment day baseline|44|||
30948883|NCT01968707|58995027|FG004|Overall Study|Did not meet treatment day baseline|36|||
30948884|NCT01968707|58995028|FG005|Overall Study|Did not meet treatment day baseline|11|||
30948885|NCT01968707|58995029|FG006|Overall Study|Did not meet treatment day baseline|34|||
30948886|NCT01968707|58995030|FG007|Overall Study|Did not meet treatment day baseline|35|||
30948887|NCT01959581|58995063|FG000|Overall Study|Lost to Follow-up|5|||
30948888|NCT01746901|58995067|FG000|Naloxone Challenge Phase|Adverse Event|2|||
30948889|NCT01746901|58995068|FG001|Naloxone Challenge Phase|Adverse Event|0|||
30948890|NCT01746901|58995069|FG002|Naloxone Challenge Phase|Adverse Event|0|||
30948891|NCT01746901|58995070|FG003|Naloxone Challenge Phase|Adverse Event|0|||
30948892|NCT01746901|58995071|FG004|Naloxone Challenge Phase|Adverse Event|0|||
30948893|NCT01746901|58995072|FG005|Naloxone Challenge Phase|Adverse Event|0|||
30948894|NCT01746901|58995073|FG006|Naloxone Challenge Phase|Adverse Event|0|||
30948895|NCT01746901|58995074|FG007|Naloxone Challenge Phase|Adverse Event|0|||
30948896|NCT01746901|58995075|FG008|Naloxone Challenge Phase|Adverse Event|0|||
30948897|NCT01746901|58995067|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
30948898|NCT01746901|58995068|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
30948899|NCT01746901|58995069|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
30948900|NCT01746901|58995070|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
30948901|NCT01746901|58995071|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
30948902|NCT01746901|58995072|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
30948903|NCT01746901|58995073|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
30948904|NCT01746901|58995074|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
30948905|NCT01746901|58995075|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
30948906|NCT01746901|58995067|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30948907|NCT01746901|58995068|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
30948908|NCT01746901|58995069|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30948909|NCT01746901|58995070|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30948910|NCT01746901|58995071|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30948911|NCT01746901|58995072|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30948912|NCT01746901|58995073|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30948913|NCT01746901|58995074|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30948914|NCT01746901|58995075|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30948915|NCT01746901|58995067|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
30844700|NCT02919475|58870582|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
30844701|NCT02919475|58870583|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30844702|NCT01066897|58870597|FG000|Overall Study|Withdrawal by Subject|1|||
30844703|NCT01066897|58870598|FG001|Overall Study|Withdrawal by Subject|0|||
30844704|NCT01066897|58870597|FG000|Overall Study|stopped study after developing the flu.|1|||
30844705|NCT01066897|58870598|FG001|Overall Study|stopped study after developing the flu.|0|||
30844706|NCT02985541|58870605|FG000|Overall Study|Withdrawal by Subject|33|||
30948916|NCT01746901|58995068|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
30948917|NCT01746901|58995069|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
30948918|NCT01746901|58995070|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
30844707|NCT02985541|58870605|FG000|Overall Study|Lost to Follow-up|26|||
30844708|NCT02985541|58870605|FG000|Overall Study|Adverse Event|27|||
30948919|NCT01746901|58995071|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
30948920|NCT01746901|58995072|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
30948921|NCT01746901|58995073|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
30948922|NCT01746901|58995074|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
30948923|NCT01746901|58995075|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
30948924|NCT01746901|58995067|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
30948925|NCT01746901|58995068|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
30948926|NCT01746901|58995069|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
30948927|NCT01746901|58995070|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
30844709|NCT02985541|58870605|FG000|Overall Study|Physician Decision|2|||
30844710|NCT02985541|58870605|FG000|Overall Study|Pregnancy|2|||
30844711|NCT02985541|58870605|FG000|Overall Study|Wish for pregnancy|44|||
30844712|NCT02985541|58870605|FG000|Overall Study|Other reason|5|||
30844713|NCT02985541|58870605|FG000|Overall Study|Not valid for analysis|2|||
30844714|NCT02910037|58870618|FG000|Overall Study|Withdrawal by Subject|4|||
30844715|NCT02910037|58870618|FG000|Overall Study|Lost to Follow-up|6|||
30844716|NCT02511184|58870653|FG000|Overall Study|Death|1|||
30844717|NCT02511184|58870654|FG001|Overall Study|Death|0|||
30844718|NCT02511184|58870653|FG000|Overall Study|Lost to Follow-up|0|||
30844719|NCT02511184|58870654|FG001|Overall Study|Lost to Follow-up|1|||
30844720|NCT02511184|58870653|FG000|Overall Study|Study terminated by sponsor|1|||
30844721|NCT02511184|58870654|FG001|Overall Study|Study terminated by sponsor|5|||
30844722|NCT02511184|58870653|FG000|Overall Study|Withdrawal by Subject|0|||
30844723|NCT02511184|58870654|FG001|Overall Study|Withdrawal by Subject|1|||
30844724|NCT02984995|58870663|FG000|Overall Study|Required stem cell transplant|13|||
30844725|NCT02984995|58870664|FG001|Overall Study|Required stem cell transplant|2|||
30844726|NCT02984995|58870663|FG000|Overall Study|Progressive disease|11|||
30844727|NCT02984995|58870664|FG001|Overall Study|Progressive disease|1|||
30844728|NCT02984995|58870663|FG000|Overall Study|Adverse Event|1|||
30844729|NCT02984995|58870664|FG001|Overall Study|Adverse Event|0|||
30844730|NCT02984683|58870688|FG000|Overall Study|Adverse Event|3|||
30844731|NCT02984683|58870689|FG001|Overall Study|Adverse Event|3|||
30761103|NCT03515824|58770093|FG003|Overall Study|Lost to Follow-up|0|||
30761104|NCT03515824|58770090|FG000|Overall Study|Study terminated by sponsor|0|||
30761105|NCT03515824|58770091|FG001|Overall Study|Study terminated by sponsor|1|||
30761106|NCT03515824|58770092|FG002|Overall Study|Study terminated by sponsor|6|||
30761107|NCT03515824|58770093|FG003|Overall Study|Study terminated by sponsor|0|||
30761108|NCT03515824|58770090|FG000|Overall Study|Status not recorded|0|||
30761109|NCT03515824|58770091|FG001|Overall Study|Status not recorded|0|||
30761110|NCT03515824|58770092|FG002|Overall Study|Status not recorded|2|||
30761111|NCT03515824|58770093|FG003|Overall Study|Status not recorded|0|||
30761112|NCT01089374|58770103|FG000|Overall Study|Lost to Follow-up|3|||
30761113|NCT01089374|58770104|FG001|Overall Study|Lost to Follow-up|0|||
30761114|NCT01089374|58770103|FG000|Overall Study|Withdrawal by Subject|1|||
30761115|NCT01089374|58770104|FG001|Overall Study|Withdrawal by Subject|0|||
30761116|NCT01089374|58770103|FG000|Overall Study|Study closed early - low accrual|6|||
30761117|NCT01089374|58770104|FG001|Overall Study|Study closed early - low accrual|0|||
30761118|NCT03511378|58770111|FG000|Overall Study|Withdrawal by Subject|2|||
30761119|NCT03511378|58770112|FG001|Overall Study|Withdrawal by Subject|2|||
30761120|NCT03511378|58770111|FG000|Overall Study|Patient not coming or schedule visit|1|||
30761121|NCT03511378|58770112|FG001|Overall Study|Patient not coming or schedule visit|0|||
30761122|NCT03511066|58770121|FG000|Overall Study|Withdrawal by Subject|1|||
30761123|NCT03511066|58770122|FG001|Overall Study|Withdrawal by Subject|2|||
30761124|NCT03511066|58770123|FG002|Overall Study|Withdrawal by Subject|3|||
30761125|NCT03511066|58770121|FG000|Overall Study|Lost to Follow-up|2|||
30761126|NCT03511066|58770122|FG001|Overall Study|Lost to Follow-up|3|||
30761127|NCT03511066|58770123|FG002|Overall Study|Lost to Follow-up|0|||
30761128|NCT03510910|58770133|FG000|Overall Study|Incomplete Survey|2|||
30761129|NCT03510910|58770134|FG001|Overall Study|Incomplete Survey|3|||
30761130|NCT03509350|58770142|FG000|Overall Study|Withdrawal by Subject|0|||
30761131|NCT03509350|58770143|FG001|Overall Study|Withdrawal by Subject|2|||
30761132|NCT00072410|58770151|FG000|Overall Study|Progressive disease|0|||
30761133|NCT00072410|58770152|FG001|Overall Study|Progressive disease|3|||
30761134|NCT03478696|58770160|FG000|Overall Study|Adverse Event|1|||
30844732|NCT02984683|58870688|FG000|Overall Study|Withdrawal by Subject|1|||
30844733|NCT02984683|58870689|FG001|Overall Study|Withdrawal by Subject|0|||
30844734|NCT02984683|58870688|FG000|Overall Study|Disease progression|7|||
30844735|NCT02984683|58870689|FG001|Overall Study|Disease progression|9|||
30844736|NCT02909101|58870697|FG000|Overall Study|Lost to Follow-up|1|||
30761135|NCT03478696|58770161|FG001|Overall Study|Adverse Event|5|||
30761136|NCT03478696|58770160|FG000|Overall Study|Lost to Follow-up|1|||
30761137|NCT03478696|58770161|FG001|Overall Study|Lost to Follow-up|0|||
30761138|NCT03478696|58770160|FG000|Overall Study|Physician Decision|6|||
30761139|NCT03478696|58770161|FG001|Overall Study|Physician Decision|3|||
30761140|NCT03478696|58770160|FG000|Overall Study|Withdrawal by Subject|9|||
30761141|NCT03478696|58770161|FG001|Overall Study|Withdrawal by Subject|4|||
30761142|NCT03477838|58770167|FG000|Overall Study|Lost to Follow-up|14|||
30844737|NCT02909101|58870698|FG001|Overall Study|Lost to Follow-up|1|||
30844738|NCT03004469|58870707|FG000|Overall Study|Adverse Event|6|||
30844739|NCT03004469|58870708|FG001|Overall Study|Adverse Event|4|||
30844740|NCT03004469|58870709|FG002|Overall Study|Adverse Event|6|||
30844741|NCT03004469|58870707|FG000|Overall Study|Lack of Efficacy|1|||
30844742|NCT03004469|58870708|FG001|Overall Study|Lack of Efficacy|0|||
30844743|NCT03004469|58870709|FG002|Overall Study|Lack of Efficacy|1|||
30761143|NCT00072176|58770173|FG000|Overall Study|Withdrawal by Subject|1|||
30761144|NCT00072176|58770174|FG001|Overall Study|Withdrawal by Subject|0|||
30761145|NCT00072176|58770173|FG000|Overall Study|Protocol Violation|0|||
30761146|NCT00072176|58770174|FG001|Overall Study|Protocol Violation|1|||
30761147|NCT00071396|58770180|FG000|Overall Study|Withdrawal by Subject|1|||
30761148|NCT00071396|58770180|FG000|Overall Study|Physician Decision|2|||
30761149|NCT03473236|58770194|FG000|Overall Study|Withdrawal by Subject|0|||
30844744|NCT03004469|58870707|FG000|Overall Study|Lost to Follow-up|23|||
30844745|NCT03004469|58870708|FG001|Overall Study|Lost to Follow-up|14|||
30844746|NCT03004469|58870709|FG002|Overall Study|Lost to Follow-up|6|||
30844747|NCT03004469|58870707|FG000|Overall Study|Non-Compliance with Study Drug|2|||
30844748|NCT03004469|58870708|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30844749|NCT03004469|58870709|FG002|Overall Study|Non-Compliance with Study Drug|0|||
30844750|NCT03004469|58870707|FG000|Overall Study|Protocol Violation|0|||
30844751|NCT03004469|58870708|FG001|Overall Study|Protocol Violation|0|||
30844752|NCT03004469|58870709|FG002|Overall Study|Protocol Violation|1|||
30844753|NCT03004469|58870707|FG000|Overall Study|Withdrawal by Subject|29|||
30844754|NCT03004469|58870708|FG001|Overall Study|Withdrawal by Subject|27|||
30844755|NCT03004469|58870709|FG002|Overall Study|Withdrawal by Subject|10|||
30844756|NCT03004469|58870707|FG000|Overall Study|Other unspecified reason|0|||
30844757|NCT03004469|58870708|FG001|Overall Study|Other unspecified reason|4|||
30626019|NCT00941031|58638082|FG000|Induction Period|Withdrawal by Subject|1|||
30626020|NCT00941031|58638083|FG001|Induction Period|Withdrawal by Subject|2|||
30626021|NCT00941031|58638084|FG002|Induction Period|Withdrawal by Subject|2|||
30626022|NCT00941031|58638085|FG003|Induction Period|Withdrawal by Subject|2|||
30626023|NCT00941031|58638086|FG004|Induction Period|Withdrawal by Subject|0|||
30626024|NCT00941031|58638087|FG005|Induction Period|Withdrawal by Subject|0|||
30626025|NCT00941031|58638088|FG006|Induction Period|Withdrawal by Subject|0|||
30626026|NCT00941031|58638082|FG000|Induction Period|Adminstative Problems|1|||
30626027|NCT00941031|58638083|FG001|Induction Period|Adminstative Problems|1|||
30626028|NCT00941031|58638084|FG002|Induction Period|Adminstative Problems|1|||
30626029|NCT00941031|58638085|FG003|Induction Period|Adminstative Problems|0|||
30626030|NCT00941031|58638086|FG004|Induction Period|Adminstative Problems|0|||
30844758|NCT03004469|58870709|FG002|Overall Study|Other unspecified reason|1|||
30844759|NCT02910713|58870718|FG000|Overall Study|Protocol Violation|2|||
30844760|NCT02910713|58870718|FG000|Overall Study|Subject Choice|4|||
30844761|NCT02910713|58870718|FG000|Overall Study|Received One Application|10|||
30844762|NCT02910713|58870718|FG000|Overall Study|Received Neither Application|18|||
30844763|NCT02910713|58870718|FG000|Overall Study|Enrollment cap|7|||
30844764|NCT02910713|58870718|FG000|Overall Study|Investigator Discretion|1|||
30844765|NCT02998541|58870726|FG000|Overall Study|Adverse Event|4|||
30844766|NCT02998541|58870727|FG001|Overall Study|Adverse Event|5|||
30844767|NCT02998541|58870728|FG002|Overall Study|Adverse Event|1|||
30844768|NCT02998541|58870726|FG000|Overall Study|Protocol Violation|1|||
30844769|NCT02998541|58870727|FG001|Overall Study|Protocol Violation|0|||
30844770|NCT02998541|58870728|FG002|Overall Study|Protocol Violation|0|||
30844771|NCT02998541|58870726|FG000|Overall Study|Withdrawal by Subject|3|||
30844772|NCT02998541|58870727|FG001|Overall Study|Withdrawal by Subject|1|||
30626031|NCT00941031|58638087|FG005|Induction Period|Adminstative Problems|0|||
30626032|NCT00941031|58638088|FG006|Induction Period|Adminstative Problems|0|||
30626033|NCT00941031|58638082|FG000|Induction Period|Adverse Event|1|||
30626034|NCT00941031|58638083|FG001|Induction Period|Adverse Event|0|||
30626035|NCT00941031|58638084|FG002|Induction Period|Adverse Event|3|||
30626036|NCT00941031|58638085|FG003|Induction Period|Adverse Event|2|||
30626037|NCT00941031|58638086|FG004|Induction Period|Adverse Event|0|||
30761150|NCT03473236|58770195|FG001|Overall Study|Withdrawal by Subject|0|||
30761151|NCT03473236|58770196|FG002|Overall Study|Withdrawal by Subject|0|||
30761152|NCT03473236|58770197|FG003|Overall Study|Withdrawal by Subject|0|||
30761153|NCT03473236|58770198|FG004|Overall Study|Withdrawal by Subject|0|||
30761154|NCT03473236|58770199|FG005|Overall Study|Withdrawal by Subject|1|||
30844773|NCT02998541|58870728|FG002|Overall Study|Withdrawal by Subject|0|||
30844774|NCT02998541|58870726|FG000|Overall Study|Lost to Follow-up|0|||
30844775|NCT02998541|58870727|FG001|Overall Study|Lost to Follow-up|3|||
30844776|NCT02998541|58870728|FG002|Overall Study|Lost to Follow-up|1|||
30844777|NCT02998541|58870726|FG000|Overall Study|Physician Decision|0|||
30948928|NCT01746901|58995071|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
30626038|NCT00941031|58638087|FG005|Induction Period|Adverse Event|0|||
30626039|NCT00941031|58638088|FG006|Induction Period|Adverse Event|0|||
30626040|NCT00941031|58638082|FG000|Maintenance Period|Withdrawal by Subject|0|||
30626041|NCT00941031|58638083|FG001|Maintenance Period|Withdrawal by Subject|0|||
30626042|NCT00941031|58638084|FG002|Maintenance Period|Withdrawal by Subject|0|||
30626043|NCT00941031|58638085|FG003|Maintenance Period|Withdrawal by Subject|0|||
30844778|NCT02998541|58870727|FG001|Overall Study|Physician Decision|0|||
30844779|NCT02998541|58870728|FG002|Overall Study|Physician Decision|3|||
30948929|NCT01746901|58995072|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
30948930|NCT01746901|58995073|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
30948931|NCT01746901|58995074|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
30948932|NCT01746901|58995075|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
30948933|NCT01746901|58995067|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30948934|NCT01746901|58995068|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
30948935|NCT01746901|58995069|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
30948936|NCT01746901|58995070|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30948937|NCT01746901|58995071|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30948938|NCT01746901|58995072|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30948939|NCT01746901|58995073|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30948940|NCT01746901|58995074|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30948941|NCT01746901|58995075|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30948942|NCT01746901|58995067|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
30948943|NCT01746901|58995068|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
30948944|NCT01746901|58995069|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
30948945|NCT01746901|58995070|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
30948946|NCT01746901|58995071|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
30948947|NCT01746901|58995072|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
30948948|NCT01746901|58995073|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
30948949|NCT01746901|58995074|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
30948950|NCT01746901|58995075|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
30948951|NCT01746901|58995067|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
30948952|NCT01746901|58995068|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
30948953|NCT01746901|58995069|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
30948954|NCT01746901|58995070|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
30948955|NCT01746901|58995071|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
30948956|NCT01746901|58995072|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
30948957|NCT01746901|58995073|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
30948958|NCT01746901|58995074|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
30948959|NCT01746901|58995075|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
30948960|NCT01746901|58995067|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
30948961|NCT01746901|58995068|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
30948962|NCT01746901|58995069|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
30948963|NCT01746901|58995070|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
30948964|NCT01746901|58995071|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
30948965|NCT01746901|58995072|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
30948966|NCT01746901|58995073|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
30948967|NCT01746901|58995074|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
30948968|NCT01746901|58995075|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
30844780|NCT02998541|58870726|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30844781|NCT02998541|58870727|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
30844782|NCT02998541|58870728|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
30844783|NCT02998151|58870736|FG000|Overall Study|Withdrawal by Subject|3|||
30844784|NCT02998151|58870736|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
30844785|NCT02998151|58870736|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
30844786|NCT01066819|58870767|FG000|Overall Study|Adverse Event|18|||
30844787|NCT01066819|58870768|FG001|Overall Study|Adverse Event|1|||
30844788|NCT01066819|58870769|FG002|Overall Study|Adverse Event|6|||
30844789|NCT01066819|58870770|FG003|Overall Study|Adverse Event|0|||
30844790|NCT01066819|58870771|FG004|Overall Study|Adverse Event|0|||
30844791|NCT01066819|58870772|FG005|Overall Study|Adverse Event|0|||
30844792|NCT01066819|58870767|FG000|Overall Study|Death|5|||
30844793|NCT01066819|58870768|FG001|Overall Study|Death|0|||
30844794|NCT01066819|58870769|FG002|Overall Study|Death|1|||
30844795|NCT01066819|58870770|FG003|Overall Study|Death|0|||
30844796|NCT01066819|58870771|FG004|Overall Study|Death|0|||
30844797|NCT01066819|58870772|FG005|Overall Study|Death|0|||
30844798|NCT01066819|58870767|FG000|Overall Study|Lack of Efficacy|22|||
30844799|NCT01066819|58870768|FG001|Overall Study|Lack of Efficacy|1|||
30844800|NCT01066819|58870769|FG002|Overall Study|Lack of Efficacy|2|||
30844801|NCT01066819|58870770|FG003|Overall Study|Lack of Efficacy|1|||
30844802|NCT01066819|58870771|FG004|Overall Study|Lack of Efficacy|0|||
30844803|NCT01066819|58870772|FG005|Overall Study|Lack of Efficacy|0|||
30844804|NCT01066819|58870767|FG000|Overall Study|Physician Decision|6|||
30948969|NCT01746901|58995067|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
30948970|NCT01746901|58995068|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
30844805|NCT01066819|58870768|FG001|Overall Study|Physician Decision|2|||
30844806|NCT01066819|58870769|FG002|Overall Study|Physician Decision|3|||
30948971|NCT01746901|58995069|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
30948972|NCT01746901|58995070|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
30948973|NCT01746901|58995071|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
30948974|NCT01746901|58995072|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
30948975|NCT01746901|58995073|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
30948976|NCT01746901|58995074|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
30948977|NCT01746901|58995075|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
30948978|NCT01746901|58995067|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
30948979|NCT01746901|58995068|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
30948980|NCT01746901|58995069|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
30948981|NCT01746901|58995070|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
30948982|NCT01746901|58995071|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
30948983|NCT01746901|58995072|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
30948984|NCT01746901|58995073|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
30948985|NCT01746901|58995074|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
30948986|NCT01746901|58995075|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
30626044|NCT00941031|58638086|FG004|Maintenance Period|Withdrawal by Subject|6|||
30626045|NCT00941031|58638087|FG005|Maintenance Period|Withdrawal by Subject|2|||
30844807|NCT01066819|58870770|FG003|Overall Study|Physician Decision|0|||
30948987|NCT01746901|58995067|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
30948988|NCT01746901|58995068|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
30948989|NCT01746901|58995069|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
30948990|NCT01746901|58995070|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
30948991|NCT01746901|58995071|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
30948992|NCT01746901|58995072|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
30948993|NCT01746901|58995073|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
30948994|NCT01746901|58995074|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
30948995|NCT01746901|58995075|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
30948996|NCT01968551|58995114|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
30948997|NCT01968551|58995115|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
30948998|NCT01968551|58995116|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
30948999|NCT01968551|58995114|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
30844808|NCT01066819|58870771|FG004|Overall Study|Physician Decision|0|||
30844809|NCT01066819|58870772|FG005|Overall Study|Physician Decision|0|||
30844810|NCT01066819|58870767|FG000|Overall Study|Protocol Violation|12|||
30844811|NCT01066819|58870768|FG001|Overall Study|Protocol Violation|6|||
30844812|NCT01066819|58870769|FG002|Overall Study|Protocol Violation|0|||
30844813|NCT01066819|58870770|FG003|Overall Study|Protocol Violation|0|||
30844814|NCT01066819|58870771|FG004|Overall Study|Protocol Violation|0|||
30844815|NCT01066819|58870772|FG005|Overall Study|Protocol Violation|0|||
30844816|NCT01066819|58870767|FG000|Overall Study|Withdrawal by Subject|29|||
30844817|NCT01066819|58870768|FG001|Overall Study|Withdrawal by Subject|11|||
30844818|NCT01066819|58870769|FG002|Overall Study|Withdrawal by Subject|6|||
30844819|NCT01066819|58870770|FG003|Overall Study|Withdrawal by Subject|0|||
30949000|NCT01968551|58995115|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
30949001|NCT01968551|58995116|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
30949002|NCT01968551|58995114|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
30949003|NCT01968551|58995115|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
30949004|NCT01968551|58995116|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
30949005|NCT01968551|58995114|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
30949006|NCT01968551|58995115|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
30949007|NCT01968551|58995116|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
30949008|NCT01968551|58995114|FG000|Extension Phase|Adverse Event|0|||
30949009|NCT01968551|58995115|FG001|Extension Phase|Adverse Event|0|||
30949010|NCT01968551|58995116|FG002|Extension Phase|Adverse Event|2|||
30949011|NCT01968551|58995114|FG000|Extension Phase|Death|0|||
30949012|NCT01968551|58995115|FG001|Extension Phase|Death|1|||
30844820|NCT01066819|58870771|FG004|Overall Study|Withdrawal by Subject|0|||
30949013|NCT01968551|58995116|FG002|Extension Phase|Death|0|||
30949014|NCT01968551|58995114|FG000|Extension Phase|Withdrew Consent|0|||
30626046|NCT00941031|58638088|FG006|Maintenance Period|Withdrawal by Subject|13|||
30844821|NCT01066819|58870772|FG005|Overall Study|Withdrawal by Subject|0|||
30844822|NCT01066819|58870767|FG000|Overall Study|Administrative|6|||
30949015|NCT01968551|58995115|FG001|Extension Phase|Withdrew Consent|0|||
30949016|NCT01968551|58995116|FG002|Extension Phase|Withdrew Consent|1|||
30949017|NCT01968551|58995114|FG000|Extension Phase|Lost to Follow-up|1|||
30761155|NCT03473236|58770200|FG006|Overall Study|Withdrawal by Subject|0|||
30761156|NCT03473236|58770201|FG007|Overall Study|Withdrawal by Subject|0|||
30761157|NCT03473236|58770202|FG008|Overall Study|Withdrawal by Subject|1|||
30761158|NCT03473236|58770203|FG009|Overall Study|Withdrawal by Subject|0|||
30761159|NCT03550378|58770235|FG000|Overall Study|Death|0|||
30761160|NCT03550378|58770236|FG001|Overall Study|Death|1|||
30761161|NCT03472534|58770243|FG000|Overall Study|Withdrawal by Subject|9|||
30761162|NCT03472534|58770243|FG000|Overall Study|Adverse Event|2|||
30761163|NCT03549130|58770249|FG000|Overall Study|Adverse Event|0|||
30761164|NCT03549130|58770250|FG001|Overall Study|Adverse Event|1|||
30761165|NCT03549130|58770249|FG000|Overall Study|Lost to Follow-up|0|||
30761166|NCT03549130|58770250|FG001|Overall Study|Lost to Follow-up|1|||
30761167|NCT03470194|58770260|FG000|Overall Study|Lost to Follow-up|11|||
30761168|NCT03470194|58770261|FG001|Overall Study|Lost to Follow-up|17|||
30761169|NCT03469336|58770267|FG000|Overall Study|Adverse Event|1|||
30761170|NCT03469258|58770277|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
30844823|NCT01066819|58870768|FG001|Overall Study|Administrative|4|||
30844824|NCT01066819|58870769|FG002|Overall Study|Administrative|2|||
30844825|NCT01066819|58870770|FG003|Overall Study|Administrative|0|||
30844826|NCT01066819|58870771|FG004|Overall Study|Administrative|0|||
30844827|NCT01066819|58870772|FG005|Overall Study|Administrative|0|||
30844828|NCT01066819|58870767|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
30844829|NCT01066819|58870768|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
30844830|NCT01066819|58870769|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
30844831|NCT01066819|58870770|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
30844832|NCT01066819|58870771|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
30844833|NCT01066819|58870772|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
30844834|NCT01066819|58870767|FG000|Overall Study|Early termination|2|||
30844835|NCT01066819|58870768|FG001|Overall Study|Early termination|0|||
30844836|NCT01066819|58870769|FG002|Overall Study|Early termination|0|||
30844837|NCT01066819|58870770|FG003|Overall Study|Early termination|0|||
30949018|NCT01968551|58995115|FG001|Extension Phase|Lost to Follow-up|0|||
30949019|NCT01968551|58995116|FG002|Extension Phase|Lost to Follow-up|1|||
30949020|NCT01707992|58995131|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
30949021|NCT01707992|58995132|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
30949022|NCT01707992|58995133|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
30949023|NCT01707992|58995134|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
30949024|NCT01707992|58995135|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
30949025|NCT01707992|58995136|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
30949026|NCT01707992|58995131|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
30949027|NCT01707992|58995132|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
30949028|NCT01707992|58995133|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
30949029|NCT01707992|58995134|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
30949030|NCT01707992|58995135|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
30949031|NCT01707992|58995136|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
30949032|NCT01707992|58995131|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
30949033|NCT01707992|58995132|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
30949034|NCT01707992|58995133|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
30949035|NCT01707992|58995134|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
30949036|NCT01707992|58995135|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
30949037|NCT01707992|58995136|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
30949038|NCT01707992|58995131|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
30844838|NCT01066819|58870771|FG004|Overall Study|Early termination|0|||
30844839|NCT01066819|58870772|FG005|Overall Study|Early termination|0|||
30949039|NCT01707992|58995132|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
30761171|NCT03503188|58770283|FG000|Overall Study|Non eligible in the sub study|0|||
30761172|NCT03503188|58770284|FG001|Overall Study|Non eligible in the sub study|1|||
30761173|NCT03502798|58770292|FG000|Overall Study|equipment failure|0|||
30761174|NCT03502798|58770293|FG001|Overall Study|equipment failure|7|||
30844840|NCT01066819|58870767|FG000|Overall Study|Failed to return|298|||
30844841|NCT01066819|58870768|FG001|Overall Study|Failed to return|107|||
30949040|NCT01707992|58995133|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
30949041|NCT01707992|58995134|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
30949042|NCT01707992|58995135|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
30949043|NCT01707992|58995136|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
30949044|NCT01707992|58995131|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
30949045|NCT01707992|58995132|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
30949046|NCT01707992|58995133|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
30949047|NCT01707992|58995134|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
30949048|NCT01707992|58995135|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
30949049|NCT01707992|58995136|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
30949050|NCT01707992|58995131|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
30949051|NCT01707992|58995132|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
30949052|NCT01707992|58995133|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
30949053|NCT01707992|58995134|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
30949054|NCT01707992|58995135|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
30949055|NCT01707992|58995136|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
30949056|NCT01707992|58995131|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
30949057|NCT01707992|58995132|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
30949058|NCT01707992|58995133|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
30949059|NCT01707992|58995134|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
30949060|NCT01707992|58995135|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
30949061|NCT01707992|58995136|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
30949062|NCT01707992|58995131|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
30949063|NCT01707992|58995132|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
30949064|NCT01707992|58995133|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
30949065|NCT01707992|58995134|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
30949066|NCT01707992|58995135|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
30949067|NCT01707992|58995136|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
30949068|NCT01707992|58995131|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
30844842|NCT01066819|58870769|FG002|Overall Study|Failed to return|68|||
30844843|NCT01066819|58870770|FG003|Overall Study|Failed to return|7|||
30844844|NCT01066819|58870771|FG004|Overall Study|Failed to return|2|||
30844845|NCT01066819|58870772|FG005|Overall Study|Failed to return|3|||
30844846|NCT01066819|58870767|FG000|Overall Study|Lab test not done|9|||
30844847|NCT01066819|58870768|FG001|Overall Study|Lab test not done|0|||
30844848|NCT01066819|58870769|FG002|Overall Study|Lab test not done|2|||
30844849|NCT01066819|58870770|FG003|Overall Study|Lab test not done|1|||
30844850|NCT01066819|58870771|FG004|Overall Study|Lab test not done|0|||
30844851|NCT01066819|58870772|FG005|Overall Study|Lab test not done|0|||
30844852|NCT01066819|58870767|FG000|Overall Study|Miscellaneous|28|||
30844853|NCT01066819|58870768|FG001|Overall Study|Miscellaneous|10|||
30844854|NCT01066819|58870769|FG002|Overall Study|Miscellaneous|18|||
30844855|NCT01066819|58870770|FG003|Overall Study|Miscellaneous|1|||
30844856|NCT01066819|58870771|FG004|Overall Study|Miscellaneous|0|||
30844857|NCT01066819|58870772|FG005|Overall Study|Miscellaneous|0|||
30844858|NCT01066819|58870767|FG000|Overall Study|Non responders|123|||
30844859|NCT01066819|58870768|FG001|Overall Study|Non responders|2|||
30844860|NCT01066819|58870769|FG002|Overall Study|Non responders|7|||
30844861|NCT01066819|58870770|FG003|Overall Study|Non responders|2|||
30844862|NCT01066819|58870771|FG004|Overall Study|Non responders|0|||
30844863|NCT01066819|58870772|FG005|Overall Study|Non responders|1|||
30844864|NCT01066819|58870767|FG000|Overall Study|Not categorised|9|||
30844865|NCT01066819|58870768|FG001|Overall Study|Not categorised|2|||
30844866|NCT01066819|58870769|FG002|Overall Study|Not categorised|6|||
30844867|NCT01066819|58870770|FG003|Overall Study|Not categorised|1|||
30844868|NCT01066819|58870771|FG004|Overall Study|Not categorised|0|||
30844869|NCT01066819|58870772|FG005|Overall Study|Not categorised|0|||
30949069|NCT01707992|58995132|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
30949070|NCT01707992|58995133|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
30949071|NCT01707992|58995134|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
30949072|NCT01707992|58995135|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
30626047|NCT00941031|58638082|FG000|Maintenance Period|Administrative Problems|0|||
30626048|NCT00941031|58638083|FG001|Maintenance Period|Administrative Problems|0|||
30626049|NCT00941031|58638084|FG002|Maintenance Period|Administrative Problems|0|||
30844870|NCT01066819|58870767|FG000|Overall Study|Relapse|16|||
30844871|NCT01066819|58870768|FG001|Overall Study|Relapse|4|||
30844872|NCT01066819|58870769|FG002|Overall Study|Relapse|3|||
30844873|NCT01066819|58870770|FG003|Overall Study|Relapse|0|||
30844874|NCT01066819|58870771|FG004|Overall Study|Relapse|0|||
30844875|NCT01066819|58870772|FG005|Overall Study|Relapse|0|||
30844876|NCT01066819|58870767|FG000|Overall Study|Results not available|1|||
30844877|NCT01066819|58870768|FG001|Overall Study|Results not available|0|||
30844878|NCT01066819|58870769|FG002|Overall Study|Results not available|0|||
30844879|NCT01066819|58870770|FG003|Overall Study|Results not available|0|||
30844880|NCT01066819|58870771|FG004|Overall Study|Results not available|0|||
30844881|NCT01066819|58870772|FG005|Overall Study|Results not available|0|||
30844882|NCT01066819|58870767|FG000|Overall Study|Screen failure|1|||
30844883|NCT01066819|58870768|FG001|Overall Study|Screen failure|0|||
30844884|NCT01066819|58870769|FG002|Overall Study|Screen failure|0|||
30844885|NCT01066819|58870770|FG003|Overall Study|Screen failure|0|||
30844886|NCT01066819|58870771|FG004|Overall Study|Screen failure|0|||
30844887|NCT01066819|58870772|FG005|Overall Study|Screen failure|0|||
30844888|NCT01066819|58870767|FG000|Overall Study|Spontaneous cure|1|||
30844889|NCT01066819|58870768|FG001|Overall Study|Spontaneous cure|0|||
30844890|NCT01066819|58870769|FG002|Overall Study|Spontaneous cure|0|||
30844891|NCT01066819|58870770|FG003|Overall Study|Spontaneous cure|0|||
30844892|NCT01066819|58870771|FG004|Overall Study|Spontaneous cure|0|||
30844893|NCT01066819|58870772|FG005|Overall Study|Spontaneous cure|0|||
30844894|NCT01066819|58870767|FG000|Overall Study|Treatment never started|85|||
30844895|NCT01066819|58870768|FG001|Overall Study|Treatment never started|19|||
30844896|NCT01066819|58870769|FG002|Overall Study|Treatment never started|19|||
30844897|NCT01066819|58870770|FG003|Overall Study|Treatment never started|3|||
30844898|NCT01066819|58870771|FG004|Overall Study|Treatment never started|2|||
30844899|NCT01066819|58870772|FG005|Overall Study|Treatment never started|2|||
30844900|NCT01066819|58870767|FG000|Overall Study|Treatment stopped|12|||
30844901|NCT01066819|58870768|FG001|Overall Study|Treatment stopped|1|||
30844902|NCT01066819|58870769|FG002|Overall Study|Treatment stopped|2|||
30844903|NCT01066819|58870770|FG003|Overall Study|Treatment stopped|1|||
30844904|NCT01066819|58870771|FG004|Overall Study|Treatment stopped|0|||
30844905|NCT01066819|58870772|FG005|Overall Study|Treatment stopped|0|||
30844906|NCT01066819|58870767|FG000|Overall Study|Other|5|||
30844907|NCT01066819|58870768|FG001|Overall Study|Other|1|||
30844908|NCT01066819|58870769|FG002|Overall Study|Other|1|||
30844909|NCT01066819|58870770|FG003|Overall Study|Other|0|||
30844910|NCT01066819|58870771|FG004|Overall Study|Other|0|||
30844911|NCT01066819|58870772|FG005|Overall Study|Other|0|||
30844912|NCT04056299|58870786|FG000|Overall Study|Sponsor discontinued study|3|||
30844913|NCT04056299|58870787|FG001|Overall Study|Sponsor discontinued study|3|||
30844914|NCT04057937|58870795|FG000|Placebo-controlled Phase|Adverse Event|3|||
30844915|NCT04057937|58870796|FG001|Placebo-controlled Phase|Adverse Event|0|||
30844916|NCT04057937|58870795|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
30844917|NCT04057937|58870796|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
30844918|NCT04057937|58870795|FG000|Active-treatment Phase|Pregnancy|0|||
30844919|NCT04057937|58870796|FG001|Active-treatment Phase|Pregnancy|1|||
30844920|NCT04057937|58870795|FG000|Active-treatment Phase|Physician Decision|0|||
30844921|NCT04057937|58870796|FG001|Active-treatment Phase|Physician Decision|1|||
30844922|NCT01069523|58870805|FG000|Overall Study|Withdrawal by Subject|4|||
30844923|NCT01069523|58870806|FG001|Overall Study|Withdrawal by Subject|7|||
30844924|NCT01069289|58870816|FG000|Overall Study|Withdrawal by Subject|15|||
30844925|NCT01069289|58870817|FG001|Overall Study|Withdrawal by Subject|26|||
30844926|NCT01069289|58870816|FG000|Overall Study|Adverse Event|21|||
30844927|NCT01069289|58870817|FG001|Overall Study|Adverse Event|28|||
30844928|NCT01069289|58870816|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
30844929|NCT01069289|58870817|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30844930|NCT01069289|58870816|FG000|Overall Study|Severe non-compliance to protocol|3|||
30844931|NCT01069289|58870817|FG001|Overall Study|Severe non-compliance to protocol|2|||
30844932|NCT01069289|58870816|FG000|Overall Study|Due to deteriorating health condition|1|||
30844933|NCT01069289|58870817|FG001|Overall Study|Due to deteriorating health condition|0|||
30844934|NCT02510794|58870836|FG000|Overall Study|Adverse Event|0|||
30844935|NCT02510794|58870837|FG001|Overall Study|Adverse Event|1|||
30844936|NCT02510794|58870838|FG002|Overall Study|Adverse Event|0|||
30844937|NCT02510794|58870839|FG003|Overall Study|Adverse Event|0|||
30844938|NCT02510794|58870836|FG000|Overall Study|Death|1|||
30844939|NCT02510794|58870837|FG001|Overall Study|Death|2|||
30844940|NCT02510794|58870838|FG002|Overall Study|Death|1|||
30844941|NCT02510794|58870839|FG003|Overall Study|Death|1|||
30844942|NCT02510794|58870836|FG000|Overall Study|Lack of Efficacy|3|||
30844943|NCT02510794|58870837|FG001|Overall Study|Lack of Efficacy|1|||
30844944|NCT02510794|58870838|FG002|Overall Study|Lack of Efficacy|1|||
30844945|NCT02510794|58870839|FG003|Overall Study|Lack of Efficacy|0|||
30844946|NCT02510794|58870836|FG000|Overall Study|Participant moved out of the area|0|||
30844947|NCT02510794|58870837|FG001|Overall Study|Participant moved out of the area|0|||
30844948|NCT02510794|58870838|FG002|Overall Study|Participant moved out of the area|0|||
30844949|NCT02510794|58870839|FG003|Overall Study|Participant moved out of the area|1|||
30949073|NCT01707992|58995136|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
30949074|NCT01707992|58995131|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
30949075|NCT01707992|58995132|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
30949076|NCT01707992|58995133|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
30949077|NCT01707992|58995134|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
30949078|NCT01707992|58995135|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
30949079|NCT01707992|58995136|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
30949080|NCT01707992|58995131|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
30949081|NCT01707992|58995132|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
30949082|NCT01707992|58995133|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
30949083|NCT01707992|58995134|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
30949084|NCT01707992|58995135|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
30949085|NCT01707992|58995136|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
30949086|NCT01707992|58995131|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
30949087|NCT01707992|58995132|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
30949088|NCT01707992|58995133|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
30949089|NCT01707992|58995134|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
30949090|NCT01707992|58995135|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
30949091|NCT01707992|58995136|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
30949092|NCT01707992|58995131|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
30949093|NCT01707992|58995132|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
30949094|NCT01707992|58995133|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
30949095|NCT01707992|58995134|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
30949096|NCT01707992|58995135|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
30949097|NCT01707992|58995136|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
30949098|NCT01707992|58995131|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
30949099|NCT01707992|58995132|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
30949100|NCT01707992|58995133|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
30949101|NCT01707992|58995134|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
30949102|NCT01707992|58995135|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
30949103|NCT01707992|58995136|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
30949104|NCT01707992|58995131|FG000|Active Treatment Phase (24 Months)|Death|0|||
30949105|NCT01707992|58995132|FG001|Active Treatment Phase (24 Months)|Death|0|||
30949106|NCT01707992|58995133|FG002|Active Treatment Phase (24 Months)|Death|0|||
30949107|NCT01707992|58995134|FG003|Active Treatment Phase (24 Months)|Death|2|||
30949108|NCT01707992|58995135|FG004|Active Treatment Phase (24 Months)|Death|0|||
30949109|NCT01707992|58995136|FG005|Active Treatment Phase (24 Months)|Death|0|||
30949110|NCT01707992|58995131|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
30949111|NCT01707992|58995132|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
30949112|NCT01707992|58995133|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
30844950|NCT02510794|58870836|FG000|Overall Study|Physician Decision|3|||
30844951|NCT02510794|58870837|FG001|Overall Study|Physician Decision|0|||
30844952|NCT02510794|58870838|FG002|Overall Study|Physician Decision|0|||
30844953|NCT02510794|58870839|FG003|Overall Study|Physician Decision|0|||
30844954|NCT02510794|58870836|FG000|Overall Study|Protocol Violation|0|||
30844955|NCT02510794|58870837|FG001|Overall Study|Protocol Violation|0|||
30844956|NCT02510794|58870838|FG002|Overall Study|Protocol Violation|1|||
30844957|NCT02510794|58870839|FG003|Overall Study|Protocol Violation|0|||
30844958|NCT02510794|58870836|FG000|Overall Study|Withdrawal by Subject|1|||
30844959|NCT02510794|58870837|FG001|Overall Study|Withdrawal by Subject|2|||
30844960|NCT02510794|58870838|FG002|Overall Study|Withdrawal by Subject|4|||
30844961|NCT02510794|58870839|FG003|Overall Study|Withdrawal by Subject|3|||
30844962|NCT02510014|58870864|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
30844963|NCT02510014|58870865|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
30844964|NCT02510014|58870864|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
30844965|NCT02510014|58870865|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
30844966|NCT02510014|58870864|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
30844967|NCT02510014|58870865|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
30844968|NCT02510014|58870864|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
30844969|NCT02510014|58870865|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
30844970|NCT02510014|58870864|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
30844971|NCT02510014|58870865|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
30844972|NCT02510014|58870864|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
30844973|NCT02510014|58870865|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
30844974|NCT02510014|58870864|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
30844975|NCT02510014|58870865|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
30844976|NCT02510014|58870864|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
30844977|NCT02510014|58870865|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
30844978|NCT02510014|58870864|FG000|Treatment Period|Adverse Event|11|||
30844979|NCT02510014|58870865|FG001|Treatment Period|Adverse Event|4|||
30844980|NCT02510014|58870864|FG000|Treatment Period|Withdrawal symptoms|3|||
30844981|NCT02510014|58870865|FG001|Treatment Period|Withdrawal symptoms|0|||
30844982|NCT02510014|58870864|FG000|Treatment Period|Lost to Follow-up|80|||
30844983|NCT02510014|58870865|FG001|Treatment Period|Lost to Follow-up|19|||
30844984|NCT02510014|58870864|FG000|Treatment Period|Physician Decision|5|||
30844985|NCT02510014|58870865|FG001|Treatment Period|Physician Decision|0|||
30844986|NCT02510014|58870864|FG000|Treatment Period|Withdrawal by Subject|67|||
30844987|NCT02510014|58870865|FG001|Treatment Period|Withdrawal by Subject|24|||
30844988|NCT02510014|58870864|FG000|Treatment Period|Withdrawn by the investigator|7|||
30844989|NCT02510014|58870865|FG001|Treatment Period|Withdrawn by the investigator|1|||
30844990|NCT02510014|58870864|FG000|Treatment Period|Protocol Violation|4|||
30844991|NCT02510014|58870865|FG001|Treatment Period|Protocol Violation|4|||
30844992|NCT02510014|58870864|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
30844993|NCT02510014|58870865|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
30844994|NCT02509312|58870873|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
30844995|NCT02509312|58870874|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
30844996|NCT02509312|58870873|FG000|Overall Study|Obstetrician refusal|0|||
30844997|NCT02509312|58870874|FG001|Overall Study|Obstetrician refusal|1|||
30844998|NCT02509312|58870873|FG000|Overall Study|Patient elected for TOLAC|1|||
30844999|NCT02509312|58870874|FG001|Overall Study|Patient elected for TOLAC|0|||
30845000|NCT02509312|58870873|FG000|Overall Study|Cesarean deemed stat|1|||
30845001|NCT02509312|58870874|FG001|Overall Study|Cesarean deemed stat|0|||
30845002|NCT02509312|58870873|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
30845003|NCT02509312|58870874|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
30845004|NCT02509156|58870884|FG000|Randomized Phase|Death|1|||
30845005|NCT02509156|58870885|FG001|Randomized Phase|Death|0|||
30845006|NCT02509156|58870884|FG000|Randomized Phase|Withdrawal by Subject|1|||
30949113|NCT01707992|58995134|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
30949114|NCT01707992|58995135|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
30949115|NCT01707992|58995136|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
30949116|NCT01707992|58995131|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
30949117|NCT01707992|58995132|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
30949118|NCT01707992|58995133|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
30845007|NCT02509156|58870885|FG001|Randomized Phase|Withdrawal by Subject|1|||
30845008|NCT01654666|58870894|FG000|Overall Study|Protocol Violation|7|||
30845009|NCT01654666|58870895|FG001|Overall Study|Protocol Violation|4|||
30845010|NCT01654666|58870896|FG002|Overall Study|Protocol Violation|8|||
30949119|NCT01707992|58995134|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
30949120|NCT01707992|58995135|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
30949121|NCT01707992|58995136|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
30949122|NCT01707992|58995131|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
30949123|NCT01707992|58995132|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
30949124|NCT01707992|58995133|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
30949125|NCT01707992|58995134|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
30949126|NCT01707992|58995135|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
30949127|NCT01707992|58995136|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
30949128|NCT01707992|58995131|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
30949129|NCT01707992|58995132|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
30845011|NCT01654666|58870894|FG000|Overall Study|Lost to Follow-up|4|||
30845012|NCT01654666|58870895|FG001|Overall Study|Lost to Follow-up|5|||
30845013|NCT01654666|58870896|FG002|Overall Study|Lost to Follow-up|5|||
30845014|NCT01654666|58870894|FG000|Overall Study|Withdrawal by Subject|4|||
30845015|NCT01654666|58870895|FG001|Overall Study|Withdrawal by Subject|4|||
30845016|NCT01654666|58870896|FG002|Overall Study|Withdrawal by Subject|1|||
30845017|NCT02519842|58870906|FG000|Base Study: Cycle 1|Screening Failure|1|||
30845018|NCT02519842|58870907|FG001|Base Study: Cycle 1|Screening Failure|1|||
30845019|NCT02519842|58870908|FG002|Base Study: Cycle 1|Screening Failure|0|||
30845020|NCT02519842|58870906|FG000|Base Study: Cycle 1|Adverse Event|1|||
30845021|NCT02519842|58870907|FG001|Base Study: Cycle 1|Adverse Event|0|||
30949130|NCT01707992|58995133|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
30845022|NCT02519842|58870908|FG002|Base Study: Cycle 1|Adverse Event|0|||
30845023|NCT02519842|58870906|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
30845024|NCT02519842|58870907|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
30845025|NCT02519842|58870908|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
30845026|NCT02519842|58870906|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
30845027|NCT02519842|58870907|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
30845028|NCT02519842|58870908|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
30845029|NCT02519842|58870906|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
30845030|NCT02519842|58870907|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
30845031|NCT02519842|58870908|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
30845032|NCT02519842|58870906|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
30845033|NCT02519842|58870907|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
30845034|NCT02519842|58870908|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
30845035|NCT02519842|58870906|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
30845036|NCT02519842|58870907|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
30845037|NCT02519842|58870908|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
30845038|NCT02519842|58870906|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
30845039|NCT02519842|58870907|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
30949131|NCT01707992|58995134|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
30949132|NCT01707992|58995135|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
30845040|NCT02519842|58870908|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
30845041|NCT02519842|58870906|FG000|Optional Extension: Cycles 2-6|Death|0|||
30845042|NCT02519842|58870907|FG001|Optional Extension: Cycles 2-6|Death|0|||
30845043|NCT02519842|58870908|FG002|Optional Extension: Cycles 2-6|Death|1|||
30845044|NCT02519842|58870906|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
30845045|NCT02519842|58870907|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
30845046|NCT02519842|58870908|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
30845047|NCT02519842|58870906|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
30845048|NCT02519842|58870907|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
30845049|NCT02519842|58870908|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
30845050|NCT02519842|58870906|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
30845051|NCT02519842|58870907|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
30845052|NCT02519842|58870908|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
30845053|NCT02519842|58870906|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
30845054|NCT02519842|58870907|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
30845055|NCT02519842|58870908|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
30845056|NCT02509078|58870918|FG000|Overall Study|Protocol Violation|1|||
30845057|NCT02509078|58870919|FG001|Overall Study|Protocol Violation|1|||
30845058|NCT02993783|58870929|FG000|Overall Study|Reason not Specified|6|||
30845059|NCT02993783|58870930|FG001|Overall Study|Reason not Specified|9|||
30845060|NCT02993471|58870936|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
30845061|NCT02993471|58870936|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
30845062|NCT02988713|58870958|FG000|Overall Study|Withdrawal by Subject|1|||
30845063|NCT02988713|58870958|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
30845064|NCT01068743|58870962|FG000|Period 3|Adverse Event|0|||
30845065|NCT01068743|58870963|FG001|Period 3|Adverse Event|1|||
30845066|NCT01068743|58870964|FG002|Period 3|Adverse Event|0|||
30845067|NCT01068743|58870965|FG003|Period 3|Adverse Event|0|||
30845068|NCT02992691|58870978|FG000|Overall Study|Adverse Event|2|||
30845069|NCT02992691|58870978|FG000|Overall Study|Withdrawal by Subject|1|||
30845070|NCT02921087|58870995|FG000|Overall Study|Withdrawal by Subject|0|||
30845071|NCT02921087|58870996|FG001|Overall Study|Withdrawal by Subject|1|||
30845072|NCT02907619|58871015|FG000|Overall Study|Study terminated by sponsor|18|||
30845073|NCT02907619|58871016|FG001|Overall Study|Study terminated by sponsor|18|||
30845074|NCT02907619|58871017|FG002|Overall Study|Study terminated by sponsor|19|||
30845075|NCT02907619|58871015|FG000|Overall Study|Death|0|||
30845076|NCT02907619|58871016|FG001|Overall Study|Death|0|||
30845077|NCT02907619|58871017|FG002|Overall Study|Death|1|||
30949133|NCT01707992|58995136|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
30949134|NCT01946165|58995153|FG000|Overall Study|Physician Decision|2|||
30949135|NCT01946165|58995154|FG001|Overall Study|Physician Decision|0|||
30949136|NCT01946165|58995153|FG000|Overall Study|Withdrawal by Subject|0|||
30949137|NCT01946165|58995154|FG001|Overall Study|Withdrawal by Subject|2|||
30949138|NCT01707667|58995163|FG000|Period 1|expulsion of colonic sensor catheter|1|||
30949139|NCT01707667|58995164|FG001|Period 1|expulsion of colonic sensor catheter|0|||
30845078|NCT02907619|58871015|FG000|Overall Study|Withdrawal by Subject|1|||
30845079|NCT02907619|58871016|FG001|Overall Study|Withdrawal by Subject|1|||
30845080|NCT02907619|58871017|FG002|Overall Study|Withdrawal by Subject|0|||
30845081|NCT02907619|58871015|FG000|Overall Study|Other|0|||
30845082|NCT02907619|58871016|FG001|Overall Study|Other|1|||
30845083|NCT02907619|58871017|FG002|Overall Study|Other|0|||
30845084|NCT02986373|58871027|FG000|Overall Study|Adverse Event|4|||
30845085|NCT02986373|58871027|FG000|Overall Study|Lost to Follow-up|1|||
30845086|NCT02986373|58871027|FG000|Overall Study|Withdrawal by Subject|10|||
30845087|NCT02986373|58871027|FG000|Overall Study|Other|24|||
30845088|NCT02986139|58871033|FG000|Overall Study|Sponsor Decision|1|||
30949140|NCT01959503|58995172|FG000|Overall Study|Death|2|||
30949141|NCT01959503|58995173|FG001|Overall Study|Death|1|||
30949142|NCT01959503|58995172|FG000|Overall Study|Randomized but not treated|1|||
30949143|NCT01959503|58995173|FG001|Overall Study|Randomized but not treated|1|||
30949144|NCT01605799|58995181|FG000|Overall Study|Withdrawal by Subject|2|||
30949145|NCT01605799|58995182|FG001|Overall Study|Withdrawal by Subject|1|||
30949146|NCT01706575|58995188|FG000|Overall Study|Participant Withdrew Consent|4|||
30949147|NCT01706575|58995188|FG000|Overall Study|Lost to Follow-up|2|||
30949148|NCT01706575|58995188|FG000|Overall Study|Started but not Treated|6|||
30949149|NCT01959425|58995194|FG000|Overall Study|Withdrawal by Subject|5|||
30949150|NCT01959425|58995195|FG001|Overall Study|Withdrawal by Subject|4|||
30949151|NCT01959425|58995194|FG000|Overall Study|Lost to Follow-up|1|||
30949152|NCT01959425|58995195|FG001|Overall Study|Lost to Follow-up|0|||
30949153|NCT01959425|58995194|FG000|Overall Study|Discontinued Subjects|6|||
30949154|NCT01959425|58995195|FG001|Overall Study|Discontinued Subjects|4|||
30949155|NCT01725529|58995204|FG000|Overall Study|Adverse Event|1|||
30949156|NCT01725529|58995205|FG001|Overall Study|Adverse Event|0|||
30949157|NCT01725529|58995206|FG002|Overall Study|Adverse Event|0|||
30949158|NCT01725529|58995204|FG000|Overall Study|Lost to Follow-up|2|||
30949159|NCT01725529|58995205|FG001|Overall Study|Lost to Follow-up|1|||
30949160|NCT01725529|58995206|FG002|Overall Study|Lost to Follow-up|1|||
30949161|NCT01725529|58995204|FG000|Overall Study|Protocol Violation|0|||
30949162|NCT01725529|58995205|FG001|Overall Study|Protocol Violation|1|||
30949163|NCT01725529|58995206|FG002|Overall Study|Protocol Violation|1|||
30949164|NCT01725529|58995204|FG000|Overall Study|Withdrawal by Subject|12|||
30949165|NCT01725529|58995205|FG001|Overall Study|Withdrawal by Subject|14|||
30949166|NCT01725529|58995206|FG002|Overall Study|Withdrawal by Subject|8|||
30949167|NCT01605097|58995214|FG000|Overall Study|Protocol Violation|1|||
30949168|NCT01605019|58995221|FG000|Overall Study|pt did not meet transplant endpoint|3|||
30949169|NCT01605019|58995222|FG001|Overall Study|pt did not meet transplant endpoint|0|||
30949170|NCT01705717|58995230|FG000|Overall Study|Adverse Event|2|||
30949171|NCT01705717|58995231|FG001|Overall Study|Adverse Event|2|||
30949172|NCT01705717|58995230|FG000|Overall Study|Lack of Efficacy|0|||
30949173|NCT01705717|58995231|FG001|Overall Study|Lack of Efficacy|1|||
30949174|NCT01705717|58995230|FG000|Overall Study|Other|0|||
30845089|NCT02986139|58871034|FG001|Overall Study|Sponsor Decision|2|||
30845090|NCT02986139|58871033|FG000|Overall Study|Withdrawal by Subject|0|||
30845091|NCT02986139|58871034|FG001|Overall Study|Withdrawal by Subject|1|||
30845092|NCT02986139|58871033|FG000|Overall Study|Lost to Follow-up|0|||
30845093|NCT02986139|58871034|FG001|Overall Study|Lost to Follow-up|1|||
30845094|NCT02989805|58871046|FG000|Overall Study|invalid consent|6|||
30845095|NCT02989805|58871047|FG001|Overall Study|invalid consent|4|||
30845096|NCT02907463|58871053|FG000|Overall Study|Lost to Follow-up|17|||
30845097|NCT02907463|58871053|FG000|Overall Study|Death|10|||
30845098|NCT02907463|58871053|FG000|Overall Study|Withdrawal by Subject|4|||
30845099|NCT02907463|58871053|FG000|Overall Study|MIS Approach was not used|2|||
30845100|NCT02907463|58871053|FG000|Overall Study|Not Implanted with Study Device|2|||
30845101|NCT02907463|58871053|FG000|Overall Study|Device Explanted|1|||
30845102|NCT02907463|58871053|FG000|Overall Study|Missing Exit Form|1|||
30845103|NCT02906917|58871067|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
30845104|NCT02906917|58871068|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
30845105|NCT02906917|58871067|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
30845106|NCT02906917|58871068|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
30845107|NCT02906917|58871067|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
30845108|NCT02906917|58871068|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
30845109|NCT02906917|58871067|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
30949175|NCT01705717|58995231|FG001|Overall Study|Other|2|||
30949176|NCT01744483|58995239|FG000|Overall Study|Death|9|||
30949177|NCT01744483|58995240|FG001|Overall Study|Death|4|||
30949178|NCT01744483|58995241|FG002|Overall Study|Death|11|||
30949179|NCT01744483|58995239|FG000|Overall Study|Lost to Follow-up|8|||
30949180|NCT01744483|58995240|FG001|Overall Study|Lost to Follow-up|9|||
30949181|NCT01744483|58995241|FG002|Overall Study|Lost to Follow-up|11|||
30949182|NCT01744483|58995239|FG000|Overall Study|Protocol Violation|1|||
30949183|NCT01744483|58995240|FG001|Overall Study|Protocol Violation|2|||
30949184|NCT01744483|58995241|FG002|Overall Study|Protocol Violation|1|||
30626050|NCT00941031|58638085|FG003|Maintenance Period|Administrative Problems|0|||
30626051|NCT00941031|58638086|FG004|Maintenance Period|Administrative Problems|1|||
30845110|NCT02906917|58871068|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
30845111|NCT02906917|58871067|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
30845112|NCT02906917|58871068|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
30949185|NCT01744483|58995239|FG000|Overall Study|Withdrawal by Subject|4|||
30949186|NCT01744483|58995240|FG001|Overall Study|Withdrawal by Subject|6|||
30949187|NCT01744483|58995241|FG002|Overall Study|Withdrawal by Subject|2|||
30949188|NCT01744483|58995239|FG000|Overall Study|No ICU Admit|5|||
30949189|NCT01744483|58995240|FG001|Overall Study|No ICU Admit|1|||
30845113|NCT02906917|58871067|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
30845114|NCT02906917|58871068|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
30845115|NCT02906917|58871067|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
30949190|NCT01744483|58995241|FG002|Overall Study|No ICU Admit|2|||
30845116|NCT02906917|58871068|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
30845117|NCT02906917|58871067|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
30845118|NCT02906917|58871068|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
30845119|NCT02982187|58871076|FG000|Overall Study|Withdrawal by Subject|0|||
30845120|NCT02982187|58871077|FG001|Overall Study|Withdrawal by Subject|0|||
30845121|NCT02982187|58871078|FG002|Overall Study|Withdrawal by Subject|0|||
30845122|NCT02982187|58871079|FG003|Overall Study|Withdrawal by Subject|0|||
30845123|NCT02982187|58871080|FG004|Overall Study|Withdrawal by Subject|0|||
30845124|NCT02982187|58871081|FG005|Overall Study|Withdrawal by Subject|0|||
30845125|NCT02982187|58871082|FG006|Overall Study|Withdrawal by Subject|1|||
30949191|NCT01744483|58995239|FG000|Overall Study|Routed to OSH|2|||
30949192|NCT01744483|58995240|FG001|Overall Study|Routed to OSH|0|||
30949193|NCT01744483|58995241|FG002|Overall Study|Routed to OSH|1|||
30949194|NCT01744093|58995251|FG000|Overall Study|Withdrawal by Subject|6|||
30949195|NCT01744093|58995252|FG001|Overall Study|Withdrawal by Subject|1|||
30949196|NCT01725451|58995266|FG000|Period 1|Withdrawal by Subject|1|||
30949197|NCT01725451|58995267|FG001|Period 1|Withdrawal by Subject|0|||
30949198|NCT01725451|58995268|FG002|Period 1|Withdrawal by Subject|0|||
30949199|NCT01725451|58995269|FG003|Period 1|Withdrawal by Subject|0|||
30949200|NCT01725451|58995266|FG000|Washout From Period 3|Protocol Violation|0|||
30949201|NCT01725451|58995267|FG001|Washout From Period 3|Protocol Violation|0|||
30949202|NCT01725451|58995268|FG002|Washout From Period 3|Protocol Violation|1|||
30949203|NCT01725451|58995269|FG003|Washout From Period 3|Protocol Violation|0|||
30949204|NCT01725451|58995266|FG000|Washout From Period 3|Adverse Event|0|||
30949205|NCT01725451|58995267|FG001|Washout From Period 3|Adverse Event|1|||
30949206|NCT01725451|58995268|FG002|Washout From Period 3|Adverse Event|0|||
30949207|NCT01725451|58995269|FG003|Washout From Period 3|Adverse Event|0|||
30949208|NCT01725451|58995266|FG000|Period 4|Adverse Event|0|||
30949209|NCT01725451|58995267|FG001|Period 4|Adverse Event|0|||
30949210|NCT01725451|58995268|FG002|Period 4|Adverse Event|1|||
30949211|NCT01725451|58995269|FG003|Period 4|Adverse Event|0|||
30949212|NCT01707290|58995286|FG000|Overall Study|Adverse event (AE)|1|||
30949213|NCT01707290|58995287|FG001|Overall Study|Adverse event (AE)|0|||
30949214|NCT01707290|58995286|FG000|Overall Study|Physician Decision|1|||
30949215|NCT01707290|58995287|FG001|Overall Study|Physician Decision|0|||
30949216|NCT01707290|58995286|FG000|Overall Study|Lost to Follow-up|3|||
30949217|NCT01707290|58995287|FG001|Overall Study|Lost to Follow-up|0|||
30949218|NCT01707290|58995286|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
30949219|NCT01707290|58995287|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
30949220|NCT01707290|58995286|FG000|Overall Study|Commercial drug available|60|||
30949221|NCT01707290|58995287|FG001|Overall Study|Commercial drug available|1|||
30949222|NCT01707290|58995286|FG000|Overall Study|Other unspecified|17|||
30949223|NCT01707290|58995287|FG001|Overall Study|Other unspecified|0|||
30949224|NCT01717040|58995298|FG000|Overall Study|Lost to Follow-up|2|||
30949225|NCT01717040|58995299|FG001|Overall Study|Lost to Follow-up|3|||
30949226|NCT01717040|58995298|FG000|Overall Study|Lack of Efficacy|1|||
30949227|NCT01717040|58995299|FG001|Overall Study|Lack of Efficacy|1|||
30949228|NCT01717040|58995298|FG000|Overall Study|Adverse Event|1|||
30845126|NCT02982187|58871083|FG007|Overall Study|Withdrawal by Subject|0|||
30845127|NCT02981953|58871093|FG000|Overall Study|Death|9|||
30845128|NCT02981953|58871093|FG000|Overall Study|Withdrawal by Subject|1|||
30845129|NCT02981953|58871093|FG000|Overall Study|Withdrawal to non-compliance|1|||
30845130|NCT01066585|58871109|FG000|Overall Study|Protocol Violation|1|||
30845131|NCT01066585|58871110|FG001|Overall Study|Protocol Violation|0|||
30845132|NCT01066585|58871109|FG000|Overall Study|Withdrawal by Subject|0|||
30949229|NCT01717040|58995299|FG001|Overall Study|Adverse Event|0|||
30949230|NCT01717040|58995298|FG000|Overall Study|Required Medication Change|0|||
30761175|NCT00066170|58770303|FG000|Overall Study|Adverse Event|2|||
30761176|NCT00066170|58770304|FG001|Overall Study|Adverse Event|4|||
30761177|NCT00066170|58770305|FG002|Overall Study|Adverse Event|1|||
30761178|NCT00066170|58770306|FG003|Overall Study|Adverse Event|7|||
30761179|NCT00066170|58770303|FG000|Overall Study|Serious Adverse Event|0|||
30761180|NCT00066170|58770304|FG001|Overall Study|Serious Adverse Event|0|||
30761181|NCT00066170|58770305|FG002|Overall Study|Serious Adverse Event|1|||
30761182|NCT00066170|58770306|FG003|Overall Study|Serious Adverse Event|1|||
30761183|NCT00066170|58770303|FG000|Overall Study|Lost to Follow-up|0|||
30761184|NCT00066170|58770304|FG001|Overall Study|Lost to Follow-up|1|||
30761185|NCT00066170|58770305|FG002|Overall Study|Lost to Follow-up|0|||
30845133|NCT01066585|58871110|FG001|Overall Study|Withdrawal by Subject|3|||
30949231|NCT01717040|58995299|FG001|Overall Study|Required Medication Change|1|||
30761186|NCT00066170|58770306|FG003|Overall Study|Lost to Follow-up|0|||
30845134|NCT02980783|58871116|FG000|Overall Study|Lost to Follow-up|1|||
30845135|NCT02980705|58871122|FG000|Overall Study|Adverse Event|0|||
30845136|NCT02980705|58871123|FG001|Overall Study|Adverse Event|1|||
30845137|NCT02980705|58871122|FG000|Overall Study|Withdrawal by Subject|6|||
30845138|NCT02980705|58871123|FG001|Overall Study|Withdrawal by Subject|9|||
30845139|NCT02980705|58871122|FG000|Overall Study|withdrew participation|0|||
30845140|NCT02980705|58871123|FG001|Overall Study|withdrew participation|1|||
30845141|NCT02980705|58871122|FG000|Overall Study|Lost to Follow-up|2|||
30845142|NCT02980705|58871123|FG001|Overall Study|Lost to Follow-up|0|||
30845143|NCT02989649|58871130|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
30845144|NCT02989649|58871130|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
30845145|NCT02989649|58871130|FG000|Overall Study|Lost For Observation During Study|3|||
30845146|NCT02989649|58871130|FG000|Overall Study|Reason Not Specified|13|||
30845147|NCT02905435|58871134|FG000|Overall Study|Death|2|||
30845148|NCT02905435|58871134|FG000|Overall Study|Physician Decision|1|||
30845149|NCT02905435|58871134|FG000|Overall Study|Lost to Follow-up|4|||
30845150|NCT02978833|58871141|FG000|Overall Study|Study terminated|1|||
30845151|NCT02978833|58871142|FG001|Overall Study|Study terminated|1|||
30845152|NCT01067339|58871151|FG000|Overall Study|Withdrawal by Subject|6|||
30845153|NCT01067339|58871152|FG001|Overall Study|Withdrawal by Subject|5|||
30845154|NCT02573259|58871165|FG000|Overall Study|Death|1|||
30845155|NCT02573259|58871166|FG001|Overall Study|Death|6|||
30845156|NCT02573259|58871167|FG002|Overall Study|Death|5|||
30845157|NCT02573259|58871168|FG003|Overall Study|Death|6|||
30845158|NCT02573259|58871169|FG004|Overall Study|Death|9|||
30845159|NCT02573259|58871170|FG005|Overall Study|Death|32|||
30845160|NCT02573259|58871171|FG006|Overall Study|Death|21|||
30845161|NCT02573259|58871165|FG000|Overall Study|Lost to Follow-up|0|||
30845162|NCT02573259|58871166|FG001|Overall Study|Lost to Follow-up|0|||
30845163|NCT02573259|58871167|FG002|Overall Study|Lost to Follow-up|0|||
30845164|NCT02573259|58871168|FG003|Overall Study|Lost to Follow-up|0|||
30845165|NCT02573259|58871169|FG004|Overall Study|Lost to Follow-up|0|||
30845166|NCT02573259|58871170|FG005|Overall Study|Lost to Follow-up|2|||
30845167|NCT02573259|58871171|FG006|Overall Study|Lost to Follow-up|1|||
30845168|NCT02573259|58871165|FG000|Overall Study|Participant refused further follow-up|0|||
30845169|NCT02573259|58871166|FG001|Overall Study|Participant refused further follow-up|2|||
30845170|NCT02573259|58871167|FG002|Overall Study|Participant refused further follow-up|1|||
30845171|NCT02573259|58871168|FG003|Overall Study|Participant refused further follow-up|0|||
30845172|NCT02573259|58871169|FG004|Overall Study|Participant refused further follow-up|3|||
30845173|NCT02573259|58871170|FG005|Overall Study|Participant refused further follow-up|20|||
30845174|NCT02573259|58871171|FG006|Overall Study|Participant refused further follow-up|7|||
30845175|NCT02573259|58871165|FG000|Overall Study|Other|0|||
30845176|NCT02573259|58871166|FG001|Overall Study|Other|0|||
30845177|NCT02573259|58871167|FG002|Overall Study|Other|0|||
30845178|NCT02573259|58871168|FG003|Overall Study|Other|0|||
30845179|NCT02573259|58871169|FG004|Overall Study|Other|1|||
30845180|NCT02573259|58871170|FG005|Overall Study|Other|4|||
30845181|NCT02573259|58871171|FG006|Overall Study|Other|5|||
30845182|NCT02977507|58871208|FG000|Overall Study|Protocol Deviation|1|||
30845183|NCT02977507|58871209|FG001|Overall Study|Protocol Deviation|0|||
30845184|NCT02977507|58871208|FG000|Overall Study|Lost to Follow-up|1|||
30845185|NCT02977507|58871209|FG001|Overall Study|Lost to Follow-up|0|||
30845186|NCT02976103|58871218|FG000|Overall Study|Withdrawal by Subject|1|||
30845187|NCT02976103|58871219|FG001|Overall Study|Withdrawal by Subject|0|||
30845188|NCT02976103|58871218|FG000|Overall Study|Lost to Follow-up|12|||
30845189|NCT02976103|58871219|FG001|Overall Study|Lost to Follow-up|8|||
30845190|NCT01066039|58871226|FG000|Overall Study|Adverse Event|6|||
30845191|NCT01066039|58871226|FG000|Overall Study|Withdrawal by Subject|17|||
30845192|NCT01066039|58871226|FG000|Overall Study|Protocol Violation|2|||
30845193|NCT01066039|58871226|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
30845194|NCT01066039|58871226|FG000|Overall Study|Investigator's Request|1|||
30845195|NCT01066039|58871226|FG000|Overall Study|Dropout due to Insulin Administration|1|||
30845196|NCT01066039|58871226|FG000|Overall Study|Additional Antihypertensive Required|4|||
30845197|NCT01066039|58871226|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
30845198|NCT01066039|58871226|FG000|Overall Study|Failure to Control Blood Pressure|1|||
30845199|NCT01066039|58871226|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
30949232|NCT01717040|58995298|FG000|Overall Study|New Substance Use Disorder|1|||
30949233|NCT01717040|58995299|FG001|Overall Study|New Substance Use Disorder|0|||
30949234|NCT01743469|58995326|FG000|Active Treatment Phase|Adverse Event|10|||
30845200|NCT02919995|58871236|FG000|Overall Study|Adverse Event|0|||
30845201|NCT02919995|58871237|FG001|Overall Study|Adverse Event|0|||
30845202|NCT02919995|58871238|FG002|Overall Study|Adverse Event|0|||
30845203|NCT02919995|58871239|FG003|Overall Study|Adverse Event|0|||
30845204|NCT02919995|58871240|FG004|Overall Study|Adverse Event|0|||
30845205|NCT02919995|58871241|FG005|Overall Study|Adverse Event|1|||
30845206|NCT02919761|58871249|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
30845207|NCT02919761|58871250|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
30845208|NCT02919761|58871251|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
30845209|NCT02919761|58871249|FG000|Part 1: Open Label|Adverse Event|1|||
30845210|NCT02919761|58871250|FG001|Part 1: Open Label|Adverse Event|0|||
30845211|NCT02919761|58871251|FG002|Part 1: Open Label|Adverse Event|0|||
30845212|NCT02919761|58871249|FG000|Part 1: Open Label|Lost to Follow-up|1|||
30845213|NCT02919761|58871250|FG001|Part 1: Open Label|Lost to Follow-up|0|||
30845214|NCT02919761|58871251|FG002|Part 1: Open Label|Lost to Follow-up|0|||
30845215|NCT02919761|58871249|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
30845216|NCT02919761|58871250|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
30845217|NCT02919761|58871251|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
30845218|NCT02919761|58871249|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
30845219|NCT02919761|58871250|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
30845220|NCT02919761|58871251|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
30845221|NCT02919761|58871249|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
30845222|NCT02919761|58871250|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
30845223|NCT02919761|58871251|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
30845224|NCT02919761|58871249|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
30845225|NCT02919761|58871250|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
30845226|NCT02919761|58871251|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
30845227|NCT02919761|58871249|FG000|Part 1: Open Label|Termination by Sponsor|1|||
30845228|NCT02919761|58871250|FG001|Part 1: Open Label|Termination by Sponsor|0|||
30845229|NCT02919761|58871251|FG002|Part 1: Open Label|Termination by Sponsor|0|||
30845230|NCT02919761|58871249|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
30845231|NCT02919761|58871250|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
30845232|NCT02919761|58871251|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
30845233|NCT02919761|58871249|FG000|Part 2: Double-blind|Adverse Event|0|||
30845234|NCT02919761|58871250|FG001|Part 2: Double-blind|Adverse Event|1|||
30845235|NCT02919761|58871251|FG002|Part 2: Double-blind|Adverse Event|0|||
30845236|NCT02919761|58871249|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
30845237|NCT02919761|58871250|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
30845238|NCT02919761|58871251|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
30845239|NCT02919761|58871249|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
30845240|NCT02919761|58871250|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
30845241|NCT02919761|58871251|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
30845242|NCT02919761|58871249|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
30845243|NCT02919761|58871250|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
30845244|NCT02919761|58871251|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
30845245|NCT02919761|58871249|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
30845246|NCT02919761|58871250|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
30845247|NCT02919761|58871251|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
30845248|NCT02919761|58871249|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
30845249|NCT02919761|58871250|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
30845250|NCT02919761|58871251|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
30845251|NCT02919761|58871249|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
30845252|NCT02919761|58871250|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
30845253|NCT02919761|58871251|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
30845254|NCT02910167|58871262|FG000|Overall Study|Adverse Event|1|||
30845255|NCT02910167|58871262|FG000|Overall Study|Lost to Follow-up|18|||
30845256|NCT01067105|58871266|FG000|Overall Study|Adverse Event|14|||
30845257|NCT01067105|58871266|FG000|Overall Study|Protocol Violation|48|||
30845258|NCT01067105|58871266|FG000|Overall Study|Withdrawal by Subject|36|||
30845259|NCT01067105|58871266|FG000|Overall Study|Lost to Follow-up|6|||
30845260|NCT01067105|58871266|FG000|Overall Study|Physician Decision|6|||
30845261|NCT01067105|58871266|FG000|Overall Study|Other|31|||
30845262|NCT02910089|58871276|FG000|Overall Study|Lost insurance eligibility|22|||
30845263|NCT02910089|58871277|FG001|Overall Study|Lost insurance eligibility|16|||
30845264|NCT02985515|58871285|FG000|Olfaction Testing|Lost to Follow-up|0|||
30845265|NCT02985515|58871286|FG001|Olfaction Testing|Lost to Follow-up|5|||
30845266|NCT02985515|58871285|FG000|Olfaction Testing|Protocol Violation|0|||
30845267|NCT02985515|58871286|FG001|Olfaction Testing|Protocol Violation|3|||
30845268|NCT02910011|58871299|FG000|Overall Study|Physician Decision|2|||
30845269|NCT02908841|58871307|FG000|Overall Study|Physician Decision|4|||
30845270|NCT02908841|58871308|FG001|Overall Study|Physician Decision|0|||
30845271|NCT02909153|58871319|FG000|Overall Study|Withdrawal by Subject|0|||
30845272|NCT02909153|58871320|FG001|Overall Study|Withdrawal by Subject|1|||
30845273|NCT02909153|58871321|FG002|Overall Study|Withdrawal by Subject|0|||
30845274|NCT02909153|58871322|FG003|Overall Study|Withdrawal by Subject|0|||
30949235|NCT01743469|58995327|FG001|Active Treatment Phase|Adverse Event|5|||
30949236|NCT01743469|58995328|FG002|Active Treatment Phase|Adverse Event|8|||
30845275|NCT02909153|58871323|FG004|Overall Study|Withdrawal by Subject|0|||
30845276|NCT02908529|58871335|FG000|Overall Study|Lost to Follow-up|0|||
30949237|NCT01743469|58995329|FG003|Active Treatment Phase|Adverse Event|1|||
30845277|NCT02908529|58871336|FG001|Overall Study|Lost to Follow-up|2|||
30845278|NCT02984267|58871346|FG000|Overall Study|Protocol Violation|1|||
30845279|NCT02984267|58871347|FG001|Overall Study|Protocol Violation|0|||
30845280|NCT02984267|58871346|FG000|Overall Study|Withdrawal by Subject|0|||
30845281|NCT02984267|58871347|FG001|Overall Study|Withdrawal by Subject|1|||
30845282|NCT02675751|58871353|FG000|Overall Study|Lost to Follow-up|16|||
30845283|NCT02974855|58871370|FG000|Overall Study|Adverse Event|0|||
30845284|NCT02974855|58871371|FG001|Overall Study|Adverse Event|1|||
30845285|NCT02974855|58871372|FG002|Overall Study|Adverse Event|0|||
30845286|NCT02974855|58871373|FG003|Overall Study|Adverse Event|1|||
30845287|NCT00455403|58871398|FG000|Overall Study|Lost to Follow-up|2|||
30845288|NCT00455403|58871399|FG001|Overall Study|Lost to Follow-up|1|||
30845289|NCT00455403|58871398|FG000|Overall Study|Withdrawal by Subject|1|||
30845290|NCT00455403|58871399|FG001|Overall Study|Withdrawal by Subject|3|||
30845291|NCT00455403|58871398|FG000|Overall Study|Protocol Violation|0|||
30845292|NCT00455403|58871399|FG001|Overall Study|Protocol Violation|2|||
30845293|NCT02979613|58871407|FG000|Double-Blind Phase|Withdrew Consent|2|||
30845294|NCT02979613|58871408|FG001|Double-Blind Phase|Withdrew Consent|4|||
30845295|NCT02979613|58871407|FG000|Double-Blind Phase|Pregnancy|2|||
30845296|NCT02979613|58871408|FG001|Double-Blind Phase|Pregnancy|2|||
30845297|NCT02979613|58871407|FG000|Double-Blind Phase|Adverse Event|2|||
30845298|NCT02979613|58871408|FG001|Double-Blind Phase|Adverse Event|0|||
30845299|NCT02979613|58871407|FG000|Double-Blind Phase|Lost to Follow-up|1|||
30845300|NCT02979613|58871408|FG001|Double-Blind Phase|Lost to Follow-up|1|||
30845301|NCT02979613|58871407|FG000|Double-Blind Phase|Protocol Violation|1|||
30845302|NCT02979613|58871408|FG001|Double-Blind Phase|Protocol Violation|1|||
30845303|NCT02979613|58871407|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
30845304|NCT02979613|58871408|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
30845305|NCT02979613|58871407|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
30845306|NCT02979613|58871408|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
30845307|NCT02979613|58871407|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
30845308|NCT02979613|58871408|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
30845309|NCT02979613|58871407|FG000|Open-Label Extension (OLE) Phase|Death|0|||
30845310|NCT02979613|58871408|FG001|Open-Label Extension (OLE) Phase|Death|1|||
30845311|NCT02979613|58871407|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
30845312|NCT02979613|58871408|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
30845313|NCT01064167|58871418|FG000|Overall Study|Protocol Violation|14|||
30845314|NCT01064167|58871419|FG001|Overall Study|Protocol Violation|15|||
30845315|NCT02974543|58871427|FG000|Overall Study|Withdrawal by Subject|1|||
30845316|NCT02974543|58871428|FG001|Overall Study|Withdrawal by Subject|0|||
30845317|NCT01064947|58871442|FG000|Overall Study|negative culture|41|||
30845318|NCT02974153|58871453|FG000|Overall Study|Adverse Event|6|||
30845319|NCT02974153|58871454|FG001|Overall Study|Adverse Event|0|||
30845320|NCT02974153|58871455|FG002|Overall Study|Adverse Event|1|||
30845321|NCT02974153|58871453|FG000|Overall Study|Lack of Efficacy|6|||
30845322|NCT02974153|58871454|FG001|Overall Study|Lack of Efficacy|5|||
30845323|NCT02974153|58871455|FG002|Overall Study|Lack of Efficacy|10|||
30845324|NCT02974153|58871453|FG000|Overall Study|Lost to Follow-up|9|||
30845325|NCT02974153|58871454|FG001|Overall Study|Lost to Follow-up|10|||
30845326|NCT02974153|58871455|FG002|Overall Study|Lost to Follow-up|17|||
30845327|NCT02974153|58871453|FG000|Overall Study|Physician Decision|0|||
30845328|NCT02974153|58871454|FG001|Overall Study|Physician Decision|2|||
30845329|NCT02974153|58871455|FG002|Overall Study|Physician Decision|1|||
30845330|NCT02974153|58871453|FG000|Overall Study|Withdrawal by Subject|9|||
30845331|NCT02974153|58871454|FG001|Overall Study|Withdrawal by Subject|16|||
30845332|NCT02974153|58871455|FG002|Overall Study|Withdrawal by Subject|11|||
30845333|NCT02974153|58871453|FG000|Overall Study|Study Burden|8|||
30845334|NCT02974153|58871454|FG001|Overall Study|Study Burden|7|||
30845335|NCT02974153|58871455|FG002|Overall Study|Study Burden|3|||
30845336|NCT02974153|58871453|FG000|Overall Study|Other|14|||
30845337|NCT02974153|58871454|FG001|Overall Study|Other|8|||
30845338|NCT02974153|58871455|FG002|Overall Study|Other|7|||
30845339|NCT02508532|58871470|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
30845340|NCT02508532|58871471|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
30845341|NCT02508532|58871472|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
30845342|NCT02508532|58871473|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
30845343|NCT02508532|58871474|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
30845344|NCT02508532|58871475|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
30845345|NCT02508532|58871476|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
30845346|NCT02508532|58871477|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
30845347|NCT02508532|58871478|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
30845348|NCT02508532|58871470|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
30845349|NCT02508532|58871471|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
30845350|NCT02508532|58871472|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
30845351|NCT02508532|58871473|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
30845352|NCT02508532|58871474|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
30845353|NCT02508532|58871475|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
30845354|NCT02508532|58871476|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
30845355|NCT02508532|58871477|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
30845356|NCT02508532|58871478|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
30845357|NCT02508532|58871470|FG000|Part 2 - Treatment|Disease Progression|0|||
30845358|NCT02508532|58871471|FG001|Part 2 - Treatment|Disease Progression|0|||
30845359|NCT02508532|58871472|FG002|Part 2 - Treatment|Disease Progression|0|||
30845360|NCT02508532|58871473|FG003|Part 2 - Treatment|Disease Progression|0|||
30845361|NCT02508532|58871474|FG004|Part 2 - Treatment|Disease Progression|0|||
30845362|NCT02508532|58871475|FG005|Part 2 - Treatment|Disease Progression|0|||
30845363|NCT02508532|58871476|FG006|Part 2 - Treatment|Disease Progression|0|||
30845364|NCT02508532|58871477|FG007|Part 2 - Treatment|Disease Progression|0|||
30845365|NCT02508532|58871478|FG008|Part 2 - Treatment|Disease Progression|118|||
30845366|NCT02508532|58871470|FG000|Part 2 - Treatment|Adverse Event|0|||
30845367|NCT02508532|58871471|FG001|Part 2 - Treatment|Adverse Event|0|||
30845368|NCT02508532|58871472|FG002|Part 2 - Treatment|Adverse Event|0|||
30845369|NCT02508532|58871473|FG003|Part 2 - Treatment|Adverse Event|0|||
30845370|NCT02508532|58871474|FG004|Part 2 - Treatment|Adverse Event|0|||
30845371|NCT02508532|58871475|FG005|Part 2 - Treatment|Adverse Event|0|||
30845372|NCT02508532|58871476|FG006|Part 2 - Treatment|Adverse Event|0|||
30845373|NCT02508532|58871477|FG007|Part 2 - Treatment|Adverse Event|0|||
30845374|NCT02508532|58871478|FG008|Part 2 - Treatment|Adverse Event|49|||
30845375|NCT02508532|58871470|FG000|Part 2 - Treatment|Physician Decision|0|||
30845376|NCT02508532|58871471|FG001|Part 2 - Treatment|Physician Decision|0|||
30845377|NCT02508532|58871472|FG002|Part 2 - Treatment|Physician Decision|0|||
30845378|NCT02508532|58871473|FG003|Part 2 - Treatment|Physician Decision|0|||
30845379|NCT02508532|58871474|FG004|Part 2 - Treatment|Physician Decision|0|||
30845380|NCT02508532|58871475|FG005|Part 2 - Treatment|Physician Decision|0|||
30845381|NCT02508532|58871476|FG006|Part 2 - Treatment|Physician Decision|0|||
30845382|NCT02508532|58871477|FG007|Part 2 - Treatment|Physician Decision|0|||
30845383|NCT02508532|58871478|FG008|Part 2 - Treatment|Physician Decision|12|||
30845384|NCT02508532|58871470|FG000|Part 2 - Treatment|Administrative|0|||
30845385|NCT02508532|58871471|FG001|Part 2 - Treatment|Administrative|0|||
30845386|NCT02508532|58871472|FG002|Part 2 - Treatment|Administrative|0|||
30845387|NCT02508532|58871473|FG003|Part 2 - Treatment|Administrative|0|||
30845388|NCT02508532|58871474|FG004|Part 2 - Treatment|Administrative|0|||
30845389|NCT02508532|58871475|FG005|Part 2 - Treatment|Administrative|0|||
30845390|NCT02508532|58871476|FG006|Part 2 - Treatment|Administrative|0|||
30845391|NCT02508532|58871477|FG007|Part 2 - Treatment|Administrative|0|||
30845392|NCT02508532|58871478|FG008|Part 2 - Treatment|Administrative|3|||
30845393|NCT02508532|58871470|FG000|Part 2 - Treatment|Sponsor Decision|0|||
30845394|NCT02508532|58871471|FG001|Part 2 - Treatment|Sponsor Decision|0|||
30761187|NCT00066170|58770303|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
30761188|NCT00066170|58770304|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
30845395|NCT02508532|58871472|FG002|Part 2 - Treatment|Sponsor Decision|0|||
30845396|NCT02508532|58871473|FG003|Part 2 - Treatment|Sponsor Decision|0|||
30845397|NCT02508532|58871474|FG004|Part 2 - Treatment|Sponsor Decision|0|||
30845398|NCT02508532|58871475|FG005|Part 2 - Treatment|Sponsor Decision|0|||
30761189|NCT00066170|58770305|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
30761190|NCT00066170|58770306|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
30761191|NCT00066170|58770303|FG000|Overall Study|Protocol Violation|3|||
30761192|NCT00066170|58770304|FG001|Overall Study|Protocol Violation|0|||
30761193|NCT00066170|58770305|FG002|Overall Study|Protocol Violation|0|||
30761194|NCT00066170|58770306|FG003|Overall Study|Protocol Violation|0|||
30761195|NCT00066170|58770303|FG000|Overall Study|Other|1|||
30761196|NCT00066170|58770304|FG001|Overall Study|Other|5|||
30761197|NCT00066170|58770305|FG002|Overall Study|Other|2|||
30845399|NCT02508532|58871476|FG006|Part 2 - Treatment|Sponsor Decision|0|||
30845400|NCT02508532|58871477|FG007|Part 2 - Treatment|Sponsor Decision|0|||
30845401|NCT02508532|58871478|FG008|Part 2 - Treatment|Sponsor Decision|28|||
30845402|NCT02508532|58871470|FG000|Part 2 - Treatment|Death|0|||
30845403|NCT02508532|58871471|FG001|Part 2 - Treatment|Death|0|||
30845404|NCT02508532|58871472|FG002|Part 2 - Treatment|Death|0|||
30845405|NCT02508532|58871473|FG003|Part 2 - Treatment|Death|0|||
30949238|NCT01743469|58995326|FG000|Active Treatment Phase|Disease Progression|40|||
30949239|NCT01743469|58995327|FG001|Active Treatment Phase|Disease Progression|47|||
30845406|NCT02508532|58871474|FG004|Part 2 - Treatment|Death|0|||
30845407|NCT02508532|58871475|FG005|Part 2 - Treatment|Death|0|||
30845408|NCT02508532|58871476|FG006|Part 2 - Treatment|Death|0|||
30845409|NCT02508532|58871477|FG007|Part 2 - Treatment|Death|0|||
30845410|NCT02508532|58871478|FG008|Part 2 - Treatment|Death|1|||
30845411|NCT02508532|58871470|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
30845412|NCT02508532|58871471|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
30845413|NCT02508532|58871472|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
30845414|NCT02508532|58871473|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
30845415|NCT02508532|58871474|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
30761198|NCT00066170|58770306|FG003|Overall Study|Other|0|||
30761199|NCT00065468|58770319|FG000|Overall Study|Death|172|||
30761200|NCT00065468|58770320|FG001|Overall Study|Death|169|||
30845416|NCT02508532|58871475|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
30845417|NCT02508532|58871476|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
30845418|NCT02508532|58871477|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
30845419|NCT02508532|58871478|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
30845420|NCT02508532|58871470|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
30845421|NCT02508532|58871471|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
30845422|NCT02508532|58871472|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
30845423|NCT02508532|58871473|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
30845424|NCT02508532|58871474|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
30845425|NCT02508532|58871475|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
30845426|NCT02508532|58871476|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
30845427|NCT02508532|58871477|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
30845428|NCT02508532|58871478|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
30845429|NCT02508532|58871470|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
30845430|NCT02508532|58871471|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
30845431|NCT02508532|58871472|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
30845432|NCT02508532|58871473|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
30845433|NCT02508532|58871474|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
30845434|NCT02508532|58871475|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
30845435|NCT02508532|58871476|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
30845436|NCT02508532|58871477|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
30845437|NCT02508532|58871478|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
30761201|NCT00065468|58770321|FG002|Overall Study|Death|171|||
30761202|NCT00065468|58770319|FG000|Overall Study|Withdrawal by Subject|3|||
30761203|NCT00065468|58770320|FG001|Overall Study|Withdrawal by Subject|4|||
30761204|NCT00065468|58770321|FG002|Overall Study|Withdrawal by Subject|5|||
30761205|NCT00065468|58770319|FG000|Overall Study|Lost to Follow-up|5|||
30761206|NCT00065468|58770320|FG001|Overall Study|Lost to Follow-up|3|||
30761207|NCT00065468|58770321|FG002|Overall Study|Lost to Follow-up|2|||
30761208|NCT00065468|58770319|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
30761209|NCT00065468|58770320|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
30761210|NCT00065468|58770321|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
30761211|NCT00065468|58770319|FG000|Overall Study|Disease progression|0|||
30761212|NCT00065468|58770320|FG001|Overall Study|Disease progression|0|||
30761213|NCT00065468|58770321|FG002|Overall Study|Disease progression|1|||
30845438|NCT02508532|58871470|FG000|Part 1 and Part 2 End of Study|Death|0|||
30845439|NCT02508532|58871471|FG001|Part 1 and Part 2 End of Study|Death|4|||
30845440|NCT02508532|58871472|FG002|Part 1 and Part 2 End of Study|Death|2|||
30845441|NCT02508532|58871473|FG003|Part 1 and Part 2 End of Study|Death|4|||
30761214|NCT00065468|58770319|FG000|Overall Study|Other|14|||
30761215|NCT00065468|58770320|FG001|Overall Study|Other|24|||
30761216|NCT00065468|58770321|FG002|Overall Study|Other|18|||
30845442|NCT02508532|58871474|FG004|Part 1 and Part 2 End of Study|Death|3|||
30845443|NCT02508532|58871475|FG005|Part 1 and Part 2 End of Study|Death|0|||
30845444|NCT02508532|58871476|FG006|Part 1 and Part 2 End of Study|Death|0|||
30845445|NCT02508532|58871477|FG007|Part 1 and Part 2 End of Study|Death|1|||
30845446|NCT02508532|58871478|FG008|Part 1 and Part 2 End of Study|Death|111|||
30845447|NCT02508532|58871470|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
30845448|NCT02508532|58871471|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
30845449|NCT02508532|58871472|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
30845450|NCT02508532|58871473|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
30761217|NCT00071006|58770329|FG000|Overall Study|Lack of Efficacy|7|||
30761218|NCT00071006|58770329|FG000|Overall Study|Adverse Event|1|||
30761219|NCT00071006|58770329|FG000|Overall Study|Withdrawal by Subject|1|||
30761220|NCT00071006|58770329|FG000|Overall Study|Other|3|||
30845451|NCT02508532|58871474|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
30845452|NCT02508532|58871475|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
30845453|NCT02508532|58871476|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
30845454|NCT02508532|58871477|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
30845455|NCT02508532|58871478|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
30845456|NCT02508532|58871470|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
30845457|NCT02508532|58871471|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
30845458|NCT02508532|58871472|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
30845459|NCT02508532|58871473|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
30845460|NCT02508532|58871474|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
30845461|NCT02508532|58871475|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
30761221|NCT00094575|58770335|FG000|Overall Study|Death|146|||
30761222|NCT00094575|58770336|FG001|Overall Study|Death|146|||
30761223|NCT00057746|58770347|FG000|Overall Study|Withdrawal by Subject|0|||
30761224|NCT00057746|58770348|FG001|Overall Study|Withdrawal by Subject|0|||
30761225|NCT00057746|58770349|FG002|Overall Study|Withdrawal by Subject|1|||
30761226|NCT00094107|58770357|FG000|Overall Study|Lack of Efficacy|23|||
30761227|NCT00094107|58770357|FG000|Overall Study|Death|5|||
30761228|NCT00094107|58770357|FG000|Overall Study|Adverse Event|3|||
30761229|NCT00094107|58770357|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
30761230|NCT00102063|58770364|FG000|Overall Study|Lack of Efficacy|5|||
30761231|NCT00102063|58770365|FG001|Overall Study|Lack of Efficacy|1|||
30761232|NCT00102063|58770366|FG002|Overall Study|Lack of Efficacy|1|||
30761233|NCT00102063|58770364|FG000|Overall Study|Adverse Event|7|||
30761234|NCT00102063|58770365|FG001|Overall Study|Adverse Event|4|||
30761235|NCT00102063|58770366|FG002|Overall Study|Adverse Event|2|||
30761236|NCT00102063|58770364|FG000|Overall Study|Withdrawal by Subject|4|||
30761237|NCT00102063|58770365|FG001|Overall Study|Withdrawal by Subject|12|||
30761238|NCT00102063|58770366|FG002|Overall Study|Withdrawal by Subject|5|||
30761239|NCT00102063|58770364|FG000|Overall Study|Lost to Follow-up|0|||
30761240|NCT00102063|58770365|FG001|Overall Study|Lost to Follow-up|0|||
30761241|NCT00102063|58770366|FG002|Overall Study|Lost to Follow-up|1|||
30761242|NCT00102063|58770364|FG000|Overall Study|Protocol Violation|0|||
30761243|NCT00102063|58770365|FG001|Overall Study|Protocol Violation|1|||
30761244|NCT00102063|58770366|FG002|Overall Study|Protocol Violation|1|||
30761245|NCT00065156|58770374|FG000|Overall Study|Adverse Event|37|||
30761246|NCT00065156|58770374|FG000|Overall Study|Lack of Efficacy|52|||
30761247|NCT00065156|58770374|FG000|Overall Study|Withdrawal by Subject|8|||
30761248|NCT00065156|58770374|FG000|Overall Study|Lost to Follow-up|1|||
30761249|NCT00065156|58770374|FG000|Overall Study|Death|11|||
30761250|NCT00065156|58770374|FG000|Overall Study|Study Closed by Sponsor|2|||
30761251|NCT00065156|58770374|FG000|Overall Study|Disease Progression|7|||
30761252|NCT00065156|58770374|FG000|Overall Study|Investigator Decision|2|||
30761253|NCT00065156|58770374|FG000|Overall Study|Non-Compliance|2|||
30761254|NCT00065156|58770374|FG000|Overall Study|Loss of Response|1|||
30761255|NCT00065156|58770374|FG000|Overall Study|Secondary Malign Disease|1|||
30761256|NCT00064298|58770380|FG000|Overall Study|Withdrawal by Subject|2|||
30761257|NCT00064298|58770381|FG001|Overall Study|Withdrawal by Subject|1|||
30761258|NCT00064298|58770380|FG000|Overall Study|Lost to Follow-up|2|||
30761259|NCT00064298|58770381|FG001|Overall Study|Lost to Follow-up|2|||
30761260|NCT00064298|58770380|FG000|Overall Study|Death|0|||
30845462|NCT02508532|58871476|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
30761261|NCT00064298|58770381|FG001|Overall Study|Death|1|||
30761262|NCT00064298|58770380|FG000|Overall Study|Disease Progression|2|||
30761263|NCT00064298|58770381|FG001|Overall Study|Disease Progression|1|||
30761264|NCT00078819|58770389|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
30761265|NCT00078819|58770390|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
30761266|NCT00078819|58770391|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
30761267|NCT00078819|58770392|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
30761268|NCT00078819|58770389|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
30761269|NCT00078819|58770390|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
30761270|NCT00078819|58770391|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
30761271|NCT00078819|58770392|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
30761272|NCT00078819|58770389|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
30761273|NCT00078819|58770390|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
30761274|NCT00078819|58770391|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
30761275|NCT00078819|58770392|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
30761276|NCT00078819|58770389|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
30761277|NCT00078819|58770390|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
30761278|NCT00078819|58770391|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
30761279|NCT00078819|58770392|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
30761280|NCT00078819|58770389|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
30761281|NCT00078819|58770390|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
30761282|NCT00078819|58770391|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
30761283|NCT00078819|58770392|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
30761284|NCT00078819|58770389|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
30761285|NCT00078819|58770390|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
30761286|NCT00078819|58770391|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
30761287|NCT00078819|58770392|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
30761288|NCT00078819|58770389|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
30761289|NCT00078819|58770390|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
30761290|NCT00078819|58770391|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
30761291|NCT00078819|58770392|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
30761292|NCT00078819|58770389|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
30845463|NCT02508532|58871477|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
30845464|NCT02508532|58871478|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
30845465|NCT02508532|58871470|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
30845466|NCT02508532|58871471|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
30845467|NCT02508532|58871472|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
30845468|NCT02508532|58871473|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
30845469|NCT02508532|58871474|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
30845470|NCT02508532|58871475|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
30845471|NCT02508532|58871476|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
30845472|NCT02508532|58871477|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
30845473|NCT02508532|58871478|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
30845474|NCT02508532|58871470|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
30845475|NCT02508532|58871471|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
30845476|NCT02508532|58871472|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
30761293|NCT00078819|58770390|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
30761294|NCT00078819|58770391|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
30761295|NCT00078819|58770392|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
30761296|NCT00098865|58770409|FG000|Overall Study|Progressive Disease|6|||
30761297|NCT00098865|58770409|FG000|Overall Study|Adverse Event|2|||
30761298|NCT00098865|58770409|FG000|Overall Study|Alternative Therapy|1|||
30761299|NCT02954458|58770417|FG000|Overall Study|Adverse Event|0|||
30845477|NCT02508532|58871473|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
30845478|NCT02508532|58871474|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
30845479|NCT02508532|58871475|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
30845480|NCT02508532|58871476|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
30845481|NCT02508532|58871477|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
30845482|NCT02508532|58871478|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
30845483|NCT02508532|58871470|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
30845484|NCT02508532|58871471|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
30845485|NCT02508532|58871472|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
30845486|NCT02508532|58871473|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
30845487|NCT02508532|58871474|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
30845488|NCT02508532|58871475|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
30845489|NCT02508532|58871476|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
30845490|NCT02508532|58871477|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
30845491|NCT02508532|58871478|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
30845492|NCT02918071|58871507|FG000|Overall Study|Withdrawal by Subject|2|||
30845493|NCT02918071|58871507|FG000|Overall Study|Lost to Follow-up|1|||
30845494|NCT02507752|58871511|FG000|Overall Study|Adverse Event|1|||
30761300|NCT02954458|58770418|FG001|Overall Study|Adverse Event|0|||
30761301|NCT02954458|58770419|FG002|Overall Study|Adverse Event|0|||
30761302|NCT02954458|58770420|FG003|Overall Study|Adverse Event|1|||
30845495|NCT02507752|58871511|FG000|Overall Study|Protocol Violation|6|||
30845496|NCT02507752|58871511|FG000|Overall Study|Lost to Follow-up|7|||
30761303|NCT02954458|58770417|FG000|Overall Study|Withdrawal by Subject|0|||
30761304|NCT02954458|58770418|FG001|Overall Study|Withdrawal by Subject|0|||
30761305|NCT02954458|58770419|FG002|Overall Study|Withdrawal by Subject|0|||
30761306|NCT02954458|58770420|FG003|Overall Study|Withdrawal by Subject|1|||
30761307|NCT02954458|58770417|FG000|Overall Study|Physician Decision|0|||
30761308|NCT02954458|58770418|FG001|Overall Study|Physician Decision|0|||
30761309|NCT02954458|58770419|FG002|Overall Study|Physician Decision|1|||
30761310|NCT02954458|58770420|FG003|Overall Study|Physician Decision|1|||
30761311|NCT02954458|58770417|FG000|Overall Study|Lost to Follow-up|1|||
30761312|NCT02954458|58770418|FG001|Overall Study|Lost to Follow-up|0|||
30761313|NCT02954458|58770419|FG002|Overall Study|Lost to Follow-up|0|||
30761314|NCT02954458|58770420|FG003|Overall Study|Lost to Follow-up|1|||
30761315|NCT02954458|58770417|FG000|Overall Study|Death|0|||
30761316|NCT02954458|58770418|FG001|Overall Study|Death|0|||
30845497|NCT02507752|58871511|FG000|Overall Study|Infusion reaction at first infusion|1|||
30845498|NCT02507752|58871511|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
30845499|NCT02507752|58871511|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
30845500|NCT02506816|58871515|FG000|Overall Study|Adverse Event|3|||
30845501|NCT02506036|58871521|FG000|First Intervention (4-6 Weeks)|Death|1|||
30845502|NCT02506036|58871522|FG001|First Intervention (4-6 Weeks)|Death|0|||
30845503|NCT02506036|58871521|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
30845504|NCT02506036|58871522|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
30845505|NCT02506036|58871521|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
30845506|NCT02506036|58871522|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
30845507|NCT01063855|58871530|FG000|Overall Study|Adverse Event|4|||
30845508|NCT01063855|58871531|FG001|Overall Study|Adverse Event|4|||
30845509|NCT01063855|58871530|FG000|Overall Study|Death|0|||
30761317|NCT02954458|58770419|FG002|Overall Study|Death|0|||
30761318|NCT02954458|58770420|FG003|Overall Study|Death|1|||
30761319|NCT02954458|58770417|FG000|Overall Study|Other|0|||
30761320|NCT02954458|58770418|FG001|Overall Study|Other|0|||
30761321|NCT02954458|58770419|FG002|Overall Study|Other|0|||
30761322|NCT02954458|58770420|FG003|Overall Study|Other|7|||
30761323|NCT03500224|58770434|FG000|Overall Study|Withdrawal by Subject|2|||
30761324|NCT03495154|58770438|FG000|Overall Study|Screen Failures Pre-Operatively|3|||
30761325|NCT03495154|58770438|FG000|Overall Study|Withdrawn Prior to Surgery|11|||
30761326|NCT03495154|58770438|FG000|Overall Study|Screen Failures During Surgery|6|||
30761327|NCT03495154|58770438|FG000|Overall Study|Death|2|||
30761328|NCT03495154|58770438|FG000|Overall Study|Lost to Follow-up|6|||
30761329|NCT03495154|58770438|FG000|Overall Study|Protocol Violation|1|||
30761330|NCT03495154|58770438|FG000|Overall Study|Withdrawal by Subject|1|||
30761331|NCT00077649|58770446|FG000|Overall Study|Adverse Event|5|||
30761332|NCT00077649|58770447|FG001|Overall Study|Adverse Event|1|||
30761333|NCT00077649|58770448|FG002|Overall Study|Adverse Event|7|||
30761334|NCT00077649|58770449|FG003|Overall Study|Adverse Event|9|||
30761335|NCT00077649|58770446|FG000|Overall Study|Lack of Efficacy|5|||
30761336|NCT00077649|58770447|FG001|Overall Study|Lack of Efficacy|3|||
30761337|NCT00077649|58770448|FG002|Overall Study|Lack of Efficacy|3|||
30761338|NCT00077649|58770449|FG003|Overall Study|Lack of Efficacy|2|||
30761339|NCT00077649|58770446|FG000|Overall Study|Withdrawal by Subject|0|||
30761340|NCT00077649|58770447|FG001|Overall Study|Withdrawal by Subject|1|||
30761341|NCT00077649|58770448|FG002|Overall Study|Withdrawal by Subject|1|||
30761342|NCT00077649|58770449|FG003|Overall Study|Withdrawal by Subject|2|||
30761343|NCT00077649|58770446|FG000|Overall Study|Lost to Follow-up|2|||
30761344|NCT00077649|58770447|FG001|Overall Study|Lost to Follow-up|2|||
30761345|NCT00077649|58770448|FG002|Overall Study|Lost to Follow-up|3|||
30761346|NCT00077649|58770449|FG003|Overall Study|Lost to Follow-up|2|||
30761347|NCT00077649|58770446|FG000|Overall Study|Abnormality of Laboratory Test|1|||
30761348|NCT00077649|58770447|FG001|Overall Study|Abnormality of Laboratory Test|2|||
30845510|NCT01063855|58871531|FG001|Overall Study|Death|1|||
30845511|NCT01063855|58871530|FG000|Overall Study|Lost to Follow-up|8|||
30845512|NCT01063855|58871531|FG001|Overall Study|Lost to Follow-up|4|||
30845513|NCT01063855|58871530|FG000|Overall Study|Pregnancy|1|||
30845514|NCT01063855|58871531|FG001|Overall Study|Pregnancy|0|||
30845515|NCT01063855|58871530|FG000|Overall Study|Lack of Efficacy|0|||
30845516|NCT01063855|58871531|FG001|Overall Study|Lack of Efficacy|1|||
30845517|NCT01063855|58871530|FG000|Overall Study|Withdrawal by Subject|11|||
30845518|NCT01063855|58871531|FG001|Overall Study|Withdrawal by Subject|8|||
30845519|NCT01063855|58871530|FG000|Overall Study|Reason not specified|13|||
30845520|NCT01063855|58871531|FG001|Overall Study|Reason not specified|11|||
30845521|NCT01063153|58871543|FG000|Overall Study|Found Ineligible During Screening|2|||
30845522|NCT01063153|58871544|FG001|Overall Study|Found Ineligible During Screening|0|||
30845523|NCT01063153|58871543|FG000|Overall Study|Lost to Follow-up|0|||
30845524|NCT01063153|58871544|FG001|Overall Study|Lost to Follow-up|7|||
30845525|NCT01063153|58871543|FG000|Overall Study|Withdrawal by Subject|0|||
30845526|NCT01063153|58871544|FG001|Overall Study|Withdrawal by Subject|1|||
30845527|NCT01063153|58871543|FG000|Overall Study|Physician Decision|0|||
30845528|NCT01063153|58871544|FG001|Overall Study|Physician Decision|4|||
30845529|NCT01062841|58871556|FG000|Overall Study|Indwelling Device Removed|41|||
30845530|NCT01062841|58871557|FG001|Overall Study|Indwelling Device Removed|48|||
30845531|NCT01062841|58871556|FG000|Overall Study|Death|3|||
30845532|NCT01062841|58871557|FG001|Overall Study|Death|5|||
30845533|NCT01062841|58871556|FG000|Overall Study|Withdrawal by Subject|2|||
30845534|NCT01062841|58871557|FG001|Overall Study|Withdrawal by Subject|0|||
30845535|NCT01062841|58871556|FG000|Overall Study|Withdrawal by Study|3|||
30845536|NCT01062841|58871557|FG001|Overall Study|Withdrawal by Study|0|||
30845537|NCT02505334|58871565|FG000|Main Treatment Period|Adverse Event|3|||
30845538|NCT02505334|58871566|FG001|Main Treatment Period|Adverse Event|3|||
30845539|NCT02505334|58871565|FG000|Main Treatment Period|Lack of Efficacy|7|||
30845540|NCT02505334|58871566|FG001|Main Treatment Period|Lack of Efficacy|17|||
30845541|NCT02505334|58871565|FG000|Main Treatment Period|Protocol Violation|0|||
30845542|NCT02505334|58871566|FG001|Main Treatment Period|Protocol Violation|1|||
30845543|NCT02505334|58871565|FG000|Main Treatment Period|Withdrawal by Subject|1|||
30845544|NCT02505334|58871566|FG001|Main Treatment Period|Withdrawal by Subject|8|||
30845545|NCT02505334|58871565|FG000|Main Treatment Period|Unclassified|4|||
30845546|NCT02505334|58871566|FG001|Main Treatment Period|Unclassified|10|||
30845547|NCT02505334|58871565|FG000|Extension Treatment Period|Adverse Event|5|||
30761349|NCT00077649|58770448|FG002|Overall Study|Abnormality of Laboratory Test|1|||
30761350|NCT00077649|58770449|FG003|Overall Study|Abnormality of Laboratory Test|2|||
30845548|NCT02505334|58871566|FG001|Extension Treatment Period|Adverse Event|0|||
30845549|NCT02505334|58871565|FG000|Extension Treatment Period|Lack of Efficacy|4|||
30761351|NCT00077649|58770446|FG000|Overall Study|Randomized but never dosed|1|||
30761352|NCT00077649|58770447|FG001|Overall Study|Randomized but never dosed|0|||
30761353|NCT00077649|58770448|FG002|Overall Study|Randomized but never dosed|0|||
30761354|NCT00077649|58770449|FG003|Overall Study|Randomized but never dosed|0|||
30845550|NCT02505334|58871566|FG001|Extension Treatment Period|Lack of Efficacy|0|||
30845551|NCT02505334|58871565|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
30845552|NCT02505334|58871566|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
30761355|NCT00038948|58770465|FG000|Overall Study|Adverse Event|131|||
30761356|NCT00038948|58770466|FG001|Overall Study|Adverse Event|43|||
30761357|NCT00038948|58770465|FG000|Overall Study|Lost to Follow-up|4|||
30761358|NCT00038948|58770466|FG001|Overall Study|Lost to Follow-up|4|||
30845553|NCT02505334|58871565|FG000|Extension Treatment Period|Unclassified|3|||
30845554|NCT02505334|58871566|FG001|Extension Treatment Period|Unclassified|0|||
30845555|NCT01062061|58871572|FG000|Overall Study|Enrolled more than once|2|||
30845556|NCT01062061|58871572|FG000|Overall Study|Investigated before study start|13|||
30845557|NCT01062061|58871572|FG000|Overall Study|Outside chief indications|10|||
30845558|NCT01062061|58871572|FG000|Overall Study|Failed to meet inclusion criteria|2|||
30845559|NCT02504320|58871584|FG000|Treatment Period 1|Positive Drug Screen|0|||
30845560|NCT02504320|58871585|FG001|Treatment Period 1|Positive Drug Screen|0|||
30845561|NCT02504320|58871586|FG002|Treatment Period 1|Positive Drug Screen|1|||
30845562|NCT02504320|58871587|FG003|Treatment Period 1|Positive Drug Screen|0|||
30845563|NCT02504320|58871584|FG000|Treatment Period 2|Positive Drug Screen|0|||
30845564|NCT02504320|58871585|FG001|Treatment Period 2|Positive Drug Screen|1|||
30761359|NCT00038948|58770465|FG000|Overall Study|Nonmedical event|5|||
30761360|NCT00038948|58770466|FG001|Overall Study|Nonmedical event|7|||
30761361|NCT00038948|58770465|FG000|Overall Study|Withdrawal by Subject|23|||
30761362|NCT00038948|58770466|FG001|Overall Study|Withdrawal by Subject|10|||
30845565|NCT02504320|58871586|FG002|Treatment Period 2|Positive Drug Screen|0|||
30845566|NCT02504320|58871587|FG003|Treatment Period 2|Positive Drug Screen|0|||
30845567|NCT02504320|58871584|FG000|Treatment Period 3|Positive Drug Screen|0|||
30845568|NCT02504320|58871585|FG001|Treatment Period 3|Positive Drug Screen|0|||
30845569|NCT02504320|58871586|FG002|Treatment Period 3|Positive Drug Screen|0|||
30845570|NCT02504320|58871587|FG003|Treatment Period 3|Positive Drug Screen|1|||
30845571|NCT02504320|58871584|FG000|Treatment Period 3|Adverse Event|0|||
30626052|NCT00941031|58638087|FG005|Maintenance Period|Administrative Problems|0|||
30626053|NCT00941031|58638088|FG006|Maintenance Period|Administrative Problems|1|||
30626054|NCT00941031|58638082|FG000|Maintenance Period|Protocol Violation|0|||
30626055|NCT00941031|58638083|FG001|Maintenance Period|Protocol Violation|0|||
30626056|NCT00941031|58638084|FG002|Maintenance Period|Protocol Violation|0|||
30626057|NCT00941031|58638085|FG003|Maintenance Period|Protocol Violation|0|||
30626058|NCT00941031|58638086|FG004|Maintenance Period|Protocol Violation|0|||
30626059|NCT00941031|58638087|FG005|Maintenance Period|Protocol Violation|0|||
30626060|NCT00941031|58638088|FG006|Maintenance Period|Protocol Violation|1|||
30626061|NCT00941031|58638082|FG000|Maintenance Period|Adverse Event|0|||
30626062|NCT00941031|58638083|FG001|Maintenance Period|Adverse Event|0|||
30626063|NCT00941031|58638084|FG002|Maintenance Period|Adverse Event|0|||
30761363|NCT00038948|58770465|FG000|Overall Study|Protocol Violation|3|||
30761364|NCT00038948|58770466|FG001|Overall Study|Protocol Violation|7|||
30761365|NCT00038948|58770465|FG000|Overall Study|Lack of Efficacy|3|||
30761366|NCT00038948|58770466|FG001|Overall Study|Lack of Efficacy|6|||
30761367|NCT00054704|58770480|FG000|Overall Study|Lack of Efficacy|2|||
30761368|NCT00054704|58770481|FG001|Overall Study|Lack of Efficacy|3|||
30761369|NCT00054704|58770480|FG000|Overall Study|Adverse Event|3|||
30761370|NCT00054704|58770481|FG001|Overall Study|Adverse Event|1|||
30761371|NCT00054704|58770480|FG000|Overall Study|Lost to Follow-up|0|||
30761372|NCT00054704|58770481|FG001|Overall Study|Lost to Follow-up|1|||
30761373|NCT00031694|58770487|FG000|Overall Study|Adverse Event|12|||
30761374|NCT00031694|58770487|FG000|Overall Study|Death|2|||
30761375|NCT00031694|58770487|FG000|Overall Study|Withdrawal by Subject|5|||
30761376|NCT00093795|58770495|FG000|Overall Study|No follow up data|20|||
30761377|NCT00093795|58770496|FG001|Overall Study|No follow up data|16|||
30761378|NCT00093795|58770497|FG002|Overall Study|No follow up data|17|||
30761379|NCT03467152|58770507|FG000|Overall Study|Adverse Event|4|||
30761380|NCT03467152|58770508|FG001|Overall Study|Adverse Event|5|||
30761381|NCT03467152|58770509|FG002|Overall Study|Adverse Event|0|||
30761382|NCT03467152|58770507|FG000|Overall Study|Subject Choice|1|||
30761383|NCT03467152|58770508|FG001|Overall Study|Subject Choice|3|||
30761384|NCT03467152|58770509|FG002|Overall Study|Subject Choice|0|||
30761385|NCT03467152|58770507|FG000|Overall Study|Lost to Follow-up|1|||
30761386|NCT03467152|58770508|FG001|Overall Study|Lost to Follow-up|0|||
30845572|NCT02504320|58871585|FG001|Treatment Period 3|Adverse Event|0|||
30845573|NCT02504320|58871586|FG002|Treatment Period 3|Adverse Event|1|||
30845574|NCT02504320|58871587|FG003|Treatment Period 3|Adverse Event|0|||
30845575|NCT01061671|58871599|FG000|Overall Study|Withdrawal by Subject|16|||
30845576|NCT01061671|58871600|FG001|Overall Study|Withdrawal by Subject|20|||
30845577|NCT01061671|58871599|FG000|Overall Study|Lost to Follow-up|3|||
30845578|NCT01061671|58871600|FG001|Overall Study|Lost to Follow-up|5|||
30845579|NCT01061671|58871599|FG000|Overall Study|Death|28|||
30845580|NCT01061671|58871600|FG001|Overall Study|Death|30|||
30845581|NCT00709995|58871608|FG000|Overall Study|Adverse Event|4|||
30845582|NCT00709995|58871609|FG001|Overall Study|Adverse Event|2|||
30845583|NCT00709995|58871608|FG000|Overall Study|Withdrawal by Subject|1|||
30845584|NCT00709995|58871609|FG001|Overall Study|Withdrawal by Subject|3|||
30845585|NCT02503540|58871618|FG000|Overall Study|Death|2|||
30761387|NCT03467152|58770509|FG002|Overall Study|Lost to Follow-up|0|||
30761388|NCT03467152|58770507|FG000|Overall Study|Withdrawal by Subject|4|||
30761389|NCT03467152|58770508|FG001|Overall Study|Withdrawal by Subject|2|||
30761390|NCT03467152|58770509|FG002|Overall Study|Withdrawal by Subject|0|||
30845586|NCT02503540|58871618|FG000|Overall Study|Withdrawal by Subject|1|||
30845587|NCT02502526|58871625|FG000|Overall Study|Lost to Follow-up|2|||
30845588|NCT02502526|58871626|FG001|Overall Study|Lost to Follow-up|2|||
30845589|NCT02502526|58871627|FG002|Overall Study|Lost to Follow-up|3|||
30845590|NCT02502526|58871625|FG000|Overall Study|Withdrawal by Subject|0|||
30761391|NCT03467152|58770507|FG000|Overall Study|Others|3|||
30761392|NCT03467152|58770508|FG001|Overall Study|Others|0|||
30761393|NCT03467152|58770509|FG002|Overall Study|Others|0|||
30761394|NCT03467152|58770507|FG000|Overall Study|Not treated|3|||
30761395|NCT03467152|58770508|FG001|Overall Study|Not treated|1|||
30761396|NCT03467152|58770509|FG002|Overall Study|Not treated|6|||
30761397|NCT03466060|58770518|FG000|Period 1|Test Lens Damage|0|||
30761398|NCT03466060|58770519|FG001|Period 1|Test Lens Damage|2|||
30761399|NCT03466060|58770520|FG002|Period 1|Test Lens Damage|0|||
30761400|NCT03466060|58770521|FG003|Period 1|Test Lens Damage|0|||
30761401|NCT03466060|58770522|FG004|Period 1|Test Lens Damage|0|||
30761402|NCT03466060|58770523|FG005|Period 1|Test Lens Damage|0|||
30761403|NCT03466060|58770518|FG000|Period 1|Withdrawal by Subject|0|||
30761404|NCT03466060|58770519|FG001|Period 1|Withdrawal by Subject|0|||
30761405|NCT03466060|58770520|FG002|Period 1|Withdrawal by Subject|2|||
30761406|NCT03466060|58770521|FG003|Period 1|Withdrawal by Subject|0|||
30761407|NCT03466060|58770522|FG004|Period 1|Withdrawal by Subject|0|||
30845591|NCT02502526|58871626|FG001|Overall Study|Withdrawal by Subject|1|||
30845592|NCT02502526|58871627|FG002|Overall Study|Withdrawal by Subject|1|||
30845593|NCT02502526|58871625|FG000|Overall Study|Disqualified due to cataract grading|0|||
30845594|NCT02502526|58871626|FG001|Overall Study|Disqualified due to cataract grading|0|||
30845595|NCT02502526|58871627|FG002|Overall Study|Disqualified due to cataract grading|1|||
30761408|NCT03466060|58770523|FG005|Period 1|Withdrawal by Subject|0|||
30761409|NCT03466060|58770518|FG000|Period 1|Lost to Follow-up|0|||
30845596|NCT02502526|58871625|FG000|Overall Study|Enrollment suspension|4|||
30761410|NCT03466060|58770519|FG001|Period 1|Lost to Follow-up|0|||
30761411|NCT03466060|58770520|FG002|Period 1|Lost to Follow-up|0|||
30761412|NCT03466060|58770521|FG003|Period 1|Lost to Follow-up|1|||
30761413|NCT03466060|58770522|FG004|Period 1|Lost to Follow-up|0|||
30761414|NCT03466060|58770523|FG005|Period 1|Lost to Follow-up|0|||
30761415|NCT03466060|58770518|FG000|Period 1|Grade 2 Conjunctivitis|0|||
30761416|NCT03466060|58770519|FG001|Period 1|Grade 2 Conjunctivitis|0|||
30877154|NCT01891344|58908782|FG006|Overall Study|Ongoing|0|||
30761417|NCT03466060|58770520|FG002|Period 1|Grade 2 Conjunctivitis|1|||
30761418|NCT03466060|58770521|FG003|Period 1|Grade 2 Conjunctivitis|0|||
30761419|NCT03466060|58770522|FG004|Period 1|Grade 2 Conjunctivitis|0|||
30845597|NCT02502526|58871626|FG001|Overall Study|Enrollment suspension|1|||
30845598|NCT02502526|58871627|FG002|Overall Study|Enrollment suspension|1|||
30845599|NCT02972515|58871636|FG000|Overall Study|Lost to Follow-up|78|||
30845600|NCT02972359|58871640|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
30845601|NCT02972359|58871640|FG000|Overall Study|Lack of Efficacy|1|||
30845602|NCT02972359|58871640|FG000|Overall Study|Adverse Event|4|||
30845603|NCT02972359|58871640|FG000|Overall Study|Death|1|||
30845604|NCT02972359|58871640|FG000|Overall Study|Withdrawal by Subject|30|||
30845605|NCT02972359|58871640|FG000|Overall Study|Protocol Violation|1|||
30845606|NCT02972359|58871640|FG000|Overall Study|Lost to Follow-up|26|||
30845607|NCT02972359|58871640|FG000|Overall Study|Other reasons|5|||
30845608|NCT02972359|58871640|FG000|Overall Study|Missing|1|||
30845609|NCT01060111|58871647|FG000|Overall Study|Adverse Event|9|||
30845610|NCT01060111|58871648|FG001|Overall Study|Adverse Event|5|||
30845611|NCT01060111|58871649|FG002|Overall Study|Adverse Event|18|||
30845612|NCT01060111|58871647|FG000|Overall Study|Lack of Efficacy|2|||
30845613|NCT01060111|58871648|FG001|Overall Study|Lack of Efficacy|1|||
30845614|NCT01060111|58871649|FG002|Overall Study|Lack of Efficacy|0|||
30845615|NCT01060111|58871647|FG000|Overall Study|Inappropriate participant|5|||
30845616|NCT01060111|58871648|FG001|Overall Study|Inappropriate participant|4|||
30845617|NCT01060111|58871649|FG002|Overall Study|Inappropriate participant|5|||
30845618|NCT01060111|58871647|FG000|Overall Study|Participants' evasion for hospital visit|0|||
30845619|NCT01060111|58871648|FG001|Overall Study|Participants' evasion for hospital visit|3|||
30845620|NCT01060111|58871649|FG002|Overall Study|Participants' evasion for hospital visit|2|||
30845621|NCT01060111|58871647|FG000|Overall Study|Participants' non-cooperation|8|||
30845622|NCT01060111|58871648|FG001|Overall Study|Participants' non-cooperation|6|||
30845623|NCT01060111|58871649|FG002|Overall Study|Participants' non-cooperation|6|||
30845624|NCT01060111|58871647|FG000|Overall Study|Adverse event and insufficient effect|0|||
30845625|NCT01060111|58871648|FG001|Overall Study|Adverse event and insufficient effect|1|||
30845626|NCT01060111|58871649|FG002|Overall Study|Adverse event and insufficient effect|0|||
30845627|NCT01060111|58871647|FG000|Overall Study|Participants' non-cooperation|1|||
30845628|NCT01060111|58871648|FG001|Overall Study|Participants' non-cooperation|0|||
30845629|NCT01060111|58871649|FG002|Overall Study|Participants' non-cooperation|0|||
30845630|NCT01060111|58871647|FG000|Overall Study|Other|2|||
30845631|NCT01060111|58871648|FG001|Overall Study|Other|3|||
30845632|NCT01060111|58871649|FG002|Overall Study|Other|4|||
30845633|NCT02969863|58871660|FG000|Overall Study|Physician Decision|1|||
30761420|NCT03466060|58770523|FG005|Period 1|Grade 2 Conjunctivitis|0|||
30761421|NCT03466060|58770518|FG000|Period 2|Lens Handling Difficulties|0|||
30761422|NCT03466060|58770519|FG001|Period 2|Lens Handling Difficulties|0|||
30761423|NCT03466060|58770520|FG002|Period 2|Lens Handling Difficulties|1|||
30761424|NCT03466060|58770521|FG003|Period 2|Lens Handling Difficulties|0|||
30761425|NCT03466060|58770522|FG004|Period 2|Lens Handling Difficulties|0|||
30761426|NCT03466060|58770523|FG005|Period 2|Lens Handling Difficulties|0|||
30761427|NCT00092547|58770539|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
30761428|NCT00092547|58770540|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
30845634|NCT02969863|58871661|FG001|Overall Study|Physician Decision|0|||
30845635|NCT02969863|58871662|FG002|Overall Study|Physician Decision|0|||
30845636|NCT02969863|58871663|FG003|Overall Study|Physician Decision|0|||
30845637|NCT02969863|58871664|FG004|Overall Study|Physician Decision|0|||
30845638|NCT02969863|58871665|FG005|Overall Study|Physician Decision|0|||
30761429|NCT00092547|58770541|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
30761430|NCT00092547|58770539|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
30761431|NCT00092547|58770540|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
30845639|NCT02969707|58871681|FG000|Overall Study|Adverse Event|1|||
30845640|NCT02969707|58871682|FG001|Overall Study|Adverse Event|2|||
30761432|NCT00092547|58770541|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
30761433|NCT00092547|58770539|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
30761434|NCT00092547|58770540|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
30761435|NCT00092547|58770541|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
30761436|NCT00092547|58770539|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
30761437|NCT00092547|58770540|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
30761438|NCT00092547|58770541|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
30761439|NCT00092547|58770539|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
30761440|NCT00092547|58770540|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
30761441|NCT00092547|58770541|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
30761442|NCT00092547|58770539|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
30761443|NCT00092547|58770540|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
30761444|NCT00092547|58770541|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
30761445|NCT00092547|58770539|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
30761446|NCT00092547|58770540|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
30761447|NCT00092547|58770541|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
30761448|NCT00092547|58770539|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
30761449|NCT00092547|58770540|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
30761450|NCT00092547|58770541|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
30761451|NCT00092547|58770539|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
30761452|NCT00092547|58770540|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
30761453|NCT00092547|58770541|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
30761454|NCT00092547|58770539|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
30761455|NCT00092547|58770540|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
30761456|NCT00092547|58770541|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
30761457|NCT00092547|58770539|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
30761458|NCT00092547|58770540|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
30761459|NCT00092547|58770541|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
30761460|NCT00092547|58770539|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
30761461|NCT00092547|58770540|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
30761462|NCT00092547|58770541|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
30761463|NCT00092547|58770539|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
30761464|NCT00092547|58770540|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
30761465|NCT00092547|58770541|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
30761466|NCT00092547|58770539|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
30761467|NCT00092547|58770540|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
30761468|NCT00092547|58770541|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
30761469|NCT00092547|58770539|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
30761470|NCT00092547|58770540|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
30761471|NCT00092547|58770541|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
30761472|NCT00092547|58770539|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
30761473|NCT00092547|58770540|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
30761474|NCT00092547|58770541|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
30761475|NCT00092547|58770539|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
30761476|NCT00092547|58770540|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
30761477|NCT00092547|58770541|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
30761478|NCT00092547|58770539|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
30761479|NCT00092547|58770540|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
30761480|NCT00092547|58770541|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
30761481|NCT00092547|58770539|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
30761482|NCT00092547|58770540|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
30761483|NCT00092547|58770541|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
30761484|NCT00092547|58770539|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
30761485|NCT00092547|58770540|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
30761486|NCT00092547|58770541|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
30761487|NCT00092547|58770539|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
30761488|NCT00092547|58770540|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
30761489|NCT00092547|58770541|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
30761490|NCT03802994|58770557|FG000|Overall Study|Lost to Follow-up|0|||
30761491|NCT03802994|58770558|FG001|Overall Study|Lost to Follow-up|2|||
30761492|NCT03802994|58770559|FG002|Overall Study|Lost to Follow-up|3|||
30761493|NCT03802994|58770560|FG003|Overall Study|Lost to Follow-up|2|||
30761494|NCT03802994|58770561|FG004|Overall Study|Lost to Follow-up|2|||
30761495|NCT03465904|58770586|FG000|Overall Study|Withdrawal by Subject|9|||
30761496|NCT03465904|58770587|FG001|Overall Study|Withdrawal by Subject|5|||
30761497|NCT03465904|58770586|FG000|Overall Study|Lost to Follow-up|10|||
30761498|NCT03465904|58770587|FG001|Overall Study|Lost to Follow-up|9|||
30761499|NCT03465904|58770586|FG000|Overall Study|Protocol Violation|8|||
30761500|NCT03465904|58770587|FG001|Overall Study|Protocol Violation|5|||
30761501|NCT03465904|58770586|FG000|Overall Study|Ineligible for mITT analysis|62|||
30761502|NCT03465904|58770587|FG001|Overall Study|Ineligible for mITT analysis|47|||
30761503|NCT03802916|58770595|FG000|Overall Study|Adverse Event|0|||
30761504|NCT03802916|58770596|FG001|Overall Study|Adverse Event|1|||
30761505|NCT03802916|58770595|FG000|Overall Study|Withdrawal by Subject|0|||
30761506|NCT03802916|58770596|FG001|Overall Study|Withdrawal by Subject|1|||
30761507|NCT00076011|58770604|FG000|Overall Study|Death|1|||
30761508|NCT00076011|58770604|FG000|Overall Study|Adverse Event|10|||
30761509|NCT00076011|58770604|FG000|Overall Study|Lack of Efficacy|25|||
30761510|NCT00076011|58770604|FG000|Overall Study|Withdrawal by Subject|1|||
30761511|NCT00076011|58770604|FG000|Overall Study|Study terminated by sponsor|3|||
30761512|NCT00076011|58770604|FG000|Overall Study|Other|11|||
30761513|NCT00076011|58770604|FG000|Overall Study|Ongoing|1|||
30761514|NCT03465436|58770612|FG000|Period 1|Protocol Violation|0|||
30761515|NCT03465436|58770613|FG001|Period 1|Protocol Violation|0|||
30761516|NCT03465436|58770614|FG002|Period 1|Protocol Violation|1|||
30761517|NCT03465436|58770615|FG003|Period 1|Protocol Violation|0|||
30761518|NCT03465436|58770612|FG000|Period 2|Protocol Violation|0|||
30761519|NCT03465436|58770613|FG001|Period 2|Protocol Violation|1|||
30761520|NCT03465436|58770614|FG002|Period 2|Protocol Violation|0|||
30761521|NCT03465436|58770615|FG003|Period 2|Protocol Violation|0|||
30761522|NCT03465436|58770612|FG000|Period 3|Protocol Violation|1|||
30761523|NCT03465436|58770613|FG001|Period 3|Protocol Violation|1|||
30761524|NCT03465436|58770614|FG002|Period 3|Protocol Violation|0|||
30761525|NCT03465436|58770615|FG003|Period 3|Protocol Violation|0|||
30761526|NCT03465436|58770612|FG000|Period 4|Protocol Violation|0|||
30761527|NCT03465436|58770613|FG001|Period 4|Protocol Violation|0|||
30761528|NCT03465436|58770614|FG002|Period 4|Protocol Violation|1|||
30761529|NCT03465436|58770615|FG003|Period 4|Protocol Violation|0|||
30761530|NCT00053846|58770629|FG000|Overall Study|Changed mind|8|||
30761531|NCT00053846|58770630|FG001|Overall Study|Changed mind|13|||
30761532|NCT00053846|58770629|FG000|Overall Study|Became too ill|8|||
30761533|NCT00053846|58770630|FG001|Overall Study|Became too ill|7|||
30761534|NCT00053846|58770629|FG000|Overall Study|Expired|5|||
30761535|NCT00053846|58770630|FG001|Overall Study|Expired|0|||
30761536|NCT00053846|58770629|FG000|Overall Study|Became ineligible|3|||
30761537|NCT00053846|58770630|FG001|Overall Study|Became ineligible|1|||
30761538|NCT00053846|58770629|FG000|Overall Study|Did not return data|1|||
30761539|NCT00053846|58770630|FG001|Overall Study|Did not return data|2|||
30761540|NCT00053846|58770629|FG000|Overall Study|Quit due to side effects|1|||
30761541|NCT00053846|58770630|FG001|Overall Study|Quit due to side effects|3|||
30761542|NCT00053846|58770629|FG000|Overall Study|Pills too large|0|||
30761543|NCT00053846|58770630|FG001|Overall Study|Pills too large|1|||
30761544|NCT00090987|58770636|FG000|Overall Study|Adverse Event|5|||
30761545|NCT00090987|58770636|FG000|Overall Study|Lack of Efficacy|7|||
30761546|NCT00090987|58770636|FG000|Overall Study|Withdrawal by Subject|3|||
30761547|NCT00090987|58770636|FG000|Overall Study|alternative therapy|1|||
30761548|NCT00090987|58770636|FG000|Overall Study|Non-compliance|4|||
30761549|NCT00090987|58770636|FG000|Overall Study|Incarcerated|1|||
30761550|NCT03464422|58770640|FG000|Overall Study|Lost to Follow-up|2|||
30761551|NCT03464422|58770640|FG000|Overall Study|Withdrawal by Subject|2|||
30761552|NCT03489304|58770646|FG000|Overall Study|Lost to Follow-up|4|||
30761553|NCT03543358|58770650|FG000|Overall Study|Death|1|||
30761554|NCT03543358|58770651|FG001|Overall Study|Death|0|||
30761555|NCT03543358|58770650|FG000|Overall Study|Disease Progression|1|||
30761556|NCT03543358|58770651|FG001|Overall Study|Disease Progression|0|||
30761557|NCT03543358|58770650|FG000|Overall Study|Parent Study Closure|1|||
30761558|NCT03543358|58770651|FG001|Overall Study|Parent Study Closure|0|||
30761559|NCT03485950|58770657|FG000|Overall Study|Adverse Event|1|||
30761560|NCT03485950|58770658|FG001|Overall Study|Adverse Event|0|||
30761561|NCT03485950|58770657|FG000|Overall Study|Death|3|||
30761562|NCT03485950|58770658|FG001|Overall Study|Death|2|||
30761563|NCT03485950|58770657|FG000|Overall Study|Withdrawal by Subject|3|||
30761564|NCT03485950|58770658|FG001|Overall Study|Withdrawal by Subject|0|||
30761565|NCT00060944|58770666|FG000|Overall Study|Adverse Event|12|||
30761566|NCT00060944|58770667|FG001|Overall Study|Adverse Event|10|||
30761567|NCT00060944|58770666|FG000|Overall Study|Death|2|||
30761568|NCT00060944|58770667|FG001|Overall Study|Death|3|||
30761569|NCT00060944|58770666|FG000|Overall Study|Withdrawal by Subject|18|||
30761570|NCT00060944|58770667|FG001|Overall Study|Withdrawal by Subject|5|||
30761571|NCT00060944|58770666|FG000|Overall Study|Disease Progression|93|||
30761572|NCT00060944|58770667|FG001|Overall Study|Disease Progression|94|||
30761573|NCT00060944|58770666|FG000|Overall Study|Lost to Follow-up|1|||
30761574|NCT00060944|58770667|FG001|Overall Study|Lost to Follow-up|0|||
30761575|NCT00060944|58770666|FG000|Overall Study|Subject Ineligible To Continue|2|||
30761576|NCT00060944|58770667|FG001|Overall Study|Subject Ineligible To Continue|1|||
30761577|NCT00060944|58770666|FG000|Overall Study|Treatment Switch|0|||
30761578|NCT00060944|58770667|FG001|Overall Study|Treatment Switch|13|||
30761579|NCT00060944|58770666|FG000|Overall Study|Other|2|||
30761580|NCT00060944|58770667|FG001|Overall Study|Other|4|||
30761581|NCT00060944|58770666|FG000|Overall Study|randomized but not treated|6|||
30761582|NCT00060944|58770667|FG001|Overall Study|randomized but not treated|4|||
30761583|NCT03462082|58770673|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
30761584|NCT03462082|58770674|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
30761585|NCT03462082|58770675|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
30761586|NCT03462082|58770676|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
30761587|NCT03462082|58770677|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
30761588|NCT03462082|58770678|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
30761589|NCT03462082|58770679|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
30761590|NCT03462082|58770680|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
30761591|NCT03461146|58770690|FG000|Overall Study|Adverse Event|2|||
30761592|NCT03461146|58770690|FG000|Overall Study|Physician Decision|1|||
30761593|NCT03541252|58770694|FG000|Overall Study|Withdrawal by Subject|1|||
30761594|NCT00031460|58770700|FG000|Overall Study|Lost to Follow-up|0|||
30761595|NCT00031460|58770701|FG001|Overall Study|Lost to Follow-up|1|||
30761596|NCT00031460|58770700|FG000|Overall Study|Withdrawal by Subject|1|||
30761597|NCT00031460|58770701|FG001|Overall Study|Withdrawal by Subject|1|||
30761598|NCT00031460|58770700|FG000|Overall Study|Non-Compliant|1|||
30761599|NCT00031460|58770701|FG001|Overall Study|Non-Compliant|1|||
30761600|NCT00031460|58770700|FG000|Overall Study|Death|0|||
30761601|NCT00031460|58770701|FG001|Overall Study|Death|1|||
30761602|NCT00031460|58770700|FG000|Overall Study|Reactivation of Disease|5|||
30761603|NCT00031460|58770701|FG001|Overall Study|Reactivation of Disease|9|||
30761604|NCT00031460|58770700|FG000|Overall Study|Disruption of blinded drug supply|2|||
30761605|NCT00031460|58770701|FG001|Overall Study|Disruption of blinded drug supply|0|||
30761606|NCT00031460|58770700|FG000|Overall Study|Confirmed unevaluable|0|||
30761607|NCT00031460|58770701|FG001|Overall Study|Confirmed unevaluable|1|||
30761608|NCT03540160|58770707|FG000|Overall Study|Protocol Violation|1|||
30761609|NCT03540160|58770707|FG000|Overall Study|Physician Decision|8|||
30761610|NCT03540160|58770707|FG000|Overall Study|Lack of Efficacy|60|||
30761611|NCT03540160|58770707|FG000|Overall Study|Pregnancy|1|||
30761612|NCT03540160|58770707|FG000|Overall Study|Adverse Event|20|||
30761613|NCT03540160|58770707|FG000|Overall Study|Withdrawal by Subject|68|||
30761614|NCT03540160|58770707|FG000|Overall Study|COVID-19|2|||
30761615|NCT03540160|58770707|FG000|Overall Study|Study Closure|10|||
30761616|NCT03540160|58770707|FG000|Overall Study|Lost to Follow-up|18|||
30761617|NCT03540160|58770707|FG000|Overall Study|Sponsor decision|191|||
30761618|NCT03459196|58770711|FG000|Overall Study|Subject didn't receive study catheter|2|||
30761619|NCT03459040|58770715|FG000|Overall Study|Death|8|||
30761620|NCT03459040|58770715|FG000|Overall Study|Withdrawal by Subject|1|||
30761621|NCT03457636|58770720|FG000|Overall Study|Lost to Follow-up|2|||
30761622|NCT03481816|58770726|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
30761623|NCT03481816|58770727|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
30761624|NCT03481816|58770726|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
30761625|NCT03481816|58770727|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
30761626|NCT03481816|58770726|FG000|Dose Expansion|Withdrawal by Subject|0|||
30761627|NCT03481816|58770727|FG001|Dose Expansion|Withdrawal by Subject|2|||
30761628|NCT03481816|58770726|FG000|Dose Expansion|Physician Decision|0|||
30761629|NCT03481816|58770727|FG001|Dose Expansion|Physician Decision|5|||
30761630|NCT03538054|58770735|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
30761631|NCT03538054|58770735|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
30761632|NCT03538054|58770735|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
30761633|NCT03480802|58770743|FG000|Overall Study|Lost to Follow-up|5|||
30761634|NCT03480802|58770744|FG001|Overall Study|Lost to Follow-up|1|||
30761635|NCT03480802|58770743|FG000|Overall Study|Withdrawal by Subject|2|||
30761636|NCT03480802|58770744|FG001|Overall Study|Withdrawal by Subject|1|||
30761637|NCT03480802|58770743|FG000|Overall Study|Relocated|0|||
30761638|NCT03480802|58770744|FG001|Overall Study|Relocated|1|||
30761639|NCT00050960|58770754|FG000|Overall Study|Progressive Disease|137|||
30761640|NCT00050960|58770755|FG001|Overall Study|Progressive Disease|93|||
30761641|NCT00050960|58770754|FG000|Overall Study|Stable Disease|19|||
30761642|NCT00050960|58770755|FG001|Overall Study|Stable Disease|48|||
30845641|NCT02969707|58871681|FG000|Overall Study|Lost to Follow-up|3|||
30761643|NCT00050960|58770754|FG000|Overall Study|Partial Response|14|||
30761644|NCT00050960|58770755|FG001|Overall Study|Partial Response|19|||
30761645|NCT00050960|58770754|FG000|Overall Study|Complete Response|0|||
30761646|NCT00050960|58770755|FG001|Overall Study|Complete Response|2|||
30761647|NCT00050960|58770754|FG000|Overall Study|Adverse Event|62|||
30761648|NCT00050960|58770755|FG001|Overall Study|Adverse Event|61|||
30761649|NCT00050960|58770754|FG000|Overall Study|Lost to Follow-up|0|||
30761650|NCT00050960|58770755|FG001|Overall Study|Lost to Follow-up|1|||
30761651|NCT00050960|58770754|FG000|Overall Study|Withdrawal by Subject|23|||
30761652|NCT00050960|58770755|FG001|Overall Study|Withdrawal by Subject|18|||
30761653|NCT00050960|58770754|FG000|Overall Study|Administrative|31|||
30761654|NCT00050960|58770755|FG001|Overall Study|Administrative|46|||
30761655|NCT00050960|58770754|FG000|Overall Study|Non-compliance|3|||
30761656|NCT00050960|58770755|FG001|Overall Study|Non-compliance|1|||
30761657|NCT00050960|58770754|FG000|Overall Study|Death|13|||
30626064|NCT00941031|58638085|FG003|Maintenance Period|Adverse Event|0|||
30626065|NCT00941031|58638086|FG004|Maintenance Period|Adverse Event|0|||
30626066|NCT00941031|58638087|FG005|Maintenance Period|Adverse Event|2|||
30626067|NCT00941031|58638088|FG006|Maintenance Period|Adverse Event|8|||
30626068|NCT00941031|58638082|FG000|Maintenance Period|Lost to Follow-up|0|||
30626069|NCT00941031|58638083|FG001|Maintenance Period|Lost to Follow-up|0|||
30626070|NCT00941031|58638084|FG002|Maintenance Period|Lost to Follow-up|0|||
30626071|NCT00941031|58638085|FG003|Maintenance Period|Lost to Follow-up|0|||
30626072|NCT00941031|58638086|FG004|Maintenance Period|Lost to Follow-up|2|||
30626073|NCT00941031|58638087|FG005|Maintenance Period|Lost to Follow-up|2|||
30761658|NCT00050960|58770755|FG001|Overall Study|Death|15|||
30761659|NCT03456856|58770761|FG000|Overall Study|Lost to Follow-up|2|||
30626074|NCT00941031|58638088|FG006|Maintenance Period|Lost to Follow-up|7|||
30845642|NCT02969707|58871682|FG001|Overall Study|Lost to Follow-up|0|||
30761660|NCT03456856|58770761|FG000|Overall Study|Withdrawal by Subject|1|||
30761661|NCT00058214|58770765|FG000|Overall Study|Adverse Event|1|||
30761662|NCT00097773|58770773|FG000|Overall Study|Lost to Follow-up|2|||
30761663|NCT00097773|58770774|FG001|Overall Study|Lost to Follow-up|2|||
30761664|NCT00097773|58770775|FG002|Overall Study|Lost to Follow-up|0|||
30761665|NCT00097773|58770776|FG003|Overall Study|Lost to Follow-up|1|||
30761666|NCT00097773|58770773|FG000|Overall Study|Physician Decision|2|||
30761667|NCT00097773|58770774|FG001|Overall Study|Physician Decision|2|||
30761668|NCT00097773|58770775|FG002|Overall Study|Physician Decision|3|||
30761669|NCT00097773|58770776|FG003|Overall Study|Physician Decision|1|||
30761670|NCT00097773|58770773|FG000|Overall Study|Withdrawal by Subject|3|||
30761671|NCT00097773|58770774|FG001|Overall Study|Withdrawal by Subject|3|||
30761672|NCT00097773|58770775|FG002|Overall Study|Withdrawal by Subject|3|||
30761673|NCT00097773|58770776|FG003|Overall Study|Withdrawal by Subject|1|||
30761674|NCT00097773|58770773|FG000|Overall Study|Adverse Event|0|||
30761675|NCT00097773|58770774|FG001|Overall Study|Adverse Event|1|||
30761676|NCT00097773|58770775|FG002|Overall Study|Adverse Event|0|||
30761677|NCT00097773|58770776|FG003|Overall Study|Adverse Event|0|||
30761678|NCT00097773|58770773|FG000|Overall Study|Other|1|||
30761679|NCT00097773|58770774|FG001|Overall Study|Other|0|||
30761680|NCT00097773|58770775|FG002|Overall Study|Other|2|||
30761681|NCT00097773|58770776|FG003|Overall Study|Other|0|||
30761682|NCT03480022|58770793|FG000|Overall Study|Pregnancy|2|||
30761683|NCT03480022|58770794|FG001|Overall Study|Pregnancy|0|||
30761684|NCT03480022|58770793|FG000|Overall Study|Adverse Event|6|||
30761685|NCT03480022|58770794|FG001|Overall Study|Adverse Event|0|||
30761686|NCT03480022|58770793|FG000|Overall Study|Lack of Efficacy|0|||
30761687|NCT03480022|58770794|FG001|Overall Study|Lack of Efficacy|2|||
30761688|NCT03480022|58770793|FG000|Overall Study|Physician Decision|0|||
30761689|NCT03480022|58770794|FG001|Overall Study|Physician Decision|1|||
30761690|NCT03480022|58770793|FG000|Overall Study|Withdrawal by Subject|2|||
30761691|NCT03480022|58770794|FG001|Overall Study|Withdrawal by Subject|0|||
30761692|NCT03480022|58770793|FG000|Overall Study|Medication concerns|1|||
30761693|NCT03480022|58770794|FG001|Overall Study|Medication concerns|0|||
30761694|NCT03480022|58770793|FG000|Overall Study|Family member COVID exposure|0|||
30761695|NCT03480022|58770794|FG001|Overall Study|Family member COVID exposure|1|||
30761696|NCT03533608|58770800|FG000|Overall Study|Withdrawal by Subject|3|||
30761697|NCT03533608|58770800|FG000|Overall Study|Physician Decision|2|||
30761698|NCT00049322|58770807|FG000|Overall Study|disease burden|0|||
30761699|NCT00049322|58770808|FG001|Overall Study|disease burden|3|||
30761700|NCT00049322|58770807|FG000|Overall Study|Adverse Event|1|||
30761701|NCT00049322|58770808|FG001|Overall Study|Adverse Event|0|||
30761702|NCT00049322|58770807|FG000|Overall Study|refused angio|0|||
30761703|NCT00049322|58770808|FG001|Overall Study|refused angio|3|||
30761704|NCT03437512|58770818|FG000|Randomized|Withdrawal by Subject|0|||
30761705|NCT03437512|58770819|FG001|Randomized|Withdrawal by Subject|2|||
30761706|NCT03437512|58770818|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
30761707|NCT03437512|58770819|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
30761708|NCT00058058|58770825|FG000|Overall Study|Withdrawal by Subject|4|||
30761709|NCT00058058|58770825|FG000|Overall Study|Ineligible|20|||
30761710|NCT00058058|58770825|FG000|Overall Study|Claustrophobic|5|||
30761711|NCT00058058|58770825|FG000|Overall Study|technical issues|6|||
30761712|NCT00058058|58770825|FG000|Overall Study|Poor positioning, illness,pain|3|||
30761713|NCT03532048|58770832|FG000|Overall Study|Lost to Follow-up|12|||
30761714|NCT03532048|58770833|FG001|Overall Study|Lost to Follow-up|17|||
30761715|NCT03532048|58770832|FG000|Overall Study|Withdrawal by Subject|7|||
30761716|NCT03532048|58770833|FG001|Overall Study|Withdrawal by Subject|0|||
30761717|NCT00008138|58770839|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
30761718|NCT00008138|58770839|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
30761719|NCT00008138|58770839|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
30761720|NCT00008138|58770839|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
30761721|NCT00008138|58770839|FG000|Interval Debulking|Withdrawal by Subject|2|||
30761722|NCT00008138|58770839|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
30761723|NCT00008138|58770839|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
30761724|NCT00008138|58770839|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
30761725|NCT03436732|58770846|FG000|Overall Study|Not treated-enrolled in different study|1|||
30761726|NCT03436732|58770847|FG001|Overall Study|Not treated-enrolled in different study|0|||
30761727|NCT03436732|58770846|FG000|Overall Study|Off study after cycle 1|1|||
30761728|NCT03436732|58770847|FG001|Overall Study|Off study after cycle 1|0|||
30761729|NCT03436732|58770846|FG000|Overall Study|Adverse Event|2|||
30761730|NCT03436732|58770847|FG001|Overall Study|Adverse Event|0|||
30761731|NCT03436732|58770846|FG000|Overall Study|Death|0|||
30761732|NCT03436732|58770847|FG001|Overall Study|Death|1|||
30761733|NCT03436420|58770854|FG000|Overall Study|Lack of Efficacy|3|||
30761734|NCT00027560|58770858|FG000|Overall Study|Withdrawal by Subject|1|||
30761735|NCT03451084|58770868|FG000|Overall Study|Withdrawal by Subject|2|||
30761736|NCT03451084|58770869|FG001|Overall Study|Withdrawal by Subject|1|||
30761737|NCT03451084|58770870|FG002|Overall Study|Withdrawal by Subject|2|||
30761738|NCT03451084|58770871|FG003|Overall Study|Withdrawal by Subject|1|||
30761739|NCT03451084|58770868|FG000|Overall Study|Disease recurrence|0|||
30761740|NCT03451084|58770869|FG001|Overall Study|Disease recurrence|2|||
30761741|NCT03451084|58770870|FG002|Overall Study|Disease recurrence|0|||
30761742|NCT03451084|58770871|FG003|Overall Study|Disease recurrence|0|||
30761743|NCT03451084|58770868|FG000|Overall Study|Lack of Efficacy|0|||
30761744|NCT03451084|58770869|FG001|Overall Study|Lack of Efficacy|3|||
30761745|NCT03451084|58770870|FG002|Overall Study|Lack of Efficacy|0|||
30761746|NCT03451084|58770871|FG003|Overall Study|Lack of Efficacy|1|||
30761747|NCT03451084|58770868|FG000|Overall Study|Death|1|||
30761748|NCT03451084|58770869|FG001|Overall Study|Death|0|||
30761749|NCT03451084|58770870|FG002|Overall Study|Death|2|||
30761750|NCT03451084|58770871|FG003|Overall Study|Death|0|||
30761751|NCT03451084|58770868|FG000|Overall Study|Physician Decision|0|||
30761752|NCT03451084|58770869|FG001|Overall Study|Physician Decision|0|||
30761753|NCT03451084|58770870|FG002|Overall Study|Physician Decision|2|||
30761754|NCT03451084|58770871|FG003|Overall Study|Physician Decision|2|||
30761755|NCT03451084|58770868|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
30761756|NCT03451084|58770869|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
30761757|NCT03451084|58770870|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
30761758|NCT03451084|58770871|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
30761759|NCT03451006|58770883|FG000|Overall Study|Withdrawal by Subject|2|||
30761760|NCT03451006|58770884|FG001|Overall Study|Withdrawal by Subject|2|||
30761761|NCT03450070|58770890|FG000|Overall Study|Withdrawal by Subject|8|||
30761762|NCT03449758|58770894|FG000|Overall Study|Major protocol deviation|1|||
30761763|NCT03449758|58770894|FG000|Overall Study|Treatment inefficacy|5|||
30761764|NCT03449758|58770894|FG000|Overall Study|Adverse Event|9|||
30761765|NCT03449758|58770894|FG000|Overall Study|Consent withdrawal|1|||
30761766|NCT03449758|58770894|FG000|Overall Study|Other unspecified reason|3|||
30761767|NCT03449446|58770906|FG000|Overall Study|Randomized but Never Treated|0|||
30761768|NCT03449446|58770907|FG001|Overall Study|Randomized but Never Treated|0|||
30761769|NCT03449446|58770908|FG002|Overall Study|Randomized but Never Treated|1|||
30761770|NCT03449446|58770909|FG003|Overall Study|Randomized but Never Treated|1|||
30761771|NCT03449446|58770910|FG004|Overall Study|Randomized but Never Treated|1|||
30761772|NCT03449446|58770911|FG005|Overall Study|Randomized but Never Treated|0|||
30761773|NCT03449446|58770912|FG006|Overall Study|Randomized but Never Treated|0|||
30761774|NCT03449446|58770906|FG000|Overall Study|Unknown Reason|33|||
30761775|NCT03449446|58770907|FG001|Overall Study|Unknown Reason|1|||
30761776|NCT03449446|58770908|FG002|Overall Study|Unknown Reason|1|||
30761777|NCT03449446|58770909|FG003|Overall Study|Unknown Reason|1|||
30761778|NCT03449446|58770910|FG004|Overall Study|Unknown Reason|2|||
30761779|NCT03449446|58770911|FG005|Overall Study|Unknown Reason|2|||
30761780|NCT03449446|58770912|FG006|Overall Study|Unknown Reason|0|||
30761781|NCT03449446|58770906|FG000|Overall Study|Withdrew Consent|1|||
30761782|NCT03449446|58770907|FG001|Overall Study|Withdrew Consent|3|||
30761783|NCT03449446|58770908|FG002|Overall Study|Withdrew Consent|1|||
30761784|NCT03449446|58770909|FG003|Overall Study|Withdrew Consent|4|||
30761785|NCT03449446|58770910|FG004|Overall Study|Withdrew Consent|4|||
30761786|NCT03449446|58770911|FG005|Overall Study|Withdrew Consent|4|||
30845643|NCT02969707|58871681|FG000|Overall Study|Physician Decision|0|||
30845644|NCT02969707|58871682|FG001|Overall Study|Physician Decision|1|||
30845645|NCT02969707|58871681|FG000|Overall Study|Protocol Violation|1|||
30845646|NCT02969707|58871682|FG001|Overall Study|Protocol Violation|1|||
30845647|NCT02969707|58871681|FG000|Overall Study|Withdrawal by Subject|3|||
30845648|NCT02969707|58871682|FG001|Overall Study|Withdrawal by Subject|4|||
30845649|NCT02967055|58871693|FG000|Overall Study|Excluded|40|||
30845650|NCT02967055|58871693|FG000|Overall Study|Screen fail|3|||
30845651|NCT02967055|58871693|FG000|Overall Study|Lost to Follow-up|2|||
30845652|NCT02967055|58871693|FG000|Overall Study|Stopped due to side effects|3|||
30845653|NCT02967055|58871693|FG000|Overall Study|Stopped due to drug cost|1|||
30845654|NCT02904265|58871699|FG000|Overall Study|Physician Decision|1|||
30845655|NCT02904265|58871700|FG001|Overall Study|Physician Decision|2|||
30845656|NCT03461211|58871708|FG000|Overall Study|Adverse Event|1|||
30845657|NCT03461211|58871709|FG001|Overall Study|Adverse Event|1|||
30845658|NCT03461211|58871708|FG000|Overall Study|Lack of Efficacy|0|||
30845659|NCT03461211|58871709|FG001|Overall Study|Lack of Efficacy|1|||
30845660|NCT02967679|58871717|FG000|Overall Study|Adverse Event|1|||
30845661|NCT02966509|58871727|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
30845662|NCT02966509|58871728|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
30949240|NCT01743469|58995328|FG002|Active Treatment Phase|Disease Progression|30|||
30949241|NCT01743469|58995329|FG003|Active Treatment Phase|Disease Progression|20|||
30761787|NCT03449446|58770912|FG006|Overall Study|Withdrew Consent|1|||
30845663|NCT02966509|58871727|FG000|Baseline Satisfaction Survey|Death|0|||
30845664|NCT02966509|58871728|FG001|Baseline Satisfaction Survey|Death|1|||
30845665|NCT02966509|58871727|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
30761788|NCT03449446|58770906|FG000|Overall Study|Adverse Event|1|||
30761789|NCT03449446|58770907|FG001|Overall Study|Adverse Event|2|||
30761790|NCT03449446|58770908|FG002|Overall Study|Adverse Event|1|||
30761791|NCT03449446|58770909|FG003|Overall Study|Adverse Event|0|||
30761792|NCT03449446|58770910|FG004|Overall Study|Adverse Event|0|||
30845666|NCT02966509|58871728|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
30845667|NCT02966509|58871727|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
30761793|NCT03449446|58770911|FG005|Overall Study|Adverse Event|2|||
30761794|NCT03449446|58770912|FG006|Overall Study|Adverse Event|0|||
30761795|NCT03449446|58770906|FG000|Overall Study|Lost to Follow-up|0|||
30761796|NCT03449446|58770907|FG001|Overall Study|Lost to Follow-up|0|||
30761797|NCT03449446|58770908|FG002|Overall Study|Lost to Follow-up|2|||
30761798|NCT03449446|58770909|FG003|Overall Study|Lost to Follow-up|1|||
30761799|NCT03449446|58770910|FG004|Overall Study|Lost to Follow-up|3|||
30761800|NCT03449446|58770911|FG005|Overall Study|Lost to Follow-up|0|||
30761801|NCT03449446|58770912|FG006|Overall Study|Lost to Follow-up|0|||
30761802|NCT03449446|58770906|FG000|Overall Study|Investigator's Discretion|0|||
30761803|NCT03449446|58770907|FG001|Overall Study|Investigator's Discretion|1|||
30761804|NCT03449446|58770908|FG002|Overall Study|Investigator's Discretion|1|||
30761805|NCT03449446|58770909|FG003|Overall Study|Investigator's Discretion|2|||
30761806|NCT03449446|58770910|FG004|Overall Study|Investigator's Discretion|0|||
30761807|NCT03449446|58770911|FG005|Overall Study|Investigator's Discretion|0|||
30761808|NCT03449446|58770912|FG006|Overall Study|Investigator's Discretion|0|||
30761809|NCT03449446|58770906|FG000|Overall Study|Non Compliance with Study Drug|1|||
30761810|NCT03449446|58770907|FG001|Overall Study|Non Compliance with Study Drug|0|||
30761811|NCT03449446|58770908|FG002|Overall Study|Non Compliance with Study Drug|0|||
30761812|NCT03449446|58770909|FG003|Overall Study|Non Compliance with Study Drug|0|||
30761813|NCT03449446|58770910|FG004|Overall Study|Non Compliance with Study Drug|0|||
30761814|NCT03449446|58770911|FG005|Overall Study|Non Compliance with Study Drug|0|||
30761815|NCT03449446|58770912|FG006|Overall Study|Non Compliance with Study Drug|0|||
30761816|NCT03449446|58770906|FG000|Overall Study|Protocol Violation|0|||
30761817|NCT03449446|58770907|FG001|Overall Study|Protocol Violation|0|||
30761818|NCT03449446|58770908|FG002|Overall Study|Protocol Violation|0|||
30761819|NCT03449446|58770909|FG003|Overall Study|Protocol Violation|0|||
30761820|NCT03449446|58770910|FG004|Overall Study|Protocol Violation|1|||
30761821|NCT03449446|58770911|FG005|Overall Study|Protocol Violation|1|||
30761822|NCT03449446|58770912|FG006|Overall Study|Protocol Violation|0|||
30761823|NCT03449446|58770906|FG000|Overall Study|Death|0|||
30761824|NCT03449446|58770907|FG001|Overall Study|Death|0|||
30761825|NCT03449446|58770908|FG002|Overall Study|Death|0|||
30761826|NCT03449446|58770909|FG003|Overall Study|Death|0|||
30761827|NCT03449446|58770910|FG004|Overall Study|Death|1|||
30761828|NCT03449446|58770911|FG005|Overall Study|Death|0|||
30761829|NCT03449446|58770912|FG006|Overall Study|Death|0|||
30761830|NCT03449134|58770931|FG000|52-Week Treatment Period|Death|2|||
30761831|NCT03449134|58770932|FG001|52-Week Treatment Period|Death|1|||
30761832|NCT03449134|58770933|FG002|52-Week Treatment Period|Death|0|||
30761833|NCT03449134|58770931|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
30761834|NCT03449134|58770932|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
30626075|NCT00941031|58638082|FG000|Maintenance Period|Lack of Efficacy|0|||
30626076|NCT00941031|58638083|FG001|Maintenance Period|Lack of Efficacy|0|||
30626077|NCT00941031|58638084|FG002|Maintenance Period|Lack of Efficacy|0|||
30626078|NCT00941031|58638085|FG003|Maintenance Period|Lack of Efficacy|0|||
30626079|NCT00941031|58638086|FG004|Maintenance Period|Lack of Efficacy|0|||
30626080|NCT00941031|58638087|FG005|Maintenance Period|Lack of Efficacy|0|||
30626081|NCT00941031|58638088|FG006|Maintenance Period|Lack of Efficacy|13|||
30626082|NCT00886834|58638109|FG000|Overall Study|Protocol Violation|0|||
30626083|NCT00886834|58638110|FG001|Overall Study|Protocol Violation|3|||
30626084|NCT00880009|58638116|FG000|Overall Study|Study terminated by sponsor|14|||
30626085|NCT00880009|58638116|FG000|Overall Study|Withdrawal by Subject|1|||
30761835|NCT03449134|58770933|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
30761836|NCT03449134|58770931|FG000|52-Week Treatment Period|Physician Decision|2|||
30761837|NCT03449134|58770932|FG001|52-Week Treatment Period|Physician Decision|3|||
30761838|NCT03449134|58770933|FG002|52-Week Treatment Period|Physician Decision|3|||
30761839|NCT03449134|58770931|FG000|52-Week Treatment Period|Screen Failure|1|||
30845668|NCT02966509|58871728|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
30761840|NCT03449134|58770932|FG001|52-Week Treatment Period|Screen Failure|0|||
30761841|NCT03449134|58770933|FG002|52-Week Treatment Period|Screen Failure|1|||
30761842|NCT03449134|58770931|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
30761843|NCT03449134|58770932|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
30761844|NCT03449134|58770933|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
30761845|NCT03449134|58770931|FG000|52-Week Treatment Period|Site Closure|1|||
30761846|NCT03449134|58770932|FG001|52-Week Treatment Period|Site Closure|0|||
30761847|NCT03449134|58770933|FG002|52-Week Treatment Period|Site Closure|0|||
30761848|NCT03529162|58770946|FG000|Overall Study|Lost to Follow-up|2|||
30761849|NCT03529162|58770947|FG001|Overall Study|Lost to Follow-up|2|||
30761850|NCT03447730|58770958|FG000|Overall Study|Adverse Event|0|||
30761851|NCT03447730|58770959|FG001|Overall Study|Adverse Event|2|||
30761852|NCT03447730|58770960|FG002|Overall Study|Adverse Event|0|||
30761853|NCT03429556|58770972|FG000|Overall Study|Lost to Follow-up|0|||
30761854|NCT03429556|58770973|FG001|Overall Study|Lost to Follow-up|1|||
30761855|NCT03429556|58770974|FG002|Overall Study|Lost to Follow-up|0|||
30761856|NCT03429556|58770975|FG003|Overall Study|Lost to Follow-up|0|||
30761857|NCT03428152|58770987|FG000|Overall Study|Physician Decision|4|||
30761858|NCT03428152|58770988|FG001|Overall Study|Physician Decision|2|||
30761859|NCT03428152|58770987|FG000|Overall Study|Protocol Violation|3|||
30761860|NCT03428152|58770988|FG001|Overall Study|Protocol Violation|5|||
30761861|NCT03428152|58770987|FG000|Overall Study|Lack of Efficacy|0|||
30761862|NCT03428152|58770988|FG001|Overall Study|Lack of Efficacy|4|||
30761863|NCT03444766|58770994|FG000|Overall Study|Other Reasons|2|||
30761864|NCT03444766|58770994|FG000|Overall Study|Participant Withdrew Consent|5|||
30761865|NCT03444766|58770994|FG000|Overall Study|Lost to Follow-up|2|||
30761866|NCT03444766|58770994|FG000|Overall Study|Death|2|||
30761867|NCT03444766|58770994|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
30761868|NCT03444766|58770994|FG000|Overall Study|Disease Progression|49|||
30761869|NCT03426436|58770998|FG000|Overall Study|Incorrect lead placement|12|||
30761870|NCT03426436|58770998|FG000|Overall Study|Withdrawal by Subject|2|||
30761871|NCT03426436|58770998|FG000|Overall Study|Consent issue|1|||
30761872|NCT03426436|58770998|FG000|Overall Study|ECGs not saved|4|||
30761873|NCT03425188|58771002|FG000|Overall Study|Withdrawal by Subject|1|||
30761874|NCT03423238|58771009|FG000|Overall Study|Lost to Follow-up|1|||
30761875|NCT03423238|58771010|FG001|Overall Study|Lost to Follow-up|0|||
30761876|NCT03423238|58771009|FG000|Overall Study|Withdrawal by Subject|1|||
30761877|NCT03423238|58771010|FG001|Overall Study|Withdrawal by Subject|0|||
30761878|NCT02953678|58771017|FG000|Overall Study|Adverse Event|20|||
30761879|NCT02953678|58771017|FG000|Overall Study|Death|7|||
30761880|NCT02953678|58771017|FG000|Overall Study|Physician Decision|23|||
30761881|NCT02953678|58771017|FG000|Overall Study|Progressive Disease of GVHD|7|||
30761882|NCT02953678|58771017|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
30761883|NCT02953678|58771017|FG000|Overall Study|Withdrawal by participant|3|||
30761884|NCT02953678|58771017|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
30761885|NCT02953678|58771017|FG000|Overall Study|Participants were transferred to commercial product.|3|||
30761886|NCT03412084|58771024|FG000|Overall Study|Withdrawal by Subject|2|||
30761887|NCT03412084|58771025|FG001|Overall Study|Withdrawal by Subject|0|||
30761888|NCT03412084|58771024|FG000|Overall Study|Participant moved|1|||
30761889|NCT03412084|58771025|FG001|Overall Study|Participant moved|0|||
30761890|NCT03412084|58771024|FG000|Overall Study|Lost to Follow-up|1|||
30761891|NCT03412084|58771025|FG001|Overall Study|Lost to Follow-up|1|||
30845669|NCT02966509|58871727|FG000|6 Month Satisfaction Decision Survey|Death|22|||
30845670|NCT02966509|58871728|FG001|6 Month Satisfaction Decision Survey|Death|25|||
30877155|NCT01891344|58908783|FG007|Overall Study|Ongoing|0|||
30626086|NCT00880009|58638116|FG000|Overall Study|Protocol Violation|1|||
30626087|NCT01104636|58638123|FG000|Overall Study|Lack of Efficacy|43|||
30626088|NCT01104636|58638123|FG000|Overall Study|Lost to Follow-up|24|||
30626089|NCT01104636|58638123|FG000|Overall Study|Withdrawal by Subject|4|||
30626090|NCT01104636|58638123|FG000|Overall Study|Other|43|||
30626091|NCT01104636|58638123|FG000|Overall Study|Study terminated by sponsor|1|||
30626092|NCT01104636|58638123|FG000|Overall Study|Pregnancy|2|||
30626093|NCT01104636|58638123|FG000|Overall Study|Adverse Event|40|||
30626094|NCT01104636|58638123|FG000|Overall Study|Ongoing|21|||
30626095|NCT01104558|58638127|FG000|Overall Study|Protocol Violation|6|||
30626096|NCT01104558|58638127|FG000|Overall Study|Missing of primary efficacy assessment|10|||
30626097|NCT01104558|58638127|FG000|Overall Study|Missing of genetic analysis results|1|||
30761892|NCT00090753|58771033|FG000|First Treatment Period|Adverse Event|20|||
30626098|NCT00886288|58638133|FG000|Overall Study|no respect of the 12 weeks period|657|||
30761893|NCT00090753|58771034|FG001|First Treatment Period|Adverse Event|8|||
30761894|NCT00090753|58771033|FG000|First Treatment Period|Death|88|||
30761895|NCT00090753|58771034|FG001|First Treatment Period|Death|62|||
30761896|NCT00090753|58771033|FG000|First Treatment Period|Lack of Efficacy|2|||
30761897|NCT00090753|58771034|FG001|First Treatment Period|Lack of Efficacy|1|||
30761898|NCT00090753|58771033|FG000|First Treatment Period|Refused Treatment|32|||
30761899|NCT00090753|58771034|FG001|First Treatment Period|Refused Treatment|25|||
30761900|NCT00090753|58771033|FG000|First Treatment Period|Lost to Follow-up|4|||
30761901|NCT00090753|58771034|FG001|First Treatment Period|Lost to Follow-up|4|||
30761902|NCT00090753|58771033|FG000|First Treatment Period|Renal Transplant|70|||
30761903|NCT00090753|58771034|FG001|First Treatment Period|Renal Transplant|50|||
30761904|NCT00090753|58771033|FG000|First Treatment Period|Mircera Commercialization|1|||
30761905|NCT00090753|58771034|FG001|First Treatment Period|Mircera Commercialization|0|||
30761906|NCT00090753|58771033|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
30761907|NCT00090753|58771034|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
30761908|NCT00090753|58771033|FG000|Extended Treatment Period|Adverse Event|11|||
30761909|NCT00090753|58771034|FG001|Extended Treatment Period|Adverse Event|0|||
30761910|NCT00090753|58771033|FG000|Extended Treatment Period|Death|58|||
30761911|NCT00090753|58771034|FG001|Extended Treatment Period|Death|30|||
30761912|NCT00090753|58771033|FG000|Extended Treatment Period|Lack of Efficacy|1|||
30761913|NCT00090753|58771034|FG001|Extended Treatment Period|Lack of Efficacy|0|||
30761914|NCT00090753|58771033|FG000|Extended Treatment Period|Refused Treatment|18|||
30761915|NCT00090753|58771034|FG001|Extended Treatment Period|Refused Treatment|12|||
30761916|NCT00090753|58771033|FG000|Extended Treatment Period|Lost to Follow-up|3|||
30761917|NCT00090753|58771034|FG001|Extended Treatment Period|Lost to Follow-up|1|||
30761918|NCT00090753|58771033|FG000|Extended Treatment Period|Renal Transplant|15|||
30761919|NCT00090753|58771034|FG001|Extended Treatment Period|Renal Transplant|12|||
30761920|NCT00090753|58771033|FG000|Extended Treatment Period|Mircera Commercialization|188|||
30761921|NCT00090753|58771034|FG001|Extended Treatment Period|Mircera Commercialization|93|||
30761922|NCT00090753|58771033|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
30761923|NCT00090753|58771034|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
30761924|NCT00048932|58771042|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
30761925|NCT00048932|58771043|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
30761926|NCT00048932|58771044|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
30761927|NCT00048932|58771042|FG000|Double Blind Period (DB)|Adverse Event|51|||
30761928|NCT00048932|58771043|FG001|Double Blind Period (DB)|Adverse Event|19|||
30761929|NCT00048932|58771044|FG002|Double Blind Period (DB)|Adverse Event|0|||
30761930|NCT00048932|58771042|FG000|Double Blind Period (DB)|Death|5|||
30761931|NCT00048932|58771043|FG001|Double Blind Period (DB)|Death|3|||
30761932|NCT00048932|58771044|FG002|Double Blind Period (DB)|Death|0|||
30761933|NCT00048932|58771042|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
30761934|NCT00048932|58771043|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
30761935|NCT00048932|58771044|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
30761936|NCT00048932|58771042|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
30761937|NCT00048932|58771043|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
30761938|NCT00048932|58771044|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
30761939|NCT00048932|58771042|FG000|Double Blind Period (DB)|Relocation|1|||
30761940|NCT00048932|58771043|FG001|Double Blind Period (DB)|Relocation|0|||
30761941|NCT00048932|58771044|FG002|Double Blind Period (DB)|Relocation|0|||
30761942|NCT00048932|58771042|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
30761943|NCT00048932|58771043|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
30761944|NCT00048932|58771044|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
30761945|NCT00048932|58771042|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
30761946|NCT00048932|58771043|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
30761947|NCT00048932|58771044|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
30761948|NCT00048932|58771042|FG000|Double Blind Period (DB)|Pregnancy|1|||
30761949|NCT00048932|58771043|FG001|Double Blind Period (DB)|Pregnancy|0|||
30761950|NCT00048932|58771044|FG002|Double Blind Period (DB)|Pregnancy|0|||
30761951|NCT00048932|58771042|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
30761952|NCT00048932|58771043|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
30761953|NCT00048932|58771044|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
30761954|NCT00048932|58771042|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
30761955|NCT00048932|58771043|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
30761956|NCT00048932|58771044|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
30761957|NCT00048932|58771042|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
30761958|NCT00048932|58771043|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
30761959|NCT00048932|58771044|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
30761960|NCT00048932|58771042|FG000|Open Label Period (OL)|Death|0|||
30761961|NCT00048932|58771043|FG001|Open Label Period (OL)|Death|0|||
30761962|NCT00048932|58771044|FG002|Open Label Period (OL)|Death|25|||
30761963|NCT00048932|58771042|FG000|Open Label Period (OL)|Adverse Event|0|||
30761964|NCT00048932|58771043|FG001|Open Label Period (OL)|Adverse Event|0|||
30761965|NCT00048932|58771044|FG002|Open Label Period (OL)|Adverse Event|103|||
30761966|NCT00048932|58771042|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
30761967|NCT00048932|58771043|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
30761968|NCT00048932|58771044|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
30761969|NCT00048932|58771042|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
30761970|NCT00048932|58771043|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
30761971|NCT00048932|58771044|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
30761972|NCT00048932|58771042|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
30761973|NCT00048932|58771043|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
30761974|NCT00048932|58771044|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
30761975|NCT00048932|58771042|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
30761976|NCT00048932|58771043|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
30761977|NCT00048932|58771044|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
30761978|NCT00048932|58771042|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
30761979|NCT00048932|58771043|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
30761980|NCT00048932|58771044|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
30761981|NCT00048932|58771042|FG000|Open Label Period (OL)|Pregnancy|0|||
30761982|NCT00048932|58771043|FG001|Open Label Period (OL)|Pregnancy|0|||
30761983|NCT00048932|58771044|FG002|Open Label Period (OL)|Pregnancy|6|||
30761984|NCT00048932|58771042|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
30761985|NCT00048932|58771043|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
30761986|NCT00048932|58771044|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
30761987|NCT00048932|58771042|FG000|Open Label Period (OL)|Investigator Retiring|0|||
30761988|NCT00048932|58771043|FG001|Open Label Period (OL)|Investigator Retiring|0|||
30761989|NCT00048932|58771044|FG002|Open Label Period (OL)|Investigator Retiring|2|||
30761990|NCT00048932|58771042|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
30761991|NCT00048932|58771043|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
30761992|NCT00048932|58771044|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
30761993|NCT00048932|58771042|FG000|Open Label Period (OL)|Participant Relocated|0|||
30761994|NCT00048932|58771043|FG001|Open Label Period (OL)|Participant Relocated|0|||
30845671|NCT02966509|58871727|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
30845672|NCT02966509|58871728|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
30845673|NCT02966509|58871727|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
30761995|NCT00048932|58771044|FG002|Open Label Period (OL)|Participant Relocated|6|||
30761996|NCT00048932|58771042|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
30761997|NCT00048932|58771043|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
30761998|NCT00048932|58771044|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
30761999|NCT00048932|58771042|FG000|Open Label Period (OL)|Site Closure|0|||
30762000|NCT00048932|58771043|FG001|Open Label Period (OL)|Site Closure|0|||
30762001|NCT00048932|58771044|FG002|Open Label Period (OL)|Site Closure|3|||
30762002|NCT00048932|58771042|FG000|Open Label Period (OL)|Trial Terminated|0|||
30762003|NCT00048932|58771043|FG001|Open Label Period (OL)|Trial Terminated|0|||
30762004|NCT00048932|58771044|FG002|Open Label Period (OL)|Trial Terminated|1|||
30762005|NCT00048932|58771042|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
30762006|NCT00048932|58771043|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
30762007|NCT00048932|58771044|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
30762008|NCT00048932|58771042|FG000|Open Label Period (OL)|Patient Decision|0|||
30762009|NCT00048932|58771043|FG001|Open Label Period (OL)|Patient Decision|0|||
30762010|NCT00048932|58771044|FG002|Open Label Period (OL)|Patient Decision|4|||
30762011|NCT00048932|58771042|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
30762012|NCT00048932|58771043|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
30762013|NCT00048932|58771044|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
30762014|NCT00048932|58771042|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
30762015|NCT00048932|58771043|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
30762016|NCT00048932|58771044|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
30762017|NCT00048932|58771042|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
30762018|NCT00048932|58771043|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
30762019|NCT00048932|58771044|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
30762020|NCT00048932|58771042|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
30762021|NCT00048932|58771043|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
30762022|NCT00048932|58771044|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
30762023|NCT00048932|58771042|FG000|Open Label Period (OL)|Investigator Decision|0|||
30762024|NCT00048932|58771043|FG001|Open Label Period (OL)|Investigator Decision|0|||
30762025|NCT00048932|58771044|FG002|Open Label Period (OL)|Investigator Decision|4|||
30762026|NCT00048932|58771042|FG000|Open Label Period (OL)|Site Staff Issues|0|||
30762027|NCT00048932|58771043|FG001|Open Label Period (OL)|Site Staff Issues|0|||
30762028|NCT00048932|58771044|FG002|Open Label Period (OL)|Site Staff Issues|2|||
30762029|NCT00048932|58771042|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
30762030|NCT00048932|58771043|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
30762031|NCT00048932|58771044|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
30762032|NCT00048932|58771042|FG000|Open Label Period (OL)|Participant Surgery|0|||
30762033|NCT00048932|58771043|FG001|Open Label Period (OL)|Participant Surgery|0|||
30762034|NCT00048932|58771044|FG002|Open Label Period (OL)|Participant Surgery|1|||
30762035|NCT00073983|58771053|FG000|Overall Study|not evaluable|1|||
30762036|NCT03812679|58771059|FG000|Overall Study|Adverse Event|2|||
30762037|NCT03812679|58771059|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
30762038|NCT03812679|58771059|FG000|Overall Study|Renal transplant|1|||
30762039|NCT03812679|58771059|FG000|Overall Study|Withdrawal by Subject|1|||
30762040|NCT03812679|58771059|FG000|Overall Study|Termination of study|2|||
30762041|NCT03812679|58771059|FG000|Overall Study|Water device replacement|1|||
30762042|NCT02952820|58771066|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
30762043|NCT02952820|58771067|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
30762044|NCT02952820|58771068|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
30762045|NCT02952820|58771066|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
30762046|NCT02952820|58771067|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
30762047|NCT02952820|58771068|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
30762048|NCT02952820|58771066|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
30762049|NCT02952820|58771067|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
30762050|NCT02952820|58771068|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
30762051|NCT02952820|58771066|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
30762052|NCT02952820|58771067|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
30762053|NCT02952820|58771068|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
30762054|NCT02952820|58771066|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
30762055|NCT02952820|58771067|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
30762056|NCT02952820|58771068|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
30762057|NCT02952820|58771066|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
30762058|NCT02952820|58771067|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
30762059|NCT02952820|58771068|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
30762060|NCT02952820|58771066|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
30762061|NCT02952820|58771067|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
30762062|NCT02952820|58771068|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
30762063|NCT02952820|58771066|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
30762064|NCT02952820|58771067|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
30762065|NCT02952820|58771068|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
30762066|NCT02952820|58771066|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
30762067|NCT02952820|58771067|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
30762068|NCT02952820|58771068|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
30762069|NCT02952820|58771066|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
30762070|NCT02952820|58771067|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
30762071|NCT02952820|58771068|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
30762072|NCT02952820|58771066|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
30762073|NCT02952820|58771067|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
30762074|NCT02952820|58771068|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
30762075|NCT02952820|58771066|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
30762076|NCT02952820|58771067|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
30762077|NCT02952820|58771068|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
30762078|NCT02952820|58771066|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
30762079|NCT02952820|58771067|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
30762080|NCT02952820|58771068|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
30762081|NCT02952820|58771066|FG000|Active Treatment Period (6 Months)|Not treated|0|||
30762082|NCT02952820|58771067|FG001|Active Treatment Period (6 Months)|Not treated|0|||
30762083|NCT02952820|58771068|FG002|Active Treatment Period (6 Months)|Not treated|1|||
30762084|NCT00006392|58771083|FG000|Overall Study|Ineligible|11|||
30762085|NCT00006392|58771084|FG001|Overall Study|Ineligible|3|||
30845674|NCT02966509|58871728|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
30845675|NCT02966509|58871727|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
30845676|NCT02966509|58871728|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
30845677|NCT02966509|58871727|FG000|6 Month Satisfaction Survey|Death|36|||
30845678|NCT02966509|58871728|FG001|6 Month Satisfaction Survey|Death|33|||
30845679|NCT02966509|58871727|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
30845680|NCT02966509|58871728|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
30845681|NCT02966509|58871727|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
30845682|NCT02966509|58871728|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
30845683|NCT02966509|58871727|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
30845684|NCT02966509|58871728|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
30845685|NCT02966509|58871727|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
30845686|NCT02966509|58871728|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
30845687|NCT02966509|58871727|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
30845688|NCT02966509|58871728|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
30845689|NCT02966353|58871734|FG000|Overall Study|Withdrawal by Subject|7|||
30845690|NCT02966353|58871734|FG000|Overall Study|Adverse Event|4|||
30845691|NCT02966353|58871734|FG000|Overall Study|Death|4|||
30845692|NCT02966353|58871734|FG000|Overall Study|Physician Decision|3|||
30845693|NCT02966353|58871734|FG000|Overall Study|Progressive disease|2|||
30845694|NCT02966353|58871734|FG000|Overall Study|Protocol deviation|2|||
30845695|NCT02965573|58871767|FG000|Overall Study|Lack of Efficacy|1|||
30845696|NCT02965573|58871768|FG001|Overall Study|Lack of Efficacy|0|||
30845697|NCT02964325|58871776|FG000|Overall Study|Lost to Follow-up|3|||
30845698|NCT02964325|58871777|FG001|Overall Study|Lost to Follow-up|3|||
30845699|NCT02964325|58871776|FG000|Overall Study|Physician Decision|5|||
30845700|NCT02964325|58871777|FG001|Overall Study|Physician Decision|4|||
30845701|NCT02964325|58871776|FG000|Overall Study|Death|1|||
30845702|NCT02964325|58871777|FG001|Overall Study|Death|3|||
30845703|NCT02964325|58871776|FG000|Overall Study|Withdrawal by Subject|2|||
30845704|NCT02964325|58871777|FG001|Overall Study|Withdrawal by Subject|1|||
30845705|NCT02964325|58871776|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
30845706|NCT02964325|58871777|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
30845707|NCT02964247|58871785|FG000|Overall Study|Lost to Follow-up|2|||
30845708|NCT02964247|58871786|FG001|Overall Study|Lost to Follow-up|0|||
30845709|NCT02964247|58871785|FG000|Overall Study|Withdrawal by Subject|1|||
30845710|NCT02964247|58871786|FG001|Overall Study|Withdrawal by Subject|2|||
30845711|NCT03654729|58871795|FG000|Overall Study|Death|9|||
30845712|NCT03654729|58871796|FG001|Overall Study|Death|9|||
30845713|NCT03654729|58871797|FG002|Overall Study|Death|16|||
30845714|NCT03654729|58871795|FG000|Overall Study|Withdrawal by Subject|8|||
30845715|NCT03654729|58871796|FG001|Overall Study|Withdrawal by Subject|6|||
30845716|NCT03654729|58871797|FG002|Overall Study|Withdrawal by Subject|4|||
30845717|NCT03654729|58871795|FG000|Overall Study|Study terminated by Sponsor|3|||
30845718|NCT03654729|58871796|FG001|Overall Study|Study terminated by Sponsor|5|||
30845719|NCT03654729|58871797|FG002|Overall Study|Study terminated by Sponsor|4|||
30845720|NCT03654729|58871795|FG000|Overall Study|Not reported|2|||
30845721|NCT03654729|58871796|FG001|Overall Study|Not reported|4|||
30845722|NCT03654729|58871797|FG002|Overall Study|Not reported|5|||
30845723|NCT03654729|58871795|FG000|Overall Study|Progressive disease|3|||
30845724|NCT03654729|58871796|FG001|Overall Study|Progressive disease|0|||
30845725|NCT03654729|58871797|FG002|Overall Study|Progressive disease|0|||
30845726|NCT03654729|58871795|FG000|Overall Study|Lost to Follow-up|2|||
30845727|NCT03654729|58871796|FG001|Overall Study|Lost to Follow-up|0|||
30845728|NCT03654729|58871797|FG002|Overall Study|Lost to Follow-up|0|||
30845729|NCT03654729|58871795|FG000|Overall Study|Physician Decision|2|||
30845730|NCT03654729|58871796|FG001|Overall Study|Physician Decision|0|||
30845731|NCT03654729|58871797|FG002|Overall Study|Physician Decision|0|||
30845732|NCT03654729|58871795|FG000|Overall Study|Protocol Violation|1|||
30845733|NCT03654729|58871796|FG001|Overall Study|Protocol Violation|1|||
30845734|NCT03654729|58871797|FG002|Overall Study|Protocol Violation|0|||
30845735|NCT03654729|58871795|FG000|Overall Study|Non-compliance with study drug|0|||
30845736|NCT03654729|58871796|FG001|Overall Study|Non-compliance with study drug|1|||
30845737|NCT03654729|58871797|FG002|Overall Study|Non-compliance with study drug|0|||
30949242|NCT01743469|58995326|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
30949243|NCT01743469|58995327|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
30949244|NCT01743469|58995328|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
30949245|NCT01743469|58995329|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
30949246|NCT01743469|58995326|FG000|Active Treatment Phase|Missing|1|||
30949247|NCT01743469|58995327|FG001|Active Treatment Phase|Missing|0|||
30949248|NCT01743469|58995328|FG002|Active Treatment Phase|Missing|0|||
30949249|NCT01743469|58995329|FG003|Active Treatment Phase|Missing|0|||
30949250|NCT01743469|58995326|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
30949251|NCT01743469|58995327|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
30949252|NCT01743469|58995328|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
30949253|NCT01743469|58995329|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
30845738|NCT03654729|58871795|FG000|Overall Study|Site terminated by Sponsor|1|||
30845739|NCT03654729|58871796|FG001|Overall Study|Site terminated by Sponsor|0|||
30845740|NCT03654729|58871797|FG002|Overall Study|Site terminated by Sponsor|0|||
30845741|NCT01377987|58871805|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
30845742|NCT01377987|58871806|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
30845743|NCT02898259|58871817|FG000|Overall Study|Adverse Event|0|||
30845744|NCT02898259|58871818|FG001|Overall Study|Adverse Event|0|||
30845745|NCT02898259|58871819|FG002|Overall Study|Adverse Event|1|||
30845746|NCT02898259|58871820|FG003|Overall Study|Adverse Event|0|||
30845747|NCT02898259|58871821|FG004|Overall Study|Adverse Event|0|||
30845748|NCT02898259|58871817|FG000|Overall Study|Lack of Efficacy|1|||
30949254|NCT01743469|58995326|FG000|Follow-up Period - Post-Treatment|Death|43|||
30845749|NCT02898259|58871818|FG001|Overall Study|Lack of Efficacy|1|||
30845750|NCT02898259|58871819|FG002|Overall Study|Lack of Efficacy|3|||
30845751|NCT02898259|58871820|FG003|Overall Study|Lack of Efficacy|0|||
30845752|NCT02898259|58871821|FG004|Overall Study|Lack of Efficacy|0|||
30845753|NCT02898259|58871817|FG000|Overall Study|Lost to Follow-up|0|||
30845754|NCT02898259|58871818|FG001|Overall Study|Lost to Follow-up|0|||
30845755|NCT02898259|58871819|FG002|Overall Study|Lost to Follow-up|1|||
30845756|NCT02898259|58871820|FG003|Overall Study|Lost to Follow-up|0|||
30845757|NCT02898259|58871821|FG004|Overall Study|Lost to Follow-up|0|||
30845758|NCT02898259|58871817|FG000|Overall Study|Transformation before study began|0|||
30949255|NCT01743469|58995327|FG001|Follow-up Period - Post-Treatment|Death|47|||
30949256|NCT01743469|58995328|FG002|Follow-up Period - Post-Treatment|Death|22|||
30949257|NCT01743469|58995329|FG003|Follow-up Period - Post-Treatment|Death|16|||
30949258|NCT01743469|58995326|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
30949259|NCT01743469|58995327|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
30949260|NCT01743469|58995328|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
30949261|NCT01743469|58995329|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
30949262|NCT01743001|58995341|FG000|Overall Study|Physician Decision|1|||
30949263|NCT01743001|58995342|FG001|Overall Study|Physician Decision|0|||
30845759|NCT02898259|58871818|FG001|Overall Study|Transformation before study began|0|||
30845760|NCT02898259|58871819|FG002|Overall Study|Transformation before study began|0|||
30845761|NCT02898259|58871820|FG003|Overall Study|Transformation before study began|1|||
30845762|NCT02898259|58871821|FG004|Overall Study|Transformation before study began|0|||
30845763|NCT02963935|58871836|FG000|Overall Study|Adverse Event|12|||
30845764|NCT02963935|58871837|FG001|Overall Study|Adverse Event|6|||
30949264|NCT01743001|58995341|FG000|Overall Study|Pregnancy|1|||
30949265|NCT01743001|58995342|FG001|Overall Study|Pregnancy|0|||
30845765|NCT02963935|58871836|FG000|Overall Study|Protocol Violation|2|||
30845766|NCT02963935|58871837|FG001|Overall Study|Protocol Violation|1|||
30845767|NCT02963935|58871836|FG000|Overall Study|Lack of Efficacy|0|||
30845768|NCT02963935|58871837|FG001|Overall Study|Lack of Efficacy|2|||
30845769|NCT02963935|58871836|FG000|Overall Study|Lost to Follow-up|1|||
30845770|NCT02963935|58871837|FG001|Overall Study|Lost to Follow-up|6|||
30845771|NCT02963935|58871836|FG000|Overall Study|Unclassified|13|||
30845772|NCT02963935|58871837|FG001|Overall Study|Unclassified|22|||
30949266|NCT01743001|58995341|FG000|Overall Study|Death|1|||
30949267|NCT01743001|58995342|FG001|Overall Study|Death|0|||
30949268|NCT01704079|58995361|FG000|Overall Study|Withdrawal by Subject|5|||
30949269|NCT01704079|58995362|FG001|Overall Study|Withdrawal by Subject|7|||
30949270|NCT01704079|58995361|FG000|Overall Study|Lost to Follow-up|2|||
30949271|NCT01704079|58995362|FG001|Overall Study|Lost to Follow-up|5|||
30845773|NCT02963701|58871845|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
30845774|NCT02963701|58871846|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
30845775|NCT01345591|58871852|FG000|Overall Study|Lost to Follow-up|1|||
30845776|NCT02961751|58871861|FG000|Overall Study|Lost to Follow-up|11|||
30845777|NCT02961751|58871861|FG000|Overall Study|Physician Decision|2|||
30845778|NCT02961751|58871861|FG000|Overall Study|Not Eligible at Enrollment|1|||
30845779|NCT02961751|58871861|FG000|Overall Study|Protocol Violation|1|||
30845780|NCT02963311|58871865|FG000|Overall Study|Withdrawal by Subject|1|||
30845781|NCT02963311|58871865|FG000|Overall Study|Screen Failure|4|||
30845782|NCT02962765|58871869|FG000|Overall Study|Protocol Violation|9|||
30845783|NCT02962765|58871869|FG000|Overall Study|Withdrawal by Subject|3|||
30845784|NCT02962765|58871869|FG000|Overall Study|Lost to Follow-up|1|||
30845785|NCT02962765|58871869|FG000|Overall Study|Death|1|||
30949272|NCT01704079|58995361|FG000|Overall Study|Adverse Event|4|||
30949273|NCT01704079|58995362|FG001|Overall Study|Adverse Event|7|||
30949274|NCT01704079|58995361|FG000|Overall Study|Protocol Violation|1|||
30949275|NCT01704079|58995362|FG001|Overall Study|Protocol Violation|0|||
30949276|NCT01704079|58995361|FG000|Overall Study|Subject noncompliance|2|||
30949277|NCT01704079|58995362|FG001|Overall Study|Subject noncompliance|3|||
30949278|NCT01704079|58995361|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
30949279|NCT01704079|58995362|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
30949280|NCT01703845|58995370|FG000|Overall Study|Adverse Event|1|||
30949281|NCT01703845|58995371|FG001|Overall Study|Adverse Event|0|||
30949282|NCT01703845|58995370|FG000|Overall Study|Protocol Violation|1|||
30949283|NCT01703845|58995371|FG001|Overall Study|Protocol Violation|0|||
30949284|NCT01703845|58995370|FG000|Overall Study|other than stated above|1|||
30949285|NCT01703845|58995371|FG001|Overall Study|other than stated above|0|||
30949286|NCT01724359|58995379|FG000|Overall Study|Adverse Event|10|||
30949287|NCT01724359|58995379|FG000|Overall Study|Death|1|||
30949288|NCT01724359|58995379|FG000|Overall Study|Other|20|||
30949289|NCT01703221|58995388|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
30949290|NCT01703221|58995389|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
30949291|NCT01703221|58995390|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
30949292|NCT01703221|58995388|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
30626099|NCT00886288|58638134|FG001|Overall Study|no respect of the 12 weeks period|227|||
30949293|NCT01703221|58995389|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
30949294|NCT01703221|58995390|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
30949295|NCT01703221|58995388|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
30626100|NCT00886288|58638133|FG000|Overall Study|Lost to Follow-up|86|||
30845786|NCT02962765|58871869|FG000|Overall Study|Limited access to study medication|3|||
30949296|NCT01703221|58995389|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
30949297|NCT01703221|58995390|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
30949298|NCT01703221|58995388|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
30949299|NCT01703221|58995389|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
30949300|NCT01703221|58995390|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
30845787|NCT00965757|58871882|FG000|Double-blind Phase|Progression of concomitant disease|1|||
30949301|NCT01703221|58995388|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
30949302|NCT01703221|58995389|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
30845788|NCT00965757|58871883|FG001|Double-blind Phase|Progression of concomitant disease|2|||
30845789|NCT00965757|58871884|FG002|Double-blind Phase|Progression of concomitant disease|0|||
30845790|NCT00965757|58871885|FG003|Double-blind Phase|Progression of concomitant disease|0|||
30845791|NCT00965757|58871882|FG000|Double-blind Phase|Adverse drug reaction|2|||
30949303|NCT01703221|58995390|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
30949304|NCT01703221|58995388|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
30845792|NCT00965757|58871883|FG001|Double-blind Phase|Adverse drug reaction|1|||
30845793|NCT00965757|58871884|FG002|Double-blind Phase|Adverse drug reaction|0|||
30845794|NCT00965757|58871885|FG003|Double-blind Phase|Adverse drug reaction|0|||
30845795|NCT00965757|58871882|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
30845796|NCT00965757|58871883|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
30845797|NCT00965757|58871884|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
30845798|NCT00965757|58871885|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
30845799|NCT00965757|58871882|FG000|Double-blind Phase|Lack of Efficacy|7|||
30845800|NCT00965757|58871883|FG001|Double-blind Phase|Lack of Efficacy|11|||
30845801|NCT00965757|58871884|FG002|Double-blind Phase|Lack of Efficacy|0|||
30845802|NCT00965757|58871885|FG003|Double-blind Phase|Lack of Efficacy|0|||
30845803|NCT00965757|58871882|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
30845804|NCT00965757|58871883|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
30845805|NCT00965757|58871884|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
30845806|NCT00965757|58871885|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
30845807|NCT00965757|58871882|FG000|Double-blind Phase|Lost to Follow-up|0|||
30845808|NCT00965757|58871883|FG001|Double-blind Phase|Lost to Follow-up|1|||
30845809|NCT00965757|58871884|FG002|Double-blind Phase|Lost to Follow-up|0|||
30845810|NCT00965757|58871885|FG003|Double-blind Phase|Lost to Follow-up|0|||
30845811|NCT00965757|58871882|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
30845812|NCT00965757|58871883|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
30845813|NCT00965757|58871884|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
30845814|NCT00965757|58871885|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
30845815|NCT00965757|58871882|FG000|Double-blind Phase|Other|1|||
30845816|NCT00965757|58871883|FG001|Double-blind Phase|Other|0|||
30845817|NCT00965757|58871884|FG002|Double-blind Phase|Other|0|||
30845818|NCT00965757|58871885|FG003|Double-blind Phase|Other|0|||
30845819|NCT00965757|58871882|FG000|Extension Phase|Progression of concomitant disease|0|||
30845820|NCT00965757|58871883|FG001|Extension Phase|Progression of concomitant disease|0|||
30845821|NCT00965757|58871884|FG002|Extension Phase|Progression of concomitant disease|4|||
30845822|NCT00965757|58871885|FG003|Extension Phase|Progression of concomitant disease|2|||
30845823|NCT00965757|58871882|FG000|Extension Phase|Adverse drug reaction|0|||
30845824|NCT00965757|58871883|FG001|Extension Phase|Adverse drug reaction|0|||
30845825|NCT00965757|58871884|FG002|Extension Phase|Adverse drug reaction|6|||
30845826|NCT00965757|58871885|FG003|Extension Phase|Adverse drug reaction|3|||
30845827|NCT00965757|58871882|FG000|Extension Phase|Abnormal Laboratory Value|0|||
30845828|NCT00965757|58871883|FG001|Extension Phase|Abnormal Laboratory Value|0|||
30845829|NCT00965757|58871884|FG002|Extension Phase|Abnormal Laboratory Value|6|||
30845830|NCT00965757|58871885|FG003|Extension Phase|Abnormal Laboratory Value|1|||
30845831|NCT00965757|58871882|FG000|Extension Phase|Lack of Efficacy|0|||
30845832|NCT00965757|58871883|FG001|Extension Phase|Lack of Efficacy|0|||
30845833|NCT00965757|58871884|FG002|Extension Phase|Lack of Efficacy|8|||
30845834|NCT00965757|58871885|FG003|Extension Phase|Lack of Efficacy|12|||
30845835|NCT00965757|58871882|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
30845836|NCT00965757|58871883|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
30626101|NCT00886288|58638134|FG001|Overall Study|Lost to Follow-up|0|||
30626102|NCT01204658|58638146|FG000|Primary Phase|Adverse Event|0|||
30845837|NCT00965757|58871884|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
30845838|NCT00965757|58871885|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
30845839|NCT00965757|58871882|FG000|Extension Phase|Lost to Follow-up|0|||
30845840|NCT00965757|58871883|FG001|Extension Phase|Lost to Follow-up|0|||
30949305|NCT01703221|58995389|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
30949306|NCT01703221|58995390|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
30949307|NCT01703221|58995388|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
30949308|NCT01703221|58995389|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
30949309|NCT01703221|58995390|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
30626103|NCT01204658|58638147|FG001|Primary Phase|Adverse Event|0|||
30626104|NCT01204658|58638148|FG002|Primary Phase|Adverse Event|1|||
30845841|NCT00965757|58871884|FG002|Extension Phase|Lost to Follow-up|0|||
30845842|NCT00965757|58871885|FG003|Extension Phase|Lost to Follow-up|1|||
30845843|NCT00965757|58871882|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
30845844|NCT00965757|58871883|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
30845845|NCT00965757|58871884|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
30845846|NCT00965757|58871885|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
30845847|NCT00965757|58871882|FG000|Extension Phase|Protocol Violation|0|||
30845848|NCT00965757|58871883|FG001|Extension Phase|Protocol Violation|0|||
30845849|NCT00965757|58871884|FG002|Extension Phase|Protocol Violation|0|||
30845850|NCT00965757|58871885|FG003|Extension Phase|Protocol Violation|1|||
30845851|NCT00965757|58871882|FG000|Extension Phase|Other|0|||
30845852|NCT00965757|58871883|FG001|Extension Phase|Other|0|||
30845853|NCT00965757|58871884|FG002|Extension Phase|Other|2|||
30845854|NCT00965757|58871885|FG003|Extension Phase|Other|1|||
30845855|NCT03072459|58871893|FG000|Overall Study|Device revised/removed|1|||
30845856|NCT03072459|58871893|FG000|Overall Study|Subject not able to return|1|||
30845857|NCT01067521|58871899|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
30845858|NCT01067521|58871900|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
30845859|NCT01067521|58871899|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
30845860|NCT01067521|58871900|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
30845861|NCT01067521|58871899|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
30845862|NCT01067521|58871900|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
30845863|NCT01067521|58871899|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
30845864|NCT01067521|58871900|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
30845865|NCT01067521|58871899|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
30845866|NCT01067521|58871900|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
30845867|NCT01067521|58871899|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
30845868|NCT01067521|58871900|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
30845869|NCT01067521|58871899|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
30845870|NCT01067521|58871900|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
30845871|NCT01067521|58871899|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
30845872|NCT01067521|58871900|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
30845873|NCT01067521|58871899|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
30845874|NCT01067521|58871900|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
30845875|NCT01067521|58871899|FG000|Open-Label Period|Death|3|||
30845876|NCT01067521|58871900|FG001|Open-Label Period|Death|1|||
30845877|NCT01067521|58871899|FG000|Open-Label Period|Adverse Event|30|||
30845878|NCT01067521|58871900|FG001|Open-Label Period|Adverse Event|28|||
30845879|NCT01067521|58871899|FG000|Open-Label Period|Withdrawal by Subject|160|||
30845880|NCT01067521|58871900|FG001|Open-Label Period|Withdrawal by Subject|88|||
30845881|NCT01067521|58871899|FG000|Open-Label Period|Physician Decision|13|||
30845882|NCT01067521|58871900|FG001|Open-Label Period|Physician Decision|11|||
30845883|NCT01067521|58871899|FG000|Open-Label Period|Non-compliance with study drug|5|||
30845884|NCT01067521|58871900|FG001|Open-Label Period|Non-compliance with study drug|0|||
30845885|NCT01067521|58871899|FG000|Open-Label Period|Protocol Violation|3|||
30845886|NCT01067521|58871900|FG001|Open-Label Period|Protocol Violation|0|||
30845887|NCT01067521|58871899|FG000|Open-Label Period|Pregnancy|14|||
30845888|NCT01067521|58871900|FG001|Open-Label Period|Pregnancy|8|||
30845889|NCT01067521|58871899|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
30845890|NCT01067521|58871900|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
30845891|NCT01067521|58871899|FG000|Open-Label Period|Lost to Follow-up|21|||
30845892|NCT01067521|58871900|FG001|Open-Label Period|Lost to Follow-up|20|||
30845893|NCT02735577|58871911|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
30845894|NCT02735577|58871911|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
30845895|NCT01345123|58871918|FG000|Overall Study|participants no longer with health plan|79|||
30845896|NCT01345123|58871919|FG001|Overall Study|participants no longer with health plan|85|||
30845897|NCT01345123|58871920|FG002|Overall Study|participants no longer with health plan|88|||
30845898|NCT02735421|58871929|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
30845899|NCT02735421|58871929|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
30845900|NCT02735421|58871929|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
30845901|NCT02735421|58871929|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
30845902|NCT02735421|58871929|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
30845903|NCT02735421|58871929|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
30949310|NCT01703221|58995388|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
30949311|NCT01703221|58995389|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
30949312|NCT01703221|58995390|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
30845904|NCT02735421|58871929|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
30845905|NCT02983799|58871946|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
30845906|NCT02983799|58871947|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
30845907|NCT02983799|58871948|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
30845908|NCT02983799|58871949|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
30845909|NCT02983799|58871950|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
30845910|NCT02983799|58871946|FG000|Overall Study|Death|20|||
30845911|NCT02983799|58871947|FG001|Overall Study|Death|5|||
30845912|NCT02983799|58871948|FG002|Overall Study|Death|23|||
30949313|NCT01722877|58995404|FG000|Overall Study|Death|1|||
30845913|NCT02983799|58871949|FG003|Overall Study|Death|47|||
30845914|NCT02983799|58871950|FG004|Overall Study|Death|7|||
30845915|NCT02983799|58871946|FG000|Overall Study|Withdrawal by Subject|1|||
30845916|NCT02983799|58871947|FG001|Overall Study|Withdrawal by Subject|0|||
30845917|NCT02983799|58871948|FG002|Overall Study|Withdrawal by Subject|3|||
30845918|NCT02983799|58871949|FG003|Overall Study|Withdrawal by Subject|4|||
30845919|NCT02983799|58871950|FG004|Overall Study|Withdrawal by Subject|1|||
30845920|NCT02983799|58871946|FG000|Overall Study|Protocol Violation|0|||
30949314|NCT01722877|58995404|FG000|Overall Study|Lost to Follow-up|1|||
30949315|NCT01703065|58995449|FG000|Overall Study|Lack of Efficacy|1|||
30845921|NCT02983799|58871947|FG001|Overall Study|Protocol Violation|1|||
30845922|NCT02983799|58871948|FG002|Overall Study|Protocol Violation|0|||
30845923|NCT02983799|58871949|FG003|Overall Study|Protocol Violation|0|||
30845924|NCT02983799|58871950|FG004|Overall Study|Protocol Violation|1|||
30845925|NCT02983799|58871946|FG000|Overall Study|Lost to Follow-up|1|||
30845926|NCT02983799|58871947|FG001|Overall Study|Lost to Follow-up|0|||
30845927|NCT02983799|58871948|FG002|Overall Study|Lost to Follow-up|1|||
30845928|NCT02983799|58871949|FG003|Overall Study|Lost to Follow-up|0|||
30845929|NCT02983799|58871950|FG004|Overall Study|Lost to Follow-up|0|||
30845930|NCT02186847|58871968|FG000|Overall Study|Protocol Violation|3|||
30845931|NCT02186847|58871969|FG001|Overall Study|Protocol Violation|0|||
30845932|NCT01066871|58871979|FG000|Overall Study|Lost to Follow-up|0|||
30845933|NCT01066871|58871980|FG001|Overall Study|Lost to Follow-up|2|||
30845934|NCT01066871|58871981|FG002|Overall Study|Lost to Follow-up|2|||
30845935|NCT01066871|58871982|FG003|Overall Study|Lost to Follow-up|0|||
30845936|NCT01066871|58871979|FG000|Overall Study|Protocol Violation|1|||
30845937|NCT01066871|58871980|FG001|Overall Study|Protocol Violation|0|||
30845938|NCT01066871|58871981|FG002|Overall Study|Protocol Violation|3|||
30845939|NCT01066871|58871982|FG003|Overall Study|Protocol Violation|2|||
30845940|NCT01066871|58871979|FG000|Overall Study|Lack of Efficacy|0|||
30845941|NCT01066871|58871980|FG001|Overall Study|Lack of Efficacy|0|||
30845942|NCT01066871|58871981|FG002|Overall Study|Lack of Efficacy|0|||
30845943|NCT01066871|58871982|FG003|Overall Study|Lack of Efficacy|1|||
30845944|NCT01066871|58871979|FG000|Overall Study|Withdrawal by Subject|3|||
30845945|NCT01066871|58871980|FG001|Overall Study|Withdrawal by Subject|1|||
30845946|NCT01066871|58871981|FG002|Overall Study|Withdrawal by Subject|0|||
30845947|NCT01066871|58871982|FG003|Overall Study|Withdrawal by Subject|0|||
30949316|NCT01703065|58995450|FG001|Overall Study|Lack of Efficacy|0|||
30949317|NCT01702987|58995463|FG000|Overall Study|Withdrawal by Subject|1|||
30949318|NCT01702987|58995464|FG001|Overall Study|Withdrawal by Subject|0|||
30949319|NCT01702519|58995485|FG000|Washout Period|Lost to Follow-up|1|||
30949320|NCT01702519|58995486|FG001|Washout Period|Lost to Follow-up|0|||
30949321|NCT01702519|58995485|FG000|Washout Period|Withdrawal by Subject|0|||
30949322|NCT01702519|58995486|FG001|Washout Period|Withdrawal by Subject|2|||
30949323|NCT01739803|58995498|FG000|Overall Study|Lost to Follow-up|9|||
30949324|NCT01739803|58995499|FG001|Overall Study|Lost to Follow-up|6|||
30949325|NCT01739335|58995511|FG000|Overall Study|Lost to Follow-up|7|||
30949326|NCT01739335|58995512|FG001|Overall Study|Lost to Follow-up|4|||
30949327|NCT01739335|58995511|FG000|Overall Study|Ineligible patient randomized|0|||
30949328|NCT01739335|58995512|FG001|Overall Study|Ineligible patient randomized|1|||
30949329|NCT01702363|58995537|FG000|Overall Study|Adverse Event|14|||
30845948|NCT01066871|58871979|FG000|Overall Study|Other|0|||
30845949|NCT01066871|58871980|FG001|Overall Study|Other|2|||
30845950|NCT01066871|58871981|FG002|Overall Study|Other|1|||
30845951|NCT01066871|58871982|FG003|Overall Study|Other|2|||
30845952|NCT02982863|58872002|FG000|Overall Study|Not eligible patients|809|||
30845953|NCT02982863|58872003|FG001|Overall Study|Not eligible patients|4261|||
30845954|NCT02982863|58872004|FG002|Overall Study|Not eligible patients|1852|||
30845955|NCT02982863|58872005|FG003|Overall Study|Not eligible patients|1400|||
30949330|NCT01702363|58995537|FG000|Overall Study|Lack of Efficacy|4|||
30845956|NCT02982863|58872006|FG004|Overall Study|Not eligible patients|492|||
30845957|NCT04343651|58872049|FG000|Overall Study|Physician Decision|2|||
30845958|NCT04343651|58872050|FG001|Overall Study|Physician Decision|1|||
30845959|NCT04343651|58872049|FG000|Overall Study|Lost to Follow-up|2|||
30845960|NCT04343651|58872050|FG001|Overall Study|Lost to Follow-up|1|||
30845961|NCT04343651|58872049|FG000|Overall Study|Protocol Violation|4|||
30845962|NCT04343651|58872050|FG001|Overall Study|Protocol Violation|6|||
30845963|NCT04343651|58872049|FG000|Overall Study|Missing|3|||
30845964|NCT04343651|58872050|FG001|Overall Study|Missing|9|||
30845965|NCT04343651|58872049|FG000|Overall Study|Withdrawal by Subject|0|||
30845966|NCT04343651|58872050|FG001|Overall Study|Withdrawal by Subject|4|||
30845967|NCT04343651|58872049|FG000|Overall Study|Death|0|||
30845968|NCT04343651|58872050|FG001|Overall Study|Death|1|||
30845969|NCT04343651|58872049|FG000|Overall Study|Did not start treatment|1|||
30845970|NCT04343651|58872050|FG001|Overall Study|Did not start treatment|1|||
30845971|NCT04343651|58872049|FG000|Overall Study|Patient did not complete visits 3-6|0|||
30845972|NCT04343651|58872050|FG001|Overall Study|Patient did not complete visits 3-6|1|||
30845973|NCT02906579|58872058|FG000|Overall Study|Adverse Event|1|||
30845974|NCT02906579|58872058|FG000|Overall Study|Physician Decision|1|||
30845975|NCT01328535|58872078|FG000|Overall Study|Ineligible|1|||
30845976|NCT02905331|58872086|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
30845977|NCT02905331|58872087|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
30845978|NCT02905331|58872088|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
30845979|NCT02905331|58872086|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
30949331|NCT01702363|58995537|FG000|Overall Study|Withdrawal by Subject|2|||
30949332|NCT01722097|58995544|FG000|Overall Study|Patient sheets not returned|6|||
30949333|NCT01722097|58995545|FG001|Overall Study|Patient sheets not returned|5|||
30949334|NCT01701973|58995560|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
30949335|NCT01701973|58995561|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
30949336|NCT01701973|58995562|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
30949337|NCT01701973|58995563|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
30949338|NCT01701973|58995564|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
30949339|NCT01701973|58995565|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
30949340|NCT01701973|58995566|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
30949341|NCT01701973|58995567|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
30949342|NCT01721317|58995618|FG000|Overall Study|Study Closed / Terminated|2|||
30845980|NCT02905331|58872087|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
30845981|NCT02905331|58872088|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
30845982|NCT02905331|58872086|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
30845983|NCT02905331|58872087|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
30845984|NCT02905331|58872088|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
30845985|NCT02905331|58872086|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
30845986|NCT02905331|58872087|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
30845987|NCT02905331|58872088|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
30845988|NCT02905331|58872086|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
30845989|NCT02905331|58872087|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
30845990|NCT02905331|58872088|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
30845991|NCT02979197|58872099|FG000|Overall Study|Adverse Event|4|||
30845992|NCT02979197|58872100|FG001|Overall Study|Adverse Event|2|||
30845993|NCT02979197|58872101|FG002|Overall Study|Adverse Event|0|||
30845994|NCT02979197|58872099|FG000|Overall Study|Protocol Violation|0|||
30845995|NCT02979197|58872100|FG001|Overall Study|Protocol Violation|1|||
30845996|NCT02979197|58872101|FG002|Overall Study|Protocol Violation|0|||
30845997|NCT02979197|58872099|FG000|Overall Study|Subject unable to commit to study dates|0|||
30845998|NCT02979197|58872100|FG001|Overall Study|Subject unable to commit to study dates|1|||
30845999|NCT02979197|58872101|FG002|Overall Study|Subject unable to commit to study dates|0|||
30846000|NCT02982239|58872111|FG000|Overall Study|Lost to Follow-up|3|||
30846001|NCT02982239|58872112|FG001|Overall Study|Lost to Follow-up|2|||
30949343|NCT01721317|58995619|FG001|Overall Study|Study Closed / Terminated|2|||
30949344|NCT01721317|58995618|FG000|Overall Study|Physician Decision|0|||
30626105|NCT01204658|58638149|FG003|Primary Phase|Adverse Event|0|||
30846002|NCT01066793|58872125|FG000|Overall Study|Death|4|||
30846003|NCT01066793|58872126|FG001|Overall Study|Death|1|||
30846004|NCT01066793|58872127|FG002|Overall Study|Death|1|||
30846005|NCT01066793|58872128|FG003|Overall Study|Death|0|||
30846006|NCT01066793|58872129|FG004|Overall Study|Death|0|||
30846007|NCT01066793|58872130|FG005|Overall Study|Death|0|||
30846008|NCT01066793|58872125|FG000|Overall Study|Lack of Efficacy|2|||
30846009|NCT01066793|58872126|FG001|Overall Study|Lack of Efficacy|1|||
30846010|NCT01066793|58872127|FG002|Overall Study|Lack of Efficacy|0|||
30846011|NCT01066793|58872128|FG003|Overall Study|Lack of Efficacy|0|||
30846012|NCT01066793|58872129|FG004|Overall Study|Lack of Efficacy|0|||
30846013|NCT01066793|58872130|FG005|Overall Study|Lack of Efficacy|0|||
30846014|NCT01066793|58872125|FG000|Overall Study|Lost to Follow-up|180|||
30846015|NCT01066793|58872126|FG001|Overall Study|Lost to Follow-up|39|||
30846016|NCT01066793|58872127|FG002|Overall Study|Lost to Follow-up|82|||
30846017|NCT01066793|58872128|FG003|Overall Study|Lost to Follow-up|16|||
30846018|NCT01066793|58872129|FG004|Overall Study|Lost to Follow-up|0|||
30846019|NCT01066793|58872130|FG005|Overall Study|Lost to Follow-up|1|||
30846020|NCT01066793|58872125|FG000|Overall Study|Physician Decision|3|||
30846021|NCT01066793|58872126|FG001|Overall Study|Physician Decision|0|||
30846022|NCT01066793|58872127|FG002|Overall Study|Physician Decision|0|||
30846023|NCT01066793|58872128|FG003|Overall Study|Physician Decision|0|||
30846024|NCT01066793|58872129|FG004|Overall Study|Physician Decision|0|||
30846025|NCT01066793|58872130|FG005|Overall Study|Physician Decision|0|||
30846026|NCT01066793|58872125|FG000|Overall Study|Protocol Violation|3|||
30846027|NCT01066793|58872126|FG001|Overall Study|Protocol Violation|2|||
30846028|NCT01066793|58872127|FG002|Overall Study|Protocol Violation|2|||
30846029|NCT01066793|58872128|FG003|Overall Study|Protocol Violation|0|||
30846030|NCT01066793|58872129|FG004|Overall Study|Protocol Violation|0|||
30846031|NCT01066793|58872130|FG005|Overall Study|Protocol Violation|0|||
30846032|NCT01066793|58872125|FG000|Overall Study|Withdrawal by Subject|7|||
30846033|NCT01066793|58872126|FG001|Overall Study|Withdrawal by Subject|4|||
30846034|NCT01066793|58872127|FG002|Overall Study|Withdrawal by Subject|1|||
30846035|NCT01066793|58872128|FG003|Overall Study|Withdrawal by Subject|0|||
30846036|NCT01066793|58872129|FG004|Overall Study|Withdrawal by Subject|0|||
30846037|NCT01066793|58872130|FG005|Overall Study|Withdrawal by Subject|0|||
30846038|NCT01066793|58872125|FG000|Overall Study|Early Termination|3|||
30846039|NCT01066793|58872126|FG001|Overall Study|Early Termination|0|||
30846040|NCT01066793|58872127|FG002|Overall Study|Early Termination|0|||
30846041|NCT01066793|58872128|FG003|Overall Study|Early Termination|0|||
30846042|NCT01066793|58872129|FG004|Overall Study|Early Termination|0|||
30846043|NCT01066793|58872130|FG005|Overall Study|Early Termination|0|||
30846044|NCT01066793|58872125|FG000|Overall Study|Lab test not done|7|||
30846045|NCT01066793|58872126|FG001|Overall Study|Lab test not done|0|||
30846046|NCT01066793|58872127|FG002|Overall Study|Lab test not done|0|||
30846047|NCT01066793|58872128|FG003|Overall Study|Lab test not done|1|||
30846048|NCT01066793|58872129|FG004|Overall Study|Lab test not done|0|||
30846049|NCT01066793|58872130|FG005|Overall Study|Lab test not done|0|||
30846050|NCT01066793|58872125|FG000|Overall Study|Miscellaneous|4|||
30846051|NCT01066793|58872126|FG001|Overall Study|Miscellaneous|5|||
30846052|NCT01066793|58872127|FG002|Overall Study|Miscellaneous|6|||
30846053|NCT01066793|58872128|FG003|Overall Study|Miscellaneous|0|||
30846054|NCT01066793|58872129|FG004|Overall Study|Miscellaneous|0|||
30846055|NCT01066793|58872130|FG005|Overall Study|Miscellaneous|0|||
30846056|NCT01066793|58872125|FG000|Overall Study|Non-responders|104|||
30846057|NCT01066793|58872126|FG001|Overall Study|Non-responders|5|||
30846058|NCT01066793|58872127|FG002|Overall Study|Non-responders|11|||
30846059|NCT01066793|58872128|FG003|Overall Study|Non-responders|25|||
30846060|NCT01066793|58872129|FG004|Overall Study|Non-responders|0|||
30846061|NCT01066793|58872130|FG005|Overall Study|Non-responders|0|||
30846062|NCT01066793|58872125|FG000|Overall Study|Other|15|||
30846063|NCT01066793|58872126|FG001|Overall Study|Other|5|||
30846064|NCT01066793|58872127|FG002|Overall Study|Other|6|||
30846065|NCT01066793|58872128|FG003|Overall Study|Other|2|||
30846066|NCT01066793|58872129|FG004|Overall Study|Other|0|||
30846067|NCT01066793|58872130|FG005|Overall Study|Other|0|||
30846068|NCT01066793|58872125|FG000|Overall Study|Relapse|20|||
30846069|NCT01066793|58872126|FG001|Overall Study|Relapse|8|||
30846070|NCT01066793|58872127|FG002|Overall Study|Relapse|2|||
30846071|NCT01066793|58872128|FG003|Overall Study|Relapse|3|||
30846072|NCT01066793|58872129|FG004|Overall Study|Relapse|0|||
30949345|NCT01721317|58995619|FG001|Overall Study|Physician Decision|1|||
30949346|NCT01721317|58995618|FG000|Overall Study|Withdrawal by Subject|0|||
30846073|NCT01066793|58872130|FG005|Overall Study|Relapse|0|||
30846074|NCT01066793|58872125|FG000|Overall Study|Result Not Available|1|||
30846075|NCT01066793|58872126|FG001|Overall Study|Result Not Available|0|||
30846076|NCT01066793|58872127|FG002|Overall Study|Result Not Available|0|||
30846077|NCT01066793|58872128|FG003|Overall Study|Result Not Available|0|||
30846078|NCT01066793|58872129|FG004|Overall Study|Result Not Available|0|||
30846079|NCT01066793|58872130|FG005|Overall Study|Result Not Available|0|||
30846080|NCT01066793|58872125|FG000|Overall Study|Treatment Interrupted|1|||
30949347|NCT01721317|58995619|FG001|Overall Study|Withdrawal by Subject|1|||
30846081|NCT01066793|58872126|FG001|Overall Study|Treatment Interrupted|1|||
30846082|NCT01066793|58872127|FG002|Overall Study|Treatment Interrupted|0|||
30846083|NCT01066793|58872128|FG003|Overall Study|Treatment Interrupted|0|||
30846084|NCT01066793|58872129|FG004|Overall Study|Treatment Interrupted|0|||
30846085|NCT01066793|58872130|FG005|Overall Study|Treatment Interrupted|0|||
30846086|NCT01066793|58872125|FG000|Overall Study|Treatment Never Started|18|||
30846087|NCT01066793|58872126|FG001|Overall Study|Treatment Never Started|5|||
30846088|NCT01066793|58872127|FG002|Overall Study|Treatment Never Started|4|||
30846089|NCT01066793|58872128|FG003|Overall Study|Treatment Never Started|1|||
30846090|NCT01066793|58872129|FG004|Overall Study|Treatment Never Started|0|||
30846091|NCT01066793|58872130|FG005|Overall Study|Treatment Never Started|0|||
30846092|NCT01066793|58872125|FG000|Overall Study|Treatment Stopped|2|||
30846093|NCT01066793|58872126|FG001|Overall Study|Treatment Stopped|1|||
30846094|NCT01066793|58872127|FG002|Overall Study|Treatment Stopped|0|||
30846095|NCT01066793|58872128|FG003|Overall Study|Treatment Stopped|1|||
30846096|NCT01066793|58872129|FG004|Overall Study|Treatment Stopped|0|||
30846097|NCT01066793|58872130|FG005|Overall Study|Treatment Stopped|0|||
30846098|NCT03985293|58872151|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
30846099|NCT03985293|58872152|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
30846100|NCT03985293|58872153|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
30846101|NCT03985293|58872154|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
30846102|NCT03985293|58872155|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
30846103|NCT03985293|58872156|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
30846104|NCT03985293|58872151|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
30846105|NCT03985293|58872152|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
30846106|NCT03985293|58872153|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
30846107|NCT03985293|58872154|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
30846108|NCT03985293|58872155|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
30846109|NCT03985293|58872156|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
30846110|NCT03985293|58872151|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
30846111|NCT03985293|58872152|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
30846112|NCT03985293|58872153|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
30949348|NCT01701193|58995629|FG000|Overall Study|Withdrawal by Subject|2|||
30949349|NCT01701193|58995630|FG001|Overall Study|Withdrawal by Subject|2|||
30949350|NCT01701193|58995631|FG002|Overall Study|Withdrawal by Subject|1|||
30949351|NCT01701193|58995632|FG003|Overall Study|Withdrawal by Subject|2|||
30949352|NCT01701193|58995629|FG000|Overall Study|Adverse Event|1|||
30949353|NCT01701193|58995630|FG001|Overall Study|Adverse Event|0|||
30949354|NCT01701193|58995631|FG002|Overall Study|Adverse Event|0|||
30949355|NCT01701193|58995632|FG003|Overall Study|Adverse Event|0|||
30949356|NCT01959347|58995680|FG000|Overall Study|Protocol Violation|9|||
30949357|NCT01959347|58995681|FG001|Overall Study|Protocol Violation|7|||
30949358|NCT01959035|58995707|FG000|Overall Study|Adverse Event|5|||
30949359|NCT01959035|58995707|FG000|Overall Study|Withdrawal by Subject|4|||
30949360|NCT01959035|58995707|FG000|Overall Study|Lost to Follow-up|1|||
30949361|NCT01959035|58995707|FG000|Overall Study|Other (no primary reason given)|1|||
30949362|NCT01700959|58995717|FG000|Overall Study|Adverse Event|0|||
30949363|NCT01700959|58995718|FG001|Overall Study|Adverse Event|1|||
30949364|NCT01700959|58995719|FG002|Overall Study|Adverse Event|1|||
30949365|NCT01700959|58995720|FG003|Overall Study|Adverse Event|2|||
30949366|NCT01700959|58995721|FG004|Overall Study|Adverse Event|0|||
30949367|NCT01700959|58995722|FG005|Overall Study|Adverse Event|2|||
30949368|NCT01700959|58995717|FG000|Overall Study|Withdrawal by Subject|15|||
30949369|NCT01700959|58995718|FG001|Overall Study|Withdrawal by Subject|9|||
30949370|NCT01700959|58995719|FG002|Overall Study|Withdrawal by Subject|12|||
30949371|NCT01700959|58995720|FG003|Overall Study|Withdrawal by Subject|11|||
30949372|NCT01700959|58995721|FG004|Overall Study|Withdrawal by Subject|8|||
30949373|NCT01700959|58995722|FG005|Overall Study|Withdrawal by Subject|12|||
30949374|NCT01700959|58995717|FG000|Overall Study|Ineligible|2|||
30949375|NCT01700959|58995718|FG001|Overall Study|Ineligible|1|||
30949376|NCT01700959|58995719|FG002|Overall Study|Ineligible|2|||
30949377|NCT01700959|58995720|FG003|Overall Study|Ineligible|0|||
30949378|NCT01700959|58995721|FG004|Overall Study|Ineligible|0|||
30949379|NCT01700959|58995722|FG005|Overall Study|Ineligible|1|||
30949380|NCT01700959|58995717|FG000|Overall Study|Noncompliant|9|||
30949381|NCT01700959|58995718|FG001|Overall Study|Noncompliant|9|||
30949382|NCT01700959|58995719|FG002|Overall Study|Noncompliant|17|||
30949383|NCT01700959|58995720|FG003|Overall Study|Noncompliant|18|||
30762086|NCT00006392|58771085|FG002|Overall Study|Ineligible|5|||
30762087|NCT00006392|58771086|FG003|Overall Study|Ineligible|5|||
30762088|NCT00006392|58771083|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
30762089|NCT00006392|58771084|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
30762090|NCT00006392|58771085|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
30762091|NCT00006392|58771086|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
30762092|NCT00379769|58771100|FG000|Main Study|Death|57|||
30762093|NCT00379769|58771101|FG001|Main Study|Death|67|||
30762094|NCT00379769|58771102|FG002|Main Study|Death|54|||
30762095|NCT00379769|58771103|FG003|Main Study|Death|72|||
30762096|NCT00379769|58771104|FG004|Main Study|Death|0|||
30949384|NCT01700959|58995721|FG004|Overall Study|Noncompliant|15|||
30762097|NCT00379769|58771105|FG005|Main Study|Death|0|||
30762098|NCT00379769|58771100|FG000|Main Study|Adverse Event|5|||
30762099|NCT00379769|58771101|FG001|Main Study|Adverse Event|8|||
30846113|NCT03985293|58872154|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
30846114|NCT03985293|58872155|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
30949385|NCT01700959|58995722|FG005|Overall Study|Noncompliant|9|||
30949386|NCT01700959|58995717|FG000|Overall Study|Side effects|1|||
30949387|NCT01700959|58995718|FG001|Overall Study|Side effects|4|||
30949388|NCT01700959|58995719|FG002|Overall Study|Side effects|8|||
30949389|NCT01700959|58995720|FG003|Overall Study|Side effects|4|||
30949390|NCT01700959|58995721|FG004|Overall Study|Side effects|4|||
30949391|NCT01700959|58995722|FG005|Overall Study|Side effects|1|||
30949392|NCT01738477|58995744|FG000|Overall Study|Lost to Follow-up|1|||
30949393|NCT01738477|58995745|FG001|Overall Study|Lost to Follow-up|4|||
30949394|NCT01737931|58995761|FG000|Overall Study|Withdrawal by Subject|0|||
30949395|NCT01737931|58995762|FG001|Overall Study|Withdrawal by Subject|1|||
30949396|NCT01737931|58995763|FG002|Overall Study|Withdrawal by Subject|1|||
30949397|NCT01737931|58995761|FG000|Overall Study|Physician Decision|0|||
30949398|NCT01737931|58995762|FG001|Overall Study|Physician Decision|1|||
30949399|NCT01737931|58995763|FG002|Overall Study|Physician Decision|0|||
30949400|NCT01958489|58995769|FG000|Period 2|Adverse Event|0|||
30949401|NCT01958489|58995770|FG001|Period 2|Adverse Event|1|||
30949402|NCT01721161|58995783|FG000|Overall Study|Adverse Event|2|||
30949403|NCT01721161|58995784|FG001|Overall Study|Adverse Event|3|||
30949404|NCT01721161|58995783|FG000|Overall Study|Lost to Follow-up|1|||
30949405|NCT01721161|58995784|FG001|Overall Study|Lost to Follow-up|2|||
30949406|NCT01721161|58995783|FG000|Overall Study|Withdrawal by Subject|1|||
30949407|NCT01721161|58995784|FG001|Overall Study|Withdrawal by Subject|1|||
30949408|NCT01721161|58995783|FG000|Overall Study|Other|0|||
30949409|NCT01721161|58995784|FG001|Overall Study|Other|1|||
30949410|NCT01699867|58995791|FG000|Overall Study|Screening Failure|3|||
30949411|NCT01699789|58995810|FG000|Overall Study|Withdrawal by Subject|18|||
30949412|NCT01699789|58995811|FG001|Overall Study|Withdrawal by Subject|23|||
30949413|NCT01699789|58995810|FG000|Overall Study|Death|1|||
30949414|NCT01699789|58995811|FG001|Overall Study|Death|2|||
30949415|NCT01699789|58995810|FG000|Overall Study|Lost to Follow-up|83|||
30949416|NCT01699789|58995811|FG001|Overall Study|Lost to Follow-up|101|||
30949417|NCT01944839|58995834|FG000|Overall Study|Physician Decision|2|||
30949418|NCT01944839|58995835|FG001|Overall Study|Physician Decision|2|||
30949419|NCT01944839|58995834|FG000|Overall Study|Protocol Violation|0|||
30949420|NCT01944839|58995835|FG001|Overall Study|Protocol Violation|1|||
30949421|NCT01944839|58995834|FG000|Overall Study|Adverse Event|10|||
30949422|NCT01944839|58995835|FG001|Overall Study|Adverse Event|5|||
30949423|NCT01944839|58995834|FG000|Overall Study|Withdrawal by Subject|9|||
30949424|NCT01944839|58995835|FG001|Overall Study|Withdrawal by Subject|17|||
30949425|NCT01944839|58995834|FG000|Overall Study|Lost to Follow-up|1|||
30949426|NCT01944839|58995835|FG001|Overall Study|Lost to Follow-up|0|||
30762100|NCT00379769|58771102|FG002|Main Study|Adverse Event|10|||
30762101|NCT00379769|58771103|FG003|Main Study|Adverse Event|11|||
30762102|NCT00379769|58771104|FG004|Main Study|Adverse Event|0|||
30762103|NCT00379769|58771105|FG005|Main Study|Adverse Event|0|||
30762104|NCT00379769|58771100|FG000|Main Study|Lost to Follow-up|29|||
30762105|NCT00379769|58771101|FG001|Main Study|Lost to Follow-up|29|||
30762106|NCT00379769|58771102|FG002|Main Study|Lost to Follow-up|25|||
30762107|NCT00379769|58771103|FG003|Main Study|Lost to Follow-up|26|||
30762108|NCT00379769|58771104|FG004|Main Study|Lost to Follow-up|0|||
30762109|NCT00379769|58771105|FG005|Main Study|Lost to Follow-up|0|||
30762110|NCT00379769|58771100|FG000|Main Study|Withdrawal by Subject|46|||
30762111|NCT00379769|58771101|FG001|Main Study|Withdrawal by Subject|56|||
30762112|NCT00379769|58771102|FG002|Main Study|Withdrawal by Subject|72|||
30762113|NCT00379769|58771103|FG003|Main Study|Withdrawal by Subject|70|||
30762114|NCT00379769|58771104|FG004|Main Study|Withdrawal by Subject|0|||
30762115|NCT00379769|58771105|FG005|Main Study|Withdrawal by Subject|0|||
30762116|NCT00379769|58771100|FG000|Main Study|Moved to survival status follow-up only|27|||
30762117|NCT00379769|58771101|FG001|Main Study|Moved to survival status follow-up only|25|||
30762118|NCT00379769|58771102|FG002|Main Study|Moved to survival status follow-up only|32|||
30762119|NCT00379769|58771103|FG003|Main Study|Moved to survival status follow-up only|36|||
30762120|NCT00379769|58771104|FG004|Main Study|Moved to survival status follow-up only|0|||
30846115|NCT03985293|58872156|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
30846116|NCT03985293|58872151|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
30846117|NCT03985293|58872152|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
30846118|NCT03985293|58872153|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
30846119|NCT03985293|58872154|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
30846120|NCT03985293|58872155|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
30846121|NCT03985293|58872156|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
30762121|NCT00379769|58771105|FG005|Main Study|Moved to survival status follow-up only|0|||
30762122|NCT00379769|58771100|FG000|Main Study|Participant moved|3|||
30846122|NCT03985293|58872151|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
30949427|NCT01944839|58995834|FG000|Overall Study|Subject non-compliance|0|||
30949428|NCT01944839|58995835|FG001|Overall Study|Subject non-compliance|3|||
30949429|NCT01944059|58995850|FG000|Overall Study|Lost to Follow-up|1|||
30949430|NCT01944059|58995850|FG000|Overall Study|Physician Decision|3|||
30949431|NCT01944059|58995850|FG000|Overall Study|Withdrawal by Subject|1|||
30949432|NCT01944059|58995850|FG000|Overall Study|Adverse Event|2|||
30846123|NCT03985293|58872152|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
30846124|NCT03985293|58872153|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
30846125|NCT03985293|58872154|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
30846126|NCT03985293|58872155|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
30846127|NCT03985293|58872156|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
30846128|NCT03985293|58872151|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
30846129|NCT03985293|58872152|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
30949433|NCT01720225|58995857|FG000|Overall Study|Withdrawal by Subject|0|||
30949434|NCT01720225|58995858|FG001|Overall Study|Withdrawal by Subject|1|||
30949435|NCT01720225|58995857|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
30949436|NCT01720225|58995858|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
30949437|NCT01943591|58995866|FG000|Overall Study|Lost to Follow-up|3|||
30846130|NCT03985293|58872153|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
30846131|NCT03985293|58872154|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
30846132|NCT03985293|58872155|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
30846133|NCT03985293|58872156|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
30846134|NCT03985293|58872151|FG000|FOLLOW-UP|Lost to Follow-up|0|||
30846135|NCT03985293|58872152|FG001|FOLLOW-UP|Lost to Follow-up|0|||
30846136|NCT03985293|58872153|FG002|FOLLOW-UP|Lost to Follow-up|1|||
30846137|NCT03985293|58872154|FG003|FOLLOW-UP|Lost to Follow-up|0|||
30846138|NCT03985293|58872155|FG004|FOLLOW-UP|Lost to Follow-up|0|||
30846139|NCT03985293|58872156|FG005|FOLLOW-UP|Lost to Follow-up|0|||
30846140|NCT02980601|58872172|FG000|Overall Study|Lost to Follow-up|2|||
30846141|NCT02980601|58872173|FG001|Overall Study|Lost to Follow-up|2|||
30846142|NCT02980601|58872172|FG000|Overall Study|Death|0|||
30846143|NCT02980601|58872173|FG001|Overall Study|Death|1|||
30846144|NCT02980601|58872172|FG000|Overall Study|Graft loss|1|||
30846145|NCT02980601|58872173|FG001|Overall Study|Graft loss|0|||
30846146|NCT02980601|58872172|FG000|Overall Study|Failed to sign consent|2|||
30846147|NCT02980601|58872173|FG001|Overall Study|Failed to sign consent|0|||
30846148|NCT02980523|58872184|FG000|Overall Study|Lost to Follow-up|1|||
30846149|NCT02980523|58872185|FG001|Overall Study|Lost to Follow-up|4|||
30846150|NCT02980523|58872186|FG002|Overall Study|Lost to Follow-up|1|||
30846151|NCT02980523|58872187|FG003|Overall Study|Lost to Follow-up|2|||
30949438|NCT01943591|58995867|FG001|Overall Study|Lost to Follow-up|4|||
30949439|NCT01943591|58995866|FG000|Overall Study|Death|2|||
30949440|NCT01943591|58995867|FG001|Overall Study|Death|7|||
30846152|NCT02980523|58872188|FG004|Overall Study|Lost to Follow-up|1|||
30949441|NCT01699087|58995873|FG000|Overall Study|Lost to Follow-up|7|||
30949442|NCT01699087|58995873|FG000|Overall Study|Screen failure (prior to treatment)|15|||
30846153|NCT02980523|58872184|FG000|Overall Study|Excluded from analysis|1|||
30846154|NCT02980523|58872185|FG001|Overall Study|Excluded from analysis|3|||
30949443|NCT01699087|58995873|FG000|Overall Study|Unable to make future visits|2|||
30846155|NCT02980523|58872186|FG002|Overall Study|Excluded from analysis|1|||
30846156|NCT02980523|58872187|FG003|Overall Study|Excluded from analysis|1|||
30846157|NCT02980523|58872188|FG004|Overall Study|Excluded from analysis|1|||
30846158|NCT02980523|58872184|FG000|Overall Study|Lack of Efficacy|1|||
30846159|NCT02980523|58872185|FG001|Overall Study|Lack of Efficacy|4|||
30949444|NCT01943435|58995881|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
30949445|NCT01943435|58995882|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
30949446|NCT01943435|58995883|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
30949447|NCT01943435|58995881|FG000|Intervention Period|Withdrawal by Subject|3|||
30949448|NCT01943435|58995882|FG001|Intervention Period|Withdrawal by Subject|3|||
30949449|NCT01943435|58995883|FG002|Intervention Period|Withdrawal by Subject|4|||
30949450|NCT01943435|58995881|FG000|2 Month Follow up|Lost to Follow-up|2|||
30949451|NCT01943435|58995882|FG001|2 Month Follow up|Lost to Follow-up|3|||
30949452|NCT01943435|58995883|FG002|2 Month Follow up|Lost to Follow-up|0|||
30949453|NCT01943435|58995881|FG000|6 Month Follow up|Lost to Follow-up|12|||
30949454|NCT01943435|58995882|FG001|6 Month Follow up|Lost to Follow-up|7|||
30949455|NCT01943435|58995883|FG002|6 Month Follow up|Lost to Follow-up|15|||
30949456|NCT01942733|58995901|FG000|Overall Study|Lost to Follow-up|1|||
30949457|NCT01942733|58995901|FG000|Overall Study|Non-compliance with IMP|1|||
30949458|NCT01942733|58995901|FG000|Overall Study|Administrative|1|||
30949459|NCT01957865|58995917|FG000|Overall Study|Found HIV negative|0|||
30949460|NCT01957865|58995918|FG001|Overall Study|Found HIV negative|0|||
30949461|NCT01957865|58995919|FG002|Overall Study|Found HIV negative|1|||
30949462|NCT01957865|58995917|FG000|Overall Study|Lost to Follow-up|0|||
30949463|NCT01957865|58995918|FG001|Overall Study|Lost to Follow-up|2|||
30949464|NCT01957865|58995919|FG002|Overall Study|Lost to Follow-up|2|||
30949465|NCT01957787|58995928|FG000|Overall Study|Death|18|||
30949466|NCT01957787|58995928|FG000|Overall Study|Lost to Follow-up|3|||
30949467|NCT01957787|58995928|FG000|Overall Study|Withdrawal by Subject|3|||
30949468|NCT01957787|58995928|FG000|Overall Study|Entered Hospice or Similar Program|2|||
30949469|NCT01957787|58995928|FG000|Overall Study|Index Tumor(s) Resected|2|||
30949470|NCT01957787|58995928|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
30949471|NCT01957787|58995928|FG000|Overall Study|Local therapy, not cryoablation|6|||
30949472|NCT01698775|58995934|FG000|Phase A|Adverse Event|2|||
30949473|NCT01698775|58995935|FG001|Phase A|Adverse Event|1|||
30949474|NCT01698775|58995934|FG000|Phase A|Death|1|||
30949475|NCT01698775|58995935|FG001|Phase A|Death|1|||
30949476|NCT01698775|58995934|FG000|Phase A|Lack of Efficacy|1|||
30949477|NCT01698775|58995935|FG001|Phase A|Lack of Efficacy|0|||
30949478|NCT01698775|58995934|FG000|Phase A|Lost to Follow-up|1|||
30949479|NCT01698775|58995935|FG001|Phase A|Lost to Follow-up|2|||
30949480|NCT01698775|58995934|FG000|Phase A|Protocol Violation|1|||
30949481|NCT01698775|58995935|FG001|Phase A|Protocol Violation|0|||
30949482|NCT01698775|58995934|FG000|Phase A|Withdrawal by Subject|3|||
30949483|NCT01698775|58995935|FG001|Phase A|Withdrawal by Subject|4|||
30949484|NCT01698775|58995934|FG000|Phase A|Kidney [transplant]|0|||
30949485|NCT01698775|58995935|FG001|Phase A|Kidney [transplant]|1|||
30949486|NCT01698775|58995934|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
30949487|NCT01698775|58995935|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
30949488|NCT01698775|58995934|FG000|Phase B|Adverse Event|6|||
30949489|NCT01698775|58995935|FG001|Phase B|Adverse Event|3|||
30762123|NCT00379769|58771101|FG001|Main Study|Participant moved|2|||
30762124|NCT00379769|58771102|FG002|Main Study|Participant moved|3|||
30762125|NCT00379769|58771103|FG003|Main Study|Participant moved|3|||
30762126|NCT00379769|58771104|FG004|Main Study|Participant moved|0|||
30762127|NCT00379769|58771105|FG005|Main Study|Participant moved|0|||
30762128|NCT00379769|58771100|FG000|Main Study|Poor compliance|3|||
30762129|NCT00379769|58771101|FG001|Main Study|Poor compliance|2|||
30762130|NCT00379769|58771102|FG002|Main Study|Poor compliance|2|||
30762131|NCT00379769|58771103|FG003|Main Study|Poor compliance|1|||
30762132|NCT00379769|58771104|FG004|Main Study|Poor compliance|0|||
30762133|NCT00379769|58771105|FG005|Main Study|Poor compliance|0|||
30762134|NCT00379769|58771100|FG000|Main Study|Prohibited glucose lowering medication|0|||
30762135|NCT00379769|58771101|FG001|Main Study|Prohibited glucose lowering medication|3|||
30762136|NCT00379769|58771102|FG002|Main Study|Prohibited glucose lowering medication|0|||
30762137|NCT00379769|58771103|FG003|Main Study|Prohibited glucose lowering medication|1|||
30762138|NCT00379769|58771104|FG004|Main Study|Prohibited glucose lowering medication|0|||
30846160|NCT02980523|58872186|FG002|Overall Study|Lack of Efficacy|4|||
30846161|NCT02980523|58872187|FG003|Overall Study|Lack of Efficacy|5|||
30846162|NCT02980523|58872188|FG004|Overall Study|Lack of Efficacy|8|||
30949490|NCT01698775|58995934|FG000|Phase B|Death|0|||
30949491|NCT01698775|58995935|FG001|Phase B|Death|1|||
30949492|NCT01698775|58995934|FG000|Phase B|Lack of Efficacy|0|||
30949493|NCT01698775|58995935|FG001|Phase B|Lack of Efficacy|1|||
30949494|NCT01698775|58995934|FG000|Phase B|Lost to Follow-up|0|||
30949495|NCT01698775|58995935|FG001|Phase B|Lost to Follow-up|1|||
30949496|NCT01698775|58995934|FG000|Phase B|Physician Decision|1|||
30949497|NCT01698775|58995935|FG001|Phase B|Physician Decision|1|||
30949498|NCT01698775|58995934|FG000|Phase B|Protocol Violation|1|||
30949499|NCT01698775|58995935|FG001|Phase B|Protocol Violation|1|||
30949500|NCT01698775|58995934|FG000|Phase B|Withdrawal by Subject|6|||
30949501|NCT01698775|58995935|FG001|Phase B|Withdrawal by Subject|2|||
30949502|NCT01941095|58995945|FG000|Overall Study|Insufficient therapeutic response|13|||
30949503|NCT01941095|58995945|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
30949504|NCT01941095|58995945|FG000|Overall Study|Adverse Event|11|||
30949505|NCT01941095|58995945|FG000|Overall Study|Physician Decision|3|||
30949506|NCT01941095|58995945|FG000|Overall Study|Withdrawal by Subject|17|||
30949507|NCT01941095|58995945|FG000|Overall Study|Lost to Follow-up|10|||
30949508|NCT01957709|58995960|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
30949509|NCT01957553|58995977|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
30949510|NCT01957553|58995978|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
30949511|NCT01957553|58995977|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
30949512|NCT01957553|58995978|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
30846163|NCT02980523|58872184|FG000|Overall Study|Did not receive intervention|0|||
30846164|NCT02980523|58872185|FG001|Overall Study|Did not receive intervention|0|||
30846165|NCT02980523|58872186|FG002|Overall Study|Did not receive intervention|0|||
30846166|NCT02980523|58872187|FG003|Overall Study|Did not receive intervention|1|||
30846167|NCT02980523|58872188|FG004|Overall Study|Did not receive intervention|0|||
30846168|NCT02980133|58872207|FG000|Overall Study|Other than specified|1|||
30846169|NCT02980133|58872208|FG001|Overall Study|Other than specified|1|||
30846170|NCT02980133|58872209|FG002|Overall Study|Other than specified|2|||
30846171|NCT02980133|58872210|FG003|Overall Study|Other than specified|2|||
30846172|NCT02980133|58872207|FG000|Overall Study|Lost to Follow-up|0|||
30846173|NCT02980133|58872208|FG001|Overall Study|Lost to Follow-up|0|||
30846174|NCT02980133|58872209|FG002|Overall Study|Lost to Follow-up|1|||
30846175|NCT02980133|58872210|FG003|Overall Study|Lost to Follow-up|3|||
30846176|NCT02980133|58872207|FG000|Overall Study|Protocol Violation|0|||
30846177|NCT02980133|58872208|FG001|Overall Study|Protocol Violation|1|||
30846178|NCT02980133|58872209|FG002|Overall Study|Protocol Violation|0|||
30846179|NCT02980133|58872210|FG003|Overall Study|Protocol Violation|0|||
30846180|NCT02980133|58872207|FG000|Overall Study|Withdrawal by parent/guardian|6|||
30846181|NCT02980133|58872208|FG001|Overall Study|Withdrawal by parent/guardian|3|||
30846182|NCT02980133|58872209|FG002|Overall Study|Withdrawal by parent/guardian|3|||
30846183|NCT02980133|58872210|FG003|Overall Study|Withdrawal by parent/guardian|1|||
30846184|NCT02980133|58872207|FG000|Overall Study|Withdrawal by Subject|0|||
30846185|NCT02980133|58872208|FG001|Overall Study|Withdrawal by Subject|0|||
30846186|NCT02980133|58872209|FG002|Overall Study|Withdrawal by Subject|1|||
30846187|NCT02980133|58872210|FG003|Overall Study|Withdrawal by Subject|0|||
30846188|NCT02979431|58872227|FG000|Overall Study|Parent/guardian withdrew consent|2|||
30846189|NCT02979431|58872228|FG001|Overall Study|Parent/guardian withdrew consent|1|||
30846190|NCT02979431|58872229|FG002|Overall Study|Parent/guardian withdrew consent|1|||
30846191|NCT02979431|58872230|FG003|Overall Study|Parent/guardian withdrew consent|1|||
30846192|NCT02979431|58872227|FG000|Overall Study|Randomized but received no study drug|1|||
30846193|NCT02979431|58872228|FG001|Overall Study|Randomized but received no study drug|1|||
30846194|NCT02979431|58872229|FG002|Overall Study|Randomized but received no study drug|0|||
30846195|NCT02979431|58872230|FG003|Overall Study|Randomized but received no study drug|0|||
30846196|NCT02979431|58872227|FG000|Overall Study|Adverse Event|0|||
30846197|NCT02979431|58872228|FG001|Overall Study|Adverse Event|0|||
30846198|NCT02979431|58872229|FG002|Overall Study|Adverse Event|1|||
30846199|NCT02979431|58872230|FG003|Overall Study|Adverse Event|0|||
30846200|NCT02979431|58872227|FG000|Overall Study|Subject left country after Day14|1|||
30846201|NCT02979431|58872228|FG001|Overall Study|Subject left country after Day14|0|||
30949513|NCT01957553|58995977|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
30949514|NCT01957553|58995978|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
30949515|NCT01957553|58995977|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
30846202|NCT02979431|58872229|FG002|Overall Study|Subject left country after Day14|0|||
30846203|NCT02979431|58872230|FG003|Overall Study|Subject left country after Day14|0|||
30846204|NCT02978417|58872242|FG000|Overall Study|Lost to Follow-up|2|||
30846205|NCT02978417|58872243|FG001|Overall Study|Lost to Follow-up|2|||
30846206|NCT04368429|58872251|FG000|Overall Study|Adverse Event|1|||
30846207|NCT04368429|58872252|FG001|Overall Study|Adverse Event|0|||
30846208|NCT02733627|58872275|FG000|Overall Study|Adverse Event|0|||
30846209|NCT02733627|58872276|FG001|Overall Study|Adverse Event|1|||
30846210|NCT02733627|58872277|FG002|Overall Study|Adverse Event|1|||
30846211|NCT02733627|58872278|FG003|Overall Study|Adverse Event|0|||
30846212|NCT02733627|58872275|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
30846213|NCT02733627|58872276|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
30846214|NCT02733627|58872277|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
30846215|NCT02733627|58872278|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
30846216|NCT02958865|58872295|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
30846217|NCT02958865|58872296|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
30846218|NCT02958865|58872297|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
30846219|NCT02958865|58872298|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
30846220|NCT02958865|58872299|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
30846221|NCT02958865|58872300|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
30626106|NCT00951483|58638164|FG000|Overall Study|Physician Decision|4|||
30846222|NCT02958865|58872301|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
30846223|NCT02958865|58872302|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
30846224|NCT02958865|58872303|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
30846225|NCT02958865|58872304|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
30846226|NCT02958865|58872305|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
30846227|NCT02958865|58872306|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
30846228|NCT02958865|58872307|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
30846229|NCT02958865|58872308|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
30846230|NCT02958865|58872309|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
30846231|NCT02958865|58872310|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
30846232|NCT02958865|58872295|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
30846233|NCT02958865|58872296|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
30846234|NCT02958865|58872297|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
30846235|NCT02958865|58872298|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
30949516|NCT01957553|58995978|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
30949517|NCT01957553|58995977|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
30949518|NCT01957553|58995978|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
30949519|NCT01957553|58995977|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
30949520|NCT01957553|58995978|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
30949521|NCT01957553|58995977|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
30949522|NCT01957553|58995978|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
30949523|NCT01957553|58995977|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
30949524|NCT01957553|58995978|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
30949525|NCT01957553|58995977|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
30949526|NCT01957553|58995978|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
30949527|NCT01957475|58996003|FG000|Test Period 1|Withdrawal by Subject|1|||
30949528|NCT01957475|58996004|FG001|Test Period 1|Withdrawal by Subject|0|||
30949529|NCT01957475|58996003|FG000|Test Period 1|Other|1|||
30949530|NCT01957475|58996004|FG001|Test Period 1|Other|0|||
30949531|NCT01957475|58996003|FG000|Test Period 1|Lack of Efficacy|0|||
30949532|NCT01957475|58996004|FG001|Test Period 1|Lack of Efficacy|1|||
30949533|NCT01957475|58996003|FG000|Test Period 2|Adverse Event|1|||
30949534|NCT01957475|58996004|FG001|Test Period 2|Adverse Event|0|||
30949535|NCT01940939|58996012|FG000|Overall Study|Withdrawal by Subject|2|||
30949536|NCT01940939|58996013|FG001|Overall Study|Withdrawal by Subject|8|||
30949537|NCT01957397|58996019|FG000|Test Period 1|sudden leakage/small bag|1|||
30949538|NCT01957397|58996020|FG001|Test Period 1|sudden leakage/small bag|1|||
30949539|NCT01957397|58996019|FG000|Test Period 1|Withdrawal by Subject|1|||
30949540|NCT01957397|58996020|FG001|Test Period 1|Withdrawal by Subject|0|||
30949541|NCT01957397|58996019|FG000|Test Period 2|Adverse Event|0|||
30949542|NCT01957397|58996020|FG001|Test Period 2|Adverse Event|1|||
30949543|NCT01957397|58996019|FG000|Test Period 3|Adverse Event|1|||
30949544|NCT01957397|58996020|FG001|Test Period 3|Adverse Event|2|||
30949545|NCT01957397|58996019|FG000|Test Period 3|the adhesive did not work|1|||
30949546|NCT01957397|58996020|FG001|Test Period 3|the adhesive did not work|0|||
30949547|NCT01940705|58996034|FG000|Overall Study|Lost to Follow-up|1|||
30949548|NCT01940705|58996035|FG001|Overall Study|Lost to Follow-up|3|||
30846236|NCT02958865|58872299|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
30626107|NCT00951483|58638165|FG001|Overall Study|Physician Decision|0|||
30949549|NCT01940705|58996036|FG002|Overall Study|Lost to Follow-up|2|||
30949550|NCT01940705|58996037|FG003|Overall Study|Lost to Follow-up|2|||
30949551|NCT01940705|58996034|FG000|Overall Study|Withdrawal by Subject|2|||
30949552|NCT01940705|58996035|FG001|Overall Study|Withdrawal by Subject|2|||
30949553|NCT01940705|58996036|FG002|Overall Study|Withdrawal by Subject|3|||
30949554|NCT01940705|58996037|FG003|Overall Study|Withdrawal by Subject|2|||
30949555|NCT01940705|58996034|FG000|Overall Study|Intervention not given|0|||
30846237|NCT02958865|58872300|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
30949556|NCT01940705|58996035|FG001|Overall Study|Intervention not given|3|||
30949557|NCT01940705|58996036|FG002|Overall Study|Intervention not given|3|||
30949558|NCT01940705|58996037|FG003|Overall Study|Intervention not given|0|||
30949559|NCT01940705|58996034|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
30846238|NCT02958865|58872301|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
30846239|NCT02958865|58872302|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
30949560|NCT01940705|58996035|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
30949561|NCT01940705|58996036|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
30949562|NCT01940705|58996037|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
30949563|NCT01957163|58996062|FG000|Overall Study|Adverse Event|5|||
30949564|NCT01957163|58996063|FG001|Overall Study|Adverse Event|2|||
30949565|NCT01957163|58996064|FG002|Overall Study|Adverse Event|4|||
30949566|NCT01957163|58996062|FG000|Overall Study|Lack of Efficacy|5|||
30949567|NCT01957163|58996063|FG001|Overall Study|Lack of Efficacy|4|||
30949568|NCT01957163|58996064|FG002|Overall Study|Lack of Efficacy|9|||
30949569|NCT01957163|58996062|FG000|Overall Study|Protocol Violation|1|||
30949570|NCT01957163|58996063|FG001|Overall Study|Protocol Violation|2|||
30949571|NCT01957163|58996064|FG002|Overall Study|Protocol Violation|0|||
30949572|NCT01957163|58996062|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
30949573|NCT01957163|58996063|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
30949574|NCT01957163|58996064|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
30949575|NCT01957163|58996062|FG000|Overall Study|Lost to Follow-up|0|||
30949576|NCT01957163|58996063|FG001|Overall Study|Lost to Follow-up|1|||
30949577|NCT01957163|58996064|FG002|Overall Study|Lost to Follow-up|0|||
30949578|NCT01957163|58996062|FG000|Overall Study|Withdrawal by Subject|4|||
30949579|NCT01957163|58996063|FG001|Overall Study|Withdrawal by Subject|2|||
30949580|NCT01957163|58996064|FG002|Overall Study|Withdrawal by Subject|4|||
30949581|NCT01939223|58996118|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
30949582|NCT01939223|58996119|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
30949583|NCT01939223|58996118|FG000|Overall Study|Disease recurrence (radiological)|1|||
30949584|NCT01939223|58996119|FG001|Overall Study|Disease recurrence (radiological)|3|||
30949585|NCT01939223|58996118|FG000|Overall Study|Study stopped by Sponsor|5|||
30949586|NCT01939223|58996119|FG001|Overall Study|Study stopped by Sponsor|7|||
30949587|NCT01939223|58996118|FG000|Overall Study|Withdrawal by Subject|6|||
30949588|NCT01939223|58996119|FG001|Overall Study|Withdrawal by Subject|0|||
30949589|NCT01954745|58996164|FG000|Overall Study|Radiological Progression|11|||
30949590|NCT01954745|58996164|FG000|Overall Study|Clinical Progression|5|||
30949591|NCT01954745|58996164|FG000|Overall Study|Adverse Event|2|||
30949592|NCT01954745|58996164|FG000|Overall Study|Death|1|||
30949593|NCT01954121|58996179|FG000|Overall Study|Lack of Efficacy|94|||
30949594|NCT01954121|58996180|FG001|Overall Study|Lack of Efficacy|41|||
30949595|NCT01954121|58996179|FG000|Overall Study|Protocol Violation|0|||
30949596|NCT01954121|58996180|FG001|Overall Study|Protocol Violation|2|||
30949597|NCT01954121|58996179|FG000|Overall Study|Lost to Follow-up|5|||
30949598|NCT01954121|58996180|FG001|Overall Study|Lost to Follow-up|6|||
30949599|NCT01954121|58996179|FG000|Overall Study|Withdrawal by Subject|18|||
30949600|NCT01954121|58996180|FG001|Overall Study|Withdrawal by Subject|12|||
30949601|NCT01954121|58996179|FG000|Overall Study|Pregnancy|1|||
30949602|NCT01954121|58996180|FG001|Overall Study|Pregnancy|1|||
30949603|NCT01954121|58996179|FG000|Overall Study|AE, serious fatal|1|||
30949604|NCT01954121|58996180|FG001|Overall Study|AE, serious fatal|0|||
30949605|NCT01954121|58996179|FG000|Overall Study|AE, non-serious non-fatal|5|||
30949606|NCT01954121|58996180|FG001|Overall Study|AE, non-serious non-fatal|22|||
30949607|NCT01954121|58996179|FG000|Overall Study|SAE, non-fatal|1|||
30949608|NCT01954121|58996180|FG001|Overall Study|SAE, non-fatal|4|||
30949609|NCT01954121|58996179|FG000|Overall Study|Non-compliant with study procedures|1|||
30949610|NCT01954121|58996180|FG001|Overall Study|Non-compliant with study procedures|0|||
30949611|NCT01954121|58996179|FG000|Overall Study|Non-compliant patient|1|||
30949612|NCT01954121|58996180|FG001|Overall Study|Non-compliant patient|1|||
30949613|NCT01954121|58996179|FG000|Overall Study|Subject did not follow instructions|0|||
30949614|NCT01954121|58996180|FG001|Overall Study|Subject did not follow instructions|2|||
30949615|NCT01952015|58996215|FG000|Induction|Protocol Violation|1|||
30949616|NCT01952015|58996215|FG000|Maintenance|Adverse Event|2|||
30949617|NCT01952015|58996215|FG000|Treatment Period 3|Physician Decision|9|||
30949618|NCT01951703|58996248|FG000|First Intervention|Withdrawal by Subject|1|||
30949619|NCT01951703|58996249|FG001|First Intervention|Withdrawal by Subject|0|||
30949620|NCT01951703|58996248|FG000|First Intervention|Subject was not compliant|1|||
30949621|NCT01951703|58996249|FG001|First Intervention|Subject was not compliant|1|||
30949622|NCT01951703|58996248|FG000|First Intervention|Physician Decision|1|||
30949623|NCT01951703|58996249|FG001|First Intervention|Physician Decision|0|||
30949624|NCT01951703|58996248|FG000|Second Intervention|Protocol Violation|0|||
30949625|NCT01951703|58996249|FG001|Second Intervention|Protocol Violation|1|||
30949626|NCT01951703|58996248|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
30949627|NCT01951703|58996249|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
30949628|NCT01937351|58996275|FG000|Overall Study|Withdrawal by Subject|4|||
30949629|NCT01937351|58996276|FG001|Overall Study|Withdrawal by Subject|2|||
30949630|NCT01937351|58996275|FG000|Overall Study|Death|1|||
30949631|NCT01937351|58996276|FG001|Overall Study|Death|0|||
30949632|NCT01937351|58996275|FG000|Overall Study|Not treated w device, per protocol fail|4|||
30949633|NCT01937351|58996276|FG001|Overall Study|Not treated w device, per protocol fail|0|||
30949634|NCT01737697|58996309|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30949635|NCT01737697|58996310|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
30949636|NCT01737697|58996311|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30949637|NCT01737697|58996312|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
30949638|NCT01737697|58996313|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
30949639|NCT01737697|58996314|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30949640|NCT01737697|58996315|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30949641|NCT01737697|58996316|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30949642|NCT01737697|58996317|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30626108|NCT00951483|58638164|FG000|Overall Study|Withdrawal by Subject|15|||
30949643|NCT01737697|58996318|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30949644|NCT01737697|58996319|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30949645|NCT01737697|58996320|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30949646|NCT01737697|58996321|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30949647|NCT01737697|58996322|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30949648|NCT01737697|58996323|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
30949649|NCT01737697|58996309|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
30949650|NCT01737697|58996310|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
30949651|NCT01737697|58996311|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
30949652|NCT01737697|58996312|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949653|NCT01737697|58996313|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949654|NCT01737697|58996314|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949655|NCT01737697|58996315|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949656|NCT01737697|58996316|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949657|NCT01737697|58996317|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949658|NCT01737697|58996318|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949659|NCT01737697|58996319|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949660|NCT01737697|58996320|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949661|NCT01737697|58996321|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949662|NCT01737697|58996322|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949663|NCT01737697|58996323|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
30949664|NCT01737697|58996309|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949665|NCT01737697|58996310|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949666|NCT01737697|58996311|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949667|NCT01737697|58996312|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
30949668|NCT01737697|58996313|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949669|NCT01737697|58996314|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949670|NCT01737697|58996315|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949671|NCT01737697|58996316|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949672|NCT01737697|58996317|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949673|NCT01737697|58996318|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949674|NCT01737697|58996319|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949675|NCT01737697|58996320|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949676|NCT01737697|58996321|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949677|NCT01737697|58996322|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949678|NCT01737697|58996323|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
30949679|NCT01737697|58996309|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949680|NCT01737697|58996310|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
30949681|NCT01737697|58996311|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949682|NCT01737697|58996312|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949683|NCT01737697|58996313|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949684|NCT01737697|58996314|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949685|NCT01737697|58996315|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949686|NCT01737697|58996316|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949687|NCT01737697|58996317|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949688|NCT01737697|58996318|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949689|NCT01737697|58996319|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949690|NCT01737697|58996320|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949691|NCT01737697|58996321|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949692|NCT01737697|58996322|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949693|NCT01737697|58996323|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
30949694|NCT01737697|58996309|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30762139|NCT00379769|58771105|FG005|Main Study|Prohibited glucose lowering medication|0|||
30762140|NCT00379769|58771100|FG000|Main Study|Site closed|4|||
30762141|NCT00379769|58771101|FG001|Main Study|Site closed|4|||
30762142|NCT00379769|58771102|FG002|Main Study|Site closed|4|||
30762143|NCT00379769|58771103|FG003|Main Study|Site closed|8|||
30762144|NCT00379769|58771104|FG004|Main Study|Site closed|0|||
30762145|NCT00379769|58771105|FG005|Main Study|Site closed|0|||
30762146|NCT00379769|58771100|FG000|Main Study|Entry criteria violation|0|||
30762147|NCT00379769|58771101|FG001|Main Study|Entry criteria violation|0|||
30762148|NCT00379769|58771102|FG002|Main Study|Entry criteria violation|1|||
30762149|NCT00379769|58771103|FG003|Main Study|Entry criteria violation|1|||
30762150|NCT00379769|58771104|FG004|Main Study|Entry criteria violation|0|||
30762151|NCT00379769|58771105|FG005|Main Study|Entry criteria violation|0|||
30762152|NCT00379769|58771100|FG000|Main Study|Participant did not take study drug|0|||
30626109|NCT00951483|58638165|FG001|Overall Study|Withdrawal by Subject|0|||
30626110|NCT01104246|58638173|FG000|Overall Study|Withdrawal by Subject|1|||
30626111|NCT01104246|58638173|FG000|Overall Study|did not meet inclusion criteria|4|||
30626112|NCT01103778|58638177|FG000|Overall Study|Lost to Follow-up|1|||
30626113|NCT01103778|58638177|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
30626114|NCT01103778|58638177|FG000|Overall Study|Screen failure|1|||
30626115|NCT01103466|58638183|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
30626116|NCT01103466|58638184|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
30626117|NCT01103466|58638185|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
30762153|NCT00379769|58771101|FG001|Main Study|Participant did not take study drug|0|||
30762154|NCT00379769|58771102|FG002|Main Study|Participant did not take study drug|1|||
30762155|NCT00379769|58771103|FG003|Main Study|Participant did not take study drug|0|||
30762156|NCT00379769|58771104|FG004|Main Study|Participant did not take study drug|0|||
30762157|NCT00379769|58771105|FG005|Main Study|Participant did not take study drug|0|||
30762158|NCT00379769|58771100|FG000|Main Study|Physician Decision|2|||
30762159|NCT00379769|58771101|FG001|Main Study|Physician Decision|2|||
30762160|NCT00379769|58771102|FG002|Main Study|Physician Decision|1|||
30762161|NCT00379769|58771103|FG003|Main Study|Physician Decision|1|||
30762162|NCT00379769|58771104|FG004|Main Study|Physician Decision|0|||
30762163|NCT00379769|58771105|FG005|Main Study|Physician Decision|0|||
30762164|NCT00379769|58771100|FG000|Main Study|Participant completed study at visit 27|1|||
30762165|NCT00379769|58771101|FG001|Main Study|Participant completed study at visit 27|0|||
30762166|NCT00379769|58771102|FG002|Main Study|Participant completed study at visit 27|0|||
30762167|NCT00379769|58771103|FG003|Main Study|Participant completed study at visit 27|0|||
30762168|NCT00379769|58771104|FG004|Main Study|Participant completed study at visit 27|0|||
30762169|NCT00379769|58771105|FG005|Main Study|Participant completed study at visit 27|0|||
30762170|NCT00379769|58771100|FG000|Main Study|Personal reasons|1|||
30949695|NCT01737697|58996310|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949696|NCT01737697|58996311|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949697|NCT01737697|58996312|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949698|NCT01737697|58996313|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
30949699|NCT01737697|58996314|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949700|NCT01737697|58996315|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949701|NCT01737697|58996316|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949702|NCT01737697|58996317|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949703|NCT01737697|58996318|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949704|NCT01737697|58996319|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949705|NCT01737697|58996320|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949706|NCT01737697|58996321|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949707|NCT01737697|58996322|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949708|NCT01737697|58996323|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
30949709|NCT01737697|58996309|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
30949710|NCT01737697|58996310|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
30949711|NCT01737697|58996311|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
30949712|NCT01737697|58996312|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
30949713|NCT01737697|58996313|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
30949714|NCT01737697|58996314|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
30762171|NCT00379769|58771101|FG001|Main Study|Personal reasons|0|||
30762172|NCT00379769|58771102|FG002|Main Study|Personal reasons|0|||
30762173|NCT00379769|58771103|FG003|Main Study|Personal reasons|0|||
30762174|NCT00379769|58771104|FG004|Main Study|Personal reasons|0|||
30762175|NCT00379769|58771105|FG005|Main Study|Personal reasons|0|||
30762176|NCT00379769|58771100|FG000|Main Study|Risk of heart failure|0|||
30762177|NCT00379769|58771101|FG001|Main Study|Risk of heart failure|1|||
30762178|NCT00379769|58771102|FG002|Main Study|Risk of heart failure|0|||
30762179|NCT00379769|58771103|FG003|Main Study|Risk of heart failure|0|||
30762180|NCT00379769|58771104|FG004|Main Study|Risk of heart failure|0|||
30762181|NCT00379769|58771105|FG005|Main Study|Risk of heart failure|0|||
30762182|NCT00379769|58771100|FG000|Main Study|Investigator refused to log temperature|0|||
30949715|NCT01737697|58996315|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
30949716|NCT01737697|58996316|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
30949717|NCT01737697|58996317|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
30762183|NCT00379769|58771101|FG001|Main Study|Investigator refused to log temperature|0|||
30762184|NCT00379769|58771102|FG002|Main Study|Investigator refused to log temperature|1|||
30762185|NCT00379769|58771103|FG003|Main Study|Investigator refused to log temperature|0|||
30762186|NCT00379769|58771104|FG004|Main Study|Investigator refused to log temperature|0|||
30762187|NCT00379769|58771105|FG005|Main Study|Investigator refused to log temperature|0|||
30762188|NCT00379769|58771100|FG000|Main Study|Reason unspecified|0|||
30762189|NCT00379769|58771101|FG001|Main Study|Reason unspecified|0|||
30949718|NCT01737697|58996318|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
30949719|NCT01737697|58996319|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
30949720|NCT01737697|58996320|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
30949721|NCT01737697|58996321|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
30949722|NCT01737697|58996322|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
30949723|NCT01737697|58996323|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
30949724|NCT01737697|58996309|FG000|Subacute Phase|Adverse Event|0|||
30949725|NCT01737697|58996310|FG001|Subacute Phase|Adverse Event|0|||
30949726|NCT01737697|58996311|FG002|Subacute Phase|Adverse Event|0|||
30949727|NCT01737697|58996312|FG003|Subacute Phase|Adverse Event|0|||
30949728|NCT01737697|58996313|FG004|Subacute Phase|Adverse Event|0|||
30949729|NCT01737697|58996314|FG005|Subacute Phase|Adverse Event|1|||
30949730|NCT01737697|58996315|FG006|Subacute Phase|Adverse Event|1|||
30949731|NCT01737697|58996316|FG007|Subacute Phase|Adverse Event|1|||
30949732|NCT01737697|58996317|FG008|Subacute Phase|Adverse Event|1|||
30949733|NCT01737697|58996318|FG009|Subacute Phase|Adverse Event|1|||
30949734|NCT01737697|58996319|FG010|Subacute Phase|Adverse Event|4|||
30949735|NCT01737697|58996320|FG011|Subacute Phase|Adverse Event|1|||
30949736|NCT01737697|58996321|FG012|Subacute Phase|Adverse Event|1|||
30949737|NCT01737697|58996322|FG013|Subacute Phase|Adverse Event|0|||
30949738|NCT01737697|58996323|FG014|Subacute Phase|Adverse Event|0|||
30949739|NCT01737697|58996309|FG000|Subacute Phase|Withdrawal by Subject|0|||
30949740|NCT01737697|58996310|FG001|Subacute Phase|Withdrawal by Subject|0|||
30949741|NCT01737697|58996311|FG002|Subacute Phase|Withdrawal by Subject|0|||
30949742|NCT01737697|58996312|FG003|Subacute Phase|Withdrawal by Subject|0|||
30949743|NCT01737697|58996313|FG004|Subacute Phase|Withdrawal by Subject|0|||
30949744|NCT01737697|58996314|FG005|Subacute Phase|Withdrawal by Subject|1|||
30949745|NCT01737697|58996315|FG006|Subacute Phase|Withdrawal by Subject|0|||
30949746|NCT01737697|58996316|FG007|Subacute Phase|Withdrawal by Subject|2|||
30949747|NCT01737697|58996317|FG008|Subacute Phase|Withdrawal by Subject|0|||
30949748|NCT01737697|58996318|FG009|Subacute Phase|Withdrawal by Subject|1|||
30949749|NCT01737697|58996319|FG010|Subacute Phase|Withdrawal by Subject|0|||
30949750|NCT01737697|58996320|FG011|Subacute Phase|Withdrawal by Subject|1|||
30949751|NCT01737697|58996321|FG012|Subacute Phase|Withdrawal by Subject|1|||
30949752|NCT01737697|58996322|FG013|Subacute Phase|Withdrawal by Subject|1|||
30949753|NCT01737697|58996323|FG014|Subacute Phase|Withdrawal by Subject|0|||
30949754|NCT01737697|58996309|FG000|Subacute Phase|Lost to Follow-up|0|||
30949755|NCT01737697|58996310|FG001|Subacute Phase|Lost to Follow-up|0|||
30949756|NCT01737697|58996311|FG002|Subacute Phase|Lost to Follow-up|0|||
30949757|NCT01737697|58996312|FG003|Subacute Phase|Lost to Follow-up|0|||
30949758|NCT01737697|58996313|FG004|Subacute Phase|Lost to Follow-up|0|||
30949759|NCT01737697|58996314|FG005|Subacute Phase|Lost to Follow-up|0|||
30949760|NCT01737697|58996315|FG006|Subacute Phase|Lost to Follow-up|0|||
30949761|NCT01737697|58996316|FG007|Subacute Phase|Lost to Follow-up|0|||
30949762|NCT01737697|58996317|FG008|Subacute Phase|Lost to Follow-up|0|||
30949763|NCT01737697|58996318|FG009|Subacute Phase|Lost to Follow-up|0|||
30949764|NCT01737697|58996319|FG010|Subacute Phase|Lost to Follow-up|0|||
30949765|NCT01737697|58996320|FG011|Subacute Phase|Lost to Follow-up|0|||
30949766|NCT01737697|58996321|FG012|Subacute Phase|Lost to Follow-up|0|||
30949767|NCT01737697|58996322|FG013|Subacute Phase|Lost to Follow-up|0|||
30949768|NCT01737697|58996323|FG014|Subacute Phase|Lost to Follow-up|1|||
30949769|NCT01737697|58996309|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
30949770|NCT01737697|58996310|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
30762190|NCT00379769|58771102|FG002|Main Study|Reason unspecified|1|||
30762191|NCT00379769|58771103|FG003|Main Study|Reason unspecified|0|||
30762192|NCT00379769|58771104|FG004|Main Study|Reason unspecified|0|||
30949771|NCT01737697|58996311|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
30949772|NCT01737697|58996312|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
30949773|NCT01737697|58996313|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
30949774|NCT01737697|58996314|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
30949775|NCT01737697|58996315|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
30949776|NCT01737697|58996316|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
30949777|NCT01737697|58996317|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
30949778|NCT01737697|58996318|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
30949779|NCT01737697|58996319|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
30949780|NCT01737697|58996320|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
30762193|NCT00379769|58771105|FG005|Main Study|Reason unspecified|0|||
30762194|NCT00379769|58771100|FG000|Observational Follow-up|Death|0|||
30762195|NCT00379769|58771101|FG001|Observational Follow-up|Death|0|||
30949781|NCT01737697|58996321|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
30949782|NCT01737697|58996322|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
30949783|NCT01737697|58996323|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
30949784|NCT01737697|58996309|FG000|Subacute Phase|Protocol Violation|0|||
30949785|NCT01737697|58996310|FG001|Subacute Phase|Protocol Violation|0|||
30949786|NCT01737697|58996311|FG002|Subacute Phase|Protocol Violation|0|||
30949787|NCT01737697|58996312|FG003|Subacute Phase|Protocol Violation|0|||
30949788|NCT01737697|58996313|FG004|Subacute Phase|Protocol Violation|0|||
30949789|NCT01737697|58996314|FG005|Subacute Phase|Protocol Violation|1|||
30949790|NCT01737697|58996315|FG006|Subacute Phase|Protocol Violation|0|||
30949791|NCT01737697|58996316|FG007|Subacute Phase|Protocol Violation|0|||
30949792|NCT01737697|58996317|FG008|Subacute Phase|Protocol Violation|0|||
30949793|NCT01737697|58996318|FG009|Subacute Phase|Protocol Violation|0|||
30949794|NCT01737697|58996319|FG010|Subacute Phase|Protocol Violation|1|||
30949795|NCT01737697|58996320|FG011|Subacute Phase|Protocol Violation|0|||
30949796|NCT01737697|58996321|FG012|Subacute Phase|Protocol Violation|0|||
30949797|NCT01737697|58996322|FG013|Subacute Phase|Protocol Violation|0|||
30949798|NCT01737697|58996323|FG014|Subacute Phase|Protocol Violation|0|||
30949799|NCT01737697|58996309|FG000|Subacute Phase|Physician Decision|0|||
30949800|NCT01737697|58996310|FG001|Subacute Phase|Physician Decision|0|||
30949801|NCT01737697|58996311|FG002|Subacute Phase|Physician Decision|0|||
30949802|NCT01737697|58996312|FG003|Subacute Phase|Physician Decision|0|||
30949803|NCT01737697|58996313|FG004|Subacute Phase|Physician Decision|0|||
30949804|NCT01737697|58996314|FG005|Subacute Phase|Physician Decision|0|||
30949805|NCT01737697|58996315|FG006|Subacute Phase|Physician Decision|0|||
30949806|NCT01737697|58996316|FG007|Subacute Phase|Physician Decision|0|||
30949807|NCT01737697|58996317|FG008|Subacute Phase|Physician Decision|1|||
30762196|NCT00379769|58771102|FG002|Observational Follow-up|Death|0|||
30762197|NCT00379769|58771103|FG003|Observational Follow-up|Death|0|||
30762198|NCT00379769|58771104|FG004|Observational Follow-up|Death|78|||
30762199|NCT00379769|58771105|FG005|Observational Follow-up|Death|70|||
30762200|NCT00379769|58771100|FG000|Observational Follow-up|Adverse Event|0|||
30949808|NCT01737697|58996318|FG009|Subacute Phase|Physician Decision|0|||
30949809|NCT01737697|58996319|FG010|Subacute Phase|Physician Decision|0|||
30949810|NCT01737697|58996320|FG011|Subacute Phase|Physician Decision|0|||
30949811|NCT01737697|58996321|FG012|Subacute Phase|Physician Decision|0|||
30949812|NCT01737697|58996322|FG013|Subacute Phase|Physician Decision|0|||
30762201|NCT00379769|58771101|FG001|Observational Follow-up|Adverse Event|0|||
30762202|NCT00379769|58771102|FG002|Observational Follow-up|Adverse Event|0|||
30762203|NCT00379769|58771103|FG003|Observational Follow-up|Adverse Event|0|||
30762204|NCT00379769|58771104|FG004|Observational Follow-up|Adverse Event|1|||
30762205|NCT00379769|58771105|FG005|Observational Follow-up|Adverse Event|0|||
30762206|NCT00379769|58771100|FG000|Observational Follow-up|Lost to Follow-up|0|||
30762207|NCT00379769|58771101|FG001|Observational Follow-up|Lost to Follow-up|0|||
30762208|NCT00379769|58771102|FG002|Observational Follow-up|Lost to Follow-up|0|||
30762209|NCT00379769|58771103|FG003|Observational Follow-up|Lost to Follow-up|0|||
30762210|NCT00379769|58771104|FG004|Observational Follow-up|Lost to Follow-up|25|||
30762211|NCT00379769|58771105|FG005|Observational Follow-up|Lost to Follow-up|27|||
30762212|NCT00379769|58771100|FG000|Observational Follow-up|Withdrawal by Subject|0|||
30762213|NCT00379769|58771101|FG001|Observational Follow-up|Withdrawal by Subject|0|||
30762214|NCT00379769|58771102|FG002|Observational Follow-up|Withdrawal by Subject|0|||
30762215|NCT00379769|58771103|FG003|Observational Follow-up|Withdrawal by Subject|0|||
30762216|NCT00379769|58771104|FG004|Observational Follow-up|Withdrawal by Subject|12|||
30762217|NCT00379769|58771105|FG005|Observational Follow-up|Withdrawal by Subject|12|||
30762218|NCT00379769|58771100|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
30762219|NCT00379769|58771101|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
30846240|NCT02958865|58872303|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
30846241|NCT02958865|58872304|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
30846242|NCT02958865|58872305|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
30846243|NCT02958865|58872306|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
30846244|NCT02958865|58872307|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
30846245|NCT02958865|58872308|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
30846246|NCT02958865|58872309|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
30846247|NCT02958865|58872310|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
30846248|NCT02958865|58872295|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
30846249|NCT02958865|58872296|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
30846250|NCT02958865|58872297|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846251|NCT02958865|58872298|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846252|NCT02958865|58872299|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846253|NCT02958865|58872300|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846254|NCT02958865|58872301|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846255|NCT02958865|58872302|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846256|NCT02958865|58872303|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846257|NCT02958865|58872304|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846258|NCT02958865|58872305|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846259|NCT02958865|58872306|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846260|NCT02958865|58872307|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846261|NCT02958865|58872308|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846262|NCT02958865|58872309|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846263|NCT02958865|58872310|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
30846264|NCT02958865|58872295|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
30846265|NCT02958865|58872296|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30846266|NCT02958865|58872297|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
30846267|NCT02958865|58872298|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
30846268|NCT02958865|58872299|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
30846269|NCT02958865|58872300|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
30846270|NCT02958865|58872301|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
30846271|NCT02958865|58872302|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30846272|NCT02958865|58872303|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30846273|NCT02958865|58872304|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30846274|NCT02958865|58872305|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30846275|NCT02958865|58872306|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30846276|NCT02958865|58872307|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30846277|NCT02958865|58872308|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30846278|NCT02958865|58872309|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30846279|NCT02958865|58872310|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30846280|NCT02958865|58872295|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846281|NCT02958865|58872296|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846282|NCT02958865|58872297|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846283|NCT02958865|58872298|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
30846284|NCT02958865|58872299|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846285|NCT02958865|58872300|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846286|NCT02958865|58872301|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
30846287|NCT02958865|58872302|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846288|NCT02958865|58872303|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846289|NCT02958865|58872304|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846290|NCT02958865|58872305|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846291|NCT02958865|58872306|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846292|NCT02958865|58872307|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846293|NCT02958865|58872308|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846294|NCT02958865|58872309|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846295|NCT02958865|58872310|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
30846296|NCT02958865|58872295|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846297|NCT02958865|58872296|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846298|NCT02958865|58872297|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
30846299|NCT02958865|58872298|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846300|NCT02958865|58872299|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846301|NCT02958865|58872300|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846302|NCT02958865|58872301|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846303|NCT02958865|58872302|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846304|NCT02958865|58872303|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846305|NCT02958865|58872304|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846306|NCT02958865|58872305|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846307|NCT02958865|58872306|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846308|NCT02958865|58872307|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846309|NCT02958865|58872308|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846310|NCT02958865|58872309|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30846311|NCT02958865|58872310|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
30949813|NCT01737697|58996323|FG014|Subacute Phase|Physician Decision|0|||
30626118|NCT01103466|58638183|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
30949814|NCT01737697|58996309|FG000|Subacute Phase|Death|0|||
30949815|NCT01737697|58996310|FG001|Subacute Phase|Death|0|||
30949816|NCT01737697|58996311|FG002|Subacute Phase|Death|0|||
30949817|NCT01737697|58996312|FG003|Subacute Phase|Death|0|||
30949818|NCT01737697|58996313|FG004|Subacute Phase|Death|0|||
30949819|NCT01737697|58996314|FG005|Subacute Phase|Death|0|||
30949820|NCT01737697|58996315|FG006|Subacute Phase|Death|0|||
30949821|NCT01737697|58996316|FG007|Subacute Phase|Death|0|||
30949822|NCT01737697|58996317|FG008|Subacute Phase|Death|0|||
30949823|NCT01737697|58996318|FG009|Subacute Phase|Death|0|||
30949824|NCT01737697|58996319|FG010|Subacute Phase|Death|1|||
30762220|NCT00379769|58771102|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
30762221|NCT00379769|58771103|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
30762222|NCT00379769|58771104|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
30762223|NCT00379769|58771105|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
30626119|NCT01103466|58638184|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
30626120|NCT01103466|58638185|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
30626121|NCT01103466|58638183|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
30626122|NCT01103466|58638184|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
30626123|NCT01103466|58638185|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
30762224|NCT00379769|58771100|FG000|Observational Follow-up|Physician Decision|0|||
30762225|NCT00379769|58771101|FG001|Observational Follow-up|Physician Decision|0|||
30762226|NCT00379769|58771102|FG002|Observational Follow-up|Physician Decision|0|||
30762227|NCT00379769|58771103|FG003|Observational Follow-up|Physician Decision|0|||
30762228|NCT00379769|58771104|FG004|Observational Follow-up|Physician Decision|8|||
30762229|NCT00379769|58771105|FG005|Observational Follow-up|Physician Decision|8|||
30762230|NCT00379769|58771100|FG000|Observational Follow-up|Site Closed Early|0|||
30762231|NCT00379769|58771101|FG001|Observational Follow-up|Site Closed Early|0|||
30762232|NCT00379769|58771102|FG002|Observational Follow-up|Site Closed Early|0|||
30762233|NCT00379769|58771103|FG003|Observational Follow-up|Site Closed Early|0|||
30762234|NCT00379769|58771104|FG004|Observational Follow-up|Site Closed Early|6|||
30762235|NCT00379769|58771105|FG005|Observational Follow-up|Site Closed Early|7|||
30762236|NCT00379769|58771100|FG000|Observational Follow-up|Participant Moved|0|||
30762237|NCT00379769|58771101|FG001|Observational Follow-up|Participant Moved|0|||
30762238|NCT00379769|58771102|FG002|Observational Follow-up|Participant Moved|0|||
30762239|NCT00379769|58771103|FG003|Observational Follow-up|Participant Moved|0|||
30762240|NCT00379769|58771104|FG004|Observational Follow-up|Participant Moved|0|||
30762241|NCT00379769|58771105|FG005|Observational Follow-up|Participant Moved|1|||
30762242|NCT00379769|58771100|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
30762243|NCT00379769|58771101|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
30762244|NCT00379769|58771102|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
30762245|NCT00379769|58771103|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
30762246|NCT00379769|58771104|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
30762247|NCT00379769|58771105|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
30762248|NCT00006164|58771134|FG000|Overall Study|Withdrew or lost to follow-up|70|||
30949825|NCT01737697|58996320|FG011|Subacute Phase|Death|0|||
30949826|NCT01737697|58996321|FG012|Subacute Phase|Death|0|||
30949827|NCT01737697|58996322|FG013|Subacute Phase|Death|0|||
30949828|NCT01737697|58996323|FG014|Subacute Phase|Death|0|||
30846312|NCT02958865|58872295|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
30846313|NCT02958865|58872296|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
30846314|NCT02958865|58872297|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
30846315|NCT02958865|58872298|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846316|NCT02958865|58872299|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846317|NCT02958865|58872300|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846318|NCT02958865|58872301|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846319|NCT02958865|58872302|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846320|NCT02958865|58872303|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846321|NCT02958865|58872304|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846322|NCT02958865|58872305|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846323|NCT02958865|58872306|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846324|NCT02958865|58872307|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846325|NCT02958865|58872308|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846326|NCT02958865|58872309|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846327|NCT02958865|58872310|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
30846328|NCT02958865|58872295|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
30846329|NCT02958865|58872296|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
30846330|NCT02958865|58872297|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
30846331|NCT02958865|58872298|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
30846332|NCT02958865|58872299|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
30846333|NCT02958865|58872300|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
30846334|NCT02958865|58872301|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
30846335|NCT02958865|58872302|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
30846336|NCT02958865|58872303|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
30846337|NCT02958865|58872304|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
30846338|NCT02958865|58872305|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
30846339|NCT02958865|58872306|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
30846340|NCT02958865|58872307|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
30846341|NCT02958865|58872308|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
30762249|NCT00006164|58771135|FG001|Overall Study|Withdrew or lost to follow-up|81|||
30762250|NCT00378599|58771141|FG000|Overall Study|Adverse Event|38|||
30762251|NCT00378599|58771141|FG000|Overall Study|Protocol Violation|2|||
30762252|NCT00378599|58771141|FG000|Overall Study|Treatment failure|7|||
30762253|NCT00378599|58771141|FG000|Overall Study|Withdrawal by Subject|5|||
30762254|NCT00378209|58771145|FG000|Overall Study|Progressive disease|11|||
30762255|NCT00378209|58771145|FG000|Overall Study|Adverse Event|3|||
30762256|NCT00378209|58771145|FG000|Overall Study|Initiation of non-protocol therapy|3|||
30762257|NCT00378209|58771145|FG000|Overall Study|Physician Decision|3|||
30762258|NCT00378209|58771145|FG000|Overall Study|Death|1|||
30762259|NCT00378209|58771145|FG000|Overall Study|Treatment delay|1|||
30762260|NCT03410992|58771152|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
30846342|NCT02958865|58872309|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
30949829|NCT01682863|58996479|FG000|Overall Study|Subject/guardian decision|19|||
30762261|NCT03410992|58771153|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
30762262|NCT03410992|58771154|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
30762263|NCT03410992|58771155|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
30846343|NCT02958865|58872310|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
30846344|NCT02958865|58872295|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30762264|NCT03410992|58771156|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
30762265|NCT03410992|58771157|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
30762266|NCT03410992|58771158|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
30762267|NCT03410992|58771159|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
30762268|NCT03410992|58771160|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
30762269|NCT03410992|58771161|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
30762270|NCT03410992|58771162|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
30762271|NCT03410992|58771152|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
30762272|NCT03410992|58771153|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
30762273|NCT03410992|58771154|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
30846345|NCT02958865|58872296|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846346|NCT02958865|58872297|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846347|NCT02958865|58872298|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846348|NCT02958865|58872299|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
30846349|NCT02958865|58872300|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846350|NCT02958865|58872301|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30762274|NCT03410992|58771155|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
30762275|NCT03410992|58771156|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
30846351|NCT02958865|58872302|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846352|NCT02958865|58872303|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846353|NCT02958865|58872304|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846354|NCT02958865|58872305|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846355|NCT02958865|58872306|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846356|NCT02958865|58872307|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846357|NCT02958865|58872308|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846358|NCT02958865|58872309|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846359|NCT02958865|58872310|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30846360|NCT02958865|58872295|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
30846361|NCT02958865|58872296|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
30846362|NCT02958865|58872297|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
30846363|NCT02958865|58872298|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
30846364|NCT02958865|58872299|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
30846365|NCT02958865|58872300|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
30846366|NCT02958865|58872301|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
30846367|NCT02958865|58872302|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
30846368|NCT02958865|58872303|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
30846369|NCT02958865|58872304|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
30846370|NCT02958865|58872305|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
30846371|NCT02958865|58872306|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
30846372|NCT02958865|58872307|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
30846373|NCT02958865|58872308|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
30846374|NCT02958865|58872309|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
30846375|NCT02958865|58872310|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
30846376|NCT02958865|58872295|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
30846377|NCT02958865|58872296|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
30846378|NCT02958865|58872297|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
30846379|NCT02958865|58872298|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
30846380|NCT02958865|58872299|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
30846381|NCT02958865|58872300|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
30846382|NCT02958865|58872301|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
30846383|NCT02958865|58872302|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
30846384|NCT02958865|58872303|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
30846385|NCT02958865|58872304|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
30846386|NCT02958865|58872305|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
30846387|NCT02958865|58872306|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
30846388|NCT02958865|58872307|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
30846389|NCT02958865|58872308|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
30846390|NCT02958865|58872309|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
30846391|NCT02958865|58872310|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
30846392|NCT02958865|58872295|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846393|NCT02958865|58872296|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846394|NCT02958865|58872297|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30762276|NCT03410992|58771157|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
30949830|NCT01682863|58996480|FG001|Overall Study|Subject/guardian decision|12|||
30949831|NCT01682863|58996481|FG002|Overall Study|Subject/guardian decision|10|||
30949832|NCT01682863|58996479|FG000|Overall Study|Lost to Follow-up|5|||
30949833|NCT01682863|58996480|FG001|Overall Study|Lost to Follow-up|1|||
30949834|NCT01682863|58996481|FG002|Overall Study|Lost to Follow-up|6|||
30949835|NCT01682863|58996479|FG000|Overall Study|Death|1|||
30949836|NCT01682863|58996480|FG001|Overall Study|Death|3|||
30949837|NCT01682863|58996481|FG002|Overall Study|Death|4|||
30949838|NCT01682863|58996479|FG000|Overall Study|Protocol deviation|1|||
30949839|NCT01682863|58996480|FG001|Overall Study|Protocol deviation|0|||
30949840|NCT01682863|58996481|FG002|Overall Study|Protocol deviation|1|||
30949841|NCT01682863|58996479|FG000|Overall Study|Technical problems|1|||
30949842|NCT01682863|58996480|FG001|Overall Study|Technical problems|0|||
30949843|NCT01682863|58996481|FG002|Overall Study|Technical problems|0|||
30949844|NCT01682863|58996479|FG000|Overall Study|Adverse Event|0|||
30949845|NCT01682863|58996480|FG001|Overall Study|Adverse Event|1|||
30949846|NCT01682863|58996481|FG002|Overall Study|Adverse Event|2|||
30949847|NCT01682863|58996479|FG000|Overall Study|Physician Decision|0|||
30949848|NCT01682863|58996480|FG001|Overall Study|Physician Decision|0|||
30949849|NCT01682863|58996481|FG002|Overall Study|Physician Decision|1|||
30949850|NCT01951625|58996494|FG000|Treatment Period|Protocol Violation|2|||
30949851|NCT01951625|58996495|FG001|Treatment Period|Protocol Violation|0|||
30949852|NCT01951625|58996496|FG002|Treatment Period|Protocol Violation|1|||
30949853|NCT01951625|58996497|FG003|Treatment Period|Protocol Violation|3|||
30949854|NCT01951625|58996498|FG004|Treatment Period|Protocol Violation|2|||
30949855|NCT01951625|58996494|FG000|Treatment Period|Physician Decision|0|||
30949856|NCT01951625|58996495|FG001|Treatment Period|Physician Decision|0|||
30949857|NCT01951625|58996496|FG002|Treatment Period|Physician Decision|0|||
30949858|NCT01951625|58996497|FG003|Treatment Period|Physician Decision|0|||
30949859|NCT01951625|58996498|FG004|Treatment Period|Physician Decision|1|||
30949860|NCT01951625|58996494|FG000|Treatment Period|Protocol driven decision point|0|||
30949861|NCT01951625|58996495|FG001|Treatment Period|Protocol driven decision point|5|||
30949862|NCT01951625|58996496|FG002|Treatment Period|Protocol driven decision point|0|||
30949863|NCT01951625|58996497|FG003|Treatment Period|Protocol driven decision point|2|||
30949864|NCT01951625|58996498|FG004|Treatment Period|Protocol driven decision point|1|||
30949865|NCT01951625|58996494|FG000|Treatment Period|Non compliance with study drug|1|||
30949866|NCT01951625|58996495|FG001|Treatment Period|Non compliance with study drug|2|||
30949867|NCT01951625|58996496|FG002|Treatment Period|Non compliance with study drug|2|||
30949868|NCT01951625|58996497|FG003|Treatment Period|Non compliance with study drug|0|||
30949869|NCT01951625|58996498|FG004|Treatment Period|Non compliance with study drug|0|||
30949870|NCT01951625|58996494|FG000|Treatment Period|Death|3|||
30949871|NCT01951625|58996495|FG001|Treatment Period|Death|2|||
30949872|NCT01951625|58996496|FG002|Treatment Period|Death|2|||
30949873|NCT01951625|58996497|FG003|Treatment Period|Death|1|||
30762277|NCT03410992|58771158|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
30762278|NCT03410992|58771159|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
30762279|NCT03410992|58771160|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
30762280|NCT03410992|58771161|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
30762281|NCT03410992|58771162|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
30762282|NCT03410992|58771152|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
30762283|NCT03410992|58771153|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
30762284|NCT03410992|58771154|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
30762285|NCT03410992|58771155|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
30762286|NCT03410992|58771156|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
30762287|NCT03410992|58771157|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
30762288|NCT03410992|58771158|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
30846395|NCT02958865|58872298|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846396|NCT02958865|58872299|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846397|NCT02958865|58872300|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846398|NCT02958865|58872301|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846399|NCT02958865|58872302|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846400|NCT02958865|58872303|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846401|NCT02958865|58872304|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
30846402|NCT02958865|58872305|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30949874|NCT01951625|58996498|FG004|Treatment Period|Death|2|||
30949875|NCT01951625|58996494|FG000|Treatment Period|Adverse Event|7|||
30949876|NCT01951625|58996495|FG001|Treatment Period|Adverse Event|10|||
30949877|NCT01951625|58996496|FG002|Treatment Period|Adverse Event|9|||
30949878|NCT01951625|58996497|FG003|Treatment Period|Adverse Event|8|||
30846403|NCT02958865|58872306|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846404|NCT02958865|58872307|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846405|NCT02958865|58872308|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846406|NCT02958865|58872309|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
30846407|NCT02958865|58872310|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
30846408|NCT02958865|58872295|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
30846409|NCT02958865|58872296|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
30626124|NCT01103466|58638183|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
30626125|NCT01103466|58638184|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
30626126|NCT01103466|58638185|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
30762289|NCT03410992|58771159|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
30762290|NCT03410992|58771160|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
30762291|NCT03410992|58771161|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
30762292|NCT03410992|58771162|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
30762293|NCT03410992|58771152|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
30762294|NCT03410992|58771153|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
30762295|NCT03410992|58771154|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
30762296|NCT03410992|58771155|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
30846410|NCT02958865|58872297|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
30949879|NCT01951625|58996498|FG004|Treatment Period|Adverse Event|8|||
30846411|NCT02958865|58872298|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
30846412|NCT02958865|58872299|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
30846413|NCT02958865|58872300|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
30846414|NCT02958865|58872301|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
30846415|NCT02958865|58872302|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
30846416|NCT02958865|58872303|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
30846417|NCT02958865|58872304|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
30846418|NCT02958865|58872305|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
30846419|NCT02958865|58872306|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
30846420|NCT02958865|58872307|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
30846421|NCT02958865|58872308|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
30846422|NCT02958865|58872309|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
30846423|NCT02958865|58872310|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
30846424|NCT02958865|58872295|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
30846425|NCT02958865|58872296|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
30846426|NCT02958865|58872297|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
30949880|NCT01951625|58996494|FG000|Treatment Period|Withdrawal by Subject|5|||
30762297|NCT03410992|58771156|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
30762298|NCT03410992|58771157|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
30762299|NCT03410992|58771158|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
30762300|NCT03410992|58771159|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
30762301|NCT03410992|58771160|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
30762302|NCT03410992|58771161|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
30762303|NCT03410992|58771162|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
30762304|NCT03410992|58771152|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
30762305|NCT03410992|58771153|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
30762306|NCT03410992|58771154|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
30762307|NCT03410992|58771155|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
30762308|NCT03410992|58771156|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
30762309|NCT03410992|58771157|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
30762310|NCT03410992|58771158|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
30762311|NCT03410992|58771159|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
30762312|NCT03410992|58771160|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
30762313|NCT03410992|58771161|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
30762314|NCT03410992|58771162|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
30762315|NCT03410992|58771152|FG000|Week 16 Assessment|Incorrect escapers|0|||
30762316|NCT03410992|58771153|FG001|Week 16 Assessment|Incorrect escapers|6|||
30762317|NCT03410992|58771154|FG002|Week 16 Assessment|Incorrect escapers|0|||
30762318|NCT03410992|58771155|FG003|Week 16 Assessment|Incorrect escapers|0|||
30762319|NCT03410992|58771156|FG004|Week 16 Assessment|Incorrect escapers|0|||
30762320|NCT03410992|58771157|FG005|Week 16 Assessment|Incorrect escapers|0|||
30762321|NCT03410992|58771158|FG006|Week 16 Assessment|Incorrect escapers|0|||
30762322|NCT03410992|58771159|FG007|Week 16 Assessment|Incorrect escapers|0|||
30762323|NCT03410992|58771160|FG008|Week 16 Assessment|Incorrect escapers|0|||
30762324|NCT03410992|58771161|FG009|Week 16 Assessment|Incorrect escapers|0|||
30762325|NCT03410992|58771162|FG010|Week 16 Assessment|Incorrect escapers|0|||
30762326|NCT03410992|58771152|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
30762327|NCT03410992|58771153|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
30762328|NCT03410992|58771154|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
30762329|NCT03410992|58771155|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
30762330|NCT03410992|58771156|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
30762331|NCT03410992|58771157|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
30762332|NCT03410992|58771158|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
30762333|NCT03410992|58771159|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
30762334|NCT03410992|58771160|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
30762335|NCT03410992|58771161|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
30762336|NCT03410992|58771162|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
30762337|NCT03410992|58771152|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
30762338|NCT03410992|58771153|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
30762339|NCT03410992|58771154|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
30762340|NCT03410992|58771155|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
30762341|NCT03410992|58771156|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
30762342|NCT03410992|58771157|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
30846427|NCT02958865|58872298|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
30846428|NCT02958865|58872299|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
30762343|NCT03410992|58771158|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
30762344|NCT03410992|58771159|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
30762345|NCT03410992|58771160|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
30762346|NCT03410992|58771161|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
30762347|NCT03410992|58771162|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
30762348|NCT03410992|58771152|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
30762349|NCT03410992|58771153|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
30762350|NCT03410992|58771154|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
30762351|NCT03410992|58771155|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
30762352|NCT03410992|58771156|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
30762353|NCT03410992|58771157|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
30762354|NCT03410992|58771158|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
30762355|NCT03410992|58771159|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
30762356|NCT03410992|58771160|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
30762357|NCT03410992|58771161|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
30762358|NCT03410992|58771162|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
30762359|NCT03410992|58771152|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
30762360|NCT03410992|58771153|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
30762361|NCT03410992|58771154|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
30762362|NCT03410992|58771155|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
30762363|NCT03410992|58771156|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
30762364|NCT03410992|58771157|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
30762365|NCT03410992|58771158|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
30762366|NCT03410992|58771159|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
30762367|NCT03410992|58771160|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
30762368|NCT03410992|58771161|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
30762369|NCT03410992|58771162|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
30762370|NCT03410992|58771152|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
30762371|NCT03410992|58771153|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
30762372|NCT03410992|58771154|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
30762373|NCT03410992|58771155|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
30846429|NCT02958865|58872300|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
30846430|NCT02958865|58872301|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
30846431|NCT02958865|58872302|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
30846432|NCT02958865|58872303|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
30846433|NCT02958865|58872304|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
30846434|NCT02958865|58872305|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
30846435|NCT02958865|58872306|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
30846436|NCT02958865|58872307|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
30846437|NCT02958865|58872308|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
30846438|NCT02958865|58872309|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
30846439|NCT02958865|58872310|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
30846440|NCT02958865|58872295|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846441|NCT02958865|58872296|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846442|NCT02958865|58872297|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846443|NCT02958865|58872298|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846444|NCT02958865|58872299|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846445|NCT02958865|58872300|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846446|NCT02958865|58872301|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846447|NCT02958865|58872302|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846448|NCT02958865|58872303|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846449|NCT02958865|58872304|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846450|NCT02958865|58872305|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30762374|NCT03410992|58771156|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
30762375|NCT03410992|58771157|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
30762376|NCT03410992|58771158|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
30762377|NCT03410992|58771159|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
30762378|NCT03410992|58771160|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
30762379|NCT03410992|58771161|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
30762380|NCT03410992|58771162|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
30762381|NCT03410992|58771152|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
30762382|NCT03410992|58771153|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
30762383|NCT03410992|58771154|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
30762384|NCT03410992|58771155|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
30762385|NCT03410992|58771156|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
30762386|NCT03410992|58771157|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
30762387|NCT03410992|58771158|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
30762388|NCT03410992|58771159|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
30762389|NCT03410992|58771160|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
30762390|NCT03410992|58771161|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
30762391|NCT03410992|58771162|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
30762392|NCT00377819|58771194|FG000|Overall Study|Adverse Event|2|||
30762393|NCT00377819|58771195|FG001|Overall Study|Adverse Event|3|||
30762394|NCT00377819|58771194|FG000|Overall Study|Withdrawal by Subject|10|||
30762395|NCT00377819|58771195|FG001|Overall Study|Withdrawal by Subject|4|||
30846451|NCT02958865|58872306|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846452|NCT02958865|58872307|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846453|NCT02958865|58872308|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
30846454|NCT02958865|58872309|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846455|NCT02958865|58872310|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
30846456|NCT02958865|58872295|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846457|NCT02958865|58872296|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846458|NCT02958865|58872297|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846459|NCT02958865|58872298|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846460|NCT02958865|58872299|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30762396|NCT00377819|58771194|FG000|Overall Study|Death|0|||
30762397|NCT00377819|58771195|FG001|Overall Study|Death|1|||
30762398|NCT00377819|58771194|FG000|Overall Study|Lost to Follow-up|0|||
30762399|NCT00377819|58771195|FG001|Overall Study|Lost to Follow-up|1|||
30762400|NCT00377819|58771194|FG000|Overall Study|Protocol Violation|1|||
30762401|NCT00377819|58771195|FG001|Overall Study|Protocol Violation|1|||
30762402|NCT03419962|58771201|FG000|Overall Study|Change to other medication|1|||
30762403|NCT03419962|58771201|FG000|Overall Study|Refusal of continuing with trial drug|1|||
30762404|NCT03419962|58771201|FG000|Overall Study|Lost to Follow-up|3|||
30762405|NCT03419962|58771201|FG000|Overall Study|Difficulty in inhaling the doses|1|||
30762406|NCT03419962|58771201|FG000|Overall Study|Missing completion data|31|||
30762407|NCT00377429|58771205|FG000|Overall Study|Withdrawal by Subject|5|||
30762408|NCT00377429|58771205|FG000|Overall Study|Adverse Event|8|||
30762409|NCT00377429|58771205|FG000|Overall Study|Physician Decision|1|||
30762410|NCT00377429|58771205|FG000|Overall Study|Patient non-compliance|1|||
30762411|NCT00376961|58771209|FG000|Initial Registration|Adverse Event|1|||
30762412|NCT00376961|58771210|FG001|Initial Registration|Adverse Event|0|||
30762413|NCT00376961|58771209|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
30762414|NCT00376961|58771210|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
30762415|NCT00376961|58771209|FG000|Initial Registration|Progression/relapse|1|||
30762416|NCT00376961|58771210|FG001|Initial Registration|Progression/relapse|0|||
30762417|NCT00376961|58771209|FG000|Initial Registration|Ineligible|3|||
30762418|NCT00376961|58771210|FG001|Initial Registration|Ineligible|0|||
30762419|NCT00376961|58771209|FG000|Maintenance|Adverse Event|0|||
30762420|NCT00376961|58771210|FG001|Maintenance|Adverse Event|1|||
30762421|NCT00376961|58771209|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
30762422|NCT00376961|58771210|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
30846461|NCT02958865|58872300|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846462|NCT02958865|58872301|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846463|NCT02958865|58872302|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846464|NCT02958865|58872303|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846465|NCT02958865|58872304|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846466|NCT02958865|58872305|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846467|NCT02958865|58872306|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846468|NCT02958865|58872307|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846469|NCT02958865|58872308|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
30846470|NCT02958865|58872309|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846471|NCT02958865|58872310|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
30846472|NCT02958865|58872295|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846473|NCT02958865|58872296|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846474|NCT02958865|58872297|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846475|NCT02958865|58872298|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846476|NCT02958865|58872299|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30762423|NCT00376961|58771209|FG000|Maintenance|Progression/relapse|0|||
30762424|NCT00376961|58771210|FG001|Maintenance|Progression/relapse|18|||
30762425|NCT00376961|58771209|FG000|Maintenance|Ineligible|0|||
30762426|NCT00376961|58771210|FG001|Maintenance|Ineligible|3|||
30762427|NCT03418324|58771220|FG000|Overall Study|Death|0|||
30762428|NCT03418324|58771221|FG001|Overall Study|Death|1|||
30762429|NCT03418324|58771220|FG000|Overall Study|Physician Decision|1|||
30846477|NCT02958865|58872300|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846478|NCT02958865|58872301|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846479|NCT02958865|58872302|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846480|NCT02958865|58872303|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846481|NCT02958865|58872304|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
30846482|NCT02958865|58872305|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846483|NCT02958865|58872306|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846484|NCT02958865|58872307|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846485|NCT02958865|58872308|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846486|NCT02958865|58872309|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846487|NCT02958865|58872310|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
30846488|NCT02958553|58872362|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
30846489|NCT02958553|58872362|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
30846490|NCT02501902|58872375|FG000|Overall Study|Subject Refused Further Follow-up|0|||
30846491|NCT02501902|58872376|FG001|Overall Study|Subject Refused Further Follow-up|0|||
30846492|NCT02501902|58872377|FG002|Overall Study|Subject Refused Further Follow-up|0|||
30762430|NCT03418324|58771221|FG001|Overall Study|Physician Decision|1|||
30762431|NCT00376259|58771229|FG000|Overall Study|Sponsor request - study termination|21|||
30762432|NCT00376259|58771230|FG001|Overall Study|Sponsor request - study termination|21|||
30762433|NCT00376259|58771229|FG000|Overall Study|Patient request|1|||
30762434|NCT00376259|58771230|FG001|Overall Study|Patient request|0|||
30762435|NCT03410056|58771240|FG000|Overall Study|Decision by Sponsor|0|||
30762436|NCT03410056|58771241|FG001|Overall Study|Decision by Sponsor|0|||
30846493|NCT02501902|58872378|FG003|Overall Study|Subject Refused Further Follow-up|0|||
30846494|NCT02501902|58872379|FG004|Overall Study|Subject Refused Further Follow-up|0|||
30846495|NCT02501902|58872380|FG005|Overall Study|Subject Refused Further Follow-up|0|||
30846496|NCT02501902|58872381|FG006|Overall Study|Subject Refused Further Follow-up|0|||
30846497|NCT02501902|58872382|FG007|Overall Study|Subject Refused Further Follow-up|1|||
30846498|NCT02501902|58872375|FG000|Overall Study|Study Terminated by Sponsor|0|||
30846499|NCT02501902|58872376|FG001|Overall Study|Study Terminated by Sponsor|3|||
30846500|NCT02501902|58872377|FG002|Overall Study|Study Terminated by Sponsor|0|||
30846501|NCT02501902|58872378|FG003|Overall Study|Study Terminated by Sponsor|1|||
30846502|NCT02501902|58872379|FG004|Overall Study|Study Terminated by Sponsor|1|||
30846503|NCT02501902|58872380|FG005|Overall Study|Study Terminated by Sponsor|0|||
30846504|NCT02501902|58872381|FG006|Overall Study|Study Terminated by Sponsor|2|||
30846505|NCT02501902|58872382|FG007|Overall Study|Study Terminated by Sponsor|4|||
30846506|NCT02501902|58872375|FG000|Overall Study|Death|3|||
30846507|NCT02501902|58872376|FG001|Overall Study|Death|4|||
30846508|NCT02501902|58872377|FG002|Overall Study|Death|4|||
30846509|NCT02501902|58872378|FG003|Overall Study|Death|10|||
30846510|NCT02501902|58872379|FG004|Overall Study|Death|10|||
30846511|NCT02501902|58872380|FG005|Overall Study|Death|11|||
30846512|NCT02501902|58872381|FG006|Overall Study|Death|7|||
30846513|NCT02501902|58872382|FG007|Overall Study|Death|15|||
30762437|NCT03410056|58771242|FG002|Overall Study|Decision by Sponsor|3|||
30762438|NCT03410056|58771243|FG003|Overall Study|Decision by Sponsor|0|||
30846514|NCT01955109|58872407|FG000|Overall Study|Adverse Event|2|||
30762439|NCT03410056|58771244|FG004|Overall Study|Decision by Sponsor|0|||
30762440|NCT03410056|58771245|FG005|Overall Study|Decision by Sponsor|0|||
30762441|NCT03410056|58771246|FG006|Overall Study|Decision by Sponsor|0|||
30762442|NCT03410056|58771240|FG000|Overall Study|Withdrawal by Subject|0|||
30762443|NCT03410056|58771241|FG001|Overall Study|Withdrawal by Subject|2|||
30762444|NCT03410056|58771242|FG002|Overall Study|Withdrawal by Subject|5|||
30762445|NCT03410056|58771243|FG003|Overall Study|Withdrawal by Subject|5|||
30762446|NCT03410056|58771244|FG004|Overall Study|Withdrawal by Subject|0|||
30762447|NCT03410056|58771245|FG005|Overall Study|Withdrawal by Subject|0|||
30762448|NCT03410056|58771246|FG006|Overall Study|Withdrawal by Subject|0|||
30762449|NCT03409666|58771264|FG000|Overall Study|Physician Decision|0|||
30762450|NCT03409666|58771265|FG001|Overall Study|Physician Decision|1|||
30762451|NCT03409666|58771264|FG000|Overall Study|Protocol Violation|0|||
30762452|NCT03409666|58771265|FG001|Overall Study|Protocol Violation|3|||
30762453|NCT03440944|58771273|FG000|Overall Study|Physician Decision|1|||
30762454|NCT03440944|58771274|FG001|Overall Study|Physician Decision|0|||
30762455|NCT03440944|58771273|FG000|Overall Study|No Acceptable Vasculature|0|||
30762456|NCT03440944|58771274|FG001|Overall Study|No Acceptable Vasculature|1|||
30762457|NCT00365105|58771283|FG000|Overall Study|Protocol Violation|5|||
30762458|NCT00365105|58771284|FG001|Overall Study|Protocol Violation|8|||
30762459|NCT00399893|58771292|FG000|Overall Study|Withdrawal by Subject|1|||
30762460|NCT00399893|58771293|FG001|Overall Study|Withdrawal by Subject|0|||
30762461|NCT00048542|58771303|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
30762462|NCT00048542|58771304|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
30762463|NCT00048542|58771305|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
30762464|NCT00048542|58771306|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
30762465|NCT00048542|58771307|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
30762466|NCT00048542|58771308|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
30762467|NCT00048542|58771309|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
30762468|NCT00048542|58771310|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
30762469|NCT00048542|58771303|FG000|Double-Blind Phase|Protocol Violation|0|||
30762470|NCT00048542|58771304|FG001|Double-Blind Phase|Protocol Violation|0|||
30762471|NCT00048542|58771305|FG002|Double-Blind Phase|Protocol Violation|1|||
30762472|NCT00048542|58771306|FG003|Double-Blind Phase|Protocol Violation|0|||
30762473|NCT00048542|58771307|FG004|Double-Blind Phase|Protocol Violation|0|||
30762474|NCT00048542|58771308|FG005|Double-Blind Phase|Protocol Violation|0|||
30762475|NCT00048542|58771309|FG006|Double-Blind Phase|Protocol Violation|0|||
30762476|NCT00048542|58771310|FG007|Double-Blind Phase|Protocol Violation|0|||
30846515|NCT01955109|58872408|FG001|Overall Study|Adverse Event|0|||
30762477|NCT00048542|58771303|FG000|Double-Blind Phase|Sponsor request or decision|2|||
30626127|NCT01103466|58638183|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
30762478|NCT00048542|58771304|FG001|Double-Blind Phase|Sponsor request or decision|0|||
30762479|NCT00048542|58771305|FG002|Double-Blind Phase|Sponsor request or decision|0|||
30762480|NCT00048542|58771306|FG003|Double-Blind Phase|Sponsor request or decision|0|||
30762481|NCT00048542|58771307|FG004|Double-Blind Phase|Sponsor request or decision|0|||
30846516|NCT01955109|58872407|FG000|Overall Study|Participant unwilling to continue|35|||
30846517|NCT01955109|58872408|FG001|Overall Study|Participant unwilling to continue|7|||
30846518|NCT01955109|58872407|FG000|Overall Study|Physician Decision|2|||
30846519|NCT01955109|58872408|FG001|Overall Study|Physician Decision|0|||
30846520|NCT01955109|58872407|FG000|Overall Study|Lost to Follow-up|3|||
30846521|NCT01955109|58872408|FG001|Overall Study|Lost to Follow-up|1|||
30846522|NCT01955109|58872407|FG000|Overall Study|Non-compliance|3|||
30846523|NCT01955109|58872408|FG001|Overall Study|Non-compliance|1|||
30846524|NCT02500732|58872416|FG000|Overall Study|Physician Decision|0|||
30846525|NCT02500732|58872417|FG001|Overall Study|Physician Decision|1|||
30846526|NCT02518048|58872423|FG000|Overall Study|Withdrawal by Subject|1|||
30846527|NCT02499952|58872428|FG000|Overall Study|Lost to Follow-up|1|||
30846528|NCT02499952|58872428|FG000|Overall Study|Death|9|||
30762482|NCT00048542|58771308|FG005|Double-Blind Phase|Sponsor request or decision|0|||
30762483|NCT00048542|58771309|FG006|Double-Blind Phase|Sponsor request or decision|0|||
30762484|NCT00048542|58771310|FG007|Double-Blind Phase|Sponsor request or decision|0|||
30762485|NCT00048542|58771303|FG000|Double-Blind Phase|Randomized in error|1|||
30762486|NCT00048542|58771304|FG001|Double-Blind Phase|Randomized in error|0|||
30762487|NCT00048542|58771305|FG002|Double-Blind Phase|Randomized in error|0|||
30762488|NCT00048542|58771306|FG003|Double-Blind Phase|Randomized in error|0|||
30762489|NCT00048542|58771307|FG004|Double-Blind Phase|Randomized in error|0|||
30762490|NCT00048542|58771308|FG005|Double-Blind Phase|Randomized in error|0|||
30762491|NCT00048542|58771309|FG006|Double-Blind Phase|Randomized in error|0|||
30762492|NCT00048542|58771310|FG007|Double-Blind Phase|Randomized in error|0|||
30762493|NCT00048542|58771303|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
30762494|NCT00048542|58771304|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
30762495|NCT00048542|58771305|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
30762496|NCT00048542|58771306|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
30762497|NCT00048542|58771307|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
30762498|NCT00048542|58771308|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
30762499|NCT00048542|58771309|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
30762500|NCT00048542|58771310|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
30762501|NCT00048542|58771303|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
30762502|NCT00048542|58771304|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
30762503|NCT00048542|58771305|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
30846529|NCT02499406|58872432|FG000|Overall Study|missed 3 treatment sessions|4|||
30846530|NCT02499172|58872440|FG000|Overall Study|Financial reason|0|||
30626128|NCT01103466|58638184|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
30762504|NCT00048542|58771306|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
30762505|NCT00048542|58771307|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
30762506|NCT00048542|58771308|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
30762507|NCT00048542|58771309|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
30846531|NCT02499172|58872441|FG001|Overall Study|Financial reason|0|||
30846532|NCT02499172|58872442|FG002|Overall Study|Financial reason|523|||
30846533|NCT02499172|58872443|FG003|Overall Study|Financial reason|436|||
30846534|NCT02499172|58872440|FG000|Overall Study|Lost to Follow-up|65|||
30846535|NCT02499172|58872441|FG001|Overall Study|Lost to Follow-up|64|||
30846536|NCT02499172|58872442|FG002|Overall Study|Lost to Follow-up|0|||
30846537|NCT02499172|58872443|FG003|Overall Study|Lost to Follow-up|0|||
30846538|NCT02498392|58872455|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
30846539|NCT02498392|58872456|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
30846540|NCT02498392|58872455|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
30846541|NCT02498392|58872456|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
30846542|NCT02498392|58872455|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
30846543|NCT02498392|58872456|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
30846544|NCT02498392|58872455|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
30846545|NCT02498392|58872456|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
30846546|NCT02498392|58872455|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
30846547|NCT02498392|58872456|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
30846548|NCT02498392|58872455|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
30846549|NCT02498392|58872456|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
30846550|NCT03205605|58872464|FG000|Overall Study|Withdrawal by Subject|1|||
30846551|NCT02498236|58872482|FG000|Overall Study|Did not show for testing|1|||
30846552|NCT02498236|58872483|FG001|Overall Study|Did not show for testing|0|||
30846553|NCT02498236|58872484|FG002|Overall Study|Did not show for testing|0|||
30846554|NCT02498236|58872485|FG003|Overall Study|Did not show for testing|0|||
30846555|NCT02498236|58872486|FG004|Overall Study|Did not show for testing|0|||
30846556|NCT02498236|58872487|FG005|Overall Study|Did not show for testing|0|||
30846557|NCT02498236|58872488|FG006|Overall Study|Did not show for testing|0|||
30846558|NCT02498236|58872489|FG007|Overall Study|Did not show for testing|1|||
30846559|NCT02498236|58872482|FG000|Overall Study|Equipment failure|0|||
30846560|NCT02498236|58872483|FG001|Overall Study|Equipment failure|0|||
30846561|NCT02498236|58872484|FG002|Overall Study|Equipment failure|0|||
30846562|NCT02498236|58872485|FG003|Overall Study|Equipment failure|0|||
30949881|NCT01951625|58996495|FG001|Treatment Period|Withdrawal by Subject|2|||
30949882|NCT01951625|58996496|FG002|Treatment Period|Withdrawal by Subject|1|||
30949883|NCT01951625|58996497|FG003|Treatment Period|Withdrawal by Subject|7|||
30846563|NCT02498236|58872486|FG004|Overall Study|Equipment failure|0|||
30846564|NCT02498236|58872487|FG005|Overall Study|Equipment failure|0|||
30846565|NCT02498236|58872488|FG006|Overall Study|Equipment failure|1|||
30846566|NCT02498236|58872489|FG007|Overall Study|Equipment failure|0|||
30846567|NCT02498236|58872482|FG000|Overall Study|Withdrawal by Subject|0|||
30846568|NCT02498236|58872483|FG001|Overall Study|Withdrawal by Subject|0|||
30846569|NCT02498236|58872484|FG002|Overall Study|Withdrawal by Subject|0|||
30949884|NCT01951625|58996498|FG004|Treatment Period|Withdrawal by Subject|3|||
30846570|NCT02498236|58872485|FG003|Overall Study|Withdrawal by Subject|0|||
30846571|NCT02498236|58872486|FG004|Overall Study|Withdrawal by Subject|1|||
30846572|NCT02498236|58872487|FG005|Overall Study|Withdrawal by Subject|0|||
30846573|NCT02498236|58872488|FG006|Overall Study|Withdrawal by Subject|0|||
30846574|NCT02498236|58872489|FG007|Overall Study|Withdrawal by Subject|0|||
30846575|NCT02496676|58872512|FG000|Phase 1 - Period 1|Adverse Event|0|||
30846576|NCT02496676|58872513|FG001|Phase 1 - Period 1|Adverse Event|1|||
30846577|NCT02496676|58872512|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
30846578|NCT02496676|58872513|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
30846579|NCT02517268|58872529|FG000|Overall Study|Withdrawal by Subject|1|||
30846580|NCT02517268|58872530|FG001|Overall Study|Withdrawal by Subject|0|||
30846581|NCT01160211|58872539|FG000|Overall Study|ongoing|90|||
30846582|NCT01160211|58872540|FG001|Overall Study|ongoing|75|||
30846583|NCT01160211|58872541|FG002|Overall Study|ongoing|79|||
30846584|NCT01160211|58872539|FG000|Overall Study|Withdrawal by Subject|3|||
30846585|NCT01160211|58872540|FG001|Overall Study|Withdrawal by Subject|5|||
30846586|NCT01160211|58872541|FG002|Overall Study|Withdrawal by Subject|3|||
30846587|NCT01160211|58872539|FG000|Overall Study|Physician Decision|2|||
30846588|NCT01160211|58872540|FG001|Overall Study|Physician Decision|0|||
30846589|NCT01160211|58872541|FG002|Overall Study|Physician Decision|0|||
30846590|NCT01160211|58872539|FG000|Overall Study|Lost to Follow-up|4|||
30846591|NCT01160211|58872540|FG001|Overall Study|Lost to Follow-up|7|||
30846592|NCT01160211|58872541|FG002|Overall Study|Lost to Follow-up|5|||
30846593|NCT01064687|58872554|FG000|Overall Study|Adverse Event|9|||
30846594|NCT01064687|58872555|FG001|Overall Study|Adverse Event|4|||
30846595|NCT01064687|58872556|FG002|Overall Study|Adverse Event|10|||
30846596|NCT01064687|58872557|FG003|Overall Study|Adverse Event|3|||
30846597|NCT01064687|58872554|FG000|Overall Study|Death|1|||
30846598|NCT01064687|58872555|FG001|Overall Study|Death|1|||
30846599|NCT01064687|58872556|FG002|Overall Study|Death|0|||
30846600|NCT01064687|58872557|FG003|Overall Study|Death|0|||
30846601|NCT01064687|58872554|FG000|Overall Study|Entry Criteria Not Met|3|||
30846602|NCT01064687|58872555|FG001|Overall Study|Entry Criteria Not Met|0|||
30846603|NCT01064687|58872556|FG002|Overall Study|Entry Criteria Not Met|0|||
30846604|NCT01064687|58872557|FG003|Overall Study|Entry Criteria Not Met|0|||
30846605|NCT01064687|58872554|FG000|Overall Study|Lack of Efficacy|1|||
30846606|NCT01064687|58872555|FG001|Overall Study|Lack of Efficacy|0|||
30846607|NCT01064687|58872556|FG002|Overall Study|Lack of Efficacy|2|||
30846608|NCT01064687|58872557|FG003|Overall Study|Lack of Efficacy|3|||
30846609|NCT01064687|58872554|FG000|Overall Study|Lost to Follow-up|7|||
30846610|NCT01064687|58872555|FG001|Overall Study|Lost to Follow-up|10|||
30846611|NCT01064687|58872556|FG002|Overall Study|Lost to Follow-up|13|||
30846612|NCT01064687|58872557|FG003|Overall Study|Lost to Follow-up|5|||
30846613|NCT01064687|58872554|FG000|Overall Study|Physician Decision|2|||
30846614|NCT01064687|58872555|FG001|Overall Study|Physician Decision|2|||
30846615|NCT01064687|58872556|FG002|Overall Study|Physician Decision|0|||
30846616|NCT01064687|58872557|FG003|Overall Study|Physician Decision|0|||
30846617|NCT01064687|58872554|FG000|Overall Study|Protocol Violation|1|||
30846618|NCT01064687|58872555|FG001|Overall Study|Protocol Violation|1|||
30846619|NCT01064687|58872556|FG002|Overall Study|Protocol Violation|0|||
30846620|NCT01064687|58872557|FG003|Overall Study|Protocol Violation|1|||
30846621|NCT01064687|58872554|FG000|Overall Study|Sponsor Decision|0|||
30846622|NCT01064687|58872555|FG001|Overall Study|Sponsor Decision|0|||
30846623|NCT01064687|58872556|FG002|Overall Study|Sponsor Decision|3|||
30846624|NCT01064687|58872557|FG003|Overall Study|Sponsor Decision|0|||
30846625|NCT01064687|58872554|FG000|Overall Study|Withdrawal by Subject|9|||
30846626|NCT01064687|58872555|FG001|Overall Study|Withdrawal by Subject|7|||
30846627|NCT01064687|58872556|FG002|Overall Study|Withdrawal by Subject|12|||
30846628|NCT01064687|58872557|FG003|Overall Study|Withdrawal by Subject|5|||
30846629|NCT01064687|58872554|FG000|Overall Study|Treatment Noncompliance|1|||
30846630|NCT01064687|58872555|FG001|Overall Study|Treatment Noncompliance|1|||
30846631|NCT01064687|58872556|FG002|Overall Study|Treatment Noncompliance|1|||
30846632|NCT01064687|58872557|FG003|Overall Study|Treatment Noncompliance|0|||
30846633|NCT02493946|58872581|FG000|DB Period|Withdrawal by Subject|8|||
30846634|NCT02493946|58872582|FG001|DB Period|Withdrawal by Subject|5|||
30846635|NCT02493946|58872583|FG002|DB Period|Withdrawal by Subject|0|||
30846636|NCT02493946|58872581|FG000|Open Label Period|Withdrawal by Subject|0|||
30846637|NCT02493946|58872582|FG001|Open Label Period|Withdrawal by Subject|0|||
30846638|NCT02493946|58872583|FG002|Open Label Period|Withdrawal by Subject|74|||
30846639|NCT02493946|58872581|FG000|Open Label Period|Adverse Event|0|||
30846640|NCT02493946|58872582|FG001|Open Label Period|Adverse Event|0|||
30949885|NCT01951625|58996494|FG000|Treatment Period|Lost to Follow-up|1|||
30846641|NCT02493946|58872583|FG002|Open Label Period|Adverse Event|4|||
30949886|NCT01951625|58996495|FG001|Treatment Period|Lost to Follow-up|0|||
30846642|NCT02493946|58872581|FG000|Open Label Period|Lost to Follow-up|0|||
30846643|NCT02493946|58872582|FG001|Open Label Period|Lost to Follow-up|0|||
30846644|NCT02493946|58872583|FG002|Open Label Period|Lost to Follow-up|1|||
30846645|NCT02493946|58872581|FG000|Open Label Period|Investigator decision, non-compliance|0|||
30846646|NCT02493946|58872582|FG001|Open Label Period|Investigator decision, non-compliance|0|||
30846647|NCT02493946|58872583|FG002|Open Label Period|Investigator decision, non-compliance|2|||
30846648|NCT02493946|58872581|FG000|Open Label Period|Investigator decision, non-availability|0|||
30846649|NCT02493946|58872582|FG001|Open Label Period|Investigator decision, non-availability|0|||
30846650|NCT02493946|58872583|FG002|Open Label Period|Investigator decision, non-availability|1|||
30846651|NCT02493946|58872581|FG000|Open Label Period|Pregnancy|0|||
30846652|NCT02493946|58872582|FG001|Open Label Period|Pregnancy|0|||
30846653|NCT02493946|58872583|FG002|Open Label Period|Pregnancy|3|||
30846654|NCT02493946|58872581|FG000|Open Label Period|Site error|0|||
30846655|NCT02493946|58872582|FG001|Open Label Period|Site error|0|||
30846656|NCT02493946|58872583|FG002|Open Label Period|Site error|1|||
30846657|NCT01064531|58872593|FG000|Overall Study|Lost to Follow-up|0|||
30846658|NCT01064531|58872594|FG001|Overall Study|Lost to Follow-up|2|||
30846659|NCT01064531|58872593|FG000|Overall Study|Physician Decision|0|||
30846660|NCT01064531|58872594|FG001|Overall Study|Physician Decision|1|||
30846661|NCT01064531|58872593|FG000|Overall Study|Withdrawal by Subject|2|||
30846662|NCT01064531|58872594|FG001|Overall Study|Withdrawal by Subject|2|||
30846663|NCT01064531|58872593|FG000|Overall Study|Revision due to femoral stem loosening|1|||
30846664|NCT01064531|58872594|FG001|Overall Study|Revision due to femoral stem loosening|0|||
30846665|NCT01064531|58872593|FG000|Overall Study|Revision due to dislocation|0|||
30846666|NCT01064531|58872594|FG001|Overall Study|Revision due to dislocation|1|||
30846667|NCT01064531|58872593|FG000|Overall Study|Death|0|||
30846668|NCT01064531|58872594|FG001|Overall Study|Death|1|||
30846669|NCT02220855|58872600|FG000|Overall Study|Adverse Event|8|||
30846670|NCT02220855|58872600|FG000|Overall Study|Disease Progression|5|||
30846671|NCT02220855|58872600|FG000|Overall Study|Withdrawal by Subject|1|||
30846672|NCT02918279|58872606|FG000|Overall Study|Lost to Follow-up|3|||
30846673|NCT02918279|58872607|FG001|Overall Study|Lost to Follow-up|6|||
30846674|NCT02918279|58872606|FG000|Overall Study|Withdrawal by Subject|5|||
30846675|NCT02918279|58872607|FG001|Overall Study|Withdrawal by Subject|15|||
30846676|NCT02918279|58872606|FG000|Overall Study|Withdrawal by parent/guardian|2|||
30762508|NCT00048542|58771310|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
30762509|NCT00048542|58771303|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
30762510|NCT00048542|58771304|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
30762511|NCT00048542|58771305|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
30762512|NCT00048542|58771306|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
30762513|NCT00048542|58771307|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
30762514|NCT00048542|58771308|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
30762515|NCT00048542|58771309|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
30762516|NCT00048542|58771310|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
30762517|NCT00048542|58771303|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
30762518|NCT00048542|58771304|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
30762519|NCT00048542|58771305|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
30846677|NCT02918279|58872607|FG001|Overall Study|Withdrawal by parent/guardian|1|||
30846678|NCT02918279|58872606|FG000|Overall Study|Other|3|||
30846679|NCT02918279|58872607|FG001|Overall Study|Other|1|||
30846680|NCT02956837|58872617|FG000|Overall Study|Serious Adverse Events|0|||
30846681|NCT02956837|58872618|FG001|Overall Study|Serious Adverse Events|1|||
30846682|NCT02956837|58872619|FG002|Overall Study|Serious Adverse Events|0|||
30846683|NCT02956837|58872620|FG003|Overall Study|Serious Adverse Events|0|||
30846684|NCT02956837|58872617|FG000|Overall Study|Withdrawal by Subject|0|||
30846685|NCT02956837|58872618|FG001|Overall Study|Withdrawal by Subject|1|||
30846686|NCT02956837|58872619|FG002|Overall Study|Withdrawal by Subject|0|||
30846687|NCT02956837|58872620|FG003|Overall Study|Withdrawal by Subject|3|||
30846688|NCT02956837|58872617|FG000|Overall Study|Lost to Follow-up|0|||
30846689|NCT02956837|58872618|FG001|Overall Study|Lost to Follow-up|1|||
30846690|NCT02956837|58872619|FG002|Overall Study|Lost to Follow-up|2|||
30846691|NCT02956837|58872620|FG003|Overall Study|Lost to Follow-up|0|||
30846692|NCT01063595|58872633|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
30846693|NCT01063595|58872634|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
30846694|NCT01063595|58872633|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
30846695|NCT01063595|58872634|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
30846696|NCT01063595|58872633|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
30846697|NCT01063595|58872634|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
30846698|NCT01063595|58872633|FG000|First Intervention|Adverse Event|1|||
30846699|NCT01063595|58872634|FG001|First Intervention|Adverse Event|4|||
30846700|NCT01063595|58872633|FG000|First Intervention|Withdrawal by Subject|1|||
30846701|NCT01063595|58872634|FG001|First Intervention|Withdrawal by Subject|0|||
30846702|NCT01063595|58872633|FG000|First Intervention|Reason not Specified|0|||
30846703|NCT01063595|58872634|FG001|First Intervention|Reason not Specified|1|||
30846704|NCT01063283|58872642|FG000|Cycle 1|Adverse Event|2|||
30846705|NCT01063283|58872643|FG001|Cycle 1|Adverse Event|0|||
30846706|NCT01063283|58872644|FG002|Cycle 1|Adverse Event|0|||
30762520|NCT00048542|58771306|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
30846707|NCT01063283|58872642|FG000|Cycle 1|Technical failure in data collection|1|||
30846708|NCT01063283|58872643|FG001|Cycle 1|Technical failure in data collection|0|||
30846709|NCT01063283|58872644|FG002|Cycle 1|Technical failure in data collection|0|||
30846710|NCT01062971|58872652|FG000|Overall Study|Protocol Violation|1|||
30846711|NCT01062971|58872653|FG001|Overall Study|Protocol Violation|3|||
30762521|NCT00048542|58771307|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
30846712|NCT01062971|58872652|FG000|Overall Study|Lost to Follow-up|3|||
30846713|NCT01062971|58872653|FG001|Overall Study|Lost to Follow-up|4|||
30762522|NCT00048542|58771308|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
30762523|NCT00048542|58771309|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
30762524|NCT00048542|58771310|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
30762525|NCT00048542|58771303|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
30762526|NCT00048542|58771304|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
30762527|NCT00048542|58771305|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
30762528|NCT00048542|58771306|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
30762529|NCT00048542|58771307|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
30762530|NCT00048542|58771308|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
30762531|NCT00048542|58771309|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
30762532|NCT00048542|58771310|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
30762533|NCT00048542|58771303|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
30762534|NCT00048542|58771304|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
30762535|NCT00048542|58771305|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
30762536|NCT00048542|58771306|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
30762537|NCT00048542|58771307|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
30762538|NCT00048542|58771308|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
30762539|NCT00048542|58771309|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
30762540|NCT00048542|58771310|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
30762541|NCT00048542|58771303|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
30762542|NCT00048542|58771304|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
30762543|NCT00048542|58771305|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
30762544|NCT00048542|58771306|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
30762545|NCT00048542|58771307|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
30762546|NCT00048542|58771308|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
30762547|NCT00048542|58771309|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
30762548|NCT00048542|58771310|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
30762549|NCT00048542|58771303|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
30762550|NCT00048542|58771304|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
30762551|NCT00048542|58771305|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
30762552|NCT00048542|58771306|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
30762553|NCT00048542|58771307|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
30762554|NCT00048542|58771308|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
30762555|NCT00048542|58771309|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
30762556|NCT00048542|58771310|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
30762557|NCT00048542|58771303|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
30846714|NCT01348165|58872666|FG000|Overall Study|Adverse Event|0|||
30846715|NCT01348165|58872667|FG001|Overall Study|Adverse Event|0|||
30846716|NCT01348165|58872668|FG002|Overall Study|Adverse Event|0|||
30846717|NCT01348165|58872669|FG003|Overall Study|Adverse Event|0|||
30846718|NCT01348165|58872670|FG004|Overall Study|Adverse Event|0|||
30846719|NCT01348165|58872671|FG005|Overall Study|Adverse Event|0|||
30846720|NCT01348165|58872672|FG006|Overall Study|Adverse Event|1|||
30846721|NCT02493868|58872692|FG000|Induction Phase: DE Participants|Adverse Event|22|||
30846722|NCT02493868|58872693|FG001|Induction Phase: DE Participants|Adverse Event|0|||
30846723|NCT02493868|58872692|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
30846724|NCT02493868|58872693|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
30846725|NCT02493868|58872692|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
30846726|NCT02493868|58872693|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
30846727|NCT02493868|58872692|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
30846728|NCT02493868|58872693|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
30846729|NCT02493868|58872692|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
30846730|NCT02493868|58872693|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
30846731|NCT02493868|58872692|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
30846732|NCT02493868|58872693|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
30846733|NCT02493868|58872692|FG000|Induction Phase: DE Participants|Other|8|||
30846734|NCT02493868|58872693|FG001|Induction Phase: DE Participants|Other|0|||
30846735|NCT02493868|58872692|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
30846736|NCT02493868|58872693|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
30846737|NCT02493868|58872692|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
30762558|NCT00048542|58771304|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
30762559|NCT00048542|58771305|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
30762560|NCT00048542|58771306|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
30762561|NCT00048542|58771307|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
30762562|NCT00048542|58771308|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
30762563|NCT00048542|58771309|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
30762564|NCT00048542|58771310|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
30762565|NCT00048542|58771303|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
30762566|NCT00048542|58771304|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
30762567|NCT00048542|58771305|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
30762568|NCT00048542|58771306|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
30762569|NCT00048542|58771307|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
30762570|NCT00048542|58771308|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
30762571|NCT00048542|58771309|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
30762572|NCT00048542|58771310|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
30762573|NCT00048542|58771303|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
30762574|NCT00048542|58771304|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
30762575|NCT00048542|58771305|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
30762576|NCT00048542|58771306|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
30762577|NCT00048542|58771307|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
30762578|NCT00048542|58771308|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
30762579|NCT00048542|58771309|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
30762580|NCT00048542|58771310|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
30762581|NCT03814590|58771353|FG000|Overall Study|Adverse Event|0|||
30762582|NCT03814590|58771354|FG001|Overall Study|Adverse Event|0|||
30762583|NCT03814590|58771355|FG002|Overall Study|Adverse Event|0|||
30762584|NCT03814590|58771356|FG003|Overall Study|Adverse Event|0|||
30762585|NCT03814590|58771357|FG004|Overall Study|Adverse Event|0|||
30762586|NCT03814590|58771358|FG005|Overall Study|Adverse Event|1|||
30762587|NCT03814590|58771359|FG006|Overall Study|Adverse Event|1|||
30762588|NCT03814590|58771360|FG007|Overall Study|Adverse Event|1|||
30762589|NCT03814590|58771361|FG008|Overall Study|Adverse Event|0|||
30762590|NCT03814590|58771362|FG009|Overall Study|Adverse Event|0|||
30762591|NCT03814590|58771363|FG010|Overall Study|Adverse Event|1|||
30762592|NCT03814590|58771364|FG011|Overall Study|Adverse Event|0|||
30762593|NCT03814590|58771365|FG012|Overall Study|Adverse Event|3|||
30762594|NCT03814590|58771366|FG013|Overall Study|Adverse Event|0|||
30762595|NCT03814590|58771353|FG000|Overall Study|Lost to Follow-up|0|||
30762596|NCT03814590|58771354|FG001|Overall Study|Lost to Follow-up|2|||
30762597|NCT03814590|58771355|FG002|Overall Study|Lost to Follow-up|1|||
30762598|NCT03814590|58771356|FG003|Overall Study|Lost to Follow-up|0|||
30762599|NCT03814590|58771357|FG004|Overall Study|Lost to Follow-up|1|||
30762600|NCT03814590|58771358|FG005|Overall Study|Lost to Follow-up|1|||
30762601|NCT03814590|58771359|FG006|Overall Study|Lost to Follow-up|1|||
30762602|NCT03814590|58771360|FG007|Overall Study|Lost to Follow-up|1|||
30762603|NCT03814590|58771361|FG008|Overall Study|Lost to Follow-up|0|||
30762604|NCT03814590|58771362|FG009|Overall Study|Lost to Follow-up|0|||
30762605|NCT03814590|58771363|FG010|Overall Study|Lost to Follow-up|1|||
30762606|NCT03814590|58771364|FG011|Overall Study|Lost to Follow-up|0|||
30762607|NCT03814590|58771365|FG012|Overall Study|Lost to Follow-up|0|||
30762608|NCT03814590|58771366|FG013|Overall Study|Lost to Follow-up|1|||
30762609|NCT03814590|58771353|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30762610|NCT03814590|58771354|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30762611|NCT03814590|58771355|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30762612|NCT03814590|58771356|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30762613|NCT03814590|58771357|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30762614|NCT03814590|58771358|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30762615|NCT03814590|58771359|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30762616|NCT03814590|58771360|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30762617|NCT03814590|58771361|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30846738|NCT02493868|58872693|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
30949887|NCT01951625|58996496|FG002|Treatment Period|Lost to Follow-up|0|||
30949888|NCT01951625|58996497|FG003|Treatment Period|Lost to Follow-up|1|||
30762618|NCT03814590|58771362|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
30762619|NCT03814590|58771363|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30846739|NCT02493868|58872692|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
30762620|NCT03814590|58771364|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30949889|NCT01951625|58996498|FG004|Treatment Period|Lost to Follow-up|0|||
30949890|NCT01951625|58996494|FG000|Follow Up Period|Non-compliance with study drug|1|||
30762621|NCT03814590|58771365|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30762622|NCT03814590|58771366|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
30762623|NCT03814590|58771353|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
30762624|NCT03814590|58771354|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
30762625|NCT03814590|58771355|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
30762626|NCT03814590|58771356|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
30762627|NCT03814590|58771357|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
30949891|NCT01951625|58996495|FG001|Follow Up Period|Non-compliance with study drug|0|||
30949892|NCT01951625|58996496|FG002|Follow Up Period|Non-compliance with study drug|0|||
30949893|NCT01951625|58996497|FG003|Follow Up Period|Non-compliance with study drug|0|||
30949894|NCT01951625|58996498|FG004|Follow Up Period|Non-compliance with study drug|0|||
30949895|NCT01951625|58996494|FG000|Follow Up Period|Death|1|||
30762628|NCT03814590|58771358|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
30762629|NCT03814590|58771359|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
30762630|NCT03814590|58771360|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
30762631|NCT03814590|58771361|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
30762632|NCT03814590|58771362|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
30762633|NCT03814590|58771363|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
30762634|NCT03814590|58771364|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
30762635|NCT03814590|58771365|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
30762636|NCT03814590|58771366|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
30762637|NCT03814590|58771353|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762638|NCT03814590|58771354|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762639|NCT03814590|58771355|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762640|NCT03814590|58771356|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762641|NCT03814590|58771357|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762642|NCT03814590|58771358|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762643|NCT03814590|58771359|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762644|NCT03814590|58771360|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
30762645|NCT03814590|58771361|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762646|NCT03814590|58771362|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
30762647|NCT03814590|58771363|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762648|NCT03814590|58771364|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762649|NCT03814590|58771365|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762650|NCT03814590|58771366|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30762651|NCT03814590|58771353|FG000|Overall Study|UNKNOWN REASON|0|||
30762652|NCT03814590|58771354|FG001|Overall Study|UNKNOWN REASON|0|||
30762653|NCT03814590|58771355|FG002|Overall Study|UNKNOWN REASON|0|||
30762654|NCT03814590|58771356|FG003|Overall Study|UNKNOWN REASON|0|||
30762655|NCT03814590|58771357|FG004|Overall Study|UNKNOWN REASON|0|||
30762656|NCT03814590|58771358|FG005|Overall Study|UNKNOWN REASON|0|||
30762657|NCT03814590|58771359|FG006|Overall Study|UNKNOWN REASON|0|||
30762658|NCT03814590|58771360|FG007|Overall Study|UNKNOWN REASON|1|||
30762659|NCT03814590|58771361|FG008|Overall Study|UNKNOWN REASON|0|||
30762660|NCT03814590|58771362|FG009|Overall Study|UNKNOWN REASON|0|||
30762661|NCT03814590|58771363|FG010|Overall Study|UNKNOWN REASON|0|||
30762662|NCT03814590|58771364|FG011|Overall Study|UNKNOWN REASON|0|||
30762663|NCT03814590|58771365|FG012|Overall Study|UNKNOWN REASON|0|||
30762664|NCT03814590|58771366|FG013|Overall Study|UNKNOWN REASON|0|||
30762665|NCT00048074|58771409|FG000|Overall Study|Adverse Event|46|||
30762666|NCT00048074|58771410|FG001|Overall Study|Adverse Event|41|||
30762667|NCT00048074|58771411|FG002|Overall Study|Adverse Event|53|||
30762668|NCT00048074|58771409|FG000|Overall Study|Death|3|||
30762669|NCT00048074|58771410|FG001|Overall Study|Death|3|||
30762670|NCT00048074|58771411|FG002|Overall Study|Death|2|||
30762671|NCT00048074|58771409|FG000|Overall Study|Lost to Follow-up|2|||
30762672|NCT00048074|58771410|FG001|Overall Study|Lost to Follow-up|6|||
30762673|NCT00048074|58771411|FG002|Overall Study|Lost to Follow-up|6|||
30762674|NCT00048074|58771409|FG000|Overall Study|Withdrawal by Subject|28|||
30762675|NCT00048074|58771410|FG001|Overall Study|Withdrawal by Subject|30|||
30762676|NCT00048074|58771411|FG002|Overall Study|Withdrawal by Subject|35|||
30762677|NCT00048074|58771409|FG000|Overall Study|Protocol Violation|1|||
30762678|NCT00048074|58771410|FG001|Overall Study|Protocol Violation|3|||
30762679|NCT00048074|58771411|FG002|Overall Study|Protocol Violation|0|||
30762680|NCT00048074|58771409|FG000|Overall Study|Study participation was terminated|0|||
30949896|NCT01951625|58996495|FG001|Follow Up Period|Death|3|||
30949897|NCT01951625|58996496|FG002|Follow Up Period|Death|2|||
30949898|NCT01951625|58996497|FG003|Follow Up Period|Death|2|||
30949899|NCT01951625|58996498|FG004|Follow Up Period|Death|1|||
30846740|NCT02493868|58872693|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
30846741|NCT02493868|58872692|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
30846742|NCT02493868|58872693|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
30846743|NCT02493868|58872692|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
30846744|NCT02493868|58872693|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
30846745|NCT02493868|58872692|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
30846746|NCT02493868|58872693|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
30626129|NCT01103466|58638185|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
30626130|NCT01103466|58638183|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
30626131|NCT01103466|58638184|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
30626132|NCT01103466|58638185|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
30626133|NCT00945945|58638195|FG000|Overall Study|Adverse Event|15|||
30626134|NCT00945945|58638196|FG001|Overall Study|Adverse Event|35|||
30626135|NCT00945945|58638195|FG000|Overall Study|Withdrawal by Subject|7|||
30626136|NCT00945945|58638196|FG001|Overall Study|Withdrawal by Subject|10|||
30626137|NCT00945945|58638195|FG000|Overall Study|Lost to Follow-up|4|||
30626138|NCT00945945|58638196|FG001|Overall Study|Lost to Follow-up|5|||
30626139|NCT00945945|58638195|FG000|Overall Study|Lack of Efficacy|6|||
30626140|NCT00945945|58638196|FG001|Overall Study|Lack of Efficacy|2|||
30626141|NCT00945945|58638195|FG000|Overall Study|Protocol Violation|4|||
30626142|NCT00945945|58638196|FG001|Overall Study|Protocol Violation|2|||
30626143|NCT00945945|58638195|FG000|Overall Study|Entry Criteria Not Met|0|||
30626144|NCT00945945|58638196|FG001|Overall Study|Entry Criteria Not Met|1|||
30626145|NCT01203956|58638202|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
30626146|NCT01203956|58638203|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
30626147|NCT01103232|58638212|FG000|Overall Study|Withdrawal by Subject|1|||
30626148|NCT01103232|58638213|FG001|Overall Study|Withdrawal by Subject|1|||
30626149|NCT01103232|58638212|FG000|Overall Study|Protocol Violation|0|||
30626150|NCT01103232|58638213|FG001|Overall Study|Protocol Violation|1|||
30626151|NCT01112982|58638219|FG000|Overall Study|Withdrawal by Subject|1|||
30626152|NCT01112982|58638219|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
30626153|NCT01203878|58638229|FG000|Overall Study|Withdrawal by Subject|0|||
30626154|NCT01203878|58638230|FG001|Overall Study|Withdrawal by Subject|0|||
30626155|NCT01203878|58638231|FG002|Overall Study|Withdrawal by Subject|1|||
30626156|NCT01203878|58638229|FG000|Overall Study|Adverse Event|0|||
30626157|NCT01203878|58638230|FG001|Overall Study|Adverse Event|0|||
30626158|NCT01203878|58638231|FG002|Overall Study|Adverse Event|2|||
30626159|NCT01112514|58638238|FG000|Overall Study|Lost to Follow-up|1|||
30626160|NCT01203098|58638245|FG000|Overall Study|Adverse Event|3|||
30626161|NCT01203098|58638246|FG001|Overall Study|Adverse Event|1|||
30626162|NCT01203098|58638247|FG002|Overall Study|Adverse Event|7|||
30626163|NCT01203098|58638245|FG000|Overall Study|Lost to Follow-up|0|||
30626164|NCT01203098|58638246|FG001|Overall Study|Lost to Follow-up|0|||
30626165|NCT01203098|58638247|FG002|Overall Study|Lost to Follow-up|1|||
30626166|NCT01203098|58638245|FG000|Overall Study|Physician Decision|2|||
30626167|NCT01203098|58638246|FG001|Overall Study|Physician Decision|2|||
30626168|NCT01203098|58638247|FG002|Overall Study|Physician Decision|0|||
30626169|NCT01203098|58638245|FG000|Overall Study|Withdrawal by Subject|1|||
30626170|NCT01203098|58638246|FG001|Overall Study|Withdrawal by Subject|1|||
30626171|NCT01203098|58638247|FG002|Overall Study|Withdrawal by Subject|3|||
30626172|NCT00945555|58638255|FG000|Overall Study|Referred to another hospital|5|||
30626173|NCT00945555|58638255|FG000|Overall Study|Worsening condition, intensive care unit|1|||
30626174|NCT00945555|58638255|FG000|Overall Study|Withdrawal by Subject|2|||
30626175|NCT00945555|58638255|FG000|Overall Study|Participant continued treatment at home|1|||
30626176|NCT00945555|58638255|FG000|Overall Study|Death|18|||
30626177|NCT00945555|58638255|FG000|Overall Study|Other|1|||
30626178|NCT01108458|58638259|FG000|Overall Study|Withdrawal by Subject|1|||
30626179|NCT01108068|58638265|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
30626180|NCT01108068|58638266|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
30626181|NCT01201850|58638273|FG000|Overall Study|Tumor progression|4|||
30626182|NCT00951171|58638279|FG000|Overall Study|Adverse Event|2|||
30626183|NCT00951171|58638280|FG001|Overall Study|Adverse Event|0|||
30626184|NCT01200992|58638288|FG000|Overall Study|Study terminated early|35|||
30626185|NCT01200992|58638289|FG001|Overall Study|Study terminated early|41|||
30626186|NCT01200992|58638288|FG000|Overall Study|Randomized but not treated|2|||
30626187|NCT01200992|58638289|FG001|Overall Study|Randomized but not treated|0|||
30626188|NCT00878215|58638301|FG000|Overall Study|Determined to be ineligible|0|||
30626189|NCT00878215|58638302|FG001|Overall Study|Determined to be ineligible|10|||
30626190|NCT00878215|58638303|FG002|Overall Study|Determined to be ineligible|0|||
30626191|NCT00878215|58638304|FG003|Overall Study|Determined to be ineligible|0|||
30626192|NCT01200758|58638316|FG000|Stage I|Death|0|||
30626193|NCT01200758|58638317|FG001|Stage I|Death|1|||
30626194|NCT01200758|58638318|FG002|Stage I|Death|0|||
30626195|NCT01200758|58638319|FG003|Stage I|Death|0|||
30626196|NCT01200758|58638316|FG000|Stage I|Physician Decision|1|||
30762681|NCT00048074|58771410|FG001|Overall Study|Study participation was terminated|1|||
30762682|NCT00048074|58771411|FG002|Overall Study|Study participation was terminated|0|||
30762683|NCT00048074|58771409|FG000|Overall Study|Husband ill|0|||
30762684|NCT00048074|58771410|FG001|Overall Study|Husband ill|1|||
30762685|NCT00048074|58771411|FG002|Overall Study|Husband ill|0|||
30762686|NCT00048074|58771409|FG000|Overall Study|Poor compliance|0|||
30762687|NCT00048074|58771410|FG001|Overall Study|Poor compliance|1|||
30762688|NCT00048074|58771411|FG002|Overall Study|Poor compliance|0|||
30762689|NCT00048074|58771409|FG000|Overall Study|Out of station|0|||
30762690|NCT00048074|58771410|FG001|Overall Study|Out of station|1|||
30762691|NCT00048074|58771411|FG002|Overall Study|Out of station|1|||
30762692|NCT00048074|58771409|FG000|Overall Study|Social reasons|1|||
30762693|NCT00048074|58771410|FG001|Overall Study|Social reasons|0|||
30762694|NCT00048074|58771411|FG002|Overall Study|Social reasons|0|||
30762695|NCT03831191|58771423|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
30762696|NCT03831191|58771424|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
30626197|NCT01200758|58638317|FG001|Stage I|Physician Decision|1|||
30762697|NCT03831191|58771425|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
30762698|NCT03831191|58771426|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
30762699|NCT03831191|58771427|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
30762700|NCT03831191|58771428|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
30846747|NCT02493868|58872692|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
30846748|NCT02493868|58872693|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
30846749|NCT02493868|58872692|FG000|Optimization Phase: DE+TE Participants|Other|10|||
30846750|NCT02493868|58872693|FG001|Optimization Phase: DE+TE Participants|Other|2|||
30846751|NCT02493868|58872692|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
30846752|NCT02493868|58872693|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
30846753|NCT02493868|58872692|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
30846754|NCT02493868|58872693|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
30846755|NCT02493868|58872692|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
30846756|NCT02493868|58872693|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
30846757|NCT02493868|58872692|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
30846758|NCT02493868|58872693|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
30846759|NCT02493868|58872692|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
30846760|NCT02493868|58872693|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
30846761|NCT02493868|58872692|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
30846762|NCT02493868|58872693|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
30846763|NCT02493868|58872692|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
30846764|NCT02493868|58872693|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
30846765|NCT02493868|58872692|FG000|Follow-up Phase|Lost to Follow-up|1|||
30846766|NCT02493868|58872693|FG001|Follow-up Phase|Lost to Follow-up|0|||
30846767|NCT02493868|58872692|FG000|Follow-up Phase|Withdrawal by Subject|3|||
30846768|NCT02493868|58872693|FG001|Follow-up Phase|Withdrawal by Subject|0|||
30846769|NCT02493868|58872692|FG000|Follow-up Phase|Investigator Decision|5|||
30846770|NCT02493868|58872693|FG001|Follow-up Phase|Investigator Decision|1|||
30846771|NCT02493868|58872692|FG000|Follow-up Phase|Other|2|||
30846772|NCT02493868|58872693|FG001|Follow-up Phase|Other|1|||
30846773|NCT02516410|58872707|FG000|Overall Study|Adverse Event|0|||
30846774|NCT02516410|58872708|FG001|Overall Study|Adverse Event|1|||
30846775|NCT02516410|58872707|FG000|Overall Study|Withdrawal by Subject|0|||
30846776|NCT02516410|58872708|FG001|Overall Study|Withdrawal by Subject|1|||
30846777|NCT02493712|58872718|FG000|Overall Study|Withdrawal by Subject|1|||
30846778|NCT02493712|58872719|FG001|Overall Study|Withdrawal by Subject|0|||
30762701|NCT03831191|58771429|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
30762702|NCT03831191|58771430|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
30762703|NCT03831191|58771431|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
30762704|NCT03831191|58771432|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
30762705|NCT03831191|58771433|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
30762706|NCT03831191|58771434|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
30762707|NCT03831191|58771435|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
30846779|NCT02493712|58872720|FG002|Overall Study|Withdrawal by Subject|2|||
30846780|NCT02493712|58872718|FG000|Overall Study|Protocol Violation|0|||
30846781|NCT02493712|58872719|FG001|Overall Study|Protocol Violation|0|||
30846782|NCT02493712|58872720|FG002|Overall Study|Protocol Violation|1|||
30846783|NCT02493712|58872718|FG000|Overall Study|Lost to Follow-up|1|||
30846784|NCT02493712|58872719|FG001|Overall Study|Lost to Follow-up|0|||
30846785|NCT02493712|58872720|FG002|Overall Study|Lost to Follow-up|0|||
30846786|NCT02493712|58872718|FG000|Overall Study|Physician Decision|0|||
30846787|NCT02493712|58872719|FG001|Overall Study|Physician Decision|1|||
30846788|NCT02493712|58872720|FG002|Overall Study|Physician Decision|0|||
30846789|NCT02493712|58872718|FG000|Overall Study|Lack of Efficacy|0|||
30846790|NCT02493712|58872719|FG001|Overall Study|Lack of Efficacy|5|||
30846791|NCT02493712|58872720|FG002|Overall Study|Lack of Efficacy|3|||
30846792|NCT02516332|58872731|FG000|Overall Study|Withdrawal by Subject|2|||
30846793|NCT02516332|58872732|FG001|Overall Study|Withdrawal by Subject|1|||
30846794|NCT02516332|58872733|FG002|Overall Study|Withdrawal by Subject|2|||
30846795|NCT02483572|58872743|FG000|Overall Study|Withdrawal by Subject|1|||
30846796|NCT02483572|58872744|FG001|Overall Study|Withdrawal by Subject|0|||
30846797|NCT02483572|58872743|FG000|Overall Study|Lost to Follow-up|1|||
30846798|NCT02483572|58872744|FG001|Overall Study|Lost to Follow-up|0|||
30846799|NCT02483572|58872743|FG000|Overall Study|Physician Decision|0|||
30846800|NCT02483572|58872744|FG001|Overall Study|Physician Decision|1|||
30846801|NCT01062425|58872752|FG000|Overall Study|Protocol Violation|3|||
30846802|NCT01062425|58872753|FG001|Overall Study|Protocol Violation|6|||
30846803|NCT01060553|58872759|FG000|Overall Study|Lost to Follow-up|3|||
30846804|NCT01060553|58872760|FG001|Overall Study|Lost to Follow-up|5|||
30846805|NCT01060553|58872759|FG000|Overall Study|Withdrawal by Subject|5|||
30846806|NCT01060553|58872760|FG001|Overall Study|Withdrawal by Subject|5|||
30846807|NCT01060553|58872759|FG000|Overall Study|Lack of Efficacy|1|||
30846808|NCT01060553|58872760|FG001|Overall Study|Lack of Efficacy|0|||
30846809|NCT02491684|58872767|FG000|Treatment Phase|Adverse Event|2|||
30846810|NCT02491684|58872768|FG001|Treatment Phase|Adverse Event|2|||
30846811|NCT02491684|58872767|FG000|Treatment Phase|Incorrect randomisation|1|||
30846812|NCT02491684|58872768|FG001|Treatment Phase|Incorrect randomisation|0|||
30846813|NCT02491684|58872767|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
30846814|NCT02491684|58872768|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
30846815|NCT01061723|58872780|FG000|Overall Study|Adverse Event|0|||
30846816|NCT01061723|58872781|FG001|Overall Study|Adverse Event|2|||
30846817|NCT01061723|58872782|FG002|Overall Study|Adverse Event|5|||
30846818|NCT01061723|58872783|FG003|Overall Study|Adverse Event|5|||
30846819|NCT01061723|58872784|FG004|Overall Study|Adverse Event|2|||
30846820|NCT01061723|58872785|FG005|Overall Study|Adverse Event|6|||
30762708|NCT03831191|58771436|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
30762709|NCT03831191|58771437|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
30762710|NCT03831191|58771423|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
30762711|NCT03831191|58771424|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
30846821|NCT01061723|58872780|FG000|Overall Study|Lack of Efficacy|2|||
30846822|NCT01061723|58872781|FG001|Overall Study|Lack of Efficacy|3|||
30846823|NCT01061723|58872782|FG002|Overall Study|Lack of Efficacy|4|||
30846824|NCT01061723|58872783|FG003|Overall Study|Lack of Efficacy|2|||
30846825|NCT01061723|58872784|FG004|Overall Study|Lack of Efficacy|1|||
30846826|NCT01061723|58872785|FG005|Overall Study|Lack of Efficacy|1|||
30846827|NCT01061723|58872780|FG000|Overall Study|Randomized but not treated|0|||
30846828|NCT01061723|58872781|FG001|Overall Study|Randomized but not treated|0|||
30846829|NCT01061723|58872782|FG002|Overall Study|Randomized but not treated|0|||
30846830|NCT01061723|58872783|FG003|Overall Study|Randomized but not treated|0|||
30949900|NCT01951625|58996494|FG000|Follow Up Period|Logistical difficulties|1|||
30949901|NCT01951625|58996495|FG001|Follow Up Period|Logistical difficulties|2|||
30949902|NCT01951625|58996496|FG002|Follow Up Period|Logistical difficulties|0|||
30949903|NCT01951625|58996497|FG003|Follow Up Period|Logistical difficulties|0|||
30949904|NCT01951625|58996498|FG004|Follow Up Period|Logistical difficulties|0|||
30949905|NCT01951625|58996494|FG000|Follow Up Period|Adverse Event|0|||
30949906|NCT01951625|58996495|FG001|Follow Up Period|Adverse Event|3|||
30949907|NCT01951625|58996496|FG002|Follow Up Period|Adverse Event|2|||
30949908|NCT01951625|58996497|FG003|Follow Up Period|Adverse Event|3|||
30949909|NCT01951625|58996498|FG004|Follow Up Period|Adverse Event|5|||
30949910|NCT01951625|58996494|FG000|Follow Up Period|Withdrawal by Subject|4|||
30949911|NCT01951625|58996495|FG001|Follow Up Period|Withdrawal by Subject|1|||
30949912|NCT01951625|58996496|FG002|Follow Up Period|Withdrawal by Subject|0|||
30949913|NCT01951625|58996497|FG003|Follow Up Period|Withdrawal by Subject|5|||
30949914|NCT01951625|58996498|FG004|Follow Up Period|Withdrawal by Subject|3|||
30949915|NCT01951625|58996494|FG000|Follow Up Period|Lost to Follow-up|1|||
30949916|NCT01951625|58996495|FG001|Follow Up Period|Lost to Follow-up|0|||
30949917|NCT01951625|58996496|FG002|Follow Up Period|Lost to Follow-up|0|||
30949918|NCT01951625|58996497|FG003|Follow Up Period|Lost to Follow-up|1|||
30949919|NCT01951625|58996498|FG004|Follow Up Period|Lost to Follow-up|1|||
30949920|NCT04400890|58996513|FG000|Overall Study|Withdrawal by Subject|3|||
30949921|NCT04400890|58996514|FG001|Overall Study|Withdrawal by Subject|2|||
30949922|NCT01936649|58996520|FG000|Overall Study|Withdrawal by Subject|4|||
30949923|NCT01936649|58996520|FG000|Overall Study|Physician Decision|2|||
30949924|NCT01936649|58996520|FG000|Overall Study|Protocol Violation|2|||
30949925|NCT01936649|58996520|FG000|Overall Study|Other than specified above|5|||
30949926|NCT01720069|58996527|FG000|Overall Study|Could not use e-diary correctly|0|||
30846831|NCT01061723|58872784|FG004|Overall Study|Randomized but not treated|0|||
30846832|NCT01061723|58872785|FG005|Overall Study|Randomized but not treated|1|||
30846833|NCT01061723|58872780|FG000|Overall Study|Other than specified above|2|||
30846834|NCT01061723|58872781|FG001|Overall Study|Other than specified above|1|||
30846835|NCT01061723|58872782|FG002|Overall Study|Other than specified above|1|||
30846836|NCT01061723|58872783|FG003|Overall Study|Other than specified above|1|||
30846837|NCT01061723|58872784|FG004|Overall Study|Other than specified above|0|||
30846838|NCT01061723|58872785|FG005|Overall Study|Other than specified above|1|||
30846839|NCT01061567|58872804|FG000|Overall Study|Adverse Event|32|||
30846840|NCT01061567|58872804|FG000|Overall Study|Death|2|||
30846841|NCT01061567|58872804|FG000|Overall Study|Lack of Efficacy|3|||
30846842|NCT01061567|58872804|FG000|Overall Study|Lost to Follow-up|24|||
30846843|NCT01061567|58872804|FG000|Overall Study|Protocol Violation|1|||
30846844|NCT01061567|58872804|FG000|Overall Study|Withdrawal by Subject|11|||
30846845|NCT01061567|58872804|FG000|Overall Study|Other reason than stated above|3|||
30846846|NCT01061333|58872808|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
30846847|NCT01061333|58872809|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
30846848|NCT02489968|58872822|FG000|Open-label Treatment Period|Adverse Event|14|||
30846849|NCT02489968|58872823|FG001|Open-label Treatment Period|Adverse Event|7|||
30846850|NCT02489968|58872824|FG002|Open-label Treatment Period|Adverse Event|0|||
30846851|NCT02489968|58872825|FG003|Open-label Treatment Period|Adverse Event|0|||
30846852|NCT02489968|58872826|FG004|Open-label Treatment Period|Adverse Event|0|||
30846853|NCT02489968|58872827|FG005|Open-label Treatment Period|Adverse Event|0|||
30626198|NCT01200758|58638318|FG002|Stage I|Physician Decision|0|||
30846854|NCT02489968|58872822|FG000|Open-label Treatment Period|Protocol Violation|2|||
30846855|NCT02489968|58872823|FG001|Open-label Treatment Period|Protocol Violation|2|||
30846856|NCT02489968|58872824|FG002|Open-label Treatment Period|Protocol Violation|0|||
30949927|NCT01720069|58996528|FG001|Overall Study|Could not use e-diary correctly|1|||
30949928|NCT01720069|58996529|FG002|Overall Study|Could not use e-diary correctly|1|||
30949929|NCT01720069|58996527|FG000|Overall Study|Randomised without baseline values|0|||
30949930|NCT01720069|58996528|FG001|Overall Study|Randomised without baseline values|0|||
30949931|NCT01720069|58996529|FG002|Overall Study|Randomised without baseline values|1|||
30626199|NCT01200758|58638319|FG003|Stage I|Physician Decision|0|||
30626200|NCT01200758|58638316|FG000|Stage I|Lack of Efficacy|2|||
30846857|NCT02489968|58872825|FG003|Open-label Treatment Period|Protocol Violation|0|||
30846858|NCT02489968|58872826|FG004|Open-label Treatment Period|Protocol Violation|0|||
30846859|NCT02489968|58872827|FG005|Open-label Treatment Period|Protocol Violation|0|||
30846860|NCT02489968|58872822|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
30846861|NCT02489968|58872823|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
30846862|NCT02489968|58872824|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
30846863|NCT02489968|58872825|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
30846864|NCT02489968|58872826|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
30846865|NCT02489968|58872827|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
30846866|NCT02489968|58872822|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
30846867|NCT02489968|58872823|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
30846868|NCT02489968|58872824|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
30846869|NCT02489968|58872825|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
30846870|NCT02489968|58872826|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
30846871|NCT02489968|58872827|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
30846872|NCT02489968|58872822|FG000|Open-label Treatment Period|Other than specified above|204|||
30846873|NCT02489968|58872823|FG001|Open-label Treatment Period|Other than specified above|189|||
30846874|NCT02489968|58872824|FG002|Open-label Treatment Period|Other than specified above|0|||
30846875|NCT02489968|58872825|FG003|Open-label Treatment Period|Other than specified above|0|||
30846876|NCT02489968|58872826|FG004|Open-label Treatment Period|Other than specified above|0|||
30846877|NCT02489968|58872827|FG005|Open-label Treatment Period|Other than specified above|0|||
30846878|NCT02489968|58872822|FG000|Double-blind Treatment Period|Adverse Event|0|||
30846879|NCT02489968|58872823|FG001|Double-blind Treatment Period|Adverse Event|0|||
30846880|NCT02489968|58872824|FG002|Double-blind Treatment Period|Adverse Event|2|||
30846881|NCT02489968|58872825|FG003|Double-blind Treatment Period|Adverse Event|6|||
30846882|NCT02489968|58872826|FG004|Double-blind Treatment Period|Adverse Event|4|||
30846883|NCT02489968|58872827|FG005|Double-blind Treatment Period|Adverse Event|5|||
30846884|NCT02489968|58872822|FG000|Double-blind Treatment Period|Protocol Violation|0|||
30846885|NCT02489968|58872823|FG001|Double-blind Treatment Period|Protocol Violation|0|||
30846886|NCT02489968|58872824|FG002|Double-blind Treatment Period|Protocol Violation|0|||
30846887|NCT02489968|58872825|FG003|Double-blind Treatment Period|Protocol Violation|0|||
30846888|NCT02489968|58872826|FG004|Double-blind Treatment Period|Protocol Violation|1|||
30846889|NCT02489968|58872827|FG005|Double-blind Treatment Period|Protocol Violation|1|||
30846890|NCT02489968|58872822|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
30846891|NCT02489968|58872823|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
30846892|NCT02489968|58872824|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
30846893|NCT02489968|58872825|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
30846894|NCT02489968|58872826|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
30846895|NCT02489968|58872827|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
30846896|NCT02489968|58872822|FG000|Double-blind Treatment Period|Other than specified above|0|||
30846897|NCT02489968|58872823|FG001|Double-blind Treatment Period|Other than specified above|0|||
30846898|NCT02489968|58872824|FG002|Double-blind Treatment Period|Other than specified above|0|||
30846899|NCT02489968|58872825|FG003|Double-blind Treatment Period|Other than specified above|0|||
30846900|NCT02489968|58872826|FG004|Double-blind Treatment Period|Other than specified above|1|||
30846901|NCT02489968|58872827|FG005|Double-blind Treatment Period|Other than specified above|0|||
30846902|NCT02483416|58872841|FG000|Overall Study|Other reason|0|||
30846903|NCT02483416|58872842|FG001|Overall Study|Other reason|1|||
30846904|NCT02483416|58872841|FG000|Overall Study|Treatment stop|3|||
30846905|NCT02483416|58872842|FG001|Overall Study|Treatment stop|0|||
30949932|NCT01720069|58996527|FG000|Overall Study|Adverse Event|0|||
30949933|NCT01720069|58996528|FG001|Overall Study|Adverse Event|0|||
30949934|NCT01720069|58996529|FG002|Overall Study|Adverse Event|1|||
30949935|NCT01720069|58996527|FG000|Overall Study|Lack of Efficacy|0|||
30949936|NCT01720069|58996528|FG001|Overall Study|Lack of Efficacy|4|||
30949937|NCT01720069|58996529|FG002|Overall Study|Lack of Efficacy|0|||
30949938|NCT01720069|58996527|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
30949939|NCT01720069|58996528|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
30949940|NCT01720069|58996529|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
30949941|NCT01720069|58996527|FG000|Overall Study|Withdrawal by Subject|0|||
30949942|NCT01720069|58996528|FG001|Overall Study|Withdrawal by Subject|2|||
30949943|NCT01720069|58996529|FG002|Overall Study|Withdrawal by Subject|1|||
30949944|NCT01720069|58996527|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
30949945|NCT01720069|58996528|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
30949946|NCT01720069|58996529|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
30949947|NCT01720069|58996527|FG000|Overall Study|Non-compliance on using e-diary|0|||
30949948|NCT01720069|58996528|FG001|Overall Study|Non-compliance on using e-diary|0|||
30949949|NCT01720069|58996529|FG002|Overall Study|Non-compliance on using e-diary|1|||
30949950|NCT01720069|58996527|FG000|Overall Study|Lost to Follow-up|0|||
30949951|NCT01720069|58996528|FG001|Overall Study|Lost to Follow-up|0|||
30949952|NCT01720069|58996529|FG002|Overall Study|Lost to Follow-up|1|||
30949953|NCT01719757|58996575|FG000|Overall Study|Adverse Event|38|||
30949954|NCT01719757|58996575|FG000|Overall Study|Withdrawal by Subject|15|||
30949955|NCT01719757|58996575|FG000|Overall Study|Lost to Follow-up|20|||
30949956|NCT01719757|58996575|FG000|Overall Study|Protocol Violation|1|||
30949957|NCT01719757|58996575|FG000|Overall Study|well controlled pain|27|||
30762712|NCT03831191|58771425|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30762713|NCT03831191|58771426|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30762714|NCT03831191|58771427|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30762715|NCT03831191|58771428|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30762716|NCT03831191|58771429|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30762717|NCT03831191|58771430|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30762718|NCT03831191|58771431|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30762719|NCT03831191|58771432|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30762720|NCT03831191|58771433|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30846906|NCT01061177|58872849|FG000|Overall Study|Adverse Event|117|||
30949958|NCT01718509|58996583|FG000|Overall Study|Lost to Follow-up|18|||
30949959|NCT01718509|58996584|FG001|Overall Study|Lost to Follow-up|15|||
30949960|NCT01718509|58996583|FG000|Overall Study|Withdrawal by Subject|7|||
30949961|NCT01718509|58996584|FG001|Overall Study|Withdrawal by Subject|13|||
30949962|NCT01718509|58996583|FG000|Overall Study|Adverse Event|5|||
30949963|NCT01718509|58996584|FG001|Overall Study|Adverse Event|7|||
30762721|NCT03831191|58771434|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30762722|NCT03831191|58771435|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30762723|NCT03831191|58771436|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30762724|NCT03831191|58771437|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
30846907|NCT01061177|58872849|FG000|Overall Study|Withdrawal by Subject|27|||
30846908|NCT01061177|58872849|FG000|Overall Study|Disease progression|17|||
30846909|NCT01061177|58872849|FG000|Overall Study|Protocol Violation|11|||
30846910|NCT01061177|58872849|FG000|Overall Study|Lost to Follow-up|9|||
30846911|NCT01061177|58872849|FG000|Overall Study|New cancer therapy|9|||
30846912|NCT01061177|58872849|FG000|Overall Study|Abnormal laboratory values|6|||
30846913|NCT01061177|58872849|FG000|Overall Study|Abnormal test procedure results|4|||
30846914|NCT01061177|58872849|FG000|Overall Study|Administratie problems|4|||
30846915|NCT01061177|58872849|FG000|Overall Study|Death|4|||
30846916|NCT02481934|58872853|FG000|Overall Study|Death|2|||
30846917|NCT02973425|58872859|FG000|Overall Study|Lost to Follow-up|49|||
30846918|NCT02973425|58872860|FG001|Overall Study|Lost to Follow-up|53|||
30949964|NCT01718509|58996583|FG000|Overall Study|Other|13|||
30949965|NCT01718509|58996584|FG001|Overall Study|Other|11|||
30949966|NCT01718509|58996583|FG000|Overall Study|Protocol Violation|4|||
30949967|NCT01718509|58996584|FG001|Overall Study|Protocol Violation|2|||
30949968|NCT01718509|58996583|FG000|Overall Study|Lack of Efficacy|1|||
30949969|NCT01718509|58996584|FG001|Overall Study|Lack of Efficacy|0|||
30949970|NCT01857934|58996590|FG000|Overall Study|Relapse or progression|2|||
30949971|NCT01857934|58996590|FG000|Overall Study|Unacceptable toxicity|3|||
30949972|NCT01857934|58996590|FG000|Overall Study|Unwillingness or inability to comply|2|||
30949973|NCT01857934|58996590|FG000|Overall Study|Physician Decision|3|||
30949974|NCT01604941|58996631|FG000|Overall Study|Adverse Event|1|||
30949975|NCT01604941|58996632|FG001|Overall Study|Adverse Event|2|||
30846919|NCT02489500|58872869|FG000|Overall Study|Death|1|||
30949976|NCT01604941|58996633|FG002|Overall Study|Adverse Event|0|||
30949977|NCT01604941|58996634|FG003|Overall Study|Adverse Event|0|||
30949978|NCT01604941|58996635|FG004|Overall Study|Adverse Event|1|||
30949979|NCT01604941|58996636|FG005|Overall Study|Adverse Event|5|||
30949980|NCT01604941|58996631|FG000|Overall Study|Non-compliance|1|||
30949981|NCT01604941|58996632|FG001|Overall Study|Non-compliance|0|||
30949982|NCT01604941|58996633|FG002|Overall Study|Non-compliance|0|||
30949983|NCT01604941|58996634|FG003|Overall Study|Non-compliance|0|||
30949984|NCT01604941|58996635|FG004|Overall Study|Non-compliance|0|||
30846920|NCT02489500|58872870|FG001|Overall Study|Death|1|||
30846921|NCT02732847|58872878|FG000|Overall Study|some filled early|42|||
30846922|NCT02732847|58872879|FG001|Overall Study|some filled early|42|||
30846923|NCT02489344|58872885|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
30846924|NCT02489344|58872885|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
30846925|NCT02489344|58872885|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
30846926|NCT02489344|58872885|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
30949985|NCT01604941|58996636|FG005|Overall Study|Non-compliance|0|||
30949986|NCT01604941|58996631|FG000|Overall Study|Participant Decision|0|||
30949987|NCT01604941|58996632|FG001|Overall Study|Participant Decision|0|||
30949988|NCT01604941|58996633|FG002|Overall Study|Participant Decision|0|||
30949989|NCT01604941|58996634|FG003|Overall Study|Participant Decision|0|||
30949990|NCT01604941|58996635|FG004|Overall Study|Participant Decision|0|||
30949991|NCT01604941|58996636|FG005|Overall Study|Participant Decision|2|||
30949992|NCT01604941|58996631|FG000|Overall Study|Early Study Termination|9|||
30949993|NCT01604941|58996632|FG001|Overall Study|Early Study Termination|2|||
30949994|NCT01604941|58996633|FG002|Overall Study|Early Study Termination|3|||
30949995|NCT01604941|58996634|FG003|Overall Study|Early Study Termination|3|||
30949996|NCT01604941|58996635|FG004|Overall Study|Early Study Termination|0|||
30949997|NCT01604941|58996636|FG005|Overall Study|Early Study Termination|0|||
30762725|NCT03831191|58771423|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
30762726|NCT03831191|58771424|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
30762727|NCT03831191|58771425|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
30762728|NCT03831191|58771426|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
30762729|NCT03831191|58771427|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
30762730|NCT03831191|58771428|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
30762731|NCT03831191|58771429|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
30762732|NCT03831191|58771430|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
30949998|NCT01604785|58996644|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
30762733|NCT03831191|58771431|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
30762734|NCT03831191|58771432|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
30762735|NCT03831191|58771433|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
30949999|NCT01604785|58996645|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
30950000|NCT01681849|58996654|FG000|Overall Study|Protocol Violation|2|||
30950001|NCT01681849|58996655|FG001|Overall Study|Protocol Violation|0|||
30950002|NCT01681849|58996656|FG002|Overall Study|Protocol Violation|0|||
30950003|NCT01681849|58996654|FG000|Overall Study|Withdrawal by Subject|3|||
30950004|NCT01681849|58996655|FG001|Overall Study|Withdrawal by Subject|5|||
30950005|NCT01681849|58996656|FG002|Overall Study|Withdrawal by Subject|33|||
30950006|NCT01681849|58996654|FG000|Overall Study|Lost to Follow-up|3|||
30950007|NCT01681849|58996655|FG001|Overall Study|Lost to Follow-up|2|||
30950008|NCT01681849|58996656|FG002|Overall Study|Lost to Follow-up|6|||
30950009|NCT01681771|58996665|FG000|Overall Study|Lost to Follow-up|4|||
30950010|NCT01681771|58996666|FG001|Overall Study|Lost to Follow-up|2|||
30950011|NCT04250350|58996672|FG000|Overall Study|Withdrawal by Subject|13|||
30950012|NCT04250350|58996672|FG000|Overall Study|Lost to Follow-up|8|||
30950013|NCT04250350|58996672|FG000|Overall Study|Adverse Event|5|||
30950014|NCT04250350|58996672|FG000|Overall Study|Lack of Efficacy|4|||
30950015|NCT04250350|58996672|FG000|Overall Study|Physician Decision|1|||
30950016|NCT04250350|58996672|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
30950017|NCT01718353|58996703|FG000|Overall Study|Lost to Follow-up|0|||
30950018|NCT01718353|58996704|FG001|Overall Study|Lost to Follow-up|1|||
30950019|NCT01718353|58996703|FG000|Overall Study|Principal Investigator's Decision|10|||
30950020|NCT01718353|58996704|FG001|Overall Study|Principal Investigator's Decision|4|||
30950021|NCT01718353|58996703|FG000|Overall Study|Randomized but not treated|2|||
30950022|NCT01718353|58996704|FG001|Overall Study|Randomized but not treated|0|||
30950023|NCT01716715|58996714|FG000|Overall Study|Never Treated|2|||
30950024|NCT01716715|58996715|FG001|Overall Study|Never Treated|4|||
30846927|NCT02488330|58872889|FG000|Overall Study|Adverse Event|1|||
30846928|NCT02488330|58872889|FG000|Overall Study|Physician Decision|2|||
30846929|NCT02488330|58872889|FG000|Overall Study|Death|2|||
30846930|NCT02488330|58872889|FG000|Overall Study|Disease Progression|3|||
30846931|NCT02488330|58872889|FG000|Overall Study|Study Termination by Sponsor|4|||
30846932|NCT02481310|58872896|FG000|Follow up|Still in follow up|0|||
30846933|NCT02481310|58872897|FG001|Follow up|Still in follow up|3|||
30846934|NCT02481310|58872898|FG002|Follow up|Still in follow up|0|||
30846935|NCT02480764|58872905|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
30846936|NCT02480764|58872906|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
30846937|NCT02480764|58872907|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
30846938|NCT02480764|58872905|FG000|Overall Study|Major Protocol Deviation|1|||
30846939|NCT02480764|58872906|FG001|Overall Study|Major Protocol Deviation|4|||
30846940|NCT02480764|58872907|FG002|Overall Study|Major Protocol Deviation|3|||
30846941|NCT02480764|58872905|FG000|Overall Study|Lost to Follow-up|0|||
30846942|NCT02480764|58872906|FG001|Overall Study|Lost to Follow-up|1|||
30846943|NCT02480764|58872907|FG002|Overall Study|Lost to Follow-up|2|||
30846944|NCT02480764|58872905|FG000|Overall Study|Voluntary Withdrawal|6|||
30846945|NCT02480764|58872906|FG001|Overall Study|Voluntary Withdrawal|5|||
30846946|NCT02480764|58872907|FG002|Overall Study|Voluntary Withdrawal|10|||
30846947|NCT02480764|58872905|FG000|Overall Study|Lack of Efficacy|0|||
30846948|NCT02480764|58872906|FG001|Overall Study|Lack of Efficacy|3|||
30846949|NCT02480764|58872907|FG002|Overall Study|Lack of Efficacy|3|||
30846950|NCT02480764|58872905|FG000|Overall Study|Reason not Specified|0|||
30846951|NCT02480764|58872906|FG001|Overall Study|Reason not Specified|1|||
30846952|NCT02480764|58872907|FG002|Overall Study|Reason not Specified|0|||
30846953|NCT02487472|58872915|FG000|Overall Study|Did not complete telephonic interviews|9|||
30846954|NCT02487472|58872915|FG000|Overall Study|Other|2|||
30846955|NCT02451670|58872923|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
30846956|NCT02451670|58872924|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
30846957|NCT02486692|58872932|FG000|Overall Study|did not login for randomization|4|||
30846958|NCT02486692|58872933|FG001|Overall Study|did not login for randomization|7|||
30846959|NCT01060007|58872950|FG000|Overall Study|Withdrawal by Subject|1|||
30846960|NCT01060007|58872950|FG000|Overall Study|Inevaluable for response at surgery|3|||
30846961|NCT02971163|58872959|FG000|Overall Study|Lost to Follow-up|4|||
30846962|NCT02971163|58872960|FG001|Overall Study|Lost to Follow-up|2|||
30846963|NCT02971007|58872969|FG000|Overall Study|Adverse Event|1|||
30626201|NCT01200758|58638317|FG001|Stage I|Lack of Efficacy|1|||
30762736|NCT03831191|58771434|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
30762737|NCT03831191|58771435|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
30762738|NCT03831191|58771436|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
30762739|NCT03831191|58771437|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
30762740|NCT03831191|58771423|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
30762741|NCT03831191|58771424|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
30762742|NCT03831191|58771425|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
30762743|NCT03831191|58771426|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
30762744|NCT03831191|58771427|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
30762745|NCT03831191|58771428|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
30762746|NCT03831191|58771429|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
30762747|NCT03831191|58771430|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
30762748|NCT03831191|58771431|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
30762749|NCT03831191|58771432|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
30762750|NCT03831191|58771433|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
30762751|NCT03831191|58771434|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
30762752|NCT03831191|58771435|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
30846964|NCT02971007|58872970|FG001|Overall Study|Adverse Event|0|||
30846965|NCT02971007|58872971|FG002|Overall Study|Adverse Event|0|||
30846966|NCT02971007|58872969|FG000|Overall Study|Lost to Follow-up|0|||
30846967|NCT02971007|58872970|FG001|Overall Study|Lost to Follow-up|1|||
30846968|NCT02971007|58872971|FG002|Overall Study|Lost to Follow-up|1|||
30846969|NCT02971007|58872969|FG000|Overall Study|Withdrawal by Subject|0|||
30846970|NCT02971007|58872970|FG001|Overall Study|Withdrawal by Subject|1|||
30846971|NCT02971007|58872971|FG002|Overall Study|Withdrawal by Subject|0|||
30846972|NCT02971007|58872969|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
30950025|NCT01697449|58996723|FG000|Overall Study|Disease progression|47|||
30950026|NCT01697449|58996723|FG000|Overall Study|Adverse Event|7|||
30950027|NCT01697449|58996723|FG000|Overall Study|Lost to Follow-up|5|||
30950028|NCT01697449|58996723|FG000|Overall Study|Withdrawal by Subject|2|||
30950029|NCT01697449|58996723|FG000|Overall Study|Physician Decision|1|||
30950030|NCT01697449|58996723|FG000|Overall Study|Death|2|||
30950031|NCT01697449|58996723|FG000|Overall Study|Other|1|||
30950032|NCT01697449|58996723|FG000|Overall Study|Missing|25|||
30950033|NCT01696981|58996732|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
30950034|NCT01696981|58996733|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
30950035|NCT01696981|58996732|FG000|Overall Study|Died Before Randomization|3|||
30950036|NCT01696981|58996733|FG001|Overall Study|Died Before Randomization|8|||
30950037|NCT01696981|58996732|FG000|Overall Study|Died Before ASU (Control)|278|||
30950038|NCT01696981|58996733|FG001|Overall Study|Died Before ASU (Control)|0|||
30950039|NCT01696981|58996732|FG000|Overall Study|Refused ASU (Control)|920|||
30950040|NCT01696981|58996733|FG001|Overall Study|Refused ASU (Control)|0|||
30950041|NCT01696981|58996732|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
30950042|NCT01696981|58996733|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
30950043|NCT01696279|58996739|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
30950044|NCT01696279|58996740|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
30950045|NCT01696279|58996741|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
30950046|NCT01696279|58996742|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
30950047|NCT01696279|58996739|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
30950048|NCT01696279|58996740|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
30950049|NCT01696279|58996741|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
30950050|NCT01696279|58996742|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
30950051|NCT01696279|58996739|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
30950052|NCT01696279|58996740|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
30950053|NCT01696279|58996741|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
30950054|NCT01696279|58996742|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
30950055|NCT01696279|58996739|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
30950056|NCT01696279|58996740|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
30950057|NCT01696279|58996741|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
30950058|NCT01696279|58996742|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
30950059|NCT01696279|58996739|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
30950060|NCT01696279|58996740|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
30950061|NCT01696279|58996741|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
30950062|NCT01696279|58996742|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
30950063|NCT01696279|58996739|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
30950064|NCT01696279|58996740|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
30950065|NCT01696279|58996741|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
30950066|NCT01696279|58996742|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
30950067|NCT01696279|58996739|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
30950068|NCT01696279|58996740|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
30950069|NCT01696279|58996741|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
30950070|NCT01696279|58996742|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
30950071|NCT01696279|58996739|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
30950072|NCT01696279|58996740|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
30950073|NCT01696279|58996741|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
30950074|NCT01696279|58996742|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
30950075|NCT01696279|58996739|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
30846973|NCT02971007|58872970|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
30846974|NCT02971007|58872971|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
30846975|NCT02971007|58872969|FG000|Overall Study|Patient discontinued study drug|0|||
30846976|NCT02971007|58872970|FG001|Overall Study|Patient discontinued study drug|1|||
30950076|NCT01696279|58996740|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
30950077|NCT01696279|58996741|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
30950078|NCT01696279|58996742|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
30950079|NCT01696279|58996739|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
30846977|NCT02971007|58872971|FG002|Overall Study|Patient discontinued study drug|0|||
30846978|NCT03881553|58872982|FG000|Overall Study|Discharged prior to participation|1|||
30846979|NCT03881553|58872983|FG001|Overall Study|Discharged prior to participation|1|||
30846980|NCT03881553|58872984|FG002|Overall Study|Discharged prior to participation|0|||
30846981|NCT03881553|58872982|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
30846982|NCT03881553|58872983|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
30846983|NCT03881553|58872984|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
30846984|NCT02970929|58872992|FG000|Overall Study|Adverse Event|18|||
30846985|NCT02970929|58872992|FG000|Overall Study|Lack of Efficacy|8|||
30846986|NCT02970929|58872992|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
30846987|NCT02970929|58872992|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
30846988|NCT02970929|58872992|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
30846989|NCT02970929|58872992|FG000|Overall Study|LOST TO FOLLOWUP|6|||
30846990|NCT02970929|58872992|FG000|Overall Study|MOVED OUT OF STATE|1|||
30846991|NCT02970929|58872992|FG000|Overall Study|Withdrawal by Subject|16|||
30846992|NCT02970305|58873009|FG000|Overall Study|Adverse Event|10|||
30846993|NCT02970305|58873010|FG001|Overall Study|Adverse Event|6|||
30846994|NCT02970305|58873009|FG000|Overall Study|Lack of Efficacy|1|||
30846995|NCT02970305|58873010|FG001|Overall Study|Lack of Efficacy|1|||
30846996|NCT02970305|58873009|FG000|Overall Study|Noncompliance with study drug|2|||
30846997|NCT02970305|58873010|FG001|Overall Study|Noncompliance with study drug|4|||
30846998|NCT02970305|58873009|FG000|Overall Study|Protocol Violation|2|||
30846999|NCT02970305|58873010|FG001|Overall Study|Protocol Violation|2|||
30847000|NCT02970305|58873009|FG000|Overall Study|Withdrawal by Subject|12|||
30847001|NCT02970305|58873010|FG001|Overall Study|Withdrawal by Subject|11|||
30847002|NCT02970305|58873009|FG000|Overall Study|Not further specified|1|||
30847003|NCT02970305|58873010|FG001|Overall Study|Not further specified|2|||
30847004|NCT02970305|58873009|FG000|Overall Study|Lost to Follow-up|1|||
30847005|NCT02970305|58873010|FG001|Overall Study|Lost to Follow-up|2|||
30847006|NCT02022033|58873029|FG000|Overall Study|Physician Decision|1|||
30847007|NCT03505671|58873035|FG000|Overall Study|Withdrawal by Subject|2|||
30847008|NCT03505671|58873036|FG001|Overall Study|Withdrawal by Subject|1|||
30950080|NCT01696279|58996740|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
30762753|NCT03831191|58771436|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
30762754|NCT03831191|58771437|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
30762755|NCT03831191|58771423|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
30762756|NCT03831191|58771424|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
30762757|NCT03831191|58771425|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
30847009|NCT03505671|58873035|FG000|Overall Study|Lost to Follow-up|1|||
30847010|NCT03505671|58873036|FG001|Overall Study|Lost to Follow-up|0|||
30847011|NCT01103349|58873057|FG000|Overall Study|Adverse Event|8|||
30847012|NCT01103349|58873058|FG001|Overall Study|Adverse Event|5|||
30847013|NCT01103349|58873059|FG002|Overall Study|Adverse Event|3|||
30847014|NCT01103349|58873057|FG000|Overall Study|Consent withdrawn|1|||
30847015|NCT01103349|58873058|FG001|Overall Study|Consent withdrawn|0|||
30847016|NCT01103349|58873059|FG002|Overall Study|Consent withdrawn|0|||
30847017|NCT01103349|58873057|FG000|Overall Study|Incorrectly included in the trial|1|||
30762758|NCT03831191|58771426|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
30762759|NCT03831191|58771427|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30762760|NCT03831191|58771428|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30762761|NCT03831191|58771429|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30762762|NCT03831191|58771430|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30762763|NCT03831191|58771431|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30762764|NCT03831191|58771432|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30762765|NCT03831191|58771433|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30762766|NCT03831191|58771434|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30762767|NCT03831191|58771435|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30762768|NCT03831191|58771436|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30762769|NCT03831191|58771437|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30762770|NCT03831191|58771423|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
30762771|NCT03831191|58771424|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
30847018|NCT01103349|58873058|FG001|Overall Study|Incorrectly included in the trial|0|||
30950081|NCT01696279|58996741|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
30762772|NCT03831191|58771425|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
30762773|NCT03831191|58771426|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
30762774|NCT03831191|58771427|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
30762775|NCT03831191|58771428|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
30762776|NCT03831191|58771429|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
30762777|NCT03831191|58771430|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
30847019|NCT01103349|58873059|FG002|Overall Study|Incorrectly included in the trial|0|||
30847020|NCT01103349|58873057|FG000|Overall Study|Withdrawal by Subject|1|||
30762778|NCT03831191|58771431|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
30762779|NCT03831191|58771432|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
30762780|NCT03831191|58771433|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
30762781|NCT03831191|58771434|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
30847021|NCT01103349|58873058|FG001|Overall Study|Withdrawal by Subject|1|||
30762782|NCT03831191|58771435|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
30762783|NCT03831191|58771436|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
30762784|NCT03831191|58771437|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
30762785|NCT03831191|58771423|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
30847022|NCT01103349|58873059|FG002|Overall Study|Withdrawal by Subject|0|||
30847023|NCT01103349|58873057|FG000|Overall Study|did not want to take trial medication|0|||
30950082|NCT01696279|58996742|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
30950083|NCT01696279|58996739|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
30762786|NCT03831191|58771424|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762787|NCT03831191|58771425|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762788|NCT03831191|58771426|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
30762789|NCT03831191|58771427|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
30847024|NCT01103349|58873058|FG001|Overall Study|did not want to take trial medication|1|||
30847025|NCT01103349|58873059|FG002|Overall Study|did not want to take trial medication|0|||
30847026|NCT01103349|58873057|FG000|Overall Study|forgot to take medication|0|||
30847027|NCT01103349|58873058|FG001|Overall Study|forgot to take medication|0|||
30847028|NCT01103349|58873059|FG002|Overall Study|forgot to take medication|1|||
30847029|NCT02959177|58873070|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
30847030|NCT02959177|58873071|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
30847031|NCT02959177|58873072|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
30847032|NCT02959177|58873070|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
30847033|NCT02959177|58873071|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
30847034|NCT02959177|58873072|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
30847035|NCT02959177|58873070|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
30847036|NCT02959177|58873071|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
30847037|NCT02959177|58873072|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
30847038|NCT02959177|58873070|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
30847039|NCT02959177|58873071|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
30847040|NCT02959177|58873072|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
30847041|NCT02959177|58873070|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
30847042|NCT02959177|58873071|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
30847043|NCT02959177|58873072|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
30847044|NCT02959177|58873070|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
30847045|NCT02959177|58873071|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
30847046|NCT02959177|58873072|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
30847047|NCT02959177|58873070|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
30847048|NCT02959177|58873071|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
30950084|NCT01696279|58996740|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
30950085|NCT01696279|58996741|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
30950086|NCT01696279|58996742|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
30950087|NCT01681069|58996753|FG000|Overall Study|Withdrawal by Subject|4|||
30950088|NCT01681069|58996754|FG001|Overall Study|Withdrawal by Subject|5|||
30950089|NCT01681069|58996753|FG000|Overall Study|Protocol Violation|1|||
30950090|NCT01681069|58996754|FG001|Overall Study|Protocol Violation|1|||
30950091|NCT01681069|58996753|FG000|Overall Study|Adverse Event|0|||
30950092|NCT01681069|58996754|FG001|Overall Study|Adverse Event|1|||
30950093|NCT01716559|58996760|FG000|Overall Study|Adverse Event|11|||
30950094|NCT01716559|58996760|FG000|Overall Study|Death|21|||
30950095|NCT01716559|58996760|FG000|Overall Study|Withdrawal by Subject|4|||
30762790|NCT03831191|58771428|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762791|NCT03831191|58771429|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762792|NCT03831191|58771430|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762793|NCT03831191|58771431|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762794|NCT03831191|58771432|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762795|NCT03831191|58771433|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762796|NCT03831191|58771434|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762797|NCT03831191|58771435|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762798|NCT03831191|58771436|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762799|NCT03831191|58771437|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
30762800|NCT03831191|58771423|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
30762801|NCT03831191|58771424|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
30762802|NCT03831191|58771425|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
30762803|NCT03831191|58771426|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
30762804|NCT03831191|58771427|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
30762805|NCT03831191|58771428|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
30762806|NCT03831191|58771429|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
30847049|NCT02959177|58873072|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
30847050|NCT04706403|58873089|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
30950096|NCT01716559|58996760|FG000|Overall Study|Other withdrawal reason|75|||
30950097|NCT01936181|58996766|FG000|Randomised, Double-blind|Adverse Event|27|||
30950098|NCT01936181|58996767|FG001|Randomised, Double-blind|Adverse Event|21|||
30950099|NCT01936181|58996768|FG002|Randomised, Double-blind|Adverse Event|0|||
30950100|NCT01936181|58996769|FG003|Randomised, Double-blind|Adverse Event|0|||
30762807|NCT03831191|58771430|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
30950101|NCT01936181|58996766|FG000|Randomised, Double-blind|Protocol Violation|1|||
30950102|NCT01936181|58996767|FG001|Randomised, Double-blind|Protocol Violation|5|||
30950103|NCT01936181|58996768|FG002|Randomised, Double-blind|Protocol Violation|0|||
30950104|NCT01936181|58996769|FG003|Randomised, Double-blind|Protocol Violation|0|||
30762808|NCT03831191|58771431|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
30762809|NCT03831191|58771432|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
30762810|NCT03831191|58771433|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
30762811|NCT03831191|58771434|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
30762812|NCT03831191|58771435|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
30762813|NCT03831191|58771436|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
30762814|NCT03831191|58771437|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
30762815|NCT03831191|58771423|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762816|NCT03831191|58771424|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762817|NCT03831191|58771425|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762818|NCT03831191|58771426|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762819|NCT03831191|58771427|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762820|NCT03831191|58771428|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762821|NCT03831191|58771429|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762822|NCT03831191|58771430|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762823|NCT03831191|58771431|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762824|NCT03831191|58771432|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762825|NCT03831191|58771433|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762826|NCT03831191|58771434|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762827|NCT03831191|58771435|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30950105|NCT01936181|58996766|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
30950106|NCT01936181|58996767|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
30847051|NCT04706403|58873090|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
30847052|NCT04706403|58873091|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
30847053|NCT04706403|58873092|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
30762828|NCT03831191|58771436|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
30762829|NCT03831191|58771437|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
30762830|NCT03831191|58771423|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762831|NCT03831191|58771424|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762832|NCT03831191|58771425|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762833|NCT03831191|58771426|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30950107|NCT01936181|58996768|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
30950108|NCT01936181|58996769|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
30950109|NCT01936181|58996766|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
30950110|NCT01936181|58996767|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
30950111|NCT01936181|58996768|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
30950112|NCT01936181|58996769|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
30950113|NCT01936181|58996766|FG000|Randomised, Double-blind|Pregnancy|0|||
30950114|NCT01936181|58996767|FG001|Randomised, Double-blind|Pregnancy|1|||
30950115|NCT01936181|58996768|FG002|Randomised, Double-blind|Pregnancy|0|||
30950116|NCT01936181|58996769|FG003|Randomised, Double-blind|Pregnancy|0|||
30950117|NCT01936181|58996766|FG000|Randomised, Double-blind|Physician Decision|4|||
30950118|NCT01936181|58996767|FG001|Randomised, Double-blind|Physician Decision|4|||
30950119|NCT01936181|58996768|FG002|Randomised, Double-blind|Physician Decision|0|||
30950120|NCT01936181|58996769|FG003|Randomised, Double-blind|Physician Decision|0|||
30950121|NCT01936181|58996766|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
30950122|NCT01936181|58996767|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
30950123|NCT01936181|58996768|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
30950124|NCT01936181|58996769|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
30950125|NCT01936181|58996766|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
30762834|NCT03831191|58771427|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762835|NCT03831191|58771428|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762836|NCT03831191|58771429|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762837|NCT03831191|58771430|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762838|NCT03831191|58771431|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30847054|NCT04706403|58873093|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
30847055|NCT02983617|58873107|FG000|Overall Study|Adverse Event|0|||
30847056|NCT02983617|58873108|FG001|Overall Study|Adverse Event|7|||
30950126|NCT01936181|58996767|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
30950127|NCT01936181|58996768|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
30950128|NCT01936181|58996769|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
30950129|NCT01936181|58996766|FG000|Transition-extension|Adverse Event|3|||
30950130|NCT01936181|58996767|FG001|Transition-extension|Adverse Event|0|||
30950131|NCT01936181|58996768|FG002|Transition-extension|Adverse Event|3|||
30847057|NCT02983617|58873107|FG000|Overall Study|Death|0|||
30847058|NCT02983617|58873108|FG001|Overall Study|Death|1|||
30847059|NCT02983617|58873107|FG000|Overall Study|Investigator's Discretion|0|||
30847060|NCT02983617|58873108|FG001|Overall Study|Investigator's Discretion|1|||
30847061|NCT02873689|58873116|FG000|Overall Study|Lack of Efficacy|1|||
30847062|NCT02873689|58873117|FG001|Overall Study|Lack of Efficacy|0|||
30847063|NCT02873689|58873116|FG000|Overall Study|Withdrawal by Subject|2|||
30847064|NCT02873689|58873117|FG001|Overall Study|Withdrawal by Subject|2|||
30847065|NCT02873689|58873116|FG000|Overall Study|Protocol Violation|1|||
30847066|NCT02873689|58873117|FG001|Overall Study|Protocol Violation|0|||
30847067|NCT02873689|58873116|FG000|Overall Study|Adverse Event|2|||
30847068|NCT02873689|58873117|FG001|Overall Study|Adverse Event|2|||
30847069|NCT02873689|58873116|FG000|Overall Study|Randomized but not Treated|1|||
30847070|NCT02873689|58873117|FG001|Overall Study|Randomized but not Treated|1|||
30847071|NCT02901431|58873131|FG000|PK Part|Adverse Event|0|||
30847072|NCT02901431|58873132|FG001|PK Part|Adverse Event|1|||
30847073|NCT02901431|58873133|FG002|PK Part|Adverse Event|0|||
30847074|NCT02901431|58873134|FG003|PK Part|Adverse Event|0|||
30847075|NCT02901431|58873135|FG004|PK Part|Adverse Event|0|||
30847076|NCT02901431|58873136|FG005|PK Part|Adverse Event|0|||
30847077|NCT02901431|58873137|FG006|PK Part|Adverse Event|0|||
30847078|NCT02901431|58873138|FG007|PK Part|Adverse Event|0|||
30847079|NCT02901431|58873139|FG008|PK Part|Adverse Event|0|||
30847080|NCT02901431|58873140|FG009|PK Part|Adverse Event|0|||
30847081|NCT02901431|58873141|FG010|PK Part|Adverse Event|0|||
30847082|NCT02901431|58873142|FG011|PK Part|Adverse Event|0|||
30847083|NCT02901431|58873143|FG012|PK Part|Adverse Event|0|||
30847084|NCT02901431|58873131|FG000|PK Part|Lost to Follow-up|0|||
30847085|NCT02901431|58873132|FG001|PK Part|Lost to Follow-up|0|||
30847086|NCT02901431|58873133|FG002|PK Part|Lost to Follow-up|1|||
30847087|NCT02901431|58873134|FG003|PK Part|Lost to Follow-up|0|||
30847088|NCT02901431|58873135|FG004|PK Part|Lost to Follow-up|0|||
30847089|NCT02901431|58873136|FG005|PK Part|Lost to Follow-up|0|||
30847090|NCT02901431|58873137|FG006|PK Part|Lost to Follow-up|0|||
30847091|NCT02901431|58873138|FG007|PK Part|Lost to Follow-up|0|||
30847092|NCT02901431|58873139|FG008|PK Part|Lost to Follow-up|0|||
30847093|NCT02901431|58873140|FG009|PK Part|Lost to Follow-up|0|||
30847094|NCT02901431|58873141|FG010|PK Part|Lost to Follow-up|0|||
30847095|NCT02901431|58873142|FG011|PK Part|Lost to Follow-up|0|||
30847096|NCT02901431|58873143|FG012|PK Part|Lost to Follow-up|0|||
30847097|NCT02901431|58873131|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
30847098|NCT02901431|58873132|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30847099|NCT02901431|58873133|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30950132|NCT01936181|58996769|FG003|Transition-extension|Adverse Event|1|||
30950133|NCT01936181|58996766|FG000|Transition-extension|Lost to Follow-up|3|||
30950134|NCT01936181|58996767|FG001|Transition-extension|Lost to Follow-up|0|||
30950135|NCT01936181|58996768|FG002|Transition-extension|Lost to Follow-up|1|||
30950136|NCT01936181|58996769|FG003|Transition-extension|Lost to Follow-up|2|||
30950137|NCT01936181|58996766|FG000|Transition-extension|Physician Decision|2|||
30950138|NCT01936181|58996767|FG001|Transition-extension|Physician Decision|0|||
30762839|NCT03831191|58771432|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762840|NCT03831191|58771433|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762841|NCT03831191|58771434|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762842|NCT03831191|58771435|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762843|NCT03831191|58771436|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
30762844|NCT03831191|58771437|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
30762845|NCT00005906|58771470|FG000|Overall Study|Lack of Efficacy|3|||
30762846|NCT00066690|58771477|FG000|Overall Study|Adverse Event|145|||
30762847|NCT00066690|58771478|FG001|Overall Study|Adverse Event|58|||
30762848|NCT00066690|58771479|FG002|Overall Study|Adverse Event|126|||
30762849|NCT00066690|58771477|FG000|Overall Study|Death|3|||
30762850|NCT00066690|58771478|FG001|Overall Study|Death|0|||
30762851|NCT00066690|58771479|FG002|Overall Study|Death|2|||
30762852|NCT00066690|58771477|FG000|Overall Study|Lack of Efficacy|114|||
30762853|NCT00066690|58771478|FG001|Overall Study|Lack of Efficacy|110|||
30847100|NCT02901431|58873134|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30847101|NCT02901431|58873135|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30847102|NCT02901431|58873136|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30847103|NCT02901431|58873137|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30847104|NCT02901431|58873138|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30847105|NCT02901431|58873139|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30847106|NCT02901431|58873140|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30847107|NCT02901431|58873141|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30847108|NCT02901431|58873142|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30847109|NCT02901431|58873143|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
30847110|NCT02901431|58873131|FG000|PK Part|Pending dose confirmation|0|||
30950139|NCT01936181|58996768|FG002|Transition-extension|Physician Decision|0|||
30847111|NCT02901431|58873132|FG001|PK Part|Pending dose confirmation|1|||
30847112|NCT02901431|58873133|FG002|PK Part|Pending dose confirmation|0|||
30847113|NCT02901431|58873134|FG003|PK Part|Pending dose confirmation|0|||
30950140|NCT01936181|58996769|FG003|Transition-extension|Physician Decision|1|||
30950141|NCT01936181|58996766|FG000|Transition-extension|Withdrawal by Subject|7|||
30950142|NCT01936181|58996767|FG001|Transition-extension|Withdrawal by Subject|0|||
30950143|NCT01936181|58996768|FG002|Transition-extension|Withdrawal by Subject|2|||
30950144|NCT01936181|58996769|FG003|Transition-extension|Withdrawal by Subject|1|||
30950145|NCT01696045|58996782|FG000|Overall Study|Study drug toxicity|1|||
30950146|NCT01696045|58996783|FG001|Overall Study|Study drug toxicity|5|||
30950147|NCT01696045|58996782|FG000|Overall Study|Disease progression|2|||
30950148|NCT01696045|58996783|FG001|Overall Study|Disease progression|2|||
30950149|NCT01716169|58996789|FG000|Overall Study|Adverse Event|1|||
30950150|NCT01716169|58996789|FG000|Overall Study|Lost to Follow-up|1|||
30950151|NCT01716169|58996789|FG000|Overall Study|Withdrawal by Subject|1|||
30950152|NCT01716169|58996789|FG000|Overall Study|inconsistent dressing application|1|||
30950153|NCT01935947|58996798|FG000|Overall Study|Adverse Event|0|||
30950154|NCT01935947|58996799|FG001|Overall Study|Adverse Event|2|||
30950155|NCT01935947|58996800|FG002|Overall Study|Adverse Event|0|||
30950156|NCT01935947|58996798|FG000|Overall Study|Diease Progression|2|||
30950157|NCT01935947|58996799|FG001|Overall Study|Diease Progression|2|||
30950158|NCT01935947|58996800|FG002|Overall Study|Diease Progression|2|||
30950159|NCT01935947|58996798|FG000|Overall Study|Death|1|||
30950160|NCT01935947|58996799|FG001|Overall Study|Death|0|||
30950161|NCT01935947|58996800|FG002|Overall Study|Death|0|||
30950162|NCT01618019|58996813|FG000|Overall Study|Withdrawal by Subject|14|||
30950163|NCT01618019|58996814|FG001|Overall Study|Withdrawal by Subject|14|||
30950164|NCT01593787|58996823|FG000|Overall Study|Adverse Event|1|||
30950165|NCT01593787|58996824|FG001|Overall Study|Adverse Event|0|||
30950166|NCT01593787|58996825|FG002|Overall Study|Adverse Event|0|||
30950167|NCT01951157|58996838|FG000|Overall Study|Progressive Disease|12|||
30950168|NCT01951157|58996839|FG001|Overall Study|Progressive Disease|13|||
30950169|NCT01951157|58996840|FG002|Overall Study|Progressive Disease|10|||
30950170|NCT01951157|58996838|FG000|Overall Study|Treatment-unrelated AE|1|||
30950171|NCT01951157|58996839|FG001|Overall Study|Treatment-unrelated AE|0|||
30950172|NCT01951157|58996840|FG002|Overall Study|Treatment-unrelated AE|3|||
30950173|NCT01951157|58996838|FG000|Overall Study|Study Termination|0|||
30950174|NCT01951157|58996839|FG001|Overall Study|Study Termination|0|||
30950175|NCT01951157|58996840|FG002|Overall Study|Study Termination|1|||
30950176|NCT01951157|58996838|FG000|Overall Study|Physician Decision|5|||
30950177|NCT01951157|58996839|FG001|Overall Study|Physician Decision|3|||
30950178|NCT01951157|58996840|FG002|Overall Study|Physician Decision|2|||
30950179|NCT01951157|58996838|FG000|Overall Study|Non-treatmentrelated death|2|||
30950180|NCT01951157|58996839|FG001|Overall Study|Non-treatmentrelated death|2|||
30950181|NCT01951157|58996840|FG002|Overall Study|Non-treatmentrelated death|2|||
30626202|NCT01200758|58638318|FG002|Stage I|Lack of Efficacy|0|||
30950182|NCT01951157|58996838|FG000|Overall Study|No treated|0|||
30950183|NCT01951157|58996839|FG001|Overall Study|No treated|1|||
30950184|NCT01951157|58996840|FG002|Overall Study|No treated|0|||
30950185|NCT01951157|58996838|FG000|Overall Study|Treatment-related AE|2|||
30950186|NCT01951157|58996839|FG001|Overall Study|Treatment-related AE|0|||
30950187|NCT01951157|58996840|FG002|Overall Study|Treatment-related AE|4|||
30950188|NCT01951157|58996838|FG000|Overall Study|Consent withdrawn by subject|0|||
30950189|NCT01951157|58996839|FG001|Overall Study|Consent withdrawn by subject|1|||
30950190|NCT01951157|58996840|FG002|Overall Study|Consent withdrawn by subject|3|||
30950191|NCT01951157|58996838|FG000|Overall Study|Treatment-related death|0|||
30950192|NCT01951157|58996839|FG001|Overall Study|Treatment-related death|2|||
30950193|NCT01951157|58996840|FG002|Overall Study|Treatment-related death|0|||
30950194|NCT01363349|58996851|FG000|Overall Study|Adverse Event|6|||
30950195|NCT01363349|58996852|FG001|Overall Study|Adverse Event|7|||
30950196|NCT01363349|58996851|FG000|Overall Study|Lack of Efficacy|3|||
30950197|NCT01363349|58996852|FG001|Overall Study|Lack of Efficacy|10|||
30950198|NCT01363349|58996851|FG000|Overall Study|Non compliance/Protocol deviations|2|||
30950199|NCT01363349|58996852|FG001|Overall Study|Non compliance/Protocol deviations|2|||
30950200|NCT01363349|58996851|FG000|Overall Study|Withdrawal by Subject|14|||
30950201|NCT01363349|58996852|FG001|Overall Study|Withdrawal by Subject|6|||
30950202|NCT01363349|58996851|FG000|Overall Study|Lost to Follow-up|5|||
30950203|NCT01363349|58996852|FG001|Overall Study|Lost to Follow-up|6|||
30950204|NCT01363349|58996851|FG000|Overall Study|Not reported|36|||
30950205|NCT01363349|58996852|FG001|Overall Study|Not reported|37|||
30950206|NCT01363349|58996851|FG000|Overall Study|missing|1|||
30950207|NCT01363349|58996852|FG001|Overall Study|missing|2|||
30950208|NCT01933919|58996943|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
30950209|NCT01933919|58996944|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
30950210|NCT01933919|58996943|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
30950211|NCT01933919|58996944|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
30950212|NCT01933919|58996943|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
30950213|NCT01933919|58996944|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
30950214|NCT01933919|58996943|FG000|Open-label Long-term Phase|Adverse Event|2|||
30950215|NCT01933919|58996944|FG001|Open-label Long-term Phase|Adverse Event|0|||
30950216|NCT01933919|58996943|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
30950217|NCT01933919|58996944|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
30950218|NCT01933919|58996943|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
30950219|NCT01933919|58996944|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
30950220|NCT01933919|58996943|FG000|Open-label Long-term Phase|Other|1|||
30950221|NCT01933919|58996944|FG001|Open-label Long-term Phase|Other|2|||
30950222|NCT01933217|58996973|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
30950223|NCT01933217|58996974|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
30950224|NCT01933217|58996973|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
30950225|NCT01933217|58996974|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
30950226|NCT01932437|58996984|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
30950227|NCT01932437|58996985|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
30950228|NCT01932437|58996986|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
30950229|NCT01932437|58996987|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
30950230|NCT01932437|58996988|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
30950231|NCT01932437|58996989|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
30847114|NCT02901431|58873135|FG004|PK Part|Pending dose confirmation|0|||
30847115|NCT02901431|58873136|FG005|PK Part|Pending dose confirmation|0|||
30847116|NCT02901431|58873137|FG006|PK Part|Pending dose confirmation|0|||
30847117|NCT02901431|58873138|FG007|PK Part|Pending dose confirmation|0|||
30847118|NCT02901431|58873139|FG008|PK Part|Pending dose confirmation|0|||
30847119|NCT02901431|58873140|FG009|PK Part|Pending dose confirmation|0|||
30847120|NCT02901431|58873141|FG010|PK Part|Pending dose confirmation|0|||
30847121|NCT02901431|58873142|FG011|PK Part|Pending dose confirmation|0|||
30847122|NCT02901431|58873143|FG012|PK Part|Pending dose confirmation|0|||
30847123|NCT02901431|58873131|FG000|PK Part|8 weeks of treatment ran out|2|||
30847124|NCT02901431|58873132|FG001|PK Part|8 weeks of treatment ran out|0|||
30847125|NCT02901431|58873133|FG002|PK Part|8 weeks of treatment ran out|0|||
30847126|NCT02901431|58873134|FG003|PK Part|8 weeks of treatment ran out|0|||
30847127|NCT02901431|58873135|FG004|PK Part|8 weeks of treatment ran out|0|||
30847128|NCT02901431|58873136|FG005|PK Part|8 weeks of treatment ran out|0|||
30847129|NCT02901431|58873137|FG006|PK Part|8 weeks of treatment ran out|0|||
30847130|NCT02901431|58873138|FG007|PK Part|8 weeks of treatment ran out|0|||
30847131|NCT02901431|58873139|FG008|PK Part|8 weeks of treatment ran out|0|||
30950232|NCT01949051|58997010|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
30950233|NCT01949051|58997011|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
30950234|NCT01949051|58997012|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
30950235|NCT01949051|58997013|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
30847132|NCT02901431|58873140|FG009|PK Part|8 weeks of treatment ran out|0|||
30950236|NCT01949051|58997014|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
30847133|NCT02901431|58873141|FG010|PK Part|8 weeks of treatment ran out|0|||
30847134|NCT02901431|58873142|FG011|PK Part|8 weeks of treatment ran out|0|||
30847135|NCT02901431|58873143|FG012|PK Part|8 weeks of treatment ran out|0|||
30847136|NCT02901431|58873131|FG000|PK Part|Stopped treatment after 8 weeks|1|||
30847137|NCT02901431|58873132|FG001|PK Part|Stopped treatment after 8 weeks|0|||
30847138|NCT02901431|58873133|FG002|PK Part|Stopped treatment after 8 weeks|1|||
30847139|NCT02901431|58873134|FG003|PK Part|Stopped treatment after 8 weeks|0|||
30847140|NCT02901431|58873135|FG004|PK Part|Stopped treatment after 8 weeks|0|||
30847141|NCT02901431|58873136|FG005|PK Part|Stopped treatment after 8 weeks|0|||
30847142|NCT02901431|58873137|FG006|PK Part|Stopped treatment after 8 weeks|0|||
30847143|NCT02901431|58873138|FG007|PK Part|Stopped treatment after 8 weeks|0|||
30847144|NCT02901431|58873139|FG008|PK Part|Stopped treatment after 8 weeks|0|||
30847145|NCT02901431|58873140|FG009|PK Part|Stopped treatment after 8 weeks|0|||
30847146|NCT02901431|58873141|FG010|PK Part|Stopped treatment after 8 weeks|0|||
30847147|NCT02901431|58873142|FG011|PK Part|Stopped treatment after 8 weeks|0|||
30847148|NCT02901431|58873143|FG012|PK Part|Stopped treatment after 8 weeks|0|||
30847149|NCT02901431|58873131|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
30847150|NCT02901431|58873132|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
30847151|NCT02901431|58873133|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
30847152|NCT02901431|58873134|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
30847153|NCT02901431|58873135|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
30847154|NCT02901431|58873136|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
30847155|NCT02901431|58873137|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
30847156|NCT02901431|58873138|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
30847157|NCT02901431|58873139|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
30847158|NCT02901431|58873140|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
30762854|NCT00066690|58771479|FG002|Overall Study|Lack of Efficacy|76|||
30762855|NCT00066690|58771477|FG000|Overall Study|Lost to Follow-up|40|||
30762856|NCT00066690|58771478|FG001|Overall Study|Lost to Follow-up|21|||
30762857|NCT00066690|58771479|FG002|Overall Study|Lost to Follow-up|29|||
30762858|NCT00066690|58771477|FG000|Overall Study|Withdrawal by Subject|50|||
30762859|NCT00066690|58771478|FG001|Overall Study|Withdrawal by Subject|55|||
30762860|NCT00066690|58771479|FG002|Overall Study|Withdrawal by Subject|49|||
30762861|NCT00066690|58771477|FG000|Overall Study|Treatment Ongoing|246|||
30762862|NCT00066690|58771478|FG001|Overall Study|Treatment Ongoing|278|||
30762863|NCT00066690|58771479|FG002|Overall Study|Treatment Ongoing|282|||
30762864|NCT03409276|58771495|FG000|Overall Study|Withdrawal by Subject|0|||
30762865|NCT03409276|58771496|FG001|Overall Study|Withdrawal by Subject|0|||
30762866|NCT03409276|58771497|FG002|Overall Study|Withdrawal by Subject|0|||
30762867|NCT03409276|58771498|FG003|Overall Study|Withdrawal by Subject|0|||
30762868|NCT03409276|58771499|FG004|Overall Study|Withdrawal by Subject|1|||
30762869|NCT03409276|58771495|FG000|Overall Study|Lost to Follow-up|0|||
30762870|NCT03409276|58771496|FG001|Overall Study|Lost to Follow-up|0|||
30762871|NCT03409276|58771497|FG002|Overall Study|Lost to Follow-up|0|||
30762872|NCT03409276|58771498|FG003|Overall Study|Lost to Follow-up|2|||
30762873|NCT03409276|58771499|FG004|Overall Study|Lost to Follow-up|2|||
30762874|NCT00004562|58771517|FG000|Overall Study|Lost to Follow-up|102|||
30762875|NCT00004562|58771518|FG001|Overall Study|Lost to Follow-up|91|||
30762876|NCT00004412|58771527|FG000|Randomized Period|Moved to Crossover Period|3|||
30626203|NCT01200758|58638319|FG003|Stage I|Lack of Efficacy|0|||
30626204|NCT01200758|58638316|FG000|Stage I|Adverse Event|5|||
30626205|NCT01200758|58638317|FG001|Stage I|Adverse Event|5|||
30626206|NCT01200758|58638318|FG002|Stage I|Adverse Event|0|||
30626207|NCT01200758|58638319|FG003|Stage I|Adverse Event|0|||
30626208|NCT01200758|58638316|FG000|Stage I|Withdrawal by Subject|1|||
30626209|NCT01200758|58638317|FG001|Stage I|Withdrawal by Subject|2|||
30762877|NCT00004412|58771528|FG001|Randomized Period|Moved to Crossover Period|0|||
30762878|NCT00004412|58771529|FG002|Randomized Period|Moved to Crossover Period|0|||
30762879|NCT03440320|58771539|FG000|Overall Study|Withdrawal by Subject|0|||
30762880|NCT03440320|58771540|FG001|Overall Study|Withdrawal by Subject|1|||
30762881|NCT00004088|58771548|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
30762882|NCT00004088|58771548|FG000|Overall Study|Withdrawal by Subject|1|||
30762883|NCT00004088|58771548|FG000|Overall Study|Protocol Violation|3|||
30762884|NCT00004088|58771548|FG000|Overall Study|Physician Decision|1|||
30762885|NCT03439072|58771552|FG000|Overall Study|Withdrawal by Subject|2|||
30847159|NCT02901431|58873141|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
30847160|NCT02901431|58873142|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
30950237|NCT01949051|58997015|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
30950238|NCT01949051|58997010|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
30950239|NCT01949051|58997011|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30626210|NCT01200758|58638318|FG002|Stage I|Withdrawal by Subject|0|||
30626211|NCT01200758|58638319|FG003|Stage I|Withdrawal by Subject|0|||
30762886|NCT03439072|58771553|FG001|Overall Study|Withdrawal by Subject|3|||
30762887|NCT03439072|58771552|FG000|Overall Study|Physician Decision|0|||
30762888|NCT03439072|58771553|FG001|Overall Study|Physician Decision|1|||
30762889|NCT00078312|58771559|FG000|Overall Study|Adverse Event|43|||
30762890|NCT00078312|58771559|FG000|Overall Study|Lack of Efficacy|15|||
30762891|NCT00078312|58771559|FG000|Overall Study|Lost to Follow-up|41|||
30762892|NCT00078312|58771559|FG000|Overall Study|Physician Decision|9|||
30762893|NCT00078312|58771559|FG000|Overall Study|Protocol Violation|3|||
30762894|NCT00078312|58771559|FG000|Overall Study|Withdrawal by Subject|33|||
30762895|NCT00078312|58771559|FG000|Overall Study|Miscellaneous|33|||
30762896|NCT00003896|58771563|FG000|Overall Study|Adverse Event|16|||
30762897|NCT00003896|58771563|FG000|Overall Study|Withdrawal by Subject|1|||
30762898|NCT00003896|58771563|FG000|Overall Study|Lack of Efficacy|1|||
30762899|NCT00003896|58771563|FG000|Overall Study|Death|3|||
30762900|NCT00003896|58771563|FG000|Overall Study|not protocol specified|3|||
30762901|NCT00003896|58771563|FG000|Overall Study|ineligible|5|||
30762902|NCT00003830|58771570|FG000|Overall Study|No follow up data|3|||
30762903|NCT00003830|58771571|FG001|Overall Study|No follow up data|0|||
30762904|NCT00003830|58771570|FG000|Overall Study|Sentinel node positive patients|829|||
30762905|NCT00003830|58771571|FG001|Overall Study|Sentinel node positive patients|793|||
30762906|NCT03407482|58771579|FG000|Overall Study|Adverse Event|12|||
30762907|NCT03407482|58771579|FG000|Overall Study|Disease Relapse|1|||
30762908|NCT03407482|58771579|FG000|Overall Study|Lost to Follow-up|1|||
30762909|NCT03407482|58771579|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30762910|NCT03407482|58771579|FG000|Overall Study|Pregnancy|2|||
30762911|NCT03407482|58771579|FG000|Overall Study|Protocol Violation|1|||
30762912|NCT03407482|58771579|FG000|Overall Study|Study Terminated By Sponsor|106|||
30762913|NCT03407482|58771579|FG000|Overall Study|Withdrawal by Subject|6|||
30762914|NCT03407482|58771579|FG000|Overall Study|Data Entry Error|1|||
30762915|NCT00003782|58771586|FG000|Overall Study|No follow up data|30|||
30762916|NCT00003782|58771587|FG001|Overall Study|No follow up data|31|||
30762917|NCT00003782|58771588|FG002|Overall Study|No follow up data|26|||
30762918|NCT03389308|58771596|FG000|Overall Study|Withdrawal by Subject|5|||
30762919|NCT03389308|58771596|FG000|Overall Study|Lost to Follow-up|3|||
30762920|NCT03389308|58771596|FG000|Overall Study|Adverse Event|2|||
30762921|NCT03389308|58771596|FG000|Overall Study|Sponsor Request|2|||
30762922|NCT03407170|58771600|FG000|Overall Study|Adverse Event|1|||
30762923|NCT03406858|58771604|FG000|Overall Study|Failure to receive treatment drug.|1|||
30762924|NCT03406858|58771604|FG000|Overall Study|ineligible|1|||
30762925|NCT03406702|58771608|FG000|Overall Study|Missed Day 27 Dosing|1|||
30847161|NCT02901431|58873143|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
30847162|NCT02901431|58873131|FG000|PK Part|Discontinued per Sponsor|0|||
30847163|NCT02901431|58873132|FG001|PK Part|Discontinued per Sponsor|3|||
30847164|NCT02901431|58873133|FG002|PK Part|Discontinued per Sponsor|0|||
30847165|NCT02901431|58873134|FG003|PK Part|Discontinued per Sponsor|0|||
30847166|NCT02901431|58873135|FG004|PK Part|Discontinued per Sponsor|0|||
30847167|NCT02901431|58873136|FG005|PK Part|Discontinued per Sponsor|0|||
30847168|NCT02901431|58873137|FG006|PK Part|Discontinued per Sponsor|0|||
30847169|NCT02901431|58873138|FG007|PK Part|Discontinued per Sponsor|0|||
30847170|NCT02901431|58873139|FG008|PK Part|Discontinued per Sponsor|0|||
30847171|NCT02901431|58873140|FG009|PK Part|Discontinued per Sponsor|0|||
30847172|NCT02901431|58873141|FG010|PK Part|Discontinued per Sponsor|0|||
30950240|NCT01949051|58997012|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30950241|NCT01949051|58997013|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30950242|NCT01949051|58997014|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30950243|NCT01949051|58997015|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30847173|NCT02901431|58873142|FG011|PK Part|Discontinued per Sponsor|0|||
30847174|NCT02901431|58873143|FG012|PK Part|Discontinued per Sponsor|0|||
30950244|NCT01949051|58997010|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
30950245|NCT01949051|58997011|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
30950246|NCT01949051|58997012|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
30950247|NCT01949051|58997013|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
30950248|NCT01949051|58997014|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
30762926|NCT00003656|58771626|FG000|Overall Study|Adverse Event|0|||
30762927|NCT00003656|58771627|FG001|Overall Study|Adverse Event|1|||
30762928|NCT00003590|58771634|FG000|Overall Study|Ineligible Patient|1|||
30762929|NCT00003590|58771634|FG000|Overall Study|Adverse Event|7|||
30762930|NCT00003590|58771634|FG000|Overall Study|Withdrawal by Subject|1|||
30847175|NCT02901431|58873131|FG000|PK Part|Withdrawal by Subject|1|||
30847176|NCT02901431|58873132|FG001|PK Part|Withdrawal by Subject|1|||
30762931|NCT00003590|58771634|FG000|Overall Study|Lack of Efficacy|11|||
30762932|NCT00003590|58771634|FG000|Overall Study|Death|1|||
30762933|NCT00003590|58771634|FG000|Overall Study|Physician Decision|1|||
30762934|NCT03416374|58771640|FG000|Between Treatment Period I and II|Other|0|||
30762935|NCT03416374|58771641|FG001|Between Treatment Period I and II|Other|9|||
30762936|NCT03416374|58771640|FG000|Treatment Period II|Lack of Efficacy|3|||
30847177|NCT02901431|58873133|FG002|PK Part|Withdrawal by Subject|3|||
30847178|NCT02901431|58873134|FG003|PK Part|Withdrawal by Subject|0|||
30847179|NCT02901431|58873135|FG004|PK Part|Withdrawal by Subject|0|||
30847180|NCT02901431|58873136|FG005|PK Part|Withdrawal by Subject|0|||
30847181|NCT02901431|58873137|FG006|PK Part|Withdrawal by Subject|0|||
30847182|NCT02901431|58873138|FG007|PK Part|Withdrawal by Subject|0|||
30847183|NCT02901431|58873139|FG008|PK Part|Withdrawal by Subject|0|||
30847184|NCT02901431|58873140|FG009|PK Part|Withdrawal by Subject|0|||
30847185|NCT02901431|58873141|FG010|PK Part|Withdrawal by Subject|0|||
30847186|NCT02901431|58873142|FG011|PK Part|Withdrawal by Subject|0|||
30847187|NCT02901431|58873143|FG012|PK Part|Withdrawal by Subject|0|||
30847188|NCT02901431|58873131|FG000|Main Treatment Part|Adverse Event|0|||
30847189|NCT02901431|58873132|FG001|Main Treatment Part|Adverse Event|0|||
30847190|NCT02901431|58873133|FG002|Main Treatment Part|Adverse Event|0|||
30847191|NCT02901431|58873134|FG003|Main Treatment Part|Adverse Event|3|||
30847192|NCT02901431|58873135|FG004|Main Treatment Part|Adverse Event|3|||
30847193|NCT02901431|58873136|FG005|Main Treatment Part|Adverse Event|4|||
30847194|NCT02901431|58873137|FG006|Main Treatment Part|Adverse Event|1|||
30847195|NCT02901431|58873138|FG007|Main Treatment Part|Adverse Event|0|||
30847196|NCT02901431|58873139|FG008|Main Treatment Part|Adverse Event|0|||
30847197|NCT02901431|58873140|FG009|Main Treatment Part|Adverse Event|0|||
30847198|NCT02901431|58873141|FG010|Main Treatment Part|Adverse Event|0|||
30847199|NCT02901431|58873142|FG011|Main Treatment Part|Adverse Event|0|||
30847200|NCT02901431|58873143|FG012|Main Treatment Part|Adverse Event|0|||
30847201|NCT02901431|58873131|FG000|Main Treatment Part|Lack of Efficacy|0|||
30847202|NCT02901431|58873132|FG001|Main Treatment Part|Lack of Efficacy|0|||
30847203|NCT02901431|58873133|FG002|Main Treatment Part|Lack of Efficacy|0|||
30847204|NCT02901431|58873134|FG003|Main Treatment Part|Lack of Efficacy|1|||
30847205|NCT02901431|58873135|FG004|Main Treatment Part|Lack of Efficacy|0|||
30847206|NCT02901431|58873136|FG005|Main Treatment Part|Lack of Efficacy|0|||
30847207|NCT02901431|58873137|FG006|Main Treatment Part|Lack of Efficacy|0|||
30847208|NCT02901431|58873138|FG007|Main Treatment Part|Lack of Efficacy|0|||
30847209|NCT02901431|58873139|FG008|Main Treatment Part|Lack of Efficacy|0|||
30847210|NCT02901431|58873140|FG009|Main Treatment Part|Lack of Efficacy|0|||
30847211|NCT02901431|58873141|FG010|Main Treatment Part|Lack of Efficacy|0|||
30847212|NCT02901431|58873142|FG011|Main Treatment Part|Lack of Efficacy|0|||
30847213|NCT02901431|58873143|FG012|Main Treatment Part|Lack of Efficacy|0|||
30847214|NCT02901431|58873131|FG000|Main Treatment Part|Lost to Follow-up|0|||
30847215|NCT02901431|58873132|FG001|Main Treatment Part|Lost to Follow-up|0|||
30847216|NCT02901431|58873133|FG002|Main Treatment Part|Lost to Follow-up|0|||
30847217|NCT02901431|58873134|FG003|Main Treatment Part|Lost to Follow-up|3|||
30847218|NCT02901431|58873135|FG004|Main Treatment Part|Lost to Follow-up|1|||
30847219|NCT02901431|58873136|FG005|Main Treatment Part|Lost to Follow-up|2|||
30847220|NCT02901431|58873137|FG006|Main Treatment Part|Lost to Follow-up|3|||
30950249|NCT01949051|58997015|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
30950250|NCT01949051|58997010|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
30950251|NCT01949051|58997011|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
30950252|NCT01949051|58997012|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
30950253|NCT01949051|58997013|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
30950254|NCT01949051|58997014|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
30950255|NCT01949051|58997015|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
30950256|NCT01949051|58997010|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
30950257|NCT01949051|58997011|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
30950258|NCT01949051|58997012|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
30950259|NCT01949051|58997013|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
30950260|NCT01949051|58997014|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
30950261|NCT01949051|58997015|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
30950262|NCT01948427|58997028|FG000|Overall Study|Serious Adverse Event|3|||
30950263|NCT01948427|58997029|FG001|Overall Study|Serious Adverse Event|0|||
30950264|NCT01948427|58997030|FG002|Overall Study|Serious Adverse Event|0|||
30950265|NCT01948427|58997031|FG003|Overall Study|Serious Adverse Event|0|||
30950266|NCT01948427|58997032|FG004|Overall Study|Serious Adverse Event|1|||
30950267|NCT01948427|58997028|FG000|Overall Study|Investigator Request|0|||
30950268|NCT01948427|58997029|FG001|Overall Study|Investigator Request|8|||
30847221|NCT02901431|58873138|FG007|Main Treatment Part|Lost to Follow-up|0|||
30847222|NCT02901431|58873139|FG008|Main Treatment Part|Lost to Follow-up|0|||
30847223|NCT02901431|58873140|FG009|Main Treatment Part|Lost to Follow-up|0|||
30950269|NCT01948427|58997030|FG002|Overall Study|Investigator Request|0|||
30950270|NCT01948427|58997031|FG003|Overall Study|Investigator Request|0|||
30847224|NCT02901431|58873141|FG010|Main Treatment Part|Lost to Follow-up|0|||
30847225|NCT02901431|58873142|FG011|Main Treatment Part|Lost to Follow-up|0|||
30847226|NCT02901431|58873143|FG012|Main Treatment Part|Lost to Follow-up|0|||
30847227|NCT02901431|58873131|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
30847228|NCT02901431|58873132|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
30847229|NCT02901431|58873133|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
30847230|NCT02901431|58873134|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
30847231|NCT02901431|58873135|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
30950271|NCT01948427|58997032|FG004|Overall Study|Investigator Request|6|||
30950272|NCT01948427|58997028|FG000|Overall Study|Lost to Follow-up|1|||
30950273|NCT01948427|58997029|FG001|Overall Study|Lost to Follow-up|0|||
30950274|NCT01948427|58997030|FG002|Overall Study|Lost to Follow-up|0|||
30847232|NCT02901431|58873136|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
30847233|NCT02901431|58873137|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
30847234|NCT02901431|58873138|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
30847235|NCT02901431|58873139|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
30847236|NCT02901431|58873140|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
30847237|NCT02901431|58873141|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
30847238|NCT02901431|58873142|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
30847239|NCT02901431|58873143|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
30847240|NCT02901431|58873131|FG000|Main Treatment Part|Physician Decision|0|||
30847241|NCT02901431|58873132|FG001|Main Treatment Part|Physician Decision|0|||
30847242|NCT02901431|58873133|FG002|Main Treatment Part|Physician Decision|0|||
30847243|NCT02901431|58873134|FG003|Main Treatment Part|Physician Decision|1|||
30847244|NCT02901431|58873135|FG004|Main Treatment Part|Physician Decision|0|||
30847245|NCT02901431|58873136|FG005|Main Treatment Part|Physician Decision|0|||
30847246|NCT02901431|58873137|FG006|Main Treatment Part|Physician Decision|1|||
30847247|NCT02901431|58873138|FG007|Main Treatment Part|Physician Decision|0|||
30847248|NCT02901431|58873139|FG008|Main Treatment Part|Physician Decision|0|||
30847249|NCT02901431|58873140|FG009|Main Treatment Part|Physician Decision|0|||
30847250|NCT02901431|58873141|FG010|Main Treatment Part|Physician Decision|0|||
30847251|NCT02901431|58873142|FG011|Main Treatment Part|Physician Decision|0|||
30847252|NCT02901431|58873143|FG012|Main Treatment Part|Physician Decision|0|||
30847253|NCT02901431|58873131|FG000|Main Treatment Part|Withdrawal by Subject|0|||
30847254|NCT02901431|58873132|FG001|Main Treatment Part|Withdrawal by Subject|0|||
30847255|NCT02901431|58873133|FG002|Main Treatment Part|Withdrawal by Subject|0|||
30847256|NCT02901431|58873134|FG003|Main Treatment Part|Withdrawal by Subject|18|||
30847257|NCT02901431|58873135|FG004|Main Treatment Part|Withdrawal by Subject|3|||
30847258|NCT02901431|58873136|FG005|Main Treatment Part|Withdrawal by Subject|5|||
30847259|NCT02901431|58873137|FG006|Main Treatment Part|Withdrawal by Subject|6|||
30847260|NCT02901431|58873138|FG007|Main Treatment Part|Withdrawal by Subject|0|||
30847261|NCT02901431|58873139|FG008|Main Treatment Part|Withdrawal by Subject|0|||
30847262|NCT02901431|58873140|FG009|Main Treatment Part|Withdrawal by Subject|0|||
30847263|NCT02901431|58873141|FG010|Main Treatment Part|Withdrawal by Subject|0|||
30847264|NCT02901431|58873142|FG011|Main Treatment Part|Withdrawal by Subject|0|||
30847265|NCT02901431|58873143|FG012|Main Treatment Part|Withdrawal by Subject|0|||
30847266|NCT02901431|58873131|FG000|Open Label Part|Adverse Event|0|||
30847267|NCT02901431|58873132|FG001|Open Label Part|Adverse Event|0|||
30847268|NCT02901431|58873133|FG002|Open Label Part|Adverse Event|0|||
30847269|NCT02901431|58873134|FG003|Open Label Part|Adverse Event|0|||
30847270|NCT02901431|58873135|FG004|Open Label Part|Adverse Event|0|||
30847271|NCT02901431|58873136|FG005|Open Label Part|Adverse Event|0|||
30847272|NCT02901431|58873137|FG006|Open Label Part|Adverse Event|0|||
30847273|NCT02901431|58873138|FG007|Open Label Part|Adverse Event|0|||
30847274|NCT02901431|58873139|FG008|Open Label Part|Adverse Event|4|||
30847275|NCT02901431|58873140|FG009|Open Label Part|Adverse Event|4|||
30847276|NCT02901431|58873141|FG010|Open Label Part|Adverse Event|0|||
30847277|NCT02901431|58873142|FG011|Open Label Part|Adverse Event|4|||
30847278|NCT02901431|58873143|FG012|Open Label Part|Adverse Event|1|||
30847279|NCT02901431|58873131|FG000|Open Label Part|Lost to Follow-up|0|||
30847280|NCT02901431|58873132|FG001|Open Label Part|Lost to Follow-up|0|||
30847281|NCT02901431|58873133|FG002|Open Label Part|Lost to Follow-up|0|||
30847282|NCT02901431|58873134|FG003|Open Label Part|Lost to Follow-up|0|||
30950275|NCT01948427|58997031|FG003|Overall Study|Lost to Follow-up|0|||
30950276|NCT01948427|58997032|FG004|Overall Study|Lost to Follow-up|4|||
30950277|NCT01948427|58997028|FG000|Overall Study|Withdrawal by Subject|2|||
30950278|NCT01948427|58997029|FG001|Overall Study|Withdrawal by Subject|0|||
30950279|NCT01948427|58997030|FG002|Overall Study|Withdrawal by Subject|0|||
30950280|NCT01948427|58997031|FG003|Overall Study|Withdrawal by Subject|0|||
30847283|NCT02901431|58873135|FG004|Open Label Part|Lost to Follow-up|0|||
30847284|NCT02901431|58873136|FG005|Open Label Part|Lost to Follow-up|0|||
30847285|NCT02901431|58873137|FG006|Open Label Part|Lost to Follow-up|0|||
30847286|NCT02901431|58873138|FG007|Open Label Part|Lost to Follow-up|0|||
30847287|NCT02901431|58873139|FG008|Open Label Part|Lost to Follow-up|2|||
30847288|NCT02901431|58873140|FG009|Open Label Part|Lost to Follow-up|2|||
30847289|NCT02901431|58873141|FG010|Open Label Part|Lost to Follow-up|1|||
30847290|NCT02901431|58873142|FG011|Open Label Part|Lost to Follow-up|1|||
30847291|NCT02901431|58873143|FG012|Open Label Part|Lost to Follow-up|1|||
30847292|NCT02901431|58873131|FG000|Open Label Part|Physician Decision|0|||
30847293|NCT02901431|58873132|FG001|Open Label Part|Physician Decision|0|||
30847294|NCT02901431|58873133|FG002|Open Label Part|Physician Decision|0|||
30847295|NCT02901431|58873134|FG003|Open Label Part|Physician Decision|0|||
30950281|NCT01948427|58997032|FG004|Overall Study|Withdrawal by Subject|1|||
30950282|NCT01948427|58997028|FG000|Overall Study|Other, Not Specified|1|||
30847296|NCT02901431|58873135|FG004|Open Label Part|Physician Decision|0|||
30847297|NCT02901431|58873136|FG005|Open Label Part|Physician Decision|0|||
30847298|NCT02901431|58873137|FG006|Open Label Part|Physician Decision|0|||
30847299|NCT02901431|58873138|FG007|Open Label Part|Physician Decision|0|||
30847300|NCT02901431|58873139|FG008|Open Label Part|Physician Decision|1|||
30847301|NCT02901431|58873140|FG009|Open Label Part|Physician Decision|1|||
30847302|NCT02901431|58873141|FG010|Open Label Part|Physician Decision|0|||
30847303|NCT02901431|58873142|FG011|Open Label Part|Physician Decision|0|||
30847304|NCT02901431|58873143|FG012|Open Label Part|Physician Decision|0|||
30847305|NCT02901431|58873131|FG000|Open Label Part|Study Terminated By Sponsor|0|||
30847306|NCT02901431|58873132|FG001|Open Label Part|Study Terminated By Sponsor|0|||
30847307|NCT02901431|58873133|FG002|Open Label Part|Study Terminated By Sponsor|0|||
30847308|NCT02901431|58873134|FG003|Open Label Part|Study Terminated By Sponsor|0|||
30847309|NCT02901431|58873135|FG004|Open Label Part|Study Terminated By Sponsor|0|||
30847310|NCT02901431|58873136|FG005|Open Label Part|Study Terminated By Sponsor|0|||
30847311|NCT02901431|58873137|FG006|Open Label Part|Study Terminated By Sponsor|0|||
30847312|NCT02901431|58873138|FG007|Open Label Part|Study Terminated By Sponsor|0|||
30847313|NCT02901431|58873139|FG008|Open Label Part|Study Terminated By Sponsor|35|||
30847314|NCT02901431|58873140|FG009|Open Label Part|Study Terminated By Sponsor|12|||
30847315|NCT02901431|58873141|FG010|Open Label Part|Study Terminated By Sponsor|21|||
30847316|NCT02901431|58873142|FG011|Open Label Part|Study Terminated By Sponsor|31|||
30847317|NCT02901431|58873143|FG012|Open Label Part|Study Terminated By Sponsor|0|||
30847318|NCT02901431|58873131|FG000|Open Label Part|Withdrawal by Subject|0|||
30847319|NCT02901431|58873132|FG001|Open Label Part|Withdrawal by Subject|0|||
30847320|NCT02901431|58873133|FG002|Open Label Part|Withdrawal by Subject|0|||
30847321|NCT02901431|58873134|FG003|Open Label Part|Withdrawal by Subject|0|||
30847322|NCT02901431|58873135|FG004|Open Label Part|Withdrawal by Subject|0|||
30847323|NCT02901431|58873136|FG005|Open Label Part|Withdrawal by Subject|0|||
30847324|NCT02901431|58873137|FG006|Open Label Part|Withdrawal by Subject|0|||
30847325|NCT02901431|58873138|FG007|Open Label Part|Withdrawal by Subject|0|||
30847326|NCT02901431|58873139|FG008|Open Label Part|Withdrawal by Subject|6|||
30847327|NCT02901431|58873140|FG009|Open Label Part|Withdrawal by Subject|5|||
30847328|NCT02901431|58873141|FG010|Open Label Part|Withdrawal by Subject|7|||
30847329|NCT02901431|58873142|FG011|Open Label Part|Withdrawal by Subject|3|||
30847330|NCT02901431|58873143|FG012|Open Label Part|Withdrawal by Subject|1|||
30847331|NCT02873377|58873170|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
30847332|NCT02873377|58873171|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
30847333|NCT02873377|58873170|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
30847334|NCT02873377|58873171|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
30847335|NCT02966795|58873180|FG000|Overall Study|Patient Left the Country|0|||
30847336|NCT02966795|58873181|FG001|Overall Study|Patient Left the Country|1|||
30847337|NCT02873221|58873189|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
30847338|NCT02873221|58873190|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
30847339|NCT02873221|58873191|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
30847340|NCT02873221|58873189|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
30847341|NCT02873221|58873190|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
30847342|NCT02873221|58873191|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
30847343|NCT02873221|58873189|FG000|Treatment Period|Protocol Violation|2|||
30847344|NCT02873221|58873190|FG001|Treatment Period|Protocol Violation|5|||
30847345|NCT02873221|58873191|FG002|Treatment Period|Protocol Violation|8|||
30847346|NCT02873221|58873189|FG000|Treatment Period|Pregnancy|4|||
30847347|NCT02873221|58873190|FG001|Treatment Period|Pregnancy|6|||
30847348|NCT02873221|58873191|FG002|Treatment Period|Pregnancy|3|||
30847349|NCT02873221|58873189|FG000|Treatment Period|Lack of Qualifying Event|0|||
30847350|NCT02873221|58873190|FG001|Treatment Period|Lack of Qualifying Event|3|||
30847351|NCT02873221|58873191|FG002|Treatment Period|Lack of Qualifying Event|1|||
30847352|NCT02873221|58873189|FG000|Treatment Period|Withdrawal of Consent|52|||
30847353|NCT02873221|58873190|FG001|Treatment Period|Withdrawal of Consent|51|||
30847354|NCT02873221|58873191|FG002|Treatment Period|Withdrawal of Consent|41|||
30847355|NCT02873221|58873189|FG000|Treatment Period|Lack of Efficacy|0|||
30847356|NCT02873221|58873190|FG001|Treatment Period|Lack of Efficacy|17|||
30847357|NCT02873221|58873191|FG002|Treatment Period|Lack of Efficacy|12|||
30847358|NCT02873221|58873189|FG000|Treatment Period|Adverse Event|4|||
30847359|NCT02873221|58873190|FG001|Treatment Period|Adverse Event|9|||
30847360|NCT02873221|58873191|FG002|Treatment Period|Adverse Event|11|||
30847361|NCT02873221|58873189|FG000|Treatment Period|Lost to Follow-up|26|||
30847362|NCT02873221|58873190|FG001|Treatment Period|Lost to Follow-up|30|||
30847363|NCT02873221|58873191|FG002|Treatment Period|Lost to Follow-up|26|||
30847364|NCT02873221|58873189|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
30847365|NCT02873221|58873190|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
30847366|NCT02873221|58873191|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
30847367|NCT02873221|58873189|FG000|Safety Follow-up Period|Protocol Violation|0|||
30847368|NCT02873221|58873190|FG001|Safety Follow-up Period|Protocol Violation|0|||
30847369|NCT02873221|58873191|FG002|Safety Follow-up Period|Protocol Violation|1|||
30847370|NCT02873221|58873189|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
30847371|NCT02873221|58873190|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
30847372|NCT02873221|58873191|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
30847373|NCT02873221|58873189|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
30847374|NCT02873221|58873190|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
30847375|NCT02873221|58873191|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
30847376|NCT02968979|58873199|FG000|Overall Study|Protocol Violation|7|||
30847377|NCT02968979|58873199|FG000|Overall Study|Withdrawal by Subject|1|||
30847378|NCT02966015|58873251|FG000|Inclusion Visit|did not answer questionnaire|8|||
30847379|NCT02966015|58873252|FG001|Inclusion Visit|did not answer questionnaire|3|||
30847380|NCT02968433|58873258|FG000|Overall Study|Withdrawal by Subject|1|||
30847381|NCT02872285|58873270|FG000|Overall Study|Withdrawal by Subject|2|||
30847382|NCT02872285|58873271|FG001|Overall Study|Withdrawal by Subject|0|||
30847383|NCT02872285|58873270|FG000|Overall Study|Lost to Follow-up|2|||
30847384|NCT02872285|58873271|FG001|Overall Study|Lost to Follow-up|2|||
30847385|NCT02872285|58873270|FG000|Overall Study|Discontinued due to back surgery|1|||
30847386|NCT02872285|58873271|FG001|Overall Study|Discontinued due to back surgery|0|||
30847387|NCT02871739|58873281|FG000|Overall Study|Lost to Follow-up|3|||
30847388|NCT02871739|58873282|FG001|Overall Study|Lost to Follow-up|2|||
30847389|NCT02871739|58873283|FG002|Overall Study|Lost to Follow-up|0|||
30847390|NCT02871739|58873284|FG003|Overall Study|Lost to Follow-up|2|||
30847391|NCT02896361|58873294|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
30847392|NCT02896361|58873295|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
30847393|NCT02896361|58873296|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
30847394|NCT02896361|58873294|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
30847395|NCT02896361|58873295|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
30847396|NCT02896361|58873296|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
30847397|NCT02962739|58873319|FG000|Overall Study|Withdrawal by Subject|0|||
30847398|NCT02962739|58873320|FG001|Overall Study|Withdrawal by Subject|1|||
30847399|NCT02962739|58873321|FG002|Overall Study|Withdrawal by Subject|0|||
30847400|NCT02962739|58873322|FG003|Overall Study|Withdrawal by Subject|0|||
30847401|NCT02962739|58873323|FG004|Overall Study|Withdrawal by Subject|0|||
30847402|NCT02962739|58873324|FG005|Overall Study|Withdrawal by Subject|0|||
30847403|NCT02962739|58873319|FG000|Overall Study|Protocol Violation|0|||
30847404|NCT02962739|58873320|FG001|Overall Study|Protocol Violation|0|||
30847405|NCT02962739|58873321|FG002|Overall Study|Protocol Violation|1|||
30847406|NCT02962739|58873322|FG003|Overall Study|Protocol Violation|0|||
30847407|NCT02962739|58873323|FG004|Overall Study|Protocol Violation|1|||
30847408|NCT02962739|58873324|FG005|Overall Study|Protocol Violation|0|||
30847409|NCT01344629|58873332|FG000|Crossover Period 2|Withdrawal by Subject|0|||
30847410|NCT01344629|58873333|FG001|Crossover Period 2|Withdrawal by Subject|1|||
30847411|NCT01092117|58873339|FG000|Index Procedure to 1 Month|Death|1|||
30847412|NCT01092117|58873339|FG000|1 Month|Death|1|||
30847413|NCT01092117|58873339|FG000|1 Month|Withdrawal by Subject|1|||
30847414|NCT01092117|58873339|FG000|1 Month|Lost to Follow-up|1|||
30847415|NCT01092117|58873339|FG000|6 Months|Death|2|||
30847416|NCT01092117|58873339|FG000|6 Months|Withdrawal by Subject|3|||
30847417|NCT01092117|58873339|FG000|12 Month|Death|11|||
30847418|NCT01092117|58873339|FG000|12 Month|Withdrawal by Subject|2|||
30847419|NCT01092117|58873339|FG000|12 Month|Lost to Follow-up|1|||
30847420|NCT01092117|58873339|FG000|Year 2|Death|5|||
30847421|NCT01092117|58873339|FG000|Year 2|Withdrawal by Subject|4|||
30847422|NCT01092117|58873339|FG000|Year 2|Lost to Follow-up|1|||
30847423|NCT01092117|58873339|FG000|Year 3|Death|7|||
30847424|NCT01092117|58873339|FG000|Year 3|Withdrawal by Subject|9|||
30847425|NCT01092117|58873339|FG000|Year 3|Lost to Follow-up|3|||
30847426|NCT01092117|58873339|FG000|Year 4|Death|8|||
30847427|NCT01092117|58873339|FG000|Year 4|Withdrawal by Subject|4|||
30847428|NCT01092117|58873339|FG000|Year 4|Lost to Follow-up|4|||
30847429|NCT01065779|58873352|FG000|Overall Study|Duplicate Investigation|1|||
30847430|NCT01065779|58873352|FG000|Overall Study|Investigation Before Contract Date|37|||
30847431|NCT01065779|58873352|FG000|Overall Study|Non-enrollment Period Administration|10|||
30847432|NCT01065779|58873352|FG000|Overall Study|Not Administered With Study Drug|17|||
30847433|NCT01065779|58873352|FG000|Overall Study|Failed to Follow-up|10|||
30847434|NCT01065779|58873352|FG000|Overall Study|Inclusion Criteria Violation|7|||
30847435|NCT02963441|58873356|FG000|Overall Study|Protocol violation or withdrawn|8|||
30847436|NCT02963441|58873356|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
30847437|NCT02963441|58873356|FG000|Overall Study|IDx-DR insufficient quality|33|||
30847438|NCT01345253|58873363|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
30847439|NCT01345253|58873364|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
30847440|NCT01345253|58873363|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
30847441|NCT01345253|58873364|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
30847442|NCT01345253|58873363|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
30847443|NCT01345253|58873364|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
30847444|NCT01345253|58873363|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
30847445|NCT01345253|58873364|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
30847446|NCT01345253|58873363|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
30847447|NCT01345253|58873364|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
30847448|NCT01345253|58873363|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
30847449|NCT01345253|58873364|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
30847450|NCT01345253|58873363|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
30847451|NCT01345253|58873364|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
30847452|NCT01345253|58873363|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
30847453|NCT01345253|58873364|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
30847454|NCT01345253|58873363|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
30847455|NCT01345253|58873364|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
30847456|NCT01345253|58873363|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
30847457|NCT01345253|58873364|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
30847458|NCT01345253|58873363|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
30847459|NCT01345253|58873364|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
30847460|NCT01345253|58873363|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
30847461|NCT01345253|58873364|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
30847462|NCT01345253|58873363|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
30847463|NCT01345253|58873364|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
30847464|NCT01345253|58873363|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
30847465|NCT01345253|58873364|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
30847466|NCT01345253|58873363|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
30847467|NCT01345253|58873364|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
30950283|NCT01948427|58997029|FG001|Overall Study|Other, Not Specified|9|||
30950284|NCT01948427|58997030|FG002|Overall Study|Other, Not Specified|0|||
30950285|NCT01948427|58997031|FG003|Overall Study|Other, Not Specified|0|||
30950286|NCT01948427|58997032|FG004|Overall Study|Other, Not Specified|2|||
30950287|NCT01948193|58997049|FG000|Overall Study|Serious event|2|||
30950288|NCT01948193|58997049|FG000|Overall Study|Lost to Follow-up|7|||
30950289|NCT01694485|58997059|FG000|Overall Study|Withdrawal by Subject|20|||
30950290|NCT01694485|58997060|FG001|Overall Study|Withdrawal by Subject|6|||
30626212|NCT01200758|58638316|FG000|Stage I|Disease Progression|9|||
30847468|NCT02477800|58873375|FG000|Placebo-Controlled Period|Adverse Event|16|||
30847469|NCT02477800|58873376|FG001|Placebo-Controlled Period|Adverse Event|25|||
30950291|NCT01694485|58997061|FG002|Overall Study|Withdrawal by Subject|7|||
30847470|NCT02477800|58873377|FG002|Placebo-Controlled Period|Adverse Event|28|||
30847471|NCT02477800|58873378|FG003|Placebo-Controlled Period|Adverse Event|0|||
30847472|NCT02477800|58873379|FG004|Placebo-Controlled Period|Adverse Event|0|||
30847473|NCT02477800|58873380|FG005|Placebo-Controlled Period|Adverse Event|0|||
30847474|NCT02477800|58873381|FG006|Placebo-Controlled Period|Adverse Event|0|||
30847475|NCT02477800|58873375|FG000|Placebo-Controlled Period|Change of Treatment|1|||
30847476|NCT02477800|58873376|FG001|Placebo-Controlled Period|Change of Treatment|2|||
30847477|NCT02477800|58873377|FG002|Placebo-Controlled Period|Change of Treatment|1|||
30847478|NCT02477800|58873378|FG003|Placebo-Controlled Period|Change of Treatment|0|||
30847479|NCT02477800|58873379|FG004|Placebo-Controlled Period|Change of Treatment|0|||
30847480|NCT02477800|58873380|FG005|Placebo-Controlled Period|Change of Treatment|0|||
30847481|NCT02477800|58873381|FG006|Placebo-Controlled Period|Change of Treatment|0|||
30950292|NCT01694485|58997062|FG003|Overall Study|Withdrawal by Subject|25|||
30950293|NCT01694485|58997063|FG004|Overall Study|Withdrawal by Subject|18|||
30847482|NCT02477800|58873375|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
30847483|NCT02477800|58873376|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
30847484|NCT02477800|58873377|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
30847485|NCT02477800|58873378|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
30847486|NCT02477800|58873379|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
30847487|NCT02477800|58873380|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
30847488|NCT02477800|58873381|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
30847489|NCT02477800|58873375|FG000|Placebo-Controlled Period|Death|0|||
30847490|NCT02477800|58873376|FG001|Placebo-Controlled Period|Death|3|||
30847491|NCT02477800|58873377|FG002|Placebo-Controlled Period|Death|2|||
30847492|NCT02477800|58873378|FG003|Placebo-Controlled Period|Death|0|||
30847493|NCT02477800|58873379|FG004|Placebo-Controlled Period|Death|0|||
30847494|NCT02477800|58873380|FG005|Placebo-Controlled Period|Death|0|||
30847495|NCT02477800|58873381|FG006|Placebo-Controlled Period|Death|0|||
30847496|NCT02477800|58873375|FG000|Placebo-Controlled Period|Disease Progression|1|||
30847497|NCT02477800|58873376|FG001|Placebo-Controlled Period|Disease Progression|0|||
30847498|NCT02477800|58873377|FG002|Placebo-Controlled Period|Disease Progression|1|||
30847499|NCT02477800|58873378|FG003|Placebo-Controlled Period|Disease Progression|0|||
30847500|NCT02477800|58873379|FG004|Placebo-Controlled Period|Disease Progression|0|||
30847501|NCT02477800|58873380|FG005|Placebo-Controlled Period|Disease Progression|0|||
30847502|NCT02477800|58873381|FG006|Placebo-Controlled Period|Disease Progression|0|||
30847503|NCT02477800|58873375|FG000|Placebo-Controlled Period|Investigator Decision|3|||
30847504|NCT02477800|58873376|FG001|Placebo-Controlled Period|Investigator Decision|2|||
30847505|NCT02477800|58873377|FG002|Placebo-Controlled Period|Investigator Decision|1|||
30847506|NCT02477800|58873378|FG003|Placebo-Controlled Period|Investigator Decision|0|||
30847507|NCT02477800|58873379|FG004|Placebo-Controlled Period|Investigator Decision|0|||
30847508|NCT02477800|58873380|FG005|Placebo-Controlled Period|Investigator Decision|0|||
30847509|NCT02477800|58873381|FG006|Placebo-Controlled Period|Investigator Decision|0|||
30847510|NCT02477800|58873375|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
30950294|NCT01694485|58997059|FG000|Overall Study|Sponsor Decision|3|||
30950295|NCT01694485|58997060|FG001|Overall Study|Sponsor Decision|0|||
30950296|NCT01694485|58997061|FG002|Overall Study|Sponsor Decision|0|||
30950297|NCT01694485|58997062|FG003|Overall Study|Sponsor Decision|2|||
30950298|NCT01694485|58997063|FG004|Overall Study|Sponsor Decision|0|||
30950299|NCT01694485|58997059|FG000|Overall Study|Lost to Follow-up|9|||
30847511|NCT02477800|58873376|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
30847512|NCT02477800|58873377|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
30950300|NCT01694485|58997060|FG001|Overall Study|Lost to Follow-up|1|||
30950301|NCT01694485|58997061|FG002|Overall Study|Lost to Follow-up|6|||
30847513|NCT02477800|58873378|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
30847514|NCT02477800|58873379|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
30847515|NCT02477800|58873380|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
30847516|NCT02477800|58873381|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
30847517|NCT02477800|58873375|FG000|Placebo-Controlled Period|Relocation|2|||
30847518|NCT02477800|58873376|FG001|Placebo-Controlled Period|Relocation|0|||
30847519|NCT02477800|58873377|FG002|Placebo-Controlled Period|Relocation|0|||
30847520|NCT02477800|58873378|FG003|Placebo-Controlled Period|Relocation|0|||
30847521|NCT02477800|58873379|FG004|Placebo-Controlled Period|Relocation|0|||
30847522|NCT02477800|58873380|FG005|Placebo-Controlled Period|Relocation|0|||
30847523|NCT02477800|58873381|FG006|Placebo-Controlled Period|Relocation|0|||
30847524|NCT02477800|58873375|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
30847525|NCT02477800|58873376|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
30950302|NCT01694485|58997062|FG003|Overall Study|Lost to Follow-up|10|||
30950303|NCT01694485|58997063|FG004|Overall Study|Lost to Follow-up|7|||
30950304|NCT01694485|58997059|FG000|Overall Study|Death|1|||
30950305|NCT01694485|58997060|FG001|Overall Study|Death|0|||
30847526|NCT02477800|58873377|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
30847527|NCT02477800|58873378|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
30847528|NCT02477800|58873379|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
30847529|NCT02477800|58873380|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
30847530|NCT02477800|58873381|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
30847531|NCT02477800|58873375|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
30847532|NCT02477800|58873376|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
30847533|NCT02477800|58873377|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
30847534|NCT02477800|58873378|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
30847535|NCT02477800|58873379|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
30847536|NCT02477800|58873380|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
30847537|NCT02477800|58873381|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
30847538|NCT02477800|58873375|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
30847539|NCT02477800|58873376|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
30847540|NCT02477800|58873377|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
30847541|NCT02477800|58873378|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
30847542|NCT02477800|58873379|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
30847543|NCT02477800|58873380|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
30847544|NCT02477800|58873381|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
30847545|NCT02477800|58873375|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
30847546|NCT02477800|58873376|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
30847547|NCT02477800|58873377|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
30847548|NCT02477800|58873378|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
30847549|NCT02477800|58873379|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
30847550|NCT02477800|58873380|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
30847551|NCT02477800|58873381|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
30847552|NCT02477800|58873375|FG000|Placebo-Controlled Period|Reason not Specified|161|||
30847553|NCT02477800|58873376|FG001|Placebo-Controlled Period|Reason not Specified|161|||
30847554|NCT02477800|58873377|FG002|Placebo-Controlled Period|Reason not Specified|189|||
30847555|NCT02477800|58873378|FG003|Placebo-Controlled Period|Reason not Specified|0|||
30847556|NCT02477800|58873379|FG004|Placebo-Controlled Period|Reason not Specified|0|||
30847557|NCT02477800|58873380|FG005|Placebo-Controlled Period|Reason not Specified|0|||
30847558|NCT02477800|58873381|FG006|Placebo-Controlled Period|Reason not Specified|0|||
30847559|NCT02477800|58873375|FG000|Long Term Extension Period|Adverse Event|0|||
30847560|NCT02477800|58873376|FG001|Long Term Extension Period|Adverse Event|0|||
30847561|NCT02477800|58873377|FG002|Long Term Extension Period|Adverse Event|0|||
30847562|NCT02477800|58873378|FG003|Long Term Extension Period|Adverse Event|6|||
30847563|NCT02477800|58873379|FG004|Long Term Extension Period|Adverse Event|2|||
30847564|NCT02477800|58873380|FG005|Long Term Extension Period|Adverse Event|4|||
30847565|NCT02477800|58873381|FG006|Long Term Extension Period|Adverse Event|3|||
30847566|NCT02477800|58873375|FG000|Long Term Extension Period|Death|0|||
30847567|NCT02477800|58873376|FG001|Long Term Extension Period|Death|0|||
30847568|NCT02477800|58873377|FG002|Long Term Extension Period|Death|0|||
30847569|NCT02477800|58873378|FG003|Long Term Extension Period|Death|1|||
30847570|NCT02477800|58873379|FG004|Long Term Extension Period|Death|1|||
30847571|NCT02477800|58873380|FG005|Long Term Extension Period|Death|1|||
30847572|NCT02477800|58873381|FG006|Long Term Extension Period|Death|2|||
30847573|NCT02477800|58873375|FG000|Long Term Extension Period|Consent Withdrawn|0|||
30847574|NCT02477800|58873376|FG001|Long Term Extension Period|Consent Withdrawn|0|||
30847575|NCT02477800|58873377|FG002|Long Term Extension Period|Consent Withdrawn|0|||
30847576|NCT02477800|58873378|FG003|Long Term Extension Period|Consent Withdrawn|10|||
30847577|NCT02477800|58873379|FG004|Long Term Extension Period|Consent Withdrawn|4|||
30847578|NCT02477800|58873380|FG005|Long Term Extension Period|Consent Withdrawn|13|||
30847579|NCT02477800|58873381|FG006|Long Term Extension Period|Consent Withdrawn|16|||
30847580|NCT02477800|58873375|FG000|Long Term Extension Period|Disease Progression|0|||
30847581|NCT02477800|58873376|FG001|Long Term Extension Period|Disease Progression|0|||
30847582|NCT02477800|58873377|FG002|Long Term Extension Period|Disease Progression|0|||
30847583|NCT02477800|58873378|FG003|Long Term Extension Period|Disease Progression|3|||
30847584|NCT02477800|58873379|FG004|Long Term Extension Period|Disease Progression|1|||
30847585|NCT02477800|58873380|FG005|Long Term Extension Period|Disease Progression|1|||
30847586|NCT02477800|58873381|FG006|Long Term Extension Period|Disease Progression|0|||
30847587|NCT02477800|58873375|FG000|Long Term Extension Period|Investigator Decision|0|||
30847588|NCT02477800|58873376|FG001|Long Term Extension Period|Investigator Decision|0|||
30847589|NCT02477800|58873377|FG002|Long Term Extension Period|Investigator Decision|0|||
30847590|NCT02477800|58873378|FG003|Long Term Extension Period|Investigator Decision|0|||
30847591|NCT02477800|58873379|FG004|Long Term Extension Period|Investigator Decision|0|||
30847592|NCT02477800|58873380|FG005|Long Term Extension Period|Investigator Decision|0|||
30847593|NCT02477800|58873381|FG006|Long Term Extension Period|Investigator Decision|2|||
30847594|NCT02477800|58873375|FG000|Long Term Extension Period|Lost to Follow-up|0|||
30847595|NCT02477800|58873376|FG001|Long Term Extension Period|Lost to Follow-up|0|||
30847596|NCT02477800|58873377|FG002|Long Term Extension Period|Lost to Follow-up|0|||
30847597|NCT02477800|58873378|FG003|Long Term Extension Period|Lost to Follow-up|0|||
30847598|NCT02477800|58873379|FG004|Long Term Extension Period|Lost to Follow-up|1|||
30950306|NCT01694485|58997061|FG002|Overall Study|Death|0|||
30950307|NCT01694485|58997062|FG003|Overall Study|Death|1|||
30950308|NCT01694485|58997063|FG004|Overall Study|Death|0|||
30950309|NCT01931735|58997084|FG000|Randomized Phase|Lost to Follow-up|2|||
30950310|NCT01931735|58997085|FG001|Randomized Phase|Lost to Follow-up|2|||
30950311|NCT01931735|58997086|FG002|Randomized Phase|Lost to Follow-up|5|||
30950312|NCT01931735|58997087|FG003|Randomized Phase|Lost to Follow-up|0|||
30950313|NCT01931735|58997084|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
30950314|NCT01931735|58997085|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
30950315|NCT01931735|58997086|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
30950316|NCT01931735|58997087|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
30950317|NCT01931735|58997084|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
30950318|NCT01931735|58997085|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
30950319|NCT01931735|58997086|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
30950320|NCT01931735|58997087|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
30950321|NCT01930799|58997097|FG000|Overall Study|Withdrawal by Subject|3|||
30950322|NCT01930799|58997097|FG000|Overall Study|Lost to Follow-up|5|||
30950323|NCT01947491|58997105|FG000|Overall Study|Lost to Follow-up|5|||
30950324|NCT01947491|58997106|FG001|Overall Study|Lost to Follow-up|3|||
30950325|NCT01947491|58997107|FG002|Overall Study|Lost to Follow-up|1|||
30950326|NCT01947491|58997108|FG003|Overall Study|Lost to Follow-up|2|||
30950327|NCT01947491|58997105|FG000|Overall Study|Lack of Efficacy|1|||
30847599|NCT02477800|58873380|FG005|Long Term Extension Period|Lost to Follow-up|3|||
30847600|NCT02477800|58873381|FG006|Long Term Extension Period|Lost to Follow-up|0|||
30847601|NCT02477800|58873375|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
30847602|NCT02477800|58873376|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
30847603|NCT02477800|58873377|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
30847604|NCT02477800|58873378|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
30847605|NCT02477800|58873379|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
30847606|NCT02477800|58873380|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
30950328|NCT01947491|58997106|FG001|Overall Study|Lack of Efficacy|0|||
30950329|NCT01947491|58997107|FG002|Overall Study|Lack of Efficacy|0|||
30762937|NCT03416374|58771641|FG001|Treatment Period II|Lack of Efficacy|11|||
30762938|NCT03416374|58771640|FG000|Treatment Period II|Adverse Event|1|||
30762939|NCT03416374|58771641|FG001|Treatment Period II|Adverse Event|4|||
30762940|NCT03416374|58771640|FG000|Treatment Period II|Death|0|||
30762941|NCT03416374|58771641|FG001|Treatment Period II|Death|1|||
30762942|NCT03416374|58771640|FG000|Treatment Period II|Other|0|||
30762943|NCT03416374|58771641|FG001|Treatment Period II|Other|2|||
30762944|NCT03799952|58771652|FG000|Overall Study|Program was too easy, discontinued|1|||
30762945|NCT03799952|58771653|FG001|Overall Study|Program was too easy, discontinued|0|||
30762946|NCT03799952|58771652|FG000|Overall Study|Lost to Follow-up|0|||
30762947|NCT03799952|58771653|FG001|Overall Study|Lost to Follow-up|2|||
30762948|NCT00077766|58771661|FG000|Overall Study|Adverse Event|1|||
30762949|NCT00077766|58771662|FG001|Overall Study|Adverse Event|1|||
30762950|NCT00077766|58771661|FG000|Overall Study|Withdrawal by Subject|4|||
30762951|NCT00077766|58771662|FG001|Overall Study|Withdrawal by Subject|3|||
30762952|NCT00077766|58771661|FG000|Overall Study|Death|12|||
30762953|NCT00077766|58771662|FG001|Overall Study|Death|10|||
30626213|NCT01200758|58638317|FG001|Stage I|Disease Progression|7|||
30626214|NCT01200758|58638318|FG002|Stage I|Disease Progression|0|||
30626215|NCT01200758|58638319|FG003|Stage I|Disease Progression|0|||
30626216|NCT01200758|58638316|FG000|Stage 2|Disease Progression|0|||
30626217|NCT01200758|58638317|FG001|Stage 2|Disease Progression|0|||
30626218|NCT01200758|58638318|FG002|Stage 2|Disease Progression|16|||
30626219|NCT01200758|58638319|FG003|Stage 2|Disease Progression|21|||
30626220|NCT01200758|58638316|FG000|Stage 2|Lack of Efficacy|0|||
30762954|NCT00077766|58771661|FG000|Overall Study|Lost to Follow-up|2|||
30762955|NCT00077766|58771662|FG001|Overall Study|Lost to Follow-up|0|||
30762956|NCT00077766|58771661|FG000|Overall Study|Protocol Violation|1|||
30762957|NCT00077766|58771662|FG001|Overall Study|Protocol Violation|0|||
30950330|NCT01947491|58997108|FG003|Overall Study|Lack of Efficacy|1|||
30626221|NCT01200758|58638317|FG001|Stage 2|Lack of Efficacy|0|||
30626222|NCT01200758|58638318|FG002|Stage 2|Lack of Efficacy|4|||
30626223|NCT01200758|58638319|FG003|Stage 2|Lack of Efficacy|2|||
30762958|NCT00077766|58771661|FG000|Overall Study|Kidney Transplantation|9|||
30762959|NCT00077766|58771662|FG001|Overall Study|Kidney Transplantation|5|||
30950331|NCT01947491|58997105|FG000|Overall Study|Protocol Violation|1|||
30950332|NCT01947491|58997106|FG001|Overall Study|Protocol Violation|0|||
30950333|NCT01947491|58997107|FG002|Overall Study|Protocol Violation|0|||
30950334|NCT01947491|58997108|FG003|Overall Study|Protocol Violation|0|||
30950335|NCT01947491|58997105|FG000|Overall Study|Withdrawal by Subject|1|||
30950336|NCT01947491|58997106|FG001|Overall Study|Withdrawal by Subject|1|||
30950337|NCT01947491|58997107|FG002|Overall Study|Withdrawal by Subject|1|||
30950338|NCT01947491|58997108|FG003|Overall Study|Withdrawal by Subject|0|||
30950339|NCT01947491|58997105|FG000|Overall Study|Worsening of condition|0|||
30950340|NCT01947491|58997106|FG001|Overall Study|Worsening of condition|1|||
30950341|NCT01947491|58997107|FG002|Overall Study|Worsening of condition|0|||
30847607|NCT02477800|58873381|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
30847608|NCT02477800|58873375|FG000|Long Term Extension Period|Study Visit Burden|0|||
30847609|NCT02477800|58873376|FG001|Long Term Extension Period|Study Visit Burden|0|||
30847610|NCT02477800|58873377|FG002|Long Term Extension Period|Study Visit Burden|0|||
30847611|NCT02477800|58873378|FG003|Long Term Extension Period|Study Visit Burden|3|||
30847612|NCT02477800|58873379|FG004|Long Term Extension Period|Study Visit Burden|0|||
30847613|NCT02477800|58873380|FG005|Long Term Extension Period|Study Visit Burden|2|||
30847614|NCT02477800|58873381|FG006|Long Term Extension Period|Study Visit Burden|2|||
30847615|NCT02477800|58873375|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
30847616|NCT02477800|58873376|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
30847617|NCT02477800|58873377|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
30847618|NCT02477800|58873378|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
30847619|NCT02477800|58873379|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
30847620|NCT02477800|58873380|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
30847621|NCT02477800|58873381|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
30950342|NCT01947491|58997108|FG003|Overall Study|Worsening of condition|0|||
30950343|NCT01947491|58997105|FG000|Overall Study|Adverse Event|0|||
30950344|NCT01947491|58997106|FG001|Overall Study|Adverse Event|1|||
30950345|NCT01947491|58997107|FG002|Overall Study|Adverse Event|0|||
30950346|NCT01947491|58997108|FG003|Overall Study|Adverse Event|2|||
30950347|NCT01715857|58997118|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
30950348|NCT01692301|58997124|FG000|Overall Study|Adverse Event|15|||
30950349|NCT01692301|58997125|FG001|Overall Study|Adverse Event|12|||
30950350|NCT01692301|58997124|FG000|Overall Study|Death|1|||
30950351|NCT01692301|58997125|FG001|Overall Study|Death|2|||
30950352|NCT01692301|58997124|FG000|Overall Study|Lack of Efficacy|0|||
30950353|NCT01692301|58997125|FG001|Overall Study|Lack of Efficacy|5|||
30950354|NCT01692301|58997124|FG000|Overall Study|Non-compliance with study treatment|1|||
30950355|NCT01692301|58997125|FG001|Overall Study|Non-compliance with study treatment|2|||
30950356|NCT01692301|58997124|FG000|Overall Study|Protocol deviation|9|||
30950357|NCT01692301|58997125|FG001|Overall Study|Protocol deviation|2|||
30950358|NCT01692301|58997124|FG000|Overall Study|Patient/guardian decision|16|||
30950359|NCT01692301|58997125|FG001|Overall Study|Patient/guardian decision|15|||
30950360|NCT01692301|58997124|FG000|Overall Study|Technical problems|0|||
30950361|NCT01692301|58997125|FG001|Overall Study|Technical problems|1|||
30950362|NCT01692301|58997124|FG000|Overall Study|Physician Decision|2|||
30950363|NCT01692301|58997125|FG001|Overall Study|Physician Decision|2|||
30950364|NCT01692301|58997124|FG000|Overall Study|Lost to Follow-up|1|||
30950365|NCT01692301|58997125|FG001|Overall Study|Lost to Follow-up|1|||
30950366|NCT01592773|58997131|FG000|Overall Study|Study Terminated by Sponsor|582|||
30950367|NCT01592773|58997131|FG000|Overall Study|Withdrawal by Subject|35|||
30950368|NCT01592773|58997131|FG000|Overall Study|Lost to Follow-up|19|||
30950369|NCT01592773|58997131|FG000|Overall Study|Adverse Event|17|||
30950370|NCT01592773|58997131|FG000|Overall Study|Lack of Efficacy|9|||
30950371|NCT01592773|58997131|FG000|Overall Study|Protocol Violation|2|||
30950372|NCT01592773|58997131|FG000|Overall Study|Inclusion/exclusion not meet|1|||
30950373|NCT01592773|58997131|FG000|Overall Study|Other Reason|1|||
30950374|NCT01930175|58997138|FG000|Core Study|Lost to Follow-up|0|||
30950375|NCT01930175|58997139|FG001|Core Study|Lost to Follow-up|1|||
30950376|NCT01930175|58997140|FG002|Core Study|Lost to Follow-up|0|||
30950377|NCT01930175|58997138|FG000|Core Study|Adverse Event|0|||
30950378|NCT01930175|58997139|FG001|Core Study|Adverse Event|0|||
30950379|NCT01930175|58997140|FG002|Core Study|Adverse Event|1|||
30950380|NCT01592695|58997151|FG000|Overall Study|Lost to Follow-up|8|||
30950381|NCT01592695|58997152|FG001|Overall Study|Lost to Follow-up|4|||
30950382|NCT01929863|58997158|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
30950383|NCT01929863|58997159|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
30950384|NCT01929863|58997158|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
30950385|NCT01929863|58997159|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
30950386|NCT01929863|58997158|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
30950387|NCT01929863|58997159|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
30950388|NCT01918085|58997172|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
30847622|NCT02477800|58873375|FG000|Long Term Extension Period|Reason not Specified|0|||
30847623|NCT02477800|58873376|FG001|Long Term Extension Period|Reason not Specified|0|||
30847624|NCT02477800|58873377|FG002|Long Term Extension Period|Reason not Specified|0|||
30847625|NCT02477800|58873378|FG003|Long Term Extension Period|Reason not Specified|126|||
30847626|NCT02477800|58873379|FG004|Long Term Extension Period|Reason not Specified|140|||
30847627|NCT02477800|58873380|FG005|Long Term Extension Period|Reason not Specified|270|||
30847628|NCT02477800|58873381|FG006|Long Term Extension Period|Reason not Specified|224|||
30847629|NCT02957747|58873395|FG000|Overall Study|Withdrawal by Subject|0|||
30847630|NCT02957747|58873396|FG001|Overall Study|Withdrawal by Subject|3|||
30847631|NCT02957747|58873395|FG000|Overall Study|Lost to Follow-up|10|||
30847632|NCT02957747|58873396|FG001|Overall Study|Lost to Follow-up|5|||
30847633|NCT01344161|58873405|FG000|Overall Study|Lost to Follow-up|4|||
30847634|NCT01344161|58873406|FG001|Overall Study|Lost to Follow-up|1|||
30847635|NCT01344161|58873405|FG000|Overall Study|Pregnancy|0|||
30950389|NCT01918085|58997173|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
30950390|NCT01714687|58997183|FG000|Overall Study|Withdrawal by Subject|1|||
30950391|NCT01714687|58997184|FG001|Overall Study|Withdrawal by Subject|0|||
30950392|NCT01714687|58997183|FG000|Overall Study|Lost to Follow-up|2|||
30950393|NCT01714687|58997184|FG001|Overall Study|Lost to Follow-up|4|||
30950394|NCT01714609|58997194|FG000|Overall Study|Protocol Violation|1|||
30950395|NCT01714609|58997195|FG001|Overall Study|Protocol Violation|0|||
30950396|NCT01929707|58997201|FG000|Intervention Period 1|Lost to Follow-up|0|||
30950397|NCT01929707|58997202|FG001|Intervention Period 1|Lost to Follow-up|0|||
30950398|NCT01929707|58997203|FG002|Intervention Period 1|Lost to Follow-up|0|||
30950399|NCT01929707|58997204|FG003|Intervention Period 1|Lost to Follow-up|1|||
30950400|NCT01929707|58997205|FG004|Intervention Period 1|Lost to Follow-up|0|||
30950401|NCT01929707|58997206|FG005|Intervention Period 1|Lost to Follow-up|0|||
30950402|NCT01929707|58997207|FG006|Intervention Period 1|Lost to Follow-up|0|||
30950403|NCT01929707|58997208|FG007|Intervention Period 1|Lost to Follow-up|0|||
30950404|NCT01929707|58997201|FG000|Intervention Period 1|Withdrawal by Subject|0|||
30950405|NCT01929707|58997202|FG001|Intervention Period 1|Withdrawal by Subject|0|||
30950406|NCT01929707|58997203|FG002|Intervention Period 1|Withdrawal by Subject|0|||
30950407|NCT01929707|58997204|FG003|Intervention Period 1|Withdrawal by Subject|2|||
30847636|NCT01344161|58873406|FG001|Overall Study|Pregnancy|1|||
30847637|NCT01344161|58873405|FG000|Overall Study|Protocol Violation|1|||
30847638|NCT01344161|58873406|FG001|Overall Study|Protocol Violation|1|||
30847639|NCT02451358|58873416|FG000|Overall Study|Withdrawal by Subject|1|||
30847640|NCT02451358|58873417|FG001|Overall Study|Withdrawal by Subject|1|||
30847641|NCT02451358|58873418|FG002|Overall Study|Withdrawal by Subject|0|||
30847642|NCT02451358|58873419|FG003|Overall Study|Withdrawal by Subject|0|||
30847643|NCT02451358|58873416|FG000|Overall Study|Protocol Violation|0|||
30847644|NCT02451358|58873417|FG001|Overall Study|Protocol Violation|1|||
30847645|NCT02451358|58873418|FG002|Overall Study|Protocol Violation|1|||
30847646|NCT02451358|58873419|FG003|Overall Study|Protocol Violation|0|||
30847647|NCT02749721|58873429|FG000|Screening|Withdrawal by Subject|1|||
30847648|NCT02749721|58873429|FG000|Screening|Lost to Follow-up|2|||
30847649|NCT02749721|58873429|FG000|Screening|Protocol Violation|3|||
30847650|NCT02749721|58873429|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
30847651|NCT02749721|58873429|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
30847652|NCT01348139|58873435|FG000|Period 1|Adverse Event|1|||
30847653|NCT01348139|58873436|FG001|Period 1|Adverse Event|0|||
30847654|NCT01348139|58873437|FG002|Period 1|Adverse Event|0|||
30847655|NCT01348139|58873438|FG003|Period 1|Adverse Event|0|||
30847656|NCT01348139|58873439|FG004|Period 1|Adverse Event|0|||
30847657|NCT01348139|58873440|FG005|Period 1|Adverse Event|0|||
30847658|NCT02868229|58873458|FG000|Overall Study|Adverse Event|1|||
30847659|NCT02868229|58873459|FG001|Overall Study|Adverse Event|0|||
30847660|NCT02868229|58873460|FG002|Overall Study|Adverse Event|0|||
30847661|NCT02868229|58873461|FG003|Overall Study|Adverse Event|1|||
30847662|NCT02868229|58873458|FG000|Overall Study|Death|0|||
30847663|NCT02868229|58873459|FG001|Overall Study|Death|0|||
30950408|NCT01929707|58997205|FG004|Intervention Period 1|Withdrawal by Subject|0|||
30950409|NCT01929707|58997206|FG005|Intervention Period 1|Withdrawal by Subject|0|||
30950410|NCT01929707|58997207|FG006|Intervention Period 1|Withdrawal by Subject|0|||
30950411|NCT01929707|58997208|FG007|Intervention Period 1|Withdrawal by Subject|0|||
30950412|NCT01929707|58997201|FG000|Intervention Period 2|Withdrawal by Subject|0|||
30847664|NCT02868229|58873460|FG002|Overall Study|Death|1|||
30847665|NCT02868229|58873461|FG003|Overall Study|Death|1|||
30950413|NCT01929707|58997202|FG001|Intervention Period 2|Withdrawal by Subject|0|||
30847666|NCT02868229|58873458|FG000|Overall Study|Missed dose|0|||
30847667|NCT02868229|58873459|FG001|Overall Study|Missed dose|0|||
30847668|NCT02868229|58873460|FG002|Overall Study|Missed dose|0|||
30847669|NCT02868229|58873461|FG003|Overall Study|Missed dose|3|||
30847670|NCT02956967|58873476|FG000|Overall Study|Adverse Event|3|||
30847671|NCT02956967|58873476|FG000|Overall Study|Reason non-related to neutropenia|10|||
30847672|NCT02956967|58873476|FG000|Overall Study|Lost to Follow-up|5|||
30847673|NCT02956967|58873476|FG000|Overall Study|Missing|1|||
30950414|NCT01929707|58997203|FG002|Intervention Period 2|Withdrawal by Subject|0|||
30847674|NCT02956967|58873476|FG000|Overall Study|Termination of Nivestim administration|29|||
30847675|NCT02867995|58873500|FG000|Overall Study|Withdrawal by Subject|0|||
30847676|NCT02867995|58873501|FG001|Overall Study|Withdrawal by Subject|1|||
30847677|NCT02867995|58873500|FG000|Overall Study|Lost to Follow-up|0|||
30847678|NCT02867995|58873501|FG001|Overall Study|Lost to Follow-up|2|||
30847679|NCT03392883|58873514|FG000|Overall Study|Lost to Follow-up|122|||
30847680|NCT03392883|58873515|FG001|Overall Study|Lost to Follow-up|13|||
30847681|NCT03392883|58873516|FG002|Overall Study|Lost to Follow-up|9|||
30847682|NCT03392883|58873514|FG000|Overall Study|Death|4|||
30847683|NCT03392883|58873515|FG001|Overall Study|Death|0|||
30847684|NCT03392883|58873516|FG002|Overall Study|Death|0|||
30847685|NCT03392883|58873514|FG000|Overall Study|Lack of Efficacy|29|||
30847686|NCT03392883|58873515|FG001|Overall Study|Lack of Efficacy|0|||
30847687|NCT03392883|58873516|FG002|Overall Study|Lack of Efficacy|0|||
30847688|NCT03392883|58873514|FG000|Overall Study|Withdrawal by Subject|180|||
30847689|NCT03392883|58873515|FG001|Overall Study|Withdrawal by Subject|0|||
30847690|NCT03392883|58873516|FG002|Overall Study|Withdrawal by Subject|0|||
30847691|NCT03392883|58873514|FG000|Overall Study|Adverse Event|1|||
30847692|NCT03392883|58873515|FG001|Overall Study|Adverse Event|0|||
30847693|NCT03392883|58873516|FG002|Overall Study|Adverse Event|0|||
30847694|NCT02748863|58873527|FG000|Treatment Period 1|Adverse Event|0|||
30847695|NCT02748863|58873528|FG001|Treatment Period 1|Adverse Event|1|||
30950415|NCT01929707|58997204|FG003|Intervention Period 2|Withdrawal by Subject|0|||
30762960|NCT00077766|58771661|FG000|Overall Study|Transplantation|5|||
30762961|NCT00077766|58771662|FG001|Overall Study|Transplantation|1|||
30762962|NCT00077766|58771661|FG000|Overall Study|Investigators Discretion|1|||
30762963|NCT00077766|58771662|FG001|Overall Study|Investigators Discretion|0|||
30762964|NCT00077766|58771661|FG000|Overall Study|Participant's decision|1|||
30762965|NCT00077766|58771662|FG001|Overall Study|Participant's decision|0|||
30762966|NCT00077766|58771661|FG000|Overall Study|Dialysis Discontinued|1|||
30762967|NCT00077766|58771662|FG001|Overall Study|Dialysis Discontinued|0|||
30762968|NCT00077766|58771661|FG000|Overall Study|Dialysis|0|||
30762969|NCT00077766|58771662|FG001|Overall Study|Dialysis|1|||
30762970|NCT00077766|58771661|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
30762971|NCT00077766|58771662|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
30950416|NCT01929707|58997205|FG004|Intervention Period 2|Withdrawal by Subject|0|||
30950417|NCT01929707|58997206|FG005|Intervention Period 2|Withdrawal by Subject|2|||
30950418|NCT01929707|58997207|FG006|Intervention Period 2|Withdrawal by Subject|0|||
30762972|NCT00077766|58771661|FG000|Overall Study|Started Nocturnal Dialysis|0|||
30847696|NCT02748863|58873529|FG002|Treatment Period 1|Adverse Event|0|||
30847697|NCT02748863|58873530|FG003|Treatment Period 1|Adverse Event|0|||
30847698|NCT02748863|58873531|FG004|Treatment Period 1|Adverse Event|0|||
30847699|NCT02748863|58873527|FG000|Treatment Period 1|Lack of Efficacy|0|||
30847700|NCT02748863|58873528|FG001|Treatment Period 1|Lack of Efficacy|0|||
30847701|NCT02748863|58873529|FG002|Treatment Period 1|Lack of Efficacy|1|||
30950419|NCT01929707|58997208|FG007|Intervention Period 2|Withdrawal by Subject|0|||
30950420|NCT01714063|58997229|FG000|Overall Study|Equipment malfunction|2|||
30950421|NCT01929395|58997240|FG000|Overall Study|Did not complete - non-related toxicity|1|||
30950422|NCT01929395|58997241|FG001|Overall Study|Did not complete - non-related toxicity|0|||
30950423|NCT01929395|58997242|FG002|Overall Study|Did not complete - non-related toxicity|0|||
30950424|NCT01929395|58997240|FG000|Overall Study|Withdrawal by Subject|0|||
30950425|NCT01929395|58997241|FG001|Overall Study|Withdrawal by Subject|1|||
30950426|NCT01929395|58997242|FG002|Overall Study|Withdrawal by Subject|0|||
30950427|NCT01929395|58997240|FG000|Overall Study|Screen Fail|0|||
30950428|NCT01929395|58997241|FG001|Overall Study|Screen Fail|0|||
30950429|NCT01929395|58997242|FG002|Overall Study|Screen Fail|1|||
30950430|NCT01713283|58997254|FG000|Overall Study|Lack of Efficacy|10|||
30950431|NCT01713283|58997255|FG001|Overall Study|Lack of Efficacy|2|||
30950432|NCT01713283|58997254|FG000|Overall Study|Lost to Follow-up|1|||
30950433|NCT01713283|58997255|FG001|Overall Study|Lost to Follow-up|1|||
30626224|NCT01200758|58638316|FG000|Stage 2|Physician Decision|0|||
30847702|NCT02748863|58873530|FG003|Treatment Period 1|Lack of Efficacy|0|||
30847703|NCT02748863|58873531|FG004|Treatment Period 1|Lack of Efficacy|0|||
30950434|NCT01592383|58997265|FG000|Overall Study|Adverse Event|1|||
30762973|NCT00077766|58771662|FG001|Overall Study|Started Nocturnal Dialysis|1|||
30762974|NCT00077766|58771661|FG000|Overall Study|Stop Dialysis|0|||
30847704|NCT02748863|58873527|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30847705|NCT02748863|58873528|FG001|Treatment Period 1|Withdrawal by Subject|1|||
30847706|NCT02748863|58873529|FG002|Treatment Period 1|Withdrawal by Subject|1|||
30847707|NCT02748863|58873530|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30847708|NCT02748863|58873531|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30847709|NCT02748863|58873527|FG000|Treatment Period 2|Lost to Follow-up|2|||
30847710|NCT02748863|58873528|FG001|Treatment Period 2|Lost to Follow-up|0|||
30847711|NCT02748863|58873529|FG002|Treatment Period 2|Lost to Follow-up|0|||
30847712|NCT02748863|58873530|FG003|Treatment Period 2|Lost to Follow-up|0|||
30950435|NCT01691521|58997273|FG000|Overall Study|Adverse Event|4|||
30950436|NCT01691521|58997274|FG001|Overall Study|Adverse Event|0|||
30762975|NCT00077766|58771662|FG001|Overall Study|Stop Dialysis|1|||
30762976|NCT00077766|58771661|FG000|Overall Study|Participants Vacation|2|||
30762977|NCT00077766|58771662|FG001|Overall Study|Participants Vacation|1|||
30762978|NCT03799718|58771669|FG000|Overall Study|Adverse Event|2|||
30762979|NCT03388138|58771675|FG000|Overall Study|Protocol Violation|1|||
30762980|NCT03388138|58771676|FG001|Overall Study|Protocol Violation|0|||
30762981|NCT02952898|58771685|FG000|Overall Study|Withdrawal by Subject|10|||
30762982|NCT02952898|58771686|FG001|Overall Study|Withdrawal by Subject|8|||
30762983|NCT02952898|58771687|FG002|Overall Study|Withdrawal by Subject|8|||
30762984|NCT02952898|58771685|FG000|Overall Study|Adverse Event|8|||
30762985|NCT02952898|58771686|FG001|Overall Study|Adverse Event|8|||
30762986|NCT02952898|58771687|FG002|Overall Study|Adverse Event|3|||
30762987|NCT02952898|58771685|FG000|Overall Study|Lost to Follow-up|3|||
30762988|NCT02952898|58771686|FG001|Overall Study|Lost to Follow-up|2|||
30762989|NCT02952898|58771687|FG002|Overall Study|Lost to Follow-up|2|||
30762990|NCT02952898|58771685|FG000|Overall Study|Non-compliance with study drug|1|||
30762991|NCT02952898|58771686|FG001|Overall Study|Non-compliance with study drug|1|||
30762992|NCT02952898|58771687|FG002|Overall Study|Non-compliance with study drug|2|||
30762993|NCT00045734|58771695|FG000|Overall Study|Protocol Violation|1|||
30762994|NCT03387046|58771701|FG000|Overall Study|Adverse Event|1|||
30762995|NCT03387046|58771702|FG001|Overall Study|Adverse Event|1|||
30762996|NCT00045110|58771711|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
30762997|NCT00045110|58771712|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
30762998|NCT00045110|58771713|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
30762999|NCT00045110|58771711|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
30763000|NCT00045110|58771712|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
30763001|NCT00045110|58771713|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
30763002|NCT00045110|58771711|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
30763003|NCT00045110|58771712|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
30763004|NCT00045110|58771713|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
30763005|NCT03353740|58771730|FG000|Overall Study|Images for these participants not viable|52|||
30763006|NCT00003476|58771734|FG000|Overall Study|Not evaluable|1|||
30763007|NCT00003470|58771738|FG000|Overall Study|Not evaluable|6|||
30763008|NCT03386344|58771745|FG000|Overall Study|Adverse Event|6|||
30763009|NCT03386344|58771746|FG001|Overall Study|Adverse Event|3|||
30763010|NCT03386344|58771747|FG002|Overall Study|Adverse Event|1|||
30763011|NCT03386344|58771745|FG000|Overall Study|Poor Compliance to Protocol|0|||
30763012|NCT03386344|58771746|FG001|Overall Study|Poor Compliance to Protocol|1|||
30763013|NCT03386344|58771747|FG002|Overall Study|Poor Compliance to Protocol|0|||
30763014|NCT03386344|58771745|FG000|Overall Study|Study Terminated by Sponsor|101|||
30763015|NCT03386344|58771746|FG001|Overall Study|Study Terminated by Sponsor|102|||
30763016|NCT03386344|58771747|FG002|Overall Study|Study Terminated by Sponsor|106|||
30763017|NCT03386344|58771745|FG000|Overall Study|Lost to Follow-up|3|||
30763018|NCT03386344|58771746|FG001|Overall Study|Lost to Follow-up|2|||
30763019|NCT03386344|58771747|FG002|Overall Study|Lost to Follow-up|1|||
30763020|NCT03386344|58771745|FG000|Overall Study|At the Participant's own Request|7|||
30763021|NCT03386344|58771746|FG001|Overall Study|At the Participant's own Request|7|||
30763022|NCT03386344|58771747|FG002|Overall Study|At the Participant's own Request|8|||
30763023|NCT03386344|58771745|FG000|Overall Study|Reason not Specified|0|||
30763024|NCT03386344|58771746|FG001|Overall Study|Reason not Specified|1|||
30763025|NCT03386344|58771747|FG002|Overall Study|Reason not Specified|0|||
30763026|NCT00399035|58771758|FG000|Overall Study|Death|289|||
30763027|NCT00399035|58771759|FG001|Overall Study|Death|141|||
30763028|NCT00399035|58771760|FG002|Overall Study|Death|234|||
30847713|NCT02748863|58873531|FG004|Treatment Period 2|Lost to Follow-up|0|||
30847714|NCT02748863|58873527|FG000|Treatment Period 2|Adverse Event|3|||
30847715|NCT02748863|58873528|FG001|Treatment Period 2|Adverse Event|2|||
30847716|NCT02748863|58873529|FG002|Treatment Period 2|Adverse Event|0|||
30847717|NCT02748863|58873530|FG003|Treatment Period 2|Adverse Event|2|||
30847718|NCT02748863|58873531|FG004|Treatment Period 2|Adverse Event|0|||
30847719|NCT02748863|58873527|FG000|Treatment Period 2|Lack of Efficacy|0|||
30847720|NCT02748863|58873528|FG001|Treatment Period 2|Lack of Efficacy|1|||
30847721|NCT02748863|58873529|FG002|Treatment Period 2|Lack of Efficacy|0|||
30847722|NCT02748863|58873530|FG003|Treatment Period 2|Lack of Efficacy|0|||
30847723|NCT02748863|58873531|FG004|Treatment Period 2|Lack of Efficacy|0|||
30847724|NCT02748863|58873527|FG000|Treatment Period 2|Pregnancy|0|||
30847725|NCT02748863|58873528|FG001|Treatment Period 2|Pregnancy|0|||
30763029|NCT00399035|58771758|FG000|Overall Study|Lost to Follow-up|2|||
30763030|NCT00399035|58771759|FG001|Overall Study|Lost to Follow-up|1|||
30763031|NCT00399035|58771760|FG002|Overall Study|Lost to Follow-up|5|||
30763032|NCT00399035|58771758|FG000|Overall Study|Withdrawal by Subject|19|||
30763033|NCT00399035|58771759|FG001|Overall Study|Withdrawal by Subject|15|||
30847726|NCT02748863|58873529|FG002|Treatment Period 2|Pregnancy|0|||
30847727|NCT02748863|58873530|FG003|Treatment Period 2|Pregnancy|0|||
30950437|NCT01691521|58997275|FG002|Overall Study|Adverse Event|1|||
30847728|NCT02748863|58873531|FG004|Treatment Period 2|Pregnancy|1|||
30763034|NCT00399035|58771760|FG002|Overall Study|Withdrawal by Subject|12|||
30763035|NCT00399035|58771758|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
30763036|NCT00399035|58771759|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
30763037|NCT00399035|58771760|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
30763038|NCT00399035|58771758|FG000|Overall Study|Severe non-compliance with protocol|2|||
30763039|NCT00399035|58771759|FG001|Overall Study|Severe non-compliance with protocol|1|||
30763040|NCT00399035|58771760|FG002|Overall Study|Severe non-compliance with protocol|0|||
30763041|NCT00073749|58771774|FG000|Overall Study|Disease Progression|2|||
30763042|NCT00073749|58771775|FG001|Overall Study|Disease Progression|0|||
30763043|NCT00073749|58771776|FG002|Overall Study|Disease Progression|3|||
30763044|NCT00073749|58771777|FG003|Overall Study|Disease Progression|2|||
30763045|NCT00073749|58771778|FG004|Overall Study|Disease Progression|3|||
30763046|NCT00073749|58771779|FG005|Overall Study|Disease Progression|1|||
30763047|NCT00073749|58771780|FG006|Overall Study|Disease Progression|3|||
30763048|NCT00073749|58771774|FG000|Overall Study|Death|0|||
30763049|NCT00073749|58771775|FG001|Overall Study|Death|1|||
30763050|NCT00073749|58771776|FG002|Overall Study|Death|1|||
30763051|NCT00073749|58771777|FG003|Overall Study|Death|0|||
30763052|NCT00073749|58771778|FG004|Overall Study|Death|0|||
30763053|NCT00073749|58771779|FG005|Overall Study|Death|0|||
30763054|NCT00073749|58771780|FG006|Overall Study|Death|29|||
30763055|NCT00073749|58771774|FG000|Overall Study|Adverse Event|0|||
30763056|NCT00073749|58771775|FG001|Overall Study|Adverse Event|3|||
30763057|NCT00073749|58771776|FG002|Overall Study|Adverse Event|6|||
30763058|NCT00073749|58771777|FG003|Overall Study|Adverse Event|4|||
30763059|NCT00073749|58771778|FG004|Overall Study|Adverse Event|2|||
30763060|NCT00073749|58771779|FG005|Overall Study|Adverse Event|1|||
30763061|NCT00073749|58771780|FG006|Overall Study|Adverse Event|0|||
30763062|NCT00073749|58771774|FG000|Overall Study|Physician Decision|0|||
30763063|NCT00073749|58771775|FG001|Overall Study|Physician Decision|0|||
30763064|NCT00073749|58771776|FG002|Overall Study|Physician Decision|1|||
30763065|NCT00073749|58771777|FG003|Overall Study|Physician Decision|0|||
30763066|NCT00073749|58771778|FG004|Overall Study|Physician Decision|0|||
30763067|NCT00073749|58771779|FG005|Overall Study|Physician Decision|2|||
30763068|NCT00073749|58771780|FG006|Overall Study|Physician Decision|0|||
30763069|NCT00073749|58771774|FG000|Overall Study|Withdrawal by Subject|0|||
30763070|NCT00073749|58771775|FG001|Overall Study|Withdrawal by Subject|1|||
30763071|NCT00073749|58771776|FG002|Overall Study|Withdrawal by Subject|0|||
30763072|NCT00073749|58771777|FG003|Overall Study|Withdrawal by Subject|0|||
30763073|NCT00073749|58771778|FG004|Overall Study|Withdrawal by Subject|1|||
30763074|NCT00073749|58771779|FG005|Overall Study|Withdrawal by Subject|0|||
30763075|NCT00073749|58771780|FG006|Overall Study|Withdrawal by Subject|2|||
30763076|NCT00073749|58771774|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
30763077|NCT00073749|58771775|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
30763078|NCT00073749|58771776|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
30763079|NCT00073749|58771777|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
30763080|NCT00073749|58771778|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
30763081|NCT00073749|58771779|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
30763082|NCT00073749|58771780|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
30763083|NCT00073749|58771774|FG000|Overall Study|Lost to Follow-up|0|||
30763084|NCT00073749|58771775|FG001|Overall Study|Lost to Follow-up|0|||
30763085|NCT00073749|58771776|FG002|Overall Study|Lost to Follow-up|0|||
30763086|NCT00073749|58771777|FG003|Overall Study|Lost to Follow-up|0|||
30763087|NCT00073749|58771778|FG004|Overall Study|Lost to Follow-up|0|||
30763088|NCT00073749|58771779|FG005|Overall Study|Lost to Follow-up|0|||
30763089|NCT00073749|58771780|FG006|Overall Study|Lost to Follow-up|2|||
30763090|NCT00073749|58771774|FG000|Overall Study|Other|0|||
30763091|NCT00073749|58771775|FG001|Overall Study|Other|0|||
30763092|NCT00073749|58771776|FG002|Overall Study|Other|0|||
30763093|NCT00073749|58771777|FG003|Overall Study|Other|0|||
30763094|NCT00073749|58771778|FG004|Overall Study|Other|0|||
30763095|NCT00073749|58771779|FG005|Overall Study|Other|2|||
30763096|NCT00073749|58771780|FG006|Overall Study|Other|0|||
30763097|NCT00398567|58771802|FG000|Overall Study|Disease Progression|3|||
30763098|NCT00398567|58771803|FG001|Overall Study|Disease Progression|4|||
30763099|NCT00398567|58771804|FG002|Overall Study|Disease Progression|27|||
30763100|NCT00398567|58771802|FG000|Overall Study|Withdrawal by Subject|1|||
30763101|NCT00398567|58771803|FG001|Overall Study|Withdrawal by Subject|0|||
30763102|NCT00398567|58771804|FG002|Overall Study|Withdrawal by Subject|4|||
30763103|NCT00398567|58771802|FG000|Overall Study|Adverse Event|0|||
30763104|NCT00398567|58771803|FG001|Overall Study|Adverse Event|0|||
30763105|NCT00398567|58771804|FG002|Overall Study|Adverse Event|2|||
30763106|NCT00398567|58771802|FG000|Overall Study|Protocol Violation|0|||
30763107|NCT00398567|58771803|FG001|Overall Study|Protocol Violation|0|||
30763108|NCT00398567|58771804|FG002|Overall Study|Protocol Violation|1|||
30763109|NCT05249569|58771810|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
30763110|NCT04779879|58771833|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
30763111|NCT04779879|58771834|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
30763112|NCT04779879|58771835|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
30763113|NCT04779879|58771836|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
30763114|NCT04779879|58771837|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
30763115|NCT04779879|58771838|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
30763116|NCT04779879|58771833|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
30763117|NCT04779879|58771834|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
30763118|NCT04779879|58771835|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
30763119|NCT04779879|58771836|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
30763120|NCT04779879|58771837|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
30763121|NCT04779879|58771838|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
30763122|NCT04779879|58771833|FG000|Part C: Up to Week 36|Death|0|||
30763123|NCT04779879|58771834|FG001|Part C: Up to Week 36|Death|0|||
30763124|NCT04779879|58771835|FG002|Part C: Up to Week 36|Death|0|||
30763125|NCT04779879|58771836|FG003|Part C: Up to Week 36|Death|0|||
30763126|NCT04779879|58771837|FG004|Part C: Up to Week 36|Death|0|||
30763127|NCT04779879|58771838|FG005|Part C: Up to Week 36|Death|1|||
30763128|NCT04779879|58771833|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
30763129|NCT04779879|58771834|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
30763130|NCT04779879|58771835|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
30763131|NCT04779879|58771836|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
30763132|NCT04779879|58771837|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
30763133|NCT04779879|58771838|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
30763134|NCT04535167|58771879|FG000|Treatment|Adverse Event|0|||
30763135|NCT04535167|58771880|FG001|Treatment|Adverse Event|0|||
30763136|NCT04535167|58771881|FG002|Treatment|Adverse Event|0|||
30763137|NCT04535167|58771882|FG003|Treatment|Adverse Event|0|||
30763138|NCT04535167|58771883|FG004|Treatment|Adverse Event|0|||
30763139|NCT04535167|58771884|FG005|Treatment|Adverse Event|0|||
30763140|NCT04535167|58771885|FG006|Treatment|Adverse Event|1|||
30763141|NCT04535167|58771879|FG000|Follow-Up|Death|0|||
30763142|NCT04535167|58771880|FG001|Follow-Up|Death|0|||
30763143|NCT04535167|58771881|FG002|Follow-Up|Death|0|||
30763144|NCT04535167|58771882|FG003|Follow-Up|Death|0|||
30763145|NCT04535167|58771883|FG004|Follow-Up|Death|0|||
30763146|NCT04535167|58771884|FG005|Follow-Up|Death|0|||
30763147|NCT04535167|58771885|FG006|Follow-Up|Death|1|||
30763148|NCT04535167|58771879|FG000|Follow-Up|Lost to Follow-up|0|||
30763149|NCT04535167|58771880|FG001|Follow-Up|Lost to Follow-up|0|||
30763150|NCT04535167|58771881|FG002|Follow-Up|Lost to Follow-up|0|||
30763151|NCT04535167|58771882|FG003|Follow-Up|Lost to Follow-up|1|||
30763152|NCT04535167|58771883|FG004|Follow-Up|Lost to Follow-up|0|||
30763153|NCT04535167|58771884|FG005|Follow-Up|Lost to Follow-up|0|||
30763154|NCT04535167|58771885|FG006|Follow-Up|Lost to Follow-up|0|||
30763155|NCT04223791|58771903|FG000|Overall Study|Lost to Follow-up|0|||
30763156|NCT04223791|58771904|FG001|Overall Study|Lost to Follow-up|4|||
30763157|NCT04223791|58771903|FG000|Overall Study|Physician Decision|5|||
30763158|NCT04223791|58771904|FG001|Overall Study|Physician Decision|1|||
30763159|NCT04223791|58771903|FG000|Overall Study|Protocol Violation|1|||
30763160|NCT04223791|58771904|FG001|Overall Study|Protocol Violation|1|||
30763161|NCT04223791|58771903|FG000|Overall Study|Withdrawal by Subject|10|||
30763162|NCT04223791|58771904|FG001|Overall Study|Withdrawal by Subject|12|||
30763163|NCT04223791|58771903|FG000|Overall Study|Pregnancy|1|||
30763164|NCT04223791|58771904|FG001|Overall Study|Pregnancy|1|||
30763165|NCT04223791|58771903|FG000|Overall Study|Ongoing in Study|305|||
30763166|NCT04223791|58771904|FG001|Overall Study|Ongoing in Study|302|||
30763167|NCT04115293|58771912|FG000|Overall Study|Adverse Event|0|||
30763168|NCT04115293|58771913|FG001|Overall Study|Adverse Event|2|||
30763169|NCT04115293|58771912|FG000|Overall Study|Withdrawal by Subject|2|||
30763170|NCT04115293|58771913|FG001|Overall Study|Withdrawal by Subject|1|||
30763171|NCT04115293|58771912|FG000|Overall Study|Physician Decision|1|||
30763172|NCT04115293|58771913|FG001|Overall Study|Physician Decision|0|||
30763173|NCT04115293|58771912|FG000|Overall Study|Death|1|||
30763174|NCT04115293|58771913|FG001|Overall Study|Death|1|||
30763175|NCT04035499|58771919|FG000|Overall Study|Death|2|||
30763176|NCT04035499|58771919|FG000|Overall Study|Withdrawal by Subject|1|||
30763177|NCT03915067|58771926|FG000|Overall Study|Adverse Event|0|||
30763178|NCT03915067|58771927|FG001|Overall Study|Adverse Event|0|||
30763179|NCT03915067|58771928|FG002|Overall Study|Adverse Event|1|||
30763180|NCT03915067|58771926|FG000|Overall Study|Withdrawal by Subject|4|||
30763181|NCT03915067|58771927|FG001|Overall Study|Withdrawal by Subject|3|||
30763182|NCT03915067|58771928|FG002|Overall Study|Withdrawal by Subject|0|||
30763183|NCT03915067|58771926|FG000|Overall Study|Lost to Follow-up|3|||
30763184|NCT03915067|58771927|FG001|Overall Study|Lost to Follow-up|2|||
30763185|NCT03915067|58771928|FG002|Overall Study|Lost to Follow-up|0|||
30763186|NCT03915067|58771926|FG000|Overall Study|Protocol Deviation|0|||
30763187|NCT03915067|58771927|FG001|Overall Study|Protocol Deviation|0|||
30763188|NCT03915067|58771928|FG002|Overall Study|Protocol Deviation|1|||
30763189|NCT03915067|58771926|FG000|Overall Study|Covid-19 Related Issues|2|||
30763190|NCT03915067|58771927|FG001|Overall Study|Covid-19 Related Issues|4|||
30763191|NCT03915067|58771928|FG002|Overall Study|Covid-19 Related Issues|4|||
30763192|NCT03915067|58771926|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
30763193|NCT03915067|58771927|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
30763194|NCT03915067|58771928|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
30763195|NCT03654404|58771936|FG000|Overall Study|Death|1|||
30763196|NCT03654404|58771936|FG000|Overall Study|Lost to Follow-up|2|||
30763197|NCT03654404|58771936|FG000|Overall Study|Withdrawal by Subject|5|||
30763199|NCT03447314|58772005|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
30763200|NCT03447314|58772006|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
30763201|NCT03447314|58772007|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
30763202|NCT03447314|58772008|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
30763203|NCT03447314|58772009|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
30763204|NCT03447314|58772010|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
30763205|NCT03447314|58772011|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
30763206|NCT03447314|58772012|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
30763207|NCT03447314|58772013|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
30763208|NCT03447314|58772014|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
30763209|NCT03447314|58772015|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
30763210|NCT03447314|58772016|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
30763211|NCT03447314|58772017|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
30763212|NCT03447314|58772018|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
30763213|NCT03447314|58772019|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
30763214|NCT03447314|58772020|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
30763215|NCT03447314|58772021|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
30763216|NCT03447314|58772022|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
30763217|NCT03447314|58772005|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
30763218|NCT03447314|58772006|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763219|NCT03447314|58772007|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
30763220|NCT03447314|58772008|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763221|NCT03447314|58772009|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763222|NCT03447314|58772010|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
30763223|NCT03447314|58772011|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
30763224|NCT03447314|58772012|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763225|NCT03447314|58772013|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763226|NCT03447314|58772014|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763227|NCT03447314|58772015|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763228|NCT03447314|58772016|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763229|NCT03447314|58772017|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763230|NCT03447314|58772018|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763231|NCT03447314|58772019|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763232|NCT03447314|58772020|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763233|NCT03447314|58772021|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30847729|NCT02865499|58873552|FG000|Baseline|Adverse Event|1|||
30847730|NCT02865499|58873552|FG000|Baseline|Withdrawal by Subject|1|||
30847731|NCT02870933|58873558|FG000|Overall Study|Death|2|||
30847732|NCT02870933|58873559|FG001|Overall Study|Death|1|||
30847733|NCT02870933|58873558|FG000|Overall Study|Withdrawal by Subject|0|||
30847734|NCT02870933|58873559|FG001|Overall Study|Withdrawal by Subject|1|||
30763234|NCT03447314|58772022|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
30763235|NCT03447314|58772005|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763236|NCT03447314|58772006|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763237|NCT03447314|58772007|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
30763238|NCT03447314|58772008|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763239|NCT03447314|58772009|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30847735|NCT02864407|58873566|FG000|Overall Study|Protocol Violation|3|||
30847736|NCT02864407|58873566|FG000|Overall Study|Lost to Follow-up|115|||
30763240|NCT03447314|58772010|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763241|NCT03447314|58772011|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763242|NCT03447314|58772012|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763243|NCT03447314|58772013|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763244|NCT03447314|58772014|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763245|NCT03447314|58772015|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763246|NCT03447314|58772016|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763247|NCT03447314|58772017|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763248|NCT03447314|58772018|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763249|NCT03447314|58772019|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763250|NCT03447314|58772020|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763251|NCT03447314|58772021|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763252|NCT03447314|58772022|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
30763253|NCT03447314|58772005|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763254|NCT03447314|58772006|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763255|NCT03447314|58772007|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
30763256|NCT03447314|58772008|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763257|NCT03447314|58772009|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763258|NCT03447314|58772010|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763259|NCT03447314|58772011|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763260|NCT03447314|58772012|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763261|NCT03447314|58772013|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763262|NCT03447314|58772014|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763263|NCT03447314|58772015|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763264|NCT03447314|58772016|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763265|NCT03447314|58772017|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763266|NCT03447314|58772018|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763267|NCT03447314|58772019|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763268|NCT03447314|58772020|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763269|NCT03447314|58772021|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763270|NCT03447314|58772022|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
30763271|NCT03447314|58772005|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763272|NCT03447314|58772006|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763273|NCT03447314|58772007|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763274|NCT03447314|58772008|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763275|NCT03447314|58772009|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763276|NCT03447314|58772010|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763277|NCT03447314|58772011|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763278|NCT03447314|58772012|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763279|NCT03447314|58772013|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763280|NCT03447314|58772014|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763281|NCT03447314|58772015|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
30763282|NCT03447314|58772016|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763283|NCT03447314|58772017|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763284|NCT03447314|58772018|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763285|NCT03447314|58772019|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763286|NCT03447314|58772020|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763287|NCT03447314|58772021|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763288|NCT03447314|58772022|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
30763289|NCT03447314|58772005|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763290|NCT03447314|58772006|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763291|NCT03447314|58772007|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763292|NCT03447314|58772008|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
30763293|NCT03447314|58772009|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30847737|NCT02864407|58873566|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
30847738|NCT02864407|58873566|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
30847739|NCT02864407|58873566|FG000|Overall Study|Consent prior to the contract date|1|||
30847740|NCT02873429|58873572|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
30847741|NCT02873429|58873573|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
30847742|NCT02873429|58873572|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
30847743|NCT02873429|58873573|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
30763294|NCT03447314|58772010|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
30763295|NCT03447314|58772011|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763296|NCT03447314|58772012|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763297|NCT03447314|58772013|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763298|NCT03447314|58772014|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763299|NCT03447314|58772015|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30847744|NCT02873429|58873572|FG000|16 Weeks|Lost to Follow-up|3|||
30847745|NCT02873429|58873573|FG001|16 Weeks|Lost to Follow-up|0|||
30847746|NCT02486302|58873579|FG000|Overall Study|Discontinued prematurely|410|||
30847747|NCT02486302|58873579|FG000|Overall Study|Documentation not completed|255|||
30847748|NCT02486302|58873579|FG000|Overall Study|Excluded due to legal reasons|8|||
30847749|NCT02486302|58873579|FG000|Overall Study|Not treated|3|||
30847750|NCT02747875|58873594|FG000|Overall Study|Physician Decision|1|||
30847751|NCT02747875|58873595|FG001|Overall Study|Physician Decision|0|||
30847752|NCT02747875|58873594|FG000|Overall Study|Adverse Event|0|||
30847753|NCT02747875|58873595|FG001|Overall Study|Adverse Event|1|||
30847754|NCT02451124|58873621|FG000|Overall Study|Withdrawal by Subject|1|||
30847755|NCT02450578|58873633|FG000|Overall Study|ECG abnormality so not treated|1|||
30847756|NCT02450578|58873634|FG001|Overall Study|ECG abnormality so not treated|0|||
30847757|NCT02450578|58873635|FG002|Overall Study|ECG abnormality so not treated|0|||
30847758|NCT02450578|58873636|FG003|Overall Study|ECG abnormality so not treated|0|||
30847759|NCT02449018|58873663|FG000|Overall Study|Abnormal laboratory value|0|||
30847760|NCT02449018|58873664|FG001|Overall Study|Abnormal laboratory value|1|||
30847761|NCT02449018|58873663|FG000|Overall Study|Administrative problems|1|||
30847762|NCT02449018|58873664|FG001|Overall Study|Administrative problems|0|||
30847763|NCT02449018|58873663|FG000|Overall Study|Adverse Event|5|||
30847764|NCT02449018|58873664|FG001|Overall Study|Adverse Event|1|||
30847765|NCT02449018|58873663|FG000|Overall Study|Protocol deviation|4|||
30847766|NCT02449018|58873664|FG001|Overall Study|Protocol deviation|0|||
30847767|NCT02449018|58873663|FG000|Overall Study|Patient decision|2|||
30847768|NCT02449018|58873664|FG001|Overall Study|Patient decision|0|||
30847769|NCT02859415|58873672|FG000|Overall Study|Physician Decision|1|||
30847770|NCT02859415|58873673|FG001|Overall Study|Physician Decision|0|||
30847771|NCT02859415|58873672|FG000|Overall Study|Off treatment due to cardiac event|0|||
30847772|NCT02859415|58873673|FG001|Overall Study|Off treatment due to cardiac event|1|||
30847773|NCT02871791|58873683|FG000|Phase 1b|Death|0|||
30847774|NCT02871791|58873684|FG001|Phase 1b|Death|1|||
30847775|NCT02871791|58873683|FG000|Phase 1b|progressive disease|6|||
30847776|NCT02871791|58873684|FG001|Phase 1b|progressive disease|2|||
30847777|NCT02871791|58873683|FG000|Phase 2|Death|1|||
30847778|NCT02871791|58873684|FG001|Phase 2|Death|0|||
30847779|NCT02871791|58873683|FG000|Phase 2|Lost to Follow-up|2|||
30847780|NCT02871791|58873684|FG001|Phase 2|Lost to Follow-up|0|||
30847781|NCT02871635|58873692|FG000|Overall Study|Primary lack of efficacy|4|||
30847782|NCT02871635|58873693|FG001|Overall Study|Primary lack of efficacy|4|||
30847783|NCT02871635|58873692|FG000|Overall Study|Protocol Violation|3|||
30847784|NCT02871635|58873693|FG001|Overall Study|Protocol Violation|1|||
30847785|NCT02871635|58873692|FG000|Overall Study|Lost to Follow-up|1|||
30847786|NCT02871635|58873693|FG001|Overall Study|Lost to Follow-up|2|||
30847787|NCT02871635|58873692|FG000|Overall Study|Pregnancy|0|||
30847788|NCT02871635|58873693|FG001|Overall Study|Pregnancy|2|||
30847789|NCT02871635|58873692|FG000|Overall Study|Physician Decision|1|||
30847790|NCT02871635|58873693|FG001|Overall Study|Physician Decision|1|||
30847791|NCT02871635|58873692|FG000|Overall Study|Withdrawal by Subject|3|||
30763300|NCT03447314|58772016|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763301|NCT03447314|58772017|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763302|NCT03447314|58772018|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30847792|NCT02871635|58873693|FG001|Overall Study|Withdrawal by Subject|4|||
30847793|NCT02871635|58873692|FG000|Overall Study|Adverse Event|4|||
30847794|NCT02871635|58873693|FG001|Overall Study|Adverse Event|4|||
30847795|NCT02871635|58873692|FG000|Overall Study|Secondary lack of efficacy|2|||
30847796|NCT02871635|58873693|FG001|Overall Study|Secondary lack of efficacy|1|||
30763303|NCT03447314|58772019|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30847797|NCT02477332|58873707|FG000|Overall Study|Adverse Event|0|||
30847798|NCT02477332|58873708|FG001|Overall Study|Adverse Event|1|||
30847799|NCT02477332|58873709|FG002|Overall Study|Adverse Event|1|||
30847800|NCT02477332|58873710|FG003|Overall Study|Adverse Event|2|||
30847801|NCT02477332|58873711|FG004|Overall Study|Adverse Event|1|||
30847802|NCT02477332|58873712|FG005|Overall Study|Adverse Event|2|||
30847803|NCT02477332|58873707|FG000|Overall Study|Lack of Efficacy|1|||
30763304|NCT03447314|58772020|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763305|NCT03447314|58772021|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763306|NCT03447314|58772022|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
30763307|NCT03423121|58772065|FG000|Overall Study|Lost to Follow-up|2|||
30763308|NCT03423121|58772066|FG001|Overall Study|Lost to Follow-up|6|||
30847804|NCT02477332|58873708|FG001|Overall Study|Lack of Efficacy|2|||
30847805|NCT02477332|58873709|FG002|Overall Study|Lack of Efficacy|1|||
30763309|NCT03423121|58772065|FG000|Overall Study|Adverse Event|1|||
30763310|NCT03423121|58772066|FG001|Overall Study|Adverse Event|0|||
30763311|NCT03335475|58772074|FG000|Overall Study|Did not wear accelerometer|4|||
30763312|NCT03335475|58772075|FG001|Overall Study|Did not wear accelerometer|0|||
30763313|NCT03335475|58772074|FG000|Overall Study|Withdrawal by Subject|0|||
30763314|NCT03335475|58772075|FG001|Overall Study|Withdrawal by Subject|1|||
30763315|NCT03252756|58772083|FG000|Overall Study|Protocol Violation|2|||
30763316|NCT03252756|58772084|FG001|Overall Study|Protocol Violation|4|||
30763317|NCT03252756|58772083|FG000|Overall Study|COVID-19 Pandemic|1|||
30763318|NCT03252756|58772084|FG001|Overall Study|COVID-19 Pandemic|1|||
30763319|NCT03252756|58772083|FG000|Overall Study|Study Drug Expiration|0|||
30763320|NCT03252756|58772084|FG001|Overall Study|Study Drug Expiration|1|||
30763321|NCT03164356|58772096|FG000|Overall Study|Lost to Follow-up|1|||
30763322|NCT03164356|58772097|FG001|Overall Study|Lost to Follow-up|1|||
30763323|NCT03164356|58772098|FG002|Overall Study|Lost to Follow-up|2|||
30763324|NCT03164356|58772099|FG003|Overall Study|Lost to Follow-up|1|||
30763325|NCT03164356|58772096|FG000|Overall Study|Physician Decision|0|||
30763326|NCT03164356|58772097|FG001|Overall Study|Physician Decision|0|||
30763327|NCT03164356|58772098|FG002|Overall Study|Physician Decision|3|||
30763328|NCT03164356|58772099|FG003|Overall Study|Physician Decision|0|||
30763329|NCT03164356|58772096|FG000|Overall Study|Protocol Violation|2|||
30763330|NCT03164356|58772097|FG001|Overall Study|Protocol Violation|1|||
30763331|NCT03164356|58772098|FG002|Overall Study|Protocol Violation|0|||
30763332|NCT03164356|58772099|FG003|Overall Study|Protocol Violation|0|||
30763333|NCT03164356|58772096|FG000|Overall Study|Withdrawal by Subject|1|||
30763334|NCT03164356|58772097|FG001|Overall Study|Withdrawal by Subject|0|||
30763335|NCT03164356|58772098|FG002|Overall Study|Withdrawal by Subject|0|||
30763336|NCT03164356|58772099|FG003|Overall Study|Withdrawal by Subject|0|||
30763337|NCT03164356|58772096|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
30763338|NCT03164356|58772097|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
30763339|NCT03164356|58772098|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
30763340|NCT03164356|58772099|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
30763341|NCT03164356|58772096|FG000|Overall Study|Subject Incarcerated|0|||
30763342|NCT03164356|58772097|FG001|Overall Study|Subject Incarcerated|1|||
30763343|NCT03164356|58772098|FG002|Overall Study|Subject Incarcerated|0|||
30763344|NCT03164356|58772099|FG003|Overall Study|Subject Incarcerated|0|||
30763345|NCT03164356|58772096|FG000|Overall Study|Prosthetist unable to participate|0|||
30763346|NCT03164356|58772097|FG001|Overall Study|Prosthetist unable to participate|2|||
30763347|NCT03164356|58772098|FG002|Overall Study|Prosthetist unable to participate|1|||
30763348|NCT03164356|58772099|FG003|Overall Study|Prosthetist unable to participate|0|||
30763349|NCT02577406|58772130|FG000|Randomized Period|Death|1|||
30763350|NCT02577406|58772131|FG001|Randomized Period|Death|0|||
30763351|NCT02577406|58772130|FG000|Randomized Period|Other reasons|0|||
30763352|NCT02577406|58772131|FG001|Randomized Period|Other reasons|20|||
30763353|NCT02577406|58772130|FG000|Treatment Period|Transition to commercially available treatment|1|||
30763354|NCT02577406|58772131|FG001|Treatment Period|Transition to commercially available treatment|0|||
30763355|NCT02577406|58772130|FG000|Treatment Period|Progressive disease|47|||
30763356|NCT02577406|58772131|FG001|Treatment Period|Progressive disease|36|||
30763357|NCT02577406|58772130|FG000|Treatment Period|Death|36|||
30763358|NCT02577406|58772131|FG001|Treatment Period|Death|23|||
30763359|NCT02577406|58772130|FG000|Treatment Period|Other reasons|3|||
30763360|NCT02577406|58772131|FG001|Treatment Period|Other reasons|37|||
30763361|NCT02577406|58772130|FG000|Treatment Period|Withdrawal by Subject|10|||
30763362|NCT02577406|58772131|FG001|Treatment Period|Withdrawal by Subject|24|||
30763363|NCT02577406|58772130|FG000|Treatment Period|Adverse Event|17|||
30763364|NCT02577406|58772131|FG001|Treatment Period|Adverse Event|12|||
30763365|NCT02577406|58772130|FG000|Treatment Period|Disease relapse|27|||
30763366|NCT02577406|58772131|FG001|Treatment Period|Disease relapse|1|||
30763367|NCT02577406|58772130|FG000|Treatment Period|HSCT|6|||
30763368|NCT02577406|58772131|FG001|Treatment Period|HSCT|2|||
30763369|NCT02577406|58772130|FG000|Treatment Period|Lost to Follow-up|0|||
30763370|NCT02577406|58772131|FG001|Treatment Period|Lost to Follow-up|1|||
30763371|NCT02577406|58772130|FG000|Treatment Period|Protocol Violation|0|||
30763372|NCT02577406|58772131|FG001|Treatment Period|Protocol Violation|1|||
30763373|NCT01925131|58772156|FG000|Overall Study|Death|0|||
30763374|NCT01925131|58772157|FG001|Overall Study|Death|0|||
30763375|NCT01925131|58772158|FG002|Overall Study|Death|1|||
30763376|NCT01925131|58772159|FG003|Overall Study|Death|0|||
30763377|NCT01925131|58772160|FG004|Overall Study|Death|0|||
30763378|NCT01925131|58772161|FG005|Overall Study|Death|0|||
30763379|NCT01925131|58772156|FG000|Overall Study|Progression/Relapse|1|||
30763380|NCT01925131|58772157|FG001|Overall Study|Progression/Relapse|1|||
30763381|NCT01925131|58772158|FG002|Overall Study|Progression/Relapse|4|||
30763382|NCT01925131|58772159|FG003|Overall Study|Progression/Relapse|0|||
30763383|NCT01925131|58772160|FG004|Overall Study|Progression/Relapse|0|||
30763384|NCT01925131|58772161|FG005|Overall Study|Progression/Relapse|1|||
30763385|NCT01925131|58772156|FG000|Overall Study|Patient Refusal|1|||
30763386|NCT01925131|58772157|FG001|Overall Study|Patient Refusal|0|||
30763387|NCT01925131|58772158|FG002|Overall Study|Patient Refusal|0|||
30763388|NCT01925131|58772159|FG003|Overall Study|Patient Refusal|0|||
30763389|NCT01925131|58772160|FG004|Overall Study|Patient Refusal|0|||
30763390|NCT01925131|58772161|FG005|Overall Study|Patient Refusal|0|||
30763391|NCT01925131|58772156|FG000|Overall Study|Adverse Event|0|||
30763392|NCT01925131|58772157|FG001|Overall Study|Adverse Event|0|||
30763393|NCT01925131|58772158|FG002|Overall Study|Adverse Event|2|||
30847806|NCT02477332|58873710|FG003|Overall Study|Lack of Efficacy|2|||
30847807|NCT02477332|58873711|FG004|Overall Study|Lack of Efficacy|1|||
30847808|NCT02477332|58873712|FG005|Overall Study|Lack of Efficacy|1|||
30847809|NCT02477332|58873707|FG000|Overall Study|Non-compliance with study treatment|0|||
30763394|NCT01925131|58772159|FG003|Overall Study|Adverse Event|0|||
30763395|NCT01925131|58772160|FG004|Overall Study|Adverse Event|1|||
30763396|NCT01925131|58772161|FG005|Overall Study|Adverse Event|3|||
30763397|NCT01925131|58772156|FG000|Overall Study|Other - Not Protocol Specified|3|||
30763398|NCT01925131|58772157|FG001|Overall Study|Other - Not Protocol Specified|1|||
30763399|NCT01925131|58772158|FG002|Overall Study|Other - Not Protocol Specified|2|||
30763400|NCT01925131|58772159|FG003|Overall Study|Other - Not Protocol Specified|5|||
30763401|NCT01925131|58772160|FG004|Overall Study|Other - Not Protocol Specified|10|||
30763402|NCT01925131|58772161|FG005|Overall Study|Other - Not Protocol Specified|6|||
30763403|NCT01809691|58772179|FG000|Overall Study|Currently on Treatment|192|||
30763404|NCT01809691|58772180|FG001|Overall Study|Currently on Treatment|100|||
30763405|NCT01809691|58772179|FG000|Overall Study|No Protocol Treatment|10|||
30763406|NCT01809691|58772180|FG001|Overall Study|No Protocol Treatment|11|||
30763407|NCT01809691|58772179|FG000|Overall Study|Adverse Event|80|||
30763408|NCT01809691|58772180|FG001|Overall Study|Adverse Event|21|||
30763409|NCT01809691|58772179|FG000|Overall Study|Disease Progression|226|||
30763410|NCT01809691|58772180|FG001|Overall Study|Disease Progression|372|||
30763411|NCT01809691|58772179|FG000|Overall Study|Death|26|||
30763412|NCT01809691|58772180|FG001|Overall Study|Death|13|||
30763413|NCT01809691|58772179|FG000|Overall Study|Participant Refusal|70|||
30763414|NCT01809691|58772180|FG001|Overall Study|Participant Refusal|72|||
30763415|NCT01809691|58772179|FG000|Overall Study|Other, Not Specified|34|||
30763416|NCT01809691|58772180|FG001|Overall Study|Other, Not Specified|52|||
30763417|NCT01698918|58772186|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
30763418|NCT01698918|58772186|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
30847810|NCT02477332|58873708|FG001|Overall Study|Non-compliance with study treatment|1|||
30847811|NCT02477332|58873709|FG002|Overall Study|Non-compliance with study treatment|2|||
30950438|NCT01691521|58997273|FG000|Overall Study|Lack of Efficacy|1|||
30950439|NCT01691521|58997274|FG001|Overall Study|Lack of Efficacy|1|||
30950440|NCT01691521|58997275|FG002|Overall Study|Lack of Efficacy|2|||
30950441|NCT01691521|58997273|FG000|Overall Study|Protocol Violation|0|||
30950442|NCT01691521|58997274|FG001|Overall Study|Protocol Violation|3|||
30763419|NCT01698918|58772186|FG000|First Line Treatment (Core+Extension)|Death|2|||
30763420|NCT01698918|58772186|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
30847812|NCT02477332|58873710|FG003|Overall Study|Non-compliance with study treatment|0|||
30847813|NCT02477332|58873711|FG004|Overall Study|Non-compliance with study treatment|0|||
30847814|NCT02477332|58873712|FG005|Overall Study|Non-compliance with study treatment|0|||
30847815|NCT02477332|58873707|FG000|Overall Study|Pregnancy|0|||
30847816|NCT02477332|58873708|FG001|Overall Study|Pregnancy|0|||
30950443|NCT01691521|58997275|FG002|Overall Study|Protocol Violation|0|||
30950444|NCT01691521|58997273|FG000|Overall Study|Lost to Follow-up|0|||
30847817|NCT02477332|58873709|FG002|Overall Study|Pregnancy|0|||
30847818|NCT02477332|58873710|FG003|Overall Study|Pregnancy|1|||
30847819|NCT02477332|58873711|FG004|Overall Study|Pregnancy|0|||
30950445|NCT01691521|58997274|FG001|Overall Study|Lost to Follow-up|2|||
30763421|NCT01698918|58772186|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
30763422|NCT01698918|58772186|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
30763423|NCT01698918|58772186|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
30763424|NCT01698918|58772186|FG000|Second Line Treatment (Core+Extension)|Death|1|||
30763425|NCT01698918|58772186|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
30763426|NCT01698918|58772186|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
30763427|NCT01574274|58772201|FG000|Overall Study|Ineligible|0|||
30847820|NCT02477332|58873712|FG005|Overall Study|Pregnancy|0|||
30763428|NCT01574274|58772202|FG001|Overall Study|Ineligible|1|||
30626225|NCT01200758|58638317|FG001|Stage 2|Physician Decision|0|||
30626226|NCT01200758|58638318|FG002|Stage 2|Physician Decision|5|||
30626227|NCT01200758|58638319|FG003|Stage 2|Physician Decision|7|||
30626228|NCT01200758|58638316|FG000|Stage 2|Adverse Event|0|||
30626229|NCT01200758|58638317|FG001|Stage 2|Adverse Event|0|||
30626230|NCT01200758|58638318|FG002|Stage 2|Adverse Event|5|||
30626231|NCT01200758|58638319|FG003|Stage 2|Adverse Event|9|||
30626232|NCT01200758|58638316|FG000|Stage 2|Withdrawal by Subject|0|||
30626233|NCT01200758|58638317|FG001|Stage 2|Withdrawal by Subject|0|||
30626234|NCT01200758|58638318|FG002|Stage 2|Withdrawal by Subject|4|||
30626235|NCT01200758|58638319|FG003|Stage 2|Withdrawal by Subject|1|||
30626236|NCT01200758|58638316|FG000|Stage 2|Lost to Follow-up|0|||
30626237|NCT01200758|58638317|FG001|Stage 2|Lost to Follow-up|0|||
30626238|NCT01200758|58638318|FG002|Stage 2|Lost to Follow-up|3|||
30626239|NCT01200758|58638319|FG003|Stage 2|Lost to Follow-up|1|||
30626240|NCT01200758|58638316|FG000|Stage 2|Protocol Violation|0|||
30626241|NCT01200758|58638317|FG001|Stage 2|Protocol Violation|0|||
30626242|NCT01200758|58638318|FG002|Stage 2|Protocol Violation|1|||
30626243|NCT01200758|58638319|FG003|Stage 2|Protocol Violation|4|||
30626244|NCT01200758|58638316|FG000|Stage 2|Death|0|||
30626245|NCT01200758|58638317|FG001|Stage 2|Death|0|||
30626246|NCT01200758|58638318|FG002|Stage 2|Death|3|||
30626247|NCT01200758|58638319|FG003|Stage 2|Death|5|||
30626248|NCT00876343|58638334|FG000|Overall Study|Adverse Event|7|||
30626249|NCT00876343|58638335|FG001|Overall Study|Adverse Event|8|||
30626250|NCT00876343|58638336|FG002|Overall Study|Adverse Event|2|||
30626251|NCT00876343|58638334|FG000|Overall Study|Withdrawal by Subject|4|||
30626252|NCT00876343|58638335|FG001|Overall Study|Withdrawal by Subject|4|||
30626253|NCT00876343|58638336|FG002|Overall Study|Withdrawal by Subject|3|||
30626254|NCT00876343|58638334|FG000|Overall Study|Lack of Efficacy|0|||
30626255|NCT00876343|58638335|FG001|Overall Study|Lack of Efficacy|0|||
30626256|NCT00876343|58638336|FG002|Overall Study|Lack of Efficacy|1|||
30626257|NCT00876343|58638334|FG000|Overall Study|Protocol Violation|4|||
30626258|NCT00876343|58638335|FG001|Overall Study|Protocol Violation|1|||
30626259|NCT00876343|58638336|FG002|Overall Study|Protocol Violation|1|||
30626260|NCT00876343|58638334|FG000|Overall Study|Physician Decision|0|||
30626261|NCT00876343|58638335|FG001|Overall Study|Physician Decision|1|||
30626262|NCT00876343|58638336|FG002|Overall Study|Physician Decision|1|||
30626263|NCT00876343|58638334|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
30626264|NCT00876343|58638335|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
30626265|NCT00876343|58638336|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
30626266|NCT00876343|58638334|FG000|Overall Study|Change of residence or other commitments|2|||
30626267|NCT00876343|58638335|FG001|Overall Study|Change of residence or other commitments|2|||
30626268|NCT00876343|58638336|FG002|Overall Study|Change of residence or other commitments|3|||
30626269|NCT01107912|58638348|FG000|Period 1|Adverse Event|0|||
30626270|NCT01107912|58638349|FG001|Period 1|Adverse Event|0|||
30626271|NCT01107912|58638350|FG002|Period 1|Adverse Event|0|||
30626272|NCT01107912|58638351|FG003|Period 1|Adverse Event|0|||
30626273|NCT01107912|58638352|FG004|Period 1|Adverse Event|2|||
30626274|NCT01107912|58638353|FG005|Period 1|Adverse Event|0|||
30626275|NCT01107912|58638348|FG000|Period 1|Physician Decision|0|||
30626276|NCT01107912|58638349|FG001|Period 1|Physician Decision|0|||
30626277|NCT01107912|58638350|FG002|Period 1|Physician Decision|0|||
30626278|NCT01107912|58638351|FG003|Period 1|Physician Decision|0|||
30626279|NCT01107912|58638352|FG004|Period 1|Physician Decision|1|||
30626280|NCT01107912|58638353|FG005|Period 1|Physician Decision|0|||
30626281|NCT01107912|58638348|FG000|Period 1|Withdrawal by Subject|1|||
30626282|NCT01107912|58638349|FG001|Period 1|Withdrawal by Subject|0|||
30626283|NCT01107912|58638350|FG002|Period 1|Withdrawal by Subject|0|||
30626284|NCT01107912|58638351|FG003|Period 1|Withdrawal by Subject|0|||
30626285|NCT01107912|58638352|FG004|Period 1|Withdrawal by Subject|0|||
30763429|NCT01574274|58772201|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
30626286|NCT01107912|58638353|FG005|Period 1|Withdrawal by Subject|0|||
30763430|NCT01574274|58772202|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
30626287|NCT01107912|58638348|FG000|Period 2|Physician Decision|0|||
30626288|NCT01107912|58638349|FG001|Period 2|Physician Decision|0|||
30626289|NCT01107912|58638350|FG002|Period 2|Physician Decision|1|||
30626290|NCT01107912|58638351|FG003|Period 2|Physician Decision|0|||
30626291|NCT01107912|58638352|FG004|Period 2|Physician Decision|0|||
30626292|NCT01107912|58638353|FG005|Period 2|Physician Decision|0|||
30626293|NCT01107912|58638348|FG000|Period 3|Adverse Event|0|||
30626294|NCT01107912|58638349|FG001|Period 3|Adverse Event|1|||
30626295|NCT01107912|58638350|FG002|Period 3|Adverse Event|1|||
30626296|NCT01107912|58638351|FG003|Period 3|Adverse Event|0|||
30763431|NCT01574274|58772201|FG000|Overall Study|Ph+ B-ALL|3|||
30626297|NCT01107912|58638352|FG004|Period 3|Adverse Event|0|||
30626298|NCT01107912|58638353|FG005|Period 3|Adverse Event|0|||
30626299|NCT01107912|58638348|FG000|Period 3|Withdrawal by Subject|0|||
30626300|NCT01107912|58638349|FG001|Period 3|Withdrawal by Subject|0|||
30626301|NCT01107912|58638350|FG002|Period 3|Withdrawal by Subject|0|||
30626302|NCT01107912|58638351|FG003|Period 3|Withdrawal by Subject|1|||
30626303|NCT01107912|58638352|FG004|Period 3|Withdrawal by Subject|0|||
30626304|NCT01107912|58638353|FG005|Period 3|Withdrawal by Subject|0|||
30626305|NCT01200524|58638371|FG000|Overall Study|Withdrawal by Subject|1|||
30626306|NCT01200524|58638372|FG001|Overall Study|Withdrawal by Subject|1|||
30626307|NCT01200524|58638373|FG002|Overall Study|Withdrawal by Subject|3|||
30626308|NCT01200524|58638371|FG000|Overall Study|Adverse Event|1|||
30626309|NCT01200524|58638372|FG001|Overall Study|Adverse Event|0|||
30626310|NCT01200524|58638373|FG002|Overall Study|Adverse Event|0|||
30626311|NCT01200524|58638371|FG000|Overall Study|Non availability of study nurse|0|||
30626312|NCT01200524|58638372|FG001|Overall Study|Non availability of study nurse|0|||
30626313|NCT01200524|58638373|FG002|Overall Study|Non availability of study nurse|1|||
30626314|NCT01100034|58638381|FG000|Overall Study|Lost to Follow-up|11|||
30626315|NCT01100034|58638381|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
30626316|NCT01100034|58638381|FG000|Overall Study|Withdrawal by Subject|4|||
30626317|NCT01100034|58638381|FG000|Overall Study|Sponsor decision|21|||
30626318|NCT01100034|58638381|FG000|Overall Study|Participated in another clinical trial|1|||
30626319|NCT01100034|58638381|FG000|Overall Study|Participants moved to another hospital|4|||
30626320|NCT01100034|58638381|FG000|Overall Study|Site closed due to non-responsiveness|1|||
30626321|NCT00876265|58638385|FG000|Overall Study|Miscellaneous reasons|4|||
30626322|NCT00876265|58638385|FG000|Overall Study|Lost to Follow-up|6|||
30626323|NCT00876265|58638385|FG000|Overall Study|Withdrawal by Subject|2|||
30626324|NCT01107444|58638393|FG000|Overall Study|Withdrawal by Subject|8|||
30626325|NCT01107444|58638394|FG001|Overall Study|Withdrawal by Subject|12|||
30626326|NCT01107444|58638393|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
30626327|NCT01107444|58638394|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
30626328|NCT00876187|58638408|FG000|Overall Study|Adverse Event|14|||
30626329|NCT00876187|58638409|FG001|Overall Study|Adverse Event|12|||
30626330|NCT00876187|58638410|FG002|Overall Study|Adverse Event|19|||
30626331|NCT00876187|58638411|FG003|Overall Study|Adverse Event|29|||
30626332|NCT00876187|58638412|FG004|Overall Study|Adverse Event|10|||
30626333|NCT00876187|58638408|FG000|Overall Study|Lack of Efficacy|59|||
30626334|NCT00876187|58638409|FG001|Overall Study|Lack of Efficacy|34|||
30626335|NCT00876187|58638410|FG002|Overall Study|Lack of Efficacy|45|||
30626336|NCT00876187|58638411|FG003|Overall Study|Lack of Efficacy|34|||
30626337|NCT00876187|58638412|FG004|Overall Study|Lack of Efficacy|59|||
30626338|NCT00876187|58638408|FG000|Overall Study|Lost to Follow-up|9|||
30626339|NCT00876187|58638409|FG001|Overall Study|Lost to Follow-up|10|||
30626340|NCT00876187|58638410|FG002|Overall Study|Lost to Follow-up|8|||
30626341|NCT00876187|58638411|FG003|Overall Study|Lost to Follow-up|8|||
30626342|NCT00876187|58638412|FG004|Overall Study|Lost to Follow-up|11|||
30626343|NCT00876187|58638408|FG000|Overall Study|Protocol Violation|6|||
30626344|NCT00876187|58638409|FG001|Overall Study|Protocol Violation|7|||
30626345|NCT00876187|58638410|FG002|Overall Study|Protocol Violation|7|||
30626346|NCT00876187|58638411|FG003|Overall Study|Protocol Violation|6|||
30626347|NCT00876187|58638412|FG004|Overall Study|Protocol Violation|3|||
30626348|NCT00876187|58638408|FG000|Overall Study|Withdrawal by Subject|16|||
30626349|NCT00876187|58638409|FG001|Overall Study|Withdrawal by Subject|26|||
30626350|NCT00876187|58638410|FG002|Overall Study|Withdrawal by Subject|32|||
30626351|NCT00876187|58638411|FG003|Overall Study|Withdrawal by Subject|38|||
30626352|NCT00876187|58638412|FG004|Overall Study|Withdrawal by Subject|37|||
30626353|NCT00876187|58638408|FG000|Overall Study|Entered extension study|101|||
30626354|NCT00876187|58638409|FG001|Overall Study|Entered extension study|120|||
30626355|NCT00876187|58638410|FG002|Overall Study|Entered extension study|156|||
30626356|NCT00876187|58638411|FG003|Overall Study|Entered extension study|151|||
30763432|NCT01574274|58772202|FG001|Overall Study|Ph+ B-ALL|4|||
30763433|NCT01574274|58772201|FG000|Overall Study|Induction Death|2|||
30763434|NCT01574274|58772202|FG001|Overall Study|Induction Death|0|||
30763435|NCT01574274|58772201|FG000|Overall Study|Induction Failure|4|||
30763436|NCT01574274|58772202|FG001|Overall Study|Induction Failure|1|||
30763437|NCT01574274|58772201|FG000|Overall Study|Adverse Event|16|||
30626357|NCT00876187|58638412|FG004|Overall Study|Entered extension study|144|||
30626358|NCT00876187|58638408|FG000|Overall Study|Randomized but not treated|3|||
30626359|NCT00876187|58638409|FG001|Overall Study|Randomized but not treated|1|||
30626360|NCT00876187|58638410|FG002|Overall Study|Randomized but not treated|3|||
30626361|NCT00876187|58638411|FG003|Overall Study|Randomized but not treated|2|||
30626362|NCT00876187|58638412|FG004|Overall Study|Randomized but not treated|3|||
30626363|NCT00876187|58638408|FG000|Overall Study|Other|2|||
30626364|NCT00876187|58638409|FG001|Overall Study|Other|5|||
30626365|NCT00876187|58638410|FG002|Overall Study|Other|9|||
30950446|NCT01691521|58997275|FG002|Overall Study|Lost to Follow-up|2|||
30950447|NCT01691521|58997273|FG000|Overall Study|Physician Decision|2|||
30950448|NCT01691521|58997274|FG001|Overall Study|Physician Decision|1|||
30950449|NCT01691521|58997275|FG002|Overall Study|Physician Decision|0|||
30950450|NCT01691521|58997273|FG000|Overall Study|Withdrawal by Subject|5|||
30950451|NCT01691521|58997274|FG001|Overall Study|Withdrawal by Subject|9|||
30950452|NCT01691521|58997275|FG002|Overall Study|Withdrawal by Subject|4|||
30626366|NCT00876187|58638411|FG003|Overall Study|Other|7|||
30626367|NCT00876187|58638412|FG004|Overall Study|Other|4|||
30626368|NCT01102374|58638429|FG000|Overall Study|Death|9|||
30626369|NCT01102374|58638430|FG001|Overall Study|Death|13|||
30626370|NCT01102374|58638429|FG000|Overall Study|Lost to Follow-up|7|||
30626371|NCT01102374|58638430|FG001|Overall Study|Lost to Follow-up|6|||
30626372|NCT01106976|58638436|FG000|Overall Study|Lost to Follow-up|8|||
30626373|NCT00875485|58638442|FG000|Challenge Dose Epoch|Pregnancy|1|||
30626374|NCT00875485|58638443|FG001|Challenge Dose Epoch|Pregnancy|0|||
30626375|NCT04547140|58638451|FG000|Overall Study|Adverse Event|0|||
30626376|NCT04547140|58638452|FG001|Overall Study|Adverse Event|1|||
30626377|NCT04547140|58638451|FG000|Overall Study|Withdrawal by Subject|0|||
30626378|NCT04547140|58638452|FG001|Overall Study|Withdrawal by Subject|1|||
30626379|NCT04547140|58638451|FG000|Overall Study|Lost to Follow-up|3|||
30626380|NCT04547140|58638452|FG001|Overall Study|Lost to Follow-up|1|||
30626381|NCT04547140|58638451|FG000|Overall Study|Death|2|||
30626382|NCT04547140|58638452|FG001|Overall Study|Death|1|||
30626383|NCT04547140|58638451|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
30626384|NCT04547140|58638452|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
30626385|NCT04547140|58638451|FG000|Overall Study|Pregnancy|1|||
30626386|NCT04547140|58638452|FG001|Overall Study|Pregnancy|0|||
30626387|NCT04547140|58638451|FG000|Overall Study|Reason Not Specified|4|||
30626388|NCT04547140|58638452|FG001|Overall Study|Reason Not Specified|1|||
30626389|NCT01098474|58638464|FG000|Active Phase|Other|0|||
30626390|NCT01098474|58638465|FG001|Active Phase|Other|0|||
30626391|NCT01098474|58638466|FG002|Active Phase|Other|3|||
30626392|NCT01098474|58638467|FG003|Active Phase|Other|0|||
30626393|NCT01098474|58638468|FG004|Active Phase|Other|0|||
30626394|NCT01098474|58638469|FG005|Active Phase|Other|0|||
30626395|NCT01098474|58638464|FG000|Active Phase|Withdrawal by Subject|1|||
30626396|NCT01098474|58638465|FG001|Active Phase|Withdrawal by Subject|1|||
30626397|NCT01098474|58638466|FG002|Active Phase|Withdrawal by Subject|2|||
30626398|NCT01098474|58638467|FG003|Active Phase|Withdrawal by Subject|0|||
30626399|NCT01098474|58638468|FG004|Active Phase|Withdrawal by Subject|0|||
30626400|NCT01098474|58638469|FG005|Active Phase|Withdrawal by Subject|0|||
30626401|NCT01098474|58638464|FG000|Active Phase|Lost to Follow-up|1|||
30626402|NCT01098474|58638465|FG001|Active Phase|Lost to Follow-up|0|||
30626403|NCT01098474|58638466|FG002|Active Phase|Lost to Follow-up|0|||
30626404|NCT01098474|58638467|FG003|Active Phase|Lost to Follow-up|0|||
30626405|NCT01098474|58638468|FG004|Active Phase|Lost to Follow-up|0|||
30626406|NCT01098474|58638469|FG005|Active Phase|Lost to Follow-up|0|||
30626407|NCT01098474|58638464|FG000|Follow Up Phase|Travelled out of study area|0|||
30626408|NCT01098474|58638465|FG001|Follow Up Phase|Travelled out of study area|0|||
30626409|NCT01098474|58638466|FG002|Follow Up Phase|Travelled out of study area|0|||
30626410|NCT01098474|58638467|FG003|Follow Up Phase|Travelled out of study area|0|||
30626411|NCT01098474|58638468|FG004|Follow Up Phase|Travelled out of study area|1|||
30626412|NCT01098474|58638469|FG005|Follow Up Phase|Travelled out of study area|0|||
30763438|NCT01574274|58772202|FG001|Overall Study|Adverse Event|13|||
30626413|NCT01098474|58638464|FG000|Follow Up Phase|Other|0|||
30626414|NCT01098474|58638465|FG001|Follow Up Phase|Other|0|||
30626415|NCT01098474|58638466|FG002|Follow Up Phase|Other|0|||
30626416|NCT01098474|58638467|FG003|Follow Up Phase|Other|0|||
30626417|NCT01098474|58638468|FG004|Follow Up Phase|Other|0|||
30626418|NCT01098474|58638469|FG005|Follow Up Phase|Other|4|||
30763439|NCT01574274|58772201|FG000|Overall Study|Remission Death|1|||
30626419|NCT01098474|58638464|FG000|Follow Up Phase|Withdrawal by Subject|0|||
30626420|NCT01098474|58638465|FG001|Follow Up Phase|Withdrawal by Subject|0|||
30626421|NCT01098474|58638466|FG002|Follow Up Phase|Withdrawal by Subject|0|||
30626422|NCT01098474|58638467|FG003|Follow Up Phase|Withdrawal by Subject|2|||
30626423|NCT01098474|58638468|FG004|Follow Up Phase|Withdrawal by Subject|0|||
30626424|NCT01098474|58638469|FG005|Follow Up Phase|Withdrawal by Subject|1|||
30626425|NCT01098474|58638464|FG000|Follow Up Phase|Lost to Follow-up|0|||
30626426|NCT01098474|58638465|FG001|Follow Up Phase|Lost to Follow-up|0|||
30626427|NCT01098474|58638466|FG002|Follow Up Phase|Lost to Follow-up|0|||
30626428|NCT01098474|58638467|FG003|Follow Up Phase|Lost to Follow-up|0|||
30626429|NCT01098474|58638468|FG004|Follow Up Phase|Lost to Follow-up|1|||
30626430|NCT01098474|58638469|FG005|Follow Up Phase|Lost to Follow-up|0|||
30626431|NCT01106898|58638493|FG000|Overall Study|Adverse Event|6|||
30626432|NCT00876733|58638501|FG000|Overall Study|Adverse Event|34|||
30626433|NCT00876733|58638502|FG001|Overall Study|Adverse Event|20|||
30626434|NCT00876733|58638503|FG002|Overall Study|Adverse Event|10|||
30626435|NCT00876733|58638504|FG003|Overall Study|Adverse Event|3|||
30626436|NCT00876733|58638501|FG000|Overall Study|Lack of Efficacy|17|||
30626437|NCT00876733|58638502|FG001|Overall Study|Lack of Efficacy|9|||
30626438|NCT00876733|58638503|FG002|Overall Study|Lack of Efficacy|10|||
30626439|NCT00876733|58638504|FG003|Overall Study|Lack of Efficacy|1|||
30626440|NCT00876733|58638501|FG000|Overall Study|Lost to Follow-up|26|||
30626441|NCT00876733|58638502|FG001|Overall Study|Lost to Follow-up|10|||
30626442|NCT00876733|58638503|FG002|Overall Study|Lost to Follow-up|3|||
30626443|NCT00876733|58638504|FG003|Overall Study|Lost to Follow-up|2|||
30626444|NCT00876733|58638501|FG000|Overall Study|Data not available|14|||
30626445|NCT00876733|58638502|FG001|Overall Study|Data not available|3|||
30626446|NCT00876733|58638503|FG002|Overall Study|Data not available|7|||
30626447|NCT00876733|58638504|FG003|Overall Study|Data not available|1|||
30626448|NCT00875017|58638524|FG000|First Intervention|Withdrawal by Subject|1|||
30626449|NCT00875017|58638525|FG001|First Intervention|Withdrawal by Subject|0|||
30626450|NCT00875017|58638526|FG002|First Intervention|Withdrawal by Subject|1|||
30626451|NCT00875017|58638527|FG003|First Intervention|Withdrawal by Subject|0|||
30626452|NCT00875017|58638528|FG004|First Intervention|Withdrawal by Subject|0|||
30626453|NCT00875017|58638529|FG005|First Intervention|Withdrawal by Subject|0|||
30626454|NCT00875017|58638524|FG000|First Intervention|Adverse Event|0|||
30626455|NCT00875017|58638525|FG001|First Intervention|Adverse Event|0|||
30626456|NCT00875017|58638526|FG002|First Intervention|Adverse Event|0|||
30626457|NCT00875017|58638527|FG003|First Intervention|Adverse Event|1|||
30626458|NCT00875017|58638528|FG004|First Intervention|Adverse Event|0|||
30626459|NCT00875017|58638529|FG005|First Intervention|Adverse Event|0|||
30626460|NCT00875017|58638524|FG000|First Intervention|Problems collecting rectal effluent|1|||
30626461|NCT00875017|58638525|FG001|First Intervention|Problems collecting rectal effluent|0|||
30626462|NCT00875017|58638526|FG002|First Intervention|Problems collecting rectal effluent|0|||
30626463|NCT00875017|58638527|FG003|First Intervention|Problems collecting rectal effluent|0|||
30626464|NCT00875017|58638528|FG004|First Intervention|Problems collecting rectal effluent|0|||
30626465|NCT00875017|58638529|FG005|First Intervention|Problems collecting rectal effluent|0|||
30626466|NCT00875017|58638524|FG000|First Intervention|Intolerance to nasogastric tube|0|||
30626467|NCT00875017|58638525|FG001|First Intervention|Intolerance to nasogastric tube|0|||
30626468|NCT00875017|58638526|FG002|First Intervention|Intolerance to nasogastric tube|0|||
30626469|NCT00875017|58638527|FG003|First Intervention|Intolerance to nasogastric tube|0|||
30626470|NCT00875017|58638528|FG004|First Intervention|Intolerance to nasogastric tube|1|||
30626471|NCT00875017|58638529|FG005|First Intervention|Intolerance to nasogastric tube|0|||
30626472|NCT00875017|58638524|FG000|Washout|Problem collecting rectal effluent|0|||
30763440|NCT01574274|58772202|FG001|Overall Study|Remission Death|0|||
30626473|NCT00875017|58638525|FG001|Washout|Problem collecting rectal effluent|0|||
30626474|NCT00875017|58638526|FG002|Washout|Problem collecting rectal effluent|1|||
30626475|NCT00875017|58638527|FG003|Washout|Problem collecting rectal effluent|0|||
30847821|NCT02477332|58873707|FG000|Overall Study|Protocol Violation|2|||
30626476|NCT00875017|58638528|FG004|Washout|Problem collecting rectal effluent|0|||
30626477|NCT00875017|58638529|FG005|Washout|Problem collecting rectal effluent|0|||
30626478|NCT00875017|58638524|FG000|Second Intervention|Adverse Event|0|||
30626479|NCT00875017|58638525|FG001|Second Intervention|Adverse Event|0|||
30626480|NCT00875017|58638526|FG002|Second Intervention|Adverse Event|0|||
30626481|NCT00875017|58638527|FG003|Second Intervention|Adverse Event|1|||
30626482|NCT00875017|58638528|FG004|Second Intervention|Adverse Event|0|||
30626483|NCT00875017|58638529|FG005|Second Intervention|Adverse Event|0|||
30626484|NCT00875017|58638524|FG000|Washout|Problems collecting rectal effluent|0|||
30626485|NCT00875017|58638525|FG001|Washout|Problems collecting rectal effluent|1|||
30626486|NCT00875017|58638526|FG002|Washout|Problems collecting rectal effluent|0|||
30763441|NCT01574274|58772201|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
30763442|NCT01574274|58772202|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
30950453|NCT01929317|58997286|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
30950454|NCT01929317|58997287|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
30950455|NCT01929317|58997286|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
30950456|NCT01929317|58997287|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
30950457|NCT01929317|58997286|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
30950458|NCT01929317|58997287|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
30950459|NCT01929317|58997286|FG000|Long-term Phase|Adverse Event|5|||
30950460|NCT01929317|58997287|FG001|Long-term Phase|Adverse Event|1|||
30950461|NCT01929317|58997286|FG000|Long-term Phase|Physician Decision|3|||
30950462|NCT01929317|58997287|FG001|Long-term Phase|Physician Decision|0|||
30950463|NCT01929317|58997286|FG000|Long-term Phase|Withdrawal by Subject|4|||
30950464|NCT01929317|58997287|FG001|Long-term Phase|Withdrawal by Subject|0|||
30950465|NCT01929317|58997286|FG000|Long-term Phase|Protocol Violation|1|||
30950466|NCT01929317|58997287|FG001|Long-term Phase|Protocol Violation|0|||
30950467|NCT01929317|58997286|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
30950468|NCT01929317|58997287|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
30950469|NCT01929317|58997286|FG000|Long-term Phase|Study Closed/Terminated|5|||
30950470|NCT01929317|58997287|FG001|Long-term Phase|Study Closed/Terminated|3|||
30950471|NCT01711879|58997301|FG000|Overall Study|Death|1|||
30950472|NCT01711879|58997302|FG001|Overall Study|Death|0|||
30950473|NCT01689649|58997325|FG000|Overall Study|Lack of Efficacy|3|||
30950474|NCT01689649|58997325|FG000|Overall Study|Non-compliance|11|||
30950475|NCT01689649|58997325|FG000|Overall Study|Protocol Violation|3|||
30950476|NCT01689649|58997325|FG000|Overall Study|Lost to Follow-up|5|||
30950477|NCT01929083|58997329|FG000|Intervention 1|Lost to Follow-up|2|||
30950478|NCT01929083|58997330|FG001|Intervention 1|Lost to Follow-up|0|||
30950479|NCT01929083|58997329|FG000|Intervention 1|Nonadherent to study medications|1|||
30950480|NCT01929083|58997330|FG001|Intervention 1|Nonadherent to study medications|0|||
30950481|NCT01929083|58997329|FG000|Intervention 2|Adverse Event|0|||
30950482|NCT01929083|58997330|FG001|Intervention 2|Adverse Event|1|||
30950483|NCT01689337|58997336|FG000|Overall Study|Study Discontinuation|1|||
30950484|NCT01688635|58997342|FG000|Washout 1|Withdrawal by Subject|1|||
30950485|NCT01688635|58997343|FG001|Washout 1|Withdrawal by Subject|0|||
30950486|NCT01688635|58997342|FG000|Washout 1|Adverse Event|0|||
30950487|NCT01688635|58997343|FG001|Washout 1|Adverse Event|1|||
30950488|NCT01688635|58997342|FG000|Washout 1|Physician Decision|0|||
30950489|NCT01688635|58997343|FG001|Washout 1|Physician Decision|1|||
30950490|NCT01688635|58997342|FG000|Washout 2|Physician Decision|1|||
30950491|NCT01688635|58997343|FG001|Washout 2|Physician Decision|0|||
30950492|NCT01688635|58997342|FG000|Washout 2|Withdrawal by Subject|1|||
30950493|NCT01688635|58997343|FG001|Washout 2|Withdrawal by Subject|0|||
30950494|NCT01688635|58997342|FG000|Washout 2|Sponsor Decision|1|||
30950495|NCT01688635|58997343|FG001|Washout 2|Sponsor Decision|2|||
30950496|NCT01688635|58997342|FG000|Washout 3|Withdrawal by Subject|1|||
30950497|NCT01688635|58997343|FG001|Washout 3|Withdrawal by Subject|0|||
30950498|NCT01591681|58997350|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
30950499|NCT01591681|58997350|FG000|Overall Study|Failed to use system during run-in|1|||
30950500|NCT01711645|58997365|FG000|Overall Study|Withdrawal by Subject|8|||
30950501|NCT01711645|58997365|FG000|Overall Study|Lost to Follow-up|6|||
30950502|NCT01711645|58997365|FG000|Overall Study|Physician Decision|5|||
30950503|NCT01590433|58997380|FG000|Overall Study|Lost to Follow-up|20|||
30950504|NCT01590433|58997381|FG001|Overall Study|Lost to Follow-up|8|||
30950505|NCT01590433|58997380|FG000|Overall Study|Withdrawal by Subject|21|||
30763443|NCT01574274|58772201|FG000|Overall Study|Other, unknown|3|||
30763444|NCT01574274|58772202|FG001|Overall Study|Other, unknown|2|||
30763445|NCT01208974|58772208|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
30763446|NCT01208974|58772209|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
30763447|NCT01208974|58772210|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
30763448|NCT01208974|58772211|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
30763449|NCT01208974|58772208|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
30763450|NCT01208974|58772209|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
30950506|NCT01590433|58997381|FG001|Overall Study|Withdrawal by Subject|11|||
30950507|NCT01590433|58997380|FG000|Overall Study|Adverse Event|11|||
30950508|NCT01590433|58997381|FG001|Overall Study|Adverse Event|3|||
30950509|NCT01928927|58997398|FG000|Overall Study|Lost to Follow-up|1|||
30950510|NCT01928927|58997399|FG001|Overall Study|Lost to Follow-up|0|||
30950511|NCT01928927|58997398|FG000|Overall Study|Withdrawal by Subject|1|||
30950512|NCT01928927|58997399|FG001|Overall Study|Withdrawal by Subject|1|||
30626487|NCT00875017|58638527|FG003|Washout|Problems collecting rectal effluent|0|||
30626488|NCT00875017|58638528|FG004|Washout|Problems collecting rectal effluent|0|||
30626489|NCT00875017|58638529|FG005|Washout|Problems collecting rectal effluent|0|||
30626490|NCT00875017|58638524|FG000|Third Intervention|Adverse Event|0|||
30626491|NCT00875017|58638525|FG001|Third Intervention|Adverse Event|1|||
30626492|NCT00875017|58638526|FG002|Third Intervention|Adverse Event|1|||
30626493|NCT00875017|58638527|FG003|Third Intervention|Adverse Event|0|||
30626494|NCT00875017|58638528|FG004|Third Intervention|Adverse Event|0|||
30626495|NCT00875017|58638529|FG005|Third Intervention|Adverse Event|0|||
30626496|NCT00875017|58638524|FG000|Washout|Withdrawal by Subject|0|||
30626497|NCT00875017|58638525|FG001|Washout|Withdrawal by Subject|0|||
30626498|NCT00875017|58638526|FG002|Washout|Withdrawal by Subject|0|||
30626499|NCT00875017|58638527|FG003|Washout|Withdrawal by Subject|0|||
30626500|NCT00875017|58638528|FG004|Washout|Withdrawal by Subject|1|||
30626501|NCT00875017|58638529|FG005|Washout|Withdrawal by Subject|0|||
30626502|NCT00875017|58638524|FG000|Fourth Intervention|Inability to comply with fasting|0|||
30626503|NCT00875017|58638525|FG001|Fourth Intervention|Inability to comply with fasting|0|||
30626504|NCT00875017|58638526|FG002|Fourth Intervention|Inability to comply with fasting|0|||
30626505|NCT00875017|58638527|FG003|Fourth Intervention|Inability to comply with fasting|0|||
30626506|NCT00875017|58638528|FG004|Fourth Intervention|Inability to comply with fasting|0|||
30626507|NCT00875017|58638529|FG005|Fourth Intervention|Inability to comply with fasting|1|||
30626508|NCT00875797|58638554|FG000|Overall Study|Protocol Violation|6|||
30626509|NCT00875797|58638555|FG001|Overall Study|Protocol Violation|3|||
30626510|NCT00874939|58638581|FG000|Overall Study|Study terminated|4|||
30626511|NCT00875563|58638591|FG000|Overall Study|Death|4|||
30626512|NCT00875563|58638591|FG000|Overall Study|Withdrawal by Subject|7|||
30626513|NCT00875563|58638591|FG000|Overall Study|No long-term (3-5 year) consent|6|||
30626514|NCT00875563|58638591|FG000|Overall Study|Still be eligible for follow-up|7|||
30626515|NCT01155869|58638597|FG000|Overall Study|Lost to Follow-up|3|||
30626516|NCT01155869|58638598|FG001|Overall Study|Lost to Follow-up|1|||
30626517|NCT01185353|58638609|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
30626518|NCT01185353|58638610|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
30626519|NCT01185353|58638611|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
30626520|NCT01185353|58638612|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
30626521|NCT01185353|58638613|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
30626522|NCT01185353|58638614|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
30626523|NCT01185353|58638615|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
30626524|NCT01185353|58638616|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
30626525|NCT01185353|58638617|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
30626526|NCT01185353|58638618|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
30626527|NCT01185353|58638609|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
30626528|NCT01185353|58638610|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
30626529|NCT01185353|58638611|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
30626530|NCT01185353|58638612|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
30626531|NCT01185353|58638613|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
30626532|NCT01185353|58638614|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
30626533|NCT01185353|58638615|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
30626534|NCT01185353|58638616|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
30626535|NCT01185353|58638617|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
30626536|NCT01185353|58638618|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
30626537|NCT01185353|58638609|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
30626538|NCT01185353|58638610|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
30626539|NCT01185353|58638611|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
30626540|NCT01185353|58638612|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
30626541|NCT01185353|58638613|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
30626542|NCT01185353|58638614|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
30626543|NCT01185353|58638615|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
30626544|NCT01185353|58638616|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
30626545|NCT01185353|58638617|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
30626546|NCT01185353|58638618|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
30847822|NCT02477332|58873708|FG001|Overall Study|Protocol Violation|0|||
30847823|NCT02477332|58873709|FG002|Overall Study|Protocol Violation|3|||
30847824|NCT02477332|58873710|FG003|Overall Study|Protocol Violation|3|||
30847825|NCT02477332|58873711|FG004|Overall Study|Protocol Violation|1|||
30847826|NCT02477332|58873712|FG005|Overall Study|Protocol Violation|1|||
30847827|NCT02477332|58873707|FG000|Overall Study|Technical problems|0|||
30626547|NCT01185353|58638609|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
30626548|NCT01185353|58638610|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
30847828|NCT02477332|58873708|FG001|Overall Study|Technical problems|0|||
30626549|NCT01185353|58638611|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
30847829|NCT02477332|58873709|FG002|Overall Study|Technical problems|1|||
30847830|NCT02477332|58873710|FG003|Overall Study|Technical problems|0|||
30847831|NCT02477332|58873711|FG004|Overall Study|Technical problems|0|||
30847832|NCT02477332|58873712|FG005|Overall Study|Technical problems|0|||
30626550|NCT01185353|58638612|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
30626551|NCT01185353|58638613|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
30626552|NCT01185353|58638614|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
30626553|NCT01185353|58638615|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
30626554|NCT01185353|58638616|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
30626555|NCT01185353|58638617|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
30626556|NCT01185353|58638618|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
30626557|NCT01185353|58638609|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
30626558|NCT01185353|58638610|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
30626559|NCT01185353|58638611|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
30626560|NCT01185353|58638612|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
30626561|NCT01185353|58638613|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
30626562|NCT01185353|58638614|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
30626563|NCT01185353|58638615|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
30950513|NCT01710709|58997420|FG000|Overall Study|Lost to Follow-up|29|||
30626564|NCT01185353|58638616|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
30626565|NCT01185353|58638617|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
30626566|NCT01185353|58638618|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
30626567|NCT01185353|58638609|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
30763451|NCT01208974|58772210|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
30763452|NCT01208974|58772211|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
30763453|NCT01208974|58772208|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
30763454|NCT01208974|58772209|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
30950514|NCT01710709|58997420|FG000|Overall Study|Adverse Event|48|||
30950515|NCT01710709|58997420|FG000|Overall Study|Participant met withdrawal criteria|33|||
30950516|NCT01710709|58997420|FG000|Overall Study|Participant withdrawn by investigator|2|||
30950517|NCT01710709|58997420|FG000|Overall Study|Withdrawal by Subject|53|||
30950518|NCT01710709|58997420|FG000|Overall Study|Protocol Violation|5|||
30950519|NCT01710709|58997420|FG000|Overall Study|Lack of Efficacy|3|||
30950520|NCT01617629|58997425|FG000|Overall Study|Death|2|||
30950521|NCT01617629|58997425|FG000|Overall Study|Investigator's Clinical Judgement|1|||
30950522|NCT01617629|58997425|FG000|Overall Study|Reason Not Specified|1|||
30950523|NCT01617629|58997425|FG000|Overall Study|Participant Withdrew Consent|2|||
30626568|NCT01185353|58638610|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
30763455|NCT01208974|58772210|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
30763456|NCT01208974|58772211|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
30763457|NCT00840177|58772221|FG000|Overall Study|Adverse Event|5|||
30763458|NCT00840177|58772222|FG001|Overall Study|Adverse Event|1|||
30763459|NCT00840177|58772223|FG002|Overall Study|Adverse Event|1|||
30763460|NCT00840177|58772221|FG000|Overall Study|Refusal unrelated to adverse events|1|||
30847833|NCT02477332|58873707|FG000|Overall Study|Lost to Follow-up|0|||
30626569|NCT01185353|58638611|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
30626570|NCT01185353|58638612|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
30626571|NCT01185353|58638613|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
30626572|NCT01185353|58638614|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
30626573|NCT01185353|58638615|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
30626574|NCT01185353|58638616|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
30626575|NCT01185353|58638617|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
30626576|NCT01185353|58638618|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
30626577|NCT01185353|58638609|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
30626578|NCT01185353|58638610|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
30626579|NCT01185353|58638611|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
30626580|NCT01185353|58638612|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
30626581|NCT01185353|58638613|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
30626582|NCT01185353|58638614|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
30626583|NCT01185353|58638615|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
30626584|NCT01185353|58638616|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
30626585|NCT01185353|58638617|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
30626586|NCT01185353|58638618|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
30626587|NCT01185353|58638609|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
30626588|NCT01185353|58638610|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
30626589|NCT01185353|58638611|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
30626590|NCT01185353|58638612|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
30626591|NCT01185353|58638613|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
30626592|NCT01185353|58638614|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
30626593|NCT01185353|58638615|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
30626594|NCT01185353|58638616|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
30626595|NCT01185353|58638617|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
30626596|NCT01185353|58638618|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
30626597|NCT01185353|58638609|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
30626598|NCT01185353|58638610|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
30626599|NCT01185353|58638611|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
30626600|NCT01185353|58638612|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
30626601|NCT01185353|58638613|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
30626602|NCT01185353|58638614|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
30626603|NCT01185353|58638615|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
30626604|NCT01185353|58638616|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
30626605|NCT01185353|58638617|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
30626606|NCT01185353|58638618|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
30626607|NCT01185353|58638609|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
30626608|NCT01185353|58638610|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
30626609|NCT01185353|58638611|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
30626610|NCT01185353|58638612|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
30626611|NCT01185353|58638613|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
30626612|NCT01185353|58638614|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
30626613|NCT01185353|58638615|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
30626614|NCT01185353|58638616|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
30626615|NCT01185353|58638617|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
30626616|NCT01185353|58638618|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
30626617|NCT01185353|58638609|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
30626618|NCT01185353|58638610|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
30626619|NCT01185353|58638611|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
30626620|NCT01185353|58638612|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
30847834|NCT02477332|58873708|FG001|Overall Study|Lost to Follow-up|0|||
30847835|NCT02477332|58873709|FG002|Overall Study|Lost to Follow-up|2|||
30847836|NCT02477332|58873710|FG003|Overall Study|Lost to Follow-up|0|||
30847837|NCT02477332|58873711|FG004|Overall Study|Lost to Follow-up|0|||
30626621|NCT01185353|58638613|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
30626622|NCT01185353|58638614|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
30626623|NCT01185353|58638615|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
30626624|NCT01185353|58638616|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
30626625|NCT01185353|58638617|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
30626626|NCT01185353|58638618|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
30626627|NCT01185353|58638609|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
30626628|NCT01185353|58638610|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
30950524|NCT01686373|58997440|FG000|Overall Study|Lost to Follow-up|3|||
30950525|NCT01686373|58997441|FG001|Overall Study|Lost to Follow-up|0|||
30950526|NCT01686373|58997440|FG000|Overall Study|Withdrawal by Subject|0|||
30950527|NCT01686373|58997441|FG001|Overall Study|Withdrawal by Subject|1|||
30950528|NCT01686373|58997440|FG000|Overall Study|Adverse Event|0|||
30950529|NCT01686373|58997441|FG001|Overall Study|Adverse Event|1|||
30950530|NCT01709695|58997449|FG000|Overall Study|Withdrawal by Subject|1|||
30950531|NCT01709695|58997450|FG001|Overall Study|Withdrawal by Subject|1|||
30950532|NCT01685983|58997460|FG000|Overall Study|Adverse Event|7|||
30950533|NCT01685983|58997460|FG000|Overall Study|Death|1|||
30950534|NCT01685983|58997460|FG000|Overall Study|Withdrawal by Subject|19|||
30950535|NCT01685983|58997460|FG000|Overall Study|Protocol Violation|2|||
30950536|NCT01685983|58997460|FG000|Overall Study|Physician Decision|13|||
30950537|NCT01685983|58997460|FG000|Overall Study|Other|7|||
30950538|NCT01685983|58997460|FG000|Overall Study|Progressive Disease|32|||
30950539|NCT01685983|58997460|FG000|Overall Study|Noncompliance with Study Drug|1|||
30626629|NCT01185353|58638611|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
30763461|NCT00840177|58772222|FG001|Overall Study|Refusal unrelated to adverse events|0|||
30763462|NCT00840177|58772223|FG002|Overall Study|Refusal unrelated to adverse events|1|||
30763463|NCT00840177|58772221|FG000|Overall Study|Progression/relapse|2|||
30763464|NCT00840177|58772222|FG001|Overall Study|Progression/relapse|0|||
30763465|NCT00840177|58772223|FG002|Overall Study|Progression/relapse|0|||
30763466|NCT00840177|58772221|FG000|Overall Study|Death|4|||
30763467|NCT00840177|58772222|FG001|Overall Study|Death|5|||
30763468|NCT00840177|58772223|FG002|Overall Study|Death|5|||
30950540|NCT01685437|58997472|FG000|Overall Study|Withdrawal by Subject|22|||
30950541|NCT01685437|58997472|FG000|Overall Study|Lost to Follow-up|3|||
30626630|NCT01185353|58638612|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
30626631|NCT01185353|58638613|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
30626632|NCT01185353|58638614|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
30626633|NCT01185353|58638615|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
30626634|NCT01185353|58638616|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
30626635|NCT01185353|58638617|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
30626636|NCT01185353|58638618|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
30626637|NCT01185353|58638609|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
30626638|NCT01185353|58638610|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
30626639|NCT01185353|58638611|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
30626640|NCT01185353|58638612|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
30626641|NCT01185353|58638613|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
30626642|NCT01185353|58638614|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
30626643|NCT01185353|58638615|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
30626644|NCT01185353|58638616|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
30626645|NCT01185353|58638617|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
30626646|NCT01185353|58638618|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
30626647|NCT01185353|58638609|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
30626648|NCT01185353|58638610|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
30626649|NCT01185353|58638611|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
30626650|NCT01185353|58638612|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
30626651|NCT01185353|58638613|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
30626652|NCT01185353|58638614|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
30626653|NCT01185353|58638615|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
30626654|NCT01185353|58638616|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
30626655|NCT01185353|58638617|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
30626656|NCT01185353|58638618|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
30626657|NCT01185353|58638609|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
30626658|NCT01185353|58638610|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
30626659|NCT01185353|58638611|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
30626660|NCT01185353|58638612|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
30626661|NCT01185353|58638613|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
30626662|NCT01185353|58638614|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
30626663|NCT01185353|58638615|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
30626664|NCT01185353|58638616|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
30626665|NCT01185353|58638617|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
30626666|NCT01185353|58638618|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
30626667|NCT01185353|58638609|FG000|Part C (Weeks 24 Through 76)|Death|0|||
30626668|NCT01185353|58638610|FG001|Part C (Weeks 24 Through 76)|Death|0|||
30626669|NCT01185353|58638611|FG002|Part C (Weeks 24 Through 76)|Death|0|||
30626670|NCT01185353|58638612|FG003|Part C (Weeks 24 Through 76)|Death|0|||
30626671|NCT01185353|58638613|FG004|Part C (Weeks 24 Through 76)|Death|0|||
30626672|NCT01185353|58638614|FG005|Part C (Weeks 24 Through 76)|Death|0|||
30626673|NCT01185353|58638615|FG006|Part C (Weeks 24 Through 76)|Death|0|||
30626674|NCT01185353|58638616|FG007|Part C (Weeks 24 Through 76)|Death|0|||
30626675|NCT01185353|58638617|FG008|Part C (Weeks 24 Through 76)|Death|0|||
30626676|NCT01185353|58638618|FG009|Part C (Weeks 24 Through 76)|Death|1|||
30626677|NCT01185353|58638609|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
30626678|NCT01185353|58638610|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
30626679|NCT01185353|58638611|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
30626680|NCT01185353|58638612|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
30626681|NCT01185353|58638613|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
30626682|NCT01185353|58638614|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
30626683|NCT01185353|58638615|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
30626684|NCT01185353|58638616|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
30626685|NCT01185353|58638617|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
30626686|NCT01185353|58638618|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
30626687|NCT01185353|58638609|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
30626688|NCT01185353|58638610|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
30626689|NCT01185353|58638611|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
30626690|NCT01185353|58638612|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
30626691|NCT01185353|58638613|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
30626692|NCT01185353|58638614|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
30626693|NCT01185353|58638615|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
30626694|NCT01185353|58638616|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
30626695|NCT01185353|58638617|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
30626696|NCT01185353|58638618|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
30626697|NCT01185353|58638609|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
30626698|NCT01185353|58638610|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
30626699|NCT01185353|58638611|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
30626700|NCT01185353|58638612|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
30626701|NCT01185353|58638613|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
30626702|NCT01185353|58638614|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
30626703|NCT01185353|58638615|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
30626704|NCT01185353|58638616|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
30626705|NCT01185353|58638617|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
30626706|NCT01185353|58638618|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
30626707|NCT01185353|58638609|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
30626708|NCT01185353|58638610|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
30626709|NCT01185353|58638611|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
30626710|NCT01185353|58638612|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
30626711|NCT01185353|58638613|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
30626712|NCT01185353|58638614|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
30626713|NCT01185353|58638615|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
30626714|NCT01185353|58638616|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
30626715|NCT01185353|58638617|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
30626716|NCT01185353|58638618|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
30626717|NCT01185353|58638609|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
30626718|NCT01185353|58638610|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
30626719|NCT01185353|58638611|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
30626720|NCT01185353|58638612|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
30626721|NCT01185353|58638613|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
30626722|NCT01185353|58638614|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
30626723|NCT01185353|58638615|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
30626724|NCT01185353|58638616|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
30626725|NCT01185353|58638617|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
30626726|NCT01185353|58638618|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
30626727|NCT01185353|58638609|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
30626728|NCT01185353|58638610|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
30626729|NCT01185353|58638611|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
30626730|NCT01185353|58638612|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
30626731|NCT01185353|58638613|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
30626732|NCT01185353|58638614|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
30626733|NCT01185353|58638615|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
30626734|NCT01185353|58638616|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
30626735|NCT01185353|58638617|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
30626736|NCT01185353|58638618|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
30626737|NCT01098240|58638657|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
30626738|NCT01098240|58638658|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
30626739|NCT01098240|58638659|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
30626740|NCT01098240|58638657|FG000|Open-Label Phase|Protocol Violation|4|||
30626741|NCT01098240|58638658|FG001|Open-Label Phase|Protocol Violation|0|||
30626742|NCT01098240|58638659|FG002|Open-Label Phase|Protocol Violation|0|||
30626743|NCT01098240|58638657|FG000|Open-Label Phase|Lost to Follow-up|13|||
30626744|NCT01098240|58638658|FG001|Open-Label Phase|Lost to Follow-up|0|||
30626745|NCT01098240|58638659|FG002|Open-Label Phase|Lost to Follow-up|0|||
30626746|NCT01098240|58638657|FG000|Open-Label Phase|Other|19|||
30626747|NCT01098240|58638658|FG001|Open-Label Phase|Other|0|||
30763469|NCT00840177|58772221|FG000|Overall Study|not protocol specified|6|||
30763470|NCT00840177|58772222|FG001|Overall Study|not protocol specified|3|||
30763471|NCT00840177|58772223|FG002|Overall Study|not protocol specified|0|||
30626748|NCT01098240|58638659|FG002|Open-Label Phase|Other|0|||
30950542|NCT01685437|58997472|FG000|Overall Study|Adverse Event|1|||
30950543|NCT01685437|58997472|FG000|Overall Study|Protocol Violation|4|||
30950544|NCT01685437|58997472|FG000|Overall Study|Unable to make visits due to work|1|||
30626749|NCT01098240|58638657|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
30626750|NCT01098240|58638658|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
30626751|NCT01098240|58638659|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
30626752|NCT01098240|58638657|FG000|Open-Label Phase|Pregnancy|1|||
30626753|NCT01098240|58638658|FG001|Open-Label Phase|Pregnancy|0|||
30626754|NCT01098240|58638659|FG002|Open-Label Phase|Pregnancy|0|||
30626755|NCT01098240|58638657|FG000|Open-Label Phase|Withdrawal by Subject|9|||
30626756|NCT01098240|58638658|FG001|Open-Label Phase|Withdrawal by Subject|0|||
30626757|NCT01098240|58638659|FG002|Open-Label Phase|Withdrawal by Subject|0|||
30626758|NCT01098240|58638657|FG000|Open-Label Phase|Adverse Event|12|||
30626759|NCT01098240|58638658|FG001|Open-Label Phase|Adverse Event|0|||
30626760|NCT01098240|58638659|FG002|Open-Label Phase|Adverse Event|0|||
30626761|NCT01098240|58638657|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
30626762|NCT01098240|58638658|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
30626763|NCT01098240|58638659|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
30626764|NCT01098240|58638657|FG000|Double-Blind Phase|Protocol Violation|0|||
30626765|NCT01098240|58638658|FG001|Double-Blind Phase|Protocol Violation|2|||
30626766|NCT01098240|58638659|FG002|Double-Blind Phase|Protocol Violation|4|||
30626767|NCT01098240|58638657|FG000|Double-Blind Phase|Lost to Follow-up|0|||
30626768|NCT01098240|58638658|FG001|Double-Blind Phase|Lost to Follow-up|2|||
30626769|NCT01098240|58638659|FG002|Double-Blind Phase|Lost to Follow-up|0|||
30626770|NCT01098240|58638657|FG000|Double-Blind Phase|Other|0|||
30626771|NCT01098240|58638658|FG001|Double-Blind Phase|Other|2|||
30626772|NCT01098240|58638659|FG002|Double-Blind Phase|Other|2|||
30626773|NCT01098240|58638657|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
30626774|NCT01098240|58638658|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
30626775|NCT01098240|58638659|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
30626776|NCT01098240|58638657|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
30626777|NCT01098240|58638658|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
30626778|NCT01098240|58638659|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
30626779|NCT01098240|58638657|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
30626780|NCT01098240|58638658|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
30626781|NCT01098240|58638659|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
30626782|NCT01098240|58638657|FG000|Double-Blind Phase|Adverse Event|0|||
30626783|NCT01098240|58638658|FG001|Double-Blind Phase|Adverse Event|3|||
30626784|NCT01098240|58638659|FG002|Double-Blind Phase|Adverse Event|3|||
30626785|NCT01098162|58638666|FG000|Overall Study|Adverse Event|37|||
30626786|NCT01098162|58638666|FG000|Overall Study|Lack of Efficacy|4|||
30626787|NCT01098162|58638666|FG000|Overall Study|Wish of Patient|7|||
30626788|NCT01098162|58638666|FG000|Overall Study|Lost to Follow-up|9|||
30626789|NCT01098162|58638666|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
30626790|NCT01098162|58638666|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
30626791|NCT01098162|58638666|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
30626792|NCT01098162|58638666|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
30626793|NCT01098162|58638666|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
30626794|NCT01098162|58638666|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
30626795|NCT01098162|58638666|FG000|Overall Study|Other Reason|1|||
30626796|NCT01098162|58638666|FG000|Overall Study|Reason Unknown|26|||
30626797|NCT01097694|58638672|FG000|Overall Study|Adverse Event|5|||
30626798|NCT01097694|58638673|FG001|Overall Study|Adverse Event|0|||
30626799|NCT01097694|58638672|FG000|Overall Study|Lost to Follow-up|0|||
30626800|NCT01097694|58638673|FG001|Overall Study|Lost to Follow-up|3|||
30626801|NCT01097694|58638672|FG000|Overall Study|Withdrawal by Subject|3|||
30626802|NCT01097694|58638673|FG001|Overall Study|Withdrawal by Subject|1|||
30626803|NCT01102140|58638681|FG000|Overall Study|Lost to Follow-up|1|||
30626804|NCT01102140|58638682|FG001|Overall Study|Lost to Follow-up|0|||
30626805|NCT01102140|58638681|FG000|Overall Study|Investigator terminated study|2|||
30626806|NCT01102140|58638682|FG001|Overall Study|Investigator terminated study|2|||
30626807|NCT00874549|58638694|FG000|Overall Study|Adverse Event|0|||
30626808|NCT00874549|58638695|FG001|Overall Study|Adverse Event|0|||
30626809|NCT00874549|58638696|FG002|Overall Study|Adverse Event|1|||
30950545|NCT01685203|58997512|FG000|Overall Study|Lost to Follow-up|3|||
30950546|NCT01685203|58997513|FG001|Overall Study|Lost to Follow-up|3|||
30626810|NCT00874549|58638697|FG003|Overall Study|Adverse Event|0|||
30626811|NCT00874549|58638694|FG000|Overall Study|Protocol Violation|1|||
30626812|NCT00874549|58638695|FG001|Overall Study|Protocol Violation|0|||
30626813|NCT00874549|58638696|FG002|Overall Study|Protocol Violation|2|||
30626814|NCT00874549|58638697|FG003|Overall Study|Protocol Violation|1|||
30626815|NCT00874549|58638694|FG000|Overall Study|Lost to Follow-up|0|||
30626816|NCT00874549|58638695|FG001|Overall Study|Lost to Follow-up|0|||
30626817|NCT00874549|58638696|FG002|Overall Study|Lost to Follow-up|1|||
30626818|NCT00874549|58638697|FG003|Overall Study|Lost to Follow-up|0|||
30950547|NCT01685203|58997514|FG002|Overall Study|Lost to Follow-up|0|||
30950548|NCT01685203|58997515|FG003|Overall Study|Lost to Follow-up|1|||
30847838|NCT02477332|58873712|FG005|Overall Study|Lost to Follow-up|0|||
30847839|NCT02477332|58873707|FG000|Overall Study|Physician Decision|0|||
30847840|NCT02477332|58873708|FG001|Overall Study|Physician Decision|0|||
30847841|NCT02477332|58873709|FG002|Overall Study|Physician Decision|1|||
30847842|NCT02477332|58873710|FG003|Overall Study|Physician Decision|3|||
30847843|NCT02477332|58873711|FG004|Overall Study|Physician Decision|0|||
30847844|NCT02477332|58873712|FG005|Overall Study|Physician Decision|1|||
30847845|NCT02477332|58873707|FG000|Overall Study|Withdrawal by Subject|0|||
30847846|NCT02477332|58873708|FG001|Overall Study|Withdrawal by Subject|3|||
30847847|NCT02477332|58873709|FG002|Overall Study|Withdrawal by Subject|1|||
30847848|NCT02477332|58873710|FG003|Overall Study|Withdrawal by Subject|2|||
30847849|NCT02477332|58873711|FG004|Overall Study|Withdrawal by Subject|1|||
30847850|NCT02477332|58873712|FG005|Overall Study|Withdrawal by Subject|0|||
30847851|NCT02477020|58873730|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
30847852|NCT02477020|58873731|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
30847853|NCT02477020|58873730|FG000|Overall Study|Voluntary Withdrawal|7|||
30847854|NCT02477020|58873731|FG001|Overall Study|Voluntary Withdrawal|16|||
30847855|NCT02477020|58873730|FG000|Overall Study|Reason not Specified|3|||
30847856|NCT02477020|58873731|FG001|Overall Study|Reason not Specified|1|||
30847857|NCT02477020|58873730|FG000|Overall Study|Lack of Efficacy|14|||
30847858|NCT02477020|58873731|FG001|Overall Study|Lack of Efficacy|5|||
30847859|NCT02862535|58873741|FG000|Overall Study|Death|7|||
30847860|NCT02862535|58873742|FG001|Overall Study|Death|3|||
30847861|NCT02862535|58873743|FG002|Overall Study|Death|2|||
30847862|NCT02862535|58873744|FG003|Overall Study|Death|5|||
30847863|NCT02862535|58873741|FG000|Overall Study|Study Terminated by Sponsor|1|||
30847864|NCT02862535|58873742|FG001|Overall Study|Study Terminated by Sponsor|3|||
30950549|NCT01685203|58997516|FG004|Overall Study|Lost to Follow-up|0|||
30847865|NCT02862535|58873743|FG002|Overall Study|Study Terminated by Sponsor|8|||
30847866|NCT02862535|58873744|FG003|Overall Study|Study Terminated by Sponsor|5|||
30847867|NCT02862535|58873741|FG000|Overall Study|Enrolled, not Treated|1|||
30847868|NCT02862535|58873742|FG001|Overall Study|Enrolled, not Treated|0|||
30950550|NCT01685203|58997517|FG005|Overall Study|Lost to Follow-up|0|||
30763472|NCT00840177|58772221|FG000|Overall Study|Ineligible|0|||
30847869|NCT02862535|58873743|FG002|Overall Study|Enrolled, not Treated|0|||
30847870|NCT02862535|58873744|FG003|Overall Study|Enrolled, not Treated|1|||
30847871|NCT02448706|58873754|FG000|Overall Study|Withdrawal by Subject|4|||
30847872|NCT02448706|58873755|FG001|Overall Study|Withdrawal by Subject|3|||
30847873|NCT02448706|58873754|FG000|Overall Study|Protocol Violation|1|||
30847874|NCT02448706|58873755|FG001|Overall Study|Protocol Violation|1|||
30847875|NCT02868281|58873765|FG000|Overall Study|Adverse Event|2|||
30626819|NCT00874549|58638694|FG000|Overall Study|Withdrawal by Subject|0|||
30626820|NCT00874549|58638695|FG001|Overall Study|Withdrawal by Subject|1|||
30626821|NCT00874549|58638696|FG002|Overall Study|Withdrawal by Subject|0|||
30626822|NCT00874549|58638697|FG003|Overall Study|Withdrawal by Subject|1|||
30626823|NCT01155479|58638712|FG000|Part I|Adverse Event|13|||
30626824|NCT01155479|58638713|FG001|Part I|Adverse Event|8|||
30626825|NCT01155479|58638714|FG002|Part I|Adverse Event|18|||
30626826|NCT01155479|58638715|FG003|Part I|Adverse Event|7|||
30847876|NCT02868281|58873766|FG001|Overall Study|Adverse Event|2|||
30847877|NCT02868281|58873765|FG000|Overall Study|Protocol Violation|13|||
30847878|NCT02868281|58873766|FG001|Overall Study|Protocol Violation|10|||
30847879|NCT02868281|58873765|FG000|Overall Study|Lost to Follow-up|3|||
30847880|NCT02868281|58873766|FG001|Overall Study|Lost to Follow-up|6|||
30847881|NCT02868281|58873765|FG000|Overall Study|Withdrawal by Subject|11|||
30847882|NCT02868281|58873766|FG001|Overall Study|Withdrawal by Subject|15|||
30847883|NCT02868281|58873765|FG000|Overall Study|Physician Decision|2|||
30847884|NCT02868281|58873766|FG001|Overall Study|Physician Decision|0|||
30847885|NCT02868281|58873765|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
30847886|NCT02868281|58873766|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
30847887|NCT02868281|58873765|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
30847888|NCT02868281|58873766|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
30847889|NCT02868281|58873765|FG000|Overall Study|Long journey/moving away|1|||
30847890|NCT02868281|58873766|FG001|Overall Study|Long journey/moving away|1|||
30847891|NCT02476006|58873772|FG000|Overall Study|Death|4|||
30847892|NCT02476006|58873772|FG000|Overall Study|Lack of treatment efficacy|2|||
30847893|NCT02476006|58873772|FG000|Overall Study|Pregnancy|1|||
30847894|NCT02476006|58873772|FG000|Overall Study|Participant did not wish to continue|39|||
30847895|NCT02476006|58873772|FG000|Overall Study|Adverse Event|41|||
30847896|NCT02476006|58873772|FG000|Overall Study|Poor compliance to study protocol|3|||
30847897|NCT02476006|58873772|FG000|Overall Study|Sponsor decision|6|||
30847898|NCT02476006|58873772|FG000|Overall Study|Lost to Follow-up|5|||
30950551|NCT01685203|58997518|FG006|Overall Study|Lost to Follow-up|0|||
30950552|NCT01685203|58997512|FG000|Overall Study|Adverse Event|0|||
30847899|NCT02476006|58873772|FG000|Overall Study|Physician Decision|5|||
30847900|NCT02476006|58873772|FG000|Overall Study|Study ended treatment not available|4|||
30847901|NCT02476006|58873772|FG000|Overall Study|Switched to commercial drug|4|||
30847902|NCT02476006|58873772|FG000|Overall Study|Excluded from study|1|||
30847903|NCT02476006|58873772|FG000|Overall Study|Protocol Violation|1|||
30847904|NCT02476006|58873772|FG000|Overall Study|Enrolled but not treated|4|||
30847905|NCT02475850|58873778|FG000|Overall Study|Death|155|||
30847906|NCT02475850|58873779|FG001|Overall Study|Death|141|||
30847907|NCT02475850|58873778|FG000|Overall Study|Lost to Follow-up|217|||
30847908|NCT02475850|58873779|FG001|Overall Study|Lost to Follow-up|188|||
30847909|NCT02475850|58873778|FG000|Overall Study|Withdrawal by Subject|221|||
30626827|NCT01155479|58638716|FG004|Part I|Adverse Event|6|||
30626828|NCT01155479|58638712|FG000|Part I|Administrative|2|||
30626829|NCT01155479|58638713|FG001|Part I|Administrative|2|||
30626830|NCT01155479|58638714|FG002|Part I|Administrative|2|||
30626831|NCT01155479|58638715|FG003|Part I|Administrative|0|||
30626832|NCT01155479|58638716|FG004|Part I|Administrative|0|||
30626833|NCT01155479|58638712|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
30626834|NCT01155479|58638713|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
30626835|NCT01155479|58638714|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
30626836|NCT01155479|58638715|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
30626837|NCT01155479|58638716|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
30626838|NCT01155479|58638712|FG000|Part I|Withdrawal by Subject|11|||
30847910|NCT02475850|58873779|FG001|Overall Study|Withdrawal by Subject|155|||
30950553|NCT01685203|58997513|FG001|Overall Study|Adverse Event|0|||
30950554|NCT01685203|58997514|FG002|Overall Study|Adverse Event|0|||
30626839|NCT01155479|58638713|FG001|Part I|Withdrawal by Subject|13|||
30847911|NCT02419612|58873788|FG000|Short-term Treatment Period|Adverse Event|1|||
30847912|NCT02419612|58873789|FG001|Short-term Treatment Period|Adverse Event|1|||
30847913|NCT02419612|58873788|FG000|Short-term Treatment Period|Death|0|||
30847914|NCT02419612|58873789|FG001|Short-term Treatment Period|Death|2|||
30847915|NCT02419612|58873788|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
30847916|NCT02419612|58873789|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
30847917|NCT02419612|58873788|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
30626840|NCT01155479|58638714|FG002|Part I|Withdrawal by Subject|8|||
30626841|NCT01155479|58638715|FG003|Part I|Withdrawal by Subject|8|||
30626842|NCT01155479|58638716|FG004|Part I|Withdrawal by Subject|9|||
30626843|NCT01155479|58638712|FG000|Part I|Lost to Follow-up|0|||
30626844|NCT01155479|58638713|FG001|Part I|Lost to Follow-up|0|||
30626845|NCT01155479|58638714|FG002|Part I|Lost to Follow-up|1|||
30626846|NCT01155479|58638715|FG003|Part I|Lost to Follow-up|1|||
30626847|NCT01155479|58638716|FG004|Part I|Lost to Follow-up|0|||
30626848|NCT01155479|58638712|FG000|Part I|Treatment Failure|3|||
30626849|NCT01155479|58638713|FG001|Part I|Treatment Failure|0|||
30626850|NCT01155479|58638714|FG002|Part I|Treatment Failure|3|||
30626851|NCT01155479|58638715|FG003|Part I|Treatment Failure|1|||
30626852|NCT01155479|58638716|FG004|Part I|Treatment Failure|2|||
30626853|NCT01155479|58638712|FG000|Part I|Did Not Receive Treatment|4|||
30626854|NCT01155479|58638713|FG001|Part I|Did Not Receive Treatment|2|||
30626855|NCT01155479|58638714|FG002|Part I|Did Not Receive Treatment|2|||
30626856|NCT01155479|58638715|FG003|Part I|Did Not Receive Treatment|6|||
30626857|NCT01155479|58638716|FG004|Part I|Did Not Receive Treatment|1|||
30626858|NCT01155479|58638712|FG000|Part I|Non-Compliance with Protocol|2|||
30626859|NCT01155479|58638713|FG001|Part I|Non-Compliance with Protocol|1|||
30626860|NCT01155479|58638714|FG002|Part I|Non-Compliance with Protocol|3|||
30626861|NCT01155479|58638715|FG003|Part I|Non-Compliance with Protocol|3|||
30626862|NCT01155479|58638716|FG004|Part I|Non-Compliance with Protocol|2|||
30626863|NCT01155479|58638712|FG000|Part II|Adverse Event|7|||
30626864|NCT01155479|58638713|FG001|Part II|Adverse Event|6|||
30626865|NCT01155479|58638714|FG002|Part II|Adverse Event|8|||
30626866|NCT01155479|58638715|FG003|Part II|Adverse Event|3|||
30626867|NCT01155479|58638716|FG004|Part II|Adverse Event|4|||
30626868|NCT01155479|58638712|FG000|Part II|Administrative|43|||
30626869|NCT01155479|58638713|FG001|Part II|Administrative|49|||
30626870|NCT01155479|58638714|FG002|Part II|Administrative|36|||
30626871|NCT01155479|58638715|FG003|Part II|Administrative|38|||
30626872|NCT01155479|58638716|FG004|Part II|Administrative|46|||
30626873|NCT01155479|58638712|FG000|Part II|Withdrawal by Subject|8|||
30626874|NCT01155479|58638713|FG001|Part II|Withdrawal by Subject|4|||
30626875|NCT01155479|58638714|FG002|Part II|Withdrawal by Subject|12|||
30626876|NCT01155479|58638715|FG003|Part II|Withdrawal by Subject|7|||
30626877|NCT01155479|58638716|FG004|Part II|Withdrawal by Subject|3|||
30626878|NCT01155479|58638712|FG000|Part II|Lost to Follow-up|1|||
30626879|NCT01155479|58638713|FG001|Part II|Lost to Follow-up|0|||
30626880|NCT01155479|58638714|FG002|Part II|Lost to Follow-up|0|||
30626881|NCT01155479|58638715|FG003|Part II|Lost to Follow-up|0|||
30950555|NCT01685203|58997515|FG003|Overall Study|Adverse Event|0|||
30950556|NCT01685203|58997516|FG004|Overall Study|Adverse Event|0|||
30950557|NCT01685203|58997517|FG005|Overall Study|Adverse Event|2|||
30950558|NCT01685203|58997518|FG006|Overall Study|Adverse Event|0|||
30950559|NCT01685203|58997512|FG000|Overall Study|Adverse event and withdrew consent|1|||
30950560|NCT01685203|58997513|FG001|Overall Study|Adverse event and withdrew consent|0|||
30950561|NCT01685203|58997514|FG002|Overall Study|Adverse event and withdrew consent|0|||
30950562|NCT01685203|58997515|FG003|Overall Study|Adverse event and withdrew consent|0|||
30950563|NCT01685203|58997516|FG004|Overall Study|Adverse event and withdrew consent|0|||
30950564|NCT01685203|58997517|FG005|Overall Study|Adverse event and withdrew consent|0|||
30950565|NCT01685203|58997518|FG006|Overall Study|Adverse event and withdrew consent|0|||
30950566|NCT01685203|58997512|FG000|Overall Study|Patient's decision|0|||
30950567|NCT01685203|58997513|FG001|Overall Study|Patient's decision|0|||
30950568|NCT01685203|58997514|FG002|Overall Study|Patient's decision|0|||
30950569|NCT01685203|58997515|FG003|Overall Study|Patient's decision|0|||
30950570|NCT01685203|58997516|FG004|Overall Study|Patient's decision|0|||
30626882|NCT01155479|58638716|FG004|Part II|Lost to Follow-up|1|||
30626883|NCT01155479|58638712|FG000|Part II|Treatment Failure|0|||
30626884|NCT01155479|58638713|FG001|Part II|Treatment Failure|1|||
30626885|NCT01155479|58638714|FG002|Part II|Treatment Failure|2|||
30626886|NCT01155479|58638715|FG003|Part II|Treatment Failure|0|||
30626887|NCT01155479|58638716|FG004|Part II|Treatment Failure|1|||
30626888|NCT01155479|58638712|FG000|Part II|Non-Compliance with Protocol|0|||
30950571|NCT01685203|58997517|FG005|Overall Study|Patient's decision|1|||
30626889|NCT01155479|58638713|FG001|Part II|Non-Compliance with Protocol|1|||
30626890|NCT01155479|58638714|FG002|Part II|Non-Compliance with Protocol|0|||
30626891|NCT01155479|58638715|FG003|Part II|Non-Compliance with Protocol|2|||
30950572|NCT01685203|58997518|FG006|Overall Study|Patient's decision|0|||
30950573|NCT01928771|58997537|FG000|Overall Study|Adverse Event|6|||
30626892|NCT01155479|58638716|FG004|Part II|Non-Compliance with Protocol|0|||
30626893|NCT01155323|58638744|FG000|First Intervention|exclusion criteria|1|||
30626894|NCT01155323|58638745|FG001|First Intervention|exclusion criteria|1|||
30626895|NCT01155323|58638744|FG000|Second Intervention|Lost to Follow-up|1|||
30626896|NCT01155323|58638745|FG001|Second Intervention|Lost to Follow-up|1|||
30626897|NCT01155167|58638753|FG000|Overall Study|Insufficient ultrasound data|2|||
30626898|NCT01155167|58638754|FG001|Overall Study|Insufficient ultrasound data|0|||
30626899|NCT01155167|58638753|FG000|Overall Study|Access site changed to femoral artery|1|||
30950574|NCT01928771|58997538|FG001|Overall Study|Adverse Event|5|||
30950575|NCT01928771|58997539|FG002|Overall Study|Adverse Event|1|||
30763473|NCT00840177|58772222|FG001|Overall Study|Ineligible|0|||
30763474|NCT00840177|58772223|FG002|Overall Study|Ineligible|3|||
30763475|NCT00840177|58772221|FG000|Overall Study|Did not start treatment|0|||
30763476|NCT00840177|58772222|FG001|Overall Study|Did not start treatment|0|||
30763477|NCT00840177|58772223|FG002|Overall Study|Did not start treatment|1|||
30763478|NCT01347580|58772233|FG000|Overall Study|Withdrawal by Subject|13|||
30763479|NCT01347580|58772234|FG001|Overall Study|Withdrawal by Subject|23|||
30763480|NCT01347580|58772233|FG000|Overall Study|Death|30|||
30763481|NCT01347580|58772234|FG001|Overall Study|Death|19|||
30626900|NCT01155167|58638754|FG001|Overall Study|Access site changed to femoral artery|0|||
30626901|NCT01106586|58638762|FG000|Overall Study|Adverse Event|9|||
30626902|NCT01106586|58638763|FG001|Overall Study|Adverse Event|15|||
30626903|NCT01106586|58638762|FG000|Overall Study|Death|1|||
30626904|NCT01106586|58638763|FG001|Overall Study|Death|3|||
30626905|NCT01106586|58638762|FG000|Overall Study|Pregnancy|2|||
30626906|NCT01106586|58638763|FG001|Overall Study|Pregnancy|2|||
30626907|NCT01106586|58638762|FG000|Overall Study|Lack of Efficacy|1|||
30626908|NCT01106586|58638763|FG001|Overall Study|Lack of Efficacy|0|||
30626909|NCT01106586|58638762|FG000|Overall Study|Investigator's Discretion|5|||
30626910|NCT01106586|58638763|FG001|Overall Study|Investigator's Discretion|8|||
30626911|NCT01106586|58638762|FG000|Overall Study|Withdrew Consent|18|||
30626912|NCT01106586|58638763|FG001|Overall Study|Withdrew Consent|30|||
30626913|NCT01106586|58638762|FG000|Overall Study|Lost to Follow-up|24|||
30626914|NCT01106586|58638763|FG001|Overall Study|Lost to Follow-up|20|||
30626915|NCT01106586|58638762|FG000|Overall Study|Participant Noncompliance|12|||
30626916|NCT01106586|58638763|FG001|Overall Study|Participant Noncompliance|10|||
30626917|NCT01106586|58638762|FG000|Overall Study|Protocol Violation|1|||
30626918|NCT01106586|58638763|FG001|Overall Study|Protocol Violation|0|||
30626919|NCT01106586|58638762|FG000|Overall Study|Participant Transferred to Another Study|212|||
30626920|NCT01106586|58638763|FG001|Overall Study|Participant Transferred to Another Study|197|||
30626921|NCT01155011|58638771|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
30626922|NCT01155011|58638772|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
30626923|NCT01155011|58638771|FG000|Baseline to 6 Months|investigator decision, moved|4|||
30626924|NCT01155011|58638772|FG001|Baseline to 6 Months|investigator decision, moved|5|||
30626925|NCT01155011|58638771|FG000|Baseline to 6 Months|Death|0|||
30626926|NCT01155011|58638772|FG001|Baseline to 6 Months|Death|1|||
30626927|NCT01155011|58638771|FG000|6 to 12 Months|Withdrawal by Subject|8|||
30626928|NCT01155011|58638772|FG001|6 to 12 Months|Withdrawal by Subject|5|||
30626929|NCT01155011|58638771|FG000|6 to 12 Months|Death|1|||
30626930|NCT01155011|58638772|FG001|6 to 12 Months|Death|5|||
30626931|NCT01106430|58638784|FG000|Overall Study|Adverse Event|8|||
30626932|NCT01106430|58638785|FG001|Overall Study|Adverse Event|10|||
30626933|NCT01106430|58638784|FG000|Overall Study|Lack of Efficacy|2|||
30626934|NCT01106430|58638785|FG001|Overall Study|Lack of Efficacy|13|||
30626935|NCT01106430|58638784|FG000|Overall Study|Lost to Follow-up|5|||
30626936|NCT01106430|58638785|FG001|Overall Study|Lost to Follow-up|1|||
30626937|NCT01106430|58638784|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
30626938|NCT01106430|58638785|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
30626939|NCT01106430|58638784|FG000|Overall Study|Moved Out Of State|0|||
30626940|NCT01106430|58638785|FG001|Overall Study|Moved Out Of State|1|||
30626941|NCT01106430|58638784|FG000|Overall Study|Refused To Take Medication|0|||
30626942|NCT01106430|58638785|FG001|Overall Study|Refused To Take Medication|1|||
30626943|NCT01106430|58638784|FG000|Overall Study|Noncompliance|0|||
30626944|NCT01106430|58638785|FG001|Overall Study|Noncompliance|1|||
30626945|NCT01106430|58638784|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
30626946|NCT01106430|58638785|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
30626947|NCT01106430|58638784|FG000|Overall Study|Previous Use Of Marijuana|1|||
30626948|NCT01106430|58638785|FG001|Overall Study|Previous Use Of Marijuana|0|||
30626949|NCT01106430|58638784|FG000|Overall Study|Protocol Violation|7|||
30626950|NCT01106430|58638785|FG001|Overall Study|Protocol Violation|2|||
30626951|NCT01106430|58638784|FG000|Overall Study|Withdrawal by Subject|8|||
30626952|NCT01106430|58638785|FG001|Overall Study|Withdrawal by Subject|4|||
30626953|NCT01154231|58638791|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
30626954|NCT01154231|58638791|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
30626955|NCT01154153|58638797|FG000|Overall Study|Poor compliance to protocol|2|||
30626956|NCT01154153|58638798|FG001|Overall Study|Poor compliance to protocol|0|||
30950576|NCT01928771|58997537|FG000|Overall Study|Death|2|||
30626957|NCT01154153|58638797|FG000|Overall Study|Unable to use labs|2|||
30626958|NCT01154153|58638798|FG001|Overall Study|Unable to use labs|3|||
30626959|NCT01154153|58638797|FG000|Overall Study|Withdrew consent|1|||
30950577|NCT01928771|58997538|FG001|Overall Study|Death|2|||
30626960|NCT01154153|58638798|FG001|Overall Study|Withdrew consent|0|||
30626961|NCT00874237|58638804|FG000|Overall Study|Physician Decision|0|||
30626962|NCT00874237|58638805|FG001|Overall Study|Physician Decision|1|||
30626963|NCT00874237|58638806|FG002|Overall Study|Physician Decision|0|||
30626964|NCT00874237|58638807|FG003|Overall Study|Physician Decision|0|||
30626965|NCT00874237|58638808|FG004|Overall Study|Physician Decision|0|||
30626966|NCT00874237|58638809|FG005|Overall Study|Physician Decision|0|||
30626967|NCT00874237|58638804|FG000|Overall Study|Withdrawal by Subject|0|||
30626968|NCT00874237|58638805|FG001|Overall Study|Withdrawal by Subject|0|||
30626969|NCT00874237|58638806|FG002|Overall Study|Withdrawal by Subject|1|||
30626970|NCT00874237|58638807|FG003|Overall Study|Withdrawal by Subject|0|||
30626971|NCT00874237|58638808|FG004|Overall Study|Withdrawal by Subject|0|||
30626972|NCT00874237|58638809|FG005|Overall Study|Withdrawal by Subject|0|||
30626973|NCT01153841|58638821|FG000|Overall Study|Adverse Event|1|||
30626974|NCT01153841|58638822|FG001|Overall Study|Adverse Event|0|||
30626975|NCT01153841|58638821|FG000|Overall Study|Withdrawal by Subject|1|||
30626976|NCT01153841|58638822|FG001|Overall Study|Withdrawal by Subject|0|||
30626977|NCT01153841|58638821|FG000|Overall Study|Protocol Violation|2|||
30626978|NCT01153841|58638822|FG001|Overall Study|Protocol Violation|0|||
30626979|NCT01153841|58638821|FG000|Overall Study|Lost to Follow-up|2|||
30626980|NCT01153841|58638822|FG001|Overall Study|Lost to Follow-up|0|||
30626981|NCT01153763|58638828|FG000|Overall Study|Study Closed|16|||
30626982|NCT01153763|58638828|FG000|Overall Study|Lost to Follow-up|1|||
30626983|NCT01153763|58638828|FG000|Overall Study|Physician Decision|2|||
30626984|NCT01153763|58638828|FG000|Overall Study|Withdrawal by Subject|2|||
30626985|NCT00871741|58638834|FG000|Overall Study|Premature study termination|9|||
30626986|NCT00871741|58638835|FG001|Overall Study|Premature study termination|7|||
30626987|NCT01152437|58638844|FG000|Overall Study|Other Adverse Event|8|||
30626988|NCT01152437|58638845|FG001|Overall Study|Other Adverse Event|1|||
30626989|NCT01152437|58638846|FG002|Overall Study|Other Adverse Event|7|||
30626990|NCT01152437|58638844|FG000|Overall Study|Not treated|0|||
30626991|NCT01152437|58638845|FG001|Overall Study|Not treated|1|||
30626992|NCT01152437|58638846|FG002|Overall Study|Not treated|2|||
30626993|NCT01152437|58638844|FG000|Overall Study|Progressive disease|27|||
30626994|NCT01152437|58638845|FG001|Overall Study|Progressive disease|13|||
30626995|NCT01152437|58638846|FG002|Overall Study|Progressive disease|32|||
30626996|NCT01152437|58638844|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
30626997|NCT01152437|58638845|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
30626998|NCT01152437|58638846|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
30626999|NCT01151579|58638858|FG000|Overall Study|Physician Decision|3|||
30627000|NCT01151579|58638859|FG001|Overall Study|Physician Decision|1|||
30627001|NCT01151579|58638858|FG000|Overall Study|Withdrawal by Subject|3|||
30627002|NCT01151579|58638859|FG001|Overall Study|Withdrawal by Subject|2|||
30627003|NCT01151579|58638858|FG000|Overall Study|Not meet inclusion criteria|6|||
30627004|NCT01151579|58638859|FG001|Overall Study|Not meet inclusion criteria|4|||
30627005|NCT01097616|58638868|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
30627006|NCT01097616|58638869|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
30627007|NCT01097616|58638870|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
30627008|NCT01097616|58638871|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
30627009|NCT01097616|58638872|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
30627010|NCT01097616|58638873|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
30627011|NCT01097616|58638874|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
30627012|NCT01097616|58638875|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
30627013|NCT01097616|58638868|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
30627014|NCT01097616|58638869|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
30627015|NCT01097616|58638870|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
30627016|NCT01097616|58638871|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
30763482|NCT01347580|58772233|FG000|Overall Study|Protocol Violation|10|||
30627017|NCT01097616|58638872|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
30627018|NCT01097616|58638873|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
30627019|NCT01097616|58638874|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
30627020|NCT01097616|58638875|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
30627021|NCT01097616|58638868|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
30627022|NCT01097616|58638869|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
30627023|NCT01097616|58638870|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
30847918|NCT02419612|58873789|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
30847919|NCT02419612|58873788|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
30627024|NCT01097616|58638871|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
30627025|NCT01097616|58638872|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
30627026|NCT01097616|58638873|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
30627027|NCT01097616|58638874|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
30627028|NCT01097616|58638875|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
30627029|NCT01097616|58638868|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
30627030|NCT01097616|58638869|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
30627031|NCT01097616|58638870|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
30627032|NCT01097616|58638871|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
30627033|NCT01097616|58638872|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
30627034|NCT01097616|58638873|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
30627035|NCT01097616|58638874|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
30627036|NCT01097616|58638875|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
30627037|NCT01097616|58638868|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
30627038|NCT01097616|58638869|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
30627039|NCT01097616|58638870|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
30627040|NCT01097616|58638871|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
30627041|NCT01097616|58638872|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
30627042|NCT01097616|58638873|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
30627043|NCT01097616|58638874|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
30627044|NCT01097616|58638875|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
30627045|NCT01097616|58638868|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
30627046|NCT01097616|58638869|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
30627047|NCT01097616|58638870|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
30627048|NCT01097616|58638871|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
30627049|NCT01097616|58638872|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
30627050|NCT01097616|58638873|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
30627051|NCT01097616|58638874|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
30627052|NCT01097616|58638875|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
30627053|NCT01097616|58638868|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
30627054|NCT01097616|58638869|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
30627055|NCT01097616|58638870|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30627056|NCT01097616|58638871|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30627057|NCT01097616|58638872|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30627058|NCT01097616|58638873|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30627059|NCT01097616|58638874|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30627060|NCT01097616|58638875|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30627061|NCT01097616|58638868|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30627062|NCT01097616|58638869|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30627063|NCT01097616|58638870|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
30627064|NCT01097616|58638871|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30627065|NCT01097616|58638872|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30627066|NCT01097616|58638873|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30627067|NCT01097616|58638874|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30627068|NCT01097616|58638875|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30627069|NCT01097616|58638868|FG000|Optional DB EXT Phase|Adverse Event|0|||
30847920|NCT02419612|58873789|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
30950578|NCT01928771|58997539|FG002|Overall Study|Death|2|||
30627070|NCT01097616|58638869|FG001|Optional DB EXT Phase|Adverse Event|7|||
30627071|NCT01097616|58638870|FG002|Optional DB EXT Phase|Adverse Event|2|||
30627072|NCT01097616|58638871|FG003|Optional DB EXT Phase|Adverse Event|0|||
30627073|NCT01097616|58638872|FG004|Optional DB EXT Phase|Adverse Event|0|||
30627074|NCT01097616|58638873|FG005|Optional DB EXT Phase|Adverse Event|0|||
30627075|NCT01097616|58638874|FG006|Optional DB EXT Phase|Adverse Event|0|||
30627076|NCT01097616|58638875|FG007|Optional DB EXT Phase|Adverse Event|0|||
30627077|NCT01097616|58638868|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
30627078|NCT01097616|58638869|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
30627079|NCT01097616|58638870|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
30627080|NCT01097616|58638871|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
30627081|NCT01097616|58638872|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
30627082|NCT01097616|58638873|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
30627083|NCT01097616|58638874|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
30627084|NCT01097616|58638875|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
30627085|NCT01097616|58638868|FG000|Optional DB EXT Phase|Protocol Violation|0|||
30627086|NCT01097616|58638869|FG001|Optional DB EXT Phase|Protocol Violation|2|||
30627087|NCT01097616|58638870|FG002|Optional DB EXT Phase|Protocol Violation|3|||
30627088|NCT01097616|58638871|FG003|Optional DB EXT Phase|Protocol Violation|0|||
30627089|NCT01097616|58638872|FG004|Optional DB EXT Phase|Protocol Violation|0|||
30627090|NCT01097616|58638873|FG005|Optional DB EXT Phase|Protocol Violation|0|||
30627091|NCT01097616|58638874|FG006|Optional DB EXT Phase|Protocol Violation|0|||
30627092|NCT01097616|58638875|FG007|Optional DB EXT Phase|Protocol Violation|0|||
30627093|NCT01097616|58638868|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
30627094|NCT01097616|58638869|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
30627095|NCT01097616|58638870|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
30627096|NCT01097616|58638871|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
30627097|NCT01097616|58638872|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
30627098|NCT01097616|58638873|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
30627099|NCT01097616|58638874|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
30627100|NCT01097616|58638875|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
30627101|NCT01097616|58638868|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
30627102|NCT01097616|58638869|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
30627103|NCT01097616|58638870|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
30627104|NCT01097616|58638871|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
30627105|NCT01097616|58638872|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
30627106|NCT01097616|58638873|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
30627107|NCT01097616|58638874|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
30627108|NCT01097616|58638875|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
30627109|NCT01097616|58638868|FG000|Optional DB EXT Phase|Physician Decision|1|||
30627110|NCT01097616|58638869|FG001|Optional DB EXT Phase|Physician Decision|0|||
30627111|NCT01097616|58638870|FG002|Optional DB EXT Phase|Physician Decision|0|||
30627112|NCT01097616|58638871|FG003|Optional DB EXT Phase|Physician Decision|0|||
30627113|NCT01097616|58638872|FG004|Optional DB EXT Phase|Physician Decision|0|||
30627114|NCT01097616|58638873|FG005|Optional DB EXT Phase|Physician Decision|0|||
30627115|NCT01097616|58638874|FG006|Optional DB EXT Phase|Physician Decision|0|||
30627116|NCT01097616|58638875|FG007|Optional DB EXT Phase|Physician Decision|0|||
30627117|NCT01097616|58638868|FG000|DB RO Phase|Adverse Event|0|||
30627118|NCT01097616|58638869|FG001|DB RO Phase|Adverse Event|0|||
30627119|NCT01097616|58638870|FG002|DB RO Phase|Adverse Event|0|||
30627120|NCT01097616|58638871|FG003|DB RO Phase|Adverse Event|0|||
30763483|NCT01347580|58772234|FG001|Overall Study|Protocol Violation|7|||
30627121|NCT01097616|58638872|FG004|DB RO Phase|Adverse Event|0|||
30627122|NCT01097616|58638873|FG005|DB RO Phase|Adverse Event|0|||
30627123|NCT01097616|58638874|FG006|DB RO Phase|Adverse Event|1|||
30763484|NCT01347580|58772233|FG000|Overall Study|Lost to Follow-up|3|||
30763485|NCT01347580|58772234|FG001|Overall Study|Lost to Follow-up|1|||
30763486|NCT01347580|58772233|FG000|Overall Study|Had other reason|9|||
30627124|NCT01097616|58638875|FG007|DB RO Phase|Adverse Event|0|||
30627125|NCT01097616|58638868|FG000|DB RO Phase|Withdrawal by Subject|0|||
30763487|NCT01347580|58772234|FG001|Overall Study|Had other reason|6|||
30763488|NCT00398411|58772242|FG000|Overall Study|Death|0|||
30627126|NCT01097616|58638869|FG001|DB RO Phase|Withdrawal by Subject|0|||
30627127|NCT01097616|58638870|FG002|DB RO Phase|Withdrawal by Subject|0|||
30627128|NCT01097616|58638871|FG003|DB RO Phase|Withdrawal by Subject|0|||
30627129|NCT01097616|58638872|FG004|DB RO Phase|Withdrawal by Subject|0|||
30627130|NCT01097616|58638873|FG005|DB RO Phase|Withdrawal by Subject|1|||
30627131|NCT01097616|58638874|FG006|DB RO Phase|Withdrawal by Subject|0|||
30627132|NCT01097616|58638875|FG007|DB RO Phase|Withdrawal by Subject|0|||
30627133|NCT01097616|58638868|FG000|DB RO Phase|Lost to Follow-up|0|||
30627134|NCT01097616|58638869|FG001|DB RO Phase|Lost to Follow-up|0|||
30627135|NCT01097616|58638870|FG002|DB RO Phase|Lost to Follow-up|0|||
30627136|NCT01097616|58638871|FG003|DB RO Phase|Lost to Follow-up|1|||
30627137|NCT01097616|58638872|FG004|DB RO Phase|Lost to Follow-up|1|||
30627138|NCT01097616|58638873|FG005|DB RO Phase|Lost to Follow-up|0|||
30627139|NCT01097616|58638874|FG006|DB RO Phase|Lost to Follow-up|0|||
30627140|NCT01097616|58638875|FG007|DB RO Phase|Lost to Follow-up|1|||
30627141|NCT01097616|58638868|FG000|DB RO Phase|Not Treated in RO|0|||
30627142|NCT01097616|58638869|FG001|DB RO Phase|Not Treated in RO|0|||
30627143|NCT01097616|58638870|FG002|DB RO Phase|Not Treated in RO|0|||
30627144|NCT01097616|58638871|FG003|DB RO Phase|Not Treated in RO|0|||
30847921|NCT02419612|58873788|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
30847922|NCT02419612|58873789|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
30847923|NCT02419612|58873788|FG000|Short-term Treatment Period|Worsening of liver function|0|||
30847924|NCT02419612|58873789|FG001|Short-term Treatment Period|Worsening of liver function|1|||
30847925|NCT02419612|58873788|FG000|Short-term Treatment Period|Subject moved out of state|0|||
30847926|NCT02419612|58873789|FG001|Short-term Treatment Period|Subject moved out of state|1|||
30847927|NCT02419612|58873788|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
30847928|NCT02419612|58873789|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
30847929|NCT02419612|58873788|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
30847930|NCT02419612|58873789|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
30847931|NCT02419612|58873788|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
30847932|NCT02419612|58873789|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
30627145|NCT01097616|58638872|FG004|DB RO Phase|Not Treated in RO|0|||
30627146|NCT01097616|58638873|FG005|DB RO Phase|Not Treated in RO|1|||
30627147|NCT01097616|58638874|FG006|DB RO Phase|Not Treated in RO|0|||
30627148|NCT01097616|58638875|FG007|DB RO Phase|Not Treated in RO|0|||
30627149|NCT00871429|58638901|FG000|Overall Study|Lost to Follow-up|6|||
30627150|NCT00871429|58638901|FG000|Overall Study|Withdrawal by Subject|17|||
30627151|NCT00871429|58638901|FG000|Overall Study|Questionnaire not completed|1|||
30627152|NCT01151345|58638909|FG000|First Intervention Period|Protocol Violation|0|||
30627153|NCT01151345|58638910|FG001|First Intervention Period|Protocol Violation|1|||
30627154|NCT00593827|58638918|FG000|Overall Study|On Active Treatment/Pending|0|||
30627155|NCT00593827|58638919|FG001|Overall Study|On Active Treatment/Pending|2|||
30627156|NCT01150097|58638928|FG000|Months 24 to 36 Post-transplantation|Death|2|||
30627157|NCT01150097|58638929|FG001|Months 24 to 36 Post-transplantation|Death|0|||
30627158|NCT01150097|58638930|FG002|Months 24 to 36 Post-transplantation|Death|0|||
30627159|NCT01150097|58638928|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
30627160|NCT01150097|58638929|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
30627161|NCT01150097|58638930|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
30627162|NCT01150097|58638928|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
30627163|NCT01150097|58638929|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
30627164|NCT01150097|58638930|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
30627165|NCT01150097|58638928|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
30627166|NCT01150097|58638929|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
30763489|NCT00398411|58772243|FG001|Overall Study|Death|1|||
30763490|NCT03352414|58772251|FG000|Overall Study|Ineligible by operative criteria|12|||
30763491|NCT03352414|58772252|FG001|Overall Study|Ineligible by operative criteria|10|||
30763492|NCT00364793|58772264|FG000|Overall Study|Adverse Event|2|||
30763493|NCT00364793|58772265|FG001|Overall Study|Adverse Event|0|||
30763494|NCT00364793|58772266|FG002|Overall Study|Adverse Event|0|||
30763495|NCT00364793|58772267|FG003|Overall Study|Adverse Event|0|||
30763496|NCT00364793|58772264|FG000|Overall Study|Death|1|||
30763497|NCT00364793|58772265|FG001|Overall Study|Death|0|||
30763498|NCT00364793|58772266|FG002|Overall Study|Death|1|||
30763499|NCT00364793|58772267|FG003|Overall Study|Death|0|||
30763500|NCT00364793|58772264|FG000|Overall Study|Lack of Efficacy|3|||
30627167|NCT01150097|58638930|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
30627168|NCT01150097|58638928|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
30627169|NCT01150097|58638929|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
30627170|NCT01150097|58638930|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
30627171|NCT01150097|58638928|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
30627172|NCT01150097|58638929|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
30627173|NCT01150097|58638930|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
30627174|NCT01150097|58638928|FG000|Months 24 to 48 Post-transplantation|Death|2|||
30627175|NCT01150097|58638929|FG001|Months 24 to 48 Post-transplantation|Death|0|||
30627176|NCT01150097|58638930|FG002|Months 24 to 48 Post-transplantation|Death|0|||
30627177|NCT01149863|58638940|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
30627178|NCT01149473|58638946|FG000|First Intervention|Adverse Event|1|||
30627179|NCT01149473|58638947|FG001|First Intervention|Adverse Event|1|||
30627180|NCT01149473|58638946|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
30627181|NCT01149473|58638947|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
30627182|NCT00872989|58638955|FG000|Overall Study|Adverse Event|7|||
30627183|NCT00872989|58638956|FG001|Overall Study|Adverse Event|15|||
30627184|NCT00872989|58638955|FG000|Overall Study|Withdrawal by Subject|8|||
30627185|NCT00872989|58638956|FG001|Overall Study|Withdrawal by Subject|5|||
30627186|NCT00872989|58638955|FG000|Overall Study|Progression/relapse|47|||
30627187|NCT00872989|58638956|FG001|Overall Study|Progression/relapse|35|||
30627188|NCT00872989|58638955|FG000|Overall Study|Not protocol specified|3|||
30627189|NCT00872989|58638956|FG001|Overall Study|Not protocol specified|8|||
30627190|NCT01148771|58638970|FG000|Washout Period|Withdrawal by Subject|0|||
30627191|NCT01148771|58638971|FG001|Washout Period|Withdrawal by Subject|1|||
30627192|NCT01148693|58638983|FG000|Overall Study|Attempts for cannulation were failed|13|||
30627193|NCT01148693|58638984|FG001|Overall Study|Attempts for cannulation were failed|10|||
30627194|NCT00872599|58638990|FG000|Second Washout Period|Adverse Event|1|||
30627195|NCT00872599|58638991|FG001|Second Washout Period|Adverse Event|1|||
30627196|NCT01148537|58639000|FG000|Overall Study|Withdrawal by Subject|1|||
30627197|NCT01148537|58639001|FG001|Overall Study|Withdrawal by Subject|0|||
30627198|NCT01148537|58639002|FG002|Overall Study|Withdrawal by Subject|2|||
30627199|NCT01148537|58639000|FG000|Overall Study|Adverse Event|2|||
30627200|NCT01148537|58639001|FG001|Overall Study|Adverse Event|0|||
30627201|NCT01148537|58639002|FG002|Overall Study|Adverse Event|1|||
30627202|NCT01148459|58639013|FG000|Overall Study|Serious Adverse Event|5|||
30627203|NCT01148459|58639014|FG001|Overall Study|Serious Adverse Event|4|||
30627204|NCT01148459|58639013|FG000|Overall Study|Withdrawal by Subject|1|||
30627205|NCT01148459|58639014|FG001|Overall Study|Withdrawal by Subject|0|||
30627206|NCT01148459|58639013|FG000|Overall Study|Migrated/moved from study area|3|||
30627207|NCT01148459|58639014|FG001|Overall Study|Migrated/moved from study area|6|||
30627208|NCT01148459|58639013|FG000|Overall Study|Lost to Follow-up|2|||
30627209|NCT01148459|58639014|FG001|Overall Study|Lost to Follow-up|0|||
30627210|NCT01148459|58639013|FG000|Overall Study|Refusal|1|||
30627211|NCT01148459|58639014|FG001|Overall Study|Refusal|0|||
30627212|NCT01148459|58639013|FG000|Overall Study|Failure to comply with study procedures|0|||
30627213|NCT01148459|58639014|FG001|Overall Study|Failure to comply with study procedures|1|||
30627214|NCT00872521|58639023|FG000|Completed PAD Induction|Patient choice|0|||
30627215|NCT00872521|58639024|FG001|Completed PAD Induction|Patient choice|1|||
30627216|NCT00872521|58639025|FG002|Completed PAD Induction|Patient choice|0|||
30627217|NCT00872521|58639023|FG000|Completed PAD Induction|Disease progression|0|||
30627218|NCT00872521|58639024|FG001|Completed PAD Induction|Disease progression|2|||
30627219|NCT00872521|58639025|FG002|Completed PAD Induction|Disease progression|0|||
30627220|NCT00872521|58639023|FG000|Completed PAD Induction|Adverse Event|4|||
30627221|NCT00872521|58639024|FG001|Completed PAD Induction|Adverse Event|0|||
30627222|NCT00872521|58639025|FG002|Completed PAD Induction|Adverse Event|0|||
30627223|NCT00872521|58639023|FG000|Completed PAD Induction|Death|1|||
30627224|NCT00872521|58639024|FG001|Completed PAD Induction|Death|1|||
30627225|NCT00872521|58639025|FG002|Completed PAD Induction|Death|0|||
30627226|NCT00872521|58639023|FG000|Primary Endpoint Analysis|Other|1|||
30627227|NCT00872521|58639024|FG001|Primary Endpoint Analysis|Other|2|||
30627228|NCT00872521|58639025|FG002|Primary Endpoint Analysis|Other|0|||
30627229|NCT00872521|58639023|FG000|Primary Endpoint Analysis|Patient choice|0|||
30627230|NCT00872521|58639024|FG001|Primary Endpoint Analysis|Patient choice|1|||
30627231|NCT00872521|58639025|FG002|Primary Endpoint Analysis|Patient choice|0|||
30627232|NCT00872521|58639023|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
30627233|NCT00872521|58639024|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
30627234|NCT00872521|58639025|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
30627235|NCT00872521|58639023|FG000|Primary Endpoint Analysis|Patient response missing|0|||
30627236|NCT00872521|58639024|FG001|Primary Endpoint Analysis|Patient response missing|0|||
30627237|NCT00872521|58639025|FG002|Primary Endpoint Analysis|Patient response missing|1|||
30847933|NCT02419612|58873788|FG000|Long-term Treatment Period|Death|0|||
30847934|NCT02419612|58873789|FG001|Long-term Treatment Period|Death|1|||
30627238|NCT00872521|58639023|FG000|Completed 3-month Follow up|Other|0|||
30627239|NCT00872521|58639024|FG001|Completed 3-month Follow up|Other|2|||
30627240|NCT00872521|58639025|FG002|Completed 3-month Follow up|Other|0|||
30627241|NCT00872521|58639023|FG000|Completed 3-month Follow up|Physician Decision|0|||
30627242|NCT00872521|58639024|FG001|Completed 3-month Follow up|Physician Decision|1|||
30627243|NCT00872521|58639025|FG002|Completed 3-month Follow up|Physician Decision|0|||
30627244|NCT00872521|58639023|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
30627245|NCT00872521|58639024|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
30627246|NCT00872521|58639025|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
30627247|NCT01148225|58639044|FG000|Overall Study|Other|185|||
30627248|NCT01190891|58639053|FG000|Overall Study|Protocol Violation|1|||
30627249|NCT01190891|58639054|FG001|Overall Study|Protocol Violation|0|||
30627250|NCT01190891|58639053|FG000|Overall Study|Withdrawal by Subject|5|||
30627251|NCT01190891|58639054|FG001|Overall Study|Withdrawal by Subject|0|||
30627252|NCT00871975|58639060|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
30627253|NCT00871975|58639060|FG000|Overall Study|Catheters could not be inserted|1|||
30627254|NCT00871975|58639060|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
30627255|NCT00871975|58639060|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
30627256|NCT01190813|58639066|FG000|Overall Study|Lost to Follow-up|1|||
30627257|NCT01190813|58639067|FG001|Overall Study|Lost to Follow-up|2|||
30627258|NCT01190813|58639066|FG000|Overall Study|Withdrawal by Subject|2|||
30627259|NCT01190813|58639067|FG001|Overall Study|Withdrawal by Subject|1|||
30627260|NCT01190813|58639066|FG000|Overall Study|Refused study treatment after randomized|1|||
30627261|NCT01190813|58639067|FG001|Overall Study|Refused study treatment after randomized|0|||
30627262|NCT01190813|58639066|FG000|Overall Study|Adverse Event|0|||
30627263|NCT01190813|58639067|FG001|Overall Study|Adverse Event|1|||
30627264|NCT00870727|58639089|FG000|Overall Study|Lost to Follow-up|0|||
30627265|NCT00870727|58639090|FG001|Overall Study|Lost to Follow-up|1|||
30627266|NCT00870727|58639089|FG000|Overall Study|Lack of Efficacy|1|||
30627267|NCT00870727|58639090|FG001|Overall Study|Lack of Efficacy|3|||
30627268|NCT00870727|58639089|FG000|Overall Study|Adverse Event|0|||
30627269|NCT00870727|58639090|FG001|Overall Study|Adverse Event|1|||
30627270|NCT01147055|58639096|FG000|First Intervention Period|Lost to Follow-up|1|||
30627271|NCT01147055|58639097|FG001|First Intervention Period|Lost to Follow-up|0|||
30627272|NCT01146665|58639105|FG000|Overall Study|Withdrawal by Subject|10|||
30627273|NCT01146665|58639106|FG001|Overall Study|Withdrawal by Subject|16|||
30627274|NCT01145885|58639121|FG000|Overall Study|Progressive Disease|7|||
30627275|NCT01190267|58639133|FG000|Overall Study|Adverse Event|10|||
30627276|NCT01190267|58639134|FG001|Overall Study|Adverse Event|0|||
30627277|NCT01190267|58639133|FG000|Overall Study|Treatment Failure|8|||
30627278|NCT01190267|58639134|FG001|Overall Study|Treatment Failure|2|||
30627279|NCT01190267|58639133|FG000|Overall Study|Lost to Follow-up|2|||
30627280|NCT01190267|58639134|FG001|Overall Study|Lost to Follow-up|0|||
30627281|NCT01190267|58639133|FG000|Overall Study|Withdrawal by Subject|13|||
30627282|NCT01190267|58639134|FG001|Overall Study|Withdrawal by Subject|1|||
30627283|NCT01190267|58639133|FG000|Overall Study|Protocol Violation|8|||
30627284|NCT01190267|58639134|FG001|Overall Study|Protocol Violation|1|||
30627285|NCT00869089|58639140|FG000|Overall Study|Lost to Follow-up|1|||
30627286|NCT00869089|58639140|FG000|Overall Study|Withdrawal by Subject|1|||
30627287|NCT00869089|58639140|FG000|Overall Study|Screen Fail|1|||
30627288|NCT01190189|58639144|FG000|Overall Study|Lost to Follow-up|4|||
30627289|NCT01190189|58639144|FG000|Overall Study|Withdrawal by Subject|1|||
30627290|NCT01190189|58639144|FG000|Overall Study|Migrated/moved from study area|1|||
30627291|NCT00871117|58639150|FG000|Overall Study|Lost to Follow-up|5|||
30627292|NCT00871117|58639151|FG001|Overall Study|Lost to Follow-up|6|||
30627293|NCT00871117|58639150|FG000|Overall Study|Other|0|||
30627294|NCT00871117|58639151|FG001|Overall Study|Other|4|||
30763501|NCT00364793|58772265|FG001|Overall Study|Lack of Efficacy|3|||
30763502|NCT00364793|58772266|FG002|Overall Study|Lack of Efficacy|1|||
30763503|NCT00364793|58772267|FG003|Overall Study|Lack of Efficacy|1|||
30763504|NCT00364793|58772264|FG000|Overall Study|Lost to Follow-up|1|||
30763505|NCT00364793|58772265|FG001|Overall Study|Lost to Follow-up|0|||
30763506|NCT00364793|58772266|FG002|Overall Study|Lost to Follow-up|2|||
30763507|NCT00364793|58772267|FG003|Overall Study|Lost to Follow-up|0|||
30763508|NCT00364793|58772264|FG000|Overall Study|Poor or non-compliance|1|||
30950579|NCT01928771|58997537|FG000|Overall Study|Lost to Follow-up|5|||
30627295|NCT00870103|58639158|FG000|Overall Study|Physician Decision|2|||
30627296|NCT00870103|58639158|FG000|Overall Study|Lost to Follow-up|2|||
30627297|NCT01145417|58639177|FG000|Overall Study|Death|1|||
30627298|NCT01145417|58639178|FG001|Overall Study|Death|0|||
30627299|NCT01145417|58639177|FG000|Overall Study|Lost to Follow-up|2|||
30627300|NCT01145417|58639178|FG001|Overall Study|Lost to Follow-up|1|||
30627301|NCT01145417|58639177|FG000|Overall Study|Withdrawal by Subject|1|||
30627302|NCT01145417|58639178|FG001|Overall Study|Withdrawal by Subject|2|||
30763509|NCT00364793|58772265|FG001|Overall Study|Poor or non-compliance|1|||
30950580|NCT01928771|58997538|FG001|Overall Study|Lost to Follow-up|6|||
30627303|NCT01145417|58639177|FG000|Overall Study|Pregnancy|1|||
30627304|NCT01145417|58639178|FG001|Overall Study|Pregnancy|0|||
30627305|NCT01145417|58639177|FG000|Overall Study|Adverse Event|0|||
30627306|NCT01145417|58639178|FG001|Overall Study|Adverse Event|1|||
30627307|NCT01145417|58639177|FG000|Overall Study|Study terminated by sponsor|35|||
30627308|NCT01145417|58639178|FG001|Overall Study|Study terminated by sponsor|43|||
30627309|NCT01145417|58639177|FG000|Overall Study|Other|1|||
30627310|NCT01145417|58639178|FG001|Overall Study|Other|0|||
30627311|NCT01144715|58639186|FG000|Overall Study|Lost to Follow-up|2|||
30627312|NCT01144715|58639187|FG001|Overall Study|Lost to Follow-up|1|||
30627313|NCT01144715|58639186|FG000|Overall Study|Withdrawal by Subject|2|||
30627314|NCT01144715|58639187|FG001|Overall Study|Withdrawal by Subject|1|||
30627315|NCT01144715|58639186|FG000|Overall Study|Adverse Event|0|||
30627316|NCT01144715|58639187|FG001|Overall Study|Adverse Event|1|||
30627317|NCT01189487|58639193|FG000|Overall Study|Lack of Efficacy|2|||
30627318|NCT01189487|58639193|FG000|Overall Study|Adverse Event|1|||
30627319|NCT01106352|58639202|FG000|Overall Study|Subjects untreated|0|||
30627320|NCT01106352|58639203|FG001|Overall Study|Subjects untreated|0|||
30627321|NCT01106352|58639204|FG002|Overall Study|Subjects untreated|0|||
30627322|NCT01106352|58639205|FG003|Overall Study|Subjects untreated|3|||
30627323|NCT01106352|58639206|FG004|Overall Study|Subjects untreated|4|||
30627324|NCT01106352|58639202|FG000|Overall Study|Sponsor Decision|1|||
30627325|NCT01106352|58639203|FG001|Overall Study|Sponsor Decision|0|||
30627326|NCT01106352|58639204|FG002|Overall Study|Sponsor Decision|0|||
30627327|NCT01106352|58639205|FG003|Overall Study|Sponsor Decision|0|||
30627328|NCT01106352|58639206|FG004|Overall Study|Sponsor Decision|0|||
30627329|NCT01106352|58639202|FG000|Overall Study|Too ill to come in for the visit|0|||
30627330|NCT01106352|58639203|FG001|Overall Study|Too ill to come in for the visit|0|||
30627331|NCT01106352|58639204|FG002|Overall Study|Too ill to come in for the visit|1|||
30627332|NCT01106352|58639205|FG003|Overall Study|Too ill to come in for the visit|0|||
30627333|NCT01106352|58639206|FG004|Overall Study|Too ill to come in for the visit|0|||
30627334|NCT01106352|58639202|FG000|Overall Study|Lost to Follow-up|0|||
30627335|NCT01106352|58639203|FG001|Overall Study|Lost to Follow-up|0|||
30627336|NCT01106352|58639204|FG002|Overall Study|Lost to Follow-up|0|||
30627337|NCT01106352|58639205|FG003|Overall Study|Lost to Follow-up|0|||
30627338|NCT01106352|58639206|FG004|Overall Study|Lost to Follow-up|1|||
30627339|NCT01106352|58639202|FG000|Overall Study|Death|0|||
30627340|NCT01106352|58639203|FG001|Overall Study|Death|0|||
30627341|NCT01106352|58639204|FG002|Overall Study|Death|1|||
30627342|NCT01106352|58639205|FG003|Overall Study|Death|3|||
30627343|NCT01106352|58639206|FG004|Overall Study|Death|1|||
30627344|NCT01106352|58639202|FG000|Overall Study|Disease progression|0|||
30627345|NCT01106352|58639203|FG001|Overall Study|Disease progression|0|||
30627346|NCT01106352|58639204|FG002|Overall Study|Disease progression|0|||
30627347|NCT01106352|58639205|FG003|Overall Study|Disease progression|1|||
30627348|NCT01106352|58639206|FG004|Overall Study|Disease progression|0|||
30627349|NCT01106352|58639202|FG000|Overall Study|Withdrawal by Subject|0|||
30627350|NCT01106352|58639203|FG001|Overall Study|Withdrawal by Subject|0|||
30627351|NCT01106352|58639204|FG002|Overall Study|Withdrawal by Subject|0|||
30627352|NCT01106352|58639205|FG003|Overall Study|Withdrawal by Subject|3|||
30627353|NCT01106352|58639206|FG004|Overall Study|Withdrawal by Subject|2|||
30627354|NCT01106352|58639202|FG000|Overall Study|Went on hospice|0|||
30627355|NCT01106352|58639203|FG001|Overall Study|Went on hospice|0|||
30627356|NCT01106352|58639204|FG002|Overall Study|Went on hospice|0|||
30627357|NCT01106352|58639205|FG003|Overall Study|Went on hospice|1|||
30627358|NCT01106352|58639206|FG004|Overall Study|Went on hospice|0|||
30627359|NCT01106352|58639202|FG000|Overall Study|Subject entered hospice|0|||
30627360|NCT01106352|58639203|FG001|Overall Study|Subject entered hospice|0|||
30627361|NCT01106352|58639204|FG002|Overall Study|Subject entered hospice|0|||
30763510|NCT00364793|58772266|FG002|Overall Study|Poor or non-compliance|0|||
30763511|NCT00364793|58772267|FG003|Overall Study|Poor or non-compliance|1|||
30763512|NCT00364793|58772264|FG000|Overall Study|No longer meets criteria|0|||
30763513|NCT00364793|58772265|FG001|Overall Study|No longer meets criteria|0|||
30763514|NCT00364793|58772266|FG002|Overall Study|No longer meets criteria|0|||
30763515|NCT00364793|58772267|FG003|Overall Study|No longer meets criteria|1|||
30847935|NCT02419612|58873788|FG000|Long-term Treatment Period|Adverse Event|0|||
30847936|NCT02419612|58873789|FG001|Long-term Treatment Period|Adverse Event|5|||
30847937|NCT02419612|58873788|FG000|Long-term Treatment Period|Other|4|||
30847938|NCT02419612|58873789|FG001|Long-term Treatment Period|Other|4|||
30847939|NCT02419612|58873788|FG000|Long-term Treatment Period|Subject Decision|2|||
30950581|NCT01928771|58997539|FG002|Overall Study|Lost to Follow-up|3|||
30950582|NCT01928771|58997537|FG000|Overall Study|Withdrawal by Subject|20|||
30950583|NCT01928771|58997538|FG001|Overall Study|Withdrawal by Subject|15|||
30950584|NCT01928771|58997539|FG002|Overall Study|Withdrawal by Subject|17|||
30950585|NCT01928771|58997537|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
30950586|NCT01928771|58997538|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
30950587|NCT01928771|58997539|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
30950588|NCT01928771|58997537|FG000|Overall Study|Other Reasons|9|||
30950589|NCT01928771|58997538|FG001|Overall Study|Other Reasons|9|||
30950590|NCT01928771|58997539|FG002|Overall Study|Other Reasons|14|||
30950591|NCT01928771|58997537|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
30950592|NCT01928771|58997538|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
30950593|NCT01928771|58997539|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
30950594|NCT01589653|58997549|FG000|Overall Study|Protocol Violation|3|||
30950595|NCT01589653|58997550|FG001|Overall Study|Protocol Violation|1|||
30950596|NCT01589653|58997549|FG000|Overall Study|Withdrawal criteria|4|||
30950597|NCT01589653|58997550|FG001|Overall Study|Withdrawal criteria|7|||
30950598|NCT01589653|58997549|FG000|Overall Study|Unclassified|0|||
30950599|NCT01589653|58997550|FG001|Overall Study|Unclassified|3|||
30950600|NCT01928615|58997556|FG000|Overall Study|Study Terminated by Sponsor|2|||
30950601|NCT01589497|58997565|FG000|Overall Study|Withdrawal by Subject|0|||
30950602|NCT01589497|58997566|FG001|Overall Study|Withdrawal by Subject|1|||
30950603|NCT01589497|58997567|FG002|Overall Study|Withdrawal by Subject|0|||
30950604|NCT01589497|58997568|FG003|Overall Study|Withdrawal by Subject|1|||
30950605|NCT01589497|58997565|FG000|Overall Study|Death|1|||
30950606|NCT01589497|58997566|FG001|Overall Study|Death|0|||
30950607|NCT01589497|58997567|FG002|Overall Study|Death|0|||
30950608|NCT01589497|58997568|FG003|Overall Study|Death|0|||
30950609|NCT01589497|58997565|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
30950610|NCT01589497|58997566|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
30950611|NCT01589497|58997567|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
30950612|NCT01589497|58997568|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
30950613|NCT01928381|58997583|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
30763516|NCT00364793|58772264|FG000|Overall Study|Withdrawal by Subject|0|||
30847940|NCT02419612|58873789|FG001|Long-term Treatment Period|Subject Decision|4|||
30950614|NCT01928381|58997584|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
30763517|NCT00364793|58772265|FG001|Overall Study|Withdrawal by Subject|1|||
30627362|NCT01106352|58639205|FG003|Overall Study|Subject entered hospice|1|||
30627363|NCT01106352|58639206|FG004|Overall Study|Subject entered hospice|0|||
30627364|NCT01106352|58639202|FG000|Overall Study|Home hospice since July 2013|0|||
30627365|NCT01106352|58639203|FG001|Overall Study|Home hospice since July 2013|0|||
30627366|NCT01106352|58639204|FG002|Overall Study|Home hospice since July 2013|0|||
30627367|NCT01106352|58639205|FG003|Overall Study|Home hospice since July 2013|1|||
30627368|NCT01106352|58639206|FG004|Overall Study|Home hospice since July 2013|0|||
30627369|NCT01144403|58639222|FG000|Overall Study|Lost to Follow-up|3|||
30627370|NCT01144403|58639222|FG000|Overall Study|Death|1|||
30627371|NCT01144403|58639222|FG000|Overall Study|Adverse Event|1|||
30627372|NCT01143389|58639229|FG000|Overall Study|Lost to Follow-up|26|||
30627373|NCT01143389|58639230|FG001|Overall Study|Lost to Follow-up|25|||
30627374|NCT00868231|58639236|FG000|Treatment Period 1|Adverse Event|0|||
30627375|NCT00868231|58639237|FG001|Treatment Period 1|Adverse Event|0|||
30627376|NCT00868231|58639238|FG002|Treatment Period 1|Adverse Event|0|||
30627377|NCT00868231|58639239|FG003|Treatment Period 1|Adverse Event|0|||
30627378|NCT00868231|58639240|FG004|Treatment Period 1|Adverse Event|1|||
30627379|NCT00868231|58639241|FG005|Treatment Period 1|Adverse Event|0|||
30627380|NCT00868231|58639236|FG000|Treatment Period 2|Adverse Event|1|||
30627381|NCT00868231|58639237|FG001|Treatment Period 2|Adverse Event|0|||
30627382|NCT00868231|58639238|FG002|Treatment Period 2|Adverse Event|0|||
30627383|NCT00868231|58639239|FG003|Treatment Period 2|Adverse Event|0|||
30627384|NCT00868231|58639240|FG004|Treatment Period 2|Adverse Event|0|||
30627385|NCT00868231|58639241|FG005|Treatment Period 2|Adverse Event|0|||
30627386|NCT00868231|58639236|FG000|Treatment Period 3|Adverse Event|0|||
30627387|NCT00868231|58639237|FG001|Treatment Period 3|Adverse Event|0|||
30627388|NCT00868231|58639238|FG002|Treatment Period 3|Adverse Event|1|||
30627389|NCT00868231|58639239|FG003|Treatment Period 3|Adverse Event|0|||
30627390|NCT00868231|58639240|FG004|Treatment Period 3|Adverse Event|0|||
30627391|NCT00868231|58639241|FG005|Treatment Period 3|Adverse Event|0|||
30627392|NCT01143077|58639252|FG000|Overall Study|Lack of Efficacy|0|||
30627393|NCT01143077|58639253|FG001|Overall Study|Lack of Efficacy|2|||
30627394|NCT01143077|58639254|FG002|Overall Study|Lack of Efficacy|1|||
30627395|NCT01143077|58639252|FG000|Overall Study|Adverse Event|5|||
30627396|NCT01143077|58639253|FG001|Overall Study|Adverse Event|6|||
30627397|NCT01143077|58639254|FG002|Overall Study|Adverse Event|5|||
30627398|NCT01143077|58639252|FG000|Overall Study|Lost to Follow-up|2|||
30627399|NCT01143077|58639253|FG001|Overall Study|Lost to Follow-up|3|||
30627400|NCT01143077|58639254|FG002|Overall Study|Lost to Follow-up|4|||
30627401|NCT01143077|58639252|FG000|Overall Study|Protocol Violation|2|||
30627402|NCT01143077|58639253|FG001|Overall Study|Protocol Violation|0|||
30627403|NCT01143077|58639254|FG002|Overall Study|Protocol Violation|0|||
30627404|NCT01143077|58639252|FG000|Overall Study|Withdrawal by Subject|4|||
30627405|NCT01143077|58639253|FG001|Overall Study|Withdrawal by Subject|3|||
30627406|NCT01143077|58639254|FG002|Overall Study|Withdrawal by Subject|3|||
30627407|NCT01143077|58639252|FG000|Overall Study|Non-compliance with study drug|0|||
30627408|NCT01143077|58639253|FG001|Overall Study|Non-compliance with study drug|1|||
30627409|NCT01143077|58639254|FG002|Overall Study|Non-compliance with study drug|1|||
30627410|NCT01143077|58639252|FG000|Overall Study|Administrative|1|||
30627411|NCT01143077|58639253|FG001|Overall Study|Administrative|0|||
30627412|NCT01143077|58639254|FG002|Overall Study|Administrative|0|||
30627413|NCT01143077|58639252|FG000|Overall Study|Principal Investigator Decision|2|||
30627414|NCT01143077|58639253|FG001|Overall Study|Principal Investigator Decision|0|||
30627415|NCT01143077|58639254|FG002|Overall Study|Principal Investigator Decision|1|||
30627416|NCT01096446|58639264|FG000|Overall Study|Death|1|||
30627417|NCT01096446|58639265|FG001|Overall Study|Death|0|||
30627418|NCT01096446|58639264|FG000|Overall Study|Protocol Violation|2|||
30627419|NCT01096446|58639265|FG001|Overall Study|Protocol Violation|0|||
30627420|NCT00864721|58639270|FG000|Overall Study|Patient request|11|||
30627421|NCT00864721|58639270|FG000|Overall Study|Hospitalized|1|||
30627422|NCT00864721|58639270|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
30627423|NCT00864721|58639270|FG000|Overall Study|Adverse Event|21|||
30627424|NCT01095666|58639277|FG000|Overall Study|Lack of Efficacy|0|||
30627425|NCT01095666|58639278|FG001|Overall Study|Lack of Efficacy|0|||
30763518|NCT00364793|58772266|FG002|Overall Study|Withdrawal by Subject|0|||
30627426|NCT01095666|58639279|FG002|Overall Study|Lack of Efficacy|1|||
30627427|NCT01095666|58639277|FG000|Overall Study|Adverse Event|2|||
30627428|NCT01095666|58639278|FG001|Overall Study|Adverse Event|1|||
30627429|NCT01095666|58639279|FG002|Overall Study|Adverse Event|3|||
30627430|NCT01095666|58639277|FG000|Overall Study|Lost to Follow-up|2|||
30627431|NCT01095666|58639278|FG001|Overall Study|Lost to Follow-up|2|||
30627432|NCT01095666|58639279|FG002|Overall Study|Lost to Follow-up|0|||
30627433|NCT01095666|58639277|FG000|Overall Study|Withdrawal by Subject|6|||
30627434|NCT01095666|58639278|FG001|Overall Study|Withdrawal by Subject|6|||
30627435|NCT01095666|58639279|FG002|Overall Study|Withdrawal by Subject|1|||
30763519|NCT00364793|58772267|FG003|Overall Study|Withdrawal by Subject|0|||
30627436|NCT01095666|58639277|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
30627437|NCT01095666|58639278|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
30627438|NCT01095666|58639279|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
30627439|NCT01100658|58639287|FG000|Overall Study|Withdrawal by Subject|1|||
30627440|NCT01100502|58639293|FG000|Overall Study|Withdrawal by Subject|18|||
30627441|NCT01100502|58639294|FG001|Overall Study|Withdrawal by Subject|25|||
30627442|NCT01100502|58639293|FG000|Overall Study|Lost to Follow-up|13|||
30627443|NCT01100502|58639294|FG001|Overall Study|Lost to Follow-up|28|||
30627444|NCT01100502|58639293|FG000|Overall Study|Site request to end participation in study|0|||
30627445|NCT01100502|58639294|FG001|Overall Study|Site request to end participation in study|1|||
30627446|NCT01100502|58639293|FG000|Overall Study|Death|45|||
30627447|NCT01100502|58639294|FG001|Overall Study|Death|40|||
30627448|NCT01094886|58639300|FG000|Overall Study|Adverse Event|2|||
30847941|NCT02419612|58873788|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
30847942|NCT02419612|58873789|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
30847943|NCT02447848|58873795|FG000|Overall Study|Patient discharged|3|||
30847944|NCT02447848|58873795|FG000|Overall Study|Lack of Efficacy|4|||
30950615|NCT01928381|58997585|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
30627449|NCT01094886|58639300|FG000|Overall Study|Withdrawal by Subject|5|||
30627450|NCT01094808|58639307|FG000|Overall Study|Withdrawal by Subject|1|||
30847945|NCT02447848|58873795|FG000|Overall Study|Withdrawal by Subject|4|||
30627451|NCT01094808|58639308|FG001|Overall Study|Withdrawal by Subject|1|||
30627452|NCT01094808|58639309|FG002|Overall Study|Withdrawal by Subject|0|||
30627453|NCT00864253|58639319|FG000|Overall Study|Adverse Event|56|||
30627454|NCT00864253|58639320|FG001|Overall Study|Adverse Event|11|||
30627455|NCT00864253|58639319|FG000|Overall Study|Unrelated Adverse Event|3|||
30627456|NCT00864253|58639320|FG001|Overall Study|Unrelated Adverse Event|1|||
30627457|NCT00864253|58639319|FG000|Overall Study|Physician Decision|11|||
30627458|NCT00864253|58639320|FG001|Overall Study|Physician Decision|15|||
30627459|NCT00864253|58639319|FG000|Overall Study|Protocol Violation|0|||
30627460|NCT00864253|58639320|FG001|Overall Study|Protocol Violation|2|||
30627461|NCT00864253|58639319|FG000|Overall Study|Lost to Follow-up|1|||
30627462|NCT00864253|58639320|FG001|Overall Study|Lost to Follow-up|1|||
30627463|NCT00864253|58639319|FG000|Overall Study|Withdrawal by Subject|18|||
30627464|NCT00864253|58639320|FG001|Overall Study|Withdrawal by Subject|18|||
30627465|NCT00864253|58639319|FG000|Overall Study|Death|1|||
30627466|NCT00864253|58639320|FG001|Overall Study|Death|0|||
30627467|NCT00864253|58639319|FG000|Overall Study|Ongoing|2|||
30627468|NCT00864253|58639320|FG001|Overall Study|Ongoing|3|||
30627469|NCT00864253|58639319|FG000|Overall Study|Untreated|7|||
30627470|NCT00864253|58639320|FG001|Overall Study|Untreated|7|||
30627471|NCT01094730|58639328|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
30627472|NCT01094730|58639329|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
30627473|NCT01094730|58639328|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
30627474|NCT01094730|58639329|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
30627475|NCT01094730|58639328|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
30627476|NCT01094730|58639329|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
30627477|NCT01094730|58639328|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
30627478|NCT01094730|58639329|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
30627479|NCT01094730|58639328|FG000|Period 2 (14 Days)|Protocol Violation|2|||
30627480|NCT01094730|58639329|FG001|Period 2 (14 Days)|Protocol Violation|0|||
30627481|NCT01094730|58639328|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
30627482|NCT01094730|58639329|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
30627483|NCT01094730|58639328|FG000|Period 2 (14 Days)|Adverse Event|0|||
30627484|NCT01094730|58639329|FG001|Period 2 (14 Days)|Adverse Event|1|||
30627485|NCT01094730|58639328|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
30627486|NCT01094730|58639329|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
30627487|NCT00864097|58639344|FG000|Overall Study|Death|0|||
30627488|NCT00864097|58639345|FG001|Overall Study|Death|1|||
30627489|NCT00864097|58639346|FG002|Overall Study|Death|0|||
30627490|NCT00864097|58639347|FG003|Overall Study|Death|0|||
30627491|NCT00864097|58639344|FG000|Overall Study|Adverse Event|6|||
30627492|NCT00864097|58639345|FG001|Overall Study|Adverse Event|8|||
30627493|NCT00864097|58639346|FG002|Overall Study|Adverse Event|11|||
30627494|NCT00864097|58639347|FG003|Overall Study|Adverse Event|9|||
30627495|NCT00864097|58639344|FG000|Overall Study|Lack of Efficacy|9|||
30627496|NCT00864097|58639345|FG001|Overall Study|Lack of Efficacy|3|||
30627497|NCT00864097|58639346|FG002|Overall Study|Lack of Efficacy|7|||
30627498|NCT00864097|58639347|FG003|Overall Study|Lack of Efficacy|2|||
30627499|NCT00864097|58639344|FG000|Overall Study|Lost to Follow-up|0|||
30627500|NCT00864097|58639345|FG001|Overall Study|Lost to Follow-up|1|||
30627501|NCT00864097|58639346|FG002|Overall Study|Lost to Follow-up|0|||
30627502|NCT00864097|58639347|FG003|Overall Study|Lost to Follow-up|1|||
30627503|NCT00864097|58639344|FG000|Overall Study|Withdrawal by Subject|15|||
30627504|NCT00864097|58639345|FG001|Overall Study|Withdrawal by Subject|11|||
30627505|NCT00864097|58639346|FG002|Overall Study|Withdrawal by Subject|11|||
30627506|NCT00864097|58639347|FG003|Overall Study|Withdrawal by Subject|12|||
30627507|NCT00864097|58639344|FG000|Overall Study|Protocol Violation|2|||
30627508|NCT00864097|58639345|FG001|Overall Study|Protocol Violation|1|||
30627509|NCT00864097|58639346|FG002|Overall Study|Protocol Violation|0|||
30627510|NCT00864097|58639347|FG003|Overall Study|Protocol Violation|1|||
30627511|NCT00864097|58639344|FG000|Overall Study|Terminated by sponsor|105|||
30627512|NCT00864097|58639345|FG001|Overall Study|Terminated by sponsor|112|||
30627513|NCT00864097|58639346|FG002|Overall Study|Terminated by sponsor|102|||
30627514|NCT00864097|58639347|FG003|Overall Study|Terminated by sponsor|99|||
30763520|NCT03351478|58772283|FG000|Overall Study|At the subject's own request|11|||
30763521|NCT03351478|58772284|FG001|Overall Study|At the subject's own request|12|||
30763522|NCT03351478|58772285|FG002|Overall Study|At the subject's own request|5|||
30763523|NCT03351478|58772283|FG000|Overall Study|Adverse Event|1|||
30763524|NCT03351478|58772284|FG001|Overall Study|Adverse Event|2|||
30763525|NCT03351478|58772285|FG002|Overall Study|Adverse Event|1|||
30763526|NCT03351478|58772283|FG000|Overall Study|Poor compliance to protocol|1|||
30627515|NCT00864097|58639344|FG000|Overall Study|Randomized but not treated|2|||
30627516|NCT00864097|58639345|FG001|Overall Study|Randomized but not treated|0|||
30627517|NCT00864097|58639346|FG002|Overall Study|Randomized but not treated|1|||
30627518|NCT00864097|58639347|FG003|Overall Study|Randomized but not treated|0|||
30627519|NCT00864097|58639344|FG000|Overall Study|Other|0|||
30627520|NCT00864097|58639345|FG001|Overall Study|Other|0|||
30627521|NCT00864097|58639346|FG002|Overall Study|Other|0|||
30627522|NCT00864097|58639347|FG003|Overall Study|Other|1|||
30627523|NCT01183013|58639364|FG000|Overall Study|Adverse Event|6|||
30627524|NCT01183013|58639365|FG001|Overall Study|Adverse Event|8|||
30627525|NCT01183013|58639366|FG002|Overall Study|Adverse Event|5|||
30627526|NCT01183013|58639367|FG003|Overall Study|Adverse Event|5|||
30627527|NCT01183013|58639368|FG004|Overall Study|Adverse Event|10|||
30627528|NCT01183013|58639369|FG005|Overall Study|Adverse Event|10|||
30627529|NCT01183013|58639370|FG006|Overall Study|Adverse Event|6|||
30627530|NCT01183013|58639364|FG000|Overall Study|Lack of Efficacy|3|||
30627531|NCT01183013|58639365|FG001|Overall Study|Lack of Efficacy|2|||
30627532|NCT01183013|58639366|FG002|Overall Study|Lack of Efficacy|1|||
30627533|NCT01183013|58639367|FG003|Overall Study|Lack of Efficacy|2|||
30627534|NCT01183013|58639368|FG004|Overall Study|Lack of Efficacy|1|||
30627535|NCT01183013|58639369|FG005|Overall Study|Lack of Efficacy|2|||
30627536|NCT01183013|58639370|FG006|Overall Study|Lack of Efficacy|0|||
30627537|NCT01183013|58639364|FG000|Overall Study|Protocol Violation|5|||
30627538|NCT01183013|58639365|FG001|Overall Study|Protocol Violation|2|||
30627539|NCT01183013|58639366|FG002|Overall Study|Protocol Violation|4|||
30627540|NCT01183013|58639367|FG003|Overall Study|Protocol Violation|0|||
30627541|NCT01183013|58639368|FG004|Overall Study|Protocol Violation|4|||
30627542|NCT01183013|58639369|FG005|Overall Study|Protocol Violation|3|||
30627543|NCT01183013|58639370|FG006|Overall Study|Protocol Violation|3|||
30627544|NCT01183013|58639364|FG000|Overall Study|Lost to Follow-up|7|||
30627545|NCT01183013|58639365|FG001|Overall Study|Lost to Follow-up|3|||
30627546|NCT01183013|58639366|FG002|Overall Study|Lost to Follow-up|4|||
30627547|NCT01183013|58639367|FG003|Overall Study|Lost to Follow-up|3|||
30627548|NCT01183013|58639368|FG004|Overall Study|Lost to Follow-up|2|||
30627549|NCT01183013|58639369|FG005|Overall Study|Lost to Follow-up|6|||
30627550|NCT01183013|58639370|FG006|Overall Study|Lost to Follow-up|5|||
30627551|NCT01183013|58639364|FG000|Overall Study|Withdrawal by Subject|9|||
30627552|NCT01183013|58639365|FG001|Overall Study|Withdrawal by Subject|13|||
30627553|NCT01183013|58639366|FG002|Overall Study|Withdrawal by Subject|10|||
30627554|NCT01183013|58639367|FG003|Overall Study|Withdrawal by Subject|8|||
30627555|NCT01183013|58639368|FG004|Overall Study|Withdrawal by Subject|7|||
30627556|NCT01183013|58639369|FG005|Overall Study|Withdrawal by Subject|9|||
30627557|NCT01183013|58639370|FG006|Overall Study|Withdrawal by Subject|10|||
30627558|NCT01183013|58639364|FG000|Overall Study|Reasons other than stated above|15|||
30627559|NCT01183013|58639365|FG001|Overall Study|Reasons other than stated above|11|||
30627560|NCT01183013|58639366|FG002|Overall Study|Reasons other than stated above|17|||
30627561|NCT01183013|58639367|FG003|Overall Study|Reasons other than stated above|12|||
30627562|NCT01183013|58639368|FG004|Overall Study|Reasons other than stated above|12|||
30627563|NCT01183013|58639369|FG005|Overall Study|Reasons other than stated above|15|||
30627564|NCT01183013|58639370|FG006|Overall Study|Reasons other than stated above|13|||
30627565|NCT01141283|58639394|FG000|Overall Study|Adverse Event|56|||
30627566|NCT01141283|58639394|FG000|Overall Study|Lost to Follow-up|4|||
30627567|NCT01141283|58639394|FG000|Overall Study|Withdrawal by Subject|14|||
30627568|NCT01141283|58639394|FG000|Overall Study|Administrative|4|||
30763527|NCT03351478|58772284|FG001|Overall Study|Poor compliance to protocol|0|||
30763528|NCT03351478|58772285|FG002|Overall Study|Poor compliance to protocol|0|||
30627569|NCT01141283|58639394|FG000|Overall Study|Lack of Efficacy|10|||
30627570|NCT00863707|58639400|FG000|Overall Study|Randomized, but drug not received|4|||
30627571|NCT00863707|58639401|FG001|Overall Study|Randomized, but drug not received|3|||
30627572|NCT01094184|58639409|FG000|Overall Study|Death|35|||
30627573|NCT01094184|58639410|FG001|Overall Study|Death|11|||
30627574|NCT01134731|58639419|FG000|Overall Study|Adverse Event|3|||
30627575|NCT01134731|58639420|FG001|Overall Study|Adverse Event|2|||
30627576|NCT01134731|58639421|FG002|Overall Study|Adverse Event|1|||
30763529|NCT03351478|58772283|FG000|Overall Study|Reason not Specified|1|||
30763530|NCT03351478|58772284|FG001|Overall Study|Reason not Specified|3|||
30627577|NCT01134731|58639419|FG000|Overall Study|Physician Decision|2|||
30627578|NCT01134731|58639420|FG001|Overall Study|Physician Decision|2|||
30627579|NCT01134731|58639421|FG002|Overall Study|Physician Decision|2|||
30627580|NCT01134731|58639419|FG000|Overall Study|Lack of Efficacy|0|||
30627581|NCT01134731|58639420|FG001|Overall Study|Lack of Efficacy|0|||
30627582|NCT01134731|58639421|FG002|Overall Study|Lack of Efficacy|1|||
30627583|NCT01134731|58639419|FG000|Overall Study|Withdrawal by Subject|3|||
30627584|NCT01134731|58639420|FG001|Overall Study|Withdrawal by Subject|3|||
30627585|NCT01134731|58639421|FG002|Overall Study|Withdrawal by Subject|1|||
30627586|NCT01134731|58639419|FG000|Overall Study|Lost to Follow-up|5|||
30627587|NCT01134731|58639420|FG001|Overall Study|Lost to Follow-up|4|||
30627588|NCT01134731|58639421|FG002|Overall Study|Lost to Follow-up|3|||
30627589|NCT01141205|58639432|FG000|Overall Study|Physician Decision|1|||
30627590|NCT01141205|58639433|FG001|Overall Study|Physician Decision|1|||
30627591|NCT01141205|58639432|FG000|Overall Study|Lost to Follow-up|1|||
30627592|NCT01141205|58639433|FG001|Overall Study|Lost to Follow-up|0|||
30627593|NCT01141205|58639432|FG000|Overall Study|Withdrawal by Subject|1|||
30627594|NCT01141205|58639433|FG001|Overall Study|Withdrawal by Subject|1|||
30627595|NCT01140503|58639443|FG000|Overall Study|Withdrawal by Subject|1|||
30627596|NCT00863317|58639449|FG000|Overall Study|Lost to Follow-up|8|||
30627597|NCT00863317|58639450|FG001|Overall Study|Lost to Follow-up|9|||
30627598|NCT01200368|58639459|FG000|Infant Series|Adverse Event|2|||
30627599|NCT01200368|58639460|FG001|Infant Series|Adverse Event|2|||
30627600|NCT01200368|58639461|FG002|Infant Series|Adverse Event|3|||
30627601|NCT01200368|58639459|FG000|Infant Series|Withdrawal by Subject|0|||
30627602|NCT01200368|58639460|FG001|Infant Series|Withdrawal by Subject|2|||
30627603|NCT01200368|58639461|FG002|Infant Series|Withdrawal by Subject|2|||
30627604|NCT01200368|58639459|FG000|Infant Series|Did not meet entrance criteria|0|||
30627605|NCT01200368|58639460|FG001|Infant Series|Did not meet entrance criteria|1|||
30627606|NCT01200368|58639461|FG002|Infant Series|Did not meet entrance criteria|0|||
30627607|NCT01200368|58639459|FG000|Infant Series|Randomized, not vaccinated|0|||
30627608|NCT01200368|58639460|FG001|Infant Series|Randomized, not vaccinated|1|||
30627609|NCT01200368|58639461|FG002|Infant Series|Randomized, not vaccinated|1|||
30627610|NCT01200368|58639459|FG000|Infant Series|Other|1|||
30627611|NCT01200368|58639460|FG001|Infant Series|Other|0|||
30627612|NCT01200368|58639461|FG002|Infant Series|Other|0|||
30627613|NCT01200368|58639459|FG000|After Infant Series|Adverse Event|6|||
30627614|NCT01200368|58639460|FG001|After Infant Series|Adverse Event|6|||
30627615|NCT01200368|58639461|FG002|After Infant Series|Adverse Event|3|||
30627616|NCT01200368|58639459|FG000|After Infant Series|Withdrawal by Subject|10|||
30627617|NCT01200368|58639460|FG001|After Infant Series|Withdrawal by Subject|8|||
30627618|NCT01200368|58639461|FG002|After Infant Series|Withdrawal by Subject|4|||
30627619|NCT01200368|58639459|FG000|After Infant Series|Lost to Follow-up|1|||
30627620|NCT01200368|58639460|FG001|After Infant Series|Lost to Follow-up|0|||
30627621|NCT01200368|58639461|FG002|After Infant Series|Lost to Follow-up|0|||
30627622|NCT01200368|58639459|FG000|After Infant Series|Other|1|||
30627623|NCT01200368|58639460|FG001|After Infant Series|Other|2|||
30627624|NCT01200368|58639461|FG002|After Infant Series|Other|2|||
30627625|NCT01200368|58639459|FG000|Toddler Dose|Adverse Event|0|||
30627626|NCT01200368|58639460|FG001|Toddler Dose|Adverse Event|3|||
30627627|NCT01200368|58639461|FG002|Toddler Dose|Adverse Event|1|||
30627628|NCT01079130|58639482|FG000|Overall Study|Adverse Event|1|||
30627629|NCT01079130|58639483|FG001|Overall Study|Adverse Event|1|||
30627630|NCT01079130|58639484|FG002|Overall Study|Adverse Event|0|||
30627631|NCT01079130|58639485|FG003|Overall Study|Adverse Event|1|||
30627632|NCT01079130|58639486|FG004|Overall Study|Adverse Event|5|||
30627633|NCT01079130|58639487|FG005|Overall Study|Adverse Event|1|||
30627634|NCT01079130|58639482|FG000|Overall Study|Administrative problems|1|||
30627635|NCT01079130|58639483|FG001|Overall Study|Administrative problems|3|||
30627636|NCT01079130|58639484|FG002|Overall Study|Administrative problems|0|||
30627637|NCT01079130|58639485|FG003|Overall Study|Administrative problems|0|||
30627638|NCT01079130|58639486|FG004|Overall Study|Administrative problems|0|||
30627639|NCT01079130|58639487|FG005|Overall Study|Administrative problems|1|||
30627640|NCT01079130|58639482|FG000|Overall Study|Withdrawal by Subject|0|||
30627641|NCT01079130|58639483|FG001|Overall Study|Withdrawal by Subject|1|||
30627642|NCT01079130|58639484|FG002|Overall Study|Withdrawal by Subject|0|||
30627643|NCT01079130|58639485|FG003|Overall Study|Withdrawal by Subject|0|||
30627644|NCT01079130|58639486|FG004|Overall Study|Withdrawal by Subject|1|||
30627645|NCT01079130|58639487|FG005|Overall Study|Withdrawal by Subject|3|||
30763531|NCT03351478|58772285|FG002|Overall Study|Reason not Specified|0|||
30627646|NCT01079130|58639482|FG000|Overall Study|Protocol deviation|0|||
30627647|NCT01079130|58639483|FG001|Overall Study|Protocol deviation|2|||
30627648|NCT01079130|58639484|FG002|Overall Study|Protocol deviation|1|||
30627649|NCT01079130|58639485|FG003|Overall Study|Protocol deviation|2|||
30627650|NCT01079130|58639486|FG004|Overall Study|Protocol deviation|0|||
30627651|NCT01079130|58639487|FG005|Overall Study|Protocol deviation|0|||
30627652|NCT01079130|58639482|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30627653|NCT01079130|58639483|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30627654|NCT01079130|58639484|FG002|Overall Study|Abnormal test procedure result(s)|0|||
30627655|NCT01079130|58639485|FG003|Overall Study|Abnormal test procedure result(s)|0|||
30627656|NCT01079130|58639486|FG004|Overall Study|Abnormal test procedure result(s)|1|||
30627657|NCT01079130|58639487|FG005|Overall Study|Abnormal test procedure result(s)|0|||
30627658|NCT01079130|58639482|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30627659|NCT01079130|58639483|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30627660|NCT01079130|58639484|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
30627661|NCT01079130|58639485|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
30627662|NCT01079130|58639486|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
30627663|NCT01079130|58639487|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
30627664|NCT01079130|58639482|FG000|Overall Study|Lost to Follow-up|0|||
30627665|NCT01079130|58639483|FG001|Overall Study|Lost to Follow-up|0|||
30627666|NCT01079130|58639484|FG002|Overall Study|Lost to Follow-up|0|||
30627667|NCT01079130|58639485|FG003|Overall Study|Lost to Follow-up|0|||
30627668|NCT01079130|58639486|FG004|Overall Study|Lost to Follow-up|1|||
30627669|NCT01079130|58639487|FG005|Overall Study|Lost to Follow-up|0|||
30627670|NCT01078974|58639501|FG000|Overall Study|Adverse Event|3|||
30627671|NCT00869557|58639507|FG000|Randomized Phase|Lost to Follow-up|2|||
30627672|NCT00869557|58639508|FG001|Randomized Phase|Lost to Follow-up|1|||
30627673|NCT00869557|58639507|FG000|Randomized Phase|Investigator's Discretion|1|||
30627674|NCT00869557|58639508|FG001|Randomized Phase|Investigator's Discretion|0|||
30627675|NCT00869557|58639507|FG000|Randomized Phase|Withdrew Consent|0|||
30627676|NCT00869557|58639508|FG001|Randomized Phase|Withdrew Consent|1|||
30627677|NCT00869557|58639507|FG000|Extension Phase|Adverse Event|2|||
30627678|NCT00869557|58639508|FG001|Extension Phase|Adverse Event|2|||
30627679|NCT00869557|58639507|FG000|Extension Phase|Lack of Efficacy|1|||
30627680|NCT00869557|58639508|FG001|Extension Phase|Lack of Efficacy|0|||
30627681|NCT00869557|58639507|FG000|Extension Phase|Lost to Follow-up|3|||
30627682|NCT00869557|58639508|FG001|Extension Phase|Lost to Follow-up|1|||
30627683|NCT00869557|58639507|FG000|Extension Phase|Investigator's Discretion|2|||
30627684|NCT00869557|58639508|FG001|Extension Phase|Investigator's Discretion|0|||
30627685|NCT00869557|58639507|FG000|Extension Phase|Withdrew Consent|2|||
30627686|NCT00869557|58639508|FG001|Extension Phase|Withdrew Consent|0|||
30627687|NCT01200290|58639515|FG000|Treatment Period|Adverse Event|1|||
30627688|NCT01200290|58639515|FG000|Post-Treatment Follow-Up Period|Death|2|||
30627689|NCT01134263|58639524|FG000|Overall Study|Serious adverse event|2|||
30627690|NCT01134263|58639525|FG001|Overall Study|Serious adverse event|1|||
30627691|NCT01134263|58639526|FG002|Overall Study|Serious adverse event|1|||
30627692|NCT01134263|58639527|FG003|Overall Study|Serious adverse event|1|||
30627693|NCT01134263|58639528|FG004|Overall Study|Serious adverse event|1|||
30627694|NCT01134263|58639524|FG000|Overall Study|Other adverse event|1|||
30627695|NCT01134263|58639525|FG001|Overall Study|Other adverse event|2|||
30627696|NCT01134263|58639526|FG002|Overall Study|Other adverse event|5|||
30627697|NCT01134263|58639527|FG003|Overall Study|Other adverse event|3|||
30627698|NCT01134263|58639528|FG004|Overall Study|Other adverse event|0|||
30627699|NCT01134263|58639524|FG000|Overall Study|Protocol Violation|8|||
30627700|NCT01134263|58639525|FG001|Overall Study|Protocol Violation|7|||
30627701|NCT01134263|58639526|FG002|Overall Study|Protocol Violation|2|||
30627702|NCT01134263|58639527|FG003|Overall Study|Protocol Violation|4|||
30627703|NCT01134263|58639528|FG004|Overall Study|Protocol Violation|2|||
30627704|NCT01134263|58639524|FG000|Overall Study|Lost to Follow-up|4|||
30627705|NCT01134263|58639525|FG001|Overall Study|Lost to Follow-up|3|||
30627706|NCT01134263|58639526|FG002|Overall Study|Lost to Follow-up|5|||
30627707|NCT01134263|58639527|FG003|Overall Study|Lost to Follow-up|3|||
30627708|NCT01134263|58639528|FG004|Overall Study|Lost to Follow-up|1|||
30627709|NCT01134263|58639524|FG000|Overall Study|Withdrawal by Subject|8|||
30627710|NCT01134263|58639525|FG001|Overall Study|Withdrawal by Subject|6|||
30627711|NCT01134263|58639526|FG002|Overall Study|Withdrawal by Subject|16|||
30627712|NCT01134263|58639527|FG003|Overall Study|Withdrawal by Subject|7|||
30627713|NCT01134263|58639528|FG004|Overall Study|Withdrawal by Subject|5|||
30627714|NCT01134263|58639524|FG000|Overall Study|Enrolled, but not treated|1|||
30627715|NCT01134263|58639525|FG001|Overall Study|Enrolled, but not treated|1|||
30627716|NCT01134263|58639526|FG002|Overall Study|Enrolled, but not treated|0|||
30627717|NCT01134263|58639527|FG003|Overall Study|Enrolled, but not treated|1|||
30627718|NCT01134263|58639528|FG004|Overall Study|Enrolled, but not treated|0|||
30627719|NCT01199822|58639549|FG000|Overall Study|Investigator discontinued therapy|0|||
30627720|NCT01199822|58639550|FG001|Overall Study|Investigator discontinued therapy|1|||
30627721|NCT01199822|58639551|FG002|Overall Study|Investigator discontinued therapy|0|||
30627722|NCT01096056|58639568|FG000|Overall Study|Lost to Follow-up|0|||
30627723|NCT01096056|58639569|FG001|Overall Study|Lost to Follow-up|1|||
30627724|NCT00866359|58639577|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
30847946|NCT02418910|58873799|FG000|Overall Study|Lost to Follow-up|3|||
30627725|NCT00866359|58639578|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
30627726|NCT00866359|58639579|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
30627727|NCT00866359|58639580|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
30627728|NCT00866359|58639577|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
30627729|NCT00866359|58639578|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
30627730|NCT00866359|58639579|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
30627731|NCT00866359|58639580|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
30627732|NCT00866359|58639577|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
30627733|NCT00866359|58639578|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
30627734|NCT00866359|58639579|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
30627735|NCT00866359|58639580|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
30627736|NCT00866359|58639577|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
30627737|NCT00866359|58639578|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
30627738|NCT00866359|58639579|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
30627739|NCT00866359|58639580|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
30627740|NCT00866359|58639577|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
30627741|NCT00866359|58639578|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
30627742|NCT00866359|58639579|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
30627743|NCT00866359|58639580|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
30627744|NCT00866359|58639577|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
30627745|NCT00866359|58639578|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
30627746|NCT00866359|58639579|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
30627747|NCT00866359|58639580|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
30627748|NCT01199198|58639609|FG000|Overall Study|Adverse Event|3|||
30627749|NCT01199198|58639610|FG001|Overall Study|Adverse Event|0|||
30627750|NCT01199198|58639609|FG000|Overall Study|Lost to Follow-up|1|||
30627751|NCT01199198|58639610|FG001|Overall Study|Lost to Follow-up|5|||
30627752|NCT01199198|58639609|FG000|Overall Study|Withdrawal by Subject|1|||
30627753|NCT01199198|58639610|FG001|Overall Study|Withdrawal by Subject|2|||
30627754|NCT01199198|58639609|FG000|Overall Study|ICU Transfer|1|||
30627755|NCT01199198|58639610|FG001|Overall Study|ICU Transfer|2|||
30627756|NCT01199198|58639609|FG000|Overall Study|Hospice-care transfer|1|||
30627757|NCT01199198|58639610|FG001|Overall Study|Hospice-care transfer|2|||
30627758|NCT01095978|58639616|FG000|Overall Study|Did not take Klacid SR|2|||
30627759|NCT01095978|58639616|FG000|Overall Study|Adverse Event|1|||
30627760|NCT01134107|58639624|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
30847947|NCT02418910|58873799|FG000|Overall Study|Withdrawal by Subject|4|||
30847948|NCT02418754|58873815|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
30627761|NCT01134107|58639625|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
30627762|NCT01134107|58639624|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
30627763|NCT01134107|58639625|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
30627764|NCT01134107|58639624|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
30627765|NCT01134107|58639625|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
30627766|NCT01134107|58639624|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
30627767|NCT01134107|58639625|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
30627768|NCT01134107|58639624|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
30847949|NCT02418754|58873816|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
30627769|NCT01134107|58639625|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
30627770|NCT01134107|58639624|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
30627771|NCT01134107|58639625|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
30627772|NCT01134107|58639624|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
30627773|NCT01134107|58639625|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
30627774|NCT01199042|58639631|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
30627775|NCT01199042|58639631|FG000|At Home (3 Months)|Lost to Follow-up|1|||
30627776|NCT01198574|58639644|FG000|Overall Study|Resigned from schools|4|||
30627777|NCT01198574|58639645|FG001|Overall Study|Resigned from schools|1|||
30627778|NCT01198574|58639646|FG002|Overall Study|Resigned from schools|1|||
30627779|NCT01198574|58639647|FG003|Overall Study|Resigned from schools|4|||
30627780|NCT01198028|58639657|FG000|Overall Study|Adverse Event|5|||
30627781|NCT01198028|58639657|FG000|Overall Study|Death|3|||
30627782|NCT01198028|58639657|FG000|Overall Study|Physician Decision|2|||
30627783|NCT01197950|58639664|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
30627784|NCT01197950|58639665|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
30627785|NCT01197950|58639666|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
30627786|NCT01092780|58639674|FG000|Washout Period 1|Adverse Event|0|||
30627787|NCT01092780|58639675|FG001|Washout Period 1|Adverse Event|1|||
30627788|NCT01092780|58639676|FG002|Washout Period 1|Adverse Event|0|||
30627789|NCT01092780|58639677|FG003|Washout Period 1|Adverse Event|0|||
30627790|NCT01092780|58639674|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
30627791|NCT01092780|58639675|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
30627792|NCT01092780|58639676|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
30627793|NCT01092780|58639677|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
30627794|NCT01092780|58639674|FG000|Washout Period 2|Adverse Event|0|||
30627795|NCT01092780|58639675|FG001|Washout Period 2|Adverse Event|1|||
30627796|NCT01092780|58639676|FG002|Washout Period 2|Adverse Event|1|||
30627797|NCT01092780|58639677|FG003|Washout Period 2|Adverse Event|0|||
30627798|NCT01092702|58639687|FG000|Overall Study|Withdrawal by Subject|7|||
30627799|NCT01092702|58639687|FG000|Overall Study|Lost to Follow-up|2|||
30627800|NCT01092546|58639691|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
30627801|NCT01197794|58639702|FG000|Overall Study|Adverse Event|3|||
30627802|NCT01197794|58639703|FG001|Overall Study|Adverse Event|2|||
30627803|NCT01197794|58639704|FG002|Overall Study|Adverse Event|4|||
30627804|NCT01197794|58639705|FG003|Overall Study|Adverse Event|4|||
30627805|NCT01197794|58639706|FG004|Overall Study|Adverse Event|4|||
30627806|NCT01197794|58639707|FG005|Overall Study|Adverse Event|2|||
30627807|NCT01197794|58639708|FG006|Overall Study|Adverse Event|3|||
30627808|NCT01197794|58639702|FG000|Overall Study|Protocol Violation|0|||
30627809|NCT01197794|58639703|FG001|Overall Study|Protocol Violation|0|||
30627810|NCT01197794|58639704|FG002|Overall Study|Protocol Violation|0|||
30627811|NCT01197794|58639705|FG003|Overall Study|Protocol Violation|0|||
30627812|NCT01197794|58639706|FG004|Overall Study|Protocol Violation|2|||
30627813|NCT01197794|58639707|FG005|Overall Study|Protocol Violation|0|||
30627814|NCT01197794|58639708|FG006|Overall Study|Protocol Violation|1|||
30627815|NCT01197794|58639702|FG000|Overall Study|Development of study withdrawal criteria|3|||
30627816|NCT01197794|58639703|FG001|Overall Study|Development of study withdrawal criteria|0|||
30627817|NCT01197794|58639704|FG002|Overall Study|Development of study withdrawal criteria|0|||
30627818|NCT01197794|58639705|FG003|Overall Study|Development of study withdrawal criteria|1|||
30627819|NCT01197794|58639706|FG004|Overall Study|Development of study withdrawal criteria|0|||
30627820|NCT01197794|58639707|FG005|Overall Study|Development of study withdrawal criteria|0|||
30627821|NCT01197794|58639708|FG006|Overall Study|Development of study withdrawal criteria|1|||
30627822|NCT01197794|58639702|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
30627823|NCT01197794|58639703|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
30627824|NCT01197794|58639704|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
30627825|NCT01197794|58639705|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
30627826|NCT01197794|58639706|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
30627827|NCT01197794|58639707|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
30627828|NCT01197794|58639708|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
30627829|NCT01197794|58639702|FG000|Overall Study|Withdrawal by Subject|3|||
30627830|NCT01197794|58639703|FG001|Overall Study|Withdrawal by Subject|3|||
30627831|NCT01197794|58639704|FG002|Overall Study|Withdrawal by Subject|4|||
30627832|NCT01197794|58639705|FG003|Overall Study|Withdrawal by Subject|1|||
30627833|NCT01197794|58639706|FG004|Overall Study|Withdrawal by Subject|1|||
30627834|NCT01197794|58639707|FG005|Overall Study|Withdrawal by Subject|5|||
30627835|NCT01197794|58639708|FG006|Overall Study|Withdrawal by Subject|6|||
30627836|NCT01197794|58639702|FG000|Overall Study|Lost to Follow-up|1|||
30627837|NCT01197794|58639703|FG001|Overall Study|Lost to Follow-up|1|||
30627838|NCT01197794|58639704|FG002|Overall Study|Lost to Follow-up|0|||
30627839|NCT01197794|58639705|FG003|Overall Study|Lost to Follow-up|1|||
30627840|NCT01197794|58639706|FG004|Overall Study|Lost to Follow-up|0|||
30627841|NCT01197794|58639707|FG005|Overall Study|Lost to Follow-up|1|||
30627842|NCT01197794|58639708|FG006|Overall Study|Lost to Follow-up|0|||
30627843|NCT01197794|58639702|FG000|Overall Study|Other|1|||
30627844|NCT01197794|58639703|FG001|Overall Study|Other|1|||
30627845|NCT01197794|58639704|FG002|Overall Study|Other|3|||
30627846|NCT01197794|58639705|FG003|Overall Study|Other|0|||
30627847|NCT01197794|58639706|FG004|Overall Study|Other|2|||
30627848|NCT01197794|58639707|FG005|Overall Study|Other|2|||
30627849|NCT01197794|58639708|FG006|Overall Study|Other|4|||
30627850|NCT01078662|58639730|FG000|Overall Study|Death|41|||
30627851|NCT01078662|58639731|FG001|Overall Study|Death|103|||
30627852|NCT01078662|58639732|FG002|Overall Study|Death|18|||
30627853|NCT01078662|58639733|FG003|Overall Study|Death|5|||
30627854|NCT01078662|58639734|FG004|Overall Study|Death|8|||
30627855|NCT01078662|58639730|FG000|Overall Study|Patients reached data cut-off|12|||
30627856|NCT01078662|58639731|FG001|Overall Study|Patients reached data cut-off|53|||
30627857|NCT01078662|58639732|FG002|Overall Study|Patients reached data cut-off|2|||
30627858|NCT01078662|58639733|FG003|Overall Study|Patients reached data cut-off|2|||
30627859|NCT01078662|58639734|FG004|Overall Study|Patients reached data cut-off|3|||
30627860|NCT01078662|58639730|FG000|Overall Study|Withdrawal by Subject|4|||
30627861|NCT01078662|58639731|FG001|Overall Study|Withdrawal by Subject|11|||
30627862|NCT01078662|58639732|FG002|Overall Study|Withdrawal by Subject|1|||
30627863|NCT01078662|58639733|FG003|Overall Study|Withdrawal by Subject|0|||
30627864|NCT01078662|58639734|FG004|Overall Study|Withdrawal by Subject|0|||
30627865|NCT01078662|58639730|FG000|Overall Study|Protocol Violation|0|||
30627866|NCT01078662|58639731|FG001|Overall Study|Protocol Violation|1|||
30627867|NCT01078662|58639732|FG002|Overall Study|Protocol Violation|0|||
30627868|NCT01078662|58639733|FG003|Overall Study|Protocol Violation|0|||
30627869|NCT01078662|58639734|FG004|Overall Study|Protocol Violation|0|||
30627870|NCT01078662|58639730|FG000|Overall Study|Lost to Follow-up|1|||
30847950|NCT02418754|58873817|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
30847951|NCT02418754|58873818|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
30847952|NCT02418754|58873819|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
30847953|NCT02418754|58873815|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
30847954|NCT02418754|58873816|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
30847955|NCT02418754|58873817|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
30847956|NCT02418754|58873818|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
30847957|NCT02418754|58873819|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
30847958|NCT02418754|58873815|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
30847959|NCT02418754|58873816|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
30847960|NCT02418754|58873817|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
30847961|NCT02418754|58873818|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
30847962|NCT02418754|58873819|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
30847963|NCT02418754|58873815|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
30847964|NCT02418754|58873816|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
30627871|NCT01078662|58639731|FG001|Overall Study|Lost to Follow-up|0|||
30847965|NCT02418754|58873817|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
30950616|NCT01928381|58997586|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
30950617|NCT01928381|58997587|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
30950618|NCT01928381|58997588|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
30950619|NCT01928381|58997589|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
30950620|NCT01928381|58997583|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
30950621|NCT01928381|58997584|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
30950622|NCT01928381|58997585|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
30950623|NCT01928381|58997586|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
30950624|NCT01928381|58997587|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
30627872|NCT01078662|58639732|FG002|Overall Study|Lost to Follow-up|0|||
30627873|NCT01078662|58639733|FG003|Overall Study|Lost to Follow-up|0|||
30627874|NCT01078662|58639734|FG004|Overall Study|Lost to Follow-up|0|||
30627875|NCT01091454|58639743|FG000|Overall Study|Ineligible|1|||
30763532|NCT03351478|58772283|FG000|Overall Study|Lost to Follow-up|0|||
30627876|NCT01140347|58639749|FG000|Overall Study|Lost to Follow-up|5|||
30627877|NCT01140347|58639750|FG001|Overall Study|Lost to Follow-up|6|||
30763533|NCT03351478|58772284|FG001|Overall Study|Lost to Follow-up|0|||
30763534|NCT03351478|58772285|FG002|Overall Study|Lost to Follow-up|1|||
30763535|NCT00363545|58772295|FG000|Overall Study|Serious Adverse Event|0|||
30763536|NCT00363545|58772296|FG001|Overall Study|Serious Adverse Event|1|||
30763537|NCT00363545|58772295|FG000|Overall Study|Withdrawal by Subject|12|||
30763538|NCT00363545|58772296|FG001|Overall Study|Withdrawal by Subject|15|||
30763539|NCT00363545|58772295|FG000|Overall Study|Migrated/moved from study area|3|||
30763540|NCT00363545|58772296|FG001|Overall Study|Migrated/moved from study area|6|||
30627878|NCT01140347|58639749|FG000|Overall Study|Withdrawal by Subject|13|||
30627879|NCT01140347|58639750|FG001|Overall Study|Withdrawal by Subject|8|||
30627880|NCT01197560|58639758|FG000|Overall Study|Adverse Event|6|||
30627881|NCT01197560|58639759|FG001|Overall Study|Adverse Event|8|||
30763541|NCT00363545|58772295|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
30763542|NCT00363545|58772296|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
30627882|NCT01197560|58639758|FG000|Overall Study|Death|3|||
30627883|NCT01197560|58639759|FG001|Overall Study|Death|5|||
30627884|NCT01197560|58639758|FG000|Overall Study|Withdrawal by Subject|1|||
30627885|NCT01197560|58639759|FG001|Overall Study|Withdrawal by Subject|1|||
30627886|NCT01197560|58639758|FG000|Overall Study|Disease progression|40|||
30627887|NCT01197560|58639759|FG001|Overall Study|Disease progression|35|||
30627888|NCT01197560|58639758|FG000|Overall Study|Miscellaneous|4|||
30627889|NCT01197560|58639759|FG001|Overall Study|Miscellaneous|3|||
30627890|NCT01197560|58639758|FG000|Overall Study|Missing|0|||
30627891|NCT01197560|58639759|FG001|Overall Study|Missing|1|||
30627892|NCT01133405|58639776|FG000|Period 1|Withdrawal by Subject|0|||
30627893|NCT01133405|58639777|FG001|Period 1|Withdrawal by Subject|1|||
30627894|NCT01133405|58639778|FG002|Period 1|Withdrawal by Subject|0|||
30627895|NCT01133405|58639779|FG003|Period 1|Withdrawal by Subject|1|||
30627896|NCT01133405|58639780|FG004|Period 1|Withdrawal by Subject|0|||
30627897|NCT01133405|58639781|FG005|Period 1|Withdrawal by Subject|1|||
30627898|NCT01133405|58639782|FG006|Period 1|Withdrawal by Subject|0|||
30627899|NCT01133405|58639783|FG007|Period 1|Withdrawal by Subject|0|||
30627900|NCT01133405|58639784|FG008|Period 1|Withdrawal by Subject|0|||
30627901|NCT01133405|58639785|FG009|Period 1|Withdrawal by Subject|0|||
30627902|NCT01133405|58639776|FG000|Period 1|Physician Decision|0|||
30627903|NCT01133405|58639777|FG001|Period 1|Physician Decision|0|||
30627904|NCT01133405|58639778|FG002|Period 1|Physician Decision|0|||
30627905|NCT01133405|58639779|FG003|Period 1|Physician Decision|1|||
30627906|NCT01133405|58639780|FG004|Period 1|Physician Decision|0|||
30627907|NCT01133405|58639781|FG005|Period 1|Physician Decision|0|||
30627908|NCT01133405|58639782|FG006|Period 1|Physician Decision|0|||
30627909|NCT01133405|58639783|FG007|Period 1|Physician Decision|0|||
30627910|NCT01133405|58639784|FG008|Period 1|Physician Decision|0|||
30627911|NCT01133405|58639785|FG009|Period 1|Physician Decision|0|||
30627912|NCT01133405|58639776|FG000|Period 1|Discontinued after randomization|1|||
30627913|NCT01133405|58639777|FG001|Period 1|Discontinued after randomization|0|||
30627914|NCT01133405|58639778|FG002|Period 1|Discontinued after randomization|0|||
30627915|NCT01133405|58639779|FG003|Period 1|Discontinued after randomization|0|||
30627916|NCT01133405|58639780|FG004|Period 1|Discontinued after randomization|0|||
30627917|NCT01133405|58639781|FG005|Period 1|Discontinued after randomization|0|||
30950625|NCT01928381|58997588|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
30627918|NCT01133405|58639782|FG006|Period 1|Discontinued after randomization|1|||
30627919|NCT01133405|58639783|FG007|Period 1|Discontinued after randomization|0|||
30627920|NCT01133405|58639784|FG008|Period 1|Discontinued after randomization|0|||
30627921|NCT01133405|58639785|FG009|Period 1|Discontinued after randomization|0|||
30627922|NCT01133405|58639776|FG000|Period 1|Received drug only in period 2|0|||
30627923|NCT01133405|58639777|FG001|Period 1|Received drug only in period 2|1|||
30627924|NCT01133405|58639778|FG002|Period 1|Received drug only in period 2|0|||
30627925|NCT01133405|58639779|FG003|Period 1|Received drug only in period 2|2|||
30627926|NCT01133405|58639780|FG004|Period 1|Received drug only in period 2|0|||
30627927|NCT01133405|58639781|FG005|Period 1|Received drug only in period 2|1|||
30627928|NCT01133405|58639782|FG006|Period 1|Received drug only in period 2|0|||
30627929|NCT01133405|58639783|FG007|Period 1|Received drug only in period 2|0|||
30627930|NCT01133405|58639784|FG008|Period 1|Received drug only in period 2|0|||
30627931|NCT01133405|58639785|FG009|Period 1|Received drug only in period 2|0|||
30627932|NCT01133405|58639776|FG000|Period 1|Received drug only in period 3|0|||
30627933|NCT01133405|58639777|FG001|Period 1|Received drug only in period 3|1|||
30847966|NCT02418754|58873818|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
30847967|NCT02418754|58873819|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
30847968|NCT02418754|58873815|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
30847969|NCT02418754|58873816|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
30847970|NCT02418754|58873817|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
30847971|NCT02418754|58873818|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
30847972|NCT02418754|58873819|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
30847973|NCT02418754|58873815|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
30847974|NCT02418754|58873816|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
30847975|NCT02418754|58873817|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
30847976|NCT02418754|58873818|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
30627934|NCT01133405|58639778|FG002|Period 1|Received drug only in period 3|1|||
30627935|NCT01133405|58639779|FG003|Period 1|Received drug only in period 3|0|||
30627936|NCT01133405|58639780|FG004|Period 1|Received drug only in period 3|0|||
30627937|NCT01133405|58639781|FG005|Period 1|Received drug only in period 3|0|||
30627938|NCT01133405|58639782|FG006|Period 1|Received drug only in period 3|0|||
30627939|NCT01133405|58639783|FG007|Period 1|Received drug only in period 3|0|||
30627940|NCT01133405|58639784|FG008|Period 1|Received drug only in period 3|0|||
30627941|NCT01133405|58639785|FG009|Period 1|Received drug only in period 3|0|||
30627942|NCT01133405|58639776|FG000|Period 2|Adverse Event|0|||
30627943|NCT01133405|58639777|FG001|Period 2|Adverse Event|0|||
30627944|NCT01133405|58639778|FG002|Period 2|Adverse Event|1|||
30627945|NCT01133405|58639779|FG003|Period 2|Adverse Event|0|||
30627946|NCT01133405|58639780|FG004|Period 2|Adverse Event|0|||
30627947|NCT01133405|58639781|FG005|Period 2|Adverse Event|0|||
30627948|NCT01133405|58639782|FG006|Period 2|Adverse Event|0|||
30627949|NCT01133405|58639783|FG007|Period 2|Adverse Event|0|||
30627950|NCT01133405|58639784|FG008|Period 2|Adverse Event|0|||
30627951|NCT01133405|58639785|FG009|Period 2|Adverse Event|0|||
30627952|NCT01133405|58639776|FG000|Period 2|Withdrawal by Subject|0|||
30627953|NCT01133405|58639777|FG001|Period 2|Withdrawal by Subject|0|||
30627954|NCT01133405|58639778|FG002|Period 2|Withdrawal by Subject|0|||
30627955|NCT01133405|58639779|FG003|Period 2|Withdrawal by Subject|1|||
30627956|NCT01133405|58639780|FG004|Period 2|Withdrawal by Subject|0|||
30627957|NCT01133405|58639781|FG005|Period 2|Withdrawal by Subject|1|||
30627958|NCT01133405|58639782|FG006|Period 2|Withdrawal by Subject|0|||
30627959|NCT01133405|58639783|FG007|Period 2|Withdrawal by Subject|0|||
30627960|NCT01133405|58639784|FG008|Period 2|Withdrawal by Subject|0|||
30627961|NCT01133405|58639785|FG009|Period 2|Withdrawal by Subject|0|||
30627962|NCT01133405|58639776|FG000|Period 2|Entry Criteria Not Met|0|||
30627963|NCT01133405|58639777|FG001|Period 2|Entry Criteria Not Met|1|||
30627964|NCT01133405|58639778|FG002|Period 2|Entry Criteria Not Met|0|||
30627965|NCT01133405|58639779|FG003|Period 2|Entry Criteria Not Met|0|||
30627966|NCT01133405|58639780|FG004|Period 2|Entry Criteria Not Met|0|||
30627967|NCT01133405|58639781|FG005|Period 2|Entry Criteria Not Met|0|||
30627968|NCT01133405|58639782|FG006|Period 2|Entry Criteria Not Met|0|||
30627969|NCT01133405|58639783|FG007|Period 2|Entry Criteria Not Met|0|||
30627970|NCT01133405|58639784|FG008|Period 2|Entry Criteria Not Met|0|||
30627971|NCT01133405|58639785|FG009|Period 2|Entry Criteria Not Met|0|||
30627972|NCT01133405|58639776|FG000|Period 2|Physician Decision|0|||
30627973|NCT01133405|58639777|FG001|Period 2|Physician Decision|0|||
30627974|NCT01133405|58639778|FG002|Period 2|Physician Decision|0|||
30627975|NCT01133405|58639779|FG003|Period 2|Physician Decision|0|||
30763543|NCT00363545|58772295|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
30763544|NCT00363545|58772296|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
30763545|NCT00363545|58772295|FG000|Overall Study|Others|1|||
30763546|NCT00363545|58772296|FG001|Overall Study|Others|0|||
30763547|NCT03351244|58772305|FG000|Overall Study|Adverse Event|7|||
30763548|NCT03351244|58772306|FG001|Overall Study|Adverse Event|11|||
30763549|NCT03351244|58772307|FG002|Overall Study|Adverse Event|12|||
30847977|NCT02418754|58873819|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
30847978|NCT02418754|58873815|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
30847979|NCT02418754|58873816|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
30847980|NCT02418754|58873817|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
30847981|NCT02418754|58873818|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
30847982|NCT02418754|58873819|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
30847983|NCT02418754|58873815|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
30847984|NCT02418754|58873816|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
30847985|NCT02418754|58873817|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
30627976|NCT01133405|58639780|FG004|Period 2|Physician Decision|0|||
30627977|NCT01133405|58639781|FG005|Period 2|Physician Decision|1|||
30627978|NCT01133405|58639782|FG006|Period 2|Physician Decision|0|||
30627979|NCT01133405|58639783|FG007|Period 2|Physician Decision|0|||
30627980|NCT01133405|58639784|FG008|Period 2|Physician Decision|0|||
30627981|NCT01133405|58639785|FG009|Period 2|Physician Decision|0|||
30627982|NCT01196078|58639817|FG000|Overall Study|Withdrawal by Subject|3|||
30627983|NCT01196078|58639818|FG001|Overall Study|Withdrawal by Subject|5|||
30763550|NCT03351244|58772305|FG000|Overall Study|Investigator's decision|0|||
30763551|NCT03351244|58772306|FG001|Overall Study|Investigator's decision|0|||
30627984|NCT01196078|58639817|FG000|Overall Study|Adverse Event|4|||
30627985|NCT01196078|58639818|FG001|Overall Study|Adverse Event|4|||
30627986|NCT01196078|58639817|FG000|Overall Study|Protocol Violation|2|||
30627987|NCT01196078|58639818|FG001|Overall Study|Protocol Violation|1|||
30627988|NCT01196078|58639817|FG000|Overall Study|Lack of Efficacy|17|||
30763552|NCT03351244|58772307|FG002|Overall Study|Investigator's decision|2|||
30627989|NCT01196078|58639818|FG001|Overall Study|Lack of Efficacy|23|||
30763553|NCT03351244|58772305|FG000|Overall Study|System error|0|||
30950626|NCT01928381|58997589|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
30950627|NCT01928381|58997583|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
30950628|NCT01928381|58997584|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
30950629|NCT01928381|58997585|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
30950630|NCT01928381|58997586|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
30950631|NCT01928381|58997587|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
30950632|NCT01928381|58997588|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
30950633|NCT01928381|58997589|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
30950634|NCT01928381|58997583|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
30950635|NCT01928381|58997584|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
30950636|NCT01928381|58997585|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
30950637|NCT01928381|58997586|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
30950638|NCT01928381|58997587|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
30950639|NCT01928381|58997588|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
30950640|NCT01928381|58997589|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
30950641|NCT01928381|58997583|FG000|Part 1 - Pain Training|Protocol Violation|1|||
30950642|NCT01928381|58997584|FG001|Part 1 - Pain Training|Protocol Violation|0|||
30847986|NCT02418754|58873818|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
30847987|NCT02418754|58873819|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
30950643|NCT01928381|58997585|FG002|Part 1 - Pain Training|Protocol Violation|0|||
30950644|NCT01928381|58997586|FG003|Part 1 - Pain Training|Protocol Violation|0|||
30950645|NCT01928381|58997587|FG004|Part 1 - Pain Training|Protocol Violation|0|||
30950646|NCT01928381|58997588|FG005|Part 1 - Pain Training|Protocol Violation|0|||
30950647|NCT01928381|58997589|FG006|Part 1 - Pain Training|Protocol Violation|0|||
30950648|NCT01928381|58997583|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
30950649|NCT01928381|58997584|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
30627990|NCT01196078|58639817|FG000|Overall Study|Lost to Follow-up|1|||
30763554|NCT03351244|58772306|FG001|Overall Study|System error|0|||
30763555|NCT03351244|58772307|FG002|Overall Study|System error|2|||
30763556|NCT03351244|58772305|FG000|Overall Study|COVID-19 restrictions|3|||
30763557|NCT03351244|58772306|FG001|Overall Study|COVID-19 restrictions|0|||
30763558|NCT03351244|58772307|FG002|Overall Study|COVID-19 restrictions|1|||
30763559|NCT03351244|58772305|FG000|Overall Study|Non-compliance|2|||
30763560|NCT03351244|58772306|FG001|Overall Study|Non-compliance|5|||
30763561|NCT03351244|58772307|FG002|Overall Study|Non-compliance|0|||
30763562|NCT03351244|58772305|FG000|Overall Study|Withdrawal by Subject|11|||
30763563|NCT03351244|58772306|FG001|Overall Study|Withdrawal by Subject|16|||
30763564|NCT03351244|58772307|FG002|Overall Study|Withdrawal by Subject|13|||
30763565|NCT03351244|58772305|FG000|Overall Study|Lost to Follow-up|2|||
30763566|NCT03351244|58772306|FG001|Overall Study|Lost to Follow-up|6|||
30763567|NCT03351244|58772307|FG002|Overall Study|Lost to Follow-up|4|||
30763568|NCT03351244|58772305|FG000|Overall Study|Protocol Violation|2|||
30763569|NCT03351244|58772306|FG001|Overall Study|Protocol Violation|2|||
30763570|NCT03351244|58772307|FG002|Overall Study|Protocol Violation|0|||
30763571|NCT03386032|58772320|FG000|Overall Study|Lack of Efficacy|6|||
30763572|NCT03386032|58772321|FG001|Overall Study|Lack of Efficacy|2|||
30763573|NCT03386032|58772322|FG002|Overall Study|Lack of Efficacy|0|||
30763574|NCT03386032|58772320|FG000|Overall Study|Adverse Event|2|||
30763575|NCT03386032|58772321|FG001|Overall Study|Adverse Event|2|||
30763576|NCT03386032|58772322|FG002|Overall Study|Adverse Event|0|||
30763577|NCT03386032|58772320|FG000|Overall Study|Withdrawal by Subject|1|||
30847988|NCT02418754|58873815|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
30847989|NCT02418754|58873816|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
30847990|NCT02418754|58873817|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
30847991|NCT02418754|58873818|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
30847992|NCT02418754|58873819|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
30847993|NCT02418754|58873815|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
30847994|NCT02418754|58873816|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
30847995|NCT02418754|58873817|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
30847996|NCT02418754|58873818|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
30847997|NCT02418754|58873819|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
30847998|NCT02418754|58873815|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
30847999|NCT02418754|58873816|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
30950650|NCT01928381|58997585|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
30950651|NCT01928381|58997586|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
30763578|NCT03386032|58772321|FG001|Overall Study|Withdrawal by Subject|0|||
30763579|NCT03386032|58772322|FG002|Overall Study|Withdrawal by Subject|0|||
30763580|NCT03386032|58772320|FG000|Overall Study|Lost to Follow-up|9|||
30950652|NCT01928381|58997587|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
30950653|NCT01928381|58997588|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
30950654|NCT01928381|58997589|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
30627991|NCT01196078|58639818|FG001|Overall Study|Lost to Follow-up|0|||
30627992|NCT01196078|58639817|FG000|Overall Study|Death|6|||
30627993|NCT01196078|58639818|FG001|Overall Study|Death|4|||
30627994|NCT01078584|58639824|FG000|Overall Study|Final Status Unknown|1073|||
30627995|NCT01078584|58639824|FG000|Overall Study|Lost to Follow-up|670|||
30627996|NCT01078584|58639824|FG000|Overall Study|Non-serious Adverse Event|577|||
30627997|NCT01078584|58639824|FG000|Overall Study|Withdrawal of Consent|244|||
30627998|NCT01078584|58639824|FG000|Overall Study|Physician Withdrew from Study|90|||
30627999|NCT01078584|58639824|FG000|Overall Study|Non-compliance|67|||
30628000|NCT01078584|58639824|FG000|Overall Study|Blood Pressure Controlled|49|||
30628001|NCT01078584|58639824|FG000|Overall Study|Physician Switched Medication|26|||
30628002|NCT01078584|58639824|FG000|Overall Study|Physician Discontinued Patient|12|||
30628003|NCT01078584|58639824|FG000|Overall Study|Lack of Efficacy|98|||
30628004|NCT01078584|58639824|FG000|Overall Study|Protocol Violation|75|||
30628005|NCT01078584|58639824|FG000|Overall Study|Serious Adverse Event|27|||
30628006|NCT01078584|58639824|FG000|Overall Study|Multiple Reasons|2|||
30628007|NCT01133171|58639844|FG000|Overall Study|Withdrawal by Subject|1|||
30628008|NCT01133171|58639845|FG001|Overall Study|Withdrawal by Subject|2|||
30628009|NCT01133171|58639846|FG002|Overall Study|Withdrawal by Subject|0|||
30628010|NCT01195844|58639854|FG000|Overall Study|Fecal sample not collected|40|||
30628011|NCT01132547|58639870|FG000|Overall Study|Withdrawal by Subject|3|||
30628012|NCT01132547|58639871|FG001|Overall Study|Withdrawal by Subject|1|||
30950655|NCT01928381|58997583|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
30950656|NCT01928381|58997584|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
30950657|NCT01928381|58997585|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
30950658|NCT01928381|58997586|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
30950659|NCT01928381|58997587|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
30950660|NCT01928381|58997588|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
30950661|NCT01928381|58997589|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
30950662|NCT01928381|58997583|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
30950663|NCT01928381|58997584|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
30950664|NCT01928381|58997585|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
30628013|NCT01132547|58639870|FG000|Overall Study|Death|1|||
30628014|NCT01132547|58639871|FG001|Overall Study|Death|0|||
30628015|NCT01194830|58639879|FG000|Overall Study|Adverse Event|3|||
30628016|NCT01194830|58639880|FG001|Overall Study|Adverse Event|2|||
30628017|NCT01194830|58639879|FG000|Overall Study|Protocol Violation|5|||
30628018|NCT01194830|58639880|FG001|Overall Study|Protocol Violation|4|||
30628019|NCT01194830|58639879|FG000|Overall Study|Lost to Follow-up|9|||
30628020|NCT01194830|58639880|FG001|Overall Study|Lost to Follow-up|7|||
30628021|NCT01194830|58639879|FG000|Overall Study|Withdrawal by Subject|2|||
30628022|NCT01194830|58639880|FG001|Overall Study|Withdrawal by Subject|1|||
30628023|NCT01194830|58639879|FG000|Overall Study|Lack of Efficacy|1|||
30628024|NCT01194830|58639880|FG001|Overall Study|Lack of Efficacy|1|||
30628025|NCT01194830|58639879|FG000|Overall Study|Non-compliance issues|4|||
30628026|NCT01194830|58639880|FG001|Overall Study|Non-compliance issues|4|||
30628027|NCT01194830|58639879|FG000|Overall Study|Other Reason|12|||
30628028|NCT01194830|58639880|FG001|Overall Study|Other Reason|8|||
30628029|NCT01194440|58639886|FG000|Baseline (First Dose)|Reason not specified|4|||
30628030|NCT01194440|58639886|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
30628031|NCT01194440|58639886|FG000|Baseline (First Dose)|Change in therapy|1|||
30628032|NCT01194440|58639886|FG000|Baseline (First Dose)|Adverse Event|1|||
30628033|NCT01194440|58639886|FG000|6-months (2nd Dose)|Change in therapy|4|||
30628034|NCT00951015|58639895|FG000|Randomization Phase 96 Week|Adverse Event|1|||
30628035|NCT00951015|58639896|FG001|Randomization Phase 96 Week|Adverse Event|1|||
30628036|NCT00951015|58639897|FG002|Randomization Phase 96 Week|Adverse Event|2|||
30628037|NCT00951015|58639898|FG003|Randomization Phase 96 Week|Adverse Event|5|||
30628038|NCT00951015|58639899|FG004|Randomization Phase 96 Week|Adverse Event|0|||
30628039|NCT00951015|58639895|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
30628040|NCT00951015|58639896|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
30628041|NCT00951015|58639897|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
30628042|NCT00951015|58639898|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
30628043|NCT00951015|58639899|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
30628044|NCT00951015|58639895|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
30628045|NCT00951015|58639896|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
30628046|NCT00951015|58639897|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
30628047|NCT00951015|58639898|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
30628048|NCT00951015|58639899|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
30628049|NCT00951015|58639895|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
30628050|NCT00951015|58639896|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
30628051|NCT00951015|58639897|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
30628052|NCT00951015|58639898|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
30628053|NCT00951015|58639899|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
30628054|NCT00951015|58639895|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
30628055|NCT00951015|58639896|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
30628056|NCT00951015|58639897|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
30628057|NCT00951015|58639898|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
30628058|NCT00951015|58639899|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
30628059|NCT00951015|58639895|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
30628060|NCT00951015|58639896|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
30628061|NCT00951015|58639897|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
30628062|NCT00951015|58639898|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
30628063|NCT00951015|58639899|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
30628064|NCT00951015|58639895|FG000|Open-label Phase|Adverse Event|0|||
30628065|NCT00951015|58639896|FG001|Open-label Phase|Adverse Event|0|||
30628066|NCT00951015|58639897|FG002|Open-label Phase|Adverse Event|0|||
30628067|NCT00951015|58639898|FG003|Open-label Phase|Adverse Event|0|||
30628068|NCT00951015|58639899|FG004|Open-label Phase|Adverse Event|3|||
30628069|NCT00951015|58639895|FG000|Open-label Phase|Lack of Efficacy|0|||
30628070|NCT00951015|58639896|FG001|Open-label Phase|Lack of Efficacy|0|||
30628071|NCT00951015|58639897|FG002|Open-label Phase|Lack of Efficacy|0|||
30628072|NCT00951015|58639898|FG003|Open-label Phase|Lack of Efficacy|0|||
30628073|NCT00951015|58639899|FG004|Open-label Phase|Lack of Efficacy|1|||
30628074|NCT00951015|58639895|FG000|Open-label Phase|Protocol Violation|0|||
30628075|NCT00951015|58639896|FG001|Open-label Phase|Protocol Violation|0|||
30628076|NCT00951015|58639897|FG002|Open-label Phase|Protocol Violation|0|||
30628077|NCT00951015|58639898|FG003|Open-label Phase|Protocol Violation|0|||
30628078|NCT00951015|58639899|FG004|Open-label Phase|Protocol Violation|12|||
30628079|NCT00951015|58639895|FG000|Open-label Phase|Lost to Follow-up|0|||
30628080|NCT00951015|58639896|FG001|Open-label Phase|Lost to Follow-up|0|||
30628081|NCT00951015|58639897|FG002|Open-label Phase|Lost to Follow-up|0|||
30628082|NCT00951015|58639898|FG003|Open-label Phase|Lost to Follow-up|0|||
30628083|NCT00951015|58639899|FG004|Open-label Phase|Lost to Follow-up|12|||
30628084|NCT00951015|58639895|FG000|Open-label Phase|Withdrawal by Subject|0|||
30628085|NCT00951015|58639896|FG001|Open-label Phase|Withdrawal by Subject|0|||
30628086|NCT00951015|58639897|FG002|Open-label Phase|Withdrawal by Subject|0|||
30628087|NCT00951015|58639898|FG003|Open-label Phase|Withdrawal by Subject|0|||
30628088|NCT00951015|58639899|FG004|Open-label Phase|Withdrawal by Subject|14|||
30628089|NCT00951015|58639895|FG000|Open-label Phase|Physician Decision|0|||
30628090|NCT00951015|58639896|FG001|Open-label Phase|Physician Decision|0|||
30628091|NCT00951015|58639897|FG002|Open-label Phase|Physician Decision|0|||
30763581|NCT03386032|58772321|FG001|Overall Study|Lost to Follow-up|3|||
30763582|NCT03386032|58772322|FG002|Overall Study|Lost to Follow-up|0|||
30763583|NCT00077610|58772333|FG000|Overall Study|Adverse Event|9|||
30763584|NCT00077610|58772334|FG001|Overall Study|Adverse Event|7|||
30763585|NCT00077610|58772335|FG002|Overall Study|Adverse Event|1|||
30763586|NCT00077610|58772333|FG000|Overall Study|Lost to Follow-up|0|||
30763587|NCT00077610|58772334|FG001|Overall Study|Lost to Follow-up|1|||
30763588|NCT00077610|58772335|FG002|Overall Study|Lost to Follow-up|2|||
30763589|NCT00077610|58772333|FG000|Overall Study|Withdrawal by Subject|4|||
30628092|NCT00951015|58639898|FG003|Open-label Phase|Physician Decision|0|||
30628093|NCT00951015|58639899|FG004|Open-label Phase|Physician Decision|8|||
30628094|NCT01139021|58639928|FG000|Overall Study|Adverse Event|0|||
30628095|NCT01139021|58639929|FG001|Overall Study|Adverse Event|0|||
30628096|NCT01139021|58639930|FG002|Overall Study|Adverse Event|0|||
30628097|NCT01139021|58639931|FG003|Overall Study|Adverse Event|0|||
30628098|NCT01139021|58639932|FG004|Overall Study|Adverse Event|1|||
30628099|NCT01139021|58639933|FG005|Overall Study|Adverse Event|0|||
30628100|NCT01139021|58639928|FG000|Overall Study|Lost to Follow-up|0|||
30848000|NCT02418754|58873817|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
30628101|NCT01139021|58639929|FG001|Overall Study|Lost to Follow-up|0|||
30628102|NCT01139021|58639930|FG002|Overall Study|Lost to Follow-up|0|||
30628103|NCT01139021|58639931|FG003|Overall Study|Lost to Follow-up|0|||
30628104|NCT01139021|58639932|FG004|Overall Study|Lost to Follow-up|2|||
30628105|NCT01139021|58639933|FG005|Overall Study|Lost to Follow-up|0|||
30628106|NCT01139021|58639928|FG000|Overall Study|Protocol Violation|1|||
30628107|NCT01139021|58639929|FG001|Overall Study|Protocol Violation|0|||
30628108|NCT01139021|58639930|FG002|Overall Study|Protocol Violation|0|||
30628109|NCT01139021|58639931|FG003|Overall Study|Protocol Violation|0|||
30628110|NCT01139021|58639932|FG004|Overall Study|Protocol Violation|2|||
30628111|NCT01139021|58639933|FG005|Overall Study|Protocol Violation|0|||
30628112|NCT01139021|58639928|FG000|Overall Study|Withdrawal by Subject|0|||
30628113|NCT01139021|58639929|FG001|Overall Study|Withdrawal by Subject|0|||
30628114|NCT01139021|58639930|FG002|Overall Study|Withdrawal by Subject|0|||
30628115|NCT01139021|58639931|FG003|Overall Study|Withdrawal by Subject|1|||
30628116|NCT01139021|58639932|FG004|Overall Study|Withdrawal by Subject|4|||
30628117|NCT01139021|58639933|FG005|Overall Study|Withdrawal by Subject|0|||
30628118|NCT01193660|58639951|FG000|Overall Study|Withdrawal by Subject|2|||
30628119|NCT01193660|58639952|FG001|Overall Study|Withdrawal by Subject|3|||
30628120|NCT01193660|58639953|FG002|Overall Study|Withdrawal by Subject|1|||
30628121|NCT01193660|58639951|FG000|Overall Study|Death|1|||
30628122|NCT01193660|58639952|FG001|Overall Study|Death|0|||
30628123|NCT01193660|58639953|FG002|Overall Study|Death|0|||
30628124|NCT01193660|58639951|FG000|Overall Study|Physician Decision|1|||
30628125|NCT01193660|58639952|FG001|Overall Study|Physician Decision|0|||
30628126|NCT01193660|58639953|FG002|Overall Study|Physician Decision|1|||
30628127|NCT01076166|58639961|FG000|Overall Study|Adverse Event|3|||
30628128|NCT01076166|58639961|FG000|Overall Study|Symptoms improved/resolved|6|||
30628129|NCT01193582|58639972|FG000|Vaccination Series|Withdrawal by Subject|11|||
30628130|NCT01193582|58639973|FG001|Vaccination Series|Withdrawal by Subject|13|||
30628131|NCT01193582|58639974|FG002|Vaccination Series|Withdrawal by Subject|8|||
30950665|NCT01928381|58997586|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
30950666|NCT01928381|58997587|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
30950667|NCT01928381|58997588|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
30950668|NCT01928381|58997589|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
30950669|NCT01928381|58997583|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
30950670|NCT01928381|58997584|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
30950671|NCT01928381|58997585|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
30950672|NCT01928381|58997586|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
30950673|NCT01928381|58997587|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
30950674|NCT01928381|58997588|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
30950675|NCT01928381|58997589|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
30950676|NCT01928381|58997583|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
30950677|NCT01928381|58997584|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
30950678|NCT01928381|58997585|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
30950679|NCT01928381|58997586|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
30950680|NCT01928381|58997587|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
30950681|NCT01928381|58997588|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
30950682|NCT01928381|58997589|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
30950683|NCT01928381|58997583|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
30950684|NCT01928381|58997584|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
30950685|NCT01928381|58997585|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
30628132|NCT01193582|58639975|FG003|Vaccination Series|Withdrawal by Subject|3|||
30628133|NCT01193582|58639972|FG000|12 Month Follow-up|Death|0|||
30628134|NCT01193582|58639973|FG001|12 Month Follow-up|Death|0|||
30628135|NCT01193582|58639974|FG002|12 Month Follow-up|Death|1|||
30628136|NCT01193582|58639975|FG003|12 Month Follow-up|Death|0|||
30628137|NCT01193582|58639972|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
30628138|NCT01193582|58639973|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
30628139|NCT01193582|58639974|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
30628140|NCT01193582|58639975|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
30628141|NCT00945477|58639987|FG000|Overall Study|Adverse Event|3|||
30628142|NCT00945477|58639987|FG000|Overall Study|Lack of Efficacy|2|||
30628143|NCT00945477|58639987|FG000|Overall Study|Withdrawal by Subject|1|||
30628144|NCT01076088|58639998|FG000|Overall Study|Adverse Event|1|||
30628145|NCT01076088|58639999|FG001|Overall Study|Adverse Event|6|||
30628146|NCT01076088|58640000|FG002|Overall Study|Adverse Event|3|||
30628147|NCT01076088|58640001|FG003|Overall Study|Adverse Event|2|||
30628148|NCT01076088|58640002|FG004|Overall Study|Adverse Event|3|||
30628149|NCT01076088|58640003|FG005|Overall Study|Adverse Event|3|||
30628150|NCT01076088|58639998|FG000|Overall Study|Lost to Follow-up|1|||
30628151|NCT01076088|58639999|FG001|Overall Study|Lost to Follow-up|1|||
30628152|NCT01076088|58640000|FG002|Overall Study|Lost to Follow-up|0|||
30628153|NCT01076088|58640001|FG003|Overall Study|Lost to Follow-up|1|||
30628154|NCT01076088|58640002|FG004|Overall Study|Lost to Follow-up|1|||
30628155|NCT01076088|58640003|FG005|Overall Study|Lost to Follow-up|2|||
30628156|NCT01076088|58639998|FG000|Overall Study|Non-compliance with study drug|0|||
30628157|NCT01076088|58639999|FG001|Overall Study|Non-compliance with study drug|0|||
30628158|NCT01076088|58640000|FG002|Overall Study|Non-compliance with study drug|0|||
30628159|NCT01076088|58640001|FG003|Overall Study|Non-compliance with study drug|1|||
30628160|NCT01076088|58640002|FG004|Overall Study|Non-compliance with study drug|0|||
30628161|NCT01076088|58640003|FG005|Overall Study|Non-compliance with study drug|0|||
30950686|NCT01928381|58997586|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
30950687|NCT01928381|58997587|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
30950688|NCT01928381|58997588|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
30950689|NCT01928381|58997589|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
30950690|NCT01928381|58997583|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
30628162|NCT01076088|58639998|FG000|Overall Study|Physician Decision|1|||
30628163|NCT01076088|58639999|FG001|Overall Study|Physician Decision|3|||
30950691|NCT01928381|58997584|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
30950692|NCT01928381|58997585|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
30950693|NCT01928381|58997586|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
30950694|NCT01928381|58997587|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
30628164|NCT01076088|58640000|FG002|Overall Study|Physician Decision|0|||
30628165|NCT01076088|58640001|FG003|Overall Study|Physician Decision|1|||
30628166|NCT01076088|58640002|FG004|Overall Study|Physician Decision|1|||
30628167|NCT01076088|58640003|FG005|Overall Study|Physician Decision|0|||
30628168|NCT01076088|58639998|FG000|Overall Study|Withdrawal by Subject|8|||
30628169|NCT01076088|58639999|FG001|Overall Study|Withdrawal by Subject|8|||
30628170|NCT01076088|58640000|FG002|Overall Study|Withdrawal by Subject|14|||
30628171|NCT01076088|58640001|FG003|Overall Study|Withdrawal by Subject|10|||
30628172|NCT01076088|58640002|FG004|Overall Study|Withdrawal by Subject|11|||
30628173|NCT01076088|58640003|FG005|Overall Study|Withdrawal by Subject|17|||
30628174|NCT01076088|58639998|FG000|Overall Study|Other protocol specified criteria|0|||
30628175|NCT01076088|58639999|FG001|Overall Study|Other protocol specified criteria|0|||
30628176|NCT01076088|58640000|FG002|Overall Study|Other protocol specified criteria|0|||
30628177|NCT01076088|58640001|FG003|Overall Study|Other protocol specified criteria|0|||
30628178|NCT01076088|58640002|FG004|Overall Study|Other protocol specified criteria|0|||
30628179|NCT01076088|58640003|FG005|Overall Study|Other protocol specified criteria|1|||
30628180|NCT01193348|58640018|FG000|Screening Period|Screen Failure|5|||
30628181|NCT01193348|58640018|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
30628182|NCT01193348|58640018|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
30628183|NCT01193348|58640018|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
30628184|NCT01193348|58640018|FG000|Extension Treatment Period|Physician Decision|1|||
30628185|NCT01193348|58640018|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
30628186|NCT00945321|58640027|FG000|Period 1|Adverse Event|0|||
30628187|NCT00945321|58640028|FG001|Period 1|Adverse Event|0|||
30628188|NCT00945321|58640029|FG002|Period 1|Adverse Event|0|||
30628189|NCT00945321|58640030|FG003|Period 1|Adverse Event|0|||
30628190|NCT00945321|58640031|FG004|Period 1|Adverse Event|1|||
30628191|NCT00945321|58640032|FG005|Period 1|Adverse Event|0|||
30628192|NCT00945321|58640027|FG000|Period 4|Lost to Follow-up|0|||
30628193|NCT00945321|58640028|FG001|Period 4|Lost to Follow-up|0|||
30628194|NCT00945321|58640029|FG002|Period 4|Lost to Follow-up|0|||
30628195|NCT00945321|58640030|FG003|Period 4|Lost to Follow-up|0|||
30628196|NCT00945321|58640031|FG004|Period 4|Lost to Follow-up|0|||
30628197|NCT00945321|58640032|FG005|Period 4|Lost to Follow-up|1|||
30628198|NCT00945243|58640050|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
30628199|NCT01192412|58640056|FG000|Overall Study|Lost to Follow-up|2|||
30628200|NCT01192412|58640057|FG001|Overall Study|Lost to Follow-up|1|||
30628201|NCT01192412|58640056|FG000|Overall Study|Withdrawal by Subject|2|||
30628202|NCT01192412|58640057|FG001|Overall Study|Withdrawal by Subject|1|||
30628203|NCT01192178|58640065|FG000|Overall Study|Withdrawal by Subject|6|||
30628204|NCT01192178|58640066|FG001|Overall Study|Withdrawal by Subject|10|||
30628205|NCT01192178|58640065|FG000|Overall Study|Protocol Violation|10|||
30628206|NCT01192178|58640066|FG001|Overall Study|Protocol Violation|3|||
30628207|NCT01192178|58640065|FG000|Overall Study|Physician Decision|2|||
30628208|NCT01192178|58640066|FG001|Overall Study|Physician Decision|4|||
30628209|NCT01192178|58640065|FG000|Overall Study|Lost to Follow-up|3|||
30628210|NCT01192178|58640066|FG001|Overall Study|Lost to Follow-up|3|||
30628211|NCT01192178|58640065|FG000|Overall Study|Adverse Event|2|||
30628212|NCT01192178|58640066|FG001|Overall Study|Adverse Event|1|||
30628213|NCT01192178|58640065|FG000|Overall Study|Lack of Efficacy|1|||
30763590|NCT00077610|58772334|FG001|Overall Study|Withdrawal by Subject|10|||
30763591|NCT00077610|58772335|FG002|Overall Study|Withdrawal by Subject|6|||
30763592|NCT00077610|58772333|FG000|Overall Study|Death|17|||
30763593|NCT00077610|58772334|FG001|Overall Study|Death|13|||
30763594|NCT00077610|58772335|FG002|Overall Study|Death|13|||
30950695|NCT01928381|58997588|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
30950696|NCT01928381|58997589|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
30950697|NCT01928381|58997583|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
30950698|NCT01928381|58997584|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
30950699|NCT01928381|58997585|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
30950700|NCT01928381|58997586|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
30950701|NCT01928381|58997587|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
30628214|NCT01192178|58640066|FG001|Overall Study|Lack of Efficacy|2|||
30628215|NCT01192100|58640074|FG000|Overall Study|Withdrawal by Subject|0|||
30628216|NCT01192100|58640075|FG001|Overall Study|Withdrawal by Subject|0|||
30628217|NCT01192100|58640076|FG002|Overall Study|Withdrawal by Subject|0|||
30628218|NCT01192100|58640077|FG003|Overall Study|Withdrawal by Subject|0|||
30628219|NCT01192100|58640078|FG004|Overall Study|Withdrawal by Subject|1|||
30628220|NCT01192100|58640079|FG005|Overall Study|Withdrawal by Subject|0|||
30628221|NCT01192100|58640074|FG000|Overall Study|Protocol Violation|0|||
30628222|NCT01192100|58640075|FG001|Overall Study|Protocol Violation|0|||
30628223|NCT01192100|58640076|FG002|Overall Study|Protocol Violation|0|||
30628224|NCT01192100|58640077|FG003|Overall Study|Protocol Violation|1|||
30628225|NCT01192100|58640078|FG004|Overall Study|Protocol Violation|0|||
30628226|NCT01192100|58640079|FG005|Overall Study|Protocol Violation|0|||
30628227|NCT00869401|58640092|FG000|Overall Study|Withdrawal by Subject|0|||
30628228|NCT00869401|58640093|FG001|Overall Study|Withdrawal by Subject|0|||
30628229|NCT00869401|58640094|FG002|Overall Study|Withdrawal by Subject|0|||
30628230|NCT00869401|58640095|FG003|Overall Study|Withdrawal by Subject|5|||
30628231|NCT00869401|58640096|FG004|Overall Study|Withdrawal by Subject|3|||
30628232|NCT01076010|58640111|FG000|Overall Study|Death|15|||
30628233|NCT01076010|58640112|FG001|Overall Study|Death|1|||
30628234|NCT01076010|58640113|FG002|Overall Study|Death|0|||
30628235|NCT01076010|58640111|FG000|Overall Study|Adverse Event|7|||
30628236|NCT01076010|58640112|FG001|Overall Study|Adverse Event|2|||
30628237|NCT01076010|58640113|FG002|Overall Study|Adverse Event|0|||
30628238|NCT01076010|58640111|FG000|Overall Study|Progressive disease|90|||
30628239|NCT01076010|58640112|FG001|Overall Study|Progressive disease|30|||
30628240|NCT01076010|58640113|FG002|Overall Study|Progressive disease|1|||
30628241|NCT01076010|58640111|FG000|Overall Study|Lack of Efficacy|4|||
30628242|NCT01076010|58640112|FG001|Overall Study|Lack of Efficacy|0|||
30628243|NCT01076010|58640113|FG002|Overall Study|Lack of Efficacy|0|||
30628244|NCT01076010|58640111|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
30763595|NCT00077610|58772333|FG000|Overall Study|Renal transplant|12|||
30763596|NCT00077610|58772334|FG001|Overall Study|Renal transplant|15|||
30763597|NCT00077610|58772335|FG002|Overall Study|Renal transplant|11|||
30950702|NCT01928381|58997588|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
30950703|NCT01928381|58997589|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
30950704|NCT01928381|58997583|FG000|Washout First Intervention|Protocol Violation|0|||
30950705|NCT01928381|58997584|FG001|Washout First Intervention|Protocol Violation|0|||
30950706|NCT01928381|58997585|FG002|Washout First Intervention|Protocol Violation|0|||
30763598|NCT00077610|58772333|FG000|Overall Study|Withdrew from dialysis care|5|||
30950707|NCT01928381|58997586|FG003|Washout First Intervention|Protocol Violation|0|||
30950708|NCT01928381|58997587|FG004|Washout First Intervention|Protocol Violation|1|||
30950709|NCT01928381|58997588|FG005|Washout First Intervention|Protocol Violation|0|||
30950710|NCT01928381|58997589|FG006|Washout First Intervention|Protocol Violation|0|||
30950711|NCT01928381|58997583|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
30950712|NCT01928381|58997584|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
30628245|NCT01076010|58640112|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
30628246|NCT01076010|58640113|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
30628247|NCT01076010|58640111|FG000|Overall Study|Significant Surgical Procedure|0|||
30763599|NCT00077610|58772334|FG001|Overall Study|Withdrew from dialysis care|0|||
30763600|NCT00077610|58772335|FG002|Overall Study|Withdrew from dialysis care|3|||
30763601|NCT00077610|58772333|FG000|Overall Study|Insufficient Therapeutic Response|1|||
30628248|NCT01076010|58640112|FG001|Overall Study|Significant Surgical Procedure|1|||
30628249|NCT01076010|58640113|FG002|Overall Study|Significant Surgical Procedure|0|||
30628250|NCT01076010|58640111|FG000|Overall Study|Protocol Violation|0|||
30628251|NCT01076010|58640112|FG001|Overall Study|Protocol Violation|1|||
30763602|NCT00077610|58772334|FG001|Overall Study|Insufficient Therapeutic Response|0|||
30763603|NCT00077610|58772335|FG002|Overall Study|Insufficient Therapeutic Response|0|||
30628252|NCT01076010|58640113|FG002|Overall Study|Protocol Violation|0|||
30628253|NCT01076010|58640111|FG000|Overall Study|Noncompliance|1|||
30628254|NCT01076010|58640112|FG001|Overall Study|Noncompliance|1|||
30628255|NCT01076010|58640113|FG002|Overall Study|Noncompliance|0|||
30628256|NCT01076010|58640111|FG000|Overall Study|Withdrawal by Subject|3|||
30628257|NCT01076010|58640112|FG001|Overall Study|Withdrawal by Subject|0|||
30628258|NCT01076010|58640113|FG002|Overall Study|Withdrawal by Subject|1|||
30628259|NCT01076010|58640111|FG000|Overall Study|Other|5|||
30628260|NCT01076010|58640112|FG001|Overall Study|Other|2|||
30628261|NCT01076010|58640113|FG002|Overall Study|Other|0|||
30628262|NCT01075152|58640123|FG000|Overall Study|Withdrawal by Subject|1|||
30848001|NCT02418754|58873818|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
30848002|NCT02418754|58873819|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
30848003|NCT02447458|58873835|FG000|Overall Study|Other|0|||
30848004|NCT02447458|58873836|FG001|Overall Study|Other|0|||
30848005|NCT02447458|58873837|FG002|Overall Study|Other|1|||
30628263|NCT01075152|58640124|FG001|Overall Study|Withdrawal by Subject|0|||
30628264|NCT01078116|58640132|FG000|Overall Study|Lost to Follow-up|17|||
30848006|NCT02447458|58873838|FG003|Overall Study|Other|0|||
30848007|NCT02447458|58873839|FG004|Overall Study|Other|0|||
30763604|NCT00077610|58772333|FG000|Overall Study|Multiple blood transfusions|0|||
30763605|NCT00077610|58772334|FG001|Overall Study|Multiple blood transfusions|0|||
30763606|NCT00077610|58772335|FG002|Overall Study|Multiple blood transfusions|1|||
30763607|NCT00077610|58772333|FG000|Overall Study|Principal Investigator's decision|1|||
30763608|NCT00077610|58772334|FG001|Overall Study|Principal Investigator's decision|0|||
30763609|NCT00077610|58772335|FG002|Overall Study|Principal Investigator's decision|1|||
30763610|NCT00077610|58772333|FG000|Overall Study|Worsening of health condition|1|||
30763611|NCT00077610|58772334|FG001|Overall Study|Worsening of health condition|1|||
30763612|NCT00077610|58772335|FG002|Overall Study|Worsening of health condition|0|||
30763613|NCT00077610|58772333|FG000|Overall Study|Given Epogen in hospital|1|||
30763614|NCT00077610|58772334|FG001|Overall Study|Given Epogen in hospital|0|||
30763615|NCT00077610|58772335|FG002|Overall Study|Given Epogen in hospital|0|||
30848008|NCT02447458|58873840|FG005|Overall Study|Other|0|||
30848009|NCT02862457|58873866|FG000|Overall Study|Death|1|||
30848010|NCT02862457|58873867|FG001|Overall Study|Death|3|||
30848011|NCT02862457|58873868|FG002|Overall Study|Death|2|||
30628265|NCT01078116|58640132|FG000|Overall Study|Adverse Event|5|||
30628266|NCT01078116|58640132|FG000|Overall Study|Withdrawal by Subject|8|||
30628267|NCT01078116|58640132|FG000|Overall Study|Lack of effectiveness|15|||
30628268|NCT01078116|58640132|FG000|Overall Study|Case report form not completed|3|||
30628269|NCT00950859|58640138|FG000|Overall Study|Adverse Event|3|||
30628270|NCT00950859|58640139|FG001|Overall Study|Adverse Event|3|||
30628271|NCT00950859|58640138|FG000|Overall Study|Insufficient Viral Load Response|12|||
30628272|NCT00950859|58640139|FG001|Overall Study|Insufficient Viral Load Response|3|||
30628273|NCT00950859|58640138|FG000|Overall Study|Protocol Violation|1|||
30628274|NCT00950859|58640139|FG001|Overall Study|Protocol Violation|1|||
30628275|NCT00950859|58640138|FG000|Overall Study|Lost to Follow-up|0|||
30628276|NCT00950859|58640139|FG001|Overall Study|Lost to Follow-up|3|||
30628277|NCT00862849|58640145|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
30628278|NCT00862849|58640146|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
30628279|NCT00862849|58640147|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
30628280|NCT00862849|58640148|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
30628281|NCT00862849|58640149|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
30763616|NCT00077610|58772333|FG000|Overall Study|Transferred to other unit|0|||
30763617|NCT00077610|58772334|FG001|Overall Study|Transferred to other unit|0|||
30763618|NCT00077610|58772335|FG002|Overall Study|Transferred to other unit|1|||
30848012|NCT02862457|58873869|FG003|Overall Study|Death|3|||
30848013|NCT02862457|58873870|FG004|Overall Study|Death|0|||
30628282|NCT00862849|58640150|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
30628283|NCT00862849|58640145|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
30628284|NCT00862849|58640146|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
30628285|NCT00862849|58640147|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
30628286|NCT00862849|58640148|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
30628287|NCT00862849|58640149|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
30628288|NCT00862849|58640150|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
30628289|NCT01090050|58640160|FG000|Overall Study|Lost to Follow-up|0|||
30628290|NCT01090050|58640161|FG001|Overall Study|Lost to Follow-up|1|||
30628291|NCT01090050|58640160|FG000|Overall Study|Lack of Efficacy|1|||
30628292|NCT01090050|58640161|FG001|Overall Study|Lack of Efficacy|5|||
30628293|NCT01090050|58640160|FG000|Overall Study|Physician Decision|0|||
30628294|NCT01090050|58640161|FG001|Overall Study|Physician Decision|1|||
30628295|NCT00944229|58640171|FG000|Overall Study|Withdrawal by Subject|11|||
30628296|NCT00944229|58640171|FG000|Overall Study|Physician Decision|14|||
30628297|NCT01077960|58640175|FG000|Overall Study|Adverse Event|6|||
30628298|NCT01077960|58640175|FG000|Overall Study|Protocol Violation|3|||
30628299|NCT01077960|58640175|FG000|Overall Study|Lost to Follow-up|5|||
30628300|NCT01077960|58640175|FG000|Overall Study|Subject decision|1|||
30763619|NCT00077610|58772333|FG000|Overall Study|Transferred to nursing home|0|||
30763620|NCT00077610|58772334|FG001|Overall Study|Transferred to nursing home|0|||
30763621|NCT00077610|58772335|FG002|Overall Study|Transferred to nursing home|1|||
30628301|NCT01077960|58640175|FG000|Overall Study|Reason unspecified|1|||
30628302|NCT00944697|58640181|FG000|Overall Study|Withdrawal by Subject|1|||
30628303|NCT00944697|58640182|FG001|Overall Study|Withdrawal by Subject|1|||
30628304|NCT00944697|58640181|FG000|Overall Study|Adverse Event|0|||
30628305|NCT00944697|58640182|FG001|Overall Study|Adverse Event|3|||
30628306|NCT00944697|58640181|FG000|Overall Study|Administrative|1|||
30628307|NCT00944697|58640182|FG001|Overall Study|Administrative|1|||
30628308|NCT01077804|58640188|FG000|Overall Study|Unreachable|102|||
30628309|NCT01077804|58640188|FG000|Overall Study|Refused to continue|79|||
30628310|NCT01077804|58640188|FG000|Overall Study|Other|18|||
30628311|NCT01075074|58640212|FG000|Overall Study|Surgeon changed to open incisional case|1|||
30628312|NCT01075074|58640213|FG001|Overall Study|Surgeon changed to open incisional case|2|||
30628313|NCT01075074|58640214|FG002|Overall Study|Surgeon changed to open incisional case|2|||
30628314|NCT00866281|58640228|FG000|Overall Study|Adverse Event|1|||
30628315|NCT00866281|58640229|FG001|Overall Study|Adverse Event|0|||
30628316|NCT00866281|58640228|FG000|Overall Study|Withdrawal by participants|3|||
30628317|NCT00866281|58640229|FG001|Overall Study|Withdrawal by participants|0|||
30628318|NCT00866281|58640228|FG000|Overall Study|Disease progression|3|||
30628319|NCT00866281|58640229|FG001|Overall Study|Disease progression|11|||
30628320|NCT00866281|58640228|FG000|Overall Study|New cancer therapy|0|||
30628321|NCT00866281|58640229|FG001|Overall Study|New cancer therapy|4|||
30628322|NCT01077258|58640238|FG000|Overall Study|Lost to Follow-up|1390|||
30628323|NCT01077258|58640238|FG000|Overall Study|Adverse drug reaction|218|||
30628324|NCT01077258|58640238|FG000|Overall Study|Lack of Efficacy|663|||
30628325|NCT01077258|58640238|FG000|Overall Study|Clinical remission|37|||
30628326|NCT01077258|58640238|FG000|Overall Study|Other reasons|260|||
30763622|NCT00077610|58772333|FG000|Overall Study|Transfer to satellite unit|1|||
30628327|NCT00943917|58640266|FG000|Stage I|Adverse Event|1|||
30628328|NCT00943917|58640267|FG001|Stage I|Adverse Event|2|||
30628329|NCT00943917|58640268|FG002|Stage I|Adverse Event|2|||
30628330|NCT00943917|58640269|FG003|Stage I|Adverse Event|0|||
30628331|NCT00943917|58640270|FG004|Stage I|Adverse Event|0|||
30628332|NCT00943917|58640271|FG005|Stage I|Adverse Event|0|||
30628333|NCT00943917|58640272|FG006|Stage I|Adverse Event|0|||
30628334|NCT00943917|58640273|FG007|Stage I|Adverse Event|0|||
30628335|NCT00943917|58640274|FG008|Stage I|Adverse Event|0|||
30763623|NCT00077610|58772334|FG001|Overall Study|Transfer to satellite unit|0|||
30628336|NCT00943917|58640275|FG009|Stage I|Adverse Event|0|||
30628337|NCT00943917|58640276|FG010|Stage I|Adverse Event|0|||
30628338|NCT00943917|58640277|FG011|Stage I|Adverse Event|0|||
30628339|NCT00943917|58640278|FG012|Stage I|Adverse Event|0|||
30628340|NCT00943917|58640279|FG013|Stage I|Adverse Event|0|||
30628341|NCT00943917|58640280|FG014|Stage I|Adverse Event|0|||
30628342|NCT00943917|58640266|FG000|Stage I|Lost to Follow-up|0|||
30628343|NCT00943917|58640267|FG001|Stage I|Lost to Follow-up|0|||
30628344|NCT00943917|58640268|FG002|Stage I|Lost to Follow-up|1|||
30628345|NCT00943917|58640269|FG003|Stage I|Lost to Follow-up|0|||
30628346|NCT00943917|58640270|FG004|Stage I|Lost to Follow-up|0|||
30628347|NCT00943917|58640271|FG005|Stage I|Lost to Follow-up|0|||
30628348|NCT00943917|58640272|FG006|Stage I|Lost to Follow-up|0|||
30628349|NCT00943917|58640273|FG007|Stage I|Lost to Follow-up|0|||
30628350|NCT00943917|58640274|FG008|Stage I|Lost to Follow-up|0|||
30628351|NCT00943917|58640275|FG009|Stage I|Lost to Follow-up|0|||
30628352|NCT00943917|58640276|FG010|Stage I|Lost to Follow-up|0|||
30628353|NCT00943917|58640277|FG011|Stage I|Lost to Follow-up|0|||
30628354|NCT00943917|58640278|FG012|Stage I|Lost to Follow-up|0|||
30628355|NCT00943917|58640279|FG013|Stage I|Lost to Follow-up|0|||
30628356|NCT00943917|58640280|FG014|Stage I|Lost to Follow-up|0|||
30628357|NCT00943917|58640266|FG000|Stage I|hyperglycemia|0|||
30628358|NCT00943917|58640267|FG001|Stage I|hyperglycemia|0|||
30628359|NCT00943917|58640268|FG002|Stage I|hyperglycemia|1|||
30628360|NCT00943917|58640269|FG003|Stage I|hyperglycemia|0|||
30628361|NCT00943917|58640270|FG004|Stage I|hyperglycemia|0|||
30628362|NCT00943917|58640271|FG005|Stage I|hyperglycemia|0|||
30628363|NCT00943917|58640272|FG006|Stage I|hyperglycemia|0|||
30628364|NCT00943917|58640273|FG007|Stage I|hyperglycemia|0|||
30628365|NCT00943917|58640274|FG008|Stage I|hyperglycemia|0|||
30628366|NCT00943917|58640275|FG009|Stage I|hyperglycemia|0|||
30628367|NCT00943917|58640276|FG010|Stage I|hyperglycemia|0|||
30628368|NCT00943917|58640277|FG011|Stage I|hyperglycemia|0|||
30628369|NCT00943917|58640278|FG012|Stage I|hyperglycemia|0|||
30628370|NCT00943917|58640279|FG013|Stage I|hyperglycemia|0|||
30628371|NCT00943917|58640280|FG014|Stage I|hyperglycemia|0|||
30628372|NCT00943917|58640266|FG000|Stage I|A1C elevation|1|||
30628373|NCT00943917|58640267|FG001|Stage I|A1C elevation|0|||
30628374|NCT00943917|58640268|FG002|Stage I|A1C elevation|0|||
30628375|NCT00943917|58640269|FG003|Stage I|A1C elevation|0|||
30628376|NCT00943917|58640270|FG004|Stage I|A1C elevation|0|||
30628377|NCT00943917|58640271|FG005|Stage I|A1C elevation|0|||
30628378|NCT00943917|58640272|FG006|Stage I|A1C elevation|0|||
30628379|NCT00943917|58640273|FG007|Stage I|A1C elevation|0|||
30628380|NCT00943917|58640274|FG008|Stage I|A1C elevation|0|||
30628381|NCT00943917|58640275|FG009|Stage I|A1C elevation|0|||
30628382|NCT00943917|58640276|FG010|Stage I|A1C elevation|0|||
30628383|NCT00943917|58640277|FG011|Stage I|A1C elevation|0|||
30628384|NCT00943917|58640278|FG012|Stage I|A1C elevation|0|||
30628385|NCT00943917|58640279|FG013|Stage I|A1C elevation|0|||
30628386|NCT00943917|58640280|FG014|Stage I|A1C elevation|0|||
30628387|NCT00943917|58640266|FG000|Stage I|Withdrawal by Subject|2|||
30628388|NCT00943917|58640267|FG001|Stage I|Withdrawal by Subject|1|||
30763624|NCT00077610|58772335|FG002|Overall Study|Transfer to satellite unit|0|||
30628389|NCT00943917|58640268|FG002|Stage I|Withdrawal by Subject|2|||
30628390|NCT00943917|58640269|FG003|Stage I|Withdrawal by Subject|0|||
30628391|NCT00943917|58640270|FG004|Stage I|Withdrawal by Subject|0|||
30628392|NCT00943917|58640271|FG005|Stage I|Withdrawal by Subject|0|||
30763625|NCT00077610|58772333|FG000|Overall Study|Transfer to other center for surgery|1|||
30628393|NCT00943917|58640272|FG006|Stage I|Withdrawal by Subject|0|||
30628394|NCT00943917|58640273|FG007|Stage I|Withdrawal by Subject|0|||
30628395|NCT00943917|58640274|FG008|Stage I|Withdrawal by Subject|0|||
30628396|NCT00943917|58640275|FG009|Stage I|Withdrawal by Subject|0|||
30628397|NCT00943917|58640276|FG010|Stage I|Withdrawal by Subject|0|||
30628398|NCT00943917|58640277|FG011|Stage I|Withdrawal by Subject|0|||
30763626|NCT00077610|58772334|FG001|Overall Study|Transfer to other center for surgery|0|||
30628399|NCT00943917|58640278|FG012|Stage I|Withdrawal by Subject|0|||
30628400|NCT00943917|58640279|FG013|Stage I|Withdrawal by Subject|0|||
30628401|NCT00943917|58640280|FG014|Stage I|Withdrawal by Subject|0|||
30628402|NCT00943917|58640266|FG000|Stage II|Adverse Event|0|||
30628403|NCT00943917|58640267|FG001|Stage II|Adverse Event|0|||
30628404|NCT00943917|58640268|FG002|Stage II|Adverse Event|0|||
30628405|NCT00943917|58640269|FG003|Stage II|Adverse Event|0|||
30628406|NCT00943917|58640270|FG004|Stage II|Adverse Event|0|||
30628407|NCT00943917|58640271|FG005|Stage II|Adverse Event|1|||
30628408|NCT00943917|58640272|FG006|Stage II|Adverse Event|3|||
30628409|NCT00943917|58640273|FG007|Stage II|Adverse Event|0|||
30628410|NCT00943917|58640274|FG008|Stage II|Adverse Event|1|||
30628411|NCT00943917|58640275|FG009|Stage II|Adverse Event|0|||
30628412|NCT00943917|58640276|FG010|Stage II|Adverse Event|0|||
30628413|NCT00943917|58640277|FG011|Stage II|Adverse Event|0|||
30628414|NCT00943917|58640278|FG012|Stage II|Adverse Event|0|||
30628415|NCT00943917|58640279|FG013|Stage II|Adverse Event|0|||
30628416|NCT00943917|58640280|FG014|Stage II|Adverse Event|0|||
30628417|NCT00943917|58640266|FG000|Stage II|Withdrawal by Subject|0|||
30628418|NCT00943917|58640267|FG001|Stage II|Withdrawal by Subject|0|||
30628419|NCT00943917|58640268|FG002|Stage II|Withdrawal by Subject|0|||
30628420|NCT00943917|58640269|FG003|Stage II|Withdrawal by Subject|0|||
30628421|NCT00943917|58640270|FG004|Stage II|Withdrawal by Subject|0|||
30628422|NCT00943917|58640271|FG005|Stage II|Withdrawal by Subject|1|||
30628423|NCT00943917|58640272|FG006|Stage II|Withdrawal by Subject|0|||
30848014|NCT02862457|58873871|FG005|Overall Study|Death|2|||
30848015|NCT02862457|58873872|FG006|Overall Study|Death|1|||
30848016|NCT02862457|58873866|FG000|Overall Study|Lost to Follow-up|1|||
30848017|NCT02862457|58873867|FG001|Overall Study|Lost to Follow-up|0|||
30848018|NCT02862457|58873868|FG002|Overall Study|Lost to Follow-up|0|||
30848019|NCT02862457|58873869|FG003|Overall Study|Lost to Follow-up|1|||
30848020|NCT02862457|58873870|FG004|Overall Study|Lost to Follow-up|0|||
30848021|NCT02862457|58873871|FG005|Overall Study|Lost to Follow-up|0|||
30848022|NCT02862457|58873872|FG006|Overall Study|Lost to Follow-up|0|||
30848023|NCT02862457|58873866|FG000|Overall Study|Withdrawal by Subject|0|||
30848024|NCT02862457|58873867|FG001|Overall Study|Withdrawal by Subject|0|||
30848025|NCT02862457|58873868|FG002|Overall Study|Withdrawal by Subject|1|||
30848026|NCT02862457|58873869|FG003|Overall Study|Withdrawal by Subject|0|||
30848027|NCT02862457|58873870|FG004|Overall Study|Withdrawal by Subject|0|||
30848028|NCT02862457|58873871|FG005|Overall Study|Withdrawal by Subject|1|||
30848029|NCT02862457|58873872|FG006|Overall Study|Withdrawal by Subject|0|||
30848030|NCT02447302|58873899|FG000|Overall Study|Physician Decision|1|||
30950713|NCT01928381|58997585|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
30848031|NCT02447302|58873900|FG001|Overall Study|Physician Decision|0|||
30848032|NCT02447302|58873901|FG002|Overall Study|Physician Decision|0|||
30848033|NCT02447302|58873899|FG000|Overall Study|Adverse Event|4|||
30848034|NCT02447302|58873900|FG001|Overall Study|Adverse Event|3|||
30848035|NCT02447302|58873901|FG002|Overall Study|Adverse Event|0|||
30950714|NCT01928381|58997586|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
30950715|NCT01928381|58997587|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
30950716|NCT01928381|58997588|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
30950717|NCT01928381|58997589|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
30628424|NCT00943917|58640273|FG007|Stage II|Withdrawal by Subject|0|||
30628425|NCT00943917|58640274|FG008|Stage II|Withdrawal by Subject|0|||
30628426|NCT00943917|58640275|FG009|Stage II|Withdrawal by Subject|0|||
30628427|NCT00943917|58640276|FG010|Stage II|Withdrawal by Subject|0|||
30628428|NCT00943917|58640277|FG011|Stage II|Withdrawal by Subject|0|||
30848036|NCT02447302|58873899|FG000|Overall Study|Withdrawal by Subject|0|||
30848037|NCT02447302|58873900|FG001|Overall Study|Withdrawal by Subject|1|||
30848038|NCT02447302|58873901|FG002|Overall Study|Withdrawal by Subject|5|||
30628429|NCT00943917|58640278|FG012|Stage II|Withdrawal by Subject|0|||
30628430|NCT00943917|58640279|FG013|Stage II|Withdrawal by Subject|0|||
30628431|NCT00943917|58640280|FG014|Stage II|Withdrawal by Subject|0|||
30628432|NCT00943917|58640266|FG000|Stage II|Pregnancy|0|||
30628433|NCT00943917|58640267|FG001|Stage II|Pregnancy|0|||
30628434|NCT00943917|58640268|FG002|Stage II|Pregnancy|0|||
30628435|NCT00943917|58640269|FG003|Stage II|Pregnancy|0|||
30628436|NCT00943917|58640270|FG004|Stage II|Pregnancy|0|||
30628437|NCT00943917|58640271|FG005|Stage II|Pregnancy|1|||
30628438|NCT00943917|58640272|FG006|Stage II|Pregnancy|0|||
30628439|NCT00943917|58640273|FG007|Stage II|Pregnancy|0|||
30628440|NCT00943917|58640274|FG008|Stage II|Pregnancy|0|||
30628441|NCT00943917|58640275|FG009|Stage II|Pregnancy|0|||
30628442|NCT00943917|58640276|FG010|Stage II|Pregnancy|0|||
30628443|NCT00943917|58640277|FG011|Stage II|Pregnancy|0|||
30628444|NCT00943917|58640278|FG012|Stage II|Pregnancy|0|||
30628445|NCT00943917|58640279|FG013|Stage II|Pregnancy|0|||
30628446|NCT00943917|58640280|FG014|Stage II|Pregnancy|0|||
30628447|NCT00943917|58640266|FG000|Stage II Continuation|Adverse Event|0|||
30628448|NCT00943917|58640267|FG001|Stage II Continuation|Adverse Event|0|||
30628449|NCT00943917|58640268|FG002|Stage II Continuation|Adverse Event|0|||
30763627|NCT00077610|58772335|FG002|Overall Study|Transfer to other center for surgery|0|||
30950718|NCT01928381|58997583|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
30950719|NCT01928381|58997584|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
30628450|NCT00943917|58640269|FG003|Stage II Continuation|Adverse Event|0|||
30628451|NCT00943917|58640270|FG004|Stage II Continuation|Adverse Event|0|||
30628452|NCT00943917|58640271|FG005|Stage II Continuation|Adverse Event|0|||
30628453|NCT00943917|58640272|FG006|Stage II Continuation|Adverse Event|0|||
30628454|NCT00943917|58640273|FG007|Stage II Continuation|Adverse Event|0|||
30628455|NCT00943917|58640274|FG008|Stage II Continuation|Adverse Event|0|||
30628456|NCT00943917|58640275|FG009|Stage II Continuation|Adverse Event|0|||
30628457|NCT00943917|58640276|FG010|Stage II Continuation|Adverse Event|0|||
30628458|NCT00943917|58640277|FG011|Stage II Continuation|Adverse Event|1|||
30628459|NCT00943917|58640278|FG012|Stage II Continuation|Adverse Event|2|||
30628460|NCT00943917|58640279|FG013|Stage II Continuation|Adverse Event|1|||
30628461|NCT00943917|58640280|FG014|Stage II Continuation|Adverse Event|1|||
30628462|NCT00943917|58640266|FG000|Stage II Continuation|Withdrawal by Subject|0|||
30628463|NCT00943917|58640267|FG001|Stage II Continuation|Withdrawal by Subject|0|||
30628464|NCT00943917|58640268|FG002|Stage II Continuation|Withdrawal by Subject|0|||
30628465|NCT00943917|58640269|FG003|Stage II Continuation|Withdrawal by Subject|0|||
30628466|NCT00943917|58640270|FG004|Stage II Continuation|Withdrawal by Subject|0|||
30628467|NCT00943917|58640271|FG005|Stage II Continuation|Withdrawal by Subject|0|||
30628468|NCT00943917|58640272|FG006|Stage II Continuation|Withdrawal by Subject|0|||
30628469|NCT00943917|58640273|FG007|Stage II Continuation|Withdrawal by Subject|0|||
30628470|NCT00943917|58640274|FG008|Stage II Continuation|Withdrawal by Subject|0|||
30628471|NCT00943917|58640275|FG009|Stage II Continuation|Withdrawal by Subject|0|||
30628472|NCT00943917|58640276|FG010|Stage II Continuation|Withdrawal by Subject|0|||
30628473|NCT00943917|58640277|FG011|Stage II Continuation|Withdrawal by Subject|0|||
30628474|NCT00943917|58640278|FG012|Stage II Continuation|Withdrawal by Subject|0|||
30628475|NCT00943917|58640279|FG013|Stage II Continuation|Withdrawal by Subject|1|||
30628476|NCT00943917|58640280|FG014|Stage II Continuation|Withdrawal by Subject|3|||
30628477|NCT00943917|58640266|FG000|Stage II Continuation|Protocol Violation|0|||
30628478|NCT00943917|58640267|FG001|Stage II Continuation|Protocol Violation|0|||
30628479|NCT00943917|58640268|FG002|Stage II Continuation|Protocol Violation|0|||
30628480|NCT00943917|58640269|FG003|Stage II Continuation|Protocol Violation|0|||
30628481|NCT00943917|58640270|FG004|Stage II Continuation|Protocol Violation|0|||
30628482|NCT00943917|58640271|FG005|Stage II Continuation|Protocol Violation|0|||
30950720|NCT01928381|58997585|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
30628483|NCT00943917|58640272|FG006|Stage II Continuation|Protocol Violation|0|||
30628484|NCT00943917|58640273|FG007|Stage II Continuation|Protocol Violation|0|||
30628485|NCT00943917|58640274|FG008|Stage II Continuation|Protocol Violation|0|||
30628486|NCT00943917|58640275|FG009|Stage II Continuation|Protocol Violation|1|||
30628487|NCT00943917|58640276|FG010|Stage II Continuation|Protocol Violation|0|||
30628488|NCT00943917|58640277|FG011|Stage II Continuation|Protocol Violation|1|||
30628489|NCT00943917|58640278|FG012|Stage II Continuation|Protocol Violation|0|||
30628490|NCT00943917|58640279|FG013|Stage II Continuation|Protocol Violation|0|||
30628491|NCT00943917|58640280|FG014|Stage II Continuation|Protocol Violation|0|||
30628492|NCT00943917|58640266|FG000|Stage II Continuation|hypoglycemia|0|||
30628493|NCT00943917|58640267|FG001|Stage II Continuation|hypoglycemia|0|||
30628494|NCT00943917|58640268|FG002|Stage II Continuation|hypoglycemia|0|||
30628495|NCT00943917|58640269|FG003|Stage II Continuation|hypoglycemia|0|||
30628496|NCT00943917|58640270|FG004|Stage II Continuation|hypoglycemia|0|||
30628497|NCT00943917|58640271|FG005|Stage II Continuation|hypoglycemia|0|||
30628498|NCT00943917|58640272|FG006|Stage II Continuation|hypoglycemia|0|||
30628499|NCT00943917|58640273|FG007|Stage II Continuation|hypoglycemia|0|||
30628500|NCT00943917|58640274|FG008|Stage II Continuation|hypoglycemia|0|||
30628501|NCT00943917|58640275|FG009|Stage II Continuation|hypoglycemia|0|||
30628502|NCT00943917|58640276|FG010|Stage II Continuation|hypoglycemia|0|||
30628503|NCT00943917|58640277|FG011|Stage II Continuation|hypoglycemia|0|||
30628504|NCT00943917|58640278|FG012|Stage II Continuation|hypoglycemia|1|||
30628505|NCT00943917|58640279|FG013|Stage II Continuation|hypoglycemia|0|||
30628506|NCT00943917|58640280|FG014|Stage II Continuation|hypoglycemia|0|||
30628507|NCT00943917|58640266|FG000|Stage II Continuation|A1C elevation|0|||
30628508|NCT00943917|58640267|FG001|Stage II Continuation|A1C elevation|0|||
30628509|NCT00943917|58640268|FG002|Stage II Continuation|A1C elevation|0|||
30628510|NCT00943917|58640269|FG003|Stage II Continuation|A1C elevation|0|||
30628511|NCT00943917|58640270|FG004|Stage II Continuation|A1C elevation|0|||
30628512|NCT00943917|58640271|FG005|Stage II Continuation|A1C elevation|0|||
30628513|NCT00943917|58640272|FG006|Stage II Continuation|A1C elevation|0|||
30628514|NCT00943917|58640273|FG007|Stage II Continuation|A1C elevation|0|||
30628515|NCT00943917|58640274|FG008|Stage II Continuation|A1C elevation|0|||
30628516|NCT00943917|58640275|FG009|Stage II Continuation|A1C elevation|0|||
30628517|NCT00943917|58640276|FG010|Stage II Continuation|A1C elevation|0|||
30628518|NCT00943917|58640277|FG011|Stage II Continuation|A1C elevation|0|||
30628519|NCT00943917|58640278|FG012|Stage II Continuation|A1C elevation|0|||
30628520|NCT00943917|58640279|FG013|Stage II Continuation|A1C elevation|1|||
30628521|NCT00943917|58640280|FG014|Stage II Continuation|A1C elevation|0|||
30628522|NCT01077024|58640315|FG000|Overall Study|Lost to Follow-up|20|||
30628523|NCT01077024|58640316|FG001|Overall Study|Lost to Follow-up|14|||
30628524|NCT01077024|58640315|FG000|Overall Study|Withdrawal by Subject|0|||
30628525|NCT01077024|58640316|FG001|Overall Study|Withdrawal by Subject|2|||
30628526|NCT01077024|58640315|FG000|Overall Study|Incarcerated|7|||
30628527|NCT01077024|58640316|FG001|Overall Study|Incarcerated|8|||
30628528|NCT01077024|58640315|FG000|Overall Study|Other|4|||
30628529|NCT01077024|58640316|FG001|Overall Study|Other|4|||
30628530|NCT01089582|58640322|FG000|Overall Study|Death|2|||
30628531|NCT01089582|58640322|FG000|Overall Study|Adverse Event|15|||
30628532|NCT01089582|58640322|FG000|Overall Study|Lost to Follow-up|8|||
30628533|NCT01089582|58640322|FG000|Overall Study|Other|4|||
30628534|NCT01089582|58640322|FG000|Overall Study|Withdrawal by Subject|1|||
30628535|NCT00862459|58640329|FG000|Overall Study|Lost to Follow-up|1|||
30628536|NCT00862459|58640330|FG001|Overall Study|Lost to Follow-up|2|||
30628537|NCT00862459|58640331|FG002|Overall Study|Lost to Follow-up|2|||
30628538|NCT00862459|58640329|FG000|Overall Study|Protocol Violation|1|||
30628539|NCT00862459|58640330|FG001|Overall Study|Protocol Violation|0|||
30628540|NCT00862459|58640331|FG002|Overall Study|Protocol Violation|0|||
30628541|NCT00862459|58640329|FG000|Overall Study|Withdrawal by Subject|1|||
30628542|NCT00862459|58640330|FG001|Overall Study|Withdrawal by Subject|1|||
30628543|NCT00862459|58640331|FG002|Overall Study|Withdrawal by Subject|3|||
30628544|NCT00862459|58640329|FG000|Overall Study|Adverse Event|0|||
30628545|NCT00862459|58640330|FG001|Overall Study|Adverse Event|1|||
30628546|NCT00862459|58640331|FG002|Overall Study|Adverse Event|0|||
30628547|NCT00862459|58640329|FG000|Overall Study|Personal reasons|1|||
30628548|NCT00862459|58640330|FG001|Overall Study|Personal reasons|0|||
30628549|NCT00862459|58640331|FG002|Overall Study|Personal reasons|0|||
30628550|NCT00862459|58640329|FG000|Overall Study|Operation|1|||
30628551|NCT00862459|58640330|FG001|Overall Study|Operation|1|||
30628552|NCT00862459|58640331|FG002|Overall Study|Operation|0|||
30628553|NCT00862459|58640329|FG000|Overall Study|Intravenous (IV) site problems|1|||
30628554|NCT00862459|58640330|FG001|Overall Study|Intravenous (IV) site problems|0|||
30628555|NCT00862459|58640331|FG002|Overall Study|Intravenous (IV) site problems|1|||
30628556|NCT00862459|58640329|FG000|Overall Study|Unable to hold still for imaging|0|||
30628557|NCT00862459|58640330|FG001|Overall Study|Unable to hold still for imaging|1|||
30628558|NCT00862459|58640331|FG002|Overall Study|Unable to hold still for imaging|0|||
30628559|NCT00862459|58640329|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
30628560|NCT00862459|58640330|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
30628561|NCT00862459|58640331|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
30628562|NCT00862459|58640329|FG000|Overall Study|Administrative problems|0|||
30628563|NCT00862459|58640330|FG001|Overall Study|Administrative problems|1|||
30628564|NCT00862459|58640331|FG002|Overall Study|Administrative problems|0|||
30628565|NCT00580047|58640343|FG000|Overall Study|Lost to Follow-up|1|||
30628566|NCT00580047|58640344|FG001|Overall Study|Lost to Follow-up|1|||
30628567|NCT00580047|58640345|FG002|Overall Study|Lost to Follow-up|0|||
30628568|NCT00580047|58640343|FG000|Overall Study|Withdrawal by Subject|1|||
30628569|NCT00580047|58640344|FG001|Overall Study|Withdrawal by Subject|1|||
30628570|NCT00580047|58640345|FG002|Overall Study|Withdrawal by Subject|2|||
30628571|NCT00580047|58640343|FG000|Overall Study|Withdrawal by Subject|1|||
30628572|NCT00580047|58640344|FG001|Overall Study|Withdrawal by Subject|0|||
30628573|NCT00580047|58640345|FG002|Overall Study|Withdrawal by Subject|0|||
30628574|NCT01074450|58640358|FG000|First Intervention|Emesis in Dosing Interval|0|||
30628575|NCT01074450|58640359|FG001|First Intervention|Emesis in Dosing Interval|2|||
30628576|NCT01074450|58640358|FG000|Second Intervention|Protocol Violation|1|||
30628577|NCT01074450|58640359|FG001|Second Intervention|Protocol Violation|0|||
30628578|NCT01074450|58640358|FG000|Second Intervention|Physician Decision|0|||
30628579|NCT01074450|58640359|FG001|Second Intervention|Physician Decision|1|||
30628580|NCT00943761|58640367|FG000|Overall Study|Lost to Follow-up|2|||
30628581|NCT00943761|58640368|FG001|Overall Study|Lost to Follow-up|0|||
30628582|NCT00943761|58640367|FG000|Overall Study|Withdrawal by Subject|2|||
30628583|NCT00943761|58640368|FG001|Overall Study|Withdrawal by Subject|1|||
30628584|NCT00949533|58640376|FG000|Overall Study|Lost to Follow-up|0|||
30628585|NCT00949533|58640377|FG001|Overall Study|Lost to Follow-up|1|||
30628586|NCT00866047|58640383|FG000|Treatment Period|Progressive disease|13|||
30628587|NCT00866047|58640383|FG000|Treatment Period|Adverse Event|16|||
30628588|NCT00866047|58640383|FG000|Treatment Period|Physician Decision|14|||
30628589|NCT00866047|58640383|FG000|Treatment Period|Withdrawal by Subject|5|||
30628590|NCT00866047|58640383|FG000|Follow-up Period|Lost to Follow-up|5|||
30628591|NCT00869323|58640387|FG000|Maintenance Therapy|concurrent illness|1|||
30628592|NCT01192022|58640395|FG000|Overall Study|Withdrawal of Consent|3|||
30628593|NCT01192022|58640396|FG001|Overall Study|Withdrawal of Consent|1|||
30628594|NCT01192022|58640397|FG002|Overall Study|Withdrawal of Consent|0|||
30628595|NCT01192022|58640398|FG003|Overall Study|Withdrawal of Consent|0|||
30628596|NCT01192022|58640399|FG004|Overall Study|Withdrawal of Consent|0|||
30628597|NCT01192022|58640395|FG000|Overall Study|Lost to Follow-up|4|||
30628598|NCT01192022|58640396|FG001|Overall Study|Lost to Follow-up|2|||
30628599|NCT01192022|58640397|FG002|Overall Study|Lost to Follow-up|1|||
30628600|NCT01192022|58640398|FG003|Overall Study|Lost to Follow-up|1|||
30628601|NCT01192022|58640399|FG004|Overall Study|Lost to Follow-up|0|||
30628602|NCT01192022|58640395|FG000|Overall Study|Adverse Event|1|||
30628603|NCT01192022|58640396|FG001|Overall Study|Adverse Event|0|||
30628604|NCT01192022|58640397|FG002|Overall Study|Adverse Event|0|||
30628605|NCT01192022|58640398|FG003|Overall Study|Adverse Event|0|||
30628606|NCT01192022|58640399|FG004|Overall Study|Adverse Event|0|||
30628607|NCT01192022|58640395|FG000|Overall Study|Fatal Adverse Event|4|||
30628608|NCT01192022|58640396|FG001|Overall Study|Fatal Adverse Event|6|||
30628609|NCT01192022|58640397|FG002|Overall Study|Fatal Adverse Event|0|||
30628610|NCT01192022|58640398|FG003|Overall Study|Fatal Adverse Event|0|||
30628611|NCT01192022|58640399|FG004|Overall Study|Fatal Adverse Event|1|||
30628612|NCT01192022|58640395|FG000|Overall Study|Physician withdrew-patient hardship|1|||
30628613|NCT01192022|58640396|FG001|Overall Study|Physician withdrew-patient hardship|0|||
30628614|NCT01192022|58640397|FG002|Overall Study|Physician withdrew-patient hardship|0|||
30628615|NCT01192022|58640398|FG003|Overall Study|Physician withdrew-patient hardship|0|||
30628616|NCT01192022|58640399|FG004|Overall Study|Physician withdrew-patient hardship|0|||
30628617|NCT01192022|58640395|FG000|Overall Study|Patient too sick from chemotherapy|0|||
30628618|NCT01192022|58640396|FG001|Overall Study|Patient too sick from chemotherapy|1|||
30628619|NCT01192022|58640397|FG002|Overall Study|Patient too sick from chemotherapy|0|||
30628620|NCT01192022|58640398|FG003|Overall Study|Patient too sick from chemotherapy|0|||
30628621|NCT01192022|58640399|FG004|Overall Study|Patient too sick from chemotherapy|0|||
30628622|NCT01192022|58640395|FG000|Overall Study|Patient needed surgery|0|||
30628623|NCT01192022|58640396|FG001|Overall Study|Patient needed surgery|1|||
30628624|NCT01192022|58640397|FG002|Overall Study|Patient needed surgery|0|||
30628625|NCT01192022|58640398|FG003|Overall Study|Patient needed surgery|0|||
30628626|NCT01192022|58640399|FG004|Overall Study|Patient needed surgery|0|||
30628627|NCT01192022|58640395|FG000|Overall Study|Parents did not allow all follow up|0|||
30628628|NCT01192022|58640396|FG001|Overall Study|Parents did not allow all follow up|0|||
30628629|NCT01192022|58640397|FG002|Overall Study|Parents did not allow all follow up|0|||
30628630|NCT01192022|58640398|FG003|Overall Study|Parents did not allow all follow up|1|||
30628631|NCT01192022|58640399|FG004|Overall Study|Parents did not allow all follow up|0|||
30628632|NCT01191944|58640412|FG000|Overall Study|Adverse Event|11|||
30628633|NCT01191944|58640413|FG001|Overall Study|Adverse Event|12|||
30628634|NCT01191944|58640412|FG000|Overall Study|Protocol Violation|1|||
30628635|NCT01191944|58640413|FG001|Overall Study|Protocol Violation|2|||
30628636|NCT01191944|58640412|FG000|Overall Study|Withdrawal by Subject|4|||
30628637|NCT01191944|58640413|FG001|Overall Study|Withdrawal by Subject|2|||
30628638|NCT01191944|58640412|FG000|Overall Study|Other|1|||
30628639|NCT01191944|58640413|FG001|Overall Study|Other|3|||
30628640|NCT01191788|58640421|FG000|Overall Study|Lost to Follow-up|21|||
30628641|NCT01191788|58640422|FG001|Overall Study|Lost to Follow-up|22|||
30628642|NCT00940875|58640431|FG000|Treatment Phase|Adverse Event|9|||
30628643|NCT00940875|58640432|FG001|Treatment Phase|Adverse Event|3|||
30628644|NCT00940875|58640431|FG000|Treatment Phase|Death|3|||
30628645|NCT00940875|58640432|FG001|Treatment Phase|Death|5|||
30628646|NCT00940875|58640431|FG000|Treatment Phase|Lack of Efficacy|1|||
30628647|NCT00940875|58640432|FG001|Treatment Phase|Lack of Efficacy|0|||
30628648|NCT00940875|58640431|FG000|Treatment Phase|Withdrawal by Subject|3|||
30628649|NCT00940875|58640432|FG001|Treatment Phase|Withdrawal by Subject|0|||
30628650|NCT00940875|58640431|FG000|Treatment Phase|Disease progression|9|||
30628651|NCT00940875|58640432|FG001|Treatment Phase|Disease progression|11|||
30628652|NCT00940875|58640431|FG000|Treatment Phase|Physician Decision|1|||
30628653|NCT00940875|58640432|FG001|Treatment Phase|Physician Decision|0|||
30628654|NCT00940875|58640431|FG000|Post-Study Treatment|Death|0|||
30628655|NCT00940875|58640432|FG001|Post-Study Treatment|Death|1|||
30628656|NCT00940875|58640431|FG000|Post-Study Treatment|Disease Progression|0|||
30628657|NCT00940875|58640432|FG001|Post-Study Treatment|Disease Progression|2|||
30628658|NCT00940485|58640441|FG000|Overall Study|HBeAb positive at Baseline|3|||
30628659|NCT00940485|58640442|FG001|Overall Study|HBeAb positive at Baseline|2|||
30628660|NCT00940485|58640441|FG000|Overall Study|Lost to Follow-up|2|||
30628661|NCT00940485|58640442|FG001|Overall Study|Lost to Follow-up|3|||
30628662|NCT00940485|58640441|FG000|Overall Study|Adverse Event|8|||
30628663|NCT00940485|58640442|FG001|Overall Study|Adverse Event|0|||
30628664|NCT00940485|58640441|FG000|Overall Study|Withdrawal by Subject|1|||
30628665|NCT00940485|58640442|FG001|Overall Study|Withdrawal by Subject|1|||
30628666|NCT00940485|58640441|FG000|Overall Study|Others|1|||
30628667|NCT00940485|58640442|FG001|Overall Study|Others|1|||
30628668|NCT00943605|58640450|FG000|Overall Study|Study termination|30|||
30628669|NCT00943605|58640451|FG001|Overall Study|Study termination|30|||
30628670|NCT01132313|58640469|FG000|Overall Study|Lack of Efficacy|1|||
30628671|NCT01132313|58640470|FG001|Overall Study|Lack of Efficacy|0|||
30628672|NCT01132313|58640471|FG002|Overall Study|Lack of Efficacy|0|||
30628673|NCT01132313|58640472|FG003|Overall Study|Lack of Efficacy|0|||
30628674|NCT01132313|58640473|FG004|Overall Study|Lack of Efficacy|0|||
30628675|NCT01132313|58640474|FG005|Overall Study|Lack of Efficacy|0|||
30628676|NCT01132313|58640475|FG006|Overall Study|Lack of Efficacy|0|||
30628677|NCT01132313|58640476|FG007|Overall Study|Lack of Efficacy|3|||
30628678|NCT01132313|58640477|FG008|Overall Study|Lack of Efficacy|14|||
30628679|NCT01132313|58640478|FG009|Overall Study|Lack of Efficacy|16|||
30628680|NCT01132313|58640479|FG010|Overall Study|Lack of Efficacy|0|||
30628681|NCT01132313|58640480|FG011|Overall Study|Lack of Efficacy|0|||
30628682|NCT01132313|58640469|FG000|Overall Study|Not treated|2|||
30628683|NCT01132313|58640470|FG001|Overall Study|Not treated|0|||
30628684|NCT01132313|58640471|FG002|Overall Study|Not treated|0|||
30628685|NCT01132313|58640472|FG003|Overall Study|Not treated|0|||
30628686|NCT01132313|58640473|FG004|Overall Study|Not treated|2|||
30628687|NCT01132313|58640474|FG005|Overall Study|Not treated|1|||
30628688|NCT01132313|58640475|FG006|Overall Study|Not treated|3|||
30628689|NCT01132313|58640476|FG007|Overall Study|Not treated|0|||
30628690|NCT01132313|58640477|FG008|Overall Study|Not treated|0|||
30628691|NCT01132313|58640478|FG009|Overall Study|Not treated|0|||
30628692|NCT01132313|58640479|FG010|Overall Study|Not treated|0|||
30628693|NCT01132313|58640480|FG011|Overall Study|Not treated|0|||
30628694|NCT01132313|58640469|FG000|Overall Study|Adverse Event|0|||
30628695|NCT01132313|58640470|FG001|Overall Study|Adverse Event|0|||
30628696|NCT01132313|58640471|FG002|Overall Study|Adverse Event|4|||
30628697|NCT01132313|58640472|FG003|Overall Study|Adverse Event|10|||
30628698|NCT01132313|58640473|FG004|Overall Study|Adverse Event|19|||
30628699|NCT01132313|58640474|FG005|Overall Study|Adverse Event|6|||
30628700|NCT01132313|58640475|FG006|Overall Study|Adverse Event|5|||
30628701|NCT01132313|58640476|FG007|Overall Study|Adverse Event|3|||
30628702|NCT01132313|58640477|FG008|Overall Study|Adverse Event|7|||
30628703|NCT01132313|58640478|FG009|Overall Study|Adverse Event|2|||
30628704|NCT01132313|58640479|FG010|Overall Study|Adverse Event|0|||
30628705|NCT01132313|58640480|FG011|Overall Study|Adverse Event|0|||
30628706|NCT01132313|58640469|FG000|Overall Study|Protocol Violation|0|||
30628707|NCT01132313|58640470|FG001|Overall Study|Protocol Violation|0|||
30628708|NCT01132313|58640471|FG002|Overall Study|Protocol Violation|0|||
30628709|NCT01132313|58640472|FG003|Overall Study|Protocol Violation|1|||
30628710|NCT01132313|58640473|FG004|Overall Study|Protocol Violation|0|||
30628711|NCT01132313|58640474|FG005|Overall Study|Protocol Violation|0|||
30628712|NCT01132313|58640475|FG006|Overall Study|Protocol Violation|0|||
30628713|NCT01132313|58640476|FG007|Overall Study|Protocol Violation|0|||
30628714|NCT01132313|58640477|FG008|Overall Study|Protocol Violation|0|||
30763628|NCT00077610|58772333|FG000|Overall Study|Change in dialysis modality|1|||
30763629|NCT00077610|58772334|FG001|Overall Study|Change in dialysis modality|0|||
30628715|NCT01132313|58640478|FG009|Overall Study|Protocol Violation|0|||
30628716|NCT01132313|58640479|FG010|Overall Study|Protocol Violation|0|||
30763630|NCT00077610|58772335|FG002|Overall Study|Change in dialysis modality|0|||
30763631|NCT00077610|58772333|FG000|Overall Study|Relocation|0|||
30763632|NCT00077610|58772334|FG001|Overall Study|Relocation|8|||
30763633|NCT00077610|58772335|FG002|Overall Study|Relocation|5|||
30763634|NCT00077610|58772333|FG000|Overall Study|Financial issues|0|||
30763635|NCT00077610|58772334|FG001|Overall Study|Financial issues|1|||
30763636|NCT00077610|58772335|FG002|Overall Study|Financial issues|0|||
30763637|NCT00077610|58772333|FG000|Overall Study|Sponsors decision to withdraw|0|||
30763638|NCT00077610|58772334|FG001|Overall Study|Sponsors decision to withdraw|0|||
30763639|NCT00077610|58772335|FG002|Overall Study|Sponsors decision to withdraw|1|||
30848039|NCT02447302|58873899|FG000|Overall Study|Sponsor Decision|0|||
30848040|NCT02447302|58873900|FG001|Overall Study|Sponsor Decision|0|||
30848041|NCT02447302|58873901|FG002|Overall Study|Sponsor Decision|1|||
30848042|NCT02454517|58873911|FG000|Overall Study|Withdrawal by Subject|3|||
30848043|NCT02454517|58873912|FG001|Overall Study|Withdrawal by Subject|0|||
30848044|NCT02454517|58873911|FG000|Overall Study|Lost to Follow-up|4|||
30848045|NCT02454517|58873912|FG001|Overall Study|Lost to Follow-up|7|||
30950721|NCT01928381|58997586|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
30950722|NCT01928381|58997587|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
30628717|NCT01132313|58640480|FG011|Overall Study|Protocol Violation|0|||
30628718|NCT01132313|58640469|FG000|Overall Study|Lost to Follow-up|0|||
30628719|NCT01132313|58640470|FG001|Overall Study|Lost to Follow-up|0|||
30628720|NCT01132313|58640471|FG002|Overall Study|Lost to Follow-up|1|||
30763640|NCT03385564|58772352|FG000|Overall Study|Adverse Event|0|||
30763641|NCT03385564|58772353|FG001|Overall Study|Adverse Event|0|||
30848046|NCT02454517|58873911|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
30628721|NCT01132313|58640472|FG003|Overall Study|Lost to Follow-up|0|||
30628722|NCT01132313|58640473|FG004|Overall Study|Lost to Follow-up|0|||
30628723|NCT01132313|58640474|FG005|Overall Study|Lost to Follow-up|0|||
30628724|NCT01132313|58640475|FG006|Overall Study|Lost to Follow-up|0|||
30628725|NCT01132313|58640476|FG007|Overall Study|Lost to Follow-up|1|||
30628726|NCT01132313|58640477|FG008|Overall Study|Lost to Follow-up|0|||
30763642|NCT03385564|58772354|FG002|Overall Study|Adverse Event|3|||
30763643|NCT03385564|58772355|FG003|Overall Study|Adverse Event|3|||
30628727|NCT01132313|58640478|FG009|Overall Study|Lost to Follow-up|0|||
30628728|NCT01132313|58640479|FG010|Overall Study|Lost to Follow-up|0|||
30763644|NCT03385564|58772352|FG000|Overall Study|Other than listed|0|||
30763645|NCT03385564|58772353|FG001|Overall Study|Other than listed|0|||
30763646|NCT03385564|58772354|FG002|Overall Study|Other than listed|0|||
30763647|NCT03385564|58772355|FG003|Overall Study|Other than listed|5|||
30763648|NCT03385564|58772352|FG000|Overall Study|Withdrawal by Subject|0|||
30763649|NCT03385564|58772353|FG001|Overall Study|Withdrawal by Subject|1|||
30763650|NCT03385564|58772354|FG002|Overall Study|Withdrawal by Subject|1|||
30628729|NCT01132313|58640480|FG011|Overall Study|Lost to Follow-up|0|||
30628730|NCT01132313|58640469|FG000|Overall Study|Withdrawal by Subject|0|||
30628731|NCT01132313|58640470|FG001|Overall Study|Withdrawal by Subject|0|||
30628732|NCT01132313|58640471|FG002|Overall Study|Withdrawal by Subject|3|||
30628733|NCT01132313|58640472|FG003|Overall Study|Withdrawal by Subject|3|||
30628734|NCT01132313|58640473|FG004|Overall Study|Withdrawal by Subject|6|||
30628735|NCT01132313|58640474|FG005|Overall Study|Withdrawal by Subject|0|||
30628736|NCT01132313|58640475|FG006|Overall Study|Withdrawal by Subject|1|||
30628737|NCT01132313|58640476|FG007|Overall Study|Withdrawal by Subject|0|||
30628738|NCT01132313|58640477|FG008|Overall Study|Withdrawal by Subject|0|||
30628739|NCT01132313|58640478|FG009|Overall Study|Withdrawal by Subject|2|||
30628740|NCT01132313|58640479|FG010|Overall Study|Withdrawal by Subject|0|||
30628741|NCT01132313|58640480|FG011|Overall Study|Withdrawal by Subject|0|||
30628742|NCT01132313|58640469|FG000|Overall Study|Lack of antiviral response|0|||
30628743|NCT01132313|58640470|FG001|Overall Study|Lack of antiviral response|0|||
30628744|NCT01132313|58640471|FG002|Overall Study|Lack of antiviral response|12|||
30628745|NCT01132313|58640472|FG003|Overall Study|Lack of antiviral response|18|||
30628746|NCT01132313|58640473|FG004|Overall Study|Lack of antiviral response|18|||
30628747|NCT01132313|58640474|FG005|Overall Study|Lack of antiviral response|18|||
30628748|NCT01132313|58640475|FG006|Overall Study|Lack of antiviral response|21|||
30628749|NCT01132313|58640476|FG007|Overall Study|Lack of antiviral response|0|||
30628750|NCT01132313|58640477|FG008|Overall Study|Lack of antiviral response|0|||
30628751|NCT01132313|58640478|FG009|Overall Study|Lack of antiviral response|0|||
30628752|NCT01132313|58640479|FG010|Overall Study|Lack of antiviral response|1|||
30628753|NCT01132313|58640480|FG011|Overall Study|Lack of antiviral response|0|||
30628754|NCT01132313|58640469|FG000|Overall Study|Other reason not defined above|0|||
30628755|NCT01132313|58640470|FG001|Overall Study|Other reason not defined above|0|||
30628756|NCT01132313|58640471|FG002|Overall Study|Other reason not defined above|0|||
30628757|NCT01132313|58640472|FG003|Overall Study|Other reason not defined above|0|||
30628758|NCT01132313|58640473|FG004|Overall Study|Other reason not defined above|0|||
30628759|NCT01132313|58640474|FG005|Overall Study|Other reason not defined above|0|||
30763651|NCT03385564|58772355|FG003|Overall Study|Withdrawal by Subject|0|||
30763652|NCT03385564|58772352|FG000|Overall Study|Lack of Efficacy|0|||
30628760|NCT01132313|58640475|FG006|Overall Study|Other reason not defined above|0|||
30628761|NCT01132313|58640476|FG007|Overall Study|Other reason not defined above|1|||
30628762|NCT01132313|58640477|FG008|Overall Study|Other reason not defined above|0|||
30763653|NCT03385564|58772353|FG001|Overall Study|Lack of Efficacy|0|||
30763654|NCT03385564|58772354|FG002|Overall Study|Lack of Efficacy|0|||
30763655|NCT03385564|58772355|FG003|Overall Study|Lack of Efficacy|1|||
30628763|NCT01132313|58640478|FG009|Overall Study|Other reason not defined above|0|||
30628764|NCT01132313|58640479|FG010|Overall Study|Other reason not defined above|0|||
30763656|NCT03385564|58772352|FG000|Overall Study|Death|0|||
30763657|NCT03385564|58772353|FG001|Overall Study|Death|0|||
30763658|NCT03385564|58772354|FG002|Overall Study|Death|1|||
30763659|NCT03385564|58772355|FG003|Overall Study|Death|0|||
30763660|NCT00066222|58772365|FG000|Overall Study|No protocol treatment received|1|||
30763661|NCT00397943|58772374|FG000|Overall Study|Unspecified reasons|12|||
30763662|NCT00397943|58772375|FG001|Overall Study|Unspecified reasons|9|||
30763663|NCT00397943|58772376|FG002|Overall Study|Unspecified reasons|0|||
30763664|NCT00397943|58772377|FG003|Overall Study|Unspecified reasons|0|||
30763665|NCT00397943|58772378|FG004|Overall Study|Unspecified reasons|0|||
30763666|NCT00066066|58772393|FG000|Overall Study|Lost to Follow-up|6|||
30763667|NCT00066066|58772394|FG001|Overall Study|Lost to Follow-up|4|||
30763668|NCT00066066|58772395|FG002|Overall Study|Lost to Follow-up|7|||
30763669|NCT00066066|58772396|FG003|Overall Study|Lost to Follow-up|4|||
30763670|NCT00066066|58772397|FG004|Overall Study|Lost to Follow-up|3|||
30763671|NCT00066066|58772398|FG005|Overall Study|Lost to Follow-up|5|||
30763672|NCT00363467|58772412|FG000|Overall Study|Physician Decision|1|||
30763673|NCT00397631|58772418|FG000|Overall Study|Adverse Event|5|||
30848047|NCT02454517|58873912|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
30628765|NCT01132313|58640480|FG011|Overall Study|Other reason not defined above|0|||
30628766|NCT00861757|58640515|FG000|Overall Study|Adverse Event|1|||
30628767|NCT00861757|58640516|FG001|Overall Study|Adverse Event|5|||
30628768|NCT00861757|58640517|FG002|Overall Study|Adverse Event|7|||
30628769|NCT00861757|58640518|FG003|Overall Study|Adverse Event|2|||
30628770|NCT00861757|58640515|FG000|Overall Study|Entry Criteria Not Met|1|||
30628771|NCT00861757|58640516|FG001|Overall Study|Entry Criteria Not Met|2|||
30628772|NCT00861757|58640517|FG002|Overall Study|Entry Criteria Not Met|1|||
30628773|NCT00861757|58640518|FG003|Overall Study|Entry Criteria Not Met|1|||
30628774|NCT00861757|58640515|FG000|Overall Study|Lack of Efficacy|3|||
30628775|NCT00861757|58640516|FG001|Overall Study|Lack of Efficacy|1|||
30628776|NCT00861757|58640517|FG002|Overall Study|Lack of Efficacy|0|||
30628777|NCT00861757|58640518|FG003|Overall Study|Lack of Efficacy|1|||
30628778|NCT00861757|58640515|FG000|Overall Study|Lost to Follow-up|1|||
30628779|NCT00861757|58640516|FG001|Overall Study|Lost to Follow-up|0|||
30628780|NCT00861757|58640517|FG002|Overall Study|Lost to Follow-up|1|||
30628781|NCT00861757|58640518|FG003|Overall Study|Lost to Follow-up|1|||
30628782|NCT00861757|58640515|FG000|Overall Study|Physician Decision|0|||
30628783|NCT00861757|58640516|FG001|Overall Study|Physician Decision|0|||
30628784|NCT00861757|58640517|FG002|Overall Study|Physician Decision|0|||
30628785|NCT00861757|58640518|FG003|Overall Study|Physician Decision|1|||
30628786|NCT00861757|58640515|FG000|Overall Study|Protocol Violation|2|||
30628787|NCT00861757|58640516|FG001|Overall Study|Protocol Violation|2|||
30628788|NCT00861757|58640517|FG002|Overall Study|Protocol Violation|4|||
30628789|NCT00861757|58640518|FG003|Overall Study|Protocol Violation|1|||
30628790|NCT00861757|58640515|FG000|Overall Study|Withdrawal by Subject|1|||
30628791|NCT00861757|58640516|FG001|Overall Study|Withdrawal by Subject|5|||
30628792|NCT00861757|58640517|FG002|Overall Study|Withdrawal by Subject|5|||
30628793|NCT00861757|58640518|FG003|Overall Study|Withdrawal by Subject|2|||
30628794|NCT01131455|58640535|FG000|Overall Study|Death of PI|6|||
30763674|NCT00397631|58772419|FG001|Overall Study|Adverse Event|6|||
30628795|NCT01131455|58640536|FG001|Overall Study|Death of PI|4|||
30763675|NCT00397631|58772418|FG000|Overall Study|Lack of Efficacy|7|||
30848048|NCT03861039|58873923|FG000|Overall Study|Adverse Event|2|||
30848049|NCT03861039|58873924|FG001|Overall Study|Adverse Event|5|||
30763676|NCT00397631|58772419|FG001|Overall Study|Lack of Efficacy|10|||
30763677|NCT00397631|58772418|FG000|Overall Study|Lost to Follow-up|8|||
30763678|NCT00397631|58772419|FG001|Overall Study|Lost to Follow-up|9|||
30763679|NCT00397631|58772418|FG000|Overall Study|Physician Decision|2|||
30763680|NCT00397631|58772419|FG001|Overall Study|Physician Decision|0|||
30763681|NCT00397631|58772418|FG000|Overall Study|Protocol Violation|0|||
30763682|NCT00397631|58772419|FG001|Overall Study|Protocol Violation|1|||
30763683|NCT00397631|58772418|FG000|Overall Study|Withdrawal by Subject|7|||
30763684|NCT00397631|58772419|FG001|Overall Study|Withdrawal by Subject|14|||
30763685|NCT00397631|58772418|FG000|Overall Study|protocol discontinuation criteria|1|||
30763686|NCT00397631|58772419|FG001|Overall Study|protocol discontinuation criteria|4|||
30763687|NCT00077376|58772425|FG000|Overall Study|Adverse Event|8|||
30763688|NCT00077376|58772425|FG000|Overall Study|Withdrawal by Subject|2|||
30763689|NCT00077376|58772425|FG000|Overall Study|Death|1|||
30763690|NCT00077376|58772425|FG000|Overall Study|Physician Decision|1|||
30763691|NCT00077376|58772425|FG000|Overall Study|Alternative therapy|5|||
30763692|NCT00077376|58772425|FG000|Overall Study|Complicating disease|1|||
30628796|NCT01131455|58640537|FG002|Overall Study|Death of PI|0|||
30628797|NCT01138007|58640548|FG000|Overall Study|Adverse Event|4|||
30763693|NCT00077376|58772425|FG000|Overall Study|Still on treatment|1|||
30763694|NCT00077376|58772425|FG000|Overall Study|Symptomatic deterioration|1|||
30763695|NCT00077376|58772425|FG000|Overall Study|Surgery|1|||
30763696|NCT00077376|58772425|FG000|Overall Study|Insurance ran out|1|||
30763697|NCT00363311|58772431|FG000|Overall Study|Adverse Event|6|||
30763698|NCT00363311|58772432|FG001|Overall Study|Adverse Event|4|||
30763699|NCT00363311|58772431|FG000|Overall Study|Lost to Follow-up|3|||
30763700|NCT00363311|58772432|FG001|Overall Study|Lost to Follow-up|0|||
30763701|NCT00363311|58772431|FG000|Overall Study|Protocol Violation|1|||
30763702|NCT00363311|58772432|FG001|Overall Study|Protocol Violation|2|||
30763703|NCT00363311|58772431|FG000|Overall Study|Withdrawal by Subject|12|||
30763704|NCT00363311|58772432|FG001|Overall Study|Withdrawal by Subject|6|||
30763705|NCT00363311|58772431|FG000|Overall Study|Physician Decision|1|||
30763706|NCT00363311|58772432|FG001|Overall Study|Physician Decision|1|||
30763707|NCT00363311|58772431|FG000|Overall Study|Sponsor Terminated Study|2|||
30763708|NCT00363311|58772432|FG001|Overall Study|Sponsor Terminated Study|2|||
30763709|NCT00363311|58772431|FG000|Overall Study|Disease Progression|46|||
30763710|NCT00363311|58772432|FG001|Overall Study|Disease Progression|26|||
30763711|NCT00363311|58772431|FG000|Overall Study|Non-Compliance|1|||
30628798|NCT01138007|58640549|FG001|Overall Study|Adverse Event|12|||
30628799|NCT01138007|58640550|FG002|Overall Study|Adverse Event|9|||
30628800|NCT01138007|58640548|FG000|Overall Study|Lack of Efficacy|2|||
30628801|NCT01138007|58640549|FG001|Overall Study|Lack of Efficacy|0|||
30628802|NCT01138007|58640550|FG002|Overall Study|Lack of Efficacy|6|||
30628803|NCT01138007|58640548|FG000|Overall Study|Protocol Violation|2|||
30628804|NCT01138007|58640549|FG001|Overall Study|Protocol Violation|3|||
30628805|NCT01138007|58640550|FG002|Overall Study|Protocol Violation|2|||
30763712|NCT00363311|58772432|FG001|Overall Study|Non-Compliance|1|||
30763713|NCT00363311|58772431|FG000|Overall Study|Participant Refused Biopsy|1|||
30763714|NCT00363311|58772432|FG001|Overall Study|Participant Refused Biopsy|0|||
30848050|NCT03861039|58873925|FG002|Overall Study|Adverse Event|11|||
30763715|NCT00363311|58772431|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
30763716|NCT00363311|58772432|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
30848051|NCT03861039|58873923|FG000|Overall Study|Withdrawal by Subject|1|||
30628806|NCT01138007|58640548|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
30628807|NCT01138007|58640549|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
30763717|NCT00363311|58772431|FG000|Overall Study|Participant Opted for Treatment|1|||
30763718|NCT00363311|58772432|FG001|Overall Study|Participant Opted for Treatment|0|||
30763719|NCT00363311|58772431|FG000|Overall Study|Participant Moved to Another Country|1|||
30848052|NCT03861039|58873924|FG001|Overall Study|Withdrawal by Subject|3|||
30763720|NCT00363311|58772432|FG001|Overall Study|Participant Moved to Another Country|0|||
30763721|NCT00363311|58772431|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
30763722|NCT00363311|58772432|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
30763723|NCT00363311|58772431|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
30763724|NCT00363311|58772432|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
30763725|NCT00363311|58772431|FG000|Overall Study|Participant Moved to Louisiana|0|||
30763726|NCT00363311|58772432|FG001|Overall Study|Participant Moved to Louisiana|1|||
30763727|NCT00362609|58772440|FG000|Overall Study|Withdrawal by Subject|0|||
30628808|NCT01138007|58640550|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
30628809|NCT01138007|58640548|FG000|Overall Study|Lost to Follow-up|3|||
30628810|NCT01138007|58640549|FG001|Overall Study|Lost to Follow-up|3|||
30628811|NCT01138007|58640550|FG002|Overall Study|Lost to Follow-up|5|||
30628812|NCT01138007|58640548|FG000|Overall Study|Physician Decision|0|||
30628813|NCT01138007|58640549|FG001|Overall Study|Physician Decision|5|||
30628814|NCT01138007|58640550|FG002|Overall Study|Physician Decision|3|||
30628815|NCT01138007|58640548|FG000|Overall Study|Withdrawal by Subject|5|||
30848053|NCT03861039|58873925|FG002|Overall Study|Withdrawal by Subject|4|||
30848054|NCT02731755|58873935|FG000|First Intervention|Withdrawal by Subject|0|||
30848055|NCT02731755|58873936|FG001|First Intervention|Withdrawal by Subject|2|||
30848056|NCT02866175|58873965|FG000|Overall Study|Adverse Event|56|||
30848057|NCT02866175|58873966|FG001|Overall Study|Adverse Event|54|||
30848058|NCT02866175|58873965|FG000|Overall Study|Withdrawal by Subject|31|||
30848059|NCT02866175|58873966|FG001|Overall Study|Withdrawal by Subject|52|||
30848060|NCT02866175|58873965|FG000|Overall Study|Death|30|||
30848061|NCT02866175|58873966|FG001|Overall Study|Death|23|||
30848062|NCT02866175|58873965|FG000|Overall Study|Other|7|||
30848063|NCT02866175|58873966|FG001|Overall Study|Other|14|||
30848064|NCT02866175|58873965|FG000|Overall Study|Progressive disease|1|||
30848065|NCT02866175|58873966|FG001|Overall Study|Progressive disease|1|||
30950723|NCT01928381|58997588|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
30950724|NCT01928381|58997589|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
30950725|NCT01928225|58997601|FG000|Overall Study|Pregnancy|1|||
30950726|NCT01928225|58997602|FG001|Overall Study|Pregnancy|0|||
30950727|NCT01928225|58997601|FG000|Overall Study|basaloid cervical cancer|1|||
30950728|NCT01928225|58997602|FG001|Overall Study|basaloid cervical cancer|0|||
30628816|NCT01138007|58640549|FG001|Overall Study|Withdrawal by Subject|6|||
30628817|NCT01138007|58640550|FG002|Overall Study|Withdrawal by Subject|15|||
30628818|NCT00865345|58640560|FG000|Overall Study|Withdrawal by Subject|2|||
30628819|NCT01131299|58640564|FG000|Overall Study|Withdrawal by Subject|4|||
30628820|NCT01131299|58640565|FG001|Overall Study|Withdrawal by Subject|7|||
30628821|NCT01130831|58640570|FG000|Overall Study|Withdrawal by Subject|7|||
30628822|NCT01130831|58640570|FG000|Overall Study|Death|4|||
30628823|NCT01130831|58640570|FG000|Overall Study|Information was missing|3|||
30763728|NCT00362609|58772441|FG001|Overall Study|Withdrawal by Subject|1|||
30763729|NCT00362609|58772440|FG000|Overall Study|Protocol Violation|0|||
30763730|NCT00362609|58772441|FG001|Overall Study|Protocol Violation|1|||
30763731|NCT00362375|58772449|FG000|Overall Study|Lost to Follow-up|40|||
30763732|NCT00362375|58772450|FG001|Overall Study|Lost to Follow-up|35|||
30763733|NCT00362297|58772458|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
30763734|NCT00362297|58772459|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
30763735|NCT00065442|58772467|FG000|Overall Study|Lost to Follow-up|1|||
30763736|NCT00065442|58772468|FG001|Overall Study|Lost to Follow-up|1|||
30763737|NCT00065442|58772467|FG000|Overall Study|Death|121|||
30763738|NCT00065442|58772468|FG001|Overall Study|Death|210|||
30763739|NCT00065442|58772467|FG000|Overall Study|Withdrawal by Subject|3|||
30763740|NCT00065442|58772468|FG001|Overall Study|Withdrawal by Subject|9|||
30763741|NCT00090402|58772477|FG000|Overall Study|Death|1|||
30763742|NCT00090402|58772478|FG001|Overall Study|Death|1|||
30848066|NCT02866175|58873965|FG000|Overall Study|Lost to Follow-up|2|||
30848067|NCT02866175|58873966|FG001|Overall Study|Lost to Follow-up|0|||
30950729|NCT01928225|58997601|FG000|Overall Study|Lost to Follow-up|1|||
30628824|NCT01130597|58640586|FG000|Overall Study|Protocol-specified (High K+)|1|||
30628825|NCT01130597|58640586|FG000|Overall Study|Adverse Event|4|||
30628826|NCT01130597|58640586|FG000|Overall Study|Death|1|||
30628827|NCT01130597|58640586|FG000|Overall Study|Protocol Violation|1|||
30628828|NCT00939003|58640592|FG000|Double-blind Treatment Period|Adverse Event|1|||
30628829|NCT00939003|58640593|FG001|Double-blind Treatment Period|Adverse Event|1|||
30628830|NCT00939003|58640592|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
30628831|NCT00939003|58640593|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
30628832|NCT00939003|58640592|FG000|Double-blind Treatment Period|Pregnancy|0|||
30628833|NCT00939003|58640593|FG001|Double-blind Treatment Period|Pregnancy|1|||
30628834|NCT00939003|58640592|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
30628835|NCT00939003|58640593|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
30628836|NCT00939003|58640592|FG000|Open-label Treatment Period|Adverse Event|4|||
30628837|NCT00939003|58640593|FG001|Open-label Treatment Period|Adverse Event|8|||
30628838|NCT00939003|58640592|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
30628839|NCT00939003|58640593|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
30628840|NCT00939003|58640592|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
30628841|NCT00939003|58640593|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
30628842|NCT00939003|58640592|FG000|Open-label Treatment Period|Pregnancy|1|||
30628843|NCT00939003|58640593|FG001|Open-label Treatment Period|Pregnancy|1|||
30628844|NCT00939003|58640592|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
30628845|NCT00939003|58640593|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
30628846|NCT00939003|58640592|FG000|Open-label Treatment Period|Site Closure|3|||
30628847|NCT00939003|58640593|FG001|Open-label Treatment Period|Site Closure|4|||
30628848|NCT01188668|58640602|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
30628849|NCT01188668|58640602|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
30628850|NCT01188668|58640602|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
30628851|NCT01130051|58640609|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
30628852|NCT01130051|58640610|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
30628853|NCT01130051|58640609|FG000|Washout Period of 14 Days|Protocol Violation|1|||
30628854|NCT01130051|58640610|FG001|Washout Period of 14 Days|Protocol Violation|1|||
30628855|NCT00865189|58640618|FG000|Overall Study|Other|1|||
30628856|NCT00865189|58640619|FG001|Overall Study|Other|2|||
30628857|NCT00865189|58640618|FG000|Overall Study|Death|4|||
30628858|NCT00865189|58640619|FG001|Overall Study|Death|11|||
30628859|NCT00865189|58640618|FG000|Overall Study|Lost to Follow-up|6|||
30628860|NCT00865189|58640619|FG001|Overall Study|Lost to Follow-up|6|||
30628861|NCT00865189|58640618|FG000|Overall Study|Withdrawal by Subject|1|||
30628862|NCT00865189|58640619|FG001|Overall Study|Withdrawal by Subject|0|||
30628863|NCT01182194|58640627|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
30628864|NCT01182194|58640628|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
30848068|NCT02866175|58873965|FG000|Overall Study|Lack of Efficacy|0|||
30628865|NCT01181726|58640636|FG000|First Intervention|Adverse Event|1|||
30628866|NCT01181726|58640637|FG001|First Intervention|Adverse Event|0|||
30628867|NCT01137071|58640643|FG000|Overall Study|Disease Progression|11|||
30628868|NCT01137071|58640643|FG000|Overall Study|Withdrawal by Subject|2|||
30628869|NCT01137071|58640643|FG000|Overall Study|Wrongly Included|1|||
30628870|NCT00860743|58640658|FG000|Overall Study|Withdrawal by Subject|3|||
30848069|NCT02866175|58873966|FG001|Overall Study|Lack of Efficacy|1|||
30628871|NCT00860743|58640659|FG001|Overall Study|Withdrawal by Subject|0|||
30628872|NCT01186796|58640667|FG000|Overall Study|Adverse Event|3|||
30628873|NCT01186796|58640668|FG001|Overall Study|Adverse Event|0|||
30628874|NCT01186796|58640667|FG000|Overall Study|Withdrawal by Subject|1|||
30628875|NCT01186796|58640668|FG001|Overall Study|Withdrawal by Subject|1|||
30628876|NCT01186796|58640667|FG000|Overall Study|Protocol Violation|0|||
30628877|NCT01186796|58640668|FG001|Overall Study|Protocol Violation|1|||
30848070|NCT02866175|58873965|FG000|Overall Study|Physician Decision|3|||
30848071|NCT02866175|58873966|FG001|Overall Study|Physician Decision|15|||
30628878|NCT01136915|58640676|FG000|Overall Study|Lost to Follow-up|2|||
30628879|NCT01136915|58640677|FG001|Overall Study|Lost to Follow-up|0|||
30628880|NCT01136915|58640676|FG000|Overall Study|Exclusion criterion met|0|||
30628881|NCT01136915|58640677|FG001|Overall Study|Exclusion criterion met|1|||
30628882|NCT00940017|58640685|FG000|Overall Study|did not meet entrance criteria|3|||
30628883|NCT00940017|58640685|FG000|Overall Study|Adverse Event|1|||
30628884|NCT01129583|58640691|FG000|Overall Study|Death|1|||
30628885|NCT01129583|58640692|FG001|Overall Study|Death|0|||
30628886|NCT01129583|58640691|FG000|Overall Study|Lost to Follow-up|1|||
30628887|NCT01129583|58640692|FG001|Overall Study|Lost to Follow-up|1|||
30628888|NCT01129583|58640691|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
30628889|NCT01129583|58640692|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
30628890|NCT01186328|58640698|FG000|Overall Study|Death|1|||
30628891|NCT01186328|58640699|FG001|Overall Study|Death|0|||
30628892|NCT01186328|58640700|FG002|Overall Study|Death|0|||
30628893|NCT00848497|58640707|FG000|Overall Study|Screen failure|2|||
30628894|NCT00848497|58640708|FG001|Overall Study|Screen failure|0|||
30628895|NCT00848497|58640707|FG000|Overall Study|Withdrawal by Subject|0|||
30628896|NCT00848497|58640708|FG001|Overall Study|Withdrawal by Subject|1|||
30628897|NCT00857623|58640718|FG000|Overall Study|Adverse Event|5|||
30628898|NCT00857623|58640719|FG001|Overall Study|Adverse Event|2|||
30628899|NCT00857623|58640718|FG000|Overall Study|Study-specific discontinuation criteria|5|||
30628900|NCT00857623|58640719|FG001|Overall Study|Study-specific discontinuation criteria|3|||
30628901|NCT00857623|58640718|FG000|Overall Study|Withdrawal by Subject|2|||
30628902|NCT00857623|58640719|FG001|Overall Study|Withdrawal by Subject|1|||
30628903|NCT00857623|58640718|FG000|Overall Study|Lack of Efficacy|1|||
30628904|NCT00857623|58640719|FG001|Overall Study|Lack of Efficacy|1|||
30628905|NCT00857623|58640718|FG000|Overall Study|Severe non-compliance to protocol|1|||
30628906|NCT00857623|58640719|FG001|Overall Study|Severe non-compliance to protocol|1|||
30628907|NCT00857623|58640718|FG000|Overall Study|Intake of prohibited medication|0|||
30628908|NCT00857623|58640719|FG001|Overall Study|Intake of prohibited medication|1|||
30628909|NCT00857623|58640718|FG000|Overall Study|Positive for HEP C|0|||
30628910|NCT00857623|58640719|FG001|Overall Study|Positive for HEP C|1|||
30628911|NCT01185782|58640727|FG000|Overall Study|Adverse Event|0|||
30628912|NCT01185782|58640728|FG001|Overall Study|Adverse Event|1|||
30628913|NCT01185782|58640727|FG000|Overall Study|Protocol Violation|1|||
30628914|NCT01185782|58640728|FG001|Overall Study|Protocol Violation|0|||
30628915|NCT01185782|58640727|FG000|Overall Study|Poor Response to Treatment|3|||
30628916|NCT01185782|58640728|FG001|Overall Study|Poor Response to Treatment|1|||
30628917|NCT01185782|58640727|FG000|Overall Study|Other|2|||
30628918|NCT01185782|58640728|FG001|Overall Study|Other|5|||
30628919|NCT01185782|58640727|FG000|Overall Study|Randomized but not treated|0|||
30628920|NCT01185782|58640728|FG001|Overall Study|Randomized but not treated|4|||
30628921|NCT01129115|58640738|FG000|Overall Study|Adverse Event|1|||
30628922|NCT01129115|58640739|FG001|Overall Study|Adverse Event|2|||
30628923|NCT01129115|58640740|FG002|Overall Study|Adverse Event|3|||
30628924|NCT01129115|58640741|FG003|Overall Study|Adverse Event|3|||
30628925|NCT01129115|58640738|FG000|Overall Study|Withdrawal by Subject|1|||
30628926|NCT01129115|58640739|FG001|Overall Study|Withdrawal by Subject|3|||
30628927|NCT01129115|58640740|FG002|Overall Study|Withdrawal by Subject|1|||
30628928|NCT01129115|58640741|FG003|Overall Study|Withdrawal by Subject|4|||
30628929|NCT01129115|58640738|FG000|Overall Study|Protocol Violation|0|||
30628930|NCT01129115|58640739|FG001|Overall Study|Protocol Violation|2|||
30628931|NCT01129115|58640740|FG002|Overall Study|Protocol Violation|2|||
30628932|NCT01129115|58640741|FG003|Overall Study|Protocol Violation|2|||
30628933|NCT01185704|58640753|FG000|Overall Study|Randomized but not treated|3|||
30628934|NCT01185704|58640754|FG001|Overall Study|Randomized but not treated|3|||
30628935|NCT01185704|58640753|FG000|Overall Study|Lack of ovarian response|5|||
30628936|NCT01185704|58640754|FG001|Overall Study|Lack of ovarian response|1|||
30628937|NCT01185704|58640753|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
30628938|NCT01185704|58640754|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
30628939|NCT01185704|58640753|FG000|Overall Study|Ectopic pregnancy|0|||
30628940|NCT01185704|58640754|FG001|Overall Study|Ectopic pregnancy|1|||
30628941|NCT01128959|58640760|FG000|Lead in Period|Adverse Event|3|||
30628942|NCT01128959|58640760|FG000|Treatment Period|Adverse Event|3|||
30628943|NCT01128959|58640760|FG000|Treatment Period|Withdrawal by Subject|1|||
30628944|NCT00859573|58640768|FG000|Overall Study|Withdrawal by Subject|4|||
30628945|NCT00859573|58640769|FG001|Overall Study|Withdrawal by Subject|1|||
30628946|NCT00859573|58640768|FG000|Overall Study|Physician Decision|1|||
30628947|NCT00859573|58640769|FG001|Overall Study|Physician Decision|1|||
30628948|NCT01136291|58640777|FG000|Overall Study|Lost to Follow-up|1|||
30628949|NCT01136291|58640778|FG001|Overall Study|Lost to Follow-up|1|||
30628950|NCT01185548|58640784|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
30628951|NCT01128569|58640797|FG000|Washout Period 1|Adverse Event|0|||
30628952|NCT01128569|58640798|FG001|Washout Period 1|Adverse Event|0|||
30628953|NCT01128569|58640799|FG002|Washout Period 1|Adverse Event|1|||
30628954|NCT01128569|58640800|FG003|Washout Period 1|Adverse Event|0|||
30628955|NCT01128569|58640801|FG004|Washout Period 1|Adverse Event|0|||
30628956|NCT01128569|58640802|FG005|Washout Period 1|Adverse Event|0|||
30763743|NCT00090402|58772479|FG002|Overall Study|Death|0|||
30763744|NCT00090402|58772477|FG000|Overall Study|subject moved|0|||
30763745|NCT00090402|58772478|FG001|Overall Study|subject moved|1|||
30763746|NCT00090402|58772479|FG002|Overall Study|subject moved|0|||
30763747|NCT00090402|58772477|FG000|Overall Study|stopped taking study medication|1|||
30763748|NCT00090402|58772478|FG001|Overall Study|stopped taking study medication|0|||
30763749|NCT00090402|58772479|FG002|Overall Study|stopped taking study medication|1|||
30763750|NCT00361283|58772490|FG000|Overall Study|Lost to Follow-up|27|||
30763751|NCT00077064|58772496|FG000|Overall Study|Adverse Event|0|||
30763752|NCT00077064|58772497|FG001|Overall Study|Adverse Event|4|||
30763753|NCT00077064|58772496|FG000|Overall Study|Patient refusal|0|||
30763754|NCT00077064|58772497|FG001|Overall Study|Patient refusal|2|||
30763755|NCT00396383|58772504|FG000|Overall Study|Death|2|||
30763756|NCT00396383|58772504|FG000|Overall Study|Lost to Follow-up|1|||
30763757|NCT00395447|58772510|FG000|Overall Study|Death|37|||
30763758|NCT00395447|58772511|FG001|Overall Study|Death|32|||
30763759|NCT00395447|58772510|FG000|Overall Study|Lost to Follow-up|52|||
30763760|NCT00395447|58772511|FG001|Overall Study|Lost to Follow-up|43|||
30763761|NCT00395447|58772510|FG000|Overall Study|Withdrawal by Subject|24|||
30763762|NCT00395447|58772511|FG001|Overall Study|Withdrawal by Subject|19|||
30763763|NCT00395447|58772510|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
30763764|NCT00395447|58772511|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
30763765|NCT03404674|58772523|FG000|Overall Study|Inability to Attend Future Visits|0|||
30763766|NCT03404674|58772524|FG001|Overall Study|Inability to Attend Future Visits|1|||
30763767|NCT03404674|58772525|FG002|Overall Study|Inability to Attend Future Visits|1|||
30763768|NCT03404674|58772526|FG003|Overall Study|Inability to Attend Future Visits|0|||
30763769|NCT03404674|58772527|FG004|Overall Study|Inability to Attend Future Visits|0|||
30763770|NCT03404674|58772528|FG005|Overall Study|Inability to Attend Future Visits|0|||
30763771|NCT03404674|58772523|FG000|Overall Study|Behavioral Problems|0|||
30763772|NCT03404674|58772524|FG001|Overall Study|Behavioral Problems|0|||
30763773|NCT03404674|58772525|FG002|Overall Study|Behavioral Problems|1|||
30763774|NCT03404674|58772526|FG003|Overall Study|Behavioral Problems|0|||
30763775|NCT03404674|58772527|FG004|Overall Study|Behavioral Problems|0|||
30763776|NCT03404674|58772528|FG005|Overall Study|Behavioral Problems|0|||
30763777|NCT03404674|58772523|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
30763778|NCT03404674|58772524|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
30763779|NCT03404674|58772525|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
30848072|NCT02866175|58873965|FG000|Overall Study|Did not receive treatment|5|||
30848073|NCT02866175|58873966|FG001|Overall Study|Did not receive treatment|15|||
30628957|NCT01128569|58640797|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30763780|NCT03404674|58772526|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
30763781|NCT03404674|58772527|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
30763782|NCT03404674|58772528|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
30763783|NCT00064662|58772545|FG000|Overall Study|Death|1|||
30848074|NCT01336205|58873979|FG000|Overall Study|Other|22|||
30848075|NCT01336205|58873980|FG001|Overall Study|Other|9|||
30763784|NCT00064662|58772546|FG001|Overall Study|Death|1|||
30763785|NCT00064662|58772545|FG000|Overall Study|Lost to Follow-up|57|||
30763786|NCT00064662|58772546|FG001|Overall Study|Lost to Follow-up|44|||
30763787|NCT00064662|58772545|FG000|Overall Study|Withdrawal by Subject|14|||
30763788|NCT00064662|58772546|FG001|Overall Study|Withdrawal by Subject|14|||
30763789|NCT00064662|58772545|FG000|Overall Study|Administratively withdrawn|2|||
30763790|NCT00064662|58772546|FG001|Overall Study|Administratively withdrawn|2|||
30763791|NCT03404518|58772554|FG000|Overall Study|Lost to Follow-up|28|||
30950730|NCT01928225|58997602|FG001|Overall Study|Lost to Follow-up|3|||
30628958|NCT01128569|58640798|FG001|Treatment Period 2|Withdrawal by Subject|1|||
30628959|NCT01128569|58640799|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30628960|NCT01128569|58640800|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30628961|NCT01128569|58640801|FG004|Treatment Period 2|Withdrawal by Subject|0|||
30628962|NCT01128569|58640802|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30628963|NCT01128413|58640812|FG000|Overall Study|Withdrawal by Subject|1|||
30628964|NCT01128413|58640813|FG001|Overall Study|Withdrawal by Subject|0|||
30628965|NCT01128413|58640812|FG000|Overall Study|NICOM Monitor Problems|2|||
30628966|NCT01128413|58640813|FG001|Overall Study|NICOM Monitor Problems|1|||
30628967|NCT01128413|58640812|FG000|Overall Study|Pt made DNR|1|||
30628968|NCT01128413|58640813|FG001|Overall Study|Pt made DNR|0|||
30628969|NCT01185080|58640822|FG000|Overall Study|Adverse Event|1|||
30628970|NCT01185080|58640823|FG001|Overall Study|Adverse Event|1|||
30628971|NCT01185080|58640824|FG002|Overall Study|Adverse Event|0|||
30628972|NCT01185080|58640822|FG000|Overall Study|Personal reasons|0|||
30628973|NCT01185080|58640823|FG001|Overall Study|Personal reasons|0|||
30628974|NCT01185080|58640824|FG002|Overall Study|Personal reasons|1|||
30628975|NCT01128179|58640834|FG000|Overall Study|Death|1|||
30628976|NCT01128179|58640835|FG001|Overall Study|Death|0|||
30628977|NCT01128179|58640834|FG000|Overall Study|Protocol Violation|1|||
30628978|NCT01128179|58640835|FG001|Overall Study|Protocol Violation|0|||
30628979|NCT01181102|58640843|FG000|Overall Study|Adverse Event|28|||
30628980|NCT01181102|58640844|FG001|Overall Study|Adverse Event|26|||
30628981|NCT01181102|58640843|FG000|Overall Study|Lack of Efficacy|3|||
30628982|NCT01181102|58640844|FG001|Overall Study|Lack of Efficacy|1|||
30628983|NCT01181102|58640843|FG000|Overall Study|Lost to Follow-up|2|||
30628984|NCT01181102|58640844|FG001|Overall Study|Lost to Follow-up|0|||
30950731|NCT01927757|58997609|FG000|Overall Study|Withdrawal by Subject|14|||
30950732|NCT01927757|58997609|FG000|Overall Study|Lost to Follow-up|2|||
30950733|NCT01927757|58997609|FG000|Overall Study|Decision by Sponsor|2|||
30950734|NCT01927757|58997609|FG000|Overall Study|Other|1|||
30950735|NCT01927757|58997609|FG000|Overall Study|Ethical Reasons|4|||
30950736|NCT01927367|58997619|FG000|Overall Study|Withdrawal by Subject|7|||
30950737|NCT01927367|58997620|FG001|Overall Study|Withdrawal by Subject|4|||
30950738|NCT01927367|58997619|FG000|Overall Study|No baseline data|0|||
30950739|NCT01927367|58997620|FG001|Overall Study|No baseline data|1|||
30950740|NCT01913639|58997626|FG000|Overall Study|Not Eligible|3|||
30950741|NCT01913483|58997632|FG000|Overall Study|Withdrawal by Subject|1|||
30950742|NCT01913483|58997633|FG001|Overall Study|Withdrawal by Subject|2|||
30950743|NCT01913483|58997632|FG000|Overall Study|Lost to Follow-up|6|||
30950744|NCT01913483|58997633|FG001|Overall Study|Lost to Follow-up|3|||
30950745|NCT01913483|58997632|FG000|Overall Study|Death|14|||
30950746|NCT01913483|58997633|FG001|Overall Study|Death|17|||
30950747|NCT01913405|58997639|FG000|Overall Study|Withdrawal by Subject|1|||
30950748|NCT01913405|58997639|FG000|Overall Study|Adverse Event|1|||
30950749|NCT01927055|58997659|FG000|Open-label|Adverse Event|6|||
30628985|NCT01181102|58640843|FG000|Overall Study|Physician Decision|3|||
30628986|NCT01181102|58640844|FG001|Overall Study|Physician Decision|1|||
30628987|NCT01181102|58640843|FG000|Overall Study|Protocol Violation|5|||
30628988|NCT01181102|58640844|FG001|Overall Study|Protocol Violation|6|||
30628989|NCT01181102|58640843|FG000|Overall Study|Withdrawal by Subject|10|||
30628990|NCT01181102|58640844|FG001|Overall Study|Withdrawal by Subject|12|||
30763792|NCT03404518|58772555|FG001|Overall Study|Lost to Follow-up|30|||
30763793|NCT03404518|58772554|FG000|Overall Study|Protocol Violation|13|||
30763794|NCT03404518|58772555|FG001|Overall Study|Protocol Violation|6|||
30848076|NCT01336205|58873979|FG000|Overall Study|Lost to Follow-up|40|||
30950750|NCT01927055|58997660|FG001|Open-label|Adverse Event|0|||
30950751|NCT01927055|58997661|FG002|Open-label|Adverse Event|0|||
30950752|NCT01927055|58997659|FG000|Open-label|Withdrawal by Subject|1|||
30950753|NCT01927055|58997660|FG001|Open-label|Withdrawal by Subject|0|||
30950754|NCT01927055|58997661|FG002|Open-label|Withdrawal by Subject|0|||
30950755|NCT01927055|58997659|FG000|Open-label|Study Stopped|4|||
30763795|NCT03404206|58772564|FG000|Overall Study|Withdrawal by Subject|1|||
30763796|NCT03404206|58772565|FG001|Overall Study|Withdrawal by Subject|1|||
30763797|NCT03404206|58772566|FG002|Overall Study|Withdrawal by Subject|0|||
30763798|NCT03404206|58772564|FG000|Overall Study|Lost to Follow-up|3|||
30763799|NCT03404206|58772565|FG001|Overall Study|Lost to Follow-up|1|||
30763800|NCT03404206|58772566|FG002|Overall Study|Lost to Follow-up|0|||
30763801|NCT03403426|58772574|FG000|Overall Study|Death|1|||
30848077|NCT01336205|58873980|FG001|Overall Study|Lost to Follow-up|20|||
30628991|NCT00858637|58640852|FG000|Active Comparison Phase|Adverse Event|14|||
30628992|NCT00858637|58640853|FG001|Active Comparison Phase|Adverse Event|0|||
30628993|NCT00858637|58640854|FG002|Active Comparison Phase|Adverse Event|0|||
30628994|NCT00858637|58640855|FG003|Active Comparison Phase|Adverse Event|9|||
30628995|NCT00858637|58640856|FG004|Active Comparison Phase|Adverse Event|0|||
30628996|NCT00858637|58640857|FG005|Active Comparison Phase|Adverse Event|0|||
30628997|NCT00858637|58640852|FG000|Active Comparison Phase|Death|1|||
30628998|NCT00858637|58640853|FG001|Active Comparison Phase|Death|0|||
30628999|NCT00858637|58640854|FG002|Active Comparison Phase|Death|0|||
30629000|NCT00858637|58640855|FG003|Active Comparison Phase|Death|1|||
30629001|NCT00858637|58640856|FG004|Active Comparison Phase|Death|0|||
30629002|NCT00858637|58640857|FG005|Active Comparison Phase|Death|0|||
30629003|NCT00858637|58640852|FG000|Active Comparison Phase|Physician Decision|1|||
30629004|NCT00858637|58640853|FG001|Active Comparison Phase|Physician Decision|0|||
30629005|NCT00858637|58640854|FG002|Active Comparison Phase|Physician Decision|0|||
30629006|NCT00858637|58640855|FG003|Active Comparison Phase|Physician Decision|1|||
30629007|NCT00858637|58640856|FG004|Active Comparison Phase|Physician Decision|0|||
30629008|NCT00858637|58640857|FG005|Active Comparison Phase|Physician Decision|0|||
30629009|NCT00858637|58640852|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
30629010|NCT00858637|58640853|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
30629011|NCT00858637|58640854|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
30629012|NCT00858637|58640855|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
30629013|NCT00858637|58640856|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
30629014|NCT00858637|58640857|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
30629015|NCT00858637|58640852|FG000|Active Comparison Phase|Other Reasons|1|||
30629016|NCT00858637|58640853|FG001|Active Comparison Phase|Other Reasons|0|||
30629017|NCT00858637|58640854|FG002|Active Comparison Phase|Other Reasons|0|||
30629018|NCT00858637|58640855|FG003|Active Comparison Phase|Other Reasons|1|||
30629019|NCT00858637|58640856|FG004|Active Comparison Phase|Other Reasons|0|||
30629020|NCT00858637|58640857|FG005|Active Comparison Phase|Other Reasons|0|||
30629021|NCT00858637|58640852|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
30629022|NCT00858637|58640853|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
30629023|NCT00858637|58640854|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
30629024|NCT00858637|58640855|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
30629025|NCT00858637|58640856|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
30629026|NCT00858637|58640857|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
30629027|NCT00858637|58640852|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
30629028|NCT00858637|58640853|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
30629029|NCT00858637|58640854|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
30629030|NCT00858637|58640855|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
30629031|NCT00858637|58640856|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
30629032|NCT00858637|58640857|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
30629033|NCT00858403|58640867|FG000|Overall Study|Withdrawal by Subject|1|||
30629034|NCT00858403|58640867|FG000|Overall Study|Death|3|||
30629035|NCT00858403|58640867|FG000|Overall Study|Disease Progression|1|||
30629036|NCT00858247|58640873|FG000|Baseline Assessment|Withdrawal by Subject|1|||
30629037|NCT00858247|58640874|FG001|Baseline Assessment|Withdrawal by Subject|1|||
30950756|NCT01927055|58997660|FG001|Open-label|Study Stopped|0|||
30629038|NCT00858247|58640873|FG000|Baseline Assessment|Poor IV access|1|||
30629039|NCT00858247|58640874|FG001|Baseline Assessment|Poor IV access|0|||
30629040|NCT00858247|58640873|FG000|Baseline Assessment|Protocol Violation|0|||
30629041|NCT00858247|58640874|FG001|Baseline Assessment|Protocol Violation|1|||
30629042|NCT00858247|58640873|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
30629043|NCT00858247|58640874|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
30629044|NCT00838435|58640880|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
30848078|NCT01336205|58873979|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
30950757|NCT01927055|58997661|FG002|Open-label|Study Stopped|0|||
30629045|NCT00838435|58640880|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
30629046|NCT00838435|58640880|FG000|Part 2 (7 Years)|Adverse Event|2|||
30629047|NCT00838435|58640880|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
30763802|NCT03403426|58772574|FG000|Overall Study|Lost to Follow-up|2|||
30763803|NCT00394901|58772582|FG000|Baseline Phase|Protocol Violation|0|||
30763804|NCT00394901|58772583|FG001|Baseline Phase|Protocol Violation|0|||
30763805|NCT00394901|58772584|FG002|Baseline Phase|Protocol Violation|1|||
30763806|NCT00394901|58772585|FG003|Baseline Phase|Protocol Violation|0|||
30763807|NCT00394901|58772582|FG000|Double-blind Phase|Adverse Event|5|||
30763808|NCT00394901|58772583|FG001|Double-blind Phase|Adverse Event|7|||
30763809|NCT00394901|58772584|FG002|Double-blind Phase|Adverse Event|16|||
30763810|NCT00394901|58772585|FG003|Double-blind Phase|Adverse Event|20|||
30763811|NCT00394901|58772582|FG000|Double-blind Phase|Lack of Efficacy|6|||
30763812|NCT00394901|58772583|FG001|Double-blind Phase|Lack of Efficacy|4|||
30763813|NCT00394901|58772584|FG002|Double-blind Phase|Lack of Efficacy|1|||
30763814|NCT00394901|58772585|FG003|Double-blind Phase|Lack of Efficacy|3|||
30763815|NCT00394901|58772582|FG000|Double-blind Phase|Withdrawal by Subject|2|||
30763816|NCT00394901|58772583|FG001|Double-blind Phase|Withdrawal by Subject|0|||
30763817|NCT00394901|58772584|FG002|Double-blind Phase|Withdrawal by Subject|0|||
30763818|NCT00394901|58772585|FG003|Double-blind Phase|Withdrawal by Subject|0|||
30763819|NCT00394901|58772582|FG000|Double-blind Phase|Lost to Follow-up|0|||
30763820|NCT00394901|58772583|FG001|Double-blind Phase|Lost to Follow-up|0|||
30763821|NCT00394901|58772584|FG002|Double-blind Phase|Lost to Follow-up|0|||
30763822|NCT00394901|58772585|FG003|Double-blind Phase|Lost to Follow-up|1|||
30763823|NCT00394901|58772582|FG000|Double-blind Phase|Protocol Violation|0|||
30763824|NCT00394901|58772583|FG001|Double-blind Phase|Protocol Violation|0|||
30763825|NCT00394901|58772584|FG002|Double-blind Phase|Protocol Violation|0|||
30763826|NCT00394901|58772585|FG003|Double-blind Phase|Protocol Violation|1|||
30763827|NCT00394901|58772582|FG000|Double-blind Phase|Death|1|||
30763828|NCT00394901|58772583|FG001|Double-blind Phase|Death|0|||
30763829|NCT00394901|58772584|FG002|Double-blind Phase|Death|0|||
30763830|NCT00394901|58772585|FG003|Double-blind Phase|Death|0|||
30763831|NCT00394901|58772582|FG000|Double-blind Phase|Subject's Personal Reason|1|||
30763832|NCT00394901|58772583|FG001|Double-blind Phase|Subject's Personal Reason|0|||
30763833|NCT00394901|58772584|FG002|Double-blind Phase|Subject's Personal Reason|0|||
30763834|NCT00394901|58772585|FG003|Double-blind Phase|Subject's Personal Reason|1|||
30763835|NCT00394901|58772582|FG000|Double-blind Phase|Lack of Compliance|0|||
30763836|NCT00394901|58772583|FG001|Double-blind Phase|Lack of Compliance|3|||
30763837|NCT00394901|58772584|FG002|Double-blind Phase|Lack of Compliance|0|||
30763838|NCT00394901|58772585|FG003|Double-blind Phase|Lack of Compliance|0|||
30763839|NCT00394901|58772582|FG000|Double-blind Phase|Entry into another study was found|0|||
30763840|NCT00394901|58772583|FG001|Double-blind Phase|Entry into another study was found|0|||
30763841|NCT00394901|58772584|FG002|Double-blind Phase|Entry into another study was found|1|||
30763842|NCT00394901|58772585|FG003|Double-blind Phase|Entry into another study was found|0|||
30763843|NCT00394901|58772582|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
30763844|NCT00394901|58772583|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
30763845|NCT00394901|58772584|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
30763846|NCT00394901|58772585|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
30763847|NCT03349060|58772601|FG000|Overall Study|Adverse Event|9|||
30763848|NCT03349060|58772602|FG001|Overall Study|Adverse Event|9|||
30763849|NCT03349060|58772603|FG002|Overall Study|Adverse Event|7|||
30763850|NCT03349060|58772601|FG000|Overall Study|Lack of Efficacy|1|||
30763851|NCT03349060|58772602|FG001|Overall Study|Lack of Efficacy|0|||
30763852|NCT03349060|58772603|FG002|Overall Study|Lack of Efficacy|2|||
30763853|NCT03349060|58772601|FG000|Overall Study|Lost to Follow-up|2|||
30763854|NCT03349060|58772602|FG001|Overall Study|Lost to Follow-up|1|||
30763855|NCT03349060|58772603|FG002|Overall Study|Lost to Follow-up|1|||
30763856|NCT03349060|58772601|FG000|Overall Study|Protocol Violation|2|||
30763857|NCT03349060|58772602|FG001|Overall Study|Protocol Violation|2|||
30763858|NCT03349060|58772603|FG002|Overall Study|Protocol Violation|1|||
30763859|NCT03349060|58772601|FG000|Overall Study|Withdrawal by Subject|5|||
30763860|NCT03349060|58772602|FG001|Overall Study|Withdrawal by Subject|3|||
30763861|NCT03349060|58772603|FG002|Overall Study|Withdrawal by Subject|4|||
30629048|NCT00838435|58640880|FG000|Part 2 (7 Years)|Physician Decision|1|||
30763862|NCT03349060|58772601|FG000|Overall Study|Medication error,no linked adverse event|0|||
30629049|NCT00838435|58640880|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
30629050|NCT00838435|58640880|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
30629051|NCT00838201|58640889|FG000|Overall Study|Investigator decision, or other reasons|2|||
30629052|NCT00838201|58640890|FG001|Overall Study|Investigator decision, or other reasons|3|||
30629053|NCT00838201|58640889|FG000|Overall Study|Noncompliance|0|||
30629054|NCT00838201|58640890|FG001|Overall Study|Noncompliance|1|||
30629055|NCT00838201|58640889|FG000|Overall Study|Administrative decision|1|||
30629056|NCT00838201|58640890|FG001|Overall Study|Administrative decision|2|||
30629057|NCT00838201|58640889|FG000|Overall Study|Disease progression|3|||
30629058|NCT00838201|58640890|FG001|Overall Study|Disease progression|3|||
30629059|NCT00838201|58640889|FG000|Overall Study|Consent withdrawn|16|||
30629060|NCT00838201|58640890|FG001|Overall Study|Consent withdrawn|19|||
30629061|NCT00838201|58640889|FG000|Overall Study|Lost to Follow-up|4|||
30629062|NCT00838201|58640890|FG001|Overall Study|Lost to Follow-up|3|||
30629063|NCT00838201|58640889|FG000|Overall Study|Adverse Event|5|||
30629064|NCT00838201|58640890|FG001|Overall Study|Adverse Event|9|||
30629065|NCT00838201|58640889|FG000|Overall Study|Death|11|||
30629066|NCT00838201|58640890|FG001|Overall Study|Death|13|||
30629067|NCT00837967|58640896|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
30629068|NCT00837967|58640897|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
30629069|NCT02756806|58640903|FG000|Overall Study|Study terminated early|5|||
30763863|NCT03349060|58772602|FG001|Overall Study|Medication error,no linked adverse event|0|||
30763864|NCT03349060|58772603|FG002|Overall Study|Medication error,no linked adverse event|1|||
30763865|NCT03349060|58772601|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
30763866|NCT03349060|58772602|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
30763867|NCT03349060|58772603|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
30763868|NCT03349060|58772601|FG000|Overall Study|Other|2|||
30763869|NCT03349060|58772602|FG001|Overall Study|Other|1|||
30763870|NCT03349060|58772603|FG002|Overall Study|Other|0|||
30763871|NCT03348904|58772614|FG000|Overall Study|Administrative reason by the sponsor|0|||
30763872|NCT03348904|58772615|FG001|Overall Study|Administrative reason by the sponsor|1|||
30763873|NCT03348904|58772616|FG002|Overall Study|Administrative reason by the sponsor|0|||
30763874|NCT00359021|58772626|FG000|Overall Study|Adverse Event|26|||
30763875|NCT00359021|58772627|FG001|Overall Study|Adverse Event|8|||
30763876|NCT00359021|58772626|FG000|Overall Study|Subject Non-Compliant|1|||
30763877|NCT00359021|58772627|FG001|Overall Study|Subject Non-Compliant|2|||
30763878|NCT00359021|58772626|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
30763879|NCT00359021|58772627|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
30763880|NCT00359021|58772626|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
30763881|NCT00359021|58772627|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
30763882|NCT00359021|58772626|FG000|Overall Study|Withdrawal by Subject|2|||
30763883|NCT00359021|58772627|FG001|Overall Study|Withdrawal by Subject|9|||
30763884|NCT00359021|58772626|FG000|Overall Study|Lost to Follow-up|1|||
30763885|NCT00359021|58772627|FG001|Overall Study|Lost to Follow-up|0|||
30763886|NCT00359021|58772626|FG000|Overall Study|Other|4|||
30763887|NCT00359021|58772627|FG001|Overall Study|Other|1|||
30763888|NCT00359021|58772626|FG000|Overall Study|Pregnancy|1|||
30763889|NCT00359021|58772627|FG001|Overall Study|Pregnancy|0|||
30763890|NCT00360269|58772637|FG000|Overall Study|Lost to Follow-up|7|||
30763891|NCT00360269|58772638|FG001|Overall Study|Lost to Follow-up|9|||
30763892|NCT00360269|58772637|FG000|Overall Study|Physician Decision|1|||
30763893|NCT00360269|58772638|FG001|Overall Study|Physician Decision|2|||
30763894|NCT00360269|58772637|FG000|Overall Study|Adverse Event|1|||
30763895|NCT00360269|58772638|FG001|Overall Study|Adverse Event|0|||
30763896|NCT00360269|58772637|FG000|Overall Study|Withdrawal by Subject|1|||
30763897|NCT00360269|58772638|FG001|Overall Study|Withdrawal by Subject|1|||
30763898|NCT00076752|58772644|FG000|Overall Study|Death|2|||
30763899|NCT00076752|58772644|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
30763900|NCT03384940|58772652|FG000|Overall Study|Progressive disease|36|||
30763901|NCT03384940|58772653|FG001|Overall Study|Progressive disease|11|||
30763902|NCT03384940|58772654|FG002|Overall Study|Progressive disease|13|||
30763903|NCT03384940|58772652|FG000|Overall Study|Clinical progression|4|||
30763904|NCT03384940|58772653|FG001|Overall Study|Clinical progression|0|||
30763905|NCT03384940|58772654|FG002|Overall Study|Clinical progression|3|||
30763906|NCT03384940|58772652|FG000|Overall Study|Adverse Event|7|||
30763907|NCT03384940|58772653|FG001|Overall Study|Adverse Event|1|||
30763908|NCT03384940|58772654|FG002|Overall Study|Adverse Event|1|||
30763909|NCT03384940|58772652|FG000|Overall Study|Withdrawal by Subject|3|||
30763910|NCT03384940|58772653|FG001|Overall Study|Withdrawal by Subject|1|||
30629070|NCT00942357|58640909|FG000|Overall Study|Ineligible|37|||
30629071|NCT00942357|58640910|FG001|Overall Study|Ineligible|40|||
30629072|NCT00939783|58640916|FG000|Overall Study|Death|6|||
30629073|NCT00939783|58640916|FG000|Overall Study|Adverse Event|39|||
30629074|NCT00939783|58640916|FG000|Overall Study|Study Terminated by Sponsor|498|||
30629075|NCT00939783|58640916|FG000|Overall Study|Withdrawal by Subject|78|||
30629076|NCT00939783|58640916|FG000|Overall Study|Other|16|||
30629077|NCT00939783|58640916|FG000|Overall Study|Lost to Follow-up|8|||
30763911|NCT03384940|58772654|FG002|Overall Study|Withdrawal by Subject|0|||
30763912|NCT03384940|58772652|FG000|Overall Study|Physician Decision|1|||
30763913|NCT03384940|58772653|FG001|Overall Study|Physician Decision|1|||
30763914|NCT03384940|58772654|FG002|Overall Study|Physician Decision|0|||
30763915|NCT03384940|58772652|FG000|Overall Study|Death|2|||
30763916|NCT03384940|58772653|FG001|Overall Study|Death|1|||
30763917|NCT03384940|58772654|FG002|Overall Study|Death|0|||
30763918|NCT03384940|58772652|FG000|Overall Study|Other|0|||
30763919|NCT03384940|58772653|FG001|Overall Study|Other|0|||
30763920|NCT03384940|58772654|FG002|Overall Study|Other|1|||
30763921|NCT00075582|58772664|FG000|Overall Study|Adverse Event|3|||
30763922|NCT00075582|58772665|FG001|Overall Study|Adverse Event|1|||
30763923|NCT00075582|58772664|FG000|Overall Study|Lack of Efficacy|4|||
30763924|NCT00075582|58772665|FG001|Overall Study|Lack of Efficacy|8|||
30763925|NCT00075582|58772664|FG000|Overall Study|Physician Decision|5|||
30763926|NCT00075582|58772665|FG001|Overall Study|Physician Decision|8|||
30763927|NCT00075582|58772664|FG000|Overall Study|Withdrawal by Subject|2|||
30763928|NCT00075582|58772665|FG001|Overall Study|Withdrawal by Subject|2|||
30763929|NCT00075582|58772664|FG000|Overall Study|Ineligible for study|36|||
30763930|NCT00075582|58772665|FG001|Overall Study|Ineligible for study|16|||
30763931|NCT00063258|58772677|FG000|Overall Study|Physician Decision|2|||
30763932|NCT00063258|58772678|FG001|Overall Study|Physician Decision|0|||
30848079|NCT01336205|58873980|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
30848080|NCT01336205|58873979|FG000|Overall Study|Lack of Efficacy|4|||
30848081|NCT01336205|58873980|FG001|Overall Study|Lack of Efficacy|0|||
30950758|NCT01927055|58997659|FG000|Open-label|Supine Hypertension|4|||
30950759|NCT01927055|58997660|FG001|Open-label|Supine Hypertension|0|||
30950760|NCT01927055|58997661|FG002|Open-label|Supine Hypertension|0|||
30950761|NCT01927055|58997659|FG000|Open-label|Difficulty attending study visits|1|||
30950762|NCT01927055|58997660|FG001|Open-label|Difficulty attending study visits|0|||
30950763|NCT01927055|58997661|FG002|Open-label|Difficulty attending study visits|0|||
30950764|NCT01927055|58997659|FG000|Double-Blind|Adverse Event|0|||
30950765|NCT01927055|58997660|FG001|Double-Blind|Adverse Event|1|||
30950766|NCT01927055|58997661|FG002|Double-Blind|Adverse Event|1|||
30950767|NCT01927055|58997659|FG000|Double-Blind|Protocol Violation|0|||
30950768|NCT01927055|58997660|FG001|Double-Blind|Protocol Violation|0|||
30950769|NCT01927055|58997661|FG002|Double-Blind|Protocol Violation|1|||
30950770|NCT01927055|58997659|FG000|Double-Blind|Withdrawal by Subject|0|||
30950771|NCT01927055|58997660|FG001|Double-Blind|Withdrawal by Subject|2|||
30950772|NCT01927055|58997661|FG002|Double-Blind|Withdrawal by Subject|3|||
30950773|NCT01927055|58997659|FG000|Double-Blind|Study Stopped|0|||
30950774|NCT01927055|58997660|FG001|Double-Blind|Study Stopped|7|||
30950775|NCT01927055|58997661|FG002|Double-Blind|Study Stopped|7|||
30950776|NCT01927055|58997659|FG000|Double-Blind|Supine Hypertension|0|||
30950777|NCT01927055|58997660|FG001|Double-Blind|Supine Hypertension|0|||
30950778|NCT01927055|58997661|FG002|Double-Blind|Supine Hypertension|1|||
30950779|NCT01927055|58997659|FG000|Double-Blind|Extended Vacation|0|||
30950780|NCT01927055|58997660|FG001|Double-Blind|Extended Vacation|1|||
30950781|NCT01927055|58997661|FG002|Double-Blind|Extended Vacation|0|||
30950782|NCT01913327|58997670|FG000|Overall Study|Withdrawal by Subject|0|||
30950783|NCT01913327|58997671|FG001|Overall Study|Withdrawal by Subject|1|||
30950784|NCT01926509|58997681|FG000|Overall Study|vital sign met discontinuation criteria|1|||
30950785|NCT01926509|58997682|FG001|Overall Study|vital sign met discontinuation criteria|0|||
30950786|NCT01926509|58997683|FG002|Overall Study|vital sign met discontinuation criteria|0|||
30950787|NCT01926509|58997684|FG003|Overall Study|vital sign met discontinuation criteria|0|||
30950788|NCT01926119|58997694|FG000|Overall Study|Withdrawal by Subject|1|||
30629078|NCT00939783|58640916|FG000|Overall Study|Protocol Violation|3|||
30763933|NCT00063258|58772677|FG000|Overall Study|Lack of Efficacy|2|||
30763934|NCT00063258|58772678|FG001|Overall Study|Lack of Efficacy|0|||
30763935|NCT00088530|58772686|FG000|Overall Study|Progressive/Relapsed Disease|28|||
30848082|NCT01336205|58873979|FG000|Overall Study|Severe noncompliance with protocol|9|||
30848083|NCT01336205|58873980|FG001|Overall Study|Severe noncompliance with protocol|2|||
30848084|NCT01336205|58873979|FG000|Overall Study|Adverse Event|56|||
30848085|NCT01336205|58873980|FG001|Overall Study|Adverse Event|6|||
30848086|NCT01336205|58873979|FG000|Overall Study|Death|1|||
30763936|NCT00088530|58772687|FG001|Overall Study|Progressive/Relapsed Disease|39|||
30763937|NCT00088530|58772686|FG000|Overall Study|Adverse Event|15|||
30763938|NCT00088530|58772687|FG001|Overall Study|Adverse Event|9|||
30763939|NCT00088530|58772686|FG000|Overall Study|Withdrawal by Subject|2|||
30848087|NCT01336205|58873980|FG001|Overall Study|Death|1|||
30848088|NCT01336205|58873979|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
30950789|NCT01912781|58997700|FG000|Overall Study|Withdrawal by Subject|2|||
30950790|NCT01912781|58997701|FG001|Overall Study|Withdrawal by Subject|0|||
30950791|NCT01925417|58997708|FG000|Overall Study|Withdrawal by Subject|2|||
30950792|NCT01925417|58997708|FG000|Overall Study|Death|1|||
30950793|NCT01911845|58997713|FG000|Overall Study|Adverse Event|2|||
30950794|NCT01911845|58997713|FG000|Overall Study|Lost to Follow-up|1|||
30950795|NCT01911845|58997713|FG000|Overall Study|Other (not specified)|3|||
30763940|NCT00088530|58772687|FG001|Overall Study|Withdrawal by Subject|5|||
30763941|NCT00088530|58772686|FG000|Overall Study|Lost to Follow-up|2|||
30763942|NCT00088530|58772687|FG001|Overall Study|Lost to Follow-up|0|||
30763943|NCT00088530|58772686|FG000|Overall Study|Physician Decision|2|||
30763944|NCT00088530|58772687|FG001|Overall Study|Physician Decision|0|||
30763945|NCT00088530|58772686|FG000|Overall Study|Sponsor decision|0|||
30763946|NCT00088530|58772687|FG001|Overall Study|Sponsor decision|1|||
30763947|NCT00088530|58772686|FG000|Overall Study|Patient never treated|1|||
30763948|NCT00088530|58772687|FG001|Overall Study|Patient never treated|0|||
30950796|NCT01925183|58997721|FG000|Overall Study|Adverse Event|1|||
30848089|NCT01336205|58873980|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
30848090|NCT01336205|58873979|FG000|Overall Study|Withdrawal by Subject|72|||
30848091|NCT01336205|58873980|FG001|Overall Study|Withdrawal by Subject|38|||
30848092|NCT01336205|58873979|FG000|Overall Study|Did not receive treatment|4|||
30848093|NCT01336205|58873980|FG001|Overall Study|Did not receive treatment|0|||
30848094|NCT02865395|58873989|FG000|Overall Study|Physician Decision|6|||
30848095|NCT02865395|58873990|FG001|Overall Study|Physician Decision|10|||
30848096|NCT02865395|58873991|FG002|Overall Study|Physician Decision|7|||
30848097|NCT01123707|58874003|FG000|Overall Study|Lost to Follow-up|3|||
30848098|NCT01123707|58874004|FG001|Overall Study|Lost to Follow-up|1|||
30848099|NCT01123707|58874005|FG002|Overall Study|Lost to Follow-up|3|||
30848100|NCT01123707|58874006|FG003|Overall Study|Lost to Follow-up|2|||
30848101|NCT01123707|58874003|FG000|Overall Study|Adverse Event|5|||
30848102|NCT01123707|58874004|FG001|Overall Study|Adverse Event|7|||
30848103|NCT01123707|58874005|FG002|Overall Study|Adverse Event|5|||
30848104|NCT01123707|58874006|FG003|Overall Study|Adverse Event|3|||
30848105|NCT01123707|58874003|FG000|Overall Study|Sponsor Discontinued Study|30|||
30848106|NCT01123707|58874004|FG001|Overall Study|Sponsor Discontinued Study|24|||
30848107|NCT01123707|58874005|FG002|Overall Study|Sponsor Discontinued Study|25|||
30848108|NCT01123707|58874006|FG003|Overall Study|Sponsor Discontinued Study|40|||
30848109|NCT01123707|58874003|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
30848110|NCT01123707|58874004|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
30848111|NCT01123707|58874005|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
30848112|NCT01123707|58874006|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
30848113|NCT01123707|58874003|FG000|Overall Study|Investigator Withdrew Participant|0|||
30848114|NCT01123707|58874004|FG001|Overall Study|Investigator Withdrew Participant|1|||
30950797|NCT01925183|58997722|FG001|Overall Study|Adverse Event|0|||
30950798|NCT01910519|58997730|FG000|Overall Study|Withdrawal by Subject|2|||
30950799|NCT01910519|58997731|FG001|Overall Study|Withdrawal by Subject|0|||
30950800|NCT01910519|58997730|FG000|Overall Study|Adverse Event|2|||
30763949|NCT00359801|58772695|FG000|Overall Study|Lost to Follow-up|72|||
30763950|NCT00359801|58772696|FG001|Overall Study|Lost to Follow-up|58|||
30763951|NCT00359801|58772695|FG000|Overall Study|Withdrawal by Subject|143|||
30763952|NCT00359801|58772696|FG001|Overall Study|Withdrawal by Subject|96|||
30763953|NCT00359801|58772695|FG000|Overall Study|Other|66|||
30763954|NCT00359801|58772696|FG001|Overall Study|Other|46|||
30763955|NCT00359801|58772695|FG000|Overall Study|Final Status Unknown: missing data|7|||
30763956|NCT00359801|58772696|FG001|Overall Study|Final Status Unknown: missing data|4|||
30763957|NCT00359801|58772695|FG000|Overall Study|Sponsor Decision|17|||
30763958|NCT00359801|58772696|FG001|Overall Study|Sponsor Decision|16|||
30763959|NCT00045032|58772705|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
30763960|NCT00045032|58772706|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
30763961|NCT00045032|58772707|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
30763962|NCT00045032|58772705|FG000|Overall Study|Death|22|||
30763963|NCT00045032|58772706|FG001|Overall Study|Death|24|||
30763964|NCT00045032|58772707|FG002|Overall Study|Death|17|||
30763965|NCT00045032|58772705|FG000|Overall Study|Insufficient Therapeutic Response|542|||
30763966|NCT00045032|58772706|FG001|Overall Study|Insufficient Therapeutic Response|437|||
30763967|NCT00045032|58772707|FG002|Overall Study|Insufficient Therapeutic Response|445|||
30763968|NCT00045032|58772705|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
30763969|NCT00045032|58772706|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
30763970|NCT00045032|58772707|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
30763971|NCT00045032|58772705|FG000|Overall Study|Other Protocol Violation|2|||
30763972|NCT00045032|58772706|FG001|Overall Study|Other Protocol Violation|0|||
30950801|NCT01910519|58997731|FG001|Overall Study|Adverse Event|0|||
30763973|NCT00045032|58772707|FG002|Overall Study|Other Protocol Violation|1|||
30763974|NCT00045032|58772705|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
30763975|NCT00045032|58772706|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
30763976|NCT00045032|58772707|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
30763977|NCT00045032|58772705|FG000|Overall Study|Failure to Return|57|||
30763978|NCT00045032|58772706|FG001|Overall Study|Failure to Return|62|||
30848115|NCT01123707|58874005|FG002|Overall Study|Investigator Withdrew Participant|1|||
30848116|NCT01123707|58874006|FG003|Overall Study|Investigator Withdrew Participant|1|||
30848117|NCT01123707|58874003|FG000|Overall Study|Subject Withdrew Consent|4|||
30848118|NCT01123707|58874004|FG001|Overall Study|Subject Withdrew Consent|5|||
30848119|NCT01123707|58874005|FG002|Overall Study|Subject Withdrew Consent|1|||
30763979|NCT00045032|58772707|FG002|Overall Study|Failure to Return|61|||
30763980|NCT00045032|58772705|FG000|Overall Study|Other|93|||
30763981|NCT00045032|58772706|FG001|Overall Study|Other|84|||
30848120|NCT01123707|58874006|FG003|Overall Study|Subject Withdrew Consent|2|||
30848121|NCT01123707|58874003|FG000|Overall Study|Lack of Efficacy|1|||
30848122|NCT01123707|58874004|FG001|Overall Study|Lack of Efficacy|2|||
30848123|NCT01123707|58874005|FG002|Overall Study|Lack of Efficacy|1|||
30848124|NCT01123707|58874006|FG003|Overall Study|Lack of Efficacy|0|||
30848125|NCT01123707|58874003|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
30848126|NCT01123707|58874004|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
30848127|NCT01123707|58874005|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
30848128|NCT01123707|58874006|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
30848129|NCT02755103|58874018|FG000|Overall Study|Lost to Follow-up|17|||
30848130|NCT02755103|58874019|FG001|Overall Study|Lost to Follow-up|15|||
30848131|NCT02755103|58874018|FG000|Overall Study|Death|0|||
30848132|NCT02755103|58874019|FG001|Overall Study|Death|1|||
30848133|NCT02755103|58874018|FG000|Overall Study|Physician Decision|0|||
30848134|NCT02755103|58874019|FG001|Overall Study|Physician Decision|1|||
30848135|NCT02755103|58874018|FG000|Overall Study|Pregnancy|0|||
30848136|NCT02755103|58874019|FG001|Overall Study|Pregnancy|1|||
30848137|NCT02755103|58874018|FG000|Overall Study|Withdrawal by Subject|3|||
30848138|NCT02755103|58874019|FG001|Overall Study|Withdrawal by Subject|0|||
30848139|NCT01258803|58874029|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
30848140|NCT01258803|58874030|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
30848141|NCT01258803|58874031|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
30848142|NCT01258803|58874032|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
30950802|NCT01910441|58997739|FG000|Overall Study|Sponsor decision|0|||
30950803|NCT01910441|58997740|FG001|Overall Study|Sponsor decision|2|||
30629079|NCT00939783|58640916|FG000|Overall Study|Enrolled but not treated|1|||
30763982|NCT00045032|58772707|FG002|Overall Study|Other|105|||
30763983|NCT00356915|58772720|FG000|Overall Study|Non compliance|1|||
30763984|NCT00356915|58772721|FG001|Overall Study|Non compliance|2|||
30763985|NCT00356915|58772722|FG002|Overall Study|Non compliance|1|||
30763986|NCT00356915|58772720|FG000|Overall Study|Protocol Violation|2|||
30763987|NCT00356915|58772721|FG001|Overall Study|Protocol Violation|3|||
30763988|NCT00356915|58772722|FG002|Overall Study|Protocol Violation|2|||
30763989|NCT00356915|58772720|FG000|Overall Study|Withdrawal by Subject|14|||
30763990|NCT00356915|58772721|FG001|Overall Study|Withdrawal by Subject|14|||
30763991|NCT00356915|58772722|FG002|Overall Study|Withdrawal by Subject|10|||
30763992|NCT00356915|58772720|FG000|Overall Study|Lack of Efficacy|0|||
30763993|NCT00356915|58772721|FG001|Overall Study|Lack of Efficacy|0|||
30763994|NCT00356915|58772722|FG002|Overall Study|Lack of Efficacy|3|||
30763995|NCT00356915|58772720|FG000|Overall Study|Lost to Follow-up|27|||
30763996|NCT00356915|58772721|FG001|Overall Study|Lost to Follow-up|34|||
30763997|NCT00356915|58772722|FG002|Overall Study|Lost to Follow-up|14|||
30763998|NCT00356915|58772720|FG000|Overall Study|Administrative Decision|0|||
30763999|NCT00356915|58772721|FG001|Overall Study|Administrative Decision|0|||
30764000|NCT00356915|58772722|FG002|Overall Study|Administrative Decision|1|||
30764001|NCT00356915|58772720|FG000|Overall Study|Physician Decision|0|||
30764002|NCT00356915|58772721|FG001|Overall Study|Physician Decision|2|||
30764003|NCT00356915|58772722|FG002|Overall Study|Physician Decision|0|||
30764004|NCT00356915|58772720|FG000|Overall Study|Adverse Event|21|||
30764005|NCT00356915|58772721|FG001|Overall Study|Adverse Event|31|||
30764006|NCT00356915|58772722|FG002|Overall Study|Adverse Event|8|||
30764007|NCT00356915|58772720|FG000|Overall Study|Miscellaneous reasons|11|||
30764008|NCT00356915|58772721|FG001|Overall Study|Miscellaneous reasons|8|||
30764009|NCT00356915|58772722|FG002|Overall Study|Miscellaneous reasons|3|||
30764010|NCT00356759|58772738|FG000|Overall Study|Death|5|||
30848143|NCT01258803|58874033|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
30950804|NCT01910441|58997739|FG000|Overall Study|Lost to Follow-up|6|||
30950805|NCT01910441|58997740|FG001|Overall Study|Lost to Follow-up|5|||
30950806|NCT01910441|58997739|FG000|Overall Study|Withdrawal by Subject|0|||
30629080|NCT00939627|58640922|FG000|Overall Study|Disease Progression|16|||
30629081|NCT00939627|58640923|FG001|Overall Study|Disease Progression|12|||
30764011|NCT00356759|58772739|FG001|Overall Study|Death|2|||
30848144|NCT01258803|58874034|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
30848145|NCT01258803|58874029|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
30848146|NCT01258803|58874030|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
30629082|NCT00939627|58640924|FG002|Overall Study|Disease Progression|0|||
30629083|NCT00939627|58640922|FG000|Overall Study|Adverse Event|6|||
30764012|NCT00356759|58772738|FG000|Overall Study|Withdrawal by Subject|2|||
30848147|NCT01258803|58874031|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
30950807|NCT01910441|58997740|FG001|Overall Study|Withdrawal by Subject|1|||
30950808|NCT01910441|58997739|FG000|Overall Study|Non-compliance|0|||
30950809|NCT01910441|58997740|FG001|Overall Study|Non-compliance|1|||
30950810|NCT01910441|58997739|FG000|Overall Study|Adverse Event|1|||
30950811|NCT01910441|58997740|FG001|Overall Study|Adverse Event|0|||
30950812|NCT01910441|58997739|FG000|Overall Study|Physician Decision|0|||
30950813|NCT01910441|58997740|FG001|Overall Study|Physician Decision|1|||
30950814|NCT01923467|58997746|FG000|Overall Study|Lost to Follow-up|62|||
30950815|NCT01923467|58997746|FG000|Overall Study|Subject non-interest|479|||
30950816|NCT01910129|58997752|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
30950817|NCT01910129|58997753|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
30950818|NCT01910129|58997754|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
30950819|NCT01910129|58997752|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
30950820|NCT01910129|58997753|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
30950821|NCT01910129|58997754|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
30950822|NCT01909973|58997774|FG000|Overall Study|Lost to Follow-up|1|||
30950823|NCT01909973|58997775|FG001|Overall Study|Lost to Follow-up|0|||
30950824|NCT01617005|58997781|FG000|Overall Study|Pregnancy|1|||
30950825|NCT01617005|58997781|FG000|Overall Study|Lack of motivation for treatment|1|||
30950826|NCT01925339|58997787|FG000|Overall Study|Adverse Event|2|||
30950827|NCT01925339|58997788|FG001|Overall Study|Adverse Event|0|||
30950828|NCT01908803|58997796|FG000|Overall Study|Adverse Event|1|||
30950829|NCT01908803|58997797|FG001|Overall Study|Adverse Event|0|||
30950830|NCT01908803|58997796|FG000|Overall Study|Physician Decision|0|||
30950831|NCT01908803|58997797|FG001|Overall Study|Physician Decision|1|||
30950832|NCT01908803|58997796|FG000|Overall Study|Withdrawal by Subject|1|||
30950833|NCT01908803|58997797|FG001|Overall Study|Withdrawal by Subject|0|||
30950834|NCT01908803|58997796|FG000|Overall Study|Randomization Error|1|||
30950835|NCT01908803|58997797|FG001|Overall Study|Randomization Error|0|||
30950836|NCT01908803|58997796|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
30950837|NCT01908803|58997797|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
30950838|NCT01908101|58997804|FG000|Overall Study|Physician Decision|1|||
30950839|NCT01908101|58997804|FG000|Overall Study|Withdrawal by Subject|1|||
30950840|NCT01908101|58997804|FG000|Overall Study|Incorrect Diagnosis|2|||
30950841|NCT01908101|58997804|FG000|Overall Study|Incorrect Starting Dose|1|||
30950842|NCT01908101|58997804|FG000|Overall Study|Did not complete the first cycle|4|||
30950843|NCT01923389|58997810|FG000|Overall Study|Protocol Violation|1|||
30950844|NCT01923389|58997811|FG001|Overall Study|Protocol Violation|0|||
30950845|NCT01907087|58997818|FG000|Overall Study|Withdrawal by Subject|1|||
30950846|NCT01616771|58997822|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
30950847|NCT01589185|58997836|FG000|Overall Study|Death|1|||
30950848|NCT01589185|58997837|FG001|Overall Study|Death|2|||
30950849|NCT01589185|58997838|FG002|Overall Study|Death|2|||
30950850|NCT01589185|58997839|FG003|Overall Study|Death|0|||
30764013|NCT00356759|58772739|FG001|Overall Study|Withdrawal by Subject|2|||
30950851|NCT01589185|58997840|FG004|Overall Study|Death|1|||
30950852|NCT01589185|58997836|FG000|Overall Study|Lost to Follow-up|1|||
30950853|NCT01589185|58997837|FG001|Overall Study|Lost to Follow-up|0|||
30950854|NCT01589185|58997838|FG002|Overall Study|Lost to Follow-up|2|||
30950855|NCT01589185|58997839|FG003|Overall Study|Lost to Follow-up|3|||
30950856|NCT01589185|58997840|FG004|Overall Study|Lost to Follow-up|0|||
30950857|NCT01588951|58997856|FG000|Overall Study|Ineligible in retrospect|0|||
30764014|NCT00356759|58772738|FG000|Overall Study|Adverse Event|1|||
30629084|NCT00939627|58640923|FG001|Overall Study|Adverse Event|7|||
30764015|NCT00356759|58772739|FG001|Overall Study|Adverse Event|3|||
30764016|NCT00356759|58772738|FG000|Overall Study|Lost to Follow-up|1|||
30764017|NCT00356759|58772739|FG001|Overall Study|Lost to Follow-up|1|||
30764018|NCT00356759|58772738|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
30764019|NCT00356759|58772739|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
30950858|NCT01588951|58997857|FG001|Overall Study|Ineligible in retrospect|0|||
30764020|NCT03804710|58772747|FG000|Overall Study|Adverse Event|0|||
30764021|NCT03804710|58772748|FG001|Overall Study|Adverse Event|3|||
30764022|NCT03804710|58772747|FG000|Overall Study|Withdrawal by Subject|2|||
30764023|NCT03804710|58772748|FG001|Overall Study|Withdrawal by Subject|1|||
30764024|NCT03804710|58772747|FG000|Overall Study|Other|0|||
30764025|NCT03804710|58772748|FG001|Overall Study|Other|1|||
30764026|NCT00356603|58772760|FG000|Overall Study|Other|6|||
30764027|NCT00356603|58772761|FG001|Overall Study|Other|3|||
30764028|NCT00002558|58772771|FG000|Overall Study|Withdrawal by Subject|0|||
30764029|NCT00002558|58772772|FG001|Overall Study|Withdrawal by Subject|1|||
30764030|NCT00002540|58772780|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
30764031|NCT00002540|58772781|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
30764032|NCT00002540|58772780|FG000|Overall Study|Died Before Randomization|2|||
30764033|NCT00002540|58772781|FG001|Overall Study|Died Before Randomization|6|||
30764034|NCT00002540|58772780|FG000|Overall Study|Died Before ASU (Control)|202|||
30764035|NCT00002540|58772781|FG001|Overall Study|Died Before ASU (Control)|0|||
30764036|NCT00002540|58772780|FG000|Overall Study|Refused ASU (Control)|597|||
30764037|NCT00002540|58772781|FG001|Overall Study|Refused ASU (Control)|0|||
30764038|NCT00002540|58772780|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
30764039|NCT00002540|58772781|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
30764040|NCT00001880|58772787|FG000|Overall Study|Death|14|||
30764041|NCT00043550|58772794|FG000|Overall Study|Withdrawal by Subject|22|||
30764042|NCT00043550|58772795|FG001|Overall Study|Withdrawal by Subject|12|||
30764043|NCT00043550|58772796|FG002|Overall Study|Withdrawal by Subject|20|||
30764044|NCT00041756|58772809|FG000|Overall Study|Adverse Event|4|||
30764045|NCT00041756|58772810|FG001|Overall Study|Adverse Event|10|||
30764046|NCT00041756|58772811|FG002|Overall Study|Adverse Event|6|||
30764047|NCT00041756|58772812|FG003|Overall Study|Adverse Event|11|||
30764048|NCT00041756|58772813|FG004|Overall Study|Adverse Event|34|||
30764049|NCT00041756|58772809|FG000|Overall Study|Protocol Violation|1|||
30764050|NCT00041756|58772810|FG001|Overall Study|Protocol Violation|1|||
30764051|NCT00041756|58772811|FG002|Overall Study|Protocol Violation|2|||
30764052|NCT00041756|58772812|FG003|Overall Study|Protocol Violation|2|||
30764053|NCT00041756|58772813|FG004|Overall Study|Protocol Violation|1|||
30764054|NCT00041756|58772809|FG000|Overall Study|Withdrawal by Subject|3|||
30764055|NCT00041756|58772810|FG001|Overall Study|Withdrawal by Subject|3|||
30764056|NCT00041756|58772811|FG002|Overall Study|Withdrawal by Subject|4|||
30764057|NCT00041756|58772812|FG003|Overall Study|Withdrawal by Subject|2|||
30764058|NCT00041756|58772813|FG004|Overall Study|Withdrawal by Subject|3|||
30764059|NCT00041756|58772809|FG000|Overall Study|Lost to Follow-up|0|||
30764060|NCT00041756|58772810|FG001|Overall Study|Lost to Follow-up|1|||
30764061|NCT00041756|58772811|FG002|Overall Study|Lost to Follow-up|0|||
30764062|NCT00041756|58772812|FG003|Overall Study|Lost to Follow-up|1|||
30764063|NCT00041756|58772813|FG004|Overall Study|Lost to Follow-up|0|||
30764064|NCT00041756|58772809|FG000|Overall Study|Unable to meet protocol criteria|0|||
30764065|NCT00041756|58772810|FG001|Overall Study|Unable to meet protocol criteria|0|||
30764066|NCT00041756|58772811|FG002|Overall Study|Unable to meet protocol criteria|1|||
30764067|NCT00041756|58772812|FG003|Overall Study|Unable to meet protocol criteria|0|||
30764068|NCT00041756|58772813|FG004|Overall Study|Unable to meet protocol criteria|1|||
30764069|NCT00041756|58772809|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
30764070|NCT00041756|58772810|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
30764071|NCT00041756|58772811|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
30764072|NCT00041756|58772812|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
30764073|NCT00041756|58772813|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
30764074|NCT00041132|58772825|FG000|Overall Study|Adverse Event|19|||
30764075|NCT00041132|58772825|FG000|Overall Study|Death|1|||
30764076|NCT00041132|58772825|FG000|Overall Study|Not Eligible|7|||
30764077|NCT00041132|58772825|FG000|Overall Study|Withdrawal by Subject|1|||
30764078|NCT00041132|58772825|FG000|Overall Study|Physician Decision|2|||
30764079|NCT00040742|58772833|FG000|Overall Study|Death|0|||
30764080|NCT00040742|58772834|FG001|Overall Study|Death|0|||
30764081|NCT00040742|58772835|FG002|Overall Study|Death|1|||
30764082|NCT00040742|58772836|FG003|Overall Study|Death|0|||
30764083|NCT00040742|58772833|FG000|Overall Study|Adverse Event|15|||
30764084|NCT00040742|58772834|FG001|Overall Study|Adverse Event|16|||
30764085|NCT00040742|58772835|FG002|Overall Study|Adverse Event|21|||
30764086|NCT00040742|58772836|FG003|Overall Study|Adverse Event|9|||
30764087|NCT00040742|58772833|FG000|Overall Study|Withdrawal by Subject|7|||
30764088|NCT00040742|58772834|FG001|Overall Study|Withdrawal by Subject|15|||
30764089|NCT00040742|58772835|FG002|Overall Study|Withdrawal by Subject|10|||
30764090|NCT00040742|58772836|FG003|Overall Study|Withdrawal by Subject|13|||
30764091|NCT00040742|58772833|FG000|Overall Study|Chemotoxicity|4|||
30764092|NCT00040742|58772834|FG001|Overall Study|Chemotoxicity|3|||
30764093|NCT00040742|58772835|FG002|Overall Study|Chemotoxicity|5|||
30764094|NCT00040742|58772836|FG003|Overall Study|Chemotoxicity|2|||
30764095|NCT00040742|58772833|FG000|Overall Study|Incomplete Forms|6|||
30764096|NCT00040742|58772834|FG001|Overall Study|Incomplete Forms|10|||
30764097|NCT00040742|58772835|FG002|Overall Study|Incomplete Forms|4|||
30764098|NCT00040742|58772836|FG003|Overall Study|Incomplete Forms|5|||
30764099|NCT00040742|58772833|FG000|Overall Study|Other medical|7|||
30764100|NCT00040742|58772834|FG001|Overall Study|Other medical|5|||
30764101|NCT00040742|58772835|FG002|Overall Study|Other medical|5|||
30764102|NCT00040742|58772836|FG003|Overall Study|Other medical|5|||
30764103|NCT00040664|58772846|FG000|Overall Study|Adverse Event|12|||
30764104|NCT00040664|58772847|FG001|Overall Study|Adverse Event|3|||
30764105|NCT00040664|58772848|FG002|Overall Study|Adverse Event|2|||
30764106|NCT00040664|58772849|FG003|Overall Study|Adverse Event|7|||
30764107|NCT00040664|58772846|FG000|Overall Study|Lack of Efficacy|9|||
30764108|NCT00040664|58772847|FG001|Overall Study|Lack of Efficacy|2|||
30764109|NCT00040664|58772848|FG002|Overall Study|Lack of Efficacy|3|||
30764110|NCT00040664|58772849|FG003|Overall Study|Lack of Efficacy|4|||
30764111|NCT00040664|58772846|FG000|Overall Study|Insufficient CD4 response|1|||
30764112|NCT00040664|58772847|FG001|Overall Study|Insufficient CD4 response|0|||
30764113|NCT00040664|58772848|FG002|Overall Study|Insufficient CD4 response|1|||
30764114|NCT00040664|58772849|FG003|Overall Study|Insufficient CD4 response|0|||
30764115|NCT00040664|58772846|FG000|Overall Study|Lost to Follow-up|4|||
30848148|NCT01258803|58874032|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
30848149|NCT01258803|58874033|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
30848150|NCT01258803|58874034|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
30848151|NCT01258803|58874029|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
30848152|NCT01258803|58874030|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
30848153|NCT01258803|58874031|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
30848154|NCT01258803|58874032|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
30848155|NCT01258803|58874033|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
30848156|NCT01258803|58874034|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
30848157|NCT02865083|58874050|FG000|Overall Study|Early Termination|3|||
30848158|NCT02865083|58874051|FG001|Overall Study|Early Termination|1|||
30848159|NCT00862251|58874060|FG000|Overall Study|Adverse Event|8|||
30848160|NCT00862251|58874061|FG001|Overall Study|Adverse Event|3|||
30848161|NCT00862251|58874062|FG002|Overall Study|Adverse Event|1|||
30848162|NCT00862251|58874060|FG000|Overall Study|Lost to Follow-up|0|||
30848163|NCT00862251|58874061|FG001|Overall Study|Lost to Follow-up|0|||
30848164|NCT00862251|58874062|FG002|Overall Study|Lost to Follow-up|1|||
30848165|NCT00862251|58874060|FG000|Overall Study|Protocol Violation|2|||
30848166|NCT00862251|58874061|FG001|Overall Study|Protocol Violation|0|||
30848167|NCT00862251|58874062|FG002|Overall Study|Protocol Violation|1|||
30848168|NCT00862251|58874060|FG000|Overall Study|Withdrawal by Subject|9|||
30848169|NCT00862251|58874061|FG001|Overall Study|Withdrawal by Subject|2|||
30848170|NCT00862251|58874062|FG002|Overall Study|Withdrawal by Subject|6|||
30848171|NCT02864381|58874091|FG000|Overall Study|Death|58|||
30764116|NCT00040664|58772847|FG001|Overall Study|Lost to Follow-up|2|||
30764117|NCT00040664|58772848|FG002|Overall Study|Lost to Follow-up|0|||
30764118|NCT00040664|58772849|FG003|Overall Study|Lost to Follow-up|2|||
30764119|NCT00040664|58772846|FG000|Overall Study|Protocol Violation|2|||
30764120|NCT00040664|58772847|FG001|Overall Study|Protocol Violation|1|||
30764121|NCT00040664|58772848|FG002|Overall Study|Protocol Violation|0|||
30764122|NCT00040664|58772849|FG003|Overall Study|Protocol Violation|1|||
30764123|NCT00040664|58772846|FG000|Overall Study|Withdrawal by Subject|7|||
30764124|NCT00040664|58772847|FG001|Overall Study|Withdrawal by Subject|0|||
30764125|NCT00040664|58772848|FG002|Overall Study|Withdrawal by Subject|3|||
30764126|NCT00040664|58772849|FG003|Overall Study|Withdrawal by Subject|4|||
30764127|NCT00040664|58772846|FG000|Overall Study|Pregnancy|3|||
30764128|NCT00040664|58772847|FG001|Overall Study|Pregnancy|0|||
30848172|NCT02864381|58874092|FG001|Overall Study|Death|61|||
30848173|NCT02864381|58874091|FG000|Overall Study|Withdrew Consent|5|||
30950859|NCT01588951|58997858|FG002|Overall Study|Ineligible in retrospect|1|||
30764129|NCT00040664|58772848|FG002|Overall Study|Pregnancy|0|||
30764130|NCT00040664|58772849|FG003|Overall Study|Pregnancy|3|||
30764131|NCT00040664|58772846|FG000|Overall Study|Medication adherence/compliance problems|8|||
30764132|NCT00040664|58772847|FG001|Overall Study|Medication adherence/compliance problems|2|||
30764133|NCT00040664|58772848|FG002|Overall Study|Medication adherence/compliance problems|1|||
30764134|NCT00040664|58772849|FG003|Overall Study|Medication adherence/compliance problems|5|||
30764135|NCT00040664|58772846|FG000|Overall Study|Poor taste|2|||
30764136|NCT00040664|58772847|FG001|Overall Study|Poor taste|0|||
30764137|NCT00040664|58772848|FG002|Overall Study|Poor taste|2|||
30764138|NCT00040664|58772849|FG003|Overall Study|Poor taste|0|||
30764139|NCT00040664|58772846|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
30848174|NCT02864381|58874092|FG001|Overall Study|Withdrew Consent|6|||
30848175|NCT02864381|58874091|FG000|Overall Study|Reason Unknown|7|||
30848176|NCT02864381|58874092|FG001|Overall Study|Reason Unknown|3|||
30848177|NCT02864381|58874091|FG000|Overall Study|Lost to Follow-up|1|||
30848178|NCT02864381|58874092|FG001|Overall Study|Lost to Follow-up|1|||
30848179|NCT02864381|58874091|FG000|Overall Study|Investigator's Discretion|1|||
30848180|NCT02864381|58874092|FG001|Overall Study|Investigator's Discretion|0|||
30848181|NCT02864381|58874091|FG000|Overall Study|Protocol Violation|0|||
30848182|NCT02864381|58874092|FG001|Overall Study|Protocol Violation|1|||
30848183|NCT02860169|58874100|FG000|Part A|Withdrawal by Subject|1|||
30848184|NCT02860169|58874100|FG000|Part A|Other (Screening failure)|6|||
30764140|NCT00040664|58772847|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
30764141|NCT00040664|58772848|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
30764142|NCT00040664|58772849|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
30764143|NCT00040664|58772846|FG000|Overall Study|Change of formulation|2|||
30764144|NCT00040664|58772847|FG001|Overall Study|Change of formulation|2|||
30764145|NCT00040664|58772848|FG002|Overall Study|Change of formulation|0|||
30764146|NCT00040664|58772849|FG003|Overall Study|Change of formulation|0|||
30764147|NCT00040664|58772846|FG000|Overall Study|Non-viability of oral suspension|1|||
30764148|NCT00040664|58772847|FG001|Overall Study|Non-viability of oral suspension|0|||
30764149|NCT00040664|58772848|FG002|Overall Study|Non-viability of oral suspension|1|||
30764150|NCT00040664|58772849|FG003|Overall Study|Non-viability of oral suspension|0|||
30764151|NCT02952586|58772869|FG000|Lead-In Phase (7 Days)|Death|0|||
30764152|NCT02952586|58772870|FG001|Lead-In Phase (7 Days)|Death|1|||
30848185|NCT02860169|58874100|FG000|Part A|Other (Survey not completed)|3|||
30848186|NCT02860169|58874100|FG000|Part A|Other (did not completed consent)|1|||
30848187|NCT02860169|58874100|FG000|Part B|Other (Screening failure)|10|||
30848188|NCT02860169|58874100|FG000|Part B|Withdrawal by Subject|1|||
30848189|NCT02860169|58874100|FG000|Part C|Other (Screening failure)|1|||
30848190|NCT00409773|58874111|FG000|Overall Study|Adverse Event|3|||
30950860|NCT01709383|58997868|FG000|Overall Study|Lost to Follow-up|1|||
30950861|NCT01709383|58997869|FG001|Overall Study|Lost to Follow-up|0|||
30629085|NCT00939627|58640924|FG002|Overall Study|Adverse Event|0|||
30629086|NCT00939627|58640922|FG000|Overall Study|Death|0|||
30629087|NCT00939627|58640923|FG001|Overall Study|Death|2|||
30629088|NCT00939627|58640924|FG002|Overall Study|Death|0|||
30629089|NCT00939627|58640922|FG000|Overall Study|Withdrawal by Subject|2|||
30629090|NCT00939627|58640923|FG001|Overall Study|Withdrawal by Subject|4|||
30629091|NCT00939627|58640924|FG002|Overall Study|Withdrawal by Subject|0|||
30629092|NCT00939627|58640922|FG000|Overall Study|Other complicating disease|1|||
30629093|NCT00939627|58640923|FG001|Overall Study|Other complicating disease|1|||
30629094|NCT00939627|58640924|FG002|Overall Study|Other complicating disease|0|||
30629095|NCT00939627|58640922|FG000|Overall Study|Not compliant|2|||
30629096|NCT00939627|58640923|FG001|Overall Study|Not compliant|0|||
30629097|NCT00939627|58640924|FG002|Overall Study|Not compliant|0|||
30764153|NCT02952586|58772869|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
30764154|NCT02952586|58772870|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
30764155|NCT02952586|58772869|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
30764156|NCT02952586|58772870|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
30764157|NCT02952586|58772869|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
30764158|NCT02952586|58772870|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
30764159|NCT02952586|58772869|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
30764160|NCT02952586|58772870|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
30764161|NCT02952586|58772869|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
30764162|NCT02952586|58772870|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
30764163|NCT02952586|58772869|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
30764164|NCT02952586|58772870|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
30764165|NCT02952586|58772869|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
30764166|NCT02952586|58772870|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
30764167|NCT02952586|58772869|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
30764168|NCT02952586|58772870|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
30764169|NCT02952586|58772869|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
30764170|NCT02952586|58772870|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
30764171|NCT02952586|58772869|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
30764172|NCT02952586|58772870|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
30764173|NCT02952586|58772869|FG000|CRT for Cisplatin (63 Days)|Death|3|||
30764174|NCT02952586|58772870|FG001|CRT for Cisplatin (63 Days)|Death|8|||
30764175|NCT02952586|58772869|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
30764176|NCT02952586|58772870|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
30764177|NCT02952586|58772869|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
30848191|NCT00409773|58874112|FG001|Overall Study|Adverse Event|4|||
30950862|NCT01588405|58997877|FG000|Overall Study|Adverse Event|1|||
30629098|NCT00939627|58640922|FG000|Overall Study|No off-tx reason given|0|||
30629099|NCT00939627|58640923|FG001|Overall Study|No off-tx reason given|2|||
30629100|NCT00939627|58640924|FG002|Overall Study|No off-tx reason given|0|||
30629101|NCT00937833|58640932|FG000|Overall Study|Protocol Violation|1|||
30629102|NCT00937833|58640933|FG001|Overall Study|Protocol Violation|2|||
30848192|NCT00409773|58874113|FG002|Overall Study|Adverse Event|4|||
30848193|NCT00409773|58874114|FG003|Overall Study|Adverse Event|2|||
30950863|NCT01588405|58997877|FG000|Overall Study|Clinical Worsening|1|||
30629103|NCT00937833|58640932|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
30629104|NCT00937833|58640933|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
30629105|NCT00937833|58640932|FG000|Overall Study|Lost to Follow-up|10|||
30629106|NCT00937833|58640933|FG001|Overall Study|Lost to Follow-up|8|||
30629107|NCT00937833|58640932|FG000|Overall Study|Withdrawal by Subject|4|||
30629108|NCT00937833|58640933|FG001|Overall Study|Withdrawal by Subject|6|||
30629109|NCT01135511|58640948|FG000|Overall Study|Adverse Event|0|||
30629110|NCT01135511|58640949|FG001|Overall Study|Adverse Event|1|||
30629111|NCT01135511|58640950|FG002|Overall Study|Adverse Event|2|||
30629112|NCT01135511|58640951|FG003|Overall Study|Adverse Event|0|||
30629113|NCT01135511|58640952|FG004|Overall Study|Adverse Event|0|||
30629114|NCT01135511|58640953|FG005|Overall Study|Adverse Event|1|||
30629115|NCT01135511|58640954|FG006|Overall Study|Adverse Event|0|||
30629116|NCT01135511|58640955|FG007|Overall Study|Adverse Event|1|||
30629117|NCT01135511|58640956|FG008|Overall Study|Adverse Event|0|||
30629118|NCT01135511|58640948|FG000|Overall Study|Lack of Efficacy|0|||
30629119|NCT01135511|58640949|FG001|Overall Study|Lack of Efficacy|1|||
30950864|NCT01923311|58997886|FG000|Overall Study|Pregnancy|1|||
30629120|NCT01135511|58640950|FG002|Overall Study|Lack of Efficacy|1|||
30629121|NCT01135511|58640951|FG003|Overall Study|Lack of Efficacy|2|||
30629122|NCT01135511|58640952|FG004|Overall Study|Lack of Efficacy|0|||
30629123|NCT01135511|58640953|FG005|Overall Study|Lack of Efficacy|0|||
30629124|NCT01135511|58640954|FG006|Overall Study|Lack of Efficacy|0|||
30629125|NCT01135511|58640955|FG007|Overall Study|Lack of Efficacy|0|||
30629126|NCT01135511|58640956|FG008|Overall Study|Lack of Efficacy|0|||
30629127|NCT01135511|58640948|FG000|Overall Study|Protocol Violation|0|||
30629128|NCT01135511|58640949|FG001|Overall Study|Protocol Violation|0|||
30629129|NCT01135511|58640950|FG002|Overall Study|Protocol Violation|3|||
30629130|NCT01135511|58640951|FG003|Overall Study|Protocol Violation|0|||
30629131|NCT01135511|58640952|FG004|Overall Study|Protocol Violation|0|||
30629132|NCT01135511|58640953|FG005|Overall Study|Protocol Violation|0|||
30629133|NCT01135511|58640954|FG006|Overall Study|Protocol Violation|0|||
30629134|NCT01135511|58640955|FG007|Overall Study|Protocol Violation|0|||
30629135|NCT01135511|58640956|FG008|Overall Study|Protocol Violation|0|||
30629136|NCT01135511|58640948|FG000|Overall Study|Pregnancy|0|||
30629137|NCT01135511|58640949|FG001|Overall Study|Pregnancy|0|||
30629138|NCT01135511|58640950|FG002|Overall Study|Pregnancy|0|||
30629139|NCT01135511|58640951|FG003|Overall Study|Pregnancy|1|||
30629140|NCT01135511|58640952|FG004|Overall Study|Pregnancy|0|||
30629141|NCT01135511|58640953|FG005|Overall Study|Pregnancy|0|||
30629142|NCT01135511|58640954|FG006|Overall Study|Pregnancy|0|||
30629143|NCT01135511|58640955|FG007|Overall Study|Pregnancy|0|||
30629144|NCT01135511|58640956|FG008|Overall Study|Pregnancy|0|||
30629145|NCT01135511|58640948|FG000|Overall Study|could not visit the clinic|0|||
30629146|NCT01135511|58640949|FG001|Overall Study|could not visit the clinic|1|||
30629147|NCT01135511|58640950|FG002|Overall Study|could not visit the clinic|2|||
30629148|NCT01135511|58640951|FG003|Overall Study|could not visit the clinic|0|||
30629149|NCT01135511|58640952|FG004|Overall Study|could not visit the clinic|0|||
30629150|NCT01135511|58640953|FG005|Overall Study|could not visit the clinic|0|||
30764178|NCT02952586|58772870|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
30950865|NCT01923311|58997887|FG001|Overall Study|Pregnancy|0|||
30950866|NCT01923311|58997886|FG000|Overall Study|Investigator's Discretion|1|||
30629151|NCT01135511|58640954|FG006|Overall Study|could not visit the clinic|0|||
30629152|NCT01135511|58640955|FG007|Overall Study|could not visit the clinic|0|||
30629153|NCT01135511|58640956|FG008|Overall Study|could not visit the clinic|0|||
30629154|NCT01135511|58640948|FG000|Overall Study|noncompliance with study drug taken|0|||
30629155|NCT01135511|58640949|FG001|Overall Study|noncompliance with study drug taken|0|||
30629156|NCT01135511|58640950|FG002|Overall Study|noncompliance with study drug taken|0|||
30629157|NCT01135511|58640951|FG003|Overall Study|noncompliance with study drug taken|0|||
30629158|NCT01135511|58640952|FG004|Overall Study|noncompliance with study drug taken|1|||
30950867|NCT01923311|58997887|FG001|Overall Study|Investigator's Discretion|0|||
30950868|NCT01923311|58997886|FG000|Overall Study|Non-Compliance with Study Drug|2|||
30950869|NCT01923311|58997887|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30764179|NCT02952586|58772869|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
30764180|NCT02952586|58772870|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
30764181|NCT02952586|58772869|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
30764182|NCT02952586|58772870|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
30764183|NCT02952586|58772869|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
30764184|NCT02952586|58772870|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
30764185|NCT02952586|58772869|FG000|CRT for Cisplatin (63 Days)|Other|1|||
30764186|NCT02952586|58772870|FG001|CRT for Cisplatin (63 Days)|Other|1|||
30764187|NCT02952586|58772869|FG000|CRT for IMRT (63 Days)|Death|5|||
30764188|NCT02952586|58772870|FG001|CRT for IMRT (63 Days)|Death|8|||
30764189|NCT02952586|58772869|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
30764190|NCT02952586|58772870|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
30764191|NCT02952586|58772869|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
30764192|NCT02952586|58772870|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
30764193|NCT02952586|58772869|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
30764194|NCT02952586|58772870|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
30764195|NCT02952586|58772869|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
30764196|NCT02952586|58772870|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
30764197|NCT02952586|58772869|FG000|CRT for IMRT (63 Days)|Other|1|||
30764198|NCT02952586|58772870|FG001|CRT for IMRT (63 Days)|Other|0|||
30764199|NCT02952586|58772869|FG000|Maintenance Phase (12 Months)|Death|17|||
30764200|NCT02952586|58772870|FG001|Maintenance Phase (12 Months)|Death|11|||
30764201|NCT02952586|58772869|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
30764202|NCT02952586|58772870|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
30764203|NCT02952586|58772869|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
30764204|NCT02952586|58772870|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
30764205|NCT02952586|58772869|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
30764206|NCT02952586|58772870|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
30764207|NCT02952586|58772869|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
30764208|NCT02952586|58772870|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
30764209|NCT02952586|58772869|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
30764210|NCT02952586|58772870|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
30764211|NCT02952586|58772869|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
30764212|NCT02952586|58772870|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
30764213|NCT02952586|58772869|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
30764214|NCT02952586|58772870|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
30764215|NCT02952586|58772869|FG000|Maintenance Phase (12 Months)|Other|2|||
30764216|NCT02952586|58772870|FG001|Maintenance Phase (12 Months)|Other|1|||
30764217|NCT02952586|58772869|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
30764218|NCT02952586|58772870|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
30764219|NCT02952586|58772869|FG000|Follow-Up Phase (90 Days)|Death|12|||
30764220|NCT02952586|58772870|FG001|Follow-Up Phase (90 Days)|Death|10|||
30764221|NCT02952586|58772869|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
30764222|NCT02952586|58772870|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
30764223|NCT02952586|58772869|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
30764224|NCT02952586|58772870|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
30764225|NCT02952586|58772869|FG000|Follow-Up Phase (90 Days)|Other|7|||
30764226|NCT02952586|58772870|FG001|Follow-Up Phase (90 Days)|Other|5|||
30629159|NCT01135511|58640953|FG005|Overall Study|noncompliance with study drug taken|0|||
30629160|NCT01135511|58640954|FG006|Overall Study|noncompliance with study drug taken|0|||
30629161|NCT01135511|58640955|FG007|Overall Study|noncompliance with study drug taken|0|||
30629162|NCT01135511|58640956|FG008|Overall Study|noncompliance with study drug taken|0|||
30629163|NCT01135511|58640948|FG000|Overall Study|Withdrawal by Subject|0|||
30629164|NCT01135511|58640949|FG001|Overall Study|Withdrawal by Subject|0|||
30629165|NCT01135511|58640950|FG002|Overall Study|Withdrawal by Subject|0|||
30629166|NCT01135511|58640951|FG003|Overall Study|Withdrawal by Subject|0|||
30629167|NCT01135511|58640952|FG004|Overall Study|Withdrawal by Subject|0|||
30629168|NCT01135511|58640953|FG005|Overall Study|Withdrawal by Subject|0|||
30629169|NCT01135511|58640954|FG006|Overall Study|Withdrawal by Subject|1|||
30629170|NCT01135511|58640955|FG007|Overall Study|Withdrawal by Subject|0|||
30629171|NCT01135511|58640956|FG008|Overall Study|Withdrawal by Subject|1|||
30764227|NCT02952586|58772869|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
30764228|NCT02952586|58772870|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
30764229|NCT02952586|58772869|FG000|LT Follow-up (up to 45 Months)|Death|51|||
30764230|NCT02952586|58772870|FG001|LT Follow-up (up to 45 Months)|Death|31|||
30764231|NCT02952586|58772869|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
30764232|NCT02952586|58772870|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
30764233|NCT02952586|58772869|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
30764234|NCT02952586|58772870|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
30764235|NCT02952586|58772869|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
30764236|NCT02952586|58772870|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
30764237|NCT03384316|58772879|FG000|Overall Study|Screen failure|0|||
30764238|NCT03384316|58772880|FG001|Overall Study|Screen failure|1|||
30764239|NCT03403192|58772892|FG000|Overall Study|Lost to Follow-up|1|||
30764240|NCT03403192|58772893|FG001|Overall Study|Lost to Follow-up|2|||
30848194|NCT00409773|58874115|FG004|Overall Study|Adverse Event|6|||
30848195|NCT00409773|58874111|FG000|Overall Study|Lost to Follow-up|6|||
30848196|NCT00409773|58874112|FG001|Overall Study|Lost to Follow-up|1|||
30764241|NCT03403192|58772894|FG002|Overall Study|Lost to Follow-up|0|||
30764242|NCT03403192|58772895|FG003|Overall Study|Lost to Follow-up|0|||
30764243|NCT03403192|58772892|FG000|Overall Study|Unable to respond|0|||
30764244|NCT03403192|58772893|FG001|Overall Study|Unable to respond|1|||
30764245|NCT03403192|58772894|FG002|Overall Study|Unable to respond|0|||
30764246|NCT03403192|58772895|FG003|Overall Study|Unable to respond|0|||
30764247|NCT03403192|58772892|FG000|Overall Study|Incomplete|3|||
30764248|NCT03403192|58772893|FG001|Overall Study|Incomplete|1|||
30764249|NCT03403192|58772894|FG002|Overall Study|Incomplete|3|||
30764250|NCT03403192|58772895|FG003|Overall Study|Incomplete|6|||
30764251|NCT00356525|58772909|FG000|Overall Study|Progressive Disease|8|||
30764252|NCT00356525|58772910|FG001|Overall Study|Progressive Disease|5|||
30764253|NCT00356525|58772911|FG002|Overall Study|Progressive Disease|4|||
30764254|NCT00356525|58772912|FG003|Overall Study|Progressive Disease|2|||
30764255|NCT00356525|58772909|FG000|Overall Study|Adverse Event|1|||
30764256|NCT00356525|58772910|FG001|Overall Study|Adverse Event|3|||
30764257|NCT00356525|58772911|FG002|Overall Study|Adverse Event|1|||
30764258|NCT00356525|58772912|FG003|Overall Study|Adverse Event|1|||
30764259|NCT00356525|58772909|FG000|Overall Study|Lost to Follow-up|1|||
30764260|NCT00356525|58772910|FG001|Overall Study|Lost to Follow-up|0|||
30764261|NCT00356525|58772911|FG002|Overall Study|Lost to Follow-up|0|||
30764262|NCT00356525|58772912|FG003|Overall Study|Lost to Follow-up|0|||
30764263|NCT00356525|58772909|FG000|Overall Study|Physician Decision|2|||
30764264|NCT00356525|58772910|FG001|Overall Study|Physician Decision|2|||
30764265|NCT00356525|58772911|FG002|Overall Study|Physician Decision|2|||
30764266|NCT00356525|58772912|FG003|Overall Study|Physician Decision|1|||
30764267|NCT00356525|58772909|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
30764268|NCT00356525|58772910|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
30764269|NCT00356525|58772911|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
30764270|NCT00356525|58772912|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
30764271|NCT00356525|58772909|FG000|Overall Study|Withdrawal by Subject|1|||
30764272|NCT00356525|58772910|FG001|Overall Study|Withdrawal by Subject|1|||
30848197|NCT00409773|58874113|FG002|Overall Study|Lost to Follow-up|2|||
30848198|NCT00409773|58874114|FG003|Overall Study|Lost to Follow-up|3|||
30950870|NCT01923311|58997886|FG000|Overall Study|Withdrew Consent|1|||
30764273|NCT00356525|58772911|FG002|Overall Study|Withdrawal by Subject|0|||
30764274|NCT00356525|58772912|FG003|Overall Study|Withdrawal by Subject|3|||
30764275|NCT00356525|58772909|FG000|Overall Study|Death|0|||
30764276|NCT00356525|58772910|FG001|Overall Study|Death|0|||
30848199|NCT00409773|58874115|FG004|Overall Study|Lost to Follow-up|1|||
30950871|NCT01923311|58997887|FG001|Overall Study|Withdrew Consent|0|||
30950872|NCT01923311|58997886|FG000|Overall Study|Study Terminated by Sponsor|12|||
30950873|NCT01923311|58997887|FG001|Overall Study|Study Terminated by Sponsor|0|||
30950874|NCT01603615|58997894|FG000|Overall Study|Did not Receive Treatment|7|||
30950875|NCT01603615|58997894|FG000|Overall Study|Lost to Follow-up|9|||
30950876|NCT01603615|58997894|FG000|Overall Study|Personal Reasons|17|||
30950877|NCT01603615|58997894|FG000|Overall Study|Other Miscellaneous|1|||
30764277|NCT00356525|58772911|FG002|Overall Study|Death|0|||
30764278|NCT00356525|58772912|FG003|Overall Study|Death|1|||
30764279|NCT00356525|58772909|FG000|Overall Study|Sponsor Decision|0|||
30764280|NCT00356525|58772910|FG001|Overall Study|Sponsor Decision|0|||
30764281|NCT00356525|58772911|FG002|Overall Study|Sponsor Decision|0|||
30764282|NCT00356525|58772912|FG003|Overall Study|Sponsor Decision|1|||
30764283|NCT00356369|58772924|FG000|Active Phase|Withdrawal by Subject|2|||
30764284|NCT00356369|58772925|FG001|Active Phase|Withdrawal by Subject|1|||
30764285|NCT03383614|58772935|FG000|Overall Study|Withdrawal by Subject|0|||
30764286|NCT03383614|58772936|FG001|Overall Study|Withdrawal by Subject|1|||
30764287|NCT03383614|58772937|FG002|Overall Study|Withdrawal by Subject|0|||
30764288|NCT03383614|58772938|FG003|Overall Study|Withdrawal by Subject|0|||
30764289|NCT03403036|58772953|FG000|Overall Study|Lack of Efficacy|5|||
30764290|NCT00356135|58772960|FG000|Overall Study|Protocol Violation|1|||
30764291|NCT00356135|58772961|FG001|Overall Study|Protocol Violation|0|||
30764292|NCT00356135|58772962|FG002|Overall Study|Protocol Violation|0|||
30764293|NCT00356135|58772960|FG000|Overall Study|Adverse Event|1|||
30764294|NCT00356135|58772961|FG001|Overall Study|Adverse Event|0|||
30764295|NCT00356135|58772962|FG002|Overall Study|Adverse Event|0|||
30764296|NCT00356135|58772960|FG000|Overall Study|Lost to Follow-up|0|||
30950878|NCT01685047|58997898|FG000|Overall Study|Withdrawal by Subject|20|||
30950879|NCT01685047|58997898|FG000|Overall Study|Death|26|||
30629221|NCT01184846|58641042|FG000|Overall Study|Adverse Event|2|||
30629222|NCT01184846|58641042|FG000|Overall Study|Insufficient response|1|||
30629223|NCT01180400|58641050|FG000|Overall Study|Withdrawal by Subject|5|||
30629224|NCT01180400|58641051|FG001|Overall Study|Withdrawal by Subject|6|||
30629225|NCT01180400|58641050|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30629226|NCT01180400|58641051|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
30629227|NCT01180400|58641050|FG000|Overall Study|Adverse Event|12|||
30629228|NCT01180400|58641051|FG001|Overall Study|Adverse Event|10|||
30629229|NCT01180400|58641050|FG000|Overall Study|Severe non-compliance to protocol|1|||
30629230|NCT01180400|58641051|FG001|Overall Study|Severe non-compliance to protocol|2|||
30629231|NCT01180400|58641050|FG000|Overall Study|Condition under investigation worsened|2|||
30629232|NCT01180400|58641051|FG001|Overall Study|Condition under investigation worsened|1|||
30629233|NCT01180400|58641050|FG000|Overall Study|Lack of Efficacy|2|||
30629234|NCT01180400|58641051|FG001|Overall Study|Lack of Efficacy|0|||
30629235|NCT01180400|58641050|FG000|Overall Study|Study-specific withdrawal criteria|1|||
30629236|NCT01180400|58641051|FG001|Overall Study|Study-specific withdrawal criteria|2|||
30629237|NCT01180400|58641050|FG000|Overall Study|Lost to Follow-up|2|||
30629238|NCT01180400|58641051|FG001|Overall Study|Lost to Follow-up|3|||
30629239|NCT01180400|58641050|FG000|Overall Study|Other|0|||
30764297|NCT00356135|58772961|FG001|Overall Study|Lost to Follow-up|0|||
30764298|NCT00356135|58772962|FG002|Overall Study|Lost to Follow-up|1|||
30764299|NCT00356135|58772960|FG000|Overall Study|Physician Decision|1|||
30629240|NCT01180400|58641051|FG001|Overall Study|Other|1|||
30629241|NCT01180244|58641059|FG000|Overall Study|Lack of Efficacy|0|||
30629242|NCT01180244|58641060|FG001|Overall Study|Lack of Efficacy|7|||
30764300|NCT00356135|58772961|FG001|Overall Study|Physician Decision|1|||
30950880|NCT01685047|58997898|FG000|Overall Study|Lost to Follow-up|8|||
30629243|NCT01180244|58641059|FG000|Overall Study|Physician Decision|3|||
30629244|NCT01180244|58641060|FG001|Overall Study|Physician Decision|0|||
30629245|NCT01180244|58641059|FG000|Overall Study|Adverse Event|1|||
30764301|NCT00356135|58772962|FG002|Overall Study|Physician Decision|1|||
30629246|NCT01180244|58641060|FG001|Overall Study|Adverse Event|0|||
30629247|NCT01180244|58641059|FG000|Overall Study|Withdrawal by Subject|0|||
30629248|NCT01180244|58641060|FG001|Overall Study|Withdrawal by Subject|1|||
30629249|NCT01180244|58641059|FG000|Overall Study|Protocol Violation|1|||
30950881|NCT01685047|58997898|FG000|Overall Study|Physician Decision|25|||
30950882|NCT01685047|58997898|FG000|Overall Study|Adverse Event|5|||
30950883|NCT01685047|58997898|FG000|Overall Study|patient withdrawn by sponsor|1|||
30950884|NCT01905683|58997902|FG000|Overall Study|Protocol Violation|1|||
30950885|NCT01905683|58997902|FG000|Overall Study|Re-injection criteria not met; others|13|||
30950886|NCT01905683|58997902|FG000|Overall Study|Physician Decision|1|||
30950887|NCT01905683|58997902|FG000|Overall Study|Lack of Efficacy|8|||
30950888|NCT01905683|58997902|FG000|Overall Study|Withdrawal by Subject|20|||
30950889|NCT01905683|58997902|FG000|Overall Study|Adverse Event|4|||
30950890|NCT01905683|58997902|FG000|Overall Study|Lost to Follow-up|4|||
30950891|NCT01921829|58997908|FG000|Overall Study|Withdrawal by Subject|0|||
30950892|NCT01921829|58997909|FG001|Overall Study|Withdrawal by Subject|1|||
30950893|NCT01904903|58997915|FG000|Overall Study|Withdrawal by Subject|1|||
30950894|NCT01921517|58997921|FG000|Overall Study|Lost to Follow-up|5|||
30950895|NCT01921517|58997922|FG001|Overall Study|Lost to Follow-up|0|||
30950896|NCT01921517|58997921|FG000|Overall Study|Newly diagnosed health concern|2|||
30950897|NCT01921517|58997922|FG001|Overall Study|Newly diagnosed health concern|0|||
30950898|NCT01921517|58997921|FG000|Overall Study|Physician Decision|0|||
30950899|NCT01921517|58997922|FG001|Overall Study|Physician Decision|2|||
30950900|NCT01921517|58997921|FG000|Overall Study|Withdrawal by Subject|7|||
30950901|NCT01921517|58997922|FG001|Overall Study|Withdrawal by Subject|3|||
30950902|NCT01921517|58997921|FG000|Overall Study|Subject missed final imaging|1|||
30950903|NCT01921517|58997922|FG001|Overall Study|Subject missed final imaging|4|||
30950904|NCT01921205|58997930|FG000|Overall Study|Adverse Event|12|||
30950905|NCT01921205|58997931|FG001|Overall Study|Adverse Event|7|||
30950906|NCT01921205|58997930|FG000|Overall Study|Lack of Efficacy|1|||
30950907|NCT01921205|58997931|FG001|Overall Study|Lack of Efficacy|0|||
30950908|NCT01921205|58997930|FG000|Overall Study|Protocol Violation|1|||
30950909|NCT01921205|58997931|FG001|Overall Study|Protocol Violation|3|||
30950910|NCT01921205|58997930|FG000|Overall Study|Lost to Follow-up|1|||
30950911|NCT01921205|58997931|FG001|Overall Study|Lost to Follow-up|1|||
30950912|NCT01921205|58997930|FG000|Overall Study|Withdrawal by Subject|6|||
30950913|NCT01921205|58997931|FG001|Overall Study|Withdrawal by Subject|5|||
30950914|NCT01921205|58997930|FG000|Overall Study|Use Of Prohibited Medication|0|||
30950915|NCT01921205|58997931|FG001|Overall Study|Use Of Prohibited Medication|1|||
30950916|NCT01921205|58997930|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
30950917|NCT01921205|58997931|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
30629250|NCT01180244|58641060|FG001|Overall Study|Protocol Violation|0|||
30629251|NCT01180244|58641059|FG000|Overall Study|Lost to Follow-up|1|||
30629252|NCT01180244|58641060|FG001|Overall Study|Lost to Follow-up|0|||
30629253|NCT01191086|58641066|FG000|Overall Study|Adverse Event|20|||
30629254|NCT01191086|58641066|FG000|Overall Study|Lack of Efficacy|10|||
30629255|NCT01191086|58641066|FG000|Overall Study|Lost to Follow-up|4|||
30629256|NCT01191086|58641066|FG000|Overall Study|Physician Decision|2|||
30629257|NCT01191086|58641066|FG000|Overall Study|Withdrawal by Subject|24|||
30629258|NCT01191086|58641066|FG000|Overall Study|Discontinuation criterion met|1|||
30629259|NCT01191086|58641066|FG000|Overall Study|Other|1|||
30629260|NCT01088412|58641073|FG000|Overall Study|Adverse Event|38|||
30629261|NCT01088412|58641074|FG001|Overall Study|Adverse Event|0|||
30629262|NCT01088412|58641075|FG002|Overall Study|Adverse Event|0|||
30629263|NCT01088412|58641073|FG000|Overall Study|Death|42|||
30629264|NCT01088412|58641074|FG001|Overall Study|Death|6|||
30629265|NCT01088412|58641075|FG002|Overall Study|Death|0|||
30629266|NCT01088412|58641073|FG000|Overall Study|Other Reason per Case Report Form|2089|||
30629267|NCT01088412|58641074|FG001|Overall Study|Other Reason per Case Report Form|103|||
30629268|NCT01088412|58641075|FG002|Overall Study|Other Reason per Case Report Form|9|||
30629269|NCT01088412|58641073|FG000|Overall Study|Withdrawal by Subject|1761|||
30629270|NCT01088412|58641074|FG001|Overall Study|Withdrawal by Subject|25|||
30629271|NCT01088412|58641075|FG002|Overall Study|Withdrawal by Subject|1|||
30629272|NCT01088412|58641073|FG000|Overall Study|Received Another GH Product|79|||
30629273|NCT01088412|58641074|FG001|Overall Study|Received Another GH Product|0|||
30629274|NCT01088412|58641075|FG002|Overall Study|Received Another GH Product|0|||
30629275|NCT01088412|58641073|FG000|Overall Study|Participant Moved|601|||
30629276|NCT01088412|58641074|FG001|Overall Study|Participant Moved|21|||
30629277|NCT01088412|58641075|FG002|Overall Study|Participant Moved|2|||
30629278|NCT01088412|58641073|FG000|Overall Study|Physician Decision|1041|||
30629279|NCT01088412|58641074|FG001|Overall Study|Physician Decision|8|||
30629280|NCT01088412|58641075|FG002|Overall Study|Physician Decision|4|||
30629281|NCT01088412|58641073|FG000|Overall Study|Sponsor Decision|4467|||
30629282|NCT01088412|58641074|FG001|Overall Study|Sponsor Decision|79|||
30629283|NCT01088412|58641075|FG002|Overall Study|Sponsor Decision|23|||
30629284|NCT01088412|58641073|FG000|Overall Study|Third Party Required to Change Brand|487|||
30629285|NCT01088412|58641074|FG001|Overall Study|Third Party Required to Change Brand|0|||
30629286|NCT01088412|58641075|FG002|Overall Study|Third Party Required to Change Brand|0|||
30629287|NCT01088412|58641073|FG000|Overall Study|Lost to Follow-up|3052|||
30629288|NCT01088412|58641074|FG001|Overall Study|Lost to Follow-up|130|||
30629289|NCT01088412|58641075|FG002|Overall Study|Lost to Follow-up|11|||
30629290|NCT01088412|58641073|FG000|Overall Study|Study Summary Not Completed|4360|||
30629291|NCT01088412|58641074|FG001|Overall Study|Study Summary Not Completed|64|||
30629292|NCT01088412|58641075|FG002|Overall Study|Study Summary Not Completed|22|||
30629293|NCT01076400|58641086|FG000|Overall Study|Adverse Event|2|||
30629294|NCT01076400|58641087|FG001|Overall Study|Adverse Event|0|||
30629295|NCT01076400|58641088|FG002|Overall Study|Adverse Event|0|||
30629296|NCT01076400|58641086|FG000|Overall Study|Progressive Disease|5|||
30629297|NCT01076400|58641087|FG001|Overall Study|Progressive Disease|0|||
30629298|NCT01076400|58641088|FG002|Overall Study|Progressive Disease|0|||
30629299|NCT01086384|58641094|FG000|2-week Run-in Period|Adverse Event|1|||
30629300|NCT01086384|58641095|FG001|2-week Run-in Period|Adverse Event|0|||
30629301|NCT01086384|58641096|FG002|2-week Run-in Period|Adverse Event|0|||
30629302|NCT01086384|58641094|FG000|2-week Run-in Period|Protocol Violation|1|||
30629303|NCT01086384|58641095|FG001|2-week Run-in Period|Protocol Violation|0|||
30629304|NCT01086384|58641096|FG002|2-week Run-in Period|Protocol Violation|0|||
30629305|NCT01086384|58641094|FG000|2-week Run-in Period|Lost to Follow-up|1|||
30629306|NCT01086384|58641095|FG001|2-week Run-in Period|Lost to Follow-up|0|||
30629307|NCT01086384|58641096|FG002|2-week Run-in Period|Lost to Follow-up|0|||
30629308|NCT01086384|58641094|FG000|2-week Run-in Period|Physician Decision|6|||
30629309|NCT01086384|58641095|FG001|2-week Run-in Period|Physician Decision|0|||
30629310|NCT01086384|58641096|FG002|2-week Run-in Period|Physician Decision|0|||
30629311|NCT01086384|58641094|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
30629312|NCT01086384|58641095|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
30629313|NCT01086384|58641096|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
30629314|NCT01086384|58641094|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
30629315|NCT01086384|58641095|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
30629316|NCT01086384|58641096|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
30629317|NCT01086384|58641094|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
30629318|NCT01086384|58641095|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
30629319|NCT01086384|58641096|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
30629320|NCT01086384|58641094|FG000|2-week Run-in Period|Randomized in Error|1|||
30629321|NCT01086384|58641095|FG001|2-week Run-in Period|Randomized in Error|0|||
30629322|NCT01086384|58641096|FG002|2-week Run-in Period|Randomized in Error|0|||
30629323|NCT01086384|58641094|FG000|Treatment Period|Withdrawal by Subject|0|||
30629324|NCT01086384|58641095|FG001|Treatment Period|Withdrawal by Subject|53|||
30629325|NCT01086384|58641096|FG002|Treatment Period|Withdrawal by Subject|55|||
30629326|NCT01086384|58641094|FG000|Treatment Period|Protocol Violation|0|||
30629327|NCT01086384|58641095|FG001|Treatment Period|Protocol Violation|26|||
30629328|NCT01086384|58641096|FG002|Treatment Period|Protocol Violation|17|||
30629329|NCT01086384|58641094|FG000|Treatment Period|Lack of Efficacy|0|||
30629330|NCT01086384|58641095|FG001|Treatment Period|Lack of Efficacy|22|||
30629331|NCT01086384|58641096|FG002|Treatment Period|Lack of Efficacy|13|||
30629332|NCT01086384|58641094|FG000|Treatment Period|Adverse Event|0|||
30629333|NCT01086384|58641095|FG001|Treatment Period|Adverse Event|19|||
30629334|NCT01086384|58641096|FG002|Treatment Period|Adverse Event|15|||
30629335|NCT01086384|58641094|FG000|Treatment Period|Lost to Follow-up|0|||
30629336|NCT01086384|58641095|FG001|Treatment Period|Lost to Follow-up|11|||
30629337|NCT01086384|58641096|FG002|Treatment Period|Lost to Follow-up|9|||
30629338|NCT01086384|58641094|FG000|Treatment Period|Physician Decision|0|||
30629339|NCT01086384|58641095|FG001|Treatment Period|Physician Decision|9|||
30629340|NCT01086384|58641096|FG002|Treatment Period|Physician Decision|6|||
30629341|NCT01086384|58641094|FG000|Treatment Period|Study Closed/Terminated|0|||
30629342|NCT01086384|58641095|FG001|Treatment Period|Study Closed/Terminated|7|||
30629343|NCT01086384|58641096|FG002|Treatment Period|Study Closed/Terminated|8|||
30629344|NCT01086384|58641094|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
30629345|NCT01086384|58641095|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
30629346|NCT01086384|58641096|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
30629347|NCT01086384|58641094|FG000|Treatment Period|Received Treatment in Error|0|||
30629348|NCT01086384|58641095|FG001|Treatment Period|Received Treatment in Error|1|||
30629349|NCT01086384|58641096|FG002|Treatment Period|Received Treatment in Error|0|||
30629350|NCT01127633|58641117|FG000|Overall Study|Adverse Event|74|||
30629351|NCT01127633|58641118|FG001|Overall Study|Adverse Event|73|||
30629352|NCT01127633|58641117|FG000|Overall Study|Death|40|||
30629353|NCT01127633|58641118|FG001|Overall Study|Death|43|||
30629354|NCT01127633|58641117|FG000|Overall Study|Lost to Follow-up|4|||
30629355|NCT01127633|58641118|FG001|Overall Study|Lost to Follow-up|0|||
30629356|NCT01127633|58641117|FG000|Overall Study|Parent/Caregiver Decision|246|||
30629357|NCT01127633|58641118|FG001|Overall Study|Parent/Caregiver Decision|228|||
30629358|NCT01127633|58641117|FG000|Overall Study|Physician Decision|60|||
30629359|NCT01127633|58641118|FG001|Overall Study|Physician Decision|45|||
30629360|NCT01127633|58641117|FG000|Overall Study|Withdrawal by Subject|57|||
30629361|NCT01127633|58641118|FG001|Overall Study|Withdrawal by Subject|72|||
30629362|NCT01127633|58641117|FG000|Overall Study|Sponsor Decision|163|||
30629363|NCT01127633|58641118|FG001|Overall Study|Sponsor Decision|195|||
30629364|NCT01127633|58641117|FG000|Overall Study|Protocol Violation|8|||
30629365|NCT01127633|58641118|FG001|Overall Study|Protocol Violation|16|||
30629366|NCT01127633|58641117|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
30629367|NCT01127633|58641118|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
30629368|NCT01127633|58641117|FG000|Overall Study|Not treated|1|||
30629369|NCT01127633|58641118|FG001|Overall Study|Not treated|0|||
30629370|NCT01122173|58641124|FG000|Overall Study|Lost to Follow-up|3|||
30629371|NCT01122173|58641124|FG000|Overall Study|Withdrawal by Subject|3|||
30629372|NCT01122173|58641124|FG000|Overall Study|Left study for other reasons|3|||
30629373|NCT01127165|58641131|FG000|Overall Study|Adverse Event|2|||
30629374|NCT01127165|58641132|FG001|Overall Study|Adverse Event|2|||
30629375|NCT01127165|58641131|FG000|Overall Study|Lack of Efficacy|10|||
30629376|NCT01127165|58641132|FG001|Overall Study|Lack of Efficacy|8|||
30629377|NCT01127165|58641131|FG000|Overall Study|Lost to Follow-up|3|||
30629378|NCT01127165|58641132|FG001|Overall Study|Lost to Follow-up|5|||
30629379|NCT01127165|58641131|FG000|Overall Study|Withdrawal by Subject|1|||
30629380|NCT01127165|58641132|FG001|Overall Study|Withdrawal by Subject|3|||
30629381|NCT01127165|58641131|FG000|Overall Study|Protocol Violation|0|||
30629382|NCT01127165|58641132|FG001|Overall Study|Protocol Violation|1|||
30629383|NCT01126619|58641138|FG000|Overall Study|Not eligible for the study|2|||
30629384|NCT01126619|58641138|FG000|Overall Study|Investigator decision|4|||
30629385|NCT01126619|58641138|FG000|Overall Study|Serious adverse event|1|||
30629386|NCT01126619|58641138|FG000|Overall Study|Withdrawal by Subject|9|||
30629387|NCT01126619|58641138|FG000|Overall Study|Non-compliance|1|||
30629388|NCT00941733|58641146|FG000|Overall Study|Death|24|||
30629389|NCT00941733|58641147|FG001|Overall Study|Death|10|||
30629390|NCT00941733|58641146|FG000|Overall Study|Withdrawal by Subject|14|||
30629391|NCT00941733|58641147|FG001|Overall Study|Withdrawal by Subject|6|||
30629392|NCT00941733|58641146|FG000|Overall Study|Adverse Event|20|||
30629393|NCT00941733|58641147|FG001|Overall Study|Adverse Event|4|||
30629394|NCT00941733|58641146|FG000|Overall Study|Lost to Follow-up|1|||
30629395|NCT00941733|58641147|FG001|Overall Study|Lost to Follow-up|2|||
30629396|NCT00941733|58641146|FG000|Overall Study|Protocol Violation|15|||
30629397|NCT00941733|58641147|FG001|Overall Study|Protocol Violation|6|||
30629398|NCT00941655|58641155|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
30629399|NCT00941655|58641156|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
30629400|NCT00941655|58641155|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
30629401|NCT00941655|58641156|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
30629402|NCT00941655|58641155|FG000|Overall Study|progressed while on chemo|0|||
30629403|NCT00941655|58641156|FG001|Overall Study|progressed while on chemo|2|||
30629404|NCT00941655|58641155|FG000|Overall Study|refused further treatment|0|||
30629405|NCT00941655|58641156|FG001|Overall Study|refused further treatment|1|||
30629406|NCT00941655|58641155|FG000|Overall Study|withdrew consent|0|||
30629407|NCT00941655|58641156|FG001|Overall Study|withdrew consent|1|||
30629408|NCT00941655|58641155|FG000|Overall Study|non-compliant|0|||
30629409|NCT00941655|58641156|FG001|Overall Study|non-compliant|1|||
30629410|NCT00939393|58641165|FG000|Overall Study|Withdrawal by Subject|1|||
30629411|NCT00939393|58641166|FG001|Overall Study|Withdrawal by Subject|0|||
30629412|NCT00939393|58641165|FG000|Overall Study|Lost to Follow-up|3|||
30629413|NCT00939393|58641166|FG001|Overall Study|Lost to Follow-up|0|||
30629414|NCT00936117|58641183|FG000|Overall Study|Adverse Event|7|||
30629415|NCT00936117|58641183|FG000|Overall Study|Unable to continue oral medication|3|||
30629416|NCT04088500|58641188|FG000|Overall Study|Reason unknown|1|||
30629417|NCT04088500|58641188|FG000|Overall Study|Participant withdrew consent|1|||
30848200|NCT00409773|58874111|FG000|Overall Study|Physician Decision|0|||
30629418|NCT04088500|58641188|FG000|Overall Study|Disease progression|3|||
30629419|NCT01082874|58641196|FG000|Overall Study|Lost to Follow-up|10|||
30629420|NCT01082874|58641197|FG001|Overall Study|Lost to Follow-up|10|||
30629421|NCT01082874|58641198|FG002|Overall Study|Lost to Follow-up|6|||
30629422|NCT01082874|58641199|FG003|Overall Study|Lost to Follow-up|10|||
30629423|NCT01082874|58641196|FG000|Overall Study|Withdrawal by Subject|1|||
30629424|NCT01082874|58641197|FG001|Overall Study|Withdrawal by Subject|2|||
30629425|NCT01082874|58641198|FG002|Overall Study|Withdrawal by Subject|5|||
30629426|NCT01082874|58641199|FG003|Overall Study|Withdrawal by Subject|3|||
30629427|NCT00933543|58641211|FG000|Overall Study|Adverse Event|2|||
30629428|NCT00933543|58641212|FG001|Overall Study|Adverse Event|1|||
30629429|NCT00933543|58641211|FG000|Overall Study|Lost to Follow-up|0|||
30629430|NCT00933543|58641212|FG001|Overall Study|Lost to Follow-up|1|||
30629431|NCT00933543|58641211|FG000|Overall Study|Withdrawal by Subject|0|||
30629432|NCT00933543|58641212|FG001|Overall Study|Withdrawal by Subject|1|||
30629433|NCT00933543|58641211|FG000|Overall Study|Lack of Efficacy|0|||
30629434|NCT00933543|58641212|FG001|Overall Study|Lack of Efficacy|3|||
30629435|NCT00933543|58641211|FG000|Overall Study|Other|1|||
30629436|NCT00933543|58641212|FG001|Overall Study|Other|1|||
30629437|NCT01082328|58641218|FG000|Overall Study|Adverse Event|1|||
30629438|NCT01079988|58641227|FG000|Overall Study|Lost to Follow-up|0|||
30629439|NCT01079988|58641228|FG001|Overall Study|Lost to Follow-up|0|||
30629440|NCT01079988|58641229|FG002|Overall Study|Lost to Follow-up|0|||
30629441|NCT01079988|58641230|FG003|Overall Study|Lost to Follow-up|1|||
30629442|NCT01079988|58641231|FG004|Overall Study|Lost to Follow-up|0|||
30629443|NCT01079988|58641227|FG000|Overall Study|Lack of Efficacy|1|||
30629444|NCT01079988|58641228|FG001|Overall Study|Lack of Efficacy|0|||
30629445|NCT01079988|58641229|FG002|Overall Study|Lack of Efficacy|0|||
30629446|NCT01079988|58641230|FG003|Overall Study|Lack of Efficacy|0|||
30629447|NCT01079988|58641231|FG004|Overall Study|Lack of Efficacy|0|||
30629448|NCT01079988|58641227|FG000|Overall Study|Other|0|||
30629449|NCT01079988|58641228|FG001|Overall Study|Other|0|||
30629450|NCT01079988|58641229|FG002|Overall Study|Other|0|||
30629451|NCT01079988|58641230|FG003|Overall Study|Other|2|||
30629452|NCT01079988|58641231|FG004|Overall Study|Other|1|||
30629453|NCT01074216|58641243|FG000|Overall Study|Physician Decision|1|||
30629454|NCT01074216|58641243|FG000|Overall Study|Not Treated|12|||
30629455|NCT01079832|58641247|FG000|Overall Study|Withdrawal by Subject|1|||
30629456|NCT01072344|58641253|FG000|Overall Study|Relasped-reached end point|7|||
30629457|NCT01072344|58641254|FG001|Overall Study|Relasped-reached end point|12|||
30629458|NCT01072344|58641253|FG000|Overall Study|Protocol Violation|1|||
30629459|NCT01072344|58641254|FG001|Overall Study|Protocol Violation|2|||
30629460|NCT01072344|58641253|FG000|Overall Study|Lost to Follow-up|3|||
30629461|NCT01072344|58641254|FG001|Overall Study|Lost to Follow-up|4|||
30629462|NCT01071954|58641260|FG000|Overall Study|Noncompliance|4|||
30629463|NCT01071954|58641260|FG000|Overall Study|Adverse Event|1|||
30629464|NCT01071954|58641260|FG000|Overall Study|Withdrawal by Subject|11|||
30629465|NCT01071954|58641260|FG000|Overall Study|Requirement for Alternative Therapy|5|||
30629466|NCT01071954|58641260|FG000|Overall Study|Administrative Decision|5|||
30629467|NCT01071954|58641260|FG000|Overall Study|Protocol Specified Criteria|1|||
30629468|NCT00837811|58641267|FG000|Overall Study|Adverse Event|4|||
30629469|NCT00837811|58641268|FG001|Overall Study|Adverse Event|6|||
30629470|NCT00837811|58641269|FG002|Overall Study|Adverse Event|0|||
30629471|NCT00837811|58641267|FG000|Overall Study|Death|1|||
30629472|NCT00837811|58641268|FG001|Overall Study|Death|1|||
30629473|NCT00837811|58641269|FG002|Overall Study|Death|0|||
30629474|NCT00837811|58641267|FG000|Overall Study|Lack of Efficacy|0|||
30629475|NCT00837811|58641268|FG001|Overall Study|Lack of Efficacy|11|||
30629476|NCT00837811|58641269|FG002|Overall Study|Lack of Efficacy|0|||
30629477|NCT00837811|58641267|FG000|Overall Study|Lost to Follow-up|1|||
30629478|NCT00837811|58641268|FG001|Overall Study|Lost to Follow-up|3|||
30629479|NCT00837811|58641269|FG002|Overall Study|Lost to Follow-up|0|||
30629480|NCT00837811|58641267|FG000|Overall Study|Physician Decision|0|||
30629481|NCT00837811|58641268|FG001|Overall Study|Physician Decision|2|||
30950918|NCT01921205|58997930|FG000|Overall Study|Non Compliance Of The Parent|0|||
30629482|NCT00837811|58641269|FG002|Overall Study|Physician Decision|1|||
30629483|NCT00837811|58641267|FG000|Overall Study|Withdrawal by Subject|1|||
30629484|NCT00837811|58641268|FG001|Overall Study|Withdrawal by Subject|9|||
30950919|NCT01921205|58997931|FG001|Overall Study|Non Compliance Of The Parent|1|||
30629485|NCT00837811|58641269|FG002|Overall Study|Withdrawal by Subject|0|||
30629486|NCT00837811|58641267|FG000|Overall Study|Sponsor Decision|0|||
30629487|NCT00837811|58641268|FG001|Overall Study|Sponsor Decision|2|||
30629488|NCT00837811|58641269|FG002|Overall Study|Sponsor Decision|0|||
30629489|NCT00857389|58641286|FG000|Overall Study|Did not proceed to transplant|2|||
30629490|NCT01071798|58641290|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
30629491|NCT01071798|58641290|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
30629492|NCT01071798|58641290|FG000|Participants Who Received One Cycle|Patient requirement|20|||
30629493|NCT01071798|58641290|FG000|Participants Who Received One Cycle|Death|5|||
30629494|NCT01071798|58641290|FG000|Participants Who Received One Cycle|Change of therapy|6|||
30629495|NCT01071798|58641290|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
30629496|NCT01071798|58641290|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
30629497|NCT01071798|58641290|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
30629498|NCT01071798|58641290|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
30629499|NCT01071798|58641290|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
30950920|NCT01921205|58997930|FG000|Overall Study|Non Compliance Of Child|0|||
30950921|NCT01921205|58997931|FG001|Overall Study|Non Compliance Of Child|1|||
30950922|NCT01920893|58997939|FG000|Overall Study|Adverse Event|5|||
30950923|NCT01920893|58997940|FG001|Overall Study|Adverse Event|2|||
30950924|NCT01920893|58997939|FG000|Overall Study|Lack of Efficacy|2|||
30950925|NCT01920893|58997940|FG001|Overall Study|Lack of Efficacy|0|||
30950926|NCT01709305|58997947|FG000|Phase 1|Clinical Adverse Event|80|||
30950927|NCT01709305|58997948|FG001|Phase 1|Clinical Adverse Event|0|||
30950928|NCT01709305|58997949|FG002|Phase 1|Clinical Adverse Event|0|||
30950929|NCT01709305|58997950|FG003|Phase 1|Clinical Adverse Event|0|||
30950930|NCT01709305|58997951|FG004|Phase 1|Clinical Adverse Event|0|||
30950931|NCT01709305|58997947|FG000|Phase 1|Death|2|||
30950932|NCT01709305|58997948|FG001|Phase 1|Death|0|||
30950933|NCT01709305|58997949|FG002|Phase 1|Death|0|||
30950934|NCT01709305|58997950|FG003|Phase 1|Death|0|||
30950935|NCT01709305|58997951|FG004|Phase 1|Death|0|||
30950936|NCT01709305|58997947|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
30629500|NCT00857311|58641308|FG000|Overall Study|Lost to Follow-up|1|||
30629501|NCT00857311|58641309|FG001|Overall Study|Lost to Follow-up|0|||
30629502|NCT00857311|58641310|FG002|Overall Study|Lost to Follow-up|0|||
30629503|NCT00857311|58641311|FG003|Overall Study|Lost to Follow-up|0|||
30629504|NCT00857233|58641317|FG000|Overall Study|Adverse Event|24|||
30629505|NCT00857233|58641317|FG000|Overall Study|Lack of Efficacy|1|||
30629506|NCT00857233|58641317|FG000|Overall Study|Non-compliance|1|||
30629507|NCT00857233|58641317|FG000|Overall Study|Withdrawal of Consent|9|||
30629508|NCT00857233|58641317|FG000|Overall Study|Lost to Follow-up|4|||
30629509|NCT00857233|58641317|FG000|Overall Study|Nursing Home Placement|14|||
30629510|NCT00857233|58641317|FG000|Overall Study|Other Reasons|2|||
30629511|NCT00856999|58641321|FG000|Overall Study|Withdrawal by Subject|5|||
30629512|NCT01071252|58641331|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
30629513|NCT01071252|58641332|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
30629514|NCT01071252|58641333|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
30629515|NCT01071252|58641334|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
30629516|NCT01071252|58641335|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
30629517|NCT01071252|58641331|FG000|Overall Study|Withdrawal by Subject|8|||
30629518|NCT01071252|58641332|FG001|Overall Study|Withdrawal by Subject|2|||
30629519|NCT01071252|58641333|FG002|Overall Study|Withdrawal by Subject|1|||
30629520|NCT01071252|58641334|FG003|Overall Study|Withdrawal by Subject|2|||
30629521|NCT01071252|58641335|FG004|Overall Study|Withdrawal by Subject|3|||
30629522|NCT01071252|58641331|FG000|Overall Study|administrative problems|1|||
30629523|NCT01071252|58641332|FG001|Overall Study|administrative problems|1|||
30629524|NCT01071252|58641333|FG002|Overall Study|administrative problems|0|||
30629525|NCT01071252|58641334|FG003|Overall Study|administrative problems|2|||
30629526|NCT01071252|58641335|FG004|Overall Study|administrative problems|1|||
30629527|NCT01071252|58641331|FG000|Overall Study|Lost to Follow-up|1|||
30629528|NCT01071252|58641332|FG001|Overall Study|Lost to Follow-up|0|||
30629529|NCT01071252|58641333|FG002|Overall Study|Lost to Follow-up|1|||
30629530|NCT01071252|58641334|FG003|Overall Study|Lost to Follow-up|2|||
30629531|NCT01071252|58641335|FG004|Overall Study|Lost to Follow-up|0|||
30629532|NCT01071252|58641331|FG000|Overall Study|Adverse Event|1|||
30629533|NCT01071252|58641332|FG001|Overall Study|Adverse Event|1|||
30629534|NCT01071252|58641333|FG002|Overall Study|Adverse Event|0|||
30629535|NCT01071252|58641334|FG003|Overall Study|Adverse Event|1|||
30950937|NCT01709305|58997948|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
30950938|NCT01709305|58997949|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
30950939|NCT01709305|58997950|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
30629536|NCT01071252|58641335|FG004|Overall Study|Adverse Event|0|||
30629537|NCT01071252|58641331|FG000|Overall Study|Death|0|||
30629538|NCT01071252|58641332|FG001|Overall Study|Death|0|||
30629539|NCT01071252|58641333|FG002|Overall Study|Death|0|||
30629540|NCT01071252|58641334|FG003|Overall Study|Death|0|||
30629541|NCT01071252|58641335|FG004|Overall Study|Death|1|||
30629542|NCT00856843|58641349|FG000|Overall Study|Withdrawal by Subject|1|||
30629543|NCT00856843|58641350|FG001|Overall Study|Withdrawal by Subject|5|||
30629544|NCT00856843|58641349|FG000|Overall Study|Lack of Efficacy|1|||
30950940|NCT01709305|58997951|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
30950941|NCT01709305|58997947|FG000|Phase 1|Laboratory Adverse Event|16|||
30950942|NCT01709305|58997948|FG001|Phase 1|Laboratory Adverse Event|0|||
30950943|NCT01709305|58997949|FG002|Phase 1|Laboratory Adverse Event|0|||
30629545|NCT00856843|58641350|FG001|Overall Study|Lack of Efficacy|0|||
30629546|NCT00856609|58641358|FG000|Overall Study|Adverse Event|1|||
30629547|NCT00856609|58641359|FG001|Overall Study|Adverse Event|0|||
30629548|NCT01071096|58641365|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
30629549|NCT01071096|58641366|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
30629550|NCT00856375|58641385|FG000|Overall Study|Other|0|||
30629551|NCT00856375|58641386|FG001|Overall Study|Other|1|||
30629552|NCT00856375|58641385|FG000|Overall Study|Death|32|||
30629553|NCT00856375|58641386|FG001|Overall Study|Death|30|||
30629554|NCT00856375|58641385|FG000|Overall Study|Sponsor Terminated Study|7|||
30629555|NCT00856375|58641386|FG001|Overall Study|Sponsor Terminated Study|7|||
30629556|NCT00856375|58641385|FG000|Overall Study|Withdrawal by Subject|2|||
30629557|NCT00856375|58641386|FG001|Overall Study|Withdrawal by Subject|1|||
30629558|NCT00856375|58641385|FG000|Overall Study|Lost to Follow-up|1|||
30629559|NCT00856375|58641386|FG001|Overall Study|Lost to Follow-up|2|||
30629560|NCT01070784|58641394|FG000|Overall Study|Withdrawal by Subject|6|||
30629561|NCT01070784|58641395|FG001|Overall Study|Withdrawal by Subject|9|||
30629562|NCT01070784|58641394|FG000|Overall Study|Adverse Event|14|||
30629563|NCT01070784|58641395|FG001|Overall Study|Adverse Event|9|||
30629564|NCT00837577|58641403|FG000|Double-blind Period|Clinical Adverse Event|1|||
30629565|NCT00837577|58641404|FG001|Double-blind Period|Clinical Adverse Event|0|||
30629566|NCT00837577|58641403|FG000|Double-blind Period|Withdrawal by Subject|1|||
30629567|NCT00837577|58641404|FG001|Double-blind Period|Withdrawal by Subject|0|||
30629568|NCT00837577|58641403|FG000|Open-label Period|Clinical Adverse Event|2|||
30629569|NCT00837577|58641404|FG001|Open-label Period|Clinical Adverse Event|2|||
30629570|NCT00837577|58641403|FG000|Open-label Period|Laboratory Adverse Event|0|||
30629571|NCT00837577|58641404|FG001|Open-label Period|Laboratory Adverse Event|1|||
30629572|NCT00837577|58641403|FG000|Open-label Period|Lack of Efficacy|4|||
30629573|NCT00837577|58641404|FG001|Open-label Period|Lack of Efficacy|3|||
30629574|NCT00837577|58641403|FG000|Open-label Period|Withdrawal by Subject|1|||
30629575|NCT00837577|58641404|FG001|Open-label Period|Withdrawal by Subject|2|||
30629576|NCT00837577|58641403|FG000|Open-label Period|Other Reason|1|||
30629577|NCT00837577|58641404|FG001|Open-label Period|Other Reason|1|||
30629578|NCT01070550|58641417|FG000|Overall Study|Adverse Event|43|||
30629579|NCT01070550|58641418|FG001|Overall Study|Adverse Event|1|||
30629580|NCT01070550|58641419|FG002|Overall Study|Adverse Event|3|||
30629581|NCT01070550|58641420|FG003|Overall Study|Adverse Event|0|||
30629582|NCT01070550|58641421|FG004|Overall Study|Adverse Event|0|||
30629583|NCT01070550|58641422|FG005|Overall Study|Adverse Event|0|||
30629584|NCT01070550|58641417|FG000|Overall Study|Death|20|||
30629585|NCT01070550|58641418|FG001|Overall Study|Death|4|||
30629586|NCT01070550|58641419|FG002|Overall Study|Death|3|||
30629587|NCT01070550|58641420|FG003|Overall Study|Death|0|||
30629588|NCT01070550|58641421|FG004|Overall Study|Death|0|||
30629589|NCT01070550|58641422|FG005|Overall Study|Death|0|||
30629590|NCT01070550|58641417|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
30629591|NCT01070550|58641418|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
30629592|NCT01070550|58641419|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
30629593|NCT01070550|58641420|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
30629594|NCT01070550|58641421|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
30629595|NCT01070550|58641422|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
30629596|NCT01070550|58641417|FG000|Overall Study|Early termination|3|||
30629597|NCT01070550|58641418|FG001|Overall Study|Early termination|0|||
30629598|NCT01070550|58641419|FG002|Overall Study|Early termination|0|||
30629599|NCT01070550|58641420|FG003|Overall Study|Early termination|0|||
30629600|NCT01070550|58641421|FG004|Overall Study|Early termination|0|||
30629601|NCT01070550|58641422|FG005|Overall Study|Early termination|0|||
30629602|NCT01070550|58641417|FG000|Overall Study|Failed to return|450|||
30629603|NCT01070550|58641418|FG001|Overall Study|Failed to return|33|||
30629604|NCT01070550|58641419|FG002|Overall Study|Failed to return|144|||
30629605|NCT01070550|58641420|FG003|Overall Study|Failed to return|40|||
30629606|NCT01070550|58641421|FG004|Overall Study|Failed to return|1|||
30629607|NCT01070550|58641422|FG005|Overall Study|Failed to return|2|||
30629608|NCT01070550|58641417|FG000|Overall Study|Incomplete treatment|2|||
30629609|NCT01070550|58641418|FG001|Overall Study|Incomplete treatment|0|||
30629610|NCT01070550|58641419|FG002|Overall Study|Incomplete treatment|0|||
30629611|NCT01070550|58641420|FG003|Overall Study|Incomplete treatment|0|||
30629612|NCT01070550|58641421|FG004|Overall Study|Incomplete treatment|0|||
30629613|NCT01070550|58641422|FG005|Overall Study|Incomplete treatment|0|||
30629614|NCT01070550|58641417|FG000|Overall Study|Lab test not done|22|||
30629615|NCT01070550|58641418|FG001|Overall Study|Lab test not done|3|||
30629616|NCT01070550|58641419|FG002|Overall Study|Lab test not done|4|||
30629617|NCT01070550|58641420|FG003|Overall Study|Lab test not done|1|||
30629618|NCT01070550|58641421|FG004|Overall Study|Lab test not done|0|||
30629619|NCT01070550|58641422|FG005|Overall Study|Lab test not done|1|||
30629620|NCT01070550|58641417|FG000|Overall Study|Lack of Efficacy|65|||
30629621|NCT01070550|58641418|FG001|Overall Study|Lack of Efficacy|1|||
30629622|NCT01070550|58641419|FG002|Overall Study|Lack of Efficacy|5|||
30629623|NCT01070550|58641420|FG003|Overall Study|Lack of Efficacy|5|||
30629624|NCT01070550|58641421|FG004|Overall Study|Lack of Efficacy|0|||
30629625|NCT01070550|58641422|FG005|Overall Study|Lack of Efficacy|1|||
30629626|NCT01070550|58641417|FG000|Overall Study|Miscellaneous|12|||
30629627|NCT01070550|58641418|FG001|Overall Study|Miscellaneous|2|||
30629628|NCT01070550|58641419|FG002|Overall Study|Miscellaneous|3|||
30629629|NCT01070550|58641420|FG003|Overall Study|Miscellaneous|1|||
30629630|NCT01070550|58641421|FG004|Overall Study|Miscellaneous|0|||
30629631|NCT01070550|58641422|FG005|Overall Study|Miscellaneous|0|||
30629632|NCT01070550|58641417|FG000|Overall Study|New treatment started|3|||
30629633|NCT01070550|58641418|FG001|Overall Study|New treatment started|1|||
30629634|NCT01070550|58641419|FG002|Overall Study|New treatment started|0|||
30629635|NCT01070550|58641420|FG003|Overall Study|New treatment started|2|||
30629636|NCT01070550|58641421|FG004|Overall Study|New treatment started|0|||
30629637|NCT01070550|58641422|FG005|Overall Study|New treatment started|0|||
30629638|NCT01070550|58641417|FG000|Overall Study|Non-responders|493|||
30629639|NCT01070550|58641418|FG001|Overall Study|Non-responders|4|||
30629640|NCT01070550|58641419|FG002|Overall Study|Non-responders|21|||
30629641|NCT01070550|58641420|FG003|Overall Study|Non-responders|20|||
30629642|NCT01070550|58641421|FG004|Overall Study|Non-responders|0|||
30629643|NCT01070550|58641422|FG005|Overall Study|Non-responders|2|||
30629644|NCT01070550|58641417|FG000|Overall Study|Not categorized|33|||
30629645|NCT01070550|58641418|FG001|Overall Study|Not categorized|2|||
30629646|NCT01070550|58641419|FG002|Overall Study|Not categorized|6|||
30629647|NCT01070550|58641420|FG003|Overall Study|Not categorized|1|||
30629648|NCT01070550|58641421|FG004|Overall Study|Not categorized|0|||
30629649|NCT01070550|58641422|FG005|Overall Study|Not categorized|1|||
30629650|NCT01070550|58641417|FG000|Overall Study|Protocol Violation|15|||
30629651|NCT01070550|58641418|FG001|Overall Study|Protocol Violation|1|||
30629652|NCT01070550|58641419|FG002|Overall Study|Protocol Violation|1|||
30848201|NCT00409773|58874112|FG001|Overall Study|Physician Decision|0|||
30629653|NCT01070550|58641420|FG003|Overall Study|Protocol Violation|1|||
30629654|NCT01070550|58641421|FG004|Overall Study|Protocol Violation|0|||
30629655|NCT01070550|58641422|FG005|Overall Study|Protocol Violation|0|||
30629656|NCT01070550|58641417|FG000|Overall Study|Relapse|44|||
30629657|NCT01070550|58641418|FG001|Overall Study|Relapse|5|||
30629658|NCT01070550|58641419|FG002|Overall Study|Relapse|14|||
30629659|NCT01070550|58641420|FG003|Overall Study|Relapse|4|||
30629660|NCT01070550|58641421|FG004|Overall Study|Relapse|0|||
30629661|NCT01070550|58641422|FG005|Overall Study|Relapse|0|||
30629662|NCT01070550|58641417|FG000|Overall Study|Result not available|3|||
30629663|NCT01070550|58641418|FG001|Overall Study|Result not available|1|||
30629664|NCT01070550|58641419|FG002|Overall Study|Result not available|3|||
30629665|NCT01070550|58641420|FG003|Overall Study|Result not available|0|||
30629666|NCT01070550|58641421|FG004|Overall Study|Result not available|0|||
30629667|NCT01070550|58641422|FG005|Overall Study|Result not available|0|||
30629668|NCT01070550|58641417|FG000|Overall Study|Screen failure|1|||
30629669|NCT01070550|58641418|FG001|Overall Study|Screen failure|0|||
30629670|NCT01070550|58641419|FG002|Overall Study|Screen failure|0|||
30629671|NCT01070550|58641420|FG003|Overall Study|Screen failure|0|||
30629672|NCT01070550|58641421|FG004|Overall Study|Screen failure|0|||
30629673|NCT01070550|58641422|FG005|Overall Study|Screen failure|0|||
30629674|NCT01070550|58641417|FG000|Overall Study|Sponsor decision|1|||
30629675|NCT01070550|58641418|FG001|Overall Study|Sponsor decision|0|||
30629676|NCT01070550|58641419|FG002|Overall Study|Sponsor decision|0|||
30629677|NCT01070550|58641420|FG003|Overall Study|Sponsor decision|0|||
30629678|NCT01070550|58641421|FG004|Overall Study|Sponsor decision|0|||
30629679|NCT01070550|58641422|FG005|Overall Study|Sponsor decision|0|||
30629680|NCT01070550|58641417|FG000|Overall Study|Treatment duration shortened|1|||
30629681|NCT01070550|58641418|FG001|Overall Study|Treatment duration shortened|0|||
30629682|NCT01070550|58641419|FG002|Overall Study|Treatment duration shortened|0|||
30629683|NCT01070550|58641420|FG003|Overall Study|Treatment duration shortened|0|||
30629684|NCT01070550|58641421|FG004|Overall Study|Treatment duration shortened|0|||
30629685|NCT01070550|58641422|FG005|Overall Study|Treatment duration shortened|0|||
30629686|NCT01070550|58641417|FG000|Overall Study|Treatment interrupted|7|||
30629687|NCT01070550|58641418|FG001|Overall Study|Treatment interrupted|0|||
30629688|NCT01070550|58641419|FG002|Overall Study|Treatment interrupted|1|||
30629689|NCT01070550|58641420|FG003|Overall Study|Treatment interrupted|1|||
30629690|NCT01070550|58641421|FG004|Overall Study|Treatment interrupted|0|||
30629691|NCT01070550|58641422|FG005|Overall Study|Treatment interrupted|0|||
30629692|NCT01070550|58641417|FG000|Overall Study|Treatment not started|14|||
30629693|NCT01070550|58641418|FG001|Overall Study|Treatment not started|2|||
30629694|NCT01070550|58641419|FG002|Overall Study|Treatment not started|4|||
30629695|NCT01070550|58641420|FG003|Overall Study|Treatment not started|0|||
30629696|NCT01070550|58641421|FG004|Overall Study|Treatment not started|0|||
30629697|NCT01070550|58641422|FG005|Overall Study|Treatment not started|0|||
30629698|NCT01070550|58641417|FG000|Overall Study|Treatment restarted|0|||
30629699|NCT01070550|58641418|FG001|Overall Study|Treatment restarted|1|||
30629700|NCT01070550|58641419|FG002|Overall Study|Treatment restarted|0|||
30629701|NCT01070550|58641420|FG003|Overall Study|Treatment restarted|0|||
30629702|NCT01070550|58641421|FG004|Overall Study|Treatment restarted|0|||
30629703|NCT01070550|58641422|FG005|Overall Study|Treatment restarted|0|||
30629704|NCT01070550|58641417|FG000|Overall Study|Treatment stopped|3|||
30629705|NCT01070550|58641418|FG001|Overall Study|Treatment stopped|0|||
30629706|NCT01070550|58641419|FG002|Overall Study|Treatment stopped|0|||
30629707|NCT01070550|58641420|FG003|Overall Study|Treatment stopped|0|||
30629708|NCT01070550|58641421|FG004|Overall Study|Treatment stopped|0|||
30629709|NCT01070550|58641422|FG005|Overall Study|Treatment stopped|0|||
30629710|NCT01070550|58641417|FG000|Overall Study|Treatment unavailable|1|||
30629711|NCT01070550|58641418|FG001|Overall Study|Treatment unavailable|0|||
30629712|NCT01070550|58641419|FG002|Overall Study|Treatment unavailable|0|||
30764302|NCT00356135|58772960|FG000|Overall Study|Subject non-compliance|1|||
30764303|NCT00356135|58772961|FG001|Overall Study|Subject non-compliance|1|||
30764304|NCT00356135|58772962|FG002|Overall Study|Subject non-compliance|3|||
30629713|NCT01070550|58641420|FG003|Overall Study|Treatment unavailable|0|||
30629714|NCT01070550|58641421|FG004|Overall Study|Treatment unavailable|0|||
30629715|NCT01070550|58641422|FG005|Overall Study|Treatment unavailable|0|||
30629716|NCT01070550|58641417|FG000|Overall Study|Treatment was stopped early|7|||
30629717|NCT01070550|58641418|FG001|Overall Study|Treatment was stopped early|0|||
30629718|NCT01070550|58641419|FG002|Overall Study|Treatment was stopped early|0|||
30629719|NCT01070550|58641420|FG003|Overall Study|Treatment was stopped early|0|||
30629720|NCT01070550|58641421|FG004|Overall Study|Treatment was stopped early|0|||
30629721|NCT01070550|58641422|FG005|Overall Study|Treatment was stopped early|0|||
30629722|NCT01070550|58641417|FG000|Overall Study|Other|5|||
30629723|NCT01070550|58641418|FG001|Overall Study|Other|0|||
30629724|NCT01070550|58641419|FG002|Overall Study|Other|0|||
30629725|NCT01070550|58641420|FG003|Overall Study|Other|1|||
30629726|NCT01070550|58641421|FG004|Overall Study|Other|0|||
30629727|NCT01070550|58641422|FG005|Overall Study|Other|0|||
30629728|NCT01070550|58641417|FG000|Overall Study|Withdrawal by Subject|35|||
30629729|NCT01070550|58641418|FG001|Overall Study|Withdrawal by Subject|0|||
30629730|NCT01070550|58641419|FG002|Overall Study|Withdrawal by Subject|3|||
30629731|NCT01070550|58641420|FG003|Overall Study|Withdrawal by Subject|0|||
30629732|NCT01070550|58641421|FG004|Overall Study|Withdrawal by Subject|0|||
30629733|NCT01070550|58641422|FG005|Overall Study|Withdrawal by Subject|0|||
30629734|NCT00848107|58641437|FG000|Overall Study|Lost to Follow-up|2|||
30629735|NCT00848107|58641437|FG000|Overall Study|Withdrawal by Subject|8|||
30629736|NCT00848107|58641437|FG000|Overall Study|Adverse Event|9|||
30629737|NCT00848107|58641437|FG000|Overall Study|Death|1|||
30629738|NCT00848107|58641437|FG000|Overall Study|Pregnancy|1|||
30629739|NCT00856297|58641446|FG000|Overall Study|Unable to classify|2|||
30629740|NCT00856297|58641447|FG001|Overall Study|Unable to classify|0|||
30629741|NCT00856297|58641448|FG002|Overall Study|Unable to classify|0|||
30629742|NCT00856297|58641449|FG003|Overall Study|Unable to classify|0|||
30629743|NCT00856297|58641450|FG004|Overall Study|Unable to classify|0|||
30629744|NCT01046136|58641469|FG000|Overall Study|Withdrawal by Subject|0|||
30629745|NCT01046136|58641470|FG001|Overall Study|Withdrawal by Subject|4|||
30629746|NCT01046136|58641469|FG000|Overall Study|Physician Decision|1|||
30629747|NCT01046136|58641470|FG001|Overall Study|Physician Decision|1|||
30629748|NCT01046136|58641469|FG000|Overall Study|Lost to Follow-up|3|||
30629749|NCT01046136|58641470|FG001|Overall Study|Lost to Follow-up|3|||
30848202|NCT00409773|58874113|FG002|Overall Study|Physician Decision|0|||
30848203|NCT00409773|58874114|FG003|Overall Study|Physician Decision|2|||
30629750|NCT01070394|58641478|FG000|Overall Study|Adverse Event|6|||
30629751|NCT01070394|58641478|FG000|Overall Study|Withdrawal by Subject|1|||
30629752|NCT00836953|58641484|FG000|Overall Study|Withdrawal by Subject|1|||
30629753|NCT00836953|58641484|FG000|Overall Study|Lost to Follow-up|1|||
30629754|NCT01070316|58641488|FG000|Extension Phase|Lack of Efficacy|3|||
30629755|NCT01070316|58641488|FG000|Extension Phase|Withdrawal by Subject|1|||
30629756|NCT01126541|58641495|FG000|Overall Study|Adverse Event|0|||
30629757|NCT01126541|58641496|FG001|Overall Study|Adverse Event|2|||
30629758|NCT01126541|58641497|FG002|Overall Study|Adverse Event|4|||
30629759|NCT01126541|58641495|FG000|Overall Study|Death|0|||
30629760|NCT01126541|58641496|FG001|Overall Study|Death|1|||
30629761|NCT01126541|58641497|FG002|Overall Study|Death|0|||
30629762|NCT01126541|58641495|FG000|Overall Study|Lack of Efficacy|6|||
30629763|NCT01126541|58641496|FG001|Overall Study|Lack of Efficacy|1|||
30629764|NCT01126541|58641497|FG002|Overall Study|Lack of Efficacy|11|||
30629765|NCT01126541|58641495|FG000|Overall Study|Lost to Follow-up|1|||
30629766|NCT01126541|58641496|FG001|Overall Study|Lost to Follow-up|2|||
30629767|NCT01126541|58641497|FG002|Overall Study|Lost to Follow-up|2|||
30629768|NCT01126541|58641495|FG000|Overall Study|Withdrawal by Subject|2|||
30629769|NCT01126541|58641496|FG001|Overall Study|Withdrawal by Subject|5|||
30629770|NCT01126541|58641497|FG002|Overall Study|Withdrawal by Subject|6|||
30629771|NCT01126541|58641495|FG000|Overall Study|Protocol Violation|0|||
30629772|NCT01126541|58641496|FG001|Overall Study|Protocol Violation|0|||
30629773|NCT01126541|58641497|FG002|Overall Study|Protocol Violation|1|||
30629774|NCT01126541|58641495|FG000|Overall Study|Administrative reason or other|1|||
30629775|NCT01126541|58641496|FG001|Overall Study|Administrative reason or other|1|||
30629776|NCT01126541|58641497|FG002|Overall Study|Administrative reason or other|2|||
30629777|NCT00836875|58641509|FG000|Overall Study|Death|3|||
30629778|NCT00836875|58641510|FG001|Overall Study|Death|2|||
30629779|NCT00836875|58641509|FG000|Overall Study|Withdrawal by Subject|0|||
30629780|NCT00836875|58641510|FG001|Overall Study|Withdrawal by Subject|1|||
30629781|NCT01125917|58641516|FG000|Overall Study|Adverse Event|43|||
30629782|NCT01125917|58641516|FG000|Overall Study|Lost to Follow-up|23|||
30629783|NCT01125917|58641516|FG000|Overall Study|Withdrawal by Subject|31|||
30629784|NCT01125917|58641516|FG000|Overall Study|Administrative|223|||
30629785|NCT01125917|58641516|FG000|Overall Study|Lack of Efficacy|19|||
30629786|NCT00847561|58641522|FG000|Overall Study|Withdrawal by Subject|4|||
30629787|NCT00847561|58641523|FG001|Overall Study|Withdrawal by Subject|3|||
30629788|NCT00847561|58641522|FG000|Overall Study|Unable to schedule|9|||
30629789|NCT00847561|58641523|FG001|Overall Study|Unable to schedule|1|||
30629790|NCT01121549|58641529|FG000|Overall Study|Adverse Event|10|||
30629791|NCT01121549|58641529|FG000|Overall Study|Lack of Efficacy|11|||
30629792|NCT01121549|58641529|FG000|Overall Study|Lost to Follow-up|12|||
30629793|NCT01121549|58641529|FG000|Overall Study|Did not meet entrance criteria|9|||
30629794|NCT01121549|58641529|FG000|Overall Study|Study terminated by sponsor|197|||
30629795|NCT01121549|58641529|FG000|Overall Study|Pregnancy|1|||
30629796|NCT01121549|58641529|FG000|Overall Study|Protocol Violation|33|||
30629797|NCT01121549|58641529|FG000|Overall Study|Withdrawal by Subject|16|||
30629798|NCT01121549|58641529|FG000|Overall Study|Other|58|||
30629799|NCT00847405|58641535|FG000|First Intervention|Adverse Event|0|||
30629800|NCT00847405|58641536|FG001|First Intervention|Adverse Event|1|||
30629801|NCT00847405|58641535|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
30629802|NCT00847405|58641536|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
30629803|NCT00836095|58641542|FG000|Overall Study|Physician Decision|0|||
30629804|NCT00836095|58641543|FG001|Overall Study|Physician Decision|3|||
30629805|NCT00835237|58641560|FG000|Overall Study|Lost to Follow-up|4|||
30629806|NCT00835237|58641561|FG001|Overall Study|Lost to Follow-up|0|||
30629807|NCT00835237|58641560|FG000|Overall Study|Withdrawal by Subject|2|||
30629808|NCT00835237|58641561|FG001|Overall Study|Withdrawal by Subject|0|||
30764305|NCT03383146|58772974|FG000|Overall Study|Screen Failure|1|||
30764306|NCT03383146|58772975|FG001|Overall Study|Screen Failure|0|||
30764307|NCT03383146|58772974|FG000|Overall Study|Adverse Event|6|||
30629809|NCT01072500|58641569|FG000|Overall Study|Death|2|||
30764308|NCT03383146|58772975|FG001|Overall Study|Adverse Event|18|||
30629810|NCT01072500|58641570|FG001|Overall Study|Death|2|||
30629811|NCT01072500|58641569|FG000|Overall Study|Lost to Follow-up|5|||
30629812|NCT01072500|58641570|FG001|Overall Study|Lost to Follow-up|2|||
30629813|NCT01072500|58641569|FG000|Overall Study|Withdrawal by Subject|17|||
30629814|NCT01072500|58641570|FG001|Overall Study|Withdrawal by Subject|10|||
30629815|NCT00847015|58641578|FG000|Overall Study|Withdrawal by Subject|1|||
30629816|NCT00847015|58641578|FG000|Overall Study|declined any surgery|1|||
30629817|NCT00847015|58641578|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
30629818|NCT00855595|58641584|FG000|Overall Study|Withdrawal by Subject|1|||
30629819|NCT00855595|58641585|FG001|Overall Study|Withdrawal by Subject|2|||
30629820|NCT00855595|58641584|FG000|Overall Study|Lost to Follow-up|3|||
30629821|NCT00855595|58641585|FG001|Overall Study|Lost to Follow-up|3|||
30629822|NCT00855595|58641584|FG000|Overall Study|Adverse Event|1|||
30629823|NCT00855595|58641585|FG001|Overall Study|Adverse Event|1|||
30629824|NCT00855595|58641584|FG000|Overall Study|patient moved out of state|1|||
30629825|NCT00855595|58641585|FG001|Overall Study|patient moved out of state|0|||
30629826|NCT00855595|58641584|FG000|Overall Study|patient left country|0|||
30629827|NCT00855595|58641585|FG001|Overall Study|patient left country|1|||
30629828|NCT00855439|58641593|FG000|Overall Study|Withdrawal by Subject|2|||
30764309|NCT03383146|58772974|FG000|Overall Study|Lack of Efficacy|0|||
30629829|NCT00855439|58641594|FG001|Overall Study|Withdrawal by Subject|0|||
30629830|NCT00855439|58641593|FG000|Overall Study|Pregnancy|1|||
30629831|NCT00855439|58641594|FG001|Overall Study|Pregnancy|0|||
30629832|NCT01064856|58641602|FG000|Double-blind (DB) Period|Adverse Event|1|||
30629833|NCT01064856|58641603|FG001|Double-blind (DB) Period|Adverse Event|0|||
30629834|NCT01064856|58641604|FG002|Double-blind (DB) Period|Adverse Event|0|||
30629835|NCT01064856|58641605|FG003|Double-blind (DB) Period|Adverse Event|0|||
30629836|NCT01064856|58641602|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
30629837|NCT01064856|58641603|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
30629838|NCT01064856|58641604|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
30629839|NCT01064856|58641605|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
30629840|NCT01064856|58641602|FG000|Open-label (OL) Period|Adverse Event|0|||
30629841|NCT01064856|58641603|FG001|Open-label (OL) Period|Adverse Event|0|||
30629842|NCT01064856|58641604|FG002|Open-label (OL) Period|Adverse Event|12|||
30629843|NCT01064856|58641605|FG003|Open-label (OL) Period|Adverse Event|6|||
30629844|NCT01064856|58641602|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
30629845|NCT01064856|58641603|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
30629846|NCT01064856|58641604|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
30629847|NCT01064856|58641605|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
30629848|NCT01064856|58641602|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
30629849|NCT01064856|58641603|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
30629850|NCT01064856|58641604|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
30629851|NCT01064856|58641605|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
30629852|NCT01064856|58641602|FG000|Open-label (OL) Period|Other|0|||
30629853|NCT01064856|58641603|FG001|Open-label (OL) Period|Other|0|||
30629854|NCT01064856|58641604|FG002|Open-label (OL) Period|Other|7|||
30629855|NCT01064856|58641605|FG003|Open-label (OL) Period|Other|7|||
30629856|NCT00846391|58641615|FG000|Overall Study|Physician Decision|0|||
30629857|NCT00846391|58641616|FG001|Overall Study|Physician Decision|0|||
30629858|NCT00846391|58641617|FG002|Overall Study|Physician Decision|1|||
30629859|NCT00846391|58641615|FG000|Overall Study|Study Terminated by Sponsor|1|||
30629860|NCT00846391|58641616|FG001|Overall Study|Study Terminated by Sponsor|2|||
30629861|NCT00846391|58641617|FG002|Overall Study|Study Terminated by Sponsor|2|||
30629862|NCT01042392|58641627|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
30629863|NCT01042392|58641628|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
30629864|NCT01042392|58641629|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
30629865|NCT01042392|58641630|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
30629866|NCT01042392|58641627|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
30629867|NCT01042392|58641628|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
30629868|NCT01042392|58641629|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
30629869|NCT01042392|58641630|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
30629870|NCT01042392|58641627|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
30629871|NCT01042392|58641628|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
30629872|NCT01042392|58641629|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
30629873|NCT01042392|58641630|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
30629874|NCT01042392|58641627|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
30629875|NCT01042392|58641628|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
30629876|NCT01042392|58641629|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
30629877|NCT01042392|58641630|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
30629878|NCT01042392|58641627|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
30629879|NCT01042392|58641628|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
30629880|NCT01042392|58641629|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
30629881|NCT01042392|58641630|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
30629882|NCT01042392|58641627|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
30629883|NCT01042392|58641628|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
30629884|NCT01042392|58641629|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
30629885|NCT01042392|58641630|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
30629886|NCT01042392|58641627|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
30629887|NCT01042392|58641628|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
30629888|NCT01042392|58641629|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
30629889|NCT01042392|58641630|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
30629890|NCT01042392|58641627|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
30629891|NCT01042392|58641628|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
30629892|NCT01042392|58641629|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
30629893|NCT01042392|58641630|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
30629894|NCT01042392|58641627|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
30629895|NCT01042392|58641628|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
30629896|NCT01042392|58641629|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
30629897|NCT01042392|58641630|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
30629898|NCT01064310|58641644|FG000|Period 1|Adverse Event|7|||
30629899|NCT01064310|58641645|FG001|Period 1|Adverse Event|10|||
30629900|NCT01064310|58641646|FG002|Period 1|Adverse Event|0|||
30629901|NCT01064310|58641644|FG000|Period 1|Physician Decision|1|||
30629902|NCT01064310|58641645|FG001|Period 1|Physician Decision|0|||
30629903|NCT01064310|58641646|FG002|Period 1|Physician Decision|0|||
30629904|NCT01064310|58641644|FG000|Period 1|Withdrawal by Subject|2|||
30629905|NCT01064310|58641645|FG001|Period 1|Withdrawal by Subject|2|||
30629906|NCT01064310|58641646|FG002|Period 1|Withdrawal by Subject|0|||
30629907|NCT01064310|58641644|FG000|Period 1|Lack of Efficacy|3|||
30629908|NCT01064310|58641645|FG001|Period 1|Lack of Efficacy|5|||
30629909|NCT01064310|58641646|FG002|Period 1|Lack of Efficacy|0|||
30629910|NCT01064310|58641644|FG000|Period 1|Entered Open-label Period|1|||
30629911|NCT01064310|58641645|FG001|Period 1|Entered Open-label Period|1|||
30629912|NCT01064310|58641646|FG002|Period 1|Entered Open-label Period|0|||
30629913|NCT01064310|58641644|FG000|Period 2|Adverse Event|2|||
30629914|NCT01064310|58641645|FG001|Period 2|Adverse Event|1|||
30629915|NCT01064310|58641646|FG002|Period 2|Adverse Event|0|||
30629916|NCT01064310|58641644|FG000|Period 2|Physician Decision|0|||
30629917|NCT01064310|58641645|FG001|Period 2|Physician Decision|1|||
30629918|NCT01064310|58641646|FG002|Period 2|Physician Decision|0|||
30629919|NCT01064310|58641644|FG000|Period 2|Entered Open-label Period|1|||
30629920|NCT01064310|58641645|FG001|Period 2|Entered Open-label Period|0|||
30629921|NCT01064310|58641646|FG002|Period 2|Entered Open-label Period|0|||
30629922|NCT01064310|58641644|FG000|Period 2|Lack of Efficacy|1|||
30629923|NCT01064310|58641645|FG001|Period 2|Lack of Efficacy|4|||
30629924|NCT01064310|58641646|FG002|Period 2|Lack of Efficacy|0|||
30629925|NCT01064310|58641644|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
30629926|NCT01064310|58641645|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
30629927|NCT01064310|58641646|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
30629928|NCT01064310|58641644|FG000|Open Label Pazopinib|Adverse Event|0|||
30629929|NCT01064310|58641645|FG001|Open Label Pazopinib|Adverse Event|0|||
30629930|NCT01064310|58641646|FG002|Open Label Pazopinib|Adverse Event|12|||
30629931|NCT01064310|58641644|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
30629932|NCT01064310|58641645|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
30629933|NCT01064310|58641646|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
30629934|NCT01064310|58641644|FG000|Open Label Pazopinib|Physician Decision|0|||
30629935|NCT01064310|58641645|FG001|Open Label Pazopinib|Physician Decision|0|||
30629936|NCT01064310|58641646|FG002|Open Label Pazopinib|Physician Decision|20|||
30629937|NCT01037244|58641659|FG000|Overall Study|Adverse Event|3|||
30629938|NCT01037244|58641660|FG001|Overall Study|Adverse Event|2|||
30629939|NCT01037244|58641661|FG002|Overall Study|Adverse Event|6|||
30629940|NCT01037244|58641662|FG003|Overall Study|Adverse Event|3|||
30629941|NCT01037244|58641659|FG000|Overall Study|Lack of Efficacy|1|||
30629942|NCT01037244|58641660|FG001|Overall Study|Lack of Efficacy|1|||
30629943|NCT01037244|58641661|FG002|Overall Study|Lack of Efficacy|0|||
30629944|NCT01037244|58641662|FG003|Overall Study|Lack of Efficacy|1|||
30629945|NCT01037244|58641659|FG000|Overall Study|Lost to Follow-up|3|||
30629946|NCT01037244|58641660|FG001|Overall Study|Lost to Follow-up|3|||
30629947|NCT01037244|58641661|FG002|Overall Study|Lost to Follow-up|4|||
30764310|NCT03383146|58772975|FG001|Overall Study|Lack of Efficacy|3|||
30764311|NCT03383146|58772974|FG000|Overall Study|Withdrawal by Subject|20|||
30629948|NCT01037244|58641662|FG003|Overall Study|Lost to Follow-up|4|||
30629949|NCT01037244|58641659|FG000|Overall Study|Withdrawal by Subject|1|||
30764312|NCT03383146|58772975|FG001|Overall Study|Withdrawal by Subject|36|||
30629950|NCT01037244|58641660|FG001|Overall Study|Withdrawal by Subject|5|||
30629951|NCT01037244|58641661|FG002|Overall Study|Withdrawal by Subject|3|||
30629952|NCT01037244|58641662|FG003|Overall Study|Withdrawal by Subject|5|||
30629953|NCT01037244|58641659|FG000|Overall Study|Partner Withdrew Consent|2|||
30629954|NCT01037244|58641660|FG001|Overall Study|Partner Withdrew Consent|1|||
30629955|NCT01037244|58641661|FG002|Overall Study|Partner Withdrew Consent|0|||
30629956|NCT01037244|58641662|FG003|Overall Study|Partner Withdrew Consent|0|||
30629957|NCT01037244|58641659|FG000|Overall Study|Various|3|||
30629958|NCT01037244|58641660|FG001|Overall Study|Various|2|||
30629959|NCT01037244|58641661|FG002|Overall Study|Various|1|||
30629960|NCT01037244|58641662|FG003|Overall Study|Various|1|||
30629961|NCT00833989|58641676|FG000|Overall Study|Physician Decision|0|||
30629962|NCT00833989|58641677|FG001|Overall Study|Physician Decision|0|||
30629963|NCT00833989|58641678|FG002|Overall Study|Physician Decision|0|||
30629964|NCT00833989|58641679|FG003|Overall Study|Physician Decision|1|||
30629965|NCT00833989|58641676|FG000|Overall Study|Withdrawal by Subject|3|||
30629966|NCT00833989|58641677|FG001|Overall Study|Withdrawal by Subject|0|||
30629967|NCT00833989|58641678|FG002|Overall Study|Withdrawal by Subject|1|||
30629968|NCT00833989|58641679|FG003|Overall Study|Withdrawal by Subject|1|||
30629969|NCT01037088|58641692|FG000|Overall Study|Withdrawal by Subject|3|||
30629970|NCT01042236|58641701|FG000|Treatment Period 1|Adverse Event|0|||
30629971|NCT01042236|58641702|FG001|Treatment Period 1|Adverse Event|1|||
30629972|NCT01042236|58641703|FG002|Treatment Period 1|Adverse Event|0|||
30629973|NCT01042236|58641704|FG003|Treatment Period 1|Adverse Event|0|||
30629974|NCT01042236|58641705|FG004|Treatment Period 1|Adverse Event|1|||
30629975|NCT01042236|58641706|FG005|Treatment Period 1|Adverse Event|0|||
30629976|NCT01042236|58641701|FG000|Treatment Period 3|Adverse Event|0|||
30629977|NCT01042236|58641702|FG001|Treatment Period 3|Adverse Event|0|||
30629978|NCT01042236|58641703|FG002|Treatment Period 3|Adverse Event|0|||
30629979|NCT01042236|58641704|FG003|Treatment Period 3|Adverse Event|1|||
30629980|NCT01042236|58641705|FG004|Treatment Period 3|Adverse Event|0|||
30629981|NCT01042236|58641706|FG005|Treatment Period 3|Adverse Event|0|||
30629982|NCT01042236|58641701|FG000|Treatment Period 3|Protocol Violation|0|||
30629983|NCT01042236|58641702|FG001|Treatment Period 3|Protocol Violation|0|||
30629984|NCT01042236|58641703|FG002|Treatment Period 3|Protocol Violation|0|||
30629985|NCT01042236|58641704|FG003|Treatment Period 3|Protocol Violation|1|||
30629986|NCT01042236|58641705|FG004|Treatment Period 3|Protocol Violation|0|||
30629987|NCT01042236|58641706|FG005|Treatment Period 3|Protocol Violation|0|||
30629988|NCT00592501|58641714|FG000|Overall Study|Withdrawal by Subject|1|||
30629989|NCT00592501|58641714|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
30629990|NCT01040832|58641720|FG000|Overall Study|Adverse Event|4|||
30629991|NCT01040832|58641721|FG001|Overall Study|Adverse Event|5|||
30629992|NCT01040832|58641720|FG000|Overall Study|Death|4|||
30629993|NCT01040832|58641721|FG001|Overall Study|Death|6|||
30629994|NCT01040832|58641720|FG000|Overall Study|Withdrawal by Subject|2|||
30629995|NCT01040832|58641721|FG001|Overall Study|Withdrawal by Subject|3|||
30629996|NCT01040832|58641720|FG000|Overall Study|Progressive disease|32|||
30629997|NCT01040832|58641721|FG001|Overall Study|Progressive disease|17|||
30629998|NCT01040832|58641720|FG000|Overall Study|Symptomatic deterioration|2|||
30629999|NCT01040832|58641721|FG001|Overall Study|Symptomatic deterioration|5|||
30630000|NCT01040832|58641720|FG000|Overall Study|Other|2|||
30630001|NCT01040832|58641721|FG001|Overall Study|Other|1|||
30630002|NCT00854581|58641727|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
30630003|NCT00854581|58641727|FG000|Induction (Up to Day 21)|Death|1|||
30630004|NCT00854581|58641727|FG000|Induction (Up to Day 21)|Physician Decision|1|||
30630005|NCT00854581|58641727|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
30630006|NCT00833911|58641736|FG000|Titration|Adverse Event|18|||
30630007|NCT00833911|58641736|FG000|Titration|Withdrawal by Subject|3|||
30630008|NCT00833911|58641736|FG000|Maintenance Phase I|Adverse Event|73|||
30630009|NCT00833911|58641736|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
30630010|NCT00833911|58641736|FG000|Maintenance Phase I|Physician Decision|10|||
30630011|NCT00833911|58641736|FG000|Maintenance Phase I|Lack of Efficacy|4|||
30630012|NCT00833911|58641736|FG000|Maintenance Phase II|Adverse Event|6|||
30630013|NCT00833911|58641736|FG000|Maintenance Phase II|Physician Decision|2|||
30630014|NCT00833911|58641736|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
30630015|NCT00833911|58641736|FG000|Maintenance Phase II|Lack of Efficacy|1|||
30630016|NCT01125293|58641750|FG000|Overall Study|Disease Progression|1|||
30630017|NCT01125293|58641751|FG001|Overall Study|Disease Progression|3|||
30630018|NCT01125293|58641752|FG002|Overall Study|Disease Progression|4|||
30630019|NCT01125293|58641753|FG003|Overall Study|Disease Progression|3|||
30630020|NCT01125293|58641754|FG004|Overall Study|Disease Progression|5|||
30630021|NCT01125293|58641755|FG005|Overall Study|Disease Progression|12|||
30630022|NCT01125293|58641750|FG000|Overall Study|Adverse Event|1|||
30630023|NCT01125293|58641751|FG001|Overall Study|Adverse Event|0|||
30630024|NCT01125293|58641752|FG002|Overall Study|Adverse Event|0|||
30630025|NCT01125293|58641753|FG003|Overall Study|Adverse Event|0|||
30630026|NCT01125293|58641754|FG004|Overall Study|Adverse Event|2|||
30630027|NCT01125293|58641755|FG005|Overall Study|Adverse Event|8|||
30630028|NCT01125293|58641750|FG000|Overall Study|Symptomatic Deterioration|1|||
30630029|NCT01125293|58641751|FG001|Overall Study|Symptomatic Deterioration|0|||
30630030|NCT01125293|58641752|FG002|Overall Study|Symptomatic Deterioration|0|||
30630031|NCT01125293|58641753|FG003|Overall Study|Symptomatic Deterioration|0|||
30630032|NCT01125293|58641754|FG004|Overall Study|Symptomatic Deterioration|0|||
30630033|NCT01125293|58641755|FG005|Overall Study|Symptomatic Deterioration|0|||
30630034|NCT01125293|58641750|FG000|Overall Study|Death|0|||
30630035|NCT01125293|58641751|FG001|Overall Study|Death|0|||
30630036|NCT01125293|58641752|FG002|Overall Study|Death|0|||
30630037|NCT01125293|58641753|FG003|Overall Study|Death|0|||
30630038|NCT01125293|58641754|FG004|Overall Study|Death|1|||
30630039|NCT01125293|58641755|FG005|Overall Study|Death|0|||
30630040|NCT01125293|58641750|FG000|Overall Study|Withdrawal by Subject|0|||
30630041|NCT01125293|58641751|FG001|Overall Study|Withdrawal by Subject|0|||
30630042|NCT01125293|58641752|FG002|Overall Study|Withdrawal by Subject|0|||
30630043|NCT01125293|58641753|FG003|Overall Study|Withdrawal by Subject|0|||
30630044|NCT01125293|58641754|FG004|Overall Study|Withdrawal by Subject|2|||
30630045|NCT01125293|58641755|FG005|Overall Study|Withdrawal by Subject|1|||
30630046|NCT01125293|58641750|FG000|Overall Study|Physician Decision|0|||
30630047|NCT01125293|58641751|FG001|Overall Study|Physician Decision|0|||
30630048|NCT01125293|58641752|FG002|Overall Study|Physician Decision|0|||
30630049|NCT01125293|58641753|FG003|Overall Study|Physician Decision|0|||
30630050|NCT01125293|58641754|FG004|Overall Study|Physician Decision|0|||
30630051|NCT01125293|58641755|FG005|Overall Study|Physician Decision|2|||
30630052|NCT01121393|58641774|FG000|Overall Study|Progressive disease|201|||
30630053|NCT01121393|58641775|FG001|Overall Study|Progressive disease|20|||
30630054|NCT01121393|58641774|FG000|Overall Study|Other Adverse events|24|||
30630055|NCT01121393|58641775|FG001|Overall Study|Other Adverse events|45|||
30630056|NCT01121393|58641774|FG000|Overall Study|Non-compliant with protocol|0|||
30630057|NCT01121393|58641775|FG001|Overall Study|Non-compliant with protocol|3|||
30630058|NCT01121393|58641774|FG000|Overall Study|Lost to Follow-up|1|||
30630059|NCT01121393|58641775|FG001|Overall Study|Lost to Follow-up|0|||
30630060|NCT01121393|58641774|FG000|Overall Study|Refused cont. medication|7|||
30630061|NCT01121393|58641775|FG001|Overall Study|Refused cont. medication|7|||
30630062|NCT01121393|58641774|FG000|Overall Study|Not treated|3|||
30630063|NCT01121393|58641775|FG001|Overall Study|Not treated|9|||
30630064|NCT01121393|58641774|FG000|Overall Study|Other than listed|6|||
30630065|NCT01121393|58641775|FG001|Overall Study|Other than listed|0|||
30630066|NCT00937521|58641826|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
30630067|NCT00937521|58641827|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
30630068|NCT00937521|58641828|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
30630069|NCT00937521|58641829|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
30630070|NCT00937521|58641830|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
30630071|NCT00937521|58641831|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
30630072|NCT00937521|58641832|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
30630073|NCT00937521|58641833|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
30630074|NCT00937521|58641826|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
30630075|NCT00937521|58641827|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
30630076|NCT00937521|58641828|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
30630077|NCT00937521|58641829|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
30630078|NCT00937521|58641830|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
30630079|NCT00937521|58641831|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
30630080|NCT00937521|58641832|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
30630081|NCT00937521|58641833|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
30630082|NCT00937521|58641826|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
30630083|NCT00937521|58641827|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
30630084|NCT00937521|58641828|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
30630085|NCT00937521|58641829|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
30630086|NCT00937521|58641830|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
30630087|NCT00937521|58641831|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
30630088|NCT00937521|58641832|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
30630089|NCT00937521|58641833|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
30630090|NCT00937521|58641826|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
30630091|NCT00937521|58641827|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
30630092|NCT00937521|58641828|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
30630093|NCT00937521|58641829|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
30630094|NCT00937521|58641830|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
30630095|NCT00937521|58641831|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
30630096|NCT00937521|58641832|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
30630097|NCT00937521|58641833|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
30630098|NCT00937521|58641826|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
30630099|NCT00937521|58641827|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
30630100|NCT00937521|58641828|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
30630101|NCT00937521|58641829|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
30630102|NCT00937521|58641830|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
30630103|NCT00937521|58641831|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
30630104|NCT00937521|58641832|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
30630105|NCT00937521|58641833|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
30630106|NCT00937521|58641826|FG000|Booster Phase|Adverse Event|0|||
30630107|NCT00937521|58641827|FG001|Booster Phase|Adverse Event|0|||
30630108|NCT00937521|58641828|FG002|Booster Phase|Adverse Event|0|||
30630109|NCT00937521|58641829|FG003|Booster Phase|Adverse Event|0|||
30630110|NCT00937521|58641830|FG004|Booster Phase|Adverse Event|0|||
30630111|NCT00937521|58641831|FG005|Booster Phase|Adverse Event|0|||
30630112|NCT00937521|58641832|FG006|Booster Phase|Adverse Event|1|||
30630113|NCT00937521|58641833|FG007|Booster Phase|Adverse Event|0|||
30630114|NCT00937521|58641826|FG000|Booster Phase|Withdrawal by Subject|1|||
30630115|NCT00937521|58641827|FG001|Booster Phase|Withdrawal by Subject|0|||
30630116|NCT00937521|58641828|FG002|Booster Phase|Withdrawal by Subject|0|||
30630117|NCT00937521|58641829|FG003|Booster Phase|Withdrawal by Subject|1|||
30630118|NCT00937521|58641830|FG004|Booster Phase|Withdrawal by Subject|0|||
30630119|NCT00937521|58641831|FG005|Booster Phase|Withdrawal by Subject|0|||
30630120|NCT00937521|58641832|FG006|Booster Phase|Withdrawal by Subject|0|||
30630121|NCT00937521|58641833|FG007|Booster Phase|Withdrawal by Subject|2|||
30630122|NCT00937521|58641826|FG000|Booster Phase|Lost to Follow-up|2|||
30630123|NCT00937521|58641827|FG001|Booster Phase|Lost to Follow-up|2|||
30630124|NCT00937521|58641828|FG002|Booster Phase|Lost to Follow-up|4|||
30630125|NCT00937521|58641829|FG003|Booster Phase|Lost to Follow-up|2|||
30630126|NCT00937521|58641830|FG004|Booster Phase|Lost to Follow-up|4|||
30630127|NCT00937521|58641831|FG005|Booster Phase|Lost to Follow-up|4|||
30630128|NCT00937521|58641832|FG006|Booster Phase|Lost to Follow-up|3|||
30630129|NCT00937521|58641833|FG007|Booster Phase|Lost to Follow-up|0|||
30630130|NCT00937521|58641826|FG000|Booster Phase|Administrative Reason|0|||
30630131|NCT00937521|58641827|FG001|Booster Phase|Administrative Reason|0|||
30630132|NCT00937521|58641828|FG002|Booster Phase|Administrative Reason|1|||
30630133|NCT00937521|58641829|FG003|Booster Phase|Administrative Reason|0|||
30630134|NCT00937521|58641830|FG004|Booster Phase|Administrative Reason|1|||
30630135|NCT00937521|58641831|FG005|Booster Phase|Administrative Reason|1|||
30630136|NCT00937521|58641832|FG006|Booster Phase|Administrative Reason|0|||
30630137|NCT00937521|58641833|FG007|Booster Phase|Administrative Reason|0|||
30630138|NCT00937521|58641826|FG000|Booster Phase|Protocol Deviation|0|||
30630139|NCT00937521|58641827|FG001|Booster Phase|Protocol Deviation|0|||
30630140|NCT00937521|58641828|FG002|Booster Phase|Protocol Deviation|0|||
30630141|NCT00937521|58641829|FG003|Booster Phase|Protocol Deviation|0|||
30630142|NCT00937521|58641830|FG004|Booster Phase|Protocol Deviation|0|||
30630143|NCT00937521|58641831|FG005|Booster Phase|Protocol Deviation|0|||
30630144|NCT00937521|58641832|FG006|Booster Phase|Protocol Deviation|1|||
30630145|NCT00937521|58641833|FG007|Booster Phase|Protocol Deviation|0|||
30630146|NCT00935883|58641868|FG000|Treatment Period|Physician Decision|1|||
30630147|NCT00935883|58641869|FG001|Treatment Period|Physician Decision|0|||
30630148|NCT00935883|58641868|FG000|Treatment Period|Withdrawal by Subject|0|||
30630149|NCT00935883|58641869|FG001|Treatment Period|Withdrawal by Subject|2|||
30630150|NCT00936975|58641875|FG000|Overall Study|Withdrawal by Subject|1|||
30630151|NCT00936975|58641875|FG000|Overall Study|Disease progression|3|||
30630152|NCT00936975|58641875|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
30630153|NCT00936897|58641882|FG000|Overall Study|Withdrawal by Subject|9|||
30630154|NCT00936897|58641883|FG001|Overall Study|Withdrawal by Subject|19|||
30630155|NCT00936897|58641882|FG000|Overall Study|Adverse Event|4|||
30630156|NCT00936897|58641883|FG001|Overall Study|Adverse Event|13|||
30630157|NCT00936897|58641882|FG000|Overall Study|Other|3|||
30630158|NCT00936897|58641883|FG001|Overall Study|Other|9|||
30630159|NCT00936897|58641882|FG000|Overall Study|Lost to Follow-up|1|||
30630160|NCT00936897|58641883|FG001|Overall Study|Lost to Follow-up|10|||
30630161|NCT00936897|58641882|FG000|Overall Study|Administrative Decision|1|||
30630162|NCT00936897|58641883|FG001|Overall Study|Administrative Decision|2|||
30630163|NCT00936897|58641882|FG000|Overall Study|Protocol Violation|1|||
30630164|NCT00936897|58641883|FG001|Overall Study|Protocol Violation|1|||
30630165|NCT00936897|58641882|FG000|Overall Study|Ineligibility Determined|0|||
30630166|NCT00936897|58641883|FG001|Overall Study|Ineligibility Determined|3|||
30630167|NCT00936897|58641882|FG000|Overall Study|Noncompliance|0|||
30630168|NCT00936897|58641883|FG001|Overall Study|Noncompliance|2|||
30630169|NCT00936897|58641882|FG000|Overall Study|Death|0|||
30630170|NCT00936897|58641883|FG001|Overall Study|Death|1|||
30630171|NCT01120691|58641892|FG000|Overall Study|Adverse Event|59|||
30630172|NCT01120691|58641893|FG001|Overall Study|Adverse Event|67|||
30630173|NCT01120691|58641894|FG002|Overall Study|Adverse Event|47|||
30630174|NCT01120691|58641892|FG000|Overall Study|Subject withdrew consent|33|||
30630175|NCT01120691|58641893|FG001|Overall Study|Subject withdrew consent|50|||
30630176|NCT01120691|58641894|FG002|Overall Study|Subject withdrew consent|44|||
30630177|NCT01120691|58641892|FG000|Overall Study|Death|21|||
30630178|NCT01120691|58641893|FG001|Overall Study|Death|22|||
30630179|NCT01120691|58641894|FG002|Overall Study|Death|24|||
30630180|NCT01120691|58641892|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
30630181|NCT01120691|58641893|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
30630182|NCT01120691|58641894|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
30630183|NCT01120691|58641892|FG000|Overall Study|Administrative problems|15|||
30630184|NCT01120691|58641893|FG001|Overall Study|Administrative problems|8|||
30630185|NCT01120691|58641894|FG002|Overall Study|Administrative problems|9|||
30630186|NCT01120691|58641892|FG000|Overall Study|Protocol deviation|13|||
30630187|NCT01120691|58641893|FG001|Overall Study|Protocol deviation|12|||
30630188|NCT01120691|58641894|FG002|Overall Study|Protocol deviation|12|||
30630189|NCT01120691|58641892|FG000|Overall Study|Lost to Follow-up|5|||
30630190|NCT01120691|58641893|FG001|Overall Study|Lost to Follow-up|6|||
30630191|NCT01120691|58641894|FG002|Overall Study|Lost to Follow-up|4|||
30630192|NCT01120691|58641892|FG000|Overall Study|Abnormal test procedure result(s)|3|||
30630193|NCT01120691|58641893|FG001|Overall Study|Abnormal test procedure result(s)|2|||
30630194|NCT01120691|58641894|FG002|Overall Study|Abnormal test procedure result(s)|1|||
30630195|NCT01120691|58641892|FG000|Overall Study|Patient's inability to use the device|3|||
30630196|NCT01120691|58641893|FG001|Overall Study|Patient's inability to use the device|1|||
30630197|NCT01120691|58641894|FG002|Overall Study|Patient's inability to use the device|0|||
30630198|NCT01120691|58641892|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30630199|NCT01120691|58641893|FG001|Overall Study|Abnormal laboratory value(s)|3|||
30630200|NCT01120691|58641894|FG002|Overall Study|Abnormal laboratory value(s)|4|||
30630201|NCT00935493|58641918|FG000|Overall Study|Lost to Follow-up|1|||
30630202|NCT00935493|58641919|FG001|Overall Study|Lost to Follow-up|1|||
30630203|NCT00935493|58641920|FG002|Overall Study|Lost to Follow-up|1|||
30630204|NCT00935493|58641918|FG000|Overall Study|Treatment Discontinued|0|||
30630205|NCT00935493|58641919|FG001|Overall Study|Treatment Discontinued|1|||
30630206|NCT00935493|58641920|FG002|Overall Study|Treatment Discontinued|0|||
30630207|NCT03856996|58641930|FG000|Overall Study|Withdrawal by Subject|1|||
30630208|NCT03856996|58641931|FG001|Overall Study|Withdrawal by Subject|0|||
30630209|NCT03856996|58641930|FG000|Overall Study|Lost to Follow-up|0|||
30630210|NCT03856996|58641931|FG001|Overall Study|Lost to Follow-up|1|||
30630211|NCT03856996|58641930|FG000|Overall Study|Adverse Event|1|||
30630212|NCT03856996|58641931|FG001|Overall Study|Adverse Event|1|||
30630213|NCT03856996|58641930|FG000|Overall Study|Other|1|||
30630214|NCT03856996|58641931|FG001|Overall Study|Other|0|||
30630215|NCT00935259|58641937|FG000|Period 1|Administrative (scheduling conflict)|1|||
30630216|NCT00935259|58641938|FG001|Period 1|Administrative (scheduling conflict)|1|||
30630217|NCT01120379|58641955|FG000|One Year Timepoint|Withdrawal by Subject|41|||
30630218|NCT01120379|58641955|FG000|One Year Timepoint|Lost to Follow-up|115|||
30630219|NCT01120379|58641955|FG000|One Year Timepoint|Death|108|||
30630220|NCT01120379|58641955|FG000|One Year Timepoint|Physician Decision|9|||
30630221|NCT01120379|58641955|FG000|One Year Timepoint|Any other reason for early termination|5|||
30630222|NCT01120379|58641955|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
30630223|NCT01120379|58641955|FG000|Two Year Timepoint|Lost to Follow-up|87|||
30630224|NCT01120379|58641955|FG000|Two Year Timepoint|Death|123|||
30630225|NCT01120379|58641955|FG000|Two Year Timepoint|Physician Decision|12|||
30630226|NCT01120379|58641955|FG000|Two Year Timepoint|Any other reason for early termination|4|||
30630227|NCT01120379|58641955|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
30630228|NCT01120379|58641955|FG000|Three Year Timepoint|Lost to Follow-up|43|||
30630229|NCT01120379|58641955|FG000|Three Year Timepoint|Death|120|||
30630230|NCT01120379|58641955|FG000|Three Year Timepoint|Physician Decision|9|||
30630231|NCT01120379|58641955|FG000|Three Year Timepoint|Any other reason for early termination|17|||
30630232|NCT01120379|58641955|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
30630233|NCT01120379|58641955|FG000|Four Year Timepoint|Lost to Follow-up|10|||
30630234|NCT01120379|58641955|FG000|Four Year Timepoint|Death|131|||
30630235|NCT01120379|58641955|FG000|Four Year Timepoint|Physician Decision|5|||
30630236|NCT01120379|58641955|FG000|Four Year Timepoint|Any other reason for early termination|217|||
30630237|NCT01120067|58641961|FG000|Overall Study|Lost to Follow-up|3|||
30630238|NCT01120067|58641962|FG001|Overall Study|Lost to Follow-up|1|||
30630239|NCT01120067|58641961|FG000|Overall Study|fail to engage >3 sessions|2|||
30764313|NCT03383146|58772974|FG000|Overall Study|Lost to Follow-up|5|||
30630240|NCT01120067|58641962|FG001|Overall Study|fail to engage >3 sessions|0|||
30630241|NCT01124045|58641970|FG000|Overall Study|Lost to Follow-up|0|||
30630242|NCT01124045|58641971|FG001|Overall Study|Lost to Follow-up|1|||
30630243|NCT01124045|58641970|FG000|Overall Study|Physician Decision|0|||
30630244|NCT01124045|58641971|FG001|Overall Study|Physician Decision|2|||
30630245|NCT01123889|58641979|FG000|Overall Study|Lost to Follow-up|3|||
30630246|NCT01123889|58641980|FG001|Overall Study|Lost to Follow-up|1|||
30630247|NCT00934947|58641988|FG000|Overall Study|Adverse Event|0|||
30630248|NCT00934947|58641989|FG001|Overall Study|Adverse Event|2|||
30630249|NCT01123655|58641999|FG000|Overall Study|Medication for RA had to be changed|1|||
30630250|NCT01123655|58642000|FG001|Overall Study|Medication for RA had to be changed|0|||
30630251|NCT01123655|58642001|FG002|Overall Study|Medication for RA had to be changed|0|||
30630252|NCT01123655|58641999|FG000|Overall Study|new illness|0|||
30630253|NCT01123655|58642000|FG001|Overall Study|new illness|1|||
30630254|NCT01123655|58642001|FG002|Overall Study|new illness|0|||
30630255|NCT01123655|58641999|FG000|Overall Study|began prohibitive drug|0|||
30630256|NCT01123655|58642000|FG001|Overall Study|began prohibitive drug|0|||
30630257|NCT01123655|58642001|FG002|Overall Study|began prohibitive drug|1|||
30630258|NCT00934791|58642009|FG000|Overall Study|Withdrawal by Subject|1|||
30630259|NCT00934791|58642010|FG001|Overall Study|Withdrawal by Subject|0|||
30630260|NCT01119443|58642018|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
30630261|NCT01119443|58642019|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
30630262|NCT01111019|58642028|FG000|Overall Study|Withdrew Prematurely|2|||
30630263|NCT01111019|58642028|FG000|Overall Study|Other|1|||
30630264|NCT01119287|58642047|FG000|Overall Study|Patient Decision, not related to AE|0|||
30630265|NCT01119287|58642048|FG001|Overall Study|Patient Decision, not related to AE|0|||
30630266|NCT01119287|58642049|FG002|Overall Study|Patient Decision, not related to AE|2|||
30630267|NCT01119287|58642050|FG003|Overall Study|Patient Decision, not related to AE|2|||
30630268|NCT01119287|58642051|FG004|Overall Study|Patient Decision, not related to AE|1|||
30630269|NCT01119287|58642052|FG005|Overall Study|Patient Decision, not related to AE|0|||
30630270|NCT01110707|58642066|FG000|Overall Study|Protocol Violation|0|||
30630271|NCT01110707|58642067|FG001|Overall Study|Protocol Violation|3|||
30630272|NCT01119131|58642077|FG000|Overall Study|Adverse Event|1|||
30630273|NCT01119131|58642078|FG001|Overall Study|Adverse Event|1|||
30630274|NCT01119131|58642079|FG002|Overall Study|Adverse Event|1|||
30630275|NCT01119131|58642077|FG000|Overall Study|Non-Compliance|1|||
30630276|NCT01119131|58642078|FG001|Overall Study|Non-Compliance|0|||
30630277|NCT01119131|58642079|FG002|Overall Study|Non-Compliance|4|||
30630278|NCT01119131|58642077|FG000|Overall Study|Physician Decision|0|||
30630279|NCT01119131|58642078|FG001|Overall Study|Physician Decision|0|||
30630280|NCT01119131|58642079|FG002|Overall Study|Physician Decision|1|||
30630281|NCT01118975|58642089|FG000|Overall Study|Adverse Event|0|||
30630282|NCT01118975|58642090|FG001|Overall Study|Adverse Event|1|||
30630283|NCT01110239|58642100|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
30630284|NCT01110239|58642101|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
30630285|NCT01110239|58642102|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
30630286|NCT01110239|58642103|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
30630287|NCT01110239|58642100|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
30630288|NCT01110239|58642101|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
30630289|NCT01110239|58642102|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
30630290|NCT01110239|58642103|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
30630291|NCT01118663|58642116|FG000|Overall Study|Adverse Event|2|||
30630292|NCT01118663|58642117|FG001|Overall Study|Adverse Event|1|||
30630293|NCT01118663|58642116|FG000|Overall Study|Withdrawal by Subject|0|||
30630294|NCT01118663|58642117|FG001|Overall Study|Withdrawal by Subject|1|||
30630295|NCT01118351|58642123|FG000|Overall Study|Adverse Event|3|||
30630296|NCT01118351|58642123|FG000|Overall Study|Withdrawal by Subject|1|||
30630297|NCT01110005|58642129|FG000|Overall Study|ineligible|1|||
30630298|NCT01110005|58642130|FG001|Overall Study|ineligible|2|||
30630299|NCT01110005|58642129|FG000|Overall Study|missing consent|3|||
30630300|NCT01110005|58642130|FG001|Overall Study|missing consent|2|||
30630301|NCT01110005|58642129|FG000|Overall Study|Withdrawal by Subject|0|||
30630302|NCT01110005|58642130|FG001|Overall Study|Withdrawal by Subject|1|||
30630303|NCT01118117|58642153|FG000|Overall Study|Death|8|||
30630304|NCT01118117|58642154|FG001|Overall Study|Death|0|||
30630305|NCT01118117|58642153|FG000|Overall Study|Lost to Follow-up|6|||
30630306|NCT01118117|58642154|FG001|Overall Study|Lost to Follow-up|0|||
30630307|NCT01118117|58642153|FG000|Overall Study|Missed 12 Month Visit|7|||
30630308|NCT01118117|58642154|FG001|Overall Study|Missed 12 Month Visit|0|||
30764314|NCT03383146|58772975|FG001|Overall Study|Lost to Follow-up|15|||
30764315|NCT03383146|58772974|FG000|Overall Study|Death|0|||
30630309|NCT01109849|58642162|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
30630310|NCT01109849|58642163|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
30630311|NCT01109849|58642164|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
30630312|NCT01109849|58642165|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
30630313|NCT01109849|58642166|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
30630314|NCT01109849|58642162|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
30630315|NCT01109849|58642163|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
30630316|NCT01109849|58642164|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
30630317|NCT01109849|58642165|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
30630318|NCT01109849|58642166|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
30630319|NCT01109849|58642162|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
30630320|NCT01109849|58642163|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
30630321|NCT01109849|58642164|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
30630322|NCT01109849|58642165|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
30630323|NCT01109849|58642166|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
30630324|NCT01109849|58642162|FG000|Initial Randomization: ADHD Treatment|move away|2|||
30630325|NCT01109849|58642163|FG001|Initial Randomization: ADHD Treatment|move away|7|||
30630326|NCT01109849|58642164|FG002|Initial Randomization: ADHD Treatment|move away|0|||
30630327|NCT01109849|58642165|FG003|Initial Randomization: ADHD Treatment|move away|0|||
30630328|NCT01109849|58642166|FG004|Initial Randomization: ADHD Treatment|move away|0|||
30630329|NCT01109849|58642162|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
30630330|NCT01109849|58642163|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
30630331|NCT01109849|58642164|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
30630332|NCT01109849|58642165|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
30630333|NCT01109849|58642166|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
30630334|NCT01109849|58642162|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
30630335|NCT01109849|58642163|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
30630336|NCT01109849|58642164|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
30630337|NCT01109849|58642165|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
30630338|NCT01109849|58642166|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
30630339|NCT01061736|58642196|FG000|Overall Study|Dose regimen not selected|0|||
30630340|NCT01061736|58642197|FG001|Overall Study|Dose regimen not selected|0|||
30630341|NCT01061736|58642198|FG002|Overall Study|Dose regimen not selected|0|||
30630342|NCT01061736|58642199|FG003|Overall Study|Dose regimen not selected|0|||
30630343|NCT01061736|58642200|FG004|Overall Study|Dose regimen not selected|0|||
30630344|NCT01061736|58642201|FG005|Overall Study|Dose regimen not selected|0|||
30630345|NCT01061736|58642202|FG006|Overall Study|Dose regimen not selected|79|||
30630346|NCT01061736|58642203|FG007|Overall Study|Dose regimen not selected|0|||
30630347|NCT01061736|58642204|FG008|Overall Study|Dose regimen not selected|0|||
30630348|NCT01061736|58642205|FG009|Overall Study|Dose regimen not selected|0|||
30630349|NCT01061736|58642196|FG000|Overall Study|Adverse Event|13|||
30630350|NCT01061736|58642197|FG001|Overall Study|Adverse Event|1|||
30630351|NCT01061736|58642198|FG002|Overall Study|Adverse Event|3|||
30630352|NCT01061736|58642199|FG003|Overall Study|Adverse Event|2|||
30630353|NCT01061736|58642200|FG004|Overall Study|Adverse Event|4|||
30630354|NCT01061736|58642201|FG005|Overall Study|Adverse Event|1|||
30630355|NCT01061736|58642202|FG006|Overall Study|Adverse Event|4|||
30630356|NCT01061736|58642203|FG007|Overall Study|Adverse Event|63|||
30630357|NCT01061736|58642204|FG008|Overall Study|Adverse Event|67|||
30630358|NCT01061736|58642205|FG009|Overall Study|Adverse Event|34|||
30630359|NCT01061736|58642196|FG000|Overall Study|Lack of Efficacy|0|||
30630360|NCT01061736|58642197|FG001|Overall Study|Lack of Efficacy|2|||
30630361|NCT01061736|58642198|FG002|Overall Study|Lack of Efficacy|1|||
30630362|NCT01061736|58642199|FG003|Overall Study|Lack of Efficacy|1|||
30630363|NCT01061736|58642200|FG004|Overall Study|Lack of Efficacy|1|||
30630364|NCT01061736|58642201|FG005|Overall Study|Lack of Efficacy|2|||
30630365|NCT01061736|58642202|FG006|Overall Study|Lack of Efficacy|1|||
30630366|NCT01061736|58642203|FG007|Overall Study|Lack of Efficacy|9|||
30630367|NCT01061736|58642204|FG008|Overall Study|Lack of Efficacy|9|||
30630368|NCT01061736|58642205|FG009|Overall Study|Lack of Efficacy|10|||
30630369|NCT01061736|58642196|FG000|Overall Study|Poor compliance to protocol|0|||
30630370|NCT01061736|58642197|FG001|Overall Study|Poor compliance to protocol|0|||
30630371|NCT01061736|58642198|FG002|Overall Study|Poor compliance to protocol|0|||
30630372|NCT01061736|58642199|FG003|Overall Study|Poor compliance to protocol|0|||
30630373|NCT01061736|58642200|FG004|Overall Study|Poor compliance to protocol|0|||
30950944|NCT01709305|58997950|FG003|Phase 1|Laboratory Adverse Event|0|||
30630374|NCT01061736|58642201|FG005|Overall Study|Poor compliance to protocol|0|||
30630375|NCT01061736|58642202|FG006|Overall Study|Poor compliance to protocol|0|||
30630376|NCT01061736|58642203|FG007|Overall Study|Poor compliance to protocol|2|||
30630377|NCT01061736|58642204|FG008|Overall Study|Poor compliance to protocol|5|||
30630378|NCT01061736|58642205|FG009|Overall Study|Poor compliance to protocol|9|||
30630379|NCT01061736|58642196|FG000|Overall Study|Not treated|0|||
30630380|NCT01061736|58642197|FG001|Overall Study|Not treated|0|||
30630381|NCT01061736|58642198|FG002|Overall Study|Not treated|0|||
30630382|NCT01061736|58642199|FG003|Overall Study|Not treated|0|||
30630383|NCT01061736|58642200|FG004|Overall Study|Not treated|1|||
30630384|NCT01061736|58642201|FG005|Overall Study|Not treated|0|||
30630385|NCT01061736|58642202|FG006|Overall Study|Not treated|0|||
30630386|NCT01061736|58642203|FG007|Overall Study|Not treated|2|||
30630387|NCT01061736|58642204|FG008|Overall Study|Not treated|1|||
30630388|NCT01061736|58642205|FG009|Overall Study|Not treated|0|||
30630389|NCT01061736|58642196|FG000|Overall Study|Other than specified above|0|||
30630390|NCT01061736|58642197|FG001|Overall Study|Other than specified above|1|||
30630391|NCT01061736|58642198|FG002|Overall Study|Other than specified above|2|||
30630392|NCT01061736|58642199|FG003|Overall Study|Other than specified above|0|||
30630393|NCT01061736|58642200|FG004|Overall Study|Other than specified above|1|||
30630394|NCT01061736|58642201|FG005|Overall Study|Other than specified above|0|||
30630395|NCT01061736|58642202|FG006|Overall Study|Other than specified above|0|||
30630396|NCT01061736|58642203|FG007|Overall Study|Other than specified above|18|||
30630397|NCT01061736|58642204|FG008|Overall Study|Other than specified above|15|||
30630398|NCT01061736|58642205|FG009|Overall Study|Other than specified above|21|||
30630399|NCT01117337|58642232|FG000|Overall Study|Lost to Follow-up|4|||
30630400|NCT01117337|58642233|FG001|Overall Study|Lost to Follow-up|0|||
30630401|NCT01108523|58642243|FG000|Overall Study|Protocol Violation|4|||
30764316|NCT03383146|58772975|FG001|Overall Study|Death|2|||
30764317|NCT03383146|58772974|FG000|Overall Study|Physician Decision|0|||
30764318|NCT03383146|58772975|FG001|Overall Study|Physician Decision|1|||
30764319|NCT03383146|58772974|FG000|Overall Study|Protocol Deviation|1|||
30848204|NCT00409773|58874115|FG004|Overall Study|Physician Decision|0|||
30950945|NCT01709305|58997951|FG004|Phase 1|Laboratory Adverse Event|0|||
30950946|NCT01709305|58997947|FG000|Phase 1|Lost to Follow-up|147|||
30950947|NCT01709305|58997948|FG001|Phase 1|Lost to Follow-up|0|||
30950948|NCT01709305|58997949|FG002|Phase 1|Lost to Follow-up|0|||
30630402|NCT01035606|58642250|FG000|Overall Study|change in health, job demands,family|3|||
30630403|NCT01035606|58642251|FG001|Overall Study|change in health, job demands,family|3|||
30630404|NCT01035606|58642252|FG002|Overall Study|change in health, job demands,family|4|||
30630405|NCT01117181|58642262|FG000|Overall Study|Lost to Follow-up|1|||
30630406|NCT01117181|58642263|FG001|Overall Study|Lost to Follow-up|0|||
30630407|NCT01117181|58642262|FG000|Overall Study|Withdrawal by Subject|0|||
30950949|NCT01709305|58997950|FG003|Phase 1|Lost to Follow-up|0|||
30630408|NCT01117181|58642263|FG001|Overall Study|Withdrawal by Subject|2|||
30630409|NCT01040130|58642271|FG000|Overall Study|Adverse Event|1|||
30630410|NCT01040130|58642272|FG001|Overall Study|Adverse Event|1|||
30630411|NCT01040130|58642273|FG002|Overall Study|Adverse Event|0|||
30630412|NCT01040130|58642274|FG003|Overall Study|Adverse Event|5|||
30630413|NCT01040130|58642275|FG004|Overall Study|Adverse Event|0|||
30630414|NCT01040130|58642276|FG005|Overall Study|Adverse Event|3|||
30630415|NCT01040130|58642271|FG000|Overall Study|Protocol Violation|0|||
30630416|NCT01040130|58642272|FG001|Overall Study|Protocol Violation|0|||
30630417|NCT01040130|58642273|FG002|Overall Study|Protocol Violation|2|||
30630418|NCT01040130|58642274|FG003|Overall Study|Protocol Violation|0|||
30630419|NCT01040130|58642275|FG004|Overall Study|Protocol Violation|0|||
30630420|NCT01040130|58642276|FG005|Overall Study|Protocol Violation|0|||
30630421|NCT01040130|58642271|FG000|Overall Study|Withdrawal by Subject|0|||
30630422|NCT01040130|58642272|FG001|Overall Study|Withdrawal by Subject|2|||
30630423|NCT01040130|58642273|FG002|Overall Study|Withdrawal by Subject|0|||
30630424|NCT01040130|58642274|FG003|Overall Study|Withdrawal by Subject|0|||
30630425|NCT01040130|58642275|FG004|Overall Study|Withdrawal by Subject|0|||
30630426|NCT01040130|58642276|FG005|Overall Study|Withdrawal by Subject|1|||
30630427|NCT01040130|58642271|FG000|Overall Study|Other reasons not listed above|2|||
30630428|NCT01040130|58642272|FG001|Overall Study|Other reasons not listed above|0|||
30630429|NCT01040130|58642273|FG002|Overall Study|Other reasons not listed above|0|||
30630430|NCT01040130|58642274|FG003|Overall Study|Other reasons not listed above|0|||
30630431|NCT01040130|58642275|FG004|Overall Study|Other reasons not listed above|0|||
30630432|NCT01040130|58642276|FG005|Overall Study|Other reasons not listed above|0|||
30630433|NCT00932451|58642286|FG000|Overall Study|Withdrawal by Subject|69|||
30630434|NCT00932451|58642286|FG000|Overall Study|Lost to Follow-up|22|||
30630435|NCT00932451|58642286|FG000|Overall Study|Death|726|||
30848205|NCT00409773|58874111|FG000|Overall Study|Protocol Violation|0|||
30630436|NCT00932451|58642286|FG000|Overall Study|Other reasons|5|||
30630437|NCT01108055|58642294|FG000|Overall Study|Ineligible|11|||
30630438|NCT01108055|58642294|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
30630439|NCT01107899|58642301|FG000|Overall Study|Physician Decision|5|||
30630440|NCT01107899|58642302|FG001|Overall Study|Physician Decision|0|||
30630441|NCT01107899|58642303|FG002|Overall Study|Physician Decision|3|||
30630442|NCT01107899|58642301|FG000|Overall Study|Withdrawal by Subject|0|||
30630443|NCT01107899|58642302|FG001|Overall Study|Withdrawal by Subject|0|||
30630444|NCT01107899|58642303|FG002|Overall Study|Withdrawal by Subject|1|||
30630445|NCT01115933|58642314|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
30630446|NCT01107743|58642371|FG000|Overall Study|Protocol Violation|46|||
30630447|NCT01059864|58642420|FG000|Open-Label Run-In Phase|Adverse Event|7|||
30630448|NCT01059864|58642421|FG001|Open-Label Run-In Phase|Adverse Event|0|||
30630449|NCT01059864|58642422|FG002|Open-Label Run-In Phase|Adverse Event|0|||
30630450|NCT01059864|58642420|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
30630451|NCT01059864|58642421|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
30630452|NCT01059864|58642422|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
30630453|NCT01059864|58642420|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
30630454|NCT01059864|58642421|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
30630455|NCT01059864|58642422|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
30630456|NCT01059864|58642420|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
30630457|NCT01059864|58642421|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
30630458|NCT01059864|58642422|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
30630459|NCT01059864|58642420|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
30630460|NCT01059864|58642421|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
30630461|NCT01059864|58642422|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
30630462|NCT01059864|58642420|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
30630463|NCT01059864|58642421|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
30630464|NCT01059864|58642422|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
30630465|NCT01035138|58642432|FG000|Overall Study|Adverse Event|4|||
30630466|NCT01035138|58642433|FG001|Overall Study|Adverse Event|0|||
30630467|NCT01035138|58642434|FG002|Overall Study|Adverse Event|2|||
30630468|NCT01035138|58642432|FG000|Overall Study|Caregiver Decision|2|||
30630469|NCT01035138|58642433|FG001|Overall Study|Caregiver Decision|0|||
30630470|NCT01035138|58642434|FG002|Overall Study|Caregiver Decision|1|||
30630471|NCT01035138|58642432|FG000|Overall Study|Withdrawal by Subject|1|||
30630472|NCT01035138|58642433|FG001|Overall Study|Withdrawal by Subject|0|||
30630473|NCT01035138|58642434|FG002|Overall Study|Withdrawal by Subject|0|||
30630474|NCT01035138|58642432|FG000|Overall Study|Physician Decision|0|||
30630475|NCT01035138|58642433|FG001|Overall Study|Physician Decision|0|||
30630476|NCT01035138|58642434|FG002|Overall Study|Physician Decision|1|||
30630477|NCT01035138|58642432|FG000|Overall Study|Sponsor Decision|66|||
30630478|NCT01035138|58642433|FG001|Overall Study|Sponsor Decision|60|||
30630479|NCT01035138|58642434|FG002|Overall Study|Sponsor Decision|42|||
30630480|NCT01035138|58642432|FG000|Overall Study|Lost to Follow-up|0|||
30630481|NCT01035138|58642433|FG001|Overall Study|Lost to Follow-up|0|||
30630482|NCT01035138|58642434|FG002|Overall Study|Lost to Follow-up|1|||
30630483|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
30630484|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
30630485|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
30630486|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
30630487|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
30630488|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
30630489|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
30630490|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
30630491|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
30764320|NCT03383146|58772975|FG001|Overall Study|Protocol Deviation|8|||
30764321|NCT03383146|58772974|FG000|Overall Study|Study Terminated by the Sponsor|48|||
30764322|NCT03383146|58772975|FG001|Overall Study|Study Terminated by the Sponsor|95|||
30764323|NCT03383146|58772974|FG000|Overall Study|Reason not Specified|4|||
30630492|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
30630493|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
30630494|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
30630495|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
30630496|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
30630497|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
30630498|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
30630499|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Program Termination|3|||
30630500|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Program Termination|0|||
30630501|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Program Termination|1|||
30630502|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Program Termination|1|||
30630503|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
30630504|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
30630505|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
30630506|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
30630507|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
30630508|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
30630509|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
30630510|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
30630511|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
30630512|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
30630513|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
30630514|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
30630515|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
30630516|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
30630517|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
30630518|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
30630519|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
30630520|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
30630521|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
30630522|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
30630523|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
30630524|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
30630525|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
30630526|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
30630527|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
30630528|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
30630529|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
30630530|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
30630531|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
30630532|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
30630533|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
30630534|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
30630535|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
30630536|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
30630537|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
30630538|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
30630539|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
30630540|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
30630541|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
30630542|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
30630543|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
30630544|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
30630545|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
30630546|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
30630547|NCT03739840|58642448|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
30630548|NCT03739840|58642449|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
30630549|NCT03739840|58642450|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
30630550|NCT03739840|58642451|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
30630551|NCT03739840|58642448|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
30630552|NCT03739840|58642449|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
30630553|NCT03739840|58642450|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
30630554|NCT03739840|58642451|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
30630555|NCT03739840|58642448|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
30630556|NCT03739840|58642449|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
30630557|NCT03739840|58642450|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
30630558|NCT03739840|58642451|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
30630559|NCT03739840|58642448|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
30630560|NCT03739840|58642449|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
30630561|NCT03739840|58642450|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
30630562|NCT03739840|58642451|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
30630563|NCT03739840|58642448|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
30630564|NCT03739840|58642449|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
30630565|NCT03739840|58642450|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
30630566|NCT03739840|58642451|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
30630567|NCT03739840|58642448|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
30630568|NCT03739840|58642449|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
30630569|NCT03739840|58642450|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
30630570|NCT03739840|58642451|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
30630571|NCT03739840|58642448|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
30630572|NCT03739840|58642449|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
30630573|NCT03739840|58642450|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
30630574|NCT03739840|58642451|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
30630575|NCT03739840|58642448|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
30630576|NCT03739840|58642449|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
30630577|NCT03739840|58642450|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
30630578|NCT03739840|58642451|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
30630579|NCT03739840|58642448|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
30630580|NCT03739840|58642449|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
30630581|NCT03739840|58642450|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
30630582|NCT03739840|58642451|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
30630583|NCT01035060|58642475|FG000|Overall Study|Lost to Follow-up|0|||
30630584|NCT01035060|58642476|FG001|Overall Study|Lost to Follow-up|7|||
30630585|NCT01035060|58642475|FG000|Overall Study|Did not quality after 2nd screening|14|||
30630586|NCT01035060|58642476|FG001|Overall Study|Did not quality after 2nd screening|1|||
30630587|NCT01035060|58642475|FG000|Overall Study|Withdrawal by Subject|8|||
30630588|NCT01035060|58642476|FG001|Overall Study|Withdrawal by Subject|6|||
30630589|NCT01035060|58642475|FG000|Overall Study|Physician Decision|2|||
30630590|NCT01035060|58642476|FG001|Overall Study|Physician Decision|0|||
30630591|NCT01039428|58642484|FG000|Overall Study|Protocol Violation|1|||
30630592|NCT01039428|58642485|FG001|Overall Study|Protocol Violation|0|||
30630593|NCT01039428|58642484|FG000|Overall Study|Withdrawal by Subject|1|||
30630594|NCT01039428|58642485|FG001|Overall Study|Withdrawal by Subject|0|||
30630595|NCT01034358|58642491|FG000|Overall Study|Withdrawal by Subject|1|||
30630596|NCT01034358|58642491|FG000|Overall Study|Protocol Violation|1|||
30630597|NCT01033734|58642499|FG000|Overall Study|Withdrawal by Subject|1|||
30630598|NCT01115855|58642514|FG000|Overall Study|Adverse Event|16|||
30630599|NCT01115855|58642515|FG001|Overall Study|Adverse Event|18|||
30630600|NCT01115855|58642514|FG000|Overall Study|Death|6|||
30630601|NCT01115855|58642515|FG001|Overall Study|Death|5|||
30630602|NCT01115855|58642514|FG000|Overall Study|Lab Abnormality|1|||
30630603|NCT01115855|58642515|FG001|Overall Study|Lab Abnormality|1|||
30630604|NCT01115855|58642514|FG000|Overall Study|Protocol Violation|0|||
30630605|NCT01115855|58642515|FG001|Overall Study|Protocol Violation|1|||
30630606|NCT01115855|58642514|FG000|Overall Study|Withdrawal by Subject|5|||
30630607|NCT01115855|58642515|FG001|Overall Study|Withdrawal by Subject|5|||
30630608|NCT01115855|58642514|FG000|Overall Study|Other|8|||
30630609|NCT01115855|58642515|FG001|Overall Study|Other|6|||
30630610|NCT01115309|58642525|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
30630611|NCT01115309|58642525|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
30630612|NCT01115309|58642525|FG000|Long-term Follow-up|Lost to Follow-up|6|||
30630613|NCT03638128|58642533|FG000|Overall Study|Withdrawal by Subject|1|||
30630614|NCT03638128|58642534|FG001|Overall Study|Withdrawal by Subject|7|||
30630615|NCT03638128|58642535|FG002|Overall Study|Withdrawal by Subject|6|||
30630616|NCT03638128|58642533|FG000|Overall Study|Sponsor Decision|15|||
30630617|NCT03638128|58642534|FG001|Overall Study|Sponsor Decision|12|||
30630618|NCT03638128|58642535|FG002|Overall Study|Sponsor Decision|19|||
30630619|NCT03638128|58642533|FG000|Overall Study|Lost to Follow-up|0|||
30630620|NCT03638128|58642534|FG001|Overall Study|Lost to Follow-up|0|||
30630621|NCT03638128|58642535|FG002|Overall Study|Lost to Follow-up|1|||
30630622|NCT01059630|58642548|FG000|Overall Study|Death|100|||
30764324|NCT03383146|58772975|FG001|Overall Study|Reason not Specified|6|||
30630623|NCT01059630|58642549|FG001|Overall Study|Death|84|||
30630624|NCT01059630|58642548|FG000|Overall Study|Lost to Follow-up|4|||
30630625|NCT01059630|58642549|FG001|Overall Study|Lost to Follow-up|1|||
30630626|NCT01059630|58642548|FG000|Overall Study|Physician Decision|2|||
30630627|NCT01059630|58642549|FG001|Overall Study|Physician Decision|4|||
30630628|NCT01059630|58642548|FG000|Overall Study|Withdrawal by Subject|21|||
30630629|NCT01059630|58642549|FG001|Overall Study|Withdrawal by Subject|14|||
30630630|NCT00932373|58642566|FG000|Overall Study|Progressive disease|3|||
30630631|NCT00932373|58642567|FG001|Overall Study|Progressive disease|1|||
30630632|NCT00932373|58642568|FG002|Overall Study|Progressive disease|0|||
30630633|NCT00932373|58642569|FG003|Overall Study|Progressive disease|0|||
30630634|NCT00932373|58642570|FG004|Overall Study|Progressive disease|10|||
30630635|NCT00932373|58642571|FG005|Overall Study|Progressive disease|1|||
30630636|NCT00932373|58642572|FG006|Overall Study|Progressive disease|0|||
30630637|NCT00932373|58642573|FG007|Overall Study|Progressive disease|2|||
30630638|NCT00932373|58642574|FG008|Overall Study|Progressive disease|1|||
30630639|NCT00932373|58642575|FG009|Overall Study|Progressive disease|9|||
30630640|NCT00932373|58642576|FG010|Overall Study|Progressive disease|2|||
30630641|NCT00932373|58642566|FG000|Overall Study|Adverse Event|0|||
30630642|NCT00932373|58642567|FG001|Overall Study|Adverse Event|0|||
30630643|NCT00932373|58642568|FG002|Overall Study|Adverse Event|0|||
30630644|NCT00932373|58642569|FG003|Overall Study|Adverse Event|0|||
30630645|NCT00932373|58642570|FG004|Overall Study|Adverse Event|2|||
30630646|NCT00932373|58642571|FG005|Overall Study|Adverse Event|1|||
30630647|NCT00932373|58642572|FG006|Overall Study|Adverse Event|0|||
30630648|NCT00932373|58642573|FG007|Overall Study|Adverse Event|1|||
30630649|NCT00932373|58642574|FG008|Overall Study|Adverse Event|0|||
30630650|NCT00932373|58642575|FG009|Overall Study|Adverse Event|2|||
30630651|NCT00932373|58642576|FG010|Overall Study|Adverse Event|1|||
30630652|NCT00932373|58642566|FG000|Overall Study|Physician Decision|0|||
30630653|NCT00932373|58642567|FG001|Overall Study|Physician Decision|0|||
30630654|NCT00932373|58642568|FG002|Overall Study|Physician Decision|1|||
30630655|NCT00932373|58642569|FG003|Overall Study|Physician Decision|0|||
30630656|NCT00932373|58642570|FG004|Overall Study|Physician Decision|2|||
30630657|NCT00932373|58642571|FG005|Overall Study|Physician Decision|0|||
30630658|NCT00932373|58642572|FG006|Overall Study|Physician Decision|0|||
30630659|NCT00932373|58642573|FG007|Overall Study|Physician Decision|0|||
30630660|NCT00932373|58642574|FG008|Overall Study|Physician Decision|0|||
30630661|NCT00932373|58642575|FG009|Overall Study|Physician Decision|1|||
30630662|NCT00932373|58642576|FG010|Overall Study|Physician Decision|0|||
30630663|NCT00932373|58642566|FG000|Overall Study|Dose limiting toxicity|0|||
30630664|NCT00932373|58642567|FG001|Overall Study|Dose limiting toxicity|0|||
30630665|NCT00932373|58642568|FG002|Overall Study|Dose limiting toxicity|0|||
30630666|NCT00932373|58642569|FG003|Overall Study|Dose limiting toxicity|0|||
30630667|NCT00932373|58642570|FG004|Overall Study|Dose limiting toxicity|0|||
30630668|NCT00932373|58642571|FG005|Overall Study|Dose limiting toxicity|1|||
30630669|NCT00932373|58642572|FG006|Overall Study|Dose limiting toxicity|0|||
30630670|NCT00932373|58642573|FG007|Overall Study|Dose limiting toxicity|0|||
30630671|NCT00932373|58642574|FG008|Overall Study|Dose limiting toxicity|0|||
30630672|NCT00932373|58642575|FG009|Overall Study|Dose limiting toxicity|0|||
30630673|NCT00932373|58642576|FG010|Overall Study|Dose limiting toxicity|0|||
30630674|NCT00932373|58642566|FG000|Overall Study|Withdrawal by Subject|0|||
30630675|NCT00932373|58642567|FG001|Overall Study|Withdrawal by Subject|0|||
30630676|NCT00932373|58642568|FG002|Overall Study|Withdrawal by Subject|0|||
30630677|NCT00932373|58642569|FG003|Overall Study|Withdrawal by Subject|0|||
30630678|NCT00932373|58642570|FG004|Overall Study|Withdrawal by Subject|0|||
30630679|NCT00932373|58642571|FG005|Overall Study|Withdrawal by Subject|0|||
30630680|NCT00932373|58642572|FG006|Overall Study|Withdrawal by Subject|0|||
30630681|NCT00932373|58642573|FG007|Overall Study|Withdrawal by Subject|0|||
30630682|NCT00932373|58642574|FG008|Overall Study|Withdrawal by Subject|1|||
30630683|NCT00932373|58642575|FG009|Overall Study|Withdrawal by Subject|0|||
30630684|NCT00932373|58642576|FG010|Overall Study|Withdrawal by Subject|0|||
30630685|NCT00932373|58642566|FG000|Overall Study|Clinical progression|0|||
30630686|NCT00932373|58642567|FG001|Overall Study|Clinical progression|0|||
30630687|NCT00932373|58642568|FG002|Overall Study|Clinical progression|0|||
30630688|NCT00932373|58642569|FG003|Overall Study|Clinical progression|0|||
30630689|NCT00932373|58642570|FG004|Overall Study|Clinical progression|0|||
30630690|NCT00932373|58642571|FG005|Overall Study|Clinical progression|0|||
30630691|NCT00932373|58642572|FG006|Overall Study|Clinical progression|1|||
30630692|NCT00932373|58642573|FG007|Overall Study|Clinical progression|0|||
30630693|NCT00932373|58642574|FG008|Overall Study|Clinical progression|0|||
30630694|NCT00932373|58642575|FG009|Overall Study|Clinical progression|0|||
30630695|NCT00932373|58642576|FG010|Overall Study|Clinical progression|0|||
30630696|NCT00932373|58642566|FG000|Overall Study|Lack of Efficacy|0|||
30630697|NCT00932373|58642567|FG001|Overall Study|Lack of Efficacy|0|||
30630698|NCT00932373|58642568|FG002|Overall Study|Lack of Efficacy|0|||
30630699|NCT00932373|58642569|FG003|Overall Study|Lack of Efficacy|0|||
30630700|NCT00932373|58642570|FG004|Overall Study|Lack of Efficacy|0|||
30630701|NCT00932373|58642571|FG005|Overall Study|Lack of Efficacy|0|||
30630702|NCT00932373|58642572|FG006|Overall Study|Lack of Efficacy|0|||
30630703|NCT00932373|58642573|FG007|Overall Study|Lack of Efficacy|0|||
30630704|NCT00932373|58642574|FG008|Overall Study|Lack of Efficacy|0|||
30630705|NCT00932373|58642575|FG009|Overall Study|Lack of Efficacy|1|||
30630706|NCT00932373|58642576|FG010|Overall Study|Lack of Efficacy|0|||
30630707|NCT01055496|58642610|FG000|Overall Study|Withdrawal by Subject|2|||
30630708|NCT01055496|58642611|FG001|Overall Study|Withdrawal by Subject|4|||
30630709|NCT01055496|58642610|FG000|Overall Study|Death|13|||
30630710|NCT01055496|58642611|FG001|Overall Study|Death|23|||
30630711|NCT01055496|58642610|FG000|Overall Study|Lost to Follow-up|0|||
30630712|NCT01055496|58642611|FG001|Overall Study|Lost to Follow-up|2|||
30630713|NCT01055496|58642610|FG000|Overall Study|Other - Unspecified|0|||
30630714|NCT01055496|58642611|FG001|Overall Study|Other - Unspecified|1|||
30630715|NCT01055262|58642638|FG000|Overall Study|Adverse Event|5|||
30630716|NCT01055262|58642638|FG000|Overall Study|Protocol Violation|3|||
30630717|NCT01055262|58642638|FG000|Overall Study|Uncooperativeness|1|||
30630718|NCT01052844|58642644|FG000|Overall Study|Adverse Event|0|||
30630719|NCT01052844|58642645|FG001|Overall Study|Adverse Event|1|||
30630720|NCT01049412|58642653|FG000|Period I|Withdrawal by Subject|4|||
30630721|NCT01049412|58642654|FG001|Period I|Withdrawal by Subject|6|||
30630722|NCT01049412|58642653|FG000|Period I|Lost to Follow-up|2|||
30630723|NCT01049412|58642654|FG001|Period I|Lost to Follow-up|2|||
30630724|NCT01049412|58642653|FG000|Period I|Physician Decision|0|||
30630725|NCT01049412|58642654|FG001|Period I|Physician Decision|3|||
30630726|NCT01049412|58642653|FG000|Period I|Protocol Violation|1|||
30630727|NCT01049412|58642654|FG001|Period I|Protocol Violation|2|||
30630728|NCT01049412|58642653|FG000|Period I|Adverse Event|1|||
30630729|NCT01049412|58642654|FG001|Period I|Adverse Event|0|||
30630730|NCT01049412|58642653|FG000|Period II|Withdrawal by Subject|2|||
30630731|NCT01049412|58642654|FG001|Period II|Withdrawal by Subject|3|||
30630732|NCT01049412|58642653|FG000|Period II|Adverse Event|1|||
30630733|NCT01049412|58642654|FG001|Period II|Adverse Event|0|||
30630734|NCT01049412|58642653|FG000|Period II|Lost to Follow-up|1|||
30630735|NCT01049412|58642654|FG001|Period II|Lost to Follow-up|0|||
30630736|NCT00934089|58642664|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
30630737|NCT00934089|58642665|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
30630738|NCT00934089|58642664|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
30630739|NCT00934089|58642665|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
30630740|NCT01032174|58642673|FG000|Overall Study|Adverse Event|0|||
30630741|NCT01032174|58642674|FG001|Overall Study|Adverse Event|1|||
30630742|NCT00933933|58642685|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
30630743|NCT00933933|58642686|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
30630744|NCT00933933|58642687|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
30630745|NCT00933933|58642685|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
30630746|NCT00933933|58642686|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
30630747|NCT00933933|58642687|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
30630748|NCT01032018|58642705|FG000|Overall Study|Lost to Follow-up|6|||
30630749|NCT01032018|58642706|FG001|Overall Study|Lost to Follow-up|5|||
30630750|NCT01032018|58642705|FG000|Overall Study|Death|0|||
30630751|NCT01032018|58642706|FG001|Overall Study|Death|1|||
30630752|NCT01031706|58642714|FG000|Overall Study|Adverse Event|1|||
30630753|NCT01031706|58642715|FG001|Overall Study|Adverse Event|0|||
30630754|NCT01031706|58642714|FG000|Overall Study|Withdrawal by Subject|1|||
30630755|NCT01031706|58642715|FG001|Overall Study|Withdrawal by Subject|1|||
30630756|NCT00927069|58642723|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
30630757|NCT00927069|58642724|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
30630758|NCT00927069|58642725|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
30630759|NCT00927069|58642726|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
30630760|NCT00927069|58642723|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
30630761|NCT00927069|58642724|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
30630762|NCT00927069|58642725|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
30630763|NCT00927069|58642726|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
30764325|NCT03616964|58772985|FG000|Overall Study|Adverse Event|15|||
30630764|NCT00927069|58642723|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
30630765|NCT00927069|58642724|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
30764326|NCT03616964|58772986|FG001|Overall Study|Adverse Event|10|||
30630766|NCT00927069|58642725|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
30630767|NCT00927069|58642726|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
30630768|NCT00927069|58642723|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
30630769|NCT00927069|58642724|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
30630770|NCT00927069|58642725|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
30630771|NCT00927069|58642726|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
30630772|NCT00927069|58642723|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
30630773|NCT00927069|58642724|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
30630774|NCT00927069|58642725|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
30630775|NCT00927069|58642726|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
30630776|NCT01031628|58642740|FG000|Overall Study|Study terminated early|0|||
30630777|NCT01031628|58642741|FG001|Overall Study|Study terminated early|1|||
30630778|NCT01031628|58642742|FG002|Overall Study|Study terminated early|3|||
30630779|NCT01031628|58642743|FG003|Overall Study|Study terminated early|0|||
30630780|NCT01031004|58642755|FG000|Overall Study|Protocol Violation|0|||
30630781|NCT01031004|58642756|FG001|Overall Study|Protocol Violation|1|||
30630782|NCT01031004|58642755|FG000|Overall Study|Lost to Follow-up|1|||
30630783|NCT01031004|58642756|FG001|Overall Study|Lost to Follow-up|0|||
30630784|NCT00931515|58642764|FG000|Overall Study|Lost to Follow-up|2|||
30630785|NCT00931515|58642765|FG001|Overall Study|Lost to Follow-up|5|||
30630786|NCT01028352|58642771|FG000|Overall Study|Ineligible due to baseline average pain|5|||
30630787|NCT01028352|58642771|FG000|Overall Study|Withdrawal by Subject|1|||
30630788|NCT00929643|58642788|FG000|Overall Study|Protocol Violation|2|||
30630789|NCT00926367|58642794|FG000|Overall Study|Withdrawal by Subject|0|||
30630790|NCT00926367|58642795|FG001|Overall Study|Withdrawal by Subject|1|||
30630791|NCT00926367|58642794|FG000|Overall Study|Lost to Follow-up|1|||
30630792|NCT00926367|58642795|FG001|Overall Study|Lost to Follow-up|0|||
30630793|NCT00926367|58642794|FG000|Overall Study|Skin Irritation|1|||
30630794|NCT00926367|58642795|FG001|Overall Study|Skin Irritation|2|||
30630795|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
30630796|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
30630797|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
30630798|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
30630799|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
30630800|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
30630801|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
30630802|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
30630803|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
30630804|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
30630805|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
30630806|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
30630807|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
30630808|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
30630809|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
30630810|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
30630811|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
30630812|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
30630813|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
30630814|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
30630815|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
30630816|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
30630817|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
30630818|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
30630819|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Death|2|||
30630820|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Death|1|||
30630821|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Death|2|||
30630822|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Graft loss|0|||
30630823|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Graft loss|2|||
30630824|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Graft loss|0|||
30630825|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
30630826|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
30630827|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
30630828|NCT01114529|58642806|FG000|Completed Study Medication at Month 24|Missing|2|||
30630829|NCT01114529|58642807|FG001|Completed Study Medication at Month 24|Missing|0|||
30764327|NCT03616964|58772987|FG002|Overall Study|Adverse Event|16|||
30630830|NCT01114529|58642808|FG002|Completed Study Medication at Month 24|Missing|0|||
30630831|NCT01114529|58642806|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
30630832|NCT01114529|58642807|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
30630833|NCT01114529|58642808|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
30764328|NCT03616964|58772985|FG000|Overall Study|Death|3|||
30764329|NCT03616964|58772986|FG001|Overall Study|Death|0|||
30764330|NCT03616964|58772987|FG002|Overall Study|Death|4|||
30630834|NCT01114529|58642806|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
30764331|NCT03616964|58772985|FG000|Overall Study|Lack of Efficacy|4|||
30764332|NCT03616964|58772986|FG001|Overall Study|Lack of Efficacy|8|||
30764333|NCT03616964|58772987|FG002|Overall Study|Lack of Efficacy|8|||
30630835|NCT01114529|58642807|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
30630836|NCT01114529|58642808|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
30630837|NCT01114529|58642806|FG000|Completed Study Phase at Month 24|Death|8|||
30630838|NCT01114529|58642807|FG001|Completed Study Phase at Month 24|Death|5|||
30630839|NCT01114529|58642808|FG002|Completed Study Phase at Month 24|Death|4|||
30630840|NCT01114529|58642806|FG000|Completed Study Phase at Month 24|Other|2|||
30630841|NCT01114529|58642807|FG001|Completed Study Phase at Month 24|Other|0|||
30630842|NCT01114529|58642808|FG002|Completed Study Phase at Month 24|Other|0|||
30630843|NCT01114529|58642806|FG000|Completed Study Phase at Month 24|Missing|2|||
30630844|NCT01114529|58642807|FG001|Completed Study Phase at Month 24|Missing|0|||
30630845|NCT01114529|58642808|FG002|Completed Study Phase at Month 24|Missing|0|||
30630846|NCT00926289|58642820|FG000|Overall Study|Adverse Event|9|||
30630847|NCT00926289|58642821|FG001|Overall Study|Adverse Event|11|||
30630848|NCT00926289|58642820|FG000|Overall Study|Protocol Violation|8|||
30630849|NCT00926289|58642821|FG001|Overall Study|Protocol Violation|12|||
30630850|NCT00926289|58642820|FG000|Overall Study|Lost to Follow-up|3|||
30630851|NCT00926289|58642821|FG001|Overall Study|Lost to Follow-up|6|||
30630852|NCT00926289|58642820|FG000|Overall Study|Withdrawal by Subject|4|||
30630853|NCT00926289|58642821|FG001|Overall Study|Withdrawal by Subject|4|||
30630854|NCT00926289|58642820|FG000|Overall Study|Other|1|||
30630855|NCT00926289|58642821|FG001|Overall Study|Other|3|||
30630856|NCT03208036|58642846|FG000|Baseline Assessment|Withdrawal by Subject|1|||
30630857|NCT03208036|58642847|FG001|Baseline Assessment|Withdrawal by Subject|1|||
30630858|NCT03208036|58642846|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
30630859|NCT03208036|58642847|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
30630860|NCT03208036|58642846|FG000|Intervention|Withdrawal by Subject|3|||
30630861|NCT03208036|58642847|FG001|Intervention|Withdrawal by Subject|2|||
30630862|NCT03208036|58642846|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
30630863|NCT03208036|58642847|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
30630864|NCT00926211|58642853|FG000|Overall Study|Lost to Follow-up|1|||
30630865|NCT01114373|58642858|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
30630866|NCT01114373|58642859|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
30630867|NCT01114373|58642858|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
30630868|NCT01114373|58642859|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
30630869|NCT01114373|58642858|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
30630870|NCT01114373|58642859|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
30848206|NCT00409773|58874112|FG001|Overall Study|Protocol Violation|2|||
30848207|NCT00409773|58874113|FG002|Overall Study|Protocol Violation|3|||
30848208|NCT00409773|58874114|FG003|Overall Study|Protocol Violation|3|||
30630871|NCT01114373|58642858|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
30630872|NCT01114373|58642859|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
30630873|NCT00925899|58642871|FG000|Part 1|Death|1|||
30630874|NCT00925899|58642872|FG001|Part 1|Death|2|||
30630875|NCT00925899|58642871|FG000|Part 1|Withdrawal by Subject|10|||
30630876|NCT00925899|58642872|FG001|Part 1|Withdrawal by Subject|9|||
30630877|NCT01114217|58642881|FG000|Overall Study|Adverse Event|5|||
30630878|NCT01114217|58642882|FG001|Overall Study|Adverse Event|3|||
30630879|NCT01114217|58642881|FG000|Overall Study|Lost to Follow-up|17|||
30630880|NCT01114217|58642882|FG001|Overall Study|Lost to Follow-up|33|||
30630881|NCT01114217|58642881|FG000|Overall Study|Withdrawal by Subject|21|||
30630882|NCT01114217|58642882|FG001|Overall Study|Withdrawal by Subject|28|||
30630883|NCT01114217|58642881|FG000|Overall Study|Other-Clerical Error|3|||
30630884|NCT01114217|58642882|FG001|Overall Study|Other-Clerical Error|0|||
30630885|NCT01114217|58642881|FG000|Overall Study|Other-Early termination|6|||
30630886|NCT01114217|58642882|FG001|Overall Study|Other-Early termination|10|||
30630887|NCT01114217|58642881|FG000|Overall Study|Other-Procedure|1|||
30630888|NCT01114217|58642882|FG001|Overall Study|Other-Procedure|1|||
30630889|NCT01114217|58642881|FG000|Overall Study|Other-Pregnancy|2|||
30630890|NCT01114217|58642882|FG001|Overall Study|Other-Pregnancy|4|||
30848209|NCT00409773|58874115|FG004|Overall Study|Protocol Violation|1|||
30848210|NCT00409773|58874111|FG000|Overall Study|Withdrawal by Subject|0|||
30848211|NCT00409773|58874112|FG001|Overall Study|Withdrawal by Subject|0|||
30630891|NCT01114217|58642881|FG000|Overall Study|Other-Protocol Violation|1|||
30630892|NCT01114217|58642882|FG001|Overall Study|Other-Protocol Violation|3|||
30630893|NCT01114217|58642881|FG000|Overall Study|Other-Lack of Efficacy|1|||
30630894|NCT01114217|58642882|FG001|Overall Study|Other-Lack of Efficacy|0|||
30630895|NCT01114217|58642881|FG000|Overall Study|Other-Non Compliance|2|||
30630896|NCT01114217|58642882|FG001|Overall Study|Other-Non Compliance|0|||
30848212|NCT00409773|58874113|FG002|Overall Study|Withdrawal by Subject|0|||
30630897|NCT01114217|58642881|FG000|Overall Study|Other-Physician Decision|1|||
30630898|NCT01114217|58642882|FG001|Overall Study|Other-Physician Decision|1|||
30630899|NCT01114217|58642881|FG000|Overall Study|Other-Sponsor Decision|10|||
30630900|NCT01114217|58642882|FG001|Overall Study|Other-Sponsor Decision|12|||
30630901|NCT01114217|58642881|FG000|Overall Study|Other-Study Termination|0|||
30848213|NCT00409773|58874114|FG003|Overall Study|Withdrawal by Subject|2|||
30630902|NCT01114217|58642882|FG001|Overall Study|Other-Study Termination|1|||
30630903|NCT01114217|58642881|FG000|Overall Study|Other-Study Withdrawn|1|||
30630904|NCT01114217|58642882|FG001|Overall Study|Other-Study Withdrawn|1|||
30630905|NCT01114217|58642881|FG000|Overall Study|Other-Site Stopped Communicating|2|||
30630906|NCT01114217|58642882|FG001|Overall Study|Other-Site Stopped Communicating|0|||
30630907|NCT01114217|58642881|FG000|Overall Study|Other-Lost to Follow-up|1|||
30630908|NCT01114217|58642882|FG001|Overall Study|Other-Lost to Follow-up|0|||
30630909|NCT01114217|58642881|FG000|Overall Study|Other-Withdrawal by Subject|1|||
30630910|NCT01114217|58642882|FG001|Overall Study|Other-Withdrawal by Subject|1|||
30630911|NCT01030536|58642891|FG000|Overall Study|Withdrawal by Subject|0|||
30630912|NCT01030536|58642892|FG001|Overall Study|Withdrawal by Subject|0|||
30630913|NCT01030536|58642893|FG002|Overall Study|Withdrawal by Subject|1|||
30630914|NCT01030536|58642894|FG003|Overall Study|Withdrawal by Subject|0|||
30630915|NCT01030536|58642895|FG004|Overall Study|Withdrawal by Subject|0|||
30630916|NCT01030536|58642891|FG000|Overall Study|undefined|1|||
30630917|NCT01030536|58642892|FG001|Overall Study|undefined|0|||
30630918|NCT01030536|58642893|FG002|Overall Study|undefined|1|||
30630919|NCT01030536|58642894|FG003|Overall Study|undefined|1|||
30630920|NCT01030536|58642895|FG004|Overall Study|undefined|0|||
30630921|NCT01030536|58642891|FG000|Overall Study|Adverse Event|0|||
30630922|NCT01030536|58642892|FG001|Overall Study|Adverse Event|3|||
30630923|NCT01030536|58642893|FG002|Overall Study|Adverse Event|1|||
30630924|NCT01030536|58642894|FG003|Overall Study|Adverse Event|0|||
30630925|NCT01030536|58642895|FG004|Overall Study|Adverse Event|1|||
30630926|NCT01030536|58642891|FG000|Overall Study|Progressive disease|6|||
30630927|NCT01030536|58642892|FG001|Overall Study|Progressive disease|2|||
30630928|NCT01030536|58642893|FG002|Overall Study|Progressive disease|3|||
30630929|NCT01030536|58642894|FG003|Overall Study|Progressive disease|2|||
30630930|NCT01030536|58642895|FG004|Overall Study|Progressive disease|0|||
30630931|NCT01030536|58642891|FG000|Overall Study|Death|0|||
30630932|NCT01030536|58642892|FG001|Overall Study|Death|1|||
30630933|NCT01030536|58642893|FG002|Overall Study|Death|0|||
30630934|NCT01030536|58642894|FG003|Overall Study|Death|0|||
30630935|NCT01030536|58642895|FG004|Overall Study|Death|0|||
30630936|NCT01030458|58642913|FG000|Overall Study|Lost to Follow-up|9|||
30630937|NCT01030458|58642914|FG001|Overall Study|Lost to Follow-up|10|||
30630938|NCT01030458|58642913|FG000|Overall Study|Withdrawal by Subject|2|||
30630939|NCT01030458|58642914|FG001|Overall Study|Withdrawal by Subject|3|||
30630940|NCT01030458|58642913|FG000|Overall Study|Logistical reasons|9|||
30630941|NCT01030458|58642914|FG001|Overall Study|Logistical reasons|5|||
30630942|NCT01030458|58642913|FG000|Overall Study|Moved or changed job|6|||
30630943|NCT01030458|58642914|FG001|Overall Study|Moved or changed job|13|||
30630944|NCT01030458|58642913|FG000|Overall Study|Side effect of medication|1|||
30630945|NCT01030458|58642914|FG001|Overall Study|Side effect of medication|1|||
30630946|NCT00930969|58642920|FG000|Overall Study|Death|5|||
30630947|NCT00930969|58642920|FG000|Overall Study|Lost to Follow-up|1|||
30630948|NCT00930969|58642920|FG000|Overall Study|Physician Decision|13|||
30630949|NCT00930969|58642920|FG000|Overall Study|Withdrawal by Subject|19|||
30630950|NCT01114139|58642926|FG000|Overall Study|Adverse Event|3|||
30630951|NCT01114139|58642927|FG001|Overall Study|Adverse Event|2|||
30630952|NCT01114139|58642926|FG000|Overall Study|Lost to Follow-up|15|||
30630953|NCT01114139|58642927|FG001|Overall Study|Lost to Follow-up|3|||
30630954|NCT01114139|58642926|FG000|Overall Study|Withdrawal by Subject|17|||
30630955|NCT01114139|58642927|FG001|Overall Study|Withdrawal by Subject|6|||
30630956|NCT01114139|58642926|FG000|Overall Study|Other-Missed 1 visit|1|||
30630957|NCT01114139|58642927|FG001|Overall Study|Other-Missed 1 visit|0|||
30630958|NCT01114139|58642926|FG000|Overall Study|Other-Protocol Violation|1|||
30630959|NCT01114139|58642927|FG001|Overall Study|Other-Protocol Violation|0|||
30630960|NCT01114139|58642926|FG000|Overall Study|Other-Out of window for study drug dose|1|||
30630961|NCT01114139|58642927|FG001|Overall Study|Other-Out of window for study drug dose|0|||
30630962|NCT01114139|58642926|FG000|Overall Study|Other-Participant falsified records|0|||
30630963|NCT01114139|58642927|FG001|Overall Study|Other-Participant falsified records|1|||
30630964|NCT01114139|58642926|FG000|Overall Study|Other-Participant went on hospice|0|||
30630965|NCT01114139|58642927|FG001|Overall Study|Other-Participant went on hospice|1|||
30630966|NCT01114139|58642926|FG000|Overall Study|Other-Physician changed treatment|1|||
30630967|NCT01114139|58642927|FG001|Overall Study|Other-Physician changed treatment|0|||
30630968|NCT01114139|58642926|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
30764334|NCT03616964|58772985|FG000|Overall Study|Lost to Follow-up|2|||
30630969|NCT01114139|58642927|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
30630970|NCT01027884|58642935|FG000|Overall Study|Adverse Event|2|||
30630971|NCT01027884|58642936|FG001|Overall Study|Adverse Event|1|||
30630972|NCT01027884|58642935|FG000|Overall Study|Protocol Violation|1|||
30630973|NCT01027884|58642936|FG001|Overall Study|Protocol Violation|0|||
30764335|NCT03616964|58772986|FG001|Overall Study|Lost to Follow-up|1|||
30630974|NCT01027884|58642935|FG000|Overall Study|Non-compliance|1|||
30630975|NCT01027884|58642936|FG001|Overall Study|Non-compliance|1|||
30630976|NCT01027884|58642935|FG000|Overall Study|Withdrawal by Subject|0|||
30630977|NCT01027884|58642936|FG001|Overall Study|Withdrawal by Subject|1|||
30764336|NCT03616964|58772987|FG002|Overall Study|Lost to Follow-up|3|||
30630978|NCT01027884|58642935|FG000|Overall Study|Lost to Follow-up|0|||
30630979|NCT01027884|58642936|FG001|Overall Study|Lost to Follow-up|1|||
30630980|NCT01027884|58642935|FG000|Overall Study|Spinal fixation surgery|0|||
30630981|NCT01027884|58642936|FG001|Overall Study|Spinal fixation surgery|3|||
30630982|NCT03387514|58642944|FG000|Overall Study|Withdrawal by Subject|2|||
30630983|NCT03387514|58642944|FG000|Overall Study|Physician Decision|1|||
30630984|NCT03387514|58642944|FG000|Overall Study|Lost to Follow-up|2|||
30630985|NCT01113749|58642959|FG000|Overall Study|Lost to Follow-up|1|||
30630986|NCT01113749|58642960|FG001|Overall Study|Lost to Follow-up|2|||
30630987|NCT01022580|58642968|FG000|Overall Study|Death|18|||
30630988|NCT01022580|58642969|FG001|Overall Study|Death|22|||
30630989|NCT01107353|58642983|FG000|Overall Study|Positive Drug Screen|1|||
30630990|NCT01107353|58642984|FG001|Overall Study|Positive Drug Screen|0|||
30630991|NCT01107197|58642992|FG000|Overall Study|Death|12|||
30630992|NCT01107197|58642993|FG001|Overall Study|Death|10|||
30630993|NCT01107197|58642992|FG000|Overall Study|Lost to Follow-up|5|||
30630994|NCT01107197|58642993|FG001|Overall Study|Lost to Follow-up|8|||
30630995|NCT01107197|58642992|FG000|Overall Study|Withdrawal by Subject|3|||
30630996|NCT01107197|58642993|FG001|Overall Study|Withdrawal by Subject|5|||
30630997|NCT01112579|58643010|FG000|Overall Study|Missed Visit|1|||
30630998|NCT01112579|58643011|FG001|Overall Study|Missed Visit|1|||
30630999|NCT01112579|58643010|FG000|Overall Study|Death|0|||
30631000|NCT01112579|58643011|FG001|Overall Study|Death|2|||
30631001|NCT01112267|58643019|FG000|Overall Study|Adverse Event|24|||
30631002|NCT01112267|58643020|FG001|Overall Study|Adverse Event|6|||
30631003|NCT01112267|58643019|FG000|Overall Study|Withdrawal by Subject|3|||
30631004|NCT01112267|58643020|FG001|Overall Study|Withdrawal by Subject|5|||
30631005|NCT01112267|58643019|FG000|Overall Study|Protocol Violation|5|||
30631006|NCT01112267|58643020|FG001|Overall Study|Protocol Violation|3|||
30631007|NCT01112267|58643019|FG000|Overall Study|Participants not compliant|1|||
30631008|NCT01112267|58643020|FG001|Overall Study|Participants not compliant|2|||
30631009|NCT01112267|58643019|FG000|Overall Study|Participants not receive any study drug|1|||
30631010|NCT01112267|58643020|FG001|Overall Study|Participants not receive any study drug|2|||
30631011|NCT00925587|58643028|FG000|Overall Study|Protocol Specified Criteria|6|||
30631012|NCT00925587|58643029|FG001|Overall Study|Protocol Specified Criteria|6|||
30631013|NCT00925587|58643028|FG000|Overall Study|Physician Decision|4|||
30631014|NCT00925587|58643029|FG001|Overall Study|Physician Decision|1|||
30631015|NCT00925587|58643028|FG000|Overall Study|Protocol Violation|6|||
30631016|NCT00925587|58643029|FG001|Overall Study|Protocol Violation|4|||
30631017|NCT00925587|58643028|FG000|Overall Study|Withdrawal by Subject|9|||
30631018|NCT00925587|58643029|FG001|Overall Study|Withdrawal by Subject|6|||
30631019|NCT00925587|58643028|FG000|Overall Study|Death|5|||
30631020|NCT00925587|58643029|FG001|Overall Study|Death|5|||
30631021|NCT00925587|58643028|FG000|Overall Study|Adverse Event|6|||
30631022|NCT00925587|58643029|FG001|Overall Study|Adverse Event|2|||
30631023|NCT00925587|58643028|FG000|Overall Study|Lost to Follow-up|0|||
30631024|NCT00925587|58643029|FG001|Overall Study|Lost to Follow-up|1|||
30631025|NCT00928707|58643041|FG000|Overall Study|Protocol Violation|1|||
30631026|NCT00928707|58643042|FG001|Overall Study|Protocol Violation|0|||
30631027|NCT00930813|58643050|FG000|Overall Study|Death|4|||
30764337|NCT03616964|58772985|FG000|Overall Study|Withdrawal by Subject|18|||
30631028|NCT00930813|58643051|FG001|Overall Study|Death|5|||
30631029|NCT00930813|58643050|FG000|Overall Study|Withdrawal by Subject|2|||
30631030|NCT00930813|58643051|FG001|Overall Study|Withdrawal by Subject|5|||
30631031|NCT00930813|58643050|FG000|Overall Study|Lost to Follow-up|2|||
30631032|NCT00930813|58643051|FG001|Overall Study|Lost to Follow-up|4|||
30631033|NCT00930579|58643059|FG000|Overall Study|Withdrawal by Subject|1|||
30631034|NCT00930579|58643059|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
30764338|NCT03616964|58772986|FG001|Overall Study|Withdrawal by Subject|14|||
30764339|NCT03616964|58772987|FG002|Overall Study|Withdrawal by Subject|21|||
30631035|NCT00925353|58643063|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
30631036|NCT01106651|58643087|FG000|Overall Study|Adverse Event|17|||
30631037|NCT01106651|58643088|FG001|Overall Study|Adverse Event|9|||
30631038|NCT01106651|58643089|FG002|Overall Study|Adverse Event|23|||
30631039|NCT01106651|58643087|FG000|Overall Study|Lost to Follow-up|8|||
30631040|NCT01106651|58643088|FG001|Overall Study|Lost to Follow-up|2|||
30631041|NCT01106651|58643089|FG002|Overall Study|Lost to Follow-up|6|||
30631042|NCT01106651|58643087|FG000|Overall Study|Physician Decision|4|||
30631043|NCT01106651|58643088|FG001|Overall Study|Physician Decision|3|||
30631044|NCT01106651|58643089|FG002|Overall Study|Physician Decision|1|||
30631045|NCT01106651|58643087|FG000|Overall Study|Protocol Violation|1|||
30631046|NCT01106651|58643088|FG001|Overall Study|Protocol Violation|2|||
30631047|NCT01106651|58643089|FG002|Overall Study|Protocol Violation|1|||
30631048|NCT01106651|58643087|FG000|Overall Study|Withdrawal by Subject|14|||
30631049|NCT01106651|58643088|FG001|Overall Study|Withdrawal by Subject|7|||
30631050|NCT01106651|58643089|FG002|Overall Study|Withdrawal by Subject|4|||
30631051|NCT01106651|58643087|FG000|Overall Study|Noncompliance with study drug|1|||
30631052|NCT01106651|58643088|FG001|Overall Study|Noncompliance with study drug|0|||
30631053|NCT01106651|58643089|FG002|Overall Study|Noncompliance with study drug|2|||
30631054|NCT01106651|58643087|FG000|Overall Study|Other|34|||
30631055|NCT01106651|58643088|FG001|Overall Study|Other|31|||
30631056|NCT01106651|58643089|FG002|Overall Study|Other|21|||
30631057|NCT01106651|58643087|FG000|Overall Study|Death|0|||
30631058|NCT01106651|58643088|FG001|Overall Study|Death|3|||
30631059|NCT01106651|58643089|FG002|Overall Study|Death|0|||
30631060|NCT01027650|58643108|FG000|Overall Study|Personal Reasons|0|||
30631061|NCT01027650|58643109|FG001|Overall Study|Personal Reasons|0|||
30631062|NCT01027650|58643110|FG002|Overall Study|Personal Reasons|0|||
30631063|NCT01027650|58643111|FG003|Overall Study|Personal Reasons|0|||
30631064|NCT01027650|58643112|FG004|Overall Study|Personal Reasons|2|||
30631065|NCT01027650|58643113|FG005|Overall Study|Personal Reasons|1|||
30631066|NCT01027650|58643114|FG006|Overall Study|Personal Reasons|0|||
30631067|NCT01027650|58643115|FG007|Overall Study|Personal Reasons|0|||
30631068|NCT01027650|58643108|FG000|Overall Study|Lost to Follow-up|0|||
30631069|NCT01027650|58643109|FG001|Overall Study|Lost to Follow-up|0|||
30848214|NCT00409773|58874115|FG004|Overall Study|Withdrawal by Subject|1|||
30848215|NCT00409773|58874111|FG000|Overall Study|Lack of Eligibility|0|||
30848216|NCT00409773|58874112|FG001|Overall Study|Lack of Eligibility|0|||
30848217|NCT00409773|58874113|FG002|Overall Study|Lack of Eligibility|0|||
30848218|NCT00409773|58874114|FG003|Overall Study|Lack of Eligibility|0|||
30848219|NCT00409773|58874115|FG004|Overall Study|Lack of Eligibility|1|||
30848220|NCT02861807|58874129|FG000|Overall Study|Lost to Follow-up|7|||
30848221|NCT02861807|58874130|FG001|Overall Study|Lost to Follow-up|6|||
30848222|NCT02861807|58874129|FG000|Overall Study|Withdrawal by Subject|5|||
30848223|NCT02861807|58874130|FG001|Overall Study|Withdrawal by Subject|8|||
30848224|NCT02858401|58874143|FG000|Overall Study|Withdrew Consent|0|||
30848225|NCT02858401|58874144|FG001|Overall Study|Withdrew Consent|0|||
30848226|NCT02858401|58874145|FG002|Overall Study|Withdrew Consent|0|||
30848227|NCT02858401|58874146|FG003|Overall Study|Withdrew Consent|0|||
30848228|NCT02858401|58874147|FG004|Overall Study|Withdrew Consent|0|||
30848229|NCT02858401|58874148|FG005|Overall Study|Withdrew Consent|1|||
30848230|NCT02858401|58874149|FG006|Overall Study|Withdrew Consent|0|||
30848231|NCT02858401|58874143|FG000|Overall Study|Lost to Follow-up|0|||
30848232|NCT02858401|58874144|FG001|Overall Study|Lost to Follow-up|1|||
30848233|NCT02858401|58874145|FG002|Overall Study|Lost to Follow-up|0|||
30848234|NCT02858401|58874146|FG003|Overall Study|Lost to Follow-up|0|||
30848235|NCT02858401|58874147|FG004|Overall Study|Lost to Follow-up|0|||
30848236|NCT02858401|58874148|FG005|Overall Study|Lost to Follow-up|0|||
30848237|NCT02858401|58874149|FG006|Overall Study|Lost to Follow-up|0|||
30848238|NCT02857283|58874176|FG000|First Exposure|Withdrawal by Subject|1|||
30848239|NCT02857283|58874177|FG001|First Exposure|Withdrawal by Subject|0|||
30848240|NCT02746679|58874195|FG000|Overall Study|Lost to Follow-up|4|||
30848241|NCT02746679|58874196|FG001|Overall Study|Lost to Follow-up|6|||
30848242|NCT02731131|58874204|FG000|Overall Study|Psychiatric Disorder|0|||
30848243|NCT02731131|58874205|FG001|Overall Study|Psychiatric Disorder|1|||
30631070|NCT01027650|58643110|FG002|Overall Study|Lost to Follow-up|0|||
30631071|NCT01027650|58643111|FG003|Overall Study|Lost to Follow-up|0|||
30631072|NCT01027650|58643112|FG004|Overall Study|Lost to Follow-up|0|||
30631073|NCT01027650|58643113|FG005|Overall Study|Lost to Follow-up|0|||
30631074|NCT01027650|58643114|FG006|Overall Study|Lost to Follow-up|1|||
30631075|NCT01027650|58643115|FG007|Overall Study|Lost to Follow-up|0|||
30631076|NCT01027650|58643108|FG000|Overall Study|Lack of Efficacy|0|||
30848244|NCT02731131|58874204|FG000|Overall Study|Refused Therapy|0|||
30848245|NCT02731131|58874205|FG001|Overall Study|Refused Therapy|1|||
30848246|NCT02746705|58874213|FG000|Overall Study|Physician Decision|1|||
30848247|NCT02746705|58874214|FG001|Overall Study|Physician Decision|1|||
30848248|NCT02746705|58874213|FG000|Overall Study|Lost to Follow-up|1|||
30848249|NCT02746705|58874214|FG001|Overall Study|Lost to Follow-up|0|||
30848250|NCT02746705|58874213|FG000|Overall Study|outlier scores deemed not valid|0|||
30631077|NCT01027650|58643109|FG001|Overall Study|Lack of Efficacy|0|||
30631078|NCT01027650|58643110|FG002|Overall Study|Lack of Efficacy|0|||
30631079|NCT01027650|58643111|FG003|Overall Study|Lack of Efficacy|0|||
30631080|NCT01027650|58643112|FG004|Overall Study|Lack of Efficacy|0|||
30631081|NCT01027650|58643113|FG005|Overall Study|Lack of Efficacy|1|||
30631082|NCT01027650|58643114|FG006|Overall Study|Lack of Efficacy|0|||
30631083|NCT01027650|58643115|FG007|Overall Study|Lack of Efficacy|0|||
30631084|NCT01106027|58643133|FG000|Overall Study|Lost graft early, discontinued|1|||
30631085|NCT00927927|58643152|FG000|Overall Study|Withdrawal by Subject|0|||
30631086|NCT00927927|58643153|FG001|Overall Study|Withdrawal by Subject|0|||
30631087|NCT00927927|58643154|FG002|Overall Study|Withdrawal by Subject|0|||
30631088|NCT00927927|58643155|FG003|Overall Study|Withdrawal by Subject|0|||
30631089|NCT00927927|58643156|FG004|Overall Study|Withdrawal by Subject|0|||
30631090|NCT00927927|58643157|FG005|Overall Study|Withdrawal by Subject|0|||
30631091|NCT00927927|58643158|FG006|Overall Study|Withdrawal by Subject|0|||
30631092|NCT00927927|58643159|FG007|Overall Study|Withdrawal by Subject|2|||
30631093|NCT00927927|58643160|FG008|Overall Study|Withdrawal by Subject|0|||
30631094|NCT00927927|58643161|FG009|Overall Study|Withdrawal by Subject|0|||
30631095|NCT00927927|58643162|FG010|Overall Study|Withdrawal by Subject|0|||
30631096|NCT00927927|58643163|FG011|Overall Study|Withdrawal by Subject|2|||
30631097|NCT00927927|58643164|FG012|Overall Study|Withdrawal by Subject|0|||
30631098|NCT00927927|58643165|FG013|Overall Study|Withdrawal by Subject|0|||
30631099|NCT00927927|58643166|FG014|Overall Study|Withdrawal by Subject|0|||
30631100|NCT01027416|58643200|FG000|Overall Study|Withdrawal by Subject|0|||
30631101|NCT01027416|58643201|FG001|Overall Study|Withdrawal by Subject|1|||
30631102|NCT01027416|58643200|FG000|Overall Study|Physician Decision|1|||
30631103|NCT01027416|58643201|FG001|Overall Study|Physician Decision|4|||
30631104|NCT00923559|58643209|FG000|Overall Study|Lost to Follow-up|2|||
30631105|NCT00923559|58643210|FG001|Overall Study|Lost to Follow-up|3|||
30631106|NCT01015638|58643220|FG000|Overall Study|Withdrawal by Subject|1|||
30631107|NCT01015638|58643221|FG001|Overall Study|Withdrawal by Subject|0|||
30631108|NCT01022502|58643227|FG000|Overall Study|Adverse Event|1|||
30631109|NCT01022502|58643227|FG000|Overall Study|employment related reasons|1|||
30631110|NCT01022502|58643227|FG000|Overall Study|Withdrawal by Subject|1|||
30764340|NCT03616964|58772985|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
30764341|NCT03616964|58772986|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
30764342|NCT03616964|58772987|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
30764343|NCT03616964|58772985|FG000|Overall Study|Sponsor's Decision|1|||
30764344|NCT03616964|58772986|FG001|Overall Study|Sponsor's Decision|0|||
30764345|NCT03616964|58772987|FG002|Overall Study|Sponsor's Decision|0|||
30764346|NCT03616964|58772985|FG000|Overall Study|Physician Decision|0|||
30764347|NCT03616964|58772986|FG001|Overall Study|Physician Decision|2|||
30764348|NCT03616964|58772987|FG002|Overall Study|Physician Decision|0|||
30764349|NCT03616964|58772985|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
30764350|NCT03616964|58772986|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
30764351|NCT03616964|58772987|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
30764352|NCT03616964|58772985|FG000|Overall Study|Protocol Violation|0|||
30764353|NCT03616964|58772986|FG001|Overall Study|Protocol Violation|1|||
30764354|NCT03616964|58772987|FG002|Overall Study|Protocol Violation|0|||
30848251|NCT02746705|58874214|FG001|Overall Study|outlier scores deemed not valid|1|||
30631111|NCT01105091|58643235|FG000|Overall Study|Death|2|||
30631112|NCT01105091|58643236|FG001|Overall Study|Death|0|||
30631113|NCT00924729|58643246|FG000|Overall Study|insufficient volume for analysis|1|||
30631114|NCT00924729|58643247|FG001|Overall Study|insufficient volume for analysis|0|||
30631115|NCT00924729|58643246|FG000|Overall Study|Protocol Violation|1|||
30631116|NCT00924729|58643247|FG001|Overall Study|Protocol Violation|0|||
30631117|NCT01099709|58643255|FG000|Period 1|Withdrawal by Subject|0|||
30950950|NCT01709305|58997951|FG004|Phase 1|Lost to Follow-up|0|||
30950951|NCT01709305|58997947|FG000|Phase 1|Travel, moving, etc.|30|||
30950952|NCT01709305|58997948|FG001|Phase 1|Travel, moving, etc.|0|||
30950953|NCT01709305|58997949|FG002|Phase 1|Travel, moving, etc.|0|||
30950954|NCT01709305|58997950|FG003|Phase 1|Travel, moving, etc.|0|||
30950955|NCT01709305|58997951|FG004|Phase 1|Travel, moving, etc.|0|||
30950956|NCT01709305|58997947|FG000|Phase 1|Physician Decision|13|||
30950957|NCT01709305|58997948|FG001|Phase 1|Physician Decision|0|||
30950958|NCT01709305|58997949|FG002|Phase 1|Physician Decision|0|||
30950959|NCT01709305|58997950|FG003|Phase 1|Physician Decision|0|||
30950960|NCT01709305|58997951|FG004|Phase 1|Physician Decision|0|||
30950961|NCT01709305|58997947|FG000|Phase 1|Protocol Violation|118|||
30950962|NCT01709305|58997948|FG001|Phase 1|Protocol Violation|0|||
30950963|NCT01709305|58997949|FG002|Phase 1|Protocol Violation|0|||
30950964|NCT01709305|58997950|FG003|Phase 1|Protocol Violation|0|||
30950965|NCT01709305|58997951|FG004|Phase 1|Protocol Violation|0|||
30950966|NCT01709305|58997947|FG000|Phase 1|Withdrawal by Subject|218|||
30950967|NCT01709305|58997948|FG001|Phase 1|Withdrawal by Subject|0|||
30950968|NCT01709305|58997949|FG002|Phase 1|Withdrawal by Subject|0|||
30950969|NCT01709305|58997950|FG003|Phase 1|Withdrawal by Subject|0|||
30950970|NCT01709305|58997951|FG004|Phase 1|Withdrawal by Subject|0|||
30950971|NCT01709305|58997947|FG000|Phase 2|Clinical Adverse Event|0|||
30950972|NCT01709305|58997948|FG001|Phase 2|Clinical Adverse Event|10|||
30950973|NCT01709305|58997949|FG002|Phase 2|Clinical Adverse Event|10|||
30950974|NCT01709305|58997950|FG003|Phase 2|Clinical Adverse Event|6|||
30950975|NCT01709305|58997951|FG004|Phase 2|Clinical Adverse Event|11|||
30950976|NCT01709305|58997947|FG000|Phase 2|Death|0|||
30950977|NCT01709305|58997948|FG001|Phase 2|Death|0|||
30950978|NCT01709305|58997949|FG002|Phase 2|Death|1|||
30950979|NCT01709305|58997950|FG003|Phase 2|Death|0|||
30950980|NCT01709305|58997951|FG004|Phase 2|Death|0|||
30950981|NCT01709305|58997947|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
30950982|NCT01709305|58997948|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
30950983|NCT01709305|58997949|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
30950984|NCT01709305|58997950|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
30950985|NCT01709305|58997951|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
30950986|NCT01709305|58997947|FG000|Phase 2|Laboratory Adverse Event|0|||
30950987|NCT01709305|58997948|FG001|Phase 2|Laboratory Adverse Event|1|||
30950988|NCT01709305|58997949|FG002|Phase 2|Laboratory Adverse Event|0|||
30950989|NCT01709305|58997950|FG003|Phase 2|Laboratory Adverse Event|1|||
30950990|NCT01709305|58997951|FG004|Phase 2|Laboratory Adverse Event|1|||
30950991|NCT01709305|58997947|FG000|Phase 2|Lost to Follow-up|0|||
30950992|NCT01709305|58997948|FG001|Phase 2|Lost to Follow-up|10|||
30950993|NCT01709305|58997949|FG002|Phase 2|Lost to Follow-up|6|||
30950994|NCT01709305|58997950|FG003|Phase 2|Lost to Follow-up|9|||
30950995|NCT01709305|58997951|FG004|Phase 2|Lost to Follow-up|5|||
30950996|NCT01709305|58997947|FG000|Phase 2|Travel, moving, etc.|0|||
30950997|NCT01709305|58997948|FG001|Phase 2|Travel, moving, etc.|2|||
30950998|NCT01709305|58997949|FG002|Phase 2|Travel, moving, etc.|3|||
30631118|NCT01099709|58643256|FG001|Period 1|Withdrawal by Subject|1|||
30950999|NCT01709305|58997950|FG003|Phase 2|Travel, moving, etc.|3|||
30951000|NCT01709305|58997951|FG004|Phase 2|Travel, moving, etc.|5|||
30951001|NCT01709305|58997947|FG000|Phase 2|Physician Decision|0|||
30951002|NCT01709305|58997948|FG001|Phase 2|Physician Decision|2|||
30951003|NCT01709305|58997949|FG002|Phase 2|Physician Decision|0|||
30951004|NCT01709305|58997950|FG003|Phase 2|Physician Decision|1|||
30951005|NCT01709305|58997951|FG004|Phase 2|Physician Decision|2|||
30951006|NCT01709305|58997947|FG000|Phase 2|Protocol Violation|0|||
30951007|NCT01709305|58997948|FG001|Phase 2|Protocol Violation|19|||
30951008|NCT01709305|58997949|FG002|Phase 2|Protocol Violation|19|||
30951009|NCT01709305|58997950|FG003|Phase 2|Protocol Violation|13|||
30951010|NCT01709305|58997951|FG004|Phase 2|Protocol Violation|9|||
30951011|NCT01709305|58997947|FG000|Phase 2|Withdrawal by Subject|0|||
30951012|NCT01709305|58997948|FG001|Phase 2|Withdrawal by Subject|8|||
30951013|NCT01709305|58997949|FG002|Phase 2|Withdrawal by Subject|6|||
30951014|NCT01709305|58997950|FG003|Phase 2|Withdrawal by Subject|15|||
30951015|NCT01709305|58997951|FG004|Phase 2|Withdrawal by Subject|12|||
30951016|NCT01684423|58997971|FG000|Overall Study|Withdrawal by Subject|0|||
30951017|NCT01684423|58997972|FG001|Overall Study|Withdrawal by Subject|0|||
30951018|NCT01684423|58997973|FG002|Overall Study|Withdrawal by Subject|1|||
30951019|NCT01684423|58997974|FG003|Overall Study|Withdrawal by Subject|0|||
30951020|NCT01684423|58997975|FG004|Overall Study|Withdrawal by Subject|0|||
30951021|NCT01709227|58997991|FG000|Overall Study|Physician Decision|1|||
30951022|NCT01709227|58997992|FG001|Overall Study|Physician Decision|0|||
30951023|NCT01709227|58997991|FG000|Overall Study|Pleural Peritoneal communication|0|||
30951024|NCT01709227|58997992|FG001|Overall Study|Pleural Peritoneal communication|9|||
30951025|NCT01684033|58997999|FG000|Period 1, First 30 Days|Adverse Event|1|||
30951026|NCT01684033|58998000|FG001|Period 1, First 30 Days|Adverse Event|1|||
30951027|NCT01684033|58997999|FG000|Period 1, First 30 Days|Noncompliance|1|||
30951028|NCT01684033|58998000|FG001|Period 1, First 30 Days|Noncompliance|0|||
30631119|NCT01099709|58643255|FG000|Period 1|Positive cotinine test|0|||
30631120|NCT01099709|58643256|FG001|Period 1|Positive cotinine test|1|||
30631121|NCT01099709|58643255|FG000|Period 1|Adverse Event|1|||
30631122|NCT01099709|58643256|FG001|Period 1|Adverse Event|0|||
30631123|NCT01099397|58643263|FG000|Overall Study|Lost to Follow-up|4|||
30631124|NCT01099397|58643263|FG000|Overall Study|Protocol Violation|4|||
30631125|NCT01099397|58643263|FG000|Overall Study|Withdrawal by Subject|5|||
30631126|NCT01022424|58643268|FG000|Overall Study|Adverse Event|1|||
30631127|NCT01022424|58643268|FG000|Overall Study|Physician Decision|1|||
30631128|NCT01022424|58643268|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
30631129|NCT01098851|58643278|FG000|Overall Study|Equipment failure|1|||
30631130|NCT01098851|58643279|FG001|Overall Study|Equipment failure|0|||
30631131|NCT01026948|58643285|FG000|Overall Study|Physician Decision|8|||
30631132|NCT01104779|58643293|FG000|Overall Study|Protocol Violation|1|||
30631133|NCT01104779|58643294|FG001|Overall Study|Protocol Violation|2|||
30631134|NCT01104779|58643295|FG002|Overall Study|Protocol Violation|2|||
30631135|NCT01104779|58643293|FG000|Overall Study|Lack of Efficacy|26|||
30631136|NCT01104779|58643294|FG001|Overall Study|Lack of Efficacy|12|||
30631137|NCT01104779|58643295|FG002|Overall Study|Lack of Efficacy|13|||
30631138|NCT01104779|58643293|FG000|Overall Study|Adverse Event|13|||
30631139|NCT01104779|58643294|FG001|Overall Study|Adverse Event|14|||
30631140|NCT01104779|58643295|FG002|Overall Study|Adverse Event|13|||
30631141|NCT01104779|58643293|FG000|Overall Study|Did not meet inc/exc criteria|1|||
30631142|NCT01104779|58643294|FG001|Overall Study|Did not meet inc/exc criteria|1|||
30631143|NCT01104779|58643295|FG002|Overall Study|Did not meet inc/exc criteria|1|||
30631144|NCT01104779|58643293|FG000|Overall Study|Other reasons|0|||
30631145|NCT01104779|58643294|FG001|Overall Study|Other reasons|1|||
30631146|NCT01104779|58643295|FG002|Overall Study|Other reasons|0|||
30631147|NCT01104779|58643293|FG000|Overall Study|Lost to Follow-up|2|||
30631148|NCT01104779|58643294|FG001|Overall Study|Lost to Follow-up|0|||
30631149|NCT01104779|58643295|FG002|Overall Study|Lost to Follow-up|1|||
30631150|NCT01104779|58643293|FG000|Overall Study|Withdrawal by Subject|16|||
30631151|NCT01104779|58643294|FG001|Overall Study|Withdrawal by Subject|25|||
30631152|NCT01104779|58643295|FG002|Overall Study|Withdrawal by Subject|32|||
30631153|NCT00918957|58643305|FG000|Overall Study|Adverse Event|2|||
30631154|NCT00918957|58643306|FG001|Overall Study|Adverse Event|0|||
30631155|NCT00918957|58643305|FG000|Overall Study|Withdrawal by Subject|1|||
30631156|NCT00918957|58643306|FG001|Overall Study|Withdrawal by Subject|0|||
30631157|NCT01022268|58643314|FG000|Overall Study|Withdrawal by Subject|1|||
30631158|NCT01022268|58643315|FG001|Overall Study|Withdrawal by Subject|0|||
30631159|NCT01022268|58643314|FG000|Overall Study|Withdrawal by Subject|1|||
30631160|NCT01022268|58643315|FG001|Overall Study|Withdrawal by Subject|0|||
30631161|NCT01015560|58643321|FG000|Overall Study|Adverse Event|1|||
30631162|NCT01015560|58643321|FG000|Overall Study|Not protocol specified|1|||
30631163|NCT01015560|58643321|FG000|Overall Study|Withdrawal by Subject|1|||
30631164|NCT00918879|58643327|FG000|Overall Study|Withdrawal by Subject|4|||
30631165|NCT00918879|58643328|FG001|Overall Study|Withdrawal by Subject|4|||
30631166|NCT00918879|58643327|FG000|Overall Study|Lost to Follow-up|1|||
30631167|NCT00918879|58643328|FG001|Overall Study|Lost to Follow-up|1|||
30631168|NCT00918879|58643327|FG000|Overall Study|Severe non-compliance to protocol|1|||
30631169|NCT00918879|58643328|FG001|Overall Study|Severe non-compliance to protocol|1|||
30631170|NCT01026792|58643334|FG000|Overall Study|Protocol Violation|1|||
30631171|NCT01026324|58643341|FG000|Follow up/Survival|Withdrawal by Subject|1|||
30631172|NCT01026324|58643342|FG001|Follow up/Survival|Withdrawal by Subject|0|||
30631173|NCT01026324|58643343|FG002|Follow up/Survival|Withdrawal by Subject|0|||
30631174|NCT01098539|58643354|FG000|Overall Study|Adverse Event|26|||
30631175|NCT01098539|58643355|FG001|Overall Study|Adverse Event|26|||
30631176|NCT01098539|58643354|FG000|Overall Study|Protocol Violation|1|||
30631177|NCT01098539|58643355|FG001|Overall Study|Protocol Violation|4|||
30631178|NCT01098539|58643354|FG000|Overall Study|Noncompliance|3|||
30631179|NCT01098539|58643355|FG001|Overall Study|Noncompliance|5|||
30631180|NCT01098539|58643354|FG000|Overall Study|Lost to Follow-up|4|||
30631181|NCT01098539|58643355|FG001|Overall Study|Lost to Follow-up|4|||
30631182|NCT01098539|58643354|FG000|Overall Study|Withdrawal by Subject|12|||
30631183|NCT01098539|58643355|FG001|Overall Study|Withdrawal by Subject|26|||
30631184|NCT01098539|58643354|FG000|Overall Study|Physician Decision|5|||
30764355|NCT03616964|58772985|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
30631185|NCT01098539|58643355|FG001|Overall Study|Physician Decision|3|||
30631186|NCT01098461|58643365|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
30631187|NCT01098461|58643366|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
30631188|NCT01098461|58643367|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
30631189|NCT01098461|58643368|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
30631190|NCT01098461|58643365|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
30631191|NCT01098461|58643366|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
30631192|NCT01098461|58643367|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
30631193|NCT01098461|58643368|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
30631194|NCT01098461|58643365|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
30631195|NCT01098461|58643366|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
30631196|NCT01098461|58643367|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
30631197|NCT01098461|58643368|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
30631198|NCT01098461|58643365|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
30631199|NCT01098461|58643366|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
30631200|NCT01098461|58643367|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
30631201|NCT01098461|58643368|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
30631202|NCT01098461|58643365|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
30631203|NCT01098461|58643366|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
30631204|NCT01098461|58643367|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
30631205|NCT01098461|58643368|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
30631206|NCT01098461|58643365|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
30631207|NCT01098461|58643366|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
30631208|NCT01098461|58643367|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
30631209|NCT01098461|58643368|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
30631210|NCT01098461|58643365|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
30631211|NCT01098461|58643366|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
30631212|NCT01098461|58643367|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
30631213|NCT01098461|58643368|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
30631214|NCT01098305|58643381|FG000|Overall Study|Lost to Follow-up|31|||
30631215|NCT01098305|58643382|FG001|Overall Study|Lost to Follow-up|33|||
30631216|NCT00833833|58643394|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
30631217|NCT00833833|58643395|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
30631218|NCT00833833|58643396|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
30631219|NCT00833833|58643397|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
30631220|NCT00833833|58643398|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
30631221|NCT00833833|58643399|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
30631222|NCT00833833|58643394|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
30631223|NCT00833833|58643395|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
30631224|NCT00833833|58643396|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
30631225|NCT00833833|58643397|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
30631226|NCT00833833|58643398|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
30631227|NCT00833833|58643399|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
30631228|NCT00833833|58643394|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
30631229|NCT00833833|58643395|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
30631230|NCT00833833|58643396|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
30631231|NCT00833833|58643397|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
30631232|NCT00833833|58643398|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
30631233|NCT00833833|58643399|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
30631234|NCT00833833|58643394|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
30631235|NCT00833833|58643395|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
30631236|NCT00833833|58643396|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
30631237|NCT00833833|58643397|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
30631238|NCT00833833|58643398|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
30631239|NCT00833833|58643399|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
30631240|NCT00833833|58643394|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
30631241|NCT00833833|58643395|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
30631242|NCT00833833|58643396|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
30631243|NCT00833833|58643397|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
30631244|NCT00833833|58643398|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
30631245|NCT00833833|58643399|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
30631246|NCT00833833|58643394|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
30631247|NCT00833833|58643395|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
30631248|NCT00833833|58643396|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
30631249|NCT00833833|58643397|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
30631250|NCT00833833|58643398|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
30631251|NCT00833833|58643399|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
30631252|NCT00833833|58643394|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
30631253|NCT00833833|58643395|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
30631254|NCT00833833|58643396|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
30631255|NCT00833833|58643397|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
30631256|NCT00833833|58643398|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
30631257|NCT00833833|58643399|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
30631258|NCT00833833|58643394|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
30631259|NCT00833833|58643395|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
30631260|NCT00833833|58643396|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
30631261|NCT00833833|58643397|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
30631262|NCT00833833|58643398|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
30631263|NCT00833833|58643399|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
30631264|NCT00833833|58643394|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
30631265|NCT00833833|58643395|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
30631266|NCT00833833|58643396|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
30631267|NCT00833833|58643397|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
30631268|NCT00833833|58643398|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
30631269|NCT00833833|58643399|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
30631270|NCT00833833|58643394|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
30631271|NCT00833833|58643395|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
30631272|NCT00833833|58643396|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
30631273|NCT00833833|58643397|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
30631274|NCT00833833|58643398|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
30631275|NCT00833833|58643399|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
30631276|NCT00833833|58643394|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
30631277|NCT00833833|58643395|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
30631278|NCT00833833|58643396|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
30631279|NCT00833833|58643397|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
30631280|NCT00833833|58643398|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
30631281|NCT00833833|58643399|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
30631282|NCT00833833|58643394|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
30631283|NCT00833833|58643395|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
30631284|NCT00833833|58643396|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
30631285|NCT00833833|58643397|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
30631286|NCT00833833|58643398|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
30631287|NCT00833833|58643399|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
30631288|NCT00833833|58643394|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
30631289|NCT00833833|58643395|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
30631290|NCT00833833|58643396|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
30631291|NCT00833833|58643397|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
30631292|NCT00833833|58643398|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
30951029|NCT01684033|58997999|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
30631293|NCT00833833|58643399|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
30631294|NCT01098071|58643419|FG000|Overall Study|Surgery (adenoidectomy)|2|||
30631295|NCT01098071|58643419|FG000|Overall Study|Lost to Follow-up|13|||
30631296|NCT01097057|58643423|FG000|Overall Study|Physician Decision|3|||
30631297|NCT01022112|58643432|FG000|Overall Study|Adverse Event|1|||
30631298|NCT01022112|58643433|FG001|Overall Study|Adverse Event|2|||
30631299|NCT01022112|58643434|FG002|Overall Study|Adverse Event|0|||
30631300|NCT01022112|58643435|FG003|Overall Study|Adverse Event|1|||
30631301|NCT01022112|58643436|FG004|Overall Study|Adverse Event|0|||
30631302|NCT01022112|58643432|FG000|Overall Study|Lack of Efficacy|1|||
30631303|NCT01022112|58643433|FG001|Overall Study|Lack of Efficacy|0|||
30631304|NCT01022112|58643434|FG002|Overall Study|Lack of Efficacy|0|||
30631305|NCT01022112|58643435|FG003|Overall Study|Lack of Efficacy|0|||
30631306|NCT01022112|58643436|FG004|Overall Study|Lack of Efficacy|1|||
30631307|NCT01022112|58643432|FG000|Overall Study|Physician Decision|0|||
30631308|NCT01022112|58643433|FG001|Overall Study|Physician Decision|0|||
30631309|NCT01022112|58643434|FG002|Overall Study|Physician Decision|1|||
30631310|NCT01022112|58643435|FG003|Overall Study|Physician Decision|0|||
30631311|NCT01022112|58643436|FG004|Overall Study|Physician Decision|1|||
30631312|NCT01022112|58643432|FG000|Overall Study|Withdrawal by Subject|0|||
30631313|NCT01022112|58643433|FG001|Overall Study|Withdrawal by Subject|1|||
30631314|NCT01022112|58643434|FG002|Overall Study|Withdrawal by Subject|2|||
30631315|NCT01022112|58643435|FG003|Overall Study|Withdrawal by Subject|2|||
30631316|NCT01022112|58643436|FG004|Overall Study|Withdrawal by Subject|1|||
30631317|NCT01022112|58643432|FG000|Overall Study|Fasting plasma glucose level increased|1|||
30631318|NCT01022112|58643433|FG001|Overall Study|Fasting plasma glucose level increased|0|||
30631319|NCT01022112|58643434|FG002|Overall Study|Fasting plasma glucose level increased|0|||
30631320|NCT01022112|58643435|FG003|Overall Study|Fasting plasma glucose level increased|0|||
30631321|NCT01022112|58643436|FG004|Overall Study|Fasting plasma glucose level increased|7|||
30631322|NCT01096667|58643453|FG000|Overall Study|Lost to Follow-up|1|||
30631323|NCT01096667|58643454|FG001|Overall Study|Lost to Follow-up|1|||
30631324|NCT01096667|58643455|FG002|Overall Study|Lost to Follow-up|1|||
30631325|NCT01096667|58643456|FG003|Overall Study|Lost to Follow-up|0|||
30631326|NCT01096667|58643457|FG004|Overall Study|Lost to Follow-up|0|||
30631327|NCT01096667|58643453|FG000|Overall Study|Withdrawal by Subject|1|||
30631328|NCT01096667|58643454|FG001|Overall Study|Withdrawal by Subject|0|||
30631329|NCT01096667|58643455|FG002|Overall Study|Withdrawal by Subject|0|||
30631330|NCT01096667|58643456|FG003|Overall Study|Withdrawal by Subject|1|||
30631331|NCT01096667|58643457|FG004|Overall Study|Withdrawal by Subject|0|||
30631332|NCT01096667|58643453|FG000|Overall Study|Reason not available|0|||
30631333|NCT01096667|58643454|FG001|Overall Study|Reason not available|1|||
30631334|NCT01096667|58643455|FG002|Overall Study|Reason not available|1|||
30631335|NCT01096667|58643456|FG003|Overall Study|Reason not available|1|||
30631336|NCT01096667|58643457|FG004|Overall Study|Reason not available|0|||
30631337|NCT01096667|58643453|FG000|Overall Study|Protocol Violation|0|||
30631338|NCT01096667|58643454|FG001|Overall Study|Protocol Violation|0|||
30631339|NCT01096667|58643455|FG002|Overall Study|Protocol Violation|0|||
30631340|NCT01096667|58643456|FG003|Overall Study|Protocol Violation|1|||
30631341|NCT01096667|58643457|FG004|Overall Study|Protocol Violation|0|||
30631342|NCT01096667|58643453|FG000|Overall Study|Not treated|1|||
30631343|NCT01096667|58643454|FG001|Overall Study|Not treated|0|||
30631344|NCT01096667|58643455|FG002|Overall Study|Not treated|0|||
30631345|NCT01096667|58643456|FG003|Overall Study|Not treated|0|||
30631346|NCT01096667|58643457|FG004|Overall Study|Not treated|0|||
30631347|NCT01014624|58643472|FG000|Overall Study|Adverse Event|0|||
30631348|NCT01014624|58643473|FG001|Overall Study|Adverse Event|1|||
30631349|NCT01014624|58643472|FG000|Overall Study|Protocol Violation|1|||
30631350|NCT01014624|58643473|FG001|Overall Study|Protocol Violation|0|||
30631351|NCT01014624|58643472|FG000|Overall Study|Withdrawal by Subject|1|||
30631352|NCT01014624|58643473|FG001|Overall Study|Withdrawal by Subject|0|||
30631353|NCT01021878|58643483|FG000|Overall Study|Lost to Follow-up|4|||
30631354|NCT01021878|58643484|FG001|Overall Study|Lost to Follow-up|3|||
30631355|NCT01021878|58643483|FG000|Overall Study|Death|0|||
30631356|NCT01021878|58643484|FG001|Overall Study|Death|1|||
30631357|NCT01021878|58643483|FG000|Overall Study|Adverse Event|6|||
30631358|NCT01021878|58643484|FG001|Overall Study|Adverse Event|5|||
30631359|NCT01021878|58643483|FG000|Overall Study|Transplantation|6|||
30631360|NCT01021878|58643484|FG001|Overall Study|Transplantation|1|||
30631361|NCT00854113|58643504|FG000|Overall Study|Adverse Event|0|||
30631362|NCT00854113|58643505|FG001|Overall Study|Adverse Event|0|||
30631363|NCT00854113|58643506|FG002|Overall Study|Adverse Event|0|||
30631364|NCT00854113|58643507|FG003|Overall Study|Adverse Event|0|||
30631365|NCT00854113|58643508|FG004|Overall Study|Adverse Event|0|||
30631366|NCT00854113|58643509|FG005|Overall Study|Adverse Event|0|||
30631367|NCT00854113|58643510|FG006|Overall Study|Adverse Event|0|||
30631368|NCT00854113|58643511|FG007|Overall Study|Adverse Event|2|||
30631369|NCT00854113|58643512|FG008|Overall Study|Adverse Event|0|||
30631370|NCT00854113|58643513|FG009|Overall Study|Adverse Event|0|||
30631371|NCT00854113|58643514|FG010|Overall Study|Adverse Event|0|||
30631372|NCT00854113|58643504|FG000|Overall Study|Withdrawal by Subject|0|||
30631373|NCT00854113|58643505|FG001|Overall Study|Withdrawal by Subject|0|||
30631374|NCT00854113|58643506|FG002|Overall Study|Withdrawal by Subject|0|||
30631375|NCT00854113|58643507|FG003|Overall Study|Withdrawal by Subject|0|||
30631376|NCT00854113|58643508|FG004|Overall Study|Withdrawal by Subject|0|||
30631377|NCT00854113|58643509|FG005|Overall Study|Withdrawal by Subject|0|||
30631378|NCT00854113|58643510|FG006|Overall Study|Withdrawal by Subject|0|||
30631379|NCT00854113|58643511|FG007|Overall Study|Withdrawal by Subject|1|||
30631380|NCT00854113|58643512|FG008|Overall Study|Withdrawal by Subject|1|||
30631381|NCT00854113|58643513|FG009|Overall Study|Withdrawal by Subject|0|||
30631382|NCT00854113|58643514|FG010|Overall Study|Withdrawal by Subject|0|||
30631383|NCT00845845|58643540|FG000|Overall Study|Lost to Follow-up|0|||
30631384|NCT00845845|58643541|FG001|Overall Study|Lost to Follow-up|4|||
30631385|NCT01104701|58643551|FG000|Overall Study|Withdrawal by Subject|0|||
30631386|NCT01104701|58643552|FG001|Overall Study|Withdrawal by Subject|1|||
30631387|NCT01104701|58643553|FG002|Overall Study|Withdrawal by Subject|2|||
30631388|NCT01104701|58643554|FG003|Overall Study|Withdrawal by Subject|1|||
30631389|NCT01104701|58643551|FG000|Overall Study|Adverse Event|0|||
30631390|NCT01104701|58643552|FG001|Overall Study|Adverse Event|0|||
30631391|NCT01104701|58643553|FG002|Overall Study|Adverse Event|0|||
30631392|NCT01104701|58643554|FG003|Overall Study|Adverse Event|1|||
30631393|NCT01104701|58643551|FG000|Overall Study|Physician Decision|0|||
30764356|NCT03616964|58772986|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
30764357|NCT03616964|58772987|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
30764358|NCT03616964|58772985|FG000|Overall Study|Randomized but Never Treated|1|||
30764359|NCT03616964|58772986|FG001|Overall Study|Randomized but Never Treated|1|||
30764360|NCT03616964|58772987|FG002|Overall Study|Randomized but Never Treated|1|||
30631394|NCT01104701|58643552|FG001|Overall Study|Physician Decision|2|||
30631395|NCT01104701|58643553|FG002|Overall Study|Physician Decision|0|||
30631396|NCT01104701|58643554|FG003|Overall Study|Physician Decision|0|||
30631397|NCT00833755|58643568|FG000|Overall Study|Physician Decision|4|||
30631398|NCT00833755|58643569|FG001|Overall Study|Physician Decision|4|||
30631399|NCT00833755|58643570|FG002|Overall Study|Physician Decision|2|||
30631400|NCT00833755|58643571|FG003|Overall Study|Physician Decision|6|||
30631401|NCT00833755|58643568|FG000|Overall Study|Subject had scheduling issues|0|||
30631402|NCT00833755|58643569|FG001|Overall Study|Subject had scheduling issues|1|||
30631403|NCT00833755|58643570|FG002|Overall Study|Subject had scheduling issues|0|||
30631404|NCT00833755|58643571|FG003|Overall Study|Subject had scheduling issues|0|||
30631405|NCT01021332|58643582|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
30631406|NCT01021332|58643582|FG000|Overall Study|Adverse Event|43|||
30631407|NCT01021332|58643582|FG000|Overall Study|Lack of Efficacy|19|||
30631408|NCT01021332|58643582|FG000|Overall Study|Withdrawal of Consent|23|||
30631409|NCT01021332|58643582|FG000|Overall Study|Lost to Follow-up|4|||
30631410|NCT01021332|58643582|FG000|Overall Study|Protocol Violation|9|||
30631411|NCT01021332|58643582|FG000|Overall Study|Miscellaneous|3|||
30631412|NCT00923091|58643596|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
30631413|NCT00923091|58643597|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
30631414|NCT00923091|58643598|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
30631415|NCT00923091|58643599|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
30631416|NCT00923091|58643600|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
30631417|NCT00923091|58643601|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
30631418|NCT00923091|58643602|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
30631419|NCT00923091|58643603|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
30631420|NCT00923091|58643604|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
30631421|NCT00923091|58643605|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
30631422|NCT00923091|58643606|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
30764361|NCT00350519|58772999|FG000|Overall Study|Death|0|||
30631423|NCT00923091|58643607|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
30631424|NCT00923091|58643608|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
30631425|NCT00923091|58643596|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
30631426|NCT00923091|58643597|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
30631427|NCT00923091|58643598|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
30631428|NCT00923091|58643599|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
30631429|NCT00923091|58643600|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
30631430|NCT00923091|58643601|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
30631431|NCT00923091|58643602|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
30631432|NCT00923091|58643603|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
30631433|NCT00923091|58643604|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
30631434|NCT00923091|58643605|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
30631435|NCT00923091|58643606|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
30631436|NCT00923091|58643607|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
30631437|NCT00923091|58643608|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
30631438|NCT00923091|58643596|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
30631439|NCT00923091|58643597|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
30631440|NCT00923091|58643598|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
30631441|NCT00923091|58643599|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
30631442|NCT00923091|58643600|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
30631443|NCT00923091|58643601|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
30631444|NCT00923091|58643602|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
30631445|NCT00923091|58643603|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
30631446|NCT00923091|58643604|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
30631447|NCT00923091|58643605|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
30631448|NCT00923091|58643606|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
30631449|NCT00923091|58643607|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
30631450|NCT00923091|58643608|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
30631451|NCT00923091|58643596|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631452|NCT00923091|58643597|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631453|NCT00923091|58643598|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631454|NCT00923091|58643599|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631455|NCT00923091|58643600|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631456|NCT00923091|58643601|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
30631457|NCT00923091|58643602|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631458|NCT00923091|58643603|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631459|NCT00923091|58643604|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631460|NCT00923091|58643605|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631461|NCT00923091|58643606|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631462|NCT00923091|58643607|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631463|NCT00923091|58643608|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
30631464|NCT00923091|58643596|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
30631465|NCT00923091|58643597|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
30631466|NCT00923091|58643598|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
30631467|NCT00923091|58643599|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
30631468|NCT00923091|58643600|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
30631469|NCT00923091|58643601|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
30631470|NCT00923091|58643602|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
30631471|NCT00923091|58643603|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
30631472|NCT00923091|58643604|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
30631473|NCT00923091|58643605|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
30631474|NCT00923091|58643606|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
30631475|NCT00923091|58643607|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
30764362|NCT00350519|58773000|FG001|Overall Study|Death|1|||
30764363|NCT00350519|58772999|FG000|Overall Study|Physician Decision|0|||
30848252|NCT02746627|58874223|FG000|Overall Study|Withdrawal by Subject|1|||
30631476|NCT00923091|58643608|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
30631477|NCT00923091|58643596|FG000|Period III (Single-Blind)|Adverse Event|5|||
30631478|NCT00923091|58643597|FG001|Period III (Single-Blind)|Adverse Event|0|||
30631479|NCT00923091|58643598|FG002|Period III (Single-Blind)|Adverse Event|0|||
30631480|NCT00923091|58643599|FG003|Period III (Single-Blind)|Adverse Event|0|||
30631481|NCT00923091|58643600|FG004|Period III (Single-Blind)|Adverse Event|0|||
30631482|NCT00923091|58643601|FG005|Period III (Single-Blind)|Adverse Event|0|||
30631483|NCT00923091|58643602|FG006|Period III (Single-Blind)|Adverse Event|0|||
30631484|NCT00923091|58643603|FG007|Period III (Single-Blind)|Adverse Event|0|||
30631485|NCT00923091|58643604|FG008|Period III (Single-Blind)|Adverse Event|0|||
30631486|NCT00923091|58643605|FG009|Period III (Single-Blind)|Adverse Event|0|||
30631487|NCT00923091|58643606|FG010|Period III (Single-Blind)|Adverse Event|0|||
30631488|NCT00923091|58643607|FG011|Period III (Single-Blind)|Adverse Event|0|||
30631489|NCT00923091|58643608|FG012|Period III (Single-Blind)|Adverse Event|0|||
30631490|NCT00923091|58643596|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
30631491|NCT00923091|58643597|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631492|NCT00923091|58643598|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631493|NCT00923091|58643599|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631494|NCT00923091|58643600|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631495|NCT00923091|58643601|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631496|NCT00923091|58643602|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631497|NCT00923091|58643603|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631498|NCT00923091|58643604|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631499|NCT00923091|58643605|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631500|NCT00923091|58643606|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631501|NCT00923091|58643607|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631502|NCT00923091|58643608|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
30631503|NCT00923091|58643596|FG000|Period III (Single-Blind)|Protocol Violation|3|||
30631504|NCT00923091|58643597|FG001|Period III (Single-Blind)|Protocol Violation|0|||
30631505|NCT00923091|58643598|FG002|Period III (Single-Blind)|Protocol Violation|0|||
30631506|NCT00923091|58643599|FG003|Period III (Single-Blind)|Protocol Violation|0|||
30631507|NCT00923091|58643600|FG004|Period III (Single-Blind)|Protocol Violation|0|||
30631508|NCT00923091|58643601|FG005|Period III (Single-Blind)|Protocol Violation|0|||
30631509|NCT00923091|58643602|FG006|Period III (Single-Blind)|Protocol Violation|0|||
30631510|NCT00923091|58643603|FG007|Period III (Single-Blind)|Protocol Violation|0|||
30631511|NCT00923091|58643604|FG008|Period III (Single-Blind)|Protocol Violation|0|||
30631512|NCT00923091|58643605|FG009|Period III (Single-Blind)|Protocol Violation|0|||
30631513|NCT00923091|58643606|FG010|Period III (Single-Blind)|Protocol Violation|0|||
30631514|NCT00923091|58643607|FG011|Period III (Single-Blind)|Protocol Violation|0|||
30631515|NCT00923091|58643608|FG012|Period III (Single-Blind)|Protocol Violation|0|||
30631516|NCT00923091|58643596|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
30631517|NCT00923091|58643597|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
30631518|NCT00923091|58643598|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
30631519|NCT00923091|58643599|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
30631520|NCT00923091|58643600|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
30631521|NCT00923091|58643601|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
30631522|NCT00923091|58643602|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
30631523|NCT00923091|58643603|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
30631524|NCT00923091|58643604|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
30631525|NCT00923091|58643605|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
30631526|NCT00923091|58643606|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
30631527|NCT00923091|58643607|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
30631528|NCT00923091|58643608|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
30631529|NCT00923091|58643596|FG000|Period IV (Double-Blind)|Adverse Event|2|||
30631530|NCT00923091|58643597|FG001|Period IV (Double-Blind)|Adverse Event|0|||
30631531|NCT00923091|58643598|FG002|Period IV (Double-Blind)|Adverse Event|0|||
30631532|NCT00923091|58643599|FG003|Period IV (Double-Blind)|Adverse Event|0|||
30631533|NCT00923091|58643600|FG004|Period IV (Double-Blind)|Adverse Event|0|||
30631534|NCT00923091|58643601|FG005|Period IV (Double-Blind)|Adverse Event|0|||
30631535|NCT00923091|58643602|FG006|Period IV (Double-Blind)|Adverse Event|0|||
30631536|NCT00923091|58643603|FG007|Period IV (Double-Blind)|Adverse Event|0|||
30631537|NCT00923091|58643604|FG008|Period IV (Double-Blind)|Adverse Event|0|||
30631538|NCT00923091|58643605|FG009|Period IV (Double-Blind)|Adverse Event|0|||
30631539|NCT00923091|58643606|FG010|Period IV (Double-Blind)|Adverse Event|0|||
30631540|NCT00923091|58643607|FG011|Period IV (Double-Blind)|Adverse Event|0|||
30631541|NCT00923091|58643608|FG012|Period IV (Double-Blind)|Adverse Event|0|||
30631542|NCT00923091|58643596|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30631543|NCT00923091|58643597|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
30631544|NCT00923091|58643598|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30631545|NCT00923091|58643599|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30631546|NCT00923091|58643600|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30631547|NCT00923091|58643601|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30631548|NCT00923091|58643602|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30631549|NCT00923091|58643603|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30631550|NCT00923091|58643604|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30631551|NCT00923091|58643605|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30631552|NCT00923091|58643606|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30764364|NCT00350519|58773000|FG001|Overall Study|Physician Decision|1|||
30631553|NCT00923091|58643607|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30631554|NCT00923091|58643608|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
30631555|NCT00923091|58643596|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
30631556|NCT00923091|58643597|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
30631557|NCT00923091|58643598|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
30631558|NCT00923091|58643599|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
30631559|NCT00923091|58643600|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
30631560|NCT00923091|58643601|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
30631561|NCT00923091|58643602|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
30631562|NCT00923091|58643603|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
30631563|NCT00923091|58643604|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
30631564|NCT00923091|58643605|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
30631565|NCT00923091|58643606|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
30631566|NCT00923091|58643607|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
30631567|NCT00923091|58643608|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
30631568|NCT00923091|58643596|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
30631569|NCT00923091|58643597|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
30631570|NCT00923091|58643598|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
30631571|NCT00923091|58643599|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
30631572|NCT00923091|58643600|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
30631573|NCT00923091|58643601|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
30631574|NCT00923091|58643602|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
30631575|NCT00923091|58643603|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
30631576|NCT00923091|58643604|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
30631577|NCT00923091|58643605|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
30631578|NCT00923091|58643606|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
30631579|NCT00923091|58643607|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
30631580|NCT00923091|58643608|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
30631581|NCT00923091|58643596|FG000|Period V (Double -Blind)|Protocol Violation|0|||
30631582|NCT00923091|58643597|FG001|Period V (Double -Blind)|Protocol Violation|0|||
30631583|NCT00923091|58643598|FG002|Period V (Double -Blind)|Protocol Violation|0|||
30631584|NCT00923091|58643599|FG003|Period V (Double -Blind)|Protocol Violation|0|||
30631585|NCT00923091|58643600|FG004|Period V (Double -Blind)|Protocol Violation|0|||
30631586|NCT00923091|58643601|FG005|Period V (Double -Blind)|Protocol Violation|0|||
30631587|NCT00923091|58643602|FG006|Period V (Double -Blind)|Protocol Violation|0|||
30631588|NCT00923091|58643603|FG007|Period V (Double -Blind)|Protocol Violation|0|||
30631589|NCT00923091|58643604|FG008|Period V (Double -Blind)|Protocol Violation|0|||
30631590|NCT00923091|58643605|FG009|Period V (Double -Blind)|Protocol Violation|0|||
30631591|NCT00923091|58643606|FG010|Period V (Double -Blind)|Protocol Violation|0|||
30631592|NCT00923091|58643607|FG011|Period V (Double -Blind)|Protocol Violation|0|||
30631593|NCT00923091|58643608|FG012|Period V (Double -Blind)|Protocol Violation|1|||
30631594|NCT00923091|58643596|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
30631595|NCT00923091|58643597|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
30631596|NCT00923091|58643598|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
30631597|NCT00923091|58643599|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
30631598|NCT00923091|58643600|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
30631599|NCT00923091|58643601|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
30631600|NCT00923091|58643602|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
30631601|NCT00923091|58643603|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
30631602|NCT00923091|58643604|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
30631603|NCT00923091|58643605|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
30631604|NCT00923091|58643606|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
30631605|NCT00923091|58643607|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
30631606|NCT00923091|58643608|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
30631607|NCT00923091|58643596|FG000|Period VI (Open-Label)|Adverse Event|17|||
30631608|NCT00923091|58643597|FG001|Period VI (Open-Label)|Adverse Event|0|||
30631609|NCT00923091|58643598|FG002|Period VI (Open-Label)|Adverse Event|4|||
30631610|NCT00923091|58643599|FG003|Period VI (Open-Label)|Adverse Event|1|||
30631611|NCT00923091|58643600|FG004|Period VI (Open-Label)|Adverse Event|1|||
30631612|NCT00923091|58643601|FG005|Period VI (Open-Label)|Adverse Event|0|||
30631613|NCT00923091|58643602|FG006|Period VI (Open-Label)|Adverse Event|0|||
30631614|NCT00923091|58643603|FG007|Period VI (Open-Label)|Adverse Event|0|||
30631615|NCT00923091|58643604|FG008|Period VI (Open-Label)|Adverse Event|0|||
30631616|NCT00923091|58643605|FG009|Period VI (Open-Label)|Adverse Event|0|||
30631617|NCT00923091|58643606|FG010|Period VI (Open-Label)|Adverse Event|0|||
30631618|NCT00923091|58643607|FG011|Period VI (Open-Label)|Adverse Event|0|||
30631619|NCT00923091|58643608|FG012|Period VI (Open-Label)|Adverse Event|0|||
30631620|NCT00923091|58643596|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
30631621|NCT00923091|58643597|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
30631622|NCT00923091|58643598|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
30631623|NCT00923091|58643599|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
30631624|NCT00923091|58643600|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
30631625|NCT00923091|58643601|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
30631626|NCT00923091|58643602|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
30631627|NCT00923091|58643603|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
30631628|NCT00923091|58643604|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
30631629|NCT00923091|58643605|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
30631630|NCT00923091|58643606|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
30631631|NCT00923091|58643607|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
30631632|NCT00923091|58643608|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
30631633|NCT00923091|58643596|FG000|Period VI (Open-Label)|Protocol Violation|6|||
30631634|NCT00923091|58643597|FG001|Period VI (Open-Label)|Protocol Violation|1|||
30631635|NCT00923091|58643598|FG002|Period VI (Open-Label)|Protocol Violation|3|||
30631636|NCT00923091|58643599|FG003|Period VI (Open-Label)|Protocol Violation|1|||
30631637|NCT00923091|58643600|FG004|Period VI (Open-Label)|Protocol Violation|4|||
30631638|NCT00923091|58643601|FG005|Period VI (Open-Label)|Protocol Violation|0|||
30631639|NCT00923091|58643602|FG006|Period VI (Open-Label)|Protocol Violation|0|||
30631640|NCT00923091|58643603|FG007|Period VI (Open-Label)|Protocol Violation|0|||
30631641|NCT00923091|58643604|FG008|Period VI (Open-Label)|Protocol Violation|0|||
30631642|NCT00923091|58643605|FG009|Period VI (Open-Label)|Protocol Violation|0|||
30631643|NCT00923091|58643606|FG010|Period VI (Open-Label)|Protocol Violation|0|||
30631644|NCT00923091|58643607|FG011|Period VI (Open-Label)|Protocol Violation|0|||
30631645|NCT00923091|58643608|FG012|Period VI (Open-Label)|Protocol Violation|0|||
30631646|NCT00923091|58643596|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
30631647|NCT00923091|58643597|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
30631648|NCT00923091|58643598|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
30631649|NCT00923091|58643599|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
30631650|NCT00923091|58643600|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
30631651|NCT00923091|58643601|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
30631652|NCT00923091|58643602|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
30631653|NCT00923091|58643603|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
30631654|NCT00923091|58643604|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
30631655|NCT00923091|58643605|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
30631656|NCT00923091|58643606|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
30631657|NCT00923091|58643607|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
30631658|NCT00923091|58643608|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
30631659|NCT00923091|58643596|FG000|Period VI (Open-Label)|Other Reason|0|||
30631660|NCT00923091|58643597|FG001|Period VI (Open-Label)|Other Reason|0|||
30631661|NCT00923091|58643598|FG002|Period VI (Open-Label)|Other Reason|0|||
30631662|NCT00923091|58643599|FG003|Period VI (Open-Label)|Other Reason|1|||
30631663|NCT00923091|58643600|FG004|Period VI (Open-Label)|Other Reason|1|||
30631664|NCT00923091|58643601|FG005|Period VI (Open-Label)|Other Reason|0|||
30631665|NCT00923091|58643602|FG006|Period VI (Open-Label)|Other Reason|0|||
30631666|NCT00923091|58643603|FG007|Period VI (Open-Label)|Other Reason|0|||
30631667|NCT00923091|58643604|FG008|Period VI (Open-Label)|Other Reason|0|||
30631668|NCT00923091|58643605|FG009|Period VI (Open-Label)|Other Reason|0|||
30631669|NCT00923091|58643606|FG010|Period VI (Open-Label)|Other Reason|0|||
30631670|NCT00923091|58643607|FG011|Period VI (Open-Label)|Other Reason|0|||
30631671|NCT00923091|58643608|FG012|Period VI (Open-Label)|Other Reason|0|||
30631672|NCT00853957|58643635|FG000|Overall Study|Adverse Event|9|||
30631673|NCT00853957|58643636|FG001|Overall Study|Adverse Event|3|||
30631674|NCT00853957|58643635|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30631675|NCT00853957|58643636|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30631676|NCT00853957|58643635|FG000|Overall Study|Subject withdrew consent|4|||
30631677|NCT00853957|58643636|FG001|Overall Study|Subject withdrew consent|5|||
30631678|NCT00853957|58643635|FG000|Overall Study|Lost to Follow-up|1|||
30631679|NCT00853957|58643636|FG001|Overall Study|Lost to Follow-up|6|||
30631680|NCT00853957|58643635|FG000|Overall Study|Protocol deviation|0|||
30631681|NCT00853957|58643636|FG001|Overall Study|Protocol deviation|3|||
30631682|NCT01021020|58643642|FG000|Period I|Protocol Violation|1|||
30631683|NCT01021020|58643642|FG000|Period I|Withdrawal by Subject|1|||
30631684|NCT01021020|58643642|FG000|14 Day Washout Period A|Physician Decision|1|||
30631685|NCT00833053|58643656|FG000|Overall Study|Adverse Event|4|||
30631686|NCT00833053|58643657|FG001|Overall Study|Adverse Event|0|||
30631687|NCT00833053|58643656|FG000|Overall Study|Treatment Failure|3|||
30631688|NCT00833053|58643657|FG001|Overall Study|Treatment Failure|1|||
30631689|NCT00833053|58643656|FG000|Overall Study|Withdrawal by Subject|0|||
30631690|NCT00833053|58643657|FG001|Overall Study|Withdrawal by Subject|1|||
30631691|NCT00833053|58643656|FG000|Overall Study|Protocol Violation|2|||
30631692|NCT00833053|58643657|FG001|Overall Study|Protocol Violation|1|||
30631693|NCT00832975|58643663|FG000|Overall Study|Lost to Follow-up|7|||
30631694|NCT00832975|58643663|FG000|Overall Study|Protocol Violation|6|||
30631695|NCT00832975|58643663|FG000|Overall Study|Death|5|||
30631696|NCT00832975|58643663|FG000|Overall Study|Physician Decision|4|||
30631697|NCT00832975|58643663|FG000|Overall Study|Withdrawal by Subject|3|||
30631698|NCT00832975|58643663|FG000|Overall Study|Other reasons|14|||
30631699|NCT01020786|58643667|FG000|Induction Period|Entry Criteria Not Met|2|||
30631700|NCT01020786|58643667|FG000|Induction Period|Adverse Event|10|||
30631701|NCT01020786|58643667|FG000|Induction Period|Progressive Disease|31|||
30631702|NCT01020786|58643667|FG000|Induction Period|Investigator Decision|3|||
30631703|NCT01020786|58643667|FG000|Induction Period|Withdrawal by Subject|3|||
30631704|NCT01020786|58643667|FG000|Maintenance Period|Adverse Event|8|||
30631705|NCT01020786|58643667|FG000|Maintenance Period|Progressive Disease|43|||
30631706|NCT01020786|58643667|FG000|Maintenance Period|Withdrawal by Subject|8|||
30631707|NCT01020786|58643667|FG000|Maintenance Period|Sponsor Decision|1|||
30631708|NCT00918645|58643672|FG000|Overall Study|Withdrawal by Subject|1|||
30631709|NCT00922935|58643679|FG000|Overall Study|Protocol Violation|0|||
30631710|NCT00922935|58643680|FG001|Overall Study|Protocol Violation|3|||
30631711|NCT00922935|58643681|FG002|Overall Study|Protocol Violation|0|||
30631712|NCT00922935|58643679|FG000|Overall Study|Physician Decision|1|||
30631713|NCT00922935|58643680|FG001|Overall Study|Physician Decision|1|||
30631714|NCT00922935|58643681|FG002|Overall Study|Physician Decision|0|||
30631715|NCT00922935|58643679|FG000|Overall Study|Lost to Follow-up|0|||
30631716|NCT00922935|58643680|FG001|Overall Study|Lost to Follow-up|1|||
30631717|NCT00922935|58643681|FG002|Overall Study|Lost to Follow-up|0|||
30631718|NCT01020474|58643691|FG000|Overall Study|Adverse Event|4|||
30631719|NCT01020474|58643692|FG001|Overall Study|Adverse Event|4|||
30631720|NCT01020474|58643691|FG000|Overall Study|Protocol Violation|0|||
30631721|NCT01020474|58643692|FG001|Overall Study|Protocol Violation|2|||
30631722|NCT01020474|58643691|FG000|Overall Study|Withdrawal by Subject|5|||
30631723|NCT01020474|58643692|FG001|Overall Study|Withdrawal by Subject|7|||
30631724|NCT01020474|58643691|FG000|Overall Study|Other Reasons|1|||
30631725|NCT01020474|58643692|FG001|Overall Study|Other Reasons|1|||
30631726|NCT01020474|58643691|FG000|Overall Study|Insufficient Clinical Response|0|||
30631727|NCT01020474|58643692|FG001|Overall Study|Insufficient Clinical Response|3|||
30631728|NCT00922779|58643698|FG000|Overall Study|Adverse Event|67|||
30631729|NCT00922779|58643698|FG000|Overall Study|Pregnancy|7|||
30631730|NCT00922779|58643698|FG000|Overall Study|Withdrawal by Subject|308|||
30631731|NCT00922779|58643698|FG000|Overall Study|Lost to Follow-up|44|||
30631732|NCT00922779|58643698|FG000|Overall Study|Other|27|||
30631733|NCT00922779|58643698|FG000|Overall Study|Missing|1874|||
30631734|NCT00924651|58643704|FG000|Overall Study|Chemo started too soon|2|||
30631735|NCT00924651|58643705|FG001|Overall Study|Chemo started too soon|3|||
30631736|NCT00924651|58643704|FG000|Overall Study|No Reason|3|||
30631737|NCT00924651|58643705|FG001|Overall Study|No Reason|7|||
30631738|NCT00924651|58643704|FG000|Overall Study|Overwhelmed|6|||
30631739|NCT00924651|58643705|FG001|Overall Study|Overwhelmed|6|||
30631740|NCT00924651|58643704|FG000|Overall Study|Noncompliant|1|||
30631741|NCT00924651|58643705|FG001|Overall Study|Noncompliant|4|||
30631742|NCT00924651|58643704|FG000|Overall Study|Medical|1|||
30631743|NCT00924651|58643705|FG001|Overall Study|Medical|3|||
30631744|NCT00924651|58643704|FG000|Overall Study|Changed Mind|10|||
30631745|NCT00924651|58643705|FG001|Overall Study|Changed Mind|1|||
30631746|NCT00924651|58643704|FG000|Overall Study|Incomplete Form|2|||
30631747|NCT00924651|58643705|FG001|Overall Study|Incomplete Form|1|||
30631748|NCT00922623|58643711|FG000|Overall Study|Other|4|||
30631749|NCT00922623|58643711|FG000|Overall Study|Lost to Follow-up|1|||
30631750|NCT01025232|58643719|FG000|Overall Study|Study drug no longer available|3|||
30631751|NCT01025232|58643720|FG001|Overall Study|Study drug no longer available|6|||
30631752|NCT01025154|58643726|FG000|Overall Study|Lost to Follow-up|1|||
30631753|NCT01025154|58643726|FG000|Overall Study|Withdrawal by Subject|1|||
30631754|NCT00832819|58643733|FG000|Overall Study|Adverse Event|0|||
30631755|NCT00832819|58643734|FG001|Overall Study|Adverse Event|1|||
30631756|NCT00832819|58643735|FG002|Overall Study|Adverse Event|0|||
30631757|NCT00832819|58643733|FG000|Overall Study|Protocol Violation|0|||
30631758|NCT00832819|58643734|FG001|Overall Study|Protocol Violation|0|||
30631759|NCT00832819|58643735|FG002|Overall Study|Protocol Violation|1|||
30631760|NCT00853723|58643744|FG000|Overall Study|Adverse Event|3|||
30631761|NCT00853723|58643745|FG001|Overall Study|Adverse Event|4|||
30631762|NCT00853723|58643746|FG002|Overall Study|Adverse Event|1|||
30631763|NCT00853723|58643744|FG000|Overall Study|Withdrawal by Subject|2|||
30631764|NCT00853723|58643745|FG001|Overall Study|Withdrawal by Subject|1|||
30631765|NCT00853723|58643746|FG002|Overall Study|Withdrawal by Subject|0|||
30631766|NCT00853723|58643744|FG000|Overall Study|Protocol Violation|1|||
30631767|NCT00853723|58643745|FG001|Overall Study|Protocol Violation|2|||
30631768|NCT00853723|58643746|FG002|Overall Study|Protocol Violation|1|||
30631769|NCT01104545|58643760|FG000|Overall Study|Adverse Event|0|||
30631770|NCT01104545|58643761|FG001|Overall Study|Adverse Event|1|||
30631771|NCT01104545|58643762|FG002|Overall Study|Adverse Event|2|||
30631772|NCT00918255|58643810|FG000|Overall Study|Adverse Event|1|||
30631773|NCT00918255|58643811|FG001|Overall Study|Adverse Event|0|||
30631774|NCT00918255|58643812|FG002|Overall Study|Adverse Event|0|||
30631775|NCT00918255|58643810|FG000|Overall Study|Withdrawal by Subject|1|||
30631776|NCT00918255|58643811|FG001|Overall Study|Withdrawal by Subject|0|||
30631777|NCT00918255|58643812|FG002|Overall Study|Withdrawal by Subject|2|||
30631778|NCT00918255|58643810|FG000|Overall Study|Lack of Efficacy|1|||
30631779|NCT00918255|58643811|FG001|Overall Study|Lack of Efficacy|0|||
30631780|NCT00918255|58643812|FG002|Overall Study|Lack of Efficacy|0|||
30631781|NCT00918255|58643810|FG000|Overall Study|Lost to Follow-up|1|||
30631782|NCT00918255|58643811|FG001|Overall Study|Lost to Follow-up|0|||
30631783|NCT00918255|58643812|FG002|Overall Study|Lost to Follow-up|2|||
30631784|NCT00918255|58643810|FG000|Overall Study|Exceeded allowed number of interventions|0|||
30631785|NCT00918255|58643811|FG001|Overall Study|Exceeded allowed number of interventions|0|||
30631786|NCT00918255|58643812|FG002|Overall Study|Exceeded allowed number of interventions|1|||
30631787|NCT00918255|58643810|FG000|Overall Study|Non-compliance|1|||
30631788|NCT00918255|58643811|FG001|Overall Study|Non-compliance|0|||
30631789|NCT00918255|58643812|FG002|Overall Study|Non-compliance|0|||
30631790|NCT00918255|58643810|FG000|Overall Study|Investigator discretion|1|||
30631791|NCT00918255|58643811|FG001|Overall Study|Investigator discretion|0|||
30631792|NCT00918255|58643812|FG002|Overall Study|Investigator discretion|0|||
30631793|NCT01096589|58643824|FG000|Overall Study|Adverse Event|2|||
30631794|NCT01096589|58643825|FG001|Overall Study|Adverse Event|1|||
30631795|NCT01096589|58643826|FG002|Overall Study|Adverse Event|2|||
30631796|NCT01096589|58643827|FG003|Overall Study|Adverse Event|1|||
30631797|NCT01096589|58643824|FG000|Overall Study|Withdrawal by Subject|2|||
30631798|NCT01096589|58643825|FG001|Overall Study|Withdrawal by Subject|1|||
30631799|NCT01096589|58643826|FG002|Overall Study|Withdrawal by Subject|1|||
30631800|NCT01096589|58643827|FG003|Overall Study|Withdrawal by Subject|1|||
30631801|NCT01096589|58643824|FG000|Overall Study|Compliance with protocol|0|||
30631802|NCT01096589|58643825|FG001|Overall Study|Compliance with protocol|0|||
30631803|NCT01096589|58643826|FG002|Overall Study|Compliance with protocol|1|||
30631804|NCT01096589|58643827|FG003|Overall Study|Compliance with protocol|0|||
30631805|NCT01096589|58643824|FG000|Overall Study|found treatment exhausting|0|||
30631806|NCT01096589|58643825|FG001|Overall Study|found treatment exhausting|0|||
30631807|NCT01096589|58643826|FG002|Overall Study|found treatment exhausting|0|||
30631808|NCT01096589|58643827|FG003|Overall Study|found treatment exhausting|1|||
30631809|NCT00845065|58643843|FG000|Overall Study|Adverse Event|3|||
30631810|NCT00845065|58643844|FG001|Overall Study|Adverse Event|23|||
30631811|NCT00845065|58643843|FG000|Overall Study|Lack of Efficacy|43|||
30631812|NCT00845065|58643844|FG001|Overall Study|Lack of Efficacy|21|||
30631813|NCT00845065|58643843|FG000|Overall Study|Non-Medical Reasons|1|||
30631814|NCT00845065|58643844|FG001|Overall Study|Non-Medical Reasons|11|||
30631815|NCT00832585|58643850|FG000|Overall Study|Withdrawal by Subject|1|||
30631816|NCT00832585|58643850|FG000|Overall Study|Lost to Follow-up|1|||
30631817|NCT00918567|58643856|FG000|Overall Study|Lack of Efficacy|3|||
30631818|NCT00918567|58643857|FG001|Overall Study|Lack of Efficacy|1|||
30631819|NCT00918567|58643856|FG000|Overall Study|Withdrawal by Subject|1|||
30631820|NCT00918567|58643857|FG001|Overall Study|Withdrawal by Subject|1|||
30631821|NCT00918567|58643856|FG000|Overall Study|Adverse Event|1|||
30631822|NCT00918567|58643857|FG001|Overall Study|Adverse Event|0|||
30631823|NCT01024920|58643865|FG000|Overall Study|Progressive disease|47|||
30631824|NCT01024920|58643866|FG001|Overall Study|Progressive disease|25|||
30631825|NCT01024920|58643865|FG000|Overall Study|Adverse Event|8|||
30631826|NCT01024920|58643866|FG001|Overall Study|Adverse Event|4|||
30631827|NCT01024920|58643865|FG000|Overall Study|Lost to Follow-up|0|||
30631828|NCT01024920|58643866|FG001|Overall Study|Lost to Follow-up|1|||
30631829|NCT01024920|58643865|FG000|Overall Study|Patient refusal to continue|4|||
30631830|NCT01024920|58643866|FG001|Overall Study|Patient refusal to continue|0|||
30631831|NCT01024920|58643865|FG000|Overall Study|Other than listed|5|||
30631832|NCT01024920|58643866|FG001|Overall Study|Other than listed|1|||
30631833|NCT01024920|58643865|FG000|Overall Study|Not treated|3|||
30631834|NCT01024920|58643866|FG001|Overall Study|Not treated|0|||
30631835|NCT01024920|58643865|FG000|Overall Study|Protocol Violation|0|||
30631836|NCT01024920|58643866|FG001|Overall Study|Protocol Violation|1|||
30631837|NCT00832117|58643874|FG000|Overall Study|Death|1|||
30631838|NCT00832117|58643874|FG000|Overall Study|Disease Progression|11|||
30631839|NCT01104311|58643883|FG000|Overall Study|Withdrawal by Subject|6|||
30631840|NCT01104311|58643884|FG001|Overall Study|Withdrawal by Subject|6|||
30631841|NCT01104311|58643883|FG000|Overall Study|Protocol Violation|0|||
30631842|NCT01104311|58643884|FG001|Overall Study|Protocol Violation|1|||
30631843|NCT01104311|58643883|FG000|Overall Study|Physician Decision|2|||
30631844|NCT01104311|58643884|FG001|Overall Study|Physician Decision|2|||
30631845|NCT01104311|58643883|FG000|Overall Study|low compliance|1|||
30631846|NCT01104311|58643884|FG001|Overall Study|low compliance|1|||
30631847|NCT01104311|58643883|FG000|Overall Study|Adverse Event|1|||
30631848|NCT01104311|58643884|FG001|Overall Study|Adverse Event|2|||
30631849|NCT00831493|58643894|FG000|Overall Study|Intractable nausea and vomiting|1|||
30631850|NCT00853567|58643901|FG000|Overall Study|Study prematurely terminated|71|||
30631851|NCT00853489|58643911|FG000|Overall Study|Lost to Follow-up|5|||
30631852|NCT00853489|58643912|FG001|Overall Study|Lost to Follow-up|2|||
30631853|NCT01019694|58643921|FG000|Overall Study|Adverse Event|12|||
30631854|NCT01019694|58643922|FG001|Overall Study|Adverse Event|16|||
30631855|NCT01019694|58643923|FG002|Overall Study|Adverse Event|19|||
30631856|NCT01019694|58643921|FG000|Overall Study|Protocol Violation|2|||
30631857|NCT01019694|58643922|FG001|Overall Study|Protocol Violation|6|||
30631858|NCT01019694|58643923|FG002|Overall Study|Protocol Violation|4|||
30631859|NCT01019694|58643921|FG000|Overall Study|Lost to Follow-up|5|||
30631860|NCT01019694|58643922|FG001|Overall Study|Lost to Follow-up|3|||
30631861|NCT01019694|58643923|FG002|Overall Study|Lost to Follow-up|3|||
30631862|NCT01019694|58643921|FG000|Overall Study|Withdrawal by Subject|4|||
30631863|NCT01019694|58643922|FG001|Overall Study|Withdrawal by Subject|6|||
30631864|NCT01019694|58643923|FG002|Overall Study|Withdrawal by Subject|12|||
30631865|NCT01019694|58643921|FG000|Overall Study|Not treated|0|||
30631866|NCT01019694|58643922|FG001|Overall Study|Not treated|2|||
30631867|NCT01019694|58643923|FG002|Overall Study|Not treated|3|||
30631868|NCT01019694|58643921|FG000|Overall Study|Other reason (not specified)|1|||
30631869|NCT01019694|58643922|FG001|Overall Study|Other reason (not specified)|5|||
30631870|NCT01019694|58643923|FG002|Overall Study|Other reason (not specified)|6|||
30631871|NCT00831415|58643931|FG000|Overall Study|Adverse Event|14|||
30631872|NCT00831415|58643931|FG000|Overall Study|Failed to return|3|||
30631873|NCT00831415|58643931|FG000|Overall Study|Physician Decision|6|||
30631874|NCT00831415|58643931|FG000|Overall Study|Lost to Follow-up|9|||
30631875|NCT00831415|58643931|FG000|Overall Study|Protocol Violation|3|||
30631876|NCT00831415|58643931|FG000|Overall Study|Withdrawal by Subject|35|||
30631877|NCT00831415|58643931|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
30631878|NCT00831415|58643931|FG000|Overall Study|Death|1|||
30631879|NCT01095653|58643938|FG000|Overall Study|Lack of Efficacy|3|||
30631880|NCT01095653|58643939|FG001|Overall Study|Lack of Efficacy|0|||
30631881|NCT01095653|58643940|FG002|Overall Study|Lack of Efficacy|0|||
30631882|NCT01095653|58643938|FG000|Overall Study|Adverse Event|1|||
30631883|NCT01095653|58643939|FG001|Overall Study|Adverse Event|4|||
30631884|NCT01095653|58643940|FG002|Overall Study|Adverse Event|4|||
30631885|NCT01095653|58643938|FG000|Overall Study|Lost to Follow-up|1|||
30631886|NCT01095653|58643939|FG001|Overall Study|Lost to Follow-up|0|||
30631887|NCT01095653|58643940|FG002|Overall Study|Lost to Follow-up|4|||
30631888|NCT01095653|58643938|FG000|Overall Study|Withdrawal by Subject|4|||
30631889|NCT01095653|58643939|FG001|Overall Study|Withdrawal by Subject|5|||
30631890|NCT01095653|58643940|FG002|Overall Study|Withdrawal by Subject|3|||
30631891|NCT01095653|58643938|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
30631892|NCT01095653|58643939|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
30631893|NCT01095653|58643940|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
30631894|NCT00920907|58643950|FG000|Induction Period|Adverse Event|0|||
30631895|NCT00920907|58643951|FG001|Induction Period|Adverse Event|2|||
30631896|NCT00920907|58643950|FG000|Induction Period|Death|1|||
30631897|NCT00920907|58643951|FG001|Induction Period|Death|1|||
30631898|NCT00920907|58643950|FG000|Induction Period|Disease Progression|12|||
30631899|NCT00920907|58643951|FG001|Induction Period|Disease Progression|11|||
30631900|NCT00920907|58643950|FG000|Induction Period|Study Drug Toxicity|8|||
30631901|NCT00920907|58643951|FG001|Induction Period|Study Drug Toxicity|6|||
30631902|NCT00920907|58643950|FG000|Induction Period|No longer meets study criteria|0|||
30631903|NCT00920907|58643951|FG001|Induction Period|No longer meets study criteria|1|||
30631904|NCT00920907|58643950|FG000|Induction Period|Withdrawal by Subject|1|||
30631905|NCT00920907|58643951|FG001|Induction Period|Withdrawal by Subject|1|||
30631906|NCT00920907|58643950|FG000|Maintenance Period|Disease Progression|3|||
30631907|NCT00920907|58643951|FG001|Maintenance Period|Disease Progression|7|||
30631908|NCT00920907|58643950|FG000|Maintenance Period|Administrative (study closure)|7|||
30631909|NCT00920907|58643951|FG001|Maintenance Period|Administrative (study closure)|2|||
30631910|NCT00920907|58643950|FG000|Maintenance Period|Study Drug Toxicity|0|||
30631911|NCT00920907|58643951|FG001|Maintenance Period|Study Drug Toxicity|2|||
30631912|NCT00920907|58643950|FG000|Maintenance Period|Death|1|||
30631913|NCT00920907|58643951|FG001|Maintenance Period|Death|1|||
30631914|NCT00920907|58643950|FG000|Maintenance Period|Withdrawal by Subject|1|||
30631915|NCT00920907|58643951|FG001|Maintenance Period|Withdrawal by Subject|0|||
30631916|NCT00920907|58643950|FG000|Maintenance Period|Adverse Event|0|||
30631917|NCT00920907|58643951|FG001|Maintenance Period|Adverse Event|1|||
30631918|NCT01103141|58643961|FG000|Overall Study|Death|0|||
30631919|NCT01103141|58643962|FG001|Overall Study|Death|1|||
30631920|NCT01103141|58643961|FG000|Overall Study|Lost to Follow-up|2|||
30631921|NCT01103141|58643962|FG001|Overall Study|Lost to Follow-up|1|||
30631922|NCT00844831|58643968|FG000|Overall Study|Withdrawal by Subject|4|||
30631923|NCT00844831|58643968|FG000|Overall Study|Adverse Event|1|||
30631924|NCT00844831|58643968|FG000|Overall Study|Physician Decision|1|||
30631925|NCT00920829|58643980|FG000|Allocation|No post randomization data|3|||
30631926|NCT00920829|58643981|FG001|Allocation|No post randomization data|1|||
30631927|NCT00920829|58643982|FG002|Allocation|No post randomization data|0|||
30631928|NCT00920829|58643983|FG003|Allocation|No post randomization data|2|||
30631929|NCT00920829|58643980|FG000|Available for Analysis|Withdrawal by Subject|6|||
30631930|NCT00920829|58643981|FG001|Available for Analysis|Withdrawal by Subject|6|||
30631931|NCT00920829|58643982|FG002|Available for Analysis|Withdrawal by Subject|6|||
30631932|NCT00920829|58643983|FG003|Available for Analysis|Withdrawal by Subject|10|||
30631933|NCT00920829|58643980|FG000|Available for Analysis|Required Medical Treatment|0|||
30631934|NCT00920829|58643981|FG001|Available for Analysis|Required Medical Treatment|1|||
30631935|NCT00920829|58643982|FG002|Available for Analysis|Required Medical Treatment|2|||
30631936|NCT00920829|58643983|FG003|Available for Analysis|Required Medical Treatment|0|||
30631937|NCT00920829|58643980|FG000|Available for Analysis|Adverse Event|1|||
30631938|NCT00920829|58643981|FG001|Available for Analysis|Adverse Event|2|||
30631939|NCT00920829|58643982|FG002|Available for Analysis|Adverse Event|1|||
30631940|NCT00920829|58643983|FG003|Available for Analysis|Adverse Event|0|||
30631941|NCT00920829|58643980|FG000|Available for Analysis|Death|1|||
30631942|NCT00920829|58643981|FG001|Available for Analysis|Death|0|||
30631943|NCT00920829|58643982|FG002|Available for Analysis|Death|0|||
30631944|NCT00920829|58643983|FG003|Available for Analysis|Death|0|||
30631945|NCT00920829|58643980|FG000|Available for Analysis|Protocol Violation|0|||
30631946|NCT00920829|58643981|FG001|Available for Analysis|Protocol Violation|0|||
30631947|NCT00920829|58643982|FG002|Available for Analysis|Protocol Violation|1|||
30631948|NCT00920829|58643983|FG003|Available for Analysis|Protocol Violation|0|||
30631949|NCT00920829|58643980|FG000|Available for Analysis|Required more treatment|0|||
30631950|NCT00920829|58643981|FG001|Available for Analysis|Required more treatment|2|||
30631951|NCT00920829|58643982|FG002|Available for Analysis|Required more treatment|0|||
30631952|NCT00920829|58643983|FG003|Available for Analysis|Required more treatment|1|||
30631953|NCT00831181|58643993|FG000|Overall Study|Adverse Event|12|||
30631954|NCT01023672|58643998|FG000|Overall Study|Worsening disease|2|||
30631955|NCT01023672|58643998|FG000|Overall Study|Death|1|||
30631956|NCT01094171|58644002|FG000|Overall Study|Lost to Follow-up|2|||
30631957|NCT01094171|58644002|FG000|Overall Study|Informed consent withdrawal|4|||
30631958|NCT01094171|58644002|FG000|Overall Study|Migration from the study area|3|||
30631959|NCT01094171|58644002|FG000|Overall Study|Other|1|||
30631960|NCT01093625|58644008|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
30631961|NCT01093625|58644009|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
30631962|NCT01093625|58644008|FG000|2-Week Visit|Withdrawal by Subject|1|||
30631963|NCT01093625|58644009|FG001|2-Week Visit|Withdrawal by Subject|0|||
30631964|NCT01093625|58644008|FG000|1-Month Visit|Lost to Follow-up|2|||
30631965|NCT01093625|58644009|FG001|1-Month Visit|Lost to Follow-up|0|||
30631966|NCT01093625|58644008|FG000|3-Month Visit|Lost to Follow-up|2|||
30631967|NCT01093625|58644009|FG001|3-Month Visit|Lost to Follow-up|0|||
30631968|NCT01093625|58644008|FG000|6-Month Visit|Withdrawal by Subject|6|||
30631969|NCT01093625|58644009|FG001|6-Month Visit|Withdrawal by Subject|7|||
30631970|NCT01093625|58644008|FG000|6-Month Visit|Lost to Follow-up|2|||
30631971|NCT01093625|58644009|FG001|6-Month Visit|Lost to Follow-up|2|||
30631972|NCT01093625|58644008|FG000|1-Year Visit|Lost to Follow-up|5|||
30764365|NCT00350519|58772999|FG000|Overall Study|Protocol Violation|1|||
30764366|NCT00350519|58773000|FG001|Overall Study|Protocol Violation|2|||
30631973|NCT01093625|58644009|FG001|1-Year Visit|Lost to Follow-up|3|||
30631974|NCT01023516|58644017|FG000|Overall Study|Voluntary discontinuation|7|||
30631975|NCT01023516|58644018|FG001|Overall Study|Voluntary discontinuation|5|||
30631976|NCT01023516|58644017|FG000|Overall Study|Adverse Event|9|||
30631977|NCT01023516|58644018|FG001|Overall Study|Adverse Event|6|||
30631978|NCT01023516|58644017|FG000|Overall Study|Safety reason|0|||
30631979|NCT01023516|58644018|FG001|Overall Study|Safety reason|3|||
30631980|NCT01023516|58644017|FG000|Overall Study|Study-specific criteria|4|||
30631981|NCT01023516|58644018|FG001|Overall Study|Study-specific criteria|2|||
30631982|NCT01023516|58644017|FG000|Overall Study|Incorrect enrolment|4|||
30631983|NCT01023516|58644018|FG001|Overall Study|Incorrect enrolment|2|||
30631984|NCT00844753|58644028|FG000|Overall Study|Lack of Efficacy|1|||
30631985|NCT00844753|58644029|FG001|Overall Study|Lack of Efficacy|0|||
30631986|NCT00844753|58644030|FG002|Overall Study|Lack of Efficacy|2|||
30631987|NCT00844753|58644031|FG003|Overall Study|Lack of Efficacy|2|||
30631988|NCT00844753|58644028|FG000|Overall Study|Adverse Event|3|||
30631989|NCT00844753|58644029|FG001|Overall Study|Adverse Event|2|||
30631990|NCT00844753|58644030|FG002|Overall Study|Adverse Event|5|||
30631991|NCT00844753|58644031|FG003|Overall Study|Adverse Event|5|||
30631992|NCT00844753|58644028|FG000|Overall Study|Lost to Follow-up|1|||
30631993|NCT00844753|58644029|FG001|Overall Study|Lost to Follow-up|1|||
30631994|NCT00844753|58644030|FG002|Overall Study|Lost to Follow-up|0|||
30631995|NCT00844753|58644031|FG003|Overall Study|Lost to Follow-up|1|||
30631996|NCT00844753|58644028|FG000|Overall Study|could not swallow medication|2|||
30631997|NCT00844753|58644029|FG001|Overall Study|could not swallow medication|0|||
30631998|NCT00844753|58644030|FG002|Overall Study|could not swallow medication|0|||
30631999|NCT00844753|58644031|FG003|Overall Study|could not swallow medication|0|||
30632000|NCT00844753|58644028|FG000|Overall Study|Withdrawal by Subject|1|||
30632001|NCT00844753|58644029|FG001|Overall Study|Withdrawal by Subject|0|||
30632002|NCT00844753|58644030|FG002|Overall Study|Withdrawal by Subject|0|||
30632003|NCT00844753|58644031|FG003|Overall Study|Withdrawal by Subject|3|||
30632004|NCT00830947|58644041|FG000|Overall Study|Lost to Follow-up|4|||
30632005|NCT00830947|58644042|FG001|Overall Study|Lost to Follow-up|4|||
30632006|NCT01018992|58644050|FG000|Overall Study|Adverse Event|8|||
30632007|NCT01018992|58644051|FG001|Overall Study|Adverse Event|3|||
30632008|NCT01018992|58644050|FG000|Overall Study|Withdrawal by Subject|3|||
30632009|NCT01018992|58644051|FG001|Overall Study|Withdrawal by Subject|8|||
30632010|NCT01018992|58644050|FG000|Overall Study|Protocol Violation|0|||
30632011|NCT01018992|58644051|FG001|Overall Study|Protocol Violation|4|||
30632012|NCT01018992|58644050|FG000|Overall Study|Lost to Follow-up|5|||
30632013|NCT01018992|58644051|FG001|Overall Study|Lost to Follow-up|1|||
30632014|NCT00917553|58644059|FG000|Overall Study|Lost to Follow-up|2|||
30632015|NCT00917553|58644060|FG001|Overall Study|Lost to Follow-up|1|||
30632016|NCT01018680|58644068|FG000|Overall Study|Adverse Event|23|||
30632017|NCT01018680|58644069|FG001|Overall Study|Adverse Event|40|||
30632018|NCT01018680|58644068|FG000|Overall Study|Withdrawal by Subject|10|||
30632019|NCT01018680|58644069|FG001|Overall Study|Withdrawal by Subject|10|||
30632020|NCT01018680|58644068|FG000|Overall Study|Protocol Violation|5|||
30632021|NCT01018680|58644069|FG001|Overall Study|Protocol Violation|8|||
30632022|NCT01018680|58644068|FG000|Overall Study|Sponsor Decision|6|||
30632023|NCT01018680|58644069|FG001|Overall Study|Sponsor Decision|7|||
30632024|NCT01018680|58644068|FG000|Overall Study|Lack of Efficacy|8|||
30632025|NCT01018680|58644069|FG001|Overall Study|Lack of Efficacy|2|||
30632026|NCT01018680|58644068|FG000|Overall Study|Lost to Follow-up|5|||
30632027|NCT01018680|58644069|FG001|Overall Study|Lost to Follow-up|3|||
30632028|NCT01018680|58644068|FG000|Overall Study|Entry Criteria Not Met|1|||
30632029|NCT01018680|58644069|FG001|Overall Study|Entry Criteria Not Met|4|||
30632030|NCT01018680|58644068|FG000|Overall Study|Physician Decision|3|||
30632031|NCT01018680|58644069|FG001|Overall Study|Physician Decision|1|||
30632032|NCT01012440|58644075|FG000|Overall Study|Withdrawal by Subject|2|||
30632033|NCT00916929|58644081|FG000|Overall Study|Lost to Follow-up|1|||
30632034|NCT00916929|58644082|FG001|Overall Study|Lost to Follow-up|3|||
30632035|NCT00916929|58644081|FG000|Overall Study|Death|5|||
30632036|NCT00916929|58644082|FG001|Overall Study|Death|10|||
30632037|NCT00916929|58644081|FG000|Overall Study|Withdrawal by Subject|1|||
30632038|NCT00916929|58644082|FG001|Overall Study|Withdrawal by Subject|5|||
30632039|NCT00916929|58644081|FG000|Overall Study|Left ventricular epicardial lead|1|||
30632040|NCT00916929|58644082|FG001|Overall Study|Left ventricular epicardial lead|2|||
30632041|NCT00916929|58644081|FG000|Overall Study|Transferred to hospice care|1|||
30632042|NCT00916929|58644082|FG001|Overall Study|Transferred to hospice care|1|||
30632043|NCT00916929|58644081|FG000|Overall Study|System explant|1|||
30632044|NCT00916929|58644082|FG001|Overall Study|System explant|0|||
30632045|NCT00916929|58644081|FG000|Overall Study|Moved to another state|0|||
30632046|NCT00916929|58644082|FG001|Overall Study|Moved to another state|1|||
30632047|NCT00916929|58644081|FG000|Overall Study|Device unable to process impedance data|0|||
30632048|NCT00916929|58644082|FG001|Overall Study|Device unable to process impedance data|7|||
30632049|NCT00844597|58644096|FG000|Overall Study|Adverse Event|0|||
30632050|NCT00844597|58644097|FG001|Overall Study|Adverse Event|0|||
30632051|NCT00844597|58644098|FG002|Overall Study|Adverse Event|0|||
30632052|NCT00844597|58644099|FG003|Overall Study|Adverse Event|1|||
30632053|NCT00844597|58644100|FG004|Overall Study|Adverse Event|0|||
30632054|NCT00844597|58644101|FG005|Overall Study|Adverse Event|0|||
30632055|NCT01017120|58644119|FG000|Overall Study|Adverse Event|9|||
30632056|NCT01017120|58644120|FG001|Overall Study|Adverse Event|0|||
30632057|NCT01017120|58644119|FG000|Overall Study|Lost to Follow-up|13|||
30632058|NCT01017120|58644120|FG001|Overall Study|Lost to Follow-up|11|||
30632059|NCT01017120|58644119|FG000|Overall Study|Lack of Efficacy|1|||
30632060|NCT01017120|58644120|FG001|Overall Study|Lack of Efficacy|0|||
30632061|NCT01017120|58644119|FG000|Overall Study|Withdrawal by Subject|39|||
30632062|NCT01017120|58644120|FG001|Overall Study|Withdrawal by Subject|21|||
30632063|NCT01017120|58644119|FG000|Overall Study|Pregnancy|1|||
30632064|NCT01017120|58644120|FG001|Overall Study|Pregnancy|1|||
30632065|NCT01017120|58644119|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
30632066|NCT01017120|58644120|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
30632067|NCT01017120|58644119|FG000|Overall Study|Relocated Out of Town|0|||
30632068|NCT01017120|58644120|FG001|Overall Study|Relocated Out of Town|2|||
30632069|NCT01017120|58644119|FG000|Overall Study|Protocol Violation|1|||
30632070|NCT01017120|58644120|FG001|Overall Study|Protocol Violation|0|||
30632071|NCT01017120|58644119|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
30632072|NCT01017120|58644120|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
30632073|NCT01016964|58644128|FG000|Overall Study|Lost to Follow-up|3|||
30632074|NCT01016964|58644129|FG001|Overall Study|Lost to Follow-up|3|||
30632075|NCT02996110|58644140|FG000|Pre-Treatment|Other Reasons|0|||
30632076|NCT02996110|58644141|FG001|Pre-Treatment|Other Reasons|1|||
30632077|NCT02996110|58644142|FG002|Pre-Treatment|Other Reasons|0|||
30632078|NCT02996110|58644143|FG003|Pre-Treatment|Other Reasons|0|||
30632079|NCT02996110|58644144|FG004|Pre-Treatment|Other Reasons|1|||
30632080|NCT02996110|58644140|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
30632081|NCT02996110|58644141|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
30632082|NCT02996110|58644142|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
30632083|NCT02996110|58644143|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
30632084|NCT02996110|58644144|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
30632085|NCT02996110|58644140|FG000|Track 1|Disease Progression|15|||
30632086|NCT02996110|58644141|FG001|Track 1|Disease Progression|17|||
30632087|NCT02996110|58644142|FG002|Track 1|Disease Progression|0|||
30632088|NCT02996110|58644143|FG003|Track 1|Disease Progression|0|||
30632089|NCT02996110|58644144|FG004|Track 1|Disease Progression|0|||
30632090|NCT02996110|58644140|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
30632091|NCT02996110|58644141|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
30632092|NCT02996110|58644142|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
30632093|NCT02996110|58644143|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
30632094|NCT02996110|58644144|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
30632095|NCT02996110|58644140|FG000|Track 1|Study Drug Toxicity|5|||
30632096|NCT02996110|58644141|FG001|Track 1|Study Drug Toxicity|3|||
30632097|NCT02996110|58644142|FG002|Track 1|Study Drug Toxicity|0|||
30632098|NCT02996110|58644143|FG003|Track 1|Study Drug Toxicity|0|||
30632099|NCT02996110|58644144|FG004|Track 1|Study Drug Toxicity|0|||
30632100|NCT02996110|58644140|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
30632101|NCT02996110|58644141|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
30632102|NCT02996110|58644142|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
30632103|NCT02996110|58644143|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
30632104|NCT02996110|58644144|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
30632105|NCT02996110|58644140|FG000|Track 1|Administrative Reason by Sponsor|0|||
30632106|NCT02996110|58644141|FG001|Track 1|Administrative Reason by Sponsor|1|||
30632107|NCT02996110|58644142|FG002|Track 1|Administrative Reason by Sponsor|0|||
30632108|NCT02996110|58644143|FG003|Track 1|Administrative Reason by Sponsor|0|||
30632109|NCT02996110|58644144|FG004|Track 1|Administrative Reason by Sponsor|0|||
30632110|NCT02996110|58644140|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
30632111|NCT02996110|58644141|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
30632112|NCT02996110|58644142|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
30632113|NCT02996110|58644143|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
30632114|NCT02996110|58644144|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
30632115|NCT02996110|58644140|FG000|Track 2|Disease Progression|33|||
30632116|NCT02996110|58644141|FG001|Track 2|Disease Progression|26|||
30632117|NCT02996110|58644142|FG002|Track 2|Disease Progression|19|||
30632118|NCT02996110|58644143|FG003|Track 2|Disease Progression|16|||
30632119|NCT02996110|58644144|FG004|Track 2|Disease Progression|15|||
30632120|NCT02996110|58644140|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
30848253|NCT02746627|58874224|FG001|Overall Study|Withdrawal by Subject|1|||
30632121|NCT02996110|58644141|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
30632122|NCT02996110|58644142|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
30632123|NCT02996110|58644143|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
30632124|NCT02996110|58644144|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
30632125|NCT02996110|58644140|FG000|Track 2|Death|0|||
30632126|NCT02996110|58644141|FG001|Track 2|Death|0|||
30632127|NCT02996110|58644142|FG002|Track 2|Death|1|||
30632128|NCT02996110|58644143|FG003|Track 2|Death|0|||
30632129|NCT02996110|58644144|FG004|Track 2|Death|1|||
30632130|NCT02996110|58644140|FG000|Track 2|Study Drug Toxicity|4|||
30632131|NCT02996110|58644141|FG001|Track 2|Study Drug Toxicity|1|||
30632132|NCT02996110|58644142|FG002|Track 2|Study Drug Toxicity|4|||
30632133|NCT02996110|58644143|FG003|Track 2|Study Drug Toxicity|1|||
30632134|NCT02996110|58644144|FG004|Track 2|Study Drug Toxicity|0|||
30848254|NCT02746627|58874225|FG002|Overall Study|Withdrawal by Subject|1|||
30632135|NCT02996110|58644140|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
30632136|NCT02996110|58644141|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
30632137|NCT02996110|58644142|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
30632138|NCT02996110|58644143|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
30632139|NCT02996110|58644144|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
30632140|NCT02996110|58644140|FG000|Track 2|Participant Withdrew Consent|1|||
30632141|NCT02996110|58644141|FG001|Track 2|Participant Withdrew Consent|2|||
30632142|NCT02996110|58644142|FG002|Track 2|Participant Withdrew Consent|3|||
30632143|NCT02996110|58644143|FG003|Track 2|Participant Withdrew Consent|1|||
30632144|NCT02996110|58644144|FG004|Track 2|Participant Withdrew Consent|1|||
30632145|NCT02996110|58644140|FG000|Track 2|Other Reasons|0|||
30632146|NCT02996110|58644141|FG001|Track 2|Other Reasons|0|||
30632147|NCT02996110|58644142|FG002|Track 2|Other Reasons|1|||
30632148|NCT02996110|58644143|FG003|Track 2|Other Reasons|0|||
30632149|NCT02996110|58644144|FG004|Track 2|Other Reasons|1|||
30632150|NCT00916617|58644162|FG000|Overall Study|Adverse Event|3|||
30632151|NCT00916617|58644163|FG001|Overall Study|Adverse Event|2|||
30632152|NCT00916617|58644164|FG002|Overall Study|Adverse Event|6|||
30632153|NCT00916617|58644165|FG003|Overall Study|Adverse Event|3|||
30632154|NCT00916617|58644162|FG000|Overall Study|Withdrawal by Subject|3|||
30632155|NCT00916617|58644163|FG001|Overall Study|Withdrawal by Subject|2|||
30632156|NCT00916617|58644164|FG002|Overall Study|Withdrawal by Subject|0|||
30632157|NCT00916617|58644165|FG003|Overall Study|Withdrawal by Subject|1|||
30632158|NCT00916617|58644162|FG000|Overall Study|Caregiver Request|3|||
30632159|NCT00916617|58644163|FG001|Overall Study|Caregiver Request|2|||
30632160|NCT00916617|58644164|FG002|Overall Study|Caregiver Request|1|||
30632161|NCT00916617|58644165|FG003|Overall Study|Caregiver Request|0|||
30632162|NCT00916617|58644162|FG000|Overall Study|Physician Decision|1|||
30632163|NCT00916617|58644163|FG001|Overall Study|Physician Decision|1|||
30632164|NCT00916617|58644164|FG002|Overall Study|Physician Decision|0|||
30632165|NCT00916617|58644165|FG003|Overall Study|Physician Decision|0|||
30632166|NCT00916617|58644162|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
30632167|NCT00916617|58644163|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
30632168|NCT00916617|58644164|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
30632169|NCT00916617|58644165|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
30632170|NCT00916617|58644162|FG000|Overall Study|Lost to Follow-up|2|||
30632171|NCT00916617|58644163|FG001|Overall Study|Lost to Follow-up|1|||
30632172|NCT00916617|58644164|FG002|Overall Study|Lost to Follow-up|0|||
30632173|NCT00916617|58644165|FG003|Overall Study|Lost to Follow-up|0|||
30632174|NCT00916617|58644162|FG000|Overall Study|Lack of Efficacy|1|||
30632175|NCT00916617|58644163|FG001|Overall Study|Lack of Efficacy|0|||
30632176|NCT00916617|58644164|FG002|Overall Study|Lack of Efficacy|0|||
30632177|NCT00916617|58644165|FG003|Overall Study|Lack of Efficacy|0|||
30632178|NCT00916617|58644162|FG000|Overall Study|Other|2|||
30632179|NCT00916617|58644163|FG001|Overall Study|Other|0|||
30632180|NCT00916617|58644164|FG002|Overall Study|Other|0|||
30632181|NCT00916617|58644165|FG003|Overall Study|Other|2|||
30632182|NCT01103063|58644177|FG000|Overall Study|Adverse Event|3|||
30632183|NCT01103063|58644178|FG001|Overall Study|Adverse Event|1|||
30632184|NCT01103063|58644177|FG000|Overall Study|Lost to Follow-up|68|||
30632185|NCT01103063|58644178|FG001|Overall Study|Lost to Follow-up|51|||
30632186|NCT01103063|58644177|FG000|Overall Study|Withdrawal by Subject|60|||
30632187|NCT01103063|58644178|FG001|Overall Study|Withdrawal by Subject|15|||
30632188|NCT01103063|58644177|FG000|Overall Study|Other|16|||
30632189|NCT01103063|58644178|FG001|Overall Study|Other|11|||
30632190|NCT01103063|58644177|FG000|Overall Study|Protocol Violation|1|||
30632191|NCT01103063|58644178|FG001|Overall Study|Protocol Violation|0|||
30632192|NCT01103063|58644177|FG000|Overall Study|Study terminated by Sponsor|326|||
30632193|NCT01103063|58644178|FG001|Overall Study|Study terminated by Sponsor|342|||
30632194|NCT01103063|58644177|FG000|Overall Study|Death|3|||
30764367|NCT00350519|58772999|FG000|Overall Study|Withdrawal by Subject|3|||
30764368|NCT00350519|58773000|FG001|Overall Study|Withdrawal by Subject|2|||
30632195|NCT01103063|58644178|FG001|Overall Study|Death|1|||
30632196|NCT01091675|58644186|FG000|Overall Study|Adverse Event|7|||
30632197|NCT01091675|58644186|FG000|Overall Study|Lack of Efficacy|27|||
30632198|NCT01091519|58644192|FG000|Overall Study|Adverse Event|12|||
30632199|NCT01091519|58644193|FG001|Overall Study|Adverse Event|16|||
30632200|NCT01091519|58644192|FG000|Overall Study|Death|1|||
30632201|NCT01091519|58644193|FG001|Overall Study|Death|0|||
30632202|NCT01091519|58644192|FG000|Overall Study|Lack of Efficacy|16|||
30632203|NCT01091519|58644193|FG001|Overall Study|Lack of Efficacy|19|||
30632204|NCT01091519|58644192|FG000|Overall Study|Lost to Follow-up|14|||
30632205|NCT01091519|58644193|FG001|Overall Study|Lost to Follow-up|24|||
30632206|NCT01091519|58644192|FG000|Overall Study|Withdrawal by Subject|2|||
30632207|NCT01091519|58644193|FG001|Overall Study|Withdrawal by Subject|2|||
30632208|NCT01091519|58644192|FG000|Overall Study|Other|6|||
30632209|NCT01091519|58644193|FG001|Overall Study|Other|8|||
30632210|NCT01091519|58644192|FG000|Overall Study|Randomized not treated|4|||
30632211|NCT01091519|58644193|FG001|Overall Study|Randomized not treated|4|||
30632212|NCT01011738|58644202|FG000|Overall Study|Death|12|||
30632213|NCT01011738|58644203|FG001|Overall Study|Death|3|||
30632214|NCT01011738|58644204|FG002|Overall Study|Death|0|||
30632215|NCT01011738|58644202|FG000|Overall Study|Unknown reasons|312|||
30632216|NCT01011738|58644203|FG001|Overall Study|Unknown reasons|291|||
30632217|NCT01011738|58644204|FG002|Overall Study|Unknown reasons|17|||
30632218|NCT00918333|58644215|FG000|Overall Study|Drug not taken per protocol|1|||
30951030|NCT01684033|58998000|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
30951031|NCT01684033|58997999|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
30951032|NCT01684033|58998000|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
30951033|NCT01684033|58997999|FG000|Period 2, Second 30 Days|Adverse Event|1|||
30951034|NCT01684033|58998000|FG001|Period 2, Second 30 Days|Adverse Event|0|||
30951035|NCT01903811|58998041|FG000|Overall Study|No measurable disease|1|||
30951036|NCT01903811|58998042|FG001|Overall Study|No measurable disease|1|||
30951037|NCT01903811|58998041|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
30951038|NCT01903811|58998042|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
30951039|NCT01903811|58998041|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
30951040|NCT01903811|58998042|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
30951041|NCT01903811|58998041|FG000|Overall Study|Withdrawal by Subject|0|||
30951042|NCT01903811|58998042|FG001|Overall Study|Withdrawal by Subject|1|||
30951043|NCT01709149|58998059|FG000|Open-label Lead-in Phase|Adverse Event|109|||
30951044|NCT01709149|58998060|FG001|Open-label Lead-in Phase|Adverse Event|0|||
30951045|NCT01709149|58998061|FG002|Open-label Lead-in Phase|Adverse Event|0|||
30951046|NCT01709149|58998059|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
30951047|NCT01709149|58998060|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
30951048|NCT01709149|58998061|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
30951049|NCT01709149|58998059|FG000|Open-label Lead-in Phase|Death|1|||
30951050|NCT01709149|58998060|FG001|Open-label Lead-in Phase|Death|0|||
30951051|NCT01709149|58998061|FG002|Open-label Lead-in Phase|Death|0|||
30951052|NCT01709149|58998059|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
30951053|NCT01709149|58998060|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
30951054|NCT01709149|58998061|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
30951055|NCT01709149|58998059|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
30951056|NCT01709149|58998060|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
30951057|NCT01709149|58998061|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
30951058|NCT01709149|58998059|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
30951059|NCT01709149|58998060|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
30951060|NCT01709149|58998061|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
30951061|NCT01709149|58998059|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
30951062|NCT01709149|58998060|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
30951063|NCT01709149|58998061|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
30951064|NCT01709149|58998059|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
30951065|NCT01709149|58998060|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
30951066|NCT01709149|58998061|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
30951067|NCT01709149|58998059|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
30951068|NCT01709149|58998060|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
30951069|NCT01709149|58998061|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
30951070|NCT01709149|58998059|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
30951071|NCT01709149|58998060|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
30951072|NCT01709149|58998061|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
30951073|NCT01568593|58998070|FG000|Overall Study|Lack of Efficacy|4|||
30951074|NCT01568593|58998071|FG001|Overall Study|Lack of Efficacy|1|||
30951075|NCT01568593|58998070|FG000|Overall Study|Adverse Event|3|||
30951076|NCT01568593|58998071|FG001|Overall Study|Adverse Event|2|||
30951077|NCT01683565|58998079|FG000|Overall Study|Lost to Follow-up|2|||
30951078|NCT01683565|58998080|FG001|Overall Study|Lost to Follow-up|0|||
30951079|NCT01683565|58998079|FG000|Overall Study|Discontinued Intervention|1|||
30951080|NCT01683565|58998080|FG001|Overall Study|Discontinued Intervention|1|||
30951081|NCT01903031|58998104|FG000|Overall Study|Not Able to Attend Clinic|1|||
30951082|NCT01903031|58998105|FG001|Overall Study|Not Able to Attend Clinic|1|||
30632219|NCT00918333|58644216|FG001|Overall Study|Drug not taken per protocol|0|||
30951083|NCT01903031|58998106|FG002|Overall Study|Not Able to Attend Clinic|0|||
30951084|NCT01903031|58998104|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
30951085|NCT01903031|58998105|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
30951086|NCT01903031|58998106|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
30632220|NCT00918333|58644215|FG000|Overall Study|Inadequate amount of drugs provided|1|||
30632221|NCT00918333|58644216|FG001|Overall Study|Inadequate amount of drugs provided|4|||
30632222|NCT00918333|58644215|FG000|Overall Study|Ineligible|1|||
30951087|NCT01903031|58998104|FG000|Overall Study|Adverse Event|0|||
30951088|NCT01903031|58998105|FG001|Overall Study|Adverse Event|1|||
30632223|NCT00918333|58644216|FG001|Overall Study|Ineligible|0|||
30632224|NCT00918333|58644215|FG000|Overall Study|Withdrawal by Subject|0|||
30632225|NCT00918333|58644216|FG001|Overall Study|Withdrawal by Subject|1|||
30632226|NCT01091363|58644227|FG000|Overall Study|Withdrawal by Subject|11|||
30632227|NCT01091363|58644228|FG001|Overall Study|Withdrawal by Subject|15|||
30632228|NCT01091363|58644227|FG000|Overall Study|Lost to Follow-up|2|||
30632229|NCT01091363|58644228|FG001|Overall Study|Lost to Follow-up|2|||
30632230|NCT01090973|58644234|FG000|Overall Study|Disease progression|1|||
30632231|NCT01090739|58644238|FG000|Enrollment|Withdrawal by Subject|24|||
30632232|NCT01090739|58644238|FG000|Enrollment|Protocol Violation|14|||
30632233|NCT01090739|58644238|FG000|Enrollment|Lost to Follow-up|5|||
30632234|NCT01090739|58644238|FG000|Enrollment|Physician Decision|5|||
30632235|NCT01090739|58644238|FG000|Enrollment|Sponsor termination of site|4|||
30632236|NCT01090739|58644238|FG000|Enrollment|Study implant limit reached|2|||
30632237|NCT01090739|58644238|FG000|Enrollment|Adverse Event|1|||
30632238|NCT01090739|58644238|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
30632239|NCT01090739|58644238|FG000|12 Month Follow-up|Lost to Follow-up|1|||
30632240|NCT01090739|58644238|FG000|12 Month Follow-up|Physician Decision|1|||
30632241|NCT01090739|58644238|FG000|12 Month Follow-up|Death|1|||
30632242|NCT01090739|58644238|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
30632243|NCT01090739|58644238|FG000|24 Month Follow-up|Lost to Follow-up|1|||
30632244|NCT01090739|58644238|FG000|24 Month Follow-up|Death|1|||
30632245|NCT01090739|58644238|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
30632246|NCT01090739|58644238|FG000|36 Month Follow-up|Visit still pending|17|||
30632247|NCT00916383|58644256|FG000|Overall Study|Adverse Event|1|||
30632248|NCT00916383|58644256|FG000|Overall Study|Death|1|||
30632249|NCT00916383|58644256|FG000|Overall Study|Protocol Violation|1|||
30632250|NCT00916305|58644266|FG000|Overall Study|Lost to Follow-up|21|||
30632251|NCT00916305|58644267|FG001|Overall Study|Lost to Follow-up|27|||
30632252|NCT00916305|58644266|FG000|Overall Study|Withdrawal by Subject|0|||
30632253|NCT00916305|58644267|FG001|Overall Study|Withdrawal by Subject|1|||
30632254|NCT00916149|58644276|FG000|Overall Study|Lost to Follow-up|3|||
30632255|NCT00916149|58644277|FG001|Overall Study|Lost to Follow-up|2|||
30632256|NCT00916149|58644278|FG002|Overall Study|Lost to Follow-up|0|||
30632257|NCT00916149|58644276|FG000|Overall Study|Unable to place scalp EEG leads|1|||
30632258|NCT00916149|58644277|FG001|Overall Study|Unable to place scalp EEG leads|0|||
30632259|NCT00916149|58644278|FG002|Overall Study|Unable to place scalp EEG leads|0|||
30632260|NCT01090427|58644288|FG000|After Controlled Period|Death|0|||
30632261|NCT01090427|58644289|FG001|After Controlled Period|Death|0|||
30632262|NCT01090427|58644290|FG002|After Controlled Period|Death|0|||
30632263|NCT01090427|58644291|FG003|After Controlled Period|Death|0|||
30632264|NCT01090427|58644292|FG004|After Controlled Period|Death|0|||
30632265|NCT01090427|58644293|FG005|After Controlled Period|Death|1|||
30632266|NCT01090427|58644294|FG006|After Controlled Period|Death|0|||
30632267|NCT01090427|58644288|FG000|After Controlled Period|Lack of Efficacy|0|||
30632268|NCT01090427|58644289|FG001|After Controlled Period|Lack of Efficacy|0|||
30632269|NCT01090427|58644290|FG002|After Controlled Period|Lack of Efficacy|0|||
30632270|NCT01090427|58644291|FG003|After Controlled Period|Lack of Efficacy|0|||
30632271|NCT01090427|58644292|FG004|After Controlled Period|Lack of Efficacy|0|||
30632272|NCT01090427|58644293|FG005|After Controlled Period|Lack of Efficacy|3|||
30632273|NCT01090427|58644294|FG006|After Controlled Period|Lack of Efficacy|2|||
30632274|NCT01090427|58644288|FG000|After Controlled Period|Adverse Event|0|||
30632275|NCT01090427|58644289|FG001|After Controlled Period|Adverse Event|0|||
30632276|NCT01090427|58644290|FG002|After Controlled Period|Adverse Event|0|||
30632277|NCT01090427|58644291|FG003|After Controlled Period|Adverse Event|2|||
30632278|NCT01090427|58644292|FG004|After Controlled Period|Adverse Event|0|||
30632279|NCT01090427|58644293|FG005|After Controlled Period|Adverse Event|1|||
30632280|NCT01090427|58644294|FG006|After Controlled Period|Adverse Event|0|||
30764369|NCT03382912|58773008|FG000|Overall Study|Physician Decision|0|||
30764370|NCT03382912|58773009|FG001|Overall Study|Physician Decision|1|||
30632281|NCT01016262|58644318|FG000|Double-blind Phase|Adverse Event|0|||
30632282|NCT01016262|58644319|FG001|Double-blind Phase|Adverse Event|0|||
30632283|NCT01016262|58644320|FG002|Double-blind Phase|Adverse Event|1|||
30632284|NCT01016262|58644321|FG003|Double-blind Phase|Adverse Event|0|||
30632285|NCT01016262|58644322|FG004|Double-blind Phase|Adverse Event|0|||
30632286|NCT01016262|58644323|FG005|Double-blind Phase|Adverse Event|0|||
30632287|NCT01016262|58644318|FG000|Double-blind Phase|Lack of Efficacy|1|||
30632288|NCT01016262|58644319|FG001|Double-blind Phase|Lack of Efficacy|0|||
30632289|NCT01016262|58644320|FG002|Double-blind Phase|Lack of Efficacy|5|||
30632290|NCT01016262|58644321|FG003|Double-blind Phase|Lack of Efficacy|0|||
30632291|NCT01016262|58644322|FG004|Double-blind Phase|Lack of Efficacy|0|||
30632292|NCT01016262|58644323|FG005|Double-blind Phase|Lack of Efficacy|0|||
30632293|NCT01016262|58644318|FG000|Double-blind Phase|Disease Progression|0|||
30632294|NCT01016262|58644319|FG001|Double-blind Phase|Disease Progression|1|||
30632295|NCT01016262|58644320|FG002|Double-blind Phase|Disease Progression|2|||
30632296|NCT01016262|58644321|FG003|Double-blind Phase|Disease Progression|0|||
30632297|NCT01016262|58644322|FG004|Double-blind Phase|Disease Progression|0|||
30632298|NCT01016262|58644323|FG005|Double-blind Phase|Disease Progression|0|||
30632299|NCT01016262|58644318|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
30632300|NCT01016262|58644319|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
30632301|NCT01016262|58644320|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
30632302|NCT01016262|58644321|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
30632303|NCT01016262|58644322|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
30632304|NCT01016262|58644323|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
30632305|NCT01016262|58644318|FG000|Open-Label Phase|Adverse Event|0|||
30632306|NCT01016262|58644319|FG001|Open-Label Phase|Adverse Event|0|||
30632307|NCT01016262|58644320|FG002|Open-Label Phase|Adverse Event|0|||
30632308|NCT01016262|58644321|FG003|Open-Label Phase|Adverse Event|1|||
30632309|NCT01016262|58644322|FG004|Open-Label Phase|Adverse Event|0|||
30632310|NCT01016262|58644323|FG005|Open-Label Phase|Adverse Event|0|||
30632311|NCT01016262|58644318|FG000|Open-Label Phase|Lost to Follow-up|0|||
30632312|NCT01016262|58644319|FG001|Open-Label Phase|Lost to Follow-up|0|||
30632313|NCT01016262|58644320|FG002|Open-Label Phase|Lost to Follow-up|0|||
30632314|NCT01016262|58644321|FG003|Open-Label Phase|Lost to Follow-up|0|||
30632315|NCT01016262|58644322|FG004|Open-Label Phase|Lost to Follow-up|1|||
30632316|NCT01016262|58644323|FG005|Open-Label Phase|Lost to Follow-up|0|||
30632317|NCT01016262|58644318|FG000|Open-Label Phase|Lack of Efficacy|0|||
30632318|NCT01016262|58644319|FG001|Open-Label Phase|Lack of Efficacy|0|||
30632319|NCT01016262|58644320|FG002|Open-Label Phase|Lack of Efficacy|0|||
30632320|NCT01016262|58644321|FG003|Open-Label Phase|Lack of Efficacy|1|||
30632321|NCT01016262|58644322|FG004|Open-Label Phase|Lack of Efficacy|0|||
30632322|NCT01016262|58644323|FG005|Open-Label Phase|Lack of Efficacy|0|||
30632323|NCT01016262|58644318|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
30632324|NCT01016262|58644319|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
30632325|NCT01016262|58644320|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
30632326|NCT01016262|58644321|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
30632327|NCT01016262|58644322|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
30632328|NCT01016262|58644323|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
30632329|NCT01001910|58644334|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
30632330|NCT01009554|58644340|FG000|Overall Study|Adverse Event|1|||
30632331|NCT01009554|58644341|FG001|Overall Study|Adverse Event|1|||
30632332|NCT01009554|58644340|FG000|Overall Study|Withdrawal by Subject|1|||
30632333|NCT01009554|58644341|FG001|Overall Study|Withdrawal by Subject|3|||
30632334|NCT01009554|58644340|FG000|Overall Study|Noncompliant with Study Product|0|||
30632335|NCT01009554|58644341|FG001|Overall Study|Noncompliant with Study Product|3|||
30632336|NCT01006590|58644349|FG000|Overall Study|Adverse Event|2|||
30632337|NCT01006590|58644350|FG001|Overall Study|Adverse Event|3|||
30632338|NCT01006590|58644349|FG000|Overall Study|Death|1|||
30632339|NCT01006590|58644350|FG001|Overall Study|Death|1|||
30632340|NCT01006590|58644349|FG000|Overall Study|Lost to Follow-up|1|||
30632341|NCT01006590|58644350|FG001|Overall Study|Lost to Follow-up|1|||
30632342|NCT01006590|58644349|FG000|Overall Study|Protocol Violation|1|||
30632343|NCT01006590|58644350|FG001|Overall Study|Protocol Violation|0|||
30632344|NCT01006590|58644349|FG000|Overall Study|Withdrawal by Subject|4|||
30632345|NCT01006590|58644350|FG001|Overall Study|Withdrawal by Subject|2|||
30764371|NCT03382912|58773008|FG000|Overall Study|Sponsor Decision|6|||
30632346|NCT01006590|58644349|FG000|Overall Study|Study specific discontinuation criteria|16|||
30632347|NCT01006590|58644350|FG001|Overall Study|Study specific discontinuation criteria|23|||
30632348|NCT01006590|58644349|FG000|Overall Study|Other|3|||
30632349|NCT01006590|58644350|FG001|Overall Study|Other|2|||
30632350|NCT01001832|58644358|FG000|Short-term Period|Adverse Event|2|||
30632351|NCT01001832|58644359|FG001|Short-term Period|Adverse Event|3|||
30632352|NCT01001832|58644358|FG000|Long-term Period|Adverse Event|2|||
30632353|NCT01001832|58644359|FG001|Long-term Period|Adverse Event|1|||
30632354|NCT01001832|58644358|FG000|Long-term Period|Withdrawal by Subject|1|||
30632355|NCT01001832|58644359|FG001|Long-term Period|Withdrawal by Subject|0|||
30632356|NCT01001832|58644358|FG000|Long-term Period|Lack of Efficacy|0|||
30632357|NCT01001832|58644359|FG001|Long-term Period|Lack of Efficacy|2|||
30632358|NCT01001832|58644358|FG000|Long-term Period|Other|1|||
30632359|NCT01001832|58644359|FG001|Long-term Period|Other|2|||
30632360|NCT01001832|58644358|FG000|Follow-up Period|Withdrawal by Subject|1|||
30632361|NCT01001832|58644359|FG001|Follow-up Period|Withdrawal by Subject|0|||
30632362|NCT01001832|58644358|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
30632363|NCT01001832|58644359|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
30632364|NCT01001832|58644358|FG000|Follow-up Period|Other|2|||
30632365|NCT01001832|58644359|FG001|Follow-up Period|Other|1|||
30632366|NCT01001598|58644368|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
30632367|NCT01001598|58644368|FG000|Overall Study|Adverse Event|1|||
30632368|NCT01006356|58644372|FG000|Overall Study|Adverse Event|6|||
30632369|NCT01006356|58644372|FG000|Overall Study|Physician Decision|1|||
30632370|NCT01006356|58644372|FG000|Overall Study|Paticipants did not cooperate|6|||
30632371|NCT01006356|58644372|FG000|Overall Study|Withdrawal by Subject|1|||
30632372|NCT01006356|58644372|FG000|Overall Study|Choice by participants|2|||
30632373|NCT01006356|58644372|FG000|Overall Study|Protocol Violation|3|||
30632374|NCT01006356|58644372|FG000|Overall Study|Other|23|||
30632375|NCT01089725|58644381|FG000|Overall Study|Adverse Event|1|||
30632376|NCT01089725|58644382|FG001|Overall Study|Adverse Event|1|||
30632377|NCT01089725|58644383|FG002|Overall Study|Adverse Event|0|||
30632378|NCT01089725|58644384|FG003|Overall Study|Adverse Event|0|||
30632379|NCT01089725|58644385|FG004|Overall Study|Adverse Event|2|||
30632380|NCT01089725|58644381|FG000|Overall Study|Lack of Efficacy|4|||
30632381|NCT01089725|58644382|FG001|Overall Study|Lack of Efficacy|3|||
30632382|NCT01089725|58644383|FG002|Overall Study|Lack of Efficacy|1|||
30632383|NCT01089725|58644384|FG003|Overall Study|Lack of Efficacy|0|||
30632384|NCT01089725|58644385|FG004|Overall Study|Lack of Efficacy|4|||
30632385|NCT01089725|58644381|FG000|Overall Study|Lost to Follow-up|2|||
30848255|NCT02856113|58874235|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
30848256|NCT02856113|58874236|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
30848257|NCT02856113|58874235|FG000|Overall Study|Significant Protocol Deviation|1|||
30848258|NCT02856113|58874236|FG001|Overall Study|Significant Protocol Deviation|0|||
30848259|NCT02856113|58874235|FG000|Overall Study|Lost to Follow-up|3|||
30848260|NCT02856113|58874236|FG001|Overall Study|Lost to Follow-up|5|||
30848261|NCT02856113|58874235|FG000|Overall Study|Voluntary Withdrawal|3|||
30848262|NCT02856113|58874236|FG001|Overall Study|Voluntary Withdrawal|5|||
30848263|NCT02856113|58874235|FG000|Overall Study|Pregnancy|0|||
30848264|NCT02856113|58874236|FG001|Overall Study|Pregnancy|1|||
30848265|NCT02856113|58874235|FG000|Overall Study|Principal Investigator Discretion|2|||
30848266|NCT02856113|58874236|FG001|Overall Study|Principal Investigator Discretion|1|||
30632386|NCT01089725|58644382|FG001|Overall Study|Lost to Follow-up|2|||
30632387|NCT01089725|58644383|FG002|Overall Study|Lost to Follow-up|0|||
30848267|NCT02856113|58874235|FG000|Overall Study|Randomized but not Treated|1|||
30848268|NCT02856113|58874236|FG001|Overall Study|Randomized but not Treated|0|||
30848269|NCT02856113|58874235|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
30632388|NCT01089725|58644384|FG003|Overall Study|Lost to Follow-up|3|||
30764372|NCT03382912|58773009|FG001|Overall Study|Sponsor Decision|6|||
30764373|NCT03382912|58773008|FG000|Overall Study|Withdrawal by Subject|0|||
30764374|NCT03382912|58773009|FG001|Overall Study|Withdrawal by Subject|5|||
30764375|NCT00350207|58773018|FG000|Overall Study|Adverse Event|5|||
30764376|NCT00350207|58773019|FG001|Overall Study|Adverse Event|2|||
30764377|NCT00350207|58773020|FG002|Overall Study|Adverse Event|2|||
30764378|NCT00350207|58773018|FG000|Overall Study|Lack of Efficacy|1|||
30764379|NCT00350207|58773019|FG001|Overall Study|Lack of Efficacy|0|||
30848270|NCT02856113|58874236|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
30848271|NCT02855411|58874243|FG000|Overall Study|Study terminated by sponsor|21|||
30632389|NCT01089725|58644385|FG004|Overall Study|Lost to Follow-up|0|||
30632390|NCT01089725|58644381|FG000|Overall Study|Protocol Violation|0|||
30632391|NCT01089725|58644382|FG001|Overall Study|Protocol Violation|0|||
30632392|NCT01089725|58644383|FG002|Overall Study|Protocol Violation|1|||
30632393|NCT01089725|58644384|FG003|Overall Study|Protocol Violation|1|||
30764380|NCT00350207|58773020|FG002|Overall Study|Lack of Efficacy|2|||
30764381|NCT00350207|58773018|FG000|Overall Study|Lost to Follow-up|1|||
30848272|NCT02855411|58874243|FG000|Overall Study|Does not meet entrance criteria|14|||
30848273|NCT02745145|58874250|FG000|Overall Study|Adverse Event|1|||
30848274|NCT02745145|58874251|FG001|Overall Study|Adverse Event|0|||
30848275|NCT02745145|58874252|FG002|Overall Study|Adverse Event|0|||
30848276|NCT02745145|58874250|FG000|Overall Study|Death|0|||
30848277|NCT02745145|58874251|FG001|Overall Study|Death|1|||
30848278|NCT02745145|58874252|FG002|Overall Study|Death|0|||
30848279|NCT02745145|58874250|FG000|Overall Study|Progressive disease|0|||
30848280|NCT02745145|58874251|FG001|Overall Study|Progressive disease|0|||
30848281|NCT02745145|58874252|FG002|Overall Study|Progressive disease|1|||
30848282|NCT02745145|58874250|FG000|Overall Study|Withdrew consent|1|||
30848283|NCT02745145|58874251|FG001|Overall Study|Withdrew consent|1|||
30848284|NCT02745145|58874252|FG002|Overall Study|Withdrew consent|1|||
30848285|NCT02745145|58874250|FG000|Overall Study|Study Termination|8|||
30848286|NCT02745145|58874251|FG001|Overall Study|Study Termination|3|||
30848287|NCT02745145|58874252|FG002|Overall Study|Study Termination|7|||
30848288|NCT02854631|58874271|FG000|Overall Study|Adverse Event|1|||
30848289|NCT02854631|58874272|FG001|Overall Study|Adverse Event|2|||
30848290|NCT02854631|58874271|FG000|Overall Study|Withdrew Consent|3|||
30848291|NCT02854631|58874272|FG001|Overall Study|Withdrew Consent|2|||
30848292|NCT02854631|58874271|FG000|Overall Study|Investigator's Discretion|2|||
30848293|NCT02854631|58874272|FG001|Overall Study|Investigator's Discretion|0|||
30848294|NCT02854631|58874271|FG000|Overall Study|Death|12|||
30848295|NCT02854631|58874272|FG001|Overall Study|Death|8|||
30848296|NCT02854631|58874271|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
30848297|NCT02854631|58874272|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
30848298|NCT02854631|58874271|FG000|Overall Study|Protocol Violation|0|||
30848299|NCT02854631|58874272|FG001|Overall Study|Protocol Violation|1|||
30848300|NCT02854631|58874271|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
30848301|NCT02854631|58874272|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
30848302|NCT02854631|58874271|FG000|Overall Study|Lost to Follow-up|4|||
30848303|NCT02854631|58874272|FG001|Overall Study|Lost to Follow-up|2|||
30848304|NCT02855359|58874280|FG000|Overall Study|Death|2|||
30848305|NCT02855359|58874281|FG001|Overall Study|Death|2|||
30848306|NCT02855359|58874282|FG002|Overall Study|Death|0|||
30848307|NCT02855359|58874283|FG003|Overall Study|Death|0|||
30848308|NCT02855359|58874280|FG000|Overall Study|Study Termination by Sponsor|9|||
30848309|NCT02855359|58874281|FG001|Overall Study|Study Termination by Sponsor|11|||
30848310|NCT02855359|58874282|FG002|Overall Study|Study Termination by Sponsor|0|||
30848311|NCT02855359|58874283|FG003|Overall Study|Study Termination by Sponsor|0|||
30848312|NCT02853929|58874297|FG000|Overall Study|Lost to Follow-up|3|||
30848313|NCT02853929|58874298|FG001|Overall Study|Lost to Follow-up|0|||
30848314|NCT02853929|58874297|FG000|Overall Study|Withdrawal by Subject|1|||
30848315|NCT02853929|58874298|FG001|Overall Study|Withdrawal by Subject|0|||
30848316|NCT02853929|58874297|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
30848317|NCT02853929|58874298|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
30848318|NCT02730819|58874334|FG000|Overall Study|Lost to Follow-up|9|||
30848319|NCT02038946|58874338|FG000|Overall Study|Death|5|||
30848320|NCT02038946|58874338|FG000|Overall Study|Withdrawal by Subject|3|||
30848321|NCT02038946|58874338|FG000|Overall Study|Lost to Follow-up|2|||
30848322|NCT02038946|58874338|FG000|Overall Study|Other reasons|2|||
30848323|NCT03143829|58874344|FG000|Overall Study|Withdrawal by Subject|2|||
30848324|NCT03143829|58874345|FG001|Overall Study|Withdrawal by Subject|5|||
30951089|NCT01903031|58998106|FG002|Overall Study|Adverse Event|0|||
30951090|NCT01903031|58998104|FG000|Overall Study|Withdrawal by Subject|0|||
30764382|NCT00350207|58773019|FG001|Overall Study|Lost to Follow-up|0|||
30764383|NCT00350207|58773020|FG002|Overall Study|Lost to Follow-up|1|||
30764384|NCT00350207|58773018|FG000|Overall Study|Withdrawal by Subject|0|||
30764385|NCT00350207|58773019|FG001|Overall Study|Withdrawal by Subject|1|||
30764386|NCT00350207|58773020|FG002|Overall Study|Withdrawal by Subject|1|||
30764387|NCT00350207|58773018|FG000|Overall Study|Other|1|||
30764388|NCT00350207|58773019|FG001|Overall Study|Other|3|||
30764389|NCT00350207|58773020|FG002|Overall Study|Other|1|||
30764390|NCT00349973|58773030|FG000|Overall Study|Adverse Event|3|||
30764391|NCT00349973|58773031|FG001|Overall Study|Adverse Event|3|||
30764392|NCT00349973|58773030|FG000|Overall Study|Withdrawal by Subject|1|||
30848325|NCT03143829|58874344|FG000|Overall Study|Lost to Follow-up|0|||
30848326|NCT03143829|58874345|FG001|Overall Study|Lost to Follow-up|2|||
30848327|NCT03143829|58874344|FG000|Overall Study|Death|1|||
30951091|NCT01903031|58998105|FG001|Overall Study|Withdrawal by Subject|1|||
30848328|NCT03143829|58874345|FG001|Overall Study|Death|1|||
30764393|NCT00349973|58773031|FG001|Overall Study|Withdrawal by Subject|0|||
30848329|NCT03143829|58874344|FG000|Overall Study|changed treatment, no longer eligible|2|||
30848330|NCT03143829|58874345|FG001|Overall Study|changed treatment, no longer eligible|2|||
30848331|NCT02853331|58874353|FG000|Overall Study|Death|59|||
30848332|NCT02853331|58874354|FG001|Overall Study|Death|95|||
30848333|NCT02853331|58874353|FG000|Overall Study|Withdrawal by Subject|5|||
30848334|NCT02853331|58874354|FG001|Overall Study|Withdrawal by Subject|9|||
30632394|NCT01089725|58644385|FG004|Overall Study|Protocol Violation|0|||
30632395|NCT01089725|58644381|FG000|Overall Study|Withdrawal by Subject|5|||
30632396|NCT01089725|58644382|FG001|Overall Study|Withdrawal by Subject|5|||
30632397|NCT01089725|58644383|FG002|Overall Study|Withdrawal by Subject|4|||
30632398|NCT01089725|58644384|FG003|Overall Study|Withdrawal by Subject|5|||
30632399|NCT01089725|58644385|FG004|Overall Study|Withdrawal by Subject|4|||
30632400|NCT01089725|58644381|FG000|Overall Study|Study Terminated by Sponsor|51|||
30632401|NCT01089725|58644382|FG001|Overall Study|Study Terminated by Sponsor|56|||
30632402|NCT01089725|58644383|FG002|Overall Study|Study Terminated by Sponsor|53|||
30632403|NCT01089725|58644384|FG003|Overall Study|Study Terminated by Sponsor|68|||
30632404|NCT01089725|58644385|FG004|Overall Study|Study Terminated by Sponsor|68|||
30632405|NCT01089725|58644381|FG000|Overall Study|Randomized, but not treated|0|||
30632406|NCT01089725|58644382|FG001|Overall Study|Randomized, but not treated|1|||
30632407|NCT01089725|58644383|FG002|Overall Study|Randomized, but not treated|2|||
30632408|NCT01089725|58644384|FG003|Overall Study|Randomized, but not treated|1|||
30632409|NCT01089725|58644385|FG004|Overall Study|Randomized, but not treated|2|||
30632410|NCT01089725|58644381|FG000|Overall Study|Other|3|||
30632411|NCT01089725|58644382|FG001|Overall Study|Other|0|||
30632412|NCT01089725|58644383|FG002|Overall Study|Other|0|||
30632413|NCT01089725|58644384|FG003|Overall Study|Other|1|||
30632414|NCT01089725|58644385|FG004|Overall Study|Other|0|||
30632415|NCT01190930|58644403|FG000|Induction|Adverse Event|17|||
30632416|NCT01190930|58644404|FG001|Induction|Adverse Event|0|||
30632417|NCT01190930|58644405|FG002|Induction|Adverse Event|0|||
30632418|NCT01190930|58644406|FG003|Induction|Adverse Event|0|||
30632419|NCT01190930|58644407|FG004|Induction|Adverse Event|0|||
30632420|NCT01190930|58644408|FG005|Induction|Adverse Event|0|||
30632421|NCT01190930|58644409|FG006|Induction|Adverse Event|0|||
30632422|NCT01190930|58644410|FG007|Induction|Adverse Event|0|||
30632423|NCT01190930|58644411|FG008|Induction|Adverse Event|0|||
30632424|NCT01190930|58644412|FG009|Induction|Adverse Event|0|||
30632425|NCT01190930|58644403|FG000|Induction|Death|34|||
30632426|NCT01190930|58644404|FG001|Induction|Death|0|||
30632427|NCT01190930|58644405|FG002|Induction|Death|0|||
30632428|NCT01190930|58644406|FG003|Induction|Death|0|||
30632429|NCT01190930|58644407|FG004|Induction|Death|0|||
30632430|NCT01190930|58644408|FG005|Induction|Death|0|||
30632431|NCT01190930|58644409|FG006|Induction|Death|0|||
30632432|NCT01190930|58644410|FG007|Induction|Death|0|||
30632433|NCT01190930|58644411|FG008|Induction|Death|0|||
30632434|NCT01190930|58644412|FG009|Induction|Death|0|||
30632435|NCT01190930|58644403|FG000|Induction|Lost to Follow-up|1|||
30632436|NCT01190930|58644404|FG001|Induction|Lost to Follow-up|0|||
30632437|NCT01190930|58644405|FG002|Induction|Lost to Follow-up|0|||
30632438|NCT01190930|58644406|FG003|Induction|Lost to Follow-up|0|||
30632439|NCT01190930|58644407|FG004|Induction|Lost to Follow-up|0|||
30632440|NCT01190930|58644408|FG005|Induction|Lost to Follow-up|0|||
30632441|NCT01190930|58644409|FG006|Induction|Lost to Follow-up|0|||
30632442|NCT01190930|58644410|FG007|Induction|Lost to Follow-up|0|||
30632443|NCT01190930|58644411|FG008|Induction|Lost to Follow-up|0|||
30632444|NCT01190930|58644412|FG009|Induction|Lost to Follow-up|0|||
30632445|NCT01190930|58644403|FG000|Induction|Physician Decision|125|||
30632446|NCT01190930|58644404|FG001|Induction|Physician Decision|3|||
30632447|NCT01190930|58644405|FG002|Induction|Physician Decision|0|||
30632448|NCT01190930|58644406|FG003|Induction|Physician Decision|0|||
30632449|NCT01190930|58644407|FG004|Induction|Physician Decision|0|||
30632450|NCT01190930|58644408|FG005|Induction|Physician Decision|0|||
30632451|NCT01190930|58644409|FG006|Induction|Physician Decision|0|||
30632452|NCT01190930|58644410|FG007|Induction|Physician Decision|0|||
30632453|NCT01190930|58644411|FG008|Induction|Physician Decision|0|||
30632454|NCT01190930|58644412|FG009|Induction|Physician Decision|0|||
30632455|NCT01190930|58644403|FG000|Induction|Withdrawal by Subject|9|||
30632456|NCT01190930|58644404|FG001|Induction|Withdrawal by Subject|0|||
30632457|NCT01190930|58644405|FG002|Induction|Withdrawal by Subject|0|||
30632458|NCT01190930|58644406|FG003|Induction|Withdrawal by Subject|0|||
30632459|NCT01190930|58644407|FG004|Induction|Withdrawal by Subject|0|||
30632460|NCT01190930|58644408|FG005|Induction|Withdrawal by Subject|0|||
30632461|NCT01190930|58644409|FG006|Induction|Withdrawal by Subject|0|||
30632462|NCT01190930|58644410|FG007|Induction|Withdrawal by Subject|0|||
30632463|NCT01190930|58644411|FG008|Induction|Withdrawal by Subject|0|||
30632464|NCT01190930|58644412|FG009|Induction|Withdrawal by Subject|0|||
30632465|NCT01190930|58644403|FG000|Induction|Refusal|235|||
30632466|NCT01190930|58644404|FG001|Induction|Refusal|0|||
30632467|NCT01190930|58644405|FG002|Induction|Refusal|0|||
30632468|NCT01190930|58644406|FG003|Induction|Refusal|0|||
30632469|NCT01190930|58644407|FG004|Induction|Refusal|0|||
30632470|NCT01190930|58644408|FG005|Induction|Refusal|0|||
30632471|NCT01190930|58644409|FG006|Induction|Refusal|0|||
30632472|NCT01190930|58644410|FG007|Induction|Refusal|0|||
30632473|NCT01190930|58644411|FG008|Induction|Refusal|0|||
30632474|NCT01190930|58644412|FG009|Induction|Refusal|0|||
30632475|NCT01190930|58644403|FG000|Induction|Inevaluable|23|||
30632476|NCT01190930|58644404|FG001|Induction|Inevaluable|1|||
30632477|NCT01190930|58644405|FG002|Induction|Inevaluable|0|||
30632478|NCT01190930|58644406|FG003|Induction|Inevaluable|0|||
30632479|NCT01190930|58644407|FG004|Induction|Inevaluable|0|||
30632480|NCT01190930|58644408|FG005|Induction|Inevaluable|0|||
30632481|NCT01190930|58644409|FG006|Induction|Inevaluable|0|||
30632482|NCT01190930|58644410|FG007|Induction|Inevaluable|0|||
30632483|NCT01190930|58644411|FG008|Induction|Inevaluable|0|||
30632484|NCT01190930|58644412|FG009|Induction|Inevaluable|0|||
30632485|NCT01190930|58644403|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
30632486|NCT01190930|58644404|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
30632487|NCT01190930|58644405|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
30632488|NCT01190930|58644406|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
30632489|NCT01190930|58644407|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
30632490|NCT01190930|58644408|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
30632491|NCT01190930|58644409|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
30632492|NCT01190930|58644410|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
30632493|NCT01190930|58644411|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
30764394|NCT03187262|58773037|FG000|Induction|Lack of Efficacy|2|||
30764395|NCT03187262|58773037|FG000|Induction|Progressive Disease|4|||
30764396|NCT03187262|58773037|FG000|Consolidation|Progressive Disease|5|||
30951092|NCT01903031|58998106|FG002|Overall Study|Withdrawal by Subject|1|||
30951093|NCT01903031|58998104|FG000|Overall Study|Protocol Violation|0|||
30764397|NCT03381196|58773043|FG000|Overall Study|Withdrawal by Subject|7|||
30951094|NCT01903031|58998105|FG001|Overall Study|Protocol Violation|0|||
30632494|NCT01190930|58644412|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
30632495|NCT01190930|58644403|FG000|Induction|High Risk Downs|80|||
30632496|NCT01190930|58644404|FG001|Induction|High Risk Downs|0|||
30632497|NCT01190930|58644405|FG002|Induction|High Risk Downs|0|||
30632498|NCT01190930|58644406|FG003|Induction|High Risk Downs|0|||
30632499|NCT01190930|58644407|FG004|Induction|High Risk Downs|0|||
30632500|NCT01190930|58644408|FG005|Induction|High Risk Downs|0|||
30632501|NCT01190930|58644409|FG006|Induction|High Risk Downs|0|||
30632502|NCT01190930|58644410|FG007|Induction|High Risk Downs|0|||
30632503|NCT01190930|58644411|FG008|Induction|High Risk Downs|0|||
30632504|NCT01190930|58644412|FG009|Induction|High Risk Downs|0|||
30632505|NCT01190930|58644403|FG000|Induction|Enrollment onto another COG Protocol|1|||
30632506|NCT01190930|58644404|FG001|Induction|Enrollment onto another COG Protocol|0|||
30632507|NCT01190930|58644405|FG002|Induction|Enrollment onto another COG Protocol|0|||
30632508|NCT01190930|58644406|FG003|Induction|Enrollment onto another COG Protocol|0|||
30632509|NCT01190930|58644407|FG004|Induction|Enrollment onto another COG Protocol|0|||
30632510|NCT01190930|58644408|FG005|Induction|Enrollment onto another COG Protocol|0|||
30632511|NCT01190930|58644409|FG006|Induction|Enrollment onto another COG Protocol|0|||
30632512|NCT01190930|58644410|FG007|Induction|Enrollment onto another COG Protocol|0|||
30632513|NCT01190930|58644411|FG008|Induction|Enrollment onto another COG Protocol|0|||
30632514|NCT01190930|58644412|FG009|Induction|Enrollment onto another COG Protocol|0|||
30632515|NCT01190930|58644403|FG000|Induction|Average Risk|1847|||
30632516|NCT01190930|58644404|FG001|Induction|Average Risk|0|||
30632517|NCT01190930|58644405|FG002|Induction|Average Risk|0|||
30632518|NCT01190930|58644406|FG003|Induction|Average Risk|0|||
30632519|NCT01190930|58644407|FG004|Induction|Average Risk|0|||
30632520|NCT01190930|58644408|FG005|Induction|Average Risk|0|||
30632521|NCT01190930|58644409|FG006|Induction|Average Risk|0|||
30632522|NCT01190930|58644410|FG007|Induction|Average Risk|0|||
30632523|NCT01190930|58644411|FG008|Induction|Average Risk|0|||
30632524|NCT01190930|58644412|FG009|Induction|Average Risk|0|||
30632525|NCT01190930|58644403|FG000|Induction|High Risk|1227|||
30632526|NCT01190930|58644404|FG001|Induction|High Risk|0|||
30632527|NCT01190930|58644405|FG002|Induction|High Risk|0|||
30632528|NCT01190930|58644406|FG003|Induction|High Risk|0|||
30632529|NCT01190930|58644407|FG004|Induction|High Risk|0|||
30632530|NCT01190930|58644408|FG005|Induction|High Risk|0|||
30632531|NCT01190930|58644409|FG006|Induction|High Risk|0|||
30632532|NCT01190930|58644410|FG007|Induction|High Risk|0|||
30632533|NCT01190930|58644411|FG008|Induction|High Risk|0|||
30632534|NCT01190930|58644412|FG009|Induction|High Risk|0|||
30632535|NCT01190930|58644403|FG000|Induction|Low Risk|443|||
30632536|NCT01190930|58644404|FG001|Induction|Low Risk|0|||
30632537|NCT01190930|58644405|FG002|Induction|Low Risk|0|||
30632538|NCT01190930|58644406|FG003|Induction|Low Risk|0|||
30632539|NCT01190930|58644407|FG004|Induction|Low Risk|0|||
30632540|NCT01190930|58644408|FG005|Induction|Low Risk|0|||
30632541|NCT01190930|58644409|FG006|Induction|Low Risk|0|||
30632542|NCT01190930|58644410|FG007|Induction|Low Risk|0|||
30632543|NCT01190930|58644411|FG008|Induction|Low Risk|0|||
30632544|NCT01190930|58644412|FG009|Induction|Low Risk|0|||
30632545|NCT01190930|58644403|FG000|Induction|Very High Risk|1012|||
30632546|NCT01190930|58644404|FG001|Induction|Very High Risk|0|||
30632547|NCT01190930|58644405|FG002|Induction|Very High Risk|0|||
30632548|NCT01190930|58644406|FG003|Induction|Very High Risk|0|||
30632549|NCT01190930|58644407|FG004|Induction|Very High Risk|0|||
30632550|NCT01190930|58644408|FG005|Induction|Very High Risk|0|||
30632551|NCT01190930|58644409|FG006|Induction|Very High Risk|0|||
30632552|NCT01190930|58644410|FG007|Induction|Very High Risk|0|||
30632553|NCT01190930|58644411|FG008|Induction|Very High Risk|0|||
30632554|NCT01190930|58644412|FG009|Induction|Very High Risk|0|||
30632555|NCT01190930|58644403|FG000|Induction|Philadelphia chromosome-positive|99|||
30632556|NCT01190930|58644404|FG001|Induction|Philadelphia chromosome-positive|0|||
30632557|NCT01190930|58644405|FG002|Induction|Philadelphia chromosome-positive|0|||
30632558|NCT01190930|58644406|FG003|Induction|Philadelphia chromosome-positive|0|||
30632559|NCT01190930|58644407|FG004|Induction|Philadelphia chromosome-positive|0|||
30632560|NCT01190930|58644408|FG005|Induction|Philadelphia chromosome-positive|0|||
30632561|NCT01190930|58644409|FG006|Induction|Philadelphia chromosome-positive|0|||
30632562|NCT01190930|58644410|FG007|Induction|Philadelphia chromosome-positive|0|||
30632563|NCT01190930|58644411|FG008|Induction|Philadelphia chromosome-positive|0|||
30632564|NCT01190930|58644412|FG009|Induction|Philadelphia chromosome-positive|0|||
30632565|NCT01190930|58644403|FG000|Induction|Incomplete Induction data|63|||
30632566|NCT01190930|58644404|FG001|Induction|Incomplete Induction data|0|||
30632567|NCT01190930|58644405|FG002|Induction|Incomplete Induction data|0|||
30632568|NCT01190930|58644406|FG003|Induction|Incomplete Induction data|0|||
30632569|NCT01190930|58644407|FG004|Induction|Incomplete Induction data|0|||
30632570|NCT01190930|58644408|FG005|Induction|Incomplete Induction data|0|||
30951095|NCT01903031|58998106|FG002|Overall Study|Protocol Violation|2|||
30632571|NCT01190930|58644409|FG006|Induction|Incomplete Induction data|0|||
30632572|NCT01190930|58644410|FG007|Induction|Incomplete Induction data|0|||
30632573|NCT01190930|58644411|FG008|Induction|Incomplete Induction data|0|||
30632574|NCT01190930|58644412|FG009|Induction|Incomplete Induction data|0|||
30632575|NCT01190930|58644403|FG000|Induction|Progressive disease|0|||
30632576|NCT01190930|58644404|FG001|Induction|Progressive disease|1|||
30632577|NCT01190930|58644405|FG002|Induction|Progressive disease|0|||
30632578|NCT01190930|58644406|FG003|Induction|Progressive disease|0|||
30951096|NCT01903031|58998104|FG000|Overall Study|Lost to Follow-up|0|||
30632579|NCT01190930|58644407|FG004|Induction|Progressive disease|0|||
30632580|NCT01190930|58644408|FG005|Induction|Progressive disease|0|||
30632581|NCT01190930|58644409|FG006|Induction|Progressive disease|0|||
30632582|NCT01190930|58644410|FG007|Induction|Progressive disease|0|||
30632583|NCT01190930|58644411|FG008|Induction|Progressive disease|0|||
30632584|NCT01190930|58644412|FG009|Induction|Progressive disease|0|||
30632585|NCT01190930|58644403|FG000|Induction|No treatment|3|||
30632586|NCT01190930|58644404|FG001|Induction|No treatment|0|||
30632587|NCT01190930|58644405|FG002|Induction|No treatment|0|||
30632588|NCT01190930|58644406|FG003|Induction|No treatment|0|||
30632589|NCT01190930|58644407|FG004|Induction|No treatment|0|||
30632590|NCT01190930|58644408|FG005|Induction|No treatment|0|||
30632591|NCT01190930|58644409|FG006|Induction|No treatment|0|||
30632592|NCT01190930|58644410|FG007|Induction|No treatment|0|||
30764398|NCT03381196|58773044|FG001|Overall Study|Withdrawal by Subject|7|||
30764399|NCT03381196|58773043|FG000|Overall Study|Other|0|||
30764400|NCT03381196|58773044|FG001|Overall Study|Other|1|||
30764401|NCT03381196|58773043|FG000|Overall Study|Lost to Follow-up|5|||
30764402|NCT03381196|58773044|FG001|Overall Study|Lost to Follow-up|4|||
30764403|NCT03381196|58773043|FG000|Overall Study|Death|0|||
30764404|NCT03381196|58773044|FG001|Overall Study|Death|1|||
30764405|NCT03381196|58773043|FG000|Overall Study|Adverse Event|1|||
30764406|NCT03381196|58773044|FG001|Overall Study|Adverse Event|0|||
30764407|NCT03381196|58773043|FG000|Overall Study|Randomized, not treated|3|||
30764408|NCT03381196|58773044|FG001|Overall Study|Randomized, not treated|6|||
30764409|NCT02950558|58773052|FG000|Overall Study|Lost to Follow-up|2|||
30764410|NCT02950558|58773053|FG001|Overall Study|Lost to Follow-up|0|||
30764411|NCT03345472|58773060|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
30764412|NCT03345472|58773060|FG000|Implant to 3 Months|Physician Decision|1|||
30764413|NCT03345472|58773060|FG000|Implant to 3 Months|Adverse Event|1|||
30764414|NCT03345472|58773060|FG000|3 Months to 12 Months|Physician Decision|3|||
30764415|NCT03345472|58773060|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
30764416|NCT03345472|58773060|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
30764417|NCT03345472|58773060|FG000|3 Months to 12 Months|Adverse Event|1|||
30764418|NCT03345472|58773060|FG000|3 Months to 12 Months|Death|1|||
30764419|NCT00349349|58773067|FG000|Overall Study|Adverse Event|5|||
30764420|NCT00349349|58773068|FG001|Overall Study|Adverse Event|6|||
30764421|NCT00349349|58773069|FG002|Overall Study|Adverse Event|2|||
30764422|NCT00349349|58773067|FG000|Overall Study|Withdrawal by Subject|5|||
30764423|NCT00349349|58773068|FG001|Overall Study|Withdrawal by Subject|2|||
30764424|NCT00349349|58773069|FG002|Overall Study|Withdrawal by Subject|1|||
30764425|NCT00349349|58773067|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
30764426|NCT00349349|58773068|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
30764427|NCT00349349|58773069|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
30764428|NCT00349349|58773067|FG000|Overall Study|Death|13|||
30764429|NCT00349349|58773068|FG001|Overall Study|Death|10|||
30764430|NCT00349349|58773069|FG002|Overall Study|Death|1|||
30764431|NCT00349349|58773067|FG000|Overall Study|Other Treatment Selected|2|||
30764432|NCT00349349|58773068|FG001|Overall Study|Other Treatment Selected|0|||
30764433|NCT00349349|58773069|FG002|Overall Study|Other Treatment Selected|0|||
30764434|NCT00349349|58773067|FG000|Overall Study|Participant Reduced General Condition|0|||
30764435|NCT00349349|58773068|FG001|Overall Study|Participant Reduced General Condition|1|||
30764436|NCT00349349|58773069|FG002|Overall Study|Participant Reduced General Condition|0|||
30764437|NCT00349349|58773067|FG000|Overall Study|Physician Decision|1|||
30764438|NCT00349349|58773068|FG001|Overall Study|Physician Decision|2|||
30764439|NCT00349349|58773069|FG002|Overall Study|Physician Decision|1|||
30764440|NCT00349349|58773067|FG000|Overall Study|No Response|0|||
30764441|NCT00349349|58773068|FG001|Overall Study|No Response|3|||
30764442|NCT00349349|58773069|FG002|Overall Study|No Response|0|||
30764443|NCT00349349|58773067|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
30764444|NCT00349349|58773068|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
30764445|NCT00349349|58773069|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
30764446|NCT02950480|58773081|FG000|Overall Study|Withdrawal by Subject|1|||
30764447|NCT02950480|58773082|FG001|Overall Study|Withdrawal by Subject|0|||
30764448|NCT00348881|58773090|FG000|Overall Study|Lost to Follow-up|12|||
30764449|NCT00348881|58773091|FG001|Overall Study|Lost to Follow-up|6|||
30764450|NCT00348881|58773090|FG000|Overall Study|Withdrawal by Subject|3|||
30764451|NCT00348881|58773091|FG001|Overall Study|Withdrawal by Subject|4|||
30764452|NCT00348881|58773090|FG000|Overall Study|Adverse Event|2|||
30764453|NCT00348881|58773091|FG001|Overall Study|Adverse Event|0|||
30764454|NCT00348881|58773090|FG000|Overall Study|Serious Adverse Event|0|||
30764455|NCT00348881|58773091|FG001|Overall Study|Serious Adverse Event|2|||
30764456|NCT03376516|58773101|FG000|Overall Study|Not treated|1|||
30951097|NCT01903031|58998105|FG001|Overall Study|Lost to Follow-up|0|||
30951098|NCT01903031|58998106|FG002|Overall Study|Lost to Follow-up|1|||
30951099|NCT01903031|58998104|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
30764457|NCT03376516|58773101|FG000|Overall Study|Consent withdrawn|1|||
30764458|NCT03797144|58773127|FG000|Enrollment|Protocol Violation|4|||
30764459|NCT03797144|58773128|FG001|Enrollment|Protocol Violation|1|||
30764460|NCT03797144|58773127|FG000|Surgery|Protocol Violation|1|||
30764461|NCT03797144|58773128|FG001|Surgery|Protocol Violation|0|||
30764462|NCT03797144|58773127|FG000|3 Month|Early termination cut-off date|2|||
30632593|NCT01190930|58644411|FG008|Induction|No treatment|0|||
30632594|NCT01190930|58644412|FG009|Induction|No treatment|0|||
30764463|NCT03797144|58773128|FG001|3 Month|Early termination cut-off date|0|||
30764464|NCT03797144|58773127|FG000|12 Month|Early termination cut-off date|8|||
30848335|NCT02853331|58874353|FG000|Overall Study|Ongoing in study|368|||
30632595|NCT01190930|58644403|FG000|Induction|Ineligible|69|||
30632596|NCT01190930|58644404|FG001|Induction|Ineligible|4|||
30632597|NCT01190930|58644405|FG002|Induction|Ineligible|0|||
30632598|NCT01190930|58644406|FG003|Induction|Ineligible|0|||
30632599|NCT01190930|58644407|FG004|Induction|Ineligible|0|||
30632600|NCT01190930|58644408|FG005|Induction|Ineligible|0|||
30632601|NCT01190930|58644409|FG006|Induction|Ineligible|0|||
30632602|NCT01190930|58644410|FG007|Induction|Ineligible|0|||
30632603|NCT01190930|58644411|FG008|Induction|Ineligible|0|||
30632604|NCT01190930|58644412|FG009|Induction|Ineligible|0|||
30632605|NCT01190930|58644403|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
30632606|NCT01190930|58644404|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
30632607|NCT01190930|58644405|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
30632608|NCT01190930|58644406|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
30632609|NCT01190930|58644407|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
30632610|NCT01190930|58644408|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
30632611|NCT01190930|58644409|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
30632612|NCT01190930|58644410|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
30632613|NCT01190930|58644411|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
30632614|NCT01190930|58644412|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
30632615|NCT01190930|58644403|FG000|Post Induction Pre-Maintenance|Death|0|||
30632616|NCT01190930|58644404|FG001|Post Induction Pre-Maintenance|Death|0|||
30632617|NCT01190930|58644405|FG002|Post Induction Pre-Maintenance|Death|8|||
30632618|NCT01190930|58644406|FG003|Post Induction Pre-Maintenance|Death|4|||
30632619|NCT01190930|58644407|FG004|Post Induction Pre-Maintenance|Death|0|||
30632620|NCT01190930|58644408|FG005|Post Induction Pre-Maintenance|Death|0|||
30632621|NCT01190930|58644409|FG006|Post Induction Pre-Maintenance|Death|0|||
30632622|NCT01190930|58644410|FG007|Post Induction Pre-Maintenance|Death|0|||
30632623|NCT01190930|58644411|FG008|Post Induction Pre-Maintenance|Death|0|||
30632624|NCT01190930|58644412|FG009|Post Induction Pre-Maintenance|Death|0|||
30632625|NCT01190930|58644403|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
30632626|NCT01190930|58644404|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
30632627|NCT01190930|58644405|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
30632628|NCT01190930|58644406|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
30632629|NCT01190930|58644407|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
30632630|NCT01190930|58644408|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
30632631|NCT01190930|58644409|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
30632632|NCT01190930|58644410|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
30632633|NCT01190930|58644411|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
30632634|NCT01190930|58644412|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
30632635|NCT01190930|58644403|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
30632636|NCT01190930|58644404|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
30632637|NCT01190930|58644405|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
30632638|NCT01190930|58644406|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
30632639|NCT01190930|58644407|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
30632640|NCT01190930|58644408|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
30632641|NCT01190930|58644409|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
30632642|NCT01190930|58644410|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
30632643|NCT01190930|58644411|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
30632644|NCT01190930|58644412|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
30632645|NCT01190930|58644403|FG000|Post Induction Pre-Maintenance|Refusal|0|||
30632646|NCT01190930|58644404|FG001|Post Induction Pre-Maintenance|Refusal|2|||
30632647|NCT01190930|58644405|FG002|Post Induction Pre-Maintenance|Refusal|694|||
30632648|NCT01190930|58644406|FG003|Post Induction Pre-Maintenance|Refusal|4|||
30632649|NCT01190930|58644407|FG004|Post Induction Pre-Maintenance|Refusal|0|||
30632650|NCT01190930|58644408|FG005|Post Induction Pre-Maintenance|Refusal|3|||
30632651|NCT01190930|58644409|FG006|Post Induction Pre-Maintenance|Refusal|0|||
30632652|NCT01190930|58644410|FG007|Post Induction Pre-Maintenance|Refusal|0|||
30632653|NCT01190930|58644411|FG008|Post Induction Pre-Maintenance|Refusal|0|||
30632654|NCT01190930|58644412|FG009|Post Induction Pre-Maintenance|Refusal|0|||
30632655|NCT01190930|58644403|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
30632656|NCT01190930|58644404|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
30632657|NCT01190930|58644405|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
30632658|NCT01190930|58644406|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
30632659|NCT01190930|58644407|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
30632660|NCT01190930|58644408|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
30632661|NCT01190930|58644409|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
30632662|NCT01190930|58644410|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
30632663|NCT01190930|58644411|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
30632664|NCT01190930|58644412|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
30632665|NCT01190930|58644403|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
30632666|NCT01190930|58644404|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
30632667|NCT01190930|58644405|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
30632668|NCT01190930|58644406|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
30632669|NCT01190930|58644407|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
30632670|NCT01190930|58644408|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
30632671|NCT01190930|58644409|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
30632672|NCT01190930|58644410|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
30632673|NCT01190930|58644411|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
30632674|NCT01190930|58644412|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
30632675|NCT01190930|58644403|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
30632676|NCT01190930|58644404|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
30632677|NCT01190930|58644405|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
30632678|NCT01190930|58644406|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
30632679|NCT01190930|58644407|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
30632680|NCT01190930|58644408|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
30632681|NCT01190930|58644409|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
30632682|NCT01190930|58644410|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
30632683|NCT01190930|58644411|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
30632684|NCT01190930|58644412|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
30632685|NCT01190930|58644403|FG000|Post Induction Pre-Maintenance|Relapse|0|||
30632686|NCT01190930|58644404|FG001|Post Induction Pre-Maintenance|Relapse|0|||
30632687|NCT01190930|58644405|FG002|Post Induction Pre-Maintenance|Relapse|1|||
30632688|NCT01190930|58644406|FG003|Post Induction Pre-Maintenance|Relapse|0|||
30632689|NCT01190930|58644407|FG004|Post Induction Pre-Maintenance|Relapse|0|||
30632690|NCT01190930|58644408|FG005|Post Induction Pre-Maintenance|Relapse|0|||
30632691|NCT01190930|58644409|FG006|Post Induction Pre-Maintenance|Relapse|0|||
30632692|NCT01190930|58644410|FG007|Post Induction Pre-Maintenance|Relapse|0|||
30632693|NCT01190930|58644411|FG008|Post Induction Pre-Maintenance|Relapse|0|||
30632694|NCT01190930|58644412|FG009|Post Induction Pre-Maintenance|Relapse|0|||
30632695|NCT01190930|58644403|FG000|Maintenance|Adverse Event|0|||
30632696|NCT01190930|58644404|FG001|Maintenance|Adverse Event|0|||
30632697|NCT01190930|58644405|FG002|Maintenance|Adverse Event|0|||
30632698|NCT01190930|58644406|FG003|Maintenance|Adverse Event|0|||
30632699|NCT01190930|58644407|FG004|Maintenance|Adverse Event|0|||
30632700|NCT01190930|58644408|FG005|Maintenance|Adverse Event|1|||
30632701|NCT01190930|58644409|FG006|Maintenance|Adverse Event|1|||
30632702|NCT01190930|58644410|FG007|Maintenance|Adverse Event|3|||
30632703|NCT01190930|58644411|FG008|Maintenance|Adverse Event|3|||
30632704|NCT01190930|58644412|FG009|Maintenance|Adverse Event|0|||
30632705|NCT01190930|58644403|FG000|Maintenance|Death|0|||
30632706|NCT01190930|58644404|FG001|Maintenance|Death|0|||
30632707|NCT01190930|58644405|FG002|Maintenance|Death|0|||
30632708|NCT01190930|58644406|FG003|Maintenance|Death|1|||
30632709|NCT01190930|58644407|FG004|Maintenance|Death|0|||
30632710|NCT01190930|58644408|FG005|Maintenance|Death|0|||
30632711|NCT01190930|58644409|FG006|Maintenance|Death|2|||
30632712|NCT01190930|58644410|FG007|Maintenance|Death|2|||
30632713|NCT01190930|58644411|FG008|Maintenance|Death|2|||
30632714|NCT01190930|58644412|FG009|Maintenance|Death|2|||
30632715|NCT01190930|58644403|FG000|Maintenance|Lost to Follow-up|0|||
30632716|NCT01190930|58644404|FG001|Maintenance|Lost to Follow-up|0|||
30632717|NCT01190930|58644405|FG002|Maintenance|Lost to Follow-up|0|||
30632718|NCT01190930|58644406|FG003|Maintenance|Lost to Follow-up|0|||
30632719|NCT01190930|58644407|FG004|Maintenance|Lost to Follow-up|0|||
30632720|NCT01190930|58644408|FG005|Maintenance|Lost to Follow-up|0|||
30632721|NCT01190930|58644409|FG006|Maintenance|Lost to Follow-up|1|||
30632722|NCT01190930|58644410|FG007|Maintenance|Lost to Follow-up|1|||
30632723|NCT01190930|58644411|FG008|Maintenance|Lost to Follow-up|1|||
30632724|NCT01190930|58644412|FG009|Maintenance|Lost to Follow-up|0|||
30632725|NCT01190930|58644403|FG000|Maintenance|Physician Decision|0|||
30632726|NCT01190930|58644404|FG001|Maintenance|Physician Decision|1|||
30632727|NCT01190930|58644405|FG002|Maintenance|Physician Decision|0|||
30632728|NCT01190930|58644406|FG003|Maintenance|Physician Decision|5|||
30632729|NCT01190930|58644407|FG004|Maintenance|Physician Decision|9|||
30632730|NCT01190930|58644408|FG005|Maintenance|Physician Decision|4|||
30632731|NCT01190930|58644409|FG006|Maintenance|Physician Decision|8|||
30632732|NCT01190930|58644410|FG007|Maintenance|Physician Decision|8|||
30632733|NCT01190930|58644411|FG008|Maintenance|Physician Decision|10|||
30632734|NCT01190930|58644412|FG009|Maintenance|Physician Decision|17|||
30632735|NCT01190930|58644403|FG000|Maintenance|Withdrawal by Subject|0|||
30632736|NCT01190930|58644404|FG001|Maintenance|Withdrawal by Subject|0|||
30632737|NCT01190930|58644405|FG002|Maintenance|Withdrawal by Subject|0|||
30632738|NCT01190930|58644406|FG003|Maintenance|Withdrawal by Subject|0|||
30632739|NCT01190930|58644407|FG004|Maintenance|Withdrawal by Subject|0|||
30632740|NCT01190930|58644408|FG005|Maintenance|Withdrawal by Subject|0|||
30632741|NCT01190930|58644409|FG006|Maintenance|Withdrawal by Subject|2|||
30632742|NCT01190930|58644410|FG007|Maintenance|Withdrawal by Subject|1|||
30632743|NCT01190930|58644411|FG008|Maintenance|Withdrawal by Subject|4|||
30632744|NCT01190930|58644412|FG009|Maintenance|Withdrawal by Subject|1|||
30632745|NCT01190930|58644403|FG000|Maintenance|Refusal|0|||
30632746|NCT01190930|58644404|FG001|Maintenance|Refusal|1|||
30632747|NCT01190930|58644405|FG002|Maintenance|Refusal|0|||
30632748|NCT01190930|58644406|FG003|Maintenance|Refusal|2|||
30632749|NCT01190930|58644407|FG004|Maintenance|Refusal|0|||
30632750|NCT01190930|58644408|FG005|Maintenance|Refusal|4|||
30632751|NCT01190930|58644409|FG006|Maintenance|Refusal|5|||
30632752|NCT01190930|58644410|FG007|Maintenance|Refusal|17|||
30632753|NCT01190930|58644411|FG008|Maintenance|Refusal|13|||
30632754|NCT01190930|58644412|FG009|Maintenance|Refusal|6|||
30632755|NCT01190930|58644403|FG000|Maintenance|second malignant neoplasm|0|||
30632756|NCT01190930|58644404|FG001|Maintenance|second malignant neoplasm|0|||
30632757|NCT01190930|58644405|FG002|Maintenance|second malignant neoplasm|0|||
30632758|NCT01190930|58644406|FG003|Maintenance|second malignant neoplasm|1|||
30632759|NCT01190930|58644407|FG004|Maintenance|second malignant neoplasm|0|||
30632760|NCT01190930|58644408|FG005|Maintenance|second malignant neoplasm|1|||
30632761|NCT01190930|58644409|FG006|Maintenance|second malignant neoplasm|0|||
30632762|NCT01190930|58644410|FG007|Maintenance|second malignant neoplasm|0|||
30632763|NCT01190930|58644411|FG008|Maintenance|second malignant neoplasm|1|||
30632764|NCT01190930|58644412|FG009|Maintenance|second malignant neoplasm|0|||
30632765|NCT01190930|58644403|FG000|Maintenance|Inevaluable|0|||
30632766|NCT01190930|58644404|FG001|Maintenance|Inevaluable|0|||
30632767|NCT01190930|58644405|FG002|Maintenance|Inevaluable|0|||
30632768|NCT01190930|58644406|FG003|Maintenance|Inevaluable|0|||
30632769|NCT01190930|58644407|FG004|Maintenance|Inevaluable|0|||
30632770|NCT01190930|58644408|FG005|Maintenance|Inevaluable|1|||
30632771|NCT01190930|58644409|FG006|Maintenance|Inevaluable|1|||
30632772|NCT01190930|58644410|FG007|Maintenance|Inevaluable|1|||
30632773|NCT01190930|58644411|FG008|Maintenance|Inevaluable|0|||
30632774|NCT01190930|58644412|FG009|Maintenance|Inevaluable|0|||
30632775|NCT01190930|58644403|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
30632776|NCT01190930|58644404|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
30632777|NCT01190930|58644405|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
30632778|NCT01190930|58644406|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
30632779|NCT01190930|58644407|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
30632780|NCT01190930|58644408|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
30764465|NCT03797144|58773128|FG001|12 Month|Early termination cut-off date|9|||
30764466|NCT03797144|58773127|FG000|24 Month|Early termination cut-off date|1|||
30764467|NCT03797144|58773128|FG001|24 Month|Early termination cut-off date|1|||
30632781|NCT01190930|58644409|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
30632782|NCT01190930|58644410|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
30632783|NCT01190930|58644411|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
30632784|NCT01190930|58644412|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
30632785|NCT01190930|58644403|FG000|Maintenance|Relapse|0|||
30632786|NCT01190930|58644404|FG001|Maintenance|Relapse|0|||
30632787|NCT01190930|58644405|FG002|Maintenance|Relapse|0|||
30632788|NCT01190930|58644406|FG003|Maintenance|Relapse|2|||
30632789|NCT01190930|58644407|FG004|Maintenance|Relapse|0|||
30632790|NCT01190930|58644408|FG005|Maintenance|Relapse|1|||
30632791|NCT01190930|58644409|FG006|Maintenance|Relapse|6|||
30632792|NCT01190930|58644410|FG007|Maintenance|Relapse|13|||
30632793|NCT01190930|58644411|FG008|Maintenance|Relapse|11|||
30632794|NCT01190930|58644412|FG009|Maintenance|Relapse|11|||
30632795|NCT01190930|58644403|FG000|Maintenance|Still on therapy|0|||
30632796|NCT01190930|58644404|FG001|Maintenance|Still on therapy|8|||
30632797|NCT01190930|58644405|FG002|Maintenance|Still on therapy|0|||
30632798|NCT01190930|58644406|FG003|Maintenance|Still on therapy|29|||
30632799|NCT01190930|58644407|FG004|Maintenance|Still on therapy|0|||
30632800|NCT01190930|58644408|FG005|Maintenance|Still on therapy|0|||
30632801|NCT01190930|58644409|FG006|Maintenance|Still on therapy|0|||
30632802|NCT01190930|58644410|FG007|Maintenance|Still on therapy|0|||
30632803|NCT01190930|58644411|FG008|Maintenance|Still on therapy|0|||
30632804|NCT01190930|58644412|FG009|Maintenance|Still on therapy|0|||
30632805|NCT01101191|58644436|FG000|Period 1|Withdrawal by Subject|1|||
30632806|NCT01101191|58644437|FG001|Period 1|Withdrawal by Subject|0|||
30632807|NCT01101191|58644436|FG000|Period 1|Adverse Event|1|||
30632808|NCT01101191|58644437|FG001|Period 1|Adverse Event|2|||
30632809|NCT01178762|58644444|FG000|Overall Study|Lost to Follow-up|15|||
30632810|NCT01178294|58644448|FG000|Overall Study|Adverse Event|4|||
30632811|NCT01178294|58644448|FG000|Overall Study|Lost to Follow-up|2|||
30632812|NCT01178294|58644448|FG000|Overall Study|Lack of Efficacy|1|||
30632813|NCT01178294|58644448|FG000|Overall Study|Death|1|||
30632814|NCT01178294|58644448|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
30632815|NCT01178294|58644448|FG000|Overall Study|Subject status is terminal|1|||
30632816|NCT01178294|58644448|FG000|Overall Study|Completion status could not be verified|1|||
30632817|NCT01178138|58644452|FG000|Overall Study|Lost to Follow-up|8|||
30632818|NCT01178138|58644452|FG000|Overall Study|Withdrawal by Subject|7|||
30632819|NCT01178138|58644452|FG000|Overall Study|Physician Decision|8|||
30632820|NCT01177670|58644461|FG000|Overall Study|Study Terminated|115|||
30632821|NCT01177670|58644461|FG000|Overall Study|Physician Decision|50|||
30632822|NCT01177670|58644461|FG000|Overall Study|Withdrawal by Subject|4|||
30632823|NCT01190228|58644468|FG000|Overall Study|Protocol Violation|4|||
30632824|NCT01190228|58644469|FG001|Overall Study|Protocol Violation|0|||
30632825|NCT01190228|58644470|FG002|Overall Study|Protocol Violation|0|||
30632826|NCT01190228|58644468|FG000|Overall Study|Withdrawal by Subject|1|||
30632827|NCT01190228|58644469|FG001|Overall Study|Withdrawal by Subject|0|||
30632828|NCT01190228|58644470|FG002|Overall Study|Withdrawal by Subject|0|||
30632829|NCT01009086|58644483|FG000|Overall Study|Lack of Efficacy|16|||
30632830|NCT01009086|58644484|FG001|Overall Study|Lack of Efficacy|15|||
30632831|NCT01009086|58644485|FG002|Overall Study|Lack of Efficacy|9|||
30632832|NCT01009086|58644483|FG000|Overall Study|Lost to Follow-up|4|||
30632833|NCT01009086|58644484|FG001|Overall Study|Lost to Follow-up|5|||
30632834|NCT01009086|58644485|FG002|Overall Study|Lost to Follow-up|3|||
30632835|NCT01009086|58644483|FG000|Overall Study|Adverse Event|12|||
30632836|NCT01009086|58644484|FG001|Overall Study|Adverse Event|11|||
30632837|NCT01009086|58644485|FG002|Overall Study|Adverse Event|8|||
30632838|NCT01009086|58644483|FG000|Overall Study|Withdrawal by Subject|9|||
30632839|NCT01009086|58644484|FG001|Overall Study|Withdrawal by Subject|11|||
30632840|NCT01009086|58644485|FG002|Overall Study|Withdrawal by Subject|13|||
30632841|NCT01009086|58644483|FG000|Overall Study|Other|3|||
30632842|NCT01009086|58644484|FG001|Overall Study|Other|5|||
30632843|NCT01009086|58644485|FG002|Overall Study|Other|1|||
30632844|NCT01190150|58644500|FG000|First Treatment|Withdrawal by Subject|1|||
30632845|NCT01190150|58644501|FG001|First Treatment|Withdrawal by Subject|0|||
30632846|NCT01190150|58644500|FG000|Washout|Withdrawal by Subject|0|||
30632847|NCT01190150|58644501|FG001|Washout|Withdrawal by Subject|1|||
30632848|NCT01190150|58644500|FG000|Washout|Difficulty in adherence|0|||
30632849|NCT01190150|58644501|FG001|Washout|Difficulty in adherence|1|||
30632850|NCT01001520|58644507|FG000|Medication Period 1|Withdrawal by Subject|2|||
30632851|NCT01001520|58644508|FG001|Medication Period 1|Withdrawal by Subject|2|||
30632852|NCT01001520|58644507|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
30632853|NCT01001520|58644508|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
30632854|NCT01001520|58644507|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
30632855|NCT01001520|58644508|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
30632856|NCT01001520|58644507|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
30632857|NCT01001520|58644508|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
30632858|NCT01001520|58644507|FG000|Washout Period|Withdrawal by Subject|2|||
30632859|NCT01001520|58644508|FG001|Washout Period|Withdrawal by Subject|1|||
30632860|NCT01001520|58644507|FG000|Medication Period 2|Withdrawal by Subject|0|||
30632861|NCT01001520|58644508|FG001|Medication Period 2|Withdrawal by Subject|3|||
30632862|NCT01189604|58644532|FG000|Overall Study|Impossible to visit|0|||
30632863|NCT01189604|58644533|FG001|Overall Study|Impossible to visit|0|||
30632864|NCT01189604|58644534|FG002|Overall Study|Impossible to visit|0|||
30632865|NCT01189604|58644535|FG003|Overall Study|Impossible to visit|0|||
30632866|NCT01189604|58644536|FG004|Overall Study|Impossible to visit|0|||
30632867|NCT01189604|58644537|FG005|Overall Study|Impossible to visit|1|||
30632868|NCT01189604|58644538|FG006|Overall Study|Impossible to visit|0|||
30632869|NCT01189604|58644532|FG000|Overall Study|Adverse Event|0|||
30632870|NCT01189604|58644533|FG001|Overall Study|Adverse Event|1|||
30632871|NCT01189604|58644534|FG002|Overall Study|Adverse Event|0|||
30632872|NCT01189604|58644535|FG003|Overall Study|Adverse Event|0|||
30632873|NCT01189604|58644536|FG004|Overall Study|Adverse Event|2|||
30632874|NCT01189604|58644537|FG005|Overall Study|Adverse Event|0|||
30632875|NCT01189604|58644538|FG006|Overall Study|Adverse Event|1|||
30632876|NCT01189604|58644532|FG000|Overall Study|Withdrawal by Subject|1|||
30632877|NCT01189604|58644533|FG001|Overall Study|Withdrawal by Subject|0|||
30632878|NCT01189604|58644534|FG002|Overall Study|Withdrawal by Subject|0|||
30632879|NCT01189604|58644535|FG003|Overall Study|Withdrawal by Subject|0|||
30632880|NCT01189604|58644536|FG004|Overall Study|Withdrawal by Subject|0|||
30632881|NCT01189604|58644537|FG005|Overall Study|Withdrawal by Subject|0|||
30632882|NCT01189604|58644538|FG006|Overall Study|Withdrawal by Subject|0|||
30632883|NCT01008696|58644556|FG000|Overall Study|Participant's evasion of hospital visit|5|||
30632884|NCT01008696|58644557|FG001|Overall Study|Participant's evasion of hospital visit|4|||
30632885|NCT01008696|58644556|FG000|Overall Study|Withdrawal by Subject|2|||
30632886|NCT01008696|58644557|FG001|Overall Study|Withdrawal by Subject|4|||
30632887|NCT01008696|58644556|FG000|Overall Study|Physician Decision|5|||
30632888|NCT01008696|58644557|FG001|Overall Study|Physician Decision|1|||
30632889|NCT01008696|58644556|FG000|Overall Study|Adverse Event|1|||
30632890|NCT01008696|58644557|FG001|Overall Study|Adverse Event|0|||
30632891|NCT01008696|58644556|FG000|Overall Study|Participants' non-cooperation|2|||
30632892|NCT01008696|58644557|FG001|Overall Study|Participants' non-cooperation|3|||
30632893|NCT01008696|58644556|FG000|Overall Study|Other|2|||
30632894|NCT01008696|58644557|FG001|Overall Study|Other|3|||
30632895|NCT01008696|58644556|FG000|Overall Study|Other|0|||
30632896|NCT01008696|58644557|FG001|Overall Study|Other|2|||
30632897|NCT01176968|58644576|FG000|Overall Study|Adverse Event|10|||
30632898|NCT01176968|58644577|FG001|Overall Study|Adverse Event|11|||
30632899|NCT01176968|58644576|FG000|Overall Study|Death|2|||
30632900|NCT01176968|58644577|FG001|Overall Study|Death|3|||
30632901|NCT01176968|58644576|FG000|Overall Study|Lack of Efficacy|0|||
30632902|NCT01176968|58644577|FG001|Overall Study|Lack of Efficacy|1|||
30632903|NCT01176968|58644576|FG000|Overall Study|Lost to Follow-up|16|||
30632904|NCT01176968|58644577|FG001|Overall Study|Lost to Follow-up|14|||
30632905|NCT01176968|58644576|FG000|Overall Study|Withdrawal by Subject|48|||
30632906|NCT01176968|58644577|FG001|Overall Study|Withdrawal by Subject|48|||
30632907|NCT01176968|58644576|FG000|Overall Study|Protocol Violation|2|||
30632908|NCT01176968|58644577|FG001|Overall Study|Protocol Violation|1|||
30632909|NCT01176968|58644576|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
30632910|NCT01176968|58644577|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
30632911|NCT01176968|58644576|FG000|Overall Study|Study terminated by sponsor|0|||
30632912|NCT01176968|58644577|FG001|Overall Study|Study terminated by sponsor|1|||
30632913|NCT01176968|58644576|FG000|Overall Study|Reason not defined|5|||
30632914|NCT01176968|58644577|FG001|Overall Study|Reason not defined|3|||
30632915|NCT01006122|58644588|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
30632916|NCT01006122|58644589|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
30632917|NCT01006122|58644588|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
30632918|NCT01006122|58644589|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
30632919|NCT01006122|58644588|FG000|First Double-blind Intervention Period|Pregnancy|0|||
30632920|NCT01006122|58644589|FG001|First Double-blind Intervention Period|Pregnancy|1|||
30632921|NCT01006122|58644588|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
30632922|NCT01006122|58644589|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
30632923|NCT01006122|58644588|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
30632924|NCT01006122|58644589|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
30632925|NCT01006122|58644588|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
30632926|NCT01006122|58644589|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
30632927|NCT01006122|58644588|FG000|First Double-blind Intervention Period|Other|3|||
30632928|NCT01006122|58644589|FG001|First Double-blind Intervention Period|Other|0|||
30632929|NCT01006122|58644588|FG000|First Double-blind Intervention Period|Adverse Event|0|||
30632930|NCT01006122|58644589|FG001|First Double-blind Intervention Period|Adverse Event|4|||
30632931|NCT01006122|58644588|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
30632932|NCT01006122|58644589|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
30632933|NCT01006122|58644588|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
30632934|NCT01006122|58644589|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
30632935|NCT01006122|58644588|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
30632936|NCT01006122|58644589|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
30632937|NCT01006122|58644588|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
30632938|NCT01006122|58644589|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
30632939|NCT01006122|58644588|FG000|Second Double-blind Intervention Period|Death|0|||
30632940|NCT01006122|58644589|FG001|Second Double-blind Intervention Period|Death|1|||
30632941|NCT01005966|58644595|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
30632942|NCT01005966|58644596|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
30632943|NCT01005966|58644597|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
30632944|NCT01005966|58644598|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
30632945|NCT01005966|58644599|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
30632946|NCT01005966|58644595|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
30632947|NCT01005966|58644596|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
30632948|NCT01005966|58644597|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
30632949|NCT01005966|58644598|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
30632950|NCT01005966|58644599|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
30632951|NCT01005966|58644595|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
30632952|NCT01005966|58644596|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
30632953|NCT01005966|58644597|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
30632954|NCT01005966|58644598|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
30632955|NCT01005966|58644599|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
30632956|NCT01005966|58644595|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
30632957|NCT01005966|58644596|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
30632958|NCT01005966|58644597|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
30632959|NCT01005966|58644598|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
30632960|NCT01005966|58644599|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
30632961|NCT01005966|58644595|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
30632962|NCT01005966|58644596|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
30632963|NCT01005966|58644597|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
30632964|NCT01005966|58644598|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
30632965|NCT01005966|58644599|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
30632966|NCT01005966|58644595|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
30632967|NCT01005966|58644596|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
30632968|NCT01005966|58644597|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
30632969|NCT01005966|58644598|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
30632970|NCT01005966|58644599|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
30632971|NCT01005966|58644595|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
30632972|NCT01005966|58644596|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
30632973|NCT01005966|58644597|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
30632974|NCT01005966|58644598|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
30632975|NCT01005966|58644599|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
30632976|NCT01005966|58644595|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
30632977|NCT01005966|58644596|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
30632978|NCT01005966|58644597|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
30632979|NCT01005966|58644598|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
30632980|NCT01005966|58644599|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
30632981|NCT01005966|58644595|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
30632982|NCT01005966|58644596|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
30632983|NCT01005966|58644597|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
30764468|NCT00347009|58773135|FG000|Overall Study|Death|1|||
30764469|NCT00347009|58773135|FG000|Overall Study|Adverse Event|6|||
30764470|NCT00347009|58773135|FG000|Overall Study|Withdrawal by Subject|3|||
30764471|NCT00347009|58773135|FG000|Overall Study|Physician Decision|5|||
30764472|NCT00347009|58773135|FG000|Overall Study|Lost to Follow-up|4|||
30764473|NCT00347009|58773135|FG000|Overall Study|Protocol Violation|2|||
30764474|NCT00347009|58773135|FG000|Overall Study|Adverse Laboratory Experience|1|||
30764475|NCT00347009|58773135|FG000|Overall Study|Insufficient Viral Suppression|3|||
30764476|NCT00347009|58773135|FG000|Overall Study|Increased ALT/HBV DNA|1|||
30764477|NCT00347009|58773135|FG000|Overall Study|Serious Adverse Event|1|||
30764478|NCT00346775|58773143|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
30764479|NCT00346775|58773144|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
30764480|NCT00346775|58773143|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
30764481|NCT00346775|58773144|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
30764482|NCT00346775|58773143|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
30764483|NCT00346775|58773144|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
30764484|NCT00346697|58773156|FG000|Overall Study|Lost to Follow-up|0|||
30764485|NCT00346697|58773157|FG001|Overall Study|Lost to Follow-up|1|||
30764486|NCT03400852|58773167|FG000|Blinded Treatment Period|Physician Decision|0|||
30764487|NCT03400852|58773168|FG001|Blinded Treatment Period|Physician Decision|1|||
30764488|NCT03400852|58773169|FG002|Blinded Treatment Period|Physician Decision|0|||
30764489|NCT03400852|58773167|FG000|Blinded Treatment Period|Adverse Event|1|||
30764490|NCT03400852|58773168|FG001|Blinded Treatment Period|Adverse Event|1|||
30764491|NCT03400852|58773169|FG002|Blinded Treatment Period|Adverse Event|0|||
30764492|NCT03400852|58773167|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
30764493|NCT03400852|58773168|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
30632984|NCT01005966|58644598|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
30632985|NCT01005966|58644599|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
30632986|NCT01005732|58644625|FG000|Overall Study|Lost to Follow-up|10|||
30632987|NCT01005732|58644625|FG000|Overall Study|Death|1|||
30632988|NCT00603382|58644639|FG000|Overall Study|Adverse Event|0|||
30632989|NCT00603382|58644640|FG001|Overall Study|Adverse Event|1|||
30632990|NCT00603382|58644641|FG002|Overall Study|Adverse Event|1|||
30632991|NCT00603382|58644642|FG003|Overall Study|Adverse Event|2|||
30632992|NCT00603382|58644643|FG004|Overall Study|Adverse Event|1|||
30632993|NCT00603382|58644644|FG005|Overall Study|Adverse Event|2|||
30632994|NCT00603382|58644639|FG000|Overall Study|Lack of Efficacy|14|||
30632995|NCT00603382|58644640|FG001|Overall Study|Lack of Efficacy|9|||
30632996|NCT00603382|58644641|FG002|Overall Study|Lack of Efficacy|3|||
30632997|NCT00603382|58644642|FG003|Overall Study|Lack of Efficacy|6|||
30632998|NCT00603382|58644643|FG004|Overall Study|Lack of Efficacy|6|||
30632999|NCT00603382|58644644|FG005|Overall Study|Lack of Efficacy|11|||
30633000|NCT00603382|58644639|FG000|Overall Study|Protocol Violation|1|||
30633001|NCT00603382|58644640|FG001|Overall Study|Protocol Violation|0|||
30633002|NCT00603382|58644641|FG002|Overall Study|Protocol Violation|1|||
30633003|NCT00603382|58644642|FG003|Overall Study|Protocol Violation|2|||
30633004|NCT00603382|58644643|FG004|Overall Study|Protocol Violation|1|||
30633005|NCT00603382|58644644|FG005|Overall Study|Protocol Violation|0|||
30633006|NCT00603382|58644639|FG000|Overall Study|Lost to Follow-up|0|||
30633007|NCT00603382|58644640|FG001|Overall Study|Lost to Follow-up|1|||
30633008|NCT00603382|58644641|FG002|Overall Study|Lost to Follow-up|1|||
30633009|NCT00603382|58644642|FG003|Overall Study|Lost to Follow-up|1|||
30633010|NCT00603382|58644643|FG004|Overall Study|Lost to Follow-up|0|||
30633011|NCT00603382|58644644|FG005|Overall Study|Lost to Follow-up|1|||
30633012|NCT00603382|58644639|FG000|Overall Study|Physician Decision|0|||
30633013|NCT00603382|58644640|FG001|Overall Study|Physician Decision|0|||
30633014|NCT00603382|58644641|FG002|Overall Study|Physician Decision|2|||
30633015|NCT00603382|58644642|FG003|Overall Study|Physician Decision|0|||
30633016|NCT00603382|58644643|FG004|Overall Study|Physician Decision|1|||
30633017|NCT00603382|58644644|FG005|Overall Study|Physician Decision|3|||
30633018|NCT00603382|58644639|FG000|Overall Study|Withdrawal by Subject|3|||
30633019|NCT00603382|58644640|FG001|Overall Study|Withdrawal by Subject|3|||
30633020|NCT00603382|58644641|FG002|Overall Study|Withdrawal by Subject|1|||
30633021|NCT00603382|58644642|FG003|Overall Study|Withdrawal by Subject|1|||
30633022|NCT00603382|58644643|FG004|Overall Study|Withdrawal by Subject|0|||
30633023|NCT00603382|58644644|FG005|Overall Study|Withdrawal by Subject|1|||
30633024|NCT01176266|58644658|FG000|Overall Study|Death|6|||
30633025|NCT01176266|58644658|FG000|Overall Study|Withdrawal by Subject|3|||
30633026|NCT01182428|58644668|FG000|Overall Study|Physician Decision|1|||
30633027|NCT01182428|58644669|FG001|Overall Study|Physician Decision|0|||
30633028|NCT01182428|58644668|FG000|Overall Study|Lost to Follow-up|9|||
30633029|NCT01182428|58644669|FG001|Overall Study|Lost to Follow-up|1|||
30633030|NCT01182428|58644668|FG000|Overall Study|Withdrawal by Subject|1|||
30633031|NCT01182428|58644669|FG001|Overall Study|Withdrawal by Subject|0|||
30633032|NCT00603304|58644677|FG000|Overall Study|Lost to Follow-up|5|||
30633033|NCT00603304|58644678|FG001|Overall Study|Lost to Follow-up|7|||
30633034|NCT00603304|58644677|FG000|Overall Study|Withdrawal by Subject|8|||
30633035|NCT00603304|58644678|FG001|Overall Study|Withdrawal by Subject|5|||
30633036|NCT00603304|58644677|FG000|Overall Study|Protocol Violation|1|||
30633037|NCT00603304|58644678|FG001|Overall Study|Protocol Violation|0|||
30633038|NCT00603304|58644677|FG000|Overall Study|Adverse Event|4|||
30633039|NCT00603304|58644678|FG001|Overall Study|Adverse Event|2|||
30633040|NCT00603304|58644677|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
30633041|NCT00603304|58644678|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
30633042|NCT00603304|58644677|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
30633043|NCT00603304|58644678|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
30633044|NCT00603304|58644677|FG000|Overall Study|Exclusionary Medication|2|||
30764494|NCT03400852|58773169|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
30764495|NCT03400852|58773167|FG000|Open Label Period|Physician Decision|0|||
30633045|NCT00603304|58644678|FG001|Overall Study|Exclusionary Medication|3|||
30633046|NCT00603304|58644677|FG000|Overall Study|Non-Compliant|0|||
30633047|NCT00603304|58644678|FG001|Overall Study|Non-Compliant|1|||
30633048|NCT00603304|58644677|FG000|Overall Study|Moved Away|0|||
30633049|NCT00603304|58644678|FG001|Overall Study|Moved Away|2|||
30633050|NCT00603304|58644677|FG000|Overall Study|Other|2|||
30633051|NCT00603304|58644678|FG001|Overall Study|Other|0|||
30633052|NCT00603304|58644677|FG000|Overall Study|Patient Decision|2|||
30633053|NCT00603304|58644678|FG001|Overall Study|Patient Decision|0|||
30633054|NCT01176032|58644688|FG000|Overall Study|Adverse Event|1|||
30633055|NCT01176032|58644689|FG001|Overall Study|Adverse Event|0|||
30633056|NCT01176032|58644688|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30633057|NCT01176032|58644689|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30633058|NCT01176032|58644688|FG000|Overall Study|Protocol Violation|1|||
30633059|NCT01176032|58644689|FG001|Overall Study|Protocol Violation|0|||
30633060|NCT01176032|58644688|FG000|Overall Study|Informed consent withdrawn|3|||
30633061|NCT01176032|58644689|FG001|Overall Study|Informed consent withdrawn|0|||
30633062|NCT01176032|58644688|FG000|Overall Study|Other|1|||
30633063|NCT01176032|58644689|FG001|Overall Study|Other|0|||
30633064|NCT01008618|58644700|FG000|Period 1 (Titration Period)|Physician Decision|2|||
30633065|NCT01008618|58644701|FG001|Period 1 (Titration Period)|Physician Decision|0|||
30633066|NCT01008618|58644702|FG002|Period 1 (Titration Period)|Physician Decision|0|||
30633067|NCT01008618|58644700|FG000|Period 1 (Titration Period)|Adverse Event|33|||
30633068|NCT01008618|58644701|FG001|Period 1 (Titration Period)|Adverse Event|0|||
30633069|NCT01008618|58644702|FG002|Period 1 (Titration Period)|Adverse Event|0|||
30633070|NCT01008618|58644700|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
30633071|NCT01008618|58644701|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
30633072|NCT01008618|58644702|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
30633073|NCT01008618|58644700|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
30633074|NCT01008618|58644701|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
30633075|NCT01008618|58644702|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
30633076|NCT01008618|58644700|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
30633077|NCT01008618|58644701|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
30633078|NCT01008618|58644702|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
30633079|NCT01008618|58644700|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
30633080|NCT01008618|58644701|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
30633081|NCT01008618|58644702|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
30633082|NCT01008618|58644700|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
30633083|NCT01008618|58644701|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
30633084|NCT01008618|58644702|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
30633085|NCT01008618|58644700|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
30633086|NCT01008618|58644701|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
30633087|NCT01008618|58644702|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
30633088|NCT01008618|58644700|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
30633089|NCT01008618|58644701|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
30633090|NCT01008618|58644702|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
30633091|NCT01008618|58644700|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
30633092|NCT01008618|58644701|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
30633093|NCT01008618|58644702|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
30633094|NCT01008618|58644700|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
30633095|NCT01008618|58644701|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
30633096|NCT01008618|58644702|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
30633097|NCT01008618|58644700|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
30633098|NCT01008618|58644701|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
30633099|NCT01008618|58644702|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
30633100|NCT01001208|58644713|FG000|Overall Study|Adverse Event|10|||
30848336|NCT02853331|58874354|FG001|Overall Study|Ongoing in study|325|||
30848337|NCT05718466|58874362|FG000|Overall Study|Withdrawal by Subject|1|||
30848338|NCT05718466|58874363|FG001|Overall Study|Withdrawal by Subject|2|||
30848339|NCT05718466|58874362|FG000|Overall Study|Death|0|||
30633101|NCT01001208|58644714|FG001|Overall Study|Adverse Event|5|||
30633102|NCT01001208|58644713|FG000|Overall Study|Lost to Follow-up|5|||
30764496|NCT03400852|58773168|FG001|Open Label Period|Physician Decision|0|||
30764497|NCT03400852|58773169|FG002|Open Label Period|Physician Decision|1|||
30764498|NCT03400852|58773167|FG000|Open Label Period|Study terminated by sponsor|0|||
30764499|NCT03400852|58773168|FG001|Open Label Period|Study terminated by sponsor|0|||
30764500|NCT03400852|58773169|FG002|Open Label Period|Study terminated by sponsor|21|||
30764501|NCT03398356|58773180|FG000|Before Treatment|Lost to Follow-up|1|||
30764502|NCT03398356|58773181|FG001|Before Treatment|Lost to Follow-up|2|||
30764503|NCT03398356|58773182|FG002|Before Treatment|Lost to Follow-up|0|||
30764504|NCT03398356|58773180|FG000|Before Treatment|drug intolerance|2|||
30764505|NCT03398356|58773181|FG001|Before Treatment|drug intolerance|1|||
30764506|NCT03398356|58773182|FG002|Before Treatment|drug intolerance|0|||
30764507|NCT03398356|58773180|FG000|Before Treatment|Withdrawal by Subject|0|||
30764508|NCT03398356|58773181|FG001|Before Treatment|Withdrawal by Subject|5|||
30764509|NCT03398356|58773182|FG002|Before Treatment|Withdrawal by Subject|0|||
30764510|NCT03398356|58773180|FG000|Before Treatment|Physician Decision|0|||
30764511|NCT03398356|58773181|FG001|Before Treatment|Physician Decision|0|||
30764512|NCT03398356|58773182|FG002|Before Treatment|Physician Decision|11|||
30764513|NCT03398356|58773180|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
30764514|NCT03398356|58773181|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
30764515|NCT03398356|58773182|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
30764516|NCT00346151|58773190|FG000|Overall Study|Withdrawal by Subject|3|||
30764517|NCT00130286|58773198|FG000|Overall Study|Withdrawal by Subject|0|||
30764518|NCT00130286|58773199|FG001|Overall Study|Withdrawal by Subject|1|||
30764519|NCT00130286|58773200|FG002|Overall Study|Withdrawal by Subject|2|||
30764520|NCT00130286|58773201|FG003|Overall Study|Withdrawal by Subject|2|||
30764521|NCT00130286|58773198|FG000|Overall Study|Adverse Event|0|||
30764522|NCT00130286|58773199|FG001|Overall Study|Adverse Event|0|||
30764523|NCT00130286|58773200|FG002|Overall Study|Adverse Event|2|||
30764524|NCT00130286|58773201|FG003|Overall Study|Adverse Event|0|||
30764525|NCT00130286|58773198|FG000|Overall Study|Missing lab specimens|0|||
30764526|NCT00130286|58773199|FG001|Overall Study|Missing lab specimens|2|||
30764527|NCT00130286|58773200|FG002|Overall Study|Missing lab specimens|0|||
30764528|NCT00130286|58773201|FG003|Overall Study|Missing lab specimens|0|||
30764529|NCT00346073|58773213|FG000|Overall Study|Serious Adverse Event|2|||
30764530|NCT00346073|58773214|FG001|Overall Study|Serious Adverse Event|0|||
30764531|NCT00346073|58773213|FG000|Overall Study|Lost to Follow-up|39|||
30764532|NCT00346073|58773214|FG001|Overall Study|Lost to Follow-up|24|||
30764533|NCT03374488|58773222|FG000|Overall Study|Death|13|||
30764534|NCT03374488|58773223|FG001|Overall Study|Death|13|||
30764535|NCT03374488|58773222|FG000|Overall Study|Withdrawal by Subject|3|||
30764536|NCT03374488|58773223|FG001|Overall Study|Withdrawal by Subject|1|||
30764537|NCT03374488|58773222|FG000|Overall Study|Physician Decision|3|||
30764538|NCT03374488|58773223|FG001|Overall Study|Physician Decision|0|||
30764539|NCT00345683|58773232|FG000|Overall Study|Lost to Follow-up|19|||
30764540|NCT00345683|58773233|FG001|Overall Study|Lost to Follow-up|7|||
30764541|NCT00345683|58773232|FG000|Overall Study|Other|6|||
30764542|NCT00345683|58773233|FG001|Overall Study|Other|2|||
30764543|NCT03828383|58773241|FG000|Overall Study|Lost to Follow-up|3|||
30764544|NCT03828383|58773242|FG001|Overall Study|Lost to Follow-up|2|||
30764545|NCT03828383|58773241|FG000|Overall Study|Withdrawal by Subject|4|||
30764546|NCT03828383|58773242|FG001|Overall Study|Withdrawal by Subject|5|||
30764547|NCT00345605|58773248|FG000|Arm 1|Adverse Event|0|||
30764548|NCT00345605|58773249|FG001|Arm 1|Adverse Event|1|||
30764549|NCT00345605|58773248|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
30764550|NCT00345605|58773249|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
30764551|NCT03394924|58773260|FG000|Overall Study|Adverse Event|0|||
30764552|NCT03394924|58773261|FG001|Overall Study|Adverse Event|5|||
30764553|NCT03394924|58773262|FG002|Overall Study|Adverse Event|0|||
30764554|NCT03394924|58773260|FG000|Overall Study|Withdrawal by Subject|2|||
30764555|NCT03394924|58773261|FG001|Overall Study|Withdrawal by Subject|0|||
30764556|NCT03394924|58773262|FG002|Overall Study|Withdrawal by Subject|0|||
30764557|NCT03394924|58773260|FG000|Overall Study|Lost to Follow-up|0|||
30633103|NCT01001208|58644714|FG001|Overall Study|Lost to Follow-up|9|||
30633104|NCT01001208|58644713|FG000|Overall Study|Physician Decision|1|||
30633105|NCT01001208|58644714|FG001|Overall Study|Physician Decision|0|||
30633106|NCT01001208|58644713|FG000|Overall Study|Withdrawal by Subject|4|||
30633107|NCT01001208|58644714|FG001|Overall Study|Withdrawal by Subject|5|||
30633108|NCT01001208|58644713|FG000|Overall Study|Ineligibility Determined|4|||
30633109|NCT01001208|58644714|FG001|Overall Study|Ineligibility Determined|2|||
30633110|NCT01001208|58644713|FG000|Overall Study|Noncompliance|4|||
30633111|NCT01001208|58644714|FG001|Overall Study|Noncompliance|7|||
30633112|NCT01001208|58644713|FG000|Overall Study|Disease Progression|0|||
30633113|NCT01001208|58644714|FG001|Overall Study|Disease Progression|3|||
30633114|NCT01001208|58644713|FG000|Overall Study|Other|0|||
30633115|NCT01001208|58644714|FG001|Overall Study|Other|2|||
30633116|NCT01000974|58644723|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
30633117|NCT01000974|58644724|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
30633118|NCT01000974|58644725|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
30633119|NCT01000974|58644723|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
30633120|NCT01000974|58644724|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
30633121|NCT01000974|58644725|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
30633122|NCT01000974|58644723|FG000|Primary Vaccination Phase|Protocol Violation|40|||
30633123|NCT01000974|58644724|FG001|Primary Vaccination Phase|Protocol Violation|3|||
30633124|NCT01000974|58644725|FG002|Primary Vaccination Phase|Protocol Violation|2|||
30633125|NCT01000974|58644723|FG000|Primary Vaccination Phase|Adverse Event|14|||
30633126|NCT01000974|58644724|FG001|Primary Vaccination Phase|Adverse Event|2|||
30633127|NCT01000974|58644725|FG002|Primary Vaccination Phase|Adverse Event|2|||
30633128|NCT01000974|58644723|FG000|Primary Vaccination Phase|Other|4|||
30633129|NCT01000974|58644724|FG001|Primary Vaccination Phase|Other|9|||
30633130|NCT01000974|58644725|FG002|Primary Vaccination Phase|Other|12|||
30951100|NCT01903031|58998105|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
30951101|NCT01903031|58998106|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
30633131|NCT01000974|58644723|FG000|Booster Vaccination Phase|Protocol Violation|0|||
30633132|NCT01000974|58644724|FG001|Booster Vaccination Phase|Protocol Violation|0|||
30633133|NCT01000974|58644725|FG002|Booster Vaccination Phase|Protocol Violation|2|||
30633134|NCT01000974|58644723|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
30633135|NCT01000974|58644724|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
30633136|NCT01000974|58644725|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
30633137|NCT01000974|58644723|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
30633138|NCT01000974|58644724|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
30633139|NCT01000974|58644725|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
30633140|NCT01000974|58644723|FG000|Booster Vaccination Phase|Other|24|||
30633141|NCT01000974|58644724|FG001|Booster Vaccination Phase|Other|6|||
30633142|NCT01000974|58644725|FG002|Booster Vaccination Phase|Other|4|||
30633143|NCT01193842|58644741|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
30633144|NCT01193842|58644742|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
30633145|NCT01193842|58644743|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
30633146|NCT01193842|58644744|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
30633147|NCT01193842|58644745|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
30633148|NCT01193842|58644741|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
30633149|NCT01193842|58644742|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
30633150|NCT01193842|58644743|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
30633151|NCT01193842|58644744|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
30633152|NCT01193842|58644745|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
30633153|NCT01193842|58644741|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
30633154|NCT01193842|58644742|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
30764558|NCT03394924|58773261|FG001|Overall Study|Lost to Follow-up|1|||
30764559|NCT03394924|58773262|FG002|Overall Study|Lost to Follow-up|0|||
30764560|NCT03394924|58773260|FG000|Overall Study|Did not meet all inclusion criteria|1|||
30764561|NCT03394924|58773261|FG001|Overall Study|Did not meet all inclusion criteria|0|||
30764562|NCT03394924|58773262|FG002|Overall Study|Did not meet all inclusion criteria|0|||
30764563|NCT00345293|58773272|FG000|Overall Study|Unable to access line for sample|1|||
30764564|NCT00345293|58773273|FG001|Overall Study|Unable to access line for sample|0|||
30764565|NCT00345293|58773272|FG000|Overall Study|Withdrawal by Subject|1|||
30764566|NCT00345293|58773273|FG001|Overall Study|Withdrawal by Subject|0|||
30764567|NCT00355121|58773282|FG000|Overall Study|Did not receive study vaccine|1|||
30764568|NCT00355121|58773283|FG001|Overall Study|Did not receive study vaccine|0|||
30764569|NCT00355121|58773284|FG002|Overall Study|Did not receive study vaccine|1|||
30764570|NCT00355121|58773282|FG000|Overall Study|Adverse Event|0|||
30764571|NCT00355121|58773283|FG001|Overall Study|Adverse Event|1|||
30764572|NCT00355121|58773284|FG002|Overall Study|Adverse Event|0|||
30764573|NCT00355121|58773282|FG000|Overall Study|Protocol Violation|7|||
30764574|NCT00355121|58773283|FG001|Overall Study|Protocol Violation|9|||
30764575|NCT00355121|58773284|FG002|Overall Study|Protocol Violation|1|||
30764576|NCT00355121|58773282|FG000|Overall Study|Lost to Follow-up|4|||
30764577|NCT00355121|58773283|FG001|Overall Study|Lost to Follow-up|7|||
30764578|NCT00355121|58773284|FG002|Overall Study|Lost to Follow-up|1|||
30764579|NCT00355121|58773282|FG000|Overall Study|Withdrawal by Subject|9|||
30764580|NCT00355121|58773283|FG001|Overall Study|Withdrawal by Subject|10|||
30764581|NCT00355121|58773284|FG002|Overall Study|Withdrawal by Subject|2|||
30764582|NCT00355121|58773282|FG000|Overall Study|Serious adverse events|0|||
30764583|NCT00355121|58773283|FG001|Overall Study|Serious adverse events|2|||
30764584|NCT00355121|58773284|FG002|Overall Study|Serious adverse events|0|||
30764585|NCT00343889|58773297|FG000|Overall Study|Lost to Follow-up|2|||
30764586|NCT00343889|58773298|FG001|Overall Study|Lost to Follow-up|0|||
30764587|NCT00343889|58773297|FG000|Overall Study|Withdrawal by Subject|0|||
30764588|NCT00343889|58773298|FG001|Overall Study|Withdrawal by Subject|1|||
30764589|NCT00343889|58773297|FG000|Overall Study|Protocol Violation|1|||
30764590|NCT00343889|58773298|FG001|Overall Study|Protocol Violation|0|||
30764591|NCT00354341|58773306|FG000|Overall Study|Adverse Event|1|||
30764592|NCT00354341|58773307|FG001|Overall Study|Adverse Event|0|||
30764593|NCT00354341|58773306|FG000|Overall Study|Death|0|||
30764594|NCT00354341|58773307|FG001|Overall Study|Death|2|||
30764595|NCT00354341|58773306|FG000|Overall Study|Refused treatment|1|||
30764596|NCT00354341|58773307|FG001|Overall Study|Refused treatment|2|||
30764597|NCT00354341|58773306|FG000|Overall Study|Failure to return|0|||
30764598|NCT00354341|58773307|FG001|Overall Study|Failure to return|1|||
30764599|NCT00354341|58773306|FG000|Overall Study|Other|1|||
30764600|NCT00354341|58773307|FG001|Overall Study|Other|2|||
30764601|NCT00354107|58773313|FG000|Overall Study|Adverse Event|2|||
30764602|NCT00354107|58773313|FG000|Overall Study|Physician Decision|2|||
30951102|NCT01616693|58998138|FG000|Evaluated for Safety|Physician Decision|1|||
30764603|NCT00354107|58773313|FG000|Overall Study|Withdrawal by Subject|1|||
30764604|NCT00354029|58773319|FG000|Overall Study|Protocol Violation|4|||
30764605|NCT00354029|58773320|FG001|Overall Study|Protocol Violation|2|||
30764606|NCT00353873|58773328|FG000|Overall Study|Protocol Violation|1|||
30764607|NCT00353873|58773329|FG001|Overall Study|Protocol Violation|2|||
30764608|NCT00353873|58773328|FG000|Overall Study|Exacerbation|1|||
30764609|NCT00353873|58773329|FG001|Overall Study|Exacerbation|0|||
30633155|NCT01193842|58644743|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
30633156|NCT01193842|58644744|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
30633157|NCT01193842|58644745|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
30633158|NCT01193842|58644741|FG000|Phase II: Randomized Groups|Death|0|||
30633159|NCT01193842|58644742|FG001|Phase II: Randomized Groups|Death|0|||
30633160|NCT01193842|58644743|FG002|Phase II: Randomized Groups|Death|0|||
30633161|NCT01193842|58644744|FG003|Phase II: Randomized Groups|Death|1|||
30633162|NCT01193842|58644745|FG004|Phase II: Randomized Groups|Death|1|||
30633163|NCT01193842|58644741|FG000|Phase II: Randomized Groups|Adverse Event|0|||
30633164|NCT01193842|58644742|FG001|Phase II: Randomized Groups|Adverse Event|0|||
30633165|NCT01193842|58644743|FG002|Phase II: Randomized Groups|Adverse Event|0|||
30633166|NCT01193842|58644744|FG003|Phase II: Randomized Groups|Adverse Event|5|||
30633167|NCT01193842|58644745|FG004|Phase II: Randomized Groups|Adverse Event|3|||
30633168|NCT01193842|58644741|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
30633169|NCT01193842|58644742|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
30633170|NCT01193842|58644743|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
30633171|NCT01193842|58644744|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
30633172|NCT01193842|58644745|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
30633173|NCT01193842|58644741|FG000|Phase II: Randomized Groups|Ineligible|0|||
30633174|NCT01193842|58644742|FG001|Phase II: Randomized Groups|Ineligible|0|||
30764610|NCT00353873|58773328|FG000|Overall Study|Adverse Event|1|||
30764611|NCT00353873|58773329|FG001|Overall Study|Adverse Event|0|||
30764612|NCT00353873|58773328|FG000|Overall Study|Physician Decision|2|||
30764613|NCT00353873|58773329|FG001|Overall Study|Physician Decision|0|||
30764614|NCT00353873|58773328|FG000|Overall Study|Withdrawal by Subject|1|||
30764615|NCT00353873|58773329|FG001|Overall Study|Withdrawal by Subject|1|||
30764616|NCT03796676|58773338|FG000|Overall Study|Adverse Event|2|||
30764617|NCT03796676|58773339|FG001|Overall Study|Adverse Event|1|||
30764618|NCT03796676|58773340|FG002|Overall Study|Adverse Event|2|||
30848340|NCT05718466|58874363|FG001|Overall Study|Death|1|||
30848341|NCT04938453|58874371|FG000|Washout Period 1|Adverse Event|1|||
30848342|NCT04938453|58874372|FG001|Washout Period 1|Adverse Event|0|||
30764619|NCT03796676|58773338|FG000|Overall Study|Lost to Follow-up|2|||
30764620|NCT03796676|58773339|FG001|Overall Study|Lost to Follow-up|1|||
30764621|NCT03796676|58773340|FG002|Overall Study|Lost to Follow-up|0|||
30764622|NCT03796676|58773338|FG000|Overall Study|Protocol Violation|0|||
30848343|NCT04938453|58874371|FG000|Washout Period 1|Physician Decision|0|||
30848344|NCT04938453|58874372|FG001|Washout Period 1|Physician Decision|1|||
30848345|NCT04590937|58874403|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
30848346|NCT04147260|58874431|FG000|Overall Study|Adverse Event|1|||
30848347|NCT04147260|58874432|FG001|Overall Study|Adverse Event|0|||
30848348|NCT04147260|58874433|FG002|Overall Study|Adverse Event|1|||
30848349|NCT04147260|58874434|FG003|Overall Study|Adverse Event|2|||
30848350|NCT04147260|58874435|FG004|Overall Study|Adverse Event|0|||
30848351|NCT04147260|58874431|FG000|Overall Study|Withdrawal by Subject|0|||
30848352|NCT04147260|58874432|FG001|Overall Study|Withdrawal by Subject|0|||
30848353|NCT04147260|58874433|FG002|Overall Study|Withdrawal by Subject|1|||
30848354|NCT04147260|58874434|FG003|Overall Study|Withdrawal by Subject|1|||
30848355|NCT04147260|58874435|FG004|Overall Study|Withdrawal by Subject|0|||
30848356|NCT04134728|58874452|FG000|Overall Study|Adverse Event|3|||
30848357|NCT04134728|58874453|FG001|Overall Study|Adverse Event|2|||
30848358|NCT04134728|58874454|FG002|Overall Study|Adverse Event|9|||
30848359|NCT04134728|58874455|FG003|Overall Study|Adverse Event|0|||
30848360|NCT04134728|58874456|FG004|Overall Study|Adverse Event|0|||
30848361|NCT04134728|58874457|FG005|Overall Study|Adverse Event|0|||
30848362|NCT04134728|58874452|FG000|Overall Study|Lack of Efficacy|3|||
30848363|NCT04134728|58874453|FG001|Overall Study|Lack of Efficacy|3|||
30848364|NCT04134728|58874454|FG002|Overall Study|Lack of Efficacy|1|||
30848365|NCT04134728|58874455|FG003|Overall Study|Lack of Efficacy|2|||
30848366|NCT04134728|58874456|FG004|Overall Study|Lack of Efficacy|0|||
30848367|NCT04134728|58874457|FG005|Overall Study|Lack of Efficacy|0|||
30848368|NCT04134728|58874452|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
30848369|NCT04134728|58874453|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
30848370|NCT04134728|58874454|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
30848371|NCT04134728|58874455|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
30848372|NCT04134728|58874456|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
30848373|NCT04134728|58874457|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
30848374|NCT04134728|58874452|FG000|Overall Study|Protocol Deviation|0|||
30848375|NCT04134728|58874453|FG001|Overall Study|Protocol Deviation|0|||
30848376|NCT04134728|58874454|FG002|Overall Study|Protocol Deviation|1|||
30633175|NCT01193842|58644743|FG002|Phase II: Randomized Groups|Ineligible|0|||
30633176|NCT01193842|58644744|FG003|Phase II: Randomized Groups|Ineligible|0|||
30633177|NCT01193842|58644745|FG004|Phase II: Randomized Groups|Ineligible|1|||
30633178|NCT01193842|58644741|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
30633179|NCT01193842|58644742|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
30764623|NCT03796676|58773339|FG001|Overall Study|Protocol Violation|0|||
30848377|NCT04134728|58874455|FG003|Overall Study|Protocol Deviation|0|||
30848378|NCT04134728|58874456|FG004|Overall Study|Protocol Deviation|0|||
30951103|NCT01616693|58998139|FG001|Evaluated for Safety|Physician Decision|0|||
30951104|NCT01616693|58998140|FG002|Evaluated for Safety|Physician Decision|1|||
30951105|NCT01616693|58998141|FG003|Evaluated for Safety|Physician Decision|0|||
30951106|NCT01616693|58998138|FG000|Received Both Vaccines|Adverse Event|2|||
30951107|NCT01616693|58998139|FG001|Received Both Vaccines|Adverse Event|0|||
30951108|NCT01616693|58998140|FG002|Received Both Vaccines|Adverse Event|0|||
30951109|NCT01616693|58998141|FG003|Received Both Vaccines|Adverse Event|0|||
30951110|NCT01616693|58998138|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
30951111|NCT01616693|58998139|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
30951112|NCT01616693|58998140|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
30951113|NCT01616693|58998141|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
30951114|NCT01616693|58998138|FG000|Received Both Vaccines|Lost to Follow-up|4|||
30951115|NCT01616693|58998139|FG001|Received Both Vaccines|Lost to Follow-up|3|||
30951116|NCT01616693|58998140|FG002|Received Both Vaccines|Lost to Follow-up|4|||
30951117|NCT01616693|58998141|FG003|Received Both Vaccines|Lost to Follow-up|4|||
30951118|NCT01616693|58998138|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
30951119|NCT01616693|58998139|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
30951120|NCT01616693|58998140|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
30951121|NCT01616693|58998141|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
30951122|NCT01616459|58998248|FG000|Overall Study|Adverse Event|1|||
30951123|NCT01616459|58998249|FG001|Overall Study|Adverse Event|1|||
30951124|NCT01616459|58998250|FG002|Overall Study|Adverse Event|2|||
30951125|NCT01616459|58998251|FG003|Overall Study|Adverse Event|0|||
30951126|NCT01616459|58998248|FG000|Overall Study|Lost to Follow-up|1|||
30951127|NCT01616459|58998249|FG001|Overall Study|Lost to Follow-up|11|||
30951128|NCT01616459|58998250|FG002|Overall Study|Lost to Follow-up|3|||
30951129|NCT01616459|58998251|FG003|Overall Study|Lost to Follow-up|2|||
30951130|NCT01616459|58998248|FG000|Overall Study|Protocol Violation|0|||
30951131|NCT01616459|58998249|FG001|Overall Study|Protocol Violation|0|||
30951132|NCT01616459|58998250|FG002|Overall Study|Protocol Violation|0|||
30951133|NCT01616459|58998251|FG003|Overall Study|Protocol Violation|2|||
30951134|NCT01616459|58998248|FG000|Overall Study|Withdrawal by Subject|2|||
30951135|NCT01616459|58998249|FG001|Overall Study|Withdrawal by Subject|4|||
30951136|NCT01616459|58998250|FG002|Overall Study|Withdrawal by Subject|4|||
30951137|NCT01616459|58998251|FG003|Overall Study|Withdrawal by Subject|4|||
30951138|NCT01616459|58998248|FG000|Overall Study|Other reason|0|||
30951139|NCT01616459|58998249|FG001|Overall Study|Other reason|1|||
30951140|NCT01616459|58998250|FG002|Overall Study|Other reason|1|||
30951141|NCT01616459|58998251|FG003|Overall Study|Other reason|0|||
30951142|NCT01919801|58998268|FG000|Overall Study|Withdrawal by Subject|1|||
30951143|NCT01919801|58998269|FG001|Overall Study|Withdrawal by Subject|0|||
30951144|NCT01919801|58998268|FG000|Overall Study|Physician Decision|0|||
30951145|NCT01919801|58998269|FG001|Overall Study|Physician Decision|1|||
30951146|NCT01919801|58998268|FG000|Overall Study|Lost to Follow-up|0|||
30951147|NCT01919801|58998269|FG001|Overall Study|Lost to Follow-up|1|||
30951148|NCT01919801|58998268|FG000|Overall Study|Other|0|||
30951149|NCT01919801|58998269|FG001|Overall Study|Other|1|||
30951150|NCT01919723|58998277|FG000|Overall Study|Blood Samples Hemolyzed|2|||
30951151|NCT01919723|58998278|FG001|Overall Study|Blood Samples Hemolyzed|2|||
30951152|NCT01919489|58998286|FG000|Overall Study|Rejected the need of injections|4|||
30951153|NCT01919489|58998287|FG001|Overall Study|Rejected the need of injections|7|||
30951154|NCT01919489|58998286|FG000|Overall Study|Adverse Event|10|||
30951155|NCT01919489|58998287|FG001|Overall Study|Adverse Event|0|||
30951156|NCT01919489|58998286|FG000|Overall Study|Hospital readmission|2|||
30951157|NCT01919489|58998287|FG001|Overall Study|Hospital readmission|9|||
30951158|NCT01919489|58998286|FG000|Overall Study|Death|2|||
30951159|NCT01919489|58998287|FG001|Overall Study|Death|1|||
30951160|NCT01919489|58998286|FG000|Overall Study|Lost to Follow-up|38|||
30951161|NCT01919489|58998287|FG001|Overall Study|Lost to Follow-up|27|||
30951162|NCT01919411|58998295|FG000|Overall Study|Lost to Follow-up|2|||
30951163|NCT01919411|58998296|FG001|Overall Study|Lost to Follow-up|4|||
30951164|NCT01919411|58998295|FG000|Overall Study|Physician Decision|1|||
30951165|NCT01919411|58998296|FG001|Overall Study|Physician Decision|0|||
30951166|NCT01919411|58998295|FG000|Overall Study|Protocol Violation|2|||
30951167|NCT01919411|58998296|FG001|Overall Study|Protocol Violation|1|||
30951168|NCT01901393|58998304|FG000|Overall Study|Adverse Event|1|||
30951169|NCT01901393|58998305|FG001|Overall Study|Adverse Event|0|||
30951170|NCT01890707|58998313|FG000|Overall Study|Lost to Follow-up|1|||
30951171|NCT01890707|58998314|FG001|Overall Study|Lost to Follow-up|1|||
30951172|NCT01900691|58998320|FG000|Overall Study|Death|7|||
30951173|NCT01900691|58998320|FG000|Overall Study|Lost to Follow-up|4|||
30951174|NCT01900691|58998320|FG000|Overall Study|Study Device Not Placed|3|||
30951175|NCT01900691|58998320|FG000|Overall Study|Non study stent placed|2|||
30951176|NCT01900691|58998320|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
30951177|NCT01900691|58998320|FG000|Overall Study|Complete stent migration through digestive tract|1|||
30633180|NCT01193842|58644743|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
30633181|NCT01193842|58644744|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
30633182|NCT01193842|58644745|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
30633183|NCT01004406|58644764|FG000|Overall Study|Withdrawal by Subject|2|||
30633184|NCT01004406|58644765|FG001|Overall Study|Withdrawal by Subject|0|||
30633185|NCT01004406|58644764|FG000|Overall Study|Lost to Follow-up|1|||
30633186|NCT01004406|58644765|FG001|Overall Study|Lost to Follow-up|0|||
30633187|NCT01182350|58644780|FG000|Overall Study|Adverse Event|5|||
30633188|NCT01182350|58644781|FG001|Overall Study|Adverse Event|0|||
30633189|NCT01182350|58644782|FG002|Overall Study|Adverse Event|0|||
30633190|NCT01182350|58644783|FG003|Overall Study|Adverse Event|0|||
30633191|NCT01182350|58644784|FG004|Overall Study|Adverse Event|0|||
30633192|NCT01182350|58644780|FG000|Overall Study|Disease Progression|15|||
30633193|NCT01182350|58644781|FG001|Overall Study|Disease Progression|12|||
30633194|NCT01182350|58644782|FG002|Overall Study|Disease Progression|0|||
30633195|NCT01182350|58644783|FG003|Overall Study|Disease Progression|1|||
30633196|NCT01182350|58644784|FG004|Overall Study|Disease Progression|0|||
30633197|NCT01182350|58644780|FG000|Overall Study|Death|0|||
30633198|NCT01182350|58644781|FG001|Overall Study|Death|1|||
30633199|NCT01182350|58644782|FG002|Overall Study|Death|1|||
30633200|NCT01182350|58644783|FG003|Overall Study|Death|0|||
30633201|NCT01182350|58644784|FG004|Overall Study|Death|0|||
30633202|NCT01182350|58644780|FG000|Overall Study|Withdrawal by Subject|3|||
30633203|NCT01182350|58644781|FG001|Overall Study|Withdrawal by Subject|1|||
30633204|NCT01182350|58644782|FG002|Overall Study|Withdrawal by Subject|0|||
30633205|NCT01182350|58644783|FG003|Overall Study|Withdrawal by Subject|1|||
30633206|NCT01182350|58644784|FG004|Overall Study|Withdrawal by Subject|0|||
30633207|NCT01182350|58644780|FG000|Overall Study|Alternative Therapy|2|||
30633208|NCT01182350|58644781|FG001|Overall Study|Alternative Therapy|0|||
30633209|NCT01182350|58644782|FG002|Overall Study|Alternative Therapy|1|||
30633210|NCT01182350|58644783|FG003|Overall Study|Alternative Therapy|0|||
30633211|NCT01182350|58644784|FG004|Overall Study|Alternative Therapy|0|||
30633212|NCT01182350|58644780|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
30633213|NCT01182350|58644781|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
30633214|NCT01182350|58644782|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
30633215|NCT01182350|58644783|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
30633216|NCT01182350|58644784|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
30633217|NCT01182350|58644780|FG000|Overall Study|Unevaluable for Biopsy|0|||
30633218|NCT01182350|58644781|FG001|Overall Study|Unevaluable for Biopsy|0|||
30633219|NCT01182350|58644782|FG002|Overall Study|Unevaluable for Biopsy|0|||
30633220|NCT01182350|58644783|FG003|Overall Study|Unevaluable for Biopsy|0|||
30633221|NCT01182350|58644784|FG004|Overall Study|Unevaluable for Biopsy|3|||
30633222|NCT01163474|58644800|FG000|Overall Study|Withdrawal by Subject|1|||
30633223|NCT01163474|58644800|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
30633224|NCT01163474|58644800|FG000|Overall Study|Lost to Follow-up|3|||
30633225|NCT00603538|58644810|FG000|Overall Study|Adverse Event|0|||
30633226|NCT00603538|58644811|FG001|Overall Study|Adverse Event|4|||
30633227|NCT00603538|58644812|FG002|Overall Study|Adverse Event|2|||
30633228|NCT00603538|58644810|FG000|Overall Study|Objective progression or relapse|3|||
30633229|NCT00603538|58644811|FG001|Overall Study|Objective progression or relapse|0|||
30633230|NCT00603538|58644812|FG002|Overall Study|Objective progression or relapse|0|||
30633231|NCT01163318|58644823|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
30633232|NCT01163318|58644823|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
30633233|NCT01163318|58644823|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
30633234|NCT01163318|58644823|FG000|Overall Study|Participants Without Case Report Form|7|||
30633235|NCT01163318|58644823|FG000|Overall Study|Multiple Reasons Per Participant|224|||
30633236|NCT01162304|58644827|FG000|Overall Study|Beck scale to high|11|||
30633237|NCT04515394|58644833|FG000|Overall Study|Participant did not receive treatment|1|||
30633238|NCT01175018|58644839|FG000|Overall Study|Adverse Event|3|||
30848379|NCT04134728|58874457|FG005|Overall Study|Protocol Deviation|0|||
30633239|NCT01175018|58644840|FG001|Overall Study|Adverse Event|1|||
30633240|NCT01174784|58644848|FG000|Overall Study|Screen fails|4|||
30633241|NCT01174550|58644855|FG000|Overall Study|Death|75|||
30633242|NCT01174550|58644856|FG001|Overall Study|Death|74|||
30633243|NCT01174550|58644855|FG000|Overall Study|Lost to Follow-up|652|||
30633244|NCT01174550|58644856|FG001|Overall Study|Lost to Follow-up|510|||
30633245|NCT01174550|58644855|FG000|Overall Study|Withdrawal by Subject|543|||
30633246|NCT01174550|58644856|FG001|Overall Study|Withdrawal by Subject|289|||
30633247|NCT01008150|58644866|FG000|Overall Study|did not receive study drug|1|||
30764624|NCT03796676|58773340|FG002|Overall Study|Protocol Violation|1|||
30764625|NCT03796676|58773338|FG000|Overall Study|Withdrawal by Subject|1|||
30848380|NCT04134728|58874452|FG000|Overall Study|Informed Consent Withdrawn|3|||
30633248|NCT01008150|58644867|FG001|Overall Study|did not receive study drug|1|||
30633249|NCT01008150|58644868|FG002|Overall Study|did not receive study drug|1|||
30633250|NCT01008150|58644869|FG003|Overall Study|did not receive study drug|0|||
30633251|NCT01007916|58644880|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
30633252|NCT01007916|58644881|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
30633253|NCT01007916|58644880|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
30633254|NCT01007916|58644881|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
30633255|NCT01007838|58644891|FG000|Overall Study|Withdrawal by Subject|1|||
30633256|NCT01007838|58644892|FG001|Overall Study|Withdrawal by Subject|0|||
30633257|NCT01007838|58644893|FG002|Overall Study|Withdrawal by Subject|0|||
30633258|NCT01007838|58644894|FG003|Overall Study|Withdrawal by Subject|0|||
30633259|NCT01007838|58644891|FG000|Overall Study|Physician Decision|1|||
30633260|NCT01007838|58644892|FG001|Overall Study|Physician Decision|0|||
30633261|NCT01007838|58644893|FG002|Overall Study|Physician Decision|0|||
30633262|NCT01007838|58644894|FG003|Overall Study|Physician Decision|0|||
30633263|NCT01007838|58644891|FG000|Overall Study|Started home haemodialysis|1|||
30633264|NCT01007838|58644892|FG001|Overall Study|Started home haemodialysis|0|||
30633265|NCT01007838|58644893|FG002|Overall Study|Started home haemodialysis|0|||
30633266|NCT01007838|58644894|FG003|Overall Study|Started home haemodialysis|0|||
30633267|NCT01007448|58644906|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
30633268|NCT01007448|58644907|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
30633269|NCT01007448|58644906|FG000|Overall Study|Staph Skin Infection Flare|1|||
30633270|NCT01007448|58644907|FG001|Overall Study|Staph Skin Infection Flare|0|||
30633271|NCT01007448|58644906|FG000|Overall Study|Participant Leaving the Country|1|||
30633272|NCT01007448|58644907|FG001|Overall Study|Participant Leaving the Country|0|||
30633273|NCT01007448|58644906|FG000|Overall Study|Participant Given Prohibited Medication|1|||
30633274|NCT01007448|58644907|FG001|Overall Study|Participant Given Prohibited Medication|0|||
30633275|NCT01007448|58644906|FG000|Overall Study|Progressive Disease|1|||
30633276|NCT01007448|58644907|FG001|Overall Study|Progressive Disease|2|||
30633277|NCT01007448|58644906|FG000|Overall Study|Lack of Efficacy|2|||
30633278|NCT01007448|58644907|FG001|Overall Study|Lack of Efficacy|0|||
30633279|NCT01007448|58644906|FG000|Overall Study|Withdrawal by Subject|2|||
30633280|NCT01007448|58644907|FG001|Overall Study|Withdrawal by Subject|3|||
30633281|NCT01007448|58644906|FG000|Overall Study|Adverse Event|1|||
30633282|NCT01007448|58644907|FG001|Overall Study|Adverse Event|4|||
30633283|NCT03538756|58644913|FG000|Long-Term Follow-up|Adverse Event|0|||
30633284|NCT03538756|58644914|FG001|Long-Term Follow-up|Adverse Event|0|||
30633285|NCT03538756|58644915|FG002|Long-Term Follow-up|Adverse Event|6|||
30633286|NCT03538756|58644913|FG000|Long-Term Follow-up|Death|0|||
30633287|NCT03538756|58644914|FG001|Long-Term Follow-up|Death|0|||
30633288|NCT03538756|58644915|FG002|Long-Term Follow-up|Death|1|||
30633289|NCT03538756|58644913|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
30633290|NCT03538756|58644914|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
30633291|NCT03538756|58644915|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
30633292|NCT03538756|58644913|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
30633293|NCT03538756|58644914|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
30633294|NCT03538756|58644915|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
30633295|NCT03538756|58644913|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
30633296|NCT03538756|58644914|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
30633297|NCT03538756|58644915|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
30633298|NCT01004250|58644925|FG000|Induction Therapy Period|Adverse Event|10|||
30633299|NCT01004250|58644925|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
30633300|NCT01004250|58644925|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
30633301|NCT01004250|58644925|FG000|Induction Therapy Period|Physician Decision|2|||
30633302|NCT01004250|58644925|FG000|Maintenance Therapy Period|Adverse Event|15|||
30633303|NCT01004250|58644925|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
30633304|NCT01004250|58644925|FG000|Maintenance Therapy Period|Protocol Violation|1|||
30633305|NCT01004250|58644925|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
30633306|NCT01004250|58644925|FG000|Maintenance Therapy Period|Physician Decision|4|||
30633307|NCT01004250|58644925|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
30633308|NCT01004172|58644933|FG000|Overall Study|Progressive Disease in CNS Only|16|||
30633309|NCT01004172|58644933|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
30633310|NCT01004172|58644933|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
30633311|NCT01004172|58644933|FG000|Overall Study|Adverse Event|1|||
30633312|NCT01004172|58644933|FG000|Overall Study|Physician Decision|1|||
30633313|NCT01004172|58644933|FG000|Overall Study|Symptomatic Deterioration|2|||
30633314|NCT01161524|58644940|FG000|Core Study (23 Weeks)|Adverse Event|3|||
30633315|NCT01161524|58644941|FG001|Core Study (23 Weeks)|Adverse Event|0|||
30633316|NCT01161524|58644942|FG002|Core Study (23 Weeks)|Adverse Event|0|||
30633317|NCT01161524|58644940|FG000|Core Study (23 Weeks)|Other|1|||
30633318|NCT01161524|58644941|FG001|Core Study (23 Weeks)|Other|0|||
30633319|NCT01161524|58644942|FG002|Core Study (23 Weeks)|Other|0|||
30633320|NCT01161524|58644940|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
30633321|NCT01161524|58644941|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
30633322|NCT01161524|58644942|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
30633323|NCT01161524|58644940|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
30633324|NCT01161524|58644941|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
30633325|NCT01161524|58644942|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
30633326|NCT01161524|58644940|FG000|Core Study (23 Weeks)|Subject Choice|3|||
30633327|NCT01161524|58644941|FG001|Core Study (23 Weeks)|Subject Choice|2|||
30633328|NCT01161524|58644942|FG002|Core Study (23 Weeks)|Subject Choice|0|||
30633329|NCT01161524|58644940|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
30633330|NCT01161524|58644941|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
30633331|NCT01161524|58644942|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
30633332|NCT01161524|58644940|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
30633333|NCT01161524|58644941|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
30633334|NCT01161524|58644942|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
30633335|NCT01161524|58644940|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
30633336|NCT01161524|58644941|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
30633337|NCT01161524|58644942|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
30633338|NCT01161524|58644940|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
30633339|NCT01161524|58644941|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
30633340|NCT01161524|58644942|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
30633341|NCT01161524|58644940|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
30633342|NCT01161524|58644941|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
30633343|NCT01161524|58644942|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
30633344|NCT01000506|58644955|FG000|Overall Study|Adverse Event|6|||
30633345|NCT01000506|58644956|FG001|Overall Study|Adverse Event|5|||
30633346|NCT01000506|58644957|FG002|Overall Study|Adverse Event|8|||
30633347|NCT01000506|58644958|FG003|Overall Study|Adverse Event|9|||
30633348|NCT01000506|58644955|FG000|Overall Study|Lack of Efficacy|8|||
30633349|NCT01000506|58644956|FG001|Overall Study|Lack of Efficacy|6|||
30633350|NCT01000506|58644957|FG002|Overall Study|Lack of Efficacy|4|||
30633351|NCT01000506|58644958|FG003|Overall Study|Lack of Efficacy|4|||
30633352|NCT01000506|58644955|FG000|Overall Study|Protocol Violation|1|||
30633353|NCT01000506|58644956|FG001|Overall Study|Protocol Violation|1|||
30633354|NCT01000506|58644957|FG002|Overall Study|Protocol Violation|0|||
30633355|NCT01000506|58644958|FG003|Overall Study|Protocol Violation|0|||
30633356|NCT01000506|58644955|FG000|Overall Study|Lost to Follow-up|1|||
30633357|NCT01000506|58644956|FG001|Overall Study|Lost to Follow-up|1|||
30633358|NCT01000506|58644957|FG002|Overall Study|Lost to Follow-up|4|||
30633359|NCT01000506|58644958|FG003|Overall Study|Lost to Follow-up|0|||
30633360|NCT01000506|58644955|FG000|Overall Study|Physician Decision|1|||
30633361|NCT01000506|58644956|FG001|Overall Study|Physician Decision|3|||
30633362|NCT01000506|58644957|FG002|Overall Study|Physician Decision|3|||
30633363|NCT01000506|58644958|FG003|Overall Study|Physician Decision|3|||
30633364|NCT01000506|58644955|FG000|Overall Study|Withdrawal by Subject|11|||
30633365|NCT01000506|58644956|FG001|Overall Study|Withdrawal by Subject|8|||
30633366|NCT01000506|58644957|FG002|Overall Study|Withdrawal by Subject|2|||
30633367|NCT01000506|58644958|FG003|Overall Study|Withdrawal by Subject|7|||
30633368|NCT01174238|58644968|FG000|Overall Study|Lost to Follow-up|2|||
30633369|NCT01174160|58644977|FG000|Overall Study|Adverse Event|1|||
30633370|NCT01174160|58644978|FG001|Overall Study|Adverse Event|0|||
30633371|NCT01174160|58644977|FG000|Overall Study|Lost to Follow-up|1|||
30633372|NCT01174160|58644978|FG001|Overall Study|Lost to Follow-up|0|||
30633373|NCT01174160|58644977|FG000|Overall Study|Physician Decision|1|||
30633374|NCT01174160|58644978|FG001|Overall Study|Physician Decision|0|||
30633375|NCT01174160|58644977|FG000|Overall Study|Protocol Violation|4|||
30633376|NCT01174160|58644978|FG001|Overall Study|Protocol Violation|6|||
30633377|NCT01174160|58644977|FG000|Overall Study|Withdrawal by Subject|1|||
30633378|NCT01174160|58644978|FG001|Overall Study|Withdrawal by Subject|0|||
30633379|NCT01161446|58644986|FG000|Overall Study|Lost to Follow-up|18|||
30633380|NCT01161446|58644987|FG001|Overall Study|Lost to Follow-up|14|||
30633381|NCT01161446|58644986|FG000|Overall Study|Withdrawal by Subject|0|||
30633382|NCT01161446|58644987|FG001|Overall Study|Withdrawal by Subject|1|||
30633383|NCT01174004|58644995|FG000|Overall Study|Adverse Event|2|||
30633384|NCT01174004|58644996|FG001|Overall Study|Adverse Event|10|||
30633385|NCT01174004|58644995|FG000|Overall Study|Withdrawal by Subject|2|||
30633386|NCT01174004|58644996|FG001|Overall Study|Withdrawal by Subject|3|||
30633387|NCT01174004|58644995|FG000|Overall Study|At Discretion of Sponsor|2|||
30633388|NCT01174004|58644996|FG001|Overall Study|At Discretion of Sponsor|2|||
30633389|NCT01174004|58644995|FG000|Overall Study|Protocol Violation|0|||
30633390|NCT01174004|58644996|FG001|Overall Study|Protocol Violation|1|||
30633391|NCT01174004|58644995|FG000|Overall Study|Physician Decision|1|||
30633392|NCT01174004|58644996|FG001|Overall Study|Physician Decision|0|||
30633393|NCT01173692|58645004|FG000|Overall Study|Adverse Event|1|||
30633394|NCT01173692|58645005|FG001|Overall Study|Adverse Event|2|||
30633395|NCT01173692|58645004|FG000|Overall Study|Withdrawal by Subject|1|||
30633396|NCT01173692|58645005|FG001|Overall Study|Withdrawal by Subject|3|||
30633397|NCT01101035|58645013|FG000|Overall Study|Adverse Event|191|||
30633398|NCT01101035|58645014|FG001|Overall Study|Adverse Event|172|||
30633399|NCT01101035|58645013|FG000|Overall Study|Major Protocol Deviation|52|||
30633400|NCT01101035|58645014|FG001|Overall Study|Major Protocol Deviation|46|||
30633401|NCT01101035|58645013|FG000|Overall Study|Lost to Follow-up|226|||
30633402|NCT01101035|58645014|FG001|Overall Study|Lost to Follow-up|223|||
30633403|NCT01101035|58645013|FG000|Overall Study|Voluntary Withdrawal|595|||
30633404|NCT01101035|58645014|FG001|Overall Study|Voluntary Withdrawal|587|||
30633405|NCT01101035|58645013|FG000|Overall Study|Reason not Specified|333|||
30633406|NCT01101035|58645014|FG001|Overall Study|Reason not Specified|363|||
30633407|NCT01100567|58645022|FG000|Overall Study|Withdrawal by Subject|5|||
30633408|NCT01100567|58645023|FG001|Overall Study|Withdrawal by Subject|8|||
30633409|NCT01100567|58645022|FG000|Overall Study|Early Hospital Discharge|6|||
30633410|NCT01100567|58645023|FG001|Overall Study|Early Hospital Discharge|4|||
30633411|NCT01100567|58645022|FG000|Overall Study|Lost to Follow-up|1|||
30633412|NCT01100567|58645023|FG001|Overall Study|Lost to Follow-up|2|||
30633413|NCT01100567|58645022|FG000|Overall Study|Physician Decision|0|||
30633414|NCT01100567|58645023|FG001|Overall Study|Physician Decision|1|||
30633415|NCT01100567|58645022|FG000|Overall Study|Deemed ineligible after consent|0|||
30633416|NCT01100567|58645023|FG001|Overall Study|Deemed ineligible after consent|1|||
30633417|NCT01160822|58645036|FG000|Overall Study|Adverse Event|0|||
30633418|NCT01160822|58645037|FG001|Overall Study|Adverse Event|0|||
30633419|NCT01160822|58645038|FG002|Overall Study|Adverse Event|0|||
30633420|NCT01160822|58645039|FG003|Overall Study|Adverse Event|0|||
30633421|NCT01160822|58645040|FG004|Overall Study|Adverse Event|1|||
30633422|NCT01160822|58645041|FG005|Overall Study|Adverse Event|2|||
30633423|NCT01160822|58645042|FG006|Overall Study|Adverse Event|5|||
30633424|NCT01160822|58645036|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30633425|NCT01160822|58645037|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30633426|NCT01160822|58645038|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
30633427|NCT01160822|58645039|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
30633428|NCT01160822|58645040|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
30633429|NCT01160822|58645041|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
30633430|NCT01160822|58645042|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
30633431|NCT01160822|58645036|FG000|Overall Study|Withdrawal by Subject|0|||
30633432|NCT01160822|58645037|FG001|Overall Study|Withdrawal by Subject|0|||
30633433|NCT01160822|58645038|FG002|Overall Study|Withdrawal by Subject|0|||
30633434|NCT01160822|58645039|FG003|Overall Study|Withdrawal by Subject|0|||
30633435|NCT01160822|58645040|FG004|Overall Study|Withdrawal by Subject|0|||
30633436|NCT01160822|58645041|FG005|Overall Study|Withdrawal by Subject|0|||
30633437|NCT01160822|58645042|FG006|Overall Study|Withdrawal by Subject|1|||
30633438|NCT01160822|58645036|FG000|Overall Study|Lost to Follow-up|0|||
30633439|NCT01160822|58645037|FG001|Overall Study|Lost to Follow-up|0|||
30633440|NCT01160822|58645038|FG002|Overall Study|Lost to Follow-up|0|||
30633441|NCT01160822|58645039|FG003|Overall Study|Lost to Follow-up|0|||
30633442|NCT01160822|58645040|FG004|Overall Study|Lost to Follow-up|1|||
30633443|NCT01160822|58645041|FG005|Overall Study|Lost to Follow-up|0|||
30633444|NCT01160822|58645042|FG006|Overall Study|Lost to Follow-up|0|||
30633445|NCT01160822|58645036|FG000|Overall Study|Administrative problems|0|||
30633446|NCT01160822|58645037|FG001|Overall Study|Administrative problems|0|||
30633447|NCT01160822|58645038|FG002|Overall Study|Administrative problems|0|||
30633448|NCT01160822|58645039|FG003|Overall Study|Administrative problems|0|||
30633449|NCT01160822|58645040|FG004|Overall Study|Administrative problems|1|||
30633450|NCT01160822|58645041|FG005|Overall Study|Administrative problems|0|||
30633451|NCT01160822|58645042|FG006|Overall Study|Administrative problems|0|||
30633452|NCT01160822|58645036|FG000|Overall Study|Protocol deviation|0|||
30633453|NCT01160822|58645037|FG001|Overall Study|Protocol deviation|0|||
30633454|NCT01160822|58645038|FG002|Overall Study|Protocol deviation|0|||
30633455|NCT01160822|58645039|FG003|Overall Study|Protocol deviation|0|||
30633456|NCT01160822|58645040|FG004|Overall Study|Protocol deviation|2|||
30633457|NCT01160822|58645041|FG005|Overall Study|Protocol deviation|0|||
30633458|NCT01160822|58645042|FG006|Overall Study|Protocol deviation|0|||
30633459|NCT01006980|58645061|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
30633460|NCT01006980|58645062|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
30633461|NCT01006980|58645061|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
30633462|NCT01006980|58645062|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
30633463|NCT01006980|58645061|FG000|Vemurafenib and Dacarbazine|Death|13|||
30633464|NCT01006980|58645062|FG001|Vemurafenib and Dacarbazine|Death|12|||
30633465|NCT01006980|58645061|FG000|Vemurafenib and Dacarbazine|Progression|257|||
30633466|NCT01006980|58645062|FG001|Vemurafenib and Dacarbazine|Progression|218|||
30633467|NCT01006980|58645061|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
30633468|NCT01006980|58645062|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
30633469|NCT01006980|58645061|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
30633470|NCT01006980|58645062|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
30633471|NCT01006980|58645061|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
30633472|NCT01006980|58645062|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
30633473|NCT01006980|58645061|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
30633474|NCT01006980|58645062|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
30633475|NCT01006980|58645061|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
30633476|NCT01006980|58645062|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
30633477|NCT01006980|58645061|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
30633478|NCT01006980|58645062|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
30633479|NCT01006980|58645061|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
30633480|NCT01006980|58645062|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
30633481|NCT01006980|58645061|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
30633482|NCT01006980|58645062|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
30633483|NCT01006980|58645061|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
30633484|NCT01006980|58645062|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
30633485|NCT00887926|58645073|FG000|Overall Study|Withdrawal by Subject|0|||
30633486|NCT00887926|58645074|FG001|Overall Study|Withdrawal by Subject|1|||
30633487|NCT00887926|58645075|FG002|Overall Study|Withdrawal by Subject|0|||
30633488|NCT00887926|58645076|FG003|Overall Study|Withdrawal by Subject|0|||
30633489|NCT00998400|58645094|FG000|Overall Study|Lack of interest/motivation|1|||
30633490|NCT00998400|58645095|FG001|Overall Study|Lack of interest/motivation|2|||
30633491|NCT00998400|58645094|FG000|Overall Study|Logistical problems|1|||
30633492|NCT00998400|58645095|FG001|Overall Study|Logistical problems|0|||
30633493|NCT00997386|58645102|FG000|Overall Study|Death|7|||
30633494|NCT00996996|58645106|FG000|Overall Study|Progressive Disease|10|||
30633495|NCT00996996|58645106|FG000|Overall Study|Non-compliance|8|||
30633496|NCT00996996|58645106|FG000|Overall Study|Lost to Follow-up|9|||
30633497|NCT00996996|58645106|FG000|Overall Study|Death|5|||
30633498|NCT00996996|58645106|FG000|Overall Study|Did Not Receive Study Medications|1|||
30633499|NCT00996918|58645115|FG000|Overall Study|Lack of Efficacy|1|||
30633500|NCT00996918|58645116|FG001|Overall Study|Lack of Efficacy|1|||
30633501|NCT00996918|58645117|FG002|Overall Study|Lack of Efficacy|2|||
30633502|NCT00996918|58645118|FG003|Overall Study|Lack of Efficacy|2|||
30633503|NCT00996918|58645119|FG004|Overall Study|Lack of Efficacy|0|||
30633504|NCT00996918|58645115|FG000|Overall Study|Adverse Event|2|||
30633505|NCT00996918|58645116|FG001|Overall Study|Adverse Event|5|||
30633506|NCT00996918|58645117|FG002|Overall Study|Adverse Event|2|||
30633507|NCT00996918|58645118|FG003|Overall Study|Adverse Event|6|||
30633508|NCT00996918|58645119|FG004|Overall Study|Adverse Event|0|||
30633509|NCT00996918|58645115|FG000|Overall Study|Withdrawal by Subject|1|||
30633510|NCT00996918|58645116|FG001|Overall Study|Withdrawal by Subject|4|||
30633511|NCT00996918|58645117|FG002|Overall Study|Withdrawal by Subject|3|||
30633512|NCT00996918|58645118|FG003|Overall Study|Withdrawal by Subject|3|||
30633513|NCT00996918|58645119|FG004|Overall Study|Withdrawal by Subject|2|||
30633514|NCT00996918|58645115|FG000|Overall Study|Physician Decision|1|||
30633515|NCT00996918|58645116|FG001|Overall Study|Physician Decision|0|||
30633516|NCT00996918|58645117|FG002|Overall Study|Physician Decision|0|||
30633517|NCT00996918|58645118|FG003|Overall Study|Physician Decision|0|||
30633518|NCT00996918|58645119|FG004|Overall Study|Physician Decision|0|||
30633519|NCT00996918|58645115|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
30633520|NCT00996918|58645116|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
30633521|NCT00996918|58645117|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
30633522|NCT00996918|58645118|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
30633523|NCT00996918|58645119|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
30633524|NCT00996918|58645115|FG000|Overall Study|Loss of Caregiver|0|||
30633525|NCT00996918|58645116|FG001|Overall Study|Loss of Caregiver|1|||
30633526|NCT00996918|58645117|FG002|Overall Study|Loss of Caregiver|0|||
30633527|NCT00996918|58645118|FG003|Overall Study|Loss of Caregiver|0|||
30633528|NCT00996918|58645119|FG004|Overall Study|Loss of Caregiver|0|||
30633529|NCT00996918|58645115|FG000|Overall Study|Other|3|||
30633530|NCT00996918|58645116|FG001|Overall Study|Other|1|||
30633531|NCT00996918|58645117|FG002|Overall Study|Other|0|||
30633532|NCT00996918|58645118|FG003|Overall Study|Other|0|||
30633533|NCT00996918|58645119|FG004|Overall Study|Other|0|||
30633534|NCT01160744|58645135|FG000|Overall Study|Withdrawal by Subject|11|||
30633535|NCT01160744|58645136|FG001|Overall Study|Withdrawal by Subject|5|||
30848381|NCT04134728|58874453|FG001|Overall Study|Informed Consent Withdrawn|6|||
30951178|NCT01890473|58998327|FG000|Overall Study|Lost to Follow-up|1|||
30848382|NCT04134728|58874454|FG002|Overall Study|Informed Consent Withdrawn|8|||
30951179|NCT01890473|58998328|FG001|Overall Study|Lost to Follow-up|0|||
30633536|NCT01160744|58645137|FG002|Overall Study|Withdrawal by Subject|6|||
30633537|NCT01160744|58645138|FG003|Overall Study|Withdrawal by Subject|4|||
30633538|NCT01160744|58645135|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
30633539|NCT01160744|58645136|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
30633540|NCT01160744|58645137|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
30633541|NCT01160744|58645138|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
30951180|NCT01890473|58998327|FG000|Overall Study|Poor/non-compliance|1|||
30633542|NCT01160354|58645153|FG000|Overall Study|Death|0|||
30633543|NCT01160354|58645154|FG001|Overall Study|Death|1|||
30633544|NCT01160354|58645155|FG002|Overall Study|Death|1|||
30633545|NCT01160198|58645166|FG000|Overall Study|Withdrawal by Subject|2|||
30633546|NCT01160198|58645167|FG001|Overall Study|Withdrawal by Subject|1|||
30633547|NCT01160198|58645168|FG002|Overall Study|Withdrawal by Subject|0|||
30633548|NCT01160198|58645166|FG000|Overall Study|Adverse Event|0|||
30633549|NCT01160198|58645167|FG001|Overall Study|Adverse Event|1|||
30633550|NCT01160198|58645168|FG002|Overall Study|Adverse Event|0|||
30633551|NCT01160198|58645166|FG000|Overall Study|Lost to Follow-up|0|||
30633552|NCT01160198|58645167|FG001|Overall Study|Lost to Follow-up|1|||
30633553|NCT01160198|58645168|FG002|Overall Study|Lost to Follow-up|0|||
30633554|NCT01160198|58645166|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
30633555|NCT01160198|58645167|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
30633556|NCT01160198|58645168|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
30633557|NCT01159574|58645176|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
30633558|NCT01159574|58645176|FG000|Treatment Phase|Adverse Event|3|||
30633559|NCT01159574|58645176|FG000|Treatment Phase|Death|6|||
30633560|NCT01159574|58645176|FG000|Treatment Phase|Physician Decision|2|||
30633561|NCT01159574|58645176|FG000|Treatment Phase|Withdrawal by Subject|7|||
30633562|NCT01159574|58645176|FG000|Treatment Phase|still on treatment|2|||
30633563|NCT01159574|58645176|FG000|Follow Up Phase|Lost to Follow-up|2|||
30633564|NCT01159574|58645176|FG000|Follow Up Phase|still being followed for overall surviva|18|||
30633565|NCT01158950|58645180|FG000|1st Intervention (1 Day)|Physician Decision|1|||
30633566|NCT01158950|58645181|FG001|1st Intervention (1 Day)|Physician Decision|2|||
30633567|NCT01172288|58645188|FG000|Overall Study|Adverse Event|1|||
30633568|NCT01172288|58645189|FG001|Overall Study|Adverse Event|0|||
30633569|NCT01172288|58645188|FG000|Overall Study|Protocol Violation|0|||
30633570|NCT01172288|58645189|FG001|Overall Study|Protocol Violation|1|||
30633571|NCT00996840|58645200|FG000|Overall Study|Adverse Event|0|||
30633572|NCT00996840|58645201|FG001|Overall Study|Adverse Event|1|||
30633573|NCT00996840|58645202|FG002|Overall Study|Adverse Event|0|||
30633574|NCT00996840|58645203|FG003|Overall Study|Adverse Event|0|||
30633575|NCT00996840|58645204|FG004|Overall Study|Adverse Event|0|||
30633576|NCT00996840|58645200|FG000|Overall Study|Physician Decision|0|||
30633577|NCT00996840|58645201|FG001|Overall Study|Physician Decision|0|||
30633578|NCT00996840|58645202|FG002|Overall Study|Physician Decision|1|||
30633579|NCT00996840|58645203|FG003|Overall Study|Physician Decision|1|||
30633580|NCT00996840|58645204|FG004|Overall Study|Physician Decision|2|||
30633581|NCT00996840|58645200|FG000|Overall Study|Withdrawal by Subject|1|||
30633582|NCT00996840|58645201|FG001|Overall Study|Withdrawal by Subject|1|||
30633583|NCT00996840|58645202|FG002|Overall Study|Withdrawal by Subject|0|||
30633584|NCT00996840|58645203|FG003|Overall Study|Withdrawal by Subject|0|||
30633585|NCT00996840|58645204|FG004|Overall Study|Withdrawal by Subject|0|||
30633586|NCT00998946|58645220|FG000|Overall Study|Lost to Follow-up|1|||
30633587|NCT00998946|58645220|FG000|Overall Study|Withdrawal by Subject|1|||
30633588|NCT00998946|58645220|FG000|Overall Study|Death|2|||
30633589|NCT00998946|58645220|FG000|Overall Study|Reason Unspecified|3|||
30633590|NCT00998946|58645220|FG000|Overall Study|Enrolled but not Dosed|2|||
30633591|NCT01158404|58645232|FG000|Overall Study|Withdrawal by Subject|0|||
30633592|NCT01158404|58645233|FG001|Overall Study|Withdrawal by Subject|1|||
30633593|NCT01158404|58645234|FG002|Overall Study|Withdrawal by Subject|0|||
30633594|NCT01158404|58645235|FG003|Overall Study|Withdrawal by Subject|0|||
30633595|NCT01158404|58645236|FG004|Overall Study|Withdrawal by Subject|3|||
30633596|NCT01158404|58645237|FG005|Overall Study|Withdrawal by Subject|1|||
30633597|NCT01158404|58645238|FG006|Overall Study|Withdrawal by Subject|0|||
30633598|NCT01158404|58645239|FG007|Overall Study|Withdrawal by Subject|1|||
30633599|NCT01158404|58645232|FG000|Overall Study|Physician Decision|0|||
30633600|NCT01158404|58645233|FG001|Overall Study|Physician Decision|0|||
30633601|NCT01158404|58645234|FG002|Overall Study|Physician Decision|0|||
30633602|NCT01158404|58645235|FG003|Overall Study|Physician Decision|0|||
30633603|NCT01158404|58645236|FG004|Overall Study|Physician Decision|0|||
30633604|NCT01158404|58645237|FG005|Overall Study|Physician Decision|0|||
30633605|NCT01158404|58645238|FG006|Overall Study|Physician Decision|0|||
30633606|NCT01158404|58645239|FG007|Overall Study|Physician Decision|1|||
30633607|NCT01158404|58645232|FG000|Overall Study|Progressive Disease|0|||
30633608|NCT01158404|58645233|FG001|Overall Study|Progressive Disease|0|||
30633609|NCT01158404|58645234|FG002|Overall Study|Progressive Disease|0|||
30633610|NCT01158404|58645235|FG003|Overall Study|Progressive Disease|0|||
30633611|NCT01158404|58645236|FG004|Overall Study|Progressive Disease|0|||
30633612|NCT01158404|58645237|FG005|Overall Study|Progressive Disease|0|||
30633613|NCT01158404|58645238|FG006|Overall Study|Progressive Disease|1|||
30633614|NCT01158404|58645239|FG007|Overall Study|Progressive Disease|0|||
30633615|NCT00998790|58645259|FG000|Overall Study|Withdrawal by Subject|21|||
30633616|NCT01001988|58645263|FG000|Overall Study|Protocol Violation|84|||
30633617|NCT01001988|58645263|FG000|Overall Study|Withdrawal by Subject|18|||
30633618|NCT01001988|58645263|FG000|Overall Study|Lost to Follow-up|15|||
30633619|NCT00996606|58645267|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
30633620|NCT00996606|58645267|FG000|Overall Study|Insufficient Therapeutic Response|2|||
30633621|NCT00996606|58645267|FG000|Overall Study|Protocol Violation|1|||
30633622|NCT00996606|58645267|FG000|Overall Study|Withdrawal by Subject|3|||
30633623|NCT00995436|58645274|FG000|Overall Study|Withdrawal by Subject|2|||
30633624|NCT00995436|58645275|FG001|Overall Study|Withdrawal by Subject|5|||
30633625|NCT00995436|58645276|FG002|Overall Study|Withdrawal by Subject|0|||
30633626|NCT00994890|58645287|FG000|Overall Study|Adverse Event|13|||
30633627|NCT00994890|58645288|FG001|Overall Study|Adverse Event|9|||
30633628|NCT00994890|58645289|FG002|Overall Study|Adverse Event|11|||
30633629|NCT00994890|58645287|FG000|Overall Study|Lack of Efficacy|0|||
30633630|NCT00994890|58645288|FG001|Overall Study|Lack of Efficacy|0|||
30633631|NCT00994890|58645289|FG002|Overall Study|Lack of Efficacy|1|||
30633632|NCT00994890|58645287|FG000|Overall Study|Lost to Follow-up|6|||
30633633|NCT00994890|58645288|FG001|Overall Study|Lost to Follow-up|1|||
30633634|NCT00994890|58645289|FG002|Overall Study|Lost to Follow-up|3|||
30633635|NCT00994890|58645287|FG000|Overall Study|No longer willing to participate|8|||
30633636|NCT00994890|58645288|FG001|Overall Study|No longer willing to participate|5|||
30633637|NCT00994890|58645289|FG002|Overall Study|No longer willing to participate|13|||
30633638|NCT00994890|58645287|FG000|Overall Study|Protocol Violation|2|||
30633639|NCT00994890|58645288|FG001|Overall Study|Protocol Violation|4|||
30633640|NCT00994890|58645289|FG002|Overall Study|Protocol Violation|0|||
30633641|NCT00994890|58645287|FG000|Overall Study|Study terminated by sponsor|199|||
30633642|NCT00994890|58645288|FG001|Overall Study|Study terminated by sponsor|201|||
30633643|NCT00994890|58645289|FG002|Overall Study|Study terminated by sponsor|197|||
30633644|NCT00994890|58645287|FG000|Overall Study|Randomized, but not treated|1|||
30633645|NCT00994890|58645288|FG001|Overall Study|Randomized, but not treated|0|||
30633646|NCT00994890|58645289|FG002|Overall Study|Randomized, but not treated|0|||
30633647|NCT00994890|58645287|FG000|Overall Study|Other|2|||
30633648|NCT00994890|58645288|FG001|Overall Study|Other|2|||
30633649|NCT00994890|58645289|FG002|Overall Study|Other|1|||
30633650|NCT00994422|58645299|FG000|Overall Study|Lost to Follow-up|7|||
30633651|NCT00994422|58645300|FG001|Overall Study|Lost to Follow-up|1|||
30633652|NCT01171976|58645311|FG000|Overall Study|Protocol Violation|0|||
30633653|NCT01171976|58645312|FG001|Overall Study|Protocol Violation|0|||
30633654|NCT01171976|58645313|FG002|Overall Study|Protocol Violation|1|||
30633655|NCT01171976|58645311|FG000|Overall Study|Death|2|||
30633656|NCT01171976|58645312|FG001|Overall Study|Death|4|||
30633657|NCT01171976|58645313|FG002|Overall Study|Death|1|||
30633658|NCT01171976|58645311|FG000|Overall Study|Lost to Follow-up|4|||
30633659|NCT01171976|58645312|FG001|Overall Study|Lost to Follow-up|0|||
30633660|NCT01171976|58645313|FG002|Overall Study|Lost to Follow-up|2|||
30633661|NCT01171976|58645311|FG000|Overall Study|Withdrawal by Subject|1|||
30633662|NCT01171976|58645312|FG001|Overall Study|Withdrawal by Subject|5|||
30633663|NCT01171976|58645313|FG002|Overall Study|Withdrawal by Subject|6|||
30633664|NCT01171976|58645311|FG000|Overall Study|Abnormal test result|1|||
30633665|NCT01171976|58645312|FG001|Overall Study|Abnormal test result|0|||
30633666|NCT01171976|58645313|FG002|Overall Study|Abnormal test result|0|||
30633667|NCT01171976|58645311|FG000|Overall Study|Adverse Event|6|||
30633668|NCT01171976|58645312|FG001|Overall Study|Adverse Event|2|||
30633669|NCT01171976|58645313|FG002|Overall Study|Adverse Event|5|||
30633670|NCT00996216|58645321|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
30633671|NCT00996216|58645321|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
30633672|NCT00996216|58645321|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
30633673|NCT00830869|58645338|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
30633674|NCT00830869|58645339|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
30633675|NCT00830869|58645340|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
30848383|NCT04134728|58874455|FG003|Overall Study|Informed Consent Withdrawn|1|||
30848384|NCT04134728|58874456|FG004|Overall Study|Informed Consent Withdrawn|1|||
30633676|NCT00830869|58645341|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
30633677|NCT00830869|58645342|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
30633678|NCT00830869|58645343|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
30633679|NCT00830869|58645344|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
30633680|NCT00830869|58645345|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
30633681|NCT00830869|58645346|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
30633682|NCT00830869|58645347|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
30633683|NCT00830869|58645348|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
30633684|NCT00830869|58645349|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
30633685|NCT00830869|58645338|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
30633686|NCT00830869|58645339|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
30633687|NCT00830869|58645340|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
30633688|NCT00830869|58645341|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
30633689|NCT00830869|58645342|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
30633690|NCT00830869|58645343|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
30633691|NCT00830869|58645344|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
30633692|NCT00830869|58645345|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
30633693|NCT00830869|58645346|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
30633694|NCT00830869|58645347|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
30633695|NCT00830869|58645348|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
30633696|NCT00830869|58645349|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
30633697|NCT00830869|58645338|FG000|Period 1: Part 1|Adverse Event|0|||
30633698|NCT00830869|58645339|FG001|Period 1: Part 1|Adverse Event|0|||
30633699|NCT00830869|58645340|FG002|Period 1: Part 1|Adverse Event|0|||
30633700|NCT00830869|58645341|FG003|Period 1: Part 1|Adverse Event|0|||
30633701|NCT00830869|58645342|FG004|Period 1: Part 1|Adverse Event|0|||
30633702|NCT00830869|58645343|FG005|Period 1: Part 1|Adverse Event|1|||
30633703|NCT00830869|58645344|FG006|Period 1: Part 1|Adverse Event|1|||
30633704|NCT00830869|58645345|FG007|Period 1: Part 1|Adverse Event|0|||
30633705|NCT00830869|58645346|FG008|Period 1: Part 1|Adverse Event|0|||
30633706|NCT00830869|58645347|FG009|Period 1: Part 1|Adverse Event|0|||
30633707|NCT00830869|58645348|FG010|Period 1: Part 1|Adverse Event|0|||
30633708|NCT00830869|58645349|FG011|Period 1: Part 1|Adverse Event|0|||
30633709|NCT00830869|58645338|FG000|Period 1: Part 1|Progressive disease|1|||
30633710|NCT00830869|58645339|FG001|Period 1: Part 1|Progressive disease|0|||
30633711|NCT00830869|58645340|FG002|Period 1: Part 1|Progressive disease|1|||
30764626|NCT03796676|58773339|FG001|Overall Study|Withdrawal by Subject|1|||
30764627|NCT03796676|58773340|FG002|Overall Study|Withdrawal by Subject|0|||
30764628|NCT03796676|58773338|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
30764629|NCT03796676|58773339|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
30764630|NCT03796676|58773340|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
30764631|NCT03342898|58773354|FG000|Overall Study|Adverse Event|3|||
30764632|NCT03342898|58773355|FG001|Overall Study|Adverse Event|1|||
30764633|NCT03342898|58773356|FG002|Overall Study|Adverse Event|0|||
30764634|NCT03342898|58773354|FG000|Overall Study|Lost to Follow-up|44|||
30764635|NCT03342898|58773355|FG001|Overall Study|Lost to Follow-up|40|||
30764636|NCT03342898|58773356|FG002|Overall Study|Lost to Follow-up|42|||
30764637|NCT03342898|58773354|FG000|Overall Study|Withdrawal of Consent|5|||
30764638|NCT03342898|58773355|FG001|Overall Study|Withdrawal of Consent|9|||
30764639|NCT03342898|58773356|FG002|Overall Study|Withdrawal of Consent|11|||
30764640|NCT03342898|58773354|FG000|Overall Study|Death|0|||
30764641|NCT03342898|58773355|FG001|Overall Study|Death|1|||
30764642|NCT03342898|58773356|FG002|Overall Study|Death|1|||
30764643|NCT03342898|58773354|FG000|Overall Study|Reason not Specified|2|||
30764644|NCT03342898|58773355|FG001|Overall Study|Reason not Specified|2|||
30764645|NCT03342898|58773356|FG002|Overall Study|Reason not Specified|0|||
30764646|NCT00339833|58773366|FG000|Overall Study|Withdrawal by Subject|1|||
30764647|NCT00339833|58773367|FG001|Overall Study|Withdrawal by Subject|2|||
30764648|NCT00339833|58773366|FG000|Overall Study|toothache|0|||
30764649|NCT00339833|58773367|FG001|Overall Study|toothache|1|||
30764650|NCT00339833|58773366|FG000|Overall Study|indigestion|0|||
30764651|NCT00339833|58773367|FG001|Overall Study|indigestion|1|||
30764652|NCT00339833|58773366|FG000|Overall Study|Chest pain|0|||
30764653|NCT00339833|58773367|FG001|Overall Study|Chest pain|1|||
30764654|NCT00339833|58773366|FG000|Overall Study|minor infection|0|||
30764655|NCT00339833|58773367|FG001|Overall Study|minor infection|1|||
30764656|NCT00339833|58773366|FG000|Overall Study|Poor venous access|2|||
30764657|NCT00339833|58773367|FG001|Overall Study|Poor venous access|2|||
30633712|NCT00830869|58645341|FG003|Period 1: Part 1|Progressive disease|6|||
30633713|NCT00830869|58645342|FG004|Period 1: Part 1|Progressive disease|4|||
30633714|NCT00830869|58645343|FG005|Period 1: Part 1|Progressive disease|4|||
30633715|NCT00830869|58645344|FG006|Period 1: Part 1|Progressive disease|1|||
30633716|NCT00830869|58645345|FG007|Period 1: Part 1|Progressive disease|0|||
30633717|NCT00830869|58645346|FG008|Period 1: Part 1|Progressive disease|0|||
30764658|NCT00339833|58773366|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
30764659|NCT00339833|58773367|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
30764660|NCT00339833|58773366|FG000|Overall Study|Error in data records|1|||
30764661|NCT00339833|58773367|FG001|Overall Study|Error in data records|0|||
30764662|NCT03793556|58773375|FG000|Overall Study|Withdrawal by Subject|12|||
30633718|NCT00830869|58645347|FG009|Period 1: Part 1|Progressive disease|0|||
30633719|NCT00830869|58645348|FG010|Period 1: Part 1|Progressive disease|0|||
30633720|NCT00830869|58645349|FG011|Period 1: Part 1|Progressive disease|0|||
30633721|NCT00830869|58645338|FG000|Period 2: Part 2|Protocol Violation|0|||
30633722|NCT00830869|58645339|FG001|Period 2: Part 2|Protocol Violation|0|||
30633723|NCT00830869|58645340|FG002|Period 2: Part 2|Protocol Violation|0|||
30633724|NCT00830869|58645341|FG003|Period 2: Part 2|Protocol Violation|0|||
30633725|NCT00830869|58645342|FG004|Period 2: Part 2|Protocol Violation|0|||
30633726|NCT00830869|58645343|FG005|Period 2: Part 2|Protocol Violation|0|||
30633727|NCT00830869|58645344|FG006|Period 2: Part 2|Protocol Violation|0|||
30633728|NCT00830869|58645345|FG007|Period 2: Part 2|Protocol Violation|1|||
30633729|NCT00830869|58645346|FG008|Period 2: Part 2|Protocol Violation|0|||
30633730|NCT00830869|58645347|FG009|Period 2: Part 2|Protocol Violation|1|||
30633731|NCT00830869|58645348|FG010|Period 2: Part 2|Protocol Violation|0|||
30633732|NCT00830869|58645349|FG011|Period 2: Part 2|Protocol Violation|0|||
30633733|NCT00830869|58645338|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
30633734|NCT00830869|58645339|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
30633735|NCT00830869|58645340|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
30633736|NCT00830869|58645341|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
30633737|NCT00830869|58645342|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
30764663|NCT03793556|58773376|FG001|Overall Study|Withdrawal by Subject|1|||
30764664|NCT03793556|58773375|FG000|Overall Study|Lost to Follow-up|1|||
30764665|NCT03793556|58773376|FG001|Overall Study|Lost to Follow-up|1|||
30764666|NCT03392194|58773387|FG000|Overall Study|Withdrawal by Subject|1|||
30764667|NCT03392194|58773388|FG001|Overall Study|Withdrawal by Subject|2|||
30764668|NCT03392194|58773387|FG000|Overall Study|Conflicts with personal schedule|1|||
30764669|NCT03392194|58773388|FG001|Overall Study|Conflicts with personal schedule|0|||
30764670|NCT03828617|58773398|FG000|Overall Study|Lost to Follow-up|22|||
30764671|NCT03828617|58773399|FG001|Overall Study|Lost to Follow-up|12|||
30764672|NCT03828617|58773400|FG002|Overall Study|Lost to Follow-up|23|||
30764673|NCT03828617|58773401|FG003|Overall Study|Lost to Follow-up|7|||
30764674|NCT03828617|58773398|FG000|Overall Study|No longer met eligibility criteria|0|||
30764675|NCT03828617|58773399|FG001|Overall Study|No longer met eligibility criteria|1|||
30764676|NCT03828617|58773400|FG002|Overall Study|No longer met eligibility criteria|1|||
30764677|NCT03828617|58773401|FG003|Overall Study|No longer met eligibility criteria|3|||
30764678|NCT03828617|58773398|FG000|Overall Study|Protocol Violation|0|||
30764679|NCT03828617|58773399|FG001|Overall Study|Protocol Violation|2|||
30764680|NCT03828617|58773400|FG002|Overall Study|Protocol Violation|0|||
30764681|NCT03828617|58773401|FG003|Overall Study|Protocol Violation|0|||
30764682|NCT03828617|58773398|FG000|Overall Study|Withdrawal by Subject|2|||
30764683|NCT03828617|58773399|FG001|Overall Study|Withdrawal by Subject|0|||
30764684|NCT03828617|58773400|FG002|Overall Study|Withdrawal by Subject|2|||
30764685|NCT03828617|58773401|FG003|Overall Study|Withdrawal by Subject|0|||
30764686|NCT03391960|58773410|FG000|Overall Study|Protocol Violation|0|||
30764687|NCT03391960|58773411|FG001|Overall Study|Protocol Violation||||
30764688|NCT03390166|58773437|FG000|Overall Study|Death|0|||
30764689|NCT03390166|58773438|FG001|Overall Study|Death|1|||
30764690|NCT03390166|58773437|FG000|Overall Study|Lost to Follow-up|6|||
30764691|NCT03390166|58773438|FG001|Overall Study|Lost to Follow-up|4|||
30764692|NCT03390166|58773437|FG000|Overall Study|Physician Decision|2|||
30764693|NCT03390166|58773438|FG001|Overall Study|Physician Decision|1|||
30764694|NCT03390166|58773437|FG000|Overall Study|Move from study area|3|||
30764695|NCT03390166|58773438|FG001|Overall Study|Move from study area|2|||
30764696|NCT03390166|58773437|FG000|Overall Study|To militarycamp for conscript|1|||
30764697|NCT03390166|58773438|FG001|Overall Study|To militarycamp for conscript|0|||
30764698|NCT03390166|58773437|FG000|Overall Study|To drug therapy course|0|||
30764699|NCT03390166|58773438|FG001|Overall Study|To drug therapy course|1|||
30764700|NCT03390166|58773437|FG000|Overall Study|Move to work oversea|0|||
30764701|NCT03390166|58773438|FG001|Overall Study|Move to work oversea|1|||
30764702|NCT03828539|58773446|FG000|Overall Study|Adverse Event|3|||
30764703|NCT03828539|58773447|FG001|Overall Study|Adverse Event|12|||
30764704|NCT03828539|58773446|FG000|Overall Study|Patient's/guardian's decision|3|||
30764705|NCT03828539|58773447|FG001|Overall Study|Patient's/guardian's decision|5|||
30764706|NCT03828539|58773446|FG000|Overall Study|Lost to Follow-up|4|||
30764707|NCT03828539|58773447|FG001|Overall Study|Lost to Follow-up|2|||
30764708|NCT03828539|58773446|FG000|Overall Study|Protocol Violation|3|||
30764709|NCT03828539|58773447|FG001|Overall Study|Protocol Violation|2|||
30764710|NCT03828539|58773446|FG000|Overall Study|Withdrawal of informed consent|2|||
30764711|NCT03828539|58773447|FG001|Overall Study|Withdrawal of informed consent|1|||
30764712|NCT03828539|58773446|FG000|Overall Study|New therapy for study indication|1|||
30764713|NCT03828539|58773447|FG001|Overall Study|New therapy for study indication|0|||
30764714|NCT03336502|58773455|FG000|Overall Study|Physician Decision|0|||
30764715|NCT03336502|58773456|FG001|Overall Study|Physician Decision|1|||
30764716|NCT03336502|58773455|FG000|Overall Study|Prohibited Drugs|1|||
30764717|NCT03336502|58773456|FG001|Overall Study|Prohibited Drugs|1|||
30764718|NCT03336502|58773455|FG000|Overall Study|Death|1|||
30764719|NCT03336502|58773456|FG001|Overall Study|Death|2|||
30633738|NCT00830869|58645343|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
30633739|NCT00830869|58645344|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
30633740|NCT00830869|58645345|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
30633741|NCT00830869|58645346|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
30633742|NCT00830869|58645347|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
30633743|NCT00830869|58645348|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
30633744|NCT00830869|58645349|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
30633745|NCT00830869|58645338|FG000|Period 2: Part 2|Adverse Event|0|||
30633746|NCT00830869|58645339|FG001|Period 2: Part 2|Adverse Event|0|||
30633747|NCT00830869|58645340|FG002|Period 2: Part 2|Adverse Event|0|||
30633748|NCT00830869|58645341|FG003|Period 2: Part 2|Adverse Event|0|||
30633749|NCT00830869|58645342|FG004|Period 2: Part 2|Adverse Event|0|||
30633750|NCT00830869|58645343|FG005|Period 2: Part 2|Adverse Event|0|||
30633751|NCT00830869|58645344|FG006|Period 2: Part 2|Adverse Event|0|||
30633752|NCT00830869|58645345|FG007|Period 2: Part 2|Adverse Event|4|||
30633753|NCT00830869|58645346|FG008|Period 2: Part 2|Adverse Event|3|||
30633754|NCT00830869|58645347|FG009|Period 2: Part 2|Adverse Event|2|||
30633755|NCT00830869|58645348|FG010|Period 2: Part 2|Adverse Event|2|||
30633756|NCT00830869|58645349|FG011|Period 2: Part 2|Adverse Event|0|||
30633757|NCT00830869|58645338|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
30633758|NCT00830869|58645339|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
30633759|NCT00830869|58645340|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
30633760|NCT00830869|58645341|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
30633761|NCT00830869|58645342|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
30633762|NCT00830869|58645343|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
30633763|NCT00830869|58645344|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
30633764|NCT00830869|58645345|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
30633765|NCT00830869|58645346|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
30633766|NCT00830869|58645347|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
30633767|NCT00830869|58645348|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
30633768|NCT00830869|58645349|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
30633769|NCT00830869|58645338|FG000|Period 2: Part 2|Progressive disease|0|||
30633770|NCT00830869|58645339|FG001|Period 2: Part 2|Progressive disease|0|||
30633771|NCT00830869|58645340|FG002|Period 2: Part 2|Progressive disease|0|||
30633772|NCT00830869|58645341|FG003|Period 2: Part 2|Progressive disease|0|||
30633773|NCT00830869|58645342|FG004|Period 2: Part 2|Progressive disease|0|||
30633774|NCT00830869|58645343|FG005|Period 2: Part 2|Progressive disease|0|||
30633775|NCT00830869|58645344|FG006|Period 2: Part 2|Progressive disease|0|||
30633776|NCT00830869|58645345|FG007|Period 2: Part 2|Progressive disease|14|||
30633777|NCT00830869|58645346|FG008|Period 2: Part 2|Progressive disease|11|||
30633778|NCT00830869|58645347|FG009|Period 2: Part 2|Progressive disease|12|||
30633779|NCT00830869|58645348|FG010|Period 2: Part 2|Progressive disease|8|||
30633780|NCT00830869|58645349|FG011|Period 2: Part 2|Progressive disease|15|||
30633781|NCT00830869|58645338|FG000|Period 2: Part 2|Other|0|||
30633782|NCT00830869|58645339|FG001|Period 2: Part 2|Other|0|||
30633783|NCT00830869|58645340|FG002|Period 2: Part 2|Other|0|||
30633784|NCT00830869|58645341|FG003|Period 2: Part 2|Other|0|||
30633785|NCT00830869|58645342|FG004|Period 2: Part 2|Other|0|||
30633786|NCT00830869|58645343|FG005|Period 2: Part 2|Other|0|||
30633787|NCT00830869|58645344|FG006|Period 2: Part 2|Other|0|||
30633788|NCT00830869|58645345|FG007|Period 2: Part 2|Other|0|||
30633789|NCT00830869|58645346|FG008|Period 2: Part 2|Other|0|||
30633790|NCT00830869|58645347|FG009|Period 2: Part 2|Other|1|||
30633791|NCT00830869|58645348|FG010|Period 2: Part 2|Other|0|||
30633792|NCT00830869|58645349|FG011|Period 2: Part 2|Other|0|||
30633793|NCT00844519|58645378|FG000|Overall Study|Withdrawal by Subject|1|||
30633794|NCT00844519|58645379|FG001|Overall Study|Withdrawal by Subject|1|||
30633795|NCT00844519|58645378|FG000|Overall Study|Adverse Event|1|||
30633796|NCT00844519|58645379|FG001|Overall Study|Adverse Event|0|||
30633797|NCT01171820|58645387|FG000|Overall Study|Death|3|||
30633798|NCT01171820|58645388|FG001|Overall Study|Death|3|||
30633799|NCT01171820|58645387|FG000|Overall Study|Lost to Follow-up|0|||
30633800|NCT01171820|58645388|FG001|Overall Study|Lost to Follow-up|1|||
30633801|NCT01171820|58645387|FG000|Overall Study|Withdrawal by Subject|2|||
30633802|NCT01171820|58645388|FG001|Overall Study|Withdrawal by Subject|0|||
30633803|NCT01171820|58645387|FG000|Overall Study|Physician Decision|0|||
30633804|NCT01171820|58645388|FG001|Overall Study|Physician Decision|1|||
30633805|NCT01171820|58645387|FG000|Overall Study|1-Year Missed Visit|1|||
30764720|NCT03336502|58773455|FG000|Overall Study|Adverse Event|2|||
30951181|NCT01890473|58998328|FG001|Overall Study|Poor/non-compliance|0|||
30633806|NCT01171820|58645388|FG001|Overall Study|1-Year Missed Visit|1|||
30951182|NCT01889069|58998338|FG000|Overall Study|Death|18|||
30633807|NCT00994110|58645396|FG000|Overall Study|Withdrawal by Subject|9|||
30633808|NCT00994110|58645397|FG001|Overall Study|Withdrawal by Subject|9|||
30633809|NCT00994110|58645396|FG000|Overall Study|Not Treated|4|||
30633810|NCT00994110|58645397|FG001|Overall Study|Not Treated|8|||
30633811|NCT00994110|58645396|FG000|Overall Study|Adverse Event|1|||
30633812|NCT00994110|58645397|FG001|Overall Study|Adverse Event|0|||
30951183|NCT01889069|58998338|FG000|Overall Study|Progression of Disease|14|||
30633813|NCT00994110|58645396|FG000|Overall Study|Patient not resected|41|||
30633814|NCT00994110|58645397|FG001|Overall Study|Patient not resected|52|||
30633815|NCT00994110|58645396|FG000|Overall Study|Pt not eligible|10|||
30633816|NCT00994110|58645397|FG001|Overall Study|Pt not eligible|5|||
30633817|NCT00993954|58645405|FG000|Overall Study|Protocol Violation|21|||
30633818|NCT00993954|58645406|FG001|Overall Study|Protocol Violation|2|||
30633819|NCT01157234|58645414|FG000|Overall Study|Withdrawal by Subject|1|||
30633820|NCT01157234|58645415|FG001|Overall Study|Withdrawal by Subject|0|||
30633821|NCT00991302|58645430|FG000|Overall Study|Death|0|||
30633822|NCT00991302|58645431|FG001|Overall Study|Death|1|||
30633823|NCT00991302|58645430|FG000|Overall Study|Lost to Follow-up|14|||
30633824|NCT00991302|58645431|FG001|Overall Study|Lost to Follow-up|12|||
30633825|NCT00995670|58645440|FG000|Overall Study|Failed arterial cannulation|1|||
30633826|NCT00995670|58645441|FG001|Overall Study|Failed arterial cannulation|0|||
30633827|NCT00995670|58645442|FG002|Overall Study|Failed arterial cannulation|3|||
30633828|NCT00601354|58645452|FG000|Overall Study|Lost to Follow-up|4|||
30633829|NCT00601354|58645453|FG001|Overall Study|Lost to Follow-up|5|||
30633830|NCT00853099|58645462|FG000|Double-blind Period|Adverse Event|7|||
30633831|NCT00853099|58645463|FG001|Double-blind Period|Adverse Event|9|||
30633832|NCT00853099|58645464|FG002|Double-blind Period|Adverse Event|13|||
30633833|NCT00853099|58645465|FG003|Double-blind Period|Adverse Event|0|||
30633834|NCT00853099|58645462|FG000|Double-blind Period|Withdrawal by Subject|2|||
30633835|NCT00853099|58645463|FG001|Double-blind Period|Withdrawal by Subject|3|||
30633836|NCT00853099|58645464|FG002|Double-blind Period|Withdrawal by Subject|0|||
30633837|NCT00853099|58645465|FG003|Double-blind Period|Withdrawal by Subject|0|||
30633838|NCT00853099|58645462|FG000|Double-blind Period|Lack of Efficacy|14|||
30633839|NCT00853099|58645463|FG001|Double-blind Period|Lack of Efficacy|17|||
30633840|NCT00853099|58645464|FG002|Double-blind Period|Lack of Efficacy|16|||
30633841|NCT00853099|58645465|FG003|Double-blind Period|Lack of Efficacy|0|||
30633842|NCT00853099|58645462|FG000|Double-blind Period|Other|0|||
30633843|NCT00853099|58645463|FG001|Double-blind Period|Other|0|||
30633844|NCT00853099|58645464|FG002|Double-blind Period|Other|1|||
30633845|NCT00853099|58645465|FG003|Double-blind Period|Other|0|||
30633846|NCT00853099|58645462|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
30633847|NCT00853099|58645463|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
30633848|NCT00853099|58645464|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
30633849|NCT00853099|58645465|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
30633850|NCT00853099|58645462|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
30633851|NCT00853099|58645463|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
30633852|NCT00853099|58645464|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
30633853|NCT00853099|58645465|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
30633854|NCT00853099|58645462|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
30633855|NCT00853099|58645463|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
30633856|NCT00853099|58645464|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
30633857|NCT00853099|58645465|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
30633858|NCT00853099|58645462|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
30633859|NCT00853099|58645463|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
30633860|NCT00853099|58645464|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
30633861|NCT00853099|58645465|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
30633862|NCT00853099|58645462|FG000|Double-blind + Open-label Periods|Other|0|||
30633863|NCT00853099|58645463|FG001|Double-blind + Open-label Periods|Other|0|||
30633864|NCT00853099|58645464|FG002|Double-blind + Open-label Periods|Other|0|||
30633865|NCT00853099|58645465|FG003|Double-blind + Open-label Periods|Other|6|||
30633866|NCT00992784|58645478|FG000|Overall Study|Adverse Event|2|||
30633867|NCT00992784|58645479|FG001|Overall Study|Adverse Event|1|||
30633868|NCT00992784|58645480|FG002|Overall Study|Adverse Event|0|||
30633869|NCT00992784|58645478|FG000|Overall Study|Withdrawal by Subject|1|||
30633870|NCT00992784|58645479|FG001|Overall Study|Withdrawal by Subject|1|||
30633871|NCT00992784|58645480|FG002|Overall Study|Withdrawal by Subject|1|||
30633872|NCT00830167|58645490|FG000|Overall Study|Lack of Efficacy|26|||
30633873|NCT00830167|58645491|FG001|Overall Study|Lack of Efficacy|10|||
30633874|NCT00830167|58645490|FG000|Overall Study|Adverse Event|8|||
30633875|NCT00830167|58645491|FG001|Overall Study|Adverse Event|24|||
30633876|NCT00830167|58645490|FG000|Overall Study|Not meeting entrance criteria|2|||
30633877|NCT00830167|58645491|FG001|Overall Study|Not meeting entrance criteria|5|||
30633878|NCT00830167|58645490|FG000|Overall Study|Withdrawal by Subject|2|||
30951184|NCT01889069|58998338|FG000|Overall Study|Lost to Follow-up|6|||
30951185|NCT01889069|58998338|FG000|Overall Study|Other|4|||
30633879|NCT00830167|58645491|FG001|Overall Study|Withdrawal by Subject|0|||
30633880|NCT00830167|58645490|FG000|Overall Study|Lost to Follow-up|0|||
30633881|NCT00830167|58645491|FG001|Overall Study|Lost to Follow-up|1|||
30633882|NCT00830167|58645490|FG000|Overall Study|Protocol Violation|0|||
30633883|NCT00830167|58645491|FG001|Overall Study|Protocol Violation|1|||
30633884|NCT00830167|58645490|FG000|Overall Study|Other|2|||
30633885|NCT00830167|58645491|FG001|Overall Study|Other|2|||
30633886|NCT00992394|58645499|FG000|Overall Study|Lack of Efficacy|6|||
30633887|NCT00992394|58645500|FG001|Overall Study|Lack of Efficacy|3|||
30633888|NCT00992394|58645499|FG000|Overall Study|Adverse Event|4|||
30633889|NCT00992394|58645500|FG001|Overall Study|Adverse Event|5|||
30633890|NCT00992394|58645499|FG000|Overall Study|Withdrawal by Subject|8|||
30633891|NCT00992394|58645500|FG001|Overall Study|Withdrawal by Subject|2|||
30633892|NCT00992394|58645499|FG000|Overall Study|Physician Decision|1|||
30633893|NCT00992394|58645500|FG001|Overall Study|Physician Decision|0|||
30633894|NCT00992394|58645499|FG000|Overall Study|Protocol Violation|2|||
30633895|NCT00992394|58645500|FG001|Overall Study|Protocol Violation|4|||
30633896|NCT00992394|58645499|FG000|Overall Study|Lost to Follow-up|2|||
30633897|NCT00992394|58645500|FG001|Overall Study|Lost to Follow-up|0|||
30633898|NCT00992394|58645499|FG000|Overall Study|Other event|1|||
30633899|NCT00992394|58645500|FG001|Overall Study|Other event|0|||
30633900|NCT00829933|58645510|FG000|Overall Study|Adverse Event|2|||
30633901|NCT00829933|58645511|FG001|Overall Study|Adverse Event|3|||
30633902|NCT00829933|58645512|FG002|Overall Study|Adverse Event|2|||
30633903|NCT00829933|58645513|FG003|Overall Study|Adverse Event|1|||
30633904|NCT00829933|58645510|FG000|Overall Study|Death|0|||
30633905|NCT00829933|58645511|FG001|Overall Study|Death|0|||
30633906|NCT00829933|58645512|FG002|Overall Study|Death|1|||
30633907|NCT00829933|58645513|FG003|Overall Study|Death|1|||
30633908|NCT00829933|58645510|FG000|Overall Study|Lack of Efficacy|0|||
30633909|NCT00829933|58645511|FG001|Overall Study|Lack of Efficacy|1|||
30633910|NCT00829933|58645512|FG002|Overall Study|Lack of Efficacy|0|||
30633911|NCT00829933|58645513|FG003|Overall Study|Lack of Efficacy|0|||
30633912|NCT00829933|58645510|FG000|Overall Study|Physician Decision|5|||
30633913|NCT00829933|58645511|FG001|Overall Study|Physician Decision|7|||
30633914|NCT00829933|58645512|FG002|Overall Study|Physician Decision|8|||
30633915|NCT00829933|58645513|FG003|Overall Study|Physician Decision|1|||
30633916|NCT00829933|58645510|FG000|Overall Study|Pregnancy|0|||
30633917|NCT00829933|58645511|FG001|Overall Study|Pregnancy|0|||
30633918|NCT00829933|58645512|FG002|Overall Study|Pregnancy|0|||
30633919|NCT00829933|58645513|FG003|Overall Study|Pregnancy|2|||
30633920|NCT00829933|58645510|FG000|Overall Study|Protocol Violation|2|||
30633921|NCT00829933|58645511|FG001|Overall Study|Protocol Violation|1|||
30633922|NCT00829933|58645512|FG002|Overall Study|Protocol Violation|0|||
30633923|NCT00829933|58645513|FG003|Overall Study|Protocol Violation|0|||
30633924|NCT00829933|58645510|FG000|Overall Study|withdrew before treatment started|5|||
30633925|NCT00829933|58645511|FG001|Overall Study|withdrew before treatment started|1|||
30633926|NCT00829933|58645512|FG002|Overall Study|withdrew before treatment started|2|||
30633927|NCT00829933|58645513|FG003|Overall Study|withdrew before treatment started|9|||
30633928|NCT01170962|58645526|FG000|Treatment Period|Lack of Efficacy|96|||
30633929|NCT01170962|58645527|FG001|Treatment Period|Lack of Efficacy|91|||
30633930|NCT01170962|58645528|FG002|Treatment Period|Lack of Efficacy|7|||
30633931|NCT01170962|58645526|FG000|Treatment Period|Adverse Event|11|||
30633932|NCT01170962|58645527|FG001|Treatment Period|Adverse Event|12|||
30633933|NCT01170962|58645528|FG002|Treatment Period|Adverse Event|3|||
30633934|NCT01170962|58645526|FG000|Treatment Period|Withdrawal by Subject|2|||
30633935|NCT01170962|58645527|FG001|Treatment Period|Withdrawal by Subject|1|||
30633936|NCT01170962|58645528|FG002|Treatment Period|Withdrawal by Subject|0|||
30633937|NCT01170962|58645526|FG000|Treatment Period|Lost to Follow-up|1|||
30633938|NCT01170962|58645527|FG001|Treatment Period|Lost to Follow-up|1|||
30633939|NCT01170962|58645528|FG002|Treatment Period|Lost to Follow-up|1|||
30633940|NCT01170962|58645526|FG000|Treatment Period|Participant no longer meets criteria|0|||
30633941|NCT01170962|58645527|FG001|Treatment Period|Participant no longer meets criteria|1|||
30633942|NCT01170962|58645528|FG002|Treatment Period|Participant no longer meets criteria|0|||
30633943|NCT01170962|58645526|FG000|Treatment Period|Request to discontinue treatment|7|||
30633944|NCT01170962|58645527|FG001|Treatment Period|Request to discontinue treatment|3|||
30764721|NCT03336502|58773456|FG001|Overall Study|Adverse Event|5|||
30633945|NCT01170962|58645528|FG002|Treatment Period|Request to discontinue treatment|1|||
30633946|NCT01170962|58645526|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
30633947|NCT01170962|58645527|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
30764722|NCT00338741|58773464|FG000|Overall Study|Lost to Follow-up|2|||
30633948|NCT01170962|58645528|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
30633949|NCT01170962|58645526|FG000|Follow up Period|Withdrawal by Subject|14|||
30633950|NCT01170962|58645527|FG001|Follow up Period|Withdrawal by Subject|10|||
30633951|NCT01170962|58645528|FG002|Follow up Period|Withdrawal by Subject|2|||
30633952|NCT01170962|58645526|FG000|Follow up Period|Lost to Follow-up|13|||
30764723|NCT00338741|58773465|FG001|Overall Study|Lost to Follow-up|0|||
30633953|NCT01170962|58645527|FG001|Follow up Period|Lost to Follow-up|8|||
30633954|NCT01170962|58645528|FG002|Follow up Period|Lost to Follow-up|1|||
30633955|NCT01170962|58645526|FG000|Follow up Period|Death|2|||
30633956|NCT01170962|58645527|FG001|Follow up Period|Death|2|||
30633957|NCT01170962|58645528|FG002|Follow up Period|Death|0|||
30633958|NCT01170962|58645526|FG000|Follow up Period|Others|10|||
30633959|NCT01170962|58645527|FG001|Follow up Period|Others|7|||
30633960|NCT01170962|58645528|FG002|Follow up Period|Others|3|||
30633961|NCT00843193|58645547|FG000|Overall Study|Adverse Event|2|||
30633962|NCT00843193|58645548|FG001|Overall Study|Adverse Event|4|||
30633963|NCT00843193|58645547|FG000|Overall Study|Lack of Efficacy|1|||
30633964|NCT00843193|58645548|FG001|Overall Study|Lack of Efficacy|1|||
30633965|NCT00843193|58645547|FG000|Overall Study|Protocol Violation|1|||
30633966|NCT00843193|58645548|FG001|Overall Study|Protocol Violation|2|||
30633967|NCT00843193|58645547|FG000|Overall Study|Lost to Follow-up|1|||
30633968|NCT00843193|58645548|FG001|Overall Study|Lost to Follow-up|0|||
30633969|NCT00843193|58645547|FG000|Overall Study|Physician Decision|0|||
30633970|NCT00843193|58645548|FG001|Overall Study|Physician Decision|1|||
30633971|NCT00843193|58645547|FG000|Overall Study|Withdrawal by Subject|3|||
30633972|NCT00843193|58645548|FG001|Overall Study|Withdrawal by Subject|3|||
30633973|NCT00829621|58645557|FG000|Overall Study|Death|1|||
30633974|NCT00829621|58645558|FG001|Overall Study|Death|0|||
30633975|NCT00829621|58645557|FG000|Overall Study|Lost to Follow-up|3|||
30633976|NCT00829621|58645558|FG001|Overall Study|Lost to Follow-up|4|||
30633977|NCT01157078|58645566|FG000|Overall Study|Withdrawal by Subject|12|||
30633978|NCT01157078|58645567|FG001|Overall Study|Withdrawal by Subject|14|||
30633979|NCT01157078|58645566|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
30633980|NCT01157078|58645567|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30633981|NCT01157078|58645566|FG000|Overall Study|Adverse Event|6|||
30633982|NCT01157078|58645567|FG001|Overall Study|Adverse Event|6|||
30633983|NCT01157078|58645566|FG000|Overall Study|Severe non-compliance to protocol|2|||
30633984|NCT01157078|58645567|FG001|Overall Study|Severe non-compliance to protocol|4|||
30633985|NCT01157078|58645566|FG000|Overall Study|Condition under investigation worsened|0|||
30633986|NCT01157078|58645567|FG001|Overall Study|Condition under investigation worsened|1|||
30633987|NCT01157078|58645566|FG000|Overall Study|Lack of Efficacy|2|||
30633988|NCT01157078|58645567|FG001|Overall Study|Lack of Efficacy|0|||
30633989|NCT01157078|58645566|FG000|Overall Study|Study-specific withdrawal criteria|2|||
30633990|NCT01157078|58645567|FG001|Overall Study|Study-specific withdrawal criteria|2|||
30633991|NCT01157078|58645566|FG000|Overall Study|Lost to Follow-up|7|||
30633992|NCT01157078|58645567|FG001|Overall Study|Lost to Follow-up|5|||
30633993|NCT01157078|58645566|FG000|Overall Study|Other|2|||
30633994|NCT01157078|58645567|FG001|Overall Study|Other|4|||
30633995|NCT00591721|58645575|FG000|Overall Study|Withdrawal by Subject|10|||
30633996|NCT00591721|58645576|FG001|Overall Study|Withdrawal by Subject|10|||
30633997|NCT00591721|58645575|FG000|Overall Study|Lost to Follow-up|1|||
30633998|NCT00591721|58645576|FG001|Overall Study|Lost to Follow-up|4|||
30633999|NCT00591721|58645575|FG000|Overall Study|Intervention not received|10|||
30634000|NCT00591721|58645576|FG001|Overall Study|Intervention not received|8|||
30634001|NCT01156844|58645586|FG000|Overall Study|Adverse Event|0|||
30634002|NCT01156844|58645587|FG001|Overall Study|Adverse Event|0|||
30634003|NCT01156844|58645588|FG002|Overall Study|Adverse Event|1|||
30634004|NCT01156844|58645589|FG003|Overall Study|Adverse Event|1|||
30634005|NCT01156844|58645586|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30634006|NCT01156844|58645587|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30634007|NCT01156844|58645588|FG002|Overall Study|Abnormal test procedure result(s)|2|||
30634008|NCT01156844|58645589|FG003|Overall Study|Abnormal test procedure result(s)|2|||
30634009|NCT01156844|58645586|FG000|Overall Study|Withdrawal by Subject|0|||
30634010|NCT01156844|58645587|FG001|Overall Study|Withdrawal by Subject|0|||
30634011|NCT01156844|58645588|FG002|Overall Study|Withdrawal by Subject|2|||
30634012|NCT01156844|58645589|FG003|Overall Study|Withdrawal by Subject|2|||
30634013|NCT01156844|58645586|FG000|Overall Study|Lost to Follow-up|0|||
30634014|NCT01156844|58645587|FG001|Overall Study|Lost to Follow-up|0|||
30848385|NCT04134728|58874457|FG005|Overall Study|Informed Consent Withdrawn|0|||
30634015|NCT01156844|58645588|FG002|Overall Study|Lost to Follow-up|1|||
30634016|NCT01156844|58645589|FG003|Overall Study|Lost to Follow-up|0|||
30634017|NCT01156844|58645586|FG000|Overall Study|Administrative problems|0|||
30634018|NCT01156844|58645587|FG001|Overall Study|Administrative problems|1|||
30634019|NCT01156844|58645588|FG002|Overall Study|Administrative problems|0|||
30634020|NCT01156844|58645589|FG003|Overall Study|Administrative problems|1|||
30634021|NCT01156844|58645586|FG000|Overall Study|Protocol deviation|2|||
30634022|NCT01156844|58645587|FG001|Overall Study|Protocol deviation|0|||
30634023|NCT01156844|58645588|FG002|Overall Study|Protocol deviation|0|||
30634024|NCT01156844|58645589|FG003|Overall Study|Protocol deviation|0|||
30634025|NCT00853021|58645602|FG000|Overall Study|Adverse Event|2|||
30634026|NCT00853021|58645602|FG000|Overall Study|Withdrawal by Subject|2|||
30634027|NCT00853021|58645602|FG000|Overall Study|Death|1|||
30634028|NCT01156532|58645606|FG000|Overall Study|Family Reasons|1|||
30634029|NCT01156532|58645606|FG000|Overall Study|Lost to Follow-up|1|||
30634030|NCT00843115|58645610|FG000|Overall Study|Death|4|||
30634031|NCT00843115|58645610|FG000|Overall Study|Adverse Event|30|||
30634032|NCT00843115|58645610|FG000|Overall Study|Lost to Follow-up|4|||
30634033|NCT00843115|58645610|FG000|Overall Study|Withdrawal by Subject|17|||
30634034|NCT00843115|58645610|FG000|Overall Study|Family wanted meds stopped|1|||
30634035|NCT00843115|58645610|FG000|Overall Study|Family does not want continuation|1|||
30634036|NCT00843115|58645610|FG000|Overall Study|Patient forgot to take meds|1|||
30634037|NCT00843115|58645610|FG000|Overall Study|Does not meet entrance criteria|1|||
30634038|NCT00843115|58645610|FG000|Overall Study|Physician Decision|1|||
30634039|NCT00843115|58645610|FG000|Overall Study|Family discontinued meds|1|||
30634040|NCT00843115|58645610|FG000|Overall Study|patient took for 2 days then stopped|1|||
30634041|NCT00843115|58645610|FG000|Overall Study|patient never took the medication|1|||
30634042|NCT00843115|58645610|FG000|Overall Study|hospitalized due to deterioration|1|||
30634043|NCT00843115|58645610|FG000|Overall Study|week 12 not done|1|||
30634044|NCT00843115|58645610|FG000|Overall Study|Syndrome De Glissement|1|||
30634045|NCT01156376|58645617|FG000|Overall Study|Adverse Event|1|||
30634046|NCT01156376|58645618|FG001|Overall Study|Adverse Event|0|||
30634047|NCT01156376|58645619|FG002|Overall Study|Adverse Event|1|||
30634048|NCT01156376|58645617|FG000|Overall Study|Withdrawal by Subject|0|||
30634049|NCT01156376|58645618|FG001|Overall Study|Withdrawal by Subject|0|||
30634050|NCT01156376|58645619|FG002|Overall Study|Withdrawal by Subject|3|||
30634051|NCT00829387|58645629|FG000|Overall Study|Withdrawal by Subject|2|||
30634052|NCT00829387|58645630|FG001|Overall Study|Withdrawal by Subject|3|||
30634053|NCT00829387|58645629|FG000|Overall Study|Disqualified by PI|1|||
30634054|NCT00829387|58645630|FG001|Overall Study|Disqualified by PI|0|||
30634055|NCT01156142|58645638|FG000|Overall Study|Withdrawal by Subject|8|||
30634056|NCT01156142|58645639|FG001|Overall Study|Withdrawal by Subject|6|||
30634057|NCT01156142|58645638|FG000|Overall Study|Ineligible|0|||
30634058|NCT01156142|58645639|FG001|Overall Study|Ineligible|1|||
30634059|NCT00842257|58645645|FG000|Overall Study|Adverse Event|1|||
30634060|NCT00852475|58645651|FG000|Overall Study|Lost to Follow-up|3|||
30634061|NCT00852475|58645652|FG001|Overall Study|Lost to Follow-up|4|||
30634062|NCT01155284|58645662|FG000|Overall Study|Withdrawal by Subject|4|||
30634063|NCT01155284|58645663|FG001|Overall Study|Withdrawal by Subject|3|||
30634064|NCT01155284|58645662|FG000|Overall Study|Lost to Follow-up|1|||
30634065|NCT01155284|58645663|FG001|Overall Study|Lost to Follow-up|2|||
30634066|NCT01155284|58645662|FG000|Overall Study|Physician Decision|1|||
30634067|NCT01155284|58645663|FG001|Overall Study|Physician Decision|0|||
30634068|NCT01155284|58645662|FG000|Overall Study|Adverse Event|1|||
30634069|NCT01155284|58645663|FG001|Overall Study|Adverse Event|0|||
30634070|NCT00852397|58645674|FG000|Overall Study|Adverse Event|4|||
30634071|NCT00852397|58645675|FG001|Overall Study|Adverse Event|6|||
30634072|NCT00852397|58645676|FG002|Overall Study|Adverse Event|4|||
30634073|NCT00852397|58645674|FG000|Overall Study|Death|0|||
30634074|NCT00852397|58645675|FG001|Overall Study|Death|0|||
30634075|NCT00852397|58645676|FG002|Overall Study|Death|1|||
30634076|NCT00852397|58645674|FG000|Overall Study|Withdrawal by Subject|4|||
30634077|NCT00852397|58645675|FG001|Overall Study|Withdrawal by Subject|1|||
30634078|NCT00852397|58645676|FG002|Overall Study|Withdrawal by Subject|2|||
30634079|NCT00852397|58645674|FG000|Overall Study|Study terminated by sponsor|2|||
30634080|NCT00852397|58645675|FG001|Overall Study|Study terminated by sponsor|1|||
30634081|NCT00852397|58645676|FG002|Overall Study|Study terminated by sponsor|6|||
30634082|NCT00852397|58645674|FG000|Overall Study|Difficulty in study site visit|1|||
30634083|NCT00852397|58645675|FG001|Overall Study|Difficulty in study site visit|0|||
30634084|NCT00852397|58645676|FG002|Overall Study|Difficulty in study site visit|0|||
30634085|NCT00852397|58645674|FG000|Overall Study|Protocol Violation|0|||
30848386|NCT04134728|58874452|FG000|Overall Study|Physician Decision|2|||
30848387|NCT04134728|58874453|FG001|Overall Study|Physician Decision|0|||
30848388|NCT04134728|58874454|FG002|Overall Study|Physician Decision|0|||
30848389|NCT04134728|58874455|FG003|Overall Study|Physician Decision|0|||
30634086|NCT00852397|58645675|FG001|Overall Study|Protocol Violation|0|||
30848390|NCT04134728|58874456|FG004|Overall Study|Physician Decision|0|||
30634087|NCT00852397|58645676|FG002|Overall Study|Protocol Violation|1|||
30634088|NCT00841321|58645686|FG000|Overall Study|Lost to Follow-up|1|||
30634089|NCT00841321|58645687|FG001|Overall Study|Lost to Follow-up|1|||
30634090|NCT00841321|58645686|FG000|Overall Study|Adverse Event|0|||
30848391|NCT04134728|58874457|FG005|Overall Study|Physician Decision|0|||
30634091|NCT00841321|58645687|FG001|Overall Study|Adverse Event|2|||
30634092|NCT00986232|58645699|FG000|Overall Study|Adverse Event|1|||
30634093|NCT00986232|58645700|FG001|Overall Study|Adverse Event|2|||
30634094|NCT00986232|58645701|FG002|Overall Study|Adverse Event|3|||
30634095|NCT00986232|58645702|FG003|Overall Study|Adverse Event|0|||
30634096|NCT00986232|58645699|FG000|Overall Study|Lost to Follow-up|19|||
30634097|NCT00986232|58645700|FG001|Overall Study|Lost to Follow-up|12|||
30634098|NCT00986232|58645701|FG002|Overall Study|Lost to Follow-up|12|||
30634099|NCT00986232|58645702|FG003|Overall Study|Lost to Follow-up|7|||
30634100|NCT00986232|58645699|FG000|Overall Study|Protocol Violation|2|||
30634101|NCT00986232|58645700|FG001|Overall Study|Protocol Violation|3|||
30634102|NCT00986232|58645701|FG002|Overall Study|Protocol Violation|0|||
30634103|NCT00986232|58645702|FG003|Overall Study|Protocol Violation|1|||
30634104|NCT00986232|58645699|FG000|Overall Study|Withdrawal by Subject|13|||
30634105|NCT00986232|58645700|FG001|Overall Study|Withdrawal by Subject|16|||
30634106|NCT00986232|58645701|FG002|Overall Study|Withdrawal by Subject|12|||
30634107|NCT00986232|58645702|FG003|Overall Study|Withdrawal by Subject|3|||
30634108|NCT00986232|58645699|FG000|Overall Study|Missed one or more bleeds|13|||
30634109|NCT00986232|58645700|FG001|Overall Study|Missed one or more bleeds|10|||
30634110|NCT00986232|58645701|FG002|Overall Study|Missed one or more bleeds|6|||
30634111|NCT00986232|58645702|FG003|Overall Study|Missed one or more bleeds|7|||
30634112|NCT00986232|58645699|FG000|Overall Study|Incomplete safety follow-up|3|||
30634113|NCT00986232|58645700|FG001|Overall Study|Incomplete safety follow-up|7|||
30634114|NCT00986232|58645701|FG002|Overall Study|Incomplete safety follow-up|2|||
30634115|NCT00986232|58645702|FG003|Overall Study|Incomplete safety follow-up|2|||
30634116|NCT00852241|58645718|FG000|Overall Study|Physician Decision|18|||
30634117|NCT01169636|58645727|FG000|Overall Study|Adverse Event|0|||
30634118|NCT01169636|58645728|FG001|Overall Study|Adverse Event|0|||
30634119|NCT01169636|58645729|FG002|Overall Study|Adverse Event|1|||
30634120|NCT01169636|58645730|FG003|Overall Study|Adverse Event|1|||
30634121|NCT01169636|58645731|FG004|Overall Study|Adverse Event|0|||
30634122|NCT01169636|58645727|FG000|Overall Study|Screen failure|0|||
30634123|NCT01169636|58645728|FG001|Overall Study|Screen failure|0|||
30634124|NCT01169636|58645729|FG002|Overall Study|Screen failure|2|||
30634125|NCT01169636|58645730|FG003|Overall Study|Screen failure|0|||
30634126|NCT01169636|58645731|FG004|Overall Study|Screen failure|0|||
30634127|NCT01169636|58645727|FG000|Overall Study|Withdrawal by Subject|0|||
30634128|NCT01169636|58645728|FG001|Overall Study|Withdrawal by Subject|0|||
30634129|NCT01169636|58645729|FG002|Overall Study|Withdrawal by Subject|0|||
30634130|NCT01169636|58645730|FG003|Overall Study|Withdrawal by Subject|0|||
30634131|NCT01169636|58645731|FG004|Overall Study|Withdrawal by Subject|3|||
30634132|NCT01169558|58645741|FG000|Overall Study|Disease progression|98|||
30634133|NCT01169558|58645741|FG000|Overall Study|Adverse Event|25|||
30764724|NCT03370510|58773473|FG000|Overall Study|COVID-19|2|||
30951186|NCT01889069|58998338|FG000|Overall Study|Consent Withdrawal|3|||
30951187|NCT02533180|58998350|FG000|Overall Study|Death|0|||
30951188|NCT02533180|58998351|FG001|Overall Study|Death|1|||
30951189|NCT02533180|58998350|FG000|Overall Study|Lost to Follow-up|0|||
30951190|NCT02533180|58998351|FG001|Overall Study|Lost to Follow-up|1|||
30951191|NCT02533180|58998350|FG000|Overall Study|Physician Decision|0|||
30951192|NCT02533180|58998351|FG001|Overall Study|Physician Decision|1|||
30951193|NCT02533180|58998350|FG000|Overall Study|Withdrawal by Subject|2|||
30951194|NCT02533180|58998351|FG001|Overall Study|Withdrawal by Subject|4|||
30951195|NCT02533180|58998350|FG000|Overall Study|Screen Failure|37|||
30951196|NCT02533180|58998351|FG001|Overall Study|Screen Failure|0|||
30951197|NCT02533180|58998350|FG000|Overall Study|Protocol Deviation|0|||
30951198|NCT02533180|58998351|FG001|Overall Study|Protocol Deviation|1|||
30951199|NCT02533180|58998350|FG000|Overall Study|On Study|0|||
30951200|NCT02533180|58998351|FG001|Overall Study|On Study|39|||
30951201|NCT01739348|58998382|FG000|Part I (Base Study)|Adverse Event|41|||
30951202|NCT01739348|58998383|FG001|Part I (Base Study)|Adverse Event|52|||
30951203|NCT01739348|58998384|FG002|Part I (Base Study)|Adverse Event|8|||
30951204|NCT01739348|58998385|FG003|Part I (Base Study)|Adverse Event|33|||
30951205|NCT01739348|58998382|FG000|Part I (Base Study)|Death|10|||
30951206|NCT01739348|58998383|FG001|Part I (Base Study)|Death|7|||
30951207|NCT01739348|58998384|FG002|Part I (Base Study)|Death|2|||
30951208|NCT01739348|58998385|FG003|Part I (Base Study)|Death|8|||
30764725|NCT03370510|58773474|FG001|Overall Study|COVID-19|0|||
30951209|NCT01739348|58998382|FG000|Part I (Base Study)|Lack of Efficacy|3|||
30634134|NCT01169558|58645741|FG000|Overall Study|Withdrawal of Consent|8|||
30634135|NCT01169558|58645741|FG000|Overall Study|Medical Decision|7|||
30634136|NCT01169558|58645741|FG000|Overall Study|Stable Disease|4|||
30634137|NCT01169558|58645741|FG000|Overall Study|Lost to Follow-up|4|||
30634138|NCT01169558|58645741|FG000|Overall Study|Need for Surgery|4|||
30951210|NCT01739348|58998383|FG001|Part I (Base Study)|Lack of Efficacy|8|||
30951211|NCT01739348|58998384|FG002|Part I (Base Study)|Lack of Efficacy|0|||
30951212|NCT01739348|58998385|FG003|Part I (Base Study)|Lack of Efficacy|7|||
30634139|NCT01169558|58645741|FG000|Overall Study|Non-compliance|2|||
30764726|NCT00351611|58773482|FG000|Overall Study|Adverse Event|11|||
30951213|NCT01739348|58998382|FG000|Part I (Base Study)|Lost to Follow-up|4|||
30634140|NCT01169558|58645741|FG000|Overall Study|Protocol Violation|2|||
30634141|NCT01169558|58645741|FG000|Overall Study|Partial response|2|||
30634142|NCT00840463|58645747|FG000|Overall Study|Adverse Event|1|||
30634143|NCT00840463|58645748|FG001|Overall Study|Adverse Event|0|||
30634144|NCT01155050|58645758|FG000|Overall Study|Lost to Follow-up|15|||
30634145|NCT01155050|58645759|FG001|Overall Study|Lost to Follow-up|20|||
30634146|NCT01155050|58645760|FG002|Overall Study|Lost to Follow-up|19|||
30634147|NCT01155050|58645761|FG003|Overall Study|Lost to Follow-up|22|||
30634148|NCT01168856|58645773|FG000|Overall Study|Lost to Follow-up|4|||
30634149|NCT01168856|58645774|FG001|Overall Study|Lost to Follow-up|34|||
30634150|NCT01168856|58645773|FG000|Overall Study|Withdrawal by Subject|6|||
30951214|NCT01739348|58998383|FG001|Part I (Base Study)|Lost to Follow-up|2|||
30951215|NCT01739348|58998384|FG002|Part I (Base Study)|Lost to Follow-up|4|||
30951216|NCT01739348|58998385|FG003|Part I (Base Study)|Lost to Follow-up|4|||
30951217|NCT01739348|58998382|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
30951218|NCT01739348|58998383|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
30951219|NCT01739348|58998384|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
30951220|NCT01739348|58998385|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
30951221|NCT01739348|58998382|FG000|Part I (Base Study)|Physician Decision|10|||
30951222|NCT01739348|58998383|FG001|Part I (Base Study)|Physician Decision|7|||
30951223|NCT01739348|58998384|FG002|Part I (Base Study)|Physician Decision|1|||
30951224|NCT01739348|58998385|FG003|Part I (Base Study)|Physician Decision|4|||
30951225|NCT01739348|58998382|FG000|Part I (Base Study)|Protocol Violation|2|||
30951226|NCT01739348|58998383|FG001|Part I (Base Study)|Protocol Violation|0|||
30951227|NCT01739348|58998384|FG002|Part I (Base Study)|Protocol Violation|1|||
30951228|NCT01739348|58998385|FG003|Part I (Base Study)|Protocol Violation|2|||
30951229|NCT01739348|58998382|FG000|Part I (Base Study)|Screen Failure|2|||
30951230|NCT01739348|58998383|FG001|Part I (Base Study)|Screen Failure|0|||
30951231|NCT01739348|58998384|FG002|Part I (Base Study)|Screen Failure|0|||
30951232|NCT01739348|58998385|FG003|Part I (Base Study)|Screen Failure|0|||
30951233|NCT01739348|58998382|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
30951234|NCT01739348|58998383|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
30951235|NCT01739348|58998384|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
30951236|NCT01739348|58998385|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
30951237|NCT01739348|58998382|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
30951238|NCT01739348|58998383|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
30951239|NCT01739348|58998384|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
30951240|NCT01739348|58998385|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
30951241|NCT01739348|58998382|FG000|Part I (Base Study)|Participant Moved|4|||
30951242|NCT01739348|58998383|FG001|Part I (Base Study)|Participant Moved|3|||
30951243|NCT01739348|58998384|FG002|Part I (Base Study)|Participant Moved|1|||
30951244|NCT01739348|58998385|FG003|Part I (Base Study)|Participant Moved|7|||
30951245|NCT01739348|58998382|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
30951246|NCT01739348|58998383|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
30951247|NCT01739348|58998384|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
30951248|NCT01739348|58998385|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
30951249|NCT01739348|58998382|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
30951250|NCT01739348|58998383|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
30951251|NCT01739348|58998384|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
30951252|NCT01739348|58998385|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
30951253|NCT01739348|58998382|FG000|Part II (Extension Study)|Adverse Event|10|||
30951254|NCT01739348|58998383|FG001|Part II (Extension Study)|Adverse Event|11|||
30951255|NCT01739348|58998384|FG002|Part II (Extension Study)|Adverse Event|7|||
30951256|NCT01739348|58998385|FG003|Part II (Extension Study)|Adverse Event|26|||
30951257|NCT01739348|58998382|FG000|Part II (Extension Study)|Death|3|||
30951258|NCT01739348|58998383|FG001|Part II (Extension Study)|Death|3|||
30951259|NCT01739348|58998384|FG002|Part II (Extension Study)|Death|2|||
30951260|NCT01739348|58998385|FG003|Part II (Extension Study)|Death|6|||
30951261|NCT01739348|58998382|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
30951262|NCT01739348|58998383|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
30951263|NCT01739348|58998384|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
30951264|NCT01739348|58998385|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
30951265|NCT01739348|58998382|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
30634151|NCT01168856|58645774|FG001|Overall Study|Withdrawal by Subject|8|||
30634152|NCT01168856|58645773|FG000|Overall Study|Physician Decision|2|||
30951266|NCT01739348|58998383|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
30951267|NCT01739348|58998384|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
30951268|NCT01739348|58998385|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
30951269|NCT01739348|58998382|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
30951270|NCT01739348|58998383|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
30951271|NCT01739348|58998384|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
30634153|NCT01168856|58645774|FG001|Overall Study|Physician Decision|1|||
30634154|NCT01168856|58645773|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
30634155|NCT01168856|58645774|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
30634156|NCT01168856|58645773|FG000|Overall Study|Participant received anti-HCV treatment|1|||
30634157|NCT01168856|58645774|FG001|Overall Study|Participant received anti-HCV treatment|0|||
30634158|NCT01168856|58645773|FG000|Overall Study|Death|0|||
30634159|NCT01168856|58645774|FG001|Overall Study|Death|2|||
30634160|NCT01168856|58645773|FG000|Overall Study|Other|1|||
30634161|NCT01168856|58645774|FG001|Overall Study|Other|291|||
30634162|NCT01168856|58645773|FG000|Overall Study|Protocol Violation|4|||
30634163|NCT01168856|58645774|FG001|Overall Study|Protocol Violation|6|||
30634164|NCT00828451|58645785|FG000|Overall Study|Death|2|||
30634165|NCT00828451|58645785|FG000|Overall Study|Lack of intravenous line|7|||
30634166|NCT00828451|58645785|FG000|Overall Study|Withdrawal by Subject|1|||
30634167|NCT00828451|58645785|FG000|Overall Study|Deterioration in clinical status|1|||
30764727|NCT00351611|58773483|FG001|Overall Study|Adverse Event|3|||
30764728|NCT00351611|58773482|FG000|Overall Study|Death|1|||
30634168|NCT00839917|58645791|FG000|Overall Study|Lost to Follow-up|1|||
30634169|NCT00839917|58645792|FG001|Overall Study|Lost to Follow-up|0|||
30764729|NCT00351611|58773483|FG001|Overall Study|Death|0|||
30764730|NCT00351611|58773482|FG000|Overall Study|Lost to Follow-up|1|||
30634170|NCT00839917|58645791|FG000|Overall Study|Did not receive vaccine|0|||
30848392|NCT04134728|58874452|FG000|Overall Study|Lost to Follow-up|1|||
30848393|NCT04134728|58874453|FG001|Overall Study|Lost to Follow-up|2|||
30848394|NCT04134728|58874454|FG002|Overall Study|Lost to Follow-up|1|||
30848395|NCT04134728|58874455|FG003|Overall Study|Lost to Follow-up|0|||
30848396|NCT04134728|58874456|FG004|Overall Study|Lost to Follow-up|0|||
30848397|NCT04134728|58874457|FG005|Overall Study|Lost to Follow-up|1|||
30848398|NCT04134728|58874452|FG000|Overall Study|Investigator Site Closed|0|||
30848399|NCT04134728|58874453|FG001|Overall Study|Investigator Site Closed|1|||
30848400|NCT04134728|58874454|FG002|Overall Study|Investigator Site Closed|1|||
30848401|NCT04134728|58874455|FG003|Overall Study|Investigator Site Closed|0|||
30764731|NCT00351611|58773483|FG001|Overall Study|Lost to Follow-up|0|||
30634171|NCT00839917|58645792|FG001|Overall Study|Did not receive vaccine|1|||
30764732|NCT00351611|58773482|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
30951272|NCT01739348|58998385|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
30764733|NCT00351611|58773483|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
30764734|NCT00351611|58773482|FG000|Overall Study|Other|1|||
30764735|NCT00351611|58773483|FG001|Overall Study|Other|0|||
30764736|NCT00351611|58773482|FG000|Overall Study|Protocol Violation|0|||
30764737|NCT00351611|58773483|FG001|Overall Study|Protocol Violation|2|||
30764738|NCT00351533|58773491|FG000|Overall Study|Extubated before first BAL|1|||
30764739|NCT00351533|58773492|FG001|Overall Study|Extubated before first BAL|0|||
30764740|NCT00351533|58773491|FG000|Overall Study|Lost to Follow-up|1|||
30764741|NCT00351533|58773492|FG001|Overall Study|Lost to Follow-up|3|||
30764742|NCT00351533|58773491|FG000|Overall Study|Physician Decision|0|||
30764743|NCT00351533|58773492|FG001|Overall Study|Physician Decision|1|||
30764744|NCT00351533|58773491|FG000|Overall Study|Withdrawal by Subject|0|||
30764745|NCT00351533|58773492|FG001|Overall Study|Withdrawal by Subject|1|||
30764746|NCT00351377|58773498|FG000|Overall Study|Adverse Event|5|||
30764747|NCT00351377|58773498|FG000|Overall Study|Death|1|||
30764748|NCT00351377|58773498|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30764749|NCT00337727|58773504|FG000|Overall Study|Adverse Event|5|||
30848402|NCT04134728|58874456|FG004|Overall Study|Investigator Site Closed|0|||
30848403|NCT04134728|58874457|FG005|Overall Study|Investigator Site Closed|0|||
30764750|NCT00337727|58773505|FG001|Overall Study|Adverse Event|3|||
30951273|NCT01739348|58998382|FG000|Part II (Extension Study)|Physician Decision|7|||
30764751|NCT00337727|58773504|FG000|Overall Study|Lost to Follow-up|5|||
30764752|NCT00337727|58773505|FG001|Overall Study|Lost to Follow-up|4|||
30764753|NCT00337727|58773504|FG000|Overall Study|Physician Decision|1|||
30764754|NCT00337727|58773505|FG001|Overall Study|Physician Decision|0|||
30764755|NCT00337727|58773504|FG000|Overall Study|Protocol Violation|4|||
30951274|NCT01739348|58998383|FG001|Part II (Extension Study)|Physician Decision|11|||
30951275|NCT01739348|58998384|FG002|Part II (Extension Study)|Physician Decision|6|||
30764756|NCT00337727|58773505|FG001|Overall Study|Protocol Violation|0|||
30848404|NCT03886272|58874491|FG000|Period 1|Withdrawal by Subject|0|||
30848405|NCT03886272|58874492|FG001|Period 1|Withdrawal by Subject|0|||
30764757|NCT00337727|58773504|FG000|Overall Study|Withdrawal by Subject|3|||
30764758|NCT00337727|58773505|FG001|Overall Study|Withdrawal by Subject|5|||
30764759|NCT00324233|58773513|FG000|First Period|unable to insert catheter|1|||
30764760|NCT00324233|58773514|FG001|First Period|unable to insert catheter|0|||
30764761|NCT00324233|58773513|FG000|Second Period|unable to insert catheter|1|||
30764762|NCT00324233|58773514|FG001|Second Period|unable to insert catheter|1|||
30764763|NCT00324233|58773513|FG000|Second Period|Protocol Violation|4|||
30764764|NCT00324233|58773514|FG001|Second Period|Protocol Violation|6|||
30764765|NCT03335566|58773522|FG000|Overall Study|Adverse Event|0|||
30764766|NCT03335566|58773523|FG001|Overall Study|Adverse Event|1|||
30764767|NCT03335566|58773522|FG000|Overall Study|Lost to Follow-up|1|||
30764768|NCT03335566|58773523|FG001|Overall Study|Lost to Follow-up|0|||
30764769|NCT03335566|58773522|FG000|Overall Study|Technical Problems|1|||
30764770|NCT03335566|58773523|FG001|Overall Study|Technical Problems|0|||
30764771|NCT03335566|58773522|FG000|Overall Study|Protocol Violation|1|||
30764772|NCT03335566|58773523|FG001|Overall Study|Protocol Violation|0|||
30764773|NCT03335566|58773522|FG000|Overall Study|Other than specified above|1|||
30764774|NCT03335566|58773523|FG001|Overall Study|Other than specified above|2|||
30764775|NCT03369418|58773531|FG000|Overall Study|Withdrawal by Subject|3|||
30764776|NCT03369418|58773532|FG001|Overall Study|Withdrawal by Subject|3|||
30764777|NCT03334630|58773540|FG000|Overall Study|Withdrawal by Subject|7|||
30764778|NCT03334630|58773541|FG001|Overall Study|Withdrawal by Subject|7|||
30764779|NCT03334630|58773540|FG000|Overall Study|Lost to Follow-up|3|||
30764780|NCT03334630|58773541|FG001|Overall Study|Lost to Follow-up|1|||
30764781|NCT03334630|58773540|FG000|Overall Study|Adverse Event|0|||
30764782|NCT03334630|58773541|FG001|Overall Study|Adverse Event|1|||
30764783|NCT03334630|58773540|FG000|Overall Study|Physician Decision|1|||
30764784|NCT03334630|58773541|FG001|Overall Study|Physician Decision|1|||
30764785|NCT03334630|58773540|FG000|Overall Study|Enrollment closed|2|||
30764786|NCT03334630|58773541|FG001|Overall Study|Enrollment closed|1|||
30764787|NCT03334630|58773540|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
30764788|NCT03334630|58773541|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
30634172|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
30634173|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
30634174|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
30634175|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
30764789|NCT03334630|58773540|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
30764790|NCT03334630|58773541|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
30764791|NCT03368170|58773549|FG000|Overall Study|Adverse Event|2|||
30764792|NCT03368170|58773550|FG001|Overall Study|Adverse Event|1|||
30764793|NCT00324155|58773558|FG000|Enrolled and Randomized|No longer met study criteria|3|||
30764794|NCT00324155|58773559|FG001|Enrolled and Randomized|No longer met study criteria|0|||
30764795|NCT00324155|58773558|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
30764796|NCT00324155|58773559|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
30764797|NCT00324155|58773558|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
30764798|NCT00324155|58773559|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
30764799|NCT00324155|58773558|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
30764800|NCT00324155|58773559|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
30764801|NCT00324155|58773558|FG000|Received Treatment in Induction Phase|Death|8|||
30764802|NCT00324155|58773559|FG001|Received Treatment in Induction Phase|Death|15|||
30764803|NCT00324155|58773558|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
30764804|NCT00324155|58773559|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
30764805|NCT00324155|58773558|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
30764806|NCT00324155|58773559|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
30764807|NCT00324155|58773558|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
30764808|NCT00324155|58773559|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
30764809|NCT00324155|58773558|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
30764810|NCT00324155|58773559|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
30764811|NCT00324155|58773558|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
30764812|NCT00324155|58773559|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
30764813|NCT00324155|58773558|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
30764814|NCT00324155|58773559|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
30764815|NCT00324155|58773558|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
30634176|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
30634177|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
30634178|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
30634179|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
30634180|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
30764816|NCT00324155|58773559|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
30764817|NCT00324155|58773558|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
30634181|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
30634182|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
30634183|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
30634184|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
30634185|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
30634186|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
30634187|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
30634188|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
30634189|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
30634190|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
30634191|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
30634192|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
30634193|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
30634194|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
30634195|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
30634196|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
30634197|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
30634198|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
30634199|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
30634200|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
30634201|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
30634202|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
30634203|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
30634204|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
30634205|NCT00839527|58645801|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
30634206|NCT00839527|58645802|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
30634207|NCT00839527|58645803|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
30634208|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
30634209|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
30634210|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
30634211|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
30634212|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
30634213|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
30634214|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
30634215|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
30634216|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
30634217|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
30634218|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
30634219|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
30634220|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
30634221|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
30634222|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
30634223|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
30634224|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
30634225|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
30634226|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
30634227|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
30634228|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
30634229|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
30634230|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
30634231|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
30634232|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
30634233|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
30634234|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
30634235|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
30634236|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
30634237|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
30634238|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
30634239|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
30634240|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
30764818|NCT00324155|58773559|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
30634241|NCT00839527|58645801|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
30848406|NCT03886272|58874493|FG002|Period 1|Withdrawal by Subject|0|||
30634242|NCT00839527|58645802|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
30634243|NCT00839527|58645803|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
30634244|NCT00600886|58645815|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
30634245|NCT00600886|58645816|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
30634246|NCT00600886|58645815|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
30634247|NCT00600886|58645816|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
30634248|NCT00600886|58645815|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
30634249|NCT00600886|58645816|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
30634250|NCT00600886|58645815|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
30634251|NCT00600886|58645816|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
30634252|NCT00600886|58645815|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
30634253|NCT00600886|58645816|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
30634254|NCT00600886|58645815|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
30634255|NCT00600886|58645816|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
30634256|NCT00600886|58645815|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
30634257|NCT00600886|58645816|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
30634258|NCT00600886|58645815|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
30634259|NCT00600886|58645816|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
30634260|NCT00600886|58645815|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
30634261|NCT00600886|58645816|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
30634262|NCT00600886|58645815|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
30634263|NCT00600886|58645816|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
30634264|NCT00600886|58645815|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
30634265|NCT00600886|58645816|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
30634266|NCT00600886|58645815|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
30634267|NCT00600886|58645816|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
30634268|NCT00600886|58645815|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
30634269|NCT00600886|58645816|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
30634270|NCT00600886|58645815|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
30634271|NCT00600886|58645816|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
30634272|NCT00600886|58645815|FG000|Extension - Same Treatment (FAS)|Death|1|||
30634273|NCT00600886|58645816|FG001|Extension - Same Treatment (FAS)|Death|1|||
30634274|NCT00600886|58645815|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
30634275|NCT00600886|58645816|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
30634276|NCT00600886|58645815|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
30634277|NCT00600886|58645816|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
30634278|NCT00600886|58645815|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
30634279|NCT00600886|58645816|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
30634280|NCT00600886|58645815|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
30634281|NCT00600886|58645816|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
30634282|NCT00600886|58645815|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
30634283|NCT00600886|58645816|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
30634284|NCT00600886|58645815|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
30634285|NCT00600886|58645816|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
30634286|NCT00600886|58645815|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
30764819|NCT00324155|58773558|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
30764820|NCT00324155|58773559|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
30764821|NCT00324155|58773558|FG000|Follow-up Phase|On-going participants still on drug|11|||
30764822|NCT00324155|58773559|FG001|Follow-up Phase|On-going participants still on drug|6|||
30764823|NCT03334396|58773586|FG000|Overall Study|Adverse Event|1|||
30764824|NCT03334396|58773587|FG001|Overall Study|Adverse Event|0|||
30764825|NCT03334396|58773588|FG002|Overall Study|Adverse Event|1|||
30764826|NCT03334396|58773589|FG003|Overall Study|Adverse Event|0|||
30764827|NCT03334396|58773590|FG004|Overall Study|Adverse Event|0|||
30764828|NCT03334396|58773591|FG005|Overall Study|Adverse Event|0|||
30764829|NCT03334396|58773592|FG006|Overall Study|Adverse Event|0|||
30634287|NCT00600886|58645816|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
30634288|NCT00600886|58645815|FG000|Extension - After Crossover (CAS)|Death|1|||
30634289|NCT00600886|58645816|FG001|Extension - After Crossover (CAS)|Death|0|||
30634290|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
30634291|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
30634292|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
30634293|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
30634294|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
30634295|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
30634296|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
30634297|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
30634298|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
30634299|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
30634300|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
30634301|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
30634302|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
30634303|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
30634304|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
30634305|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
30634306|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
30634307|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
30634308|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
30634309|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
30634310|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
30634311|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
30634312|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
30634313|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
30634314|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
30634315|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
30634316|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
30634317|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
30634318|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
30634319|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
30634320|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
30634321|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
30634322|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
30634323|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
30634324|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
30634325|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
30634326|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
30634327|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
30634328|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
30634329|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
30634330|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
30634331|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
30634332|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
30634333|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
30634334|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
30634335|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
30634336|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
30634337|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
30634338|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
30634339|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
30634340|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
30634341|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
30634342|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Site closed|0|||
30634343|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Site closed|0|||
30634344|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Site closed|1|||
30634345|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Site closed|0|||
30634346|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
30634347|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
30634348|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
30634349|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
30634350|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
30634351|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
30634352|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
30634353|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
30634354|NCT00838903|58645840|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
30634355|NCT00838903|58645841|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
30634356|NCT00838903|58645842|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
30634357|NCT00838903|58645843|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
30634358|NCT00838903|58645840|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
30634359|NCT00838903|58645841|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
30634360|NCT00838903|58645842|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
30634361|NCT00838903|58645843|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
30634362|NCT00838903|58645840|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
30634363|NCT00838903|58645841|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
30634364|NCT00838903|58645842|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
30634365|NCT00838903|58645843|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
30634366|NCT00838903|58645840|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
30634367|NCT00838903|58645841|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
30634368|NCT00838903|58645842|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
30634369|NCT00838903|58645843|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
30634370|NCT00838903|58645840|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
30634371|NCT00838903|58645841|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
30634372|NCT00838903|58645842|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
30634373|NCT00838903|58645843|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
30634374|NCT00838903|58645840|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
30634375|NCT00838903|58645841|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
30634376|NCT00838903|58645842|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
30634377|NCT00838903|58645843|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
30634378|NCT00838903|58645840|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
30634379|NCT00838903|58645841|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
30634380|NCT00838903|58645842|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
30634381|NCT00838903|58645843|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
30634382|NCT00838903|58645840|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
30634383|NCT00838903|58645841|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
30634384|NCT00838903|58645842|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
30634385|NCT00838903|58645843|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
30634386|NCT00838903|58645840|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
30634387|NCT00838903|58645841|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
30634388|NCT00838903|58645842|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
30634389|NCT00838903|58645843|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
30634390|NCT00838903|58645840|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
30634391|NCT00838903|58645841|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
30634392|NCT00838903|58645842|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
30634393|NCT00838903|58645843|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
30634394|NCT00838903|58645840|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
30634395|NCT00838903|58645841|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
30634396|NCT00838903|58645842|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
30634397|NCT00838903|58645843|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
30634398|NCT00838903|58645840|FG000|Follow-up Period (8 Weeks)|Missing|1|||
30634399|NCT00838903|58645841|FG001|Follow-up Period (8 Weeks)|Missing|2|||
30634400|NCT00838903|58645842|FG002|Follow-up Period (8 Weeks)|Missing|1|||
30634401|NCT00838903|58645843|FG003|Follow-up Period (8 Weeks)|Missing|1|||
30634402|NCT00828139|58645857|FG000|Overall Study|Adverse Event|8|||
30634403|NCT00828139|58645858|FG001|Overall Study|Adverse Event|1|||
30634404|NCT00828139|58645859|FG002|Overall Study|Adverse Event|10|||
30634405|NCT00828139|58645860|FG003|Overall Study|Adverse Event|5|||
30634406|NCT00828139|58645857|FG000|Overall Study|Death|2|||
30634407|NCT00828139|58645858|FG001|Overall Study|Death|1|||
30634408|NCT00828139|58645859|FG002|Overall Study|Death|0|||
30634409|NCT00828139|58645860|FG003|Overall Study|Death|2|||
30634410|NCT00828139|58645857|FG000|Overall Study|Refusal unrelated to toxicity|3|||
30634411|NCT00828139|58645858|FG001|Overall Study|Refusal unrelated to toxicity|4|||
30634412|NCT00828139|58645859|FG002|Overall Study|Refusal unrelated to toxicity|5|||
30634413|NCT00828139|58645860|FG003|Overall Study|Refusal unrelated to toxicity|3|||
30634414|NCT00828139|58645857|FG000|Overall Study|Disease Progression|24|||
30634415|NCT00828139|58645858|FG001|Overall Study|Disease Progression|33|||
30634416|NCT00828139|58645859|FG002|Overall Study|Disease Progression|35|||
30634417|NCT00828139|58645860|FG003|Overall Study|Disease Progression|39|||
30634418|NCT00828139|58645857|FG000|Overall Study|Other|4|||
30634419|NCT00828139|58645858|FG001|Overall Study|Other|2|||
30634420|NCT00828139|58645859|FG002|Overall Study|Other|5|||
30634421|NCT00828139|58645860|FG003|Overall Study|Other|2|||
30634422|NCT00838513|58645870|FG000|Screening Period|Screen Failure|3|||
30634423|NCT00838513|58645870|FG000|Extension Treatment Period|Death|1|||
30634424|NCT00838513|58645870|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
30634425|NCT00600106|58645876|FG000|Overall Study|Withdrawal by Subject|1|||
30634426|NCT00600106|58645877|FG001|Overall Study|Withdrawal by Subject|1|||
30634427|NCT00850993|58645887|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
30634428|NCT00850993|58645888|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
30634429|NCT00850993|58645889|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
30634430|NCT00850993|58645890|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
30634431|NCT00818779|58645902|FG000|Overall Study|Protocol Violation|1|||
30634432|NCT00818779|58645903|FG001|Overall Study|Protocol Violation|0|||
30764830|NCT03334396|58773593|FG007|Overall Study|Adverse Event|0|||
30764831|NCT03334396|58773586|FG000|Overall Study|Lack of Efficacy|10|||
30764832|NCT03334396|58773587|FG001|Overall Study|Lack of Efficacy|4|||
30764833|NCT03334396|58773588|FG002|Overall Study|Lack of Efficacy|1|||
30764834|NCT03334396|58773589|FG003|Overall Study|Lack of Efficacy|3|||
30764835|NCT03334396|58773590|FG004|Overall Study|Lack of Efficacy|1|||
30634433|NCT00818779|58645902|FG000|Overall Study|Lost to Follow-up|1|||
30634434|NCT00818779|58645903|FG001|Overall Study|Lost to Follow-up|0|||
30634435|NCT00818779|58645902|FG000|Overall Study|Adverse Event|4|||
30634436|NCT00818779|58645903|FG001|Overall Study|Adverse Event|1|||
30634437|NCT00850759|58645913|FG000|Overall Study|Lost to Follow-up|7|||
30634438|NCT00850759|58645914|FG001|Overall Study|Lost to Follow-up|5|||
30634439|NCT00850759|58645915|FG002|Overall Study|Lost to Follow-up|5|||
30634440|NCT00850759|58645916|FG003|Overall Study|Lost to Follow-up|3|||
30634441|NCT00827827|58645928|FG000|Overall Study|Lost to Follow-up|3|||
30634442|NCT00827827|58645929|FG001|Overall Study|Lost to Follow-up|0|||
30634443|NCT00827827|58645928|FG000|Overall Study|Fall at home- hospitalization|1|||
30634444|NCT00827827|58645929|FG001|Overall Study|Fall at home- hospitalization|0|||
30634445|NCT00827827|58645928|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
30634446|NCT00827827|58645929|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
30634447|NCT00827827|58645928|FG000|Overall Study|Gout|1|||
30634448|NCT00827827|58645929|FG001|Overall Study|Gout|0|||
30634449|NCT00827827|58645928|FG000|Overall Study|Transportation issues|1|||
30634450|NCT00827827|58645929|FG001|Overall Study|Transportation issues|0|||
30634451|NCT00827827|58645928|FG000|Overall Study|Burned with water at home|1|||
30634452|NCT00827827|58645929|FG001|Overall Study|Burned with water at home|0|||
30634453|NCT00600028|58645938|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
30634454|NCT00600028|58645939|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
30634455|NCT00600028|58645938|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
30634456|NCT00600028|58645939|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
30634457|NCT00600028|58645938|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
30634458|NCT00600028|58645939|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
30634459|NCT03542266|58645948|FG000|Treatment Phase|Withdrawal by Subject|1|||
30634460|NCT03542266|58645948|FG000|Treatment Phase|Adverse Event|1|||
30634461|NCT03542266|58645948|FG000|Treatment Phase|PD|1|||
30634462|NCT03201250|58645955|FG000|Overall Study|screen failures|3|||
30634463|NCT03201250|58645956|FG001|Overall Study|screen failures|0|||
30634464|NCT03201250|58645957|FG002|Overall Study|screen failures|0|||
30634465|NCT00818623|58645974|FG000|Overall Study|Adverse Event|1|||
30634466|NCT00818623|58645975|FG001|Overall Study|Adverse Event|0|||
30634467|NCT00818623|58645976|FG002|Overall Study|Adverse Event|1|||
30634468|NCT00818623|58645977|FG003|Overall Study|Adverse Event|0|||
30634469|NCT00818623|58645978|FG004|Overall Study|Adverse Event|0|||
30634470|NCT00818623|58645979|FG005|Overall Study|Adverse Event|1|||
30634471|NCT00818623|58645980|FG006|Overall Study|Adverse Event|0|||
30634472|NCT00818623|58645981|FG007|Overall Study|Adverse Event|0|||
30634473|NCT00818623|58645974|FG000|Overall Study|Bad prostate specific antigen response|0|||
30634474|NCT00818623|58645975|FG001|Overall Study|Bad prostate specific antigen response|3|||
30634475|NCT00818623|58645976|FG002|Overall Study|Bad prostate specific antigen response|2|||
30634476|NCT00818623|58645977|FG003|Overall Study|Bad prostate specific antigen response|5|||
30634477|NCT00818623|58645978|FG004|Overall Study|Bad prostate specific antigen response|0|||
30634478|NCT00818623|58645979|FG005|Overall Study|Bad prostate specific antigen response|1|||
30764836|NCT03334396|58773591|FG005|Overall Study|Lack of Efficacy|0|||
30764837|NCT03334396|58773592|FG006|Overall Study|Lack of Efficacy|0|||
30764838|NCT03334396|58773593|FG007|Overall Study|Lack of Efficacy|1|||
30634479|NCT00818623|58645980|FG006|Overall Study|Bad prostate specific antigen response|0|||
30634480|NCT00818623|58645981|FG007|Overall Study|Bad prostate specific antigen response|0|||
30634481|NCT00818623|58645974|FG000|Overall Study|Withdrawal by Subject|0|||
30634482|NCT00818623|58645975|FG001|Overall Study|Withdrawal by Subject|1|||
30951276|NCT01739348|58998385|FG003|Part II (Extension Study)|Physician Decision|12|||
30634483|NCT00818623|58645976|FG002|Overall Study|Withdrawal by Subject|1|||
30634484|NCT00818623|58645977|FG003|Overall Study|Withdrawal by Subject|0|||
30634485|NCT00818623|58645978|FG004|Overall Study|Withdrawal by Subject|0|||
30634486|NCT00818623|58645979|FG005|Overall Study|Withdrawal by Subject|1|||
30634487|NCT00818623|58645980|FG006|Overall Study|Withdrawal by Subject|1|||
30764839|NCT03334396|58773586|FG000|Overall Study|Lost to Follow-up|0|||
30634488|NCT00818623|58645981|FG007|Overall Study|Withdrawal by Subject|1|||
30634489|NCT00818623|58645974|FG000|Overall Study|Protocol Violation|1|||
30634490|NCT00818623|58645975|FG001|Overall Study|Protocol Violation|0|||
30634491|NCT00818623|58645976|FG002|Overall Study|Protocol Violation|0|||
30634492|NCT00818623|58645977|FG003|Overall Study|Protocol Violation|0|||
30634493|NCT00818623|58645978|FG004|Overall Study|Protocol Violation|1|||
30634494|NCT00818623|58645979|FG005|Overall Study|Protocol Violation|0|||
30634495|NCT00818623|58645980|FG006|Overall Study|Protocol Violation|1|||
30634496|NCT00818623|58645981|FG007|Overall Study|Protocol Violation|0|||
30634497|NCT00818623|58645974|FG000|Overall Study|Need of additional treatment|0|||
30634498|NCT00818623|58645975|FG001|Overall Study|Need of additional treatment|0|||
30634499|NCT00818623|58645976|FG002|Overall Study|Need of additional treatment|0|||
30634500|NCT00818623|58645977|FG003|Overall Study|Need of additional treatment|0|||
30634501|NCT00818623|58645978|FG004|Overall Study|Need of additional treatment|1|||
30634502|NCT00818623|58645979|FG005|Overall Study|Need of additional treatment|0|||
30634503|NCT00818623|58645980|FG006|Overall Study|Need of additional treatment|0|||
30634504|NCT00818623|58645981|FG007|Overall Study|Need of additional treatment|0|||
30634505|NCT00818623|58645974|FG000|Overall Study|Lack of trial drug at site|0|||
30634506|NCT00818623|58645975|FG001|Overall Study|Lack of trial drug at site|0|||
30634507|NCT00818623|58645976|FG002|Overall Study|Lack of trial drug at site|0|||
30634508|NCT00818623|58645977|FG003|Overall Study|Lack of trial drug at site|0|||
30634509|NCT00818623|58645978|FG004|Overall Study|Lack of trial drug at site|2|||
30634510|NCT00818623|58645979|FG005|Overall Study|Lack of trial drug at site|0|||
30634511|NCT00818623|58645980|FG006|Overall Study|Lack of trial drug at site|1|||
30634512|NCT00818623|58645981|FG007|Overall Study|Lack of trial drug at site|0|||
30634513|NCT00818623|58645974|FG000|Overall Study|Disease progression|0|||
30634514|NCT00818623|58645975|FG001|Overall Study|Disease progression|0|||
30634515|NCT00818623|58645976|FG002|Overall Study|Disease progression|0|||
30634516|NCT00818623|58645977|FG003|Overall Study|Disease progression|0|||
30634517|NCT00818623|58645978|FG004|Overall Study|Disease progression|0|||
30634518|NCT00818623|58645979|FG005|Overall Study|Disease progression|0|||
30634519|NCT00818623|58645980|FG006|Overall Study|Disease progression|1|||
30634520|NCT00818623|58645981|FG007|Overall Study|Disease progression|0|||
30634521|NCT00827359|58645999|FG000|Overall Study|Progressive Diseas|19|||
30634522|NCT00827359|58645999|FG000|Overall Study|Unacceptable Toxicity|5|||
30634523|NCT00827359|58645999|FG000|Overall Study|Ineligible|1|||
30634524|NCT00818389|58646005|FG000|Overall Study|Death|1|||
30634525|NCT00818389|58646006|FG001|Overall Study|Death|3|||
30634526|NCT00818389|58646005|FG000|Overall Study|ALS Disease Progression|1|||
30634527|NCT00818389|58646006|FG001|Overall Study|ALS Disease Progression|0|||
30634528|NCT00818389|58646005|FG000|Overall Study|Withdrawal by Subject|2|||
30634529|NCT00818389|58646006|FG001|Overall Study|Withdrawal by Subject|2|||
30634530|NCT00818389|58646005|FG000|Overall Study|Adverse Event|0|||
30634531|NCT00818389|58646006|FG001|Overall Study|Adverse Event|1|||
30634532|NCT00850135|58646012|FG000|Overall Study|Physician Decision|1|||
30634533|NCT01154816|58646030|FG000|Overall Study|Withdrawal by Subject|1|||
30764840|NCT03334396|58773587|FG001|Overall Study|Lost to Follow-up|0|||
30764841|NCT03334396|58773588|FG002|Overall Study|Lost to Follow-up|1|||
30764842|NCT03334396|58773589|FG003|Overall Study|Lost to Follow-up|0|||
30764843|NCT03334396|58773590|FG004|Overall Study|Lost to Follow-up|0|||
30764844|NCT03334396|58773591|FG005|Overall Study|Lost to Follow-up|0|||
30764845|NCT03334396|58773592|FG006|Overall Study|Lost to Follow-up|1|||
30764846|NCT03334396|58773593|FG007|Overall Study|Lost to Follow-up|0|||
30764847|NCT03334396|58773586|FG000|Overall Study|Physician Decision|1|||
30764848|NCT03334396|58773587|FG001|Overall Study|Physician Decision|0|||
30764849|NCT03334396|58773588|FG002|Overall Study|Physician Decision|0|||
30764850|NCT03334396|58773589|FG003|Overall Study|Physician Decision|0|||
30764851|NCT03334396|58773590|FG004|Overall Study|Physician Decision|0|||
30764852|NCT03334396|58773591|FG005|Overall Study|Physician Decision|0|||
30764853|NCT03334396|58773592|FG006|Overall Study|Physician Decision|0|||
30764854|NCT03334396|58773593|FG007|Overall Study|Physician Decision|0|||
30764855|NCT03334396|58773586|FG000|Overall Study|Withdrawal by Subject|10|||
30951277|NCT01739348|58998382|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
30634534|NCT01154816|58646031|FG001|Overall Study|Withdrawal by Subject|0|||
30634535|NCT01154816|58646032|FG002|Overall Study|Withdrawal by Subject|0|||
30764856|NCT03334396|58773587|FG001|Overall Study|Withdrawal by Subject|5|||
30634536|NCT01154816|58646033|FG003|Overall Study|Withdrawal by Subject|1|||
30634537|NCT01154816|58646034|FG004|Overall Study|Withdrawal by Subject|0|||
30634538|NCT01154816|58646035|FG005|Overall Study|Withdrawal by Subject|0|||
30634539|NCT01154816|58646036|FG006|Overall Study|Withdrawal by Subject|0|||
30764857|NCT03334396|58773588|FG002|Overall Study|Withdrawal by Subject|7|||
30764858|NCT03334396|58773589|FG003|Overall Study|Withdrawal by Subject|2|||
30764859|NCT03334396|58773590|FG004|Overall Study|Withdrawal by Subject|2|||
30764860|NCT03334396|58773591|FG005|Overall Study|Withdrawal by Subject|1|||
30764861|NCT03334396|58773592|FG006|Overall Study|Withdrawal by Subject|2|||
30764862|NCT03334396|58773593|FG007|Overall Study|Withdrawal by Subject|0|||
30764863|NCT03334396|58773586|FG000|Overall Study|Pregnancy|0|||
30634540|NCT01154816|58646037|FG007|Overall Study|Withdrawal by Subject|0|||
30634541|NCT01154816|58646038|FG008|Overall Study|Withdrawal by Subject|1|||
30634542|NCT01154816|58646039|FG009|Overall Study|Withdrawal by Subject|3|||
30634543|NCT01154816|58646040|FG010|Overall Study|Withdrawal by Subject|0|||
30634544|NCT01154816|58646041|FG011|Overall Study|Withdrawal by Subject|0|||
30634545|NCT01154816|58646030|FG000|Overall Study|Progressive Disease|13|||
30634546|NCT01154816|58646031|FG001|Overall Study|Progressive Disease|8|||
30634547|NCT01154816|58646032|FG002|Overall Study|Progressive Disease|9|||
30634548|NCT01154816|58646033|FG003|Overall Study|Progressive Disease|9|||
30634549|NCT01154816|58646034|FG004|Overall Study|Progressive Disease|8|||
30634550|NCT01154816|58646035|FG005|Overall Study|Progressive Disease|8|||
30634551|NCT01154816|58646036|FG006|Overall Study|Progressive Disease|5|||
30634552|NCT01154816|58646037|FG007|Overall Study|Progressive Disease|6|||
30634553|NCT01154816|58646038|FG008|Overall Study|Progressive Disease|8|||
30634554|NCT01154816|58646039|FG009|Overall Study|Progressive Disease|6|||
30634555|NCT01154816|58646040|FG010|Overall Study|Progressive Disease|10|||
30634556|NCT01154816|58646041|FG011|Overall Study|Progressive Disease|3|||
30634557|NCT01154816|58646030|FG000|Overall Study|Physician Decision|1|||
30634558|NCT01154816|58646031|FG001|Overall Study|Physician Decision|0|||
30634559|NCT01154816|58646032|FG002|Overall Study|Physician Decision|1|||
30634560|NCT01154816|58646033|FG003|Overall Study|Physician Decision|0|||
30634561|NCT01154816|58646034|FG004|Overall Study|Physician Decision|2|||
30634562|NCT01154816|58646035|FG005|Overall Study|Physician Decision|0|||
30634563|NCT01154816|58646036|FG006|Overall Study|Physician Decision|0|||
30634564|NCT01154816|58646037|FG007|Overall Study|Physician Decision|0|||
30634565|NCT01154816|58646038|FG008|Overall Study|Physician Decision|0|||
30634566|NCT01154816|58646039|FG009|Overall Study|Physician Decision|1|||
30634567|NCT01154816|58646040|FG010|Overall Study|Physician Decision|1|||
30634568|NCT01154816|58646041|FG011|Overall Study|Physician Decision|1|||
30634569|NCT01154816|58646030|FG000|Overall Study|Adverse Event|5|||
30634570|NCT01154816|58646031|FG001|Overall Study|Adverse Event|2|||
30634571|NCT01154816|58646032|FG002|Overall Study|Adverse Event|0|||
30634572|NCT01154816|58646033|FG003|Overall Study|Adverse Event|0|||
30634573|NCT01154816|58646034|FG004|Overall Study|Adverse Event|0|||
30634574|NCT01154816|58646035|FG005|Overall Study|Adverse Event|0|||
30634575|NCT01154816|58646036|FG006|Overall Study|Adverse Event|1|||
30634576|NCT01154816|58646037|FG007|Overall Study|Adverse Event|1|||
30634577|NCT01154816|58646038|FG008|Overall Study|Adverse Event|0|||
30634578|NCT01154816|58646039|FG009|Overall Study|Adverse Event|0|||
30634579|NCT01154816|58646040|FG010|Overall Study|Adverse Event|0|||
30634580|NCT01154816|58646041|FG011|Overall Study|Adverse Event|0|||
30634581|NCT00849901|58646087|FG000|Acute Treatment Phase|Adverse Event|9|||
30634582|NCT00849901|58646088|FG001|Acute Treatment Phase|Adverse Event|1|||
30634583|NCT00849901|58646089|FG002|Acute Treatment Phase|Adverse Event|3|||
30634584|NCT00849901|58646087|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
30634585|NCT00849901|58646088|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
30634586|NCT00849901|58646089|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
30634587|NCT00849901|58646087|FG000|Acute Treatment Phase|Protocol Violation|0|||
30634588|NCT00849901|58646088|FG001|Acute Treatment Phase|Protocol Violation|2|||
30634589|NCT00849901|58646089|FG002|Acute Treatment Phase|Protocol Violation|1|||
30634590|NCT00849901|58646087|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
30634591|NCT00849901|58646088|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
30634592|NCT00849901|58646089|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
30634593|NCT00849901|58646087|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
30634594|NCT00849901|58646088|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
30634595|NCT00849901|58646089|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
30764864|NCT03334396|58773587|FG001|Overall Study|Pregnancy|1|||
30764865|NCT03334396|58773588|FG002|Overall Study|Pregnancy|0|||
30764866|NCT03334396|58773589|FG003|Overall Study|Pregnancy|0|||
30764867|NCT03334396|58773590|FG004|Overall Study|Pregnancy|0|||
30764868|NCT03334396|58773591|FG005|Overall Study|Pregnancy|0|||
30764869|NCT03334396|58773592|FG006|Overall Study|Pregnancy|0|||
30764870|NCT03334396|58773593|FG007|Overall Study|Pregnancy|0|||
30764871|NCT03334396|58773586|FG000|Overall Study|Ineligible|0|||
30764872|NCT03334396|58773587|FG001|Overall Study|Ineligible|1|||
30764873|NCT03334396|58773588|FG002|Overall Study|Ineligible|0|||
30634596|NCT00849901|58646087|FG000|Acute Treatment Phase|Physician Decision|1|||
30634597|NCT00849901|58646088|FG001|Acute Treatment Phase|Physician Decision|1|||
30634598|NCT00849901|58646089|FG002|Acute Treatment Phase|Physician Decision|1|||
30634599|NCT00849901|58646087|FG000|Acute Treatment Phase|Sponsor Decision|1|||
30634600|NCT00849901|58646088|FG001|Acute Treatment Phase|Sponsor Decision|0|||
30634601|NCT00849901|58646089|FG002|Acute Treatment Phase|Sponsor Decision|0|||
30634602|NCT00849901|58646087|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
30634603|NCT00849901|58646088|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
30634604|NCT00849901|58646089|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
30764874|NCT03334396|58773589|FG003|Overall Study|Ineligible|0|||
30764875|NCT03334396|58773590|FG004|Overall Study|Ineligible|0|||
30764876|NCT03334396|58773591|FG005|Overall Study|Ineligible|0|||
30764877|NCT03334396|58773592|FG006|Overall Study|Ineligible|0|||
30634605|NCT00849901|58646087|FG000|Extension Phase|Adverse Event|2|||
30634606|NCT00849901|58646088|FG001|Extension Phase|Adverse Event|8|||
30634607|NCT00849901|58646089|FG002|Extension Phase|Adverse Event|4|||
30764878|NCT03334396|58773593|FG007|Overall Study|Ineligible|0|||
30764879|NCT03334396|58773586|FG000|Overall Study|Started New Job|1|||
30764880|NCT03334396|58773587|FG001|Overall Study|Started New Job|0|||
30764881|NCT03334396|58773588|FG002|Overall Study|Started New Job|0|||
30764882|NCT03334396|58773589|FG003|Overall Study|Started New Job|0|||
30764883|NCT03334396|58773590|FG004|Overall Study|Started New Job|0|||
30764884|NCT03334396|58773591|FG005|Overall Study|Started New Job|0|||
30764885|NCT03334396|58773592|FG006|Overall Study|Started New Job|0|||
30764886|NCT03334396|58773593|FG007|Overall Study|Started New Job|0|||
30764887|NCT03338998|58773612|FG000|Treatment Period|Withdrawal by Subject|1|||
30764888|NCT03338998|58773613|FG001|Treatment Period|Withdrawal by Subject|1|||
30764889|NCT03338998|58773612|FG000|Treatment Period|Adverse Event|0|||
30764890|NCT03338998|58773613|FG001|Treatment Period|Adverse Event|2|||
30764891|NCT03338998|58773612|FG000|Treatment Period|Protocol deviation|1|||
30764892|NCT03338998|58773613|FG001|Treatment Period|Protocol deviation|0|||
30764893|NCT03338998|58773612|FG000|Treatment Period|Physician Decision|2|||
30764894|NCT03338998|58773613|FG001|Treatment Period|Physician Decision|0|||
30764895|NCT03338998|58773612|FG000|Treatment Period|Subject failed swallow test|4|||
30764896|NCT03338998|58773613|FG001|Treatment Period|Subject failed swallow test|0|||
30764897|NCT03338998|58773612|FG000|Safety Follow-Up Period|Adverse Event|0|||
30764898|NCT03338998|58773613|FG001|Safety Follow-Up Period|Adverse Event|1|||
30764899|NCT03338998|58773612|FG000|Safety Follow-Up Period|Protocol deviation|1|||
30764900|NCT03338998|58773613|FG001|Safety Follow-Up Period|Protocol deviation|0|||
30764901|NCT03338998|58773612|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
30764902|NCT03338998|58773613|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
30764903|NCT03338296|58773622|FG000|Overall Study|Adverse Event|0|||
30764904|NCT03338296|58773623|FG001|Overall Study|Adverse Event|1|||
30764905|NCT03338296|58773622|FG000|Overall Study|Withdrawal by Subject|14|||
30764906|NCT03338296|58773623|FG001|Overall Study|Withdrawal by Subject|13|||
30764907|NCT03338296|58773622|FG000|Overall Study|Lost to Follow-up|10|||
30764908|NCT03338296|58773623|FG001|Overall Study|Lost to Follow-up|10|||
30764909|NCT03338296|58773622|FG000|Overall Study|Study Terminated by Sponsor|77|||
30764910|NCT03338296|58773623|FG001|Overall Study|Study Terminated by Sponsor|76|||
30764911|NCT03338296|58773622|FG000|Overall Study|Other|2|||
30764912|NCT03338296|58773623|FG001|Overall Study|Other|7|||
30764913|NCT03338296|58773622|FG000|Overall Study|Missing|0|||
30764914|NCT03338296|58773623|FG001|Overall Study|Missing|1|||
30764915|NCT03338062|58773631|FG000|Overall Study|Alternative Therapy|1|||
30764916|NCT03338062|58773632|FG001|Overall Study|Alternative Therapy|0|||
30764917|NCT03364192|58773639|FG000|Overall Study|Ineligible|10|||
30764918|NCT03364192|58773639|FG000|Overall Study|Withdrawal by Subject|5|||
30764919|NCT03364192|58773639|FG000|Overall Study|Lost to Follow-up|1|||
30764920|NCT03783962|58773646|FG000|Overall Study|Lost to Follow-up|3|||
30764921|NCT03783962|58773647|FG001|Overall Study|Lost to Follow-up|6|||
30764922|NCT03783962|58773646|FG000|Overall Study|Protocol Violation|0|||
30764923|NCT03783962|58773647|FG001|Overall Study|Protocol Violation|1|||
30764924|NCT03361228|58773655|FG000|Overall Study|Other|1|||
30764925|NCT03361228|58773656|FG001|Overall Study|Other|1|||
30764926|NCT03361228|58773655|FG000|Overall Study|Death|3|||
30764927|NCT03361228|58773656|FG001|Overall Study|Death|0|||
30764928|NCT03359590|58773662|FG000|First Intervention|Withdrawal by Subject|1|||
30764929|NCT03359590|58773663|FG001|First Intervention|Withdrawal by Subject|1|||
30764930|NCT03359590|58773662|FG000|First Intervention|Protocol Violation|0|||
30764931|NCT03359590|58773663|FG001|First Intervention|Protocol Violation|1|||
30764932|NCT05085964|58773671|FG000|Overall Study|Premature termination of study|21|||
30764933|NCT05085964|58773672|FG001|Overall Study|Premature termination of study|0|||
30764934|NCT02891200|58773681|FG000|Overall Study|Lost to Follow-up|31|||
30764935|NCT02891200|58773682|FG001|Overall Study|Lost to Follow-up|36|||
30764936|NCT02891200|58773681|FG000|Overall Study|Death|10|||
30764937|NCT02891200|58773682|FG001|Overall Study|Death|9|||
30764938|NCT02891200|58773681|FG000|Overall Study|Withdrawal by Subject|1|||
30764939|NCT02891200|58773682|FG001|Overall Study|Withdrawal by Subject|4|||
30764940|NCT02946580|58773690|FG000|Overall Study|Withdrawal by Subject|1|||
30764941|NCT02946580|58773691|FG001|Overall Study|Withdrawal by Subject|2|||
30634608|NCT00849901|58646087|FG000|Extension Phase|Lost to Follow-up|3|||
30764942|NCT02946580|58773690|FG000|Overall Study|Adverse Event|0|||
30764943|NCT02946580|58773691|FG001|Overall Study|Adverse Event|2|||
30951278|NCT01739348|58998383|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
30764944|NCT02946580|58773690|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
30764945|NCT02946580|58773691|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
30764946|NCT00323609|58773699|FG000|Overall Study|Death|16|||
30634609|NCT00849901|58646088|FG001|Extension Phase|Lost to Follow-up|0|||
30764947|NCT00323609|58773700|FG001|Overall Study|Death|21|||
30634610|NCT00849901|58646089|FG002|Extension Phase|Lost to Follow-up|1|||
30634611|NCT00849901|58646087|FG000|Extension Phase|Protocol Violation|2|||
30634612|NCT00849901|58646088|FG001|Extension Phase|Protocol Violation|2|||
30634613|NCT00849901|58646089|FG002|Extension Phase|Protocol Violation|4|||
30634614|NCT00849901|58646087|FG000|Extension Phase|Withdrawal by Subject|7|||
30634615|NCT00849901|58646088|FG001|Extension Phase|Withdrawal by Subject|6|||
30634616|NCT00849901|58646089|FG002|Extension Phase|Withdrawal by Subject|3|||
30634617|NCT00849901|58646087|FG000|Extension Phase|Parent or Caregiver Decision|10|||
30634618|NCT00849901|58646088|FG001|Extension Phase|Parent or Caregiver Decision|4|||
30634619|NCT00849901|58646089|FG002|Extension Phase|Parent or Caregiver Decision|4|||
30634620|NCT00849901|58646087|FG000|Extension Phase|Physician Decision|1|||
30634621|NCT00849901|58646088|FG001|Extension Phase|Physician Decision|2|||
30634622|NCT00849901|58646089|FG002|Extension Phase|Physician Decision|0|||
30634623|NCT00849901|58646087|FG000|Extension Phase|Lack of Efficacy|2|||
30634624|NCT00849901|58646088|FG001|Extension Phase|Lack of Efficacy|4|||
30634625|NCT00849901|58646089|FG002|Extension Phase|Lack of Efficacy|1|||
30634626|NCT01168232|58646103|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
30634627|NCT01168232|58646103|FG000|Overall Study|Ineligible- Wrong cell type|6|||
30634628|NCT01168232|58646103|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
30634629|NCT00817531|58646107|FG000|Overall Study|Adverse Event|1|||
30634630|NCT00817531|58646107|FG000|Overall Study|Lack of Efficacy|1|||
30634631|NCT00817063|58646113|FG000|Overall Study|Adverse Event|32|||
30634632|NCT00817063|58646114|FG001|Overall Study|Adverse Event|13|||
30634633|NCT00817063|58646113|FG000|Overall Study|Death|1|||
30634634|NCT00817063|58646114|FG001|Overall Study|Death|1|||
30634635|NCT00817063|58646113|FG000|Overall Study|Lack of Efficacy|33|||
30634636|NCT00817063|58646114|FG001|Overall Study|Lack of Efficacy|86|||
30634637|NCT00817063|58646113|FG000|Overall Study|Failure to Return|13|||
30634638|NCT00817063|58646114|FG001|Overall Study|Failure to Return|12|||
30634639|NCT00817063|58646113|FG000|Overall Study|Violation of Selection at Entry|7|||
30634640|NCT00817063|58646114|FG001|Overall Study|Violation of Selection at Entry|4|||
30634641|NCT00817063|58646113|FG000|Overall Study|Protocol Violation|3|||
30634642|NCT00817063|58646114|FG001|Overall Study|Protocol Violation|8|||
30634643|NCT00817063|58646113|FG000|Overall Study|Withdrawal by Subject|17|||
30634644|NCT00817063|58646114|FG001|Overall Study|Withdrawal by Subject|37|||
30634645|NCT00817063|58646113|FG000|Overall Study|Early Improvement|19|||
30634646|NCT00817063|58646114|FG001|Overall Study|Early Improvement|4|||
30634647|NCT00817063|58646113|FG000|Overall Study|Administrative|10|||
30634648|NCT00817063|58646114|FG001|Overall Study|Administrative|4|||
30634649|NCT00817063|58646113|FG000|Overall Study|Abnormality of Laboratory Test|2|||
30634650|NCT00817063|58646114|FG001|Overall Study|Abnormality of Laboratory Test|1|||
30634651|NCT01167140|58646120|FG000|Overall Study|Withdrawal by Subject|1|||
30634652|NCT01166750|58646126|FG000|Overall Study|Lost to Follow-up|1|||
30634653|NCT01166750|58646127|FG001|Overall Study|Lost to Follow-up|0|||
30634654|NCT00826267|58646136|FG000|Overall Study|Other Adverse Event|1|||
30634655|NCT00826267|58646137|FG001|Overall Study|Other Adverse Event|0|||
30634656|NCT00826267|58646138|FG002|Overall Study|Other Adverse Event|0|||
30634657|NCT00986154|58646149|FG000|Overall Study|Death|136|||
30634658|NCT00986154|58646150|FG001|Overall Study|Death|127|||
30634659|NCT00986154|58646149|FG000|Overall Study|Lost to Follow-up|7|||
30634660|NCT00986154|58646150|FG001|Overall Study|Lost to Follow-up|4|||
30634661|NCT00986154|58646149|FG000|Overall Study|Withdrawal by Subject|32|||
30634662|NCT00986154|58646150|FG001|Overall Study|Withdrawal by Subject|33|||
30634663|NCT00986154|58646149|FG000|Overall Study|investigator/subject decide not continue|6|||
30634664|NCT00986154|58646150|FG001|Overall Study|investigator/subject decide not continue|3|||
30634665|NCT00986154|58646149|FG000|Overall Study|never received study drug|25|||
30634666|NCT00986154|58646150|FG001|Overall Study|never received study drug|27|||
30634667|NCT00848965|58646156|FG000|Overall Study|Adverse Event|1|||
30634668|NCT00848965|58646156|FG000|Overall Study|Withdrawal by Subject|1|||
30634669|NCT01154036|58646175|FG000|Phase I|Physician Decision|0|||
30634670|NCT01154036|58646176|FG001|Phase I|Physician Decision|1|||
30634671|NCT01154036|58646177|FG002|Phase I|Physician Decision|0|||
30634672|NCT01154036|58646178|FG003|Phase I|Physician Decision|0|||
30634673|NCT01154036|58646179|FG004|Phase I|Physician Decision|0|||
30764948|NCT00323609|58773701|FG002|Overall Study|Death|0|||
30634674|NCT01154036|58646180|FG005|Phase I|Physician Decision|0|||
30634675|NCT01154036|58646181|FG006|Phase I|Physician Decision|0|||
30634676|NCT01154036|58646182|FG007|Phase I|Physician Decision|0|||
30634677|NCT01154036|58646175|FG000|Phase I|Lost to Follow-up|0|||
30634678|NCT01154036|58646176|FG001|Phase I|Lost to Follow-up|3|||
30634679|NCT01154036|58646177|FG002|Phase I|Lost to Follow-up|6|||
30634680|NCT01154036|58646178|FG003|Phase I|Lost to Follow-up|0|||
30634681|NCT01154036|58646179|FG004|Phase I|Lost to Follow-up|0|||
30634682|NCT01154036|58646180|FG005|Phase I|Lost to Follow-up|0|||
30634683|NCT01154036|58646181|FG006|Phase I|Lost to Follow-up|0|||
30634684|NCT01154036|58646182|FG007|Phase I|Lost to Follow-up|0|||
30634685|NCT01154036|58646175|FG000|Phase I|Protocol Violation|0|||
30634686|NCT01154036|58646176|FG001|Phase I|Protocol Violation|3|||
30634687|NCT01154036|58646177|FG002|Phase I|Protocol Violation|9|||
30634688|NCT01154036|58646178|FG003|Phase I|Protocol Violation|0|||
30634689|NCT01154036|58646179|FG004|Phase I|Protocol Violation|0|||
30634690|NCT01154036|58646180|FG005|Phase I|Protocol Violation|0|||
30634691|NCT01154036|58646181|FG006|Phase I|Protocol Violation|0|||
30634692|NCT01154036|58646182|FG007|Phase I|Protocol Violation|0|||
30634693|NCT01154036|58646175|FG000|Phase I|Withdrawal by Subject|2|||
30634694|NCT01154036|58646176|FG001|Phase I|Withdrawal by Subject|10|||
30634695|NCT01154036|58646177|FG002|Phase I|Withdrawal by Subject|29|||
30634696|NCT01154036|58646178|FG003|Phase I|Withdrawal by Subject|0|||
30634697|NCT01154036|58646179|FG004|Phase I|Withdrawal by Subject|0|||
30634698|NCT01154036|58646180|FG005|Phase I|Withdrawal by Subject|0|||
30634699|NCT01154036|58646181|FG006|Phase I|Withdrawal by Subject|0|||
30634700|NCT01154036|58646182|FG007|Phase I|Withdrawal by Subject|0|||
30634701|NCT01154036|58646175|FG000|Phase I|Adverse Event|1|||
30634702|NCT01154036|58646176|FG001|Phase I|Adverse Event|11|||
30634703|NCT01154036|58646177|FG002|Phase I|Adverse Event|12|||
30634704|NCT01154036|58646178|FG003|Phase I|Adverse Event|0|||
30634705|NCT01154036|58646179|FG004|Phase I|Adverse Event|0|||
30634706|NCT01154036|58646180|FG005|Phase I|Adverse Event|0|||
30634707|NCT01154036|58646181|FG006|Phase I|Adverse Event|0|||
30634708|NCT01154036|58646182|FG007|Phase I|Adverse Event|0|||
30634709|NCT01154036|58646175|FG000|Phase II|Adverse Event|0|||
30634710|NCT01154036|58646176|FG001|Phase II|Adverse Event|0|||
30634711|NCT01154036|58646177|FG002|Phase II|Adverse Event|0|||
30634712|NCT01154036|58646178|FG003|Phase II|Adverse Event|0|||
30634713|NCT01154036|58646179|FG004|Phase II|Adverse Event|1|||
30634714|NCT01154036|58646180|FG005|Phase II|Adverse Event|1|||
30634715|NCT01154036|58646181|FG006|Phase II|Adverse Event|1|||
30634716|NCT01154036|58646182|FG007|Phase II|Adverse Event|1|||
30634717|NCT01154036|58646175|FG000|Phase II|Physician Decision|0|||
30634718|NCT01154036|58646176|FG001|Phase II|Physician Decision|0|||
30634719|NCT01154036|58646177|FG002|Phase II|Physician Decision|0|||
30634720|NCT01154036|58646178|FG003|Phase II|Physician Decision|0|||
30634721|NCT01154036|58646179|FG004|Phase II|Physician Decision|0|||
30634722|NCT01154036|58646180|FG005|Phase II|Physician Decision|0|||
30634723|NCT01154036|58646181|FG006|Phase II|Physician Decision|1|||
30634724|NCT01154036|58646182|FG007|Phase II|Physician Decision|0|||
30634725|NCT01154036|58646175|FG000|Phase II|Lost to Follow-up|0|||
30634726|NCT01154036|58646176|FG001|Phase II|Lost to Follow-up|0|||
30634727|NCT01154036|58646177|FG002|Phase II|Lost to Follow-up|0|||
30634728|NCT01154036|58646178|FG003|Phase II|Lost to Follow-up|1|||
30634729|NCT01154036|58646179|FG004|Phase II|Lost to Follow-up|2|||
30634730|NCT01154036|58646180|FG005|Phase II|Lost to Follow-up|0|||
30634731|NCT01154036|58646181|FG006|Phase II|Lost to Follow-up|2|||
30634732|NCT01154036|58646182|FG007|Phase II|Lost to Follow-up|1|||
30634733|NCT01154036|58646175|FG000|Phase II|Protocol Violation|0|||
30634734|NCT01154036|58646176|FG001|Phase II|Protocol Violation|0|||
30634735|NCT01154036|58646177|FG002|Phase II|Protocol Violation|0|||
30634736|NCT01154036|58646178|FG003|Phase II|Protocol Violation|0|||
30764949|NCT00323609|58773702|FG003|Overall Study|Death|0|||
30764950|NCT00323609|58773699|FG000|Overall Study|Lost to Follow-up|9|||
30764951|NCT00323609|58773700|FG001|Overall Study|Lost to Follow-up|10|||
30764952|NCT00323609|58773701|FG002|Overall Study|Lost to Follow-up|0|||
30764953|NCT00323609|58773702|FG003|Overall Study|Lost to Follow-up|0|||
30848407|NCT03886272|58874494|FG003|Period 1|Withdrawal by Subject|0|||
30848408|NCT03886272|58874495|FG004|Period 1|Withdrawal by Subject|0|||
30848409|NCT03886272|58874496|FG005|Period 1|Withdrawal by Subject|1|||
30848410|NCT03886272|58874497|FG006|Period 1|Withdrawal by Subject|0|||
30848411|NCT03732833|58874516|FG000|Overall Study|Adverse Event|0|||
30848412|NCT03732833|58874517|FG001|Overall Study|Adverse Event|3|||
30951279|NCT01739348|58998384|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
30951280|NCT01739348|58998385|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
30634737|NCT01154036|58646179|FG004|Phase II|Protocol Violation|1|||
30634738|NCT01154036|58646180|FG005|Phase II|Protocol Violation|2|||
30634739|NCT01154036|58646181|FG006|Phase II|Protocol Violation|0|||
30634740|NCT01154036|58646182|FG007|Phase II|Protocol Violation|0|||
30634741|NCT01154036|58646175|FG000|Phase II|Withdrawal by Subject|0|||
30634742|NCT01154036|58646176|FG001|Phase II|Withdrawal by Subject|0|||
30634743|NCT01154036|58646177|FG002|Phase II|Withdrawal by Subject|0|||
30634744|NCT01154036|58646178|FG003|Phase II|Withdrawal by Subject|0|||
30634745|NCT01154036|58646179|FG004|Phase II|Withdrawal by Subject|4|||
30634746|NCT01154036|58646180|FG005|Phase II|Withdrawal by Subject|2|||
30634747|NCT01154036|58646181|FG006|Phase II|Withdrawal by Subject|5|||
30634748|NCT01154036|58646182|FG007|Phase II|Withdrawal by Subject|4|||
30634749|NCT00816595|58646204|FG000|Overall Study|Withdrawal by Subject|2|||
30634750|NCT00816595|58646205|FG001|Overall Study|Withdrawal by Subject|0|||
30634751|NCT01166438|58646215|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
30634752|NCT01166438|58646216|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
30764954|NCT00323609|58773699|FG000|Overall Study|Physician Decision|2|||
30848413|NCT03732833|58874518|FG002|Overall Study|Adverse Event|1|||
30634753|NCT01166438|58646215|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
30634754|NCT01166438|58646216|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
30634755|NCT01166438|58646215|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
30634756|NCT01166438|58646216|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
30634757|NCT01166438|58646215|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
30634758|NCT01166438|58646216|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
30634759|NCT01166438|58646215|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
30634760|NCT01166438|58646216|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
30634761|NCT01166438|58646215|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
30634762|NCT01166438|58646216|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
30634763|NCT01153958|58646225|FG000|Overall Study|Study Terminated|36|||
30634764|NCT01153958|58646226|FG001|Overall Study|Study Terminated|32|||
30634765|NCT00599638|58646236|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
30634766|NCT00599638|58646237|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
30634767|NCT00599638|58646238|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
30634768|NCT00599638|58646239|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
30634769|NCT00599638|58646236|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
30634770|NCT00599638|58646237|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
30634771|NCT00599638|58646238|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
30634772|NCT00599638|58646239|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
30634773|NCT00599638|58646236|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
30634774|NCT00599638|58646237|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
30634775|NCT00599638|58646238|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
30634776|NCT00599638|58646239|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
30634777|NCT00599638|58646236|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
30634778|NCT00599638|58646237|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
30634779|NCT00599638|58646238|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
30634780|NCT00599638|58646239|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
30634781|NCT00599638|58646236|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
30634782|NCT00599638|58646237|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
30634783|NCT00599638|58646238|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
30634784|NCT00599638|58646239|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
30634785|NCT00599638|58646236|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
30634786|NCT00599638|58646237|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
30634787|NCT00599638|58646238|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
30634788|NCT00599638|58646239|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
30634789|NCT00599638|58646236|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
30634790|NCT00599638|58646237|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
30634791|NCT00599638|58646238|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
30634792|NCT00599638|58646239|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
30634793|NCT00599638|58646236|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
30634794|NCT00599638|58646237|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
30634795|NCT00599638|58646238|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
30634796|NCT00599638|58646239|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
30634797|NCT00599638|58646236|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
30634798|NCT00599638|58646237|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
30634799|NCT00599638|58646238|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
30634800|NCT00599638|58646239|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
30634801|NCT01166282|58646249|FG000|Open-label Period|Adverse Event|0|||
30634802|NCT01166282|58646250|FG001|Open-label Period|Adverse Event|0|||
30634803|NCT01166282|58646251|FG002|Open-label Period|Adverse Event|6|||
30634804|NCT01166282|58646249|FG000|Open-label Period|Withdrawal by Subject|0|||
30634805|NCT01166282|58646250|FG001|Open-label Period|Withdrawal by Subject|0|||
30634806|NCT01166282|58646251|FG002|Open-label Period|Withdrawal by Subject|4|||
30634807|NCT01166282|58646249|FG000|Open-label Period|Lack of Efficacy|0|||
30634808|NCT01166282|58646250|FG001|Open-label Period|Lack of Efficacy|0|||
30634809|NCT01166282|58646251|FG002|Open-label Period|Lack of Efficacy|2|||
30634810|NCT01166282|58646249|FG000|Open-label Period|Remission|0|||
30634811|NCT01166282|58646250|FG001|Open-label Period|Remission|0|||
30634812|NCT01166282|58646251|FG002|Open-label Period|Remission|4|||
30634813|NCT01166282|58646249|FG000|Open-label Period|Irregular Compliance|0|||
30634814|NCT01166282|58646250|FG001|Open-label Period|Irregular Compliance|0|||
30634815|NCT01166282|58646251|FG002|Open-label Period|Irregular Compliance|1|||
30634816|NCT01153724|58646259|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30764955|NCT00323609|58773700|FG001|Overall Study|Physician Decision|0|||
30634817|NCT01153724|58646259|FG000|Treatment Period 2|Adverse Event|1|||
30634818|NCT01153724|58646259|FG000|Treatment Period 2|Other reason not defined above|1|||
30634819|NCT01152788|58646267|FG000|Overall Study|Withdrawal by Subject|0|||
30634820|NCT01152788|58646268|FG001|Overall Study|Withdrawal by Subject|3|||
30634821|NCT01152788|58646267|FG000|Overall Study|No treatment|0|||
30634822|NCT01152788|58646268|FG001|Overall Study|No treatment|1|||
30634823|NCT01165424|58646274|FG000|Overall Study|Clinical adverse experiences|1|||
30634824|NCT01165424|58646274|FG000|Overall Study|Laboratory adverse experiences|1|||
30634825|NCT01165424|58646274|FG000|Overall Study|Did not meet entry criteria|1|||
30634826|NCT01165424|58646274|FG000|Overall Study|Participant moved (relocated)|1|||
30634827|NCT01152554|58646280|FG000|Overall Study|Withdrawal by Subject|73|||
30634828|NCT01152554|58646281|FG001|Overall Study|Withdrawal by Subject|28|||
30634829|NCT01152554|58646280|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
30634830|NCT01152554|58646281|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
30634831|NCT01152554|58646280|FG000|Overall Study|Adverse Event|67|||
30634832|NCT01152554|58646281|FG001|Overall Study|Adverse Event|14|||
30634833|NCT01152554|58646280|FG000|Overall Study|Severe non-compliance to protocol|36|||
30634834|NCT01152554|58646281|FG001|Overall Study|Severe non-compliance to protocol|14|||
30634835|NCT01152554|58646280|FG000|Overall Study|Condition under investigation worsened|5|||
30634836|NCT01152554|58646281|FG001|Overall Study|Condition under investigation worsened|2|||
30634837|NCT01152554|58646280|FG000|Overall Study|Lack of Efficacy|20|||
30634838|NCT01152554|58646281|FG001|Overall Study|Lack of Efficacy|3|||
30634839|NCT01152554|58646280|FG000|Overall Study|Study-specific withdrawal criteria|17|||
30634840|NCT01152554|58646281|FG001|Overall Study|Study-specific withdrawal criteria|8|||
30634841|NCT01152554|58646280|FG000|Overall Study|Lost to Follow-up|87|||
30634842|NCT01152554|58646281|FG001|Overall Study|Lost to Follow-up|32|||
30634843|NCT01152554|58646280|FG000|Overall Study|Other|28|||
30634844|NCT01152554|58646281|FG001|Overall Study|Other|8|||
30634845|NCT01152554|58646280|FG000|Overall Study|Death|1|||
30634846|NCT01152554|58646281|FG001|Overall Study|Death|1|||
30634847|NCT00598702|58646295|FG000|Overall Study|Other|0|||
30634848|NCT00598702|58646296|FG001|Overall Study|Other|2|||
30634849|NCT00598702|58646297|FG002|Overall Study|Other|0|||
30634850|NCT00598702|58646298|FG003|Overall Study|Other|0|||
30634851|NCT00598702|58646299|FG004|Overall Study|Other|0|||
30634852|NCT00598702|58646300|FG005|Overall Study|Other|1|||
30634853|NCT00598702|58646301|FG006|Overall Study|Other|0|||
30634854|NCT00598702|58646302|FG007|Overall Study|Other|0|||
30634855|NCT00598702|58646295|FG000|Overall Study|Early discharge from hospital|0|||
30634856|NCT00598702|58646296|FG001|Overall Study|Early discharge from hospital|0|||
30634857|NCT00598702|58646297|FG002|Overall Study|Early discharge from hospital|2|||
30634858|NCT00598702|58646298|FG003|Overall Study|Early discharge from hospital|5|||
30634859|NCT00598702|58646299|FG004|Overall Study|Early discharge from hospital|0|||
30634860|NCT00598702|58646300|FG005|Overall Study|Early discharge from hospital|10|||
30634861|NCT00598702|58646301|FG006|Overall Study|Early discharge from hospital|1|||
30634862|NCT00598702|58646302|FG007|Overall Study|Early discharge from hospital|0|||
30634863|NCT00598702|58646295|FG000|Overall Study|Adverse Event|0|||
30634864|NCT00598702|58646296|FG001|Overall Study|Adverse Event|0|||
30634865|NCT00598702|58646297|FG002|Overall Study|Adverse Event|0|||
30634866|NCT00598702|58646298|FG003|Overall Study|Adverse Event|1|||
30634867|NCT00598702|58646299|FG004|Overall Study|Adverse Event|0|||
30634868|NCT00598702|58646300|FG005|Overall Study|Adverse Event|0|||
30634869|NCT00598702|58646301|FG006|Overall Study|Adverse Event|0|||
30764956|NCT00323609|58773701|FG002|Overall Study|Physician Decision|0|||
30764957|NCT00323609|58773702|FG003|Overall Study|Physician Decision|1|||
30764958|NCT00323609|58773699|FG000|Overall Study|Withdrawal by Subject|11|||
30764959|NCT00323609|58773700|FG001|Overall Study|Withdrawal by Subject|23|||
30764960|NCT00323609|58773701|FG002|Overall Study|Withdrawal by Subject|4|||
30764961|NCT00323609|58773702|FG003|Overall Study|Withdrawal by Subject|4|||
30764962|NCT00323609|58773699|FG000|Overall Study|Other non-VCF-related medical condition|3|||
30764963|NCT00323609|58773700|FG001|Overall Study|Other non-VCF-related medical condition|2|||
30764964|NCT00323609|58773701|FG002|Overall Study|Other non-VCF-related medical condition|0|||
30764965|NCT00323609|58773702|FG003|Overall Study|Other non-VCF-related medical condition|0|||
30764966|NCT00323609|58773699|FG000|Overall Study|Sponsor discontinued trial|29|||
30634870|NCT00598702|58646302|FG007|Overall Study|Adverse Event|0|||
30634871|NCT00598702|58646295|FG000|Overall Study|Withdrawal by Subject|0|||
30634872|NCT00598702|58646296|FG001|Overall Study|Withdrawal by Subject|0|||
30634873|NCT00598702|58646297|FG002|Overall Study|Withdrawal by Subject|0|||
30634874|NCT00598702|58646298|FG003|Overall Study|Withdrawal by Subject|1|||
30634875|NCT00598702|58646299|FG004|Overall Study|Withdrawal by Subject|1|||
30764967|NCT00323609|58773700|FG001|Overall Study|Sponsor discontinued trial|29|||
30951281|NCT01739348|58998382|FG000|Part II (Extension Study)|Participant Moved|3|||
30634876|NCT00598702|58646300|FG005|Overall Study|Withdrawal by Subject|0|||
30634877|NCT00598702|58646301|FG006|Overall Study|Withdrawal by Subject|0|||
30634878|NCT00598702|58646302|FG007|Overall Study|Withdrawal by Subject|0|||
30634879|NCT00598702|58646295|FG000|Overall Study|Physician Decision|0|||
30634880|NCT00598702|58646296|FG001|Overall Study|Physician Decision|0|||
30634881|NCT00598702|58646297|FG002|Overall Study|Physician Decision|0|||
30634882|NCT00598702|58646298|FG003|Overall Study|Physician Decision|0|||
30634883|NCT00598702|58646299|FG004|Overall Study|Physician Decision|1|||
30634884|NCT00598702|58646300|FG005|Overall Study|Physician Decision|0|||
30951282|NCT01739348|58998383|FG001|Part II (Extension Study)|Participant Moved|3|||
30764968|NCT00323609|58773701|FG002|Overall Study|Sponsor discontinued trial|0|||
30764969|NCT00323609|58773702|FG003|Overall Study|Sponsor discontinued trial|0|||
30764970|NCT00323609|58773699|FG000|Overall Study|Unrelenting or severe back pain|1|||
30764971|NCT00323609|58773700|FG001|Overall Study|Unrelenting or severe back pain|1|||
30764972|NCT00323609|58773701|FG002|Overall Study|Unrelenting or severe back pain|0|||
30764973|NCT00323609|58773702|FG003|Overall Study|Unrelenting or severe back pain|0|||
30764974|NCT00323609|58773699|FG000|Overall Study|Logistical withdrawal|9|||
30764975|NCT00323609|58773700|FG001|Overall Study|Logistical withdrawal|5|||
30764976|NCT00323609|58773701|FG002|Overall Study|Logistical withdrawal|0|||
30764977|NCT00323609|58773702|FG003|Overall Study|Logistical withdrawal|1|||
30764978|NCT00323609|58773699|FG000|Overall Study|Other reason|11|||
30764979|NCT00323609|58773700|FG001|Overall Study|Other reason|8|||
30764980|NCT00323609|58773701|FG002|Overall Study|Other reason|4|||
30764981|NCT00323609|58773702|FG003|Overall Study|Other reason|9|||
30764982|NCT04598152|58773708|FG000|Overall Study|Lost to Follow-up|0|||
30764983|NCT04598152|58773709|FG001|Overall Study|Lost to Follow-up|1|||
30764984|NCT00323297|58773717|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
30764985|NCT00323297|58773718|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
30764986|NCT00323297|58773717|FG000|Part A (Double Blind Randomized)|Death|0|||
30764987|NCT00323297|58773718|FG001|Part A (Double Blind Randomized)|Death|1|||
30764988|NCT00323297|58773717|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
30764989|NCT00323297|58773718|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
30764990|NCT00323297|58773717|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
30764991|NCT00323297|58773718|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
30764992|NCT00323297|58773717|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
30764993|NCT00323297|58773718|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
30764994|NCT00323297|58773717|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
30764995|NCT00323297|58773718|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
30764996|NCT00323297|58773717|FG000|Part B (Open-label)|Death|0|||
30764997|NCT00323297|58773718|FG001|Part B (Open-label)|Death|1|||
30764998|NCT00323297|58773717|FG000|Part B (Open-label)|Reason unspecified|0|||
30764999|NCT00323297|58773718|FG001|Part B (Open-label)|Reason unspecified|1|||
30765000|NCT00323297|58773717|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
30765001|NCT00323297|58773718|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
30765002|NCT00323297|58773717|FG000|Part B (Open-label)|Lack of Efficacy|3|||
30765003|NCT00323297|58773718|FG001|Part B (Open-label)|Lack of Efficacy|1|||
30848414|NCT03732833|58874516|FG000|Overall Study|Withdrawal by Subject|11|||
30848415|NCT03732833|58874517|FG001|Overall Study|Withdrawal by Subject|13|||
30848416|NCT03732833|58874518|FG002|Overall Study|Withdrawal by Subject|8|||
30848417|NCT03732833|58874516|FG000|Overall Study|Lost to Follow-up|3|||
30848418|NCT03732833|58874517|FG001|Overall Study|Lost to Follow-up|5|||
30848419|NCT03732833|58874518|FG002|Overall Study|Lost to Follow-up|4|||
30848420|NCT03732833|58874516|FG000|Overall Study|Pregnancy|0|||
30848421|NCT03732833|58874517|FG001|Overall Study|Pregnancy|2|||
30848422|NCT03732833|58874518|FG002|Overall Study|Pregnancy|0|||
30848423|NCT03732833|58874516|FG000|Overall Study|Physician Decision|2|||
30848424|NCT03732833|58874517|FG001|Overall Study|Physician Decision|3|||
30848425|NCT03732833|58874518|FG002|Overall Study|Physician Decision|1|||
30848426|NCT03732833|58874516|FG000|Overall Study|Covid-19 related and other reasons|2|||
30848427|NCT03732833|58874517|FG001|Overall Study|Covid-19 related and other reasons|7|||
30848428|NCT03732833|58874518|FG002|Overall Study|Covid-19 related and other reasons|3|||
30848429|NCT03493919|58874535|FG000|Overall Study|Other|2|||
30848430|NCT03493919|58874536|FG001|Overall Study|Other|0|||
30848431|NCT03493919|58874537|FG002|Overall Study|Other|1|||
30848432|NCT03493919|58874538|FG003|Overall Study|Other|0|||
30848433|NCT03493919|58874535|FG000|Overall Study|Withdrawal by Subject|9|||
30848434|NCT03493919|58874536|FG001|Overall Study|Withdrawal by Subject|3|||
30848435|NCT03493919|58874537|FG002|Overall Study|Withdrawal by Subject|1|||
30848436|NCT03493919|58874538|FG003|Overall Study|Withdrawal by Subject|1|||
30848437|NCT03493919|58874535|FG000|Overall Study|Lost to Follow-up|5|||
30848438|NCT03493919|58874536|FG001|Overall Study|Lost to Follow-up|0|||
30848439|NCT03493919|58874537|FG002|Overall Study|Lost to Follow-up|0|||
30848440|NCT03493919|58874538|FG003|Overall Study|Lost to Follow-up|3|||
30848441|NCT03493919|58874535|FG000|Overall Study|Adverse Event|0|||
30848442|NCT03493919|58874536|FG001|Overall Study|Adverse Event|1|||
30848443|NCT03493919|58874537|FG002|Overall Study|Adverse Event|0|||
30848444|NCT03493919|58874538|FG003|Overall Study|Adverse Event|0|||
30765004|NCT00323297|58773717|FG000|Part B (Open-label)|Adverse Event|5|||
30765005|NCT00323297|58773718|FG001|Part B (Open-label)|Adverse Event|5|||
30765006|NCT00323297|58773717|FG000|Part B (Open-label)|Protocol Violation|0|||
30848445|NCT03280628|58874556|FG000|Overall Study|Lost to Follow-up|8|||
30848446|NCT03280628|58874557|FG001|Overall Study|Lost to Follow-up|6|||
30848447|NCT03280628|58874558|FG002|Overall Study|Lost to Follow-up|11|||
30848448|NCT03194646|58874570|FG000|Overall Study|Adverse Event|24|||
30848449|NCT03194646|58874571|FG001|Overall Study|Adverse Event|25|||
30848450|NCT03194646|58874572|FG002|Overall Study|Adverse Event|14|||
30765007|NCT00323297|58773718|FG001|Part B (Open-label)|Protocol Violation|1|||
30765008|NCT00323063|58773726|FG000|Overall Study|Adverse Event|1|||
30765009|NCT00323063|58773727|FG001|Overall Study|Adverse Event|0|||
30765010|NCT00323063|58773726|FG000|Overall Study|brain mets discovered prior to treatment|1|||
30765011|NCT00323063|58773727|FG001|Overall Study|brain mets discovered prior to treatment|0|||
30765012|NCT00322049|58773737|FG000|Overall Study|Moved out of area|0|||
30765013|NCT00322049|58773738|FG001|Overall Study|Moved out of area|0|||
30765014|NCT00322049|58773739|FG002|Overall Study|Moved out of area|0|||
30765015|NCT00322049|58773740|FG003|Overall Study|Moved out of area|1|||
30765016|NCT00322049|58773737|FG000|Overall Study|Infected with Dengue during study|0|||
30765017|NCT00322049|58773738|FG001|Overall Study|Infected with Dengue during study|1|||
30765018|NCT00322049|58773739|FG002|Overall Study|Infected with Dengue during study|0|||
30765019|NCT00322049|58773740|FG003|Overall Study|Infected with Dengue during study|0|||
30765020|NCT00321893|58773761|FG000|Overall Study|Non-Compliance/Refusal|16|||
30765021|NCT00321893|58773762|FG001|Overall Study|Non-Compliance/Refusal|10|||
30765022|NCT00321893|58773761|FG000|Overall Study|Lost to Follow-up|2|||
30765023|NCT00321893|58773762|FG001|Overall Study|Lost to Follow-up|1|||
30765024|NCT00321893|58773761|FG000|Overall Study|Adverse Event|6|||
30765025|NCT00321893|58773762|FG001|Overall Study|Adverse Event|3|||
30765026|NCT00371345|58773770|FG000|Overall Study|Disease Progression|21|||
30765027|NCT00371345|58773771|FG001|Overall Study|Disease Progression|35|||
30765028|NCT00371345|58773770|FG000|Overall Study|Study Drug Toxicity|1|||
30765029|NCT00371345|58773771|FG001|Overall Study|Study Drug Toxicity|7|||
30765030|NCT00371345|58773770|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
30765031|NCT00371345|58773771|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
30765032|NCT00371345|58773770|FG000|Overall Study|Participant Request|1|||
30765033|NCT00371345|58773771|FG001|Overall Study|Participant Request|1|||
30765034|NCT00371345|58773770|FG000|Overall Study|Participant Withdrew Consent|0|||
30765035|NCT00371345|58773771|FG001|Overall Study|Participant Withdrew Consent|1|||
30765036|NCT00321737|58773794|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
30765037|NCT00321737|58773795|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
30765038|NCT00321737|58773796|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
30765039|NCT00321737|58773794|FG000|Overall Study|Adverse Event|11|||
30765040|NCT00321737|58773795|FG001|Overall Study|Adverse Event|3|||
30765041|NCT00321737|58773796|FG002|Overall Study|Adverse Event|6|||
30765042|NCT00321737|58773794|FG000|Overall Study|Lost to Follow-up|5|||
30765043|NCT00321737|58773795|FG001|Overall Study|Lost to Follow-up|5|||
30765044|NCT00321737|58773796|FG002|Overall Study|Lost to Follow-up|6|||
30765045|NCT00321737|58773794|FG000|Overall Study|Withdrawal by Subject|19|||
30765046|NCT00321737|58773795|FG001|Overall Study|Withdrawal by Subject|12|||
30765047|NCT00321737|58773796|FG002|Overall Study|Withdrawal by Subject|17|||
30765048|NCT00321737|58773794|FG000|Overall Study|Protocol Violation|0|||
30765049|NCT00321737|58773795|FG001|Overall Study|Protocol Violation|0|||
30765050|NCT00321737|58773796|FG002|Overall Study|Protocol Violation|1|||
30634885|NCT00598702|58646301|FG006|Overall Study|Physician Decision|0|||
30634886|NCT00598702|58646302|FG007|Overall Study|Physician Decision|0|||
30634887|NCT00598702|58646295|FG000|Overall Study|Dose limiting toxicity|0|||
30634888|NCT00598702|58646296|FG001|Overall Study|Dose limiting toxicity|0|||
30765051|NCT00321737|58773794|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
30765052|NCT00321737|58773795|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
30765053|NCT00321737|58773796|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
30765054|NCT00321737|58773794|FG000|Overall Study|Possible Barrett's Esophagus|2|||
30765055|NCT00321737|58773795|FG001|Overall Study|Possible Barrett's Esophagus|1|||
30765056|NCT00321737|58773796|FG002|Overall Study|Possible Barrett's Esophagus|1|||
30765057|NCT00321737|58773794|FG000|Overall Study|Therapeutic Failure|6|||
30765058|NCT00321737|58773795|FG001|Overall Study|Therapeutic Failure|0|||
30765059|NCT00321737|58773796|FG002|Overall Study|Therapeutic Failure|2|||
30765060|NCT00321737|58773794|FG000|Overall Study|Pregnancy|0|||
30765061|NCT00321737|58773795|FG001|Overall Study|Pregnancy|2|||
30765062|NCT00321737|58773796|FG002|Overall Study|Pregnancy|0|||
30765063|NCT00321737|58773794|FG000|Overall Study|Noncompliance|2|||
30765064|NCT00321737|58773795|FG001|Overall Study|Noncompliance|0|||
30765065|NCT00321737|58773796|FG002|Overall Study|Noncompliance|0|||
30765066|NCT00321737|58773794|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
30765067|NCT00321737|58773795|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
30765068|NCT00321737|58773796|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
30765069|NCT00320801|58773806|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
30765070|NCT00320801|58773807|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
30765071|NCT00320801|58773808|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
30765072|NCT00320801|58773809|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
30765073|NCT00320801|58773806|FG000|Open-label Run-in Period|Adverse Event|33|||
30765074|NCT00320801|58773807|FG001|Open-label Run-in Period|Adverse Event|0|||
30765075|NCT00320801|58773808|FG002|Open-label Run-in Period|Adverse Event|0|||
30634889|NCT00598702|58646297|FG002|Overall Study|Dose limiting toxicity|0|||
30634890|NCT00598702|58646298|FG003|Overall Study|Dose limiting toxicity|1|||
30634891|NCT00598702|58646299|FG004|Overall Study|Dose limiting toxicity|1|||
30634892|NCT00598702|58646300|FG005|Overall Study|Dose limiting toxicity|1|||
30634893|NCT00598702|58646301|FG006|Overall Study|Dose limiting toxicity|0|||
30634894|NCT00598702|58646302|FG007|Overall Study|Dose limiting toxicity|0|||
30634895|NCT01148810|58646322|FG000|Overall Study|Adverse Event|0|||
30634896|NCT01148810|58646323|FG001|Overall Study|Adverse Event|2|||
30634897|NCT01148810|58646322|FG000|Overall Study|Lack of Efficacy|0|||
30634898|NCT01148810|58646323|FG001|Overall Study|Lack of Efficacy|1|||
30634899|NCT01148810|58646322|FG000|Overall Study|Withdrawal by Subject|0|||
30634900|NCT01148810|58646323|FG001|Overall Study|Withdrawal by Subject|2|||
30634901|NCT01148810|58646322|FG000|Overall Study|Protocol Violation|1|||
30634902|NCT01148810|58646323|FG001|Overall Study|Protocol Violation|0|||
30634903|NCT01151618|58646330|FG000|Overall Study|Adverse Event|2|||
30634904|NCT01151618|58646330|FG000|Overall Study|Withdrawal by Subject|7|||
30634905|NCT01164956|58646334|FG000|Overall Study|Side Effects|1|||
30634906|NCT01164956|58646335|FG001|Overall Study|Side Effects|0|||
30634907|NCT01164956|58646336|FG002|Overall Study|Side Effects|1|||
30634908|NCT01164722|58646346|FG000|Overall Study|Adverse Event|0|||
30634909|NCT01164722|58646347|FG001|Overall Study|Adverse Event|1|||
30634910|NCT01164722|58646346|FG000|Overall Study|Withdrawal by Subject|3|||
30634911|NCT01164722|58646347|FG001|Overall Study|Withdrawal by Subject|4|||
30634912|NCT01164722|58646346|FG000|Overall Study|Lost to Follow-up|3|||
30634913|NCT01164722|58646347|FG001|Overall Study|Lost to Follow-up|6|||
30634914|NCT01164722|58646346|FG000|Overall Study|met protocol criteria for non-treatment|11|||
30634915|NCT01164722|58646347|FG001|Overall Study|met protocol criteria for non-treatment|1|||
30634916|NCT01164722|58646346|FG000|Overall Study|enrolled on other study, concomitant med|1|||
30634917|NCT01164722|58646347|FG001|Overall Study|enrolled on other study, concomitant med|3|||
30634918|NCT01151540|58646353|FG000|Overall Study|Other|2|||
30765076|NCT00320801|58773809|FG003|Open-label Run-in Period|Adverse Event|0|||
30765077|NCT00320801|58773806|FG000|Open-label Run-in Period|Administrative|10|||
30765078|NCT00320801|58773807|FG001|Open-label Run-in Period|Administrative|0|||
30765079|NCT00320801|58773808|FG002|Open-label Run-in Period|Administrative|0|||
30765080|NCT00320801|58773809|FG003|Open-label Run-in Period|Administrative|0|||
30765081|NCT00320801|58773806|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
30765082|NCT00320801|58773807|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
30765083|NCT00320801|58773808|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
30765084|NCT00320801|58773809|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
30765085|NCT00320801|58773806|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
30765086|NCT00320801|58773807|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
30765087|NCT00320801|58773808|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
30765088|NCT00320801|58773809|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
30765089|NCT00320801|58773806|FG000|Open-label Run-in Period|Did not qualify|1|||
30765090|NCT00320801|58773807|FG001|Open-label Run-in Period|Did not qualify|0|||
30765091|NCT00320801|58773808|FG002|Open-label Run-in Period|Did not qualify|0|||
30765092|NCT00320801|58773809|FG003|Open-label Run-in Period|Did not qualify|0|||
30765093|NCT00320801|58773806|FG000|Double-blind Phase|Withdrawal by Subject|0|||
30765094|NCT00320801|58773807|FG001|Double-blind Phase|Withdrawal by Subject|0|||
30765095|NCT00320801|58773808|FG002|Double-blind Phase|Withdrawal by Subject|1|||
30765096|NCT00320801|58773809|FG003|Double-blind Phase|Withdrawal by Subject|0|||
30765097|NCT00320801|58773806|FG000|Double-blind Phase|Adverse Event|0|||
30765098|NCT00320801|58773807|FG001|Double-blind Phase|Adverse Event|2|||
30765099|NCT00320801|58773808|FG002|Double-blind Phase|Adverse Event|8|||
30765100|NCT00320801|58773809|FG003|Double-blind Phase|Adverse Event|0|||
30765101|NCT00320801|58773806|FG000|Double-blind Phase|Administrative|0|||
30765102|NCT00320801|58773807|FG001|Double-blind Phase|Administrative|0|||
30765103|NCT00320801|58773808|FG002|Double-blind Phase|Administrative|4|||
30765104|NCT00320801|58773809|FG003|Double-blind Phase|Administrative|0|||
30765105|NCT00320801|58773806|FG000|Double-blind Phase|Lack of Efficacy|0|||
30765106|NCT00320801|58773807|FG001|Double-blind Phase|Lack of Efficacy|9|||
30765107|NCT00320801|58773808|FG002|Double-blind Phase|Lack of Efficacy|1|||
30765108|NCT00320801|58773809|FG003|Double-blind Phase|Lack of Efficacy|0|||
30634919|NCT01151540|58646353|FG000|Overall Study|Adverse event, non-fatal|4|||
30634920|NCT01151540|58646353|FG000|Overall Study|Withdrawal by Subject|7|||
30634921|NCT01163786|58646357|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
30634922|NCT01163786|58646357|FG000|Treatment With Bortezomib|Adverse Event|2|||
30634923|NCT01163786|58646357|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
30634924|NCT00984282|58646363|FG000|Double Blind Treatment|Adverse Event|40|||
30634925|NCT00984282|58646364|FG001|Double Blind Treatment|Adverse Event|6|||
30634926|NCT00984282|58646363|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
30634927|NCT00984282|58646364|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
30765109|NCT00320801|58773806|FG000|Extension Phase|Withdrawal by Subject|0|||
30765110|NCT00320801|58773807|FG001|Extension Phase|Withdrawal by Subject|0|||
30634928|NCT00984282|58646363|FG000|Double Blind Treatment|Physician Decision|1|||
30634929|NCT00984282|58646364|FG001|Double Blind Treatment|Physician Decision|2|||
30765111|NCT00320801|58773808|FG002|Extension Phase|Withdrawal by Subject|0|||
30765112|NCT00320801|58773809|FG003|Extension Phase|Withdrawal by Subject|6|||
30634930|NCT00984282|58646363|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
30634931|NCT00984282|58646364|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
30634932|NCT00984282|58646363|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
30634933|NCT00984282|58646364|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
30634934|NCT00984282|58646363|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
30634935|NCT00984282|58646364|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
30634936|NCT00984282|58646363|FG000|Double Blind Treatment|Lost to Follow-up|3|||
30634937|NCT00984282|58646364|FG001|Double Blind Treatment|Lost to Follow-up|0|||
30634938|NCT00984282|58646363|FG000|Double Blind Treatment|Death|8|||
30634939|NCT00984282|58646364|FG001|Double Blind Treatment|Death|4|||
30634940|NCT00984282|58646363|FG000|Double Blind Treatment|Not treated|0|||
30634941|NCT00984282|58646364|FG001|Double Blind Treatment|Not treated|1|||
30634942|NCT00984282|58646363|FG000|Double Blind Treatment|Switched to commercial drug|6|||
30634943|NCT00984282|58646364|FG001|Double Blind Treatment|Switched to commercial drug|1|||
30634944|NCT00984282|58646363|FG000|Double Blind Treatment|protocol driven decision point|1|||
30634945|NCT00984282|58646364|FG001|Double Blind Treatment|protocol driven decision point|1|||
30634946|NCT00984282|58646363|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
30634947|NCT00984282|58646364|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
30634948|NCT00984282|58646363|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
30634949|NCT00984282|58646364|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
30634950|NCT00984282|58646363|FG000|Open-label Treatment|Adverse Event|20|||
30634951|NCT00984282|58646364|FG001|Open-label Treatment|Adverse Event|30|||
30634952|NCT00984282|58646363|FG000|Open-label Treatment|Withdrawal by Subject|6|||
30634953|NCT00984282|58646364|FG001|Open-label Treatment|Withdrawal by Subject|21|||
30634954|NCT00984282|58646363|FG000|Open-label Treatment|Death|7|||
30634955|NCT00984282|58646364|FG001|Open-label Treatment|Death|15|||
30634956|NCT00984282|58646363|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
30634957|NCT00984282|58646364|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
30634958|NCT00984282|58646363|FG000|Open-label Treatment|Lost to Follow-up|1|||
30634959|NCT00984282|58646364|FG001|Open-label Treatment|Lost to Follow-up|1|||
30634960|NCT00984282|58646363|FG000|Open-label Treatment|Patient convenience|1|||
30634961|NCT00984282|58646364|FG001|Open-label Treatment|Patient convenience|0|||
30634962|NCT00984282|58646363|FG000|Open-label Treatment|Non-compliant with study medication|1|||
30634963|NCT00984282|58646364|FG001|Open-label Treatment|Non-compliant with study medication|0|||
30634964|NCT00984282|58646363|FG000|Open-label Treatment|Target lesion removed|0|||
30634965|NCT00984282|58646364|FG001|Open-label Treatment|Target lesion removed|1|||
30634966|NCT00984282|58646363|FG000|Open-label Treatment|Protocol driven decision point|1|||
30634967|NCT00984282|58646364|FG001|Open-label Treatment|Protocol driven decision point|1|||
30634968|NCT00984282|58646363|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
30634969|NCT00984282|58646364|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
30634970|NCT00984282|58646363|FG000|Open-label Treatment|Switched to commercial drug|6|||
30634971|NCT00984282|58646364|FG001|Open-label Treatment|Switched to commercial drug|7|||
30634972|NCT00984282|58646363|FG000|Open-label Treatment|Physician Decision|1|||
30634973|NCT00984282|58646364|FG001|Open-label Treatment|Physician Decision|0|||
30634974|NCT00984282|58646363|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
30634975|NCT00984282|58646364|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
30634976|NCT00984282|58646363|FG000|Long Term Follow-up|Death|27|||
30634977|NCT00984282|58646364|FG001|Long Term Follow-up|Death|68|||
30634978|NCT00984282|58646363|FG000|Long Term Follow-up|Lost to Follow-up|3|||
30634979|NCT00984282|58646364|FG001|Long Term Follow-up|Lost to Follow-up|6|||
30634980|NCT00984282|58646363|FG000|Long Term Follow-up|Protocol driven decision point|25|||
30634981|NCT00984282|58646364|FG001|Long Term Follow-up|Protocol driven decision point|26|||
30634982|NCT00984282|58646363|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
30634983|NCT00984282|58646364|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
30634984|NCT00984282|58646363|FG000|Long Term Follow-up|Switched to commercial drug|4|||
30634985|NCT00984282|58646364|FG001|Long Term Follow-up|Switched to commercial drug|2|||
30634986|NCT00984282|58646363|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
30634987|NCT00984282|58646364|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
30634988|NCT01147874|58646372|FG000|Overall Study|Adverse Event|5|||
30634989|NCT01147874|58646372|FG000|Overall Study|Investigator's Request|1|||
30634990|NCT01147874|58646372|FG000|Overall Study|Lost to Follow-up|25|||
30634991|NCT01147874|58646372|FG000|Overall Study|Other|5|||
30634992|NCT01147874|58646372|FG000|Overall Study|Protocol Violation|5|||
30634993|NCT01147874|58646372|FG000|Overall Study|Sponsor's Decision|2|||
30634994|NCT01147874|58646372|FG000|Overall Study|Withdrawal by Subject|24|||
30634995|NCT01147640|58646378|FG000|Overall Study|Adverse Event|2|||
30634996|NCT01147640|58646379|FG001|Overall Study|Adverse Event|0|||
30634997|NCT01147640|58646378|FG000|Overall Study|Physician Decision|1|||
30634998|NCT01147640|58646379|FG001|Overall Study|Physician Decision|0|||
30634999|NCT01147640|58646378|FG000|Overall Study|Withdrawal by Subject|1|||
30635000|NCT01147640|58646379|FG001|Overall Study|Withdrawal by Subject|0|||
30635001|NCT01147640|58646378|FG000|Overall Study|Lost to Follow-up|0|||
30635002|NCT01147640|58646379|FG001|Overall Study|Lost to Follow-up|1|||
30635003|NCT01147640|58646378|FG000|Overall Study|Didn't meet eligibility criteria|1|||
30635004|NCT01147640|58646379|FG001|Overall Study|Didn't meet eligibility criteria|0|||
30635005|NCT01121900|58646385|FG000|First Intervention Period|Adverse Event|1|||
30635006|NCT01121900|58646386|FG001|First Intervention Period|Adverse Event|1|||
30635007|NCT01121900|58646385|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
30635008|NCT01121900|58646386|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
30635009|NCT01121666|58646394|FG000|Overall Study|Protocol Violation|29|||
30635010|NCT01121666|58646395|FG001|Overall Study|Protocol Violation|10|||
30635011|NCT00984126|58646405|FG000|Overall Study|Protocol Violation|0|||
30635012|NCT00984126|58646406|FG001|Overall Study|Protocol Violation|0|||
30635013|NCT00984126|58646407|FG002|Overall Study|Protocol Violation|1|||
30635014|NCT00984126|58646408|FG003|Overall Study|Protocol Violation|2|||
30635015|NCT00984126|58646405|FG000|Overall Study|Adverse Event|0|||
30635016|NCT00984126|58646406|FG001|Overall Study|Adverse Event|0|||
30635017|NCT00984126|58646407|FG002|Overall Study|Adverse Event|0|||
30635018|NCT00984126|58646408|FG003|Overall Study|Adverse Event|2|||
30635019|NCT00984126|58646405|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
30635020|NCT00984126|58646406|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
30635021|NCT00984126|58646407|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
30635022|NCT00984126|58646408|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
30635023|NCT00984126|58646405|FG000|Overall Study|Withdrawal criteria|0|||
30635024|NCT00984126|58646406|FG001|Overall Study|Withdrawal criteria|1|||
30635025|NCT00984126|58646407|FG002|Overall Study|Withdrawal criteria|3|||
30635026|NCT00984126|58646408|FG003|Overall Study|Withdrawal criteria|9|||
30635027|NCT00979602|58646429|FG000|Overall Study|Serious Adverse Event|5|||
30635028|NCT00979602|58646430|FG001|Overall Study|Serious Adverse Event|3|||
30635029|NCT00979602|58646429|FG000|Overall Study|Protocol Violation|3|||
30635030|NCT00979602|58646430|FG001|Overall Study|Protocol Violation|0|||
30635031|NCT00979602|58646429|FG000|Overall Study|Withdrawal by Subject|31|||
30635032|NCT00979602|58646430|FG001|Overall Study|Withdrawal by Subject|25|||
30848451|NCT03194646|58874573|FG003|Overall Study|Adverse Event|17|||
30848452|NCT03194646|58874570|FG000|Overall Study|Lack of Efficacy|4|||
30848453|NCT03194646|58874571|FG001|Overall Study|Lack of Efficacy|2|||
30848454|NCT03194646|58874572|FG002|Overall Study|Lack of Efficacy|2|||
30848455|NCT03194646|58874573|FG003|Overall Study|Lack of Efficacy|12|||
30848456|NCT03194646|58874570|FG000|Overall Study|Lost to Follow-up|30|||
30848457|NCT03194646|58874571|FG001|Overall Study|Lost to Follow-up|22|||
30848458|NCT03194646|58874572|FG002|Overall Study|Lost to Follow-up|12|||
30635033|NCT00979602|58646429|FG000|Overall Study|Lost to Follow-up|100|||
30635034|NCT00979602|58646430|FG001|Overall Study|Lost to Follow-up|96|||
30635035|NCT00979602|58646429|FG000|Overall Study|Migrated/moved from study area|3|||
30635036|NCT00979602|58646430|FG001|Overall Study|Migrated/moved from study area|6|||
30635037|NCT00979602|58646429|FG000|Overall Study|Others|3|||
30635038|NCT00979602|58646430|FG001|Overall Study|Others|3|||
30635039|NCT00816361|58646455|FG000|Overall Study|Withdrawal by Subject|0|||
30635040|NCT00816361|58646456|FG001|Overall Study|Withdrawal by Subject|0|||
30635041|NCT00816361|58646457|FG002|Overall Study|Withdrawal by Subject|0|||
30635042|NCT00816361|58646458|FG003|Overall Study|Withdrawal by Subject|0|||
30635043|NCT00816361|58646459|FG004|Overall Study|Withdrawal by Subject|1|||
30635044|NCT00816361|58646460|FG005|Overall Study|Withdrawal by Subject|2|||
30635045|NCT00816361|58646461|FG006|Overall Study|Withdrawal by Subject|0|||
30635046|NCT00816361|58646462|FG007|Overall Study|Withdrawal by Subject|2|||
30635047|NCT00816361|58646463|FG008|Overall Study|Withdrawal by Subject|1|||
30635048|NCT00816361|58646455|FG000|Overall Study|Death|4|||
30635049|NCT00816361|58646456|FG001|Overall Study|Death|3|||
30635050|NCT00816361|58646457|FG002|Overall Study|Death|3|||
30635051|NCT00816361|58646458|FG003|Overall Study|Death|3|||
30635052|NCT00816361|58646459|FG004|Overall Study|Death|1|||
30635053|NCT00816361|58646460|FG005|Overall Study|Death|1|||
30635054|NCT00816361|58646461|FG006|Overall Study|Death|3|||
30848459|NCT03194646|58874573|FG003|Overall Study|Lost to Follow-up|35|||
30635055|NCT00816361|58646462|FG007|Overall Study|Death|7|||
30635056|NCT00816361|58646463|FG008|Overall Study|Death|8|||
30635057|NCT00816361|58646455|FG000|Overall Study|Other|0|||
30635058|NCT00816361|58646456|FG001|Overall Study|Other|0|||
30635059|NCT00816361|58646457|FG002|Overall Study|Other|0|||
30635060|NCT00816361|58646458|FG003|Overall Study|Other|0|||
30848460|NCT03194646|58874570|FG000|Overall Study|Non-compliance with study drug|4|||
30848461|NCT03194646|58874571|FG001|Overall Study|Non-compliance with study drug|0|||
30635061|NCT00816361|58646459|FG004|Overall Study|Other|0|||
30635062|NCT00816361|58646460|FG005|Overall Study|Other|0|||
30635063|NCT00816361|58646461|FG006|Overall Study|Other|0|||
30635064|NCT00816361|58646462|FG007|Overall Study|Other|0|||
30635065|NCT00816361|58646463|FG008|Overall Study|Other|1|||
30635066|NCT00826111|58646486|FG000|Overall Study|Lost to Follow-up|0|||
30635067|NCT00826111|58646487|FG001|Overall Study|Lost to Follow-up|1|||
30635068|NCT00826111|58646486|FG000|Overall Study|Protocol Violation|1|||
30635069|NCT00826111|58646487|FG001|Overall Study|Protocol Violation|0|||
30635070|NCT00826111|58646486|FG000|Overall Study|Withdrawal by Subject|5|||
30635071|NCT00826111|58646487|FG001|Overall Study|Withdrawal by Subject|0|||
30635072|NCT00826111|58646486|FG000|Overall Study|Physician Decision|1|||
30635073|NCT00826111|58646487|FG001|Overall Study|Physician Decision|1|||
30635074|NCT00982644|58646498|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
30635075|NCT00982644|58646499|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
30635076|NCT00982644|58646498|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
30635077|NCT00982644|58646499|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
30635078|NCT00982644|58646498|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
30635079|NCT00982644|58646499|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
30635080|NCT00982644|58646498|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
30635081|NCT00982644|58646499|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
30635082|NCT00982644|58646498|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
30635083|NCT00982644|58646499|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
30635084|NCT00982644|58646498|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
30635085|NCT00982644|58646499|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
30635086|NCT00982644|58646498|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
30635087|NCT00982644|58646499|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
30635088|NCT00982644|58646498|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
30635089|NCT00982644|58646499|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
30635090|NCT00982644|58646498|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
30635091|NCT00982644|58646499|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
30635092|NCT00982644|58646498|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
30635093|NCT00982644|58646499|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
30635094|NCT00815659|58646505|FG000|Overall Study|Adverse Event|9|||
30635095|NCT00815659|58646505|FG000|Overall Study|Withdrawal by Subject|9|||
30635096|NCT00815659|58646505|FG000|Overall Study|Lost to Follow-up|4|||
30635097|NCT00815659|58646505|FG000|Overall Study|Protocol Violation|1|||
30635098|NCT00825175|58646511|FG000|Overall Study|Withdrawal by Subject|0|||
30635099|NCT00825175|58646512|FG001|Overall Study|Withdrawal by Subject|5|||
30635100|NCT00824473|58646520|FG000|Overall Study|Adverse Event|4|||
30635101|NCT00824473|58646521|FG001|Overall Study|Adverse Event|5|||
30635102|NCT00824473|58646520|FG000|Overall Study|Lack of Efficacy|2|||
30635103|NCT00824473|58646521|FG001|Overall Study|Lack of Efficacy|2|||
30635104|NCT00824473|58646520|FG000|Overall Study|Protocol Violation|2|||
30635105|NCT00824473|58646521|FG001|Overall Study|Protocol Violation|0|||
30635106|NCT00824473|58646520|FG000|Overall Study|Non-Compliance|4|||
30635107|NCT00824473|58646521|FG001|Overall Study|Non-Compliance|2|||
30635108|NCT00824473|58646520|FG000|Overall Study|Withdrawal by Subject|2|||
30635109|NCT00824473|58646521|FG001|Overall Study|Withdrawal by Subject|3|||
30635110|NCT00824473|58646520|FG000|Overall Study|Other|1|||
30635111|NCT00824473|58646521|FG001|Overall Study|Other|1|||
30635112|NCT00815191|58646533|FG000|Overall Study|Protocol Violation|1|||
30635113|NCT00815191|58646534|FG001|Overall Study|Protocol Violation|1|||
30635114|NCT00812929|58646540|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
30635115|NCT00812929|58646541|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
30635116|NCT00812929|58646542|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
30635117|NCT00812929|58646543|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
30635118|NCT00812929|58646544|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
30635119|NCT00812929|58646545|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
30765113|NCT00320801|58773806|FG000|Extension Phase|Adverse Event|0|||
30765114|NCT00320801|58773807|FG001|Extension Phase|Adverse Event|0|||
30635120|NCT00812929|58646546|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
30635121|NCT00812929|58646547|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
30635122|NCT00812929|58646548|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
30635123|NCT00812929|58646549|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
30635124|NCT00812929|58646540|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
30635125|NCT00812929|58646541|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
30635126|NCT00812929|58646542|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
30635127|NCT00812929|58646543|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
30635128|NCT00812929|58646544|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
30635129|NCT00812929|58646545|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
30635130|NCT00812929|58646546|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
30635131|NCT00812929|58646547|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
30635132|NCT00812929|58646548|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
30635133|NCT00812929|58646549|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
30635134|NCT00812929|58646540|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
30635135|NCT00812929|58646541|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
30635136|NCT00812929|58646542|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
30635137|NCT00812929|58646543|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
30635138|NCT00812929|58646544|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
30635139|NCT00812929|58646545|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
30635140|NCT00812929|58646546|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
30635141|NCT00812929|58646547|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
30635142|NCT00812929|58646548|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
30635143|NCT00812929|58646549|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
30635144|NCT00824161|58646566|FG000|Overall Study|Withdrawal by Subject|1|||
30635145|NCT00824161|58646566|FG000|Overall Study|Screen Failure|1|||
30635146|NCT00979134|58646575|FG000|Overall Study|Disease progression|18|||
30635147|NCT00979134|58646576|FG001|Overall Study|Disease progression|2|||
30635148|NCT00979134|58646577|FG002|Overall Study|Disease progression|5|||
30635149|NCT00979134|58646575|FG000|Overall Study|Adverse Event|0|||
30635150|NCT00979134|58646576|FG001|Overall Study|Adverse Event|0|||
30635151|NCT00979134|58646577|FG002|Overall Study|Adverse Event|2|||
30635152|NCT00979134|58646575|FG000|Overall Study|Withdrawal by Subject|1|||
30635153|NCT00979134|58646576|FG001|Overall Study|Withdrawal by Subject|1|||
30635154|NCT00979134|58646577|FG002|Overall Study|Withdrawal by Subject|2|||
30635155|NCT00979134|58646575|FG000|Overall Study|Lost to Follow-up|2|||
30635156|NCT00979134|58646576|FG001|Overall Study|Lost to Follow-up|2|||
30635157|NCT00979134|58646577|FG002|Overall Study|Lost to Follow-up|0|||
30635158|NCT00979134|58646575|FG000|Overall Study|Death|4|||
30635159|NCT00979134|58646576|FG001|Overall Study|Death|0|||
30635160|NCT00979134|58646577|FG002|Overall Study|Death|26|||
30635161|NCT00979134|58646575|FG000|Overall Study|Other|8|||
30635162|NCT00979134|58646576|FG001|Overall Study|Other|1|||
30635163|NCT00979134|58646577|FG002|Overall Study|Other|5|||
30635164|NCT00824005|58646592|FG000|Overall Study|Death|0|||
30635165|NCT00824005|58646593|FG001|Overall Study|Death|1|||
30635166|NCT00824005|58646592|FG000|Overall Study|Lost to Follow-up|0|||
30635167|NCT00824005|58646593|FG001|Overall Study|Lost to Follow-up|1|||
30951283|NCT01739348|58998384|FG002|Part II (Extension Study)|Participant Moved|0|||
30951284|NCT01739348|58998385|FG003|Part II (Extension Study)|Participant Moved|3|||
30951285|NCT01739348|58998382|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
30951286|NCT01739348|58998383|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
30951287|NCT01739348|58998384|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
30951288|NCT01739348|58998385|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
30951289|NCT01739348|58998382|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
30951290|NCT01739348|58998383|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
30951291|NCT01739348|58998384|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
30951292|NCT01739348|58998385|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
30951293|NCT01738646|58998417|FG000|Overall Study|Still Receiving Treatment|2|||
30951294|NCT01716104|58998424|FG000|Overall Study|Do not meet inclusion criteria|6|||
30951295|NCT01716104|58998425|FG001|Overall Study|Do not meet inclusion criteria|7|||
30951296|NCT04426695|58998505|FG000|Overall Study|Death|2|||
30951297|NCT04426695|58998506|FG001|Overall Study|Death|0|||
30951298|NCT04426695|58998507|FG002|Overall Study|Death|1|||
30951299|NCT04426695|58998508|FG003|Overall Study|Death|27|||
30635168|NCT00814879|58646601|FG000|By Week 24|Cancer Diagnosis|1|||
30635169|NCT00814879|58646602|FG001|By Week 24|Cancer Diagnosis|0|||
30635170|NCT00814879|58646601|FG000|By Week 24|Incarceration|0|||
30635171|NCT00814879|58646602|FG001|By Week 24|Incarceration|1|||
30635172|NCT00814879|58646601|FG000|By Week 48|Lost to Follow-up|2|||
30635173|NCT00814879|58646602|FG001|By Week 48|Lost to Follow-up|2|||
30635174|NCT00814879|58646601|FG000|By Week 48|Death|0|||
30635175|NCT00814879|58646602|FG001|By Week 48|Death|1|||
30951300|NCT04426695|58998509|FG004|Overall Study|Death|25|||
30635176|NCT03347422|58646611|FG000|Part A (26 Weeks)|Adverse Event|3|||
30635177|NCT03347422|58646612|FG001|Part A (26 Weeks)|Adverse Event|0|||
30635178|NCT03347422|58646611|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
30635179|NCT03347422|58646612|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
30635180|NCT03347422|58646611|FG000|Part B (149 Weeks)|Adverse Event|0|||
30635181|NCT03347422|58646612|FG001|Part B (149 Weeks)|Adverse Event|1|||
30635182|NCT03347422|58646611|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
30635183|NCT03347422|58646612|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
30635184|NCT03347422|58646611|FG000|Part B (149 Weeks)|Other|1|||
30635185|NCT03347422|58646612|FG001|Part B (149 Weeks)|Other|0|||
30635186|NCT00814801|58646628|FG000|Overall Study|Adverse Event|15|||
30635187|NCT00814801|58646629|FG001|Overall Study|Adverse Event|16|||
30635188|NCT00814801|58646630|FG002|Overall Study|Adverse Event|19|||
30635189|NCT00814801|58646628|FG000|Overall Study|Withdrawal by Subject|9|||
30635190|NCT00814801|58646629|FG001|Overall Study|Withdrawal by Subject|11|||
30635191|NCT00814801|58646630|FG002|Overall Study|Withdrawal by Subject|14|||
30635192|NCT00814801|58646628|FG000|Overall Study|Inappropriate as a subject|1|||
30635193|NCT00814801|58646629|FG001|Overall Study|Inappropriate as a subject|1|||
30635194|NCT00814801|58646630|FG002|Overall Study|Inappropriate as a subject|1|||
30635195|NCT00814801|58646628|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
30635196|NCT00814801|58646629|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
30635197|NCT00814801|58646630|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
30635198|NCT00814801|58646628|FG000|Overall Study|Missing or change of caregiver|6|||
30635199|NCT00814801|58646629|FG001|Overall Study|Missing or change of caregiver|2|||
30635200|NCT00814801|58646630|FG002|Overall Study|Missing or change of caregiver|4|||
30635201|NCT00814801|58646628|FG000|Overall Study|Non-compliance|0|||
30635202|NCT00814801|58646629|FG001|Overall Study|Non-compliance|1|||
30635203|NCT00814801|58646630|FG002|Overall Study|Non-compliance|1|||
30635204|NCT00814801|58646628|FG000|Overall Study|Other|2|||
30635205|NCT00814801|58646629|FG001|Overall Study|Other|6|||
30635206|NCT00814801|58646630|FG002|Overall Study|Other|4|||
30635207|NCT00823615|58646638|FG000|Period 2|Lost to Follow-up|2|||
30635208|NCT00823615|58646639|FG001|Period 2|Lost to Follow-up|0|||
30635209|NCT00823615|58646638|FG000|Period 2|Time/Job Conflict|1|||
30635210|NCT00823615|58646639|FG001|Period 2|Time/Job Conflict|2|||
30635211|NCT00812461|58646647|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
30635212|NCT00812461|58646648|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
30635213|NCT00812461|58646647|FG000|All Treated Patients|Adverse Event|8|||
30635214|NCT00812461|58646648|FG001|All Treated Patients|Adverse Event|15|||
30635215|NCT00812461|58646647|FG000|All Treated Patients|Lack of Efficacy|13|||
30635216|NCT00812461|58646648|FG001|All Treated Patients|Lack of Efficacy|7|||
30635217|NCT00812461|58646647|FG000|All Treated Patients|Non-compliance|6|||
30635218|NCT00812461|58646648|FG001|All Treated Patients|Non-compliance|9|||
30635219|NCT00812461|58646647|FG000|All Treated Patients|Protocol Violation|36|||
30635220|NCT00812461|58646648|FG001|All Treated Patients|Protocol Violation|27|||
30635221|NCT00812461|58646647|FG000|All Treated Patients|Withdrawal by Subject|45|||
30635222|NCT00812461|58646648|FG001|All Treated Patients|Withdrawal by Subject|54|||
30635223|NCT00812461|58646647|FG000|All Treated Patients|Lost to Follow-up|11|||
30635224|NCT00812461|58646648|FG001|All Treated Patients|Lost to Follow-up|14|||
30635225|NCT00812461|58646647|FG000|All Treated Patients|Other Reason|13|||
30635226|NCT00812461|58646648|FG001|All Treated Patients|Other Reason|21|||
30635227|NCT00599326|58646654|FG000|Overall Study|Lost to Follow-up|1|||
30635228|NCT00599326|58646654|FG000|Overall Study|Noncompliant|1|||
30635229|NCT00978432|58646661|FG000|Overall Study|Withdrawal by Subject|0|||
30635230|NCT00978432|58646662|FG001|Overall Study|Withdrawal by Subject|0|||
30635231|NCT00978432|58646663|FG002|Overall Study|Withdrawal by Subject|1|||
30635232|NCT00978432|58646661|FG000|Overall Study|Lack of Efficacy|1|||
30635233|NCT00978432|58646662|FG001|Overall Study|Lack of Efficacy|1|||
30635234|NCT00978432|58646663|FG002|Overall Study|Lack of Efficacy|3|||
30635235|NCT00978432|58646661|FG000|Overall Study|Adverse Event|2|||
30635236|NCT00978432|58646662|FG001|Overall Study|Adverse Event|0|||
30635237|NCT00978432|58646663|FG002|Overall Study|Adverse Event|1|||
30635238|NCT00975780|58646673|FG000|Follow Up|Death|88|||
30635239|NCT00975780|58646674|FG001|Follow Up|Death|122|||
30635240|NCT00975780|58646673|FG000|Follow Up|Facility Withdrawal|7|||
30635241|NCT00975780|58646674|FG001|Follow Up|Facility Withdrawal|23|||
30635242|NCT00975780|58646673|FG000|Follow Up|Discharged from Facility|7|||
30635243|NCT00975780|58646674|FG001|Follow Up|Discharged from Facility|12|||
30635244|NCT00814489|58646683|FG000|Overall Study|Other|2|||
30635245|NCT00814489|58646684|FG001|Overall Study|Other|0|||
30635246|NCT00814489|58646685|FG002|Overall Study|Other|1|||
30635247|NCT00814333|58646697|FG000|Enrollment|Lost to Follow-up|1|||
30635248|NCT00814333|58646698|FG001|Enrollment|Lost to Follow-up|0|||
30635249|NCT01147250|58646706|FG000|Overall Study|Lost to Follow-up|14|||
30635250|NCT01147250|58646707|FG001|Overall Study|Lost to Follow-up|11|||
30635251|NCT01147250|58646706|FG000|Overall Study|Withdrawal by Subject|83|||
30635252|NCT01147250|58646707|FG001|Overall Study|Withdrawal by Subject|88|||
30635253|NCT01147250|58646706|FG000|Overall Study|Site termination by sponsor|13|||
30635254|NCT01147250|58646707|FG001|Overall Study|Site termination by sponsor|5|||
30635255|NCT01147250|58646706|FG000|Overall Study|Other than specified|0|||
30635256|NCT01147250|58646707|FG001|Overall Study|Other than specified|1|||
30635257|NCT00813943|58646716|FG000|Overall Study|Ongoing at cut-off date|5|||
30635258|NCT00813943|58646717|FG001|Overall Study|Ongoing at cut-off date|5|||
30635259|NCT00813943|58646718|FG002|Overall Study|Ongoing at cut-off date|3|||
30635260|NCT00821509|58646730|FG000|Overall Study|Withdrawal by Subject|12|||
30635261|NCT00821509|58646731|FG001|Overall Study|Withdrawal by Subject|11|||
30635262|NCT00821509|58646732|FG002|Overall Study|Withdrawal by Subject|34|||
30635263|NCT00821431|58646742|FG000|Overall Study|Adverse Event|6|||
30635264|NCT00821431|58646743|FG001|Overall Study|Adverse Event|3|||
30635265|NCT00821431|58646742|FG000|Overall Study|Withdrawal by Subject|5|||
30635266|NCT00821431|58646743|FG001|Overall Study|Withdrawal by Subject|0|||
30635267|NCT00821431|58646742|FG000|Overall Study|Lost to Follow-up|1|||
30635268|NCT00821431|58646743|FG001|Overall Study|Lost to Follow-up|0|||
30635269|NCT00821431|58646742|FG000|Overall Study|Protocol Violation|3|||
30635270|NCT00821431|58646743|FG001|Overall Study|Protocol Violation|1|||
30635271|NCT00821431|58646742|FG000|Overall Study|Physician Decision|0|||
30635272|NCT00821431|58646743|FG001|Overall Study|Physician Decision|1|||
30635273|NCT03982368|58646752|FG000|Overall Study|Adverse Event|6|||
30635274|NCT03982368|58646753|FG001|Overall Study|Adverse Event|4|||
30635275|NCT03982368|58646754|FG002|Overall Study|Adverse Event|3|||
30635276|NCT03982368|58646752|FG000|Overall Study|Lost to Follow-up|2|||
30635277|NCT03982368|58646753|FG001|Overall Study|Lost to Follow-up|1|||
30635278|NCT03982368|58646754|FG002|Overall Study|Lost to Follow-up|0|||
30635279|NCT03982368|58646752|FG000|Overall Study|Withdrawal by Subject|1|||
30635280|NCT03982368|58646753|FG001|Overall Study|Withdrawal by Subject|2|||
30635281|NCT03982368|58646754|FG002|Overall Study|Withdrawal by Subject|0|||
30635282|NCT03982368|58646752|FG000|Overall Study|unknow|4|||
30635283|NCT03982368|58646753|FG001|Overall Study|unknow|0|||
30635284|NCT03982368|58646754|FG002|Overall Study|unknow|2|||
30635285|NCT00813865|58646765|FG000|Overall Study|Failure to Respond|3|||
30635286|NCT00813865|58646765|FG000|Overall Study|Lost to Follow-up|3|||
30635287|NCT00813865|58646765|FG000|Overall Study|Withdrawal by Subject|1|||
30635288|NCT01147172|58646769|FG000|Overall Study|Withdrawal by Subject|2|||
30635289|NCT01147172|58646769|FG000|Overall Study|Lost to Follow-up|2|||
30635290|NCT01120964|58646777|FG000|Overall Study|Did not receive full treatment|1|||
30635291|NCT01120964|58646778|FG001|Overall Study|Did not receive full treatment|0|||
30635292|NCT01146860|58646786|FG000|Overall Study|Withdrawal by Subject|0|||
30635293|NCT01146860|58646787|FG001|Overall Study|Withdrawal by Subject|1|||
30635294|NCT00591565|58646793|FG000|Overall Study|lost follow up, withdrawn|5|||
30765115|NCT00320801|58773808|FG002|Extension Phase|Adverse Event|0|||
30765116|NCT00320801|58773809|FG003|Extension Phase|Adverse Event|8|||
30765117|NCT00320801|58773806|FG000|Extension Phase|Administrative|0|||
30765118|NCT00320801|58773807|FG001|Extension Phase|Administrative|0|||
30765119|NCT00320801|58773808|FG002|Extension Phase|Administrative|0|||
30765120|NCT00320801|58773809|FG003|Extension Phase|Administrative|29|||
30765121|NCT00320801|58773806|FG000|Extension Phase|Lack of Efficacy|0|||
30765122|NCT00320801|58773807|FG001|Extension Phase|Lack of Efficacy|0|||
30765123|NCT00320801|58773808|FG002|Extension Phase|Lack of Efficacy|0|||
30765124|NCT00320801|58773809|FG003|Extension Phase|Lack of Efficacy|2|||
30765125|NCT00320801|58773806|FG000|Extension Phase|Lost to Follow-up|0|||
30765126|NCT00320801|58773807|FG001|Extension Phase|Lost to Follow-up|0|||
30765127|NCT00320801|58773808|FG002|Extension Phase|Lost to Follow-up|0|||
30765128|NCT00320801|58773809|FG003|Extension Phase|Lost to Follow-up|3|||
30765129|NCT00320489|58773821|FG000|Overall Study|Adverse Event|26|||
30765130|NCT00320489|58773822|FG001|Overall Study|Adverse Event|25|||
30765131|NCT00320489|58773821|FG000|Overall Study|Clinical Relapse|26|||
30765132|NCT00320489|58773822|FG001|Overall Study|Clinical Relapse|20|||
30635295|NCT01146782|58646797|FG000|Screening Cohort|Screen Failure|187|||
30635296|NCT01146782|58646797|FG000|Screening Cohort|Lost to Follow-up|4|||
30635297|NCT01146782|58646797|FG000|Screening Cohort|Physician Decision|1|||
30635298|NCT01146782|58646797|FG000|Screening Cohort|Withdrawal by Subject|29|||
30635299|NCT01146782|58646797|FG000|Safety Cohort|Screen Failure|61|||
30635300|NCT01146782|58646797|FG000|Safety Cohort|Withdrawal by Subject|4|||
30635301|NCT01146782|58646797|FG000|Safety Cohort|Control AHI <5|4|||
30635302|NCT01146782|58646797|FG000|Safety Cohort|TST <4 hrs|14|||
30635303|NCT01146782|58646797|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
30635304|NCT01146782|58646797|FG000|Primary Endpoint Cohort|Physician Decision|1|||
30635305|NCT00978120|58646806|FG000|Overall Study|Death|0|||
30765133|NCT00320489|58773821|FG000|Overall Study|Death|0|||
30635306|NCT00978120|58646807|FG001|Overall Study|Death|0|||
30765134|NCT00320489|58773822|FG001|Overall Study|Death|2|||
30765135|NCT00320489|58773821|FG000|Overall Study|Entry Criteria Exclusion|2|||
30765136|NCT00320489|58773822|FG001|Overall Study|Entry Criteria Exclusion|4|||
30635307|NCT00978120|58646808|FG002|Overall Study|Death|0|||
30635308|NCT00978120|58646809|FG003|Overall Study|Death|1|||
30765137|NCT00320489|58773821|FG000|Overall Study|Lack of Efficacy|16|||
30765138|NCT00320489|58773822|FG001|Overall Study|Lack of Efficacy|7|||
30635309|NCT00978120|58646806|FG000|Overall Study|Lost to Follow-up|0|||
30635310|NCT00978120|58646807|FG001|Overall Study|Lost to Follow-up|0|||
30635311|NCT00978120|58646808|FG002|Overall Study|Lost to Follow-up|3|||
30635312|NCT00978120|58646809|FG003|Overall Study|Lost to Follow-up|0|||
30635313|NCT00978120|58646806|FG000|Overall Study|Withdrawal by Subject|2|||
30635314|NCT00978120|58646807|FG001|Overall Study|Withdrawal by Subject|0|||
30635315|NCT00978120|58646808|FG002|Overall Study|Withdrawal by Subject|0|||
30635316|NCT00978120|58646809|FG003|Overall Study|Withdrawal by Subject|0|||
30635317|NCT00978120|58646806|FG000|Overall Study|Moved out of state|0|||
30635318|NCT00978120|58646807|FG001|Overall Study|Moved out of state|0|||
30635319|NCT00978120|58646808|FG002|Overall Study|Moved out of state|0|||
30635320|NCT00978120|58646809|FG003|Overall Study|Moved out of state|1|||
30635321|NCT00978042|58646825|FG000|Initial Treatment Period|Treated in Error|0|||
30635322|NCT00978042|58646826|FG001|Initial Treatment Period|Treated in Error|3|||
30635323|NCT00978042|58646825|FG000|Initial Treatment Period|Ineligibility|1|||
30635324|NCT00978042|58646826|FG001|Initial Treatment Period|Ineligibility|0|||
30635325|NCT00978042|58646825|FG000|Initial Treatment Period|Lost to Follow-up|21|||
30635326|NCT00978042|58646826|FG001|Initial Treatment Period|Lost to Follow-up|3|||
30635327|NCT00978042|58646825|FG000|Initial Treatment Period|Adverse Event|2|||
30635328|NCT00978042|58646826|FG001|Initial Treatment Period|Adverse Event|0|||
30635329|NCT00978042|58646825|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
30635330|NCT00978042|58646826|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
30635331|NCT00978042|58646825|FG000|Initial Treatment Period|Consent withdrawn|22|||
30635332|NCT00978042|58646826|FG001|Initial Treatment Period|Consent withdrawn|9|||
30635333|NCT00978042|58646825|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
30635334|NCT00978042|58646826|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
30635335|NCT01133678|58646834|FG000|Overall Study|Death|1|||
30635336|NCT01133678|58646835|FG001|Overall Study|Death|1|||
30635337|NCT01133522|58646851|FG000|Overall Study|Withdrawal by Subject|0|||
30635338|NCT01133522|58646852|FG001|Overall Study|Withdrawal by Subject|1|||
30635339|NCT01133522|58646853|FG002|Overall Study|Withdrawal by Subject|0|||
30635340|NCT01133522|58646854|FG003|Overall Study|Withdrawal by Subject|1|||
30635341|NCT01133522|58646855|FG004|Overall Study|Withdrawal by Subject|0|||
30635342|NCT01133522|58646856|FG005|Overall Study|Withdrawal by Subject|0|||
30635343|NCT01133522|58646857|FG006|Overall Study|Withdrawal by Subject|0|||
30635344|NCT01133522|58646858|FG007|Overall Study|Withdrawal by Subject|0|||
30635345|NCT01133522|58646859|FG008|Overall Study|Withdrawal by Subject|0|||
30635346|NCT01133522|58646860|FG009|Overall Study|Withdrawal by Subject|0|||
30635347|NCT01133522|58646851|FG000|Overall Study|Physician Decision|0|||
30635348|NCT01133522|58646852|FG001|Overall Study|Physician Decision|0|||
30635349|NCT01133522|58646853|FG002|Overall Study|Physician Decision|0|||
30635350|NCT01133522|58646854|FG003|Overall Study|Physician Decision|0|||
30635351|NCT01133522|58646855|FG004|Overall Study|Physician Decision|1|||
30635352|NCT01133522|58646856|FG005|Overall Study|Physician Decision|0|||
30635353|NCT01133522|58646857|FG006|Overall Study|Physician Decision|0|||
30635354|NCT01133522|58646858|FG007|Overall Study|Physician Decision|0|||
30635355|NCT01133522|58646859|FG008|Overall Study|Physician Decision|0|||
30635356|NCT01133522|58646860|FG009|Overall Study|Physician Decision|0|||
30635357|NCT01133288|58646889|FG000|Eligibility Assessment|met exclusion criteria|5|||
30635358|NCT01133288|58646889|FG000|Intervention Allocation|study terminated|2|||
30635359|NCT00883090|58646897|FG000|Overall Study|Sponsor's decision|1|||
30635360|NCT00883090|58646897|FG000|Overall Study|Withdrawal by Subject|1|||
30635361|NCT01132820|58646901|FG000|Overall Study|Ineligible: wrong cell type|1|||
30635362|NCT01132820|58646901|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
30635363|NCT01132820|58646901|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
30635364|NCT01132820|58646901|FG000|Overall Study|Never treated|1|||
30635365|NCT01132820|58646901|FG000|Overall Study|Inadequate data|1|||
30635366|NCT00885352|58646920|FG000|Overall Study|Adverse Event|2|||
30635367|NCT00885352|58646921|FG001|Overall Study|Adverse Event|3|||
30635368|NCT00885352|58646920|FG000|Overall Study|Lost to Follow-up|2|||
30635369|NCT00885352|58646921|FG001|Overall Study|Lost to Follow-up|2|||
30635370|NCT00885352|58646920|FG000|Overall Study|Physician Decision|0|||
30635371|NCT00885352|58646921|FG001|Overall Study|Physician Decision|3|||
30635372|NCT00885352|58646920|FG000|Overall Study|Protocol Violation|0|||
30635373|NCT00885352|58646921|FG001|Overall Study|Protocol Violation|2|||
30635374|NCT00885352|58646920|FG000|Overall Study|Withdrawal by Subject|1|||
30635375|NCT00885352|58646921|FG001|Overall Study|Withdrawal by Subject|5|||
30635376|NCT00885352|58646920|FG000|Overall Study|Contradiction to study medication|0|||
30635377|NCT00885352|58646921|FG001|Overall Study|Contradiction to study medication|2|||
30635378|NCT00885352|58646920|FG000|Overall Study|Excluded medication|2|||
30635379|NCT00885352|58646921|FG001|Overall Study|Excluded medication|2|||
30635380|NCT00885352|58646920|FG000|Overall Study|Lab abnormalities|1|||
30635381|NCT00885352|58646921|FG001|Overall Study|Lab abnormalities|1|||
30635382|NCT00885118|58646932|FG000|Overall Study|Adverse Event|1|||
30635383|NCT00885118|58646933|FG001|Overall Study|Adverse Event|0|||
30635384|NCT00885118|58646934|FG002|Overall Study|Adverse Event|0|||
30635385|NCT00885118|58646935|FG003|Overall Study|Adverse Event|0|||
30635386|NCT00885118|58646936|FG004|Overall Study|Adverse Event|0|||
30635387|NCT00885118|58646932|FG000|Overall Study|Withdrawal by Subject|0|||
30635388|NCT00885118|58646933|FG001|Overall Study|Withdrawal by Subject|0|||
30635389|NCT00885118|58646934|FG002|Overall Study|Withdrawal by Subject|0|||
30635390|NCT00885118|58646935|FG003|Overall Study|Withdrawal by Subject|0|||
30635391|NCT00885118|58646936|FG004|Overall Study|Withdrawal by Subject|1|||
30635392|NCT00885118|58646932|FG000|Overall Study|Other reason not defined above|0|||
30635393|NCT00885118|58646933|FG001|Overall Study|Other reason not defined above|0|||
30635394|NCT00885118|58646934|FG002|Overall Study|Other reason not defined above|1|||
30635395|NCT00885118|58646935|FG003|Overall Study|Other reason not defined above|0|||
30635396|NCT00885118|58646936|FG004|Overall Study|Other reason not defined above|0|||
30635397|NCT00880906|58646954|FG000|Overall Study|Lost to Follow-up|0|||
30635398|NCT00880906|58646955|FG001|Overall Study|Lost to Follow-up|1|||
30635399|NCT00880906|58646954|FG000|Overall Study|Did not meet criteria following patholog|12|||
30635400|NCT00880906|58646955|FG001|Overall Study|Did not meet criteria following patholog|6|||
30635401|NCT00882310|58646961|FG000|Overall Study|Screen Failure|10|||
30635402|NCT00882310|58646961|FG000|Overall Study|Never received treatment|1|||
30635403|NCT00882310|58646961|FG000|Overall Study|Death|6|||
30635404|NCT00882310|58646961|FG000|Overall Study|Progression of disease|4|||
30635405|NCT00882310|58646961|FG000|Overall Study|Adverse Event|1|||
30635406|NCT00884650|58646967|FG000|Overall Study|Did not return complete pain diaries|7|||
30635407|NCT00884650|58646968|FG001|Overall Study|Did not return complete pain diaries|7|||
30635408|NCT00884650|58646967|FG000|Overall Study|Admitted Post-Op|1|||
30635409|NCT00884650|58646968|FG001|Overall Study|Admitted Post-Op|0|||
30635410|NCT00884650|58646967|FG000|Overall Study|Femoral Stress Fracture|1|||
30635411|NCT00884650|58646968|FG001|Overall Study|Femoral Stress Fracture|0|||
30635412|NCT00884650|58646967|FG000|Overall Study|Pain Pump Complication|0|||
30635413|NCT00884650|58646968|FG001|Overall Study|Pain Pump Complication|1|||
30635414|NCT00881608|58646980|FG000|Overall Study|Study prematurely terminated|11|||
30635415|NCT01088399|58646995|FG000|Overall Study|Adverse Event|211|||
30635416|NCT01088399|58646996|FG001|Overall Study|Adverse Event|16|||
30635417|NCT01088399|58646997|FG002|Overall Study|Adverse Event|0|||
30951301|NCT04426695|58998510|FG005|Overall Study|Death|21|||
30951302|NCT04426695|58998511|FG006|Overall Study|Death|42|||
30951303|NCT04426695|58998512|FG007|Overall Study|Death|23|||
30635418|NCT01088399|58646995|FG000|Overall Study|Death|204|||
30635419|NCT01088399|58646996|FG001|Overall Study|Death|45|||
30635420|NCT01088399|58646997|FG002|Overall Study|Death|0|||
30635421|NCT01088399|58646995|FG000|Overall Study|Lack of Efficacy|298|||
30635422|NCT01088399|58646996|FG001|Overall Study|Lack of Efficacy|7|||
30635423|NCT01088399|58646997|FG002|Overall Study|Lack of Efficacy|5|||
30635424|NCT01088399|58646995|FG000|Overall Study|Lost to Follow-up|1070|||
30635425|NCT01088399|58646996|FG001|Overall Study|Lost to Follow-up|278|||
30635426|NCT01088399|58646997|FG002|Overall Study|Lost to Follow-up|58|||
30635427|NCT01088399|58646995|FG000|Overall Study|Physician Decision|531|||
30635428|NCT01088399|58646996|FG001|Overall Study|Physician Decision|88|||
30635429|NCT01088399|58646997|FG002|Overall Study|Physician Decision|16|||
30635430|NCT01088399|58646995|FG000|Overall Study|Withdrawal by Subject|544|||
30635431|NCT01088399|58646996|FG001|Overall Study|Withdrawal by Subject|195|||
30635432|NCT01088399|58646997|FG002|Overall Study|Withdrawal by Subject|33|||
30635433|NCT01088399|58646995|FG000|Overall Study|Change to or start of somatropin therapy|234|||
30635434|NCT01088399|58646996|FG001|Overall Study|Change to or start of somatropin therapy|17|||
30635435|NCT01088399|58646997|FG002|Overall Study|Change to or start of somatropin therapy|12|||
30635436|NCT01088399|58646995|FG000|Overall Study|Sponsor decision|1573|||
30635437|NCT01088399|58646996|FG001|Overall Study|Sponsor decision|298|||
30635438|NCT01088399|58646997|FG002|Overall Study|Sponsor decision|7|||
30635439|NCT01088399|58646995|FG000|Overall Study|Protocol Violation|10|||
30635440|NCT01088399|58646996|FG001|Overall Study|Protocol Violation|1|||
30635441|NCT01088399|58646997|FG002|Overall Study|Protocol Violation|0|||
30635442|NCT01088399|58646995|FG000|Overall Study|Enrollment criteria not met|48|||
30635443|NCT01088399|58646996|FG001|Overall Study|Enrollment criteria not met|119|||
30635444|NCT01088399|58646997|FG002|Overall Study|Enrollment criteria not met|70|||
30635445|NCT01088399|58646995|FG000|Overall Study|Study summary visit not completed|2398|||
30635446|NCT01088399|58646996|FG001|Overall Study|Study summary visit not completed|283|||
30635447|NCT01088399|58646997|FG002|Overall Study|Study summary visit not completed|80|||
30635448|NCT00598078|58647005|FG000|Period 2 (Day 2)|Adverse Event|1|||
30635449|NCT00598078|58647006|FG001|Period 2 (Day 2)|Adverse Event|0|||
30635450|NCT01079195|58647014|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
30635451|NCT01079195|58647014|FG000|Overall Study|No Documentation Available|437|||
30635452|NCT01079195|58647014|FG000|Overall Study|Adverse Event|157|||
30635453|NCT01079195|58647014|FG000|Overall Study|Reason Unknown|39|||
30635454|NCT01079195|58647014|FG000|Overall Study|Withdrawal by Subject|18|||
30951304|NCT04426695|58998513|FG008|Overall Study|Death|37|||
30635455|NCT01079195|58647014|FG000|Overall Study|Financial Reasons|15|||
30635456|NCT01079195|58647014|FG000|Overall Study|Lack of Effectiveness|12|||
30635457|NCT01079195|58647014|FG000|Overall Study|Physician Decision|4|||
30635458|NCT01079195|58647014|FG000|Overall Study|Improved Status of Participant|4|||
30635459|NCT01079195|58647014|FG000|Overall Study|No Follow-up Documentation Available|4|||
30635460|NCT01079195|58647014|FG000|Overall Study|Non-compliance|2|||
30635461|NCT00883558|58647018|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
30635462|NCT00883558|58647019|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
30635463|NCT00883558|58647020|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
30635464|NCT00883558|58647018|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
30635465|NCT00883558|58647019|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
30635466|NCT00883558|58647020|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
30635467|NCT00883558|58647018|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
30635468|NCT00883558|58647019|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
30635469|NCT00883558|58647020|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
30635470|NCT00883558|58647018|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
30635471|NCT00883558|58647019|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
30635472|NCT00883558|58647020|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
30635473|NCT00883558|58647018|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
30635474|NCT00883558|58647019|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
30635475|NCT00883558|58647020|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
30635476|NCT00880750|58647028|FG000|First Intervention|Adverse Event|1|||
30635477|NCT00880750|58647029|FG001|First Intervention|Adverse Event|0|||
30635478|NCT00880750|58647028|FG000|First Intervention|Unable to collect urine|4|||
30635479|NCT00880750|58647029|FG001|First Intervention|Unable to collect urine|0|||
30635480|NCT00880750|58647028|FG000|First Intervention|Non-compliance with meals|0|||
30635481|NCT00880750|58647029|FG001|First Intervention|Non-compliance with meals|1|||
30635482|NCT00880750|58647028|FG000|First Intervention|Withdrawal by Subject|2|||
30635483|NCT00880750|58647029|FG001|First Intervention|Withdrawal by Subject|0|||
30635484|NCT00880750|58647028|FG000|First Intervention|Lost to Follow-up|2|||
30635485|NCT00880750|58647029|FG001|First Intervention|Lost to Follow-up|0|||
30635486|NCT00880750|58647028|FG000|Second Intervention|Withdrawal by Subject|2|||
30635487|NCT00880750|58647029|FG001|Second Intervention|Withdrawal by Subject|2|||
30765139|NCT00320489|58773821|FG000|Overall Study|Lost to Follow-up|21|||
30765140|NCT00320489|58773822|FG001|Overall Study|Lost to Follow-up|22|||
30765141|NCT00320489|58773821|FG000|Overall Study|Physician Decision|8|||
30765142|NCT00320489|58773822|FG001|Overall Study|Physician Decision|8|||
30765143|NCT00320489|58773821|FG000|Overall Study|Protocol Violation|4|||
30765144|NCT00320489|58773822|FG001|Overall Study|Protocol Violation|4|||
30765145|NCT00320489|58773821|FG000|Overall Study|Sponsor Decision|3|||
30765146|NCT00320489|58773822|FG001|Overall Study|Sponsor Decision|3|||
30765147|NCT00320489|58773821|FG000|Overall Study|Withdrawal by Subject|39|||
30765148|NCT00320489|58773822|FG001|Overall Study|Withdrawal by Subject|41|||
30765149|NCT03928028|58773831|FG000|Overall Study|Physician Decision|9|||
30765150|NCT03928028|58773832|FG001|Overall Study|Physician Decision|6|||
30765151|NCT03928028|58773833|FG002|Overall Study|Physician Decision|3|||
30765152|NCT03928028|58773831|FG000|Overall Study|Withdrawal by Subject|12|||
30765153|NCT03928028|58773832|FG001|Overall Study|Withdrawal by Subject|3|||
30765154|NCT03928028|58773833|FG002|Overall Study|Withdrawal by Subject|3|||
30765155|NCT00320411|58773841|FG000|Overall Study|No investigational product admin.|4|||
30765156|NCT00320255|58773851|FG000|Overall Study|Lack of Efficacy|1|||
30765157|NCT00320255|58773852|FG001|Overall Study|Lack of Efficacy|0|||
30765158|NCT00320255|58773853|FG002|Overall Study|Lack of Efficacy|0|||
30765159|NCT00320255|58773854|FG003|Overall Study|Lack of Efficacy|0|||
30765160|NCT00320255|58773855|FG004|Overall Study|Lack of Efficacy|0|||
30765161|NCT00320255|58773856|FG005|Overall Study|Lack of Efficacy|0|||
30765162|NCT00320255|58773851|FG000|Overall Study|Adverse Event|5|||
30765163|NCT00320255|58773852|FG001|Overall Study|Adverse Event|2|||
30765164|NCT00320255|58773853|FG002|Overall Study|Adverse Event|3|||
30765165|NCT00320255|58773854|FG003|Overall Study|Adverse Event|2|||
30765166|NCT00320255|58773855|FG004|Overall Study|Adverse Event|0|||
30765167|NCT00320255|58773856|FG005|Overall Study|Adverse Event|0|||
30765168|NCT00320255|58773851|FG000|Overall Study|Withdrawal by Subject|1|||
30765169|NCT00320255|58773852|FG001|Overall Study|Withdrawal by Subject|2|||
30765170|NCT00320255|58773853|FG002|Overall Study|Withdrawal by Subject|2|||
30635488|NCT00880750|58647028|FG000|Second Intervention|Protocol Violation|1|||
30635489|NCT00880750|58647029|FG001|Second Intervention|Protocol Violation|0|||
30765171|NCT00320255|58773854|FG003|Overall Study|Withdrawal by Subject|4|||
30765172|NCT00320255|58773855|FG004|Overall Study|Withdrawal by Subject|0|||
30765173|NCT00320255|58773856|FG005|Overall Study|Withdrawal by Subject|0|||
30765174|NCT00320255|58773851|FG000|Overall Study|Poor compliance/noncompliance|1|||
30765175|NCT00320255|58773852|FG001|Overall Study|Poor compliance/noncompliance|1|||
30765176|NCT00320255|58773853|FG002|Overall Study|Poor compliance/noncompliance|0|||
30765177|NCT00320255|58773854|FG003|Overall Study|Poor compliance/noncompliance|1|||
30765178|NCT00320255|58773855|FG004|Overall Study|Poor compliance/noncompliance|0|||
30765179|NCT00320255|58773856|FG005|Overall Study|Poor compliance/noncompliance|0|||
30765180|NCT00320255|58773851|FG000|Overall Study|No longer meets study criteria|0|||
30765181|NCT00320255|58773852|FG001|Overall Study|No longer meets study criteria|0|||
30765182|NCT00320255|58773853|FG002|Overall Study|No longer meets study criteria|0|||
30765183|NCT00320255|58773854|FG003|Overall Study|No longer meets study criteria|1|||
30765184|NCT00320255|58773855|FG004|Overall Study|No longer meets study criteria|0|||
30765185|NCT00320255|58773856|FG005|Overall Study|No longer meets study criteria|0|||
30765186|NCT00320255|58773851|FG000|Overall Study|Other|3|||
30765187|NCT00320255|58773852|FG001|Overall Study|Other|2|||
30765188|NCT00320255|58773853|FG002|Overall Study|Other|1|||
30765189|NCT00320255|58773854|FG003|Overall Study|Other|0|||
30765190|NCT00320255|58773855|FG004|Overall Study|Other|0|||
30765191|NCT00320255|58773856|FG005|Overall Study|Other|0|||
30765192|NCT00370331|58773873|FG000|Overall Study|Adverse Event|4|||
30765193|NCT00370331|58773874|FG001|Overall Study|Adverse Event|13|||
30765194|NCT00370331|58773873|FG000|Overall Study|Withdrawal by Subject|2|||
30765195|NCT00370331|58773874|FG001|Overall Study|Withdrawal by Subject|4|||
30765196|NCT00370331|58773873|FG000|Overall Study|Lost to Follow-up|0|||
30765197|NCT00370331|58773874|FG001|Overall Study|Lost to Follow-up|3|||
30765198|NCT00370331|58773873|FG000|Overall Study|Lack of Efficacy|0|||
30765199|NCT00370331|58773874|FG001|Overall Study|Lack of Efficacy|1|||
30765200|NCT00370331|58773873|FG000|Overall Study|Non-compliance|0|||
30765201|NCT00370331|58773874|FG001|Overall Study|Non-compliance|1|||
30765202|NCT00370331|58773873|FG000|Overall Study|Protocol Violation|1|||
30765203|NCT00370331|58773874|FG001|Overall Study|Protocol Violation|1|||
30765204|NCT02962960|58773883|FG000|Overall Study|Withdrawal by Subject|1|||
30765205|NCT02962960|58773884|FG001|Overall Study|Withdrawal by Subject|1|||
30765206|NCT02962960|58773885|FG002|Overall Study|Withdrawal by Subject|0|||
30765207|NCT02962960|58773883|FG000|Overall Study|Adverse Event|1|||
30765208|NCT02962960|58773884|FG001|Overall Study|Adverse Event|1|||
30765209|NCT02962960|58773885|FG002|Overall Study|Adverse Event|0|||
30765210|NCT02962960|58773883|FG000|Overall Study|Protocol Violation|1|||
30765211|NCT02962960|58773884|FG001|Overall Study|Protocol Violation|0|||
30765212|NCT02962960|58773885|FG002|Overall Study|Protocol Violation|0|||
30765213|NCT00369941|58773897|FG000|Overall Study|Never Treated|1|||
30765214|NCT00369941|58773898|FG001|Overall Study|Never Treated|2|||
30765215|NCT00369941|58773897|FG000|Overall Study|Adverse Event|14|||
30765216|NCT00369941|58773898|FG001|Overall Study|Adverse Event|28|||
30765217|NCT00369941|58773897|FG000|Overall Study|Lack of Efficacy|6|||
30765218|NCT00369941|58773898|FG001|Overall Study|Lack of Efficacy|10|||
30765219|NCT00369941|58773897|FG000|Overall Study|Lost to Follow-up|12|||
30765220|NCT00369941|58773898|FG001|Overall Study|Lost to Follow-up|22|||
30765221|NCT00369941|58773897|FG000|Overall Study|Protocol Violation|5|||
30765222|NCT00369941|58773898|FG001|Overall Study|Protocol Violation|3|||
30765223|NCT00369941|58773897|FG000|Overall Study|Withdrawal by Subject|5|||
30765224|NCT00369941|58773898|FG001|Overall Study|Withdrawal by Subject|18|||
30765225|NCT00369941|58773897|FG000|Overall Study|Pregnancy|4|||
30765226|NCT00369941|58773898|FG001|Overall Study|Pregnancy|2|||
30765227|NCT00369941|58773897|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
30765228|NCT00369941|58773898|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
30635490|NCT00880750|58647028|FG000|Second Intervention|Unable to collect urine|1|||
30635491|NCT00880750|58647029|FG001|Second Intervention|Unable to collect urine|0|||
30635492|NCT00597766|58647038|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
30635493|NCT00597766|58647039|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
30635494|NCT00597766|58647040|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
30635495|NCT00597766|58647038|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
30635496|NCT00597766|58647039|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
30765229|NCT00369941|58773897|FG000|Overall Study|Moved|11|||
30765230|NCT00369941|58773898|FG001|Overall Study|Moved|5|||
30765231|NCT00369941|58773897|FG000|Overall Study|Treatment with Prohibited Medication|3|||
30765232|NCT00369941|58773898|FG001|Overall Study|Treatment with Prohibited Medication|1|||
30765233|NCT00369941|58773897|FG000|Overall Study|Employment Interfered with Study Visits|1|||
30765234|NCT00369941|58773898|FG001|Overall Study|Employment Interfered with Study Visits|0|||
30765235|NCT00369941|58773897|FG000|Overall Study|Study Site Terminated|2|||
30765236|NCT00369941|58773898|FG001|Overall Study|Study Site Terminated|0|||
30765237|NCT00369941|58773897|FG000|Overall Study|Miscellaneous|3|||
30635497|NCT00597766|58647040|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
30635498|NCT00979992|58647048|FG000|Overall Study|Ineligible - inadequate pathology|1|||
30765238|NCT00369941|58773898|FG001|Overall Study|Miscellaneous|3|||
30635499|NCT00979992|58647048|FG000|Overall Study|Ineligible - wrong cell type|2|||
30765239|NCT00319553|58773907|FG000|Overall Study|Protocol Violation|1|||
30765240|NCT00319553|58773908|FG001|Overall Study|Protocol Violation|2|||
30765241|NCT00319553|58773907|FG000|Overall Study|Lost to Follow-up|2|||
30765242|NCT00319553|58773908|FG001|Overall Study|Lost to Follow-up|1|||
30765243|NCT00319553|58773907|FG000|Overall Study|Withdrawal by Subject|1|||
30765244|NCT00319553|58773908|FG001|Overall Study|Withdrawal by Subject|1|||
30635500|NCT00979992|58647048|FG000|Overall Study|Refused - Never Treated|2|||
30635501|NCT01079741|58647057|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
30635502|NCT01079741|58647058|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
30635503|NCT01079741|58647059|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
30635504|NCT01079741|58647060|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
30635505|NCT01079741|58647061|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
30635506|NCT01079741|58647057|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
30635507|NCT01079741|58647058|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
30635508|NCT01079741|58647059|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
30635509|NCT01079741|58647060|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
30635510|NCT01079741|58647061|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
30635511|NCT01079663|58647075|FG000|Overall Study|Adverse Event|0|||
30635512|NCT01079663|58647076|FG001|Overall Study|Adverse Event|2|||
30635513|NCT01079663|58647075|FG000|Overall Study|Protocol Violation|0|||
30635514|NCT01079663|58647076|FG001|Overall Study|Protocol Violation|2|||
30635515|NCT00879814|58647086|FG000|Overall Study|Adverse Event|0|||
30635516|NCT00879814|58647087|FG001|Overall Study|Adverse Event|1|||
30635517|NCT00879814|58647088|FG002|Overall Study|Adverse Event|0|||
30635518|NCT00879814|58647089|FG003|Overall Study|Adverse Event|0|||
30635519|NCT00879814|58647086|FG000|Overall Study|Lost to Follow-up|1|||
30635520|NCT00879814|58647087|FG001|Overall Study|Lost to Follow-up|0|||
30635521|NCT00879814|58647088|FG002|Overall Study|Lost to Follow-up|0|||
30635522|NCT00879814|58647089|FG003|Overall Study|Lost to Follow-up|2|||
30635523|NCT00879814|58647086|FG000|Overall Study|Participant Failed to Return|0|||
30635524|NCT00879814|58647087|FG001|Overall Study|Participant Failed to Return|0|||
30635525|NCT00879814|58647088|FG002|Overall Study|Participant Failed to Return|0|||
30635526|NCT00879814|58647089|FG003|Overall Study|Participant Failed to Return|1|||
30635527|NCT00879814|58647086|FG000|Overall Study|Withdrawal by Subject|3|||
30635528|NCT00879814|58647087|FG001|Overall Study|Withdrawal by Subject|1|||
30635529|NCT00879814|58647088|FG002|Overall Study|Withdrawal by Subject|1|||
30635530|NCT00879814|58647089|FG003|Overall Study|Withdrawal by Subject|2|||
30635531|NCT00879814|58647086|FG000|Overall Study|Physician Decision|0|||
30635532|NCT00879814|58647087|FG001|Overall Study|Physician Decision|0|||
30635533|NCT00879814|58647088|FG002|Overall Study|Physician Decision|1|||
30635534|NCT00879814|58647089|FG003|Overall Study|Physician Decision|0|||
30635535|NCT00879814|58647086|FG000|Overall Study|Other|0|||
30635536|NCT00879814|58647087|FG001|Overall Study|Other|0|||
30635537|NCT00879814|58647088|FG002|Overall Study|Other|1|||
30635538|NCT00879814|58647089|FG003|Overall Study|Other|0|||
30635539|NCT01132664|58647104|FG000|Phase lb|Adverse Event|0|||
30635540|NCT01132664|58647105|FG001|Phase lb|Adverse Event|1|||
30635541|NCT01132664|58647106|FG002|Phase lb|Adverse Event|0|||
30635542|NCT01132664|58647107|FG003|Phase lb|Adverse Event|0|||
30635543|NCT01132664|58647108|FG004|Phase lb|Adverse Event|0|||
30635544|NCT01132664|58647104|FG000|Phase lb|Withdrawal by Subject|1|||
30635545|NCT01132664|58647105|FG001|Phase lb|Withdrawal by Subject|2|||
30635546|NCT01132664|58647106|FG002|Phase lb|Withdrawal by Subject|0|||
30635547|NCT01132664|58647107|FG003|Phase lb|Withdrawal by Subject|0|||
30635548|NCT01132664|58647108|FG004|Phase lb|Withdrawal by Subject|0|||
30635549|NCT01132664|58647104|FG000|Phase lb|Disease Progression|4|||
30635550|NCT01132664|58647105|FG001|Phase lb|Disease Progression|9|||
30635551|NCT01132664|58647106|FG002|Phase lb|Disease Progression|0|||
30635552|NCT01132664|58647107|FG003|Phase lb|Disease Progression|0|||
30635553|NCT01132664|58647108|FG004|Phase lb|Disease Progression|0|||
30635554|NCT01132664|58647104|FG000|Phase ll|Death|0|||
30635555|NCT01132664|58647105|FG001|Phase ll|Death|0|||
30635556|NCT01132664|58647106|FG002|Phase ll|Death|2|||
30635557|NCT01132664|58647107|FG003|Phase ll|Death|0|||
30635558|NCT01132664|58647108|FG004|Phase ll|Death|0|||
30635559|NCT01132664|58647104|FG000|Phase ll|Adverse Event|0|||
30635560|NCT01132664|58647105|FG001|Phase ll|Adverse Event|0|||
30635561|NCT01132664|58647106|FG002|Phase ll|Adverse Event|10|||
30635562|NCT01132664|58647107|FG003|Phase ll|Adverse Event|0|||
30635563|NCT01132664|58647108|FG004|Phase ll|Adverse Event|0|||
30635564|NCT01132664|58647104|FG000|Phase ll|Withdrawal by Subject|0|||
30635565|NCT01132664|58647105|FG001|Phase ll|Withdrawal by Subject|0|||
30635566|NCT01132664|58647106|FG002|Phase ll|Withdrawal by Subject|3|||
30635567|NCT01132664|58647107|FG003|Phase ll|Withdrawal by Subject|0|||
30635568|NCT01132664|58647108|FG004|Phase ll|Withdrawal by Subject|0|||
30951305|NCT04426695|58998514|FG009|Overall Study|Death|14|||
30635569|NCT01132664|58647104|FG000|Phase ll|Disease progression|0|||
30635570|NCT01132664|58647105|FG001|Phase ll|Disease progression|0|||
30635571|NCT01132664|58647106|FG002|Phase ll|Disease progression|35|||
30635572|NCT01132664|58647107|FG003|Phase ll|Disease progression|0|||
30635573|NCT01132664|58647108|FG004|Phase ll|Disease progression|0|||
30635574|NCT01132664|58647104|FG000|BM Cohort|Disease progression|0|||
30635575|NCT01132664|58647105|FG001|BM Cohort|Disease progression|0|||
30635576|NCT01132664|58647106|FG002|BM Cohort|Disease progression|0|||
30635577|NCT01132664|58647107|FG003|BM Cohort|Disease progression|3|||
30635578|NCT01132664|58647108|FG004|BM Cohort|Disease progression|4|||
30635579|NCT01132664|58647104|FG000|BM Cohort|Adverse Event|0|||
30635580|NCT01132664|58647105|FG001|BM Cohort|Adverse Event|0|||
30635581|NCT01132664|58647106|FG002|BM Cohort|Adverse Event|0|||
30635582|NCT01132664|58647107|FG003|BM Cohort|Adverse Event|0|||
30635583|NCT01132664|58647108|FG004|BM Cohort|Adverse Event|1|||
30635584|NCT01132664|58647104|FG000|BM Cohort|Withdrawal by Subject|0|||
30635585|NCT01132664|58647105|FG001|BM Cohort|Withdrawal by Subject|0|||
30635586|NCT01132664|58647106|FG002|BM Cohort|Withdrawal by Subject|0|||
30635587|NCT01132664|58647107|FG003|BM Cohort|Withdrawal by Subject|0|||
30635588|NCT01132664|58647108|FG004|BM Cohort|Withdrawal by Subject|1|||
30635589|NCT00591409|58647130|FG000|Overall Study|Not Treated|0|||
30635590|NCT00591409|58647131|FG001|Overall Study|Not Treated|0|||
30635591|NCT00591409|58647132|FG002|Overall Study|Not Treated|0|||
30635592|NCT00591409|58647133|FG003|Overall Study|Not Treated|0|||
30635593|NCT00591409|58647134|FG004|Overall Study|Not Treated|1|||
30635594|NCT00591409|58647135|FG005|Overall Study|Not Treated|0|||
30635595|NCT00591409|58647136|FG006|Overall Study|Not Treated|0|||
30635596|NCT00591409|58647137|FG007|Overall Study|Not Treated|0|||
30635597|NCT00591409|58647138|FG008|Overall Study|Not Treated|0|||
30635598|NCT00591409|58647139|FG009|Overall Study|Not Treated|1|||
30635599|NCT01078805|58647161|FG000|Overall Study|Clinically significant abnormal lab|5|||
30635600|NCT01078805|58647161|FG000|Overall Study|Death|134|||
30635601|NCT01078805|58647161|FG000|Overall Study|Lost to Follow-up|676|||
30635602|NCT01078805|58647161|FG000|Overall Study|Physician Decision|169|||
30635603|NCT01078805|58647161|FG000|Overall Study|Serious adverse event|26|||
30635604|NCT01078805|58647161|FG000|Overall Study|Sponsor decision|46|||
30635605|NCT01078805|58647161|FG000|Overall Study|Withdrawal by Subject|739|||
30635606|NCT01078805|58647161|FG000|Overall Study|Other|173|||
30635607|NCT01078805|58647161|FG000|Overall Study|Didn't take study drug|82|||
30635608|NCT00820027|58647169|FG000|Overall Study|Adverse Event|15|||
30635609|NCT00820027|58647170|FG001|Overall Study|Adverse Event|8|||
30635610|NCT00820027|58647171|FG002|Overall Study|Adverse Event|10|||
30635611|NCT00820027|58647172|FG003|Overall Study|Adverse Event|5|||
30635612|NCT00820027|58647169|FG000|Overall Study|Lack of Efficacy|2|||
30635613|NCT00820027|58647170|FG001|Overall Study|Lack of Efficacy|1|||
30635614|NCT00820027|58647171|FG002|Overall Study|Lack of Efficacy|2|||
30635615|NCT00820027|58647172|FG003|Overall Study|Lack of Efficacy|2|||
30635616|NCT00820027|58647169|FG000|Overall Study|Physician Decision|0|||
30635617|NCT00820027|58647170|FG001|Overall Study|Physician Decision|1|||
30635618|NCT00820027|58647171|FG002|Overall Study|Physician Decision|1|||
30635619|NCT00820027|58647172|FG003|Overall Study|Physician Decision|0|||
30635620|NCT00820027|58647169|FG000|Overall Study|Protocol Violation|3|||
30635621|NCT00820027|58647170|FG001|Overall Study|Protocol Violation|0|||
30635622|NCT00820027|58647171|FG002|Overall Study|Protocol Violation|4|||
30635623|NCT00820027|58647172|FG003|Overall Study|Protocol Violation|0|||
30635624|NCT00820027|58647169|FG000|Overall Study|Withdrawal by Subject|6|||
30635625|NCT00820027|58647170|FG001|Overall Study|Withdrawal by Subject|4|||
30635626|NCT00820027|58647171|FG002|Overall Study|Withdrawal by Subject|4|||
30635627|NCT00820027|58647172|FG003|Overall Study|Withdrawal by Subject|6|||
30635628|NCT01076153|58647183|FG000|Overall Study|Symptoms improved/resolved|10|||
30635629|NCT01076153|58647183|FG000|Overall Study|Adverse Event|1|||
30635630|NCT01076075|58647193|FG000|Overall Study|Adverse Event|3|||
30635631|NCT01076075|58647194|FG001|Overall Study|Adverse Event|9|||
30635632|NCT01076075|58647193|FG000|Overall Study|Lack of Efficacy|5|||
30635633|NCT01076075|58647194|FG001|Overall Study|Lack of Efficacy|4|||
30635634|NCT01076075|58647193|FG000|Overall Study|Lost to Follow-up|6|||
30635635|NCT01076075|58647194|FG001|Overall Study|Lost to Follow-up|5|||
30635636|NCT01076075|58647193|FG000|Overall Study|other|19|||
30635637|NCT01076075|58647194|FG001|Overall Study|other|9|||
30635638|NCT01076075|58647193|FG000|Overall Study|Protocol Violation|0|||
30635639|NCT01076075|58647194|FG001|Overall Study|Protocol Violation|1|||
30765245|NCT00369785|58773916|FG000|Overall Study|Physician Decision|3|||
30765246|NCT00369785|58773917|FG001|Overall Study|Physician Decision|2|||
30765247|NCT00369785|58773916|FG000|Overall Study|Death|1|||
30765248|NCT00369785|58773917|FG001|Overall Study|Death|2|||
30765249|NCT00369785|58773916|FG000|Overall Study|Withdrawal by Subject|7|||
30765250|NCT00369785|58773917|FG001|Overall Study|Withdrawal by Subject|6|||
30635640|NCT01076075|58647193|FG000|Overall Study|Withdrawal by Subject|8|||
30635641|NCT01076075|58647194|FG001|Overall Study|Withdrawal by Subject|19|||
30635642|NCT01075763|58647205|FG000|Overall Study|Lost to Follow-up|2|||
30635643|NCT01075763|58647206|FG001|Overall Study|Lost to Follow-up|1|||
30635644|NCT01075763|58647205|FG000|Overall Study|Lack of Efficacy|0|||
30635645|NCT01075763|58647206|FG001|Overall Study|Lack of Efficacy|1|||
30635646|NCT01075763|58647205|FG000|Overall Study|Withdrawal by Subject|2|||
30635647|NCT01075763|58647206|FG001|Overall Study|Withdrawal by Subject|2|||
30635648|NCT00881530|58647218|FG000|Overall Study|Adverse Event|5|||
30635649|NCT00881530|58647219|FG001|Overall Study|Adverse Event|1|||
30635650|NCT00881530|58647220|FG002|Overall Study|Adverse Event|1|||
30635651|NCT00881530|58647221|FG003|Overall Study|Adverse Event|4|||
30765251|NCT00369785|58773916|FG000|Overall Study|Toxicity|6|||
30635652|NCT00881530|58647222|FG004|Overall Study|Adverse Event|10|||
30635653|NCT00881530|58647223|FG005|Overall Study|Adverse Event|2|||
30635654|NCT00881530|58647218|FG000|Overall Study|Lack of Efficacy|1|||
30635655|NCT00881530|58647219|FG001|Overall Study|Lack of Efficacy|0|||
30635656|NCT00881530|58647220|FG002|Overall Study|Lack of Efficacy|0|||
30635657|NCT00881530|58647221|FG003|Overall Study|Lack of Efficacy|0|||
30635658|NCT00881530|58647222|FG004|Overall Study|Lack of Efficacy|1|||
30635659|NCT00881530|58647223|FG005|Overall Study|Lack of Efficacy|1|||
30635660|NCT00881530|58647218|FG000|Overall Study|Not compliant with the protocol|0|||
30635661|NCT00881530|58647219|FG001|Overall Study|Not compliant with the protocol|0|||
30635662|NCT00881530|58647220|FG002|Overall Study|Not compliant with the protocol|0|||
30635663|NCT00881530|58647221|FG003|Overall Study|Not compliant with the protocol|0|||
30635664|NCT00881530|58647222|FG004|Overall Study|Not compliant with the protocol|2|||
30635665|NCT00881530|58647223|FG005|Overall Study|Not compliant with the protocol|0|||
30635666|NCT00881530|58647218|FG000|Overall Study|Lost to Follow-up|0|||
30635667|NCT00881530|58647219|FG001|Overall Study|Lost to Follow-up|1|||
30635668|NCT00881530|58647220|FG002|Overall Study|Lost to Follow-up|1|||
30635669|NCT00881530|58647221|FG003|Overall Study|Lost to Follow-up|3|||
30635670|NCT00881530|58647222|FG004|Overall Study|Lost to Follow-up|1|||
30635671|NCT00881530|58647223|FG005|Overall Study|Lost to Follow-up|0|||
30635672|NCT00881530|58647218|FG000|Overall Study|Refused to continue medication|7|||
30635673|NCT00881530|58647219|FG001|Overall Study|Refused to continue medication|2|||
30635674|NCT00881530|58647220|FG002|Overall Study|Refused to continue medication|1|||
30635675|NCT00881530|58647221|FG003|Overall Study|Refused to continue medication|2|||
30635676|NCT00881530|58647222|FG004|Overall Study|Refused to continue medication|0|||
30635677|NCT00881530|58647223|FG005|Overall Study|Refused to continue medication|0|||
30635678|NCT00881530|58647218|FG000|Overall Study|Other reason not defined above|1|||
30635679|NCT00881530|58647219|FG001|Overall Study|Other reason not defined above|1|||
30635680|NCT00881530|58647220|FG002|Overall Study|Other reason not defined above|2|||
30635681|NCT00881530|58647221|FG003|Overall Study|Other reason not defined above|0|||
30635682|NCT00881530|58647222|FG004|Overall Study|Other reason not defined above|0|||
30635683|NCT00881530|58647223|FG005|Overall Study|Other reason not defined above|2|||
30635684|NCT01075685|58647239|FG000|Overall Study|Protocol Violation|9|||
30635685|NCT01075685|58647240|FG001|Overall Study|Protocol Violation|1|||
30635686|NCT01075685|58647239|FG000|Overall Study|Withdrawal by Subject|20|||
30635687|NCT01075685|58647240|FG001|Overall Study|Withdrawal by Subject|5|||
30635688|NCT01075685|58647239|FG000|Overall Study|Lost to Follow-up|563|||
30635689|NCT01075685|58647240|FG001|Overall Study|Lost to Follow-up|220|||
30635690|NCT01075217|58647248|FG000|Overall Study|Adverse Event|1|||
30635691|NCT01075217|58647249|FG001|Overall Study|Adverse Event|1|||
30635692|NCT01075217|58647248|FG000|Overall Study|Physician Decision|1|||
30635693|NCT01075217|58647249|FG001|Overall Study|Physician Decision|0|||
30635694|NCT01078571|58647263|FG000|Overall Study|Adverse Event|36|||
30635695|NCT01078571|58647263|FG000|Overall Study|Lack of effectiveness|36|||
30635696|NCT01078571|58647263|FG000|Overall Study|Reason not reported|21|||
30635697|NCT01078571|58647263|FG000|Overall Study|Withdrawal by Subject|12|||
30635698|NCT01078571|58647263|FG000|Overall Study|Lost to Follow-up|8|||
30635699|NCT01078571|58647263|FG000|Overall Study|Protocol Violation|2|||
30635700|NCT00977106|58647274|FG000|Overall Study|Adverse Event|5|||
30635701|NCT00977106|58647275|FG001|Overall Study|Adverse Event|6|||
30635702|NCT00977106|58647274|FG000|Overall Study|Withdrawal by Subject|2|||
30635703|NCT00977106|58647275|FG001|Overall Study|Withdrawal by Subject|2|||
30635704|NCT00977106|58647274|FG000|Overall Study|Lack of Efficacy|2|||
30635705|NCT00977106|58647275|FG001|Overall Study|Lack of Efficacy|2|||
30635706|NCT00977106|58647274|FG000|Overall Study|Protocol Violation|0|||
30635707|NCT00977106|58647275|FG001|Overall Study|Protocol Violation|1|||
30635708|NCT00977106|58647274|FG000|Overall Study|Other|1|||
30635709|NCT00977106|58647275|FG001|Overall Study|Other|0|||
30635710|NCT01077713|58647285|FG000|Overall Study|Withdrawal by Subject|1|||
30635711|NCT01077713|58647286|FG001|Overall Study|Withdrawal by Subject|2|||
30635712|NCT01077713|58647285|FG000|Overall Study|Progressive Disease (PD)|0|||
30635713|NCT01077713|58647286|FG001|Overall Study|Progressive Disease (PD)|1|||
30635714|NCT01077713|58647285|FG000|Overall Study|Death|28|||
30635715|NCT01077713|58647286|FG001|Overall Study|Death|29|||
30635716|NCT01077713|58647285|FG000|Overall Study|Lost to Follow-up|1|||
30635717|NCT01077713|58647286|FG001|Overall Study|Lost to Follow-up|1|||
30635718|NCT01077713|58647285|FG000|Overall Study|Adverse Event|2|||
30635719|NCT01077713|58647286|FG001|Overall Study|Adverse Event|1|||
30635720|NCT01077713|58647285|FG000|Overall Study|Other|4|||
30635721|NCT01077713|58647286|FG001|Overall Study|Other|2|||
30635722|NCT00813709|58647295|FG000|Double Blind Period|Adverse Event|4|||
30635723|NCT00813709|58647296|FG001|Double Blind Period|Adverse Event|1|||
30635724|NCT00813709|58647297|FG002|Double Blind Period|Adverse Event|4|||
30635725|NCT00813709|58647298|FG003|Double Blind Period|Adverse Event|0|||
30635726|NCT00813709|58647299|FG004|Double Blind Period|Adverse Event|0|||
30635727|NCT00813709|58647300|FG005|Double Blind Period|Adverse Event|0|||
30635728|NCT00813709|58647295|FG000|Double Blind Period|Lost to Follow-up|3|||
30635729|NCT00813709|58647296|FG001|Double Blind Period|Lost to Follow-up|2|||
30635730|NCT00813709|58647297|FG002|Double Blind Period|Lost to Follow-up|2|||
30635731|NCT00813709|58647298|FG003|Double Blind Period|Lost to Follow-up|0|||
30635732|NCT00813709|58647299|FG004|Double Blind Period|Lost to Follow-up|0|||
30635733|NCT00813709|58647300|FG005|Double Blind Period|Lost to Follow-up|0|||
30635734|NCT00813709|58647295|FG000|Double Blind Period|Switched to open label phase|9|||
30635735|NCT00813709|58647296|FG001|Double Blind Period|Switched to open label phase|26|||
30635736|NCT00813709|58647297|FG002|Double Blind Period|Switched to open label phase|18|||
30635737|NCT00813709|58647298|FG003|Double Blind Period|Switched to open label phase|0|||
30635738|NCT00813709|58647299|FG004|Double Blind Period|Switched to open label phase|0|||
30635739|NCT00813709|58647300|FG005|Double Blind Period|Switched to open label phase|0|||
30635740|NCT00813709|58647295|FG000|Double Blind Period|Randomized but not treated|1|||
30635741|NCT00813709|58647296|FG001|Double Blind Period|Randomized but not treated|3|||
30635742|NCT00813709|58647297|FG002|Double Blind Period|Randomized but not treated|1|||
30635743|NCT00813709|58647298|FG003|Double Blind Period|Randomized but not treated|0|||
30635744|NCT00813709|58647299|FG004|Double Blind Period|Randomized but not treated|0|||
30635745|NCT00813709|58647300|FG005|Double Blind Period|Randomized but not treated|0|||
30635746|NCT00813709|58647295|FG000|Double Blind Period|Other|14|||
30635747|NCT00813709|58647296|FG001|Double Blind Period|Other|9|||
30635748|NCT00813709|58647297|FG002|Double Blind Period|Other|6|||
30635749|NCT00813709|58647298|FG003|Double Blind Period|Other|0|||
30635750|NCT00813709|58647299|FG004|Double Blind Period|Other|0|||
30635751|NCT00813709|58647300|FG005|Double Blind Period|Other|0|||
30635752|NCT00813709|58647295|FG000|Open Label Period|Adverse Event|0|||
30635753|NCT00813709|58647296|FG001|Open Label Period|Adverse Event|0|||
30635754|NCT00813709|58647297|FG002|Open Label Period|Adverse Event|0|||
30635755|NCT00813709|58647298|FG003|Open Label Period|Adverse Event|5|||
30635756|NCT00813709|58647299|FG004|Open Label Period|Adverse Event|4|||
30635757|NCT00813709|58647300|FG005|Open Label Period|Adverse Event|3|||
30635758|NCT00813709|58647295|FG000|Open Label Period|Lack of Efficacy|0|||
30635759|NCT00813709|58647296|FG001|Open Label Period|Lack of Efficacy|0|||
30635760|NCT00813709|58647297|FG002|Open Label Period|Lack of Efficacy|0|||
30635761|NCT00813709|58647298|FG003|Open Label Period|Lack of Efficacy|3|||
30635762|NCT00813709|58647299|FG004|Open Label Period|Lack of Efficacy|1|||
30635763|NCT00813709|58647300|FG005|Open Label Period|Lack of Efficacy|1|||
30635764|NCT00813709|58647295|FG000|Open Label Period|Randomized but not treated|0|||
30635765|NCT00813709|58647296|FG001|Open Label Period|Randomized but not treated|0|||
30635766|NCT00813709|58647297|FG002|Open Label Period|Randomized but not treated|0|||
30635767|NCT00813709|58647298|FG003|Open Label Period|Randomized but not treated|1|||
30635768|NCT00813709|58647299|FG004|Open Label Period|Randomized but not treated|0|||
30635769|NCT00813709|58647300|FG005|Open Label Period|Randomized but not treated|1|||
30635770|NCT00813709|58647295|FG000|Open Label Period|Other|0|||
30635771|NCT00813709|58647296|FG001|Open Label Period|Other|0|||
30635772|NCT00813709|58647297|FG002|Open Label Period|Other|0|||
30635773|NCT00813709|58647298|FG003|Open Label Period|Other|11|||
30635774|NCT00813709|58647299|FG004|Open Label Period|Other|5|||
30635775|NCT00813709|58647300|FG005|Open Label Period|Other|6|||
30635776|NCT01077323|58647332|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
30635777|NCT01077323|58647333|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
30635778|NCT01077323|58647334|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
30635779|NCT01077323|58647332|FG000|Overall Study|Dispensing of drug in baseline period|0|||
30635780|NCT01077323|58647333|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
30635781|NCT01077323|58647334|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
30635782|NCT01077323|58647332|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
30635783|NCT01077323|58647333|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
30635784|NCT01077323|58647334|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
30635785|NCT00976950|58647342|FG000|Overall Study|Adverse Event|3|||
30635786|NCT00976950|58647342|FG000|Overall Study|Events with no relationship to Aptivus|3|||
30635787|NCT00976716|58647346|FG000|Overall Study|Adverse Event|1|||
30635788|NCT00819247|58647354|FG000|Overall Study|Adverse Event|0|||
30635789|NCT00819247|58647355|FG001|Overall Study|Adverse Event|5|||
30635790|NCT00819247|58647356|FG002|Overall Study|Adverse Event|3|||
30635791|NCT00819247|58647354|FG000|Overall Study|Insufficient testosterone response|5|||
30635792|NCT00819247|58647355|FG001|Overall Study|Insufficient testosterone response|8|||
30635793|NCT00819247|58647356|FG002|Overall Study|Insufficient testosterone response|10|||
30635794|NCT00819247|58647354|FG000|Overall Study|Withdrawal by Subject|1|||
30635795|NCT00819247|58647355|FG001|Overall Study|Withdrawal by Subject|0|||
30635796|NCT00819247|58647356|FG002|Overall Study|Withdrawal by Subject|0|||
30635797|NCT00819247|58647354|FG000|Overall Study|Protocol Violation|1|||
30635798|NCT00819247|58647355|FG001|Overall Study|Protocol Violation|0|||
30635799|NCT00819247|58647356|FG002|Overall Study|Protocol Violation|1|||
30635800|NCT00819247|58647354|FG000|Overall Study|Mistakenly withdrawn|0|||
30635801|NCT00819247|58647355|FG001|Overall Study|Mistakenly withdrawn|1|||
30635802|NCT00819247|58647356|FG002|Overall Study|Mistakenly withdrawn|0|||
30635803|NCT00819247|58647354|FG000|Overall Study|Bad prostate-specific antigen response|3|||
30635804|NCT00819247|58647355|FG001|Overall Study|Bad prostate-specific antigen response|2|||
30635805|NCT00819247|58647356|FG002|Overall Study|Bad prostate-specific antigen response|0|||
30635806|NCT00819247|58647354|FG000|Overall Study|Other|1|||
30635807|NCT00819247|58647355|FG001|Overall Study|Other|0|||
30635808|NCT00819247|58647356|FG002|Overall Study|Other|0|||
30635809|NCT00973674|58647366|FG000|Overall Study|Protocol Violation|2|||
30635810|NCT00973674|58647367|FG001|Overall Study|Protocol Violation|0|||
30635811|NCT00819091|58647376|FG000|Overall Study|Adverse Event|3|||
30635812|NCT00819091|58647377|FG001|Overall Study|Adverse Event|5|||
30635813|NCT00819091|58647376|FG000|Overall Study|Protocol Violation|0|||
30635814|NCT00819091|58647377|FG001|Overall Study|Protocol Violation|1|||
30635815|NCT00819091|58647376|FG000|Overall Study|Lost to Follow-up|2|||
30635816|NCT00819091|58647377|FG001|Overall Study|Lost to Follow-up|0|||
30635817|NCT00819091|58647376|FG000|Overall Study|Withdrawal by Subject|1|||
30635818|NCT00819091|58647377|FG001|Overall Study|Withdrawal by Subject|2|||
30635819|NCT00819091|58647376|FG000|Overall Study|Other|1|||
30635820|NCT00819091|58647377|FG001|Overall Study|Other|2|||
30635821|NCT00973362|58647385|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
30635822|NCT00973362|58647386|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
30635823|NCT00973362|58647385|FG000|Baseline Evaluation|No colposcopy visit|62|||
30635824|NCT00973362|58647386|FG001|Baseline Evaluation|No colposcopy visit|0|||
30635825|NCT00973362|58647385|FG000|Baseline Evaluation|Inevaluable|686|||
30635826|NCT00973362|58647386|FG001|Baseline Evaluation|Inevaluable|223|||
30635827|NCT00973362|58647385|FG000|3-Year Follow-up|Lost to Follow-up|17|||
30635828|NCT00973362|58647386|FG001|3-Year Follow-up|Lost to Follow-up|0|||
30765252|NCT00369785|58773917|FG001|Overall Study|Toxicity|4|||
30765253|NCT00369785|58773916|FG000|Overall Study|Never started|0|||
30765254|NCT00369785|58773917|FG001|Overall Study|Never started|2|||
30765255|NCT00369785|58773916|FG000|Overall Study|Progression|4|||
30765256|NCT00369785|58773917|FG001|Overall Study|Progression|4|||
30765257|NCT00369785|58773916|FG000|Overall Study|Multiple reasons|6|||
30765258|NCT00369785|58773917|FG001|Overall Study|Multiple reasons|5|||
30848462|NCT03194646|58874572|FG002|Overall Study|Non-compliance with study drug|1|||
30848463|NCT03194646|58874573|FG003|Overall Study|Non-compliance with study drug|1|||
30848464|NCT03194646|58874570|FG000|Overall Study|Other|87|||
30848465|NCT03194646|58874571|FG001|Overall Study|Other|67|||
30765259|NCT00369707|58773923|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
30765260|NCT00369707|58773923|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
30765261|NCT00369707|58773923|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
30765262|NCT00369707|58773923|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
30765263|NCT00369707|58773923|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
30765264|NCT00369707|58773923|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
30765265|NCT00369707|58773923|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
30765266|NCT00369707|58773923|FG000|Follow up for 2 Years After Treatment|Death|1|||
30765267|NCT00369707|58773923|FG000|Follow up for 2 Years After Treatment|Other|2|||
30848466|NCT03194646|58874572|FG002|Overall Study|Other|34|||
30951306|NCT04426695|58998515|FG010|Overall Study|Death|8|||
30635829|NCT00819013|58647399|FG000|Overall Study|Not meeting continuing study eligibility|2|||
30635830|NCT00819013|58647400|FG001|Overall Study|Not meeting continuing study eligibility|1|||
30635831|NCT00819013|58647401|FG002|Overall Study|Not meeting continuing study eligibility|2|||
30635832|NCT00819013|58647402|FG003|Overall Study|Not meeting continuing study eligibility|1|||
30635833|NCT00819013|58647399|FG000|Overall Study|Adverse Event|0|||
30635834|NCT00819013|58647400|FG001|Overall Study|Adverse Event|0|||
30635835|NCT00819013|58647401|FG002|Overall Study|Adverse Event|1|||
30635836|NCT00819013|58647402|FG003|Overall Study|Adverse Event|0|||
30635837|NCT00819013|58647399|FG000|Overall Study|Withdrawal by Subject|1|||
30635838|NCT00819013|58647400|FG001|Overall Study|Withdrawal by Subject|0|||
30635839|NCT00819013|58647401|FG002|Overall Study|Withdrawal by Subject|1|||
30635840|NCT00819013|58647402|FG003|Overall Study|Withdrawal by Subject|0|||
30765268|NCT02943460|58773930|FG000|Blinded Study Phase|Adverse Event|3|||
30765269|NCT02943460|58773931|FG001|Blinded Study Phase|Adverse Event|0|||
30765270|NCT02943460|58773932|FG002|Blinded Study Phase|Adverse Event|0|||
30765271|NCT02943460|58773930|FG000|Blinded Study Phase|Withdrew Consent|0|||
30635841|NCT00819013|58647399|FG000|Overall Study|Lost to Follow-up|0|||
30635842|NCT00819013|58647400|FG001|Overall Study|Lost to Follow-up|0|||
30848467|NCT03194646|58874573|FG003|Overall Study|Other|31|||
30951307|NCT04426695|58998516|FG011|Overall Study|Death|7|||
30635843|NCT00819013|58647401|FG002|Overall Study|Lost to Follow-up|1|||
30765272|NCT02943460|58773931|FG001|Blinded Study Phase|Withdrew Consent|1|||
30765273|NCT02943460|58773932|FG002|Blinded Study Phase|Withdrew Consent|0|||
30951308|NCT04426695|58998517|FG012|Overall Study|Death|13|||
30635844|NCT00819013|58647402|FG003|Overall Study|Lost to Follow-up|2|||
30635845|NCT00819013|58647399|FG000|Overall Study|Death|0|||
30635846|NCT00819013|58647400|FG001|Overall Study|Death|0|||
30635847|NCT00819013|58647401|FG002|Overall Study|Death|0|||
30635848|NCT00819013|58647402|FG003|Overall Study|Death|1|||
30635849|NCT00976560|58647414|FG000|Overall Study|Adverse Event|5|||
30635850|NCT00976560|58647415|FG001|Overall Study|Adverse Event|5|||
30635851|NCT00976560|58647414|FG000|Overall Study|Lack of Efficacy|3|||
30635852|NCT00976560|58647415|FG001|Overall Study|Lack of Efficacy|5|||
30635853|NCT00976560|58647414|FG000|Overall Study|Protocol Violation|1|||
30635854|NCT00976560|58647415|FG001|Overall Study|Protocol Violation|0|||
30635855|NCT00976560|58647414|FG000|Overall Study|Lost to Follow-up|1|||
30635856|NCT00976560|58647415|FG001|Overall Study|Lost to Follow-up|0|||
30635857|NCT00976560|58647414|FG000|Overall Study|Physician Decision|2|||
30635858|NCT00976560|58647415|FG001|Overall Study|Physician Decision|0|||
30635859|NCT00976560|58647414|FG000|Overall Study|Withdrawal by Subject|2|||
30635860|NCT00976560|58647415|FG001|Overall Study|Withdrawal by Subject|3|||
30635861|NCT00976482|58647421|FG000|Overall Study|Death|208|||
30635862|NCT00976482|58647421|FG000|Overall Study|Withdrawal by Subject|45|||
30635863|NCT00976482|58647421|FG000|Overall Study|Center terminated|1|||
30635864|NCT00976482|58647421|FG000|Overall Study|Protocol Violation|5|||
30635865|NCT00975156|58647427|FG000|Overall Study|Protocol Violation|0|||
30635866|NCT00975156|58647428|FG001|Overall Study|Protocol Violation|1|||
30635867|NCT00810043|58647440|FG000|Overall Study|Withdrawal by Subject|1|||
30635868|NCT00810043|58647441|FG001|Overall Study|Withdrawal by Subject|0|||
30635869|NCT00810043|58647442|FG002|Overall Study|Withdrawal by Subject|2|||
30635870|NCT00810043|58647440|FG000|Overall Study|Lost to Follow-up|1|||
30635871|NCT00810043|58647441|FG001|Overall Study|Lost to Follow-up|0|||
30635872|NCT00810043|58647442|FG002|Overall Study|Lost to Follow-up|0|||
30635873|NCT00810043|58647440|FG000|Overall Study|Physician Decision|0|||
30635874|NCT00810043|58647441|FG001|Overall Study|Physician Decision|0|||
30635875|NCT00810043|58647442|FG002|Overall Study|Physician Decision|2|||
30635876|NCT00810043|58647440|FG000|Overall Study|Death|2|||
30635877|NCT00810043|58647441|FG001|Overall Study|Death|0|||
30635878|NCT00810043|58647442|FG002|Overall Study|Death|0|||
30635879|NCT00810043|58647440|FG000|Overall Study|Unrelated medical problem|0|||
30635880|NCT00810043|58647441|FG001|Overall Study|Unrelated medical problem|1|||
30635881|NCT00810043|58647442|FG002|Overall Study|Unrelated medical problem|0|||
30635882|NCT00810043|58647440|FG000|Overall Study|Non-medical problem|0|||
30635883|NCT00810043|58647441|FG001|Overall Study|Non-medical problem|0|||
30635884|NCT00810043|58647442|FG002|Overall Study|Non-medical problem|1|||
30635885|NCT00810043|58647440|FG000|Overall Study|No longer met enrollment criteria|0|||
30635886|NCT00810043|58647441|FG001|Overall Study|No longer met enrollment criteria|0|||
30635887|NCT00810043|58647442|FG002|Overall Study|No longer met enrollment criteria|3|||
30635888|NCT01120184|58647454|FG000|Overall Study|Adverse Event|0|||
30635889|NCT01120184|58647455|FG001|Overall Study|Adverse Event|1|||
30635890|NCT01120184|58647456|FG002|Overall Study|Adverse Event|0|||
30635891|NCT01120184|58647454|FG000|Overall Study|Lost to Follow-up|13|||
30635892|NCT01120184|58647455|FG001|Overall Study|Lost to Follow-up|13|||
30635893|NCT01120184|58647456|FG002|Overall Study|Lost to Follow-up|11|||
30635894|NCT01120184|58647454|FG000|Overall Study|Physician Decision|9|||
30635895|NCT01120184|58647455|FG001|Overall Study|Physician Decision|1|||
30635896|NCT01120184|58647456|FG002|Overall Study|Physician Decision|3|||
30635897|NCT01120184|58647454|FG000|Overall Study|Reason not Specified|8|||
30635898|NCT01120184|58647455|FG001|Overall Study|Reason not Specified|3|||
30635899|NCT01120184|58647456|FG002|Overall Study|Reason not Specified|12|||
30635900|NCT01120184|58647454|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
30635901|NCT01120184|58647455|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
30635902|NCT01120184|58647456|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
30635903|NCT01120184|58647454|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
30635904|NCT01120184|58647455|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
30635905|NCT01120184|58647456|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
30635906|NCT01120184|58647454|FG000|Overall Study|Death|170|||
30635907|NCT01120184|58647455|FG001|Overall Study|Death|176|||
30635908|NCT01120184|58647456|FG002|Overall Study|Death|169|||
30635909|NCT01120028|58647468|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
30635910|NCT01120028|58647469|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
30765274|NCT02943460|58773930|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
30765275|NCT02943460|58773931|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
30765276|NCT02943460|58773932|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
30635911|NCT01120028|58647470|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
30635912|NCT01120028|58647471|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
30635913|NCT01120028|58647468|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
30848468|NCT03194646|58874570|FG000|Overall Study|Physician Decision|7|||
30635914|NCT01120028|58647469|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
30635915|NCT01120028|58647470|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
30635916|NCT01120028|58647471|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
30635917|NCT00878800|58647487|FG000|Overall Study|Adverse Event|0|||
30635918|NCT00878800|58647488|FG001|Overall Study|Adverse Event|0|||
30635919|NCT00878800|58647489|FG002|Overall Study|Adverse Event|2|||
30635920|NCT00878800|58647490|FG003|Overall Study|Adverse Event|0|||
30635921|NCT00878800|58647491|FG004|Overall Study|Adverse Event|1|||
30635922|NCT00878800|58647487|FG000|Overall Study|Progressive disease|1|||
30635923|NCT00878800|58647488|FG001|Overall Study|Progressive disease|5|||
30635924|NCT00878800|58647489|FG002|Overall Study|Progressive disease|6|||
30635925|NCT00878800|58647490|FG003|Overall Study|Progressive disease|5|||
30635926|NCT00878800|58647491|FG004|Overall Study|Progressive disease|13|||
30635927|NCT00878800|58647487|FG000|Overall Study|Withdrew consent|1|||
30635928|NCT00878800|58647488|FG001|Overall Study|Withdrew consent|1|||
30635929|NCT00878800|58647489|FG002|Overall Study|Withdrew consent|0|||
30635930|NCT00878800|58647490|FG003|Overall Study|Withdrew consent|1|||
30635931|NCT00878800|58647491|FG004|Overall Study|Withdrew consent|1|||
30635932|NCT00878800|58647487|FG000|Overall Study|Death|0|||
30635933|NCT00878800|58647488|FG001|Overall Study|Death|0|||
30635934|NCT00878800|58647489|FG002|Overall Study|Death|1|||
30635935|NCT00878800|58647490|FG003|Overall Study|Death|0|||
30635936|NCT00878800|58647491|FG004|Overall Study|Death|0|||
30635937|NCT00878800|58647487|FG000|Overall Study|Other|1|||
30635938|NCT00878800|58647488|FG001|Overall Study|Other|1|||
30635939|NCT00878800|58647489|FG002|Overall Study|Other|0|||
30635940|NCT00878800|58647490|FG003|Overall Study|Other|0|||
30635941|NCT00878800|58647491|FG004|Overall Study|Other|1|||
30635942|NCT01119950|58647502|FG000|Overall Study|Adverse Event|25|||
30635943|NCT01119950|58647502|FG000|Overall Study|Withdrawal by Subject|9|||
30635944|NCT01119950|58647502|FG000|Overall Study|Protocol Violation|5|||
30635945|NCT01119950|58647502|FG000|Overall Study|Lost to Follow-up|4|||
30635946|NCT01119950|58647502|FG000|Overall Study|Administrative|2|||
30635947|NCT01119950|58647502|FG000|Overall Study|Abnormal lab value|1|||
30635948|NCT01119950|58647502|FG000|Overall Study|Death|1|||
30635949|NCT01145222|58647532|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
30635950|NCT01145222|58647533|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
30635951|NCT01145222|58647534|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
30635952|NCT01145222|58647535|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
30635953|NCT01145222|58647532|FG000|Overall Study|Poor bowel preparation|0|||
30635954|NCT01145222|58647533|FG001|Overall Study|Poor bowel preparation|0|||
30635955|NCT01145222|58647534|FG002|Overall Study|Poor bowel preparation|0|||
30635956|NCT01145222|58647535|FG003|Overall Study|Poor bowel preparation|1|||
30635957|NCT01145066|58647548|FG000|Overall Study|To resume NSAIDs|2|||
30635958|NCT01145066|58647549|FG001|Overall Study|To resume NSAIDs|2|||
30635959|NCT01145066|58647550|FG002|Overall Study|To resume NSAIDs|1|||
30635960|NCT01145066|58647548|FG000|Overall Study|Non-related surgery|0|||
30635961|NCT01145066|58647549|FG001|Overall Study|Non-related surgery|0|||
30635962|NCT01145066|58647550|FG002|Overall Study|Non-related surgery|1|||
30635963|NCT01145066|58647548|FG000|Overall Study|Withdrawal by Subject|0|||
30635964|NCT01145066|58647549|FG001|Overall Study|Withdrawal by Subject|0|||
30635965|NCT01145066|58647550|FG002|Overall Study|Withdrawal by Subject|2|||
30635966|NCT01145066|58647548|FG000|Overall Study|To start new med|1|||
30635967|NCT01145066|58647549|FG001|Overall Study|To start new med|0|||
30635968|NCT01145066|58647550|FG002|Overall Study|To start new med|0|||
30635969|NCT01145066|58647548|FG000|Overall Study|problems swallowing capsule|1|||
30635970|NCT01145066|58647549|FG001|Overall Study|problems swallowing capsule|0|||
30635971|NCT01145066|58647550|FG002|Overall Study|problems swallowing capsule|0|||
30635972|NCT01145066|58647548|FG000|Overall Study|Abdominal discomfort|0|||
30635973|NCT01145066|58647549|FG001|Overall Study|Abdominal discomfort|1|||
30635974|NCT01145066|58647550|FG002|Overall Study|Abdominal discomfort|0|||
30635975|NCT01145066|58647548|FG000|Overall Study|Low platelet count|0|||
30635976|NCT01145066|58647549|FG001|Overall Study|Low platelet count|1|||
30635977|NCT01145066|58647550|FG002|Overall Study|Low platelet count|0|||
30635978|NCT01132118|58647560|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
30765277|NCT02943460|58773930|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
30765278|NCT02943460|58773931|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
30765279|NCT02943460|58773932|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
30848469|NCT03194646|58874571|FG001|Overall Study|Physician Decision|9|||
30635979|NCT01132118|58647561|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
30635980|NCT01132118|58647560|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
30635981|NCT01132118|58647561|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
30635982|NCT01132118|58647560|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
30635983|NCT01132118|58647561|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
30635984|NCT00972816|58647575|FG000|Overall Study|Adverse Event|0|||
30635985|NCT00972816|58647576|FG001|Overall Study|Adverse Event|0|||
30635986|NCT00972816|58647577|FG002|Overall Study|Adverse Event|1|||
30635987|NCT00972816|58647578|FG003|Overall Study|Adverse Event|0|||
30635988|NCT00972816|58647579|FG004|Overall Study|Adverse Event|0|||
30635989|NCT00972816|58647580|FG005|Overall Study|Adverse Event|0|||
30635990|NCT00972816|58647581|FG006|Overall Study|Adverse Event|0|||
30635991|NCT00972816|58647582|FG007|Overall Study|Adverse Event|0|||
30635992|NCT00972816|58647575|FG000|Overall Study|Withdrawal by Subject|4|||
30635993|NCT00972816|58647576|FG001|Overall Study|Withdrawal by Subject|2|||
30635994|NCT00972816|58647577|FG002|Overall Study|Withdrawal by Subject|1|||
30635995|NCT00972816|58647578|FG003|Overall Study|Withdrawal by Subject|3|||
30635996|NCT00972816|58647579|FG004|Overall Study|Withdrawal by Subject|0|||
30635997|NCT00972816|58647580|FG005|Overall Study|Withdrawal by Subject|1|||
30635998|NCT00972816|58647581|FG006|Overall Study|Withdrawal by Subject|1|||
30635999|NCT00972816|58647582|FG007|Overall Study|Withdrawal by Subject|2|||
30636000|NCT00972816|58647575|FG000|Overall Study|Lost to Follow-up|11|||
30636001|NCT00972816|58647576|FG001|Overall Study|Lost to Follow-up|9|||
30636002|NCT00972816|58647577|FG002|Overall Study|Lost to Follow-up|7|||
30636003|NCT00972816|58647578|FG003|Overall Study|Lost to Follow-up|5|||
30636004|NCT00972816|58647579|FG004|Overall Study|Lost to Follow-up|11|||
30636005|NCT00972816|58647580|FG005|Overall Study|Lost to Follow-up|10|||
30636006|NCT00972816|58647581|FG006|Overall Study|Lost to Follow-up|7|||
30636007|NCT00972816|58647582|FG007|Overall Study|Lost to Follow-up|7|||
30636008|NCT00972816|58647575|FG000|Overall Study|Inappropriate enrolment|0|||
30636009|NCT00972816|58647576|FG001|Overall Study|Inappropriate enrolment|0|||
30636010|NCT00972816|58647577|FG002|Overall Study|Inappropriate enrolment|0|||
30636011|NCT00972816|58647578|FG003|Overall Study|Inappropriate enrolment|0|||
30636012|NCT00972816|58647579|FG004|Overall Study|Inappropriate enrolment|0|||
30636013|NCT00972816|58647580|FG005|Overall Study|Inappropriate enrolment|0|||
30636014|NCT00972816|58647581|FG006|Overall Study|Inappropriate enrolment|2|||
30636015|NCT00972816|58647582|FG007|Overall Study|Inappropriate enrolment|0|||
30636016|NCT00972816|58647575|FG000|Overall Study|Unable to classify|2|||
30636017|NCT00972816|58647576|FG001|Overall Study|Unable to classify|0|||
30636018|NCT00972816|58647577|FG002|Overall Study|Unable to classify|0|||
30636019|NCT00972816|58647578|FG003|Overall Study|Unable to classify|0|||
30636020|NCT00972816|58647579|FG004|Overall Study|Unable to classify|1|||
30636021|NCT00972816|58647580|FG005|Overall Study|Unable to classify|0|||
30636022|NCT00972816|58647581|FG006|Overall Study|Unable to classify|0|||
30636023|NCT00972816|58647582|FG007|Overall Study|Unable to classify|0|||
30636024|NCT00969618|58647600|FG000|Overall Study|Adverse Event|29|||
30636025|NCT00969618|58647600|FG000|Overall Study|Entry Criteria Not Met|3|||
30636026|NCT00969618|58647600|FG000|Overall Study|Lack of Efficacy|2|||
30636027|NCT00969618|58647600|FG000|Overall Study|Lost to Follow-up|7|||
30636028|NCT00969618|58647600|FG000|Overall Study|Physician Decision|1|||
30636029|NCT00969618|58647600|FG000|Overall Study|Protocol Violation|9|||
30636030|NCT00969618|58647600|FG000|Overall Study|Withdrawal by Subject|27|||
30636031|NCT00969540|58647606|FG000|Overall Study|Lost to Follow-up|1|||
30636032|NCT00969540|58647607|FG001|Overall Study|Lost to Follow-up|1|||
30636033|NCT00975000|58647627|FG000|Overall Study|Other|1|||
30636034|NCT00975000|58647628|FG001|Overall Study|Other|0|||
30636035|NCT00975000|58647627|FG000|Overall Study|Adverse Event|1|||
30636036|NCT00975000|58647628|FG001|Overall Study|Adverse Event|1|||
30636037|NCT00975000|58647627|FG000|Overall Study|Withdrawal by Subject|2|||
30636038|NCT00975000|58647628|FG001|Overall Study|Withdrawal by Subject|2|||
30636039|NCT00975000|58647627|FG000|Overall Study|Lost to Follow-up|0|||
30636040|NCT00975000|58647628|FG001|Overall Study|Lost to Follow-up|1|||
30636041|NCT00975000|58647627|FG000|Overall Study|Protocol-specified Criteria|1|||
30636042|NCT00975000|58647628|FG001|Overall Study|Protocol-specified Criteria|0|||
30636043|NCT00975000|58647627|FG000|Overall Study|Non-compliance|0|||
30636044|NCT00975000|58647628|FG001|Overall Study|Non-compliance|1|||
30636045|NCT00974922|58647634|FG000|Overall Study|study terminated|24|||
30636046|NCT00972504|58647638|FG000|Overall Study|Adverse Event|2|||
30636047|NCT00972504|58647638|FG000|Overall Study|Investigator discretion|1|||
30636048|NCT00969228|58647650|FG000|Overall Study|Adverse Event|1|||
30636049|NCT00969228|58647651|FG001|Overall Study|Adverse Event|0|||
30636050|NCT00969228|58647650|FG000|Overall Study|Withdrawal by Subject|4|||
30636051|NCT00969228|58647651|FG001|Overall Study|Withdrawal by Subject|0|||
30636052|NCT00969228|58647650|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
30636053|NCT00969228|58647651|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
30636054|NCT00969150|58647659|FG000|Overall Study|Adverse Event|4|||
30636055|NCT00969150|58647660|FG001|Overall Study|Adverse Event|14|||
30636056|NCT00969150|58647659|FG000|Overall Study|Lack of Efficacy|1|||
30636057|NCT00969150|58647660|FG001|Overall Study|Lack of Efficacy|1|||
30636058|NCT00969150|58647659|FG000|Overall Study|Protocol Violation|9|||
30636059|NCT00969150|58647660|FG001|Overall Study|Protocol Violation|12|||
30636060|NCT00969150|58647659|FG000|Overall Study|Withdrawal by Subject|13|||
30636061|NCT00969150|58647660|FG001|Overall Study|Withdrawal by Subject|9|||
30636062|NCT00969150|58647659|FG000|Overall Study|Lost to Follow-up|5|||
30636063|NCT00969150|58647660|FG001|Overall Study|Lost to Follow-up|4|||
30636064|NCT00969150|58647659|FG000|Overall Study|Other reasons|1|||
30636065|NCT00969150|58647660|FG001|Overall Study|Other reasons|0|||
30636066|NCT00974220|58647668|FG000|Treatment Period 1|Adverse Event|2|||
30636067|NCT00974220|58647669|FG001|Treatment Period 1|Adverse Event|1|||
30636068|NCT00974220|58647668|FG000|Treatment Period 1|noncompliant subjects|0|||
30636069|NCT00974220|58647669|FG001|Treatment Period 1|noncompliant subjects|1|||
30636070|NCT00971178|58647678|FG000|Overall Study|Lost to Follow-up|2|||
30636071|NCT00971178|58647679|FG001|Overall Study|Lost to Follow-up|2|||
30636072|NCT00971178|58647680|FG002|Overall Study|Lost to Follow-up|2|||
30636073|NCT03670602|58647690|FG000|Overall Study|Lost to Follow-up|1|||
30636074|NCT03670602|58647691|FG001|Overall Study|Lost to Follow-up|0|||
30636075|NCT03670602|58647690|FG000|Overall Study|Withdrawal by Subject|0|||
30636076|NCT03670602|58647691|FG001|Overall Study|Withdrawal by Subject|3|||
30636077|NCT00968526|58647699|FG000|Overall Study|Adverse Event|2|||
30636078|NCT00968526|58647700|FG001|Overall Study|Adverse Event|0|||
30636079|NCT00968526|58647699|FG000|Overall Study|Migrated/moved from study area|1|||
30636080|NCT00968526|58647700|FG001|Overall Study|Migrated/moved from study area|0|||
30636081|NCT03664674|58647717|FG000|Overall Study|Adverse Event|1|||
30636082|NCT03664674|58647718|FG001|Overall Study|Adverse Event|1|||
30636083|NCT03664674|58647717|FG000|Overall Study|Physician Decision|0|||
30636084|NCT03664674|58647718|FG001|Overall Study|Physician Decision|1|||
30636085|NCT03664674|58647717|FG000|Overall Study|Withdrawal by Subject|2|||
30636086|NCT03664674|58647718|FG001|Overall Study|Withdrawal by Subject|0|||
30636087|NCT00967668|58647729|FG000|Overall Study|Withdrawal by Subject|13|||
30636088|NCT00967668|58647730|FG001|Overall Study|Withdrawal by Subject|8|||
30636089|NCT00967668|58647731|FG002|Overall Study|Withdrawal by Subject|8|||
30636090|NCT00967668|58647729|FG000|Overall Study|Death|0|||
30636091|NCT00967668|58647730|FG001|Overall Study|Death|2|||
30636092|NCT00967668|58647731|FG002|Overall Study|Death|4|||
30636093|NCT00967668|58647729|FG000|Overall Study|Removed due to behavior|1|||
30636094|NCT00967668|58647730|FG001|Overall Study|Removed due to behavior|1|||
30636095|NCT00967668|58647731|FG002|Overall Study|Removed due to behavior|2|||
30636096|NCT00967668|58647729|FG000|Overall Study|Refused Year 2|11|||
30636097|NCT00967668|58647730|FG001|Overall Study|Refused Year 2|6|||
30636098|NCT00967668|58647731|FG002|Overall Study|Refused Year 2|4|||
30636099|NCT00967668|58647729|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
30636100|NCT00967668|58647730|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
30636101|NCT00967668|58647731|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
30636102|NCT00967668|58647729|FG000|Overall Study|Lost to Follow-up|15|||
30636103|NCT00967668|58647730|FG001|Overall Study|Lost to Follow-up|9|||
30636104|NCT00967668|58647731|FG002|Overall Study|Lost to Follow-up|16|||
30636105|NCT00967668|58647729|FG000|Overall Study|Refused 12-mo assessment|3|||
30636106|NCT00967668|58647730|FG001|Overall Study|Refused 12-mo assessment|1|||
30636107|NCT00967668|58647731|FG002|Overall Study|Refused 12-mo assessment|9|||
30636108|NCT00967668|58647729|FG000|Overall Study|Pregnancy|1|||
30636109|NCT00967668|58647730|FG001|Overall Study|Pregnancy|0|||
30636110|NCT00967668|58647731|FG002|Overall Study|Pregnancy|0|||
30636111|NCT00970944|58647744|FG000|Overall Study|Death|1|||
30636112|NCT00970944|58647745|FG001|Overall Study|Death|0|||
30636113|NCT00970944|58647744|FG000|Overall Study|Physician Decision|0|||
30636114|NCT00970944|58647745|FG001|Overall Study|Physician Decision|2|||
30636115|NCT04839289|58647754|FG000|Overall Study|Withdrawal by Subject|1|||
30636116|NCT04839289|58647755|FG001|Overall Study|Withdrawal by Subject|0|||
30636117|NCT04440813|58647763|FG000|Overall Study|Lost to Follow-up|5|||
30636118|NCT04440813|58647764|FG001|Overall Study|Lost to Follow-up|5|||
30636119|NCT04233073|58647778|FG000|Overall Study|Death|5|||
30636120|NCT04120116|58647786|FG000|Overall Study|Lost to Follow-up|0|||
30636121|NCT04120116|58647787|FG001|Overall Study|Lost to Follow-up|1|||
30636122|NCT04120116|58647788|FG002|Overall Study|Lost to Follow-up|0|||
30636123|NCT04120116|58647789|FG003|Overall Study|Lost to Follow-up|2|||
30636124|NCT04120116|58647786|FG000|Overall Study|Withdrawal by Subject|1|||
30636125|NCT04120116|58647787|FG001|Overall Study|Withdrawal by Subject|0|||
30636126|NCT04120116|58647788|FG002|Overall Study|Withdrawal by Subject|1|||
30636127|NCT04120116|58647789|FG003|Overall Study|Withdrawal by Subject|1|||
30636128|NCT04120116|58647786|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
30636129|NCT04120116|58647787|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
30636130|NCT04120116|58647788|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
30636131|NCT04120116|58647789|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
30636132|NCT03657810|58647812|FG000|Overall Study|Adverse Event|0|||
30636133|NCT03657810|58647813|FG001|Overall Study|Adverse Event|1|||
30636134|NCT03657810|58647814|FG002|Overall Study|Adverse Event|0|||
30636135|NCT03657810|58647812|FG000|Overall Study|Lack of Efficacy|4|||
30636136|NCT03657810|58647813|FG001|Overall Study|Lack of Efficacy|1|||
30636137|NCT03657810|58647814|FG002|Overall Study|Lack of Efficacy|3|||
30636138|NCT03657810|58647812|FG000|Overall Study|Protocol Violation|1|||
30636139|NCT03657810|58647813|FG001|Overall Study|Protocol Violation|0|||
30636140|NCT03657810|58647814|FG002|Overall Study|Protocol Violation|0|||
30636141|NCT03657810|58647812|FG000|Overall Study|Lost to Follow-up|0|||
30636142|NCT03657810|58647813|FG001|Overall Study|Lost to Follow-up|1|||
30636143|NCT03657810|58647814|FG002|Overall Study|Lost to Follow-up|0|||
30636144|NCT03657810|58647812|FG000|Overall Study|Not provided|0|||
30636145|NCT03657810|58647813|FG001|Overall Study|Not provided|1|||
30636146|NCT03657810|58647814|FG002|Overall Study|Not provided|0|||
30636147|NCT03370341|58647836|FG000|Overall Study|Lost to Follow-up|0|||
30636148|NCT03370341|58647837|FG001|Overall Study|Lost to Follow-up|1|||
30636149|NCT02614066|58647889|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
30636150|NCT02614066|58647890|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
30636151|NCT02614066|58647891|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
30636152|NCT02614066|58647892|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
30636153|NCT02614066|58647889|FG000|Overall Study|Full Consent Withdrawn|0|||
30636154|NCT02614066|58647890|FG001|Overall Study|Full Consent Withdrawn|1|||
30636155|NCT02614066|58647891|FG002|Overall Study|Full Consent Withdrawn|0|||
30636156|NCT02614066|58647892|FG003|Overall Study|Full Consent Withdrawn|3|||
30636157|NCT02614066|58647889|FG000|Overall Study|Lost to Follow-up|0|||
30636158|NCT02614066|58647890|FG001|Overall Study|Lost to Follow-up|1|||
30636159|NCT02614066|58647891|FG002|Overall Study|Lost to Follow-up|0|||
30636160|NCT02614066|58647892|FG003|Overall Study|Lost to Follow-up|0|||
30636161|NCT02614066|58647889|FG000|Overall Study|Still on-study|1|||
30636162|NCT02614066|58647890|FG001|Overall Study|Still on-study|9|||
30636163|NCT02614066|58647891|FG002|Overall Study|Still on-study|5|||
30636164|NCT02614066|58647892|FG003|Overall Study|Still on-study|32|||
30636165|NCT02614066|58647889|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
30636166|NCT02614066|58647890|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
30636167|NCT02614066|58647891|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
30636168|NCT02614066|58647892|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
30636169|NCT02544074|58647921|FG000|Overall Study|Withdrawal by Subject|0|||
30636170|NCT02544074|58647922|FG001|Overall Study|Withdrawal by Subject|1|||
30636171|NCT02544074|58647923|FG002|Overall Study|Withdrawal by Subject|0|||
30636172|NCT02544074|58647924|FG003|Overall Study|Withdrawal by Subject|0|||
30636173|NCT02544074|58647925|FG004|Overall Study|Withdrawal by Subject|0|||
30636174|NCT02544074|58647926|FG005|Overall Study|Withdrawal by Subject|0|||
30636175|NCT02544074|58647927|FG006|Overall Study|Withdrawal by Subject|0|||
30636176|NCT02544074|58647928|FG007|Overall Study|Withdrawal by Subject|0|||
30636177|NCT02544074|58647929|FG008|Overall Study|Withdrawal by Subject|0|||
30636178|NCT02544074|58647930|FG009|Overall Study|Withdrawal by Subject|0|||
30636179|NCT02544074|58647931|FG010|Overall Study|Withdrawal by Subject|0|||
30636180|NCT02544074|58647932|FG011|Overall Study|Withdrawal by Subject|0|||
30636181|NCT02544074|58647933|FG012|Overall Study|Withdrawal by Subject|0|||
30636182|NCT02544074|58647934|FG013|Overall Study|Withdrawal by Subject|0|||
30636183|NCT02544074|58647935|FG014|Overall Study|Withdrawal by Subject|0|||
30636184|NCT02544074|58647936|FG015|Overall Study|Withdrawal by Subject|0|||
30636185|NCT02544074|58647937|FG016|Overall Study|Withdrawal by Subject|0|||
30636186|NCT02544074|58647938|FG017|Overall Study|Withdrawal by Subject|0|||
30636187|NCT02544074|58647939|FG018|Overall Study|Withdrawal by Subject|0|||
30636188|NCT02544074|58647940|FG019|Overall Study|Withdrawal by Subject|0|||
30636189|NCT02544074|58647941|FG020|Overall Study|Withdrawal by Subject|0|||
30636190|NCT02544074|58647921|FG000|Overall Study|Tablet error|0|||
30636191|NCT02544074|58647922|FG001|Overall Study|Tablet error|0|||
30636192|NCT02544074|58647923|FG002|Overall Study|Tablet error|0|||
30636193|NCT02544074|58647924|FG003|Overall Study|Tablet error|0|||
30636194|NCT02544074|58647925|FG004|Overall Study|Tablet error|0|||
30636195|NCT02544074|58647926|FG005|Overall Study|Tablet error|1|||
30636196|NCT02544074|58647927|FG006|Overall Study|Tablet error|0|||
30636197|NCT02544074|58647928|FG007|Overall Study|Tablet error|0|||
30765280|NCT02943460|58773930|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
30765281|NCT02943460|58773931|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
30636198|NCT02544074|58647929|FG008|Overall Study|Tablet error|0|||
30636199|NCT02544074|58647930|FG009|Overall Study|Tablet error|1|||
30636200|NCT02544074|58647931|FG010|Overall Study|Tablet error|0|||
30636201|NCT02544074|58647932|FG011|Overall Study|Tablet error|0|||
30636202|NCT02544074|58647933|FG012|Overall Study|Tablet error|0|||
30636203|NCT02544074|58647934|FG013|Overall Study|Tablet error|0|||
30636204|NCT02544074|58647935|FG014|Overall Study|Tablet error|0|||
30765282|NCT02943460|58773932|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
30765283|NCT03768206|58773943|FG000|Overall Study|Lost to Follow-up|2|||
30765284|NCT03768206|58773944|FG001|Overall Study|Lost to Follow-up|1|||
30765285|NCT03768206|58773943|FG000|Overall Study|Withdrawal by Subject|0|||
30765286|NCT03768206|58773944|FG001|Overall Study|Withdrawal by Subject|1|||
30765287|NCT03767894|58773951|FG000|Overall Study|Withdrawal by Subject|1|||
30765288|NCT03766646|58773957|FG000|Overall Study|Withdrawal by Subject|1|||
30636205|NCT02544074|58647936|FG015|Overall Study|Tablet error|0|||
30636206|NCT02544074|58647937|FG016|Overall Study|Tablet error|0|||
30636207|NCT02544074|58647938|FG017|Overall Study|Tablet error|0|||
30636208|NCT02544074|58647939|FG018|Overall Study|Tablet error|0|||
30636209|NCT02544074|58647940|FG019|Overall Study|Tablet error|0|||
30636210|NCT02544074|58647941|FG020|Overall Study|Tablet error|0|||
30636211|NCT02502799|58647979|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
30636212|NCT02502799|58647980|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
30636213|NCT02502799|58647981|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
30636214|NCT02502799|58647982|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
30636215|NCT02502799|58647979|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
30636216|NCT02502799|58647980|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
30636217|NCT02502799|58647981|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
30636218|NCT02502799|58647982|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
30636219|NCT02502799|58647979|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
30636220|NCT02502799|58647980|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
30636221|NCT02502799|58647981|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
30636222|NCT02502799|58647982|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
30636223|NCT02502799|58647979|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
30636224|NCT02502799|58647980|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
30636225|NCT02502799|58647981|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
30636226|NCT02502799|58647982|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
30636227|NCT02502799|58647979|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
30636228|NCT02502799|58647980|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
30636229|NCT02502799|58647981|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
30636230|NCT02502799|58647982|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
30951309|NCT04426695|58998518|FG013|Overall Study|Death|25|||
30951310|NCT04426695|58998519|FG014|Overall Study|Death|19|||
30951311|NCT04426695|58998520|FG015|Overall Study|Death|7|||
30951312|NCT04426695|58998521|FG016|Overall Study|Death|8|||
30951313|NCT04426695|58998522|FG017|Overall Study|Death|4|||
30951314|NCT04426695|58998505|FG000|Overall Study|Lost to Follow-up|2|||
30951315|NCT04426695|58998506|FG001|Overall Study|Lost to Follow-up|4|||
30951316|NCT04426695|58998507|FG002|Overall Study|Lost to Follow-up|1|||
30951317|NCT04426695|58998508|FG003|Overall Study|Lost to Follow-up|19|||
30951318|NCT04426695|58998509|FG004|Overall Study|Lost to Follow-up|10|||
30951319|NCT04426695|58998510|FG005|Overall Study|Lost to Follow-up|14|||
30951320|NCT04426695|58998511|FG006|Overall Study|Lost to Follow-up|5|||
30951321|NCT04426695|58998512|FG007|Overall Study|Lost to Follow-up|14|||
30951322|NCT04426695|58998513|FG008|Overall Study|Lost to Follow-up|10|||
30636231|NCT02086448|58647995|FG000|Overall Study|Withdrawal by Subject|1|||
30951323|NCT04426695|58998514|FG009|Overall Study|Lost to Follow-up|11|||
30951324|NCT04426695|58998515|FG010|Overall Study|Lost to Follow-up|12|||
30951325|NCT04426695|58998516|FG011|Overall Study|Lost to Follow-up|6|||
30951326|NCT04426695|58998517|FG012|Overall Study|Lost to Follow-up|2|||
30951327|NCT04426695|58998518|FG013|Overall Study|Lost to Follow-up|2|||
30951328|NCT04426695|58998519|FG014|Overall Study|Lost to Follow-up|2|||
30951329|NCT04426695|58998520|FG015|Overall Study|Lost to Follow-up|0|||
30951330|NCT04426695|58998521|FG016|Overall Study|Lost to Follow-up|0|||
30951331|NCT04426695|58998522|FG017|Overall Study|Lost to Follow-up|0|||
30951332|NCT04426695|58998505|FG000|Overall Study|Participant Decision|1|||
30951333|NCT04426695|58998506|FG001|Overall Study|Participant Decision|2|||
30951334|NCT04426695|58998507|FG002|Overall Study|Participant Decision|2|||
30951335|NCT04426695|58998508|FG003|Overall Study|Participant Decision|12|||
30951336|NCT04426695|58998509|FG004|Overall Study|Participant Decision|18|||
30951337|NCT04426695|58998510|FG005|Overall Study|Participant Decision|22|||
30951338|NCT04426695|58998511|FG006|Overall Study|Participant Decision|13|||
30951339|NCT04426695|58998512|FG007|Overall Study|Participant Decision|13|||
30951340|NCT04426695|58998513|FG008|Overall Study|Participant Decision|10|||
30951341|NCT04426695|58998514|FG009|Overall Study|Participant Decision|15|||
30951342|NCT04426695|58998515|FG010|Overall Study|Participant Decision|16|||
30951343|NCT04426695|58998516|FG011|Overall Study|Participant Decision|17|||
30951344|NCT04426695|58998517|FG012|Overall Study|Participant Decision|2|||
30951345|NCT04426695|58998518|FG013|Overall Study|Participant Decision|1|||
30951346|NCT04426695|58998519|FG014|Overall Study|Participant Decision|2|||
30951347|NCT04426695|58998520|FG015|Overall Study|Participant Decision|0|||
30951348|NCT04426695|58998521|FG016|Overall Study|Participant Decision|0|||
30951349|NCT04426695|58998522|FG017|Overall Study|Participant Decision|0|||
30951350|NCT04426695|58998505|FG000|Overall Study|Adverse Event|0|||
30951351|NCT04426695|58998506|FG001|Overall Study|Adverse Event|0|||
30951352|NCT04426695|58998507|FG002|Overall Study|Adverse Event|0|||
30951353|NCT04426695|58998508|FG003|Overall Study|Adverse Event|0|||
30951354|NCT04426695|58998509|FG004|Overall Study|Adverse Event|0|||
30951355|NCT04426695|58998510|FG005|Overall Study|Adverse Event|0|||
30951356|NCT04426695|58998511|FG006|Overall Study|Adverse Event|0|||
30951357|NCT04426695|58998512|FG007|Overall Study|Adverse Event|1|||
30951358|NCT04426695|58998513|FG008|Overall Study|Adverse Event|0|||
30951359|NCT04426695|58998514|FG009|Overall Study|Adverse Event|0|||
30951360|NCT04426695|58998515|FG010|Overall Study|Adverse Event|1|||
30951361|NCT04426695|58998516|FG011|Overall Study|Adverse Event|1|||
30951362|NCT04426695|58998517|FG012|Overall Study|Adverse Event|0|||
30951363|NCT04426695|58998518|FG013|Overall Study|Adverse Event|0|||
30951364|NCT04426695|58998519|FG014|Overall Study|Adverse Event|0|||
30951365|NCT04426695|58998520|FG015|Overall Study|Adverse Event|0|||
30951366|NCT04426695|58998521|FG016|Overall Study|Adverse Event|0|||
30636232|NCT02086448|58647996|FG001|Overall Study|Withdrawal by Subject|0|||
30636233|NCT02086448|58647997|FG002|Overall Study|Withdrawal by Subject|0|||
30636234|NCT02086448|58647998|FG003|Overall Study|Withdrawal by Subject|2|||
30636235|NCT01993836|58648011|FG000|Overall Study|Surgery Cancelled|3|||
30636236|NCT01993836|58648012|FG001|Overall Study|Surgery Cancelled|0|||
30636237|NCT01993836|58648013|FG002|Overall Study|Surgery Cancelled|0|||
30636238|NCT01993836|58648011|FG000|Overall Study|Physician Decision|2|||
30636239|NCT01993836|58648012|FG001|Overall Study|Physician Decision|1|||
30636240|NCT01993836|58648013|FG002|Overall Study|Physician Decision|0|||
30636241|NCT01993836|58648011|FG000|Overall Study|Death|0|||
30636242|NCT01993836|58648012|FG001|Overall Study|Death|2|||
30636243|NCT01993836|58648013|FG002|Overall Study|Death|0|||
30636244|NCT01993836|58648011|FG000|Overall Study|Withdrawal by Subject|12|||
30636245|NCT01993836|58648012|FG001|Overall Study|Withdrawal by Subject|10|||
30636246|NCT01993836|58648013|FG002|Overall Study|Withdrawal by Subject|5|||
30636247|NCT00753545|58648028|FG000|Overall Study|Death|98|||
30636248|NCT00753545|58648029|FG001|Overall Study|Death|112|||
30636249|NCT00753545|58648028|FG000|Overall Study|Lost to Follow-up|2|||
30636250|NCT00753545|58648029|FG001|Overall Study|Lost to Follow-up|3|||
30636251|NCT00753545|58648028|FG000|Overall Study|Protocol Violation|1|||
30636252|NCT00753545|58648029|FG001|Overall Study|Protocol Violation|0|||
30636253|NCT00753545|58648028|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
30636254|NCT00753545|58648029|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
30636255|NCT00278915|58648044|FG000|Overall Study|Lack of Efficacy|1|||
30636256|NCT00970632|58648051|FG000|Overall Study|Adverse Event|2|||
30636257|NCT00970632|58648052|FG001|Overall Study|Adverse Event|2|||
30636258|NCT00970632|58648053|FG002|Overall Study|Adverse Event|1|||
30636259|NCT00970632|58648051|FG000|Overall Study|Lack of Efficacy|3|||
30636260|NCT00970632|58648052|FG001|Overall Study|Lack of Efficacy|0|||
30636261|NCT00970632|58648053|FG002|Overall Study|Lack of Efficacy|0|||
30636262|NCT00970632|58648051|FG000|Overall Study|Lost to Follow-up|3|||
30636263|NCT00970632|58648052|FG001|Overall Study|Lost to Follow-up|0|||
30636264|NCT00970632|58648053|FG002|Overall Study|Lost to Follow-up|2|||
30636265|NCT00970632|58648051|FG000|Overall Study|Protocol Violation|8|||
30636266|NCT00970632|58648052|FG001|Overall Study|Protocol Violation|5|||
30636267|NCT00970632|58648053|FG002|Overall Study|Protocol Violation|8|||
30636268|NCT00970632|58648051|FG000|Overall Study|Withdrawal by Subject|7|||
30636269|NCT00970632|58648052|FG001|Overall Study|Withdrawal by Subject|6|||
30636270|NCT00970632|58648053|FG002|Overall Study|Withdrawal by Subject|4|||
30636271|NCT00970632|58648051|FG000|Overall Study|Entry criteria not met|0|||
30636272|NCT00970632|58648052|FG001|Overall Study|Entry criteria not met|2|||
30636273|NCT00970632|58648053|FG002|Overall Study|Entry criteria not met|2|||
30636274|NCT00970632|58648051|FG000|Overall Study|Sponsor decision|1|||
30636275|NCT00970632|58648052|FG001|Overall Study|Sponsor decision|0|||
30636276|NCT00970632|58648053|FG002|Overall Study|Sponsor decision|1|||
30636277|NCT01144364|58648063|FG000|Induction Phase|Disease progression|14|||
30636278|NCT01144364|58648064|FG001|Induction Phase|Disease progression|0|||
30636279|NCT01144364|58648065|FG002|Induction Phase|Disease progression|0|||
30636280|NCT01144364|58648063|FG000|Induction Phase|Adverse Event|9|||
30636281|NCT01144364|58648064|FG001|Induction Phase|Adverse Event|0|||
30636282|NCT01144364|58648065|FG002|Induction Phase|Adverse Event|0|||
30636283|NCT01144364|58648063|FG000|Induction Phase|Death|1|||
30636284|NCT01144364|58648064|FG001|Induction Phase|Death|0|||
30636285|NCT01144364|58648065|FG002|Induction Phase|Death|0|||
30636286|NCT01144364|58648063|FG000|Induction Phase|Withdrawal by Subject|1|||
30636287|NCT01144364|58648064|FG001|Induction Phase|Withdrawal by Subject|0|||
30848470|NCT03194646|58874572|FG002|Overall Study|Physician Decision|5|||
30636288|NCT01144364|58648065|FG002|Induction Phase|Withdrawal by Subject|0|||
30636289|NCT01144364|58648063|FG000|Induction Phase|Lost to Follow-up|2|||
30636290|NCT01144364|58648064|FG001|Induction Phase|Lost to Follow-up|0|||
30636291|NCT01144364|58648065|FG002|Induction Phase|Lost to Follow-up|0|||
30636292|NCT01144364|58648063|FG000|Induction Phase|Physician Decision|1|||
30636293|NCT01144364|58648064|FG001|Induction Phase|Physician Decision|0|||
30636294|NCT01144364|58648065|FG002|Induction Phase|Physician Decision|0|||
30636295|NCT01144364|58648063|FG000|Induction Phase|Stable disease|2|||
30636296|NCT01144364|58648064|FG001|Induction Phase|Stable disease|0|||
30636297|NCT01144364|58648065|FG002|Induction Phase|Stable disease|0|||
30636298|NCT01144364|58648063|FG000|Induction Phase|Secondary neoplasia|1|||
30636299|NCT01144364|58648064|FG001|Induction Phase|Secondary neoplasia|0|||
30636300|NCT01144364|58648065|FG002|Induction Phase|Secondary neoplasia|0|||
30636301|NCT01144364|58648063|FG000|Induction Phase|Protocol Violation|1|||
30636302|NCT01144364|58648064|FG001|Induction Phase|Protocol Violation|0|||
30636303|NCT01144364|58648065|FG002|Induction Phase|Protocol Violation|0|||
30636304|NCT01144364|58648063|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
30636305|NCT01144364|58648064|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
30636306|NCT01144364|58648065|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
30636307|NCT01144364|58648063|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
30636308|NCT01144364|58648064|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
30636309|NCT01144364|58648065|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
30636310|NCT01144364|58648063|FG000|Follow-Up/Maintenance Phase|Death|0|||
30636311|NCT01144364|58648064|FG001|Follow-Up/Maintenance Phase|Death|2|||
30636312|NCT01144364|58648065|FG002|Follow-Up/Maintenance Phase|Death|0|||
30636313|NCT01144364|58648063|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
30636314|NCT01144364|58648064|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
30636315|NCT01144364|58648065|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
30636316|NCT01144364|58648063|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
30636317|NCT01144364|58648064|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
30636318|NCT01144364|58648065|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
30636319|NCT01144364|58648063|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
30636320|NCT01144364|58648064|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
30636321|NCT01144364|58648065|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
30636322|NCT01144364|58648063|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
30636323|NCT01144364|58648064|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
30636324|NCT01144364|58648065|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
30636325|NCT01119248|58648075|FG000|Overall Study|Physician Decision|5|||
30636326|NCT01131494|58648080|FG000|Overall Study|Withdrawal by Subject|2|||
30636327|NCT01131260|58648087|FG000|Overall Study|Randomization error|5|||
30636328|NCT01131260|58648088|FG001|Overall Study|Randomization error|1|||
30636329|NCT01131260|58648087|FG000|Overall Study|Declined to continue participation|8|||
30636330|NCT01131260|58648088|FG001|Overall Study|Declined to continue participation|13|||
30636331|NCT01131260|58648087|FG000|Overall Study|Physician Decision|22|||
30636332|NCT01131260|58648088|FG001|Overall Study|Physician Decision|24|||
30636333|NCT01131260|58648087|FG000|Overall Study|Technical problems|7|||
30636334|NCT01131260|58648088|FG001|Overall Study|Technical problems|6|||
30636335|NCT01131260|58648087|FG000|Overall Study|Staff error|2|||
30636336|NCT01131260|58648088|FG001|Overall Study|Staff error|1|||
30636337|NCT01131260|58648087|FG000|Overall Study|Ineligible|0|||
30636338|NCT01131260|58648088|FG001|Overall Study|Ineligible|2|||
30636339|NCT00965094|58648098|FG000|Overall Study|Adverse Event|5|||
30636340|NCT00965094|58648099|FG001|Overall Study|Adverse Event|0|||
30636341|NCT00965094|58648098|FG000|Overall Study|Lost to Follow-up|0|||
30636342|NCT00965094|58648099|FG001|Overall Study|Lost to Follow-up|1|||
30636343|NCT01131182|58648108|FG000|Overall Study|Withdrawal by Subject|1|||
30636344|NCT01131182|58648109|FG001|Overall Study|Withdrawal by Subject|1|||
30636345|NCT01131182|58648108|FG000|Overall Study|Lost to Follow-up|14|||
30636346|NCT01131182|58648109|FG001|Overall Study|Lost to Follow-up|15|||
30636347|NCT01131182|58648108|FG000|Overall Study|Other Reason|1|||
30636348|NCT01131182|58648109|FG001|Overall Study|Other Reason|0|||
30636349|NCT00964860|58648117|FG000|Overall Study|Withdrawal by Subject|0|||
30636350|NCT00964860|58648118|FG001|Overall Study|Withdrawal by Subject|1|||
30636351|NCT01131104|58648124|FG000|Overall Study|Withdrawal by Subject|3|||
30636352|NCT01131104|58648124|FG000|Overall Study|Physician Decision|4|||
30636353|NCT01131104|58648124|FG000|Overall Study|Information Not Available|5|||
30636354|NCT01131104|58648124|FG000|Overall Study|No Information on Index Date of Onset|1|||
30636355|NCT01118780|58648130|FG000|Overall Study|Adverse Event|15|||
30636356|NCT01118780|58648131|FG001|Overall Study|Adverse Event|15|||
30636357|NCT01118780|58648130|FG000|Overall Study|Death|1|||
30636358|NCT01118780|58648131|FG001|Overall Study|Death|0|||
30636359|NCT01118780|58648130|FG000|Overall Study|Lack of Efficacy|2|||
30636360|NCT01118780|58648131|FG001|Overall Study|Lack of Efficacy|6|||
30636361|NCT01118780|58648130|FG000|Overall Study|Physician Decision|2|||
30636362|NCT01118780|58648131|FG001|Overall Study|Physician Decision|0|||
30636363|NCT01118780|58648130|FG000|Overall Study|Protocol Violation|3|||
30636364|NCT01118780|58648131|FG001|Overall Study|Protocol Violation|6|||
30636365|NCT01118780|58648130|FG000|Overall Study|Withdrawal by Subject|13|||
30636366|NCT01118780|58648131|FG001|Overall Study|Withdrawal by Subject|8|||
30765289|NCT03766646|58773958|FG001|Overall Study|Withdrawal by Subject|0|||
30636367|NCT00964782|58648142|FG000|Overall Study|Lost to Follow-up|1|||
30636368|NCT00964782|58648143|FG001|Overall Study|Lost to Follow-up|0|||
30636369|NCT00966654|58648151|FG000|Overall Study|Study was terminated,PI left institution|12|||
30636370|NCT03262116|58648163|FG000|Overall Study|Physician Decision|0|||
30636371|NCT03262116|58648164|FG001|Overall Study|Physician Decision|2|||
30636372|NCT03262116|58648165|FG002|Overall Study|Physician Decision|1|||
30636373|NCT03262116|58648166|FG003|Overall Study|Physician Decision|1|||
30636374|NCT03262116|58648167|FG004|Overall Study|Physician Decision|1|||
30636375|NCT03262116|58648168|FG005|Overall Study|Physician Decision|2|||
30636376|NCT01130168|58648176|FG000|Period 1|Withdrawal by Subject|0|||
30636377|NCT01130168|58648177|FG001|Period 1|Withdrawal by Subject|1|||
30636378|NCT01130168|58648178|FG002|Period 1|Withdrawal by Subject|0|||
30636379|NCT01130168|58648179|FG003|Period 1|Withdrawal by Subject|1|||
30636380|NCT01130168|58648180|FG004|Period 1|Withdrawal by Subject|0|||
30636381|NCT01130168|58648181|FG005|Period 1|Withdrawal by Subject|0|||
30636382|NCT01130168|58648176|FG000|Period 1|Discontinued For Other Reason|0|||
30636383|NCT01130168|58648177|FG001|Period 1|Discontinued For Other Reason|0|||
30636384|NCT01130168|58648178|FG002|Period 1|Discontinued For Other Reason|1|||
30636385|NCT01130168|58648179|FG003|Period 1|Discontinued For Other Reason|1|||
30636386|NCT01130168|58648180|FG004|Period 1|Discontinued For Other Reason|0|||
30636387|NCT01130168|58648181|FG005|Period 1|Discontinued For Other Reason|0|||
30636388|NCT01130168|58648176|FG000|Period 1|Adverse Event|0|||
30636389|NCT01130168|58648177|FG001|Period 1|Adverse Event|0|||
30636390|NCT01130168|58648178|FG002|Period 1|Adverse Event|0|||
30636391|NCT01130168|58648179|FG003|Period 1|Adverse Event|1|||
30636392|NCT01130168|58648180|FG004|Period 1|Adverse Event|0|||
30636393|NCT01130168|58648181|FG005|Period 1|Adverse Event|0|||
30636394|NCT01144052|58648192|FG000|Overall Study|Withdrawal by Subject|1|||
30636395|NCT01144052|58648193|FG001|Overall Study|Withdrawal by Subject|1|||
30636396|NCT01143896|58648203|FG000|Overall Study|Did not complete Baseline Interview|5|||
30636397|NCT01143896|58648204|FG001|Overall Study|Did not complete Baseline Interview|4|||
30636398|NCT01143896|58648203|FG000|Overall Study|Lost to Follow-up|18|||
30636399|NCT01143896|58648204|FG001|Overall Study|Lost to Follow-up|13|||
30636400|NCT01143896|58648203|FG000|Overall Study|Withdrawal by Subject|13|||
30636401|NCT01143896|58648204|FG001|Overall Study|Withdrawal by Subject|5|||
30636402|NCT01143896|58648203|FG000|Overall Study|Death|6|||
30636403|NCT01143896|58648204|FG001|Overall Study|Death|3|||
30636404|NCT01118312|58648213|FG000|Overall Study|Lost to Follow-up|33|||
30636405|NCT01118312|58648214|FG001|Overall Study|Lost to Follow-up|32|||
30636406|NCT01118312|58648213|FG000|Overall Study|Withdrawal by Subject|1|||
30636407|NCT01118312|58648214|FG001|Overall Study|Withdrawal by Subject|3|||
30636408|NCT01117766|58648220|FG000|First Intervention|Adverse Event|0|||
30636409|NCT01117766|58648221|FG001|First Intervention|Adverse Event|1|||
30636410|NCT01117766|58648220|FG000|First Intervention|Protocol Violation|1|||
30765290|NCT03766646|58773957|FG000|Overall Study|Protocol Violation|0|||
30765291|NCT03766646|58773958|FG001|Overall Study|Protocol Violation|3|||
30765292|NCT03765164|58773966|FG000|Pre-intervention|Withdrawal by Subject|5|||
30765293|NCT03765164|58773967|FG001|Pre-intervention|Withdrawal by Subject|6|||
30765294|NCT00369629|58773973|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
30765295|NCT00369629|58773974|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
30765296|NCT00369629|58773975|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
30765297|NCT00369629|58773976|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
30765298|NCT00369629|58773973|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
30765299|NCT00369629|58773974|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
30765300|NCT00369629|58773975|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
30765301|NCT00369629|58773976|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
30765302|NCT00369629|58773973|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
30765303|NCT00369629|58773974|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
30765304|NCT00369629|58773975|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
30765305|NCT00369629|58773976|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
30765306|NCT00369629|58773973|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
30765307|NCT00369629|58773974|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
30765308|NCT00369629|58773975|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
30765309|NCT00369629|58773976|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
30765310|NCT00369629|58773973|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
30636411|NCT01117766|58648221|FG001|First Intervention|Protocol Violation|0|||
30636412|NCT01117766|58648220|FG000|Washout Period|Protocol Violation|0|||
30636413|NCT01117766|58648221|FG001|Washout Period|Protocol Violation|2|||
30636414|NCT01117766|58648220|FG000|Second Intervention|Lost to Follow-up|1|||
30636415|NCT01117766|58648221|FG001|Second Intervention|Lost to Follow-up|0|||
30636416|NCT01117766|58648220|FG000|Second Intervention|Other|1|||
30636417|NCT01117766|58648221|FG001|Second Intervention|Other|2|||
30636418|NCT01117766|58648220|FG000|Second Intervention|Adverse Event|0|||
30765311|NCT00369629|58773974|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
30765312|NCT00369629|58773975|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
30765313|NCT00369629|58773976|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
30765314|NCT00369629|58773973|FG000|Completed 4 More Cycles|Progressive disease|2|||
30765315|NCT00369629|58773974|FG001|Completed 4 More Cycles|Progressive disease|1|||
30765316|NCT00369629|58773975|FG002|Completed 4 More Cycles|Progressive disease|2|||
30765317|NCT00369629|58773976|FG003|Completed 4 More Cycles|Progressive disease|0|||
30765318|NCT00369629|58773973|FG000|Follow up for 1 Year|Death|2|||
30765319|NCT00369629|58773974|FG001|Follow up for 1 Year|Death|1|||
30765320|NCT00369629|58773975|FG002|Follow up for 1 Year|Death|1|||
30765321|NCT00369629|58773976|FG003|Follow up for 1 Year|Death|0|||
30765322|NCT00369629|58773973|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
30765323|NCT00369629|58773974|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
30765324|NCT00369629|58773975|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
30765325|NCT00369629|58773976|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
30765326|NCT00369629|58773973|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
30765327|NCT00369629|58773974|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
30765328|NCT00369629|58773975|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
30765329|NCT00369629|58773976|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
30765330|NCT02469064|58773988|FG000|Overall Study|Request not to receive intervention.|1|||
30765331|NCT02469064|58773989|FG001|Overall Study|Request not to receive intervention.|3|||
30765332|NCT02446912|58773998|FG000|Overall Study|Adverse Event|3|||
30765333|NCT02446912|58773999|FG001|Overall Study|Adverse Event|13|||
30765334|NCT02446912|58774000|FG002|Overall Study|Adverse Event|5|||
30765335|NCT02446912|58773998|FG000|Overall Study|Condition under investigation worsened|0|||
30765336|NCT02446912|58773999|FG001|Overall Study|Condition under investigation worsened|1|||
30765337|NCT02446912|58774000|FG002|Overall Study|Condition under investigation worsened|1|||
30765338|NCT02446912|58773998|FG000|Overall Study|Study-specific withdrawal criteria|1|||
30765339|NCT02446912|58773999|FG001|Overall Study|Study-specific withdrawal criteria|0|||
30765340|NCT02446912|58774000|FG002|Overall Study|Study-specific withdrawal criteria|0|||
30765341|NCT02446912|58773998|FG000|Overall Study|Lack of Efficacy|1|||
30765342|NCT02446912|58773999|FG001|Overall Study|Lack of Efficacy|4|||
30765343|NCT02446912|58774000|FG002|Overall Study|Lack of Efficacy|7|||
30765344|NCT02446912|58773998|FG000|Overall Study|Lost to Follow-up|0|||
30765345|NCT02446912|58773999|FG001|Overall Study|Lost to Follow-up|0|||
30765346|NCT02446912|58774000|FG002|Overall Study|Lost to Follow-up|2|||
30951367|NCT04426695|58998522|FG017|Overall Study|Adverse Event|0|||
30951368|NCT04426695|58998505|FG000|Overall Study|Sponsor Request|0|||
30951369|NCT04426695|58998506|FG001|Overall Study|Sponsor Request|0|||
30951370|NCT04426695|58998507|FG002|Overall Study|Sponsor Request|0|||
30765347|NCT02446912|58773998|FG000|Overall Study|Severe non-compliance to protocol|1|||
30765348|NCT02446912|58773999|FG001|Overall Study|Severe non-compliance to protocol|0|||
30765349|NCT02446912|58774000|FG002|Overall Study|Severe non-compliance to protocol|1|||
30765350|NCT02446912|58773998|FG000|Overall Study|Withdrawal by Subject|10|||
30951371|NCT04426695|58998508|FG003|Overall Study|Sponsor Request|0|||
30636419|NCT01117766|58648221|FG001|Second Intervention|Adverse Event|2|||
30636420|NCT01117766|58648220|FG000|Second Intervention|Withdrawal by Subject|0|||
30636421|NCT01117766|58648221|FG001|Second Intervention|Withdrawal by Subject|1|||
30636422|NCT01117454|58648229|FG000|Overall Study|Pregnancy|0|||
30636423|NCT01117454|58648230|FG001|Overall Study|Pregnancy|1|||
30636424|NCT01116440|58648238|FG000|Treatment|Withdrawal by Subject|2|||
30636425|NCT01116440|58648239|FG001|Treatment|Withdrawal by Subject|2|||
30636426|NCT01116440|58648238|FG000|Treatment|Lost to Follow-up|1|||
30636427|NCT01116440|58648239|FG001|Treatment|Lost to Follow-up|1|||
30636428|NCT01116440|58648238|FG000|Treatment|Protocol Violation|0|||
30636429|NCT01116440|58648239|FG001|Treatment|Protocol Violation|2|||
30636430|NCT01116440|58648238|FG000|Treatment|Lack of Efficacy|0|||
30636431|NCT01116440|58648239|FG001|Treatment|Lack of Efficacy|1|||
30636432|NCT01116440|58648238|FG000|Treatment|Adverse Event|0|||
30951372|NCT04426695|58998509|FG004|Overall Study|Sponsor Request|0|||
30951373|NCT04426695|58998510|FG005|Overall Study|Sponsor Request|0|||
30636433|NCT01116440|58648239|FG001|Treatment|Adverse Event|1|||
30636434|NCT01116440|58648238|FG000|Withdrawal|Withdrawal by Subject|0|||
30636435|NCT01116440|58648239|FG001|Withdrawal|Withdrawal by Subject|1|||
30636436|NCT01116440|58648238|FG000|Withdrawal|Lost to Follow-up|0|||
30636437|NCT01116440|58648239|FG001|Withdrawal|Lost to Follow-up|1|||
30636438|NCT01116440|58648238|FG000|Follow-up|Lost to Follow-up|0|||
30636439|NCT01116440|58648239|FG001|Follow-up|Lost to Follow-up|1|||
30636440|NCT01116440|58648238|FG000|Follow-up|Withdrawal by Subject|0|||
30636441|NCT01116440|58648239|FG001|Follow-up|Withdrawal by Subject|1|||
30636442|NCT01129622|58648247|FG000|Overall Study|Withdrawal by Subject|2|||
30636443|NCT01128842|58648252|FG000|Overall Study|Adverse Event|1|||
30636444|NCT01128842|58648252|FG000|Overall Study|Disease Progression|6|||
30636445|NCT03624036|58648261|FG000|Overall Study|Still on Study|5|||
30636446|NCT03624036|58648262|FG001|Overall Study|Still on Study|1|||
30636447|NCT03624036|58648263|FG002|Overall Study|Still on Study|3|||
30636448|NCT03624036|58648264|FG003|Overall Study|Still on Study|3|||
30636449|NCT03624036|58648261|FG000|Overall Study|Death|1|||
30636450|NCT03624036|58648262|FG001|Overall Study|Death|2|||
30636451|NCT03624036|58648263|FG002|Overall Study|Death|0|||
30636452|NCT03624036|58648264|FG003|Overall Study|Death|0|||
30636453|NCT03624036|58648261|FG000|Overall Study|Enrolled but Never Treated|1|||
30636454|NCT03624036|58648262|FG001|Overall Study|Enrolled but Never Treated|0|||
30636455|NCT03624036|58648263|FG002|Overall Study|Enrolled but Never Treated|0|||
30636456|NCT03624036|58648264|FG003|Overall Study|Enrolled but Never Treated|0|||
30636457|NCT01143038|58648274|FG000|Overall Study|Withdrawal by Subject|4|||
30636458|NCT01143038|58648274|FG000|Overall Study|Requirement for alternative therapy|5|||
30636459|NCT01143038|58648274|FG000|Overall Study|Adverse Event|3|||
30636460|NCT01143038|58648274|FG000|Overall Study|Lost to Follow-up|2|||
30636461|NCT01143038|58648274|FG000|Overall Study|Protocol Deviation|1|||
30636462|NCT01143038|58648274|FG000|Overall Study|Death|1|||
30636463|NCT00966264|58648280|FG000|Overall Study|Lost to Follow-up|4|||
30636464|NCT00966264|58648281|FG001|Overall Study|Lost to Follow-up|3|||
30636465|NCT00915525|58648289|FG000|Overall Study|Protocol Violation|9|||
30636466|NCT00915525|58648290|FG001|Overall Study|Protocol Violation|4|||
30636467|NCT00915525|58648289|FG000|Overall Study|Withdrawal by Subject|59|||
30636468|NCT00915525|58648290|FG001|Overall Study|Withdrawal by Subject|21|||
30636469|NCT00915525|58648289|FG000|Overall Study|Lost to Follow-up|27|||
30636470|NCT00915525|58648290|FG001|Overall Study|Lost to Follow-up|16|||
30636471|NCT00915525|58648289|FG000|Overall Study|Pregnancy|2|||
30636472|NCT00915525|58648290|FG001|Overall Study|Pregnancy|0|||
30636473|NCT00915525|58648289|FG000|Overall Study|Lack of Efficacy|15|||
30636474|NCT00915525|58648290|FG001|Overall Study|Lack of Efficacy|32|||
30636475|NCT00915525|58648289|FG000|Overall Study|Adverse Event|29|||
30636476|NCT00915525|58648290|FG001|Overall Study|Adverse Event|13|||
30636477|NCT00915525|58648289|FG000|Overall Study|Missing|12|||
30636478|NCT00915525|58648290|FG001|Overall Study|Missing|1|||
30636479|NCT00915525|58648289|FG000|Overall Study|Other Reason|35|||
30636480|NCT00915525|58648290|FG001|Overall Study|Other Reason|12|||
30636481|NCT00915525|58648289|FG000|Overall Study|Site Closed|27|||
30636482|NCT00915525|58648290|FG001|Overall Study|Site Closed|9|||
30636483|NCT00915525|58648289|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
30636484|NCT00915525|58648290|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
30636485|NCT00915525|58648289|FG000|Overall Study|Study Burden|28|||
30636486|NCT00915525|58648290|FG001|Overall Study|Study Burden|12|||
30636487|NCT00915525|58648289|FG000|Overall Study|Non-Compliance|3|||
30636488|NCT00915525|58648290|FG001|Overall Study|Non-Compliance|1|||
30765351|NCT02446912|58773999|FG001|Overall Study|Withdrawal by Subject|15|||
30765352|NCT02446912|58774000|FG002|Overall Study|Withdrawal by Subject|15|||
30636489|NCT00915525|58648289|FG000|Overall Study|Patient Moved|15|||
30636490|NCT00915525|58648290|FG001|Overall Study|Patient Moved|9|||
30636491|NCT01074047|58648318|FG000|Treatment Phase|Adverse Event|89|||
30636492|NCT01074047|58648319|FG001|Treatment Phase|Adverse Event|66|||
30636493|NCT01074047|58648318|FG000|Treatment Phase|Disease Progression|16|||
30636494|NCT01074047|58648319|FG001|Treatment Phase|Disease Progression|21|||
30636495|NCT01074047|58648318|FG000|Treatment Phase|Withdrawal by Subject|27|||
30636496|NCT01074047|58648319|FG001|Treatment Phase|Withdrawal by Subject|48|||
30636497|NCT01074047|58648318|FG000|Treatment Phase|Death|53|||
30636498|NCT01074047|58648319|FG001|Treatment Phase|Death|58|||
30636499|NCT01074047|58648318|FG000|Treatment Phase|Lost to Follow-up|0|||
30636500|NCT01074047|58648319|FG001|Treatment Phase|Lost to Follow-up|1|||
30636501|NCT01074047|58648318|FG000|Treatment Phase|Protocol Violation|0|||
30636502|NCT01074047|58648319|FG001|Treatment Phase|Protocol Violation|1|||
30636503|NCT01074047|58648318|FG000|Treatment Phase|Miscellaneous|32|||
30636504|NCT01074047|58648319|FG001|Treatment Phase|Miscellaneous|39|||
30636505|NCT01074047|58648318|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
30636506|NCT01074047|58648319|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
30636507|NCT01074047|58648318|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
30636508|NCT01074047|58648319|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
30636509|NCT01074047|58648318|FG000|Survival Follow-Up Phase|Death|116|||
30636510|NCT01074047|58648319|FG001|Survival Follow-Up Phase|Death|124|||
30636511|NCT01074047|58648318|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
30636512|NCT01074047|58648319|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
30636513|NCT01074047|58648318|FG000|Extension Phase|Physician Decision|1|||
30636514|NCT01074047|58648319|FG001|Extension Phase|Physician Decision|0|||
30636515|NCT01074047|58648318|FG000|Extension Phase|Adverse Event|5|||
30636516|NCT01074047|58648319|FG001|Extension Phase|Adverse Event|0|||
30636517|NCT01074047|58648318|FG000|Extension Phase|Disease Progression|9|||
30636518|NCT01074047|58648319|FG001|Extension Phase|Disease Progression|0|||
30636519|NCT01074047|58648318|FG000|Extension Phase|Withdrawal by Subject|2|||
30636520|NCT01074047|58648319|FG001|Extension Phase|Withdrawal by Subject|0|||
30636521|NCT01074047|58648318|FG000|Extension Phase|Death|5|||
30636522|NCT01074047|58648319|FG001|Extension Phase|Death|0|||
30636523|NCT01142726|58648335|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
30636524|NCT01142726|58648336|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
30636525|NCT01142726|58648337|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
30636526|NCT01142726|58648335|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
30636527|NCT01142726|58648336|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
30636528|NCT01142726|58648337|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
30636529|NCT01142726|58648335|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
30636530|NCT01142726|58648336|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
30636531|NCT01142726|58648337|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
30636532|NCT01142726|58648335|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
30636533|NCT01142726|58648336|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
30636534|NCT01142726|58648337|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
30636535|NCT01142726|58648335|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
30636536|NCT01142726|58648336|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
30636537|NCT01142726|58648337|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
30636538|NCT01142726|58648335|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
30636539|NCT01142726|58648336|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
30636540|NCT01142726|58648337|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
30765353|NCT02446912|58773998|FG000|Overall Study|Miscellaneous|2|||
30765354|NCT02446912|58773999|FG001|Overall Study|Miscellaneous|2|||
30765355|NCT02446912|58774000|FG002|Overall Study|Miscellaneous|4|||
30765356|NCT00736840|58774008|FG000|Overall Study|Lost to Follow-up|13|||
30765357|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Adverse Event|11|||
30765358|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Adverse Event|23|||
30765359|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Adverse Event|29|||
30765360|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Adverse Event|2|||
30765361|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Adverse Event|8|||
30765362|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
30765363|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
30765364|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
30765365|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
30765366|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
30636541|NCT01142726|58648335|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
30636542|NCT01142726|58648336|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
30636543|NCT01142726|58648337|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
30636544|NCT01142726|58648335|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
30636545|NCT01142726|58648336|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
30636546|NCT01142726|58648337|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
30636547|NCT01142726|58648335|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
30636548|NCT01142726|58648336|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
30636549|NCT01142726|58648337|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
30636550|NCT01142726|58648335|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
30636551|NCT01142726|58648336|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
30636552|NCT01142726|58648337|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
30636553|NCT01142726|58648335|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
30636554|NCT01142726|58648336|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
30765367|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
30765368|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
30765369|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
30765370|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
30765371|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
30765372|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
30765373|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
30765374|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
30765375|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
30765376|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
30765377|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
30765378|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
30636555|NCT01142726|58648337|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
30636556|NCT01142726|58648335|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
30636557|NCT01142726|58648336|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
30636558|NCT01142726|58648337|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
30636559|NCT01142726|58648335|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
30636560|NCT01142726|58648336|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
30636561|NCT01142726|58648337|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
30636562|NCT01142726|58648335|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
30636563|NCT01142726|58648336|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
30636564|NCT01142726|58648337|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
30636565|NCT01142726|58648335|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
30636566|NCT01142726|58648336|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
30636567|NCT01142726|58648337|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
30636568|NCT01142726|58648335|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
30636569|NCT01142726|58648336|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
30636570|NCT01142726|58648337|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
30636571|NCT01073267|58648353|FG000|Overall Study|Disease Progression|3|||
30636572|NCT01142336|58648359|FG000|Overall Study|Adverse Event|1|||
30636573|NCT01142336|58648360|FG001|Overall Study|Adverse Event|1|||
30636574|NCT01142336|58648359|FG000|Overall Study|Lost to Follow-up|0|||
30636575|NCT01142336|58648360|FG001|Overall Study|Lost to Follow-up|1|||
30636576|NCT00915681|58648369|FG000|Overall Study|Screening failures|46|||
30636577|NCT01128296|58648373|FG000|Overall Study|Physician Decision|0|||
30636578|NCT01128296|58648374|FG001|Overall Study|Physician Decision|0|||
30636579|NCT01128296|58648375|FG002|Overall Study|Physician Decision|0|||
30636580|NCT01128296|58648376|FG003|Overall Study|Physician Decision|0|||
30636581|NCT01128296|58648377|FG004|Overall Study|Physician Decision|0|||
30636582|NCT01128296|58648378|FG005|Overall Study|Physician Decision|3|||
30636583|NCT01128296|58648373|FG000|Overall Study|Withdrawal by Subject|0|||
30636584|NCT01128296|58648374|FG001|Overall Study|Withdrawal by Subject|0|||
30636585|NCT01128296|58648375|FG002|Overall Study|Withdrawal by Subject|0|||
30636586|NCT01128296|58648376|FG003|Overall Study|Withdrawal by Subject|0|||
30636587|NCT01128296|58648377|FG004|Overall Study|Withdrawal by Subject|0|||
30636588|NCT01128296|58648378|FG005|Overall Study|Withdrawal by Subject|2|||
30636589|NCT01115738|58648392|FG000|Overall Study|Death|1|||
30636590|NCT01115738|58648393|FG001|Overall Study|Death|0|||
30636591|NCT01115738|58648394|FG002|Overall Study|Death|0|||
30636592|NCT01115738|58648392|FG000|Overall Study|Lost to Follow-up|0|||
30636593|NCT01115738|58648393|FG001|Overall Study|Lost to Follow-up|0|||
30636594|NCT01115738|58648394|FG002|Overall Study|Lost to Follow-up|1|||
30636595|NCT01115738|58648392|FG000|Overall Study|Physician Decision|18|||
30636596|NCT01115738|58648393|FG001|Overall Study|Physician Decision|15|||
30636597|NCT01115738|58648394|FG002|Overall Study|Physician Decision|17|||
30636598|NCT01115738|58648392|FG000|Overall Study|Withdrawal by Subject|6|||
30636599|NCT01115738|58648393|FG001|Overall Study|Withdrawal by Subject|6|||
30765379|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
30765380|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
30765381|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
30636600|NCT01115738|58648394|FG002|Overall Study|Withdrawal by Subject|9|||
30636601|NCT01141478|58648412|FG000|Overall Study|Withdrawal by Subject|1|||
30636602|NCT01141478|58648413|FG001|Overall Study|Withdrawal by Subject|1|||
30636603|NCT01114880|58648421|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
30636604|NCT01114880|58648422|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
30848471|NCT03194646|58874573|FG003|Overall Study|Physician Decision|4|||
30848472|NCT03194646|58874570|FG000|Overall Study|Pregnancy|4|||
30848473|NCT03194646|58874571|FG001|Overall Study|Pregnancy|5|||
30636605|NCT01114880|58648421|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
30636606|NCT01114880|58648422|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
30636607|NCT01114880|58648421|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
30636608|NCT01114880|58648422|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
30636609|NCT01114880|58648421|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
30636610|NCT01114880|58648422|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
30636611|NCT01114880|58648421|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
30636612|NCT01114880|58648422|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
30636613|NCT01114880|58648421|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
30636614|NCT01114880|58648422|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
30636615|NCT01114724|58648430|FG000|Overall Study|Death|8|||
30636616|NCT01114724|58648430|FG000|Overall Study|Lost to Follow-up|1|||
30636617|NCT01114724|58648430|FG000|Overall Study|Withdrawal by Subject|1|||
30636618|NCT00964392|58648437|FG000|Overall Study|Withdrawal by Subject|4|||
30636619|NCT00964392|58648438|FG001|Overall Study|Withdrawal by Subject|6|||
30636620|NCT00964392|58648437|FG000|Overall Study|Lost to Follow-up|4|||
30636621|NCT00964392|58648438|FG001|Overall Study|Lost to Follow-up|10|||
30636622|NCT00964392|58648437|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
30636623|NCT00964392|58648438|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
30636624|NCT00964392|58648437|FG000|Overall Study|Not completed|44|||
30636625|NCT00964392|58648438|FG001|Overall Study|Not completed|168|||
30951374|NCT04426695|58998511|FG006|Overall Study|Sponsor Request|1|||
30765382|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
30765383|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
30765384|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
30765385|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
30765386|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
30765387|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
30765388|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
30765389|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
30765390|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
30765391|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
30765392|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Move|0|||
30765393|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Move|1|||
30765394|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Move|0|||
30848474|NCT03194646|58874572|FG002|Overall Study|Pregnancy|1|||
30765395|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Move|0|||
30765396|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Move|0|||
30765397|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
30765398|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
30765399|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
30848475|NCT03194646|58874573|FG003|Overall Study|Pregnancy|2|||
30848476|NCT03194646|58874570|FG000|Overall Study|Protocol Violation|4|||
30848477|NCT03194646|58874571|FG001|Overall Study|Protocol Violation|2|||
30848478|NCT03194646|58874572|FG002|Overall Study|Protocol Violation|1|||
30848479|NCT03194646|58874573|FG003|Overall Study|Protocol Violation|1|||
30848480|NCT03194646|58874570|FG000|Overall Study|Site terminated by sponsor|0|||
30848481|NCT03194646|58874571|FG001|Overall Study|Site terminated by sponsor|0|||
30848482|NCT03194646|58874572|FG002|Overall Study|Site terminated by sponsor|2|||
30848483|NCT03194646|58874573|FG003|Overall Study|Site terminated by sponsor|0|||
30848484|NCT03194646|58874570|FG000|Overall Study|Study terminated by sponsor|60|||
30848485|NCT03194646|58874571|FG001|Overall Study|Study terminated by sponsor|61|||
30848486|NCT03194646|58874572|FG002|Overall Study|Study terminated by sponsor|30|||
30848487|NCT03194646|58874573|FG003|Overall Study|Study terminated by sponsor|34|||
30951375|NCT04426695|58998512|FG007|Overall Study|Sponsor Request|0|||
30951376|NCT04426695|58998513|FG008|Overall Study|Sponsor Request|0|||
30951377|NCT04426695|58998514|FG009|Overall Study|Sponsor Request|0|||
30636626|NCT00914589|58648447|FG000|Overall Study|Adverse Event|1|||
30848488|NCT03194646|58874570|FG000|Overall Study|Withdrawal by Subject|74|||
30848489|NCT03194646|58874571|FG001|Overall Study|Withdrawal by Subject|75|||
30951378|NCT04426695|58998515|FG010|Overall Study|Sponsor Request|0|||
30636627|NCT00914589|58648448|FG001|Overall Study|Adverse Event|0|||
30636628|NCT00914589|58648449|FG002|Overall Study|Adverse Event|1|||
30636629|NCT00914589|58648447|FG000|Overall Study|Protocol Violation|8|||
30636630|NCT00914589|58648448|FG001|Overall Study|Protocol Violation|6|||
30636631|NCT00914589|58648449|FG002|Overall Study|Protocol Violation|3|||
30636632|NCT00914589|58648447|FG000|Overall Study|unclassified|16|||
30636633|NCT00914589|58648448|FG001|Overall Study|unclassified|9|||
30636634|NCT00914589|58648449|FG002|Overall Study|unclassified|7|||
30636635|NCT00914589|58648447|FG000|Overall Study|Death|0|||
30636636|NCT00914589|58648448|FG001|Overall Study|Death|1|||
30636637|NCT00914589|58648449|FG002|Overall Study|Death|1|||
30636638|NCT00912405|58648457|FG000|Overall Study|Lost to Follow-up|5|||
30636639|NCT00878722|58648469|FG000|Overall Study|Progressive disease|3|||
30636640|NCT00878722|58648470|FG001|Overall Study|Progressive disease|3|||
30636641|NCT00878722|58648471|FG002|Overall Study|Progressive disease|3|||
30636642|NCT00878722|58648472|FG003|Overall Study|Progressive disease|7|||
30636643|NCT00878722|58648473|FG004|Overall Study|Progressive disease|7|||
30636644|NCT00878722|58648474|FG005|Overall Study|Progressive disease|1|||
30636645|NCT00878722|58648475|FG006|Overall Study|Progressive disease|4|||
30636646|NCT00878722|58648476|FG007|Overall Study|Progressive disease|3|||
30636647|NCT00878722|58648469|FG000|Overall Study|Death|0|||
30636648|NCT00878722|58648470|FG001|Overall Study|Death|0|||
30636649|NCT00878722|58648471|FG002|Overall Study|Death|0|||
30636650|NCT00878722|58648472|FG003|Overall Study|Death|1|||
30636651|NCT00878722|58648473|FG004|Overall Study|Death|0|||
30636652|NCT00878722|58648474|FG005|Overall Study|Death|1|||
30636653|NCT00878722|58648475|FG006|Overall Study|Death|0|||
30636654|NCT00878722|58648476|FG007|Overall Study|Death|2|||
30636655|NCT00878722|58648469|FG000|Overall Study|Adverse Event|0|||
30636656|NCT00878722|58648470|FG001|Overall Study|Adverse Event|0|||
30636657|NCT00878722|58648471|FG002|Overall Study|Adverse Event|0|||
30636658|NCT00878722|58648472|FG003|Overall Study|Adverse Event|0|||
30636659|NCT00878722|58648473|FG004|Overall Study|Adverse Event|0|||
30636660|NCT00878722|58648474|FG005|Overall Study|Adverse Event|0|||
30636661|NCT00878722|58648475|FG006|Overall Study|Adverse Event|2|||
30636662|NCT00878722|58648476|FG007|Overall Study|Adverse Event|0|||
30636663|NCT00878722|58648469|FG000|Overall Study|Withdrawal by Subject|0|||
30636664|NCT00878722|58648470|FG001|Overall Study|Withdrawal by Subject|0|||
30636665|NCT00878722|58648471|FG002|Overall Study|Withdrawal by Subject|0|||
30636666|NCT00878722|58648472|FG003|Overall Study|Withdrawal by Subject|0|||
30636667|NCT00878722|58648473|FG004|Overall Study|Withdrawal by Subject|0|||
30636668|NCT00878722|58648474|FG005|Overall Study|Withdrawal by Subject|0|||
30636669|NCT00878722|58648475|FG006|Overall Study|Withdrawal by Subject|0|||
30636670|NCT00878722|58648476|FG007|Overall Study|Withdrawal by Subject|2|||
30636671|NCT00878722|58648469|FG000|Overall Study|Relapse|0|||
30636672|NCT00878722|58648470|FG001|Overall Study|Relapse|0|||
30636673|NCT00878722|58648471|FG002|Overall Study|Relapse|0|||
30636674|NCT00878722|58648472|FG003|Overall Study|Relapse|1|||
30636675|NCT00878722|58648473|FG004|Overall Study|Relapse|0|||
30636676|NCT00878722|58648474|FG005|Overall Study|Relapse|0|||
30636677|NCT00878722|58648475|FG006|Overall Study|Relapse|0|||
30636678|NCT00878722|58648476|FG007|Overall Study|Relapse|0|||
30636679|NCT00964158|58648504|FG000|Overall Study|Lost to Follow-up|0|||
30636680|NCT00964158|58648505|FG001|Overall Study|Lost to Follow-up|1|||
30636681|NCT00964158|58648506|FG002|Overall Study|Lost to Follow-up|2|||
30636682|NCT00964158|58648504|FG000|Overall Study|Withdrawal by Subject|0|||
30636683|NCT00964158|58648505|FG001|Overall Study|Withdrawal by Subject|0|||
30636684|NCT00964158|58648506|FG002|Overall Study|Withdrawal by Subject|6|||
30636685|NCT00961350|58648519|FG000|Overall Study|Adverse Event|18|||
30636686|NCT00961350|58648520|FG001|Overall Study|Adverse Event|33|||
30636687|NCT00961350|58648519|FG000|Overall Study|Withdrawal by Subject|10|||
30765400|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
30636688|NCT00961350|58648520|FG001|Overall Study|Withdrawal by Subject|10|||
30636689|NCT00961350|58648519|FG000|Overall Study|Lost to Follow-up|3|||
30636690|NCT00961350|58648520|FG001|Overall Study|Lost to Follow-up|3|||
30636691|NCT00961350|58648519|FG000|Overall Study|Misc|16|||
30636692|NCT00961350|58648520|FG001|Overall Study|Misc|21|||
30636693|NCT00963924|58648528|FG000|Overall Study|Adverse Event|1|||
30636694|NCT00963924|58648529|FG001|Overall Study|Adverse Event|0|||
30636695|NCT00963924|58648528|FG000|Overall Study|Withdrawal by Subject|0|||
30636696|NCT00963924|58648529|FG001|Overall Study|Withdrawal by Subject|1|||
30636697|NCT00963924|58648528|FG000|Overall Study|Changed antipsychotic|0|||
30636698|NCT00963924|58648529|FG001|Overall Study|Changed antipsychotic|1|||
30636699|NCT00963924|58648528|FG000|Overall Study|Lost to Follow-up|0|||
30636700|NCT00963924|58648529|FG001|Overall Study|Lost to Follow-up|1|||
30636701|NCT03265665|58648539|FG000|24-week Data Collection|Withdrawal by Subject|2|||
30636702|NCT03265665|58648540|FG001|24-week Data Collection|Withdrawal by Subject|2|||
30636703|NCT03265665|58648539|FG000|24-week Data Collection|Lost to Follow-up|4|||
30636704|NCT03265665|58648540|FG001|24-week Data Collection|Lost to Follow-up|5|||
30636705|NCT03265665|58648539|FG000|36-week Data Collection|Lost to Follow-up|6|||
30636706|NCT03265665|58648540|FG001|36-week Data Collection|Lost to Follow-up|8|||
30636707|NCT01114646|58648550|FG000|Overall Study|Withdrawal by Subject|3|||
30636708|NCT01114646|58648551|FG001|Overall Study|Withdrawal by Subject|2|||
30636709|NCT00965562|58648560|FG000|Overall Study|Lost to Follow-up|1|||
30636710|NCT00965562|58648561|FG001|Overall Study|Lost to Follow-up|2|||
30636711|NCT00965562|58648562|FG002|Overall Study|Lost to Follow-up|3|||
30636712|NCT00965562|58648560|FG000|Overall Study|Withdrawal by Subject|2|||
30636713|NCT00965562|58648561|FG001|Overall Study|Withdrawal by Subject|2|||
30636714|NCT00965562|58648562|FG002|Overall Study|Withdrawal by Subject|0|||
30636715|NCT00912093|58648576|FG000|The Controlled Phase|Death|0|||
30951379|NCT04426695|58998516|FG011|Overall Study|Sponsor Request|0|||
30951380|NCT04426695|58998517|FG012|Overall Study|Sponsor Request|0|||
30951381|NCT04426695|58998518|FG013|Overall Study|Sponsor Request|0|||
30951382|NCT04426695|58998519|FG014|Overall Study|Sponsor Request|0|||
30951383|NCT04426695|58998520|FG015|Overall Study|Sponsor Request|0|||
30951384|NCT04426695|58998521|FG016|Overall Study|Sponsor Request|0|||
30951385|NCT04426695|58998522|FG017|Overall Study|Sponsor Request|0|||
30636716|NCT00912093|58648577|FG001|The Controlled Phase|Death|1|||
30636717|NCT00912093|58648578|FG002|The Controlled Phase|Death|0|||
30636718|NCT00912093|58648579|FG003|The Controlled Phase|Death|0|||
30636719|NCT00912093|58648580|FG004|The Controlled Phase|Death|0|||
30636720|NCT00912093|58648576|FG000|The Controlled Phase|Medical Condition|0|||
30636721|NCT00912093|58648577|FG001|The Controlled Phase|Medical Condition|1|||
30636722|NCT00912093|58648578|FG002|The Controlled Phase|Medical Condition|0|||
30636723|NCT00912093|58648579|FG003|The Controlled Phase|Medical Condition|0|||
30636724|NCT00912093|58648580|FG004|The Controlled Phase|Medical Condition|0|||
30636725|NCT00912093|58648576|FG000|The Controlled Phase|Lost to Follow-up|0|||
30636726|NCT00912093|58648577|FG001|The Controlled Phase|Lost to Follow-up|0|||
30636727|NCT00912093|58648578|FG002|The Controlled Phase|Lost to Follow-up|0|||
30636728|NCT00912093|58648579|FG003|The Controlled Phase|Lost to Follow-up|0|||
30636729|NCT00912093|58648580|FG004|The Controlled Phase|Lost to Follow-up|1|||
30636730|NCT00965484|58648588|FG000|Overall Study|Protocol Violation|1|||
30636731|NCT00965484|58648588|FG000|Overall Study|Withdrawal by Subject|1|||
30636732|NCT00961116|58648592|FG000|Washout Period of 7 Days|Adverse Event|1|||
30636733|NCT00961116|58648593|FG001|Washout Period of 7 Days|Adverse Event|1|||
30636734|NCT00961116|58648592|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
30636735|NCT00961116|58648593|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
30636736|NCT00961116|58648592|FG000|Washout Period of 7 Days|Protocol Violation|0|||
30636737|NCT00961116|58648593|FG001|Washout Period of 7 Days|Protocol Violation|1|||
30636738|NCT00912015|58648604|FG000|Overall Study|Lack of Efficacy|1|||
30636739|NCT00912015|58648605|FG001|Overall Study|Lack of Efficacy|0|||
30636740|NCT00912015|58648606|FG002|Overall Study|Lack of Efficacy|0|||
30636741|NCT00912015|58648607|FG003|Overall Study|Lack of Efficacy|0|||
30636742|NCT00912015|58648604|FG000|Overall Study|Withdrawal by Subject|8|||
30636743|NCT00912015|58648605|FG001|Overall Study|Withdrawal by Subject|8|||
30636744|NCT00912015|58648606|FG002|Overall Study|Withdrawal by Subject|3|||
30636745|NCT00912015|58648607|FG003|Overall Study|Withdrawal by Subject|0|||
30636746|NCT00912015|58648604|FG000|Overall Study|Protocol Violation|1|||
30636747|NCT00912015|58648605|FG001|Overall Study|Protocol Violation|0|||
30636748|NCT00912015|58648606|FG002|Overall Study|Protocol Violation|0|||
30636749|NCT00912015|58648607|FG003|Overall Study|Protocol Violation|1|||
30636750|NCT00912015|58648604|FG000|Overall Study|Adverse Event|6|||
30636751|NCT00912015|58648605|FG001|Overall Study|Adverse Event|0|||
30636752|NCT00912015|58648606|FG002|Overall Study|Adverse Event|0|||
30636753|NCT00912015|58648607|FG003|Overall Study|Adverse Event|1|||
30848490|NCT03194646|58874572|FG002|Overall Study|Withdrawal by Subject|36|||
30848491|NCT03194646|58874573|FG003|Overall Study|Withdrawal by Subject|131|||
30951386|NCT04426695|58998505|FG000|Overall Study|Physician Decision|0|||
30636754|NCT00960804|58648620|FG000|Overall Study|Adverse Event|1|||
30636755|NCT00960804|58648621|FG001|Overall Study|Adverse Event|0|||
30636756|NCT00960804|58648622|FG002|Overall Study|Adverse Event|0|||
30636757|NCT00960804|58648620|FG000|Overall Study|Withdrawal by Subject|1|||
30636758|NCT00960804|58648621|FG001|Overall Study|Withdrawal by Subject|0|||
30636759|NCT00960804|58648622|FG002|Overall Study|Withdrawal by Subject|0|||
30636760|NCT00960804|58648620|FG000|Overall Study|Study terminated by the sponsor|5|||
30636761|NCT00960804|58648621|FG001|Overall Study|Study terminated by the sponsor|4|||
30636762|NCT00960804|58648622|FG002|Overall Study|Study terminated by the sponsor|10|||
30636763|NCT01126580|58648633|FG000|Overall Study|Adverse Event|14|||
30636764|NCT01126580|58648634|FG001|Overall Study|Adverse Event|8|||
30636765|NCT01126580|58648635|FG002|Overall Study|Adverse Event|12|||
30636766|NCT01126580|58648633|FG000|Overall Study|Withdrawal by Subject|11|||
30951387|NCT04426695|58998506|FG001|Overall Study|Physician Decision|0|||
30636767|NCT01126580|58648634|FG001|Overall Study|Withdrawal by Subject|19|||
30636768|NCT01126580|58648635|FG002|Overall Study|Withdrawal by Subject|14|||
30636769|NCT01126580|58648633|FG000|Overall Study|Sponsor Decision|5|||
30636770|NCT01126580|58648634|FG001|Overall Study|Sponsor Decision|4|||
30951388|NCT04426695|58998507|FG002|Overall Study|Physician Decision|0|||
30951389|NCT04426695|58998508|FG003|Overall Study|Physician Decision|0|||
30951390|NCT04426695|58998509|FG004|Overall Study|Physician Decision|0|||
30636771|NCT01126580|58648635|FG002|Overall Study|Sponsor Decision|7|||
30636772|NCT01126580|58648633|FG000|Overall Study|Physician Decision|1|||
30636773|NCT01126580|58648634|FG001|Overall Study|Physician Decision|1|||
30636774|NCT01126580|58648635|FG002|Overall Study|Physician Decision|2|||
30636775|NCT01126580|58648633|FG000|Overall Study|Entry Criteria Not Met|1|||
30636776|NCT01126580|58648634|FG001|Overall Study|Entry Criteria Not Met|1|||
30636777|NCT01126580|58648635|FG002|Overall Study|Entry Criteria Not Met|2|||
30636778|NCT01126580|58648633|FG000|Overall Study|Lack of Efficacy|2|||
30636779|NCT01126580|58648634|FG001|Overall Study|Lack of Efficacy|3|||
30636780|NCT01126580|58648635|FG002|Overall Study|Lack of Efficacy|4|||
30636781|NCT01126580|58648633|FG000|Overall Study|Protocol Violation|0|||
30636782|NCT01126580|58648634|FG001|Overall Study|Protocol Violation|1|||
30636783|NCT01126580|58648635|FG002|Overall Study|Protocol Violation|2|||
30636784|NCT01126580|58648633|FG000|Overall Study|Lost to Follow-up|15|||
30636785|NCT01126580|58648634|FG001|Overall Study|Lost to Follow-up|13|||
30636786|NCT01126580|58648635|FG002|Overall Study|Lost to Follow-up|9|||
30636787|NCT01126580|58648633|FG000|Overall Study|Treatment Non-compliance|0|||
30636788|NCT01126580|58648634|FG001|Overall Study|Treatment Non-compliance|2|||
30636789|NCT01126580|58648635|FG002|Overall Study|Treatment Non-compliance|3|||
30636790|NCT00911157|58648646|FG000|Overall Study|Adverse Event|4|||
30636791|NCT00911157|58648647|FG001|Overall Study|Adverse Event|1|||
30636792|NCT00911157|58648646|FG000|Overall Study|Withdrawal by Subject|1|||
30636793|NCT00911157|58648647|FG001|Overall Study|Withdrawal by Subject|1|||
30636794|NCT00911157|58648646|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
30636795|NCT00911157|58648647|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
30636796|NCT00911157|58648646|FG000|Overall Study|Need to treat for lung cancer|1|||
30636797|NCT00911157|58648647|FG001|Overall Study|Need to treat for lung cancer|0|||
30636798|NCT00960570|58648653|FG000|21 Day Washout Period|Adverse Event|1|||
30636799|NCT00960570|58648653|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
30636800|NCT00960570|58648653|FG000|1 Day Period Between Dosing|Adverse Event|2|||
30636801|NCT00960570|58648653|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
30636802|NCT01126424|58648666|FG000|Overall Study|Adverse Event|0|||
30636803|NCT01126424|58648667|FG001|Overall Study|Adverse Event|0|||
30636804|NCT01126424|58648668|FG002|Overall Study|Adverse Event|0|||
30636805|NCT01126424|58648669|FG003|Overall Study|Adverse Event|0|||
30636806|NCT01126424|58648670|FG004|Overall Study|Adverse Event|1|||
30636807|NCT01126424|58648671|FG005|Overall Study|Adverse Event|0|||
30636808|NCT01126424|58648666|FG000|Overall Study|Withdrawal by Subject|0|||
30636809|NCT01126424|58648667|FG001|Overall Study|Withdrawal by Subject|0|||
30636810|NCT01126424|58648668|FG002|Overall Study|Withdrawal by Subject|1|||
30636811|NCT01126424|58648669|FG003|Overall Study|Withdrawal by Subject|3|||
30636812|NCT01126424|58648670|FG004|Overall Study|Withdrawal by Subject|1|||
30636813|NCT01126424|58648671|FG005|Overall Study|Withdrawal by Subject|0|||
30636814|NCT01126268|58648679|FG000|Overall Study|Adverse Event|1|||
30636815|NCT00879658|58648690|FG000|Overall Study|Abnormal laboratory value(s)|3|||
30636816|NCT00879658|58648691|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30636817|NCT00879658|58648692|FG002|Overall Study|Abnormal laboratory value(s)|0|||
30636818|NCT00879658|58648693|FG003|Overall Study|Abnormal laboratory value(s)|1|||
30636819|NCT00879658|58648694|FG004|Overall Study|Abnormal laboratory value(s)|0|||
30636820|NCT00879658|58648695|FG005|Overall Study|Abnormal laboratory value(s)|0|||
30636821|NCT00879658|58648696|FG006|Overall Study|Abnormal laboratory value(s)|0|||
30636822|NCT00879658|58648690|FG000|Overall Study|Administrative problems|2|||
30636823|NCT00879658|58648691|FG001|Overall Study|Administrative problems|1|||
30636824|NCT00879658|58648692|FG002|Overall Study|Administrative problems|0|||
30636825|NCT00879658|58648693|FG003|Overall Study|Administrative problems|1|||
30951391|NCT04426695|58998510|FG005|Overall Study|Physician Decision|0|||
30636826|NCT00879658|58648694|FG004|Overall Study|Administrative problems|0|||
30636827|NCT00879658|58648695|FG005|Overall Study|Administrative problems|0|||
30636828|NCT00879658|58648696|FG006|Overall Study|Administrative problems|0|||
30636829|NCT00879658|58648690|FG000|Overall Study|Adverse Event|6|||
30636830|NCT00879658|58648691|FG001|Overall Study|Adverse Event|4|||
30636831|NCT00879658|58648692|FG002|Overall Study|Adverse Event|3|||
30636832|NCT00879658|58648693|FG003|Overall Study|Adverse Event|1|||
30636833|NCT00879658|58648694|FG004|Overall Study|Adverse Event|2|||
30636834|NCT00879658|58648695|FG005|Overall Study|Adverse Event|0|||
30636835|NCT00879658|58648696|FG006|Overall Study|Adverse Event|0|||
30636836|NCT00879658|58648690|FG000|Overall Study|Protocol Violation|1|||
30636837|NCT00879658|58648691|FG001|Overall Study|Protocol Violation|0|||
30636838|NCT00879658|58648692|FG002|Overall Study|Protocol Violation|0|||
30636839|NCT00879658|58648693|FG003|Overall Study|Protocol Violation|0|||
30636840|NCT00879658|58648694|FG004|Overall Study|Protocol Violation|0|||
30636841|NCT00879658|58648695|FG005|Overall Study|Protocol Violation|0|||
30636842|NCT00879658|58648696|FG006|Overall Study|Protocol Violation|0|||
30636843|NCT00879658|58648690|FG000|Overall Study|Withdrawal by Subject|3|||
30636844|NCT00879658|58648691|FG001|Overall Study|Withdrawal by Subject|0|||
30636845|NCT00879658|58648692|FG002|Overall Study|Withdrawal by Subject|2|||
30636846|NCT00879658|58648693|FG003|Overall Study|Withdrawal by Subject|0|||
30636847|NCT00879658|58648694|FG004|Overall Study|Withdrawal by Subject|0|||
30636848|NCT00879658|58648695|FG005|Overall Study|Withdrawal by Subject|1|||
30636849|NCT00879658|58648696|FG006|Overall Study|Withdrawal by Subject|0|||
30636850|NCT00879658|58648690|FG000|Overall Study|Lack of Efficacy|0|||
30636851|NCT00879658|58648691|FG001|Overall Study|Lack of Efficacy|0|||
30636852|NCT00879658|58648692|FG002|Overall Study|Lack of Efficacy|2|||
30636853|NCT00879658|58648693|FG003|Overall Study|Lack of Efficacy|0|||
30636854|NCT00879658|58648694|FG004|Overall Study|Lack of Efficacy|0|||
30636855|NCT00879658|58648695|FG005|Overall Study|Lack of Efficacy|0|||
30636856|NCT00879658|58648696|FG006|Overall Study|Lack of Efficacy|0|||
30636857|NCT00879658|58648690|FG000|Overall Study|misrandomized (never received study med)|0|||
30636858|NCT00879658|58648691|FG001|Overall Study|misrandomized (never received study med)|0|||
30636859|NCT00879658|58648692|FG002|Overall Study|misrandomized (never received study med)|0|||
30636860|NCT00879658|58648693|FG003|Overall Study|misrandomized (never received study med)|1|||
30636861|NCT00879658|58648694|FG004|Overall Study|misrandomized (never received study med)|0|||
30636862|NCT00879658|58648695|FG005|Overall Study|misrandomized (never received study med)|0|||
30636863|NCT00879658|58648696|FG006|Overall Study|misrandomized (never received study med)|0|||
30636864|NCT00959946|58648726|FG000|Overall Study|Adverse Event|0|||
30636865|NCT00959946|58648727|FG001|Overall Study|Adverse Event|0|||
30636866|NCT00959946|58648728|FG002|Overall Study|Adverse Event|2|||
30636867|NCT00959946|58648729|FG003|Overall Study|Adverse Event|1|||
30636868|NCT00959946|58648730|FG004|Overall Study|Adverse Event|0|||
30636869|NCT00959946|58648731|FG005|Overall Study|Adverse Event|1|||
30636870|NCT00959946|58648732|FG006|Overall Study|Adverse Event|0|||
30636871|NCT00959946|58648733|FG007|Overall Study|Adverse Event|0|||
30636872|NCT00959946|58648726|FG000|Overall Study|Death|0|||
30636873|NCT00959946|58648727|FG001|Overall Study|Death|0|||
30636874|NCT00959946|58648728|FG002|Overall Study|Death|0|||
30636875|NCT00959946|58648729|FG003|Overall Study|Death|0|||
30636876|NCT00959946|58648730|FG004|Overall Study|Death|0|||
30636877|NCT00959946|58648731|FG005|Overall Study|Death|1|||
30636878|NCT00959946|58648732|FG006|Overall Study|Death|0|||
30636879|NCT00959946|58648733|FG007|Overall Study|Death|0|||
30636880|NCT00959946|58648726|FG000|Overall Study|Disease Progression|2|||
30636881|NCT00959946|58648727|FG001|Overall Study|Disease Progression|4|||
30636882|NCT00959946|58648728|FG002|Overall Study|Disease Progression|2|||
30636883|NCT00959946|58648729|FG003|Overall Study|Disease Progression|4|||
30636884|NCT00959946|58648730|FG004|Overall Study|Disease Progression|4|||
30848492|NCT03194646|58874570|FG000|Overall Study|Missing|4|||
30848493|NCT03194646|58874571|FG001|Overall Study|Missing|0|||
30848494|NCT03194646|58874572|FG002|Overall Study|Missing|1|||
30951392|NCT04426695|58998511|FG006|Overall Study|Physician Decision|0|||
30636885|NCT00959946|58648731|FG005|Overall Study|Disease Progression|6|||
30636886|NCT00959946|58648732|FG006|Overall Study|Disease Progression|2|||
30636887|NCT00959946|58648733|FG007|Overall Study|Disease Progression|2|||
30636888|NCT00959946|58648726|FG000|Overall Study|Withdrawal by Subject|0|||
30636889|NCT00959946|58648727|FG001|Overall Study|Withdrawal by Subject|0|||
30636890|NCT00959946|58648728|FG002|Overall Study|Withdrawal by Subject|0|||
30636891|NCT00959946|58648729|FG003|Overall Study|Withdrawal by Subject|0|||
30636892|NCT00959946|58648730|FG004|Overall Study|Withdrawal by Subject|0|||
30636893|NCT00959946|58648731|FG005|Overall Study|Withdrawal by Subject|1|||
30636894|NCT00959946|58648732|FG006|Overall Study|Withdrawal by Subject|0|||
30636895|NCT00959946|58648733|FG007|Overall Study|Withdrawal by Subject|0|||
30636896|NCT00911937|58648758|FG000|Overall Study|Death|1|||
30636897|NCT00911937|58648759|FG001|Overall Study|Death|0|||
30636898|NCT00911937|58648758|FG000|Overall Study|Lost to Follow-up|8|||
30636899|NCT00911937|58648759|FG001|Overall Study|Lost to Follow-up|5|||
30636900|NCT00911937|58648758|FG000|Overall Study|Withdrawal by Subject|10|||
30636901|NCT00911937|58648759|FG001|Overall Study|Withdrawal by Subject|7|||
30636902|NCT00911937|58648758|FG000|Overall Study|Withdrawn due to pregnancy|1|||
30636903|NCT00911937|58648759|FG001|Overall Study|Withdrawn due to pregnancy|0|||
30636904|NCT00911937|58648758|FG000|Overall Study|Adverse Event|11|||
30636905|NCT00911937|58648759|FG001|Overall Study|Adverse Event|25|||
30636906|NCT00911937|58648758|FG000|Overall Study|Lack of Efficacy|11|||
30636907|NCT00911937|58648759|FG001|Overall Study|Lack of Efficacy|6|||
30636908|NCT00911937|58648758|FG000|Overall Study|Did not meet inclusion criteria|9|||
30636909|NCT00911937|58648759|FG001|Overall Study|Did not meet inclusion criteria|11|||
30636910|NCT00911937|58648758|FG000|Overall Study|Protocol Violation|14|||
30636911|NCT00911937|58648759|FG001|Overall Study|Protocol Violation|23|||
30636912|NCT00911937|58648758|FG000|Overall Study|Randomized but not treated|13|||
30636913|NCT00911937|58648759|FG001|Overall Study|Randomized but not treated|13|||
30636914|NCT00911937|58648758|FG000|Overall Study|Other|9|||
30636915|NCT00911937|58648759|FG001|Overall Study|Other|5|||
30636916|NCT00880048|58648768|FG000|Overall Study|Adverse Event|2|||
30636917|NCT00880048|58648769|FG001|Overall Study|Adverse Event|3|||
30636918|NCT00880048|58648770|FG002|Overall Study|Adverse Event|5|||
30636919|NCT00880048|58648768|FG000|Overall Study|Lack of Efficacy|1|||
30636920|NCT00880048|58648769|FG001|Overall Study|Lack of Efficacy|2|||
30636921|NCT00880048|58648770|FG002|Overall Study|Lack of Efficacy|2|||
30636922|NCT00880048|58648768|FG000|Overall Study|Protocol Violation|4|||
30636923|NCT00880048|58648769|FG001|Overall Study|Protocol Violation|6|||
30636924|NCT00880048|58648770|FG002|Overall Study|Protocol Violation|5|||
30636925|NCT00880048|58648768|FG000|Overall Study|Lost to Follow-up|6|||
30636926|NCT00880048|58648769|FG001|Overall Study|Lost to Follow-up|6|||
30636927|NCT00880048|58648770|FG002|Overall Study|Lost to Follow-up|5|||
30636928|NCT00880048|58648768|FG000|Overall Study|Physician Decision|1|||
30636929|NCT00880048|58648769|FG001|Overall Study|Physician Decision|1|||
30636930|NCT00880048|58648770|FG002|Overall Study|Physician Decision|7|||
30636931|NCT00880048|58648768|FG000|Overall Study|Withdrawal by Subject|5|||
30636932|NCT00880048|58648769|FG001|Overall Study|Withdrawal by Subject|8|||
30636933|NCT00880048|58648770|FG002|Overall Study|Withdrawal by Subject|5|||
30636934|NCT00880048|58648768|FG000|Overall Study|Study closed/terminated|9|||
30636935|NCT00880048|58648769|FG001|Overall Study|Study closed/terminated|7|||
30636936|NCT00880048|58648770|FG002|Overall Study|Study closed/terminated|6|||
30636937|NCT00962208|58648780|FG000|Overall Study|Could not achieve good vision|9|||
30636938|NCT00962208|58648781|FG001|Overall Study|Could not achieve good vision|0|||
30636939|NCT00962208|58648780|FG000|Overall Study|Contraindicated to continue study|5|||
30636940|NCT00962208|58648781|FG001|Overall Study|Contraindicated to continue study|1|||
30636941|NCT00962208|58648780|FG000|Overall Study|Lost to Follow-up|0|||
30636942|NCT00962208|58648781|FG001|Overall Study|Lost to Follow-up|9|||
30636943|NCT01076543|58648793|FG000|Overall Study|Withdrawal by Subject|2|||
30636944|NCT01076543|58648794|FG001|Overall Study|Withdrawal by Subject|0|||
30636945|NCT01076543|58648795|FG002|Overall Study|Withdrawal by Subject|0|||
30636946|NCT01076543|58648796|FG003|Overall Study|Withdrawal by Subject|0|||
30636947|NCT01076543|58648797|FG004|Overall Study|Withdrawal by Subject|0|||
30636948|NCT01076543|58648798|FG005|Overall Study|Withdrawal by Subject|0|||
30636949|NCT01072877|58648818|FG000|Overall Study|Lost to Follow-up|1|||
30636950|NCT01072877|58648819|FG001|Overall Study|Lost to Follow-up|1|||
30636951|NCT01072877|58648820|FG002|Overall Study|Lost to Follow-up|0|||
30636952|NCT01072877|58648821|FG003|Overall Study|Lost to Follow-up|2|||
30636953|NCT01072877|58648822|FG004|Overall Study|Lost to Follow-up|0|||
30636954|NCT00961896|58648839|FG000|Overall Study|Abnormal laboratory value|0|||
30636955|NCT00961896|58648840|FG001|Overall Study|Abnormal laboratory value|0|||
30636956|NCT00961896|58648841|FG002|Overall Study|Abnormal laboratory value|1|||
30636957|NCT00957528|58648855|FG000|Overall Study|Protocol Violation|0|||
30636958|NCT00957528|58648856|FG001|Overall Study|Protocol Violation|1|||
30636959|NCT00957528|58648857|FG002|Overall Study|Protocol Violation|0|||
30636960|NCT00957528|58648855|FG000|Overall Study|Withdrawal by Subject|0|||
30636961|NCT00957528|58648856|FG001|Overall Study|Withdrawal by Subject|0|||
30636962|NCT00957528|58648857|FG002|Overall Study|Withdrawal by Subject|1|||
30636963|NCT00958776|58648867|FG000|Overall Study|Adverse Event|0|||
30636964|NCT00958776|58648868|FG001|Overall Study|Adverse Event|1|||
30636965|NCT00958776|58648867|FG000|Overall Study|Physician Decision|1|||
30636966|NCT00958776|58648868|FG001|Overall Study|Physician Decision|0|||
30636967|NCT00958776|58648867|FG000|Overall Study|Lost to Follow-up|2|||
30636968|NCT00958776|58648868|FG001|Overall Study|Lost to Follow-up|6|||
30636969|NCT00958776|58648867|FG000|Overall Study|Withdrawal by Subject|7|||
30636970|NCT00958776|58648868|FG001|Overall Study|Withdrawal by Subject|16|||
30636971|NCT00958776|58648867|FG000|Overall Study|Protocol Violation|1|||
30636972|NCT00958776|58648868|FG001|Overall Study|Protocol Violation|1|||
30636973|NCT00958776|58648867|FG000|Overall Study|Death|2|||
30636974|NCT00958776|58648868|FG001|Overall Study|Death|1|||
30636975|NCT00958776|58648867|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
30636976|NCT00958776|58648868|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
30636977|NCT00958776|58648867|FG000|Overall Study|Missing|1|||
30636978|NCT00958776|58648868|FG001|Overall Study|Missing|1|||
30636979|NCT00596830|58648877|FG000|Overall Study|Death|258|||
30636980|NCT00596830|58648878|FG001|Overall Study|Death|247|||
30636981|NCT00596830|58648877|FG000|Overall Study|Lost to Follow-up|7|||
30636982|NCT00596830|58648878|FG001|Overall Study|Lost to Follow-up|11|||
30636983|NCT00596830|58648877|FG000|Overall Study|Withdrawal by Subject|22|||
30636984|NCT00596830|58648878|FG001|Overall Study|Withdrawal by Subject|12|||
30636985|NCT00596830|58648877|FG000|Overall Study|Study terminated by sponsor|51|||
30636986|NCT00596830|58648878|FG001|Overall Study|Study terminated by sponsor|62|||
30636987|NCT00596830|58648877|FG000|Overall Study|Follow-up was discontinued|1|||
30636988|NCT00596830|58648878|FG001|Overall Study|Follow-up was discontinued|0|||
30636989|NCT00596830|58648877|FG000|Overall Study|Randomized but not treated|3|||
30636990|NCT00596830|58648878|FG001|Overall Study|Randomized but not treated|7|||
30636991|NCT00957372|58648887|FG000|PART I|Lost to Follow-up|0|||
30636992|NCT00957372|58648888|FG001|PART I|Lost to Follow-up|0|||
30636993|NCT00957372|58648889|FG002|PART I|Lost to Follow-up|1|||
30636994|NCT00957372|58648890|FG003|PART I|Lost to Follow-up|0|||
30636995|NCT00957372|58648887|FG000|PART II|Withdrawal by Subject|0|||
30636996|NCT00957372|58648888|FG001|PART II|Withdrawal by Subject|0|||
30636997|NCT00957372|58648889|FG002|PART II|Withdrawal by Subject|0|||
30636998|NCT00957372|58648890|FG003|PART II|Withdrawal by Subject|8|||
30636999|NCT00957372|58648887|FG000|PART II|Physician Decision|0|||
30637000|NCT00957372|58648888|FG001|PART II|Physician Decision|0|||
30637001|NCT00957372|58648889|FG002|PART II|Physician Decision|0|||
30637002|NCT00957372|58648890|FG003|PART II|Physician Decision|1|||
30637003|NCT00957372|58648887|FG000|PART II|Pregnancy|0|||
30637004|NCT00957372|58648888|FG001|PART II|Pregnancy|0|||
30637005|NCT00957372|58648889|FG002|PART II|Pregnancy|0|||
30637006|NCT00957372|58648890|FG003|PART II|Pregnancy|1|||
30637007|NCT00957372|58648887|FG000|PART II|Not Know|0|||
30637008|NCT00957372|58648888|FG001|PART II|Not Know|0|||
30637009|NCT00957372|58648889|FG002|PART II|Not Know|0|||
30637010|NCT00957372|58648890|FG003|PART II|Not Know|20|||
30637011|NCT00957372|58648887|FG000|PART II|Adverse Event|0|||
30637012|NCT00957372|58648888|FG001|PART II|Adverse Event|0|||
30637013|NCT00957372|58648889|FG002|PART II|Adverse Event|0|||
30637014|NCT00957372|58648890|FG003|PART II|Adverse Event|10|||
30637015|NCT00957372|58648887|FG000|PART II|Patient non-compliance|0|||
30637016|NCT00957372|58648888|FG001|PART II|Patient non-compliance|0|||
30637017|NCT00957372|58648889|FG002|PART II|Patient non-compliance|0|||
30637018|NCT00957372|58648890|FG003|PART II|Patient non-compliance|4|||
30637019|NCT00953160|58648906|FG000|Overall Study|Lost to Follow-up|23|||
30637020|NCT00953160|58648906|FG000|Overall Study|Withdrawal by Subject|4|||
30637021|NCT00952848|58648910|FG000|Overall Study|Withdrawal by Subject|4|||
30637022|NCT00952614|58648914|FG000|Overall Study|Death|3|||
30637023|NCT00952614|58648914|FG000|Overall Study|Lost to Follow-up|3|||
30637024|NCT00952614|58648914|FG000|Overall Study|other reason|1|||
30637025|NCT00911859|58648922|FG000|Treatment Period|Adverse Event|3|||
30637026|NCT00911859|58648923|FG001|Treatment Period|Adverse Event|3|||
30637027|NCT00911859|58648924|FG002|Treatment Period|Adverse Event|7|||
30637028|NCT00911859|58648922|FG000|Treatment Period|Death|1|||
30637029|NCT00911859|58648923|FG001|Treatment Period|Death|3|||
30637030|NCT00911859|58648924|FG002|Treatment Period|Death|5|||
30637031|NCT00911859|58648922|FG000|Treatment Period|Lack of Efficacy|1|||
30637032|NCT00911859|58648923|FG001|Treatment Period|Lack of Efficacy|7|||
30637033|NCT00911859|58648924|FG002|Treatment Period|Lack of Efficacy|5|||
30637034|NCT00911859|58648922|FG000|Treatment Period|Physician Decision|3|||
30637035|NCT00911859|58648923|FG001|Treatment Period|Physician Decision|3|||
30637036|NCT00911859|58648924|FG002|Treatment Period|Physician Decision|3|||
30637037|NCT00911859|58648922|FG000|Treatment Period|Withdrawal by Subject|0|||
30637038|NCT00911859|58648923|FG001|Treatment Period|Withdrawal by Subject|4|||
30637039|NCT00911859|58648924|FG002|Treatment Period|Withdrawal by Subject|5|||
30848495|NCT03194646|58874573|FG003|Overall Study|Missing|12|||
30848496|NCT03058146|58874607|FG000|Overall Study|Withdrawal by Subject|4|||
30637040|NCT00911859|58648922|FG000|Treatment Period|Did not receive study treatment|0|||
30637041|NCT00911859|58648923|FG001|Treatment Period|Did not receive study treatment|1|||
30637042|NCT00911859|58648924|FG002|Treatment Period|Did not receive study treatment|0|||
30637043|NCT00911859|58648922|FG000|Maintainance Period|Lack of Efficacy|0|||
30637044|NCT00911859|58648923|FG001|Maintainance Period|Lack of Efficacy|0|||
30637045|NCT00911859|58648924|FG002|Maintainance Period|Lack of Efficacy|9|||
30637046|NCT00911859|58648922|FG000|Maintainance Period|Physician Decision|0|||
30637047|NCT00911859|58648923|FG001|Maintainance Period|Physician Decision|0|||
30637048|NCT00911859|58648924|FG002|Maintainance Period|Physician Decision|9|||
30637049|NCT00911859|58648922|FG000|Maintainance Period|Withdrawal by Subject|0|||
30637050|NCT00911859|58648923|FG001|Maintainance Period|Withdrawal by Subject|0|||
30637051|NCT00911859|58648924|FG002|Maintainance Period|Withdrawal by Subject|3|||
30637052|NCT00911859|58648922|FG000|Follow-up Period|Death|5|||
30637053|NCT00911859|58648923|FG001|Follow-up Period|Death|8|||
30637054|NCT00911859|58648924|FG002|Follow-up Period|Death|10|||
30637055|NCT00911859|58648922|FG000|Follow-up Period|Lost to Follow-up|1|||
30637056|NCT00911859|58648923|FG001|Follow-up Period|Lost to Follow-up|1|||
30637057|NCT00911859|58648924|FG002|Follow-up Period|Lost to Follow-up|0|||
30637058|NCT00911859|58648922|FG000|Follow-up Period|Withdrawal by Subject|0|||
30637059|NCT00911859|58648923|FG001|Follow-up Period|Withdrawal by Subject|4|||
30637060|NCT00911859|58648924|FG002|Follow-up Period|Withdrawal by Subject|4|||
30637061|NCT00911859|58648922|FG000|Follow-up Period|Study terminated by sponsor|5|||
30637062|NCT00911859|58648923|FG001|Follow-up Period|Study terminated by sponsor|33|||
30637063|NCT00911859|58648924|FG002|Follow-up Period|Study terminated by sponsor|27|||
30637064|NCT00956592|58648934|FG000|Overall Study|Protocol Violation|1|||
30637065|NCT00956592|58648935|FG001|Overall Study|Protocol Violation|3|||
30637066|NCT02725593|58648945|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
30637067|NCT02725593|58648946|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
30637068|NCT02725593|58648945|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
30637069|NCT02725593|58648946|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
30637070|NCT02725593|58648945|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
30637071|NCT02725593|58648946|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
30637072|NCT02725593|58648945|FG000|Long Term Extension|Withdrawal by Subject|1|||
30637073|NCT02725593|58648946|FG001|Long Term Extension|Withdrawal by Subject|3|||
30637074|NCT00911625|58648954|FG000|Overall Study|Lost to Follow-up|7|||
30637075|NCT00911625|58648955|FG001|Overall Study|Lost to Follow-up|0|||
30637076|NCT00596752|58648963|FG000|Overall Study|Other Reason|44|||
30637077|NCT00596752|58648964|FG001|Overall Study|Other Reason|49|||
30637078|NCT00596752|58648963|FG000|Overall Study|Adverse Event|34|||
30637079|NCT00596752|58648964|FG001|Overall Study|Adverse Event|34|||
30637080|NCT00596752|58648963|FG000|Overall Study|Lost to Follow-up|22|||
30637081|NCT00596752|58648964|FG001|Overall Study|Lost to Follow-up|38|||
30637082|NCT00596752|58648963|FG000|Overall Study|Withdrawal by Subject|12|||
30637083|NCT00596752|58648964|FG001|Overall Study|Withdrawal by Subject|9|||
30637084|NCT00596752|58648963|FG000|Overall Study|Unsatisfactory Compliance|9|||
30637085|NCT00596752|58648964|FG001|Overall Study|Unsatisfactory Compliance|6|||
30637086|NCT00596752|58648963|FG000|Overall Study|Lack of Efficacy|4|||
30637087|NCT00596752|58648964|FG001|Overall Study|Lack of Efficacy|7|||
30637088|NCT00596752|58648963|FG000|Overall Study|Protocol Violation|1|||
30637089|NCT00596752|58648964|FG001|Overall Study|Protocol Violation|0|||
30637090|NCT00958074|58648972|FG000|Overall Study|Withdrawal by Subject|0|||
30637091|NCT00958074|58648973|FG001|Overall Study|Withdrawal by Subject|1|||
30637092|NCT00809965|58648982|FG000|Overall Study|Death|194|||
30637093|NCT00809965|58648983|FG001|Overall Study|Death|147|||
30637094|NCT00809965|58648984|FG002|Overall Study|Death|196|||
30765401|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
30765402|NCT00318461|58774017|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
30765403|NCT00318461|58774018|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
30765404|NCT00318461|58774019|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
30765405|NCT00318461|58774020|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
30765406|NCT00318461|58774021|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
30765407|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Work commitment|0|||
30765408|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Work commitment|0|||
30765409|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Work commitment|0|||
30765410|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Work commitment|0|||
30765411|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Work commitment|1|||
30765412|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Investigator decision|0|||
30765413|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Investigator decision|0|||
30765414|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Investigator decision|0|||
30765415|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Investigator decision|0|||
30765416|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Investigator decision|1|||
30765417|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Lack of time|1|||
30765418|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Lack of time|0|||
30765419|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Lack of time|0|||
30951393|NCT04426695|58998512|FG007|Overall Study|Physician Decision|0|||
30951394|NCT04426695|58998513|FG008|Overall Study|Physician Decision|0|||
30951395|NCT04426695|58998514|FG009|Overall Study|Physician Decision|1|||
30951396|NCT04426695|58998515|FG010|Overall Study|Physician Decision|0|||
30951397|NCT04426695|58998516|FG011|Overall Study|Physician Decision|0|||
30637095|NCT00809965|58648982|FG000|Overall Study|Lost to Follow-up|17|||
30637096|NCT00809965|58648983|FG001|Overall Study|Lost to Follow-up|10|||
30637097|NCT00809965|58648984|FG002|Overall Study|Lost to Follow-up|18|||
30637098|NCT00809965|58648982|FG000|Overall Study|Withdrawal by Subject|405|||
30637099|NCT00809965|58648983|FG001|Overall Study|Withdrawal by Subject|448|||
30637100|NCT00809965|58648984|FG002|Overall Study|Withdrawal by Subject|441|||
30637101|NCT00809965|58648982|FG000|Overall Study|Other Reason|167|||
30637102|NCT00809965|58648983|FG001|Overall Study|Other Reason|170|||
30637103|NCT00809965|58648984|FG002|Overall Study|Other Reason|189|||
30637104|NCT00597376|58648994|FG000|Overall Study|Withdrawal by Subject|4|||
30951398|NCT04426695|58998517|FG012|Overall Study|Physician Decision|1|||
30637105|NCT00597376|58648995|FG001|Overall Study|Withdrawal by Subject|3|||
30637106|NCT00597376|58648994|FG000|Overall Study|Adverse Event|4|||
30637107|NCT00597376|58648995|FG001|Overall Study|Adverse Event|1|||
30637108|NCT00910689|58649031|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
30637109|NCT00910689|58649032|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
30637110|NCT00910689|58649033|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
30637111|NCT00910689|58649034|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
30637112|NCT00910689|58649031|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
30637113|NCT00910689|58649032|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
30637114|NCT00910689|58649033|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
30637115|NCT00910689|58649034|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
30637116|NCT00910689|58649031|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
30637117|NCT00910689|58649032|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
30637118|NCT00910689|58649033|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
30637119|NCT00910689|58649034|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
30637120|NCT00910689|58649031|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
30637121|NCT00910689|58649032|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
30637122|NCT00910689|58649033|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
30637123|NCT00910689|58649034|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
30637124|NCT00910689|58649031|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
30637125|NCT00910689|58649032|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
30637126|NCT00910689|58649033|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
30637127|NCT00910689|58649034|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
30637128|NCT00910689|58649031|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
30637129|NCT00910689|58649032|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
30637130|NCT00910689|58649033|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
30637131|NCT00910689|58649034|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
30637132|NCT00910689|58649031|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
30637133|NCT00910689|58649032|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
30637134|NCT00910689|58649033|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
30637135|NCT00910689|58649034|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
30637136|NCT00910689|58649031|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
30637137|NCT00910689|58649032|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
30637138|NCT00910689|58649033|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
30637139|NCT00910689|58649034|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
30637140|NCT00910689|58649031|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
30637141|NCT00910689|58649032|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
30637142|NCT00910689|58649033|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
30637143|NCT00910689|58649034|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
30637144|NCT00910689|58649031|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
30637145|NCT00910689|58649032|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
30637146|NCT00910689|58649033|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
30637147|NCT00910689|58649034|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
30637148|NCT00910689|58649031|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
30637149|NCT00910689|58649032|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
30637150|NCT00910689|58649033|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
30637151|NCT00910689|58649034|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
30637152|NCT00910689|58649031|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
30637153|NCT00910689|58649032|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
30637154|NCT00910689|58649033|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
30637155|NCT00910689|58649034|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
30637156|NCT00910689|58649031|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
30637157|NCT00910689|58649032|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
30637158|NCT00910689|58649033|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
30637159|NCT00910689|58649034|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
30637160|NCT00910689|58649031|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
30637161|NCT00910689|58649032|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
30637162|NCT00910689|58649033|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
30637163|NCT00910689|58649034|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
30637164|NCT00910689|58649031|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
30637165|NCT00910689|58649032|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
30637166|NCT00910689|58649033|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
30951399|NCT04426695|58998518|FG013|Overall Study|Physician Decision|0|||
30637167|NCT00910689|58649034|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
30951400|NCT04426695|58998519|FG014|Overall Study|Physician Decision|0|||
30637168|NCT00910689|58649031|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
30637169|NCT00910689|58649032|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
30637170|NCT00910689|58649033|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
30637171|NCT00910689|58649034|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
30637172|NCT00910689|58649031|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
30637173|NCT00910689|58649032|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
30637174|NCT00910689|58649033|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
30637175|NCT00910689|58649034|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
30637176|NCT00910689|58649031|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
30637177|NCT00910689|58649032|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
30637178|NCT00910689|58649033|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
30637179|NCT00910689|58649034|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
30637180|NCT00910689|58649031|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
30637181|NCT00910689|58649032|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
30637182|NCT00910689|58649033|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
30637183|NCT00910689|58649034|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
30637184|NCT00910689|58649031|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
30637185|NCT00910689|58649032|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
30637186|NCT00910689|58649033|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
30637187|NCT00910689|58649034|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
30637188|NCT00910689|58649031|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
30637189|NCT00910689|58649032|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
30637190|NCT00910689|58649033|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
30637191|NCT00910689|58649034|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
30637192|NCT00807001|58649049|FG000|Overall Study|Non-compliance|0|||
30637193|NCT00807001|58649050|FG001|Overall Study|Non-compliance|1|||
30637194|NCT00807001|58649051|FG002|Overall Study|Non-compliance|0|||
30637195|NCT00807001|58649052|FG003|Overall Study|Non-compliance|0|||
30637196|NCT00807001|58649053|FG004|Overall Study|Non-compliance|0|||
30637197|NCT00809341|58649067|FG000|Overall Study|Physician Decision|0|||
30637198|NCT00809341|58649068|FG001|Overall Study|Physician Decision|1|||
30637199|NCT01125800|58649079|FG000|Phase I|Protocol Violation|0|||
30637200|NCT01125800|58649080|FG001|Phase I|Protocol Violation|3|||
30637201|NCT01125800|58649081|FG002|Phase I|Protocol Violation|1|||
30637202|NCT01125800|58649082|FG003|Phase I|Protocol Violation|1|||
30765420|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Lack of time|0|||
30765421|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Lack of time|0|||
30765422|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
30765423|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
30765424|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
30765425|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
30765426|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
30765427|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
30765428|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
30765429|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
30765430|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
30765431|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
30765432|NCT00318461|58774017|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
30765433|NCT00318461|58774018|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
30765434|NCT00318461|58774019|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
30765435|NCT00318461|58774020|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
30765436|NCT00318461|58774021|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
30765437|NCT00318461|58774017|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
30765438|NCT00318461|58774018|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
30765439|NCT00318461|58774019|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
30765440|NCT00318461|58774020|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
30765441|NCT00318461|58774021|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
30765442|NCT00318461|58774017|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
30765443|NCT00318461|58774018|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
30765444|NCT00318461|58774019|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
30765445|NCT00318461|58774020|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
30765446|NCT00318461|58774021|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
30765447|NCT00318461|58774017|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
30765448|NCT00318461|58774018|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
30765449|NCT00318461|58774019|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
30765450|NCT00318461|58774020|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
30765451|NCT00318461|58774021|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
30765452|NCT00318461|58774017|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
30765453|NCT00318461|58774018|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
30637203|NCT01125800|58649083|FG004|Phase I|Protocol Violation|0|||
30637204|NCT01125800|58649079|FG000|Phase I|Adverse Event|2|||
30637205|NCT01125800|58649080|FG001|Phase I|Adverse Event|2|||
30637206|NCT01125800|58649081|FG002|Phase I|Adverse Event|1|||
30637207|NCT01125800|58649082|FG003|Phase I|Adverse Event|7|||
30637208|NCT01125800|58649083|FG004|Phase I|Adverse Event|0|||
30637209|NCT01125800|58649079|FG000|Phase I|Administrative problems|1|||
30637210|NCT01125800|58649080|FG001|Phase I|Administrative problems|0|||
30637211|NCT01125800|58649081|FG002|Phase I|Administrative problems|0|||
30637212|NCT01125800|58649082|FG003|Phase I|Administrative problems|0|||
30637213|NCT01125800|58649083|FG004|Phase I|Administrative problems|0|||
30637214|NCT01125800|58649079|FG000|Phase I|Withdrawal by Subject|0|||
30637215|NCT01125800|58649080|FG001|Phase I|Withdrawal by Subject|0|||
30637216|NCT01125800|58649081|FG002|Phase I|Withdrawal by Subject|1|||
30637217|NCT01125800|58649082|FG003|Phase I|Withdrawal by Subject|0|||
30637218|NCT01125800|58649083|FG004|Phase I|Withdrawal by Subject|0|||
30637219|NCT01125800|58649079|FG000|Phase I|Disease progression|5|||
30637220|NCT01125800|58649080|FG001|Phase I|Disease progression|4|||
30637221|NCT01125800|58649081|FG002|Phase I|Disease progression|1|||
30637222|NCT01125800|58649082|FG003|Phase I|Disease progression|3|||
30637223|NCT01125800|58649083|FG004|Phase I|Disease progression|0|||
30637224|NCT01125800|58649079|FG000|Phase II|Protocol Violation|0|||
30637225|NCT01125800|58649080|FG001|Phase II|Protocol Violation|0|||
30637226|NCT01125800|58649081|FG002|Phase II|Protocol Violation|0|||
30637227|NCT01125800|58649082|FG003|Phase II|Protocol Violation|0|||
30637228|NCT01125800|58649083|FG004|Phase II|Protocol Violation|1|||
30637229|NCT01125800|58649079|FG000|Phase II|Adverse Event|0|||
30637230|NCT01125800|58649080|FG001|Phase II|Adverse Event|0|||
30637231|NCT01125800|58649081|FG002|Phase II|Adverse Event|0|||
30637232|NCT01125800|58649082|FG003|Phase II|Adverse Event|0|||
30637233|NCT01125800|58649083|FG004|Phase II|Adverse Event|2|||
30637234|NCT01125800|58649079|FG000|Phase II|Disease progression|0|||
30637235|NCT01125800|58649080|FG001|Phase II|Disease progression|0|||
30637236|NCT01125800|58649081|FG002|Phase II|Disease progression|0|||
30637237|NCT01125800|58649082|FG003|Phase II|Disease progression|1|||
30637238|NCT01125800|58649083|FG004|Phase II|Disease progression|8|||
30637239|NCT01125722|58649100|FG000|Overall Study|Withdrawal by Subject|2|||
30637240|NCT01125722|58649101|FG001|Overall Study|Withdrawal by Subject|1|||
30637241|NCT01125722|58649100|FG000|Overall Study|Lost to Follow-up|1|||
30637242|NCT01125722|58649101|FG001|Overall Study|Lost to Follow-up|0|||
30637243|NCT00811135|58649107|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
30637244|NCT00811135|58649107|FG000|Overall Study|Death|3|||
30637245|NCT00811135|58649107|FG000|Overall Study|Protocol Violation|2|||
30637246|NCT00811135|58649107|FG000|Overall Study|Violation of Selection Criteria|1|||
30637247|NCT00811135|58649107|FG000|Overall Study|Refused Treatment|1|||
30637248|NCT00811135|58649107|FG000|Overall Study|Withdrawal by Subject|3|||
30637249|NCT00811135|58649107|FG000|Overall Study|Administrative/Other Unspecified|11|||
30637250|NCT00811135|58649107|FG000|Overall Study|Ongoing|59|||
30637251|NCT00811057|58649114|FG000|Overall Study|Protocol Violation|5|||
30637252|NCT00811057|58649115|FG001|Overall Study|Protocol Violation|10|||
30637253|NCT00811057|58649116|FG002|Overall Study|Protocol Violation|10|||
30637254|NCT00879970|58649127|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
30637255|NCT00879970|58649128|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
30637256|NCT00879970|58649129|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
30637257|NCT00879970|58649130|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
30637258|NCT00879970|58649131|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
30637259|NCT00879970|58649127|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
30637260|NCT00879970|58649128|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
30637261|NCT00879970|58649129|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
30637262|NCT00879970|58649130|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
30637263|NCT00879970|58649131|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
30637264|NCT00879970|58649127|FG000|Period 1 TZD Randomization|Death|2|||
30637265|NCT00879970|58649128|FG001|Period 1 TZD Randomization|Death|1|||
30637266|NCT00879970|58649129|FG002|Period 1 TZD Randomization|Death|0|||
30637267|NCT00879970|58649130|FG003|Period 1 TZD Randomization|Death|0|||
30637268|NCT00879970|58649131|FG004|Period 1 TZD Randomization|Death|0|||
30637269|NCT00879970|58649127|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
30637270|NCT00879970|58649128|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
30637271|NCT00879970|58649129|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
30637272|NCT00879970|58649130|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
30637273|NCT00879970|58649131|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
30637274|NCT00879970|58649127|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
30637275|NCT00879970|58649128|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
30637276|NCT00879970|58649129|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
30637277|NCT00879970|58649130|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
30637278|NCT00879970|58649131|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
30637279|NCT00879970|58649127|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
30637280|NCT00879970|58649128|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
30637281|NCT00879970|58649129|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
30637282|NCT00879970|58649130|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
30637283|NCT00879970|58649131|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
30637284|NCT00879970|58649127|FG000|Period 2 Vitamin D Randomization|Death|0|||
30637285|NCT00879970|58649128|FG001|Period 2 Vitamin D Randomization|Death|0|||
30637286|NCT00879970|58649129|FG002|Period 2 Vitamin D Randomization|Death|0|||
30637287|NCT00879970|58649130|FG003|Period 2 Vitamin D Randomization|Death|2|||
30637288|NCT00879970|58649131|FG004|Period 2 Vitamin D Randomization|Death|0|||
30637289|NCT00808639|58649149|FG000|Overall Study|Disease progression before surgery.|1|||
30637290|NCT00810901|58649155|FG000|Overall Study|Lost to Follow-up|88|||
30637291|NCT00810901|58649156|FG001|Overall Study|Lost to Follow-up|58|||
30637292|NCT00910299|58649164|FG000|Overall Study|Withdrawal by Subject|16|||
30637293|NCT00910299|58649165|FG001|Overall Study|Withdrawal by Subject|13|||
30637294|NCT00910299|58649164|FG000|Overall Study|Sponsor Decision|58|||
30637295|NCT00910299|58649165|FG001|Overall Study|Sponsor Decision|60|||
30637296|NCT00910299|58649164|FG000|Overall Study|Didn't receive any study drug|2|||
30637297|NCT00910299|58649165|FG001|Overall Study|Didn't receive any study drug|1|||
30637298|NCT00595504|58649173|FG000|Overall Study|Withdrawal by Subject|1|||
30637299|NCT00595504|58649174|FG001|Overall Study|Withdrawal by Subject|3|||
30637300|NCT00595504|58649173|FG000|Overall Study|Physician Decision|1|||
30637301|NCT00595504|58649174|FG001|Overall Study|Physician Decision|0|||
30637302|NCT00808483|58649182|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
30637303|NCT00808483|58649183|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
30637304|NCT00808483|58649182|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
30637305|NCT00808483|58649183|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
30637306|NCT00808483|58649182|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
30637307|NCT00808483|58649183|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
30637308|NCT00810511|58649198|FG000|Overall Study|Protocol Violation|0|||
30637309|NCT00810511|58649199|FG001|Overall Study|Protocol Violation|1|||
30637310|NCT00810511|58649198|FG000|Overall Study|Lack of Efficacy|9|||
30637311|NCT00810511|58649199|FG001|Overall Study|Lack of Efficacy|1|||
30637312|NCT00810511|58649198|FG000|Overall Study|death in the family|0|||
30637313|NCT00810511|58649199|FG001|Overall Study|death in the family|1|||
30637314|NCT00810511|58649198|FG000|Overall Study|Lost to Follow-up|1|||
30637315|NCT00810511|58649199|FG001|Overall Study|Lost to Follow-up|0|||
30637316|NCT00810511|58649198|FG000|Overall Study|deposits on contact lens|0|||
30637317|NCT00810511|58649199|FG001|Overall Study|deposits on contact lens|1|||
30637318|NCT00596362|58649205|FG000|Overall Study|Progressive Disease|1|||
30637319|NCT00907803|58649212|FG000|Overall Study|Withdrawal of consent - long commute|1|||
30637320|NCT00907803|58649213|FG001|Overall Study|Withdrawal of consent - long commute|0|||
30637321|NCT00907803|58649214|FG002|Overall Study|Withdrawal of consent - long commute|0|||
30637322|NCT00907803|58649212|FG000|Overall Study|Adverse Event|2|||
30637323|NCT00907803|58649213|FG001|Overall Study|Adverse Event|0|||
30637324|NCT00907803|58649214|FG002|Overall Study|Adverse Event|0|||
30637325|NCT00907803|58649212|FG000|Overall Study|Withdrawal by Subject|0|||
30637326|NCT00907803|58649213|FG001|Overall Study|Withdrawal by Subject|1|||
30637327|NCT00907803|58649214|FG002|Overall Study|Withdrawal by Subject|0|||
30637328|NCT00907803|58649212|FG000|Overall Study|Lost to Follow-up|0|||
30637329|NCT00907803|58649213|FG001|Overall Study|Lost to Follow-up|1|||
30637330|NCT00907803|58649214|FG002|Overall Study|Lost to Follow-up|0|||
30637331|NCT00907803|58649212|FG000|Overall Study|Protocol Violation|0|||
30637332|NCT00907803|58649213|FG001|Overall Study|Protocol Violation|1|||
30637333|NCT00907803|58649214|FG002|Overall Study|Protocol Violation|0|||
30637334|NCT00808249|58649226|FG000|Overall Study|Adverse Event|4|||
30637335|NCT00808249|58649227|FG001|Overall Study|Adverse Event|7|||
30637336|NCT00808249|58649228|FG002|Overall Study|Adverse Event|10|||
30637337|NCT00808249|58649229|FG003|Overall Study|Adverse Event|6|||
30637338|NCT00808249|58649226|FG000|Overall Study|Lost to Follow-up|2|||
30637339|NCT00808249|58649227|FG001|Overall Study|Lost to Follow-up|3|||
30637340|NCT00808249|58649228|FG002|Overall Study|Lost to Follow-up|3|||
30637341|NCT00808249|58649229|FG003|Overall Study|Lost to Follow-up|5|||
30637342|NCT00808249|58649226|FG000|Overall Study|Withdrawal by Subject|4|||
30637343|NCT00808249|58649227|FG001|Overall Study|Withdrawal by Subject|0|||
30637344|NCT00808249|58649228|FG002|Overall Study|Withdrawal by Subject|2|||
30637345|NCT00808249|58649229|FG003|Overall Study|Withdrawal by Subject|4|||
30637346|NCT00808249|58649226|FG000|Overall Study|Protocol Violation|3|||
30637347|NCT00808249|58649227|FG001|Overall Study|Protocol Violation|3|||
30637348|NCT00808249|58649228|FG002|Overall Study|Protocol Violation|3|||
30637349|NCT00808249|58649229|FG003|Overall Study|Protocol Violation|0|||
30637350|NCT00808249|58649226|FG000|Overall Study|Lack of Efficacy|1|||
30637351|NCT00808249|58649227|FG001|Overall Study|Lack of Efficacy|1|||
30637352|NCT00808249|58649228|FG002|Overall Study|Lack of Efficacy|0|||
30637353|NCT00808249|58649229|FG003|Overall Study|Lack of Efficacy|0|||
30637354|NCT00808249|58649226|FG000|Overall Study|study specific discontinuation criteria|1|||
30637355|NCT00808249|58649227|FG001|Overall Study|study specific discontinuation criteria|0|||
30637356|NCT00808249|58649228|FG002|Overall Study|study specific discontinuation criteria|1|||
30637357|NCT00808249|58649229|FG003|Overall Study|study specific discontinuation criteria|0|||
30637358|NCT00808249|58649226|FG000|Overall Study|All other reasons|2|||
30637359|NCT00808249|58649227|FG001|Overall Study|All other reasons|1|||
30637360|NCT00808249|58649228|FG002|Overall Study|All other reasons|3|||
30637361|NCT00808249|58649229|FG003|Overall Study|All other reasons|1|||
30637362|NCT00908895|58649241|FG000|Overall Study|Lost to Follow-up|1|||
30637363|NCT00908895|58649242|FG001|Overall Study|Lost to Follow-up|3|||
30637364|NCT00908895|58649241|FG000|Overall Study|algodystrophy|2|||
30637365|NCT00908895|58649242|FG001|Overall Study|algodystrophy|2|||
30848497|NCT03058146|58874608|FG001|Overall Study|Withdrawal by Subject|1|||
30848498|NCT03058146|58874607|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
30848499|NCT03058146|58874608|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
30848500|NCT03004443|58874618|FG000|Overall Study|Pregnancy|0|||
30848501|NCT03004443|58874619|FG001|Overall Study|Pregnancy|1|||
30637366|NCT00908895|58649241|FG000|Overall Study|Adverse Event|1|||
30637367|NCT00908895|58649242|FG001|Overall Study|Adverse Event|1|||
30637368|NCT00591253|58649251|FG000|Overall Study|Adverse Event|3|||
30637369|NCT00591253|58649252|FG001|Overall Study|Adverse Event|3|||
30637370|NCT00591253|58649253|FG002|Overall Study|Adverse Event|1|||
30637371|NCT00591253|58649251|FG000|Overall Study|Protocol Violation|2|||
30637372|NCT00591253|58649252|FG001|Overall Study|Protocol Violation|2|||
30637373|NCT00591253|58649253|FG002|Overall Study|Protocol Violation|2|||
30637374|NCT00591253|58649251|FG000|Overall Study|Lost to Follow-up|2|||
30637375|NCT00591253|58649252|FG001|Overall Study|Lost to Follow-up|4|||
30637376|NCT00591253|58649253|FG002|Overall Study|Lost to Follow-up|0|||
30637377|NCT00591253|58649251|FG000|Overall Study|Withdrawal by Subject|1|||
30637378|NCT00591253|58649252|FG001|Overall Study|Withdrawal by Subject|7|||
30637379|NCT00591253|58649253|FG002|Overall Study|Withdrawal by Subject|6|||
30637380|NCT00591253|58649251|FG000|Overall Study|Lack of Efficacy|1|||
30637381|NCT00591253|58649252|FG001|Overall Study|Lack of Efficacy|0|||
30637382|NCT00591253|58649253|FG002|Overall Study|Lack of Efficacy|3|||
30637383|NCT00591253|58649251|FG000|Overall Study|Other|5|||
30637384|NCT00591253|58649252|FG001|Overall Study|Other|5|||
30637385|NCT00591253|58649253|FG002|Overall Study|Other|3|||
30637386|NCT00908583|58649261|FG000|Phase 1|Withdrawal by Subject|1|||
30637387|NCT00908583|58649261|FG000|Phase 1|Adverse Event|4|||
30637388|NCT00908583|58649261|FG000|Phase 2|Physician Decision|1|||
30637389|NCT00908583|58649261|FG000|Phase 2|Adverse Event|1|||
30637390|NCT00908583|58649261|FG000|Phase 3|Adverse Event|2|||
30637391|NCT00908583|58649261|FG000|Phase 4|Adverse Event|1|||
30637392|NCT00908583|58649261|FG000|Phase 4|Physician Decision|1|||
30637393|NCT00908583|58649261|FG000|Phase 5|Adverse Event|3|||
30637394|NCT00909363|58649282|FG000|Overall Study|Withdrawal by Subject|1|||
30637395|NCT00909363|58649283|FG001|Overall Study|Withdrawal by Subject|0|||
30637396|NCT00909363|58649284|FG002|Overall Study|Withdrawal by Subject|0|||
30637397|NCT00909363|58649282|FG000|Overall Study|Lack of Efficacy|1|||
30637398|NCT00909363|58649283|FG001|Overall Study|Lack of Efficacy|0|||
30637399|NCT00909363|58649284|FG002|Overall Study|Lack of Efficacy|0|||
30637400|NCT00810355|58649298|FG000|Overall Study|Lost to Follow-up|13|||
30637401|NCT00810355|58649299|FG001|Overall Study|Lost to Follow-up|17|||
30637402|NCT00810355|58649300|FG002|Overall Study|Lost to Follow-up|11|||
30637403|NCT00810355|58649298|FG000|Overall Study|Withdrawal by Subject|1|||
30637404|NCT00810355|58649299|FG001|Overall Study|Withdrawal by Subject|0|||
30637405|NCT00810355|58649300|FG002|Overall Study|Withdrawal by Subject|0|||
30637406|NCT00908349|58649308|FG000|Overall Study|Adverse Event|10|||
30637407|NCT00908349|58649308|FG000|Overall Study|Withdrawal by Subject|9|||
30637408|NCT00908349|58649308|FG000|Overall Study|Physician Decision|5|||
30637409|NCT00908349|58649308|FG000|Overall Study|Lost to Follow-up|5|||
30637410|NCT00908349|58649308|FG000|Overall Study|Various|6|||
30637411|NCT01125566|58649314|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
30637412|NCT01125566|58649315|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
30637413|NCT01125566|58649316|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
30637414|NCT01125566|58649314|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
30637415|NCT01125566|58649315|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
30637416|NCT01125566|58649316|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
30637417|NCT01125566|58649314|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
30848502|NCT02851511|58874629|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
30951401|NCT04426695|58998520|FG015|Overall Study|Physician Decision|0|||
30637418|NCT01125566|58649315|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
30637419|NCT01125566|58649316|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
30637420|NCT01125566|58649314|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
30637421|NCT01125566|58649315|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
30637422|NCT01125566|58649316|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
30637423|NCT01125566|58649314|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
30637424|NCT01125566|58649315|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
30637425|NCT01125566|58649316|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
30637426|NCT01125566|58649314|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
30637427|NCT01125566|58649315|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
30637428|NCT01125566|58649316|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
30637429|NCT01125566|58649314|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
30637430|NCT01125566|58649315|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
30637431|NCT01125566|58649316|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
30637432|NCT01125566|58649314|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
30637433|NCT01125566|58649315|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
30637434|NCT01125566|58649316|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
30637435|NCT01125566|58649314|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
30637436|NCT01125566|58649315|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
30637437|NCT01125566|58649316|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
30637438|NCT01125566|58649314|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
30637439|NCT01125566|58649315|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
30637440|NCT01125566|58649316|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
30637441|NCT01125566|58649314|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
30637442|NCT01125566|58649315|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
30637443|NCT01125566|58649316|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
30637444|NCT01125566|58649314|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
30637445|NCT01125566|58649315|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
30637446|NCT01125566|58649316|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
30637447|NCT00810277|58649323|FG000|Overall Study|Adverse Event|1|||
30637448|NCT00595582|58649327|FG000|Overall Study|Pilot study that PI terminated|2|||
30637449|NCT00595582|58649327|FG000|Overall Study|Lost to Follow-up|1|||
30637450|NCT00595582|58649327|FG000|Overall Study|Adverse Event|2|||
30637451|NCT00595582|58649327|FG000|Overall Study|Physician Decision|5|||
30637452|NCT00808015|58649331|FG000|Overall Study|Death|1|||
30637453|NCT00808015|58649331|FG000|Overall Study|Lack of Efficacy|58|||
30637454|NCT00808015|58649331|FG000|Overall Study|Lost to Follow-up|76|||
30637455|NCT00808015|58649331|FG000|Overall Study|Participants not willing to participate|158|||
30637456|NCT00808015|58649331|FG000|Overall Study|Adverse Event|22|||
30637457|NCT00808015|58649331|FG000|Overall Study|Other|25|||
30637458|NCT00808015|58649331|FG000|Overall Study|Enrolled but not treated|4|||
30637459|NCT00810199|58649337|FG000|Overall Study|Adverse Event|24|||
30637460|NCT00810199|58649338|FG001|Overall Study|Adverse Event|26|||
30637461|NCT00810199|58649337|FG000|Overall Study|Death|4|||
30637462|NCT00810199|58649338|FG001|Overall Study|Death|6|||
30637463|NCT00810199|58649337|FG000|Overall Study|Withdrew consent|9|||
30637464|NCT00810199|58649338|FG001|Overall Study|Withdrew consent|12|||
30637465|NCT00810199|58649337|FG000|Overall Study|Insufficient therapeutic response|5|||
30637466|NCT00810199|58649338|FG001|Overall Study|Insufficient therapeutic response|14|||
30637467|NCT00810199|58649337|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
30637468|NCT00810199|58649338|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
30637469|NCT00810199|58649337|FG000|Overall Study|Administrative/Other|5|||
30637470|NCT00810199|58649338|FG001|Overall Study|Administrative/Other|6|||
30637471|NCT00810199|58649337|FG000|Overall Study|Protocol Violation|2|||
30637472|NCT00810199|58649338|FG001|Overall Study|Protocol Violation|6|||
30637473|NCT00810199|58649337|FG000|Overall Study|Failure to return|1|||
30637474|NCT00810199|58649338|FG001|Overall Study|Failure to return|4|||
30637475|NCT00810199|58649337|FG000|Overall Study|Did not receive study drug|2|||
30637476|NCT00810199|58649338|FG001|Overall Study|Did not receive study drug|1|||
30637477|NCT00877006|58649352|FG000|Treatment Period|Death|2|||
30637478|NCT00877006|58649353|FG001|Treatment Period|Death|1|||
30637479|NCT00877006|58649352|FG000|Treatment Period|Adverse Event|10|||
30637480|NCT00877006|58649353|FG001|Treatment Period|Adverse Event|3|||
30637481|NCT00877006|58649352|FG000|Treatment Period|Withdrawal by Subject|2|||
30637482|NCT00877006|58649353|FG001|Treatment Period|Withdrawal by Subject|3|||
30637483|NCT00877006|58649352|FG000|Treatment Period|Protocol Violation|1|||
30637484|NCT00877006|58649353|FG001|Treatment Period|Protocol Violation|0|||
30637485|NCT00877006|58649352|FG000|Treatment Period|Lost to Follow-up|0|||
30637486|NCT00877006|58649353|FG001|Treatment Period|Lost to Follow-up|1|||
30637487|NCT00877006|58649352|FG000|Treatment Period|Disease Progression|1|||
30637488|NCT00877006|58649353|FG001|Treatment Period|Disease Progression|2|||
30637489|NCT00877006|58649352|FG000|Treatment Period|Started New Treatment Regimen|2|||
30637490|NCT00877006|58649353|FG001|Treatment Period|Started New Treatment Regimen|5|||
30637491|NCT00877006|58649352|FG000|Treatment Period|Other|4|||
30637492|NCT00877006|58649353|FG001|Treatment Period|Other|4|||
30637493|NCT00877006|58649352|FG000|Treatment Period|Randomized but Not Treated|3|||
30637494|NCT00877006|58649353|FG001|Treatment Period|Randomized but Not Treated|8|||
30637495|NCT00877006|58649352|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
30637496|NCT00877006|58649353|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
30637497|NCT00877006|58649352|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
30637498|NCT00877006|58649353|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
30637499|NCT00877006|58649352|FG000|Long-Term Follow-up Period|Death|26|||
30637500|NCT00877006|58649353|FG001|Long-Term Follow-up Period|Death|18|||
30637501|NCT00877006|58649352|FG000|Long-Term Follow-up Period|Other|7|||
30637502|NCT00877006|58649353|FG001|Long-Term Follow-up Period|Other|9|||
30637503|NCT00876928|58649363|FG000|Overall Study|Lost to Follow-up|2|||
30637504|NCT00876928|58649364|FG001|Overall Study|Lost to Follow-up|5|||
30637505|NCT00876928|58649363|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
30637506|NCT00876928|58649364|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
30637507|NCT00807937|58649374|FG000|Overall Study|Adverse Event|12|||
30637508|NCT00807937|58649375|FG001|Overall Study|Adverse Event|12|||
30637509|NCT00807937|58649376|FG002|Overall Study|Adverse Event|5|||
30637510|NCT00807937|58649377|FG003|Overall Study|Adverse Event|4|||
30637511|NCT00807937|58649374|FG000|Overall Study|Protocol Violation|4|||
30637512|NCT00807937|58649375|FG001|Overall Study|Protocol Violation|5|||
30637513|NCT00807937|58649376|FG002|Overall Study|Protocol Violation|3|||
30637514|NCT00807937|58649377|FG003|Overall Study|Protocol Violation|3|||
30637515|NCT00807937|58649374|FG000|Overall Study|Withdrawal by Subject|5|||
30637516|NCT00807937|58649375|FG001|Overall Study|Withdrawal by Subject|4|||
30637517|NCT00807937|58649376|FG002|Overall Study|Withdrawal by Subject|1|||
30637518|NCT00807937|58649377|FG003|Overall Study|Withdrawal by Subject|4|||
30637519|NCT00807937|58649374|FG000|Overall Study|Lost to Follow-up|4|||
30637520|NCT00807937|58649375|FG001|Overall Study|Lost to Follow-up|0|||
30637521|NCT00807937|58649376|FG002|Overall Study|Lost to Follow-up|2|||
30637522|NCT00807937|58649377|FG003|Overall Study|Lost to Follow-up|1|||
30637523|NCT00807937|58649374|FG000|Overall Study|Lack of Efficacy|0|||
30637524|NCT00807937|58649375|FG001|Overall Study|Lack of Efficacy|0|||
30637525|NCT00807937|58649376|FG002|Overall Study|Lack of Efficacy|1|||
30637526|NCT00807937|58649377|FG003|Overall Study|Lack of Efficacy|2|||
30637527|NCT00807937|58649374|FG000|Overall Study|Intake of prohibited medicine|0|||
30637528|NCT00807937|58649375|FG001|Overall Study|Intake of prohibited medicine|0|||
30637529|NCT00807937|58649376|FG002|Overall Study|Intake of prohibited medicine|2|||
30637530|NCT00807937|58649377|FG003|Overall Study|Intake of prohibited medicine|0|||
30637531|NCT00807937|58649374|FG000|Overall Study|All other reasons (not provided)|2|||
30951402|NCT04426695|58998521|FG016|Overall Study|Physician Decision|0|||
30951403|NCT04426695|58998522|FG017|Overall Study|Physician Decision|0|||
30951404|NCT04426695|58998505|FG000|Overall Study|Randomized but Never Treated|3|||
30951405|NCT04426695|58998506|FG001|Overall Study|Randomized but Never Treated|1|||
30951406|NCT04426695|58998507|FG002|Overall Study|Randomized but Never Treated|0|||
30951407|NCT04426695|58998508|FG003|Overall Study|Randomized but Never Treated|4|||
30951408|NCT04426695|58998509|FG004|Overall Study|Randomized but Never Treated|5|||
30951409|NCT04426695|58998510|FG005|Overall Study|Randomized but Never Treated|5|||
30951410|NCT04426695|58998511|FG006|Overall Study|Randomized but Never Treated|4|||
30951411|NCT04426695|58998512|FG007|Overall Study|Randomized but Never Treated|6|||
30951412|NCT04426695|58998513|FG008|Overall Study|Randomized but Never Treated|6|||
30951413|NCT04426695|58998514|FG009|Overall Study|Randomized but Never Treated|3|||
30951414|NCT04426695|58998515|FG010|Overall Study|Randomized but Never Treated|3|||
30951415|NCT04426695|58998516|FG011|Overall Study|Randomized but Never Treated|6|||
30951416|NCT04426695|58998517|FG012|Overall Study|Randomized but Never Treated|1|||
30951417|NCT04426695|58998518|FG013|Overall Study|Randomized but Never Treated|2|||
30637532|NCT00807937|58649375|FG001|Overall Study|All other reasons (not provided)|4|||
30637533|NCT00807937|58649376|FG002|Overall Study|All other reasons (not provided)|0|||
30637534|NCT00807937|58649377|FG003|Overall Study|All other reasons (not provided)|1|||
30637535|NCT00906945|58649392|FG000|Overall Study|Found to be not eligible|0|||
30637536|NCT00906945|58649393|FG001|Overall Study|Found to be not eligible|0|||
30637537|NCT00906945|58649394|FG002|Overall Study|Found to be not eligible|0|||
30637538|NCT00906945|58649395|FG003|Overall Study|Found to be not eligible|1|||
30951418|NCT04426695|58998519|FG014|Overall Study|Randomized but Never Treated|0|||
30637539|NCT00906945|58649396|FG004|Overall Study|Found to be not eligible|1|||
30637540|NCT00906945|58649397|FG005|Overall Study|Found to be not eligible|1|||
30637541|NCT00906945|58649392|FG000|Overall Study|Physician Decision|0|||
30637542|NCT00906945|58649393|FG001|Overall Study|Physician Decision|0|||
30637543|NCT00906945|58649394|FG002|Overall Study|Physician Decision|0|||
30637544|NCT00906945|58649395|FG003|Overall Study|Physician Decision|0|||
30637545|NCT00906945|58649396|FG004|Overall Study|Physician Decision|0|||
30637546|NCT00906945|58649397|FG005|Overall Study|Physician Decision|1|||
30637547|NCT00807235|58649415|FG000|Overall Study|Adverse Event|1|||
30637548|NCT00807235|58649416|FG001|Overall Study|Adverse Event|0|||
30637549|NCT00876694|58649424|FG000|Overall Study|Adverse Event|10|||
30637550|NCT00876694|58649425|FG001|Overall Study|Adverse Event|7|||
30637551|NCT00876694|58649424|FG000|Overall Study|Subject withdrew consent|6|||
30637552|NCT00876694|58649425|FG001|Overall Study|Subject withdrew consent|4|||
30637553|NCT00876694|58649424|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30637554|NCT00876694|58649425|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30637555|NCT00876694|58649424|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30637556|NCT00876694|58649425|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30637557|NCT00876694|58649424|FG000|Overall Study|Administrative problems|1|||
30637558|NCT00876694|58649425|FG001|Overall Study|Administrative problems|1|||
30637559|NCT00876694|58649424|FG000|Overall Study|Death|1|||
30637560|NCT00876694|58649425|FG001|Overall Study|Death|0|||
30637561|NCT00805441|58649433|FG000|Overall Study|Adverse Event|5|||
30637562|NCT00805441|58649434|FG001|Overall Study|Adverse Event|2|||
30637563|NCT00805441|58649433|FG000|Overall Study|Lack of Efficacy|0|||
30637564|NCT00805441|58649434|FG001|Overall Study|Lack of Efficacy|2|||
30637565|NCT00805441|58649433|FG000|Overall Study|Protocol Violation|4|||
30637566|NCT00805441|58649434|FG001|Overall Study|Protocol Violation|8|||
30637567|NCT00805441|58649433|FG000|Overall Study|Lost to Follow-up|10|||
30637568|NCT00805441|58649434|FG001|Overall Study|Lost to Follow-up|13|||
30637569|NCT00805441|58649433|FG000|Overall Study|Withdrawal by Subject|15|||
30637570|NCT00805441|58649434|FG001|Overall Study|Withdrawal by Subject|9|||
30637571|NCT00805441|58649433|FG000|Overall Study|Physician Decision|0|||
30637572|NCT00805441|58649434|FG001|Overall Study|Physician Decision|1|||
30637573|NCT00805441|58649433|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
30637574|NCT00805441|58649434|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
30637575|NCT00590317|58649442|FG000|Overall Study|Lack of Efficacy|1|||
30637576|NCT00590317|58649443|FG001|Overall Study|Lack of Efficacy|5|||
30637577|NCT01139762|58649452|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
30637578|NCT01139762|58649453|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
30637579|NCT01139762|58649454|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
30637580|NCT01139762|58649452|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
30637581|NCT01139762|58649453|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
30637582|NCT01139762|58649454|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
30637583|NCT01139762|58649452|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
30637584|NCT01139762|58649453|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
30637585|NCT01139762|58649454|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
30637586|NCT01139762|58649452|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
30637587|NCT01139762|58649453|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
30637588|NCT01139762|58649454|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
30637589|NCT01139762|58649452|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
30637590|NCT01139762|58649453|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
30637591|NCT01139762|58649454|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
30637592|NCT01139762|58649452|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
30637593|NCT01139762|58649453|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
30637594|NCT01139762|58649454|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
30637595|NCT01139762|58649452|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
30637596|NCT01139762|58649453|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
30637597|NCT01139762|58649454|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
30637598|NCT01139762|58649452|FG000|Double-Blind Randomized Active Treatment|Death|0|||
30637599|NCT01139762|58649453|FG001|Double-Blind Randomized Active Treatment|Death|1|||
30637600|NCT01139762|58649454|FG002|Double-Blind Randomized Active Treatment|Death|1|||
30637601|NCT01139762|58649452|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
30637602|NCT01139762|58649453|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
30637603|NCT01139762|58649454|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
30637604|NCT01139762|58649452|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
30637605|NCT01139762|58649453|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
30637606|NCT01139762|58649454|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
30637607|NCT01139762|58649452|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
30637608|NCT01139762|58649453|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
30637609|NCT01139762|58649454|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
30637610|NCT01139762|58649452|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
30637611|NCT01139762|58649453|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
30637612|NCT01139762|58649454|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
30637613|NCT01139762|58649452|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
30637614|NCT01139762|58649453|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
30637615|NCT01139762|58649454|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
30637616|NCT01139762|58649452|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
30637617|NCT01139762|58649453|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
30637618|NCT01139762|58649454|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
30637619|NCT01139762|58649452|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
30637620|NCT01139762|58649453|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
30637621|NCT01139762|58649454|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
30637622|NCT00805285|58649461|FG000|Overall Study|Lack of Efficacy|1|||
30637623|NCT01139450|58649468|FG000|Overall Study|Withdrawal by Subject|7|||
30637624|NCT01139450|58649469|FG001|Overall Study|Withdrawal by Subject|10|||
30637625|NCT01139450|58649470|FG002|Overall Study|Withdrawal by Subject|13|||
30637626|NCT01139450|58649468|FG000|Overall Study|Lack of Efficacy|3|||
30637627|NCT01139450|58649469|FG001|Overall Study|Lack of Efficacy|1|||
30637628|NCT01139450|58649470|FG002|Overall Study|Lack of Efficacy|8|||
30637629|NCT01139450|58649468|FG000|Overall Study|Protocol Violation|6|||
30637630|NCT01139450|58649469|FG001|Overall Study|Protocol Violation|5|||
30637631|NCT01139450|58649470|FG002|Overall Study|Protocol Violation|2|||
30637632|NCT01139450|58649468|FG000|Overall Study|Lost to Follow-up|9|||
30637633|NCT01139450|58649469|FG001|Overall Study|Lost to Follow-up|7|||
30637634|NCT01139450|58649470|FG002|Overall Study|Lost to Follow-up|11|||
30637635|NCT01139450|58649468|FG000|Overall Study|Administrative|0|||
30637636|NCT01139450|58649469|FG001|Overall Study|Administrative|0|||
30637637|NCT01139450|58649470|FG002|Overall Study|Administrative|1|||
30637638|NCT01139450|58649468|FG000|Overall Study|Adverse Event|2|||
30637639|NCT01139450|58649469|FG001|Overall Study|Adverse Event|2|||
30637640|NCT01139450|58649470|FG002|Overall Study|Adverse Event|3|||
30637641|NCT00805207|58649487|FG000|Overall Study|Protocol Violation|0|||
30637642|NCT00805207|58649488|FG001|Overall Study|Protocol Violation|0|||
30637643|NCT00805207|58649489|FG002|Overall Study|Protocol Violation|1|||
30637644|NCT00805207|58649490|FG003|Overall Study|Protocol Violation|0|||
30637645|NCT00805207|58649491|FG004|Overall Study|Protocol Violation|0|||
30637646|NCT00805207|58649492|FG005|Overall Study|Protocol Violation|0|||
30637647|NCT00805207|58649493|FG006|Overall Study|Protocol Violation|0|||
30637648|NCT00805207|58649494|FG007|Overall Study|Protocol Violation|0|||
30637649|NCT00805207|58649495|FG008|Overall Study|Protocol Violation|0|||
30637650|NCT00805207|58649487|FG000|Overall Study|Physician Decision|0|||
30637651|NCT00805207|58649488|FG001|Overall Study|Physician Decision|1|||
30637652|NCT00805207|58649489|FG002|Overall Study|Physician Decision|0|||
30637653|NCT00805207|58649490|FG003|Overall Study|Physician Decision|0|||
30637654|NCT00805207|58649491|FG004|Overall Study|Physician Decision|0|||
30637655|NCT00805207|58649492|FG005|Overall Study|Physician Decision|1|||
30637656|NCT00805207|58649493|FG006|Overall Study|Physician Decision|0|||
30637657|NCT00805207|58649494|FG007|Overall Study|Physician Decision|0|||
30637658|NCT00805207|58649495|FG008|Overall Study|Physician Decision|0|||
30637659|NCT00805207|58649487|FG000|Overall Study|Withdrawal by Subject|0|||
30637660|NCT00805207|58649488|FG001|Overall Study|Withdrawal by Subject|1|||
30637661|NCT00805207|58649489|FG002|Overall Study|Withdrawal by Subject|0|||
30637662|NCT00805207|58649490|FG003|Overall Study|Withdrawal by Subject|0|||
30637663|NCT00805207|58649491|FG004|Overall Study|Withdrawal by Subject|1|||
30637664|NCT00805207|58649492|FG005|Overall Study|Withdrawal by Subject|2|||
30637665|NCT00805207|58649493|FG006|Overall Study|Withdrawal by Subject|0|||
30637666|NCT00805207|58649494|FG007|Overall Study|Withdrawal by Subject|0|||
30637667|NCT00805207|58649495|FG008|Overall Study|Withdrawal by Subject|0|||
30637668|NCT00805675|58649522|FG000|Overall Study|Adverse Event|0|||
30637669|NCT00805675|58649523|FG001|Overall Study|Adverse Event|0|||
30637670|NCT00805675|58649524|FG002|Overall Study|Adverse Event|1|||
30637671|NCT00589303|58649538|FG000|Overall Study|Withdrawal by Subject|2|||
30637672|NCT00589303|58649539|FG001|Overall Study|Withdrawal by Subject|1|||
30637673|NCT00952380|58649550|FG000|Overall Study|Other|0|||
30637674|NCT00952380|58649551|FG001|Overall Study|Other|0|||
30637675|NCT00952380|58649552|FG002|Overall Study|Other|0|||
30637676|NCT00952380|58649553|FG003|Overall Study|Other|0|||
30637677|NCT00952380|58649554|FG004|Overall Study|Other|1|||
30637678|NCT00952380|58649550|FG000|Overall Study|Withdrawal by Subject|0|||
30637679|NCT00952380|58649551|FG001|Overall Study|Withdrawal by Subject|0|||
30637680|NCT00952380|58649552|FG002|Overall Study|Withdrawal by Subject|1|||
30637681|NCT00952380|58649553|FG003|Overall Study|Withdrawal by Subject|0|||
30637682|NCT00952380|58649554|FG004|Overall Study|Withdrawal by Subject|2|||
30637683|NCT00952380|58649550|FG000|Overall Study|Adverse Event|0|||
30637684|NCT00952380|58649551|FG001|Overall Study|Adverse Event|1|||
30637685|NCT00952380|58649552|FG002|Overall Study|Adverse Event|0|||
30637686|NCT00952380|58649553|FG003|Overall Study|Adverse Event|0|||
30637687|NCT00952380|58649554|FG004|Overall Study|Adverse Event|3|||
30637688|NCT00952380|58649550|FG000|Overall Study|Physician Decision|0|||
30637689|NCT00952380|58649551|FG001|Overall Study|Physician Decision|0|||
30637690|NCT00952380|58649552|FG002|Overall Study|Physician Decision|1|||
30637691|NCT00952380|58649553|FG003|Overall Study|Physician Decision|2|||
30637692|NCT00952380|58649554|FG004|Overall Study|Physician Decision|0|||
30637693|NCT00952380|58649550|FG000|Overall Study|Non-compliant to protocol|0|||
30637694|NCT00952380|58649551|FG001|Overall Study|Non-compliant to protocol|0|||
30637695|NCT00952380|58649552|FG002|Overall Study|Non-compliant to protocol|0|||
30637696|NCT00952380|58649553|FG003|Overall Study|Non-compliant to protocol|1|||
30637697|NCT00952380|58649554|FG004|Overall Study|Non-compliant to protocol|0|||
30637698|NCT00803179|58649571|FG000|Overall Study|Lost to Follow-up|3|||
30637699|NCT00804193|58649578|FG000|Overall Study|Lack of baseline fungus|32|||
30637700|NCT00804193|58649579|FG001|Overall Study|Lack of baseline fungus|31|||
30637701|NCT00804193|58649580|FG002|Overall Study|Lack of baseline fungus|19|||
30637702|NCT00804193|58649578|FG000|Overall Study|Adverse Event|0|||
30637703|NCT00804193|58649579|FG001|Overall Study|Adverse Event|0|||
30637704|NCT00804193|58649580|FG002|Overall Study|Adverse Event|2|||
30637705|NCT00804193|58649578|FG000|Overall Study|Lack of Efficacy|1|||
30637706|NCT00804193|58649579|FG001|Overall Study|Lack of Efficacy|1|||
30637707|NCT00804193|58649580|FG002|Overall Study|Lack of Efficacy|3|||
30637708|NCT00804193|58649578|FG000|Overall Study|Protocol Violation|0|||
30637709|NCT00804193|58649579|FG001|Overall Study|Protocol Violation|8|||
30637710|NCT00804193|58649580|FG002|Overall Study|Protocol Violation|2|||
30637711|NCT00804193|58649578|FG000|Overall Study|Lost to Follow-up|3|||
30637712|NCT00804193|58649579|FG001|Overall Study|Lost to Follow-up|3|||
30637713|NCT00804193|58649580|FG002|Overall Study|Lost to Follow-up|4|||
30637714|NCT00804193|58649578|FG000|Overall Study|Withdrawal by Subject|3|||
30637715|NCT00804193|58649579|FG001|Overall Study|Withdrawal by Subject|1|||
30637716|NCT00804193|58649580|FG002|Overall Study|Withdrawal by Subject|2|||
30637717|NCT00957996|58649590|FG000|Overall Study|Death|4|||
30637718|NCT00957996|58649591|FG001|Overall Study|Death|10|||
30637719|NCT00957996|58649590|FG000|Overall Study|Lost to Follow-up|4|||
30637720|NCT00957996|58649591|FG001|Overall Study|Lost to Follow-up|7|||
30637721|NCT00957996|58649590|FG000|Overall Study|Withdrawal by Subject|9|||
30637722|NCT00957996|58649591|FG001|Overall Study|Withdrawal by Subject|2|||
30637723|NCT00957996|58649590|FG000|Overall Study|Adverse Event|2|||
30637724|NCT00957996|58649591|FG001|Overall Study|Adverse Event|1|||
30637725|NCT00957996|58649590|FG000|Overall Study|Physician Decision|1|||
30637726|NCT00957996|58649591|FG001|Overall Study|Physician Decision|1|||
30637727|NCT00957996|58649590|FG000|Overall Study|Influenza-related complication|0|||
30637728|NCT00957996|58649591|FG001|Overall Study|Influenza-related complication|1|||
30637729|NCT00957996|58649590|FG000|Overall Study|Missing|1|||
30637730|NCT00957996|58649591|FG001|Overall Study|Missing|0|||
30637731|NCT00957996|58649590|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
30637732|NCT00957996|58649591|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
30637733|NCT00589693|58649601|FG000|Overall Study|randomized in error|12|||
30637734|NCT00589693|58649602|FG001|Overall Study|randomized in error|6|||
30637735|NCT00589693|58649601|FG000|Overall Study|Adverse Event|4|||
30637736|NCT00589693|58649602|FG001|Overall Study|Adverse Event|4|||
30637737|NCT00589693|58649601|FG000|Overall Study|Death|26|||
30637738|NCT00589693|58649602|FG001|Overall Study|Death|16|||
30637739|NCT00589693|58649601|FG000|Overall Study|Lack of Efficacy|0|||
30637740|NCT00589693|58649602|FG001|Overall Study|Lack of Efficacy|1|||
30637741|NCT00589693|58649601|FG000|Overall Study|Lost to Follow-up|1|||
30637742|NCT00589693|58649602|FG001|Overall Study|Lost to Follow-up|0|||
30637743|NCT00589693|58649601|FG000|Overall Study|Physician Decision|0|||
30637744|NCT00589693|58649602|FG001|Overall Study|Physician Decision|1|||
30637745|NCT00589693|58649601|FG000|Overall Study|Protocol Violation|1|||
30637746|NCT00589693|58649602|FG001|Overall Study|Protocol Violation|1|||
30637747|NCT00803101|58649610|FG000|Overall Study|Death / Serious Adverse Event|4|||
30637748|NCT00803101|58649611|FG001|Overall Study|Death / Serious Adverse Event|6|||
30637749|NCT00803101|58649610|FG000|Overall Study|Withdrawal by Subject|6|||
30637750|NCT00803101|58649611|FG001|Overall Study|Withdrawal by Subject|4|||
30637751|NCT00803101|58649610|FG000|Overall Study|Lost to Follow-up|2|||
30637752|NCT00803101|58649611|FG001|Overall Study|Lost to Follow-up|2|||
30637753|NCT00803101|58649610|FG000|Overall Study|Protocol Violation|1|||
30637754|NCT00803101|58649611|FG001|Overall Study|Protocol Violation|7|||
30637755|NCT00803101|58649610|FG000|Overall Study|Surgery finished outside protocol window|1|||
30637756|NCT00803101|58649611|FG001|Overall Study|Surgery finished outside protocol window|1|||
30637757|NCT00803101|58649610|FG000|Overall Study|Patient died outside SAE report period|1|||
30637758|NCT00803101|58649611|FG001|Overall Study|Patient died outside SAE report period|0|||
30637759|NCT00803101|58649610|FG000|Overall Study|Patient did not attend scheduled visit|2|||
30637760|NCT00803101|58649611|FG001|Overall Study|Patient did not attend scheduled visit|1|||
30637761|NCT00803101|58649610|FG000|Overall Study|Patient did not have surgery|1|||
30637762|NCT00803101|58649611|FG001|Overall Study|Patient did not have surgery|1|||
30637763|NCT00801229|58649619|FG000|Signed Consent|Withdrawal by Subject|2|||
30637764|NCT00801229|58649620|FG001|Signed Consent|Withdrawal by Subject|2|||
30637765|NCT00801229|58649619|FG000|Signed Consent|Found Ineligible|1|||
30637766|NCT00801229|58649620|FG001|Signed Consent|Found Ineligible|1|||
30637767|NCT00801229|58649619|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
30637768|NCT00801229|58649620|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
30637769|NCT00801229|58649619|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
30637770|NCT00801229|58649620|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
30637771|NCT00801229|58649619|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
30637772|NCT00801229|58649620|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
30637773|NCT00801229|58649619|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
30637774|NCT00801229|58649620|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
30637775|NCT00801229|58649619|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
30637776|NCT00801229|58649620|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
30637777|NCT00801229|58649619|FG000|Received Study Drug/Placebo|Adverse Event|1|||
30637778|NCT00801229|58649620|FG001|Received Study Drug/Placebo|Adverse Event|1|||
30637779|NCT00948246|58649626|FG000|Overall Study|Lost to Follow-up|11|||
30637780|NCT00948246|58649626|FG000|Overall Study|Adverse Event|11|||
30637781|NCT00948246|58649626|FG000|Overall Study|Death|1|||
30637782|NCT00948246|58649626|FG000|Overall Study|Withdrawal by Subject|1|||
30637783|NCT00800683|58649632|FG000|Overall Study|Adverse Event|11|||
30637784|NCT00800683|58649633|FG001|Overall Study|Adverse Event|8|||
30637785|NCT00800683|58649632|FG000|Overall Study|Lost to Follow-up|3|||
30637786|NCT00800683|58649633|FG001|Overall Study|Lost to Follow-up|1|||
30637787|NCT00800683|58649632|FG000|Overall Study|Withdrawal by Subject|1|||
30848503|NCT02851511|58874630|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
30848504|NCT02851511|58874631|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
30848505|NCT02851511|58874632|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
30848506|NCT02851511|58874629|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
30848507|NCT02851511|58874630|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
30951419|NCT04426695|58998520|FG015|Overall Study|Randomized but Never Treated|0|||
30951420|NCT04426695|58998521|FG016|Overall Study|Randomized but Never Treated|0|||
30951421|NCT04426695|58998522|FG017|Overall Study|Randomized but Never Treated|0|||
30951422|NCT01838200|58998599|FG000|Overall Study|Adverse Event|0|||
30951423|NCT01838200|58998600|FG001|Overall Study|Adverse Event|2|||
30637788|NCT00800683|58649633|FG001|Overall Study|Withdrawal by Subject|7|||
30637789|NCT00800683|58649632|FG000|Overall Study|Lack of Efficacy|1|||
30637790|NCT00800683|58649633|FG001|Overall Study|Lack of Efficacy|1|||
30637791|NCT00800683|58649632|FG000|Overall Study|Other|1|||
30637792|NCT00800683|58649633|FG001|Overall Study|Other|2|||
30637793|NCT01124864|58649645|FG000|Overall Study|Follow up phase competed as per protocol|18|||
30637794|NCT01124864|58649646|FG001|Overall Study|Follow up phase competed as per protocol|22|||
30637795|NCT01124864|58649647|FG002|Overall Study|Follow up phase competed as per protocol|24|||
30637796|NCT01124864|58649648|FG003|Overall Study|Follow up phase competed as per protocol|18|||
30637797|NCT01124864|58649649|FG004|Overall Study|Follow up phase competed as per protocol|26|||
30637798|NCT01124864|58649650|FG005|Overall Study|Follow up phase competed as per protocol|2|||
30637799|NCT01124864|58649645|FG000|Overall Study|Death|6|||
30637800|NCT01124864|58649646|FG001|Overall Study|Death|9|||
30637801|NCT01124864|58649647|FG002|Overall Study|Death|6|||
30637802|NCT01124864|58649648|FG003|Overall Study|Death|2|||
30637803|NCT01124864|58649649|FG004|Overall Study|Death|1|||
30637804|NCT01124864|58649650|FG005|Overall Study|Death|0|||
30637805|NCT01124864|58649645|FG000|Overall Study|Withdrawal by Subject|2|||
30637806|NCT01124864|58649646|FG001|Overall Study|Withdrawal by Subject|3|||
30637807|NCT01124864|58649647|FG002|Overall Study|Withdrawal by Subject|4|||
30637808|NCT01124864|58649648|FG003|Overall Study|Withdrawal by Subject|0|||
30637809|NCT01124864|58649649|FG004|Overall Study|Withdrawal by Subject|2|||
30637810|NCT01124864|58649650|FG005|Overall Study|Withdrawal by Subject|1|||
30637811|NCT01124864|58649645|FG000|Overall Study|Lost to Follow-up|1|||
30637812|NCT01124864|58649646|FG001|Overall Study|Lost to Follow-up|1|||
30637813|NCT01124864|58649647|FG002|Overall Study|Lost to Follow-up|0|||
30637814|NCT01124864|58649648|FG003|Overall Study|Lost to Follow-up|1|||
30637815|NCT01124864|58649649|FG004|Overall Study|Lost to Follow-up|0|||
30637816|NCT01124864|58649650|FG005|Overall Study|Lost to Follow-up|0|||
30637817|NCT01124864|58649645|FG000|Overall Study|Protocol Violation|1|||
30637818|NCT01124864|58649646|FG001|Overall Study|Protocol Violation|0|||
30637819|NCT01124864|58649647|FG002|Overall Study|Protocol Violation|0|||
30637820|NCT01124864|58649648|FG003|Overall Study|Protocol Violation|0|||
30637821|NCT01124864|58649649|FG004|Overall Study|Protocol Violation|1|||
30637822|NCT01124864|58649650|FG005|Overall Study|Protocol Violation|0|||
30637823|NCT01113710|58649666|FG000|Overall Study|Adverse Event|64|||
30637824|NCT01113710|58649666|FG000|Overall Study|Lack of Efficacy|41|||
30637825|NCT01113710|58649666|FG000|Overall Study|No Information Available|40|||
30637826|NCT01113710|58649666|FG000|Overall Study|Withdrawal by Subject|28|||
30637827|NCT01113710|58649666|FG000|Overall Study|Lost to Follow-up|20|||
30637828|NCT01113710|58649666|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
30637829|NCT01113710|58649666|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
30637830|NCT01113710|58649666|FG000|Overall Study|Lack of Patient's Compliance|8|||
30637831|NCT01113710|58649666|FG000|Overall Study|Other|7|||
30637832|NCT01113710|58649666|FG000|Overall Study|Adverse Event/Other|5|||
30637833|NCT01113710|58649666|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
30637834|NCT01113710|58649666|FG000|Overall Study|Lack of Efficacy/Other|4|||
30637835|NCT01113710|58649666|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
30637836|NCT01113710|58649666|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
30637837|NCT01113710|58649666|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
30637838|NCT01113710|58649666|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
30637839|NCT01113710|58649666|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
30637840|NCT01113710|58649666|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
30637841|NCT01113710|58649666|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
30637842|NCT01113710|58649666|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
30637843|NCT01113710|58649666|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
30637844|NCT01113710|58649666|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
30637845|NCT01113710|58649666|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
30637846|NCT01113710|58649666|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
30637847|NCT01113710|58649666|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
30637848|NCT01124162|58649672|FG000|First Intervention|Adverse Event|2|||
30637849|NCT01124162|58649673|FG001|First Intervention|Adverse Event|0|||
30637850|NCT01124162|58649672|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
30637851|NCT01124162|58649673|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
30637852|NCT00906399|58649682|FG000|Year 1|Randomized But Not Treated|0|||
30637853|NCT00906399|58649683|FG001|Year 1|Randomized But Not Treated|1|||
30951424|NCT01838200|58998599|FG000|Overall Study|Progressive disease|3|||
30637854|NCT00906399|58649684|FG002|Year 1|Randomized But Not Treated|3|||
30637855|NCT00906399|58649685|FG003|Year 1|Randomized But Not Treated|0|||
30637856|NCT00906399|58649686|FG004|Year 1|Randomized But Not Treated|0|||
30637857|NCT00906399|58649687|FG005|Year 1|Randomized But Not Treated|0|||
30637858|NCT00906399|58649688|FG006|Year 1|Randomized But Not Treated|0|||
30637859|NCT00906399|58649682|FG000|Year 1|Adverse Event|4|||
30637860|NCT00906399|58649683|FG001|Year 1|Adverse Event|22|||
30637861|NCT00906399|58649684|FG002|Year 1|Adverse Event|24|||
30637862|NCT00906399|58649685|FG003|Year 1|Adverse Event|0|||
30637863|NCT00906399|58649686|FG004|Year 1|Adverse Event|0|||
30637864|NCT00906399|58649687|FG005|Year 1|Adverse Event|0|||
30637865|NCT00906399|58649688|FG006|Year 1|Adverse Event|0|||
30637866|NCT00906399|58649682|FG000|Year 1|Lost to Follow-up|4|||
30637867|NCT00906399|58649683|FG001|Year 1|Lost to Follow-up|4|||
30637868|NCT00906399|58649684|FG002|Year 1|Lost to Follow-up|2|||
30637869|NCT00906399|58649685|FG003|Year 1|Lost to Follow-up|0|||
30637870|NCT00906399|58649686|FG004|Year 1|Lost to Follow-up|0|||
30637871|NCT00906399|58649687|FG005|Year 1|Lost to Follow-up|0|||
30637872|NCT00906399|58649688|FG006|Year 1|Lost to Follow-up|0|||
30637873|NCT00906399|58649682|FG000|Year 1|Withdrawal by Subject|30|||
30637874|NCT00906399|58649683|FG001|Year 1|Withdrawal by Subject|32|||
30637875|NCT00906399|58649684|FG002|Year 1|Withdrawal by Subject|36|||
30637876|NCT00906399|58649685|FG003|Year 1|Withdrawal by Subject|0|||
30637877|NCT00906399|58649686|FG004|Year 1|Withdrawal by Subject|0|||
30637878|NCT00906399|58649687|FG005|Year 1|Withdrawal by Subject|0|||
30637879|NCT00906399|58649688|FG006|Year 1|Withdrawal by Subject|0|||
30637880|NCT00906399|58649682|FG000|Year 1|Physician Decision|0|||
30637881|NCT00906399|58649683|FG001|Year 1|Physician Decision|1|||
30637882|NCT00906399|58649684|FG002|Year 1|Physician Decision|3|||
30637883|NCT00906399|58649685|FG003|Year 1|Physician Decision|0|||
30637884|NCT00906399|58649686|FG004|Year 1|Physician Decision|0|||
30637885|NCT00906399|58649687|FG005|Year 1|Physician Decision|0|||
30637886|NCT00906399|58649688|FG006|Year 1|Physician Decision|0|||
30637887|NCT00906399|58649682|FG000|Year 1|Death|2|||
30637888|NCT00906399|58649683|FG001|Year 1|Death|1|||
30637889|NCT00906399|58649684|FG002|Year 1|Death|1|||
30637890|NCT00906399|58649685|FG003|Year 1|Death|0|||
30637891|NCT00906399|58649686|FG004|Year 1|Death|0|||
30637892|NCT00906399|58649687|FG005|Year 1|Death|0|||
30637893|NCT00906399|58649688|FG006|Year 1|Death|0|||
30637894|NCT00906399|58649682|FG000|Year 1|Other|4|||
30637895|NCT00906399|58649683|FG001|Year 1|Other|2|||
30637896|NCT00906399|58649684|FG002|Year 1|Other|7|||
30637897|NCT00906399|58649685|FG003|Year 1|Other|0|||
30637898|NCT00906399|58649686|FG004|Year 1|Other|0|||
30637899|NCT00906399|58649687|FG005|Year 1|Other|0|||
30637900|NCT00906399|58649688|FG006|Year 1|Other|0|||
30637901|NCT00906399|58649682|FG000|Year 2|Adverse Event|0|||
30637902|NCT00906399|58649683|FG001|Year 2|Adverse Event|0|||
30637903|NCT00906399|58649684|FG002|Year 2|Adverse Event|0|||
30637904|NCT00906399|58649685|FG003|Year 2|Adverse Event|9|||
30637905|NCT00906399|58649686|FG004|Year 2|Adverse Event|8|||
30637906|NCT00906399|58649687|FG005|Year 2|Adverse Event|11|||
30637907|NCT00906399|58649688|FG006|Year 2|Adverse Event|6|||
30637908|NCT00906399|58649682|FG000|Year 2|Lost to Follow-up|0|||
30637909|NCT00906399|58649683|FG001|Year 2|Lost to Follow-up|0|||
30637910|NCT00906399|58649684|FG002|Year 2|Lost to Follow-up|0|||
30637911|NCT00906399|58649685|FG003|Year 2|Lost to Follow-up|1|||
30637912|NCT00906399|58649686|FG004|Year 2|Lost to Follow-up|4|||
30637913|NCT00906399|58649687|FG005|Year 2|Lost to Follow-up|2|||
30637914|NCT00906399|58649688|FG006|Year 2|Lost to Follow-up|4|||
30637915|NCT00906399|58649682|FG000|Year 2|Withdrawal by Subject|0|||
30637916|NCT00906399|58649683|FG001|Year 2|Withdrawal by Subject|0|||
30637917|NCT00906399|58649684|FG002|Year 2|Withdrawal by Subject|0|||
30637918|NCT00906399|58649685|FG003|Year 2|Withdrawal by Subject|17|||
30637919|NCT00906399|58649686|FG004|Year 2|Withdrawal by Subject|18|||
30637920|NCT00906399|58649687|FG005|Year 2|Withdrawal by Subject|27|||
30637921|NCT00906399|58649688|FG006|Year 2|Withdrawal by Subject|13|||
30637922|NCT00906399|58649682|FG000|Year 2|Physician Decision|0|||
30637923|NCT00906399|58649683|FG001|Year 2|Physician Decision|0|||
30637924|NCT00906399|58649684|FG002|Year 2|Physician Decision|0|||
30637925|NCT00906399|58649685|FG003|Year 2|Physician Decision|0|||
30637926|NCT00906399|58649686|FG004|Year 2|Physician Decision|2|||
30637927|NCT00906399|58649687|FG005|Year 2|Physician Decision|6|||
30637928|NCT00906399|58649688|FG006|Year 2|Physician Decision|3|||
30637929|NCT00906399|58649682|FG000|Year 2|Death|0|||
30637930|NCT00906399|58649683|FG001|Year 2|Death|0|||
30637931|NCT00906399|58649684|FG002|Year 2|Death|0|||
30637932|NCT00906399|58649685|FG003|Year 2|Death|1|||
30637933|NCT00906399|58649686|FG004|Year 2|Death|0|||
30637934|NCT00906399|58649687|FG005|Year 2|Death|0|||
30637935|NCT00906399|58649688|FG006|Year 2|Death|3|||
30637936|NCT00906399|58649682|FG000|Year 2|Other|0|||
30637937|NCT00906399|58649683|FG001|Year 2|Other|0|||
30765454|NCT00318461|58774019|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
30637938|NCT00906399|58649684|FG002|Year 2|Other|0|||
30637939|NCT00906399|58649685|FG003|Year 2|Other|2|||
30637940|NCT00906399|58649686|FG004|Year 2|Other|3|||
30637941|NCT00906399|58649687|FG005|Year 2|Other|1|||
30637942|NCT00906399|58649688|FG006|Year 2|Other|0|||
30637943|NCT01111838|58649700|FG000|Overall Study|Patient Ineligible|2|||
30637944|NCT01111838|58649700|FG000|Overall Study|Not Treated|3|||
30637945|NCT01111838|58649700|FG000|Overall Study|Clinical deterioration|1|||
30637946|NCT01111838|58649700|FG000|Overall Study|Other Complicating Disease|1|||
30637947|NCT00947856|58649706|FG000|Treatment Period|Progressive Disease|33|||
30637948|NCT00947856|58649707|FG001|Treatment Period|Progressive Disease|12|||
30637949|NCT00947856|58649706|FG000|Treatment Period|Adverse Event|15|||
30637950|NCT00947856|58649707|FG001|Treatment Period|Adverse Event|9|||
30637951|NCT00947856|58649706|FG000|Treatment Period|Physician Decision|14|||
30637952|NCT00947856|58649707|FG001|Treatment Period|Physician Decision|6|||
30637953|NCT00947856|58649706|FG000|Treatment Period|Study Stopped by Sponsor|4|||
30637954|NCT00947856|58649707|FG001|Treatment Period|Study Stopped by Sponsor|4|||
30637955|NCT00947856|58649706|FG000|Treatment Period|Withdrawal by Subject|12|||
30637956|NCT00947856|58649707|FG001|Treatment Period|Withdrawal by Subject|1|||
30637957|NCT00947856|58649706|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
30637958|NCT00947856|58649707|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
30637959|NCT00947856|58649706|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
30637960|NCT00947856|58649707|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
30637961|NCT00947856|58649706|FG000|Follow-up Period|Lost to Follow-up|7|||
30637962|NCT00947856|58649707|FG001|Follow-up Period|Lost to Follow-up|0|||
30637963|NCT00947856|58649706|FG000|Follow-up Period|Patient unavailable for site visits|1|||
30637964|NCT00947856|58649707|FG001|Follow-up Period|Patient unavailable for site visits|0|||
30951425|NCT01838200|58998600|FG001|Overall Study|Progressive disease|0|||
30637965|NCT00947856|58649706|FG000|Follow-up Period|Withdrawal by Subject|1|||
30951426|NCT03219034|58998643|FG000|Overall Study|Lost to Follow-up|9|||
30951427|NCT03219034|58998644|FG001|Overall Study|Lost to Follow-up|13|||
30637966|NCT00947856|58649707|FG001|Follow-up Period|Withdrawal by Subject|0|||
30637967|NCT00947544|58649722|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
30637968|NCT00947544|58649723|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
30637969|NCT00907335|58649735|FG000|Overall Study|Withdrawal by Subject|2|||
30637970|NCT00907335|58649736|FG001|Overall Study|Withdrawal by Subject|0|||
30637971|NCT00907335|58649735|FG000|Overall Study|Adverse Event|4|||
30637972|NCT00907335|58649736|FG001|Overall Study|Adverse Event|1|||
30637973|NCT00907335|58649735|FG000|Overall Study|Lost to Follow-up|2|||
30637974|NCT00907335|58649736|FG001|Overall Study|Lost to Follow-up|0|||
30637975|NCT00947154|58649742|FG000|Overall Study|Lost to Follow-up|1|||
30637976|NCT01124006|58649750|FG000|Overall Study|Withdrawal by Subject|2|||
30637977|NCT01124006|58649751|FG001|Overall Study|Withdrawal by Subject|2|||
30637978|NCT01124006|58649752|FG002|Overall Study|Withdrawal by Subject|0|||
30637979|NCT01124006|58649750|FG000|Overall Study|Lost to Follow-up|1|||
30637980|NCT01124006|58649751|FG001|Overall Study|Lost to Follow-up|0|||
30637981|NCT01124006|58649752|FG002|Overall Study|Lost to Follow-up|1|||
30637982|NCT01124006|58649750|FG000|Overall Study|Other|0|||
30637983|NCT01124006|58649751|FG001|Overall Study|Other|0|||
30637984|NCT01124006|58649752|FG002|Overall Study|Other|1|||
30637985|NCT00952068|58649760|FG000|Overall Study|Adverse Event|3|||
30637986|NCT00952068|58649760|FG000|Overall Study|Withdrawal by Subject|4|||
30637987|NCT01123850|58649764|FG000|Overall Study|Slow enrollment|45|||
30637988|NCT01123382|58649770|FG000|Overall Study|Withdrawal by Subject|1|||
30637989|NCT01123382|58649771|FG001|Overall Study|Withdrawal by Subject|4|||
30637990|NCT01123382|58649770|FG000|Overall Study|Lost to Follow-up|1|||
30637991|NCT01123382|58649771|FG001|Overall Study|Lost to Follow-up|2|||
30637992|NCT00951912|58649780|FG000|Overall Study|Lack of Efficacy|1|||
30637993|NCT00951912|58649781|FG001|Overall Study|Lack of Efficacy|0|||
30637994|NCT00951912|58649782|FG002|Overall Study|Lack of Efficacy|0|||
30637995|NCT00951912|58649780|FG000|Overall Study|Adverse Event|0|||
30637996|NCT00951912|58649781|FG001|Overall Study|Adverse Event|1|||
30637997|NCT00951912|58649782|FG002|Overall Study|Adverse Event|1|||
30637998|NCT00951912|58649780|FG000|Overall Study|Lost to Follow-up|2|||
30637999|NCT00951912|58649781|FG001|Overall Study|Lost to Follow-up|2|||
30638000|NCT00951912|58649782|FG002|Overall Study|Lost to Follow-up|0|||
30638001|NCT00951912|58649780|FG000|Overall Study|Physician Decision|1|||
30638002|NCT00951912|58649781|FG001|Overall Study|Physician Decision|0|||
30638003|NCT00951912|58649782|FG002|Overall Study|Physician Decision|1|||
30638004|NCT00951912|58649780|FG000|Overall Study|Withdrawal by Subject|1|||
30638005|NCT00951912|58649781|FG001|Overall Study|Withdrawal by Subject|1|||
30638006|NCT00951912|58649782|FG002|Overall Study|Withdrawal by Subject|0|||
30638007|NCT00951912|58649780|FG000|Overall Study|Other:Depression|1|||
30638008|NCT00951912|58649781|FG001|Overall Study|Other:Depression|0|||
30638009|NCT00951912|58649782|FG002|Overall Study|Other:Depression|0|||
30638010|NCT00951912|58649780|FG000|Overall Study|Other: Colon cancer|1|||
30638011|NCT00951912|58649781|FG001|Overall Study|Other: Colon cancer|0|||
30638012|NCT00951912|58649782|FG002|Overall Study|Other: Colon cancer|0|||
30638013|NCT00951912|58649780|FG000|Overall Study|Other: Stroke|0|||
30638014|NCT00951912|58649781|FG001|Overall Study|Other: Stroke|1|||
30638015|NCT00951912|58649782|FG002|Overall Study|Other: Stroke|0|||
30638016|NCT01123148|58649790|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
30638017|NCT01123148|58649790|FG000|Overall Study|Didn't meet milestone criteria|1|||
30638018|NCT01123070|58649798|FG000|Part B Double Blind Period|Protocol Violation|0|||
30638019|NCT01123070|58649799|FG001|Part B Double Blind Period|Protocol Violation|0|||
30638020|NCT01123070|58649800|FG002|Part B Double Blind Period|Protocol Violation|0|||
30638021|NCT01123070|58649801|FG003|Part B Double Blind Period|Protocol Violation|1|||
30638022|NCT01123070|58649798|FG000|Part B Double Blind Period|Adverse Event|0|||
30638023|NCT01123070|58649799|FG001|Part B Double Blind Period|Adverse Event|0|||
30638024|NCT01123070|58649800|FG002|Part B Double Blind Period|Adverse Event|2|||
30638025|NCT01123070|58649801|FG003|Part B Double Blind Period|Adverse Event|0|||
30638026|NCT01123070|58649798|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
30638027|NCT01123070|58649799|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
30638028|NCT01123070|58649800|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
30638029|NCT01123070|58649801|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
30638030|NCT01122680|58649812|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
30638031|NCT01122680|58649813|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
30638032|NCT01122680|58649814|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
30638033|NCT01122680|58649815|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
30638034|NCT01122680|58649812|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
30638035|NCT01122680|58649813|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
30638036|NCT01122680|58649814|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
30638037|NCT01122680|58649815|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
30638038|NCT01122680|58649812|FG000|Period 1 (4 Weeks)|Other|1|||
30638039|NCT01122680|58649813|FG001|Period 1 (4 Weeks)|Other|1|||
30638040|NCT01122680|58649814|FG002|Period 1 (4 Weeks)|Other|0|||
30638041|NCT01122680|58649815|FG003|Period 1 (4 Weeks)|Other|0|||
30638042|NCT01122680|58649812|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
30638043|NCT01122680|58649813|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
30638044|NCT01122680|58649814|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
30638045|NCT01122680|58649815|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
30638046|NCT01122680|58649812|FG000|Period 2 (4 Weeks)|Other|1|||
30638047|NCT01122680|58649813|FG001|Period 2 (4 Weeks)|Other|0|||
30638048|NCT01122680|58649814|FG002|Period 2 (4 Weeks)|Other|0|||
30638049|NCT01122680|58649815|FG003|Period 2 (4 Weeks)|Other|0|||
30638050|NCT01122680|58649812|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
30638051|NCT01122680|58649813|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
30638052|NCT01122680|58649814|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
30638053|NCT01122680|58649815|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
30638054|NCT01122680|58649812|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
30638055|NCT01122680|58649813|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
30638056|NCT01122680|58649814|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
30638057|NCT01122680|58649815|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
30638058|NCT00946998|58649827|FG000|Overall Study|Exited prior to first outcome assessment|5|||
30638059|NCT00946998|58649828|FG001|Overall Study|Exited prior to first outcome assessment|3|||
30638060|NCT01138826|58649834|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
30638061|NCT01138826|58649835|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
30638062|NCT01138826|58649836|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
30638063|NCT01138826|58649837|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
30638064|NCT01138826|58649838|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
30638065|NCT01138826|58649839|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
30638066|NCT00906087|58649847|FG000|Initial Washout|Withdrawal by Subject|1|||
30638067|NCT00906087|58649847|FG000|Initial Washout|Physician Decision|1|||
30638068|NCT00907257|58649856|FG000|Overall Study|Adverse Event|0|||
30638069|NCT00907257|58649857|FG001|Overall Study|Adverse Event|4|||
30638070|NCT00907257|58649856|FG000|Overall Study|Protocol Violation|1|||
30638071|NCT00907257|58649857|FG001|Overall Study|Protocol Violation|2|||
30638072|NCT00907257|58649856|FG000|Overall Study|Lost to Follow-up|3|||
30638073|NCT00907257|58649857|FG001|Overall Study|Lost to Follow-up|3|||
30638074|NCT00907257|58649856|FG000|Overall Study|Withdrawal by Subject|1|||
30638075|NCT00907257|58649857|FG001|Overall Study|Withdrawal by Subject|2|||
30638076|NCT00907257|58649856|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
30638077|NCT00907257|58649857|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
30638078|NCT00907257|58649856|FG000|Overall Study|Moved|1|||
30638079|NCT00907257|58649857|FG001|Overall Study|Moved|0|||
30638080|NCT00907257|58649856|FG000|Overall Study|Personal Reasons|6|||
30638081|NCT00907257|58649857|FG001|Overall Study|Personal Reasons|1|||
30638082|NCT01138046|58649863|FG000|Overall Study|Withdrawal due to death|6|||
30638083|NCT00876460|58649875|FG000|Combination Therapy Phase|Progressive disease|2|||
30638084|NCT00876460|58649876|FG001|Combination Therapy Phase|Progressive disease|3|||
30638085|NCT00876460|58649877|FG002|Combination Therapy Phase|Progressive disease|3|||
30638086|NCT00876460|58649878|FG003|Combination Therapy Phase|Progressive disease|3|||
30638087|NCT00876460|58649879|FG004|Combination Therapy Phase|Progressive disease|3|||
30638088|NCT00876460|58649880|FG005|Combination Therapy Phase|Progressive disease|1|||
30638089|NCT00876460|58649881|FG006|Combination Therapy Phase|Progressive disease|1|||
30638090|NCT00876460|58649882|FG007|Combination Therapy Phase|Progressive disease|1|||
30638091|NCT00876460|58649875|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
30638092|NCT00876460|58649876|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
30638093|NCT00876460|58649877|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
30638094|NCT00876460|58649878|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
30638095|NCT00876460|58649879|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
30638096|NCT00876460|58649880|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
30638097|NCT00876460|58649881|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
30638098|NCT00876460|58649882|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
30765455|NCT00318461|58774020|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
30638099|NCT00876460|58649875|FG000|Combination Therapy Phase|Adverse Event|0|||
30638100|NCT00876460|58649876|FG001|Combination Therapy Phase|Adverse Event|2|||
30638101|NCT00876460|58649877|FG002|Combination Therapy Phase|Adverse Event|0|||
30638102|NCT00876460|58649878|FG003|Combination Therapy Phase|Adverse Event|2|||
30638103|NCT00876460|58649879|FG004|Combination Therapy Phase|Adverse Event|2|||
30638104|NCT00876460|58649880|FG005|Combination Therapy Phase|Adverse Event|0|||
30638105|NCT00876460|58649881|FG006|Combination Therapy Phase|Adverse Event|3|||
30638106|NCT00876460|58649882|FG007|Combination Therapy Phase|Adverse Event|2|||
30638107|NCT00876460|58649875|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
30638108|NCT00876460|58649876|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
30638109|NCT00876460|58649877|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
30638110|NCT00876460|58649878|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
30638111|NCT00876460|58649879|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
30638112|NCT00876460|58649880|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
30638113|NCT00876460|58649881|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
30638114|NCT00876460|58649882|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
30638115|NCT00876460|58649875|FG000|Combination Therapy Phase|Other reason not defined above|0|||
30638116|NCT00876460|58649876|FG001|Combination Therapy Phase|Other reason not defined above|0|||
30638117|NCT00876460|58649877|FG002|Combination Therapy Phase|Other reason not defined above|0|||
30638118|NCT00876460|58649878|FG003|Combination Therapy Phase|Other reason not defined above|0|||
30638119|NCT00876460|58649879|FG004|Combination Therapy Phase|Other reason not defined above|0|||
30638120|NCT00876460|58649880|FG005|Combination Therapy Phase|Other reason not defined above|0|||
30638121|NCT00876460|58649881|FG006|Combination Therapy Phase|Other reason not defined above|1|||
30638122|NCT00876460|58649882|FG007|Combination Therapy Phase|Other reason not defined above|2|||
30638123|NCT00876460|58649875|FG000|Combination Therapy Phase|Not treated|0|||
30638124|NCT00876460|58649876|FG001|Combination Therapy Phase|Not treated|0|||
30638125|NCT00876460|58649877|FG002|Combination Therapy Phase|Not treated|0|||
30638126|NCT00876460|58649878|FG003|Combination Therapy Phase|Not treated|0|||
30638127|NCT00876460|58649879|FG004|Combination Therapy Phase|Not treated|0|||
30638128|NCT00876460|58649880|FG005|Combination Therapy Phase|Not treated|0|||
30638129|NCT00876460|58649881|FG006|Combination Therapy Phase|Not treated|1|||
30638130|NCT00876460|58649882|FG007|Combination Therapy Phase|Not treated|0|||
30638131|NCT00876460|58649875|FG000|Mono Therapy Phase|Progressive disease|0|||
30638132|NCT00876460|58649876|FG001|Mono Therapy Phase|Progressive disease|0|||
30638133|NCT00876460|58649877|FG002|Mono Therapy Phase|Progressive disease|0|||
30638134|NCT00876460|58649878|FG003|Mono Therapy Phase|Progressive disease|0|||
30638135|NCT00876460|58649879|FG004|Mono Therapy Phase|Progressive disease|2|||
30638136|NCT00876460|58649880|FG005|Mono Therapy Phase|Progressive disease|0|||
30638137|NCT00876460|58649881|FG006|Mono Therapy Phase|Progressive disease|1|||
30638138|NCT00876460|58649882|FG007|Mono Therapy Phase|Progressive disease|3|||
30638139|NCT00876460|58649875|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
30638140|NCT00876460|58649876|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
30638141|NCT00876460|58649877|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
30638142|NCT00876460|58649878|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
30638143|NCT00876460|58649879|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
30638144|NCT00876460|58649880|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
30638145|NCT00876460|58649881|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
30638146|NCT00876460|58649882|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
30638147|NCT00876460|58649875|FG000|Mono Therapy Phase|Adverse Event|0|||
30638148|NCT00876460|58649876|FG001|Mono Therapy Phase|Adverse Event|0|||
30638149|NCT00876460|58649877|FG002|Mono Therapy Phase|Adverse Event|0|||
30638150|NCT00876460|58649878|FG003|Mono Therapy Phase|Adverse Event|1|||
30638151|NCT00876460|58649879|FG004|Mono Therapy Phase|Adverse Event|0|||
30638152|NCT00876460|58649880|FG005|Mono Therapy Phase|Adverse Event|0|||
30638153|NCT00876460|58649881|FG006|Mono Therapy Phase|Adverse Event|0|||
30638154|NCT00876460|58649882|FG007|Mono Therapy Phase|Adverse Event|0|||
30638155|NCT00908115|58649912|FG000|Overall Study|Other|14|||
30638156|NCT01137812|58649918|FG000|Overall Study|Adverse Event|21|||
30638157|NCT01137812|58649919|FG001|Overall Study|Adverse Event|14|||
30638158|NCT01137812|58649918|FG000|Overall Study|Lost to Follow-up|6|||
30638159|NCT01137812|58649919|FG001|Overall Study|Lost to Follow-up|8|||
30638160|NCT01137812|58649918|FG000|Overall Study|Physician Decision|25|||
30638161|NCT01137812|58649919|FG001|Overall Study|Physician Decision|17|||
30638162|NCT01137812|58649918|FG000|Overall Study|Protocol Violation|5|||
30638163|NCT01137812|58649919|FG001|Overall Study|Protocol Violation|4|||
30638164|NCT01137812|58649918|FG000|Overall Study|Withdrawal by Subject|5|||
30638165|NCT01137812|58649919|FG001|Overall Study|Withdrawal by Subject|13|||
30638166|NCT01137812|58649918|FG000|Overall Study|Death|2|||
30765456|NCT00318461|58774021|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
30638167|NCT01137812|58649919|FG001|Overall Study|Death|0|||
30638168|NCT01137812|58649918|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
30638169|NCT01137812|58649919|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
30638170|NCT01137812|58649918|FG000|Overall Study|Other|19|||
30638171|NCT01137812|58649919|FG001|Overall Study|Other|27|||
30638172|NCT01137578|58649925|FG000|Overall Study|Participant requested to Discontinue|3|||
30638173|NCT01137578|58649926|FG001|Overall Study|Participant requested to Discontinue|0|||
30638174|NCT01137578|58649927|FG002|Overall Study|Participant requested to Discontinue|0|||
30638175|NCT01137578|58649925|FG000|Overall Study|Withdrawal by Subject|1|||
30638176|NCT01137578|58649926|FG001|Overall Study|Withdrawal by Subject|0|||
30638177|NCT01137578|58649927|FG002|Overall Study|Withdrawal by Subject|0|||
30638178|NCT01137578|58649925|FG000|Overall Study|Other|12|||
30638179|NCT01137578|58649926|FG001|Overall Study|Other|2|||
30638180|NCT01137578|58649927|FG002|Overall Study|Other|6|||
30638181|NCT00946920|58649957|FG000|Overall Study|Withdrawal by Subject|28|||
30638182|NCT00946920|58649958|FG001|Overall Study|Withdrawal by Subject|15|||
30638183|NCT00946920|58649957|FG000|Overall Study|Lost to Follow-up|2|||
30638184|NCT00946920|58649958|FG001|Overall Study|Lost to Follow-up|2|||
30638185|NCT00946920|58649957|FG000|Overall Study|Physician Decision|5|||
30638186|NCT00946920|58649958|FG001|Overall Study|Physician Decision|2|||
30638187|NCT00946920|58649957|FG000|Overall Study|Adverse Event|41|||
30638188|NCT00946920|58649958|FG001|Overall Study|Adverse Event|14|||
30638189|NCT00946920|58649957|FG000|Overall Study|Protocol Violation|16|||
30638190|NCT00946920|58649958|FG001|Overall Study|Protocol Violation|8|||
30638191|NCT00946920|58649957|FG000|Overall Study|Miscellaneous reasons|18|||
30638192|NCT00946920|58649958|FG001|Overall Study|Miscellaneous reasons|3|||
30638193|NCT00946530|58649968|FG000|Overall Study|Withdrawal by Subject|0|||
30638194|NCT00946530|58649969|FG001|Overall Study|Withdrawal by Subject|3|||
30638195|NCT00946530|58649970|FG002|Overall Study|Withdrawal by Subject|0|||
30638196|NCT00946530|58649971|FG003|Overall Study|Withdrawal by Subject|3|||
30638197|NCT00946530|58649968|FG000|Overall Study|Physician Decision|1|||
30638198|NCT00946530|58649969|FG001|Overall Study|Physician Decision|1|||
30638199|NCT00946530|58649970|FG002|Overall Study|Physician Decision|1|||
30638200|NCT00946530|58649971|FG003|Overall Study|Physician Decision|1|||
30638201|NCT00946296|58649987|FG000|Overall Study|Physician Decision|3|||
30638202|NCT00946296|58649988|FG001|Overall Study|Physician Decision|0|||
30638203|NCT00945906|58649994|FG000|Overall Study|Withdrawal by Subject|1|||
30638204|NCT00945906|58649994|FG000|Overall Study|Did not want to return for last visit|2|||
30638205|NCT00945906|58649994|FG000|Overall Study|Unable to return for last visit|2|||
30638206|NCT00945906|58649994|FG000|Overall Study|Moved to another country|2|||
30638207|NCT00594646|58649998|FG000|Overall Study|Withdrawal by Subject|1|||
30638208|NCT00594646|58649998|FG000|Overall Study|Lost to Follow-up|15|||
30638209|NCT01111604|58650006|FG000|Overall Study|Lost to Follow-up|0|||
30638210|NCT01111604|58650007|FG001|Overall Study|Lost to Follow-up|0|||
30638211|NCT01111604|58650008|FG002|Overall Study|Lost to Follow-up|1|||
30638212|NCT01111604|58650006|FG000|Overall Study|Withdrew Consent|3|||
30638213|NCT01111604|58650007|FG001|Overall Study|Withdrew Consent|0|||
30638214|NCT01111604|58650008|FG002|Overall Study|Withdrew Consent|2|||
30638215|NCT01111604|58650006|FG000|Overall Study|Withdrawal by Subject|2|||
30638216|NCT01111604|58650007|FG001|Overall Study|Withdrawal by Subject|0|||
30638217|NCT01111604|58650008|FG002|Overall Study|Withdrawal by Subject|0|||
30638218|NCT01111604|58650006|FG000|Overall Study|Death|1|||
30638219|NCT01111604|58650007|FG001|Overall Study|Death|0|||
30638220|NCT01111604|58650008|FG002|Overall Study|Death|0|||
30638221|NCT01111604|58650006|FG000|Overall Study|Met Exclusion Criteria|2|||
30638222|NCT01111604|58650007|FG001|Overall Study|Met Exclusion Criteria|0|||
30638223|NCT01111604|58650008|FG002|Overall Study|Met Exclusion Criteria|0|||
30638224|NCT00950742|58650036|FG000|Overall Study|Other Adverse Event|1|||
30638225|NCT00950742|58650037|FG001|Overall Study|Other Adverse Event|0|||
30638226|NCT00950742|58650036|FG000|Overall Study|Withdrawal by Subject|3|||
30638227|NCT00950742|58650037|FG001|Overall Study|Withdrawal by Subject|0|||
30638228|NCT00950742|58650036|FG000|Overall Study|Progressive Disease|6|||
30638229|NCT00950742|58650037|FG001|Overall Study|Progressive Disease|2|||
30638230|NCT00950742|58650036|FG000|Overall Study|Dose limiting toxicity|6|||
30638231|NCT00950742|58650037|FG001|Overall Study|Dose limiting toxicity|0|||
30638232|NCT00955110|58650047|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
30638233|NCT00955110|58650047|FG000|Treatment Phase|Adverse Event|2|||
30638234|NCT00955110|58650047|FG000|Treatment Phase|Administrative reasons|2|||
30638235|NCT00955110|58650047|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
30638236|NCT00955110|58650047|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
30765457|NCT00318461|58774017|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
30638237|NCT00950664|58650061|FG000|First Intervention|Lost to Follow-up|1|||
30638238|NCT00950664|58650062|FG001|First Intervention|Lost to Follow-up|3|||
30638239|NCT00950664|58650061|FG000|First Intervention|Withdrawal by Subject|2|||
30638240|NCT00950664|58650062|FG001|First Intervention|Withdrawal by Subject|2|||
30638241|NCT01111526|58650068|FG000|Overall Study|GVHD Disease Progression|0|||
30638242|NCT01111526|58650069|FG001|Overall Study|GVHD Disease Progression|1|||
30638243|NCT01111526|58650070|FG002|Overall Study|GVHD Disease Progression|2|||
30638244|NCT01111292|58650076|FG000|Treatment|Physician Decision|1|||
30638245|NCT01111292|58650077|FG001|Treatment|Physician Decision|1|||
30638246|NCT00944658|58650085|FG000|Treatment 12 Weeks|Adverse Event|0|||
30638247|NCT00944658|58650086|FG001|Treatment 12 Weeks|Adverse Event|2|||
30638248|NCT01110200|58650094|FG000|Overall Study|Adverse Event|28|||
30638249|NCT01110200|58650095|FG001|Overall Study|Adverse Event|28|||
30638250|NCT01110200|58650094|FG000|Overall Study|Withdrawal by Subject|25|||
30638251|NCT01110200|58650095|FG001|Overall Study|Withdrawal by Subject|32|||
30638252|NCT01110200|58650094|FG000|Overall Study|Lack of Efficacy|16|||
30638253|NCT01110200|58650095|FG001|Overall Study|Lack of Efficacy|25|||
30638254|NCT01110200|58650094|FG000|Overall Study|Protocol Violation|14|||
30638255|NCT01110200|58650095|FG001|Overall Study|Protocol Violation|12|||
30638256|NCT01110200|58650094|FG000|Overall Study|Physician Decision|13|||
30638257|NCT01110200|58650095|FG001|Overall Study|Physician Decision|17|||
30638258|NCT01110200|58650094|FG000|Overall Study|Lost to Follow-up|10|||
30638259|NCT01110200|58650095|FG001|Overall Study|Lost to Follow-up|7|||
30638260|NCT01108796|58650105|FG000|Overall Study|Adverse Event|0|||
30638261|NCT01108796|58650106|FG001|Overall Study|Adverse Event|1|||
30638262|NCT01108796|58650105|FG000|Overall Study|Lost to Follow-up|7|||
30638263|NCT01108796|58650106|FG001|Overall Study|Lost to Follow-up|6|||
30638264|NCT01108718|58650116|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
30638265|NCT01108718|58650117|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
30638266|NCT01137110|58650124|FG000|Overall Study|Protocol Violation|1|||
30638267|NCT01137110|58650125|FG001|Overall Study|Protocol Violation|0|||
30638268|NCT01136954|58650133|FG000|Overall Study|Adverse Event|3|||
30638269|NCT01136954|58650134|FG001|Overall Study|Adverse Event|2|||
30638270|NCT01136954|58650133|FG000|Overall Study|Withdrawal by Subject|6|||
30638271|NCT01136954|58650134|FG001|Overall Study|Withdrawal by Subject|2|||
30638272|NCT01136954|58650133|FG000|Overall Study|Lack of Efficacy|14|||
30638273|NCT01136954|58650134|FG001|Overall Study|Lack of Efficacy|13|||
30638274|NCT01136954|58650133|FG000|Overall Study|Physician Decision|0|||
30638275|NCT01136954|58650134|FG001|Overall Study|Physician Decision|1|||
30638276|NCT01136954|58650133|FG000|Overall Study|Other|1|||
30638277|NCT01136954|58650134|FG001|Overall Study|Other|3|||
30638278|NCT01136876|58650143|FG000|Overall Study|Lost to Follow-up|0|||
30638279|NCT01136876|58650144|FG001|Overall Study|Lost to Follow-up|1|||
30638280|NCT01136876|58650143|FG000|Overall Study|Physician Decision|3|||
30638281|NCT01136876|58650144|FG001|Overall Study|Physician Decision|5|||
30638282|NCT01136876|58650143|FG000|Overall Study|Missing NGAL measurement|2|||
30638283|NCT01136876|58650144|FG001|Overall Study|Missing NGAL measurement|5|||
30638284|NCT01105130|58650155|FG000|Overall Study|Withdrawal by Subject|4|||
30638285|NCT01105130|58650156|FG001|Overall Study|Withdrawal by Subject|6|||
30638286|NCT01105130|58650157|FG002|Overall Study|Withdrawal by Subject|2|||
30638287|NCT01105130|58650155|FG000|Overall Study|Never Started|2|||
30638288|NCT01105130|58650156|FG001|Overall Study|Never Started|2|||
30638289|NCT01105130|58650157|FG002|Overall Study|Never Started|4|||
30638290|NCT01105130|58650155|FG000|Overall Study|Toxicity|1|||
30638291|NCT01105130|58650156|FG001|Overall Study|Toxicity|3|||
30638292|NCT01105130|58650157|FG002|Overall Study|Toxicity|2|||
30638293|NCT01105130|58650155|FG000|Overall Study|Multiple Reasons|3|||
30638294|NCT01105130|58650156|FG001|Overall Study|Multiple Reasons|0|||
30638295|NCT01105130|58650157|FG002|Overall Study|Multiple Reasons|2|||
30638296|NCT01108094|58650169|FG000|Overall Study|Adverse Event|2|||
30638297|NCT01108094|58650170|FG001|Overall Study|Adverse Event|0|||
30638298|NCT01108094|58650171|FG002|Overall Study|Adverse Event|0|||
30638299|NCT01108094|58650172|FG003|Overall Study|Adverse Event|0|||
30638300|NCT01108094|58650169|FG000|Overall Study|Withdrawal by Subject|1|||
30638301|NCT01108094|58650170|FG001|Overall Study|Withdrawal by Subject|0|||
30638302|NCT01108094|58650171|FG002|Overall Study|Withdrawal by Subject|0|||
30638303|NCT01108094|58650172|FG003|Overall Study|Withdrawal by Subject|0|||
30638304|NCT00954174|58650189|FG000|Overall Study|Adverse Event|28|||
30638305|NCT00954174|58650190|FG001|Overall Study|Adverse Event|23|||
30638306|NCT00954174|58650191|FG002|Overall Study|Adverse Event|4|||
30638307|NCT00954174|58650192|FG003|Overall Study|Adverse Event|9|||
30638308|NCT00954174|58650189|FG000|Overall Study|Death|4|||
30638309|NCT00954174|58650190|FG001|Overall Study|Death|2|||
30638310|NCT00954174|58650191|FG002|Overall Study|Death|0|||
30638311|NCT00954174|58650192|FG003|Overall Study|Death|0|||
30638312|NCT00954174|58650189|FG000|Overall Study|Lack of Efficacy|32|||
30638313|NCT00954174|58650190|FG001|Overall Study|Lack of Efficacy|22|||
30638314|NCT00954174|58650191|FG002|Overall Study|Lack of Efficacy|8|||
30638315|NCT00954174|58650192|FG003|Overall Study|Lack of Efficacy|6|||
30638316|NCT00954174|58650189|FG000|Overall Study|Withdrawal by Subject|14|||
30638317|NCT00954174|58650190|FG001|Overall Study|Withdrawal by Subject|10|||
30638318|NCT00954174|58650191|FG002|Overall Study|Withdrawal by Subject|4|||
30638319|NCT00954174|58650192|FG003|Overall Study|Withdrawal by Subject|3|||
30638320|NCT00954174|58650189|FG000|Overall Study|Medical Reason|4|||
30638321|NCT00954174|58650190|FG001|Overall Study|Medical Reason|2|||
30638322|NCT00954174|58650191|FG002|Overall Study|Medical Reason|1|||
30638323|NCT00954174|58650192|FG003|Overall Study|Medical Reason|0|||
30638324|NCT00954174|58650189|FG000|Overall Study|Ineligible|40|||
30638325|NCT00954174|58650190|FG001|Overall Study|Ineligible|47|||
30638326|NCT00954174|58650191|FG002|Overall Study|Ineligible|7|||
30638327|NCT00954174|58650192|FG003|Overall Study|Ineligible|4|||
30638328|NCT00954174|58650189|FG000|Overall Study|Never Treated|4|||
30638329|NCT00954174|58650190|FG001|Overall Study|Never Treated|17|||
30638330|NCT00954174|58650191|FG002|Overall Study|Never Treated|0|||
30638331|NCT00954174|58650192|FG003|Overall Study|Never Treated|3|||
30638332|NCT01136408|58650208|FG000|Overall Study|Adverse Event|4|||
30638333|NCT01136408|58650209|FG001|Overall Study|Adverse Event|8|||
30638334|NCT01136408|58650210|FG002|Overall Study|Adverse Event|4|||
30638335|NCT01136408|58650208|FG000|Overall Study|Protocol Violation|1|||
30638336|NCT01136408|58650209|FG001|Overall Study|Protocol Violation|1|||
30638337|NCT01136408|58650210|FG002|Overall Study|Protocol Violation|1|||
30638338|NCT01136174|58650226|FG000|Overall Study|Adverse Event|0|||
30638339|NCT01136174|58650227|FG001|Overall Study|Adverse Event|0|||
30638340|NCT01136174|58650228|FG002|Overall Study|Adverse Event|0|||
30638341|NCT01136174|58650229|FG003|Overall Study|Adverse Event|4|||
30638342|NCT01135394|58650248|FG000|Screening|Lost to Follow-up|2|||
30638343|NCT01135394|58650248|FG000|Screening|Withdrawal by Subject|10|||
30638344|NCT01135394|58650248|FG000|Screening|Screening failure|16|||
30638345|NCT01135394|58650248|FG000|Screening|Physician Decision|5|||
30638346|NCT01135394|58650248|FG000|Baseline Assessment|Withdrawal by Subject|9|||
30638347|NCT01135394|58650248|FG000|Baseline Assessment|Physician Decision|3|||
30638348|NCT01135394|58650248|FG000|Baseline Assessment|Lost to Follow-up|2|||
30638349|NCT01135394|58650248|FG000|Baseline Assessment|Adverse Event|1|||
30638350|NCT01135394|58650248|FG000|Study Treatment|Withdrawal by Subject|1|||
30638351|NCT01135394|58650248|FG000|Study Treatment|Physician Decision|1|||
30638352|NCT01135394|58650248|FG000|Study Treatment|Adverse Event|2|||
30638353|NCT00949884|58650255|FG000|Overall Study|Adverse Event|14|||
30638354|NCT00949884|58650256|FG001|Overall Study|Adverse Event|3|||
30638355|NCT00949884|58650257|FG002|Overall Study|Adverse Event|12|||
30638356|NCT00949884|58650255|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
30638357|NCT00949884|58650256|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
30638358|NCT00949884|58650257|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
30638359|NCT00949884|58650255|FG000|Overall Study|Lost to Follow-up|7|||
30638360|NCT00949884|58650256|FG001|Overall Study|Lost to Follow-up|5|||
30638361|NCT00949884|58650257|FG002|Overall Study|Lost to Follow-up|5|||
30638362|NCT00949884|58650255|FG000|Overall Study|Physician Decision|5|||
30638363|NCT00949884|58650256|FG001|Overall Study|Physician Decision|0|||
30638364|NCT00949884|58650257|FG002|Overall Study|Physician Decision|6|||
30638365|NCT00949884|58650255|FG000|Overall Study|Treatment non-compliance|5|||
30638366|NCT00949884|58650256|FG001|Overall Study|Treatment non-compliance|0|||
30638367|NCT00949884|58650257|FG002|Overall Study|Treatment non-compliance|8|||
30638368|NCT00949884|58650255|FG000|Overall Study|Withdrawal by Subject|13|||
30638369|NCT00949884|58650256|FG001|Overall Study|Withdrawal by Subject|4|||
30638370|NCT00949884|58650257|FG002|Overall Study|Withdrawal by Subject|16|||
30638371|NCT00949884|58650255|FG000|Overall Study|Lack of Efficacy|4|||
30638372|NCT00949884|58650256|FG001|Overall Study|Lack of Efficacy|2|||
30638373|NCT00949884|58650257|FG002|Overall Study|Lack of Efficacy|7|||
30638374|NCT00949884|58650255|FG000|Overall Study|Study terminated by sponsor|0|||
30638375|NCT00949884|58650256|FG001|Overall Study|Study terminated by sponsor|0|||
30638376|NCT00949884|58650257|FG002|Overall Study|Study terminated by sponsor|1|||
30638377|NCT00949650|58650268|FG000|Overall Study|Progressive disease|188|||
30638378|NCT00949650|58650269|FG001|Overall Study|Progressive disease|19|||
30638379|NCT00949650|58650268|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
30638380|NCT00949650|58650269|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
30638381|NCT00949650|58650268|FG000|Overall Study|Other Adverse Event (AE)|28|||
30638382|NCT00949650|58650269|FG001|Overall Study|Other Adverse Event (AE)|17|||
30638383|NCT00949650|58650268|FG000|Overall Study|Protocol Violation|1|||
30638384|NCT00949650|58650269|FG001|Overall Study|Protocol Violation|4|||
30638385|NCT00949650|58650268|FG000|Overall Study|Refusal to continue medication|7|||
30638386|NCT00949650|58650269|FG001|Overall Study|Refusal to continue medication|11|||
30638387|NCT00949650|58650268|FG000|Overall Study|Not treated|1|||
30638388|NCT00949650|58650269|FG001|Overall Study|Not treated|4|||
30638389|NCT00949650|58650268|FG000|Overall Study|Other not specified above|5|||
30638390|NCT00949650|58650269|FG001|Overall Study|Other not specified above|0|||
30638391|NCT00908037|58650286|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
30638392|NCT00908037|58650287|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
30638393|NCT00908037|58650288|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
30638394|NCT00908037|58650289|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
30638395|NCT00908037|58650290|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
30638396|NCT00908037|58650291|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
30638397|NCT00908037|58650292|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
30638398|NCT00908037|58650293|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
30638399|NCT00908037|58650294|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
30638400|NCT00908037|58650295|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
30638401|NCT00908037|58650296|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
30638402|NCT00908037|58650297|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
30638403|NCT00908037|58650286|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
30638404|NCT00908037|58650287|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
30638405|NCT00908037|58650288|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
30638406|NCT00908037|58650289|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
30638407|NCT00908037|58650290|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
30638408|NCT00908037|58650291|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
30638409|NCT00908037|58650292|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
30638410|NCT00908037|58650293|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
30638411|NCT00908037|58650294|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
30638412|NCT00908037|58650295|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
30638413|NCT00908037|58650296|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
30638414|NCT00908037|58650297|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
30638415|NCT00908037|58650286|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
30638416|NCT00908037|58650287|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
30638417|NCT00908037|58650288|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
30638418|NCT00908037|58650289|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
30638419|NCT00908037|58650290|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
30638420|NCT00908037|58650291|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
30638421|NCT00908037|58650292|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
30638422|NCT00908037|58650293|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
30638423|NCT00908037|58650294|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
30765458|NCT00318461|58774018|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
30765459|NCT00318461|58774019|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
30765460|NCT00318461|58774020|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
30765461|NCT00318461|58774021|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
30765462|NCT03764072|58774048|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
30765463|NCT03764072|58774049|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
30765464|NCT03764072|58774050|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
30765465|NCT03764072|58774051|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
30765466|NCT03764072|58774052|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
30765467|NCT03764072|58774053|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
30765468|NCT03764072|58774048|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
30765469|NCT03764072|58774049|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
30765470|NCT03764072|58774050|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
30765471|NCT03764072|58774051|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
30765472|NCT03764072|58774052|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
30765473|NCT03764072|58774053|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
30765474|NCT03764072|58774048|FG000|Overall Study|Lost to Follow-up|0|||
30765475|NCT03764072|58774049|FG001|Overall Study|Lost to Follow-up|0|||
30765476|NCT03764072|58774050|FG002|Overall Study|Lost to Follow-up|0|||
30765477|NCT03764072|58774051|FG003|Overall Study|Lost to Follow-up|0|||
30765478|NCT03764072|58774052|FG004|Overall Study|Lost to Follow-up|1|||
30765479|NCT03764072|58774053|FG005|Overall Study|Lost to Follow-up|0|||
30765480|NCT03333928|58774075|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
30765481|NCT03333928|58774076|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
30765482|NCT03333928|58774077|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
30765483|NCT03333928|58774075|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
30765484|NCT03333928|58774076|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
30765485|NCT03333928|58774077|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
30765486|NCT03333928|58774075|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
30765487|NCT03333928|58774076|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
30765488|NCT03333928|58774077|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
30765489|NCT03333928|58774075|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
30765490|NCT03333928|58774076|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
30638424|NCT00908037|58650295|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
30638425|NCT00908037|58650296|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
30638426|NCT00908037|58650297|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
30638427|NCT00908037|58650286|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
30638428|NCT00908037|58650287|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
30638429|NCT00908037|58650288|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
30638430|NCT00908037|58650289|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
30638431|NCT00908037|58650290|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
30638432|NCT00908037|58650291|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
30638433|NCT00908037|58650292|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
30638434|NCT00908037|58650293|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
30638435|NCT00908037|58650294|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
30638436|NCT00908037|58650295|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
30638437|NCT00908037|58650296|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
30638438|NCT00908037|58650297|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
30638439|NCT00908037|58650286|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
30638440|NCT00908037|58650287|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
30638441|NCT00908037|58650288|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
30638442|NCT00908037|58650289|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
30638443|NCT00908037|58650290|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
30638444|NCT00908037|58650291|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
30638445|NCT00908037|58650292|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
30638446|NCT00908037|58650293|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
30638447|NCT00908037|58650294|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
30638448|NCT00908037|58650295|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
30638449|NCT00908037|58650296|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
30638450|NCT00908037|58650297|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
30638451|NCT00908037|58650286|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
30638452|NCT00908037|58650287|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
30638453|NCT00908037|58650288|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
30638454|NCT00908037|58650289|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
30638455|NCT00908037|58650290|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
30638456|NCT00908037|58650291|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
30638457|NCT00908037|58650292|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
30638458|NCT00908037|58650293|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
30638459|NCT00908037|58650294|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
30638460|NCT00908037|58650295|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
30638461|NCT00908037|58650296|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
30638462|NCT00908037|58650297|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
30638463|NCT00908037|58650286|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
30638464|NCT00908037|58650287|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
30638465|NCT00908037|58650288|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
30638466|NCT00908037|58650289|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
30638467|NCT00908037|58650290|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
30638468|NCT00908037|58650291|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
30638469|NCT00908037|58650292|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
30638470|NCT00908037|58650293|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
30638471|NCT00908037|58650294|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
30638472|NCT00908037|58650295|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
30638473|NCT00908037|58650296|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
30638474|NCT00908037|58650297|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
30638475|NCT00908037|58650286|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
30638476|NCT00908037|58650287|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
30638477|NCT00908037|58650288|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
30638478|NCT00908037|58650289|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
30638479|NCT00908037|58650290|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
30638480|NCT00908037|58650291|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
30638481|NCT00908037|58650292|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
30638482|NCT00908037|58650293|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
30638483|NCT00908037|58650294|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
30638484|NCT00908037|58650295|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
30638485|NCT00908037|58650296|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
30638486|NCT00908037|58650297|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
30638487|NCT00908037|58650286|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
30638488|NCT00908037|58650287|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
30638489|NCT00908037|58650288|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
30638490|NCT00908037|58650289|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
30638491|NCT00908037|58650290|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
30638492|NCT00908037|58650291|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
30638493|NCT00908037|58650292|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
30638494|NCT00908037|58650293|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
30638495|NCT00908037|58650294|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
30638496|NCT00908037|58650295|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
30638497|NCT00908037|58650296|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
30638498|NCT00908037|58650297|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
30638499|NCT00904215|58650349|FG000|Overall Study|Adverse Event|25|||
30638500|NCT00904215|58650349|FG000|Overall Study|Protocol Violation|10|||
30638501|NCT00904215|58650349|FG000|Overall Study|Lost to Follow-up|63|||
30638502|NCT00904215|58650349|FG000|Overall Study|Withdrawal by Subject|9|||
30638503|NCT00904215|58650349|FG000|Overall Study|Other|28|||
30638504|NCT00905307|58650359|FG000|Overall Study|Switched to Open Label Rescue|7|||
30638505|NCT00905307|58650360|FG001|Overall Study|Switched to Open Label Rescue|17|||
30638506|NCT00905307|58650361|FG002|Overall Study|Switched to Open Label Rescue|11|||
30638507|NCT00905307|58650362|FG003|Overall Study|Switched to Open Label Rescue|11|||
30638508|NCT00905307|58650363|FG004|Overall Study|Switched to Open Label Rescue|4|||
30638509|NCT00905307|58650364|FG005|Overall Study|Switched to Open Label Rescue|15|||
30638510|NCT00905307|58650359|FG000|Overall Study|Lost to Follow-up|0|||
30638511|NCT00905307|58650360|FG001|Overall Study|Lost to Follow-up|0|||
30638512|NCT00905307|58650361|FG002|Overall Study|Lost to Follow-up|0|||
30638513|NCT00905307|58650362|FG003|Overall Study|Lost to Follow-up|0|||
30638514|NCT00905307|58650363|FG004|Overall Study|Lost to Follow-up|1|||
30638515|NCT00905307|58650364|FG005|Overall Study|Lost to Follow-up|1|||
30638516|NCT00905307|58650359|FG000|Overall Study|Adverse Event|3|||
30638517|NCT00905307|58650360|FG001|Overall Study|Adverse Event|4|||
30638518|NCT00905307|58650361|FG002|Overall Study|Adverse Event|5|||
30638519|NCT00905307|58650362|FG003|Overall Study|Adverse Event|11|||
30638520|NCT00905307|58650363|FG004|Overall Study|Adverse Event|3|||
30638521|NCT00905307|58650364|FG005|Overall Study|Adverse Event|5|||
30638522|NCT00905307|58650359|FG000|Overall Study|Withdrawal by Subject|5|||
30638523|NCT00905307|58650360|FG001|Overall Study|Withdrawal by Subject|13|||
30638524|NCT00905307|58650361|FG002|Overall Study|Withdrawal by Subject|15|||
30638525|NCT00905307|58650362|FG003|Overall Study|Withdrawal by Subject|11|||
30638526|NCT00905307|58650363|FG004|Overall Study|Withdrawal by Subject|4|||
30638527|NCT00905307|58650364|FG005|Overall Study|Withdrawal by Subject|13|||
30638528|NCT00905307|58650359|FG000|Overall Study|Protocol Violation|1|||
30638529|NCT00905307|58650360|FG001|Overall Study|Protocol Violation|0|||
30638530|NCT00905307|58650361|FG002|Overall Study|Protocol Violation|1|||
30638531|NCT00905307|58650362|FG003|Overall Study|Protocol Violation|0|||
30638532|NCT00905307|58650363|FG004|Overall Study|Protocol Violation|0|||
30638533|NCT00905307|58650364|FG005|Overall Study|Protocol Violation|0|||
30638534|NCT00905307|58650359|FG000|Overall Study|Lack of Efficacy|6|||
30638535|NCT00905307|58650360|FG001|Overall Study|Lack of Efficacy|3|||
30638536|NCT00905307|58650361|FG002|Overall Study|Lack of Efficacy|5|||
30638537|NCT00905307|58650362|FG003|Overall Study|Lack of Efficacy|4|||
30638538|NCT00905307|58650363|FG004|Overall Study|Lack of Efficacy|4|||
30638539|NCT00905307|58650364|FG005|Overall Study|Lack of Efficacy|8|||
30638540|NCT00907881|58650391|FG000|Overall Study|Lost to Follow-up|59|||
30638541|NCT00907881|58650391|FG000|Overall Study|Noncompliance|5|||
30638542|NCT00907881|58650391|FG000|Overall Study|Withdrawal by Subject|5|||
30951428|NCT03219034|58998643|FG000|Overall Study|Additional dental work needed|1|||
30638543|NCT00907881|58650391|FG000|Overall Study|Protocol Violation|1|||
30638544|NCT00907881|58650391|FG000|Overall Study|Missing discontinuation information|15|||
30638545|NCT00904917|58650399|FG000|Overall Study|Lost to Follow-up|2|||
30638546|NCT00904917|58650400|FG001|Overall Study|Lost to Follow-up|2|||
30638547|NCT00904917|58650401|FG002|Overall Study|Lost to Follow-up|2|||
30638548|NCT00904917|58650402|FG003|Overall Study|Lost to Follow-up|2|||
30638549|NCT00904839|58650417|FG000|Overall Study|Adverse Event|0|||
30638550|NCT00904839|58650418|FG001|Overall Study|Adverse Event|5|||
30638551|NCT00904839|58650419|FG002|Overall Study|Adverse Event|4|||
30638552|NCT00904839|58650417|FG000|Overall Study|Protocol Violation|0|||
30638553|NCT00904839|58650418|FG001|Overall Study|Protocol Violation|1|||
30638554|NCT00904839|58650419|FG002|Overall Study|Protocol Violation|1|||
30638555|NCT00904839|58650417|FG000|Overall Study|Lost to Follow-up|0|||
30638556|NCT00904839|58650418|FG001|Overall Study|Lost to Follow-up|1|||
30638557|NCT00904839|58650419|FG002|Overall Study|Lost to Follow-up|2|||
30638558|NCT00904839|58650417|FG000|Overall Study|Withdrawal by Subject|0|||
30638559|NCT00904839|58650418|FG001|Overall Study|Withdrawal by Subject|2|||
30638560|NCT00904839|58650419|FG002|Overall Study|Withdrawal by Subject|0|||
30638561|NCT00904839|58650417|FG000|Overall Study|Not treated|1|||
30638562|NCT00904839|58650418|FG001|Overall Study|Not treated|0|||
30638563|NCT00904839|58650419|FG002|Overall Study|Not treated|1|||
30638564|NCT00904839|58650417|FG000|Overall Study|Other than above|0|||
30638565|NCT00904839|58650418|FG001|Overall Study|Other than above|9|||
30638566|NCT00904839|58650419|FG002|Overall Study|Other than above|7|||
30638567|NCT00903357|58650430|FG000|First Intervention|Withdrawal by Subject|5|||
30638568|NCT00903357|58650431|FG001|First Intervention|Withdrawal by Subject|3|||
30638569|NCT00903357|58650430|FG000|First Intervention|Flu|0|||
30638570|NCT00903357|58650431|FG001|First Intervention|Flu|1|||
30638571|NCT00903357|58650430|FG000|Wash Out Period of 2 Weeks|Flu|0|||
30638572|NCT00903357|58650431|FG001|Wash Out Period of 2 Weeks|Flu|1|||
30638573|NCT00903357|58650430|FG000|Second Intervention|Lost to Follow-up|1|||
30638574|NCT00903357|58650431|FG001|Second Intervention|Lost to Follow-up|0|||
30638575|NCT00904371|58650441|FG000|Overall Study|Adverse Event|2|||
30638576|NCT00904371|58650441|FG000|Overall Study|Lost to Follow-up|4|||
30638577|NCT00904371|58650441|FG000|Overall Study|Discontinued at target blood pressure|2|||
30638578|NCT00904371|58650441|FG000|Overall Study|Continued with Tritace|1|||
30638579|NCT01104662|58650453|FG000|Overall Study|Adverse Event|2|||
30638580|NCT01104662|58650454|FG001|Overall Study|Adverse Event|2|||
30638581|NCT01104662|58650455|FG002|Overall Study|Adverse Event|0|||
30638582|NCT01104662|58650456|FG003|Overall Study|Adverse Event|1|||
30638583|NCT01104662|58650457|FG004|Overall Study|Adverse Event|1|||
30638584|NCT01104662|58650458|FG005|Overall Study|Adverse Event|1|||
30638585|NCT01104662|58650459|FG006|Overall Study|Adverse Event|0|||
30638586|NCT01104662|58650460|FG007|Overall Study|Adverse Event|0|||
30638587|NCT01104662|58650453|FG000|Overall Study|Clinical Failure|1|||
30638588|NCT01104662|58650454|FG001|Overall Study|Clinical Failure|0|||
30638589|NCT01104662|58650455|FG002|Overall Study|Clinical Failure|0|||
30638590|NCT01104662|58650456|FG003|Overall Study|Clinical Failure|0|||
30638591|NCT01104662|58650457|FG004|Overall Study|Clinical Failure|0|||
30638592|NCT01104662|58650458|FG005|Overall Study|Clinical Failure|1|||
30638593|NCT01104662|58650459|FG006|Overall Study|Clinical Failure|0|||
30638594|NCT01104662|58650460|FG007|Overall Study|Clinical Failure|0|||
30638595|NCT01104662|58650453|FG000|Overall Study|Participant left investigator's care|1|||
30638596|NCT01104662|58650454|FG001|Overall Study|Participant left investigator's care|1|||
30638597|NCT01104662|58650455|FG002|Overall Study|Participant left investigator's care|0|||
30638598|NCT01104662|58650456|FG003|Overall Study|Participant left investigator's care|0|||
30638599|NCT01104662|58650457|FG004|Overall Study|Participant left investigator's care|0|||
30638600|NCT01104662|58650458|FG005|Overall Study|Participant left investigator's care|0|||
30638601|NCT01104662|58650459|FG006|Overall Study|Participant left investigator's care|0|||
30638602|NCT01104662|58650460|FG007|Overall Study|Participant left investigator's care|0|||
30638603|NCT01104662|58650453|FG000|Overall Study|Reason not specified|3|||
30638604|NCT01104662|58650454|FG001|Overall Study|Reason not specified|3|||
30638605|NCT01104662|58650455|FG002|Overall Study|Reason not specified|0|||
30638606|NCT01104662|58650456|FG003|Overall Study|Reason not specified|0|||
30638607|NCT01104662|58650457|FG004|Overall Study|Reason not specified|0|||
30638608|NCT01104662|58650458|FG005|Overall Study|Reason not specified|1|||
30638609|NCT01104662|58650459|FG006|Overall Study|Reason not specified|0|||
30638610|NCT01104662|58650460|FG007|Overall Study|Reason not specified|0|||
30848508|NCT02851511|58874631|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
30848509|NCT02851511|58874632|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
30951429|NCT03219034|58998644|FG001|Overall Study|Additional dental work needed|0|||
30638611|NCT01104662|58650453|FG000|Overall Study|Randomized but not treated|3|||
30638612|NCT01104662|58650454|FG001|Overall Study|Randomized but not treated|4|||
30638613|NCT01104662|58650455|FG002|Overall Study|Randomized but not treated|1|||
30638614|NCT01104662|58650456|FG003|Overall Study|Randomized but not treated|0|||
30638615|NCT01104662|58650457|FG004|Overall Study|Randomized but not treated|0|||
30638616|NCT01104662|58650458|FG005|Overall Study|Randomized but not treated|1|||
30638617|NCT01104662|58650459|FG006|Overall Study|Randomized but not treated|0|||
30638618|NCT01104662|58650460|FG007|Overall Study|Randomized but not treated|0|||
30638619|NCT01104584|58650479|FG000|Overall Study|Study drug never administered|21|||
30638620|NCT01104584|58650479|FG000|Overall Study|Study prematurely discontinued|2|||
30638621|NCT01103960|58650503|FG000|Overall Study|Adverse Event|2|||
30638622|NCT01103960|58650504|FG001|Overall Study|Adverse Event|1|||
30638623|NCT01103960|58650503|FG000|Overall Study|Withdrawal by Subject|2|||
30638624|NCT01103960|58650504|FG001|Overall Study|Withdrawal by Subject|1|||
30638625|NCT01103960|58650503|FG000|Overall Study|Other|1|||
30638626|NCT01103960|58650504|FG001|Overall Study|Other|0|||
30638627|NCT01107392|58650512|FG000|Overall Study|Adverse Event|2|||
30638628|NCT01107392|58650513|FG001|Overall Study|Adverse Event|0|||
30638629|NCT01107392|58650512|FG000|Overall Study|Personal Reasons|2|||
30638630|NCT01107392|58650513|FG001|Overall Study|Personal Reasons|3|||
30638631|NCT01107392|58650512|FG000|Overall Study|Administrative decision|1|||
30638632|NCT01107392|58650513|FG001|Overall Study|Administrative decision|0|||
30638633|NCT01106846|58650521|FG000|Overall Study|Change in surgical procedure|0|||
30638634|NCT01106846|58650522|FG001|Overall Study|Change in surgical procedure|1|||
30638635|NCT00902577|58650528|FG000|Overall Study|Withdrawal by Subject|6|||
30638636|NCT00902577|58650528|FG000|Overall Study|FMISO production failure|2|||
30638637|NCT01106690|58650563|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
30638638|NCT01106690|58650564|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
30638639|NCT01106690|58650565|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
30638640|NCT01106690|58650563|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
30638641|NCT01106690|58650564|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
30638642|NCT01106690|58650565|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
30638643|NCT01106690|58650563|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
30638644|NCT01106690|58650564|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
30638645|NCT01106690|58650565|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
30638646|NCT01106690|58650563|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
30638647|NCT01106690|58650564|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
30638648|NCT01106690|58650565|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
30638649|NCT01106690|58650563|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
30638650|NCT01106690|58650564|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
30638651|NCT01106690|58650565|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
30638652|NCT01106690|58650563|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
30638653|NCT01106690|58650564|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
30638654|NCT01106690|58650565|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
30638655|NCT01106690|58650563|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
30638656|NCT01106690|58650564|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
30638657|NCT01106690|58650565|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
30638658|NCT01106690|58650563|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
30638659|NCT01106690|58650564|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
30638660|NCT01106690|58650565|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
30638661|NCT01106690|58650563|FG000|Core Period: Baseline to Week 26|Other|10|||
30638662|NCT01106690|58650564|FG001|Core Period: Baseline to Week 26|Other|2|||
30638663|NCT01106690|58650565|FG002|Core Period: Baseline to Week 26|Other|6|||
30638664|NCT01106690|58650563|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
30638665|NCT01106690|58650564|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
30638666|NCT01106690|58650565|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
30638667|NCT01106690|58650563|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
30638668|NCT01106690|58650564|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
30638669|NCT01106690|58650565|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
30638670|NCT01106690|58650563|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
30638671|NCT01106690|58650564|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
30638672|NCT01106690|58650565|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
30638673|NCT01106690|58650563|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
30638674|NCT01106690|58650564|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
30638675|NCT01106690|58650565|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
30638676|NCT01106690|58650563|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
30638677|NCT01106690|58650564|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
30638678|NCT01106690|58650565|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
30638679|NCT01106690|58650563|FG000|Extension Period: Week 26 to Week 52|Other|8|||
30638680|NCT01106690|58650564|FG001|Extension Period: Week 26 to Week 52|Other|3|||
30638681|NCT01106690|58650565|FG002|Extension Period: Week 26 to Week 52|Other|4|||
30638682|NCT01106690|58650563|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
30638683|NCT01106690|58650564|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
30848510|NCT02851511|58874629|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
30848511|NCT02851511|58874630|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
30638684|NCT01106690|58650565|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
30638685|NCT01103180|58650595|FG000|Overall Study|Withdrawal by Subject|8|||
30638686|NCT01103180|58650596|FG001|Overall Study|Withdrawal by Subject|13|||
30638687|NCT01103180|58650595|FG000|Overall Study|Lost to Follow-up|13|||
30638688|NCT01103180|58650596|FG001|Overall Study|Lost to Follow-up|7|||
30638689|NCT01103180|58650595|FG000|Overall Study|Physician Decision|1|||
30638690|NCT01103180|58650596|FG001|Overall Study|Physician Decision|0|||
30638691|NCT01103180|58650595|FG000|Overall Study|Protocol Violation|0|||
30638692|NCT01103180|58650596|FG001|Overall Study|Protocol Violation|1|||
30638693|NCT00944034|58650614|FG000|Overall Study|Inappropriate enrollment|0|||
30638694|NCT00944034|58650615|FG001|Overall Study|Inappropriate enrollment|1|||
30638695|NCT00944034|58650616|FG002|Overall Study|Inappropriate enrollment|0|||
30638696|NCT00944034|58650617|FG003|Overall Study|Inappropriate enrollment|1|||
30638697|NCT00944034|58650618|FG004|Overall Study|Inappropriate enrollment|2|||
30638698|NCT00944034|58650619|FG005|Overall Study|Inappropriate enrollment|1|||
30638699|NCT00944034|58650620|FG006|Overall Study|Inappropriate enrollment|0|||
30638700|NCT00944034|58650621|FG007|Overall Study|Inappropriate enrollment|0|||
30951430|NCT03219034|58998643|FG000|Overall Study|UPPP Surgery|1|||
30951431|NCT03219034|58998644|FG001|Overall Study|UPPP Surgery|0|||
30951432|NCT03219034|58998643|FG000|Overall Study|Dental sensitivity|0|||
30951433|NCT03219034|58998644|FG001|Overall Study|Dental sensitivity|1|||
30951434|NCT03219034|58998643|FG000|Overall Study|Death in family|0|||
30951435|NCT03219034|58998644|FG001|Overall Study|Death in family|1|||
30951436|NCT01706198|58998668|FG000|Overall Study|Adverse Event|12|||
30951437|NCT01706198|58998669|FG001|Overall Study|Adverse Event|15|||
30951438|NCT01706198|58998668|FG000|Overall Study|Protocol Violation|7|||
30951439|NCT01706198|58998669|FG001|Overall Study|Protocol Violation|5|||
30951440|NCT01706198|58998668|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
30951441|NCT01706198|58998669|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
30951442|NCT01706198|58998668|FG000|Overall Study|Lost to Follow-up|97|||
30951443|NCT01706198|58998669|FG001|Overall Study|Lost to Follow-up|93|||
30951444|NCT01706198|58998668|FG000|Overall Study|Physician Decision|23|||
30951445|NCT01706198|58998669|FG001|Overall Study|Physician Decision|37|||
30951446|NCT01706198|58998668|FG000|Overall Study|Withdrawal by Subject|23|||
30951447|NCT01706198|58998669|FG001|Overall Study|Withdrawal by Subject|31|||
30951448|NCT01705730|58998675|FG000|Overall Study|Lack of Efficacy|1|||
30951449|NCT01705730|58998675|FG000|Overall Study|Adverse Event|3|||
30951450|NCT01705730|58998675|FG000|Overall Study|Lost to Follow-up|1|||
30951451|NCT01705730|58998675|FG000|Overall Study|Reason not Specified|4|||
30951452|NCT01705652|58998681|FG000|Overall Study|Adverse Event|1|||
30951453|NCT01705652|58998682|FG001|Overall Study|Adverse Event|0|||
30951454|NCT01705652|58998681|FG000|Overall Study|Withdrawal by Subject|1|||
30951455|NCT01705652|58998682|FG001|Overall Study|Withdrawal by Subject|2|||
30951456|NCT01705652|58998681|FG000|Overall Study|non-compliance|1|||
30951457|NCT01705652|58998682|FG001|Overall Study|non-compliance|1|||
30951458|NCT01705574|58998710|FG000|Double-Blind Phase|Lost to Follow-up|12|||
30951459|NCT01705574|58998711|FG001|Double-Blind Phase|Lost to Follow-up|16|||
30951460|NCT01705574|58998712|FG002|Double-Blind Phase|Lost to Follow-up|0|||
30951461|NCT01705574|58998713|FG003|Double-Blind Phase|Lost to Follow-up|0|||
30951462|NCT01705574|58998710|FG000|Double-Blind Phase|Adverse Event|3|||
30951463|NCT01705574|58998711|FG001|Double-Blind Phase|Adverse Event|10|||
30951464|NCT01705574|58998712|FG002|Double-Blind Phase|Adverse Event|0|||
30951465|NCT01705574|58998713|FG003|Double-Blind Phase|Adverse Event|0|||
30951466|NCT01705574|58998710|FG000|Double-Blind Phase|Withdrew Consent|8|||
30951467|NCT01705574|58998711|FG001|Double-Blind Phase|Withdrew Consent|5|||
30951468|NCT01705574|58998712|FG002|Double-Blind Phase|Withdrew Consent|0|||
30951469|NCT01705574|58998713|FG003|Double-Blind Phase|Withdrew Consent|0|||
30951470|NCT01705574|58998710|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
30951471|NCT01705574|58998711|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
30951472|NCT01705574|58998712|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
30951473|NCT01705574|58998713|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
30951474|NCT01705574|58998710|FG000|Double-Blind Phase|Pregnancy|1|||
30951475|NCT01705574|58998711|FG001|Double-Blind Phase|Pregnancy|1|||
30951476|NCT01705574|58998712|FG002|Double-Blind Phase|Pregnancy|0|||
30951477|NCT01705574|58998713|FG003|Double-Blind Phase|Pregnancy|0|||
30951478|NCT01705574|58998710|FG000|Double-Blind Phase|Protocol Violation|1|||
30951479|NCT01705574|58998711|FG001|Double-Blind Phase|Protocol Violation|0|||
30951480|NCT01705574|58998712|FG002|Double-Blind Phase|Protocol Violation|0|||
30951481|NCT01705574|58998713|FG003|Double-Blind Phase|Protocol Violation|0|||
30951482|NCT01705574|58998710|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
30638701|NCT00944034|58650622|FG008|Overall Study|Inappropriate enrollment|1|||
30951483|NCT01705574|58998711|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
30638702|NCT00944034|58650623|FG009|Overall Study|Inappropriate enrollment|1|||
30638703|NCT00944034|58650624|FG010|Overall Study|Inappropriate enrollment|0|||
30951484|NCT01705574|58998712|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
30951485|NCT01705574|58998713|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
30951486|NCT01705574|58998710|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
30951487|NCT01705574|58998711|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
30951488|NCT01705574|58998712|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
30638704|NCT00944034|58650625|FG011|Overall Study|Inappropriate enrollment|0|||
30638705|NCT00944034|58650614|FG000|Overall Study|Withdrawal by Subject|3|||
30638706|NCT00944034|58650615|FG001|Overall Study|Withdrawal by Subject|2|||
30638707|NCT00944034|58650616|FG002|Overall Study|Withdrawal by Subject|6|||
30638708|NCT00944034|58650617|FG003|Overall Study|Withdrawal by Subject|2|||
30638709|NCT00944034|58650618|FG004|Overall Study|Withdrawal by Subject|5|||
30638710|NCT00944034|58650619|FG005|Overall Study|Withdrawal by Subject|8|||
30638711|NCT00944034|58650620|FG006|Overall Study|Withdrawal by Subject|2|||
30638712|NCT00944034|58650621|FG007|Overall Study|Withdrawal by Subject|2|||
30638713|NCT00944034|58650622|FG008|Overall Study|Withdrawal by Subject|3|||
30638714|NCT00944034|58650623|FG009|Overall Study|Withdrawal by Subject|4|||
30638715|NCT00944034|58650624|FG010|Overall Study|Withdrawal by Subject|0|||
30638716|NCT00944034|58650625|FG011|Overall Study|Withdrawal by Subject|4|||
30638717|NCT00944034|58650614|FG000|Overall Study|Lost to Follow-up|0|||
30638718|NCT00944034|58650615|FG001|Overall Study|Lost to Follow-up|4|||
30638719|NCT00944034|58650616|FG002|Overall Study|Lost to Follow-up|2|||
30638720|NCT00944034|58650617|FG003|Overall Study|Lost to Follow-up|0|||
30638721|NCT00944034|58650618|FG004|Overall Study|Lost to Follow-up|5|||
30638722|NCT00944034|58650619|FG005|Overall Study|Lost to Follow-up|7|||
30638723|NCT00944034|58650620|FG006|Overall Study|Lost to Follow-up|0|||
30638724|NCT00944034|58650621|FG007|Overall Study|Lost to Follow-up|1|||
30638725|NCT00944034|58650622|FG008|Overall Study|Lost to Follow-up|5|||
30638726|NCT00944034|58650623|FG009|Overall Study|Lost to Follow-up|1|||
30638727|NCT00944034|58650624|FG010|Overall Study|Lost to Follow-up|1|||
30638728|NCT00944034|58650625|FG011|Overall Study|Lost to Follow-up|0|||
30638729|NCT00944034|58650614|FG000|Overall Study|Death|0|||
30638730|NCT00944034|58650615|FG001|Overall Study|Death|0|||
30638731|NCT00944034|58650616|FG002|Overall Study|Death|1|||
30638732|NCT00944034|58650617|FG003|Overall Study|Death|0|||
30638733|NCT00944034|58650618|FG004|Overall Study|Death|0|||
30638734|NCT00944034|58650619|FG005|Overall Study|Death|0|||
30638735|NCT00944034|58650620|FG006|Overall Study|Death|0|||
30638736|NCT00944034|58650621|FG007|Overall Study|Death|0|||
30638737|NCT00944034|58650622|FG008|Overall Study|Death|0|||
30638738|NCT00944034|58650623|FG009|Overall Study|Death|0|||
30638739|NCT00944034|58650624|FG010|Overall Study|Death|0|||
30638740|NCT00944034|58650625|FG011|Overall Study|Death|0|||
30638741|NCT00944034|58650614|FG000|Overall Study|Protocol Violation|2|||
30638742|NCT00944034|58650615|FG001|Overall Study|Protocol Violation|0|||
30638743|NCT00944034|58650616|FG002|Overall Study|Protocol Violation|0|||
30638744|NCT00944034|58650617|FG003|Overall Study|Protocol Violation|1|||
30638745|NCT00944034|58650618|FG004|Overall Study|Protocol Violation|2|||
30638746|NCT00944034|58650619|FG005|Overall Study|Protocol Violation|3|||
30638747|NCT00944034|58650620|FG006|Overall Study|Protocol Violation|0|||
30638748|NCT00944034|58650621|FG007|Overall Study|Protocol Violation|1|||
30638749|NCT00944034|58650622|FG008|Overall Study|Protocol Violation|1|||
30638750|NCT00944034|58650623|FG009|Overall Study|Protocol Violation|4|||
30638751|NCT00944034|58650624|FG010|Overall Study|Protocol Violation|0|||
30638752|NCT00944034|58650625|FG011|Overall Study|Protocol Violation|0|||
30638753|NCT00944034|58650614|FG000|Overall Study|Unable to classify|0|||
30638754|NCT00944034|58650615|FG001|Overall Study|Unable to classify|0|||
30638755|NCT00944034|58650616|FG002|Overall Study|Unable to classify|0|||
30638756|NCT00944034|58650617|FG003|Overall Study|Unable to classify|0|||
30638757|NCT00944034|58650618|FG004|Overall Study|Unable to classify|0|||
30638758|NCT00944034|58650619|FG005|Overall Study|Unable to classify|1|||
30638759|NCT00944034|58650620|FG006|Overall Study|Unable to classify|1|||
30638760|NCT00944034|58650621|FG007|Overall Study|Unable to classify|1|||
30638761|NCT00944034|58650622|FG008|Overall Study|Unable to classify|0|||
30638762|NCT00944034|58650623|FG009|Overall Study|Unable to classify|0|||
30638763|NCT00944034|58650624|FG010|Overall Study|Unable to classify|0|||
30638764|NCT00944034|58650625|FG011|Overall Study|Unable to classify|0|||
30638765|NCT00944034|58650614|FG000|Overall Study|Administrative reason|0|||
30638766|NCT00944034|58650615|FG001|Overall Study|Administrative reason|0|||
30638767|NCT00944034|58650616|FG002|Overall Study|Administrative reason|0|||
30638768|NCT00944034|58650617|FG003|Overall Study|Administrative reason|0|||
30638769|NCT00944034|58650618|FG004|Overall Study|Administrative reason|0|||
30638770|NCT00944034|58650619|FG005|Overall Study|Administrative reason|0|||
30638771|NCT00944034|58650620|FG006|Overall Study|Administrative reason|1|||
30638772|NCT00944034|58650621|FG007|Overall Study|Administrative reason|0|||
30638773|NCT00944034|58650622|FG008|Overall Study|Administrative reason|0|||
30638774|NCT00944034|58650623|FG009|Overall Study|Administrative reason|0|||
30638775|NCT00944034|58650624|FG010|Overall Study|Administrative reason|0|||
30638776|NCT00944034|58650625|FG011|Overall Study|Administrative reason|0|||
30638777|NCT01106534|58650668|FG000|Overall Study|Withdrawal by Subject|18|||
30638778|NCT01106534|58650668|FG000|Overall Study|Lost to Follow-up|2|||
30638779|NCT01106534|58650668|FG000|Overall Study|Death|16|||
30638780|NCT01106534|58650668|FG000|Overall Study|Physician Decision|1|||
30638781|NCT00941304|58650678|FG000|Overall Study|Lost to Follow-up|1|||
30638782|NCT00941304|58650679|FG001|Overall Study|Lost to Follow-up|0|||
30638783|NCT00941304|58650680|FG002|Overall Study|Lost to Follow-up|0|||
30638784|NCT00941304|58650681|FG003|Overall Study|Lost to Follow-up|0|||
30638785|NCT00941304|58650682|FG004|Overall Study|Lost to Follow-up|0|||
30638786|NCT00941070|58650694|FG000|Overall Study|Patient non-compliant|1|||
30638787|NCT01098812|58650703|FG000|Overall Study|Death|2|||
30638788|NCT01098812|58650704|FG001|Overall Study|Death|0|||
30638789|NCT01098812|58650705|FG002|Overall Study|Death|1|||
30638790|NCT01098812|58650703|FG000|Overall Study|Lost to Follow-up|0|||
30638791|NCT01098812|58650704|FG001|Overall Study|Lost to Follow-up|1|||
30638792|NCT01098812|58650705|FG002|Overall Study|Lost to Follow-up|0|||
30638793|NCT00903201|58650715|FG000|Overall Study|Adverse Event|1|||
30638794|NCT00903201|58650716|FG001|Overall Study|Adverse Event|4|||
30638795|NCT00903201|58650717|FG002|Overall Study|Adverse Event|0|||
30638796|NCT00903201|58650715|FG000|Overall Study|Protocol Violation|2|||
30638797|NCT00903201|58650716|FG001|Overall Study|Protocol Violation|1|||
30638798|NCT00903201|58650717|FG002|Overall Study|Protocol Violation|0|||
30638799|NCT00903201|58650715|FG000|Overall Study|Lost to Follow-up|0|||
30638800|NCT00903201|58650716|FG001|Overall Study|Lost to Follow-up|1|||
30638801|NCT00903201|58650717|FG002|Overall Study|Lost to Follow-up|0|||
30638802|NCT00903201|58650715|FG000|Overall Study|Physician Decision|1|||
30638803|NCT00903201|58650716|FG001|Overall Study|Physician Decision|0|||
30638804|NCT00903201|58650717|FG002|Overall Study|Physician Decision|1|||
30638805|NCT00903201|58650715|FG000|Overall Study|Withdrawal by Subject|1|||
30638806|NCT00903201|58650716|FG001|Overall Study|Withdrawal by Subject|0|||
30638807|NCT00903201|58650717|FG002|Overall Study|Withdrawal by Subject|1|||
30638808|NCT00902265|58650727|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
30638809|NCT00902265|58650727|FG000|Overall Study|Adverse Event|2|||
30638810|NCT00902265|58650727|FG000|Overall Study|Lack of Efficacy|2|||
30638811|NCT00902265|58650727|FG000|Overall Study|Protocol Violation|1|||
30638812|NCT00943722|58650754|FG000|Base Study|Adverse Event|0|||
30638813|NCT00943722|58650755|FG001|Base Study|Adverse Event|0|||
30638814|NCT00943722|58650756|FG002|Base Study|Adverse Event|0|||
30638815|NCT00943722|58650757|FG003|Base Study|Adverse Event|1|||
30638816|NCT00943722|58650758|FG004|Base Study|Adverse Event|0|||
30638817|NCT00943722|58650759|FG005|Base Study|Adverse Event|0|||
30638818|NCT00943722|58650760|FG006|Base Study|Adverse Event|0|||
30638819|NCT00943722|58650754|FG000|Base Study|Lost to Follow-up|12|||
30638820|NCT00943722|58650755|FG001|Base Study|Lost to Follow-up|8|||
30638821|NCT00943722|58650756|FG002|Base Study|Lost to Follow-up|10|||
30638822|NCT00943722|58650757|FG003|Base Study|Lost to Follow-up|8|||
30638823|NCT00943722|58650758|FG004|Base Study|Lost to Follow-up|11|||
30638824|NCT00943722|58650759|FG005|Base Study|Lost to Follow-up|0|||
30638825|NCT00943722|58650760|FG006|Base Study|Lost to Follow-up|0|||
30638826|NCT00943722|58650754|FG000|Base Study|Physician Decision|1|||
30638827|NCT00943722|58650755|FG001|Base Study|Physician Decision|0|||
30638828|NCT00943722|58650756|FG002|Base Study|Physician Decision|0|||
30638829|NCT00943722|58650757|FG003|Base Study|Physician Decision|0|||
30638830|NCT00943722|58650758|FG004|Base Study|Physician Decision|1|||
30638831|NCT00943722|58650759|FG005|Base Study|Physician Decision|0|||
30638832|NCT00943722|58650760|FG006|Base Study|Physician Decision|0|||
30638833|NCT00943722|58650754|FG000|Base Study|Pregnancy|0|||
30638834|NCT00943722|58650755|FG001|Base Study|Pregnancy|0|||
30638835|NCT00943722|58650756|FG002|Base Study|Pregnancy|1|||
30951489|NCT01705574|58998713|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
30951490|NCT01705574|58998710|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
30951491|NCT01705574|58998711|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
30638836|NCT00943722|58650757|FG003|Base Study|Pregnancy|0|||
30638837|NCT00943722|58650758|FG004|Base Study|Pregnancy|2|||
30638838|NCT00943722|58650759|FG005|Base Study|Pregnancy|0|||
30638839|NCT00943722|58650760|FG006|Base Study|Pregnancy|0|||
30638840|NCT00943722|58650754|FG000|Base Study|Protocol Violation|0|||
30638841|NCT00943722|58650755|FG001|Base Study|Protocol Violation|1|||
30638842|NCT00943722|58650756|FG002|Base Study|Protocol Violation|0|||
30638843|NCT00943722|58650757|FG003|Base Study|Protocol Violation|0|||
30638844|NCT00943722|58650758|FG004|Base Study|Protocol Violation|2|||
30638845|NCT00943722|58650759|FG005|Base Study|Protocol Violation|0|||
30638846|NCT00943722|58650760|FG006|Base Study|Protocol Violation|0|||
30638847|NCT00943722|58650754|FG000|Base Study|Withdrawal by Subject|12|||
30638848|NCT00943722|58650755|FG001|Base Study|Withdrawal by Subject|13|||
30638849|NCT00943722|58650756|FG002|Base Study|Withdrawal by Subject|2|||
30638850|NCT00943722|58650757|FG003|Base Study|Withdrawal by Subject|13|||
30638851|NCT00943722|58650758|FG004|Base Study|Withdrawal by Subject|8|||
30638852|NCT00943722|58650759|FG005|Base Study|Withdrawal by Subject|0|||
30638853|NCT00943722|58650760|FG006|Base Study|Withdrawal by Subject|0|||
30638854|NCT00943722|58650754|FG000|Base Study|Month 12 visit not completed|0|||
30638855|NCT00943722|58650755|FG001|Base Study|Month 12 visit not completed|0|||
30638856|NCT00943722|58650756|FG002|Base Study|Month 12 visit not completed|0|||
30638857|NCT00943722|58650757|FG003|Base Study|Month 12 visit not completed|0|||
30638858|NCT00943722|58650758|FG004|Base Study|Month 12 visit not completed|2|||
30638859|NCT00943722|58650759|FG005|Base Study|Month 12 visit not completed|0|||
30638860|NCT00943722|58650760|FG006|Base Study|Month 12 visit not completed|0|||
30638861|NCT00943722|58650754|FG000|First Extension Study: EXT 1|Adverse Event|0|||
30638862|NCT00943722|58650755|FG001|First Extension Study: EXT 1|Adverse Event|0|||
30638863|NCT00943722|58650756|FG002|First Extension Study: EXT 1|Adverse Event|0|||
30638864|NCT00943722|58650757|FG003|First Extension Study: EXT 1|Adverse Event|0|||
30638865|NCT00943722|58650758|FG004|First Extension Study: EXT 1|Adverse Event|0|||
30638866|NCT00943722|58650759|FG005|First Extension Study: EXT 1|Adverse Event|1|||
30638867|NCT00943722|58650760|FG006|First Extension Study: EXT 1|Adverse Event|0|||
30638868|NCT00943722|58650754|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
30638869|NCT00943722|58650755|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
30638870|NCT00943722|58650756|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
30638871|NCT00943722|58650757|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
30638872|NCT00943722|58650758|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
30638873|NCT00943722|58650759|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
30638874|NCT00943722|58650760|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
30638875|NCT00943722|58650754|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
30638876|NCT00943722|58650755|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
30638877|NCT00943722|58650756|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
30638878|NCT00943722|58650757|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
30638879|NCT00943722|58650758|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
30638880|NCT00943722|58650759|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
30638881|NCT00943722|58650760|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
30638882|NCT00943722|58650754|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
30638883|NCT00943722|58650755|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
30638884|NCT00943722|58650756|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
30638885|NCT00943722|58650757|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
30638886|NCT00943722|58650758|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
30638887|NCT00943722|58650759|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
30638888|NCT00943722|58650760|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
30638889|NCT00943722|58650754|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
30638890|NCT00943722|58650755|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
30638891|NCT00943722|58650756|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
30638892|NCT00943722|58650757|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
30638893|NCT00943722|58650758|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
30638894|NCT00943722|58650759|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
30638895|NCT00943722|58650760|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
30638896|NCT00943722|58650754|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
30638897|NCT00943722|58650755|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
30638898|NCT00943722|58650756|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
30638899|NCT00943722|58650757|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
30638900|NCT00943722|58650758|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
30638901|NCT00943722|58650759|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
30638902|NCT00943722|58650760|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
30638903|NCT00943722|58650754|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
30638904|NCT00943722|58650755|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
30638905|NCT00943722|58650756|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
30638906|NCT00943722|58650757|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
30638907|NCT00943722|58650758|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
30638908|NCT00943722|58650759|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
30638909|NCT00943722|58650760|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
30638910|NCT00943722|58650754|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
30638911|NCT00943722|58650755|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
30638912|NCT00943722|58650756|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
30638913|NCT00943722|58650757|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
30638914|NCT00943722|58650758|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
30638915|NCT00943722|58650759|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
30638916|NCT00943722|58650760|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
30638917|NCT00943722|58650754|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
30638918|NCT00943722|58650755|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
30638919|NCT00943722|58650756|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
30638920|NCT00943722|58650757|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
30638921|NCT00943722|58650758|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
30638922|NCT00943722|58650759|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
30638923|NCT00943722|58650760|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
30638924|NCT00901485|58650783|FG000|Overall Study|Lack of Efficacy|0|||
30638925|NCT00901485|58650784|FG001|Overall Study|Lack of Efficacy|2|||
30638926|NCT00901485|58650783|FG000|Overall Study|Withdrawal by Subject|1|||
30638927|NCT00901485|58650784|FG001|Overall Study|Withdrawal by Subject|2|||
30638928|NCT00896337|58650790|FG000|Overall Study|Death|7|||
30638929|NCT00896337|58650790|FG000|Overall Study|Withdrawal by Subject|7|||
30638930|NCT00896337|58650790|FG000|Overall Study|Lost to Follow-up|11|||
30638931|NCT00953706|58650801|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
30638932|NCT00953706|58650802|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
30638933|NCT00953706|58650803|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
30638934|NCT00953706|58650804|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
30638935|NCT00953706|58650801|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
30638936|NCT00953706|58650802|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
30638937|NCT00953706|58650803|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
30638938|NCT00953706|58650804|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
30638939|NCT00953706|58650801|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
30638940|NCT00953706|58650802|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
30638941|NCT00953706|58650803|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
30638942|NCT00953706|58650804|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
30638943|NCT00953706|58650801|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
30638944|NCT00953706|58650802|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
30638945|NCT00953706|58650803|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
30638946|NCT00953706|58650804|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
30638947|NCT00953706|58650801|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
30765491|NCT03333928|58774077|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
30638948|NCT00953706|58650802|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
30638949|NCT00953706|58650803|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
30638950|NCT00953706|58650804|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
30638951|NCT00953706|58650801|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
30638952|NCT00953706|58650802|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
30638953|NCT00953706|58650803|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
30638954|NCT00953706|58650804|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
30638955|NCT00953706|58650801|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
30638956|NCT00953706|58650802|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
30638957|NCT00953706|58650803|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
30638958|NCT00953706|58650804|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
30638959|NCT00953706|58650801|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
30638960|NCT00953706|58650802|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
30638961|NCT00953706|58650803|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
30638962|NCT00953706|58650804|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
30638963|NCT00953706|58650801|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
30638964|NCT00953706|58650802|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
30638965|NCT00953706|58650803|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
30638966|NCT00953706|58650804|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
30638967|NCT00953706|58650801|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
30638968|NCT00953706|58650802|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
30638969|NCT00953706|58650803|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
30638970|NCT00953706|58650804|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
30638971|NCT00953706|58650801|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
30638972|NCT00953706|58650802|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
30638973|NCT00953706|58650803|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
30638974|NCT00953706|58650804|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
30638975|NCT00940992|58650817|FG000|Overall Study|Adverse Event|2|||
30638976|NCT00940992|58650818|FG001|Overall Study|Adverse Event|0|||
30638977|NCT00940992|58650819|FG002|Overall Study|Adverse Event|1|||
30638978|NCT00940992|58650817|FG000|Overall Study|subject request|2|||
30638979|NCT00940992|58650818|FG001|Overall Study|subject request|1|||
30638980|NCT00940992|58650819|FG002|Overall Study|subject request|0|||
30638981|NCT00940992|58650817|FG000|Overall Study|Lost to Follow-up|0|||
30638982|NCT00940992|58650818|FG001|Overall Study|Lost to Follow-up|1|||
30638983|NCT00940992|58650819|FG002|Overall Study|Lost to Follow-up|1|||
30638984|NCT00938964|58650829|FG000|Overall Study|Death|3|||
30638985|NCT00938964|58650830|FG001|Overall Study|Death|3|||
30638986|NCT00938964|58650829|FG000|Overall Study|Lost to Follow-up|2|||
30638987|NCT00938964|58650830|FG001|Overall Study|Lost to Follow-up|3|||
30638988|NCT00938964|58650829|FG000|Overall Study|Withdrawal by Subject|22|||
30638989|NCT00938964|58650830|FG001|Overall Study|Withdrawal by Subject|18|||
30951492|NCT01705574|58998712|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
30951493|NCT01705574|58998713|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
30638990|NCT00938964|58650829|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
30638991|NCT00938964|58650830|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
30638992|NCT00938886|58650838|FG000|Overall Study|Death|0|||
30638993|NCT00938886|58650839|FG001|Overall Study|Death|1|||
30638994|NCT00938886|58650838|FG000|Overall Study|Withdrawal by Subject|4|||
30638995|NCT00938886|58650839|FG001|Overall Study|Withdrawal by Subject|7|||
30638996|NCT00938886|58650838|FG000|Overall Study|Lost to Follow-up|3|||
30638997|NCT00938886|58650839|FG001|Overall Study|Lost to Follow-up|2|||
30638998|NCT00942708|58650845|FG000|Overall Study|Withdrawal by Subject|1|||
30638999|NCT00937950|58650850|FG000|Overall Study|Withdrawal by Subject|23|||
30639000|NCT00937950|58650850|FG000|Overall Study|Migrated/moved from study area|27|||
30639001|NCT00937950|58650850|FG000|Overall Study|Lost to Follow-up|144|||
30639002|NCT00937950|58650850|FG000|Overall Study|Missing confirmed|4|||
30639003|NCT00937950|58650850|FG000|Overall Study|Other|18|||
30639004|NCT00942162|58650857|FG000|Overall Study|Death|45|||
30639005|NCT00942162|58650858|FG001|Overall Study|Death|35|||
30639006|NCT00942162|58650859|FG002|Overall Study|Death|0|||
30639007|NCT00942162|58650857|FG000|Overall Study|Withdrawal by Subject|7|||
30639008|NCT00942162|58650858|FG001|Overall Study|Withdrawal by Subject|2|||
30639009|NCT00942162|58650859|FG002|Overall Study|Withdrawal by Subject|0|||
30639010|NCT00942162|58650857|FG000|Overall Study|Lost to Follow-up|4|||
30639011|NCT00942162|58650858|FG001|Overall Study|Lost to Follow-up|0|||
30639012|NCT00942162|58650859|FG002|Overall Study|Lost to Follow-up|0|||
30639013|NCT00942162|58650857|FG000|Overall Study|Other|14|||
30639014|NCT00942162|58650858|FG001|Overall Study|Other|13|||
30639015|NCT00942162|58650859|FG002|Overall Study|Other|2|||
30639016|NCT00942084|58650869|FG000|Overall Study|Death|2|||
30639017|NCT00941928|58650873|FG000|Overall Study|Withdrawal by Subject|1|||
30639018|NCT00941928|58650873|FG000|Overall Study|Disease Progression|1|||
30639019|NCT00937560|58650877|FG000|Initial Treatment|Death|6|||
30639020|NCT00937560|58650877|FG000|Initial Treatment|Withdraw consent|3|||
30639021|NCT00937560|58650877|FG000|Initial Treatment|Adverse Event|1|||
30639022|NCT00937560|58650877|FG000|Initial Treatment|Lost to Follow-up|1|||
30639023|NCT00937560|58650877|FG000|Initial Treatment|No end of study page|10|||
30639024|NCT00937560|58650877|FG000|Maintenance Treatment|Death|12|||
30639025|NCT00937560|58650877|FG000|Maintenance Treatment|Withdraw consent|5|||
30639026|NCT00937560|58650877|FG000|Maintenance Treatment|According to protocol|1|||
30639027|NCT00594568|58650884|FG000|Initial Treatment|Adverse Event|51|||
30639028|NCT00594568|58650885|FG001|Initial Treatment|Adverse Event|121|||
30639029|NCT00594568|58650886|FG002|Initial Treatment|Adverse Event|144|||
30639030|NCT00594568|58650884|FG000|Initial Treatment|Death|6|||
30639031|NCT00594568|58650885|FG001|Initial Treatment|Death|11|||
30639032|NCT00594568|58650886|FG002|Initial Treatment|Death|15|||
30639033|NCT00594568|58650884|FG000|Initial Treatment|Lost to Follow-up|4|||
30639034|NCT00594568|58650885|FG001|Initial Treatment|Lost to Follow-up|1|||
30639035|NCT00594568|58650886|FG002|Initial Treatment|Lost to Follow-up|4|||
30639036|NCT00594568|58650884|FG000|Initial Treatment|Physician Decision|3|||
30639037|NCT00594568|58650885|FG001|Initial Treatment|Physician Decision|2|||
30639038|NCT00594568|58650886|FG002|Initial Treatment|Physician Decision|4|||
30639039|NCT00594568|58650884|FG000|Initial Treatment|Protocol Violation|2|||
30639040|NCT00594568|58650885|FG001|Initial Treatment|Protocol Violation|2|||
30639041|NCT00594568|58650886|FG002|Initial Treatment|Protocol Violation|5|||
30639042|NCT00594568|58650884|FG000|Initial Treatment|Withdrawal by Subject|25|||
30639043|NCT00594568|58650885|FG001|Initial Treatment|Withdrawal by Subject|31|||
30639044|NCT00594568|58650886|FG002|Initial Treatment|Withdrawal by Subject|46|||
30639045|NCT00594568|58650884|FG000|Initial Treatment|Sponsor decision|193|||
30639046|NCT00594568|58650885|FG001|Initial Treatment|Sponsor decision|142|||
30639047|NCT00594568|58650886|FG002|Initial Treatment|Sponsor decision|147|||
30639048|NCT00594568|58650884|FG000|Initial Treatment|Caregiver decision|21|||
30639049|NCT00594568|58650885|FG001|Initial Treatment|Caregiver decision|36|||
30639050|NCT00594568|58650886|FG002|Initial Treatment|Caregiver decision|36|||
30639051|NCT00594568|58650884|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
30639052|NCT00594568|58650885|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
30639053|NCT00594568|58650886|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
30639054|NCT00594568|58650884|FG000|Initial Treatment|Entry criteria exclusion|0|||
30639055|NCT00594568|58650885|FG001|Initial Treatment|Entry criteria exclusion|1|||
30639056|NCT00594568|58650886|FG002|Initial Treatment|Entry criteria exclusion|1|||
30639057|NCT00594568|58650884|FG000|Delayed Start|Death|0|||
30639058|NCT00594568|58650885|FG001|Delayed Start|Death|0|||
30639059|NCT00594568|58650886|FG002|Delayed Start|Death|1|||
30639060|NCT00594568|58650884|FG000|Delayed Start|Adverse Event|12|||
30639061|NCT00594568|58650885|FG001|Delayed Start|Adverse Event|2|||
30639062|NCT00594568|58650886|FG002|Delayed Start|Adverse Event|2|||
30639063|NCT00594568|58650884|FG000|Delayed Start|Withdrawal by Subject|4|||
30639064|NCT00594568|58650885|FG001|Delayed Start|Withdrawal by Subject|3|||
30639065|NCT00594568|58650886|FG002|Delayed Start|Withdrawal by Subject|0|||
30639066|NCT00594568|58650884|FG000|Delayed Start|Physician Decision|0|||
30639067|NCT00594568|58650885|FG001|Delayed Start|Physician Decision|0|||
30639068|NCT00594568|58650886|FG002|Delayed Start|Physician Decision|1|||
30639069|NCT00594568|58650884|FG000|Delayed Start|Lost to Follow-up|0|||
30639070|NCT00594568|58650885|FG001|Delayed Start|Lost to Follow-up|0|||
30639071|NCT00594568|58650886|FG002|Delayed Start|Lost to Follow-up|1|||
30639072|NCT00594568|58650884|FG000|Delayed Start|Caregiver Decision|5|||
30639073|NCT00594568|58650885|FG001|Delayed Start|Caregiver Decision|6|||
30639074|NCT00594568|58650886|FG002|Delayed Start|Caregiver Decision|2|||
30639075|NCT00594568|58650884|FG000|Delayed Start|Sponsor Decision|77|||
30639076|NCT00594568|58650885|FG001|Delayed Start|Sponsor Decision|66|||
30639077|NCT00594568|58650886|FG002|Delayed Start|Sponsor Decision|59|||
30639078|NCT00594568|58650884|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
30639079|NCT00594568|58650885|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
30639080|NCT00594568|58650886|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
30639081|NCT00594568|58650884|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
30639082|NCT00594568|58650885|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
30639083|NCT00594568|58650886|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
30765492|NCT03333928|58774075|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
30765493|NCT03333928|58774076|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
30765494|NCT03333928|58774077|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
30765495|NCT03333928|58774075|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
30765496|NCT03333928|58774076|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
30765497|NCT03333928|58774077|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
30765498|NCT03333928|58774075|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
30765499|NCT03333928|58774076|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
30765500|NCT03333928|58774077|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
30765501|NCT03333928|58774075|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
30765502|NCT03333928|58774076|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
30765503|NCT03333928|58774077|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
30765504|NCT02945410|58774099|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
30765505|NCT02945410|58774100|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
30765506|NCT02945410|58774101|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
30765507|NCT02945410|58774102|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
30765508|NCT02945410|58774103|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
30639084|NCT00594568|58650884|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
30765509|NCT02945410|58774104|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
30765510|NCT02945410|58774099|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
30765511|NCT02945410|58774100|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
30765512|NCT02945410|58774101|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
30639085|NCT00594568|58650885|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
30639086|NCT00594568|58650886|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
30639087|NCT00594568|58650884|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
30639088|NCT00594568|58650885|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
30639089|NCT00594568|58650886|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
30639090|NCT00594568|58650884|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
30639091|NCT00594568|58650885|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
30639092|NCT00594568|58650886|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
30639093|NCT00594568|58650884|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
30639094|NCT00594568|58650885|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
30639095|NCT00594568|58650886|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
30639096|NCT00875056|58650914|FG000|Overall Study|Adverse Event|6|||
30639097|NCT00875056|58650915|FG001|Overall Study|Adverse Event|1|||
30639098|NCT00875056|58650916|FG002|Overall Study|Adverse Event|2|||
30639099|NCT00875056|58650914|FG000|Overall Study|Progressive Disease|14|||
30639100|NCT00875056|58650915|FG001|Overall Study|Progressive Disease|8|||
30639101|NCT00875056|58650916|FG002|Overall Study|Progressive Disease|3|||
30639102|NCT00875056|58650914|FG000|Overall Study|Withdrawal by Subject|3|||
30639103|NCT00875056|58650915|FG001|Overall Study|Withdrawal by Subject|0|||
30639104|NCT00875056|58650916|FG002|Overall Study|Withdrawal by Subject|1|||
30639105|NCT00940602|58650926|FG000|Overall Study|Administrative problems|1|||
30639106|NCT00940602|58650927|FG001|Overall Study|Administrative problems|1|||
30639107|NCT00940602|58650926|FG000|Overall Study|Patient/guardian decision|13|||
30639108|NCT00940602|58650927|FG001|Overall Study|Patient/guardian decision|28|||
30639109|NCT00940602|58650926|FG000|Overall Study|Physician Decision|8|||
30639110|NCT00940602|58650927|FG001|Overall Study|Physician Decision|5|||
30639111|NCT00940602|58650926|FG000|Overall Study|Pregnancy|1|||
30639112|NCT00940602|58650927|FG001|Overall Study|Pregnancy|0|||
30639113|NCT00940602|58650926|FG000|Overall Study|Protocol Deviation (untreated)|1|||
30639114|NCT00940602|58650927|FG001|Overall Study|Protocol Deviation (untreated)|0|||
30639115|NCT00940602|58650926|FG000|Overall Study|Disease progression|8|||
30639116|NCT00940602|58650927|FG001|Overall Study|Disease progression|2|||
30639117|NCT00940602|58650926|FG000|Overall Study|Death|38|||
30639118|NCT00940602|58650927|FG001|Overall Study|Death|19|||
30639119|NCT00940602|58650926|FG000|Overall Study|Lost to Follow-up|3|||
30639120|NCT00940602|58650927|FG001|Overall Study|Lost to Follow-up|1|||
30639121|NCT00940602|58650926|FG000|Overall Study|Patient withdrew consent|26|||
30639122|NCT00940602|58650927|FG001|Overall Study|Patient withdrew consent|13|||
30639123|NCT00940602|58650926|FG000|Overall Study|Adverse Event|7|||
30639124|NCT00940602|58650927|FG001|Overall Study|Adverse Event|2|||
30639125|NCT00940602|58650926|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
30639126|NCT00940602|58650927|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
30639127|NCT00874822|58650934|FG000|Overall Study|excluded by criteria|8|||
30639128|NCT00875524|58650940|FG000|Overall Study|Serious adverse event|0|||
30639129|NCT00875524|58650941|FG001|Overall Study|Serious adverse event|1|||
30639130|NCT00875524|58650940|FG000|Overall Study|Protocol Violation|4|||
30639131|NCT00875524|58650941|FG001|Overall Study|Protocol Violation|0|||
30639132|NCT00875524|58650940|FG000|Overall Study|Lost to Follow-up|1|||
30639133|NCT00875524|58650941|FG001|Overall Study|Lost to Follow-up|0|||
30639134|NCT00875524|58650940|FG000|Overall Study|Withdrawal by Subject|3|||
30639135|NCT00875524|58650941|FG001|Overall Study|Withdrawal by Subject|5|||
30639136|NCT01094288|58650955|FG000|Overall Study|Adverse Event|0|||
30639137|NCT01094288|58650956|FG001|Overall Study|Adverse Event|3|||
30639138|NCT01094288|58650957|FG002|Overall Study|Adverse Event|1|||
30639139|NCT01094288|58650958|FG003|Overall Study|Adverse Event|1|||
30951494|NCT01705574|58998710|FG000|Open-Label Extension Phase|Adverse Event|3|||
30951495|NCT01705574|58998711|FG001|Open-Label Extension Phase|Adverse Event|0|||
30951496|NCT01705574|58998712|FG002|Open-Label Extension Phase|Adverse Event|0|||
30951497|NCT01705574|58998713|FG003|Open-Label Extension Phase|Adverse Event|1|||
30951498|NCT01705574|58998710|FG000|Open-Label Extension Phase|Death|2|||
30951499|NCT01705574|58998711|FG001|Open-Label Extension Phase|Death|0|||
30951500|NCT01705574|58998712|FG002|Open-Label Extension Phase|Death|1|||
30639140|NCT01094288|58650959|FG004|Overall Study|Adverse Event|0|||
30639141|NCT01094288|58650960|FG005|Overall Study|Adverse Event|0|||
30639142|NCT01094288|58650961|FG006|Overall Study|Adverse Event|0|||
30639143|NCT01094288|58650962|FG007|Overall Study|Adverse Event|0|||
30639144|NCT01094288|58650955|FG000|Overall Study|Withdrawal by Subject|0|||
30639145|NCT01094288|58650956|FG001|Overall Study|Withdrawal by Subject|1|||
30639146|NCT01094288|58650957|FG002|Overall Study|Withdrawal by Subject|2|||
30639147|NCT01094288|58650958|FG003|Overall Study|Withdrawal by Subject|0|||
30639148|NCT01094288|58650959|FG004|Overall Study|Withdrawal by Subject|0|||
30765513|NCT02945410|58774102|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
30951501|NCT01705574|58998713|FG003|Open-Label Extension Phase|Death|0|||
30951502|NCT01705574|58998710|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
30951503|NCT01705574|58998711|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
30639149|NCT01094288|58650960|FG005|Overall Study|Withdrawal by Subject|0|||
30639150|NCT01094288|58650961|FG006|Overall Study|Withdrawal by Subject|0|||
30639151|NCT01094288|58650962|FG007|Overall Study|Withdrawal by Subject|2|||
30639152|NCT01094288|58650955|FG000|Overall Study|Initiation of Alternative Therapy|0|||
30639153|NCT01094288|58650956|FG001|Overall Study|Initiation of Alternative Therapy|0|||
30639154|NCT01094288|58650957|FG002|Overall Study|Initiation of Alternative Therapy|1|||
30639155|NCT01094288|58650958|FG003|Overall Study|Initiation of Alternative Therapy|0|||
30639156|NCT01094288|58650959|FG004|Overall Study|Initiation of Alternative Therapy|0|||
30639157|NCT01094288|58650960|FG005|Overall Study|Initiation of Alternative Therapy|0|||
30639158|NCT01094288|58650961|FG006|Overall Study|Initiation of Alternative Therapy|0|||
30639159|NCT01094288|58650962|FG007|Overall Study|Initiation of Alternative Therapy|0|||
30639160|NCT01094288|58650955|FG000|Overall Study|Reason not Specified|2|||
30639161|NCT01094288|58650956|FG001|Overall Study|Reason not Specified|3|||
30639162|NCT01094288|58650957|FG002|Overall Study|Reason not Specified|0|||
30639163|NCT01094288|58650958|FG003|Overall Study|Reason not Specified|1|||
30639164|NCT01094288|58650959|FG004|Overall Study|Reason not Specified|0|||
30639165|NCT01094288|58650960|FG005|Overall Study|Reason not Specified|0|||
30639166|NCT01094288|58650961|FG006|Overall Study|Reason not Specified|0|||
30639167|NCT01094288|58650962|FG007|Overall Study|Reason not Specified|0|||
30639168|NCT01094288|58650955|FG000|Overall Study|Ongoing Participants|0|||
30639169|NCT01094288|58650956|FG001|Overall Study|Ongoing Participants|3|||
30639170|NCT01094288|58650957|FG002|Overall Study|Ongoing Participants|0|||
30639171|NCT01094288|58650958|FG003|Overall Study|Ongoing Participants|0|||
30639172|NCT01094288|58650959|FG004|Overall Study|Ongoing Participants|0|||
30639173|NCT01094288|58650960|FG005|Overall Study|Ongoing Participants|0|||
30639174|NCT01094288|58650961|FG006|Overall Study|Ongoing Participants|0|||
30639175|NCT01094288|58650962|FG007|Overall Study|Ongoing Participants|0|||
30639176|NCT00874120|58650986|FG000|First Intervention|Adverse Event|0|||
30639177|NCT00874120|58650987|FG001|First Intervention|Adverse Event|1|||
30639178|NCT00874120|58650986|FG000|First Intervention|Withdrawal by Subject|2|||
30639179|NCT00874120|58650987|FG001|First Intervention|Withdrawal by Subject|0|||
30639180|NCT00874120|58650986|FG000|First Intervention|Lost to Follow-up|0|||
30639181|NCT00874120|58650987|FG001|First Intervention|Lost to Follow-up|1|||
30639182|NCT00874120|58650986|FG000|First Intervention|Protocol Violation|3|||
30639183|NCT00874120|58650987|FG001|First Intervention|Protocol Violation|0|||
30639184|NCT00874120|58650986|FG000|First Intervention|positive drug test|1|||
30639185|NCT00874120|58650987|FG001|First Intervention|positive drug test|0|||
30639186|NCT00874120|58650986|FG000|Second Intervention|Withdrawal by Subject|1|||
30639187|NCT00874120|58650987|FG001|Second Intervention|Withdrawal by Subject|0|||
30639188|NCT00874120|58650986|FG000|Second Intervention|Protocol Violation|1|||
30639189|NCT00874120|58650987|FG001|Second Intervention|Protocol Violation|0|||
30639190|NCT00939822|58650995|FG000|Overall Study|Lost to Follow-up|1|||
30639191|NCT00939822|58650996|FG001|Overall Study|Lost to Follow-up|0|||
30639192|NCT00939822|58650995|FG000|Overall Study|withdrew from study due to busy schedule|1|||
30639193|NCT00939822|58650996|FG001|Overall Study|withdrew from study due to busy schedule|1|||
30639194|NCT00939822|58650995|FG000|Overall Study|Mental health issues|0|||
30639195|NCT00939822|58650996|FG001|Overall Study|Mental health issues|2|||
30639196|NCT00939510|58651002|FG000|Overall Study|Withdrawal by Subject|1|||
30639197|NCT01098266|58651008|FG000|Overall Study|Physician Decision|1|||
30639198|NCT01098266|58651009|FG001|Overall Study|Physician Decision|0|||
30639199|NCT01098266|58651008|FG000|Overall Study|Death|3|||
30639200|NCT01098266|58651009|FG001|Overall Study|Death|2|||
30639201|NCT01098266|58651008|FG000|Overall Study|Withdrawal by Subject|3|||
30639202|NCT01098266|58651009|FG001|Overall Study|Withdrawal by Subject|5|||
30639203|NCT00935532|58651017|FG000|Overall Study|Adverse Event|11|||
30639204|NCT00935532|58651018|FG001|Overall Study|Adverse Event|6|||
30639205|NCT00935532|58651017|FG000|Overall Study|Death|1|||
30639206|NCT00935532|58651018|FG001|Overall Study|Death|0|||
30639207|NCT00935532|58651017|FG000|Overall Study|Lost to Follow-up|1|||
30639208|NCT00935532|58651018|FG001|Overall Study|Lost to Follow-up|0|||
30639209|NCT00935532|58651017|FG000|Overall Study|Physician Decision|1|||
30639210|NCT00935532|58651018|FG001|Overall Study|Physician Decision|2|||
30639211|NCT00935532|58651017|FG000|Overall Study|Protocol Violation|2|||
30639212|NCT00935532|58651018|FG001|Overall Study|Protocol Violation|1|||
30639213|NCT00935532|58651017|FG000|Overall Study|Subject Decision|2|||
30639214|NCT00935532|58651018|FG001|Overall Study|Subject Decision|1|||
30639215|NCT00935532|58651017|FG000|Overall Study|Sponsor Decision|0|||
30639216|NCT00935532|58651018|FG001|Overall Study|Sponsor Decision|1|||
30639217|NCT00935532|58651017|FG000|Overall Study|Loss Glucose Control|4|||
30639218|NCT00935532|58651018|FG001|Overall Study|Loss Glucose Control|0|||
30639219|NCT01093586|58651024|FG000|Overall Study|Failed to engraft|3|||
30639220|NCT00937404|58651028|FG000|Overall Study|Protocol Violation|1|||
30639221|NCT00937404|58651028|FG000|Overall Study|Withdrawal by Subject|1|||
30639222|NCT01098110|58651035|FG000|Overall Study|Withdrawal by Subject|14|||
30639223|NCT01098110|58651036|FG001|Overall Study|Withdrawal by Subject|24|||
30639224|NCT01098110|58651037|FG002|Overall Study|Withdrawal by Subject|19|||
30639225|NCT01098110|58651035|FG000|Overall Study|Adverse Event|30|||
30639226|NCT01098110|58651036|FG001|Overall Study|Adverse Event|32|||
30639227|NCT01098110|58651037|FG002|Overall Study|Adverse Event|43|||
30639228|NCT01098110|58651035|FG000|Overall Study|Lack of Efficacy|13|||
30639229|NCT01098110|58651036|FG001|Overall Study|Lack of Efficacy|9|||
30639230|NCT01098110|58651037|FG002|Overall Study|Lack of Efficacy|27|||
30639231|NCT01098110|58651035|FG000|Overall Study|Other|4|||
30639232|NCT01098110|58651036|FG001|Overall Study|Other|7|||
30639233|NCT01098110|58651037|FG002|Overall Study|Other|5|||
30639234|NCT01098110|58651035|FG000|Overall Study|Untreated|1|||
30639235|NCT01098110|58651036|FG001|Overall Study|Untreated|1|||
30639236|NCT01098110|58651037|FG002|Overall Study|Untreated|0|||
30639237|NCT01092728|58651047|FG000|Overall Study|Withdrawal by Subject|2|||
30639238|NCT01092728|58651048|FG001|Overall Study|Withdrawal by Subject|0|||
30639239|NCT01092728|58651047|FG000|Overall Study|Adverse Event|0|||
30639240|NCT01092728|58651048|FG001|Overall Study|Adverse Event|1|||
30639241|NCT01092728|58651047|FG000|Overall Study|Disease Progression|1|||
30639242|NCT01092728|58651048|FG001|Overall Study|Disease Progression|13|||
30639243|NCT01092728|58651047|FG000|Overall Study|Prohibited Concomitant Medications|1|||
30639244|NCT01092728|58651048|FG001|Overall Study|Prohibited Concomitant Medications|0|||
30639245|NCT01096550|58651056|FG000|Overall Study|discontinued site|10|||
30639246|NCT01096550|58651057|FG001|Overall Study|discontinued site|11|||
30639247|NCT01096550|58651056|FG000|Overall Study|non-regular treatment track at clinic|1|||
30639248|NCT01096550|58651057|FG001|Overall Study|non-regular treatment track at clinic|1|||
30639249|NCT01096550|58651056|FG000|Overall Study|clinic readmission|1|||
30639250|NCT01096550|58651057|FG001|Overall Study|clinic readmission|1|||
30639251|NCT01096550|58651056|FG000|Overall Study|Withdrawal by Subject|0|||
30639252|NCT01096550|58651057|FG001|Overall Study|Withdrawal by Subject|1|||
30639253|NCT01096550|58651056|FG000|Overall Study|non-African American participant|13|||
30639254|NCT01096550|58651057|FG001|Overall Study|non-African American participant|6|||
30639255|NCT01096550|58651056|FG000|Overall Study|Lost to Follow-up|12|||
30639256|NCT01096550|58651057|FG001|Overall Study|Lost to Follow-up|9|||
30639257|NCT01101542|58651063|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
30639258|NCT01101542|58651063|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
30639259|NCT01101542|58651063|FG000|Year 4 Surveillance Period|Other|287|||
30639260|NCT01101542|58651063|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
30639261|NCT01101542|58651063|FG000|Year 5 Surveillance Period|Pregnancy|1|||
30639262|NCT01101542|58651063|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
30639263|NCT01101542|58651063|FG000|Year 6 Surveillance Period|Pregnancy|1|||
30639264|NCT01101542|58651063|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
30639265|NCT00937326|58651072|FG000|Overall Study|Adverse Event|0|||
30639266|NCT00937326|58651073|FG001|Overall Study|Adverse Event|3|||
30639267|NCT00937326|58651074|FG002|Overall Study|Adverse Event|1|||
30639268|NCT00937326|58651075|FG003|Overall Study|Adverse Event|1|||
30639269|NCT00937326|58651076|FG004|Overall Study|Adverse Event|2|||
30639270|NCT00937326|58651072|FG000|Overall Study|Death|0|||
30639271|NCT00937326|58651073|FG001|Overall Study|Death|0|||
30639272|NCT00937326|58651074|FG002|Overall Study|Death|1|||
30639273|NCT00937326|58651075|FG003|Overall Study|Death|0|||
30639274|NCT00937326|58651076|FG004|Overall Study|Death|0|||
30639275|NCT00937326|58651072|FG000|Overall Study|Withdrawal by Subject|3|||
30639276|NCT00937326|58651073|FG001|Overall Study|Withdrawal by Subject|4|||
30639277|NCT00937326|58651074|FG002|Overall Study|Withdrawal by Subject|1|||
30639278|NCT00937326|58651075|FG003|Overall Study|Withdrawal by Subject|4|||
30639279|NCT00937326|58651076|FG004|Overall Study|Withdrawal by Subject|3|||
30639280|NCT00937326|58651072|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
30639281|NCT00937326|58651073|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
30639282|NCT00937326|58651074|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
30639283|NCT00937326|58651075|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
30639284|NCT00937326|58651076|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
30639285|NCT00873730|58651095|FG000|Overall Study|Protocol Deviation|5|||
30639286|NCT00873730|58651096|FG001|Overall Study|Protocol Deviation|2|||
30639287|NCT00873730|58651095|FG000|Overall Study|Adverse Event|0|||
30639288|NCT00873730|58651096|FG001|Overall Study|Adverse Event|2|||
30639289|NCT00873730|58651095|FG000|Overall Study|Withdrawal by Subject|0|||
30639290|NCT00873730|58651096|FG001|Overall Study|Withdrawal by Subject|1|||
30639291|NCT00873730|58651095|FG000|Overall Study|Sponsor decision|1|||
30765514|NCT02945410|58774103|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
30765515|NCT02945410|58774104|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
30639292|NCT00873730|58651096|FG001|Overall Study|Sponsor decision|0|||
30639293|NCT00874432|58651106|FG000|Overall Study|Withdrawal by Subject|1|||
30639294|NCT00874432|58651107|FG001|Overall Study|Withdrawal by Subject|0|||
30639295|NCT00874432|58651108|FG002|Overall Study|Withdrawal by Subject|0|||
30639296|NCT00874432|58651109|FG003|Overall Study|Withdrawal by Subject|0|||
30639297|NCT00874432|58651106|FG000|Overall Study|Physician Decision|1|||
30639298|NCT00874432|58651107|FG001|Overall Study|Physician Decision|0|||
30639299|NCT00874432|58651108|FG002|Overall Study|Physician Decision|0|||
30639300|NCT00874432|58651109|FG003|Overall Study|Physician Decision|0|||
30639301|NCT00874432|58651106|FG000|Overall Study|Other|1|||
30639302|NCT00874432|58651107|FG001|Overall Study|Other|2|||
30639303|NCT00874432|58651108|FG002|Overall Study|Other|8|||
30639304|NCT00874432|58651109|FG003|Overall Study|Other|3|||
30639305|NCT00935220|58651121|FG000|Overall Study|Adverse Event|1|||
30639306|NCT00935220|58651121|FG000|Overall Study|Other reason (not specified)|1|||
30639307|NCT00874276|58651127|FG000|Overall Study|Withdrawal by Subject|1|||
30639308|NCT00874276|58651128|FG001|Overall Study|Withdrawal by Subject|1|||
30639309|NCT00594958|58651139|FG000|Overall Study|Withdrawal by Subject|1|||
30639310|NCT00594958|58651140|FG001|Overall Study|Withdrawal by Subject|0|||
30639311|NCT00594958|58651141|FG002|Overall Study|Withdrawal by Subject|1|||
30639312|NCT00594958|58651139|FG000|Overall Study|Adverse Event|4|||
30639313|NCT00594958|58651140|FG001|Overall Study|Adverse Event|1|||
30639314|NCT00594958|58651141|FG002|Overall Study|Adverse Event|2|||
30639315|NCT00594958|58651139|FG000|Overall Study|Pregnancy|0|||
30639316|NCT00594958|58651140|FG001|Overall Study|Pregnancy|2|||
30639317|NCT00594958|58651141|FG002|Overall Study|Pregnancy|0|||
30639318|NCT00594958|58651139|FG000|Overall Study|Protocol Violation|1|||
30639319|NCT00594958|58651140|FG001|Overall Study|Protocol Violation|0|||
30639320|NCT00594958|58651141|FG002|Overall Study|Protocol Violation|2|||
30639321|NCT00594958|58651139|FG000|Overall Study|Lost to Follow-up|5|||
30639322|NCT00594958|58651140|FG001|Overall Study|Lost to Follow-up|0|||
30639323|NCT00594958|58651141|FG002|Overall Study|Lost to Follow-up|3|||
30639324|NCT00594958|58651139|FG000|Overall Study|administrative|3|||
30639325|NCT00594958|58651140|FG001|Overall Study|administrative|0|||
30639326|NCT00594958|58651141|FG002|Overall Study|administrative|2|||
30639327|NCT00594880|58651151|FG000|Overall Study|Withdrawal by Subject|1|||
30639328|NCT00594880|58651152|FG001|Overall Study|Withdrawal by Subject|1|||
30639329|NCT00594880|58651151|FG000|Overall Study|Lost to Follow-up|1|||
30639330|NCT00594880|58651152|FG001|Overall Study|Lost to Follow-up|0|||
30639331|NCT00871858|58651164|FG000|Overall Study|Protocol Violation|3|||
30639332|NCT00871858|58651165|FG001|Overall Study|Protocol Violation|4|||
30639333|NCT00871858|58651164|FG000|Overall Study|Adverse Event|1|||
30639334|NCT00871858|58651165|FG001|Overall Study|Adverse Event|1|||
30639335|NCT00871858|58651164|FG000|Overall Study|Withdrawal by Subject|1|||
30639336|NCT00871858|58651165|FG001|Overall Study|Withdrawal by Subject|1|||
30639337|NCT00871858|58651164|FG000|Overall Study|Lost to Follow-up|0|||
30639338|NCT00871858|58651165|FG001|Overall Study|Lost to Follow-up|1|||
30639339|NCT00871780|58651171|FG000|Overall Study|Enrolled But Not Treated|6|||
30639340|NCT00871780|58651171|FG000|Overall Study|Withdrawal by Subject|9|||
30639341|NCT00871780|58651171|FG000|Overall Study|Adverse Event|6|||
30639342|NCT00871780|58651171|FG000|Overall Study|Voluntary Discontinuation|4|||
30639343|NCT00871780|58651171|FG000|Overall Study|Death|1|||
30639344|NCT00871780|58651171|FG000|Overall Study|Physician Decision|1|||
30639345|NCT00594178|58651178|FG000|Overall Study|Physician Decision|5|||
30639346|NCT00933270|58651182|FG000|Overall Study|Withdrawal by Subject|26|||
30639347|NCT00933270|58651182|FG000|Overall Study|Insufficient Follow-up|10|||
30639348|NCT00933270|58651182|FG000|Overall Study|Lost to Follow-up|14|||
30639349|NCT00933270|58651182|FG000|Overall Study|Adverse Event|1|||
30639350|NCT00933270|58651182|FG000|Overall Study|Missed Visit|2|||
30639351|NCT00933270|58651182|FG000|Overall Study|Death|24|||
30639352|NCT00933270|58651182|FG000|Overall Study|Moved or would not return|10|||
30639353|NCT00936858|58651187|FG000|Overall Study|Death|3|||
30639354|NCT00936858|58651187|FG000|Overall Study|Progression|29|||
30639355|NCT00936858|58651187|FG000|Overall Study|Withdrawal by Subject|5|||
30639356|NCT00936858|58651187|FG000|Overall Study|Adverse Event|1|||
30639357|NCT00936858|58651187|FG000|Overall Study|Physician Decision|7|||
30639358|NCT00936858|58651187|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
30639359|NCT00936858|58651187|FG000|Overall Study|Lost to Follow-up|1|||
30639360|NCT00872170|58651194|FG000|Overall Study|Adverse Event|1|||
30639361|NCT00872170|58651195|FG001|Overall Study|Adverse Event|0|||
30639362|NCT00936702|58651200|FG000|Overall Study|Disease progression|34|||
30639363|NCT00936702|58651200|FG000|Overall Study|Adverse Event|8|||
30639364|NCT00936702|58651200|FG000|Overall Study|Withdrawal by Subject|2|||
30639365|NCT00936702|58651200|FG000|Overall Study|Alternative Treatment|1|||
30639366|NCT00936702|58651200|FG000|Overall Study|Other|1|||
30639367|NCT00594100|58651204|FG000|Procedure|Technical Failure|9|||
30639368|NCT00594100|58651204|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
30639369|NCT00594100|58651204|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
30639370|NCT00594100|58651204|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
30639371|NCT01092182|58651211|FG000|Overall Study|Death|0|||
30639372|NCT01092182|58651212|FG001|Overall Study|Death|5|||
30639373|NCT01092182|58651213|FG002|Overall Study|Death|3|||
30639374|NCT01092182|58651211|FG000|Overall Study|participant safety|1|||
30639375|NCT01092182|58651212|FG001|Overall Study|participant safety|2|||
30639376|NCT01092182|58651213|FG002|Overall Study|participant safety|0|||
30639377|NCT01092182|58651211|FG000|Overall Study|Physician Decision|0|||
30639378|NCT01092182|58651212|FG001|Overall Study|Physician Decision|6|||
30639379|NCT01092182|58651213|FG002|Overall Study|Physician Decision|0|||
30639380|NCT01092182|58651211|FG000|Overall Study|Did not meet criteria|0|||
30639381|NCT01092182|58651212|FG001|Overall Study|Did not meet criteria|0|||
30639382|NCT01092182|58651213|FG002|Overall Study|Did not meet criteria|25|||
30639383|NCT01092182|58651211|FG000|Overall Study|Non-compliance|0|||
30639384|NCT01092182|58651212|FG001|Overall Study|Non-compliance|3|||
30639385|NCT01092182|58651213|FG002|Overall Study|Non-compliance|0|||
30639386|NCT01092182|58651211|FG000|Overall Study|Participant refused follow-up|0|||
30639387|NCT01092182|58651212|FG001|Overall Study|Participant refused follow-up|2|||
30639388|NCT01092182|58651213|FG002|Overall Study|Participant refused follow-up|0|||
30639389|NCT00932646|58651221|FG000|Overall Study|Adverse Event|2|||
30639390|NCT00932646|58651222|FG001|Overall Study|Adverse Event|1|||
30639391|NCT00932646|58651223|FG002|Overall Study|Adverse Event|1|||
30639392|NCT00932646|58651224|FG003|Overall Study|Adverse Event|1|||
30639393|NCT00932646|58651221|FG000|Overall Study|Lost to Follow-up|2|||
30639394|NCT00932646|58651222|FG001|Overall Study|Lost to Follow-up|1|||
30639395|NCT00932646|58651223|FG002|Overall Study|Lost to Follow-up|0|||
30639396|NCT00932646|58651224|FG003|Overall Study|Lost to Follow-up|0|||
30639397|NCT00932646|58651221|FG000|Overall Study|Withdrawal by Subject|1|||
30639398|NCT00932646|58651222|FG001|Overall Study|Withdrawal by Subject|1|||
30639399|NCT00932646|58651223|FG002|Overall Study|Withdrawal by Subject|3|||
30639400|NCT00932646|58651224|FG003|Overall Study|Withdrawal by Subject|0|||
30639401|NCT00871234|58651238|FG000|Overall Study|Adverse Event|2|||
30639402|NCT00871234|58651238|FG000|Overall Study|Lost to Follow-up|3|||
30639403|NCT01091246|58651245|FG000|Overall Study|Lost to Follow-up|23|||
30639404|NCT01091246|58651246|FG001|Overall Study|Lost to Follow-up|11|||
30639405|NCT01091246|58651247|FG002|Overall Study|Lost to Follow-up|7|||
30639406|NCT01091246|58651245|FG000|Overall Study|Adverse Event|1|||
30639407|NCT01091246|58651246|FG001|Overall Study|Adverse Event|0|||
30639408|NCT01091246|58651247|FG002|Overall Study|Adverse Event|1|||
30639409|NCT01091246|58651245|FG000|Overall Study|Withdrawal by Subject|9|||
30639410|NCT01091246|58651246|FG001|Overall Study|Withdrawal by Subject|5|||
30639411|NCT01091246|58651247|FG002|Overall Study|Withdrawal by Subject|4|||
30639412|NCT01091246|58651245|FG000|Overall Study|Subject not dosed|2|||
30639413|NCT01091246|58651246|FG001|Overall Study|Subject not dosed|0|||
30639414|NCT01091246|58651247|FG002|Overall Study|Subject not dosed|1|||
30639415|NCT01097330|58651259|FG000|Overall Study|Study terminated early|7|||
30639416|NCT01097330|58651260|FG001|Overall Study|Study terminated early|5|||
30639417|NCT00934440|58651266|FG000|Overall Study|Lost to Follow-up|1|||
30639418|NCT00934362|58651273|FG000|Overall Study|Adverse Event|1|||
30639419|NCT00934362|58651274|FG001|Overall Study|Adverse Event|0|||
30639420|NCT00934128|58651282|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
30639421|NCT00934128|58651283|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
30639422|NCT00934128|58651282|FG000|First Intervention (2 Hours)|Adverse Event|4|||
30639423|NCT00934128|58651283|FG001|First Intervention (2 Hours)|Adverse Event|1|||
30639424|NCT00934128|58651282|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
30639425|NCT00934128|58651283|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
30639426|NCT00934128|58651282|FG000|Washout Period (1 Hour)|Patient preference|1|||
30639427|NCT00934128|58651283|FG001|Washout Period (1 Hour)|Patient preference|3|||
30639428|NCT00934128|58651282|FG000|Washout Period (1 Hour)|Pain|1|||
30639429|NCT00934128|58651283|FG001|Washout Period (1 Hour)|Pain|0|||
30639430|NCT00934128|58651282|FG000|Washout Period (1 Hour)|Too tired|1|||
30639431|NCT00934128|58651283|FG001|Washout Period (1 Hour)|Too tired|0|||
30639432|NCT00934128|58651282|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
30639433|NCT00934128|58651283|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
30639434|NCT00934128|58651282|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
30639435|NCT00934128|58651283|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
30639436|NCT00871000|58651291|FG000|Overall Study|Withdrawal by Subject|1|||
30639437|NCT00871000|58651292|FG001|Overall Study|Withdrawal by Subject|0|||
30639438|NCT01096784|58651300|FG000|Overall Study|Withdrawal by Subject|2|||
30639439|NCT01096784|58651301|FG001|Overall Study|Withdrawal by Subject|1|||
30639440|NCT01096784|58651300|FG000|Overall Study|Adverse Event|11|||
30639441|NCT01096784|58651301|FG001|Overall Study|Adverse Event|9|||
30639442|NCT01096784|58651300|FG000|Overall Study|Protocol Deviation|2|||
30639443|NCT01096784|58651301|FG001|Overall Study|Protocol Deviation|2|||
30639444|NCT01096784|58651300|FG000|Overall Study|Administrative Decision|0|||
30639445|NCT01096784|58651301|FG001|Overall Study|Administrative Decision|1|||
30639446|NCT01096784|58651300|FG000|Overall Study|Other Unspecified|0|||
30639447|NCT01096784|58651301|FG001|Overall Study|Other Unspecified|1|||
30639448|NCT00934050|58651315|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
30639449|NCT00934050|58651316|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
30639450|NCT00934050|58651317|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
30639451|NCT00934050|58651318|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
30639452|NCT00934050|58651319|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
30639453|NCT00934050|58651320|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
30639454|NCT00934050|58651315|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
30639455|NCT00934050|58651316|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
30639456|NCT00934050|58651317|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
30639457|NCT00934050|58651318|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
30639458|NCT00934050|58651319|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
30639459|NCT00934050|58651320|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
30639460|NCT00934050|58651315|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
30639461|NCT00934050|58651316|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
30639462|NCT00934050|58651317|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
30639463|NCT00934050|58651318|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
30639464|NCT00934050|58651319|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
30639465|NCT00934050|58651320|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
30639466|NCT00934050|58651315|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
30639467|NCT00934050|58651316|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
30639468|NCT00934050|58651317|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
30639469|NCT00934050|58651318|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
30639470|NCT00934050|58651319|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
30639471|NCT00934050|58651320|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
30639472|NCT00934050|58651315|FG000|Enrolled After 15 Dec 2009|Death|0|||
30639473|NCT00934050|58651316|FG001|Enrolled After 15 Dec 2009|Death|0|||
30639474|NCT00934050|58651317|FG002|Enrolled After 15 Dec 2009|Death|0|||
30639475|NCT00934050|58651318|FG003|Enrolled After 15 Dec 2009|Death|0|||
30639476|NCT00934050|58651319|FG004|Enrolled After 15 Dec 2009|Death|0|||
30639477|NCT00934050|58651320|FG005|Enrolled After 15 Dec 2009|Death|1|||
30639478|NCT00934050|58651315|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
30639479|NCT00934050|58651316|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
30639480|NCT00934050|58651317|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
30639481|NCT00934050|58651318|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
30639482|NCT00934050|58651319|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
30639483|NCT00934050|58651320|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
30639484|NCT00934050|58651315|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
30639485|NCT00934050|58651316|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
30639486|NCT00934050|58651317|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
30639487|NCT00934050|58651318|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
30639488|NCT00934050|58651319|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
30639489|NCT00934050|58651320|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
30639490|NCT01091168|58651332|FG000|Overall Study|Progressive disease|250|||
30639491|NCT01091168|58651333|FG001|Overall Study|Progressive disease|234|||
30639492|NCT01091168|58651332|FG000|Overall Study|Adverse Event|21|||
30639493|NCT01091168|58651333|FG001|Overall Study|Adverse Event|24|||
30639494|NCT01091168|58651332|FG000|Overall Study|Lost to Follow-up|0|||
30639495|NCT01091168|58651333|FG001|Overall Study|Lost to Follow-up|1|||
30639496|NCT01091168|58651332|FG000|Overall Study|Physician, patient's decision, other|27|||
30639497|NCT01091168|58651333|FG001|Overall Study|Physician, patient's decision, other|37|||
30639498|NCT00864916|58651341|FG000|Overall Study|Lost to Follow-up|4|||
30639499|NCT00864916|58651342|FG001|Overall Study|Lost to Follow-up|4|||
30639500|NCT00864916|58651341|FG000|Overall Study|Protocol Violation|1|||
30639501|NCT00864916|58651342|FG001|Overall Study|Protocol Violation|0|||
30639502|NCT00864916|58651341|FG000|Overall Study|Withdrawal by Subject|1|||
30639503|NCT00864916|58651342|FG001|Overall Study|Withdrawal by Subject|0|||
30639504|NCT00864682|58651351|FG000|Overall Study|Protocol Violation|2|||
30639505|NCT00864682|58651352|FG001|Overall Study|Protocol Violation|1|||
30639506|NCT00864682|58651353|FG002|Overall Study|Protocol Violation|2|||
30639507|NCT00931944|58651361|FG000|Overall Study|Adverse Event|4|||
30639508|NCT00931944|58651361|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
30639509|NCT00931944|58651361|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
30639510|NCT00931944|58651361|FG000|Overall Study|Death|28|||
30639511|NCT00931944|58651361|FG000|Overall Study|Other|2|||
30639512|NCT00929994|58651365|FG000|Overall Study|Withdrawal by Subject|1|||
30639513|NCT00929994|58651365|FG000|Overall Study|medical issue unrelated to intervention|4|||
30639514|NCT00929994|58651365|FG000|Overall Study|employment|1|||
30639515|NCT01090310|58651376|FG000|Core Study|Adverse Event|2|||
30639516|NCT01090310|58651377|FG001|Core Study|Adverse Event|2|||
30639517|NCT01090310|58651378|FG002|Core Study|Adverse Event|1|||
30639518|NCT01090310|58651379|FG003|Core Study|Adverse Event|1|||
30639519|NCT01090310|58651376|FG000|Core Study|Subject withdrew consent|0|||
30639520|NCT01090310|58651377|FG001|Core Study|Subject withdrew consent|3|||
30639521|NCT01090310|58651378|FG002|Core Study|Subject withdrew consent|1|||
30639522|NCT01090310|58651379|FG003|Core Study|Subject withdrew consent|1|||
30639523|NCT01090310|58651376|FG000|Core Study|Abnormal test procedure result|0|||
30639524|NCT01090310|58651377|FG001|Core Study|Abnormal test procedure result|0|||
30639525|NCT01090310|58651378|FG002|Core Study|Abnormal test procedure result|1|||
30639526|NCT01090310|58651379|FG003|Core Study|Abnormal test procedure result|0|||
30639527|NCT01090310|58651376|FG000|Core Study|Administrative reasons|5|||
30639528|NCT01090310|58651377|FG001|Core Study|Administrative reasons|6|||
30639529|NCT01090310|58651378|FG002|Core Study|Administrative reasons|4|||
30639530|NCT01090310|58651379|FG003|Core Study|Administrative reasons|4|||
30639531|NCT01090310|58651376|FG000|Core Study|Protocol deviation|1|||
30639532|NCT01090310|58651377|FG001|Core Study|Protocol deviation|0|||
30639533|NCT01090310|58651378|FG002|Core Study|Protocol deviation|0|||
30639534|NCT01090310|58651379|FG003|Core Study|Protocol deviation|1|||
30639535|NCT01090310|58651376|FG000|Extension Study|Aministrative problems|13|||
30639536|NCT01090310|58651377|FG001|Extension Study|Aministrative problems|15|||
30639537|NCT01090310|58651378|FG002|Extension Study|Aministrative problems|14|||
30639538|NCT01090310|58651379|FG003|Extension Study|Aministrative problems|18|||
30639539|NCT01090310|58651376|FG000|Extension Study|Adverse Event|0|||
30639540|NCT01090310|58651377|FG001|Extension Study|Adverse Event|0|||
30639541|NCT01090310|58651378|FG002|Extension Study|Adverse Event|0|||
30639542|NCT01090310|58651379|FG003|Extension Study|Adverse Event|1|||
30639543|NCT01090310|58651376|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
30639544|NCT01090310|58651377|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
30639545|NCT01090310|58651378|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
30639546|NCT01090310|58651379|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
30639547|NCT01090310|58651376|FG000|Extension Study|Subject withdrew consent|0|||
30639548|NCT01090310|58651377|FG001|Extension Study|Subject withdrew consent|1|||
30639549|NCT01090310|58651378|FG002|Extension Study|Subject withdrew consent|0|||
30639550|NCT01090310|58651379|FG003|Extension Study|Subject withdrew consent|0|||
30639551|NCT01090076|58651391|FG000|Overall Study|Death|1|||
30639552|NCT01090076|58651392|FG001|Overall Study|Death|1|||
30639553|NCT01090076|58651391|FG000|Overall Study|Withdrawal by Subject|0|||
30639554|NCT01090076|58651392|FG001|Overall Study|Withdrawal by Subject|1|||
30639555|NCT00869050|58651400|FG000|Overall Study|Screen Failure|3|||
30639556|NCT00927186|58651406|FG000|12 Months Primary Study|Adverse Event|5|||
30639557|NCT00927186|58651407|FG001|12 Months Primary Study|Adverse Event|2|||
30639558|NCT00927186|58651406|FG000|12 Months Primary Study|Lost to Follow-up|1|||
30639559|NCT00927186|58651407|FG001|12 Months Primary Study|Lost to Follow-up|0|||
30639560|NCT00927186|58651406|FG000|12 Months Primary Study|Protocol Violation|0|||
30639561|NCT00927186|58651407|FG001|12 Months Primary Study|Protocol Violation|1|||
30639562|NCT00927186|58651406|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
30639563|NCT00927186|58651407|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
30639564|NCT00593554|58651418|FG000|Overall Study|Death|1|||
30639565|NCT00593554|58651419|FG001|Overall Study|Death|2|||
30639566|NCT00593554|58651418|FG000|Overall Study|Physician Decision|0|||
30639567|NCT00593554|58651419|FG001|Overall Study|Physician Decision|1|||
30639568|NCT00593554|58651418|FG000|Overall Study|Withdrawal by Subject|1|||
30639569|NCT00593554|58651419|FG001|Overall Study|Withdrawal by Subject|0|||
30639570|NCT00593554|58651418|FG000|Overall Study|Disease Progression|1|||
30639571|NCT00593554|58651419|FG001|Overall Study|Disease Progression|2|||
30639572|NCT01101308|58651425|FG000|Period 1|Adverse Event|2|||
30639573|NCT01101308|58651426|FG001|Period 1|Adverse Event|1|||
30639574|NCT01101308|58651425|FG000|Period 1|Positive for cotinine|1|||
30639575|NCT01101308|58651426|FG001|Period 1|Positive for cotinine|0|||
30639576|NCT00926796|58651435|FG000|Overall Study|Did not receive randomized treatment|4|||
30639577|NCT00926796|58651436|FG001|Overall Study|Did not receive randomized treatment|7|||
30639578|NCT00926796|58651435|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
30639579|NCT00926796|58651436|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
30639580|NCT00926796|58651435|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
30639581|NCT00926796|58651436|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
30639582|NCT00926796|58651435|FG000|Overall Study|Adverse Event|7|||
30639583|NCT00926796|58651436|FG001|Overall Study|Adverse Event|14|||
30639584|NCT00926796|58651435|FG000|Overall Study|Lost to Follow-up|22|||
30639585|NCT00926796|58651436|FG001|Overall Study|Lost to Follow-up|13|||
30639586|NCT00926796|58651435|FG000|Overall Study|Protocol Violation|15|||
30639587|NCT00926796|58651436|FG001|Overall Study|Protocol Violation|11|||
30639588|NCT00926796|58651435|FG000|Overall Study|Withdrawal by Subject|1|||
30639589|NCT00926796|58651436|FG001|Overall Study|Withdrawal by Subject|0|||
30639590|NCT01087736|58651446|FG000|Overall Study|Lost to Follow-up|1|||
30639591|NCT01087736|58651447|FG001|Overall Study|Lost to Follow-up|0|||
30639592|NCT01087736|58651446|FG000|Overall Study|Death|0|||
30639593|NCT01087736|58651447|FG001|Overall Study|Death|1|||
30639594|NCT01087736|58651446|FG000|Overall Study|Withdrawal by Subject|0|||
30639595|NCT01087736|58651447|FG001|Overall Study|Withdrawal by Subject|1|||
30639596|NCT01079936|58651457|FG000|Phase I: MTD|First Remission Status|2|||
30639597|NCT01079936|58651458|FG001|Phase I: MTD|First Remission Status|0|||
30639598|NCT01079936|58651459|FG002|Phase I: MTD|First Remission Status|0|||
30639599|NCT01079936|58651460|FG003|Phase I: MTD|First Remission Status|0|||
30639600|NCT01079936|58651461|FG004|Phase I: MTD|First Remission Status|0|||
30639601|NCT01079936|58651457|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
30639602|NCT01079936|58651458|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
30639603|NCT01079936|58651459|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
30639604|NCT01079936|58651460|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
30639605|NCT01079936|58651461|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
30639606|NCT01079936|58651457|FG000|Phase II|Adverse Event|0|||
30639607|NCT01079936|58651458|FG001|Phase II|Adverse Event|0|||
30639608|NCT01079936|58651459|FG002|Phase II|Adverse Event|1|||
30639609|NCT01079936|58651460|FG003|Phase II|Adverse Event|0|||
30639610|NCT01079936|58651461|FG004|Phase II|Adverse Event|0|||
30639611|NCT01079936|58651457|FG000|Phase II|Insurance Issue|0|||
30639612|NCT01079936|58651458|FG001|Phase II|Insurance Issue|0|||
30639613|NCT01079936|58651459|FG002|Phase II|Insurance Issue|0|||
30639614|NCT01079936|58651460|FG003|Phase II|Insurance Issue|0|||
30639615|NCT01079936|58651461|FG004|Phase II|Insurance Issue|1|||
30639616|NCT00931710|58651474|FG000|Overall Study|Adverse Event|16|||
30639617|NCT00931710|58651475|FG001|Overall Study|Adverse Event|10|||
30639618|NCT00931710|58651474|FG000|Overall Study|Abnormal test procedure results|2|||
30639619|NCT00931710|58651475|FG001|Overall Study|Abnormal test procedure results|0|||
30639620|NCT00931710|58651474|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
30639621|NCT00931710|58651475|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
30639622|NCT00931710|58651474|FG000|Overall Study|Patient withdrew consent|4|||
30639623|NCT00931710|58651475|FG001|Overall Study|Patient withdrew consent|9|||
30639624|NCT00931710|58651474|FG000|Overall Study|Lost to Follow-up|6|||
30639625|NCT00931710|58651475|FG001|Overall Study|Lost to Follow-up|5|||
30639626|NCT00931710|58651474|FG000|Overall Study|Protocol deviation|1|||
30639627|NCT00931710|58651475|FG001|Overall Study|Protocol deviation|2|||
30639628|NCT01100528|58651481|FG000|Overall Study|Death|1|||
30639629|NCT01100528|58651481|FG000|Overall Study|Withdrawal by Subject|2|||
30639630|NCT01079234|58651488|FG000|Main: Week 0 to 26|Adverse Event|5|||
30639631|NCT01079234|58651489|FG001|Main: Week 0 to 26|Adverse Event|4|||
30639632|NCT01079234|58651490|FG002|Main: Week 0 to 26|Adverse Event|1|||
30639633|NCT01079234|58651491|FG003|Main: Week 0 to 26|Adverse Event|0|||
30639634|NCT01079234|58651488|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
30639635|NCT01079234|58651489|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
30639636|NCT01079234|58651490|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
30639637|NCT01079234|58651491|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
30639638|NCT01079234|58651488|FG000|Main: Week 0 to 26|Protocol Violation|6|||
30639639|NCT01079234|58651489|FG001|Main: Week 0 to 26|Protocol Violation|2|||
30639640|NCT01079234|58651490|FG002|Main: Week 0 to 26|Protocol Violation|4|||
30639641|NCT01079234|58651491|FG003|Main: Week 0 to 26|Protocol Violation|0|||
30639642|NCT01079234|58651488|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
30639643|NCT01079234|58651489|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
30639644|NCT01079234|58651490|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
30639645|NCT01079234|58651491|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
30639646|NCT01079234|58651488|FG000|Main: Week 0 to 26|Unclassified|7|||
30639647|NCT01079234|58651489|FG001|Main: Week 0 to 26|Unclassified|13|||
30639648|NCT01079234|58651490|FG002|Main: Week 0 to 26|Unclassified|4|||
30639649|NCT01079234|58651491|FG003|Main: Week 0 to 26|Unclassified|0|||
30639650|NCT01079234|58651488|FG000|Extension: Week 27 to 52|Adverse Event|0|||
30639651|NCT01079234|58651489|FG001|Extension: Week 27 to 52|Adverse Event|0|||
30639652|NCT01079234|58651490|FG002|Extension: Week 27 to 52|Adverse Event|1|||
30639653|NCT01079234|58651491|FG003|Extension: Week 27 to 52|Adverse Event|0|||
30639654|NCT01079234|58651488|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
30639655|NCT01079234|58651489|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
30639656|NCT01079234|58651490|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
30639657|NCT01079234|58651491|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
30639658|NCT01079234|58651488|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
30639659|NCT01079234|58651489|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
30639660|NCT01079234|58651490|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
30639661|NCT01079234|58651491|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
30639662|NCT01079234|58651488|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
30639663|NCT01079234|58651489|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
30639664|NCT01079234|58651490|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
30639665|NCT01079234|58651491|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
30639666|NCT01079234|58651488|FG000|Extension: Week 27 to 52|Unclassified|0|||
30639667|NCT01079234|58651489|FG001|Extension: Week 27 to 52|Unclassified|0|||
30639668|NCT01079234|58651490|FG002|Extension: Week 27 to 52|Unclassified|4|||
30639669|NCT01079234|58651491|FG003|Extension: Week 27 to 52|Unclassified|7|||
30639670|NCT00931632|58651502|FG000|Overall Study|Withdrawal by Subject|2|||
30639671|NCT00931632|58651503|FG001|Overall Study|Withdrawal by Subject|3|||
30639672|NCT00931632|58651502|FG000|Overall Study|Adverse Event|19|||
30639673|NCT00931632|58651503|FG001|Overall Study|Adverse Event|15|||
30639674|NCT01078922|58651509|FG000|Overall Study|Adverse Event|1|||
30639675|NCT00863746|58651516|FG000|Treatment|Not treated|4|||
30639676|NCT00863746|58651517|FG001|Treatment|Not treated|2|||
30639677|NCT00863746|58651516|FG000|Treatment|Adverse Event|41|||
30639678|NCT00863746|58651517|FG001|Treatment|Adverse Event|16|||
30639679|NCT00863746|58651516|FG000|Treatment|non-compliant with study medication|4|||
30639680|NCT00863746|58651517|FG001|Treatment|non-compliant with study medication|0|||
30639681|NCT00863746|58651516|FG000|Treatment|Consent withdrawn|15|||
30639682|NCT00863746|58651517|FG001|Treatment|Consent withdrawn|14|||
30639683|NCT00863746|58651516|FG000|Treatment|Lost to Follow-up|1|||
30639684|NCT00863746|58651517|FG001|Treatment|Lost to Follow-up|0|||
30639685|NCT00863746|58651516|FG000|Treatment|Protocol Violation|5|||
30639686|NCT00863746|58651517|FG001|Treatment|Protocol Violation|3|||
30639687|NCT00863746|58651516|FG000|Treatment|Other|1|||
30639688|NCT00863746|58651517|FG001|Treatment|Other|0|||
30639689|NCT00863746|58651516|FG000|Survival Follow up|Death|244|||
30639690|NCT00863746|58651517|FG001|Survival Follow up|Death|271|||
30639691|NCT00863746|58651516|FG000|Survival Follow up|Lost to Follow-up|2|||
30639692|NCT00863746|58651517|FG001|Survival Follow up|Lost to Follow-up|1|||
30639693|NCT00863746|58651516|FG000|Survival Follow up|Consent Withdrawn|7|||
30639694|NCT00863746|58651517|FG001|Survival Follow up|Consent Withdrawn|8|||
30765516|NCT02945410|58774099|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
30765517|NCT02945410|58774100|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
30765518|NCT02945410|58774101|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
30765519|NCT02945410|58774102|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
30765520|NCT02945410|58774103|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
30765521|NCT02945410|58774104|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
30765522|NCT02945254|58774114|FG000|Overall Study|Lost to Follow-up|1|||
30765523|NCT02945254|58774115|FG001|Overall Study|Lost to Follow-up|0|||
30765524|NCT02945254|58774114|FG000|Overall Study|Withdrawal by Subject|1|||
30765525|NCT02945254|58774115|FG001|Overall Study|Withdrawal by Subject|0|||
30765526|NCT02943070|58774133|FG000|Overall Study|Physician Decision|1|||
30765527|NCT02943070|58774133|FG000|Overall Study|Adverse Event|2|||
30765528|NCT02943070|58774133|FG000|Overall Study|Death|2|||
30765529|NCT02943070|58774133|FG000|Overall Study|Withdrawal by Subject|3|||
30765530|NCT02943070|58774133|FG000|Overall Study|Lost to Follow-up|4|||
30765531|NCT02943070|58774133|FG000|Overall Study|Retreatment or TURP|13|||
30639695|NCT00926328|58651525|FG000|Overall Study|Lost to Follow-up|12|||
30639696|NCT00926328|58651526|FG001|Overall Study|Lost to Follow-up|14|||
30639697|NCT00863512|58651534|FG000|Overall Study|Adverse Event|2|||
30639698|NCT00863512|58651535|FG001|Overall Study|Adverse Event|0|||
30639699|NCT00863512|58651534|FG000|Overall Study|Withdrawal by Subject|11|||
30639700|NCT00863512|58651535|FG001|Overall Study|Withdrawal by Subject|0|||
30639701|NCT00863512|58651534|FG000|Overall Study|Physician Decision|1|||
30639702|NCT00863512|58651535|FG001|Overall Study|Physician Decision|0|||
30639703|NCT00868192|58651541|FG000|Overall Study|Ineligible|4|||
30639704|NCT00867568|58651545|FG000|Overall Study|Lack of Efficacy|10|||
30639705|NCT00867568|58651545|FG000|Overall Study|Adverse Event|4|||
30639706|NCT00867568|58651545|FG000|Overall Study|Withdrawal by Subject|1|||
30639707|NCT00930930|58651551|FG000|Overall Study|Death|1|||
30639708|NCT00930930|58651552|FG001|Overall Study|Death|0|||
30639709|NCT00930930|58651551|FG000|Overall Study|Physician Decision|1|||
30639710|NCT00930930|58651552|FG001|Overall Study|Physician Decision|0|||
30639711|NCT00930930|58651551|FG000|Overall Study|Adverse Event|13|||
30639712|NCT00930930|58651552|FG001|Overall Study|Adverse Event|3|||
30639713|NCT00930930|58651551|FG000|Overall Study|Withdrawal by Subject|3|||
30639714|NCT00930930|58651552|FG001|Overall Study|Withdrawal by Subject|1|||
30639715|NCT00930930|58651551|FG000|Overall Study|Disease progression|2|||
30639716|NCT00930930|58651552|FG001|Overall Study|Disease progression|3|||
30639717|NCT00930930|58651551|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
30639718|NCT00930930|58651552|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
30639719|NCT00930930|58651551|FG000|Overall Study|patients not compliant|1|||
30639720|NCT00930930|58651552|FG001|Overall Study|patients not compliant|1|||
30639721|NCT00862654|58651562|FG000|Overall Study|Lack of Efficacy|1|||
30639722|NCT00862654|58651563|FG001|Overall Study|Lack of Efficacy|0|||
30639723|NCT00862654|58651564|FG002|Overall Study|Lack of Efficacy|1|||
30639724|NCT00862654|58651565|FG003|Overall Study|Lack of Efficacy|0|||
30639725|NCT00862654|58651562|FG000|Overall Study|Lost to Follow-up|1|||
30639726|NCT00862654|58651563|FG001|Overall Study|Lost to Follow-up|2|||
30639727|NCT00862654|58651564|FG002|Overall Study|Lost to Follow-up|1|||
30639728|NCT00862654|58651565|FG003|Overall Study|Lost to Follow-up|3|||
30639729|NCT00862654|58651562|FG000|Overall Study|Adverse Event|0|||
30639730|NCT00862654|58651563|FG001|Overall Study|Adverse Event|1|||
30639731|NCT00862654|58651564|FG002|Overall Study|Adverse Event|1|||
30639732|NCT00862654|58651565|FG003|Overall Study|Adverse Event|0|||
30639733|NCT00862654|58651562|FG000|Overall Study|Pregnancy|1|||
30639734|NCT00862654|58651563|FG001|Overall Study|Pregnancy|1|||
30639735|NCT00862654|58651564|FG002|Overall Study|Pregnancy|0|||
30639736|NCT00862654|58651565|FG003|Overall Study|Pregnancy|0|||
30639737|NCT00862654|58651562|FG000|Overall Study|Withdrawal by Subject|2|||
30639738|NCT00862654|58651563|FG001|Overall Study|Withdrawal by Subject|2|||
30639739|NCT00862654|58651564|FG002|Overall Study|Withdrawal by Subject|2|||
30639740|NCT00862654|58651565|FG003|Overall Study|Withdrawal by Subject|3|||
30639741|NCT00862654|58651562|FG000|Overall Study|Subject mistake|0|||
30639742|NCT00862654|58651563|FG001|Overall Study|Subject mistake|1|||
30639743|NCT00862654|58651564|FG002|Overall Study|Subject mistake|0|||
30639744|NCT00862654|58651565|FG003|Overall Study|Subject mistake|0|||
30639745|NCT00862654|58651562|FG000|Overall Study|Familly constraint|0|||
30639746|NCT00862654|58651563|FG001|Overall Study|Familly constraint|1|||
30639747|NCT00862654|58651564|FG002|Overall Study|Familly constraint|0|||
30639748|NCT00862654|58651565|FG003|Overall Study|Familly constraint|0|||
30639749|NCT00862654|58651562|FG000|Overall Study|Never used study drugs|1|||
30639750|NCT00862654|58651563|FG001|Overall Study|Never used study drugs|0|||
30639751|NCT00862654|58651564|FG002|Overall Study|Never used study drugs|0|||
30639752|NCT00862654|58651565|FG003|Overall Study|Never used study drugs|0|||
30639753|NCT00862654|58651562|FG000|Overall Study|Included after end of inclusions|0|||
30639754|NCT00862654|58651563|FG001|Overall Study|Included after end of inclusions|0|||
30848512|NCT02851511|58874631|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
30639755|NCT00862654|58651564|FG002|Overall Study|Included after end of inclusions|1|||
30639756|NCT00862654|58651565|FG003|Overall Study|Included after end of inclusions|0|||
30639757|NCT00867490|58651575|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
30639758|NCT00867490|58651575|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
30639759|NCT00867490|58651575|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
30639760|NCT00867490|58651575|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
30639761|NCT00867490|58651575|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
30639762|NCT00930774|58651586|FG000|Overall Study|Withdrawal by Subject|1|||
30639763|NCT00930774|58651587|FG001|Overall Study|Withdrawal by Subject|9|||
30639764|NCT00930774|58651588|FG002|Overall Study|Withdrawal by Subject|2|||
30639765|NCT00930774|58651589|FG003|Overall Study|Withdrawal by Subject|0|||
30639766|NCT00867334|58651602|FG000|Overall Study|Withdrawal by Subject|0|||
30639767|NCT00867334|58651603|FG001|Overall Study|Withdrawal by Subject|1|||
30639768|NCT00867334|58651602|FG000|Overall Study|Withdrawal by Subject|1|||
30639769|NCT00867334|58651603|FG001|Overall Study|Withdrawal by Subject|0|||
30639770|NCT00867334|58651602|FG000|Overall Study|Withdrawal by Subject|1|||
30639771|NCT00867334|58651603|FG001|Overall Study|Withdrawal by Subject|0|||
30639772|NCT00925704|58651615|FG000|First Intervention|Withdrew consent|0|||
30639773|NCT00925704|58651616|FG001|First Intervention|Withdrew consent|0|||
30639774|NCT00925704|58651617|FG002|First Intervention|Withdrew consent|0|||
30639775|NCT00925704|58651618|FG003|First Intervention|Withdrew consent|1|||
30639776|NCT00925704|58651619|FG004|First Intervention|Withdrew consent|1|||
30639777|NCT00925704|58651620|FG005|First Intervention|Withdrew consent|0|||
30639778|NCT00925704|58651615|FG000|Second Intervention|Withdrawal by Subject|1|||
30639779|NCT00925704|58651616|FG001|Second Intervention|Withdrawal by Subject|0|||
30639780|NCT00925704|58651617|FG002|Second Intervention|Withdrawal by Subject|0|||
30639781|NCT00925704|58651618|FG003|Second Intervention|Withdrawal by Subject|0|||
30639782|NCT00925704|58651619|FG004|Second Intervention|Withdrawal by Subject|1|||
30639783|NCT00925704|58651620|FG005|Second Intervention|Withdrawal by Subject|0|||
30639784|NCT00925704|58651615|FG000|Third Intervention|Withdrew consent|0|||
30639785|NCT00925704|58651616|FG001|Third Intervention|Withdrew consent|0|||
30639786|NCT00925704|58651617|FG002|Third Intervention|Withdrew consent|0|||
30639787|NCT00925704|58651618|FG003|Third Intervention|Withdrew consent|0|||
30639788|NCT00925704|58651619|FG004|Third Intervention|Withdrew consent|0|||
30639789|NCT00925704|58651620|FG005|Third Intervention|Withdrew consent|1|||
30639790|NCT01076192|58651631|FG000|Overall Study|Other|197|||
30639791|NCT01076036|58651636|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
30639792|NCT01075958|58651640|FG000|Overall Study|Blood sample could not be obtained|44|||
30639793|NCT01096316|58651646|FG000|Overall Study|Lost to Follow-up|15|||
30639794|NCT01096316|58651647|FG001|Overall Study|Lost to Follow-up|9|||
30639795|NCT00925548|58651655|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
30639796|NCT00925548|58651656|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
30639797|NCT00866788|58651667|FG000|Overall Study|Adverse Event|0|||
30639798|NCT00866788|58651668|FG001|Overall Study|Adverse Event|2|||
30639799|NCT00866788|58651669|FG002|Overall Study|Adverse Event|0|||
30639800|NCT00866788|58651670|FG003|Overall Study|Adverse Event|1|||
30639801|NCT00866788|58651667|FG000|Overall Study|Lost to Follow-up|1|||
30639802|NCT00866788|58651668|FG001|Overall Study|Lost to Follow-up|1|||
30639803|NCT00866788|58651669|FG002|Overall Study|Lost to Follow-up|0|||
30639804|NCT00866788|58651670|FG003|Overall Study|Lost to Follow-up|2|||
30639805|NCT00866788|58651667|FG000|Overall Study|Withdrawal by Subject|2|||
30639806|NCT00866788|58651668|FG001|Overall Study|Withdrawal by Subject|1|||
30639807|NCT00866788|58651669|FG002|Overall Study|Withdrawal by Subject|0|||
30639808|NCT00866788|58651670|FG003|Overall Study|Withdrawal by Subject|1|||
30639809|NCT00866788|58651667|FG000|Overall Study|Pregnancy|0|||
30639810|NCT00866788|58651668|FG001|Overall Study|Pregnancy|1|||
30639811|NCT00866788|58651669|FG002|Overall Study|Pregnancy|0|||
30639812|NCT00866788|58651670|FG003|Overall Study|Pregnancy|0|||
30639813|NCT00866788|58651667|FG000|Overall Study|Disease progression|3|||
30639814|NCT00866788|58651668|FG001|Overall Study|Disease progression|1|||
30639815|NCT00866788|58651669|FG002|Overall Study|Disease progression|1|||
30639816|NCT00866788|58651670|FG003|Overall Study|Disease progression|0|||
30639817|NCT00866788|58651667|FG000|Overall Study|Physician Decision|0|||
30639818|NCT00866788|58651668|FG001|Overall Study|Physician Decision|0|||
30639819|NCT00866788|58651669|FG002|Overall Study|Physician Decision|1|||
30639820|NCT00866788|58651670|FG003|Overall Study|Physician Decision|1|||
30639821|NCT00860470|58651685|FG000|Overall Study|Death|6|||
30639822|NCT00860470|58651686|FG001|Overall Study|Death|10|||
30848513|NCT02851511|58874632|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
30639823|NCT00860470|58651685|FG000|Overall Study|Moved away|8|||
30639824|NCT00860470|58651686|FG001|Overall Study|Moved away|10|||
30639825|NCT00860470|58651685|FG000|Overall Study|Lost to Follow-up|34|||
30639826|NCT00860470|58651686|FG001|Overall Study|Lost to Follow-up|39|||
30639827|NCT00923364|58651692|FG000|Overall Study|Death|3|||
30639828|NCT00923364|58651693|FG001|Overall Study|Death|0|||
30639829|NCT00923364|58651692|FG000|Overall Study|Did not go to transplant|1|||
30639830|NCT00923364|58651693|FG001|Overall Study|Did not go to transplant|0|||
30639831|NCT01096160|58651708|FG000|Overall Study|Adverse Event|0|||
30639832|NCT01096160|58651709|FG001|Overall Study|Adverse Event|0|||
30639833|NCT01096160|58651710|FG002|Overall Study|Adverse Event|1|||
30639834|NCT01096160|58651711|FG003|Overall Study|Adverse Event|0|||
30639835|NCT01096160|58651712|FG004|Overall Study|Adverse Event|0|||
30639836|NCT01096160|58651713|FG005|Overall Study|Adverse Event|0|||
30639837|NCT01096160|58651714|FG006|Overall Study|Adverse Event|0|||
30639838|NCT01096160|58651715|FG007|Overall Study|Adverse Event|0|||
30639839|NCT01096160|58651716|FG008|Overall Study|Adverse Event|0|||
30639840|NCT01096160|58651717|FG009|Overall Study|Adverse Event|1|||
30951504|NCT01705574|58998712|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
30951505|NCT01705574|58998713|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
30951506|NCT01705574|58998710|FG000|Open-Label Extension Phase|Physician Decision|0|||
30951507|NCT01705574|58998711|FG001|Open-Label Extension Phase|Physician Decision|0|||
30951508|NCT01705574|58998712|FG002|Open-Label Extension Phase|Physician Decision|2|||
30951509|NCT01705574|58998713|FG003|Open-Label Extension Phase|Physician Decision|0|||
30951510|NCT01705574|58998710|FG000|Open-Label Extension Phase|Pregnancy|0|||
30951511|NCT01705574|58998711|FG001|Open-Label Extension Phase|Pregnancy|0|||
30951512|NCT01705574|58998712|FG002|Open-Label Extension Phase|Pregnancy|1|||
30951513|NCT01705574|58998713|FG003|Open-Label Extension Phase|Pregnancy|1|||
30951514|NCT01737710|58998734|FG000|Overall Study|Lost to Follow-up|0|||
30951515|NCT01737710|58998735|FG001|Overall Study|Lost to Follow-up|2|||
30951516|NCT01737710|58998736|FG002|Overall Study|Lost to Follow-up|2|||
30951517|NCT01737710|58998737|FG003|Overall Study|Lost to Follow-up|0|||
30951518|NCT01737710|58998738|FG004|Overall Study|Lost to Follow-up|0|||
30951519|NCT01737710|58998734|FG000|Overall Study|Withdrawal by Subject|1|||
30951520|NCT01737710|58998735|FG001|Overall Study|Withdrawal by Subject|1|||
30951521|NCT01737710|58998736|FG002|Overall Study|Withdrawal by Subject|1|||
30951522|NCT01737710|58998737|FG003|Overall Study|Withdrawal by Subject|0|||
30951523|NCT01737710|58998738|FG004|Overall Study|Withdrawal by Subject|0|||
30951524|NCT01737710|58998734|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
30951525|NCT01737710|58998735|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
30951526|NCT01737710|58998736|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
30951527|NCT01737710|58998737|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
30951528|NCT01737710|58998738|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
30951529|NCT01682876|58998753|FG000|Overall Study|Administrative reason|4|||
30951530|NCT01682876|58998754|FG001|Overall Study|Administrative reason|4|||
30951531|NCT01682876|58998755|FG002|Overall Study|Administrative reason|0|||
30951532|NCT01682876|58998756|FG003|Overall Study|Administrative reason|3|||
30951533|NCT01682876|58998753|FG000|Overall Study|Adverse Event|0|||
30951534|NCT01682876|58998754|FG001|Overall Study|Adverse Event|0|||
30951535|NCT01682876|58998755|FG002|Overall Study|Adverse Event|0|||
30951536|NCT01682876|58998756|FG003|Overall Study|Adverse Event|1|||
30951537|NCT01682876|58998753|FG000|Overall Study|Lost to Follow-up|11|||
30951538|NCT01682876|58998754|FG001|Overall Study|Lost to Follow-up|15|||
30951539|NCT01682876|58998755|FG002|Overall Study|Lost to Follow-up|9|||
30951540|NCT01682876|58998756|FG003|Overall Study|Lost to Follow-up|11|||
30951541|NCT01682876|58998753|FG000|Overall Study|Protocol Violation|1|||
30951542|NCT01682876|58998754|FG001|Overall Study|Protocol Violation|1|||
30951543|NCT01682876|58998755|FG002|Overall Study|Protocol Violation|1|||
30951544|NCT01682876|58998756|FG003|Overall Study|Protocol Violation|1|||
30951545|NCT01682876|58998753|FG000|Overall Study|Withdrawal by Subject|4|||
30951546|NCT01682876|58998754|FG001|Overall Study|Withdrawal by Subject|0|||
30951547|NCT01682876|58998755|FG002|Overall Study|Withdrawal by Subject|0|||
30951548|NCT01682876|58998756|FG003|Overall Study|Withdrawal by Subject|2|||
30951549|NCT01682876|58998753|FG000|Overall Study|Other|1|||
30951550|NCT01682876|58998754|FG001|Overall Study|Other|0|||
30951551|NCT01682876|58998755|FG002|Overall Study|Other|1|||
30951552|NCT01682876|58998756|FG003|Overall Study|Other|1|||
30951553|NCT01682720|58998773|FG000|Overall Study|Randomized but Not Treated|0|||
30951554|NCT01682720|58998774|FG001|Overall Study|Randomized but Not Treated|1|||
30951555|NCT01682720|58998775|FG002|Overall Study|Randomized but Not Treated|1|||
30951556|NCT01682720|58998776|FG003|Overall Study|Randomized but Not Treated|0|||
30951557|NCT01682720|58998773|FG000|Overall Study|Terminated by Sponsor|83|||
30951558|NCT01682720|58998774|FG001|Overall Study|Terminated by Sponsor|0|||
30951559|NCT01682720|58998775|FG002|Overall Study|Terminated by Sponsor|0|||
30951560|NCT01682720|58998776|FG003|Overall Study|Terminated by Sponsor|0|||
30951561|NCT01682720|58998773|FG000|Overall Study|Efficacy Failure|0|||
30951562|NCT01682720|58998774|FG001|Overall Study|Efficacy Failure|3|||
30951563|NCT01682720|58998775|FG002|Overall Study|Efficacy Failure|3|||
30951564|NCT01682720|58998776|FG003|Overall Study|Efficacy Failure|30|||
30951565|NCT01682720|58998773|FG000|Overall Study|Lost to Follow-up|1|||
30951566|NCT01682720|58998774|FG001|Overall Study|Lost to Follow-up|1|||
30951567|NCT01682720|58998775|FG002|Overall Study|Lost to Follow-up|0|||
30951568|NCT01682720|58998776|FG003|Overall Study|Lost to Follow-up|6|||
30951569|NCT01682720|58998773|FG000|Overall Study|Subject Withdrew Consent|0|||
30951570|NCT01682720|58998774|FG001|Overall Study|Subject Withdrew Consent|0|||
30848514|NCT02851511|58874629|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
30951571|NCT01682720|58998775|FG002|Overall Study|Subject Withdrew Consent|2|||
30951572|NCT01682720|58998776|FG003|Overall Study|Subject Withdrew Consent|2|||
30951573|NCT01682720|58998773|FG000|Overall Study|Adverse Event|1|||
30951574|NCT01682720|58998774|FG001|Overall Study|Adverse Event|0|||
30951575|NCT01682720|58998775|FG002|Overall Study|Adverse Event|1|||
30951576|NCT01682720|58998776|FG003|Overall Study|Adverse Event|1|||
30951577|NCT01714544|58998795|FG000|Overall Study|Lost to Follow-up|1|||
30951578|NCT01714544|58998795|FG000|Overall Study|Physician Decision|1|||
30951579|NCT01714544|58998795|FG000|Overall Study|Withdrawal by Subject|1|||
30639841|NCT01096160|58651708|FG000|Overall Study|Met stopping criteria per protocol|0|||
30639842|NCT01096160|58651709|FG001|Overall Study|Met stopping criteria per protocol|0|||
30639843|NCT01096160|58651710|FG002|Overall Study|Met stopping criteria per protocol|0|||
30639844|NCT01096160|58651711|FG003|Overall Study|Met stopping criteria per protocol|0|||
30639845|NCT01096160|58651712|FG004|Overall Study|Met stopping criteria per protocol|1|||
30639846|NCT01096160|58651713|FG005|Overall Study|Met stopping criteria per protocol|0|||
30639847|NCT01096160|58651714|FG006|Overall Study|Met stopping criteria per protocol|2|||
30639848|NCT01096160|58651715|FG007|Overall Study|Met stopping criteria per protocol|0|||
30639849|NCT01096160|58651716|FG008|Overall Study|Met stopping criteria per protocol|2|||
30639850|NCT01096160|58651717|FG009|Overall Study|Met stopping criteria per protocol|0|||
30639851|NCT00860158|58651752|FG000|Overall Study|Study Terminated|1|||
30639852|NCT00929526|58651758|FG000|Overall Study|Withdrawal by Subject|1|||
30639853|NCT00929526|58651759|FG001|Overall Study|Withdrawal by Subject|11|||
30639854|NCT00929526|58651758|FG000|Overall Study|Lost to Follow-up|8|||
30639855|NCT00929526|58651759|FG001|Overall Study|Lost to Follow-up|12|||
30639856|NCT00929526|58651758|FG000|Overall Study|Other|8|||
30639857|NCT00929526|58651759|FG001|Overall Study|Other|6|||
30639858|NCT00859456|58651765|FG000|Overall Study|Adverse Event|3|||
30639859|NCT00859456|58651765|FG000|Overall Study|Progressive disease|2|||
30639860|NCT00859456|58651765|FG000|Overall Study|Non-compliance|3|||
30639861|NCT01075646|58651773|FG000|Overall Study|Lost to Follow-up|4|||
30639862|NCT01075646|58651774|FG001|Overall Study|Lost to Follow-up|3|||
30639863|NCT01075646|58651775|FG002|Overall Study|Lost to Follow-up|1|||
30639864|NCT01075646|58651776|FG003|Overall Study|Lost to Follow-up|2|||
30639865|NCT01075412|58651788|FG000|Overall Study|Withdrawal by Subject|0|||
30639866|NCT01075412|58651789|FG001|Overall Study|Withdrawal by Subject|1|||
30639867|NCT00799903|58651796|FG000|Overall Study|Investigator Site Closed|25|||
30639868|NCT00799903|58651797|FG001|Overall Study|Investigator Site Closed|23|||
30639869|NCT00799903|58651796|FG000|Overall Study|Withdrawal by Subject|179|||
30639870|NCT00799903|58651797|FG001|Overall Study|Withdrawal by Subject|175|||
30639871|NCT00799903|58651796|FG000|Overall Study|Lost to Follow-up|69|||
30639872|NCT00799903|58651797|FG001|Overall Study|Lost to Follow-up|80|||
30639873|NCT01075256|58651806|FG000|Overall Study|Withdrawal by Subject|1|||
30639874|NCT01075256|58651807|FG001|Overall Study|Withdrawal by Subject|0|||
30639875|NCT01075256|58651808|FG002|Overall Study|Withdrawal by Subject|0|||
30639876|NCT00923130|58651821|FG000|Overall Study|Stopped treatment due to progression|17|||
30639877|NCT00923130|58651821|FG000|Overall Study|Death|1|||
30639878|NCT00923130|58651821|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
30639879|NCT00923130|58651821|FG000|Overall Study|Switched to alternative treatment|2|||
30639880|NCT00923130|58651821|FG000|Overall Study|Refused further treatment|2|||
30639881|NCT03253627|58651827|FG000|Overall Study|Lost to Follow-up|1|||
30639882|NCT03253627|58651828|FG001|Overall Study|Lost to Follow-up|2|||
30639883|NCT03253627|58651827|FG000|Overall Study|Withdrawal by Subject|0|||
30639884|NCT03253627|58651828|FG001|Overall Study|Withdrawal by Subject|2|||
30639885|NCT03253627|58651827|FG000|Overall Study|Inability to complete MRI|1|||
30639886|NCT03253627|58651828|FG001|Overall Study|Inability to complete MRI|0|||
30639887|NCT01075178|58651836|FG000|Subject Matching|eligible but not matched|130|||
30639888|NCT01075178|58651837|FG001|Subject Matching|eligible but not matched|403|||
30639889|NCT01075178|58651836|FG000|Subject Chart Review|died before chart review period|0|||
30639890|NCT01075178|58651837|FG001|Subject Chart Review|died before chart review period|2|||
30639891|NCT01075178|58651836|FG000|Subject Chart Review|no data collected due to site closure|3|||
30639892|NCT01075178|58651837|FG001|Subject Chart Review|no data collected due to site closure|4|||
30639893|NCT01075178|58651836|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
30639894|NCT01075178|58651837|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
30639895|NCT00799825|58651843|FG000|Overall Study|Adverse Event|1|||
30639896|NCT00799825|58651843|FG000|Overall Study|Withdrawal by Subject|6|||
30639897|NCT00799825|58651843|FG000|Overall Study|Lost to Follow-up|38|||
30639898|NCT00799825|58651843|FG000|Overall Study|Pregnancy|3|||
30639899|NCT00799591|58651847|FG000|Overall Study|De-escalation of doses|20|||
30639900|NCT00799591|58651847|FG000|Overall Study|Death|14|||
30639901|NCT00799591|58651847|FG000|Overall Study|Technical failure|12|||
30639902|NCT00799591|58651847|FG000|Overall Study|Resistant germ|11|||
30639903|NCT00799591|58651847|FG000|Overall Study|New infection|4|||
30848515|NCT02851511|58874630|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
30639904|NCT00799591|58651847|FG000|Overall Study|Resistance germ and technical failure|2|||
30848516|NCT02851511|58874631|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
30848517|NCT02851511|58874632|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
30639905|NCT00799591|58651847|FG000|Overall Study|Persistance of fever undetermined origin|1|||
30639906|NCT00799591|58651847|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
30639907|NCT00799591|58651847|FG000|Overall Study|Infectious origin not probable|1|||
30639908|NCT01075100|58651853|FG000|Overall Study|Adverse Event|15|||
30639909|NCT01075100|58651854|FG001|Overall Study|Adverse Event|18|||
30639910|NCT01075100|58651853|FG000|Overall Study|Patient Request|4|||
30639911|NCT01075100|58651854|FG001|Overall Study|Patient Request|4|||
30639912|NCT01075100|58651853|FG000|Overall Study|Investigator Request|2|||
30639913|NCT01075100|58651854|FG001|Overall Study|Investigator Request|1|||
30639914|NCT01075100|58651853|FG000|Overall Study|Disease Progression|25|||
30639915|NCT01075100|58651854|FG001|Overall Study|Disease Progression|29|||
30639916|NCT01075100|58651853|FG000|Overall Study|Other|3|||
30639917|NCT01075100|58651854|FG001|Overall Study|Other|1|||
30639918|NCT00803023|58651866|FG000|Overall Study|Adverse Event|5|||
30765532|NCT02943070|58774133|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
30765533|NCT03332212|58774157|FG000|Overall Study|Not treated|0|||
30765534|NCT03332212|58774158|FG001|Overall Study|Not treated|1|||
30765535|NCT03332212|58774159|FG002|Overall Study|Not treated|0|||
30765536|NCT03332212|58774160|FG003|Overall Study|Not treated|0|||
30765537|NCT03332212|58774157|FG000|Overall Study|Adverse Event|0|||
30765538|NCT03332212|58774158|FG001|Overall Study|Adverse Event|0|||
30765539|NCT03332212|58774159|FG002|Overall Study|Adverse Event|0|||
30765540|NCT03332212|58774160|FG003|Overall Study|Adverse Event|1|||
30765541|NCT03332212|58774157|FG000|Overall Study|worsening of disease under study|1|||
30765542|NCT03332212|58774158|FG001|Overall Study|worsening of disease under study|1|||
30765543|NCT03332212|58774159|FG002|Overall Study|worsening of disease under study|0|||
30765544|NCT03332212|58774160|FG003|Overall Study|worsening of disease under study|0|||
30765545|NCT03331666|58774170|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
30765546|NCT03331666|58774171|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
30765547|NCT03331042|58774181|FG000|Overall Study|Protocol Violation|1|||
30765548|NCT03331042|58774182|FG001|Overall Study|Protocol Violation|0|||
30765549|NCT03331042|58774183|FG002|Overall Study|Protocol Violation|0|||
30765550|NCT03331042|58774184|FG003|Overall Study|Protocol Violation|0|||
30765551|NCT03331042|58774181|FG000|Overall Study|Physician Decision|0|||
30765552|NCT03331042|58774182|FG001|Overall Study|Physician Decision|0|||
30765553|NCT03331042|58774183|FG002|Overall Study|Physician Decision|1|||
30765554|NCT03331042|58774184|FG003|Overall Study|Physician Decision|0|||
30765555|NCT03331042|58774181|FG000|Overall Study|Lost to Follow-up|0|||
30765556|NCT03331042|58774182|FG001|Overall Study|Lost to Follow-up|0|||
30765557|NCT03331042|58774183|FG002|Overall Study|Lost to Follow-up|0|||
30765558|NCT03331042|58774184|FG003|Overall Study|Lost to Follow-up|1|||
30765559|NCT03762668|58774202|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
30765560|NCT03762668|58774203|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
30765561|NCT03762200|58774209|FG000|Overall Study|Death|2|||
30765562|NCT03711370|58774215|FG000|Overall Study|Lost to Follow-up|16|||
30765563|NCT03711370|58774216|FG001|Overall Study|Lost to Follow-up|10|||
30765564|NCT03711370|58774215|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
30765565|NCT03711370|58774216|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
30765566|NCT03329404|58774232|FG000|Overall Study|The study was suspended.|1|||
30765567|NCT03329404|58774233|FG001|Overall Study|The study was suspended.|4|||
30765568|NCT03478930|58774241|FG000|Overall Study|Adverse Event|0|||
30765569|NCT03478930|58774242|FG001|Overall Study|Adverse Event|1|||
30765570|NCT03478930|58774241|FG000|Overall Study|Lack of Efficacy|3|||
30765571|NCT03478930|58774242|FG001|Overall Study|Lack of Efficacy|3|||
30765572|NCT03478930|58774241|FG000|Overall Study|Withdrawal by Subject|6|||
30765573|NCT03478930|58774242|FG001|Overall Study|Withdrawal by Subject|5|||
30765574|NCT03038438|58774248|FG000|Overall Study|Death|3|||
30765575|NCT03038438|58774248|FG000|Overall Study|Lost to Follow-up|8|||
30765576|NCT03038438|58774248|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
30765577|NCT03038438|58774248|FG000|Overall Study|Withdrawal by Subject|5|||
30765578|NCT03038438|58774248|FG000|Overall Study|No 36-Month Follow-Up|18|||
30765579|NCT03523000|58774252|FG000|Overall Study|Withdrawal by Subject|3|||
30765580|NCT03523000|58774253|FG001|Overall Study|Withdrawal by Subject|0|||
30765581|NCT03523000|58774252|FG000|Overall Study|Unsuccessful trial|2|||
30765582|NCT03523000|58774253|FG001|Overall Study|Unsuccessful trial|0|||
30765583|NCT03327220|58774264|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
30765584|NCT03327220|58774265|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
30765585|NCT03327220|58774264|FG000|Overall Study|Investigator Decision|2|||
30765586|NCT03327220|58774265|FG001|Overall Study|Investigator Decision|0|||
30765587|NCT03327220|58774264|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
30765588|NCT03327220|58774265|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
30639919|NCT00803023|58651867|FG001|Overall Study|Adverse Event|4|||
30639920|NCT00803023|58651868|FG002|Overall Study|Adverse Event|8|||
30765589|NCT03327220|58774264|FG000|Overall Study|Fungal infection|1|||
30765590|NCT03327220|58774265|FG001|Overall Study|Fungal infection|0|||
30765591|NCT03327220|58774264|FG000|Overall Study|Discharged to Rehabilitation|0|||
30765592|NCT03327220|58774265|FG001|Overall Study|Discharged to Rehabilitation|1|||
30765593|NCT03327220|58774264|FG000|Overall Study|Missing|1|||
30765594|NCT03327220|58774265|FG001|Overall Study|Missing|0|||
30765595|NCT00318149|58774277|FG000|Overall Study|Adverse Event|0|||
30765596|NCT00318149|58774278|FG001|Overall Study|Adverse Event|0|||
30765597|NCT00318149|58774279|FG002|Overall Study|Adverse Event|0|||
30639921|NCT00803023|58651869|FG003|Overall Study|Adverse Event|6|||
30639922|NCT00803023|58651866|FG000|Overall Study|Withdrawal by Subject|0|||
30639923|NCT00803023|58651867|FG001|Overall Study|Withdrawal by Subject|2|||
30639924|NCT00803023|58651868|FG002|Overall Study|Withdrawal by Subject|0|||
30639925|NCT00803023|58651869|FG003|Overall Study|Withdrawal by Subject|0|||
30639926|NCT00803023|58651866|FG000|Overall Study|Lost to Follow-up|0|||
30639927|NCT00803023|58651867|FG001|Overall Study|Lost to Follow-up|1|||
30639928|NCT00803023|58651868|FG002|Overall Study|Lost to Follow-up|2|||
30639929|NCT00803023|58651869|FG003|Overall Study|Lost to Follow-up|1|||
30639930|NCT00803023|58651866|FG000|Overall Study|Lack of Efficacy|0|||
30639931|NCT00803023|58651867|FG001|Overall Study|Lack of Efficacy|1|||
30639932|NCT00803023|58651868|FG002|Overall Study|Lack of Efficacy|1|||
30639933|NCT00803023|58651869|FG003|Overall Study|Lack of Efficacy|1|||
30639934|NCT00859222|58651882|FG000|Overall Study|Adverse Event|2|||
30639935|NCT00859222|58651883|FG001|Overall Study|Adverse Event|3|||
30639936|NCT00859222|58651884|FG002|Overall Study|Adverse Event|6|||
30639937|NCT00859222|58651885|FG003|Overall Study|Adverse Event|24|||
30639938|NCT00859222|58651886|FG004|Overall Study|Adverse Event|15|||
30639939|NCT00859222|58651882|FG000|Overall Study|DLT|1|||
30639940|NCT00859222|58651883|FG001|Overall Study|DLT|0|||
30639941|NCT00859222|58651884|FG002|Overall Study|DLT|0|||
30639942|NCT00859222|58651885|FG003|Overall Study|DLT|0|||
30639943|NCT00859222|58651886|FG004|Overall Study|DLT|0|||
30639944|NCT01072448|58651903|FG000|Overall Study|Adverse Event|9|||
30639945|NCT01072448|58651904|FG001|Overall Study|Adverse Event|10|||
30639946|NCT01072448|58651903|FG000|Overall Study|Subject withdrew consent|4|||
30639947|NCT01072448|58651904|FG001|Overall Study|Subject withdrew consent|9|||
30639948|NCT01072448|58651903|FG000|Overall Study|Protocol deviation|3|||
30639949|NCT01072448|58651904|FG001|Overall Study|Protocol deviation|4|||
30639950|NCT01072448|58651903|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30639951|NCT01072448|58651904|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30639952|NCT01072448|58651903|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30639953|NCT01072448|58651904|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
30639954|NCT01072448|58651903|FG000|Overall Study|Lost to Follow-up|1|||
30639955|NCT01072448|58651904|FG001|Overall Study|Lost to Follow-up|1|||
30639956|NCT01072448|58651903|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30639957|NCT01072448|58651904|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30639958|NCT01072448|58651903|FG000|Overall Study|Death|0|||
30639959|NCT01072448|58651904|FG001|Overall Study|Death|2|||
30639960|NCT00922974|58651913|FG000|Phase II Component|Protocol Violation|2|||
30639961|NCT00922974|58651914|FG001|Phase II Component|Protocol Violation|0|||
30639962|NCT00922974|58651913|FG000|Phase II Component|Not evaluable for treatment review|5|||
30639963|NCT00922974|58651914|FG001|Phase II Component|Not evaluable for treatment review|0|||
30639964|NCT00922974|58651913|FG000|Phase III Component|Protocol Violation|8|||
30639965|NCT00922974|58651914|FG001|Phase III Component|Protocol Violation|6|||
30639966|NCT00858988|58651924|FG000|Analysis|Lactulose unable to be detected in urine|2|||
30639967|NCT00858988|58651925|FG001|Analysis|Lactulose unable to be detected in urine|1|||
30639968|NCT00858832|58651933|FG000|Overall Study|became ineligible: delivered vaginally|1|||
30639969|NCT00858832|58651934|FG001|Overall Study|became ineligible: delivered vaginally|0|||
30639970|NCT00858832|58651933|FG000|Overall Study|Adverse Event|0|||
30639971|NCT00858832|58651934|FG001|Overall Study|Adverse Event|1|||
30639972|NCT01071512|58651940|FG000|Overall Study|Adverse Event|1|||
30639973|NCT01071512|58651940|FG000|Overall Study|Development of antibodies to drug|2|||
30639974|NCT01071512|58651940|FG000|Overall Study|positive anti-JC virus antibody test|2|||
30639975|NCT00858442|58651946|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
30639976|NCT00858442|58651947|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
30639977|NCT01071278|58651954|FG000|Overall Study|Premature Discontinuation|254|||
30639978|NCT01071278|58651954|FG000|Overall Study|Completion Status Unknown|459|||
30639979|NCT00858208|58651960|FG000|Overall Study|Adverse Event|3|||
30639980|NCT00858208|58651960|FG000|Overall Study|Lost to Follow-up|26|||
30639981|NCT00858208|58651960|FG000|Overall Study|Participant refused|40|||
30639982|NCT00858208|58651960|FG000|Overall Study|Other|10|||
30639983|NCT01071200|58651966|FG000|Overall Study|Lack of ovarian response|1|||
30639984|NCT01071200|58651967|FG001|Overall Study|Lack of ovarian response|1|||
30639985|NCT01071200|58651966|FG000|Overall Study|No fertilization|4|||
30639986|NCT01071200|58651967|FG001|Overall Study|No fertilization|0|||
30639987|NCT01071200|58651966|FG000|Overall Study|No oocytes retrieved|1|||
30639988|NCT01071200|58651967|FG001|Overall Study|No oocytes retrieved|1|||
30639989|NCT01071200|58651966|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
30639990|NCT01071200|58651967|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
30639991|NCT01071200|58651966|FG000|Overall Study|No viable embryos|0|||
30639992|NCT01071200|58651967|FG001|Overall Study|No viable embryos|1|||
30639993|NCT02207569|58651973|FG000|1-Month|Death|6|||
30639994|NCT02207569|58651973|FG000|1-Month|Withdrawal by Subject|2|||
30639995|NCT02207569|58651973|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
30639996|NCT02207569|58651973|FG000|6-Month|Death|8|||
30639997|NCT02207569|58651973|FG000|6-Month|Withdrawal by Subject|2|||
30639998|NCT02207569|58651973|FG000|12-Month|Death|14|||
30639999|NCT02207569|58651973|FG000|12-Month|Withdrawal by Subject|2|||
30640000|NCT02207569|58651973|FG000|24-Month|Death|23|||
30640001|NCT02207569|58651973|FG000|24-Month|Withdrawal by Subject|3|||
30640002|NCT02207569|58651973|FG000|36-Month|Death|23|||
30640003|NCT02207569|58651973|FG000|36-Month|Withdrawal by Subject|4|||
30640004|NCT02207569|58651973|FG000|48-Month|Death|25|||
30640005|NCT02207569|58651973|FG000|48-Month|Withdrawal by Subject|2|||
30640006|NCT02207569|58651973|FG000|48-Month|Lost to Follow-up|4|||
30640007|NCT02207569|58651973|FG000|60-Month|Death|1|||
30640008|NCT02207569|58651973|FG000|60-Month|Lost to Follow-up|1|||
30640009|NCT02207569|58651973|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
30640010|NCT02207569|58651973|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
30640011|NCT01070966|58651977|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
30640012|NCT01070966|58651977|FG000|Participants for Safety Evaluation|Off-label use|9|||
30640013|NCT01070966|58651977|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
30640014|NCT01070966|58651977|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
30640015|NCT01070966|58651977|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
30640016|NCT01070966|58651977|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
30640017|NCT01070966|58651977|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
30640018|NCT01070966|58651977|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
30640019|NCT01070888|58651990|FG000|First Intervention (14 Days)|Adverse Event|0|||
30640020|NCT01070888|58651991|FG001|First Intervention (14 Days)|Adverse Event|1|||
30640021|NCT01070888|58651990|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
30640022|NCT01070888|58651991|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
30640023|NCT01070888|58651990|FG000|Washout (14 Days)|Physician Decision|1|||
30640024|NCT01070888|58651991|FG001|Washout (14 Days)|Physician Decision|0|||
30640025|NCT00857896|58651997|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
30640026|NCT00857818|58652004|FG000|Overall Study|Lack of Efficacy|1|||
30640027|NCT00857818|58652005|FG001|Overall Study|Lack of Efficacy|0|||
30640028|NCT00857818|58652004|FG000|Overall Study|Adverse Event|3|||
30640029|NCT00857818|58652005|FG001|Overall Study|Adverse Event|0|||
30640030|NCT00857818|58652004|FG000|Overall Study|Withdrawal by Subject|0|||
30640031|NCT00857818|58652005|FG001|Overall Study|Withdrawal by Subject|4|||
30640032|NCT00857818|58652004|FG000|Overall Study|Sponsor terminated study|6|||
30640033|NCT00857818|58652005|FG001|Overall Study|Sponsor terminated study|4|||
30640034|NCT00857818|58652004|FG000|Overall Study|Investigator decision|1|||
30640035|NCT00857818|58652005|FG001|Overall Study|Investigator decision|0|||
30640036|NCT01074944|58652011|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
30640037|NCT01074944|58652012|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
30640038|NCT01074944|58652013|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
30640039|NCT01074944|58652014|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
30640040|NCT01074944|58652015|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
30640041|NCT01074944|58652011|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
30640042|NCT01074944|58652012|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
30640043|NCT01074944|58652013|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
30640044|NCT01074944|58652014|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
30640045|NCT01074944|58652015|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
30640046|NCT01074944|58652011|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
30640047|NCT01074944|58652012|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
30640048|NCT01074944|58652013|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
30640049|NCT01074944|58652014|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
30640050|NCT01074944|58652015|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
30640051|NCT01074944|58652011|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
30640052|NCT01074944|58652012|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
30640053|NCT01074944|58652013|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
30640054|NCT01074944|58652014|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
30640055|NCT01074944|58652015|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
30640056|NCT01074944|58652011|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
30640057|NCT01074944|58652012|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
30640058|NCT01074944|58652013|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
30640059|NCT01074944|58652014|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
30640060|NCT01074944|58652015|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
30640061|NCT01074944|58652011|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
30640062|NCT01074944|58652012|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
30640063|NCT01074944|58652013|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
30640064|NCT01074944|58652014|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
30765598|NCT00318149|58774280|FG003|Overall Study|Adverse Event|0|||
30765599|NCT00318149|58774281|FG004|Overall Study|Adverse Event|0|||
30640065|NCT01074944|58652015|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
30640066|NCT01074944|58652011|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
30640067|NCT01074944|58652012|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
30640068|NCT01074944|58652013|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
30640069|NCT01074944|58652014|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
30640070|NCT01074944|58652015|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
30640071|NCT01074944|58652011|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
30640072|NCT01074944|58652012|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
30640073|NCT01074944|58652013|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
30640074|NCT01074944|58652014|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
30640075|NCT01074944|58652015|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
30640076|NCT01074944|58652011|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
30640077|NCT01074944|58652012|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
30640078|NCT01074944|58652013|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
30640079|NCT01074944|58652014|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
30640080|NCT01074944|58652015|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
30640081|NCT01074944|58652011|FG000|Long Term Treatment|Adverse Event|0|||
30640082|NCT01074944|58652012|FG001|Long Term Treatment|Adverse Event|0|||
30640083|NCT01074944|58652013|FG002|Long Term Treatment|Adverse Event|0|||
30640084|NCT01074944|58652014|FG003|Long Term Treatment|Adverse Event|3|||
30640085|NCT01074944|58652015|FG004|Long Term Treatment|Adverse Event|0|||
30640086|NCT01074944|58652011|FG000|Long Term Treatment|Lost to Follow-up|0|||
30640087|NCT01074944|58652012|FG001|Long Term Treatment|Lost to Follow-up|0|||
30640088|NCT01074944|58652013|FG002|Long Term Treatment|Lost to Follow-up|0|||
30640089|NCT01074944|58652014|FG003|Long Term Treatment|Lost to Follow-up|2|||
30640090|NCT01074944|58652015|FG004|Long Term Treatment|Lost to Follow-up|0|||
30640091|NCT01074944|58652011|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
30640092|NCT01074944|58652012|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
30640093|NCT01074944|58652013|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
30640094|NCT01074944|58652014|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
30640095|NCT01074944|58652015|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
30640096|NCT01074944|58652011|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
30640097|NCT01074944|58652012|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
30640098|NCT01074944|58652013|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
30640099|NCT01074944|58652014|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
30640100|NCT01074944|58652015|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
30640101|NCT01074944|58652011|FG000|Long Term Treatment|Withdrawal by Subject|0|||
30640102|NCT01074944|58652012|FG001|Long Term Treatment|Withdrawal by Subject|0|||
30640103|NCT01074944|58652013|FG002|Long Term Treatment|Withdrawal by Subject|0|||
30640104|NCT01074944|58652014|FG003|Long Term Treatment|Withdrawal by Subject|2|||
30640105|NCT01074944|58652015|FG004|Long Term Treatment|Withdrawal by Subject|0|||
30640106|NCT01074944|58652011|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
30640107|NCT01074944|58652012|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
30640108|NCT01074944|58652013|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
30640109|NCT01074944|58652014|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
30640110|NCT01074944|58652015|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
30640111|NCT01074944|58652011|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
30640112|NCT01074944|58652012|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
30640113|NCT01074944|58652013|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
30640114|NCT01074944|58652014|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
30640115|NCT01074944|58652015|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
30640116|NCT00802945|58652025|FG000|Overall Study|Death|27|||
30640117|NCT00802945|58652026|FG001|Overall Study|Death|23|||
30640118|NCT00802945|58652025|FG000|Overall Study|Terminated by sponsor|8|||
30640119|NCT00802945|58652026|FG001|Overall Study|Terminated by sponsor|12|||
30640120|NCT01074554|58652036|FG000|Overall Study|Adverse Event|3|||
30640121|NCT01074554|58652037|FG001|Overall Study|Adverse Event|3|||
30640122|NCT01074554|58652036|FG000|Overall Study|Lost to Follow-up|0|||
30640123|NCT01074554|58652037|FG001|Overall Study|Lost to Follow-up|1|||
30640124|NCT00857584|58652045|FG000|Overall Study|Lack of Efficacy|1|||
30640125|NCT00857584|58652046|FG001|Overall Study|Lack of Efficacy|2|||
30640126|NCT00857584|58652045|FG000|Overall Study|Adverse Event|2|||
30640127|NCT00857584|58652046|FG001|Overall Study|Adverse Event|2|||
30640128|NCT00857584|58652045|FG000|Overall Study|Physician Decision|1|||
30640129|NCT00857584|58652046|FG001|Overall Study|Physician Decision|1|||
30640130|NCT00798967|58652054|FG000|Overall Study|Adverse Event|2|||
30640131|NCT00798967|58652055|FG001|Overall Study|Adverse Event|3|||
30640132|NCT00798967|58652054|FG000|Overall Study|Withdrawal by Subject|0|||
30640133|NCT00798967|58652055|FG001|Overall Study|Withdrawal by Subject|1|||
30640134|NCT00798967|58652054|FG000|Overall Study|Physician Decision|1|||
30640135|NCT00798967|58652055|FG001|Overall Study|Physician Decision|0|||
30640136|NCT00798967|58652054|FG000|Overall Study|Randomized in error by site|1|||
30640137|NCT00798967|58652055|FG001|Overall Study|Randomized in error by site|0|||
30640138|NCT01074242|58652062|FG000|Overall Study|Case report before date of contract|40|||
30640139|NCT01074242|58652062|FG000|Overall Study|Lost to Follow-up|1|||
30640140|NCT01074242|58652062|FG000|Overall Study|Case report unclear|6|||
30640141|NCT01074242|58652062|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
30640142|NCT01074242|58652062|FG000|Overall Study|Duplicate Case Report Form|5|||
30640143|NCT00798889|58652066|FG000|Overall Study|Adverse Event|53|||
30640144|NCT00798889|58652066|FG000|Overall Study|Protocol Violation|2|||
30640145|NCT00798889|58652066|FG000|Overall Study|Withdrawal by Subject|31|||
30640146|NCT00798889|58652066|FG000|Overall Study|Lost to Follow-up|1|||
30640147|NCT00798889|58652066|FG000|Overall Study|Lack of Efficacy|213|||
30640148|NCT00798889|58652066|FG000|Overall Study|Decision of Sponsor|11|||
30640149|NCT00798889|58652066|FG000|Overall Study|Enrolled, Not treated|3|||
30640150|NCT00796861|58652070|FG000|Overall Study|Withdrawal by Subject|2|||
30640151|NCT00796861|58652070|FG000|Overall Study|Death|2|||
30640152|NCT00802867|58652074|FG000|Overall Study|Lost to Follow-up|6|||
30640153|NCT00802867|58652074|FG000|Overall Study|Protocol Violation|6|||
30640154|NCT00802867|58652074|FG000|Overall Study|Withdrawal by Subject|1|||
30640155|NCT00798655|58652078|FG000|Overall Study|Did not receive at least one dose of pan|2|||
30640156|NCT00796549|58652082|FG000|Overall Study|Adverse Event|11|||
30640157|NCT00796549|58652082|FG000|Overall Study|not entered|149|||
30640158|NCT00796549|58652082|FG000|Overall Study|Other|2|||
30640159|NCT00796549|58652082|FG000|Overall Study|Progressive disease|56|||
30640160|NCT00856492|58652091|FG000|Overall Study|Ineligible or withdrew consent|1|||
30640161|NCT00856492|58652092|FG001|Overall Study|Ineligible or withdrew consent|1|||
30640162|NCT00856492|58652093|FG002|Overall Study|Ineligible or withdrew consent|2|||
30640163|NCT00856180|58652104|FG000|Overall Study|Adverse Event|4|||
30640164|NCT00856180|58652104|FG000|Overall Study|Progressive Disease|16|||
30640165|NCT00900627|58652116|FG000|Overall Study|Condition under investigation worsened|4|||
30640166|NCT00900627|58652117|FG001|Overall Study|Condition under investigation worsened|0|||
30640167|NCT00900627|58652118|FG002|Overall Study|Condition under investigation worsened|5|||
30640168|NCT00900627|58652119|FG003|Overall Study|Condition under investigation worsened|3|||
30640169|NCT00900627|58652120|FG004|Overall Study|Condition under investigation worsened|0|||
30640170|NCT00900627|58652121|FG005|Overall Study|Condition under investigation worsened|0|||
30640171|NCT00900627|58652116|FG000|Overall Study|Withdrawal by Subject|1|||
30640172|NCT00900627|58652117|FG001|Overall Study|Withdrawal by Subject|0|||
30640173|NCT00900627|58652118|FG002|Overall Study|Withdrawal by Subject|1|||
30640174|NCT00900627|58652119|FG003|Overall Study|Withdrawal by Subject|0|||
30640175|NCT00900627|58652120|FG004|Overall Study|Withdrawal by Subject|1|||
30640176|NCT00900627|58652121|FG005|Overall Study|Withdrawal by Subject|2|||
30640177|NCT00900627|58652116|FG000|Overall Study|Adverse Event|1|||
30640178|NCT00900627|58652117|FG001|Overall Study|Adverse Event|2|||
30640179|NCT00900627|58652118|FG002|Overall Study|Adverse Event|0|||
30640180|NCT00900627|58652119|FG003|Overall Study|Adverse Event|3|||
30640181|NCT00900627|58652120|FG004|Overall Study|Adverse Event|0|||
30640182|NCT00900627|58652121|FG005|Overall Study|Adverse Event|0|||
30640183|NCT00900627|58652116|FG000|Overall Study|Death|0|||
30640184|NCT00900627|58652117|FG001|Overall Study|Death|0|||
30640185|NCT00900627|58652118|FG002|Overall Study|Death|0|||
30640186|NCT00900627|58652119|FG003|Overall Study|Death|0|||
30640187|NCT00900627|58652120|FG004|Overall Study|Death|28|||
30640188|NCT00900627|58652121|FG005|Overall Study|Death|24|||
30640189|NCT00866320|58652135|FG000|Overall Study|Withdrawal by Subject|4|||
30640190|NCT00866320|58652135|FG000|Overall Study|Death|2|||
30640191|NCT00869518|58652143|FG000|Overall Study|Lost to Follow-up|1|||
30640192|NCT00869518|58652144|FG001|Overall Study|Lost to Follow-up|1|||
30640193|NCT00797563|58652150|FG000|Overall Study|Adverse Event|1|||
30640194|NCT00869440|58652158|FG000|Overall Study|Withdrawal by Subject|1|||
30640195|NCT00869440|58652159|FG001|Overall Study|Withdrawal by Subject|0|||
30640196|NCT00869440|58652160|FG002|Overall Study|Withdrawal by Subject|0|||
30640197|NCT00869440|58652161|FG003|Overall Study|Withdrawal by Subject|0|||
30640198|NCT00869440|58652158|FG000|Overall Study|Physician Decision|1|||
30640199|NCT00869440|58652159|FG001|Overall Study|Physician Decision|1|||
30640200|NCT00869440|58652160|FG002|Overall Study|Physician Decision|0|||
30640201|NCT00869440|58652161|FG003|Overall Study|Physician Decision|0|||
30640202|NCT00895947|58652173|FG000|Overall Study|Adverse Event|3|||
30640203|NCT00895947|58652174|FG001|Overall Study|Adverse Event|4|||
30640204|NCT00895947|58652173|FG000|Overall Study|Lost to Follow-up|3|||
30640205|NCT00895947|58652174|FG001|Overall Study|Lost to Follow-up|4|||
30640206|NCT00895947|58652173|FG000|Overall Study|Protocol Violation|4|||
30640207|NCT00895947|58652174|FG001|Overall Study|Protocol Violation|2|||
30640208|NCT00895947|58652173|FG000|Overall Study|Withdrawal by Subject|2|||
30640209|NCT00895947|58652174|FG001|Overall Study|Withdrawal by Subject|0|||
30640210|NCT00869362|58652182|FG000|Overall Study|Death|0|||
30640211|NCT00869362|58652183|FG001|Overall Study|Death|2|||
30640212|NCT00869362|58652182|FG000|Overall Study|Lost to Follow-up|1|||
30640213|NCT00869362|58652183|FG001|Overall Study|Lost to Follow-up|3|||
30640214|NCT00588445|58652190|FG000|Overall Study|Protocol Violation|1|||
30640215|NCT00588445|58652190|FG000|Overall Study|Withdrawal by Subject|3|||
30640216|NCT00588445|58652190|FG000|Overall Study|Disease Progression|1|||
30640217|NCT00588445|58652190|FG000|Overall Study|Not Treated|10|||
30640218|NCT00796315|58652196|FG000|Overall Study|Protocol Violation|0|||
30640219|NCT00796315|58652197|FG001|Overall Study|Protocol Violation|1|||
30640220|NCT00796315|58652198|FG002|Overall Study|Protocol Violation|0|||
30640221|NCT00855166|58652211|FG000|Overall Study|Adverse Event|0|||
30640222|NCT00855166|58652212|FG001|Overall Study|Adverse Event|2|||
30640223|NCT00855166|58652211|FG000|Overall Study|Death|0|||
30640224|NCT00855166|58652212|FG001|Overall Study|Death|1|||
30640225|NCT00855166|58652211|FG000|Overall Study|Withdrawal by Subject|1|||
30640226|NCT00855166|58652212|FG001|Overall Study|Withdrawal by Subject|4|||
30640227|NCT00855166|58652211|FG000|Overall Study|Poor/non-compliance|2|||
30640228|NCT00855166|58652212|FG001|Overall Study|Poor/non-compliance|0|||
30640229|NCT00855166|58652211|FG000|Overall Study|Administrative reasons by sponsor|1|||
30640230|NCT00855166|58652212|FG001|Overall Study|Administrative reasons by sponsor|0|||
30640231|NCT00855166|58652211|FG000|Overall Study|Subject no longer meets study criteria|1|||
30640232|NCT00855166|58652212|FG001|Overall Study|Subject no longer meets study criteria|1|||
30640233|NCT00587587|58652222|FG000|Overall Study|Lost to Follow-up|6|||
30640234|NCT00587587|58652223|FG001|Overall Study|Lost to Follow-up|1|||
30640235|NCT00854620|58652231|FG000|Overall Study|Adverse Event|1|||
30640236|NCT00793585|58652237|FG000|Overall Study|Adverse Event|1|||
30640237|NCT00793585|58652238|FG001|Overall Study|Adverse Event|1|||
30640238|NCT00793585|58652237|FG000|Overall Study|Protocol Violation|1|||
30640239|NCT00793585|58652238|FG001|Overall Study|Protocol Violation|2|||
30640240|NCT00898443|58652246|FG000|Overall Study|Withdrawal by Subject|1|||
30640241|NCT00898443|58652247|FG001|Overall Study|Withdrawal by Subject|0|||
30640242|NCT00900159|58652255|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
30640243|NCT00900159|58652256|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
30640244|NCT00854308|58652275|FG000|Overall Study|Disease progression|42|||
30640245|NCT00854308|58652276|FG001|Overall Study|Disease progression|50|||
30640246|NCT00854308|58652275|FG000|Overall Study|Adverse Event|8|||
30640247|NCT00854308|58652276|FG001|Overall Study|Adverse Event|3|||
30640248|NCT00854308|58652275|FG000|Overall Study|Death|2|||
30640249|NCT00854308|58652276|FG001|Overall Study|Death|5|||
30640250|NCT00854308|58652275|FG000|Overall Study|Physician Decision|6|||
30640251|NCT00854308|58652276|FG001|Overall Study|Physician Decision|6|||
30640252|NCT00854308|58652275|FG000|Overall Study|Withdrawal by Subject|4|||
30640253|NCT00854308|58652276|FG001|Overall Study|Withdrawal by Subject|2|||
30640254|NCT00854308|58652275|FG000|Overall Study|Sponsor's decision to terminate study|0|||
30640255|NCT00854308|58652276|FG001|Overall Study|Sponsor's decision to terminate study|1|||
30640256|NCT00592852|58652282|FG000|Overall Study|Non-compliance|1|||
30640257|NCT00592852|58652282|FG000|Overall Study|Adverse Event|3|||
30640258|NCT00592852|58652282|FG000|Overall Study|Found ineligible|1|||
30640259|NCT00592852|58652282|FG000|Overall Study|Withdrawal by Subject|1|||
30640260|NCT00895245|58652286|FG000|Overall Study|Lack of Efficacy|6|||
30640261|NCT00865306|58652292|FG000|Controlled Trial|Lost to Follow-up|1|||
30640262|NCT00865306|58652293|FG001|Controlled Trial|Lost to Follow-up|1|||
30640263|NCT00865306|58652292|FG000|Controlled Trial|Difficulty commuting|2|||
30640264|NCT00865306|58652293|FG001|Controlled Trial|Difficulty commuting|0|||
30640265|NCT00865306|58652292|FG000|Controlled Trial|Improved btw baseline and first session|1|||
30640266|NCT00865306|58652293|FG001|Controlled Trial|Improved btw baseline and first session|0|||
30640267|NCT00865306|58652292|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
30640268|NCT00865306|58652293|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
30640269|NCT00865306|58652292|FG000|Controlled Trial|Withdrawal by Subject|0|||
30640270|NCT00865306|58652293|FG001|Controlled Trial|Withdrawal by Subject|1|||
30640271|NCT00896649|58652299|FG000|Overall Study|Physician Decision|1|||
30640272|NCT00896649|58652299|FG000|Overall Study|Pregnancy|1|||
30640273|NCT00896649|58652299|FG000|Overall Study|missing documentation|1|||
30640274|NCT00896649|58652299|FG000|Overall Study|technical difficulties|2|||
30640275|NCT00796003|58652306|FG000|Overall Study|Disease Progression|2|||
30640276|NCT00796003|58652307|FG001|Overall Study|Disease Progression|13|||
30640277|NCT00796003|58652306|FG000|Overall Study|Adverse Event|1|||
30640278|NCT00796003|58652307|FG001|Overall Study|Adverse Event|7|||
30640279|NCT00796003|58652306|FG000|Overall Study|Specified organ function not met|0|||
30640280|NCT00796003|58652307|FG001|Overall Study|Specified organ function not met|1|||
30640281|NCT00796003|58652306|FG000|Overall Study|Physician Decision|0|||
30640282|NCT00796003|58652307|FG001|Overall Study|Physician Decision|4|||
30640283|NCT00796003|58652306|FG000|Overall Study|Withdrawal by Subject|0|||
30640284|NCT00796003|58652307|FG001|Overall Study|Withdrawal by Subject|1|||
30640285|NCT00796003|58652306|FG000|Overall Study|Other|0|||
30640286|NCT00796003|58652307|FG001|Overall Study|Other|1|||
30640287|NCT00796003|58652306|FG000|Overall Study|Participants Not treated|0|||
30640288|NCT00796003|58652307|FG001|Overall Study|Participants Not treated|2|||
30640289|NCT00895011|58652319|FG000|Overall Study|Withdrawal by Subject|14|||
30640290|NCT00895011|58652320|FG001|Overall Study|Withdrawal by Subject|7|||
30640291|NCT00895011|58652321|FG002|Overall Study|Withdrawal by Subject|2|||
30640292|NCT00895011|58652319|FG000|Overall Study|Lost to Follow-up|5|||
30640293|NCT00895011|58652320|FG001|Overall Study|Lost to Follow-up|4|||
30640294|NCT00895011|58652321|FG002|Overall Study|Lost to Follow-up|1|||
30640295|NCT00895011|58652319|FG000|Overall Study|Protocol Violation|3|||
30640296|NCT00895011|58652320|FG001|Overall Study|Protocol Violation|1|||
30640297|NCT00895011|58652321|FG002|Overall Study|Protocol Violation|3|||
30640298|NCT00895011|58652319|FG000|Overall Study|Adverse Event|1|||
30640299|NCT00895011|58652320|FG001|Overall Study|Adverse Event|2|||
30640300|NCT00895011|58652321|FG002|Overall Study|Adverse Event|2|||
30640301|NCT00895011|58652319|FG000|Overall Study|schedule conflict|1|||
30640302|NCT00895011|58652320|FG001|Overall Study|schedule conflict|0|||
30640303|NCT00895011|58652321|FG002|Overall Study|schedule conflict|0|||
30640304|NCT00899847|58652330|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
30640305|NCT00795535|58652336|FG000|Overall Study|incomplete data and technical problems|20|||
30640306|NCT00853762|58652344|FG000|Overall Study|Premature Termination|16|||
30640307|NCT00853762|58652345|FG001|Overall Study|Premature Termination|15|||
30640308|NCT00853762|58652346|FG002|Overall Study|Premature Termination|14|||
30640309|NCT00853762|58652347|FG003|Overall Study|Premature Termination|21|||
30640310|NCT00853762|58652344|FG000|Overall Study|Protocol Violation|0|||
30640311|NCT00853762|58652345|FG001|Overall Study|Protocol Violation|0|||
30640312|NCT00853762|58652346|FG002|Overall Study|Protocol Violation|0|||
30640313|NCT00853762|58652347|FG003|Overall Study|Protocol Violation|1|||
30640314|NCT00853762|58652344|FG000|Overall Study|Withdrawal by Subject|0|||
30640315|NCT00853762|58652345|FG001|Overall Study|Withdrawal by Subject|0|||
30640316|NCT00853762|58652346|FG002|Overall Study|Withdrawal by Subject|1|||
30640317|NCT00853762|58652347|FG003|Overall Study|Withdrawal by Subject|0|||
30640318|NCT00853762|58652344|FG000|Overall Study|Other|0|||
30640319|NCT00853762|58652345|FG001|Overall Study|Other|2|||
30640320|NCT00853762|58652346|FG002|Overall Study|Other|0|||
30640321|NCT00853762|58652347|FG003|Overall Study|Other|0|||
30640322|NCT00853762|58652344|FG000|Overall Study|Randomised but not Treated|0|||
30640323|NCT00853762|58652345|FG001|Overall Study|Randomised but not Treated|2|||
30640324|NCT00853762|58652346|FG002|Overall Study|Randomised but not Treated|2|||
30640325|NCT00853762|58652347|FG003|Overall Study|Randomised but not Treated|0|||
30640326|NCT00789529|58652359|FG000|Overall Study|Withdrawal by Subject|0|||
30640327|NCT00789529|58652360|FG001|Overall Study|Withdrawal by Subject|1|||
30640328|NCT00789529|58652359|FG000|Overall Study|Other Reason|1|||
30640329|NCT00789529|58652360|FG001|Overall Study|Other Reason|0|||
30640330|NCT00894933|58652366|FG000|Overall Study|Lost to Follow-up|2|||
30640331|NCT00894933|58652366|FG000|Overall Study|Cancelled Procedure|1|||
30640332|NCT00894933|58652366|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
30640333|NCT00792805|58652373|FG000|Overall Study|Adverse Event|12|||
30640334|NCT00792805|58652374|FG001|Overall Study|Adverse Event|10|||
30640335|NCT00792805|58652375|FG002|Overall Study|Adverse Event|10|||
30640336|NCT00792805|58652373|FG000|Overall Study|Subject withdrew consent|5|||
30640337|NCT00792805|58652374|FG001|Overall Study|Subject withdrew consent|6|||
30640338|NCT00792805|58652375|FG002|Overall Study|Subject withdrew consent|5|||
30640339|NCT00792805|58652373|FG000|Overall Study|Administrative problems|2|||
30640340|NCT00792805|58652374|FG001|Overall Study|Administrative problems|0|||
30640341|NCT00792805|58652375|FG002|Overall Study|Administrative problems|4|||
30640342|NCT00792805|58652373|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30640343|NCT00792805|58652374|FG001|Overall Study|Abnormal test procedure result(s)|2|||
30640344|NCT00792805|58652375|FG002|Overall Study|Abnormal test procedure result(s)|0|||
30640345|NCT00792805|58652373|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30640346|NCT00792805|58652374|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
30640347|NCT00792805|58652375|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
30640348|NCT00792805|58652373|FG000|Overall Study|Lost to Follow-up|1|||
30640349|NCT00792805|58652374|FG001|Overall Study|Lost to Follow-up|1|||
30640350|NCT00792805|58652375|FG002|Overall Study|Lost to Follow-up|6|||
30640351|NCT00792805|58652373|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30640352|NCT00792805|58652374|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30640353|NCT00792805|58652375|FG002|Overall Study|Abnormal laboratory value(s)|1|||
30640354|NCT00792805|58652373|FG000|Overall Study|Protocol deviation|0|||
30640355|NCT00792805|58652374|FG001|Overall Study|Protocol deviation|1|||
30640356|NCT00792805|58652375|FG002|Overall Study|Protocol deviation|1|||
30640357|NCT00925002|58652386|FG000|Overall Study|Other|1|||
30640358|NCT00925002|58652387|FG001|Overall Study|Other|4|||
30951580|NCT01703858|58998802|FG000|Overall Study|Withdrawal by Subject|0|||
30951581|NCT01703858|58998803|FG001|Overall Study|Withdrawal by Subject|1|||
30640359|NCT00925002|58652388|FG002|Overall Study|Other|0|||
30640360|NCT00925002|58652386|FG000|Overall Study|Death|1|||
30765600|NCT00318149|58774282|FG005|Overall Study|Adverse Event|2|||
30765601|NCT00317603|58774298|FG000|Overall Study|Progressive Disease|3|||
30640361|NCT00925002|58652387|FG001|Overall Study|Death|1|||
30640362|NCT00925002|58652388|FG002|Overall Study|Death|5|||
30640363|NCT00925002|58652386|FG000|Overall Study|Adverse Event|3|||
30640364|NCT00925002|58652387|FG001|Overall Study|Adverse Event|1|||
30640365|NCT00925002|58652388|FG002|Overall Study|Adverse Event|2|||
30640366|NCT00925002|58652386|FG000|Overall Study|Participant withdrew consent|1|||
30640367|NCT00925002|58652387|FG001|Overall Study|Participant withdrew consent|3|||
30640368|NCT00925002|58652388|FG002|Overall Study|Participant withdrew consent|3|||
30640369|NCT00928746|58652397|FG000|Overall Study|Adverse Event|2|||
30640370|NCT00928746|58652397|FG000|Overall Study|Protocol Violation|1|||
30640371|NCT00928746|58652397|FG000|Overall Study|Withdrawal by Subject|1|||
30640372|NCT00928746|58652397|FG000|Overall Study|Other|2|||
30640373|NCT00922428|58652403|FG000|Overall Study|retrospective/extremely implausible data|2|||
30640374|NCT00922428|58652403|FG000|Overall Study|no medication use or questionable use|13|||
30640375|NCT00894543|58652415|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
30640376|NCT00894543|58652416|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
30640377|NCT00894543|58652415|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
30640378|NCT00894543|58652416|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
30640379|NCT00922272|58652422|FG000|Open-label Phase|Adverse Event|5|||
30640380|NCT00922272|58652423|FG001|Open-label Phase|Adverse Event|0|||
30640381|NCT00922272|58652422|FG000|Open-label Phase|Protocol Violation|1|||
30640382|NCT00922272|58652423|FG001|Open-label Phase|Protocol Violation|0|||
30640383|NCT00922272|58652422|FG000|Open-label Phase|Withdrawal by Subject|11|||
30640384|NCT00922272|58652423|FG001|Open-label Phase|Withdrawal by Subject|0|||
30640385|NCT00922272|58652422|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
30640386|NCT00922272|58652423|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
30640387|NCT00922272|58652422|FG000|Open-label Phase|Withdrawal criteria met|5|||
30640388|NCT00922272|58652423|FG001|Open-label Phase|Withdrawal criteria met|0|||
30640389|NCT00922272|58652422|FG000|Double-blind Phase|Adverse Event|1|||
30640390|NCT00922272|58652423|FG001|Double-blind Phase|Adverse Event|1|||
30640391|NCT00922272|58652422|FG000|Double-blind Phase|Withdrawal by Subject|1|||
30640392|NCT00922272|58652423|FG001|Double-blind Phase|Withdrawal by Subject|1|||
30640393|NCT00922272|58652422|FG000|Double-blind Phase|Lost to Follow-up|2|||
30640394|NCT00922272|58652423|FG001|Double-blind Phase|Lost to Follow-up|1|||
30640395|NCT00922272|58652422|FG000|Double-blind Phase|Withdrawal criteria met|1|||
30640396|NCT00922272|58652423|FG001|Double-blind Phase|Withdrawal criteria met|1|||
30640397|NCT00922272|58652422|FG000|Double-blind Phase|Noncompliance|1|||
30640398|NCT00922272|58652423|FG001|Double-blind Phase|Noncompliance|1|||
30640399|NCT00922272|58652422|FG000|Double-blind Phase|Positive urine drug screen|1|||
30640400|NCT00922272|58652423|FG001|Double-blind Phase|Positive urine drug screen|1|||
30640401|NCT00853372|58652433|FG000|Overall Study|Death|30|||
30640402|NCT00853372|58652434|FG001|Overall Study|Death|26|||
30640403|NCT00853372|58652433|FG000|Overall Study|Lost to Follow-up|1|||
30640404|NCT00853372|58652434|FG001|Overall Study|Lost to Follow-up|2|||
30640405|NCT00853372|58652433|FG000|Overall Study|Full Consent Withdrawn|1|||
30640406|NCT00853372|58652434|FG001|Overall Study|Full Consent Withdrawn|1|||
30640407|NCT00848536|58652442|FG000|Overall Study|Adverse Event|2|||
30640408|NCT00848536|58652443|FG001|Overall Study|Adverse Event|2|||
30640409|NCT00848536|58652442|FG000|Overall Study|Withdrawal by Subject|0|||
30640410|NCT00848536|58652443|FG001|Overall Study|Withdrawal by Subject|1|||
30640411|NCT00848536|58652442|FG000|Overall Study|Protocol Violation|0|||
30640412|NCT00848536|58652443|FG001|Overall Study|Protocol Violation|1|||
30640413|NCT00848536|58652442|FG000|Overall Study|Noncompliance|1|||
30640414|NCT00848536|58652443|FG001|Overall Study|Noncompliance|0|||
30640415|NCT00848536|58652442|FG000|Overall Study|Inadequate Control of IOP|1|||
30640416|NCT00848536|58652443|FG001|Overall Study|Inadequate Control of IOP|1|||
30640417|NCT00848536|58652442|FG000|Overall Study|Patient Moved|0|||
30640418|NCT00848536|58652443|FG001|Overall Study|Patient Moved|2|||
30640419|NCT00922116|58652449|FG000|Overall Study|Adverse Event|4|||
30640420|NCT00922116|58652449|FG000|Overall Study|Death|1|||
30640421|NCT00922116|58652449|FG000|Overall Study|Lost to Follow-up|1|||
30640422|NCT00922116|58652449|FG000|Overall Study|Withdrawal by Subject|4|||
30640423|NCT00922116|58652449|FG000|Overall Study|Other|5|||
30640424|NCT00921024|58652455|FG000|Overall Study|Lost to Follow-up|2|||
30640425|NCT00921024|58652456|FG001|Overall Study|Lost to Follow-up|0|||
30640426|NCT00921024|58652455|FG000|Overall Study|Received concomittant therapy|2|||
30640427|NCT00921024|58652456|FG001|Overall Study|Received concomittant therapy|0|||
30640428|NCT00921024|58652455|FG000|Overall Study|Withdrawal by Subject|0|||
30640429|NCT00921024|58652456|FG001|Overall Study|Withdrawal by Subject|3|||
30640430|NCT00928668|58652462|FG000|Overall Study|Adverse Event|1|||
30640431|NCT00928668|58652463|FG001|Overall Study|Adverse Event|0|||
30640432|NCT00928668|58652464|FG002|Overall Study|Adverse Event|0|||
30640433|NCT00928668|58652465|FG003|Overall Study|Adverse Event|0|||
30640434|NCT00928668|58652466|FG004|Overall Study|Adverse Event|0|||
30640435|NCT00928668|58652462|FG000|Overall Study|Protocol Violation|0|||
30640436|NCT00928668|58652463|FG001|Overall Study|Protocol Violation|0|||
30640437|NCT00928668|58652464|FG002|Overall Study|Protocol Violation|0|||
30640438|NCT00928668|58652465|FG003|Overall Study|Protocol Violation|0|||
30640439|NCT00928668|58652466|FG004|Overall Study|Protocol Violation|1|||
30640440|NCT00928668|58652462|FG000|Overall Study|Withdrawal by Subject|0|||
30640441|NCT00928668|58652463|FG001|Overall Study|Withdrawal by Subject|1|||
30640442|NCT00928668|58652464|FG002|Overall Study|Withdrawal by Subject|1|||
30640443|NCT00928668|58652465|FG003|Overall Study|Withdrawal by Subject|0|||
30640444|NCT00928668|58652466|FG004|Overall Study|Withdrawal by Subject|0|||
30640445|NCT00928668|58652462|FG000|Overall Study|Other reasons not listed above|0|||
30640446|NCT00928668|58652463|FG001|Overall Study|Other reasons not listed above|0|||
30640447|NCT00928668|58652464|FG002|Overall Study|Other reasons not listed above|0|||
30640448|NCT00928668|58652465|FG003|Overall Study|Other reasons not listed above|1|||
30640449|NCT00928668|58652466|FG004|Overall Study|Other reasons not listed above|0|||
30640450|NCT00592774|58652488|FG000|Overall Study|Adverse Event|5|||
30640451|NCT00592774|58652489|FG001|Overall Study|Adverse Event|19|||
30640452|NCT00592774|58652490|FG002|Overall Study|Adverse Event|2|||
30640453|NCT00592774|58652491|FG003|Overall Study|Adverse Event|14|||
30640454|NCT00592774|58652492|FG004|Overall Study|Adverse Event|8|||
30640455|NCT00592774|58652488|FG000|Overall Study|Protocol Violation|0|||
30640456|NCT00592774|58652489|FG001|Overall Study|Protocol Violation|1|||
30640457|NCT00592774|58652490|FG002|Overall Study|Protocol Violation|0|||
30640458|NCT00592774|58652491|FG003|Overall Study|Protocol Violation|0|||
30640459|NCT00592774|58652492|FG004|Overall Study|Protocol Violation|1|||
30640460|NCT00592774|58652488|FG000|Overall Study|Withdrawal by Subject|3|||
30640461|NCT00592774|58652489|FG001|Overall Study|Withdrawal by Subject|7|||
30640462|NCT00592774|58652490|FG002|Overall Study|Withdrawal by Subject|0|||
30640463|NCT00592774|58652491|FG003|Overall Study|Withdrawal by Subject|0|||
30640464|NCT00592774|58652492|FG004|Overall Study|Withdrawal by Subject|0|||
30640465|NCT00592774|58652488|FG000|Overall Study|Lack of Efficacy|3|||
30640466|NCT00592774|58652489|FG001|Overall Study|Lack of Efficacy|3|||
30640467|NCT00592774|58652490|FG002|Overall Study|Lack of Efficacy|0|||
30640468|NCT00592774|58652491|FG003|Overall Study|Lack of Efficacy|0|||
30640469|NCT00592774|58652492|FG004|Overall Study|Lack of Efficacy|2|||
30640470|NCT00592774|58652488|FG000|Overall Study|Physician Decision|0|||
30640471|NCT00592774|58652489|FG001|Overall Study|Physician Decision|1|||
30640472|NCT00592774|58652490|FG002|Overall Study|Physician Decision|1|||
30640473|NCT00592774|58652491|FG003|Overall Study|Physician Decision|0|||
30640474|NCT00592774|58652492|FG004|Overall Study|Physician Decision|1|||
30640475|NCT00592774|58652488|FG000|Overall Study|Other|0|||
30640476|NCT00592774|58652489|FG001|Overall Study|Other|1|||
30640477|NCT00592774|58652490|FG002|Overall Study|Other|1|||
30640478|NCT00592774|58652491|FG003|Overall Study|Other|0|||
30640479|NCT00592774|58652492|FG004|Overall Study|Other|2|||
30640480|NCT00837694|58652510|FG000|Overall Study|Lost to Follow-up|2|||
30640481|NCT00837694|58652511|FG001|Overall Study|Lost to Follow-up|0|||
30640482|NCT00837694|58652512|FG002|Overall Study|Lost to Follow-up|2|||
30640483|NCT00837694|58652513|FG003|Overall Study|Lost to Follow-up|1|||
30640484|NCT00837694|58652514|FG004|Overall Study|Lost to Follow-up|1|||
30640485|NCT00837694|58652515|FG005|Overall Study|Lost to Follow-up|1|||
30640486|NCT00852202|58652532|FG000|Overall Study|Adverse Event|2|||
30640487|NCT00852202|58652533|FG001|Overall Study|Adverse Event|3|||
30640488|NCT00852202|58652534|FG002|Overall Study|Adverse Event|7|||
30640489|NCT00852202|58652532|FG000|Overall Study|Lack of Efficacy|4|||
30640490|NCT00852202|58652533|FG001|Overall Study|Lack of Efficacy|1|||
30640491|NCT00852202|58652534|FG002|Overall Study|Lack of Efficacy|2|||
30640492|NCT00852202|58652532|FG000|Overall Study|Protocol Violation|2|||
30640493|NCT00852202|58652533|FG001|Overall Study|Protocol Violation|2|||
30640494|NCT00852202|58652534|FG002|Overall Study|Protocol Violation|7|||
30640495|NCT00852202|58652532|FG000|Overall Study|Withdrawal by Subject|3|||
30640496|NCT00852202|58652533|FG001|Overall Study|Withdrawal by Subject|1|||
30640497|NCT00852202|58652534|FG002|Overall Study|Withdrawal by Subject|2|||
30640498|NCT00852202|58652532|FG000|Overall Study|Lost to Follow-up|5|||
30640499|NCT00852202|58652533|FG001|Overall Study|Lost to Follow-up|5|||
30640500|NCT00852202|58652534|FG002|Overall Study|Lost to Follow-up|6|||
30640501|NCT00852202|58652532|FG000|Overall Study|pregnancy,moving away and surgery|1|||
30640502|NCT00852202|58652533|FG001|Overall Study|pregnancy,moving away and surgery|0|||
30640503|NCT00852202|58652534|FG002|Overall Study|pregnancy,moving away and surgery|2|||
30640504|NCT01074008|58652552|FG000|Overall Study|Adverse Event|0|||
30951582|NCT01703858|58998804|FG002|Overall Study|Withdrawal by Subject|0|||
30951583|NCT01714310|58998820|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
30640505|NCT01074008|58652553|FG001|Overall Study|Adverse Event|1|||
30640506|NCT01074008|58652554|FG002|Overall Study|Adverse Event|0|||
30640507|NCT01074008|58652555|FG003|Overall Study|Adverse Event|0|||
30640508|NCT01074008|58652556|FG004|Overall Study|Adverse Event|0|||
30640509|NCT01074008|58652557|FG005|Overall Study|Adverse Event|0|||
30640510|NCT01074008|58652558|FG006|Overall Study|Adverse Event|0|||
30640511|NCT01074008|58652559|FG007|Overall Study|Adverse Event|0|||
30640512|NCT01074008|58652560|FG008|Overall Study|Adverse Event|0|||
30640513|NCT01074008|58652552|FG000|Overall Study|Withdrawal by Subject|1|||
30640514|NCT01074008|58652553|FG001|Overall Study|Withdrawal by Subject|1|||
30640515|NCT01074008|58652554|FG002|Overall Study|Withdrawal by Subject|1|||
30640516|NCT01074008|58652555|FG003|Overall Study|Withdrawal by Subject|0|||
30640517|NCT01074008|58652556|FG004|Overall Study|Withdrawal by Subject|1|||
30640518|NCT01074008|58652557|FG005|Overall Study|Withdrawal by Subject|0|||
30640519|NCT01074008|58652558|FG006|Overall Study|Withdrawal by Subject|0|||
30640520|NCT01074008|58652559|FG007|Overall Study|Withdrawal by Subject|0|||
30640521|NCT01074008|58652560|FG008|Overall Study|Withdrawal by Subject|0|||
30640522|NCT01074008|58652552|FG000|Overall Study|Lost to Follow-up|0|||
30640523|NCT01074008|58652553|FG001|Overall Study|Lost to Follow-up|1|||
30640524|NCT01074008|58652554|FG002|Overall Study|Lost to Follow-up|1|||
30640525|NCT01074008|58652555|FG003|Overall Study|Lost to Follow-up|1|||
30640526|NCT01074008|58652556|FG004|Overall Study|Lost to Follow-up|1|||
30640527|NCT01074008|58652557|FG005|Overall Study|Lost to Follow-up|0|||
30640528|NCT01074008|58652558|FG006|Overall Study|Lost to Follow-up|1|||
30640529|NCT01074008|58652559|FG007|Overall Study|Lost to Follow-up|0|||
30640530|NCT01074008|58652560|FG008|Overall Study|Lost to Follow-up|4|||
30640531|NCT01073930|58652591|FG000|Overall Study|Withdrawal by Subject|3|||
30640532|NCT01073930|58652592|FG001|Overall Study|Withdrawal by Subject|2|||
30640533|NCT01073930|58652591|FG000|Overall Study|Lost to Follow-up|0|||
30640534|NCT01073930|58652592|FG001|Overall Study|Lost to Follow-up|1|||
30640535|NCT01073930|58652591|FG000|Overall Study|Adverse Event|0|||
30640536|NCT01073930|58652592|FG001|Overall Study|Adverse Event|1|||
30640537|NCT01073930|58652591|FG000|Overall Study|Noncompliance with study drug|0|||
30640538|NCT01073930|58652592|FG001|Overall Study|Noncompliance with study drug|1|||
30640539|NCT01073930|58652591|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
30640540|NCT01073930|58652592|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
30640541|NCT01073618|58652598|FG000|Overall Study|Death|208|||
30640542|NCT01073618|58652598|FG000|Overall Study|Adverse Event|19|||
30640543|NCT01073618|58652598|FG000|Overall Study|Other|80|||
30640544|NCT01073462|58652602|FG000|Overall Study|Death|14|||
30640545|NCT01073462|58652602|FG000|Overall Study|Kidney transplant|10|||
30640546|NCT01073462|58652602|FG000|Overall Study|Low parathyroid hormone levels|8|||
30640547|NCT01073462|58652602|FG000|Overall Study|Serious adverse event|2|||
30640548|NCT01073462|58652602|FG000|Overall Study|Lost to Follow-up|7|||
30640549|NCT00789373|58652606|FG000|Induction|Adverse Event|64|||
30640550|NCT00789373|58652607|FG001|Induction|Adverse Event|0|||
30640551|NCT00789373|58652608|FG002|Induction|Adverse Event|0|||
30640552|NCT00789373|58652606|FG000|Induction|Death Due to study disease|24|||
30640553|NCT00789373|58652607|FG001|Induction|Death Due to study disease|0|||
30640554|NCT00789373|58652608|FG002|Induction|Death Due to study disease|0|||
30640555|NCT00789373|58652606|FG000|Induction|Death due to adverse event|19|||
30640556|NCT00789373|58652607|FG001|Induction|Death due to adverse event|0|||
30640557|NCT00789373|58652608|FG002|Induction|Death due to adverse event|0|||
30640558|NCT00789373|58652606|FG000|Induction|Death due to toxicity|11|||
30640559|NCT00789373|58652607|FG001|Induction|Death due to toxicity|0|||
30640560|NCT00789373|58652608|FG002|Induction|Death due to toxicity|0|||
30640561|NCT00789373|58652606|FG000|Induction|Death due to procedure|1|||
30640562|NCT00789373|58652607|FG001|Induction|Death due to procedure|0|||
30640563|NCT00789373|58652608|FG002|Induction|Death due to procedure|0|||
30640564|NCT00789373|58652606|FG000|Induction|Investigator decision|7|||
30640565|NCT00789373|58652607|FG001|Induction|Investigator decision|0|||
30640566|NCT00789373|58652608|FG002|Induction|Investigator decision|0|||
30640567|NCT00789373|58652606|FG000|Induction|Protocol entry criteria not met|9|||
30640568|NCT00789373|58652607|FG001|Induction|Protocol entry criteria not met|0|||
30640569|NCT00789373|58652608|FG002|Induction|Protocol entry criteria not met|0|||
30640570|NCT00789373|58652606|FG000|Induction|Lost to Follow-up|6|||
30640571|NCT00789373|58652607|FG001|Induction|Lost to Follow-up|0|||
30640572|NCT00789373|58652608|FG002|Induction|Lost to Follow-up|0|||
30640573|NCT00789373|58652606|FG000|Induction|Protocol Violation|1|||
30640574|NCT00789373|58652607|FG001|Induction|Protocol Violation|0|||
30640575|NCT00789373|58652608|FG002|Induction|Protocol Violation|0|||
30640576|NCT00789373|58652606|FG000|Induction|Progressive Disease|220|||
30640577|NCT00789373|58652607|FG001|Induction|Progressive Disease|0|||
30951584|NCT01714310|58998821|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
30640578|NCT00789373|58652608|FG002|Induction|Progressive Disease|0|||
30640579|NCT00789373|58652606|FG000|Induction|Withdrawal by Subject|37|||
30640580|NCT00789373|58652607|FG001|Induction|Withdrawal by Subject|0|||
30640581|NCT00789373|58652608|FG002|Induction|Withdrawal by Subject|0|||
30640582|NCT00789373|58652606|FG000|Maintenance|Adverse Event|0|||
30640583|NCT00789373|58652607|FG001|Maintenance|Adverse Event|65|||
30640584|NCT00789373|58652608|FG002|Maintenance|Adverse Event|12|||
30640585|NCT00789373|58652606|FG000|Maintenance|Death due to study disease|0|||
30640586|NCT00789373|58652607|FG001|Maintenance|Death due to study disease|3|||
30640587|NCT00789373|58652608|FG002|Maintenance|Death due to study disease|1|||
30640588|NCT00789373|58652606|FG000|Maintenance|Death due to adverse event|0|||
30640589|NCT00789373|58652607|FG001|Maintenance|Death due to adverse event|4|||
30765602|NCT03326518|58774305|FG000|Overall Study|Protocol Violation|1|||
30640590|NCT00789373|58652608|FG002|Maintenance|Death due to adverse event|1|||
30640591|NCT00789373|58652606|FG000|Maintenance|Death due to toxicity|0|||
30640592|NCT00789373|58652607|FG001|Maintenance|Death due to toxicity|1|||
30640593|NCT00789373|58652608|FG002|Maintenance|Death due to toxicity|2|||
30640594|NCT00789373|58652606|FG000|Maintenance|Investigator Decision|0|||
30640595|NCT00789373|58652607|FG001|Maintenance|Investigator Decision|4|||
30640596|NCT00789373|58652608|FG002|Maintenance|Investigator Decision|2|||
30640597|NCT00789373|58652606|FG000|Maintenance|Protocol entry criteria not met|0|||
30640598|NCT00789373|58652607|FG001|Maintenance|Protocol entry criteria not met|2|||
30640599|NCT00789373|58652608|FG002|Maintenance|Protocol entry criteria not met|0|||
30640600|NCT00789373|58652606|FG000|Maintenance|Lost to Follow-up|0|||
30640601|NCT00789373|58652607|FG001|Maintenance|Lost to Follow-up|2|||
30640602|NCT00789373|58652608|FG002|Maintenance|Lost to Follow-up|0|||
30640603|NCT00789373|58652606|FG000|Maintenance|Progressive Disease|0|||
30640604|NCT00789373|58652607|FG001|Maintenance|Progressive Disease|253|||
30640605|NCT00789373|58652608|FG002|Maintenance|Progressive Disease|152|||
30640606|NCT00789373|58652606|FG000|Maintenance|Withdrawal by Subject|0|||
30640607|NCT00789373|58652607|FG001|Maintenance|Withdrawal by Subject|21|||
30640608|NCT00789373|58652608|FG002|Maintenance|Withdrawal by Subject|8|||
30640609|NCT00789373|58652606|FG000|Maintenance|Sponsor Decision|0|||
30640610|NCT00789373|58652607|FG001|Maintenance|Sponsor Decision|0|||
30640611|NCT00789373|58652608|FG002|Maintenance|Sponsor Decision|2|||
30640612|NCT00789373|58652606|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
30640613|NCT00789373|58652607|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
30640614|NCT00789373|58652608|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
30640615|NCT00851890|58652623|FG000|Overall Study|Lost to Follow-up|0|||
30640616|NCT00851890|58652624|FG001|Overall Study|Lost to Follow-up|1|||
30640617|NCT00851890|58652625|FG002|Overall Study|Lost to Follow-up|0|||
30640618|NCT00851890|58652626|FG003|Overall Study|Lost to Follow-up|1|||
30640619|NCT00788827|58652636|FG000|Overall Study|Lack of Efficacy|2|||
30640620|NCT00592072|58652642|FG000|Wash Out Period|Lost to Follow-up|1|||
30640621|NCT00592072|58652643|FG001|Wash Out Period|Lost to Follow-up|1|||
30640622|NCT00792571|58652649|FG000|Overall Study|Death|1|||
30640623|NCT00792571|58652649|FG000|Overall Study|Adverse Event|4|||
30640624|NCT00792571|58652649|FG000|Overall Study|Withdrawal by Subject|1|||
30640625|NCT00792571|58652649|FG000|Overall Study|Other|4|||
30640626|NCT01069484|58652655|FG000|Overall Study|Death-in-near-family|1|||
30640627|NCT01069484|58652656|FG001|Overall Study|Death-in-near-family|0|||
30640628|NCT01069484|58652655|FG000|Overall Study|No specific reason|8|||
30640629|NCT01069484|58652656|FG001|Overall Study|No specific reason|2|||
30640630|NCT01069484|58652655|FG000|Overall Study|Illness mother or child|3|||
30640631|NCT01069484|58652656|FG001|Overall Study|Illness mother or child|1|||
30640632|NCT00794365|58652663|FG000|Overall Study|Lost to Follow-up|38|||
30640633|NCT00794365|58652663|FG000|Overall Study|Other|17|||
30640634|NCT00794365|58652663|FG000|Overall Study|Poor Compliance|11|||
30640635|NCT00794365|58652663|FG000|Overall Study|Adverse Event|10|||
30640636|NCT00794365|58652663|FG000|Overall Study|Lack of Efficacy|3|||
30640637|NCT01067144|58652669|FG000|Treatment|Did not receive allocated intervention|4|||
30640638|NCT01067144|58652670|FG001|Treatment|Did not receive allocated intervention|7|||
30640639|NCT01067144|58652669|FG000|Follow-up|Lost to Follow-up|22|||
30640640|NCT01067144|58652670|FG001|Follow-up|Lost to Follow-up|12|||
30640641|NCT01067144|58652669|FG000|Follow-up|Censored owing to second surgery|19|||
30640642|NCT01067144|58652670|FG001|Follow-up|Censored owing to second surgery|28|||
30640643|NCT01067144|58652669|FG000|Follow-up|Withdrawal by Subject|18|||
30640644|NCT01067144|58652670|FG001|Follow-up|Withdrawal by Subject|14|||
30640645|NCT01067144|58652669|FG000|Follow-up|Surgery cancelled|0|||
30640646|NCT01067144|58652670|FG001|Follow-up|Surgery cancelled|1|||
30640647|NCT01067144|58652669|FG000|Follow-up|Death|0|||
30640648|NCT01067144|58652670|FG001|Follow-up|Death|1|||
30640649|NCT01078298|58652678|FG000|Overall Study|Lost to Follow-up|12|||
30640650|NCT01078298|58652679|FG001|Overall Study|Lost to Follow-up|13|||
30640651|NCT01078298|58652678|FG000|Overall Study|Withdrawal by Subject|31|||
30640652|NCT01078298|58652679|FG001|Overall Study|Withdrawal by Subject|33|||
30640653|NCT01078298|58652678|FG000|Overall Study|Protocol Violation|6|||
30640654|NCT01078298|58652679|FG001|Overall Study|Protocol Violation|6|||
30640655|NCT01078298|58652678|FG000|Overall Study|Adverse Event|6|||
30640656|NCT01078298|58652679|FG001|Overall Study|Adverse Event|5|||
30640657|NCT01078298|58652678|FG000|Overall Study|Death|2|||
30640658|NCT01078298|58652679|FG001|Overall Study|Death|0|||
30640659|NCT01078298|58652678|FG000|Overall Study|Did not meet entrance criteria|0|||
30640660|NCT01078298|58652679|FG001|Overall Study|Did not meet entrance criteria|1|||
30640661|NCT01078298|58652678|FG000|Overall Study|Other|24|||
30640662|NCT01078298|58652679|FG001|Overall Study|Other|32|||
30640663|NCT00788593|58652685|FG000|Placebo Run-in Phase|Adverse Event|2|||
30640664|NCT00788593|58652686|FG001|Placebo Run-in Phase|Adverse Event|0|||
30640665|NCT00788593|58652687|FG002|Placebo Run-in Phase|Adverse Event|0|||
30640666|NCT00788593|58652685|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
30640667|NCT00788593|58652686|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
30640668|NCT00788593|58652687|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
30640669|NCT00788593|58652685|FG000|Placebo Run-in Phase|Protocol Violation|2|||
30640670|NCT00788593|58652686|FG001|Placebo Run-in Phase|Protocol Violation|0|||
30640671|NCT00788593|58652687|FG002|Placebo Run-in Phase|Protocol Violation|0|||
30640672|NCT00788593|58652685|FG000|First Intervention Period|Adverse Event|0|||
30640673|NCT00788593|58652686|FG001|First Intervention Period|Adverse Event|1|||
30640674|NCT00788593|58652687|FG002|First Intervention Period|Adverse Event|0|||
30640675|NCT00788593|58652685|FG000|Second Intervention Period|Lost to Follow-up|0|||
30640676|NCT00788593|58652686|FG001|Second Intervention Period|Lost to Follow-up|1|||
30640677|NCT00788593|58652687|FG002|Second Intervention Period|Lost to Follow-up|0|||
30640678|NCT00788593|58652685|FG000|Second Intervention Period|Other|0|||
30640679|NCT00788593|58652686|FG001|Second Intervention Period|Other|0|||
30640680|NCT00788593|58652687|FG002|Second Intervention Period|Other|1|||
30640681|NCT00793819|58652699|FG000|Overall Study|Adverse Event|8|||
30640682|NCT00793819|58652700|FG001|Overall Study|Adverse Event|4|||
30640683|NCT00793819|58652699|FG000|Overall Study|Lack of Efficacy|1|||
30640684|NCT00793819|58652700|FG001|Overall Study|Lack of Efficacy|1|||
30640685|NCT00793819|58652699|FG000|Overall Study|Withdrawal by Subject|4|||
30640686|NCT00793819|58652700|FG001|Overall Study|Withdrawal by Subject|3|||
30640687|NCT00793819|58652699|FG000|Overall Study|Lost to Follow-up|1|||
30640688|NCT00793819|58652700|FG001|Overall Study|Lost to Follow-up|1|||
30640689|NCT00792259|58652709|FG000|Overall Study|Poor Quality Scans|1|||
30640690|NCT00792259|58652710|FG001|Overall Study|Poor Quality Scans|0|||
30640691|NCT00792259|58652711|FG002|Overall Study|Poor Quality Scans|0|||
30640692|NCT00894387|58652721|FG000|Overall Study|Adverse Event|44|||
30640693|NCT00894387|58652722|FG001|Overall Study|Adverse Event|45|||
30640694|NCT00894387|58652721|FG000|Overall Study|Abnormal Laboratory values|2|||
30640695|NCT00894387|58652722|FG001|Overall Study|Abnormal Laboratory values|2|||
30640696|NCT00894387|58652721|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30640697|NCT00894387|58652722|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30640698|NCT00894387|58652721|FG000|Overall Study|Lost to Follow-up|3|||
30640699|NCT00894387|58652722|FG001|Overall Study|Lost to Follow-up|5|||
30640700|NCT00894387|58652721|FG000|Overall Study|Administrative problems|2|||
30640701|NCT00894387|58652722|FG001|Overall Study|Administrative problems|2|||
30640702|NCT00894387|58652721|FG000|Overall Study|Death|77|||
30640703|NCT00894387|58652722|FG001|Overall Study|Death|76|||
30640704|NCT00894387|58652721|FG000|Overall Study|Protocol Deviation|4|||
30640705|NCT00894387|58652722|FG001|Overall Study|Protocol Deviation|0|||
30640706|NCT00894387|58652721|FG000|Overall Study|Patient's request|25|||
30640707|NCT00894387|58652722|FG001|Overall Study|Patient's request|30|||
30640708|NCT00894387|58652721|FG000|Overall Study|Other (Missing)|5|||
30640709|NCT00894387|58652722|FG001|Overall Study|Other (Missing)|3|||
30640710|NCT00894387|58652721|FG000|Overall Study|Mis-randomized|13|||
30640711|NCT00894387|58652722|FG001|Overall Study|Mis-randomized|9|||
30640712|NCT00894387|58652721|FG000|Overall Study|GCP non-compliance|0|||
30640713|NCT00894387|58652722|FG001|Overall Study|GCP non-compliance|2|||
30951585|NCT01714310|58998822|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
30951586|NCT01714310|58998820|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
30951587|NCT01714310|58998821|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
30951588|NCT01714310|58998822|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
30951589|NCT01714310|58998820|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
30951590|NCT01714310|58998821|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
30951591|NCT01714310|58998822|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
30951592|NCT01714310|58998820|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
30951593|NCT01714310|58998821|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
30951594|NCT01714310|58998822|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
30951595|NCT01713998|58998843|FG000|Overall Study|Lost to Follow-up|2|||
30951596|NCT01713998|58998844|FG001|Overall Study|Lost to Follow-up|0|||
30951597|NCT01713998|58998845|FG002|Overall Study|Lost to Follow-up|2|||
30951598|NCT01713998|58998843|FG000|Overall Study|Withdrawal by Subject|1|||
30951599|NCT01713998|58998844|FG001|Overall Study|Withdrawal by Subject|0|||
30951600|NCT01713998|58998845|FG002|Overall Study|Withdrawal by Subject|0|||
30951601|NCT01681628|58998855|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
30640714|NCT00928512|58652733|FG000|Overall Study|Adverse Event|4|||
30640715|NCT00928512|58652734|FG001|Overall Study|Adverse Event|3|||
30640716|NCT00928512|58652735|FG002|Overall Study|Adverse Event|2|||
30640717|NCT00928512|58652736|FG003|Overall Study|Adverse Event|8|||
30640718|NCT00928512|58652737|FG004|Overall Study|Adverse Event|6|||
30640719|NCT00928512|58652733|FG000|Overall Study|Lack of Efficacy|2|||
30640720|NCT00928512|58652734|FG001|Overall Study|Lack of Efficacy|0|||
30640721|NCT00928512|58652735|FG002|Overall Study|Lack of Efficacy|4|||
30640722|NCT00928512|58652736|FG003|Overall Study|Lack of Efficacy|7|||
30640723|NCT00928512|58652737|FG004|Overall Study|Lack of Efficacy|3|||
30765603|NCT03326518|58774306|FG001|Overall Study|Protocol Violation|0|||
30640724|NCT00928512|58652733|FG000|Overall Study|Protocol Violation|0|||
30640725|NCT00928512|58652734|FG001|Overall Study|Protocol Violation|1|||
30640726|NCT00928512|58652735|FG002|Overall Study|Protocol Violation|0|||
30640727|NCT00928512|58652736|FG003|Overall Study|Protocol Violation|1|||
30640728|NCT00928512|58652737|FG004|Overall Study|Protocol Violation|3|||
30951602|NCT01681628|58998856|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
30951603|NCT01681628|58998855|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
30951604|NCT01681628|58998856|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
30951605|NCT01681628|58998855|FG000|19 Months Follow-up|Death|1|||
30951606|NCT01681628|58998856|FG001|19 Months Follow-up|Death|0|||
30951607|NCT01681628|58998855|FG000|19 Months Follow-up|Lost to Follow-up|61|||
30951608|NCT01681628|58998856|FG001|19 Months Follow-up|Lost to Follow-up|43|||
30951609|NCT00016354|58998878|FG000|Overall Study|Lack of Efficacy|0|||
30951610|NCT00016354|58998879|FG001|Overall Study|Lack of Efficacy|0|||
30951611|NCT00016354|58998880|FG002|Overall Study|Lack of Efficacy|0|||
30640729|NCT00928512|58652733|FG000|Overall Study|Withdrawal by Subject|3|||
30640730|NCT00928512|58652734|FG001|Overall Study|Withdrawal by Subject|0|||
30640731|NCT00928512|58652735|FG002|Overall Study|Withdrawal by Subject|3|||
30640732|NCT00928512|58652736|FG003|Overall Study|Withdrawal by Subject|4|||
30640733|NCT00928512|58652737|FG004|Overall Study|Withdrawal by Subject|0|||
30640734|NCT00928512|58652733|FG000|Overall Study|Lost to Follow-up|1|||
30640735|NCT00928512|58652734|FG001|Overall Study|Lost to Follow-up|1|||
30640736|NCT00928512|58652735|FG002|Overall Study|Lost to Follow-up|2|||
30640737|NCT00928512|58652736|FG003|Overall Study|Lost to Follow-up|1|||
30640738|NCT00928512|58652737|FG004|Overall Study|Lost to Follow-up|3|||
30640739|NCT00928512|58652733|FG000|Overall Study|Administrative Problems|0|||
30640740|NCT00928512|58652734|FG001|Overall Study|Administrative Problems|1|||
30640741|NCT00928512|58652735|FG002|Overall Study|Administrative Problems|0|||
30640742|NCT00928512|58652736|FG003|Overall Study|Administrative Problems|0|||
30640743|NCT00928512|58652737|FG004|Overall Study|Administrative Problems|0|||
30640744|NCT00787891|58652755|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
30640745|NCT00787891|58652756|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
30640746|NCT00787891|58652755|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
30640747|NCT00787891|58652756|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
30640748|NCT00787891|58652755|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
30640749|NCT00787891|58652756|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
30640750|NCT00787891|58652755|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
30640751|NCT00787891|58652756|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
30640752|NCT00787891|58652755|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
30640753|NCT00787891|58652756|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
30640754|NCT00787891|58652755|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
30640755|NCT00787891|58652756|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
30640756|NCT00787891|58652755|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
30640757|NCT00787891|58652756|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
30640758|NCT00787891|58652755|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
30640759|NCT00787891|58652756|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
30640760|NCT00787891|58652755|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
30640761|NCT00787891|58652756|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
30640762|NCT00787891|58652755|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
30640763|NCT00787891|58652756|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
30640764|NCT00892437|58652766|FG000|Randomized Phase|Randomized but not treated|6|||
30640765|NCT00892437|58652767|FG001|Randomized Phase|Randomized but not treated|0|||
30640766|NCT00892437|58652766|FG000|Randomized Phase|Adverse Event|2|||
30640767|NCT00892437|58652767|FG001|Randomized Phase|Adverse Event|2|||
30640768|NCT00892437|58652766|FG000|Randomized Phase|Lost to Follow-up|1|||
30640769|NCT00892437|58652767|FG001|Randomized Phase|Lost to Follow-up|3|||
30640770|NCT00892437|58652766|FG000|Randomized Phase|Investigator's Discretion|1|||
30640771|NCT00892437|58652767|FG001|Randomized Phase|Investigator's Discretion|0|||
30640772|NCT00892437|58652766|FG000|Randomized Phase|Withdrew Consent|1|||
30640773|NCT00892437|58652767|FG001|Randomized Phase|Withdrew Consent|0|||
30640774|NCT00892437|58652766|FG000|Open-Label Extension Phase|Adverse Event|4|||
30640775|NCT00892437|58652767|FG001|Open-Label Extension Phase|Adverse Event|2|||
30640776|NCT00892437|58652766|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
30951612|NCT00016354|58998881|FG003|Overall Study|Lack of Efficacy|0|||
30640777|NCT00892437|58652767|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
30640778|NCT00892437|58652766|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
30640779|NCT00892437|58652767|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
30640780|NCT00892437|58652766|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
30640781|NCT00892437|58652767|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
30640782|NCT00892437|58652766|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
30640783|NCT00892437|58652767|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
30640784|NCT00792103|58652774|FG000|Overall Study|Enrolled, not treated|15|||
30640785|NCT00792103|58652774|FG000|Overall Study|Lost to Follow-up|17|||
30640786|NCT00792103|58652774|FG000|Overall Study|Adverse Event|25|||
30640787|NCT00792103|58652774|FG000|Overall Study|Withdrawal by Subject|52|||
30640788|NCT00792103|58652774|FG000|Overall Study|Protocol Violation|10|||
30765604|NCT03326518|58774307|FG002|Overall Study|Protocol Violation|0|||
30640789|NCT00792103|58652774|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
30640790|NCT00892281|58652780|FG000|Overall Study|Adverse Event|65|||
30640791|NCT00892281|58652781|FG001|Overall Study|Adverse Event|8|||
30640792|NCT00892281|58652780|FG000|Overall Study|Lost to Follow-up|81|||
30640793|NCT00892281|58652781|FG001|Overall Study|Lost to Follow-up|8|||
30640794|NCT00892281|58652780|FG000|Overall Study|Pregnancy|1|||
30640795|NCT00892281|58652781|FG001|Overall Study|Pregnancy|0|||
30640796|NCT00892281|58652780|FG000|Overall Study|Protocol Violation|7|||
30640797|NCT00892281|58652781|FG001|Overall Study|Protocol Violation|2|||
30640798|NCT00892281|58652780|FG000|Overall Study|Withdrawal by Subject|86|||
30640799|NCT00892281|58652781|FG001|Overall Study|Withdrawal by Subject|14|||
30640800|NCT00892281|58652780|FG000|Overall Study|Subject failed to return for final visit|2|||
30848518|NCT02851511|58874629|FG000|Phase I|Physician Decision|0|||
30848519|NCT02851511|58874630|FG001|Phase I|Physician Decision|0|||
30848520|NCT02851511|58874631|FG002|Phase I|Physician Decision|0|||
30848521|NCT02851511|58874632|FG003|Phase I|Physician Decision|1|||
30848522|NCT02851511|58874629|FG000|Phase I|Withdrawal by Subject|2|||
30848523|NCT02851511|58874630|FG001|Phase I|Withdrawal by Subject|1|||
30848524|NCT02851511|58874631|FG002|Phase I|Withdrawal by Subject|0|||
30640801|NCT00892281|58652781|FG001|Overall Study|Subject failed to return for final visit|0|||
30640802|NCT00892281|58652780|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
30640803|NCT00892281|58652781|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
30640804|NCT00892281|58652780|FG000|Overall Study|Final visit completed 4 weeks late|0|||
30640805|NCT00892281|58652781|FG001|Overall Study|Final visit completed 4 weeks late|1|||
30640806|NCT00892281|58652780|FG000|Overall Study|Subject completed day after study closed|1|||
30640807|NCT00892281|58652781|FG001|Overall Study|Subject completed day after study closed|0|||
30640808|NCT00892281|58652780|FG000|Overall Study|Family emergency|1|||
30640809|NCT00892281|58652781|FG001|Overall Study|Family emergency|0|||
30640810|NCT00892281|58652780|FG000|Overall Study|Last visit not done - death in family|1|||
30640811|NCT00892281|58652781|FG001|Overall Study|Last visit not done - death in family|0|||
30640812|NCT00892281|58652780|FG000|Overall Study|Did not meet incl/excl criteria|1|||
30640813|NCT00892281|58652781|FG001|Overall Study|Did not meet incl/excl criteria|0|||
30640814|NCT00892281|58652780|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
30640815|NCT00892281|58652781|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
30640816|NCT00892281|58652780|FG000|Overall Study|Unable to redeem the drug voucher|1|||
30640817|NCT00892281|58652781|FG001|Overall Study|Unable to redeem the drug voucher|0|||
30640818|NCT00892281|58652780|FG000|Overall Study|Subject not good candidate for study|1|||
30640819|NCT00892281|58652781|FG001|Overall Study|Subject not good candidate for study|0|||
30640820|NCT00892281|58652780|FG000|Overall Study|Subject did not return for any visits|1|||
30640821|NCT00892281|58652781|FG001|Overall Study|Subject did not return for any visits|0|||
30640822|NCT00892281|58652780|FG000|Overall Study|Subject missed several visits/lost meds|1|||
30640823|NCT00892281|58652781|FG001|Overall Study|Subject missed several visits/lost meds|0|||
30640824|NCT00892281|58652780|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
30640825|NCT00892281|58652781|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
30640826|NCT00892281|58652780|FG000|Overall Study|Scheduled for knee replacement|0|||
30640827|NCT00892281|58652781|FG001|Overall Study|Scheduled for knee replacement|1|||
30640828|NCT00892281|58652780|FG000|Overall Study|PI complained of inadequate compensation|3|||
30640829|NCT00892281|58652781|FG001|Overall Study|PI complained of inadequate compensation|0|||
30640830|NCT00892281|58652780|FG000|Overall Study|Subject lost interest in program|0|||
30640831|NCT00892281|58652781|FG001|Overall Study|Subject lost interest in program|1|||
30640832|NCT00892281|58652780|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
30640833|NCT00892281|58652781|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
30640834|NCT00892281|58652780|FG000|Overall Study|Death in family|1|||
30640835|NCT00892281|58652781|FG001|Overall Study|Death in family|0|||
30640836|NCT00892281|58652780|FG000|Overall Study|Lack of efficacy of study product|2|||
30640837|NCT00892281|58652781|FG001|Overall Study|Lack of efficacy of study product|0|||
30765605|NCT03326518|58774305|FG000|Overall Study|Withdrawal by Subject|1|||
30765606|NCT03326518|58774306|FG001|Overall Study|Withdrawal by Subject|0|||
30765607|NCT03326518|58774307|FG002|Overall Study|Withdrawal by Subject|0|||
30765608|NCT03326518|58774305|FG000|Overall Study|Lost to Follow-up|1|||
30765609|NCT03326518|58774306|FG001|Overall Study|Lost to Follow-up|0|||
30765610|NCT03326518|58774307|FG002|Overall Study|Lost to Follow-up|1|||
30765611|NCT00317369|58774318|FG000|Overall Study|Adverse Event|2|||
30765612|NCT00317369|58774319|FG001|Overall Study|Adverse Event|1|||
30765613|NCT00317369|58774320|FG002|Overall Study|Adverse Event|0|||
30765614|NCT00317369|58774318|FG000|Overall Study|Lack of Efficacy|0|||
30765615|NCT00317369|58774319|FG001|Overall Study|Lack of Efficacy|1|||
30640838|NCT00892281|58652780|FG000|Overall Study|Subject not seen by PI at final visit|1|||
30640839|NCT00892281|58652781|FG001|Overall Study|Subject not seen by PI at final visit|0|||
30640840|NCT00892281|58652780|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
30640841|NCT00892281|58652781|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
30765616|NCT00317369|58774320|FG002|Overall Study|Lack of Efficacy|1|||
30848525|NCT02851511|58874632|FG003|Phase I|Withdrawal by Subject|3|||
30640842|NCT00892281|58652780|FG000|Overall Study|Missed multiple visits|1|||
30640843|NCT00892281|58652781|FG001|Overall Study|Missed multiple visits|0|||
30640844|NCT00892281|58652780|FG000|Overall Study|Missed visits rescheduled out of window|1|||
30640845|NCT00892281|58652781|FG001|Overall Study|Missed visits rescheduled out of window|0|||
30640846|NCT00892281|58652780|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
30640847|NCT00892281|58652781|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
30640848|NCT00892281|58652780|FG000|Overall Study|Subject had history of drug abuse|1|||
30640849|NCT00892281|58652781|FG001|Overall Study|Subject had history of drug abuse|0|||
30640850|NCT00892281|58652780|FG000|Overall Study|Rash on hand|1|||
30640851|NCT00892281|58652781|FG001|Overall Study|Rash on hand|0|||
30640852|NCT00892281|58652780|FG000|Overall Study|Visit 4 date out of window|1|||
30640853|NCT00892281|58652781|FG001|Overall Study|Visit 4 date out of window|0|||
30640854|NCT00784693|58652789|FG000|Overall Study|Lost to Follow-up|0|||
30640855|NCT00784693|58652790|FG001|Overall Study|Lost to Follow-up|1|||
30640856|NCT00784693|58652789|FG000|Overall Study|Lack of Efficacy|1|||
30640857|NCT00784693|58652790|FG001|Overall Study|Lack of Efficacy|1|||
30640858|NCT00784693|58652789|FG000|Overall Study|Withdrawal by Subject|0|||
30640859|NCT00784693|58652790|FG001|Overall Study|Withdrawal by Subject|4|||
30640860|NCT00784693|58652789|FG000|Overall Study|Randomized but not Treated|1|||
30640861|NCT00784693|58652790|FG001|Overall Study|Randomized but not Treated|0|||
30640862|NCT00784693|58652789|FG000|Overall Study|Other|1|||
30640863|NCT00784693|58652790|FG001|Overall Study|Other|0|||
30640864|NCT00893763|58652798|FG000|Overall Study|extubated|110|||
30640865|NCT00893763|58652799|FG001|Overall Study|extubated|110|||
30640866|NCT00892047|58652809|FG000|Overall Study|Adverse Event|2|||
30640867|NCT00892047|58652810|FG001|Overall Study|Adverse Event|2|||
30640868|NCT00892047|58652809|FG000|Overall Study|subject burden|2|||
30640869|NCT00892047|58652810|FG001|Overall Study|subject burden|3|||
30640870|NCT00892047|58652809|FG000|Overall Study|Lack of Efficacy|0|||
30640871|NCT00892047|58652810|FG001|Overall Study|Lack of Efficacy|2|||
30640872|NCT00787267|58652818|FG000|Overall Study|Screen failure/Ineligible|10|||
30640873|NCT00787267|58652818|FG000|Overall Study|No Reason Provided|1|||
30640874|NCT00787267|58652818|FG000|Overall Study|Withdrawal by Subject|1|||
30640875|NCT00928434|58652825|FG000|Overall Study|Adverse Event|14|||
30640876|NCT00928434|58652826|FG001|Overall Study|Adverse Event|5|||
30640877|NCT00928434|58652827|FG002|Overall Study|Adverse Event|18|||
30640878|NCT00928434|58652825|FG000|Overall Study|Protocol Violation|5|||
30640879|NCT00928434|58652826|FG001|Overall Study|Protocol Violation|0|||
30640880|NCT00928434|58652827|FG002|Overall Study|Protocol Violation|8|||
30640881|NCT00928434|58652825|FG000|Overall Study|Physician Decision|2|||
30640882|NCT00928434|58652826|FG001|Overall Study|Physician Decision|0|||
30640883|NCT00928434|58652827|FG002|Overall Study|Physician Decision|3|||
30640884|NCT00928434|58652825|FG000|Overall Study|Lost to Follow-up|1|||
30640885|NCT00928434|58652826|FG001|Overall Study|Lost to Follow-up|0|||
30640886|NCT00928434|58652827|FG002|Overall Study|Lost to Follow-up|3|||
30765617|NCT00317369|58774318|FG000|Overall Study|Withdrawal by Subject|0|||
30765618|NCT00317369|58774319|FG001|Overall Study|Withdrawal by Subject|0|||
30765619|NCT00317369|58774320|FG002|Overall Study|Withdrawal by Subject|1|||
30765620|NCT03325894|58774330|FG000|Overall Study|Adverse Event|2|||
30765621|NCT03325894|58774331|FG001|Overall Study|Adverse Event|3|||
30765622|NCT03325894|58774330|FG000|Overall Study|Protocol Violation|1|||
30765623|NCT03325894|58774331|FG001|Overall Study|Protocol Violation|2|||
30765624|NCT03325894|58774330|FG000|Overall Study|Withdrawal by Subject|10|||
30765625|NCT03325894|58774331|FG001|Overall Study|Withdrawal by Subject|6|||
30765626|NCT03325894|58774330|FG000|Overall Study|Lost to Follow-up|4|||
30765627|NCT03325894|58774331|FG001|Overall Study|Lost to Follow-up|9|||
30765628|NCT03325894|58774330|FG000|Overall Study|Lack of Efficacy|8|||
30765629|NCT03325894|58774331|FG001|Overall Study|Lack of Efficacy|14|||
30765630|NCT03325894|58774330|FG000|Overall Study|Study Terminated by Sponsor|38|||
30765631|NCT03325894|58774331|FG001|Overall Study|Study Terminated by Sponsor|43|||
30640887|NCT00928434|58652825|FG000|Overall Study|Withdrawal by Subject|5|||
30640888|NCT00928434|58652826|FG001|Overall Study|Withdrawal by Subject|3|||
30640889|NCT00928434|58652827|FG002|Overall Study|Withdrawal by Subject|2|||
30765632|NCT03325894|58774330|FG000|Overall Study|Other (Not received Treatment)|1|||
30765633|NCT03325894|58774331|FG001|Overall Study|Other (Not received Treatment)|0|||
30765634|NCT01239368|58774350|FG000|Overall Study|Principal investigator discretion|1|||
30848526|NCT02851511|58874629|FG000|Phase II|Physician Decision|18|||
30951613|NCT00016354|58998882|FG004|Overall Study|Lack of Efficacy|0|||
30951614|NCT00016354|58998883|FG005|Overall Study|Lack of Efficacy|0|||
30640890|NCT00928434|58652825|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
30640891|NCT00928434|58652826|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
30640892|NCT00928434|58652827|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
30640893|NCT00928434|58652825|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
30640894|NCT00928434|58652826|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
30640895|NCT00928434|58652827|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
30640896|NCT00928434|58652825|FG000|Overall Study|Other (not meeting above criteria)|5|||
30640897|NCT00928434|58652826|FG001|Overall Study|Other (not meeting above criteria)|1|||
30640898|NCT00928434|58652827|FG002|Overall Study|Other (not meeting above criteria)|2|||
30640899|NCT00787189|58652845|FG000|Overall Study|Lost to Follow-up|2|||
30640900|NCT00787189|58652846|FG001|Overall Study|Lost to Follow-up|2|||
30640901|NCT00784459|58652854|FG000|Overall Study|Adverse Event|0|||
30640902|NCT00784459|58652855|FG001|Overall Study|Adverse Event|2|||
30640903|NCT00786799|58652863|FG000|Overall Study|Lost to Follow-up|1|||
30640904|NCT00786799|58652864|FG001|Overall Study|Lost to Follow-up|1|||
30640905|NCT00786565|58652875|FG000|Enrollment Prior to Surgery|Site Closed|3|||
30640906|NCT00786565|58652875|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
30640907|NCT00786565|58652875|FG000|Post Surgery|Abnormal macular pucker|1|||
30640908|NCT00786565|58652875|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
30640909|NCT00784147|58652883|FG000|Overall Study|Lost to Follow-up|2|||
30640910|NCT00784147|58652884|FG001|Overall Study|Lost to Follow-up|4|||
30640911|NCT00784147|58652883|FG000|Overall Study|Withdrawal by Subject|1|||
30640912|NCT00784147|58652884|FG001|Overall Study|Withdrawal by Subject|3|||
30640913|NCT00784147|58652883|FG000|Overall Study|Physician Decision|2|||
30640914|NCT00784147|58652884|FG001|Overall Study|Physician Decision|1|||
30640915|NCT00784147|58652883|FG000|Overall Study|Protocol Violation|1|||
30640916|NCT00784147|58652884|FG001|Overall Study|Protocol Violation|1|||
30640917|NCT00784147|58652883|FG000|Overall Study|Death|2|||
30640918|NCT00784147|58652884|FG001|Overall Study|Death|0|||
30640919|NCT00891813|58652890|FG000|Overall Study|Adverse Event|3|||
30640920|NCT00891813|58652890|FG000|Overall Study|Withdrawal by Subject|1|||
30640921|NCT00891813|58652890|FG000|Overall Study|Patient Noncompliance|6|||
30640922|NCT00891813|58652890|FG000|Overall Study|Protocol Violation|2|||
30640923|NCT00783835|58652907|FG000|Overall Study|Adverse Event|3|||
30640924|NCT00783835|58652907|FG000|Overall Study|Medical Criteria|1|||
30640925|NCT00783835|58652907|FG000|Overall Study|Withdrawal by Subject|2|||
30640926|NCT00783835|58652907|FG000|Overall Study|Lost to Follow-up|1|||
30640927|NCT00783835|58652907|FG000|Overall Study|Participant not Adherent|3|||
30640928|NCT00783289|58652915|FG000|Overall Study|Protocol Violation|0|||
30640929|NCT00783289|58652916|FG001|Overall Study|Protocol Violation|1|||
30640930|NCT00783289|58652917|FG002|Overall Study|Protocol Violation|0|||
30640931|NCT00783289|58652918|FG003|Overall Study|Protocol Violation|0|||
30640932|NCT00847912|58652933|FG000|Overall Study|Protocol Violation|6|||
30640933|NCT00847912|58652934|FG001|Overall Study|Protocol Violation|7|||
30640934|NCT00847912|58652933|FG000|Overall Study|Withdrawal by Subject|3|||
30640935|NCT00847912|58652934|FG001|Overall Study|Withdrawal by Subject|6|||
30640936|NCT00850564|58652941|FG000|Overall Study|Withdrawal by Subject|2|||
30640937|NCT00837148|58652945|FG000|Overall Study|Adverse Event|1|||
30640938|NCT00837148|58652945|FG000|Overall Study|Death|1|||
30640939|NCT00849940|58652949|FG000|Overall Study|Physician Decision|4|||
30640940|NCT00849472|58652953|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
30640941|NCT00849472|58652953|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
30765635|NCT01239368|58774351|FG001|Overall Study|Principal investigator discretion|0|||
30951615|NCT00016354|58998884|FG006|Overall Study|Lack of Efficacy|0|||
30640942|NCT00849472|58652953|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
30640943|NCT00849472|58652953|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
30640944|NCT00849472|58652953|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
30640945|NCT00849472|58652953|FG000|Weekly Paclitaxel|Disease Progression|1|||
30640946|NCT00849472|58652953|FG000|Weekly Paclitaxel|Adverse Event|11|||
30640947|NCT00849472|58652953|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
30640948|NCT00849472|58652953|FG000|Weekly Paclitaxel|Physician Decision|3|||
30640949|NCT00849472|58652953|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
30640950|NCT00849472|58652953|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
30640951|NCT00849472|58652953|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
30640952|NCT00849472|58652953|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
30640953|NCT00849472|58652953|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
30640954|NCT00849472|58652953|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
30640955|NCT00849472|58652953|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
30640956|NCT00849472|58652953|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
30640957|NCT00782509|58652961|FG000|Overall Study|Adverse Event|20|||
30640958|NCT00782509|58652962|FG001|Overall Study|Adverse Event|10|||
30640959|NCT00782509|58652963|FG002|Overall Study|Adverse Event|20|||
30640960|NCT00782509|58652961|FG000|Overall Study|Lost to Follow-up|1|||
30640961|NCT00782509|58652962|FG001|Overall Study|Lost to Follow-up|2|||
30640962|NCT00782509|58652963|FG002|Overall Study|Lost to Follow-up|3|||
30640963|NCT00782509|58652961|FG000|Overall Study|Withdrawal by Subject|3|||
30640964|NCT00782509|58652962|FG001|Overall Study|Withdrawal by Subject|5|||
30640965|NCT00782509|58652963|FG002|Overall Study|Withdrawal by Subject|8|||
30640966|NCT00782509|58652961|FG000|Overall Study|Non compliance with protocol|2|||
30640967|NCT00782509|58652962|FG001|Overall Study|Non compliance with protocol|0|||
30640968|NCT00782509|58652963|FG002|Overall Study|Non compliance with protocol|0|||
30640969|NCT00782509|58652961|FG000|Overall Study|Other reasons not stated above|5|||
30640970|NCT00782509|58652962|FG001|Overall Study|Other reasons not stated above|2|||
30640971|NCT00782509|58652963|FG002|Overall Study|Other reasons not stated above|3|||
30640972|NCT00782509|58652961|FG000|Overall Study|Lack of Efficacy|10|||
30640973|NCT00782509|58652962|FG001|Overall Study|Lack of Efficacy|5|||
30640974|NCT00782509|58652963|FG002|Overall Study|Lack of Efficacy|2|||
30640975|NCT00927810|58652982|FG000|Overall Study|Withdrawal by Subject|0|||
30640976|NCT00927810|58652983|FG001|Overall Study|Withdrawal by Subject|3|||
30640977|NCT00927810|58652984|FG002|Overall Study|Withdrawal by Subject|0|||
30640978|NCT00927810|58652985|FG003|Overall Study|Withdrawal by Subject|1|||
30640979|NCT00927810|58652982|FG000|Overall Study|Lost to Follow-up|0|||
30640980|NCT00927810|58652983|FG001|Overall Study|Lost to Follow-up|2|||
30640981|NCT00927810|58652984|FG002|Overall Study|Lost to Follow-up|1|||
30640982|NCT00927810|58652985|FG003|Overall Study|Lost to Follow-up|1|||
30640983|NCT00927810|58652982|FG000|Overall Study|Death|0|||
30640984|NCT00927810|58652983|FG001|Overall Study|Death|2|||
30640985|NCT00927810|58652984|FG002|Overall Study|Death|0|||
30640986|NCT00927810|58652985|FG003|Overall Study|Death|0|||
30640987|NCT00927810|58652982|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30640988|NCT00927810|58652983|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30640989|NCT00927810|58652984|FG002|Overall Study|Abnormal laboratory value(s)|0|||
30640990|NCT00927810|58652985|FG003|Overall Study|Abnormal laboratory value(s)|0|||
30640991|NCT00848926|58653003|FG000|Treatment Period|Progressive disease|45|||
30640992|NCT00848926|58653003|FG000|Treatment Period|Adverse Event|20|||
30640993|NCT00848926|58653003|FG000|Treatment Period|Physician Decision|12|||
30640994|NCT00848926|58653003|FG000|Treatment Period|Withdrawal by Subject|7|||
30640995|NCT00848926|58653003|FG000|Follow-up Period|Lost to Follow-up|7|||
30640996|NCT00848926|58653003|FG000|Follow-up Period|Withdrawal by Subject|3|||
30640997|NCT00848926|58653003|FG000|Follow-up Period|Other|2|||
30640998|NCT00847132|58653009|FG000|Overall Study|Death|1|||
30640999|NCT00847132|58653010|FG001|Overall Study|Death|1|||
30641000|NCT00918138|58653018|FG000|Overall Study|Subject withdrew consent|1|||
30641001|NCT00918138|58653019|FG001|Overall Study|Subject withdrew consent|1|||
30641002|NCT00918138|58653018|FG000|Overall Study|Death|1|||
30641003|NCT00918138|58653019|FG001|Overall Study|Death|0|||
30641004|NCT00782275|58653025|FG000|Overall Study|Adverse Event|11|||
30641005|NCT00782275|58653025|FG000|Overall Study|Withdrawal by Subject|1|||
30641006|NCT00782275|58653025|FG000|Overall Study|Progressive Disease|21|||
30641007|NCT00782275|58653025|FG000|Overall Study|Physician Decision|4|||
30641008|NCT00782275|58653025|FG000|Overall Study|Not started treatment|1|||
30641009|NCT00782275|58653025|FG000|Overall Study|Other|3|||
30641010|NCT00791557|58653029|FG000|Overall Study|Adverse Event|1|||
30641011|NCT00920790|58653033|FG000|Overall Study|aggravation of general condition|14|||
30848527|NCT02851511|58874630|FG001|Phase II|Physician Decision|16|||
30848528|NCT02851511|58874631|FG002|Phase II|Physician Decision|0|||
30641012|NCT00781963|58653039|FG000|Overall Study|Death|3|||
30641013|NCT00781963|58653040|FG001|Overall Study|Death|0|||
30641014|NCT00781963|58653039|FG000|Overall Study|Lost to Follow-up|2|||
30641015|NCT00781963|58653040|FG001|Overall Study|Lost to Follow-up|1|||
30641016|NCT00781963|58653039|FG000|Overall Study|Withdrawal by Subject|3|||
30641017|NCT00781963|58653040|FG001|Overall Study|Withdrawal by Subject|1|||
30641018|NCT00781963|58653039|FG000|Overall Study|Refused follow-up|9|||
30641019|NCT00781963|58653040|FG001|Overall Study|Refused follow-up|0|||
30641020|NCT00920556|58653046|FG000|Overall Study|Adverse Event|16|||
30641021|NCT00920556|58653046|FG000|Overall Study|Physician Decision|7|||
30641022|NCT00920556|58653046|FG000|Overall Study|Withdrawal by Subject|1|||
30641023|NCT00781885|58653054|FG000|Overall Study|Physician Decision|1|||
30641024|NCT00918684|58653058|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
30641025|NCT00918684|58653058|FG000|Treatment Phase|Lack of Efficacy|6|||
30641026|NCT00918684|58653058|FG000|Treatment Phase|Lost to Follow-up|2|||
30641027|NCT00918684|58653058|FG000|Treatment Phase|Physician Decision|8|||
30641028|NCT00918684|58653058|FG000|Treatment Phase|Protocol Violation|1|||
30641029|NCT00918684|58653058|FG000|Treatment Phase|Withdrawal by Subject|8|||
30641030|NCT00786409|58653062|FG000|Overall Study|Withdrawal by Subject|2|||
30641031|NCT00786409|58653062|FG000|Overall Study|Adverse Event|2|||
30641032|NCT00786409|58653062|FG000|Overall Study|Pregnancy|2|||
30641033|NCT00786409|58653062|FG000|Overall Study|Lost to Follow-up|1|||
30641034|NCT00919854|58653066|FG000|Overall Study|Adverse Event|1|||
30641035|NCT00891735|58653074|FG000|Overall Study|Adverse Event|2|||
30641036|NCT00891735|58653075|FG001|Overall Study|Adverse Event|0|||
30641037|NCT00891735|58653076|FG002|Overall Study|Adverse Event|2|||
30641038|NCT00891735|58653077|FG003|Overall Study|Adverse Event|0|||
30641039|NCT00891735|58653074|FG000|Overall Study|Death|8|||
30641040|NCT00891735|58653075|FG001|Overall Study|Death|5|||
30641041|NCT00891735|58653076|FG002|Overall Study|Death|4|||
30641042|NCT00891735|58653077|FG003|Overall Study|Death|5|||
30641043|NCT00891735|58653074|FG000|Overall Study|Lost to Follow-up|2|||
30641044|NCT00891735|58653075|FG001|Overall Study|Lost to Follow-up|2|||
30848529|NCT02851511|58874632|FG003|Phase II|Physician Decision|0|||
30951616|NCT00016354|58998885|FG007|Overall Study|Lack of Efficacy|1|||
30951617|NCT01681472|58998893|FG000|Overall Study|Adverse Event|0|||
30951618|NCT01681472|58998894|FG001|Overall Study|Adverse Event|1|||
30951619|NCT01681472|58998895|FG002|Overall Study|Adverse Event|0|||
30951620|NCT01681472|58998896|FG003|Overall Study|Adverse Event|0|||
30951621|NCT01049308|58998925|FG000|Pill Counts|Withdrawal by Subject|83|||
30951622|NCT01713686|58998932|FG000|Overall Study|Lost to Follow-up|9|||
30951623|NCT01713686|58998932|FG000|Overall Study|Withdrawal by Subject|6|||
30951624|NCT01047436|58998938|FG000|Overall Study|Protocol Violation|1|||
30951625|NCT01047436|58998939|FG001|Overall Study|Protocol Violation|0|||
30951626|NCT01681004|58998947|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
30951627|NCT01681004|58998948|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
30951628|NCT01681004|58998947|FG000|Study Completion|Lost to Follow-up|8|||
30951629|NCT01681004|58998948|FG001|Study Completion|Lost to Follow-up|3|||
30951630|NCT01681004|58998947|FG000|Study Completion|Physician Decision|1|||
30951631|NCT01681004|58998948|FG001|Study Completion|Physician Decision|3|||
30951632|NCT01681004|58998947|FG000|Study Completion|Site Termination|2|||
30951633|NCT01681004|58998948|FG001|Study Completion|Site Termination|1|||
30951634|NCT01681004|58998947|FG000|Study Completion|Death|1|||
30951635|NCT01681004|58998948|FG001|Study Completion|Death|1|||
30951636|NCT01046110|58998960|FG000|Overall Study|Adverse Event|9|||
30951637|NCT01046110|58998961|FG001|Overall Study|Adverse Event|2|||
30951638|NCT01046110|58998960|FG000|Overall Study|Lack of Efficacy|0|||
30951639|NCT01046110|58998961|FG001|Overall Study|Lack of Efficacy|1|||
30951640|NCT01046110|58998960|FG000|Overall Study|Protocol Violation|7|||
30951641|NCT01046110|58998961|FG001|Overall Study|Protocol Violation|12|||
30951642|NCT01046110|58998960|FG000|Overall Study|Withdrawal Criteria|3|||
30951643|NCT01046110|58998961|FG001|Overall Study|Withdrawal Criteria|5|||
30951644|NCT01046110|58998960|FG000|Overall Study|Unclassified|36|||
30951645|NCT01046110|58998961|FG001|Overall Study|Unclassified|35|||
30951646|NCT01713530|58998969|FG000|Overall Study|Adverse Event|0|||
30951647|NCT01713530|58998970|FG001|Overall Study|Adverse Event|5|||
30951648|NCT01713530|58998969|FG000|Overall Study|Withdrawal criteria|21|||
30951649|NCT01713530|58998970|FG001|Overall Study|Withdrawal criteria|12|||
30951650|NCT01713530|58998969|FG000|Overall Study|Unclassified|4|||
30951651|NCT01713530|58998970|FG001|Overall Study|Unclassified|2|||
30951652|NCT01045798|58998978|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
30951653|NCT01045798|58998979|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
30951654|NCT01045798|58998978|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
30848530|NCT02851511|58874629|FG000|Phase II|Withdrawal by Subject|18|||
30848531|NCT02851511|58874630|FG001|Phase II|Withdrawal by Subject|16|||
30848532|NCT02851511|58874631|FG002|Phase II|Withdrawal by Subject|0|||
30951655|NCT01045798|58998979|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
30951656|NCT01045798|58998978|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
30951657|NCT01045798|58998979|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
30951658|NCT01045798|58998978|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
30951659|NCT01045798|58998979|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
30951660|NCT01712984|58998992|FG000|Overall Study|Adverse Event|0|||
30951661|NCT01712984|58998993|FG001|Overall Study|Adverse Event|0|||
30951662|NCT01712984|58998994|FG002|Overall Study|Adverse Event|1|||
30641045|NCT00891735|58653076|FG002|Overall Study|Lost to Follow-up|2|||
30641046|NCT00891735|58653077|FG003|Overall Study|Lost to Follow-up|2|||
30641047|NCT00891735|58653074|FG000|Overall Study|Physician's decision to withdraw patient|1|||
30641048|NCT00891735|58653075|FG001|Overall Study|Physician's decision to withdraw patient|0|||
30641049|NCT00891735|58653076|FG002|Overall Study|Physician's decision to withdraw patient|0|||
30641050|NCT00891735|58653077|FG003|Overall Study|Physician's decision to withdraw patient|0|||
30641051|NCT00891735|58653074|FG000|Overall Study|Patient's decision to withdraw|4|||
30641052|NCT00891735|58653075|FG001|Overall Study|Patient's decision to withdraw|9|||
30641053|NCT00891735|58653076|FG002|Overall Study|Patient's decision to withdraw|4|||
30641054|NCT00891735|58653077|FG003|Overall Study|Patient's decision to withdraw|8|||
30641055|NCT00891657|58653089|FG000|Overall Study|Withdrawal by Subject|1|||
30641056|NCT00891657|58653090|FG001|Overall Study|Withdrawal by Subject|1|||
30641057|NCT00917124|58653098|FG000|Overall Study|Protocol Violation|4|||
30641058|NCT00917124|58653099|FG001|Overall Study|Protocol Violation|6|||
30641059|NCT00889863|58653105|FG000|Part I: Open Label|Death|1|||
30641060|NCT00889863|58653106|FG001|Part I: Open Label|Death|0|||
30641061|NCT00889863|58653105|FG000|Part I: Open Label|Adverse Event|4|||
30641062|NCT00889863|58653106|FG001|Part I: Open Label|Adverse Event|0|||
30641063|NCT00889863|58653105|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
30641064|NCT00889863|58653106|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
30641065|NCT00889863|58653105|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
30641066|NCT00889863|58653106|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
30641067|NCT00889863|58653105|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
30641068|NCT00889863|58653106|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
30641069|NCT00889863|58653105|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
30641070|NCT00889863|58653106|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
30641071|NCT00889863|58653105|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
30641072|NCT00889863|58653106|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
30641073|NCT00915018|58653116|FG000|Overall Study|Death|75|||
30641074|NCT00915018|58653117|FG001|Overall Study|Death|70|||
30765636|NCT01239368|58774352|FG002|Overall Study|Principal investigator discretion|0|||
30765637|NCT01239368|58774353|FG003|Overall Study|Principal investigator discretion|0|||
30765638|NCT01239368|58774354|FG004|Overall Study|Principal investigator discretion|1|||
30765639|NCT01239368|58774355|FG005|Overall Study|Principal investigator discretion|2|||
30765640|NCT01239368|58774356|FG006|Overall Study|Principal investigator discretion|0|||
30765641|NCT01239368|58774357|FG007|Overall Study|Principal investigator discretion|0|||
30765642|NCT01239368|58774358|FG008|Overall Study|Principal investigator discretion|0|||
30765643|NCT01239368|58774359|FG009|Overall Study|Principal investigator discretion|1|||
30765644|NCT01239368|58774350|FG000|Overall Study|Disease progression on study|1|||
30765645|NCT01239368|58774351|FG001|Overall Study|Disease progression on study|1|||
30641075|NCT00915018|58653116|FG000|Overall Study|Lost to Follow-up|10|||
30641076|NCT00915018|58653117|FG001|Overall Study|Lost to Follow-up|5|||
30641077|NCT00915018|58653116|FG000|Overall Study|Withdrawal by Subject|38|||
30641078|NCT00915018|58653117|FG001|Overall Study|Withdrawal by Subject|27|||
30641079|NCT00915018|58653116|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
30641080|NCT00915018|58653117|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
30641081|NCT00916578|58653123|FG000|Overall Study|Physician Decision|2|||
30641082|NCT00916578|58653123|FG000|Overall Study|Withdrawal by Subject|3|||
30641083|NCT00916578|58653123|FG000|Overall Study|Insurance Denial|2|||
30641084|NCT00889707|58653129|FG000|Overall Study|Adverse Event|1|||
30641085|NCT00889707|58653130|FG001|Overall Study|Adverse Event|0|||
30641086|NCT00889707|58653129|FG000|Overall Study|Withdrawal by Subject|4|||
30641087|NCT00889707|58653130|FG001|Overall Study|Withdrawal by Subject|3|||
30641088|NCT00889707|58653129|FG000|Overall Study|Lost to Follow-up|0|||
30641089|NCT00889707|58653130|FG001|Overall Study|Lost to Follow-up|2|||
30641090|NCT00889707|58653129|FG000|Overall Study|Lack of Efficacy|2|||
30641091|NCT00889707|58653130|FG001|Overall Study|Lack of Efficacy|5|||
30641092|NCT00914940|58653136|FG000|D0 to D100 Post-transplant|Death|2|||
30641093|NCT00914940|58653136|FG000|D101 to 2 Years Post-transplant|Death|8|||
30641094|NCT00914940|58653136|FG000|2 Years to 5 Years Post-transplant|Death|3|||
30641095|NCT00835978|58653144|FG000|Overall Study|Death|33|||
30641096|NCT00835978|58653145|FG001|Overall Study|Death|40|||
30641097|NCT00835978|58653146|FG002|Overall Study|Death|49|||
30641098|NCT00835978|58653147|FG003|Overall Study|Death|4|||
30641099|NCT00835978|58653144|FG000|Overall Study|Lost to Follow-up|3|||
30641100|NCT00835978|58653145|FG001|Overall Study|Lost to Follow-up|4|||
30641101|NCT00835978|58653146|FG002|Overall Study|Lost to Follow-up|2|||
30641102|NCT00835978|58653147|FG003|Overall Study|Lost to Follow-up|1|||
30951663|NCT01712984|58998992|FG000|Overall Study|Protocol Violation|2|||
30951664|NCT01712984|58998993|FG001|Overall Study|Protocol Violation|0|||
30951665|NCT01712984|58998994|FG002|Overall Study|Protocol Violation|1|||
30641103|NCT00835978|58653144|FG000|Overall Study|Other|5|||
30641104|NCT00835978|58653145|FG001|Overall Study|Other|1|||
30641105|NCT00835978|58653146|FG002|Overall Study|Other|8|||
30641106|NCT00835978|58653147|FG003|Overall Study|Other|0|||
30641107|NCT00835978|58653144|FG000|Overall Study|Objective progression or relapse|2|||
30641108|NCT00835978|58653145|FG001|Overall Study|Objective progression or relapse|0|||
30641109|NCT00835978|58653146|FG002|Overall Study|Objective progression or relapse|1|||
30641110|NCT00835978|58653147|FG003|Overall Study|Objective progression or relapse|0|||
30641111|NCT00835978|58653144|FG000|Overall Study|Adverse Event|1|||
30641112|NCT00835978|58653145|FG001|Overall Study|Adverse Event|0|||
30641113|NCT00835978|58653146|FG002|Overall Study|Adverse Event|1|||
30641114|NCT00835978|58653147|FG003|Overall Study|Adverse Event|0|||
30641115|NCT00835978|58653144|FG000|Overall Study|Withdrawal by Subject|0|||
30641116|NCT00835978|58653145|FG001|Overall Study|Withdrawal by Subject|3|||
30641117|NCT00835978|58653146|FG002|Overall Study|Withdrawal by Subject|0|||
30641118|NCT00835978|58653147|FG003|Overall Study|Withdrawal by Subject|5|||
30641119|NCT00835978|58653144|FG000|Overall Study|Study terminated by sponsor|12|||
30641120|NCT00835978|58653145|FG001|Overall Study|Study terminated by sponsor|8|||
30641121|NCT00835978|58653146|FG002|Overall Study|Study terminated by sponsor|30|||
30641122|NCT00835978|58653147|FG003|Overall Study|Study terminated by sponsor|0|||
30641123|NCT00914628|58653164|FG000|Overall Study|Death|35|||
30641124|NCT00914628|58653165|FG001|Overall Study|Death|17|||
30641125|NCT00914628|58653164|FG000|Overall Study|Medical decision|4|||
30641126|NCT00914628|58653165|FG001|Overall Study|Medical decision|0|||
30641127|NCT00914628|58653164|FG000|Overall Study|Protocol Violation|1|||
30641128|NCT00914628|58653165|FG001|Overall Study|Protocol Violation|0|||
30641129|NCT00914628|58653164|FG000|Overall Study|Lack of Efficacy|1|||
30641130|NCT00914628|58653165|FG001|Overall Study|Lack of Efficacy|0|||
30641131|NCT00914628|58653164|FG000|Overall Study|non-randomized|1|||
30641132|NCT00914628|58653165|FG001|Overall Study|non-randomized|0|||
30641133|NCT00914628|58653164|FG000|Overall Study|Relapse|1|||
30641134|NCT00914628|58653165|FG001|Overall Study|Relapse|2|||
30641135|NCT00914628|58653164|FG000|Overall Study|Study terminated by Sponsor|14|||
30641136|NCT00914628|58653165|FG001|Overall Study|Study terminated by Sponsor|8|||
30641137|NCT00914628|58653164|FG000|Overall Study|Patients who did not receive a single dose|7|||
30641138|NCT00914628|58653165|FG001|Overall Study|Patients who did not receive a single dose|1|||
30641139|NCT01077518|58653177|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
30641140|NCT01077518|58653178|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
30641141|NCT01077518|58653179|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
30641142|NCT01077518|58653177|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
30641143|NCT01077518|58653178|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
30641144|NCT01077518|58653179|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
30641145|NCT01077518|58653177|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
30641146|NCT01077518|58653178|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
30641147|NCT01077518|58653179|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
30641148|NCT01077518|58653177|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
30641149|NCT01077518|58653178|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
30641150|NCT01077518|58653179|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
30641151|NCT01077518|58653177|FG000|Optional Ofa Phase|Physician Decision|0|||
30641152|NCT01077518|58653178|FG001|Optional Ofa Phase|Physician Decision|0|||
30641153|NCT01077518|58653179|FG002|Optional Ofa Phase|Physician Decision|1|||
30641154|NCT01077518|58653177|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
30641155|NCT01077518|58653178|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
30641156|NCT01077518|58653179|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
30641157|NCT01077518|58653177|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
30641158|NCT01077518|58653178|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
30641159|NCT01077518|58653179|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
30641160|NCT00835120|58653188|FG000|Overall Study|Lack of Efficacy|1|||
30641161|NCT00835120|58653188|FG000|Overall Study|Lost to Follow-up|3|||
30641162|NCT00835120|58653188|FG000|Overall Study|Adverse Event|2|||
30641163|NCT00835120|58653188|FG000|Overall Study|Withdrawal by Subject|2|||
30641164|NCT00914316|58653196|FG000|Phase 1|Physician Decision|4|||
30641165|NCT00914316|58653197|FG001|Phase 1|Physician Decision|0|||
30641166|NCT00914316|58653198|FG002|Phase 1|Physician Decision|1|||
30641167|NCT00914316|58653199|FG003|Phase 1|Physician Decision|2|||
30641168|NCT00914316|58653196|FG000|Phase 1|Withdrawal by Subject|0|||
30641169|NCT00914316|58653197|FG001|Phase 1|Withdrawal by Subject|2|||
30641170|NCT00914316|58653198|FG002|Phase 1|Withdrawal by Subject|4|||
30641171|NCT00914316|58653199|FG003|Phase 1|Withdrawal by Subject|0|||
30641172|NCT00914316|58653196|FG000|Phase 1|Adverse Event|1|||
30848533|NCT02851511|58874632|FG003|Phase II|Withdrawal by Subject|0|||
30951666|NCT01712984|58998992|FG000|Overall Study|Lost to Follow-up|8|||
30641173|NCT00914316|58653197|FG001|Phase 1|Adverse Event|0|||
30641174|NCT00914316|58653198|FG002|Phase 1|Adverse Event|0|||
30641175|NCT00914316|58653199|FG003|Phase 1|Adverse Event|0|||
30641176|NCT00914316|58653196|FG000|Phase 2|Withdrawal by Subject|1|||
30641177|NCT00914316|58653197|FG001|Phase 2|Withdrawal by Subject|0|||
30641178|NCT00914316|58653198|FG002|Phase 2|Withdrawal by Subject|1|||
30641179|NCT00914316|58653199|FG003|Phase 2|Withdrawal by Subject|0|||
30641180|NCT00827632|58653211|FG000|Overall Study|Lost to Follow-up|8|||
30641181|NCT00827632|58653212|FG001|Overall Study|Lost to Follow-up|12|||
30641182|NCT00827632|58653211|FG000|Overall Study|Early withdrawal|14|||
30641183|NCT00827632|58653212|FG001|Overall Study|Early withdrawal|11|||
30641184|NCT00827242|58653220|FG000|Overall Study|Withdrawal by Subject|2|||
30641185|NCT00827242|58653221|FG001|Overall Study|Withdrawal by Subject|4|||
30641186|NCT00827242|58653220|FG000|Overall Study|Protocol Violation|1|||
30641187|NCT00827242|58653221|FG001|Overall Study|Protocol Violation|3|||
30641188|NCT00827242|58653220|FG000|Overall Study|Lost to Follow-up|0|||
30641189|NCT00827242|58653221|FG001|Overall Study|Lost to Follow-up|3|||
30641190|NCT00827242|58653220|FG000|Overall Study|Adverse Event Excluding Death|2|||
30641191|NCT00827242|58653221|FG001|Overall Study|Adverse Event Excluding Death|1|||
30641192|NCT00827242|58653220|FG000|Overall Study|Entry Criteria Not Met|4|||
30641193|NCT00827242|58653221|FG001|Overall Study|Entry Criteria Not Met|1|||
30641194|NCT00827242|58653220|FG000|Overall Study|Physician Decision|2|||
30641195|NCT00827242|58653221|FG001|Overall Study|Physician Decision|0|||
30641196|NCT00827242|58653220|FG000|Overall Study|Death|1|||
30641197|NCT00827242|58653221|FG001|Overall Study|Death|0|||
30641198|NCT00827242|58653220|FG000|Overall Study|Lack of Efficacy|1|||
30641199|NCT00827242|58653221|FG001|Overall Study|Lack of Efficacy|0|||
30641200|NCT01077362|58653230|FG000|Overall Study|Lack of Efficacy|13|||
30641201|NCT01077362|58653231|FG001|Overall Study|Lack of Efficacy|8|||
30641202|NCT01077362|58653232|FG002|Overall Study|Lack of Efficacy|10|||
30641203|NCT01077362|58653230|FG000|Overall Study|Lost to Follow-up|1|||
30641204|NCT01077362|58653231|FG001|Overall Study|Lost to Follow-up|0|||
30641205|NCT01077362|58653232|FG002|Overall Study|Lost to Follow-up|3|||
30641206|NCT01077362|58653230|FG000|Overall Study|Adverse Event|12|||
30641207|NCT01077362|58653231|FG001|Overall Study|Adverse Event|7|||
30641208|NCT01077362|58653232|FG002|Overall Study|Adverse Event|4|||
30641209|NCT01077362|58653230|FG000|Overall Study|Withdrawal by Subject|5|||
30641210|NCT01077362|58653231|FG001|Overall Study|Withdrawal by Subject|3|||
30641211|NCT01077362|58653232|FG002|Overall Study|Withdrawal by Subject|5|||
30641212|NCT01077362|58653230|FG000|Overall Study|Other|0|||
30641213|NCT01077362|58653231|FG001|Overall Study|Other|1|||
30641214|NCT01077362|58653232|FG002|Overall Study|Other|2|||
30641215|NCT00846586|58653247|FG000|Overall Study|Adverse Event|20|||
30641216|NCT00846586|58653248|FG001|Overall Study|Adverse Event|10|||
30641217|NCT00846586|58653247|FG000|Overall Study|Subject withdrew consent|8|||
30641218|NCT00846586|58653248|FG001|Overall Study|Subject withdrew consent|10|||
30641219|NCT00846586|58653247|FG000|Overall Study|Administrative problems|5|||
30641220|NCT00846586|58653248|FG001|Overall Study|Administrative problems|4|||
30641221|NCT00846586|58653247|FG000|Overall Study|Death|2|||
30641222|NCT00846586|58653248|FG001|Overall Study|Death|0|||
30641223|NCT00846586|58653247|FG000|Overall Study|Protocol deviation|2|||
30641224|NCT00846586|58653248|FG001|Overall Study|Protocol deviation|6|||
30641225|NCT00846586|58653247|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30641226|NCT00846586|58653248|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30641227|NCT00846586|58653247|FG000|Overall Study|Lost to Follow-up|1|||
30641228|NCT00846586|58653248|FG001|Overall Study|Lost to Follow-up|4|||
30641229|NCT00846586|58653247|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30641230|NCT00846586|58653248|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30641231|NCT00785785|58653256|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
30641232|NCT00785785|58653257|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
30641233|NCT00785785|58653256|FG000|Core Phase up to 36 Months|Adverse Event|31|||
30641234|NCT00785785|58653257|FG001|Core Phase up to 36 Months|Adverse Event|21|||
30641235|NCT00785785|58653256|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
30641236|NCT00785785|58653257|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
30641237|NCT00785785|58653256|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
30641238|NCT00785785|58653257|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
30641239|NCT00785785|58653256|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
30641240|NCT00785785|58653257|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
30641241|NCT00785785|58653256|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
30641242|NCT00785785|58653257|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
30641243|NCT00785785|58653256|FG000|Core Phase up to 36 Months|Administrative problems|3|||
30641244|NCT00785785|58653257|FG001|Core Phase up to 36 Months|Administrative problems|3|||
30641245|NCT00785785|58653256|FG000|Core Phase up to 36 Months|Death|5|||
30641246|NCT00785785|58653257|FG001|Core Phase up to 36 Months|Death|8|||
30641247|NCT00785785|58653256|FG000|Core Phase up to 36 Months|Disease progression|139|||
30641248|NCT00785785|58653257|FG001|Core Phase up to 36 Months|Disease progression|119|||
30641249|NCT00785785|58653256|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
30641250|NCT00785785|58653257|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
30641251|NCT00785785|58653256|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
30641252|NCT00785785|58653257|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
30641253|NCT00785785|58653256|FG000|Optional Extension Phase|Adverse Event|4|||
30641254|NCT00785785|58653257|FG001|Optional Extension Phase|Adverse Event|5|||
30641255|NCT00785785|58653256|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
30641256|NCT00785785|58653257|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
30641257|NCT00785785|58653256|FG000|Optional Extension Phase|Lost to Follow-up|1|||
30641258|NCT00785785|58653257|FG001|Optional Extension Phase|Lost to Follow-up|0|||
30641259|NCT00785785|58653256|FG000|Optional Extension Phase|Administrative problems|2|||
30641260|NCT00785785|58653257|FG001|Optional Extension Phase|Administrative problems|0|||
30641261|NCT00785785|58653256|FG000|Optional Extension Phase|Death|1|||
30641262|NCT00785785|58653257|FG001|Optional Extension Phase|Death|5|||
30641263|NCT00785785|58653256|FG000|Optional Extension Phase|Disease progression|22|||
30641264|NCT00785785|58653257|FG001|Optional Extension Phase|Disease progression|70|||
30641265|NCT00785785|58653256|FG000|Optional Extension Phase|Protocol deviation|0|||
30641266|NCT00785785|58653257|FG001|Optional Extension Phase|Protocol deviation|2|||
30641267|NCT00785785|58653256|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
30641268|NCT00785785|58653257|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
30641269|NCT01077284|58653268|FG000|Overall Study|Adverse Event|2|||
30641270|NCT01077284|58653269|FG001|Overall Study|Adverse Event|0|||
30641271|NCT01077284|58653270|FG002|Overall Study|Adverse Event|1|||
30641272|NCT01077284|58653268|FG000|Overall Study|Lost to Follow-up|1|||
30641273|NCT01077284|58653269|FG001|Overall Study|Lost to Follow-up|2|||
30641274|NCT01077284|58653270|FG002|Overall Study|Lost to Follow-up|0|||
30641275|NCT01077284|58653268|FG000|Overall Study|Withdrawal by Subject|2|||
30641276|NCT01077284|58653269|FG001|Overall Study|Withdrawal by Subject|3|||
30641277|NCT01077284|58653270|FG002|Overall Study|Withdrawal by Subject|1|||
30641278|NCT01077284|58653268|FG000|Overall Study|Other|0|||
30641279|NCT01077284|58653269|FG001|Overall Study|Other|0|||
30641280|NCT01077284|58653270|FG002|Overall Study|Other|1|||
30641281|NCT00826618|58653278|FG000|Overall Study|Withdrawal by Subject|1|||
30641282|NCT01077128|58653282|FG000|Overall Study|Adverse Event|8|||
30641283|NCT01077128|58653282|FG000|Overall Study|Lack of Efficacy|1|||
30641284|NCT01077128|58653282|FG000|Overall Study|Disease exacerbation|1|||
30641285|NCT01077128|58653282|FG000|Overall Study|Adverse event and consent withdrawal|1|||
30641286|NCT01077128|58653282|FG000|Overall Study|Adverse event and disease exacerbation|1|||
30951667|NCT01712984|58998993|FG001|Overall Study|Lost to Follow-up|10|||
30951668|NCT01712984|58998994|FG002|Overall Study|Lost to Follow-up|1|||
30641287|NCT01077128|58653282|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
30641288|NCT01077128|58653282|FG000|Overall Study|Other|54|||
30641289|NCT00826540|58653336|FG000|Overall Study|ineligible|3|||
30641290|NCT00826540|58653336|FG000|Overall Study|Withdrawal by Subject|1|||
30641291|NCT01077050|58653340|FG000|Overall Study|Subjects signed ICF could not be located|1|||
30641292|NCT01077050|58653340|FG000|Overall Study|Screen failure|8|||
30641293|NCT00592384|58653346|FG000|Overall Study|Withdrawal by Subject|5|||
30641294|NCT00592384|58653347|FG001|Overall Study|Withdrawal by Subject|6|||
30641295|NCT00846040|58653356|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
30641296|NCT00846040|58653357|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
30641297|NCT00846040|58653358|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
30641298|NCT00846040|58653356|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
30641299|NCT00846040|58653357|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
30641300|NCT00846040|58653358|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
30641301|NCT00826228|58653367|FG000|Overall Study|Withdrawal by Subject|1|||
30641302|NCT00825994|58653372|FG000|Overall Study|Withdrawal by Subject|2|||
30641303|NCT00825994|58653372|FG000|Overall Study|Lost to Follow-up|1|||
30641304|NCT00825994|58653372|FG000|Overall Study|Protocol Violation|1|||
30641305|NCT00825994|58653372|FG000|Overall Study|Placebo Responder at V2|1|||
30641306|NCT00825916|58653379|FG000|Overall Study|Lost to Follow-up|4|||
30641307|NCT00825916|58653380|FG001|Overall Study|Lost to Follow-up|2|||
30641308|NCT00825916|58653381|FG002|Overall Study|Lost to Follow-up|1|||
30641309|NCT00791479|58653428|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
30641310|NCT00791479|58653429|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
30641311|NCT00791479|58653430|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
30641312|NCT00791479|58653431|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
30641313|NCT00791479|58653432|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
30641314|NCT00791479|58653433|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
30641315|NCT00791479|58653428|FG000|Overall Study|Adverse Event|0|||
30641316|NCT00791479|58653429|FG001|Overall Study|Adverse Event|1|||
30641317|NCT00791479|58653430|FG002|Overall Study|Adverse Event|0|||
30951669|NCT01712984|58998992|FG000|Overall Study|Withdrawal by Subject|6|||
30641318|NCT00791479|58653431|FG003|Overall Study|Adverse Event|2|||
30641319|NCT00791479|58653432|FG004|Overall Study|Adverse Event|0|||
30641320|NCT00791479|58653433|FG005|Overall Study|Adverse Event|1|||
30951670|NCT01712984|58998993|FG001|Overall Study|Withdrawal by Subject|6|||
30641321|NCT00791479|58653428|FG000|Overall Study|Lost to Follow-up|0|||
30951671|NCT01712984|58998994|FG002|Overall Study|Withdrawal by Subject|7|||
30951672|NCT01042678|58999005|FG000|Overall Study|Physician Decision|1|||
30951673|NCT01042678|58999006|FG001|Overall Study|Physician Decision|0|||
30641322|NCT00791479|58653429|FG001|Overall Study|Lost to Follow-up|1|||
30951674|NCT01042678|58999007|FG002|Overall Study|Physician Decision|0|||
30641323|NCT00791479|58653430|FG002|Overall Study|Lost to Follow-up|0|||
30641324|NCT00791479|58653431|FG003|Overall Study|Lost to Follow-up|0|||
30641325|NCT00791479|58653432|FG004|Overall Study|Lost to Follow-up|0|||
30641326|NCT00791479|58653433|FG005|Overall Study|Lost to Follow-up|1|||
30641327|NCT00791479|58653428|FG000|Overall Study|Protocol Violation|2|||
30641328|NCT00791479|58653429|FG001|Overall Study|Protocol Violation|1|||
30641329|NCT00791479|58653430|FG002|Overall Study|Protocol Violation|0|||
30641330|NCT00791479|58653431|FG003|Overall Study|Protocol Violation|1|||
30641331|NCT00791479|58653432|FG004|Overall Study|Protocol Violation|0|||
30641332|NCT00791479|58653433|FG005|Overall Study|Protocol Violation|0|||
30641333|NCT00791479|58653428|FG000|Overall Study|Withdrawal by Subject|0|||
30641334|NCT00791479|58653429|FG001|Overall Study|Withdrawal by Subject|0|||
30641335|NCT00791479|58653430|FG002|Overall Study|Withdrawal by Subject|0|||
30641336|NCT00791479|58653431|FG003|Overall Study|Withdrawal by Subject|1|||
30641337|NCT00791479|58653432|FG004|Overall Study|Withdrawal by Subject|0|||
30641338|NCT00791479|58653433|FG005|Overall Study|Withdrawal by Subject|1|||
30641339|NCT00890097|58653457|FG000|Overall Study|Adverse Event|21|||
30641340|NCT00890097|58653458|FG001|Overall Study|Adverse Event|32|||
30641341|NCT00890097|58653459|FG002|Overall Study|Adverse Event|28|||
30641342|NCT00890097|58653457|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
30641343|NCT00890097|58653458|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
30641344|NCT00890097|58653459|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
30641345|NCT00890097|58653457|FG000|Overall Study|Withdrew Consent|9|||
30641346|NCT00890097|58653458|FG001|Overall Study|Withdrew Consent|6|||
30641347|NCT00890097|58653459|FG002|Overall Study|Withdrew Consent|9|||
30641348|NCT00890097|58653457|FG000|Overall Study|Lost to Follow-up|5|||
30641349|NCT00890097|58653458|FG001|Overall Study|Lost to Follow-up|5|||
30641350|NCT00890097|58653459|FG002|Overall Study|Lost to Follow-up|5|||
30641351|NCT00890097|58653457|FG000|Overall Study|Noncompliance|0|||
30641352|NCT00890097|58653458|FG001|Overall Study|Noncompliance|4|||
30641353|NCT00890097|58653459|FG002|Overall Study|Noncompliance|4|||
30641354|NCT00890097|58653457|FG000|Overall Study|Sponsor Decision|7|||
30641355|NCT00890097|58653458|FG001|Overall Study|Sponsor Decision|11|||
30641356|NCT00890097|58653459|FG002|Overall Study|Sponsor Decision|7|||
30641357|NCT00890097|58653457|FG000|Overall Study|Did not attend final visit|2|||
30641358|NCT00890097|58653458|FG001|Overall Study|Did not attend final visit|3|||
30641359|NCT00890097|58653459|FG002|Overall Study|Did not attend final visit|0|||
30641360|NCT00890097|58653457|FG000|Overall Study|Subject Decision|3|||
30641361|NCT00890097|58653458|FG001|Overall Study|Subject Decision|2|||
30641362|NCT00890097|58653459|FG002|Overall Study|Subject Decision|6|||
30641363|NCT00890097|58653457|FG000|Overall Study|Randomization Error|2|||
30641364|NCT00890097|58653458|FG001|Overall Study|Randomization Error|0|||
30641365|NCT00890097|58653459|FG002|Overall Study|Randomization Error|0|||
30641366|NCT00890097|58653457|FG000|Overall Study|Failed inclusion criteria|3|||
30641367|NCT00890097|58653458|FG001|Overall Study|Failed inclusion criteria|4|||
30641368|NCT00890097|58653459|FG002|Overall Study|Failed inclusion criteria|0|||
30641369|NCT00890097|58653457|FG000|Overall Study|Transportation|0|||
30641370|NCT00890097|58653458|FG001|Overall Study|Transportation|2|||
30641371|NCT00890097|58653459|FG002|Overall Study|Transportation|0|||
30641372|NCT00890097|58653457|FG000|Overall Study|Subject Moved|0|||
30641373|NCT00890097|58653458|FG001|Overall Study|Subject Moved|4|||
30641374|NCT00890097|58653459|FG002|Overall Study|Subject Moved|0|||
30641375|NCT00890097|58653457|FG000|Overall Study|Protocol Deviation|1|||
30641376|NCT00890097|58653458|FG001|Overall Study|Protocol Deviation|1|||
30641377|NCT00890097|58653459|FG002|Overall Study|Protocol Deviation|1|||
30641378|NCT00913458|58653467|FG000|Phase 1|Non-Responder|54|||
30641379|NCT00913458|58653468|FG001|Phase 1|Non-Responder|0|||
30641380|NCT00913458|58653469|FG002|Phase 1|Non-Responder|0|||
30641381|NCT00913458|58653470|FG003|Phase 1|Non-Responder|0|||
30641382|NCT00913458|58653471|FG004|Phase 1|Non-Responder|0|||
30848534|NCT02851511|58874629|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
30848535|NCT02851511|58874630|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
30848536|NCT02851511|58874631|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
30848537|NCT02851511|58874632|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
30641383|NCT00913458|58653472|FG005|Phase 1|Non-Responder|0|||
30641384|NCT00913458|58653473|FG006|Phase 1|Non-Responder|0|||
30641385|NCT00913458|58653467|FG000|Phase 1|Subject Request|17|||
30641386|NCT00913458|58653468|FG001|Phase 1|Subject Request|0|||
30641387|NCT00913458|58653469|FG002|Phase 1|Subject Request|0|||
30641388|NCT00913458|58653470|FG003|Phase 1|Subject Request|0|||
30641389|NCT00913458|58653471|FG004|Phase 1|Subject Request|0|||
30641390|NCT00913458|58653472|FG005|Phase 1|Subject Request|0|||
30641391|NCT00913458|58653473|FG006|Phase 1|Subject Request|0|||
30641392|NCT00913458|58653467|FG000|Phase 1|Adverse Event|20|||
30641393|NCT00913458|58653468|FG001|Phase 1|Adverse Event|0|||
30641394|NCT00913458|58653469|FG002|Phase 1|Adverse Event|0|||
30641395|NCT00913458|58653470|FG003|Phase 1|Adverse Event|0|||
30641396|NCT00913458|58653471|FG004|Phase 1|Adverse Event|0|||
30641397|NCT00913458|58653472|FG005|Phase 1|Adverse Event|0|||
30641398|NCT00913458|58653473|FG006|Phase 1|Adverse Event|0|||
30641399|NCT00913458|58653467|FG000|Phase 1|Lost to Follow-up|2|||
30641400|NCT00913458|58653468|FG001|Phase 1|Lost to Follow-up|0|||
30641401|NCT00913458|58653469|FG002|Phase 1|Lost to Follow-up|0|||
30641402|NCT00913458|58653470|FG003|Phase 1|Lost to Follow-up|0|||
30641403|NCT00913458|58653471|FG004|Phase 1|Lost to Follow-up|0|||
30641404|NCT00913458|58653472|FG005|Phase 1|Lost to Follow-up|0|||
30641405|NCT00913458|58653473|FG006|Phase 1|Lost to Follow-up|0|||
30641406|NCT00913458|58653467|FG000|Phase 1|Protocol Violation|10|||
30641407|NCT00913458|58653468|FG001|Phase 1|Protocol Violation|0|||
30641408|NCT00913458|58653469|FG002|Phase 1|Protocol Violation|0|||
30641409|NCT00913458|58653470|FG003|Phase 1|Protocol Violation|0|||
30641410|NCT00913458|58653471|FG004|Phase 1|Protocol Violation|0|||
30641411|NCT00913458|58653472|FG005|Phase 1|Protocol Violation|0|||
30641412|NCT00913458|58653473|FG006|Phase 1|Protocol Violation|0|||
30641413|NCT00913458|58653467|FG000|Phase 1|Sponsor|2|||
30641414|NCT00913458|58653468|FG001|Phase 1|Sponsor|0|||
30641415|NCT00913458|58653469|FG002|Phase 1|Sponsor|0|||
30641416|NCT00913458|58653470|FG003|Phase 1|Sponsor|0|||
30641417|NCT00913458|58653471|FG004|Phase 1|Sponsor|0|||
30641418|NCT00913458|58653472|FG005|Phase 1|Sponsor|0|||
30641419|NCT00913458|58653473|FG006|Phase 1|Sponsor|0|||
30641420|NCT00913458|58653467|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
30641421|NCT00913458|58653468|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
30641422|NCT00913458|58653469|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
30641423|NCT00913458|58653470|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
30641424|NCT00913458|58653471|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
30641425|NCT00913458|58653472|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
30641426|NCT00913458|58653473|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
30641427|NCT00913458|58653467|FG000|Phase 2|Non-Responder|0|||
30641428|NCT00913458|58653468|FG001|Phase 2|Non-Responder|5|||
30641429|NCT00913458|58653469|FG002|Phase 2|Non-Responder|7|||
30641430|NCT00913458|58653470|FG003|Phase 2|Non-Responder|12|||
30641431|NCT00913458|58653471|FG004|Phase 2|Non-Responder|0|||
30641432|NCT00913458|58653472|FG005|Phase 2|Non-Responder|0|||
30641433|NCT00913458|58653473|FG006|Phase 2|Non-Responder|0|||
30641434|NCT00913458|58653467|FG000|Phase 2|Subject Request|0|||
30641435|NCT00913458|58653468|FG001|Phase 2|Subject Request|0|||
30641436|NCT00913458|58653469|FG002|Phase 2|Subject Request|1|||
30641437|NCT00913458|58653470|FG003|Phase 2|Subject Request|2|||
30641438|NCT00913458|58653471|FG004|Phase 2|Subject Request|0|||
30641439|NCT00913458|58653472|FG005|Phase 2|Subject Request|0|||
30641440|NCT00913458|58653473|FG006|Phase 2|Subject Request|0|||
30641441|NCT00913458|58653467|FG000|Phase 2|Adverse Event|0|||
30641442|NCT00913458|58653468|FG001|Phase 2|Adverse Event|3|||
30641443|NCT00913458|58653469|FG002|Phase 2|Adverse Event|0|||
30641444|NCT00913458|58653470|FG003|Phase 2|Adverse Event|1|||
30641445|NCT00913458|58653471|FG004|Phase 2|Adverse Event|0|||
30641446|NCT00913458|58653472|FG005|Phase 2|Adverse Event|0|||
30641447|NCT00913458|58653473|FG006|Phase 2|Adverse Event|0|||
30641448|NCT00913458|58653467|FG000|Phase 2|Lost to Follow-up|0|||
30641449|NCT00913458|58653468|FG001|Phase 2|Lost to Follow-up|0|||
30641450|NCT00913458|58653469|FG002|Phase 2|Lost to Follow-up|0|||
30641451|NCT00913458|58653470|FG003|Phase 2|Lost to Follow-up|1|||
30641452|NCT00913458|58653471|FG004|Phase 2|Lost to Follow-up|0|||
30641453|NCT00913458|58653472|FG005|Phase 2|Lost to Follow-up|0|||
30641454|NCT00913458|58653473|FG006|Phase 2|Lost to Follow-up|0|||
30641455|NCT00913458|58653467|FG000|Phase 2|Protocol Violation|0|||
30641456|NCT00913458|58653468|FG001|Phase 2|Protocol Violation|2|||
30641457|NCT00913458|58653469|FG002|Phase 2|Protocol Violation|0|||
30641458|NCT00913458|58653470|FG003|Phase 2|Protocol Violation|0|||
30641459|NCT00913458|58653471|FG004|Phase 2|Protocol Violation|0|||
30641460|NCT00913458|58653472|FG005|Phase 2|Protocol Violation|0|||
30641461|NCT00913458|58653473|FG006|Phase 2|Protocol Violation|0|||
30641462|NCT00913458|58653467|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
30641463|NCT00913458|58653468|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
30641464|NCT00913458|58653469|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
30641465|NCT00913458|58653470|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
30641466|NCT00913458|58653471|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
30641467|NCT00913458|58653472|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
30641468|NCT00913458|58653473|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
30641469|NCT00913458|58653467|FG000|Phase 3|Adverse Event|0|||
30641470|NCT00913458|58653468|FG001|Phase 3|Adverse Event|0|||
30641471|NCT00913458|58653469|FG002|Phase 3|Adverse Event|0|||
30641472|NCT00913458|58653470|FG003|Phase 3|Adverse Event|0|||
30641473|NCT00913458|58653471|FG004|Phase 3|Adverse Event|5|||
30641474|NCT00913458|58653472|FG005|Phase 3|Adverse Event|4|||
30641475|NCT00913458|58653473|FG006|Phase 3|Adverse Event|1|||
30641476|NCT00913458|58653467|FG000|Phase 3|Lost to Follow-up|0|||
30641477|NCT00913458|58653468|FG001|Phase 3|Lost to Follow-up|0|||
30641478|NCT00913458|58653469|FG002|Phase 3|Lost to Follow-up|0|||
30641479|NCT00913458|58653470|FG003|Phase 3|Lost to Follow-up|0|||
30641480|NCT00913458|58653471|FG004|Phase 3|Lost to Follow-up|2|||
30641481|NCT00913458|58653472|FG005|Phase 3|Lost to Follow-up|0|||
30641482|NCT00913458|58653473|FG006|Phase 3|Lost to Follow-up|0|||
30641483|NCT00913458|58653467|FG000|Phase 3|Non-Responder|0|||
30641484|NCT00913458|58653468|FG001|Phase 3|Non-Responder|0|||
30641485|NCT00913458|58653469|FG002|Phase 3|Non-Responder|0|||
30641486|NCT00913458|58653470|FG003|Phase 3|Non-Responder|0|||
30641487|NCT00913458|58653471|FG004|Phase 3|Non-Responder|0|||
30641488|NCT00913458|58653472|FG005|Phase 3|Non-Responder|1|||
30641489|NCT00913458|58653473|FG006|Phase 3|Non-Responder|3|||
30641490|NCT00913458|58653467|FG000|Phase 3|Withdrawal by Subject|0|||
30641491|NCT00913458|58653468|FG001|Phase 3|Withdrawal by Subject|0|||
30641492|NCT00913458|58653469|FG002|Phase 3|Withdrawal by Subject|0|||
30641493|NCT00913458|58653470|FG003|Phase 3|Withdrawal by Subject|0|||
30641494|NCT00913458|58653471|FG004|Phase 3|Withdrawal by Subject|1|||
30641495|NCT00913458|58653472|FG005|Phase 3|Withdrawal by Subject|2|||
30641496|NCT00913458|58653473|FG006|Phase 3|Withdrawal by Subject|0|||
30641497|NCT00913458|58653467|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
30641498|NCT00913458|58653468|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
30641499|NCT00913458|58653469|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
30641500|NCT00913458|58653470|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
30641501|NCT00913458|58653471|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
30641502|NCT00913458|58653472|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
30641503|NCT00913458|58653473|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
30641504|NCT00785707|58653490|FG000|Overall Study|Lost to Follow-up|7|||
30641505|NCT00913380|58653496|FG000|Clinical Outcomes|Lost to Follow-up|6|||
30641506|NCT00913380|58653497|FG001|Clinical Outcomes|Lost to Follow-up|6|||
30641507|NCT00785629|58653507|FG000|Overall Study|Adverse Event|2|||
30641508|NCT00785629|58653508|FG001|Overall Study|Adverse Event|1|||
30641509|NCT00785629|58653509|FG002|Overall Study|Adverse Event|1|||
30641510|NCT00785629|58653510|FG003|Overall Study|Adverse Event|5|||
30641511|NCT00785629|58653507|FG000|Overall Study|Protocol Violation|1|||
30641512|NCT00785629|58653508|FG001|Overall Study|Protocol Violation|2|||
30641513|NCT00785629|58653509|FG002|Overall Study|Protocol Violation|4|||
30641514|NCT00785629|58653510|FG003|Overall Study|Protocol Violation|5|||
30641515|NCT00785629|58653507|FG000|Overall Study|administrative decision|5|||
30641516|NCT00785629|58653508|FG001|Overall Study|administrative decision|1|||
30641517|NCT00785629|58653509|FG002|Overall Study|administrative decision|3|||
30641518|NCT00785629|58653510|FG003|Overall Study|administrative decision|4|||
30641519|NCT00785629|58653507|FG000|Overall Study|Withdrawal by Subject|0|||
30641520|NCT00785629|58653508|FG001|Overall Study|Withdrawal by Subject|1|||
30641521|NCT00785629|58653509|FG002|Overall Study|Withdrawal by Subject|2|||
30641522|NCT00785629|58653510|FG003|Overall Study|Withdrawal by Subject|2|||
30641523|NCT00916344|58653518|FG000|Overall Study|Death|2|||
30641524|NCT00916344|58653518|FG000|Overall Study|ICD upgrade|1|||
30641525|NCT00916344|58653518|FG000|Overall Study|Drop-out|5|||
30641526|NCT00913770|58653525|FG000|Overall Study|Unable to contact|24|||
30641527|NCT00913770|58653526|FG001|Overall Study|Unable to contact|19|||
30641528|NCT00913770|58653527|FG002|Overall Study|Unable to contact|13|||
30641529|NCT00913770|58653525|FG000|Overall Study|Refused|11|||
30641530|NCT00913770|58653526|FG001|Overall Study|Refused|10|||
30641531|NCT00913770|58653527|FG002|Overall Study|Refused|8|||
30641532|NCT00780559|58653537|FG000|Overall Study|Lost to Follow-up|2|||
30641533|NCT00780559|58653538|FG001|Overall Study|Lost to Follow-up|7|||
30641534|NCT00780559|58653537|FG000|Overall Study|Death|1|||
30641535|NCT00780559|58653538|FG001|Overall Study|Death|0|||
30641536|NCT00912912|58653546|FG000|Overall Study|Withdrawal by Subject|1|||
30641537|NCT00912912|58653546|FG000|Overall Study|Disease Progression|3|||
30641538|NCT00889005|58653552|FG000|Overall Study|Lost to Follow-up|4|||
30641539|NCT00889005|58653553|FG001|Overall Study|Lost to Follow-up|2|||
30641540|NCT00889005|58653552|FG000|Overall Study|Withdrawal by Subject|4|||
30641541|NCT00889005|58653553|FG001|Overall Study|Withdrawal by Subject|0|||
30641542|NCT00779857|58653559|FG000|Overall Study|Death|1|||
30641543|NCT00779857|58653559|FG000|Overall Study|Withdrawal by Subject|3|||
30641544|NCT00779857|58653559|FG000|Overall Study|Missed Visit|2|||
30641545|NCT00913692|58653563|FG000|Screening (4 Months)|Physician Decision|3|||
30641546|NCT00913692|58653563|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
30641547|NCT00913692|58653563|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
30641548|NCT00784927|58653570|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
30641549|NCT00784927|58653570|FG000|Overall Study|Protocol Violation|1|||
30641550|NCT00784927|58653570|FG000|Overall Study|Ineligible|1|||
30641551|NCT00779779|58653575|FG000|Overall Study|Adverse Event|1|||
30641552|NCT00779779|58653575|FG000|Overall Study|Protocol Violation|14|||
30641553|NCT00779779|58653575|FG000|Overall Study|Withdrawal by Subject|4|||
30641554|NCT00779779|58653575|FG000|Overall Study|Lost to Follow-up|5|||
30641555|NCT00845728|58653581|FG000|Overall Study|Abnormal laboratory value (s)|2|||
30641556|NCT00845728|58653582|FG001|Overall Study|Abnormal laboratory value (s)|2|||
30641557|NCT00845728|58653581|FG000|Overall Study|Patient's inability to use the device|4|||
30641558|NCT00845728|58653582|FG001|Overall Study|Patient's inability to use the device|6|||
30641559|NCT00845728|58653581|FG000|Overall Study|Abnormal test procedure result (s)|7|||
30641560|NCT00845728|58653582|FG001|Overall Study|Abnormal test procedure result (s)|2|||
30641561|NCT00845728|58653581|FG000|Overall Study|Lost to Follow-up|22|||
30641562|NCT00845728|58653582|FG001|Overall Study|Lost to Follow-up|13|||
30641563|NCT00845728|58653581|FG000|Overall Study|Death|24|||
30641564|NCT00845728|58653582|FG001|Overall Study|Death|26|||
30641565|NCT00845728|58653581|FG000|Overall Study|Administrative Problems|34|||
30641566|NCT00845728|58653582|FG001|Overall Study|Administrative Problems|26|||
30641567|NCT00845728|58653581|FG000|Overall Study|Protocol Violation|36|||
30641568|NCT00845728|58653582|FG001|Overall Study|Protocol Violation|24|||
30641569|NCT00845728|58653581|FG000|Overall Study|Lack of Efficacy|51|||
30641570|NCT00845728|58653582|FG001|Overall Study|Lack of Efficacy|39|||
30641571|NCT00845728|58653581|FG000|Overall Study|Adverse Event|101|||
30641572|NCT00845728|58653582|FG001|Overall Study|Adverse Event|96|||
30641573|NCT00845728|58653581|FG000|Overall Study|Withdrawal by Subject|105|||
30641574|NCT00845728|58653582|FG001|Overall Study|Withdrawal by Subject|108|||
30641575|NCT00779467|58653592|FG000|Overall Study|Lack of Efficacy|11|||
30641576|NCT00779467|58653593|FG001|Overall Study|Lack of Efficacy|2|||
30641577|NCT00779467|58653594|FG002|Overall Study|Lack of Efficacy|6|||
30641578|NCT00779467|58653595|FG003|Overall Study|Lack of Efficacy|11|||
30641579|NCT00779467|58653592|FG000|Overall Study|failed inclusion criteria|3|||
30641580|NCT00779467|58653593|FG001|Overall Study|failed inclusion criteria|3|||
30641581|NCT00779467|58653594|FG002|Overall Study|failed inclusion criteria|1|||
30641582|NCT00779467|58653595|FG003|Overall Study|failed inclusion criteria|2|||
30641583|NCT00779467|58653592|FG000|Overall Study|missing data|1|||
30641584|NCT00779467|58653593|FG001|Overall Study|missing data|0|||
30641585|NCT00779467|58653594|FG002|Overall Study|missing data|1|||
30641586|NCT00779467|58653595|FG003|Overall Study|missing data|4|||
30641587|NCT00779467|58653592|FG000|Overall Study|technical issue|0|||
30641588|NCT00779467|58653593|FG001|Overall Study|technical issue|0|||
30641589|NCT00779467|58653594|FG002|Overall Study|technical issue|2|||
30641590|NCT00779467|58653595|FG003|Overall Study|technical issue|1|||
30641591|NCT00779467|58653592|FG000|Overall Study|unavailable research staff|0|||
30641592|NCT00779467|58653593|FG001|Overall Study|unavailable research staff|0|||
30641593|NCT00779467|58653594|FG002|Overall Study|unavailable research staff|0|||
30641594|NCT00779467|58653595|FG003|Overall Study|unavailable research staff|1|||
30641595|NCT00778921|58653608|FG000|Overall Study|Adverse Event|9|||
30641596|NCT00778921|58653609|FG001|Overall Study|Adverse Event|10|||
30641597|NCT00778921|58653610|FG002|Overall Study|Adverse Event|14|||
30641598|NCT00778921|58653608|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
30641599|NCT00778921|58653609|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
30641600|NCT00778921|58653610|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
30641601|NCT00778921|58653608|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
30641602|NCT00778921|58653609|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
30641603|NCT00778921|58653610|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
30641604|NCT00778921|58653608|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
30641605|NCT00778921|58653609|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
30641606|NCT00778921|58653610|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
30641607|NCT00778921|58653608|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
30641608|NCT00778921|58653609|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
30641609|NCT00778921|58653610|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
30641610|NCT00778921|58653608|FG000|Overall Study|Patient withdrew request|3|||
30641611|NCT00778921|58653609|FG001|Overall Study|Patient withdrew request|1|||
30641612|NCT00778921|58653610|FG002|Overall Study|Patient withdrew request|6|||
30641613|NCT00778921|58653608|FG000|Overall Study|Lost to Follow-up|0|||
30641614|NCT00778921|58653609|FG001|Overall Study|Lost to Follow-up|2|||
30641615|NCT00778921|58653610|FG002|Overall Study|Lost to Follow-up|1|||
30641616|NCT00778921|58653608|FG000|Overall Study|Administrative Problems|1|||
30641617|NCT00778921|58653609|FG001|Overall Study|Administrative Problems|2|||
30641618|NCT00778921|58653610|FG002|Overall Study|Administrative Problems|0|||
30641619|NCT00778921|58653608|FG000|Overall Study|Protocol Violation|3|||
30641620|NCT00778921|58653609|FG001|Overall Study|Protocol Violation|0|||
30641621|NCT00778921|58653610|FG002|Overall Study|Protocol Violation|2|||
30641622|NCT00778921|58653608|FG000|Overall Study|Not treated|0|||
30641623|NCT00778921|58653609|FG001|Overall Study|Not treated|2|||
30641624|NCT00778921|58653610|FG002|Overall Study|Not treated|2|||
30641625|NCT00915876|58653620|FG000|Overall Study|Adverse Event|0|||
30641626|NCT00915876|58653621|FG001|Overall Study|Adverse Event|1|||
30641627|NCT00587431|58653629|FG000|Overall Study|Adverse Event|1|||
30641628|NCT00587431|58653630|FG001|Overall Study|Adverse Event|0|||
30641629|NCT00587431|58653629|FG000|Overall Study|Withdrawal by Subject|0|||
30641630|NCT00587431|58653630|FG001|Overall Study|Withdrawal by Subject|1|||
30641631|NCT00776659|58653639|FG000|Overall Study|Lost to Follow-up|15|||
30641632|NCT00776659|58653639|FG000|Overall Study|Withdrawal by Subject|10|||
30641633|NCT00776659|58653639|FG000|Overall Study|Study Terminated by Sponsor|1|||
30641634|NCT00825682|58653645|FG000|Overall Study|personal reasons/ inconvenience|13|||
30641635|NCT00825682|58653646|FG001|Overall Study|personal reasons/ inconvenience|5|||
30641636|NCT00833794|58653655|FG000|Open-label Phase|Adverse Event|225|||
30641637|NCT00833794|58653656|FG001|Open-label Phase|Adverse Event|0|||
30641638|NCT00833794|58653655|FG000|Open-label Phase|Lack of Efficacy|28|||
30641639|NCT00833794|58653656|FG001|Open-label Phase|Lack of Efficacy|0|||
30641640|NCT00833794|58653655|FG000|Open-label Phase|Withdrawal by Subject|48|||
30641641|NCT00833794|58653656|FG001|Open-label Phase|Withdrawal by Subject|0|||
30641642|NCT00833794|58653655|FG000|Open-label Phase|Physician Decision|20|||
30641643|NCT00833794|58653656|FG001|Open-label Phase|Physician Decision|0|||
30641644|NCT00833794|58653655|FG000|Open-label Phase|Administrative reason|1|||
30641645|NCT00833794|58653656|FG001|Open-label Phase|Administrative reason|0|||
30641646|NCT00833794|58653655|FG000|Open-label Phase|Protocol Violation|47|||
30641647|NCT00833794|58653656|FG001|Open-label Phase|Protocol Violation|0|||
30641648|NCT00833794|58653655|FG000|Open-label Phase|Did not complete wash-out period|12|||
30641649|NCT00833794|58653656|FG001|Open-label Phase|Did not complete wash-out period|0|||
30641650|NCT00833794|58653655|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
30641651|NCT00833794|58653656|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
30641652|NCT00833794|58653655|FG000|Double-blind Phase|Adverse Event|44|||
30641653|NCT00833794|58653656|FG001|Double-blind Phase|Adverse Event|11|||
30641654|NCT00833794|58653655|FG000|Double-blind Phase|Lack of Efficacy|34|||
30641655|NCT00833794|58653656|FG001|Double-blind Phase|Lack of Efficacy|22|||
30641656|NCT00833794|58653655|FG000|Double-blind Phase|Withdrawal by Subject|23|||
30641657|NCT00833794|58653656|FG001|Double-blind Phase|Withdrawal by Subject|6|||
30641658|NCT00833794|58653655|FG000|Double-blind Phase|Physician Decision|4|||
30641659|NCT00833794|58653656|FG001|Double-blind Phase|Physician Decision|7|||
30641660|NCT00833794|58653655|FG000|Double-blind Phase|Administrative reason|1|||
30641661|NCT00833794|58653656|FG001|Double-blind Phase|Administrative reason|3|||
30641662|NCT00912288|58653666|FG000|Overall Study|Death|0|||
30641663|NCT00912288|58653667|FG001|Overall Study|Death|1|||
30641664|NCT00912288|58653666|FG000|Overall Study|Adverse Event|1|||
30641665|NCT00912288|58653667|FG001|Overall Study|Adverse Event|1|||
30641666|NCT00912288|58653666|FG000|Overall Study|Lost to Follow-up|1|||
30641667|NCT00912288|58653667|FG001|Overall Study|Lost to Follow-up|0|||
30641668|NCT00912288|58653666|FG000|Overall Study|Protocol Violation|1|||
30641669|NCT00912288|58653667|FG001|Overall Study|Protocol Violation|0|||
30641670|NCT00912288|58653666|FG000|Overall Study|Withdrawal by Subject|3|||
30641671|NCT00912288|58653667|FG001|Overall Study|Withdrawal by Subject|3|||
30641672|NCT00912288|58653666|FG000|Overall Study|Study terminated by sponsor|34|||
30641673|NCT00912288|58653667|FG001|Overall Study|Study terminated by sponsor|35|||
30641674|NCT00912288|58653666|FG000|Overall Study|Other|1|||
30641675|NCT00912288|58653667|FG001|Overall Study|Other|0|||
30641676|NCT00778375|58653673|FG000|Overall Study|Ineligible|3|||
30641677|NCT00777829|58653679|FG000|Overall Study|Withdrawal by Subject|0|||
30641678|NCT00777829|58653680|FG001|Overall Study|Withdrawal by Subject|2|||
30641679|NCT00775021|58653688|FG000|First Intervention|Lost to Follow-up|1|||
30641680|NCT00775021|58653689|FG001|First Intervention|Lost to Follow-up|0|||
30641681|NCT00775021|58653688|FG000|Second Intervention|Adverse Event|0|||
30641682|NCT00775021|58653689|FG001|Second Intervention|Adverse Event|1|||
30641683|NCT00777205|58653697|FG000|Overall Study|Lost to Follow-up|25|||
30641684|NCT00777205|58653698|FG001|Overall Study|Lost to Follow-up|9|||
30641685|NCT00777205|58653697|FG000|Overall Study|Withdrawal by Subject|6|||
30641686|NCT00777205|58653698|FG001|Overall Study|Withdrawal by Subject|4|||
30641687|NCT00777205|58653697|FG000|Overall Study|Death|0|||
30641688|NCT00777205|58653698|FG001|Overall Study|Death|2|||
30641689|NCT00777205|58653697|FG000|Overall Study|Protocol Violation|0|||
30641690|NCT00777205|58653698|FG001|Overall Study|Protocol Violation|56|||
30641691|NCT00833638|58653709|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
30641692|NCT00833638|58653710|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
30641693|NCT00833638|58653711|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
30641694|NCT00833638|58653709|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
30641695|NCT00833638|58653710|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
30641696|NCT00833638|58653711|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
30641697|NCT00833638|58653709|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
30641698|NCT00833638|58653710|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
30641699|NCT00833638|58653711|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
30641700|NCT00833638|58653709|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
30641701|NCT00833638|58653710|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
30641702|NCT00833638|58653711|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
30641703|NCT00833638|58653709|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
30641704|NCT00833638|58653710|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
30641705|NCT00833638|58653711|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
30641706|NCT00833638|58653709|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
30641707|NCT00833638|58653710|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
30641708|NCT00833638|58653711|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
30951675|NCT01042678|58999008|FG003|Overall Study|Physician Decision|0|||
30951676|NCT01042678|58999009|FG004|Overall Study|Physician Decision|0|||
30951677|NCT01042678|58999010|FG005|Overall Study|Physician Decision|0|||
30951678|NCT01042600|58999020|FG000|Overall Study|Ineligible|1|||
30641709|NCT00833638|58653709|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
30641710|NCT00833638|58653710|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
30641711|NCT00833638|58653711|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
30641712|NCT00833638|58653709|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
30641713|NCT00833638|58653710|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
30641714|NCT00833638|58653711|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
30641715|NCT00833638|58653709|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
30641716|NCT00833638|58653710|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
30641717|NCT00833638|58653711|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
30641718|NCT01041404|58653729|FG000|Overall Study|Adverse Event|45|||
30641719|NCT01041404|58653730|FG001|Overall Study|Adverse Event|35|||
30641720|NCT01041404|58653729|FG000|Overall Study|Lack of Efficacy|200|||
30641721|NCT01041404|58653730|FG001|Overall Study|Lack of Efficacy|210|||
30641722|NCT01041404|58653729|FG000|Overall Study|Violation of Selection Criteria|0|||
30641723|NCT01041404|58653730|FG001|Overall Study|Violation of Selection Criteria|1|||
30641724|NCT01041404|58653729|FG000|Overall Study|Protocol Violation|4|||
30641725|NCT01041404|58653730|FG001|Overall Study|Protocol Violation|0|||
30641726|NCT01041404|58653729|FG000|Overall Study|Withdrawal by Subject|29|||
30641727|NCT01041404|58653730|FG001|Overall Study|Withdrawal by Subject|23|||
30641728|NCT01041404|58653729|FG000|Overall Study|Failure to Return|1|||
30641729|NCT01041404|58653730|FG001|Overall Study|Failure to Return|2|||
30641730|NCT01041404|58653729|FG000|Overall Study|Other|11|||
30641731|NCT01041404|58653730|FG001|Overall Study|Other|23|||
30641732|NCT00777049|58653741|FG000|Overall Study|Withdrawal by Subject|1|||
30765646|NCT01239368|58774352|FG002|Overall Study|Disease progression on study|1|||
30765647|NCT01239368|58774353|FG003|Overall Study|Disease progression on study|1|||
30765648|NCT01239368|58774354|FG004|Overall Study|Disease progression on study|4|||
30765649|NCT01239368|58774355|FG005|Overall Study|Disease progression on study|2|||
30765650|NCT01239368|58774356|FG006|Overall Study|Disease progression on study|5|||
30765651|NCT01239368|58774357|FG007|Overall Study|Disease progression on study|0|||
30765652|NCT01239368|58774358|FG008|Overall Study|Disease progression on study|0|||
30765653|NCT01239368|58774359|FG009|Overall Study|Disease progression on study|2|||
30765654|NCT01239368|58774350|FG000|Overall Study|Refused further treatment|0|||
30765655|NCT01239368|58774351|FG001|Overall Study|Refused further treatment|0|||
30765656|NCT01239368|58774352|FG002|Overall Study|Refused further treatment|0|||
30765657|NCT01239368|58774353|FG003|Overall Study|Refused further treatment|0|||
30765658|NCT01239368|58774354|FG004|Overall Study|Refused further treatment|0|||
30765659|NCT01239368|58774355|FG005|Overall Study|Refused further treatment|0|||
30765660|NCT01239368|58774356|FG006|Overall Study|Refused further treatment|0|||
30765661|NCT01239368|58774357|FG007|Overall Study|Refused further treatment|0|||
30765662|NCT01239368|58774358|FG008|Overall Study|Refused further treatment|0|||
30765663|NCT01239368|58774359|FG009|Overall Study|Refused further treatment|1|||
30765664|NCT01239368|58774350|FG000|Overall Study|Death|0|||
30765665|NCT01239368|58774351|FG001|Overall Study|Death|0|||
30765666|NCT01239368|58774352|FG002|Overall Study|Death|0|||
30765667|NCT01239368|58774353|FG003|Overall Study|Death|0|||
30765668|NCT01239368|58774354|FG004|Overall Study|Death|0|||
30765669|NCT01239368|58774355|FG005|Overall Study|Death|0|||
30765670|NCT01239368|58774356|FG006|Overall Study|Death|1|||
30765671|NCT01239368|58774357|FG007|Overall Study|Death|0|||
30765672|NCT01239368|58774358|FG008|Overall Study|Death|0|||
30765673|NCT01239368|58774359|FG009|Overall Study|Death|0|||
30765674|NCT02903420|58774401|FG000|Overall Study|Death|3|||
30765675|NCT00369161|58774411|FG000|Overall Study|Adverse Event|15|||
30765676|NCT00369161|58774412|FG001|Overall Study|Adverse Event|13|||
30765677|NCT00369161|58774411|FG000|Overall Study|Abnormal laboratory value|0|||
30765678|NCT00369161|58774412|FG001|Overall Study|Abnormal laboratory value|1|||
30765679|NCT00369161|58774411|FG000|Overall Study|Lack of Efficacy|3|||
30765680|NCT00369161|58774412|FG001|Overall Study|Lack of Efficacy|1|||
30765681|NCT00369161|58774411|FG000|Overall Study|Protocol Violation|0|||
30765682|NCT00369161|58774412|FG001|Overall Study|Protocol Violation|2|||
30765683|NCT00369161|58774411|FG000|Overall Study|Withdrawal by Subject|2|||
30765684|NCT00369161|58774412|FG001|Overall Study|Withdrawal by Subject|3|||
30765685|NCT00369161|58774411|FG000|Overall Study|Death|1|||
30848538|NCT02851511|58874629|FG000|Phase II|Lost to Follow-up|0|||
30765686|NCT00369161|58774412|FG001|Overall Study|Death|2|||
30848539|NCT02851511|58874630|FG001|Phase II|Lost to Follow-up|1|||
30848540|NCT02851511|58874631|FG002|Phase II|Lost to Follow-up|0|||
30641733|NCT00777049|58653742|FG001|Overall Study|Withdrawal by Subject|0|||
30641734|NCT00777049|58653741|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
30765687|NCT00369161|58774411|FG000|Overall Study|Graft loss|4|||
30765688|NCT00369161|58774412|FG001|Overall Study|Graft loss|0|||
30765689|NCT00369161|58774411|FG000|Overall Study|Administrative Problem|2|||
30765690|NCT00369161|58774412|FG001|Overall Study|Administrative Problem|2|||
30765691|NCT00337571|58774422|FG000|Overall Study|Lack of Efficacy|3|||
30848541|NCT02851511|58874632|FG003|Phase II|Lost to Follow-up|0|||
30765692|NCT00337571|58774423|FG001|Overall Study|Lack of Efficacy|0|||
30765693|NCT00337571|58774424|FG002|Overall Study|Lack of Efficacy|0|||
30765694|NCT00337571|58774425|FG003|Overall Study|Lack of Efficacy|0|||
30765695|NCT00337571|58774422|FG000|Overall Study|Adverse Event|4|||
30765696|NCT00337571|58774423|FG001|Overall Study|Adverse Event|5|||
30765697|NCT00337571|58774424|FG002|Overall Study|Adverse Event|8|||
30765698|NCT00337571|58774425|FG003|Overall Study|Adverse Event|4|||
30765699|NCT00337571|58774422|FG000|Overall Study|Withdrawal by Subject|2|||
30765700|NCT00337571|58774423|FG001|Overall Study|Withdrawal by Subject|2|||
30951679|NCT01042600|58999021|FG001|Overall Study|Ineligible|0|||
30765701|NCT00337571|58774424|FG002|Overall Study|Withdrawal by Subject|1|||
30951680|NCT01041976|58999030|FG000|Overall Study|Withdrawal by Subject|3|||
30641735|NCT00777049|58653742|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
30641736|NCT00774787|58653748|FG000|Overall Study|Lost to Follow-up|1|||
30641737|NCT00888927|58653756|FG000|Overall Study|Adverse Event|0|||
30641738|NCT00888927|58653757|FG001|Overall Study|Adverse Event|0|||
30641739|NCT00888927|58653758|FG002|Overall Study|Adverse Event|0|||
30641740|NCT00888927|58653759|FG003|Overall Study|Adverse Event|1|||
30641741|NCT00888927|58653756|FG000|Overall Study|Withdrawal of consent|0|||
30641742|NCT00888927|58653757|FG001|Overall Study|Withdrawal of consent|0|||
30641743|NCT00888927|58653758|FG002|Overall Study|Withdrawal of consent|0|||
30641744|NCT00888927|58653759|FG003|Overall Study|Withdrawal of consent|1|||
30641745|NCT01040780|58653771|FG000|Overall Study|Protocol Violation|1|||
30641746|NCT01040780|58653772|FG001|Overall Study|Protocol Violation|3|||
30641747|NCT00888849|58653783|FG000|Overall Study|Death|4|||
30641748|NCT00888849|58653784|FG001|Overall Study|Death|7|||
30951681|NCT01041976|58999031|FG001|Overall Study|Withdrawal by Subject|0|||
30951682|NCT01041976|58999030|FG000|Overall Study|Incarceration|2|||
30951683|NCT01041976|58999031|FG001|Overall Study|Incarceration|0|||
30951684|NCT01041976|58999030|FG000|Overall Study|Death|0|||
30951685|NCT01041976|58999031|FG001|Overall Study|Death|4|||
30951686|NCT01712516|58999057|FG000|Overall Study|Technical problems|0|||
30951687|NCT01712516|58999058|FG001|Overall Study|Technical problems|0|||
30951688|NCT01712516|58999059|FG002|Overall Study|Technical problems|0|||
30951689|NCT01712516|58999060|FG003|Overall Study|Technical problems|2|||
30641749|NCT00888849|58653783|FG000|Overall Study|Lost to Follow-up|1|||
30641750|NCT00888849|58653784|FG001|Overall Study|Lost to Follow-up|2|||
30641751|NCT01059812|58653792|FG000|Overall Study|Adverse Event|9|||
30641752|NCT01059812|58653793|FG001|Overall Study|Adverse Event|5|||
30641753|NCT01059812|58653792|FG000|Overall Study|Lack of Efficacy|2|||
30641754|NCT01059812|58653793|FG001|Overall Study|Lack of Efficacy|2|||
30641755|NCT01059812|58653792|FG000|Overall Study|Protocol Violation|3|||
30641756|NCT01059812|58653793|FG001|Overall Study|Protocol Violation|1|||
30641757|NCT01059812|58653792|FG000|Overall Study|Withdrawal Criteria|9|||
30641758|NCT01059812|58653793|FG001|Overall Study|Withdrawal Criteria|4|||
30641759|NCT01059812|58653792|FG000|Overall Study|Unclassified|14|||
30641760|NCT01059812|58653793|FG001|Overall Study|Unclassified|4|||
30641761|NCT00888615|58653799|FG000|Overall Study|No treatment|2|||
30641762|NCT00845650|58653809|FG000|Overall Study|Withdrawal by Subject|0|||
30951690|NCT01712516|58999057|FG000|Overall Study|Lost to Follow-up|0|||
30951691|NCT01712516|58999058|FG001|Overall Study|Lost to Follow-up|0|||
30641763|NCT00845650|58653810|FG001|Overall Study|Withdrawal by Subject|0|||
30641764|NCT00845650|58653811|FG002|Overall Study|Withdrawal by Subject|0|||
30641765|NCT00845650|58653812|FG003|Overall Study|Withdrawal by Subject|0|||
30641766|NCT00845650|58653813|FG004|Overall Study|Withdrawal by Subject|2|||
30641767|NCT00845650|58653814|FG005|Overall Study|Withdrawal by Subject|0|||
30641768|NCT00845650|58653809|FG000|Overall Study|Lost to Follow-up|0|||
30641769|NCT00845650|58653810|FG001|Overall Study|Lost to Follow-up|0|||
30641770|NCT00845650|58653811|FG002|Overall Study|Lost to Follow-up|3|||
30641771|NCT00845650|58653812|FG003|Overall Study|Lost to Follow-up|1|||
30951692|NCT01712516|58999059|FG002|Overall Study|Lost to Follow-up|2|||
30951693|NCT01712516|58999060|FG003|Overall Study|Lost to Follow-up|1|||
30951694|NCT01712516|58999057|FG000|Overall Study|Death|0|||
30641772|NCT00845650|58653813|FG004|Overall Study|Lost to Follow-up|0|||
30641773|NCT00845650|58653814|FG005|Overall Study|Lost to Follow-up|1|||
30641774|NCT00845650|58653809|FG000|Overall Study|Sponsor hold on dosing|0|||
30641775|NCT00845650|58653810|FG001|Overall Study|Sponsor hold on dosing|0|||
30765702|NCT00337571|58774425|FG003|Overall Study|Withdrawal by Subject|0|||
30765703|NCT00337571|58774422|FG000|Overall Study|Lost to Follow-up|3|||
30765704|NCT00337571|58774423|FG001|Overall Study|Lost to Follow-up|1|||
30765705|NCT00337571|58774424|FG002|Overall Study|Lost to Follow-up|0|||
30765706|NCT00337571|58774425|FG003|Overall Study|Lost to Follow-up|1|||
30765707|NCT00337571|58774422|FG000|Overall Study|Poor/noncompliance|1|||
30765708|NCT00337571|58774423|FG001|Overall Study|Poor/noncompliance|1|||
30641776|NCT00845650|58653811|FG002|Overall Study|Sponsor hold on dosing|0|||
30641777|NCT00845650|58653812|FG003|Overall Study|Sponsor hold on dosing|0|||
30765709|NCT00337571|58774424|FG002|Overall Study|Poor/noncompliance|1|||
30951695|NCT01712516|58999058|FG001|Overall Study|Death|1|||
30641778|NCT00845650|58653813|FG004|Overall Study|Sponsor hold on dosing|1|||
30641779|NCT00845650|58653814|FG005|Overall Study|Sponsor hold on dosing|1|||
30641780|NCT00845650|58653809|FG000|Overall Study|Unable to access IV line|1|||
30641781|NCT00845650|58653810|FG001|Overall Study|Unable to access IV line|0|||
30641782|NCT00845650|58653811|FG002|Overall Study|Unable to access IV line|0|||
30641783|NCT00845650|58653812|FG003|Overall Study|Unable to access IV line|0|||
30641784|NCT00845650|58653813|FG004|Overall Study|Unable to access IV line|0|||
30641785|NCT00845650|58653814|FG005|Overall Study|Unable to access IV line|0|||
30641786|NCT00888381|58653832|FG000|Overall Study|Lost to Follow-up|0|||
30641787|NCT00888381|58653833|FG001|Overall Study|Lost to Follow-up|1|||
30641788|NCT00887913|58653839|FG000|Overall Study|Withdrawal by Subject|6|||
30641789|NCT00833560|58653843|FG000|Overall Study|Toxicity|13|||
30641790|NCT00833560|58653843|FG000|Overall Study|Adverse Event|11|||
30641791|NCT00833560|58653843|FG000|Overall Study|Protocol Violation|6|||
30641792|NCT00833560|58653843|FG000|Overall Study|Lack of Efficacy|4|||
30641793|NCT00833560|58653843|FG000|Overall Study|Death|2|||
30641794|NCT00833560|58653843|FG000|Overall Study|Pregression of other disease|1|||
30641795|NCT00833560|58653843|FG000|Overall Study|Other|5|||
30641796|NCT00887679|58653847|FG000|Overall Study|Withdrawal by Subject|1|||
30641797|NCT00887679|58653847|FG000|Overall Study|Lost to Follow-up|4|||
30641798|NCT00887679|58653847|FG000|Overall Study|Physician Decision|5|||
30641799|NCT00833482|58653854|FG000|Days 11-20|Adverse Event|0|||
30641800|NCT00833482|58653855|FG001|Days 11-20|Adverse Event|2|||
30641801|NCT00833482|58653856|FG002|Days 11-20|Adverse Event|0|||
30641802|NCT00833482|58653857|FG003|Days 11-20|Adverse Event|0|||
30641803|NCT00833482|58653858|FG004|Days 11-20|Adverse Event|0|||
30641804|NCT00833482|58653859|FG005|Days 11-20|Adverse Event|0|||
30641805|NCT00833482|58653854|FG000|Days 11-20|Withdrawal by Subject|0|||
30641806|NCT00833482|58653855|FG001|Days 11-20|Withdrawal by Subject|1|||
30641807|NCT00833482|58653856|FG002|Days 11-20|Withdrawal by Subject|0|||
30641808|NCT00833482|58653857|FG003|Days 11-20|Withdrawal by Subject|0|||
30641809|NCT00833482|58653858|FG004|Days 11-20|Withdrawal by Subject|0|||
30641810|NCT00833482|58653859|FG005|Days 11-20|Withdrawal by Subject|0|||
30641811|NCT00833482|58653854|FG000|Days 21-30|Adverse Event|0|||
30641812|NCT00833482|58653855|FG001|Days 21-30|Adverse Event|0|||
30641813|NCT00833482|58653856|FG002|Days 21-30|Adverse Event|1|||
30641814|NCT00833482|58653857|FG003|Days 21-30|Adverse Event|0|||
30641815|NCT00833482|58653858|FG004|Days 21-30|Adverse Event|0|||
30641816|NCT00833482|58653859|FG005|Days 21-30|Adverse Event|0|||
30641817|NCT00833482|58653854|FG000|Days 21-30|Withdrawal by Subject|0|||
30641818|NCT00833482|58653855|FG001|Days 21-30|Withdrawal by Subject|0|||
30641819|NCT00833482|58653856|FG002|Days 21-30|Withdrawal by Subject|0|||
30641820|NCT00833482|58653857|FG003|Days 21-30|Withdrawal by Subject|0|||
30641821|NCT00833482|58653858|FG004|Days 21-30|Withdrawal by Subject|1|||
30641822|NCT00833482|58653859|FG005|Days 21-30|Withdrawal by Subject|0|||
30641823|NCT00845182|58653884|FG000|Overall Study|Lost to Follow-up|3|||
30641824|NCT00845182|58653885|FG001|Overall Study|Lost to Follow-up|3|||
30641825|NCT00845182|58653886|FG002|Overall Study|Lost to Follow-up|4|||
30641826|NCT00845182|58653884|FG000|Overall Study|Adverse Event|0|||
30641827|NCT00845182|58653885|FG001|Overall Study|Adverse Event|1|||
30641828|NCT00845182|58653886|FG002|Overall Study|Adverse Event|1|||
30641829|NCT00845182|58653884|FG000|Overall Study|Physician Decision|0|||
30641830|NCT00845182|58653885|FG001|Overall Study|Physician Decision|0|||
30641831|NCT00845182|58653886|FG002|Overall Study|Physician Decision|1|||
30641832|NCT00833248|58653900|FG000|Overall Study|Adverse Event|3|||
30641833|NCT00833248|58653901|FG001|Overall Study|Adverse Event|0|||
30641834|NCT00833248|58653900|FG000|Overall Study|Protocol Violation|1|||
30641835|NCT00833248|58653901|FG001|Overall Study|Protocol Violation|2|||
30641836|NCT00833248|58653900|FG000|Overall Study|Withdrawal by Subject|0|||
30641837|NCT00833248|58653901|FG001|Overall Study|Withdrawal by Subject|1|||
30641838|NCT00887289|58653907|FG000|Overall Study|Lack of Efficacy|14|||
30641839|NCT00887289|58653907|FG000|Overall Study|Adverse Event|27|||
30641840|NCT00887289|58653907|FG000|Overall Study|Withdrawal by Subject|26|||
30641841|NCT00887289|58653907|FG000|Overall Study|Lost to Follow-up|8|||
30641842|NCT00887289|58653907|FG000|Overall Study|Other|20|||
30641843|NCT00833092|58653913|FG000|Overall Study|Withdrawal by Subject|2|||
30641844|NCT00833092|58653914|FG001|Overall Study|Withdrawal by Subject|3|||
30641845|NCT00833092|58653913|FG000|Overall Study|Protocol Violation|2|||
30641846|NCT00833092|58653914|FG001|Overall Study|Protocol Violation|1|||
30765710|NCT00337571|58774425|FG003|Overall Study|Poor/noncompliance|1|||
30951696|NCT01712516|58999059|FG002|Overall Study|Death|0|||
30641847|NCT00833092|58653913|FG000|Overall Study|Diarrhea|0|||
30765711|NCT00337571|58774422|FG000|Overall Study|No longer met study criteria|1|||
30641848|NCT00833092|58653914|FG001|Overall Study|Diarrhea|2|||
30641849|NCT00833092|58653913|FG000|Overall Study|constipation|0|||
30641850|NCT00833092|58653914|FG001|Overall Study|constipation|1|||
30641851|NCT00823264|58653922|FG000|Overall Study|Protocol Violation|2|||
30641852|NCT00823264|58653923|FG001|Overall Study|Protocol Violation|0|||
30641853|NCT00832780|58653929|FG000|Overall Study|Death|16|||
30641854|NCT00832780|58653929|FG000|Overall Study|Lost to Follow-up|4|||
30641855|NCT00832780|58653929|FG000|Overall Study|no reason given|2|||
30641856|NCT00832780|58653929|FG000|Overall Study|other complicating condition|2|||
30641857|NCT00832780|58653929|FG000|Overall Study|Physician Decision|1|||
30641858|NCT00591838|58653938|FG000|Overall Study|Withdrawal by Subject|0|||
30641859|NCT00591838|58653939|FG001|Overall Study|Withdrawal by Subject|0|||
30641860|NCT00591838|58653940|FG002|Overall Study|Withdrawal by Subject|0|||
30641861|NCT00591838|58653941|FG003|Overall Study|Withdrawal by Subject|1|||
30641862|NCT00591838|58653942|FG004|Overall Study|Withdrawal by Subject|0|||
30641863|NCT00832624|58653955|FG000|Overall Study|Study Terminated|10|||
30641864|NCT00832078|58653959|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
30641865|NCT00832078|58653960|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
30641866|NCT00832078|58653959|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
30641867|NCT00832078|58653960|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
30641868|NCT00822172|58653968|FG000|Overall Study|Adverse Event|10|||
30641869|NCT00822172|58653969|FG001|Overall Study|Adverse Event|12|||
30641870|NCT00822172|58653968|FG000|Overall Study|Death|1|||
30641871|NCT00822172|58653969|FG001|Overall Study|Death|0|||
30641872|NCT00822172|58653968|FG000|Overall Study|Lost to Follow-up|3|||
30641873|NCT00822172|58653969|FG001|Overall Study|Lost to Follow-up|1|||
30641874|NCT00822172|58653968|FG000|Overall Study|Withdrawal by Subject|1|||
30641875|NCT00822172|58653969|FG001|Overall Study|Withdrawal by Subject|4|||
30765712|NCT00337571|58774423|FG001|Overall Study|No longer met study criteria|0|||
30765713|NCT00337571|58774424|FG002|Overall Study|No longer met study criteria|0|||
30765714|NCT00337571|58774425|FG003|Overall Study|No longer met study criteria|0|||
30765715|NCT00337571|58774422|FG000|Overall Study|High Potassium level|0|||
30765716|NCT00337571|58774423|FG001|Overall Study|High Potassium level|0|||
30765717|NCT00337571|58774424|FG002|Overall Study|High Potassium level|0|||
30765718|NCT00337571|58774425|FG003|Overall Study|High Potassium level|1|||
30765719|NCT00368927|58774437|FG000|Overall Study|Lost to Follow-up|2|||
30765720|NCT00368927|58774438|FG001|Overall Study|Lost to Follow-up|0|||
30765721|NCT00368927|58774437|FG000|Overall Study|Adverse Event|1|||
30765722|NCT00368927|58774438|FG001|Overall Study|Adverse Event|1|||
30765723|NCT00368927|58774437|FG000|Overall Study|Withdrawal by Subject|1|||
30765724|NCT00368927|58774438|FG001|Overall Study|Withdrawal by Subject|2|||
30765725|NCT00368927|58774437|FG000|Overall Study|Physician Decision|1|||
30765726|NCT00368927|58774438|FG001|Overall Study|Physician Decision|0|||
30765727|NCT00316589|58774461|FG000|Overall Study|Withdrawal by Subject|0|||
30765728|NCT00316589|58774462|FG001|Overall Study|Withdrawal by Subject|5|||
30765729|NCT00316589|58774463|FG002|Overall Study|Withdrawal by Subject|0|||
30765730|NCT00316589|58774464|FG003|Overall Study|Withdrawal by Subject|1|||
30765731|NCT00316589|58774461|FG000|Overall Study|Subject unwilling/unable to comply|0|||
30765732|NCT00316589|58774462|FG001|Overall Study|Subject unwilling/unable to comply|6|||
30765733|NCT00316589|58774463|FG002|Overall Study|Subject unwilling/unable to comply|0|||
30765734|NCT00316589|58774464|FG003|Overall Study|Subject unwilling/unable to comply|2|||
30765735|NCT00316589|58774461|FG000|Overall Study|Adverse Event|1|||
30765736|NCT00316589|58774462|FG001|Overall Study|Adverse Event|0|||
30765737|NCT00316589|58774463|FG002|Overall Study|Adverse Event|0|||
30765738|NCT00316589|58774464|FG003|Overall Study|Adverse Event|1|||
30765739|NCT00316589|58774461|FG000|Overall Study|Physician Decision|0|||
30765740|NCT00316589|58774462|FG001|Overall Study|Physician Decision|1|||
30765741|NCT00316589|58774463|FG002|Overall Study|Physician Decision|0|||
30848542|NCT02478320|58874653|FG000|Overall Study|Adverse Event|2|||
30848543|NCT02478320|58874654|FG001|Overall Study|Adverse Event|0|||
30641876|NCT00822172|58653968|FG000|Overall Study|site closed|0|||
30641877|NCT00822172|58653969|FG001|Overall Study|site closed|1|||
30641878|NCT00822172|58653968|FG000|Overall Study|Other|0|||
30641879|NCT00822172|58653969|FG001|Overall Study|Other|1|||
30641880|NCT00832000|58653975|FG000|Overall Study|Adverse Event|2|||
30641881|NCT00832000|58653976|FG001|Overall Study|Adverse Event|0|||
30641882|NCT00832000|58653975|FG000|Overall Study|Withdrawal by Subject|1|||
30765742|NCT00316589|58774464|FG003|Overall Study|Physician Decision|0|||
30765743|NCT00316589|58774461|FG000|Overall Study|Other reason|0|||
30765744|NCT00316589|58774462|FG001|Overall Study|Other reason|12|||
30765745|NCT00316589|58774463|FG002|Overall Study|Other reason|1|||
30765746|NCT00316589|58774464|FG003|Overall Study|Other reason|1|||
30765747|NCT00316277|58774478|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
30765748|NCT00316277|58774479|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
30765749|NCT00316277|58774478|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
30765750|NCT00316277|58774479|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
30765751|NCT00316277|58774478|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
30765752|NCT00316277|58774479|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
30765753|NCT00316277|58774478|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
30765754|NCT00316277|58774479|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
30848544|NCT02478320|58874653|FG000|Overall Study|Death|1|||
30765755|NCT00316277|58774478|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
30765756|NCT00316277|58774479|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
30848545|NCT02478320|58874654|FG001|Overall Study|Death|0|||
30641883|NCT00832000|58653976|FG001|Overall Study|Withdrawal by Subject|0|||
30641884|NCT00832000|58653975|FG000|Overall Study|No calls to IVR in either period|1|||
30641885|NCT00832000|58653976|FG001|Overall Study|No calls to IVR in either period|1|||
30641886|NCT00832000|58653975|FG000|Overall Study|No calls to IVR in period 2|2|||
30641887|NCT00832000|58653976|FG001|Overall Study|No calls to IVR in period 2|0|||
30641888|NCT00911508|58654013|FG000|Overall Study|Lost to Follow-up|27|||
30641889|NCT00911508|58654014|FG001|Overall Study|Lost to Follow-up|18|||
30641890|NCT00911508|58654013|FG000|Overall Study|Withdrawal by Subject|79|||
30641891|NCT00911508|58654014|FG001|Overall Study|Withdrawal by Subject|112|||
30641892|NCT00774397|58654040|FG000|Overall Study|Adverse Event|1|||
30641893|NCT00774397|58654041|FG001|Overall Study|Adverse Event|3|||
30641894|NCT00774397|58654042|FG002|Overall Study|Adverse Event|16|||
30641895|NCT00774397|58654043|FG003|Overall Study|Adverse Event|8|||
30641896|NCT00774397|58654044|FG004|Overall Study|Adverse Event|8|||
30641897|NCT00774397|58654045|FG005|Overall Study|Adverse Event|3|||
30641898|NCT00774397|58654046|FG006|Overall Study|Adverse Event|16|||
30641899|NCT00774397|58654040|FG000|Overall Study|Lack of Efficacy|11|||
30641900|NCT00774397|58654041|FG001|Overall Study|Lack of Efficacy|4|||
30641901|NCT00774397|58654042|FG002|Overall Study|Lack of Efficacy|5|||
30641902|NCT00774397|58654043|FG003|Overall Study|Lack of Efficacy|3|||
30641903|NCT00774397|58654044|FG004|Overall Study|Lack of Efficacy|27|||
30641904|NCT00774397|58654045|FG005|Overall Study|Lack of Efficacy|15|||
30641905|NCT00774397|58654046|FG006|Overall Study|Lack of Efficacy|9|||
30641906|NCT00774397|58654040|FG000|Overall Study|Protocol Violation|0|||
30641907|NCT00774397|58654041|FG001|Overall Study|Protocol Violation|1|||
30641908|NCT00774397|58654042|FG002|Overall Study|Protocol Violation|3|||
30641909|NCT00774397|58654043|FG003|Overall Study|Protocol Violation|1|||
30641910|NCT00774397|58654044|FG004|Overall Study|Protocol Violation|2|||
30641911|NCT00774397|58654045|FG005|Overall Study|Protocol Violation|1|||
30641912|NCT00774397|58654046|FG006|Overall Study|Protocol Violation|0|||
30641913|NCT00774397|58654040|FG000|Overall Study|Lost to Follow-up|0|||
30641914|NCT00774397|58654041|FG001|Overall Study|Lost to Follow-up|1|||
30641915|NCT00774397|58654042|FG002|Overall Study|Lost to Follow-up|1|||
30641916|NCT00774397|58654043|FG003|Overall Study|Lost to Follow-up|1|||
30641917|NCT00774397|58654044|FG004|Overall Study|Lost to Follow-up|0|||
30641918|NCT00774397|58654045|FG005|Overall Study|Lost to Follow-up|1|||
30641919|NCT00774397|58654046|FG006|Overall Study|Lost to Follow-up|0|||
30641920|NCT00774397|58654040|FG000|Overall Study|Refused to continue trial medication|1|||
30641921|NCT00774397|58654041|FG001|Overall Study|Refused to continue trial medication|3|||
30641922|NCT00774397|58654042|FG002|Overall Study|Refused to continue trial medication|2|||
30641923|NCT00774397|58654043|FG003|Overall Study|Refused to continue trial medication|2|||
30641924|NCT00774397|58654044|FG004|Overall Study|Refused to continue trial medication|6|||
30641925|NCT00774397|58654045|FG005|Overall Study|Refused to continue trial medication|2|||
30641926|NCT00774397|58654046|FG006|Overall Study|Refused to continue trial medication|3|||
30641927|NCT00774397|58654040|FG000|Overall Study|Not treated|0|||
30641928|NCT00774397|58654041|FG001|Overall Study|Not treated|0|||
30641929|NCT00774397|58654042|FG002|Overall Study|Not treated|0|||
30641930|NCT00774397|58654043|FG003|Overall Study|Not treated|0|||
30641931|NCT00774397|58654044|FG004|Overall Study|Not treated|1|||
30641932|NCT00774397|58654045|FG005|Overall Study|Not treated|0|||
30641933|NCT00774397|58654046|FG006|Overall Study|Not treated|1|||
30641934|NCT00774397|58654040|FG000|Overall Study|Other than those stated above|1|||
30641935|NCT00774397|58654041|FG001|Overall Study|Other than those stated above|1|||
30641936|NCT00774397|58654042|FG002|Overall Study|Other than those stated above|3|||
30641937|NCT00774397|58654043|FG003|Overall Study|Other than those stated above|2|||
30641938|NCT00774397|58654044|FG004|Overall Study|Other than those stated above|2|||
30641939|NCT00774397|58654045|FG005|Overall Study|Other than those stated above|0|||
30641940|NCT00774397|58654046|FG006|Overall Study|Other than those stated above|1|||
30641941|NCT00909870|58654101|FG000|Overall Study|Adverse Event|13|||
30641942|NCT00909870|58654102|FG001|Overall Study|Adverse Event|7|||
30641943|NCT00909870|58654101|FG000|Overall Study|Protocol Violation|1|||
30641944|NCT00909870|58654102|FG001|Overall Study|Protocol Violation|2|||
30641945|NCT00909870|58654101|FG000|Overall Study|Withdrawal by Subject|5|||
30848546|NCT02478320|58874653|FG000|Overall Study|Lack of Efficacy|4|||
30848547|NCT02478320|58874654|FG001|Overall Study|Lack of Efficacy|0|||
30848548|NCT02478320|58874653|FG000|Overall Study|Withdrawal by Subject|2|||
30848549|NCT02478320|58874654|FG001|Overall Study|Withdrawal by Subject|0|||
30848550|NCT02478320|58874653|FG000|Overall Study|Screen Failure|3|||
30641946|NCT00909870|58654102|FG001|Overall Study|Withdrawal by Subject|8|||
30848551|NCT02478320|58874654|FG001|Overall Study|Screen Failure|0|||
30848552|NCT02252042|58874679|FG000|Overall Study|Adverse Event|9|||
30641947|NCT00909870|58654101|FG000|Overall Study|Lost to Follow-up|3|||
30848553|NCT02252042|58874680|FG001|Overall Study|Adverse Event|6|||
30641948|NCT00909870|58654102|FG001|Overall Study|Lost to Follow-up|3|||
30641949|NCT00909870|58654101|FG000|Overall Study|Physician Decision|0|||
30641950|NCT00909870|58654102|FG001|Overall Study|Physician Decision|2|||
30641951|NCT00909870|58654101|FG000|Overall Study|Other|1|||
30848554|NCT02252042|58874679|FG000|Overall Study|Death|209|||
30848555|NCT02252042|58874680|FG001|Overall Study|Death|217|||
30641952|NCT00909870|58654102|FG001|Overall Study|Other|5|||
30641953|NCT00768469|58654111|FG000|Overall Study|Adverse Event|0|||
30641954|NCT00768469|58654112|FG001|Overall Study|Adverse Event|2|||
30641955|NCT00768469|58654111|FG000|Overall Study|Disease Progression|3|||
30641956|NCT00768469|58654112|FG001|Overall Study|Disease Progression|4|||
30641957|NCT00768469|58654111|FG000|Overall Study|Withdrawal by Subject|0|||
30641958|NCT00768469|58654112|FG001|Overall Study|Withdrawal by Subject|1|||
30641959|NCT00886821|58654133|FG000|Stage 2|Adverse Event|0|||
30641960|NCT00886821|58654134|FG001|Stage 2|Adverse Event|0|||
30641961|NCT00886821|58654135|FG002|Stage 2|Adverse Event|0|||
30641962|NCT00886821|58654136|FG003|Stage 2|Adverse Event|0|||
30641963|NCT00886821|58654137|FG004|Stage 2|Adverse Event|0|||
30641964|NCT00886821|58654138|FG005|Stage 2|Adverse Event|0|||
30641965|NCT00886821|58654139|FG006|Stage 2|Adverse Event|0|||
30641966|NCT00886821|58654140|FG007|Stage 2|Adverse Event|0|||
30641967|NCT00886821|58654141|FG008|Stage 2|Adverse Event|0|||
30641968|NCT00886821|58654142|FG009|Stage 2|Adverse Event|0|||
30641969|NCT00886821|58654143|FG010|Stage 2|Adverse Event|0|||
30641970|NCT00886821|58654144|FG011|Stage 2|Adverse Event|1|||
30641971|NCT00886821|58654145|FG012|Stage 2|Adverse Event|3|||
30641972|NCT00886821|58654146|FG013|Stage 2|Adverse Event|0|||
30641973|NCT00886821|58654133|FG000|Stage 2|Lost to Follow-up|0|||
30641974|NCT00886821|58654134|FG001|Stage 2|Lost to Follow-up|0|||
30641975|NCT00886821|58654135|FG002|Stage 2|Lost to Follow-up|0|||
30641976|NCT00886821|58654136|FG003|Stage 2|Lost to Follow-up|0|||
30641977|NCT00886821|58654137|FG004|Stage 2|Lost to Follow-up|0|||
30641978|NCT00886821|58654138|FG005|Stage 2|Lost to Follow-up|0|||
30641979|NCT00886821|58654139|FG006|Stage 2|Lost to Follow-up|0|||
30641980|NCT00886821|58654140|FG007|Stage 2|Lost to Follow-up|0|||
30641981|NCT00886821|58654141|FG008|Stage 2|Lost to Follow-up|0|||
30641982|NCT00886821|58654142|FG009|Stage 2|Lost to Follow-up|0|||
30641983|NCT00886821|58654143|FG010|Stage 2|Lost to Follow-up|0|||
30641984|NCT00886821|58654144|FG011|Stage 2|Lost to Follow-up|0|||
30641985|NCT00886821|58654145|FG012|Stage 2|Lost to Follow-up|2|||
30641986|NCT00886821|58654146|FG013|Stage 2|Lost to Follow-up|1|||
30641987|NCT00886743|58654190|FG000|Overall Study|Adverse Event|3|||
30641988|NCT00886743|58654190|FG000|Overall Study|Other|1|||
30641989|NCT00886587|58654196|FG000|Overall Study|Adverse Event|2|||
30641990|NCT00886587|58654197|FG001|Overall Study|Adverse Event|1|||
30641991|NCT00886587|58654196|FG000|Overall Study|Protocol Violation|2|||
30951697|NCT01712516|58999060|FG003|Overall Study|Death|0|||
30951698|NCT01712516|58999057|FG000|Overall Study|Protocol deviation|1|||
30951699|NCT01712516|58999058|FG001|Overall Study|Protocol deviation|0|||
30951700|NCT01712516|58999059|FG002|Overall Study|Protocol deviation|1|||
30951701|NCT01712516|58999060|FG003|Overall Study|Protocol deviation|0|||
30951702|NCT01712516|58999057|FG000|Overall Study|Physician Decision|2|||
30951703|NCT01712516|58999058|FG001|Overall Study|Physician Decision|0|||
30951704|NCT01712516|58999059|FG002|Overall Study|Physician Decision|0|||
30951705|NCT01712516|58999060|FG003|Overall Study|Physician Decision|1|||
30951706|NCT01712516|58999057|FG000|Overall Study|Withdrawal by Subject|3|||
30951707|NCT01712516|58999058|FG001|Overall Study|Withdrawal by Subject|9|||
30951708|NCT01712516|58999059|FG002|Overall Study|Withdrawal by Subject|3|||
30951709|NCT01712516|58999060|FG003|Overall Study|Withdrawal by Subject|9|||
30951710|NCT01703000|58999070|FG000|Overall Study|Death|1|||
30951711|NCT01040728|58999074|FG000|Overall Study|Adverse Event|4|||
30951712|NCT01040728|58999075|FG001|Overall Study|Adverse Event|8|||
30951713|NCT01040728|58999076|FG002|Overall Study|Adverse Event|0|||
30641992|NCT00886587|58654197|FG001|Overall Study|Protocol Violation|0|||
30641993|NCT00886587|58654196|FG000|Overall Study|Withdrawal by Subject|0|||
30641994|NCT00886587|58654197|FG001|Overall Study|Withdrawal by Subject|1|||
30641995|NCT00886119|58654203|FG000|Period 1|Did not meet inclusion criteria|1|||
30641996|NCT00886119|58654204|FG001|Period 1|Did not meet inclusion criteria|0|||
30641997|NCT00768079|58654213|FG000|Overall Study|Lost to Follow-up|2|||
30951714|NCT01040728|58999077|FG003|Overall Study|Adverse Event|4|||
30951715|NCT01040728|58999074|FG000|Overall Study|Withdrawal by Subject|0|||
30951716|NCT01040728|58999075|FG001|Overall Study|Withdrawal by Subject|1|||
30951717|NCT01040728|58999076|FG002|Overall Study|Withdrawal by Subject|1|||
30641998|NCT00768079|58654214|FG001|Overall Study|Lost to Follow-up|0|||
30951718|NCT01040728|58999077|FG003|Overall Study|Withdrawal by Subject|0|||
30951719|NCT01040728|58999074|FG000|Overall Study|Protocol Violation|0|||
30641999|NCT00768079|58654215|FG002|Overall Study|Lost to Follow-up|4|||
30642000|NCT00768079|58654213|FG000|Overall Study|Participant incarcerated|0|||
30642001|NCT00768079|58654214|FG001|Overall Study|Participant incarcerated|1|||
30642002|NCT00768079|58654215|FG002|Overall Study|Participant incarcerated|0|||
30642003|NCT00767455|58654225|FG000|Overall Study|Investigator error|19|||
30642004|NCT00766831|58654231|FG000|Overall Study|Withdrawal by Subject|4|||
30642005|NCT00766831|58654231|FG000|Overall Study|Lost to Follow-up|3|||
30642006|NCT00766831|58654231|FG000|Overall Study|Adverse Event|20|||
30642007|NCT00766831|58654231|FG000|Overall Study|Protocol Violation|15|||
30642008|NCT00766831|58654231|FG000|Overall Study|Physician Decision|5|||
30642009|NCT00766831|58654231|FG000|Overall Study|Withdrawal of consent|26|||
30642010|NCT00766831|58654231|FG000|Overall Study|Non cooperation by participants|14|||
30642011|NCT00766831|58654231|FG000|Overall Study|Other|28|||
30642012|NCT00766675|58654235|FG000|Overall Study|Adverse Event|16|||
30642013|NCT00766675|58654235|FG000|Overall Study|Lost to Follow-up|2|||
30642014|NCT00766675|58654235|FG000|Overall Study|Withdrawal by Subject|11|||
30642015|NCT00766675|58654235|FG000|Overall Study|Protocol Violation|8|||
30642016|NCT00766675|58654235|FG000|Overall Study|Participant took prohibited medication|1|||
30642017|NCT00766675|58654235|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
30642018|NCT00766675|58654235|FG000|Overall Study|Insufficient therapy|1|||
30642019|NCT00766597|58654239|FG000|Overall Study|Unexpected closure of study|4|||
30642020|NCT00766597|58654239|FG000|Overall Study|Without CCR5-tropic virus|5|||
30642021|NCT00910962|58654248|FG000|Overall Study|Adverse Event|5|||
30642022|NCT00910962|58654249|FG001|Overall Study|Adverse Event|20|||
30642023|NCT00910962|58654250|FG002|Overall Study|Adverse Event|17|||
30642024|NCT00910962|58654248|FG000|Overall Study|Protocol Violation|1|||
30642025|NCT00910962|58654249|FG001|Overall Study|Protocol Violation|3|||
30642026|NCT00910962|58654250|FG002|Overall Study|Protocol Violation|3|||
30642027|NCT00910962|58654248|FG000|Overall Study|Lost to Follow-up|0|||
30642028|NCT00910962|58654249|FG001|Overall Study|Lost to Follow-up|3|||
30642029|NCT00910962|58654250|FG002|Overall Study|Lost to Follow-up|1|||
30642030|NCT00910962|58654248|FG000|Overall Study|Physician Decision|0|||
30642031|NCT00910962|58654249|FG001|Overall Study|Physician Decision|6|||
30642032|NCT00910962|58654250|FG002|Overall Study|Physician Decision|6|||
30642033|NCT00910962|58654248|FG000|Overall Study|Withdrawal by Subject|25|||
30642034|NCT00910962|58654249|FG001|Overall Study|Withdrawal by Subject|32|||
30642035|NCT00910962|58654250|FG002|Overall Study|Withdrawal by Subject|32|||
30642036|NCT00910962|58654248|FG000|Overall Study|Reached defined stopping criteria|12|||
30642037|NCT00910962|58654249|FG001|Overall Study|Reached defined stopping criteria|14|||
30642038|NCT00910962|58654250|FG002|Overall Study|Reached defined stopping criteria|17|||
30642039|NCT00773461|58654262|FG000|Overall Study|Adverse Event|1|||
30642040|NCT00773461|58654263|FG001|Overall Study|Adverse Event|3|||
30642041|NCT00773461|58654262|FG000|Overall Study|Withdrawal by Subject|4|||
30642042|NCT00773461|58654263|FG001|Overall Study|Withdrawal by Subject|1|||
30642043|NCT00773383|58654270|FG000|Overall Study|Adverse Event|4|||
30642044|NCT00773383|58654270|FG000|Overall Study|Death|1|||
30642045|NCT00773383|58654270|FG000|Overall Study|Progression of Disease|23|||
30642046|NCT00773383|58654270|FG000|Overall Study|Other|2|||
30642047|NCT00773383|58654270|FG000|Overall Study|No study dose received|1|||
30642048|NCT00757003|58654278|FG000|Overall Study|Death|33|||
30642049|NCT00757003|58654278|FG000|Overall Study|Lost to Follow-up|9|||
30642050|NCT00757003|58654278|FG000|Overall Study|Withdrawal by Subject|4|||
30642051|NCT00757003|58654278|FG000|Overall Study|Surgically explanted|2|||
30642052|NCT00757003|58654278|FG000|Overall Study|Not implanted|1|||
30642053|NCT00766363|58654287|FG000|Overall Study|Withdrawal by Subject|1|||
30642054|NCT00766363|58654288|FG001|Overall Study|Withdrawal by Subject|0|||
30642055|NCT00766363|58654289|FG002|Overall Study|Withdrawal by Subject|0|||
30642056|NCT00766363|58654290|FG003|Overall Study|Withdrawal by Subject|0|||
30642057|NCT00766363|58654287|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
30642058|NCT00766363|58654288|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
30642059|NCT00766363|58654289|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
30642060|NCT00766363|58654290|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
30642061|NCT02636946|58654303|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
30642062|NCT02636946|58654304|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
30642063|NCT02636946|58654303|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
30642064|NCT02636946|58654304|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
30642065|NCT02636946|58654303|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
30642066|NCT02636946|58654304|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
30642067|NCT02636946|58654303|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
30642068|NCT02636946|58654304|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
30642069|NCT02636946|58654303|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
30642070|NCT02636946|58654304|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
30642071|NCT02636946|58654303|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
30642072|NCT02636946|58654304|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
30642073|NCT00766051|58654312|FG000|Overall Study|Withdrawal by Subject|2|||
30642074|NCT00766051|58654313|FG001|Overall Study|Withdrawal by Subject|0|||
30642075|NCT00909792|58654321|FG000|Period 1|Did not meet inclusion criteria|0|||
30642076|NCT00909792|58654322|FG001|Period 1|Did not meet inclusion criteria|1|||
30642077|NCT00909792|58654321|FG000|Period 2|Biomicroscopy|1|||
30642078|NCT00909792|58654322|FG001|Period 2|Biomicroscopy|0|||
30642079|NCT00909792|58654321|FG000|Period 2|Lost to Follow-up|0|||
30642080|NCT00909792|58654322|FG001|Period 2|Lost to Follow-up|1|||
30642081|NCT00765817|58654330|FG000|Overall Study|Adverse Event|13|||
30642082|NCT00765817|58654331|FG001|Overall Study|Adverse Event|1|||
30642083|NCT00765817|58654330|FG000|Overall Study|Death|0|||
30642084|NCT00765817|58654331|FG001|Overall Study|Death|1|||
30642085|NCT00765817|58654330|FG000|Overall Study|Entry criteria not met|2|||
30642086|NCT00765817|58654331|FG001|Overall Study|Entry criteria not met|2|||
30642087|NCT00765817|58654330|FG000|Overall Study|Loss of glucose control|0|||
30642088|NCT00765817|58654331|FG001|Overall Study|Loss of glucose control|2|||
30642089|NCT00765817|58654330|FG000|Overall Study|Lost to Follow-up|1|||
30642090|NCT00765817|58654331|FG001|Overall Study|Lost to Follow-up|3|||
30642091|NCT00765817|58654330|FG000|Overall Study|Physician Decision|2|||
30642092|NCT00765817|58654331|FG001|Overall Study|Physician Decision|1|||
30642093|NCT00765817|58654330|FG000|Overall Study|Protocol Violation|1|||
30642094|NCT00765817|58654331|FG001|Overall Study|Protocol Violation|1|||
30642095|NCT00765817|58654330|FG000|Overall Study|Subject decision|7|||
30642096|NCT00765817|58654331|FG001|Overall Study|Subject decision|11|||
30642097|NCT00772603|58654340|FG000|Overall Study|Withdrawal by Subject|11|||
30642098|NCT00772603|58654341|FG001|Overall Study|Withdrawal by Subject|10|||
30642099|NCT00772603|58654342|FG002|Overall Study|Withdrawal by Subject|6|||
30642100|NCT00772603|58654340|FG000|Overall Study|Adverse Event|37|||
30848556|NCT02252042|58874679|FG000|Overall Study|Physician Decision|0|||
30848557|NCT02252042|58874680|FG001|Overall Study|Physician Decision|2|||
30951720|NCT01040728|58999075|FG001|Overall Study|Protocol Violation|0|||
30951721|NCT01040728|58999076|FG002|Overall Study|Protocol Violation|0|||
30642101|NCT00772603|58654341|FG001|Overall Study|Adverse Event|18|||
30642102|NCT00772603|58654342|FG002|Overall Study|Adverse Event|10|||
30765757|NCT00368849|58774493|FG000|Overall Study|Withdrawal by Subject|0|||
30765758|NCT00368849|58774494|FG001|Overall Study|Withdrawal by Subject|1|||
30765759|NCT00368849|58774493|FG000|Overall Study|Physician Decision|0|||
30765760|NCT00368849|58774494|FG001|Overall Study|Physician Decision|1|||
30642103|NCT00772603|58654340|FG000|Overall Study|Subject Non-compliance|1|||
30642104|NCT00772603|58654341|FG001|Overall Study|Subject Non-compliance|6|||
30642105|NCT00772603|58654342|FG002|Overall Study|Subject Non-compliance|4|||
30642106|NCT00772603|58654340|FG000|Overall Study|Protocol Violation|0|||
30642107|NCT00772603|58654341|FG001|Overall Study|Protocol Violation|1|||
30642108|NCT00772603|58654342|FG002|Overall Study|Protocol Violation|1|||
30642109|NCT00772603|58654340|FG000|Overall Study|Lost to Follow-up|1|||
30642110|NCT00772603|58654341|FG001|Overall Study|Lost to Follow-up|5|||
30642111|NCT00772603|58654342|FG002|Overall Study|Lost to Follow-up|2|||
30642112|NCT00772603|58654340|FG000|Overall Study|Physician Decision|0|||
30642113|NCT00772603|58654341|FG001|Overall Study|Physician Decision|0|||
30642114|NCT00772603|58654342|FG002|Overall Study|Physician Decision|1|||
30642115|NCT00772603|58654340|FG000|Overall Study|Other|2|||
30642116|NCT00772603|58654341|FG001|Overall Study|Other|0|||
30642117|NCT00772603|58654342|FG002|Overall Study|Other|2|||
30642118|NCT00772447|58654355|FG000|Overall Study|Withdrawal by Subject|9|||
30642119|NCT00772447|58654356|FG001|Overall Study|Withdrawal by Subject|5|||
30642120|NCT00772447|58654355|FG000|Overall Study|Physician Decision|4|||
30642121|NCT00772447|58654356|FG001|Overall Study|Physician Decision|8|||
30642122|NCT00772447|58654355|FG000|Overall Study|Lost to Follow-up|2|||
30642123|NCT00772447|58654356|FG001|Overall Study|Lost to Follow-up|4|||
30642124|NCT00772447|58654355|FG000|Overall Study|incorrect enrolment|3|||
30642125|NCT00772447|58654356|FG001|Overall Study|incorrect enrolment|4|||
30642126|NCT00772447|58654355|FG000|Overall Study|Protocol Violation|0|||
30642127|NCT00772447|58654356|FG001|Overall Study|Protocol Violation|1|||
30642128|NCT00772447|58654355|FG000|Overall Study|all others|2|||
30642129|NCT00772447|58654356|FG001|Overall Study|all others|2|||
30642130|NCT00765037|58654363|FG000|Overall Study|Lost to Follow-up|5|||
30642131|NCT00765037|58654363|FG000|Overall Study|Adverse Event|1|||
30642132|NCT00831844|58654377|FG000|Overall Study|Adverse Event|2|||
30642133|NCT00831844|58654378|FG001|Overall Study|Adverse Event|0|||
30642134|NCT00831844|58654379|FG002|Overall Study|Adverse Event|0|||
30642135|NCT00831844|58654380|FG003|Overall Study|Adverse Event|0|||
30642136|NCT00831844|58654381|FG004|Overall Study|Adverse Event|1|||
30642137|NCT00831844|58654382|FG005|Overall Study|Adverse Event|1|||
30765761|NCT00316199|58774501|FG000|Overall Study|Adverse Event|2|||
30765762|NCT00316199|58774501|FG000|Overall Study|Death|8|||
30765763|NCT00316199|58774501|FG000|Overall Study|Lost to Follow-up|2|||
30765764|NCT00316121|58774507|FG000|Overall Study|Death|1|||
30765765|NCT00316121|58774508|FG001|Overall Study|Death|0|||
30765766|NCT00316121|58774507|FG000|Overall Study|Lost to Follow-up|14|||
30765767|NCT00316121|58774508|FG001|Overall Study|Lost to Follow-up|8|||
30642138|NCT00831844|58654383|FG006|Overall Study|Adverse Event|2|||
30642139|NCT00831844|58654384|FG007|Overall Study|Adverse Event|0|||
30642140|NCT00831844|58654385|FG008|Overall Study|Adverse Event|0|||
30642141|NCT00831844|58654386|FG009|Overall Study|Adverse Event|0|||
30642142|NCT00831844|58654377|FG000|Overall Study|Death|0|||
30642143|NCT00831844|58654378|FG001|Overall Study|Death|0|||
30642144|NCT00831844|58654379|FG002|Overall Study|Death|0|||
30642145|NCT00831844|58654380|FG003|Overall Study|Death|1|||
30642146|NCT00831844|58654381|FG004|Overall Study|Death|0|||
30642147|NCT00831844|58654382|FG005|Overall Study|Death|0|||
30642148|NCT00831844|58654383|FG006|Overall Study|Death|0|||
30642149|NCT00831844|58654384|FG007|Overall Study|Death|0|||
30765768|NCT00316121|58774507|FG000|Overall Study|Withdrawal by Subject|2|||
30642150|NCT00831844|58654385|FG008|Overall Study|Death|0|||
30642151|NCT00831844|58654386|FG009|Overall Study|Death|0|||
30642152|NCT00831844|58654377|FG000|Overall Study|Lack of Efficacy|8|||
30642153|NCT00831844|58654378|FG001|Overall Study|Lack of Efficacy|10|||
30642154|NCT00831844|58654379|FG002|Overall Study|Lack of Efficacy|15|||
30642155|NCT00831844|58654380|FG003|Overall Study|Lack of Efficacy|8|||
30642156|NCT00831844|58654381|FG004|Overall Study|Lack of Efficacy|11|||
30642157|NCT00831844|58654382|FG005|Overall Study|Lack of Efficacy|17|||
30642158|NCT00831844|58654383|FG006|Overall Study|Lack of Efficacy|8|||
30642159|NCT00831844|58654384|FG007|Overall Study|Lack of Efficacy|9|||
30642160|NCT00831844|58654385|FG008|Overall Study|Lack of Efficacy|7|||
30642161|NCT00831844|58654386|FG009|Overall Study|Lack of Efficacy|0|||
30642162|NCT00831844|58654377|FG000|Overall Study|Physician Decision|0|||
30642163|NCT00831844|58654378|FG001|Overall Study|Physician Decision|1|||
30642164|NCT00831844|58654379|FG002|Overall Study|Physician Decision|3|||
30642165|NCT00831844|58654380|FG003|Overall Study|Physician Decision|1|||
30642166|NCT00831844|58654381|FG004|Overall Study|Physician Decision|1|||
30642167|NCT00831844|58654382|FG005|Overall Study|Physician Decision|1|||
30642168|NCT00831844|58654383|FG006|Overall Study|Physician Decision|0|||
30642169|NCT00831844|58654384|FG007|Overall Study|Physician Decision|0|||
30642170|NCT00831844|58654385|FG008|Overall Study|Physician Decision|1|||
30642171|NCT00831844|58654386|FG009|Overall Study|Physician Decision|0|||
30642172|NCT00831844|58654377|FG000|Overall Study|Withdrawal by Subject|0|||
30642173|NCT00831844|58654378|FG001|Overall Study|Withdrawal by Subject|0|||
30642174|NCT00831844|58654379|FG002|Overall Study|Withdrawal by Subject|1|||
30642175|NCT00831844|58654380|FG003|Overall Study|Withdrawal by Subject|0|||
30642176|NCT00831844|58654381|FG004|Overall Study|Withdrawal by Subject|0|||
30642177|NCT00831844|58654382|FG005|Overall Study|Withdrawal by Subject|0|||
30642178|NCT00831844|58654383|FG006|Overall Study|Withdrawal by Subject|0|||
30642179|NCT00831844|58654384|FG007|Overall Study|Withdrawal by Subject|1|||
30642180|NCT00831844|58654385|FG008|Overall Study|Withdrawal by Subject|1|||
30642181|NCT00831844|58654386|FG009|Overall Study|Withdrawal by Subject|0|||
30642182|NCT00831844|58654377|FG000|Overall Study|Ineligible|0|||
30642183|NCT00831844|58654378|FG001|Overall Study|Ineligible|1|||
30642184|NCT00831844|58654379|FG002|Overall Study|Ineligible|1|||
30642185|NCT00831844|58654380|FG003|Overall Study|Ineligible|0|||
30642186|NCT00831844|58654381|FG004|Overall Study|Ineligible|1|||
30642187|NCT00831844|58654382|FG005|Overall Study|Ineligible|0|||
30642188|NCT00831844|58654383|FG006|Overall Study|Ineligible|0|||
30642189|NCT00831844|58654384|FG007|Overall Study|Ineligible|0|||
30642190|NCT00831844|58654385|FG008|Overall Study|Ineligible|0|||
30642191|NCT00831844|58654386|FG009|Overall Study|Ineligible|0|||
30642192|NCT00764881|58654410|FG000|Overall Study|Adverse Event|5|||
30642193|NCT00764881|58654411|FG001|Overall Study|Adverse Event|1|||
30642194|NCT00764881|58654410|FG000|Overall Study|Withdrawal by Subject|1|||
30642195|NCT00764881|58654411|FG001|Overall Study|Withdrawal by Subject|3|||
30642196|NCT00764881|58654410|FG000|Overall Study|Protocol Violation|2|||
30642197|NCT00764881|58654411|FG001|Overall Study|Protocol Violation|2|||
30642198|NCT00764881|58654410|FG000|Overall Study|Lost to Follow-up|2|||
30642199|NCT00764881|58654411|FG001|Overall Study|Lost to Follow-up|0|||
30642200|NCT00764881|58654410|FG000|Overall Study|Noncompliant|1|||
30642201|NCT00764881|58654411|FG001|Overall Study|Noncompliant|0|||
30642202|NCT00764881|58654410|FG000|Overall Study|Accidentally discontinued study drug|1|||
30642203|NCT00764881|58654411|FG001|Overall Study|Accidentally discontinued study drug|0|||
30765769|NCT00316121|58774508|FG001|Overall Study|Withdrawal by Subject|0|||
30765770|NCT00316121|58774507|FG000|Overall Study|Reason is missing|1|||
30765771|NCT00316121|58774508|FG001|Overall Study|Reason is missing|0|||
30765772|NCT00316121|58774507|FG000|Overall Study|Subject relocated|1|||
30765773|NCT00316121|58774508|FG001|Overall Study|Subject relocated|1|||
30765774|NCT00316121|58774507|FG000|Overall Study|Subject refused to return|1|||
30765775|NCT00316121|58774508|FG001|Overall Study|Subject refused to return|0|||
30765776|NCT00316121|58774507|FG000|Overall Study|Subject no show for visit x 3|1|||
30765777|NCT00316121|58774508|FG001|Overall Study|Subject no show for visit x 3|0|||
30765778|NCT00316121|58774507|FG000|Overall Study|Subject did not have 24 month visit|1|||
30642204|NCT00764881|58654410|FG000|Overall Study|Wished to become pregnant|1|||
30642205|NCT00764881|58654411|FG001|Overall Study|Wished to become pregnant|0|||
30642206|NCT00764881|58654410|FG000|Overall Study|Carcinoma detected|1|||
30642207|NCT00764881|58654411|FG001|Overall Study|Carcinoma detected|0|||
30765779|NCT00316121|58774508|FG001|Overall Study|Subject did not have 24 month visit|0|||
30765780|NCT00337103|58774527|FG000|Overall Study|Progressive Disease|414|||
30765781|NCT00337103|58774528|FG001|Overall Study|Progressive Disease|410|||
30765782|NCT00337103|58774527|FG000|Overall Study|Adverse Event|45|||
30642208|NCT00764881|58654410|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
30642209|NCT00764881|58654411|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
30642210|NCT00764881|58654410|FG000|Overall Study|no treatment or no observation|2|||
30642211|NCT00764881|58654411|FG001|Overall Study|no treatment or no observation|2|||
30642212|NCT00844558|58654419|FG000|Overall Study|Withdrawal by Subject|9|||
30642213|NCT00844558|58654420|FG001|Overall Study|Withdrawal by Subject|2|||
30642214|NCT00844558|58654419|FG000|Overall Study|Death|1|||
30765783|NCT00337103|58774528|FG001|Overall Study|Adverse Event|59|||
30765784|NCT00337103|58774527|FG000|Overall Study|Subject Choice|34|||
30765785|NCT00337103|58774528|FG001|Overall Study|Subject Choice|27|||
30765786|NCT00337103|58774527|FG000|Overall Study|Clinical Progression|27|||
30765787|NCT00337103|58774528|FG001|Overall Study|Clinical Progression|24|||
30642215|NCT00844558|58654420|FG001|Overall Study|Death|0|||
30642216|NCT00844558|58654419|FG000|Overall Study|Protocol Violation|1|||
30642217|NCT00844558|58654420|FG001|Overall Study|Protocol Violation|1|||
30642218|NCT00844558|58654419|FG000|Overall Study|Lost to Follow-up|0|||
30642219|NCT00844558|58654420|FG001|Overall Study|Lost to Follow-up|1|||
30642220|NCT00844558|58654419|FG000|Overall Study|Physician Decision|1|||
30642221|NCT00844558|58654420|FG001|Overall Study|Physician Decision|0|||
30642222|NCT00772369|58654431|FG000|Overall Study|Did not return record release form|1|||
30642223|NCT00821236|58654438|FG000|Overall Study|Lost to Follow-up|3|||
30642224|NCT00756457|58654448|FG000|Overall Study|Lost to Follow-up|1|||
30642225|NCT00756457|58654449|FG001|Overall Study|Lost to Follow-up|2|||
30642226|NCT00844480|58654473|FG000|Overall Study|Withdrawal by Subject|2|||
30642227|NCT00844480|58654474|FG001|Overall Study|Withdrawal by Subject|3|||
30642228|NCT00771901|58654483|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
30642229|NCT00771901|58654484|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
30642230|NCT00771901|58654485|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
30642231|NCT00843856|58654495|FG000|Overall Study|Lost to Follow-up|1|||
30642232|NCT00843856|58654496|FG001|Overall Study|Lost to Follow-up|2|||
30642233|NCT00764491|58654504|FG000|Overall Study|Lost to Follow-up|35|||
30642234|NCT00764491|58654505|FG001|Overall Study|Lost to Follow-up|17|||
30642235|NCT00843778|58654511|FG000|Overall Study|Adverse Event|15|||
30642236|NCT00843778|58654511|FG000|Overall Study|Lack of Efficacy|14|||
30642237|NCT00843778|58654511|FG000|Overall Study|Loss of efficacy|2|||
30642238|NCT00843778|58654511|FG000|Overall Study|Withdrawal by Subject|4|||
30642239|NCT00910728|58654524|FG000|Overall Study|Lack of Efficacy|2|||
30642240|NCT00910728|58654525|FG001|Overall Study|Lack of Efficacy|3|||
30642241|NCT00910728|58654526|FG002|Overall Study|Lack of Efficacy|1|||
30642242|NCT00910728|58654527|FG003|Overall Study|Lack of Efficacy|2|||
30642243|NCT00910728|58654528|FG004|Overall Study|Lack of Efficacy|1|||
30642244|NCT00910728|58654529|FG005|Overall Study|Lack of Efficacy|0|||
30642245|NCT00910728|58654530|FG006|Overall Study|Lack of Efficacy|2|||
30642246|NCT00910728|58654531|FG007|Overall Study|Lack of Efficacy|2|||
30642247|NCT00910728|58654532|FG008|Overall Study|Lack of Efficacy|2|||
30642248|NCT00910728|58654524|FG000|Overall Study|Withdrawal by Subject|0|||
30642249|NCT00910728|58654525|FG001|Overall Study|Withdrawal by Subject|0|||
30642250|NCT00910728|58654526|FG002|Overall Study|Withdrawal by Subject|0|||
30642251|NCT00910728|58654527|FG003|Overall Study|Withdrawal by Subject|0|||
30642252|NCT00910728|58654528|FG004|Overall Study|Withdrawal by Subject|3|||
30642253|NCT00910728|58654529|FG005|Overall Study|Withdrawal by Subject|1|||
30642254|NCT00910728|58654530|FG006|Overall Study|Withdrawal by Subject|2|||
30642255|NCT00910728|58654531|FG007|Overall Study|Withdrawal by Subject|0|||
30642256|NCT00910728|58654532|FG008|Overall Study|Withdrawal by Subject|0|||
30642257|NCT00910728|58654524|FG000|Overall Study|(not specified)|2|||
30642258|NCT00910728|58654525|FG001|Overall Study|(not specified)|0|||
30642259|NCT00910728|58654526|FG002|Overall Study|(not specified)|1|||
30642260|NCT00910728|58654527|FG003|Overall Study|(not specified)|0|||
30642261|NCT00910728|58654528|FG004|Overall Study|(not specified)|1|||
30642262|NCT00910728|58654529|FG005|Overall Study|(not specified)|0|||
30642263|NCT00910728|58654530|FG006|Overall Study|(not specified)|0|||
30765788|NCT00337103|58774527|FG000|Overall Study|Physician Decision|15|||
30765789|NCT00337103|58774528|FG001|Overall Study|Physician Decision|14|||
30765790|NCT00337103|58774527|FG000|Overall Study|Withdrawal by Subject|8|||
30765791|NCT00337103|58774528|FG001|Overall Study|Withdrawal by Subject|5|||
30765792|NCT00337103|58774527|FG000|Overall Study|Other|5|||
30765793|NCT00337103|58774528|FG001|Overall Study|Other|6|||
30765794|NCT00337103|58774527|FG000|Overall Study|Entry Criteria Not Met|4|||
30765795|NCT00337103|58774528|FG001|Overall Study|Entry Criteria Not Met|1|||
30642264|NCT00910728|58654531|FG007|Overall Study|(not specified)|0|||
30642265|NCT00910728|58654532|FG008|Overall Study|(not specified)|0|||
30642266|NCT00910728|58654524|FG000|Overall Study|Adverse Event|2|||
30642267|NCT00910728|58654525|FG001|Overall Study|Adverse Event|0|||
30642268|NCT00910728|58654526|FG002|Overall Study|Adverse Event|1|||
30642269|NCT00910728|58654527|FG003|Overall Study|Adverse Event|1|||
30765796|NCT00337103|58774527|FG000|Overall Study|Lost to Follow-up|1|||
30765797|NCT00337103|58774528|FG001|Overall Study|Lost to Follow-up|2|||
30765798|NCT00337103|58774527|FG000|Overall Study|Death|1|||
30642270|NCT00910728|58654528|FG004|Overall Study|Adverse Event|0|||
30642271|NCT00910728|58654529|FG005|Overall Study|Adverse Event|0|||
30642272|NCT00910728|58654530|FG006|Overall Study|Adverse Event|2|||
30642273|NCT00910728|58654531|FG007|Overall Study|Adverse Event|1|||
30642274|NCT00910728|58654532|FG008|Overall Study|Adverse Event|1|||
30642275|NCT00820222|58654554|FG000|Overall Study|Lost to Follow-up|10|||
30642276|NCT00820222|58654555|FG001|Overall Study|Lost to Follow-up|9|||
30642277|NCT00820222|58654554|FG000|Overall Study|Withdrawal by Subject|19|||
30642278|NCT00820222|58654555|FG001|Overall Study|Withdrawal by Subject|21|||
30642279|NCT00820222|58654554|FG000|Overall Study|Physician Decision|93|||
30642280|NCT00820222|58654555|FG001|Overall Study|Physician Decision|88|||
30642281|NCT00820222|58654554|FG000|Overall Study|Sponsor Terminated Study|43|||
30642282|NCT00820222|58654555|FG001|Overall Study|Sponsor Terminated Study|65|||
30642283|NCT00820222|58654554|FG000|Overall Study|Unkown|11|||
30642284|NCT00820222|58654555|FG001|Overall Study|Unkown|7|||
30642285|NCT01039688|58654564|FG000|Overall Study|Adverse Event|38|||
30642286|NCT01039688|58654565|FG001|Overall Study|Adverse Event|39|||
30642287|NCT01039688|58654566|FG002|Overall Study|Adverse Event|24|||
30642288|NCT01039688|58654564|FG000|Overall Study|Lack of Efficacy|20|||
30642289|NCT01039688|58654565|FG001|Overall Study|Lack of Efficacy|11|||
30642290|NCT01039688|58654566|FG002|Overall Study|Lack of Efficacy|26|||
30642291|NCT01039688|58654564|FG000|Overall Study|Lost to Follow-up|11|||
30642292|NCT01039688|58654565|FG001|Overall Study|Lost to Follow-up|9|||
30642293|NCT01039688|58654566|FG002|Overall Study|Lost to Follow-up|5|||
30642294|NCT01039688|58654564|FG000|Overall Study|Other|13|||
30642295|NCT01039688|58654565|FG001|Overall Study|Other|25|||
30642296|NCT01039688|58654566|FG002|Overall Study|Other|12|||
30642297|NCT01039688|58654564|FG000|Overall Study|Withdrawal by Subject|23|||
30642298|NCT01039688|58654565|FG001|Overall Study|Withdrawal by Subject|27|||
30642299|NCT01039688|58654566|FG002|Overall Study|Withdrawal by Subject|13|||
30642300|NCT01039688|58654564|FG000|Overall Study|Death|2|||
30642301|NCT01039688|58654565|FG001|Overall Study|Death|0|||
30642302|NCT01039688|58654566|FG002|Overall Study|Death|0|||
30642303|NCT02237508|58654587|FG000|Overall Study|Withdrawal by Subject|0|||
30642304|NCT02237508|58654588|FG001|Overall Study|Withdrawal by Subject|2|||
30642305|NCT02237508|58654589|FG002|Overall Study|Withdrawal by Subject|0|||
30642306|NCT02237508|58654590|FG003|Overall Study|Withdrawal by Subject|1|||
30642307|NCT02237508|58654591|FG004|Overall Study|Withdrawal by Subject|0|||
30642308|NCT02237508|58654592|FG005|Overall Study|Withdrawal by Subject|1|||
30642309|NCT02237508|58654593|FG006|Overall Study|Withdrawal by Subject|1|||
30642310|NCT02237508|58654594|FG007|Overall Study|Withdrawal by Subject|0|||
30642311|NCT02237508|58654595|FG008|Overall Study|Withdrawal by Subject|1|||
30642312|NCT02237508|58654596|FG009|Overall Study|Withdrawal by Subject|0|||
30642313|NCT02237508|58654587|FG000|Overall Study|Physician Decision|0|||
30642314|NCT02237508|58654588|FG001|Overall Study|Physician Decision|1|||
30642315|NCT02237508|58654589|FG002|Overall Study|Physician Decision|0|||
30642316|NCT02237508|58654590|FG003|Overall Study|Physician Decision|0|||
30642317|NCT02237508|58654591|FG004|Overall Study|Physician Decision|0|||
30642318|NCT02237508|58654592|FG005|Overall Study|Physician Decision|0|||
30642319|NCT02237508|58654593|FG006|Overall Study|Physician Decision|0|||
30642320|NCT02237508|58654594|FG007|Overall Study|Physician Decision|0|||
30642321|NCT02237508|58654595|FG008|Overall Study|Physician Decision|0|||
30642322|NCT02237508|58654596|FG009|Overall Study|Physician Decision|0|||
30642323|NCT02237508|58654587|FG000|Overall Study|Protocol Violation|0|||
30642324|NCT02237508|58654588|FG001|Overall Study|Protocol Violation|0|||
30642325|NCT02237508|58654589|FG002|Overall Study|Protocol Violation|1|||
30642326|NCT02237508|58654590|FG003|Overall Study|Protocol Violation|0|||
30642327|NCT02237508|58654591|FG004|Overall Study|Protocol Violation|0|||
30642328|NCT02237508|58654592|FG005|Overall Study|Protocol Violation|0|||
30642329|NCT02237508|58654593|FG006|Overall Study|Protocol Violation|0|||
30642330|NCT02237508|58654594|FG007|Overall Study|Protocol Violation|0|||
30642331|NCT02237508|58654595|FG008|Overall Study|Protocol Violation|0|||
30642332|NCT02237508|58654596|FG009|Overall Study|Protocol Violation|0|||
30642333|NCT00909090|58654616|FG000|Overall Study|Lost to Follow-up|17|||
30642334|NCT00909090|58654617|FG001|Overall Study|Lost to Follow-up|17|||
30642335|NCT00909480|58654628|FG000|Overall Study|Adverse Event|5|||
30642336|NCT00909480|58654629|FG001|Overall Study|Adverse Event|3|||
30642337|NCT00909480|58654628|FG000|Overall Study|Protocol Violation|6|||
30642338|NCT00909480|58654629|FG001|Overall Study|Protocol Violation|8|||
30642339|NCT00909480|58654628|FG000|Overall Study|Withdrawal criteria|9|||
30642340|NCT00909480|58654629|FG001|Overall Study|Withdrawal criteria|11|||
30642341|NCT00909480|58654628|FG000|Overall Study|Unclassified|18|||
30642342|NCT00909480|58654629|FG001|Overall Study|Unclassified|19|||
30642343|NCT01058096|58654637|FG000|Double-blind Treatment Phase|Adverse Event|11|||
30642344|NCT01058096|58654638|FG001|Double-blind Treatment Phase|Adverse Event|15|||
30642345|NCT01058096|58654637|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
30642346|NCT01058096|58654638|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
30642347|NCT01058096|58654637|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
30642348|NCT01058096|58654638|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
30642349|NCT01058096|58654637|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
30642350|NCT01058096|58654638|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
30642351|NCT01058096|58654637|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
30642352|NCT01058096|58654638|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
30642353|NCT01058096|58654637|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
30642354|NCT01058096|58654638|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
30642355|NCT01057862|58654646|FG000|Overall Study|Withdrawal by Subject|1|||
30642356|NCT01057862|58654647|FG001|Overall Study|Withdrawal by Subject|2|||
30642357|NCT01038128|58654653|FG000|Overall Study|Lack of Efficacy|1|||
30642358|NCT01038128|58654653|FG000|Overall Study|Lost to Follow-up|1|||
30642359|NCT01038128|58654653|FG000|Overall Study|Withdrawal by Subject|2|||
30642360|NCT00842530|58654674|FG000|Overall Study|Serious adverse event|0|||
30642361|NCT00842530|58654675|FG001|Overall Study|Serious adverse event|6|||
30642362|NCT00842530|58654674|FG000|Overall Study|Other adverse event|6|||
30642363|NCT00842530|58654675|FG001|Overall Study|Other adverse event|1|||
30642364|NCT00842530|58654674|FG000|Overall Study|Protocol Violation|32|||
30642365|NCT00842530|58654675|FG001|Overall Study|Protocol Violation|14|||
30642366|NCT00842530|58654674|FG000|Overall Study|Lost to Follow-up|6|||
30642367|NCT00842530|58654675|FG001|Overall Study|Lost to Follow-up|8|||
30642368|NCT00842530|58654674|FG000|Overall Study|Withdrawal by Subject|73|||
30642369|NCT00842530|58654675|FG001|Overall Study|Withdrawal by Subject|28|||
30642370|NCT00819910|58654686|FG000|Overall Study|Adverse Event|0|||
30642371|NCT00819910|58654687|FG001|Overall Study|Adverse Event|0|||
30642372|NCT00819910|58654688|FG002|Overall Study|Adverse Event|2|||
30642373|NCT00819910|58654689|FG003|Overall Study|Adverse Event|1|||
30642374|NCT00819910|58654686|FG000|Overall Study|Withdrawal by Subject|1|||
30642375|NCT00819910|58654687|FG001|Overall Study|Withdrawal by Subject|1|||
30642376|NCT00819910|58654688|FG002|Overall Study|Withdrawal by Subject|1|||
30642377|NCT00819910|58654689|FG003|Overall Study|Withdrawal by Subject|0|||
30642378|NCT00819910|58654686|FG000|Overall Study|Lost to Follow-up|1|||
30642379|NCT00819910|58654687|FG001|Overall Study|Lost to Follow-up|0|||
30642380|NCT00819910|58654688|FG002|Overall Study|Lost to Follow-up|0|||
30765799|NCT00337103|58774528|FG001|Overall Study|Death|0|||
30765800|NCT00415532|58774537|FG000|Treatment Period|Adverse Event|2|||
30765801|NCT00415532|58774538|FG001|Treatment Period|Adverse Event|3|||
30765802|NCT00415532|58774537|FG000|Treatment Period|Death|2|||
30765803|NCT00415532|58774538|FG001|Treatment Period|Death|1|||
30765804|NCT00415532|58774537|FG000|Treatment Period|Lost to Follow-up|1|||
30765805|NCT00415532|58774538|FG001|Treatment Period|Lost to Follow-up|1|||
30951722|NCT01040728|58999077|FG003|Overall Study|Protocol Violation|1|||
30951723|NCT01040728|58999074|FG000|Overall Study|Lack of Efficacy|0|||
30951724|NCT01040728|58999075|FG001|Overall Study|Lack of Efficacy|1|||
30951725|NCT01040728|58999076|FG002|Overall Study|Lack of Efficacy|0|||
30951726|NCT01040728|58999077|FG003|Overall Study|Lack of Efficacy|1|||
30951727|NCT01040728|58999074|FG000|Overall Study|Other reasons not listed above|0|||
30951728|NCT01040728|58999075|FG001|Overall Study|Other reasons not listed above|1|||
30951729|NCT01040728|58999076|FG002|Overall Study|Other reasons not listed above|0|||
30951730|NCT01040728|58999077|FG003|Overall Study|Other reasons not listed above|0|||
30951731|NCT01593020|58999095|FG000|Overall Study|Adverse Event|1|||
30951732|NCT01593020|58999096|FG001|Overall Study|Adverse Event|1|||
30951733|NCT01593020|58999095|FG000|Overall Study|Death|0|||
30951734|NCT01593020|58999096|FG001|Overall Study|Death|1|||
30951735|NCT01593020|58999095|FG000|Overall Study|Ineligible|1|||
30951736|NCT01593020|58999096|FG001|Overall Study|Ineligible|0|||
30951737|NCT01040260|58999104|FG000|Overall Study|Withdrawal by Subject|12|||
30951738|NCT01040260|58999105|FG001|Overall Study|Withdrawal by Subject|6|||
30951739|NCT01040260|58999104|FG000|Overall Study|Lost to Follow-up|3|||
30951740|NCT01040260|58999105|FG001|Overall Study|Lost to Follow-up|5|||
30951741|NCT01712438|58999111|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
30951742|NCT01712438|58999111|FG000|Overall Study|Ongoing ITI treatment|6|||
30951743|NCT01712438|58999111|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
30951744|NCT01712438|58999111|FG000|Overall Study|Prematurely Discontinued|25|||
30951745|NCT01712204|58999122|FG000|Overall Study|Adverse Event|3|||
30951746|NCT01712204|58999123|FG001|Overall Study|Adverse Event|1|||
30951747|NCT01712204|58999122|FG000|Overall Study|Withdrawal by Subject|3|||
30951748|NCT01712204|58999123|FG001|Overall Study|Withdrawal by Subject|3|||
30951749|NCT01712204|58999122|FG000|Overall Study|Lost to Follow-up|1|||
30642381|NCT00819910|58654689|FG003|Overall Study|Lost to Follow-up|0|||
30765806|NCT00415532|58774537|FG000|Treatment Period|Protocol Violation|1|||
30765807|NCT00415532|58774538|FG001|Treatment Period|Protocol Violation|0|||
30951750|NCT01712204|58999123|FG001|Overall Study|Lost to Follow-up|0|||
30951751|NCT01712204|58999122|FG000|Overall Study|Protocol Violation|1|||
30951752|NCT01712204|58999123|FG001|Overall Study|Protocol Violation|1|||
30642382|NCT00830518|58654703|FG000|Overall Study|Progressive Disease|18|||
30642383|NCT00830518|58654704|FG001|Overall Study|Progressive Disease|8|||
30642384|NCT00830518|58654703|FG000|Overall Study|Symptomatic Deterioration|4|||
30642385|NCT00830518|58654704|FG001|Overall Study|Symptomatic Deterioration|1|||
30765808|NCT00415532|58774537|FG000|Treatment Period|Withdrawal by Subject|6|||
30642386|NCT00830518|58654703|FG000|Overall Study|Adverse Event|14|||
30642387|NCT00830518|58654704|FG001|Overall Study|Adverse Event|1|||
30642388|NCT00830518|58654703|FG000|Overall Study|Withdrawal by Patient|2|||
30642389|NCT00830518|58654704|FG001|Overall Study|Withdrawal by Patient|0|||
30642390|NCT00830518|58654703|FG000|Overall Study|Reason not Specified|8|||
30642391|NCT00830518|58654704|FG001|Overall Study|Reason not Specified|1|||
30642392|NCT00908544|58654713|FG000|Overall Study|Withdrawal by Subject|2|||
30642393|NCT00908544|58654714|FG001|Overall Study|Withdrawal by Subject|4|||
30642394|NCT00908544|58654713|FG000|Overall Study|Lack of Efficacy|0|||
30642395|NCT00908544|58654714|FG001|Overall Study|Lack of Efficacy|1|||
30642396|NCT00908544|58654713|FG000|Overall Study|Pregnancy|1|||
30642397|NCT00908544|58654714|FG001|Overall Study|Pregnancy|0|||
30642398|NCT00908544|58654713|FG000|Overall Study|Relocation abroad|1|||
30642399|NCT00908544|58654714|FG001|Overall Study|Relocation abroad|1|||
30642400|NCT00908544|58654713|FG000|Overall Study|Unable to visit sutdy center|1|||
30642401|NCT00908544|58654714|FG001|Overall Study|Unable to visit sutdy center|0|||
30642402|NCT00830440|58654722|FG000|Overall Study|Protocol Violation|1|||
30642403|NCT00830440|58654723|FG001|Overall Study|Protocol Violation|0|||
30642404|NCT00830440|58654722|FG000|Overall Study|Withdrawal by Subject|1|||
30642405|NCT00830440|58654723|FG001|Overall Study|Withdrawal by Subject|0|||
30642406|NCT00830440|58654722|FG000|Overall Study|unsuccessful procedure|4|||
30642407|NCT00830440|58654723|FG001|Overall Study|unsuccessful procedure|0|||
30642408|NCT00830440|58654722|FG000|Overall Study|Adverse Event|2|||
30642409|NCT00830440|58654723|FG001|Overall Study|Adverse Event|0|||
30642410|NCT00908310|58654730|FG000|Overall Study|Death|37|||
30642411|NCT00908310|58654730|FG000|Overall Study|Withdrawal by Subject|7|||
30765809|NCT00415532|58774538|FG001|Treatment Period|Withdrawal by Subject|6|||
30765810|NCT00415532|58774537|FG000|Treatment Period|Other|2|||
30765811|NCT00415532|58774538|FG001|Treatment Period|Other|2|||
30765812|NCT00415532|58774537|FG000|Treatment Period|Ineligibility determined|1|||
30765813|NCT00415532|58774538|FG001|Treatment Period|Ineligibility determined|1|||
30765814|NCT00415532|58774537|FG000|Treatment Period|Noncompliance|1|||
30765815|NCT00415532|58774538|FG001|Treatment Period|Noncompliance|1|||
30951753|NCT01592864|58999131|FG000|Overall Study|Withdrawal by Subject|0|||
30951754|NCT01592864|58999132|FG001|Overall Study|Withdrawal by Subject|1|||
30951755|NCT01592786|58999138|FG000|Overall Study|Adverse Event|60|||
30642412|NCT00908310|58654730|FG000|Overall Study|Lost to Follow-up|7|||
30642413|NCT00908310|58654730|FG000|Overall Study|Screening failure|5|||
30765816|NCT00415532|58774537|FG000|Treatment Period|Requirement for alternative therapy|1|||
30765817|NCT00415532|58774538|FG001|Treatment Period|Requirement for alternative therapy|0|||
30951756|NCT01592786|58999138|FG000|Overall Study|Lack of Efficacy|19|||
30951757|NCT01592786|58999138|FG000|Overall Study|Protocol Violation|14|||
30951758|NCT01592786|58999138|FG000|Overall Study|Withdrawal by Subject|23|||
30951759|NCT01592786|58999138|FG000|Overall Study|Lost to Follow-up|19|||
30951760|NCT01592786|58999138|FG000|Overall Study|Other|3|||
30951761|NCT01711736|58999144|FG000|Overall Study|Lost to Follow-up|4|||
30951762|NCT01711736|58999145|FG001|Overall Study|Lost to Follow-up|1|||
30951763|NCT01711736|58999144|FG000|Overall Study|Withdrawal by Subject|6|||
30951764|NCT01711736|58999145|FG001|Overall Study|Withdrawal by Subject|6|||
30951765|NCT01711736|58999144|FG000|Overall Study|Migrated/moved from study area|2|||
30951766|NCT01711736|58999145|FG001|Overall Study|Migrated/moved from study area|1|||
30951767|NCT01592708|58999154|FG000|Overall Study|Protocol Violation|3|||
30951768|NCT01592708|58999155|FG001|Overall Study|Protocol Violation|0|||
30642414|NCT00908310|58654730|FG000|Overall Study|Other reasons|4|||
30642415|NCT00830128|58654734|FG000|Overall Study|Adverse Event|5|||
30642416|NCT00830128|58654734|FG000|Overall Study|Lack of Efficacy|7|||
30642417|NCT00830128|58654734|FG000|Overall Study|Protocol Violation|1|||
30642418|NCT00830128|58654734|FG000|Overall Study|Withdrawal by Subject|2|||
30765818|NCT00415532|58774537|FG000|Safety Follow Up Period|Adverse Event|1|||
30765819|NCT00415532|58774538|FG001|Safety Follow Up Period|Adverse Event|3|||
30765820|NCT00415532|58774537|FG000|Safety Follow Up Period|Death|3|||
30765821|NCT00415532|58774538|FG001|Safety Follow Up Period|Death|0|||
30765822|NCT00415532|58774537|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
30765823|NCT00415532|58774538|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
30765824|NCT00415532|58774537|FG000|Safety Follow Up Period|Other|1|||
30765825|NCT00415532|58774538|FG001|Safety Follow Up Period|Other|4|||
30765826|NCT00415532|58774537|FG000|Safety Follow Up Period|Ineligibility determined|1|||
30765827|NCT00415532|58774538|FG001|Safety Follow Up Period|Ineligibility determined|1|||
30848558|NCT02252042|58874679|FG000|Overall Study|Transferred to Extension Study|7|||
30642419|NCT00830128|58654734|FG000|Overall Study|Family obligation|1|||
30642420|NCT00830128|58654734|FG000|Overall Study|Relocation|1|||
30642421|NCT00830128|58654734|FG000|Overall Study|Work obligation|1|||
30765828|NCT00415532|58774537|FG000|Safety Follow Up Period|Noncompliance|1|||
30951769|NCT01042522|58999166|FG000|Overall Study|Adverse Event|1|||
30951770|NCT01042522|58999167|FG001|Overall Study|Adverse Event|2|||
30951771|NCT01042522|58999166|FG000|Overall Study|Disease Progression|5|||
30642422|NCT00830128|58654734|FG000|Overall Study|Operating a vehicle|1|||
30848559|NCT02252042|58874680|FG001|Overall Study|Transferred to Extension Study|1|||
30951772|NCT01042522|58999167|FG001|Overall Study|Disease Progression|0|||
30951773|NCT01042522|58999166|FG000|Overall Study|Death|1|||
30951774|NCT01042522|58999167|FG001|Overall Study|Death|0|||
30951775|NCT01042522|58999166|FG000|Overall Study|Patient Refused|0|||
30951776|NCT01042522|58999167|FG001|Overall Study|Patient Refused|3|||
30951777|NCT01042522|58999166|FG000|Overall Study|Withdrawal by Subject|1|||
30848560|NCT02252042|58874679|FG000|Overall Study|Did Not Continue on Extension Study|7|||
30848561|NCT02252042|58874680|FG001|Overall Study|Did Not Continue on Extension Study|2|||
30848562|NCT02252042|58874679|FG000|Overall Study|Withdrawal by Subject|15|||
30848563|NCT02252042|58874680|FG001|Overall Study|Withdrawal by Subject|20|||
30848564|NCT00378482|58874707|FG000|Overall Study|Lost to Follow-up|1|||
30848565|NCT00378482|58874707|FG000|Overall Study|Lack of Efficacy|8|||
30848566|NCT00378482|58874707|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
30848567|NCT00378482|58874707|FG000|Overall Study|Withdrawal by Subject|4|||
30951778|NCT01042522|58999167|FG001|Overall Study|Withdrawal by Subject|1|||
30642423|NCT00841906|58654740|FG000|Overall Study|Withdrawal by Subject|2|||
30642424|NCT00841906|58654741|FG001|Overall Study|Withdrawal by Subject|0|||
30642425|NCT00771667|58654753|FG000|Induction Phase|Adverse Event|5|||
30642426|NCT00771667|58654754|FG001|Induction Phase|Adverse Event|2|||
30642427|NCT00771667|58654755|FG002|Induction Phase|Adverse Event|4|||
30642428|NCT00771667|58654756|FG003|Induction Phase|Adverse Event|1|||
30642429|NCT00771667|58654757|FG004|Induction Phase|Adverse Event|0|||
30642430|NCT00771667|58654758|FG005|Induction Phase|Adverse Event|0|||
30642431|NCT00771667|58654759|FG006|Induction Phase|Adverse Event|0|||
30642432|NCT00771667|58654760|FG007|Induction Phase|Adverse Event|0|||
30642433|NCT00771667|58654761|FG008|Induction Phase|Adverse Event|0|||
30642434|NCT00771667|58654762|FG009|Induction Phase|Adverse Event|0|||
30642435|NCT00771667|58654753|FG000|Induction Phase|Lack of Efficacy|9|||
30642436|NCT00771667|58654754|FG001|Induction Phase|Lack of Efficacy|2|||
30642437|NCT00771667|58654755|FG002|Induction Phase|Lack of Efficacy|4|||
30642438|NCT00771667|58654756|FG003|Induction Phase|Lack of Efficacy|3|||
30642439|NCT00771667|58654757|FG004|Induction Phase|Lack of Efficacy|0|||
30642440|NCT00771667|58654758|FG005|Induction Phase|Lack of Efficacy|0|||
30642441|NCT00771667|58654759|FG006|Induction Phase|Lack of Efficacy|0|||
30642442|NCT00771667|58654760|FG007|Induction Phase|Lack of Efficacy|0|||
30642443|NCT00771667|58654761|FG008|Induction Phase|Lack of Efficacy|0|||
30642444|NCT00771667|58654762|FG009|Induction Phase|Lack of Efficacy|0|||
30642445|NCT00771667|58654753|FG000|Induction Phase|Lost to Follow-up|1|||
30642446|NCT00771667|58654754|FG001|Induction Phase|Lost to Follow-up|0|||
30642447|NCT00771667|58654755|FG002|Induction Phase|Lost to Follow-up|1|||
30642448|NCT00771667|58654756|FG003|Induction Phase|Lost to Follow-up|0|||
30642449|NCT00771667|58654757|FG004|Induction Phase|Lost to Follow-up|0|||
30642450|NCT00771667|58654758|FG005|Induction Phase|Lost to Follow-up|0|||
30642451|NCT00771667|58654759|FG006|Induction Phase|Lost to Follow-up|0|||
30642452|NCT00771667|58654760|FG007|Induction Phase|Lost to Follow-up|0|||
30642453|NCT00771667|58654761|FG008|Induction Phase|Lost to Follow-up|0|||
30642454|NCT00771667|58654762|FG009|Induction Phase|Lost to Follow-up|0|||
30642455|NCT00771667|58654753|FG000|Induction Phase|Other|4|||
30642456|NCT00771667|58654754|FG001|Induction Phase|Other|6|||
30642457|NCT00771667|58654755|FG002|Induction Phase|Other|3|||
30642458|NCT00771667|58654756|FG003|Induction Phase|Other|4|||
30642459|NCT00771667|58654757|FG004|Induction Phase|Other|0|||
30642460|NCT00771667|58654758|FG005|Induction Phase|Other|0|||
30642461|NCT00771667|58654759|FG006|Induction Phase|Other|0|||
30642462|NCT00771667|58654760|FG007|Induction Phase|Other|0|||
30642463|NCT00771667|58654761|FG008|Induction Phase|Other|0|||
30642464|NCT00771667|58654762|FG009|Induction Phase|Other|0|||
30642465|NCT00771667|58654753|FG000|Maintenance Phase|Adverse Event|0|||
30642466|NCT00771667|58654754|FG001|Maintenance Phase|Adverse Event|0|||
30848568|NCT00378482|58874707|FG000|Overall Study|Adverse Event|9|||
30848569|NCT05288673|58874714|FG000|Overall Study|Consent withdrawn by subject|0|||
30848570|NCT05288673|58874715|FG001|Overall Study|Consent withdrawn by subject|0|||
30642467|NCT00771667|58654755|FG002|Maintenance Phase|Adverse Event|0|||
30642468|NCT00771667|58654756|FG003|Maintenance Phase|Adverse Event|0|||
30642469|NCT00771667|58654757|FG004|Maintenance Phase|Adverse Event|1|||
30642470|NCT00771667|58654758|FG005|Maintenance Phase|Adverse Event|3|||
30642471|NCT00771667|58654759|FG006|Maintenance Phase|Adverse Event|5|||
30642472|NCT00771667|58654760|FG007|Maintenance Phase|Adverse Event|1|||
30848571|NCT05288673|58874716|FG002|Overall Study|Consent withdrawn by subject|1|||
30951779|NCT01702844|58999173|FG000|Overall Study|Adverse Event|9|||
30642473|NCT00771667|58654761|FG008|Maintenance Phase|Adverse Event|8|||
30642474|NCT00771667|58654762|FG009|Maintenance Phase|Adverse Event|7|||
30642475|NCT00771667|58654753|FG000|Maintenance Phase|Lack of Efficacy|0|||
30642476|NCT00771667|58654754|FG001|Maintenance Phase|Lack of Efficacy|0|||
30642477|NCT00771667|58654755|FG002|Maintenance Phase|Lack of Efficacy|0|||
30642478|NCT00771667|58654756|FG003|Maintenance Phase|Lack of Efficacy|0|||
30642479|NCT00771667|58654757|FG004|Maintenance Phase|Lack of Efficacy|1|||
30642480|NCT00771667|58654758|FG005|Maintenance Phase|Lack of Efficacy|3|||
30642481|NCT00771667|58654759|FG006|Maintenance Phase|Lack of Efficacy|3|||
30642482|NCT00771667|58654760|FG007|Maintenance Phase|Lack of Efficacy|2|||
30642483|NCT00771667|58654761|FG008|Maintenance Phase|Lack of Efficacy|11|||
30642484|NCT00771667|58654762|FG009|Maintenance Phase|Lack of Efficacy|7|||
30642485|NCT00771667|58654753|FG000|Maintenance Phase|Other|0|||
30642486|NCT00771667|58654754|FG001|Maintenance Phase|Other|0|||
30642487|NCT00771667|58654755|FG002|Maintenance Phase|Other|0|||
30642488|NCT00771667|58654756|FG003|Maintenance Phase|Other|0|||
30642489|NCT00771667|58654757|FG004|Maintenance Phase|Other|0|||
30642490|NCT00771667|58654758|FG005|Maintenance Phase|Other|1|||
30642491|NCT00771667|58654759|FG006|Maintenance Phase|Other|2|||
30642492|NCT00771667|58654760|FG007|Maintenance Phase|Other|2|||
30642493|NCT00771667|58654761|FG008|Maintenance Phase|Other|3|||
30642494|NCT00771667|58654762|FG009|Maintenance Phase|Other|3|||
30642495|NCT00770965|58654784|FG000|Safety Set|Withdrawal by Subject|0|||
30642496|NCT00770965|58654785|FG001|Safety Set|Withdrawal by Subject|0|||
30642497|NCT00770965|58654786|FG002|Safety Set|Withdrawal by Subject|0|||
30642498|NCT00770965|58654787|FG003|Safety Set|Withdrawal by Subject|1|||
30642499|NCT00770965|58654784|FG000|Safety Set|Protocol deviation|0|||
30642500|NCT00770965|58654785|FG001|Safety Set|Protocol deviation|0|||
30642501|NCT00770965|58654786|FG002|Safety Set|Protocol deviation|1|||
30642502|NCT00770965|58654787|FG003|Safety Set|Protocol deviation|0|||
30642503|NCT00770965|58654784|FG000|Excluded Set|Administrative problems|14|||
30642504|NCT00770965|58654785|FG001|Excluded Set|Administrative problems|12|||
30642505|NCT00770965|58654786|FG002|Excluded Set|Administrative problems|12|||
30642506|NCT00770965|58654787|FG003|Excluded Set|Administrative problems|10|||
30642507|NCT00770965|58654784|FG000|Excluded Set|Withdrawal by Subject|1|||
30642508|NCT00770965|58654785|FG001|Excluded Set|Withdrawal by Subject|1|||
30642509|NCT00770965|58654786|FG002|Excluded Set|Withdrawal by Subject|2|||
30642510|NCT00770965|58654787|FG003|Excluded Set|Withdrawal by Subject|3|||
30642511|NCT00763555|58654799|FG000|Overall Study|Adverse Event|2|||
30642512|NCT00763555|58654800|FG001|Overall Study|Adverse Event|1|||
30642513|NCT00763555|58654799|FG000|Overall Study|Withdrawal by Subject|2|||
30642514|NCT00763555|58654800|FG001|Overall Study|Withdrawal by Subject|6|||
30642515|NCT00763555|58654799|FG000|Overall Study|Lost to Follow-up|0|||
30642516|NCT00763555|58654800|FG001|Overall Study|Lost to Follow-up|3|||
30642517|NCT00763321|58654809|FG000|Open-label Period|Adverse Event|24|||
30642518|NCT00763321|58654810|FG001|Open-label Period|Adverse Event|0|||
30642519|NCT00763321|58654811|FG002|Open-label Period|Adverse Event|0|||
30642520|NCT00763321|58654809|FG000|Open-label Period|Lost to Follow-up|14|||
30642521|NCT00763321|58654810|FG001|Open-label Period|Lost to Follow-up|0|||
30642522|NCT00763321|58654811|FG002|Open-label Period|Lost to Follow-up|0|||
30642523|NCT00763321|58654809|FG000|Open-label Period|Withdrawal by Subject|7|||
30642524|NCT00763321|58654810|FG001|Open-label Period|Withdrawal by Subject|0|||
30642525|NCT00763321|58654811|FG002|Open-label Period|Withdrawal by Subject|0|||
30642526|NCT00763321|58654809|FG000|Open-label Period|Subject noncompliant|7|||
30642527|NCT00763321|58654810|FG001|Open-label Period|Subject noncompliant|0|||
30642528|NCT00763321|58654811|FG002|Open-label Period|Subject noncompliant|0|||
30642529|NCT00763321|58654809|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
30642530|NCT00763321|58654810|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
30642531|NCT00763321|58654811|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
30642532|NCT00763321|58654809|FG000|Open-label Period|Lack of Efficacy|2|||
30642533|NCT00763321|58654810|FG001|Open-label Period|Lack of Efficacy|0|||
30642534|NCT00763321|58654811|FG002|Open-label Period|Lack of Efficacy|0|||
30642535|NCT00763321|58654809|FG000|Open-label Period|Other|4|||
30642536|NCT00763321|58654810|FG001|Open-label Period|Other|0|||
30642537|NCT00763321|58654811|FG002|Open-label Period|Other|0|||
30642538|NCT00763321|58654809|FG000|Double-blind Period|Lack of Efficacy|0|||
30642539|NCT00763321|58654810|FG001|Double-blind Period|Lack of Efficacy|9|||
30642540|NCT00763321|58654811|FG002|Double-blind Period|Lack of Efficacy|17|||
30951780|NCT01702844|58999173|FG000|Overall Study|Death|1|||
30642541|NCT00763321|58654809|FG000|Double-blind Period|Adverse Event|0|||
30642542|NCT00763321|58654810|FG001|Double-blind Period|Adverse Event|4|||
30642543|NCT00763321|58654811|FG002|Double-blind Period|Adverse Event|4|||
30642544|NCT00763321|58654809|FG000|Double-blind Period|Lost to Follow-up|0|||
30642545|NCT00763321|58654810|FG001|Double-blind Period|Lost to Follow-up|4|||
30642546|NCT00763321|58654811|FG002|Double-blind Period|Lost to Follow-up|2|||
30642547|NCT00763321|58654809|FG000|Double-blind Period|Withdrawal by Subject|0|||
30642548|NCT00763321|58654810|FG001|Double-blind Period|Withdrawal by Subject|2|||
30642549|NCT00763321|58654811|FG002|Double-blind Period|Withdrawal by Subject|3|||
30642550|NCT00763321|58654809|FG000|Double-blind Period|Other|0|||
30642551|NCT00763321|58654810|FG001|Double-blind Period|Other|2|||
30642552|NCT00763321|58654811|FG002|Double-blind Period|Other|3|||
30642553|NCT00770653|58654820|FG000|Overall Study|Adverse Event|13|||
30642554|NCT00770653|58654821|FG001|Overall Study|Adverse Event|5|||
30642555|NCT00770653|58654820|FG000|Overall Study|Protocol Violation|8|||
30642556|NCT00770653|58654821|FG001|Overall Study|Protocol Violation|6|||
30642557|NCT00770653|58654820|FG000|Overall Study|Withdrawal by Subject|4|||
30642558|NCT00770653|58654821|FG001|Overall Study|Withdrawal by Subject|7|||
30642559|NCT00770653|58654820|FG000|Overall Study|Lack of Compliance|1|||
30642560|NCT00770653|58654821|FG001|Overall Study|Lack of Compliance|4|||
30642561|NCT00770653|58654820|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
30642562|NCT00770653|58654821|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
30642563|NCT00770653|58654820|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
30642564|NCT00770653|58654821|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
30642565|NCT00770653|58654820|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
30642566|NCT00770653|58654821|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
30642567|NCT00770653|58654820|FG000|Overall Study|Lost to Follow-up|1|||
30642568|NCT00770653|58654821|FG001|Overall Study|Lost to Follow-up|2|||
30642569|NCT00770653|58654820|FG000|Overall Study|Physician Decision|1|||
30642570|NCT00770653|58654821|FG001|Overall Study|Physician Decision|0|||
30642571|NCT00819052|58654829|FG000|Overall Study|Adverse Event|0|||
30642572|NCT00819052|58654830|FG001|Overall Study|Adverse Event|5|||
30642573|NCT00819052|58654829|FG000|Overall Study|Protocol Violation|1|||
30642574|NCT00819052|58654830|FG001|Overall Study|Protocol Violation|2|||
30642575|NCT00819052|58654829|FG000|Overall Study|Lost to Follow-up|1|||
30642576|NCT00819052|58654830|FG001|Overall Study|Lost to Follow-up|2|||
30642577|NCT00819052|58654829|FG000|Overall Study|Withdrawal by Subject|1|||
30642578|NCT00819052|58654830|FG001|Overall Study|Withdrawal by Subject|2|||
30642579|NCT00819052|58654829|FG000|Overall Study|Lack of Efficacy|1|||
30642580|NCT00819052|58654830|FG001|Overall Study|Lack of Efficacy|1|||
30642581|NCT00819052|58654829|FG000|Overall Study|Pregnancy|1|||
30642582|NCT00819052|58654830|FG001|Overall Study|Pregnancy|2|||
30642583|NCT00819052|58654829|FG000|Overall Study|Death or events leading to death|1|||
30642584|NCT00819052|58654830|FG001|Overall Study|Death or events leading to death|0|||
30642585|NCT00763009|58654839|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
30642586|NCT00841672|58654846|FG000|Overall Study|Adverse Event|7|||
30642587|NCT00841672|58654847|FG001|Overall Study|Adverse Event|16|||
30642588|NCT00841672|58654846|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30642589|NCT00841672|58654847|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30642590|NCT00841672|58654846|FG000|Overall Study|Subject withdrew consent|2|||
30642591|NCT00841672|58654847|FG001|Overall Study|Subject withdrew consent|4|||
30642592|NCT00841672|58654846|FG000|Overall Study|Lost to Follow-up|1|||
30642593|NCT00841672|58654847|FG001|Overall Study|Lost to Follow-up|1|||
30642594|NCT00841672|58654846|FG000|Overall Study|Administrative problems|9|||
30642595|NCT00841672|58654847|FG001|Overall Study|Administrative problems|9|||
30642596|NCT00841672|58654846|FG000|Overall Study|Misrandomized|1|||
30642597|NCT00841672|58654847|FG001|Overall Study|Misrandomized|0|||
30642598|NCT00841672|58654846|FG000|Overall Study|Protocol Deviation|0|||
30642599|NCT00841672|58654847|FG001|Overall Study|Protocol Deviation|1|||
30642600|NCT00908232|58654853|FG000|Cycle 1 to 4|Death|5|||
30642601|NCT00908232|58654854|FG001|Cycle 1 to 4|Death|0|||
30642602|NCT00908232|58654855|FG002|Cycle 1 to 4|Death|0|||
30642603|NCT00908232|58654856|FG003|Cycle 1 to 4|Death|0|||
30642604|NCT00908232|58654853|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
30642605|NCT00908232|58654854|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
30642606|NCT00908232|58654855|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
30642607|NCT00908232|58654856|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
30642608|NCT00908232|58654853|FG000|Cycle 1 to 4|Progressive Disease|6|||
30642609|NCT00908232|58654854|FG001|Cycle 1 to 4|Progressive Disease|0|||
30642610|NCT00908232|58654855|FG002|Cycle 1 to 4|Progressive Disease|0|||
30642611|NCT00908232|58654856|FG003|Cycle 1 to 4|Progressive Disease|0|||
30642612|NCT00908232|58654853|FG000|Cycle 1 to 4|Adverse Event|12|||
30642613|NCT00908232|58654854|FG001|Cycle 1 to 4|Adverse Event|0|||
30642614|NCT00908232|58654855|FG002|Cycle 1 to 4|Adverse Event|0|||
30642615|NCT00908232|58654856|FG003|Cycle 1 to 4|Adverse Event|0|||
30642616|NCT00908232|58654853|FG000|Cycle 1 to 4|Other|1|||
30642617|NCT00908232|58654854|FG001|Cycle 1 to 4|Other|0|||
30642618|NCT00908232|58654855|FG002|Cycle 1 to 4|Other|0|||
30642619|NCT00908232|58654856|FG003|Cycle 1 to 4|Other|0|||
30642620|NCT00908232|58654853|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
30642621|NCT00908232|58654854|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
30642622|NCT00908232|58654855|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
30642623|NCT00908232|58654856|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
30642624|NCT00908232|58654853|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
30642625|NCT00908232|58654854|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
30642626|NCT00908232|58654855|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
30642627|NCT00908232|58654856|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
30642628|NCT00908232|58654853|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
30642629|NCT00908232|58654854|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
30642630|NCT00908232|58654855|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
30642631|NCT00908232|58654856|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
30642632|NCT00908232|58654853|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
30642633|NCT00908232|58654854|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
30642634|NCT00908232|58654855|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
30642635|NCT00908232|58654856|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
30642636|NCT00908232|58654853|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
30642637|NCT00908232|58654854|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
30642638|NCT00908232|58654855|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
30642639|NCT00908232|58654856|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
30642640|NCT00908232|58654853|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
30642641|NCT00908232|58654854|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
30642642|NCT00908232|58654855|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
30642643|NCT00908232|58654856|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
30642644|NCT00908232|58654853|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
30642645|NCT00908232|58654854|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
30642646|NCT00908232|58654855|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
30642647|NCT00908232|58654856|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
30642648|NCT00908232|58654853|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
30642649|NCT00908232|58654854|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
30642650|NCT00908232|58654855|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
30642651|NCT00908232|58654856|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
30642652|NCT00770341|58654865|FG000|Overall Study|Did not meet eligibility criteria|1|||
30642653|NCT00770341|58654866|FG001|Overall Study|Did not meet eligibility criteria|0|||
30642654|NCT00770341|58654867|FG002|Overall Study|Did not meet eligibility criteria|0|||
30642655|NCT00770341|58654865|FG000|Overall Study|Withdrawal by Subject|0|||
30642656|NCT00770341|58654866|FG001|Overall Study|Withdrawal by Subject|1|||
30642657|NCT00770341|58654867|FG002|Overall Study|Withdrawal by Subject|0|||
30642658|NCT00770341|58654865|FG000|Overall Study|Clinical Adverse Event|3|||
30642659|NCT00770341|58654866|FG001|Overall Study|Clinical Adverse Event|1|||
30642660|NCT00770341|58654867|FG002|Overall Study|Clinical Adverse Event|2|||
30642661|NCT00770341|58654865|FG000|Overall Study|Laboratory adverse event|3|||
30642662|NCT00770341|58654866|FG001|Overall Study|Laboratory adverse event|3|||
30642663|NCT00770341|58654867|FG002|Overall Study|Laboratory adverse event|0|||
30642664|NCT00770341|58654865|FG000|Overall Study|Lack of Efficacy|3|||
30642665|NCT00770341|58654866|FG001|Overall Study|Lack of Efficacy|0|||
30642666|NCT00770341|58654867|FG002|Overall Study|Lack of Efficacy|1|||
30642667|NCT00770341|58654865|FG000|Overall Study|Other|1|||
30642668|NCT00770341|58654866|FG001|Overall Study|Other|0|||
30642669|NCT00770341|58654867|FG002|Overall Study|Other|0|||
30642670|NCT00770341|58654865|FG000|Overall Study|Not treated|1|||
30642671|NCT00770341|58654866|FG001|Overall Study|Not treated|0|||
30642672|NCT00770341|58654867|FG002|Overall Study|Not treated|0|||
30642673|NCT00762463|58654884|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
30642674|NCT00762463|58654885|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
30642675|NCT00762463|58654886|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
30642676|NCT00762463|58654887|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
30642677|NCT00762463|58654884|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
30642678|NCT00762463|58654885|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
30642679|NCT00762463|58654886|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
30642680|NCT00762463|58654887|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
30642681|NCT00762463|58654884|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
30642682|NCT00762463|58654885|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
30642683|NCT00762463|58654886|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
30642684|NCT00762463|58654887|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
30642685|NCT00762463|58654884|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
30642686|NCT00762463|58654885|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
30642687|NCT00762463|58654886|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
30642688|NCT00762463|58654887|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
30642689|NCT00762463|58654884|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
30642690|NCT00762463|58654885|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
30848572|NCT04604795|58874762|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
30848573|NCT04604795|58874763|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
30642691|NCT00762463|58654886|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
30642692|NCT00762463|58654887|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
30642693|NCT00762463|58654884|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
30951781|NCT01702844|58999173|FG000|Overall Study|Withdrawal by Subject|3|||
30642694|NCT00762463|58654885|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
30951782|NCT01702844|58999173|FG000|Overall Study|Physician Decision|6|||
30642695|NCT00762463|58654886|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
30642696|NCT00762463|58654887|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
30642697|NCT00762463|58654884|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
30642698|NCT00762463|58654885|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
30642699|NCT00762463|58654886|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
30642700|NCT00762463|58654887|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
30642701|NCT00762463|58654884|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
30642702|NCT00762463|58654885|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
30642703|NCT00762463|58654886|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
30642704|NCT00762463|58654887|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
30642705|NCT00762385|58654900|FG000|First Intervention|Lens Issue|1|||
30642706|NCT00762385|58654901|FG001|First Intervention|Lens Issue|1|||
30642707|NCT00762385|58654900|FG000|First Intervention|Lost to Follow-up|0|||
30642708|NCT00762385|58654901|FG001|First Intervention|Lost to Follow-up|2|||
30642709|NCT00762385|58654900|FG000|First Intervention|Ineligible|1|||
30642710|NCT00762385|58654901|FG001|First Intervention|Ineligible|0|||
30642711|NCT00762385|58654900|FG000|First Intervention|Protocol Violation|0|||
30642712|NCT00762385|58654901|FG001|First Intervention|Protocol Violation|1|||
30642713|NCT00762385|58654900|FG000|Second Intervention|Protocol Violation|3|||
30642714|NCT00762385|58654901|FG001|Second Intervention|Protocol Violation|3|||
30642715|NCT00906282|58654910|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
30642716|NCT00906282|58654910|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
30642717|NCT00906282|58654910|FG000|Preoperative Chemotherapy|Progressive disease|6|||
30642718|NCT00906282|58654910|FG000|Preoperative Chemotherapy|Toxicity|1|||
30642719|NCT00762229|58654917|FG000|Overall Study|Lost to Follow-up|1|||
30642720|NCT00762229|58654918|FG001|Overall Study|Lost to Follow-up|1|||
30642721|NCT00762229|58654917|FG000|Overall Study|did not recveive intervention|0|||
30642722|NCT00762229|58654918|FG001|Overall Study|did not recveive intervention|1|||
30642723|NCT00907374|58654926|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
30642724|NCT00907374|58654927|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
30642725|NCT00818662|58654937|FG000|Overall Study|Adverse Event|5|||
30642726|NCT00818662|58654938|FG001|Overall Study|Adverse Event|14|||
30642727|NCT00818662|58654939|FG002|Overall Study|Adverse Event|4|||
30642728|NCT00818662|58654940|FG003|Overall Study|Adverse Event|3|||
30642729|NCT00818662|58654937|FG000|Overall Study|Withdrawal by Subject|5|||
30642730|NCT00818662|58654938|FG001|Overall Study|Withdrawal by Subject|4|||
30642731|NCT00818662|58654939|FG002|Overall Study|Withdrawal by Subject|2|||
30642732|NCT00818662|58654940|FG003|Overall Study|Withdrawal by Subject|2|||
30642733|NCT00818662|58654937|FG000|Overall Study|Death|1|||
30642734|NCT00818662|58654938|FG001|Overall Study|Death|3|||
30642735|NCT00818662|58654939|FG002|Overall Study|Death|0|||
30642736|NCT00818662|58654940|FG003|Overall Study|Death|0|||
30642737|NCT00818662|58654937|FG000|Overall Study|Physician Decision|1|||
30642738|NCT00818662|58654938|FG001|Overall Study|Physician Decision|0|||
30642739|NCT00818662|58654939|FG002|Overall Study|Physician Decision|0|||
30642740|NCT00818662|58654940|FG003|Overall Study|Physician Decision|0|||
30642741|NCT00818662|58654937|FG000|Overall Study|Lost to Follow-up|0|||
30642742|NCT00818662|58654938|FG001|Overall Study|Lost to Follow-up|0|||
30642743|NCT00818662|58654939|FG002|Overall Study|Lost to Follow-up|0|||
30642744|NCT00818662|58654940|FG003|Overall Study|Lost to Follow-up|1|||
30642745|NCT00818662|58654937|FG000|Overall Study|Unwilling or Unable to Participate|4|||
30642746|NCT00818662|58654938|FG001|Overall Study|Unwilling or Unable to Participate|6|||
30642747|NCT00818662|58654939|FG002|Overall Study|Unwilling or Unable to Participate|2|||
30642748|NCT00818662|58654940|FG003|Overall Study|Unwilling or Unable to Participate|4|||
30765829|NCT00415532|58774538|FG001|Safety Follow Up Period|Noncompliance|0|||
30765830|NCT00415532|58774537|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
30765831|NCT00415532|58774538|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
30765832|NCT00315731|58774544|FG000|Overall Study|Lost to Follow-up|1|||
30765833|NCT00315731|58774544|FG000|Overall Study|Death|5|||
30765834|NCT00062868|58774571|FG000|Dose Level 1|Death|2|||
30765835|NCT00062868|58774572|FG001|Dose Level 1|Death|0|||
30765836|NCT00062868|58774573|FG002|Dose Level 1|Death|0|||
30765837|NCT00062868|58774574|FG003|Dose Level 1|Death|2|||
30765838|NCT00062868|58774575|FG004|Dose Level 1|Death|0|||
30765839|NCT00062868|58774576|FG005|Dose Level 1|Death|0|||
30765840|NCT00062868|58774577|FG006|Dose Level 1|Death|3|||
30765841|NCT00062868|58774578|FG007|Dose Level 1|Death|0|||
30765842|NCT00062868|58774579|FG008|Dose Level 1|Death|0|||
30765843|NCT00062868|58774580|FG009|Dose Level 1|Death|0|||
30765844|NCT00062868|58774581|FG010|Dose Level 1|Death|0|||
30765845|NCT00062868|58774582|FG011|Dose Level 1|Death|0|||
30765846|NCT00062868|58774583|FG012|Dose Level 1|Death|0|||
30765847|NCT00062868|58774584|FG013|Dose Level 1|Death|0|||
30765848|NCT00062868|58774585|FG014|Dose Level 1|Death|0|||
30765849|NCT00062868|58774586|FG015|Dose Level 1|Death|0|||
30765850|NCT00062868|58774587|FG016|Dose Level 1|Death|0|||
30642749|NCT00818662|58654937|FG000|Overall Study|Protocol Violation|1|||
30642750|NCT00818662|58654938|FG001|Overall Study|Protocol Violation|1|||
30642751|NCT00818662|58654939|FG002|Overall Study|Protocol Violation|0|||
30642752|NCT00818662|58654940|FG003|Overall Study|Protocol Violation|0|||
30642753|NCT00818662|58654937|FG000|Overall Study|Requires a Prohibited Medication|1|||
30642754|NCT00818662|58654938|FG001|Overall Study|Requires a Prohibited Medication|0|||
30642755|NCT00818662|58654939|FG002|Overall Study|Requires a Prohibited Medication|0|||
30642756|NCT00818662|58654940|FG003|Overall Study|Requires a Prohibited Medication|0|||
30642757|NCT00818662|58654937|FG000|Overall Study|Safety Risk|1|||
30642758|NCT00818662|58654938|FG001|Overall Study|Safety Risk|1|||
30642759|NCT00818662|58654939|FG002|Overall Study|Safety Risk|0|||
30642760|NCT00818662|58654940|FG003|Overall Study|Safety Risk|1|||
30642761|NCT00818662|58654937|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
30642762|NCT00818662|58654938|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
30642763|NCT00818662|58654939|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
30642764|NCT00818662|58654940|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
30642765|NCT00818662|58654937|FG000|Overall Study|Participant's health declined|0|||
30642766|NCT00818662|58654938|FG001|Overall Study|Participant's health declined|0|||
30642767|NCT00818662|58654939|FG002|Overall Study|Participant's health declined|0|||
30642768|NCT00818662|58654940|FG003|Overall Study|Participant's health declined|1|||
30642769|NCT00818662|58654937|FG000|Overall Study|Caregiver to pursue other treatment|0|||
30642770|NCT00818662|58654938|FG001|Overall Study|Caregiver to pursue other treatment|1|||
30642771|NCT00818662|58654939|FG002|Overall Study|Caregiver to pursue other treatment|0|||
30642772|NCT00818662|58654940|FG003|Overall Study|Caregiver to pursue other treatment|0|||
30642773|NCT00818662|58654937|FG000|Overall Study|Moving out of state|0|||
30642774|NCT00818662|58654938|FG001|Overall Study|Moving out of state|0|||
30642775|NCT00818662|58654939|FG002|Overall Study|Moving out of state|0|||
30642776|NCT00818662|58654940|FG003|Overall Study|Moving out of state|1|||
30642777|NCT00818662|58654937|FG000|Overall Study|Declined move to another study site|1|||
30642778|NCT00818662|58654938|FG001|Overall Study|Declined move to another study site|0|||
30642779|NCT00818662|58654939|FG002|Overall Study|Declined move to another study site|0|||
30642780|NCT00818662|58654940|FG003|Overall Study|Declined move to another study site|0|||
30642781|NCT00818662|58654937|FG000|Overall Study|Change in living situation|0|||
30642782|NCT00818662|58654938|FG001|Overall Study|Change in living situation|0|||
30642783|NCT00818662|58654939|FG002|Overall Study|Change in living situation|0|||
30642784|NCT00818662|58654940|FG003|Overall Study|Change in living situation|1|||
30642785|NCT00818662|58654937|FG000|Overall Study|Study partner decision|0|||
30642786|NCT00818662|58654938|FG001|Overall Study|Study partner decision|0|||
30642787|NCT00818662|58654939|FG002|Overall Study|Study partner decision|0|||
30642788|NCT00818662|58654940|FG003|Overall Study|Study partner decision|1|||
30765851|NCT00062868|58774588|FG017|Dose Level 1|Death|0|||
30765852|NCT00062868|58774589|FG018|Dose Level 1|Death|7|||
30765853|NCT00062868|58774590|FG019|Dose Level 1|Death|0|||
30765854|NCT00062868|58774591|FG020|Dose Level 1|Death|1|||
30765855|NCT00062868|58774571|FG000|Dose Level 1|Lost to Follow-up|0|||
30765856|NCT00062868|58774572|FG001|Dose Level 1|Lost to Follow-up|0|||
30765857|NCT00062868|58774573|FG002|Dose Level 1|Lost to Follow-up|0|||
30642789|NCT00818662|58654937|FG000|Overall Study|Admitted to long term nursing care|0|||
30642790|NCT00818662|58654938|FG001|Overall Study|Admitted to long term nursing care|1|||
30642791|NCT00818662|58654939|FG002|Overall Study|Admitted to long term nursing care|0|||
30642792|NCT00818662|58654940|FG003|Overall Study|Admitted to long term nursing care|0|||
30765858|NCT00062868|58774574|FG003|Dose Level 1|Lost to Follow-up|0|||
30642793|NCT00903786|58654951|FG000|Overall Study|Physician Decision|6|||
30642794|NCT00903786|58654951|FG000|Overall Study|Lack of Efficacy|5|||
30765859|NCT00062868|58774575|FG004|Dose Level 1|Lost to Follow-up|0|||
30765860|NCT00062868|58774576|FG005|Dose Level 1|Lost to Follow-up|0|||
30642795|NCT00903786|58654951|FG000|Overall Study|Reason other than lack of efficacy|4|||
30642796|NCT00762073|58654960|FG000|Overall Study|Lack of Efficacy|1|||
30642797|NCT00762073|58654961|FG001|Overall Study|Lack of Efficacy|1|||
30642798|NCT00762073|58654962|FG002|Overall Study|Lack of Efficacy|0|||
30642799|NCT00762073|58654963|FG003|Overall Study|Lack of Efficacy|0|||
30642800|NCT00762073|58654960|FG000|Overall Study|Adverse Event|1|||
30642801|NCT00762073|58654961|FG001|Overall Study|Adverse Event|0|||
30642802|NCT00762073|58654962|FG002|Overall Study|Adverse Event|1|||
30642803|NCT00762073|58654963|FG003|Overall Study|Adverse Event|1|||
30642804|NCT00762073|58654960|FG000|Overall Study|Significant Subject Noncompliance|0|||
30642805|NCT00762073|58654961|FG001|Overall Study|Significant Subject Noncompliance|1|||
30642806|NCT00762073|58654962|FG002|Overall Study|Significant Subject Noncompliance|0|||
30642807|NCT00762073|58654963|FG003|Overall Study|Significant Subject Noncompliance|1|||
30642808|NCT00762073|58654960|FG000|Overall Study|Withdrawal by Subject|1|||
30642809|NCT00762073|58654961|FG001|Overall Study|Withdrawal by Subject|2|||
30642810|NCT00762073|58654962|FG002|Overall Study|Withdrawal by Subject|1|||
30642811|NCT00762073|58654963|FG003|Overall Study|Withdrawal by Subject|1|||
30642812|NCT00762073|58654960|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
30642813|NCT00762073|58654961|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
30642814|NCT00762073|58654962|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
30642815|NCT00762073|58654963|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
30642816|NCT00761761|58654982|FG000|Overall Study|Lost to Follow-up|3|||
30642817|NCT00761761|58654983|FG001|Overall Study|Lost to Follow-up|1|||
30642818|NCT00761761|58654982|FG000|Overall Study|Withdrawal by Subject|3|||
30642819|NCT00761761|58654983|FG001|Overall Study|Withdrawal by Subject|0|||
30642820|NCT00761605|58654991|FG000|Overall Study|Adverse Event|26|||
30642821|NCT00761605|58654991|FG000|Overall Study|Death|2|||
30642822|NCT00761605|58654991|FG000|Overall Study|Lack of Efficacy|26|||
30642823|NCT00761605|58654991|FG000|Overall Study|Lost to Follow-up|29|||
30642824|NCT00761605|58654991|FG000|Overall Study|Withdrawal by Subject|37|||
30642825|NCT00761605|58654991|FG000|Overall Study|Other|21|||
30642826|NCT00761527|58654999|FG000|Overall Study|Adverse Event|3|||
30642827|NCT00761527|58654999|FG000|Overall Study|Poor Compliance|8|||
30642828|NCT00761527|58654999|FG000|Overall Study|Lost to Follow-up|9|||
30642829|NCT00761527|58654999|FG000|Overall Study|Unknown reason|2|||
30642830|NCT00770029|58655005|FG000|Overall Study|Lost to Follow-up|2|||
30642831|NCT00770029|58655006|FG001|Overall Study|Lost to Follow-up|0|||
30642832|NCT00770029|58655005|FG000|Overall Study|Withdrawal by Subject|3|||
30642833|NCT00770029|58655006|FG001|Overall Study|Withdrawal by Subject|3|||
30642834|NCT00770029|58655005|FG000|Overall Study|Adverse Event|1|||
30642835|NCT00770029|58655006|FG001|Overall Study|Adverse Event|0|||
30642836|NCT00817414|58655017|FG000|Overall Study|Adverse Event|1|||
30642837|NCT00817414|58655018|FG001|Overall Study|Adverse Event|1|||
30642838|NCT00817414|58655019|FG002|Overall Study|Adverse Event|1|||
30642839|NCT00817414|58655020|FG003|Overall Study|Adverse Event|0|||
30642840|NCT00817414|58655021|FG004|Overall Study|Adverse Event|0|||
30642841|NCT00817414|58655017|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
30642842|NCT00817414|58655018|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
30642843|NCT00817414|58655019|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
30642844|NCT00817414|58655020|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
30642845|NCT00817414|58655021|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
30642846|NCT00817414|58655017|FG000|Overall Study|Withdrawal by Subject|1|||
30642847|NCT00817414|58655018|FG001|Overall Study|Withdrawal by Subject|1|||
30642848|NCT00817414|58655019|FG002|Overall Study|Withdrawal by Subject|0|||
30642849|NCT00817414|58655020|FG003|Overall Study|Withdrawal by Subject|0|||
30642850|NCT00817414|58655021|FG004|Overall Study|Withdrawal by Subject|0|||
30765861|NCT00062868|58774577|FG006|Dose Level 1|Lost to Follow-up|0|||
30765862|NCT00062868|58774578|FG007|Dose Level 1|Lost to Follow-up|0|||
30765863|NCT00062868|58774579|FG008|Dose Level 1|Lost to Follow-up|0|||
30642851|NCT00817414|58655017|FG000|Overall Study|Lost to Follow-up|0|||
30642852|NCT00817414|58655018|FG001|Overall Study|Lost to Follow-up|0|||
30642853|NCT00817414|58655019|FG002|Overall Study|Lost to Follow-up|1|||
30642854|NCT00817414|58655020|FG003|Overall Study|Lost to Follow-up|1|||
30642855|NCT00817414|58655021|FG004|Overall Study|Lost to Follow-up|1|||
30642856|NCT00817414|58655017|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
30642857|NCT00817414|58655018|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
30642858|NCT00817414|58655019|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
30951783|NCT01702532|58999179|FG000|Overall Study|Adverse Event|0|||
30951784|NCT01702532|58999180|FG001|Overall Study|Adverse Event|1|||
30642859|NCT00817414|58655020|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
30642860|NCT00817414|58655021|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
30642861|NCT00817414|58655017|FG000|Overall Study|Protocol Violation|0|||
30642862|NCT00817414|58655018|FG001|Overall Study|Protocol Violation|0|||
30642863|NCT00817414|58655019|FG002|Overall Study|Protocol Violation|0|||
30642864|NCT00817414|58655020|FG003|Overall Study|Protocol Violation|0|||
30642865|NCT00817414|58655021|FG004|Overall Study|Protocol Violation|1|||
30642866|NCT00769561|58655040|FG000|Overall Study|Withdrawal by Subject|2|||
30642867|NCT00769561|58655041|FG001|Overall Study|Withdrawal by Subject|2|||
30642868|NCT00769561|58655040|FG000|Overall Study|Lost to Follow-up|1|||
30642869|NCT00769561|58655041|FG001|Overall Study|Lost to Follow-up|3|||
30642870|NCT00817336|58655049|FG000|Overall Study|Withdrawal by Subject|1|||
30642871|NCT00817336|58655050|FG001|Overall Study|Withdrawal by Subject|1|||
30642872|NCT00761215|58655058|FG000|Overall Study|Randomized but didn't receive drug|1|||
30642873|NCT00761215|58655059|FG001|Overall Study|Randomized but didn't receive drug|1|||
30642874|NCT00761215|58655060|FG002|Overall Study|Randomized but didn't receive drug|2|||
30642875|NCT00761215|58655058|FG000|Overall Study|Lost to Follow-up|6|||
30642876|NCT00761215|58655059|FG001|Overall Study|Lost to Follow-up|3|||
30642877|NCT00761215|58655060|FG002|Overall Study|Lost to Follow-up|6|||
30642878|NCT00761215|58655058|FG000|Overall Study|Withdrawal by Subject|1|||
30642879|NCT00761215|58655059|FG001|Overall Study|Withdrawal by Subject|0|||
30642880|NCT00761215|58655060|FG002|Overall Study|Withdrawal by Subject|0|||
30642881|NCT00761215|58655058|FG000|Overall Study|Bacteremia|1|||
30642882|NCT00761215|58655059|FG001|Overall Study|Bacteremia|0|||
30642883|NCT00761215|58655060|FG002|Overall Study|Bacteremia|0|||
30642884|NCT05101122|58655093|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
30642885|NCT05101122|58655093|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
30642886|NCT05101122|58655093|FG000|AD313 80/5|Withdrawal by Subject|1|||
30642887|NCT05101122|58655093|FG000|AD313 80/10|Physician Decision|1|||
30642888|NCT05038163|58655115|FG000|Stage 1|Did not complete survey|374|||
30642889|NCT05038163|58655116|FG001|Stage 1|Did not complete survey|0|||
30642890|NCT05038163|58655117|FG002|Stage 1|Did not complete survey|0|||
30642891|NCT05038163|58655118|FG003|Stage 1|Did not complete survey|0|||
30642892|NCT05038163|58655119|FG004|Stage 1|Did not complete survey|0|||
30642893|NCT05038163|58655120|FG005|Stage 1|Did not complete survey|0|||
30642894|NCT05038163|58655115|FG000|Stage 2|Did not complete Stage 2 survey|0|||
30642895|NCT05038163|58655116|FG001|Stage 2|Did not complete Stage 2 survey|29|||
30642896|NCT05038163|58655117|FG002|Stage 2|Did not complete Stage 2 survey|30|||
30642897|NCT05038163|58655118|FG003|Stage 2|Did not complete Stage 2 survey|24|||
30642898|NCT05038163|58655119|FG004|Stage 2|Did not complete Stage 2 survey|21|||
30642899|NCT05038163|58655120|FG005|Stage 2|Did not complete Stage 2 survey|100|||
30765864|NCT00062868|58774580|FG009|Dose Level 1|Lost to Follow-up|0|||
30765865|NCT00062868|58774581|FG010|Dose Level 1|Lost to Follow-up|0|||
30765866|NCT00062868|58774582|FG011|Dose Level 1|Lost to Follow-up|0|||
30765867|NCT00062868|58774583|FG012|Dose Level 1|Lost to Follow-up|1|||
30765868|NCT00062868|58774584|FG013|Dose Level 1|Lost to Follow-up|0|||
30765869|NCT00062868|58774585|FG014|Dose Level 1|Lost to Follow-up|0|||
30951785|NCT01702454|58999189|FG000|Overall Study|Consent withdrawal|0|||
30951786|NCT01702454|58999190|FG001|Overall Study|Consent withdrawal|1|||
30951787|NCT01702454|58999189|FG000|Overall Study|Migrated/moved from study area|0|||
30951788|NCT01702454|58999190|FG001|Overall Study|Migrated/moved from study area|1|||
30951789|NCT01702454|58999189|FG000|Overall Study|Lost to Follow-up|3|||
30951790|NCT01702454|58999190|FG001|Overall Study|Lost to Follow-up|6|||
30951791|NCT01702298|58999203|FG000|Overall Study|Withdrawal by Subject|1|||
30642900|NCT04516746|58655148|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090|||
30642901|NCT04516746|58655149|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305|||
30642902|NCT04516746|58655148|FG000|Overall Study|Withdrawal by Subject|362|||
30642903|NCT04516746|58655149|FG001|Overall Study|Withdrawal by Subject|408|||
30642904|NCT04516746|58655148|FG000|Overall Study|Lost to Follow-up|157|||
30765870|NCT00062868|58774586|FG015|Dose Level 1|Lost to Follow-up|0|||
30765871|NCT00062868|58774587|FG016|Dose Level 1|Lost to Follow-up|0|||
30765872|NCT00062868|58774588|FG017|Dose Level 1|Lost to Follow-up|0|||
30951792|NCT01701362|58999209|FG000|Overall Study|Adverse events not related to study drug|1|||
30951793|NCT01701362|58999210|FG001|Overall Study|Adverse events not related to study drug|6|||
30642905|NCT04516746|58655149|FG001|Overall Study|Lost to Follow-up|86|||
30642906|NCT04516746|58655148|FG000|Overall Study|Protocol deviation|18|||
30642907|NCT04516746|58655149|FG001|Overall Study|Protocol deviation|7|||
30642908|NCT04516746|58655148|FG000|Overall Study|Death|8|||
30642909|NCT04516746|58655149|FG001|Overall Study|Death|7|||
30642910|NCT04516746|58655148|FG000|Overall Study|Physician Decision|0|||
30642911|NCT04516746|58655149|FG001|Overall Study|Physician Decision|2|||
30642912|NCT04516746|58655148|FG000|Overall Study|Other|0|||
30642913|NCT04516746|58655149|FG001|Overall Study|Other|1|||
30642914|NCT04413617|58655179|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
30642915|NCT04413617|58655180|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
30642916|NCT04413617|58655181|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
30642917|NCT04413617|58655182|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
30642918|NCT04413617|58655183|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
30642919|NCT04413617|58655179|FG000|Overall Study|Protocol Violation|0|||
30642920|NCT04413617|58655180|FG001|Overall Study|Protocol Violation|1|||
30642921|NCT04413617|58655181|FG002|Overall Study|Protocol Violation|0|||
30642922|NCT04413617|58655182|FG003|Overall Study|Protocol Violation|0|||
30642923|NCT04413617|58655183|FG004|Overall Study|Protocol Violation|1|||
30642924|NCT04413617|58655179|FG000|Overall Study|Lack of Efficacy|2|||
30642925|NCT04413617|58655180|FG001|Overall Study|Lack of Efficacy|0|||
30642926|NCT04413617|58655181|FG002|Overall Study|Lack of Efficacy|2|||
30642927|NCT04413617|58655182|FG003|Overall Study|Lack of Efficacy|1|||
30642928|NCT04413617|58655183|FG004|Overall Study|Lack of Efficacy|0|||
30642929|NCT04413617|58655179|FG000|Overall Study|Withdrawal by Subject|3|||
30642930|NCT04413617|58655180|FG001|Overall Study|Withdrawal by Subject|4|||
30642931|NCT04413617|58655181|FG002|Overall Study|Withdrawal by Subject|2|||
30642932|NCT04413617|58655182|FG003|Overall Study|Withdrawal by Subject|5|||
30642933|NCT04413617|58655183|FG004|Overall Study|Withdrawal by Subject|3|||
30642934|NCT04413617|58655179|FG000|Overall Study|Death|1|||
30642935|NCT04413617|58655180|FG001|Overall Study|Death|0|||
30642936|NCT04413617|58655181|FG002|Overall Study|Death|0|||
30642937|NCT04413617|58655182|FG003|Overall Study|Death|0|||
30642938|NCT04413617|58655183|FG004|Overall Study|Death|0|||
30642939|NCT04413617|58655179|FG000|Overall Study|Adverse Event|1|||
30642940|NCT04413617|58655180|FG001|Overall Study|Adverse Event|0|||
30642941|NCT04413617|58655181|FG002|Overall Study|Adverse Event|0|||
30642942|NCT04413617|58655182|FG003|Overall Study|Adverse Event|1|||
30642943|NCT04413617|58655183|FG004|Overall Study|Adverse Event|1|||
30642944|NCT04413617|58655179|FG000|Overall Study|COVID-19|0|||
30642945|NCT04413617|58655180|FG001|Overall Study|COVID-19|1|||
30642946|NCT04413617|58655181|FG002|Overall Study|COVID-19|0|||
30642947|NCT04413617|58655182|FG003|Overall Study|COVID-19|0|||
30642948|NCT04413617|58655183|FG004|Overall Study|COVID-19|0|||
30642949|NCT04055116|58655219|FG000|First Intervention|Physician Decision|2|||
30642950|NCT04055116|58655220|FG001|First Intervention|Physician Decision|7|||
30642951|NCT03512262|58655266|FG000|Overall Study|Adverse Event|8|||
30642952|NCT03512262|58655267|FG001|Overall Study|Adverse Event|3|||
30642953|NCT03512262|58655266|FG000|Overall Study|Death (non-treatment emergent)|1|||
30642954|NCT03512262|58655267|FG001|Overall Study|Death (non-treatment emergent)|0|||
30642955|NCT03512262|58655266|FG000|Overall Study|Withdrawal by Subject|17|||
30642956|NCT03512262|58655267|FG001|Overall Study|Withdrawal by Subject|9|||
30642957|NCT03512262|58655266|FG000|Overall Study|Lost to Follow-up|7|||
30642958|NCT03512262|58655267|FG001|Overall Study|Lost to Follow-up|1|||
30642959|NCT03512262|58655266|FG000|Overall Study|Other than Specified|2|||
30642960|NCT03512262|58655267|FG001|Overall Study|Other than Specified|2|||
30642961|NCT03499600|58655275|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
30642962|NCT03499600|58655276|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
30642963|NCT03007979|58655290|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
30642964|NCT02960893|58655296|FG000|Randomization Phase (8-week)|Adverse Event|5|||
30642965|NCT02960893|58655297|FG001|Randomization Phase (8-week)|Adverse Event|0|||
30642966|NCT02960893|58655296|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
30642967|NCT02960893|58655297|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
30642968|NCT02960893|58655296|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
30642969|NCT02960893|58655297|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
30642970|NCT02960893|58655296|FG000|Extension Phase (48-week)|Adverse Event|2|||
30642971|NCT02960893|58655297|FG001|Extension Phase (48-week)|Adverse Event|3|||
30642972|NCT02960893|58655296|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
30642973|NCT02960893|58655297|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
30642974|NCT02960893|58655296|FG000|Extension Phase (48-week)|Other Reason|2|||
30642975|NCT02960893|58655297|FG001|Extension Phase (48-week)|Other Reason|1|||
30642976|NCT02960893|58655296|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
30642977|NCT02960893|58655297|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
30642978|NCT02960893|58655296|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
30642979|NCT02960893|58655297|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
30642980|NCT02867813|58655312|FG000|Overall Study|Withdrawal by Subject|57|||
30642981|NCT02867813|58655313|FG001|Overall Study|Withdrawal by Subject|56|||
30642982|NCT02867813|58655312|FG000|Overall Study|Decision by Sponsor|7|||
30642983|NCT02867813|58655313|FG001|Overall Study|Decision by Sponsor|7|||
30642984|NCT02867813|58655312|FG000|Overall Study|Lost to Follow-up|91|||
30642985|NCT02867813|58655313|FG001|Overall Study|Lost to Follow-up|78|||
30765873|NCT00062868|58774589|FG018|Dose Level 1|Lost to Follow-up|2|||
30765874|NCT00062868|58774590|FG019|Dose Level 1|Lost to Follow-up|0|||
30765875|NCT00062868|58774591|FG020|Dose Level 1|Lost to Follow-up|1|||
30765876|NCT00062868|58774571|FG000|Dose Level 2|Death|0|||
30765877|NCT00062868|58774572|FG001|Dose Level 2|Death|3|||
30765878|NCT00062868|58774573|FG002|Dose Level 2|Death|0|||
30765879|NCT00062868|58774574|FG003|Dose Level 2|Death|0|||
30765880|NCT00062868|58774575|FG004|Dose Level 2|Death|2|||
30765881|NCT00062868|58774576|FG005|Dose Level 2|Death|0|||
30765882|NCT00062868|58774577|FG006|Dose Level 2|Death|0|||
30765883|NCT00062868|58774578|FG007|Dose Level 2|Death|0|||
30765884|NCT00062868|58774579|FG008|Dose Level 2|Death|0|||
30765885|NCT00062868|58774580|FG009|Dose Level 2|Death|0|||
30765886|NCT00062868|58774581|FG010|Dose Level 2|Death|1|||
30765887|NCT00062868|58774582|FG011|Dose Level 2|Death|0|||
30765888|NCT00062868|58774583|FG012|Dose Level 2|Death|0|||
30642986|NCT02867813|58655312|FG000|Overall Study|Missing|2|||
30642987|NCT02867813|58655313|FG001|Overall Study|Missing|1|||
30642988|NCT02867813|58655312|FG000|Overall Study|Death|294|||
30642989|NCT02867813|58655313|FG001|Overall Study|Death|268|||
30642990|NCT02278055|58655325|FG000|Overall Study|Adverse Event|1|||
30642991|NCT02278055|58655325|FG000|Overall Study|Lost to Follow-up|1|||
30642992|NCT02278055|58655325|FG000|Overall Study|Withdrawal by Subject|2|||
30642993|NCT02278055|58655325|FG000|Overall Study|Progressive Disease|4|||
30642994|NCT02231879|58655331|FG000|Overall Study|Adverse Event|2|||
30642995|NCT02231879|58655332|FG001|Overall Study|Adverse Event|1|||
30642996|NCT02231879|58655331|FG000|Overall Study|Lack of Efficacy|0|||
30642997|NCT02231879|58655332|FG001|Overall Study|Lack of Efficacy|1|||
30642998|NCT01833806|58655353|FG000|Overall Study|Alternative treatment|2|||
30642999|NCT01833806|58655353|FG000|Overall Study|Death|5|||
30765889|NCT00062868|58774584|FG013|Dose Level 2|Death|0|||
30765890|NCT00062868|58774585|FG014|Dose Level 2|Death|0|||
30765891|NCT00062868|58774586|FG015|Dose Level 2|Death|0|||
30951794|NCT01701362|58999209|FG000|Overall Study|Adverse events related to study drug|12|||
30643000|NCT01833806|58655353|FG000|Overall Study|Physician Decision|1|||
30643001|NCT01833806|58655353|FG000|Overall Study|Lost to Follow-up|1|||
30643002|NCT01712490|58655359|FG000|Overall Study|Ongoing|601|||
30643003|NCT01712490|58655360|FG001|Overall Study|Ongoing|586|||
30643004|NCT01712490|58655359|FG000|Overall Study|Other|11|||
30643005|NCT01712490|58655360|FG001|Overall Study|Other|11|||
30643006|NCT01712490|58655359|FG000|Overall Study|Withdrawal by Subject|36|||
30643007|NCT01712490|58655360|FG001|Overall Study|Withdrawal by Subject|44|||
30643008|NCT01712490|58655359|FG000|Overall Study|Lost to Follow-up|16|||
30643009|NCT01712490|58655360|FG001|Overall Study|Lost to Follow-up|29|||
30643010|NCT01439802|58655366|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
30643011|NCT01439802|58655366|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
30643012|NCT00816556|58655377|FG000|Overall Study|Adverse Event|1|||
30643013|NCT00816556|58655378|FG001|Overall Study|Adverse Event|1|||
30643014|NCT00816556|58655379|FG002|Overall Study|Adverse Event|1|||
30643015|NCT00816556|58655377|FG000|Overall Study|Withdrawal by Subject|1|||
30643016|NCT00816556|58655378|FG001|Overall Study|Withdrawal by Subject|1|||
30643017|NCT00816556|58655379|FG002|Overall Study|Withdrawal by Subject|1|||
30643018|NCT00816556|58655377|FG000|Overall Study|Lost to Follow-up|0|||
30643019|NCT00816556|58655378|FG001|Overall Study|Lost to Follow-up|0|||
30643020|NCT00816556|58655379|FG002|Overall Study|Lost to Follow-up|1|||
30643021|NCT00760747|58655389|FG000|Study Period II|Adverse Event|3|||
30643022|NCT00760747|58655390|FG001|Study Period II|Adverse Event|4|||
30643023|NCT00760747|58655389|FG000|Study Period II|Lack of Efficacy|0|||
30765892|NCT00062868|58774587|FG016|Dose Level 2|Death|2|||
30765893|NCT00062868|58774588|FG017|Dose Level 2|Death|0|||
30765894|NCT00062868|58774589|FG018|Dose Level 2|Death|0|||
30951795|NCT01701362|58999210|FG001|Overall Study|Adverse events related to study drug|10|||
30951796|NCT01701362|58999209|FG000|Overall Study|Protocol Violation|5|||
30643024|NCT00760747|58655390|FG001|Study Period II|Lack of Efficacy|6|||
30643025|NCT00760747|58655389|FG000|Study Period II|Parent/Caregiver Decision|3|||
30643026|NCT00760747|58655390|FG001|Study Period II|Parent/Caregiver Decision|0|||
30643027|NCT00760747|58655389|FG000|Study Period II|Protocol Violation|6|||
30643028|NCT00760747|58655390|FG001|Study Period II|Protocol Violation|3|||
30643029|NCT00760747|58655389|FG000|Study Period II|Withdrawal by Subject|1|||
30643030|NCT00760747|58655390|FG001|Study Period II|Withdrawal by Subject|0|||
30643031|NCT00760747|58655389|FG000|Study Period II|No drug administered|0|||
30765895|NCT00062868|58774590|FG019|Dose Level 2|Death|0|||
30765896|NCT00062868|58774591|FG020|Dose Level 2|Death|0|||
30765897|NCT00062868|58774571|FG000|Dose Level 2|Lost to Follow-up|0|||
30765898|NCT00062868|58774572|FG001|Dose Level 2|Lost to Follow-up|0|||
30643032|NCT00760747|58655390|FG001|Study Period II|No drug administered|1|||
30643033|NCT00760747|58655389|FG000|Study Period III|Adverse Event|1|||
30643034|NCT00760747|58655390|FG001|Study Period III|Adverse Event|0|||
30643035|NCT00760747|58655389|FG000|Study Period III|Lack of Efficacy|1|||
30643036|NCT00760747|58655390|FG001|Study Period III|Lack of Efficacy|0|||
30643037|NCT00760747|58655389|FG000|Study Period III|Parent/Caregiver Decision|0|||
30643038|NCT00760747|58655390|FG001|Study Period III|Parent/Caregiver Decision|1|||
30643039|NCT00760747|58655389|FG000|Study Period III|Protocol Violation|1|||
30643040|NCT00760747|58655390|FG001|Study Period III|Protocol Violation|1|||
30643041|NCT00760747|58655389|FG000|Study Period III|Physician Decision|0|||
30643042|NCT00760747|58655390|FG001|Study Period III|Physician Decision|1|||
30643043|NCT00760669|58655396|FG000|Overall Study|Not assessed for overall improvement|18|||
30643044|NCT00760669|58655396|FG000|Overall Study|Participants missing efficacy assessment|6|||
30643045|NCT00760669|58655396|FG000|Overall Study|Participants with overlapping cases|1|||
30643046|NCT00760669|58655396|FG000|Overall Study|Took drug before entering in contract|5|||
30643047|NCT00769483|58655406|FG000|Overall Study|Withdrawal by Subject|0|||
30643048|NCT00769483|58655407|FG001|Overall Study|Withdrawal by Subject|1|||
30643049|NCT00769483|58655408|FG002|Overall Study|Withdrawal by Subject|0|||
30643050|NCT00769483|58655409|FG003|Overall Study|Withdrawal by Subject|0|||
30643051|NCT00769483|58655410|FG004|Overall Study|Withdrawal by Subject|1|||
30643052|NCT00769483|58655411|FG005|Overall Study|Withdrawal by Subject|0|||
30643053|NCT00760513|58655429|FG000|Overall Study|Withdrawal by Subject|5|||
30643054|NCT00760513|58655430|FG001|Overall Study|Withdrawal by Subject|7|||
30643055|NCT00907296|58655448|FG000|Overall Study|Ineligibility Determined|1|||
30643056|NCT00907296|58655449|FG001|Overall Study|Ineligibility Determined|0|||
30643057|NCT00907296|58655450|FG002|Overall Study|Ineligibility Determined|0|||
30643058|NCT00907296|58655451|FG003|Overall Study|Ineligibility Determined|1|||
30643059|NCT00907296|58655452|FG004|Overall Study|Ineligibility Determined|0|||
30643060|NCT00907296|58655453|FG005|Overall Study|Ineligibility Determined|0|||
30643061|NCT00907296|58655454|FG006|Overall Study|Ineligibility Determined|0|||
30643062|NCT00907296|58655455|FG007|Overall Study|Ineligibility Determined|1|||
30643063|NCT00907296|58655456|FG008|Overall Study|Ineligibility Determined|0|||
30643064|NCT00907296|58655457|FG009|Overall Study|Ineligibility Determined|0|||
30643065|NCT00907296|58655448|FG000|Overall Study|Protocol Deviation|0|||
30643066|NCT00907296|58655449|FG001|Overall Study|Protocol Deviation|1|||
30643067|NCT00907296|58655450|FG002|Overall Study|Protocol Deviation|0|||
30643068|NCT00907296|58655451|FG003|Overall Study|Protocol Deviation|0|||
30643069|NCT00907296|58655452|FG004|Overall Study|Protocol Deviation|0|||
30643070|NCT00907296|58655453|FG005|Overall Study|Protocol Deviation|0|||
30643071|NCT00907296|58655454|FG006|Overall Study|Protocol Deviation|0|||
30643072|NCT00907296|58655455|FG007|Overall Study|Protocol Deviation|0|||
30643073|NCT00907296|58655456|FG008|Overall Study|Protocol Deviation|0|||
30643074|NCT00907296|58655457|FG009|Overall Study|Protocol Deviation|0|||
30643075|NCT00907296|58655448|FG000|Overall Study|Noncompliance|1|||
30643076|NCT00907296|58655449|FG001|Overall Study|Noncompliance|1|||
30643077|NCT00907296|58655450|FG002|Overall Study|Noncompliance|1|||
30643078|NCT00907296|58655451|FG003|Overall Study|Noncompliance|0|||
30643079|NCT00907296|58655452|FG004|Overall Study|Noncompliance|0|||
30643080|NCT00907296|58655453|FG005|Overall Study|Noncompliance|1|||
30643081|NCT00907296|58655454|FG006|Overall Study|Noncompliance|0|||
30643082|NCT00907296|58655455|FG007|Overall Study|Noncompliance|2|||
30643083|NCT00907296|58655456|FG008|Overall Study|Noncompliance|0|||
30643084|NCT00907296|58655457|FG009|Overall Study|Noncompliance|0|||
30643085|NCT00907296|58655448|FG000|Overall Study|Adverse Event|2|||
30643086|NCT00907296|58655449|FG001|Overall Study|Adverse Event|0|||
30643087|NCT00907296|58655450|FG002|Overall Study|Adverse Event|0|||
30643088|NCT00907296|58655451|FG003|Overall Study|Adverse Event|0|||
30643089|NCT00907296|58655452|FG004|Overall Study|Adverse Event|0|||
30643090|NCT00907296|58655453|FG005|Overall Study|Adverse Event|0|||
30643091|NCT00907296|58655454|FG006|Overall Study|Adverse Event|1|||
30643092|NCT00907296|58655455|FG007|Overall Study|Adverse Event|0|||
30643093|NCT00907296|58655456|FG008|Overall Study|Adverse Event|0|||
30643094|NCT00907296|58655457|FG009|Overall Study|Adverse Event|1|||
30643095|NCT00907296|58655448|FG000|Overall Study|Withdrawal by Subject|7|||
30643096|NCT00907296|58655449|FG001|Overall Study|Withdrawal by Subject|2|||
30643097|NCT00907296|58655450|FG002|Overall Study|Withdrawal by Subject|1|||
30643098|NCT00907296|58655451|FG003|Overall Study|Withdrawal by Subject|1|||
30643099|NCT00907296|58655452|FG004|Overall Study|Withdrawal by Subject|1|||
30643100|NCT00907296|58655453|FG005|Overall Study|Withdrawal by Subject|5|||
30643101|NCT00907296|58655454|FG006|Overall Study|Withdrawal by Subject|3|||
30643102|NCT00907296|58655455|FG007|Overall Study|Withdrawal by Subject|2|||
30643103|NCT00907296|58655456|FG008|Overall Study|Withdrawal by Subject|4|||
30643104|NCT00907296|58655457|FG009|Overall Study|Withdrawal by Subject|2|||
30643105|NCT00907296|58655448|FG000|Overall Study|Lost to Follow-up|9|||
30643106|NCT00907296|58655449|FG001|Overall Study|Lost to Follow-up|1|||
30643107|NCT00907296|58655450|FG002|Overall Study|Lost to Follow-up|0|||
30643108|NCT00907296|58655451|FG003|Overall Study|Lost to Follow-up|2|||
30643109|NCT00907296|58655452|FG004|Overall Study|Lost to Follow-up|0|||
30643110|NCT00907296|58655453|FG005|Overall Study|Lost to Follow-up|3|||
30643111|NCT00907296|58655454|FG006|Overall Study|Lost to Follow-up|2|||
30643112|NCT00907296|58655455|FG007|Overall Study|Lost to Follow-up|2|||
30643113|NCT00907296|58655456|FG008|Overall Study|Lost to Follow-up|0|||
30643114|NCT00907296|58655457|FG009|Overall Study|Lost to Follow-up|4|||
30643115|NCT00816400|58655488|FG000|Overall Study|Death|2|||
30643116|NCT00816400|58655489|FG001|Overall Study|Death|3|||
30643117|NCT00816400|58655490|FG002|Overall Study|Death|3|||
30643118|NCT00816400|58655491|FG003|Overall Study|Death|3|||
30643119|NCT00816400|58655492|FG004|Overall Study|Death|2|||
30643120|NCT00816400|58655493|FG005|Overall Study|Death|3|||
30643121|NCT00816400|58655494|FG006|Overall Study|Death|2|||
30643122|NCT00816400|58655495|FG007|Overall Study|Death|5|||
30643123|NCT00816400|58655496|FG008|Overall Study|Death|6|||
30643124|NCT00816400|58655488|FG000|Overall Study|In hospice care at the end of the study|0|||
30643125|NCT00816400|58655489|FG001|Overall Study|In hospice care at the end of the study|0|||
30643126|NCT00816400|58655490|FG002|Overall Study|In hospice care at the end of the study|2|||
30643127|NCT00816400|58655491|FG003|Overall Study|In hospice care at the end of the study|0|||
30643128|NCT00816400|58655492|FG004|Overall Study|In hospice care at the end of the study|0|||
30643129|NCT00816400|58655493|FG005|Overall Study|In hospice care at the end of the study|0|||
30643130|NCT00816400|58655494|FG006|Overall Study|In hospice care at the end of the study|0|||
30643131|NCT00816400|58655495|FG007|Overall Study|In hospice care at the end of the study|0|||
30643132|NCT00816400|58655496|FG008|Overall Study|In hospice care at the end of the study|0|||
30643133|NCT00906204|58655519|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
30643134|NCT00906204|58655520|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
30643135|NCT00906204|58655519|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
30643136|NCT00906204|58655520|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
30643137|NCT00906204|58655519|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
30643138|NCT00906204|58655520|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
30643139|NCT00906204|58655519|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
30643140|NCT00906204|58655520|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
30643141|NCT00906204|58655519|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
30643142|NCT00906204|58655520|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
30643143|NCT00905424|58655557|FG000|Overall Study|Lost to Follow-up|3|||
30643144|NCT00905424|58655558|FG001|Overall Study|Lost to Follow-up|3|||
30643145|NCT00905424|58655557|FG000|Overall Study|Withdrawal by Subject|1|||
30643146|NCT00905424|58655558|FG001|Overall Study|Withdrawal by Subject|2|||
30643147|NCT00905424|58655557|FG000|Overall Study|Adverse Event|4|||
30643148|NCT00905424|58655558|FG001|Overall Study|Adverse Event|2|||
30643149|NCT00905424|58655557|FG000|Overall Study|Non-compliance with study medication|2|||
30643150|NCT00905424|58655558|FG001|Overall Study|Non-compliance with study medication|0|||
30643151|NCT00905424|58655557|FG000|Overall Study|Sponsor decision|1|||
30643152|NCT00905424|58655558|FG001|Overall Study|Sponsor decision|0|||
30643153|NCT00905424|58655557|FG000|Overall Study|Positive urine drug screen|0|||
30643154|NCT00905424|58655558|FG001|Overall Study|Positive urine drug screen|1|||
30643155|NCT00905424|58655557|FG000|Overall Study|Non-adherence to visit schedule|0|||
30643156|NCT00905424|58655558|FG001|Overall Study|Non-adherence to visit schedule|1|||
30643157|NCT00816166|58655568|FG000|Overall Study|Lost to Follow-up|6|||
30643158|NCT00816166|58655569|FG001|Overall Study|Lost to Follow-up|10|||
30643159|NCT00816166|58655568|FG000|Overall Study|Death|4|||
30643160|NCT00816166|58655569|FG001|Overall Study|Death|2|||
30643161|NCT00815308|58655575|FG000|Overall Study|Adverse Event|4|||
30643162|NCT00815308|58655575|FG000|Overall Study|Withdrawal by Subject|0|||
30643163|NCT00815308|58655575|FG000|Overall Study|Protocol Violation|6|||
30643164|NCT01039376|58655581|FG000|Overall Study|Lost to Follow-up|5|||
30643165|NCT01039376|58655582|FG001|Overall Study|Lost to Follow-up|12|||
30643166|NCT01039376|58655581|FG000|Overall Study|Physician Decision|15|||
30643167|NCT01039376|58655582|FG001|Overall Study|Physician Decision|10|||
30643168|NCT01039376|58655581|FG000|Overall Study|Withdrawal by Subject|20|||
30643169|NCT01039376|58655582|FG001|Overall Study|Withdrawal by Subject|32|||
30643170|NCT01039376|58655581|FG000|Overall Study|Study terminated by Sponsor|90|||
30643171|NCT01039376|58655582|FG001|Overall Study|Study terminated by Sponsor|72|||
30643172|NCT00905034|58655589|FG000|Overall Study|Withdrawal by Subject|1|||
30643173|NCT00828568|58655596|FG000|Randomized|Withdrawal by Subject|1|||
30643174|NCT00828568|58655597|FG001|Randomized|Withdrawal by Subject|0|||
30643175|NCT00828568|58655598|FG002|Randomized|Withdrawal by Subject|2|||
30643176|NCT00828568|58655596|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
30643177|NCT00828568|58655597|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
30643178|NCT00828568|58655598|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
30643179|NCT00828568|58655596|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
30643180|NCT00828568|58655597|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
30643181|NCT00828568|58655598|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
30643182|NCT00828568|58655596|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
30643183|NCT00828568|58655597|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
30643184|NCT00828568|58655598|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
30643185|NCT00828568|58655596|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
30643186|NCT00828568|58655597|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
30643187|NCT00828568|58655598|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
30643188|NCT01038752|58655609|FG000|Overall Study|Tumor Progression|2|||
30643189|NCT01038752|58655610|FG001|Overall Study|Tumor Progression|2|||
30643190|NCT01038752|58655609|FG000|Overall Study|Lost to Follow-up|3|||
30643191|NCT01038752|58655610|FG001|Overall Study|Lost to Follow-up|3|||
30643192|NCT00903630|58655619|FG000|Phase 2|Adverse Event|0|||
30643193|NCT00903630|58655620|FG001|Phase 2|Adverse Event|0|||
30643194|NCT00903630|58655621|FG002|Phase 2|Adverse Event|1|||
30643195|NCT01037114|58655631|FG000|Year 20|Others|1|||
30643196|NCT00840970|58655635|FG000|Overall Study|Adverse Event|0|||
30643197|NCT00840970|58655636|FG001|Overall Study|Adverse Event|0|||
30643198|NCT00840970|58655637|FG002|Overall Study|Adverse Event|1|||
30643199|NCT01054820|58655647|FG000|Overall Study|Withdrawal by Subject|2|||
30643200|NCT00840658|58655655|FG000|Overall Study|Death|2|||
30643201|NCT00840658|58655656|FG001|Overall Study|Death|2|||
30643202|NCT00840658|58655657|FG002|Overall Study|Death|3|||
30643203|NCT00840658|58655658|FG003|Overall Study|Death|3|||
30643204|NCT00840658|58655655|FG000|Overall Study|Lost to Follow-up|3|||
30643205|NCT00840658|58655656|FG001|Overall Study|Lost to Follow-up|1|||
30643206|NCT00840658|58655657|FG002|Overall Study|Lost to Follow-up|2|||
30643207|NCT00840658|58655658|FG003|Overall Study|Lost to Follow-up|1|||
30643208|NCT01036724|58655674|FG000|Overall Study|Adverse Event|1|||
30643209|NCT01036724|58655675|FG001|Overall Study|Adverse Event|2|||
30643210|NCT01036724|58655674|FG000|Overall Study|Lack of Efficacy|1|||
30643211|NCT01036724|58655675|FG001|Overall Study|Lack of Efficacy|1|||
30643212|NCT01036724|58655674|FG000|Overall Study|Protocol Violation|4|||
30643213|NCT01036724|58655675|FG001|Overall Study|Protocol Violation|5|||
30643214|NCT01052714|58655683|FG000|Overall Study|Adverse Event|6|||
30643215|NCT01052714|58655684|FG001|Overall Study|Adverse Event|3|||
30643216|NCT01052714|58655685|FG002|Overall Study|Adverse Event|0|||
30643217|NCT01052714|58655683|FG000|Overall Study|Death|1|||
30643218|NCT01052714|58655684|FG001|Overall Study|Death|2|||
30643219|NCT01052714|58655685|FG002|Overall Study|Death|0|||
30643220|NCT01052714|58655683|FG000|Overall Study|Lost to Follow-up|2|||
30643221|NCT01052714|58655684|FG001|Overall Study|Lost to Follow-up|3|||
30643222|NCT01052714|58655685|FG002|Overall Study|Lost to Follow-up|0|||
30643223|NCT01052714|58655683|FG000|Overall Study|Physician Decision|9|||
30643224|NCT01052714|58655684|FG001|Overall Study|Physician Decision|9|||
30643225|NCT01052714|58655685|FG002|Overall Study|Physician Decision|1|||
30643226|NCT01052714|58655683|FG000|Overall Study|Withdrawal by Subject|7|||
30643227|NCT01052714|58655684|FG001|Overall Study|Withdrawal by Subject|12|||
30643228|NCT01052714|58655685|FG002|Overall Study|Withdrawal by Subject|1|||
30643229|NCT01052480|58655702|FG000|Overall Study|Lost to Follow-up|3|||
30643230|NCT01052480|58655703|FG001|Overall Study|Lost to Follow-up|3|||
30643231|NCT01052480|58655702|FG000|Overall Study|Protocol Violation|1|||
30643232|NCT01052480|58655703|FG001|Overall Study|Protocol Violation|0|||
30643233|NCT01052480|58655702|FG000|Overall Study|Withdrawal by Subject|3|||
30643234|NCT01052480|58655703|FG001|Overall Study|Withdrawal by Subject|7|||
30643235|NCT01052480|58655702|FG000|Overall Study|Physician Decision|0|||
30643236|NCT01052480|58655703|FG001|Overall Study|Physician Decision|2|||
30643237|NCT01052480|58655702|FG000|Overall Study|Death|1|||
30643238|NCT01052480|58655703|FG001|Overall Study|Death|5|||
30643239|NCT00904722|58655709|FG000|Overall Study|Physician Decision|1|||
30643240|NCT01029782|58655715|FG000|Overall Study|Lost to Follow-up|2|||
30765899|NCT00062868|58774573|FG002|Dose Level 2|Lost to Follow-up|0|||
30765900|NCT00062868|58774574|FG003|Dose Level 2|Lost to Follow-up|0|||
30765901|NCT00062868|58774575|FG004|Dose Level 2|Lost to Follow-up|0|||
30765902|NCT00062868|58774576|FG005|Dose Level 2|Lost to Follow-up|0|||
30643241|NCT01029782|58655716|FG001|Overall Study|Lost to Follow-up|2|||
30643242|NCT01029782|58655715|FG000|Overall Study|Diagnosis changed|1|||
30643243|NCT01029782|58655716|FG001|Overall Study|Diagnosis changed|1|||
30643244|NCT01029782|58655715|FG000|Overall Study|Adverse Event|0|||
30643245|NCT01029782|58655716|FG001|Overall Study|Adverse Event|1|||
30643246|NCT01029782|58655715|FG000|Overall Study|Physician Decision|0|||
30643247|NCT01029782|58655716|FG001|Overall Study|Physician Decision|1|||
30643248|NCT01029782|58655715|FG000|Overall Study|Protocol Violation|0|||
30643249|NCT01029782|58655716|FG001|Overall Study|Protocol Violation|2|||
30643250|NCT01029782|58655715|FG000|Overall Study|Withdrawal by Subject|0|||
30643251|NCT01029782|58655716|FG001|Overall Study|Withdrawal by Subject|1|||
30643252|NCT01029704|58655731|FG000|Overall Study|Adverse Event|0|||
30643253|NCT01029704|58655732|FG001|Overall Study|Adverse Event|0|||
30643254|NCT01029704|58655733|FG002|Overall Study|Adverse Event|0|||
30643255|NCT01029704|58655734|FG003|Overall Study|Adverse Event|0|||
30643256|NCT01029704|58655735|FG004|Overall Study|Adverse Event|0|||
30643257|NCT01029704|58655736|FG005|Overall Study|Adverse Event|0|||
30643258|NCT01029704|58655737|FG006|Overall Study|Adverse Event|1|||
30643259|NCT01029704|58655738|FG007|Overall Study|Adverse Event|1|||
30643260|NCT01029704|58655739|FG008|Overall Study|Adverse Event|0|||
30643261|NCT01029704|58655731|FG000|Overall Study|Withdrawal by Subject|0|||
30643262|NCT01029704|58655732|FG001|Overall Study|Withdrawal by Subject|0|||
30643263|NCT01029704|58655733|FG002|Overall Study|Withdrawal by Subject|0|||
30643264|NCT01029704|58655734|FG003|Overall Study|Withdrawal by Subject|0|||
30643265|NCT01029704|58655735|FG004|Overall Study|Withdrawal by Subject|2|||
30643266|NCT01029704|58655736|FG005|Overall Study|Withdrawal by Subject|1|||
30643267|NCT01029704|58655737|FG006|Overall Study|Withdrawal by Subject|1|||
30643268|NCT01029704|58655738|FG007|Overall Study|Withdrawal by Subject|1|||
30643269|NCT01029704|58655739|FG008|Overall Study|Withdrawal by Subject|0|||
30643270|NCT01029704|58655731|FG000|Overall Study|Lost to Follow-up|0|||
30643271|NCT01029704|58655732|FG001|Overall Study|Lost to Follow-up|0|||
30643272|NCT01029704|58655733|FG002|Overall Study|Lost to Follow-up|0|||
30643273|NCT01029704|58655734|FG003|Overall Study|Lost to Follow-up|0|||
30643274|NCT01029704|58655735|FG004|Overall Study|Lost to Follow-up|0|||
30643275|NCT01029704|58655736|FG005|Overall Study|Lost to Follow-up|0|||
30643276|NCT01029704|58655737|FG006|Overall Study|Lost to Follow-up|1|||
30643277|NCT01029704|58655738|FG007|Overall Study|Lost to Follow-up|1|||
30643278|NCT01029704|58655739|FG008|Overall Study|Lost to Follow-up|1|||
30643279|NCT01029704|58655731|FG000|Overall Study|Lack of Efficacy|0|||
30643280|NCT01029704|58655732|FG001|Overall Study|Lack of Efficacy|0|||
30643281|NCT01029704|58655733|FG002|Overall Study|Lack of Efficacy|0|||
30643282|NCT01029704|58655734|FG003|Overall Study|Lack of Efficacy|0|||
30643283|NCT01029704|58655735|FG004|Overall Study|Lack of Efficacy|2|||
30643284|NCT01029704|58655736|FG005|Overall Study|Lack of Efficacy|3|||
30643285|NCT01029704|58655737|FG006|Overall Study|Lack of Efficacy|1|||
30643286|NCT01029704|58655738|FG007|Overall Study|Lack of Efficacy|2|||
30643287|NCT01029704|58655739|FG008|Overall Study|Lack of Efficacy|0|||
30643288|NCT01029704|58655731|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
30643289|NCT01029704|58655732|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
30643290|NCT01029704|58655733|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
30643291|NCT01029704|58655734|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
30765903|NCT00062868|58774577|FG006|Dose Level 2|Lost to Follow-up|0|||
30765904|NCT00062868|58774578|FG007|Dose Level 2|Lost to Follow-up|0|||
30765905|NCT00062868|58774579|FG008|Dose Level 2|Lost to Follow-up|0|||
30765906|NCT00062868|58774580|FG009|Dose Level 2|Lost to Follow-up|0|||
30765907|NCT00062868|58774581|FG010|Dose Level 2|Lost to Follow-up|0|||
30765908|NCT00062868|58774582|FG011|Dose Level 2|Lost to Follow-up|0|||
30765909|NCT00062868|58774583|FG012|Dose Level 2|Lost to Follow-up|0|||
30765910|NCT00062868|58774584|FG013|Dose Level 2|Lost to Follow-up|1|||
30765911|NCT00062868|58774585|FG014|Dose Level 2|Lost to Follow-up|0|||
30765912|NCT00062868|58774586|FG015|Dose Level 2|Lost to Follow-up|0|||
30765913|NCT00062868|58774587|FG016|Dose Level 2|Lost to Follow-up|1|||
30765914|NCT00062868|58774588|FG017|Dose Level 2|Lost to Follow-up|0|||
30643292|NCT01029704|58655735|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
30643293|NCT01029704|58655736|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
30643294|NCT01029704|58655737|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
30643295|NCT01029704|58655738|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
30643296|NCT01029704|58655739|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
30643297|NCT00840034|58655761|FG000|Acute Treatment Phase|Adverse Event|6|||
30643298|NCT00840034|58655762|FG001|Acute Treatment Phase|Adverse Event|8|||
30643299|NCT00840034|58655761|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
30643300|NCT00840034|58655762|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
30643301|NCT00840034|58655761|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
30643302|NCT00840034|58655762|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
30643303|NCT00840034|58655761|FG000|Acute Treatment Phase|Physician Decision|0|||
30643304|NCT00840034|58655762|FG001|Acute Treatment Phase|Physician Decision|1|||
30643305|NCT00840034|58655761|FG000|Acute Treatment Phase|Protocol Violation|2|||
30848574|NCT04604795|58874764|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
30643306|NCT00840034|58655762|FG001|Acute Treatment Phase|Protocol Violation|4|||
30643307|NCT00840034|58655761|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
30848575|NCT04604795|58874765|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
30848576|NCT04604795|58874766|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
30643308|NCT00840034|58655762|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
30643309|NCT00840034|58655761|FG000|Taper Phase|Adverse Event|1|||
30765915|NCT00062868|58774589|FG018|Dose Level 2|Lost to Follow-up|0|||
30765916|NCT00062868|58774590|FG019|Dose Level 2|Lost to Follow-up|0|||
30765917|NCT00062868|58774591|FG020|Dose Level 2|Lost to Follow-up|0|||
30848577|NCT04604795|58874767|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
30643310|NCT00840034|58655762|FG001|Taper Phase|Adverse Event|0|||
30643311|NCT00840034|58655761|FG000|Taper Phase|Lost to Follow-up|1|||
30765918|NCT00062868|58774571|FG000|Dose Level 3|Death|0|||
30643312|NCT00840034|58655762|FG001|Taper Phase|Lost to Follow-up|1|||
30643313|NCT00840034|58655761|FG000|Taper Phase|Withdrawal by Subject|1|||
30643314|NCT00840034|58655762|FG001|Taper Phase|Withdrawal by Subject|1|||
30643315|NCT00813904|58655770|FG000|Overall Study|Death|1|||
30643316|NCT00839956|58655774|FG000|Overall Study|Adverse Event|2|||
30643317|NCT00839956|58655774|FG000|Overall Study|Lack of Efficacy|6|||
30643318|NCT00839956|58655774|FG000|Overall Study|Physician Decision|1|||
30643319|NCT00839956|58655774|FG000|Overall Study|Withdrawal by Subject|3|||
30643320|NCT00839800|58655780|FG000|Overall Study|Adverse Event|8|||
30643321|NCT00839800|58655781|FG001|Overall Study|Adverse Event|12|||
30643322|NCT00839800|58655780|FG000|Overall Study|Lost to Follow-up|31|||
30643323|NCT00839800|58655781|FG001|Overall Study|Lost to Follow-up|26|||
30643324|NCT00839800|58655780|FG000|Overall Study|Withdrawal by Subject|28|||
30643325|NCT00839800|58655781|FG001|Overall Study|Withdrawal by Subject|34|||
30643326|NCT00839800|58655780|FG000|Overall Study|Incorrect Enrolment|3|||
30643327|NCT00839800|58655781|FG001|Overall Study|Incorrect Enrolment|3|||
30643328|NCT00839800|58655780|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
30643329|NCT00839800|58655781|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
30643330|NCT00839800|58655780|FG000|Overall Study|Safety Reasons|2|||
30643331|NCT00839800|58655781|FG001|Overall Study|Safety Reasons|1|||
30643332|NCT00839800|58655780|FG000|Overall Study|Other|8|||
30643333|NCT00839800|58655781|FG001|Overall Study|Other|14|||
30643334|NCT00839800|58655780|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
30643335|NCT00839800|58655781|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
30643336|NCT00753415|58655815|FG000|Part A|Disease progression|1|||
30643337|NCT00753415|58655816|FG001|Part A|Disease progression|0|||
30643338|NCT00753415|58655817|FG002|Part A|Disease progression|1|||
30643339|NCT00753415|58655818|FG003|Part A|Disease progression|2|||
30643340|NCT00753415|58655819|FG004|Part A|Disease progression|0|||
30765919|NCT00062868|58774572|FG001|Dose Level 3|Death|0|||
30765920|NCT00062868|58774573|FG002|Dose Level 3|Death|0|||
30643341|NCT00753415|58655820|FG005|Part A|Disease progression|0|||
30643342|NCT00753415|58655821|FG006|Part A|Disease progression|0|||
30643343|NCT00753415|58655822|FG007|Part A|Disease progression|0|||
30643344|NCT00753415|58655823|FG008|Part A|Disease progression|0|||
30643345|NCT00753415|58655824|FG009|Part A|Disease progression|0|||
30643346|NCT00753415|58655815|FG000|Part A|Withdrawal by Subject|0|||
30643347|NCT00753415|58655816|FG001|Part A|Withdrawal by Subject|0|||
30643348|NCT00753415|58655817|FG002|Part A|Withdrawal by Subject|1|||
30643349|NCT00753415|58655818|FG003|Part A|Withdrawal by Subject|0|||
30643350|NCT00753415|58655819|FG004|Part A|Withdrawal by Subject|0|||
30643351|NCT00753415|58655820|FG005|Part A|Withdrawal by Subject|0|||
30643352|NCT00753415|58655821|FG006|Part A|Withdrawal by Subject|0|||
30643353|NCT00753415|58655822|FG007|Part A|Withdrawal by Subject|0|||
30643354|NCT00753415|58655823|FG008|Part A|Withdrawal by Subject|0|||
30643355|NCT00753415|58655824|FG009|Part A|Withdrawal by Subject|0|||
30643356|NCT00753415|58655815|FG000|Part B|Lost to Follow-up|0|||
30643357|NCT00753415|58655816|FG001|Part B|Lost to Follow-up|0|||
30643358|NCT00753415|58655817|FG002|Part B|Lost to Follow-up|0|||
30643359|NCT00753415|58655818|FG003|Part B|Lost to Follow-up|0|||
30643360|NCT00753415|58655819|FG004|Part B|Lost to Follow-up|0|||
30643361|NCT00753415|58655820|FG005|Part B|Lost to Follow-up|0|||
30643362|NCT00753415|58655821|FG006|Part B|Lost to Follow-up|0|||
30643363|NCT00753415|58655822|FG007|Part B|Lost to Follow-up|1|||
30643364|NCT00753415|58655823|FG008|Part B|Lost to Follow-up|1|||
30643365|NCT00753415|58655824|FG009|Part B|Lost to Follow-up|0|||
30643366|NCT00753415|58655815|FG000|Part B|Disease progression|0|||
30643367|NCT00753415|58655816|FG001|Part B|Disease progression|0|||
30643368|NCT00753415|58655817|FG002|Part B|Disease progression|0|||
30643369|NCT00753415|58655818|FG003|Part B|Disease progression|0|||
30643370|NCT00753415|58655819|FG004|Part B|Disease progression|0|||
30643371|NCT00753415|58655820|FG005|Part B|Disease progression|0|||
30643372|NCT00753415|58655821|FG006|Part B|Disease progression|0|||
30643373|NCT00753415|58655822|FG007|Part B|Disease progression|0|||
30765921|NCT00062868|58774574|FG003|Dose Level 3|Death|0|||
30643374|NCT00753415|58655823|FG008|Part B|Disease progression|2|||
30643375|NCT00753415|58655824|FG009|Part B|Disease progression|1|||
30643376|NCT00754741|58655851|FG000|Overall Study|Died or disenrolled|57|||
30765922|NCT00062868|58774575|FG004|Dose Level 3|Death|0|||
30765923|NCT00062868|58774576|FG005|Dose Level 3|Death|0|||
30643377|NCT00754741|58655852|FG001|Overall Study|Died or disenrolled|69|||
30643378|NCT00754741|58655853|FG002|Overall Study|Died or disenrolled|54|||
30643379|NCT00752791|58655861|FG000|Overall Study|Adverse Event|7|||
30643380|NCT00752791|58655861|FG000|Overall Study|Withdrawal by Subject|1|||
30643381|NCT00752791|58655861|FG000|Overall Study|Physician Decision|1|||
30643382|NCT00752791|58655861|FG000|Overall Study|Death|1|||
30643383|NCT00752791|58655861|FG000|Overall Study|Renal transplant|3|||
30643384|NCT00752791|58655861|FG000|Overall Study|Switched to hemodialysis|2|||
30643385|NCT00752791|58655861|FG000|Overall Study|Protocol deviation|1|||
30643386|NCT00902304|58655872|FG000|Overall Study|Adverse Event|4|||
30643387|NCT00902304|58655873|FG001|Overall Study|Adverse Event|10|||
30765924|NCT00062868|58774577|FG006|Dose Level 3|Death|0|||
30643388|NCT00902304|58655874|FG002|Overall Study|Adverse Event|25|||
30643389|NCT00902304|58655872|FG000|Overall Study|Investigator discretion|3|||
30643390|NCT00902304|58655873|FG001|Overall Study|Investigator discretion|5|||
30643391|NCT00902304|58655874|FG002|Overall Study|Investigator discretion|13|||
30643392|NCT00902304|58655872|FG000|Overall Study|Lost to Follow-up|7|||
30643393|NCT00902304|58655873|FG001|Overall Study|Lost to Follow-up|7|||
30643394|NCT00902304|58655874|FG002|Overall Study|Lost to Follow-up|7|||
30643395|NCT00902304|58655872|FG000|Overall Study|Protocol Violation|9|||
30643396|NCT00902304|58655873|FG001|Overall Study|Protocol Violation|18|||
30643397|NCT00902304|58655874|FG002|Overall Study|Protocol Violation|20|||
30643398|NCT00902304|58655872|FG000|Overall Study|Withdrawal by Subject|32|||
30643399|NCT00902304|58655873|FG001|Overall Study|Withdrawal by Subject|22|||
30643400|NCT00902304|58655874|FG002|Overall Study|Withdrawal by Subject|43|||
30643401|NCT00902304|58655872|FG000|Overall Study|includes pregnancy|3|||
30643402|NCT00902304|58655873|FG001|Overall Study|includes pregnancy|9|||
30643403|NCT00902304|58655874|FG002|Overall Study|includes pregnancy|2|||
30643404|NCT00759109|58655885|FG000|Overall Study|Adverse Event|17|||
30643405|NCT00759109|58655886|FG001|Overall Study|Adverse Event|12|||
30643406|NCT00759109|58655885|FG000|Overall Study|Inability to comply|1|||
30643407|NCT00759109|58655886|FG001|Overall Study|Inability to comply|1|||
30643408|NCT00759109|58655885|FG000|Overall Study|Withdrawal by Subject|9|||
30643409|NCT00759109|58655886|FG001|Overall Study|Withdrawal by Subject|5|||
30643410|NCT00759109|58655885|FG000|Overall Study|Death|4|||
30643411|NCT00759109|58655886|FG001|Overall Study|Death|3|||
30643412|NCT00759109|58655885|FG000|Overall Study|Lost to Follow-up|4|||
30643413|NCT00759109|58655886|FG001|Overall Study|Lost to Follow-up|6|||
30643414|NCT00759109|58655885|FG000|Overall Study|Started new therapy|2|||
30643415|NCT00759109|58655886|FG001|Overall Study|Started new therapy|6|||
30643416|NCT00759109|58655885|FG000|Overall Study|HCV RNA negative|1|||
30643417|NCT00759109|58655886|FG001|Overall Study|HCV RNA negative|0|||
30643418|NCT00759109|58655885|FG000|Overall Study|Participant moved to a different city|0|||
30643419|NCT00759109|58655886|FG001|Overall Study|Participant moved to a different city|1|||
30643420|NCT00759109|58655885|FG000|Overall Study|Participant had a liver transplant|0|||
30643421|NCT00759109|58655886|FG001|Overall Study|Participant had a liver transplant|1|||
30643422|NCT00759109|58655885|FG000|Overall Study|Lost during study|1|||
30643423|NCT00759109|58655886|FG001|Overall Study|Lost during study|0|||
30643424|NCT00759031|58655894|FG000|First Intervention (1 Day)|Physician Decision|1|||
30643425|NCT00759031|58655895|FG001|First Intervention (1 Day)|Physician Decision|0|||
30643426|NCT00759031|58655894|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
30643427|NCT00759031|58655895|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
30643428|NCT00759031|58655894|FG000|First Intervention (1 Day)|Screening failure|1|||
30643429|NCT00759031|58655895|FG001|First Intervention (1 Day)|Screening failure|0|||
30643430|NCT00758485|58655903|FG000|Overall Study|Lost to Follow-up|0|||
30643431|NCT00758485|58655904|FG001|Overall Study|Lost to Follow-up|1|||
30643432|NCT00758485|58655903|FG000|Overall Study|Not Treated|1|||
30643433|NCT00758485|58655904|FG001|Overall Study|Not Treated|2|||
30643434|NCT00757783|58655913|FG000|Overall Study|Adverse Event|0|||
30643435|NCT00757783|58655914|FG001|Overall Study|Adverse Event|2|||
30643436|NCT00757783|58655913|FG000|Overall Study|Lost to Follow-up|1|||
30643437|NCT00757783|58655914|FG001|Overall Study|Lost to Follow-up|1|||
30643438|NCT00757783|58655913|FG000|Overall Study|Protocol Violation|1|||
30643439|NCT00757783|58655914|FG001|Overall Study|Protocol Violation|0|||
30643440|NCT00757783|58655913|FG000|Overall Study|Withdrawal by Subject|2|||
30643441|NCT00757783|58655914|FG001|Overall Study|Withdrawal by Subject|1|||
30643442|NCT00757783|58655913|FG000|Overall Study|Other|1|||
30643443|NCT00757783|58655914|FG001|Overall Study|Other|2|||
30643444|NCT00757705|58655920|FG000|Overall Study|Adverse Event|19|||
30643445|NCT00757705|58655920|FG000|Overall Study|Lost to Follow-up|16|||
30643446|NCT00757705|58655920|FG000|Overall Study|Withdrawal by Subject|25|||
30643447|NCT00757705|58655920|FG000|Overall Study|Insufficient Response|26|||
30643448|NCT00757705|58655920|FG000|Overall Study|Ineligible to continue|8|||
30643449|NCT00757705|58655920|FG000|Overall Study|Non-compliant|9|||
30643450|NCT00757705|58655920|FG000|Overall Study|Other|18|||
30951797|NCT01701362|58999210|FG001|Overall Study|Protocol Violation|3|||
30643451|NCT00757627|58655924|FG000|Overall Study|Adverse Event|15|||
30643452|NCT00757627|58655924|FG000|Overall Study|Lack of Efficacy|10|||
30643453|NCT00757627|58655924|FG000|Overall Study|Lost to Follow-up|28|||
30643454|NCT00757627|58655924|FG000|Overall Study|Withdrawal by Subject|27|||
30643455|NCT00757627|58655924|FG000|Overall Study|Other|1|||
30643456|NCT01023308|58655935|FG000|Overall Study|Abnormal test proceedure results|3|||
30643457|NCT01023308|58655936|FG001|Overall Study|Abnormal test proceedure results|8|||
30643458|NCT01023308|58655935|FG000|Overall Study|Administrative problems|2|||
30643459|NCT01023308|58655936|FG001|Overall Study|Administrative problems|1|||
30643460|NCT01023308|58655935|FG000|Overall Study|Adverse Event|130|||
30643461|NCT01023308|58655936|FG001|Overall Study|Adverse Event|66|||
30643462|NCT01023308|58655935|FG000|Overall Study|Death|21|||
30643463|NCT01023308|58655936|FG001|Overall Study|Death|17|||
30643464|NCT01023308|58655935|FG000|Overall Study|Disease progression|82|||
30643465|NCT01023308|58655936|FG001|Overall Study|Disease progression|153|||
30643466|NCT01023308|58655935|FG000|Overall Study|New Cancer therapy|4|||
30643467|NCT01023308|58655936|FG001|Overall Study|New Cancer therapy|7|||
30643468|NCT01023308|58655935|FG000|Overall Study|Protocol Violation|3|||
30643469|NCT01023308|58655936|FG001|Overall Study|Protocol Violation|4|||
30643470|NCT01023308|58655935|FG000|Overall Study|Untreated|5|||
30643471|NCT01023308|58655936|FG001|Overall Study|Untreated|5|||
30643472|NCT01023308|58655935|FG000|Overall Study|Lost to Follow-up|1|||
30643473|NCT01023308|58655936|FG001|Overall Study|Lost to Follow-up|0|||
30643474|NCT01023308|58655935|FG000|Overall Study|Withdrawal by Subject|34|||
30643475|NCT01023308|58655936|FG001|Overall Study|Withdrawal by Subject|18|||
30643476|NCT01022996|58655942|FG000|Overall Study|Adverse Event|14|||
30643477|NCT01022996|58655942|FG000|Overall Study|Withdrawal by Subject|3|||
30643478|NCT01022996|58655942|FG000|Overall Study|Lost to Follow-up|1|||
30643479|NCT01022996|58655942|FG000|Overall Study|Administrative problems|6|||
30643480|NCT01022996|58655942|FG000|Overall Study|Disease Progression|32|||
30643481|NCT01022996|58655942|FG000|Overall Study|Protocol Violation|1|||
30643482|NCT00757237|58655948|FG000|Overall Study|Lost to Follow-up|0|||
30643483|NCT00757237|58655949|FG001|Overall Study|Lost to Follow-up|1|||
30643484|NCT00757237|58655948|FG000|Overall Study|Protocol Violation|0|||
30643485|NCT00757237|58655949|FG001|Overall Study|Protocol Violation|2|||
30643486|NCT00757237|58655948|FG000|Overall Study|Physician Decision|2|||
30643487|NCT00757237|58655949|FG001|Overall Study|Physician Decision|3|||
30643488|NCT00757237|58655948|FG000|Overall Study|Withdrawal by Subject|8|||
30643489|NCT00757237|58655949|FG001|Overall Study|Withdrawal by Subject|12|||
30643490|NCT00757237|58655948|FG000|Overall Study|Safety or Tolerability|3|||
30643491|NCT00757237|58655949|FG001|Overall Study|Safety or Tolerability|5|||
30643492|NCT00757237|58655948|FG000|Overall Study|Other|0|||
30643493|NCT00757237|58655949|FG001|Overall Study|Other|2|||
30643494|NCT01029392|58655957|FG000|Overall Study|Withdrawal by Subject|18|||
30643495|NCT01029392|58655958|FG001|Overall Study|Withdrawal by Subject|11|||
30643496|NCT01029392|58655957|FG000|Overall Study|Physician Decision|2|||
30643497|NCT01029392|58655958|FG001|Overall Study|Physician Decision|0|||
30643498|NCT00903006|58655970|FG000|Overall Study|Withdrawal by Subject|2|||
30643499|NCT00903006|58655971|FG001|Overall Study|Withdrawal by Subject|0|||
30643500|NCT00903006|58655972|FG002|Overall Study|Withdrawal by Subject|0|||
30643501|NCT00903006|58655973|FG003|Overall Study|Withdrawal by Subject|0|||
30643502|NCT00903006|58655970|FG000|Overall Study|Progressive Disease|0|||
30643503|NCT00903006|58655971|FG001|Overall Study|Progressive Disease|3|||
30643504|NCT00903006|58655972|FG002|Overall Study|Progressive Disease|1|||
30643505|NCT00903006|58655973|FG003|Overall Study|Progressive Disease|0|||
30643506|NCT00839332|58655986|FG000|Phase 1|Disease Progression|38|||
30643507|NCT00839332|58655987|FG001|Phase 1|Disease Progression|0|||
30643508|NCT00839332|58655988|FG002|Phase 1|Disease Progression|0|||
30643509|NCT00839332|58655986|FG000|Phase 1|Adverse Event|6|||
30643510|NCT00839332|58655987|FG001|Phase 1|Adverse Event|0|||
30643511|NCT00839332|58655988|FG002|Phase 1|Adverse Event|0|||
30765925|NCT00062868|58774578|FG007|Dose Level 3|Death|0|||
30765926|NCT00062868|58774579|FG008|Dose Level 3|Death|0|||
30765927|NCT00062868|58774580|FG009|Dose Level 3|Death|0|||
30765928|NCT00062868|58774581|FG010|Dose Level 3|Death|0|||
30765929|NCT00062868|58774582|FG011|Dose Level 3|Death|1|||
30765930|NCT00062868|58774583|FG012|Dose Level 3|Death|0|||
30765931|NCT00062868|58774584|FG013|Dose Level 3|Death|0|||
30765932|NCT00062868|58774585|FG014|Dose Level 3|Death|0|||
30765933|NCT00062868|58774586|FG015|Dose Level 3|Death|0|||
30765934|NCT00062868|58774587|FG016|Dose Level 3|Death|0|||
30643512|NCT00839332|58655986|FG000|Phase 1|Withdrawal by Subject|4|||
30643513|NCT00839332|58655987|FG001|Phase 1|Withdrawal by Subject|0|||
30643514|NCT00839332|58655988|FG002|Phase 1|Withdrawal by Subject|0|||
30643515|NCT00839332|58655986|FG000|Phase 1|Physician Decision|2|||
30643516|NCT00839332|58655987|FG001|Phase 1|Physician Decision|0|||
30643517|NCT00839332|58655988|FG002|Phase 1|Physician Decision|0|||
30643518|NCT00839332|58655986|FG000|Phase 2|Protocol Violation|0|||
30643519|NCT00839332|58655987|FG001|Phase 2|Protocol Violation|1|||
30643520|NCT00839332|58655988|FG002|Phase 2|Protocol Violation|0|||
30765935|NCT00062868|58774588|FG017|Dose Level 3|Death|1|||
30643521|NCT00839332|58655986|FG000|Phase 2|Disease Progression|0|||
30643522|NCT00839332|58655987|FG001|Phase 2|Disease Progression|46|||
30643523|NCT00839332|58655988|FG002|Phase 2|Disease Progression|21|||
30765936|NCT00062868|58774589|FG018|Dose Level 3|Death|0|||
30643524|NCT00839332|58655986|FG000|Phase 2|Adverse Event|0|||
30643525|NCT00839332|58655987|FG001|Phase 2|Adverse Event|8|||
30643526|NCT00839332|58655988|FG002|Phase 2|Adverse Event|6|||
30643527|NCT00839332|58655986|FG000|Phase 2|Death|0|||
30765937|NCT00062868|58774590|FG019|Dose Level 3|Death|0|||
30765938|NCT00062868|58774591|FG020|Dose Level 3|Death|0|||
30643528|NCT00839332|58655987|FG001|Phase 2|Death|4|||
30643529|NCT00839332|58655988|FG002|Phase 2|Death|2|||
30643530|NCT00839332|58655986|FG000|Phase 2|Withdrawal by Subject|0|||
30643531|NCT00839332|58655987|FG001|Phase 2|Withdrawal by Subject|5|||
30643532|NCT00839332|58655988|FG002|Phase 2|Withdrawal by Subject|8|||
30643533|NCT00839332|58655986|FG000|Phase 2|Physician Decision|0|||
30643534|NCT00839332|58655987|FG001|Phase 2|Physician Decision|4|||
30643535|NCT00839332|58655988|FG002|Phase 2|Physician Decision|1|||
30643536|NCT00839332|58655986|FG000|Phase 2|Lost to Follow-up|0|||
30643537|NCT00839332|58655987|FG001|Phase 2|Lost to Follow-up|0|||
30643538|NCT00839332|58655988|FG002|Phase 2|Lost to Follow-up|1|||
30643539|NCT00902850|58655999|FG000|Overall Study|Physician Decision|2|||
30643540|NCT00902850|58656000|FG001|Overall Study|Physician Decision|2|||
30643541|NCT00902538|58656009|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
30643542|NCT00902538|58656010|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
30643543|NCT00902538|58656011|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
30643544|NCT00902538|58656012|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
30643545|NCT00902538|58656013|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
30643546|NCT00902538|58656014|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
30643547|NCT00902538|58656009|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
30643548|NCT00902538|58656010|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
30643549|NCT00902538|58656011|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
30643550|NCT00902538|58656012|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
30643551|NCT00902538|58656013|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
30643552|NCT00902538|58656014|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
30643553|NCT00902538|58656009|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
30643554|NCT00902538|58656010|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
30643555|NCT00902538|58656011|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
30643556|NCT00902538|58656012|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
30643557|NCT00902538|58656013|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
30643558|NCT00902538|58656014|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
30643559|NCT00902538|58656009|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
30643560|NCT00902538|58656010|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
30643561|NCT00902538|58656011|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
30643562|NCT00902538|58656012|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
30643563|NCT00902538|58656013|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
30643564|NCT00902538|58656014|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
30643565|NCT00902538|58656009|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
30643566|NCT00902538|58656010|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
30643567|NCT00902538|58656011|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
30643568|NCT00902538|58656012|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
30643569|NCT00902538|58656013|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
30643570|NCT00902538|58656014|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
30643571|NCT00902538|58656009|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
30643572|NCT00902538|58656010|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
30643573|NCT00902538|58656011|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
30643574|NCT00902538|58656012|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
30643575|NCT00902538|58656013|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
30643576|NCT00902538|58656014|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
30643577|NCT00902538|58656009|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
30643578|NCT00902538|58656010|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
30643579|NCT00902538|58656011|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
30643580|NCT00902538|58656012|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
30643581|NCT00902538|58656013|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
30643582|NCT00902538|58656014|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
30643583|NCT00902538|58656009|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
30643584|NCT00902538|58656010|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
30643585|NCT00902538|58656011|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
30643586|NCT00902538|58656012|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
30643587|NCT00902538|58656013|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
30643588|NCT00902538|58656014|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
30643589|NCT00902538|58656009|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
30643590|NCT00902538|58656010|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
30643591|NCT00902538|58656011|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
30643592|NCT00902538|58656012|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
30643593|NCT00902538|58656013|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
30643594|NCT00902538|58656014|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
30643595|NCT00902538|58656009|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
30643596|NCT00902538|58656010|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
30643597|NCT00902538|58656011|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
30848578|NCT04604795|58874768|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
30643598|NCT00902538|58656012|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
30643599|NCT00902538|58656013|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
30643600|NCT00902538|58656014|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
30643601|NCT00902538|58656009|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
30643602|NCT00902538|58656010|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
30643603|NCT00902538|58656011|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
30643604|NCT00902538|58656012|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
30643605|NCT00902538|58656013|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
30643606|NCT00902538|58656014|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
30643607|NCT00902538|58656009|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
30643608|NCT00902538|58656010|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
30643609|NCT00902538|58656011|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
30643610|NCT00902538|58656012|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
30643611|NCT00902538|58656013|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
30643612|NCT00902538|58656014|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
30643613|NCT00902538|58656009|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
30643614|NCT00902538|58656010|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
30643615|NCT00902538|58656011|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
30643616|NCT00902538|58656012|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
30643617|NCT00902538|58656013|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
30643618|NCT00902538|58656014|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
30643619|NCT00902538|58656009|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
30643620|NCT00902538|58656010|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
30643621|NCT00902538|58656011|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
30643622|NCT00902538|58656012|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
30643623|NCT00902538|58656013|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
30643624|NCT00902538|58656014|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
30643625|NCT00902538|58656009|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
30643626|NCT00902538|58656010|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
30643627|NCT00902538|58656011|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
30643628|NCT00902538|58656012|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
30765939|NCT00062868|58774571|FG000|Dose Level 3|Lost to Follow-up|0|||
30765940|NCT00062868|58774572|FG001|Dose Level 3|Lost to Follow-up|0|||
30765941|NCT00062868|58774573|FG002|Dose Level 3|Lost to Follow-up|0|||
30765942|NCT00062868|58774574|FG003|Dose Level 3|Lost to Follow-up|0|||
30765943|NCT00062868|58774575|FG004|Dose Level 3|Lost to Follow-up|0|||
30765944|NCT00062868|58774576|FG005|Dose Level 3|Lost to Follow-up|0|||
30765945|NCT00062868|58774577|FG006|Dose Level 3|Lost to Follow-up|0|||
30765946|NCT00062868|58774578|FG007|Dose Level 3|Lost to Follow-up|0|||
30765947|NCT00062868|58774579|FG008|Dose Level 3|Lost to Follow-up|0|||
30765948|NCT00062868|58774580|FG009|Dose Level 3|Lost to Follow-up|0|||
30765949|NCT00062868|58774581|FG010|Dose Level 3|Lost to Follow-up|0|||
30765950|NCT00062868|58774582|FG011|Dose Level 3|Lost to Follow-up|0|||
30765951|NCT00062868|58774583|FG012|Dose Level 3|Lost to Follow-up|0|||
30765952|NCT00062868|58774584|FG013|Dose Level 3|Lost to Follow-up|0|||
30765953|NCT00062868|58774585|FG014|Dose Level 3|Lost to Follow-up|1|||
30765954|NCT00062868|58774586|FG015|Dose Level 3|Lost to Follow-up|0|||
30765955|NCT00062868|58774587|FG016|Dose Level 3|Lost to Follow-up|0|||
30765956|NCT00062868|58774588|FG017|Dose Level 3|Lost to Follow-up|0|||
30765957|NCT00062868|58774589|FG018|Dose Level 3|Lost to Follow-up|0|||
30765958|NCT00062868|58774590|FG019|Dose Level 3|Lost to Follow-up|0|||
30765959|NCT00062868|58774591|FG020|Dose Level 3|Lost to Follow-up|0|||
30765960|NCT00062868|58774571|FG000|Dose Level 3|Withdrew|0|||
30765961|NCT00062868|58774572|FG001|Dose Level 3|Withdrew|0|||
30765962|NCT00062868|58774573|FG002|Dose Level 3|Withdrew|2|||
30765963|NCT00062868|58774574|FG003|Dose Level 3|Withdrew|0|||
30765964|NCT00062868|58774575|FG004|Dose Level 3|Withdrew|0|||
30765965|NCT00062868|58774576|FG005|Dose Level 3|Withdrew|0|||
30765966|NCT00062868|58774577|FG006|Dose Level 3|Withdrew|0|||
30643629|NCT00902538|58656013|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
30643630|NCT00902538|58656014|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
30765967|NCT00062868|58774578|FG007|Dose Level 3|Withdrew|0|||
30765968|NCT00062868|58774579|FG008|Dose Level 3|Withdrew|0|||
30765969|NCT00062868|58774580|FG009|Dose Level 3|Withdrew|0|||
30765970|NCT00062868|58774581|FG010|Dose Level 3|Withdrew|0|||
30643631|NCT00902538|58656009|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
30765971|NCT00062868|58774582|FG011|Dose Level 3|Withdrew|0|||
30765972|NCT00062868|58774583|FG012|Dose Level 3|Withdrew|0|||
30765973|NCT00062868|58774584|FG013|Dose Level 3|Withdrew|0|||
30765974|NCT00062868|58774585|FG014|Dose Level 3|Withdrew|0|||
30765975|NCT00062868|58774586|FG015|Dose Level 3|Withdrew|0|||
30765976|NCT00062868|58774587|FG016|Dose Level 3|Withdrew|0|||
30765977|NCT00062868|58774588|FG017|Dose Level 3|Withdrew|0|||
30765978|NCT00062868|58774589|FG018|Dose Level 3|Withdrew|0|||
30765979|NCT00062868|58774590|FG019|Dose Level 3|Withdrew|0|||
30643632|NCT00902538|58656010|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
30643633|NCT00902538|58656011|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
30643634|NCT00902538|58656012|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
30643635|NCT00902538|58656013|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
30643636|NCT00902538|58656014|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
30643637|NCT00902538|58656009|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
30643638|NCT00902538|58656010|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
30643639|NCT00902538|58656011|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
30643640|NCT00902538|58656012|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
30643641|NCT00902538|58656013|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
30643642|NCT00902538|58656014|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
30643643|NCT01036022|58656036|FG000|Overall Study|Adverse Event|1|||
30643644|NCT01036022|58656037|FG001|Overall Study|Adverse Event|3|||
30643645|NCT01036022|58656038|FG002|Overall Study|Adverse Event|2|||
30643646|NCT01036022|58656039|FG003|Overall Study|Adverse Event|1|||
30643647|NCT01036022|58656040|FG004|Overall Study|Adverse Event|0|||
30643648|NCT01036022|58656041|FG005|Overall Study|Adverse Event|2|||
30643649|NCT01036022|58656036|FG000|Overall Study|Lack of Efficacy|1|||
30643650|NCT01036022|58656037|FG001|Overall Study|Lack of Efficacy|1|||
30643651|NCT01036022|58656038|FG002|Overall Study|Lack of Efficacy|1|||
30643652|NCT01036022|58656039|FG003|Overall Study|Lack of Efficacy|0|||
30643653|NCT01036022|58656040|FG004|Overall Study|Lack of Efficacy|1|||
30643654|NCT01036022|58656041|FG005|Overall Study|Lack of Efficacy|1|||
30643655|NCT01036022|58656036|FG000|Overall Study|Physician Decision|0|||
30643656|NCT01036022|58656037|FG001|Overall Study|Physician Decision|0|||
30643657|NCT01036022|58656038|FG002|Overall Study|Physician Decision|1|||
30643658|NCT01036022|58656039|FG003|Overall Study|Physician Decision|0|||
30643659|NCT01036022|58656040|FG004|Overall Study|Physician Decision|0|||
30643660|NCT01036022|58656041|FG005|Overall Study|Physician Decision|0|||
30643661|NCT01036022|58656036|FG000|Overall Study|Withdrawal by Subject|0|||
30643662|NCT01036022|58656037|FG001|Overall Study|Withdrawal by Subject|0|||
30643663|NCT01036022|58656038|FG002|Overall Study|Withdrawal by Subject|0|||
30643664|NCT01036022|58656039|FG003|Overall Study|Withdrawal by Subject|1|||
30643665|NCT01036022|58656040|FG004|Overall Study|Withdrawal by Subject|2|||
30643666|NCT01036022|58656041|FG005|Overall Study|Withdrawal by Subject|0|||
30643667|NCT00752557|58656066|FG000|Overall Study|Withdrawal by Subject|4|||
30643668|NCT00752557|58656067|FG001|Overall Study|Withdrawal by Subject|3|||
30643669|NCT00752557|58656068|FG002|Overall Study|Withdrawal by Subject|3|||
30643670|NCT00752557|58656066|FG000|Overall Study|Unspecified resaons|0|||
30643671|NCT00752557|58656067|FG001|Overall Study|Unspecified resaons|2|||
30643672|NCT00752557|58656068|FG002|Overall Study|Unspecified resaons|2|||
30643673|NCT00752557|58656066|FG000|Overall Study|Lost to Follow-up|1|||
30643674|NCT00752557|58656067|FG001|Overall Study|Lost to Follow-up|0|||
30643675|NCT00752557|58656068|FG002|Overall Study|Lost to Follow-up|1|||
30643676|NCT00747643|58656080|FG000|Overall Study|Withdrawal by Subject|36|||
30643677|NCT00747643|58656081|FG001|Overall Study|Withdrawal by Subject|27|||
30643678|NCT01022762|58656089|FG000|Overall Study|Adverse Event|3|||
30643679|NCT01022762|58656090|FG001|Overall Study|Adverse Event|1|||
30643680|NCT01022762|58656089|FG000|Overall Study|Lack of Efficacy|0|||
30643681|NCT01022762|58656090|FG001|Overall Study|Lack of Efficacy|1|||
30643682|NCT01022762|58656089|FG000|Overall Study|Protocol Violation|7|||
30643683|NCT01022762|58656090|FG001|Overall Study|Protocol Violation|6|||
30643684|NCT01022762|58656089|FG000|Overall Study|Unclassified|12|||
30643685|NCT01022762|58656090|FG001|Overall Study|Unclassified|20|||
30643686|NCT01028378|58656096|FG000|Overall Study|Lost to Follow-up|12|||
30643687|NCT01028378|58656096|FG000|Overall Study|Withdrawal by Subject|1|||
30643688|NCT01028378|58656096|FG000|Overall Study|Adminstrative Reasons|4|||
30643689|NCT00747565|58656102|FG000|Overall Study|Withdrawal by Subject|10|||
30643690|NCT00747565|58656103|FG001|Overall Study|Withdrawal by Subject|6|||
30643691|NCT00747565|58656102|FG000|Overall Study|Lost to Follow-up|4|||
30643692|NCT00747565|58656103|FG001|Overall Study|Lost to Follow-up|1|||
30643693|NCT01028300|58656109|FG000|Overall Study|Study Terminated|4|||
30643694|NCT00752089|58656113|FG000|Overall Study|Adverse Event|1|||
30643695|NCT00752089|58656113|FG000|Overall Study|Protocol Deviation|2|||
30643696|NCT00752089|58656113|FG000|Overall Study|Could not attend visit 9|1|||
30643697|NCT00752089|58656113|FG000|Overall Study|Not capable of wearing partial denture|1|||
30643698|NCT00752089|58656113|FG000|Overall Study|Cannot continue the study|1|||
30643699|NCT00751933|58656124|FG000|Overall Study|Withdrawal by Subject|0|||
30643700|NCT00751933|58656125|FG001|Overall Study|Withdrawal by Subject|1|||
30643701|NCT00751933|58656126|FG002|Overall Study|Withdrawal by Subject|0|||
30643702|NCT00751933|58656127|FG003|Overall Study|Withdrawal by Subject|0|||
30643703|NCT00751933|58656124|FG000|Overall Study|Physician Decision|0|||
30643704|NCT00751933|58656125|FG001|Overall Study|Physician Decision|0|||
30643705|NCT00751933|58656126|FG002|Overall Study|Physician Decision|1|||
30643706|NCT00751933|58656127|FG003|Overall Study|Physician Decision|1|||
30643707|NCT00751621|58656131|FG000|Overall Study|Adverse Event|1|||
30765980|NCT00062868|58774591|FG020|Dose Level 3|Withdrew|0|||
30765981|NCT00075504|58774637|FG000|Overall Study|Withdrawal by Subject|9|||
30765982|NCT00075504|58774638|FG001|Overall Study|Withdrawal by Subject|7|||
30765983|NCT00062166|58774644|FG000|Overall Study|Withdrawal by Subject|6|||
30765984|NCT00087438|58774649|FG000|Overall Study|Ineligible / No protocol treatment|4|||
30765985|NCT00321464|58774657|FG000|Overall Study|Death|169|||
30765986|NCT00321464|58774658|FG001|Overall Study|Death|174|||
30765987|NCT00321464|58774657|FG000|Overall Study|Disease progression|124|||
30765988|NCT00321464|58774658|FG001|Overall Study|Disease progression|124|||
30765989|NCT00321464|58774657|FG000|Overall Study|Withdrawal by Subject|117|||
30765990|NCT00321464|58774658|FG001|Overall Study|Withdrawal by Subject|118|||
30765991|NCT00321464|58774657|FG000|Overall Study|Participant request|57|||
30643708|NCT00751621|58656131|FG000|Overall Study|Withdrawal by Subject|1|||
30643709|NCT00751621|58656131|FG000|Overall Study|Subject moved to another country|1|||
30643710|NCT00751621|58656131|FG000|Overall Study|Poor adherence to asthma treatment|1|||
30643711|NCT01028222|58656139|FG000|Overall Study|Protocol deviation|1|||
30643712|NCT01028222|58656140|FG001|Overall Study|Protocol deviation|0|||
30643713|NCT01028222|58656139|FG000|Overall Study|Disease progression|33|||
30643714|NCT01028222|58656140|FG001|Overall Study|Disease progression|9|||
30643715|NCT01028222|58656139|FG000|Overall Study|Administrative problems|1|||
30643716|NCT01028222|58656140|FG001|Overall Study|Administrative problems|1|||
30643717|NCT01028222|58656139|FG000|Overall Study|Lost to Follow-up|0|||
30643718|NCT01028222|58656140|FG001|Overall Study|Lost to Follow-up|1|||
30643719|NCT01028222|58656139|FG000|Overall Study|Withdrawal by Subject|1|||
30643720|NCT01028222|58656140|FG001|Overall Study|Withdrawal by Subject|0|||
30643721|NCT01028222|58656139|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
30643722|NCT01028222|58656140|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
30643723|NCT01028222|58656139|FG000|Overall Study|Adverse Event|2|||
30643724|NCT01028222|58656140|FG001|Overall Study|Adverse Event|0|||
30643725|NCT00586495|58656147|FG000|Treatment Period|Adverse Event|11|||
30643726|NCT00586495|58656147|FG000|Treatment Period|Death|1|||
30643727|NCT00586495|58656147|FG000|Treatment Period|Protocol Violation|1|||
30643728|NCT00586495|58656147|FG000|Treatment Period|Withdrawal by Subject|1|||
30643729|NCT00586495|58656147|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
30643730|NCT00586495|58656147|FG000|Treatment Period|Switch to commercial drug|10|||
30643731|NCT00586495|58656147|FG000|Follow-up|Death|40|||
30643732|NCT00586495|58656147|FG000|Follow-up|Lost to Follow-up|1|||
30643733|NCT00586495|58656147|FG000|Follow-up|Withdrawal by Subject|4|||
30643734|NCT00586495|58656147|FG000|Follow-up|Protocol driven decision point|37|||
30643735|NCT00586495|58656147|FG000|Follow-up|Switch to commercial drug|10|||
30643736|NCT01027754|58656153|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
30643737|NCT01027754|58656154|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
30643738|NCT01027754|58656153|FG000|Overall Study|Withdrawal by Subject|0|||
30643739|NCT01027754|58656154|FG001|Overall Study|Withdrawal by Subject|5|||
30643740|NCT01034540|58656166|FG000|Overall Study|Adverse Event|0|||
30643741|NCT01034540|58656167|FG001|Overall Study|Adverse Event|1|||
30643742|NCT00774930|58656177|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
30643743|NCT00774930|58656178|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
30643744|NCT00774930|58656177|FG000|DB Phase|Adverse Event|1|||
30643745|NCT00774930|58656178|FG001|DB Phase|Adverse Event|2|||
30643746|NCT00774930|58656177|FG000|DB Phase|Subject Decision|1|||
30643747|NCT00774930|58656178|FG001|DB Phase|Subject Decision|5|||
30643748|NCT00774930|58656177|FG000|DB Phase|Sponsor Decision|0|||
30643749|NCT00774930|58656178|FG001|DB Phase|Sponsor Decision|1|||
30643750|NCT00774930|58656177|FG000|DB Phase|Disease Progression|1|||
30643751|NCT00774930|58656178|FG001|DB Phase|Disease Progression|1|||
30643752|NCT00774930|58656177|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
30643753|NCT00774930|58656178|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
30643754|NCT00774930|58656177|FG000|IOL Phase|Adverse Event|1|||
30643755|NCT00774930|58656178|FG001|IOL Phase|Adverse Event|1|||
30643756|NCT00774930|58656177|FG000|IOL Phase|Subject Decision|4|||
30643757|NCT00774930|58656178|FG001|IOL Phase|Subject Decision|3|||
30643758|NCT00774930|58656177|FG000|IOL Phase|Physician Decision|3|||
30765992|NCT00321464|58774658|FG001|Overall Study|Participant request|61|||
30765993|NCT00321464|58774657|FG000|Overall Study|Adverse Event|43|||
30765994|NCT00321464|58774658|FG001|Overall Study|Adverse Event|28|||
30643759|NCT00774930|58656178|FG001|IOL Phase|Physician Decision|2|||
30643760|NCT00774930|58656177|FG000|IOL Phase|Sponsor Decision|1|||
30643761|NCT00774930|58656178|FG001|IOL Phase|Sponsor Decision|0|||
30643762|NCT00774930|58656177|FG000|IOL Phase|Disease Progression|2|||
30643763|NCT00774930|58656178|FG001|IOL Phase|Disease Progression|1|||
30643764|NCT00774930|58656177|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
30643765|NCT00774930|58656178|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
30643766|NCT00774930|58656177|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
30765995|NCT00321464|58774657|FG000|Overall Study|Physician Decision|15|||
30765996|NCT00321464|58774658|FG001|Overall Study|Physician Decision|14|||
30643767|NCT00774930|58656178|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
30765997|NCT00321464|58774657|FG000|Overall Study|Noncompliance|4|||
30643768|NCT00774930|58656177|FG000|IOL Phase|Other|1|||
30643769|NCT00774930|58656178|FG001|IOL Phase|Other|0|||
30643770|NCT00774930|58656177|FG000|IOL Phase|Brain radiation|0|||
30643771|NCT00774930|58656178|FG001|IOL Phase|Brain radiation|1|||
30643772|NCT00774930|58656177|FG000|LTOLE Phase|Adverse Event|7|||
30643773|NCT00774930|58656178|FG001|LTOLE Phase|Adverse Event|3|||
30643774|NCT00774930|58656177|FG000|LTOLE Phase|Subject decision|0|||
30643775|NCT00774930|58656178|FG001|LTOLE Phase|Subject decision|5|||
30643776|NCT00774930|58656177|FG000|LTOLE Phase|Physician Decision|4|||
30643777|NCT00774930|58656178|FG001|LTOLE Phase|Physician Decision|1|||
30643778|NCT00774930|58656177|FG000|LTOLE Phase|Sponsor decision|2|||
30643779|NCT00774930|58656178|FG001|LTOLE Phase|Sponsor decision|1|||
30643780|NCT00774930|58656177|FG000|LTOLE Phase|Disease Progression|2|||
30643781|NCT00774930|58656178|FG001|LTOLE Phase|Disease Progression|5|||
30643782|NCT00774930|58656177|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
30643783|NCT00774930|58656178|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
30643784|NCT00774930|58656177|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
30643785|NCT00774930|58656178|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
30643786|NCT01027364|58656199|FG000|Overall Study|Adverse Event|1|||
30643787|NCT01027364|58656200|FG001|Overall Study|Adverse Event|0|||
30643788|NCT01027364|58656201|FG002|Overall Study|Adverse Event|1|||
30643789|NCT01027364|58656202|FG003|Overall Study|Adverse Event|0|||
30643790|NCT01027364|58656199|FG000|Overall Study|Lost to Follow-up|1|||
30643791|NCT01027364|58656200|FG001|Overall Study|Lost to Follow-up|0|||
30643792|NCT01027364|58656201|FG002|Overall Study|Lost to Follow-up|0|||
30643793|NCT01027364|58656202|FG003|Overall Study|Lost to Follow-up|0|||
30643794|NCT01027364|58656199|FG000|Overall Study|Protocol Violation|1|||
30643795|NCT01027364|58656200|FG001|Overall Study|Protocol Violation|0|||
30643796|NCT01027364|58656201|FG002|Overall Study|Protocol Violation|0|||
30643797|NCT01027364|58656202|FG003|Overall Study|Protocol Violation|1|||
30643798|NCT01027364|58656199|FG000|Overall Study|Withdrawal by Subject|1|||
30643799|NCT01027364|58656200|FG001|Overall Study|Withdrawal by Subject|2|||
30643800|NCT01027364|58656201|FG002|Overall Study|Withdrawal by Subject|0|||
30643801|NCT01027364|58656202|FG003|Overall Study|Withdrawal by Subject|0|||
30643802|NCT01027286|58656230|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
30643803|NCT01027286|58656231|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
30643804|NCT01027286|58656230|FG000|Overall Study|Lost to Follow-up|0|||
30643805|NCT01027286|58656231|FG001|Overall Study|Lost to Follow-up|1|||
30643806|NCT01026974|58656241|FG000|Overall Study|Withdrawal by Subject|0|||
30643807|NCT01026974|58656242|FG001|Overall Study|Withdrawal by Subject|1|||
30643808|NCT01026974|58656243|FG002|Overall Study|Withdrawal by Subject|7|||
30643809|NCT01026974|58656244|FG003|Overall Study|Withdrawal by Subject|2|||
30643810|NCT01026974|58656241|FG000|Overall Study|Lost to Follow-up|1|||
30643811|NCT01026974|58656242|FG001|Overall Study|Lost to Follow-up|1|||
30643812|NCT01026974|58656243|FG002|Overall Study|Lost to Follow-up|4|||
30643813|NCT01026974|58656244|FG003|Overall Study|Lost to Follow-up|0|||
30643814|NCT01026974|58656241|FG000|Overall Study|Adverse Event|0|||
30643815|NCT01026974|58656242|FG001|Overall Study|Adverse Event|0|||
30643816|NCT01026974|58656243|FG002|Overall Study|Adverse Event|0|||
30643817|NCT01026974|58656244|FG003|Overall Study|Adverse Event|1|||
30643818|NCT01026974|58656241|FG000|Overall Study|Inappropriate enrollment|0|||
30643819|NCT01026974|58656242|FG001|Overall Study|Inappropriate enrollment|0|||
30643820|NCT01026974|58656243|FG002|Overall Study|Inappropriate enrollment|1|||
30643821|NCT01026974|58656244|FG003|Overall Study|Inappropriate enrollment|0|||
30643822|NCT00897390|58656259|FG000|Overall Study|Adverse Event|2|||
30643823|NCT00897390|58656259|FG000|Overall Study|No Longer Met Study Criteria|1|||
30643824|NCT00897390|58656259|FG000|Overall Study|Personal Reasons|1|||
30643825|NCT00897390|58656259|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
30643826|NCT01034462|58656272|FG000|Overall Study|Adverse Event|7|||
30643827|NCT01034462|58656273|FG001|Overall Study|Adverse Event|17|||
30643828|NCT01034462|58656272|FG000|Overall Study|Lack of Efficacy|4|||
30643829|NCT01034462|58656273|FG001|Overall Study|Lack of Efficacy|4|||
30643830|NCT01034462|58656272|FG000|Overall Study|Protocol Violation|10|||
30643831|NCT01034462|58656273|FG001|Overall Study|Protocol Violation|7|||
30951798|NCT01701362|58999209|FG000|Overall Study|No longer willing to participate|8|||
30643832|NCT01034462|58656272|FG000|Overall Study|Withdrawal by Subject|9|||
30643833|NCT01034462|58656273|FG001|Overall Study|Withdrawal by Subject|8|||
30643834|NCT01034462|58656272|FG000|Overall Study|Lost to Follow-up|14|||
30643835|NCT01034462|58656273|FG001|Overall Study|Lost to Follow-up|16|||
30643836|NCT01034462|58656272|FG000|Overall Study|Other reasons|1|||
30643837|NCT01034462|58656273|FG001|Overall Study|Other reasons|2|||
30643838|NCT01033448|58656281|FG000|Overall Study|Withdrawal by Subject|4|||
30643839|NCT01033448|58656281|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
30643840|NCT01033448|58656281|FG000|Overall Study|Lost to Follow-up|3|||
30643841|NCT01033448|58656281|FG000|Overall Study|Withdrew due to other reasons|3|||
30643842|NCT01033448|58656281|FG000|Overall Study|Unknown disposition|1|||
30643843|NCT00746941|58656291|FG000|Overall Study|Death|2|||
30643844|NCT00746941|58656292|FG001|Overall Study|Death|0|||
30643845|NCT00746941|58656293|FG002|Overall Study|Death|0|||
30643846|NCT00746941|58656294|FG003|Overall Study|Death|6|||
30643847|NCT00746941|58656291|FG000|Overall Study|Physician Decision|0|||
30643848|NCT00746941|58656292|FG001|Overall Study|Physician Decision|0|||
30643849|NCT00746941|58656293|FG002|Overall Study|Physician Decision|2|||
30643850|NCT00746941|58656294|FG003|Overall Study|Physician Decision|0|||
30643851|NCT00746941|58656291|FG000|Overall Study|Withdrawal by Subject|3|||
30643852|NCT00746941|58656292|FG001|Overall Study|Withdrawal by Subject|0|||
30643853|NCT00746941|58656293|FG002|Overall Study|Withdrawal by Subject|0|||
30643854|NCT00746941|58656294|FG003|Overall Study|Withdrawal by Subject|2|||
30643855|NCT00746941|58656291|FG000|Overall Study|Other, reason not provided|2|||
30643856|NCT00746941|58656292|FG001|Overall Study|Other, reason not provided|4|||
30643857|NCT00746941|58656293|FG002|Overall Study|Other, reason not provided|0|||
30643858|NCT00746941|58656294|FG003|Overall Study|Other, reason not provided|4|||
30643859|NCT00746941|58656291|FG000|Overall Study|Adverse Event|0|||
30643860|NCT00746941|58656292|FG001|Overall Study|Adverse Event|0|||
30643861|NCT00746941|58656293|FG002|Overall Study|Adverse Event|0|||
30643862|NCT00746941|58656294|FG003|Overall Study|Adverse Event|1|||
30848579|NCT04604795|58874769|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
30848580|NCT04604795|58874770|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
30848581|NCT04604795|58874771|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
30848582|NCT04604795|58874762|FG000|Part B: Up to Day 14|Adverse Event|0|||
30643863|NCT00746785|58656306|FG000|Overall Study|Lost to Follow-up|29|||
30643864|NCT00746785|58656307|FG001|Overall Study|Lost to Follow-up|25|||
30643865|NCT00746785|58656308|FG002|Overall Study|Lost to Follow-up|27|||
30643866|NCT00750919|58656316|FG000|Overall Study|Adverse Event|9|||
30643867|NCT00750919|58656316|FG000|Overall Study|Withdrawal by Subject|1|||
30643868|NCT00750919|58656316|FG000|Overall Study|Lack of Efficacy|8|||
30643869|NCT00750919|58656316|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
30643870|NCT00750919|58656316|FG000|Overall Study|Other|36|||
30643871|NCT00746551|58656322|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
30643872|NCT00746551|58656323|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
30643873|NCT00746551|58656322|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
30643874|NCT00746551|58656323|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
30643875|NCT00746551|58656322|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
30643876|NCT00746551|58656323|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
30643877|NCT00753649|58656331|FG000|Overall Study|Migrated/moved from study area|1|||
30643878|NCT00753649|58656332|FG001|Overall Study|Migrated/moved from study area|0|||
30643879|NCT00753649|58656331|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
30643880|NCT00753649|58656332|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
30643881|NCT00753649|58656331|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
30643882|NCT00753649|58656332|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
30643883|NCT00753649|58656331|FG000|Overall Study|Protocol Violation|2|||
30643884|NCT00753649|58656332|FG001|Overall Study|Protocol Violation|0|||
30643885|NCT00750139|58656342|FG000|Overall Study|Adverse Event|1|||
30848583|NCT04604795|58874763|FG001|Part B: Up to Day 14|Adverse Event|0|||
30848584|NCT04604795|58874764|FG002|Part B: Up to Day 14|Adverse Event|0|||
30848585|NCT04604795|58874765|FG003|Part B: Up to Day 14|Adverse Event|0|||
30643886|NCT00750139|58656343|FG001|Overall Study|Adverse Event|2|||
30643887|NCT00750139|58656344|FG002|Overall Study|Adverse Event|0|||
30643888|NCT00750139|58656345|FG003|Overall Study|Adverse Event|1|||
30643889|NCT00750139|58656342|FG000|Overall Study|Lost to Follow-up|17|||
30643890|NCT00750139|58656343|FG001|Overall Study|Lost to Follow-up|12|||
30643891|NCT00750139|58656344|FG002|Overall Study|Lost to Follow-up|15|||
30643892|NCT00750139|58656345|FG003|Overall Study|Lost to Follow-up|6|||
30643893|NCT00750139|58656342|FG000|Overall Study|Withdrawal by Subject|3|||
30643894|NCT00750139|58656343|FG001|Overall Study|Withdrawal by Subject|2|||
30643895|NCT00750139|58656344|FG002|Overall Study|Withdrawal by Subject|6|||
30643896|NCT00750139|58656345|FG003|Overall Study|Withdrawal by Subject|2|||
30643897|NCT00750139|58656342|FG000|Overall Study|Physician Decision|1|||
30643898|NCT00750139|58656343|FG001|Overall Study|Physician Decision|1|||
30643899|NCT00750139|58656344|FG002|Overall Study|Physician Decision|0|||
30643900|NCT00750139|58656345|FG003|Overall Study|Physician Decision|0|||
30643901|NCT00750139|58656342|FG000|Overall Study|Non-compliance|1|||
30643902|NCT00750139|58656343|FG001|Overall Study|Non-compliance|0|||
30643903|NCT00750139|58656344|FG002|Overall Study|Non-compliance|1|||
30643904|NCT00750139|58656345|FG003|Overall Study|Non-compliance|3|||
30643905|NCT00750139|58656342|FG000|Overall Study|Termination by sponsor|4|||
30643906|NCT00750139|58656343|FG001|Overall Study|Termination by sponsor|0|||
30643907|NCT00750139|58656344|FG002|Overall Study|Termination by sponsor|0|||
30643908|NCT00750139|58656345|FG003|Overall Study|Termination by sponsor|1|||
30643909|NCT00750139|58656342|FG000|Overall Study|Non-specific|62|||
30643910|NCT00750139|58656343|FG001|Overall Study|Non-specific|42|||
30848586|NCT04604795|58874766|FG004|Part B: Up to Day 14|Adverse Event|2|||
30643911|NCT00750139|58656344|FG002|Overall Study|Non-specific|79|||
30643912|NCT00750139|58656345|FG003|Overall Study|Non-specific|33|||
30765998|NCT00321464|58774658|FG001|Overall Study|Noncompliance|10|||
30765999|NCT00321464|58774657|FG000|Overall Study|Lost to Follow-up|7|||
30766000|NCT00321464|58774658|FG001|Overall Study|Lost to Follow-up|8|||
30766001|NCT00321464|58774657|FG000|Overall Study|Protocol deviation|0|||
30766002|NCT00321464|58774658|FG001|Overall Study|Protocol deviation|2|||
30766003|NCT00321464|58774657|FG000|Overall Study|Ineligibility determined|2|||
30766004|NCT00321464|58774658|FG001|Overall Study|Ineligibility determined|1|||
30643913|NCT00750061|58656359|FG000|Overall Study|Adverse Event|2|||
30766005|NCT00321464|58774657|FG000|Overall Study|Other|21|||
30766006|NCT00321464|58774658|FG001|Overall Study|Other|18|||
30766007|NCT02889796|58774668|FG000|Overall Study|Withdrew Consent|18|||
30766008|NCT02889796|58774669|FG001|Overall Study|Withdrew Consent|29|||
30766009|NCT02889796|58774670|FG002|Overall Study|Withdrew Consent|20|||
30643914|NCT00750061|58656360|FG001|Overall Study|Adverse Event|0|||
30643915|NCT00750061|58656359|FG000|Overall Study|Withdrawal by Subject|0|||
30643916|NCT00750061|58656360|FG001|Overall Study|Withdrawal by Subject|1|||
30643917|NCT00750061|58656359|FG000|Overall Study|Physician Decision|0|||
30643918|NCT00750061|58656360|FG001|Overall Study|Physician Decision|1|||
30643919|NCT00744757|58656366|FG000|Overall Study|Objective disease progression|7|||
30643920|NCT00744757|58656366|FG000|Overall Study|Physician Decision|5|||
30643921|NCT00744757|58656366|FG000|Overall Study|Withdrawal by Subject|1|||
30643922|NCT00744757|58656366|FG000|Overall Study|Death|6|||
30643923|NCT00744757|58656366|FG000|Overall Study|Adverse Event|2|||
30643924|NCT00745849|58656370|FG000|First Intervention|Withdrawal by Subject|0|||
30643925|NCT00745849|58656371|FG001|First Intervention|Withdrawal by Subject|1|||
30643926|NCT00745849|58656370|FG000|First Intervention|Lost to Follow-up|1|||
30643927|NCT00745849|58656371|FG001|First Intervention|Lost to Follow-up|1|||
30643928|NCT00745849|58656370|FG000|Second Intervention|Lost to Follow-up|2|||
30766010|NCT02889796|58774671|FG003|Overall Study|Withdrew Consent|1|||
30766011|NCT02889796|58774672|FG004|Overall Study|Withdrew Consent|2|||
30643929|NCT00745849|58656371|FG001|Second Intervention|Lost to Follow-up|1|||
30643930|NCT00749203|58656388|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
30643931|NCT00749203|58656389|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
30643932|NCT00749203|58656388|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
30643933|NCT00749203|58656389|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
30643934|NCT00749203|58656388|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
30643935|NCT00749203|58656389|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
30643936|NCT00749203|58656388|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
30643937|NCT00749203|58656389|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
30643938|NCT00749203|58656388|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
30643939|NCT00749203|58656389|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
30643940|NCT00749203|58656388|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
30643941|NCT00749203|58656389|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
30643942|NCT00748969|58656397|FG000|Overall Study|Withdrawal by Subject|1|||
30643943|NCT00748969|58656398|FG001|Overall Study|Withdrawal by Subject|0|||
30643944|NCT00748969|58656397|FG000|Overall Study|Withdrawal by Subject|0|||
30643945|NCT00748969|58656398|FG001|Overall Study|Withdrawal by Subject|1|||
30643946|NCT00745615|58656408|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
30643947|NCT00745615|58656409|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
30643948|NCT00745615|58656410|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
30643949|NCT00745615|58656411|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
30643950|NCT00745615|58656412|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
30643951|NCT00745615|58656413|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
30643952|NCT00745615|58656408|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
30643953|NCT00745615|58656409|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
30643954|NCT00745615|58656410|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
30643955|NCT00745615|58656411|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
30643956|NCT00745615|58656412|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
30643957|NCT00745615|58656413|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
30643958|NCT00745615|58656408|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
30643959|NCT00745615|58656409|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
30643960|NCT00745615|58656410|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
30766012|NCT02889796|58774673|FG005|Overall Study|Withdrew Consent|35|||
30643961|NCT00745615|58656411|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
30766013|NCT02889796|58774668|FG000|Overall Study|Investigator's Discretion|10|||
30766014|NCT02889796|58774669|FG001|Overall Study|Investigator's Discretion|9|||
30643962|NCT00745615|58656412|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
30643963|NCT00745615|58656413|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
30643964|NCT00745615|58656408|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
30643965|NCT00745615|58656409|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
30643966|NCT00745615|58656410|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
30643967|NCT00745615|58656411|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
30766015|NCT02889796|58774670|FG002|Overall Study|Investigator's Discretion|10|||
30951799|NCT01701362|58999210|FG001|Overall Study|No longer willing to participate|14|||
30643968|NCT00745615|58656412|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
30643969|NCT00745615|58656413|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
30643970|NCT00745615|58656408|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
30643971|NCT00745615|58656409|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
30643972|NCT00745615|58656410|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
30643973|NCT00745615|58656411|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
30643974|NCT00745615|58656412|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
30643975|NCT00745615|58656413|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
30643976|NCT00745615|58656408|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
30643977|NCT00745615|58656409|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
30643978|NCT00745615|58656410|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
30643979|NCT00745615|58656411|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
30643980|NCT00745615|58656412|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
30643981|NCT00745615|58656413|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
30643982|NCT00745615|58656408|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
30643983|NCT00745615|58656409|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
30643984|NCT00745615|58656410|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
30643985|NCT00745615|58656411|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
30643986|NCT00745615|58656412|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
30951800|NCT01701362|58999209|FG000|Overall Study|Lost to Follow-up|6|||
30951801|NCT01701362|58999210|FG001|Overall Study|Lost to Follow-up|9|||
30951802|NCT01701362|58999209|FG000|Overall Study|Insufficient clinical response|6|||
30951803|NCT01701362|58999210|FG001|Overall Study|Insufficient clinical response|6|||
30951804|NCT01701362|58999209|FG000|Overall Study|Death|0|||
30951805|NCT01701362|58999210|FG001|Overall Study|Death|1|||
30951806|NCT01701362|58999209|FG000|Overall Study|Randomized but not treated|1|||
30951807|NCT01701362|58999210|FG001|Overall Study|Randomized but not treated|2|||
30951808|NCT01701362|58999209|FG000|Overall Study|Reasons other than those mentioned above|3|||
30951809|NCT01701362|58999210|FG001|Overall Study|Reasons other than those mentioned above|5|||
30951810|NCT01710800|58999239|FG000|Overall Study|Withdrawal by Subject|21|||
30951811|NCT01710800|58999239|FG000|Overall Study|Protocol Violation|1|||
30951812|NCT01710020|58999245|FG000|Period 1|Protocol Violation|1|||
30951813|NCT01700348|58999251|FG000|Overall Study|Withdrawal by Subject|22|||
30951814|NCT01700348|58999251|FG000|Overall Study|Lost to Follow-up|1|||
30951815|NCT01700192|58999259|FG000|Overall Study|Adverse Event|73|||
30951816|NCT01700192|58999260|FG001|Overall Study|Adverse Event|18|||
30951817|NCT01700192|58999259|FG000|Overall Study|Lack of Efficacy|1|||
30951818|NCT01700192|58999260|FG001|Overall Study|Lack of Efficacy|0|||
30951819|NCT01700192|58999259|FG000|Overall Study|Lost to Follow-up|42|||
30951820|NCT01700192|58999260|FG001|Overall Study|Lost to Follow-up|29|||
30951821|NCT01700192|58999259|FG000|Overall Study|Noncompliance with study drug|0|||
30951822|NCT01700192|58999260|FG001|Overall Study|Noncompliance with study drug|5|||
30951823|NCT01700192|58999259|FG000|Overall Study|Physician Decision|2|||
30951824|NCT01700192|58999260|FG001|Overall Study|Physician Decision|3|||
30951825|NCT01700192|58999259|FG000|Overall Study|Pregnancy|1|||
30951826|NCT01700192|58999260|FG001|Overall Study|Pregnancy|4|||
30951827|NCT01700192|58999259|FG000|Overall Study|Progressive disease|1|||
30951828|NCT01700192|58999260|FG001|Overall Study|Progressive disease|0|||
30951829|NCT01700192|58999259|FG000|Overall Study|Protocol Violation|3|||
30951830|NCT01700192|58999260|FG001|Overall Study|Protocol Violation|4|||
30951831|NCT01700192|58999259|FG000|Overall Study|Technical problems|0|||
30951832|NCT01700192|58999260|FG001|Overall Study|Technical problems|1|||
30951833|NCT01700192|58999259|FG000|Overall Study|Withdrawal by Subject|56|||
30951834|NCT01700192|58999260|FG001|Overall Study|Withdrawal by Subject|64|||
30951835|NCT01700192|58999259|FG000|Overall Study|Never received study drug|1|||
30643987|NCT00745615|58656413|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
30643988|NCT00745615|58656408|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
30643989|NCT00745615|58656409|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
30643990|NCT00745615|58656410|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
30951836|NCT01700192|58999260|FG001|Overall Study|Never received study drug|0|||
30951837|NCT01709864|58999277|FG000|Overall Study|Physician Decision|0|||
30951838|NCT01709864|58999278|FG001|Overall Study|Physician Decision|1|||
30951839|NCT01709864|58999277|FG000|Overall Study|subject/guardian decision|5|||
30951840|NCT01709864|58999278|FG001|Overall Study|subject/guardian decision|6|||
30643991|NCT00745615|58656411|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
30643992|NCT00745615|58656412|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
30643993|NCT00745615|58656413|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
30643994|NCT00745615|58656408|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
30643995|NCT00745615|58656409|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
30643996|NCT00745615|58656410|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
30643997|NCT00745615|58656411|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
30643998|NCT00745615|58656412|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
30643999|NCT00745615|58656413|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
30644000|NCT00745615|58656408|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
30644001|NCT00745615|58656409|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
30644002|NCT00745615|58656410|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
30644003|NCT00745615|58656411|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
30644004|NCT00745615|58656412|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
30644005|NCT00745615|58656413|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
30644006|NCT00745615|58656408|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
30644007|NCT00745615|58656409|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
30644008|NCT00745615|58656410|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
30644009|NCT00745615|58656411|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
30766016|NCT02889796|58774671|FG003|Overall Study|Investigator's Discretion|3|||
30766017|NCT02889796|58774672|FG004|Overall Study|Investigator's Discretion|0|||
30766018|NCT02889796|58774673|FG005|Overall Study|Investigator's Discretion|15|||
30766019|NCT02889796|58774668|FG000|Overall Study|Adverse Event|17|||
30766020|NCT02889796|58774669|FG001|Overall Study|Adverse Event|8|||
30766021|NCT02889796|58774670|FG002|Overall Study|Adverse Event|8|||
30766022|NCT02889796|58774671|FG003|Overall Study|Adverse Event|4|||
30766023|NCT02889796|58774672|FG004|Overall Study|Adverse Event|1|||
30766024|NCT02889796|58774673|FG005|Overall Study|Adverse Event|7|||
30766025|NCT02889796|58774668|FG000|Overall Study|Lost to Follow-up|5|||
30766026|NCT02889796|58774669|FG001|Overall Study|Lost to Follow-up|7|||
30766027|NCT02889796|58774670|FG002|Overall Study|Lost to Follow-up|2|||
30766028|NCT02889796|58774671|FG003|Overall Study|Lost to Follow-up|0|||
30766029|NCT02889796|58774672|FG004|Overall Study|Lost to Follow-up|2|||
30766030|NCT02889796|58774673|FG005|Overall Study|Lost to Follow-up|6|||
30644010|NCT00745615|58656412|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
30644011|NCT00745615|58656413|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
30644012|NCT00745615|58656408|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
30644013|NCT00745615|58656409|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
30644014|NCT00745615|58656410|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
30644015|NCT00745615|58656411|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
30644016|NCT00745615|58656412|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
30644017|NCT00745615|58656413|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
30644018|NCT00745615|58656408|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
30644019|NCT00745615|58656409|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
30644020|NCT00745615|58656410|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
30644021|NCT00745615|58656411|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
30644022|NCT00745615|58656412|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
30644023|NCT00745615|58656413|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
30644024|NCT00745615|58656408|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
30644025|NCT00745615|58656409|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
30644026|NCT00745615|58656410|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
30766031|NCT02889796|58774668|FG000|Overall Study|Protocol Violation|0|||
30766032|NCT02889796|58774669|FG001|Overall Study|Protocol Violation|1|||
30766033|NCT02889796|58774670|FG002|Overall Study|Protocol Violation|3|||
30766034|NCT02889796|58774671|FG003|Overall Study|Protocol Violation|0|||
30766035|NCT02889796|58774672|FG004|Overall Study|Protocol Violation|0|||
30766036|NCT02889796|58774673|FG005|Overall Study|Protocol Violation|4|||
30766037|NCT02889796|58774668|FG000|Overall Study|Non-compliance With Study Drug|0|||
30766038|NCT02889796|58774669|FG001|Overall Study|Non-compliance With Study Drug|2|||
30644027|NCT00745615|58656411|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
30644028|NCT00745615|58656412|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
30644029|NCT00745615|58656413|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
30644030|NCT00744523|58656427|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
30644031|NCT00744523|58656428|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
30766039|NCT02889796|58774670|FG002|Overall Study|Non-compliance With Study Drug|0|||
30766040|NCT02889796|58774671|FG003|Overall Study|Non-compliance With Study Drug|0|||
30766041|NCT02889796|58774672|FG004|Overall Study|Non-compliance With Study Drug|1|||
30766042|NCT02889796|58774673|FG005|Overall Study|Non-compliance With Study Drug|2|||
30766043|NCT02889796|58774668|FG000|Overall Study|Death|1|||
30951841|NCT01709864|58999277|FG000|Overall Study|Lost to Follow-up|1|||
30644032|NCT04517253|58656439|FG000|Overall Study|Adverse Event|1|||
30644033|NCT04517253|58656440|FG001|Overall Study|Adverse Event|0|||
30644034|NCT04517253|58656441|FG002|Overall Study|Adverse Event|0|||
30644035|NCT04517253|58656439|FG000|Overall Study|Death|0|||
30644036|NCT04517253|58656440|FG001|Overall Study|Death|1|||
30644037|NCT04517253|58656441|FG002|Overall Study|Death|0|||
30644038|NCT00744991|58656451|FG000|Overall Study|Progressive Disease|11|||
30644039|NCT00744991|58656451|FG000|Overall Study|Withdrawal by Subject|8|||
30644040|NCT00744991|58656451|FG000|Overall Study|Physician Decision|3|||
30644041|NCT00744991|58656451|FG000|Overall Study|Adverse Event|2|||
30644042|NCT00744991|58656451|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
30644043|NCT00839254|58656475|FG000|Overall Study|Protocol Violation|0|||
30644044|NCT00839254|58656476|FG001|Overall Study|Protocol Violation|1|||
30644045|NCT00839254|58656477|FG002|Overall Study|Protocol Violation|1|||
30644046|NCT00839254|58656478|FG003|Overall Study|Protocol Violation|1|||
30644047|NCT00839254|58656479|FG004|Overall Study|Protocol Violation|0|||
30644048|NCT00839254|58656480|FG005|Overall Study|Protocol Violation|0|||
30644049|NCT00839254|58656481|FG006|Overall Study|Protocol Violation|1|||
30644050|NCT00839254|58656482|FG007|Overall Study|Protocol Violation|2|||
30644051|NCT00839254|58656475|FG000|Overall Study|Physician Decision|0|||
30644052|NCT00839254|58656476|FG001|Overall Study|Physician Decision|1|||
30644053|NCT00839254|58656477|FG002|Overall Study|Physician Decision|0|||
30644054|NCT00839254|58656478|FG003|Overall Study|Physician Decision|0|||
30644055|NCT00839254|58656479|FG004|Overall Study|Physician Decision|0|||
30644056|NCT00839254|58656480|FG005|Overall Study|Physician Decision|0|||
30644057|NCT00839254|58656481|FG006|Overall Study|Physician Decision|0|||
30644058|NCT00839254|58656482|FG007|Overall Study|Physician Decision|1|||
30644059|NCT00839254|58656475|FG000|Overall Study|Wrong treatment number allocation|0|||
30644060|NCT00839254|58656476|FG001|Overall Study|Wrong treatment number allocation|1|||
30644061|NCT00839254|58656477|FG002|Overall Study|Wrong treatment number allocation|0|||
30644062|NCT00839254|58656478|FG003|Overall Study|Wrong treatment number allocation|0|||
30644063|NCT00839254|58656479|FG004|Overall Study|Wrong treatment number allocation|0|||
30644064|NCT00839254|58656480|FG005|Overall Study|Wrong treatment number allocation|1|||
30766044|NCT02889796|58774669|FG001|Overall Study|Death|1|||
30766045|NCT02889796|58774670|FG002|Overall Study|Death|0|||
30766046|NCT02889796|58774671|FG003|Overall Study|Death|1|||
30766047|NCT02889796|58774672|FG004|Overall Study|Death|0|||
30644065|NCT00839254|58656481|FG006|Overall Study|Wrong treatment number allocation|0|||
30644066|NCT00839254|58656482|FG007|Overall Study|Wrong treatment number allocation|0|||
30644067|NCT00839254|58656475|FG000|Overall Study|Adverse Event|12|||
30644068|NCT00839254|58656476|FG001|Overall Study|Adverse Event|6|||
30644069|NCT00839254|58656477|FG002|Overall Study|Adverse Event|3|||
30644070|NCT00839254|58656478|FG003|Overall Study|Adverse Event|5|||
30766048|NCT02889796|58774673|FG005|Overall Study|Death|1|||
30766049|NCT02889796|58774668|FG000|Overall Study|Pregnancy|0|||
30644071|NCT00839254|58656479|FG004|Overall Study|Adverse Event|2|||
30644072|NCT00839254|58656480|FG005|Overall Study|Adverse Event|1|||
30644073|NCT00839254|58656481|FG006|Overall Study|Adverse Event|0|||
30644074|NCT00839254|58656482|FG007|Overall Study|Adverse Event|1|||
30644075|NCT00839254|58656475|FG000|Overall Study|Withdrawal by Subject|87|||
30766050|NCT02889796|58774669|FG001|Overall Study|Pregnancy|1|||
30766051|NCT02889796|58774670|FG002|Overall Study|Pregnancy|1|||
30766052|NCT02889796|58774671|FG003|Overall Study|Pregnancy|0|||
30766053|NCT02889796|58774672|FG004|Overall Study|Pregnancy|0|||
30766054|NCT02889796|58774673|FG005|Overall Study|Pregnancy|0|||
30766055|NCT02889796|58774668|FG000|Overall Study|Randomized but not Dosed|2|||
30766056|NCT02889796|58774669|FG001|Overall Study|Randomized but not Dosed|0|||
30766057|NCT02889796|58774670|FG002|Overall Study|Randomized but not Dosed|0|||
30766058|NCT02889796|58774671|FG003|Overall Study|Randomized but not Dosed|0|||
30766059|NCT02889796|58774672|FG004|Overall Study|Randomized but not Dosed|0|||
30766060|NCT02889796|58774673|FG005|Overall Study|Randomized but not Dosed|2|||
30766061|NCT02889562|58774698|FG000|Overall Study|Physician Decision|0|||
30644076|NCT00839254|58656476|FG001|Overall Study|Withdrawal by Subject|53|||
30644077|NCT00839254|58656477|FG002|Overall Study|Withdrawal by Subject|54|||
30644078|NCT00839254|58656478|FG003|Overall Study|Withdrawal by Subject|32|||
30644079|NCT00839254|58656479|FG004|Overall Study|Withdrawal by Subject|27|||
30644080|NCT00839254|58656480|FG005|Overall Study|Withdrawal by Subject|15|||
30644081|NCT00839254|58656481|FG006|Overall Study|Withdrawal by Subject|22|||
30644082|NCT00839254|58656482|FG007|Overall Study|Withdrawal by Subject|9|||
30644083|NCT00839254|58656475|FG000|Overall Study|Wrong group allocation|0|||
30644084|NCT00839254|58656476|FG001|Overall Study|Wrong group allocation|0|||
30644085|NCT00839254|58656477|FG002|Overall Study|Wrong group allocation|0|||
30644086|NCT00839254|58656478|FG003|Overall Study|Wrong group allocation|0|||
30644087|NCT00839254|58656479|FG004|Overall Study|Wrong group allocation|0|||
30644088|NCT00839254|58656480|FG005|Overall Study|Wrong group allocation|0|||
30644089|NCT00839254|58656481|FG006|Overall Study|Wrong group allocation|1|||
30644090|NCT00839254|58656482|FG007|Overall Study|Wrong group allocation|0|||
30644091|NCT00839254|58656475|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
30644092|NCT00839254|58656476|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
30644093|NCT00839254|58656477|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
30644094|NCT00839254|58656478|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
30644095|NCT00839254|58656479|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
30644096|NCT00839254|58656480|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
30644097|NCT00839254|58656481|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
30644098|NCT00839254|58656482|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
30644099|NCT00839254|58656475|FG000|Overall Study|Withdrawn due to non-compliance|2|||
30644100|NCT00839254|58656476|FG001|Overall Study|Withdrawn due to non-compliance|0|||
30644101|NCT00839254|58656477|FG002|Overall Study|Withdrawn due to non-compliance|0|||
30644102|NCT00839254|58656478|FG003|Overall Study|Withdrawn due to non-compliance|0|||
30644103|NCT00839254|58656479|FG004|Overall Study|Withdrawn due to non-compliance|0|||
30644104|NCT00839254|58656480|FG005|Overall Study|Withdrawn due to non-compliance|0|||
30644105|NCT00839254|58656481|FG006|Overall Study|Withdrawn due to non-compliance|0|||
30644106|NCT00839254|58656482|FG007|Overall Study|Withdrawn due to non-compliance|0|||
30644107|NCT00839254|58656475|FG000|Overall Study|Lost to Follow-up|51|||
30644108|NCT00839254|58656476|FG001|Overall Study|Lost to Follow-up|30|||
30644109|NCT00839254|58656477|FG002|Overall Study|Lost to Follow-up|32|||
30644110|NCT00839254|58656478|FG003|Overall Study|Lost to Follow-up|24|||
30644111|NCT00839254|58656479|FG004|Overall Study|Lost to Follow-up|8|||
30644112|NCT00839254|58656480|FG005|Overall Study|Lost to Follow-up|8|||
30644113|NCT00839254|58656481|FG006|Overall Study|Lost to Follow-up|4|||
30644114|NCT00839254|58656482|FG007|Overall Study|Lost to Follow-up|2|||
30644115|NCT00586339|58656534|FG000|Overall Study|Withdrawal by Subject|1|||
30644116|NCT00586339|58656535|FG001|Overall Study|Withdrawal by Subject|3|||
30644117|NCT00586339|58656536|FG002|Overall Study|Withdrawal by Subject|1|||
30766062|NCT02889562|58774699|FG001|Overall Study|Physician Decision|1|||
30644118|NCT00586339|58656534|FG000|Overall Study|Migrated/moved from study area|3|||
30644119|NCT00586339|58656535|FG001|Overall Study|Migrated/moved from study area|2|||
30644120|NCT00586339|58656536|FG002|Overall Study|Migrated/moved from study area|4|||
30644121|NCT00586339|58656534|FG000|Overall Study|Lost to Follow-up|3|||
30644122|NCT00586339|58656535|FG001|Overall Study|Lost to Follow-up|2|||
30644123|NCT00586339|58656536|FG002|Overall Study|Lost to Follow-up|1|||
30766063|NCT02889562|58774698|FG000|Overall Study|Withdrawal by Subject|0|||
30766064|NCT02889562|58774699|FG001|Overall Study|Withdrawal by Subject|1|||
30766065|NCT03323164|58774707|FG000|Overall Study|Poor quality imaging/scans|2|||
30644124|NCT00812968|58656544|FG000|Overall Study|Relapse after erythroid response|6|||
30644125|NCT00812968|58656544|FG000|Overall Study|Disease progression|1|||
30644126|NCT00812968|58656544|FG000|Overall Study|No further treatment required|1|||
30644127|NCT00812968|58656544|FG000|Overall Study|Study closed due to marketing approval|3|||
30644128|NCT00839098|58656553|FG000|Overall Study|Withdrawal by Subject|2|||
30644129|NCT00839098|58656554|FG001|Overall Study|Withdrawal by Subject|1|||
30644130|NCT00839098|58656555|FG002|Overall Study|Withdrawal by Subject|7|||
30644131|NCT00813748|58656565|FG000|Skin Test Substudy|Physician Decision|0|||
30644132|NCT00813748|58656566|FG001|Skin Test Substudy|Physician Decision|1|||
30644133|NCT00813592|58656574|FG000|Overall Study|Disease assessment was not completed per|2|||
30644134|NCT00813358|58656579|FG000|Overall Study|Death|32|||
30644135|NCT00813358|58656579|FG000|Overall Study|Lost to Follow-up|12|||
30644136|NCT00813358|58656579|FG000|Overall Study|other endpoints|5|||
30644137|NCT00813358|58656579|FG000|Overall Study|Withdrawal by Subject|20|||
30644138|NCT00812812|58656585|FG000|Overall Study|Adverse Event|2|||
30644139|NCT00812812|58656586|FG001|Overall Study|Adverse Event|1|||
30644140|NCT00812812|58656585|FG000|Overall Study|Lack of Efficacy|1|||
30644141|NCT00812812|58656586|FG001|Overall Study|Lack of Efficacy|0|||
30644142|NCT00812812|58656585|FG000|Overall Study|Lost to Follow-up|0|||
30644143|NCT00812812|58656586|FG001|Overall Study|Lost to Follow-up|1|||
30644144|NCT00812812|58656585|FG000|Overall Study|Withdrawal by Subject|0|||
30644145|NCT00812812|58656586|FG001|Overall Study|Withdrawal by Subject|2|||
30644146|NCT00810082|58656596|FG000|Overall Study|Lost to Follow-up|0|||
30644147|NCT00810082|58656597|FG001|Overall Study|Lost to Follow-up|4|||
30644148|NCT00748189|58656605|FG000|Overall Study|Death|99|||
30644149|NCT00748189|58656606|FG001|Overall Study|Death|84|||
30644150|NCT00748189|58656605|FG000|Overall Study|Withdrawal by Subject|23|||
30644151|NCT00748189|58656606|FG001|Overall Study|Withdrawal by Subject|29|||
30644152|NCT00748189|58656605|FG000|Overall Study|Physician Decision|16|||
30644153|NCT00748189|58656606|FG001|Overall Study|Physician Decision|5|||
30644154|NCT00748189|58656605|FG000|Overall Study|Lost to Follow-up|8|||
30644155|NCT00748189|58656606|FG001|Overall Study|Lost to Follow-up|15|||
30644156|NCT00748189|58656605|FG000|Overall Study|Study terminated by Sponsor|70|||
30644157|NCT00748189|58656606|FG001|Overall Study|Study terminated by Sponsor|79|||
30644158|NCT00744055|58656619|FG000|Overall Study|Withdrawal by Subject|6|||
30644159|NCT00744055|58656620|FG001|Overall Study|Withdrawal by Subject|9|||
30644160|NCT00744055|58656619|FG000|Overall Study|Lack of Efficacy|0|||
30644161|NCT00744055|58656620|FG001|Overall Study|Lack of Efficacy|1|||
30644162|NCT00744055|58656619|FG000|Overall Study|Physician Decision|0|||
30644163|NCT00744055|58656620|FG001|Overall Study|Physician Decision|2|||
30951842|NCT01709864|58999278|FG001|Overall Study|Lost to Follow-up|0|||
30644164|NCT00744055|58656619|FG000|Overall Study|Protocol Violation|1|||
30644165|NCT00744055|58656620|FG001|Overall Study|Protocol Violation|1|||
30644166|NCT00744055|58656619|FG000|Overall Study|Lost to Follow-up|0|||
30644167|NCT00744055|58656620|FG001|Overall Study|Lost to Follow-up|1|||
30644168|NCT00748033|58656628|FG000|Overall Study|Adverse Event|0|||
30644169|NCT00748033|58656629|FG001|Overall Study|Adverse Event|1|||
30644170|NCT00735553|58656646|FG000|Overall Study|Study prematurely terminated|77|||
30644171|NCT00740779|58656657|FG000|Overall Study|Adverse Event|4|||
30644172|NCT00740779|58656658|FG001|Overall Study|Adverse Event|6|||
30644173|NCT00740779|58656659|FG002|Overall Study|Adverse Event|3|||
30644174|NCT00740779|58656657|FG000|Overall Study|Protocol Violation|1|||
30644175|NCT00740779|58656658|FG001|Overall Study|Protocol Violation|1|||
30644176|NCT00740779|58656659|FG002|Overall Study|Protocol Violation|1|||
30644177|NCT00740779|58656657|FG000|Overall Study|Lack of Efficacy|0|||
30644178|NCT00740779|58656658|FG001|Overall Study|Lack of Efficacy|0|||
30644179|NCT00740779|58656659|FG002|Overall Study|Lack of Efficacy|2|||
30644180|NCT00740779|58656657|FG000|Overall Study|Withdrawal by Subject|2|||
30644181|NCT00740779|58656658|FG001|Overall Study|Withdrawal by Subject|4|||
30644182|NCT00740779|58656659|FG002|Overall Study|Withdrawal by Subject|2|||
30644183|NCT00740779|58656657|FG000|Overall Study|Lost to Follow-up|2|||
30644184|NCT00740779|58656658|FG001|Overall Study|Lost to Follow-up|3|||
30644185|NCT00740779|58656659|FG002|Overall Study|Lost to Follow-up|5|||
30644186|NCT00735475|58656669|FG000|Overall Study|Adverse Event|0|||
30644187|NCT00735475|58656670|FG001|Overall Study|Adverse Event|1|||
30644188|NCT00735475|58656669|FG000|Overall Study|Death|1|||
30644189|NCT00735475|58656670|FG001|Overall Study|Death|1|||
30644190|NCT00735475|58656669|FG000|Overall Study|Lost to Follow-up|3|||
30644191|NCT00735475|58656670|FG001|Overall Study|Lost to Follow-up|3|||
30644192|NCT00735475|58656669|FG000|Overall Study|Physician Decision|0|||
30644193|NCT00735475|58656670|FG001|Overall Study|Physician Decision|1|||
30644194|NCT00735475|58656669|FG000|Overall Study|Withdrawal by Subject|4|||
30644195|NCT00735475|58656670|FG001|Overall Study|Withdrawal by Subject|5|||
30644196|NCT01026818|58656679|FG000|Screening Period|Entry Criteria Not Met|105|||
30644197|NCT01026818|58656680|FG001|Screening Period|Entry Criteria Not Met|0|||
30644198|NCT01026818|58656681|FG002|Screening Period|Entry Criteria Not Met|0|||
30644199|NCT01026818|58656682|FG003|Screening Period|Entry Criteria Not Met|0|||
30644200|NCT01026818|58656679|FG000|Screening Period|Withdrawal by Subject|49|||
30644201|NCT01026818|58656680|FG001|Screening Period|Withdrawal by Subject|0|||
30644202|NCT01026818|58656681|FG002|Screening Period|Withdrawal by Subject|0|||
30644203|NCT01026818|58656682|FG003|Screening Period|Withdrawal by Subject|0|||
30644204|NCT01026818|58656679|FG000|Screening Period|Protocol Deviation|3|||
30644205|NCT01026818|58656680|FG001|Screening Period|Protocol Deviation|0|||
30644206|NCT01026818|58656681|FG002|Screening Period|Protocol Deviation|0|||
30644207|NCT01026818|58656682|FG003|Screening Period|Protocol Deviation|0|||
30644208|NCT01026818|58656679|FG000|Screening Period|Adverse Event|2|||
30644209|NCT01026818|58656680|FG001|Screening Period|Adverse Event|0|||
30644210|NCT01026818|58656681|FG002|Screening Period|Adverse Event|0|||
30644211|NCT01026818|58656682|FG003|Screening Period|Adverse Event|0|||
30644212|NCT01026818|58656679|FG000|Screening Period|Physician Decision|1|||
30644213|NCT01026818|58656680|FG001|Screening Period|Physician Decision|0|||
30644214|NCT01026818|58656681|FG002|Screening Period|Physician Decision|0|||
30644215|NCT01026818|58656682|FG003|Screening Period|Physician Decision|0|||
30644216|NCT01026818|58656679|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
30644217|NCT01026818|58656680|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
30644218|NCT01026818|58656681|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
30644219|NCT01026818|58656682|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
30644220|NCT01026818|58656679|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
30644221|NCT01026818|58656680|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
30644222|NCT01026818|58656681|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
30644223|NCT01026818|58656682|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
30644224|NCT01026818|58656679|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
30644225|NCT01026818|58656680|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
30644226|NCT01026818|58656681|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
30644227|NCT01026818|58656682|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
30644228|NCT01026818|58656679|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
30644229|NCT01026818|58656680|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
30644230|NCT01026818|58656681|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
30644231|NCT01026818|58656682|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
30644232|NCT01026818|58656679|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
30644233|NCT01026818|58656680|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
30644234|NCT01026818|58656681|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
30644235|NCT01026818|58656682|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
30644236|NCT01026818|58656679|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
30644237|NCT01026818|58656680|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
30644238|NCT01026818|58656681|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
30644239|NCT01026818|58656682|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
30644240|NCT01026818|58656679|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
30644241|NCT01026818|58656680|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
30644242|NCT01026818|58656681|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
30644243|NCT01026818|58656682|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
30644244|NCT01026818|58656679|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
30644245|NCT01026818|58656680|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
30644246|NCT01026818|58656681|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
30644247|NCT01026818|58656682|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
30644248|NCT01026818|58656679|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
30644249|NCT01026818|58656680|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
30644250|NCT01026818|58656681|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
30644251|NCT01026818|58656682|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
30644252|NCT01026818|58656679|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
30644253|NCT01026818|58656680|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
30644254|NCT01026818|58656681|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
30644255|NCT01026818|58656682|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
30644256|NCT01026818|58656679|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
30644257|NCT01026818|58656680|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
30644258|NCT01026818|58656681|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
30644259|NCT01026818|58656682|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
30644260|NCT01026818|58656679|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
30644261|NCT01026818|58656680|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
30644262|NCT01026818|58656681|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
30644263|NCT01026818|58656682|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
30644264|NCT01026818|58656679|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
30644265|NCT01026818|58656680|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
30766066|NCT03323164|58774708|FG001|Overall Study|Poor quality imaging/scans|2|||
30644266|NCT01026818|58656681|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
30766067|NCT03323086|58774720|FG000|Overall Study|Lost to Follow-up|3|||
30766068|NCT03323086|58774721|FG001|Overall Study|Lost to Follow-up|2|||
30644267|NCT01026818|58656682|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
30644268|NCT01026818|58656679|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
30644269|NCT01026818|58656680|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
30644270|NCT01026818|58656681|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
30644271|NCT01026818|58656682|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
30644272|NCT01026818|58656679|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
30644273|NCT01026818|58656680|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
30644274|NCT01026818|58656681|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
30644275|NCT01026818|58656682|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
30644276|NCT01026818|58656679|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
30644277|NCT01026818|58656680|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
30644278|NCT01026818|58656681|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
30644279|NCT01026818|58656682|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
30644280|NCT01026818|58656679|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
30644281|NCT01026818|58656680|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
30644282|NCT01026818|58656681|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
30644283|NCT01026818|58656682|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
30644284|NCT01026818|58656679|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
30644285|NCT01026818|58656680|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
30644286|NCT01026818|58656681|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
30644287|NCT01026818|58656682|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
30644288|NCT01026818|58656679|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
30644289|NCT01026818|58656680|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
30644290|NCT01026818|58656681|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
30644291|NCT01026818|58656682|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
30644292|NCT00735397|58656694|FG000|Overall Study|Adverse Event|194|||
30644293|NCT00735397|58656694|FG000|Overall Study|Lost to Follow-up|33|||
30644294|NCT00735397|58656694|FG000|Overall Study|Participant choice|252|||
30644295|NCT00735397|58656694|FG000|Overall Study|Inadequate therapeutic effect|202|||
30644296|NCT00735397|58656694|FG000|Overall Study|Administrative/Other|502|||
30644297|NCT00735007|58656701|FG000|Overall Study|Adverse Event|4|||
30644298|NCT00735007|58656701|FG000|Overall Study|Protocol Violation|1|||
30644299|NCT00743509|58656705|FG000|Overall Study|Withdrawal by Subject|2|||
30644300|NCT00734929|58656711|FG000|Overall Study|Lost to Follow-up|1|||
30644301|NCT00734929|58656712|FG001|Overall Study|Lost to Follow-up|2|||
30644302|NCT00734929|58656711|FG000|Overall Study|No intervention/ screen fail|5|||
30644303|NCT00734929|58656712|FG001|Overall Study|No intervention/ screen fail|3|||
30644304|NCT00734851|58656720|FG000|Overall Study|Withdrawal by Subject|2|||
30644305|NCT00734851|58656720|FG000|Overall Study|Lost to Follow-up|1|||
30644306|NCT00734851|58656720|FG000|Overall Study|Physician Decision|18|||
30644307|NCT00734617|58656726|FG000|Overall Study|Adverse Event|4|||
30644308|NCT00734617|58656727|FG001|Overall Study|Adverse Event|7|||
30644309|NCT00734617|58656726|FG000|Overall Study|Withdrawal by Subject|103|||
30644310|NCT00734617|58656727|FG001|Overall Study|Withdrawal by Subject|95|||
30644311|NCT00743431|58656733|FG000|Overall Study|Toxicity|6|||
30644312|NCT00743431|58656733|FG000|Overall Study|Tumor progression|56|||
30644313|NCT00743431|58656733|FG000|Overall Study|Withdrawal by Subject|13|||
30644314|NCT00743431|58656733|FG000|Overall Study|Death|9|||
30644315|NCT00743431|58656733|FG000|Overall Study|Reason for discontinuation not specified|29|||
30644316|NCT00743431|58656733|FG000|Overall Study|No documentation available|13|||
30644317|NCT00734539|58656739|FG000|Main Study|Death|33|||
30644318|NCT00734539|58656740|FG001|Main Study|Death|32|||
30644319|NCT00734539|58656739|FG000|Main Study|Physician Decision|2|||
30644320|NCT00734539|58656740|FG001|Main Study|Physician Decision|0|||
30644321|NCT00734539|58656739|FG000|Main Study|Withdrawal by Subject|1|||
30644322|NCT00734539|58656740|FG001|Main Study|Withdrawal by Subject|3|||
30644323|NCT00734539|58656739|FG000|Main Study|Enrolled in error; ineligible|1|||
30644324|NCT00734539|58656740|FG001|Main Study|Enrolled in error; ineligible|0|||
30644325|NCT00743275|58656751|FG000|Overall Study|Protocol Violation|0|||
30644326|NCT00743275|58656752|FG001|Overall Study|Protocol Violation|1|||
30644327|NCT00734149|58656758|FG000|Overall Study|Withdrawal by Subject|1|||
30644328|NCT00743197|58656766|FG000|Overall Study|Study terminated due to departure of PI.|1|||
30644329|NCT00743197|58656767|FG001|Overall Study|Study terminated due to departure of PI.|2|||
30644330|NCT00734071|58656775|FG000|Overall Study|Adverse Event|4|||
30951843|NCT01709864|58999277|FG000|Overall Study|non-compliance with study treatment|1|||
30644331|NCT00734071|58656776|FG001|Overall Study|Adverse Event|3|||
30644332|NCT00734071|58656775|FG000|Overall Study|Lack of Efficacy|3|||
30644333|NCT00734071|58656776|FG001|Overall Study|Lack of Efficacy|1|||
30644334|NCT00734071|58656775|FG000|Overall Study|Noncompliance|2|||
30644335|NCT00734071|58656776|FG001|Overall Study|Noncompliance|2|||
30644336|NCT00734071|58656775|FG000|Overall Study|Protocol Deviations|3|||
30644337|NCT00734071|58656776|FG001|Overall Study|Protocol Deviations|4|||
30644338|NCT00734071|58656775|FG000|Overall Study|Voluntary Withdrawal|9|||
30644339|NCT00734071|58656776|FG001|Overall Study|Voluntary Withdrawal|7|||
30644340|NCT00734071|58656775|FG000|Overall Study|Lost to Follow-up|16|||
30644341|NCT00734071|58656776|FG001|Overall Study|Lost to Follow-up|8|||
30644342|NCT00734071|58656775|FG000|Overall Study|Other|1|||
30644343|NCT00734071|58656776|FG001|Overall Study|Other|2|||
30644344|NCT00739297|58656782|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
30644345|NCT00739297|58656783|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
30644346|NCT00739297|58656784|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
30644347|NCT00739297|58656785|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
30644348|NCT00739297|58656786|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
30644349|NCT00739297|58656787|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
30644350|NCT00739297|58656788|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
30644351|NCT00739297|58656782|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
30644352|NCT00739297|58656783|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
30644353|NCT00739297|58656784|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
30644354|NCT00739297|58656785|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
30644355|NCT00739297|58656786|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
30644356|NCT00739297|58656787|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
30644357|NCT00739297|58656788|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
30644358|NCT00739063|58656804|FG000|Overall Study|Screen failures|8|||
30644359|NCT01026194|58656810|FG000|Period 1：Double Blind Period|Adverse Event|2|||
30644360|NCT01026194|58656811|FG001|Period 1：Double Blind Period|Adverse Event|1|||
30644361|NCT01026194|58656810|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
30644362|NCT01026194|58656811|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
30644363|NCT01026194|58656810|FG000|Period 1：Double Blind Period|Physician Decision|0|||
30644364|NCT01026194|58656811|FG001|Period 1：Double Blind Period|Physician Decision|4|||
30644365|NCT01026194|58656810|FG000|Period 2：Open-label Period|Adverse Event|4|||
30644366|NCT01026194|58656811|FG001|Period 2：Open-label Period|Adverse Event|5|||
30644367|NCT01026194|58656810|FG000|Period 2：Open-label Period|Physician Decision|3|||
30644368|NCT01026194|58656811|FG001|Period 2：Open-label Period|Physician Decision|1|||
30644369|NCT01026194|58656810|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
30644370|NCT01026194|58656811|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
30644371|NCT01033136|58656821|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
30644372|NCT01033136|58656822|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
30644373|NCT00738673|58656832|FG000|Overall Study|Adverse Event|1|||
30644374|NCT00738673|58656833|FG001|Overall Study|Adverse Event|0|||
30644375|NCT00738673|58656832|FG000|Overall Study|Lack of Efficacy|19|||
30644376|NCT00738673|58656833|FG001|Overall Study|Lack of Efficacy|8|||
30644377|NCT00738673|58656832|FG000|Overall Study|Protocol Violation|1|||
30644378|NCT00738673|58656833|FG001|Overall Study|Protocol Violation|2|||
30644379|NCT00738673|58656832|FG000|Overall Study|Withdrawal by Subject|3|||
30644380|NCT00738673|58656833|FG001|Overall Study|Withdrawal by Subject|1|||
30644381|NCT00811954|58656842|FG000|Overall Study|Death|10|||
30644382|NCT00811954|58656843|FG001|Overall Study|Death|6|||
30644383|NCT00811954|58656844|FG002|Overall Study|Death|13|||
30644384|NCT00811954|58656842|FG000|Overall Study|Lost to Follow-up|29|||
30644385|NCT00811954|58656843|FG001|Overall Study|Lost to Follow-up|23|||
30644386|NCT00811954|58656844|FG002|Overall Study|Lost to Follow-up|34|||
30644387|NCT00811954|58656842|FG000|Overall Study|Not able to get to clinic|28|||
30644388|NCT00811954|58656843|FG001|Overall Study|Not able to get to clinic|35|||
30644389|NCT00811954|58656844|FG002|Overall Study|Not able to get to clinic|30|||
30644390|NCT00811954|58656842|FG000|Overall Study|Not willing to adhere to requirements|12|||
30644391|NCT00811954|58656843|FG001|Overall Study|Not willing to adhere to requirements|2|||
30644392|NCT00811954|58656844|FG002|Overall Study|Not willing to adhere to requirements|16|||
30644393|NCT00811954|58656842|FG000|Overall Study|Withdraw consent prior study completion|4|||
30644394|NCT00811954|58656843|FG001|Overall Study|Withdraw consent prior study completion|6|||
30644395|NCT00811954|58656844|FG002|Overall Study|Withdraw consent prior study completion|5|||
30644396|NCT00811954|58656842|FG000|Overall Study|Site Closure|4|||
30644397|NCT00811954|58656843|FG001|Overall Study|Site Closure|0|||
30644398|NCT00811954|58656844|FG002|Overall Study|Site Closure|1|||
30644399|NCT00811954|58656842|FG000|Overall Study|Severe Debilitation|2|||
30644400|NCT00811954|58656843|FG001|Overall Study|Severe Debilitation|0|||
30644401|NCT00811954|58656844|FG002|Overall Study|Severe Debilitation|1|||
30644402|NCT00811954|58656842|FG000|Overall Study|Complete Protocol: No follow-up|0|||
30644403|NCT00811954|58656843|FG001|Overall Study|Complete Protocol: No follow-up|0|||
30644404|NCT00811954|58656844|FG002|Overall Study|Complete Protocol: No follow-up|1|||
30644405|NCT01032200|58656854|FG000|Overall Study|Death|1|||
30644406|NCT01032200|58656855|FG001|Overall Study|Death|1|||
30644407|NCT01032200|58656854|FG000|Overall Study|Withdrawal by Subject|1|||
30644408|NCT01032200|58656855|FG001|Overall Study|Withdrawal by Subject|3|||
30644409|NCT01032200|58656854|FG000|Overall Study|Toxicity|0|||
30644410|NCT01032200|58656855|FG001|Overall Study|Toxicity|2|||
30644411|NCT01032200|58656854|FG000|Overall Study|Progression|1|||
30644412|NCT01032200|58656855|FG001|Overall Study|Progression|0|||
30644413|NCT01032200|58656854|FG000|Overall Study|Multiple|1|||
30644414|NCT01032200|58656855|FG001|Overall Study|Multiple|1|||
30644415|NCT00738283|58656861|FG000|Overall Study|Death|1|||
30644416|NCT00738283|58656861|FG000|Overall Study|Transfer to another facility|2|||
30644417|NCT00738283|58656861|FG000|Overall Study|Discharge home prior to end of study|1|||
30644418|NCT00586105|58656874|FG000|Overall Study|Adverse Event|4|||
30644419|NCT00586105|58656874|FG000|Overall Study|Death|2|||
30644420|NCT00586105|58656874|FG000|Overall Study|Protocol Violation|1|||
30848587|NCT04604795|58874767|FG005|Part B: Up to Day 14|Adverse Event|1|||
30644421|NCT00586105|58656874|FG000|Overall Study|Withdrawal by Subject|3|||
30644422|NCT00586105|58656874|FG000|Overall Study|Disease progression|19|||
30644423|NCT00586105|58656874|FG000|Overall Study|Switched to commercial drug|9|||
30644424|NCT00586105|58656874|FG000|Overall Study|Reason not reported|1|||
30644425|NCT00743119|58656878|FG000|Overall Study|unreliable|3|||
30644426|NCT00743119|58656878|FG000|Overall Study|Withdrawal by Subject|1|||
30644427|NCT00733369|58656892|FG000|Overall Study|Lost to Follow-up|2|||
30644428|NCT00733369|58656893|FG001|Overall Study|Lost to Follow-up|1|||
30644429|NCT00733369|58656892|FG000|Overall Study|Adverse Event|4|||
30644430|NCT00733369|58656893|FG001|Overall Study|Adverse Event|4|||
30644431|NCT00733369|58656892|FG000|Overall Study|Protocol Violation|4|||
30644432|NCT00733369|58656893|FG001|Overall Study|Protocol Violation|4|||
30644433|NCT00813124|58656899|FG000|Overall Study|Death|2|||
30644434|NCT00813124|58656899|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
30644435|NCT00813124|58656899|FG000|Overall Study|Withdrawal by Subject|1|||
30644436|NCT00733291|58656905|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
30644437|NCT00733291|58656906|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
30644438|NCT00733291|58656907|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
30644439|NCT00733291|58656908|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
30644440|NCT00732199|58656921|FG000|Overall Study|Withdrawal by Subject|25|||
30644441|NCT00732199|58656922|FG001|Overall Study|Withdrawal by Subject|18|||
30644442|NCT00732199|58656921|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
30644443|NCT00732199|58656922|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
30644444|NCT00807040|58656933|FG000|Overall Study|Death|24|||
30644445|NCT00807040|58656934|FG001|Overall Study|Death|29|||
30644446|NCT00807040|58656933|FG000|Overall Study|Withdrawal by Subject|8|||
30644447|NCT00807040|58656934|FG001|Overall Study|Withdrawal by Subject|6|||
30644448|NCT00807040|58656933|FG000|Overall Study|Lost to Follow-up|4|||
30644449|NCT00807040|58656934|FG001|Overall Study|Lost to Follow-up|6|||
30644450|NCT00811720|58656942|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
30644451|NCT00811720|58656943|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
30644452|NCT00811720|58656942|FG000|All Treated Patients|Adverse Event|20|||
30644453|NCT00811720|58656943|FG001|All Treated Patients|Adverse Event|62|||
30644454|NCT00811720|58656942|FG000|All Treated Patients|Lack of Efficacy|22|||
30644455|NCT00811720|58656943|FG001|All Treated Patients|Lack of Efficacy|18|||
30644456|NCT00811720|58656942|FG000|All Treated Patients|Non-compliance|0|||
30644457|NCT00811720|58656943|FG001|All Treated Patients|Non-compliance|14|||
30644458|NCT00811720|58656942|FG000|All Treated Patients|Protocol Violation|9|||
30644459|NCT00811720|58656943|FG001|All Treated Patients|Protocol Violation|16|||
30644460|NCT00811720|58656942|FG000|All Treated Patients|Withdrawal by Subject|28|||
30644461|NCT00811720|58656943|FG001|All Treated Patients|Withdrawal by Subject|34|||
30644462|NCT00811720|58656942|FG000|All Treated Patients|Lost to Follow-up|10|||
30766069|NCT02888080|58774729|FG000|Overall Study|Subject / Guardian decision|1|||
30766070|NCT02888080|58774730|FG001|Overall Study|Subject / Guardian decision|3|||
30766071|NCT02888080|58774729|FG000|Overall Study|New Therapy for study indication|1|||
30766072|NCT02888080|58774730|FG001|Overall Study|New Therapy for study indication|0|||
30766073|NCT02888080|58774729|FG000|Overall Study|Lack of Efficacy|0|||
30766074|NCT02888080|58774730|FG001|Overall Study|Lack of Efficacy|1|||
30766075|NCT02888080|58774729|FG000|Overall Study|Adverse Event|0|||
30766076|NCT02888080|58774730|FG001|Overall Study|Adverse Event|1|||
30766077|NCT03322462|58774736|FG000|Overall Study|Technical difficulties|2|||
30766078|NCT03322462|58774736|FG000|Overall Study|Other|1|||
30766079|NCT00086580|58774744|FG000|Treatment Period|Disease progression|9|||
30766080|NCT00086580|58774745|FG001|Treatment Period|Disease progression|8|||
30848588|NCT04604795|58874768|FG006|Part B: Up to Day 14|Adverse Event|0|||
30644463|NCT00811720|58656943|FG001|All Treated Patients|Lost to Follow-up|16|||
30644464|NCT00811720|58656942|FG000|All Treated Patients|Other Reason|7|||
30644465|NCT00811720|58656943|FG001|All Treated Patients|Other Reason|4|||
30644466|NCT04202679|58656951|FG000|Overall Study|Adverse Event|2|||
30644467|NCT04202679|58656952|FG001|Overall Study|Adverse Event|0|||
30766081|NCT00086580|58774744|FG000|Treatment Period|Unable to comply with protocol|3|||
30644468|NCT04202679|58656951|FG000|Overall Study|Poor compliance to protocol|1|||
30644469|NCT04202679|58656952|FG001|Overall Study|Poor compliance to protocol|0|||
30644470|NCT04202679|58656951|FG000|Overall Study|Withdrawal by Subject|23|||
30644471|NCT04202679|58656952|FG001|Overall Study|Withdrawal by Subject|6|||
30644472|NCT00811642|58656959|FG000|Overall Study|Adverse Event|3|||
30644473|NCT00811642|58656959|FG000|Overall Study|Protocol Violation|1|||
30644474|NCT00811642|58656959|FG000|Overall Study|Death|2|||
30644475|NCT00811642|58656959|FG000|Overall Study|Withdrawal by Subject|7|||
30644476|NCT00811642|58656959|FG000|Overall Study|Cumulative use of antifungal agent|2|||
30644477|NCT00809926|58656965|FG000|Overall Study|Adverse Event|18|||
30644478|NCT00809926|58656966|FG001|Overall Study|Adverse Event|10|||
30644479|NCT00809926|58656965|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
30644480|NCT00809926|58656966|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
30644481|NCT00809926|58656965|FG000|Overall Study|Patient withdrew consent|8|||
30644482|NCT00809926|58656966|FG001|Overall Study|Patient withdrew consent|6|||
30644483|NCT00809926|58656965|FG000|Overall Study|Lost to Follow-up|2|||
30644484|NCT00809926|58656966|FG001|Overall Study|Lost to Follow-up|1|||
30644485|NCT00809926|58656965|FG000|Overall Study|Administrative Problems|0|||
30644486|NCT00809926|58656966|FG001|Overall Study|Administrative Problems|1|||
30644487|NCT00809926|58656965|FG000|Overall Study|Protocol deviation|0|||
30644488|NCT00809926|58656966|FG001|Overall Study|Protocol deviation|2|||
30644489|NCT00590980|58656972|FG000|Overall Study|Did not meet all inclusion criteria|10|||
30644490|NCT00590902|58656976|FG000|Overall Study|Death|1|||
30644491|NCT00590824|58656984|FG000|Overall Study|Disease could not be resected|0|||
30644492|NCT00590824|58656985|FG001|Overall Study|Disease could not be resected|2|||
30644493|NCT00590824|58656986|FG002|Overall Study|Disease could not be resected|1|||
30644494|NCT00590824|58656987|FG003|Overall Study|Disease could not be resected|0|||
30644495|NCT00590824|58656984|FG000|Overall Study|Adverse Event|0|||
30766082|NCT00086580|58774745|FG001|Treatment Period|Unable to comply with protocol|1|||
30766083|NCT00086580|58774744|FG000|Treatment Period|Withdrawal by Subject|7|||
30766084|NCT00086580|58774745|FG001|Treatment Period|Withdrawal by Subject|8|||
30766085|NCT00086580|58774744|FG000|Treatment Period|Physician Decision|13|||
30766086|NCT00086580|58774745|FG001|Treatment Period|Physician Decision|7|||
30766087|NCT00086580|58774744|FG000|Treatment Period|AE - not treatment related|7|||
30766088|NCT00086580|58774745|FG001|Treatment Period|AE - not treatment related|7|||
30766089|NCT00086580|58774744|FG000|Treatment Period|Toxicity - treatment related|15|||
30766090|NCT00086580|58774745|FG001|Treatment Period|Toxicity - treatment related|15|||
30766091|NCT00086580|58774744|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
30766092|NCT00086580|58774745|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
30766093|NCT00086580|58774744|FG000|Treatment Period|Death|5|||
30766094|NCT00086580|58774745|FG001|Treatment Period|Death|7|||
30766095|NCT00086580|58774744|FG000|Treatment Period|Other|5|||
30766096|NCT00086580|58774745|FG001|Treatment Period|Other|3|||
30766097|NCT00086580|58774744|FG000|Follow-up Period|Disease progression|72|||
30766098|NCT00086580|58774745|FG001|Follow-up Period|Disease progression|99|||
30766099|NCT00086580|58774744|FG000|Follow-up Period|Unable to comply with protocol|5|||
30766100|NCT00086580|58774745|FG001|Follow-up Period|Unable to comply with protocol|0|||
30766101|NCT00086580|58774744|FG000|Follow-up Period|Withdrawal by Subject|6|||
30766102|NCT00086580|58774745|FG001|Follow-up Period|Withdrawal by Subject|6|||
30766103|NCT00086580|58774744|FG000|Follow-up Period|Physician Decision|0|||
30766104|NCT00086580|58774745|FG001|Follow-up Period|Physician Decision|1|||
30766105|NCT00086580|58774744|FG000|Follow-up Period|AE - not related|1|||
30766106|NCT00086580|58774745|FG001|Follow-up Period|AE - not related|0|||
30766107|NCT00086580|58774744|FG000|Follow-up Period|Death|13|||
30766108|NCT00086580|58774745|FG001|Follow-up Period|Death|7|||
30766109|NCT00086580|58774744|FG000|Follow-up Period|Other|7|||
30766110|NCT00086580|58774745|FG001|Follow-up Period|Other|6|||
30766111|NCT00086580|58774744|FG000|Observation Period|Unable to comply with protocol|1|||
30766112|NCT00086580|58774745|FG001|Observation Period|Unable to comply with protocol|1|||
30766113|NCT00086580|58774744|FG000|Observation Period|Withdrawal by Subject|4|||
30766114|NCT00086580|58774745|FG001|Observation Period|Withdrawal by Subject|2|||
30766115|NCT00086580|58774744|FG000|Observation Period|Death|33|||
30766116|NCT00086580|58774745|FG001|Observation Period|Death|55|||
30766117|NCT00086580|58774744|FG000|Observation Period|Other|8|||
30766118|NCT00086580|58774745|FG001|Observation Period|Other|7|||
30766119|NCT00086502|58774753|FG000|Overall Study|Adverse Event|11|||
30766120|NCT00086502|58774754|FG001|Overall Study|Adverse Event|2|||
30766121|NCT00086502|58774753|FG000|Overall Study|Lack of Efficacy|0|||
30644496|NCT00590824|58656985|FG001|Overall Study|Adverse Event|0|||
30766122|NCT00086502|58774754|FG001|Overall Study|Lack of Efficacy|2|||
30766123|NCT00086502|58774753|FG000|Overall Study|Lost to Follow-up|3|||
30766124|NCT00086502|58774754|FG001|Overall Study|Lost to Follow-up|1|||
30766125|NCT00086502|58774753|FG000|Overall Study|Physician Decision|1|||
30766126|NCT00086502|58774754|FG001|Overall Study|Physician Decision|1|||
30766127|NCT00086502|58774753|FG000|Overall Study|Pregnancy|0|||
30644497|NCT00590824|58656986|FG002|Overall Study|Adverse Event|0|||
30766128|NCT00086502|58774754|FG001|Overall Study|Pregnancy|1|||
30644498|NCT00590824|58656987|FG003|Overall Study|Adverse Event|1|||
30766129|NCT00086502|58774753|FG000|Overall Study|Protocol Violation|3|||
30766130|NCT00086502|58774754|FG001|Overall Study|Protocol Violation|3|||
30644499|NCT00590590|58657000|FG000|Overall Study|Lack of Efficacy|1|||
30644500|NCT00590590|58657001|FG001|Overall Study|Lack of Efficacy|2|||
30644501|NCT00590590|58657002|FG002|Overall Study|Lack of Efficacy|0|||
30644502|NCT00590590|58657000|FG000|Overall Study|Adverse Event|1|||
30644503|NCT00590590|58657001|FG001|Overall Study|Adverse Event|0|||
30644504|NCT00590590|58657002|FG002|Overall Study|Adverse Event|0|||
30644505|NCT00590590|58657000|FG000|Overall Study|Protocol Violation|0|||
30644506|NCT00590590|58657001|FG001|Overall Study|Protocol Violation|0|||
30644507|NCT00590590|58657002|FG002|Overall Study|Protocol Violation|2|||
30644508|NCT00590590|58657000|FG000|Overall Study|Lost to Follow-up|4|||
30644509|NCT00590590|58657001|FG001|Overall Study|Lost to Follow-up|1|||
30644510|NCT00590590|58657002|FG002|Overall Study|Lost to Follow-up|2|||
30644511|NCT00590590|58657000|FG000|Overall Study|Withdrawal by Subject|0|||
30644512|NCT00590590|58657001|FG001|Overall Study|Withdrawal by Subject|1|||
30644513|NCT00590590|58657002|FG002|Overall Study|Withdrawal by Subject|1|||
30644514|NCT00590590|58657000|FG000|Overall Study|Did not complete due to study closure|1|||
30644515|NCT00590590|58657001|FG001|Overall Study|Did not complete due to study closure|1|||
30644516|NCT00590590|58657002|FG002|Overall Study|Did not complete due to study closure|1|||
30644517|NCT00590590|58657000|FG000|Overall Study|Did not complete study|0|||
30644518|NCT00590590|58657001|FG001|Overall Study|Did not complete study|1|||
30644519|NCT00590590|58657002|FG002|Overall Study|Did not complete study|0|||
30644520|NCT00809614|58657012|FG000|Overall Study|Lack of Efficacy|2|||
30644521|NCT00809614|58657013|FG001|Overall Study|Lack of Efficacy|3|||
30644522|NCT00809614|58657012|FG000|Overall Study|Withdrawal by Subject|1|||
30644523|NCT00809614|58657013|FG001|Overall Study|Withdrawal by Subject|1|||
30644524|NCT00731731|58657022|FG000|Overall Study|Protocol Violation|0|||
30644525|NCT00731731|58657023|FG001|Overall Study|Protocol Violation|0|||
30644526|NCT00731731|58657024|FG002|Overall Study|Protocol Violation|1|||
30644527|NCT00731731|58657022|FG000|Overall Study|Cancel prior to treatment|0|||
30644528|NCT00731731|58657023|FG001|Overall Study|Cancel prior to treatment|0|||
30644529|NCT00731731|58657024|FG002|Overall Study|Cancel prior to treatment|2|||
30644530|NCT00806494|58657037|FG000|Overall Study|Adverse Event|29|||
30644531|NCT00806494|58657037|FG000|Overall Study|Lack of Efficacy|6|||
30644532|NCT00806494|58657037|FG000|Overall Study|Lost to Follow-up|10|||
30644533|NCT00806494|58657037|FG000|Overall Study|Other|30|||
30644534|NCT00806494|58657037|FG000|Overall Study|Withdrawal by Subject|5|||
30644535|NCT00806416|58657044|FG000|Period 1 - Part I|Adverse Event|0|||
30644536|NCT00806416|58657045|FG001|Period 1 - Part I|Adverse Event|1|||
30644537|NCT00806416|58657046|FG002|Period 1 - Part I|Adverse Event|0|||
30644538|NCT00806416|58657047|FG003|Period 1 - Part I|Adverse Event|0|||
30644539|NCT00806416|58657044|FG000|Period 1 - Part I|Lost to Follow-up|0|||
30644540|NCT00806416|58657045|FG001|Period 1 - Part I|Lost to Follow-up|2|||
30644541|NCT00806416|58657046|FG002|Period 1 - Part I|Lost to Follow-up|0|||
30644542|NCT00806416|58657047|FG003|Period 1 - Part I|Lost to Follow-up|0|||
30644543|NCT00806416|58657044|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
30644544|NCT00806416|58657045|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
30644545|NCT00806416|58657046|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
30644546|NCT00806416|58657047|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
30644547|NCT00806416|58657044|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
30644548|NCT00806416|58657045|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
30644549|NCT00806416|58657046|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
30644550|NCT00806416|58657047|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
30644551|NCT02724969|58657057|FG000|Overall Study|Lost to Follow-up|12|||
30644552|NCT02724969|58657058|FG001|Overall Study|Lost to Follow-up|6|||
30644553|NCT02724969|58657057|FG000|Overall Study|Withdrawal by Subject|3|||
30644554|NCT02724969|58657058|FG001|Overall Study|Withdrawal by Subject|3|||
30644555|NCT02724969|58657057|FG000|Overall Study|Infant demise|0|||
30766131|NCT00086502|58774753|FG000|Overall Study|Withdrawal by Subject|5|||
30766132|NCT00086502|58774754|FG001|Overall Study|Withdrawal by Subject|6|||
30644556|NCT02724969|58657058|FG001|Overall Study|Infant demise|2|||
30644557|NCT00811252|58657067|FG000|Overall Study|Adverse Event|6|||
30644558|NCT00811252|58657068|FG001|Overall Study|Adverse Event|10|||
30644559|NCT00811252|58657069|FG002|Overall Study|Adverse Event|15|||
30644560|NCT00811252|58657067|FG000|Overall Study|Lack of Efficacy|7|||
30644561|NCT00811252|58657068|FG001|Overall Study|Lack of Efficacy|2|||
30644562|NCT00811252|58657069|FG002|Overall Study|Lack of Efficacy|0|||
30644563|NCT00811252|58657067|FG000|Overall Study|Protocol Violation|3|||
30644564|NCT00811252|58657068|FG001|Overall Study|Protocol Violation|3|||
30644565|NCT00811252|58657069|FG002|Overall Study|Protocol Violation|2|||
30644566|NCT00811252|58657067|FG000|Overall Study|Withdrawal of Consent|1|||
30644567|NCT00811252|58657068|FG001|Overall Study|Withdrawal of Consent|2|||
30644568|NCT00811252|58657069|FG002|Overall Study|Withdrawal of Consent|2|||
30644569|NCT00811252|58657067|FG000|Overall Study|Lost to Follow-up|0|||
30644570|NCT00811252|58657068|FG001|Overall Study|Lost to Follow-up|0|||
30644571|NCT00811252|58657069|FG002|Overall Study|Lost to Follow-up|2|||
30766133|NCT00086502|58774753|FG000|Overall Study|Patient Moved|1|||
30644572|NCT00811252|58657067|FG000|Overall Study|Administrative or Other Reasons|0|||
30644573|NCT00811252|58657068|FG001|Overall Study|Administrative or Other Reasons|3|||
30644574|NCT00811252|58657069|FG002|Overall Study|Administrative or Other Reasons|2|||
30644575|NCT00736957|58657086|FG000|Overall Study|Adverse Event|43|||
30766134|NCT00086502|58774754|FG001|Overall Study|Patient Moved|1|||
30766135|NCT00086502|58774753|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
30766136|NCT00086502|58774754|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
30766137|NCT00086502|58774753|FG000|Overall Study|Patient Accidentally Unblinded|1|||
30766138|NCT00086502|58774754|FG001|Overall Study|Patient Accidentally Unblinded|0|||
30766139|NCT03826667|58774760|FG000|Overall Study|Protocol deviation|21|||
30766140|NCT03636542|58774772|FG000|Overall Study|Lost to Follow-up|1|||
30766141|NCT03636542|58774773|FG001|Overall Study|Lost to Follow-up|1|||
30766142|NCT03636542|58774772|FG000|Overall Study|Physician Decision|0|||
30644576|NCT00736957|58657086|FG000|Overall Study|Withdrawal by Subject|49|||
30644577|NCT00736957|58657086|FG000|Overall Study|violation of eligibility criteria|2|||
30644578|NCT00736957|58657086|FG000|Overall Study|did not attend hospital appointments|1|||
30644579|NCT00736957|58657086|FG000|Overall Study|not eligible for Treatment Period I|22|||
30644580|NCT00736957|58657086|FG000|Overall Study|Physician Decision|5|||
30644581|NCT00736879|58657094|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
30644582|NCT00736879|58657095|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
30644583|NCT00736879|58657096|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
30644584|NCT00736879|58657097|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
30644585|NCT00736879|58657094|FG000|Double Blind Treatment Period|Adverse Event|0|||
30644586|NCT00736879|58657095|FG001|Double Blind Treatment Period|Adverse Event|1|||
30644587|NCT00736879|58657096|FG002|Double Blind Treatment Period|Adverse Event|1|||
30644588|NCT00736879|58657097|FG003|Double Blind Treatment Period|Adverse Event|0|||
30644589|NCT00736879|58657094|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
30644590|NCT00736879|58657095|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
30644591|NCT00736879|58657096|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
30644592|NCT00736879|58657097|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
30644593|NCT00736879|58657094|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
30766143|NCT03636542|58774773|FG001|Overall Study|Physician Decision|1|||
30766144|NCT03636542|58774772|FG000|Overall Study|Withdrawal by Subject|1|||
30644594|NCT00736879|58657095|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
30644595|NCT00736879|58657096|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
30644596|NCT00736879|58657097|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
30644597|NCT00736879|58657094|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
30644598|NCT00736879|58657095|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
30644599|NCT00736879|58657096|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
30644600|NCT00736879|58657097|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
30644601|NCT00736879|58657094|FG000|Double Blind Treatment Period|No longer met criteria|0|||
30644602|NCT00736879|58657095|FG001|Double Blind Treatment Period|No longer met criteria|1|||
30644603|NCT00736879|58657096|FG002|Double Blind Treatment Period|No longer met criteria|0|||
30644604|NCT00736879|58657097|FG003|Double Blind Treatment Period|No longer met criteria|0|||
30644605|NCT00736879|58657094|FG000|Double Blind Treatment Period|non-specified|0|||
30644606|NCT00736879|58657095|FG001|Double Blind Treatment Period|non-specified|1|||
30644607|NCT00736879|58657096|FG002|Double Blind Treatment Period|non-specified|0|||
30644608|NCT00736879|58657097|FG003|Double Blind Treatment Period|non-specified|0|||
30644609|NCT00736879|58657094|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
30644610|NCT00736879|58657095|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
30644611|NCT00736879|58657096|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
30644612|NCT00736879|58657097|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
30644613|NCT00736879|58657094|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
30644614|NCT00736879|58657095|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
30644615|NCT00736879|58657096|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
30644616|NCT00736879|58657097|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
30644617|NCT00806260|58657116|FG000|Period 1 (1 Day)|Adverse Event|0|||
30644618|NCT00806260|58657117|FG001|Period 1 (1 Day)|Adverse Event|0|||
30644619|NCT00806260|58657118|FG002|Period 1 (1 Day)|Adverse Event|0|||
30644620|NCT00806260|58657119|FG003|Period 1 (1 Day)|Adverse Event|0|||
30644621|NCT00806260|58657120|FG004|Period 1 (1 Day)|Adverse Event|3|||
30766145|NCT03636542|58774773|FG001|Overall Study|Withdrawal by Subject|0|||
30644622|NCT00806260|58657121|FG005|Period 1 (1 Day)|Adverse Event|0|||
30644623|NCT00806260|58657116|FG000|Period 2|Adverse Event|0|||
30644624|NCT00806260|58657117|FG001|Period 2|Adverse Event|0|||
30644625|NCT00806260|58657118|FG002|Period 2|Adverse Event|0|||
30766146|NCT03305770|58774781|FG000|Overall Study|Physician Decision - prior to dispense|0|||
30644626|NCT00806260|58657119|FG003|Period 2|Adverse Event|1|||
30766147|NCT03305770|58774782|FG001|Overall Study|Physician Decision - prior to dispense|1|||
30766148|NCT03305770|58774781|FG000|Overall Study|Subject moved|1|||
30766149|NCT03305770|58774782|FG001|Overall Study|Subject moved|0|||
30766150|NCT00086190|58774793|FG000|Overall Study|Adverse Event|6|||
30644627|NCT00806260|58657120|FG004|Period 2|Adverse Event|0|||
30644628|NCT00806260|58657121|FG005|Period 2|Adverse Event|0|||
30644629|NCT00806260|58657116|FG000|Period 2|Protocol Violation|1|||
30644630|NCT00806260|58657117|FG001|Period 2|Protocol Violation|0|||
30644631|NCT00806260|58657118|FG002|Period 2|Protocol Violation|1|||
30644632|NCT00806260|58657119|FG003|Period 2|Protocol Violation|0|||
30644633|NCT00806260|58657120|FG004|Period 2|Protocol Violation|0|||
30644634|NCT00806260|58657121|FG005|Period 2|Protocol Violation|0|||
30644635|NCT00806260|58657116|FG000|Period 2|Need to take concomitant medication|1|||
30644636|NCT00806260|58657117|FG001|Period 2|Need to take concomitant medication|0|||
30644637|NCT00806260|58657118|FG002|Period 2|Need to take concomitant medication|0|||
30644638|NCT00806260|58657119|FG003|Period 2|Need to take concomitant medication|0|||
30644639|NCT00806260|58657120|FG004|Period 2|Need to take concomitant medication|0|||
30644640|NCT00806260|58657121|FG005|Period 2|Need to take concomitant medication|0|||
30644641|NCT00806260|58657116|FG000|Period 2|sponsor request|0|||
30644642|NCT00806260|58657117|FG001|Period 2|sponsor request|0|||
30644643|NCT00806260|58657118|FG002|Period 2|sponsor request|1|||
30644644|NCT00806260|58657119|FG003|Period 2|sponsor request|1|||
30644645|NCT00806260|58657120|FG004|Period 2|sponsor request|0|||
30644646|NCT00806260|58657121|FG005|Period 2|sponsor request|0|||
30644647|NCT00806260|58657116|FG000|Period 3|Protocol Violation|0|||
30644648|NCT00806260|58657117|FG001|Period 3|Protocol Violation|1|||
30644649|NCT00806260|58657118|FG002|Period 3|Protocol Violation|1|||
30644650|NCT00806260|58657119|FG003|Period 3|Protocol Violation|0|||
30644651|NCT00806260|58657120|FG004|Period 3|Protocol Violation|0|||
30644652|NCT00806260|58657121|FG005|Period 3|Protocol Violation|0|||
30644653|NCT00806260|58657116|FG000|Period 3|Pregnancy|1|||
30644654|NCT00806260|58657117|FG001|Period 3|Pregnancy|0|||
30644655|NCT00806260|58657118|FG002|Period 3|Pregnancy|0|||
30644656|NCT00806260|58657119|FG003|Period 3|Pregnancy|0|||
30644657|NCT00806260|58657120|FG004|Period 3|Pregnancy|0|||
30644658|NCT00806260|58657121|FG005|Period 3|Pregnancy|0|||
30644659|NCT00742885|58657135|FG000|Overall Study|Lost to Follow-up|1|||
30644660|NCT00742885|58657136|FG001|Overall Study|Lost to Follow-up|0|||
30644661|NCT00811174|58657145|FG000|Overall Study|Protocol Violation|2|||
30644662|NCT00811174|58657145|FG000|Overall Study|Sponsors Decision|1|||
30644663|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
30644664|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
30644665|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
30644666|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
30644667|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
30644668|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
30644669|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
30644670|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
30644671|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
30644672|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
30644673|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
30644674|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
30644675|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
30644676|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
30644677|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
30644678|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
30644679|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
30644680|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
30644681|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
30644682|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
30644683|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
30644684|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
30644685|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
30644686|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
30644687|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
30644688|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
30644689|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
30644690|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
30644691|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
30644692|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
30644693|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
30644694|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
30848589|NCT04604795|58874769|FG007|Part B: Up to Day 14|Adverse Event|0|||
30848590|NCT04604795|58874770|FG008|Part B: Up to Day 14|Adverse Event|0|||
30644695|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
30644696|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
30644697|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
30644698|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
30644699|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
30644700|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
30644701|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
30644702|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
30644703|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
30644704|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
30644705|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
30644706|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
30644707|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
30644708|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
30644709|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
30644710|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
30644711|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
30644712|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
30644713|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
30644714|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
30644715|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
30644716|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
30644717|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
30644718|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
30644719|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
30644720|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
30644721|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
30644722|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
30644723|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
30644724|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
30644725|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
30644726|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
30644727|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
30644728|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
30644729|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
30644730|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
30644731|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
30644732|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
30644733|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Change of location|0|||
30644734|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Change of location|0|||
30644735|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Change of location|0|||
30644736|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Change of location|1|||
30644737|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Change of location|0|||
30644738|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
30644739|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
30644740|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
30644741|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
30644742|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
30644743|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
30644744|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
30644745|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
30644746|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
30644747|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
30644748|NCT00730405|58657154|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
30644749|NCT00730405|58657155|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
30644750|NCT00730405|58657156|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
30644751|NCT00730405|58657157|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
30644752|NCT00730405|58657158|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
30766151|NCT00086190|58774794|FG001|Overall Study|Adverse Event|2|||
30766152|NCT00086190|58774795|FG002|Overall Study|Adverse Event|2|||
30644753|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
30644754|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
30644755|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
30644756|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
30766153|NCT00086190|58774793|FG000|Overall Study|Withdrawal by Subject|0|||
30766154|NCT00086190|58774794|FG001|Overall Study|Withdrawal by Subject|2|||
30644757|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
30644758|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
30644759|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
30644760|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
30644761|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
30644762|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
30644763|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
30644764|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
30644765|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
30644766|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
30644767|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
30644768|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Death|0|||
30644769|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Death|1|||
30644770|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Death|0|||
30644771|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Death|1|||
30644772|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Death|0|||
30644773|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Change of location|1|||
30644774|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Change of location|1|||
30644775|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Change of location|0|||
30644776|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Change of location|1|||
30644777|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Change of location|0|||
30644778|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
30644779|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
30644780|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
30644781|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
30644782|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
30644783|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
30644784|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
30644785|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
30644786|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
30644787|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
30644788|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
30644789|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
30644790|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
30644791|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
30644792|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
30644793|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
30644794|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
30644795|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
30644796|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
30644797|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
30644798|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
30644799|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
30644800|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
30644801|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
30644802|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
30644803|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
30644804|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
30644805|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
30644806|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
30644807|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
30644808|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
30644809|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
30644810|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
30644811|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
30644812|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
30644813|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
30644814|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
30644815|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
30644816|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
30644817|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
30644818|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
30644819|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
30644820|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
30644821|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
30644822|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
30644823|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
30644824|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
30644825|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
30644826|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
30644827|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
30644828|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Missing|0|||
30644829|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Missing|0|||
30644830|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Missing|2|||
30644831|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Missing|0|||
30644832|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Missing|0|||
30644833|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
30644834|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
30644835|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
30951844|NCT01709864|58999278|FG001|Overall Study|non-compliance with study treatment|1|||
30951845|NCT01709864|58999277|FG000|Overall Study|Adverse Event|0|||
30951846|NCT01709864|58999278|FG001|Overall Study|Adverse Event|2|||
30951847|NCT01709864|58999277|FG000|Overall Study|Death|0|||
30951848|NCT01709864|58999278|FG001|Overall Study|Death|1|||
30951849|NCT01709708|58999286|FG000|Overall Study|Protocol Violation|1|||
30951850|NCT01709708|58999287|FG001|Overall Study|Protocol Violation|2|||
30951851|NCT01709318|58999310|FG000|Overall Study|Adverse Event|3|||
30951852|NCT01709318|58999311|FG001|Overall Study|Adverse Event|4|||
30951853|NCT01709318|58999312|FG002|Overall Study|Adverse Event|2|||
30951854|NCT01709318|58999313|FG003|Overall Study|Adverse Event|2|||
30951855|NCT01709318|58999314|FG004|Overall Study|Adverse Event|0|||
30951856|NCT01709318|58999315|FG005|Overall Study|Adverse Event|1|||
30951857|NCT01709318|58999316|FG006|Overall Study|Adverse Event|2|||
30951858|NCT01709318|58999310|FG000|Overall Study|Lost to Follow-up|2|||
30951859|NCT01709318|58999311|FG001|Overall Study|Lost to Follow-up|0|||
30951860|NCT01709318|58999312|FG002|Overall Study|Lost to Follow-up|0|||
30951861|NCT01709318|58999313|FG003|Overall Study|Lost to Follow-up|0|||
30951862|NCT01709318|58999314|FG004|Overall Study|Lost to Follow-up|1|||
30951863|NCT01709318|58999315|FG005|Overall Study|Lost to Follow-up|1|||
30951864|NCT01709318|58999316|FG006|Overall Study|Lost to Follow-up|1|||
30951865|NCT01709318|58999310|FG000|Overall Study|Non-compliance with Study Drug|0|||
30951866|NCT01709318|58999311|FG001|Overall Study|Non-compliance with Study Drug|2|||
30951867|NCT01709318|58999312|FG002|Overall Study|Non-compliance with Study Drug|1|||
30951868|NCT01709318|58999313|FG003|Overall Study|Non-compliance with Study Drug|1|||
30951869|NCT01709318|58999314|FG004|Overall Study|Non-compliance with Study Drug|0|||
30951870|NCT01709318|58999315|FG005|Overall Study|Non-compliance with Study Drug|0|||
30951871|NCT01709318|58999316|FG006|Overall Study|Non-compliance with Study Drug|2|||
30951872|NCT01709318|58999310|FG000|Overall Study|Physician Decision|0|||
30951873|NCT01709318|58999311|FG001|Overall Study|Physician Decision|0|||
30951874|NCT01709318|58999312|FG002|Overall Study|Physician Decision|0|||
30951875|NCT01709318|58999313|FG003|Overall Study|Physician Decision|0|||
30951876|NCT01709318|58999314|FG004|Overall Study|Physician Decision|0|||
30951877|NCT01709318|58999315|FG005|Overall Study|Physician Decision|0|||
30644836|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
30644837|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
30644838|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
30644839|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
30644840|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
30644841|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
30644842|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
30644843|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
30644844|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
30644845|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
30951878|NCT01709318|58999316|FG006|Overall Study|Physician Decision|1|||
30951879|NCT01709318|58999310|FG000|Overall Study|Pregnancy|0|||
30951880|NCT01709318|58999311|FG001|Overall Study|Pregnancy|0|||
30951881|NCT01709318|58999312|FG002|Overall Study|Pregnancy|0|||
30951882|NCT01709318|58999313|FG003|Overall Study|Pregnancy|0|||
30951883|NCT01709318|58999314|FG004|Overall Study|Pregnancy|1|||
30951884|NCT01709318|58999315|FG005|Overall Study|Pregnancy|0|||
30951885|NCT01709318|58999316|FG006|Overall Study|Pregnancy|0|||
30951886|NCT01709318|58999310|FG000|Overall Study|Protocol Violation|0|||
30951887|NCT01709318|58999311|FG001|Overall Study|Protocol Violation|0|||
30951888|NCT01709318|58999312|FG002|Overall Study|Protocol Violation|0|||
30951889|NCT01709318|58999313|FG003|Overall Study|Protocol Violation|0|||
30951890|NCT01709318|58999314|FG004|Overall Study|Protocol Violation|2|||
30644846|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
30644847|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
30644848|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
30644849|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
30644850|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
30644851|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
30644852|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
30644853|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
30644854|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
30644855|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
30644856|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
30644857|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
30766155|NCT00086190|58774795|FG002|Overall Study|Withdrawal by Subject|2|||
30766156|NCT00086190|58774793|FG000|Overall Study|Protocol Violation|1|||
30766157|NCT00086190|58774794|FG001|Overall Study|Protocol Violation|0|||
30766158|NCT00086190|58774795|FG002|Overall Study|Protocol Violation|0|||
30766159|NCT00086190|58774793|FG000|Overall Study|Moved|1|||
30766160|NCT00086190|58774794|FG001|Overall Study|Moved|0|||
30766161|NCT00086190|58774795|FG002|Overall Study|Moved|0|||
30766162|NCT00086190|58774793|FG000|Overall Study|Worsening depression|0|||
30766163|NCT00086190|58774794|FG001|Overall Study|Worsening depression|0|||
30766164|NCT00086190|58774795|FG002|Overall Study|Worsening depression|2|||
30766165|NCT03320824|58774805|FG000|Overall Study|Withdrawal by Subject|8|||
30766166|NCT03320824|58774806|FG001|Overall Study|Withdrawal by Subject|1|||
30766167|NCT03320824|58774805|FG000|Overall Study|Lost to Follow-up|10|||
30766168|NCT03320824|58774806|FG001|Overall Study|Lost to Follow-up|1|||
30766169|NCT03320824|58774805|FG000|Overall Study|moved out of state|0|||
30766170|NCT03320824|58774806|FG001|Overall Study|moved out of state|1|||
30766171|NCT03320824|58774805|FG000|Overall Study|could not complete final visit|0|||
30766172|NCT03320824|58774806|FG001|Overall Study|could not complete final visit|1|||
30766173|NCT03275350|58774818|FG000|Overall Study|Lost to Follow-up|4|||
30951891|NCT01709318|58999315|FG005|Overall Study|Protocol Violation|0|||
30951892|NCT01709318|58999316|FG006|Overall Study|Protocol Violation|1|||
30951893|NCT01709318|58999310|FG000|Overall Study|Technical Problems|1|||
30644858|NCT00730405|58657154|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
30644859|NCT00730405|58657155|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
30644860|NCT00730405|58657156|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
30644861|NCT00730405|58657157|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
30644862|NCT00730405|58657158|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
30644863|NCT00736723|58657174|FG000|Overall Study|Withdrawal by Subject|4|||
30644864|NCT00736723|58657175|FG001|Overall Study|Withdrawal by Subject|3|||
30644865|NCT00736645|58657185|FG000|Overall Study|Adverse Event|0|||
30644866|NCT00736645|58657186|FG001|Overall Study|Adverse Event|2|||
30644867|NCT00736645|58657187|FG002|Overall Study|Adverse Event|0|||
30644868|NCT00736645|58657188|FG003|Overall Study|Adverse Event|0|||
30644869|NCT00736489|58657198|FG000|Period 1|Lost to Follow-up|1|||
30644870|NCT00736489|58657199|FG001|Period 1|Lost to Follow-up|0|||
30644871|NCT00736489|58657200|FG002|Period 1|Lost to Follow-up|0|||
30644872|NCT00736489|58657201|FG003|Period 1|Lost to Follow-up|0|||
30644873|NCT00736489|58657202|FG004|Period 1|Lost to Follow-up|0|||
30644874|NCT00736489|58657203|FG005|Period 1|Lost to Follow-up|0|||
30644875|NCT00736489|58657198|FG000|Period 1|Withdrawal by Subject|0|||
30644876|NCT00736489|58657199|FG001|Period 1|Withdrawal by Subject|0|||
30644877|NCT00736489|58657200|FG002|Period 1|Withdrawal by Subject|0|||
30644878|NCT00736489|58657201|FG003|Period 1|Withdrawal by Subject|0|||
30644879|NCT00736489|58657202|FG004|Period 1|Withdrawal by Subject|0|||
30644880|NCT00736489|58657203|FG005|Period 1|Withdrawal by Subject|1|||
30644881|NCT00730327|58657235|FG000|Overall Study|Lost to Follow-up|14|||
30644882|NCT00730327|58657236|FG001|Overall Study|Lost to Follow-up|16|||
30644883|NCT00730327|58657235|FG000|Overall Study|Adverse Event|8|||
30644884|NCT00730327|58657236|FG001|Overall Study|Adverse Event|1|||
30644885|NCT00730327|58657235|FG000|Overall Study|Withdrawal by Subject|3|||
30644886|NCT00730327|58657236|FG001|Overall Study|Withdrawal by Subject|13|||
30644887|NCT00730327|58657235|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
30644888|NCT00730327|58657236|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
30644889|NCT00742417|58657251|FG000|Randomized|Withdrawal by legal representative|0|||
30644890|NCT00742417|58657252|FG001|Randomized|Withdrawal by legal representative|1|||
30644891|NCT00742417|58657251|FG000|Randomized|Withdrawal by Subject|1|||
30644892|NCT00742417|58657252|FG001|Randomized|Withdrawal by Subject|0|||
30644893|NCT00742417|58657251|FG000|Randomized|Physician Decision|1|||
30766174|NCT03275350|58774819|FG001|Overall Study|Lost to Follow-up|6|||
30766175|NCT03275350|58774818|FG000|Overall Study|Death|2|||
30766176|NCT03275350|58774819|FG001|Overall Study|Death|1|||
30766177|NCT03275350|58774818|FG000|Overall Study|Physician Decision|1|||
30766178|NCT03275350|58774819|FG001|Overall Study|Physician Decision|0|||
30644894|NCT00742417|58657252|FG001|Randomized|Physician Decision|0|||
30644895|NCT00742417|58657251|FG000|Intensive Period|Withdrawal by Subject|1|||
30644896|NCT00742417|58657252|FG001|Intensive Period|Withdrawal by Subject|1|||
30644897|NCT00742417|58657251|FG000|Intensive Period|Adverse Event|2|||
30644898|NCT00742417|58657252|FG001|Intensive Period|Adverse Event|0|||
30644899|NCT00811018|58657260|FG000|Overall Study|Additional Chronic Treatment|31|||
30644900|NCT00811018|58657260|FG000|Overall Study|Adverse Event|79|||
30644901|NCT00811018|58657260|FG000|Overall Study|Death|147|||
30644902|NCT00811018|58657260|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
30644903|NCT00811018|58657260|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
30644904|NCT00811018|58657260|FG000|Overall Study|Investigator Decision|57|||
30644905|NCT00811018|58657260|FG000|Overall Study|Lost to Follow-up|19|||
30644906|NCT00811018|58657260|FG000|Overall Study|Pregnancy|6|||
30644907|NCT00811018|58657260|FG000|Overall Study|Sponsor Decision|450|||
30644908|NCT00811018|58657260|FG000|Overall Study|Withdrawal by Subject|70|||
30644909|NCT00811018|58657260|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
30644910|NCT00811018|58657260|FG000|Overall Study|Other|26|||
30644911|NCT00730171|58657269|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
30644912|NCT00730171|58657269|FG000|Overall Study|Adverse Event|193|||
30644913|NCT00730171|58657269|FG000|Overall Study|Protocol Violation|48|||
30644914|NCT00730171|58657269|FG000|Overall Study|Withdrawal by Subject|202|||
30644915|NCT00730171|58657269|FG000|Overall Study|Lost to Follow-up|121|||
30644916|NCT00730171|58657269|FG000|Overall Study|Insufficient Therapeutic Response|141|||
30644917|NCT00730171|58657269|FG000|Overall Study|Other|61|||
30644918|NCT00730015|58657280|FG000|Overall Study|Adverse Event|11|||
30644919|NCT00730015|58657281|FG001|Overall Study|Adverse Event|10|||
30766179|NCT03275350|58774818|FG000|Overall Study|Incarcerated|1|||
30766180|NCT03275350|58774819|FG001|Overall Study|Incarcerated|1|||
30644920|NCT00730015|58657282|FG002|Overall Study|Adverse Event|8|||
30644921|NCT00730015|58657280|FG000|Overall Study|Protocol Violation|2|||
30644922|NCT00730015|58657281|FG001|Overall Study|Protocol Violation|6|||
30644923|NCT00730015|58657282|FG002|Overall Study|Protocol Violation|4|||
30644924|NCT00730015|58657280|FG000|Overall Study|Withdrawal by Subject|12|||
30644925|NCT00730015|58657281|FG001|Overall Study|Withdrawal by Subject|12|||
30644926|NCT00730015|58657282|FG002|Overall Study|Withdrawal by Subject|8|||
30951894|NCT01709318|58999311|FG001|Overall Study|Technical Problems|0|||
30644927|NCT00730015|58657280|FG000|Overall Study|Lost to Follow-up|4|||
30644928|NCT00730015|58657281|FG001|Overall Study|Lost to Follow-up|10|||
30644929|NCT00730015|58657282|FG002|Overall Study|Lost to Follow-up|3|||
30644930|NCT00730015|58657280|FG000|Overall Study|Lack of Efficacy|1|||
30644931|NCT00730015|58657281|FG001|Overall Study|Lack of Efficacy|2|||
30644932|NCT00730015|58657282|FG002|Overall Study|Lack of Efficacy|8|||
30644933|NCT00730015|58657280|FG000|Overall Study|Other Reason|1|||
30644934|NCT00730015|58657281|FG001|Overall Study|Other Reason|0|||
30644935|NCT00730015|58657282|FG002|Overall Study|Other Reason|1|||
30644936|NCT00806026|58657301|FG000|Overall Study|Death|0|||
30644937|NCT00806026|58657302|FG001|Overall Study|Death|0|||
30644938|NCT00806026|58657303|FG002|Overall Study|Death|0|||
30644939|NCT00806026|58657304|FG003|Overall Study|Death|1|||
30644940|NCT00806026|58657305|FG004|Overall Study|Death|0|||
30644941|NCT00806026|58657306|FG005|Overall Study|Death|0|||
30644942|NCT00806026|58657301|FG000|Overall Study|Did not meet entrance criteria|4|||
30644943|NCT00806026|58657302|FG001|Overall Study|Did not meet entrance criteria|1|||
30644944|NCT00806026|58657303|FG002|Overall Study|Did not meet entrance criteria|2|||
30644945|NCT00806026|58657304|FG003|Overall Study|Did not meet entrance criteria|1|||
30644946|NCT00806026|58657305|FG004|Overall Study|Did not meet entrance criteria|0|||
30644947|NCT00806026|58657306|FG005|Overall Study|Did not meet entrance criteria|0|||
30644948|NCT00806026|58657301|FG000|Overall Study|Lack of Efficacy|5|||
30644949|NCT00806026|58657302|FG001|Overall Study|Lack of Efficacy|18|||
30644950|NCT00806026|58657303|FG002|Overall Study|Lack of Efficacy|13|||
30644951|NCT00806026|58657304|FG003|Overall Study|Lack of Efficacy|4|||
30644952|NCT00806026|58657305|FG004|Overall Study|Lack of Efficacy|8|||
30644953|NCT00806026|58657306|FG005|Overall Study|Lack of Efficacy|7|||
30644954|NCT00806026|58657301|FG000|Overall Study|Lost to Follow-up|8|||
30644955|NCT00806026|58657302|FG001|Overall Study|Lost to Follow-up|15|||
30644956|NCT00806026|58657303|FG002|Overall Study|Lost to Follow-up|8|||
30644957|NCT00806026|58657304|FG003|Overall Study|Lost to Follow-up|2|||
30644958|NCT00806026|58657305|FG004|Overall Study|Lost to Follow-up|6|||
30644959|NCT00806026|58657306|FG005|Overall Study|Lost to Follow-up|6|||
30644960|NCT00806026|58657301|FG000|Overall Study|Withdrawal by Subject|14|||
30644961|NCT00806026|58657302|FG001|Overall Study|Withdrawal by Subject|17|||
30644962|NCT00806026|58657303|FG002|Overall Study|Withdrawal by Subject|9|||
30766181|NCT03319732|58774826|FG000|Overall Study|Adverse Event|40|||
30951895|NCT01709318|58999312|FG002|Overall Study|Technical Problems|0|||
30644963|NCT00806026|58657304|FG003|Overall Study|Withdrawal by Subject|2|||
30644964|NCT00806026|58657305|FG004|Overall Study|Withdrawal by Subject|5|||
30644965|NCT00806026|58657306|FG005|Overall Study|Withdrawal by Subject|3|||
30644966|NCT00806026|58657301|FG000|Overall Study|Other|3|||
30766182|NCT03319732|58774826|FG000|Overall Study|Withdrawal by Subject|50|||
30644967|NCT00806026|58657302|FG001|Overall Study|Other|6|||
30644968|NCT00806026|58657303|FG002|Overall Study|Other|8|||
30644969|NCT00806026|58657304|FG003|Overall Study|Other|2|||
30644970|NCT00806026|58657305|FG004|Overall Study|Other|0|||
30644971|NCT00806026|58657306|FG005|Overall Study|Other|4|||
30644972|NCT00806026|58657301|FG000|Overall Study|Protocol Violation|6|||
30644973|NCT00806026|58657302|FG001|Overall Study|Protocol Violation|9|||
30644974|NCT00806026|58657303|FG002|Overall Study|Protocol Violation|9|||
30644975|NCT00806026|58657304|FG003|Overall Study|Protocol Violation|0|||
30644976|NCT00806026|58657305|FG004|Overall Study|Protocol Violation|2|||
30644977|NCT00806026|58657306|FG005|Overall Study|Protocol Violation|3|||
30644978|NCT00806026|58657301|FG000|Overall Study|Adverse Event|52|||
30644979|NCT00806026|58657302|FG001|Overall Study|Adverse Event|35|||
30644980|NCT00806026|58657303|FG002|Overall Study|Adverse Event|44|||
30644981|NCT00806026|58657304|FG003|Overall Study|Adverse Event|17|||
30644982|NCT00806026|58657305|FG004|Overall Study|Adverse Event|9|||
30644983|NCT00806026|58657306|FG005|Overall Study|Adverse Event|9|||
30644984|NCT04026165|58657321|FG000|Run-in Placebo Period|Enrollment Error|13|||
30644985|NCT04026165|58657322|FG001|Run-in Placebo Period|Enrollment Error|0|||
30644986|NCT04026165|58657323|FG002|Run-in Placebo Period|Enrollment Error|0|||
30644987|NCT04026165|58657324|FG003|Run-in Placebo Period|Enrollment Error|0|||
30644988|NCT04026165|58657321|FG000|Run-in Placebo Period|Run-in Failure|4|||
30644989|NCT04026165|58657322|FG001|Run-in Placebo Period|Run-in Failure|0|||
30644990|NCT04026165|58657323|FG002|Run-in Placebo Period|Run-in Failure|0|||
30644991|NCT04026165|58657324|FG003|Run-in Placebo Period|Run-in Failure|0|||
30644992|NCT04026165|58657321|FG000|Run-in Placebo Period|Protocol Violation|2|||
30644993|NCT04026165|58657322|FG001|Run-in Placebo Period|Protocol Violation|0|||
30644994|NCT04026165|58657323|FG002|Run-in Placebo Period|Protocol Violation|0|||
30644995|NCT04026165|58657324|FG003|Run-in Placebo Period|Protocol Violation|0|||
30644996|NCT04026165|58657321|FG000|Run-in Placebo Period|Withdrew Consent|2|||
30644997|NCT04026165|58657322|FG001|Run-in Placebo Period|Withdrew Consent|0|||
30644998|NCT04026165|58657323|FG002|Run-in Placebo Period|Withdrew Consent|0|||
30644999|NCT04026165|58657324|FG003|Run-in Placebo Period|Withdrew Consent|0|||
30645000|NCT04026165|58657321|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
30645001|NCT04026165|58657322|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
30645002|NCT04026165|58657323|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
30645003|NCT04026165|58657324|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
30645004|NCT04026165|58657321|FG000|Run-in SEL Period|Run-in Failure|0|||
30645005|NCT04026165|58657322|FG001|Run-in SEL Period|Run-in Failure|26|||
30645006|NCT04026165|58657323|FG002|Run-in SEL Period|Run-in Failure|0|||
30645007|NCT04026165|58657324|FG003|Run-in SEL Period|Run-in Failure|0|||
30645008|NCT04026165|58657321|FG000|Run-in SEL Period|Withdrew Consent|0|||
30645009|NCT04026165|58657322|FG001|Run-in SEL Period|Withdrew Consent|10|||
30645010|NCT04026165|58657323|FG002|Run-in SEL Period|Withdrew Consent|0|||
30645011|NCT04026165|58657324|FG003|Run-in SEL Period|Withdrew Consent|0|||
30645012|NCT04026165|58657321|FG000|Run-in SEL Period|Enrollment Error|0|||
30645013|NCT04026165|58657322|FG001|Run-in SEL Period|Enrollment Error|4|||
30645014|NCT04026165|58657323|FG002|Run-in SEL Period|Enrollment Error|0|||
30645015|NCT04026165|58657324|FG003|Run-in SEL Period|Enrollment Error|0|||
30645016|NCT04026165|58657321|FG000|Run-in SEL Period|Protocol Violation|0|||
30645017|NCT04026165|58657322|FG001|Run-in SEL Period|Protocol Violation|3|||
30645018|NCT04026165|58657323|FG002|Run-in SEL Period|Protocol Violation|0|||
30645019|NCT04026165|58657324|FG003|Run-in SEL Period|Protocol Violation|0|||
30645020|NCT04026165|58657321|FG000|Run-in SEL Period|Investigator's Discretion|0|||
30645021|NCT04026165|58657322|FG001|Run-in SEL Period|Investigator's Discretion|2|||
30645022|NCT04026165|58657323|FG002|Run-in SEL Period|Investigator's Discretion|0|||
30645023|NCT04026165|58657324|FG003|Run-in SEL Period|Investigator's Discretion|0|||
30645024|NCT04026165|58657321|FG000|Run-in SEL Period|Death|0|||
30645025|NCT04026165|58657322|FG001|Run-in SEL Period|Death|1|||
30645026|NCT04026165|58657323|FG002|Run-in SEL Period|Death|0|||
30645027|NCT04026165|58657324|FG003|Run-in SEL Period|Death|0|||
30645028|NCT04026165|58657321|FG000|Randomized Period|Withdrew Consent|0|||
30645029|NCT04026165|58657322|FG001|Randomized Period|Withdrew Consent|0|||
30645030|NCT04026165|58657323|FG002|Randomized Period|Withdrew Consent|5|||
30645031|NCT04026165|58657324|FG003|Randomized Period|Withdrew Consent|8|||
30645032|NCT04026165|58657321|FG000|Randomized Period|Death|0|||
30645033|NCT04026165|58657322|FG001|Randomized Period|Death|0|||
30645034|NCT04026165|58657323|FG002|Randomized Period|Death|5|||
30645035|NCT04026165|58657324|FG003|Randomized Period|Death|7|||
30645036|NCT04026165|58657321|FG000|Randomized Period|Investigator's Discretion|0|||
30645037|NCT04026165|58657322|FG001|Randomized Period|Investigator's Discretion|0|||
30645038|NCT04026165|58657323|FG002|Randomized Period|Investigator's Discretion|2|||
30645039|NCT04026165|58657324|FG003|Randomized Period|Investigator's Discretion|2|||
30645040|NCT04026165|58657321|FG000|Randomized Period|Lost to Follow-up|0|||
30645041|NCT04026165|58657322|FG001|Randomized Period|Lost to Follow-up|0|||
30645042|NCT04026165|58657323|FG002|Randomized Period|Lost to Follow-up|2|||
30645043|NCT04026165|58657324|FG003|Randomized Period|Lost to Follow-up|2|||
30645044|NCT00805792|58657332|FG000|Overall Study|Death|3|||
30645045|NCT00805792|58657332|FG000|Overall Study|Lost to Follow-up|2|||
30645046|NCT00590044|58657338|FG000|Overall Study|Withdrawal by Subject|2|||
30645047|NCT00590044|58657339|FG001|Overall Study|Withdrawal by Subject|2|||
30645048|NCT00590044|58657338|FG000|Overall Study|wrong insulin arm assigned|1|||
30645049|NCT00590044|58657339|FG001|Overall Study|wrong insulin arm assigned|0|||
30645050|NCT00590044|58657338|FG000|Overall Study|Protocol Violation|1|||
30645051|NCT00590044|58657339|FG001|Overall Study|Protocol Violation|0|||
30645052|NCT00805480|58657352|FG000|Overall Study|Withdrawal by Subject|13|||
30645053|NCT00805480|58657353|FG001|Overall Study|Withdrawal by Subject|5|||
30645054|NCT00805480|58657354|FG002|Overall Study|Withdrawal by Subject|11|||
30645055|NCT00805480|58657355|FG003|Overall Study|Withdrawal by Subject|5|||
30645056|NCT00805480|58657352|FG000|Overall Study|Lost to Follow-up|1|||
30645057|NCT00805480|58657353|FG001|Overall Study|Lost to Follow-up|2|||
30645058|NCT00805480|58657354|FG002|Overall Study|Lost to Follow-up|0|||
30645059|NCT00805480|58657355|FG003|Overall Study|Lost to Follow-up|0|||
30645060|NCT00805480|58657352|FG000|Overall Study|Adverse Event|0|||
30645061|NCT00805480|58657353|FG001|Overall Study|Adverse Event|0|||
30645062|NCT00805480|58657354|FG002|Overall Study|Adverse Event|1|||
30645063|NCT00805480|58657355|FG003|Overall Study|Adverse Event|0|||
30645064|NCT00729937|58657371|FG000|Overall Study|Lost to Follow-up|49|||
30645065|NCT00729937|58657372|FG001|Overall Study|Lost to Follow-up|58|||
30645066|NCT00729937|58657373|FG002|Overall Study|Lost to Follow-up|18|||
30645067|NCT00729937|58657374|FG003|Overall Study|Lost to Follow-up|33|||
30645068|NCT00729937|58657375|FG004|Overall Study|Lost to Follow-up|18|||
30645069|NCT00729937|58657376|FG005|Overall Study|Lost to Follow-up|23|||
30645070|NCT00729937|58657371|FG000|Overall Study|Physician Decision|7|||
30645071|NCT00729937|58657372|FG001|Overall Study|Physician Decision|16|||
30645072|NCT00729937|58657373|FG002|Overall Study|Physician Decision|2|||
30645073|NCT00729937|58657374|FG003|Overall Study|Physician Decision|0|||
30645074|NCT00729937|58657375|FG004|Overall Study|Physician Decision|5|||
30645075|NCT00729937|58657376|FG005|Overall Study|Physician Decision|8|||
30645076|NCT00729937|58657371|FG000|Overall Study|Death|1|||
30645077|NCT00729937|58657372|FG001|Overall Study|Death|0|||
30645078|NCT00729937|58657373|FG002|Overall Study|Death|1|||
30645079|NCT00729937|58657374|FG003|Overall Study|Death|0|||
30645080|NCT00729937|58657375|FG004|Overall Study|Death|0|||
30645081|NCT00729937|58657376|FG005|Overall Study|Death|1|||
30645082|NCT00729937|58657371|FG000|Overall Study|Withdrawal by Subject|3|||
30645083|NCT00729937|58657372|FG001|Overall Study|Withdrawal by Subject|5|||
30645084|NCT00729937|58657373|FG002|Overall Study|Withdrawal by Subject|6|||
30645085|NCT00729937|58657374|FG003|Overall Study|Withdrawal by Subject|0|||
30645086|NCT00729937|58657375|FG004|Overall Study|Withdrawal by Subject|4|||
30645087|NCT00729937|58657376|FG005|Overall Study|Withdrawal by Subject|2|||
30645088|NCT00729937|58657371|FG000|Overall Study|Randomized but not treated|12|||
30645089|NCT00729937|58657372|FG001|Overall Study|Randomized but not treated|6|||
30645090|NCT00729937|58657373|FG002|Overall Study|Randomized but not treated|1|||
30645091|NCT00729937|58657374|FG003|Overall Study|Randomized but not treated|0|||
30645092|NCT00729937|58657375|FG004|Overall Study|Randomized but not treated|1|||
30645093|NCT00729937|58657376|FG005|Overall Study|Randomized but not treated|3|||
30645094|NCT00729937|58657371|FG000|Overall Study|Did not meet eligibility criteria|2|||
30645095|NCT00729937|58657372|FG001|Overall Study|Did not meet eligibility criteria|1|||
30645096|NCT00729937|58657373|FG002|Overall Study|Did not meet eligibility criteria|0|||
30645097|NCT00729937|58657374|FG003|Overall Study|Did not meet eligibility criteria|0|||
30645098|NCT00729937|58657375|FG004|Overall Study|Did not meet eligibility criteria|0|||
30645099|NCT00729937|58657376|FG005|Overall Study|Did not meet eligibility criteria|0|||
30645100|NCT00729937|58657371|FG000|Overall Study|Incarcerated|0|||
30645101|NCT00729937|58657372|FG001|Overall Study|Incarcerated|2|||
30645102|NCT00729937|58657373|FG002|Overall Study|Incarcerated|1|||
30645103|NCT00729937|58657374|FG003|Overall Study|Incarcerated|1|||
30645104|NCT00729937|58657375|FG004|Overall Study|Incarcerated|0|||
30645105|NCT00729937|58657376|FG005|Overall Study|Incarcerated|0|||
30645106|NCT00729859|58657393|FG000|Overall Study|Adverse Event|0|||
30645107|NCT00729859|58657394|FG001|Overall Study|Adverse Event|1|||
30645108|NCT00729859|58657395|FG002|Overall Study|Adverse Event|0|||
30645109|NCT00729859|58657393|FG000|Overall Study|Withdrawal by Subject|0|||
30645110|NCT00729859|58657394|FG001|Overall Study|Withdrawal by Subject|1|||
30645111|NCT00729859|58657395|FG002|Overall Study|Withdrawal by Subject|0|||
30645112|NCT00810394|58657411|FG000|Overall Study|Withdrawal by Subject|3|||
30645113|NCT00736333|58657415|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
30645114|NCT00736333|58657415|FG000|Overall Study|Data Missing|2|||
30645115|NCT00736333|58657415|FG000|Overall Study|Tumor Progression|75|||
30645116|NCT00736333|58657415|FG000|Overall Study|Toxicity|6|||
30645117|NCT00736333|58657415|FG000|Overall Study|Withdrawal by Subject|10|||
30645118|NCT00736333|58657415|FG000|Overall Study|Death|7|||
30645119|NCT00736333|58657415|FG000|Overall Study|Other|4|||
30645120|NCT00736255|58657421|FG000|Overall Study|Adverse Event|1|||
30645121|NCT00736255|58657422|FG001|Overall Study|Adverse Event|0|||
30645122|NCT00736255|58657421|FG000|Overall Study|Physician Decision|1|||
30766183|NCT03319732|58774826|FG000|Overall Study|MS relapse|10|||
30766184|NCT03319732|58774826|FG000|Overall Study|reason not specified|5|||
30766185|NCT03304522|58774833|FG000|Overall Study|Adverse Event|0|||
30766186|NCT03304522|58774834|FG001|Overall Study|Adverse Event|4|||
30766187|NCT03304522|58774833|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
30766188|NCT03304522|58774834|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
30766189|NCT03304522|58774833|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
30766190|NCT03304522|58774834|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
30766191|NCT03304522|58774833|FG000|Overall Study|Other|0|||
30766192|NCT03304522|58774834|FG001|Overall Study|Other|1|||
30766193|NCT03315286|58774842|FG000|Overall Study|Lost to Follow-up|0|||
30766194|NCT03315286|58774843|FG001|Overall Study|Lost to Follow-up|3|||
30645123|NCT00736255|58657422|FG001|Overall Study|Physician Decision|0|||
30645124|NCT00736255|58657421|FG000|Overall Study|Non-compliance|1|||
30645125|NCT00736255|58657422|FG001|Overall Study|Non-compliance|1|||
30645126|NCT03920254|58657431|FG000|Overall Study|Adverse Event|1|||
30645127|NCT03920254|58657432|FG001|Overall Study|Adverse Event|0|||
30645128|NCT03920254|58657433|FG002|Overall Study|Adverse Event|0|||
30645129|NCT03920254|58657431|FG000|Overall Study|Physician Decision|0|||
30645130|NCT03920254|58657432|FG001|Overall Study|Physician Decision|1|||
30645131|NCT03920254|58657433|FG002|Overall Study|Physician Decision|2|||
30645132|NCT03920254|58657431|FG000|Overall Study|Study Terminated By Sponsor|12|||
30766195|NCT03315286|58774842|FG000|Overall Study|Withdrawal by Subject|1|||
30766196|NCT03315286|58774843|FG001|Overall Study|Withdrawal by Subject|0|||
30766197|NCT03315286|58774842|FG000|Overall Study|Protocol Violation|0|||
30766198|NCT03315286|58774843|FG001|Overall Study|Protocol Violation|1|||
30766199|NCT03273946|58774849|FG000|Overall Study|Withdrawal by Subject|5|||
30766200|NCT03273946|58774849|FG000|Overall Study|Unwillingness of the guardian|1|||
30766201|NCT03273946|58774849|FG000|Overall Study|Participant refused to use the drug|2|||
30766202|NCT03273946|58774849|FG000|Overall Study|Participant relative refused to use drug|1|||
30645133|NCT03920254|58657432|FG001|Overall Study|Study Terminated By Sponsor|17|||
30645134|NCT03920254|58657433|FG002|Overall Study|Study Terminated By Sponsor|12|||
30766203|NCT00314951|58774855|FG000|Treatment|Didn't meet criteria for mITT population|16|||
30766204|NCT00314951|58774856|FG001|Treatment|Didn't meet criteria for mITT population|11|||
30766205|NCT00314951|58774855|FG000|Follow-up|mITT failure|44|||
30766206|NCT00314951|58774856|FG001|Follow-up|mITT failure|34|||
30766207|NCT00085644|58774864|FG000|Double-Blind Period|Adverse Event|5|||
30766208|NCT00085644|58774865|FG001|Double-Blind Period|Adverse Event|2|||
30766209|NCT00085644|58774866|FG002|Double-Blind Period|Adverse Event|0|||
30766210|NCT00085644|58774864|FG000|Double-Blind Period|Withdrawal by Subject|3|||
30766211|NCT00085644|58774865|FG001|Double-Blind Period|Withdrawal by Subject|0|||
30766212|NCT00085644|58774866|FG002|Double-Blind Period|Withdrawal by Subject|0|||
30766213|NCT00085644|58774864|FG000|Double-Blind Period|Lost to Follow-up|2|||
30766214|NCT00085644|58774865|FG001|Double-Blind Period|Lost to Follow-up|1|||
30766215|NCT00085644|58774866|FG002|Double-Blind Period|Lost to Follow-up|0|||
30766216|NCT00085644|58774864|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
30766217|NCT00085644|58774865|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
30766218|NCT00085644|58774866|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
30766219|NCT00085644|58774864|FG000|Double-Blind Period|Contemplating pregnancy|1|||
30766220|NCT00085644|58774865|FG001|Double-Blind Period|Contemplating pregnancy|0|||
30766221|NCT00085644|58774866|FG002|Double-Blind Period|Contemplating pregnancy|0|||
30766222|NCT00085644|58774864|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
30766223|NCT00085644|58774865|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
30766224|NCT00085644|58774866|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
30766225|NCT00085644|58774864|FG000|Open-Label Period|Adverse Event|0|||
30645135|NCT03920254|58657431|FG000|Overall Study|Withdrawal by Subject|0|||
30645136|NCT03920254|58657432|FG001|Overall Study|Withdrawal by Subject|0|||
30645137|NCT03920254|58657433|FG002|Overall Study|Withdrawal by Subject|1|||
30645138|NCT00729469|58657443|FG000|Overall Study|Adverse Event|14|||
30645139|NCT00729469|58657444|FG001|Overall Study|Adverse Event|25|||
30645140|NCT00729469|58657443|FG000|Overall Study|Lost to Follow-up|9|||
30766226|NCT00085644|58774865|FG001|Open-Label Period|Adverse Event|0|||
30766227|NCT00085644|58774866|FG002|Open-Label Period|Adverse Event|38|||
30766228|NCT00085644|58774864|FG000|Open-Label Period|Withdrawal by Subject|0|||
30766229|NCT00085644|58774865|FG001|Open-Label Period|Withdrawal by Subject|0|||
30766230|NCT00085644|58774866|FG002|Open-Label Period|Withdrawal by Subject|29|||
30645141|NCT00729469|58657444|FG001|Overall Study|Lost to Follow-up|9|||
30645142|NCT00729469|58657443|FG000|Overall Study|Protocol Violation|2|||
30766231|NCT00085644|58774864|FG000|Open-Label Period|Lost to Follow-up|0|||
30766232|NCT00085644|58774865|FG001|Open-Label Period|Lost to Follow-up|0|||
30766233|NCT00085644|58774866|FG002|Open-Label Period|Lost to Follow-up|13|||
30766234|NCT00085644|58774864|FG000|Open-Label Period|Lack of Efficacy|0|||
30766235|NCT00085644|58774865|FG001|Open-Label Period|Lack of Efficacy|0|||
30645143|NCT00729469|58657444|FG001|Overall Study|Protocol Violation|1|||
30645144|NCT00729469|58657443|FG000|Overall Study|Withdrawal by Subject|19|||
30645145|NCT00729469|58657444|FG001|Overall Study|Withdrawal by Subject|8|||
30766236|NCT00085644|58774866|FG002|Open-Label Period|Lack of Efficacy|15|||
30766237|NCT00085644|58774864|FG000|Open-Label Period|Pregnancy|0|||
30766238|NCT00085644|58774865|FG001|Open-Label Period|Pregnancy|0|||
30766239|NCT00085644|58774866|FG002|Open-Label Period|Pregnancy|3|||
30766240|NCT00085644|58774864|FG000|Open-Label Period|Contemplating pregnancy|0|||
30766241|NCT00085644|58774865|FG001|Open-Label Period|Contemplating pregnancy|0|||
30766242|NCT00085644|58774866|FG002|Open-Label Period|Contemplating pregnancy|3|||
30766243|NCT00085644|58774864|FG000|Open-Label Period|Protocol Violation|0|||
30766244|NCT00085644|58774865|FG001|Open-Label Period|Protocol Violation|0|||
30766245|NCT00085644|58774866|FG002|Open-Label Period|Protocol Violation|4|||
30766246|NCT00085644|58774864|FG000|Open-Label Period|Personal reason|0|||
30766247|NCT00085644|58774865|FG001|Open-Label Period|Personal reason|0|||
30766248|NCT00085644|58774866|FG002|Open-Label Period|Personal reason|4|||
30766249|NCT03315208|58774875|FG000|Overall Study|Lost to Follow-up|11|||
30766250|NCT03315208|58774876|FG001|Overall Study|Lost to Follow-up|6|||
30766251|NCT03315208|58774875|FG000|Overall Study|Withdrawal by Subject|2|||
30766252|NCT03315208|58774876|FG001|Overall Study|Withdrawal by Subject|0|||
30766253|NCT00314795|58774883|FG000|Overall Study|Adverse Event|8|||
30766254|NCT00314795|58774883|FG000|Overall Study|Death|4|||
30766255|NCT00314795|58774883|FG000|Overall Study|Reason not Specified|3|||
30766256|NCT00314795|58774883|FG000|Overall Study|Renal Transplant|3|||
30766257|NCT00314795|58774883|FG000|Overall Study|Participants Withdrew Consent|2|||
30766258|NCT00314327|58774887|FG000|Overall Study|Withdrawal by Subject|1|||
30766259|NCT00336479|58774895|FG000|Overall Study|Adverse Event|8|||
30766260|NCT00336479|58774896|FG001|Overall Study|Adverse Event|11|||
30766261|NCT00336479|58774897|FG002|Overall Study|Adverse Event|18|||
30766262|NCT00336479|58774898|FG003|Overall Study|Adverse Event|4|||
30766263|NCT00336479|58774895|FG000|Overall Study|Noncompliant|1|||
30766264|NCT00336479|58774896|FG001|Overall Study|Noncompliant|7|||
30766265|NCT00336479|58774897|FG002|Overall Study|Noncompliant|3|||
30766266|NCT00336479|58774898|FG003|Overall Study|Noncompliant|0|||
30766267|NCT00336479|58774895|FG000|Overall Study|Physician Decision|2|||
30766268|NCT00336479|58774896|FG001|Overall Study|Physician Decision|3|||
30645146|NCT00729469|58657443|FG000|Overall Study|Other-Not mentioned|9|||
30645147|NCT00729469|58657444|FG001|Overall Study|Other-Not mentioned|4|||
30645148|NCT00742183|58657452|FG000|Overall Study|Adverse Event|2|||
30645149|NCT00742183|58657453|FG001|Overall Study|Adverse Event|2|||
30645150|NCT00742183|58657452|FG000|Overall Study|Death|1|||
30645151|NCT00742183|58657453|FG001|Overall Study|Death|0|||
30645152|NCT00742183|58657452|FG000|Overall Study|Physician Decision|0|||
30766269|NCT00336479|58774897|FG002|Overall Study|Physician Decision|1|||
30766270|NCT00336479|58774898|FG003|Overall Study|Physician Decision|0|||
30766271|NCT00336479|58774895|FG000|Overall Study|Lost to Follow-up|3|||
30766272|NCT00336479|58774896|FG001|Overall Study|Lost to Follow-up|2|||
30766273|NCT00336479|58774897|FG002|Overall Study|Lost to Follow-up|0|||
30766274|NCT00336479|58774898|FG003|Overall Study|Lost to Follow-up|0|||
30766275|NCT00336479|58774895|FG000|Overall Study|Withdrawal by Subject|3|||
30766276|NCT00336479|58774896|FG001|Overall Study|Withdrawal by Subject|2|||
30766277|NCT00336479|58774897|FG002|Overall Study|Withdrawal by Subject|3|||
30766278|NCT00336479|58774898|FG003|Overall Study|Withdrawal by Subject|0|||
30766279|NCT00336479|58774895|FG000|Overall Study|Other|0|||
30766280|NCT00336479|58774896|FG001|Overall Study|Other|0|||
30951896|NCT01709318|58999313|FG003|Overall Study|Technical Problems|0|||
30951897|NCT01709318|58999314|FG004|Overall Study|Technical Problems|0|||
30645153|NCT00742183|58657453|FG001|Overall Study|Physician Decision|2|||
30645154|NCT00742183|58657452|FG000|Overall Study|Lost to Follow-up|4|||
30645155|NCT00742183|58657453|FG001|Overall Study|Lost to Follow-up|4|||
30645156|NCT00742183|58657452|FG000|Overall Study|Required skin-graft|1|||
30645157|NCT00742183|58657453|FG001|Overall Study|Required skin-graft|1|||
30645158|NCT00742183|58657452|FG000|Overall Study|Withdrawal by Subject|1|||
30645159|NCT00742183|58657453|FG001|Overall Study|Withdrawal by Subject|0|||
30645160|NCT00742183|58657452|FG000|Overall Study|Lack of Efficacy|0|||
30645161|NCT00742183|58657453|FG001|Overall Study|Lack of Efficacy|3|||
30645162|NCT00808444|58657461|FG000|Overall Study|Withdrawal by Subject|1|||
30766281|NCT00336479|58774897|FG002|Overall Study|Other|1|||
30766282|NCT00336479|58774898|FG003|Overall Study|Other|0|||
30766283|NCT00336479|58774895|FG000|Overall Study|Virologic Stopping Rule|20|||
30766284|NCT00336479|58774896|FG001|Overall Study|Virologic Stopping Rule|0|||
30766285|NCT00336479|58774897|FG002|Overall Study|Virologic Stopping Rule|0|||
30766286|NCT00336479|58774898|FG003|Overall Study|Virologic Stopping Rule|0|||
30951898|NCT01709318|58999315|FG005|Overall Study|Technical Problems|0|||
30645163|NCT00808444|58657462|FG001|Overall Study|Withdrawal by Subject|0|||
30645164|NCT00808444|58657461|FG000|Overall Study|Lost to Follow-up|0|||
30645165|NCT00808444|58657462|FG001|Overall Study|Lost to Follow-up|1|||
30766287|NCT00314249|58774911|FG000|Overall Study|Adverse Event|73|||
30766288|NCT00314249|58774912|FG001|Overall Study|Adverse Event|94|||
30766289|NCT00314249|58774911|FG000|Overall Study|Lack of Efficacy|33|||
30766290|NCT00314249|58774912|FG001|Overall Study|Lack of Efficacy|24|||
30766291|NCT00314249|58774911|FG000|Overall Study|Withdrawal by Subject|21|||
30766292|NCT00314249|58774912|FG001|Overall Study|Withdrawal by Subject|28|||
30766293|NCT00314249|58774911|FG000|Overall Study|Lost to Follow-up|15|||
30766294|NCT00314249|58774912|FG001|Overall Study|Lost to Follow-up|9|||
30766295|NCT00314249|58774911|FG000|Overall Study|Physician Decision|1|||
30766296|NCT00314249|58774912|FG001|Overall Study|Physician Decision|1|||
30766297|NCT00314249|58774911|FG000|Overall Study|Withdrawn for other reasons|4|||
30645166|NCT00742027|58657468|FG000|Overall Study|Disease Progression|76|||
30645167|NCT00742027|58657468|FG000|Overall Study|New Cancer Therapy|19|||
30645168|NCT00742027|58657468|FG000|Overall Study|Withdrawal by Subject|18|||
30645169|NCT00742027|58657468|FG000|Overall Study|Death|7|||
30645170|NCT00742027|58657468|FG000|Overall Study|Lost to Follow-up|4|||
30645171|NCT00742027|58657468|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
30645172|NCT00742027|58657468|FG000|Overall Study|Missing|2|||
30645173|NCT00742027|58657468|FG000|Overall Study|Administrative Problems|1|||
30645174|NCT03996369|58657474|FG000|Overall Study|Protocol deviation|1|||
30645175|NCT03996369|58657475|FG001|Overall Study|Protocol deviation|1|||
30645176|NCT03996369|58657474|FG000|Overall Study|Physician Decision|4|||
30645177|NCT03996369|58657475|FG001|Overall Study|Physician Decision|2|||
30645178|NCT03996369|58657474|FG000|Overall Study|Participant decision|0|||
30645179|NCT03996369|58657475|FG001|Overall Study|Participant decision|1|||
30645180|NCT03996369|58657474|FG000|Overall Study|Lack of Efficacy|4|||
30645181|NCT03996369|58657475|FG001|Overall Study|Lack of Efficacy|0|||
30645182|NCT03996369|58657474|FG000|Overall Study|Adverse Event|9|||
30645183|NCT03996369|58657475|FG001|Overall Study|Adverse Event|0|||
30645184|NCT03996369|58657474|FG000|Overall Study|Withdrawal by Subject|6|||
30645185|NCT03996369|58657475|FG001|Overall Study|Withdrawal by Subject|8|||
30645186|NCT03996369|58657474|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
30645187|NCT03996369|58657475|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
30645188|NCT03996369|58657474|FG000|Overall Study|Lost to Follow-up|0|||
30645189|NCT03996369|58657475|FG001|Overall Study|Lost to Follow-up|1|||
30645190|NCT00808210|58657483|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
30645191|NCT00808210|58657484|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
30645192|NCT00808210|58657483|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
30645193|NCT00808210|58657484|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
30645194|NCT00808210|58657483|FG000|Double-Blind TX Period|Adverse Event|0|||
30645195|NCT00808210|58657484|FG001|Double-Blind TX Period|Adverse Event|1|||
30645196|NCT00808210|58657483|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
30645197|NCT00808210|58657484|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
30645198|NCT00808210|58657483|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
30645199|NCT00808210|58657484|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
30645200|NCT00808210|58657483|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
30645201|NCT00808210|58657484|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
30645202|NCT00736099|58657492|FG000|Overall Study|Adverse Event|61|||
30645203|NCT00736099|58657493|FG001|Overall Study|Adverse Event|18|||
30645204|NCT00736099|58657492|FG000|Overall Study|Protocol Violation|10|||
30645205|NCT00736099|58657493|FG001|Overall Study|Protocol Violation|4|||
30645206|NCT00736099|58657492|FG000|Overall Study|Lost to Follow-up|12|||
30645207|NCT00736099|58657493|FG001|Overall Study|Lost to Follow-up|5|||
30645208|NCT00736099|58657492|FG000|Overall Study|Withdrawal by Subject|42|||
30645209|NCT00736099|58657493|FG001|Overall Study|Withdrawal by Subject|13|||
30645210|NCT00736099|58657492|FG000|Overall Study|Lack of Efficacy|15|||
30645211|NCT00736099|58657493|FG001|Overall Study|Lack of Efficacy|8|||
30645212|NCT00736099|58657492|FG000|Overall Study|Other reason|43|||
30645213|NCT00736099|58657493|FG001|Overall Study|Other reason|10|||
30645214|NCT00735943|58657499|FG000|Overall Study|Lost to Follow-up|1|||
30645215|NCT00735943|58657499|FG000|Overall Study|Adverse Event|1|||
30645216|NCT00735709|58657507|FG000|Overall Study|Adverse Event|2|||
30645217|NCT00735709|58657508|FG001|Overall Study|Adverse Event|3|||
30645218|NCT00735709|58657509|FG002|Overall Study|Adverse Event|1|||
30645219|NCT00735709|58657510|FG003|Overall Study|Adverse Event|5|||
30645220|NCT00735709|58657507|FG000|Overall Study|Lack of Efficacy|8|||
30645221|NCT00735709|58657508|FG001|Overall Study|Lack of Efficacy|4|||
30645222|NCT00735709|58657509|FG002|Overall Study|Lack of Efficacy|2|||
30645223|NCT00735709|58657510|FG003|Overall Study|Lack of Efficacy|3|||
30645224|NCT00735709|58657507|FG000|Overall Study|Noncompliance|0|||
30645225|NCT00735709|58657508|FG001|Overall Study|Noncompliance|0|||
30645226|NCT00735709|58657509|FG002|Overall Study|Noncompliance|1|||
30645227|NCT00735709|58657510|FG003|Overall Study|Noncompliance|0|||
30645228|NCT00735709|58657507|FG000|Overall Study|Protocol deviations|1|||
30645229|NCT00735709|58657508|FG001|Overall Study|Protocol deviations|2|||
30645230|NCT00735709|58657509|FG002|Overall Study|Protocol deviations|1|||
30645231|NCT00735709|58657510|FG003|Overall Study|Protocol deviations|1|||
30645232|NCT00735709|58657507|FG000|Overall Study|Voluntary Withdrawal|1|||
30645233|NCT00735709|58657508|FG001|Overall Study|Voluntary Withdrawal|3|||
30645234|NCT00735709|58657509|FG002|Overall Study|Voluntary Withdrawal|5|||
30766298|NCT00314249|58774912|FG001|Overall Study|Withdrawn for other reasons|1|||
30766299|NCT00314249|58774911|FG000|Overall Study|Non-Compliant|5|||
30766300|NCT00314249|58774912|FG001|Overall Study|Non-Compliant|6|||
30766301|NCT03315130|58774921|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
30766302|NCT03315130|58774922|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
30766303|NCT03315130|58774923|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
30766304|NCT03315130|58774924|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
30766305|NCT03315130|58774921|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
30766306|NCT03315130|58774922|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
30766307|NCT03315130|58774923|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
30766308|NCT03315130|58774924|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
30766309|NCT03315130|58774921|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
30766310|NCT03315130|58774922|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
30766311|NCT03315130|58774923|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
30766312|NCT03315130|58774924|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
30766313|NCT03315130|58774921|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
30766314|NCT03315130|58774922|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
30766315|NCT03315130|58774923|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
30766316|NCT03315130|58774924|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
30766317|NCT03315130|58774921|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
30766318|NCT03315130|58774922|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
30766319|NCT03315130|58774923|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
30645235|NCT00735709|58657510|FG003|Overall Study|Voluntary Withdrawal|7|||
30645236|NCT00735709|58657507|FG000|Overall Study|Lost to Follow-up|0|||
30645237|NCT00735709|58657508|FG001|Overall Study|Lost to Follow-up|1|||
30645238|NCT00735709|58657509|FG002|Overall Study|Lost to Follow-up|1|||
30645239|NCT00735709|58657510|FG003|Overall Study|Lost to Follow-up|1|||
30645240|NCT00735709|58657507|FG000|Overall Study|Excluded medication|1|||
30766320|NCT03315130|58774924|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
30766321|NCT03315130|58774921|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
30645241|NCT00735709|58657508|FG001|Overall Study|Excluded medication|0|||
30645242|NCT00735709|58657509|FG002|Overall Study|Excluded medication|0|||
30645243|NCT00735709|58657510|FG003|Overall Study|Excluded medication|1|||
30645244|NCT00729157|58657520|FG000|Overall Study|Withdrawal by Subject|1|||
30645245|NCT00728689|58657526|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
30766322|NCT03315130|58774922|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
30645246|NCT00728689|58657527|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
30766323|NCT03315130|58774923|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
30766324|NCT03315130|58774924|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
30766325|NCT03273166|58774944|FG000|Overall Study|Withdrawn prior to Completion|31|||
30766326|NCT03314662|58774952|FG000|Overall Study|Withdrawal by Subject|1|||
30766327|NCT03314662|58774953|FG001|Overall Study|Withdrawal by Subject|1|||
30766328|NCT03314662|58774954|FG002|Overall Study|Withdrawal by Subject|1|||
30766329|NCT03314662|58774952|FG000|Overall Study|Lost to Follow-up|5|||
30766330|NCT03314662|58774953|FG001|Overall Study|Lost to Follow-up|4|||
30766331|NCT03314662|58774954|FG002|Overall Study|Lost to Follow-up|4|||
30766332|NCT03314662|58774952|FG000|Overall Study|Death|2|||
30766333|NCT03314662|58774953|FG001|Overall Study|Death|0|||
30766334|NCT03314662|58774954|FG002|Overall Study|Death|0|||
30766335|NCT03271528|58774972|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
30766336|NCT03271528|58774973|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
30645247|NCT00727909|58657535|FG000|Overall Study|Withdrawal by Subject|5|||
30645248|NCT00727909|58657536|FG001|Overall Study|Withdrawal by Subject|11|||
30645249|NCT00727909|58657537|FG002|Overall Study|Withdrawal by Subject|8|||
30766337|NCT03271528|58774972|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
30645250|NCT00727909|58657538|FG003|Overall Study|Withdrawal by Subject|5|||
30645251|NCT00727909|58657535|FG000|Overall Study|Death|0|||
30645252|NCT00727909|58657536|FG001|Overall Study|Death|0|||
30645253|NCT00727909|58657537|FG002|Overall Study|Death|1|||
30645254|NCT00727909|58657538|FG003|Overall Study|Death|0|||
30645255|NCT00726895|58657542|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
30645256|NCT00726895|58657543|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
30645257|NCT00585325|58657552|FG000|Overall Study|Withdrawal by Subject|1|||
30645258|NCT00585325|58657553|FG001|Overall Study|Withdrawal by Subject|1|||
30645259|NCT00726661|58657561|FG000|Overall Study|Lost to Follow-up|36|||
30645260|NCT00726661|58657562|FG001|Overall Study|Lost to Follow-up|11|||
30645261|NCT00726661|58657561|FG000|Overall Study|Withdrawal by Subject|17|||
30766338|NCT03271528|58774973|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
30766339|NCT03271528|58774972|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
30766340|NCT03271528|58774973|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
30951899|NCT01709318|58999316|FG006|Overall Study|Technical Problems|0|||
30645262|NCT00726661|58657562|FG001|Overall Study|Withdrawal by Subject|13|||
30645263|NCT00726661|58657561|FG000|Overall Study|Trial terminated by sponsor|214|||
30645264|NCT00726661|58657562|FG001|Overall Study|Trial terminated by sponsor|187|||
30645265|NCT00726661|58657561|FG000|Overall Study|Death|475|||
30645266|NCT00726661|58657562|FG001|Overall Study|Death|159|||
30645267|NCT00726661|58657561|FG000|Overall Study|Physician Decision|25|||
30645268|NCT00726661|58657562|FG001|Overall Study|Physician Decision|13|||
30645269|NCT00726661|58657561|FG000|Overall Study|Other|47|||
30645270|NCT00726661|58657562|FG001|Overall Study|Other|35|||
30645271|NCT00741091|58657578|FG000|Overall Study|Death|13|||
30645272|NCT00741091|58657578|FG000|Overall Study|Lost to Follow-up|16|||
30645273|NCT00741091|58657578|FG000|Overall Study|Withdrawal by Subject|6|||
30645274|NCT00741091|58657578|FG000|Overall Study|Missed Visit|22|||
30645275|NCT00741013|58657585|FG000|Overall Study|Adverse Event|1|||
30645276|NCT00741013|58657586|FG001|Overall Study|Adverse Event|0|||
30645277|NCT00741013|58657587|FG002|Overall Study|Adverse Event|0|||
30645278|NCT00741013|58657585|FG000|Overall Study|Withdrawal by Subject|0|||
30645279|NCT00741013|58657586|FG001|Overall Study|Withdrawal by Subject|0|||
30645280|NCT00741013|58657587|FG002|Overall Study|Withdrawal by Subject|1|||
30645281|NCT00741013|58657585|FG000|Overall Study|Discovered failed screen after enrolled|0|||
30645282|NCT00741013|58657586|FG001|Overall Study|Discovered failed screen after enrolled|2|||
30645283|NCT00741013|58657587|FG002|Overall Study|Discovered failed screen after enrolled|0|||
30645284|NCT00740857|58657598|FG000|Overall Study|Withdrawal by Subject|1|||
30645285|NCT00740857|58657599|FG001|Overall Study|Withdrawal by Subject|0|||
30645286|NCT00740857|58657600|FG002|Overall Study|Withdrawal by Subject|0|||
30645287|NCT00808132|58657613|FG000|Overall Study|Adverse Event|34|||
30848591|NCT04604795|58874771|FG009|Part B: Up to Day 14|Adverse Event|0|||
30951900|NCT01709318|58999310|FG000|Overall Study|Withdrawal by Subject|3|||
30951901|NCT01709318|58999311|FG001|Overall Study|Withdrawal by Subject|0|||
30645288|NCT00808132|58657614|FG001|Overall Study|Adverse Event|33|||
30645289|NCT00808132|58657615|FG002|Overall Study|Adverse Event|16|||
30645290|NCT00808132|58657616|FG003|Overall Study|Adverse Event|31|||
30645291|NCT00808132|58657617|FG004|Overall Study|Adverse Event|33|||
30645292|NCT00808132|58657613|FG000|Overall Study|Death|0|||
30645293|NCT00808132|58657614|FG001|Overall Study|Death|0|||
30645294|NCT00808132|58657615|FG002|Overall Study|Death|0|||
30645295|NCT00808132|58657616|FG003|Overall Study|Death|0|||
30645296|NCT00808132|58657617|FG004|Overall Study|Death|1|||
30645297|NCT00808132|58657613|FG000|Overall Study|Physician Decision|0|||
30645298|NCT00808132|58657614|FG001|Overall Study|Physician Decision|1|||
30645299|NCT00808132|58657615|FG002|Overall Study|Physician Decision|0|||
30645300|NCT00808132|58657616|FG003|Overall Study|Physician Decision|0|||
30645301|NCT00808132|58657617|FG004|Overall Study|Physician Decision|0|||
30645302|NCT00808132|58657613|FG000|Overall Study|Lost to Follow-up|8|||
30645303|NCT00808132|58657614|FG001|Overall Study|Lost to Follow-up|10|||
30645304|NCT00808132|58657615|FG002|Overall Study|Lost to Follow-up|11|||
30645305|NCT00808132|58657616|FG003|Overall Study|Lost to Follow-up|8|||
30645306|NCT00808132|58657617|FG004|Overall Study|Lost to Follow-up|9|||
30645307|NCT00808132|58657613|FG000|Overall Study|Protocol Violation|8|||
30645308|NCT00808132|58657614|FG001|Overall Study|Protocol Violation|9|||
30645309|NCT00808132|58657615|FG002|Overall Study|Protocol Violation|4|||
30645310|NCT00808132|58657616|FG003|Overall Study|Protocol Violation|9|||
30645311|NCT00808132|58657617|FG004|Overall Study|Protocol Violation|5|||
30645312|NCT00808132|58657613|FG000|Overall Study|Withdrawal by Subject|27|||
30645313|NCT00808132|58657614|FG001|Overall Study|Withdrawal by Subject|18|||
30645314|NCT00808132|58657615|FG002|Overall Study|Withdrawal by Subject|2|||
30645315|NCT00808132|58657616|FG003|Overall Study|Withdrawal by Subject|7|||
30645316|NCT00808132|58657617|FG004|Overall Study|Withdrawal by Subject|16|||
30645317|NCT00808132|58657613|FG000|Overall Study|Other|6|||
30645318|NCT00808132|58657614|FG001|Overall Study|Other|4|||
30645319|NCT00808132|58657615|FG002|Overall Study|Other|6|||
30645320|NCT00808132|58657616|FG003|Overall Study|Other|2|||
30645321|NCT00808132|58657617|FG004|Overall Study|Other|15|||
30848592|NCT04604795|58874762|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
30951902|NCT01709318|58999312|FG002|Overall Study|Withdrawal by Subject|3|||
30951903|NCT01709318|58999313|FG003|Overall Study|Withdrawal by Subject|3|||
30645322|NCT00808132|58657613|FG000|Overall Study|Randomized, but not treated|10|||
30645323|NCT00808132|58657614|FG001|Overall Study|Randomized, but not treated|7|||
30645324|NCT00808132|58657615|FG002|Overall Study|Randomized, but not treated|9|||
30645325|NCT00808132|58657616|FG003|Overall Study|Randomized, but not treated|8|||
30645326|NCT00808132|58657617|FG004|Overall Study|Randomized, but not treated|9|||
30645327|NCT00808132|58657613|FG000|Overall Study|Unsatisfactory response|5|||
30645328|NCT00808132|58657614|FG001|Overall Study|Unsatisfactory response|6|||
30645329|NCT00808132|58657615|FG002|Overall Study|Unsatisfactory response|6|||
30645330|NCT00808132|58657616|FG003|Overall Study|Unsatisfactory response|4|||
30645331|NCT00808132|58657617|FG004|Overall Study|Unsatisfactory response|12|||
30645332|NCT00727441|58657632|FG000|Overall Study|Disease Progression|11|||
30645333|NCT00727441|58657633|FG001|Overall Study|Disease Progression|14|||
30645334|NCT00727441|58657634|FG002|Overall Study|Disease Progression|17|||
30645335|NCT00727441|58657632|FG000|Overall Study|Eligibility|7|||
30645336|NCT00727441|58657633|FG001|Overall Study|Eligibility|5|||
30645337|NCT00727441|58657634|FG002|Overall Study|Eligibility|7|||
30645338|NCT00727441|58657632|FG000|Overall Study|Death|0|||
30645339|NCT00727441|58657633|FG001|Overall Study|Death|1|||
30645340|NCT00727441|58657634|FG002|Overall Study|Death|1|||
30645341|NCT00727441|58657632|FG000|Overall Study|Physician Decision|0|||
30645342|NCT00727441|58657633|FG001|Overall Study|Physician Decision|1|||
30645343|NCT00727441|58657634|FG002|Overall Study|Physician Decision|0|||
30645344|NCT00727441|58657632|FG000|Overall Study|Withdrawal by Subject|0|||
30645345|NCT00727441|58657633|FG001|Overall Study|Withdrawal by Subject|1|||
30645346|NCT00727441|58657634|FG002|Overall Study|Withdrawal by Subject|0|||
30645347|NCT00717769|58657648|FG000|Overall Study|Adverse Event|9|||
30645348|NCT00717769|58657649|FG001|Overall Study|Adverse Event|6|||
30645349|NCT00717769|58657650|FG002|Overall Study|Adverse Event|1|||
30645350|NCT00717769|58657648|FG000|Overall Study|Lack of compliance|0|||
30645351|NCT00717769|58657649|FG001|Overall Study|Lack of compliance|2|||
30645352|NCT00717769|58657650|FG002|Overall Study|Lack of compliance|0|||
30645353|NCT00717769|58657648|FG000|Overall Study|Lost to Follow-up|3|||
30645354|NCT00717769|58657649|FG001|Overall Study|Lost to Follow-up|4|||
30645355|NCT00717769|58657650|FG002|Overall Study|Lost to Follow-up|0|||
30645356|NCT00717769|58657648|FG000|Overall Study|Lack of Efficacy|1|||
30645357|NCT00717769|58657649|FG001|Overall Study|Lack of Efficacy|2|||
30645358|NCT00717769|58657650|FG002|Overall Study|Lack of Efficacy|0|||
30645359|NCT00717769|58657648|FG000|Overall Study|Protocol Violation|0|||
30645360|NCT00717769|58657649|FG001|Overall Study|Protocol Violation|2|||
30645361|NCT00717769|58657650|FG002|Overall Study|Protocol Violation|0|||
30645362|NCT00717769|58657648|FG000|Overall Study|Sponsor decision|1|||
30645363|NCT00717769|58657649|FG001|Overall Study|Sponsor decision|0|||
30645364|NCT00717769|58657650|FG002|Overall Study|Sponsor decision|10|||
30645365|NCT00717769|58657648|FG000|Overall Study|Withdrew consent|2|||
30645366|NCT00717769|58657649|FG001|Overall Study|Withdrew consent|2|||
30645367|NCT00717769|58657650|FG002|Overall Study|Withdrew consent|0|||
30645368|NCT04153929|58657668|FG000|Overall Study|Other than listed|2|||
30645369|NCT04153929|58657669|FG001|Overall Study|Other than listed|2|||
30645370|NCT04153929|58657670|FG002|Overall Study|Other than listed|0|||
30645371|NCT04153929|58657671|FG003|Overall Study|Other than listed|1|||
30645372|NCT04153929|58657672|FG004|Overall Study|Other than listed|0|||
30645373|NCT04153929|58657673|FG005|Overall Study|Other than listed|2|||
30645374|NCT04153929|58657674|FG006|Overall Study|Other than listed|2|||
30645375|NCT04153929|58657675|FG007|Overall Study|Other than listed|1|||
30645376|NCT04153929|58657668|FG000|Overall Study|Lost to Follow-up|2|||
30645377|NCT04153929|58657669|FG001|Overall Study|Lost to Follow-up|1|||
30645378|NCT04153929|58657670|FG002|Overall Study|Lost to Follow-up|0|||
30645379|NCT04153929|58657671|FG003|Overall Study|Lost to Follow-up|1|||
30645380|NCT04153929|58657672|FG004|Overall Study|Lost to Follow-up|1|||
30645381|NCT04153929|58657673|FG005|Overall Study|Lost to Follow-up|0|||
30645382|NCT04153929|58657674|FG006|Overall Study|Lost to Follow-up|0|||
30645383|NCT04153929|58657675|FG007|Overall Study|Lost to Follow-up|0|||
30645384|NCT04153929|58657668|FG000|Overall Study|Withdrawal by Subject|3|||
30645385|NCT04153929|58657669|FG001|Overall Study|Withdrawal by Subject|1|||
30645386|NCT04153929|58657670|FG002|Overall Study|Withdrawal by Subject|0|||
30645387|NCT04153929|58657671|FG003|Overall Study|Withdrawal by Subject|3|||
30645388|NCT04153929|58657672|FG004|Overall Study|Withdrawal by Subject|1|||
30645389|NCT04153929|58657673|FG005|Overall Study|Withdrawal by Subject|0|||
30645390|NCT04153929|58657674|FG006|Overall Study|Withdrawal by Subject|1|||
30645391|NCT04153929|58657675|FG007|Overall Study|Withdrawal by Subject|0|||
30645392|NCT04153929|58657668|FG000|Overall Study|Protocol Violation|0|||
30645393|NCT04153929|58657669|FG001|Overall Study|Protocol Violation|0|||
30645394|NCT04153929|58657670|FG002|Overall Study|Protocol Violation|0|||
30645395|NCT04153929|58657671|FG003|Overall Study|Protocol Violation|0|||
30645396|NCT04153929|58657672|FG004|Overall Study|Protocol Violation|0|||
30645397|NCT04153929|58657673|FG005|Overall Study|Protocol Violation|0|||
30645398|NCT04153929|58657674|FG006|Overall Study|Protocol Violation|1|||
30645399|NCT04153929|58657675|FG007|Overall Study|Protocol Violation|2|||
30645400|NCT04153929|58657668|FG000|Overall Study|Adverse Event|3|||
30645401|NCT04153929|58657669|FG001|Overall Study|Adverse Event|5|||
30645402|NCT04153929|58657670|FG002|Overall Study|Adverse Event|5|||
30645403|NCT04153929|58657671|FG003|Overall Study|Adverse Event|11|||
30645404|NCT04153929|58657672|FG004|Overall Study|Adverse Event|15|||
30645405|NCT04153929|58657673|FG005|Overall Study|Adverse Event|4|||
30645406|NCT04153929|58657674|FG006|Overall Study|Adverse Event|8|||
30645407|NCT04153929|58657675|FG007|Overall Study|Adverse Event|2|||
30645408|NCT04153929|58657668|FG000|Overall Study|Not treated|1|||
30645409|NCT04153929|58657669|FG001|Overall Study|Not treated|0|||
30645410|NCT04153929|58657670|FG002|Overall Study|Not treated|0|||
30645411|NCT04153929|58657671|FG003|Overall Study|Not treated|0|||
30645412|NCT04153929|58657672|FG004|Overall Study|Not treated|0|||
30645413|NCT04153929|58657673|FG005|Overall Study|Not treated|0|||
30645414|NCT04153929|58657674|FG006|Overall Study|Not treated|1|||
30645415|NCT04153929|58657675|FG007|Overall Study|Not treated|0|||
30645416|NCT00591214|58657693|FG000|Overall Study|Physician Decision|7|||
30645417|NCT00591214|58657693|FG000|Overall Study|Withdrawal by Subject|1|||
30645418|NCT00725725|58657700|FG000|Overall Study|Adverse Event|1|||
30645419|NCT00725725|58657701|FG001|Overall Study|Adverse Event|3|||
30645420|NCT00725725|58657702|FG002|Overall Study|Adverse Event|2|||
30645421|NCT00725725|58657700|FG000|Overall Study|Lost to Follow-up|2|||
30645422|NCT00725725|58657701|FG001|Overall Study|Lost to Follow-up|0|||
30645423|NCT00725725|58657702|FG002|Overall Study|Lost to Follow-up|2|||
30645424|NCT00725725|58657700|FG000|Overall Study|Withdrawal by Subject|1|||
30645425|NCT00725725|58657701|FG001|Overall Study|Withdrawal by Subject|0|||
30645426|NCT00725725|58657702|FG002|Overall Study|Withdrawal by Subject|1|||
30645427|NCT00725725|58657700|FG000|Overall Study|Protocol Violation|0|||
30645428|NCT00725725|58657701|FG001|Overall Study|Protocol Violation|1|||
30645429|NCT00725725|58657702|FG002|Overall Study|Protocol Violation|0|||
30645430|NCT00725101|58657710|FG000|Overall Study|Death|3|||
30645431|NCT00725101|58657710|FG000|Overall Study|Lost to Follow-up|353|||
30645432|NCT00725101|58657710|FG000|Overall Study|Protocol Violation|1|||
30645433|NCT00725101|58657710|FG000|Overall Study|Withdrawal by Subject|127|||
30645434|NCT00725101|58657710|FG000|Overall Study|not specified/no reason given|11|||
30645435|NCT00585169|58657714|FG000|Overall Study|Withdrawal by Subject|1|||
30645436|NCT00807742|58657722|FG000|Overall Study|Death|9|||
30645437|NCT00807742|58657723|FG001|Overall Study|Death|2|||
30645438|NCT00807742|58657722|FG000|Overall Study|Withdrawal by Subject|2|||
30645439|NCT00807742|58657723|FG001|Overall Study|Withdrawal by Subject|1|||
30645440|NCT00807742|58657722|FG000|Overall Study|Lost to Follow-up|35|||
30645441|NCT00807742|58657723|FG001|Overall Study|Lost to Follow-up|51|||
30645442|NCT00724945|58657729|FG000|Period 1|non-compliance|1|||
30645443|NCT00724945|58657730|FG001|Period 1|non-compliance|0|||
30645444|NCT00724945|58657729|FG000|Period 1|Adverse Event|1|||
30645445|NCT00724945|58657730|FG001|Period 1|Adverse Event|1|||
30645446|NCT00724945|58657729|FG000|Period 1|Lost to Follow-up|1|||
30645447|NCT00724945|58657730|FG001|Period 1|Lost to Follow-up|0|||
30645448|NCT00724945|58657729|FG000|Period 2|lens comfort issue|3|||
30645449|NCT00724945|58657730|FG001|Period 2|lens comfort issue|0|||
30645450|NCT00724945|58657729|FG000|Period 2|lens physiology issue|1|||
30645451|NCT00724945|58657730|FG001|Period 2|lens physiology issue|0|||
30645452|NCT00803452|58657738|FG000|Overall Study|Adverse Event|0|||
30645453|NCT00803452|58657739|FG001|Overall Study|Adverse Event|2|||
30645454|NCT00803452|58657738|FG000|Overall Study|Lost to Follow-up|0|||
30645455|NCT00803452|58657739|FG001|Overall Study|Lost to Follow-up|3|||
30645456|NCT00589108|58657748|FG000|Overall Study|Lost to Follow-up|1|||
30645457|NCT00589108|58657749|FG001|Overall Study|Lost to Follow-up|1|||
30645458|NCT00589108|58657750|FG002|Overall Study|Lost to Follow-up|1|||
30645459|NCT00589108|58657748|FG000|Overall Study|Death|3|||
30645460|NCT00589108|58657749|FG001|Overall Study|Death|3|||
30645461|NCT00589108|58657750|FG002|Overall Study|Death|4|||
30645462|NCT00717067|58657763|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
30645463|NCT00717067|58657764|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
30645464|NCT00717067|58657765|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
30645465|NCT00717067|58657766|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
30645466|NCT00717067|58657767|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
30645467|NCT00802438|58657789|FG000|Overall Study|Screen Failure|20|||
30645468|NCT00802438|58657789|FG000|Overall Study|Withdrawal by Subject|7|||
30645469|NCT00802438|58657789|FG000|Overall Study|Physician Decision|1|||
30645470|NCT00588952|58657799|FG000|Overall Study|Adverse Event|0|||
30645471|NCT00588952|58657800|FG001|Overall Study|Adverse Event|2|||
30645472|NCT00588952|58657799|FG000|Overall Study|Withdrawal by Subject|3|||
30645473|NCT00588952|58657800|FG001|Overall Study|Withdrawal by Subject|5|||
30645474|NCT01021748|58657815|FG000|Overall Study|Adverse Event|2|||
30645475|NCT01021748|58657816|FG001|Overall Study|Adverse Event|1|||
30645476|NCT01021748|58657817|FG002|Overall Study|Adverse Event|2|||
30645477|NCT01021748|58657818|FG003|Overall Study|Adverse Event|0|||
30645478|NCT01021748|58657819|FG004|Overall Study|Adverse Event|2|||
30645479|NCT01021748|58657820|FG005|Overall Study|Adverse Event|0|||
30645480|NCT01021748|58657821|FG006|Overall Study|Adverse Event|1|||
30645481|NCT01021748|58657822|FG007|Overall Study|Adverse Event|0|||
30645482|NCT01021748|58657823|FG008|Overall Study|Adverse Event|7|||
30645483|NCT01021748|58657815|FG000|Overall Study|Physician Decision|1|||
30645484|NCT01021748|58657816|FG001|Overall Study|Physician Decision|0|||
30645485|NCT01021748|58657817|FG002|Overall Study|Physician Decision|1|||
30645486|NCT01021748|58657818|FG003|Overall Study|Physician Decision|1|||
30645487|NCT01021748|58657819|FG004|Overall Study|Physician Decision|0|||
30645488|NCT01021748|58657820|FG005|Overall Study|Physician Decision|0|||
30645489|NCT01021748|58657821|FG006|Overall Study|Physician Decision|1|||
30645490|NCT01021748|58657822|FG007|Overall Study|Physician Decision|1|||
30645491|NCT01021748|58657823|FG008|Overall Study|Physician Decision|2|||
30645492|NCT01021748|58657815|FG000|Overall Study|Progressive Disease|3|||
30645493|NCT01021748|58657816|FG001|Overall Study|Progressive Disease|3|||
30645494|NCT01021748|58657817|FG002|Overall Study|Progressive Disease|4|||
30645495|NCT01021748|58657818|FG003|Overall Study|Progressive Disease|6|||
30645496|NCT01021748|58657819|FG004|Overall Study|Progressive Disease|7|||
30645497|NCT01021748|58657820|FG005|Overall Study|Progressive Disease|3|||
30645498|NCT01021748|58657821|FG006|Overall Study|Progressive Disease|0|||
30766341|NCT03271528|58774972|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
30766342|NCT03271528|58774973|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
30766343|NCT03271528|58774972|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
30766344|NCT03271528|58774973|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
30766345|NCT03271528|58774972|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
30645499|NCT01021748|58657822|FG007|Overall Study|Progressive Disease|5|||
30645500|NCT01021748|58657823|FG008|Overall Study|Progressive Disease|6|||
30645501|NCT01021748|58657815|FG000|Overall Study|Withdrawal by Subject|0|||
30645502|NCT01021748|58657816|FG001|Overall Study|Withdrawal by Subject|0|||
30645503|NCT01021748|58657817|FG002|Overall Study|Withdrawal by Subject|0|||
30645504|NCT01021748|58657818|FG003|Overall Study|Withdrawal by Subject|0|||
30645505|NCT01021748|58657819|FG004|Overall Study|Withdrawal by Subject|0|||
30645506|NCT01021748|58657820|FG005|Overall Study|Withdrawal by Subject|0|||
30645507|NCT01021748|58657821|FG006|Overall Study|Withdrawal by Subject|1|||
30645508|NCT01021748|58657822|FG007|Overall Study|Withdrawal by Subject|0|||
30645509|NCT01021748|58657823|FG008|Overall Study|Withdrawal by Subject|1|||
30645510|NCT01021748|58657815|FG000|Overall Study|Not Treated|0|||
30645511|NCT01021748|58657816|FG001|Overall Study|Not Treated|1|||
30645512|NCT01021748|58657817|FG002|Overall Study|Not Treated|0|||
30645513|NCT01021748|58657818|FG003|Overall Study|Not Treated|0|||
30645514|NCT01021748|58657819|FG004|Overall Study|Not Treated|0|||
30645515|NCT01021748|58657820|FG005|Overall Study|Not Treated|0|||
30645516|NCT01021748|58657821|FG006|Overall Study|Not Treated|0|||
30645517|NCT01021748|58657822|FG007|Overall Study|Not Treated|0|||
30645518|NCT01021748|58657823|FG008|Overall Study|Not Treated|0|||
30645519|NCT00802360|58657847|FG000|Overall Study|Stimulation failure|4|||
30645520|NCT00802360|58657848|FG001|Overall Study|Stimulation failure|0|||
30645521|NCT00802360|58657849|FG002|Overall Study|Stimulation failure|3|||
30645522|NCT00802360|58657850|FG003|Overall Study|Stimulation failure|3|||
30645523|NCT00802360|58657847|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
30645524|NCT00802360|58657848|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
30645525|NCT00802360|58657849|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
30645526|NCT00802360|58657850|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
30645527|NCT00802360|58657847|FG000|Overall Study|Cycle cancelled|0|||
30645528|NCT00802360|58657848|FG001|Overall Study|Cycle cancelled|1|||
30645529|NCT00802360|58657849|FG002|Overall Study|Cycle cancelled|1|||
30645530|NCT00802360|58657850|FG003|Overall Study|Cycle cancelled|1|||
30645531|NCT00802360|58657847|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
30645532|NCT00802360|58657848|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
30645533|NCT00802360|58657849|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
30645534|NCT00802360|58657850|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
30645535|NCT00802360|58657847|FG000|Overall Study|No positive serum pregnancy|17|||
30645536|NCT00802360|58657848|FG001|Overall Study|No positive serum pregnancy|20|||
30645537|NCT00802360|58657849|FG002|Overall Study|No positive serum pregnancy|14|||
30645538|NCT00802360|58657850|FG003|Overall Study|No positive serum pregnancy|10|||
30645539|NCT00802360|58657847|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
30645540|NCT00802360|58657848|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
30645541|NCT00802360|58657849|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
30645542|NCT00802360|58657850|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
30645543|NCT00802360|58657847|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
30645544|NCT00802360|58657848|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
30645545|NCT00802360|58657849|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
30645546|NCT00802360|58657850|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
30645547|NCT00802360|58657847|FG000|Overall Study|Other|2|||
30645548|NCT00802360|58657848|FG001|Overall Study|Other|3|||
30645549|NCT00802360|58657849|FG002|Overall Study|Other|6|||
30645550|NCT00802360|58657850|FG003|Overall Study|Other|3|||
30766346|NCT03271528|58774973|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
30645551|NCT01026038|58657865|FG000|Overall Study|Lost to Follow-up|1|||
30645552|NCT01026038|58657866|FG001|Overall Study|Lost to Follow-up|1|||
30645553|NCT01026038|58657867|FG002|Overall Study|Lost to Follow-up|0|||
30848593|NCT04604795|58874763|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
30645554|NCT00801892|58657886|FG000|Main Study Period|Withdrawal by Subject|0|||
30645555|NCT00801892|58657887|FG001|Main Study Period|Withdrawal by Subject|1|||
30645556|NCT00801892|58657886|FG000|Sham Crossover Period|Lost to Follow-up|0|||
30645557|NCT00801892|58657887|FG001|Sham Crossover Period|Lost to Follow-up|2|||
30645558|NCT02680587|58657901|FG000|Overall Study|Withdrawal by Subject|1|||
30645559|NCT02680587|58657902|FG001|Overall Study|Withdrawal by Subject|0|||
30645560|NCT00589420|58657912|FG000|Overall Study|screen failure|1|||
30645561|NCT01025336|58657921|FG000|Overall Study|Protocol Violation|0|||
30645562|NCT01025336|58657922|FG001|Overall Study|Protocol Violation|0|||
30645563|NCT01025336|58657923|FG002|Overall Study|Protocol Violation|0|||
30645564|NCT01025336|58657924|FG003|Overall Study|Protocol Violation|2|||
30645565|NCT01025336|58657925|FG004|Overall Study|Protocol Violation|0|||
30645566|NCT00796978|58657959|FG000|Overall Study|Cardiac adverse event|5|||
30645567|NCT00796978|58657959|FG000|Overall Study|Adverse Event|4|||
30645568|NCT00796978|58657959|FG000|Overall Study|Withdrawal by Subject|3|||
30645569|NCT00796822|58657965|FG000|Overall Study|Lost to Follow-up|2|||
30645570|NCT00796822|58657966|FG001|Overall Study|Lost to Follow-up|0|||
30645571|NCT00796822|58657965|FG000|Overall Study|Adverse Event|1|||
30645572|NCT00796822|58657966|FG001|Overall Study|Adverse Event|0|||
30645573|NCT01020812|58657972|FG000|Overall Study|Physician Decision|1|||
30645574|NCT01020812|58657972|FG000|Overall Study|Withdrawal by Subject|1|||
30645575|NCT01020812|58657972|FG000|Overall Study|Protocol Violation|1|||
30645576|NCT01032044|58657978|FG000|Overall Study|Protocol Violation|14|||
30645577|NCT01032044|58657979|FG001|Overall Study|Protocol Violation|8|||
30645578|NCT01032044|58657978|FG000|Overall Study|Adverse Event|0|||
30645579|NCT01032044|58657979|FG001|Overall Study|Adverse Event|1|||
30645580|NCT01032044|58657978|FG000|Overall Study|Lost to Follow-up|11|||
30645581|NCT01032044|58657979|FG001|Overall Study|Lost to Follow-up|11|||
30645582|NCT01024946|58657985|FG000|Overall Study|Screen Failure|3|||
30645583|NCT01024946|58657985|FG000|Overall Study|Withdrawal by Subject|1|||
30645584|NCT01024946|58657985|FG000|Overall Study|Adverse Event|1|||
30645585|NCT00724867|58657989|FG000|Overall Study|Adverse Event|25|||
30645586|NCT00724867|58657989|FG000|Overall Study|Lack of Efficacy|14|||
30645587|NCT00724867|58657989|FG000|Overall Study|Lost to Follow-up|12|||
30645588|NCT00724867|58657989|FG000|Overall Study|Non-compliance with study drug|6|||
30645589|NCT00724867|58657989|FG000|Overall Study|Physician Decision|17|||
30645590|NCT00724867|58657989|FG000|Overall Study|Protocol Violation|1|||
30645591|NCT00724867|58657989|FG000|Overall Study|Withdrawal by Subject|31|||
30645592|NCT00724867|58657989|FG000|Overall Study|Sponsor decision to end study|14|||
30645593|NCT00724867|58657989|FG000|Overall Study|Subject incarcerated|1|||
30645594|NCT00724867|58657989|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
30645595|NCT00724867|58657989|FG000|Overall Study|Subject moved out of state|1|||
30645596|NCT00724867|58657989|FG000|Overall Study|Elected to exit due to site closure|2|||
30645597|NCT00724711|58657998|FG000|Overall Study|Adverse Event|7|||
30645598|NCT00724711|58657999|FG001|Overall Study|Adverse Event|3|||
30645599|NCT00724711|58657998|FG000|Overall Study|Pregnancy|0|||
30645600|NCT00724711|58657999|FG001|Overall Study|Pregnancy|1|||
30645601|NCT00724711|58657998|FG000|Overall Study|Lack of Efficacy|0|||
30645602|NCT00724711|58657999|FG001|Overall Study|Lack of Efficacy|1|||
30645603|NCT00724711|58657998|FG000|Overall Study|Physician Decision|0|||
30645604|NCT00724711|58657999|FG001|Overall Study|Physician Decision|3|||
30645605|NCT00724711|58657998|FG000|Overall Study|Withdrawal by Subject|5|||
30645606|NCT00724711|58657999|FG001|Overall Study|Withdrawal by Subject|4|||
30645607|NCT00724711|58657998|FG000|Overall Study|Lost to Follow-up|4|||
30645608|NCT00724711|58657999|FG001|Overall Study|Lost to Follow-up|5|||
30645609|NCT00724711|58657998|FG000|Overall Study|Protocol Violation|1|||
30645610|NCT00724711|58657999|FG001|Overall Study|Protocol Violation|0|||
30645611|NCT01024244|58658010|FG000|Overall Study|Adverse Event|1|||
30645612|NCT01024244|58658011|FG001|Overall Study|Adverse Event|2|||
30645613|NCT01024244|58658012|FG002|Overall Study|Adverse Event|0|||
30645614|NCT01024244|58658013|FG003|Overall Study|Adverse Event|1|||
30645615|NCT01024244|58658014|FG004|Overall Study|Adverse Event|2|||
30645616|NCT01024244|58658010|FG000|Overall Study|Entry Criteria Not Met|0|||
30645617|NCT01024244|58658011|FG001|Overall Study|Entry Criteria Not Met|1|||
30645618|NCT01024244|58658012|FG002|Overall Study|Entry Criteria Not Met|0|||
30645619|NCT01024244|58658013|FG003|Overall Study|Entry Criteria Not Met|0|||
30645620|NCT01024244|58658014|FG004|Overall Study|Entry Criteria Not Met|0|||
30645621|NCT01024244|58658010|FG000|Overall Study|Lack of Efficacy|1|||
30645622|NCT01024244|58658011|FG001|Overall Study|Lack of Efficacy|0|||
30645623|NCT01024244|58658012|FG002|Overall Study|Lack of Efficacy|0|||
30645624|NCT01024244|58658013|FG003|Overall Study|Lack of Efficacy|0|||
30645625|NCT01024244|58658014|FG004|Overall Study|Lack of Efficacy|0|||
30645626|NCT01024244|58658010|FG000|Overall Study|Protocol Violation|1|||
30645627|NCT01024244|58658011|FG001|Overall Study|Protocol Violation|0|||
30645628|NCT01024244|58658012|FG002|Overall Study|Protocol Violation|0|||
30645629|NCT01024244|58658013|FG003|Overall Study|Protocol Violation|0|||
30645630|NCT01024244|58658014|FG004|Overall Study|Protocol Violation|2|||
30645631|NCT01024244|58658010|FG000|Overall Study|Sponsor Decision|14|||
30645632|NCT01024244|58658011|FG001|Overall Study|Sponsor Decision|7|||
30645633|NCT01024244|58658012|FG002|Overall Study|Sponsor Decision|14|||
30645634|NCT01024244|58658013|FG003|Overall Study|Sponsor Decision|12|||
30645635|NCT01024244|58658014|FG004|Overall Study|Sponsor Decision|10|||
30645636|NCT01024244|58658010|FG000|Overall Study|Withdrawal by Subject|0|||
30645637|NCT01024244|58658011|FG001|Overall Study|Withdrawal by Subject|1|||
30645638|NCT01024244|58658012|FG002|Overall Study|Withdrawal by Subject|0|||
30645639|NCT01024244|58658013|FG003|Overall Study|Withdrawal by Subject|0|||
30645640|NCT01024244|58658014|FG004|Overall Study|Withdrawal by Subject|0|||
30645641|NCT00721279|58658028|FG000|Overall Study|Lack of Efficacy|6|||
30645642|NCT00721279|58658029|FG001|Overall Study|Lack of Efficacy|3|||
30645643|NCT00721279|58658028|FG000|Overall Study|Tolerability insufficient|5|||
30645644|NCT00721279|58658029|FG001|Overall Study|Tolerability insufficient|2|||
30645645|NCT00721279|58658028|FG000|Overall Study|Withdrawal by Subject|13|||
30645646|NCT00721279|58658029|FG001|Overall Study|Withdrawal by Subject|3|||
30645647|NCT00721279|58658028|FG000|Overall Study|Other|12|||
30645648|NCT00721279|58658029|FG001|Overall Study|Other|16|||
30645649|NCT01030952|58658038|FG000|Overall Study|Protocol Violation|0|||
30645650|NCT01030952|58658039|FG001|Overall Study|Protocol Violation|1|||
30645651|NCT01030952|58658038|FG000|Overall Study|Informed consent withdrawal|1|||
30645652|NCT01030952|58658039|FG001|Overall Study|Informed consent withdrawal|0|||
30645653|NCT01030952|58658038|FG000|Overall Study|Lost to Follow-up|0|||
30645654|NCT01030952|58658039|FG001|Overall Study|Lost to Follow-up|1|||
30645655|NCT01030952|58658038|FG000|Overall Study|Unexplained|1|||
30645656|NCT01030952|58658039|FG001|Overall Study|Unexplained|1|||
30645657|NCT01030874|58658049|FG000|Overall Study|Withdrawal by Subject|1|||
30645658|NCT01030874|58658050|FG001|Overall Study|Withdrawal by Subject|0|||
30645659|NCT01030874|58658049|FG000|Overall Study|Discharged in first 2 weeks|17|||
30645660|NCT01030874|58658050|FG001|Overall Study|Discharged in first 2 weeks|16|||
30645661|NCT03611751|58658059|FG000|Pre-treatment|Randomized but not treated|1|||
30645662|NCT03611751|58658060|FG001|Pre-treatment|Randomized but not treated|1|||
30645663|NCT03611751|58658061|FG002|Pre-treatment|Randomized but not treated|0|||
30645664|NCT03611751|58658059|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
30766347|NCT03271528|58774972|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
30766348|NCT03271528|58774973|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
30645665|NCT03611751|58658060|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
30645666|NCT03611751|58658061|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
30645667|NCT03611751|58658059|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
30645668|NCT03611751|58658060|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
30645669|NCT03611751|58658061|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
30645670|NCT03611751|58658059|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
30645671|NCT03611751|58658060|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
30645672|NCT03611751|58658061|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
30645673|NCT03611751|58658059|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
30645674|NCT03611751|58658060|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
30645675|NCT03611751|58658061|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
30645676|NCT03611751|58658059|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
30645677|NCT03611751|58658060|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
30645678|NCT03611751|58658061|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
30645679|NCT03611751|58658059|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
30645680|NCT03611751|58658060|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
30645681|NCT03611751|58658061|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
30645682|NCT03611751|58658059|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
30645683|NCT03611751|58658060|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
30645684|NCT03611751|58658061|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
30645685|NCT03611751|58658059|FG000|Treatment Week 0 - Week 16|Death|0|||
30645686|NCT03611751|58658060|FG001|Treatment Week 0 - Week 16|Death|0|||
30645687|NCT03611751|58658061|FG002|Treatment Week 0 - Week 16|Death|1|||
30645688|NCT03611751|58658059|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
30645689|NCT03611751|58658060|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
30645690|NCT03611751|58658061|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
30645691|NCT03611751|58658059|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
30645692|NCT03611751|58658060|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
30645693|NCT03611751|58658061|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
30645694|NCT03611751|58658059|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
30645695|NCT03611751|58658060|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
30645696|NCT03611751|58658061|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
30645697|NCT03611751|58658059|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
30766349|NCT03301714|58774982|FG000|Overall Study|Lost to Follow-up|10|||
30766350|NCT03301714|58774983|FG001|Overall Study|Lost to Follow-up|4|||
30766351|NCT03301714|58774984|FG002|Overall Study|Lost to Follow-up|4|||
30766352|NCT03301714|58774982|FG000|Overall Study|Did not receive allocated intervention|0|||
30645698|NCT03611751|58658060|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
30645699|NCT03611751|58658061|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
30645700|NCT03611751|58658059|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
30951904|NCT01709318|58999314|FG004|Overall Study|Withdrawal by Subject|0|||
30645701|NCT03611751|58658060|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
30645702|NCT03611751|58658061|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
30645703|NCT03611751|58658059|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
30645704|NCT03611751|58658060|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
30645705|NCT03611751|58658061|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
30645706|NCT03611751|58658059|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
30645707|NCT03611751|58658060|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
30645708|NCT03611751|58658061|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
30645709|NCT03611751|58658059|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
30645710|NCT03611751|58658060|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
30645711|NCT03611751|58658061|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
30645712|NCT03611751|58658059|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
30645713|NCT03611751|58658060|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
30645714|NCT03611751|58658061|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
30645715|NCT03611751|58658059|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
30645716|NCT03611751|58658060|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
30645717|NCT03611751|58658061|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
30645718|NCT03611751|58658059|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
30645719|NCT03611751|58658060|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
30766353|NCT03301714|58774983|FG001|Overall Study|Did not receive allocated intervention|2|||
30766354|NCT03301714|58774984|FG002|Overall Study|Did not receive allocated intervention|3|||
30766355|NCT03299686|58774997|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
30766356|NCT03299686|58774998|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
30645720|NCT03611751|58658061|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
30645721|NCT03611751|58658059|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
30645722|NCT03611751|58658060|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
30645723|NCT03611751|58658061|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
30645724|NCT03611751|58658059|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
30645725|NCT03611751|58658060|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
30645726|NCT03611751|58658061|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
30645727|NCT03611751|58658059|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
30645728|NCT03611751|58658060|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
30766357|NCT03299686|58774997|FG000|Treatment Epoch|Physician Decision|1|||
30766358|NCT03299686|58774998|FG001|Treatment Epoch|Physician Decision|0|||
30766359|NCT03299686|58774997|FG000|Treatment Epoch|Adverse Event|8|||
30766360|NCT03299686|58774998|FG001|Treatment Epoch|Adverse Event|4|||
30766361|NCT03299686|58774997|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
30766362|NCT03299686|58774998|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
30766363|NCT03462758|58775006|FG000|Overall Study|Chose no or other method of contraception|20|||
30766364|NCT03462758|58775007|FG001|Overall Study|Chose no or other method of contraception|23|||
30766365|NCT03462758|58775006|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
30766366|NCT03462758|58775007|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
30766367|NCT03462758|58775006|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
30766368|NCT03462758|58775007|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
30766369|NCT03462758|58775006|FG000|Overall Study|Medical contraindication|2|||
30766370|NCT03462758|58775007|FG001|Overall Study|Medical contraindication|2|||
30766371|NCT03462758|58775006|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
30766372|NCT03462758|58775007|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
30766373|NCT00075270|58775015|FG000|Overall Study|Withdrawal by Subject|28|||
30766374|NCT00075270|58775016|FG001|Overall Study|Withdrawal by Subject|21|||
30766375|NCT00075270|58775015|FG000|Overall Study|Lost to Follow-up|25|||
30766376|NCT00075270|58775016|FG001|Overall Study|Lost to Follow-up|28|||
30766377|NCT00075270|58775015|FG000|Overall Study|Protocol Violation|0|||
30766378|NCT00075270|58775016|FG001|Overall Study|Protocol Violation|2|||
30766379|NCT00075270|58775015|FG000|Overall Study|Death|198|||
30766380|NCT00075270|58775016|FG001|Overall Study|Death|215|||
30766381|NCT00075270|58775015|FG000|Overall Study|Other/Unknown|9|||
30766382|NCT00075270|58775016|FG001|Overall Study|Other/Unknown|5|||
30766383|NCT00075270|58775015|FG000|Overall Study|Missing|26|||
30766384|NCT00075270|58775016|FG001|Overall Study|Missing|13|||
30766385|NCT00074958|58775023|FG000|Overall Study|Adverse Event|1|||
30766386|NCT03298984|58775031|FG000|Overall Study|Physician Decision|1|||
30766387|NCT03298984|58775032|FG001|Overall Study|Physician Decision|0|||
30766388|NCT03298984|58775033|FG002|Overall Study|Physician Decision|0|||
30766389|NCT03298984|58775034|FG003|Overall Study|Physician Decision|6|||
30766390|NCT03298984|58775031|FG000|Overall Study|Lack of Efficacy|0|||
30766391|NCT03298984|58775032|FG001|Overall Study|Lack of Efficacy|1|||
30766392|NCT03298984|58775033|FG002|Overall Study|Lack of Efficacy|1|||
30766393|NCT03298984|58775034|FG003|Overall Study|Lack of Efficacy|4|||
30766394|NCT03298984|58775031|FG000|Overall Study|Relapsed disease (following remission)|0|||
30766395|NCT03298984|58775032|FG001|Overall Study|Relapsed disease (following remission)|0|||
30645729|NCT03611751|58658061|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
30645730|NCT00721123|58658078|FG000|Overall Study|Adverse Event|96|||
30645731|NCT00721123|58658078|FG000|Overall Study|Death|10|||
30766396|NCT03298984|58775033|FG002|Overall Study|Relapsed disease (following remission)|1|||
30766397|NCT03298984|58775034|FG003|Overall Study|Relapsed disease (following remission)|1|||
30766398|NCT03298984|58775031|FG000|Overall Study|Adverse Event|0|||
30951905|NCT01709318|58999315|FG005|Overall Study|Withdrawal by Subject|2|||
30766399|NCT03298984|58775032|FG001|Overall Study|Adverse Event|0|||
30766400|NCT03298984|58775033|FG002|Overall Study|Adverse Event|0|||
30766401|NCT03298984|58775034|FG003|Overall Study|Adverse Event|1|||
30645732|NCT00721123|58658078|FG000|Overall Study|Insufficient Therapeutic Response|21|||
30645733|NCT00721123|58658078|FG000|Overall Study|Protocol Violation|1|||
30645734|NCT00721123|58658078|FG000|Overall Study|Refused Treatment|41|||
30645735|NCT00721123|58658078|FG000|Overall Study|Failure to Return|9|||
30645736|NCT00721123|58658078|FG000|Overall Study|Withdrawal by Subject|5|||
30645737|NCT00720499|58658098|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
30645738|NCT00720499|58658099|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
30645739|NCT00720499|58658098|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
30645740|NCT00720499|58658099|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
30645741|NCT00720499|58658098|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
30645742|NCT00720499|58658099|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
30645743|NCT00724243|58658106|FG000|Overall Study|Lack of Efficacy|10|||
30645744|NCT00724243|58658106|FG000|Overall Study|Adverse Event|5|||
30645745|NCT00720343|58658110|FG000|Overall Study|Physician Decision|3|||
30645746|NCT00720343|58658110|FG000|Overall Study|No data|3|||
30645747|NCT00720109|58658116|FG000|Induction Period|Did not meet eligibility criteria|3|||
30645748|NCT00720109|58658117|FG001|Induction Period|Did not meet eligibility criteria|0|||
30645749|NCT00720109|58658118|FG002|Induction Period|Did not meet eligibility criteria|0|||
30645750|NCT00720109|58658116|FG000|Induction Period|Bone Marrow Transplant|2|||
30645751|NCT00720109|58658117|FG001|Induction Period|Bone Marrow Transplant|0|||
30645752|NCT00720109|58658118|FG002|Induction Period|Bone Marrow Transplant|0|||
30645753|NCT00720109|58658116|FG000|Induction Period|Physician Decision|1|||
30645754|NCT00720109|58658117|FG001|Induction Period|Physician Decision|0|||
30645755|NCT00720109|58658118|FG002|Induction Period|Physician Decision|0|||
30645756|NCT00720109|58658116|FG000|Risk Stratification Period|Adverse Event|0|||
30645757|NCT00720109|58658117|FG001|Risk Stratification Period|Adverse Event|1|||
30645758|NCT00720109|58658118|FG002|Risk Stratification Period|Adverse Event|0|||
30645759|NCT00720109|58658116|FG000|Risk Stratification Period|Physician Decision|0|||
30645760|NCT00720109|58658117|FG001|Risk Stratification Period|Physician Decision|2|||
30645761|NCT00720109|58658118|FG002|Risk Stratification Period|Physician Decision|1|||
30645762|NCT00720109|58658116|FG000|Risk Stratification Period|Bone marrow transplant|0|||
30645763|NCT00720109|58658117|FG001|Risk Stratification Period|Bone marrow transplant|9|||
30645764|NCT00720109|58658118|FG002|Risk Stratification Period|Bone marrow transplant|7|||
30645765|NCT00720109|58658116|FG000|Risk Stratification Period|Disease progression or relapse|0|||
30645766|NCT00720109|58658117|FG001|Risk Stratification Period|Disease progression or relapse|2|||
30645767|NCT00720109|58658118|FG002|Risk Stratification Period|Disease progression or relapse|0|||
30645768|NCT00720109|58658116|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
30645769|NCT00720109|58658117|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
30645770|NCT00720109|58658118|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
30645785|NCT01015118|58658138|FG000|Overall Study|Protocol Violation|5|||
30645786|NCT01015118|58658139|FG001|Overall Study|Protocol Violation|6|||
30645787|NCT01015118|58658138|FG000|Overall Study|Withdrawal by Subject|103|||
30645788|NCT01015118|58658139|FG001|Overall Study|Withdrawal by Subject|27|||
30645789|NCT01015118|58658138|FG000|Overall Study|Other Adverse Event (AE)|141|||
30766402|NCT03298984|58775031|FG000|Overall Study|Death|0|||
30766403|NCT03298984|58775032|FG001|Overall Study|Death|0|||
30766404|NCT03298984|58775033|FG002|Overall Study|Death|0|||
30645790|NCT01015118|58658139|FG001|Overall Study|Other Adverse Event (AE)|33|||
30645791|NCT01015118|58658138|FG000|Overall Study|Worsening or AE of underlying disease|5|||
30645792|NCT01015118|58658139|FG001|Overall Study|Worsening or AE of underlying disease|4|||
30645793|NCT01015118|58658138|FG000|Overall Study|Progressive disease|364|||
30645794|NCT01015118|58658139|FG001|Overall Study|Progressive disease|229|||
30645795|NCT01015118|58658138|FG000|Overall Study|Not treated|9|||
30645796|NCT01015118|58658139|FG001|Overall Study|Not treated|5|||
30645797|NCT01015118|58658138|FG000|Overall Study|Other than stated above|42|||
30645798|NCT01015118|58658139|FG001|Overall Study|Other than stated above|23|||
30766405|NCT03298984|58775034|FG003|Overall Study|Death|2|||
30645799|NCT00800176|58658151|FG000|Overall Study|Adverse Event|2|||
30766406|NCT03298984|58775031|FG000|Overall Study|Insurance Company Decision|0|||
30766407|NCT03298984|58775032|FG001|Overall Study|Insurance Company Decision|0|||
30766408|NCT03298984|58775033|FG002|Overall Study|Insurance Company Decision|0|||
30766409|NCT03298984|58775034|FG003|Overall Study|Insurance Company Decision|1|||
30766410|NCT02940574|58775047|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
30766411|NCT02940574|58775048|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
30766412|NCT02940574|58775047|FG000|1-year Follow-up|Lost to Follow-up|3|||
30645800|NCT00800176|58658152|FG001|Overall Study|Adverse Event|1|||
30645801|NCT00800176|58658153|FG002|Overall Study|Adverse Event|0|||
30766413|NCT02940574|58775048|FG001|1-year Follow-up|Lost to Follow-up|4|||
30766414|NCT03606512|58775060|FG000|Overall Study|Lost to Follow-up|0|||
30766415|NCT03606512|58775061|FG001|Overall Study|Lost to Follow-up|1|||
30766416|NCT03606512|58775060|FG000|Overall Study|'moved from study area|0|||
30766417|NCT03606512|58775061|FG001|Overall Study|'moved from study area|1|||
30766418|NCT03760250|58775083|FG000|Overall Study|Withdrawal by Subject|1|||
30766419|NCT03760250|58775083|FG000|Overall Study|Physician Decision|1|||
30766420|NCT03757988|58775087|FG000|Overall Study|Withdrawal by Subject|1|||
30766421|NCT00313781|58775094|FG000|Before Crossover|Death|22|||
30766422|NCT00313781|58775095|FG001|Before Crossover|Death|8|||
30951906|NCT01709318|58999316|FG006|Overall Study|Withdrawal by Subject|4|||
30951907|NCT01709318|58999310|FG000|Overall Study|Other Protocol Specified Criteria|0|||
30951908|NCT01709318|58999311|FG001|Overall Study|Other Protocol Specified Criteria|1|||
30951909|NCT01709318|58999312|FG002|Overall Study|Other Protocol Specified Criteria|0|||
30645802|NCT00800176|58658154|FG003|Overall Study|Adverse Event|2|||
30645803|NCT00800176|58658155|FG004|Overall Study|Adverse Event|1|||
30645804|NCT00800176|58658156|FG005|Overall Study|Adverse Event|1|||
30645805|NCT00800176|58658151|FG000|Overall Study|Refused treatment|3|||
30645806|NCT00800176|58658152|FG001|Overall Study|Refused treatment|2|||
30645807|NCT00800176|58658153|FG002|Overall Study|Refused treatment|0|||
30645808|NCT00800176|58658154|FG003|Overall Study|Refused treatment|0|||
30645809|NCT00800176|58658155|FG004|Overall Study|Refused treatment|1|||
30645810|NCT00800176|58658156|FG005|Overall Study|Refused treatment|4|||
30645811|NCT00800176|58658151|FG000|Overall Study|Failure to return|3|||
30645812|NCT00800176|58658152|FG001|Overall Study|Failure to return|3|||
30645813|NCT00800176|58658153|FG002|Overall Study|Failure to return|0|||
30645814|NCT00800176|58658154|FG003|Overall Study|Failure to return|2|||
30645815|NCT00800176|58658155|FG004|Overall Study|Failure to return|0|||
30645816|NCT00800176|58658156|FG005|Overall Study|Failure to return|0|||
30645817|NCT00800176|58658151|FG000|Overall Study|Other|1|||
30645818|NCT00800176|58658152|FG001|Overall Study|Other|0|||
30645819|NCT00800176|58658153|FG002|Overall Study|Other|0|||
30645820|NCT00800176|58658154|FG003|Overall Study|Other|0|||
30645821|NCT00800176|58658155|FG004|Overall Study|Other|2|||
30645822|NCT00800176|58658156|FG005|Overall Study|Other|0|||
30645823|NCT00715429|58658172|FG000|Overall Study|Did not complete the study diary|0|||
30645824|NCT00715429|58658173|FG001|Overall Study|Did not complete the study diary|1|||
30645825|NCT00715117|58658195|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
30645826|NCT00715117|58658196|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
30645827|NCT00723229|58658209|FG000|First Intervention|Lost to Follow-up|7|||
30645828|NCT00723229|58658210|FG001|First Intervention|Lost to Follow-up|3|||
30951910|NCT01709318|58999313|FG003|Overall Study|Other Protocol Specified Criteria|0|||
30951911|NCT01709318|58999314|FG004|Overall Study|Other Protocol Specified Criteria|0|||
30951912|NCT01709318|58999315|FG005|Overall Study|Other Protocol Specified Criteria|0|||
30951913|NCT01709318|58999316|FG006|Overall Study|Other Protocol Specified Criteria|0|||
30951914|NCT01699178|58999334|FG000|Overall Study|Adverse Event|1|||
30951915|NCT01699178|58999335|FG001|Overall Study|Adverse Event|5|||
30951916|NCT01699178|58999334|FG000|Overall Study|Lost to Follow-up|1|||
30951917|NCT01699178|58999335|FG001|Overall Study|Lost to Follow-up|6|||
30951918|NCT01699178|58999334|FG000|Overall Study|Non-compliance with Study Drug|3|||
30951919|NCT01699178|58999335|FG001|Overall Study|Non-compliance with Study Drug|1|||
30951920|NCT01699178|58999334|FG000|Overall Study|Physician Decision|1|||
30951921|NCT01699178|58999335|FG001|Overall Study|Physician Decision|0|||
30951922|NCT01699178|58999334|FG000|Overall Study|Withdrawal by Subject|4|||
30951923|NCT01699178|58999335|FG001|Overall Study|Withdrawal by Subject|12|||
30951924|NCT01699178|58999334|FG000|Overall Study|Hematocrit >54%|1|||
30645829|NCT01030718|58658225|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
30645830|NCT01030718|58658226|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
30645831|NCT01030718|58658227|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
30645832|NCT01030718|58658225|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
30766423|NCT00313781|58775096|FG002|Before Crossover|Death|0|||
30766424|NCT00313781|58775094|FG000|Before Crossover|Lost to Follow-up|0|||
30766425|NCT00313781|58775095|FG001|Before Crossover|Lost to Follow-up|3|||
30951925|NCT01699178|58999335|FG001|Overall Study|Hematocrit >54%|1|||
30951926|NCT01699178|58999334|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
30951927|NCT01699178|58999335|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
30645833|NCT01030718|58658226|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
30645834|NCT01030718|58658227|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
30645835|NCT01030718|58658225|FG000|Studies CA180-031 and -036 Combined|Death|0|||
30645836|NCT01030718|58658226|FG001|Studies CA180-031 and -036 Combined|Death|1|||
30645837|NCT01030718|58658227|FG002|Studies CA180-031 and -036 Combined|Death|0|||
30645838|NCT01030718|58658225|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
30645839|NCT01030718|58658226|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
30645840|NCT01030718|58658227|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
30645841|NCT01030718|58658225|FG000|Study CA180-036 Only|insufficient effect|1|||
30645842|NCT01030718|58658226|FG001|Study CA180-036 Only|insufficient effect|1|||
30645843|NCT01030718|58658227|FG002|Study CA180-036 Only|insufficient effect|5|||
30645844|NCT01030718|58658225|FG000|Study CA180-036 Only|Adverse Event|2|||
30645845|NCT01030718|58658226|FG001|Study CA180-036 Only|Adverse Event|3|||
30645846|NCT01030718|58658227|FG002|Study CA180-036 Only|Adverse Event|0|||
30645847|NCT01030718|58658225|FG000|Study CA180-036 Only|Death|0|||
30645848|NCT01030718|58658226|FG001|Study CA180-036 Only|Death|1|||
30645849|NCT01030718|58658227|FG002|Study CA180-036 Only|Death|0|||
30645850|NCT01030718|58658225|FG000|Study CA180-036 Only|Other Reasons|0|||
30645851|NCT01030718|58658226|FG001|Study CA180-036 Only|Other Reasons|2|||
30645852|NCT01030718|58658227|FG002|Study CA180-036 Only|Other Reasons|0|||
30645853|NCT00722761|58658247|FG000|Overall Study|Lost to Follow-up|1|||
30645854|NCT00722761|58658248|FG001|Overall Study|Lost to Follow-up|4|||
30645855|NCT00722761|58658247|FG000|Overall Study|Withdrawal by Subject|5|||
30645856|NCT00722761|58658248|FG001|Overall Study|Withdrawal by Subject|2|||
30645857|NCT00719953|58658254|FG000|Overall Study|Adverse Event|4|||
30645858|NCT01019486|58658261|FG000|Overall Study|Withdrawal by Subject|1|||
30645859|NCT01019486|58658262|FG001|Overall Study|Withdrawal by Subject|1|||
30645860|NCT01019486|58658263|FG002|Overall Study|Withdrawal by Subject|1|||
30645861|NCT00714493|58658272|FG000|Overall Study|Adverse Event|11|||
30645862|NCT00714493|58658272|FG000|Overall Study|Death|3|||
30645863|NCT00714493|58658272|FG000|Overall Study|Lack of Efficacy|10|||
30645864|NCT00714493|58658272|FG000|Overall Study|Lost to Follow-up|3|||
30645865|NCT00714493|58658272|FG000|Overall Study|Protocol Violation|12|||
30645866|NCT00714493|58658272|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
30645867|NCT00714493|58658272|FG000|Overall Study|OTHER|2|||
30645868|NCT01019252|58658278|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
30645869|NCT01019252|58658279|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
30645870|NCT01019252|58658278|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
30645871|NCT01019252|58658279|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
30645872|NCT01019252|58658278|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
30645873|NCT01019252|58658279|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
30645874|NCT01019252|58658278|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
30645875|NCT01019252|58658279|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
30645876|NCT01013870|58658287|FG000|Overall Study|Lost to Follow-up|1|||
30645877|NCT01013870|58658288|FG001|Overall Study|Lost to Follow-up|3|||
30645878|NCT01013792|58658296|FG000|Overall Study|Study suspended|2|||
30645879|NCT01013792|58658297|FG001|Overall Study|Study suspended|1|||
30645880|NCT01013792|58658296|FG000|Overall Study|Adverse Event|0|||
30645881|NCT01013792|58658297|FG001|Overall Study|Adverse Event|3|||
30645882|NCT01013792|58658296|FG000|Overall Study|Lost to Follow-up|0|||
30645883|NCT01013792|58658297|FG001|Overall Study|Lost to Follow-up|1|||
30645884|NCT01018862|58658306|FG000|Overall Study|Adverse Event|2|||
30645885|NCT01018862|58658307|FG001|Overall Study|Adverse Event|0|||
30645886|NCT01018862|58658308|FG002|Overall Study|Adverse Event|6|||
30645887|NCT01018862|58658306|FG000|Overall Study|Lack of Efficacy|1|||
30645888|NCT01018862|58658307|FG001|Overall Study|Lack of Efficacy|0|||
30645889|NCT01018862|58658308|FG002|Overall Study|Lack of Efficacy|2|||
30645890|NCT01018862|58658306|FG000|Overall Study|Lost to Follow-up|3|||
30645891|NCT01018862|58658307|FG001|Overall Study|Lost to Follow-up|1|||
30645892|NCT01018862|58658308|FG002|Overall Study|Lost to Follow-up|0|||
30645893|NCT01018862|58658306|FG000|Overall Study|Protocol Violation|1|||
30645894|NCT01018862|58658307|FG001|Overall Study|Protocol Violation|3|||
30645895|NCT01018862|58658308|FG002|Overall Study|Protocol Violation|3|||
30645896|NCT01018862|58658306|FG000|Overall Study|Withdrawal by Subject|1|||
30645897|NCT01018862|58658307|FG001|Overall Study|Withdrawal by Subject|2|||
30645898|NCT01018862|58658308|FG002|Overall Study|Withdrawal by Subject|1|||
30645899|NCT01018862|58658306|FG000|Overall Study|administrative problems|5|||
30645900|NCT01018862|58658307|FG001|Overall Study|administrative problems|4|||
30645901|NCT01018862|58658308|FG002|Overall Study|administrative problems|4|||
30951928|NCT01699178|58999334|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
30645902|NCT01018394|58658318|FG000|Overall Study|Withdrawal by Subject|5|||
30645903|NCT01018394|58658319|FG001|Overall Study|Withdrawal by Subject|5|||
30645904|NCT01018394|58658318|FG000|Overall Study|Lost to Follow-up|4|||
30645905|NCT01018394|58658319|FG001|Overall Study|Lost to Follow-up|3|||
30645906|NCT01017146|58658327|FG000|Overall Study|Adverse Event|11|||
30645907|NCT01017146|58658328|FG001|Overall Study|Adverse Event|1|||
30951929|NCT01699178|58999335|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
30645908|NCT01017146|58658327|FG000|Overall Study|Lost to Follow-up|14|||
30645909|NCT01017146|58658328|FG001|Overall Study|Lost to Follow-up|14|||
30645910|NCT01017146|58658327|FG000|Overall Study|Noncompliance with Study Product|1|||
30645911|NCT01017146|58658328|FG001|Overall Study|Noncompliance with Study Product|1|||
30645912|NCT01017146|58658327|FG000|Overall Study|Withdrawal by Subject|32|||
30645913|NCT01017146|58658328|FG001|Overall Study|Withdrawal by Subject|16|||
30645914|NCT01017146|58658327|FG000|Overall Study|Relocation|0|||
30645915|NCT01017146|58658328|FG001|Overall Study|Relocation|4|||
30645916|NCT01017146|58658327|FG000|Overall Study|Pregnancy|2|||
30645917|NCT01017146|58658328|FG001|Overall Study|Pregnancy|1|||
30645918|NCT01017146|58658327|FG000|Overall Study|Protocol Violation|2|||
30645919|NCT01017146|58658328|FG001|Overall Study|Protocol Violation|0|||
30645920|NCT01017146|58658327|FG000|Overall Study|Took Excluded Medication|2|||
30645921|NCT01017146|58658328|FG001|Overall Study|Took Excluded Medication|0|||
30645922|NCT01017146|58658327|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
30645923|NCT01017146|58658328|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
30645924|NCT01017146|58658327|FG000|Overall Study|Change in Work Situation|1|||
30645925|NCT01017146|58658328|FG001|Overall Study|Change in Work Situation|0|||
30645926|NCT01010750|58658340|FG000|Second Intervention|Adverse Event|0|||
30645927|NCT01010750|58658341|FG001|Second Intervention|Adverse Event|1|||
30645928|NCT01010750|58658342|FG002|Second Intervention|Adverse Event|0|||
30645929|NCT01010750|58658343|FG003|Second Intervention|Adverse Event|0|||
30645930|NCT01010750|58658344|FG004|Second Intervention|Adverse Event|0|||
30645931|NCT01010750|58658345|FG005|Second Intervention|Adverse Event|0|||
30645932|NCT01012622|58658353|FG000|Overall Study|Withdrawal by Subject|6|||
30645933|NCT01012622|58658353|FG000|Overall Study|Lost to Follow-up|5|||
30645934|NCT01012622|58658353|FG000|Overall Study|Adverse Event|7|||
30645935|NCT01012622|58658353|FG000|Overall Study|non-compliance with the drug|9|||
30645936|NCT01012622|58658353|FG000|Overall Study|Other|1|||
30645937|NCT01012622|58658353|FG000|Overall Study|screening failure|1|||
30645938|NCT01012622|58658353|FG000|Overall Study|withdrawal of consent by a parent|2|||
30645939|NCT00722371|58658364|FG000|Overall Study|Adverse Event|6|||
30645940|NCT00722371|58658365|FG001|Overall Study|Adverse Event|13|||
30645941|NCT00722371|58658366|FG002|Overall Study|Adverse Event|9|||
30645942|NCT00722371|58658367|FG003|Overall Study|Adverse Event|10|||
30645943|NCT00722371|58658368|FG004|Overall Study|Adverse Event|6|||
30645944|NCT00722371|58658369|FG005|Overall Study|Adverse Event|8|||
30645945|NCT00722371|58658370|FG006|Overall Study|Adverse Event|4|||
30645946|NCT00722371|58658364|FG000|Overall Study|Contraindication|0|||
30645947|NCT00722371|58658365|FG001|Overall Study|Contraindication|0|||
30645948|NCT00722371|58658366|FG002|Overall Study|Contraindication|1|||
30645949|NCT00722371|58658367|FG003|Overall Study|Contraindication|0|||
30645950|NCT00722371|58658368|FG004|Overall Study|Contraindication|0|||
30645951|NCT00722371|58658369|FG005|Overall Study|Contraindication|0|||
30645952|NCT00722371|58658370|FG006|Overall Study|Contraindication|0|||
30645953|NCT00722371|58658364|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
30645954|NCT00722371|58658365|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
30645955|NCT00722371|58658366|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
30645956|NCT00722371|58658367|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
30645957|NCT00722371|58658368|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
30645958|NCT00722371|58658369|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
30645959|NCT00722371|58658370|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
30645960|NCT00722371|58658364|FG000|Overall Study|Excluded medication|0|||
30951930|NCT01683409|58999346|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
30645961|NCT00722371|58658365|FG001|Overall Study|Excluded medication|1|||
30645962|NCT00722371|58658366|FG002|Overall Study|Excluded medication|1|||
30645963|NCT00722371|58658367|FG003|Overall Study|Excluded medication|0|||
30645964|NCT00722371|58658368|FG004|Overall Study|Excluded medication|0|||
30645965|NCT00722371|58658369|FG005|Overall Study|Excluded medication|0|||
30645966|NCT00722371|58658370|FG006|Overall Study|Excluded medication|1|||
30645967|NCT00722371|58658364|FG000|Overall Study|Hyperglycemia|2|||
30645968|NCT00722371|58658365|FG001|Overall Study|Hyperglycemia|6|||
30645969|NCT00722371|58658366|FG002|Overall Study|Hyperglycemia|4|||
30645970|NCT00722371|58658367|FG003|Overall Study|Hyperglycemia|2|||
30645971|NCT00722371|58658368|FG004|Overall Study|Hyperglycemia|5|||
30645972|NCT00722371|58658369|FG005|Overall Study|Hyperglycemia|1|||
30645973|NCT00722371|58658370|FG006|Overall Study|Hyperglycemia|1|||
30645974|NCT00722371|58658364|FG000|Overall Study|Hypoglycemia|1|||
30766426|NCT00313781|58775096|FG002|Before Crossover|Lost to Follow-up|0|||
30766427|NCT00313781|58775094|FG000|Before Crossover|Withdrawal by Subject|3|||
30766428|NCT00313781|58775095|FG001|Before Crossover|Withdrawal by Subject|1|||
30766429|NCT00313781|58775096|FG002|Before Crossover|Withdrawal by Subject|0|||
30766430|NCT00313781|58775094|FG000|Before Crossover|Other|45|||
30766431|NCT00313781|58775095|FG001|Before Crossover|Other|30|||
30766432|NCT00313781|58775096|FG002|Before Crossover|Other|0|||
30766433|NCT00313781|58775094|FG000|Before Crossover|Crossover|0|||
30766434|NCT00313781|58775095|FG001|Before Crossover|Crossover|37|||
30766435|NCT00313781|58775096|FG002|Before Crossover|Crossover|0|||
30645975|NCT00722371|58658365|FG001|Overall Study|Hypoglycemia|0|||
30645976|NCT00722371|58658366|FG002|Overall Study|Hypoglycemia|0|||
30645977|NCT00722371|58658367|FG003|Overall Study|Hypoglycemia|0|||
30645978|NCT00722371|58658368|FG004|Overall Study|Hypoglycemia|0|||
30645979|NCT00722371|58658369|FG005|Overall Study|Hypoglycemia|0|||
30645980|NCT00722371|58658370|FG006|Overall Study|Hypoglycemia|0|||
30645981|NCT00722371|58658364|FG000|Overall Study|Lack of Efficacy|4|||
30645982|NCT00722371|58658365|FG001|Overall Study|Lack of Efficacy|6|||
30645983|NCT00722371|58658366|FG002|Overall Study|Lack of Efficacy|6|||
30645984|NCT00722371|58658367|FG003|Overall Study|Lack of Efficacy|6|||
30645985|NCT00722371|58658368|FG004|Overall Study|Lack of Efficacy|2|||
30645986|NCT00722371|58658369|FG005|Overall Study|Lack of Efficacy|3|||
30645987|NCT00722371|58658370|FG006|Overall Study|Lack of Efficacy|0|||
30645988|NCT00722371|58658364|FG000|Overall Study|Lost to Follow-up|11|||
30645989|NCT00722371|58658365|FG001|Overall Study|Lost to Follow-up|14|||
30645990|NCT00722371|58658366|FG002|Overall Study|Lost to Follow-up|21|||
30645991|NCT00722371|58658367|FG003|Overall Study|Lost to Follow-up|13|||
30645992|NCT00722371|58658368|FG004|Overall Study|Lost to Follow-up|8|||
30645993|NCT00722371|58658369|FG005|Overall Study|Lost to Follow-up|16|||
30645994|NCT00722371|58658370|FG006|Overall Study|Lost to Follow-up|13|||
30645995|NCT00722371|58658364|FG000|Overall Study|Physician Decision|5|||
30645996|NCT00722371|58658365|FG001|Overall Study|Physician Decision|2|||
30645997|NCT00722371|58658366|FG002|Overall Study|Physician Decision|2|||
30645998|NCT00722371|58658367|FG003|Overall Study|Physician Decision|5|||
30645999|NCT00722371|58658368|FG004|Overall Study|Physician Decision|2|||
30646000|NCT00722371|58658369|FG005|Overall Study|Physician Decision|3|||
30646001|NCT00722371|58658370|FG006|Overall Study|Physician Decision|4|||
30646002|NCT00722371|58658364|FG000|Overall Study|Pregnancy|1|||
30646003|NCT00722371|58658365|FG001|Overall Study|Pregnancy|1|||
30646004|NCT00722371|58658366|FG002|Overall Study|Pregnancy|0|||
30766436|NCT00313781|58775094|FG000|Before Crossover|Randomized, not treated|5|||
30646005|NCT00722371|58658367|FG003|Overall Study|Pregnancy|0|||
30646006|NCT00722371|58658368|FG004|Overall Study|Pregnancy|0|||
30646007|NCT00722371|58658369|FG005|Overall Study|Pregnancy|1|||
30646008|NCT00722371|58658370|FG006|Overall Study|Pregnancy|0|||
30646009|NCT00722371|58658364|FG000|Overall Study|Protocol Violation|6|||
30646010|NCT00722371|58658365|FG001|Overall Study|Protocol Violation|1|||
30646011|NCT00722371|58658366|FG002|Overall Study|Protocol Violation|0|||
30646012|NCT00722371|58658367|FG003|Overall Study|Protocol Violation|1|||
30646013|NCT00722371|58658368|FG004|Overall Study|Protocol Violation|4|||
30646014|NCT00722371|58658369|FG005|Overall Study|Protocol Violation|2|||
30646015|NCT00722371|58658370|FG006|Overall Study|Protocol Violation|1|||
30646016|NCT00722371|58658364|FG000|Overall Study|Withdrawal by Subject|18|||
30646017|NCT00722371|58658365|FG001|Overall Study|Withdrawal by Subject|27|||
30646018|NCT00722371|58658366|FG002|Overall Study|Withdrawal by Subject|19|||
30646019|NCT00722371|58658367|FG003|Overall Study|Withdrawal by Subject|23|||
30646020|NCT00722371|58658368|FG004|Overall Study|Withdrawal by Subject|19|||
30646021|NCT00722371|58658369|FG005|Overall Study|Withdrawal by Subject|18|||
30646022|NCT00722371|58658370|FG006|Overall Study|Withdrawal by Subject|26|||
30766437|NCT00313781|58775095|FG001|Before Crossover|Randomized, not treated|0|||
30646023|NCT00722137|58658388|FG000|Overall Study|Overt Disease Progression|5|||
30646024|NCT00722137|58658389|FG001|Overall Study|Overt Disease Progression|4|||
30646025|NCT00722137|58658388|FG000|Overall Study|Adverse Event|17|||
30646026|NCT00722137|58658389|FG001|Overall Study|Adverse Event|21|||
30646027|NCT00722137|58658388|FG000|Overall Study|Death|12|||
30766438|NCT00313781|58775096|FG002|Before Crossover|Randomized, not treated|0|||
30646028|NCT00722137|58658389|FG001|Overall Study|Death|7|||
30646029|NCT00722137|58658388|FG000|Overall Study|Withdrawal by Subject|6|||
30646030|NCT00722137|58658389|FG001|Overall Study|Withdrawal by Subject|9|||
30646031|NCT00722137|58658388|FG000|Overall Study|Other Reason Unknown|3|||
30646032|NCT00722137|58658389|FG001|Overall Study|Other Reason Unknown|4|||
30646033|NCT00722137|58658388|FG000|Overall Study|Randomized But Not Treated|2|||
30646034|NCT00722137|58658389|FG001|Overall Study|Randomized But Not Treated|3|||
30646035|NCT00796666|58658403|FG000|Overall Study|Death|2|||
30646036|NCT00796666|58658404|FG001|Overall Study|Death|4|||
30646037|NCT00796666|58658403|FG000|Overall Study|Withdrawal by Subject|2|||
30646038|NCT00796666|58658404|FG001|Overall Study|Withdrawal by Subject|0|||
30646039|NCT00796666|58658403|FG000|Overall Study|Adverse Event|7|||
30646040|NCT00796666|58658404|FG001|Overall Study|Adverse Event|5|||
30646041|NCT00796666|58658403|FG000|Overall Study|Protocol Violation|1|||
30646042|NCT00796666|58658404|FG001|Overall Study|Protocol Violation|0|||
30646043|NCT00796666|58658403|FG000|Overall Study|Other|1|||
30646044|NCT00796666|58658404|FG001|Overall Study|Other|0|||
30646045|NCT00796666|58658403|FG000|Overall Study|Terminated by sponsor|53|||
30646046|NCT00796666|58658404|FG001|Overall Study|Terminated by sponsor|55|||
30646047|NCT00796666|58658403|FG000|Overall Study|Randomized and not treated|1|||
30646048|NCT00796666|58658404|FG001|Overall Study|Randomized and not treated|0|||
30646049|NCT00799708|58658413|FG000|Overall Study|non-compliance|1|||
30646050|NCT00799708|58658414|FG001|Overall Study|non-compliance|0|||
30646051|NCT00799708|58658415|FG002|Overall Study|non-compliance|0|||
30646052|NCT00796510|58658427|FG000|Overall Study|Death|1|||
30646053|NCT00796510|58658428|FG001|Overall Study|Death|0|||
30646054|NCT00796510|58658427|FG000|Overall Study|Study Terminated|2|||
30646055|NCT00796510|58658428|FG001|Overall Study|Study Terminated|0|||
30646056|NCT00588640|58658434|FG000|Overall Study|Physician Decision|1|||
30646057|NCT00588640|58658434|FG000|Overall Study|Ineligible Patient|1|||
30646058|NCT01016912|58658443|FG000|End of Treatment Period|Lack of Efficacy|0|||
30646059|NCT01016912|58658444|FG001|End of Treatment Period|Lack of Efficacy|1|||
30646060|NCT01016912|58658445|FG002|End of Treatment Period|Lack of Efficacy|0|||
30646061|NCT01016912|58658446|FG003|End of Treatment Period|Lack of Efficacy|4|||
30646062|NCT01016912|58658447|FG004|End of Treatment Period|Lack of Efficacy|4|||
30646063|NCT01016912|58658443|FG000|End of Treatment Period|Adverse Event|0|||
30646064|NCT01016912|58658444|FG001|End of Treatment Period|Adverse Event|1|||
30646065|NCT01016912|58658445|FG002|End of Treatment Period|Adverse Event|1|||
30646066|NCT01016912|58658446|FG003|End of Treatment Period|Adverse Event|0|||
30646067|NCT01016912|58658447|FG004|End of Treatment Period|Adverse Event|0|||
30646068|NCT01016912|58658443|FG000|End of Treatment Period|Completed double-blind period only|0|||
30646069|NCT01016912|58658444|FG001|End of Treatment Period|Completed double-blind period only|1|||
30646070|NCT01016912|58658445|FG002|End of Treatment Period|Completed double-blind period only|0|||
30646071|NCT01016912|58658446|FG003|End of Treatment Period|Completed double-blind period only|0|||
30646072|NCT01016912|58658447|FG004|End of Treatment Period|Completed double-blind period only|0|||
30646073|NCT01016912|58658443|FG000|Follow-up Period|Other reason|0|||
30646074|NCT01016912|58658444|FG001|Follow-up Period|Other reason|0|||
30646075|NCT01016912|58658445|FG002|Follow-up Period|Other reason|1|||
30646076|NCT01016912|58658446|FG003|Follow-up Period|Other reason|1|||
30646077|NCT01016912|58658447|FG004|Follow-up Period|Other reason|0|||
30646078|NCT00802672|58658482|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
30646079|NCT00802672|58658483|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
30646080|NCT00802672|58658484|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
30646081|NCT00802672|58658482|FG000|Overall Study|Adverse Event|1|||
30646082|NCT00802672|58658483|FG001|Overall Study|Adverse Event|1|||
30646083|NCT00802672|58658484|FG002|Overall Study|Adverse Event|1|||
30646084|NCT00802672|58658482|FG000|Overall Study|Protocol Violation|2|||
30646085|NCT00802672|58658483|FG001|Overall Study|Protocol Violation|1|||
30646086|NCT00802672|58658484|FG002|Overall Study|Protocol Violation|1|||
30646087|NCT00802672|58658482|FG000|Overall Study|Lost to Follow-up|5|||
30646088|NCT00802672|58658483|FG001|Overall Study|Lost to Follow-up|5|||
30646089|NCT00802672|58658484|FG002|Overall Study|Lost to Follow-up|3|||
30646090|NCT00802672|58658482|FG000|Overall Study|Withdrawal by Subject|1|||
30646091|NCT00802672|58658483|FG001|Overall Study|Withdrawal by Subject|1|||
30646092|NCT00802672|58658484|FG002|Overall Study|Withdrawal by Subject|2|||
30646093|NCT00802672|58658482|FG000|Overall Study|other|3|||
30646094|NCT00802672|58658483|FG001|Overall Study|other|1|||
30646095|NCT00802672|58658484|FG002|Overall Study|other|2|||
30646096|NCT00714415|58658494|FG000|Overall Study|Lack of Efficacy|1|||
30646097|NCT00714415|58658495|FG001|Overall Study|Lack of Efficacy|0|||
30646098|NCT00714415|58658494|FG000|Overall Study|Death|1|||
30646099|NCT00714415|58658495|FG001|Overall Study|Death|0|||
30646100|NCT00714259|58658501|FG000|Overall Study|Death|2|||
30646101|NCT00796120|58658507|FG000|Overall Study|Death|3|||
30646102|NCT00796120|58658508|FG001|Overall Study|Death|0|||
30646103|NCT00796120|58658507|FG000|Overall Study|Adverse Event|11|||
30646104|NCT00796120|58658508|FG001|Overall Study|Adverse Event|6|||
30646105|NCT00796120|58658507|FG000|Overall Study|Progressive disease|22|||
30646106|NCT00796120|58658508|FG001|Overall Study|Progressive disease|13|||
30646107|NCT00796120|58658507|FG000|Overall Study|Participant refusal|3|||
30766439|NCT00313781|58775094|FG000|After Crossover|Death|0|||
30766440|NCT00313781|58775095|FG001|After Crossover|Death|0|||
30766441|NCT00313781|58775096|FG002|After Crossover|Death|6|||
30766442|NCT00313781|58775094|FG000|After Crossover|Withdrawal by Subject|0|||
30766443|NCT00313781|58775095|FG001|After Crossover|Withdrawal by Subject|0|||
30766444|NCT00313781|58775096|FG002|After Crossover|Withdrawal by Subject|3|||
30766445|NCT00313781|58775094|FG000|After Crossover|Other|0|||
30951931|NCT01683409|58999347|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
30646108|NCT00796120|58658508|FG001|Overall Study|Participant refusal|4|||
30646109|NCT00796120|58658507|FG000|Overall Study|Other|6|||
30646110|NCT00796120|58658508|FG001|Overall Study|Other|17|||
30646111|NCT00796120|58658507|FG000|Overall Study|Physician Decision|16|||
30646112|NCT00796120|58658508|FG001|Overall Study|Physician Decision|17|||
30646113|NCT00796120|58658507|FG000|Overall Study|Randomized but not treated|0|||
30646114|NCT00796120|58658508|FG001|Overall Study|Randomized but not treated|3|||
30646115|NCT00795886|58658514|FG000|Overall Study|Death|10|||
30646116|NCT00719563|58658521|FG000|Overall Study|Adverse Event|16|||
30646117|NCT00719563|58658522|FG001|Overall Study|Adverse Event|13|||
30646118|NCT00719563|58658521|FG000|Overall Study|Medical condition changed|3|||
30646119|NCT00719563|58658522|FG001|Overall Study|Medical condition changed|5|||
30646120|NCT00719563|58658521|FG000|Overall Study|Lack of Efficacy|3|||
30646121|NCT00719563|58658522|FG001|Overall Study|Lack of Efficacy|7|||
30646122|NCT00719563|58658521|FG000|Overall Study|Personal reasons|6|||
30646123|NCT00719563|58658522|FG001|Overall Study|Personal reasons|7|||
30646124|NCT00719563|58658521|FG000|Overall Study|Unknown reasons|4|||
30646125|NCT00719563|58658522|FG001|Overall Study|Unknown reasons|6|||
30646126|NCT00719563|58658521|FG000|Overall Study|Noncompliant|1|||
30646127|NCT00719563|58658522|FG001|Overall Study|Noncompliant|1|||
30646128|NCT00719563|58658521|FG000|Overall Study|Lost to Follow-up|5|||
30646129|NCT00719563|58658522|FG001|Overall Study|Lost to Follow-up|3|||
30646130|NCT00795184|58658529|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
30646131|NCT00795184|58658530|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
30646132|NCT00718861|58658541|FG000|Overall Study|Withdrawal by Subject|15|||
30646133|NCT00718861|58658542|FG001|Overall Study|Withdrawal by Subject|10|||
30646134|NCT00718861|58658541|FG000|Overall Study|Adverse Event|2|||
30646135|NCT00718861|58658542|FG001|Overall Study|Adverse Event|1|||
30646136|NCT00718861|58658541|FG000|Overall Study|Lost to Follow-up|2|||
30646137|NCT00718861|58658542|FG001|Overall Study|Lost to Follow-up|1|||
30646138|NCT00718861|58658541|FG000|Overall Study|Administrative Problems|1|||
30646139|NCT00718861|58658542|FG001|Overall Study|Administrative Problems|1|||
30646140|NCT00718861|58658541|FG000|Overall Study|Death|1|||
30646141|NCT00718861|58658542|FG001|Overall Study|Death|5|||
30646142|NCT01016600|58658552|FG000|Overall Study|Did not start treatment|1|||
30646143|NCT01016600|58658553|FG001|Overall Study|Did not start treatment|0|||
30646144|NCT01016600|58658554|FG002|Overall Study|Did not start treatment|0|||
30646145|NCT01016600|58658555|FG003|Overall Study|Did not start treatment|0|||
30646146|NCT01016132|58658566|FG000|Overall Study|Discomfort|1|||
30646147|NCT01015820|58658572|FG000|Overall Study|Suboptimal measurements|1|||
30646148|NCT01015820|58658573|FG001|Overall Study|Suboptimal measurements|0|||
30646149|NCT01010204|58658596|FG000|Overall Study|Lost to Follow-up|2|||
30646150|NCT01010204|58658597|FG001|Overall Study|Lost to Follow-up|2|||
30646151|NCT01010204|58658596|FG000|Overall Study|Adverse Event|1|||
30646152|NCT01010204|58658597|FG001|Overall Study|Adverse Event|3|||
30646153|NCT01010204|58658596|FG000|Overall Study|Withdrawal by Subject|2|||
30646154|NCT01010204|58658597|FG001|Overall Study|Withdrawal by Subject|3|||
30646155|NCT01010204|58658596|FG000|Overall Study|psychiatric hospitalization|2|||
30646156|NCT01010204|58658597|FG001|Overall Study|psychiatric hospitalization|1|||
30646157|NCT00718549|58658603|FG000|Induction Phase|Disease Progression|1|||
30646158|NCT00718549|58658604|FG001|Induction Phase|Disease Progression|0|||
30646159|NCT00718549|58658605|FG002|Induction Phase|Disease Progression|0|||
30646160|NCT00718549|58658603|FG000|Induction Phase|Eligibility Criteria Violation|2|||
30766446|NCT00313781|58775095|FG001|After Crossover|Other|0|||
30646161|NCT00718549|58658604|FG001|Induction Phase|Eligibility Criteria Violation|0|||
30646162|NCT00718549|58658605|FG002|Induction Phase|Eligibility Criteria Violation|0|||
30646163|NCT00718549|58658603|FG000|Induction Phase|Early Termination - No Additional Info|59|||
30646164|NCT00718549|58658604|FG001|Induction Phase|Early Termination - No Additional Info|0|||
30646165|NCT00718549|58658605|FG002|Induction Phase|Early Termination - No Additional Info|0|||
30646166|NCT00718549|58658603|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
30646167|NCT00718549|58658604|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
30646168|NCT00718549|58658605|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
30646169|NCT00718549|58658603|FG000|Maintenance/ Observation Phase|Death|0|||
30766447|NCT00313781|58775096|FG002|After Crossover|Other|18|||
30646170|NCT00718549|58658604|FG001|Maintenance/ Observation Phase|Death|1|||
30646171|NCT00718549|58658605|FG002|Maintenance/ Observation Phase|Death|2|||
30646172|NCT00718549|58658603|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
30766448|NCT00368537|58775107|FG000|Randomization|No study drug dosed|13|||
30766449|NCT00368537|58775108|FG001|Randomization|No study drug dosed|6|||
30646173|NCT00718549|58658604|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
30646174|NCT00718549|58658605|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
30646175|NCT00718549|58658603|FG000|Maintenance/ Observation Phase|Progression|0|||
30766450|NCT00368537|58775107|FG000|Baseline Participants|Lost to Follow-up|16|||
30766451|NCT00368537|58775108|FG001|Baseline Participants|Lost to Follow-up|17|||
30646176|NCT00718549|58658604|FG001|Maintenance/ Observation Phase|Progression|5|||
30646177|NCT00718549|58658605|FG002|Maintenance/ Observation Phase|Progression|14|||
30646178|NCT00718549|58658603|FG000|Maintenance/ Observation Phase|Relapse|0|||
30646179|NCT00718549|58658604|FG001|Maintenance/ Observation Phase|Relapse|3|||
30646180|NCT00718549|58658605|FG002|Maintenance/ Observation Phase|Relapse|2|||
30646181|NCT00793624|58658622|FG000|Overall Study|Adverse Event|18|||
30646182|NCT00793624|58658623|FG001|Overall Study|Adverse Event|16|||
30646183|NCT00793624|58658624|FG002|Overall Study|Adverse Event|15|||
30646184|NCT00793624|58658625|FG003|Overall Study|Adverse Event|20|||
30646185|NCT00793624|58658622|FG000|Overall Study|Lost to Follow-up|2|||
30646186|NCT00793624|58658623|FG001|Overall Study|Lost to Follow-up|2|||
30646187|NCT00793624|58658624|FG002|Overall Study|Lost to Follow-up|4|||
30766452|NCT00368537|58775107|FG000|Baseline Participants|Withdrawal by Subject|6|||
30766453|NCT00368537|58775108|FG001|Baseline Participants|Withdrawal by Subject|4|||
30766454|NCT00368537|58775107|FG000|Baseline Participants|Death|1|||
30766455|NCT00368537|58775108|FG001|Baseline Participants|Death|2|||
30766456|NCT00368537|58775107|FG000|Baseline Participants|No susceptibility|1|||
30766457|NCT00368537|58775108|FG001|Baseline Participants|No susceptibility|0|||
30646188|NCT00793624|58658625|FG003|Overall Study|Lost to Follow-up|0|||
30646189|NCT00793624|58658622|FG000|Overall Study|Withdrawal by Subject|20|||
30646190|NCT00793624|58658623|FG001|Overall Study|Withdrawal by Subject|9|||
30646191|NCT00793624|58658624|FG002|Overall Study|Withdrawal by Subject|11|||
30646192|NCT00793624|58658625|FG003|Overall Study|Withdrawal by Subject|14|||
30646193|NCT00793624|58658622|FG000|Overall Study|Lack of Efficacy|9|||
30646194|NCT00793624|58658623|FG001|Overall Study|Lack of Efficacy|2|||
30646195|NCT00793624|58658624|FG002|Overall Study|Lack of Efficacy|1|||
30646196|NCT00793624|58658625|FG003|Overall Study|Lack of Efficacy|3|||
30646197|NCT00793624|58658622|FG000|Overall Study|Non compliance with protocol|2|||
30646198|NCT00793624|58658623|FG001|Overall Study|Non compliance with protocol|3|||
30646199|NCT00793624|58658624|FG002|Overall Study|Non compliance with protocol|2|||
30646200|NCT00793624|58658625|FG003|Overall Study|Non compliance with protocol|3|||
30646201|NCT00793624|58658622|FG000|Overall Study|Other reason not described above|6|||
30646202|NCT00793624|58658623|FG001|Overall Study|Other reason not described above|4|||
30646203|NCT00793624|58658624|FG002|Overall Study|Other reason not described above|6|||
30646204|NCT00793624|58658625|FG003|Overall Study|Other reason not described above|3|||
30646205|NCT00794950|58658643|FG000|BCG Induction|Withdrawal by Subject|2|||
30646206|NCT00794950|58658643|FG000|BCG Induction|ineligible|3|||
30646207|NCT00794950|58658643|FG000|BCG Induction|noncompliant w. BCG|1|||
30646208|NCT00794950|58658643|FG000|BCG Induction|Adverse Event|1|||
30646209|NCT00794950|58658643|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
30646210|NCT00794950|58658643|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
30646211|NCT00794950|58658643|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
30646212|NCT00794950|58658643|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
30646213|NCT00793546|58658650|FG000|Overall Study|Death|3|||
30646214|NCT00793546|58658651|FG001|Overall Study|Death|0|||
30646215|NCT00793546|58658650|FG000|Overall Study|Lost to Follow-up|1|||
30646216|NCT00793546|58658651|FG001|Overall Study|Lost to Follow-up|0|||
30646217|NCT00793546|58658650|FG000|Overall Study|Withdrawal by Subject|1|||
30646218|NCT00793546|58658651|FG001|Overall Study|Withdrawal by Subject|1|||
30766458|NCT00368537|58775107|FG000|Baseline Participants|Patient uncompliant|0|||
30766459|NCT00368537|58775108|FG001|Baseline Participants|Patient uncompliant|1|||
30766460|NCT00313703|58775118|FG000|Overall Study|Lost to Follow-up|11|||
30766461|NCT00313703|58775119|FG001|Overall Study|Lost to Follow-up|2|||
30766462|NCT00313703|58775120|FG002|Overall Study|Lost to Follow-up|5|||
30848594|NCT04604795|58874764|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
30848595|NCT04604795|58874765|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
30848596|NCT04604795|58874766|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
30848597|NCT04604795|58874767|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
30848598|NCT04604795|58874768|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
30646219|NCT00793546|58658650|FG000|Overall Study|Study Terminated by Sponsor|8|||
30646220|NCT00793546|58658651|FG001|Overall Study|Study Terminated by Sponsor|27|||
30646221|NCT00793546|58658650|FG000|Overall Study|Other|1|||
30646222|NCT00793546|58658651|FG001|Overall Study|Other|0|||
30646223|NCT00798694|58658661|FG000|Overall Study|Lost to Follow-up|1|||
30646224|NCT00798694|58658662|FG001|Overall Study|Lost to Follow-up|1|||
30646225|NCT00798694|58658661|FG000|Overall Study|Physician Decision|1|||
30646226|NCT00798694|58658662|FG001|Overall Study|Physician Decision|0|||
30646227|NCT00718315|58658677|FG000|Overall Study|Adverse Event|1|||
30766463|NCT00313703|58775121|FG003|Overall Study|Lost to Follow-up|12|||
30766464|NCT00313313|58775134|FG000|Overall Study|Lack of Efficacy|14|||
30766465|NCT00313313|58775135|FG001|Overall Study|Lack of Efficacy|9|||
30646228|NCT00718315|58658678|FG001|Overall Study|Adverse Event|2|||
30646229|NCT00718315|58658679|FG002|Overall Study|Adverse Event|3|||
30646230|NCT00718315|58658677|FG000|Overall Study|Death|6|||
30646231|NCT00718315|58658678|FG001|Overall Study|Death|6|||
30646232|NCT00718315|58658679|FG002|Overall Study|Death|5|||
30646233|NCT00718315|58658677|FG000|Overall Study|Lost to Follow-up|2|||
30646234|NCT00718315|58658678|FG001|Overall Study|Lost to Follow-up|3|||
30646235|NCT00718315|58658679|FG002|Overall Study|Lost to Follow-up|4|||
30646236|NCT00718315|58658677|FG000|Overall Study|Protocol Violation|5|||
30646237|NCT00718315|58658678|FG001|Overall Study|Protocol Violation|5|||
30646238|NCT00718315|58658679|FG002|Overall Study|Protocol Violation|3|||
30646239|NCT00718315|58658677|FG000|Overall Study|Erlotinib dose decreased|4|||
30646240|NCT00718315|58658678|FG001|Overall Study|Erlotinib dose decreased|3|||
30646241|NCT00718315|58658679|FG002|Overall Study|Erlotinib dose decreased|1|||
30646242|NCT00718315|58658677|FG000|Overall Study|Use of Minocyclin|1|||
30646243|NCT00718315|58658678|FG001|Overall Study|Use of Minocyclin|1|||
30646244|NCT00718315|58658679|FG002|Overall Study|Use of Minocyclin|1|||
30646245|NCT00718315|58658677|FG000|Overall Study|Disease progression|0|||
30646246|NCT00718315|58658678|FG001|Overall Study|Disease progression|1|||
30646247|NCT00718315|58658679|FG002|Overall Study|Disease progression|1|||
30646248|NCT00718315|58658677|FG000|Overall Study|Other|0|||
30646249|NCT00718315|58658678|FG001|Overall Study|Other|0|||
30646250|NCT00718315|58658679|FG002|Overall Study|Other|1|||
30646251|NCT00718315|58658677|FG000|Overall Study|Use of ATB and Corticoids|0|||
30646252|NCT00718315|58658678|FG001|Overall Study|Use of ATB and Corticoids|1|||
30646253|NCT00718315|58658679|FG002|Overall Study|Use of ATB and Corticoids|2|||
30646254|NCT00798304|58658690|FG000|Overall Study|Adverse Event|0|||
30646255|NCT00798304|58658691|FG001|Overall Study|Adverse Event|1|||
30646256|NCT00798304|58658692|FG002|Overall Study|Adverse Event|1|||
30646257|NCT00798304|58658690|FG000|Overall Study|Discontinuation by Sponsor|14|||
30646258|NCT00798304|58658691|FG001|Overall Study|Discontinuation by Sponsor|21|||
30646259|NCT00798304|58658692|FG002|Overall Study|Discontinuation by Sponsor|9|||
30646260|NCT00718237|58658702|FG000|Overall Study|Adverse Event|1|||
30646261|NCT00718237|58658703|FG001|Overall Study|Adverse Event|3|||
30646262|NCT00718237|58658702|FG000|Overall Study|Lost to Follow-up|2|||
30646263|NCT00718237|58658703|FG001|Overall Study|Lost to Follow-up|2|||
30646264|NCT00718237|58658702|FG000|Overall Study|Physician Decision|1|||
30646265|NCT00718237|58658703|FG001|Overall Study|Physician Decision|0|||
30646266|NCT00718237|58658702|FG000|Overall Study|Withdrawal by Subject|9|||
30646267|NCT00718237|58658703|FG001|Overall Study|Withdrawal by Subject|10|||
30646268|NCT00793780|58658713|FG000|Overall Study|Withdrawal by Subject|2|||
30646269|NCT00793780|58658714|FG001|Overall Study|Withdrawal by Subject|1|||
30646270|NCT02643303|58658729|FG000|Overall Study|Progressive Disease|4|||
30646271|NCT02643303|58658730|FG001|Overall Study|Progressive Disease|4|||
30646272|NCT02643303|58658731|FG002|Overall Study|Progressive Disease|1|||
30646273|NCT02643303|58658732|FG003|Overall Study|Progressive Disease|12|||
30646274|NCT02643303|58658733|FG004|Overall Study|Progressive Disease|6|||
30646275|NCT02643303|58658734|FG005|Overall Study|Progressive Disease|4|||
30646276|NCT02643303|58658735|FG006|Overall Study|Progressive Disease|8|||
30646277|NCT02643303|58658736|FG007|Overall Study|Progressive Disease|2|||
30646278|NCT02643303|58658737|FG008|Overall Study|Progressive Disease|6|||
30646279|NCT02643303|58658729|FG000|Overall Study|Adverse Event|0|||
30646280|NCT02643303|58658730|FG001|Overall Study|Adverse Event|1|||
30646281|NCT02643303|58658731|FG002|Overall Study|Adverse Event|0|||
30646282|NCT02643303|58658732|FG003|Overall Study|Adverse Event|0|||
30646283|NCT02643303|58658733|FG004|Overall Study|Adverse Event|1|||
30646284|NCT02643303|58658734|FG005|Overall Study|Adverse Event|0|||
30646285|NCT02643303|58658735|FG006|Overall Study|Adverse Event|0|||
30766466|NCT00313313|58775136|FG002|Overall Study|Lack of Efficacy|20|||
30766467|NCT00313313|58775134|FG000|Overall Study|Withdrawal of consent by subject|18|||
30951932|NCT01683409|58999348|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
30646286|NCT02643303|58658736|FG007|Overall Study|Adverse Event|0|||
30766468|NCT00313313|58775135|FG001|Overall Study|Withdrawal of consent by subject|17|||
30766469|NCT00313313|58775136|FG002|Overall Study|Withdrawal of consent by subject|31|||
30646287|NCT02643303|58658737|FG008|Overall Study|Adverse Event|0|||
30766470|NCT00313313|58775134|FG000|Overall Study|Lost to Follow-up|10|||
30646288|NCT02643303|58658729|FG000|Overall Study|Withdrawal by Subject|0|||
30766471|NCT00313313|58775135|FG001|Overall Study|Lost to Follow-up|7|||
30951933|NCT01683409|58999349|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
30646289|NCT02643303|58658730|FG001|Overall Study|Withdrawal by Subject|0|||
30646290|NCT02643303|58658731|FG002|Overall Study|Withdrawal by Subject|0|||
30646291|NCT02643303|58658732|FG003|Overall Study|Withdrawal by Subject|1|||
30646292|NCT02643303|58658733|FG004|Overall Study|Withdrawal by Subject|0|||
30646293|NCT02643303|58658734|FG005|Overall Study|Withdrawal by Subject|0|||
30646294|NCT02643303|58658735|FG006|Overall Study|Withdrawal by Subject|1|||
30646295|NCT02643303|58658736|FG007|Overall Study|Withdrawal by Subject|1|||
30646296|NCT02643303|58658737|FG008|Overall Study|Withdrawal by Subject|1|||
30646297|NCT00790036|58658759|FG000|Overall Study|Abnormal lab values|3|||
30766472|NCT00313313|58775136|FG002|Overall Study|Lost to Follow-up|9|||
30766473|NCT00313313|58775134|FG000|Overall Study|Adverse Event|15|||
30766474|NCT00313313|58775135|FG001|Overall Study|Adverse Event|16|||
30766475|NCT00313313|58775136|FG002|Overall Study|Adverse Event|12|||
30766476|NCT00313313|58775134|FG000|Overall Study|Physician Decision|2|||
30766477|NCT00313313|58775135|FG001|Overall Study|Physician Decision|6|||
30766478|NCT00313313|58775136|FG002|Overall Study|Physician Decision|4|||
30766479|NCT00313313|58775134|FG000|Overall Study|Poor/Noncompliance|3|||
30766480|NCT00313313|58775135|FG001|Overall Study|Poor/Noncompliance|6|||
30766481|NCT00313313|58775136|FG002|Overall Study|Poor/Noncompliance|2|||
30766482|NCT00313313|58775134|FG000|Overall Study|Pregnancy|1|||
30766483|NCT00313313|58775135|FG001|Overall Study|Pregnancy|2|||
30766484|NCT00313313|58775136|FG002|Overall Study|Pregnancy|0|||
30766485|NCT00313313|58775134|FG000|Overall Study|Death|0|||
30848599|NCT04604795|58874769|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
30646298|NCT00790036|58658760|FG001|Overall Study|Abnormal lab values|2|||
30646299|NCT00790036|58658759|FG000|Overall Study|Administrative problems|5|||
30646300|NCT00790036|58658760|FG001|Overall Study|Administrative problems|9|||
30646301|NCT00790036|58658759|FG000|Overall Study|Adverse Event|113|||
30646302|NCT00790036|58658760|FG001|Overall Study|Adverse Event|44|||
30646303|NCT00790036|58658759|FG000|Overall Study|Death|1|||
30646304|NCT00790036|58658760|FG001|Overall Study|Death|0|||
30646305|NCT00790036|58658759|FG000|Overall Study|Disease progression|24|||
30646306|NCT00790036|58658760|FG001|Overall Study|Disease progression|48|||
30646307|NCT00790036|58658759|FG000|Overall Study|Lost to Follow-up|1|||
30646308|NCT00790036|58658760|FG001|Overall Study|Lost to Follow-up|2|||
30646309|NCT00790036|58658759|FG000|Overall Study|Protocol Violation|10|||
30646310|NCT00790036|58658760|FG001|Overall Study|Protocol Violation|2|||
30646311|NCT00790036|58658759|FG000|Overall Study|Withdrawal by Subject|18|||
30646312|NCT00790036|58658760|FG001|Overall Study|Withdrawal by Subject|7|||
30646313|NCT00790036|58658759|FG000|Overall Study|Subject/guardian decision|20|||
30646314|NCT00790036|58658760|FG001|Overall Study|Subject/guardian decision|7|||
30646315|NCT00789958|58658767|FG000|Overall Study|Adverse Event|3|||
30646316|NCT00789958|58658767|FG000|Overall Study|Withdrawal by Subject|4|||
30646317|NCT00789958|58658767|FG000|Overall Study|Progression|3|||
30646318|NCT00789958|58658767|FG000|Overall Study|not protocol specified|1|||
30646319|NCT00789958|58658767|FG000|Overall Study|Not eligible/not analyzable|26|||
30646320|NCT00789880|58658779|FG000|Overall Study|Adverse Event|0|||
30646321|NCT00789880|58658780|FG001|Overall Study|Adverse Event|0|||
30646322|NCT00789880|58658781|FG002|Overall Study|Adverse Event|0|||
30646323|NCT00789880|58658782|FG003|Overall Study|Adverse Event|0|||
30646324|NCT00789880|58658783|FG004|Overall Study|Adverse Event|1|||
30646325|NCT00789880|58658784|FG005|Overall Study|Adverse Event|0|||
30646326|NCT00789880|58658779|FG000|Overall Study|Protocol Violation|0|||
30646327|NCT00789880|58658780|FG001|Overall Study|Protocol Violation|1|||
30646328|NCT00789880|58658781|FG002|Overall Study|Protocol Violation|0|||
30646329|NCT00789880|58658782|FG003|Overall Study|Protocol Violation|1|||
30646330|NCT00789880|58658783|FG004|Overall Study|Protocol Violation|0|||
30646331|NCT00789880|58658784|FG005|Overall Study|Protocol Violation|0|||
30646332|NCT00789880|58658779|FG000|Overall Study|Withdrawal by Subject|1|||
30646333|NCT00789880|58658780|FG001|Overall Study|Withdrawal by Subject|0|||
30646334|NCT00789880|58658781|FG002|Overall Study|Withdrawal by Subject|0|||
30646335|NCT00789880|58658782|FG003|Overall Study|Withdrawal by Subject|0|||
30646336|NCT00789880|58658783|FG004|Overall Study|Withdrawal by Subject|2|||
30646337|NCT00789880|58658784|FG005|Overall Study|Withdrawal by Subject|0|||
30646338|NCT00792298|58658798|FG000|Treatment Period 1|Adverse Event|0|||
30646339|NCT00792298|58658799|FG001|Treatment Period 1|Adverse Event|1|||
30646340|NCT00792298|58658800|FG002|Treatment Period 1|Adverse Event|0|||
30646341|NCT00792298|58658801|FG003|Treatment Period 1|Adverse Event|1|||
30646342|NCT00792298|58658802|FG004|Treatment Period 1|Adverse Event|0|||
30646343|NCT00792298|58658803|FG005|Treatment Period 1|Adverse Event|1|||
30646344|NCT00792298|58658804|FG006|Treatment Period 1|Adverse Event|1|||
30766486|NCT00313313|58775135|FG001|Overall Study|Death|0|||
30646345|NCT00792298|58658805|FG007|Treatment Period 1|Adverse Event|0|||
30646346|NCT00792298|58658798|FG000|Treatment Period 1|Lack of Efficacy|0|||
30766487|NCT00313313|58775136|FG002|Overall Study|Death|2|||
30646347|NCT00792298|58658799|FG001|Treatment Period 1|Lack of Efficacy|0|||
30848600|NCT04604795|58874770|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
30646348|NCT00792298|58658800|FG002|Treatment Period 1|Lack of Efficacy|1|||
30646349|NCT00792298|58658801|FG003|Treatment Period 1|Lack of Efficacy|0|||
30646350|NCT00792298|58658802|FG004|Treatment Period 1|Lack of Efficacy|0|||
30646351|NCT00792298|58658803|FG005|Treatment Period 1|Lack of Efficacy|0|||
30766488|NCT00313313|58775134|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
30646352|NCT00792298|58658804|FG006|Treatment Period 1|Lack of Efficacy|0|||
30646353|NCT00792298|58658805|FG007|Treatment Period 1|Lack of Efficacy|0|||
30646354|NCT00792298|58658798|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30646355|NCT00792298|58658799|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30646356|NCT00792298|58658800|FG002|Treatment Period 1|Withdrawal by Subject|1|||
30646357|NCT00792298|58658801|FG003|Treatment Period 1|Withdrawal by Subject|2|||
30646358|NCT00792298|58658802|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30646359|NCT00792298|58658803|FG005|Treatment Period 1|Withdrawal by Subject|2|||
30646360|NCT00792298|58658804|FG006|Treatment Period 1|Withdrawal by Subject|1|||
30646361|NCT00792298|58658805|FG007|Treatment Period 1|Withdrawal by Subject|0|||
30646362|NCT00792298|58658798|FG000|Treatment Period 1|Lost to Follow-up|0|||
30646363|NCT00792298|58658799|FG001|Treatment Period 1|Lost to Follow-up|0|||
30646364|NCT00792298|58658800|FG002|Treatment Period 1|Lost to Follow-up|0|||
30646365|NCT00792298|58658801|FG003|Treatment Period 1|Lost to Follow-up|0|||
30646366|NCT00792298|58658802|FG004|Treatment Period 1|Lost to Follow-up|0|||
30646367|NCT00792298|58658803|FG005|Treatment Period 1|Lost to Follow-up|0|||
30646368|NCT00792298|58658804|FG006|Treatment Period 1|Lost to Follow-up|1|||
30646369|NCT00792298|58658805|FG007|Treatment Period 1|Lost to Follow-up|0|||
30646370|NCT00792298|58658798|FG000|Treatment Period 1|Physician Decision|0|||
30646371|NCT00792298|58658799|FG001|Treatment Period 1|Physician Decision|0|||
30646372|NCT00792298|58658800|FG002|Treatment Period 1|Physician Decision|0|||
30646373|NCT00792298|58658801|FG003|Treatment Period 1|Physician Decision|1|||
30646374|NCT00792298|58658802|FG004|Treatment Period 1|Physician Decision|0|||
30646375|NCT00792298|58658803|FG005|Treatment Period 1|Physician Decision|0|||
30646376|NCT00792298|58658804|FG006|Treatment Period 1|Physician Decision|1|||
30646377|NCT00792298|58658805|FG007|Treatment Period 1|Physician Decision|0|||
30646378|NCT00792298|58658798|FG000|Treatment Period 1|Protocol Violation|0|||
30646379|NCT00792298|58658799|FG001|Treatment Period 1|Protocol Violation|0|||
30646380|NCT00792298|58658800|FG002|Treatment Period 1|Protocol Violation|0|||
30646381|NCT00792298|58658801|FG003|Treatment Period 1|Protocol Violation|0|||
30646382|NCT00792298|58658802|FG004|Treatment Period 1|Protocol Violation|0|||
30646383|NCT00792298|58658803|FG005|Treatment Period 1|Protocol Violation|0|||
30646384|NCT00792298|58658804|FG006|Treatment Period 1|Protocol Violation|0|||
30646385|NCT00792298|58658805|FG007|Treatment Period 1|Protocol Violation|1|||
30646386|NCT00792298|58658798|FG000|Washout|Adverse Event|0|||
30646387|NCT00792298|58658799|FG001|Washout|Adverse Event|0|||
30766489|NCT00313313|58775135|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
30766490|NCT00313313|58775136|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
30766491|NCT00312845|58775146|FG000|Overall Study|Adverse Event|19|||
30766492|NCT00312845|58775147|FG001|Overall Study|Adverse Event|5|||
30766493|NCT00312845|58775146|FG000|Overall Study|Death|2|||
30766494|NCT00312845|58775147|FG001|Overall Study|Death|2|||
30766495|NCT00312845|58775146|FG000|Overall Study|Withdrawal by Subject|14|||
30766496|NCT00312845|58775147|FG001|Overall Study|Withdrawal by Subject|6|||
30766497|NCT00312845|58775146|FG000|Overall Study|Disease Progression|56|||
30766498|NCT00312845|58775147|FG001|Overall Study|Disease Progression|77|||
30766499|NCT00312845|58775146|FG000|Overall Study|Lost to Follow-up|2|||
30766500|NCT00312845|58775147|FG001|Overall Study|Lost to Follow-up|0|||
30766501|NCT00312845|58775146|FG000|Overall Study|Other|6|||
30766502|NCT00312845|58775147|FG001|Overall Study|Other|5|||
30766503|NCT00368069|58775155|FG000|Overall Study|Adverse Event|5|||
30766504|NCT00368069|58775156|FG001|Overall Study|Adverse Event|2|||
30766505|NCT00368069|58775155|FG000|Overall Study|Lack of Efficacy|0|||
30766506|NCT00368069|58775156|FG001|Overall Study|Lack of Efficacy|1|||
30766507|NCT00368069|58775155|FG000|Overall Study|Lost to Follow-up|1|||
30766508|NCT00368069|58775156|FG001|Overall Study|Lost to Follow-up|0|||
30766509|NCT00368069|58775155|FG000|Overall Study|Protocol Violation|0|||
30766510|NCT00368069|58775156|FG001|Overall Study|Protocol Violation|2|||
30766511|NCT00368069|58775155|FG000|Overall Study|Withdrawal of Consent|2|||
30766512|NCT00368069|58775156|FG001|Overall Study|Withdrawal of Consent|1|||
30766513|NCT00368069|58775155|FG000|Overall Study|no blood sampling possible|0|||
30766514|NCT00368069|58775156|FG001|Overall Study|no blood sampling possible|1|||
30766515|NCT00367991|58775164|FG000|Overall Study|Withdrawal by Subject|1|||
30646388|NCT00792298|58658800|FG002|Washout|Adverse Event|0|||
30646389|NCT00792298|58658801|FG003|Washout|Adverse Event|0|||
30646390|NCT00792298|58658802|FG004|Washout|Adverse Event|0|||
30646391|NCT00792298|58658803|FG005|Washout|Adverse Event|1|||
30766516|NCT00367991|58775165|FG001|Overall Study|Withdrawal by Subject|1|||
30766517|NCT00367991|58775164|FG000|Overall Study|Adverse Event|1|||
30766518|NCT00367991|58775165|FG001|Overall Study|Adverse Event|1|||
30766519|NCT00367835|58775173|FG000|Overall Study|Adverse Event|14|||
30766520|NCT00367835|58775174|FG001|Overall Study|Adverse Event|1|||
30646392|NCT00792298|58658804|FG006|Washout|Adverse Event|0|||
30646393|NCT00792298|58658805|FG007|Washout|Adverse Event|0|||
30646394|NCT00792298|58658798|FG000|Washout|Withdrawal by Subject|0|||
30646395|NCT00792298|58658799|FG001|Washout|Withdrawal by Subject|0|||
30646396|NCT00792298|58658800|FG002|Washout|Withdrawal by Subject|1|||
30646397|NCT00792298|58658801|FG003|Washout|Withdrawal by Subject|0|||
30766521|NCT00367835|58775173|FG000|Overall Study|Protocol Violation|1|||
30766522|NCT00367835|58775174|FG001|Overall Study|Protocol Violation|7|||
30766523|NCT00367835|58775173|FG000|Overall Study|Withdrawal by Subject|7|||
30766524|NCT00367835|58775174|FG001|Overall Study|Withdrawal by Subject|6|||
30766525|NCT00367835|58775173|FG000|Overall Study|Lost to Follow-up|1|||
30766526|NCT00367835|58775174|FG001|Overall Study|Lost to Follow-up|4|||
30766527|NCT00367835|58775173|FG000|Overall Study|Lack of Efficacy|3|||
30766528|NCT00367835|58775174|FG001|Overall Study|Lack of Efficacy|12|||
30766529|NCT00367835|58775173|FG000|Overall Study|Subject in juvenile detention center|1|||
30766530|NCT00367835|58775174|FG001|Overall Study|Subject in juvenile detention center|0|||
30766531|NCT00367835|58775173|FG000|Overall Study|refused blood collection|1|||
30766532|NCT00367835|58775174|FG001|Overall Study|refused blood collection|0|||
30766533|NCT00367835|58775173|FG000|Overall Study|Did not respond to calls|1|||
30766534|NCT00367835|58775174|FG001|Overall Study|Did not respond to calls|0|||
30766535|NCT00367835|58775173|FG000|Overall Study|History of lead poisoning|0|||
30766536|NCT00367835|58775174|FG001|Overall Study|History of lead poisoning|1|||
30766537|NCT03267940|58775186|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
30766538|NCT03267940|58775187|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
30766539|NCT03267940|58775188|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
30766540|NCT03267940|58775189|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
30766541|NCT03267940|58775190|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
30766542|NCT03267940|58775191|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
30766543|NCT03267940|58775186|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
30766544|NCT03267940|58775187|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
30766545|NCT03267940|58775188|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
30766546|NCT03267940|58775189|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
30766547|NCT03267940|58775190|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
30766548|NCT03267940|58775191|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
30766549|NCT03267940|58775186|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
30766550|NCT03267940|58775187|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
30766551|NCT03267940|58775188|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
30766552|NCT03267940|58775189|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
30766553|NCT03267940|58775190|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
30766554|NCT03267940|58775191|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
30766555|NCT03267940|58775186|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
30766556|NCT03267940|58775187|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
30766557|NCT03267940|58775188|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
30766558|NCT03267940|58775189|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
30766559|NCT03267940|58775190|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
30766560|NCT03267940|58775191|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
30766561|NCT03267940|58775186|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
30766562|NCT03267940|58775187|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
30766563|NCT03267940|58775188|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
30766564|NCT03267940|58775189|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
30766565|NCT03267940|58775190|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
30766566|NCT03267940|58775191|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
30766567|NCT03267940|58775186|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
30766568|NCT03267940|58775187|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
30766569|NCT03267940|58775188|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
30766570|NCT03267940|58775189|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
30766571|NCT03267940|58775190|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
30766572|NCT03267940|58775191|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
30766573|NCT03267940|58775186|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
30766574|NCT03267940|58775187|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
30766575|NCT03267940|58775188|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
30766576|NCT03267940|58775189|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
30766577|NCT03267940|58775190|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
30766578|NCT03267940|58775191|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
30766579|NCT03267940|58775186|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
30766580|NCT03267940|58775187|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
30766581|NCT03267940|58775188|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
30766582|NCT03267940|58775189|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
30766583|NCT03267940|58775190|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
30766584|NCT03267940|58775191|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
30766585|NCT03267940|58775186|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
30766586|NCT03267940|58775187|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
30766587|NCT03267940|58775188|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
30766588|NCT03267940|58775189|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
30766589|NCT03267940|58775190|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
30766590|NCT03267940|58775191|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
30766591|NCT03296566|58775211|FG000|Overall Study|Lost to Follow-up|19|||
30766592|NCT03296566|58775212|FG001|Overall Study|Lost to Follow-up|46|||
30766593|NCT03296566|58775211|FG000|Overall Study|Withdrawal by Subject|0|||
30766594|NCT03296566|58775212|FG001|Overall Study|Withdrawal by Subject|3|||
30766595|NCT03755882|58775218|FG000|Period 1|Protocol Violation|1|||
30766596|NCT03755882|58775219|FG001|Period 1|Protocol Violation|0|||
30766597|NCT03755882|58775218|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
30766598|NCT03755882|58775219|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
30766599|NCT00312377|58775227|FG000|Overall Study|Death|403|||
30766600|NCT00312377|58775228|FG001|Overall Study|Death|418|||
30766601|NCT00312377|58775227|FG000|Overall Study|Withdrawal by Subject|23|||
30766602|NCT00312377|58775228|FG001|Overall Study|Withdrawal by Subject|30|||
30766603|NCT00312377|58775227|FG000|Overall Study|Lost to Follow-up|9|||
30766604|NCT00312377|58775228|FG001|Overall Study|Lost to Follow-up|12|||
30766605|NCT00312377|58775227|FG000|Overall Study|Non-compliance|0|||
30766606|NCT00312377|58775228|FG001|Overall Study|Non-compliance|2|||
30766607|NCT00312377|58775227|FG000|Overall Study|Randomised but never received treatment|6|||
30766608|NCT00312377|58775228|FG001|Overall Study|Randomised but never received treatment|6|||
30766609|NCT00312377|58775227|FG000|Overall Study|Discontinue treatment survival follow up|202|||
30766610|NCT00312377|58775228|FG001|Overall Study|Discontinue treatment survival follow up|200|||
30766611|NCT00312377|58775227|FG000|Overall Study|Site ended participation in study|1|||
30766612|NCT00312377|58775228|FG001|Overall Study|Site ended participation in study|0|||
30766613|NCT03295318|58775237|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
30766614|NCT03295318|58775238|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
30766615|NCT03295318|58775239|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
30766616|NCT03295318|58775237|FG000|Overall Study|Death|1|||
30766617|NCT03295318|58775238|FG001|Overall Study|Death|1|||
30766618|NCT03295318|58775239|FG002|Overall Study|Death|1|||
30766619|NCT03295318|58775237|FG000|Overall Study|Protocol Violation|4|||
30766620|NCT03295318|58775238|FG001|Overall Study|Protocol Violation|3|||
30766621|NCT03295318|58775239|FG002|Overall Study|Protocol Violation|3|||
30766622|NCT03295318|58775237|FG000|Overall Study|Withdrawal by Subject|0|||
30766623|NCT03295318|58775238|FG001|Overall Study|Withdrawal by Subject|0|||
30766624|NCT03295318|58775239|FG002|Overall Study|Withdrawal by Subject|1|||
30766625|NCT03295318|58775237|FG000|Overall Study|Subject discontinued due to travel|0|||
30766626|NCT03295318|58775238|FG001|Overall Study|Subject discontinued due to travel|1|||
30766627|NCT03295318|58775239|FG002|Overall Study|Subject discontinued due to travel|0|||
30766628|NCT03311230|58775269|FG000|Overall Study|Withdrawal by Subject|1|||
30766629|NCT03311230|58775270|FG001|Overall Study|Withdrawal by Subject|4|||
30766630|NCT03311230|58775271|FG002|Overall Study|Withdrawal by Subject|2|||
30646398|NCT00792298|58658802|FG004|Washout|Withdrawal by Subject|0|||
30646399|NCT00792298|58658803|FG005|Washout|Withdrawal by Subject|1|||
30646400|NCT00792298|58658804|FG006|Washout|Withdrawal by Subject|0|||
30646401|NCT00792298|58658805|FG007|Washout|Withdrawal by Subject|0|||
30646402|NCT00792298|58658798|FG000|Treatment Period 2|Lack of Efficacy|0|||
30646403|NCT00792298|58658799|FG001|Treatment Period 2|Lack of Efficacy|0|||
30646404|NCT00792298|58658800|FG002|Treatment Period 2|Lack of Efficacy|0|||
30646405|NCT00792298|58658801|FG003|Treatment Period 2|Lack of Efficacy|0|||
30646406|NCT00792298|58658802|FG004|Treatment Period 2|Lack of Efficacy|1|||
30646407|NCT00792298|58658803|FG005|Treatment Period 2|Lack of Efficacy|0|||
30646408|NCT00792298|58658804|FG006|Treatment Period 2|Lack of Efficacy|0|||
30646409|NCT00792298|58658805|FG007|Treatment Period 2|Lack of Efficacy|0|||
30646410|NCT00792298|58658798|FG000|Treatment Period 2|Physician Decision|0|||
30646411|NCT00792298|58658799|FG001|Treatment Period 2|Physician Decision|0|||
30646412|NCT00792298|58658800|FG002|Treatment Period 2|Physician Decision|0|||
30646413|NCT00792298|58658801|FG003|Treatment Period 2|Physician Decision|0|||
30646414|NCT00792298|58658802|FG004|Treatment Period 2|Physician Decision|0|||
30766631|NCT03311230|58775272|FG003|Overall Study|Withdrawal by Subject|7|||
30766632|NCT03311230|58775269|FG000|Overall Study|Unrelated injury|0|||
30766633|NCT03311230|58775270|FG001|Overall Study|Unrelated injury|1|||
30766634|NCT03311230|58775271|FG002|Overall Study|Unrelated injury|0|||
30766635|NCT03311230|58775272|FG003|Overall Study|Unrelated injury|0|||
30766636|NCT00312221|58775285|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
30646415|NCT00792298|58658803|FG005|Treatment Period 2|Physician Decision|0|||
30646416|NCT00792298|58658804|FG006|Treatment Period 2|Physician Decision|1|||
30646417|NCT00792298|58658805|FG007|Treatment Period 2|Physician Decision|0|||
30646418|NCT00792298|58658798|FG000|Treatment Period 2|Pregnancy|0|||
30646419|NCT00792298|58658799|FG001|Treatment Period 2|Pregnancy|0|||
30646420|NCT00792298|58658800|FG002|Treatment Period 2|Pregnancy|1|||
30646421|NCT00792298|58658801|FG003|Treatment Period 2|Pregnancy|0|||
30646422|NCT00792298|58658802|FG004|Treatment Period 2|Pregnancy|0|||
30646423|NCT00792298|58658803|FG005|Treatment Period 2|Pregnancy|0|||
30646424|NCT00792298|58658804|FG006|Treatment Period 2|Pregnancy|0|||
30646425|NCT00792298|58658805|FG007|Treatment Period 2|Pregnancy|0|||
30646426|NCT00792298|58658798|FG000|Treatment Period 2|Withdrawal by Subject|1|||
30646427|NCT00792298|58658799|FG001|Treatment Period 2|Withdrawal by Subject|1|||
30646428|NCT00792298|58658800|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30646429|NCT00792298|58658801|FG003|Treatment Period 2|Withdrawal by Subject|2|||
30646430|NCT00792298|58658802|FG004|Treatment Period 2|Withdrawal by Subject|1|||
30646431|NCT00792298|58658803|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30646432|NCT00792298|58658804|FG006|Treatment Period 2|Withdrawal by Subject|0|||
30646433|NCT00792298|58658805|FG007|Treatment Period 2|Withdrawal by Subject|2|||
30646434|NCT00718159|58658829|FG000|Overall Study|Progressive Disease|3|||
30646435|NCT00718159|58658830|FG001|Overall Study|Progressive Disease|3|||
30646436|NCT00718159|58658831|FG002|Overall Study|Progressive Disease|2|||
30646437|NCT00718159|58658832|FG003|Overall Study|Progressive Disease|0|||
30646438|NCT00718159|58658833|FG004|Overall Study|Progressive Disease|6|||
30646439|NCT00718159|58658834|FG005|Overall Study|Progressive Disease|0|||
30646440|NCT00718159|58658835|FG006|Overall Study|Progressive Disease|0|||
30646441|NCT00718159|58658829|FG000|Overall Study|Death due to Adverse Event|0|||
30646442|NCT00718159|58658830|FG001|Overall Study|Death due to Adverse Event|0|||
30646443|NCT00718159|58658831|FG002|Overall Study|Death due to Adverse Event|0|||
30646444|NCT00718159|58658832|FG003|Overall Study|Death due to Adverse Event|2|||
30646445|NCT00718159|58658833|FG004|Overall Study|Death due to Adverse Event|2|||
30646446|NCT00718159|58658834|FG005|Overall Study|Death due to Adverse Event|0|||
30646447|NCT00718159|58658835|FG006|Overall Study|Death due to Adverse Event|0|||
30646448|NCT00718159|58658829|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
30646449|NCT00718159|58658830|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
30646450|NCT00718159|58658831|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
30646451|NCT00718159|58658832|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
30646452|NCT00718159|58658833|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
30646453|NCT00718159|58658834|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
30646454|NCT00718159|58658835|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
30646455|NCT00718159|58658829|FG000|Overall Study|Investigator Decision|0|||
30646456|NCT00718159|58658830|FG001|Overall Study|Investigator Decision|0|||
30646457|NCT00718159|58658831|FG002|Overall Study|Investigator Decision|0|||
30646458|NCT00718159|58658832|FG003|Overall Study|Investigator Decision|0|||
30646459|NCT00718159|58658833|FG004|Overall Study|Investigator Decision|0|||
30646460|NCT00718159|58658834|FG005|Overall Study|Investigator Decision|1|||
30646461|NCT00718159|58658835|FG006|Overall Study|Investigator Decision|1|||
30646462|NCT00718081|58658854|FG000|Overall Study|Adverse Event|0|||
30646463|NCT00718081|58658855|FG001|Overall Study|Adverse Event|1|||
30646464|NCT00718081|58658856|FG002|Overall Study|Adverse Event|0|||
30646465|NCT00718081|58658854|FG000|Overall Study|Lack of Efficacy|7|||
30646466|NCT00718081|58658855|FG001|Overall Study|Lack of Efficacy|3|||
30646467|NCT00718081|58658856|FG002|Overall Study|Lack of Efficacy|21|||
30646468|NCT00788710|58658867|FG000|Overall Study|Adverse Event|1|||
30646469|NCT00788710|58658868|FG001|Overall Study|Adverse Event|3|||
30646470|NCT00788710|58658869|FG002|Overall Study|Adverse Event|4|||
30646471|NCT00788710|58658867|FG000|Overall Study|Lack of Efficacy|0|||
30646472|NCT00788710|58658868|FG001|Overall Study|Lack of Efficacy|0|||
30646473|NCT00788710|58658869|FG002|Overall Study|Lack of Efficacy|1|||
30646474|NCT00788710|58658867|FG000|Overall Study|Lost to Follow-up|0|||
30646475|NCT00788710|58658868|FG001|Overall Study|Lost to Follow-up|1|||
30951934|NCT01683409|58999350|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
30951935|NCT01683409|58999346|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
30951936|NCT01683409|58999347|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
30951937|NCT01683409|58999348|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
30951938|NCT01683409|58999349|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
30951939|NCT01683409|58999350|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
30951940|NCT01683409|58999346|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
30951941|NCT01683409|58999347|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
30951942|NCT01683409|58999348|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
30646476|NCT00788710|58658869|FG002|Overall Study|Lost to Follow-up|0|||
30951943|NCT01683409|58999349|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
30951944|NCT01683409|58999350|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
30646477|NCT00788710|58658867|FG000|Overall Study|Physician Decision|2|||
30646478|NCT00788710|58658868|FG001|Overall Study|Physician Decision|1|||
30646479|NCT00788710|58658869|FG002|Overall Study|Physician Decision|0|||
30646480|NCT00788710|58658867|FG000|Overall Study|Protocol Violation|0|||
30646481|NCT00788710|58658868|FG001|Overall Study|Protocol Violation|1|||
30646482|NCT00788710|58658869|FG002|Overall Study|Protocol Violation|1|||
30646483|NCT00788710|58658867|FG000|Overall Study|Withdrawal by Subject|2|||
30646484|NCT00788710|58658868|FG001|Overall Study|Withdrawal by Subject|2|||
30646485|NCT00788710|58658869|FG002|Overall Study|Withdrawal by Subject|0|||
30646486|NCT00787930|58658877|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
30951945|NCT01683409|58999346|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
30951946|NCT01683409|58999347|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
30951947|NCT01683409|58999348|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
30951948|NCT01683409|58999349|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
30951949|NCT01683409|58999350|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
30951950|NCT01683409|58999346|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
30951951|NCT01683409|58999347|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
30951952|NCT01683409|58999348|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
30951953|NCT01683409|58999349|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
30951954|NCT01683409|58999350|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
30646487|NCT00588094|58658887|FG000|Overall Study|Adverse Event|3|||
30646488|NCT00588094|58658887|FG000|Overall Study|Progression of Disease|2|||
30646489|NCT03373383|58658896|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
30646490|NCT03373383|58658897|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
30646491|NCT03373383|58658898|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
30646492|NCT03373383|58658899|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
30646493|NCT03373383|58658900|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
30646494|NCT03373383|58658896|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
30646495|NCT03373383|58658897|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
30646496|NCT03373383|58658898|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
30646497|NCT03373383|58658899|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
30646498|NCT03373383|58658900|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
30646499|NCT03373383|58658896|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
30646500|NCT03373383|58658897|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
30646501|NCT03373383|58658898|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
30646502|NCT03373383|58658899|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
30646503|NCT03373383|58658900|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
30646504|NCT03373383|58658896|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
30646505|NCT03373383|58658897|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
30646506|NCT03373383|58658898|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
30646507|NCT03373383|58658899|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
30646508|NCT03373383|58658900|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
30646509|NCT03373383|58658896|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
30646510|NCT03373383|58658897|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
30646511|NCT03373383|58658898|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
30646512|NCT03373383|58658899|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
30646513|NCT03373383|58658900|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
30646514|NCT03373383|58658896|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
30646515|NCT03373383|58658897|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
30646516|NCT03373383|58658898|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
30646517|NCT03373383|58658899|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
30646518|NCT03373383|58658900|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
30646519|NCT03373383|58658896|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
30646520|NCT03373383|58658897|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
30646521|NCT03373383|58658898|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
30646522|NCT03373383|58658899|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
30646523|NCT03373383|58658900|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
30646524|NCT03373383|58658896|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
30766637|NCT00312221|58775286|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
30766638|NCT00312221|58775287|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
30766639|NCT00312221|58775288|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
30766640|NCT00312221|58775285|FG000|Open-label Run-in Period|Adverse Event|74|||
30646525|NCT03373383|58658897|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
30766641|NCT00312221|58775286|FG001|Open-label Run-in Period|Adverse Event|0|||
30766642|NCT00312221|58775287|FG002|Open-label Run-in Period|Adverse Event|0|||
30766643|NCT00312221|58775288|FG003|Open-label Run-in Period|Adverse Event|0|||
30766644|NCT00312221|58775285|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
30766645|NCT00312221|58775286|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
30766646|NCT00312221|58775287|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
30766647|NCT00312221|58775288|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
30766648|NCT00312221|58775285|FG000|Open-label Run-in Period|Administrative|42|||
30766649|NCT00312221|58775286|FG001|Open-label Run-in Period|Administrative|0|||
30766650|NCT00312221|58775287|FG002|Open-label Run-in Period|Administrative|0|||
30646526|NCT03373383|58658898|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
30646527|NCT03373383|58658899|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
30646528|NCT03373383|58658900|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
30646529|NCT03373383|58658896|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
30646530|NCT03373383|58658897|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
30646531|NCT03373383|58658898|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
30766651|NCT00312221|58775288|FG003|Open-label Run-in Period|Administrative|0|||
30646532|NCT03373383|58658899|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
30646533|NCT03373383|58658900|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
30646534|NCT00784654|58658927|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
30646535|NCT00784654|58658928|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
30646536|NCT00784654|58658929|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
30646537|NCT00784654|58658927|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
30646538|NCT00784654|58658928|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
30646539|NCT00784654|58658929|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
30646540|NCT00784654|58658927|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
30646541|NCT00784654|58658928|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
30646542|NCT00784654|58658929|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
30646543|NCT00784654|58658927|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
30766652|NCT00312221|58775285|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
30766653|NCT00312221|58775286|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
30646544|NCT00784654|58658928|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
30646545|NCT00784654|58658929|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
30646546|NCT00784654|58658927|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
30646547|NCT00784654|58658928|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
30646548|NCT00784654|58658929|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
30646549|NCT00784654|58658927|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
30646550|NCT00784654|58658928|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
30646551|NCT00784654|58658929|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
30646552|NCT00784654|58658927|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
30646553|NCT00784654|58658928|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
30646554|NCT00784654|58658929|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
30646555|NCT00784654|58658927|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
30646556|NCT00784654|58658928|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
30646557|NCT00784654|58658929|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
30646558|NCT00784654|58658927|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
30646559|NCT00784654|58658928|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
30646560|NCT00784654|58658929|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
30646561|NCT00784654|58658927|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
30646562|NCT00784654|58658928|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
30646563|NCT00784654|58658929|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
30646564|NCT00784654|58658927|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
30646565|NCT00784654|58658928|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
30646566|NCT00784654|58658929|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
30646567|NCT00784654|58658927|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
30646568|NCT00784654|58658928|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
30646569|NCT00784654|58658929|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
30646570|NCT00784654|58658927|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
30646571|NCT00784654|58658928|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
30646572|NCT00784654|58658929|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
30646573|NCT00784654|58658927|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30646574|NCT00784654|58658928|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
30646575|NCT00784654|58658929|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
30646576|NCT00784654|58658927|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
30646577|NCT00784654|58658928|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
30646578|NCT00784654|58658929|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
30646579|NCT00784654|58658927|FG000|Randomized Withdrawal Period|Adverse Event|0|||
30646580|NCT00784654|58658928|FG001|Randomized Withdrawal Period|Adverse Event|1|||
30646581|NCT00784654|58658929|FG002|Randomized Withdrawal Period|Adverse Event|1|||
30646582|NCT00784654|58658927|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
30646583|NCT00784654|58658928|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
30646584|NCT00784654|58658929|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
30646585|NCT00784654|58658927|FG000|Randomized Withdrawal Period|Family reasons|0|||
30646586|NCT00784654|58658928|FG001|Randomized Withdrawal Period|Family reasons|0|||
30646587|NCT00784654|58658929|FG002|Randomized Withdrawal Period|Family reasons|1|||
30646588|NCT00787150|58658943|FG000|Overall Study|Adverse Event|4|||
30646589|NCT00787150|58658944|FG001|Overall Study|Adverse Event|4|||
30766654|NCT00312221|58775287|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
30766655|NCT00312221|58775288|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
30766656|NCT00312221|58775285|FG000|Open-label Run-in Period|Did not qualify|5|||
30766657|NCT00312221|58775286|FG001|Open-label Run-in Period|Did not qualify|0|||
30646590|NCT00787150|58658945|FG002|Overall Study|Adverse Event|4|||
30646591|NCT00787150|58658943|FG000|Overall Study|Physician Decision|1|||
30646592|NCT00787150|58658944|FG001|Overall Study|Physician Decision|2|||
30646593|NCT00787150|58658945|FG002|Overall Study|Physician Decision|1|||
30646594|NCT00787150|58658943|FG000|Overall Study|Withdrawal by Subject|2|||
30646595|NCT00787150|58658944|FG001|Overall Study|Withdrawal by Subject|1|||
30646596|NCT00787150|58658945|FG002|Overall Study|Withdrawal by Subject|0|||
30646597|NCT00787150|58658943|FG000|Overall Study|Dosing incorrect study durg|2|||
30646598|NCT00787150|58658944|FG001|Overall Study|Dosing incorrect study durg|0|||
30646599|NCT00787150|58658945|FG002|Overall Study|Dosing incorrect study durg|0|||
30646600|NCT00786838|58658955|FG000|Overall Study|Physician Decision|4|||
30646601|NCT00786838|58658955|FG000|Overall Study|Death|4|||
30646602|NCT00786838|58658955|FG000|Overall Study|Adverse Event|6|||
30646603|NCT00786838|58658955|FG000|Overall Study|Progressive disease|31|||
30646604|NCT00786838|58658955|FG000|Overall Study|Withdrawal by Subject|4|||
30646605|NCT00785980|58658964|FG000|7 Day Washout Period|Protocol Violation|3|||
30646606|NCT00791518|58658971|FG000|Overall Study|Protocol Violation|93|||
30646607|NCT00785512|58658992|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
30646608|NCT00785512|58658993|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
30646609|NCT00785512|58658992|FG000|Overall Study|Adverse Event|0|||
30646610|NCT00785512|58658993|FG001|Overall Study|Adverse Event|0|||
30646611|NCT00785512|58658992|FG000|Overall Study|Lack of Efficacy|0|||
30646612|NCT00785512|58658993|FG001|Overall Study|Lack of Efficacy|2|||
30646613|NCT00785512|58658992|FG000|Overall Study|Withdrawal by Subject|0|||
30646614|NCT00785512|58658993|FG001|Overall Study|Withdrawal by Subject|1|||
30646615|NCT00785512|58658992|FG000|Overall Study|Lost to Follow-up|3|||
30646616|NCT00785512|58658993|FG001|Overall Study|Lost to Follow-up|0|||
30766658|NCT00312221|58775287|FG002|Open-label Run-in Period|Did not qualify|0|||
30766659|NCT00312221|58775288|FG003|Open-label Run-in Period|Did not qualify|0|||
30766660|NCT00312221|58775285|FG000|Double-blind Phase|Withdrawal by Subject|0|||
30766661|NCT00312221|58775286|FG001|Double-blind Phase|Withdrawal by Subject|6|||
30766662|NCT00312221|58775287|FG002|Double-blind Phase|Withdrawal by Subject|8|||
30766663|NCT00312221|58775288|FG003|Double-blind Phase|Withdrawal by Subject|7|||
30646617|NCT00785512|58658992|FG000|Overall Study|Precedure Refused|0|||
30646618|NCT00785512|58658993|FG001|Overall Study|Precedure Refused|0|||
30646619|NCT00785512|58658992|FG000|Overall Study|IVRS Programing Error|0|||
30646620|NCT00785512|58658993|FG001|Overall Study|IVRS Programing Error|0|||
30646621|NCT00785512|58658992|FG000|Overall Study|Physician Decision|0|||
30646622|NCT00785512|58658993|FG001|Overall Study|Physician Decision|0|||
30646623|NCT00785512|58658992|FG000|Overall Study|Lack of compliance|0|||
30646624|NCT00785512|58658993|FG001|Overall Study|Lack of compliance|1|||
30646625|NCT00785356|58659003|FG000|Overall Study|Study prematurely terminated|8|||
30646626|NCT00785044|58659011|FG000|Overall Study|Dosed at non-participating sites|152|||
30646627|NCT00785044|58659011|FG000|Overall Study|Death|77|||
30646628|NCT00785044|58659011|FG000|Overall Study|Lost to Follow-up|266|||
30646629|NCT00785044|58659011|FG000|Overall Study|Withdrawal by Subject|1|||
30646630|NCT00784810|58659018|FG000|Overall Study|Adverse Event|32|||
30646631|NCT00784810|58659019|FG001|Overall Study|Adverse Event|20|||
30646632|NCT00784810|58659018|FG000|Overall Study|Lack of Efficacy|14|||
30646633|NCT00784810|58659019|FG001|Overall Study|Lack of Efficacy|11|||
30646634|NCT00784810|58659018|FG000|Overall Study|Withdrawal by Subject|11|||
30646635|NCT00784810|58659019|FG001|Overall Study|Withdrawal by Subject|9|||
30646636|NCT00784810|58659018|FG000|Overall Study|Administrative|5|||
30646637|NCT00784810|58659019|FG001|Overall Study|Administrative|8|||
30646638|NCT00784810|58659018|FG000|Overall Study|Lost to Follow-up|1|||
30646639|NCT00784810|58659019|FG001|Overall Study|Lost to Follow-up|1|||
30646640|NCT00791128|58659025|FG000|Overall Study|Adverse Event|4|||
30646641|NCT00791128|58659025|FG000|Overall Study|Device migration|2|||
30646642|NCT00791128|58659025|FG000|Overall Study|non-compliance by subject|2|||
30646643|NCT00791128|58659025|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
30646644|NCT00776230|58659045|FG000|Overall Study|Lost to Follow-up|2|||
30646645|NCT00776230|58659046|FG001|Overall Study|Lost to Follow-up|1|||
30646646|NCT00776230|58659047|FG002|Overall Study|Lost to Follow-up|5|||
30766664|NCT00312221|58775285|FG000|Double-blind Phase|Adverse Event|0|||
30766665|NCT00312221|58775286|FG001|Double-blind Phase|Adverse Event|10|||
30766666|NCT00312221|58775287|FG002|Double-blind Phase|Adverse Event|19|||
30646647|NCT00776230|58659045|FG000|Overall Study|Not vaccinated at Day 0|1|||
30646648|NCT00776230|58659046|FG001|Overall Study|Not vaccinated at Day 0|0|||
30646649|NCT00776230|58659047|FG002|Overall Study|Not vaccinated at Day 0|0|||
30646650|NCT00776230|58659045|FG000|Overall Study|Withdrawal by Subject|0|||
30766667|NCT00312221|58775288|FG003|Double-blind Phase|Adverse Event|18|||
30646651|NCT00776230|58659046|FG001|Overall Study|Withdrawal by Subject|1|||
30646652|NCT00776230|58659047|FG002|Overall Study|Withdrawal by Subject|0|||
30766668|NCT00312221|58775285|FG000|Double-blind Phase|Lost to Follow-up|0|||
30766669|NCT00312221|58775286|FG001|Double-blind Phase|Lost to Follow-up|0|||
30646653|NCT00776230|58659045|FG000|Overall Study|Subject missed Visit 4|0|||
30646654|NCT00776230|58659046|FG001|Overall Study|Subject missed Visit 4|1|||
30646655|NCT00776230|58659047|FG002|Overall Study|Subject missed Visit 4|0|||
30646656|NCT00775606|58659057|FG000|Overall Study|Study sponsor terminated funding|3|||
30646657|NCT00775606|58659058|FG001|Overall Study|Study sponsor terminated funding|0|||
30646658|NCT02960763|58659077|FG000|Step 1|Withdrawal by Subject|10|||
30646659|NCT02960763|58659078|FG001|Step 1|Withdrawal by Subject|8|||
30646660|NCT02960763|58659079|FG002|Step 1|Withdrawal by Subject|13|||
30646661|NCT02960763|58659080|FG003|Step 1|Withdrawal by Subject|0|||
30646662|NCT02960763|58659081|FG004|Step 1|Withdrawal by Subject|0|||
30646663|NCT02960763|58659077|FG000|Step 1|Lost to Follow-up|7|||
30646664|NCT02960763|58659078|FG001|Step 1|Lost to Follow-up|9|||
30646665|NCT02960763|58659079|FG002|Step 1|Lost to Follow-up|12|||
30646666|NCT02960763|58659080|FG003|Step 1|Lost to Follow-up|0|||
30646667|NCT02960763|58659081|FG004|Step 1|Lost to Follow-up|0|||
30646668|NCT02960763|58659077|FG000|Step 1|Death|1|||
30646669|NCT02960763|58659078|FG001|Step 1|Death|1|||
30646670|NCT02960763|58659079|FG002|Step 1|Death|1|||
30646671|NCT02960763|58659080|FG003|Step 1|Death|0|||
30646672|NCT02960763|58659081|FG004|Step 1|Death|0|||
30646673|NCT02960763|58659077|FG000|Step 1|Investigator discretion|1|||
30646674|NCT02960763|58659078|FG001|Step 1|Investigator discretion|0|||
30646675|NCT02960763|58659079|FG002|Step 1|Investigator discretion|1|||
30646676|NCT02960763|58659080|FG003|Step 1|Investigator discretion|0|||
30646677|NCT02960763|58659081|FG004|Step 1|Investigator discretion|0|||
30646678|NCT02960763|58659077|FG000|Step 1|Other|0|||
30646679|NCT02960763|58659078|FG001|Step 1|Other|0|||
30646680|NCT02960763|58659079|FG002|Step 1|Other|1|||
30646681|NCT02960763|58659080|FG003|Step 1|Other|0|||
30646682|NCT02960763|58659081|FG004|Step 1|Other|0|||
30646683|NCT02960763|58659077|FG000|Step 2|Withdrawal by Subject|0|||
30646684|NCT02960763|58659078|FG001|Step 2|Withdrawal by Subject|0|||
30646685|NCT02960763|58659079|FG002|Step 2|Withdrawal by Subject|0|||
30646686|NCT02960763|58659080|FG003|Step 2|Withdrawal by Subject|7|||
30646687|NCT02960763|58659081|FG004|Step 2|Withdrawal by Subject|3|||
30646688|NCT02960763|58659077|FG000|Step 2|Lost to Follow-up|0|||
30646689|NCT02960763|58659078|FG001|Step 2|Lost to Follow-up|0|||
30646690|NCT02960763|58659079|FG002|Step 2|Lost to Follow-up|0|||
30646691|NCT02960763|58659080|FG003|Step 2|Lost to Follow-up|4|||
30646692|NCT02960763|58659081|FG004|Step 2|Lost to Follow-up|1|||
30646693|NCT02960763|58659077|FG000|Step 2|Investigator discretion|0|||
30646694|NCT02960763|58659078|FG001|Step 2|Investigator discretion|0|||
30646695|NCT02960763|58659079|FG002|Step 2|Investigator discretion|0|||
30646696|NCT02960763|58659080|FG003|Step 2|Investigator discretion|0|||
30646697|NCT02960763|58659081|FG004|Step 2|Investigator discretion|1|||
30646698|NCT00775528|58659093|FG000|Overall Study|Protocol Violation|1|||
30646699|NCT00775450|58659102|FG000|Overall Study|Serious Adverse Event|2|||
30646700|NCT00775450|58659103|FG001|Overall Study|Serious Adverse Event|0|||
30646701|NCT00775450|58659104|FG002|Overall Study|Serious Adverse Event|0|||
30646702|NCT00775450|58659105|FG003|Overall Study|Serious Adverse Event|0|||
30646703|NCT00775450|58659106|FG004|Overall Study|Serious Adverse Event|0|||
30646704|NCT00775450|58659102|FG000|Overall Study|Protocol Violation|0|||
30646705|NCT00775450|58659103|FG001|Overall Study|Protocol Violation|0|||
30646706|NCT00775450|58659104|FG002|Overall Study|Protocol Violation|0|||
30646707|NCT00775450|58659105|FG003|Overall Study|Protocol Violation|0|||
30646708|NCT00775450|58659106|FG004|Overall Study|Protocol Violation|1|||
30646709|NCT00775450|58659102|FG000|Overall Study|Withdrawal by Subject|1|||
30646710|NCT00775450|58659103|FG001|Overall Study|Withdrawal by Subject|0|||
30646711|NCT00775450|58659104|FG002|Overall Study|Withdrawal by Subject|0|||
30646712|NCT00775450|58659105|FG003|Overall Study|Withdrawal by Subject|0|||
30646713|NCT00775450|58659106|FG004|Overall Study|Withdrawal by Subject|1|||
30646714|NCT00775138|58659122|FG000|Overall Study|Withdrawal by Subject|0|||
30646715|NCT00775138|58659123|FG001|Overall Study|Withdrawal by Subject|0|||
30646716|NCT00775138|58659124|FG002|Overall Study|Withdrawal by Subject|2|||
30646717|NCT00775138|58659125|FG003|Overall Study|Withdrawal by Subject|2|||
30646718|NCT00775138|58659122|FG000|Overall Study|Adverse Event|0|||
30646719|NCT00775138|58659123|FG001|Overall Study|Adverse Event|0|||
30646720|NCT00775138|58659124|FG002|Overall Study|Adverse Event|1|||
30646721|NCT00775138|58659125|FG003|Overall Study|Adverse Event|0|||
30646722|NCT04605991|58659137|FG000|Overall Study|Adverse Event|5|||
30646723|NCT04605991|58659137|FG000|Overall Study|Lack of Efficacy|1|||
30646724|NCT04605991|58659137|FG000|Overall Study|Lost to Follow-up|8|||
30646725|NCT04605991|58659137|FG000|Overall Study|Physician Decision|4|||
30646726|NCT04605991|58659137|FG000|Overall Study|Withdrawal by Subject|14|||
30646727|NCT04605991|58659137|FG000|Overall Study|Non-compliance with study|1|||
30646728|NCT00783796|58659141|FG000|Overall Study|Did not receive any stent|4|||
30646729|NCT00783796|58659141|FG000|Overall Study|Received non-XIENCE V stent|1|||
30646730|NCT00783796|58659141|FG000|Overall Study|Received commercial XIENCE V stent|1|||
30646731|NCT00783718|58659150|FG000|Induction Phase|Adverse Event|4|||
30646732|NCT00783718|58659151|FG001|Induction Phase|Adverse Event|0|||
30646733|NCT00783718|58659152|FG002|Induction Phase|Adverse Event|7|||
30646734|NCT00783718|58659153|FG003|Induction Phase|Adverse Event|0|||
30646735|NCT00783718|58659154|FG004|Induction Phase|Adverse Event|0|||
30646736|NCT00783718|58659155|FG005|Induction Phase|Adverse Event|0|||
30646737|NCT00783718|58659156|FG006|Induction Phase|Adverse Event|0|||
30646738|NCT00783718|58659150|FG000|Induction Phase|Protocol Violation|1|||
30646739|NCT00783718|58659151|FG001|Induction Phase|Protocol Violation|1|||
30646740|NCT00783718|58659152|FG002|Induction Phase|Protocol Violation|6|||
30646741|NCT00783718|58659153|FG003|Induction Phase|Protocol Violation|0|||
30646742|NCT00783718|58659154|FG004|Induction Phase|Protocol Violation|0|||
30646743|NCT00783718|58659155|FG005|Induction Phase|Protocol Violation|0|||
30646744|NCT00783718|58659156|FG006|Induction Phase|Protocol Violation|0|||
30646745|NCT00783718|58659150|FG000|Induction Phase|Lack of Efficacy|5|||
30646746|NCT00783718|58659151|FG001|Induction Phase|Lack of Efficacy|2|||
30646747|NCT00783718|58659152|FG002|Induction Phase|Lack of Efficacy|14|||
30646748|NCT00783718|58659153|FG003|Induction Phase|Lack of Efficacy|0|||
30646749|NCT00783718|58659154|FG004|Induction Phase|Lack of Efficacy|0|||
30646750|NCT00783718|58659155|FG005|Induction Phase|Lack of Efficacy|0|||
30646751|NCT00783718|58659156|FG006|Induction Phase|Lack of Efficacy|0|||
30646752|NCT00783718|58659150|FG000|Induction Phase|Withdrawal by Subject|3|||
30646753|NCT00783718|58659151|FG001|Induction Phase|Withdrawal by Subject|4|||
30646754|NCT00783718|58659152|FG002|Induction Phase|Withdrawal by Subject|8|||
30646755|NCT00783718|58659153|FG003|Induction Phase|Withdrawal by Subject|0|||
30646756|NCT00783718|58659154|FG004|Induction Phase|Withdrawal by Subject|0|||
30646757|NCT00783718|58659155|FG005|Induction Phase|Withdrawal by Subject|0|||
30646758|NCT00783718|58659156|FG006|Induction Phase|Withdrawal by Subject|0|||
30646759|NCT00783718|58659150|FG000|Induction Phase|Lost to Follow-up|1|||
30646760|NCT00783718|58659151|FG001|Induction Phase|Lost to Follow-up|0|||
30646761|NCT00783718|58659152|FG002|Induction Phase|Lost to Follow-up|1|||
30646762|NCT00783718|58659153|FG003|Induction Phase|Lost to Follow-up|0|||
30646763|NCT00783718|58659154|FG004|Induction Phase|Lost to Follow-up|0|||
30766670|NCT00312221|58775287|FG002|Double-blind Phase|Lost to Follow-up|2|||
30766671|NCT00312221|58775288|FG003|Double-blind Phase|Lost to Follow-up|2|||
30766672|NCT00312221|58775285|FG000|Double-blind Phase|Administrative|0|||
30766673|NCT00312221|58775286|FG001|Double-blind Phase|Administrative|26|||
30766674|NCT00312221|58775287|FG002|Double-blind Phase|Administrative|37|||
30766675|NCT00312221|58775288|FG003|Double-blind Phase|Administrative|33|||
30766676|NCT00312221|58775285|FG000|Double-blind Phase|Lack of Efficacy|0|||
30766677|NCT00312221|58775286|FG001|Double-blind Phase|Lack of Efficacy|17|||
30766678|NCT00312221|58775287|FG002|Double-blind Phase|Lack of Efficacy|6|||
30848601|NCT04604795|58874771|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
30848602|NCT04604795|58874762|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
30848603|NCT04604795|58874763|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
30646764|NCT00783718|58659155|FG005|Induction Phase|Lost to Follow-up|0|||
30646765|NCT00783718|58659156|FG006|Induction Phase|Lost to Follow-up|0|||
30646766|NCT00783718|58659150|FG000|Maintenance Phase|Adverse Event|12|||
30646767|NCT00783718|58659151|FG001|Maintenance Phase|Adverse Event|0|||
30646768|NCT00783718|58659152|FG002|Maintenance Phase|Adverse Event|0|||
30646769|NCT00783718|58659153|FG003|Maintenance Phase|Adverse Event|15|||
30646770|NCT00783718|58659154|FG004|Maintenance Phase|Adverse Event|7|||
30646771|NCT00783718|58659155|FG005|Maintenance Phase|Adverse Event|6|||
30646772|NCT00783718|58659156|FG006|Maintenance Phase|Adverse Event|16|||
30646773|NCT00783718|58659150|FG000|Maintenance Phase|Protocol Violation|1|||
30646774|NCT00783718|58659151|FG001|Maintenance Phase|Protocol Violation|0|||
30646775|NCT00783718|58659152|FG002|Maintenance Phase|Protocol Violation|0|||
30646776|NCT00783718|58659153|FG003|Maintenance Phase|Protocol Violation|0|||
30646777|NCT00783718|58659154|FG004|Maintenance Phase|Protocol Violation|0|||
30646778|NCT00783718|58659155|FG005|Maintenance Phase|Protocol Violation|0|||
30646779|NCT00783718|58659156|FG006|Maintenance Phase|Protocol Violation|2|||
30646780|NCT00783718|58659150|FG000|Maintenance Phase|Lack of Efficacy|83|||
30646781|NCT00783718|58659151|FG001|Maintenance Phase|Lack of Efficacy|0|||
30646782|NCT00783718|58659152|FG002|Maintenance Phase|Lack of Efficacy|0|||
30646783|NCT00783718|58659153|FG003|Maintenance Phase|Lack of Efficacy|61|||
30646784|NCT00783718|58659154|FG004|Maintenance Phase|Lack of Efficacy|31|||
30646785|NCT00783718|58659155|FG005|Maintenance Phase|Lack of Efficacy|33|||
30646786|NCT00783718|58659156|FG006|Maintenance Phase|Lack of Efficacy|155|||
30646787|NCT00783718|58659150|FG000|Maintenance Phase|Withdrawal by Subject|6|||
30646788|NCT00783718|58659151|FG001|Maintenance Phase|Withdrawal by Subject|0|||
30646789|NCT00783718|58659152|FG002|Maintenance Phase|Withdrawal by Subject|0|||
30646790|NCT00783718|58659153|FG003|Maintenance Phase|Withdrawal by Subject|2|||
30646791|NCT00783718|58659154|FG004|Maintenance Phase|Withdrawal by Subject|5|||
30766679|NCT00312221|58775288|FG003|Double-blind Phase|Lack of Efficacy|10|||
30766680|NCT03294538|58775312|FG000|Overall Study|Adverse Event|0|||
30848604|NCT04604795|58874764|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
30646792|NCT00783718|58659155|FG005|Maintenance Phase|Withdrawal by Subject|2|||
30646793|NCT00783718|58659156|FG006|Maintenance Phase|Withdrawal by Subject|20|||
30646794|NCT00783718|58659150|FG000|Maintenance Phase|Lost to Follow-up|3|||
30646795|NCT00783718|58659151|FG001|Maintenance Phase|Lost to Follow-up|0|||
30646796|NCT00783718|58659152|FG002|Maintenance Phase|Lost to Follow-up|0|||
30646797|NCT00783718|58659153|FG003|Maintenance Phase|Lost to Follow-up|0|||
30766681|NCT03294538|58775313|FG001|Overall Study|Adverse Event|1|||
30646798|NCT00783718|58659154|FG004|Maintenance Phase|Lost to Follow-up|2|||
30646799|NCT00783718|58659155|FG005|Maintenance Phase|Lost to Follow-up|0|||
30646800|NCT00783718|58659156|FG006|Maintenance Phase|Lost to Follow-up|2|||
30646801|NCT00774748|58659175|FG000|Overall Study|Lost to Follow-up|3|||
30646802|NCT00587860|58659185|FG000|Overall Study|Lost to Follow-up|2|||
30646803|NCT00587860|58659186|FG001|Overall Study|Lost to Follow-up|2|||
30646804|NCT00587860|58659185|FG000|Overall Study|Withdrawal by Subject|3|||
30646805|NCT00587860|58659186|FG001|Overall Study|Withdrawal by Subject|3|||
30646806|NCT00583453|58659194|FG000|Overall Study|discontinued intervention|0|||
30646807|NCT00583453|58659195|FG001|Overall Study|discontinued intervention|2|||
30646808|NCT00583219|58659203|FG000|Phase 2|Withdrawal by Subject|1|||
30646809|NCT01072175|58659223|FG000|Part A (Drug-Drug Interaction)|Death|1|||
30646810|NCT01072175|58659224|FG001|Part A (Drug-Drug Interaction)|Death|0|||
30646811|NCT01072175|58659225|FG002|Part A (Drug-Drug Interaction)|Death|0|||
30646812|NCT01072175|58659226|FG003|Part A (Drug-Drug Interaction)|Death|0|||
30646813|NCT01072175|58659227|FG004|Part A (Drug-Drug Interaction)|Death|0|||
30646814|NCT01072175|58659228|FG005|Part A (Drug-Drug Interaction)|Death|0|||
30646815|NCT01072175|58659229|FG006|Part A (Drug-Drug Interaction)|Death|0|||
30646816|NCT01072175|58659230|FG007|Part A (Drug-Drug Interaction)|Death|0|||
30646817|NCT01072175|58659231|FG008|Part A (Drug-Drug Interaction)|Death|0|||
30646818|NCT01072175|58659232|FG009|Part A (Drug-Drug Interaction)|Death|0|||
30646819|NCT01072175|58659233|FG010|Part A (Drug-Drug Interaction)|Death|0|||
30646820|NCT01072175|58659234|FG011|Part A (Drug-Drug Interaction)|Death|0|||
30646821|NCT01072175|58659235|FG012|Part A (Drug-Drug Interaction)|Death|0|||
30646822|NCT01072175|58659223|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
30646823|NCT01072175|58659224|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646824|NCT01072175|58659225|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646825|NCT01072175|58659226|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646826|NCT01072175|58659227|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646827|NCT01072175|58659228|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646828|NCT01072175|58659229|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646829|NCT01072175|58659230|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646830|NCT01072175|58659231|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646831|NCT01072175|58659232|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646832|NCT01072175|58659233|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646833|NCT01072175|58659234|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646834|NCT01072175|58659235|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
30646835|NCT01072175|58659223|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
30646836|NCT01072175|58659224|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646837|NCT01072175|58659225|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646838|NCT01072175|58659226|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646839|NCT01072175|58659227|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646840|NCT01072175|58659228|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646841|NCT01072175|58659229|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646842|NCT01072175|58659230|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646843|NCT01072175|58659231|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646844|NCT01072175|58659232|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646845|NCT01072175|58659233|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646846|NCT01072175|58659234|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646847|NCT01072175|58659235|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
30646848|NCT01072175|58659223|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
30646849|NCT01072175|58659224|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
30646850|NCT01072175|58659225|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
30646851|NCT01072175|58659226|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
30646852|NCT01072175|58659227|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
30646853|NCT01072175|58659228|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
30646854|NCT01072175|58659229|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
30646855|NCT01072175|58659230|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
30646856|NCT01072175|58659231|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
30646857|NCT01072175|58659232|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
30646858|NCT01072175|58659233|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
30646859|NCT01072175|58659234|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
30646860|NCT01072175|58659235|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
30646861|NCT01072175|58659223|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
30646862|NCT01072175|58659224|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
30646863|NCT01072175|58659225|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
30646864|NCT01072175|58659226|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
30646865|NCT01072175|58659227|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
30646866|NCT01072175|58659228|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
30646867|NCT01072175|58659229|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
30766682|NCT03294538|58775314|FG002|Overall Study|Adverse Event|1|||
30646868|NCT01072175|58659230|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
30646869|NCT01072175|58659231|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
30646870|NCT01072175|58659232|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
30646871|NCT01072175|58659233|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
30646872|NCT01072175|58659234|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
30646873|NCT01072175|58659235|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
30766683|NCT03294538|58775312|FG000|Overall Study|Lost to Follow-up|1|||
30951955|NCT01683409|58999346|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
30951956|NCT01683409|58999347|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
30951957|NCT01683409|58999348|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
30951958|NCT01683409|58999349|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
30951959|NCT01683409|58999350|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
30951960|NCT01683409|58999346|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
30951961|NCT01683409|58999347|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
30951962|NCT01683409|58999348|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
30951963|NCT01683409|58999349|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
30951964|NCT01683409|58999350|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
30951965|NCT01683409|58999346|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
30951966|NCT01683409|58999347|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
30951967|NCT01683409|58999348|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
30951968|NCT01683409|58999349|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
30951969|NCT01683409|58999350|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
30951970|NCT01683409|58999346|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
30951971|NCT01683409|58999347|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
30951972|NCT01683409|58999348|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
30951973|NCT01683409|58999349|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
30951974|NCT01683409|58999350|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
30951975|NCT01683409|58999346|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
30951976|NCT01683409|58999347|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
30951977|NCT01683409|58999348|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
30951978|NCT01683409|58999349|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
30951979|NCT01683409|58999350|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
30951980|NCT01683409|58999346|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
30951981|NCT01683409|58999347|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
30951982|NCT01683409|58999348|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
30951983|NCT01683409|58999349|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
30951984|NCT01683409|58999350|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
30951985|NCT01699022|58999376|FG000|Overall Study|Early discontinuation from the study|3|||
30951986|NCT01683019|58999384|FG000|Overall Study|Withdrawal by Subject|2|||
30951987|NCT01683019|58999385|FG001|Overall Study|Withdrawal by Subject|1|||
30951988|NCT01683019|58999386|FG002|Overall Study|Withdrawal by Subject|4|||
30951989|NCT01709162|58999396|FG000|Overall Study|Disease progression|3|||
30951990|NCT01709162|58999397|FG001|Overall Study|Disease progression|3|||
30951991|NCT01709162|58999396|FG000|Overall Study|Study drug toxicity|2|||
30951992|NCT01709162|58999397|FG001|Overall Study|Study drug toxicity|0|||
30951993|NCT01709162|58999396|FG000|Overall Study|Administrative reason by sponsor|0|||
30951994|NCT01709162|58999397|FG001|Overall Study|Administrative reason by sponsor|1|||
30951995|NCT01709162|58999396|FG000|Overall Study|Other|1|||
30951996|NCT01709162|58999397|FG001|Overall Study|Other|0|||
30646874|NCT01072175|58659223|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
30766684|NCT03294538|58775313|FG001|Overall Study|Lost to Follow-up|0|||
30766685|NCT03294538|58775314|FG002|Overall Study|Lost to Follow-up|0|||
30951997|NCT01709162|58999396|FG000|Overall Study|Withdrawal by Subject|0|||
30951998|NCT01709162|58999397|FG001|Overall Study|Withdrawal by Subject|1|||
30951999|NCT01698554|58999407|FG000|Overall Study|Adverse Event|2|||
30952000|NCT01698554|58999408|FG001|Overall Study|Adverse Event|5|||
30952001|NCT01698554|58999409|FG002|Overall Study|Adverse Event|0|||
30952002|NCT01698554|58999410|FG003|Overall Study|Adverse Event|1|||
30952003|NCT01698554|58999407|FG000|Overall Study|Lost to Follow-up|1|||
30952004|NCT01698554|58999408|FG001|Overall Study|Lost to Follow-up|0|||
30952005|NCT01698554|58999409|FG002|Overall Study|Lost to Follow-up|0|||
30952006|NCT01698554|58999410|FG003|Overall Study|Lost to Follow-up|0|||
30952007|NCT01698554|58999407|FG000|Overall Study|Personal Reasons|0|||
30766686|NCT03294538|58775312|FG000|Overall Study|Outside of Visit Window|4|||
30952008|NCT01698554|58999408|FG001|Overall Study|Personal Reasons|5|||
30952009|NCT01698554|58999409|FG002|Overall Study|Personal Reasons|1|||
30952010|NCT01698554|58999410|FG003|Overall Study|Personal Reasons|1|||
30952011|NCT01698554|58999407|FG000|Overall Study|Protocol Violation|2|||
30952012|NCT01698554|58999408|FG001|Overall Study|Protocol Violation|0|||
30952013|NCT01698554|58999409|FG002|Overall Study|Protocol Violation|1|||
30952014|NCT01698554|58999410|FG003|Overall Study|Protocol Violation|0|||
30952015|NCT01698554|58999407|FG000|Overall Study|Other Miscellaneous Reasons|1|||
30646875|NCT01072175|58659224|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
30766687|NCT03294538|58775313|FG001|Overall Study|Outside of Visit Window|4|||
30766688|NCT03294538|58775314|FG002|Overall Study|Outside of Visit Window|1|||
30766689|NCT03265600|58775324|FG000|Overall Study|Lost to Follow-up|17|||
30766690|NCT03265600|58775325|FG001|Overall Study|Lost to Follow-up|5|||
30766691|NCT03265600|58775324|FG000|Overall Study|Withdrawal by Subject|4|||
30766692|NCT03265600|58775325|FG001|Overall Study|Withdrawal by Subject|2|||
30766693|NCT03265600|58775324|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
30766694|NCT03265600|58775325|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
30766695|NCT00335153|58775331|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
30766696|NCT00335153|58775331|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
30766697|NCT00335153|58775331|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
30766698|NCT00335153|58775331|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
30766699|NCT00335153|58775331|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
30766700|NCT00335153|58775331|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
30646876|NCT01072175|58659225|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
30646877|NCT01072175|58659226|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
30646878|NCT01072175|58659227|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
30646879|NCT01072175|58659228|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
30646880|NCT01072175|58659229|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
30646881|NCT01072175|58659230|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
30646882|NCT01072175|58659231|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
30646883|NCT01072175|58659232|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
30646884|NCT01072175|58659233|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
30646885|NCT01072175|58659234|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
30646886|NCT01072175|58659235|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
30646887|NCT01072175|58659223|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
30646888|NCT01072175|58659224|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
30646889|NCT01072175|58659225|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
30646890|NCT01072175|58659226|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
30646891|NCT01072175|58659227|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
30646892|NCT01072175|58659228|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
30646893|NCT01072175|58659229|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
30646894|NCT01072175|58659230|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
30646895|NCT01072175|58659231|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
30646896|NCT01072175|58659232|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
30646897|NCT01072175|58659233|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
30646898|NCT01072175|58659234|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
30646899|NCT01072175|58659235|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
30646900|NCT01072175|58659223|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
30646901|NCT01072175|58659224|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
30646902|NCT01072175|58659225|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
30646903|NCT01072175|58659226|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
30646904|NCT01072175|58659227|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
30646905|NCT01072175|58659228|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
30646906|NCT01072175|58659229|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
30646907|NCT01072175|58659230|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
30646908|NCT01072175|58659231|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
30646909|NCT01072175|58659232|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
30646910|NCT01072175|58659233|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
30646911|NCT01072175|58659234|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
30646912|NCT01072175|58659235|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
30646913|NCT01072175|58659223|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
30646914|NCT01072175|58659224|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
30646915|NCT01072175|58659225|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
30646916|NCT01072175|58659226|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
30646917|NCT01072175|58659227|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
30646918|NCT01072175|58659228|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
30646919|NCT01072175|58659229|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
30646920|NCT01072175|58659230|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
30952016|NCT01698554|58999408|FG001|Overall Study|Other Miscellaneous Reasons|0|||
30646921|NCT01072175|58659231|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
30766701|NCT00335153|58775331|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
30766702|NCT00335153|58775331|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
30646922|NCT01072175|58659232|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
30646923|NCT01072175|58659233|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
30646924|NCT01072175|58659234|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
30646925|NCT01072175|58659235|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
30646926|NCT01072175|58659223|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
30646927|NCT01072175|58659224|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
30646928|NCT01072175|58659225|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
30646929|NCT01072175|58659226|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
30646930|NCT01072175|58659227|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
30646931|NCT01072175|58659228|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
30646932|NCT01072175|58659229|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
30646933|NCT01072175|58659230|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
30646934|NCT01072175|58659231|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
30646935|NCT01072175|58659232|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
30646936|NCT01072175|58659233|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
30646937|NCT01072175|58659234|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
30646938|NCT01072175|58659235|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
30646939|NCT01072175|58659223|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
30646940|NCT01072175|58659224|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
30646941|NCT01072175|58659225|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
30646942|NCT01072175|58659226|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
30646943|NCT01072175|58659227|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
30646944|NCT01072175|58659228|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
30646945|NCT01072175|58659229|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
30646946|NCT01072175|58659230|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
30646947|NCT01072175|58659231|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
30646948|NCT01072175|58659232|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
30646949|NCT01072175|58659233|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
30646950|NCT01072175|58659234|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
30646951|NCT01072175|58659235|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
30646952|NCT01072175|58659223|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
30646953|NCT01072175|58659224|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
30646954|NCT01072175|58659225|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
30646955|NCT01072175|58659226|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
30646956|NCT01072175|58659227|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
30646957|NCT01072175|58659228|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
30646958|NCT01072175|58659229|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
30646959|NCT01072175|58659230|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
30646960|NCT01072175|58659231|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
30646961|NCT01072175|58659232|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
30646962|NCT01072175|58659233|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
30646963|NCT01072175|58659234|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
30646964|NCT01072175|58659235|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
30646965|NCT01072175|58659223|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
30646966|NCT01072175|58659224|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
30646967|NCT01072175|58659225|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
30646968|NCT01072175|58659226|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
30646969|NCT01072175|58659227|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
30646970|NCT01072175|58659228|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
30646971|NCT01072175|58659229|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
30646972|NCT01072175|58659230|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
30646973|NCT01072175|58659231|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
30646974|NCT01072175|58659232|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
30646975|NCT01072175|58659233|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
30646976|NCT01072175|58659234|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
30646977|NCT01072175|58659235|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
30646978|NCT01072175|58659223|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646979|NCT01072175|58659224|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646980|NCT01072175|58659225|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646981|NCT01072175|58659226|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646982|NCT01072175|58659227|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646983|NCT01072175|58659228|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646984|NCT01072175|58659229|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646985|NCT01072175|58659230|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646986|NCT01072175|58659231|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
30646987|NCT01072175|58659232|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646988|NCT01072175|58659233|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646989|NCT01072175|58659234|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646990|NCT01072175|58659235|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
30646991|NCT01072175|58659223|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30646992|NCT01072175|58659224|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30646993|NCT01072175|58659225|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30646994|NCT01072175|58659226|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30646995|NCT01072175|58659227|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30646996|NCT01072175|58659228|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30646997|NCT01072175|58659229|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30646998|NCT01072175|58659230|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30646999|NCT01072175|58659231|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
30647000|NCT01072175|58659232|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30647001|NCT01072175|58659233|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30647002|NCT01072175|58659234|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30647003|NCT01072175|58659235|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
30647004|NCT01072175|58659223|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647005|NCT01072175|58659224|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647006|NCT01072175|58659225|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647007|NCT01072175|58659226|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647008|NCT01072175|58659227|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647009|NCT01072175|58659228|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647010|NCT01072175|58659229|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647011|NCT01072175|58659230|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647012|NCT01072175|58659231|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
30647013|NCT01072175|58659232|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647014|NCT01072175|58659233|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647015|NCT01072175|58659234|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647016|NCT01072175|58659235|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
30647017|NCT01072175|58659223|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30647018|NCT01072175|58659224|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30647019|NCT01072175|58659225|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30647020|NCT01072175|58659226|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30647021|NCT01072175|58659227|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30766703|NCT00335153|58775331|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
30766704|NCT00335153|58775331|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
30766705|NCT03265132|58775337|FG000|Overall Study|Adverse Event|0|||
30766706|NCT03265132|58775338|FG001|Overall Study|Adverse Event|1|||
30766707|NCT03265132|58775337|FG000|Overall Study|Lack of Efficacy|0|||
30766708|NCT03265132|58775338|FG001|Overall Study|Lack of Efficacy|2|||
30766709|NCT03265132|58775337|FG000|Overall Study|Progressive disease|0|||
30766710|NCT03265132|58775338|FG001|Overall Study|Progressive disease|2|||
30766711|NCT03265132|58775337|FG000|Overall Study|Withdrawal by Subject|0|||
30766712|NCT03265132|58775338|FG001|Overall Study|Withdrawal by Subject|1|||
30766713|NCT02939950|58775348|FG000|Overall Study|Lost to Follow-up|13|||
30766714|NCT02939950|58775349|FG001|Overall Study|Lost to Follow-up|16|||
30766715|NCT02939950|58775348|FG000|Overall Study|Positive slit lamp findings|0|||
30766716|NCT02939950|58775349|FG001|Overall Study|Positive slit lamp findings|1|||
30766717|NCT02939950|58775348|FG000|Overall Study|Chalazion upper lid|0|||
30766718|NCT02939950|58775349|FG001|Overall Study|Chalazion upper lid|1|||
30766719|NCT02939950|58775348|FG000|Overall Study|Lack of motivation|0|||
30766720|NCT02939950|58775349|FG001|Overall Study|Lack of motivation|2|||
30766721|NCT02939950|58775348|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
30766722|NCT02939950|58775349|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
30766723|NCT02939950|58775348|FG000|Overall Study|Military orders|1|||
30766724|NCT02939950|58775349|FG001|Overall Study|Military orders|0|||
30766725|NCT02939950|58775348|FG000|Overall Study|Participant Relocated|5|||
30766726|NCT02939950|58775349|FG001|Overall Study|Participant Relocated|3|||
30766727|NCT02939950|58775348|FG000|Overall Study|Study related symptoms|8|||
30766728|NCT02939950|58775349|FG001|Overall Study|Study related symptoms|8|||
30766729|NCT02939950|58775348|FG000|Overall Study|Unacceptable lens movement|2|||
30647022|NCT01072175|58659228|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30766730|NCT02939950|58775349|FG001|Overall Study|Unacceptable lens movement|0|||
30766731|NCT02939950|58775348|FG000|Overall Study|Protocol Violation|6|||
30766732|NCT02939950|58775349|FG001|Overall Study|Protocol Violation|3|||
30766733|NCT02939950|58775348|FG000|Overall Study|Physician Decision|2|||
30952017|NCT01698554|58999409|FG002|Overall Study|Other Miscellaneous Reasons|0|||
30647023|NCT01072175|58659229|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30647024|NCT01072175|58659230|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30647025|NCT01072175|58659231|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
30647026|NCT01072175|58659232|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30647027|NCT01072175|58659233|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30647028|NCT01072175|58659234|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30647029|NCT01072175|58659235|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
30647030|NCT01072175|58659223|FG000|Part D (HPMC Capsules)|Death|0|||
30647031|NCT01072175|58659224|FG001|Part D (HPMC Capsules)|Death|0|||
30647032|NCT01072175|58659225|FG002|Part D (HPMC Capsules)|Death|0|||
30647033|NCT01072175|58659226|FG003|Part D (HPMC Capsules)|Death|0|||
30647034|NCT01072175|58659227|FG004|Part D (HPMC Capsules)|Death|0|||
30647035|NCT01072175|58659228|FG005|Part D (HPMC Capsules)|Death|0|||
30647036|NCT01072175|58659229|FG006|Part D (HPMC Capsules)|Death|0|||
30647037|NCT01072175|58659230|FG007|Part D (HPMC Capsules)|Death|0|||
30647038|NCT01072175|58659231|FG008|Part D (HPMC Capsules)|Death|0|||
30647039|NCT01072175|58659232|FG009|Part D (HPMC Capsules)|Death|10|||
30647040|NCT01072175|58659233|FG010|Part D (HPMC Capsules)|Death|12|||
30647041|NCT01072175|58659234|FG011|Part D (HPMC Capsules)|Death|28|||
30647042|NCT01072175|58659235|FG012|Part D (HPMC Capsules)|Death|26|||
30647043|NCT01072175|58659223|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
30647044|NCT01072175|58659224|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
30647045|NCT01072175|58659225|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
30647046|NCT01072175|58659226|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
30647047|NCT01072175|58659227|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
30647048|NCT01072175|58659228|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
30647049|NCT01072175|58659229|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
30647050|NCT01072175|58659230|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
30647051|NCT01072175|58659231|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
30766734|NCT02939950|58775349|FG001|Overall Study|Physician Decision|0|||
30766735|NCT02939950|58775348|FG000|Overall Study|Pregnancy|6|||
30766736|NCT02939950|58775349|FG001|Overall Study|Pregnancy|7|||
30766737|NCT02939950|58775348|FG000|Overall Study|Withdrawal by Subject|12|||
30766738|NCT02939950|58775349|FG001|Overall Study|Withdrawal by Subject|28|||
30647052|NCT01072175|58659232|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
30647053|NCT01072175|58659233|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
30647054|NCT01072175|58659234|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
30647055|NCT01072175|58659235|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
30647056|NCT01072175|58659223|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
30647057|NCT01072175|58659224|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
30647058|NCT01072175|58659225|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
30647059|NCT01072175|58659226|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
30647060|NCT01072175|58659227|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
30647061|NCT01072175|58659228|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
30647062|NCT01072175|58659229|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
30647063|NCT01072175|58659230|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
30647064|NCT01072175|58659231|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
30647065|NCT01072175|58659232|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
30647066|NCT01072175|58659233|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
30647067|NCT01072175|58659234|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
30647068|NCT01072175|58659235|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
30647069|NCT01072175|58659223|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
30647070|NCT01072175|58659224|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
30647071|NCT01072175|58659225|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
30647072|NCT01072175|58659226|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
30647073|NCT01072175|58659227|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
30647074|NCT01072175|58659228|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
30647075|NCT01072175|58659229|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
30647076|NCT01072175|58659230|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
30647077|NCT01072175|58659231|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
30647078|NCT01072175|58659232|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
30647079|NCT01072175|58659233|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
30647080|NCT01072175|58659234|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
30647081|NCT01072175|58659235|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
30647082|NCT01072175|58659223|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
30647083|NCT01072175|58659224|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
30647084|NCT01072175|58659225|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
30647085|NCT01072175|58659226|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
30647086|NCT01072175|58659227|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
30647087|NCT01072175|58659228|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
30647088|NCT01072175|58659229|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
30766739|NCT02939950|58775348|FG000|Overall Study|Adverse Event|7|||
30766740|NCT02939950|58775349|FG001|Overall Study|Adverse Event|3|||
30766741|NCT02939950|58775348|FG000|Overall Study|Randomized, not dispensed|1|||
30647089|NCT01072175|58659230|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
30647090|NCT01072175|58659231|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
30647091|NCT01072175|58659232|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
30647092|NCT01072175|58659233|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
30647093|NCT01072175|58659234|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
30647094|NCT01072175|58659235|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
30647095|NCT01071317|58659269|FG000|Overall Study|Lost to Follow-up|2|||
30647096|NCT01071317|58659270|FG001|Overall Study|Lost to Follow-up|2|||
30647097|NCT00783094|58659287|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
30647098|NCT00783094|58659288|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
30647099|NCT00783094|58659289|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
30766742|NCT02939950|58775349|FG001|Overall Study|Randomized, not dispensed|0|||
30766743|NCT02939950|58775348|FG000|Overall Study|Ineligible at Baseline|2|||
30766744|NCT02939950|58775349|FG001|Overall Study|Ineligible at Baseline|8|||
30766745|NCT03753542|58775357|FG000|Overall Study|Lost to Follow-up|9|||
30766746|NCT03753542|58775358|FG001|Overall Study|Lost to Follow-up|14|||
30766747|NCT03292588|58775366|FG000|Overall Study|Death|1|||
30766748|NCT03292588|58775367|FG001|Overall Study|Death|0|||
30766749|NCT03292588|58775366|FG000|Overall Study|Lost to Follow-up|12|||
30766750|NCT03292588|58775367|FG001|Overall Study|Lost to Follow-up|16|||
30766751|NCT03292588|58775366|FG000|Overall Study|Physician Decision|0|||
30766752|NCT03292588|58775367|FG001|Overall Study|Physician Decision|1|||
30766753|NCT03292588|58775366|FG000|Overall Study|Withdrawal by Subject|4|||
30766754|NCT03292588|58775367|FG001|Overall Study|Withdrawal by Subject|4|||
30766755|NCT03292588|58775366|FG000|Overall Study|Move out of town|1|||
30766756|NCT03292588|58775367|FG001|Overall Study|Move out of town|0|||
30766757|NCT03292588|58775366|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
30766758|NCT03292588|58775367|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
30766759|NCT03752528|58775375|FG000|Part A|Lost to Follow-up|1|||
30766760|NCT03752528|58775375|FG000|Part A|Protocol Violation|1|||
30766761|NCT03752528|58775375|FG000|Part B|Protocol Violation|1|||
30766762|NCT03752528|58775375|FG000|Part B|Study terminated by sponsor|3|||
30766763|NCT00334295|58775382|FG000|Overall Study|Patients received fewer than 3 injection|5|||
30766764|NCT03292432|58775388|FG000|Overall Study|Lost to Follow-up|11|||
30766765|NCT03292432|58775389|FG001|Overall Study|Lost to Follow-up|8|||
30647100|NCT00783094|58659287|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
30647101|NCT00783094|58659288|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
30647102|NCT00783094|58659289|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
30647103|NCT00783094|58659287|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
30647104|NCT00783094|58659288|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
30647105|NCT00783094|58659289|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
30647106|NCT00783094|58659287|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
30647107|NCT00783094|58659288|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
30647108|NCT00783094|58659289|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
30647109|NCT00783094|58659287|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
30647110|NCT00783094|58659288|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
30647111|NCT00783094|58659289|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
30647112|NCT00783094|58659287|FG000|Open-Label Extension Period|Adverse Event|12|||
30647113|NCT00783094|58659288|FG001|Open-Label Extension Period|Adverse Event|7|||
30766766|NCT03292432|58775388|FG000|Overall Study|Death|2|||
30766767|NCT03292432|58775389|FG001|Overall Study|Death|1|||
30766768|NCT03292432|58775388|FG000|Overall Study|Withdrawal by Subject|1|||
30647114|NCT00783094|58659289|FG002|Open-Label Extension Period|Adverse Event|16|||
30647115|NCT00783094|58659287|FG000|Open-Label Extension Period|Death|0|||
30647116|NCT00783094|58659288|FG001|Open-Label Extension Period|Death|0|||
30647117|NCT00783094|58659289|FG002|Open-Label Extension Period|Death|1|||
30647118|NCT00783094|58659287|FG000|Open-Label Extension Period|Protocol Violation|4|||
30766769|NCT03292432|58775389|FG001|Overall Study|Withdrawal by Subject|2|||
30848605|NCT04604795|58874765|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
30848606|NCT04604795|58874766|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
30848607|NCT04604795|58874767|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
30766770|NCT03292432|58775388|FG000|Overall Study|Site closed before any data collected|1|||
30766771|NCT03292432|58775389|FG001|Overall Study|Site closed before any data collected|0|||
30766772|NCT03291808|58775395|FG000|Overall Study|Lost to Follow-up|6|||
30766773|NCT03291808|58775395|FG000|Overall Study|Research burden|4|||
30647119|NCT00783094|58659288|FG001|Open-Label Extension Period|Protocol Violation|5|||
30766774|NCT03263806|58775401|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
30766775|NCT03263806|58775402|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
30766776|NCT03263806|58775401|FG000|Overall Study|Withdrawal by Subject|0|||
30766777|NCT03263806|58775402|FG001|Overall Study|Withdrawal by Subject|1|||
30766778|NCT03263806|58775401|FG000|Overall Study|Study Termination|5|||
30766779|NCT03263806|58775402|FG001|Overall Study|Study Termination|6|||
30766780|NCT03751280|58775410|FG000|Overall Study|Adverse Event|0|||
30647120|NCT00783094|58659289|FG002|Open-Label Extension Period|Protocol Violation|7|||
30647121|NCT00783094|58659287|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
30647122|NCT00783094|58659288|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
30647123|NCT00783094|58659289|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
30647124|NCT00783094|58659287|FG000|Open-Label Extension Period|Physician Decision|4|||
30647125|NCT00783094|58659288|FG001|Open-Label Extension Period|Physician Decision|2|||
30647126|NCT00783094|58659289|FG002|Open-Label Extension Period|Physician Decision|3|||
30647127|NCT00783094|58659287|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
30647128|NCT00783094|58659288|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
30647129|NCT00783094|58659289|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
30647130|NCT00790582|58659302|FG000|Overall Study|Death|14|||
30647131|NCT00790582|58659303|FG001|Overall Study|Death|32|||
30647132|NCT00790582|58659302|FG000|Overall Study|Physician Decision|7|||
30647133|NCT00790582|58659303|FG001|Overall Study|Physician Decision|1|||
30647134|NCT00790582|58659302|FG000|Overall Study|Lost to Follow-up|3|||
30647135|NCT00790582|58659303|FG001|Overall Study|Lost to Follow-up|3|||
30647136|NCT00790582|58659302|FG000|Overall Study|Withdrawal by Subject|7|||
30647137|NCT00790582|58659303|FG001|Overall Study|Withdrawal by Subject|51|||
30647138|NCT01048541|58659311|FG000|Overall Study|Withdrawal by Subject|1|||
30647139|NCT01048541|58659312|FG001|Overall Study|Withdrawal by Subject|0|||
30647140|NCT00774046|58659318|FG000|Screening|Not eligible|56|||
30647141|NCT00774046|58659318|FG000|Enrollment|Desired other therapy/refused|28|||
30647142|NCT00774046|58659318|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
30647143|NCT01046903|58659322|FG000|Overall Study|Lost to Follow-up|16|||
30647144|NCT01046903|58659322|FG000|Overall Study|Adverse Event|4|||
30647145|NCT01046903|58659322|FG000|Overall Study|Withdrawal by Subject|3|||
30647146|NCT01046903|58659322|FG000|Overall Study|Other|5|||
30647147|NCT00773968|58659326|FG000|Overall Study|Adverse Event|2|||
30647148|NCT00773968|58659326|FG000|Overall Study|Death|1|||
30647149|NCT00773968|58659326|FG000|Overall Study|Failure to Return|2|||
30647150|NCT00773968|58659326|FG000|Overall Study|Lack of Efficacy|3|||
30647151|NCT00773968|58659326|FG000|Overall Study|Protocol Violation|1|||
30647152|NCT00773968|58659326|FG000|Overall Study|Withdrawal by Subject|11|||
30647153|NCT00773968|58659326|FG000|Overall Study|Screen Failure|17|||
30647154|NCT00773968|58659326|FG000|Overall Study|Other|8|||
30647155|NCT00782626|58659330|FG000|Overall Study|Adverse Event|1|||
30647156|NCT00782626|58659330|FG000|Overall Study|Progressive Disease|5|||
30647157|NCT00782626|58659330|FG000|Overall Study|Other Complicating Disease|1|||
30647158|NCT01071083|58659339|FG000|Overall Study|Adverse Event|1|||
30647159|NCT01071083|58659340|FG001|Overall Study|Adverse Event|0|||
30647160|NCT01071083|58659341|FG002|Overall Study|Adverse Event|1|||
30647161|NCT01071083|58659342|FG003|Overall Study|Adverse Event|0|||
30647162|NCT01071083|58659343|FG004|Overall Study|Adverse Event|1|||
30647163|NCT01071083|58659339|FG000|Overall Study|Withdrawal by Subject|3|||
30647164|NCT01071083|58659340|FG001|Overall Study|Withdrawal by Subject|0|||
30766781|NCT03751280|58775411|FG001|Overall Study|Adverse Event|1|||
30766782|NCT03751280|58775410|FG000|Overall Study|Lost to Follow-up|3|||
30766783|NCT03751280|58775411|FG001|Overall Study|Lost to Follow-up|5|||
30766784|NCT03751280|58775410|FG000|Overall Study|Physician Decision|0|||
30766785|NCT03751280|58775411|FG001|Overall Study|Physician Decision|2|||
30766786|NCT03751280|58775410|FG000|Overall Study|Protocol Violation|0|||
30766787|NCT03751280|58775411|FG001|Overall Study|Protocol Violation|2|||
30766788|NCT03751280|58775410|FG000|Overall Study|Withdrawal by Subject|5|||
30766789|NCT03751280|58775411|FG001|Overall Study|Withdrawal by Subject|2|||
30766790|NCT00311363|58775421|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
30766791|NCT00311363|58775422|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
30766792|NCT00311363|58775423|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
30766793|NCT00311363|58775421|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
30647165|NCT01071083|58659341|FG002|Overall Study|Withdrawal by Subject|2|||
30647166|NCT01071083|58659342|FG003|Overall Study|Withdrawal by Subject|0|||
30647167|NCT01071083|58659343|FG004|Overall Study|Withdrawal by Subject|3|||
30647168|NCT01071083|58659339|FG000|Overall Study|Physician Decision|1|||
30647169|NCT01071083|58659340|FG001|Overall Study|Physician Decision|0|||
30647170|NCT01071083|58659341|FG002|Overall Study|Physician Decision|0|||
30647171|NCT01071083|58659342|FG003|Overall Study|Physician Decision|1|||
30766794|NCT00311363|58775422|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
30766795|NCT00311363|58775423|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
30766796|NCT00311363|58775421|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
30647172|NCT01071083|58659343|FG004|Overall Study|Physician Decision|1|||
30647173|NCT01071083|58659339|FG000|Overall Study|Early Rescue|1|||
30647174|NCT01071083|58659340|FG001|Overall Study|Early Rescue|0|||
30647175|NCT01071083|58659341|FG002|Overall Study|Early Rescue|0|||
30647176|NCT01071083|58659342|FG003|Overall Study|Early Rescue|0|||
30647177|NCT01071083|58659343|FG004|Overall Study|Early Rescue|1|||
30647178|NCT01071083|58659339|FG000|Overall Study|Subject Moved|0|||
30647179|NCT01071083|58659340|FG001|Overall Study|Subject Moved|1|||
30647180|NCT01071083|58659341|FG002|Overall Study|Subject Moved|0|||
30647181|NCT01071083|58659342|FG003|Overall Study|Subject Moved|0|||
30647182|NCT01071083|58659343|FG004|Overall Study|Subject Moved|0|||
30647183|NCT01071083|58659339|FG000|Overall Study|Images Not Usable (Motion)|0|||
30647184|NCT01071083|58659340|FG001|Overall Study|Images Not Usable (Motion)|1|||
30647185|NCT01071083|58659341|FG002|Overall Study|Images Not Usable (Motion)|0|||
30647186|NCT01071083|58659342|FG003|Overall Study|Images Not Usable (Motion)|0|||
30647187|NCT01071083|58659343|FG004|Overall Study|Images Not Usable (Motion)|0|||
30647188|NCT01071083|58659339|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
30647189|NCT01071083|58659340|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
30647190|NCT01071083|58659341|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
30647191|NCT01071083|58659342|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
30647192|NCT01071083|58659343|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
30647193|NCT01071083|58659339|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
30647194|NCT01071083|58659340|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
30647195|NCT01071083|58659341|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
30647196|NCT01071083|58659342|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
30647197|NCT01071083|58659343|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
30647198|NCT01071083|58659339|FG000|Overall Study|Subject Refused to Continue|1|||
30647199|NCT01071083|58659340|FG001|Overall Study|Subject Refused to Continue|0|||
30647200|NCT01071083|58659341|FG002|Overall Study|Subject Refused to Continue|0|||
30647201|NCT01071083|58659342|FG003|Overall Study|Subject Refused to Continue|0|||
30647202|NCT01071083|58659343|FG004|Overall Study|Subject Refused to Continue|0|||
30647203|NCT01070771|58659355|FG000|Overall Study|Adverse Event|2|||
30647204|NCT01070771|58659355|FG000|Overall Study|Protocol Violation|1|||
30647205|NCT01070381|58659360|FG000|Period 2, 1 Week of Wear|Handling|0|||
30647206|NCT01070381|58659361|FG001|Period 2, 1 Week of Wear|Handling|1|||
30647207|NCT01070381|58659360|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
30647208|NCT01070381|58659361|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
30647209|NCT01010126|58659382|FG000|Overall Study|Withdrawal by Subject|1|||
30647210|NCT01010126|58659383|FG001|Overall Study|Withdrawal by Subject|0|||
30647211|NCT01010126|58659384|FG002|Overall Study|Withdrawal by Subject|1|||
30647212|NCT01010126|58659385|FG003|Overall Study|Withdrawal by Subject|0|||
30647213|NCT01010126|58659386|FG004|Overall Study|Withdrawal by Subject|3|||
30647214|NCT01010126|58659387|FG005|Overall Study|Withdrawal by Subject|0|||
30647215|NCT01043705|58659404|FG000|Overall Study|Death|28|||
30647216|NCT01043705|58659405|FG001|Overall Study|Death|60|||
30647217|NCT01043705|58659406|FG002|Overall Study|Death|26|||
30647218|NCT01043705|58659404|FG000|Overall Study|Lost to Follow-up|27|||
30647219|NCT01043705|58659405|FG001|Overall Study|Lost to Follow-up|12|||
30647220|NCT01043705|58659406|FG002|Overall Study|Lost to Follow-up|0|||
30647221|NCT01043705|58659404|FG000|Overall Study|Multiple Reasons|4|||
30647222|NCT01043705|58659405|FG001|Overall Study|Multiple Reasons|7|||
30647223|NCT01043705|58659406|FG002|Overall Study|Multiple Reasons|0|||
30647224|NCT01043705|58659404|FG000|Overall Study|Protocol Violation|2|||
30647225|NCT01043705|58659405|FG001|Overall Study|Protocol Violation|1|||
30647226|NCT01043705|58659406|FG002|Overall Study|Protocol Violation|0|||
30647227|NCT01043705|58659404|FG000|Overall Study|Withdrawal by Subject|8|||
30647228|NCT01043705|58659405|FG001|Overall Study|Withdrawal by Subject|6|||
30647229|NCT01043705|58659406|FG002|Overall Study|Withdrawal by Subject|0|||
30647230|NCT01043705|58659404|FG000|Overall Study|Site Closure|8|||
30647231|NCT01043705|58659405|FG001|Overall Study|Site Closure|0|||
30647232|NCT01043705|58659406|FG002|Overall Study|Site Closure|0|||
30647233|NCT01043705|58659404|FG000|Overall Study|Subsequent Procedure|9|||
30647234|NCT01043705|58659405|FG001|Overall Study|Subsequent Procedure|24|||
30647235|NCT01043705|58659406|FG002|Overall Study|Subsequent Procedure|29|||
30647236|NCT01043705|58659404|FG000|Overall Study|Adverse Event|0|||
30647237|NCT01043705|58659405|FG001|Overall Study|Adverse Event|2|||
30647238|NCT01043705|58659406|FG002|Overall Study|Adverse Event|0|||
30647239|NCT01043705|58659404|FG000|Overall Study|Screen Fail|21|||
30647240|NCT01043705|58659405|FG001|Overall Study|Screen Fail|0|||
30647241|NCT01043705|58659406|FG002|Overall Study|Screen Fail|0|||
30647242|NCT01043705|58659404|FG000|Overall Study|Other|0|||
30647243|NCT01043705|58659405|FG001|Overall Study|Other|19|||
30647244|NCT01043705|58659406|FG002|Overall Study|Other|25|||
30647245|NCT01070303|58659425|FG000|Overall Study|Adverse Event|39|||
30647246|NCT01070303|58659425|FG000|Overall Study|Withdrawal by Subject|20|||
30647247|NCT01070303|58659425|FG000|Overall Study|Lost to Follow-up|9|||
30647248|NCT01070303|58659425|FG000|Overall Study|Protocol Violation|0|||
30647249|NCT01070303|58659425|FG000|Overall Study|Lack of Efficacy|2|||
30647250|NCT01070303|58659425|FG000|Overall Study|Administrative Reason|1|||
30647251|NCT01070303|58659425|FG000|Overall Study|Other|18|||
30647252|NCT01009814|58659440|FG000|Overall Study|No longer met study criteria|1|||
30647253|NCT01009814|58659441|FG001|Overall Study|No longer met study criteria|1|||
30647254|NCT01009814|58659442|FG002|Overall Study|No longer met study criteria|0|||
30647255|NCT01009814|58659443|FG003|Overall Study|No longer met study criteria|0|||
30647256|NCT01009814|58659444|FG004|Overall Study|No longer met study criteria|0|||
30647257|NCT03824587|58659462|FG000|Run-in Period|Screen Failure|0|||
30647258|NCT03824587|58659463|FG001|Run-in Period|Screen Failure|275|||
30647259|NCT03824587|58659462|FG000|Treatment Period|Adverse Event|4|||
30647260|NCT03824587|58659463|FG001|Treatment Period|Adverse Event|1|||
30647261|NCT03824587|58659462|FG000|Treatment Period|Withdrawal by Subject|0|||
30647262|NCT03824587|58659463|FG001|Treatment Period|Withdrawal by Subject|1|||
30647263|NCT03824587|58659462|FG000|Treatment Period|Kidney Transplant|1|||
30647264|NCT03824587|58659463|FG001|Treatment Period|Kidney Transplant|1|||
30647265|NCT00773734|58659473|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
30647266|NCT00773734|58659474|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
30647267|NCT00773734|58659475|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
30647268|NCT00773734|58659476|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
30647269|NCT00773734|58659477|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
30647270|NCT00773734|58659478|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
30647271|NCT00773734|58659473|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
30647272|NCT00773734|58659474|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
30647273|NCT00773734|58659475|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
30647274|NCT00773734|58659476|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
30647275|NCT00773734|58659477|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
30647276|NCT00773734|58659478|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
30647277|NCT00773734|58659473|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
30647278|NCT00773734|58659474|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
30647279|NCT00773734|58659475|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
30647280|NCT00773734|58659476|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
30647281|NCT00773734|58659477|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
30647282|NCT00773734|58659478|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
30647283|NCT00773734|58659473|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
30647284|NCT00773734|58659474|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
30647285|NCT00773734|58659475|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
30647286|NCT00773734|58659476|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
30647287|NCT00773734|58659477|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
30647288|NCT00773734|58659478|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
30647289|NCT00773734|58659473|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
30647290|NCT00773734|58659474|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
30647291|NCT00773734|58659475|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
30647292|NCT00773734|58659476|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
30647293|NCT00773734|58659477|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
30647294|NCT00773734|58659478|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
30647295|NCT00773734|58659473|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
30647296|NCT00773734|58659474|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
30647297|NCT00773734|58659475|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
30647298|NCT00773734|58659476|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
30647299|NCT00773734|58659477|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
30647300|NCT00773734|58659478|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
30647301|NCT00773734|58659473|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
30647302|NCT00773734|58659474|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
30647303|NCT00773734|58659475|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
30647304|NCT00773734|58659476|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
30647305|NCT00773734|58659477|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
30647306|NCT00773734|58659478|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
30647307|NCT00773734|58659473|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
30647308|NCT00773734|58659474|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
30647309|NCT00773734|58659475|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
30848608|NCT04604795|58874768|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
30848609|NCT04604795|58874769|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
30848610|NCT04604795|58874770|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
30647310|NCT00773734|58659476|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
30647311|NCT00773734|58659477|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
30848611|NCT04604795|58874771|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
30848612|NCT04604795|58874762|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
30647312|NCT00773734|58659478|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
30647313|NCT00773734|58659473|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
30647314|NCT00773734|58659474|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
30647315|NCT00773734|58659475|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
30647316|NCT00773734|58659476|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
30647317|NCT00773734|58659477|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
30647318|NCT00773734|58659478|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
30647319|NCT00773734|58659473|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
30647320|NCT00773734|58659474|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
30647321|NCT00773734|58659475|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
30647322|NCT00773734|58659476|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
30647323|NCT00773734|58659477|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
30647324|NCT00773734|58659478|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
30647325|NCT00773734|58659473|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
30647326|NCT00773734|58659474|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
30647327|NCT00773734|58659475|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
30647328|NCT00773734|58659476|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
30647329|NCT00773734|58659477|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
30647330|NCT00773734|58659478|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
30647331|NCT00773734|58659473|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
30647332|NCT00773734|58659474|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
30647333|NCT00773734|58659475|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
30647334|NCT00773734|58659476|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
30647335|NCT00773734|58659477|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
30647336|NCT00773734|58659478|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
30647337|NCT00773734|58659473|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
30647338|NCT00773734|58659474|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
30647339|NCT00773734|58659475|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
30647340|NCT00773734|58659476|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
30647341|NCT00773734|58659477|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
30647342|NCT00773734|58659478|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
30647343|NCT00773734|58659473|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
30647344|NCT00773734|58659474|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
30647345|NCT00773734|58659475|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
30647346|NCT00773734|58659476|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
30647347|NCT00773734|58659477|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
30647348|NCT00773734|58659478|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
30647349|NCT00773734|58659473|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
30647350|NCT00773734|58659474|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
30647351|NCT00773734|58659475|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
30647352|NCT00773734|58659476|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
30647353|NCT00773734|58659477|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
30647354|NCT00773734|58659478|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
30647355|NCT00773734|58659473|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
30647356|NCT00773734|58659474|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
30647357|NCT00773734|58659475|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
30647358|NCT00773734|58659476|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
30647359|NCT00773734|58659477|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
30647360|NCT00773734|58659478|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
30647361|NCT00773734|58659473|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
30647362|NCT00773734|58659474|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
30647363|NCT00773734|58659475|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
30647364|NCT00773734|58659476|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
30647365|NCT00773734|58659477|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
30647366|NCT00773734|58659478|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
30647367|NCT00773734|58659473|FG000|Extension: Active Treatment Week 24-52|Other|0|||
30647368|NCT00773734|58659474|FG001|Extension: Active Treatment Week 24-52|Other|0|||
30766797|NCT00311363|58775422|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
30766798|NCT00311363|58775423|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
30766799|NCT00311363|58775421|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
30766800|NCT00311363|58775422|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
30766801|NCT00311363|58775423|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
30766802|NCT00311363|58775421|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
30766803|NCT00311363|58775422|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
30766804|NCT00311363|58775423|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
30766805|NCT00311363|58775421|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
30766806|NCT00311363|58775422|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
30647369|NCT00773734|58659475|FG002|Extension: Active Treatment Week 24-52|Other|1|||
30647370|NCT00773734|58659476|FG003|Extension: Active Treatment Week 24-52|Other|2|||
30647371|NCT00773734|58659477|FG004|Extension: Active Treatment Week 24-52|Other|0|||
30647372|NCT00773734|58659478|FG005|Extension: Active Treatment Week 24-52|Other|1|||
30647373|NCT00773734|58659473|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
30647374|NCT00773734|58659474|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
30647375|NCT00773734|58659475|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
30647376|NCT00773734|58659476|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
30647377|NCT00773734|58659477|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
30647378|NCT00773734|58659478|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
30647379|NCT00773734|58659473|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
30647380|NCT00773734|58659474|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
30647381|NCT00773734|58659475|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
30647382|NCT00773734|58659476|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
30647383|NCT00773734|58659477|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
30647384|NCT00773734|58659478|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
30647385|NCT00773734|58659473|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
30647386|NCT00773734|58659474|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
30647387|NCT00773734|58659475|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
30647388|NCT00773734|58659476|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
30647389|NCT00773734|58659477|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
30647390|NCT00773734|58659478|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
30647391|NCT00773734|58659473|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
30647392|NCT00773734|58659474|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
30647393|NCT00773734|58659475|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
30647394|NCT00773734|58659476|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
30647395|NCT00773734|58659477|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
30647396|NCT00773734|58659478|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
30647397|NCT01009580|58659537|FG000|Overall Study|Adverse Event|4|||
30647398|NCT01009580|58659538|FG001|Overall Study|Adverse Event|4|||
30647399|NCT01009580|58659537|FG000|Overall Study|Lack of Efficacy|0|||
30647400|NCT01009580|58659538|FG001|Overall Study|Lack of Efficacy|1|||
30647401|NCT01009580|58659537|FG000|Overall Study|Protocol Violation|2|||
30647402|NCT01009580|58659538|FG001|Overall Study|Protocol Violation|3|||
30647403|NCT01009580|58659537|FG000|Overall Study|Withdrawal Criteria|4|||
30647404|NCT01009580|58659538|FG001|Overall Study|Withdrawal Criteria|6|||
30647405|NCT01009580|58659537|FG000|Overall Study|Unclassified|17|||
30647406|NCT01009580|58659538|FG001|Overall Study|Unclassified|21|||
30647407|NCT01009346|58659544|FG000|Overall Study|Adverse Event|4|||
30647408|NCT01001702|58659549|FG000|Overall Study|Lost to Follow-up|7|||
30647409|NCT01001702|58659549|FG000|Overall Study|Adverse Event|7|||
30647410|NCT01001702|58659549|FG000|Overall Study|Sponsor Discontinued Study|4|||
30647411|NCT01001702|58659549|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
30647412|NCT01001702|58659549|FG000|Overall Study|Investigator withdrew Subject|10|||
30647413|NCT01001702|58659549|FG000|Overall Study|Withdrawal by Subject|19|||
30647414|NCT01001702|58659549|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
30647415|NCT01070069|58659558|FG000|Overall Study|Death|1|||
30647416|NCT01070069|58659559|FG001|Overall Study|Death|0|||
30647417|NCT01070069|58659560|FG002|Overall Study|Death|2|||
30647418|NCT01070069|58659561|FG003|Overall Study|Death|0|||
30647419|NCT01070069|58659562|FG004|Overall Study|Death|1|||
30647420|NCT01070069|58659558|FG000|Overall Study|Withdrawal by Subject|1|||
30647421|NCT01070069|58659559|FG001|Overall Study|Withdrawal by Subject|1|||
30647422|NCT01070069|58659560|FG002|Overall Study|Withdrawal by Subject|4|||
30647423|NCT01070069|58659561|FG003|Overall Study|Withdrawal by Subject|0|||
30647424|NCT01070069|58659562|FG004|Overall Study|Withdrawal by Subject|0|||
30647425|NCT01070069|58659558|FG000|Overall Study|Lost to Follow-up|4|||
30647426|NCT01070069|58659559|FG001|Overall Study|Lost to Follow-up|1|||
30647427|NCT01070069|58659560|FG002|Overall Study|Lost to Follow-up|0|||
30647428|NCT01070069|58659561|FG003|Overall Study|Lost to Follow-up|0|||
30647429|NCT01070069|58659562|FG004|Overall Study|Lost to Follow-up|3|||
30647430|NCT01068665|58659579|FG000|Overall Study|Adverse Event|5|||
30647431|NCT01068665|58659580|FG001|Overall Study|Adverse Event|4|||
30647432|NCT01068665|58659579|FG000|Overall Study|Lack of Efficacy|0|||
30647433|NCT01068665|58659580|FG001|Overall Study|Lack of Efficacy|2|||
30766807|NCT00311363|58775423|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
30647434|NCT01068665|58659579|FG000|Overall Study|Protocol Violation|5|||
30647435|NCT01068665|58659580|FG001|Overall Study|Protocol Violation|2|||
30647436|NCT01068665|58659579|FG000|Overall Study|Withdrawal Criteria|3|||
30647437|NCT01068665|58659580|FG001|Overall Study|Withdrawal Criteria|9|||
30647438|NCT01068665|58659579|FG000|Overall Study|Other|17|||
30647439|NCT01068665|58659580|FG001|Overall Study|Other|12|||
30766808|NCT00311363|58775421|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
30647440|NCT01001390|58659586|FG000|Overall Study|Failure to wear AFO device|2|||
30647441|NCT01001390|58659587|FG001|Overall Study|Failure to wear AFO device|0|||
30647442|NCT00772954|58659595|FG000|Overall Study|Adverse Event|0|||
30647443|NCT00772954|58659596|FG001|Overall Study|Adverse Event|0|||
30647444|NCT00772954|58659597|FG002|Overall Study|Adverse Event|1|||
30647445|NCT00781768|58659607|FG000|Overall Study|Not transplanted.|0|||
30647446|NCT00781768|58659608|FG001|Overall Study|Not transplanted.|2|||
30647447|NCT01005680|58659616|FG000|Overall Study|Lost to Follow-up|4|||
30647448|NCT01005680|58659617|FG001|Overall Study|Lost to Follow-up|6|||
30766809|NCT00311363|58775422|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
30766810|NCT00311363|58775423|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
30766811|NCT00311363|58775421|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
30766812|NCT00311363|58775422|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
30766813|NCT00311363|58775423|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
30766814|NCT00311363|58775421|FG000|24-Week Single-Blind Treatment Period|Death|1|||
30766815|NCT00311363|58775422|FG001|24-Week Single-Blind Treatment Period|Death|0|||
30766816|NCT00311363|58775423|FG002|24-Week Single-Blind Treatment Period|Death|0|||
30766817|NCT00311363|58775421|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
30766818|NCT00311363|58775422|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
30766819|NCT00311363|58775423|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
30766820|NCT00311363|58775421|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
30647449|NCT01005680|58659616|FG000|Overall Study|Withdrawal by Subject|1|||
30647450|NCT01005680|58659617|FG001|Overall Study|Withdrawal by Subject|4|||
30647451|NCT01005680|58659616|FG000|Overall Study|Physician Decision|1|||
30647452|NCT01005680|58659617|FG001|Overall Study|Physician Decision|1|||
30647453|NCT01005602|58659626|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
30848613|NCT04604795|58874763|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
30848614|NCT04604795|58874764|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
30848615|NCT04604795|58874765|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
30952018|NCT01698554|58999410|FG003|Overall Study|Other Miscellaneous Reasons|0|||
30647454|NCT01005602|58659627|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
30647455|NCT01068509|58659643|FG000|Overall Study|Death|0|||
30647456|NCT01068509|58659644|FG001|Overall Study|Death|0|||
30647457|NCT01068509|58659645|FG002|Overall Study|Death|1|||
30647458|NCT01068509|58659643|FG000|Overall Study|Disease Progression|5|||
30647459|NCT01068509|58659644|FG001|Overall Study|Disease Progression|20|||
30647460|NCT01068509|58659645|FG002|Overall Study|Disease Progression|18|||
30647461|NCT01068509|58659643|FG000|Overall Study|Lost to Follow-up|1|||
30647462|NCT01068509|58659644|FG001|Overall Study|Lost to Follow-up|0|||
30647463|NCT01068509|58659645|FG002|Overall Study|Lost to Follow-up|0|||
30647464|NCT01068509|58659643|FG000|Overall Study|Withdrew Consent|0|||
30647465|NCT01068509|58659644|FG001|Overall Study|Withdrew Consent|1|||
30647466|NCT01068509|58659645|FG002|Overall Study|Withdrew Consent|2|||
30647467|NCT01068509|58659643|FG000|Overall Study|Reason Not Specified|0|||
30647468|NCT01068509|58659644|FG001|Overall Study|Reason Not Specified|1|||
30766821|NCT00311363|58775422|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
30766822|NCT00311363|58775423|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
30766823|NCT00311363|58775421|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
30766824|NCT00311363|58775422|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
30766825|NCT00311363|58775423|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
30766826|NCT00311363|58775421|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
30766827|NCT00311363|58775422|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
30766828|NCT00311363|58775423|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
30766829|NCT00311363|58775421|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
30766830|NCT00311363|58775422|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
30766831|NCT00311363|58775423|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
30766832|NCT00311363|58775421|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
30766833|NCT00311363|58775422|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
30766834|NCT00311363|58775423|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
30766835|NCT00333983|58775436|FG000|Overall Study|Lost to Follow-up|2|||
30952019|NCT01698320|58999422|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
30952020|NCT01698320|58999423|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
30647469|NCT01068509|58659645|FG002|Overall Study|Reason Not Specified|0|||
30647470|NCT01009034|58659652|FG000|Overall Study|Lost to Follow-up|2|||
30647471|NCT01009034|58659652|FG000|Overall Study|Withdrawal by Subject|2|||
30647472|NCT00768430|58659658|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
30766836|NCT00333983|58775437|FG001|Overall Study|Lost to Follow-up|1|||
30766837|NCT00333983|58775438|FG002|Overall Study|Lost to Follow-up|0|||
30647473|NCT00768430|58659659|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
30647474|NCT01064297|58659668|FG000|Overall Study|Lost to Follow-up|791|||
30647475|NCT01064297|58659669|FG001|Overall Study|Lost to Follow-up|48|||
30647476|NCT01064297|58659670|FG002|Overall Study|Lost to Follow-up|133|||
30647477|NCT00781456|58659687|FG000|Overall Study|Adverse Event|3|||
30647478|NCT00781456|58659688|FG001|Overall Study|Adverse Event|3|||
30647479|NCT00781456|58659687|FG000|Overall Study|Withdrawal by Subject|3|||
30647480|NCT00781456|58659688|FG001|Overall Study|Withdrawal by Subject|5|||
30647481|NCT00781456|58659687|FG000|Overall Study|Protocol Violation|4|||
30647482|NCT00781456|58659688|FG001|Overall Study|Protocol Violation|1|||
30647483|NCT00781456|58659687|FG000|Overall Study|Noncompliance With Protocol|1|||
30647484|NCT00781456|58659688|FG001|Overall Study|Noncompliance With Protocol|1|||
30647485|NCT00781456|58659687|FG000|Overall Study|Lost to Follow-up|10|||
30647486|NCT00781456|58659688|FG001|Overall Study|Lost to Follow-up|5|||
30647487|NCT00781456|58659687|FG000|Overall Study|Other Reason, Unknown|0|||
30647488|NCT00781456|58659688|FG001|Overall Study|Other Reason, Unknown|1|||
30647489|NCT00587158|58659696|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
30647490|NCT00587158|58659697|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
30647491|NCT00587158|58659696|FG000|Overall Study|Physician Decision|0|||
30647492|NCT00587158|58659697|FG001|Overall Study|Physician Decision|1|||
30647493|NCT00587158|58659696|FG000|Overall Study|Lost to Follow-up|1|||
30647494|NCT00587158|58659697|FG001|Overall Study|Lost to Follow-up|2|||
30647495|NCT00587158|58659696|FG000|Overall Study|Death|0|||
30647496|NCT00587158|58659697|FG001|Overall Study|Death|1|||
30647497|NCT00587158|58659696|FG000|Overall Study|Subject did not want to take study med|0|||
30647498|NCT00587158|58659697|FG001|Overall Study|Subject did not want to take study med|1|||
30647499|NCT00582907|58659703|FG000|1st Course|Withdrawal by Subject|1|||
30647500|NCT00582907|58659704|FG001|1st Course|Withdrawal by Subject|0|||
30647501|NCT00582907|58659705|FG002|1st Course|Withdrawal by Subject|0|||
30647502|NCT00582907|58659706|FG003|1st Course|Withdrawal by Subject|0|||
30647503|NCT00582907|58659703|FG000|1st Course|Lost to Follow-up|0|||
30647504|NCT00582907|58659704|FG001|1st Course|Lost to Follow-up|0|||
30647505|NCT00582907|58659705|FG002|1st Course|Lost to Follow-up|0|||
30647506|NCT00582907|58659706|FG003|1st Course|Lost to Follow-up|1|||
30647507|NCT00582907|58659703|FG000|2nd Course|Lack of Efficacy|1|||
30647508|NCT00582907|58659704|FG001|2nd Course|Lack of Efficacy|0|||
30766838|NCT00333983|58775436|FG000|Overall Study|Adverse Event|1|||
30766839|NCT00333983|58775437|FG001|Overall Study|Adverse Event|1|||
30766840|NCT00333983|58775438|FG002|Overall Study|Adverse Event|1|||
30766841|NCT00333983|58775436|FG000|Overall Study|Withdrawal by Subject|0|||
30766842|NCT00333983|58775437|FG001|Overall Study|Withdrawal by Subject|3|||
30766843|NCT00333983|58775438|FG002|Overall Study|Withdrawal by Subject|1|||
30766844|NCT03262012|58775450|FG000|Overall Study|Withdrawal by Subject|15|||
30766845|NCT03262012|58775451|FG001|Overall Study|Withdrawal by Subject|13|||
30766846|NCT03262012|58775452|FG002|Overall Study|Withdrawal by Subject|8|||
30766847|NCT03262012|58775453|FG003|Overall Study|Withdrawal by Subject|7|||
30766848|NCT03262012|58775450|FG000|Overall Study|Adverse Event|10|||
30766849|NCT03262012|58775451|FG001|Overall Study|Adverse Event|12|||
30766850|NCT03262012|58775452|FG002|Overall Study|Adverse Event|4|||
30766851|NCT03262012|58775453|FG003|Overall Study|Adverse Event|6|||
30766852|NCT03262012|58775450|FG000|Overall Study|Physician Decision|2|||
30766853|NCT03262012|58775451|FG001|Overall Study|Physician Decision|5|||
30766854|NCT03262012|58775452|FG002|Overall Study|Physician Decision|1|||
30766855|NCT03262012|58775453|FG003|Overall Study|Physician Decision|0|||
30766856|NCT03262012|58775450|FG000|Overall Study|Lack of Efficacy|0|||
30766857|NCT03262012|58775451|FG001|Overall Study|Lack of Efficacy|5|||
30766858|NCT03262012|58775452|FG002|Overall Study|Lack of Efficacy|1|||
30766859|NCT03262012|58775453|FG003|Overall Study|Lack of Efficacy|2|||
30766860|NCT03262012|58775450|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
30766861|NCT03262012|58775451|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
30766862|NCT03262012|58775452|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
30766863|NCT03262012|58775453|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
30766864|NCT03288142|58775465|FG000|Overall Study|Lost to Follow-up|22|||
30766865|NCT03288142|58775466|FG001|Overall Study|Lost to Follow-up|15|||
30766866|NCT00310817|58775478|FG000|Overall Study|AE or Death|3|||
30766867|NCT00310817|58775479|FG001|Overall Study|AE or Death|1|||
30766868|NCT00310817|58775480|FG002|Overall Study|AE or Death|0|||
30766869|NCT00310817|58775481|FG003|Overall Study|AE or Death|0|||
30647509|NCT00582907|58659705|FG002|2nd Course|Lack of Efficacy|0|||
30647510|NCT00582907|58659706|FG003|2nd Course|Lack of Efficacy|0|||
30647511|NCT01062113|58659715|FG000|Overall Study|Adverse Event|1|||
30647512|NCT01062113|58659716|FG001|Overall Study|Adverse Event|0|||
30766870|NCT00310817|58775478|FG000|Overall Study|Withdrawal by Subject|1|||
30766871|NCT00310817|58775479|FG001|Overall Study|Withdrawal by Subject|4|||
30766872|NCT00310817|58775480|FG002|Overall Study|Withdrawal by Subject|6|||
30766873|NCT00310817|58775481|FG003|Overall Study|Withdrawal by Subject|7|||
30766874|NCT00310817|58775478|FG000|Overall Study|Lost to Follow-up|2|||
30766875|NCT00310817|58775479|FG001|Overall Study|Lost to Follow-up|1|||
30647513|NCT01062113|58659717|FG002|Overall Study|Adverse Event|0|||
30647514|NCT01062113|58659715|FG000|Overall Study|Lack of Efficacy|38|||
30647515|NCT01062113|58659716|FG001|Overall Study|Lack of Efficacy|22|||
30766876|NCT00310817|58775480|FG002|Overall Study|Lost to Follow-up|0|||
30766877|NCT00310817|58775481|FG003|Overall Study|Lost to Follow-up|0|||
30766878|NCT00310817|58775478|FG000|Overall Study|Inappropriate Enrollment|1|||
30766879|NCT00310817|58775479|FG001|Overall Study|Inappropriate Enrollment|0|||
30766880|NCT00310817|58775480|FG002|Overall Study|Inappropriate Enrollment|1|||
30766881|NCT00310817|58775481|FG003|Overall Study|Inappropriate Enrollment|0|||
30766882|NCT00310817|58775478|FG000|Overall Study|Protocol Violation|1|||
30766883|NCT00310817|58775479|FG001|Overall Study|Protocol Violation|1|||
30766884|NCT00310817|58775480|FG002|Overall Study|Protocol Violation|1|||
30766885|NCT00310817|58775481|FG003|Overall Study|Protocol Violation|1|||
30766886|NCT00310817|58775478|FG000|Overall Study|Unable to classify|3|||
30766887|NCT00310817|58775479|FG001|Overall Study|Unable to classify|1|||
30766888|NCT00310817|58775480|FG002|Overall Study|Unable to classify|0|||
30766889|NCT00310817|58775481|FG003|Overall Study|Unable to classify|0|||
30766890|NCT02940886|58775526|FG000|Overall Study|Adverse Event|7|||
30766891|NCT02940886|58775527|FG001|Overall Study|Adverse Event|3|||
30766892|NCT02940886|58775526|FG000|Overall Study|Protocol Violation|0|||
30766893|NCT02940886|58775527|FG001|Overall Study|Protocol Violation|2|||
30848616|NCT04604795|58874766|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
30952021|NCT01698320|58999424|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
30647516|NCT01062113|58659717|FG002|Overall Study|Lack of Efficacy|31|||
30647517|NCT01062113|58659715|FG000|Overall Study|Withdrawal by Subject|1|||
30647518|NCT01062113|58659716|FG001|Overall Study|Withdrawal by Subject|0|||
30647519|NCT01062113|58659717|FG002|Overall Study|Withdrawal by Subject|0|||
30647520|NCT00772330|58659725|FG000|Overall Study|Lost to Follow-up|3|||
30647521|NCT01038869|58659732|FG000|Overall Study|Withdrawal by Subject|1|||
30647522|NCT01038869|58659732|FG000|Overall Study|Lost to Follow-up|6|||
30647523|NCT01038713|58659743|FG000|Overall Study|Patient to hospice|1|||
30647524|NCT01038713|58659744|FG001|Overall Study|Patient to hospice|1|||
30647525|NCT01038713|58659745|FG002|Overall Study|Patient to hospice|1|||
30647526|NCT01038713|58659743|FG000|Overall Study|Lost to Follow-up|3|||
30647527|NCT01038713|58659744|FG001|Overall Study|Lost to Follow-up|0|||
30647528|NCT01038713|58659745|FG002|Overall Study|Lost to Follow-up|0|||
30647529|NCT01038713|58659743|FG000|Overall Study|Neuroendocrine Tumor|0|||
30647530|NCT01038713|58659744|FG001|Overall Study|Neuroendocrine Tumor|1|||
30647531|NCT01038713|58659745|FG002|Overall Study|Neuroendocrine Tumor|0|||
30647532|NCT01038713|58659743|FG000|Overall Study|died from PEP|0|||
30647533|NCT01038713|58659744|FG001|Overall Study|died from PEP|1|||
30647534|NCT01038713|58659745|FG002|Overall Study|died from PEP|0|||
30647535|NCT01038713|58659743|FG000|Overall Study|Autoimmune Pancreatitis|1|||
30647536|NCT01038713|58659744|FG001|Overall Study|Autoimmune Pancreatitis|0|||
30647537|NCT01038713|58659745|FG002|Overall Study|Autoimmune Pancreatitis|0|||
30647538|NCT00768040|58659755|FG000|Overall Study|Adverse Event|3|||
30647539|NCT00768040|58659756|FG001|Overall Study|Adverse Event|2|||
30647540|NCT00768040|58659755|FG000|Overall Study|Abnormal laboratory value|1|||
30647541|NCT00768040|58659756|FG001|Overall Study|Abnormal laboratory value|1|||
30647542|NCT00767806|58659764|FG000|Overall Study|Adverse Event|30|||
30647543|NCT00767806|58659765|FG001|Overall Study|Adverse Event|11|||
30647544|NCT00767806|58659764|FG000|Overall Study|Withdrawal by Subject|8|||
30647545|NCT00767806|58659765|FG001|Overall Study|Withdrawal by Subject|13|||
30647546|NCT00767806|58659764|FG000|Overall Study|Protocol Violation|6|||
30647547|NCT00767806|58659765|FG001|Overall Study|Protocol Violation|5|||
30647548|NCT00767806|58659764|FG000|Overall Study|Lack of Efficacy|1|||
30647549|NCT00767806|58659765|FG001|Overall Study|Lack of Efficacy|9|||
30647550|NCT00767806|58659764|FG000|Overall Study|Physician Decision|4|||
30647551|NCT00767806|58659765|FG001|Overall Study|Physician Decision|3|||
30647552|NCT00767806|58659764|FG000|Overall Study|Lost to Follow-up|1|||
30647553|NCT00767806|58659765|FG001|Overall Study|Lost to Follow-up|4|||
30647554|NCT00767806|58659764|FG000|Overall Study|Entry Criteria Not Met|1|||
30647555|NCT00767806|58659765|FG001|Overall Study|Entry Criteria Not Met|1|||
30647556|NCT00767806|58659764|FG000|Overall Study|Sponsor Decision|0|||
30647557|NCT00767806|58659765|FG001|Overall Study|Sponsor Decision|1|||
30647558|NCT00780910|58659771|FG000|Overall Study|Adverse Event|2|||
30766894|NCT02940886|58775526|FG000|Overall Study|Withdrawal by Subject|28|||
30766895|NCT02940886|58775527|FG001|Overall Study|Withdrawal by Subject|20|||
30766896|NCT02940886|58775526|FG000|Overall Study|Death|1|||
30766897|NCT02940886|58775527|FG001|Overall Study|Death|0|||
30766898|NCT02940886|58775526|FG000|Overall Study|Lack of Efficacy|1|||
30766899|NCT02940886|58775527|FG001|Overall Study|Lack of Efficacy|0|||
30647559|NCT00767104|58659777|FG000|Overall Study|Lost to Follow-up|1|||
30647560|NCT00767104|58659778|FG001|Overall Study|Lost to Follow-up|2|||
30647561|NCT00771472|58659786|FG000|Overall Study|Physician Decision|2|||
30647562|NCT00771472|58659787|FG001|Overall Study|Physician Decision|3|||
30647563|NCT00771472|58659786|FG000|Overall Study|Progressive Disease|3|||
30647564|NCT00771472|58659787|FG001|Overall Study|Progressive Disease|1|||
30647565|NCT00771472|58659786|FG000|Overall Study|Protocol Violation|1|||
30647566|NCT00771472|58659787|FG001|Overall Study|Protocol Violation|0|||
30647567|NCT00771316|58659794|FG000|Overall Study|Adverse Event|0|||
30647568|NCT00771316|58659795|FG001|Overall Study|Adverse Event|1|||
30647569|NCT00771316|58659794|FG000|Overall Study|Patient withdrew consent|1|||
30647570|NCT00771316|58659795|FG001|Overall Study|Patient withdrew consent|0|||
30647571|NCT00771316|58659794|FG000|Overall Study|Discontinued due to early termination|1|||
30647572|NCT00771316|58659795|FG001|Overall Study|Discontinued due to early termination|0|||
30647573|NCT00770770|58659803|FG000|Overall Study|Lost to Follow-up|1|||
30647574|NCT00770770|58659804|FG001|Overall Study|Lost to Follow-up|0|||
30647575|NCT00770770|58659803|FG000|Overall Study|Withdrawal by Subject|1|||
30647576|NCT00770770|58659804|FG001|Overall Study|Withdrawal by Subject|0|||
30647577|NCT00770770|58659803|FG000|Overall Study|Death|0|||
30647578|NCT00770770|58659804|FG001|Overall Study|Death|1|||
30647579|NCT00770770|58659803|FG000|Overall Study|Study Terminated|8|||
30647580|NCT00770770|58659804|FG001|Overall Study|Study Terminated|0|||
30647581|NCT00766636|58659812|FG000|Overall Study|Withdrawal by Subject|1|||
30647582|NCT00766636|58659813|FG001|Overall Study|Withdrawal by Subject|1|||
30647583|NCT00766636|58659812|FG000|Overall Study|Incomplete Treatment|0|||
30647584|NCT00766636|58659813|FG001|Overall Study|Incomplete Treatment|1|||
30647585|NCT00766636|58659812|FG000|Overall Study|Adverse Event|1|||
30647586|NCT00766636|58659813|FG001|Overall Study|Adverse Event|0|||
30647587|NCT00766636|58659812|FG000|Overall Study|Disease Progression|1|||
30647588|NCT00766636|58659813|FG001|Overall Study|Disease Progression|0|||
30647589|NCT00770692|58659823|FG000|Overall Study|Withdrawal by Subject|7|||
30647590|NCT00770692|58659824|FG001|Overall Study|Withdrawal by Subject|9|||
30647591|NCT00770692|58659825|FG002|Overall Study|Withdrawal by Subject|9|||
30647592|NCT00770692|58659826|FG003|Overall Study|Withdrawal by Subject|6|||
30647593|NCT00770692|58659823|FG000|Overall Study|Adverse Event|3|||
30647594|NCT00770692|58659824|FG001|Overall Study|Adverse Event|0|||
30647595|NCT00770692|58659825|FG002|Overall Study|Adverse Event|4|||
30647596|NCT00770692|58659826|FG003|Overall Study|Adverse Event|4|||
30647597|NCT00770692|58659823|FG000|Overall Study|Investigator judgment|2|||
30647598|NCT00770692|58659824|FG001|Overall Study|Investigator judgment|0|||
30647599|NCT00770692|58659825|FG002|Overall Study|Investigator judgment|1|||
30647600|NCT00770692|58659826|FG003|Overall Study|Investigator judgment|1|||
30647601|NCT02743819|58659840|FG000|Overall Study|Lack of Efficacy|5|||
30647602|NCT02743819|58659840|FG000|Overall Study|Death|2|||
30647603|NCT02743819|58659840|FG000|Overall Study|Adverse Event|1|||
30766900|NCT02940886|58775526|FG000|Overall Study|Lost to Follow-up|49|||
30766901|NCT02940886|58775527|FG001|Overall Study|Lost to Follow-up|21|||
30766902|NCT02940886|58775526|FG000|Overall Study|Physician Decision|9|||
30766903|NCT02940886|58775527|FG001|Overall Study|Physician Decision|4|||
30766904|NCT02940886|58775526|FG000|Overall Study|Sponsor decision|0|||
30766905|NCT02940886|58775527|FG001|Overall Study|Sponsor decision|1|||
30766906|NCT02940886|58775526|FG000|Overall Study|No treatment|7|||
30766907|NCT02940886|58775527|FG001|Overall Study|No treatment|2|||
30766908|NCT02940886|58775526|FG000|Overall Study|Enrolment error|0|||
30766909|NCT02940886|58775527|FG001|Overall Study|Enrolment error|1|||
30766910|NCT03285958|58775537|FG000|Overall Study|Lost to Follow-up|1|||
30647604|NCT01004822|58659852|FG000|Overall Study|Objective progression or relapse|3|||
30647605|NCT01004822|58659853|FG001|Overall Study|Objective progression or relapse|3|||
30647606|NCT01004822|58659854|FG002|Overall Study|Objective progression or relapse|0|||
30647607|NCT01004822|58659855|FG003|Overall Study|Objective progression or relapse|1|||
30647608|NCT01004822|58659856|FG004|Overall Study|Objective progression or relapse|2|||
30647609|NCT01004822|58659857|FG005|Overall Study|Objective progression or relapse|2|||
30647610|NCT01004822|58659858|FG006|Overall Study|Objective progression or relapse|1|||
30647611|NCT01004822|58659859|FG007|Overall Study|Objective progression or relapse|4|||
30647612|NCT01004822|58659852|FG000|Overall Study|Global deterioration of health status|0|||
30647613|NCT01004822|58659853|FG001|Overall Study|Global deterioration of health status|0|||
30647614|NCT01004822|58659854|FG002|Overall Study|Global deterioration of health status|0|||
30647615|NCT01004822|58659855|FG003|Overall Study|Global deterioration of health status|1|||
30647616|NCT01004822|58659856|FG004|Overall Study|Global deterioration of health status|0|||
30647617|NCT01004822|58659857|FG005|Overall Study|Global deterioration of health status|0|||
30647618|NCT01004822|58659858|FG006|Overall Study|Global deterioration of health status|1|||
30647619|NCT01004822|58659859|FG007|Overall Study|Global deterioration of health status|0|||
30647620|NCT01004822|58659852|FG000|Overall Study|No longer willing to continue|0|||
30766911|NCT03285958|58775538|FG001|Overall Study|Lost to Follow-up|1|||
30766912|NCT03285958|58775537|FG000|Overall Study|Withdrawal by Subject|1|||
30647621|NCT01004822|58659853|FG001|Overall Study|No longer willing to continue|0|||
30647622|NCT01004822|58659854|FG002|Overall Study|No longer willing to continue|0|||
30766913|NCT03285958|58775538|FG001|Overall Study|Withdrawal by Subject|0|||
30766914|NCT03285958|58775537|FG000|Overall Study|Not able to attend required orientation|3|||
30647623|NCT01004822|58659855|FG003|Overall Study|No longer willing to continue|1|||
30647624|NCT01004822|58659856|FG004|Overall Study|No longer willing to continue|2|||
30647625|NCT01004822|58659857|FG005|Overall Study|No longer willing to continue|1|||
30647626|NCT01004822|58659858|FG006|Overall Study|No longer willing to continue|1|||
30647627|NCT01004822|58659859|FG007|Overall Study|No longer willing to continue|0|||
30766915|NCT03285958|58775538|FG001|Overall Study|Not able to attend required orientation|0|||
30766916|NCT03285646|58775547|FG000|Overall Study|Adverse Event|1|||
30647628|NCT01004822|58659852|FG000|Overall Study|Adverse Event|0|||
30647629|NCT01004822|58659853|FG001|Overall Study|Adverse Event|0|||
30647630|NCT01004822|58659854|FG002|Overall Study|Adverse Event|0|||
30647631|NCT01004822|58659855|FG003|Overall Study|Adverse Event|0|||
30647632|NCT01004822|58659856|FG004|Overall Study|Adverse Event|0|||
30647633|NCT01004822|58659857|FG005|Overall Study|Adverse Event|0|||
30647634|NCT01004822|58659858|FG006|Overall Study|Adverse Event|1|||
30647635|NCT01004822|58659859|FG007|Overall Study|Adverse Event|1|||
30647636|NCT01004822|58659852|FG000|Overall Study|Other|0|||
30647637|NCT01004822|58659853|FG001|Overall Study|Other|0|||
30647638|NCT01004822|58659854|FG002|Overall Study|Other|4|||
30647639|NCT01004822|58659855|FG003|Overall Study|Other|1|||
30647640|NCT01004822|58659856|FG004|Overall Study|Other|0|||
30647641|NCT01004822|58659857|FG005|Overall Study|Other|1|||
30647642|NCT01004822|58659858|FG006|Overall Study|Other|0|||
30647643|NCT01004822|58659859|FG007|Overall Study|Other|0|||
30647644|NCT01001234|58659884|FG000|Overall Study|Withdrawal by Subject|2|||
30647645|NCT01001234|58659885|FG001|Overall Study|Withdrawal by Subject|0|||
30647646|NCT01001234|58659886|FG002|Overall Study|Withdrawal by Subject|3|||
30647647|NCT01001234|58659887|FG003|Overall Study|Withdrawal by Subject|0|||
30766917|NCT03285646|58775548|FG001|Overall Study|Adverse Event|0|||
30766918|NCT03285646|58775547|FG000|Overall Study|Withdrawal by Subject|10|||
30766919|NCT03285646|58775548|FG001|Overall Study|Withdrawal by Subject|2|||
30766920|NCT03285646|58775547|FG000|Overall Study|Lost to Follow-up|2|||
30766921|NCT03285646|58775548|FG001|Overall Study|Lost to Follow-up|1|||
30766922|NCT03285646|58775547|FG000|Overall Study|Investigator/Sponsor Decision|0|||
30766923|NCT03285646|58775548|FG001|Overall Study|Investigator/Sponsor Decision|1|||
30766924|NCT03309202|58775559|FG000|Overall Study|Lost to Follow-up|1|||
30647648|NCT01001234|58659888|FG004|Overall Study|Withdrawal by Subject|0|||
30647649|NCT01001234|58659884|FG000|Overall Study|Protocol Violation|34|||
30647650|NCT01001234|58659885|FG001|Overall Study|Protocol Violation|3|||
30647651|NCT01001234|58659886|FG002|Overall Study|Protocol Violation|19|||
30647652|NCT01001234|58659887|FG003|Overall Study|Protocol Violation|18|||
30647653|NCT01001234|58659888|FG004|Overall Study|Protocol Violation|0|||
30647654|NCT01001234|58659884|FG000|Overall Study|Lost to Follow-up|0|||
30647655|NCT01001234|58659885|FG001|Overall Study|Lost to Follow-up|0|||
30647656|NCT01001234|58659886|FG002|Overall Study|Lost to Follow-up|1|||
30647657|NCT01001234|58659887|FG003|Overall Study|Lost to Follow-up|2|||
30766925|NCT03309202|58775560|FG001|Overall Study|Lost to Follow-up|0|||
30766926|NCT03309202|58775561|FG002|Overall Study|Lost to Follow-up|0|||
30766927|NCT03309202|58775562|FG003|Overall Study|Lost to Follow-up|0|||
30766928|NCT00074490|58775577|FG000|Overall Study|Progressive malignancy|0|||
30647658|NCT01001234|58659888|FG004|Overall Study|Lost to Follow-up|0|||
30647659|NCT01001234|58659884|FG000|Overall Study|Physician Decision|1|||
30647660|NCT01001234|58659885|FG001|Overall Study|Physician Decision|0|||
30647661|NCT01001234|58659886|FG002|Overall Study|Physician Decision|0|||
30647662|NCT01001234|58659887|FG003|Overall Study|Physician Decision|0|||
30647663|NCT01001234|58659888|FG004|Overall Study|Physician Decision|0|||
30647664|NCT01001234|58659884|FG000|Overall Study|Not Treated: Adverse Event|1|||
30647665|NCT01001234|58659885|FG001|Overall Study|Not Treated: Adverse Event|0|||
30647666|NCT01001234|58659886|FG002|Overall Study|Not Treated: Adverse Event|0|||
30647667|NCT01001234|58659887|FG003|Overall Study|Not Treated: Adverse Event|0|||
30647668|NCT01001234|58659888|FG004|Overall Study|Not Treated: Adverse Event|0|||
30647669|NCT01001234|58659884|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
30647670|NCT01001234|58659885|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
30647671|NCT01001234|58659886|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
30647672|NCT01001234|58659887|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
30647673|NCT01001234|58659888|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
30766929|NCT00074490|58775578|FG001|Overall Study|Progressive malignancy|7|||
30766930|NCT00074490|58775579|FG002|Overall Study|Progressive malignancy|0|||
30766931|NCT00074490|58775580|FG003|Overall Study|Progressive malignancy|0|||
30647674|NCT01001234|58659884|FG000|Overall Study|Not Treated: Protocol Violation|3|||
30647675|NCT01001234|58659885|FG001|Overall Study|Not Treated: Protocol Violation|0|||
30647676|NCT01001234|58659886|FG002|Overall Study|Not Treated: Protocol Violation|0|||
30647677|NCT01001234|58659887|FG003|Overall Study|Not Treated: Protocol Violation|0|||
30647678|NCT01001234|58659888|FG004|Overall Study|Not Treated: Protocol Violation|0|||
30647679|NCT01001234|58659884|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
30647680|NCT01001234|58659885|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
30647681|NCT01001234|58659886|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
30647682|NCT01001234|58659887|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
30766932|NCT00074490|58775581|FG004|Overall Study|Progressive malignancy|3|||
30766933|NCT00074490|58775582|FG005|Overall Study|Progressive malignancy|0|||
30647683|NCT01001234|58659888|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
30766934|NCT03285490|58775597|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
30766935|NCT03285490|58775598|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
30766936|NCT03285490|58775597|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
30766937|NCT03285490|58775598|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
30766938|NCT02939716|58775605|FG000|Overall Study|scanner failure|0|||
30766939|NCT02939716|58775606|FG001|Overall Study|scanner failure|0|||
30766940|NCT02939716|58775607|FG002|Overall Study|scanner failure|0|||
30647684|NCT01001234|58659884|FG000|Overall Study|Not Treated: Pregnancy|3|||
30647685|NCT01001234|58659885|FG001|Overall Study|Not Treated: Pregnancy|0|||
30647686|NCT01001234|58659886|FG002|Overall Study|Not Treated: Pregnancy|0|||
30647687|NCT01001234|58659887|FG003|Overall Study|Not Treated: Pregnancy|0|||
30647688|NCT01001234|58659888|FG004|Overall Study|Not Treated: Pregnancy|0|||
30647689|NCT01001234|58659884|FG000|Overall Study|Not Treated: Physician Decision|37|||
30647690|NCT01001234|58659885|FG001|Overall Study|Not Treated: Physician Decision|4|||
30647691|NCT01001234|58659886|FG002|Overall Study|Not Treated: Physician Decision|0|||
30647692|NCT01001234|58659887|FG003|Overall Study|Not Treated: Physician Decision|0|||
30647693|NCT01001234|58659888|FG004|Overall Study|Not Treated: Physician Decision|0|||
30647694|NCT01001234|58659884|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
30647695|NCT01001234|58659885|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
30647696|NCT01001234|58659886|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
30647697|NCT01001234|58659887|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
30647698|NCT01001234|58659888|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
30647699|NCT01004510|58659894|FG000|Overall Study|Adverse Event|1|||
30647700|NCT02609503|58659898|FG000|Overall Study|Adverse Event|1|||
30647701|NCT02609503|58659898|FG000|Overall Study|Death|1|||
30647702|NCT02609503|58659898|FG000|Overall Study|Withdrawal by Subject|1|||
30647703|NCT02609503|58659898|FG000|Overall Study|Disease progression|1|||
30647704|NCT01004432|58659905|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
30647705|NCT01004432|58659906|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
30647706|NCT01004432|58659907|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
30647707|NCT01004432|58659908|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
30647708|NCT01004432|58659909|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
30647709|NCT01004432|58659905|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
30647710|NCT01004432|58659906|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
30647711|NCT01004432|58659907|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
30647712|NCT01004432|58659908|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
30647713|NCT01004432|58659909|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
30647714|NCT01004432|58659905|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
30647715|NCT01004432|58659906|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
30647716|NCT01004432|58659907|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
30647717|NCT01004432|58659908|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
30647718|NCT01004432|58659909|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
30647719|NCT01004432|58659905|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
30647720|NCT01004432|58659906|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
30647721|NCT01004432|58659907|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
30647722|NCT01004432|58659908|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
30647723|NCT01004432|58659909|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
30647724|NCT01004432|58659905|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
30647725|NCT01004432|58659906|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
30647726|NCT01004432|58659907|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
30647727|NCT01004432|58659908|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
30647728|NCT01004432|58659909|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
30766941|NCT02939716|58775608|FG003|Overall Study|scanner failure|1|||
30766942|NCT02939716|58775609|FG004|Overall Study|scanner failure|1|||
30766943|NCT02939716|58775610|FG005|Overall Study|scanner failure|1|||
30766944|NCT00367133|58775639|FG000|2 Years|Death|20|||
30766945|NCT00367133|58775640|FG001|2 Years|Death|12|||
30766946|NCT00367133|58775641|FG002|2 Years|Death|12|||
30766947|NCT00367133|58775639|FG000|2 Years|Dropped|34|||
30766948|NCT00367133|58775640|FG001|2 Years|Dropped|19|||
30766949|NCT00367133|58775641|FG002|2 Years|Dropped|33|||
30647729|NCT01004432|58659905|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
30766950|NCT00367133|58775639|FG000|2 Years|Missed visit|4|||
30766951|NCT00367133|58775640|FG001|2 Years|Missed visit|5|||
30766952|NCT00367133|58775641|FG002|2 Years|Missed visit|4|||
30766953|NCT00367055|58775651|FG000|Overall Study|Adverse Event|6|||
30647730|NCT01004432|58659906|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
30766954|NCT00367055|58775652|FG001|Overall Study|Adverse Event|3|||
30766955|NCT00367055|58775651|FG000|Overall Study|Patient's Willing|3|||
30766956|NCT00367055|58775652|FG001|Overall Study|Patient's Willing|2|||
30766957|NCT00367055|58775651|FG000|Overall Study|Lack of Efficacy|1|||
30952022|NCT01698320|58999422|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
30766958|NCT00367055|58775652|FG001|Overall Study|Lack of Efficacy|2|||
30766959|NCT00367055|58775651|FG000|Overall Study|Lost to Follow-up|1|||
30766960|NCT00367055|58775652|FG001|Overall Study|Lost to Follow-up|1|||
30766961|NCT00367055|58775651|FG000|Overall Study|Protocol Violation|0|||
30766962|NCT00367055|58775652|FG001|Overall Study|Protocol Violation|1|||
30766963|NCT00367055|58775651|FG000|Overall Study|Stopping Criterion Met|0|||
30766964|NCT00367055|58775652|FG001|Overall Study|Stopping Criterion Met|1|||
30766965|NCT00367055|58775651|FG000|Overall Study|Participant Living too Far from Hospital|0|||
30766966|NCT00367055|58775652|FG001|Overall Study|Participant Living too Far from Hospital|1|||
30766967|NCT00057330|58775660|FG000|Overall Study|Adverse Event|9|||
30766968|NCT00057330|58775661|FG001|Overall Study|Adverse Event|12|||
30766969|NCT00057330|58775660|FG000|Overall Study|Death|1|||
30766970|NCT00057330|58775661|FG001|Overall Study|Death|0|||
30766971|NCT00057330|58775660|FG000|Overall Study|Protocol Violation|1|||
30952023|NCT01698320|58999423|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
30952024|NCT01698320|58999424|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
30952025|NCT01698320|58999422|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
30952026|NCT01698320|58999423|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
30952027|NCT01698320|58999424|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
30952028|NCT01698320|58999422|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
30647731|NCT01004432|58659907|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
30647732|NCT01004432|58659908|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
30647733|NCT01004432|58659909|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
30647734|NCT01004432|58659905|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
30647735|NCT01004432|58659906|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
30647736|NCT01004432|58659907|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
30647737|NCT01004432|58659908|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
30647738|NCT01004432|58659909|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
30647739|NCT01004432|58659905|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
30647740|NCT01004432|58659906|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
30647741|NCT01004432|58659907|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
30647742|NCT01004432|58659908|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
30647743|NCT01004432|58659909|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
30647744|NCT01004432|58659905|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
30647745|NCT01004432|58659906|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
30647746|NCT01004432|58659907|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
30647747|NCT01004432|58659908|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
30647748|NCT01004432|58659909|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
30647749|NCT01004432|58659905|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
30952029|NCT01698320|58999423|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
30952030|NCT01698320|58999424|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
30952031|NCT01698320|58999422|FG000|12-Week Double-Blind Period|Adverse Event|0|||
30952032|NCT01698320|58999423|FG001|12-Week Double-Blind Period|Adverse Event|1|||
30952033|NCT01698320|58999424|FG002|12-Week Double-Blind Period|Adverse Event|1|||
30952034|NCT01698320|58999422|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
30952035|NCT01698320|58999423|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
30952036|NCT01698320|58999424|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
30952037|NCT01698320|58999422|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
30952038|NCT01698320|58999423|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
30952039|NCT01698320|58999424|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
30952040|NCT01698320|58999422|FG000|12-Week Double-Blind Period|Pregnancy|0|||
30952041|NCT01698320|58999423|FG001|12-Week Double-Blind Period|Pregnancy|1|||
30952042|NCT01698320|58999424|FG002|12-Week Double-Blind Period|Pregnancy|1|||
30952043|NCT01698320|58999422|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
30952044|NCT01698320|58999423|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
30952045|NCT01698320|58999424|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
30952046|NCT01698320|58999422|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
30952047|NCT01698320|58999423|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
30952048|NCT01698320|58999424|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
30952049|NCT01698320|58999422|FG000|40-Week Open-Label Period|Adverse Event|0|||
30952050|NCT01698320|58999423|FG001|40-Week Open-Label Period|Adverse Event|3|||
30647750|NCT01004432|58659906|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
30647751|NCT01004432|58659907|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
30766972|NCT00057330|58775661|FG001|Overall Study|Protocol Violation|1|||
30766973|NCT00057330|58775660|FG000|Overall Study|Withdrawal by Subject|115|||
30766974|NCT00057330|58775661|FG001|Overall Study|Withdrawal by Subject|84|||
30766975|NCT00057330|58775660|FG000|Overall Study|Lost to Follow-up|745|||
30766976|NCT00057330|58775661|FG001|Overall Study|Lost to Follow-up|617|||
30647752|NCT01004432|58659908|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
30647753|NCT01004432|58659909|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
30647754|NCT01004432|58659905|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
30647755|NCT01004432|58659906|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
30647756|NCT01004432|58659907|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
30647757|NCT01004432|58659908|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
30647758|NCT01004432|58659909|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
30647759|NCT01004432|58659905|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
30647760|NCT01004432|58659906|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
30647761|NCT01004432|58659907|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
30647762|NCT01004432|58659908|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
30647763|NCT01004432|58659909|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
30647764|NCT01004432|58659905|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
30647765|NCT01004432|58659906|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
30647766|NCT01004432|58659907|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
30647767|NCT01004432|58659908|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
30647768|NCT01004432|58659909|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
30647769|NCT01004432|58659905|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
30647770|NCT01004432|58659906|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
30647771|NCT01004432|58659907|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
30647772|NCT01004432|58659908|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
30647773|NCT01004432|58659909|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
30647774|NCT01004432|58659905|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
30647775|NCT01004432|58659906|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
30647776|NCT01004432|58659907|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
30647777|NCT01004432|58659908|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
30647778|NCT01004432|58659909|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
30766977|NCT00057330|58775660|FG000|Overall Study|Physician Decision|1|||
30766978|NCT00057330|58775661|FG001|Overall Study|Physician Decision|0|||
30766979|NCT00057330|58775660|FG000|Overall Study|Other|260|||
30766980|NCT00057330|58775661|FG001|Overall Study|Other|206|||
30766981|NCT03283696|58775669|FG000|Overall Study|Physician Decision|5|||
30766982|NCT03283696|58775670|FG001|Overall Study|Physician Decision|6|||
30766983|NCT03283696|58775669|FG000|Overall Study|Withdrawal by Subject|2|||
30766984|NCT03283696|58775670|FG001|Overall Study|Withdrawal by Subject|0|||
30766985|NCT02939560|58775676|FG000|Overall Study|Withdrawal by Subject|2|||
30766986|NCT02939560|58775676|FG000|Overall Study|Protocol Violation|1|||
30766987|NCT03748706|58775680|FG000|Overall Study|Lost to Follow-up|1|||
30766988|NCT03747302|58775686|FG000|Overall Study|Withdrawal by Subject|1|||
30766989|NCT03747302|58775687|FG001|Overall Study|Withdrawal by Subject|2|||
30766990|NCT00056862|58775697|FG000|Overall Study|Protocol Violation|1|||
30766991|NCT00056862|58775698|FG001|Overall Study|Protocol Violation|0|||
30766992|NCT00056316|58775706|FG000|Overall Study|Withdrawal by Subject|2|||
30766993|NCT00056316|58775707|FG001|Overall Study|Withdrawal by Subject|2|||
30766994|NCT00056316|58775706|FG000|Overall Study|Death/NH placement of pt|1|||
30766995|NCT00056316|58775707|FG001|Overall Study|Death/NH placement of pt|1|||
30766996|NCT03308968|58775716|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
30766997|NCT03308968|58775717|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
30766998|NCT03308968|58775718|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
30766999|NCT03308968|58775716|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
30767000|NCT03308968|58775717|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
30767001|NCT03308968|58775718|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
30767002|NCT03308968|58775716|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
30767003|NCT03308968|58775717|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
30767004|NCT03308968|58775718|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
30767005|NCT03308968|58775716|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
30767006|NCT03308968|58775717|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
30767007|NCT03308968|58775718|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
30767008|NCT03308968|58775716|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
30952051|NCT01698320|58999424|FG002|40-Week Open-Label Period|Adverse Event|2|||
30647779|NCT01000610|58659923|FG000|Overall Study|Adverse Event|1|||
30767009|NCT03308968|58775717|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
30952052|NCT01698320|58999422|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
30647780|NCT01000610|58659923|FG000|Overall Study|Lost to Follow-up|4|||
30767010|NCT03308968|58775718|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
30767011|NCT03308968|58775716|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
30767012|NCT03308968|58775717|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
30767013|NCT03308968|58775718|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
30767014|NCT03308968|58775716|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
30952053|NCT01698320|58999423|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
30647781|NCT01000610|58659923|FG000|Overall Study|Treatment failure|1|||
30647782|NCT01877655|58659929|FG000|Overall Study|Death|57|||
30647783|NCT01877655|58659930|FG001|Overall Study|Death|52|||
30647784|NCT01877655|58659929|FG000|Overall Study|Withdrawal by Subject|18|||
30647785|NCT01877655|58659930|FG001|Overall Study|Withdrawal by Subject|26|||
30647786|NCT01877655|58659929|FG000|Overall Study|Physician Decision|11|||
30647787|NCT01877655|58659930|FG001|Overall Study|Physician Decision|10|||
30647788|NCT01877655|58659929|FG000|Overall Study|Miscellaneous|4|||
30647789|NCT01877655|58659930|FG001|Overall Study|Miscellaneous|4|||
30647790|NCT01877655|58659929|FG000|Overall Study|Randomized but Never Received Drug|8|||
30647791|NCT01877655|58659930|FG001|Overall Study|Randomized but Never Received Drug|5|||
30647792|NCT00586924|58659942|FG000|Overall Study|Adverse event/serious adverse event|0|||
30647793|NCT00586924|58659943|FG001|Overall Study|Adverse event/serious adverse event|0|||
30647794|NCT00586924|58659944|FG002|Overall Study|Adverse event/serious adverse event|0|||
30647795|NCT00586924|58659945|FG003|Overall Study|Adverse event/serious adverse event|1|||
30647796|NCT00586924|58659946|FG004|Overall Study|Adverse event/serious adverse event|0|||
30647797|NCT00586924|58659947|FG005|Overall Study|Adverse event/serious adverse event|2|||
30647798|NCT00586924|58659942|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
30647799|NCT00586924|58659943|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
30647800|NCT00586924|58659944|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
30647801|NCT00586924|58659945|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
30647802|NCT00586924|58659946|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
30647803|NCT00586924|58659947|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
30647804|NCT00586924|58659942|FG000|Overall Study|Disease progression|0|||
30647805|NCT00586924|58659943|FG001|Overall Study|Disease progression|0|||
30647806|NCT00586924|58659944|FG002|Overall Study|Disease progression|0|||
30647807|NCT00586924|58659945|FG003|Overall Study|Disease progression|1|||
30647808|NCT00586924|58659946|FG004|Overall Study|Disease progression|1|||
30647809|NCT00586924|58659947|FG005|Overall Study|Disease progression|0|||
30647810|NCT00586924|58659942|FG000|Overall Study|Development of neutralizing antibodies|2|||
30647811|NCT00586924|58659943|FG001|Overall Study|Development of neutralizing antibodies|2|||
30647812|NCT00586924|58659944|FG002|Overall Study|Development of neutralizing antibodies|2|||
30647813|NCT00586924|58659945|FG003|Overall Study|Development of neutralizing antibodies|0|||
30647814|NCT00586924|58659946|FG004|Overall Study|Development of neutralizing antibodies|0|||
30647815|NCT00586924|58659947|FG005|Overall Study|Development of neutralizing antibodies|22|||
30647816|NCT00586924|58659942|FG000|Overall Study|Complete response|0|||
30647817|NCT00586924|58659943|FG001|Overall Study|Complete response|1|||
30647818|NCT00586924|58659944|FG002|Overall Study|Complete response|0|||
30647819|NCT00586924|58659945|FG003|Overall Study|Complete response|0|||
30647820|NCT00586924|58659946|FG004|Overall Study|Complete response|2|||
30647821|NCT00586924|58659947|FG005|Overall Study|Complete response|2|||
30647822|NCT00586924|58659942|FG000|Overall Study|Other|1|||
30647823|NCT00586924|58659943|FG001|Overall Study|Other|0|||
30647824|NCT00586924|58659944|FG002|Overall Study|Other|1|||
30647825|NCT00586924|58659945|FG003|Overall Study|Other|1|||
30647826|NCT00586924|58659946|FG004|Overall Study|Other|1|||
30647827|NCT00586924|58659947|FG005|Overall Study|Other|6|||
30647828|NCT01000376|58659963|FG000|Cycle 1 Day 1|Adverse Event|1|||
30647829|NCT01000376|58659964|FG001|Cycle 1 Day 1|Adverse Event|0|||
30647830|NCT01000376|58659963|FG000|Cycle 1 Day 1|Progressive Disease|1|||
30647831|NCT01000376|58659964|FG001|Cycle 1 Day 1|Progressive Disease|0|||
30647832|NCT01038635|58659979|FG000|Overall Study|Disease Progression|2|||
30647833|NCT01038635|58659980|FG001|Overall Study|Disease Progression|0|||
30647834|NCT01038635|58659981|FG002|Overall Study|Disease Progression|0|||
30647835|NCT01038635|58659982|FG003|Overall Study|Disease Progression|0|||
30647836|NCT01038635|58659983|FG004|Overall Study|Disease Progression|0|||
30647837|NCT01038635|58659984|FG005|Overall Study|Disease Progression|0|||
30647838|NCT01038635|58659985|FG006|Overall Study|Disease Progression|1|||
30647839|NCT01038635|58659986|FG007|Overall Study|Disease Progression|4|||
30647840|NCT01038635|58659987|FG008|Overall Study|Disease Progression|0|||
30647841|NCT01038635|58659979|FG000|Overall Study|Death|0|||
30647842|NCT01038635|58659980|FG001|Overall Study|Death|0|||
30647843|NCT01038635|58659981|FG002|Overall Study|Death|0|||
30647844|NCT01038635|58659982|FG003|Overall Study|Death|0|||
30647845|NCT01038635|58659983|FG004|Overall Study|Death|1|||
30647846|NCT01038635|58659984|FG005|Overall Study|Death|0|||
30647847|NCT01038635|58659985|FG006|Overall Study|Death|1|||
30647848|NCT01038635|58659986|FG007|Overall Study|Death|1|||
30647849|NCT01038635|58659987|FG008|Overall Study|Death|2|||
30647850|NCT01000064|58660008|FG000|Overall Study|Withdrawal by Subject|1|||
30647851|NCT01000064|58660009|FG001|Overall Study|Withdrawal by Subject|1|||
30647852|NCT00766090|58660020|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30647853|NCT00766090|58660021|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30647854|NCT00766090|58660022|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30647855|NCT00766090|58660023|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30647856|NCT00766090|58660024|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30647857|NCT00766090|58660025|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30647858|NCT00766090|58660026|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30647859|NCT00766090|58660027|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30647860|NCT00766090|58660028|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
30647861|NCT00766090|58660029|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30647862|NCT00766090|58660030|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30647863|NCT00766090|58660031|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30647864|NCT00766090|58660020|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
30647865|NCT00766090|58660021|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
30647866|NCT00766090|58660022|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
30647867|NCT00766090|58660023|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
30647868|NCT00766090|58660024|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
30647869|NCT00766090|58660025|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
30647870|NCT00766090|58660026|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
30647871|NCT00766090|58660027|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
30647872|NCT00766090|58660028|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
30647873|NCT00766090|58660029|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
30647874|NCT00766090|58660030|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
30647875|NCT00766090|58660031|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
30647876|NCT00766090|58660020|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
30647877|NCT00766090|58660021|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30647878|NCT00766090|58660022|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30647879|NCT00766090|58660023|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
30647880|NCT00766090|58660024|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30647881|NCT00766090|58660025|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30647882|NCT00766090|58660026|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30647883|NCT00766090|58660027|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30647884|NCT00766090|58660028|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30647885|NCT00766090|58660029|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30647886|NCT00766090|58660030|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30647887|NCT00766090|58660031|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30647888|NCT00766090|58660020|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
30647889|NCT00766090|58660021|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
30647890|NCT00766090|58660022|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
30647891|NCT00766090|58660023|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
30647892|NCT00766090|58660024|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
30647893|NCT00766090|58660025|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
30647894|NCT00766090|58660026|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
30647895|NCT00766090|58660027|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
30647896|NCT00766090|58660028|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
30647897|NCT00766090|58660029|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
30647898|NCT00766090|58660030|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
30647899|NCT00766090|58660031|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
30647900|NCT00766090|58660020|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30647901|NCT00766090|58660021|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30647902|NCT00766090|58660022|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30647903|NCT00766090|58660023|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30647904|NCT00766090|58660024|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
30647905|NCT00766090|58660025|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30647906|NCT00766090|58660026|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30647907|NCT00766090|58660027|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30647908|NCT00766090|58660028|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30647909|NCT00766090|58660029|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30647910|NCT00766090|58660030|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30647911|NCT00766090|58660031|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
30647912|NCT00766090|58660020|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
30647913|NCT00766090|58660021|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
30647914|NCT00766090|58660022|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
30647915|NCT00766090|58660023|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
30647916|NCT00766090|58660024|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
30647917|NCT00766090|58660025|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
30647918|NCT00766090|58660026|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
30647919|NCT00766090|58660027|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
30647920|NCT00766090|58660028|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
30647921|NCT00766090|58660029|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
30647922|NCT00766090|58660030|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
30647923|NCT00766090|58660031|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
30647924|NCT00766090|58660020|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
30647925|NCT00766090|58660021|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
30647926|NCT00766090|58660022|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
30647927|NCT00766090|58660023|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
30647928|NCT00766090|58660024|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
30647929|NCT00766090|58660025|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
30647930|NCT00766090|58660026|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
30647931|NCT00766090|58660027|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
30647932|NCT00766090|58660028|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
30647933|NCT00766090|58660029|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
30647934|NCT00766090|58660030|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
30647935|NCT00766090|58660031|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
30647936|NCT00766090|58660020|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
30647937|NCT00766090|58660021|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
30647938|NCT00766090|58660022|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
30647939|NCT00766090|58660023|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
30647940|NCT00766090|58660024|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
30647941|NCT00766090|58660025|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
30647942|NCT00766090|58660026|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
30647943|NCT00766090|58660027|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
30647944|NCT00766090|58660028|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
30647945|NCT00766090|58660029|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
30647946|NCT00766090|58660030|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
30647947|NCT00766090|58660031|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
30647948|NCT00766090|58660020|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
30647949|NCT00766090|58660021|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
30647950|NCT00766090|58660022|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
30647951|NCT00766090|58660023|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
30647952|NCT00766090|58660024|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
30647953|NCT00766090|58660025|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
30647954|NCT00766090|58660026|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
30647955|NCT00766090|58660027|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
30647956|NCT00766090|58660028|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
30647957|NCT00766090|58660029|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
30647958|NCT00766090|58660030|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
30647959|NCT00766090|58660031|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
30647960|NCT00766090|58660020|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
30647961|NCT00766090|58660021|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
30647962|NCT00766090|58660022|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
30647963|NCT00766090|58660023|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
30647964|NCT00766090|58660024|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
30647965|NCT00766090|58660025|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
30647966|NCT00766090|58660026|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
30647967|NCT00766090|58660027|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
30647968|NCT00766090|58660028|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
30647969|NCT00766090|58660029|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
30647970|NCT00766090|58660030|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
30647971|NCT00766090|58660031|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
30647972|NCT00580801|58660048|FG000|Overall Study|Physician Decision|1|||
30647973|NCT00580801|58660049|FG001|Overall Study|Physician Decision|0|||
30647974|NCT00580801|58660050|FG002|Overall Study|Physician Decision|0|||
30647975|NCT00580801|58660048|FG000|Overall Study|Adverse Event|2|||
30647976|NCT00580801|58660049|FG001|Overall Study|Adverse Event|0|||
30647977|NCT00580801|58660050|FG002|Overall Study|Adverse Event|0|||
30647978|NCT00580801|58660048|FG000|Overall Study|Lost to Follow-up|2|||
30647979|NCT00580801|58660049|FG001|Overall Study|Lost to Follow-up|0|||
30647980|NCT00580801|58660050|FG002|Overall Study|Lost to Follow-up|0|||
30647981|NCT00580801|58660048|FG000|Overall Study|Reached a virologic endpoint|0|||
30647982|NCT00580801|58660049|FG001|Overall Study|Reached a virologic endpoint|1|||
30647983|NCT00580801|58660050|FG002|Overall Study|Reached a virologic endpoint|2|||
30647984|NCT00580801|58660048|FG000|Overall Study|Participant non-compliant|0|||
30647985|NCT00580801|58660049|FG001|Overall Study|Participant non-compliant|0|||
30647986|NCT00580801|58660050|FG002|Overall Study|Participant non-compliant|1|||
30647987|NCT00580801|58660048|FG000|Overall Study|Travel|1|||
30647988|NCT00580801|58660049|FG001|Overall Study|Travel|0|||
30647989|NCT00580801|58660050|FG002|Overall Study|Travel|0|||
30647990|NCT01059539|58660058|FG000|Overall Study|Adverse Event|66|||
30647991|NCT01059539|58660058|FG000|Overall Study|Insufficient Therapeutic Response|26|||
30647992|NCT01059539|58660058|FG000|Overall Study|Protocol Violation|55|||
30647993|NCT01059539|58660058|FG000|Overall Study|Withdrawal of Consent|80|||
30647994|NCT01059539|58660058|FG000|Overall Study|Lost to Follow-up|42|||
30647995|NCT01059539|58660058|FG000|Overall Study|Reason Not Specified|2|||
30952054|NCT01698320|58999424|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
30952055|NCT01698320|58999422|FG000|40-Week Open-Label Period|Pregnancy|0|||
30647996|NCT00999908|58660062|FG000|Treatment Period 1|Subject withdrew consent|2|||
30647997|NCT00999908|58660063|FG001|Treatment Period 1|Subject withdrew consent|0|||
30647998|NCT00999908|58660064|FG002|Treatment Period 1|Subject withdrew consent|0|||
30647999|NCT00999908|58660062|FG000|Treatment Period 2|Protocol Violation|1|||
30648000|NCT00999908|58660063|FG001|Treatment Period 2|Protocol Violation|0|||
30648001|NCT00999908|58660064|FG002|Treatment Period 2|Protocol Violation|0|||
30648002|NCT00580723|58660072|FG000|Overall Study|Did not want to participate in extension|3|||
30648003|NCT00580723|58660072|FG000|Overall Study|Lost to Follow-up|5|||
30648004|NCT00999596|58660076|FG000|Overall Study|Statistical population not required|101|||
30648005|NCT04676867|58660085|FG000|Overall Study|Screen failure|0|||
30648006|NCT04676867|58660086|FG001|Overall Study|Screen failure|0|||
30648007|NCT04676867|58660087|FG002|Overall Study|Screen failure|6|||
30648008|NCT04676867|58660088|FG003|Overall Study|Screen failure|2|||
30648009|NCT04676867|58660085|FG000|Overall Study|Death|0|||
30648010|NCT04676867|58660086|FG001|Overall Study|Death|0|||
30648011|NCT04676867|58660087|FG002|Overall Study|Death|1|||
30648012|NCT04676867|58660088|FG003|Overall Study|Death|0|||
30648013|NCT04676867|58660085|FG000|Overall Study|Withdrawal by Subject|2|||
30648014|NCT04676867|58660086|FG001|Overall Study|Withdrawal by Subject|2|||
30648015|NCT04676867|58660087|FG002|Overall Study|Withdrawal by Subject|4|||
30648016|NCT04676867|58660088|FG003|Overall Study|Withdrawal by Subject|4|||
30648017|NCT04676867|58660085|FG000|Overall Study|Lost to Follow-up|1|||
30648018|NCT04676867|58660086|FG001|Overall Study|Lost to Follow-up|0|||
30648019|NCT04676867|58660087|FG002|Overall Study|Lost to Follow-up|0|||
30648020|NCT04676867|58660088|FG003|Overall Study|Lost to Follow-up|0|||
30648021|NCT00770224|58660098|FG000|Step 1: Induction|Adverse Event|3|||
30648022|NCT00770224|58660099|FG001|Step 1: Induction|Adverse Event|0|||
30648023|NCT00770224|58660098|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
30648024|NCT00770224|58660099|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
30648025|NCT00770224|58660098|FG000|Step 1: Induction|Other reason not protocol specified|2|||
30648026|NCT00770224|58660099|FG001|Step 1: Induction|Other reason not protocol specified|0|||
30648027|NCT00770224|58660098|FG000|Step 1: Induction|Ineligible|2|||
30648028|NCT00770224|58660099|FG001|Step 1: Induction|Ineligible|0|||
30648029|NCT00770224|58660098|FG000|Step 1: Induction|No protocol treatment given|1|||
30648030|NCT00770224|58660099|FG001|Step 1: Induction|No protocol treatment given|0|||
30648031|NCT00770224|58660098|FG000|Step 2: Maintenance|Adverse Event|0|||
30648032|NCT00770224|58660099|FG001|Step 2: Maintenance|Adverse Event|10|||
30648033|NCT00770224|58660098|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
30648034|NCT00770224|58660099|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
30648035|NCT00770224|58660098|FG000|Step 2: Maintenance|Progression/relapse|0|||
30648036|NCT00770224|58660099|FG001|Step 2: Maintenance|Progression/relapse|1|||
30648037|NCT00770224|58660098|FG000|Step 2: Maintenance|Death|0|||
30648038|NCT00770224|58660099|FG001|Step 2: Maintenance|Death|2|||
30648039|NCT00770224|58660098|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
30648040|NCT00770224|58660099|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
30648041|NCT00770224|58660098|FG000|Step 2: Maintenance|Ineligible|0|||
30648042|NCT00770224|58660099|FG001|Step 2: Maintenance|Ineligible|2|||
30648043|NCT02399215|58660106|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
30648044|NCT02399215|58660106|FG000|Overall Study|Withdrawal by Subject|1|||
30648045|NCT01057589|58660110|FG000|Overall Study|Disease Progression|35|||
30648046|NCT01057589|58660110|FG000|Overall Study|Adverse Event|10|||
30648047|NCT01057589|58660110|FG000|Overall Study|Physician Decision|8|||
30648048|NCT01057589|58660110|FG000|Overall Study|Withdrawal by Subject|3|||
30648049|NCT01057589|58660110|FG000|Overall Study|Sponsor Decision|1|||
30648050|NCT01057589|58660110|FG000|Overall Study|Death|8|||
30648051|NCT01057589|58660110|FG000|Overall Study|Lost to Follow-up|1|||
30648052|NCT01716117|58660116|FG000|Overall Study|Death|5|||
30648053|NCT01716117|58660117|FG001|Overall Study|Death|2|||
30648054|NCT01716117|58660116|FG000|Overall Study|Withdrawal by Subject|2|||
30648055|NCT01716117|58660117|FG001|Overall Study|Withdrawal by Subject|0|||
30648056|NCT00579553|58660133|FG000|Overall Study|Lost to Follow-up|16|||
30648057|NCT00579553|58660134|FG001|Overall Study|Lost to Follow-up|13|||
30648058|NCT01650831|58660140|FG000|Overall Study|Screen failure|1|||
30648059|NCT00581893|58660148|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
30648060|NCT00581893|58660149|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
30648061|NCT00770146|58660157|FG000|Treatment Period|Withdrawal by Subject|6|||
30648062|NCT00770146|58660158|FG001|Treatment Period|Withdrawal by Subject|13|||
30648063|NCT00770146|58660157|FG000|Treatment Period|Adverse Event|2|||
30648064|NCT00770146|58660158|FG001|Treatment Period|Adverse Event|26|||
30648065|NCT00770146|58660157|FG000|Treatment Period|Other|1|||
30648066|NCT00770146|58660158|FG001|Treatment Period|Other|5|||
30648067|NCT00770146|58660157|FG000|Treatment Period|Protocol non-compliance|0|||
30648068|NCT00770146|58660158|FG001|Treatment Period|Protocol non-compliance|1|||
30648069|NCT00770146|58660157|FG000|Follow-up Period|Withdrawal by Subject|7|||
30767015|NCT03308968|58775717|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
30648070|NCT00770146|58660158|FG001|Follow-up Period|Withdrawal by Subject|13|||
30648071|NCT00770146|58660157|FG000|Follow-up Period|Adverse Event|0|||
30648072|NCT00770146|58660158|FG001|Follow-up Period|Adverse Event|2|||
30648073|NCT00770146|58660157|FG000|Follow-up Period|Other|4|||
30648074|NCT00770146|58660158|FG001|Follow-up Period|Other|5|||
30648075|NCT01056341|58660169|FG000|Overall Study|Treatment Intolerance|0|||
30648076|NCT01056341|58660170|FG001|Overall Study|Treatment Intolerance|2|||
30648077|NCT01056341|58660171|FG002|Overall Study|Treatment Intolerance|0|||
30648078|NCT01056341|58660172|FG003|Overall Study|Treatment Intolerance|2|||
30648079|NCT01056341|58660173|FG004|Overall Study|Treatment Intolerance|0|||
30648080|NCT01056341|58660169|FG000|Overall Study|Lack of Efficacy|32|||
30648081|NCT01056341|58660170|FG001|Overall Study|Lack of Efficacy|30|||
30648082|NCT01056341|58660171|FG002|Overall Study|Lack of Efficacy|7|||
30648083|NCT01056341|58660172|FG003|Overall Study|Lack of Efficacy|25|||
30648084|NCT01056341|58660173|FG004|Overall Study|Lack of Efficacy|9|||
30648085|NCT01056341|58660169|FG000|Overall Study|Other reasons|4|||
30648086|NCT01056341|58660170|FG001|Overall Study|Other reasons|4|||
30648087|NCT01056341|58660171|FG002|Overall Study|Other reasons|8|||
30648088|NCT01056341|58660172|FG003|Overall Study|Other reasons|9|||
30648089|NCT01056341|58660173|FG004|Overall Study|Other reasons|5|||
30648090|NCT00999518|58660196|FG000|Overall Study|Adverse Event|1|||
30648091|NCT00999518|58660197|FG001|Overall Study|Adverse Event|6|||
30648092|NCT00999518|58660198|FG002|Overall Study|Adverse Event|3|||
30648093|NCT00999518|58660199|FG003|Overall Study|Adverse Event|1|||
30648094|NCT00999518|58660200|FG004|Overall Study|Adverse Event|2|||
30648095|NCT00999518|58660196|FG000|Overall Study|Lack of Efficacy|2|||
30648096|NCT00999518|58660197|FG001|Overall Study|Lack of Efficacy|0|||
30648097|NCT00999518|58660198|FG002|Overall Study|Lack of Efficacy|0|||
30648098|NCT00999518|58660199|FG003|Overall Study|Lack of Efficacy|2|||
30648099|NCT00999518|58660200|FG004|Overall Study|Lack of Efficacy|2|||
30648100|NCT00999518|58660196|FG000|Overall Study|Lost to Follow-up|0|||
30648101|NCT00999518|58660197|FG001|Overall Study|Lost to Follow-up|0|||
30648102|NCT00999518|58660198|FG002|Overall Study|Lost to Follow-up|0|||
30648103|NCT00999518|58660199|FG003|Overall Study|Lost to Follow-up|4|||
30648104|NCT00999518|58660200|FG004|Overall Study|Lost to Follow-up|1|||
30648105|NCT00999518|58660196|FG000|Overall Study|Did not meet entrance criteria|0|||
30648106|NCT00999518|58660197|FG001|Overall Study|Did not meet entrance criteria|0|||
30648107|NCT00999518|58660198|FG002|Overall Study|Did not meet entrance criteria|0|||
30648108|NCT00999518|58660199|FG003|Overall Study|Did not meet entrance criteria|0|||
30648109|NCT00999518|58660200|FG004|Overall Study|Did not meet entrance criteria|1|||
30648110|NCT00999518|58660196|FG000|Overall Study|Study terminated by sponsor|10|||
30648111|NCT00999518|58660197|FG001|Overall Study|Study terminated by sponsor|6|||
30648112|NCT00999518|58660198|FG002|Overall Study|Study terminated by sponsor|5|||
30648113|NCT00999518|58660199|FG003|Overall Study|Study terminated by sponsor|5|||
30648114|NCT00999518|58660200|FG004|Overall Study|Study terminated by sponsor|9|||
30648115|NCT00999518|58660196|FG000|Overall Study|Pregnancy|0|||
30648116|NCT00999518|58660197|FG001|Overall Study|Pregnancy|0|||
30648117|NCT00999518|58660198|FG002|Overall Study|Pregnancy|1|||
30648118|NCT00999518|58660199|FG003|Overall Study|Pregnancy|0|||
30648119|NCT00999518|58660200|FG004|Overall Study|Pregnancy|0|||
30648120|NCT00999518|58660196|FG000|Overall Study|Protocol Violation|0|||
30648121|NCT00999518|58660197|FG001|Overall Study|Protocol Violation|1|||
30648122|NCT00999518|58660198|FG002|Overall Study|Protocol Violation|0|||
30648123|NCT00999518|58660199|FG003|Overall Study|Protocol Violation|0|||
30648124|NCT00999518|58660200|FG004|Overall Study|Protocol Violation|2|||
30648125|NCT00999518|58660196|FG000|Overall Study|Withdrawal by Subject|5|||
30648126|NCT00999518|58660197|FG001|Overall Study|Withdrawal by Subject|4|||
30648127|NCT00999518|58660198|FG002|Overall Study|Withdrawal by Subject|10|||
30767016|NCT03308968|58775718|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
30648128|NCT00999518|58660199|FG003|Overall Study|Withdrawal by Subject|6|||
30767017|NCT03308968|58775716|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
30767018|NCT03308968|58775717|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
30648129|NCT00999518|58660200|FG004|Overall Study|Withdrawal by Subject|1|||
30648130|NCT00999518|58660196|FG000|Overall Study|Other|5|||
30648131|NCT00999518|58660197|FG001|Overall Study|Other|7|||
30648132|NCT00999518|58660198|FG002|Overall Study|Other|1|||
30648133|NCT00999518|58660199|FG003|Overall Study|Other|4|||
30767019|NCT03308968|58775718|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
30648134|NCT00999518|58660200|FG004|Overall Study|Other|5|||
30648135|NCT00999518|58660196|FG000|Overall Study|Randomized but not Treated|1|||
30648136|NCT00999518|58660197|FG001|Overall Study|Randomized but not Treated|1|||
30648137|NCT00999518|58660198|FG002|Overall Study|Randomized but not Treated|2|||
30648138|NCT00999518|58660199|FG003|Overall Study|Randomized but not Treated|0|||
30648139|NCT00999518|58660200|FG004|Overall Study|Randomized but not Treated|1|||
30648140|NCT01056263|58660216|FG000|Overall Study|Adverse Event|12|||
30648141|NCT01056263|58660216|FG000|Overall Study|Death|1|||
30648142|NCT01056263|58660216|FG000|Overall Study|Withdrawal by Subject|1|||
30648143|NCT01056263|58660216|FG000|Overall Study|Lack of Efficacy|29|||
30648144|NCT01056263|58660216|FG000|Overall Study|Progressive disease|2|||
30648145|NCT01056263|58660216|FG000|Overall Study|Neoplasm progression|1|||
30648146|NCT01056263|58660216|FG000|Overall Study|Objective progression or relapse|1|||
30648147|NCT01056263|58660216|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
30648148|NCT01056107|58660224|FG000|Overall Study|Withdrawal by Subject|0|||
30648149|NCT01056107|58660225|FG001|Overall Study|Withdrawal by Subject|1|||
30648150|NCT01056107|58660226|FG002|Overall Study|Withdrawal by Subject|3|||
30648151|NCT01056107|58660227|FG003|Overall Study|Withdrawal by Subject|0|||
30648152|NCT01003886|58660237|FG000|Overall Study|Lack of Efficacy|5|||
30648153|NCT01003886|58660237|FG000|Overall Study|Lost to Follow-up|169|||
30648154|NCT01003886|58660237|FG000|Overall Study|Withdrawal by Subject|39|||
30648155|NCT01003886|58660237|FG000|Overall Study|Other|14|||
30648156|NCT01003886|58660237|FG000|Overall Study|Adverse Event|3|||
30648157|NCT01003184|58660243|FG000|Overall Study|Adverse Event|12|||
30648158|NCT01003184|58660244|FG001|Overall Study|Adverse Event|5|||
30648159|NCT01003184|58660243|FG000|Overall Study|Lost to Follow-up|1|||
30648160|NCT01003184|58660244|FG001|Overall Study|Lost to Follow-up|0|||
30648161|NCT01003184|58660243|FG000|Overall Study|Loss of glucose control|1|||
30648162|NCT01003184|58660244|FG001|Overall Study|Loss of glucose control|1|||
30648163|NCT01003184|58660243|FG000|Overall Study|Protocol Violation|3|||
30648164|NCT01003184|58660244|FG001|Overall Study|Protocol Violation|0|||
30648165|NCT01003184|58660243|FG000|Overall Study|Withdrawal by Subject|1|||
30648166|NCT01003184|58660244|FG001|Overall Study|Withdrawal by Subject|6|||
30648167|NCT01003184|58660243|FG000|Overall Study|Physician Decision|1|||
30648168|NCT01003184|58660244|FG001|Overall Study|Physician Decision|0|||
30648169|NCT01029353|58660254|FG000|Overall Study|Lost to Follow-up|4|||
30648170|NCT01029353|58660255|FG001|Overall Study|Lost to Follow-up|5|||
30648171|NCT01029353|58660256|FG002|Overall Study|Lost to Follow-up|5|||
30648172|NCT01029353|58660257|FG003|Overall Study|Lost to Follow-up|4|||
30648173|NCT01029353|58660254|FG000|Overall Study|Consent Withdrawn|2|||
30648174|NCT01029353|58660255|FG001|Overall Study|Consent Withdrawn|0|||
30648175|NCT01029353|58660256|FG002|Overall Study|Consent Withdrawn|0|||
30648176|NCT01029353|58660257|FG003|Overall Study|Consent Withdrawn|0|||
30648177|NCT01029353|58660254|FG000|Overall Study|Primary Outcome Indeterminate|1|||
30648178|NCT01029353|58660255|FG001|Overall Study|Primary Outcome Indeterminate|3|||
30648179|NCT01029353|58660256|FG002|Overall Study|Primary Outcome Indeterminate|2|||
30648180|NCT01029353|58660257|FG003|Overall Study|Primary Outcome Indeterminate|0|||
30648181|NCT01008410|58660269|FG000|Overall Study|Adverse Event|13|||
30648182|NCT01008410|58660270|FG001|Overall Study|Adverse Event|7|||
30648183|NCT01008410|58660269|FG000|Overall Study|Withdrawal by Subject|6|||
30648184|NCT01008410|58660270|FG001|Overall Study|Withdrawal by Subject|2|||
30648185|NCT01008410|58660269|FG000|Overall Study|Lost to Follow-up|1|||
30648186|NCT01008410|58660270|FG001|Overall Study|Lost to Follow-up|0|||
30648187|NCT01008410|58660269|FG000|Overall Study|Noncompliance|1|||
30648188|NCT01008410|58660270|FG001|Overall Study|Noncompliance|0|||
30648189|NCT01008410|58660269|FG000|Overall Study|Low Cortisol|2|||
30648190|NCT01008410|58660270|FG001|Overall Study|Low Cortisol|0|||
30648191|NCT01008410|58660269|FG000|Overall Study|Lack of Efficacy|2|||
30648192|NCT01008410|58660270|FG001|Overall Study|Lack of Efficacy|6|||
30648193|NCT01008410|58660269|FG000|Overall Study|Met Exclusion Criterion|0|||
30648194|NCT01008410|58660270|FG001|Overall Study|Met Exclusion Criterion|1|||
30648195|NCT01023269|58660276|FG000|Overall Study|early termination of the study|2|||
30648196|NCT01023269|58660277|FG001|Overall Study|early termination of the study|0|||
30648197|NCT01007942|58660309|FG000|Overall Study|Adverse Event|29|||
30648198|NCT01007942|58660310|FG001|Overall Study|Adverse Event|14|||
30648199|NCT01007942|58660309|FG000|Overall Study|Abnormal test procedure|0|||
30648200|NCT01007942|58660310|FG001|Overall Study|Abnormal test procedure|1|||
30648201|NCT01007942|58660309|FG000|Overall Study|Disease progression|217|||
30648202|NCT01007942|58660310|FG001|Overall Study|Disease progression|242|||
30648203|NCT01007942|58660309|FG000|Overall Study|New cancer therapy|5|||
30648204|NCT01007942|58660310|FG001|Overall Study|New cancer therapy|1|||
30648205|NCT01007942|58660309|FG000|Overall Study|Protocol Violation|1|||
30648206|NCT01007942|58660310|FG001|Overall Study|Protocol Violation|1|||
30952056|NCT01698320|58999423|FG001|40-Week Open-Label Period|Pregnancy|2|||
30952057|NCT01698320|58999424|FG002|40-Week Open-Label Period|Pregnancy|1|||
30648207|NCT01007942|58660309|FG000|Overall Study|Withdrawal by Subject|19|||
30648208|NCT01007942|58660310|FG001|Overall Study|Withdrawal by Subject|14|||
30648209|NCT01007942|58660309|FG000|Overall Study|Lost to Follow-up|1|||
30648210|NCT01007942|58660310|FG001|Overall Study|Lost to Follow-up|0|||
30648211|NCT01007942|58660309|FG000|Overall Study|Administrative problems|2|||
30648212|NCT01007942|58660310|FG001|Overall Study|Administrative problems|0|||
30648213|NCT01007942|58660309|FG000|Overall Study|Death|3|||
30648214|NCT01007942|58660310|FG001|Overall Study|Death|2|||
30648215|NCT01007942|58660309|FG000|Overall Study|Patients untreated|4|||
30648216|NCT01007942|58660310|FG001|Overall Study|Patients untreated|3|||
30648217|NCT01023035|58660323|FG000|Treatment Period|Adverse Event|27|||
30648218|NCT01023035|58660324|FG001|Treatment Period|Adverse Event|32|||
30648219|NCT01023035|58660325|FG002|Treatment Period|Adverse Event|50|||
30952058|NCT01698320|58999422|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
30648220|NCT01023035|58660323|FG000|Treatment Period|Non-Medical Reasons|19|||
30648221|NCT01023035|58660324|FG001|Treatment Period|Non-Medical Reasons|22|||
30648222|NCT01023035|58660325|FG002|Treatment Period|Non-Medical Reasons|44|||
30648223|NCT01023035|58660323|FG000|Treatment Period|Treatment Failure|26|||
30648224|NCT01023035|58660324|FG001|Treatment Period|Treatment Failure|31|||
30648225|NCT01023035|58660325|FG002|Treatment Period|Treatment Failure|24|||
30648226|NCT01023035|58660323|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
30648227|NCT01023035|58660324|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
30648228|NCT01023035|58660325|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
30648229|NCT01023035|58660323|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
30648230|NCT01023035|58660324|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
30648231|NCT01023035|58660325|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
30648232|NCT01028651|58660335|FG000|Overall Study|Death|2|||
30648233|NCT01028651|58660335|FG000|Overall Study|Adverse Event|1|||
30648234|NCT01028027|58660343|FG000|Overall Study|Lost to Follow-up|4|||
30648235|NCT01028027|58660344|FG001|Overall Study|Lost to Follow-up|1|||
30648236|NCT01028027|58660343|FG000|Overall Study|Withdrawal by Subject|5|||
30648237|NCT01028027|58660344|FG001|Overall Study|Withdrawal by Subject|3|||
30648238|NCT01028027|58660343|FG000|Overall Study|Adverse Event|4|||
30648239|NCT01028027|58660344|FG001|Overall Study|Adverse Event|7|||
30648240|NCT01028027|58660343|FG000|Overall Study|Protocol Violation|3|||
30648241|NCT01028027|58660344|FG001|Overall Study|Protocol Violation|1|||
30648242|NCT01028027|58660343|FG000|Overall Study|Lack of Efficacy|0|||
30648243|NCT01028027|58660344|FG001|Overall Study|Lack of Efficacy|1|||
30648244|NCT01007552|58660350|FG000|Overall Study|Withdrawal by Subject|1|||
30648245|NCT01007396|58660354|FG000|Overall Study|Lost to Follow-up|47|||
30648246|NCT00998738|58660358|FG000|Overall Study|Uknown|1|||
30648247|NCT00997334|58660362|FG000|Overall Study|still on therapy|12|||
30648248|NCT00997334|58660362|FG000|Overall Study|Adverse Event|3|||
30648249|NCT00997334|58660362|FG000|Overall Study|Patient non-compliance|1|||
30648250|NCT00997334|58660362|FG000|Overall Study|Withdrawal by Subject|3|||
30648251|NCT00997334|58660362|FG000|Overall Study|Death|2|||
30648252|NCT00997334|58660362|FG000|Overall Study|Urgent Palliative Care|2|||
30648253|NCT00997334|58660362|FG000|Overall Study|No lesion amenable|1|||
30648254|NCT00997334|58660362|FG000|Overall Study|Ineligible|1|||
30648255|NCT00996944|58660368|FG000|Double-blind Treatment Period|Adverse Event|2|||
30648256|NCT00996944|58660369|FG001|Double-blind Treatment Period|Adverse Event|1|||
30648257|NCT00996944|58660368|FG000|Double-blind Treatment Period|Protocol Violation|1|||
30648258|NCT00996944|58660369|FG001|Double-blind Treatment Period|Protocol Violation|0|||
30648259|NCT00996944|58660368|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
30648260|NCT00996944|58660369|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
30648261|NCT00996944|58660368|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
30648262|NCT00996944|58660369|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
30648263|NCT00996944|58660368|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
30648264|NCT00996944|58660369|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
30648265|NCT01002482|58660379|FG000|Overall Study|Withdrawal by Subject|14|||
30648266|NCT01002482|58660380|FG001|Overall Study|Withdrawal by Subject|21|||
30648267|NCT01002482|58660379|FG000|Overall Study|Included twice|1|||
30767020|NCT03308968|58775716|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
30767021|NCT03308968|58775717|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
30767022|NCT03308968|58775718|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
30767023|NCT03308968|58775716|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
30767024|NCT03308968|58775717|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
30767025|NCT03308968|58775718|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
30767026|NCT03308968|58775716|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
30767027|NCT03308968|58775717|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
30767028|NCT03308968|58775718|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
30767029|NCT03308968|58775716|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
30767030|NCT03308968|58775717|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
30767031|NCT03308968|58775718|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
30767032|NCT03308968|58775716|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
30648268|NCT01002482|58660380|FG001|Overall Study|Included twice|0|||
30767033|NCT03308968|58775717|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
30767034|NCT03308968|58775718|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
30648269|NCT01027949|58660386|FG000|Overall Study|Death|174|||
30648270|NCT01027949|58660386|FG000|Overall Study|Progressive Disease|163|||
30648271|NCT01027949|58660386|FG000|Overall Study|Adverse Event|172|||
30648272|NCT01027949|58660386|FG000|Overall Study|Withdrawal by Subject|113|||
30648273|NCT01027949|58660386|FG000|Overall Study|Lost to Follow-up|17|||
30648274|NCT01027949|58660386|FG000|Overall Study|Protocol Violation|13|||
30648275|NCT01027949|58660386|FG000|Overall Study|PI Decision|8|||
30648276|NCT01027949|58660386|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
30648277|NCT01027949|58660386|FG000|Overall Study|Non-compliance with Study Procedures|7|||
30767035|NCT03308968|58775716|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
30767036|NCT03308968|58775717|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
30767037|NCT03308968|58775718|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
30767038|NCT02940730|58775731|FG000|Intervention 2|Physician Decision|7|||
30767039|NCT02940730|58775732|FG001|Intervention 2|Physician Decision|0|||
30767040|NCT03741062|58775740|FG000|Overall Study|Protocol Violation|1|||
30767041|NCT03741062|58775741|FG001|Overall Study|Protocol Violation|0|||
30648278|NCT01027949|58660386|FG000|Overall Study|Lung Transplant|5|||
30648279|NCT01027949|58660386|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
30648280|NCT01027949|58660386|FG000|Overall Study|Use of Excluded Medication|2|||
30648281|NCT01027949|58660386|FG000|Overall Study|Patient Self-discontinuation|1|||
30648282|NCT01027949|58660386|FG000|Overall Study|Pregnancy|1|||
30648283|NCT01027949|58660386|FG000|Overall Study|Surgery|1|||
30648284|NCT01038323|58660393|FG000|Overall Study|Withdrawal by Subject|3|||
30648285|NCT01038323|58660394|FG001|Overall Study|Withdrawal by Subject|2|||
30648286|NCT01038323|58660395|FG002|Overall Study|Withdrawal by Subject|4|||
30648287|NCT01027871|58660406|FG000|Overall Study|Physician Decision|1|||
30648288|NCT01027871|58660407|FG001|Overall Study|Physician Decision|5|||
30648289|NCT01027871|58660408|FG002|Overall Study|Physician Decision|0|||
30648290|NCT01027871|58660406|FG000|Overall Study|Protocol Violation|0|||
30648291|NCT01027871|58660407|FG001|Overall Study|Protocol Violation|2|||
30648292|NCT01027871|58660408|FG002|Overall Study|Protocol Violation|2|||
30648293|NCT01027871|58660406|FG000|Overall Study|Withdrawal by Subject|1|||
30648294|NCT01027871|58660407|FG001|Overall Study|Withdrawal by Subject|2|||
30648295|NCT01027871|58660408|FG002|Overall Study|Withdrawal by Subject|2|||
30648296|NCT01027871|58660406|FG000|Overall Study|Adverse Event|0|||
30648297|NCT01027871|58660407|FG001|Overall Study|Adverse Event|2|||
30648298|NCT01027871|58660408|FG002|Overall Study|Adverse Event|2|||
30648299|NCT01027871|58660406|FG000|Overall Study|Sponsor Decision|0|||
30648300|NCT01027871|58660407|FG001|Overall Study|Sponsor Decision|2|||
30648301|NCT01027871|58660408|FG002|Overall Study|Sponsor Decision|0|||
30648302|NCT01027871|58660406|FG000|Overall Study|Discontinued Prior to Treatment|0|||
30648303|NCT01027871|58660407|FG001|Overall Study|Discontinued Prior to Treatment|0|||
30648304|NCT01027871|58660408|FG002|Overall Study|Discontinued Prior to Treatment|1|||
30648305|NCT01021553|58660424|FG000|Overall Study|Adverse Event|1|||
30648306|NCT01021553|58660425|FG001|Overall Study|Adverse Event|0|||
30648307|NCT01021553|58660426|FG002|Overall Study|Adverse Event|0|||
30648308|NCT01021553|58660424|FG000|Overall Study|Lack of Efficacy|2|||
30648309|NCT01021553|58660425|FG001|Overall Study|Lack of Efficacy|2|||
30648310|NCT01021553|58660426|FG002|Overall Study|Lack of Efficacy|0|||
30648311|NCT01021553|58660424|FG000|Overall Study|Protocol Violation|0|||
30648312|NCT01021553|58660425|FG001|Overall Study|Protocol Violation|2|||
30648313|NCT01021553|58660426|FG002|Overall Study|Protocol Violation|2|||
30648314|NCT01021553|58660424|FG000|Overall Study|Lost to Follow-up|0|||
30648315|NCT01021553|58660425|FG001|Overall Study|Lost to Follow-up|0|||
30648316|NCT01021553|58660426|FG002|Overall Study|Lost to Follow-up|1|||
30648317|NCT01021553|58660424|FG000|Overall Study|Withdrawal by Subject|1|||
30648318|NCT01021553|58660425|FG001|Overall Study|Withdrawal by Subject|1|||
30648319|NCT01021553|58660426|FG002|Overall Study|Withdrawal by Subject|0|||
30648320|NCT01026389|58660441|FG000|Overall Study|Withdrawal by Subject|1|||
30648321|NCT01026389|58660442|FG001|Overall Study|Withdrawal by Subject|3|||
30648322|NCT01026389|58660441|FG000|Overall Study|change of treatment, patient moved|4|||
30648323|NCT01026389|58660442|FG001|Overall Study|change of treatment, patient moved|2|||
30648324|NCT01006616|58660452|FG000|Period 1 (6 Months)|Adverse Event|10|||
30648325|NCT01006616|58660453|FG001|Period 1 (6 Months)|Adverse Event|31|||
30648326|NCT01006616|58660454|FG002|Period 1 (6 Months)|Adverse Event|37|||
30648327|NCT01006616|58660455|FG003|Period 1 (6 Months)|Adverse Event|9|||
30648328|NCT01006616|58660452|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
30648329|NCT01006616|58660453|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
30648330|NCT01006616|58660454|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
30648331|NCT01006616|58660455|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
30767042|NCT03281668|58775747|FG000|Overall Study|Physician Decision|1|||
30767043|NCT03281668|58775747|FG000|Overall Study|scheduling conflict, family circumstance|2|||
30767044|NCT03281668|58775747|FG000|Overall Study|Withdrawal by Subject|4|||
30767045|NCT03281668|58775747|FG000|Overall Study|Lost to Follow-up|1|||
30648332|NCT01006616|58660452|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
30648333|NCT01006616|58660453|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
30648334|NCT01006616|58660454|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
30648335|NCT01006616|58660455|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
30648336|NCT01006616|58660452|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
30648337|NCT01006616|58660453|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
30648338|NCT01006616|58660454|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
30648339|NCT01006616|58660455|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
30648340|NCT01006616|58660452|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
30767046|NCT03307252|58775762|FG000|Part 2, Period 1|Treatment not received|0|||
30648341|NCT01006616|58660453|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
30648342|NCT01006616|58660454|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
30648343|NCT01006616|58660455|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
30648344|NCT01006616|58660452|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
30648345|NCT01006616|58660453|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
30648346|NCT01006616|58660454|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
30648347|NCT01006616|58660455|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
30648348|NCT01006616|58660452|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
30648349|NCT01006616|58660453|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
30648350|NCT01006616|58660454|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
30648351|NCT01006616|58660455|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
30648352|NCT01006616|58660452|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
30648353|NCT01006616|58660453|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
30648354|NCT01006616|58660454|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
30648355|NCT01006616|58660455|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
30648356|NCT01006616|58660452|FG000|Period 1 (6 Months)|Not Treated|0|||
30648357|NCT01006616|58660453|FG001|Period 1 (6 Months)|Not Treated|0|||
30648358|NCT01006616|58660454|FG002|Period 1 (6 Months)|Not Treated|1|||
30648359|NCT01006616|58660455|FG003|Period 1 (6 Months)|Not Treated|1|||
30648360|NCT01006616|58660452|FG000|Period 2 (18 Months)|Adverse Event|6|||
30648361|NCT01006616|58660453|FG001|Period 2 (18 Months)|Adverse Event|6|||
30648362|NCT01006616|58660454|FG002|Period 2 (18 Months)|Adverse Event|6|||
30648363|NCT01006616|58660455|FG003|Period 2 (18 Months)|Adverse Event|4|||
30648364|NCT01006616|58660452|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
30648365|NCT01006616|58660453|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
30648366|NCT01006616|58660454|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
30648367|NCT01006616|58660455|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
30648368|NCT01006616|58660452|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
30648369|NCT01006616|58660453|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
30648370|NCT01006616|58660454|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
30648371|NCT01006616|58660455|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
30648372|NCT01006616|58660452|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
30648373|NCT01006616|58660453|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
30648374|NCT01006616|58660454|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
30648375|NCT01006616|58660455|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
30648376|NCT01006616|58660452|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
30648377|NCT01006616|58660453|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
30648378|NCT01006616|58660454|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
30648379|NCT01006616|58660455|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
30648380|NCT01006616|58660452|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
30648381|NCT01006616|58660453|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
30648382|NCT01006616|58660454|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
30648383|NCT01006616|58660455|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
30648384|NCT01006616|58660452|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
30648385|NCT01006616|58660453|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
30648386|NCT01006616|58660454|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
30648387|NCT01006616|58660455|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
30648388|NCT01006616|58660452|FG000|Period 2 (18 Months)|Study Terminated|63|||
30648389|NCT01006616|58660453|FG001|Period 2 (18 Months)|Study Terminated|46|||
30648390|NCT01006616|58660454|FG002|Period 2 (18 Months)|Study Terminated|44|||
30648391|NCT01006616|58660455|FG003|Period 2 (18 Months)|Study Terminated|70|||
30648392|NCT00996632|58660467|FG000|Overall Study|Physician Decision|0|||
30648393|NCT00996632|58660468|FG001|Overall Study|Physician Decision|0|||
30648394|NCT01025843|58660484|FG000|Washout 4|Withdrawal by Subject|0|||
30648395|NCT01025843|58660485|FG001|Washout 4|Withdrawal by Subject|0|||
30648396|NCT01025843|58660486|FG002|Washout 4|Withdrawal by Subject|1|||
30648397|NCT01025843|58660487|FG003|Washout 4|Withdrawal by Subject|1|||
30648398|NCT01025843|58660488|FG004|Washout 4|Withdrawal by Subject|0|||
30767047|NCT03307252|58775763|FG001|Part 2, Period 1|Treatment not received|0|||
30767048|NCT03307252|58775764|FG002|Part 2, Period 1|Treatment not received|0|||
30767049|NCT03307252|58775765|FG003|Part 2, Period 1|Treatment not received|0|||
30767050|NCT03307252|58775766|FG004|Part 2, Period 1|Treatment not received|0|||
30648399|NCT01025843|58660489|FG005|Washout 4|Withdrawal by Subject|0|||
30648400|NCT01025843|58660490|FG006|Washout 4|Withdrawal by Subject|0|||
30648401|NCT01025843|58660491|FG007|Washout 4|Withdrawal by Subject|0|||
30648402|NCT01025843|58660492|FG008|Washout 4|Withdrawal by Subject|0|||
30648403|NCT01025843|58660493|FG009|Washout 4|Withdrawal by Subject|0|||
30648404|NCT01036763|58660521|FG000|Overall Study|Adverse Event|25|||
30648405|NCT01036763|58660521|FG000|Overall Study|Lost to Follow-up|28|||
30648406|NCT01036763|58660521|FG000|Overall Study|Other reason (not specified)|40|||
30648407|NCT01021007|58660527|FG000|Overall Study|Lost to Follow-up|1|||
30648408|NCT01021007|58660528|FG001|Overall Study|Lost to Follow-up|1|||
30648409|NCT01021007|58660527|FG000|Overall Study|Adverse Event|1|||
30767051|NCT03307252|58775767|FG005|Part 2, Period 1|Treatment not received|1|||
30767052|NCT03307252|58775768|FG006|Part 2, Period 1|Treatment not received|0|||
30767053|NCT03307252|58775769|FG007|Part 2, Period 1|Treatment not received|0|||
30767054|NCT03307252|58775770|FG008|Part 2, Period 1|Treatment not received|0|||
30767055|NCT03307252|58775771|FG009|Part 2, Period 1|Treatment not received|0|||
30767056|NCT03307252|58775772|FG010|Part 2, Period 1|Treatment not received|0|||
30767057|NCT03307252|58775762|FG000|Part 2, Period 3|Other than listed|0|||
30767058|NCT03307252|58775763|FG001|Part 2, Period 3|Other than listed|0|||
30767059|NCT03307252|58775764|FG002|Part 2, Period 3|Other than listed|0|||
30648410|NCT01021007|58660528|FG001|Overall Study|Adverse Event|3|||
30648411|NCT01020773|58660536|FG000|Overall Study|Withdrawal by Subject|4|||
30648412|NCT01020773|58660537|FG001|Overall Study|Withdrawal by Subject|3|||
30648413|NCT01020305|58660543|FG000|Overall Study|Adverse Event|2|||
30648414|NCT01036529|58660549|FG000|Overall Study|Adverse Event|0|||
30648415|NCT01036529|58660550|FG001|Overall Study|Adverse Event|1|||
30767060|NCT03307252|58775765|FG003|Part 2, Period 3|Other than listed|0|||
30648416|NCT01036529|58660549|FG000|Overall Study|Lost to Follow-up|0|||
30648417|NCT01036529|58660550|FG001|Overall Study|Lost to Follow-up|1|||
30648418|NCT01036529|58660549|FG000|Overall Study|Physician Decision|1|||
30648419|NCT01036529|58660550|FG001|Overall Study|Physician Decision|0|||
30648420|NCT01036529|58660549|FG000|Overall Study|Withdrawal by Subject|1|||
30648421|NCT01036529|58660550|FG001|Overall Study|Withdrawal by Subject|1|||
30648422|NCT01036529|58660549|FG000|Overall Study|Sponsor study termination|11|||
30648423|NCT01036529|58660550|FG001|Overall Study|Sponsor study termination|12|||
30648424|NCT01024751|58660558|FG000|Enrolled Participants|Ineligible at baseline|3|||
30648425|NCT01024751|58660559|FG001|Enrolled Participants|Ineligible at baseline|4|||
30648426|NCT01024751|58660558|FG000|Eligible Participants|Withdrawal by Subject|0|||
30648427|NCT01024751|58660559|FG001|Eligible Participants|Withdrawal by Subject|1|||
30648428|NCT01024751|58660558|FG000|Eligible Participants|Lost to Follow-up|0|||
30648429|NCT01024751|58660559|FG001|Eligible Participants|Lost to Follow-up|1|||
30648430|NCT01024751|58660558|FG000|Eligible Participants|Ineligible|0|||
30648431|NCT01024751|58660559|FG001|Eligible Participants|Ineligible|1|||
30648432|NCT01019369|58660567|FG000|Overall Study|Lost to Follow-up|10|||
30648433|NCT01019369|58660568|FG001|Overall Study|Lost to Follow-up|6|||
30767061|NCT03307252|58775766|FG004|Part 2, Period 3|Other than listed|1|||
30767062|NCT03307252|58775767|FG005|Part 2, Period 3|Other than listed|0|||
30767063|NCT03307252|58775768|FG006|Part 2, Period 3|Other than listed|0|||
30767064|NCT03307252|58775769|FG007|Part 2, Period 3|Other than listed|0|||
30767065|NCT03307252|58775770|FG008|Part 2, Period 3|Other than listed|0|||
30767066|NCT03307252|58775771|FG009|Part 2, Period 3|Other than listed|0|||
30767067|NCT03307252|58775772|FG010|Part 2, Period 3|Other than listed|0|||
30767068|NCT03307252|58775762|FG000|Part 2, Period 4|Other than listed|0|||
30767069|NCT03307252|58775763|FG001|Part 2, Period 4|Other than listed|0|||
30767070|NCT03307252|58775764|FG002|Part 2, Period 4|Other than listed|0|||
30767071|NCT03307252|58775765|FG003|Part 2, Period 4|Other than listed|0|||
30767072|NCT03307252|58775766|FG004|Part 2, Period 4|Other than listed|0|||
30767073|NCT03307252|58775767|FG005|Part 2, Period 4|Other than listed|0|||
30767074|NCT03307252|58775768|FG006|Part 2, Period 4|Other than listed|1|||
30767075|NCT03307252|58775769|FG007|Part 2, Period 4|Other than listed|0|||
30767076|NCT03307252|58775770|FG008|Part 2, Period 4|Other than listed|0|||
30767077|NCT03307252|58775771|FG009|Part 2, Period 4|Other than listed|0|||
30767078|NCT03307252|58775772|FG010|Part 2, Period 4|Other than listed|0|||
30767079|NCT03307252|58775762|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
30767080|NCT03307252|58775763|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
30767081|NCT03307252|58775764|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
30767082|NCT03307252|58775765|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
30767083|NCT03307252|58775766|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
30767084|NCT03307252|58775767|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
30648434|NCT01019369|58660567|FG000|Overall Study|Withdrawal by Subject|0|||
30648435|NCT01019369|58660568|FG001|Overall Study|Withdrawal by Subject|1|||
30952059|NCT01698320|58999423|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
30648436|NCT01019135|58660578|FG000|Overall Study|Did not receive allocated intervention|12|||
30767085|NCT03307252|58775768|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
30767086|NCT03307252|58775769|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
30767087|NCT03307252|58775770|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
30952060|NCT01698320|58999424|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
30648437|NCT01019135|58660579|FG001|Overall Study|Did not receive allocated intervention|6|||
30648438|NCT01019135|58660580|FG002|Overall Study|Did not receive allocated intervention|25|||
30648439|NCT01019135|58660578|FG000|Overall Study|Did not attend CR|8|||
30648440|NCT01019135|58660579|FG001|Overall Study|Did not attend CR|13|||
30648441|NCT01019135|58660580|FG002|Overall Study|Did not attend CR|6|||
30648442|NCT01018979|58660590|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
30648443|NCT01018979|58660591|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
30648444|NCT01018979|58660590|FG000|Overall Study|Not received at least one dose|0|||
30648445|NCT01018979|58660591|FG001|Overall Study|Not received at least one dose|1|||
30648446|NCT01572493|58660609|FG000|Overall Study|Physician Decision|1|||
30648447|NCT01572493|58660610|FG001|Overall Study|Physician Decision|0|||
30648448|NCT01572493|58660611|FG002|Overall Study|Physician Decision|0|||
30648449|NCT01572493|58660612|FG003|Overall Study|Physician Decision|0|||
30648450|NCT01572493|58660613|FG004|Overall Study|Physician Decision|0|||
30648451|NCT01572493|58660614|FG005|Overall Study|Physician Decision|0|||
30648452|NCT01572493|58660615|FG006|Overall Study|Physician Decision|0|||
30648453|NCT01572493|58660616|FG007|Overall Study|Physician Decision|0|||
30648454|NCT01572493|58660617|FG008|Overall Study|Physician Decision|0|||
30648455|NCT01572493|58660609|FG000|Overall Study|Switched to alternative treatment|0|||
30648456|NCT01572493|58660610|FG001|Overall Study|Switched to alternative treatment|1|||
30648457|NCT01572493|58660611|FG002|Overall Study|Switched to alternative treatment|2|||
30648458|NCT01572493|58660612|FG003|Overall Study|Switched to alternative treatment|1|||
30648459|NCT01572493|58660613|FG004|Overall Study|Switched to alternative treatment|2|||
30648460|NCT01572493|58660614|FG005|Overall Study|Switched to alternative treatment|0|||
30648461|NCT01572493|58660615|FG006|Overall Study|Switched to alternative treatment|2|||
30648462|NCT01572493|58660616|FG007|Overall Study|Switched to alternative treatment|0|||
30648463|NCT01572493|58660617|FG008|Overall Study|Switched to alternative treatment|2|||
30648464|NCT01572493|58660609|FG000|Overall Study|Death|0|||
30648465|NCT01572493|58660610|FG001|Overall Study|Death|0|||
30648466|NCT01572493|58660611|FG002|Overall Study|Death|0|||
30648467|NCT01572493|58660612|FG003|Overall Study|Death|1|||
30648468|NCT01572493|58660613|FG004|Overall Study|Death|0|||
30648469|NCT01572493|58660614|FG005|Overall Study|Death|1|||
30648470|NCT01572493|58660615|FG006|Overall Study|Death|0|||
30648471|NCT01572493|58660616|FG007|Overall Study|Death|0|||
30648472|NCT01572493|58660617|FG008|Overall Study|Death|0|||
30648473|NCT01572493|58660609|FG000|Overall Study|Adverse Event|0|||
30648474|NCT01572493|58660610|FG001|Overall Study|Adverse Event|0|||
30648475|NCT01572493|58660611|FG002|Overall Study|Adverse Event|0|||
30648476|NCT01572493|58660612|FG003|Overall Study|Adverse Event|0|||
30648477|NCT01572493|58660613|FG004|Overall Study|Adverse Event|0|||
30648478|NCT01572493|58660614|FG005|Overall Study|Adverse Event|0|||
30648479|NCT01572493|58660615|FG006|Overall Study|Adverse Event|1|||
30648480|NCT01572493|58660616|FG007|Overall Study|Adverse Event|0|||
30648481|NCT01572493|58660617|FG008|Overall Study|Adverse Event|0|||
30648482|NCT01018511|58660644|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
30648483|NCT01018511|58660645|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
30648484|NCT01018511|58660646|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
30648485|NCT01018511|58660647|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
30648486|NCT01018511|58660644|FG000|Overall Study|Adverse Event|5|||
30648487|NCT01018511|58660645|FG001|Overall Study|Adverse Event|9|||
30648488|NCT01018511|58660646|FG002|Overall Study|Adverse Event|13|||
30648489|NCT01018511|58660647|FG003|Overall Study|Adverse Event|10|||
30648490|NCT01018511|58660644|FG000|Overall Study|Lack of Efficacy|4|||
30648491|NCT01018511|58660645|FG001|Overall Study|Lack of Efficacy|1|||
30648492|NCT01018511|58660646|FG002|Overall Study|Lack of Efficacy|1|||
30648493|NCT01018511|58660647|FG003|Overall Study|Lack of Efficacy|2|||
30767088|NCT03307252|58775771|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
30767089|NCT03307252|58775772|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
30767090|NCT03307174|58775790|FG000|Overall Study|Unplanned ICU Administrion|5|||
30767091|NCT03307174|58775791|FG001|Overall Study|Unplanned ICU Administrion|3|||
30767092|NCT03307174|58775790|FG000|Overall Study|Aborted Surgery|1|||
30767093|NCT03307174|58775791|FG001|Overall Study|Aborted Surgery|2|||
30767094|NCT03307174|58775790|FG000|Overall Study|Hypotension|6|||
30648494|NCT01018511|58660644|FG000|Overall Study|Withdrawal by Subject|6|||
30648495|NCT01018511|58660645|FG001|Overall Study|Withdrawal by Subject|5|||
30648496|NCT01018511|58660646|FG002|Overall Study|Withdrawal by Subject|11|||
30648497|NCT01018511|58660647|FG003|Overall Study|Withdrawal by Subject|9|||
30648498|NCT01018511|58660644|FG000|Overall Study|Lost to Follow-up|0|||
30648499|NCT01018511|58660645|FG001|Overall Study|Lost to Follow-up|0|||
30648500|NCT01018511|58660646|FG002|Overall Study|Lost to Follow-up|1|||
30648501|NCT01018511|58660647|FG003|Overall Study|Lost to Follow-up|0|||
30648502|NCT01018511|58660644|FG000|Overall Study|Protocol Violation|5|||
30648503|NCT01018511|58660645|FG001|Overall Study|Protocol Violation|8|||
30648504|NCT01018511|58660646|FG002|Overall Study|Protocol Violation|7|||
30648505|NCT01018511|58660647|FG003|Overall Study|Protocol Violation|9|||
30648506|NCT01018511|58660644|FG000|Overall Study|Miscellaneous|0|||
30648507|NCT01018511|58660645|FG001|Overall Study|Miscellaneous|2|||
30767095|NCT03307174|58775791|FG001|Overall Study|Hypotension|0|||
30648508|NCT01018511|58660646|FG002|Overall Study|Miscellaneous|0|||
30648509|NCT01018511|58660647|FG003|Overall Study|Miscellaneous|0|||
30648510|NCT00996476|58660668|FG000|Overall Study|Withdrawal by Subject|1|||
30648511|NCT00996476|58660669|FG001|Overall Study|Withdrawal by Subject|2|||
30648512|NCT00996476|58660670|FG002|Overall Study|Withdrawal by Subject|1|||
30648513|NCT00996476|58660671|FG003|Overall Study|Withdrawal by Subject|0|||
30648514|NCT00996476|58660672|FG004|Overall Study|Withdrawal by Subject|1|||
30648515|NCT00996476|58660668|FG000|Overall Study|Adverse Event|0|||
30648516|NCT00996476|58660669|FG001|Overall Study|Adverse Event|1|||
30648517|NCT00996476|58660670|FG002|Overall Study|Adverse Event|0|||
30648518|NCT00996476|58660671|FG003|Overall Study|Adverse Event|0|||
30648519|NCT00996476|58660672|FG004|Overall Study|Adverse Event|1|||
30648520|NCT02269267|58660689|FG000|Overall Study|Death|5|||
30648521|NCT01017731|58660693|FG000|Overall Study|Lost to Follow-up|2|||
30648522|NCT01017731|58660693|FG000|Overall Study|Withdrawal by Subject|3|||
30648523|NCT01017731|58660693|FG000|Overall Study|Physician Decision|2|||
30648524|NCT01017731|58660693|FG000|Overall Study|Adverse Event|1|||
30648525|NCT01035905|58660700|FG000|Overall Study|Lack of Efficacy|1|||
30648526|NCT01035905|58660701|FG001|Overall Study|Lack of Efficacy|1|||
30648527|NCT00779584|58660725|FG000|Overall Study|Protocol Violation|0|||
30648528|NCT00779584|58660726|FG001|Overall Study|Protocol Violation|0|||
30648529|NCT00779584|58660727|FG002|Overall Study|Protocol Violation|0|||
30648530|NCT00779584|58660728|FG003|Overall Study|Protocol Violation|0|||
30648531|NCT00779584|58660729|FG004|Overall Study|Protocol Violation|0|||
30648532|NCT00779584|58660730|FG005|Overall Study|Protocol Violation|1|||
30648533|NCT00779584|58660731|FG006|Overall Study|Protocol Violation|0|||
30648534|NCT00779584|58660732|FG007|Overall Study|Protocol Violation|0|||
30648535|NCT00779584|58660733|FG008|Overall Study|Protocol Violation|0|||
30648536|NCT00779584|58660725|FG000|Overall Study|Withdrawal by Subject|1|||
30648537|NCT00779584|58660726|FG001|Overall Study|Withdrawal by Subject|1|||
30648538|NCT00779584|58660727|FG002|Overall Study|Withdrawal by Subject|2|||
30648539|NCT00779584|58660728|FG003|Overall Study|Withdrawal by Subject|0|||
30648540|NCT00779584|58660729|FG004|Overall Study|Withdrawal by Subject|0|||
30648541|NCT00779584|58660730|FG005|Overall Study|Withdrawal by Subject|2|||
30648542|NCT00779584|58660731|FG006|Overall Study|Withdrawal by Subject|1|||
30648543|NCT00779584|58660732|FG007|Overall Study|Withdrawal by Subject|0|||
30648544|NCT00779584|58660733|FG008|Overall Study|Withdrawal by Subject|0|||
30648545|NCT00779584|58660725|FG000|Overall Study|Lost to Follow-up|0|||
30648546|NCT00779584|58660726|FG001|Overall Study|Lost to Follow-up|0|||
30648547|NCT00779584|58660727|FG002|Overall Study|Lost to Follow-up|0|||
30648548|NCT00779584|58660728|FG003|Overall Study|Lost to Follow-up|0|||
30648549|NCT00779584|58660729|FG004|Overall Study|Lost to Follow-up|1|||
30648550|NCT00779584|58660730|FG005|Overall Study|Lost to Follow-up|0|||
30648551|NCT00779584|58660731|FG006|Overall Study|Lost to Follow-up|0|||
30648552|NCT00779584|58660732|FG007|Overall Study|Lost to Follow-up|0|||
30648553|NCT00779584|58660733|FG008|Overall Study|Lost to Follow-up|0|||
30648554|NCT00779584|58660725|FG000|Overall Study|Progression of Disease|0|||
30648555|NCT00779584|58660726|FG001|Overall Study|Progression of Disease|1|||
30648556|NCT00779584|58660727|FG002|Overall Study|Progression of Disease|2|||
30648557|NCT00779584|58660728|FG003|Overall Study|Progression of Disease|6|||
30648558|NCT00779584|58660729|FG004|Overall Study|Progression of Disease|5|||
30648559|NCT00779584|58660730|FG005|Overall Study|Progression of Disease|1|||
30648560|NCT00779584|58660731|FG006|Overall Study|Progression of Disease|4|||
30648561|NCT00779584|58660732|FG007|Overall Study|Progression of Disease|2|||
30648562|NCT00779584|58660733|FG008|Overall Study|Progression of Disease|1|||
30648563|NCT00779584|58660725|FG000|Overall Study|Adverse Event|1|||
30648564|NCT00779584|58660726|FG001|Overall Study|Adverse Event|0|||
30648565|NCT00779584|58660727|FG002|Overall Study|Adverse Event|2|||
30648566|NCT00779584|58660728|FG003|Overall Study|Adverse Event|0|||
30648567|NCT00779584|58660729|FG004|Overall Study|Adverse Event|0|||
30648568|NCT00779584|58660730|FG005|Overall Study|Adverse Event|0|||
30648569|NCT00779584|58660731|FG006|Overall Study|Adverse Event|2|||
30648570|NCT00779584|58660732|FG007|Overall Study|Adverse Event|1|||
30648571|NCT00779584|58660733|FG008|Overall Study|Adverse Event|1|||
30648572|NCT00779584|58660725|FG000|Overall Study|Symptomatic Deterioration|1|||
30648573|NCT00779584|58660726|FG001|Overall Study|Symptomatic Deterioration|1|||
30648574|NCT00779584|58660727|FG002|Overall Study|Symptomatic Deterioration|1|||
30648575|NCT00779584|58660728|FG003|Overall Study|Symptomatic Deterioration|0|||
30648576|NCT00779584|58660729|FG004|Overall Study|Symptomatic Deterioration|0|||
30648577|NCT00779584|58660730|FG005|Overall Study|Symptomatic Deterioration|1|||
30648578|NCT00779584|58660731|FG006|Overall Study|Symptomatic Deterioration|1|||
30648579|NCT00779584|58660732|FG007|Overall Study|Symptomatic Deterioration|0|||
30648580|NCT00779584|58660733|FG008|Overall Study|Symptomatic Deterioration|0|||
30648581|NCT00779584|58660725|FG000|Overall Study|Ongoing in Study|0|||
30648582|NCT00779584|58660726|FG001|Overall Study|Ongoing in Study|0|||
30648583|NCT00779584|58660727|FG002|Overall Study|Ongoing in Study|0|||
30648584|NCT00779584|58660728|FG003|Overall Study|Ongoing in Study|0|||
30648585|NCT00779584|58660729|FG004|Overall Study|Ongoing in Study|1|||
30648586|NCT00779584|58660730|FG005|Overall Study|Ongoing in Study|1|||
30648587|NCT00779584|58660731|FG006|Overall Study|Ongoing in Study|0|||
30648588|NCT00779584|58660732|FG007|Overall Study|Ongoing in Study|0|||
30648589|NCT00779584|58660733|FG008|Overall Study|Ongoing in Study|0|||
30648590|NCT00995930|58660755|FG000|Overall Study|Protocol deviation|2|||
30648591|NCT00995930|58660756|FG001|Overall Study|Protocol deviation|5|||
30648592|NCT00995930|58660755|FG000|Overall Study|Death|0|||
30648593|NCT00995930|58660756|FG001|Overall Study|Death|1|||
30648594|NCT00995930|58660755|FG000|Overall Study|Administrative problems|4|||
30648595|NCT00995930|58660756|FG001|Overall Study|Administrative problems|2|||
30648596|NCT00995930|58660755|FG000|Overall Study|Lost to Follow-up|1|||
30648597|NCT00995930|58660756|FG001|Overall Study|Lost to Follow-up|2|||
30648598|NCT00995930|58660755|FG000|Overall Study|Withdrawal by Subject|3|||
30648599|NCT00995930|58660756|FG001|Overall Study|Withdrawal by Subject|4|||
30648600|NCT00995930|58660755|FG000|Overall Study|Adverse Event|11|||
30648601|NCT00995930|58660756|FG001|Overall Study|Adverse Event|14|||
30648602|NCT00779506|58660763|FG000|Overall Study|Screening Failed|2|||
30648603|NCT00779506|58660763|FG000|Overall Study|Adverse Event|4|||
30648604|NCT00779506|58660763|FG000|Overall Study|Lack of Efficacy|11|||
30648605|NCT00779506|58660763|FG000|Overall Study|Protocol Violation|5|||
30648606|NCT00779506|58660763|FG000|Overall Study|Withdrawal by Subject|6|||
30648607|NCT00779506|58660763|FG000|Overall Study|Lost to Follow-up|1|||
30648608|NCT00995774|58660769|FG000|Training Period 2|Withdrawal by Subject|2|||
30648609|NCT00995774|58660770|FG001|Training Period 2|Withdrawal by Subject|0|||
30648610|NCT00765388|58660776|FG000|Period 1|Lack of Efficacy|1|||
30648611|NCT00765388|58660777|FG001|Period 1|Lack of Efficacy|2|||
30648612|NCT00765388|58660776|FG000|Period 1|Lost to Follow-up|0|||
30648613|NCT00765388|58660777|FG001|Period 1|Lost to Follow-up|1|||
30648614|NCT00765388|58660776|FG000|Period 1|Herpes Zoster|0|||
30648615|NCT00765388|58660777|FG001|Period 1|Herpes Zoster|1|||
30648616|NCT00765388|58660776|FG000|Period 1|Hip operation|0|||
30648617|NCT00765388|58660777|FG001|Period 1|Hip operation|1|||
30648618|NCT00769132|58660792|FG000|Period 1|Adverse Event|1|||
30648619|NCT00769132|58660793|FG001|Period 1|Adverse Event|0|||
30648620|NCT00769132|58660794|FG002|Period 1|Adverse Event|0|||
30648621|NCT00769132|58660795|FG003|Period 1|Adverse Event|1|||
30648622|NCT00769132|58660792|FG000|Period 2|Withdrawal by Subject|0|||
30648623|NCT00769132|58660793|FG001|Period 2|Withdrawal by Subject|0|||
30648624|NCT00769132|58660794|FG002|Period 2|Withdrawal by Subject|0|||
30648625|NCT00769132|58660795|FG003|Period 2|Withdrawal by Subject|1|||
30648626|NCT00769132|58660792|FG000|Period 3|Withdrawal by Subject|1|||
30648627|NCT00769132|58660793|FG001|Period 3|Withdrawal by Subject|0|||
30648628|NCT00769132|58660794|FG002|Period 3|Withdrawal by Subject|0|||
30648629|NCT00769132|58660795|FG003|Period 3|Withdrawal by Subject|0|||
30648630|NCT00769132|58660792|FG000|Period 4|Withdrawal by Subject|0|||
30648631|NCT00769132|58660793|FG001|Period 4|Withdrawal by Subject|1|||
30648632|NCT00769132|58660794|FG002|Period 4|Withdrawal by Subject|0|||
30648633|NCT00769132|58660795|FG003|Period 4|Withdrawal by Subject|0|||
30648634|NCT00991952|58660807|FG000|Overall Study|Adverse Event|0|||
30648635|NCT00991952|58660808|FG001|Overall Study|Adverse Event|1|||
30648636|NCT00779038|58660814|FG000|Overall Study|Study Prematurely Terminated|13|||
30648637|NCT00765076|58660821|FG000|Overall Study|Adverse Event|1|||
30648638|NCT00765076|58660822|FG001|Overall Study|Adverse Event|0|||
30648639|NCT00765076|58660823|FG002|Overall Study|Adverse Event|0|||
30648640|NCT00765076|58660821|FG000|Overall Study|Withdrawal by Subject|0|||
30648641|NCT00765076|58660822|FG001|Overall Study|Withdrawal by Subject|0|||
30648642|NCT00765076|58660823|FG002|Overall Study|Withdrawal by Subject|1|||
30648643|NCT00994682|58660833|FG000|Double Bilnd|Withdrawal by Subject|5|||
30648644|NCT00994682|58660834|FG001|Double Bilnd|Withdrawal by Subject|6|||
30648645|NCT00994682|58660833|FG000|Double Bilnd|Lost to Follow-up|3|||
30648646|NCT00994682|58660834|FG001|Double Bilnd|Lost to Follow-up|3|||
30648647|NCT00994682|58660833|FG000|Double Bilnd|Adverse Event|1|||
30648648|NCT00994682|58660834|FG001|Double Bilnd|Adverse Event|0|||
30848617|NCT04604795|58874767|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
30648649|NCT00994682|58660833|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
30648650|NCT00994682|58660834|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
30648651|NCT00994682|58660833|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
30648652|NCT00994682|58660834|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
30648653|NCT00994682|58660833|FG000|Pioglitazone Open Label|Physician Decision|6|||
30648654|NCT00994682|58660834|FG001|Pioglitazone Open Label|Physician Decision|1|||
30648655|NCT00768898|58660844|FG000|Overall Study|Unrelated injury|1|||
30648656|NCT00768898|58660844|FG000|Overall Study|Headache|1|||
30648657|NCT00994448|58660855|FG000|Overall Study|Adverse Event|1|||
30648658|NCT00994448|58660856|FG001|Overall Study|Adverse Event|0|||
30648659|NCT00994448|58660855|FG000|Overall Study|Lost to Follow-up|5|||
30648660|NCT00994448|58660856|FG001|Overall Study|Lost to Follow-up|1|||
30648661|NCT00994448|58660855|FG000|Overall Study|Withdrawal by Subject|1|||
30648662|NCT00994448|58660856|FG001|Overall Study|Withdrawal by Subject|1|||
30648663|NCT00994448|58660855|FG000|Overall Study|Physician Decision|1|||
30648664|NCT00994448|58660856|FG001|Overall Study|Physician Decision|0|||
30648665|NCT00991406|58660862|FG000|Overall Study|One participant did not respond to FES.|1|||
30648666|NCT01017575|58660871|FG000|Overall Study|Lack of Efficacy|0|||
30648667|NCT01017575|58660872|FG001|Overall Study|Lack of Efficacy|1|||
30648668|NCT01017575|58660873|FG002|Overall Study|Lack of Efficacy|0|||
30648669|NCT01017575|58660874|FG003|Overall Study|Lack of Efficacy|1|||
30648670|NCT01017575|58660875|FG004|Overall Study|Lack of Efficacy|1|||
30648671|NCT01017575|58660871|FG000|Overall Study|Adverse Event|0|||
30648672|NCT01017575|58660872|FG001|Overall Study|Adverse Event|1|||
30648673|NCT01017575|58660873|FG002|Overall Study|Adverse Event|0|||
30648674|NCT01017575|58660874|FG003|Overall Study|Adverse Event|0|||
30648675|NCT01017575|58660875|FG004|Overall Study|Adverse Event|2|||
30648676|NCT01017575|58660871|FG000|Overall Study|Withdrawal by Subject|1|||
30648677|NCT01017575|58660872|FG001|Overall Study|Withdrawal by Subject|0|||
30648678|NCT01017575|58660873|FG002|Overall Study|Withdrawal by Subject|0|||
30648679|NCT01017575|58660874|FG003|Overall Study|Withdrawal by Subject|0|||
30648680|NCT01017575|58660875|FG004|Overall Study|Withdrawal by Subject|0|||
30648681|NCT01017263|58660887|FG000|Overall Study|not eligible|12|||
30648682|NCT00768664|58660891|FG000|Overall Study|Death|57|||
30648683|NCT00768664|58660891|FG000|Overall Study|Lost to Follow-up|2|||
30648684|NCT00768664|58660891|FG000|Overall Study|Other|9|||
30648685|NCT00768664|58660891|FG000|Overall Study|Participant refused|1|||
30648686|NCT00778336|58660899|FG000|Index Procedure-Discharge|Death|6|||
30648687|NCT00778336|58660900|FG001|Index Procedure-Discharge|Death|3|||
30648688|NCT00778336|58660901|FG002|Index Procedure-Discharge|Death|2|||
30648689|NCT00778336|58660902|FG003|Index Procedure-Discharge|Death|0|||
30648690|NCT00778336|58660899|FG000|3 Month Follow Up|Lost to Follow-up|15|||
30648691|NCT00778336|58660900|FG001|3 Month Follow Up|Lost to Follow-up|20|||
30648692|NCT00778336|58660901|FG002|3 Month Follow Up|Lost to Follow-up|3|||
30648693|NCT00778336|58660902|FG003|3 Month Follow Up|Lost to Follow-up|0|||
30648694|NCT00778336|58660899|FG000|3 Month Follow Up|Death|8|||
30648695|NCT00778336|58660900|FG001|3 Month Follow Up|Death|3|||
30648696|NCT00778336|58660901|FG002|3 Month Follow Up|Death|2|||
30648697|NCT00778336|58660902|FG003|3 Month Follow Up|Death|0|||
30648698|NCT01253161|58660912|FG000|Overall Study|Adverse Event|1|||
30648699|NCT00581113|58660918|FG000|Overall Study|Withdrawal by Subject|0|||
30648700|NCT00581113|58660919|FG001|Overall Study|Withdrawal by Subject|1|||
30648701|NCT01016015|58660925|FG000|Overall Study|Not Treated|3|||
30648702|NCT01016015|58660925|FG000|Overall Study|Withdrawal by Subject|1|||
30648703|NCT01016015|58660925|FG000|Overall Study|Adverse Event|15|||
30648704|NCT01015703|58660934|FG000|Overall Study|Withdrawal by Subject|0|||
30648705|NCT01015703|58660935|FG001|Overall Study|Withdrawal by Subject|1|||
30648706|NCT01015703|58660936|FG002|Overall Study|Withdrawal by Subject|0|||
30648707|NCT01015703|58660937|FG003|Overall Study|Withdrawal by Subject|0|||
30648708|NCT01015703|58660938|FG004|Overall Study|Withdrawal by Subject|0|||
30648709|NCT01015703|58660934|FG000|Overall Study|Adverse Event|1|||
30648710|NCT01015703|58660935|FG001|Overall Study|Adverse Event|0|||
30648711|NCT01015703|58660936|FG002|Overall Study|Adverse Event|0|||
30648712|NCT01015703|58660937|FG003|Overall Study|Adverse Event|0|||
30648713|NCT01015703|58660938|FG004|Overall Study|Adverse Event|0|||
30648714|NCT01015703|58660934|FG000|Overall Study|Protocol Violation|1|||
30648715|NCT01015703|58660935|FG001|Overall Study|Protocol Violation|0|||
30648716|NCT01015703|58660936|FG002|Overall Study|Protocol Violation|0|||
30648717|NCT01015703|58660937|FG003|Overall Study|Protocol Violation|0|||
30648718|NCT01015703|58660938|FG004|Overall Study|Protocol Violation|0|||
30648719|NCT04439071|58660952|FG000|Overall Study|Lost to Follow-up|0|||
30648720|NCT04439071|58660953|FG001|Overall Study|Lost to Follow-up|3|||
30648721|NCT04439071|58660952|FG000|Overall Study|Withdrawal by Subject|3|||
30648722|NCT04439071|58660953|FG001|Overall Study|Withdrawal by Subject|8|||
30648723|NCT04439071|58660952|FG000|Overall Study|Death|6|||
30648724|NCT04439071|58660953|FG001|Overall Study|Death|4|||
30648725|NCT04439071|58660952|FG000|Overall Study|Other than specified|3|||
30648726|NCT04439071|58660953|FG001|Overall Study|Other than specified|3|||
30648727|NCT04439071|58660952|FG000|Overall Study|Randomized but not treated|2|||
30648728|NCT04439071|58660953|FG001|Overall Study|Randomized but not treated|0|||
30648729|NCT01017029|58660961|FG000|Overall Study|Lost to Follow-up|1|||
30648730|NCT01017029|58660962|FG001|Overall Study|Lost to Follow-up|0|||
30648731|NCT01017029|58660961|FG000|Overall Study|Administrative problem|0|||
30648732|NCT01017029|58660962|FG001|Overall Study|Administrative problem|1|||
30648733|NCT01017029|58660961|FG000|Overall Study|Death|3|||
30648734|NCT01017029|58660962|FG001|Overall Study|Death|1|||
30648735|NCT00994214|58660972|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
30648736|NCT00994214|58660973|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
30648737|NCT00994214|58660974|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
30648738|NCT00994214|58660975|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
30648739|NCT00994214|58660972|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
30648740|NCT00994214|58660973|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
30648741|NCT00994214|58660974|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
30648742|NCT00994214|58660975|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
30648743|NCT00994214|58660972|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
30648744|NCT00994214|58660973|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
30648745|NCT00994214|58660974|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
30648746|NCT00994214|58660975|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
30648747|NCT00994214|58660972|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
30648748|NCT00994214|58660973|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
30648749|NCT00994214|58660974|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
30648750|NCT00994214|58660975|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
30648751|NCT00994214|58660972|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
30648752|NCT00994214|58660973|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
30648753|NCT00994214|58660974|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
30648754|NCT00994214|58660975|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
30648755|NCT00994214|58660972|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
30648756|NCT00994214|58660973|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
30648757|NCT00994214|58660974|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
30648758|NCT00994214|58660975|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
30648759|NCT01034657|58661003|FG000|Core Phase|Withdrawal by Subject|1|||
30648760|NCT01034657|58661004|FG001|Core Phase|Withdrawal by Subject|0|||
30648761|NCT01034657|58661005|FG002|Core Phase|Withdrawal by Subject|0|||
30648762|NCT01034657|58661003|FG000|Core Phase|Lack of Efficacy|2|||
30648763|NCT01034657|58661004|FG001|Core Phase|Lack of Efficacy|0|||
30648764|NCT01034657|58661005|FG002|Core Phase|Lack of Efficacy|0|||
30648765|NCT01034657|58661003|FG000|Core Phase|Abnormal laboratory value|1|||
30648766|NCT01034657|58661004|FG001|Core Phase|Abnormal laboratory value|0|||
30648767|NCT01034657|58661005|FG002|Core Phase|Abnormal laboratory value|0|||
30648768|NCT01034657|58661003|FG000|Core Phase|Adverse Event|8|||
30648769|NCT01034657|58661004|FG001|Core Phase|Adverse Event|0|||
30648770|NCT01034657|58661005|FG002|Core Phase|Adverse Event|0|||
30648771|NCT01034657|58661003|FG000|Core Phase|Protocol Violation|2|||
30648772|NCT01034657|58661004|FG001|Core Phase|Protocol Violation|0|||
30648773|NCT01034657|58661005|FG002|Core Phase|Protocol Violation|0|||
30648774|NCT01034657|58661003|FG000|Randomized Phase|Withdrawal by Subject|0|||
30648775|NCT01034657|58661004|FG001|Randomized Phase|Withdrawal by Subject|2|||
30648776|NCT01034657|58661005|FG002|Randomized Phase|Withdrawal by Subject|0|||
30648777|NCT01034657|58661003|FG000|Randomized Phase|Lack of Efficacy|5|||
30648778|NCT01034657|58661004|FG001|Randomized Phase|Lack of Efficacy|1|||
30648779|NCT01034657|58661005|FG002|Randomized Phase|Lack of Efficacy|0|||
30648780|NCT01034657|58661003|FG000|Randomized Phase|Abnormal laboratory value|0|||
30648781|NCT01034657|58661004|FG001|Randomized Phase|Abnormal laboratory value|1|||
30648782|NCT01034657|58661005|FG002|Randomized Phase|Abnormal laboratory value|0|||
30648783|NCT01034657|58661003|FG000|Randomized Phase|Adverse Event|0|||
30648784|NCT01034657|58661004|FG001|Randomized Phase|Adverse Event|2|||
30648785|NCT01034657|58661005|FG002|Randomized Phase|Adverse Event|1|||
30648786|NCT01014767|58661019|FG000|Overall Study|PI left institution, data unavailable|12|||
30648787|NCT01014767|58661020|FG001|Overall Study|PI left institution, data unavailable|1|||
30648788|NCT01014767|58661021|FG002|Overall Study|PI left institution, data unavailable|4|||
30648789|NCT01014767|58661022|FG003|Overall Study|PI left institution, data unavailable|1|||
30648790|NCT02016781|58661034|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
30648791|NCT02016781|58661035|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
30648792|NCT02016781|58661034|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
30648793|NCT02016781|58661035|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
30648794|NCT02016781|58661034|FG000|Final Database Lock|Withdrawal by Subject|2|||
30648795|NCT02016781|58661035|FG001|Final Database Lock|Withdrawal by Subject|1|||
30648796|NCT02016781|58661034|FG000|Final Database Lock|Lost to Follow-up|11|||
30648797|NCT02016781|58661035|FG001|Final Database Lock|Lost to Follow-up|4|||
30648798|NCT02016781|58661034|FG000|Final Database Lock|Missing data|0|||
30648799|NCT02016781|58661035|FG001|Final Database Lock|Missing data|3|||
30648800|NCT01014689|58661043|FG000|Overall Study|Lack of Efficacy|0|||
30648801|NCT01014689|58661044|FG001|Overall Study|Lack of Efficacy|1|||
30648802|NCT01014689|58661043|FG000|Overall Study|Adverse Event|3|||
30648803|NCT01014689|58661044|FG001|Overall Study|Adverse Event|0|||
30767096|NCT03307174|58775790|FG000|Overall Study|Nonfunctional epidural|1|||
30767097|NCT03307174|58775791|FG001|Overall Study|Nonfunctional epidural|1|||
30648804|NCT01014689|58661043|FG000|Overall Study|Withdrawal by Subject|5|||
30648805|NCT01014689|58661044|FG001|Overall Study|Withdrawal by Subject|4|||
30648806|NCT01014689|58661043|FG000|Overall Study|Protocol Violation|1|||
30648807|NCT01014689|58661044|FG001|Overall Study|Protocol Violation|1|||
30648808|NCT01014689|58661043|FG000|Overall Study|Lost to Follow-up|3|||
30648809|NCT01014689|58661044|FG001|Overall Study|Lost to Follow-up|7|||
30648810|NCT01014689|58661043|FG000|Overall Study|Pregnancy|1|||
30648811|NCT01014689|58661044|FG001|Overall Study|Pregnancy|0|||
30648812|NCT01014533|58661052|FG000|Overall Study|Protocol Violation|3|||
30648813|NCT01014533|58661053|FG001|Overall Study|Protocol Violation|2|||
30648814|NCT01014533|58661052|FG000|Overall Study|Withdrawal by Subject|2|||
30648815|NCT01014533|58661053|FG001|Overall Study|Withdrawal by Subject|0|||
30648816|NCT01014533|58661052|FG000|Overall Study|unable to come to appointment|0|||
30648817|NCT01014533|58661053|FG001|Overall Study|unable to come to appointment|3|||
30648818|NCT01014143|58661076|FG000|Second Intervention|Lost to Follow-up|2|||
30648819|NCT01014143|58661077|FG001|Second Intervention|Lost to Follow-up|0|||
30648820|NCT01014143|58661078|FG002|Second Intervention|Lost to Follow-up|0|||
30648821|NCT01013753|58661086|FG000|Overall Study|Adverse Event|8|||
30648822|NCT01013753|58661086|FG000|Overall Study|Protocol Violation|3|||
30648823|NCT01013753|58661086|FG000|Overall Study|Lost to Follow-up|1|||
30648824|NCT01013753|58661086|FG000|Overall Study|Withdrawal by Subject|2|||
30648825|NCT01013753|58661086|FG000|Overall Study|Other|2|||
30648826|NCT00757042|58661111|FG000|Overall Study|Lost to Follow-up|0|||
30648827|NCT00757042|58661112|FG001|Overall Study|Lost to Follow-up|0|||
30648828|NCT00757042|58661113|FG002|Overall Study|Lost to Follow-up|0|||
30648829|NCT00757042|58661114|FG003|Overall Study|Lost to Follow-up|0|||
30648830|NCT00757042|58661115|FG004|Overall Study|Lost to Follow-up|0|||
30648831|NCT00757042|58661116|FG005|Overall Study|Lost to Follow-up|0|||
30648832|NCT00757042|58661117|FG006|Overall Study|Lost to Follow-up|0|||
30648833|NCT00757042|58661118|FG007|Overall Study|Lost to Follow-up|0|||
30648834|NCT00757042|58661119|FG008|Overall Study|Lost to Follow-up|1|||
30648835|NCT00757042|58661120|FG009|Overall Study|Lost to Follow-up|0|||
30648836|NCT00757042|58661121|FG010|Overall Study|Lost to Follow-up|0|||
30648837|NCT00757042|58661111|FG000|Overall Study|Ineligibility Determined|0|||
30648838|NCT00757042|58661112|FG001|Overall Study|Ineligibility Determined|0|||
30648839|NCT00757042|58661113|FG002|Overall Study|Ineligibility Determined|0|||
30648840|NCT00757042|58661114|FG003|Overall Study|Ineligibility Determined|0|||
30648841|NCT00757042|58661115|FG004|Overall Study|Ineligibility Determined|0|||
30648842|NCT00757042|58661116|FG005|Overall Study|Ineligibility Determined|0|||
30648843|NCT00757042|58661117|FG006|Overall Study|Ineligibility Determined|0|||
30648844|NCT00757042|58661118|FG007|Overall Study|Ineligibility Determined|0|||
30648845|NCT00757042|58661119|FG008|Overall Study|Ineligibility Determined|0|||
30648846|NCT00757042|58661120|FG009|Overall Study|Ineligibility Determined|0|||
30648847|NCT00757042|58661121|FG010|Overall Study|Ineligibility Determined|1|||
30648848|NCT00757042|58661111|FG000|Overall Study|Withdrawal by Subject|0|||
30648849|NCT00757042|58661112|FG001|Overall Study|Withdrawal by Subject|0|||
30648850|NCT00757042|58661113|FG002|Overall Study|Withdrawal by Subject|0|||
30648851|NCT00757042|58661114|FG003|Overall Study|Withdrawal by Subject|0|||
30648852|NCT00757042|58661115|FG004|Overall Study|Withdrawal by Subject|0|||
30648853|NCT00757042|58661116|FG005|Overall Study|Withdrawal by Subject|0|||
30648854|NCT00757042|58661117|FG006|Overall Study|Withdrawal by Subject|0|||
30648855|NCT00757042|58661118|FG007|Overall Study|Withdrawal by Subject|0|||
30648856|NCT00757042|58661119|FG008|Overall Study|Withdrawal by Subject|0|||
30648857|NCT00757042|58661120|FG009|Overall Study|Withdrawal by Subject|1|||
30648858|NCT00757042|58661121|FG010|Overall Study|Withdrawal by Subject|0|||
30648859|NCT01013597|58661152|FG000|Overall Study|Withdrawal by Subject|1|||
30648860|NCT01013285|58661171|FG000|Overall Study|Death|48|||
30648861|NCT01013285|58661172|FG001|Overall Study|Death|89|||
30848618|NCT04604795|58874768|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
30848619|NCT04604795|58874769|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
30648862|NCT01033643|58661182|FG000|Overall Study|Withdrew Consent|0|||
30648863|NCT01033643|58661183|FG001|Overall Study|Withdrew Consent|3|||
30648864|NCT01033643|58661184|FG002|Overall Study|Withdrew Consent|0|||
30648865|NCT01033643|58661185|FG003|Overall Study|Withdrew Consent|0|||
30648866|NCT01033643|58661186|FG004|Overall Study|Withdrew Consent|0|||
30648867|NCT01033643|58661187|FG005|Overall Study|Withdrew Consent|1|||
30648868|NCT01013207|58661201|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
30648869|NCT01033487|58661205|FG000|Fourth Intervention Period|Adverse Event|0|||
30648870|NCT01033487|58661206|FG001|Fourth Intervention Period|Adverse Event|0|||
30648871|NCT01033487|58661207|FG002|Fourth Intervention Period|Adverse Event|0|||
30648872|NCT01033487|58661208|FG003|Fourth Intervention Period|Adverse Event|0|||
30648873|NCT01033487|58661209|FG004|Fourth Intervention Period|Adverse Event|0|||
30648874|NCT01033487|58661210|FG005|Fourth Intervention Period|Adverse Event|0|||
30952061|NCT01698320|58999422|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
30648875|NCT01033487|58661211|FG006|Fourth Intervention Period|Adverse Event|0|||
30648876|NCT01033487|58661212|FG007|Fourth Intervention Period|Adverse Event|0|||
30648877|NCT01033487|58661213|FG008|Fourth Intervention Period|Adverse Event|1|||
30648878|NCT01033487|58661214|FG009|Fourth Intervention Period|Adverse Event|0|||
30648879|NCT01033019|58661230|FG000|Overall Study|Withdrawal by Subject|1|||
30767098|NCT03307174|58775790|FG000|Overall Study|Planned epidural removal|1|||
30767099|NCT03307174|58775791|FG001|Overall Study|Planned epidural removal|0|||
30767100|NCT03307174|58775790|FG000|Overall Study|Intrathecal catheter placement|0|||
30767101|NCT03307174|58775791|FG001|Overall Study|Intrathecal catheter placement|1|||
30767102|NCT03258814|58775799|FG000|Overall Study|Early Termination|4|||
30767103|NCT03258814|58775800|FG001|Overall Study|Early Termination|3|||
30767104|NCT03258814|58775801|FG002|Overall Study|Early Termination|10|||
30767105|NCT03257410|58775810|FG000|Overall Study|Adverse Event|2|||
30648880|NCT01033019|58661231|FG001|Overall Study|Withdrawal by Subject|0|||
30648881|NCT00603447|58661245|FG000|Overall Study|Adverse Event|0|||
30648882|NCT00603447|58661246|FG001|Overall Study|Adverse Event|1|||
30648883|NCT00603447|58661247|FG002|Overall Study|Adverse Event|1|||
30648884|NCT00603447|58661248|FG003|Overall Study|Adverse Event|2|||
30648885|NCT00603447|58661249|FG004|Overall Study|Adverse Event|1|||
30648886|NCT00603447|58661250|FG005|Overall Study|Adverse Event|2|||
30648887|NCT00603447|58661251|FG006|Overall Study|Adverse Event|10|||
30648888|NCT00603447|58661245|FG000|Overall Study|Other|0|||
30648889|NCT00603447|58661246|FG001|Overall Study|Other|0|||
30648890|NCT00603447|58661247|FG002|Overall Study|Other|1|||
30648891|NCT00603447|58661248|FG003|Overall Study|Other|0|||
30648892|NCT00603447|58661249|FG004|Overall Study|Other|3|||
30648893|NCT00603447|58661250|FG005|Overall Study|Other|0|||
30648894|NCT00603447|58661251|FG006|Overall Study|Other|13|||
30648895|NCT00603447|58661245|FG000|Overall Study|Withdrew Consent|0|||
30648896|NCT00603447|58661246|FG001|Overall Study|Withdrew Consent|2|||
30648897|NCT00603447|58661247|FG002|Overall Study|Withdrew Consent|0|||
30648898|NCT00603447|58661248|FG003|Overall Study|Withdrew Consent|0|||
30648899|NCT00603447|58661249|FG004|Overall Study|Withdrew Consent|1|||
30648900|NCT00603447|58661250|FG005|Overall Study|Withdrew Consent|0|||
30648901|NCT00603447|58661251|FG006|Overall Study|Withdrew Consent|1|||
30648902|NCT00778258|58661276|FG000|Overall Study|Adverse Event|1|||
30648903|NCT00778258|58661277|FG001|Overall Study|Adverse Event|0|||
30648904|NCT00778258|58661278|FG002|Overall Study|Adverse Event|0|||
30648905|NCT00778258|58661279|FG003|Overall Study|Adverse Event|0|||
30648906|NCT00778258|58661280|FG004|Overall Study|Adverse Event|0|||
30648907|NCT00778258|58661281|FG005|Overall Study|Adverse Event|1|||
30648908|NCT00778258|58661282|FG006|Overall Study|Adverse Event|0|||
30648909|NCT00778258|58661283|FG007|Overall Study|Adverse Event|0|||
30648910|NCT00778258|58661284|FG008|Overall Study|Adverse Event|0|||
30648911|NCT00778258|58661276|FG000|Overall Study|Lost to Follow-up|0|||
30648912|NCT00778258|58661277|FG001|Overall Study|Lost to Follow-up|0|||
30648913|NCT00778258|58661278|FG002|Overall Study|Lost to Follow-up|2|||
30648914|NCT00778258|58661279|FG003|Overall Study|Lost to Follow-up|0|||
30767106|NCT03257410|58775811|FG001|Overall Study|Adverse Event|3|||
30767107|NCT03257410|58775810|FG000|Overall Study|Protocol Violation|1|||
30767108|NCT03257410|58775811|FG001|Overall Study|Protocol Violation|2|||
30767109|NCT03257410|58775810|FG000|Overall Study|Lost to Follow-up|1|||
30767110|NCT03257410|58775811|FG001|Overall Study|Lost to Follow-up|0|||
30648915|NCT00778258|58661280|FG004|Overall Study|Lost to Follow-up|0|||
30648916|NCT00778258|58661281|FG005|Overall Study|Lost to Follow-up|3|||
30648917|NCT00778258|58661282|FG006|Overall Study|Lost to Follow-up|2|||
30648918|NCT00778258|58661283|FG007|Overall Study|Lost to Follow-up|2|||
30648919|NCT00778258|58661284|FG008|Overall Study|Lost to Follow-up|0|||
30648920|NCT00778258|58661276|FG000|Overall Study|Withdrawal by Subject|6|||
30648921|NCT00778258|58661277|FG001|Overall Study|Withdrawal by Subject|2|||
30648922|NCT00778258|58661278|FG002|Overall Study|Withdrawal by Subject|8|||
30648923|NCT00778258|58661279|FG003|Overall Study|Withdrawal by Subject|2|||
30648924|NCT00778258|58661280|FG004|Overall Study|Withdrawal by Subject|0|||
30648925|NCT00778258|58661281|FG005|Overall Study|Withdrawal by Subject|6|||
30648926|NCT00778258|58661282|FG006|Overall Study|Withdrawal by Subject|12|||
30648927|NCT00778258|58661283|FG007|Overall Study|Withdrawal by Subject|12|||
30767111|NCT03257410|58775810|FG000|Overall Study|Withdrawal by Subject|1|||
30767112|NCT03257410|58775811|FG001|Overall Study|Withdrawal by Subject|2|||
30648928|NCT00778258|58661284|FG008|Overall Study|Withdrawal by Subject|4|||
30648929|NCT00778258|58661276|FG000|Overall Study|New Contraindication|0|||
30648930|NCT00778258|58661277|FG001|Overall Study|New Contraindication|0|||
30648931|NCT00778258|58661278|FG002|Overall Study|New Contraindication|0|||
30648932|NCT00778258|58661279|FG003|Overall Study|New Contraindication|0|||
30648933|NCT00778258|58661280|FG004|Overall Study|New Contraindication|0|||
30767113|NCT03257410|58775810|FG000|Overall Study|Physician Decision|1|||
30848620|NCT04604795|58874770|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
30648934|NCT00778258|58661281|FG005|Overall Study|New Contraindication|0|||
30767114|NCT03257410|58775811|FG001|Overall Study|Physician Decision|1|||
30767115|NCT03257410|58775810|FG000|Overall Study|Renal transplantation|2|||
30648935|NCT00778258|58661282|FG006|Overall Study|New Contraindication|0|||
30648936|NCT00778258|58661283|FG007|Overall Study|New Contraindication|1|||
30648937|NCT00778258|58661284|FG008|Overall Study|New Contraindication|0|||
30648938|NCT00778258|58661276|FG000|Overall Study|Non-compliance|0|||
30648939|NCT00778258|58661277|FG001|Overall Study|Non-compliance|0|||
30648940|NCT00778258|58661278|FG002|Overall Study|Non-compliance|0|||
30648941|NCT00778258|58661279|FG003|Overall Study|Non-compliance|1|||
30648942|NCT00778258|58661280|FG004|Overall Study|Non-compliance|0|||
30648943|NCT00778258|58661281|FG005|Overall Study|Non-compliance|0|||
30648944|NCT00778258|58661282|FG006|Overall Study|Non-compliance|0|||
30648945|NCT00778258|58661283|FG007|Overall Study|Non-compliance|0|||
30648946|NCT00778258|58661284|FG008|Overall Study|Non-compliance|0|||
30648947|NCT00778258|58661276|FG000|Overall Study|Other|0|||
30648948|NCT00778258|58661277|FG001|Overall Study|Other|0|||
30648949|NCT00778258|58661278|FG002|Overall Study|Other|0|||
30648950|NCT00778258|58661279|FG003|Overall Study|Other|0|||
30648951|NCT00778258|58661280|FG004|Overall Study|Other|0|||
30648952|NCT00778258|58661281|FG005|Overall Study|Other|0|||
30648953|NCT00778258|58661282|FG006|Overall Study|Other|1|||
30648954|NCT00778258|58661283|FG007|Overall Study|Other|0|||
30648955|NCT00778258|58661284|FG008|Overall Study|Other|0|||
30648956|NCT00988208|58661312|FG000|Overall Study|Adverse Event|71|||
30648957|NCT00988208|58661313|FG001|Overall Study|Adverse Event|122|||
30648958|NCT00988208|58661312|FG000|Overall Study|Disease Progression|103|||
30648959|NCT00988208|58661313|FG001|Overall Study|Disease Progression|89|||
30648960|NCT00988208|58661312|FG000|Overall Study|Withdrawal by Subject|50|||
30648961|NCT00988208|58661313|FG001|Overall Study|Withdrawal by Subject|57|||
30648962|NCT00988208|58661312|FG000|Overall Study|Death|9|||
30648963|NCT00988208|58661313|FG001|Overall Study|Death|15|||
30648964|NCT00988208|58661312|FG000|Overall Study|Lost to Follow-up|2|||
30648965|NCT00988208|58661313|FG001|Overall Study|Lost to Follow-up|3|||
30648966|NCT00988208|58661312|FG000|Overall Study|Protocol Violation|9|||
30648967|NCT00988208|58661313|FG001|Overall Study|Protocol Violation|2|||
30648968|NCT00988208|58661312|FG000|Overall Study|Sponsor Decision|102|||
30648969|NCT00988208|58661313|FG001|Overall Study|Sponsor Decision|78|||
30648970|NCT00988208|58661312|FG000|Overall Study|Clinical Progression|17|||
30648971|NCT00988208|58661313|FG001|Overall Study|Clinical Progression|16|||
30648972|NCT00988208|58661312|FG000|Overall Study|Biochemical Progression|21|||
30648973|NCT00988208|58661313|FG001|Overall Study|Biochemical Progression|7|||
30648974|NCT00988208|58661312|FG000|Overall Study|Clinical Deterioration|7|||
30648975|NCT00988208|58661313|FG001|Overall Study|Clinical Deterioration|14|||
30648976|NCT00988208|58661312|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
30648977|NCT00988208|58661313|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
30648978|NCT00988208|58661312|FG000|Overall Study|Other|8|||
30648979|NCT00988208|58661313|FG001|Overall Study|Other|3|||
30648980|NCT00990704|58661321|FG000|Overall Study|Adverse Event|1|||
30648981|NCT00990704|58661322|FG001|Overall Study|Adverse Event|1|||
30648982|NCT00990704|58661321|FG000|Overall Study|Physician Decision|0|||
30648983|NCT00990704|58661322|FG001|Overall Study|Physician Decision|1|||
30648984|NCT04089553|58661330|FG000|Overall Study|Death|12|||
30648985|NCT04089553|58661331|FG001|Overall Study|Death|11|||
30648986|NCT04089553|58661330|FG000|Overall Study|Lost to Follow-up|2|||
30648987|NCT04089553|58661331|FG001|Overall Study|Lost to Follow-up|2|||
30648988|NCT04089553|58661330|FG000|Overall Study|Progressive disease|0|||
30648989|NCT04089553|58661331|FG001|Overall Study|Progressive disease|1|||
30648990|NCT04089553|58661330|FG000|Overall Study|Withdrawal by Subject|5|||
30648991|NCT04089553|58661331|FG001|Overall Study|Withdrawal by Subject|2|||
30648992|NCT04089553|58661330|FG000|Overall Study|Other|6|||
30648993|NCT04089553|58661331|FG001|Overall Study|Other|2|||
30648994|NCT00993668|58661340|FG000|Single-Blind Period|Adverse Event|1|||
30648995|NCT00993668|58661341|FG001|Single-Blind Period|Adverse Event|1|||
30648996|NCT00993668|58661340|FG000|Single-Blind Period|Lack of Efficacy|0|||
30648997|NCT00993668|58661341|FG001|Single-Blind Period|Lack of Efficacy|1|||
30648998|NCT00993668|58661340|FG000|Single-Blind Period|Lost to Follow-up|3|||
30648999|NCT00993668|58661341|FG001|Single-Blind Period|Lost to Follow-up|1|||
30649000|NCT00993668|58661340|FG000|Open-Label Period|Adverse Event|9|||
30649001|NCT00993668|58661341|FG001|Open-Label Period|Adverse Event|8|||
30649002|NCT00993668|58661340|FG000|Open-Label Period|Lack of Efficacy|4|||
30767116|NCT03257410|58775811|FG001|Overall Study|Renal transplantation|0|||
30649003|NCT00993668|58661341|FG001|Open-Label Period|Lack of Efficacy|3|||
30649004|NCT00993668|58661340|FG000|Open-Label Period|Withdrawal by Subject|4|||
30649005|NCT00993668|58661341|FG001|Open-Label Period|Withdrawal by Subject|3|||
30649006|NCT00993668|58661340|FG000|Open-Label Period|Lost to Follow-up|6|||
30649007|NCT00993668|58661341|FG001|Open-Label Period|Lost to Follow-up|1|||
30649008|NCT00778102|58661350|FG000|Overall Study|Adverse Event|8|||
30649009|NCT00778102|58661351|FG001|Overall Study|Adverse Event|5|||
30649010|NCT00778102|58661350|FG000|Overall Study|Death|1|||
30649011|NCT00778102|58661351|FG001|Overall Study|Death|1|||
30649012|NCT00778102|58661350|FG000|Overall Study|Lost to Follow-up|1|||
30649013|NCT00778102|58661351|FG001|Overall Study|Lost to Follow-up|0|||
30649014|NCT00778102|58661350|FG000|Overall Study|Violation of Selection Criteria|1|||
30649015|NCT00778102|58661351|FG001|Overall Study|Violation of Selection Criteria|1|||
30649016|NCT00778102|58661350|FG000|Overall Study|Protocol Violation|0|||
30649017|NCT00778102|58661351|FG001|Overall Study|Protocol Violation|1|||
30649018|NCT00778102|58661350|FG000|Overall Study|Refused Treatment|2|||
30649019|NCT00778102|58661351|FG001|Overall Study|Refused Treatment|3|||
30649020|NCT00778102|58661350|FG000|Overall Study|Withdrawal by Subject|1|||
30649021|NCT00778102|58661351|FG001|Overall Study|Withdrawal by Subject|1|||
30649022|NCT00778102|58661350|FG000|Overall Study|Administrative Reason|7|||
30649023|NCT00778102|58661351|FG001|Overall Study|Administrative Reason|10|||
30649024|NCT00756886|58661359|FG000|Overall Study|Lost to Follow-up|1|||
30649025|NCT00756886|58661360|FG001|Overall Study|Lost to Follow-up|0|||
30649026|NCT00756886|58661359|FG000|Overall Study|Adverse Event|0|||
30649027|NCT00756886|58661360|FG001|Overall Study|Adverse Event|3|||
30649028|NCT00756886|58661359|FG000|Overall Study|Lack of Efficacy|1|||
30649029|NCT00756886|58661360|FG001|Overall Study|Lack of Efficacy|0|||
30649030|NCT00756886|58661359|FG000|Overall Study|Ineligible|9|||
30649031|NCT00756886|58661360|FG001|Overall Study|Ineligible|4|||
30649032|NCT00756730|58661368|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
30649033|NCT00756730|58661369|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
30649034|NCT00756730|58661368|FG000|Overall Study|persistent low-level viremmia|0|||
30649035|NCT00756730|58661369|FG001|Overall Study|persistent low-level viremmia|1|||
30649036|NCT00984620|58661377|FG000|Overall Study|Adverse Event|5|||
30649037|NCT00984620|58661378|FG001|Overall Study|Adverse Event|5|||
30649038|NCT00984620|58661377|FG000|Overall Study|Lost to Follow-up|1|||
30649039|NCT00984620|58661378|FG001|Overall Study|Lost to Follow-up|1|||
30649040|NCT00984620|58661377|FG000|Overall Study|Withdrawal by Subject|0|||
30649041|NCT00984620|58661378|FG001|Overall Study|Withdrawal by Subject|2|||
30649042|NCT00984620|58661377|FG000|Overall Study|reason other than listed above|0|||
30649043|NCT00984620|58661378|FG001|Overall Study|reason other than listed above|4|||
30649044|NCT00777946|58661389|FG000|Overall Study|Adverse Event|11|||
30649045|NCT00777946|58661390|FG001|Overall Study|Adverse Event|1|||
30649046|NCT00777946|58661391|FG002|Overall Study|Adverse Event|3|||
30649047|NCT00777946|58661389|FG000|Overall Study|Lack of Efficacy|0|||
30649048|NCT00777946|58661390|FG001|Overall Study|Lack of Efficacy|0|||
30649049|NCT00777946|58661391|FG002|Overall Study|Lack of Efficacy|9|||
30649050|NCT00777946|58661389|FG000|Overall Study|Condition no longer required study drug|1|||
30649051|NCT00777946|58661390|FG001|Overall Study|Condition no longer required study drug|0|||
30649052|NCT00777946|58661391|FG002|Overall Study|Condition no longer required study drug|0|||
30649053|NCT00777946|58661389|FG000|Overall Study|Patient withdrew consent|3|||
30649054|NCT00777946|58661390|FG001|Overall Study|Patient withdrew consent|2|||
30649055|NCT00777946|58661391|FG002|Overall Study|Patient withdrew consent|3|||
30649056|NCT00777946|58661389|FG000|Overall Study|Lost to Follow-up|3|||
30649057|NCT00777946|58661390|FG001|Overall Study|Lost to Follow-up|1|||
30649058|NCT00777946|58661391|FG002|Overall Study|Lost to Follow-up|0|||
30767117|NCT03257410|58775810|FG000|Overall Study|Switch to peritoneal dialysis|1|||
30767118|NCT03257410|58775811|FG001|Overall Study|Switch to peritoneal dialysis|0|||
30767119|NCT03257410|58775810|FG000|Overall Study|Death|3|||
30848621|NCT04604795|58874771|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
30649059|NCT00777946|58661389|FG000|Overall Study|Protocol deviation|2|||
30649060|NCT00777946|58661390|FG001|Overall Study|Protocol deviation|1|||
30649061|NCT00777946|58661391|FG002|Overall Study|Protocol deviation|1|||
30649062|NCT00777946|58661389|FG000|Overall Study|Randomized in error|1|||
30649063|NCT00777946|58661390|FG001|Overall Study|Randomized in error|1|||
30649064|NCT00777946|58661391|FG002|Overall Study|Randomized in error|0|||
30649065|NCT00990314|58661399|FG000|Overall Study|Death|2|||
30649066|NCT00990314|58661399|FG000|Overall Study|Adverse Event|2|||
30649067|NCT00990314|58661399|FG000|Overall Study|Withdrawal by Subject|3|||
30649068|NCT00990314|58661399|FG000|Overall Study|Non-Compliance|1|||
30767120|NCT03257410|58775811|FG001|Overall Study|Death|2|||
30767121|NCT03257410|58775810|FG000|Overall Study|Change to another dialysis center|2|||
30767122|NCT03257410|58775811|FG001|Overall Study|Change to another dialysis center|2|||
30649069|NCT00990314|58661399|FG000|Overall Study|Physician Decision|3|||
30649070|NCT00990314|58661399|FG000|Overall Study|Lack of Efficacy|1|||
30649071|NCT00756652|58661405|FG000|Original Phase|Withdrawal by Subject|864|||
30649072|NCT00756652|58661406|FG001|Original Phase|Withdrawal by Subject|23|||
30649073|NCT00756652|58661405|FG000|Original Phase|Lost to Follow-up|601|||
30649074|NCT00756652|58661406|FG001|Original Phase|Lost to Follow-up|0|||
30649075|NCT00756652|58661405|FG000|Original Phase|Other Discontinuation|797|||
30649076|NCT00756652|58661406|FG001|Original Phase|Other Discontinuation|5|||
30649077|NCT00756652|58661405|FG000|Original Phase|Participant Noncompliance|18622|||
30649078|NCT00756652|58661406|FG001|Original Phase|Participant Noncompliance|424|||
30649079|NCT00756652|58661405|FG000|Original Phase|Unknown Discontinuation Reason|2|||
30649080|NCT00756652|58661406|FG001|Original Phase|Unknown Discontinuation Reason|0|||
30649081|NCT00756652|58661405|FG000|Original Phase|Participants without data|3259|||
30649082|NCT00756652|58661406|FG001|Original Phase|Participants without data|466|||
30649083|NCT00756652|58661405|FG000|Original Phase|Death|168|||
30649084|NCT00756652|58661406|FG001|Original Phase|Death|1|||
30649085|NCT00756652|58661405|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
30649086|NCT00756652|58661406|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
30649087|NCT00756652|58661405|FG000|Re-Op Phase|Withdrawal by Subject|62|||
30649088|NCT00756652|58661406|FG001|Re-Op Phase|Withdrawal by Subject|0|||
30649089|NCT00756652|58661405|FG000|Re-Op Phase|Death|6|||
30649090|NCT00756652|58661406|FG001|Re-Op Phase|Death|0|||
30649091|NCT00756652|58661405|FG000|Re-Op Phase|Lost to Follow-up|340|||
30649092|NCT00756652|58661406|FG001|Re-Op Phase|Lost to Follow-up|0|||
30649093|NCT00756652|58661405|FG000|Re-Op Phase|Site Closed|2454|||
30649094|NCT00756652|58661406|FG001|Re-Op Phase|Site Closed|0|||
30649095|NCT00756652|58661405|FG000|Re-Op Phase|Withdrawn after explant|14|||
30649096|NCT00756652|58661406|FG001|Re-Op Phase|Withdrawn after explant|0|||
30649097|NCT00777556|58661410|FG000|Overall Study|Inappropriate self-selection|34|||
30649098|NCT00777556|58661410|FG000|Overall Study|Dispensed but did not use product|12|||
30649099|NCT00777556|58661410|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
30649100|NCT00602979|58661419|FG000|Overall Study|Lost to Follow-up|3|||
30649101|NCT00602979|58661420|FG001|Overall Study|Lost to Follow-up|2|||
30649102|NCT00602979|58661421|FG002|Overall Study|Lost to Follow-up|3|||
30649103|NCT00602979|58661422|FG003|Overall Study|Lost to Follow-up|2|||
30649104|NCT00602979|58661423|FG004|Overall Study|Lost to Follow-up|3|||
30649105|NCT00602979|58661419|FG000|Overall Study|Failed Intubation|0|||
30649106|NCT00602979|58661420|FG001|Overall Study|Failed Intubation|1|||
30649107|NCT00602979|58661421|FG002|Overall Study|Failed Intubation|0|||
30649108|NCT00602979|58661422|FG003|Overall Study|Failed Intubation|1|||
30649109|NCT00602979|58661423|FG004|Overall Study|Failed Intubation|0|||
30649110|NCT04081363|58661437|FG000|Overall Study|Withdrawal by Subject|1|||
30649111|NCT04081363|58661438|FG001|Overall Study|Withdrawal by Subject|0|||
30649112|NCT00993044|58661444|FG000|Irinotecan 50 mg|Physician Decision|1|||
30649113|NCT00777088|58661458|FG000|Overall Study|PED Treatment not attempted|1|||
30649114|NCT00763282|58661474|FG000|Overall Study|Withdrawal by Subject|6|||
30649115|NCT00763282|58661475|FG001|Overall Study|Withdrawal by Subject|5|||
30649116|NCT00763282|58661474|FG000|Overall Study|Death|4|||
30649117|NCT00763282|58661475|FG001|Overall Study|Death|3|||
30649118|NCT00763282|58661474|FG000|Overall Study|Lost to Follow-up|22|||
30649119|NCT00763282|58661475|FG001|Overall Study|Lost to Follow-up|26|||
30649120|NCT00988598|58661485|FG000|Overall Study|Withdrawal by Subject|2|||
30649121|NCT00988598|58661486|FG001|Overall Study|Withdrawal by Subject|0|||
30649122|NCT00979628|58661495|FG000|Overall Study|received regimen < 24 hours|7|||
30649123|NCT00979628|58661496|FG001|Overall Study|received regimen < 24 hours|6|||
30649124|NCT00979628|58661497|FG002|Overall Study|received regimen < 24 hours|5|||
30649125|NCT00979628|58661495|FG000|Overall Study|received steroids|1|||
30649126|NCT00979628|58661496|FG001|Overall Study|received steroids|1|||
30649127|NCT00979628|58661497|FG002|Overall Study|received steroids|0|||
30649128|NCT00979628|58661495|FG000|Overall Study|transferred to ICU|1|||
30649129|NCT00979628|58661496|FG001|Overall Study|transferred to ICU|2|||
30649130|NCT00979628|58661497|FG002|Overall Study|transferred to ICU|1|||
30649131|NCT00762970|58661511|FG000|Overall Study|Withdrawal by Subject|7|||
30649132|NCT00762970|58661512|FG001|Overall Study|Withdrawal by Subject|4|||
30649133|NCT00762970|58661513|FG002|Overall Study|Withdrawal by Subject|0|||
30649134|NCT00762970|58661511|FG000|Overall Study|Protocol Violation|3|||
30649135|NCT00762970|58661512|FG001|Overall Study|Protocol Violation|1|||
30649136|NCT00762970|58661513|FG002|Overall Study|Protocol Violation|1|||
30649137|NCT00762970|58661511|FG000|Overall Study|Lost to Follow-up|1|||
30649138|NCT00762970|58661512|FG001|Overall Study|Lost to Follow-up|2|||
30649139|NCT00762970|58661513|FG002|Overall Study|Lost to Follow-up|0|||
30649140|NCT00762970|58661511|FG000|Overall Study|Difficulty of handling lens|1|||
30649141|NCT00762970|58661512|FG001|Overall Study|Difficulty of handling lens|2|||
30649142|NCT00762970|58661513|FG002|Overall Study|Difficulty of handling lens|0|||
30649143|NCT00988442|58661523|FG000|Overall Study|Death|1|||
30649144|NCT00988442|58661524|FG001|Overall Study|Death|2|||
30649145|NCT00988442|58661523|FG000|Overall Study|Lost to Follow-up|0|||
30649146|NCT00988442|58661524|FG001|Overall Study|Lost to Follow-up|1|||
30649147|NCT00988442|58661523|FG000|Overall Study|Early Study Closure|29|||
30649148|NCT00988442|58661524|FG001|Overall Study|Early Study Closure|25|||
30649149|NCT03258723|58661533|FG000|Overall Study|COVID Interruption of study|54|||
30649150|NCT03258723|58661533|FG000|Overall Study|Lost to Follow-up|8|||
30649151|NCT00992186|58661537|FG000|Overall Study|Withdrawal by Subject|2|||
30649152|NCT00992186|58661537|FG000|Overall Study|Protocol Violation|1|||
30649153|NCT00992186|58661537|FG000|Overall Study|Physician Decision|1|||
30649154|NCT00992186|58661537|FG000|Overall Study|Adverse Event|9|||
30649155|NCT00992186|58661537|FG000|Overall Study|Progressive Disease|30|||
30649156|NCT00992186|58661537|FG000|Overall Study|Refusal To Receive Study Agent|3|||
30649157|NCT00992108|58661544|FG000|Overall Study|Lost to Follow-up|0|||
30649158|NCT00992108|58661545|FG001|Overall Study|Lost to Follow-up|1|||
30649159|NCT00752986|58661554|FG000|Overall Study|Withdrawal by Subject|2|||
30649160|NCT00752986|58661555|FG001|Overall Study|Withdrawal by Subject|1|||
30649161|NCT00752986|58661556|FG002|Overall Study|Withdrawal by Subject|2|||
30649162|NCT00752986|58661554|FG000|Overall Study|Protocol Violation|3|||
30649163|NCT00752986|58661555|FG001|Overall Study|Protocol Violation|0|||
30649164|NCT00752986|58661556|FG002|Overall Study|Protocol Violation|0|||
30649165|NCT03483103|58661564|FG000|Pre-Treatment Phase|Other reasons|1|||
30649166|NCT03483103|58661564|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
30649167|NCT03483103|58661564|FG000|Pre-Treatment Phase|Disease-related complications|1|||
30649168|NCT03483103|58661564|FG000|Pre-Treatment Phase|Death|5|||
30649169|NCT03483103|58661564|FG000|Treatment Phase|Withdrawal by Subject|6|||
30649170|NCT03483103|58661564|FG000|Treatment Phase|Other reasons|2|||
30649171|NCT03483103|58661564|FG000|Treatment Phase|Death|20|||
30649172|NCT03483103|58661564|FG000|Treatment Phase|Ongoing in study|26|||
30649173|NCT03483103|58661564|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
30649174|NCT03483103|58661564|FG000|Treatment Phase|Received nonconforming product|1|||
30649175|NCT00762892|58661570|FG000|Overall Study|Lost to Follow-up|2|||
30649176|NCT00762892|58661571|FG001|Overall Study|Lost to Follow-up|5|||
30649177|NCT00762892|58661570|FG000|Overall Study|Withdrawal by Subject|0|||
30767123|NCT03257410|58775810|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
30767124|NCT03257410|58775811|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
30767125|NCT03257410|58775810|FG000|Overall Study|Miscellaneous|2|||
30952062|NCT01698320|58999423|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
30952063|NCT01698320|58999424|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
30952064|NCT01698008|58999434|FG000|Overall Study|Withdrawal by Subject|1|||
30952065|NCT01698008|58999435|FG001|Overall Study|Withdrawal by Subject|2|||
30952066|NCT01697696|58999451|FG000|Overall Study|Study terminated by sponsor|0|||
30952067|NCT01697696|58999452|FG001|Overall Study|Study terminated by sponsor|3|||
30952068|NCT01697696|58999451|FG000|Overall Study|Protocol deviation|1|||
30952069|NCT01697696|58999452|FG001|Overall Study|Protocol deviation|0|||
30952070|NCT01697696|58999451|FG000|Overall Study|Physician Decision|1|||
30952071|NCT01697696|58999452|FG001|Overall Study|Physician Decision|0|||
30952072|NCT01697696|58999451|FG000|Overall Study|Death|4|||
30952073|NCT01697696|58999452|FG001|Overall Study|Death|2|||
30952074|NCT01697696|58999451|FG000|Overall Study|Lost to Follow-up|10|||
30952075|NCT01697696|58999452|FG001|Overall Study|Lost to Follow-up|7|||
30952076|NCT01697696|58999451|FG000|Overall Study|Subject/guardian decision|31|||
30952077|NCT01697696|58999452|FG001|Overall Study|Subject/guardian decision|35|||
30952078|NCT01569152|58999460|FG000|Phase IIa, Period 1|Early Escape|5|||
30952079|NCT01569152|58999461|FG001|Phase IIa, Period 1|Early Escape|22|||
30952080|NCT01569152|58999462|FG002|Phase IIa, Period 1|Early Escape|0|||
30952081|NCT01569152|58999460|FG000|Phase IIa, Period 1|Adverse Event|4|||
30952082|NCT01569152|58999461|FG001|Phase IIa, Period 1|Adverse Event|0|||
30952083|NCT01569152|58999462|FG002|Phase IIa, Period 1|Adverse Event|0|||
30952084|NCT01569152|58999460|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
30952085|NCT01569152|58999461|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
30952086|NCT01569152|58999462|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
30952087|NCT01569152|58999460|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
30952088|NCT01569152|58999461|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
30952089|NCT01569152|58999462|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
30952090|NCT01569152|58999460|FG000|Phase IIa, Period 1|Protocol Violation|0|||
30952091|NCT01569152|58999461|FG001|Phase IIa, Period 1|Protocol Violation|1|||
30952092|NCT01569152|58999462|FG002|Phase IIa, Period 1|Protocol Violation|0|||
30952093|NCT01569152|58999460|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
30952094|NCT01569152|58999461|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
30952095|NCT01569152|58999462|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
30952096|NCT01569152|58999460|FG000|Safety Extension, Period 3|Adverse Event|0|||
30952097|NCT01569152|58999461|FG001|Safety Extension, Period 3|Adverse Event|0|||
30649178|NCT00762892|58661571|FG001|Overall Study|Withdrawal by Subject|1|||
30649179|NCT00762892|58661570|FG000|Overall Study|Death|1|||
30649180|NCT00762892|58661571|FG001|Overall Study|Death|0|||
30649181|NCT00762892|58661570|FG000|Overall Study|Pregnancy|1|||
30649182|NCT00762892|58661571|FG001|Overall Study|Pregnancy|0|||
30649183|NCT00762892|58661570|FG000|Overall Study|Incarceration|1|||
30649184|NCT00762892|58661571|FG001|Overall Study|Incarceration|0|||
30952098|NCT01569152|58999462|FG002|Safety Extension, Period 3|Adverse Event|4|||
30952099|NCT01569152|58999460|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
30952100|NCT01569152|58999461|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
30649185|NCT00755716|58661580|FG000|Overall Study|Adverse Event|1|||
30649186|NCT00755716|58661581|FG001|Overall Study|Adverse Event|4|||
30649187|NCT00755716|58661582|FG002|Overall Study|Adverse Event|1|||
30649188|NCT00755716|58661580|FG000|Overall Study|Lack of Efficacy|2|||
30649189|NCT00755716|58661581|FG001|Overall Study|Lack of Efficacy|0|||
30649190|NCT00755716|58661582|FG002|Overall Study|Lack of Efficacy|0|||
30649191|NCT00755716|58661580|FG000|Overall Study|Lost to Follow-up|5|||
30649192|NCT00755716|58661581|FG001|Overall Study|Lost to Follow-up|3|||
30649193|NCT00755716|58661582|FG002|Overall Study|Lost to Follow-up|1|||
30649194|NCT00755716|58661580|FG000|Overall Study|work schedule issues|0|||
30649195|NCT00755716|58661581|FG001|Overall Study|work schedule issues|1|||
30649196|NCT00755716|58661582|FG002|Overall Study|work schedule issues|1|||
30649197|NCT00755326|58661592|FG000|Overall Study|Lost to Follow-up|2|||
30649198|NCT00755326|58661593|FG001|Overall Study|Lost to Follow-up|3|||
30649199|NCT03084471|58661600|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
30649200|NCT03084471|58661600|FG000|Overall Study|Condition under investigation worsened|84|||
30649201|NCT03084471|58661600|FG000|Overall Study|Lack of therapeutic response|2|||
30649202|NCT03084471|58661600|FG000|Overall Study|Protocol Violation|1|||
30649203|NCT03084471|58661600|FG000|Overall Study|Adverse Event|73|||
30649204|NCT03084471|58661600|FG000|Overall Study|Withdrawal by Subject|12|||
30649205|NCT03084471|58661600|FG000|Overall Study|Disease relapse|181|||
30649206|NCT03084471|58661600|FG000|Overall Study|Subjective disease progression|359|||
30649207|NCT03084471|58661600|FG000|Overall Study|Other (as recorded)|33|||
30649208|NCT03084471|58661600|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
30649209|NCT00754936|58661607|FG000|Overall Study|Lost to Follow-up|3|||
30649210|NCT00754936|58661607|FG000|Overall Study|Physician Decision|1|||
30649211|NCT00754936|58661607|FG000|Overall Study|Withdrawal by Subject|2|||
30649212|NCT00754936|58661607|FG000|Overall Study|Side Effects|3|||
30649213|NCT00754936|58661607|FG000|Overall Study|Inter-current medical events|3|||
30649214|NCT00762502|58661614|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
30649215|NCT00762502|58661615|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
30649216|NCT00762502|58661616|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
30649217|NCT00762502|58661614|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
30649218|NCT00762502|58661615|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
30649219|NCT00762502|58661616|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
30649220|NCT00762502|58661614|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
30649221|NCT00762502|58661615|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
30649222|NCT00762502|58661616|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
30649223|NCT00762268|58661624|FG000|Overall Study|Withdrawal by Subject|3|||
30649224|NCT00762268|58661625|FG001|Overall Study|Withdrawal by Subject|3|||
30649225|NCT00975884|58661633|FG000|Overall Study|Adverse Event|1|||
30649226|NCT00975884|58661634|FG001|Overall Study|Adverse Event|0|||
30649227|NCT00975884|58661633|FG000|Overall Study|Lost to Follow-up|5|||
30649228|NCT00975884|58661634|FG001|Overall Study|Lost to Follow-up|3|||
30649229|NCT00975884|58661633|FG000|Overall Study|Withdrawal by Subject|9|||
30649230|NCT00975884|58661634|FG001|Overall Study|Withdrawal by Subject|9|||
30649231|NCT00975884|58661633|FG000|Overall Study|Other|1|||
30649232|NCT00975884|58661634|FG001|Overall Study|Other|3|||
30649233|NCT00578227|58661653|FG000|Overall Study|Lost to Follow-up|0|||
30649234|NCT00578227|58661654|FG001|Overall Study|Lost to Follow-up|1|||
30649235|NCT00578227|58661655|FG002|Overall Study|Lost to Follow-up|1|||
30649236|NCT00578227|58661653|FG000|Overall Study|Withdrawal by Subject|5|||
30649237|NCT00578227|58661654|FG001|Overall Study|Withdrawal by Subject|1|||
30649238|NCT00578227|58661655|FG002|Overall Study|Withdrawal by Subject|3|||
30649239|NCT00978380|58661665|FG000|Overall Study|Protocol Violation|2|||
30649240|NCT00978380|58661665|FG000|Overall Study|Withdrawal criteria|9|||
30649241|NCT00978380|58661665|FG000|Overall Study|Unclassified|8|||
30649242|NCT00577993|58661673|FG000|Overall Study|Adverse Event|1|||
30649243|NCT00577993|58661674|FG001|Overall Study|Adverse Event|0|||
30649244|NCT00577993|58661675|FG002|Overall Study|Adverse Event|0|||
30649245|NCT00577993|58661673|FG000|Overall Study|Death|0|||
30649246|NCT00577993|58661674|FG001|Overall Study|Death|1|||
30649247|NCT00577993|58661675|FG002|Overall Study|Death|1|||
30649248|NCT00577993|58661673|FG000|Overall Study|Lack of Efficacy|0|||
30649249|NCT00577993|58661674|FG001|Overall Study|Lack of Efficacy|1|||
30649250|NCT00577993|58661675|FG002|Overall Study|Lack of Efficacy|0|||
30767126|NCT03257410|58775811|FG001|Overall Study|Miscellaneous|2|||
30767127|NCT03257410|58775810|FG000|Overall Study|Other|0|||
30767128|NCT03257410|58775811|FG001|Overall Study|Other|1|||
30649251|NCT00577993|58661673|FG000|Overall Study|Protocol Violation|2|||
30649252|NCT00577993|58661674|FG001|Overall Study|Protocol Violation|3|||
30649253|NCT00577993|58661675|FG002|Overall Study|Protocol Violation|0|||
30649254|NCT00577993|58661673|FG000|Overall Study|Withdrawal by Subject|1|||
30649255|NCT00577993|58661674|FG001|Overall Study|Withdrawal by Subject|0|||
30649256|NCT00577993|58661675|FG002|Overall Study|Withdrawal by Subject|2|||
30649257|NCT00577993|58661673|FG000|Overall Study|Conversion|2|||
30649258|NCT00577993|58661674|FG001|Overall Study|Conversion|5|||
30767129|NCT00056160|58775819|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
30649259|NCT00577993|58661675|FG002|Overall Study|Conversion|0|||
30649260|NCT00577993|58661673|FG000|Overall Study|Uninsured|1|||
30649261|NCT00577993|58661674|FG001|Overall Study|Uninsured|0|||
30649262|NCT00577993|58661675|FG002|Overall Study|Uninsured|0|||
30649263|NCT00975806|58661684|FG000|Overall Study|Adverse Event|2|||
30649264|NCT00975806|58661685|FG001|Overall Study|Adverse Event|1|||
30649265|NCT00975806|58661686|FG002|Overall Study|Adverse Event|2|||
30649266|NCT00975806|58661684|FG000|Overall Study|Disease Progression|1|||
30649267|NCT00975806|58661685|FG001|Overall Study|Disease Progression|5|||
30649268|NCT00975806|58661686|FG002|Overall Study|Disease Progression|1|||
30649269|NCT00975806|58661684|FG000|Overall Study|Withdrawal by Subject|1|||
30649270|NCT00975806|58661685|FG001|Overall Study|Withdrawal by Subject|0|||
30649271|NCT00975806|58661686|FG002|Overall Study|Withdrawal by Subject|0|||
30649272|NCT00975806|58661684|FG000|Overall Study|Death|0|||
30649273|NCT00975806|58661685|FG001|Overall Study|Death|1|||
30649274|NCT00975806|58661686|FG002|Overall Study|Death|0|||
30649275|NCT00975806|58661684|FG000|Overall Study|Physician decision and disease related|1|||
30649276|NCT00975806|58661685|FG001|Overall Study|Physician decision and disease related|0|||
30649277|NCT00975806|58661686|FG002|Overall Study|Physician decision and disease related|1|||
30649278|NCT00978068|58661698|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
30649279|NCT00978068|58661699|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
30649280|NCT00978068|58661698|FG000|Overall Study|Death|1|||
30649281|NCT00978068|58661699|FG001|Overall Study|Death|2|||
30649282|NCT00978068|58661698|FG000|Overall Study|Lost to Follow-up|1|||
30649283|NCT00978068|58661699|FG001|Overall Study|Lost to Follow-up|2|||
30649284|NCT00978068|58661698|FG000|Overall Study|Physician Decision|0|||
30649285|NCT00978068|58661699|FG001|Overall Study|Physician Decision|1|||
30649286|NCT00978068|58661698|FG000|Overall Study|Unable to Comply with Study|0|||
30649287|NCT00978068|58661699|FG001|Overall Study|Unable to Comply with Study|2|||
30649288|NCT00603525|58661711|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
30649289|NCT00603525|58661712|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
30649290|NCT00603525|58661713|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
30649291|NCT00603525|58661711|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
30649292|NCT00603525|58661712|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
30649293|NCT00603525|58661713|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
30649294|NCT00603525|58661711|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
30649295|NCT00603525|58661712|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
30649296|NCT00603525|58661713|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
30649297|NCT00603525|58661711|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
30649298|NCT00603525|58661712|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
30767130|NCT00056160|58775820|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
30767131|NCT00056160|58775819|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
30767132|NCT00056160|58775820|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
30767133|NCT00056160|58775819|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
30767134|NCT00056160|58775820|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
30767135|NCT00056160|58775819|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
30767136|NCT00056160|58775820|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
30767137|NCT00056160|58775819|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
30767138|NCT00056160|58775820|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
30767139|NCT00056160|58775819|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
30767140|NCT00056160|58775820|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
30767141|NCT00056160|58775819|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
30767142|NCT00056160|58775820|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
30767143|NCT00056160|58775819|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
30767144|NCT00056160|58775820|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
30767145|NCT00056160|58775819|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
30767146|NCT00056160|58775820|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
30767147|NCT00056160|58775819|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
30767148|NCT00056160|58775820|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
30767149|NCT00056160|58775819|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
30767150|NCT00056160|58775820|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
30767151|NCT00056160|58775819|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
30767152|NCT00056160|58775820|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
30767153|NCT00056160|58775819|FG000|Final Follow-up|Transferred into expanded access study.|3|||
30767154|NCT00056160|58775820|FG001|Final Follow-up|Transferred into expanded access study.|0|||
30649299|NCT00603525|58661713|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30649300|NCT00603525|58661711|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
30649301|NCT00603525|58661712|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
30649302|NCT00603525|58661713|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
30649303|NCT00603525|58661711|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
30649304|NCT00603525|58661712|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
30649305|NCT00603525|58661713|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
30649306|NCT00603525|58661711|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
30649307|NCT00603525|58661712|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
30649308|NCT00603525|58661713|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
30649309|NCT00603525|58661711|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
30649310|NCT00603525|58661712|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
30649311|NCT00603525|58661713|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
30649312|NCT00603525|58661711|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
30649313|NCT00603525|58661712|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
30649314|NCT00603525|58661713|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
30767155|NCT00056160|58775819|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
30767156|NCT00056160|58775820|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
30767157|NCT00056160|58775819|FG000|Final Follow-up|Adverse Event|1|||
30767158|NCT00056160|58775820|FG001|Final Follow-up|Adverse Event|0|||
30767159|NCT00061932|58775828|FG000|Overall Study|Withdrawal by Subject|13|||
30767160|NCT00061932|58775829|FG001|Overall Study|Withdrawal by Subject|4|||
30767161|NCT03280264|58775836|FG000|Overall Study|Adverse Event|1|||
30767162|NCT03280264|58775836|FG000|Overall Study|Physician Decision|1|||
30767163|NCT03280264|58775836|FG000|Overall Study|Withdrawal by Subject|1|||
30767164|NCT00060840|58775843|FG000|Overall Study|Change in surgical plan|2|||
30767165|NCT00060840|58775844|FG001|Overall Study|Change in surgical plan|6|||
30767166|NCT00060840|58775843|FG000|Overall Study|Death|0|||
30649315|NCT00603525|58661711|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
30649316|NCT00603525|58661712|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
30767167|NCT00060840|58775844|FG001|Overall Study|Death|1|||
30767168|NCT00060840|58775843|FG000|Overall Study|Withdrawal by Subject|0|||
30767169|NCT00060840|58775844|FG001|Overall Study|Withdrawal by Subject|1|||
30767170|NCT00060840|58775843|FG000|Overall Study|Subinvestigator unavailable|0|||
30767171|NCT00060840|58775844|FG001|Overall Study|Subinvestigator unavailable|1|||
30767172|NCT00060840|58775843|FG000|Overall Study|Physician Decision|1|||
30767173|NCT00060840|58775844|FG001|Overall Study|Physician Decision|0|||
30767174|NCT00060840|58775843|FG000|Overall Study|Other|1|||
30767175|NCT00060840|58775844|FG001|Overall Study|Other|0|||
30767176|NCT03280108|58775852|FG000|Overall Study|Lost to Follow-up|2|||
30767177|NCT03280108|58775853|FG001|Overall Study|Lost to Follow-up|0|||
30767178|NCT00059202|58775866|FG000|Overall Study|Withdrawal by Subject|5|||
30767179|NCT00059202|58775867|FG001|Overall Study|Withdrawal by Subject|9|||
30767180|NCT00059202|58775866|FG000|Overall Study|Protocol Violation|1|||
30767181|NCT00059202|58775867|FG001|Overall Study|Protocol Violation|3|||
30767182|NCT00059202|58775866|FG000|Overall Study|drug toxicity|0|||
30767183|NCT00059202|58775867|FG001|Overall Study|drug toxicity|3|||
30767184|NCT03278626|58775876|FG000|Overall Study|Death|2|||
30767185|NCT03278626|58775876|FG000|Overall Study|Toxicity|1|||
30767186|NCT03278626|58775876|FG000|Overall Study|Disease Progression|2|||
30767187|NCT03277846|58775882|FG000|Overall Study|Inpatient stay too brief|12|||
30767188|NCT03277846|58775883|FG001|Overall Study|Inpatient stay too brief|11|||
30767189|NCT00073008|58775891|FG000|Overall Study|Missing|6|||
30767190|NCT00073008|58775892|FG001|Overall Study|Missing|6|||
30767191|NCT00073008|58775891|FG000|Overall Study|Withdrawal by Subject|2|||
30767192|NCT00073008|58775892|FG001|Overall Study|Withdrawal by Subject|2|||
30767193|NCT00073008|58775891|FG000|Overall Study|Lost to Follow-up|1|||
30767194|NCT00073008|58775892|FG001|Overall Study|Lost to Follow-up|3|||
30848622|NCT04604795|58874762|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
30848623|NCT04604795|58874763|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
30848624|NCT04604795|58874764|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
30767195|NCT00073008|58775891|FG000|Overall Study|Death|46|||
30767196|NCT00073008|58775892|FG001|Overall Study|Death|47|||
30767197|NCT00073008|58775891|FG000|Overall Study|"Other selected on Case Report Form"|7|||
30767198|NCT00073008|58775892|FG001|Overall Study|"Other selected on Case Report Form"|5|||
30848625|NCT04604795|58874765|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
30848626|NCT04604795|58874766|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
30952101|NCT01569152|58999462|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
30952102|NCT01569152|58999460|FG000|Safety Extension, Period 3|Physician Decision|0|||
30767199|NCT00058422|58775898|FG000|Overall Study|Not treated|2|||
30767200|NCT00072384|58775902|FG000|Overall Study|Physician Decision|1|||
30848627|NCT04604795|58874767|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
30848628|NCT04604795|58874768|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
30952103|NCT01569152|58999461|FG001|Safety Extension, Period 3|Physician Decision|0|||
30952104|NCT01569152|58999462|FG002|Safety Extension, Period 3|Physician Decision|2|||
30649317|NCT00603525|58661713|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
30767201|NCT00072384|58775902|FG000|Overall Study|Ineligible|8|||
30767202|NCT00054132|58775908|FG000|Overall Study|Not Treated|1|||
30952105|NCT01569152|58999460|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
30767203|NCT00071760|58775913|FG000|Overall Study|Adverse Event|3|||
30767204|NCT00071760|58775913|FG000|Overall Study|Lost to Follow-up|4|||
30767205|NCT00071760|58775913|FG000|Overall Study|Protocol Violation|1|||
30767206|NCT00071760|58775913|FG000|Overall Study|Withdrawal by Subject|3|||
30767207|NCT00071760|58775913|FG000|Overall Study|Insufficient Viral Load Response|3|||
30767208|NCT00071760|58775913|FG000|Overall Study|Pulmonary Tuberculosis|1|||
30767209|NCT00071760|58775913|FG000|Overall Study|Unavailability of RTV|8|||
30767210|NCT00071760|58775913|FG000|Overall Study|Relocation|1|||
30649318|NCT00603525|58661711|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
30649319|NCT00603525|58661712|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
30649320|NCT00603525|58661713|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
30649321|NCT00603525|58661711|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
30649322|NCT00603525|58661712|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
30649323|NCT00603525|58661713|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
30649324|NCT00603525|58661711|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
30649325|NCT00603525|58661712|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
30649326|NCT00603525|58661713|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
30649327|NCT00603525|58661711|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
30649328|NCT00603525|58661712|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
30649329|NCT00603525|58661713|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
30649330|NCT00603525|58661711|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
30649331|NCT00603525|58661712|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
30649332|NCT00603525|58661713|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
30649333|NCT00762034|58661726|FG000|Induction Period|Protocol Violation|1|||
30649334|NCT00762034|58661727|FG001|Induction Period|Protocol Violation|2|||
30767211|NCT00071760|58775913|FG000|Overall Study|Investigator's Recommendation (Rec.)|4|||
30767212|NCT00071760|58775913|FG000|Overall Study|Study Team Rec./Resistance|1|||
30649335|NCT00762034|58661726|FG000|Induction Period|Entry Criterion Not Met|12|||
30649336|NCT00762034|58661727|FG001|Induction Period|Entry Criterion Not Met|11|||
30649337|NCT00762034|58661726|FG000|Induction Period|Adverse Event|27|||
30649338|NCT00762034|58661727|FG001|Induction Period|Adverse Event|38|||
30649339|NCT00762034|58661726|FG000|Induction Period|Lost to Follow-up|1|||
30649340|NCT00762034|58661727|FG001|Induction Period|Lost to Follow-up|1|||
30649341|NCT00762034|58661726|FG000|Induction Period|Progressive Disease|73|||
30649342|NCT00762034|58661727|FG001|Induction Period|Progressive Disease|55|||
30649343|NCT00762034|58661726|FG000|Induction Period|Physician Decision|21|||
30649344|NCT00762034|58661727|FG001|Induction Period|Physician Decision|20|||
30649345|NCT00762034|58661726|FG000|Induction Period|Withdrawal by Subject|15|||
30649346|NCT00762034|58661727|FG001|Induction Period|Withdrawal by Subject|19|||
30767213|NCT00071760|58775913|FG000|Overall Study|Ongoing|25|||
30767214|NCT00053898|58775925|FG000|Overall Study|No follow-up data from any source|9|||
30767215|NCT00053898|58775926|FG001|Overall Study|No follow-up data from any source|12|||
30767216|NCT00053898|58775925|FG000|Overall Study|Follow-up from telephone contact only|5|||
30767217|NCT00053898|58775926|FG001|Overall Study|Follow-up from telephone contact only|1|||
30767218|NCT03256552|58775962|FG000|Overall Study|Protocol Violation|1|||
30767219|NCT03256552|58775962|FG000|Overall Study|Physician Decision|1|||
30767220|NCT03256552|58775962|FG000|Overall Study|Adverse Event|1|||
30767221|NCT03256552|58775962|FG000|Overall Study|Withdrawal by Subject|2|||
30767222|NCT00071058|58775972|FG000|Overall Study|brain tumor-removed from study|1|||
30767223|NCT00053352|58775979|FG000|Overall Study|Lost to Follow-up|0|||
30649347|NCT00762034|58661726|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
30649348|NCT00762034|58661727|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
30649349|NCT00762034|58661726|FG000|Induction Period|Deaths Due to Study Disease|9|||
30649350|NCT00762034|58661727|FG001|Induction Period|Deaths Due to Study Disease|9|||
30649351|NCT00762034|58661726|FG000|Maintenance Period|Protocol Violation|1|||
30649352|NCT00762034|58661727|FG001|Maintenance Period|Protocol Violation|3|||
30649353|NCT00762034|58661726|FG000|Maintenance Period|Entry Criterion Not Met|0|||
30767224|NCT00053352|58775980|FG001|Overall Study|Lost to Follow-up|1|||
30767225|NCT00053352|58775979|FG000|Overall Study|Physician Decision|11|||
30767226|NCT00053352|58775980|FG001|Overall Study|Physician Decision|1|||
30767227|NCT00053352|58775979|FG000|Overall Study|Withdrawal by Subject|1|||
30767228|NCT00053352|58775980|FG001|Overall Study|Withdrawal by Subject|0|||
30767229|NCT00053352|58775979|FG000|Overall Study|Ineligible|8|||
30767230|NCT00053352|58775980|FG001|Overall Study|Ineligible|8|||
30767231|NCT00053352|58775979|FG000|Overall Study|Disease at new site|1|||
30767232|NCT00053352|58775980|FG001|Overall Study|Disease at new site|0|||
30767233|NCT03245398|58775989|FG000|Overall Study|Travelled to another island|1|||
30767234|NCT03245398|58775990|FG001|Overall Study|Travelled to another island|0|||
30767235|NCT03244618|58776000|FG000|Overall Study|Lost to Follow-up|3|||
30767236|NCT03244618|58776001|FG001|Overall Study|Lost to Follow-up|4|||
30767237|NCT03244618|58776000|FG000|Overall Study|Protocol Violation|4|||
30649354|NCT00762034|58661727|FG001|Maintenance Period|Entry Criterion Not Met|2|||
30649355|NCT00762034|58661726|FG000|Maintenance Period|Adverse Event|42|||
30649356|NCT00762034|58661727|FG001|Maintenance Period|Adverse Event|26|||
30767238|NCT03244618|58776001|FG001|Overall Study|Protocol Violation|3|||
30767239|NCT03244618|58776000|FG000|Overall Study|Withdrawal by Subject|0|||
30767240|NCT03244618|58776001|FG001|Overall Study|Withdrawal by Subject|2|||
30767241|NCT00052962|58776009|FG000|Overall Study|Not evaluable|0|||
30767242|NCT00052962|58776010|FG001|Overall Study|Not evaluable|2|||
30767243|NCT00052962|58776009|FG000|Overall Study|Not randomized/not evaluable|1|||
30767244|NCT00052962|58776010|FG001|Overall Study|Not randomized/not evaluable|0|||
30767245|NCT00051636|58776018|FG000|Period 1 - Core|Adverse Event|2|||
30767246|NCT00051636|58776019|FG001|Period 1 - Core|Adverse Event|2|||
30767247|NCT00051636|58776018|FG000|Period 1 - Core|Protocol Violation|1|||
30767248|NCT00051636|58776019|FG001|Period 1 - Core|Protocol Violation|0|||
30767249|NCT00051636|58776018|FG000|Period 1 - Core|Withdrawal by Subject|1|||
30767250|NCT00051636|58776019|FG001|Period 1 - Core|Withdrawal by Subject|2|||
30767251|NCT00051636|58776018|FG000|Period 1 - Core|Lost to Follow-up|0|||
30767252|NCT00051636|58776019|FG001|Period 1 - Core|Lost to Follow-up|2|||
30767253|NCT00051636|58776018|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
30767254|NCT00051636|58776019|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
30767255|NCT00051636|58776018|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
30767256|NCT00051636|58776019|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
30767257|NCT00051636|58776018|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
30767258|NCT00051636|58776019|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
30767259|NCT00051636|58776018|FG000|Period 2- Extended Observation Period|Death|4|||
30767260|NCT00051636|58776019|FG001|Period 2- Extended Observation Period|Death|5|||
30767261|NCT00051636|58776018|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
30767262|NCT00051636|58776019|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
30767263|NCT03255382|58776027|FG000|Overall Study|Adverse Event|3|||
30767264|NCT03255382|58776028|FG001|Overall Study|Adverse Event|0|||
30767265|NCT03255382|58776027|FG000|Overall Study|Lost to Follow-up|2|||
30649357|NCT00762034|58661726|FG000|Maintenance Period|Progressive Disease|186|||
30649358|NCT00762034|58661727|FG001|Maintenance Period|Progressive Disease|224|||
30649359|NCT00762034|58661726|FG000|Maintenance Period|Physician Decision|25|||
30649360|NCT00762034|58661727|FG001|Maintenance Period|Physician Decision|20|||
30649361|NCT00762034|58661726|FG000|Maintenance Period|Withdrawal by Subject|34|||
30649362|NCT00762034|58661727|FG001|Maintenance Period|Withdrawal by Subject|14|||
30649363|NCT00762034|58661726|FG000|Maintenance Period|Death not due to study disease|2|||
30649364|NCT00762034|58661727|FG001|Maintenance Period|Death not due to study disease|5|||
30649365|NCT00762034|58661726|FG000|Maintenance Period|Death due to study disease|3|||
30649366|NCT00762034|58661727|FG001|Maintenance Period|Death due to study disease|3|||
30649367|NCT00762034|58661726|FG000|Maintenance Period|Other|1|||
30649368|NCT00762034|58661727|FG001|Maintenance Period|Other|1|||
30649369|NCT00761956|58661759|FG000|Overall Study|Lost to Follow-up|6|||
30649370|NCT00761956|58661760|FG001|Overall Study|Lost to Follow-up|11|||
30649371|NCT00761956|58661759|FG000|Overall Study|Withdrawal by Subject|3|||
30649372|NCT00761956|58661760|FG001|Overall Study|Withdrawal by Subject|8|||
30649373|NCT00761956|58661759|FG000|Overall Study|Death|0|||
30649374|NCT00761956|58661760|FG001|Overall Study|Death|1|||
30649375|NCT00761956|58661759|FG000|Overall Study|Adverse Event|26|||
30649376|NCT00761956|58661760|FG001|Overall Study|Adverse Event|34|||
30649377|NCT00754624|58661766|FG000|Overall Study|Adverse Event|16|||
30649378|NCT00754624|58661766|FG000|Overall Study|Death|1|||
30649379|NCT00754624|58661766|FG000|Overall Study|Physician Decision|8|||
30649380|NCT00754624|58661766|FG000|Overall Study|Protocol Violation|1|||
30649381|NCT00754624|58661766|FG000|Overall Study|Withdrawal by Subject|28|||
30649382|NCT00754624|58661766|FG000|Overall Study|Various|12|||
30649383|NCT00754624|58661766|FG000|Overall Study|Lost to Follow-up|3|||
30649384|NCT00586846|58661779|FG000|Overall Study|Physician Decision|1|||
30649385|NCT00586846|58661779|FG000|Overall Study|Death|1|||
30649386|NCT00586846|58661779|FG000|Overall Study|Evaluable for Toxicity Only|4|||
30649387|NCT00973700|58661788|FG000|Overall Study|Withdrawal by Subject|2|||
30649388|NCT00973700|58661789|FG001|Overall Study|Withdrawal by Subject|2|||
30649389|NCT00973700|58661790|FG002|Overall Study|Withdrawal by Subject|8|||
30649390|NCT00973700|58661791|FG003|Overall Study|Withdrawal by Subject|4|||
30649391|NCT00973700|58661792|FG004|Overall Study|Withdrawal by Subject|4|||
30649392|NCT00973700|58661788|FG000|Overall Study|Lost to Follow-up|5|||
30767266|NCT03255382|58776028|FG001|Overall Study|Lost to Follow-up|0|||
30767267|NCT03255382|58776027|FG000|Overall Study|Withdrawal by Subject|2|||
30767268|NCT03255382|58776028|FG001|Overall Study|Withdrawal by Subject|0|||
30649393|NCT00973700|58661789|FG001|Overall Study|Lost to Follow-up|0|||
30649394|NCT00973700|58661790|FG002|Overall Study|Lost to Follow-up|1|||
30649395|NCT00973700|58661791|FG003|Overall Study|Lost to Follow-up|8|||
30649396|NCT00973700|58661792|FG004|Overall Study|Lost to Follow-up|5|||
30649397|NCT00973700|58661788|FG000|Overall Study|Inappropriate enrolment|0|||
30649398|NCT00973700|58661789|FG001|Overall Study|Inappropriate enrolment|0|||
30649399|NCT00973700|58661790|FG002|Overall Study|Inappropriate enrolment|0|||
30767269|NCT03255382|58776027|FG000|Overall Study|Other|6|||
30767270|NCT03255382|58776028|FG001|Overall Study|Other|0|||
30767271|NCT03254602|58776035|FG000|Overall Study|Lost to Follow-up|4|||
30649400|NCT00973700|58661791|FG003|Overall Study|Inappropriate enrolment|4|||
30649401|NCT00973700|58661792|FG004|Overall Study|Inappropriate enrolment|0|||
30649402|NCT00973700|58661788|FG000|Overall Study|Unable to Classify|0|||
30649403|NCT00973700|58661789|FG001|Overall Study|Unable to Classify|0|||
30649404|NCT00973700|58661790|FG002|Overall Study|Unable to Classify|1|||
30649405|NCT00973700|58661791|FG003|Overall Study|Unable to Classify|2|||
30649406|NCT00973700|58661792|FG004|Overall Study|Unable to Classify|1|||
30649407|NCT00754390|58661819|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
30649408|NCT00754390|58661819|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
30649409|NCT00754390|58661819|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
30649410|NCT00754390|58661819|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
30649411|NCT00754234|58661826|FG000|Overall Study|Withdrawal by Subject|3|||
30649412|NCT00753922|58661834|FG000|Overall Study|Lost to Follow-up|155|||
30649413|NCT00753922|58661835|FG001|Overall Study|Lost to Follow-up|24|||
30649414|NCT00753922|58661836|FG002|Overall Study|Lost to Follow-up|28|||
30649415|NCT00753922|58661837|FG003|Overall Study|Lost to Follow-up|5|||
30649416|NCT00753922|58661834|FG000|Overall Study|Withdrawal by Subject|9|||
30649417|NCT00753922|58661835|FG001|Overall Study|Withdrawal by Subject|11|||
30649418|NCT00753922|58661836|FG002|Overall Study|Withdrawal by Subject|4|||
30649419|NCT00753922|58661837|FG003|Overall Study|Withdrawal by Subject|2|||
30649420|NCT00753922|58661834|FG000|Overall Study|Patient Non-compliance|55|||
30649421|NCT00753922|58661835|FG001|Overall Study|Patient Non-compliance|22|||
30649422|NCT00753922|58661836|FG002|Overall Study|Patient Non-compliance|14|||
30649423|NCT00753922|58661837|FG003|Overall Study|Patient Non-compliance|11|||
30649424|NCT00753922|58661834|FG000|Overall Study|Patients Not Completing Visit|11|||
30649425|NCT00753922|58661835|FG001|Overall Study|Patients Not Completing Visit|0|||
30649426|NCT00753922|58661836|FG002|Overall Study|Patients Not Completing Visit|1|||
30649427|NCT00753922|58661837|FG003|Overall Study|Patients Not Completing Visit|0|||
30649428|NCT00753922|58661834|FG000|Overall Study|Death|2|||
30649429|NCT00753922|58661835|FG001|Overall Study|Death|23|||
30649430|NCT00753922|58661836|FG002|Overall Study|Death|2|||
30649431|NCT00753922|58661837|FG003|Overall Study|Death|1|||
30649432|NCT00753922|58661834|FG000|Overall Study|Discontinuation Due to Explantation|14|||
30649433|NCT00753922|58661835|FG001|Overall Study|Discontinuation Due to Explantation|14|||
30649434|NCT00753922|58661836|FG002|Overall Study|Discontinuation Due to Explantation|14|||
30649435|NCT00753922|58661837|FG003|Overall Study|Discontinuation Due to Explantation|4|||
30649436|NCT00761176|58661849|FG000|Overall Study|Death|1|||
30649437|NCT00761176|58661850|FG001|Overall Study|Death|0|||
30649438|NCT00761176|58661849|FG000|Overall Study|Withdrawal by Subject|1|||
30649439|NCT00761176|58661850|FG001|Overall Study|Withdrawal by Subject|1|||
30649440|NCT00760552|58661858|FG000|Overall Study|Death|2|||
30649441|NCT00760552|58661859|FG001|Overall Study|Death|0|||
30649442|NCT00760552|58661858|FG000|Overall Study|Lost to Follow-up|11|||
30649443|NCT00760552|58661859|FG001|Overall Study|Lost to Follow-up|10|||
30649444|NCT00753766|58661867|FG000|Overall Study|Physician Decision|1|||
30649445|NCT00753766|58661868|FG001|Overall Study|Physician Decision|0|||
30649446|NCT00976898|58661875|FG000|Overall Study|Protocol Violation|1|||
30649447|NCT00976898|58661875|FG000|Overall Study|Adverse Event|1|||
30649448|NCT00976898|58661875|FG000|Overall Study|Physician Decision|1|||
30649449|NCT00976898|58661875|FG000|Overall Study|Liver Transplant|1|||
30649450|NCT00976898|58661875|FG000|Overall Study|Progressive Disease|1|||
30649451|NCT02620579|58661887|FG000|Overall Study|Physician Decision|0|||
30649452|NCT02620579|58661888|FG001|Overall Study|Physician Decision|0|||
30649453|NCT02620579|58661889|FG002|Overall Study|Physician Decision|0|||
30649454|NCT02620579|58661890|FG003|Overall Study|Physician Decision|1|||
30649455|NCT02620579|58661887|FG000|Overall Study|Withdrawal by Subject|0|||
30649456|NCT02620579|58661888|FG001|Overall Study|Withdrawal by Subject|1|||
30767272|NCT00038142|58776041|FG000|Overall Study|Ineligible|1|||
30767273|NCT00038142|58776042|FG001|Overall Study|Ineligible|0|||
30767274|NCT00038142|58776041|FG000|Overall Study|Progressive Disease|11|||
30767275|NCT00038142|58776042|FG001|Overall Study|Progressive Disease|7|||
30767276|NCT00038142|58776041|FG000|Overall Study|Death|1|||
30649457|NCT02620579|58661889|FG002|Overall Study|Withdrawal by Subject|1|||
30649458|NCT02620579|58661890|FG003|Overall Study|Withdrawal by Subject|0|||
30767277|NCT00038142|58776042|FG001|Overall Study|Death|0|||
30649459|NCT00753688|58661906|FG000|Overall Study|Death|102|||
30649460|NCT00753688|58661907|FG001|Overall Study|Death|203|||
30649461|NCT00753688|58661906|FG000|Overall Study|Missing|4|||
30649462|NCT00753688|58661907|FG001|Overall Study|Missing|9|||
30649463|NCT00753688|58661906|FG000|Overall Study|Participant Withdrew Consent|2|||
30649464|NCT00753688|58661907|FG001|Overall Study|Participant Withdrew Consent|2|||
30649465|NCT00753688|58661906|FG000|Overall Study|Ongoing - in Follow-up|15|||
30649466|NCT00753688|58661907|FG001|Overall Study|Ongoing - in Follow-up|31|||
30649467|NCT00753688|58661906|FG000|Overall Study|Adverse Event|0|||
30767278|NCT00038142|58776041|FG000|Overall Study|Adverse Event|1|||
30767279|NCT00038142|58776042|FG001|Overall Study|Adverse Event|0|||
30767280|NCT00038142|58776041|FG000|Overall Study|Unknown Reason|8|||
30767281|NCT00038142|58776042|FG001|Overall Study|Unknown Reason|0|||
30767282|NCT00366899|58776050|FG000|Infant Series|Withdrawal by Subject|4|||
30767283|NCT00366899|58776051|FG001|Infant Series|Withdrawal by Subject|7|||
30767284|NCT00366899|58776050|FG000|Infant Series|Protocol Violation|2|||
30767285|NCT00366899|58776051|FG001|Infant Series|Protocol Violation|1|||
30767286|NCT00366899|58776050|FG000|Infant Series|Failed to return|1|||
30767287|NCT00366899|58776051|FG001|Infant Series|Failed to return|1|||
30767288|NCT00366899|58776050|FG000|Infant Series|Lost to Follow-up|0|||
30767289|NCT00366899|58776051|FG001|Infant Series|Lost to Follow-up|2|||
30767290|NCT00366899|58776050|FG000|Infant Series|Adverse Event|0|||
30649468|NCT00753688|58661907|FG001|Overall Study|Adverse Event|1|||
30649469|NCT00586612|58661915|FG000|Primary Phase|Protocol Violation|1|||
30649470|NCT00586612|58661916|FG001|Primary Phase|Protocol Violation|0|||
30649471|NCT00586612|58661915|FG000|Primary Phase|Lost to Follow-up|0|||
30767291|NCT00366899|58776051|FG001|Infant Series|Adverse Event|1|||
30767292|NCT00366899|58776050|FG000|Infant Series|Physician Decision|1|||
30767293|NCT00366899|58776051|FG001|Infant Series|Physician Decision|0|||
30767294|NCT00366899|58776050|FG000|Infant Series|Randomized but not consented|1|||
30649472|NCT00586612|58661916|FG001|Primary Phase|Lost to Follow-up|1|||
30649473|NCT00586612|58661915|FG000|Primary Phase|Withdrawal by Subject|0|||
30649474|NCT00586612|58661916|FG001|Primary Phase|Withdrawal by Subject|2|||
30649475|NCT00586612|58661915|FG000|Booster Phase|Lost to Follow-up|3|||
30649476|NCT00586612|58661916|FG001|Booster Phase|Lost to Follow-up|1|||
30649477|NCT00586690|58661924|FG000|Overall Study|Death|2|||
30649478|NCT00586690|58661925|FG001|Overall Study|Death|0|||
30649479|NCT00586690|58661924|FG000|Overall Study|Disease Progression|10|||
30649480|NCT00586690|58661925|FG001|Overall Study|Disease Progression|0|||
30649481|NCT00586690|58661924|FG000|Overall Study|Adverse Event|1|||
30649482|NCT00586690|58661925|FG001|Overall Study|Adverse Event|0|||
30649483|NCT00586690|58661924|FG000|Overall Study|Lack of Efficacy|2|||
30649484|NCT00586690|58661925|FG001|Overall Study|Lack of Efficacy|0|||
30649485|NCT00586690|58661924|FG000|Overall Study|Lab can't accommodate|1|||
30649486|NCT00586690|58661925|FG001|Overall Study|Lab can't accommodate|0|||
30649487|NCT00976820|58661934|FG000|Overall Study|Lost to Follow-up|5|||
30649488|NCT00976820|58661935|FG001|Overall Study|Lost to Follow-up|16|||
30649489|NCT00976820|58661936|FG002|Overall Study|Lost to Follow-up|2|||
30649490|NCT00976820|58661937|FG003|Overall Study|Lost to Follow-up|3|||
30649491|NCT00976820|58661934|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
30649492|NCT00976820|58661935|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
30649493|NCT00976820|58661936|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
30649494|NCT00976820|58661937|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
30649495|NCT00976820|58661934|FG000|Overall Study|Withdrawal by Subject|2|||
30649496|NCT00976820|58661935|FG001|Overall Study|Withdrawal by Subject|4|||
30649497|NCT00976820|58661936|FG002|Overall Study|Withdrawal by Subject|1|||
30649498|NCT00976820|58661937|FG003|Overall Study|Withdrawal by Subject|4|||
30649499|NCT00760474|58661988|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
30649500|NCT00760474|58661989|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
30649501|NCT00760474|58661988|FG000|Placebo Washout Period|Other|0|||
30649502|NCT00760474|58661989|FG001|Placebo Washout Period|Other|1|||
30649503|NCT00760474|58661988|FG000|Period 2 (P2)|Lost to Follow-up|1|||
30649504|NCT00760474|58661989|FG001|Period 2 (P2)|Lost to Follow-up|0|||
30649505|NCT00760474|58661988|FG000|Period 2 (P2)|Adverse Event|0|||
30649506|NCT00760474|58661989|FG001|Period 2 (P2)|Adverse Event|1|||
30649507|NCT00975416|58661998|FG000|Overall Study|early discharge from tx|3|||
30649508|NCT00975416|58661999|FG001|Overall Study|early discharge from tx|5|||
30649509|NCT00760084|58662006|FG000|Overall Study|Physician Decision|5|||
30649510|NCT00760084|58662006|FG000|Overall Study|Withdrawal by Subject|2|||
30649511|NCT00760084|58662006|FG000|Overall Study|Progressive Disease|3|||
30649512|NCT00752206|58662012|FG000|Overall Study|Disease progression|8|||
30649513|NCT00752206|58662013|FG001|Overall Study|Disease progression|11|||
30649514|NCT00752206|58662012|FG000|Overall Study|Pregnancy|1|||
30649515|NCT00752206|58662013|FG001|Overall Study|Pregnancy|0|||
30649516|NCT00752128|58662019|FG000|Overall Study|Withdrawal by Subject|4|||
30649517|NCT00976508|58662026|FG000|Overall Study|Death|7|||
30649518|NCT00976508|58662027|FG001|Overall Study|Death|1|||
30649519|NCT00976508|58662026|FG000|Overall Study|Lost to Follow-up|1|||
30649520|NCT00976508|58662027|FG001|Overall Study|Lost to Follow-up|0|||
30649521|NCT00976508|58662026|FG000|Overall Study|Withdrawal by Subject|1|||
30649522|NCT00976508|58662027|FG001|Overall Study|Withdrawal by Subject|0|||
30649523|NCT00976508|58662026|FG000|Overall Study|Disease Progression|4|||
30649524|NCT00976508|58662027|FG001|Overall Study|Disease Progression|4|||
30649525|NCT00976508|58662026|FG000|Overall Study|Subject Enrolled in Hospice|1|||
30649526|NCT00976508|58662027|FG001|Overall Study|Subject Enrolled in Hospice|0|||
30649527|NCT00976508|58662026|FG000|Overall Study|Terminated by the Sponsor|0|||
30649528|NCT00976508|58662027|FG001|Overall Study|Terminated by the Sponsor|1|||
30649529|NCT00973622|58662038|FG000|Overall Study|did not attend MRI|14|||
30649530|NCT00973622|58662039|FG001|Overall Study|did not attend MRI|3|||
30649531|NCT00973622|58662038|FG000|Overall Study|did not pass MRI screen|6|||
30649532|NCT00973622|58662039|FG001|Overall Study|did not pass MRI screen|0|||
30848629|NCT04604795|58874769|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
30848630|NCT04604795|58874770|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
30649533|NCT00973622|58662038|FG000|Overall Study|did not complete rTMS sessions|11|||
30649534|NCT00973622|58662039|FG001|Overall Study|did not complete rTMS sessions|2|||
30649535|NCT04044716|58662047|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
30649536|NCT04044716|58662048|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
30649537|NCT04044716|58662049|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
30649538|NCT04044716|58662047|FG000|Overall Study|Lost to Follow-up|2|||
30649539|NCT04044716|58662048|FG001|Overall Study|Lost to Follow-up|3|||
30649540|NCT04044716|58662049|FG002|Overall Study|Lost to Follow-up|0|||
30649541|NCT00753454|58662056|FG000|Overall Study|Adverse Event|4|||
30649542|NCT00753454|58662056|FG000|Overall Study|Lack of Efficacy|1|||
30649543|NCT00753454|58662056|FG000|Overall Study|Lost to Follow-up|3|||
30649544|NCT00753454|58662056|FG000|Overall Study|Withdrawal by Subject|5|||
30649545|NCT00753454|58662056|FG000|Overall Study|Investigator Decision|1|||
30649546|NCT00976274|58662062|FG000|Overall Study|Lost to Follow-up|5|||
30649547|NCT00976274|58662063|FG001|Overall Study|Lost to Follow-up|5|||
30649548|NCT00976274|58662062|FG000|Overall Study|Withdrawal by Subject|1|||
30649549|NCT00976274|58662063|FG001|Overall Study|Withdrawal by Subject|1|||
30649550|NCT00976274|58662062|FG000|Overall Study|Physician Decision|1|||
30649551|NCT00976274|58662063|FG001|Overall Study|Physician Decision|2|||
30649552|NCT00759148|58662071|FG000|Overall Study|Adverse Event|1|||
30767295|NCT00366899|58776051|FG001|Infant Series|Randomized but not consented|0|||
30767296|NCT00366899|58776050|FG000|After Infant Series|Lost to Follow-up|4|||
30767297|NCT00366899|58776051|FG001|After Infant Series|Lost to Follow-up|3|||
30767298|NCT00366899|58776050|FG000|After Infant Series|Withdrawal by Subject|1|||
30767299|NCT00366899|58776051|FG001|After Infant Series|Withdrawal by Subject|4|||
30767300|NCT00366899|58776050|FG000|After Infant Series|Adverse Event|1|||
30767301|NCT00366899|58776051|FG001|After Infant Series|Adverse Event|2|||
30767302|NCT00366899|58776050|FG000|After Infant Series|Protocol Violation|1|||
30767303|NCT00366899|58776051|FG001|After Infant Series|Protocol Violation|0|||
30767304|NCT00366899|58776050|FG000|Toddler Dose|Withdrawal by Subject|1|||
30649553|NCT00759148|58662072|FG001|Overall Study|Adverse Event|6|||
30649554|NCT00759148|58662071|FG000|Overall Study|Withdrawal by Subject|3|||
30649555|NCT00759148|58662072|FG001|Overall Study|Withdrawal by Subject|7|||
30649556|NCT00759148|58662071|FG000|Overall Study|Lost to Follow-up|3|||
30649557|NCT00759148|58662072|FG001|Overall Study|Lost to Follow-up|9|||
30649558|NCT00759148|58662071|FG000|Overall Study|Treatment Failure|6|||
30649559|NCT00759148|58662072|FG001|Overall Study|Treatment Failure|10|||
30649560|NCT00759148|58662071|FG000|Overall Study|Reason not given|1|||
30649561|NCT00759148|58662072|FG001|Overall Study|Reason not given|0|||
30649562|NCT02794285|58662082|FG000|Overall Study|Adverse Event|11|||
30649563|NCT02794285|58662083|FG001|Overall Study|Adverse Event|4|||
30649564|NCT02794285|58662084|FG002|Overall Study|Adverse Event|5|||
30649565|NCT02794285|58662085|FG003|Overall Study|Adverse Event|8|||
30649566|NCT02794285|58662082|FG000|Overall Study|Condition Under Investigation Improved|1|||
30649567|NCT02794285|58662083|FG001|Overall Study|Condition Under Investigation Improved|0|||
30649568|NCT02794285|58662084|FG002|Overall Study|Condition Under Investigation Improved|0|||
30649569|NCT02794285|58662085|FG003|Overall Study|Condition Under Investigation Improved|0|||
30649570|NCT02794285|58662082|FG000|Overall Study|Condition Under Investigation Worsened|0|||
30649571|NCT02794285|58662083|FG001|Overall Study|Condition Under Investigation Worsened|2|||
30767305|NCT00366899|58776051|FG001|Toddler Dose|Withdrawal by Subject|1|||
30767306|NCT00366899|58776050|FG000|Toddler Dose|Protocol Violation|1|||
30767307|NCT00366899|58776051|FG001|Toddler Dose|Protocol Violation|0|||
30767308|NCT03254134|58776085|FG000|Overall Study|Not eligible patients|599|||
30767309|NCT03254134|58776086|FG001|Overall Study|Not eligible patients|3630|||
30767310|NCT00037830|58776095|FG000|Overall Study|Adverse Event|2|||
30848631|NCT04604795|58874771|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
30649572|NCT02794285|58662084|FG002|Overall Study|Condition Under Investigation Worsened|1|||
30649573|NCT02794285|58662085|FG003|Overall Study|Condition Under Investigation Worsened|0|||
30649574|NCT02794285|58662082|FG000|Overall Study|Death|2|||
30649575|NCT02794285|58662083|FG001|Overall Study|Death|1|||
30649576|NCT02794285|58662084|FG002|Overall Study|Death|2|||
30649577|NCT02794285|58662085|FG003|Overall Study|Death|0|||
30649578|NCT02794285|58662082|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
30649579|NCT02794285|58662083|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
30649580|NCT02794285|58662084|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
30649581|NCT02794285|58662085|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
30649582|NCT02794285|58662082|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
30649583|NCT02794285|58662083|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
30649584|NCT02794285|58662084|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
30649585|NCT02794285|58662085|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
30649586|NCT02794285|58662082|FG000|Overall Study|Lack of Efficacy|10|||
30649587|NCT02794285|58662083|FG001|Overall Study|Lack of Efficacy|6|||
30767311|NCT00037830|58776096|FG001|Overall Study|Adverse Event|0|||
30767312|NCT00037830|58776097|FG002|Overall Study|Adverse Event|0|||
30767313|NCT00037830|58776095|FG000|Overall Study|Withdrawal by Subject|4|||
30767314|NCT00037830|58776096|FG001|Overall Study|Withdrawal by Subject|5|||
30848632|NCT04314284|58874867|FG000|Overall Study|Withdrawal by Subject|4|||
30649588|NCT02794285|58662084|FG002|Overall Study|Lack of Efficacy|3|||
30649589|NCT02794285|58662085|FG003|Overall Study|Lack of Efficacy|3|||
30767315|NCT00037830|58776097|FG002|Overall Study|Withdrawal by Subject|1|||
30767316|NCT00037830|58776095|FG000|Overall Study|Protocol Violation|2|||
30767317|NCT00037830|58776096|FG001|Overall Study|Protocol Violation|2|||
30649590|NCT02794285|58662082|FG000|Overall Study|Lost to Follow-up|5|||
30767318|NCT00037830|58776097|FG002|Overall Study|Protocol Violation|0|||
30649591|NCT02794285|58662083|FG001|Overall Study|Lost to Follow-up|6|||
30649592|NCT02794285|58662084|FG002|Overall Study|Lost to Follow-up|3|||
30649593|NCT02794285|58662085|FG003|Overall Study|Lost to Follow-up|1|||
30767319|NCT00037830|58776095|FG000|Overall Study|Unrelated Medical Problem|2|||
30649594|NCT02794285|58662082|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
30649595|NCT02794285|58662083|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
30649596|NCT02794285|58662084|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
30649597|NCT02794285|58662085|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
30649598|NCT02794285|58662082|FG000|Overall Study|Withdrawal by Subject|38|||
30649599|NCT02794285|58662083|FG001|Overall Study|Withdrawal by Subject|29|||
30649600|NCT02794285|58662084|FG002|Overall Study|Withdrawal by Subject|20|||
30649601|NCT02794285|58662085|FG003|Overall Study|Withdrawal by Subject|12|||
30649602|NCT02794285|58662082|FG000|Overall Study|Missing|1|||
30649603|NCT02794285|58662083|FG001|Overall Study|Missing|0|||
30649604|NCT02794285|58662084|FG002|Overall Study|Missing|0|||
30649605|NCT02794285|58662085|FG003|Overall Study|Missing|0|||
30649606|NCT02794285|58662082|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
30649607|NCT02794285|58662083|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
30649608|NCT02794285|58662084|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
30649609|NCT02794285|58662085|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
30649610|NCT02794285|58662082|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
30848633|NCT04314284|58874868|FG001|Overall Study|Withdrawal by Subject|7|||
30848634|NCT04314284|58874867|FG000|Overall Study|Consented but did not complete survey|0|||
30848635|NCT04314284|58874868|FG001|Overall Study|Consented but did not complete survey|6|||
30848636|NCT04246489|58874874|FG000|Overall Study|Ongoing at cut-off date|6|||
30848637|NCT04203823|58874880|FG000|Overall Study|Withdrawal by Subject|2|||
30848638|NCT04203823|58874881|FG001|Overall Study|Withdrawal by Subject|2|||
30848639|NCT04203823|58874880|FG000|Overall Study|Adverse Event|1|||
30649611|NCT02794285|58662083|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
30649612|NCT02794285|58662084|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
30649613|NCT02794285|58662085|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
30649614|NCT00970268|58662097|FG000|Overall Study|Withdrawal by Subject|12|||
30649615|NCT00970268|58662098|FG001|Overall Study|Withdrawal by Subject|19|||
30649616|NCT00970268|58662097|FG000|Overall Study|Adverse Event|15|||
30649617|NCT00970268|58662098|FG001|Overall Study|Adverse Event|12|||
30649618|NCT00970268|58662097|FG000|Overall Study|Lack of Efficacy|3|||
30649619|NCT00970268|58662098|FG001|Overall Study|Lack of Efficacy|6|||
30649620|NCT00970268|58662097|FG000|Overall Study|Protocol Violation|4|||
30649621|NCT00970268|58662098|FG001|Overall Study|Protocol Violation|7|||
30649622|NCT00970268|58662097|FG000|Overall Study|Other Reason|3|||
30649623|NCT00970268|58662098|FG001|Overall Study|Other Reason|1|||
30649624|NCT00970268|58662097|FG000|Overall Study|COPD Exacerbation|4|||
30649625|NCT00970268|58662098|FG001|Overall Study|COPD Exacerbation|2|||
30649626|NCT00970268|58662097|FG000|Overall Study|Lost to Follow-up|1|||
30649627|NCT00970268|58662098|FG001|Overall Study|Lost to Follow-up|2|||
30649628|NCT00970268|58662097|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
30649629|NCT00970268|58662098|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
30649630|NCT00969332|58662110|FG000|Overall Study|Physician Decision|8|||
30649631|NCT00969332|58662110|FG000|Overall Study|Withdrawal by Subject|3|||
30649632|NCT00968864|58662115|FG000|Overall Study|Protocol exception/ not evaluable|1|||
30649633|NCT00758680|58662133|FG000|Overall Study|Adverse Event|0|||
30649634|NCT00758680|58662134|FG001|Overall Study|Adverse Event|0|||
30649635|NCT00758680|58662135|FG002|Overall Study|Adverse Event|0|||
30649636|NCT00758680|58662136|FG003|Overall Study|Adverse Event|0|||
30649637|NCT00758680|58662137|FG004|Overall Study|Adverse Event|0|||
30649638|NCT00758680|58662138|FG005|Overall Study|Adverse Event|0|||
30649639|NCT00758680|58662139|FG006|Overall Study|Adverse Event|0|||
30649640|NCT00758680|58662140|FG007|Overall Study|Adverse Event|1|||
30649641|NCT00758680|58662141|FG008|Overall Study|Adverse Event|0|||
30649642|NCT00758680|58662142|FG009|Overall Study|Adverse Event|1|||
30649643|NCT00758680|58662133|FG000|Overall Study|Laboratory Adverse Event|0|||
30649644|NCT00758680|58662134|FG001|Overall Study|Laboratory Adverse Event|0|||
30649645|NCT00758680|58662135|FG002|Overall Study|Laboratory Adverse Event|0|||
30649646|NCT00758680|58662136|FG003|Overall Study|Laboratory Adverse Event|0|||
30649647|NCT00758680|58662137|FG004|Overall Study|Laboratory Adverse Event|0|||
30649648|NCT00758680|58662138|FG005|Overall Study|Laboratory Adverse Event|0|||
30649649|NCT00758680|58662139|FG006|Overall Study|Laboratory Adverse Event|0|||
30649650|NCT00758680|58662140|FG007|Overall Study|Laboratory Adverse Event|0|||
30649651|NCT00758680|58662141|FG008|Overall Study|Laboratory Adverse Event|1|||
30649652|NCT00758680|58662142|FG009|Overall Study|Laboratory Adverse Event|0|||
30649653|NCT00758680|58662133|FG000|Overall Study|Withdrawal by Subject|0|||
30649654|NCT00758680|58662134|FG001|Overall Study|Withdrawal by Subject|0|||
30649655|NCT00758680|58662135|FG002|Overall Study|Withdrawal by Subject|0|||
30649656|NCT00758680|58662136|FG003|Overall Study|Withdrawal by Subject|0|||
30649657|NCT00758680|58662137|FG004|Overall Study|Withdrawal by Subject|0|||
30649658|NCT00758680|58662138|FG005|Overall Study|Withdrawal by Subject|0|||
30848640|NCT04203823|58874881|FG001|Overall Study|Adverse Event|1|||
30649659|NCT00758680|58662139|FG006|Overall Study|Withdrawal by Subject|1|||
30649660|NCT00758680|58662140|FG007|Overall Study|Withdrawal by Subject|0|||
30649661|NCT00758680|58662141|FG008|Overall Study|Withdrawal by Subject|1|||
30649662|NCT00758680|58662142|FG009|Overall Study|Withdrawal by Subject|0|||
30649663|NCT00758602|58662167|FG000|Overall Study|Adverse Event|11|||
30649664|NCT00758602|58662168|FG001|Overall Study|Adverse Event|10|||
30649665|NCT00758602|58662167|FG000|Overall Study|Lost to Follow-up|4|||
30649666|NCT00758602|58662168|FG001|Overall Study|Lost to Follow-up|3|||
30649667|NCT00758602|58662167|FG000|Overall Study|Withdrawal by Subject|1|||
30649668|NCT00758602|58662168|FG001|Overall Study|Withdrawal by Subject|3|||
30649669|NCT00758602|58662167|FG000|Overall Study|Protocol Violation|0|||
30649670|NCT00758602|58662168|FG001|Overall Study|Protocol Violation|2|||
30649671|NCT00758602|58662167|FG000|Overall Study|Death|0|||
30649672|NCT00758602|58662168|FG001|Overall Study|Death|1|||
30649673|NCT00758602|58662167|FG000|Overall Study|Reason not specified|3|||
30649674|NCT00758602|58662168|FG001|Overall Study|Reason not specified|3|||
30649675|NCT00711529|58662177|FG000|Overall Study|Protocol Violation|2|||
30649676|NCT00711529|58662178|FG001|Overall Study|Protocol Violation|0|||
30649677|NCT00711529|58662177|FG000|Overall Study|Withdrawal by Subject|2|||
30649678|NCT00711529|58662178|FG001|Overall Study|Withdrawal by Subject|6|||
30649679|NCT00601419|58662184|FG000|Overall Study|Lost to Follow-up|3|||
30649680|NCT00601419|58662184|FG000|Overall Study|Missed Visits|1|||
30649681|NCT00712933|58662204|FG000|Overall Study|Adverse Event|69|||
30649682|NCT00712933|58662204|FG000|Overall Study|Lack of Efficacy|6|||
30649683|NCT00712933|58662204|FG000|Overall Study|Lost to Follow-up|22|||
30649684|NCT00712933|58662204|FG000|Overall Study|Non-compliance with study drug|13|||
30649685|NCT00712933|58662204|FG000|Overall Study|Other Pregnancy|37|||
30649686|NCT00712933|58662204|FG000|Overall Study|Sponsor decision|14|||
30649687|NCT00712933|58662204|FG000|Overall Study|Withdrew consent|4|||
30649688|NCT00712933|58662204|FG000|Overall Study|Hip replacement surgery|1|||
30649689|NCT00712933|58662204|FG000|Overall Study|Involved in Clinical research|3|||
30649690|NCT00712933|58662204|FG000|Overall Study|Participant hospitalized|1|||
30649691|NCT00712933|58662204|FG000|Overall Study|Participant travelled overseas|2|||
30649692|NCT00712933|58662204|FG000|Overall Study|Death of patient|1|||
30649693|NCT00712933|58662204|FG000|Overall Study|Other Physician decision|1|||
30649694|NCT00712933|58662204|FG000|Overall Study|Not committed to contraception|1|||
30649695|NCT00712933|58662204|FG000|Overall Study|Participant received medication|1|||
30649696|NCT00712933|58662204|FG000|Overall Study|Physician Decision|36|||
30649697|NCT00712933|58662204|FG000|Overall Study|Protocol Violation|4|||
30649698|NCT00712933|58662204|FG000|Overall Study|Withdrawal by Subject|151|||
30649699|NCT00712543|58662214|FG000|Day 8-14|Lost to Follow-up|0|||
30649700|NCT00712543|58662215|FG001|Day 8-14|Lost to Follow-up|2|||
30649701|NCT00709111|58662221|FG000|Overall Study|Withdrawal by Subject|1|||
30649702|NCT00709111|58662221|FG000|Overall Study|Unable to attend clinic visits|1|||
30649703|NCT00710749|58662225|FG000|First Intervention|Withdrawal by Subject|1|||
30649704|NCT00710749|58662226|FG001|First Intervention|Withdrawal by Subject|0|||
30649705|NCT00699907|58662246|FG000|Overall Study|Withdrawal by Subject|2|||
30649706|NCT00699907|58662247|FG001|Overall Study|Withdrawal by Subject|1|||
30649707|NCT00699907|58662248|FG002|Overall Study|Withdrawal by Subject|0|||
30649708|NCT00699907|58662246|FG000|Overall Study|No usable sample|0|||
30649709|NCT00699907|58662247|FG001|Overall Study|No usable sample|9|||
30649710|NCT00699907|58662248|FG002|Overall Study|No usable sample|8|||
30649711|NCT00710593|58662258|FG000|Overall Study|Incarceration|1|||
30649712|NCT00710593|58662259|FG001|Overall Study|Incarceration|0|||
30649713|NCT00710593|58662258|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
30649714|NCT00710593|58662259|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
30649715|NCT00710593|58662258|FG000|Overall Study|Lost to Follow-up|3|||
30649716|NCT00710593|58662259|FG001|Overall Study|Lost to Follow-up|1|||
30649717|NCT00710593|58662258|FG000|Overall Study|Moved out of area|1|||
30649718|NCT00710593|58662259|FG001|Overall Study|Moved out of area|0|||
30649719|NCT00710593|58662258|FG000|Overall Study|Failure to adhere or complete study eval|1|||
30649720|NCT00710593|58662259|FG001|Overall Study|Failure to adhere or complete study eval|1|||
30649721|NCT00710593|58662258|FG000|Overall Study|Protocol Violation|1|||
30649722|NCT00710593|58662259|FG001|Overall Study|Protocol Violation|1|||
30649723|NCT00710593|58662258|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
30649724|NCT00710593|58662259|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
30649725|NCT00599313|58662281|FG000|Overall Study|Adverse Event|19|||
30649726|NCT00599313|58662281|FG000|Overall Study|Disease Progression|12|||
30649727|NCT00599313|58662281|FG000|Overall Study|Patient Request|4|||
30649728|NCT00599313|58662281|FG000|Overall Study|Ineligible|1|||
30649729|NCT00708175|58662287|FG000|Overall Study|Adverse Event|4|||
30649730|NCT00708175|58662288|FG001|Overall Study|Adverse Event|5|||
30649731|NCT00708175|58662287|FG000|Overall Study|Protocol Violation|2|||
30649732|NCT00708175|58662288|FG001|Overall Study|Protocol Violation|3|||
30649733|NCT00708175|58662287|FG000|Overall Study|Lost to Follow-up|5|||
30649734|NCT00708175|58662288|FG001|Overall Study|Lost to Follow-up|3|||
30649735|NCT00708175|58662287|FG000|Overall Study|Withdrawal by Subject|5|||
30649736|NCT00708175|58662288|FG001|Overall Study|Withdrawal by Subject|7|||
30649737|NCT00708175|58662287|FG000|Overall Study|BMD loss >7%|2|||
30649738|NCT00708175|58662288|FG001|Overall Study|BMD loss >7%|3|||
30649739|NCT00707239|58662297|FG000|Overall Study|Adverse Event|5|||
30649740|NCT00707239|58662298|FG001|Overall Study|Adverse Event|3|||
30649741|NCT00707239|58662299|FG002|Overall Study|Adverse Event|2|||
30649742|NCT00707239|58662297|FG000|Overall Study|Death|3|||
30649743|NCT00707239|58662298|FG001|Overall Study|Death|1|||
30649744|NCT00707239|58662299|FG002|Overall Study|Death|3|||
30649745|NCT00707239|58662297|FG000|Overall Study|Physician Decision|1|||
30649746|NCT00707239|58662298|FG001|Overall Study|Physician Decision|1|||
30649747|NCT00707239|58662299|FG002|Overall Study|Physician Decision|2|||
30649748|NCT00707239|58662297|FG000|Overall Study|Protocol Violation|0|||
30649749|NCT00707239|58662298|FG001|Overall Study|Protocol Violation|0|||
30649750|NCT00707239|58662299|FG002|Overall Study|Protocol Violation|1|||
30649751|NCT00707239|58662297|FG000|Overall Study|Lack of Efficacy|1|||
30649752|NCT00707239|58662298|FG001|Overall Study|Lack of Efficacy|2|||
30649753|NCT00707239|58662299|FG002|Overall Study|Lack of Efficacy|0|||
30649754|NCT00707239|58662297|FG000|Overall Study|Randomized, but not treated|1|||
30649755|NCT00707239|58662298|FG001|Overall Study|Randomized, but not treated|1|||
30649756|NCT00707239|58662299|FG002|Overall Study|Randomized, but not treated|1|||
30649757|NCT00707239|58662297|FG000|Overall Study|Other|8|||
30649758|NCT00707239|58662298|FG001|Overall Study|Other|3|||
30649759|NCT00707239|58662299|FG002|Overall Study|Other|5|||
30649760|NCT00968708|58662312|FG000|Overall Study|Adverse Event|169|||
30649761|NCT00968708|58662313|FG001|Overall Study|Adverse Event|150|||
30649762|NCT00968708|58662312|FG000|Overall Study|Major Protocol Deviation|0|||
30649763|NCT00968708|58662313|FG001|Overall Study|Major Protocol Deviation|1|||
30649764|NCT00968708|58662312|FG000|Overall Study|Lost to Follow-up|19|||
30649765|NCT00968708|58662313|FG001|Overall Study|Lost to Follow-up|11|||
30649766|NCT00968708|58662312|FG000|Overall Study|Voluntary Withdrawal|104|||
30649767|NCT00968708|58662313|FG001|Overall Study|Voluntary Withdrawal|101|||
30649768|NCT00968708|58662312|FG000|Overall Study|Investigator Discretion|0|||
30649769|NCT00968708|58662313|FG001|Overall Study|Investigator Discretion|1|||
30649770|NCT00968708|58662312|FG000|Overall Study|Other|26|||
30649771|NCT00968708|58662313|FG001|Overall Study|Other|34|||
30649772|NCT00967694|58662319|FG000|Overall Study|Withdrawal by Subject|6|||
30649773|NCT00967616|58662325|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
30649774|NCT00967616|58662326|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
30649775|NCT00967616|58662325|FG000|Overall Study|Death|0|||
30649776|NCT00967616|58662326|FG001|Overall Study|Death|3|||
30649777|NCT00967616|58662325|FG000|Overall Study|Withdrawal by Subject|8|||
30649778|NCT00967616|58662326|FG001|Overall Study|Withdrawal by Subject|4|||
30649779|NCT00967616|58662325|FG000|Overall Study|Progressive Disease|31|||
30649780|NCT00967616|58662326|FG001|Overall Study|Progressive Disease|18|||
30649781|NCT00967616|58662325|FG000|Overall Study|Other|8|||
30649782|NCT00967616|58662326|FG001|Overall Study|Other|8|||
30649783|NCT00967616|58662325|FG000|Overall Study|Protocol Violation|1|||
30649784|NCT00967616|58662326|FG001|Overall Study|Protocol Violation|0|||
30649785|NCT00971204|58662336|FG000|Overall Study|Did not meet all criteria-not treated|14|||
30649786|NCT00971204|58662336|FG000|Overall Study|Lost to Follow-up|10|||
30649787|NCT00974090|58662342|FG000|Period 1: Double Blind Period|Adverse Event|2|||
30649788|NCT00974090|58662343|FG001|Period 1: Double Blind Period|Adverse Event|1|||
30649789|NCT00974090|58662342|FG000|Period 1: Double Blind Period|Physician Decision|1|||
30767320|NCT00037830|58776096|FG001|Overall Study|Unrelated Medical Problem|0|||
30767321|NCT00037830|58776097|FG002|Overall Study|Unrelated Medical Problem|0|||
30767322|NCT03242434|58776107|FG000|Overall Study|Death|0|||
30649790|NCT00974090|58662343|FG001|Period 1: Double Blind Period|Physician Decision|0|||
30649791|NCT00974090|58662342|FG000|Period 2: Open-label Period|Adverse Event|4|||
30649792|NCT00974090|58662343|FG001|Period 2: Open-label Period|Adverse Event|6|||
30649793|NCT00974090|58662342|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
30649794|NCT00974090|58662343|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
30649795|NCT00974090|58662342|FG000|Period 2: Open-label Period|Physician Decision|0|||
30649796|NCT00974090|58662343|FG001|Period 2: Open-label Period|Physician Decision|3|||
30649797|NCT00974090|58662342|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
30649798|NCT00974090|58662343|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
30649799|NCT00971048|58662355|FG000|Overall Study|Protocol Violation|1|||
30649800|NCT00971048|58662356|FG001|Overall Study|Protocol Violation|2|||
30649801|NCT00971048|58662357|FG002|Overall Study|Protocol Violation|0|||
30649802|NCT00971048|58662358|FG003|Overall Study|Protocol Violation|1|||
30649803|NCT00971048|58662355|FG000|Overall Study|Adverse Event|0|||
30649804|NCT00971048|58662356|FG001|Overall Study|Adverse Event|0|||
30649805|NCT00971048|58662357|FG002|Overall Study|Adverse Event|1|||
30649806|NCT00971048|58662358|FG003|Overall Study|Adverse Event|0|||
30649807|NCT00971048|58662355|FG000|Overall Study|Physician Decision|0|||
30649808|NCT00971048|58662356|FG001|Overall Study|Physician Decision|0|||
30767323|NCT03242434|58776108|FG001|Overall Study|Death|2|||
30767324|NCT02939014|58776117|FG000|Overall Study|Lost to Follow-up|1|||
30767325|NCT02939014|58776118|FG001|Overall Study|Lost to Follow-up|0|||
30649809|NCT00971048|58662357|FG002|Overall Study|Physician Decision|0|||
30649810|NCT00971048|58662358|FG003|Overall Study|Physician Decision|1|||
30649811|NCT00699751|58662372|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
30649812|NCT00699751|58662373|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
30649813|NCT00699751|58662372|FG000|Period 1: Without/Before Drug Switch|Death|28|||
30649814|NCT00699751|58662373|FG001|Period 1: Without/Before Drug Switch|Death|29|||
30649815|NCT00699751|58662372|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
30649816|NCT00699751|58662373|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
30649817|NCT00699751|58662372|FG000|Period 1: Without/Before Drug Switch|Other|30|||
30649818|NCT00699751|58662373|FG001|Period 1: Without/Before Drug Switch|Other|20|||
30649819|NCT00699751|58662372|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
30767326|NCT02939014|58776117|FG000|Overall Study|Death|4|||
30767327|NCT02939014|58776118|FG001|Overall Study|Death|3|||
30767328|NCT00051558|58776127|FG000|Overall Study|Adverse Event|30|||
30767329|NCT00051558|58776128|FG001|Overall Study|Adverse Event|18|||
30767330|NCT00051558|58776127|FG000|Overall Study|Withdrawal by Subject|29|||
30767331|NCT00051558|58776128|FG001|Overall Study|Withdrawal by Subject|42|||
30767332|NCT00051558|58776127|FG000|Overall Study|Death|9|||
30767333|NCT00051558|58776128|FG001|Overall Study|Death|15|||
30767334|NCT00051558|58776127|FG000|Overall Study|Lost to Follow-up|4|||
30767335|NCT00051558|58776128|FG001|Overall Study|Lost to Follow-up|13|||
30767336|NCT00051558|58776127|FG000|Overall Study|Protocol Violation|3|||
30767337|NCT00051558|58776128|FG001|Overall Study|Protocol Violation|4|||
30767338|NCT00051558|58776127|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
30767339|NCT00051558|58776128|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
30767340|NCT00051558|58776127|FG000|Overall Study|Sponsor Decision|6|||
30767341|NCT00051558|58776128|FG001|Overall Study|Sponsor Decision|1|||
30767342|NCT00051558|58776127|FG000|Overall Study|Other|2|||
30767343|NCT00051558|58776128|FG001|Overall Study|Other|1|||
30767344|NCT00051558|58776127|FG000|Overall Study|Significant Lab Value|2|||
30767345|NCT00051558|58776128|FG001|Overall Study|Significant Lab Value|0|||
30767346|NCT00051558|58776127|FG000|Overall Study|Physician Decision|5|||
30767347|NCT00051558|58776128|FG001|Overall Study|Physician Decision|0|||
30767348|NCT03251482|58776139|FG000|Overall Study|Withdrawal by Subject|0|||
30767349|NCT03251482|58776140|FG001|Overall Study|Withdrawal by Subject|1|||
30767350|NCT03251482|58776141|FG002|Overall Study|Withdrawal by Subject|0|||
30649820|NCT00699751|58662373|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
30649821|NCT00699751|58662372|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
30649822|NCT00699751|58662373|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
30649823|NCT00699751|58662372|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
30649824|NCT00699751|58662373|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
30649825|NCT00699751|58662372|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
30649826|NCT00699751|58662373|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
30649827|NCT00970502|58662380|FG000|Overall Study|Withdrawal by Subject|1|||
30649828|NCT00967226|58662390|FG000|Overall Study|Adverse Event|0|||
30649829|NCT00967226|58662391|FG001|Overall Study|Adverse Event|5|||
30649830|NCT00967226|58662390|FG000|Overall Study|Protocol Violation|2|||
30649831|NCT00967226|58662391|FG001|Overall Study|Protocol Violation|0|||
30649832|NCT00967226|58662390|FG000|Overall Study|Physician Decision|0|||
30649833|NCT00967226|58662391|FG001|Overall Study|Physician Decision|1|||
30649834|NCT00706381|58662425|FG000|Overall Study|Lost to Follow-up|0|||
30649835|NCT00706381|58662426|FG001|Overall Study|Lost to Follow-up|1|||
30649836|NCT00706381|58662427|FG002|Overall Study|Lost to Follow-up|1|||
30649837|NCT00706381|58662428|FG003|Overall Study|Lost to Follow-up|0|||
30649838|NCT00964886|58662445|FG000|Overall Study|Lost to Follow-up|2|||
30649839|NCT00964886|58662446|FG001|Overall Study|Lost to Follow-up|2|||
30649840|NCT00964886|58662447|FG002|Overall Study|Lost to Follow-up|6|||
30649841|NCT00964886|58662448|FG003|Overall Study|Lost to Follow-up|4|||
30649842|NCT00964886|58662445|FG000|Overall Study|Withdrawal by Subject|6|||
30649843|NCT00964886|58662446|FG001|Overall Study|Withdrawal by Subject|2|||
30649844|NCT00964886|58662447|FG002|Overall Study|Withdrawal by Subject|5|||
30649845|NCT00964886|58662448|FG003|Overall Study|Withdrawal by Subject|3|||
30649846|NCT00964886|58662445|FG000|Overall Study|Adverse Event|3|||
30649847|NCT00964886|58662446|FG001|Overall Study|Adverse Event|1|||
30649848|NCT00964886|58662447|FG002|Overall Study|Adverse Event|5|||
30649849|NCT00964886|58662448|FG003|Overall Study|Adverse Event|2|||
30649850|NCT00964886|58662445|FG000|Overall Study|Protocol Violation|0|||
30767351|NCT03251482|58776142|FG003|Overall Study|Withdrawal by Subject|0|||
30767352|NCT03251482|58776143|FG004|Overall Study|Withdrawal by Subject|0|||
30767353|NCT03249454|58776155|FG000|Overall Study|Withdrawal by Subject|0|||
30767354|NCT03249454|58776156|FG001|Overall Study|Withdrawal by Subject|0|||
30767355|NCT03249454|58776157|FG002|Overall Study|Withdrawal by Subject|0|||
30767356|NCT03249454|58776158|FG003|Overall Study|Withdrawal by Subject|0|||
30767357|NCT03249454|58776159|FG004|Overall Study|Withdrawal by Subject|0|||
30767358|NCT03249454|58776160|FG005|Overall Study|Withdrawal by Subject|0|||
30767359|NCT03249454|58776161|FG006|Overall Study|Withdrawal by Subject|0|||
30767360|NCT03249454|58776162|FG007|Overall Study|Withdrawal by Subject|0|||
30767361|NCT03249454|58776163|FG008|Overall Study|Withdrawal by Subject|0|||
30767362|NCT03249454|58776164|FG009|Overall Study|Withdrawal by Subject|1|||
30767363|NCT03249454|58776165|FG010|Overall Study|Withdrawal by Subject|1|||
30767364|NCT03732248|58776178|FG000|Overall Study|Withdrawal by Subject|1|||
30767365|NCT03732248|58776179|FG001|Overall Study|Withdrawal by Subject|0|||
30767366|NCT00310037|58776187|FG000|Overall Study|Adverse Event|7|||
30767367|NCT00310037|58776188|FG001|Overall Study|Adverse Event|14|||
30767368|NCT00310037|58776187|FG000|Overall Study|Withdrawal by Subject|4|||
30767369|NCT00310037|58776188|FG001|Overall Study|Withdrawal by Subject|3|||
30767370|NCT00310037|58776187|FG000|Overall Study|Progression|6|||
30767371|NCT00310037|58776188|FG001|Overall Study|Progression|0|||
30767372|NCT00310037|58776187|FG000|Overall Study|Non-protocol treatment|1|||
30649851|NCT00964886|58662446|FG001|Overall Study|Protocol Violation|2|||
30767373|NCT00310037|58776188|FG001|Overall Study|Non-protocol treatment|0|||
30767374|NCT00309959|58776194|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
30649852|NCT00964886|58662447|FG002|Overall Study|Protocol Violation|0|||
30767375|NCT03238924|58776205|FG000|Overall Study|Withdrawal by Subject|2|||
30767376|NCT03238924|58776206|FG001|Overall Study|Withdrawal by Subject|2|||
30767377|NCT03247816|58776212|FG000|Overall Study|Adverse Event|12|||
30767378|NCT03247816|58776212|FG000|Overall Study|Physician Decision|3|||
30767379|NCT03247816|58776212|FG000|Overall Study|Lack of Efficacy|1|||
30767380|NCT03247816|58776212|FG000|Overall Study|Lost to Follow-up|10|||
30649853|NCT00964886|58662448|FG003|Overall Study|Protocol Violation|0|||
30649854|NCT00705757|58662465|FG000|Overall Study|Lack of Efficacy|5|||
30649855|NCT00705757|58662466|FG001|Overall Study|Lack of Efficacy|1|||
30649856|NCT00705757|58662467|FG002|Overall Study|Lack of Efficacy|3|||
30767381|NCT03247816|58776212|FG000|Overall Study|Missing Feraccru stop date|3|||
30767382|NCT00333359|58776230|FG000|Overall Study|Adverse Event|29|||
30767383|NCT00333359|58776231|FG001|Overall Study|Adverse Event|35|||
30767384|NCT00333359|58776230|FG000|Overall Study|Withdrawal by Subject|19|||
30767385|NCT00333359|58776231|FG001|Overall Study|Withdrawal by Subject|37|||
30952106|NCT01569152|58999461|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
30952107|NCT01569152|58999462|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
30952108|NCT01569074|58999487|FG000|Overall Study|Study stopped|6|||
30649857|NCT00705757|58662465|FG000|Overall Study|Lost to Follow-up|7|||
30649858|NCT00705757|58662466|FG001|Overall Study|Lost to Follow-up|6|||
30649859|NCT00705757|58662467|FG002|Overall Study|Lost to Follow-up|6|||
30649860|NCT00705757|58662465|FG000|Overall Study|Withdrawal by Subject|1|||
30649861|NCT00705757|58662466|FG001|Overall Study|Withdrawal by Subject|1|||
30649862|NCT00705757|58662467|FG002|Overall Study|Withdrawal by Subject|2|||
30649863|NCT00960752|58662495|FG000|Overall Study|Adverse Event|0|||
30649864|NCT00960752|58662496|FG001|Overall Study|Adverse Event|0|||
30649865|NCT00960752|58662497|FG002|Overall Study|Adverse Event|1|||
30649866|NCT00960752|58662495|FG000|Overall Study|Progression|0|||
30649867|NCT00960752|58662496|FG001|Overall Study|Progression|0|||
30649868|NCT00960752|58662497|FG002|Overall Study|Progression|1|||
30649869|NCT00758524|58662511|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
30649870|NCT00758524|58662512|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
30649871|NCT00758524|58662513|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
30649872|NCT00758524|58662514|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30767386|NCT00333359|58776230|FG000|Overall Study|Physician Decision|2|||
30952109|NCT01569074|58999488|FG001|Overall Study|Study stopped|6|||
30952110|NCT01569074|58999489|FG002|Overall Study|Study stopped|8|||
30952111|NCT01569074|58999490|FG003|Overall Study|Study stopped|7|||
30952112|NCT01569074|58999491|FG004|Overall Study|Study stopped|7|||
30952113|NCT01569074|58999487|FG000|Overall Study|Study-specific discontinuation criteria|0|||
30952114|NCT01569074|58999488|FG001|Overall Study|Study-specific discontinuation criteria|1|||
30952115|NCT01569074|58999489|FG002|Overall Study|Study-specific discontinuation criteria|0|||
30952116|NCT01569074|58999490|FG003|Overall Study|Study-specific discontinuation criteria|0|||
30952117|NCT01569074|58999491|FG004|Overall Study|Study-specific discontinuation criteria|0|||
30952118|NCT01569074|58999487|FG000|Overall Study|Severe non-compliance to protocol|0|||
30952119|NCT01569074|58999488|FG001|Overall Study|Severe non-compliance to protocol|0|||
30952120|NCT01569074|58999489|FG002|Overall Study|Severe non-compliance to protocol|1|||
30952121|NCT01569074|58999490|FG003|Overall Study|Severe non-compliance to protocol|0|||
30952122|NCT01569074|58999491|FG004|Overall Study|Severe non-compliance to protocol|0|||
30952123|NCT01569074|58999487|FG000|Overall Study|eg change in circumstances|0|||
30952124|NCT01569074|58999488|FG001|Overall Study|eg change in circumstances|2|||
30952125|NCT01569074|58999489|FG002|Overall Study|eg change in circumstances|0|||
30952126|NCT01569074|58999490|FG003|Overall Study|eg change in circumstances|1|||
30952127|NCT01569074|58999491|FG004|Overall Study|eg change in circumstances|1|||
30952128|NCT01569074|58999487|FG000|Overall Study|Adverse Event|1|||
30952129|NCT01569074|58999488|FG001|Overall Study|Adverse Event|0|||
30952130|NCT01569074|58999489|FG002|Overall Study|Adverse Event|3|||
30952131|NCT01569074|58999490|FG003|Overall Study|Adverse Event|0|||
30952132|NCT01569074|58999491|FG004|Overall Study|Adverse Event|0|||
30952133|NCT01604408|58999509|FG000|Treatment Period 1|Protocol Violation|0|||
30952134|NCT01604408|58999510|FG001|Treatment Period 1|Protocol Violation|1|||
30952135|NCT01604408|58999509|FG000|Treatment Period 2|Withdrawal by Subject|1|||
30952136|NCT01604408|58999510|FG001|Treatment Period 2|Withdrawal by Subject|1|||
30767387|NCT00333359|58776231|FG001|Overall Study|Physician Decision|2|||
30767388|NCT00333359|58776230|FG000|Overall Study|Protocol Non-compliance|2|||
30767389|NCT00333359|58776231|FG001|Overall Study|Protocol Non-compliance|8|||
30952137|NCT01604408|58999509|FG000|Treatment Period 2|Protocol Violation|1|||
30649873|NCT00758524|58662515|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
30649874|NCT00758524|58662516|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
30649875|NCT00758524|58662517|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30767390|NCT00333359|58776230|FG000|Overall Study|Lost to Follow-up|15|||
30767391|NCT00333359|58776231|FG001|Overall Study|Lost to Follow-up|25|||
30952138|NCT01604408|58999510|FG001|Treatment Period 2|Protocol Violation|0|||
30952139|NCT01604408|58999509|FG000|Treatment Period 2|Adverse Event|0|||
30952140|NCT01604408|58999510|FG001|Treatment Period 2|Adverse Event|1|||
30649876|NCT00758524|58662518|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30649877|NCT00758524|58662519|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30649878|NCT00758524|58662520|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30649879|NCT00758524|58662521|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30649880|NCT00758524|58662522|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30649881|NCT00758524|58662523|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30649882|NCT00758524|58662524|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30649883|NCT00758524|58662525|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30649884|NCT00758524|58662526|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30649885|NCT00758524|58662527|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
30649886|NCT00758524|58662511|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
30649887|NCT00758524|58662512|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649888|NCT00758524|58662513|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
30649889|NCT00758524|58662514|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
30649890|NCT00758524|58662515|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
30649891|NCT00758524|58662516|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
30649892|NCT00758524|58662517|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649893|NCT00758524|58662518|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649894|NCT00758524|58662519|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649895|NCT00758524|58662520|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649896|NCT00758524|58662521|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649897|NCT00758524|58662522|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649898|NCT00758524|58662523|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649899|NCT00758524|58662524|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649900|NCT00758524|58662525|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649901|NCT00758524|58662526|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649902|NCT00758524|58662527|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
30649903|NCT00758524|58662511|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
30649904|NCT00758524|58662512|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
30649905|NCT00758524|58662513|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
30649906|NCT00758524|58662514|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
30649907|NCT00758524|58662515|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
30649908|NCT00758524|58662516|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
30649909|NCT00758524|58662517|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
30649910|NCT00758524|58662518|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
30649911|NCT00758524|58662519|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
30649912|NCT00758524|58662520|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
30649913|NCT00758524|58662521|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
30649914|NCT00758524|58662522|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
30649915|NCT00758524|58662523|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
30649916|NCT00758524|58662524|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
30649917|NCT00758524|58662525|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
30649918|NCT00758524|58662526|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
30649919|NCT00758524|58662527|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
30649920|NCT00758524|58662511|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649921|NCT00758524|58662512|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
30649922|NCT00758524|58662513|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
30649923|NCT00758524|58662514|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649924|NCT00758524|58662515|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
30649925|NCT00758524|58662516|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
30649926|NCT00758524|58662517|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649927|NCT00758524|58662518|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649928|NCT00758524|58662519|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649929|NCT00758524|58662520|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649930|NCT00758524|58662521|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649931|NCT00758524|58662522|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649932|NCT00758524|58662523|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649933|NCT00758524|58662524|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649934|NCT00758524|58662525|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649935|NCT00758524|58662526|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649936|NCT00758524|58662527|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
30649937|NCT00758524|58662511|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649938|NCT00758524|58662512|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649939|NCT00758524|58662513|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
30649940|NCT00758524|58662514|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
30649941|NCT00758524|58662515|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30767392|NCT00333359|58776230|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
30848641|NCT04203823|58874880|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30649942|NCT00758524|58662516|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649943|NCT00758524|58662517|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649944|NCT00758524|58662518|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649945|NCT00758524|58662519|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649946|NCT00758524|58662520|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649947|NCT00758524|58662521|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649948|NCT00758524|58662522|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649949|NCT00758524|58662523|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649950|NCT00758524|58662524|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649951|NCT00758524|58662525|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649952|NCT00758524|58662526|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649953|NCT00758524|58662527|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
30649954|NCT00758524|58662511|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649955|NCT00758524|58662512|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649956|NCT00758524|58662513|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649957|NCT00758524|58662514|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649958|NCT00758524|58662515|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
30649959|NCT00758524|58662516|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649960|NCT00758524|58662517|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649961|NCT00758524|58662518|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649962|NCT00758524|58662519|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649963|NCT00758524|58662520|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649964|NCT00758524|58662521|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649965|NCT00758524|58662522|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649966|NCT00758524|58662523|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649967|NCT00758524|58662524|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649968|NCT00758524|58662525|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649969|NCT00758524|58662526|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649970|NCT00758524|58662527|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
30649971|NCT00758524|58662511|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649972|NCT00758524|58662512|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
30649973|NCT00758524|58662513|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649974|NCT00758524|58662514|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649975|NCT00758524|58662515|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649976|NCT00758524|58662516|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649977|NCT00758524|58662517|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649978|NCT00758524|58662518|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649979|NCT00758524|58662519|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649980|NCT00758524|58662520|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649981|NCT00758524|58662521|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649982|NCT00758524|58662522|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649983|NCT00758524|58662523|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649984|NCT00758524|58662524|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649985|NCT00758524|58662525|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649986|NCT00758524|58662526|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649987|NCT00758524|58662527|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
30649988|NCT00758524|58662511|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30649989|NCT00758524|58662512|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
30649990|NCT00758524|58662513|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30649991|NCT00758524|58662514|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30649992|NCT00758524|58662515|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30649993|NCT00758524|58662516|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30649994|NCT00758524|58662517|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30649995|NCT00758524|58662518|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30649996|NCT00758524|58662519|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30649997|NCT00758524|58662520|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30649998|NCT00758524|58662521|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30649999|NCT00758524|58662522|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30650000|NCT00758524|58662523|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30650001|NCT00758524|58662524|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30650002|NCT00758524|58662525|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30650003|NCT00758524|58662526|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30650004|NCT00758524|58662527|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
30650005|NCT00758524|58662511|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650006|NCT00758524|58662512|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650007|NCT00758524|58662513|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650008|NCT00758524|58662514|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650009|NCT00758524|58662515|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650010|NCT00758524|58662516|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650011|NCT00758524|58662517|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650012|NCT00758524|58662518|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650013|NCT00758524|58662519|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
30650014|NCT00758524|58662520|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650015|NCT00758524|58662521|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650016|NCT00758524|58662522|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650017|NCT00758524|58662523|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650018|NCT00758524|58662524|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650019|NCT00758524|58662525|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650020|NCT00758524|58662526|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650021|NCT00758524|58662527|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
30650022|NCT00758524|58662511|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650023|NCT00758524|58662512|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650024|NCT00758524|58662513|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650025|NCT00758524|58662514|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650026|NCT00758524|58662515|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650027|NCT00758524|58662516|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650028|NCT00758524|58662517|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
30650029|NCT00758524|58662518|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650030|NCT00758524|58662519|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650031|NCT00758524|58662520|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650032|NCT00758524|58662521|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650033|NCT00758524|58662522|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650034|NCT00758524|58662523|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650035|NCT00758524|58662524|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650036|NCT00758524|58662525|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650037|NCT00758524|58662526|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650038|NCT00758524|58662527|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
30650039|NCT00757588|58662567|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
30650040|NCT00757588|58662568|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
30650041|NCT00757588|58662567|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
30650042|NCT00757588|58662568|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
30650043|NCT00757588|58662567|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
30650044|NCT00757588|58662568|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
30650045|NCT00757588|58662567|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
30650046|NCT00757588|58662568|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
30650047|NCT00757588|58662567|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
30650048|NCT00757588|58662568|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
30650049|NCT00757588|58662567|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
30650050|NCT00757588|58662568|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
30650051|NCT00757588|58662567|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
30650052|NCT00757588|58662568|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
30650053|NCT00757588|58662567|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
30650054|NCT00757588|58662568|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
30650055|NCT00757588|58662567|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
30650056|NCT00757588|58662568|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
30650057|NCT00757588|58662567|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
30650058|NCT00757588|58662568|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
30650059|NCT00757588|58662567|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
30650060|NCT00757588|58662568|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
30650061|NCT00757588|58662567|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
30952141|NCT01604408|58999509|FG000|Treatment Period 3|Protocol Violation|1|||
30952142|NCT01604408|58999510|FG001|Treatment Period 3|Protocol Violation|1|||
30952143|NCT01604408|58999509|FG000|Treatment Period 3|Adverse Event|0|||
30952144|NCT01604408|58999510|FG001|Treatment Period 3|Adverse Event|3|||
30650062|NCT00757588|58662568|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
30650063|NCT00757588|58662567|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
30650064|NCT00757588|58662568|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
30650065|NCT00757588|58662567|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
30650066|NCT00757588|58662568|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
30650067|NCT00757588|58662567|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
30650068|NCT00757588|58662568|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
30650069|NCT00757588|58662567|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
30650070|NCT00757588|58662568|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
30650071|NCT00744796|58662574|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
30650072|NCT00705679|58662583|FG000|Overall Study|Adverse Event|1|||
30650073|NCT00705679|58662584|FG001|Overall Study|Adverse Event|1|||
30650074|NCT00705679|58662585|FG002|Overall Study|Adverse Event|0|||
30650075|NCT00705679|58662586|FG003|Overall Study|Adverse Event|0|||
30650076|NCT00705679|58662587|FG004|Overall Study|Adverse Event|0|||
30650077|NCT00705679|58662583|FG000|Overall Study|Death|0|||
30650078|NCT00705679|58662584|FG001|Overall Study|Death|0|||
30650079|NCT00705679|58662585|FG002|Overall Study|Death|3|||
30650080|NCT00705679|58662586|FG003|Overall Study|Death|2|||
30650081|NCT00705679|58662587|FG004|Overall Study|Death|1|||
30650082|NCT00705679|58662583|FG000|Overall Study|Lost to Follow-up|32|||
30650083|NCT00705679|58662584|FG001|Overall Study|Lost to Follow-up|60|||
30650084|NCT00705679|58662585|FG002|Overall Study|Lost to Follow-up|44|||
30650085|NCT00705679|58662586|FG003|Overall Study|Lost to Follow-up|30|||
30650086|NCT00705679|58662587|FG004|Overall Study|Lost to Follow-up|35|||
30650087|NCT00705679|58662583|FG000|Overall Study|Physician Decision|0|||
30650088|NCT00705679|58662584|FG001|Overall Study|Physician Decision|1|||
30650089|NCT00705679|58662585|FG002|Overall Study|Physician Decision|0|||
30650090|NCT00705679|58662586|FG003|Overall Study|Physician Decision|1|||
30650091|NCT00705679|58662587|FG004|Overall Study|Physician Decision|0|||
30650092|NCT00705679|58662583|FG000|Overall Study|Withdrawal by Subject|32|||
30650093|NCT00705679|58662584|FG001|Overall Study|Withdrawal by Subject|77|||
30650094|NCT00705679|58662585|FG002|Overall Study|Withdrawal by Subject|68|||
30650095|NCT00705679|58662586|FG003|Overall Study|Withdrawal by Subject|47|||
30650096|NCT00705679|58662587|FG004|Overall Study|Withdrawal by Subject|33|||
30650097|NCT00751348|58662610|FG000|Overall Study|Withdrawal by Subject|5|||
30650098|NCT00751348|58662611|FG001|Overall Study|Withdrawal by Subject|2|||
30650099|NCT00751348|58662610|FG000|Overall Study|Migration from study area|1|||
30650100|NCT00751348|58662611|FG001|Overall Study|Migration from study area|0|||
30650101|NCT00751114|58662619|FG000|Overall Study|Adverse Event|2|||
30650102|NCT00751114|58662620|FG001|Overall Study|Adverse Event|4|||
30650103|NCT00751114|58662619|FG000|Overall Study|Protocol Violation|8|||
30650104|NCT00751114|58662620|FG001|Overall Study|Protocol Violation|9|||
30650105|NCT00751114|58662619|FG000|Overall Study|Withdrawal by Subject|9|||
30650106|NCT00751114|58662620|FG001|Overall Study|Withdrawal by Subject|4|||
30650107|NCT00751114|58662619|FG000|Overall Study|Lost to Follow-up|4|||
30650108|NCT00751114|58662620|FG001|Overall Study|Lost to Follow-up|7|||
30650109|NCT00751114|58662619|FG000|Overall Study|Lack of Efficacy|0|||
30650110|NCT00751114|58662620|FG001|Overall Study|Lack of Efficacy|7|||
30650111|NCT00751114|58662619|FG000|Overall Study|Not Treated|13|||
30650112|NCT00751114|58662620|FG001|Overall Study|Not Treated|1|||
30650113|NCT00751114|58662619|FG000|Overall Study|Out of country for 2 months|1|||
30650114|NCT00751114|58662620|FG001|Overall Study|Out of country for 2 months|0|||
30650115|NCT00751114|58662619|FG000|Overall Study|Move to another city|1|||
30650116|NCT00751114|58662620|FG001|Overall Study|Move to another city|0|||
30650117|NCT00960440|58662630|FG000|Overall Study|Death|0|||
30650118|NCT00960440|58662631|FG001|Overall Study|Death|0|||
30650119|NCT00960440|58662632|FG002|Overall Study|Death|0|||
30650120|NCT00960440|58662633|FG003|Overall Study|Death|1|||
30650121|NCT00960440|58662630|FG000|Overall Study|Adverse Event|12|||
30650122|NCT00960440|58662631|FG001|Overall Study|Adverse Event|12|||
30767393|NCT00333359|58776231|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
30767394|NCT00333359|58776230|FG000|Overall Study|Treatment Failure|3|||
30767395|NCT00333359|58776231|FG001|Overall Study|Treatment Failure|8|||
30767396|NCT00333359|58776230|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
30767397|NCT00333359|58776231|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
30767398|NCT03246724|58776243|FG000|Overall Study|Withdrawal by Subject|5|||
30767399|NCT03246724|58776244|FG001|Overall Study|Withdrawal by Subject|2|||
30767400|NCT03246724|58776245|FG002|Overall Study|Withdrawal by Subject|4|||
30767401|NCT03246724|58776246|FG003|Overall Study|Withdrawal by Subject|2|||
30767402|NCT03246724|58776243|FG000|Overall Study|Ineligible on day of surgery|7|||
30767403|NCT03246724|58776244|FG001|Overall Study|Ineligible on day of surgery|2|||
30650123|NCT00960440|58662632|FG002|Overall Study|Adverse Event|4|||
30650124|NCT00960440|58662633|FG003|Overall Study|Adverse Event|4|||
30650125|NCT00960440|58662630|FG000|Overall Study|Lack of Efficacy|2|||
30650126|NCT00960440|58662631|FG001|Overall Study|Lack of Efficacy|5|||
30650127|NCT00960440|58662632|FG002|Overall Study|Lack of Efficacy|3|||
30650128|NCT00960440|58662633|FG003|Overall Study|Lack of Efficacy|8|||
30650129|NCT00960440|58662630|FG000|Overall Study|Protocol Violation|2|||
30650130|NCT00960440|58662631|FG001|Overall Study|Protocol Violation|8|||
30650131|NCT00960440|58662632|FG002|Overall Study|Protocol Violation|3|||
30650132|NCT00960440|58662633|FG003|Overall Study|Protocol Violation|4|||
30650133|NCT00960440|58662630|FG000|Overall Study|Withdrawal by Subject|9|||
30650134|NCT00960440|58662631|FG001|Overall Study|Withdrawal by Subject|5|||
30650135|NCT00960440|58662632|FG002|Overall Study|Withdrawal by Subject|2|||
30650136|NCT00960440|58662633|FG003|Overall Study|Withdrawal by Subject|1|||
30650137|NCT00960440|58662630|FG000|Overall Study|Other|1|||
30650138|NCT00960440|58662631|FG001|Overall Study|Other|1|||
30650139|NCT00960440|58662632|FG002|Overall Study|Other|1|||
30650140|NCT00960440|58662633|FG003|Overall Study|Other|0|||
30650141|NCT04909853|58662686|FG000|Part 1|Assigned but not treated|0|||
30650142|NCT04909853|58662687|FG001|Part 1|Assigned but not treated|0|||
30650143|NCT04909853|58662688|FG002|Part 1|Assigned but not treated|1|||
30650144|NCT04909853|58662689|FG003|Part 1|Assigned but not treated|0|||
30650145|NCT04909853|58662686|FG000|Part 2|Adverse Event|0|||
30650146|NCT04909853|58662687|FG001|Part 2|Adverse Event|0|||
30650147|NCT04909853|58662688|FG002|Part 2|Adverse Event|0|||
30650148|NCT04909853|58662689|FG003|Part 2|Adverse Event|1|||
30650149|NCT04811664|58662702|FG000|Overall Study|Lost to Follow-up|78|||
30650150|NCT04811664|58662703|FG001|Overall Study|Lost to Follow-up|125|||
30650151|NCT04811664|58662704|FG002|Overall Study|Lost to Follow-up|46|||
30650152|NCT04811664|58662702|FG000|Overall Study|Withdrawal by Subject|39|||
30650153|NCT04811664|58662703|FG001|Overall Study|Withdrawal by Subject|76|||
30650154|NCT04811664|58662704|FG002|Overall Study|Withdrawal by Subject|12|||
30650155|NCT04811664|58662702|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
30650156|NCT04811664|58662703|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
30650157|NCT04811664|58662704|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
30650158|NCT04811664|58662702|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
30650159|NCT04811664|58662703|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
30650160|NCT04811664|58662704|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
30650161|NCT04811664|58662702|FG000|Overall Study|Protocol Violation|0|||
30650162|NCT04811664|58662703|FG001|Overall Study|Protocol Violation|5|||
30650163|NCT04811664|58662704|FG002|Overall Study|Protocol Violation|11|||
30650164|NCT04811664|58662702|FG000|Overall Study|Study Terminated by Sponsor|4|||
30650165|NCT04811664|58662703|FG001|Overall Study|Study Terminated by Sponsor|3|||
30650166|NCT04811664|58662704|FG002|Overall Study|Study Terminated by Sponsor|34|||
30650167|NCT04811664|58662702|FG000|Overall Study|Early Study Closure|3|||
30650168|NCT04811664|58662703|FG001|Overall Study|Early Study Closure|7|||
30650169|NCT04811664|58662704|FG002|Overall Study|Early Study Closure|79|||
30650170|NCT04811664|58662702|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
30650171|NCT04811664|58662703|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
30650172|NCT04811664|58662704|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
30650183|NCT04119414|58662725|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
30650184|NCT03762265|58662754|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
30650185|NCT03762265|58662755|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
30650186|NCT03762265|58662754|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
30650187|NCT03762265|58662755|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
30650188|NCT03762265|58662754|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
30650189|NCT03762265|58662755|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
30650190|NCT03762265|58662754|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
30650191|NCT03762265|58662755|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
30650192|NCT03762265|58662754|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
30650193|NCT03762265|58662755|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
30650194|NCT03762265|58662754|FG000|BT Period: Weeks 1 to 37|Other|0|||
30650195|NCT03762265|58662755|FG001|BT Period: Weeks 1 to 37|Other|1|||
30767404|NCT03246724|58776245|FG002|Overall Study|Ineligible on day of surgery|0|||
30650196|NCT03762265|58662754|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
30650197|NCT03762265|58662755|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
30650198|NCT03762265|58662754|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
30650199|NCT03762265|58662755|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
30650200|NCT03762265|58662754|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
30650201|NCT03762265|58662755|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
30650202|NCT03762265|58662754|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
30650203|NCT03762265|58662755|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
30650204|NCT03762265|58662754|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
30650205|NCT03762265|58662755|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
30650206|NCT03762265|58662754|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
30650207|NCT03762265|58662755|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
30650208|NCT03762265|58662754|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
30952145|NCT01604408|58999509|FG000|Treatment Period 3|Withdrawal by Subject|3|||
30650209|NCT03762265|58662755|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
30767405|NCT03246724|58776246|FG003|Overall Study|Ineligible on day of surgery|3|||
30952146|NCT01604408|58999510|FG001|Treatment Period 3|Withdrawal by Subject|1|||
30952147|NCT01604408|58999509|FG000|Treatment Period 3|Sponsor Decision|1|||
30650210|NCT03762265|58662754|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
30650211|NCT03762265|58662755|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
30650212|NCT03762265|58662754|FG000|LTE Period: Weeks 61 to 109|Other|1|||
30650213|NCT03762265|58662755|FG001|LTE Period: Weeks 61 to 109|Other|0|||
30650214|NCT03713632|58662791|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
30650215|NCT03713632|58662792|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
30650216|NCT03713632|58662793|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
30650217|NCT03713632|58662794|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
30650218|NCT03713632|58662795|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
30650219|NCT03713632|58662791|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
30650220|NCT03713632|58662792|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
30650221|NCT03713632|58662793|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
30650222|NCT03713632|58662794|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
30650223|NCT03713632|58662795|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
30650224|NCT03713632|58662791|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
30650225|NCT03713632|58662792|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
30650226|NCT03713632|58662793|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
30650227|NCT03713632|58662794|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
30650228|NCT03713632|58662795|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
30650229|NCT03713632|58662791|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
30650230|NCT03713632|58662792|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
30650231|NCT03713632|58662793|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
30650232|NCT03713632|58662794|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
30650233|NCT03713632|58662795|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
30650234|NCT03713632|58662791|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
30650235|NCT03713632|58662792|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
30650236|NCT03713632|58662793|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
30650237|NCT03713632|58662794|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
30650238|NCT03713632|58662795|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
30650239|NCT03713632|58662791|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
30650240|NCT03713632|58662792|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
30650241|NCT03713632|58662793|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
30650242|NCT03713632|58662794|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
30650243|NCT03713632|58662795|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
30650244|NCT03713632|58662791|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
30650245|NCT03713632|58662792|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
30650246|NCT03713632|58662793|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
30650247|NCT03713632|58662794|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
30650248|NCT03713632|58662795|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
30650249|NCT03713632|58662791|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
30650250|NCT03713632|58662792|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
30650251|NCT03713632|58662793|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
30650252|NCT03713632|58662794|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
30650253|NCT03713632|58662795|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
30650254|NCT03713632|58662791|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
30650255|NCT03713632|58662792|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
30767406|NCT03246724|58776243|FG000|Overall Study|Study completed before surgical date|2|||
30767407|NCT03246724|58776244|FG001|Overall Study|Study completed before surgical date|1|||
30767408|NCT03246724|58776245|FG002|Overall Study|Study completed before surgical date|8|||
30767409|NCT03246724|58776246|FG003|Overall Study|Study completed before surgical date|1|||
30767410|NCT03246724|58776243|FG000|Overall Study|Transferred to other arm|0|||
30650256|NCT03713632|58662793|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
30767411|NCT03246724|58776244|FG001|Overall Study|Transferred to other arm|0|||
30767412|NCT03246724|58776245|FG002|Overall Study|Transferred to other arm|1|||
30952148|NCT01604408|58999510|FG001|Treatment Period 3|Sponsor Decision|0|||
30650257|NCT03713632|58662794|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
30650258|NCT03713632|58662795|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
30650259|NCT03713632|58662791|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
30650260|NCT03713632|58662792|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
30650261|NCT03713632|58662793|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
30650262|NCT03713632|58662794|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
30650263|NCT03713632|58662795|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
30650264|NCT03713632|58662791|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
30650265|NCT03713632|58662792|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
30650266|NCT03713632|58662793|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
30650267|NCT03713632|58662794|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
30650268|NCT03713632|58662795|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
30650269|NCT03713632|58662791|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
30650270|NCT03713632|58662792|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
30650271|NCT03713632|58662793|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
30650272|NCT03713632|58662794|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
30650273|NCT03713632|58662795|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
30650274|NCT03713632|58662791|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
30650275|NCT03713632|58662792|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
30650276|NCT03713632|58662793|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
30650277|NCT03713632|58662794|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
30650278|NCT03713632|58662795|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
30650279|NCT03713632|58662791|FG000|Treatment Period 2 (After Week 16)|Death|0|||
30650280|NCT03713632|58662792|FG001|Treatment Period 2 (After Week 16)|Death|1|||
30650281|NCT03713632|58662793|FG002|Treatment Period 2 (After Week 16)|Death|0|||
30650282|NCT03713632|58662794|FG003|Treatment Period 2 (After Week 16)|Death|0|||
30650283|NCT03713632|58662795|FG004|Treatment Period 2 (After Week 16)|Death|0|||
30952149|NCT01604408|58999509|FG000|Treatment Period 4|Death|1|||
30952150|NCT01604408|58999510|FG001|Treatment Period 4|Death|0|||
30952151|NCT01604408|58999509|FG000|Treatment Period 4|Withdrawal by Subject|2|||
30952152|NCT01604408|58999510|FG001|Treatment Period 4|Withdrawal by Subject|1|||
30952153|NCT01604408|58999509|FG000|Treatment Period 4|Adverse Event|0|||
30952154|NCT01604408|58999510|FG001|Treatment Period 4|Adverse Event|1|||
30952155|NCT01604408|58999509|FG000|Treatment Period 5|Adverse Event|4|||
30952156|NCT01604408|58999510|FG001|Treatment Period 5|Adverse Event|0|||
30952157|NCT01604408|58999509|FG000|Treatment Period 6|Lost to Follow-up|0|||
30952158|NCT01604408|58999510|FG001|Treatment Period 6|Lost to Follow-up|1|||
30952159|NCT01604408|58999509|FG000|Treatment Period 6|Adverse Event|2|||
30952160|NCT01604408|58999510|FG001|Treatment Period 6|Adverse Event|0|||
30952161|NCT01604408|58999509|FG000|Treatment Period 6|Sponsor decision|0|||
30952162|NCT01604408|58999510|FG001|Treatment Period 6|Sponsor decision|1|||
30650284|NCT03713632|58662791|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
30650285|NCT03713632|58662792|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
30650286|NCT03713632|58662793|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
30650287|NCT03713632|58662794|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
30650288|NCT03713632|58662795|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
30650289|NCT03704051|58662806|FG000|Overall Study|Withdrawal by Subject|4|||
30650290|NCT03704051|58662807|FG001|Overall Study|Withdrawal by Subject|0|||
30650291|NCT03642938|58662823|FG000|Overall Study|Withdrawal by Subject|0|||
30650292|NCT03642938|58662824|FG001|Overall Study|Withdrawal by Subject|0|||
30650293|NCT03642938|58662825|FG002|Overall Study|Withdrawal by Subject|0|||
30650294|NCT03642938|58662826|FG003|Overall Study|Withdrawal by Subject|1|||
30650295|NCT03562767|58662839|FG000|Overall Study|Physician Decision|2|||
30650296|NCT03562767|58662840|FG001|Overall Study|Physician Decision|0|||
30650297|NCT03562767|58662841|FG002|Overall Study|Physician Decision|0|||
30650298|NCT03562767|58662839|FG000|Overall Study|Logistic Reason|1|||
30650299|NCT03562767|58662840|FG001|Overall Study|Logistic Reason|3|||
30650300|NCT03562767|58662841|FG002|Overall Study|Logistic Reason|0|||
30650301|NCT03406156|58662855|FG000|Overall Study|Death|6|||
30650302|NCT03406156|58662856|FG001|Overall Study|Death|2|||
30650303|NCT03406156|58662855|FG000|Overall Study|Withdrawal by Subject|0|||
30650304|NCT03406156|58662856|FG001|Overall Study|Withdrawal by Subject|2|||
30650305|NCT03406156|58662855|FG000|Overall Study|COVID-19 infection|1|||
30650306|NCT03406156|58662856|FG001|Overall Study|COVID-19 infection|0|||
30952163|NCT01604408|58999509|FG000|Observation Period|Adverse Event|1|||
30650307|NCT03406156|58662855|FG000|Overall Study|Non-compliance with study procedures|0|||
30952164|NCT01604408|58999510|FG001|Observation Period|Adverse Event|1|||
30952165|NCT01604408|58999509|FG000|Observation Period|Withdrawal by Subject|0|||
30650308|NCT03406156|58662856|FG001|Overall Study|Non-compliance with study procedures|1|||
30650309|NCT03406156|58662855|FG000|Overall Study|Other, not specified|0|||
30650310|NCT03406156|58662856|FG001|Overall Study|Other, not specified|1|||
30650311|NCT03358472|58662867|FG000|Overall Study|Death|6|||
30650312|NCT03358472|58662868|FG001|Overall Study|Death|3|||
30650313|NCT03358472|58662869|FG002|Overall Study|Death|10|||
30650314|NCT03358472|58662867|FG000|Overall Study|Physician Decision|0|||
30650315|NCT03358472|58662868|FG001|Overall Study|Physician Decision|1|||
30650316|NCT03358472|58662869|FG002|Overall Study|Physician Decision|0|||
30650317|NCT03358472|58662867|FG000|Overall Study|Withdrawal by Subject|0|||
30650318|NCT03358472|58662868|FG001|Overall Study|Withdrawal by Subject|0|||
30650319|NCT03358472|58662869|FG002|Overall Study|Withdrawal by Subject|1|||
30650320|NCT03358472|58662867|FG000|Overall Study|On-going at clinical cut off date|9|||
30650321|NCT03358472|58662868|FG001|Overall Study|On-going at clinical cut off date|6|||
30650322|NCT03358472|58662869|FG002|Overall Study|On-going at clinical cut off date|5|||
30650323|NCT03333941|58662877|FG000|Overall Study|Lost to Follow-up|10|||
30650324|NCT03333941|58662877|FG000|Overall Study|Death|2|||
30650325|NCT03333941|58662877|FG000|Overall Study|Adverse Event|1|||
30650326|NCT03315754|58662881|FG000|Overall Study|COVID-19 complications leading to death|1|||
30650327|NCT03315754|58662881|FG000|Overall Study|insurance coverage issue|1|||
30650328|NCT02864394|58662900|FG000|Overall Study|Death|135|||
30650329|NCT02864394|58662901|FG001|Overall Study|Death|150|||
30650330|NCT02864394|58662900|FG000|Overall Study|Withdrawal by Subject|1|||
30650331|NCT02864394|58662901|FG001|Overall Study|Withdrawal by Subject|9|||
30848642|NCT04203823|58874881|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
30650332|NCT02864394|58662900|FG000|Overall Study|Ongoing In Study|77|||
30650333|NCT02864394|58662901|FG001|Overall Study|Ongoing In Study|53|||
30650334|NCT02836236|58662909|FG000|Overall Study|Randomized but Never Treated|1|||
30650335|NCT02836236|58662910|FG001|Overall Study|Randomized but Never Treated|0|||
30650336|NCT02836236|58662909|FG000|Overall Study|Withdrew Consent|2|||
30650337|NCT02836236|58662910|FG001|Overall Study|Withdrew Consent|0|||
30650338|NCT02836236|58662909|FG000|Overall Study|Adverse Event|0|||
30650339|NCT02836236|58662910|FG001|Overall Study|Adverse Event|1|||
30650340|NCT02836236|58662909|FG000|Overall Study|Investigator's Discretion|1|||
30650341|NCT02836236|58662910|FG001|Overall Study|Investigator's Discretion|0|||
30650342|NCT02836236|58662909|FG000|Overall Study|Still on Study|101|||
30650343|NCT02836236|58662910|FG001|Overall Study|Still on Study|49|||
30650344|NCT02795676|58662918|FG000|Overall Study|Adverse Event|2|||
30650345|NCT02795676|58662919|FG001|Overall Study|Adverse Event|0|||
30650346|NCT02795676|58662918|FG000|Overall Study|Withdrawal by Subject|3|||
30650347|NCT02795676|58662919|FG001|Overall Study|Withdrawal by Subject|1|||
30650348|NCT02440711|58662927|FG000|Second Intervention|Lost to Follow-up|1|||
30650349|NCT02440711|58662928|FG001|Second Intervention|Lost to Follow-up|0|||
30650350|NCT02358031|58662939|FG000|Overall Study|Death|226|||
30650351|NCT02358031|58662940|FG001|Overall Study|Death|204|||
30650352|NCT02358031|58662941|FG002|Overall Study|Death|249|||
30650353|NCT02358031|58662939|FG000|Overall Study|Lost to Follow-up|0|||
30650354|NCT02358031|58662940|FG001|Overall Study|Lost to Follow-up|1|||
30650355|NCT02358031|58662941|FG002|Overall Study|Lost to Follow-up|1|||
30650356|NCT02358031|58662939|FG000|Overall Study|Withdrawal by Subject|14|||
30650357|NCT02358031|58662940|FG001|Overall Study|Withdrawal by Subject|12|||
30650358|NCT02358031|58662941|FG002|Overall Study|Withdrawal by Subject|17|||
30650359|NCT02358031|58662939|FG000|Overall Study|Ongoing in Study|61|||
30767413|NCT03246724|58776246|FG003|Overall Study|Transferred to other arm|0|||
30767414|NCT03246724|58776243|FG000|Overall Study|Unable to obtain medication timely|0|||
30767415|NCT03246724|58776244|FG001|Overall Study|Unable to obtain medication timely|2|||
30767416|NCT03246724|58776245|FG002|Overall Study|Unable to obtain medication timely|2|||
30767417|NCT03246724|58776246|FG003|Overall Study|Unable to obtain medication timely|1|||
30767418|NCT03246724|58776243|FG000|Overall Study|Re-consented to participate|0|||
30767419|NCT03246724|58776244|FG001|Overall Study|Re-consented to participate|0|||
30767420|NCT03246724|58776245|FG002|Overall Study|Re-consented to participate|0|||
30767421|NCT03246724|58776246|FG003|Overall Study|Re-consented to participate|1|||
30767422|NCT03246646|58776258|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
30767423|NCT03246646|58776259|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
30767424|NCT03246646|58776258|FG000|Overall Study|Withdrawal by Subject|3|||
30767425|NCT03246646|58776259|FG001|Overall Study|Withdrawal by Subject|0|||
30767426|NCT03246646|58776258|FG000|Overall Study|Lost to Follow-up|7|||
30767427|NCT03246646|58776259|FG001|Overall Study|Lost to Follow-up|0|||
30767428|NCT01347112|58776267|FG000|Overall Study|Withdrawal by Subject|1|||
30650360|NCT02358031|58662940|FG001|Overall Study|Ongoing in Study|64|||
30650361|NCT02358031|58662941|FG002|Overall Study|Ongoing in Study|33|||
30650362|NCT02258451|58662951|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|88|||
30650363|NCT02258451|58662952|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|95|||
30650364|NCT02258451|58662951|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|6|||
30650365|NCT02258451|58662952|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
30650366|NCT02258451|58662951|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
30650367|NCT02258451|58662952|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
30650368|NCT02258451|58662951|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
30650369|NCT02258451|58662952|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
30650370|NCT02258451|58662951|FG000|Overall Study|Death|4|||
30650371|NCT02258451|58662952|FG001|Overall Study|Death|3|||
30650372|NCT02258451|58662951|FG000|Overall Study|Withdrawal by Subject|21|||
30650373|NCT02258451|58662952|FG001|Overall Study|Withdrawal by Subject|12|||
30650374|NCT02258451|58662951|FG000|Overall Study|Discontinuation all treatment due to TS-1 started|1|||
30650375|NCT02258451|58662952|FG001|Overall Study|Discontinuation all treatment due to TS-1 started|0|||
30650376|NCT02258451|58662951|FG000|Overall Study|Discontinuation all treatment due to event point reached|1|||
30650377|NCT02258451|58662952|FG001|Overall Study|Discontinuation all treatment due to event point reached|1|||
30650378|NCT02258451|58662951|FG000|Overall Study|Physician Decision|0|||
30767429|NCT01347112|58776268|FG001|Overall Study|Withdrawal by Subject|7|||
30767430|NCT01347112|58776267|FG000|Overall Study|Lost to Follow-up|3|||
30650379|NCT02258451|58662952|FG001|Overall Study|Physician Decision|2|||
30650380|NCT02258451|58662951|FG000|Overall Study|Never treated|2|||
30650381|NCT02258451|58662952|FG001|Overall Study|Never treated|3|||
30650382|NCT02258451|58662951|FG000|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|3|||
30767431|NCT01347112|58776268|FG001|Overall Study|Lost to Follow-up|5|||
30848643|NCT03703466|58874934|FG000|Overall Study|Death|2|||
30650383|NCT02258451|58662952|FG001|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|11|||
30650384|NCT02223767|58662962|FG000|Overall Study|Withdrawal by Subject|4|||
30650385|NCT02223767|58662963|FG001|Overall Study|Withdrawal by Subject|4|||
30650386|NCT01956773|58662982|FG000|Overall Study|Lost to Follow-up|628|||
30650387|NCT01956773|58662983|FG001|Overall Study|Lost to Follow-up|1|||
30650388|NCT01946529|58662992|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
30650389|NCT01946529|58662993|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
30650390|NCT01946529|58662994|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
30650391|NCT01946529|58662992|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
30650392|NCT01946529|58662993|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
30650393|NCT01946529|58662994|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
30650394|NCT01666808|58663016|FG000|Overall Study|Lost to Follow-up|9|||
30650395|NCT01666808|58663017|FG001|Overall Study|Lost to Follow-up|15|||
30650396|NCT01666808|58663016|FG000|Overall Study|Withdrawal by Subject|3|||
30650397|NCT01666808|58663017|FG001|Overall Study|Withdrawal by Subject|1|||
30650398|NCT01666808|58663016|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
30650399|NCT01666808|58663017|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
30650400|NCT00964028|58663034|FG000|Overall Study|Withdrawal by Subject|0|||
30650401|NCT00964028|58663035|FG001|Overall Study|Withdrawal by Subject|1|||
30650402|NCT00960206|58663044|FG000|Overall Study|Death|7|||
30650403|NCT00960206|58663045|FG001|Overall Study|Death|4|||
30650404|NCT00960206|58663046|FG002|Overall Study|Death|1|||
30650405|NCT00960206|58663044|FG000|Overall Study|Unwilling/Unable to return|1|||
30650406|NCT00960206|58663045|FG001|Overall Study|Unwilling/Unable to return|2|||
30650407|NCT00960206|58663046|FG002|Overall Study|Unwilling/Unable to return|0|||
30650408|NCT00960206|58663044|FG000|Overall Study|Lost to Follow-up|8|||
30650409|NCT00960206|58663045|FG001|Overall Study|Lost to Follow-up|14|||
30650410|NCT00960206|58663046|FG002|Overall Study|Lost to Follow-up|8|||
30650411|NCT00960206|58663044|FG000|Overall Study|Withdrawal by Subject|2|||
30650412|NCT00960206|58663045|FG001|Overall Study|Withdrawal by Subject|4|||
30650413|NCT00960206|58663046|FG002|Overall Study|Withdrawal by Subject|0|||
30650414|NCT00960206|58663044|FG000|Overall Study|Revision of study component|2|||
30650415|NCT00960206|58663045|FG001|Overall Study|Revision of study component|2|||
30650416|NCT00960206|58663046|FG002|Overall Study|Revision of study component|2|||
30650417|NCT00960206|58663044|FG000|Overall Study|Missing 10 year data|20|||
30650418|NCT00960206|58663045|FG001|Overall Study|Missing 10 year data|1|||
30650419|NCT00960206|58663046|FG002|Overall Study|Missing 10 year data|1|||
30650420|NCT00751036|58663057|FG000|Overall Study|Disease Progression|28|||
30650421|NCT00751036|58663058|FG001|Overall Study|Disease Progression|29|||
30650422|NCT00751036|58663057|FG000|Overall Study|Adverse Event|6|||
30650423|NCT00751036|58663058|FG001|Overall Study|Adverse Event|4|||
30650424|NCT00751036|58663057|FG000|Overall Study|Administrative Problems|3|||
30650425|NCT00751036|58663058|FG001|Overall Study|Administrative Problems|4|||
30650426|NCT00751036|58663057|FG000|Overall Study|Withdrawal by Subject|5|||
30650427|NCT00751036|58663058|FG001|Overall Study|Withdrawal by Subject|2|||
30650428|NCT00751036|58663057|FG000|Overall Study|Death|3|||
30650429|NCT00751036|58663058|FG001|Overall Study|Death|3|||
30650430|NCT00751036|58663057|FG000|Overall Study|Lost to Follow-up|0|||
30650431|NCT00751036|58663058|FG001|Overall Study|Lost to Follow-up|1|||
30650432|NCT00751036|58663057|FG000|Overall Study|Protocol Violation|1|||
30650433|NCT00751036|58663058|FG001|Overall Study|Protocol Violation|0|||
30650434|NCT00751036|58663057|FG000|Overall Study|Missing end of Treatment Page|2|||
30650435|NCT00751036|58663058|FG001|Overall Study|Missing end of Treatment Page|3|||
30650436|NCT00961298|58663064|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
30650437|NCT00961298|58663064|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
30650438|NCT00961298|58663064|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
30650439|NCT00744328|58663071|FG000|Overall Study|Lost to Follow-up|2|||
30650440|NCT00744328|58663072|FG001|Overall Study|Lost to Follow-up|5|||
30650441|NCT00744328|58663073|FG002|Overall Study|Lost to Follow-up|3|||
30650442|NCT00744328|58663071|FG000|Overall Study|Withdrawal by Subject|5|||
30650443|NCT00744328|58663072|FG001|Overall Study|Withdrawal by Subject|3|||
30650444|NCT00744328|58663073|FG002|Overall Study|Withdrawal by Subject|4|||
30650445|NCT00744328|58663071|FG000|Overall Study|Found ineligible after randomization|0|||
30650446|NCT00744328|58663072|FG001|Overall Study|Found ineligible after randomization|0|||
30650447|NCT00744328|58663073|FG002|Overall Study|Found ineligible after randomization|1|||
30650448|NCT03245840|58663083|FG000|Overall Study|Adverse Event|6|||
30650449|NCT03245840|58663084|FG001|Overall Study|Adverse Event|0|||
30650450|NCT03245840|58663083|FG000|Overall Study|Death|2|||
30650451|NCT03245840|58663084|FG001|Overall Study|Death|0|||
30650452|NCT03245840|58663083|FG000|Overall Study|Withdrawal by Subject|31|||
30650453|NCT03245840|58663084|FG001|Overall Study|Withdrawal by Subject|1|||
30650454|NCT03245840|58663083|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
30650455|NCT03245840|58663084|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
30650456|NCT03245840|58663083|FG000|Overall Study|Physician Decision|4|||
30650457|NCT03245840|58663084|FG001|Overall Study|Physician Decision|1|||
30650458|NCT03245840|58663083|FG000|Overall Study|Study Terminated by Sponsor|56|||
30650459|NCT03245840|58663084|FG001|Overall Study|Study Terminated by Sponsor|6|||
30650460|NCT03245840|58663083|FG000|Overall Study|Site Terminated by Sponsor|4|||
30650461|NCT03245840|58663084|FG001|Overall Study|Site Terminated by Sponsor|0|||
30650462|NCT03245840|58663083|FG000|Overall Study|Lost to Follow-up|12|||
30650463|NCT03245840|58663084|FG001|Overall Study|Lost to Follow-up|2|||
30650464|NCT03245840|58663083|FG000|Overall Study|Pregnancy|2|||
30650465|NCT03245840|58663084|FG001|Overall Study|Pregnancy|0|||
30650466|NCT03245840|58663083|FG000|Overall Study|Non-Compliance with Study Drug|2|||
30650467|NCT03245840|58663084|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30650468|NCT03245840|58663083|FG000|Overall Study|Not treated|1|||
30650469|NCT03245840|58663084|FG001|Overall Study|Not treated|1|||
30650470|NCT00959894|58663090|FG000|Overall Study|Lost to Follow-up|10|||
30650471|NCT00959894|58663090|FG000|Overall Study|Adverse Event|3|||
30650472|NCT00959894|58663090|FG000|Overall Study|Withdrawal by Subject|1|||
30650473|NCT00959894|58663090|FG000|Overall Study|Need for contraindicated medication|1|||
30650474|NCT00959894|58663090|FG000|Overall Study|Subject moved out of town|1|||
30650475|NCT00750880|58663095|FG000|Overall Study|Adverse Event|76|||
30650476|NCT00750880|58663095|FG000|Overall Study|Death|4|||
30650477|NCT00750880|58663095|FG000|Overall Study|Lack of Efficacy|46|||
30650478|NCT00750880|58663095|FG000|Overall Study|Lost to Follow-up|10|||
30650479|NCT00750880|58663095|FG000|Overall Study|Protocol Violation|15|||
30650480|NCT00750880|58663095|FG000|Overall Study|Withdrawal by Subject|33|||
30650481|NCT00750880|58663095|FG000|Overall Study|Physician Decision|20|||
30650482|NCT00750880|58663095|FG000|Overall Study|Administrative|11|||
30650483|NCT00746590|58663100|FG000|Overall Study|Death|1|||
30650484|NCT01032629|58663107|FG000|Overall Study|Closed Site|21|||
30650485|NCT01032629|58663108|FG001|Overall Study|Closed Site|18|||
30650486|NCT01032629|58663109|FG002|Overall Study|Closed Site|16|||
30650487|NCT01032629|58663107|FG000|Overall Study|Withdrawal by Subject|50|||
30650488|NCT01032629|58663108|FG001|Overall Study|Withdrawal by Subject|36|||
30650489|NCT01032629|58663109|FG002|Overall Study|Withdrawal by Subject|35|||
30650490|NCT01032629|58663107|FG000|Overall Study|Lost to Follow-up|74|||
30650491|NCT01032629|58663108|FG001|Overall Study|Lost to Follow-up|47|||
30767432|NCT00308711|58776278|FG000|Overall Study|Withdrawal by Subject|1|||
30767433|NCT00308711|58776279|FG001|Overall Study|Withdrawal by Subject|0|||
30767434|NCT00308711|58776280|FG002|Overall Study|Withdrawal by Subject|1|||
30767435|NCT00308711|58776278|FG000|Overall Study|Protocol Violation|0|||
30767436|NCT00308711|58776279|FG001|Overall Study|Protocol Violation|1|||
30650492|NCT01032629|58663109|FG002|Overall Study|Lost to Follow-up|37|||
30650493|NCT00749944|58663120|FG000|Overall Study|Lost to Follow-up|2|||
30650494|NCT00749944|58663121|FG001|Overall Study|Lost to Follow-up|1|||
30650495|NCT00749944|58663120|FG000|Overall Study|Other|1|||
30650496|NCT00749944|58663121|FG001|Overall Study|Other|0|||
30650497|NCT00749944|58663120|FG000|Overall Study|Withdrawal by Subject|2|||
30650498|NCT00749944|58663121|FG001|Overall Study|Withdrawal by Subject|0|||
30650499|NCT00749398|58663127|FG000|Overall Study|Lack of Efficacy|7|||
30650500|NCT00749398|58663127|FG000|Overall Study|Adverse Event|4|||
30650501|NCT00749398|58663127|FG000|Overall Study|Serious adverse event|11|||
30650502|NCT00749398|58663127|FG000|Overall Study|Withdrawal by Subject|17|||
30767437|NCT00308711|58776280|FG002|Overall Study|Protocol Violation|1|||
30767438|NCT00308711|58776278|FG000|Overall Study|Lost to Follow-up|0|||
30767439|NCT00308711|58776279|FG001|Overall Study|Lost to Follow-up|1|||
30650503|NCT00749398|58663127|FG000|Overall Study|Lost to Follow-up|11|||
30650504|NCT00749398|58663127|FG000|Overall Study|Reason not specified|2|||
30650505|NCT00749398|58663127|FG000|Overall Study|Unknown reason|1|||
30650506|NCT00746356|58663131|FG000|Overall Study|Withdrawal by Subject|2|||
30650507|NCT00746356|58663132|FG001|Overall Study|Withdrawal by Subject|3|||
30650508|NCT00746356|58663131|FG000|Overall Study|Death|7|||
30650509|NCT00746356|58663132|FG001|Overall Study|Death|3|||
30650510|NCT00746356|58663131|FG000|Overall Study|Lost to Follow-up|1|||
30650511|NCT00746356|58663132|FG001|Overall Study|Lost to Follow-up|0|||
30767440|NCT00308711|58776280|FG002|Overall Study|Lost to Follow-up|0|||
30767441|NCT00308711|58776278|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
30767442|NCT00308711|58776279|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
30650512|NCT00746356|58663131|FG000|Overall Study|Removal of Device|0|||
30650513|NCT00746356|58663132|FG001|Overall Study|Removal of Device|1|||
30650514|NCT00746356|58663131|FG000|Overall Study|Patient relocated|1|||
30650515|NCT00746356|58663132|FG001|Overall Study|Patient relocated|0|||
30650516|NCT01012973|58663142|FG000|Overall Study|Adverse Event|5|||
30650517|NCT01012973|58663143|FG001|Overall Study|Adverse Event|5|||
30650518|NCT01012973|58663142|FG000|Overall Study|Lack of Efficacy|0|||
30650519|NCT01012973|58663143|FG001|Overall Study|Lack of Efficacy|5|||
30650520|NCT01012973|58663142|FG000|Overall Study|Lost to Follow-up|1|||
30650521|NCT01012973|58663143|FG001|Overall Study|Lost to Follow-up|0|||
30650522|NCT01012973|58663142|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
30848644|NCT03703466|58874935|FG001|Overall Study|Death|1|||
30650523|NCT01012973|58663143|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
30650524|NCT01012973|58663142|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
30650525|NCT01012973|58663143|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
30650526|NCT01012973|58663142|FG000|Overall Study|Protocol Violation|5|||
30650527|NCT01012973|58663143|FG001|Overall Study|Protocol Violation|2|||
30650528|NCT01012973|58663142|FG000|Overall Study|Withdrawal by Subject|4|||
30650529|NCT01012973|58663143|FG001|Overall Study|Withdrawal by Subject|6|||
30650530|NCT00748540|58663153|FG000|Overall Study|Physician Decision|1|||
30650531|NCT01012739|58663157|FG000|Treatment Period 1|Adverse Event|0|||
30650532|NCT01012739|58663158|FG001|Treatment Period 1|Adverse Event|0|||
30650533|NCT01012739|58663159|FG002|Treatment Period 1|Adverse Event|0|||
30650534|NCT01012739|58663160|FG003|Treatment Period 1|Adverse Event|1|||
30650535|NCT01012739|58663157|FG000|Treatment Period 2|Abnormal test procedure results|0|||
30650536|NCT01012739|58663158|FG001|Treatment Period 2|Abnormal test procedure results|0|||
30650537|NCT01012739|58663159|FG002|Treatment Period 2|Abnormal test procedure results|0|||
30650538|NCT01012739|58663160|FG003|Treatment Period 2|Abnormal test procedure results|1|||
30650539|NCT00742924|58663175|FG000|Overall Study|Adverse Event|0|||
30650540|NCT00742924|58663176|FG001|Overall Study|Adverse Event|0|||
30650541|NCT00742924|58663177|FG002|Overall Study|Adverse Event|1|||
30650542|NCT00742924|58663178|FG003|Overall Study|Adverse Event|1|||
30650543|NCT00742924|58663175|FG000|Overall Study|Lack of Efficacy|5|||
30650544|NCT00742924|58663176|FG001|Overall Study|Lack of Efficacy|1|||
30650545|NCT00742924|58663177|FG002|Overall Study|Lack of Efficacy|2|||
30650546|NCT00742924|58663178|FG003|Overall Study|Lack of Efficacy|4|||
30650547|NCT00742924|58663175|FG000|Overall Study|Physician Decision|0|||
30650548|NCT00742924|58663176|FG001|Overall Study|Physician Decision|0|||
30650549|NCT00742924|58663177|FG002|Overall Study|Physician Decision|0|||
30650550|NCT00742924|58663178|FG003|Overall Study|Physician Decision|1|||
30650551|NCT00742924|58663175|FG000|Overall Study|Withdrawal by Subject|0|||
30650552|NCT00742924|58663176|FG001|Overall Study|Withdrawal by Subject|1|||
30650553|NCT00742924|58663177|FG002|Overall Study|Withdrawal by Subject|1|||
30650554|NCT00742924|58663178|FG003|Overall Study|Withdrawal by Subject|0|||
30650555|NCT00698815|58663191|FG000|Overall Study|Death|1|||
30767443|NCT00308711|58776280|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
30952166|NCT01604408|58999510|FG001|Observation Period|Withdrawal by Subject|2|||
30952167|NCT01567826|58999518|FG000|Overall Study|Lost to Follow-up|3|||
30650556|NCT00698815|58663192|FG001|Overall Study|Death|2|||
30650557|NCT00698815|58663193|FG002|Overall Study|Death|4|||
30650558|NCT00698815|58663191|FG000|Overall Study|Withdrawal by Subject|6|||
30650559|NCT00698815|58663192|FG001|Overall Study|Withdrawal by Subject|3|||
30650560|NCT00698815|58663193|FG002|Overall Study|Withdrawal by Subject|2|||
30650561|NCT00698815|58663191|FG000|Overall Study|MD discretion|2|||
30650562|NCT00698815|58663192|FG001|Overall Study|MD discretion|7|||
30650563|NCT00698815|58663193|FG002|Overall Study|MD discretion|2|||
30650564|NCT00698815|58663191|FG000|Overall Study|Did not receive protocol treatment|1|||
30650565|NCT00698815|58663192|FG001|Overall Study|Did not receive protocol treatment|2|||
30650566|NCT00698815|58663193|FG002|Overall Study|Did not receive protocol treatment|2|||
30650567|NCT00745498|58663204|FG000|Overall Study|Lost to Follow-up|1|||
30650568|NCT00745498|58663205|FG001|Overall Study|Lost to Follow-up|1|||
30650569|NCT00745498|58663206|FG002|Overall Study|Lost to Follow-up|3|||
30650570|NCT00745498|58663204|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
30650571|NCT00745498|58663205|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
30650572|NCT00745498|58663206|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
30650573|NCT00745498|58663204|FG000|Overall Study|Non-PDR related VH|0|||
30650574|NCT00745498|58663205|FG001|Overall Study|Non-PDR related VH|1|||
30650575|NCT00745498|58663206|FG002|Overall Study|Non-PDR related VH|1|||
30650576|NCT00745498|58663204|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
30650577|NCT00745498|58663205|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
30650578|NCT00745498|58663206|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
30952168|NCT01567826|58999519|FG001|Overall Study|Lost to Follow-up|2|||
30952169|NCT01697462|58999527|FG000|Overall Study|Disease Progression|1|||
30650579|NCT00744874|58663214|FG000|Overall Study|Lost to Follow-up|1|||
30650580|NCT00744874|58663214|FG000|Overall Study|Withdrawal by Subject|1|||
30650581|NCT00744874|58663214|FG000|Overall Study|Study Device not available at procedure|1|||
30650582|NCT00744874|58663214|FG000|Overall Study|Unable to accomodate schedule|1|||
30650583|NCT00576901|58663225|FG000|Overall Study|Withdrawal by Subject|1|||
30650584|NCT00576901|58663225|FG000|Overall Study|Disease course|1|||
30650585|NCT00576901|58663225|FG000|Overall Study|Protocol Violation|1|||
30650586|NCT00699283|58663231|FG000|Overall Study|Lack of Efficacy|15|||
30650587|NCT00699283|58663232|FG001|Overall Study|Lack of Efficacy|5|||
30650588|NCT00699283|58663231|FG000|Overall Study|Lost to Follow-up|2|||
30650589|NCT00699283|58663232|FG001|Overall Study|Lost to Follow-up|0|||
30650590|NCT00699283|58663231|FG000|Overall Study|Withdrawal by Subject|1|||
30650591|NCT00699283|58663232|FG001|Overall Study|Withdrawal by Subject|0|||
30650592|NCT00699283|58663231|FG000|Overall Study|Other Reason|5|||
30767444|NCT00308711|58776278|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
30650593|NCT00699283|58663232|FG001|Overall Study|Other Reason|1|||
30650594|NCT00699283|58663231|FG000|Overall Study|SAE, non-fatal|1|||
30650595|NCT00699283|58663232|FG001|Overall Study|SAE, non-fatal|1|||
30650596|NCT00699283|58663231|FG000|Overall Study|AE, non-serious non-fatal|8|||
30650597|NCT00699283|58663232|FG001|Overall Study|AE, non-serious non-fatal|1|||
30650598|NCT00699283|58663231|FG000|Overall Study|AE of unknown type|1|||
30650599|NCT00699283|58663232|FG001|Overall Study|AE of unknown type|0|||
30650600|NCT00740584|58663237|FG000|Overall Study|Withdrawal by Subject|1|||
30650601|NCT01023815|58663246|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
30650602|NCT01023815|58663247|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
30650603|NCT01023815|58663248|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
30650604|NCT01023815|58663249|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
30650605|NCT01023815|58663246|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
30650606|NCT01023815|58663247|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
30650607|NCT01023815|58663248|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
30650608|NCT01023815|58663249|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
30650609|NCT01023815|58663246|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
30650610|NCT01023815|58663247|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
30650611|NCT01023815|58663248|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
30650612|NCT01023815|58663249|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
30650613|NCT01023815|58663246|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
30650614|NCT01023815|58663247|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
30650615|NCT01023815|58663248|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
30650616|NCT01023815|58663249|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
30650617|NCT01023815|58663246|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
30650618|NCT01023815|58663247|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
30650619|NCT01023815|58663248|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
30650620|NCT01023815|58663249|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
30650621|NCT01023659|58663263|FG000|Overall Study|Lost to Follow-up|73|||
30650622|NCT01023659|58663264|FG001|Overall Study|Lost to Follow-up|228|||
30650623|NCT01023659|58663265|FG002|Overall Study|Lost to Follow-up|99|||
30650624|NCT00740116|58663276|FG000|Overall Study|Withdrawal by Subject|1|||
30650625|NCT00740116|58663277|FG001|Overall Study|Withdrawal by Subject|1|||
30650626|NCT00740116|58663276|FG000|Overall Study|Protocol Violation|1|||
30650627|NCT00740116|58663277|FG001|Overall Study|Protocol Violation|4|||
30650628|NCT00698581|58663287|FG000|Overall Study|Lack of Efficacy|23|||
30650629|NCT00698581|58663288|FG001|Overall Study|Lack of Efficacy|11|||
30650630|NCT00698581|58663287|FG000|Overall Study|Withdrawal by Subject|6|||
30650631|NCT00698581|58663288|FG001|Overall Study|Withdrawal by Subject|0|||
30650632|NCT00698581|58663287|FG000|Overall Study|Other reason|9|||
30650633|NCT00698581|58663288|FG001|Overall Study|Other reason|1|||
30650634|NCT00698581|58663287|FG000|Overall Study|SAE, non-fatal|1|||
30650635|NCT00698581|58663288|FG001|Overall Study|SAE, non-fatal|0|||
30650636|NCT00698581|58663287|FG000|Overall Study|AE, non-serious non-fatal|4|||
30650637|NCT00698581|58663288|FG001|Overall Study|AE, non-serious non-fatal|0|||
30650638|NCT00698581|58663287|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
30650639|NCT00698581|58663288|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
30650640|NCT00698581|58663287|FG000|Overall Study|AE of unknown type|1|||
30650641|NCT00698581|58663288|FG001|Overall Study|AE of unknown type|0|||
30650642|NCT01023581|58663302|FG000|Overall Study|Adverse Event|4|||
30650643|NCT01023581|58663303|FG001|Overall Study|Adverse Event|4|||
30650644|NCT01023581|58663304|FG002|Overall Study|Adverse Event|7|||
30650645|NCT01023581|58663305|FG003|Overall Study|Adverse Event|3|||
30650646|NCT01023581|58663306|FG004|Overall Study|Adverse Event|2|||
30767445|NCT00308711|58776279|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
30767446|NCT00308711|58776280|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
30767447|NCT00308555|58776290|FG000|Overall Study|Withdrawal by Subject|1|||
30767448|NCT00308555|58776291|FG001|Overall Study|Withdrawal by Subject|0|||
30650647|NCT01023581|58663307|FG005|Overall Study|Adverse Event|5|||
30650648|NCT01023581|58663308|FG006|Overall Study|Adverse Event|11|||
30767449|NCT00308555|58776290|FG000|Overall Study|Physician Decision|2|||
30650649|NCT01023581|58663302|FG000|Overall Study|Major protocol deviation|2|||
30650650|NCT01023581|58663303|FG001|Overall Study|Major protocol deviation|0|||
30650651|NCT01023581|58663304|FG002|Overall Study|Major protocol deviation|3|||
30650652|NCT01023581|58663305|FG003|Overall Study|Major protocol deviation|0|||
30650653|NCT01023581|58663306|FG004|Overall Study|Major protocol deviation|0|||
30650654|NCT01023581|58663307|FG005|Overall Study|Major protocol deviation|0|||
30650655|NCT01023581|58663308|FG006|Overall Study|Major protocol deviation|0|||
30650656|NCT01023581|58663302|FG000|Overall Study|Lost to Follow-up|4|||
30650657|NCT01023581|58663303|FG001|Overall Study|Lost to Follow-up|8|||
30650658|NCT01023581|58663304|FG002|Overall Study|Lost to Follow-up|7|||
30650659|NCT01023581|58663305|FG003|Overall Study|Lost to Follow-up|2|||
30650660|NCT01023581|58663306|FG004|Overall Study|Lost to Follow-up|5|||
30650661|NCT01023581|58663307|FG005|Overall Study|Lost to Follow-up|2|||
30650662|NCT01023581|58663308|FG006|Overall Study|Lost to Follow-up|2|||
30650663|NCT01023581|58663302|FG000|Overall Study|Withdrawal by Subject|13|||
30650664|NCT01023581|58663303|FG001|Overall Study|Withdrawal by Subject|8|||
30650665|NCT01023581|58663304|FG002|Overall Study|Withdrawal by Subject|16|||
30650666|NCT01023581|58663305|FG003|Overall Study|Withdrawal by Subject|10|||
30650667|NCT01023581|58663306|FG004|Overall Study|Withdrawal by Subject|6|||
30650668|NCT01023581|58663307|FG005|Overall Study|Withdrawal by Subject|8|||
30650669|NCT01023581|58663308|FG006|Overall Study|Withdrawal by Subject|5|||
30650670|NCT01023581|58663302|FG000|Overall Study|Pregnancy|0|||
30650671|NCT01023581|58663303|FG001|Overall Study|Pregnancy|0|||
30650672|NCT01023581|58663304|FG002|Overall Study|Pregnancy|0|||
30650673|NCT01023581|58663305|FG003|Overall Study|Pregnancy|2|||
30650674|NCT01023581|58663306|FG004|Overall Study|Pregnancy|0|||
30650675|NCT01023581|58663307|FG005|Overall Study|Pregnancy|1|||
30650676|NCT01023581|58663308|FG006|Overall Study|Pregnancy|0|||
30650677|NCT01023581|58663302|FG000|Overall Study|Lack of Efficacy|9|||
30650678|NCT01023581|58663303|FG001|Overall Study|Lack of Efficacy|3|||
30650679|NCT01023581|58663304|FG002|Overall Study|Lack of Efficacy|6|||
30650680|NCT01023581|58663305|FG003|Overall Study|Lack of Efficacy|2|||
30650681|NCT01023581|58663306|FG004|Overall Study|Lack of Efficacy|1|||
30650682|NCT01023581|58663307|FG005|Overall Study|Lack of Efficacy|2|||
30650683|NCT01023581|58663308|FG006|Overall Study|Lack of Efficacy|1|||
30650684|NCT01023581|58663302|FG000|Overall Study|Physician Decision|2|||
30650685|NCT01023581|58663303|FG001|Overall Study|Physician Decision|0|||
30650686|NCT01023581|58663304|FG002|Overall Study|Physician Decision|2|||
30650687|NCT01023581|58663305|FG003|Overall Study|Physician Decision|1|||
30650688|NCT01023581|58663306|FG004|Overall Study|Physician Decision|1|||
30650689|NCT01023581|58663307|FG005|Overall Study|Physician Decision|1|||
30650690|NCT01023581|58663308|FG006|Overall Study|Physician Decision|1|||
30650691|NCT01023581|58663302|FG000|Overall Study|Other|1|||
30650692|NCT01023581|58663303|FG001|Overall Study|Other|0|||
30650693|NCT01023581|58663304|FG002|Overall Study|Other|1|||
30650694|NCT01023581|58663305|FG003|Overall Study|Other|0|||
30848645|NCT03703466|58874936|FG002|Overall Study|Death|0|||
30848646|NCT03703466|58874934|FG000|Overall Study|Protocol Violation|1|||
30848647|NCT03703466|58874935|FG001|Overall Study|Protocol Violation|0|||
30848648|NCT03703466|58874936|FG002|Overall Study|Protocol Violation|0|||
30848649|NCT03703466|58874934|FG000|Overall Study|Withdrawal by Subject|0|||
30848650|NCT03703466|58874935|FG001|Overall Study|Withdrawal by Subject|3|||
30848651|NCT03703466|58874936|FG002|Overall Study|Withdrawal by Subject|0|||
30848652|NCT03703466|58874934|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1|||
30848653|NCT03703466|58874935|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
30650695|NCT01023581|58663306|FG004|Overall Study|Other|1|||
30650696|NCT01023581|58663307|FG005|Overall Study|Other|0|||
30650697|NCT01023581|58663308|FG006|Overall Study|Other|0|||
30650698|NCT00962780|58663326|FG000|Overall Study|Death|0|||
30650699|NCT00962780|58663327|FG001|Overall Study|Death|1|||
30650700|NCT00962780|58663326|FG000|Overall Study|Protocol Violation|9|||
30650701|NCT00962780|58663327|FG001|Overall Study|Protocol Violation|4|||
30650702|NCT00962780|58663326|FG000|Overall Study|Withdrawal by Subject|1|||
30650703|NCT00962780|58663327|FG001|Overall Study|Withdrawal by Subject|8|||
30650704|NCT00962780|58663326|FG000|Overall Study|Other|0|||
30650705|NCT00962780|58663327|FG001|Overall Study|Other|1|||
30650706|NCT00739882|58663341|FG000|Double-blind Period|Adverse Event|1|||
30650707|NCT00739882|58663342|FG001|Double-blind Period|Adverse Event|2|||
30650708|NCT00739882|58663341|FG000|Double-blind Period|Protocol Violation|1|||
30650709|NCT00739882|58663342|FG001|Double-blind Period|Protocol Violation|0|||
30650710|NCT00739882|58663341|FG000|Double-blind Period|Lack of Efficacy|1|||
30650711|NCT00739882|58663342|FG001|Double-blind Period|Lack of Efficacy|1|||
30650712|NCT00739882|58663341|FG000|Double-blind Period|Other|16|||
30650713|NCT00739882|58663342|FG001|Double-blind Period|Other|8|||
30650714|NCT00739882|58663341|FG000|Open-label Period|Adverse Event|1|||
30650715|NCT00739882|58663342|FG001|Open-label Period|Adverse Event|0|||
30650716|NCT00739882|58663341|FG000|Open-label Period|Other|9|||
30650717|NCT00739882|58663342|FG001|Open-label Period|Other|5|||
30650718|NCT00961220|58663350|FG000|Overall Study|Adverse Event|3|||
30650719|NCT00961220|58663350|FG000|Overall Study|Lack of Efficacy|1|||
30650720|NCT00961220|58663350|FG000|Overall Study|No IV access for O6BG|1|||
30848654|NCT03703466|58874936|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
30848655|NCT03248128|58874995|FG000|Overall Study|Lost to Follow-up|1|||
30848656|NCT03248128|58874996|FG001|Overall Study|Lost to Follow-up|0|||
30650721|NCT00961220|58663350|FG000|Overall Study|O6BG no longer supplied|1|||
30650722|NCT00961220|58663350|FG000|Overall Study|Complete Response prior to 12 courses|1|||
30650723|NCT00734656|58663356|FG000|Lab Session 1|Withdrawal by Subject|2|||
30848657|NCT03248128|58874995|FG000|Overall Study|Withdrawal by Subject|16|||
30650724|NCT00734656|58663357|FG001|Lab Session 1|Withdrawal by Subject|0|||
30650725|NCT00734656|58663358|FG002|Lab Session 1|Withdrawal by Subject|0|||
30650726|NCT00734656|58663359|FG003|Lab Session 1|Withdrawal by Subject|0|||
30650727|NCT00734656|58663356|FG000|Washout 1|Withdrawal by Subject|1|||
30650728|NCT00734656|58663357|FG001|Washout 1|Withdrawal by Subject|5|||
30650729|NCT00734656|58663358|FG002|Washout 1|Withdrawal by Subject|2|||
30650730|NCT00734656|58663359|FG003|Washout 1|Withdrawal by Subject|3|||
30650731|NCT00734656|58663356|FG000|Lab Session 2|Withdrawal by Subject|1|||
30650732|NCT00734656|58663357|FG001|Lab Session 2|Withdrawal by Subject|0|||
30650733|NCT00734656|58663358|FG002|Lab Session 2|Withdrawal by Subject|0|||
30650734|NCT00734656|58663359|FG003|Lab Session 2|Withdrawal by Subject|1|||
30650735|NCT00734656|58663356|FG000|Washout 2|Withdrawal by Subject|1|||
30650736|NCT00734656|58663357|FG001|Washout 2|Withdrawal by Subject|1|||
30650737|NCT00734656|58663358|FG002|Washout 2|Withdrawal by Subject|1|||
30650738|NCT00734656|58663359|FG003|Washout 2|Withdrawal by Subject|0|||
30650739|NCT00734656|58663356|FG000|Washout 3|Withdrawal by Subject|1|||
30650740|NCT00734656|58663357|FG001|Washout 3|Withdrawal by Subject|0|||
30650741|NCT00734656|58663358|FG002|Washout 3|Withdrawal by Subject|0|||
30650742|NCT00734656|58663359|FG003|Washout 3|Withdrawal by Subject|1|||
30650743|NCT00734656|58663356|FG000|Lab Session 4|Withdrawal by Subject|0|||
30650744|NCT00734656|58663357|FG001|Lab Session 4|Withdrawal by Subject|0|||
30650745|NCT00734656|58663358|FG002|Lab Session 4|Withdrawal by Subject|0|||
30650746|NCT00734656|58663359|FG003|Lab Session 4|Withdrawal by Subject|1|||
30767450|NCT00308555|58776291|FG001|Overall Study|Physician Decision|0|||
30767451|NCT00050778|58776300|FG000|Overall Study|Adverse Event|13|||
30767452|NCT00050778|58776301|FG001|Overall Study|Adverse Event|3|||
30767453|NCT00050778|58776302|FG002|Overall Study|Adverse Event|2|||
30767454|NCT00050778|58776300|FG000|Overall Study|Death|0|||
30767455|NCT00050778|58776301|FG001|Overall Study|Death|1|||
30767456|NCT00050778|58776302|FG002|Overall Study|Death|1|||
30767457|NCT00050778|58776300|FG000|Overall Study|Lack of Efficacy|16|||
30767458|NCT00050778|58776301|FG001|Overall Study|Lack of Efficacy|2|||
30767459|NCT00050778|58776302|FG002|Overall Study|Lack of Efficacy|2|||
30767460|NCT00050778|58776300|FG000|Overall Study|Lost to Follow-up|0|||
30767461|NCT00050778|58776301|FG001|Overall Study|Lost to Follow-up|2|||
30767462|NCT00050778|58776302|FG002|Overall Study|Lost to Follow-up|4|||
30767463|NCT00050778|58776300|FG000|Overall Study|Physician Decision|3|||
30767464|NCT00050778|58776301|FG001|Overall Study|Physician Decision|0|||
30767465|NCT00050778|58776302|FG002|Overall Study|Physician Decision|2|||
30767466|NCT00050778|58776300|FG000|Overall Study|Protocol Violation|2|||
30767467|NCT00050778|58776301|FG001|Overall Study|Protocol Violation|0|||
30767468|NCT00050778|58776302|FG002|Overall Study|Protocol Violation|1|||
30767469|NCT00050778|58776300|FG000|Overall Study|Withdrawal by Subject|6|||
30767470|NCT00050778|58776301|FG001|Overall Study|Withdrawal by Subject|8|||
30767471|NCT00050778|58776302|FG002|Overall Study|Withdrawal by Subject|4|||
30767472|NCT00050778|58776300|FG000|Overall Study|Randomized but not treated|4|||
30767473|NCT00050778|58776301|FG001|Overall Study|Randomized but not treated|5|||
30767474|NCT00050778|58776302|FG002|Overall Study|Randomized but not treated|2|||
30767475|NCT00050778|58776300|FG000|Overall Study|Familial and personal reasons|1|||
30767476|NCT00050778|58776301|FG001|Overall Study|Familial and personal reasons|0|||
30767477|NCT00050778|58776302|FG002|Overall Study|Familial and personal reasons|0|||
30767478|NCT00050622|58776312|FG000|Overall Study|Adverse Event|1|||
30767479|NCT00308087|58776338|FG000|Overall Study|Progressive Disease|19|||
30767480|NCT00308087|58776339|FG001|Overall Study|Progressive Disease|21|||
30767481|NCT00308087|58776338|FG000|Overall Study|Study Closure|11|||
30767482|NCT00308087|58776339|FG001|Overall Study|Study Closure|12|||
30767483|NCT00308087|58776338|FG000|Overall Study|Withdrawal by Subject|2|||
30767484|NCT00308087|58776339|FG001|Overall Study|Withdrawal by Subject|1|||
30767485|NCT00308087|58776338|FG000|Overall Study|Other|4|||
30767486|NCT00308087|58776339|FG001|Overall Study|Other|3|||
30767487|NCT00307931|58776345|FG000|Overall Study|Adverse Event|1|||
30650747|NCT00961064|58663369|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
30650748|NCT00961064|58663369|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
30650749|NCT00961064|58663369|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
30767488|NCT02796170|58776351|FG000|Overall Study|Lost to Follow-up|3|||
30767489|NCT02796170|58776352|FG001|Overall Study|Lost to Follow-up|0|||
30767490|NCT00049842|58776360|FG000|Treatment Phase|Adverse Event|47|||
30767491|NCT00049842|58776361|FG001|Treatment Phase|Adverse Event|12|||
30767492|NCT00049842|58776360|FG000|Treatment Phase|Withdrawal by Subject|35|||
30767493|NCT00049842|58776361|FG001|Treatment Phase|Withdrawal by Subject|46|||
30767494|NCT00049842|58776360|FG000|Treatment Phase|Non-compliance with protocol|7|||
30767495|NCT00049842|58776361|FG001|Treatment Phase|Non-compliance with protocol|8|||
30767496|NCT00049842|58776360|FG000|Treatment Phase|Lost to Follow-up|4|||
30952170|NCT01697462|58999527|FG000|Overall Study|Adverse Event|6|||
30767497|NCT00049842|58776361|FG001|Treatment Phase|Lost to Follow-up|8|||
30767498|NCT00049842|58776360|FG000|Treatment Phase|Administrative|0|||
30767499|NCT00049842|58776361|FG001|Treatment Phase|Administrative|3|||
30767500|NCT00049842|58776360|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
30650750|NCT00961064|58663369|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
30650751|NCT00961064|58663369|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
30650752|NCT00961064|58663369|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
30650753|NCT00961064|58663369|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
30650754|NCT00961064|58663369|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
30650755|NCT00739648|58663376|FG000|Overall Study|Adverse Event|3|||
30650756|NCT00739648|58663377|FG001|Overall Study|Adverse Event|15|||
30650757|NCT00739648|58663376|FG000|Overall Study|Withdrawal by Subject|13|||
30650758|NCT00739648|58663377|FG001|Overall Study|Withdrawal by Subject|25|||
30650759|NCT00739648|58663376|FG000|Overall Study|Lost to Follow-up|4|||
30650760|NCT00739648|58663377|FG001|Overall Study|Lost to Follow-up|7|||
30650761|NCT00739648|58663376|FG000|Overall Study|Death|2|||
30650762|NCT00739648|58663377|FG001|Overall Study|Death|0|||
30650763|NCT00739648|58663376|FG000|Overall Study|Do not know|4|||
30650764|NCT00739648|58663377|FG001|Overall Study|Do not know|6|||
30650765|NCT01032239|58663389|FG000|Overall Study|Lost to Follow-up|3|||
30650766|NCT01032239|58663390|FG001|Overall Study|Lost to Follow-up|2|||
30650767|NCT01032239|58663389|FG000|Overall Study|Withdrawal by Subject|2|||
30650768|NCT01032239|58663390|FG001|Overall Study|Withdrawal by Subject|3|||
30650769|NCT01032239|58663389|FG000|Overall Study|Death|1|||
30650770|NCT01032239|58663390|FG001|Overall Study|Death|0|||
30650771|NCT01032239|58663389|FG000|Overall Study|Protocol Violation|1|||
30650772|NCT01032239|58663390|FG001|Overall Study|Protocol Violation|0|||
30650773|NCT00734578|58663399|FG000|Overall Study|Adverse Event|4|||
30650774|NCT00734578|58663400|FG001|Overall Study|Adverse Event|6|||
30650775|NCT00734578|58663401|FG002|Overall Study|Adverse Event|1|||
30650776|NCT00734578|58663399|FG000|Overall Study|Protocol Violation|8|||
30650777|NCT00734578|58663400|FG001|Overall Study|Protocol Violation|6|||
30650778|NCT00734578|58663401|FG002|Overall Study|Protocol Violation|3|||
30650779|NCT00734578|58663399|FG000|Overall Study|Withdrawal by Subject|7|||
30650780|NCT00734578|58663400|FG001|Overall Study|Withdrawal by Subject|8|||
30650781|NCT00734578|58663401|FG002|Overall Study|Withdrawal by Subject|11|||
30650782|NCT00734578|58663399|FG000|Overall Study|Lost to Follow-up|9|||
30650783|NCT00734578|58663400|FG001|Overall Study|Lost to Follow-up|3|||
30650784|NCT00734578|58663401|FG002|Overall Study|Lost to Follow-up|5|||
30650785|NCT00734578|58663399|FG000|Overall Study|Lack of Efficacy|3|||
30650786|NCT00734578|58663400|FG001|Overall Study|Lack of Efficacy|2|||
30650787|NCT00734578|58663401|FG002|Overall Study|Lack of Efficacy|5|||
30650788|NCT00734578|58663399|FG000|Overall Study|Randomized in error|1|||
30650789|NCT00734578|58663400|FG001|Overall Study|Randomized in error|0|||
30650790|NCT00734578|58663401|FG002|Overall Study|Randomized in error|0|||
30650791|NCT00734578|58663399|FG000|Overall Study|Exclusion criteria|1|||
30650792|NCT00734578|58663400|FG001|Overall Study|Exclusion criteria|0|||
30767501|NCT00049842|58776361|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
30767502|NCT00049842|58776360|FG000|Follow-up Phase|Adverse Event|6|||
30767503|NCT00049842|58776361|FG001|Follow-up Phase|Adverse Event|1|||
30767504|NCT00049842|58776360|FG000|Follow-up Phase|Other|1|||
30767505|NCT00049842|58776361|FG001|Follow-up Phase|Other|4|||
30767506|NCT00307151|58776371|FG000|Overall Study|Death|4|||
30767507|NCT00307151|58776372|FG001|Overall Study|Death|3|||
30767508|NCT00307151|58776373|FG002|Overall Study|Death|10|||
30767509|NCT00307151|58776374|FG003|Overall Study|Death|3|||
30767510|NCT00307151|58776371|FG000|Overall Study|Severe debilitation, unable to continue|1|||
30650793|NCT00734578|58663401|FG002|Overall Study|Exclusion criteria|0|||
30650794|NCT00739102|58663409|FG000|Overall Study|Death|5|||
30650795|NCT00739102|58663409|FG000|Overall Study|Withdrawal by Subject|10|||
30767511|NCT00307151|58776372|FG001|Overall Study|Severe debilitation, unable to continue|0|||
30767512|NCT00307151|58776373|FG002|Overall Study|Severe debilitation, unable to continue|0|||
30767513|NCT00307151|58776374|FG003|Overall Study|Severe debilitation, unable to continue|0|||
30848658|NCT03248128|58874996|FG001|Overall Study|Withdrawal by Subject|14|||
30650796|NCT00959192|58663417|FG000|Overall Study|Adverse Event|1|||
30650797|NCT00959192|58663418|FG001|Overall Study|Adverse Event|1|||
30848659|NCT03248128|58874995|FG000|Overall Study|Site Closed|4|||
30848660|NCT03248128|58874996|FG001|Overall Study|Site Closed|3|||
30952171|NCT01697462|58999527|FG000|Overall Study|Lost to Follow-up|21|||
30650798|NCT00959192|58663419|FG002|Overall Study|Adverse Event|1|||
30650799|NCT00959192|58663420|FG003|Overall Study|Adverse Event|0|||
30767514|NCT00307151|58776371|FG000|Overall Study|Subject unable to get to clinic|1|||
30848661|NCT03248128|58874995|FG000|Overall Study|Randomized, but did not receive treatment|1|||
30650800|NCT00959192|58663417|FG000|Overall Study|Investigator Request|1|||
30650801|NCT00959192|58663418|FG001|Overall Study|Investigator Request|0|||
30650802|NCT00959192|58663419|FG002|Overall Study|Investigator Request|0|||
30650803|NCT00959192|58663420|FG003|Overall Study|Investigator Request|0|||
30650804|NCT00959192|58663417|FG000|Overall Study|Caregiver Request|0|||
30650805|NCT00959192|58663418|FG001|Overall Study|Caregiver Request|0|||
30650806|NCT00959192|58663419|FG002|Overall Study|Caregiver Request|2|||
30767515|NCT00307151|58776372|FG001|Overall Study|Subject unable to get to clinic|0|||
30650807|NCT00959192|58663420|FG003|Overall Study|Caregiver Request|1|||
30650808|NCT00696787|58663434|FG000|Overall Study|Adverse Event|1|||
30650809|NCT00696787|58663435|FG001|Overall Study|Adverse Event|0|||
30650810|NCT00696787|58663436|FG002|Overall Study|Adverse Event|6|||
30650811|NCT00696787|58663434|FG000|Overall Study|Discontinuation by Sponsor|9|||
30650812|NCT00696787|58663435|FG001|Overall Study|Discontinuation by Sponsor|13|||
30650813|NCT00696787|58663436|FG002|Overall Study|Discontinuation by Sponsor|14|||
30650814|NCT00696787|58663434|FG000|Overall Study|Lack of Efficacy|0|||
30650815|NCT00696787|58663435|FG001|Overall Study|Lack of Efficacy|1|||
30650816|NCT00696787|58663436|FG002|Overall Study|Lack of Efficacy|0|||
30650817|NCT00696787|58663434|FG000|Overall Study|Lost to Follow-up|4|||
30650818|NCT00696787|58663435|FG001|Overall Study|Lost to Follow-up|0|||
30650819|NCT00696787|58663436|FG002|Overall Study|Lost to Follow-up|3|||
30650820|NCT00696787|58663434|FG000|Overall Study|Withdrawal by Subject|0|||
30650821|NCT00696787|58663435|FG001|Overall Study|Withdrawal by Subject|3|||
30650822|NCT00696787|58663436|FG002|Overall Study|Withdrawal by Subject|2|||
30650823|NCT00696787|58663434|FG000|Overall Study|Failed to return|1|||
30650824|NCT00696787|58663435|FG001|Overall Study|Failed to return|3|||
30650825|NCT00696787|58663436|FG002|Overall Study|Failed to return|1|||
30650826|NCT01012037|58663447|FG000|Overall Study|Adverse Event|0|||
30650827|NCT01012037|58663448|FG001|Overall Study|Adverse Event|8|||
30650828|NCT01012037|58663449|FG002|Overall Study|Adverse Event|3|||
30650829|NCT01012037|58663447|FG000|Overall Study|Protocol Violation|0|||
30650830|NCT01012037|58663448|FG001|Overall Study|Protocol Violation|3|||
30650831|NCT01012037|58663449|FG002|Overall Study|Protocol Violation|5|||
30650832|NCT01012037|58663447|FG000|Overall Study|Withdrawal by Subject|0|||
30650833|NCT01012037|58663448|FG001|Overall Study|Withdrawal by Subject|4|||
30650834|NCT01012037|58663449|FG002|Overall Study|Withdrawal by Subject|1|||
30650835|NCT01012037|58663447|FG000|Overall Study|Other reason (not specified)|1|||
30650836|NCT01012037|58663448|FG001|Overall Study|Other reason (not specified)|1|||
30650837|NCT01012037|58663449|FG002|Overall Study|Other reason (not specified)|1|||
30650838|NCT00734032|58663461|FG000|Overall Study|Adverse Event|0|||
30650839|NCT00734032|58663462|FG001|Overall Study|Adverse Event|1|||
30650840|NCT00734032|58663463|FG002|Overall Study|Adverse Event|0|||
30650841|NCT00734032|58663464|FG003|Overall Study|Adverse Event|0|||
30650842|NCT01010633|58663476|FG000|Overall Study|Adverse Event|1|||
30650843|NCT01010633|58663477|FG001|Overall Study|Adverse Event|1|||
30650844|NCT01010633|58663476|FG000|Overall Study|Protocol Violation|1|||
30650845|NCT01010633|58663477|FG001|Overall Study|Protocol Violation|2|||
30650846|NCT01010633|58663476|FG000|Overall Study|Withdrawal by Subject|2|||
30650847|NCT01010633|58663477|FG001|Overall Study|Withdrawal by Subject|1|||
30650848|NCT01010633|58663476|FG000|Overall Study|Investigator decision|0|||
30650849|NCT01010633|58663477|FG001|Overall Study|Investigator decision|1|||
30650850|NCT00733954|58663485|FG000|Overall Study|Lost to Follow-up|5|||
30767516|NCT00307151|58776373|FG002|Overall Study|Subject unable to get to clinic|6|||
30767517|NCT00307151|58776374|FG003|Overall Study|Subject unable to get to clinic|2|||
30767518|NCT00307151|58776371|FG000|Overall Study|Withdrew consent|0|||
30767519|NCT00307151|58776372|FG001|Overall Study|Withdrew consent|1|||
30767520|NCT00307151|58776373|FG002|Overall Study|Withdrew consent|1|||
30767521|NCT00307151|58776374|FG003|Overall Study|Withdrew consent|3|||
30767522|NCT00307151|58776371|FG000|Overall Study|Not willing to adhere to study reqs|2|||
30767523|NCT00307151|58776372|FG001|Overall Study|Not willing to adhere to study reqs|0|||
30767524|NCT00307151|58776373|FG002|Overall Study|Not willing to adhere to study reqs|2|||
30767525|NCT00307151|58776374|FG003|Overall Study|Not willing to adhere to study reqs|2|||
30767526|NCT00307151|58776371|FG000|Overall Study|Clinic unable to contact subject|3|||
30767527|NCT00307151|58776372|FG001|Overall Study|Clinic unable to contact subject|3|||
30767528|NCT00307151|58776373|FG002|Overall Study|Clinic unable to contact subject|1|||
30650851|NCT00733954|58663486|FG001|Overall Study|Lost to Follow-up|2|||
30650852|NCT00733954|58663485|FG000|Overall Study|Protocol Violation|1|||
30650853|NCT00733954|58663486|FG001|Overall Study|Protocol Violation|0|||
30767529|NCT00307151|58776374|FG003|Overall Study|Clinic unable to contact subject|1|||
30767530|NCT02654132|58776386|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
30650854|NCT00733954|58663485|FG000|Overall Study|Withdrawal by Subject|2|||
30650855|NCT00733954|58663486|FG001|Overall Study|Withdrawal by Subject|0|||
30650856|NCT00733408|58663492|FG000|Overall Study|Adverse Event|4|||
30650857|NCT01010867|58663496|FG000|Overall Study|< 50% adherence to probiotic|1|||
30650858|NCT00576823|58663503|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
30650859|NCT00576823|58663504|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
30650860|NCT00576823|58663505|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
30650861|NCT00576823|58663503|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
30650862|NCT00576823|58663504|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
30650863|NCT00576823|58663505|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
30650864|NCT00732940|58663518|FG000|Overall Study|Withdrawal by Subject|1|||
30767531|NCT02654132|58776387|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
30767532|NCT02654132|58776386|FG000|Treatment Period|Disease progression|43|||
30848662|NCT03248128|58874996|FG001|Overall Study|Randomized, but did not receive treatment|3|||
30650865|NCT00732940|58663519|FG001|Overall Study|Withdrawal by Subject|2|||
30650866|NCT00732940|58663518|FG000|Overall Study|Adverse Event|0|||
30650867|NCT00732940|58663519|FG001|Overall Study|Adverse Event|1|||
30650868|NCT00732940|58663518|FG000|Overall Study|Lost to Follow-up|1|||
30650869|NCT00732940|58663519|FG001|Overall Study|Lost to Follow-up|0|||
30650870|NCT00962390|58663529|FG000|Overall Study|Adverse Event|0|||
30650871|NCT00962390|58663530|FG001|Overall Study|Adverse Event|0|||
30650872|NCT00962390|58663531|FG002|Overall Study|Adverse Event|3|||
30650873|NCT00962390|58663532|FG003|Overall Study|Adverse Event|1|||
30650874|NCT00962390|58663529|FG000|Overall Study|Lost to Follow-up|2|||
30650875|NCT00962390|58663530|FG001|Overall Study|Lost to Follow-up|2|||
30650876|NCT00962390|58663531|FG002|Overall Study|Lost to Follow-up|0|||
30650877|NCT00962390|58663532|FG003|Overall Study|Lost to Follow-up|0|||
30650878|NCT00962390|58663529|FG000|Overall Study|Protocol Violation|1|||
30650879|NCT00962390|58663530|FG001|Overall Study|Protocol Violation|0|||
30650880|NCT00962390|58663531|FG002|Overall Study|Protocol Violation|0|||
30650881|NCT00962390|58663532|FG003|Overall Study|Protocol Violation|0|||
30650882|NCT00962390|58663529|FG000|Overall Study|Withdrawal by Subject|1|||
30650883|NCT00962390|58663530|FG001|Overall Study|Withdrawal by Subject|1|||
30650884|NCT00962390|58663531|FG002|Overall Study|Withdrawal by Subject|1|||
30650885|NCT00962390|58663532|FG003|Overall Study|Withdrawal by Subject|0|||
30650886|NCT00732472|58663546|FG000|Overall Study|Adverse Event|0|||
30650887|NCT00732472|58663547|FG001|Overall Study|Adverse Event|1|||
30650888|NCT00732472|58663548|FG002|Overall Study|Adverse Event|1|||
30650889|NCT00732472|58663549|FG003|Overall Study|Adverse Event|1|||
30650890|NCT00732472|58663546|FG000|Overall Study|Protocol Violation|0|||
30650891|NCT00732472|58663547|FG001|Overall Study|Protocol Violation|0|||
30650892|NCT00732472|58663548|FG002|Overall Study|Protocol Violation|0|||
30650893|NCT00732472|58663549|FG003|Overall Study|Protocol Violation|1|||
30650894|NCT00732472|58663546|FG000|Overall Study|Withdrawal by Subject|0|||
30650895|NCT00732472|58663547|FG001|Overall Study|Withdrawal by Subject|2|||
30767533|NCT02654132|58776387|FG001|Treatment Period|Disease progression|38|||
30767534|NCT02654132|58776386|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
30848663|NCT02802631|58875039|FG000|Overall Study|Withdrawal by Subject|1|||
30848664|NCT02802631|58875040|FG001|Overall Study|Withdrawal by Subject|0|||
30848665|NCT02802631|58875041|FG002|Overall Study|Withdrawal by Subject|0|||
30848666|NCT02802631|58875042|FG003|Overall Study|Withdrawal by Subject|0|||
30650896|NCT00732472|58663548|FG002|Overall Study|Withdrawal by Subject|0|||
30650897|NCT00732472|58663549|FG003|Overall Study|Withdrawal by Subject|1|||
30650898|NCT00960986|58663564|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
30650899|NCT00960986|58663565|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
30650900|NCT00960986|58663566|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
30650901|NCT00960986|58663567|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
30650902|NCT00960986|58663564|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
30650903|NCT00960986|58663565|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
30650904|NCT00960986|58663566|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
30650905|NCT00960986|58663567|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
30650906|NCT00960986|58663564|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
30650907|NCT00960986|58663565|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
30650908|NCT00960986|58663566|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
30650909|NCT00960986|58663567|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
30650910|NCT00960986|58663564|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
30650911|NCT00960986|58663565|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
30650912|NCT00960986|58663566|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
30650913|NCT00960986|58663567|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
30650914|NCT00960986|58663564|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
30650915|NCT00960986|58663565|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
30650916|NCT00960986|58663566|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
30650917|NCT00960986|58663567|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
30650918|NCT00960986|58663564|FG000|Period 3 (7-week Therapy Period)|Death|0|||
30650919|NCT00960986|58663565|FG001|Period 3 (7-week Therapy Period)|Death|0|||
30650920|NCT00960986|58663566|FG002|Period 3 (7-week Therapy Period)|Death|1|||
30767535|NCT02654132|58776387|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
30767536|NCT02654132|58776386|FG000|Treatment Period|Other reasons|4|||
30767537|NCT02654132|58776387|FG001|Treatment Period|Other reasons|2|||
30767538|NCT02654132|58776386|FG000|Treatment Period|Study drug toxicity|2|||
30767539|NCT02654132|58776387|FG001|Treatment Period|Study drug toxicity|2|||
30767540|NCT02654132|58776386|FG000|Treatment Period|Withdrawal by Subject|2|||
30767541|NCT02654132|58776387|FG001|Treatment Period|Withdrawal by Subject|1|||
30848667|NCT02802631|58875043|FG004|Overall Study|Withdrawal by Subject|0|||
30650921|NCT00960986|58663567|FG003|Period 3 (7-week Therapy Period)|Death|0|||
30650922|NCT00960986|58663564|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
30650923|NCT00960986|58663565|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
30848668|NCT02802631|58875044|FG005|Overall Study|Withdrawal by Subject|0|||
30650924|NCT00960986|58663566|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
30650925|NCT00960986|58663567|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
30650926|NCT00960986|58663564|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
30650927|NCT00960986|58663565|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
30650928|NCT00960986|58663566|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
30767542|NCT02654132|58776386|FG000|Treatment Period|Maximum Clinical Benefit|0|||
30767543|NCT02654132|58776387|FG001|Treatment Period|Maximum Clinical Benefit|2|||
30767544|NCT02654132|58776386|FG000|Treatment Period|Participant request to discontinue|2|||
30767545|NCT02654132|58776387|FG001|Treatment Period|Participant request to discontinue|0|||
30767546|NCT02654132|58776386|FG000|Treatment Period|Administrative reasons by sponsor|0|||
30767547|NCT02654132|58776387|FG001|Treatment Period|Administrative reasons by sponsor|1|||
30767548|NCT02654132|58776386|FG000|Treatment Period|Death|1|||
30767549|NCT02654132|58776387|FG001|Treatment Period|Death|0|||
30767550|NCT03241342|58776396|FG000|Overall Study|Adverse Event|5|||
30767551|NCT03241342|58776397|FG001|Overall Study|Adverse Event|8|||
30767552|NCT03241342|58776398|FG002|Overall Study|Adverse Event|4|||
30767553|NCT03241342|58776396|FG000|Overall Study|Lack of Efficacy|0|||
30767554|NCT03241342|58776397|FG001|Overall Study|Lack of Efficacy|0|||
30767555|NCT03241342|58776398|FG002|Overall Study|Lack of Efficacy|1|||
30767556|NCT03241342|58776396|FG000|Overall Study|noncompliance with study drug|2|||
30767557|NCT03241342|58776397|FG001|Overall Study|noncompliance with study drug|1|||
30767558|NCT03241342|58776398|FG002|Overall Study|noncompliance with study drug|1|||
30767559|NCT03241342|58776396|FG000|Overall Study|sponsor decision|0|||
30767560|NCT03241342|58776397|FG001|Overall Study|sponsor decision|1|||
30767561|NCT03241342|58776398|FG002|Overall Study|sponsor decision|2|||
30767562|NCT03241342|58776396|FG000|Overall Study|not reported|15|||
30767563|NCT03241342|58776397|FG001|Overall Study|not reported|21|||
30767564|NCT03241342|58776398|FG002|Overall Study|not reported|19|||
30767565|NCT00306995|58776413|FG000|Study Part I|Withdrawal by Subject|0|||
30767566|NCT00306995|58776414|FG001|Study Part I|Withdrawal by Subject|0|||
30767567|NCT00306995|58776415|FG002|Study Part I|Withdrawal by Subject|0|||
30767568|NCT00306995|58776416|FG003|Study Part I|Withdrawal by Subject|0|||
30767569|NCT00306995|58776417|FG004|Study Part I|Withdrawal by Subject|0|||
30767570|NCT00306995|58776418|FG005|Study Part I|Withdrawal by Subject|0|||
30767571|NCT00306995|58776419|FG006|Study Part I|Withdrawal by Subject|1|||
30767572|NCT00306995|58776413|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
30767573|NCT00306995|58776414|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
30767574|NCT00306995|58776415|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
30767575|NCT00306995|58776416|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
30767576|NCT00306995|58776417|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
30767577|NCT00306995|58776418|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
30767578|NCT00306995|58776419|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
30767579|NCT00121108|58776466|FG000|Overall Study|Lost to Follow-up|10|||
30767580|NCT00121108|58776467|FG001|Overall Study|Lost to Follow-up|22|||
30767581|NCT00121108|58776466|FG000|Overall Study|Withdrawal by Subject|106|||
30767582|NCT00121108|58776467|FG001|Overall Study|Withdrawal by Subject|195|||
30767583|NCT00121108|58776466|FG000|Overall Study|Death|5|||
30767584|NCT00121108|58776467|FG001|Overall Study|Death|8|||
30767585|NCT02387996|58776474|FG000|Overall Study|Disease Progression|167|||
30767586|NCT02387996|58776474|FG000|Overall Study|Study Drug Toxicity|31|||
30767587|NCT02387996|58776474|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
30767588|NCT02387996|58776474|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
30767589|NCT02387996|58776474|FG000|Overall Study|Subject Withdrew Consent|5|||
30767590|NCT02387996|58776474|FG000|Overall Study|Lost to Follow-up|1|||
30767591|NCT02387996|58776474|FG000|Overall Study|Poor/Non-Compliance|1|||
30767592|NCT02387996|58776474|FG000|Overall Study|Other Reasons|5|||
30767593|NCT02387996|58776474|FG000|Overall Study|Death|1|||
30767594|NCT03212326|58776478|FG000|Overall Study|Physician Decision|4|||
30767595|NCT03229486|58776517|FG000|Overall Study|Protocol Violation|0|||
30767596|NCT03229486|58776518|FG001|Overall Study|Protocol Violation|1|||
30767597|NCT01779050|58776526|FG000|Overall Study|Withdrawal by Subject|1|||
30767598|NCT01779050|58776527|FG001|Overall Study|Withdrawal by Subject|0|||
30767599|NCT00306527|58776537|FG000|Overall Study|Lost to Follow-up|3|||
30767600|NCT00306527|58776538|FG001|Overall Study|Lost to Follow-up|4|||
30767601|NCT00306527|58776539|FG002|Overall Study|Lost to Follow-up|3|||
30767602|NCT00306527|58776540|FG003|Overall Study|Lost to Follow-up|0|||
30767603|NCT00306527|58776537|FG000|Overall Study|Withdrawal by Subject|2|||
30767604|NCT00306527|58776538|FG001|Overall Study|Withdrawal by Subject|3|||
30767605|NCT00306527|58776539|FG002|Overall Study|Withdrawal by Subject|0|||
30767606|NCT00306527|58776540|FG003|Overall Study|Withdrawal by Subject|3|||
30952172|NCT01697462|58999527|FG000|Overall Study|Withdrawal by Subject|12|||
30650929|NCT00960986|58663567|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
30650930|NCT00960986|58663564|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
30650931|NCT00960986|58663565|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
30650932|NCT00960986|58663566|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
30650933|NCT00960986|58663567|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
30650934|NCT00960986|58663564|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
30650935|NCT00960986|58663565|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
30650936|NCT00960986|58663566|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
30650937|NCT00960986|58663567|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
30650938|NCT00732238|58663579|FG000|Overall Study|Bacteremia|4|||
30650939|NCT00732238|58663580|FG001|Overall Study|Bacteremia|1|||
30650940|NCT00732238|58663579|FG000|Overall Study|Asymptomatic bacteriuria|1|||
30650941|NCT00732238|58663580|FG001|Overall Study|Asymptomatic bacteriuria|0|||
30650942|NCT00958880|58663590|FG000|Overall Study|Lost to Follow-up|2|||
30650943|NCT00958880|58663591|FG001|Overall Study|Lost to Follow-up|2|||
30650944|NCT00732160|58663601|FG000|Overall Study|Adverse Event|1|||
30650945|NCT00732160|58663602|FG001|Overall Study|Adverse Event|0|||
30650946|NCT00732160|58663603|FG002|Overall Study|Adverse Event|1|||
30650947|NCT00732160|58663604|FG003|Overall Study|Adverse Event|1|||
30650948|NCT00732160|58663601|FG000|Overall Study|scheduling|4|||
30650949|NCT00732160|58663602|FG001|Overall Study|scheduling|4|||
30650950|NCT00732160|58663603|FG002|Overall Study|scheduling|2|||
30650951|NCT00732160|58663604|FG003|Overall Study|scheduling|1|||
30650952|NCT00958724|58663614|FG000|Overall Study|Disease Progression|6|||
30650953|NCT00738400|58663620|FG000|Overall Study|Adverse Event|3|||
30650954|NCT00738400|58663621|FG001|Overall Study|Adverse Event|1|||
30650955|NCT00738400|58663620|FG000|Overall Study|Withdrawal by Subject|0|||
30650956|NCT00738400|58663621|FG001|Overall Study|Withdrawal by Subject|1|||
30650957|NCT00738400|58663620|FG000|Overall Study|Lack of Efficacy|0|||
30650958|NCT00738400|58663621|FG001|Overall Study|Lack of Efficacy|1|||
30650959|NCT00738400|58663620|FG000|Overall Study|Lost to Follow-up|0|||
30650960|NCT00738400|58663621|FG001|Overall Study|Lost to Follow-up|3|||
30650961|NCT00738400|58663620|FG000|Overall Study|Protocol Violation|1|||
30650962|NCT00738400|58663621|FG001|Overall Study|Protocol Violation|0|||
30650963|NCT00738400|58663620|FG000|Overall Study|Non-compliant with study medication|0|||
30650964|NCT00738400|58663621|FG001|Overall Study|Non-compliant with study medication|1|||
30650965|NCT01009463|58663631|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
30650966|NCT01009463|58663632|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
30650967|NCT01009463|58663633|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
30650968|NCT01009463|58663634|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
30650969|NCT01009463|58663635|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
30650970|NCT01009463|58663631|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
30650971|NCT01009463|58663632|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
30650972|NCT01009463|58663633|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
30650973|NCT01009463|58663634|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
30650974|NCT01009463|58663635|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
30650975|NCT01009463|58663631|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
30650976|NCT01009463|58663632|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
30650977|NCT01009463|58663633|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
30650978|NCT01009463|58663634|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
30650979|NCT01009463|58663635|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
30650980|NCT01009463|58663631|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
30650981|NCT01009463|58663632|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
30650982|NCT01009463|58663633|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
30650983|NCT01009463|58663634|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
30650984|NCT01009463|58663635|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
30650985|NCT01009463|58663631|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
30650986|NCT01009463|58663632|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
30650987|NCT01009463|58663633|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
30650988|NCT01009463|58663634|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
30650989|NCT01009463|58663635|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
30650990|NCT01009463|58663631|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
30650991|NCT01009463|58663632|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
30650992|NCT01009463|58663633|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
30650993|NCT01009463|58663634|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
30650994|NCT01009463|58663635|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
30650995|NCT01009463|58663631|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
30650996|NCT01009463|58663632|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
30650997|NCT01009463|58663633|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
30650998|NCT01009463|58663634|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
30650999|NCT01009463|58663635|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
30651000|NCT01009463|58663631|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
30651001|NCT01009463|58663632|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
30651002|NCT01009463|58663633|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
30651003|NCT01009463|58663634|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
30651004|NCT01009463|58663635|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
30651005|NCT01009463|58663631|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
30651006|NCT01009463|58663632|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
30651007|NCT01009463|58663633|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
30651008|NCT01009463|58663634|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
30651009|NCT01009463|58663635|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
30651010|NCT01009463|58663631|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
30651011|NCT01009463|58663632|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
30651012|NCT01009463|58663633|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
30651013|NCT01009463|58663634|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
30651014|NCT01009463|58663635|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
30651015|NCT01009463|58663631|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
30651016|NCT01009463|58663632|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
30651017|NCT01009463|58663633|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
30767607|NCT00306527|58776537|FG000|Overall Study|Adverse Event|0|||
30767608|NCT00306527|58776538|FG001|Overall Study|Adverse Event|0|||
30767609|NCT00306527|58776539|FG002|Overall Study|Adverse Event|1|||
30767610|NCT00306527|58776540|FG003|Overall Study|Adverse Event|1|||
30767611|NCT00306527|58776537|FG000|Overall Study|Death|1|||
30767612|NCT00306527|58776538|FG001|Overall Study|Death|0|||
30767613|NCT00306527|58776539|FG002|Overall Study|Death|1|||
30767614|NCT00306527|58776540|FG003|Overall Study|Death|2|||
30767615|NCT00306293|58776554|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
30767616|NCT00306293|58776555|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
30767617|NCT00306293|58776554|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
30767618|NCT00306293|58776555|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
30767619|NCT00306293|58776554|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
30767620|NCT00306293|58776555|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
30767621|NCT00306293|58776554|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
30767622|NCT00306293|58776555|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
30767623|NCT00306293|58776554|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
30767624|NCT00306293|58776555|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
30767625|NCT00306293|58776554|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
30767626|NCT00306293|58776555|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
30767627|NCT00306293|58776554|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
30767628|NCT00306293|58776555|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
30651018|NCT01009463|58663634|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
30651019|NCT01009463|58663635|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
30651020|NCT01009463|58663631|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30651021|NCT01009463|58663632|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
30651022|NCT01009463|58663633|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
30767629|NCT00306293|58776554|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
30767630|NCT00306293|58776555|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
30767631|NCT00294671|58776565|FG000|Overall Study|Lack of Efficacy|11|||
30767632|NCT00294671|58776566|FG001|Overall Study|Lack of Efficacy|23|||
30767633|NCT00294671|58776565|FG000|Overall Study|Liver transplant|7|||
30767634|NCT00294671|58776566|FG001|Overall Study|Liver transplant|9|||
30651023|NCT01009463|58663634|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
30651024|NCT01009463|58663635|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
30651025|NCT01009463|58663631|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
30651026|NCT01009463|58663632|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
30651027|NCT01009463|58663633|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
30651028|NCT01009463|58663634|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
30651029|NCT01009463|58663635|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
30651030|NCT00958568|58663646|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
30651031|NCT00958568|58663647|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
30651032|NCT00958568|58663648|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
30651033|NCT00958568|58663649|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
30651034|NCT00958568|58663646|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
30651035|NCT00958568|58663647|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
30651036|NCT00958568|58663648|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
30651037|NCT00958568|58663649|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
30651038|NCT00958568|58663646|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
30651039|NCT00958568|58663647|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
30651040|NCT00958568|58663648|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
30651041|NCT00958568|58663649|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
30651042|NCT00958568|58663646|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
30651043|NCT00958568|58663647|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
30651044|NCT00958568|58663648|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
30651045|NCT00958568|58663649|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
30767635|NCT00294671|58776565|FG000|Overall Study|Drug related adverse event (AE)|4|||
30767636|NCT00294671|58776566|FG001|Overall Study|Drug related adverse event (AE)|2|||
30767637|NCT00294671|58776565|FG000|Overall Study|Non-drug related AE|3|||
30767638|NCT00294671|58776566|FG001|Overall Study|Non-drug related AE|2|||
30767639|NCT00294671|58776565|FG000|Overall Study|Lost to Follow-up|1|||
30767640|NCT00294671|58776566|FG001|Overall Study|Lost to Follow-up|3|||
30767641|NCT00294671|58776565|FG000|Overall Study|Non-compliance|1|||
30767642|NCT00294671|58776566|FG001|Overall Study|Non-compliance|0|||
30767643|NCT00294671|58776565|FG000|Overall Study|Death|0|||
30767644|NCT00294671|58776566|FG001|Overall Study|Death|1|||
30767645|NCT01495598|58776572|FG000|Overall Study|Death during follow up period|2|||
30767646|NCT01495598|58776572|FG000|Overall Study|Death on study|1|||
30767647|NCT01495598|58776572|FG000|Overall Study|Lost to Follow-up|3|||
30767648|NCT01495598|58776572|FG000|Overall Study|Physician Decision|8|||
30848669|NCT02802631|58875045|FG006|Overall Study|Withdrawal by Subject|0|||
30952173|NCT01697462|58999527|FG000|Overall Study|Investigator Decision|21|||
30651046|NCT00958568|58663646|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
30651047|NCT00958568|58663647|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
30651048|NCT00958568|58663648|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
30651049|NCT00958568|58663649|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
30651050|NCT00958568|58663646|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
30651051|NCT00958568|58663647|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
30651052|NCT00958568|58663648|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
30651053|NCT00958568|58663649|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
30651054|NCT00958568|58663646|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
30651055|NCT00958568|58663647|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
30651056|NCT00958568|58663648|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
30651057|NCT00958568|58663649|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
30651058|NCT00958568|58663646|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
30651059|NCT00958568|58663647|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
30651060|NCT00958568|58663648|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
30651061|NCT00958568|58663649|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
30651062|NCT00958568|58663646|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
30651063|NCT00958568|58663647|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
30651064|NCT00958568|58663648|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
30651065|NCT00958568|58663649|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
30651066|NCT00958568|58663646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
30651067|NCT00958568|58663647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
30651068|NCT00958568|58663648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
30651069|NCT00958568|58663649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
30767649|NCT02937454|58776603|FG000|Overall Study|Adverse Event|0|||
30767650|NCT02937454|58776604|FG001|Overall Study|Adverse Event|1|||
30767651|NCT02937454|58776603|FG000|Overall Study|Death|98|||
30848670|NCT02802631|58875046|FG007|Overall Study|Withdrawal by Subject|0|||
30848671|NCT02802631|58875039|FG000|Overall Study|Physician Decision|1|||
30848672|NCT02802631|58875040|FG001|Overall Study|Physician Decision|0|||
30651070|NCT00958568|58663646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
30651071|NCT00958568|58663647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
30651072|NCT00958568|58663648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
30651073|NCT00958568|58663649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
30651074|NCT00958568|58663646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
30651075|NCT00958568|58663647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
30651076|NCT00958568|58663648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
30651077|NCT00958568|58663649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
30651078|NCT00958568|58663646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
30651079|NCT00958568|58663647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
30651080|NCT00958568|58663648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
30651081|NCT00958568|58663649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
30651082|NCT00958568|58663646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
30651083|NCT00958568|58663647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
30651084|NCT00958568|58663648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
30651085|NCT00958568|58663649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
30651086|NCT00958568|58663646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
30651087|NCT00958568|58663647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
30651088|NCT00958568|58663648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
30651089|NCT00958568|58663649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
30651090|NCT00958568|58663646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
30651091|NCT00958568|58663647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
30651092|NCT00958568|58663648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
30767652|NCT02937454|58776604|FG001|Overall Study|Death|95|||
30767653|NCT02937454|58776603|FG000|Overall Study|Lost to Follow-up|1|||
30767654|NCT02937454|58776604|FG001|Overall Study|Lost to Follow-up|1|||
30767655|NCT02937454|58776603|FG000|Overall Study|Physician Decision|0|||
30767656|NCT02937454|58776604|FG001|Overall Study|Physician Decision|1|||
30767657|NCT02937454|58776603|FG000|Overall Study|Protocol Violation|6|||
30767658|NCT02937454|58776604|FG001|Overall Study|Protocol Violation|10|||
30767659|NCT02937454|58776603|FG000|Overall Study|Withdrawal by Subject|27|||
30767660|NCT02937454|58776604|FG001|Overall Study|Withdrawal by Subject|15|||
30767661|NCT02937454|58776603|FG000|Overall Study|Other|8|||
30767662|NCT02937454|58776604|FG001|Overall Study|Other|5|||
30767663|NCT03211858|58776623|FG000|Overall Study|Adverse Event|8|||
30848673|NCT02802631|58875041|FG002|Overall Study|Physician Decision|0|||
30848674|NCT02802631|58875042|FG003|Overall Study|Physician Decision|0|||
30848675|NCT02802631|58875043|FG004|Overall Study|Physician Decision|0|||
30848676|NCT02802631|58875044|FG005|Overall Study|Physician Decision|0|||
30848677|NCT02802631|58875045|FG006|Overall Study|Physician Decision|1|||
30848678|NCT02802631|58875046|FG007|Overall Study|Physician Decision|0|||
30848679|NCT02802631|58875039|FG000|Overall Study|Adverse Event|0|||
30848680|NCT02802631|58875040|FG001|Overall Study|Adverse Event|2|||
30848681|NCT02802631|58875041|FG002|Overall Study|Adverse Event|0|||
30848682|NCT02802631|58875042|FG003|Overall Study|Adverse Event|1|||
30848683|NCT02802631|58875043|FG004|Overall Study|Adverse Event|6|||
30651093|NCT00958568|58663649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
30651094|NCT00958568|58663646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
30651095|NCT00958568|58663647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
30651096|NCT00958568|58663648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
30651097|NCT00958568|58663649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
30651098|NCT00958568|58663646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
30651099|NCT00958568|58663647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
30651100|NCT00958568|58663648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
30651101|NCT00958568|58663649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
30651102|NCT00958568|58663646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
30651103|NCT00958568|58663647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
30651104|NCT00958568|58663648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
30651105|NCT00958568|58663649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
30651106|NCT00958568|58663646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
30651107|NCT00958568|58663647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
30767664|NCT03211858|58776624|FG001|Overall Study|Adverse Event|6|||
30848684|NCT02802631|58875044|FG005|Overall Study|Adverse Event|1|||
30848685|NCT02802631|58875045|FG006|Overall Study|Adverse Event|4|||
30848686|NCT02802631|58875046|FG007|Overall Study|Adverse Event|0|||
30848687|NCT02802631|58875039|FG000|Overall Study|Sponsor Decision|0|||
30848688|NCT02802631|58875040|FG001|Overall Study|Sponsor Decision|0|||
30952174|NCT01697462|58999527|FG000|Overall Study|Death|1|||
30952175|NCT01697462|58999527|FG000|Overall Study|Other|10|||
30651108|NCT00958568|58663648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
30651109|NCT00958568|58663649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
30651110|NCT00958568|58663646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
30651111|NCT00958568|58663647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
30651112|NCT00958568|58663648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
30651113|NCT00958568|58663649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
30651114|NCT00958568|58663646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
30651115|NCT00958568|58663647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
30651116|NCT00958568|58663648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
30651117|NCT00958568|58663649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
30651118|NCT00958568|58663646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
30651119|NCT00958568|58663647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
30651120|NCT00958568|58663648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
30651121|NCT00958568|58663649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
30651122|NCT00958568|58663646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
30651123|NCT00958568|58663647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
30651124|NCT00958568|58663648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
30651125|NCT00958568|58663649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
30651126|NCT00958568|58663646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
30651127|NCT00958568|58663647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
30651128|NCT00958568|58663648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
30651129|NCT00958568|58663649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
30651130|NCT00958568|58663646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
30651131|NCT00958568|58663647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
30651132|NCT00958568|58663648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
30651133|NCT00958568|58663649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
30651134|NCT00958568|58663646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
30651135|NCT00958568|58663647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
30651136|NCT00958568|58663648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
30651137|NCT00958568|58663649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
30651138|NCT00958568|58663646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
30651139|NCT00958568|58663647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
30651140|NCT00958568|58663648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
30651141|NCT00958568|58663649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
30651142|NCT00958568|58663646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
30651143|NCT00958568|58663647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
30651144|NCT00958568|58663648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
30767665|NCT03211858|58776623|FG000|Overall Study|Lack of Efficacy|0|||
30767666|NCT03211858|58776624|FG001|Overall Study|Lack of Efficacy|4|||
30767667|NCT03211858|58776623|FG000|Overall Study|Poor compliance to protocol|6|||
30767668|NCT03211858|58776624|FG001|Overall Study|Poor compliance to protocol|2|||
30767669|NCT03211858|58776623|FG000|Overall Study|Non-serious Hypoglycemia|1|||
30767670|NCT03211858|58776624|FG001|Overall Study|Non-serious Hypoglycemia|0|||
30767671|NCT03211858|58776623|FG000|Overall Study|Other than specified above|22|||
30767672|NCT03211858|58776624|FG001|Overall Study|Other than specified above|21|||
30767673|NCT03211156|58776636|FG000|Overall Study|Withdrawal by Subject|0|||
30767674|NCT03211156|58776637|FG001|Overall Study|Withdrawal by Subject|2|||
30767675|NCT03211156|58776636|FG000|Overall Study|Lost to Follow-up|1|||
30767676|NCT03211156|58776637|FG001|Overall Study|Lost to Follow-up|1|||
30767677|NCT03211156|58776636|FG000|Overall Study|Adverse Event|1|||
30767678|NCT03211156|58776637|FG001|Overall Study|Adverse Event|0|||
30767679|NCT04472494|58776645|FG000|Pre-treatment|Other reasons|2|||
30651145|NCT00958568|58663649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
30651146|NCT00958412|58663660|FG000|Overall Study|Study prematurely terminated|18|||
30651147|NCT00958256|58663664|FG000|Overall Study|Adverse Event|3|||
30651148|NCT00696709|58663673|FG000|Overall Study|Withdrawal by Subject|1|||
30651149|NCT00696709|58663674|FG001|Overall Study|Withdrawal by Subject|2|||
30651150|NCT00696709|58663675|FG002|Overall Study|Withdrawal by Subject|1|||
30651151|NCT00696709|58663676|FG003|Overall Study|Withdrawal by Subject|4|||
30651152|NCT00696709|58663677|FG004|Overall Study|Withdrawal by Subject|3|||
30651153|NCT00696709|58663673|FG000|Overall Study|Protocol Violation|1|||
30651154|NCT00696709|58663674|FG001|Overall Study|Protocol Violation|0|||
30651155|NCT00696709|58663675|FG002|Overall Study|Protocol Violation|0|||
30651156|NCT00696709|58663676|FG003|Overall Study|Protocol Violation|0|||
30651157|NCT00696709|58663677|FG004|Overall Study|Protocol Violation|0|||
30651158|NCT00696709|58663673|FG000|Overall Study|Lost to Follow-up|1|||
30651159|NCT00696709|58663674|FG001|Overall Study|Lost to Follow-up|1|||
30651160|NCT00696709|58663675|FG002|Overall Study|Lost to Follow-up|0|||
30651161|NCT00696709|58663676|FG003|Overall Study|Lost to Follow-up|0|||
30651162|NCT00696709|58663677|FG004|Overall Study|Lost to Follow-up|0|||
30651163|NCT00696709|58663673|FG000|Overall Study|Adverse Event|0|||
30651164|NCT00696709|58663674|FG001|Overall Study|Adverse Event|0|||
30651165|NCT00696709|58663675|FG002|Overall Study|Adverse Event|0|||
30651166|NCT00696709|58663676|FG003|Overall Study|Adverse Event|1|||
30651167|NCT00696709|58663677|FG004|Overall Study|Adverse Event|0|||
30651168|NCT01006265|58663697|FG000|Overall Study|Lost to Follow-up|1|||
30651169|NCT01006265|58663698|FG001|Overall Study|Lost to Follow-up|0|||
30651170|NCT01006265|58663699|FG002|Overall Study|Lost to Follow-up|1|||
30651171|NCT01006265|58663700|FG003|Overall Study|Lost to Follow-up|0|||
30651172|NCT01006265|58663697|FG000|Overall Study|Withdrawal by Subject|4|||
30651173|NCT01006265|58663698|FG001|Overall Study|Withdrawal by Subject|7|||
30651174|NCT01006265|58663699|FG002|Overall Study|Withdrawal by Subject|5|||
30651175|NCT01006265|58663700|FG003|Overall Study|Withdrawal by Subject|5|||
30651176|NCT01006265|58663697|FG000|Overall Study|Administrative reason|1|||
30651177|NCT01006265|58663698|FG001|Overall Study|Administrative reason|2|||
30651178|NCT01006265|58663699|FG002|Overall Study|Administrative reason|3|||
30651179|NCT01006265|58663700|FG003|Overall Study|Administrative reason|0|||
30651180|NCT01008995|58663712|FG000|Controlled Period|Adverse Event|1|||
30651181|NCT01008995|58663713|FG001|Controlled Period|Adverse Event|2|||
30651182|NCT01008995|58663714|FG002|Controlled Period|Adverse Event|0|||
30651183|NCT01008995|58663715|FG003|Controlled Period|Adverse Event|0|||
30651184|NCT01008995|58663712|FG000|Controlled Period|Other|2|||
30651185|NCT01008995|58663713|FG001|Controlled Period|Other|1|||
30651186|NCT01008995|58663714|FG002|Controlled Period|Other|0|||
30651187|NCT01008995|58663715|FG003|Controlled Period|Other|0|||
30651188|NCT01008995|58663712|FG000|After Controlled Period|Adverse Event|0|||
30651189|NCT01008995|58663713|FG001|After Controlled Period|Adverse Event|0|||
30651190|NCT01008995|58663714|FG002|After Controlled Period|Adverse Event|1|||
30767680|NCT04472494|58776646|FG001|Pre-treatment|Other reasons|0|||
30651191|NCT01008995|58663715|FG003|After Controlled Period|Adverse Event|1|||
30651192|NCT01008995|58663712|FG000|After Controlled Period|Other|0|||
30651193|NCT01008995|58663713|FG001|After Controlled Period|Other|0|||
30767681|NCT04472494|58776645|FG000|Treatment|Death|5|||
30767682|NCT04472494|58776646|FG001|Treatment|Death|2|||
30767683|NCT04472494|58776645|FG000|Treatment|Hospital discharge|1|||
30767684|NCT04472494|58776646|FG001|Treatment|Hospital discharge|1|||
30767685|NCT04419506|58776656|FG000|Overall Study|Adverse Event|0|||
30767686|NCT04419506|58776657|FG001|Overall Study|Adverse Event|10|||
30767687|NCT04419506|58776658|FG002|Overall Study|Adverse Event|0|||
30848689|NCT02802631|58875041|FG002|Overall Study|Sponsor Decision|6|||
30848690|NCT02802631|58875042|FG003|Overall Study|Sponsor Decision|0|||
30848691|NCT02802631|58875043|FG004|Overall Study|Sponsor Decision|2|||
30952176|NCT01697462|58999527|FG000|Overall Study|Missing|5|||
30952177|NCT01696994|58999533|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
30848692|NCT02802631|58875044|FG005|Overall Study|Sponsor Decision|0|||
30651194|NCT01008995|58663714|FG002|After Controlled Period|Other|1|||
30651195|NCT01008995|58663715|FG003|After Controlled Period|Other|0|||
30651196|NCT00957944|58663725|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
30651197|NCT00957944|58663726|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
30651198|NCT01005875|58663732|FG000|Overall Study|Death|3|||
30651199|NCT01005719|58663736|FG000|Period 1|Adverse Event|0|||
30651200|NCT01005719|58663737|FG001|Period 1|Adverse Event|0|||
30767688|NCT04419506|58776659|FG003|Overall Study|Adverse Event|3|||
30767689|NCT04419506|58776656|FG000|Overall Study|Withdrawal by Subject|0|||
30848693|NCT02802631|58875045|FG006|Overall Study|Sponsor Decision|0|||
30651201|NCT01005719|58663738|FG002|Period 1|Adverse Event|0|||
30651202|NCT01005719|58663739|FG003|Period 1|Adverse Event|1|||
30651203|NCT01005719|58663740|FG004|Period 1|Adverse Event|0|||
30651204|NCT01005719|58663741|FG005|Period 1|Adverse Event|0|||
30651205|NCT01005719|58663736|FG000|Period 1|Delay in completing study procedures|0|||
30651206|NCT01005719|58663737|FG001|Period 1|Delay in completing study procedures|0|||
30651207|NCT01005719|58663738|FG002|Period 1|Delay in completing study procedures|0|||
30651208|NCT01005719|58663739|FG003|Period 1|Delay in completing study procedures|0|||
30651209|NCT01005719|58663740|FG004|Period 1|Delay in completing study procedures|0|||
30651210|NCT01005719|58663741|FG005|Period 1|Delay in completing study procedures|1|||
30651211|NCT01005719|58663736|FG000|Period 2|Adverse Event|0|||
30651212|NCT01005719|58663737|FG001|Period 2|Adverse Event|0|||
30651213|NCT01005719|58663738|FG002|Period 2|Adverse Event|0|||
30651214|NCT01005719|58663739|FG003|Period 2|Adverse Event|0|||
30651215|NCT01005719|58663740|FG004|Period 2|Adverse Event|1|||
30651216|NCT01005719|58663741|FG005|Period 2|Adverse Event|1|||
30651217|NCT00953576|58663752|FG000|Overall Study|Adverse Event|0|||
30651218|NCT00953576|58663753|FG001|Overall Study|Adverse Event|1|||
30651219|NCT00953576|58663752|FG000|Overall Study|Ineligible after Consent|2|||
30651220|NCT00953576|58663753|FG001|Overall Study|Ineligible after Consent|0|||
30651221|NCT01005329|58663768|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
30651222|NCT01005251|58663778|FG000|Overall Study|Withdrawal by Subject|2|||
30651223|NCT01005251|58663779|FG001|Overall Study|Withdrawal by Subject|5|||
30651224|NCT01005251|58663780|FG002|Overall Study|Withdrawal by Subject|3|||
30651225|NCT01005251|58663781|FG003|Overall Study|Withdrawal by Subject|4|||
30651226|NCT01005251|58663782|FG004|Overall Study|Withdrawal by Subject|9|||
30651227|NCT01005251|58663778|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
30651228|NCT01005251|58663779|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30651229|NCT01005251|58663780|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
30651230|NCT01005251|58663781|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
30651231|NCT01005251|58663782|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
30651232|NCT01005251|58663778|FG000|Overall Study|Adverse Event|2|||
30651233|NCT01005251|58663779|FG001|Overall Study|Adverse Event|6|||
30651234|NCT01005251|58663780|FG002|Overall Study|Adverse Event|8|||
30651235|NCT01005251|58663781|FG003|Overall Study|Adverse Event|5|||
30651236|NCT01005251|58663782|FG004|Overall Study|Adverse Event|4|||
30651237|NCT01005251|58663778|FG000|Overall Study|Protocol Violation|1|||
30651238|NCT01005251|58663779|FG001|Overall Study|Protocol Violation|0|||
30651239|NCT01005251|58663780|FG002|Overall Study|Protocol Violation|0|||
30651240|NCT01005251|58663781|FG003|Overall Study|Protocol Violation|0|||
30651241|NCT01005251|58663782|FG004|Overall Study|Protocol Violation|2|||
30651242|NCT01005251|58663778|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
30651243|NCT01005251|58663779|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
30651244|NCT01005251|58663780|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
30651245|NCT01005251|58663781|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
30651246|NCT01005251|58663782|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
30651247|NCT01005251|58663778|FG000|Overall Study|Lost to Follow-up|1|||
30651248|NCT01005251|58663779|FG001|Overall Study|Lost to Follow-up|4|||
30651249|NCT01005251|58663780|FG002|Overall Study|Lost to Follow-up|2|||
30651250|NCT01005251|58663781|FG003|Overall Study|Lost to Follow-up|0|||
30651251|NCT01005251|58663782|FG004|Overall Study|Lost to Follow-up|0|||
30651252|NCT01005251|58663778|FG000|Overall Study|Physician Decision|0|||
30651253|NCT01005251|58663779|FG001|Overall Study|Physician Decision|0|||
30651254|NCT01005251|58663780|FG002|Overall Study|Physician Decision|0|||
30651255|NCT01005251|58663781|FG003|Overall Study|Physician Decision|0|||
30651256|NCT01005251|58663782|FG004|Overall Study|Physician Decision|2|||
30651257|NCT01005251|58663778|FG000|Overall Study|Patient moved|1|||
30651258|NCT01005251|58663779|FG001|Overall Study|Patient moved|0|||
30651259|NCT01005251|58663780|FG002|Overall Study|Patient moved|0|||
30651260|NCT01005251|58663781|FG003|Overall Study|Patient moved|0|||
30651261|NCT01005251|58663782|FG004|Overall Study|Patient moved|0|||
30651262|NCT01005251|58663778|FG000|Overall Study|Wrong drug dispensed|0|||
30651263|NCT01005251|58663779|FG001|Overall Study|Wrong drug dispensed|1|||
30651264|NCT01005251|58663780|FG002|Overall Study|Wrong drug dispensed|0|||
30651265|NCT01005251|58663781|FG003|Overall Study|Wrong drug dispensed|0|||
30651266|NCT01005251|58663782|FG004|Overall Study|Wrong drug dispensed|0|||
30651267|NCT01005251|58663778|FG000|Overall Study|Randomized in error|0|||
30651268|NCT01005251|58663779|FG001|Overall Study|Randomized in error|0|||
30651269|NCT01005251|58663780|FG002|Overall Study|Randomized in error|1|||
30651270|NCT01005251|58663781|FG003|Overall Study|Randomized in error|1|||
30651271|NCT01005251|58663782|FG004|Overall Study|Randomized in error|0|||
30651272|NCT01005251|58663778|FG000|Overall Study|Lack of Efficacy|0|||
30651273|NCT01005251|58663779|FG001|Overall Study|Lack of Efficacy|0|||
30651274|NCT01005251|58663780|FG002|Overall Study|Lack of Efficacy|1|||
30651275|NCT01005251|58663781|FG003|Overall Study|Lack of Efficacy|1|||
30651276|NCT01005251|58663782|FG004|Overall Study|Lack of Efficacy|0|||
30651277|NCT03048578|58663796|FG000|Overall Study|Withdrawal by Subject|5|||
30651278|NCT03048578|58663797|FG001|Overall Study|Withdrawal by Subject|6|||
30651279|NCT03048578|58663796|FG000|Overall Study|Lost to Follow-up|22|||
30651280|NCT03048578|58663797|FG001|Overall Study|Lost to Follow-up|10|||
30651281|NCT03048578|58663796|FG000|Overall Study|Adverse Event|1|||
30651282|NCT03048578|58663797|FG001|Overall Study|Adverse Event|2|||
30651283|NCT03048578|58663796|FG000|Overall Study|Terminated|3|||
30651284|NCT03048578|58663797|FG001|Overall Study|Terminated|2|||
30651285|NCT01008449|58663805|FG000|Overall Study|Lost to Follow-up|29|||
30651286|NCT01008449|58663806|FG001|Overall Study|Lost to Follow-up|19|||
30651287|NCT00696241|58663817|FG000|Overall Study|Adverse Event|11|||
30651288|NCT00696241|58663818|FG001|Overall Study|Adverse Event|3|||
30651289|NCT00696241|58663819|FG002|Overall Study|Adverse Event|6|||
30651290|NCT00696241|58663820|FG003|Overall Study|Adverse Event|4|||
30651291|NCT00696241|58663821|FG004|Overall Study|Adverse Event|5|||
30651292|NCT00696241|58663817|FG000|Overall Study|Protocol Violation|1|||
30651293|NCT00696241|58663818|FG001|Overall Study|Protocol Violation|1|||
30651294|NCT00696241|58663819|FG002|Overall Study|Protocol Violation|2|||
30651295|NCT00696241|58663820|FG003|Overall Study|Protocol Violation|0|||
30651296|NCT00696241|58663821|FG004|Overall Study|Protocol Violation|3|||
30651297|NCT00696241|58663817|FG000|Overall Study|Lost to Follow-up|1|||
30651298|NCT00696241|58663818|FG001|Overall Study|Lost to Follow-up|4|||
30651299|NCT00696241|58663819|FG002|Overall Study|Lost to Follow-up|1|||
30651300|NCT00696241|58663820|FG003|Overall Study|Lost to Follow-up|2|||
30651301|NCT00696241|58663821|FG004|Overall Study|Lost to Follow-up|0|||
30651302|NCT00696241|58663817|FG000|Overall Study|Withdrawal by Subject|4|||
30651303|NCT00696241|58663818|FG001|Overall Study|Withdrawal by Subject|8|||
30651304|NCT00696241|58663819|FG002|Overall Study|Withdrawal by Subject|6|||
30651305|NCT00696241|58663820|FG003|Overall Study|Withdrawal by Subject|1|||
30651306|NCT00696241|58663821|FG004|Overall Study|Withdrawal by Subject|0|||
30651307|NCT00696241|58663817|FG000|Overall Study|Lack of Efficacy|1|||
30651308|NCT00696241|58663818|FG001|Overall Study|Lack of Efficacy|5|||
30651309|NCT00696241|58663819|FG002|Overall Study|Lack of Efficacy|4|||
30651310|NCT00696241|58663820|FG003|Overall Study|Lack of Efficacy|5|||
30651311|NCT00696241|58663821|FG004|Overall Study|Lack of Efficacy|3|||
30651312|NCT00696241|58663817|FG000|Overall Study|Other|6|||
30651313|NCT00696241|58663818|FG001|Overall Study|Other|1|||
30651314|NCT00696241|58663819|FG002|Overall Study|Other|5|||
30651315|NCT00696241|58663820|FG003|Overall Study|Other|2|||
30651316|NCT00696241|58663821|FG004|Overall Study|Other|1|||
30651317|NCT00957008|58663837|FG000|Overall Study|Withdrawal by Subject|13|||
30651318|NCT00957008|58663838|FG001|Overall Study|Withdrawal by Subject|10|||
30651319|NCT00957008|58663839|FG002|Overall Study|Withdrawal by Subject|12|||
30651320|NCT00957008|58663840|FG003|Overall Study|Withdrawal by Subject|16|||
30651321|NCT00957008|58663837|FG000|Overall Study|Lost to Follow-up|3|||
30651322|NCT00957008|58663838|FG001|Overall Study|Lost to Follow-up|1|||
30651323|NCT00957008|58663839|FG002|Overall Study|Lost to Follow-up|3|||
30651324|NCT00957008|58663840|FG003|Overall Study|Lost to Follow-up|4|||
30651325|NCT00957008|58663837|FG000|Overall Study|Physician Decision|1|||
30651326|NCT00957008|58663838|FG001|Overall Study|Physician Decision|0|||
30651327|NCT00957008|58663839|FG002|Overall Study|Physician Decision|1|||
30651328|NCT00957008|58663840|FG003|Overall Study|Physician Decision|1|||
30651329|NCT00957008|58663837|FG000|Overall Study|Relocated; Family conflict|4|||
30651330|NCT00957008|58663838|FG001|Overall Study|Relocated; Family conflict|1|||
30651331|NCT00957008|58663839|FG002|Overall Study|Relocated; Family conflict|1|||
30651332|NCT00957008|58663840|FG003|Overall Study|Relocated; Family conflict|3|||
30651333|NCT00952484|58663857|FG000|Overall Study|Withdrawal by Subject|0|||
30651334|NCT00952484|58663858|FG001|Overall Study|Withdrawal by Subject|1|||
30651335|NCT00952484|58663859|FG002|Overall Study|Withdrawal by Subject|0|||
30651336|NCT00689611|58663870|FG000|Overall Study|Death|6|||
30651337|NCT00689611|58663871|FG001|Overall Study|Death|9|||
30651338|NCT00689611|58663870|FG000|Overall Study|Withdrawal by Subject|8|||
30651339|NCT00689611|58663871|FG001|Overall Study|Withdrawal by Subject|9|||
30651340|NCT00689611|58663870|FG000|Overall Study|Lost to Follow-up|27|||
30651341|NCT00689611|58663871|FG001|Overall Study|Lost to Follow-up|28|||
30651342|NCT00689299|58663880|FG000|Overall Study|Adverse Event|2|||
30767690|NCT04419506|58776657|FG001|Overall Study|Withdrawal by Subject|0|||
30767691|NCT04419506|58776658|FG002|Overall Study|Withdrawal by Subject|0|||
30651343|NCT00689299|58663881|FG001|Overall Study|Adverse Event|1|||
30651344|NCT00689299|58663882|FG002|Overall Study|Adverse Event|1|||
30651345|NCT00689299|58663880|FG000|Overall Study|Lost to Follow-up|0|||
30651346|NCT00689299|58663881|FG001|Overall Study|Lost to Follow-up|1|||
30651347|NCT00689299|58663882|FG002|Overall Study|Lost to Follow-up|1|||
30651348|NCT00689299|58663880|FG000|Overall Study|Withdrawal by Subject|4|||
30651349|NCT00689299|58663881|FG001|Overall Study|Withdrawal by Subject|1|||
30651350|NCT00689299|58663882|FG002|Overall Study|Withdrawal by Subject|3|||
30651351|NCT00689299|58663880|FG000|Overall Study|Protocol Violation|1|||
30651352|NCT00689299|58663881|FG001|Overall Study|Protocol Violation|0|||
30651353|NCT00689299|58663882|FG002|Overall Study|Protocol Violation|0|||
30651354|NCT02506244|58663893|FG000|Overall Study|Did not undergo active monitoring|458|||
30651355|NCT02506244|58663894|FG001|Overall Study|Did not undergo active monitoring|459|||
30651356|NCT02506244|58663895|FG002|Overall Study|Did not undergo active monitoring|0|||
30767692|NCT04419506|58776659|FG003|Overall Study|Withdrawal by Subject|1|||
30767693|NCT04419506|58776656|FG000|Overall Study|poor-compliance|0|||
30767694|NCT04419506|58776657|FG001|Overall Study|poor-compliance|0|||
30767695|NCT04419506|58776658|FG002|Overall Study|poor-compliance|0|||
30767696|NCT04419506|58776659|FG003|Overall Study|poor-compliance|1|||
30767697|NCT03236506|58776672|FG000|Overall Study|Death|1|||
30767698|NCT03236506|58776673|FG001|Overall Study|Death|1|||
30767699|NCT03236506|58776674|FG002|Overall Study|Death|1|||
30767700|NCT03236506|58776672|FG000|Overall Study|Withdrawal by Subject|3|||
30767701|NCT03236506|58776673|FG001|Overall Study|Withdrawal by Subject|3|||
30767702|NCT03236506|58776674|FG002|Overall Study|Withdrawal by Subject|4|||
30767703|NCT03236506|58776672|FG000|Overall Study|Did not initiate treatment|2|||
30767704|NCT03236506|58776673|FG001|Overall Study|Did not initiate treatment|1|||
30767705|NCT03236506|58776674|FG002|Overall Study|Did not initiate treatment|2|||
30952178|NCT01696994|58999534|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
30651357|NCT00948974|58663905|FG000|Overall Study|Lost to Follow-up|23|||
30651358|NCT00948974|58663906|FG001|Overall Study|Lost to Follow-up|20|||
30651359|NCT01007435|58663916|FG000|Overall Study|Adverse Event|16|||
30651360|NCT01007435|58663917|FG001|Overall Study|Adverse Event|25|||
30651361|NCT01007435|58663918|FG002|Overall Study|Adverse Event|47|||
30651362|NCT01007435|58663919|FG003|Overall Study|Adverse Event|31|||
30651363|NCT01007435|58663916|FG000|Overall Study|Death|2|||
30651364|NCT01007435|58663917|FG001|Overall Study|Death|4|||
30651365|NCT01007435|58663918|FG002|Overall Study|Death|2|||
30651366|NCT01007435|58663919|FG003|Overall Study|Death|1|||
30651367|NCT01007435|58663916|FG000|Overall Study|Insufficient Therapeutic Response|21|||
30651368|NCT01007435|58663917|FG001|Overall Study|Insufficient Therapeutic Response|7|||
30651369|NCT01007435|58663918|FG002|Overall Study|Insufficient Therapeutic Response|2|||
30651370|NCT01007435|58663919|FG003|Overall Study|Insufficient Therapeutic Response|9|||
30651371|NCT01007435|58663916|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
30651372|NCT01007435|58663917|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
30651373|NCT01007435|58663918|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
30651374|NCT01007435|58663919|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
30651375|NCT01007435|58663916|FG000|Overall Study|Other Protocol Violation|2|||
30651376|NCT01007435|58663917|FG001|Overall Study|Other Protocol Violation|0|||
30651377|NCT01007435|58663918|FG002|Overall Study|Other Protocol Violation|1|||
30651378|NCT01007435|58663919|FG003|Overall Study|Other Protocol Violation|0|||
30651379|NCT01007435|58663916|FG000|Overall Study|Refused Treatment|13|||
30651380|NCT01007435|58663917|FG001|Overall Study|Refused Treatment|13|||
30651381|NCT01007435|58663918|FG002|Overall Study|Refused Treatment|5|||
30651382|NCT01007435|58663919|FG003|Overall Study|Refused Treatment|8|||
30651383|NCT01007435|58663916|FG000|Overall Study|Failure to Return|5|||
30651384|NCT01007435|58663917|FG001|Overall Study|Failure to Return|4|||
30651385|NCT01007435|58663918|FG002|Overall Study|Failure to Return|3|||
30651386|NCT01007435|58663919|FG003|Overall Study|Failure to Return|6|||
30651387|NCT01007435|58663916|FG000|Overall Study|Reason not Specified|1|||
30651388|NCT01007435|58663917|FG001|Overall Study|Reason not Specified|1|||
30651389|NCT01007435|58663918|FG002|Overall Study|Reason not Specified|2|||
30651390|NCT01007435|58663919|FG003|Overall Study|Reason not Specified|1|||
30651391|NCT00948896|58663937|FG000|Randomization to 24 Months of Age|Death|1|||
30651392|NCT00948896|58663938|FG001|Randomization to 24 Months of Age|Death|0|||
30651393|NCT00948896|58663939|FG002|Randomization to 24 Months of Age|Death|0|||
30651394|NCT00948896|58663940|FG003|Randomization to 24 Months of Age|Death|0|||
30651395|NCT00948896|58663941|FG004|Randomization to 24 Months of Age|Death|2|||
30651396|NCT00948896|58663942|FG005|Randomization to 24 Months of Age|Death|1|||
30651397|NCT00948896|58663943|FG006|Randomization to 24 Months of Age|Death|2|||
30651398|NCT00948896|58663944|FG007|Randomization to 24 Months of Age|Death|1|||
30651399|NCT00948896|58663937|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
30651400|NCT00948896|58663938|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
30651401|NCT00948896|58663939|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
30651402|NCT00948896|58663940|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
30651403|NCT00948896|58663941|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
30651404|NCT00948896|58663942|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
30952179|NCT01696994|58999533|FG000|Overall Study|Died Before Randomization|1|||
30952180|NCT01696994|58999534|FG001|Overall Study|Died Before Randomization|2|||
30952181|NCT01696994|58999533|FG000|Overall Study|Died Before ASU (Control)|73|||
30651405|NCT00948896|58663943|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
30651406|NCT00948896|58663944|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
30651407|NCT00948896|58663937|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
30651408|NCT00948896|58663938|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
30767706|NCT03227692|58776693|FG000|Overall Study|Protocol Violation|1|||
30767707|NCT03227692|58776694|FG001|Overall Study|Protocol Violation|1|||
30651409|NCT00948896|58663939|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
30767708|NCT03227692|58776693|FG000|Overall Study|Lost to Follow-up|4|||
30651410|NCT00948896|58663940|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
30651411|NCT00948896|58663941|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
30651412|NCT00948896|58663942|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
30651413|NCT00948896|58663943|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
30651414|NCT00948896|58663944|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
30651415|NCT00948896|58663937|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
30651416|NCT00948896|58663938|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
30651417|NCT00948896|58663939|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
30651418|NCT00948896|58663940|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
30651419|NCT00948896|58663941|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
30651420|NCT00948896|58663942|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
30651421|NCT00948896|58663943|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
30651422|NCT00948896|58663944|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
30651423|NCT00948896|58663937|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
30651424|NCT00948896|58663938|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
30651425|NCT00948896|58663939|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
30651426|NCT00948896|58663940|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
30651427|NCT00948896|58663941|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
30651428|NCT00948896|58663942|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
30651429|NCT00948896|58663943|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
30651430|NCT00948896|58663944|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
30651431|NCT00948896|58663937|FG000|24 Months of Age to 36 Months of Age|Death|0|||
30651432|NCT00948896|58663938|FG001|24 Months of Age to 36 Months of Age|Death|2|||
30651433|NCT00948896|58663939|FG002|24 Months of Age to 36 Months of Age|Death|2|||
30651434|NCT00948896|58663940|FG003|24 Months of Age to 36 Months of Age|Death|0|||
30651435|NCT00948896|58663941|FG004|24 Months of Age to 36 Months of Age|Death|0|||
30651436|NCT00948896|58663942|FG005|24 Months of Age to 36 Months of Age|Death|1|||
30651437|NCT00948896|58663943|FG006|24 Months of Age to 36 Months of Age|Death|0|||
30651438|NCT00948896|58663944|FG007|24 Months of Age to 36 Months of Age|Death|0|||
30651439|NCT00948896|58663937|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
30651440|NCT00948896|58663938|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
30651441|NCT00948896|58663939|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
30651442|NCT00948896|58663940|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
30651443|NCT00948896|58663941|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
30651444|NCT00948896|58663942|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
30651445|NCT00948896|58663943|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
30651446|NCT00948896|58663944|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
30651447|NCT00948896|58663937|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
30651448|NCT00948896|58663938|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
30651449|NCT00948896|58663939|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
30651450|NCT00948896|58663940|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
30651451|NCT00948896|58663941|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
30651452|NCT00948896|58663942|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
30651453|NCT00948896|58663943|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
30651454|NCT00948896|58663944|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
30651455|NCT00948896|58663937|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
30651456|NCT00948896|58663938|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
30651457|NCT00948896|58663939|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
30651458|NCT00948896|58663940|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
30651459|NCT00948896|58663941|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
30651460|NCT00948896|58663942|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
30651461|NCT00948896|58663943|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
30651462|NCT00948896|58663944|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
30651463|NCT00948896|58663937|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
30651464|NCT00948896|58663938|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
30651465|NCT00948896|58663939|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
30651466|NCT00948896|58663940|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
30651467|NCT00948896|58663941|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
30651468|NCT00948896|58663942|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
30651469|NCT00948896|58663943|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
30651470|NCT00948896|58663944|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
30651471|NCT01004159|58663966|FG000|Overall Study|Adverse Event|2|||
30651472|NCT01004159|58663966|FG000|Overall Study|Disease Progression|18|||
30651473|NCT00948818|58663972|FG000|Overall Study|Adverse Event|10|||
30651474|NCT00948818|58663973|FG001|Overall Study|Adverse Event|32|||
30651475|NCT00948818|58663972|FG000|Overall Study|Protocol Violation|9|||
30651476|NCT00948818|58663973|FG001|Overall Study|Protocol Violation|10|||
30651477|NCT00948818|58663972|FG000|Overall Study|Withdrawal by Subject|25|||
30651478|NCT00948818|58663973|FG001|Overall Study|Withdrawal by Subject|25|||
30651479|NCT00948818|58663972|FG000|Overall Study|Lost to Follow-up|10|||
30651480|NCT00948818|58663973|FG001|Overall Study|Lost to Follow-up|17|||
30651481|NCT00948818|58663972|FG000|Overall Study|Lack of Efficacy|4|||
30651482|NCT00948818|58663973|FG001|Overall Study|Lack of Efficacy|5|||
30651483|NCT00948818|58663972|FG000|Overall Study|Other Reason|4|||
30651484|NCT00948818|58663973|FG001|Overall Study|Other Reason|5|||
30651485|NCT00948506|58663984|FG000|Overall Study|Withdrawal by Subject|3|||
30651486|NCT00948506|58663985|FG001|Overall Study|Withdrawal by Subject|1|||
30651487|NCT00955682|58663996|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
30651488|NCT00955682|58663997|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
30651489|NCT00689221|58664013|FG000|Overall Study|Ongoing at cut-off date|39|||
30651490|NCT00689221|58664014|FG001|Overall Study|Ongoing at cut-off date|36|||
30651491|NCT01875445|58664022|FG000|Overall Study|Lost to Follow-up|5|||
30651492|NCT01875445|58664023|FG001|Overall Study|Lost to Follow-up|0|||
30651493|NCT01875445|58664022|FG000|Overall Study|Withdrawal by Subject|2|||
30651494|NCT01875445|58664023|FG001|Overall Study|Withdrawal by Subject|0|||
30651495|NCT00688909|58664029|FG000|Overall Study|Adverse Event|28|||
30651496|NCT00688909|58664029|FG000|Overall Study|Patient withdrew consent|2|||
30651497|NCT00688909|58664029|FG000|Overall Study|Administrative problems|1|||
30651498|NCT00688909|58664029|FG000|Overall Study|Protocol Violation|2|||
30651499|NCT00948428|58664037|FG000|Overall Study|Withdrawal by Subject|6|||
30651500|NCT00948428|58664038|FG001|Overall Study|Withdrawal by Subject|12|||
30651501|NCT00948428|58664039|FG002|Overall Study|Withdrawal by Subject|7|||
30651502|NCT00948428|58664037|FG000|Overall Study|Adverse Event|6|||
30651503|NCT00948428|58664038|FG001|Overall Study|Adverse Event|3|||
30651504|NCT00948428|58664039|FG002|Overall Study|Adverse Event|0|||
30651505|NCT00948428|58664037|FG000|Overall Study|Lost to Follow-up|2|||
30651506|NCT00948428|58664038|FG001|Overall Study|Lost to Follow-up|1|||
30651507|NCT00948428|58664039|FG002|Overall Study|Lost to Follow-up|1|||
30651508|NCT00948428|58664037|FG000|Overall Study|Death|2|||
30651509|NCT00948428|58664038|FG001|Overall Study|Death|0|||
30767709|NCT03227692|58776694|FG001|Overall Study|Lost to Follow-up|2|||
30767710|NCT03227692|58776693|FG000|Overall Study|Adverse Event|0|||
30767711|NCT03227692|58776694|FG001|Overall Study|Adverse Event|2|||
30767712|NCT03210220|58776702|FG000|Overall Study|Physician Decision|1|||
30767713|NCT03210220|58776703|FG001|Overall Study|Physician Decision|0|||
30651510|NCT00948428|58664039|FG002|Overall Study|Death|0|||
30651511|NCT00948428|58664037|FG000|Overall Study|Intercurrent Illness|1|||
30651512|NCT00948428|58664038|FG001|Overall Study|Intercurrent Illness|0|||
30651513|NCT00948428|58664039|FG002|Overall Study|Intercurrent Illness|0|||
30651514|NCT00948428|58664037|FG000|Overall Study|Non-compliance|1|||
30651515|NCT00948428|58664038|FG001|Overall Study|Non-compliance|2|||
30651516|NCT00948428|58664039|FG002|Overall Study|Non-compliance|0|||
30651517|NCT00948194|58664049|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
30651518|NCT00948194|58664050|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
30651519|NCT00691483|58664058|FG000|Overall Study|Adverse Event|14|||
30767714|NCT03209518|58776709|FG000|Overall Study|Case Report Forms Uncollected|1|||
30651520|NCT00691483|58664059|FG001|Overall Study|Adverse Event|6|||
30651521|NCT00691483|58664058|FG000|Overall Study|Lost to Follow-up|17|||
30651522|NCT00691483|58664059|FG001|Overall Study|Lost to Follow-up|10|||
30651523|NCT00691483|58664058|FG000|Overall Study|Withdrawal by Subject|24|||
30651524|NCT00691483|58664059|FG001|Overall Study|Withdrawal by Subject|7|||
30651525|NCT00691483|58664058|FG000|Overall Study|Other known cause|6|||
30767715|NCT03209518|58776709|FG000|Overall Study|Protocol Deviation|1|||
30767716|NCT03725852|58776715|FG000|Overall Study|Death|1|||
30651526|NCT00691483|58664059|FG001|Overall Study|Other known cause|1|||
30651527|NCT00691483|58664058|FG000|Overall Study|Randomized by not treated|7|||
30651528|NCT00691483|58664059|FG001|Overall Study|Randomized by not treated|1|||
30651529|NCT00691093|58664065|FG000|Overall Study|Adverse Event|1|||
30651530|NCT00691093|58664065|FG000|Overall Study|Lost to Follow-up|1|||
30651531|NCT00691093|58664065|FG000|Overall Study|Lack of Efficacy|1|||
30651532|NCT00691093|58664065|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
30651533|NCT00947882|58664078|FG000|Overall Study|Adverse Event|0|||
30651534|NCT00947882|58664079|FG001|Overall Study|Adverse Event|1|||
30651535|NCT00947882|58664080|FG002|Overall Study|Adverse Event|4|||
30651536|NCT00947882|58664081|FG003|Overall Study|Adverse Event|4|||
30651537|NCT00947882|58664078|FG000|Overall Study|Withdrawal by Subject|2|||
30651538|NCT00947882|58664079|FG001|Overall Study|Withdrawal by Subject|0|||
30651539|NCT00947882|58664080|FG002|Overall Study|Withdrawal by Subject|8|||
30651540|NCT00947882|58664081|FG003|Overall Study|Withdrawal by Subject|2|||
30651541|NCT00947882|58664078|FG000|Overall Study|Protocol Violation|0|||
30651542|NCT00947882|58664079|FG001|Overall Study|Protocol Violation|0|||
30651543|NCT00947882|58664080|FG002|Overall Study|Protocol Violation|1|||
30651544|NCT00947882|58664081|FG003|Overall Study|Protocol Violation|0|||
30651545|NCT00947882|58664078|FG000|Overall Study|Lost to Follow-up|0|||
30651546|NCT00947882|58664079|FG001|Overall Study|Lost to Follow-up|2|||
30651547|NCT00947882|58664080|FG002|Overall Study|Lost to Follow-up|1|||
30651548|NCT00947882|58664081|FG003|Overall Study|Lost to Follow-up|0|||
30651549|NCT00947882|58664078|FG000|Overall Study|Other/Unknown|10|||
30651550|NCT00947882|58664079|FG001|Overall Study|Other/Unknown|13|||
30651551|NCT00947882|58664080|FG002|Overall Study|Other/Unknown|3|||
30767717|NCT03725852|58776716|FG001|Overall Study|Death|0|||
30651552|NCT00947882|58664081|FG003|Overall Study|Other/Unknown|6|||
30651553|NCT00947882|58664078|FG000|Overall Study|Trial Terminated by Sponsor|62|||
30651554|NCT00947882|58664079|FG001|Overall Study|Trial Terminated by Sponsor|61|||
30651555|NCT00947882|58664080|FG002|Overall Study|Trial Terminated by Sponsor|62|||
30651556|NCT00947882|58664081|FG003|Overall Study|Trial Terminated by Sponsor|70|||
30651557|NCT00688753|58664092|FG000|Overall Study|Disease progression|55|||
30651558|NCT00688753|58664092|FG000|Overall Study|Missing|1|||
30651559|NCT00688753|58664092|FG000|Overall Study|Death|9|||
30651560|NCT00688753|58664092|FG000|Overall Study|Withdrawal by Subject|3|||
30651561|NCT00688753|58664092|FG000|Overall Study|Adverse Event|20|||
30651562|NCT00688753|58664092|FG000|Overall Study|Protocol Violation|1|||
30651563|NCT00688753|58664092|FG000|Overall Study|Lost to Follow-up|3|||
30651564|NCT00951080|58664098|FG000|Overall Study|Adverse Event|3|||
30651565|NCT00951080|58664099|FG001|Overall Study|Adverse Event|3|||
30651566|NCT00951080|58664098|FG000|Overall Study|Lost to Follow-up|0|||
30651567|NCT00951080|58664099|FG001|Overall Study|Lost to Follow-up|1|||
30651568|NCT00951080|58664098|FG000|Overall Study|Physician Decision|4|||
30651569|NCT00951080|58664099|FG001|Overall Study|Physician Decision|1|||
30651570|NCT00951080|58664098|FG000|Overall Study|Other|19|||
30651571|NCT00951080|58664099|FG001|Overall Study|Other|22|||
30651572|NCT00946322|58664105|FG000|Pre-treatment|participant failure to follow up|1|||
30651573|NCT00946322|58664105|FG000|Post-treatment|participant failure to follow up|2|||
30651574|NCT00950690|58664109|FG000|Overall Study|Death|4|||
30651575|NCT00950690|58664109|FG000|Overall Study|Adverse Event|15|||
30651576|NCT00950690|58664109|FG000|Overall Study|Lack of Efficacy|22|||
30651577|NCT00950690|58664109|FG000|Overall Study|Lost to Follow-up|40|||
30651578|NCT00950690|58664109|FG000|Overall Study|Other|163|||
30651579|NCT00694369|58664118|FG000|Overall Study|Adverse Event|0|||
30651580|NCT00694369|58664119|FG001|Overall Study|Adverse Event|1|||
30651581|NCT00694369|58664120|FG002|Overall Study|Adverse Event|0|||
30651582|NCT00694369|58664121|FG003|Overall Study|Adverse Event|1|||
30651583|NCT00694369|58664122|FG004|Overall Study|Adverse Event|3|||
30651584|NCT00694369|58664118|FG000|Overall Study|Lost to Follow-up|0|||
30651585|NCT00694369|58664119|FG001|Overall Study|Lost to Follow-up|0|||
30651586|NCT00694369|58664120|FG002|Overall Study|Lost to Follow-up|1|||
30651587|NCT00694369|58664121|FG003|Overall Study|Lost to Follow-up|1|||
30651588|NCT00694369|58664122|FG004|Overall Study|Lost to Follow-up|0|||
30651589|NCT00694369|58664118|FG000|Overall Study|Physician Decision|0|||
30651590|NCT00694369|58664119|FG001|Overall Study|Physician Decision|0|||
30651591|NCT00694369|58664120|FG002|Overall Study|Physician Decision|0|||
30651592|NCT00694369|58664121|FG003|Overall Study|Physician Decision|0|||
30651593|NCT00694369|58664122|FG004|Overall Study|Physician Decision|1|||
30651594|NCT00694369|58664118|FG000|Overall Study|Protocol Violation|0|||
30651595|NCT00694369|58664119|FG001|Overall Study|Protocol Violation|1|||
30651596|NCT00694369|58664120|FG002|Overall Study|Protocol Violation|0|||
30651597|NCT00694369|58664121|FG003|Overall Study|Protocol Violation|0|||
30651598|NCT00694369|58664122|FG004|Overall Study|Protocol Violation|0|||
30651599|NCT00694369|58664118|FG000|Overall Study|Withdrawal by Subject|1|||
30651600|NCT00694369|58664119|FG001|Overall Study|Withdrawal by Subject|1|||
30651601|NCT00694369|58664120|FG002|Overall Study|Withdrawal by Subject|1|||
30767718|NCT03725852|58776715|FG000|Overall Study|Withdrawal by Subject|1|||
30767719|NCT03725852|58776716|FG001|Overall Study|Withdrawal by Subject|0|||
30767720|NCT03725852|58776715|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
30767721|NCT03725852|58776716|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
30767722|NCT00304031|58776725|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
30767723|NCT00304031|58776726|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
30767724|NCT00304031|58776727|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
30767725|NCT00304031|58776725|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
30767726|NCT00304031|58776726|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
30767727|NCT00304031|58776727|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
30767728|NCT00304031|58776725|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
30767729|NCT00304031|58776726|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
30767730|NCT00304031|58776727|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
30767731|NCT00304031|58776725|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
30767732|NCT00304031|58776726|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
30848694|NCT02802631|58875046|FG007|Overall Study|Sponsor Decision|4|||
30848695|NCT02754479|58875078|FG000|Overall Study|Lost to Follow-up|1|||
30848696|NCT02036476|58875091|FG000|Overall Study|Withdrawal by Subject|2|||
30848697|NCT02036476|58875091|FG000|Overall Study|Progressive Disease|4|||
30848698|NCT02036476|58875091|FG000|Overall Study|Unacceptable Toxicity|2|||
30848699|NCT00643994|58875141|FG000|Overall Study|Death|24|||
30952182|NCT01696994|58999534|FG001|Overall Study|Died Before ASU (Control)|0|||
30767733|NCT00304031|58776727|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
30848700|NCT00643994|58875141|FG000|Overall Study|Lost to Follow-up|72|||
30848701|NCT00643617|58875147|FG000|Overall Study|Death|6|||
30952183|NCT01696994|58999533|FG000|Overall Study|No Ovaries at Baseline|4807|||
30651602|NCT00694369|58664121|FG003|Overall Study|Withdrawal by Subject|1|||
30651603|NCT00694369|58664122|FG004|Overall Study|Withdrawal by Subject|2|||
30651604|NCT03412747|58664137|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
30651605|NCT03412747|58664138|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
30651606|NCT03412747|58664139|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
30651607|NCT03412747|58664137|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
30651608|NCT03412747|58664138|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
30767734|NCT00304031|58776725|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
30651609|NCT03412747|58664139|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
30651610|NCT03412747|58664137|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
30651611|NCT03412747|58664138|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
30651612|NCT03412747|58664139|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
30651613|NCT03412747|58664137|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
30651614|NCT03412747|58664138|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
30651615|NCT03412747|58664139|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
30651616|NCT03412747|58664137|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
30651617|NCT03412747|58664138|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
30651618|NCT03412747|58664139|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
30651619|NCT03412747|58664137|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
30651620|NCT03412747|58664138|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
30651621|NCT03412747|58664139|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
30651622|NCT03412747|58664137|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
30651623|NCT03412747|58664138|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
30651624|NCT03412747|58664139|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
30651625|NCT03412747|58664137|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
30651626|NCT03412747|58664138|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
30651627|NCT03412747|58664139|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
30651628|NCT03412747|58664137|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
30651629|NCT03412747|58664138|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
30651630|NCT03412747|58664139|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
30651631|NCT03412747|58664137|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
30651632|NCT03412747|58664138|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
30651633|NCT03412747|58664139|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
30651634|NCT03412747|58664137|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
30651635|NCT03412747|58664138|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
30651636|NCT03412747|58664139|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
30651637|NCT03412747|58664137|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
30651638|NCT03412747|58664138|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
30651639|NCT03412747|58664139|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
30651640|NCT03412747|58664137|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
30651641|NCT03412747|58664138|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
30651642|NCT03412747|58664139|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
30651643|NCT03412747|58664137|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
30651644|NCT03412747|58664138|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
30651645|NCT03412747|58664139|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
30651646|NCT03412747|58664137|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
30651647|NCT03412747|58664138|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
30651648|NCT03412747|58664139|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
30651649|NCT03412747|58664137|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
30651650|NCT03412747|58664138|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
30651651|NCT03412747|58664139|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
30651652|NCT00513019|58664159|FG000|Overall Study|Adverse Event|1|||
30767735|NCT00304031|58776726|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
30767736|NCT00304031|58776727|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
30651653|NCT00513019|58664160|FG001|Overall Study|Adverse Event|0|||
30767737|NCT00304031|58776725|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
30651654|NCT00513019|58664159|FG000|Overall Study|Withdrawal by Subject|4|||
30651655|NCT00513019|58664160|FG001|Overall Study|Withdrawal by Subject|5|||
30651656|NCT00954512|58664181|FG000|Overall Study|Withdrawal by Subject|0|||
30651657|NCT00954512|58664182|FG001|Overall Study|Withdrawal by Subject|0|||
30651658|NCT00954512|58664183|FG002|Overall Study|Withdrawal by Subject|0|||
30651659|NCT00954512|58664184|FG003|Overall Study|Withdrawal by Subject|0|||
30651660|NCT00954512|58664185|FG004|Overall Study|Withdrawal by Subject|0|||
30651661|NCT00954512|58664186|FG005|Overall Study|Withdrawal by Subject|1|||
30651662|NCT00954512|58664181|FG000|Overall Study|Adverse Event|0|||
30651663|NCT00954512|58664182|FG001|Overall Study|Adverse Event|0|||
30651664|NCT00954512|58664183|FG002|Overall Study|Adverse Event|0|||
30651665|NCT00954512|58664184|FG003|Overall Study|Adverse Event|0|||
30651666|NCT00954512|58664185|FG004|Overall Study|Adverse Event|1|||
30651667|NCT00954512|58664186|FG005|Overall Study|Adverse Event|2|||
30651668|NCT00954512|58664181|FG000|Overall Study|Physician Decision|0|||
30651669|NCT00954512|58664182|FG001|Overall Study|Physician Decision|1|||
30651670|NCT00954512|58664183|FG002|Overall Study|Physician Decision|0|||
30651671|NCT00954512|58664184|FG003|Overall Study|Physician Decision|1|||
30651672|NCT00954512|58664185|FG004|Overall Study|Physician Decision|0|||
30651673|NCT00954512|58664186|FG005|Overall Study|Physician Decision|0|||
30651674|NCT00954512|58664181|FG000|Overall Study|Symptomatic Deterioration|0|||
30651675|NCT00954512|58664182|FG001|Overall Study|Symptomatic Deterioration|1|||
30651676|NCT00954512|58664183|FG002|Overall Study|Symptomatic Deterioration|0|||
30651677|NCT00954512|58664184|FG003|Overall Study|Symptomatic Deterioration|0|||
30651678|NCT00954512|58664185|FG004|Overall Study|Symptomatic Deterioration|2|||
30651679|NCT00954512|58664186|FG005|Overall Study|Symptomatic Deterioration|0|||
30651680|NCT00954512|58664181|FG000|Overall Study|Progression of Disease|2|||
30651681|NCT00954512|58664182|FG001|Overall Study|Progression of Disease|1|||
30651682|NCT00954512|58664183|FG002|Overall Study|Progression of Disease|0|||
30651683|NCT00954512|58664184|FG003|Overall Study|Progression of Disease|1|||
30651684|NCT00954512|58664185|FG004|Overall Study|Progression of Disease|1|||
30651685|NCT00954512|58664186|FG005|Overall Study|Progression of Disease|1|||
30651686|NCT00691015|58664199|FG000|Overall Study|Refused further treatment|1|||
30651687|NCT00950300|58664205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
30651688|NCT00950300|58664206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
30651689|NCT00950300|58664205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
30651690|NCT00950300|58664206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
30651691|NCT00950300|58664205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
30651692|NCT00950300|58664206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
30651693|NCT00950300|58664205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
30651694|NCT00950300|58664206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
30651695|NCT00950300|58664205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
30651696|NCT00950300|58664206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
30651697|NCT00950300|58664205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
30651698|NCT00950300|58664206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
30651699|NCT00950300|58664205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
30651700|NCT00950300|58664206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
30651701|NCT00950300|58664205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
30651702|NCT00950300|58664206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
30651703|NCT00950300|58664205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
30651704|NCT00950300|58664206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
30651705|NCT00950300|58664205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
30651706|NCT00950300|58664206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
30651707|NCT00950300|58664205|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
30651708|NCT00950300|58664206|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
30651709|NCT00950300|58664205|FG000|TFFU Period|Death|4|||
30651710|NCT00950300|58664206|FG001|TFFU Period|Death|1|||
30651711|NCT00950300|58664205|FG000|TFFU Period|Refused Treatment|10|||
30651712|NCT00950300|58664206|FG001|TFFU Period|Refused Treatment|11|||
30651713|NCT00950300|58664205|FG000|TFFU Period|Failure to Return|16|||
30767738|NCT00304031|58776726|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
30767739|NCT00304031|58776727|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
30767740|NCT00304031|58776725|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
30767741|NCT00304031|58776726|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
30767742|NCT00304031|58776727|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
30767743|NCT00304031|58776725|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
30767744|NCT00304031|58776726|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
30767745|NCT00304031|58776727|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
30651714|NCT00950300|58664206|FG001|TFFU Period|Failure to Return|16|||
30651715|NCT00950300|58664205|FG000|TFFU Period|Recurrence of Disease|63|||
30651716|NCT00950300|58664206|FG001|TFFU Period|Recurrence of Disease|72|||
30651717|NCT00950300|58664205|FG000|TFFU Period|Other|4|||
30651718|NCT00950300|58664206|FG001|TFFU Period|Other|3|||
30651719|NCT00950300|58664205|FG000|SFU Period|Death|44|||
30651720|NCT00950300|58664206|FG001|SFU Period|Death|42|||
30651721|NCT00950300|58664205|FG000|SFU Period|Lost to Follow-up|30|||
30651722|NCT00950300|58664206|FG001|SFU Period|Lost to Follow-up|28|||
30651723|NCT00950300|58664205|FG000|SFU Period|Withdrawal by Subject|4|||
30651724|NCT00950300|58664206|FG001|SFU Period|Withdrawal by Subject|8|||
30651725|NCT00949988|58664213|FG000|Overall Study|Withdrawal by Subject|3|||
30651726|NCT00731692|58664220|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
30651727|NCT00731692|58664221|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
30651728|NCT00731692|58664222|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
30651729|NCT00731692|58664220|FG000|Core Study (36 Months)|Physician Decision|1|||
30651730|NCT00731692|58664221|FG001|Core Study (36 Months)|Physician Decision|0|||
30651731|NCT00731692|58664222|FG002|Core Study (36 Months)|Physician Decision|2|||
30651732|NCT00731692|58664220|FG000|Core Study (36 Months)|Death|2|||
30651733|NCT00731692|58664221|FG001|Core Study (36 Months)|Death|1|||
30651734|NCT00731692|58664222|FG002|Core Study (36 Months)|Death|2|||
30651735|NCT00731692|58664220|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
30651736|NCT00731692|58664221|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
30651737|NCT00731692|58664222|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
30651738|NCT00731692|58664220|FG000|Core Study (36 Months)|Administrative|2|||
30651739|NCT00731692|58664221|FG001|Core Study (36 Months)|Administrative|2|||
30651740|NCT00731692|58664222|FG002|Core Study (36 Months)|Administrative|6|||
30651741|NCT00731692|58664220|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
30651742|NCT00731692|58664221|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
30651743|NCT00731692|58664222|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
30651744|NCT00731692|58664220|FG000|Core Study (36 Months)|Protocol Violation|4|||
30651745|NCT00731692|58664221|FG001|Core Study (36 Months)|Protocol Violation|5|||
30651746|NCT00731692|58664222|FG002|Core Study (36 Months)|Protocol Violation|8|||
30651747|NCT00731692|58664220|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
30651748|NCT00731692|58664221|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
30651749|NCT00731692|58664222|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
30651750|NCT00731692|58664220|FG000|Core Study (36 Months)|Adverse Event|25|||
30651751|NCT00731692|58664221|FG001|Core Study (36 Months)|Adverse Event|28|||
30651752|NCT00731692|58664222|FG002|Core Study (36 Months)|Adverse Event|29|||
30651753|NCT00731692|58664220|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
30651754|NCT00731692|58664221|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
30651755|NCT00731692|58664222|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
30651756|NCT00731692|58664220|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
30651757|NCT00731692|58664221|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
30651758|NCT00731692|58664222|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
30651759|NCT00731692|58664220|FG000|Extension Phase|Abnormal test procedure|0|||
30651760|NCT00731692|58664221|FG001|Extension Phase|Abnormal test procedure|0|||
30651761|NCT00731692|58664222|FG002|Extension Phase|Abnormal test procedure|1|||
30651762|NCT00731692|58664220|FG000|Extension Phase|Abnormal lab values|0|||
30651763|NCT00731692|58664221|FG001|Extension Phase|Abnormal lab values|0|||
30651764|NCT00731692|58664222|FG002|Extension Phase|Abnormal lab values|1|||
30651765|NCT00731692|58664220|FG000|Extension Phase|Lost to Follow-up|0|||
30651766|NCT00731692|58664221|FG001|Extension Phase|Lost to Follow-up|1|||
30651767|NCT00731692|58664222|FG002|Extension Phase|Lost to Follow-up|4|||
30651768|NCT00731692|58664220|FG000|Extension Phase|Withdrawal by Subject|4|||
30651769|NCT00731692|58664221|FG001|Extension Phase|Withdrawal by Subject|5|||
30651770|NCT00731692|58664222|FG002|Extension Phase|Withdrawal by Subject|3|||
30651771|NCT00731692|58664220|FG000|Extension Phase|Adverse Event|1|||
30651772|NCT00731692|58664221|FG001|Extension Phase|Adverse Event|1|||
30651773|NCT00731692|58664222|FG002|Extension Phase|Adverse Event|15|||
30651774|NCT00687193|58664244|FG000|Overall Study|Adverse Event|0|||
30651775|NCT00687193|58664245|FG001|Overall Study|Adverse Event|1|||
30651776|NCT00687193|58664246|FG002|Overall Study|Adverse Event|2|||
30651777|NCT00687193|58664247|FG003|Overall Study|Adverse Event|3|||
30651778|NCT00687193|58664248|FG004|Overall Study|Adverse Event|0|||
30651779|NCT00687193|58664249|FG005|Overall Study|Adverse Event|2|||
30651780|NCT00687193|58664244|FG000|Overall Study|Lack of Efficacy|1|||
30651781|NCT00687193|58664245|FG001|Overall Study|Lack of Efficacy|1|||
30651782|NCT00687193|58664246|FG002|Overall Study|Lack of Efficacy|0|||
30651783|NCT00687193|58664247|FG003|Overall Study|Lack of Efficacy|0|||
30651784|NCT00687193|58664248|FG004|Overall Study|Lack of Efficacy|0|||
30651785|NCT00687193|58664249|FG005|Overall Study|Lack of Efficacy|2|||
30651786|NCT00687193|58664244|FG000|Overall Study|Protocol Violation|1|||
30651787|NCT00687193|58664245|FG001|Overall Study|Protocol Violation|2|||
30651788|NCT00687193|58664246|FG002|Overall Study|Protocol Violation|0|||
30651789|NCT00687193|58664247|FG003|Overall Study|Protocol Violation|1|||
30651790|NCT00687193|58664248|FG004|Overall Study|Protocol Violation|2|||
30651791|NCT00687193|58664249|FG005|Overall Study|Protocol Violation|0|||
30651792|NCT00730912|58664269|FG000|Overall Study|Discontinued|0|||
30651793|NCT00730912|58664270|FG001|Overall Study|Discontinued|0|||
30651794|NCT00730912|58664271|FG002|Overall Study|Discontinued|1|||
30651795|NCT00737698|58664282|FG000|Overall Study|Withdrawal by Subject|6|||
30651796|NCT00737698|58664283|FG001|Overall Study|Withdrawal by Subject|5|||
30651797|NCT00737698|58664284|FG002|Overall Study|Withdrawal by Subject|3|||
30651798|NCT00737698|58664282|FG000|Overall Study|Death|0|||
30651799|NCT00737698|58664283|FG001|Overall Study|Death|0|||
30651800|NCT00737698|58664284|FG002|Overall Study|Death|1|||
30651801|NCT00730756|58664294|FG000|Overall Study|Adverse Event|2|||
30651802|NCT00730756|58664295|FG001|Overall Study|Adverse Event|0|||
30651803|NCT00730756|58664294|FG000|Overall Study|Lack of Efficacy|1|||
30651804|NCT00730756|58664295|FG001|Overall Study|Lack of Efficacy|1|||
30651805|NCT00730756|58664294|FG000|Overall Study|Protocol Deviation|1|||
30651806|NCT00730756|58664295|FG001|Overall Study|Protocol Deviation|2|||
30651807|NCT00730756|58664294|FG000|Overall Study|Lost to Follow-up|0|||
30651808|NCT00730756|58664295|FG001|Overall Study|Lost to Follow-up|1|||
30651809|NCT00730756|58664294|FG000|Overall Study|Withdrew Consent|0|||
30651810|NCT00730756|58664295|FG001|Overall Study|Withdrew Consent|1|||
30651811|NCT00730132|58664301|FG000|Overall Study|Protocol Violation|154|||
30651812|NCT00730132|58664301|FG000|Overall Study|Death|1|||
30651813|NCT00737464|58664308|FG000|Overall Study|Adverse Event|1|||
30651814|NCT00737464|58664308|FG000|Overall Study|Death|6|||
30651815|NCT00737464|58664308|FG000|Overall Study|Other - Failure to Return|1|||
30651816|NCT00737464|58664308|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
30651817|NCT00737464|58664308|FG000|Overall Study|Other reasons|4|||
30651818|NCT00729586|58664314|FG000|Overall Study|Ineligible|0|||
30651819|NCT00729586|58664315|FG001|Overall Study|Ineligible|1|||
30651820|NCT00729586|58664314|FG000|Overall Study|never treated|1|||
30651821|NCT00729586|58664315|FG001|Overall Study|never treated|0|||
30651822|NCT00949910|58664322|FG000|Overall Study|Progressive Disease|3750|||
30651823|NCT00949910|58664322|FG000|Overall Study|Symptomatic Deterioration|1088|||
30651824|NCT00949910|58664322|FG000|Overall Study|Lost to Follow-up|100|||
30651825|NCT00949910|58664322|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
30651826|NCT00949910|58664322|FG000|Overall Study|Participant Refusal|390|||
30651827|NCT00949910|58664322|FG000|Overall Study|Death Due to Malignant Disease|456|||
30651828|NCT00949910|58664322|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
30651829|NCT00949910|58664322|FG000|Overall Study|Death Due to Adverse Event|115|||
30651830|NCT00949910|58664322|FG000|Overall Study|Death Due to Toxicity|3|||
30651831|NCT00949910|58664322|FG000|Overall Study|Death from Unknown Cause|5|||
30651832|NCT00949910|58664322|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
30651833|NCT00949910|58664322|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
30651834|NCT00949910|58664322|FG000|Overall Study|Switched to Commercial Treatment|4|||
30651835|NCT00949910|58664322|FG000|Overall Study|Violation of Eligibility|23|||
30651836|NCT00949910|58664322|FG000|Overall Study|Logistical Reasons|13|||
30651837|NCT00949910|58664322|FG000|Overall Study|Non-Compliance|10|||
30651838|NCT00949910|58664322|FG000|Overall Study|Prolonged Dosing Interruption|4|||
30651839|NCT00949910|58664322|FG000|Overall Study|Adverse Event|83|||
30651840|NCT00949910|58664322|FG000|Overall Study|Serious Adverse Event|6|||
30651841|NCT00949910|58664322|FG000|Overall Study|Physician/Participant Decision|7|||
30651842|NCT00949910|58664322|FG000|Overall Study|Other|4|||
30651843|NCT00949910|58664322|FG000|Overall Study|No Data|9|||
30651844|NCT00686959|58664328|FG000|Overall Study|Participants censored (no death events)|124|||
30651845|NCT00686959|58664329|FG001|Overall Study|Participants censored (no death events)|117|||
30651846|NCT00946088|58664337|FG000|Overall Study|Withdrawal by Subject|0|||
30651847|NCT00946088|58664338|FG001|Overall Study|Withdrawal by Subject|1|||
30651848|NCT00736996|58664349|FG000|Overall Study|Lost to Follow-up|1|||
30651849|NCT00736996|58664350|FG001|Overall Study|Lost to Follow-up|9|||
30651850|NCT00736996|58664351|FG002|Overall Study|Lost to Follow-up|2|||
30651851|NCT00728962|58664365|FG000|Implant Placement Surgery|Adverse Event|8|||
30651852|NCT00728962|58664365|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
30651853|NCT00728962|58664365|FG000|Implant Placement Surgery|Protocol Violation|1|||
30651854|NCT00728962|58664365|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
30952184|NCT01696994|58999534|FG001|Overall Study|No Ovaries at Baseline|4851|||
30952185|NCT01696994|58999533|FG000|Overall Study|Refused ASU (Control)|311|||
30952186|NCT01696994|58999534|FG001|Overall Study|Refused ASU (Control)|0|||
30952187|NCT01696994|58999533|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
30952188|NCT01696994|58999534|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
30651855|NCT00728962|58664365|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
30651856|NCT00954122|58664369|FG000|Overall Study|Withdrawal by Subject|5|||
30651857|NCT00954122|58664369|FG000|Overall Study|Adverse Event|1|||
30651858|NCT00954122|58664369|FG000|Overall Study|Safety Reason|1|||
30952189|NCT01592240|58999713|FG000|Overall Study|Adverse Event|1|||
30651859|NCT00586066|58664376|FG000|Overall Study|Lost to Follow-up|6|||
30651860|NCT00586066|58664377|FG001|Overall Study|Lost to Follow-up|3|||
30651861|NCT00586066|58664376|FG000|Overall Study|Lack of Efficacy|5|||
30651862|NCT00586066|58664377|FG001|Overall Study|Lack of Efficacy|3|||
30651863|NCT00586066|58664376|FG000|Overall Study|Adverse Event|2|||
30651864|NCT00586066|58664377|FG001|Overall Study|Adverse Event|2|||
30651865|NCT00586066|58664376|FG000|Overall Study|Physician Decision|1|||
30651866|NCT00586066|58664377|FG001|Overall Study|Physician Decision|0|||
30651867|NCT00586066|58664376|FG000|Overall Study|Withdrawal of consent|4|||
30651868|NCT00586066|58664377|FG001|Overall Study|Withdrawal of consent|2|||
30651869|NCT01186016|58664385|FG000|Overall Study|Withdrawal by Subject|46|||
30651870|NCT01186016|58664386|FG001|Overall Study|Withdrawal by Subject|29|||
30651871|NCT00728884|58664392|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
30651872|NCT00728884|58664392|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
30651873|NCT00728494|58664398|FG000|Overall Study|Adverse Event|7|||
30651874|NCT00728494|58664399|FG001|Overall Study|Adverse Event|0|||
30651875|NCT00728494|58664398|FG000|Overall Study|Withdrawal by Subject|0|||
30651876|NCT00728494|58664399|FG001|Overall Study|Withdrawal by Subject|2|||
30651877|NCT00728494|58664398|FG000|Overall Study|Lack of Efficacy|2|||
30651878|NCT00728494|58664399|FG001|Overall Study|Lack of Efficacy|4|||
30651879|NCT00728494|58664398|FG000|Overall Study|No data available|0|||
30651880|NCT00728494|58664399|FG001|Overall Study|No data available|1|||
30651881|NCT00728416|58664407|FG000|Overall Study|Adverse Event|1|||
30651882|NCT00728416|58664408|FG001|Overall Study|Adverse Event|1|||
30651883|NCT00728416|58664407|FG000|Overall Study|Treatment Failure|0|||
30651884|NCT00728416|58664408|FG001|Overall Study|Treatment Failure|1|||
30651885|NCT00728416|58664407|FG000|Overall Study|Withdrawal by Subject|1|||
30651886|NCT00728416|58664408|FG001|Overall Study|Withdrawal by Subject|0|||
30651887|NCT00728182|58664416|FG000|Overall Study|Adverse Event|1|||
30651888|NCT00728182|58664417|FG001|Overall Study|Adverse Event|0|||
30651889|NCT00728182|58664416|FG000|Overall Study|Lost to Follow-up|2|||
30651890|NCT00728182|58664417|FG001|Overall Study|Lost to Follow-up|0|||
30651891|NCT00728182|58664416|FG000|Overall Study|Death|0|||
30651892|NCT00728182|58664417|FG001|Overall Study|Death|2|||
30651893|NCT00728182|58664416|FG000|Overall Study|Protocol Noncompliance|0|||
30651894|NCT00728182|58664417|FG001|Overall Study|Protocol Noncompliance|1|||
30651895|NCT00941330|58664427|FG000|Overall Study|Other|1|||
30651896|NCT00941330|58664428|FG001|Overall Study|Other|0|||
30651897|NCT00941330|58664427|FG000|Overall Study|Physician Decision|0|||
30651898|NCT00941330|58664428|FG001|Overall Study|Physician Decision|2|||
30651899|NCT00736450|58664434|FG000|Overall Study|Not ABC gene eligible|19|||
30651900|NCT00736450|58664434|FG000|Overall Study|Withdrawal by Subject|5|||
30651901|NCT00736450|58664434|FG000|Overall Study|Physician Decision|1|||
30651902|NCT00686881|58664440|FG000|Overall Study|Withdrawal by Subject|11|||
30651903|NCT00686881|58664441|FG001|Overall Study|Withdrawal by Subject|18|||
30651904|NCT00686881|58664440|FG000|Overall Study|Lost to Follow-up|0|||
30651905|NCT00686881|58664441|FG001|Overall Study|Lost to Follow-up|1|||
30651906|NCT00686881|58664440|FG000|Overall Study|Treatment-related adverse event|10|||
30651907|NCT00686881|58664441|FG001|Overall Study|Treatment-related adverse event|9|||
30651908|NCT00686881|58664440|FG000|Overall Study|Met discontinuation criteria|5|||
30651909|NCT00686881|58664441|FG001|Overall Study|Met discontinuation criteria|0|||
30651910|NCT00686881|58664440|FG000|Overall Study|Onset of malignant tumor|11|||
30651911|NCT00686881|58664441|FG001|Overall Study|Onset of malignant tumor|11|||
30651912|NCT00686881|58664440|FG000|Overall Study|Lack of Efficacy|4|||
30651913|NCT00686881|58664441|FG001|Overall Study|Lack of Efficacy|3|||
30651914|NCT00686881|58664440|FG000|Overall Study|Physician Decision|1|||
30651915|NCT00686881|58664441|FG001|Overall Study|Physician Decision|0|||
30651916|NCT00686881|58664440|FG000|Overall Study|Circumstances of site|1|||
30651917|NCT00686881|58664441|FG001|Overall Study|Circumstances of site|1|||
30651918|NCT00686881|58664440|FG000|Overall Study|Did not meet protocol eligibility|1|||
30651919|NCT00686881|58664441|FG001|Overall Study|Did not meet protocol eligibility|0|||
30651920|NCT00686881|58664440|FG000|Overall Study|Irregular visits|1|||
30651921|NCT00686881|58664441|FG001|Overall Study|Irregular visits|0|||
30651922|NCT00686881|58664440|FG000|Overall Study|Study discontinuation|35|||
30651923|NCT00686881|58664441|FG001|Overall Study|Study discontinuation|32|||
30651924|NCT00686881|58664440|FG000|Overall Study|Never received study drug|2|||
30651925|NCT00686881|58664441|FG001|Overall Study|Never received study drug|6|||
30651926|NCT00727714|58664449|FG000|Overall Study|Lost to Follow-up|2|||
30651927|NCT00727558|58664455|FG000|Overall Study|Lens issue|0|||
30651928|NCT00727558|58664456|FG001|Overall Study|Lens issue|1|||
30651929|NCT00727558|58664455|FG000|Overall Study|Adverse Event|0|||
30651930|NCT00727558|58664456|FG001|Overall Study|Adverse Event|1|||
30651931|NCT00727558|58664455|FG000|Overall Study|Subject unable to return for follow-up|1|||
30651932|NCT00727558|58664456|FG001|Overall Study|Subject unable to return for follow-up|1|||
30651933|NCT00727558|58664455|FG000|Overall Study|Lost to Follow-up|1|||
30651934|NCT00727558|58664456|FG001|Overall Study|Lost to Follow-up|0|||
30651935|NCT00688597|58664465|FG000|Overall Study|Adverse Event|2|||
30651936|NCT00688597|58664466|FG001|Overall Study|Adverse Event|0|||
30651937|NCT00688597|58664467|FG002|Overall Study|Adverse Event|0|||
30651938|NCT00688597|58664465|FG000|Overall Study|Physician Decision|1|||
30651939|NCT00688597|58664466|FG001|Overall Study|Physician Decision|0|||
30651940|NCT00688597|58664467|FG002|Overall Study|Physician Decision|0|||
30651941|NCT00735904|58664475|FG000|Overall Study|Adverse Event|3|||
30651942|NCT00735904|58664475|FG000|Overall Study|Death|20|||
30651943|NCT00735904|58664475|FG000|Overall Study|Protocol Violation|1|||
30651944|NCT00735904|58664475|FG000|Overall Study|Withdrawal by Subject|1|||
30651945|NCT00735904|58664475|FG000|Overall Study|Study Terminated by Sponsor|5|||
30651946|NCT00735904|58664475|FG000|Overall Study|Other|8|||
30651947|NCT00688519|58664481|FG000|Overall Study|Adverse Event|2|||
30651948|NCT00688519|58664482|FG001|Overall Study|Adverse Event|3|||
30651949|NCT00688519|58664481|FG000|Overall Study|Lost to Follow-up|3|||
30651950|NCT00688519|58664482|FG001|Overall Study|Lost to Follow-up|3|||
30651951|NCT00688519|58664481|FG000|Overall Study|Lack of Efficacy|3|||
30651952|NCT00688519|58664482|FG001|Overall Study|Lack of Efficacy|1|||
30651953|NCT00688519|58664481|FG000|Overall Study|Withdrawal by Subject|7|||
30651954|NCT00688519|58664482|FG001|Overall Study|Withdrawal by Subject|6|||
30651955|NCT00688519|58664481|FG000|Overall Study|Prohibited medication|1|||
30651956|NCT00688519|58664482|FG001|Overall Study|Prohibited medication|0|||
30651957|NCT00688519|58664481|FG000|Overall Study|Non-compliance|0|||
30651958|NCT00688519|58664482|FG001|Overall Study|Non-compliance|1|||
30651959|NCT00688519|58664481|FG000|Overall Study|Subject moved out of state|1|||
30651960|NCT00688519|58664482|FG001|Overall Study|Subject moved out of state|0|||
30651961|NCT00688519|58664481|FG000|Overall Study|Investigator decision|1|||
30651962|NCT00688519|58664482|FG001|Overall Study|Investigator decision|0|||
30651963|NCT00688519|58664481|FG000|Overall Study|Subject moved out of area|1|||
30651964|NCT00688519|58664482|FG001|Overall Study|Subject moved out of area|0|||
30651965|NCT00688519|58664481|FG000|Overall Study|Pregnancy|0|||
30651966|NCT00688519|58664482|FG001|Overall Study|Pregnancy|1|||
30651967|NCT00721630|58664488|FG000|Overall Study|Participant found to be ineligible|1|||
30651968|NCT00686725|58664494|FG000|Overall Study|Adverse Event|1|||
30651969|NCT00686725|58664495|FG001|Overall Study|Adverse Event|1|||
30651970|NCT00686725|58664494|FG000|Overall Study|Progressive Disease|17|||
30651971|NCT00686725|58664495|FG001|Overall Study|Progressive Disease|23|||
30651972|NCT00686725|58664494|FG000|Overall Study|Lost to Follow-up|7|||
30651973|NCT00686725|58664495|FG001|Overall Study|Lost to Follow-up|5|||
30651974|NCT00686725|58664494|FG000|Overall Study|Death|6|||
30651975|NCT00686725|58664495|FG001|Overall Study|Death|3|||
30651976|NCT00686725|58664494|FG000|Overall Study|Withdrawal by Subject|13|||
30651977|NCT00686725|58664495|FG001|Overall Study|Withdrawal by Subject|4|||
30651978|NCT00686725|58664494|FG000|Overall Study|Protocol Violation|1|||
30651979|NCT00686725|58664495|FG001|Overall Study|Protocol Violation|3|||
30651980|NCT00686725|58664494|FG000|Overall Study|Other|1|||
30651981|NCT00686725|58664495|FG001|Overall Study|Other|3|||
30651982|NCT00727402|58664501|FG000|Overall Study|Physician Decision|116|||
30651983|NCT00727246|58664509|FG000|Overall Study|could not complete MRI|0|||
30651984|NCT00727246|58664510|FG001|Overall Study|could not complete MRI|1|||
30651985|NCT00727246|58664511|FG002|Overall Study|could not complete MRI|0|||
30651986|NCT00727246|58664512|FG003|Overall Study|could not complete MRI|1|||
30651987|NCT00727246|58664509|FG000|Overall Study|incidental finding|0|||
30651988|NCT00727246|58664510|FG001|Overall Study|incidental finding|0|||
30651989|NCT00727246|58664511|FG002|Overall Study|incidental finding|0|||
30651990|NCT00727246|58664512|FG003|Overall Study|incidental finding|1|||
30651991|NCT00727246|58664509|FG000|Overall Study|withdrawn|0|||
30651992|NCT00727246|58664510|FG001|Overall Study|withdrawn|0|||
30651993|NCT00727246|58664511|FG002|Overall Study|withdrawn|1|||
30651994|NCT00727246|58664512|FG003|Overall Study|withdrawn|0|||
30651995|NCT00686647|58664522|FG000|Overall Study|Lost to Follow-up|1|||
30651996|NCT00686647|58664522|FG000|Overall Study|Death|1|||
30767746|NCT00304031|58776725|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
30767747|NCT00304031|58776726|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
30767748|NCT00304031|58776727|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
30767749|NCT00332189|58776742|FG000|Overall Study|Adverse Event|3|||
30767750|NCT00332189|58776742|FG000|Overall Study|Uncooperative/Noncompliant|3|||
30767751|NCT00332189|58776742|FG000|Overall Study|Withdrawal by Subject|9|||
30767752|NCT00332189|58776742|FG000|Overall Study|Lack of Efficacy|4|||
30767753|NCT00332189|58776742|FG000|Overall Study|Moved out of country|2|||
30767754|NCT00331799|58776747|FG000|Overall Study|Withdrawal by Subject|2|||
30651997|NCT00687973|58664529|FG000|Overall Study|Adverse Event|18|||
30651998|NCT00687973|58664530|FG001|Overall Study|Adverse Event|28|||
30651999|NCT00687973|58664529|FG000|Overall Study|Lack of Efficacy|2|||
30652000|NCT00687973|58664530|FG001|Overall Study|Lack of Efficacy|3|||
30767755|NCT00331799|58776747|FG000|Overall Study|Sedation|1|||
30767756|NCT00303719|58776753|FG000|Overall Study|Not evaluable, prior therapies|0|||
30652001|NCT00687973|58664529|FG000|Overall Study|Protocol Violation|1|||
30652002|NCT00687973|58664530|FG001|Overall Study|Protocol Violation|2|||
30652003|NCT00687973|58664529|FG000|Overall Study|Administrative Reasons|0|||
30652004|NCT00687973|58664530|FG001|Overall Study|Administrative Reasons|2|||
30652005|NCT00687973|58664529|FG000|Overall Study|Withdrawal by Subject|3|||
30652006|NCT00687973|58664530|FG001|Overall Study|Withdrawal by Subject|3|||
30652007|NCT00721396|58664541|FG000|Overall Study|Adverse Event|4|||
30652008|NCT00721396|58664542|FG001|Overall Study|Adverse Event|7|||
30652009|NCT00721396|58664543|FG002|Overall Study|Adverse Event|2|||
30652010|NCT00721396|58664544|FG003|Overall Study|Adverse Event|0|||
30652011|NCT00721396|58664541|FG000|Overall Study|Withdrawal by Subject|12|||
30652012|NCT00721396|58664542|FG001|Overall Study|Withdrawal by Subject|15|||
30652013|NCT00721396|58664543|FG002|Overall Study|Withdrawal by Subject|3|||
30652014|NCT00721396|58664544|FG003|Overall Study|Withdrawal by Subject|7|||
30652015|NCT00721396|58664541|FG000|Overall Study|Lost to Follow-up|7|||
30652016|NCT00721396|58664542|FG001|Overall Study|Lost to Follow-up|9|||
30652017|NCT00721396|58664543|FG002|Overall Study|Lost to Follow-up|3|||
30652018|NCT00721396|58664544|FG003|Overall Study|Lost to Follow-up|3|||
30652019|NCT00721396|58664541|FG000|Overall Study|Protocol Violation|4|||
30652020|NCT00721396|58664542|FG001|Overall Study|Protocol Violation|3|||
30652021|NCT00721396|58664543|FG002|Overall Study|Protocol Violation|1|||
30652022|NCT00721396|58664544|FG003|Overall Study|Protocol Violation|0|||
30652023|NCT00721396|58664541|FG000|Overall Study|Inappropriate enrollment|0|||
30652024|NCT00721396|58664542|FG001|Overall Study|Inappropriate enrollment|2|||
30652025|NCT00721396|58664543|FG002|Overall Study|Inappropriate enrollment|0|||
30652026|NCT00721396|58664544|FG003|Overall Study|Inappropriate enrollment|0|||
30652027|NCT00721396|58664541|FG000|Overall Study|Administrative reason|3|||
30652028|NCT00721396|58664542|FG001|Overall Study|Administrative reason|0|||
30652029|NCT00721396|58664543|FG002|Overall Study|Administrative reason|1|||
30652030|NCT00721396|58664544|FG003|Overall Study|Administrative reason|0|||
30652031|NCT00943826|58664561|FG000|Concurrent Phase|Adverse Event|50|||
30652032|NCT00943826|58664562|FG001|Concurrent Phase|Adverse Event|27|||
30652033|NCT00943826|58664561|FG000|Concurrent Phase|Withdrew consent|3|||
30652034|NCT00943826|58664562|FG001|Concurrent Phase|Withdrew consent|7|||
30652035|NCT00943826|58664561|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
30652036|NCT00943826|58664562|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
30767757|NCT00303719|58776754|FG001|Overall Study|Not evaluable, prior therapies|30|||
30767758|NCT00303719|58776753|FG000|Overall Study|Lost to Follow-up|0|||
30767759|NCT00303719|58776754|FG001|Overall Study|Lost to Follow-up|7|||
30767760|NCT00331409|58776761|FG000|Overall Study|Lack of Efficacy|4|||
30652037|NCT00943826|58664561|FG000|Concurrent Phase|Administrative reasons|2|||
30652038|NCT00943826|58664562|FG001|Concurrent Phase|Administrative reasons|1|||
30652039|NCT00943826|58664561|FG000|Concurrent Phase|Protocol Violation|1|||
30652040|NCT00943826|58664562|FG001|Concurrent Phase|Protocol Violation|0|||
30652041|NCT00943826|58664561|FG000|Maintenance Phase|Adverse Event|31|||
30652042|NCT00943826|58664562|FG001|Maintenance Phase|Adverse Event|30|||
30652043|NCT00943826|58664561|FG000|Maintenance Phase|Withdrew consent|2|||
30652044|NCT00943826|58664562|FG001|Maintenance Phase|Withdrew consent|4|||
30652045|NCT00943826|58664561|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
30652046|NCT00943826|58664562|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
30652047|NCT00943826|58664561|FG000|Maintenance Phase|Administrative reasons|4|||
30652048|NCT00943826|58664562|FG001|Maintenance Phase|Administrative reasons|1|||
30652049|NCT00943826|58664561|FG000|Maintenance Phase|Failure to return|0|||
30652050|NCT00943826|58664562|FG001|Maintenance Phase|Failure to return|1|||
30652051|NCT00943826|58664561|FG000|Monotherapy Phase|Adverse Event|42|||
30652052|NCT00943826|58664562|FG001|Monotherapy Phase|Adverse Event|5|||
30652053|NCT00943826|58664561|FG000|Monotherapy Phase|Administrative reasons|11|||
30652054|NCT00943826|58664562|FG001|Monotherapy Phase|Administrative reasons|5|||
30652055|NCT00943826|58664561|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
30652056|NCT00943826|58664562|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
30652057|NCT00943826|58664561|FG000|Monotherapy Phase|Withdrew Consent|2|||
30652058|NCT00943826|58664562|FG001|Monotherapy Phase|Withdrew Consent|3|||
30652059|NCT00943826|58664561|FG000|Monotherapy Phase|Failure to return|2|||
30652060|NCT00943826|58664562|FG001|Monotherapy Phase|Failure to return|1|||
30652061|NCT00943826|58664561|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
30652062|NCT00943826|58664562|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
30652063|NCT00943826|58664561|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
30652064|NCT00943826|58664562|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
30652065|NCT00943826|58664561|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
30652066|NCT00943826|58664562|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
30767761|NCT00303485|58776767|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
30767762|NCT00303485|58776768|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
30767763|NCT00303485|58776767|FG000|Overall Study|Failure to return|0|||
30767764|NCT00303485|58776768|FG001|Overall Study|Failure to return|1|||
30767765|NCT00303485|58776767|FG000|Overall Study|Withdrawal by Subject|1|||
30767766|NCT00303485|58776768|FG001|Overall Study|Withdrawal by Subject|0|||
30767767|NCT03235726|58776782|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
30767768|NCT03235726|58776783|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
30767769|NCT03235726|58776784|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
30848702|NCT00643617|58875148|FG001|Overall Study|Death|9|||
30952190|NCT01592240|58999714|FG001|Overall Study|Adverse Event|0|||
30652067|NCT00943826|58664561|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
30952191|NCT01592240|58999715|FG002|Overall Study|Adverse Event|0|||
30952192|NCT01592240|58999716|FG003|Overall Study|Adverse Event|1|||
30767770|NCT03235726|58776785|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
30767771|NCT03235726|58776786|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
30767772|NCT03235726|58776787|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
30767773|NCT03235726|58776788|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
30767774|NCT03235726|58776789|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
30767775|NCT03235726|58776790|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
30952193|NCT01592240|58999717|FG004|Overall Study|Adverse Event|1|||
30952194|NCT01592240|58999718|FG005|Overall Study|Adverse Event|0|||
30952195|NCT01592240|58999719|FG006|Overall Study|Adverse Event|0|||
30652068|NCT00943826|58664562|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
30652069|NCT01004003|58664578|FG000|Overall Study|Progressive disease|2|||
30652070|NCT01004003|58664579|FG001|Overall Study|Progressive disease|1|||
30652071|NCT01004003|58664580|FG002|Overall Study|Progressive disease|1|||
30652072|NCT01004003|58664581|FG003|Overall Study|Progressive disease|0|||
30652073|NCT01004003|58664582|FG004|Overall Study|Progressive disease|2|||
30652074|NCT01004003|58664583|FG005|Overall Study|Progressive disease|1|||
30652075|NCT01004003|58664584|FG006|Overall Study|Progressive disease|1|||
30652076|NCT01004003|58664585|FG007|Overall Study|Progressive disease|39|||
30652077|NCT01004003|58664586|FG008|Overall Study|Progressive disease|22|||
30652078|NCT01004003|58664578|FG000|Overall Study|Adverse Event|4|||
30652079|NCT01004003|58664579|FG001|Overall Study|Adverse Event|2|||
30652080|NCT01004003|58664580|FG002|Overall Study|Adverse Event|3|||
30652081|NCT01004003|58664581|FG003|Overall Study|Adverse Event|3|||
30652082|NCT01004003|58664582|FG004|Overall Study|Adverse Event|2|||
30652083|NCT01004003|58664583|FG005|Overall Study|Adverse Event|2|||
30952196|NCT01592240|58999713|FG000|Overall Study|Death|0|||
30652084|NCT01004003|58664584|FG006|Overall Study|Adverse Event|7|||
30952197|NCT01592240|58999714|FG001|Overall Study|Death|1|||
30952198|NCT01592240|58999715|FG002|Overall Study|Death|0|||
30952199|NCT01592240|58999716|FG003|Overall Study|Death|0|||
30952200|NCT01592240|58999717|FG004|Overall Study|Death|0|||
30952201|NCT01592240|58999718|FG005|Overall Study|Death|0|||
30952202|NCT01592240|58999719|FG006|Overall Study|Death|0|||
30952203|NCT01592240|58999713|FG000|Overall Study|Lost to Follow-up|1|||
30952204|NCT01592240|58999714|FG001|Overall Study|Lost to Follow-up|3|||
30952205|NCT01592240|58999715|FG002|Overall Study|Lost to Follow-up|1|||
30952206|NCT01592240|58999716|FG003|Overall Study|Lost to Follow-up|0|||
30952207|NCT01592240|58999717|FG004|Overall Study|Lost to Follow-up|3|||
30952208|NCT01592240|58999718|FG005|Overall Study|Lost to Follow-up|2|||
30952209|NCT01592240|58999719|FG006|Overall Study|Lost to Follow-up|0|||
30952210|NCT01592240|58999713|FG000|Overall Study|Protocol Violation|0|||
30952211|NCT01592240|58999714|FG001|Overall Study|Protocol Violation|0|||
30952212|NCT01592240|58999715|FG002|Overall Study|Protocol Violation|0|||
30952213|NCT01592240|58999716|FG003|Overall Study|Protocol Violation|0|||
30952214|NCT01592240|58999717|FG004|Overall Study|Protocol Violation|0|||
30952215|NCT01592240|58999718|FG005|Overall Study|Protocol Violation|1|||
30952216|NCT01592240|58999719|FG006|Overall Study|Protocol Violation|0|||
30952217|NCT01592240|58999713|FG000|Overall Study|Withdrawal by Subject|0|||
30652085|NCT01004003|58664585|FG007|Overall Study|Adverse Event|21|||
30652086|NCT01004003|58664586|FG008|Overall Study|Adverse Event|6|||
30652087|NCT01004003|58664578|FG000|Overall Study|Refused to continue taking trial med.|0|||
30652088|NCT01004003|58664579|FG001|Overall Study|Refused to continue taking trial med.|0|||
30652089|NCT01004003|58664580|FG002|Overall Study|Refused to continue taking trial med.|0|||
30952218|NCT01592240|58999714|FG001|Overall Study|Withdrawal by Subject|4|||
30952219|NCT01592240|58999715|FG002|Overall Study|Withdrawal by Subject|4|||
30952220|NCT01592240|58999716|FG003|Overall Study|Withdrawal by Subject|1|||
30952221|NCT01592240|58999717|FG004|Overall Study|Withdrawal by Subject|3|||
30952222|NCT01592240|58999718|FG005|Overall Study|Withdrawal by Subject|0|||
30952223|NCT01592240|58999719|FG006|Overall Study|Withdrawal by Subject|2|||
30652090|NCT01004003|58664581|FG003|Overall Study|Refused to continue taking trial med.|0|||
30652091|NCT01004003|58664582|FG004|Overall Study|Refused to continue taking trial med.|0|||
30652092|NCT01004003|58664583|FG005|Overall Study|Refused to continue taking trial med.|0|||
30652093|NCT01004003|58664584|FG006|Overall Study|Refused to continue taking trial med.|0|||
30652094|NCT01004003|58664585|FG007|Overall Study|Refused to continue taking trial med.|0|||
30652095|NCT01004003|58664586|FG008|Overall Study|Refused to continue taking trial med.|2|||
30652096|NCT01004003|58664578|FG000|Overall Study|Other|0|||
30652097|NCT01004003|58664579|FG001|Overall Study|Other|0|||
30652098|NCT01004003|58664580|FG002|Overall Study|Other|0|||
30652099|NCT01004003|58664581|FG003|Overall Study|Other|0|||
30652100|NCT01004003|58664582|FG004|Overall Study|Other|0|||
30652101|NCT01004003|58664583|FG005|Overall Study|Other|1|||
30652102|NCT01004003|58664584|FG006|Overall Study|Other|0|||
30652103|NCT01004003|58664585|FG007|Overall Study|Other|0|||
30652104|NCT01004003|58664586|FG008|Overall Study|Other|0|||
30652105|NCT00943670|58664608|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
30652106|NCT00943670|58664608|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
30652107|NCT00943670|58664608|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
30652108|NCT00943670|58664608|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
30652109|NCT00943670|58664608|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
30652110|NCT00943670|58664608|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
30652111|NCT00943670|58664608|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
30652112|NCT00943670|58664608|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
30767776|NCT03235726|58776791|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
30767777|NCT03235726|58776782|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
30767778|NCT03235726|58776783|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
30767779|NCT03235726|58776784|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
30767780|NCT03235726|58776785|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
30767781|NCT03235726|58776786|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
30767782|NCT03235726|58776787|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
30767783|NCT03235726|58776788|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
30767784|NCT03235726|58776789|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
30767785|NCT03235726|58776790|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
30767786|NCT03235726|58776791|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
30767787|NCT00303953|58776826|FG000|Overall Study|Ineligible|1|||
30767788|NCT00303953|58776826|FG000|Overall Study|Death|1|||
30767789|NCT00303953|58776826|FG000|Overall Study|Adverse Event|4|||
30767790|NCT00303953|58776826|FG000|Overall Study|Lack of Efficacy|12|||
30767791|NCT00303953|58776826|FG000|Overall Study|Physician Decision|1|||
30767792|NCT03723590|58776830|FG000|Overall Study|Withdrawal by Subject|3|||
30767793|NCT02935894|58776834|FG000|Overall Study|Subject dismissed|1|||
30767794|NCT03224182|58776840|FG000|Overall Study|Study Drug Not Instilled|6|||
30767795|NCT03224182|58776841|FG001|Overall Study|Study Drug Not Instilled|1|||
30767796|NCT03224182|58776840|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
30767797|NCT03224182|58776841|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
30767798|NCT03224182|58776840|FG000|Overall Study|Withdrew of Consent|4|||
30767799|NCT03224182|58776841|FG001|Overall Study|Withdrew of Consent|2|||
30767800|NCT03224182|58776840|FG000|Overall Study|Investigator Decision|3|||
30767801|NCT03224182|58776841|FG001|Overall Study|Investigator Decision|1|||
30767802|NCT03224182|58776840|FG000|Overall Study|Sponsor Decision|26|||
30767803|NCT03224182|58776841|FG001|Overall Study|Sponsor Decision|12|||
30767804|NCT03224182|58776840|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
30767805|NCT03224182|58776841|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
30952224|NCT01592240|58999713|FG000|Overall Study|Other|0|||
30952225|NCT01592240|58999714|FG001|Overall Study|Other|3|||
30952226|NCT01592240|58999715|FG002|Overall Study|Other|1|||
30952227|NCT01592240|58999716|FG003|Overall Study|Other|1|||
30952228|NCT01592240|58999717|FG004|Overall Study|Other|0|||
30652113|NCT00943670|58664608|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
30652114|NCT00943670|58664608|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
30652115|NCT00938366|58664625|FG000|Overall Study|Withdrawal by Subject|1|||
30952229|NCT01592240|58999718|FG005|Overall Study|Other|0|||
30952230|NCT01592240|58999719|FG006|Overall Study|Other|1|||
30952231|NCT01592240|58999713|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
30767806|NCT03224182|58776840|FG000|Overall Study|Lost to Follow-up|1|||
30767807|NCT03224182|58776841|FG001|Overall Study|Lost to Follow-up|0|||
30767808|NCT03224182|58776840|FG000|Overall Study|Participant Had Recurrence|11|||
30767809|NCT03224182|58776841|FG001|Overall Study|Participant Had Recurrence|5|||
30767810|NCT03224182|58776840|FG000|Overall Study|Death|0|||
30767811|NCT03224182|58776841|FG001|Overall Study|Death|1|||
30767812|NCT03224182|58776840|FG000|Overall Study|Reason not Specified|3|||
30767813|NCT03224182|58776841|FG001|Overall Study|Reason not Specified|3|||
30767814|NCT03224182|58776840|FG000|Overall Study|Other|1|||
30767815|NCT03224182|58776841|FG001|Overall Study|Other|0|||
30767816|NCT02935192|58776849|FG000|Overall Study|Withdrawal by Subject|8|||
30767817|NCT02935192|58776850|FG001|Overall Study|Withdrawal by Subject|4|||
30767818|NCT03722264|58776856|FG000|Overall Study|Physician Decision|3|||
30767819|NCT03722030|58776864|FG000|Overall Study|Withdrawal by Subject|1|||
30848703|NCT00643617|58875147|FG000|Overall Study|Lost to Follow-up|42|||
30952232|NCT01592240|58999714|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
30952233|NCT01592240|58999715|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
30952234|NCT01592240|58999716|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
30652116|NCT00938366|58664626|FG001|Overall Study|Withdrawal by Subject|0|||
30652117|NCT00943592|58664632|FG000|Overall Study|Death|3|||
30652118|NCT00943124|58664636|FG000|Period 1|Withdrawal by Subject|1|||
30652119|NCT00943124|58664637|FG001|Period 1|Withdrawal by Subject|1|||
30652120|NCT00943124|58664636|FG000|Period 1|Did Not Follow Study Procedures|1|||
30652121|NCT00943124|58664637|FG001|Period 1|Did Not Follow Study Procedures|0|||
30652122|NCT00943124|58664636|FG000|Period 1|Personal Reasons|0|||
30652123|NCT00943124|58664637|FG001|Period 1|Personal Reasons|1|||
30652124|NCT00492050|58664643|FG000|Overall Study|Adverse Event|1|||
30652125|NCT00492050|58664643|FG000|Overall Study|Lack of Efficacy|1|||
30652126|NCT00492050|58664643|FG000|Overall Study|Withdrawal by Subject|3|||
30652127|NCT00492050|58664643|FG000|Overall Study|Unable to collect SCT|2|||
30652128|NCT00492050|58664643|FG000|Overall Study|Progressive Disease|2|||
30652129|NCT00726622|58664649|FG000|Overall Study|Withdrawal by Subject|16|||
30652130|NCT00726622|58664650|FG001|Overall Study|Withdrawal by Subject|2|||
30652131|NCT00726622|58664649|FG000|Overall Study|Physician Decision|0|||
30652132|NCT00726622|58664650|FG001|Overall Study|Physician Decision|1|||
30652133|NCT00726622|58664649|FG000|Overall Study|Metastasis|2|||
30652134|NCT00726622|58664650|FG001|Overall Study|Metastasis|0|||
30652135|NCT00940316|58664659|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
30652136|NCT00940316|58664660|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
30652137|NCT00940316|58664661|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
30652138|NCT00940316|58664659|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
30652139|NCT00940316|58664660|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
30767820|NCT03722030|58776865|FG001|Overall Study|Withdrawal by Subject|0|||
30952235|NCT01592240|58999717|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
30952236|NCT01592240|58999718|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
30952237|NCT01592240|58999719|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
30952238|NCT01591616|58999762|FG000|Overall Study|Withdrawal by Subject|1|||
30952239|NCT01591460|58999918|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
30952240|NCT01591460|58999918|FG000|Overall Study|Futility Rule (Week 12)|7|||
30952241|NCT01591460|58999918|FG000|Overall Study|Futility Rule (Week 24)|3|||
30952242|NCT01591460|58999918|FG000|Overall Study|Rebound or Breakthrough|3|||
30952243|NCT01591460|58999918|FG000|Overall Study|Treatment Discontinued by Error|1|||
30952244|NCT01591460|58999918|FG000|Overall Study|Lost to Follow-up|1|||
30952245|NCT01591460|58999918|FG000|Overall Study|Noncompliance|1|||
30952246|NCT01591460|58999918|FG000|Overall Study|Participant Refusal|3|||
30952247|NCT01591460|58999918|FG000|Overall Study|Withdrawal by Subject|1|||
30952248|NCT01591460|58999918|FG000|Overall Study|Protocol Violation|1|||
30952249|NCT01591382|58999941|FG000|Overall Study|Discharged Prior to Study Completion|2|||
30952250|NCT01591382|58999942|FG001|Overall Study|Discharged Prior to Study Completion|1|||
30952251|NCT01591382|58999941|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
30952252|NCT01591382|58999942|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
30652140|NCT00940316|58664661|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
30652141|NCT00940316|58664659|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
30652142|NCT00940316|58664660|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
30767821|NCT03221842|58776872|FG000|Period 1 (Open-label)|Adverse Event|4|||
30767822|NCT03221842|58776873|FG001|Period 1 (Open-label)|Adverse Event|0|||
30767823|NCT03221842|58776872|FG000|Period 1 (Open-label)|Physician Decision|2|||
30767824|NCT03221842|58776873|FG001|Period 1 (Open-label)|Physician Decision|0|||
30767825|NCT03221842|58776872|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
30952253|NCT01696214|58999960|FG000|Overall Study|Lost to Follow-up|1|||
30652143|NCT00940316|58664661|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
30767826|NCT03221842|58776873|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
30767827|NCT03221842|58776872|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
30848704|NCT00643617|58875148|FG001|Overall Study|Lost to Follow-up|51|||
30952254|NCT01696214|58999961|FG001|Overall Study|Lost to Follow-up|0|||
30952255|NCT01696214|58999962|FG002|Overall Study|Lost to Follow-up|0|||
30652144|NCT00940316|58664659|FG000|Treated After Cycle 5|Adverse Event|0|||
30652145|NCT00940316|58664660|FG001|Treated After Cycle 5|Adverse Event|0|||
30652146|NCT00940316|58664661|FG002|Treated After Cycle 5|Adverse Event|1|||
30652147|NCT00940316|58664659|FG000|Treated After Cycle 5|Progressive disease|0|||
30652148|NCT00940316|58664660|FG001|Treated After Cycle 5|Progressive disease|1|||
30652149|NCT00940316|58664661|FG002|Treated After Cycle 5|Progressive disease|0|||
30652150|NCT00726388|58664677|FG000|Overall Study|Withdrawal by Subject|5|||
30652151|NCT00726388|58664677|FG000|Overall Study|Adverse Event|3|||
30767828|NCT03221842|58776873|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
30767829|NCT03221842|58776872|FG000|Period 1 (Open-label)|Other|2|||
30767830|NCT03221842|58776873|FG001|Period 1 (Open-label)|Other|0|||
30767831|NCT03221842|58776872|FG000|Period 2 (Randomized, Blinded)|Death|0|||
30767832|NCT03221842|58776873|FG001|Period 2 (Randomized, Blinded)|Death|1|||
30767833|NCT03221842|58776872|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
30652152|NCT00726388|58664677|FG000|Overall Study|Lost to Follow-up|10|||
30652153|NCT00726388|58664677|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
30652154|NCT00726388|58664677|FG000|Overall Study|Other|5|||
30652155|NCT00726388|58664677|FG000|Overall Study|Enrolled, Not Treated|79|||
30652156|NCT00572455|58664695|FG000|Stage I (14 Days)|Adverse Event|0|||
30652157|NCT00572455|58664696|FG001|Stage I (14 Days)|Adverse Event|0|||
30767834|NCT03221842|58776873|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
30767835|NCT03364738|58776883|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
30767836|NCT03364738|58776883|FG000|Overall Study|Withdrawal by Subject|1|||
30767837|NCT03364738|58776883|FG000|Overall Study|Adverse Event|1|||
30767838|NCT00303329|58776890|FG000|Overall Study|Adverse Event|7|||
30767839|NCT00303329|58776891|FG001|Overall Study|Adverse Event|14|||
30767840|NCT00303329|58776890|FG000|Overall Study|Abnormal Laboratory Values|0|||
30767841|NCT00303329|58776891|FG001|Overall Study|Abnormal Laboratory Values|1|||
30767842|NCT00303329|58776890|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
30767843|NCT00303329|58776891|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30767844|NCT00303329|58776890|FG000|Overall Study|Condition no longer requires study drug|0|||
30767845|NCT00303329|58776891|FG001|Overall Study|Condition no longer requires study drug|8|||
30767846|NCT00303329|58776890|FG000|Overall Study|Protocol Violation|3|||
30767847|NCT00303329|58776891|FG001|Overall Study|Protocol Violation|0|||
30767848|NCT00303329|58776890|FG000|Overall Study|Withdrawal by Subject|9|||
30767849|NCT00303329|58776891|FG001|Overall Study|Withdrawal by Subject|15|||
30767850|NCT00303329|58776890|FG000|Overall Study|Lost to Follow-up|0|||
30767851|NCT00303329|58776891|FG001|Overall Study|Lost to Follow-up|1|||
30767852|NCT00303329|58776890|FG000|Overall Study|Administrative problems|1|||
30848705|NCT00504582|58875175|FG000|Overall Study|Lost to Follow-up|1|||
30848706|NCT00504582|58875176|FG001|Overall Study|Lost to Follow-up|0|||
30848707|NCT00504582|58875177|FG002|Overall Study|Lost to Follow-up|0|||
30848708|NCT00314366|58875200|FG000|Overall Study|not treated due to patient medical condi|1|||
30848709|NCT00314366|58875201|FG001|Overall Study|not treated due to patient medical condi|0|||
30848710|NCT01595061|58875210|FG000|Overall Study|Never Treated|3|||
30652158|NCT00572455|58664697|FG002|Stage I (14 Days)|Adverse Event|0|||
30652159|NCT00572455|58664698|FG003|Stage I (14 Days)|Adverse Event|0|||
30652160|NCT00572455|58664699|FG004|Stage I (14 Days)|Adverse Event|0|||
30652161|NCT00572455|58664700|FG005|Stage I (14 Days)|Adverse Event|3|||
30652162|NCT00572455|58664701|FG006|Stage I (14 Days)|Adverse Event|0|||
30652163|NCT00572455|58664702|FG007|Stage I (14 Days)|Adverse Event|0|||
30652164|NCT00572455|58664703|FG008|Stage I (14 Days)|Adverse Event|0|||
30652165|NCT00572455|58664704|FG009|Stage I (14 Days)|Adverse Event|0|||
30652166|NCT00572455|58664705|FG010|Stage I (14 Days)|Adverse Event|0|||
30652167|NCT00572455|58664706|FG011|Stage I (14 Days)|Adverse Event|0|||
30652168|NCT00572455|58664707|FG012|Stage I (14 Days)|Adverse Event|0|||
30652169|NCT00572455|58664708|FG013|Stage I (14 Days)|Adverse Event|0|||
30652170|NCT00572455|58664695|FG000|Stage I (14 Days)|Other|0|||
30652171|NCT00572455|58664696|FG001|Stage I (14 Days)|Other|0|||
30652172|NCT00572455|58664697|FG002|Stage I (14 Days)|Other|0|||
30652173|NCT00572455|58664698|FG003|Stage I (14 Days)|Other|0|||
30652174|NCT00572455|58664699|FG004|Stage I (14 Days)|Other|1|||
30652175|NCT00572455|58664700|FG005|Stage I (14 Days)|Other|0|||
30767853|NCT00303329|58776891|FG001|Overall Study|Administrative problems|0|||
30767854|NCT00303329|58776890|FG000|Overall Study|Death|2|||
30767855|NCT00303329|58776891|FG001|Overall Study|Death|12|||
30767856|NCT00303329|58776890|FG000|Overall Study|Stopped at end of core|3|||
30767857|NCT00303329|58776891|FG001|Overall Study|Stopped at end of core|9|||
30767858|NCT00303329|58776890|FG000|Overall Study|Stopped at end of extension 1|1|||
30652176|NCT00572455|58664701|FG006|Stage I (14 Days)|Other|0|||
30652177|NCT00572455|58664702|FG007|Stage I (14 Days)|Other|0|||
30652178|NCT00572455|58664703|FG008|Stage I (14 Days)|Other|0|||
30652179|NCT00572455|58664704|FG009|Stage I (14 Days)|Other|0|||
30652180|NCT00572455|58664705|FG010|Stage I (14 Days)|Other|0|||
30652181|NCT00572455|58664706|FG011|Stage I (14 Days)|Other|0|||
30652182|NCT00572455|58664707|FG012|Stage I (14 Days)|Other|0|||
30652183|NCT00572455|58664708|FG013|Stage I (14 Days)|Other|0|||
30652184|NCT00572455|58664695|FG000|Stage II (28 Days)|Adverse Event|0|||
30652185|NCT00572455|58664696|FG001|Stage II (28 Days)|Adverse Event|0|||
30652186|NCT00572455|58664697|FG002|Stage II (28 Days)|Adverse Event|0|||
30652187|NCT00572455|58664698|FG003|Stage II (28 Days)|Adverse Event|0|||
30652188|NCT00572455|58664699|FG004|Stage II (28 Days)|Adverse Event|0|||
30652189|NCT00572455|58664700|FG005|Stage II (28 Days)|Adverse Event|0|||
30652190|NCT00572455|58664701|FG006|Stage II (28 Days)|Adverse Event|0|||
30652191|NCT00572455|58664702|FG007|Stage II (28 Days)|Adverse Event|0|||
30652192|NCT00572455|58664703|FG008|Stage II (28 Days)|Adverse Event|1|||
30652193|NCT00572455|58664704|FG009|Stage II (28 Days)|Adverse Event|3|||
30652194|NCT00572455|58664705|FG010|Stage II (28 Days)|Adverse Event|3|||
30652195|NCT00572455|58664706|FG011|Stage II (28 Days)|Adverse Event|4|||
30652196|NCT00572455|58664707|FG012|Stage II (28 Days)|Adverse Event|5|||
30652197|NCT00572455|58664708|FG013|Stage II (28 Days)|Adverse Event|1|||
30652198|NCT00572455|58664695|FG000|Stage II (28 Days)|Death|0|||
30652199|NCT00572455|58664696|FG001|Stage II (28 Days)|Death|0|||
30652200|NCT00572455|58664697|FG002|Stage II (28 Days)|Death|0|||
30652201|NCT00572455|58664698|FG003|Stage II (28 Days)|Death|0|||
30652202|NCT00572455|58664699|FG004|Stage II (28 Days)|Death|0|||
30652203|NCT00572455|58664700|FG005|Stage II (28 Days)|Death|0|||
30652204|NCT00572455|58664701|FG006|Stage II (28 Days)|Death|0|||
30652205|NCT00572455|58664702|FG007|Stage II (28 Days)|Death|0|||
30652206|NCT00572455|58664703|FG008|Stage II (28 Days)|Death|1|||
30652207|NCT00572455|58664704|FG009|Stage II (28 Days)|Death|0|||
30652208|NCT00572455|58664705|FG010|Stage II (28 Days)|Death|0|||
30652209|NCT00572455|58664706|FG011|Stage II (28 Days)|Death|0|||
30652210|NCT00572455|58664707|FG012|Stage II (28 Days)|Death|0|||
30767859|NCT00303329|58776891|FG001|Overall Study|Stopped at end of extension 1|0|||
30767860|NCT00329849|58776899|FG000|Overall Study|Withdrawal by Subject|6|||
30767861|NCT00329849|58776900|FG001|Overall Study|Withdrawal by Subject|4|||
30767862|NCT02934178|58776912|FG000|Received Vaccination 2|Death|0|||
30767863|NCT02934178|58776913|FG001|Received Vaccination 2|Death|1|||
30767864|NCT02934178|58776912|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
30767865|NCT02934178|58776913|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
30767866|NCT00329303|58776922|FG000|Overall Study|Lack of Efficacy|1|||
30767867|NCT00329303|58776923|FG001|Overall Study|Lack of Efficacy|0|||
30767868|NCT00329303|58776922|FG000|Overall Study|Decision of the sponsor|0|||
30767869|NCT00329303|58776923|FG001|Overall Study|Decision of the sponsor|1|||
30767870|NCT00329303|58776922|FG000|Overall Study|Patient no longer available|1|||
30767871|NCT00329303|58776923|FG001|Overall Study|Patient no longer available|0|||
30767872|NCT00329303|58776922|FG000|Overall Study|Patient relocated|0|||
30767873|NCT00329303|58776923|FG001|Overall Study|Patient relocated|1|||
30767874|NCT03216850|58776930|FG000|Overall Study|Pre-analytical error|6|||
30767875|NCT00302159|58776934|FG000|Overall Study|pt declined before treatment started|1|||
30767876|NCT00302159|58776934|FG000|Overall Study|pt started Avastin|1|||
30767877|NCT00302081|58776942|FG000|Overall Study|Adverse Event|6|||
30767878|NCT00302081|58776943|FG001|Overall Study|Adverse Event|5|||
30767879|NCT00302081|58776944|FG002|Overall Study|Adverse Event|4|||
30767880|NCT00302081|58776942|FG000|Overall Study|Lost to Follow-up|21|||
30767881|NCT00302081|58776943|FG001|Overall Study|Lost to Follow-up|18|||
30767882|NCT00302081|58776944|FG002|Overall Study|Lost to Follow-up|28|||
30767883|NCT00302081|58776942|FG000|Overall Study|Withdrawal by Subject|8|||
30848711|NCT01595061|58875210|FG000|Overall Study|Inadequate Pathology|1|||
30848712|NCT02852005|58875231|FG000|Overall Study|Lost to Follow-up|0|||
30652211|NCT00572455|58664708|FG013|Stage II (28 Days)|Death|0|||
30652212|NCT00572455|58664695|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
30652213|NCT00572455|58664696|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
30652214|NCT00572455|58664697|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
30652215|NCT00572455|58664698|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
30652216|NCT00572455|58664699|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
30652217|NCT00572455|58664700|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
30767884|NCT00302081|58776943|FG001|Overall Study|Withdrawal by Subject|12|||
30767885|NCT00302081|58776944|FG002|Overall Study|Withdrawal by Subject|8|||
30767886|NCT00302081|58776942|FG000|Overall Study|Protocol Violation|5|||
30767887|NCT00302081|58776943|FG001|Overall Study|Protocol Violation|1|||
30767888|NCT00302081|58776944|FG002|Overall Study|Protocol Violation|2|||
30767889|NCT00302081|58776942|FG000|Overall Study|Lack of Efficacy|1|||
30652218|NCT00572455|58664701|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
30652219|NCT00572455|58664702|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
30652220|NCT00572455|58664703|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
30652221|NCT00572455|58664704|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
30652222|NCT00572455|58664705|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
30652223|NCT00572455|58664706|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
30652224|NCT00572455|58664707|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
30652225|NCT00572455|58664708|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
30652226|NCT00572455|58664695|FG000|Stage II (28 Days)|Other|0|||
30652227|NCT00572455|58664696|FG001|Stage II (28 Days)|Other|0|||
30652228|NCT00572455|58664697|FG002|Stage II (28 Days)|Other|0|||
30652229|NCT00572455|58664698|FG003|Stage II (28 Days)|Other|0|||
30652230|NCT00572455|58664699|FG004|Stage II (28 Days)|Other|0|||
30652231|NCT00572455|58664700|FG005|Stage II (28 Days)|Other|0|||
30652232|NCT00572455|58664701|FG006|Stage II (28 Days)|Other|0|||
30652233|NCT00572455|58664702|FG007|Stage II (28 Days)|Other|0|||
30652234|NCT00572455|58664703|FG008|Stage II (28 Days)|Other|1|||
30652235|NCT00572455|58664704|FG009|Stage II (28 Days)|Other|0|||
30652236|NCT00572455|58664705|FG010|Stage II (28 Days)|Other|0|||
30652237|NCT00572455|58664706|FG011|Stage II (28 Days)|Other|0|||
30652238|NCT00572455|58664707|FG012|Stage II (28 Days)|Other|0|||
30652239|NCT00572455|58664708|FG013|Stage II (28 Days)|Other|0|||
30652240|NCT00572455|58664695|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
30652241|NCT00572455|58664696|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
30767890|NCT00302081|58776943|FG001|Overall Study|Lack of Efficacy|0|||
30767891|NCT00302081|58776944|FG002|Overall Study|Lack of Efficacy|5|||
30767892|NCT00302081|58776942|FG000|Overall Study|Death|2|||
30767893|NCT00302081|58776943|FG001|Overall Study|Death|1|||
30767894|NCT00302081|58776944|FG002|Overall Study|Death|0|||
30767895|NCT00302081|58776942|FG000|Overall Study|Other|13|||
30767896|NCT00302081|58776943|FG001|Overall Study|Other|6|||
30767897|NCT00302081|58776944|FG002|Overall Study|Other|5|||
30767898|NCT00302003|58776952|FG000|Overall Study|Lack of Efficacy|62|||
30767899|NCT00302003|58776952|FG000|Overall Study|Lost to Follow-up|1|||
30767900|NCT00302003|58776952|FG000|Overall Study|Physician Decision|2|||
30767901|NCT00302003|58776952|FG000|Overall Study|Withdrawal by Subject|5|||
30767902|NCT00302003|58776952|FG000|Overall Study|Ineligible|9|||
30767903|NCT00302003|58776952|FG000|Overall Study|Protocol Violation|1|||
30767904|NCT00036270|58776958|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
30767905|NCT00036270|58776959|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
30767906|NCT00036270|58776958|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
30767907|NCT00036270|58776959|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
30767908|NCT00036270|58776958|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
30767909|NCT00036270|58776959|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
30767910|NCT00036270|58776958|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
30767911|NCT00036270|58776959|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
30767912|NCT00036270|58776958|FG000|Study Treatment to 5 Year Report|Other|277|||
30767913|NCT00036270|58776959|FG001|Study Treatment to 5 Year Report|Other|288|||
30652242|NCT00572455|58664697|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
30652243|NCT00572455|58664698|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
30652244|NCT00572455|58664699|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
30652245|NCT00572455|58664700|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
30652246|NCT00572455|58664701|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
30767914|NCT00036270|58776958|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
30767915|NCT00036270|58776959|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
30767916|NCT00036270|58776958|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
30767917|NCT00036270|58776959|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
30767918|NCT00036270|58776958|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
30652247|NCT00572455|58664702|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
30652248|NCT00572455|58664703|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
30652249|NCT00572455|58664704|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
30767919|NCT00036270|58776959|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
30767920|NCT00036270|58776958|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
30767921|NCT00036270|58776959|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
30652250|NCT00572455|58664705|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
30652251|NCT00572455|58664706|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
30652252|NCT00572455|58664707|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
30652253|NCT00572455|58664708|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
30652254|NCT01003691|58664742|FG000|Overall Study|Adverse Event|0|||
30652255|NCT01003691|58664743|FG001|Overall Study|Adverse Event|0|||
30652256|NCT01003691|58664744|FG002|Overall Study|Adverse Event|0|||
30652257|NCT01003691|58664745|FG003|Overall Study|Adverse Event|1|||
30652258|NCT00686335|58664756|FG000|Run-in Period|Adverse Event|1|||
30652259|NCT00686335|58664756|FG000|Run-in Period|asthma exacerbation|1|||
30652260|NCT00686335|58664756|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
30652261|NCT01002989|58664762|FG000|Overall Study|exclusion criteria, no consent|5|||
30652262|NCT00685945|58664766|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
30652263|NCT01007123|58664780|FG000|Overall Study|Adverse Event|3|||
30652264|NCT01007123|58664781|FG001|Overall Study|Adverse Event|4|||
30652265|NCT01007123|58664782|FG002|Overall Study|Adverse Event|7|||
30652266|NCT01007123|58664783|FG003|Overall Study|Adverse Event|1|||
30652267|NCT01007123|58664780|FG000|Overall Study|Lack of Efficacy|1|||
30652268|NCT01007123|58664781|FG001|Overall Study|Lack of Efficacy|0|||
30652269|NCT01007123|58664782|FG002|Overall Study|Lack of Efficacy|1|||
30652270|NCT01007123|58664783|FG003|Overall Study|Lack of Efficacy|4|||
30652271|NCT01007123|58664780|FG000|Overall Study|Protocol Violation|1|||
30652272|NCT01007123|58664781|FG001|Overall Study|Protocol Violation|1|||
30652273|NCT01007123|58664782|FG002|Overall Study|Protocol Violation|2|||
30652274|NCT01007123|58664783|FG003|Overall Study|Protocol Violation|1|||
30652275|NCT01007123|58664780|FG000|Overall Study|Withdrawal by Subject|1|||
30652276|NCT01007123|58664781|FG001|Overall Study|Withdrawal by Subject|0|||
30652277|NCT01007123|58664782|FG002|Overall Study|Withdrawal by Subject|1|||
30652278|NCT01007123|58664783|FG003|Overall Study|Withdrawal by Subject|0|||
30652279|NCT01007123|58664780|FG000|Overall Study|Lost to Follow-up|0|||
30652280|NCT01007123|58664781|FG001|Overall Study|Lost to Follow-up|1|||
30652281|NCT01007123|58664782|FG002|Overall Study|Lost to Follow-up|0|||
30652282|NCT01007123|58664783|FG003|Overall Study|Lost to Follow-up|0|||
30652283|NCT00687739|58664798|FG000|Overall Study|Lost to Follow-up|2|||
30652284|NCT00687739|58664799|FG001|Overall Study|Lost to Follow-up|2|||
30652285|NCT00687739|58664800|FG002|Overall Study|Lost to Follow-up|1|||
30652286|NCT00687739|58664801|FG003|Overall Study|Lost to Follow-up|2|||
30652287|NCT00687739|58664798|FG000|Overall Study|Adverse Event|0|||
30652288|NCT00687739|58664799|FG001|Overall Study|Adverse Event|1|||
30652289|NCT00687739|58664800|FG002|Overall Study|Adverse Event|1|||
30652290|NCT00687739|58664801|FG003|Overall Study|Adverse Event|0|||
30652291|NCT01006889|58664813|FG000|Overall Study|Withdrawal by Subject|3|||
30652292|NCT01001429|58664820|FG000|Overall Study|surgery cancelled|0|||
30652293|NCT01001429|58664821|FG001|Overall Study|surgery cancelled|1|||
30652294|NCT01000961|58664851|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
30652295|NCT01000961|58664852|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
30652296|NCT01000961|58664851|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
30652297|NCT01000961|58664852|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
30652298|NCT01000805|58664862|FG000|Overall Study|Adverse Event|21|||
30652299|NCT01000805|58664863|FG001|Overall Study|Adverse Event|9|||
30652300|NCT01000805|58664862|FG000|Overall Study|Lack of Efficacy|5|||
30652301|NCT01000805|58664863|FG001|Overall Study|Lack of Efficacy|16|||
30652302|NCT01000805|58664862|FG000|Overall Study|Lost to Follow-up|16|||
30652303|NCT01000805|58664863|FG001|Overall Study|Lost to Follow-up|21|||
30652304|NCT01000805|58664862|FG000|Overall Study|Physician Decision|0|||
30652305|NCT01000805|58664863|FG001|Overall Study|Physician Decision|1|||
30652306|NCT01000805|58664862|FG000|Overall Study|Protocol Violation|12|||
30652307|NCT01000805|58664863|FG001|Overall Study|Protocol Violation|8|||
30652308|NCT01000805|58664862|FG000|Overall Study|Withdrawal by Subject|16|||
30652309|NCT01000805|58664863|FG001|Overall Study|Withdrawal by Subject|6|||
30848713|NCT02852005|58875232|FG001|Overall Study|Lost to Follow-up|0|||
30652310|NCT01000805|58664862|FG000|Overall Study|Sponsor Decision|0|||
30652311|NCT01000805|58664863|FG001|Overall Study|Sponsor Decision|1|||
30652312|NCT00684307|58664875|FG000|Overall Study|Adverse Event|11|||
30652313|NCT00684307|58664876|FG001|Overall Study|Adverse Event|6|||
30652314|NCT00684307|58664877|FG002|Overall Study|Adverse Event|15|||
30652315|NCT00684307|58664878|FG003|Overall Study|Adverse Event|16|||
30652316|NCT00684307|58664879|FG004|Overall Study|Adverse Event|8|||
30652317|NCT00684307|58664875|FG000|Overall Study|Development of increasing Liver Function|0|||
30652318|NCT00684307|58664876|FG001|Overall Study|Development of increasing Liver Function|2|||
30652319|NCT00684307|58664877|FG002|Overall Study|Development of increasing Liver Function|0|||
30652320|NCT00684307|58664878|FG003|Overall Study|Development of increasing Liver Function|1|||
30652321|NCT00684307|58664879|FG004|Overall Study|Development of increasing Liver Function|0|||
30652322|NCT00684307|58664875|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
30652323|NCT00684307|58664876|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
30652324|NCT00684307|58664877|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
30652325|NCT00684307|58664878|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
30652326|NCT00684307|58664879|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
30652327|NCT00684307|58664875|FG000|Overall Study|Incorrect enrolment or randomization|4|||
30652328|NCT00684307|58664876|FG001|Overall Study|Incorrect enrolment or randomization|0|||
30652329|NCT00684307|58664877|FG002|Overall Study|Incorrect enrolment or randomization|0|||
30652330|NCT00684307|58664878|FG003|Overall Study|Incorrect enrolment or randomization|0|||
30652331|NCT00684307|58664879|FG004|Overall Study|Incorrect enrolment or randomization|0|||
30652332|NCT00684307|58664875|FG000|Overall Study|Interupted IP for more than 7 days|0|||
30652333|NCT00684307|58664876|FG001|Overall Study|Interupted IP for more than 7 days|4|||
30652334|NCT00684307|58664877|FG002|Overall Study|Interupted IP for more than 7 days|1|||
30652335|NCT00684307|58664878|FG003|Overall Study|Interupted IP for more than 7 days|3|||
30652336|NCT00684307|58664879|FG004|Overall Study|Interupted IP for more than 7 days|3|||
30652337|NCT00684307|58664875|FG000|Overall Study|Severe non compliance to protocol|1|||
30652338|NCT00684307|58664876|FG001|Overall Study|Severe non compliance to protocol|0|||
30652339|NCT00684307|58664877|FG002|Overall Study|Severe non compliance to protocol|0|||
30652340|NCT00684307|58664878|FG003|Overall Study|Severe non compliance to protocol|1|||
30652341|NCT00684307|58664879|FG004|Overall Study|Severe non compliance to protocol|2|||
30652342|NCT00684307|58664875|FG000|Overall Study|Participant not willing to continue|7|||
30652343|NCT00684307|58664876|FG001|Overall Study|Participant not willing to continue|10|||
30652344|NCT00684307|58664877|FG002|Overall Study|Participant not willing to continue|11|||
30652345|NCT00684307|58664878|FG003|Overall Study|Participant not willing to continue|5|||
30652346|NCT00684307|58664879|FG004|Overall Study|Participant not willing to continue|8|||
30652347|NCT00684307|58664875|FG000|Overall Study|Criteria from the CSR|0|||
30652348|NCT00684307|58664876|FG001|Overall Study|Criteria from the CSR|0|||
30652349|NCT00684307|58664877|FG002|Overall Study|Criteria from the CSR|1|||
30652350|NCT00684307|58664878|FG003|Overall Study|Criteria from the CSR|3|||
30652351|NCT00684307|58664879|FG004|Overall Study|Criteria from the CSR|3|||
30652352|NCT00683917|58664894|FG000|Overall Study|Study prematurely terminated|10|||
30652353|NCT00687271|58664906|FG000|Overall Study|Adverse Event|1|||
30652354|NCT00687271|58664907|FG001|Overall Study|Adverse Event|3|||
30652355|NCT00687271|58664908|FG002|Overall Study|Adverse Event|1|||
30652356|NCT00687271|58664909|FG003|Overall Study|Adverse Event|0|||
30652357|NCT00687271|58664906|FG000|Overall Study|Lost to Follow-up|0|||
30652358|NCT00687271|58664907|FG001|Overall Study|Lost to Follow-up|1|||
30652359|NCT00687271|58664908|FG002|Overall Study|Lost to Follow-up|0|||
30652360|NCT00687271|58664909|FG003|Overall Study|Lost to Follow-up|0|||
30652361|NCT00687271|58664906|FG000|Overall Study|Protocol Violation|2|||
30652362|NCT00687271|58664907|FG001|Overall Study|Protocol Violation|1|||
30767922|NCT00036270|58776958|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
30767923|NCT00036270|58776959|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
30767924|NCT00036270|58776958|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
30767925|NCT00036270|58776959|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
30767926|NCT00301067|58776965|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
30767927|NCT00301067|58776966|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
30652363|NCT00687271|58664908|FG002|Overall Study|Protocol Violation|1|||
30652364|NCT00687271|58664909|FG003|Overall Study|Protocol Violation|0|||
30652365|NCT00687271|58664906|FG000|Overall Study|Withdrawal by Subject|0|||
30652366|NCT00687271|58664907|FG001|Overall Study|Withdrawal by Subject|1|||
30652367|NCT00687271|58664908|FG002|Overall Study|Withdrawal by Subject|3|||
30652368|NCT00687271|58664909|FG003|Overall Study|Withdrawal by Subject|0|||
30652369|NCT04617275|58664927|FG000|Treatment Period|Adverse Event|1|||
30652370|NCT04617275|58664928|FG001|Treatment Period|Adverse Event|6|||
30652371|NCT04617275|58664929|FG002|Treatment Period|Adverse Event|4|||
30652372|NCT04617275|58664930|FG003|Treatment Period|Adverse Event|6|||
30652373|NCT04617275|58664931|FG004|Treatment Period|Adverse Event|7|||
30767928|NCT00301067|58776967|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
30652374|NCT04617275|58664932|FG005|Treatment Period|Adverse Event|8|||
30652375|NCT04617275|58664933|FG006|Treatment Period|Adverse Event|0|||
30652376|NCT04617275|58664934|FG007|Treatment Period|Adverse Event|12|||
30652377|NCT04617275|58664927|FG000|Treatment Period|Lost to Follow-up|0|||
30652378|NCT04617275|58664928|FG001|Treatment Period|Lost to Follow-up|0|||
30652379|NCT04617275|58664929|FG002|Treatment Period|Lost to Follow-up|2|||
30652380|NCT04617275|58664930|FG003|Treatment Period|Lost to Follow-up|0|||
30848714|NCT02852005|58875233|FG002|Overall Study|Lost to Follow-up|0|||
30652381|NCT04617275|58664931|FG004|Treatment Period|Lost to Follow-up|0|||
30652382|NCT04617275|58664932|FG005|Treatment Period|Lost to Follow-up|3|||
30652383|NCT04617275|58664933|FG006|Treatment Period|Lost to Follow-up|0|||
30652384|NCT04617275|58664934|FG007|Treatment Period|Lost to Follow-up|2|||
30652385|NCT04617275|58664927|FG000|Treatment Period|No longer meets eligibility criteria|0|||
30652386|NCT04617275|58664928|FG001|Treatment Period|No longer meets eligibility criteria|0|||
30652387|NCT04617275|58664929|FG002|Treatment Period|No longer meets eligibility criteria|0|||
30652388|NCT04617275|58664930|FG003|Treatment Period|No longer meets eligibility criteria|1|||
30652389|NCT04617275|58664931|FG004|Treatment Period|No longer meets eligibility criteria|0|||
30652390|NCT04617275|58664932|FG005|Treatment Period|No longer meets eligibility criteria|0|||
30652391|NCT04617275|58664933|FG006|Treatment Period|No longer meets eligibility criteria|0|||
30652392|NCT04617275|58664934|FG007|Treatment Period|No longer meets eligibility criteria|0|||
30652393|NCT04617275|58664927|FG000|Treatment Period|Other|0|||
30652394|NCT04617275|58664928|FG001|Treatment Period|Other|1|||
30652395|NCT04617275|58664929|FG002|Treatment Period|Other|0|||
30652396|NCT04617275|58664930|FG003|Treatment Period|Other|0|||
30652397|NCT04617275|58664931|FG004|Treatment Period|Other|0|||
30652398|NCT04617275|58664932|FG005|Treatment Period|Other|0|||
30652399|NCT04617275|58664933|FG006|Treatment Period|Other|0|||
30652400|NCT04617275|58664934|FG007|Treatment Period|Other|0|||
30652401|NCT04617275|58664927|FG000|Treatment Period|Withdrawal by Subject|2|||
30652402|NCT04617275|58664928|FG001|Treatment Period|Withdrawal by Subject|0|||
30652403|NCT04617275|58664929|FG002|Treatment Period|Withdrawal by Subject|0|||
30652404|NCT04617275|58664930|FG003|Treatment Period|Withdrawal by Subject|2|||
30652405|NCT04617275|58664931|FG004|Treatment Period|Withdrawal by Subject|2|||
30652406|NCT04617275|58664932|FG005|Treatment Period|Withdrawal by Subject|0|||
30652407|NCT04617275|58664933|FG006|Treatment Period|Withdrawal by Subject|1|||
30652408|NCT04617275|58664934|FG007|Treatment Period|Withdrawal by Subject|2|||
30652409|NCT04617275|58664927|FG000|Follow-up Period|Adverse Event|1|||
30652410|NCT04617275|58664928|FG001|Follow-up Period|Adverse Event|1|||
30652411|NCT04617275|58664929|FG002|Follow-up Period|Adverse Event|2|||
30652412|NCT04617275|58664930|FG003|Follow-up Period|Adverse Event|3|||
30652413|NCT04617275|58664931|FG004|Follow-up Period|Adverse Event|4|||
30652414|NCT04617275|58664932|FG005|Follow-up Period|Adverse Event|3|||
30652415|NCT04617275|58664933|FG006|Follow-up Period|Adverse Event|0|||
30652416|NCT04617275|58664934|FG007|Follow-up Period|Adverse Event|3|||
30652417|NCT04617275|58664927|FG000|Follow-up Period|Lost to Follow-up|0|||
30652418|NCT04617275|58664928|FG001|Follow-up Period|Lost to Follow-up|1|||
30652419|NCT04617275|58664929|FG002|Follow-up Period|Lost to Follow-up|2|||
30652420|NCT04617275|58664930|FG003|Follow-up Period|Lost to Follow-up|0|||
30652421|NCT04617275|58664931|FG004|Follow-up Period|Lost to Follow-up|0|||
30652422|NCT04617275|58664932|FG005|Follow-up Period|Lost to Follow-up|4|||
30652423|NCT04617275|58664933|FG006|Follow-up Period|Lost to Follow-up|0|||
30652424|NCT04617275|58664934|FG007|Follow-up Period|Lost to Follow-up|3|||
30652425|NCT04617275|58664927|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
30652426|NCT04617275|58664928|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
30767929|NCT00301067|58776968|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
30767930|NCT00301067|58776965|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
30767931|NCT00301067|58776966|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
30767932|NCT00301067|58776967|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
30652427|NCT04617275|58664929|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
30652428|NCT04617275|58664930|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
30652429|NCT04617275|58664931|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
30652430|NCT04617275|58664932|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
30652431|NCT04617275|58664933|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
30652432|NCT04617275|58664934|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
30652433|NCT04617275|58664927|FG000|Follow-up Period|Other|0|||
30652434|NCT04617275|58664928|FG001|Follow-up Period|Other|1|||
30652435|NCT04617275|58664929|FG002|Follow-up Period|Other|0|||
30652436|NCT04617275|58664930|FG003|Follow-up Period|Other|0|||
30652437|NCT04617275|58664931|FG004|Follow-up Period|Other|0|||
30652438|NCT04617275|58664932|FG005|Follow-up Period|Other|0|||
30652439|NCT04617275|58664933|FG006|Follow-up Period|Other|0|||
30652440|NCT04617275|58664934|FG007|Follow-up Period|Other|0|||
30652441|NCT04617275|58664927|FG000|Follow-up Period|Withdrawal by Subject|2|||
30652442|NCT04617275|58664928|FG001|Follow-up Period|Withdrawal by Subject|0|||
30652443|NCT04617275|58664929|FG002|Follow-up Period|Withdrawal by Subject|0|||
30652444|NCT04617275|58664930|FG003|Follow-up Period|Withdrawal by Subject|2|||
30652445|NCT04617275|58664931|FG004|Follow-up Period|Withdrawal by Subject|2|||
30652446|NCT04617275|58664932|FG005|Follow-up Period|Withdrawal by Subject|0|||
30652447|NCT04617275|58664933|FG006|Follow-up Period|Withdrawal by Subject|1|||
30652448|NCT04617275|58664934|FG007|Follow-up Period|Withdrawal by Subject|2|||
30652449|NCT01031537|58664969|FG000|Overall Study|medical reasons not related to study|3|||
30767933|NCT00301067|58776968|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
30767934|NCT00301067|58776965|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
30767935|NCT00301067|58776966|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
30767936|NCT00301067|58776967|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
30652450|NCT01031537|58664969|FG000|Overall Study|Lack of Efficacy|1|||
30652451|NCT01031537|58664969|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
30652452|NCT01031537|58664969|FG000|Overall Study|moved, met exclusion criteria|10|||
30767937|NCT00301067|58776968|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
30767938|NCT00301067|58776965|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
30767939|NCT00301067|58776966|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
30767940|NCT00301067|58776967|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
30767941|NCT00301067|58776968|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
30767942|NCT00301067|58776965|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
30767943|NCT00301067|58776966|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
30767944|NCT00301067|58776967|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
30767945|NCT00301067|58776968|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
30767946|NCT00301067|58776965|FG000|Follow up Until Death|Alive at last data cut point|1|||
30767947|NCT00301067|58776966|FG001|Follow up Until Death|Alive at last data cut point|0|||
30767948|NCT00301067|58776967|FG002|Follow up Until Death|Alive at last data cut point|0|||
30848715|NCT02852005|58875234|FG003|Overall Study|Lost to Follow-up|0|||
30848716|NCT02852005|58875235|FG004|Overall Study|Lost to Follow-up|1|||
30848717|NCT02852005|58875231|FG000|Overall Study|Withdrawal by Subject|1|||
30848718|NCT02852005|58875232|FG001|Overall Study|Withdrawal by Subject|0|||
30848719|NCT02852005|58875233|FG002|Overall Study|Withdrawal by Subject|0|||
30848720|NCT02852005|58875234|FG003|Overall Study|Withdrawal by Subject|0|||
30848721|NCT02852005|58875235|FG004|Overall Study|Withdrawal by Subject|0|||
30952256|NCT01696214|58999963|FG003|Overall Study|Lost to Follow-up|0|||
30652453|NCT01031537|58664969|FG000|Overall Study|Withdrawal by Subject|5|||
30652454|NCT01031537|58664969|FG000|Overall Study|PI removal, no longer met eligibility|12|||
30652455|NCT01031381|58664973|FG000|Overall Study|Physician Decision|3|||
30652456|NCT01031381|58664973|FG000|Overall Study|Withdrawal by Subject|6|||
30652457|NCT00685399|58664985|FG000|Treatment Period 1|Withdrawal by Subject|2|||
30652458|NCT00685399|58664986|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30767949|NCT00301067|58776968|FG003|Follow up Until Death|Alive at last data cut point|1|||
30767950|NCT00007020|58776979|FG000|Overall Study|Death|16|||
30767951|NCT00007020|58776979|FG000|Overall Study|Lost to Follow-up|13|||
30767952|NCT00007020|58776979|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
30767953|NCT00007020|58776979|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
30767954|NCT00007020|58776979|FG000|Overall Study|Pt cared for by outside physician|4|||
30767955|NCT00007020|58776979|FG000|Overall Study|No evidence of treatment|6|||
30767956|NCT00300755|58776988|FG000|Overall Study|Adverse Event|1|||
30767957|NCT00300755|58776989|FG001|Overall Study|Adverse Event|2|||
30767958|NCT00300755|58776990|FG002|Overall Study|Adverse Event|1|||
30767959|NCT00300755|58776988|FG000|Overall Study|Withdrawal by Subject|0|||
30767960|NCT00300755|58776989|FG001|Overall Study|Withdrawal by Subject|2|||
30767961|NCT00300755|58776990|FG002|Overall Study|Withdrawal by Subject|0|||
30767962|NCT00300755|58776988|FG000|Overall Study|Protocol Violation|0|||
30767963|NCT00300755|58776989|FG001|Overall Study|Protocol Violation|0|||
30767964|NCT00300755|58776990|FG002|Overall Study|Protocol Violation|1|||
30767965|NCT00033540|58776998|FG000|Overall Study|Adverse Event|14|||
30767966|NCT00033540|58776998|FG000|Overall Study|Death|1|||
30767967|NCT00033540|58776998|FG000|Overall Study|Progression|26|||
30767968|NCT00033540|58776998|FG000|Overall Study|Withdrawal by Subject|6|||
30848722|NCT02851615|58875251|FG000|Overall Study|Cognitive Issue|1|||
30848723|NCT02851615|58875252|FG001|Overall Study|Cognitive Issue|0|||
30848724|NCT02851615|58875251|FG000|Overall Study|Lost to Follow-up|0|||
30652459|NCT00685399|58664987|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30652460|NCT00685399|58664988|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30652461|NCT00685399|58664989|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30652462|NCT00685399|58664990|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30652463|NCT00685399|58664991|FG006|Treatment Period 1|Withdrawal by Subject|0|||
30652464|NCT00685399|58664992|FG007|Treatment Period 1|Withdrawal by Subject|0|||
30652465|NCT00685399|58664985|FG000|Treatment Period 1|Protocol Violation|1|||
30652466|NCT00685399|58664986|FG001|Treatment Period 1|Protocol Violation|0|||
30652467|NCT00685399|58664987|FG002|Treatment Period 1|Protocol Violation|0|||
30652468|NCT00685399|58664988|FG003|Treatment Period 1|Protocol Violation|0|||
30767969|NCT00033540|58776998|FG000|Overall Study|Other|5|||
30767970|NCT00033540|58776998|FG000|Overall Study|Ineligible|3|||
30767971|NCT00033540|58776998|FG000|Overall Study|Never received treatment|2|||
30767972|NCT00300365|58777005|FG000|Overall Study|Lost to Follow-up|1|||
30767973|NCT00300365|58777006|FG001|Overall Study|Lost to Follow-up|0|||
30767974|NCT00300365|58777005|FG000|Overall Study|Physician Decision|2|||
30767975|NCT00300365|58777006|FG001|Overall Study|Physician Decision|0|||
30767976|NCT00300365|58777005|FG000|Overall Study|Withdrawal by Subject|1|||
30767977|NCT00300365|58777006|FG001|Overall Study|Withdrawal by Subject|0|||
30767978|NCT00300365|58777005|FG000|Overall Study|Adverse Event|0|||
30767979|NCT00300365|58777006|FG001|Overall Study|Adverse Event|2|||
30767980|NCT00048048|58777021|FG000|Core Treatment|Withdrawal by Subject|0|||
30652469|NCT00685399|58664989|FG004|Treatment Period 1|Protocol Violation|0|||
30652470|NCT00685399|58664990|FG005|Treatment Period 1|Protocol Violation|0|||
30652471|NCT00685399|58664991|FG006|Treatment Period 1|Protocol Violation|0|||
30652472|NCT00685399|58664992|FG007|Treatment Period 1|Protocol Violation|0|||
30652473|NCT00685399|58664985|FG000|Treatment Period 1|Administrative|2|||
30652474|NCT00685399|58664986|FG001|Treatment Period 1|Administrative|0|||
30652475|NCT00685399|58664987|FG002|Treatment Period 1|Administrative|0|||
30652476|NCT00685399|58664988|FG003|Treatment Period 1|Administrative|0|||
30652477|NCT00685399|58664989|FG004|Treatment Period 1|Administrative|0|||
30652478|NCT00685399|58664990|FG005|Treatment Period 1|Administrative|0|||
30652479|NCT00685399|58664991|FG006|Treatment Period 1|Administrative|0|||
30652480|NCT00685399|58664992|FG007|Treatment Period 1|Administrative|0|||
30652481|NCT00685399|58664985|FG000|Treatment Period 1|Lack of Efficacy|1|||
30652482|NCT00685399|58664986|FG001|Treatment Period 1|Lack of Efficacy|0|||
30652483|NCT00685399|58664987|FG002|Treatment Period 1|Lack of Efficacy|0|||
30652484|NCT00685399|58664988|FG003|Treatment Period 1|Lack of Efficacy|0|||
30652485|NCT00685399|58664989|FG004|Treatment Period 1|Lack of Efficacy|0|||
30652486|NCT00685399|58664990|FG005|Treatment Period 1|Lack of Efficacy|0|||
30652487|NCT00685399|58664991|FG006|Treatment Period 1|Lack of Efficacy|0|||
30652488|NCT00685399|58664992|FG007|Treatment Period 1|Lack of Efficacy|0|||
30652489|NCT00685399|58664985|FG000|Treatment Period 2|Administrative Problems|0|||
30652490|NCT00685399|58664986|FG001|Treatment Period 2|Administrative Problems|2|||
30652491|NCT00685399|58664987|FG002|Treatment Period 2|Administrative Problems|1|||
30652492|NCT00685399|58664988|FG003|Treatment Period 2|Administrative Problems|0|||
30652493|NCT00685399|58664989|FG004|Treatment Period 2|Administrative Problems|0|||
30652494|NCT00685399|58664990|FG005|Treatment Period 2|Administrative Problems|0|||
30652495|NCT00685399|58664991|FG006|Treatment Period 2|Administrative Problems|0|||
30652496|NCT00685399|58664992|FG007|Treatment Period 2|Administrative Problems|0|||
30652497|NCT00685399|58664985|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30652498|NCT00685399|58664986|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30652499|NCT00685399|58664987|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30652500|NCT00685399|58664988|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30652501|NCT00685399|58664989|FG004|Treatment Period 2|Withdrawal by Subject|0|||
30652502|NCT00685399|58664990|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30652503|NCT00685399|58664991|FG006|Treatment Period 2|Withdrawal by Subject|0|||
30652504|NCT00685399|58664992|FG007|Treatment Period 2|Withdrawal by Subject|2|||
30652505|NCT00685399|58664985|FG000|Treatment Period 2|Adverse Event|0|||
30652506|NCT00685399|58664986|FG001|Treatment Period 2|Adverse Event|0|||
30652507|NCT00685399|58664987|FG002|Treatment Period 2|Adverse Event|0|||
30652508|NCT00685399|58664988|FG003|Treatment Period 2|Adverse Event|0|||
30652509|NCT00685399|58664989|FG004|Treatment Period 2|Adverse Event|0|||
30652510|NCT00685399|58664990|FG005|Treatment Period 2|Adverse Event|1|||
30652511|NCT00685399|58664991|FG006|Treatment Period 2|Adverse Event|0|||
30652512|NCT00685399|58664992|FG007|Treatment Period 2|Adverse Event|0|||
30652513|NCT00685399|58664985|FG000|Treatment Period 2|Lack of Efficacy|0|||
30652514|NCT00685399|58664986|FG001|Treatment Period 2|Lack of Efficacy|10|||
30652515|NCT00685399|58664987|FG002|Treatment Period 2|Lack of Efficacy|2|||
30652516|NCT00685399|58664988|FG003|Treatment Period 2|Lack of Efficacy|0|||
30652517|NCT00685399|58664989|FG004|Treatment Period 2|Lack of Efficacy|0|||
30652518|NCT00685399|58664990|FG005|Treatment Period 2|Lack of Efficacy|1|||
30652519|NCT00685399|58664991|FG006|Treatment Period 2|Lack of Efficacy|0|||
30652520|NCT00685399|58664992|FG007|Treatment Period 2|Lack of Efficacy|0|||
30652521|NCT00685399|58664985|FG000|Extension|Administrative Issues|0|||
30652522|NCT00685399|58664986|FG001|Extension|Administrative Issues|0|||
30652523|NCT00685399|58664987|FG002|Extension|Administrative Issues|0|||
30652524|NCT00685399|58664988|FG003|Extension|Administrative Issues|1|||
30652525|NCT00685399|58664989|FG004|Extension|Administrative Issues|0|||
30652526|NCT00685399|58664990|FG005|Extension|Administrative Issues|0|||
30652527|NCT00685399|58664991|FG006|Extension|Administrative Issues|0|||
30652528|NCT00685399|58664992|FG007|Extension|Administrative Issues|0|||
30652529|NCT00685399|58664985|FG000|Extension|Withdrawal by Subject|0|||
30652530|NCT00685399|58664986|FG001|Extension|Withdrawal by Subject|0|||
30652531|NCT00685399|58664987|FG002|Extension|Withdrawal by Subject|0|||
30652532|NCT00685399|58664988|FG003|Extension|Withdrawal by Subject|1|||
30848725|NCT02851615|58875252|FG001|Overall Study|Lost to Follow-up|4|||
30848726|NCT02849743|58875261|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
30848727|NCT02849743|58875262|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
30848728|NCT02849743|58875261|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
30848729|NCT02849743|58875262|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
30848730|NCT02851069|58875297|FG000|Overall Study|Failure to Return|3|||
30848731|NCT02851069|58875297|FG000|Overall Study|Other|3|||
30652533|NCT00685399|58664989|FG004|Extension|Withdrawal by Subject|0|||
30652534|NCT00685399|58664990|FG005|Extension|Withdrawal by Subject|0|||
30652535|NCT00685399|58664991|FG006|Extension|Withdrawal by Subject|0|||
30652536|NCT00685399|58664992|FG007|Extension|Withdrawal by Subject|0|||
30652537|NCT00685399|58664985|FG000|Extension|Protocol Violation|0|||
30652538|NCT00685399|58664986|FG001|Extension|Protocol Violation|0|||
30652539|NCT00685399|58664987|FG002|Extension|Protocol Violation|0|||
30652540|NCT00685399|58664988|FG003|Extension|Protocol Violation|1|||
30652541|NCT00685399|58664989|FG004|Extension|Protocol Violation|0|||
30652542|NCT00685399|58664990|FG005|Extension|Protocol Violation|0|||
30652543|NCT00685399|58664991|FG006|Extension|Protocol Violation|0|||
30652544|NCT00685399|58664992|FG007|Extension|Protocol Violation|0|||
30652545|NCT00685399|58664985|FG000|Extension|Lack of Efficacy|0|||
30652546|NCT00685399|58664986|FG001|Extension|Lack of Efficacy|0|||
30652547|NCT00685399|58664987|FG002|Extension|Lack of Efficacy|0|||
30652548|NCT00685399|58664988|FG003|Extension|Lack of Efficacy|2|||
30652549|NCT00685399|58664989|FG004|Extension|Lack of Efficacy|0|||
30652550|NCT00685399|58664990|FG005|Extension|Lack of Efficacy|0|||
30652551|NCT00685399|58664991|FG006|Extension|Lack of Efficacy|0|||
30652552|NCT00685399|58664992|FG007|Extension|Lack of Efficacy|0|||
30652553|NCT00685399|58664985|FG000|Extension|Adverse Event|0|||
30652554|NCT00685399|58664986|FG001|Extension|Adverse Event|0|||
30652555|NCT00685399|58664987|FG002|Extension|Adverse Event|0|||
30652556|NCT00685399|58664988|FG003|Extension|Adverse Event|2|||
30652557|NCT00685399|58664989|FG004|Extension|Adverse Event|0|||
30652558|NCT00685399|58664990|FG005|Extension|Adverse Event|0|||
30652559|NCT00685399|58664991|FG006|Extension|Adverse Event|0|||
30652560|NCT00685399|58664992|FG007|Extension|Adverse Event|0|||
30652561|NCT00685165|58665019|FG000|Washout Period of 14 Days|Adverse Event|1|||
30652562|NCT00685165|58665020|FG001|Washout Period of 14 Days|Adverse Event|0|||
30652563|NCT00683449|58665031|FG000|Overall Study|Lost to Follow-up|0|||
30652564|NCT00683449|58665032|FG001|Overall Study|Lost to Follow-up|1|||
30652565|NCT00683449|58665033|FG002|Overall Study|Lost to Follow-up|0|||
30652566|NCT00683449|58665034|FG003|Overall Study|Lost to Follow-up|0|||
30652567|NCT00683449|58665035|FG004|Overall Study|Lost to Follow-up|0|||
30652568|NCT00683293|58665054|FG000|Overall Study|Withdrawal by Subject|2|||
30652569|NCT00683293|58665055|FG001|Overall Study|Withdrawal by Subject|3|||
30652570|NCT00726232|58665067|FG000|Initial Phase (Dose-finding)|Death|0|||
30652571|NCT00726232|58665068|FG001|Initial Phase (Dose-finding)|Death|0|||
30652572|NCT00726232|58665069|FG002|Initial Phase (Dose-finding)|Death|0|||
30652573|NCT00726232|58665070|FG003|Initial Phase (Dose-finding)|Death|0|||
30652574|NCT00726232|58665071|FG004|Initial Phase (Dose-finding)|Death|1|||
30652575|NCT00726232|58665072|FG005|Initial Phase (Dose-finding)|Death|0|||
30652576|NCT00726232|58665073|FG006|Initial Phase (Dose-finding)|Death|0|||
30652577|NCT00726232|58665074|FG007|Initial Phase (Dose-finding)|Death|0|||
30652578|NCT00726232|58665067|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
30652579|NCT00726232|58665068|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
30652580|NCT00726232|58665069|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
30652581|NCT00726232|58665070|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
30767981|NCT00048048|58777022|FG001|Core Treatment|Withdrawal by Subject|0|||
30767982|NCT00048048|58777023|FG002|Core Treatment|Withdrawal by Subject|1|||
30767983|NCT00048048|58777024|FG003|Core Treatment|Withdrawal by Subject|0|||
30767984|NCT00048048|58777025|FG004|Core Treatment|Withdrawal by Subject|0|||
30767985|NCT00048048|58777026|FG005|Core Treatment|Withdrawal by Subject|0|||
30767986|NCT00048048|58777027|FG006|Core Treatment|Withdrawal by Subject|0|||
30767987|NCT00048048|58777028|FG007|Core Treatment|Withdrawal by Subject|0|||
30767988|NCT00048048|58777029|FG008|Core Treatment|Withdrawal by Subject|0|||
30767989|NCT00048048|58777030|FG009|Core Treatment|Withdrawal by Subject|0|||
30767990|NCT00048048|58777031|FG010|Core Treatment|Withdrawal by Subject|0|||
30767991|NCT00048048|58777032|FG011|Core Treatment|Withdrawal by Subject|0|||
30767992|NCT00048048|58777021|FG000|Core Treatment|Adverse Event|0|||
30767993|NCT00048048|58777022|FG001|Core Treatment|Adverse Event|0|||
30767994|NCT00048048|58777023|FG002|Core Treatment|Adverse Event|0|||
30767995|NCT00048048|58777024|FG003|Core Treatment|Adverse Event|0|||
30767996|NCT00048048|58777025|FG004|Core Treatment|Adverse Event|0|||
30767997|NCT00048048|58777026|FG005|Core Treatment|Adverse Event|0|||
30767998|NCT00048048|58777027|FG006|Core Treatment|Adverse Event|0|||
30652582|NCT00726232|58665071|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
30652583|NCT00726232|58665072|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
30652584|NCT00726232|58665073|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
30652585|NCT00726232|58665074|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
30652586|NCT00726232|58665067|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
30652587|NCT00726232|58665068|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
30767999|NCT00048048|58777028|FG007|Core Treatment|Adverse Event|1|||
30768000|NCT00048048|58777029|FG008|Core Treatment|Adverse Event|0|||
30768001|NCT00048048|58777030|FG009|Core Treatment|Adverse Event|0|||
30768002|NCT00048048|58777031|FG010|Core Treatment|Adverse Event|0|||
30768003|NCT00048048|58777032|FG011|Core Treatment|Adverse Event|0|||
30768004|NCT00048048|58777021|FG000|Extension Year 1|Early withdrawals|0|||
30768005|NCT00048048|58777022|FG001|Extension Year 1|Early withdrawals|0|||
30652588|NCT00726232|58665069|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
30652589|NCT00726232|58665070|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
30652590|NCT00726232|58665071|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
30768006|NCT00048048|58777023|FG002|Extension Year 1|Early withdrawals|0|||
30768007|NCT00048048|58777024|FG003|Extension Year 1|Early withdrawals|0|||
30768008|NCT00048048|58777025|FG004|Extension Year 1|Early withdrawals|0|||
30768009|NCT00048048|58777026|FG005|Extension Year 1|Early withdrawals|0|||
30768010|NCT00048048|58777027|FG006|Extension Year 1|Early withdrawals|0|||
30768011|NCT00048048|58777028|FG007|Extension Year 1|Early withdrawals|0|||
30768012|NCT00048048|58777029|FG008|Extension Year 1|Early withdrawals|0|||
30768013|NCT00048048|58777030|FG009|Extension Year 1|Early withdrawals|2|||
30768014|NCT00048048|58777031|FG010|Extension Year 1|Early withdrawals|2|||
30768015|NCT00048048|58777032|FG011|Extension Year 1|Early withdrawals|4|||
30768016|NCT00048048|58777021|FG000|Extension Year 2|Early withdrawals|0|||
30768017|NCT00048048|58777022|FG001|Extension Year 2|Early withdrawals|0|||
30768018|NCT00048048|58777023|FG002|Extension Year 2|Early withdrawals|0|||
30768019|NCT00048048|58777024|FG003|Extension Year 2|Early withdrawals|0|||
30768020|NCT00048048|58777025|FG004|Extension Year 2|Early withdrawals|0|||
30768021|NCT00048048|58777026|FG005|Extension Year 2|Early withdrawals|0|||
30768022|NCT00048048|58777027|FG006|Extension Year 2|Early withdrawals|0|||
30768023|NCT00048048|58777028|FG007|Extension Year 2|Early withdrawals|0|||
30768024|NCT00048048|58777029|FG008|Extension Year 2|Early withdrawals|0|||
30768025|NCT00048048|58777030|FG009|Extension Year 2|Early withdrawals|0|||
30768026|NCT00048048|58777031|FG010|Extension Year 2|Early withdrawals|4|||
30768027|NCT00048048|58777032|FG011|Extension Year 2|Early withdrawals|2|||
30768028|NCT00300053|58777062|FG000|Overall Study|Patient/Caregiver Preference|2|||
30768029|NCT00300053|58777063|FG001|Overall Study|Patient/Caregiver Preference|2|||
30768030|NCT00300053|58777064|FG002|Overall Study|Patient/Caregiver Preference|3|||
30768031|NCT00300053|58777062|FG000|Overall Study|Death|0|||
30768032|NCT00300053|58777063|FG001|Overall Study|Death|0|||
30768033|NCT00300053|58777064|FG002|Overall Study|Death|3|||
30768034|NCT00300053|58777062|FG000|Overall Study|Lost to Follow-up|0|||
30768035|NCT00300053|58777063|FG001|Overall Study|Lost to Follow-up|1|||
30768036|NCT00300053|58777064|FG002|Overall Study|Lost to Follow-up|0|||
30768037|NCT00299975|58777076|FG000|Overall Study|Adverse Event|1|||
30768038|NCT00299975|58777077|FG001|Overall Study|Adverse Event|0|||
30768039|NCT00299975|58777078|FG002|Overall Study|Adverse Event|2|||
30768040|NCT00299975|58777076|FG000|Overall Study|Pregnancy|0|||
30652591|NCT00726232|58665072|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
30652592|NCT00726232|58665073|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
30652593|NCT00726232|58665074|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
30652594|NCT00726232|58665067|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
30652595|NCT00726232|58665068|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
30652596|NCT00726232|58665069|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
30652597|NCT00726232|58665070|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
30652598|NCT00726232|58665071|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
30652599|NCT00726232|58665072|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
30652600|NCT00726232|58665073|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
30652601|NCT00726232|58665074|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
30652602|NCT00726232|58665067|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
30652603|NCT00726232|58665068|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
30652604|NCT00726232|58665069|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
30652605|NCT00726232|58665070|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
30652606|NCT00726232|58665071|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
30652607|NCT00726232|58665072|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
30652608|NCT00726232|58665073|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
30652609|NCT00726232|58665074|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
30652610|NCT00726232|58665067|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
30652611|NCT00726232|58665068|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
30652612|NCT00726232|58665069|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
30652613|NCT00726232|58665070|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
30652614|NCT00726232|58665071|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
30652615|NCT00726232|58665072|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
30652616|NCT00726232|58665073|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
30652617|NCT00726232|58665074|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
30652618|NCT00726232|58665067|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
30652619|NCT00726232|58665068|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
30768041|NCT00299975|58777077|FG001|Overall Study|Pregnancy|0|||
30768042|NCT00299975|58777078|FG002|Overall Study|Pregnancy|1|||
30768043|NCT00299975|58777076|FG000|Overall Study|Lack of Efficacy|1|||
30768044|NCT00299975|58777077|FG001|Overall Study|Lack of Efficacy|0|||
30768045|NCT00299975|58777078|FG002|Overall Study|Lack of Efficacy|1|||
30848732|NCT02849509|58875309|FG000|Overall Study|Worsening of disease under study|1|||
30848733|NCT02849509|58875310|FG001|Overall Study|Worsening of disease under study|1|||
30768046|NCT00299975|58777076|FG000|Overall Study|Lost to Follow-up|1|||
30652620|NCT00726232|58665069|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
30652621|NCT00726232|58665070|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
30652622|NCT00726232|58665071|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
30652623|NCT00726232|58665072|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
30652624|NCT00726232|58665073|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
30652625|NCT00726232|58665074|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
30652626|NCT00726232|58665067|FG000|Expansion Phase|Death|0|||
30848734|NCT02849509|58875311|FG002|Overall Study|Worsening of disease under study|1|||
30848735|NCT02849509|58875309|FG000|Overall Study|Worsening of other pre-existing disease|0|||
30652627|NCT00726232|58665068|FG001|Expansion Phase|Death|0|||
30652628|NCT00726232|58665069|FG002|Expansion Phase|Death|0|||
30652629|NCT00726232|58665070|FG003|Expansion Phase|Death|0|||
30652630|NCT00726232|58665071|FG004|Expansion Phase|Death|0|||
30652631|NCT00726232|58665072|FG005|Expansion Phase|Death|0|||
30652632|NCT00726232|58665073|FG006|Expansion Phase|Death|0|||
30652633|NCT00726232|58665074|FG007|Expansion Phase|Death|1|||
30652634|NCT00726232|58665067|FG000|Expansion Phase|Adverse Event|0|||
30652635|NCT00726232|58665068|FG001|Expansion Phase|Adverse Event|0|||
30652636|NCT00726232|58665069|FG002|Expansion Phase|Adverse Event|0|||
30652637|NCT00726232|58665070|FG003|Expansion Phase|Adverse Event|0|||
30652638|NCT00726232|58665071|FG004|Expansion Phase|Adverse Event|0|||
30652639|NCT00726232|58665072|FG005|Expansion Phase|Adverse Event|0|||
30652640|NCT00726232|58665073|FG006|Expansion Phase|Adverse Event|6|||
30652641|NCT00726232|58665074|FG007|Expansion Phase|Adverse Event|11|||
30652642|NCT00726232|58665067|FG000|Expansion Phase|Withdrawal by Subject|0|||
30652643|NCT00726232|58665068|FG001|Expansion Phase|Withdrawal by Subject|0|||
30652644|NCT00726232|58665069|FG002|Expansion Phase|Withdrawal by Subject|0|||
30652645|NCT00726232|58665070|FG003|Expansion Phase|Withdrawal by Subject|0|||
30652646|NCT00726232|58665071|FG004|Expansion Phase|Withdrawal by Subject|0|||
30652647|NCT00726232|58665072|FG005|Expansion Phase|Withdrawal by Subject|0|||
30652648|NCT00726232|58665073|FG006|Expansion Phase|Withdrawal by Subject|2|||
30652649|NCT00726232|58665074|FG007|Expansion Phase|Withdrawal by Subject|3|||
30652650|NCT00726232|58665067|FG000|Expansion Phase|Disease progression|0|||
30652651|NCT00726232|58665068|FG001|Expansion Phase|Disease progression|0|||
30652652|NCT00726232|58665069|FG002|Expansion Phase|Disease progression|0|||
30652653|NCT00726232|58665070|FG003|Expansion Phase|Disease progression|0|||
30652654|NCT00726232|58665071|FG004|Expansion Phase|Disease progression|0|||
30652655|NCT00726232|58665072|FG005|Expansion Phase|Disease progression|0|||
30652656|NCT00726232|58665073|FG006|Expansion Phase|Disease progression|4|||
30652657|NCT00726232|58665074|FG007|Expansion Phase|Disease progression|0|||
30652658|NCT00726232|58665067|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
30652659|NCT00726232|58665068|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
30652660|NCT00726232|58665069|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
30652661|NCT00726232|58665070|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
30652662|NCT00726232|58665071|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
30652663|NCT00726232|58665072|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
30652664|NCT00726232|58665073|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
30652665|NCT00726232|58665074|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
30652666|NCT00726232|58665067|FG000|Expansion Phase|Per Investigator: lack of response|0|||
30652667|NCT00726232|58665068|FG001|Expansion Phase|Per Investigator: lack of response|0|||
30652668|NCT00726232|58665069|FG002|Expansion Phase|Per Investigator: lack of response|0|||
30652669|NCT00726232|58665070|FG003|Expansion Phase|Per Investigator: lack of response|0|||
30768047|NCT00299975|58777077|FG001|Overall Study|Lost to Follow-up|0|||
30768048|NCT00299975|58777078|FG002|Overall Study|Lost to Follow-up|0|||
30768049|NCT00299975|58777076|FG000|Overall Study|Withdrawal by Subject|0|||
30768050|NCT00299975|58777077|FG001|Overall Study|Withdrawal by Subject|1|||
30768051|NCT00299975|58777078|FG002|Overall Study|Withdrawal by Subject|3|||
30768052|NCT00299975|58777076|FG000|Overall Study|Physician Decision|0|||
30768053|NCT00299975|58777077|FG001|Overall Study|Physician Decision|0|||
30652670|NCT00726232|58665071|FG004|Expansion Phase|Per Investigator: lack of response|0|||
30652671|NCT00726232|58665072|FG005|Expansion Phase|Per Investigator: lack of response|0|||
30652672|NCT00726232|58665073|FG006|Expansion Phase|Per Investigator: lack of response|1|||
30652673|NCT00726232|58665074|FG007|Expansion Phase|Per Investigator: lack of response|7|||
30652674|NCT00726232|58665067|FG000|Expansion Phase|Unspecified reason|0|||
30652675|NCT00726232|58665068|FG001|Expansion Phase|Unspecified reason|0|||
30652676|NCT00726232|58665069|FG002|Expansion Phase|Unspecified reason|0|||
30652677|NCT00726232|58665070|FG003|Expansion Phase|Unspecified reason|0|||
30652678|NCT00726232|58665071|FG004|Expansion Phase|Unspecified reason|0|||
30652679|NCT00726232|58665072|FG005|Expansion Phase|Unspecified reason|0|||
30652680|NCT00726232|58665073|FG006|Expansion Phase|Unspecified reason|1|||
30768054|NCT00299975|58777078|FG002|Overall Study|Physician Decision|1|||
30768055|NCT00004980|58777088|FG000|Overall Study|Withdrawal by Subject|1|||
30768056|NCT00004980|58777089|FG001|Overall Study|Withdrawal by Subject|0|||
30768057|NCT00004980|58777088|FG000|Overall Study|memory difficulties|1|||
30652681|NCT00726232|58665074|FG007|Expansion Phase|Unspecified reason|0|||
30652682|NCT00720382|58665095|FG000|Overall Study|Adverse Event|54|||
30652683|NCT00720382|58665096|FG001|Overall Study|Adverse Event|17|||
30652684|NCT00720382|58665095|FG000|Overall Study|Lack of Efficacy|18|||
30652685|NCT00720382|58665096|FG001|Overall Study|Lack of Efficacy|7|||
30652686|NCT00720382|58665095|FG000|Overall Study|Non-Compliance|15|||
30652687|NCT00720382|58665096|FG001|Overall Study|Non-Compliance|5|||
30652688|NCT00720382|58665095|FG000|Overall Study|Withdrawal by Subject|47|||
30652689|NCT00720382|58665096|FG001|Overall Study|Withdrawal by Subject|11|||
30652690|NCT00720382|58665095|FG000|Overall Study|Lost to Follow-up|28|||
30652691|NCT00720382|58665096|FG001|Overall Study|Lost to Follow-up|14|||
30652692|NCT00720382|58665095|FG000|Overall Study|administrative|14|||
30652693|NCT00720382|58665096|FG001|Overall Study|administrative|5|||
30652694|NCT00720226|58665104|FG000|Overall Study|Withdrawal by Subject|7|||
30652695|NCT00720226|58665105|FG001|Overall Study|Withdrawal by Subject|4|||
30652696|NCT00725920|58665113|FG000|Overall Study|Lack of Efficacy|3|||
30652697|NCT00725920|58665114|FG001|Overall Study|Lack of Efficacy|6|||
30652698|NCT00725842|58665120|FG000|Overall Study|Lost to Follow-up|19|||
30652699|NCT00725842|58665120|FG000|Overall Study|Death|1|||
30652700|NCT00725842|58665120|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
30652701|NCT00725842|58665120|FG000|Overall Study|Consent date prior to study start date|5|||
30652702|NCT00725842|58665120|FG000|Overall Study|Inclusion criterion not met|1|||
30652703|NCT00725842|58665120|FG000|Overall Study|No Visit 1 data|1|||
30652704|NCT00725764|58665124|FG000|Overall Study|Withdrawal by Subject|2|||
30652705|NCT00725764|58665124|FG000|Overall Study|Physician Decision|1|||
30652706|NCT00725764|58665124|FG000|Overall Study|Progressive Disease|7|||
30652707|NCT00725764|58665124|FG000|Overall Study|Lost to Follow-up|1|||
30652708|NCT00725764|58665124|FG000|Overall Study|Death|1|||
30652709|NCT00725764|58665124|FG000|Overall Study|Participant non compliant with protocol|1|||
30652710|NCT00725764|58665124|FG000|Overall Study|Decline in performance status|1|||
30652711|NCT00725608|58665129|FG000|Overall Study|Lost to Follow-up|60|||
30652712|NCT00725608|58665129|FG000|Overall Study|Adverse Event|14|||
30652713|NCT00725608|58665129|FG000|Overall Study|Individual reasons|86|||
30652714|NCT00725608|58665129|FG000|Overall Study|Other|7|||
30652715|NCT00725452|58665133|FG000|Overall Study|Adverse Event|3|||
30652716|NCT00725452|58665133|FG000|Overall Study|Lack of Efficacy|2|||
30652717|NCT00725452|58665133|FG000|Overall Study|Reason not specified|1|||
30652718|NCT00725452|58665133|FG000|Overall Study|Physician Decision|1|||
30652719|NCT00725452|58665133|FG000|Overall Study|Withdrawal by Subject|3|||
30652720|NCT00725452|58665133|FG000|Overall Study|Lost to Follow-up|1|||
30652721|NCT00725296|58665137|FG000|Overall Study|Adverse Event|11|||
30652722|NCT00725296|58665137|FG000|Overall Study|Lack of Efficacy|7|||
30652723|NCT00725296|58665137|FG000|Overall Study|Withdrawal by Subject|3|||
30652724|NCT00725296|58665137|FG000|Overall Study|Non-Compliance|2|||
30768058|NCT00004980|58777089|FG001|Overall Study|memory difficulties|1|||
30768059|NCT00004980|58777088|FG000|Overall Study|Physician Decision|0|||
30768060|NCT00004980|58777089|FG001|Overall Study|Physician Decision|1|||
30768061|NCT00326963|58777095|FG000|Overall Study|Adverse Event|2|||
30768062|NCT00326963|58777095|FG000|Overall Study|Injection site reaction|1|||
30768063|NCT00326963|58777095|FG000|Overall Study|Death|1|||
30768064|NCT00326963|58777095|FG000|Overall Study|Failure to return|10|||
30768065|NCT00326963|58777095|FG000|Overall Study|Withdrawal by Subject|10|||
30768066|NCT00326963|58777095|FG000|Overall Study|Refused treatment / did not cooperate|5|||
30768067|NCT00326963|58777095|FG000|Overall Study|Violation of selection criteria at entry|2|||
30768068|NCT00326963|58777095|FG000|Overall Study|Other protocol violation|1|||
30768069|NCT00326963|58777095|FG000|Overall Study|Administrative / other|1|||
30768070|NCT00326885|58777100|FG000|Overall Study|Adverse Event|1|||
30768071|NCT00326885|58777100|FG000|Overall Study|Withdrawal by Subject|3|||
30768072|NCT00326885|58777100|FG000|Overall Study|Physician Decision|1|||
30768073|NCT00326885|58777100|FG000|Overall Study|Hospice withdrew consent|2|||
30768074|NCT00326495|58777105|FG000|Overall Study|Switched to alternative treatment|1|||
30848736|NCT02849509|58875310|FG001|Overall Study|Worsening of other pre-existing disease|1|||
30652725|NCT00725296|58665137|FG000|Overall Study|Lost to Follow-up|1|||
30848737|NCT02849509|58875311|FG002|Overall Study|Worsening of other pre-existing disease|2|||
30652726|NCT00725296|58665137|FG000|Overall Study|Other|38|||
30652727|NCT00719680|58665142|FG000|Overall Study|Adverse Event|1|||
30652728|NCT00719680|58665142|FG000|Overall Study|Lost to Follow-up|1|||
30652729|NCT00719680|58665142|FG000|Overall Study|Withdrawal by Subject|3|||
30652730|NCT00719212|58665146|FG000|Overall Study|Death|41|||
30652731|NCT00719212|58665146|FG000|Overall Study|Lost to Follow-up|2|||
30652732|NCT00719212|58665146|FG000|Overall Study|Withdrawal by Subject|1|||
30652733|NCT00585052|58665150|FG000|Overall Study|Withdrawal by Subject|1|||
30652734|NCT00724282|58665154|FG000|Overall Study|Withdrawal by Subject|3|||
30652735|NCT00724282|58665154|FG000|Overall Study|Physician Decision|1|||
30652736|NCT00724126|58665160|FG000|Overall Study|Adverse Event|2|||
30652737|NCT00724126|58665161|FG001|Overall Study|Adverse Event|0|||
30768075|NCT00326495|58777105|FG000|Overall Study|Disease progression before treatment|1|||
30768076|NCT00326495|58777105|FG000|Overall Study|Refused further treatment|2|||
30652738|NCT00724126|58665160|FG000|Overall Study|Withdrawal by Subject|8|||
30652739|NCT00724126|58665161|FG001|Overall Study|Withdrawal by Subject|6|||
30652740|NCT00724126|58665160|FG000|Overall Study|Lost to Follow-up|6|||
30652741|NCT00724126|58665161|FG001|Overall Study|Lost to Follow-up|6|||
30652742|NCT00724126|58665160|FG000|Overall Study|Noncompliance|2|||
30652743|NCT00724126|58665161|FG001|Overall Study|Noncompliance|1|||
30652744|NCT00724126|58665160|FG000|Overall Study|Subject randomized although ineligible|1|||
30652745|NCT00724126|58665161|FG001|Overall Study|Subject randomized although ineligible|1|||
30652746|NCT00724126|58665160|FG000|Overall Study|Subject had to leave vicinity of site|0|||
30652747|NCT00724126|58665161|FG001|Overall Study|Subject had to leave vicinity of site|1|||
30652748|NCT00723892|58665169|FG000|Overall Study|Participant not tracked|33|||
30652749|NCT00723892|58665170|FG001|Overall Study|Participant not tracked|35|||
30652750|NCT00723892|58665169|FG000|Overall Study|Virological criterion|24|||
30652751|NCT00723892|58665170|FG001|Overall Study|Virological criterion|9|||
30652752|NCT00723892|58665169|FG000|Overall Study|Withdrawal by Subject|6|||
30652753|NCT00723892|58665170|FG001|Overall Study|Withdrawal by Subject|9|||
30652754|NCT00723892|58665169|FG000|Overall Study|End planned|11|||
30652755|NCT00723892|58665170|FG001|Overall Study|End planned|7|||
30652756|NCT00723892|58665169|FG000|Overall Study|Bad tolerance|5|||
30652757|NCT00723892|58665170|FG001|Overall Study|Bad tolerance|5|||
30652758|NCT00723892|58665169|FG000|Overall Study|Multiple reasons|17|||
30768077|NCT00326495|58777105|FG000|Overall Study|Subject off study before assessment|1|||
30768078|NCT00326417|58777111|FG000|Overall Study|Withdrawal by Subject|0|||
30652759|NCT00723892|58665170|FG001|Overall Study|Multiple reasons|12|||
30768079|NCT00326417|58777112|FG001|Overall Study|Withdrawal by Subject|0|||
30768080|NCT00326417|58777113|FG002|Overall Study|Withdrawal by Subject|1|||
30768081|NCT00326417|58777114|FG003|Overall Study|Withdrawal by Subject|0|||
30768082|NCT00326417|58777111|FG000|Overall Study|Arm Closed|7|||
30768083|NCT00326417|58777112|FG001|Overall Study|Arm Closed|0|||
30768084|NCT00326417|58777113|FG002|Overall Study|Arm Closed|0|||
30768085|NCT00326417|58777114|FG003|Overall Study|Arm Closed|3|||
30768086|NCT00326417|58777111|FG000|Overall Study|Death|7|||
30768087|NCT00326417|58777112|FG001|Overall Study|Death|0|||
30768088|NCT00326417|58777113|FG002|Overall Study|Death|0|||
30768089|NCT00326417|58777114|FG003|Overall Study|Death|0|||
30768090|NCT03825341|58777124|FG000|Overall Study|Withdrawal by Subject|0|||
30768091|NCT03825341|58777125|FG001|Overall Study|Withdrawal by Subject|1|||
30768092|NCT00297479|58777136|FG000|Overall Study|Lost to Follow-up|37|||
30768093|NCT00297479|58777137|FG001|Overall Study|Lost to Follow-up|54|||
30768094|NCT00297479|58777138|FG002|Overall Study|Lost to Follow-up|51|||
30768095|NCT00688870|58777148|FG000|Infant Series|Parent or legal guardian request|4|||
30768096|NCT00688870|58777149|FG001|Infant Series|Parent or legal guardian request|0|||
30768097|NCT00297167|58777159|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
30768098|NCT00297167|58777160|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
30768099|NCT00297167|58777161|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
30768100|NCT00297167|58777159|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
30768101|NCT00297167|58777160|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
30652760|NCT00723892|58665169|FG000|Overall Study|Other|6|||
30652761|NCT00723892|58665170|FG001|Overall Study|Other|3|||
30652762|NCT00723892|58665169|FG000|Overall Study|Study end|1|||
30652763|NCT00723892|58665170|FG001|Overall Study|Study end|3|||
30652764|NCT00723892|58665169|FG000|Overall Study|Weight loss|1|||
30652765|NCT00723892|58665170|FG001|Overall Study|Weight loss|3|||
30652766|NCT00723892|58665169|FG000|Overall Study|Alcohol abuse|0|||
30652767|NCT00723892|58665170|FG001|Overall Study|Alcohol abuse|1|||
30652768|NCT00723892|58665169|FG000|Overall Study|Intercurrent infection|2|||
30652769|NCT00723892|58665170|FG001|Overall Study|Intercurrent infection|0|||
30652770|NCT00723892|58665169|FG000|Overall Study|Drug addiction|1|||
30768102|NCT00297167|58777161|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
30768103|NCT03216226|58777170|FG000|Overall Study|Adverse Event|3|||
30768104|NCT03216226|58777171|FG001|Overall Study|Adverse Event|0|||
30652771|NCT00723892|58665170|FG001|Overall Study|Drug addiction|0|||
30652772|NCT00718666|58665179|FG000|Booster Phase Year 5|No active participation request|0|||
30652773|NCT00718666|58665180|FG001|Booster Phase Year 5|No active participation request|0|||
30652774|NCT00718666|58665181|FG002|Booster Phase Year 5|No active participation request|1|||
30652775|NCT00718666|58665179|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
30652776|NCT00718666|58665180|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
30652777|NCT00718666|58665181|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
30652778|NCT00718666|58665179|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
30768105|NCT03216226|58777170|FG000|Overall Study|Protocol Violation|1|||
30652779|NCT00718666|58665180|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
30652780|NCT00718666|58665181|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
30768106|NCT03216226|58777171|FG001|Overall Study|Protocol Violation|3|||
30768107|NCT03216226|58777170|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
30768108|NCT03216226|58777171|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
30652781|NCT00718666|58665179|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
30652782|NCT00718666|58665180|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
30652783|NCT00718666|58665181|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
30652784|NCT03950440|58665202|FG000|Overall Study|Death|8|||
30652785|NCT03950440|58665203|FG001|Overall Study|Death|2|||
30652786|NCT03950440|58665204|FG002|Overall Study|Death|1|||
30652787|NCT00718510|58665214|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
30652788|NCT00718510|58665215|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
30652789|NCT00718510|58665214|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
30652790|NCT00718510|58665215|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
30652791|NCT00585286|58665221|FG000|Overall Study|Lost to Follow-up|1|||
30652792|NCT00723190|58665225|FG000|Overall Study|Withdrawal by Subject|45|||
30652793|NCT00723190|58665225|FG000|Overall Study|Lost to Follow-up|37|||
30652794|NCT00723190|58665225|FG000|Overall Study|Adverse Event|18|||
30652795|NCT00723190|58665225|FG000|Overall Study|Lack of Efficacy|16|||
30652796|NCT00723190|58665225|FG000|Overall Study|Protocol Violation|15|||
30652797|NCT00723190|58665225|FG000|Overall Study|Other-Premature Discontinuation|9|||
30652798|NCT00723190|58665225|FG000|Overall Study|Other-Not included in safety population|2|||
30652799|NCT00722800|58665231|FG000|Overall Study|Withdrawal by Subject|1|||
30652800|NCT00722800|58665232|FG001|Overall Study|Withdrawal by Subject|0|||
30652801|NCT00722800|58665231|FG000|Overall Study|Physician Decision|1|||
30652802|NCT00722800|58665232|FG001|Overall Study|Physician Decision|0|||
30652803|NCT00718042|58665244|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
30652804|NCT00718042|58665245|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
30652805|NCT00718042|58665246|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
30652806|NCT00718042|58665247|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
30652807|NCT00718042|58665248|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
30652808|NCT00718042|58665249|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
30652809|NCT00718042|58665244|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
30652810|NCT00718042|58665245|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
30652811|NCT00718042|58665246|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
30652812|NCT00718042|58665247|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
30652813|NCT00718042|58665248|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
30652814|NCT00718042|58665249|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
30652815|NCT00718042|58665244|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
30652816|NCT00718042|58665245|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
30652817|NCT00718042|58665246|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
30652818|NCT00718042|58665247|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
30652819|NCT00718042|58665248|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
30652820|NCT00718042|58665249|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
30652821|NCT00718042|58665244|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
30768109|NCT03216226|58777170|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
30768110|NCT03216226|58777171|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
30768111|NCT03216226|58777170|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
30768112|NCT03216226|58777171|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
30768113|NCT03215758|58777179|FG000|Overall Study|Technical Problems|1|||
30652822|NCT00718042|58665245|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
30652823|NCT00718042|58665246|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
30652824|NCT00718042|58665247|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
30652825|NCT00718042|58665248|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
30652826|NCT00718042|58665249|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
30652827|NCT00718042|58665244|FG000|Donor Follow-up|Lost to Follow-up|13|||
30652828|NCT00718042|58665245|FG001|Donor Follow-up|Lost to Follow-up|0|||
30652829|NCT00718042|58665246|FG002|Donor Follow-up|Lost to Follow-up|0|||
30652830|NCT00718042|58665247|FG003|Donor Follow-up|Lost to Follow-up|0|||
30652831|NCT00718042|58665248|FG004|Donor Follow-up|Lost to Follow-up|19|||
30652832|NCT00718042|58665249|FG005|Donor Follow-up|Lost to Follow-up|0|||
30652833|NCT00741598|58665263|FG000|Overall Study|Lost to Follow-up|3|||
30652834|NCT00741598|58665264|FG001|Overall Study|Lost to Follow-up|4|||
30652835|NCT00741598|58665263|FG000|Overall Study|Lack of Efficacy|1|||
30652836|NCT00741598|58665264|FG001|Overall Study|Lack of Efficacy|2|||
30652837|NCT00741598|58665263|FG000|Overall Study|Physician Decision|1|||
30652838|NCT00741598|58665264|FG001|Overall Study|Physician Decision|1|||
30652839|NCT00741598|58665263|FG000|Overall Study|Pregnancy|1|||
30652840|NCT00741598|58665264|FG001|Overall Study|Pregnancy|0|||
30652841|NCT00741598|58665263|FG000|Overall Study|Withdrawal by Subject|3|||
30652842|NCT00741598|58665264|FG001|Overall Study|Withdrawal by Subject|2|||
30768114|NCT03215758|58777180|FG001|Overall Study|Technical Problems|0|||
30652843|NCT00717886|58665271|FG000|Overall Study|Withdrawal by Subject|3|||
30652844|NCT00717886|58665271|FG000|Overall Study|Treatment Failure|1|||
30652845|NCT00741286|58665277|FG000|Overall Study|Lost to Follow-up|15|||
30652846|NCT00741286|58665278|FG001|Overall Study|Lost to Follow-up|10|||
30652847|NCT00741286|58665277|FG000|Overall Study|Adverse Event|1|||
30652848|NCT00741286|58665278|FG001|Overall Study|Adverse Event|6|||
30652849|NCT00741286|58665277|FG000|Overall Study|Protocol Violation|3|||
30652850|NCT00741286|58665278|FG001|Overall Study|Protocol Violation|2|||
30652851|NCT00741286|58665277|FG000|Overall Study|Primary Outcome|1|||
30652852|NCT00741286|58665278|FG001|Overall Study|Primary Outcome|1|||
30652853|NCT00716482|58665284|FG000|Overall Study|Lost to Follow-up|6|||
30652854|NCT00716482|58665284|FG000|Overall Study|Inadequate acquisition or analysis|50|||
30652855|NCT00716482|58665284|FG000|Overall Study|no pathology obtained|10|||
30652856|NCT00716482|58665284|FG000|Overall Study|technical/machine error|28|||
30652857|NCT00716482|58665284|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
30652858|NCT00716092|58665297|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
30652859|NCT00716092|58665298|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
30652860|NCT00716092|58665299|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
30652861|NCT00715624|58665309|FG000|Overall Study|Adverse Event|12|||
30652862|NCT00715624|58665310|FG001|Overall Study|Adverse Event|37|||
30652863|NCT00715624|58665309|FG000|Overall Study|Lack of Efficacy|11|||
30652864|NCT00715624|58665310|FG001|Overall Study|Lack of Efficacy|11|||
30652865|NCT00715624|58665309|FG000|Overall Study|Lost to Follow-up|1|||
30652866|NCT00715624|58665310|FG001|Overall Study|Lost to Follow-up|2|||
30652867|NCT00715624|58665309|FG000|Overall Study|Protocol Violation|1|||
30652868|NCT00715624|58665310|FG001|Overall Study|Protocol Violation|0|||
30652869|NCT00715624|58665309|FG000|Overall Study|Withdrawal by Subject|11|||
30652870|NCT00715624|58665310|FG001|Overall Study|Withdrawal by Subject|25|||
30652871|NCT00715624|58665309|FG000|Overall Study|Familial and personal reasons|10|||
30652872|NCT00715624|58665310|FG001|Overall Study|Familial and personal reasons|22|||
30652873|NCT00715624|58665309|FG000|Overall Study|Poor compliance|6|||
30652874|NCT00715624|58665310|FG001|Overall Study|Poor compliance|13|||
30652875|NCT00715624|58665309|FG000|Overall Study|Sponsor decision|0|||
30652876|NCT00715624|58665310|FG001|Overall Study|Sponsor decision|4|||
30652877|NCT00715624|58665309|FG000|Overall Study|Incorrect randomization (not treated)|0|||
30652878|NCT00715624|58665310|FG001|Overall Study|Incorrect randomization (not treated)|1|||
30652879|NCT00715624|58665309|FG000|Overall Study|Other|0|||
30652880|NCT00715624|58665310|FG001|Overall Study|Other|1|||
30652881|NCT00576199|58665316|FG000|Overall Study|Adverse Event|12|||
30652882|NCT00576199|58665316|FG000|Overall Study|Insufficient Therapeutic Response|14|||
30652883|NCT00576199|58665316|FG000|Overall Study|Refused Treatment|2|||
30652884|NCT00576199|58665316|FG000|Overall Study|Reason Unspecified|2|||
30652885|NCT00715078|58665323|FG000|Overall Study|Death|29|||
30652886|NCT00715078|58665324|FG001|Overall Study|Death|36|||
30652887|NCT00715078|58665325|FG002|Overall Study|Death|36|||
30652888|NCT00715078|58665323|FG000|Overall Study|Withdrawal by Subject|1|||
30652889|NCT00715078|58665324|FG001|Overall Study|Withdrawal by Subject|0|||
30652890|NCT00715078|58665325|FG002|Overall Study|Withdrawal by Subject|1|||
30652891|NCT00715078|58665323|FG000|Overall Study|Unable to start due to disease prog.|0|||
30652892|NCT00715078|58665324|FG001|Overall Study|Unable to start due to disease prog.|0|||
30652893|NCT00715078|58665325|FG002|Overall Study|Unable to start due to disease prog.|1|||
30652894|NCT00679627|58665335|FG000|Overall Study|Death|41|||
30652895|NCT00679627|58665336|FG001|Overall Study|Death|29|||
30952257|NCT01543087|58999996|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
30952258|NCT01543087|58999997|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
30952259|NCT01543087|58999998|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
30952260|NCT01543087|58999999|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
30952261|NCT01543087|59000000|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
30952262|NCT01543087|59000001|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
30952263|NCT01543087|58999996|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
30952264|NCT01543087|58999997|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
30952265|NCT01543087|58999998|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
30952266|NCT01543087|58999999|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
30952267|NCT01543087|59000000|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
30952268|NCT01543087|59000001|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
30952269|NCT01543087|58999996|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
30952270|NCT01543087|58999997|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
30952271|NCT01543087|58999998|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
30952272|NCT01543087|58999999|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
30952273|NCT01543087|59000000|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
30952274|NCT01543087|59000001|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
30952275|NCT01543087|58999996|FG000|Stage 1 (48 Months)|Other than specified|5|||
30652896|NCT00679627|58665335|FG000|Overall Study|Adverse Event|43|||
30652897|NCT00679627|58665336|FG001|Overall Study|Adverse Event|53|||
30652898|NCT00679627|58665335|FG000|Overall Study|Withdrawal by Subject|168|||
30652899|NCT00679627|58665336|FG001|Overall Study|Withdrawal by Subject|172|||
30768115|NCT03215758|58777179|FG000|Overall Study|Protocol deviation|0|||
30768116|NCT03215758|58777180|FG001|Overall Study|Protocol deviation|1|||
30768117|NCT03215758|58777179|FG000|Overall Study|Physician Decision|0|||
30768118|NCT03215758|58777180|FG001|Overall Study|Physician Decision|1|||
30768119|NCT03215758|58777179|FG000|Overall Study|Death|0|||
30768120|NCT03215758|58777180|FG001|Overall Study|Death|1|||
30768121|NCT03215758|58777179|FG000|Overall Study|Adverse Event|1|||
30768122|NCT03215758|58777180|FG001|Overall Study|Adverse Event|2|||
30768123|NCT03215758|58777179|FG000|Overall Study|Subject/Guardian Decision|3|||
30768124|NCT03215758|58777180|FG001|Overall Study|Subject/Guardian Decision|3|||
30768125|NCT00290771|58777188|FG000|Overall Study|Disease progression|95|||
30768126|NCT00290771|58777189|FG001|Overall Study|Disease progression|73|||
30768127|NCT00290771|58777188|FG000|Overall Study|Death|11|||
30768128|NCT00290771|58777189|FG001|Overall Study|Death|10|||
30768129|NCT00290771|58777188|FG000|Overall Study|Adverse Event|12|||
30768130|NCT00290771|58777189|FG001|Overall Study|Adverse Event|6|||
30768131|NCT00290771|58777188|FG000|Overall Study|Withdrawal by Subject|5|||
30768132|NCT00290771|58777189|FG001|Overall Study|Withdrawal by Subject|6|||
30768133|NCT00290771|58777188|FG000|Overall Study|Administrative problems|2|||
30768134|NCT00290771|58777189|FG001|Overall Study|Administrative problems|1|||
30768135|NCT00290771|58777188|FG000|Overall Study|Protocol Violation|2|||
30768136|NCT00290771|58777189|FG001|Overall Study|Protocol Violation|0|||
30768137|NCT00290771|58777188|FG000|Overall Study|Lost to Follow-up|0|||
30768138|NCT00290771|58777189|FG001|Overall Study|Lost to Follow-up|1|||
30768139|NCT00274625|58777198|FG000|Overall Study|Lost to Follow-up|46|||
30768140|NCT00274625|58777199|FG001|Overall Study|Lost to Follow-up|54|||
30768141|NCT00274625|58777198|FG000|Overall Study|Excluded from analysis|14|||
30768142|NCT00274625|58777199|FG001|Overall Study|Excluded from analysis|8|||
30768143|NCT00290693|58777205|FG000|Overall Study|Withdrawal by Subject|2|||
30768144|NCT03214666|58777216|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
30768145|NCT03214666|58777217|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
30768146|NCT03214666|58777218|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
30768147|NCT03214666|58777219|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
30768148|NCT03214666|58777220|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
30768149|NCT03214666|58777221|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
30768150|NCT00274469|58777238|FG000|Overall Study|Death|63|||
30768151|NCT00274469|58777239|FG001|Overall Study|Death|74|||
30768152|NCT00274469|58777238|FG000|Overall Study|Did not consent to OS follow-up|16|||
30768153|NCT00274469|58777239|FG001|Overall Study|Did not consent to OS follow-up|19|||
30768154|NCT03214588|58777248|FG000|Overall Study|Adverse Event|1|||
30768155|NCT03214588|58777249|FG001|Overall Study|Adverse Event|0|||
30768156|NCT03214588|58777250|FG002|Overall Study|Adverse Event|2|||
30768157|NCT03214588|58777248|FG000|Overall Study|Reason Not Specified|0|||
30768158|NCT03214588|58777249|FG001|Overall Study|Reason Not Specified|1|||
30768159|NCT03214588|58777250|FG002|Overall Study|Reason Not Specified|0|||
30768160|NCT03166618|58777260|FG000|Overall Study|Study was Terminated|0|||
30768161|NCT03166618|58777261|FG001|Overall Study|Study was Terminated|1|||
30768162|NCT03162796|58777278|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
30768163|NCT03162796|58777279|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
30768164|NCT03162796|58777280|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
30768165|NCT03162796|58777278|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
30768166|NCT03162796|58777279|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
30768167|NCT03162796|58777280|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
30768168|NCT03162796|58777278|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
30768169|NCT03162796|58777279|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
30768170|NCT03162796|58777280|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
30768171|NCT03162796|58777278|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
30768172|NCT03162796|58777279|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
30768173|NCT03162796|58777280|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
30768174|NCT03162796|58777278|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
30768175|NCT03162796|58777279|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
30768176|NCT03162796|58777280|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
30768177|NCT03162796|58777278|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
30768178|NCT03162796|58777279|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
30768179|NCT03162796|58777280|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
30768180|NCT03162796|58777278|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
30768181|NCT03162796|58777279|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
30768182|NCT03162796|58777280|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
30768183|NCT03162796|58777278|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
30768184|NCT03162796|58777279|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
30768185|NCT03162796|58777280|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
30768186|NCT03162796|58777278|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
30768187|NCT03162796|58777279|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
30768188|NCT03162796|58777280|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
30768189|NCT03162796|58777278|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
30768190|NCT03162796|58777279|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
30768191|NCT03162796|58777280|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
30768192|NCT03162796|58777278|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
30768193|NCT03162796|58777279|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
30768194|NCT03162796|58777280|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
30768195|NCT03162328|58777293|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
30652900|NCT00679627|58665335|FG000|Overall Study|Lost to Follow-up|22|||
30652901|NCT00679627|58665336|FG001|Overall Study|Lost to Follow-up|26|||
30652902|NCT00679627|58665335|FG000|Overall Study|Early Study Closure|425|||
30652903|NCT00679627|58665336|FG001|Overall Study|Early Study Closure|405|||
30652904|NCT00714688|58665345|FG000|Overall Study|Lack of Efficacy|14|||
30652905|NCT00714688|58665346|FG001|Overall Study|Lack of Efficacy|1|||
30652906|NCT00714688|58665347|FG002|Overall Study|Lack of Efficacy|4|||
30652907|NCT00714688|58665345|FG000|Overall Study|Withdrawal by Subject|4|||
30652908|NCT00714688|58665346|FG001|Overall Study|Withdrawal by Subject|3|||
30652909|NCT00714688|58665347|FG002|Overall Study|Withdrawal by Subject|3|||
30652910|NCT00714688|58665345|FG000|Overall Study|Lost to Follow-up|5|||
30652911|NCT00714688|58665346|FG001|Overall Study|Lost to Follow-up|2|||
30652912|NCT00714688|58665347|FG002|Overall Study|Lost to Follow-up|0|||
30768196|NCT03162328|58777294|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
30768197|NCT03162328|58777295|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
30768198|NCT03162328|58777293|FG000|Screening Period|Withdrawal by Subject|1|||
30768199|NCT03162328|58777294|FG001|Screening Period|Withdrawal by Subject|0|||
30768200|NCT03162328|58777295|FG002|Screening Period|Withdrawal by Subject|0|||
30768201|NCT03162328|58777293|FG000|Study Period|Withdrawal by Subject|0|||
30768202|NCT03162328|58777294|FG001|Study Period|Withdrawal by Subject|0|||
30768203|NCT03162328|58777295|FG002|Study Period|Withdrawal by Subject|1|||
30768204|NCT00272987|58777309|FG000|Overall Study|Adverse Event|1|||
30652913|NCT00714688|58665345|FG000|Overall Study|Adverse Event|2|||
30652914|NCT00714688|58665346|FG001|Overall Study|Adverse Event|15|||
30652915|NCT00714688|58665347|FG002|Overall Study|Adverse Event|19|||
30652916|NCT00714688|58665345|FG000|Overall Study|Subject Non-compliant|3|||
30652917|NCT00714688|58665346|FG001|Overall Study|Subject Non-compliant|5|||
30652918|NCT00714688|58665347|FG002|Overall Study|Subject Non-compliant|5|||
30652919|NCT00714688|58665345|FG000|Overall Study|Ineligible to Continue the Study|0|||
30652920|NCT00714688|58665346|FG001|Overall Study|Ineligible to Continue the Study|1|||
30652921|NCT00714688|58665347|FG002|Overall Study|Ineligible to Continue the Study|1|||
30652922|NCT00714688|58665345|FG000|Overall Study|Sponsor's Decision|0|||
30652923|NCT00714688|58665346|FG001|Overall Study|Sponsor's Decision|2|||
30652924|NCT00714688|58665347|FG002|Overall Study|Sponsor's Decision|0|||
30652925|NCT00714688|58665345|FG000|Overall Study|Other|1|||
30652926|NCT00714688|58665346|FG001|Overall Study|Other|6|||
30652927|NCT00714688|58665347|FG002|Overall Study|Other|5|||
30652928|NCT00679549|58665357|FG000|Overall Study|dropout|2|||
30652929|NCT00679549|58665358|FG001|Overall Study|dropout|4|||
30652930|NCT00679549|58665357|FG000|Overall Study|missing outcome echocardiograms|4|||
30652931|NCT00679549|58665358|FG001|Overall Study|missing outcome echocardiograms|5|||
30652932|NCT01031069|58665368|FG000|Overall Study|Serious Adverse Event|0|||
30768205|NCT00272987|58777310|FG001|Overall Study|Adverse Event|0|||
30768206|NCT00272987|58777311|FG002|Overall Study|Adverse Event|0|||
30768207|NCT00272987|58777309|FG000|Overall Study|Lost to Follow-up|3|||
30768208|NCT00272987|58777310|FG001|Overall Study|Lost to Follow-up|1|||
30768209|NCT00272987|58777311|FG002|Overall Study|Lost to Follow-up|1|||
30768210|NCT00272987|58777309|FG000|Overall Study|Withdrawal by Subject|1|||
30652933|NCT01031069|58665369|FG001|Overall Study|Serious Adverse Event|1|||
30652934|NCT01031069|58665370|FG002|Overall Study|Serious Adverse Event|0|||
30652935|NCT01031069|58665371|FG003|Overall Study|Serious Adverse Event|0|||
30652936|NCT01031069|58665368|FG000|Overall Study|Withdrawal by Subject|2|||
30652937|NCT01031069|58665369|FG001|Overall Study|Withdrawal by Subject|3|||
30652938|NCT01031069|58665370|FG002|Overall Study|Withdrawal by Subject|18|||
30652939|NCT01031069|58665371|FG003|Overall Study|Withdrawal by Subject|18|||
30652940|NCT01031069|58665368|FG000|Overall Study|Migrated/moved from study area|1|||
30652941|NCT01031069|58665369|FG001|Overall Study|Migrated/moved from study area|2|||
30652942|NCT01031069|58665370|FG002|Overall Study|Migrated/moved from study area|1|||
30652943|NCT01031069|58665371|FG003|Overall Study|Migrated/moved from study area|1|||
30652944|NCT01031069|58665368|FG000|Overall Study|Lost to Follow-up|9|||
30652945|NCT01031069|58665369|FG001|Overall Study|Lost to Follow-up|5|||
30652946|NCT01031069|58665370|FG002|Overall Study|Lost to Follow-up|21|||
30652947|NCT01031069|58665371|FG003|Overall Study|Lost to Follow-up|15|||
30652948|NCT01031069|58665368|FG000|Overall Study|Other|0|||
30652949|NCT01031069|58665369|FG001|Overall Study|Other|0|||
30652950|NCT01031069|58665370|FG002|Overall Study|Other|1|||
30652951|NCT01031069|58665371|FG003|Overall Study|Other|0|||
30652952|NCT00679081|58665383|FG000|Overall Study|Lost to Follow-up|1|||
30652953|NCT00682435|58665391|FG000|Overall Study|Insufficient data|5|||
30652954|NCT00682435|58665391|FG000|Overall Study|Erroneously enrolled twice|2|||
30652955|NCT00713830|58665397|FG000|Overall Study|Adverse Event|23|||
30652956|NCT00713830|58665398|FG001|Overall Study|Adverse Event|71|||
30652957|NCT00713830|58665397|FG000|Overall Study|Lack of Efficacy|24|||
30652958|NCT00713830|58665398|FG001|Overall Study|Lack of Efficacy|16|||
30652959|NCT00713830|58665397|FG000|Overall Study|Lost to Follow-up|2|||
30652960|NCT00713830|58665398|FG001|Overall Study|Lost to Follow-up|9|||
30652961|NCT00713830|58665397|FG000|Overall Study|Withdrawal by Subject|13|||
30652962|NCT00713830|58665398|FG001|Overall Study|Withdrawal by Subject|23|||
30768211|NCT00272987|58777310|FG001|Overall Study|Withdrawal by Subject|0|||
30652963|NCT00713830|58665397|FG000|Overall Study|Poor Compliance to Protocol|7|||
30652964|NCT00713830|58665398|FG001|Overall Study|Poor Compliance to Protocol|14|||
30652965|NCT00713830|58665397|FG000|Overall Study|Familial and Personal Reasons|9|||
30652966|NCT00713830|58665398|FG001|Overall Study|Familial and Personal Reasons|34|||
30652967|NCT00713830|58665397|FG000|Overall Study|Sponsor Decision|4|||
30652968|NCT00713830|58665398|FG001|Overall Study|Sponsor Decision|10|||
30652969|NCT00681811|58665406|FG000|Overall Study|Adverse Event|1|||
30652970|NCT00681811|58665407|FG001|Overall Study|Adverse Event|1|||
30652971|NCT00681811|58665406|FG000|Overall Study|Withdrawal by Subject|2|||
30652972|NCT00681811|58665407|FG001|Overall Study|Withdrawal by Subject|2|||
30768212|NCT00272987|58777311|FG002|Overall Study|Withdrawal by Subject|3|||
30768213|NCT00272987|58777309|FG000|Overall Study|Sponsor Terminated study|0|||
30768214|NCT00272987|58777310|FG001|Overall Study|Sponsor Terminated study|1|||
30652973|NCT00681811|58665406|FG000|Overall Study|Non-compliance|0|||
30652974|NCT00681811|58665407|FG001|Overall Study|Non-compliance|1|||
30652975|NCT00681187|58665426|FG000|Overall Study|Withdrawal by Subject|1|||
30652976|NCT00681187|58665427|FG001|Overall Study|Withdrawal by Subject|0|||
30652977|NCT00681187|58665426|FG000|Overall Study|Death|0|||
30652978|NCT00681187|58665427|FG001|Overall Study|Death|1|||
30652979|NCT00681187|58665426|FG000|Overall Study|Adverse Event|0|||
30652980|NCT00681187|58665427|FG001|Overall Study|Adverse Event|1|||
30768215|NCT00272987|58777311|FG002|Overall Study|Sponsor Terminated study|1|||
30768216|NCT00272987|58777309|FG000|Overall Study|Disease progression|1|||
30768217|NCT00272987|58777310|FG001|Overall Study|Disease progression|1|||
30768218|NCT00272987|58777311|FG002|Overall Study|Disease progression|2|||
30768219|NCT00272987|58777309|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
30768220|NCT00272987|58777310|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
30768221|NCT00272987|58777311|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
30768222|NCT00272987|58777309|FG000|Overall Study|Death|1|||
30652981|NCT00681109|58665449|FG000|Overall Study|Lost to Follow-up|2|||
30652982|NCT00681109|58665450|FG001|Overall Study|Lost to Follow-up|6|||
30652983|NCT00681109|58665451|FG002|Overall Study|Lost to Follow-up|0|||
30652984|NCT00680407|58665465|FG000|Overall Study|Lost to Follow-up|3|||
30652985|NCT00680407|58665466|FG001|Overall Study|Lost to Follow-up|3|||
30652986|NCT00680407|58665467|FG002|Overall Study|Lost to Follow-up|1|||
30652987|NCT00680407|58665465|FG000|Overall Study|Withdrawal by Subject|5|||
30652988|NCT00680407|58665466|FG001|Overall Study|Withdrawal by Subject|2|||
30652989|NCT00680407|58665467|FG002|Overall Study|Withdrawal by Subject|2|||
30652990|NCT00677365|58665479|FG000|Overall Study|Adverse Event|2|||
30652991|NCT00677365|58665480|FG001|Overall Study|Adverse Event|1|||
30652992|NCT00677365|58665481|FG002|Overall Study|Adverse Event|1|||
30652993|NCT00677365|58665482|FG003|Overall Study|Adverse Event|2|||
30652994|NCT00677365|58665479|FG000|Overall Study|Withdrawal by Subject|0|||
30652995|NCT00677365|58665480|FG001|Overall Study|Withdrawal by Subject|0|||
30652996|NCT00677365|58665481|FG002|Overall Study|Withdrawal by Subject|1|||
30652997|NCT00677365|58665482|FG003|Overall Study|Withdrawal by Subject|0|||
30652998|NCT00677365|58665479|FG000|Overall Study|Other reason|0|||
30652999|NCT00677365|58665480|FG001|Overall Study|Other reason|0|||
30653000|NCT00677365|58665481|FG002|Overall Study|Other reason|0|||
30653001|NCT00677365|58665482|FG003|Overall Study|Other reason|1|||
30653002|NCT00680017|58665494|FG000|Overall Study|Adverse Event|13|||
30653003|NCT00680017|58665495|FG001|Overall Study|Adverse Event|7|||
30653004|NCT00680017|58665494|FG000|Overall Study|Withdrawal by Subject|2|||
30653005|NCT00680017|58665495|FG001|Overall Study|Withdrawal by Subject|5|||
30653006|NCT00680017|58665494|FG000|Overall Study|Lost to Follow-up|2|||
30653007|NCT00680017|58665495|FG001|Overall Study|Lost to Follow-up|0|||
30653008|NCT00676663|58665503|FG000|Overall Study|Death|43|||
30653009|NCT00676663|58665504|FG001|Overall Study|Death|27|||
30653010|NCT00676663|58665503|FG000|Overall Study|Withdrew Consent|1|||
30653011|NCT00676663|58665504|FG001|Overall Study|Withdrew Consent|8|||
30653012|NCT00676663|58665503|FG000|Overall Study|Lost to Follow-up|1|||
30653013|NCT00676663|58665504|FG001|Overall Study|Lost to Follow-up|3|||
30653014|NCT00678691|58665514|FG000|Overall Study|Adverse Event|6|||
30653015|NCT00678691|58665515|FG001|Overall Study|Adverse Event|4|||
30653016|NCT00679939|58665523|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
30653017|NCT00679939|58665524|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
30653018|NCT00679939|58665523|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
30653019|NCT00679939|58665524|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
30653020|NCT00679939|58665523|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
30653021|NCT00679939|58665524|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
30653022|NCT00679939|58665523|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
30653023|NCT00679939|58665524|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
30653024|NCT00679939|58665523|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
30653025|NCT00679939|58665524|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
30653026|NCT00679939|58665523|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
30653027|NCT00679939|58665524|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
30653028|NCT00679939|58665523|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
30653029|NCT00679939|58665524|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
30653030|NCT00679939|58665523|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
30768223|NCT00272987|58777310|FG001|Overall Study|Death|0|||
30768224|NCT00272987|58777311|FG002|Overall Study|Death|0|||
30768225|NCT01730950|58777321|FG000|Overall Study|Protocol Violation|6|||
30768226|NCT01730950|58777322|FG001|Overall Study|Protocol Violation|6|||
30768227|NCT00271505|58777329|FG000|Overall Study|Screen Failure|3|||
30768228|NCT00271505|58777329|FG000|Overall Study|Adverse Event|1|||
30768229|NCT00271505|58777329|FG000|Overall Study|Death|1|||
30768230|NCT01642186|58777337|FG000|Overall Study|Death|0|||
30653031|NCT00679939|58665524|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
30653032|NCT00679939|58665523|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
30653033|NCT00679939|58665524|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
30653034|NCT00679939|58665523|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
30653035|NCT00679939|58665524|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
30653036|NCT00673933|58665534|FG000|Overall Study|Withdrawal by Subject|2|||
30653037|NCT00673933|58665534|FG000|Overall Study|Lost to Follow-up|1|||
30653038|NCT00571519|58665547|FG000|Overall Study|Subject withdrew consent|0|||
30653039|NCT00571519|58665548|FG001|Overall Study|Subject withdrew consent|1|||
30768231|NCT01642186|58777338|FG001|Overall Study|Death|2|||
30768232|NCT01642186|58777339|FG002|Overall Study|Death|2|||
30768233|NCT01642186|58777337|FG000|Overall Study|Lost to Follow-up|0|||
30768234|NCT01642186|58777338|FG001|Overall Study|Lost to Follow-up|0|||
30768235|NCT01642186|58777339|FG002|Overall Study|Lost to Follow-up|1|||
30768236|NCT00423514|58777349|FG000|Overall Study|Ineligible|1|||
30768237|NCT00423514|58777350|FG001|Overall Study|Ineligible|0|||
30768238|NCT00289991|58777358|FG000|Overall Study|Death|35|||
30768239|NCT00289991|58777359|FG001|Overall Study|Death|38|||
30768240|NCT00289991|58777358|FG000|Overall Study|Adverse Event|15|||
30768241|NCT00289991|58777359|FG001|Overall Study|Adverse Event|13|||
30768242|NCT00289991|58777358|FG000|Overall Study|Failure of prophylaxis|1|||
30768243|NCT00289991|58777359|FG001|Overall Study|Failure of prophylaxis|1|||
30768244|NCT00289991|58777358|FG000|Overall Study|Fungal breakthrough infection|0|||
30768245|NCT00289991|58777359|FG001|Overall Study|Fungal breakthrough infection|1|||
30653040|NCT00571519|58665549|FG002|Overall Study|Subject withdrew consent|0|||
30653041|NCT00571519|58665550|FG003|Overall Study|Subject withdrew consent|2|||
30768246|NCT00289991|58777358|FG000|Overall Study|Lost to Follow-up|0|||
30768247|NCT00289991|58777359|FG001|Overall Study|Lost to Follow-up|1|||
30768248|NCT00289991|58777358|FG000|Overall Study|Withdrawal by Subject|2|||
30952276|NCT01543087|58999997|FG001|Stage 1 (48 Months)|Other than specified|0|||
30952277|NCT01543087|58999998|FG002|Stage 1 (48 Months)|Other than specified|9|||
30952278|NCT01543087|58999999|FG003|Stage 1 (48 Months)|Other than specified|0|||
30952279|NCT01543087|59000000|FG004|Stage 1 (48 Months)|Other than specified|0|||
30952280|NCT01543087|59000001|FG005|Stage 1 (48 Months)|Other than specified|0|||
30952281|NCT01543087|58999996|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
30952282|NCT01543087|58999997|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
30653042|NCT00571519|58665551|FG004|Overall Study|Subject withdrew consent|1|||
30653043|NCT00571519|58665552|FG005|Overall Study|Subject withdrew consent|1|||
30653044|NCT00571519|58665553|FG006|Overall Study|Subject withdrew consent|2|||
30653045|NCT00571519|58665547|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
30653046|NCT00571519|58665548|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
30653047|NCT00571519|58665549|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
30653048|NCT00571519|58665550|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
30768249|NCT00289991|58777359|FG001|Overall Study|Withdrawal by Subject|12|||
30768250|NCT00289991|58777358|FG000|Overall Study|Other|5|||
30768251|NCT00289991|58777359|FG001|Overall Study|Other|14|||
30768252|NCT00289913|58777370|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30768253|NCT00289913|58777371|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
30768254|NCT00289913|58777372|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30768255|NCT00289913|58777373|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30768256|NCT00289913|58777374|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30768257|NCT00289913|58777370|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
30768258|NCT00289913|58777371|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
30768259|NCT00289913|58777372|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
30768260|NCT00289913|58777373|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
30768261|NCT00289913|58777374|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
30768262|NCT00289913|58777370|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
30768263|NCT00289913|58777371|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
30768264|NCT00289913|58777372|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
30768265|NCT00289913|58777373|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
30768266|NCT00289913|58777374|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
30768267|NCT00289913|58777370|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
30768268|NCT00289913|58777371|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
30768269|NCT00289913|58777372|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
30768270|NCT00289913|58777373|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
30768271|NCT00289913|58777374|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
30768272|NCT00289913|58777370|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
30768273|NCT00289913|58777371|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
30768274|NCT00289913|58777372|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
30768275|NCT00289913|58777373|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
30768276|NCT00289913|58777374|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
30848738|NCT02849509|58875309|FG000|Overall Study|Other adverse event|36|||
30848739|NCT02849509|58875310|FG001|Overall Study|Other adverse event|41|||
30848740|NCT02849509|58875311|FG002|Overall Study|Other adverse event|8|||
30848741|NCT02849509|58875309|FG000|Overall Study|Withdrawal by Subject|6|||
30848742|NCT02849509|58875310|FG001|Overall Study|Withdrawal by Subject|17|||
30848743|NCT02849509|58875311|FG002|Overall Study|Withdrawal by Subject|12|||
30768277|NCT00289913|58777370|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
30768278|NCT00289913|58777371|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
30848744|NCT02849509|58875309|FG000|Overall Study|Lost to Follow-up|27|||
30952283|NCT01543087|58999998|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
30768279|NCT00289913|58777372|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
30768280|NCT00289913|58777373|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
30653049|NCT00571519|58665551|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
30653050|NCT00571519|58665552|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
30653051|NCT00571519|58665553|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
30653052|NCT00571519|58665547|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
30653053|NCT00571519|58665548|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
30653054|NCT00571519|58665549|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
30653055|NCT00571519|58665550|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
30653056|NCT00571519|58665551|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
30653057|NCT00571519|58665552|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
30653058|NCT00571519|58665553|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
30653059|NCT00571519|58665547|FG000|Overall Study|Termination of study by Sponsor|2|||
30653060|NCT00571519|58665548|FG001|Overall Study|Termination of study by Sponsor|7|||
30653061|NCT00571519|58665549|FG002|Overall Study|Termination of study by Sponsor|10|||
30653062|NCT00571519|58665550|FG003|Overall Study|Termination of study by Sponsor|24|||
30653063|NCT00571519|58665551|FG004|Overall Study|Termination of study by Sponsor|8|||
30653064|NCT00571519|58665552|FG005|Overall Study|Termination of study by Sponsor|9|||
30653065|NCT00571519|58665553|FG006|Overall Study|Termination of study by Sponsor|22|||
30768281|NCT00289913|58777374|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
30768282|NCT00289913|58777370|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
30768283|NCT00289913|58777371|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
30768284|NCT00289913|58777372|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
30768285|NCT00289913|58777373|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
30768286|NCT00289913|58777374|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
30653066|NCT00571519|58665547|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
30653067|NCT00571519|58665548|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
30653068|NCT00571519|58665549|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
30653069|NCT00571519|58665550|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
30653070|NCT00571519|58665551|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
30653071|NCT00571519|58665552|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
30653072|NCT00571519|58665553|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
30653073|NCT00676195|58665569|FG000|Overall Study|Lost to Follow-up|1|||
30653074|NCT00676195|58665569|FG000|Overall Study|Adverse Event|1|||
30653075|NCT00676195|58665569|FG000|Overall Study|Physician Decision|1|||
30653076|NCT00675103|58665574|FG000|Overall Study|Lack of Efficacy|2|||
30653077|NCT00675103|58665574|FG000|Overall Study|Adverse Event|1|||
30653078|NCT00675025|58665580|FG000|Overall Study|Study Terminated by Sponsor|38|||
30653079|NCT00675025|58665581|FG001|Overall Study|Study Terminated by Sponsor|42|||
30653080|NCT00675025|58665580|FG000|Overall Study|Adverse Event|6|||
30653081|NCT00675025|58665581|FG001|Overall Study|Adverse Event|11|||
30653082|NCT00675025|58665580|FG000|Overall Study|Lost to Follow-up|6|||
30653083|NCT00675025|58665581|FG001|Overall Study|Lost to Follow-up|4|||
30653084|NCT00675025|58665580|FG000|Overall Study|Withdrawal by Subject|4|||
30653085|NCT00675025|58665581|FG001|Overall Study|Withdrawal by Subject|6|||
30653086|NCT00678379|58665599|FG000|Overall Study|Injection performed after tonsillectomy|2|||
30653087|NCT00678379|58665600|FG001|Overall Study|Injection performed after tonsillectomy|0|||
30653088|NCT00678379|58665601|FG002|Overall Study|Injection performed after tonsillectomy|1|||
30653089|NCT00678379|58665599|FG000|Overall Study|Incomplete Data|4|||
30653090|NCT00678379|58665600|FG001|Overall Study|Incomplete Data|3|||
30653091|NCT00678379|58665601|FG002|Overall Study|Incomplete Data|3|||
30653092|NCT00674323|58665612|FG000|Overall Study|Adverse Event|0|||
30653093|NCT00674323|58665613|FG001|Overall Study|Adverse Event|1|||
30653094|NCT00674323|58665614|FG002|Overall Study|Adverse Event|0|||
30653095|NCT00674323|58665612|FG000|Overall Study|Protocol Violation|1|||
30653096|NCT00674323|58665613|FG001|Overall Study|Protocol Violation|0|||
30653097|NCT00674323|58665614|FG002|Overall Study|Protocol Violation|0|||
30653098|NCT00678301|58665624|FG000|Overall Study|Non-compliance with study procedures|0|||
30653099|NCT00678301|58665625|FG001|Overall Study|Non-compliance with study procedures|1|||
30653100|NCT00678301|58665624|FG000|Overall Study|Adverse Event|1|||
30653101|NCT00678301|58665625|FG001|Overall Study|Adverse Event|0|||
30653102|NCT00678301|58665624|FG000|Overall Study|Withdrawal by Subject|4|||
30653103|NCT00678301|58665625|FG001|Overall Study|Withdrawal by Subject|0|||
30653104|NCT00678301|58665624|FG000|Overall Study|Lost to Follow-up|3|||
30653105|NCT00678301|58665625|FG001|Overall Study|Lost to Follow-up|1|||
30653106|NCT00939770|58665639|FG000|Overall Study|Adverse Event|1|||
30653107|NCT00939770|58665640|FG001|Overall Study|Adverse Event|1|||
30653108|NCT00939770|58665641|FG002|Overall Study|Adverse Event|0|||
30653109|NCT00939770|58665642|FG003|Overall Study|Adverse Event|0|||
30653110|NCT00939770|58665643|FG004|Overall Study|Adverse Event|6|||
30653111|NCT00939770|58665644|FG005|Overall Study|Adverse Event|2|||
30653112|NCT00939770|58665645|FG006|Overall Study|Adverse Event|1|||
30653113|NCT00939770|58665646|FG007|Overall Study|Adverse Event|1|||
30653114|NCT00939770|58665639|FG000|Overall Study|Lack of Efficacy|4|||
30653115|NCT00939770|58665640|FG001|Overall Study|Lack of Efficacy|6|||
30653116|NCT00939770|58665641|FG002|Overall Study|Lack of Efficacy|13|||
30653117|NCT00939770|58665642|FG003|Overall Study|Lack of Efficacy|9|||
30653118|NCT00939770|58665643|FG004|Overall Study|Lack of Efficacy|16|||
30653119|NCT00939770|58665644|FG005|Overall Study|Lack of Efficacy|8|||
30653120|NCT00939770|58665645|FG006|Overall Study|Lack of Efficacy|11|||
30653121|NCT00939770|58665646|FG007|Overall Study|Lack of Efficacy|1|||
30653122|NCT00939770|58665639|FG000|Overall Study|Lost to Follow-up|0|||
30653123|NCT00939770|58665640|FG001|Overall Study|Lost to Follow-up|0|||
30653124|NCT00939770|58665641|FG002|Overall Study|Lost to Follow-up|0|||
30653125|NCT00939770|58665642|FG003|Overall Study|Lost to Follow-up|0|||
30653126|NCT00939770|58665643|FG004|Overall Study|Lost to Follow-up|1|||
30653127|NCT00939770|58665644|FG005|Overall Study|Lost to Follow-up|0|||
30653128|NCT00939770|58665645|FG006|Overall Study|Lost to Follow-up|0|||
30653129|NCT00939770|58665646|FG007|Overall Study|Lost to Follow-up|0|||
30653130|NCT00939770|58665639|FG000|Overall Study|Physician Decision|0|||
30653131|NCT00939770|58665640|FG001|Overall Study|Physician Decision|0|||
30653132|NCT00939770|58665641|FG002|Overall Study|Physician Decision|2|||
30653133|NCT00939770|58665642|FG003|Overall Study|Physician Decision|0|||
30653134|NCT00939770|58665643|FG004|Overall Study|Physician Decision|7|||
30653135|NCT00939770|58665644|FG005|Overall Study|Physician Decision|1|||
30653136|NCT00939770|58665645|FG006|Overall Study|Physician Decision|0|||
30653137|NCT00939770|58665646|FG007|Overall Study|Physician Decision|6|||
30653138|NCT00939770|58665639|FG000|Overall Study|Protocol Violation|0|||
30653139|NCT00939770|58665640|FG001|Overall Study|Protocol Violation|0|||
30653140|NCT00939770|58665641|FG002|Overall Study|Protocol Violation|0|||
30653141|NCT00939770|58665642|FG003|Overall Study|Protocol Violation|0|||
30768287|NCT00289913|58777370|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
30768288|NCT00289913|58777371|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
30768289|NCT00289913|58777372|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
30768290|NCT00289913|58777373|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
30653142|NCT00939770|58665643|FG004|Overall Study|Protocol Violation|1|||
30653143|NCT00939770|58665644|FG005|Overall Study|Protocol Violation|0|||
30768291|NCT00289913|58777374|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
30768292|NCT00289913|58777370|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
30768293|NCT00289913|58777371|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
30768294|NCT00289913|58777372|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
30768295|NCT00289913|58777373|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
30653144|NCT00939770|58665645|FG006|Overall Study|Protocol Violation|0|||
30653145|NCT00939770|58665646|FG007|Overall Study|Protocol Violation|0|||
30653146|NCT00939770|58665639|FG000|Overall Study|Withdrawal by Subject|0|||
30653147|NCT00939770|58665640|FG001|Overall Study|Withdrawal by Subject|1|||
30653148|NCT00939770|58665641|FG002|Overall Study|Withdrawal by Subject|5|||
30653149|NCT00939770|58665642|FG003|Overall Study|Withdrawal by Subject|2|||
30653150|NCT00939770|58665643|FG004|Overall Study|Withdrawal by Subject|6|||
30653151|NCT00939770|58665644|FG005|Overall Study|Withdrawal by Subject|0|||
30653152|NCT00939770|58665645|FG006|Overall Study|Withdrawal by Subject|2|||
30653153|NCT00939770|58665646|FG007|Overall Study|Withdrawal by Subject|2|||
30653154|NCT00939692|58665679|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
30653155|NCT00939692|58665680|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
30768296|NCT00289913|58777374|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
30768297|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30768298|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30768299|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
30768300|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30768301|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30768302|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
30768303|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
30768304|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
30768305|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
30653156|NCT00939692|58665679|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
30653157|NCT00939692|58665680|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
30653158|NCT04672252|58665688|FG000|Overall Study|Protocol Violation|1|||
30653159|NCT04672252|58665689|FG001|Overall Study|Protocol Violation|0|||
30653160|NCT00584740|58665697|FG000|Overall Study|Adverse Event|1|||
30653161|NCT00584740|58665698|FG001|Overall Study|Adverse Event|1|||
30653162|NCT00584740|58665697|FG000|Overall Study|Lack of Efficacy|8|||
30653163|NCT00584740|58665698|FG001|Overall Study|Lack of Efficacy|2|||
30653164|NCT00584740|58665697|FG000|Overall Study|Withdrawal by Subject|3|||
30653165|NCT00584740|58665698|FG001|Overall Study|Withdrawal by Subject|2|||
30653166|NCT00584740|58665697|FG000|Overall Study|Lost to Follow-up|0|||
30653167|NCT00584740|58665698|FG001|Overall Study|Lost to Follow-up|1|||
30653168|NCT00942968|58665704|FG000|Overall Study|Adverse Event|60|||
30653169|NCT00942968|58665704|FG000|Overall Study|Death|76|||
30653170|NCT00942968|58665704|FG000|Overall Study|Protocol Violation|9|||
30653171|NCT00942968|58665704|FG000|Overall Study|Lost to Follow-up|4|||
30653172|NCT00942968|58665704|FG000|Overall Study|Withdrawal by Subject|44|||
30653173|NCT00942968|58665704|FG000|Overall Study|Sponsor request|5|||
30653174|NCT00942968|58665704|FG000|Overall Study|Physician Decision|11|||
30653175|NCT00942968|58665704|FG000|Overall Study|Progression of disease|12|||
30653176|NCT00942968|58665704|FG000|Overall Study|Inferior vena cava filter placement|4|||
30653177|NCT00942968|58665704|FG000|Overall Study|Pulmonary embolism (PE)|1|||
30653178|NCT00942968|58665704|FG000|Overall Study|Participant required pancreatic biopsy|1|||
30653179|NCT00942968|58665704|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
30653180|NCT00942734|58665708|FG000|Overall Study|Adverse Event|2|||
30653181|NCT00942734|58665708|FG000|Overall Study|Protocol Violation|3|||
30653182|NCT00942734|58665708|FG000|Overall Study|Disease Progression|2|||
30653183|NCT00942734|58665708|FG000|Overall Study|Physician Decision|1|||
30653184|NCT00584194|58665712|FG000|Overall Study|Other|135|||
30653185|NCT00942422|58665716|FG000|Overall Study|Withdrawal by Subject|1|||
30653186|NCT00942422|58665716|FG000|Overall Study|Death|1|||
30653187|NCT00942422|58665716|FG000|Overall Study|Progressive diease|1|||
30653188|NCT00677833|58665724|FG000|Overall Study|Withdrawal by Subject|4|||
30653189|NCT00677833|58665725|FG001|Overall Study|Withdrawal by Subject|0|||
30653190|NCT00677833|58665726|FG002|Overall Study|Withdrawal by Subject|1|||
30653191|NCT00677833|58665727|FG003|Overall Study|Withdrawal by Subject|3|||
30653192|NCT00677833|58665724|FG000|Overall Study|Lost to Follow-up|0|||
30653193|NCT00677833|58665725|FG001|Overall Study|Lost to Follow-up|0|||
30653194|NCT00677833|58665726|FG002|Overall Study|Lost to Follow-up|1|||
30653195|NCT00677833|58665727|FG003|Overall Study|Lost to Follow-up|0|||
30653196|NCT00942266|58665737|FG000|Overall Study|Withdrawal by Subject|1|||
30653197|NCT00942266|58665738|FG001|Overall Study|Withdrawal by Subject|0|||
30768306|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
30768307|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
30768308|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
30768309|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
30768310|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
30768311|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
30768312|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
30768313|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
30768314|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
30768315|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
30768316|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
30768317|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
30768318|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
30768319|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
30768320|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
30768321|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
30768322|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
30768323|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
30768324|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
30768325|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
30768326|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
30768327|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
30653198|NCT00942266|58665737|FG000|Overall Study|Adverse Event|2|||
30653199|NCT00942266|58665738|FG001|Overall Study|Adverse Event|1|||
30653200|NCT00942266|58665737|FG000|Overall Study|Disease Progression|38|||
30653201|NCT00942266|58665738|FG001|Overall Study|Disease Progression|11|||
30653202|NCT00942266|58665737|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
30768328|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
30768329|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
30768330|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
30768331|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
30653203|NCT00942266|58665738|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
30653204|NCT00942266|58665737|FG000|Overall Study|Intercurrent illness|0|||
30653205|NCT00942266|58665738|FG001|Overall Study|Intercurrent illness|1|||
30653206|NCT00942266|58665737|FG000|Overall Study|Physician Decision|2|||
30653207|NCT00942266|58665738|FG001|Overall Study|Physician Decision|0|||
30653208|NCT00942266|58665737|FG000|Overall Study|medical deterioration (pneumonia)|0|||
30653209|NCT00942266|58665738|FG001|Overall Study|medical deterioration (pneumonia)|1|||
30653210|NCT00942188|58665748|FG000|Overall Study|Adverse Event|0|||
30653211|NCT00942188|58665749|FG001|Overall Study|Adverse Event|3|||
30653212|NCT00942188|58665750|FG002|Overall Study|Adverse Event|2|||
30653213|NCT00942188|58665751|FG003|Overall Study|Adverse Event|0|||
30653214|NCT00942188|58665748|FG000|Overall Study|Lack of Efficacy|0|||
30653215|NCT00942188|58665749|FG001|Overall Study|Lack of Efficacy|0|||
30653216|NCT00942188|58665750|FG002|Overall Study|Lack of Efficacy|0|||
30653217|NCT00942188|58665751|FG003|Overall Study|Lack of Efficacy|1|||
30653218|NCT00942188|58665748|FG000|Overall Study|Protocol Violation|1|||
30653219|NCT00942188|58665749|FG001|Overall Study|Protocol Violation|1|||
30653220|NCT00942188|58665750|FG002|Overall Study|Protocol Violation|0|||
30653221|NCT00942188|58665751|FG003|Overall Study|Protocol Violation|0|||
30653222|NCT00942188|58665748|FG000|Overall Study|Lost to Follow-up|2|||
30653223|NCT00942188|58665749|FG001|Overall Study|Lost to Follow-up|1|||
30653224|NCT00942188|58665750|FG002|Overall Study|Lost to Follow-up|2|||
30653225|NCT00942188|58665751|FG003|Overall Study|Lost to Follow-up|0|||
30653226|NCT00942188|58665748|FG000|Overall Study|Withdrawal by Subject|1|||
30653227|NCT00942188|58665749|FG001|Overall Study|Withdrawal by Subject|3|||
30653228|NCT00942188|58665750|FG002|Overall Study|Withdrawal by Subject|4|||
30653229|NCT00942188|58665751|FG003|Overall Study|Withdrawal by Subject|2|||
30653230|NCT00942188|58665748|FG000|Overall Study|Physician Decision|0|||
30653231|NCT00942188|58665749|FG001|Overall Study|Physician Decision|0|||
30653232|NCT00942188|58665750|FG002|Overall Study|Physician Decision|1|||
30653233|NCT00942188|58665751|FG003|Overall Study|Physician Decision|0|||
30653234|NCT00942188|58665748|FG000|Overall Study|Sponsor Decision|0|||
30653235|NCT00942188|58665749|FG001|Overall Study|Sponsor Decision|2|||
30768332|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
30768333|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
30768334|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
30768335|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
30768336|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
30768337|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
30768338|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
30653236|NCT00942188|58665750|FG002|Overall Study|Sponsor Decision|0|||
30653237|NCT00942188|58665751|FG003|Overall Study|Sponsor Decision|1|||
30653238|NCT00673231|58665765|FG000|Overall Study|Withdrawal by Subject|14|||
30653239|NCT00673231|58665766|FG001|Overall Study|Withdrawal by Subject|10|||
30768339|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
30768340|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
30653240|NCT00673231|58665767|FG002|Overall Study|Withdrawal by Subject|8|||
30653241|NCT00673231|58665768|FG003|Overall Study|Withdrawal by Subject|6|||
30653242|NCT00673231|58665765|FG000|Overall Study|Adverse Event|6|||
30653243|NCT00673231|58665766|FG001|Overall Study|Adverse Event|5|||
30768341|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
30768342|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
30768343|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
30768344|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
30768345|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
30768346|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
30768347|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
30768348|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
30768349|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
30768350|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
30768351|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
30768352|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
30768353|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
30768354|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
30653244|NCT00673231|58665767|FG002|Overall Study|Adverse Event|9|||
30653245|NCT00673231|58665768|FG003|Overall Study|Adverse Event|6|||
30653246|NCT00673231|58665765|FG000|Overall Study|Lost to Follow-up|1|||
30653247|NCT00673231|58665766|FG001|Overall Study|Lost to Follow-up|2|||
30653248|NCT00673231|58665767|FG002|Overall Study|Lost to Follow-up|1|||
30653249|NCT00673231|58665768|FG003|Overall Study|Lost to Follow-up|2|||
30653250|NCT00673231|58665765|FG000|Overall Study|Death|0|||
30653251|NCT00673231|58665766|FG001|Overall Study|Death|0|||
30653252|NCT00673231|58665767|FG002|Overall Study|Death|1|||
30653253|NCT00673231|58665768|FG003|Overall Study|Death|0|||
30653254|NCT00673231|58665765|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
30653255|NCT00673231|58665766|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
30653256|NCT00673231|58665767|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
30653257|NCT00673231|58665768|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
30653258|NCT00672841|58665780|FG000|Overall Study|Comfort care|1|||
30653259|NCT00672841|58665781|FG001|Overall Study|Comfort care|4|||
30653260|NCT00672841|58665780|FG000|Overall Study|icteric specimens|0|||
30653261|NCT00672841|58665781|FG001|Overall Study|icteric specimens|3|||
30653262|NCT00672841|58665780|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
30653263|NCT00672841|58665781|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
30653264|NCT00672841|58665780|FG000|Overall Study|Adverse Event|0|||
30653265|NCT00672841|58665781|FG001|Overall Study|Adverse Event|3|||
30653266|NCT00672841|58665780|FG000|Overall Study|Pregnancy|0|||
30653267|NCT00672841|58665781|FG001|Overall Study|Pregnancy|1|||
30653268|NCT00673465|58665790|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
30653269|NCT00673465|58665791|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
30653270|NCT00673465|58665792|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
30653271|NCT00673465|58665793|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
30653272|NCT00673465|58665794|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
30653273|NCT00673465|58665795|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
30653274|NCT00673465|58665796|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
30653275|NCT00673465|58665797|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
30653276|NCT00673465|58665798|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
30653277|NCT00673465|58665799|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
30653278|NCT00673465|58665800|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
30653279|NCT00673465|58665801|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
30653280|NCT00673465|58665790|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
30653281|NCT00673465|58665791|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
30653282|NCT00673465|58665792|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
30653283|NCT00673465|58665793|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
30653284|NCT00673465|58665794|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
30653285|NCT00673465|58665795|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
30653286|NCT00673465|58665796|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
30653287|NCT00673465|58665797|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
30653288|NCT00673465|58665798|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
30653289|NCT00673465|58665799|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
30653290|NCT00673465|58665800|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
30653291|NCT00673465|58665801|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
30653292|NCT00941798|58665811|FG000|Overall Study|Withdrawal by Subject|72|||
30653293|NCT00941798|58665812|FG001|Overall Study|Withdrawal by Subject|74|||
30653294|NCT00941798|58665811|FG000|Overall Study|Adverse Event|43|||
30768355|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
30768356|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
30768357|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
30653295|NCT00941798|58665812|FG001|Overall Study|Adverse Event|23|||
30653296|NCT00941798|58665811|FG000|Overall Study|Lost to Follow-up|29|||
30653297|NCT00941798|58665812|FG001|Overall Study|Lost to Follow-up|23|||
30653298|NCT00941798|58665811|FG000|Overall Study|Protocol Violation|17|||
30653299|NCT00941798|58665812|FG001|Overall Study|Protocol Violation|20|||
30653300|NCT00941798|58665811|FG000|Overall Study|Administrative problems|13|||
30653301|NCT00941798|58665812|FG001|Overall Study|Administrative problems|23|||
30653302|NCT00941798|58665811|FG000|Overall Study|Lack of Efficacy|10|||
30653303|NCT00941798|58665812|FG001|Overall Study|Lack of Efficacy|17|||
30653304|NCT00941798|58665811|FG000|Overall Study|Patient's inability to use device|6|||
30653305|NCT00941798|58665812|FG001|Overall Study|Patient's inability to use device|1|||
30653306|NCT00941798|58665811|FG000|Overall Study|Abnormal test procedure results|3|||
30653307|NCT00941798|58665812|FG001|Overall Study|Abnormal test procedure results|1|||
30653308|NCT00941798|58665811|FG000|Overall Study|Abnormal laboratory values|1|||
30653309|NCT00941798|58665812|FG001|Overall Study|Abnormal laboratory values|2|||
30653310|NCT00941798|58665811|FG000|Overall Study|Death|0|||
30653311|NCT00941798|58665812|FG001|Overall Study|Death|1|||
30653312|NCT00583102|58665818|FG000|Overall Study|Adverse Event|3|||
30653313|NCT05208866|58665826|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
30653314|NCT04745351|58665841|FG000|Overall Study|Death|51|||
30653315|NCT04745351|58665842|FG001|Overall Study|Death|25|||
30653316|NCT04745351|58665841|FG000|Overall Study|Lost to Follow-up|9|||
30653317|NCT04745351|58665842|FG001|Overall Study|Lost to Follow-up|3|||
30653318|NCT04745351|58665841|FG000|Overall Study|Randomized but Never Treated|3|||
30653319|NCT04745351|58665842|FG001|Overall Study|Randomized but Never Treated|3|||
30653320|NCT04745351|58665841|FG000|Overall Study|Adverse Event|4|||
30653321|NCT04745351|58665842|FG001|Overall Study|Adverse Event|0|||
30653322|NCT04745351|58665841|FG000|Overall Study|Withdrew Consent|1|||
30653323|NCT04745351|58665842|FG001|Overall Study|Withdrew Consent|2|||
30653324|NCT04745351|58665841|FG000|Overall Study|Investigator's Discretion|2|||
30653325|NCT04745351|58665842|FG001|Overall Study|Investigator's Discretion|0|||
30653326|NCT04745351|58665841|FG000|Overall Study|Protocol Violation|1|||
30653327|NCT04745351|58665842|FG001|Overall Study|Protocol Violation|0|||
30653328|NCT04427501|58665867|FG000|Overall Study|Death|0|||
30653329|NCT04427501|58665868|FG001|Overall Study|Death|0|||
30653330|NCT04427501|58665869|FG002|Overall Study|Death|0|||
30653331|NCT04427501|58665870|FG003|Overall Study|Death|0|||
30653332|NCT04427501|58665871|FG004|Overall Study|Death|0|||
30653333|NCT04427501|58665872|FG005|Overall Study|Death|15|||
30653334|NCT04427501|58665873|FG006|Overall Study|Death|0|||
30653335|NCT04427501|58665874|FG007|Overall Study|Death|0|||
30653336|NCT04427501|58665875|FG008|Overall Study|Death|0|||
30653337|NCT04427501|58665876|FG009|Overall Study|Death|0|||
30653338|NCT04427501|58665867|FG000|Overall Study|Lost to Follow-up|5|||
30653339|NCT04427501|58665868|FG001|Overall Study|Lost to Follow-up|1|||
30653340|NCT04427501|58665869|FG002|Overall Study|Lost to Follow-up|2|||
30653341|NCT04427501|58665870|FG003|Overall Study|Lost to Follow-up|0|||
30653342|NCT04427501|58665871|FG004|Overall Study|Lost to Follow-up|2|||
30653343|NCT04427501|58665872|FG005|Overall Study|Lost to Follow-up|11|||
30653344|NCT04427501|58665873|FG006|Overall Study|Lost to Follow-up|10|||
30653345|NCT04427501|58665874|FG007|Overall Study|Lost to Follow-up|10|||
30653346|NCT04427501|58665875|FG008|Overall Study|Lost to Follow-up|2|||
30653347|NCT04427501|58665876|FG009|Overall Study|Lost to Follow-up|5|||
30653348|NCT04427501|58665867|FG000|Overall Study|Physician Decision|0|||
30653349|NCT04427501|58665868|FG001|Overall Study|Physician Decision|3|||
30653350|NCT04427501|58665869|FG002|Overall Study|Physician Decision|0|||
30653351|NCT04427501|58665870|FG003|Overall Study|Physician Decision|0|||
30653352|NCT04427501|58665871|FG004|Overall Study|Physician Decision|0|||
30653353|NCT04427501|58665872|FG005|Overall Study|Physician Decision|0|||
30653354|NCT04427501|58665873|FG006|Overall Study|Physician Decision|2|||
30653355|NCT04427501|58665874|FG007|Overall Study|Physician Decision|0|||
30653356|NCT04427501|58665875|FG008|Overall Study|Physician Decision|0|||
30653357|NCT04427501|58665876|FG009|Overall Study|Physician Decision|0|||
30653358|NCT04427501|58665867|FG000|Overall Study|Withdrawal by Subject|9|||
30653359|NCT04427501|58665868|FG001|Overall Study|Withdrawal by Subject|2|||
30653360|NCT04427501|58665869|FG002|Overall Study|Withdrawal by Subject|2|||
30653361|NCT04427501|58665870|FG003|Overall Study|Withdrawal by Subject|3|||
30653362|NCT04427501|58665871|FG004|Overall Study|Withdrawal by Subject|7|||
30848745|NCT02849509|58875310|FG001|Overall Study|Lost to Follow-up|67|||
30653363|NCT04427501|58665872|FG005|Overall Study|Withdrawal by Subject|25|||
30653364|NCT04427501|58665873|FG006|Overall Study|Withdrawal by Subject|15|||
30653365|NCT04427501|58665874|FG007|Overall Study|Withdrawal by Subject|7|||
30653366|NCT04427501|58665875|FG008|Overall Study|Withdrawal by Subject|4|||
30653367|NCT04427501|58665876|FG009|Overall Study|Withdrawal by Subject|1|||
30653368|NCT04427501|58665867|FG000|Overall Study|Other - as reported by the investigator|1|||
30653369|NCT04427501|58665868|FG001|Overall Study|Other - as reported by the investigator|0|||
30653370|NCT04427501|58665869|FG002|Overall Study|Other - as reported by the investigator|0|||
30653371|NCT04427501|58665870|FG003|Overall Study|Other - as reported by the investigator|0|||
30653372|NCT04427501|58665871|FG004|Overall Study|Other - as reported by the investigator|0|||
30653373|NCT04427501|58665872|FG005|Overall Study|Other - as reported by the investigator|6|||
30653374|NCT04427501|58665873|FG006|Overall Study|Other - as reported by the investigator|6|||
30653375|NCT04427501|58665874|FG007|Overall Study|Other - as reported by the investigator|0|||
30653376|NCT04427501|58665875|FG008|Overall Study|Other - as reported by the investigator|0|||
30653377|NCT04427501|58665876|FG009|Overall Study|Other - as reported by the investigator|0|||
30653378|NCT03439124|58665928|FG000|Overall Study|Adverse Event|2|||
30653379|NCT03439124|58665929|FG001|Overall Study|Adverse Event|0|||
30653380|NCT03439124|58665928|FG000|Overall Study|Lost to Follow-up|1|||
30653381|NCT03439124|58665929|FG001|Overall Study|Lost to Follow-up|0|||
30653382|NCT03439124|58665928|FG000|Overall Study|Other reasons|1|||
30653383|NCT03439124|58665929|FG001|Overall Study|Other reasons|0|||
30653384|NCT03212989|58665948|FG000|Overall Study|Physician Decision|8|||
30653385|NCT03200548|58665956|FG000|Overall Study|Withdrawal by Subject|5|||
30653386|NCT03200548|58665957|FG001|Overall Study|Withdrawal by Subject|11|||
30653387|NCT03200548|58665958|FG002|Overall Study|Withdrawal by Subject|7|||
30653388|NCT03200548|58665959|FG003|Overall Study|Withdrawal by Subject|6|||
30653389|NCT03158688|58665971|FG000|Overall Study|Withdrawal by Subject|14|||
30653390|NCT03158688|58665972|FG001|Overall Study|Withdrawal by Subject|28|||
30653391|NCT03158688|58665971|FG000|Overall Study|Decision by sponsor|13|||
30653392|NCT03158688|58665972|FG001|Overall Study|Decision by sponsor|37|||
30653393|NCT03158688|58665971|FG000|Overall Study|Lost to Follow-up|4|||
30653394|NCT03158688|58665972|FG001|Overall Study|Lost to Follow-up|3|||
30653395|NCT03158688|58665971|FG000|Overall Study|Death|74|||
30653396|NCT03158688|58665972|FG001|Overall Study|Death|142|||
30653397|NCT03138733|58665980|FG000|Overall Study|Death|17|||
30653398|NCT03138733|58665981|FG001|Overall Study|Death|18|||
30653399|NCT03138733|58665980|FG000|Overall Study|Withdrawal by Subject|11|||
30653400|NCT03138733|58665981|FG001|Overall Study|Withdrawal by Subject|6|||
30768358|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
30768359|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
30768360|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
30768361|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
30768362|NCT00289913|58777370|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
30768363|NCT00289913|58777371|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
30768364|NCT00289913|58777372|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
30768365|NCT00289913|58777373|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
30768366|NCT00289913|58777374|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
30768367|NCT00289913|58777370|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30768368|NCT00289913|58777371|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
30768369|NCT00289913|58777372|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30768370|NCT00289913|58777373|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30653401|NCT03138733|58665980|FG000|Overall Study|Lost to Follow-up|3|||
30653402|NCT03138733|58665981|FG001|Overall Study|Lost to Follow-up|2|||
30653403|NCT03138733|58665980|FG000|Overall Study|Adverse Event|1|||
30653404|NCT03138733|58665981|FG001|Overall Study|Adverse Event|0|||
30653405|NCT03138733|58665980|FG000|Overall Study|Protocol Violation|1|||
30653406|NCT03138733|58665981|FG001|Overall Study|Protocol Violation|3|||
30653407|NCT03138733|58665980|FG000|Overall Study|Administrative or logistical reason|1|||
30653408|NCT03138733|58665981|FG001|Overall Study|Administrative or logistical reason|0|||
30653409|NCT03138733|58665980|FG000|Overall Study|The patient was transferred to another hospital|1|||
30653410|NCT03138733|58665981|FG001|Overall Study|The patient was transferred to another hospital|0|||
30768371|NCT00289913|58777374|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
30768372|NCT00289913|58777370|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
30653411|NCT03137173|58665989|FG000|Overall Study|Withdrawal by Subject|8|||
30768373|NCT00289913|58777371|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
30768374|NCT00289913|58777372|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
30768375|NCT00289913|58777373|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
30768376|NCT00289913|58777374|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
30768377|NCT00289913|58777370|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
30768378|NCT00289913|58777371|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
30768379|NCT00289913|58777372|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
30653412|NCT03137173|58665990|FG001|Overall Study|Withdrawal by Subject|13|||
30653413|NCT03137173|58665989|FG000|Overall Study|Death|1|||
30653414|NCT03137173|58665990|FG001|Overall Study|Death|3|||
30653415|NCT03137173|58665989|FG000|Overall Study|Physician Decision|1|||
30653416|NCT03137173|58665990|FG001|Overall Study|Physician Decision|0|||
30653417|NCT03137173|58665989|FG000|Overall Study|Lost to Follow-up|13|||
30653418|NCT03137173|58665990|FG001|Overall Study|Lost to Follow-up|18|||
30653419|NCT03137173|58665989|FG000|Overall Study|Other reasons|3|||
30653420|NCT03137173|58665990|FG001|Overall Study|Other reasons|2|||
30653421|NCT02087423|58666016|FG000|Overall Study|Withdrawal by Subject|20|||
30653422|NCT02087423|58666017|FG001|Overall Study|Withdrawal by Subject|20|||
30653423|NCT02087423|58666018|FG002|Overall Study|Withdrawal by Subject|3|||
30653424|NCT02087423|58666016|FG000|Overall Study|Death|68|||
30653425|NCT02087423|58666017|FG001|Overall Study|Death|207|||
30653426|NCT02087423|58666018|FG002|Overall Study|Death|40|||
30653427|NCT02087423|58666016|FG000|Overall Study|Lost to Follow-up|0|||
30653428|NCT02087423|58666017|FG001|Overall Study|Lost to Follow-up|2|||
30653429|NCT02087423|58666018|FG002|Overall Study|Lost to Follow-up|0|||
30653430|NCT02087423|58666016|FG000|Overall Study|Terminated from study at final DCO|23|||
30653431|NCT02087423|58666017|FG001|Overall Study|Terminated from study at final DCO|36|||
30653432|NCT02087423|58666018|FG002|Overall Study|Terminated from study at final DCO|25|||
30653433|NCT01575808|58666052|FG000|Overall Study|Death|2|||
30653434|NCT01575808|58666053|FG001|Overall Study|Death|0|||
30653435|NCT01575808|58666052|FG000|Overall Study|Withdrawal by Subject|1|||
30653436|NCT01575808|58666053|FG001|Overall Study|Withdrawal by Subject|0|||
30653437|NCT01546753|58666063|FG000|Overall Study|anxiety|1|||
30653438|NCT01546753|58666064|FG001|Overall Study|anxiety|1|||
30653439|NCT01546753|58666063|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
30653440|NCT01546753|58666064|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
30653441|NCT00680901|58666079|FG000|Overall Study|Lost to Follow-up|8|||
30653442|NCT00680901|58666080|FG001|Overall Study|Lost to Follow-up|8|||
30653443|NCT00680901|58666079|FG000|Overall Study|Withdrawal by Subject|4|||
30653444|NCT00680901|58666080|FG001|Overall Study|Withdrawal by Subject|13|||
30768380|NCT00289913|58777373|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
30768381|NCT00289913|58777374|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
30768382|NCT00289913|58777370|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
30768383|NCT00289913|58777371|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
30768384|NCT00289913|58777372|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
30768385|NCT00289913|58777373|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
30768386|NCT00289913|58777374|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
30768387|NCT00289913|58777370|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
30768388|NCT00289913|58777371|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
30768389|NCT00289913|58777372|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
30768390|NCT00289913|58777373|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
30768391|NCT00289913|58777374|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
30768392|NCT00289913|58777370|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
30768393|NCT00289913|58777371|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
30653445|NCT00680901|58666079|FG000|Overall Study|Physician Decision|0|||
30768394|NCT00289913|58777372|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
30768395|NCT00289913|58777373|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
30768396|NCT00289913|58777374|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
30768397|NCT00289913|58777370|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
30768398|NCT00289913|58777371|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
30768399|NCT00289913|58777372|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
30768400|NCT00289913|58777373|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
30768401|NCT00289913|58777374|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
30768402|NCT00289913|58777370|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
30768403|NCT00289913|58777371|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
30768404|NCT00289913|58777372|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
30768405|NCT00289913|58777373|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
30768406|NCT00289913|58777374|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
30768407|NCT00289289|58777392|FG000|Overall Study|Withdrawal by Subject|5|||
30768408|NCT00289289|58777393|FG001|Overall Study|Withdrawal by Subject|3|||
30768409|NCT00289289|58777394|FG002|Overall Study|Withdrawal by Subject|15|||
30768410|NCT00289289|58777392|FG000|Overall Study|Lost to Follow-up|1|||
30768411|NCT00289289|58777393|FG001|Overall Study|Lost to Follow-up|0|||
30768412|NCT00289289|58777394|FG002|Overall Study|Lost to Follow-up|1|||
30768413|NCT00289289|58777392|FG000|Overall Study|Death|4|||
30768414|NCT00289289|58777393|FG001|Overall Study|Death|2|||
30768415|NCT00289289|58777394|FG002|Overall Study|Death|5|||
30768416|NCT00289289|58777392|FG000|Overall Study|No implant attempted|0|||
30768417|NCT00289289|58777393|FG001|Overall Study|No implant attempted|0|||
30768418|NCT00289289|58777394|FG002|Overall Study|No implant attempted|1|||
30768419|NCT00289289|58777392|FG000|Overall Study|Physician Decision|1|||
30768420|NCT00289289|58777393|FG001|Overall Study|Physician Decision|0|||
30653446|NCT00680901|58666080|FG001|Overall Study|Physician Decision|1|||
30653447|NCT00680901|58666079|FG000|Overall Study|Ongoing: On Study Treatment|16|||
30653448|NCT00680901|58666080|FG001|Overall Study|Ongoing: On Study Treatment|13|||
30653449|NCT00680901|58666079|FG000|Overall Study|Ongoing: In Follow Up|45|||
30653450|NCT00680901|58666080|FG001|Overall Study|Ongoing: In Follow Up|41|||
30768421|NCT00289289|58777394|FG002|Overall Study|Physician Decision|6|||
30768422|NCT00289289|58777392|FG000|Overall Study|Non-study device implanted|2|||
30768423|NCT00289289|58777393|FG001|Overall Study|Non-study device implanted|1|||
30768424|NCT00289289|58777394|FG002|Overall Study|Non-study device implanted|3|||
30768425|NCT00289289|58777392|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
30768426|NCT00289289|58777393|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
30768427|NCT00289289|58777394|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
30768428|NCT00289289|58777392|FG000|Overall Study|Other Exit Reason|6|||
30768429|NCT00289289|58777393|FG001|Overall Study|Other Exit Reason|4|||
30768430|NCT00289289|58777394|FG002|Overall Study|Other Exit Reason|12|||
30768431|NCT00270257|58777403|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
30768432|NCT00270257|58777404|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
30768433|NCT00269633|58777414|FG000|Overall Study|Withdrawal by Subject|1|||
30768434|NCT00269633|58777415|FG001|Overall Study|Withdrawal by Subject|0|||
30768435|NCT00269477|58777425|FG000|Overall Study|Protocol Violation|5|||
30768436|NCT00269477|58777426|FG001|Overall Study|Protocol Violation|5|||
30768437|NCT00269477|58777427|FG002|Overall Study|Protocol Violation|1|||
30768438|NCT00269477|58777428|FG003|Overall Study|Protocol Violation|0|||
30768439|NCT00269477|58777425|FG000|Overall Study|Missed post-vaccination blood draw|0|||
30768440|NCT00269477|58777426|FG001|Overall Study|Missed post-vaccination blood draw|1|||
30768441|NCT00269477|58777427|FG002|Overall Study|Missed post-vaccination blood draw|0|||
30768442|NCT00269477|58777428|FG003|Overall Study|Missed post-vaccination blood draw|0|||
30768443|NCT00269399|58777440|FG000|Overall Study|Lack of Efficacy|27|||
30768444|NCT00269399|58777441|FG001|Overall Study|Lack of Efficacy|10|||
30848746|NCT02849509|58875311|FG002|Overall Study|Lost to Follow-up|36|||
30848747|NCT02849509|58875309|FG000|Overall Study|Other, reason not specified|14|||
30848748|NCT02849509|58875310|FG001|Overall Study|Other, reason not specified|29|||
30848749|NCT02849509|58875311|FG002|Overall Study|Other, reason not specified|25|||
30848750|NCT02849509|58875309|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
30848751|NCT02849509|58875310|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
30952284|NCT01543087|58999999|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
30653451|NCT00941720|58666086|FG000|Overall Study|Withdrawal by Subject|1|||
30653452|NCT00941720|58666086|FG000|Overall Study|Insurance denied participation|11|||
30653453|NCT00941720|58666086|FG000|Overall Study|ineligible|2|||
30653454|NCT00933686|58666092|FG000|Overall Study|Protocol Violation|0|||
30653455|NCT00933686|58666093|FG001|Overall Study|Protocol Violation|1|||
30653456|NCT00933686|58666092|FG000|Overall Study|Lost to Follow-up|2|||
30653457|NCT00933686|58666093|FG001|Overall Study|Lost to Follow-up|2|||
30653458|NCT00933686|58666092|FG000|Overall Study|Withdrawal by Subject|6|||
30653459|NCT00933686|58666093|FG001|Overall Study|Withdrawal by Subject|5|||
30653460|NCT00933686|58666092|FG000|Overall Study|Adverse Event|1|||
30653461|NCT00933686|58666093|FG001|Overall Study|Adverse Event|1|||
30653462|NCT00933686|58666092|FG000|Overall Study|Physician Decision|1|||
30653463|NCT00933686|58666093|FG001|Overall Study|Physician Decision|0|||
30653464|NCT00933686|58666092|FG000|Overall Study|Failure to show up at endpoint visits|0|||
30653465|NCT00933686|58666093|FG001|Overall Study|Failure to show up at endpoint visits|2|||
30653466|NCT00937040|58666101|FG000|Overall Study|Adverse Event|5|||
30653467|NCT00937040|58666102|FG001|Overall Study|Adverse Event|8|||
30653468|NCT00937040|58666101|FG000|Overall Study|Lost to Follow-up|12|||
30653469|NCT00937040|58666102|FG001|Overall Study|Lost to Follow-up|12|||
30653470|NCT00937040|58666101|FG000|Overall Study|Protocol Violation|3|||
30653471|NCT00937040|58666102|FG001|Overall Study|Protocol Violation|0|||
30653472|NCT00937040|58666101|FG000|Overall Study|Withdrawal by Subject|13|||
30653473|NCT00937040|58666102|FG001|Overall Study|Withdrawal by Subject|7|||
30653474|NCT00937040|58666101|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
30653475|NCT00937040|58666102|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
30653476|NCT00937040|58666101|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
30653477|NCT00937040|58666102|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
30653478|NCT00673387|58666116|FG000|Overall Study|Withdrawal by Subject|15|||
30768445|NCT00269399|58777440|FG000|Overall Study|Adverse Event|10|||
30952285|NCT01543087|59000000|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
30952286|NCT01543087|59000001|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
30653479|NCT00673387|58666117|FG001|Overall Study|Withdrawal by Subject|16|||
30653480|NCT00673387|58666118|FG002|Overall Study|Withdrawal by Subject|20|||
30653481|NCT00673387|58666119|FG003|Overall Study|Withdrawal by Subject|16|||
30653482|NCT00673387|58666120|FG004|Overall Study|Withdrawal by Subject|18|||
30768446|NCT00269399|58777441|FG001|Overall Study|Adverse Event|4|||
30653483|NCT00673387|58666121|FG005|Overall Study|Withdrawal by Subject|21|||
30653484|NCT00673387|58666122|FG006|Overall Study|Withdrawal by Subject|15|||
30653485|NCT00673387|58666123|FG007|Overall Study|Withdrawal by Subject|21|||
30653486|NCT00673387|58666116|FG000|Overall Study|Adverse Event|3|||
30653487|NCT00673387|58666117|FG001|Overall Study|Adverse Event|1|||
30653488|NCT00673387|58666118|FG002|Overall Study|Adverse Event|5|||
30653489|NCT00673387|58666119|FG003|Overall Study|Adverse Event|2|||
30653490|NCT00673387|58666120|FG004|Overall Study|Adverse Event|6|||
30653491|NCT00673387|58666121|FG005|Overall Study|Adverse Event|2|||
30653492|NCT00673387|58666122|FG006|Overall Study|Adverse Event|5|||
30653493|NCT00673387|58666123|FG007|Overall Study|Adverse Event|5|||
30653494|NCT00673387|58666116|FG000|Overall Study|Physician Decision|0|||
30653495|NCT00673387|58666117|FG001|Overall Study|Physician Decision|0|||
30768447|NCT00269399|58777440|FG000|Overall Study|Withdrawal by Subject|2|||
30768448|NCT00269399|58777441|FG001|Overall Study|Withdrawal by Subject|5|||
30768449|NCT00269399|58777440|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
30768450|NCT00269399|58777441|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
30768451|NCT00269399|58777440|FG000|Overall Study|Other|0|||
30768452|NCT00269399|58777441|FG001|Overall Study|Other|4|||
30768453|NCT00269399|58777440|FG000|Overall Study|Development of exclusion criteria|0|||
30768454|NCT00269399|58777441|FG001|Overall Study|Development of exclusion criteria|1|||
30768455|NCT00269087|58777447|FG000|Overall Study|Adverse Event|20|||
30768456|NCT00269087|58777447|FG000|Overall Study|Withdrawal by Subject|1|||
30768457|NCT00269087|58777447|FG000|Overall Study|Exacerbation of COPD|13|||
30768458|NCT00289133|58777453|FG000|Overall Study|Non-study device implanted|12|||
30768459|NCT00289133|58777454|FG001|Overall Study|Non-study device implanted|0|||
30768460|NCT00289133|58777453|FG000|Overall Study|Protocol Violation|32|||
30768461|NCT00289133|58777454|FG001|Overall Study|Protocol Violation|38|||
30768462|NCT00289133|58777453|FG000|Overall Study|Withdrawal by Subject|9|||
30768463|NCT00289133|58777454|FG001|Overall Study|Withdrawal by Subject|10|||
30768464|NCT00289133|58777453|FG000|Overall Study|Death|5|||
30768465|NCT00289133|58777454|FG001|Overall Study|Death|10|||
30768466|NCT00289133|58777453|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
30768467|NCT00289133|58777454|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
30768468|NCT00289133|58777453|FG000|Overall Study|Physician Decision|41|||
30768469|NCT00289133|58777454|FG001|Overall Study|Physician Decision|45|||
30768470|NCT00289133|58777453|FG000|Overall Study|Revision|8|||
30768471|NCT00289133|58777454|FG001|Overall Study|Revision|6|||
30768472|NCT00289133|58777453|FG000|Overall Study|Lost to Follow-up|92|||
30768473|NCT00289133|58777454|FG001|Overall Study|Lost to Follow-up|115|||
30768474|NCT00288587|58777466|FG000|Overall Study|Death|4|||
30768475|NCT00288587|58777467|FG001|Overall Study|Death|4|||
30768476|NCT00288587|58777466|FG000|Overall Study|Transplant|0|||
30768477|NCT00288587|58777467|FG001|Overall Study|Transplant|3|||
30768478|NCT00288587|58777466|FG000|Overall Study|Adverse Event|0|||
30768479|NCT00288587|58777467|FG001|Overall Study|Adverse Event|1|||
30768480|NCT00288587|58777466|FG000|Overall Study|Physician Decision|0|||
30768481|NCT00288587|58777467|FG001|Overall Study|Physician Decision|2|||
30768482|NCT00288587|58777466|FG000|Overall Study|Severe Aortic Stenosis|1|||
30768483|NCT00288587|58777467|FG001|Overall Study|Severe Aortic Stenosis|0|||
30768484|NCT00268463|58777475|FG000|Overall Study|study terminated due to low accrual|10|||
30768485|NCT00268463|58777476|FG001|Overall Study|study terminated due to low accrual|12|||
30768486|NCT00288509|58777482|FG000|Treatment Cycle 1|Adverse Event|1|||
30768487|NCT00288509|58777482|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
30768488|NCT00288509|58777482|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
30768489|NCT00288509|58777482|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
30768490|NCT00288509|58777482|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
30653496|NCT00673387|58666118|FG002|Overall Study|Physician Decision|0|||
30653497|NCT00673387|58666119|FG003|Overall Study|Physician Decision|0|||
30653498|NCT00673387|58666120|FG004|Overall Study|Physician Decision|0|||
30653499|NCT00673387|58666121|FG005|Overall Study|Physician Decision|5|||
30653500|NCT00673387|58666122|FG006|Overall Study|Physician Decision|1|||
30653501|NCT00673387|58666123|FG007|Overall Study|Physician Decision|1|||
30653502|NCT00673387|58666116|FG000|Overall Study|Protocol Violation|3|||
30653503|NCT00673387|58666117|FG001|Overall Study|Protocol Violation|0|||
30653504|NCT00673387|58666118|FG002|Overall Study|Protocol Violation|1|||
30653505|NCT00673387|58666119|FG003|Overall Study|Protocol Violation|2|||
30653506|NCT00673387|58666120|FG004|Overall Study|Protocol Violation|0|||
30768491|NCT00288509|58777482|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
30768492|NCT00288509|58777482|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
30768493|NCT00288509|58777482|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
30768494|NCT00288509|58777482|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
30768495|NCT00288509|58777482|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
30768496|NCT00288509|58777482|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
30653507|NCT00673387|58666121|FG005|Overall Study|Protocol Violation|1|||
30768497|NCT00288509|58777482|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
30768498|NCT00288509|58777482|FG000|Treatment Cycle 4|Physician Decision|4|||
30768499|NCT00288509|58777482|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
30653508|NCT00673387|58666122|FG006|Overall Study|Protocol Violation|1|||
30653509|NCT00673387|58666123|FG007|Overall Study|Protocol Violation|3|||
30653510|NCT00673387|58666116|FG000|Overall Study|Lost to Follow-up|8|||
30653511|NCT00673387|58666117|FG001|Overall Study|Lost to Follow-up|6|||
30653512|NCT00673387|58666118|FG002|Overall Study|Lost to Follow-up|5|||
30653513|NCT00673387|58666119|FG003|Overall Study|Lost to Follow-up|6|||
30653514|NCT00673387|58666120|FG004|Overall Study|Lost to Follow-up|6|||
30653515|NCT00673387|58666121|FG005|Overall Study|Lost to Follow-up|5|||
30653516|NCT00673387|58666122|FG006|Overall Study|Lost to Follow-up|8|||
30653517|NCT00673387|58666123|FG007|Overall Study|Lost to Follow-up|5|||
30653518|NCT00933608|58666153|FG000|Overall Study|Adverse Event|4|||
30653519|NCT00933608|58666154|FG001|Overall Study|Adverse Event|2|||
30653520|NCT00933608|58666153|FG000|Overall Study|Physician Decision|1|||
30653521|NCT00933608|58666154|FG001|Overall Study|Physician Decision|0|||
30653522|NCT00574951|58666160|FG000|Overall Study|Ineligible - improper prior treatment|1|||
30653523|NCT01557751|58666164|FG000|Overall Study|Physician Decision|3|||
30653524|NCT00936884|58666170|FG000|Double-blind|Withdrawal by Subject|6|||
30653525|NCT00936884|58666171|FG001|Double-blind|Withdrawal by Subject|4|||
30653526|NCT00936884|58666172|FG002|Double-blind|Withdrawal by Subject|0|||
30653527|NCT00936884|58666170|FG000|Double-blind|Death|2|||
30653528|NCT00936884|58666171|FG001|Double-blind|Death|1|||
30653529|NCT00936884|58666172|FG002|Double-blind|Death|0|||
30653530|NCT00936884|58666170|FG000|Double-blind|Lack of Efficacy|1|||
30653531|NCT00936884|58666171|FG001|Double-blind|Lack of Efficacy|1|||
30653532|NCT00936884|58666172|FG002|Double-blind|Lack of Efficacy|0|||
30653533|NCT00936884|58666170|FG000|Double-blind|Adverse Event|1|||
30653534|NCT00936884|58666171|FG001|Double-blind|Adverse Event|0|||
30653535|NCT00936884|58666172|FG002|Double-blind|Adverse Event|0|||
30653536|NCT00936884|58666170|FG000|Double-blind|Physician Decision|1|||
30653537|NCT00936884|58666171|FG001|Double-blind|Physician Decision|0|||
30653538|NCT00936884|58666172|FG002|Double-blind|Physician Decision|0|||
30653539|NCT00936884|58666170|FG000|Double-blind|No post baseline diary entry|1|||
30653540|NCT00936884|58666171|FG001|Double-blind|No post baseline diary entry|0|||
30768500|NCT00266825|58777488|FG000|Completed Follow-Up|Lost to Follow-up|14|||
30768501|NCT00266825|58777489|FG001|Completed Follow-Up|Lost to Follow-up|19|||
30768502|NCT00266825|58777488|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
30768503|NCT00266825|58777489|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
30768504|NCT00265889|58777497|FG000|Overall Study|Physician Decision|1|||
30768505|NCT00265889|58777497|FG000|Overall Study|Protocol Violation|1|||
30768506|NCT00265889|58777497|FG000|Overall Study|Insurance denied the request|3|||
30768507|NCT03209362|58777503|FG000|Overall Study|Adverse Event|0|||
30768508|NCT03209362|58777504|FG001|Overall Study|Adverse Event|1|||
30768509|NCT03209362|58777503|FG000|Overall Study|Lost to Follow-up|0|||
30768510|NCT03209362|58777504|FG001|Overall Study|Lost to Follow-up|1|||
30768511|NCT03209362|58777503|FG000|Overall Study|Withdrawal by Subject|2|||
30768512|NCT03209362|58777504|FG001|Overall Study|Withdrawal by Subject|0|||
30768513|NCT03209362|58777503|FG000|Overall Study|Other|0|||
30768514|NCT03209362|58777504|FG001|Overall Study|Other|1|||
30768515|NCT02932462|58777512|FG000|Overall Study|Adverse Event|1|||
30768516|NCT02932462|58777513|FG001|Overall Study|Adverse Event|2|||
30768517|NCT02932462|58777512|FG000|Overall Study|Lost to Follow-up|4|||
30768518|NCT02932462|58777513|FG001|Overall Study|Lost to Follow-up|1|||
30653541|NCT00936884|58666172|FG002|Double-blind|No post baseline diary entry|0|||
30653542|NCT00936884|58666170|FG000|Double-blind|Did not receive study drug|0|||
30653543|NCT00936884|58666171|FG001|Double-blind|Did not receive study drug|1|||
30653544|NCT00936884|58666172|FG002|Double-blind|Did not receive study drug|0|||
30653545|NCT00668863|58666188|FG000|Overall Study|Objective Progression or Relapse|42|||
30653546|NCT00668863|58666188|FG000|Overall Study|Adverse Event|13|||
30653547|NCT00668863|58666188|FG000|Overall Study|Study Terminated by Sponsor|8|||
30653548|NCT00668863|58666188|FG000|Overall Study|Global Deterioration of Health Status|4|||
30768519|NCT02932462|58777512|FG000|Overall Study|Protocol Violation|0|||
30768520|NCT02932462|58777513|FG001|Overall Study|Protocol Violation|5|||
30768521|NCT02932462|58777512|FG000|Overall Study|Withdrawal by Subject|1|||
30768522|NCT02932462|58777513|FG001|Overall Study|Withdrawal by Subject|4|||
30768523|NCT02932462|58777512|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30653549|NCT00668863|58666188|FG000|Overall Study|Withdrawal by Subject|1|||
30653550|NCT00668863|58666188|FG000|Overall Study|Surgery|1|||
30653551|NCT00668863|58666188|FG000|Overall Study|Subject's work scheduling problem|1|||
30653552|NCT00668863|58666188|FG000|Overall Study|Physician Decision|1|||
30653553|NCT00935012|58666192|FG000|Overall Study|Death|19|||
30653554|NCT00935012|58666192|FG000|Overall Study|Withdrawal by Subject|3|||
30653555|NCT00935012|58666192|FG000|Overall Study|Other|5|||
30653556|NCT00935012|58666192|FG000|Overall Study|Adverse Event|2|||
30653557|NCT00932360|58666196|FG000|Washout (One Week)|Withdrawal by Subject|0|||
30653558|NCT00932360|58666197|FG001|Washout (One Week)|Withdrawal by Subject|0|||
30653559|NCT00932360|58666198|FG002|Washout (One Week)|Withdrawal by Subject|0|||
30653560|NCT00932360|58666199|FG003|Washout (One Week)|Withdrawal by Subject|0|||
30653561|NCT00932360|58666200|FG004|Washout (One Week)|Withdrawal by Subject|2|||
30653562|NCT00932360|58666201|FG005|Washout (One Week)|Withdrawal by Subject|0|||
30653563|NCT00668707|58666217|FG000|Overall Study|Cancer Recurrence|58|||
30653564|NCT00668707|58666218|FG001|Overall Study|Cancer Recurrence|58|||
30653565|NCT00668707|58666217|FG000|Overall Study|Withdrawal by Subject|117|||
30653566|NCT00668707|58666218|FG001|Overall Study|Withdrawal by Subject|100|||
30653567|NCT00668707|58666217|FG000|Overall Study|Lost to Follow-up|3|||
30653568|NCT00668707|58666218|FG001|Overall Study|Lost to Follow-up|6|||
30653569|NCT00668707|58666217|FG000|Overall Study|Protocol Violation|10|||
30653570|NCT00668707|58666218|FG001|Overall Study|Protocol Violation|12|||
30653571|NCT00668707|58666217|FG000|Overall Study|Death|11|||
30653572|NCT00668707|58666218|FG001|Overall Study|Death|4|||
30653573|NCT00668395|58666232|FG000|Overall Study|Withdrawal by Subject|4|||
30653574|NCT00668395|58666233|FG001|Overall Study|Withdrawal by Subject|4|||
30653575|NCT00668395|58666234|FG002|Overall Study|Withdrawal by Subject|1|||
30653576|NCT00668395|58666232|FG000|Overall Study|Adverse Event|1|||
30653577|NCT00668395|58666233|FG001|Overall Study|Adverse Event|1|||
30653578|NCT00668395|58666234|FG002|Overall Study|Adverse Event|0|||
30653579|NCT00668395|58666232|FG000|Overall Study|Physician Decision|1|||
30653580|NCT00668395|58666233|FG001|Overall Study|Physician Decision|1|||
30653581|NCT00668395|58666234|FG002|Overall Study|Physician Decision|0|||
30653582|NCT00668317|58666242|FG000|Overall Study|Adverse Event|2|||
30653583|NCT00670111|58666263|FG000|Enrollment to One Month|Testing Failure|0|||
30653584|NCT00670111|58666264|FG001|Enrollment to One Month|Testing Failure|0|||
30653585|NCT00670111|58666265|FG002|Enrollment to One Month|Testing Failure|13|||
30653586|NCT00670111|58666263|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
30653587|NCT00670111|58666264|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
30653588|NCT00670111|58666265|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
30653589|NCT00670111|58666263|FG000|Enrollment to One Month|Physician Decision|1|||
30653590|NCT00670111|58666264|FG001|Enrollment to One Month|Physician Decision|0|||
30653591|NCT00670111|58666265|FG002|Enrollment to One Month|Physician Decision|0|||
30653592|NCT00672139|58666275|FG000|Overall Study|Death|14|||
30653593|NCT00672139|58666276|FG001|Overall Study|Death|23|||
30653594|NCT00672139|58666275|FG000|Overall Study|Withdrawal by Subject|2|||
30653595|NCT00672139|58666276|FG001|Overall Study|Withdrawal by Subject|11|||
30653596|NCT00672139|58666275|FG000|Overall Study|Adverse Event|4|||
30653597|NCT00672139|58666276|FG001|Overall Study|Adverse Event|7|||
30653598|NCT00672139|58666275|FG000|Overall Study|Physician Decision|2|||
30653599|NCT00672139|58666276|FG001|Overall Study|Physician Decision|0|||
30653600|NCT00672139|58666275|FG000|Overall Study|Lack of Efficacy|4|||
30653601|NCT00672139|58666276|FG001|Overall Study|Lack of Efficacy|1|||
30653602|NCT00672139|58666275|FG000|Overall Study|Protocol Violation|1|||
30653603|NCT00672139|58666276|FG001|Overall Study|Protocol Violation|1|||
30653604|NCT00672139|58666275|FG000|Overall Study|hospice discharge, caregiver requests|3|||
30653605|NCT00672139|58666276|FG001|Overall Study|hospice discharge, caregiver requests|2|||
30653606|NCT00570739|58666286|FG000|Overall Study|Adverse Event|8|||
30653607|NCT00570739|58666287|FG001|Overall Study|Adverse Event|6|||
30653608|NCT00570739|58666288|FG002|Overall Study|Adverse Event|2|||
30653609|NCT00570739|58666289|FG003|Overall Study|Adverse Event|2|||
30653610|NCT00570739|58666286|FG000|Overall Study|Lost to Follow-up|4|||
30653611|NCT00570739|58666287|FG001|Overall Study|Lost to Follow-up|5|||
30653612|NCT00570739|58666288|FG002|Overall Study|Lost to Follow-up|4|||
30653613|NCT00570739|58666289|FG003|Overall Study|Lost to Follow-up|1|||
30653614|NCT00570739|58666286|FG000|Overall Study|Physician Decision|1|||
30653615|NCT00570739|58666287|FG001|Overall Study|Physician Decision|1|||
30653616|NCT00570739|58666288|FG002|Overall Study|Physician Decision|0|||
30653617|NCT00570739|58666289|FG003|Overall Study|Physician Decision|0|||
30653618|NCT00570739|58666286|FG000|Overall Study|Withdrawal by Subject|7|||
30653619|NCT00570739|58666287|FG001|Overall Study|Withdrawal by Subject|7|||
30653620|NCT00570739|58666288|FG002|Overall Study|Withdrawal by Subject|3|||
30653621|NCT00570739|58666289|FG003|Overall Study|Withdrawal by Subject|5|||
30653622|NCT00570739|58666286|FG000|Overall Study|Required restricted medication|0|||
30653623|NCT00570739|58666287|FG001|Overall Study|Required restricted medication|0|||
30653624|NCT00570739|58666288|FG002|Overall Study|Required restricted medication|1|||
30653625|NCT00570739|58666289|FG003|Overall Study|Required restricted medication|0|||
30653626|NCT00570739|58666286|FG000|Overall Study|Met discontinuation criteria|1|||
30653627|NCT00570739|58666287|FG001|Overall Study|Met discontinuation criteria|0|||
30653628|NCT00570739|58666288|FG002|Overall Study|Met discontinuation criteria|1|||
30653629|NCT00570739|58666289|FG003|Overall Study|Met discontinuation criteria|1|||
30653630|NCT00570739|58666286|FG000|Overall Study|Other|0|||
30653631|NCT00570739|58666287|FG001|Overall Study|Other|2|||
30653632|NCT00570739|58666288|FG002|Overall Study|Other|5|||
30653633|NCT00570739|58666289|FG003|Overall Study|Other|3|||
30653634|NCT03689530|58666321|FG000|Overall Study|Withdrawal by Subject|53|||
30653635|NCT03689530|58666322|FG001|Overall Study|Withdrawal by Subject|16|||
30653636|NCT04188106|58666328|FG000|Overall Study|Lost to Follow-up|5|||
30653637|NCT04188106|58666328|FG000|Overall Study|Non-Compliance|1|||
30653638|NCT00669955|58666336|FG000|Overall Study|Adverse Event|3|||
30653639|NCT00669955|58666337|FG001|Overall Study|Adverse Event|5|||
30653640|NCT00669955|58666336|FG000|Overall Study|Death|0|||
30653641|NCT00669955|58666337|FG001|Overall Study|Death|1|||
30653642|NCT00669955|58666336|FG000|Overall Study|Withdrawal by Subject|2|||
30653643|NCT00669955|58666337|FG001|Overall Study|Withdrawal by Subject|3|||
30653644|NCT00669955|58666336|FG000|Overall Study|Lost to Follow-up|5|||
30653645|NCT00669955|58666337|FG001|Overall Study|Lost to Follow-up|7|||
30653646|NCT00669955|58666336|FG000|Overall Study|Protocol Violation|2|||
30653647|NCT00669955|58666337|FG001|Overall Study|Protocol Violation|7|||
30653648|NCT00669955|58666336|FG000|Overall Study|Investigator Sponsor Judgement|0|||
30653649|NCT00669955|58666337|FG001|Overall Study|Investigator Sponsor Judgement|1|||
30653650|NCT00669955|58666336|FG000|Overall Study|not compliant with study drug/visit|2|||
30653651|NCT00669955|58666337|FG001|Overall Study|not compliant with study drug/visit|3|||
30653652|NCT00671749|58666343|FG000|Overall Study|Adverse Event|2|||
30653653|NCT00671749|58666343|FG000|Overall Study|Withdrawal by Subject|4|||
30653654|NCT00671749|58666343|FG000|Overall Study|Protocol Violation|1|||
30653655|NCT00671749|58666343|FG000|Overall Study|Lost to Follow-up|1|||
30653656|NCT00669877|58666347|FG000|Overall Study|Disease Progression/Death|4|||
30653657|NCT00882999|58666358|FG000|Overall Study|Adverse Event|0|||
30653658|NCT00882999|58666359|FG001|Overall Study|Adverse Event|0|||
30653659|NCT00882999|58666360|FG002|Overall Study|Adverse Event|0|||
30653660|NCT00882999|58666361|FG003|Overall Study|Adverse Event|0|||
30653661|NCT00882999|58666362|FG004|Overall Study|Adverse Event|1|||
30653662|NCT00882999|58666363|FG005|Overall Study|Adverse Event|0|||
30653663|NCT00882999|58666364|FG006|Overall Study|Adverse Event|0|||
30653664|NCT00882999|58666358|FG000|Overall Study|Death|0|||
30653665|NCT00882999|58666359|FG001|Overall Study|Death|1|||
30768524|NCT02932462|58777513|FG001|Overall Study|Non-Compliance With Study Drug|1|||
30768525|NCT02932462|58777512|FG000|Overall Study|Progressive Disease|1|||
30768526|NCT02932462|58777513|FG001|Overall Study|Progressive Disease|0|||
30768527|NCT03206788|58777521|FG000|Overall Study|Withdrawal by Subject|0|||
30768528|NCT03206788|58777522|FG001|Overall Study|Withdrawal by Subject|1|||
30768529|NCT03206788|58777521|FG000|Overall Study|Adverse Event|0|||
30653666|NCT00882999|58666360|FG002|Overall Study|Death|0|||
30653667|NCT00882999|58666361|FG003|Overall Study|Death|0|||
30653668|NCT00882999|58666362|FG004|Overall Study|Death|0|||
30653669|NCT00882999|58666363|FG005|Overall Study|Death|0|||
30653670|NCT00882999|58666364|FG006|Overall Study|Death|0|||
30653671|NCT00882999|58666358|FG000|Overall Study|Withdrawal by Subject|7|||
30653672|NCT00882999|58666359|FG001|Overall Study|Withdrawal by Subject|6|||
30653673|NCT00882999|58666360|FG002|Overall Study|Withdrawal by Subject|3|||
30653674|NCT00882999|58666361|FG003|Overall Study|Withdrawal by Subject|3|||
30653675|NCT00882999|58666362|FG004|Overall Study|Withdrawal by Subject|6|||
30653676|NCT00882999|58666363|FG005|Overall Study|Withdrawal by Subject|5|||
30653677|NCT00882999|58666364|FG006|Overall Study|Withdrawal by Subject|5|||
30653678|NCT00882999|58666358|FG000|Overall Study|Lost to Follow-up|0|||
30653679|NCT00882999|58666359|FG001|Overall Study|Lost to Follow-up|1|||
30653680|NCT00882999|58666360|FG002|Overall Study|Lost to Follow-up|1|||
30653681|NCT00882999|58666361|FG003|Overall Study|Lost to Follow-up|2|||
30653682|NCT00882999|58666362|FG004|Overall Study|Lost to Follow-up|1|||
30653683|NCT00882999|58666363|FG005|Overall Study|Lost to Follow-up|1|||
30653684|NCT00882999|58666364|FG006|Overall Study|Lost to Follow-up|2|||
30653685|NCT00882999|58666358|FG000|Overall Study|Physician Decision|1|||
30653686|NCT00882999|58666359|FG001|Overall Study|Physician Decision|0|||
30653687|NCT00882999|58666360|FG002|Overall Study|Physician Decision|0|||
30653688|NCT00882999|58666361|FG003|Overall Study|Physician Decision|0|||
30768530|NCT03206788|58777522|FG001|Overall Study|Adverse Event|1|||
30653689|NCT00882999|58666362|FG004|Overall Study|Physician Decision|0|||
30653690|NCT00882999|58666363|FG005|Overall Study|Physician Decision|1|||
30653691|NCT00882999|58666364|FG006|Overall Study|Physician Decision|1|||
30653692|NCT00671437|58666387|FG000|Overall Study|Progressive disease before C1 week 8|8|||
30653693|NCT00671437|58666387|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
30653694|NCT00671437|58666387|FG000|Overall Study|Adverse Event|3|||
30653695|NCT00671437|58666387|FG000|Overall Study|Ineligible post-hoc|1|||
30653696|NCT00882921|58666399|FG000|Overall Study|Death|2|||
30653697|NCT00882921|58666399|FG000|Overall Study|Other|3|||
30653698|NCT00882921|58666399|FG000|Overall Study|Lost to Follow-up|2|||
30768531|NCT03206788|58777521|FG000|Overall Study|Physician Decision|0|||
30768532|NCT03206788|58777522|FG001|Overall Study|Physician Decision|1|||
30768533|NCT03205150|58777531|FG000|Overall Study|Protocol deviation|1|||
30653699|NCT00882921|58666399|FG000|Overall Study|Termination By Investigator|3|||
30653700|NCT00882921|58666399|FG000|Overall Study|Withdrawal Of Consent|1|||
30653701|NCT00582712|58666404|FG000|Overall Study|Adverse Event|1|||
30653702|NCT00582712|58666404|FG000|Overall Study|Lack of Efficacy|1|||
30653703|NCT00582712|58666404|FG000|Overall Study|Withdrawal by Subject|1|||
30653704|NCT00582712|58666404|FG000|Overall Study|Complicating disease requiring treatment|1|||
30653705|NCT00582790|58666408|FG000|Overall Study|Rapid progression of disease|1|||
30653706|NCT00881751|58666415|FG000|Overall Study|Physician Decision|0|||
30653707|NCT00881751|58666416|FG001|Overall Study|Physician Decision|1|||
30653708|NCT00881751|58666415|FG000|Overall Study|Adverse Event|0|||
30653709|NCT00881751|58666416|FG001|Overall Study|Adverse Event|2|||
30653710|NCT00881751|58666415|FG000|Overall Study|Withdrawal by Subject|0|||
30653711|NCT00881751|58666416|FG001|Overall Study|Withdrawal by Subject|2|||
30653712|NCT00934856|58666428|FG000|Feasibility Part|Progressive disease|4|||
30653713|NCT00934856|58666429|FG001|Feasibility Part|Progressive disease|4|||
30653714|NCT00934856|58666430|FG002|Feasibility Part|Progressive disease|2|||
30653715|NCT00934856|58666431|FG003|Feasibility Part|Progressive disease|3|||
30653716|NCT00934856|58666432|FG004|Feasibility Part|Progressive disease|0|||
30653717|NCT00934856|58666433|FG005|Feasibility Part|Progressive disease|0|||
30653718|NCT00934856|58666428|FG000|Feasibility Part|Physician Decision|0|||
30653719|NCT00934856|58666429|FG001|Feasibility Part|Physician Decision|0|||
30653720|NCT00934856|58666430|FG002|Feasibility Part|Physician Decision|1|||
30653721|NCT00934856|58666431|FG003|Feasibility Part|Physician Decision|0|||
30653722|NCT00934856|58666432|FG004|Feasibility Part|Physician Decision|0|||
30653723|NCT00934856|58666433|FG005|Feasibility Part|Physician Decision|0|||
30653724|NCT00934856|58666428|FG000|Feasibility Part|Adverse Event|1|||
30653725|NCT00934856|58666429|FG001|Feasibility Part|Adverse Event|1|||
30653726|NCT00934856|58666430|FG002|Feasibility Part|Adverse Event|0|||
30653727|NCT00934856|58666431|FG003|Feasibility Part|Adverse Event|1|||
30653728|NCT00934856|58666432|FG004|Feasibility Part|Adverse Event|0|||
30653729|NCT00934856|58666433|FG005|Feasibility Part|Adverse Event|2|||
30653730|NCT00934856|58666428|FG000|Feasibility Part|Withdrawal by Subject|0|||
30653731|NCT00934856|58666429|FG001|Feasibility Part|Withdrawal by Subject|0|||
30653732|NCT00934856|58666430|FG002|Feasibility Part|Withdrawal by Subject|0|||
30653733|NCT00934856|58666431|FG003|Feasibility Part|Withdrawal by Subject|1|||
30653734|NCT00934856|58666432|FG004|Feasibility Part|Withdrawal by Subject|0|||
30653735|NCT00934856|58666433|FG005|Feasibility Part|Withdrawal by Subject|1|||
30653736|NCT00934856|58666428|FG000|Extension Part|Adverse Event|0|||
30653737|NCT00934856|58666429|FG001|Extension Part|Adverse Event|0|||
30653738|NCT00934856|58666430|FG002|Extension Part|Adverse Event|0|||
30653739|NCT00934856|58666431|FG003|Extension Part|Adverse Event|1|||
30653740|NCT00934856|58666432|FG004|Extension Part|Adverse Event|4|||
30653741|NCT00934856|58666433|FG005|Extension Part|Adverse Event|4|||
30653742|NCT00934856|58666428|FG000|Extension Part|Progressive disease|0|||
30653743|NCT00934856|58666429|FG001|Extension Part|Progressive disease|0|||
30653744|NCT00934856|58666430|FG002|Extension Part|Progressive disease|0|||
30653745|NCT00934856|58666431|FG003|Extension Part|Progressive disease|1|||
30653746|NCT00934856|58666432|FG004|Extension Part|Progressive disease|0|||
30653747|NCT00934856|58666433|FG005|Extension Part|Progressive disease|0|||
30653748|NCT00934856|58666428|FG000|Extension Part|Non-compliance with drug|0|||
30653749|NCT00934856|58666429|FG001|Extension Part|Non-compliance with drug|0|||
30653750|NCT00934856|58666430|FG002|Extension Part|Non-compliance with drug|0|||
30653751|NCT00934856|58666431|FG003|Extension Part|Non-compliance with drug|0|||
30653752|NCT00934856|58666432|FG004|Extension Part|Non-compliance with drug|0|||
30653753|NCT00934856|58666433|FG005|Extension Part|Non-compliance with drug|1|||
30653754|NCT00934700|58666467|FG000|Overall Study|missing scan|5|||
30653755|NCT00934700|58666468|FG001|Overall Study|missing scan|9|||
30653756|NCT00934700|58666467|FG000|Overall Study|Death|8|||
30653757|NCT00934700|58666468|FG001|Overall Study|Death|3|||
30653758|NCT00930176|58666475|FG000|Overall Study|Death|1|||
30653759|NCT00669409|58666485|FG000|Part 2|Withdrawal by Subject|0|||
30653760|NCT00669409|58666486|FG001|Part 2|Withdrawal by Subject|0|||
30653761|NCT00669409|58666487|FG002|Part 2|Withdrawal by Subject|0|||
30653762|NCT00669409|58666488|FG003|Part 2|Withdrawal by Subject|0|||
30653763|NCT00669409|58666489|FG004|Part 2|Withdrawal by Subject|0|||
30653764|NCT00669409|58666490|FG005|Part 2|Withdrawal by Subject|0|||
30653765|NCT00669409|58666491|FG006|Part 2|Withdrawal by Subject|0|||
30653766|NCT00669409|58666492|FG007|Part 2|Withdrawal by Subject|0|||
30653767|NCT00669409|58666493|FG008|Part 2|Withdrawal by Subject|0|||
30653768|NCT00669409|58666494|FG009|Part 2|Withdrawal by Subject|1|||
30653769|NCT00669409|58666495|FG010|Part 2|Withdrawal by Subject|0|||
30653770|NCT00669331|58666524|FG000|Randomisation to First Dose|Adverse Event|1|||
30653771|NCT00669331|58666525|FG001|Randomisation to First Dose|Adverse Event|0|||
30653772|NCT00669331|58666524|FG000|Randomisation to First Dose|Protocol Violation|1|||
30653773|NCT00669331|58666525|FG001|Randomisation to First Dose|Protocol Violation|0|||
30653774|NCT00669331|58666524|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
30653775|NCT00669331|58666525|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
30768534|NCT03205150|58777532|FG001|Overall Study|Protocol deviation|3|||
30653776|NCT00669331|58666524|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
30653777|NCT00669331|58666525|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
30653778|NCT00669331|58666524|FG000|Randomisation to First Dose|Death|1|||
30653779|NCT00669331|58666525|FG001|Randomisation to First Dose|Death|0|||
30653780|NCT00669331|58666524|FG000|Randomisation to First Dose|Sponsor decision|0|||
30653781|NCT00669331|58666525|FG001|Randomisation to First Dose|Sponsor decision|1|||
30653782|NCT00669331|58666524|FG000|Randomisation to First Dose|Randomised in error|3|||
30653783|NCT00669331|58666525|FG001|Randomisation to First Dose|Randomised in error|10|||
30653784|NCT00669331|58666524|FG000|Blinded Treatment Period|Adverse Event|16|||
30653785|NCT00669331|58666525|FG001|Blinded Treatment Period|Adverse Event|10|||
30653786|NCT00669331|58666524|FG000|Blinded Treatment Period|Protocol Violation|1|||
30653787|NCT00669331|58666525|FG001|Blinded Treatment Period|Protocol Violation|1|||
30653788|NCT00669331|58666524|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
30653789|NCT00669331|58666525|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
30653790|NCT00669331|58666524|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
30653791|NCT00669331|58666525|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
30653792|NCT00669331|58666524|FG000|Blinded Treatment Period|Death|0|||
30653793|NCT00669331|58666525|FG001|Blinded Treatment Period|Death|2|||
30768535|NCT03205150|58777533|FG002|Overall Study|Protocol deviation|0|||
30768536|NCT03205150|58777531|FG000|Overall Study|Patient/guardian decision|0|||
30768537|NCT03205150|58777532|FG001|Overall Study|Patient/guardian decision|3|||
30768538|NCT03205150|58777533|FG002|Overall Study|Patient/guardian decision|0|||
30768539|NCT03205150|58777531|FG000|Overall Study|Adverse Event|1|||
30768540|NCT03205150|58777532|FG001|Overall Study|Adverse Event|1|||
30768541|NCT03205150|58777533|FG002|Overall Study|Adverse Event|1|||
30768542|NCT03205150|58777531|FG000|Overall Study|Lost to Follow-up|0|||
30768543|NCT03205150|58777532|FG001|Overall Study|Lost to Follow-up|0|||
30768544|NCT03205150|58777533|FG002|Overall Study|Lost to Follow-up|1|||
30952287|NCT01543087|58999996|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
30952288|NCT01543087|58999997|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
30952289|NCT01543087|58999998|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
30952290|NCT01543087|58999999|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
30952291|NCT01543087|59000000|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
30952292|NCT01543087|59000001|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
30952293|NCT01543087|58999996|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
30952294|NCT01543087|58999997|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
30952295|NCT01543087|58999998|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
30952296|NCT01543087|58999999|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
30952297|NCT01543087|59000000|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
30952298|NCT01543087|59000001|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
30952299|NCT01696058|59000039|FG000|Overall Study|Adverse Event|21|||
30952300|NCT01696058|59000040|FG001|Overall Study|Adverse Event|11|||
30952301|NCT01696058|59000039|FG000|Overall Study|Lack of Efficacy|2|||
30952302|NCT01696058|59000040|FG001|Overall Study|Lack of Efficacy|3|||
30952303|NCT01696058|59000039|FG000|Overall Study|Protocol Violation|9|||
30952304|NCT01696058|59000040|FG001|Overall Study|Protocol Violation|3|||
30952305|NCT01696058|59000039|FG000|Overall Study|Lost to Follow-up|2|||
30952306|NCT01696058|59000040|FG001|Overall Study|Lost to Follow-up|5|||
30952307|NCT01696058|59000039|FG000|Overall Study|Withdrawal by Subject|4|||
30952308|NCT01696058|59000040|FG001|Overall Study|Withdrawal by Subject|6|||
30952309|NCT01696058|59000039|FG000|Overall Study|Other reason prematurely discontinued|5|||
30952310|NCT01696058|59000040|FG001|Overall Study|Other reason prematurely discontinued|3|||
30952311|NCT01695746|59000046|FG000|Overall Study|Adverse Event|1|||
30952312|NCT01695746|59000046|FG000|Overall Study|Non-compliance by the participant|3|||
30952313|NCT01695746|59000046|FG000|Overall Study|Protocol Violation|5|||
30952314|NCT01695746|59000046|FG000|Overall Study|Participant not willing to participate|3|||
30952315|NCT01694420|59000057|FG000|Overall Study|Lost to Follow-up|3|||
30952316|NCT01675479|59000228|FG000|Overall Study|Lost to Follow-up|11|||
30952317|NCT00089973|59000350|FG000|Overall Study|Adverse Event|3|||
30952318|NCT00089973|59000350|FG000|Overall Study|Withdrawal by Subject|1|||
30952319|NCT00089973|59000350|FG000|Overall Study|Disease progression|45|||
30653794|NCT00669331|58666524|FG000|Blinded Treatment Period|Physician Decision|3|||
30653795|NCT00669331|58666525|FG001|Blinded Treatment Period|Physician Decision|3|||
30768545|NCT02932306|58777544|FG000|Overall Study|Withdrawal by Subject|16|||
30952320|NCT00089973|59000350|FG000|Overall Study|Death|1|||
30768546|NCT02932306|58777545|FG001|Overall Study|Withdrawal by Subject|25|||
30768547|NCT02932306|58777544|FG000|Overall Study|Adverse Event|3|||
30768548|NCT02932306|58777545|FG001|Overall Study|Adverse Event|0|||
30952321|NCT00089661|59000368|FG000|Overall Study|Adverse Event|0|||
30952322|NCT00089661|59000369|FG001|Overall Study|Adverse Event|2|||
30952323|NCT00089661|59000368|FG000|Overall Study|Death|1|||
30952324|NCT00089661|59000369|FG001|Overall Study|Death|0|||
30952325|NCT00089661|59000368|FG000|Overall Study|Lost to Follow-up|0|||
30653796|NCT00669331|58666524|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
30653797|NCT00669331|58666525|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
30653798|NCT00932126|58666533|FG000|Overall Study|Adverse Event|0|||
30653799|NCT00932126|58666534|FG001|Overall Study|Adverse Event|0|||
30653800|NCT00932126|58666535|FG002|Overall Study|Adverse Event|0|||
30653801|NCT00932126|58666536|FG003|Overall Study|Adverse Event|0|||
30653802|NCT00932126|58666537|FG004|Overall Study|Adverse Event|0|||
30653803|NCT00932126|58666538|FG005|Overall Study|Adverse Event|0|||
30653804|NCT00932126|58666539|FG006|Overall Study|Adverse Event|1|||
30653805|NCT00932126|58666540|FG007|Overall Study|Adverse Event|2|||
30653806|NCT00932126|58666533|FG000|Overall Study|Protocol Violation|0|||
30653807|NCT00932126|58666534|FG001|Overall Study|Protocol Violation|0|||
30653808|NCT00932126|58666535|FG002|Overall Study|Protocol Violation|0|||
30653809|NCT00932126|58666536|FG003|Overall Study|Protocol Violation|0|||
30653810|NCT00932126|58666537|FG004|Overall Study|Protocol Violation|1|||
30653811|NCT00932126|58666538|FG005|Overall Study|Protocol Violation|0|||
30653812|NCT00932126|58666539|FG006|Overall Study|Protocol Violation|0|||
30653813|NCT00932126|58666540|FG007|Overall Study|Protocol Violation|0|||
30653814|NCT00932126|58666533|FG000|Overall Study|Withdrawal by Subject|0|||
30653815|NCT00932126|58666534|FG001|Overall Study|Withdrawal by Subject|0|||
30653816|NCT00932126|58666535|FG002|Overall Study|Withdrawal by Subject|1|||
30653817|NCT00932126|58666536|FG003|Overall Study|Withdrawal by Subject|0|||
30653818|NCT00932126|58666537|FG004|Overall Study|Withdrawal by Subject|0|||
30653819|NCT00932126|58666538|FG005|Overall Study|Withdrawal by Subject|0|||
30653820|NCT00932126|58666539|FG006|Overall Study|Withdrawal by Subject|0|||
30653821|NCT00932126|58666540|FG007|Overall Study|Withdrawal by Subject|1|||
30653822|NCT00932126|58666533|FG000|Overall Study|Objective progression or relapse|3|||
30653823|NCT00932126|58666534|FG001|Overall Study|Objective progression or relapse|3|||
30653824|NCT00932126|58666535|FG002|Overall Study|Objective progression or relapse|2|||
30653825|NCT00932126|58666536|FG003|Overall Study|Objective progression or relapse|3|||
30653826|NCT00932126|58666537|FG004|Overall Study|Objective progression or relapse|3|||
30653827|NCT00932126|58666538|FG005|Overall Study|Objective progression or relapse|3|||
30653828|NCT00932126|58666539|FG006|Overall Study|Objective progression or relapse|3|||
30653829|NCT00932126|58666540|FG007|Overall Study|Objective progression or relapse|5|||
30653830|NCT00932126|58666533|FG000|Overall Study|Other|0|||
30653831|NCT00932126|58666534|FG001|Overall Study|Other|0|||
30768549|NCT02932306|58777544|FG000|Overall Study|Pregnancy|2|||
30768550|NCT02932306|58777545|FG001|Overall Study|Pregnancy|0|||
30653832|NCT00932126|58666535|FG002|Overall Study|Other|0|||
30653833|NCT00932126|58666536|FG003|Overall Study|Other|0|||
30653834|NCT00932126|58666537|FG004|Overall Study|Other|1|||
30653835|NCT00932126|58666538|FG005|Overall Study|Other|0|||
30653836|NCT00932126|58666539|FG006|Overall Study|Other|1|||
30653837|NCT00932126|58666540|FG007|Overall Study|Other|2|||
30653838|NCT00667225|58666562|FG000|Overall Study|Subject had no more lesions to treat.|1|||
30653839|NCT00667225|58666563|FG001|Overall Study|Subject had no more lesions to treat.|0|||
30653840|NCT00667225|58666562|FG000|Overall Study|Lost to Follow-up|0|||
30653841|NCT00667225|58666563|FG001|Overall Study|Lost to Follow-up|1|||
30653842|NCT00929864|58666571|FG000|Overall Study|Death|1|||
30653843|NCT00929864|58666572|FG001|Overall Study|Death|1|||
30653844|NCT00929864|58666571|FG000|Overall Study|Adverse Event|11|||
30653845|NCT00929864|58666572|FG001|Overall Study|Adverse Event|30|||
30653846|NCT00929864|58666571|FG000|Overall Study|Lack of Efficacy|19|||
30653847|NCT00929864|58666572|FG001|Overall Study|Lack of Efficacy|16|||
30653848|NCT00929864|58666571|FG000|Overall Study|Lost to Follow-up|7|||
30653849|NCT00929864|58666572|FG001|Overall Study|Lost to Follow-up|12|||
30653850|NCT00929864|58666571|FG000|Overall Study|Withdrawal by Subject|20|||
30653851|NCT00929864|58666572|FG001|Overall Study|Withdrawal by Subject|9|||
30653852|NCT00929864|58666571|FG000|Overall Study|No longer met criteria|2|||
30768551|NCT02932306|58777544|FG000|Overall Study|Protocol Violation|1|||
30768552|NCT02932306|58777545|FG001|Overall Study|Protocol Violation|1|||
30653853|NCT00929864|58666572|FG001|Overall Study|No longer met criteria|1|||
30653854|NCT00929864|58666571|FG000|Overall Study|Poor or non-compliance|3|||
30768553|NCT02932306|58777544|FG000|Overall Study|Noncompliance with Study Drug|1|||
30848752|NCT02849509|58875311|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
30653855|NCT00929864|58666572|FG001|Overall Study|Poor or non-compliance|3|||
30653856|NCT00929864|58666571|FG000|Overall Study|Pregnancy|0|||
30653857|NCT00929864|58666572|FG001|Overall Study|Pregnancy|3|||
30653858|NCT00929864|58666571|FG000|Overall Study|Administrative reason by Sponsor|1|||
30653859|NCT00929864|58666572|FG001|Overall Study|Administrative reason by Sponsor|1|||
30653860|NCT00929864|58666571|FG000|Overall Study|Non-specified|2|||
30653861|NCT00929864|58666572|FG001|Overall Study|Non-specified|7|||
30653862|NCT00597753|58666580|FG000|Overall Study|Adverse Event|6|||
30653863|NCT00597753|58666581|FG001|Overall Study|Adverse Event|2|||
30653864|NCT00597753|58666580|FG000|Overall Study|Death|55|||
30653865|NCT00597753|58666581|FG001|Overall Study|Death|29|||
30653866|NCT00597753|58666580|FG000|Overall Study|Lack of Efficacy|2|||
30653867|NCT00597753|58666581|FG001|Overall Study|Lack of Efficacy|0|||
30768554|NCT02932306|58777545|FG001|Overall Study|Noncompliance with Study Drug|1|||
30768555|NCT02932306|58777544|FG000|Overall Study|Lost to Follow-up|36|||
30768556|NCT02932306|58777545|FG001|Overall Study|Lost to Follow-up|40|||
30768557|NCT02932306|58777544|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
30768558|NCT02932306|58777545|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
30768559|NCT02932306|58777544|FG000|Overall Study|Lack of Efficacy|0|||
30768560|NCT02932306|58777545|FG001|Overall Study|Lack of Efficacy|2|||
30653868|NCT00597753|58666580|FG000|Overall Study|Lost to Follow-up|10|||
30653869|NCT00597753|58666581|FG001|Overall Study|Lost to Follow-up|3|||
30653870|NCT00597753|58666580|FG000|Overall Study|Physician Decision|5|||
30653871|NCT00597753|58666581|FG001|Overall Study|Physician Decision|1|||
30653872|NCT00597753|58666580|FG000|Overall Study|Pregnancy|1|||
30653873|NCT00597753|58666581|FG001|Overall Study|Pregnancy|0|||
30653874|NCT00597753|58666580|FG000|Overall Study|Withdrawal by Subject|35|||
30653875|NCT00597753|58666581|FG001|Overall Study|Withdrawal by Subject|12|||
30653876|NCT00597753|58666580|FG000|Overall Study|Discontinued Dialysis|0|||
30653877|NCT00597753|58666581|FG001|Overall Study|Discontinued Dialysis|1|||
30653878|NCT00597753|58666580|FG000|Overall Study|Never dosed|2|||
30653879|NCT00597753|58666581|FG001|Overall Study|Never dosed|0|||
30653880|NCT00597753|58666580|FG000|Overall Study|Noncompliance|2|||
30653881|NCT00597753|58666581|FG001|Overall Study|Noncompliance|1|||
30653882|NCT00597753|58666580|FG000|Overall Study|Relocation|17|||
30653883|NCT00597753|58666581|FG001|Overall Study|Relocation|6|||
30653884|NCT00597753|58666580|FG000|Overall Study|Renal transplant|10|||
30653885|NCT00597753|58666581|FG001|Overall Study|Renal transplant|3|||
30653886|NCT00597753|58666580|FG000|Overall Study|Site closed by sponsor|19|||
30653887|NCT00597753|58666581|FG001|Overall Study|Site closed by sponsor|7|||
30653888|NCT00597753|58666580|FG000|Overall Study|Site elected to close|2|||
30653889|NCT00597753|58666581|FG001|Overall Study|Site elected to close|4|||
30653890|NCT00665431|58666590|FG000|Overall Study|Adverse Event|16|||
30653891|NCT00665431|58666591|FG001|Overall Study|Adverse Event|22|||
30653892|NCT00665431|58666592|FG002|Overall Study|Adverse Event|6|||
30653893|NCT00665431|58666590|FG000|Overall Study|Withdrawal by Subject|17|||
30653894|NCT00665431|58666591|FG001|Overall Study|Withdrawal by Subject|25|||
30653895|NCT00665431|58666592|FG002|Overall Study|Withdrawal by Subject|15|||
30653896|NCT00665431|58666590|FG000|Overall Study|Lost to Follow-up|3|||
30653897|NCT00665431|58666591|FG001|Overall Study|Lost to Follow-up|3|||
30653898|NCT00665431|58666592|FG002|Overall Study|Lost to Follow-up|1|||
30653899|NCT00665431|58666590|FG000|Overall Study|Other|4|||
30653900|NCT00665431|58666591|FG001|Overall Study|Other|7|||
30653901|NCT00665431|58666592|FG002|Overall Study|Other|2|||
30653902|NCT00934622|58666600|FG000|Overall Study|Lost to Follow-up|7|||
30653903|NCT00934622|58666600|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
30653904|NCT00881361|58666606|FG000|Overall Study|Terminated prior to surgery|27|||
30653905|NCT00881361|58666607|FG001|Overall Study|Terminated prior to surgery|7|||
30653906|NCT00881361|58666608|FG002|Overall Study|Terminated prior to surgery|0|||
30653907|NCT00881361|58666606|FG000|Overall Study|Ineligible|17|||
30653908|NCT00881361|58666607|FG001|Overall Study|Ineligible|2|||
30653909|NCT00881361|58666608|FG002|Overall Study|Ineligible|2|||
30653910|NCT01000727|58666619|FG000|Overall Study|Lost to Follow-up|41|||
30653911|NCT01000727|58666620|FG001|Overall Study|Lost to Follow-up|43|||
30653912|NCT01000727|58666619|FG000|Overall Study|Withdrawal by Subject|111|||
30653913|NCT01000727|58666620|FG001|Overall Study|Withdrawal by Subject|109|||
30653914|NCT01000727|58666619|FG000|Overall Study|Study closed/terminated|23|||
30653915|NCT01000727|58666620|FG001|Overall Study|Study closed/terminated|24|||
30768561|NCT02932306|58777544|FG000|Overall Study|Worsening condition|2|||
30768562|NCT02932306|58777545|FG001|Overall Study|Worsening condition|0|||
30768563|NCT02932306|58777544|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
30768564|NCT02932306|58777545|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
30768565|NCT02932228|58777553|FG000|Overall Study|Death|8|||
30768566|NCT02932228|58777554|FG001|Overall Study|Death|23|||
30768567|NCT02932228|58777553|FG000|Overall Study|not eligible upon chart review|2|||
30768568|NCT02932228|58777554|FG001|Overall Study|not eligible upon chart review|5|||
30768569|NCT02931838|58777568|FG000|Overall Study|Reason not provided by investigator|1|||
30653916|NCT00881205|58666630|FG000|Overall Study|Adverse Event|8|||
30653917|NCT00881205|58666631|FG001|Overall Study|Adverse Event|3|||
30653918|NCT00881205|58666630|FG000|Overall Study|Withdrawal by Subject|1|||
30653919|NCT00881205|58666631|FG001|Overall Study|Withdrawal by Subject|2|||
30653920|NCT00881205|58666630|FG000|Overall Study|Lost to Follow-up|0|||
30653921|NCT00881205|58666631|FG001|Overall Study|Lost to Follow-up|1|||
30653922|NCT00881205|58666630|FG000|Overall Study|Administrative problems|1|||
30653923|NCT00881205|58666631|FG001|Overall Study|Administrative problems|1|||
30653924|NCT00881205|58666630|FG000|Overall Study|Condition no longer requires drug|1|||
30653925|NCT00881205|58666631|FG001|Overall Study|Condition no longer requires drug|0|||
30653926|NCT00879879|58666638|FG000|Overall Study|Death|1|||
30653927|NCT00879879|58666638|FG000|Overall Study|Withdrawal by Subject|1|||
30653928|NCT00879879|58666638|FG000|Overall Study|Physician Decision|1|||
30653929|NCT00661999|58666647|FG000|Overall Study|Adverse Event|11|||
30653930|NCT00661999|58666648|FG001|Overall Study|Adverse Event|5|||
30653931|NCT00661999|58666649|FG002|Overall Study|Adverse Event|8|||
30653932|NCT00661999|58666647|FG000|Overall Study|Death|8|||
30653933|NCT00661999|58666648|FG001|Overall Study|Death|6|||
30653934|NCT00661999|58666649|FG002|Overall Study|Death|3|||
30653935|NCT00661999|58666647|FG000|Overall Study|Other Reasons|5|||
30653936|NCT00661999|58666648|FG001|Overall Study|Other Reasons|12|||
30653937|NCT00661999|58666649|FG002|Overall Study|Other Reasons|23|||
30653938|NCT00661999|58666647|FG000|Overall Study|Withdrawal by Subject|30|||
30653939|NCT00661999|58666648|FG001|Overall Study|Withdrawal by Subject|23|||
30653940|NCT00661999|58666649|FG002|Overall Study|Withdrawal by Subject|14|||
30653941|NCT00661999|58666647|FG000|Overall Study|Alternative Treatment|1|||
30653942|NCT00661999|58666648|FG001|Overall Study|Alternative Treatment|0|||
30653943|NCT00661999|58666649|FG002|Overall Study|Alternative Treatment|0|||
30653944|NCT00661999|58666647|FG000|Overall Study|Other Medical Problems|4|||
30653945|NCT00661999|58666648|FG001|Overall Study|Other Medical Problems|4|||
30653946|NCT00661999|58666649|FG002|Overall Study|Other Medical Problems|9|||
30653947|NCT00665353|58666657|FG000|Study Step 1|Adverse Event|1|||
30653948|NCT00665353|58666657|FG000|Study Step 1|Withdrawal by Subject|2|||
30653949|NCT00665353|58666657|FG000|Study Step 2|Lost to Follow-up|2|||
30653950|NCT00665353|58666657|FG000|Study Step 2|Lack of Efficacy|12|||
30653951|NCT00597207|58666663|FG000|Overall Study|Lost to Follow-up|5|||
30653952|NCT00597207|58666664|FG001|Overall Study|Lost to Follow-up|7|||
30653953|NCT00879645|58666674|FG000|Overall Study|Adverse Event|1|||
30653954|NCT00879645|58666675|FG001|Overall Study|Adverse Event|0|||
30653955|NCT00879645|58666676|FG002|Overall Study|Adverse Event|0|||
30653956|NCT00879645|58666677|FG003|Overall Study|Adverse Event|0|||
30653957|NCT00664105|58666687|FG000|Overall Study|Death|3|||
30653958|NCT00664105|58666687|FG000|Overall Study|Withdrawal by Subject|5|||
30653959|NCT00664105|58666687|FG000|Overall Study|Adverse Event|9|||
30653960|NCT00664105|58666687|FG000|Overall Study|Disease progression|7|||
30653961|NCT00661687|58666692|FG000|Overall Study|Study related symptoms and complaints|5|||
30653962|NCT00661687|58666692|FG000|Overall Study|Positive slit lamp findings|4|||
30653963|NCT00661687|58666692|FG000|Overall Study|Inability to maintain wearing schedule|3|||
30653964|NCT00661687|58666692|FG000|Overall Study|Physician Decision|1|||
30653965|NCT00661687|58666692|FG000|Overall Study|Adverse Event|2|||
30653966|NCT00596817|58666701|FG000|Open-label Period|Adverse Event|0|||
30653967|NCT00596817|58666702|FG001|Open-label Period|Adverse Event|49|||
30653968|NCT00596817|58666701|FG000|Open-label Period|Lack of Efficacy|0|||
30653969|NCT00596817|58666702|FG001|Open-label Period|Lack of Efficacy|33|||
30653970|NCT00596817|58666701|FG000|Open-label Period|Other Reasons|0|||
30653971|NCT00596817|58666702|FG001|Open-label Period|Other Reasons|65|||
30653972|NCT00596817|58666701|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
30653973|NCT00596817|58666702|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
30653974|NCT00596817|58666701|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
30653975|NCT00596817|58666702|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
30653976|NCT00596817|58666701|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
30653977|NCT00596817|58666702|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
30653978|NCT00596817|58666701|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
30653979|NCT00596817|58666702|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
30653980|NCT00596817|58666701|FG000|Double-blind Period|Adverse Event|5|||
30653981|NCT00596817|58666702|FG001|Double-blind Period|Adverse Event|16|||
30653982|NCT00596817|58666701|FG000|Double-blind Period|Lack of Efficacy|52|||
30653983|NCT00596817|58666702|FG001|Double-blind Period|Lack of Efficacy|28|||
30653984|NCT00596817|58666701|FG000|Double-blind Period|Non-compliance With Study Product|3|||
30653985|NCT00596817|58666702|FG001|Double-blind Period|Non-compliance With Study Product|4|||
30653986|NCT00596817|58666701|FG000|Double-blind Period|Protocol Violation|11|||
30653987|NCT00596817|58666702|FG001|Double-blind Period|Protocol Violation|8|||
30653988|NCT00596817|58666701|FG000|Double-blind Period|Withdrawal of Consent|7|||
30653989|NCT00596817|58666702|FG001|Double-blind Period|Withdrawal of Consent|3|||
30653990|NCT00596817|58666701|FG000|Double-blind Period|Lost to Follow-up|0|||
30768570|NCT02931838|58777569|FG001|Overall Study|Reason not provided by investigator|0|||
30848753|NCT02853305|58875324|FG000|Overall Study|Death|244|||
30653991|NCT00596817|58666702|FG001|Double-blind Period|Lost to Follow-up|2|||
30653992|NCT00596817|58666701|FG000|Double-blind Period|Other Reasons|10|||
30653993|NCT00596817|58666702|FG001|Double-blind Period|Other Reasons|18|||
30653994|NCT01000649|58666713|FG000|Overall Study|Adverse Event|5|||
30653995|NCT01000649|58666714|FG001|Overall Study|Adverse Event|1|||
30653996|NCT01000649|58666715|FG002|Overall Study|Adverse Event|2|||
30653997|NCT01000649|58666716|FG003|Overall Study|Adverse Event|4|||
30653998|NCT01000649|58666713|FG000|Overall Study|Lost to Follow-up|0|||
30653999|NCT01000649|58666714|FG001|Overall Study|Lost to Follow-up|2|||
30654000|NCT01000649|58666715|FG002|Overall Study|Lost to Follow-up|0|||
30654001|NCT01000649|58666716|FG003|Overall Study|Lost to Follow-up|2|||
30654002|NCT00879411|58666725|FG000|Overall Study|lost to follow-up (non-AE)|162|||
30654003|NCT01000493|58666731|FG000|Overall Study|Adverse Event|3|||
30654004|NCT01000493|58666732|FG001|Overall Study|Adverse Event|6|||
30654005|NCT01000493|58666731|FG000|Overall Study|Lack of Efficacy|1|||
30654006|NCT01000493|58666732|FG001|Overall Study|Lack of Efficacy|1|||
30654007|NCT01000493|58666731|FG000|Overall Study|Protocol Violation|1|||
30654008|NCT01000493|58666732|FG001|Overall Study|Protocol Violation|8|||
30654009|NCT01000493|58666731|FG000|Overall Study|Study closed/terminated|25|||
30654010|NCT01000493|58666732|FG001|Overall Study|Study closed/terminated|23|||
30654011|NCT01000493|58666731|FG000|Overall Study|Lost to Follow-up|5|||
30654012|NCT01000493|58666732|FG001|Overall Study|Lost to Follow-up|9|||
30654013|NCT01000493|58666731|FG000|Overall Study|Physician Decision|1|||
30654014|NCT01000493|58666732|FG001|Overall Study|Physician Decision|1|||
30654015|NCT01000493|58666731|FG000|Overall Study|Withdrawal by Subject|3|||
30654016|NCT01000493|58666732|FG001|Overall Study|Withdrawal by Subject|7|||
30654017|NCT00666757|58666740|FG000|Overall Study|Lost to Follow-up|39|||
30768571|NCT02931838|58777570|FG002|Overall Study|Reason not provided by investigator|1|||
30768572|NCT02931838|58777571|FG003|Overall Study|Reason not provided by investigator|0|||
30768573|NCT02931838|58777572|FG004|Overall Study|Reason not provided by investigator|0|||
30768574|NCT02931838|58777573|FG005|Overall Study|Reason not provided by investigator|0|||
30768575|NCT02931838|58777568|FG000|Overall Study|Poor/non-compliance|0|||
30768576|NCT02931838|58777569|FG001|Overall Study|Poor/non-compliance|0|||
30768577|NCT02931838|58777570|FG002|Overall Study|Poor/non-compliance|1|||
30768578|NCT02931838|58777571|FG003|Overall Study|Poor/non-compliance|0|||
30768579|NCT02931838|58777572|FG004|Overall Study|Poor/non-compliance|0|||
30768580|NCT02931838|58777573|FG005|Overall Study|Poor/non-compliance|0|||
30768581|NCT02931838|58777568|FG000|Overall Study|Lack of Efficacy|5|||
30768582|NCT02931838|58777569|FG001|Overall Study|Lack of Efficacy|4|||
30768583|NCT02931838|58777570|FG002|Overall Study|Lack of Efficacy|0|||
30768584|NCT02931838|58777571|FG003|Overall Study|Lack of Efficacy|0|||
30768585|NCT02931838|58777572|FG004|Overall Study|Lack of Efficacy|0|||
30768586|NCT02931838|58777573|FG005|Overall Study|Lack of Efficacy|1|||
30768587|NCT02931838|58777568|FG000|Overall Study|Lost to Follow-up|1|||
30768588|NCT02931838|58777569|FG001|Overall Study|Lost to Follow-up|0|||
30768589|NCT02931838|58777570|FG002|Overall Study|Lost to Follow-up|1|||
30768590|NCT02931838|58777571|FG003|Overall Study|Lost to Follow-up|1|||
30768591|NCT02931838|58777572|FG004|Overall Study|Lost to Follow-up|2|||
30952326|NCT00089661|59000369|FG001|Overall Study|Lost to Follow-up|3|||
30654018|NCT00666757|58666741|FG001|Overall Study|Lost to Follow-up|35|||
30654019|NCT00666757|58666740|FG000|Overall Study|Protocol Violation|23|||
30654020|NCT00666757|58666741|FG001|Overall Study|Protocol Violation|24|||
30654021|NCT00666757|58666740|FG000|Overall Study|Adverse Event|22|||
30654022|NCT00666757|58666741|FG001|Overall Study|Adverse Event|12|||
30654023|NCT00666757|58666740|FG000|Overall Study|Withdrawal by Subject|13|||
30654024|NCT00666757|58666741|FG001|Overall Study|Withdrawal by Subject|17|||
30654025|NCT00666757|58666740|FG000|Overall Study|Lack of Efficacy|3|||
30654026|NCT00666757|58666741|FG001|Overall Study|Lack of Efficacy|6|||
30654027|NCT00666757|58666740|FG000|Overall Study|Physician Decision|0|||
30654028|NCT00666757|58666741|FG001|Overall Study|Physician Decision|2|||
30654029|NCT00666757|58666740|FG000|Overall Study|Sponsor decision|0|||
30654030|NCT00666757|58666741|FG001|Overall Study|Sponsor decision|1|||
30654031|NCT01000337|58666752|FG000|Overall Study|Lost to Follow-up|4|||
30654032|NCT01000337|58666753|FG001|Overall Study|Lost to Follow-up|3|||
30654033|NCT00666679|58666761|FG000|First Intervention|Lost to Follow-up|1|||
30654034|NCT00666679|58666762|FG001|First Intervention|Lost to Follow-up|0|||
30654035|NCT00666679|58666761|FG000|First Intervention|Protocol Violation|1|||
30654036|NCT00666679|58666762|FG001|First Intervention|Protocol Violation|0|||
30654037|NCT00666679|58666761|FG000|First Intervention|Withdrawal by Subject|1|||
30654038|NCT00666679|58666762|FG001|First Intervention|Withdrawal by Subject|0|||
30654039|NCT00666679|58666761|FG000|First Intervention|Randomized did not start treatment|1|||
30654040|NCT00666679|58666762|FG001|First Intervention|Randomized did not start treatment|1|||
30654041|NCT00666679|58666761|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
30654042|NCT00666679|58666762|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
30654043|NCT00666679|58666761|FG000|Washout Period of 1 Week|Protocol Violation|0|||
30654044|NCT00666679|58666762|FG001|Washout Period of 1 Week|Protocol Violation|1|||
30654045|NCT00666679|58666761|FG000|Second Intervention|Adverse Event|1|||
30654046|NCT00666679|58666762|FG001|Second Intervention|Adverse Event|0|||
30654047|NCT00666679|58666761|FG000|Second Intervention|Death|0|||
30654048|NCT00666679|58666762|FG001|Second Intervention|Death|1|||
30768592|NCT02931838|58777573|FG005|Overall Study|Lost to Follow-up|0|||
30768593|NCT02931838|58777568|FG000|Overall Study|Subject request to discontinue treatment|4|||
30654049|NCT00595413|58666772|FG000|Overall Study|Adverse Event|0|||
30654050|NCT00595413|58666773|FG001|Overall Study|Adverse Event|2|||
30768594|NCT02931838|58777569|FG001|Overall Study|Subject request to discontinue treatment|3|||
30768595|NCT02931838|58777570|FG002|Overall Study|Subject request to discontinue treatment|3|||
30768596|NCT02931838|58777571|FG003|Overall Study|Subject request to discontinue treatment|0|||
30848754|NCT02853305|58875325|FG001|Overall Study|Death|207|||
30654051|NCT00595413|58666774|FG002|Overall Study|Adverse Event|1|||
30654052|NCT00595413|58666775|FG003|Overall Study|Adverse Event|1|||
30654053|NCT00595413|58666772|FG000|Overall Study|Lost to Follow-up|2|||
30654054|NCT00595413|58666773|FG001|Overall Study|Lost to Follow-up|2|||
30654055|NCT00595413|58666774|FG002|Overall Study|Lost to Follow-up|1|||
30654056|NCT00595413|58666775|FG003|Overall Study|Lost to Follow-up|3|||
30654057|NCT00595413|58666772|FG000|Overall Study|Death|0|||
30654058|NCT00595413|58666773|FG001|Overall Study|Death|0|||
30654059|NCT00595413|58666774|FG002|Overall Study|Death|1|||
30654060|NCT00595413|58666775|FG003|Overall Study|Death|0|||
30654061|NCT00595413|58666772|FG000|Overall Study|Other|5|||
30654062|NCT00595413|58666773|FG001|Overall Study|Other|1|||
30654063|NCT00595413|58666774|FG002|Overall Study|Other|5|||
30654064|NCT00595413|58666775|FG003|Overall Study|Other|0|||
30654065|NCT01000025|58666787|FG000|Overall Study|Adverse Event|43|||
30654066|NCT01000025|58666788|FG001|Overall Study|Adverse Event|2|||
30654067|NCT01000025|58666787|FG000|Overall Study|Withdrawal by Subject|13|||
30654068|NCT01000025|58666788|FG001|Overall Study|Withdrawal by Subject|8|||
30654069|NCT01000025|58666787|FG000|Overall Study|Death|23|||
30654070|NCT01000025|58666788|FG001|Overall Study|Death|13|||
30654071|NCT01000025|58666787|FG000|Overall Study|Lack of Efficacy|363|||
30654072|NCT01000025|58666788|FG001|Overall Study|Lack of Efficacy|208|||
30654073|NCT01000025|58666787|FG000|Overall Study|Intercurrent Illness|26|||
30654074|NCT01000025|58666788|FG001|Overall Study|Intercurrent Illness|7|||
30654075|NCT00595335|58666796|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
30654076|NCT00595335|58666797|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
30654077|NCT00595335|58666796|FG000|Baseline to Six Months|Disease Progression|1|||
30654078|NCT00595335|58666797|FG001|Baseline to Six Months|Disease Progression|1|||
30654079|NCT00595335|58666796|FG000|Baseline to Six Months|Adverse Event|1|||
30654080|NCT00595335|58666797|FG001|Baseline to Six Months|Adverse Event|0|||
30654081|NCT00595335|58666796|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
30654082|NCT00595335|58666797|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
30654083|NCT00595335|58666796|FG000|Six Months to Twelve Months|Disease Progression|1|||
30654084|NCT00595335|58666797|FG001|Six Months to Twelve Months|Disease Progression|0|||
30654085|NCT00661609|58666807|FG000|Overall Study|Adverse Event|4|||
30654086|NCT00661609|58666807|FG000|Overall Study|Death|20|||
30654087|NCT00661609|58666807|FG000|Overall Study|Withdrawal by Subject|2|||
30654088|NCT00661609|58666807|FG000|Overall Study|PI Decision|1|||
30654089|NCT00661609|58666807|FG000|Overall Study|Survival follow up stage discontinued|11|||
30654090|NCT00661609|58666807|FG000|Overall Study|Disease progression|3|||
30654091|NCT00661531|58666811|FG000|Overall Study|Withdrawal by Subject|3|||
30654092|NCT00998309|58666815|FG000|Overall Study|Protocol Violation|4|||
30654093|NCT00999713|58666869|FG000|Overall Study|Physician Decision|2|||
30654094|NCT00999713|58666870|FG001|Overall Study|Physician Decision|0|||
30654095|NCT00997373|58666878|FG000|Overall Study|Withdrawal by Subject|5|||
30654096|NCT00997373|58666879|FG001|Overall Study|Withdrawal by Subject|0|||
30654097|NCT00997373|58666878|FG000|Overall Study|wrong tumor type|4|||
30654098|NCT00997373|58666879|FG001|Overall Study|wrong tumor type|0|||
30654099|NCT00997373|58666878|FG000|Overall Study|could not have hysterectomy|6|||
30654100|NCT00997373|58666879|FG001|Overall Study|could not have hysterectomy|0|||
30654101|NCT00663871|58666887|FG000|Overall Study|Lost to Follow-up|5|||
30654102|NCT00663871|58666888|FG001|Overall Study|Lost to Follow-up|5|||
30654103|NCT00663871|58666887|FG000|Overall Study|Withdrawal by Subject|5|||
30654104|NCT00663871|58666888|FG001|Overall Study|Withdrawal by Subject|2|||
30768597|NCT02931838|58777572|FG004|Overall Study|Subject request to discontinue treatment|1|||
30768598|NCT02931838|58777573|FG005|Overall Study|Subject request to discontinue treatment|0|||
30768599|NCT02931838|58777568|FG000|Overall Study|Withdrawal by Subject|1|||
30768600|NCT02931838|58777569|FG001|Overall Study|Withdrawal by Subject|2|||
30768601|NCT02931838|58777570|FG002|Overall Study|Withdrawal by Subject|0|||
30768602|NCT02931838|58777571|FG003|Overall Study|Withdrawal by Subject|1|||
30768603|NCT02931838|58777572|FG004|Overall Study|Withdrawal by Subject|0|||
30768604|NCT02931838|58777573|FG005|Overall Study|Withdrawal by Subject|0|||
30768605|NCT02931838|58777568|FG000|Overall Study|Adverse Event|2|||
30768606|NCT02931838|58777569|FG001|Overall Study|Adverse Event|1|||
30768607|NCT02931838|58777570|FG002|Overall Study|Adverse Event|2|||
30768608|NCT02931838|58777571|FG003|Overall Study|Adverse Event|1|||
30654105|NCT04152447|58666898|FG000|Overall Study|Lost to Follow-up|1|||
30654106|NCT04152447|58666899|FG001|Overall Study|Lost to Follow-up|0|||
30654107|NCT04152447|58666898|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
30768609|NCT02931838|58777572|FG004|Overall Study|Adverse Event|3|||
30768610|NCT02931838|58777573|FG005|Overall Study|Adverse Event|1|||
30654108|NCT04152447|58666899|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
30654109|NCT04152447|58666898|FG000|Overall Study|Withdrawal by Subject|0|||
30654110|NCT04152447|58666899|FG001|Overall Study|Withdrawal by Subject|1|||
30654111|NCT04152447|58666898|FG000|Overall Study|Found ineligible after enrolling|1|||
30654112|NCT04152447|58666899|FG001|Overall Study|Found ineligible after enrolling|1|||
30654113|NCT04152447|58666898|FG000|Overall Study|Did not receive VR headset in time.|0|||
30654114|NCT04152447|58666899|FG001|Overall Study|Did not receive VR headset in time.|2|||
30768611|NCT03201562|58777595|FG000|Overall Study|Physician Decision|0|||
30654115|NCT00996593|58666905|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
30654116|NCT00996593|58666905|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
30654117|NCT00996593|58666905|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
30654118|NCT00996593|58666905|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
30654119|NCT00996593|58666905|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
30654120|NCT00996593|58666905|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
30654121|NCT00996593|58666905|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
30654122|NCT00996593|58666905|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
30654123|NCT00996593|58666905|FG000|Long-Term Follow-Up|Site Closed|1|||
30654124|NCT00570661|58666909|FG000|Overall Study|Disease worsening|5|||
30654125|NCT00570661|58666909|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
30654126|NCT00570661|58666909|FG000|Overall Study|Adverse Event|1|||
30654127|NCT00934544|58666916|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
30654128|NCT00934544|58666917|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
30654129|NCT00934544|58666918|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
30654130|NCT00934544|58666916|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
30654131|NCT00934544|58666917|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
30654132|NCT00934544|58666918|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
30654133|NCT00934544|58666916|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
30654134|NCT00934544|58666917|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
30654135|NCT00934544|58666918|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
30654136|NCT00934544|58666916|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
30654137|NCT00934544|58666917|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
30654138|NCT00934544|58666918|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
30654139|NCT00934544|58666916|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
30654140|NCT00934544|58666917|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
30654141|NCT00934544|58666918|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
30654142|NCT00934544|58666916|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
30654143|NCT00934544|58666917|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
30654144|NCT00934544|58666918|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
30654145|NCT00934544|58666916|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
30654146|NCT00934544|58666917|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
30654147|NCT00934544|58666918|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
30654148|NCT00934544|58666916|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
30654149|NCT00934544|58666917|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
30654150|NCT00934544|58666918|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
30654151|NCT00934544|58666916|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
30654152|NCT00934544|58666917|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
30654153|NCT00934544|58666918|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
30654154|NCT00934544|58666916|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
30654155|NCT00934544|58666917|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
30654156|NCT00934544|58666918|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
30654157|NCT00934544|58666916|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
30654158|NCT00934544|58666917|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
30654159|NCT00934544|58666918|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
30654160|NCT00934544|58666916|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
30654161|NCT00934544|58666917|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
30654162|NCT00934544|58666918|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
30654163|NCT00934544|58666916|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
30654164|NCT00934544|58666917|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
30654165|NCT00934544|58666918|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
30654166|NCT00934544|58666916|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
30654167|NCT00934544|58666917|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
30654168|NCT00934544|58666918|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
30654169|NCT00934544|58666916|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
30654170|NCT00934544|58666917|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
30654171|NCT00934544|58666918|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
30654172|NCT00934544|58666916|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
30654173|NCT00934544|58666917|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
30654174|NCT00934544|58666918|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
30654175|NCT00999167|58666937|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
30654176|NCT00999167|58666938|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
30768612|NCT03201562|58777596|FG001|Overall Study|Physician Decision|0|||
30768613|NCT03201562|58777597|FG002|Overall Study|Physician Decision|1|||
30768614|NCT03201562|58777595|FG000|Overall Study|Adverse Event|0|||
30768615|NCT03201562|58777596|FG001|Overall Study|Adverse Event|0|||
30654177|NCT00999167|58666939|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
30654178|NCT00999167|58666937|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
30654179|NCT00999167|58666938|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
30654180|NCT00999167|58666939|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
30654181|NCT00999167|58666937|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
30654182|NCT00999167|58666938|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
30654183|NCT00999167|58666939|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
30654184|NCT00999167|58666937|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
30768616|NCT03201562|58777597|FG002|Overall Study|Adverse Event|1|||
30768617|NCT03201562|58777595|FG000|Overall Study|Lost to Follow-up|0|||
30768618|NCT03201562|58777596|FG001|Overall Study|Lost to Follow-up|1|||
30768619|NCT03201562|58777597|FG002|Overall Study|Lost to Follow-up|2|||
30768620|NCT03200860|58777607|FG000|Overall Study|Withdrawal by Subject|1|||
30768621|NCT03200860|58777608|FG001|Overall Study|Withdrawal by Subject|0|||
30768622|NCT03198754|58777616|FG000|Overall Study|Withdrawal by Subject|5|||
30768623|NCT03198754|58777617|FG001|Overall Study|Withdrawal by Subject|4|||
30768624|NCT03198754|58777616|FG000|Overall Study|Lost to Follow-up|4|||
30768625|NCT03198754|58777617|FG001|Overall Study|Lost to Follow-up|3|||
30768626|NCT03198754|58777616|FG000|Overall Study|Ineligible|2|||
30768627|NCT03198754|58777617|FG001|Overall Study|Ineligible|1|||
30768628|NCT03198520|58777623|FG000|Overall Study|Physician Decision|2|||
30768629|NCT03198520|58777623|FG000|Overall Study|Protocol Violation|2|||
30768630|NCT03198520|58777623|FG000|Overall Study|Withdrawal by Subject|1|||
30768631|NCT03198520|58777623|FG000|Overall Study|Study Ended|1|||
30654185|NCT00999167|58666938|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
30654186|NCT00999167|58666939|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
30654187|NCT00999167|58666937|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
30654188|NCT00999167|58666938|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
30654189|NCT00999167|58666939|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
30654190|NCT00999167|58666937|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
30654191|NCT00999167|58666938|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
30654192|NCT00999167|58666939|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
30654193|NCT00999167|58666937|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
30654194|NCT00999167|58666938|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
30654195|NCT00999167|58666939|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
30654196|NCT00999167|58666937|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
30654197|NCT00999167|58666938|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
30654198|NCT00999167|58666939|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
30654199|NCT00570505|58666949|FG000|Overall Study|Adverse Event|7|||
30654200|NCT00570505|58666949|FG000|Overall Study|Withdrawal by Subject|7|||
30654201|NCT00570505|58666949|FG000|Overall Study|Lost to Follow-up|23|||
30654202|NCT00570505|58666949|FG000|Overall Study|Other loss to follow-up|4|||
30654203|NCT00931892|58666955|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
30654204|NCT00931892|58666956|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
30654205|NCT00666211|58667004|FG000|Overall Study|Withdrawal by Subject|10|||
30654206|NCT00666211|58667005|FG001|Overall Study|Withdrawal by Subject|13|||
30654207|NCT00666211|58667004|FG000|Overall Study|went off medication, no more pain|1|||
30654208|NCT00666211|58667005|FG001|Overall Study|went off medication, no more pain|0|||
30654209|NCT00666211|58667004|FG000|Overall Study|patient non-compliant|6|||
30654210|NCT00666211|58667005|FG001|Overall Study|patient non-compliant|6|||
30768632|NCT03194464|58777635|FG000|Overall Study|data not usable|2|||
30768633|NCT03192904|58777643|FG000|Overall Study|Physician Decision|3|||
30768634|NCT03192904|58777644|FG001|Overall Study|Physician Decision|1|||
30768635|NCT03192904|58777643|FG000|Overall Study|Lost to Follow-up|0|||
30768636|NCT03192904|58777644|FG001|Overall Study|Lost to Follow-up|1|||
30768637|NCT03268954|58777652|FG000|Overall Study|Ongoing|23|||
30768638|NCT03268954|58777653|FG001|Overall Study|Ongoing|31|||
30768639|NCT03268954|58777652|FG000|Overall Study|Adverse Event|53|||
30768640|NCT03268954|58777653|FG001|Overall Study|Adverse Event|62|||
30768641|NCT03268954|58777652|FG000|Overall Study|Withdrawal by Subject|25|||
30768642|NCT03268954|58777653|FG001|Overall Study|Withdrawal by Subject|16|||
30768643|NCT03268954|58777652|FG000|Overall Study|Progressive Disease|61|||
30768644|NCT03268954|58777653|FG001|Overall Study|Progressive Disease|48|||
30768645|NCT03268954|58777652|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
30768646|NCT03268954|58777653|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
30768647|NCT03268954|58777652|FG000|Overall Study|Reason not Specified|40|||
30768648|NCT03268954|58777653|FG001|Overall Study|Reason not Specified|40|||
30768649|NCT03188536|58777659|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
30768650|NCT03188536|58777659|FG000|Overall Study|Not participated/met inclusion criteria|1|||
30768651|NCT03187756|58777663|FG000|Overall Study|Termination of study|4|||
30768652|NCT03187132|58777669|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
30768653|NCT03187132|58777670|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
30654211|NCT00666211|58667004|FG000|Overall Study|disease progression|1|||
30654212|NCT00666211|58667005|FG001|Overall Study|disease progression|8|||
30654213|NCT00666211|58667004|FG000|Overall Study|Lost to Follow-up|2|||
30654214|NCT00666211|58667005|FG001|Overall Study|Lost to Follow-up|0|||
30654215|NCT00666211|58667004|FG000|Overall Study|toxicity|0|||
30654216|NCT00666211|58667005|FG001|Overall Study|toxicity|2|||
30654217|NCT00666211|58667004|FG000|Overall Study|hospital admission|0|||
30654218|NCT00666211|58667005|FG001|Overall Study|hospital admission|5|||
30654219|NCT00666211|58667004|FG000|Overall Study|Death|0|||
30654220|NCT00666211|58667005|FG001|Overall Study|Death|2|||
30654221|NCT00666211|58667004|FG000|Overall Study|off tx for other complicating disease|0|||
30654222|NCT00666211|58667005|FG001|Overall Study|off tx for other complicating disease|1|||
30654223|NCT00666211|58667004|FG000|Overall Study|Physician Decision|0|||
30654224|NCT00666211|58667005|FG001|Overall Study|Physician Decision|1|||
30654225|NCT00878709|58667013|FG000|Overall Study|Withdrawal by Subject|197|||
30654226|NCT00878709|58667014|FG001|Overall Study|Withdrawal by Subject|120|||
30654227|NCT00878709|58667013|FG000|Overall Study|Lost to Follow-up|35|||
30654228|NCT00878709|58667014|FG001|Overall Study|Lost to Follow-up|33|||
30654229|NCT00878709|58667013|FG000|Overall Study|Other Reasons|93|||
30654230|NCT00878709|58667014|FG001|Overall Study|Other Reasons|84|||
30654231|NCT00927758|58667021|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
30654232|NCT00927758|58667022|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
30654233|NCT00927758|58667023|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
30654234|NCT00927758|58667024|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
30654235|NCT00927758|58667025|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
30654236|NCT00927758|58667026|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
30654237|NCT00927758|58667021|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
30654238|NCT00927758|58667022|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
30654239|NCT00927758|58667023|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
30654240|NCT00927758|58667024|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
30654241|NCT00927758|58667025|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
30654242|NCT00927758|58667026|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
30654243|NCT00927368|58667037|FG000|Overall Study|enrollment in another study|1|||
30654244|NCT00927368|58667038|FG001|Overall Study|enrollment in another study|1|||
30654245|NCT00927368|58667039|FG002|Overall Study|enrollment in another study|2|||
30654246|NCT00927368|58667037|FG000|Overall Study|Lost to Follow-up|4|||
30654247|NCT00927368|58667038|FG001|Overall Study|Lost to Follow-up|0|||
30654248|NCT00927368|58667039|FG002|Overall Study|Lost to Follow-up|0|||
30654249|NCT00927368|58667037|FG000|Overall Study|equipment failure|1|||
30654250|NCT00927368|58667038|FG001|Overall Study|equipment failure|0|||
30654251|NCT00927368|58667039|FG002|Overall Study|equipment failure|0|||
30654252|NCT00927368|58667037|FG000|Overall Study|ineligible post randomization|0|||
30654253|NCT00927368|58667038|FG001|Overall Study|ineligible post randomization|3|||
30654254|NCT00927368|58667039|FG002|Overall Study|ineligible post randomization|1|||
30654255|NCT00927368|58667037|FG000|Overall Study|cancellation of surgery|0|||
30654256|NCT00927368|58667038|FG001|Overall Study|cancellation of surgery|1|||
30654257|NCT00927368|58667039|FG002|Overall Study|cancellation of surgery|2|||
30654258|NCT00662857|58667047|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
30654259|NCT00662857|58667048|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
30654260|NCT00662857|58667047|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
30654261|NCT00662857|58667048|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
30654262|NCT00662857|58667047|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
30654263|NCT00662857|58667048|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
30654264|NCT00878553|58667061|FG000|Sleep Study|Withdrawal by Subject|2|||
30654265|NCT00878553|58667062|FG001|Sleep Study|Withdrawal by Subject|0|||
30654266|NCT00878553|58667063|FG002|Sleep Study|Withdrawal by Subject|0|||
30654267|NCT00878553|58667064|FG003|Sleep Study|Withdrawal by Subject|0|||
30654268|NCT00878553|58667065|FG004|Sleep Study|Withdrawal by Subject|0|||
30654269|NCT00878553|58667061|FG000|Sleep Study|Lost to Follow-up|1|||
30654270|NCT00878553|58667062|FG001|Sleep Study|Lost to Follow-up|0|||
30654271|NCT00878553|58667063|FG002|Sleep Study|Lost to Follow-up|0|||
30654272|NCT00878553|58667064|FG003|Sleep Study|Lost to Follow-up|0|||
30654273|NCT00878553|58667065|FG004|Sleep Study|Lost to Follow-up|0|||
30654274|NCT00878553|58667061|FG000|Sleep Study|car accident|1|||
30654275|NCT00878553|58667062|FG001|Sleep Study|car accident|0|||
30654276|NCT00878553|58667063|FG002|Sleep Study|car accident|0|||
30654277|NCT00878553|58667064|FG003|Sleep Study|car accident|0|||
30654278|NCT00878553|58667065|FG004|Sleep Study|car accident|0|||
30654279|NCT00878553|58667061|FG000|Sleep Study|family emergency|1|||
30654280|NCT00878553|58667062|FG001|Sleep Study|family emergency|0|||
30848755|NCT02853305|58875326|FG002|Overall Study|Death|263|||
30848756|NCT02853305|58875324|FG000|Overall Study|Withdrawal by Subject|2|||
30654281|NCT00878553|58667063|FG002|Sleep Study|family emergency|0|||
30654282|NCT00878553|58667064|FG003|Sleep Study|family emergency|0|||
30654283|NCT00878553|58667065|FG004|Sleep Study|family emergency|0|||
30654284|NCT00878553|58667061|FG000|PK Study|Withdrawal by Subject|0|||
30654285|NCT00878553|58667062|FG001|PK Study|Withdrawal by Subject|0|||
30654286|NCT00878553|58667063|FG002|PK Study|Withdrawal by Subject|0|||
30654287|NCT00878553|58667064|FG003|PK Study|Withdrawal by Subject|1|||
30654288|NCT00878553|58667065|FG004|PK Study|Withdrawal by Subject|0|||
30654289|NCT00996437|58667084|FG000|Overall Study|Death|1|||
30654290|NCT00996437|58667085|FG001|Overall Study|Death|0|||
30654291|NCT00996437|58667084|FG000|Overall Study|Dropped|2|||
30654292|NCT00996437|58667085|FG001|Overall Study|Dropped|2|||
30654293|NCT00996437|58667084|FG000|Overall Study|Missed|2|||
30654294|NCT00996437|58667085|FG001|Overall Study|Missed|5|||
30654295|NCT00662311|58667094|FG000|Overall Study|Respiratory Infection|1|||
30654296|NCT00662311|58667095|FG001|Overall Study|Respiratory Infection|0|||
30654297|NCT00662311|58667096|FG002|Overall Study|Respiratory Infection|0|||
30654298|NCT00929708|58667109|FG000|Overall Study|Protocol Violation|2|||
30654299|NCT00929708|58667110|FG001|Overall Study|Protocol Violation|1|||
30654300|NCT00929708|58667111|FG002|Overall Study|Protocol Violation|1|||
30654301|NCT00929708|58667112|FG003|Overall Study|Protocol Violation|1|||
30654302|NCT00929708|58667113|FG004|Overall Study|Protocol Violation|1|||
30654303|NCT00929708|58667109|FG000|Overall Study|Withdrawal by Subject|2|||
30654304|NCT00929708|58667110|FG001|Overall Study|Withdrawal by Subject|0|||
30654305|NCT00929708|58667111|FG002|Overall Study|Withdrawal by Subject|0|||
30654306|NCT00929708|58667112|FG003|Overall Study|Withdrawal by Subject|2|||
30654307|NCT00929708|58667113|FG004|Overall Study|Withdrawal by Subject|1|||
30654308|NCT00929708|58667109|FG000|Overall Study|Adverse Event|0|||
30654309|NCT00929708|58667110|FG001|Overall Study|Adverse Event|0|||
30654310|NCT00929708|58667111|FG002|Overall Study|Adverse Event|0|||
30654311|NCT00929708|58667112|FG003|Overall Study|Adverse Event|0|||
30654312|NCT00929708|58667113|FG004|Overall Study|Adverse Event|3|||
30654313|NCT00929708|58667109|FG000|Overall Study|Physician Decision|0|||
30654314|NCT00929708|58667110|FG001|Overall Study|Physician Decision|2|||
30654315|NCT00929708|58667111|FG002|Overall Study|Physician Decision|2|||
30654316|NCT00929708|58667112|FG003|Overall Study|Physician Decision|2|||
30654317|NCT00929708|58667113|FG004|Overall Study|Physician Decision|1|||
30654318|NCT00929708|58667109|FG000|Overall Study|Lost to Follow-up|0|||
30654319|NCT00929708|58667110|FG001|Overall Study|Lost to Follow-up|0|||
30654320|NCT00929708|58667111|FG002|Overall Study|Lost to Follow-up|0|||
30654321|NCT00929708|58667112|FG003|Overall Study|Lost to Follow-up|1|||
30654322|NCT00929708|58667113|FG004|Overall Study|Lost to Follow-up|0|||
30768654|NCT03187132|58777669|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
30768655|NCT03187132|58777670|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
30768656|NCT03187132|58777669|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
30768657|NCT03187132|58777670|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
30768658|NCT03187132|58777669|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
30768659|NCT03187132|58777670|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
30768660|NCT03187132|58777669|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
30768661|NCT03187132|58777670|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
30768662|NCT03187132|58777669|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
30768663|NCT03187132|58777670|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
30768664|NCT03187132|58777669|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
30768665|NCT03187132|58777670|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
30768666|NCT03187132|58777669|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
30768667|NCT03187132|58777670|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
30768668|NCT03187132|58777669|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
30768669|NCT03187132|58777670|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
30768670|NCT03187132|58777669|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
30768671|NCT03187132|58777670|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
30768672|NCT03187132|58777669|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
30768673|NCT03187132|58777670|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
30768674|NCT03184558|58777676|FG000|Overall Study|Withdrawal by Subject|2|||
30768675|NCT03184558|58777676|FG000|Overall Study|Death|16|||
30768676|NCT03184558|58777676|FG000|Overall Study|Lost to Follow-up|2|||
30768677|NCT03184558|58777676|FG000|Overall Study|Other|9|||
30768678|NCT03183778|58777680|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
30654323|NCT00996281|58667127|FG000|Overall Study|Adverse Event|75|||
30654324|NCT00996281|58667128|FG001|Overall Study|Adverse Event|37|||
30654325|NCT00996281|58667127|FG000|Overall Study|Major Protocol Deviation|6|||
30654326|NCT00996281|58667128|FG001|Overall Study|Major Protocol Deviation|7|||
30768679|NCT03182686|58777686|FG000|Overall Study|Lost to Follow-up|2|||
30768680|NCT03182686|58777687|FG001|Overall Study|Lost to Follow-up|0|||
30768681|NCT03182686|58777686|FG000|Overall Study|Adverse Event|2|||
30654327|NCT00996281|58667127|FG000|Overall Study|Lost to Follow-up|14|||
30654328|NCT00996281|58667128|FG001|Overall Study|Lost to Follow-up|16|||
30654329|NCT00996281|58667127|FG000|Overall Study|Withdrawal by Subject|31|||
30654330|NCT00996281|58667128|FG001|Overall Study|Withdrawal by Subject|20|||
30654331|NCT00996281|58667127|FG000|Overall Study|Lack of Efficacy|0|||
30768682|NCT03182686|58777687|FG001|Overall Study|Adverse Event|0|||
30768683|NCT03182686|58777686|FG000|Overall Study|Withdrawal by Subject|3|||
30768684|NCT03182686|58777687|FG001|Overall Study|Withdrawal by Subject|0|||
30768685|NCT03181594|58777693|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
30768686|NCT03181594|58777693|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
30768687|NCT03181594|58777693|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
30768688|NCT03181594|58777693|FG000|Initial Study Protocol (12-month FU)|Death|1|||
30768689|NCT03181594|58777693|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
30768690|NCT03181594|58777693|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
30768691|NCT03180736|58777699|FG000|Overall Study|Adverse Event|3|||
30768692|NCT03180736|58777700|FG001|Overall Study|Adverse Event|4|||
30654332|NCT00996281|58667128|FG001|Overall Study|Lack of Efficacy|2|||
30654333|NCT00996281|58667127|FG000|Overall Study|Other|5|||
30654334|NCT00996281|58667128|FG001|Overall Study|Other|7|||
30654335|NCT00996203|58667134|FG000|Overall Study|Adverse Event|3|||
30654336|NCT00996203|58667134|FG000|Overall Study|Lost to Follow-up|1|||
30654337|NCT00996203|58667134|FG000|Overall Study|Lack of Efficacy|1|||
30654338|NCT00996203|58667134|FG000|Overall Study|Protocol Violation|2|||
30654339|NCT00877929|58667141|FG000|Overall Study|Adverse Event|11|||
30654340|NCT00877929|58667142|FG001|Overall Study|Adverse Event|20|||
30654341|NCT00877929|58667141|FG000|Overall Study|Protocol Violation|3|||
30654342|NCT00877929|58667142|FG001|Overall Study|Protocol Violation|3|||
30654343|NCT00877929|58667141|FG000|Overall Study|Lost to Follow-up|0|||
30654344|NCT00877929|58667142|FG001|Overall Study|Lost to Follow-up|1|||
30654345|NCT00877929|58667141|FG000|Overall Study|Withdrawal by Subject|4|||
30654346|NCT00877929|58667142|FG001|Overall Study|Withdrawal by Subject|4|||
30654347|NCT00877929|58667141|FG000|Overall Study|Lack of Efficacy|0|||
30654348|NCT00877929|58667142|FG001|Overall Study|Lack of Efficacy|1|||
30654349|NCT00877929|58667141|FG000|Overall Study|Other reason (not specified)|2|||
30654350|NCT00877929|58667142|FG001|Overall Study|Other reason (not specified)|6|||
30654351|NCT00931268|58667152|FG000|Overall Study|Lost to Follow-up|6|||
30654352|NCT00996125|58667158|FG000|Overall Study|Adverse Event|0|||
30654353|NCT00996125|58667159|FG001|Overall Study|Adverse Event|2|||
30654354|NCT00996125|58667158|FG000|Overall Study|Lost to Follow-up|1|||
30654355|NCT00996125|58667159|FG001|Overall Study|Lost to Follow-up|6|||
30654356|NCT00996125|58667158|FG000|Overall Study|Withdrawal by Subject|4|||
30654357|NCT00996125|58667159|FG001|Overall Study|Withdrawal by Subject|3|||
30654358|NCT04211363|58667167|FG000|Overall Study|Adverse Event|5|||
30654359|NCT04211363|58667168|FG001|Overall Study|Adverse Event|2|||
30768693|NCT03180736|58777699|FG000|Overall Study|Death|10|||
30768694|NCT03180736|58777700|FG001|Overall Study|Death|7|||
30768695|NCT03180736|58777699|FG000|Overall Study|Withdrawal by Subject|5|||
30768696|NCT03180736|58777700|FG001|Overall Study|Withdrawal by Subject|12|||
30768697|NCT03180736|58777699|FG000|Overall Study|Lost to Follow-up|1|||
30768698|NCT03180736|58777700|FG001|Overall Study|Lost to Follow-up|0|||
30768699|NCT03180736|58777699|FG000|Overall Study|Lack of Efficacy|66|||
30768700|NCT03180736|58777700|FG001|Overall Study|Lack of Efficacy|87|||
30768701|NCT03180736|58777699|FG000|Overall Study|Physician Decision|4|||
30768702|NCT03180736|58777700|FG001|Overall Study|Physician Decision|7|||
30768703|NCT03180736|58777699|FG000|Overall Study|randomized but not treated|2|||
30768704|NCT03180736|58777700|FG001|Overall Study|randomized but not treated|3|||
30768705|NCT03178942|58777713|FG000|Overall Study|Withdrawal by Subject|2|||
30768706|NCT03178942|58777714|FG001|Overall Study|Withdrawal by Subject|0|||
30768707|NCT03178942|58777713|FG000|Overall Study|Lost to Follow-up|1|||
30768708|NCT03178942|58777714|FG001|Overall Study|Lost to Follow-up|2|||
30768709|NCT03175198|58777720|FG000|Overall Study|Adverse Event|480|||
30768710|NCT03175198|58777720|FG000|Overall Study|No actual visit|120|||
30768711|NCT03175198|58777720|FG000|Overall Study|Registration rule not followed|4|||
30768712|NCT03175198|58777720|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
30768713|NCT03175198|58777720|FG000|Overall Study|Other personal reason|509|||
30768714|NCT03175198|58777720|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
30768715|NCT03175198|58777720|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
30768716|NCT03175198|58777720|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
30768717|NCT03175198|58777720|FG000|Overall Study|To conduct invasive treatment of operation|53|||
30768718|NCT03175198|58777720|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
30768719|NCT03175120|58777726|FG000|Overall Study|Adverse Event|2|||
30768720|NCT03175120|58777727|FG001|Overall Study|Adverse Event|2|||
30768721|NCT03175120|58777726|FG000|Overall Study|Protocol Violation|5|||
30654360|NCT04211363|58667167|FG000|Overall Study|Physician Decision|0|||
30768722|NCT03175120|58777727|FG001|Overall Study|Protocol Violation|2|||
30654361|NCT04211363|58667168|FG001|Overall Study|Physician Decision|1|||
30654362|NCT04211363|58667167|FG000|Overall Study|Protocol Violation|1|||
30654363|NCT04211363|58667168|FG001|Overall Study|Protocol Violation|0|||
30654364|NCT04211363|58667167|FG000|Overall Study|Pregnancy|1|||
30654365|NCT04211363|58667168|FG001|Overall Study|Pregnancy|0|||
30654366|NCT04211363|58667167|FG000|Overall Study|Lost to Follow-up|12|||
30654367|NCT04211363|58667168|FG001|Overall Study|Lost to Follow-up|4|||
30654368|NCT04211363|58667167|FG000|Overall Study|Withdrawal by Subject|11|||
30654369|NCT04211363|58667168|FG001|Overall Study|Withdrawal by Subject|11|||
30654370|NCT04211363|58667167|FG000|Overall Study|Other|1|||
30654371|NCT04211363|58667168|FG001|Overall Study|Other|2|||
30654372|NCT00995345|58667179|FG000|Overall Study|Withdrawal by Subject|4|||
30654373|NCT00995345|58667180|FG001|Overall Study|Withdrawal by Subject|2|||
30654374|NCT00995345|58667181|FG002|Overall Study|Withdrawal by Subject|1|||
30654375|NCT00995345|58667182|FG003|Overall Study|Withdrawal by Subject|3|||
30654376|NCT00995345|58667183|FG004|Overall Study|Withdrawal by Subject|1|||
30654377|NCT00995345|58667179|FG000|Overall Study|Adverse Event|3|||
30654378|NCT00995345|58667180|FG001|Overall Study|Adverse Event|1|||
30654379|NCT00995345|58667181|FG002|Overall Study|Adverse Event|2|||
30654380|NCT00995345|58667182|FG003|Overall Study|Adverse Event|0|||
30654381|NCT00995345|58667183|FG004|Overall Study|Adverse Event|1|||
30654382|NCT00995345|58667179|FG000|Overall Study|Lost to Follow-up|2|||
30654383|NCT00995345|58667180|FG001|Overall Study|Lost to Follow-up|2|||
30654384|NCT00995345|58667181|FG002|Overall Study|Lost to Follow-up|2|||
30654385|NCT00995345|58667182|FG003|Overall Study|Lost to Follow-up|1|||
30654386|NCT00995345|58667183|FG004|Overall Study|Lost to Follow-up|0|||
30654387|NCT00995345|58667179|FG000|Overall Study|all other reasons combined|2|||
30654388|NCT00995345|58667180|FG001|Overall Study|all other reasons combined|2|||
30654389|NCT00995345|58667181|FG002|Overall Study|all other reasons combined|2|||
30654390|NCT00995345|58667182|FG003|Overall Study|all other reasons combined|1|||
30654391|NCT00995345|58667183|FG004|Overall Study|all other reasons combined|3|||
30654392|NCT00660907|58667197|FG000|Overall Study|Incorrect Enrollment|1|||
30654393|NCT00660907|58667198|FG001|Overall Study|Incorrect Enrollment|1|||
30654394|NCT00660907|58667197|FG000|Overall Study|Adverse Event|33|||
30654395|NCT00660907|58667198|FG001|Overall Study|Adverse Event|19|||
30654396|NCT00660907|58667197|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
30654397|NCT00660907|58667198|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
30654398|NCT00660907|58667197|FG000|Overall Study|Withdrawal by Subject|23|||
30654399|NCT00660907|58667198|FG001|Overall Study|Withdrawal by Subject|32|||
30654400|NCT00660907|58667197|FG000|Overall Study|Lost to Follow-up|3|||
30654401|NCT00660907|58667198|FG001|Overall Study|Lost to Follow-up|3|||
30654402|NCT00660907|58667197|FG000|Overall Study|Poor/Non-Compliance|5|||
30654403|NCT00660907|58667198|FG001|Overall Study|Poor/Non-Compliance|1|||
30654404|NCT00660907|58667197|FG000|Overall Study|Safety|1|||
30654405|NCT00660907|58667198|FG001|Overall Study|Safety|0|||
30654406|NCT00660907|58667197|FG000|Overall Study|Death|1|||
30654407|NCT00660907|58667198|FG001|Overall Study|Death|3|||
30654408|NCT00660907|58667197|FG000|Overall Study|Various|11|||
30654409|NCT00660907|58667198|FG001|Overall Study|Various|8|||
30654410|NCT00877773|58667204|FG000|Overall Study|Disease Progression|44|||
30654411|NCT00659815|58667210|FG000|Overall Study|Study related symptoms and complaints|2|||
30654412|NCT00659815|58667211|FG001|Overall Study|Study related symptoms and complaints|1|||
30654413|NCT00659815|58667210|FG000|Overall Study|Inability to maintain wearing schedule|1|||
30654414|NCT00659815|58667211|FG001|Overall Study|Inability to maintain wearing schedule|2|||
30654415|NCT00659815|58667210|FG000|Overall Study|Withdrawal by Subject|1|||
30654416|NCT00659815|58667211|FG001|Overall Study|Withdrawal by Subject|1|||
30654417|NCT00994643|58667217|FG000|Overall Study|Withdrawal by Subject|1|||
30654418|NCT00660829|58667223|FG000|Overall Study|Adverse Event|3|||
30654419|NCT00660829|58667224|FG001|Overall Study|Adverse Event|4|||
30654420|NCT00660829|58667223|FG000|Overall Study|Lack of Efficacy|2|||
30654421|NCT00660829|58667224|FG001|Overall Study|Lack of Efficacy|3|||
30654422|NCT00660829|58667223|FG000|Overall Study|Non-Compliance|0|||
30654423|NCT00660829|58667224|FG001|Overall Study|Non-Compliance|4|||
30654424|NCT00660829|58667223|FG000|Overall Study|Withdrawal by Subject|1|||
30654425|NCT00660829|58667224|FG001|Overall Study|Withdrawal by Subject|2|||
30848757|NCT02853305|58875325|FG001|Overall Study|Withdrawal by Subject|4|||
30848758|NCT02853305|58875326|FG002|Overall Study|Withdrawal by Subject|2|||
30952327|NCT00089661|59000368|FG000|Overall Study|Withdrawal by Subject|11|||
30952328|NCT00089661|59000369|FG001|Overall Study|Withdrawal by Subject|9|||
30654426|NCT00660829|58667223|FG000|Overall Study|Lost to Follow-up|3|||
30654427|NCT00660829|58667224|FG001|Overall Study|Lost to Follow-up|2|||
30654428|NCT00660829|58667223|FG000|Overall Study|Other|9|||
30654429|NCT00660829|58667224|FG001|Overall Study|Other|4|||
30654430|NCT00877383|58667232|FG000|Overall Study|Adverse Event|13|||
30654431|NCT00877383|58667233|FG001|Overall Study|Adverse Event|14|||
30654432|NCT00877383|58667232|FG000|Overall Study|Lost to Follow-up|5|||
30654433|NCT00877383|58667233|FG001|Overall Study|Lost to Follow-up|3|||
30654434|NCT00877383|58667232|FG000|Overall Study|Subject withdrew consent|3|||
30654435|NCT00877383|58667233|FG001|Overall Study|Subject withdrew consent|12|||
30654436|NCT00877383|58667232|FG000|Overall Study|Subject no longer requires study drug|2|||
30654437|NCT00877383|58667233|FG001|Overall Study|Subject no longer requires study drug|0|||
30654438|NCT00877383|58667232|FG000|Overall Study|Administrative problems|2|||
30768723|NCT03175120|58777726|FG000|Overall Study|Lost to Follow-up|1|||
30768724|NCT03175120|58777727|FG001|Overall Study|Lost to Follow-up|0|||
30768725|NCT03175120|58777726|FG000|Overall Study|Withdrawal by Subject|2|||
30768726|NCT03175120|58777727|FG001|Overall Study|Withdrawal by Subject|5|||
30768727|NCT03175120|58777726|FG000|Overall Study|Other|2|||
30768728|NCT03175120|58777727|FG001|Overall Study|Other|3|||
30768729|NCT03172702|58777733|FG000|Overall Study|Adverse Event|9|||
30768730|NCT03172702|58777733|FG000|Overall Study|Death|2|||
30768731|NCT03172702|58777733|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
30768732|NCT03172702|58777733|FG000|Overall Study|Withdrawal by Subject|5|||
30768733|NCT03172702|58777733|FG000|Overall Study|Other|2|||
30768734|NCT02795182|58777742|FG000|Overall Study|Death|5|||
30768735|NCT02795182|58777743|FG001|Overall Study|Death|4|||
30768736|NCT02795182|58777744|FG002|Overall Study|Death|4|||
30768737|NCT02795182|58777745|FG003|Overall Study|Death|18|||
30768738|NCT02795182|58777742|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
30768739|NCT02795182|58777743|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
30654439|NCT00877383|58667233|FG001|Overall Study|Administrative problems|0|||
30654440|NCT00877383|58667232|FG000|Overall Study|Protocol deviation|2|||
30654441|NCT00877383|58667233|FG001|Overall Study|Protocol deviation|6|||
30654442|NCT00877383|58667232|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30654443|NCT00877383|58667233|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30654444|NCT00877383|58667232|FG000|Overall Study|Death|1|||
30654445|NCT00877383|58667233|FG001|Overall Study|Death|2|||
30654446|NCT00993473|58667241|FG000|Overall Study|Adverse Event|0|||
30654447|NCT00993473|58667242|FG001|Overall Study|Adverse Event|2|||
30654448|NCT00993473|58667241|FG000|Overall Study|Protocol Violation|1|||
30654449|NCT00993473|58667242|FG001|Overall Study|Protocol Violation|2|||
30654450|NCT00993473|58667241|FG000|Overall Study|Lost to Follow-up|1|||
30654451|NCT00993473|58667242|FG001|Overall Study|Lost to Follow-up|0|||
30654452|NCT00993473|58667241|FG000|Overall Study|Withdrawal by Subject|1|||
30654453|NCT00993473|58667242|FG001|Overall Study|Withdrawal by Subject|5|||
30654454|NCT00993473|58667241|FG000|Overall Study|Technical problem with CGM device|0|||
30654455|NCT00993473|58667242|FG001|Overall Study|Technical problem with CGM device|1|||
30654456|NCT00993473|58667241|FG000|Overall Study|Family event|1|||
30654457|NCT00993473|58667242|FG001|Overall Study|Family event|0|||
30654458|NCT00660595|58667250|FG000|Overall Study|Lost to Follow-up|0|||
30654459|NCT00660595|58667251|FG001|Overall Study|Lost to Follow-up|1|||
30654460|NCT00660595|58667250|FG000|Overall Study|Did not consent to participate in study|12|||
30654461|NCT00660595|58667251|FG001|Overall Study|Did not consent to participate in study|8|||
30654462|NCT00660595|58667250|FG000|Overall Study|Participant left hospital|1|||
30654463|NCT00660595|58667251|FG001|Overall Study|Participant left hospital|0|||
30654464|NCT00660595|58667250|FG000|Overall Study|Non Specified reasons|5|||
30654465|NCT00660595|58667251|FG001|Overall Study|Non Specified reasons|0|||
30654466|NCT00929240|58667257|FG000|Initial Treatment Phase|Adverse Event|31|||
30654467|NCT00929240|58667258|FG001|Initial Treatment Phase|Adverse Event|0|||
30654468|NCT00929240|58667259|FG002|Initial Treatment Phase|Adverse Event|0|||
30654469|NCT00929240|58667257|FG000|Initial Treatment Phase|Disease progression|41|||
30654470|NCT00929240|58667258|FG001|Initial Treatment Phase|Disease progression|0|||
30654471|NCT00929240|58667259|FG002|Initial Treatment Phase|Disease progression|0|||
30654472|NCT00929240|58667257|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
30654473|NCT00929240|58667258|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
30654474|NCT00929240|58667259|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
30654475|NCT00929240|58667257|FG000|Initial Treatment Phase|Protocol Violation|5|||
30654476|NCT00929240|58667258|FG001|Initial Treatment Phase|Protocol Violation|0|||
30654477|NCT00929240|58667259|FG002|Initial Treatment Phase|Protocol Violation|0|||
30654478|NCT00929240|58667257|FG000|Initial Treatment Phase|Death|2|||
30654479|NCT00929240|58667258|FG001|Initial Treatment Phase|Death|0|||
30768740|NCT02795182|58777744|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
30768741|NCT02795182|58777745|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
30768742|NCT02795182|58777742|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
30654480|NCT00929240|58667259|FG002|Initial Treatment Phase|Death|0|||
30654481|NCT00929240|58667257|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
30768743|NCT02795182|58777743|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
30848759|NCT02853305|58875324|FG000|Overall Study|Ongoing in Trial|105|||
30654482|NCT00929240|58667258|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
30654483|NCT00929240|58667259|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
30654484|NCT00929240|58667257|FG000|Initial Treatment Phase|Physician Decision|4|||
30654485|NCT00929240|58667258|FG001|Initial Treatment Phase|Physician Decision|0|||
30654486|NCT00929240|58667259|FG002|Initial Treatment Phase|Physician Decision|0|||
30654487|NCT00929240|58667257|FG000|Maintenance Phase|Disease progression|0|||
30654488|NCT00929240|58667258|FG001|Maintenance Phase|Disease progression|73|||
30654489|NCT00929240|58667259|FG002|Maintenance Phase|Disease progression|60|||
30654490|NCT00929240|58667257|FG000|Maintenance Phase|Adverse Event|0|||
30654491|NCT00929240|58667258|FG001|Maintenance Phase|Adverse Event|9|||
30654492|NCT00929240|58667259|FG002|Maintenance Phase|Adverse Event|12|||
30654493|NCT00929240|58667257|FG000|Maintenance Phase|Withdrawal by Subject|0|||
30654494|NCT00929240|58667258|FG001|Maintenance Phase|Withdrawal by Subject|2|||
30654495|NCT00929240|58667259|FG002|Maintenance Phase|Withdrawal by Subject|6|||
30654496|NCT00929240|58667257|FG000|Maintenance Phase|Protocol Violation|0|||
30654497|NCT00929240|58667258|FG001|Maintenance Phase|Protocol Violation|1|||
30654498|NCT00929240|58667259|FG002|Maintenance Phase|Protocol Violation|0|||
30654499|NCT00929240|58667257|FG000|Maintenance Phase|Health authority/Study termination|0|||
30654500|NCT00929240|58667258|FG001|Maintenance Phase|Health authority/Study termination|1|||
30654501|NCT00929240|58667259|FG002|Maintenance Phase|Health authority/Study termination|2|||
30654502|NCT00929240|58667257|FG000|Maintenance Phase|Physician Decision|0|||
30654503|NCT00929240|58667258|FG001|Maintenance Phase|Physician Decision|2|||
30654504|NCT00929240|58667259|FG002|Maintenance Phase|Physician Decision|1|||
30654505|NCT00929240|58667257|FG000|Maintenance Phase|Change of treatment|0|||
30654506|NCT00929240|58667258|FG001|Maintenance Phase|Change of treatment|4|||
30654507|NCT00929240|58667259|FG002|Maintenance Phase|Change of treatment|0|||
30654508|NCT00929240|58667257|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
30654509|NCT00929240|58667258|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
30654510|NCT00929240|58667259|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
30654511|NCT00929240|58667257|FG000|Maintenance Phase|Participant not treated|0|||
30654512|NCT00929240|58667258|FG001|Maintenance Phase|Participant not treated|2|||
30654513|NCT00929240|58667259|FG002|Maintenance Phase|Participant not treated|0|||
30654514|NCT00993317|58667270|FG000|Overall Study|Adverse Event|2|||
30654515|NCT00993317|58667271|FG001|Overall Study|Adverse Event|4|||
30654516|NCT00993317|58667270|FG000|Overall Study|Lack of Efficacy|18|||
30654517|NCT00993317|58667271|FG001|Overall Study|Lack of Efficacy|18|||
30654518|NCT00993317|58667270|FG000|Overall Study|Withdrawal by Subject|0|||
30654519|NCT00993317|58667271|FG001|Overall Study|Withdrawal by Subject|2|||
30654520|NCT00993317|58667270|FG000|Overall Study|Investigator's opinion|0|||
30654521|NCT00993317|58667271|FG001|Overall Study|Investigator's opinion|1|||
30654522|NCT00993317|58667270|FG000|Overall Study|Early study termination at the site|1|||
30654523|NCT00993317|58667271|FG001|Overall Study|Early study termination at the site|0|||
30654524|NCT01030133|58667279|FG000|Overall Study|failed to experience pain at level 7/10|2|||
30654525|NCT01030133|58667280|FG001|Overall Study|failed to experience pain at level 7/10|2|||
30654526|NCT00877071|58667290|FG000|Overall Study|disease progression|2|||
30654527|NCT00987389|58667296|FG000|Overall Study|Ineligible|0|||
30654528|NCT00987389|58667297|FG001|Overall Study|Ineligible|3|||
30654529|NCT00987389|58667298|FG002|Overall Study|Ineligible|0|||
30654530|NCT00987389|58667299|FG003|Overall Study|Ineligible|0|||
30654531|NCT00987389|58667296|FG000|Overall Study|Lost to Follow-up|4|||
30654532|NCT00987389|58667297|FG001|Overall Study|Lost to Follow-up|1|||
30654533|NCT00987389|58667298|FG002|Overall Study|Lost to Follow-up|3|||
30654534|NCT00987389|58667299|FG003|Overall Study|Lost to Follow-up|1|||
30654535|NCT00987389|58667296|FG000|Overall Study|Withdrawal by Subject|4|||
30654536|NCT00987389|58667297|FG001|Overall Study|Withdrawal by Subject|3|||
30654537|NCT00987389|58667298|FG002|Overall Study|Withdrawal by Subject|2|||
30654538|NCT00987389|58667299|FG003|Overall Study|Withdrawal by Subject|1|||
30654539|NCT00987389|58667296|FG000|Overall Study|Withdrawn from Treatment|0|||
30654540|NCT00987389|58667297|FG001|Overall Study|Withdrawn from Treatment|1|||
30654541|NCT00987389|58667298|FG002|Overall Study|Withdrawn from Treatment|0|||
30654542|NCT00987389|58667299|FG003|Overall Study|Withdrawn from Treatment|0|||
30654543|NCT00987389|58667296|FG000|Overall Study|Multiple different reasons|1|||
30654544|NCT00987389|58667297|FG001|Overall Study|Multiple different reasons|0|||
30654545|NCT00987389|58667298|FG002|Overall Study|Multiple different reasons|3|||
30654546|NCT00987389|58667299|FG003|Overall Study|Multiple different reasons|1|||
30654547|NCT00929162|58667309|FG000|Overall Study|Adverse Event|8|||
30654548|NCT00929162|58667310|FG001|Overall Study|Adverse Event|5|||
30654549|NCT00929162|58667309|FG000|Overall Study|Withdrawal by Subject|3|||
30654550|NCT00929162|58667310|FG001|Overall Study|Withdrawal by Subject|1|||
30654551|NCT00929162|58667309|FG000|Overall Study|Protocol Violation|32|||
30654552|NCT00929162|58667310|FG001|Overall Study|Protocol Violation|30|||
30654553|NCT00929162|58667309|FG000|Overall Study|Other termination reason|5|||
30654554|NCT00929162|58667310|FG001|Overall Study|Other termination reason|6|||
30654555|NCT00992459|58667318|FG000|Overall Study|Withdrawal by Subject|0|||
30654556|NCT00992459|58667319|FG001|Overall Study|Withdrawal by Subject|1|||
30654557|NCT00992459|58667318|FG000|Overall Study|Adverse Event|1|||
30654558|NCT00992459|58667319|FG001|Overall Study|Adverse Event|0|||
30654559|NCT00930722|58667325|FG000|Overall Study|Lost to Follow-up|16|||
30654560|NCT00930722|58667325|FG000|Overall Study|No longer willing to participate|9|||
30654561|NCT00930722|58667325|FG000|Overall Study|Study terminated by sponsor|2|||
30654562|NCT00992225|58667329|FG000|Overall Study|Entry Criteria Not Met|8|||
30654563|NCT00992225|58667329|FG000|Overall Study|Adverse Event|2|||
30654564|NCT00659581|58667333|FG000|Overall Study|Adverse Event|1006|||
30654565|NCT00659581|58667333|FG000|Overall Study|Lack of Efficacy|1183|||
30654566|NCT00659581|58667333|FG000|Overall Study|Other|6393|||
30654567|NCT00991289|58667337|FG000|Overall Study|Adverse Event|1|||
30654568|NCT00991289|58667337|FG000|Overall Study|Physician Decision|2|||
30654569|NCT00991289|58667337|FG000|Overall Study|Withdrawal by Subject|3|||
30654570|NCT00991289|58667337|FG000|Overall Study|Lost to Follow-up|4|||
30654571|NCT00991289|58667337|FG000|Overall Study|Protocol Violation|2|||
30654572|NCT00930644|58667341|FG000|Overall Study|Withdrawal by Subject|4|||
30654573|NCT00930644|58667341|FG000|Overall Study|Physician Decision|2|||
30654574|NCT00930644|58667341|FG000|Overall Study|Death|1|||
30654575|NCT00930644|58667341|FG000|Overall Study|Adverse Event|16|||
30654576|NCT00990821|58667362|FG000|Overall Study|Withdrawal by Subject|0|||
30654577|NCT00990821|58667363|FG001|Overall Study|Withdrawal by Subject|2|||
30654578|NCT00990821|58667364|FG002|Overall Study|Withdrawal by Subject|0|||
30654579|NCT00990821|58667365|FG003|Overall Study|Withdrawal by Subject|0|||
30654580|NCT00990821|58667366|FG004|Overall Study|Withdrawal by Subject|3|||
30768744|NCT02795182|58777744|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
30768745|NCT02795182|58777745|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
30654581|NCT00990821|58667367|FG005|Overall Study|Withdrawal by Subject|3|||
30654582|NCT00990821|58667368|FG006|Overall Study|Withdrawal by Subject|1|||
30654583|NCT00990821|58667369|FG007|Overall Study|Withdrawal by Subject|0|||
30654584|NCT00990821|58667370|FG008|Overall Study|Withdrawal by Subject|0|||
30768746|NCT02795182|58777742|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
30768747|NCT02795182|58777743|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
30768748|NCT02795182|58777744|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
30768749|NCT02795182|58777745|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
30952329|NCT00089661|59000368|FG000|Overall Study|Disease progression|1|||
30952330|NCT00089661|59000369|FG001|Overall Study|Disease progression|3|||
30768750|NCT02795182|58777742|FG000|Overall Study|Withdrawal by Subject|4|||
30768751|NCT02795182|58777743|FG001|Overall Study|Withdrawal by Subject|0|||
30768752|NCT02795182|58777744|FG002|Overall Study|Withdrawal by Subject|0|||
30768753|NCT02795182|58777745|FG003|Overall Study|Withdrawal by Subject|3|||
30768754|NCT02795182|58777742|FG000|Overall Study|Lost to Follow-up|0|||
30768755|NCT02795182|58777743|FG001|Overall Study|Lost to Follow-up|0|||
30768756|NCT02795182|58777744|FG002|Overall Study|Lost to Follow-up|1|||
30768757|NCT02795182|58777745|FG003|Overall Study|Lost to Follow-up|1|||
30768758|NCT02795182|58777742|FG000|Overall Study|Roll Over to Long Term Extension|3|||
30768759|NCT02795182|58777743|FG001|Overall Study|Roll Over to Long Term Extension|3|||
30768760|NCT02795182|58777744|FG002|Overall Study|Roll Over to Long Term Extension|2|||
30768761|NCT02795182|58777745|FG003|Overall Study|Roll Over to Long Term Extension|5|||
30768762|NCT02795182|58777742|FG000|Overall Study|Progressive Disease|0|||
30768763|NCT02795182|58777743|FG001|Overall Study|Progressive Disease|1|||
30768764|NCT02795182|58777744|FG002|Overall Study|Progressive Disease|0|||
30768765|NCT02795182|58777745|FG003|Overall Study|Progressive Disease|4|||
30952331|NCT00089661|59000368|FG000|Overall Study|Ineligibility determined|4|||
30952332|NCT00089661|59000369|FG001|Overall Study|Ineligibility determined|4|||
30952333|NCT00089661|59000368|FG000|Overall Study|Noncompliance|2|||
30952334|NCT00089661|59000369|FG001|Overall Study|Noncompliance|4|||
30952335|NCT00089661|59000368|FG000|Overall Study|Other|2|||
30952336|NCT00089661|59000369|FG001|Overall Study|Other|1|||
30952337|NCT00089583|59000386|FG000|Overall Study|Adverse Event|0|||
30654585|NCT00990821|58667371|FG009|Overall Study|Withdrawal by Subject|1|||
30654586|NCT00990821|58667372|FG010|Overall Study|Withdrawal by Subject|3|||
30654587|NCT00990821|58667373|FG011|Overall Study|Withdrawal by Subject|5|||
30654588|NCT00990821|58667374|FG012|Overall Study|Withdrawal by Subject|2|||
30768766|NCT02795182|58777742|FG000|Overall Study|Physician Decision|0|||
30654589|NCT00990821|58667375|FG013|Overall Study|Withdrawal by Subject|1|||
30654590|NCT00990665|58667392|FG000|Overall Study|Unsuccessful Implant|8|||
30654591|NCT00990665|58667392|FG000|Overall Study|Death|29|||
30952338|NCT00089583|59000387|FG001|Overall Study|Adverse Event|3|||
30952339|NCT00089583|59000386|FG000|Overall Study|Insufficient Viral Load Response|5|||
30952340|NCT00089583|59000387|FG001|Overall Study|Insufficient Viral Load Response|5|||
30654592|NCT00990665|58667392|FG000|Overall Study|Heart Transplant|1|||
30654593|NCT00990665|58667392|FG000|Overall Study|Withdrawal by Subject|6|||
30654594|NCT00990665|58667392|FG000|Overall Study|Lost to Follow-up|1|||
30654595|NCT00990665|58667392|FG000|Overall Study|System Explant|3|||
30654596|NCT00658567|58667401|FG000|Overall Study|Adverse Event|5|||
30654597|NCT00658567|58667402|FG001|Overall Study|Adverse Event|2|||
30654598|NCT00658567|58667403|FG002|Overall Study|Adverse Event|3|||
30768767|NCT02795182|58777743|FG001|Overall Study|Physician Decision|0|||
30768768|NCT02795182|58777744|FG002|Overall Study|Physician Decision|0|||
30768769|NCT02795182|58777745|FG003|Overall Study|Physician Decision|1|||
30768770|NCT03167242|58777774|FG000|Overall Study|Patient/Guardian Decision|0|||
30768771|NCT03167242|58777775|FG001|Overall Study|Patient/Guardian Decision|1|||
30768772|NCT03167242|58777776|FG002|Overall Study|Patient/Guardian Decision|2|||
30768773|NCT03167242|58777777|FG003|Overall Study|Patient/Guardian Decision|1|||
30768774|NCT03167242|58777778|FG004|Overall Study|Patient/Guardian Decision|1|||
30768775|NCT03167242|58777779|FG005|Overall Study|Patient/Guardian Decision|1|||
30768776|NCT03167242|58777780|FG006|Overall Study|Patient/Guardian Decision|0|||
30768777|NCT03167242|58777781|FG007|Overall Study|Patient/Guardian Decision|0|||
30768778|NCT03167242|58777782|FG008|Overall Study|Patient/Guardian Decision|0|||
30768779|NCT03167242|58777783|FG009|Overall Study|Patient/Guardian Decision|0|||
30768780|NCT03167242|58777784|FG010|Overall Study|Patient/Guardian Decision|1|||
30768781|NCT03167242|58777785|FG011|Overall Study|Patient/Guardian Decision|0|||
30768782|NCT03167242|58777774|FG000|Overall Study|Lost to Follow-up|0|||
30768783|NCT03167242|58777775|FG001|Overall Study|Lost to Follow-up|0|||
30768784|NCT03167242|58777776|FG002|Overall Study|Lost to Follow-up|1|||
30768785|NCT03167242|58777777|FG003|Overall Study|Lost to Follow-up|0|||
30768786|NCT03167242|58777778|FG004|Overall Study|Lost to Follow-up|0|||
30768787|NCT03167242|58777779|FG005|Overall Study|Lost to Follow-up|1|||
30768788|NCT03167242|58777780|FG006|Overall Study|Lost to Follow-up|2|||
30768789|NCT03167242|58777781|FG007|Overall Study|Lost to Follow-up|1|||
30768790|NCT03167242|58777782|FG008|Overall Study|Lost to Follow-up|0|||
30654599|NCT00658567|58667401|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
30768791|NCT03167242|58777783|FG009|Overall Study|Lost to Follow-up|0|||
30768792|NCT03167242|58777784|FG010|Overall Study|Lost to Follow-up|1|||
30768793|NCT03167242|58777785|FG011|Overall Study|Lost to Follow-up|1|||
30768794|NCT03167242|58777774|FG000|Overall Study|Reason not provided|0|||
30768795|NCT03167242|58777775|FG001|Overall Study|Reason not provided|0|||
30768796|NCT03167242|58777776|FG002|Overall Study|Reason not provided|0|||
30768797|NCT03167242|58777777|FG003|Overall Study|Reason not provided|0|||
30768798|NCT03167242|58777778|FG004|Overall Study|Reason not provided|0|||
30768799|NCT03167242|58777779|FG005|Overall Study|Reason not provided|0|||
30848760|NCT02853305|58875325|FG001|Overall Study|Ongoing in Trial|96|||
30848761|NCT02853305|58875326|FG002|Overall Study|Ongoing in Trial|87|||
30848762|NCT02848729|58875336|FG000|Overall Study|Withdrawal by Subject|1|||
30848763|NCT02848729|58875337|FG001|Overall Study|Withdrawal by Subject|0|||
30848764|NCT02848729|58875336|FG000|Overall Study|Emesis|15|||
30848765|NCT02848729|58875337|FG001|Overall Study|Emesis|11|||
30848766|NCT00158756|58875355|FG000|Overall Study|Withdrawal by Subject|5|||
30848767|NCT00158756|58875356|FG001|Overall Study|Withdrawal by Subject|0|||
30848768|NCT00158756|58875357|FG002|Overall Study|Withdrawal by Subject|6|||
30848769|NCT00158756|58875358|FG003|Overall Study|Withdrawal by Subject|1|||
30848770|NCT00158756|58875359|FG004|Overall Study|Withdrawal by Subject|3|||
30848771|NCT00158756|58875355|FG000|Overall Study|Adverse Event|0|||
30848772|NCT00158756|58875356|FG001|Overall Study|Adverse Event|0|||
30848773|NCT00158756|58875357|FG002|Overall Study|Adverse Event|1|||
30848774|NCT00158756|58875358|FG003|Overall Study|Adverse Event|0|||
30848775|NCT00158756|58875359|FG004|Overall Study|Adverse Event|0|||
30848776|NCT00158756|58875355|FG000|Overall Study|Serious adverse event|0|||
30848777|NCT00158756|58875356|FG001|Overall Study|Serious adverse event|0|||
30848778|NCT00158756|58875357|FG002|Overall Study|Serious adverse event|1|||
30848779|NCT00158756|58875358|FG003|Overall Study|Serious adverse event|0|||
30654600|NCT00658567|58667402|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
30768800|NCT03167242|58777780|FG006|Overall Study|Reason not provided|0|||
30768801|NCT03167242|58777781|FG007|Overall Study|Reason not provided|0|||
30768802|NCT03167242|58777782|FG008|Overall Study|Reason not provided|1|||
30768803|NCT03167242|58777783|FG009|Overall Study|Reason not provided|0|||
30768804|NCT03167242|58777784|FG010|Overall Study|Reason not provided|0|||
30768805|NCT03167242|58777785|FG011|Overall Study|Reason not provided|0|||
30768806|NCT03286426|58777821|FG000|Overall Study|Physician Decision|3|||
30768807|NCT02882152|58777840|FG000|Overall Study|Lost to Follow-up|1|||
30768808|NCT02882152|58777841|FG001|Overall Study|Lost to Follow-up|0|||
30768809|NCT00286091|58777849|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
30768810|NCT00286091|58777850|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
30768811|NCT00286091|58777849|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
30848780|NCT00158756|58875359|FG004|Overall Study|Serious adverse event|0|||
30848781|NCT02730195|58875371|FG000|Overall Study|Withdrawal by Subject|1|||
30848782|NCT02730351|58875379|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
30848783|NCT02730351|58875380|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
30848784|NCT02730351|58875379|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
30848785|NCT02730351|58875380|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
30654601|NCT00658567|58667403|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
30654602|NCT00658567|58667401|FG000|Overall Study|Physician Decision|0|||
30654603|NCT00658567|58667402|FG001|Overall Study|Physician Decision|1|||
30654604|NCT00658567|58667403|FG002|Overall Study|Physician Decision|0|||
30654605|NCT00658567|58667401|FG000|Overall Study|At Discretion of Sponsor|1|||
30654606|NCT00658567|58667402|FG001|Overall Study|At Discretion of Sponsor|1|||
30654607|NCT00658567|58667403|FG002|Overall Study|At Discretion of Sponsor|1|||
30654608|NCT00875433|58667411|FG000|Overall Study|Progressive disease|41|||
30654609|NCT00875433|58667411|FG000|Overall Study|Other Adverse Event|14|||
30654610|NCT00875433|58667411|FG000|Overall Study|Withdrawal by Subject|2|||
30654611|NCT00875433|58667411|FG000|Overall Study|Other|3|||
30654612|NCT00985985|58667419|FG000|Overall Study|Adverse Event|4|||
30654613|NCT00985985|58667420|FG001|Overall Study|Adverse Event|2|||
30654614|NCT00985985|58667421|FG002|Overall Study|Adverse Event|2|||
30654615|NCT00985985|58667422|FG003|Overall Study|Adverse Event|2|||
30654616|NCT00985985|58667419|FG000|Overall Study|Lost to Follow-up|4|||
30654617|NCT00985985|58667420|FG001|Overall Study|Lost to Follow-up|11|||
30654618|NCT00985985|58667421|FG002|Overall Study|Lost to Follow-up|2|||
30654619|NCT00985985|58667422|FG003|Overall Study|Lost to Follow-up|3|||
30654620|NCT00985985|58667419|FG000|Overall Study|Protocol Violation|1|||
30654621|NCT00985985|58667420|FG001|Overall Study|Protocol Violation|2|||
30848786|NCT02730351|58875379|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
30848787|NCT02730351|58875380|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
30848788|NCT02730351|58875379|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
30848789|NCT02730351|58875380|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
30848790|NCT02730351|58875379|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
30654622|NCT00985985|58667421|FG002|Overall Study|Protocol Violation|0|||
30654623|NCT00985985|58667422|FG003|Overall Study|Protocol Violation|1|||
30654624|NCT00985985|58667419|FG000|Overall Study|Lack of Efficacy|5|||
30654625|NCT00985985|58667420|FG001|Overall Study|Lack of Efficacy|6|||
30654626|NCT00985985|58667421|FG002|Overall Study|Lack of Efficacy|1|||
30654627|NCT00985985|58667422|FG003|Overall Study|Lack of Efficacy|3|||
30654628|NCT00985985|58667419|FG000|Overall Study|Withdrawal by Subject|4|||
30654629|NCT00985985|58667420|FG001|Overall Study|Withdrawal by Subject|2|||
30654630|NCT00985985|58667421|FG002|Overall Study|Withdrawal by Subject|2|||
30654631|NCT00985985|58667422|FG003|Overall Study|Withdrawal by Subject|2|||
30654632|NCT00985985|58667419|FG000|Overall Study|Other Reason|6|||
30654633|NCT00985985|58667420|FG001|Overall Study|Other Reason|1|||
30654634|NCT00985985|58667421|FG002|Overall Study|Other Reason|4|||
30654635|NCT00985985|58667422|FG003|Overall Study|Other Reason|2|||
30654636|NCT00923936|58667439|FG000|Overall Study|progressive disease on study|2|||
30654637|NCT00923936|58667440|FG001|Overall Study|progressive disease on study|1|||
30768812|NCT00286091|58777850|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
30768813|NCT00286091|58777849|FG000|Double-blind Treatment Phase|Death|58|||
30768814|NCT00286091|58777850|FG001|Double-blind Treatment Phase|Death|65|||
30768815|NCT00286091|58777849|FG000|Double-blind Treatment Phase|Adverse Event|28|||
30768816|NCT00286091|58777850|FG001|Double-blind Treatment Phase|Adverse Event|40|||
30768817|NCT00286091|58777849|FG000|Double-blind Treatment Phase|Disease Progression|22|||
30768818|NCT00286091|58777850|FG001|Double-blind Treatment Phase|Disease Progression|35|||
30768819|NCT00286091|58777849|FG000|Double-blind Treatment Phase|Other|25|||
30768820|NCT00286091|58777850|FG001|Double-blind Treatment Phase|Other|33|||
30654638|NCT00923936|58667439|FG000|Overall Study|Adverse Event|2|||
30654639|NCT00923936|58667440|FG001|Overall Study|Adverse Event|1|||
30768821|NCT00286091|58777849|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
30768822|NCT00286091|58777850|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
30768823|NCT00286091|58777849|FG000|Double-blind Treatment Phase|Noncompliance|8|||
30768824|NCT00286091|58777850|FG001|Double-blind Treatment Phase|Noncompliance|8|||
30768825|NCT00286091|58777849|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
30768826|NCT00286091|58777850|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
30654640|NCT00923936|58667439|FG000|Overall Study|Lost to follow up|2|||
30654641|NCT00923936|58667440|FG001|Overall Study|Lost to follow up|0|||
30654642|NCT00923936|58667439|FG000|Overall Study|Continuing in follow up period|2|||
30654643|NCT00923936|58667440|FG001|Overall Study|Continuing in follow up period|1|||
30654644|NCT00924950|58667448|FG000|Overall Study|Lost to Follow-up|2|||
30654645|NCT00988637|58667457|FG000|Overall Study|Lost to Follow-up|2|||
30654646|NCT00988637|58667458|FG001|Overall Study|Lost to Follow-up|1|||
30654647|NCT00988637|58667457|FG000|Overall Study|Withdrawal by Subject|1|||
30654648|NCT00988637|58667458|FG001|Overall Study|Withdrawal by Subject|1|||
30654649|NCT00988637|58667457|FG000|Overall Study|non-compliance with study drug|0|||
30654650|NCT00988637|58667458|FG001|Overall Study|non-compliance with study drug|1|||
30654651|NCT00923702|58667469|FG000|Overall Study|Ongoing enrollment|0|||
30654652|NCT00923702|58667470|FG001|Overall Study|Ongoing enrollment|0|||
30768827|NCT00286091|58777849|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
30768828|NCT00286091|58777850|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
30768829|NCT00286091|58777849|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
30768830|NCT00286091|58777850|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
30768831|NCT00286091|58777849|FG000|Open-label Treatment Phase|Physician Decision|24|||
30768832|NCT00286091|58777850|FG001|Open-label Treatment Phase|Physician Decision|21|||
30768833|NCT00286091|58777849|FG000|Open-label Treatment Phase|Adverse Event|5|||
30768834|NCT00286091|58777850|FG001|Open-label Treatment Phase|Adverse Event|16|||
30768835|NCT00286091|58777849|FG000|Open-label Treatment Phase|Other|11|||
30768836|NCT00286091|58777850|FG001|Open-label Treatment Phase|Other|11|||
30768837|NCT00286091|58777849|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
30768838|NCT00286091|58777850|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
30768839|NCT00286091|58777849|FG000|Open-label Treatment Phase|Death|10|||
30768840|NCT00286091|58777850|FG001|Open-label Treatment Phase|Death|7|||
30768841|NCT00286091|58777849|FG000|Open-label Treatment Phase|Disease Progression|9|||
30768842|NCT00286091|58777850|FG001|Open-label Treatment Phase|Disease Progression|3|||
30768843|NCT00286091|58777849|FG000|Open-label Treatment Phase|Noncompliance|3|||
30768844|NCT00286091|58777850|FG001|Open-label Treatment Phase|Noncompliance|1|||
30768845|NCT00286091|58777849|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
30768846|NCT00286091|58777850|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
30768847|NCT00286091|58777849|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
30768848|NCT00286091|58777850|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
30768849|NCT00286091|58777849|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
30768850|NCT00286091|58777850|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
30768851|NCT00285857|58777858|FG000|Overall Study|Withdrawal by Subject|2|||
30768852|NCT00285857|58777858|FG000|Overall Study|Inadequate initial breast cytology|1|||
30654653|NCT00923702|58667471|FG002|Overall Study|Ongoing enrollment|0|||
30654654|NCT00923702|58667472|FG003|Overall Study|Ongoing enrollment|0|||
30654655|NCT00923702|58667473|FG004|Overall Study|Ongoing enrollment|354|||
30654656|NCT00923156|58667488|FG000|Overall Study|Adverse Event|0|||
30654657|NCT00923156|58667489|FG001|Overall Study|Adverse Event|2|||
30654658|NCT00923156|58667490|FG002|Overall Study|Adverse Event|1|||
30654659|NCT00923156|58667488|FG000|Overall Study|Abnormal laboratory values|0|||
30654660|NCT00923156|58667489|FG001|Overall Study|Abnormal laboratory values|0|||
30654661|NCT00923156|58667490|FG002|Overall Study|Abnormal laboratory values|1|||
30654662|NCT00923156|58667488|FG000|Overall Study|Withdrawal by Subject|0|||
30654663|NCT00923156|58667489|FG001|Overall Study|Withdrawal by Subject|1|||
30654664|NCT00923156|58667490|FG002|Overall Study|Withdrawal by Subject|0|||
30654665|NCT00923156|58667488|FG000|Overall Study|Death|0|||
30654666|NCT00923156|58667489|FG001|Overall Study|Death|1|||
30654667|NCT00923156|58667490|FG002|Overall Study|Death|0|||
30654668|NCT00923156|58667488|FG000|Overall Study|Lack of Efficacy|0|||
30654669|NCT00923156|58667489|FG001|Overall Study|Lack of Efficacy|0|||
30654670|NCT00923156|58667490|FG002|Overall Study|Lack of Efficacy|1|||
30654671|NCT00874731|58667498|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
30768853|NCT00285857|58777858|FG000|Overall Study|Adverse Event|1|||
30768854|NCT00284141|58777867|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
30768855|NCT00284141|58777867|FG000|Overall Study|Adverse Event|19|||
30768856|NCT00284141|58777867|FG000|Overall Study|Participant's request|9|||
30768857|NCT00284141|58777867|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
30768858|NCT00284141|58777867|FG000|Overall Study|Clinical deterioration / death|2|||
30768859|NCT00284141|58777867|FG000|Overall Study|General decline|1|||
30768860|NCT00284141|58777867|FG000|Overall Study|Pneumonia|1|||
30768861|NCT00284141|58777867|FG000|Overall Study|Did not take study medication|2|||
30768862|NCT00284141|58777867|FG000|Overall Study|Ongoing treatment|2|||
30768863|NCT00265343|58777875|FG000|Overall Study|Adverse Event|10|||
30768864|NCT00265343|58777876|FG001|Overall Study|Adverse Event|7|||
30768865|NCT00265343|58777875|FG000|Overall Study|Withdrawal by Subject|3|||
30768866|NCT00265343|58777876|FG001|Overall Study|Withdrawal by Subject|9|||
30768867|NCT00265343|58777875|FG000|Overall Study|Other|8|||
30768868|NCT00265343|58777876|FG001|Overall Study|Other|3|||
30768869|NCT00283595|58777884|FG000|Overall Study|Withdrawal by Subject|1|||
30768870|NCT00283595|58777885|FG001|Overall Study|Withdrawal by Subject|2|||
30768871|NCT00265109|58777891|FG000|Overall Study|Withdrawal by Subject|5|||
30848791|NCT02730351|58875380|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
30768872|NCT00265109|58777891|FG000|Overall Study|Adverse Event|1|||
30768873|NCT03235024|58777898|FG000|Overall Study|Adverse Event|2|||
30768874|NCT03235024|58777899|FG001|Overall Study|Adverse Event|2|||
30654672|NCT00874731|58667499|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
30768875|NCT03235024|58777898|FG000|Overall Study|Death|1|||
30768876|NCT03235024|58777899|FG001|Overall Study|Death|0|||
30768877|NCT03235024|58777898|FG000|Overall Study|Lost to Follow-up|2|||
30654673|NCT00874731|58667500|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
30654674|NCT00874731|58667498|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
30654675|NCT00874731|58667499|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
30654676|NCT00874731|58667500|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
30654677|NCT00874731|58667498|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
30654678|NCT00874731|58667499|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
30654679|NCT00874731|58667500|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
30654680|NCT00924638|58667510|FG000|Overall Study|Death|3|||
30654681|NCT00924638|58667511|FG001|Overall Study|Death|2|||
30654682|NCT00924638|58667510|FG000|Overall Study|Lost to Follow-up|1|||
30654683|NCT00924638|58667511|FG001|Overall Study|Lost to Follow-up|1|||
30654684|NCT00924638|58667510|FG000|Overall Study|Withdrawal by Subject|5|||
30654685|NCT00924638|58667511|FG001|Overall Study|Withdrawal by Subject|7|||
30654686|NCT00924638|58667510|FG000|Overall Study|Physician Decision|3|||
30654687|NCT00924638|58667511|FG001|Overall Study|Physician Decision|3|||
30654688|NCT00874497|58667519|FG000|Overall Study|Lost to Follow-up|2|||
30654689|NCT00874497|58667520|FG001|Overall Study|Lost to Follow-up|4|||
30654690|NCT00874497|58667519|FG000|Overall Study|Adverse Event|9|||
30654691|NCT00874497|58667520|FG001|Overall Study|Adverse Event|4|||
30654692|NCT00874497|58667519|FG000|Overall Study|Sponsor Discontinued Trial|7|||
30654693|NCT00874497|58667520|FG001|Overall Study|Sponsor Discontinued Trial|3|||
30654694|NCT00874497|58667519|FG000|Overall Study|Met Withdrawal Criteria|4|||
30654695|NCT00874497|58667520|FG001|Overall Study|Met Withdrawal Criteria|2|||
30654696|NCT00874497|58667519|FG000|Overall Study|Physician Decision|1|||
30654697|NCT00874497|58667520|FG001|Overall Study|Physician Decision|1|||
30768878|NCT03235024|58777899|FG001|Overall Study|Lost to Follow-up|5|||
30768879|NCT03235024|58777898|FG000|Overall Study|Protocol Violation|1|||
30768880|NCT03235024|58777899|FG001|Overall Study|Protocol Violation|0|||
30768881|NCT03235024|58777898|FG000|Overall Study|Withdrawal by Subject|0|||
30768882|NCT03235024|58777899|FG001|Overall Study|Withdrawal by Subject|3|||
30768883|NCT03233308|58777905|FG000|Overall Study|Adverse Event|1|||
30768884|NCT03233308|58777905|FG000|Overall Study|Protocol Violation|1|||
30768885|NCT00283439|58777920|FG000|Overall Study|Adverse Event|0|||
30768886|NCT00283439|58777921|FG001|Overall Study|Adverse Event|0|||
30768887|NCT00283439|58777922|FG002|Overall Study|Adverse Event|0|||
30768888|NCT00283439|58777923|FG003|Overall Study|Adverse Event|1|||
30768889|NCT00283439|58777920|FG000|Overall Study|Death|0|||
30768890|NCT00283439|58777921|FG001|Overall Study|Death|0|||
30768891|NCT00283439|58777922|FG002|Overall Study|Death|1|||
30768892|NCT00283439|58777923|FG003|Overall Study|Death|0|||
30768893|NCT00283439|58777920|FG000|Overall Study|Disease progression|0|||
30768894|NCT00283439|58777921|FG001|Overall Study|Disease progression|1|||
30768895|NCT00283439|58777922|FG002|Overall Study|Disease progression|0|||
30768896|NCT00283439|58777923|FG003|Overall Study|Disease progression|0|||
30768897|NCT00283439|58777920|FG000|Overall Study|Requirement for alternative therapy|1|||
30768898|NCT00283439|58777921|FG001|Overall Study|Requirement for alternative therapy|2|||
30768899|NCT00283439|58777922|FG002|Overall Study|Requirement for alternative therapy|5|||
30768900|NCT00283439|58777923|FG003|Overall Study|Requirement for alternative therapy|2|||
30768901|NCT00283439|58777920|FG000|Overall Study|Stem cell transplant|6|||
30768902|NCT00283439|58777921|FG001|Overall Study|Stem cell transplant|6|||
30768903|NCT00283439|58777922|FG002|Overall Study|Stem cell transplant|4|||
30768904|NCT00283439|58777923|FG003|Overall Study|Stem cell transplant|3|||
30768905|NCT00283439|58777920|FG000|Overall Study|Treatment discontinued|0|||
30768906|NCT00283439|58777921|FG001|Overall Study|Treatment discontinued|2|||
30768907|NCT00283439|58777922|FG002|Overall Study|Treatment discontinued|1|||
30768908|NCT00283439|58777923|FG003|Overall Study|Treatment discontinued|3|||
30768909|NCT00283439|58777920|FG000|Overall Study|Other|1|||
30768910|NCT00283439|58777921|FG001|Overall Study|Other|0|||
30768911|NCT00283439|58777922|FG002|Overall Study|Other|0|||
30768912|NCT00283439|58777923|FG003|Overall Study|Other|0|||
30768913|NCT03233230|58777937|FG000|Overall Study|Adverse Event|6|||
30768914|NCT03233230|58777938|FG001|Overall Study|Adverse Event|3|||
30768915|NCT03233230|58777939|FG002|Overall Study|Adverse Event|6|||
30768916|NCT03233230|58777940|FG003|Overall Study|Adverse Event|3|||
30768917|NCT03233230|58777937|FG000|Overall Study|Protocol Violation|1|||
30768918|NCT03233230|58777938|FG001|Overall Study|Protocol Violation|2|||
30768919|NCT03233230|58777939|FG002|Overall Study|Protocol Violation|1|||
30768920|NCT03233230|58777940|FG003|Overall Study|Protocol Violation|1|||
30768921|NCT03233230|58777937|FG000|Overall Study|Lack of Efficacy|1|||
30768922|NCT03233230|58777938|FG001|Overall Study|Lack of Efficacy|0|||
30768923|NCT03233230|58777939|FG002|Overall Study|Lack of Efficacy|0|||
30768924|NCT03233230|58777940|FG003|Overall Study|Lack of Efficacy|0|||
30654698|NCT00874497|58667519|FG000|Overall Study|Withdrawal by Subject|5|||
30654699|NCT00874497|58667520|FG001|Overall Study|Withdrawal by Subject|4|||
30654700|NCT00924560|58667529|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
30768925|NCT03233230|58777937|FG000|Overall Study|Other|5|||
30768926|NCT03233230|58777938|FG001|Overall Study|Other|5|||
30768927|NCT03233230|58777939|FG002|Overall Study|Other|5|||
30768928|NCT03233230|58777940|FG003|Overall Study|Other|3|||
30768929|NCT03233230|58777937|FG000|Overall Study|Withdrawal by Subject|2|||
30768930|NCT03233230|58777938|FG001|Overall Study|Withdrawal by Subject|2|||
30654701|NCT00924560|58667530|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
30654702|NCT00924560|58667531|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
30654703|NCT00924560|58667529|FG000|Overall Study|Non Compliance with the Protocol|20|||
30654704|NCT00924560|58667530|FG001|Overall Study|Non Compliance with the Protocol|15|||
30654705|NCT00924560|58667531|FG002|Overall Study|Non Compliance with the Protocol|4|||
30654706|NCT00924560|58667529|FG000|Overall Study|Physician Decision|2|||
30654707|NCT00924560|58667530|FG001|Overall Study|Physician Decision|3|||
30654708|NCT00924560|58667531|FG002|Overall Study|Physician Decision|4|||
30654709|NCT00924560|58667529|FG000|Overall Study|Withdrawal by Subject|50|||
30654710|NCT00924560|58667530|FG001|Overall Study|Withdrawal by Subject|44|||
30654711|NCT00924560|58667531|FG002|Overall Study|Withdrawal by Subject|18|||
30654712|NCT00924560|58667529|FG000|Overall Study|Adverse Event|39|||
30654713|NCT00924560|58667530|FG001|Overall Study|Adverse Event|33|||
30654714|NCT00924560|58667531|FG002|Overall Study|Adverse Event|0|||
30654715|NCT00924560|58667529|FG000|Overall Study|Pregnancy|5|||
30654716|NCT00924560|58667530|FG001|Overall Study|Pregnancy|7|||
30654717|NCT00924560|58667531|FG002|Overall Study|Pregnancy|1|||
30654718|NCT00924560|58667529|FG000|Overall Study|Lost to Follow-up|78|||
30654719|NCT00924560|58667530|FG001|Overall Study|Lost to Follow-up|94|||
30654720|NCT00924560|58667531|FG002|Overall Study|Lost to Follow-up|45|||
30654721|NCT00924560|58667529|FG000|Overall Study|Miscellaneous Reasons|13|||
30654722|NCT00924560|58667530|FG001|Overall Study|Miscellaneous Reasons|10|||
30654723|NCT00924560|58667531|FG002|Overall Study|Miscellaneous Reasons|10|||
30654724|NCT00923078|58667544|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
30654725|NCT00923078|58667545|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
30654726|NCT00923078|58667546|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
30654727|NCT00923078|58667544|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
30654728|NCT00923078|58667545|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
30654729|NCT00923078|58667546|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
30654730|NCT00978731|58667557|FG000|Overall Study|Death|4|||
30654731|NCT00978731|58667558|FG001|Overall Study|Death|1|||
30654732|NCT00978731|58667559|FG002|Overall Study|Death|1|||
30654733|NCT00978731|58667560|FG003|Overall Study|Death|0|||
30654734|NCT00978731|58667557|FG000|Overall Study|Lost to Follow-up|0|||
30654735|NCT00978731|58667558|FG001|Overall Study|Lost to Follow-up|0|||
30654736|NCT00978731|58667559|FG002|Overall Study|Lost to Follow-up|0|||
30654737|NCT00978731|58667560|FG003|Overall Study|Lost to Follow-up|1|||
30654738|NCT00978731|58667557|FG000|Overall Study|Adverse Event|5|||
30654739|NCT00978731|58667558|FG001|Overall Study|Adverse Event|2|||
30654740|NCT00978731|58667559|FG002|Overall Study|Adverse Event|0|||
30654741|NCT00978731|58667560|FG003|Overall Study|Adverse Event|0|||
30654742|NCT00978731|58667557|FG000|Overall Study|Participant's request|1|||
30654743|NCT00978731|58667558|FG001|Overall Study|Participant's request|0|||
30654744|NCT00978731|58667559|FG002|Overall Study|Participant's request|0|||
30654745|NCT00978731|58667560|FG003|Overall Study|Participant's request|0|||
30654746|NCT00978731|58667557|FG000|Overall Study|Administrative reason|3|||
30654747|NCT00978731|58667558|FG001|Overall Study|Administrative reason|3|||
30654748|NCT00978731|58667559|FG002|Overall Study|Administrative reason|1|||
30654749|NCT00978731|58667560|FG003|Overall Study|Administrative reason|0|||
30654750|NCT00978731|58667557|FG000|Overall Study|Deterioration without progression|0|||
30654751|NCT00978731|58667558|FG001|Overall Study|Deterioration without progression|1|||
30654752|NCT00978731|58667559|FG002|Overall Study|Deterioration without progression|0|||
30654753|NCT00978731|58667560|FG003|Overall Study|Deterioration without progression|0|||
30654754|NCT00978731|58667557|FG000|Overall Study|Disease progression/relapse|5|||
30654755|NCT00978731|58667558|FG001|Overall Study|Disease progression/relapse|4|||
30654756|NCT00978731|58667559|FG002|Overall Study|Disease progression/relapse|2|||
30654757|NCT00978731|58667560|FG003|Overall Study|Disease progression/relapse|2|||
30654758|NCT00978731|58667557|FG000|Overall Study|Study closure|3|||
30654759|NCT00978731|58667558|FG001|Overall Study|Study closure|4|||
30654760|NCT00978731|58667559|FG002|Overall Study|Study closure|1|||
30654761|NCT00978731|58667560|FG003|Overall Study|Study closure|1|||
30654762|NCT00978731|58667557|FG000|Overall Study|No response|1|||
30654763|NCT00978731|58667558|FG001|Overall Study|No response|0|||
30654764|NCT00978731|58667559|FG002|Overall Study|No response|0|||
30654765|NCT00978731|58667560|FG003|Overall Study|No response|0|||
30654766|NCT05056870|58667574|FG000|Period 1|Site COVID-19 Related|3|||
30768931|NCT03233230|58777939|FG002|Overall Study|Withdrawal by Subject|0|||
30768932|NCT03233230|58777940|FG003|Overall Study|Withdrawal by Subject|1|||
30654767|NCT05056870|58667575|FG001|Period 1|Site COVID-19 Related|3|||
30654768|NCT05056870|58667574|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
30654769|NCT05056870|58667575|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
30654770|NCT05056870|58667574|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
30654771|NCT05056870|58667575|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
30654772|NCT05056870|58667574|FG000|Period 2|COVID-19 Related|1|||
30654773|NCT05056870|58667575|FG001|Period 2|COVID-19 Related|0|||
30654774|NCT05056870|58667574|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
30654775|NCT05056870|58667575|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
30654776|NCT04488822|58667599|FG000|Overall Study|Adverse Event|8|||
30654777|NCT04488822|58667599|FG000|Overall Study|Withdrawal by Subject|1|||
30654778|NCT04396626|58667612|FG000|Overall Study|Premature termination of study|975|||
30654779|NCT04242186|58667616|FG000|Overall Study|Death|5|||
30654780|NCT03934216|58667623|FG000|Randomization|Randomized in Error|1|||
30654781|NCT03934216|58667624|FG001|Randomization|Randomized in Error|1|||
30654782|NCT03934216|58667623|FG000|Treatment Period|Adverse Event|10|||
30654783|NCT03934216|58667624|FG001|Treatment Period|Adverse Event|3|||
30654784|NCT03934216|58667623|FG000|Treatment Period|Withdrawal by Participant|6|||
30654785|NCT03934216|58667624|FG001|Treatment Period|Withdrawal by Participant|2|||
30654786|NCT03934216|58667623|FG000|Treatment Period|Other Reasons|2|||
30654787|NCT03934216|58667624|FG001|Treatment Period|Other Reasons|2|||
30654788|NCT03183128|58667670|FG000|Overall Study|Adverse Event|1|||
30654789|NCT03183128|58667671|FG001|Overall Study|Adverse Event|2|||
30654790|NCT03183128|58667670|FG000|Overall Study|Withdrawal by Subject|1|||
30654791|NCT03183128|58667671|FG001|Overall Study|Withdrawal by Subject|8|||
30654792|NCT03183128|58667670|FG000|Overall Study|Protocol Violation|2|||
30654793|NCT03183128|58667671|FG001|Overall Study|Protocol Violation|0|||
30654794|NCT03183128|58667670|FG000|Overall Study|Lack of Efficacy|4|||
30654795|NCT03183128|58667671|FG001|Overall Study|Lack of Efficacy|27|||
30654796|NCT03183128|58667670|FG000|Overall Study|Lost to Follow-up|1|||
30654797|NCT03183128|58667671|FG001|Overall Study|Lost to Follow-up|0|||
30768933|NCT03233230|58777937|FG000|Overall Study|Lost to Follow-up|0|||
30952341|NCT00089583|59000386|FG000|Overall Study|Withdrawal by Subject|0|||
30952342|NCT00089583|59000387|FG001|Overall Study|Withdrawal by Subject|4|||
30952343|NCT00089583|59000386|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
30952344|NCT00089583|59000387|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
30952345|NCT00089583|59000386|FG000|Overall Study|Participant Refused Study Medication|0|||
30952346|NCT00089583|59000387|FG001|Overall Study|Participant Refused Study Medication|2|||
30952347|NCT00089583|59000386|FG000|Overall Study|Non-Compliance|0|||
30952348|NCT00089583|59000387|FG001|Overall Study|Non-Compliance|4|||
30952349|NCT00089583|59000386|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
30952350|NCT00089583|59000387|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
30952351|NCT00089583|59000386|FG000|Overall Study|Participant Management Criteria Met|0|||
30952352|NCT00089583|59000387|FG001|Overall Study|Participant Management Criteria Met|1|||
30952353|NCT00089583|59000386|FG000|Overall Study|Reason Not Provided|0|||
30952354|NCT00089583|59000387|FG001|Overall Study|Reason Not Provided|1|||
30952355|NCT00089583|59000386|FG000|Overall Study|Protocol Violation|0|||
30952356|NCT00089583|59000387|FG001|Overall Study|Protocol Violation|3|||
30952357|NCT00089583|59000386|FG000|Overall Study|Principal Investigator Decision|0|||
30952358|NCT00089583|59000387|FG001|Overall Study|Principal Investigator Decision|10|||
30952359|NCT00089583|59000386|FG000|Overall Study|Start of Disallowed Medication|0|||
30952360|NCT00089583|59000387|FG001|Overall Study|Start of Disallowed Medication|1|||
30952361|NCT00089583|59000386|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
30952362|NCT00089583|59000387|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
30952363|NCT00089583|59000386|FG000|Overall Study|Participant Incarcerated|0|||
30952364|NCT00089583|59000387|FG001|Overall Study|Participant Incarcerated|1|||
30952365|NCT00088881|59000399|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
30952366|NCT00088881|59000399|FG000|Step 1 - R-CHOP|Adverse Event|1|||
30952367|NCT00088881|59000399|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
30952368|NCT00088881|59000399|FG000|Step 1 - R-CHOP|Physician Decision|1|||
30952369|NCT00088881|59000399|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
30952370|NCT00088881|59000399|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
30952371|NCT00088881|59000399|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
30952372|NCT00087555|59000447|FG000|Overall Study|Adverse Event|3|||
30654798|NCT03183128|58667670|FG000|Overall Study|Death|2|||
30654799|NCT03183128|58667671|FG001|Overall Study|Death|0|||
30654800|NCT03183128|58667670|FG000|Overall Study|Physician Decision|1|||
30654801|NCT03183128|58667671|FG001|Overall Study|Physician Decision|0|||
30768934|NCT03233230|58777938|FG001|Overall Study|Lost to Follow-up|3|||
30848792|NCT01376349|58875389|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
30952373|NCT00087555|59000448|FG001|Overall Study|Adverse Event|6|||
30952374|NCT00087555|59000449|FG002|Overall Study|Adverse Event|14|||
30952375|NCT00087555|59000447|FG000|Overall Study|Lost to Follow-up|0|||
30952376|NCT00087555|59000448|FG001|Overall Study|Lost to Follow-up|1|||
30654802|NCT02308488|58667713|FG000|Overall Study|Withdrawal by Subject|2|||
30654803|NCT02159950|58667719|FG000|Overall Study|Adverse Event|0|||
30654804|NCT02159950|58667720|FG001|Overall Study|Adverse Event|1|||
30952377|NCT00087555|59000449|FG002|Overall Study|Lost to Follow-up|1|||
30952378|NCT00087555|59000447|FG000|Overall Study|Non - Compliance|1|||
30952379|NCT00087555|59000448|FG001|Overall Study|Non - Compliance|0|||
30952380|NCT00087555|59000449|FG002|Overall Study|Non - Compliance|0|||
30654805|NCT02159950|58667719|FG000|Overall Study|Progression|0|||
30654806|NCT02159950|58667720|FG001|Overall Study|Progression|1|||
30654807|NCT02152137|58667726|FG000|Overall Study|Withdrawal by Subject|1|||
30654808|NCT02152137|58667726|FG000|Overall Study|Originally assigned to Arm B|3|||
30654809|NCT02007512|58667734|FG000|Double Blind Treatment Period|Adverse Event|4|||
30654810|NCT02007512|58667735|FG001|Double Blind Treatment Period|Adverse Event|2|||
30654811|NCT02007512|58667736|FG002|Double Blind Treatment Period|Adverse Event|6|||
30654812|NCT02007512|58667737|FG003|Double Blind Treatment Period|Adverse Event|2|||
30654813|NCT02007512|58667734|FG000|Double Blind Treatment Period|Death|1|||
30654814|NCT02007512|58667735|FG001|Double Blind Treatment Period|Death|0|||
30654815|NCT02007512|58667736|FG002|Double Blind Treatment Period|Death|0|||
30654816|NCT02007512|58667737|FG003|Double Blind Treatment Period|Death|0|||
30654817|NCT02007512|58667734|FG000|Double Blind Treatment Period|Disease progression|44|||
30654818|NCT02007512|58667735|FG001|Double Blind Treatment Period|Disease progression|49|||
30654819|NCT02007512|58667736|FG002|Double Blind Treatment Period|Disease progression|45|||
30654820|NCT02007512|58667737|FG003|Double Blind Treatment Period|Disease progression|51|||
30654821|NCT02007512|58667734|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
30654822|NCT02007512|58667735|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
30654823|NCT02007512|58667736|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
30654824|NCT02007512|58667737|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
30654825|NCT02007512|58667734|FG000|Double Blind Treatment Period|Protocol Violation|0|||
30654826|NCT02007512|58667735|FG001|Double Blind Treatment Period|Protocol Violation|0|||
30654827|NCT02007512|58667736|FG002|Double Blind Treatment Period|Protocol Violation|0|||
30654828|NCT02007512|58667737|FG003|Double Blind Treatment Period|Protocol Violation|1|||
30654829|NCT02007512|58667734|FG000|Double Blind Treatment Period|Other|0|||
30654830|NCT02007512|58667735|FG001|Double Blind Treatment Period|Other|0|||
30654831|NCT02007512|58667736|FG002|Double Blind Treatment Period|Other|1|||
30654832|NCT02007512|58667737|FG003|Double Blind Treatment Period|Other|2|||
30654833|NCT02007512|58667734|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
30654834|NCT02007512|58667735|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
30654835|NCT02007512|58667736|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
30654836|NCT02007512|58667737|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
30654837|NCT02007512|58667734|FG000|Open Label Treatment Period|Adverse Event|0|||
30654838|NCT02007512|58667735|FG001|Open Label Treatment Period|Adverse Event|1|||
30654839|NCT02007512|58667736|FG002|Open Label Treatment Period|Adverse Event|0|||
30654840|NCT02007512|58667737|FG003|Open Label Treatment Period|Adverse Event|0|||
30654841|NCT02007512|58667734|FG000|Open Label Treatment Period|Other|0|||
30654842|NCT02007512|58667735|FG001|Open Label Treatment Period|Other|0|||
30654843|NCT02007512|58667736|FG002|Open Label Treatment Period|Other|0|||
30654844|NCT02007512|58667737|FG003|Open Label Treatment Period|Other|1|||
30654845|NCT02007512|58667734|FG000|Open Label Treatment Period|Disease progression|0|||
30654846|NCT02007512|58667735|FG001|Open Label Treatment Period|Disease progression|17|||
30654847|NCT02007512|58667736|FG002|Open Label Treatment Period|Disease progression|0|||
30654848|NCT02007512|58667737|FG003|Open Label Treatment Period|Disease progression|11|||
30654849|NCT02007512|58667734|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
30654850|NCT02007512|58667735|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
30654851|NCT02007512|58667736|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
30654852|NCT02007512|58667737|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
30654853|NCT01942135|58667752|FG000|Overall Study|Adverse Event|9|||
30654854|NCT01942135|58667753|FG001|Overall Study|Adverse Event|3|||
30654855|NCT01942135|58667752|FG000|Overall Study|Global deterioration of health status|8|||
30654856|NCT01942135|58667753|FG001|Overall Study|Global deterioration of health status|3|||
30654857|NCT01942135|58667752|FG000|Overall Study|Randomized Not Treated|2|||
30654858|NCT01942135|58667753|FG001|Overall Study|Randomized Not Treated|2|||
30654859|NCT01942135|58667752|FG000|Overall Study|Death|0|||
30952381|NCT00087555|59000447|FG000|Overall Study|Protocol Violation|0|||
30952382|NCT00087555|59000448|FG001|Overall Study|Protocol Violation|0|||
30952383|NCT00087555|59000449|FG002|Overall Study|Protocol Violation|2|||
30952384|NCT00087555|59000447|FG000|Overall Study|Screen Failure|1|||
30952385|NCT00087555|59000448|FG001|Overall Study|Screen Failure|1|||
30952386|NCT00087555|59000449|FG002|Overall Study|Screen Failure|0|||
30654860|NCT01942135|58667753|FG001|Overall Study|Death|1|||
30654861|NCT01942135|58667752|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85|||
30654862|NCT01942135|58667753|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87|||
30952387|NCT00087555|59000447|FG000|Overall Study|Pregnancy|0|||
30952388|NCT00087555|59000448|FG001|Overall Study|Pregnancy|1|||
30952389|NCT00087555|59000449|FG002|Overall Study|Pregnancy|1|||
30952390|NCT00087555|59000447|FG000|Overall Study|Withdrawal by Subject|3|||
30654863|NCT01942135|58667752|FG000|Overall Study|Participant Refused toContinue Treatment|1|||
30654864|NCT01942135|58667753|FG001|Overall Study|Participant Refused toContinue Treatment|1|||
30654865|NCT01942135|58667752|FG000|Overall Study|Withdrawal by Subject|4|||
30654866|NCT01942135|58667753|FG001|Overall Study|Withdrawal by Subject|2|||
30654867|NCT01942135|58667752|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238|||
30654868|NCT01942135|58667753|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75|||
30654869|NCT01889238|58667759|FG000|Overall Study|Treatment ongoing|9|||
30654870|NCT01696968|58667782|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
30654871|NCT01696968|58667783|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
30654872|NCT01696968|58667782|FG000|Overall Study|Died Before Randomization|3|||
30654873|NCT01696968|58667783|FG001|Overall Study|Died Before Randomization|8|||
30654874|NCT01696968|58667782|FG000|Overall Study|Died Before ASU (Control)|278|||
30654875|NCT01696968|58667783|FG001|Overall Study|Died Before ASU (Control)|0|||
30654876|NCT01696968|58667782|FG000|Overall Study|Refused ASU (Control)|920|||
30654877|NCT01696968|58667783|FG001|Overall Study|Refused ASU (Control)|0|||
30654878|NCT01696968|58667782|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
30654879|NCT01696968|58667783|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
30768935|NCT03233230|58777939|FG002|Overall Study|Lost to Follow-up|0|||
30768936|NCT03233230|58777940|FG003|Overall Study|Lost to Follow-up|0|||
30768937|NCT00283049|58777953|FG000|Overall Study|Adverse Event|6|||
30768938|NCT00283049|58777954|FG001|Overall Study|Adverse Event|1|||
30768939|NCT00283049|58777955|FG002|Overall Study|Adverse Event|4|||
30768940|NCT00283049|58777953|FG000|Overall Study|Protocol Violation|3|||
30768941|NCT00283049|58777954|FG001|Overall Study|Protocol Violation|0|||
30768942|NCT00283049|58777955|FG002|Overall Study|Protocol Violation|3|||
30768943|NCT00283049|58777953|FG000|Overall Study|Death|1|||
30768944|NCT00283049|58777954|FG001|Overall Study|Death|1|||
30768945|NCT00283049|58777955|FG002|Overall Study|Death|1|||
30768946|NCT00283049|58777953|FG000|Overall Study|Lack of Efficacy|0|||
30768947|NCT00283049|58777954|FG001|Overall Study|Lack of Efficacy|1|||
30768948|NCT00283049|58777955|FG002|Overall Study|Lack of Efficacy|1|||
30768949|NCT00283049|58777953|FG000|Overall Study|Lost to Follow-up|4|||
30768950|NCT00283049|58777954|FG001|Overall Study|Lost to Follow-up|2|||
30768951|NCT00283049|58777955|FG002|Overall Study|Lost to Follow-up|5|||
30768952|NCT00283049|58777953|FG000|Overall Study|Withdrawal by Subject|26|||
30768953|NCT00283049|58777954|FG001|Overall Study|Withdrawal by Subject|24|||
30768954|NCT00283049|58777955|FG002|Overall Study|Withdrawal by Subject|19|||
30768955|NCT00283049|58777953|FG000|Overall Study|Discontinuation of Study|18|||
30768956|NCT00283049|58777954|FG001|Overall Study|Discontinuation of Study|16|||
30768957|NCT00283049|58777955|FG002|Overall Study|Discontinuation of Study|20|||
30768958|NCT00283049|58777953|FG000|Overall Study|No longer requires study treatment|0|||
30768959|NCT00283049|58777954|FG001|Overall Study|No longer requires study treatment|0|||
30768960|NCT00283049|58777955|FG002|Overall Study|No longer requires study treatment|1|||
30768961|NCT00264875|58777963|FG000|Overall Study|Adverse Event|6|||
30768962|NCT00264875|58777963|FG000|Overall Study|Lost to Follow-up|6|||
30768963|NCT00264875|58777963|FG000|Overall Study|Protocol Violation|11|||
30654880|NCT00978341|58667795|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
30654881|NCT00978341|58667796|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
30654882|NCT00978029|58667806|FG000|Overall Study|Adverse Event|1|||
30654883|NCT00978029|58667807|FG001|Overall Study|Adverse Event|2|||
30654884|NCT00978029|58667808|FG002|Overall Study|Adverse Event|5|||
30654885|NCT00978029|58667806|FG000|Overall Study|Withdrawal by Subject|0|||
30654886|NCT00978029|58667807|FG001|Overall Study|Withdrawal by Subject|0|||
30654887|NCT00978029|58667808|FG002|Overall Study|Withdrawal by Subject|1|||
30654888|NCT00978029|58667806|FG000|Overall Study|Protocol Violation|0|||
30654889|NCT00978029|58667807|FG001|Overall Study|Protocol Violation|1|||
30654890|NCT00978029|58667808|FG002|Overall Study|Protocol Violation|0|||
30654891|NCT00871377|58667816|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
30654892|NCT00871377|58667817|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
30654893|NCT00871377|58667818|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
30654894|NCT00871377|58667819|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
30654895|NCT00871377|58667820|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
30654896|NCT00871377|58667821|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
30654897|NCT00871377|58667816|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
30654898|NCT00871377|58667817|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
30654899|NCT00871377|58667818|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
30768964|NCT00264875|58777963|FG000|Overall Study|Withdrawal by Subject|7|||
30768965|NCT03152110|58777967|FG000|Overall Study|Withdrawal by Subject|3|||
30768966|NCT03151408|58777974|FG000|Overall Study|Adverse Event|24|||
30654900|NCT00871377|58667819|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
30654901|NCT00871377|58667820|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
30654902|NCT00871377|58667821|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
30768967|NCT03151408|58777975|FG001|Overall Study|Adverse Event|23|||
30768968|NCT03151408|58777974|FG000|Overall Study|Death|46|||
30768969|NCT03151408|58777975|FG001|Overall Study|Death|26|||
30654903|NCT00871377|58667816|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
30654904|NCT00871377|58667817|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
30654905|NCT00871377|58667818|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
30654906|NCT00871377|58667819|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
30654907|NCT00871377|58667820|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
30654908|NCT00871377|58667821|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
30654909|NCT00871377|58667816|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
30654910|NCT00871377|58667817|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
30654911|NCT00871377|58667818|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
30654912|NCT00871377|58667819|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
30654913|NCT00871377|58667820|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
30654914|NCT00871377|58667821|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
30654915|NCT00871377|58667816|FG000|Third Intervention (10 Weeks)|Death|0|||
30654916|NCT00871377|58667817|FG001|Third Intervention (10 Weeks)|Death|0|||
30654917|NCT00871377|58667818|FG002|Third Intervention (10 Weeks)|Death|0|||
30654918|NCT00871377|58667819|FG003|Third Intervention (10 Weeks)|Death|1|||
30654919|NCT00871377|58667820|FG004|Third Intervention (10 Weeks)|Death|0|||
30654920|NCT00871377|58667821|FG005|Third Intervention (10 Weeks)|Death|0|||
30654921|NCT00977561|58667831|FG000|Overall Study|Death|3|||
30654922|NCT00977561|58667832|FG001|Overall Study|Death|2|||
30654923|NCT00977561|58667831|FG000|Overall Study|Study terminated|0|||
30952391|NCT00087555|59000448|FG001|Overall Study|Withdrawal by Subject|2|||
30952392|NCT00087555|59000449|FG002|Overall Study|Withdrawal by Subject|1|||
30952393|NCT00087555|59000447|FG000|Overall Study|Lack of Efficacy|2|||
30952394|NCT00087555|59000448|FG001|Overall Study|Lack of Efficacy|0|||
30952395|NCT00087555|59000449|FG002|Overall Study|Lack of Efficacy|1|||
30952396|NCT00087555|59000447|FG000|Overall Study|Non Compliance|0|||
30654924|NCT00977561|58667832|FG001|Overall Study|Study terminated|2|||
30654925|NCT00977561|58667831|FG000|Overall Study|Other|2|||
30654926|NCT00977561|58667832|FG001|Overall Study|Other|0|||
30654927|NCT00594165|58667840|FG000|Overall Study|Major protocol violation|1|||
30654928|NCT00594165|58667840|FG000|Overall Study|Lack of Efficacy|12|||
30654929|NCT00594165|58667840|FG000|Overall Study|Adverse Event|52|||
30654930|NCT00594165|58667840|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
30654931|NCT00594165|58667840|FG000|Overall Study|Subject withdrew consent|27|||
30654932|NCT00594165|58667840|FG000|Overall Study|Study ended per sponsor|102|||
30654933|NCT00594165|58667840|FG000|Overall Study|Lost to Follow-up|4|||
30654934|NCT00594165|58667840|FG000|Overall Study|Other: PI discretion|5|||
30654935|NCT00594165|58667840|FG000|Overall Study|Other: Subject moving|3|||
30654936|NCT00594165|58667840|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
30654937|NCT00594165|58667840|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
30654938|NCT00594165|58667840|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
30654939|NCT00594165|58667840|FG000|Overall Study|Other: Site terminated participation|2|||
30654940|NCT00975923|58667846|FG000|Overall Study|Withdrawal by Subject|0|||
30654941|NCT00975923|58667847|FG001|Overall Study|Withdrawal by Subject|1|||
30768970|NCT03151408|58777974|FG000|Overall Study|Physician Decision|13|||
30768971|NCT03151408|58777975|FG001|Overall Study|Physician Decision|19|||
30768972|NCT03151408|58777974|FG000|Overall Study|Withdrawal by Subject|16|||
30654942|NCT00928070|58667856|FG000|Overall Study|Lost to Follow-up|1|||
30654943|NCT00928070|58667857|FG001|Overall Study|Lost to Follow-up|2|||
30952397|NCT00087555|59000448|FG001|Overall Study|Non Compliance|0|||
30654944|NCT00928070|58667856|FG000|Overall Study|Withdrawal by Subject|10|||
30768973|NCT03151408|58777975|FG001|Overall Study|Withdrawal by Subject|20|||
30952398|NCT00087555|59000449|FG002|Overall Study|Non Compliance|1|||
30654945|NCT00928070|58667857|FG001|Overall Study|Withdrawal by Subject|3|||
30654946|NCT00928070|58667856|FG000|Overall Study|Adverse Event|14|||
30654947|NCT00928070|58667857|FG001|Overall Study|Adverse Event|26|||
30654948|NCT00928070|58667856|FG000|Overall Study|Lack of Efficacy|9|||
30654949|NCT00928070|58667857|FG001|Overall Study|Lack of Efficacy|5|||
30654950|NCT00928070|58667856|FG000|Overall Study|Did not meet entrance criteria|16|||
30654951|NCT00928070|58667857|FG001|Overall Study|Did not meet entrance criteria|9|||
30654952|NCT00928070|58667856|FG000|Overall Study|Protocol Violation|6|||
30654953|NCT00928070|58667857|FG001|Overall Study|Protocol Violation|5|||
30654954|NCT00928070|58667856|FG000|Overall Study|Randomized but not treated|2|||
30654955|NCT00928070|58667857|FG001|Overall Study|Randomized but not treated|2|||
30654956|NCT00928070|58667856|FG000|Overall Study|Other|5|||
30654957|NCT00928070|58667857|FG001|Overall Study|Other|5|||
30654958|NCT00924404|58667865|FG000|Overall Study|Lost to Follow-up|6|||
30654959|NCT00924404|58667866|FG001|Overall Study|Lost to Follow-up|4|||
30654960|NCT00976937|58667874|FG000|Overall Study|Adverse Event|4|||
30654961|NCT00976937|58667875|FG001|Overall Study|Adverse Event|5|||
30654962|NCT00976937|58667874|FG000|Overall Study|Lost to Follow-up|2|||
30654963|NCT00976937|58667875|FG001|Overall Study|Lost to Follow-up|1|||
30654964|NCT00976937|58667874|FG000|Overall Study|Withdrawal by Subject|5|||
30654965|NCT00976937|58667875|FG001|Overall Study|Withdrawal by Subject|3|||
30654966|NCT00976937|58667874|FG000|Overall Study|Poor compliance to protocol|3|||
30654967|NCT00976937|58667875|FG001|Overall Study|Poor compliance to protocol|0|||
30654968|NCT00976937|58667874|FG000|Overall Study|Personal and Familial Reason|2|||
30654969|NCT00976937|58667875|FG001|Overall Study|Personal and Familial Reason|2|||
30654970|NCT00976703|58667883|FG000|Overall Study|Physician Decision|1|||
30654971|NCT00976703|58667884|FG001|Overall Study|Physician Decision|1|||
30654972|NCT00976703|58667883|FG000|Overall Study|ineligible for study|2|||
30654973|NCT00976703|58667884|FG001|Overall Study|ineligible for study|2|||
30654974|NCT00975689|58667892|FG000|Overall Study|Adverse Event|0|||
30654975|NCT00975689|58667893|FG001|Overall Study|Adverse Event|3|||
30654976|NCT00975689|58667892|FG000|Overall Study|Withdrawal by Subject|1|||
30654977|NCT00975689|58667893|FG001|Overall Study|Withdrawal by Subject|0|||
30654978|NCT00975689|58667892|FG000|Overall Study|Physician Decision|1|||
30654979|NCT00975689|58667893|FG001|Overall Study|Physician Decision|0|||
30654980|NCT00922766|58667899|FG000|Overall Study|Death|3|||
30654981|NCT00922766|58667899|FG000|Overall Study|Withdrawal by Subject|2|||
30654982|NCT00922766|58667899|FG000|Overall Study|Other|1|||
30654983|NCT00922766|58667899|FG000|Overall Study|Adverse Event|1|||
30654984|NCT00917852|58667903|FG000|Overall Study|Death|6|||
30654985|NCT00976391|58667910|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
30654986|NCT00976391|58667911|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
30654987|NCT00976391|58667910|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
30654988|NCT00976391|58667911|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
30654989|NCT00976391|58667910|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
30654990|NCT00976391|58667911|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
30654991|NCT00976391|58667910|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
30654992|NCT00976391|58667911|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
30654993|NCT00976391|58667910|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
30654994|NCT00976391|58667911|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
30654995|NCT00976391|58667910|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
30654996|NCT00976391|58667911|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
30654997|NCT00976391|58667910|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
30654998|NCT00976391|58667911|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
30654999|NCT00976391|58667910|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
30655000|NCT00976391|58667911|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
30655001|NCT00976391|58667910|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
30655002|NCT00976391|58667911|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
30655003|NCT00976391|58667910|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
30655004|NCT00976391|58667911|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
30655005|NCT00976391|58667910|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
30655006|NCT00976391|58667911|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
30655007|NCT00976391|58667910|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
30655008|NCT00976391|58667911|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
30655009|NCT00976391|58667910|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
30655010|NCT00976391|58667911|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
30655011|NCT00976391|58667910|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
30655012|NCT00976391|58667911|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
30655013|NCT00917462|58667917|FG000|Overall Study|Clinical Deterioration|1|||
30655014|NCT00979901|58667925|FG000|Overall Study|Adverse Event|1|||
30655015|NCT00979901|58667926|FG001|Overall Study|Adverse Event|3|||
30655016|NCT00979901|58667927|FG002|Overall Study|Adverse Event|9|||
30655017|NCT00979901|58667928|FG003|Overall Study|Adverse Event|2|||
30655018|NCT00979901|58667925|FG000|Overall Study|Lack of Efficacy|8|||
30655019|NCT00979901|58667926|FG001|Overall Study|Lack of Efficacy|4|||
30655020|NCT00979901|58667927|FG002|Overall Study|Lack of Efficacy|9|||
30655021|NCT00979901|58667928|FG003|Overall Study|Lack of Efficacy|0|||
30655022|NCT00979901|58667925|FG000|Overall Study|Lost to Follow-up|1|||
30655023|NCT00979901|58667926|FG001|Overall Study|Lost to Follow-up|1|||
30655024|NCT00979901|58667927|FG002|Overall Study|Lost to Follow-up|2|||
30655025|NCT00979901|58667928|FG003|Overall Study|Lost to Follow-up|0|||
30655026|NCT00979901|58667925|FG000|Overall Study|Protocol Violation|2|||
30655027|NCT00979901|58667926|FG001|Overall Study|Protocol Violation|2|||
30655028|NCT00979901|58667927|FG002|Overall Study|Protocol Violation|7|||
30655029|NCT00979901|58667928|FG003|Overall Study|Protocol Violation|1|||
30655030|NCT00979901|58667925|FG000|Overall Study|Withdrawal by Subject|2|||
30655031|NCT00979901|58667926|FG001|Overall Study|Withdrawal by Subject|1|||
30655032|NCT00979901|58667927|FG002|Overall Study|Withdrawal by Subject|1|||
30655033|NCT00979901|58667928|FG003|Overall Study|Withdrawal by Subject|1|||
30655034|NCT00979901|58667925|FG000|Overall Study|Noncompliance|1|||
30655035|NCT00979901|58667926|FG001|Overall Study|Noncompliance|0|||
30655036|NCT00979901|58667927|FG002|Overall Study|Noncompliance|0|||
30655037|NCT00979901|58667928|FG003|Overall Study|Noncompliance|0|||
30655038|NCT00979901|58667925|FG000|Overall Study|out-of-state|1|||
30655039|NCT00979901|58667926|FG001|Overall Study|out-of-state|0|||
30655040|NCT00979901|58667927|FG002|Overall Study|out-of-state|0|||
30655041|NCT00979901|58667928|FG003|Overall Study|out-of-state|0|||
30655042|NCT00979901|58667925|FG000|Overall Study|vacation|1|||
30655043|NCT00979901|58667926|FG001|Overall Study|vacation|0|||
30655044|NCT00979901|58667927|FG002|Overall Study|vacation|0|||
30655045|NCT00979901|58667928|FG003|Overall Study|vacation|0|||
30655046|NCT00979901|58667925|FG000|Overall Study|elevated lab values pre-randomization|1|||
30655047|NCT00979901|58667926|FG001|Overall Study|elevated lab values pre-randomization|0|||
30655048|NCT00979901|58667927|FG002|Overall Study|elevated lab values pre-randomization|0|||
30655049|NCT00979901|58667928|FG003|Overall Study|elevated lab values pre-randomization|0|||
30655050|NCT00979901|58667925|FG000|Overall Study|Discontinued in Error|0|||
30655051|NCT00979901|58667926|FG001|Overall Study|Discontinued in Error|1|||
30655052|NCT00979901|58667927|FG002|Overall Study|Discontinued in Error|0|||
30655053|NCT00979901|58667928|FG003|Overall Study|Discontinued in Error|0|||
30655054|NCT00979901|58667925|FG000|Overall Study|Left Country|0|||
30655055|NCT00979901|58667926|FG001|Overall Study|Left Country|0|||
30655056|NCT00979901|58667927|FG002|Overall Study|Left Country|1|||
30655057|NCT00979901|58667928|FG003|Overall Study|Left Country|0|||
30655058|NCT00979901|58667925|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
30655059|NCT00979901|58667926|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
30655060|NCT00979901|58667927|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
30655061|NCT00979901|58667928|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
30655062|NCT00975611|58667937|FG000|Overall Study|Screen Fail|16|||
30655063|NCT00975611|58667937|FG000|Overall Study|Physician Decision|1|||
30655064|NCT00970307|58667944|FG000|Overall Study|Serious Adverse Event|1|||
30655065|NCT00970307|58667945|FG001|Overall Study|Serious Adverse Event|0|||
30655066|NCT00970307|58667946|FG002|Overall Study|Serious Adverse Event|0|||
30655067|NCT00970307|58667944|FG000|Overall Study|Withdrawal by Subject|2|||
30655068|NCT00970307|58667945|FG001|Overall Study|Withdrawal by Subject|3|||
30655069|NCT00970307|58667946|FG002|Overall Study|Withdrawal by Subject|2|||
30655070|NCT00917384|58667956|FG000|Overall Study|Lost to Follow-up|4|||
30655071|NCT00917384|58667957|FG001|Overall Study|Lost to Follow-up|2|||
30655072|NCT00917384|58667956|FG000|Overall Study|Withdrawal by Subject|10|||
30655073|NCT00917384|58667957|FG001|Overall Study|Withdrawal by Subject|2|||
30655074|NCT00864513|58667963|FG000|Overall Study|Withdrawal by Subject|3|||
30655075|NCT00917150|58667971|FG000|Overall Study|Adverse Event|12|||
30655076|NCT00917150|58667972|FG001|Overall Study|Adverse Event|7|||
30655077|NCT00917150|58667973|FG002|Overall Study|Adverse Event|12|||
30655078|NCT00917150|58667974|FG003|Overall Study|Adverse Event|11|||
30655079|NCT00917150|58667971|FG000|Overall Study|Death|1|||
30655080|NCT00917150|58667972|FG001|Overall Study|Death|4|||
30655081|NCT00917150|58667973|FG002|Overall Study|Death|3|||
30655082|NCT00917150|58667974|FG003|Overall Study|Death|2|||
30655083|NCT00917150|58667971|FG000|Overall Study|Lost to Follow-up|1|||
30655084|NCT00917150|58667972|FG001|Overall Study|Lost to Follow-up|0|||
30655085|NCT00917150|58667973|FG002|Overall Study|Lost to Follow-up|4|||
30655086|NCT00917150|58667974|FG003|Overall Study|Lost to Follow-up|2|||
30655087|NCT00917150|58667971|FG000|Overall Study|Physician Decision|0|||
30655088|NCT00917150|58667972|FG001|Overall Study|Physician Decision|2|||
30655089|NCT00917150|58667973|FG002|Overall Study|Physician Decision|0|||
30655090|NCT00917150|58667974|FG003|Overall Study|Physician Decision|1|||
30655091|NCT00917150|58667971|FG000|Overall Study|Protocol Violation|5|||
30655092|NCT00917150|58667972|FG001|Overall Study|Protocol Violation|5|||
30655093|NCT00917150|58667973|FG002|Overall Study|Protocol Violation|3|||
30655094|NCT00917150|58667974|FG003|Overall Study|Protocol Violation|5|||
30655095|NCT00917150|58667971|FG000|Overall Study|Withdrawal by Subject|15|||
30655096|NCT00917150|58667972|FG001|Overall Study|Withdrawal by Subject|16|||
30655097|NCT00917150|58667973|FG002|Overall Study|Withdrawal by Subject|18|||
30655098|NCT00917150|58667974|FG003|Overall Study|Withdrawal by Subject|11|||
30655099|NCT00917150|58667971|FG000|Overall Study|Other than specified|3|||
30655100|NCT00917150|58667972|FG001|Overall Study|Other than specified|3|||
30655101|NCT00917150|58667973|FG002|Overall Study|Other than specified|2|||
30655102|NCT00917150|58667974|FG003|Overall Study|Other than specified|2|||
30655103|NCT00659425|58667994|FG000|Overall Study|Disease progression|1|||
30655104|NCT00659425|58667995|FG001|Overall Study|Disease progression|0|||
30655105|NCT00659425|58667996|FG002|Overall Study|Disease progression|0|||
30655106|NCT00659425|58667997|FG003|Overall Study|Disease progression|1|||
30655107|NCT00659425|58667998|FG004|Overall Study|Disease progression|0|||
30655108|NCT00659425|58667999|FG005|Overall Study|Disease progression|2|||
30655109|NCT00659425|58668000|FG006|Overall Study|Disease progression|4|||
30655110|NCT00659425|58668001|FG007|Overall Study|Disease progression|3|||
30655111|NCT00659425|58668002|FG008|Overall Study|Disease progression|5|||
30655112|NCT00659425|58668003|FG009|Overall Study|Disease progression|3|||
30655113|NCT00659425|58667994|FG000|Overall Study|Death|0|||
30655114|NCT00659425|58667995|FG001|Overall Study|Death|0|||
30655115|NCT00659425|58667996|FG002|Overall Study|Death|0|||
30655116|NCT00659425|58667997|FG003|Overall Study|Death|1|||
30655117|NCT00659425|58667998|FG004|Overall Study|Death|0|||
30655118|NCT00659425|58667999|FG005|Overall Study|Death|0|||
30655119|NCT00659425|58668000|FG006|Overall Study|Death|1|||
30655120|NCT00659425|58668001|FG007|Overall Study|Death|0|||
30655121|NCT00659425|58668002|FG008|Overall Study|Death|0|||
30655122|NCT00659425|58668003|FG009|Overall Study|Death|0|||
30655123|NCT00659425|58667994|FG000|Overall Study|Adverse Event|0|||
30655124|NCT00659425|58667995|FG001|Overall Study|Adverse Event|0|||
30655125|NCT00659425|58667996|FG002|Overall Study|Adverse Event|0|||
30655126|NCT00659425|58667997|FG003|Overall Study|Adverse Event|0|||
30655127|NCT00659425|58667998|FG004|Overall Study|Adverse Event|0|||
30655128|NCT00659425|58667999|FG005|Overall Study|Adverse Event|1|||
30655129|NCT00659425|58668000|FG006|Overall Study|Adverse Event|0|||
30655130|NCT00659425|58668001|FG007|Overall Study|Adverse Event|3|||
30655131|NCT00659425|58668002|FG008|Overall Study|Adverse Event|1|||
30655132|NCT00659425|58668003|FG009|Overall Study|Adverse Event|4|||
30655133|NCT00659425|58667994|FG000|Overall Study|Investigator Discretion|0|||
30655134|NCT00659425|58667995|FG001|Overall Study|Investigator Discretion|0|||
30655135|NCT00659425|58667996|FG002|Overall Study|Investigator Discretion|0|||
30655136|NCT00659425|58667997|FG003|Overall Study|Investigator Discretion|0|||
30655137|NCT00659425|58667998|FG004|Overall Study|Investigator Discretion|0|||
30655138|NCT00659425|58667999|FG005|Overall Study|Investigator Discretion|1|||
30655139|NCT00659425|58668000|FG006|Overall Study|Investigator Discretion|0|||
30655140|NCT00659425|58668001|FG007|Overall Study|Investigator Discretion|3|||
30655141|NCT00659425|58668002|FG008|Overall Study|Investigator Discretion|0|||
30655142|NCT00659425|58668003|FG009|Overall Study|Investigator Discretion|0|||
30655143|NCT00659425|58667994|FG000|Overall Study|Other|0|||
30655144|NCT00659425|58667995|FG001|Overall Study|Other|1|||
30655145|NCT00659425|58667996|FG002|Overall Study|Other|1|||
30655146|NCT00659425|58667997|FG003|Overall Study|Other|2|||
30655147|NCT00659425|58667998|FG004|Overall Study|Other|4|||
30655148|NCT00659425|58667999|FG005|Overall Study|Other|0|||
30655149|NCT00659425|58668000|FG006|Overall Study|Other|3|||
30952399|NCT00087555|59000447|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
30952400|NCT00087555|59000448|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
30952401|NCT00087555|59000449|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
30952402|NCT00087555|59000447|FG000|Overall Study|Patient wanted to go back on Med|1|||
30952403|NCT00087555|59000448|FG001|Overall Study|Patient wanted to go back on Med|0|||
30952404|NCT00087555|59000449|FG002|Overall Study|Patient wanted to go back on Med|0|||
30952405|NCT00086619|59000472|FG000|Overall Study|Withdrawal by Subject|6|||
30952406|NCT00086619|59000473|FG001|Overall Study|Withdrawal by Subject|6|||
30952407|NCT00086619|59000472|FG000|Overall Study|Adverse Event|8|||
30952408|NCT00086619|59000473|FG001|Overall Study|Adverse Event|10|||
30952409|NCT00086619|59000472|FG000|Overall Study|Protocol Violation|1|||
30952410|NCT00086619|59000473|FG001|Overall Study|Protocol Violation|1|||
30655150|NCT00659425|58668001|FG007|Overall Study|Other|2|||
30655151|NCT00659425|58668002|FG008|Overall Study|Other|0|||
30655152|NCT00659425|58668003|FG009|Overall Study|Other|6|||
30655153|NCT00656851|58668040|FG000|Overall Study|Withdrawal by Subject|0|||
30655154|NCT00656851|58668041|FG001|Overall Study|Withdrawal by Subject|4|||
30655155|NCT00656617|58668047|FG000|Overall Study|Adverse Event|1|||
30655156|NCT00656617|58668047|FG000|Overall Study|Death|2|||
30655157|NCT00656617|58668047|FG000|Overall Study|Insurance Issues|2|||
30655158|NCT00656617|58668047|FG000|Overall Study|Move to different clinical trial|2|||
30655159|NCT00659269|58668054|FG000|Overall Study|Physician Decision|1|||
30655160|NCT00659269|58668055|FG001|Overall Study|Physician Decision|1|||
30655161|NCT00658333|58668072|FG000|Overall Study|Adverse Event|2|||
30655162|NCT00658333|58668073|FG001|Overall Study|Adverse Event|1|||
30655163|NCT00658879|58668079|FG000|Overall Study|Protocol Violation|1|||
30768974|NCT03151408|58777974|FG000|Overall Study|Progressive disease|45|||
30768975|NCT03151408|58777975|FG001|Overall Study|Progressive disease|61|||
30768976|NCT03151408|58777974|FG000|Overall Study|non-compliance by patient|1|||
30768977|NCT03151408|58777975|FG001|Overall Study|non-compliance by patient|0|||
30768978|NCT03151408|58777974|FG000|Overall Study|other reasons|56|||
30768979|NCT03151408|58777975|FG001|Overall Study|other reasons|52|||
30768980|NCT03151408|58777974|FG000|Overall Study|randomized and not treated|2|||
30768981|NCT03151408|58777975|FG001|Overall Study|randomized and not treated|2|||
30768982|NCT00546754|58777983|FG000|Overall Study|Serious Adverse Event|1|||
30768983|NCT00546754|58777984|FG001|Overall Study|Serious Adverse Event|1|||
30768984|NCT00546754|58777983|FG000|Overall Study|Adverse Event|11|||
30768985|NCT00546754|58777984|FG001|Overall Study|Adverse Event|16|||
30768986|NCT00546754|58777983|FG000|Overall Study|Lack of Efficacy|1|||
30768987|NCT00546754|58777984|FG001|Overall Study|Lack of Efficacy|1|||
30768988|NCT00546754|58777983|FG000|Overall Study|Lost to Follow-up|9|||
30768989|NCT00546754|58777984|FG001|Overall Study|Lost to Follow-up|15|||
30768990|NCT00546754|58777983|FG000|Overall Study|Protocol Violation|3|||
30768991|NCT00546754|58777984|FG001|Overall Study|Protocol Violation|0|||
30768992|NCT00546754|58777983|FG000|Overall Study|Withdrawal by Subject|6|||
30768993|NCT00546754|58777984|FG001|Overall Study|Withdrawal by Subject|7|||
30768994|NCT00546754|58777983|FG000|Overall Study|Dyspnea|1|||
30768995|NCT00546754|58777984|FG001|Overall Study|Dyspnea|0|||
30768996|NCT00546754|58777983|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
30768997|NCT00546754|58777984|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
30768998|NCT00546754|58777983|FG000|Overall Study|Hip Replacement|1|||
30768999|NCT00546754|58777984|FG001|Overall Study|Hip Replacement|0|||
30769000|NCT00546754|58777983|FG000|Overall Study|Suicide|1|||
30769001|NCT00546754|58777984|FG001|Overall Study|Suicide|0|||
30769002|NCT00546754|58777983|FG000|Overall Study|Missing Cooperation|1|||
30769003|NCT00546754|58777984|FG001|Overall Study|Missing Cooperation|0|||
30769004|NCT00546754|58777983|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
30769005|NCT00546754|58777984|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
30769006|NCT00546754|58777983|FG000|Overall Study|Patient's Decision|0|||
30655164|NCT00570037|58668085|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
30769007|NCT00546754|58777984|FG001|Overall Study|Patient's Decision|1|||
30769008|NCT00546754|58777983|FG000|Overall Study|Missing|14|||
30769009|NCT00546754|58777984|FG001|Overall Study|Missing|7|||
30769010|NCT00282347|58777992|FG000|Treatment Period|Death|2|||
30769011|NCT00282347|58777993|FG001|Treatment Period|Death|0|||
30769012|NCT00282347|58777992|FG000|Treatment Period|Lost to Follow-up|2|||
30952411|NCT00085917|59000486|FG000|Overall Study|Adverse Event|4|||
30952412|NCT00085917|59000487|FG001|Overall Study|Adverse Event|3|||
30952413|NCT00084747|59000493|FG000|Overall Study|Relapsed|8|||
30952414|NCT00084747|59000493|FG000|Overall Study|Death|3|||
30952415|NCT00084747|59000493|FG000|Overall Study|Withdrawal by Subject|2|||
30769013|NCT00282347|58777993|FG001|Treatment Period|Lost to Follow-up|5|||
30769014|NCT00282347|58777992|FG000|Treatment Period|Withdrawal by Subject|1|||
30769015|NCT00282347|58777993|FG001|Treatment Period|Withdrawal by Subject|3|||
30769016|NCT00282347|58777992|FG000|Treatment Period|Physician Decision|0|||
30769017|NCT00282347|58777993|FG001|Treatment Period|Physician Decision|1|||
30769018|NCT00282347|58777992|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
30952416|NCT00081159|59000528|FG000|Overall Study|Withdrawal by Subject|0|||
30655165|NCT00570037|58668086|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
30655166|NCT00863655|58668094|FG000|Overall Study|Protocol Violation|4|||
30655167|NCT00863655|58668095|FG001|Overall Study|Protocol Violation|0|||
30655168|NCT00863655|58668094|FG000|Overall Study|Adverse Event|52|||
30655169|NCT00863655|58668095|FG001|Overall Study|Adverse Event|8|||
30655170|NCT00863655|58668094|FG000|Overall Study|Withdrawal by Subject|47|||
30655171|NCT00863655|58668095|FG001|Overall Study|Withdrawal by Subject|7|||
30655172|NCT00863655|58668094|FG000|Overall Study|Administrative problems|1|||
30655173|NCT00863655|58668095|FG001|Overall Study|Administrative problems|0|||
30655174|NCT00863655|58668094|FG000|Overall Study|Death|7|||
30655175|NCT00863655|58668095|FG001|Overall Study|Death|1|||
30655176|NCT00863655|58668094|FG000|Overall Study|New cancer therapy|5|||
30655177|NCT00863655|58668095|FG001|Overall Study|New cancer therapy|1|||
30655178|NCT00863655|58668094|FG000|Overall Study|Disease progression|364|||
30655179|NCT00863655|58668095|FG001|Overall Study|Disease progression|221|||
30655180|NCT00863655|58668094|FG000|Overall Study|Treatment completed as per protocol|5|||
30655181|NCT00863655|58668095|FG001|Overall Study|Treatment completed as per protocol|1|||
30655182|NCT00658723|58668103|FG000|Overall Study|Lost to Follow-up|0|||
30655183|NCT00658723|58668104|FG001|Overall Study|Lost to Follow-up|2|||
30655184|NCT00658723|58668105|FG002|Overall Study|Lost to Follow-up|2|||
30655185|NCT00658723|58668103|FG000|Overall Study|Death|2|||
30655186|NCT00658723|58668104|FG001|Overall Study|Death|1|||
30655187|NCT00658723|58668105|FG002|Overall Study|Death|4|||
30655188|NCT00658723|58668103|FG000|Overall Study|Scheduling Issue|1|||
30655189|NCT00658723|58668104|FG001|Overall Study|Scheduling Issue|1|||
30655190|NCT00658723|58668105|FG002|Overall Study|Scheduling Issue|0|||
30655191|NCT00658723|58668103|FG000|Overall Study|Withdrawal by Subject|1|||
30655192|NCT00658723|58668104|FG001|Overall Study|Withdrawal by Subject|0|||
30655193|NCT00658723|58668105|FG002|Overall Study|Withdrawal by Subject|1|||
30655194|NCT00593385|58668116|FG000|Overall Study|Death|14|||
30655195|NCT00593385|58668116|FG000|Overall Study|Lost to Follow-up|17|||
30655196|NCT00593385|58668116|FG000|Overall Study|Withdrawal by Subject|9|||
30655197|NCT00658021|58668125|FG000|28-Week Treatment Period|Adverse Event|3|||
30655198|NCT00658021|58668126|FG001|28-Week Treatment Period|Adverse Event|1|||
30655199|NCT00658021|58668127|FG002|28-Week Treatment Period|Adverse Event|0|||
30655200|NCT00658021|58668125|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
30655201|NCT00658021|58668126|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
30655202|NCT00658021|58668127|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
30655203|NCT00658021|58668125|FG000|28-Week Treatment Period|Protocol Violation|0|||
30655204|NCT00658021|58668126|FG001|28-Week Treatment Period|Protocol Violation|2|||
30655205|NCT00658021|58668127|FG002|28-Week Treatment Period|Protocol Violation|1|||
30655206|NCT00658021|58668125|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
30655207|NCT00658021|58668126|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
30655208|NCT00658021|58668127|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
30655209|NCT00658021|58668125|FG000|28-Week Treatment Period|Physician Decision|1|||
30655210|NCT00658021|58668126|FG001|28-Week Treatment Period|Physician Decision|2|||
30655211|NCT00658021|58668127|FG002|28-Week Treatment Period|Physician Decision|1|||
30655212|NCT00658021|58668125|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
30655213|NCT00658021|58668126|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
30655214|NCT00658021|58668127|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
30655215|NCT00658021|58668125|FG000|28-Week Treatment Period|Loss of glucose control|1|||
30655216|NCT00658021|58668126|FG001|28-Week Treatment Period|Loss of glucose control|1|||
30655217|NCT00658021|58668127|FG002|28-Week Treatment Period|Loss of glucose control|10|||
30655218|NCT00658021|58668125|FG000|28-Week Treatment Period|Other|2|||
30655219|NCT00658021|58668126|FG001|28-Week Treatment Period|Other|3|||
30655220|NCT00658021|58668127|FG002|28-Week Treatment Period|Other|1|||
30655221|NCT00658021|58668125|FG000|28-Week Treatment Period|Did not receive treatment|2|||
30655222|NCT00658021|58668126|FG001|28-Week Treatment Period|Did not receive treatment|0|||
30655223|NCT00658021|58668127|FG002|28-Week Treatment Period|Did not receive treatment|0|||
30655224|NCT00658021|58668125|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
30655225|NCT00658021|58668126|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
30655226|NCT00658021|58668127|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
30655227|NCT00658021|58668125|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
30655228|NCT00658021|58668126|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
30655229|NCT00658021|58668127|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
30655230|NCT00920816|58668141|FG000|Overall Study|Death|116|||
30655231|NCT00920816|58668142|FG001|Overall Study|Death|63|||
30655232|NCT00920816|58668143|FG002|Overall Study|Death|8|||
30655233|NCT00920816|58668144|FG003|Overall Study|Death|3|||
30655234|NCT00920816|58668141|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
30655235|NCT00920816|58668142|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
30655236|NCT00920816|58668143|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
30769019|NCT00282347|58777993|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
30655237|NCT00920816|58668144|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
30655238|NCT00920816|58668141|FG000|Overall Study|Global deterioration of health status|2|||
30655239|NCT00920816|58668142|FG001|Overall Study|Global deterioration of health status|0|||
30655240|NCT00920816|58668143|FG002|Overall Study|Global deterioration of health status|0|||
30655241|NCT00920816|58668144|FG003|Overall Study|Global deterioration of health status|0|||
30655242|NCT00920816|58668141|FG000|Overall Study|Objective progression or relapse|6|||
30655243|NCT00920816|58668142|FG001|Overall Study|Objective progression or relapse|2|||
30655244|NCT00920816|58668143|FG002|Overall Study|Objective progression or relapse|0|||
30655245|NCT00920816|58668144|FG003|Overall Study|Objective progression or relapse|0|||
30655246|NCT00920816|58668141|FG000|Overall Study|Other|26|||
30655247|NCT00920816|58668142|FG001|Overall Study|Other|15|||
30655248|NCT00920816|58668143|FG002|Overall Study|Other|1|||
30655249|NCT00920816|58668144|FG003|Overall Study|Other|2|||
30655250|NCT00920816|58668141|FG000|Overall Study|Lost to Follow-up|11|||
30655251|NCT00920816|58668142|FG001|Overall Study|Lost to Follow-up|2|||
30655252|NCT00920816|58668143|FG002|Overall Study|Lost to Follow-up|0|||
30655253|NCT00920816|58668144|FG003|Overall Study|Lost to Follow-up|0|||
30655254|NCT00920816|58668141|FG000|Overall Study|Adverse Event|1|||
30655255|NCT00920816|58668142|FG001|Overall Study|Adverse Event|1|||
30655256|NCT00920816|58668143|FG002|Overall Study|Adverse Event|1|||
30655257|NCT00920816|58668144|FG003|Overall Study|Adverse Event|0|||
30655258|NCT00920816|58668141|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
30655259|NCT00920816|58668142|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
30655260|NCT00920816|58668143|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
30655261|NCT00920816|58668144|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
30655262|NCT00920816|58668141|FG000|Overall Study|Randomized but not treated|3|||
30655263|NCT00920816|58668142|FG001|Overall Study|Randomized but not treated|0|||
30655264|NCT00920816|58668143|FG002|Overall Study|Randomized but not treated|0|||
30655265|NCT00920816|58668144|FG003|Overall Study|Randomized but not treated|0|||
30655266|NCT00657709|58668159|FG000|Overall Study|AE or Death|7|||
30655267|NCT00657709|58668160|FG001|Overall Study|AE or Death|7|||
30655268|NCT00657709|58668161|FG002|Overall Study|AE or Death|6|||
30655269|NCT00657709|58668162|FG003|Overall Study|AE or Death|7|||
30655270|NCT00657709|58668163|FG004|Overall Study|AE or Death|1|||
30655271|NCT00657709|58668159|FG000|Overall Study|Withdrawal by Subject|7|||
30655272|NCT00657709|58668160|FG001|Overall Study|Withdrawal by Subject|15|||
30655273|NCT00657709|58668161|FG002|Overall Study|Withdrawal by Subject|15|||
30655274|NCT00657709|58668162|FG003|Overall Study|Withdrawal by Subject|5|||
30655275|NCT00657709|58668163|FG004|Overall Study|Withdrawal by Subject|9|||
30769020|NCT00282347|58777992|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
30769021|NCT00282347|58777993|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
30769022|NCT00282347|58777992|FG000|Safety Follow-up Period|Physician Decision|1|||
30769023|NCT00282347|58777993|FG001|Safety Follow-up Period|Physician Decision|1|||
30769024|NCT00282347|58777992|FG000|Safety Follow-up Period|Protocol Deviation|0|||
30769025|NCT00282347|58777993|FG001|Safety Follow-up Period|Protocol Deviation|2|||
30769026|NCT00282347|58777992|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
30769027|NCT00282347|58777993|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
30769028|NCT00282347|58777992|FG000|B Cell Follow-up Period|Physician Decision|1|||
30769029|NCT00282347|58777993|FG001|B Cell Follow-up Period|Physician Decision|0|||
30769030|NCT00282347|58777992|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
30769031|NCT00282347|58777993|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
30769032|NCT00405964|58778003|FG000|Overall Study|Treatment Failure|17|||
30655276|NCT00657709|58668159|FG000|Overall Study|Lost to Follow-up|9|||
30655277|NCT00657709|58668160|FG001|Overall Study|Lost to Follow-up|9|||
30769033|NCT00405964|58778004|FG001|Overall Study|Treatment Failure|45|||
30769034|NCT00405964|58778003|FG000|Overall Study|Adverse Event|7|||
30769035|NCT00405964|58778004|FG001|Overall Study|Adverse Event|16|||
30655278|NCT00657709|58668161|FG002|Overall Study|Lost to Follow-up|7|||
30655279|NCT00657709|58668162|FG003|Overall Study|Lost to Follow-up|1|||
30655280|NCT00657709|58668163|FG004|Overall Study|Lost to Follow-up|21|||
30655281|NCT00657709|58668159|FG000|Overall Study|Protocol Violation|0|||
30655282|NCT00657709|58668160|FG001|Overall Study|Protocol Violation|2|||
30655283|NCT00657709|58668161|FG002|Overall Study|Protocol Violation|0|||
30655284|NCT00657709|58668162|FG003|Overall Study|Protocol Violation|1|||
30655285|NCT00657709|58668163|FG004|Overall Study|Protocol Violation|2|||
30655286|NCT00915356|58668190|FG000|Overall Study|Withdrawal by Subject|1|||
30655287|NCT00915356|58668191|FG001|Overall Study|Withdrawal by Subject|0|||
30655288|NCT00915356|58668192|FG002|Overall Study|Withdrawal by Subject|0|||
30655289|NCT00915356|58668193|FG003|Overall Study|Withdrawal by Subject|0|||
30655290|NCT00915356|58668194|FG004|Overall Study|Withdrawal by Subject|0|||
30655291|NCT00657553|58668208|FG000|Overall Study|low accrual, no analysis run|5|||
30655292|NCT00657553|58668209|FG001|Overall Study|low accrual, no analysis run|5|||
30655293|NCT00862719|58668219|FG000|Overall Study|Disease Progression|5|||
30655294|NCT00862719|58668220|FG001|Overall Study|Disease Progression|0|||
30655295|NCT00862719|58668221|FG002|Overall Study|Disease Progression|1|||
30655296|NCT00862719|58668222|FG003|Overall Study|Disease Progression|0|||
30655297|NCT00862719|58668219|FG000|Overall Study|Death|5|||
30655298|NCT00862719|58668220|FG001|Overall Study|Death|6|||
30655299|NCT00862719|58668221|FG002|Overall Study|Death|1|||
30655300|NCT00862719|58668222|FG003|Overall Study|Death|1|||
30655301|NCT00862719|58668219|FG000|Overall Study|Engraftment failure|0|||
30655302|NCT00862719|58668220|FG001|Overall Study|Engraftment failure|0|||
30655303|NCT00862719|58668221|FG002|Overall Study|Engraftment failure|1|||
30655304|NCT00862719|58668222|FG003|Overall Study|Engraftment failure|0|||
30655305|NCT00862719|58668219|FG000|Overall Study|Veno-Occlusive Disease|0|||
30655306|NCT00862719|58668220|FG001|Overall Study|Veno-Occlusive Disease|0|||
30655307|NCT00862719|58668221|FG002|Overall Study|Veno-Occlusive Disease|1|||
30655308|NCT00862719|58668222|FG003|Overall Study|Veno-Occlusive Disease|0|||
30655309|NCT00862641|58668236|FG000|Overall Study|Randomized, but drug not received|1|||
30655310|NCT00862641|58668237|FG001|Overall Study|Randomized, but drug not received|4|||
30655311|NCT00862641|58668238|FG002|Overall Study|Randomized, but drug not received|1|||
30655312|NCT00862641|58668239|FG003|Overall Study|Randomized, but drug not received|4|||
30655313|NCT00861471|58668249|FG000|Overall Study|Withdrawal by Subject|1|||
30655314|NCT00861471|58668249|FG000|Overall Study|Adverse Event|2|||
30655315|NCT00861471|58668249|FG000|Overall Study|Lack of Efficacy|3|||
30655316|NCT00861471|58668249|FG000|Overall Study|treatment for lumbar laminectomy|1|||
30655317|NCT00861471|58668249|FG000|Overall Study|Physician Decision|2|||
30655318|NCT00860067|58668256|FG000|Overall Study|Lost to Follow-up|46|||
30655319|NCT00860067|58668257|FG001|Overall Study|Lost to Follow-up|9|||
30655320|NCT00860067|58668258|FG002|Overall Study|Lost to Follow-up|9|||
30655321|NCT00860067|58668256|FG000|Overall Study|Withdrawal by Subject|4|||
30655322|NCT00860067|58668257|FG001|Overall Study|Withdrawal by Subject|0|||
30655323|NCT00860067|58668258|FG002|Overall Study|Withdrawal by Subject|0|||
30655324|NCT00860067|58668256|FG000|Overall Study|Pregnancy|1|||
30655325|NCT00860067|58668257|FG001|Overall Study|Pregnancy|0|||
30655326|NCT00860067|58668258|FG002|Overall Study|Pregnancy|0|||
30655327|NCT00858117|58668269|FG000|Treatment on Study|Adverse Event|2|||
30655328|NCT00858117|58668269|FG000|Follow up for 5 Years|Death|4|||
30655329|NCT00858117|58668269|FG000|Follow up for 5 Years|No further data collected for study|9|||
30655330|NCT00652951|58668276|FG000|Booster Phase|Adverse event, non-fatal|0|||
30655331|NCT00652951|58668277|FG001|Booster Phase|Adverse event, non-fatal|1|||
30655332|NCT00652951|58668278|FG002|Booster Phase|Adverse event, non-fatal|0|||
30655333|NCT00652951|58668276|FG000|Booster Phase|Other|1|||
30655334|NCT00652951|58668277|FG001|Booster Phase|Other|0|||
30655335|NCT00652951|58668278|FG002|Booster Phase|Other|0|||
30655336|NCT00848211|58668290|FG000|Overall Study|Protocol Violation|0|||
30655337|NCT00848211|58668291|FG001|Overall Study|Protocol Violation|1|||
30952417|NCT00081159|59000529|FG001|Overall Study|Withdrawal by Subject|3|||
30655338|NCT00848211|58668292|FG002|Overall Study|Protocol Violation|1|||
30655339|NCT00848211|58668293|FG003|Overall Study|Protocol Violation|0|||
30655340|NCT00848211|58668290|FG000|Overall Study|Adverse Event|0|||
30655341|NCT00848211|58668291|FG001|Overall Study|Adverse Event|0|||
30655342|NCT00848211|58668292|FG002|Overall Study|Adverse Event|0|||
30655343|NCT00848211|58668293|FG003|Overall Study|Adverse Event|0|||
30655344|NCT00592683|58668305|FG000|Overall Study|Found ineligible|0|||
30655345|NCT00592683|58668306|FG001|Overall Study|Found ineligible|1|||
30655346|NCT00592683|58668305|FG000|Overall Study|Withdrawal by Subject|1|||
30655347|NCT00592683|58668306|FG001|Overall Study|Withdrawal by Subject|0|||
30655348|NCT00592683|58668305|FG000|Overall Study|Adverse Event|0|||
30655349|NCT00592683|58668306|FG001|Overall Study|Adverse Event|2|||
30655350|NCT00592683|58668305|FG000|Overall Study|Protocol Violation|1|||
30655351|NCT00592683|58668306|FG001|Overall Study|Protocol Violation|0|||
30655352|NCT00592683|58668305|FG000|Overall Study|Study drug expired|1|||
30655353|NCT00592683|58668306|FG001|Overall Study|Study drug expired|0|||
30655354|NCT00592683|58668305|FG000|Overall Study|Other|1|||
30655355|NCT00592683|58668306|FG001|Overall Study|Other|0|||
30655356|NCT00592683|58668305|FG000|Overall Study|Lost to Follow-up|0|||
30655357|NCT00592683|58668306|FG001|Overall Study|Lost to Follow-up|1|||
30655358|NCT00847665|58668314|FG000|Overall Study|Withdrawal by Subject|1|||
30655359|NCT00847665|58668315|FG001|Overall Study|Withdrawal by Subject|0|||
30655360|NCT00916370|58668323|FG000|Overall Study|Death|3|||
30655361|NCT00916370|58668324|FG001|Overall Study|Death|1|||
30655362|NCT00916370|58668323|FG000|Overall Study|Withdrawal by Subject|2|||
30655363|NCT00916370|58668324|FG001|Overall Study|Withdrawal by Subject|0|||
30655364|NCT00916370|58668323|FG000|Overall Study|Physician Decision|0|||
30655365|NCT00916370|58668324|FG001|Overall Study|Physician Decision|1|||
30655366|NCT00847197|58668333|FG000|Overall Study|Adverse Event|21|||
30655367|NCT00847197|58668334|FG001|Overall Study|Adverse Event|3|||
30655368|NCT00847197|58668333|FG000|Overall Study|Protocol Violation|0|||
30655369|NCT00847197|58668334|FG001|Overall Study|Protocol Violation|1|||
30655370|NCT00847197|58668333|FG000|Overall Study|Withdrawal by Subject|3|||
30655371|NCT00847197|58668334|FG001|Overall Study|Withdrawal by Subject|1|||
30655372|NCT00654901|58668344|FG000|Overall Study|Lost to Follow-up|1|||
30655373|NCT00654901|58668345|FG001|Overall Study|Lost to Follow-up|0|||
30655374|NCT00654901|58668346|FG002|Overall Study|Lost to Follow-up|1|||
30655375|NCT00654901|58668347|FG003|Overall Study|Lost to Follow-up|0|||
30655376|NCT00654901|58668344|FG000|Overall Study|Withdrawal by Subject|3|||
30655377|NCT00654901|58668345|FG001|Overall Study|Withdrawal by Subject|0|||
30655378|NCT00654901|58668346|FG002|Overall Study|Withdrawal by Subject|1|||
30655379|NCT00654901|58668347|FG003|Overall Study|Withdrawal by Subject|0|||
30655380|NCT00846807|58668357|FG000|Overall Study|Adverse Event|270|||
30655381|NCT00846807|58668357|FG000|Overall Study|Lost to Follow-up|94|||
30655382|NCT00846807|58668357|FG000|Overall Study|Withdrawal by Subject|56|||
30655383|NCT00846807|58668357|FG000|Overall Study|Non compliant with European label|7|||
30655384|NCT00846807|58668357|FG000|Overall Study|Switch to other anticoagulants|89|||
30655385|NCT00846807|58668357|FG000|Overall Study|No prescription after hospital discharge|56|||
30655386|NCT00846807|58668357|FG000|Overall Study|Other|60|||
30655387|NCT00846495|58668363|FG000|Overall Study|Lost to Follow-up|1|||
30655388|NCT00846495|58668364|FG001|Overall Study|Lost to Follow-up|0|||
30655389|NCT00846495|58668363|FG000|Overall Study|Adverse Event|5|||
30655390|NCT00846495|58668364|FG001|Overall Study|Adverse Event|1|||
30655391|NCT00846495|58668363|FG000|Overall Study|Lack of Efficacy|1|||
30655392|NCT00846495|58668364|FG001|Overall Study|Lack of Efficacy|2|||
30655393|NCT00846495|58668363|FG000|Overall Study|Physician Decision|1|||
30655394|NCT00846495|58668364|FG001|Overall Study|Physician Decision|0|||
30655395|NCT00654745|58668370|FG000|Overall Study|Adverse Event|12|||
30655396|NCT00654745|58668370|FG000|Overall Study|Lost to Follow-up|7|||
30655397|NCT00654745|58668370|FG000|Overall Study|Protocol Violation|11|||
30655398|NCT00654745|58668370|FG000|Overall Study|Withdrawal by Subject|10|||
30655399|NCT00654745|58668370|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
30655400|NCT00846027|58668380|FG000|Overall Study|Death|3|||
30655401|NCT00846027|58668380|FG000|Overall Study|Disease Progression|30|||
30655402|NCT00846027|58668380|FG000|Overall Study|Toxicity|12|||
30655403|NCT00846027|58668380|FG000|Overall Study|Patient Decision|7|||
30655404|NCT00846027|58668380|FG000|Overall Study|Investigator Discretion|29|||
30655405|NCT00846027|58668380|FG000|Overall Study|Protocol Violation|2|||
30655406|NCT00846027|58668380|FG000|Overall Study|Subject Not Treated|7|||
30655407|NCT00646399|58668386|FG000|Overall Study|Death|63|||
30655408|NCT00646399|58668387|FG001|Overall Study|Death|53|||
30655409|NCT00646399|58668386|FG000|Overall Study|Withdrawal by Subject|9|||
30655410|NCT00646399|58668387|FG001|Overall Study|Withdrawal by Subject|10|||
30655411|NCT00646399|58668386|FG000|Overall Study|Other Reason|11|||
30655412|NCT00646399|58668387|FG001|Overall Study|Other Reason|11|||
30655413|NCT00652327|58668395|FG000|Overall Study|Adverse Event|0|||
30655414|NCT00652327|58668396|FG001|Overall Study|Adverse Event|2|||
30655415|NCT00652327|58668395|FG000|Overall Study|Lost to Follow-up|0|||
30655416|NCT00652327|58668396|FG001|Overall Study|Lost to Follow-up|3|||
30655417|NCT00645853|58668404|FG000|Overall Study|Adverse Event|18|||
30655418|NCT00645853|58668405|FG001|Overall Study|Adverse Event|7|||
30655419|NCT00645853|58668404|FG000|Overall Study|AZ study closure in Hungary|60|||
30655420|NCT00645853|58668405|FG001|Overall Study|AZ study closure in Hungary|40|||
30655421|NCT00645853|58668404|FG000|Overall Study|Withdrawal by Subject|5|||
30655422|NCT00645853|58668405|FG001|Overall Study|Withdrawal by Subject|2|||
30655423|NCT00645853|58668404|FG000|Overall Study|Protocol Violation|0|||
30655424|NCT00645853|58668405|FG001|Overall Study|Protocol Violation|2|||
30655425|NCT00645853|58668404|FG000|Overall Study|Discontinuation criteria|2|||
30655426|NCT00645853|58668405|FG001|Overall Study|Discontinuation criteria|2|||
30655427|NCT00645853|58668404|FG000|Overall Study|recall of ICF, planned operation, death|7|||
30655428|NCT00645853|58668405|FG001|Overall Study|recall of ICF, planned operation, death|4|||
30655429|NCT00652093|58668417|FG000|Overall Study|Withdrawal by Subject|0|||
30655430|NCT00652093|58668418|FG001|Overall Study|Withdrawal by Subject|0|||
30655431|NCT00652093|58668419|FG002|Overall Study|Withdrawal by Subject|1|||
30655432|NCT00652093|58668420|FG003|Overall Study|Withdrawal by Subject|0|||
30655433|NCT00652093|58668421|FG004|Overall Study|Withdrawal by Subject|1|||
30655434|NCT00652093|58668422|FG005|Overall Study|Withdrawal by Subject|0|||
30655435|NCT00652093|58668417|FG000|Overall Study|Physician Decision|0|||
30655436|NCT00652093|58668418|FG001|Overall Study|Physician Decision|0|||
30655437|NCT00652093|58668419|FG002|Overall Study|Physician Decision|0|||
30655438|NCT00652093|58668420|FG003|Overall Study|Physician Decision|0|||
30655439|NCT00652093|58668421|FG004|Overall Study|Physician Decision|1|||
30655440|NCT00652093|58668422|FG005|Overall Study|Physician Decision|0|||
30655441|NCT00651937|58668438|FG000|Overall Study|Withdrawal by Subject|4|||
30655442|NCT00651937|58668439|FG001|Overall Study|Withdrawal by Subject|1|||
30655443|NCT00654355|58668447|FG000|Overall Study|Lost to Follow-up|2|||
30655444|NCT00654355|58668448|FG001|Overall Study|Lost to Follow-up|2|||
30655445|NCT00651313|58668456|FG000|Overall Study|Adverse Event|0|||
30655446|NCT00651313|58668457|FG001|Overall Study|Adverse Event|1|||
30655447|NCT00651313|58668456|FG000|Overall Study|Withdrawal by Subject|3|||
30655448|NCT00651313|58668457|FG001|Overall Study|Withdrawal by Subject|1|||
30655449|NCT00651313|58668456|FG000|Overall Study|Lost to Follow-up|1|||
30655450|NCT00651313|58668457|FG001|Overall Study|Lost to Follow-up|1|||
30655451|NCT00651313|58668456|FG000|Overall Study|Adminstrative Discontinuation|2|||
30655452|NCT00651313|58668457|FG001|Overall Study|Adminstrative Discontinuation|3|||
30655453|NCT00969761|58668475|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
30655454|NCT00969761|58668476|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
30655455|NCT00969761|58668477|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
30655456|NCT00969761|58668478|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
30655457|NCT00969761|58668479|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
30655458|NCT00969761|58668480|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
30655459|NCT00969761|58668481|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
30655460|NCT00969761|58668482|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
30655461|NCT00969761|58668483|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
30655462|NCT00969761|58668484|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
30655463|NCT00969761|58668485|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
30655464|NCT00969761|58668486|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
30655465|NCT00969761|58668475|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
30655466|NCT00969761|58668476|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
30655467|NCT00969761|58668477|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
30655468|NCT00969761|58668478|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
30655469|NCT00969761|58668479|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
30655470|NCT00969761|58668480|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
30769036|NCT00405964|58778003|FG000|Overall Study|Lost to Follow-up|5|||
30769037|NCT00405964|58778004|FG001|Overall Study|Lost to Follow-up|5|||
30769038|NCT00405964|58778003|FG000|Overall Study|Withdrawal by Subject|19|||
30769039|NCT00405964|58778004|FG001|Overall Study|Withdrawal by Subject|23|||
30769040|NCT00405964|58778003|FG000|Overall Study|Protocol Violation|11|||
30769041|NCT00405964|58778004|FG001|Overall Study|Protocol Violation|6|||
30769042|NCT00264797|58778012|FG000|Overall Study|Withdrawal by Subject|11|||
30769043|NCT00264797|58778013|FG001|Overall Study|Withdrawal by Subject|11|||
30769044|NCT00264797|58778012|FG000|Overall Study|Lost to Follow-up|9|||
30769045|NCT00264797|58778013|FG001|Overall Study|Lost to Follow-up|17|||
30769046|NCT00264797|58778012|FG000|Overall Study|Moved from area|3|||
30769047|NCT00264797|58778013|FG001|Overall Study|Moved from area|1|||
30769048|NCT00264797|58778012|FG000|Overall Study|Practical Problems|2|||
30769049|NCT00264797|58778013|FG001|Overall Study|Practical Problems|3|||
30769050|NCT00264797|58778012|FG000|Overall Study|Incarceration|4|||
30769051|NCT00264797|58778013|FG001|Overall Study|Incarceration|5|||
30769052|NCT00264797|58778012|FG000|Overall Study|Pressure/advice from Outsiders|1|||
30769053|NCT00264797|58778013|FG001|Overall Study|Pressure/advice from Outsiders|1|||
30769054|NCT00264797|58778012|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
30769055|NCT00264797|58778013|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
30769056|NCT00264797|58778012|FG000|Overall Study|Other|3|||
30769057|NCT00264797|58778013|FG001|Overall Study|Other|4|||
30769058|NCT03148756|58778021|FG000|Overall Study|Study Terminated|0|||
30769059|NCT03148756|58778022|FG001|Overall Study|Study Terminated|1|||
30655471|NCT00969761|58668481|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
30769060|NCT00282113|58778031|FG000|Overall Study|Removed at parents request|1|||
30769061|NCT00282113|58778032|FG001|Overall Study|Removed at parents request|0|||
30769062|NCT00282113|58778033|FG002|Overall Study|Removed at parents request|0|||
30769063|NCT00281957|58778043|FG000|Overall Study|Adverse Event|7|||
30769064|NCT00281957|58778044|FG001|Overall Study|Adverse Event|2|||
30769065|NCT00281957|58778043|FG000|Overall Study|Death|1|||
30769066|NCT00281957|58778044|FG001|Overall Study|Death|0|||
30769067|NCT00281957|58778043|FG000|Overall Study|Progression/relapse|47|||
30769068|NCT00281957|58778044|FG001|Overall Study|Progression/relapse|35|||
30769069|NCT00281957|58778043|FG000|Overall Study|Not protocol specified|8|||
30769070|NCT00281957|58778044|FG001|Overall Study|Not protocol specified|1|||
30769071|NCT00281957|58778043|FG000|Overall Study|Not eligible|1|||
30769072|NCT00281957|58778044|FG001|Overall Study|Not eligible|2|||
30769073|NCT00281957|58778043|FG000|Overall Study|Did not start treatment|3|||
30655472|NCT00969761|58668482|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
30655473|NCT00969761|58668483|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
30655474|NCT00969761|58668484|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
30655475|NCT00969761|58668485|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
30655476|NCT00969761|58668486|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
30769074|NCT00281957|58778044|FG001|Overall Study|Did not start treatment|1|||
30769075|NCT00281957|58778043|FG000|Overall Study|Refusal unrelated to adverse events|0|||
30769076|NCT00281957|58778044|FG001|Overall Study|Refusal unrelated to adverse events|1|||
30769077|NCT00281099|58778054|FG000|Overall Study|Death|46|||
30769078|NCT00281099|58778055|FG001|Overall Study|Death|57|||
30769079|NCT00281099|58778054|FG000|Overall Study|Lost to Follow-up|10|||
30769080|NCT00281099|58778055|FG001|Overall Study|Lost to Follow-up|19|||
30769081|NCT00281099|58778054|FG000|Overall Study|Withdrawal by Subject|65|||
30769082|NCT00281099|58778055|FG001|Overall Study|Withdrawal by Subject|70|||
30769083|NCT00281099|58778054|FG000|Overall Study|Physician Decision|79|||
30769084|NCT00281099|58778055|FG001|Overall Study|Physician Decision|72|||
30769085|NCT00281099|58778054|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
30769086|NCT00281099|58778055|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
30769087|NCT00262925|58778062|FG000|Overall Study|Lack of Efficacy|3|||
30769088|NCT00262925|58778062|FG000|Overall Study|Adverse Event|4|||
30769089|NCT00262925|58778062|FG000|Overall Study|Death|2|||
30769090|NCT00262925|58778062|FG000|Overall Study|alternative therapy|1|||
30769091|NCT00262925|58778062|FG000|Overall Study|Other|1|||
30769092|NCT03720470|58778072|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
30769093|NCT03720470|58778073|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
30769094|NCT03720470|58778074|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
30769095|NCT03720470|58778075|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
30769096|NCT03720470|58778076|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
30769097|NCT03720470|58778077|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
30769098|NCT03720470|58778072|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
30769099|NCT03720470|58778073|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
30769100|NCT03720470|58778074|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
30769101|NCT03720470|58778075|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
30769102|NCT03720470|58778076|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
30769103|NCT03720470|58778077|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
30769104|NCT03720470|58778072|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
30769105|NCT03720470|58778073|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
30769106|NCT03720470|58778074|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
30769107|NCT03720470|58778075|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
30769108|NCT03720470|58778076|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
30769109|NCT03720470|58778077|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
30769110|NCT03720470|58778072|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
30769111|NCT03720470|58778073|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
30769112|NCT03720470|58778074|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
30769113|NCT03720470|58778075|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
30769114|NCT03720470|58778076|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
30769115|NCT03720470|58778077|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
30769116|NCT03720470|58778072|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
30769117|NCT03720470|58778073|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
30769118|NCT03720470|58778074|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
30769119|NCT03720470|58778075|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
30769120|NCT03720470|58778076|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
30769121|NCT03720470|58778077|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
30769122|NCT03720470|58778072|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
30769123|NCT03720470|58778073|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
30769124|NCT03720470|58778074|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
30769125|NCT03720470|58778075|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
30769126|NCT03720470|58778076|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
30769127|NCT03720470|58778077|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
30769128|NCT03720470|58778072|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
30769129|NCT03720470|58778073|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
30769130|NCT03720470|58778074|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
30769131|NCT03720470|58778075|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
30769132|NCT03720470|58778076|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
30769133|NCT03720470|58778077|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
30769134|NCT03720470|58778072|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
30655477|NCT00969761|58668475|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
30655478|NCT00969761|58668476|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
30655479|NCT00969761|58668477|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
30655480|NCT00969761|58668478|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
30655481|NCT00969761|58668479|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
30655482|NCT00969761|58668480|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
30655483|NCT00969761|58668481|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
30655484|NCT00969761|58668482|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
30655485|NCT00969761|58668483|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
30655486|NCT00969761|58668484|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
30655487|NCT00969761|58668485|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
30655488|NCT00969761|58668486|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
30655489|NCT00969761|58668475|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
30655490|NCT00969761|58668476|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
30655491|NCT00969761|58668477|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
30655492|NCT00969761|58668478|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
30655493|NCT00969761|58668479|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
30655494|NCT00969761|58668480|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
30655495|NCT00969761|58668481|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
30655496|NCT00969761|58668482|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
30655497|NCT00969761|58668483|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
30655498|NCT00969761|58668484|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
30655499|NCT00969761|58668485|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
30655500|NCT00969761|58668486|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
30655501|NCT00969761|58668475|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
30655502|NCT00969761|58668476|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
30655503|NCT00969761|58668477|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
30655504|NCT00969761|58668478|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
30655505|NCT00969761|58668479|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
30655506|NCT00969761|58668480|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
30655507|NCT00969761|58668481|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
30655508|NCT00969761|58668482|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
30655509|NCT00969761|58668483|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
30655510|NCT00969761|58668484|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
30655511|NCT00969761|58668485|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
30655512|NCT00969761|58668486|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
30655513|NCT00969761|58668475|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
30769135|NCT03720470|58778073|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
30769136|NCT03720470|58778074|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
30769137|NCT03720470|58778075|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
30769138|NCT03720470|58778076|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
30769139|NCT03720470|58778077|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
30769140|NCT03720470|58778072|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
30769141|NCT03720470|58778073|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
30769142|NCT03720470|58778074|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
30769143|NCT03720470|58778075|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
30769144|NCT03720470|58778076|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
30769145|NCT03720470|58778077|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
30769146|NCT03720470|58778072|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
30769147|NCT03720470|58778073|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
30769148|NCT03720470|58778074|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
30655514|NCT00969761|58668476|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
30655515|NCT00969761|58668477|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
30769149|NCT03720470|58778075|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
30769150|NCT03720470|58778076|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
30769151|NCT03720470|58778077|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
30769152|NCT03720470|58778072|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
30769153|NCT03720470|58778073|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
30769154|NCT03720470|58778074|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
30848793|NCT01376349|58875390|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
30848794|NCT01376349|58875391|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
30848795|NCT01376349|58875389|FG000|Raondomized Treatment|Adverse Event|13|||
30952418|NCT00081159|59000528|FG000|Overall Study|Myelosuppression prior to treatment|0|||
30769155|NCT03720470|58778075|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
30952419|NCT00081159|59000529|FG001|Overall Study|Myelosuppression prior to treatment|1|||
30769156|NCT03720470|58778076|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
30769157|NCT03720470|58778077|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
30769158|NCT03720470|58778072|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
30769159|NCT03720470|58778073|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
30769160|NCT03720470|58778074|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
30769161|NCT03720470|58778075|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
30769162|NCT03720470|58778076|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
30769163|NCT03720470|58778077|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
30769164|NCT03720470|58778072|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
30769165|NCT03720470|58778073|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
30769166|NCT03720470|58778074|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
30769167|NCT03720470|58778075|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
30769168|NCT03720470|58778076|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
30769169|NCT03720470|58778077|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
30769170|NCT03720470|58778072|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
30769171|NCT03720470|58778073|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
30769172|NCT03720470|58778074|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
30769173|NCT03720470|58778075|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
30769174|NCT03720470|58778076|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
30769175|NCT03720470|58778077|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
30769176|NCT03720470|58778072|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
30769177|NCT03720470|58778073|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
30769178|NCT03720470|58778074|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
30769179|NCT03720470|58778075|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
30769180|NCT03720470|58778076|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
30769181|NCT03720470|58778077|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
30769182|NCT03720470|58778072|FG000|Treatment Period: Final 4 Weeks|Other|0|||
30769183|NCT03720470|58778073|FG001|Treatment Period: Final 4 Weeks|Other|1|||
30769184|NCT03720470|58778074|FG002|Treatment Period: Final 4 Weeks|Other|0|||
30769185|NCT03720470|58778075|FG003|Treatment Period: Final 4 Weeks|Other|2|||
30769186|NCT03720470|58778076|FG004|Treatment Period: Final 4 Weeks|Other|1|||
30769187|NCT03720470|58778077|FG005|Treatment Period: Final 4 Weeks|Other|0|||
30769188|NCT00262847|58778100|FG000|Overall Study|Disease Progression|309|||
30769189|NCT00262847|58778101|FG001|Overall Study|Disease Progression|274|||
30769190|NCT00262847|58778102|FG002|Overall Study|Disease Progression|195|||
30769191|NCT00262847|58778100|FG000|Overall Study|Patient Refusal|41|||
30769192|NCT00262847|58778101|FG001|Overall Study|Patient Refusal|52|||
30769193|NCT00262847|58778102|FG002|Overall Study|Patient Refusal|47|||
30769194|NCT00262847|58778100|FG000|Overall Study|Adverse Event|74|||
30769195|NCT00262847|58778101|FG001|Overall Study|Adverse Event|88|||
30769196|NCT00262847|58778102|FG002|Overall Study|Adverse Event|108|||
30769197|NCT00262847|58778100|FG000|Overall Study|Death|8|||
30769198|NCT00262847|58778101|FG001|Overall Study|Death|8|||
30769199|NCT00262847|58778102|FG002|Overall Study|Death|11|||
30769200|NCT00262847|58778100|FG000|Overall Study|Concomitant disease|3|||
30769201|NCT00262847|58778101|FG001|Overall Study|Concomitant disease|2|||
30769202|NCT00262847|58778102|FG002|Overall Study|Concomitant disease|4|||
30848796|NCT01376349|58875390|FG001|Raondomized Treatment|Adverse Event|17|||
30848797|NCT01376349|58875391|FG002|Raondomized Treatment|Adverse Event|14|||
30848798|NCT01376349|58875389|FG000|Raondomized Treatment|Unkown|1|||
30848799|NCT01376349|58875390|FG001|Raondomized Treatment|Unkown|2|||
30848800|NCT01376349|58875391|FG002|Raondomized Treatment|Unkown|1|||
30848801|NCT01376349|58875389|FG000|Raondomized Treatment|Alternative Treatment|0|||
30848802|NCT01376349|58875390|FG001|Raondomized Treatment|Alternative Treatment|0|||
30848803|NCT01376349|58875391|FG002|Raondomized Treatment|Alternative Treatment|1|||
30769203|NCT00262847|58778100|FG000|Overall Study|Other Reasons|79|||
30848804|NCT00158600|58875429|FG000|Overall Study|unable to commit time to study|0|||
30848805|NCT00158600|58875430|FG001|Overall Study|unable to commit time to study|1|||
30848806|NCT00158600|58875429|FG000|Overall Study|Adverse Event|2|||
30848807|NCT00158600|58875430|FG001|Overall Study|Adverse Event|1|||
30769204|NCT00262847|58778101|FG001|Overall Study|Other Reasons|88|||
30848808|NCT00158600|58875429|FG000|Overall Study|Death|1|||
30848809|NCT00158600|58875430|FG001|Overall Study|Death|0|||
30848810|NCT00158600|58875429|FG000|Overall Study|Withdrawal by Subject|2|||
30848811|NCT00158600|58875430|FG001|Overall Study|Withdrawal by Subject|2|||
30848812|NCT01680458|58875437|FG000|Overall Study|Protocol Violation|3|||
30769205|NCT00262847|58778102|FG002|Overall Study|Other Reasons|27|||
30769206|NCT00262847|58778100|FG000|Overall Study|Did not receive study treatment|4|||
30769207|NCT00262847|58778101|FG001|Overall Study|Did not receive study treatment|1|||
30769208|NCT00262847|58778102|FG002|Overall Study|Did not receive study treatment|4|||
30769209|NCT04270760|58778118|FG000|Overall Study|Withdrawal by Subject|0|||
30769210|NCT04270760|58778119|FG001|Overall Study|Withdrawal by Subject|1|||
30848813|NCT04543136|58875441|FG000|Overall Study|Withdrawal by Subject|0|||
30848814|NCT04543136|58875442|FG001|Overall Study|Withdrawal by Subject|1|||
30848815|NCT04543136|58875443|FG002|Overall Study|Withdrawal by Subject|0|||
30848816|NCT04543136|58875444|FG003|Overall Study|Withdrawal by Subject|1|||
30848817|NCT04543136|58875445|FG004|Overall Study|Withdrawal by Subject|0|||
30848818|NCT04543136|58875446|FG005|Overall Study|Withdrawal by Subject|0|||
30848819|NCT00709761|58875454|FG000|Overall Study|Withdrawal by Subject|8|||
30848820|NCT00709761|58875454|FG000|Overall Study|study closed/terminated|17|||
30848821|NCT00709761|58875454|FG000|Overall Study|Lost to Follow-up|2|||
30655516|NCT00969761|58668478|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
30655517|NCT00969761|58668479|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
30655518|NCT00969761|58668480|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
30655519|NCT00969761|58668481|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
30655520|NCT00969761|58668482|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
30655521|NCT00969761|58668483|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
30655522|NCT00969761|58668484|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
30655523|NCT00969761|58668485|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
30655524|NCT00969761|58668486|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
30655525|NCT00845871|58668512|FG000|Assessment Period|Adverse Event|2|||
30655526|NCT00845871|58668512|FG000|Assessment Period|Abnormal laboratory values|1|||
30655527|NCT00845871|58668512|FG000|Assessment Period|Abnormal test procedure results|1|||
30655528|NCT00845871|58668512|FG000|Assessment Period|Patient withdrew consent|3|||
30655529|NCT00915278|58668542|FG000|Overall Study|Death|1|||
30655530|NCT00915278|58668543|FG001|Overall Study|Death|0|||
30655531|NCT00915278|58668544|FG002|Overall Study|Death|0|||
30655532|NCT00915278|58668545|FG003|Overall Study|Death|0|||
30655533|NCT00915278|58668546|FG004|Overall Study|Death|0|||
30655534|NCT00915278|58668547|FG005|Overall Study|Death|0|||
30655535|NCT00915278|58668542|FG000|Overall Study|Lost to Follow-up|0|||
30655536|NCT00915278|58668543|FG001|Overall Study|Lost to Follow-up|1|||
30655537|NCT00915278|58668544|FG002|Overall Study|Lost to Follow-up|0|||
30655538|NCT00915278|58668545|FG003|Overall Study|Lost to Follow-up|0|||
30655539|NCT00915278|58668546|FG004|Overall Study|Lost to Follow-up|0|||
30655540|NCT00915278|58668547|FG005|Overall Study|Lost to Follow-up|0|||
30655541|NCT00915278|58668542|FG000|Overall Study|Withdrawal by Subject|0|||
30655542|NCT00915278|58668543|FG001|Overall Study|Withdrawal by Subject|1|||
30655543|NCT00915278|58668544|FG002|Overall Study|Withdrawal by Subject|0|||
30655544|NCT00915278|58668545|FG003|Overall Study|Withdrawal by Subject|0|||
30655545|NCT00915278|58668546|FG004|Overall Study|Withdrawal by Subject|1|||
30655546|NCT00915278|58668547|FG005|Overall Study|Withdrawal by Subject|4|||
30655547|NCT00915278|58668542|FG000|Overall Study|Adverse Event|4|||
30655548|NCT00915278|58668543|FG001|Overall Study|Adverse Event|1|||
30655549|NCT00915278|58668544|FG002|Overall Study|Adverse Event|0|||
30655550|NCT00915278|58668545|FG003|Overall Study|Adverse Event|0|||
30655551|NCT00915278|58668546|FG004|Overall Study|Adverse Event|0|||
30655552|NCT00915278|58668547|FG005|Overall Study|Adverse Event|0|||
30655553|NCT00915278|58668542|FG000|Overall Study|Progressive disease/clinical progression|0|||
30655554|NCT00915278|58668543|FG001|Overall Study|Progressive disease/clinical progression|0|||
30655555|NCT00915278|58668544|FG002|Overall Study|Progressive disease/clinical progression|0|||
30655556|NCT00915278|58668545|FG003|Overall Study|Progressive disease/clinical progression|3|||
30655557|NCT00915278|58668546|FG004|Overall Study|Progressive disease/clinical progression|1|||
30655558|NCT00915278|58668547|FG005|Overall Study|Progressive disease/clinical progression|2|||
30655559|NCT00915278|58668542|FG000|Overall Study|Infusion related AEs|0|||
30655560|NCT00915278|58668543|FG001|Overall Study|Infusion related AEs|0|||
30655561|NCT00915278|58668544|FG002|Overall Study|Infusion related AEs|0|||
30655562|NCT00915278|58668545|FG003|Overall Study|Infusion related AEs|0|||
30655563|NCT00915278|58668546|FG004|Overall Study|Infusion related AEs|0|||
30769211|NCT04270760|58778120|FG002|Overall Study|Withdrawal by Subject|3|||
30769212|NCT04270760|58778121|FG003|Overall Study|Withdrawal by Subject|0|||
30769213|NCT04270760|58778122|FG004|Overall Study|Withdrawal by Subject|0|||
30769214|NCT04270760|58778118|FG000|Overall Study|Lost to Follow-up|1|||
30769215|NCT04270760|58778119|FG001|Overall Study|Lost to Follow-up|2|||
30769216|NCT04270760|58778120|FG002|Overall Study|Lost to Follow-up|1|||
30848822|NCT02848651|58875464|FG000|Overall Study|Death|85|||
30848823|NCT02848651|58875464|FG000|Overall Study|Lost to Follow-up|1|||
30655564|NCT00915278|58668547|FG005|Overall Study|Infusion related AEs|2|||
30655565|NCT00915278|58668542|FG000|Overall Study|Admission to hospice|0|||
30655566|NCT00915278|58668543|FG001|Overall Study|Admission to hospice|0|||
30655567|NCT00915278|58668544|FG002|Overall Study|Admission to hospice|1|||
30769217|NCT04270760|58778121|FG003|Overall Study|Lost to Follow-up|0|||
30769218|NCT04270760|58778122|FG004|Overall Study|Lost to Follow-up|0|||
30769219|NCT04270760|58778118|FG000|Overall Study|Death|0|||
30655568|NCT00915278|58668545|FG003|Overall Study|Admission to hospice|0|||
30655569|NCT00915278|58668546|FG004|Overall Study|Admission to hospice|0|||
30655570|NCT00915278|58668547|FG005|Overall Study|Admission to hospice|0|||
30655571|NCT00844857|58668563|FG000|Overall Study|Adverse Event|24|||
30655572|NCT00844857|58668564|FG001|Overall Study|Adverse Event|5|||
30655573|NCT00844857|58668563|FG000|Overall Study|Sponsor Decision|1|||
30655574|NCT00844857|58668564|FG001|Overall Study|Sponsor Decision|1|||
30655575|NCT00844857|58668563|FG000|Overall Study|Physician Decision|2|||
30655576|NCT00844857|58668564|FG001|Overall Study|Physician Decision|0|||
30655577|NCT00844857|58668563|FG000|Overall Study|Parent/Caregiver Decision|6|||
30655578|NCT00844857|58668564|FG001|Overall Study|Parent/Caregiver Decision|2|||
30655579|NCT00844857|58668563|FG000|Overall Study|Withdrawal by Subject|8|||
30655580|NCT00844857|58668564|FG001|Overall Study|Withdrawal by Subject|7|||
30769220|NCT04270760|58778119|FG001|Overall Study|Death|0|||
30769221|NCT04270760|58778120|FG002|Overall Study|Death|0|||
30769222|NCT04270760|58778121|FG003|Overall Study|Death|0|||
30769223|NCT04270760|58778122|FG004|Overall Study|Death|1|||
30769224|NCT00280397|58778139|FG000|Overall Study|Adverse Event|1|||
30769225|NCT00262301|58778148|FG000|Double-blind Phase|Lost to Follow-up|1|||
30769226|NCT00262301|58778149|FG001|Double-blind Phase|Lost to Follow-up|0|||
30769227|NCT00262301|58778150|FG002|Double-blind Phase|Lost to Follow-up|0|||
30848824|NCT02848651|58875464|FG000|Overall Study|Non-Compliance|1|||
30655581|NCT00844857|58668563|FG000|Overall Study|Protocol Violation|6|||
30655582|NCT00844857|58668564|FG001|Overall Study|Protocol Violation|0|||
30655583|NCT00844857|58668563|FG000|Overall Study|Lack of Efficacy|5|||
30655584|NCT00844857|58668564|FG001|Overall Study|Lack of Efficacy|5|||
30655585|NCT00844857|58668563|FG000|Overall Study|Clinical Relapse|0|||
30655586|NCT00844857|58668564|FG001|Overall Study|Clinical Relapse|1|||
30655587|NCT00844857|58668563|FG000|Overall Study|Entry Criteria Not Met|0|||
30655588|NCT00844857|58668564|FG001|Overall Study|Entry Criteria Not Met|1|||
30655589|NCT00844857|58668563|FG000|Overall Study|Lost to Follow-up|2|||
30655590|NCT00844857|58668564|FG001|Overall Study|Lost to Follow-up|3|||
30655591|NCT00844857|58668563|FG000|Overall Study|Did Not Take Study Drug|3|||
30655592|NCT00844857|58668564|FG001|Overall Study|Did Not Take Study Drug|1|||
30655593|NCT00844857|58668563|FG000|Overall Study|Good Clinical Practice Violations|21|||
30655594|NCT00844857|58668564|FG001|Overall Study|Good Clinical Practice Violations|11|||
30655595|NCT00569803|58668581|FG000|Overall Study|Lost to Follow-up|1|||
30655596|NCT00569803|58668582|FG001|Overall Study|Lost to Follow-up|0|||
30655597|NCT00569803|58668583|FG002|Overall Study|Lost to Follow-up|0|||
30655598|NCT00569803|58668584|FG003|Overall Study|Lost to Follow-up|0|||
30655599|NCT00569803|58668585|FG004|Overall Study|Lost to Follow-up|0|||
30655600|NCT00569803|58668586|FG005|Overall Study|Lost to Follow-up|0|||
30655601|NCT00569803|58668587|FG006|Overall Study|Lost to Follow-up|0|||
30655602|NCT00569803|58668588|FG007|Overall Study|Lost to Follow-up|0|||
30655603|NCT00569803|58668581|FG000|Overall Study|injection syringe leaked during dosing|0|||
30655604|NCT00569803|58668582|FG001|Overall Study|injection syringe leaked during dosing|0|||
30655605|NCT00569803|58668583|FG002|Overall Study|injection syringe leaked during dosing|0|||
30655606|NCT00569803|58668584|FG003|Overall Study|injection syringe leaked during dosing|1|||
30655607|NCT00569803|58668585|FG004|Overall Study|injection syringe leaked during dosing|0|||
30655608|NCT00569803|58668586|FG005|Overall Study|injection syringe leaked during dosing|0|||
30655609|NCT00569803|58668587|FG006|Overall Study|injection syringe leaked during dosing|0|||
30655610|NCT00569803|58668588|FG007|Overall Study|injection syringe leaked during dosing|0|||
30655611|NCT00569803|58668581|FG000|Overall Study|Withdrawal by Subject|0|||
30655612|NCT00569803|58668582|FG001|Overall Study|Withdrawal by Subject|0|||
30655613|NCT00569803|58668583|FG002|Overall Study|Withdrawal by Subject|0|||
30655614|NCT00569803|58668584|FG003|Overall Study|Withdrawal by Subject|0|||
30655615|NCT00569803|58668585|FG004|Overall Study|Withdrawal by Subject|0|||
30655616|NCT00569803|58668586|FG005|Overall Study|Withdrawal by Subject|0|||
30655617|NCT00569803|58668587|FG006|Overall Study|Withdrawal by Subject|0|||
30655618|NCT00569803|58668588|FG007|Overall Study|Withdrawal by Subject|1|||
30655619|NCT00920426|58668613|FG000|ITZ111451|Adverse Event|1|||
30655620|NCT00920426|58668614|FG001|ITZ111451|Adverse Event|0|||
30655621|NCT00920426|58668615|FG002|ITZ111451|Adverse Event|0|||
30655622|NCT00920426|58668616|FG003|ITZ111451|Adverse Event|0|||
30655623|NCT00644995|58668630|FG000|Overall Study|Lost to Follow-up|1|||
30655624|NCT00644995|58668631|FG001|Overall Study|Lost to Follow-up|4|||
30655625|NCT00644995|58668630|FG000|Overall Study|Refused|1|||
30655626|NCT00644995|58668631|FG001|Overall Study|Refused|0|||
30655627|NCT00914966|58668639|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
30655628|NCT00914966|58668639|FG000|Step 1: 1500 Units|Physician Decision|1|||
30655629|NCT00914966|58668639|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
30655630|NCT00914810|58668650|FG000|Overall Study|Withdrawal by Subject|1|||
30655631|NCT00914810|58668651|FG001|Overall Study|Withdrawal by Subject|0|||
30655632|NCT00914810|58668650|FG000|Overall Study|Relocated out of state|1|||
30655633|NCT00914810|58668651|FG001|Overall Study|Relocated out of state|0|||
30769228|NCT00262301|58778148|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
30769229|NCT00262301|58778149|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
30655634|NCT00914810|58668650|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
30655635|NCT00914810|58668651|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
30655636|NCT00644917|58668657|FG000|Overall Study|Withdrawal by Subject|2|||
30655637|NCT00914732|58668668|FG000|Overall Study|Lost to Follow-up|6|||
30655638|NCT00914732|58668669|FG001|Overall Study|Lost to Follow-up|7|||
30655639|NCT00914732|58668670|FG002|Overall Study|Lost to Follow-up|9|||
30655640|NCT00914732|58668668|FG000|Overall Study|Withdrawal by Subject|3|||
30655641|NCT00914732|58668669|FG001|Overall Study|Withdrawal by Subject|0|||
30655642|NCT00914732|58668670|FG002|Overall Study|Withdrawal by Subject|2|||
30655643|NCT00914732|58668668|FG000|Overall Study|Adverse Event|1|||
30655644|NCT00914732|58668669|FG001|Overall Study|Adverse Event|0|||
30655645|NCT00914732|58668670|FG002|Overall Study|Adverse Event|0|||
30655646|NCT00844545|58668679|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
30655647|NCT00844545|58668679|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
30655648|NCT00844545|58668679|FG000|Extension Treatment Period|Adverse Event|2|||
30655649|NCT00844545|58668679|FG000|Post Treatment Period|Withdrawal by Subject|1|||
30655650|NCT00651157|58668684|FG000|Overall Study|Death|1|||
30655651|NCT00651157|58668684|FG000|Overall Study|Protocol Violation|1|||
30655652|NCT00843843|58668690|FG000|Overall Study|Physician Decision|1|||
30655653|NCT00843843|58668691|FG001|Overall Study|Physician Decision|1|||
30655654|NCT00843843|58668690|FG000|Overall Study|Protocol Violation|1|||
30655655|NCT00843843|58668691|FG001|Overall Study|Protocol Violation|1|||
30655656|NCT00650845|58668699|FG000|Overall Study|Withdrawal by Subject|5|||
30655657|NCT00650845|58668700|FG001|Overall Study|Withdrawal by Subject|0|||
30655658|NCT00650845|58668699|FG000|Overall Study|Protocol Violation|0|||
30655659|NCT00650845|58668700|FG001|Overall Study|Protocol Violation|13|||
30655660|NCT00842985|58668707|FG000|Screening|Did not meet entrance requirements|27|||
30655661|NCT00842985|58668707|FG000|First Intervention|Withdrawal by Subject|3|||
30655662|NCT00842985|58668707|FG000|First Intervention|Protocol Violation|3|||
30655663|NCT00842985|58668707|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
30655664|NCT00842985|58668707|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
30655665|NCT00842829|58668716|FG000|Dose Titration Period|Adverse Event|11|||
30655666|NCT00842829|58668717|FG001|Dose Titration Period|Adverse Event|10|||
30655667|NCT00842829|58668718|FG002|Dose Titration Period|Adverse Event|0|||
30655668|NCT00842829|58668716|FG000|Dose Titration Period|Lack of Efficacy|4|||
30655669|NCT00842829|58668717|FG001|Dose Titration Period|Lack of Efficacy|1|||
30655670|NCT00842829|58668718|FG002|Dose Titration Period|Lack of Efficacy|0|||
30655671|NCT00842829|58668716|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
30655672|NCT00842829|58668717|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
30655673|NCT00842829|58668718|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
30655674|NCT00842829|58668716|FG000|Dose Titration Period|Withdrawal by Subject|2|||
30655675|NCT00842829|58668717|FG001|Dose Titration Period|Withdrawal by Subject|6|||
30655676|NCT00842829|58668718|FG002|Dose Titration Period|Withdrawal by Subject|0|||
30655677|NCT00842829|58668716|FG000|Dose Titration Period|Other|5|||
30655678|NCT00842829|58668717|FG001|Dose Titration Period|Other|4|||
30655679|NCT00842829|58668718|FG002|Dose Titration Period|Other|0|||
30655680|NCT00842829|58668716|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
30655681|NCT00842829|58668717|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
30655682|NCT00842829|58668718|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
30655683|NCT00842829|58668716|FG000|Dose Titration Period|Non-compliance to study drug|2|||
30655684|NCT00842829|58668717|FG001|Dose Titration Period|Non-compliance to study drug|1|||
30655685|NCT00842829|58668718|FG002|Dose Titration Period|Non-compliance to study drug|0|||
30655686|NCT00842829|58668716|FG000|Treatment Period|Adverse Event|0|||
30655687|NCT00842829|58668717|FG001|Treatment Period|Adverse Event|0|||
30655688|NCT00842829|58668718|FG002|Treatment Period|Adverse Event|15|||
30655689|NCT00842829|58668716|FG000|Treatment Period|Lack of Efficacy|0|||
30655690|NCT00842829|58668717|FG001|Treatment Period|Lack of Efficacy|0|||
30655691|NCT00842829|58668718|FG002|Treatment Period|Lack of Efficacy|6|||
30655692|NCT00842829|58668716|FG000|Treatment Period|Unstable persistent cancer pain|0|||
30655693|NCT00842829|58668717|FG001|Treatment Period|Unstable persistent cancer pain|0|||
30655694|NCT00842829|58668718|FG002|Treatment Period|Unstable persistent cancer pain|5|||
30655695|NCT00842829|58668716|FG000|Treatment Period|Withdrawal by Subject|0|||
30655696|NCT00842829|58668717|FG001|Treatment Period|Withdrawal by Subject|0|||
30655697|NCT00842829|58668718|FG002|Treatment Period|Withdrawal by Subject|11|||
30655698|NCT00842829|58668716|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
30655699|NCT00842829|58668717|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
30655700|NCT00842829|58668718|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
30655701|NCT00842829|58668716|FG000|Treatment Period|Protocol Violation|0|||
30848825|NCT02848651|58875464|FG000|Overall Study|Symptomatic Deterioration|1|||
30655702|NCT00842829|58668717|FG001|Treatment Period|Protocol Violation|0|||
30655703|NCT00842829|58668718|FG002|Treatment Period|Protocol Violation|2|||
30655704|NCT00842829|58668716|FG000|Treatment Period|Other|0|||
30655705|NCT00842829|58668717|FG001|Treatment Period|Other|0|||
30655706|NCT00842829|58668718|FG002|Treatment Period|Other|18|||
30655707|NCT00842829|58668716|FG000|Treatment Period|Non-compliance to study procedures|0|||
30655708|NCT00842829|58668717|FG001|Treatment Period|Non-compliance to study procedures|0|||
30848826|NCT02848651|58875464|FG000|Overall Study|Physician Decision|4|||
30655709|NCT00842829|58668718|FG002|Treatment Period|Non-compliance to study procedures|4|||
30655710|NCT00842829|58668716|FG000|Treatment Period|Unclear completion status|0|||
30655711|NCT00842829|58668717|FG001|Treatment Period|Unclear completion status|0|||
30655712|NCT00842829|58668718|FG002|Treatment Period|Unclear completion status|1|||
30655713|NCT00842829|58668716|FG000|Continuation Period|Adverse Event|0|||
30655714|NCT00842829|58668717|FG001|Continuation Period|Adverse Event|0|||
30655715|NCT00842829|58668718|FG002|Continuation Period|Adverse Event|32|||
30655716|NCT00842829|58668716|FG000|Continuation Period|Lack of Efficacy|0|||
30655717|NCT00842829|58668717|FG001|Continuation Period|Lack of Efficacy|0|||
30655718|NCT00842829|58668718|FG002|Continuation Period|Lack of Efficacy|6|||
30655719|NCT00842829|58668716|FG000|Continuation Period|Unstable persistent cancer pain|0|||
30655720|NCT00842829|58668717|FG001|Continuation Period|Unstable persistent cancer pain|0|||
30655721|NCT00842829|58668718|FG002|Continuation Period|Unstable persistent cancer pain|3|||
30655722|NCT00842829|58668716|FG000|Continuation Period|Withdrawal by Subject|0|||
30655723|NCT00842829|58668717|FG001|Continuation Period|Withdrawal by Subject|0|||
30655724|NCT00842829|58668718|FG002|Continuation Period|Withdrawal by Subject|10|||
30655725|NCT00842829|58668716|FG000|Continuation Period|Other|0|||
30655726|NCT00842829|58668717|FG001|Continuation Period|Other|0|||
30655727|NCT00842829|58668718|FG002|Continuation Period|Other|7|||
30655728|NCT00842829|58668716|FG000|Continuation Period|Non-compliance to study procedures|0|||
30655729|NCT00842829|58668717|FG001|Continuation Period|Non-compliance to study procedures|0|||
30655730|NCT00842829|58668718|FG002|Continuation Period|Non-compliance to study procedures|2|||
30655731|NCT00842829|58668716|FG000|Continuation Period|Non-compliance to study drug|0|||
30655732|NCT00842829|58668717|FG001|Continuation Period|Non-compliance to study drug|0|||
30655733|NCT00842829|58668718|FG002|Continuation Period|Non-compliance to study drug|1|||
30655734|NCT00653263|58668730|FG000|Overall Study|Withdrawal by Subject|1|||
30655735|NCT00653263|58668730|FG000|Overall Study|Physician Decision|1|||
30655736|NCT00842361|58668736|FG000|Overall Study|Protocol Violation|1|||
30655737|NCT00842361|58668737|FG001|Overall Study|Protocol Violation|0|||
30655738|NCT00842361|58668736|FG000|Overall Study|Unclassified|0|||
30655739|NCT00842361|58668737|FG001|Overall Study|Unclassified|2|||
30655740|NCT00841035|58668743|FG000|Phase 1 Overall Study|Physician Decision|13|||
30655741|NCT00642811|58668754|FG000|Overall Study|Adverse Event|2|||
30655742|NCT00642811|58668755|FG001|Overall Study|Adverse Event|3|||
30655743|NCT00642811|58668756|FG002|Overall Study|Adverse Event|0|||
30655744|NCT00642811|58668757|FG003|Overall Study|Adverse Event|0|||
30655745|NCT00642811|58668758|FG004|Overall Study|Adverse Event|0|||
30655746|NCT00642811|58668759|FG005|Overall Study|Adverse Event|1|||
30655747|NCT00642811|58668754|FG000|Overall Study|Developement of discontinuation criteria|0|||
30655748|NCT00642811|58668755|FG001|Overall Study|Developement of discontinuation criteria|0|||
30655749|NCT00642811|58668756|FG002|Overall Study|Developement of discontinuation criteria|0|||
30655750|NCT00642811|58668757|FG003|Overall Study|Developement of discontinuation criteria|0|||
30655751|NCT00642811|58668758|FG004|Overall Study|Developement of discontinuation criteria|1|||
30655752|NCT00642811|58668759|FG005|Overall Study|Developement of discontinuation criteria|0|||
30655753|NCT00642811|58668754|FG000|Overall Study|Severe Non-compliance to protocol|1|||
30769230|NCT00262301|58778150|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
30769231|NCT00279305|58778160|FG000|Overall Study|Pregnancy|1|||
30769232|NCT00279305|58778161|FG001|Overall Study|Pregnancy|0|||
30769233|NCT00279305|58778160|FG000|Overall Study|Withdrawal by Subject|2|||
30769234|NCT00279305|58778161|FG001|Overall Study|Withdrawal by Subject|0|||
30769235|NCT00279305|58778160|FG000|Overall Study|Dificulting establishing IV|1|||
30769236|NCT00279305|58778161|FG001|Overall Study|Dificulting establishing IV|0|||
30769237|NCT00279305|58778160|FG000|Overall Study|FDA Safety Alert|4|||
30655754|NCT00642811|58668755|FG001|Overall Study|Severe Non-compliance to protocol|0|||
30655755|NCT00642811|58668756|FG002|Overall Study|Severe Non-compliance to protocol|0|||
30655756|NCT00642811|58668757|FG003|Overall Study|Severe Non-compliance to protocol|0|||
30655757|NCT00642811|58668758|FG004|Overall Study|Severe Non-compliance to protocol|0|||
30655758|NCT00642811|58668759|FG005|Overall Study|Severe Non-compliance to protocol|0|||
30655759|NCT00642811|58668754|FG000|Overall Study|Other|0|||
30769238|NCT00279305|58778161|FG001|Overall Study|FDA Safety Alert|1|||
30769239|NCT00278993|58778167|FG000|Overall Study|Adverse Event|24|||
30769240|NCT00278993|58778167|FG000|Overall Study|Withdrawal by Subject|5|||
30769241|NCT00278993|58778167|FG000|Overall Study|Progressive Disease|65|||
30769242|NCT00278993|58778167|FG000|Overall Study|Physician Decision|9|||
30769243|NCT00278993|58778167|FG000|Overall Study|Not Otherwise Specified|4|||
30655760|NCT00642811|58668755|FG001|Overall Study|Other|1|||
30655761|NCT00642811|58668756|FG002|Overall Study|Other|0|||
30655762|NCT00642811|58668757|FG003|Overall Study|Other|1|||
30655763|NCT00642811|58668758|FG004|Overall Study|Other|0|||
30655764|NCT00642811|58668759|FG005|Overall Study|Other|0|||
30655765|NCT00838929|58668776|FG000|Overall Study|Protocol Violation|0|||
30655766|NCT00838929|58668777|FG001|Overall Study|Protocol Violation|1|||
30655767|NCT00838929|58668778|FG002|Overall Study|Protocol Violation|0|||
30655768|NCT00838929|58668776|FG000|Overall Study|Disease progression|0|||
30655769|NCT00838929|58668777|FG001|Overall Study|Disease progression|2|||
30655770|NCT00838929|58668778|FG002|Overall Study|Disease progression|1|||
30655771|NCT00916058|58668791|FG000|Phase 1|Screen Failure|0|||
30655772|NCT00916058|58668792|FG001|Phase 1|Screen Failure|0|||
30655773|NCT00916058|58668793|FG002|Phase 1|Screen Failure|0|||
30655774|NCT00916058|58668794|FG003|Phase 1|Screen Failure|0|||
30655775|NCT00916058|58668795|FG004|Phase 1|Screen Failure|0|||
30655776|NCT00916058|58668796|FG005|Phase 1|Screen Failure|1|||
30655777|NCT00916058|58668797|FG006|Phase 1|Screen Failure|0|||
30655778|NCT00916058|58668791|FG000|Phase 2|Screen Failure|0|||
30655779|NCT00916058|58668792|FG001|Phase 2|Screen Failure|0|||
30655780|NCT00916058|58668793|FG002|Phase 2|Screen Failure|0|||
30655781|NCT00916058|58668794|FG003|Phase 2|Screen Failure|0|||
30655782|NCT00916058|58668795|FG004|Phase 2|Screen Failure|0|||
30655783|NCT00916058|58668796|FG005|Phase 2|Screen Failure|0|||
30655784|NCT00916058|58668797|FG006|Phase 2|Screen Failure|3|||
30655785|NCT00912782|58668817|FG000|Overall Study|Death|2|||
30655786|NCT00912782|58668818|FG001|Overall Study|Death|1|||
30655787|NCT00912782|58668817|FG000|Overall Study|Lost to Follow-up|0|||
30655788|NCT00912782|58668818|FG001|Overall Study|Lost to Follow-up|1|||
30655789|NCT00912782|58668817|FG000|Overall Study|Did not receive vascular access type|1|||
30655790|NCT00912782|58668818|FG001|Overall Study|Did not receive vascular access type|2|||
30655791|NCT00912782|58668817|FG000|Overall Study|Relocated before study completion|0|||
30655792|NCT00912782|58668818|FG001|Overall Study|Relocated before study completion|1|||
30655793|NCT03444038|58668824|FG000|Overall Study|Adverse Event|12|||
30655794|NCT03444038|58668824|FG000|Overall Study|Withdrawal by Subject|7|||
30655795|NCT03444038|58668824|FG000|Overall Study|Lost to Follow-up|1|||
30655796|NCT03444038|58668824|FG000|Overall Study|Physician Decision|2|||
30655797|NCT03444038|58668824|FG000|Overall Study|Lack of Efficacy|7|||
30655798|NCT00911534|58668830|FG000|Overall Study|Adverse Event|4|||
30655799|NCT00911534|58668831|FG001|Overall Study|Adverse Event|4|||
30655800|NCT00911534|58668830|FG000|Overall Study|Lost to Follow-up|2|||
30655801|NCT00911534|58668831|FG001|Overall Study|Lost to Follow-up|4|||
30655802|NCT00911534|58668830|FG000|Overall Study|Withdrawal by Subject|2|||
30655803|NCT00911534|58668831|FG001|Overall Study|Withdrawal by Subject|1|||
30655804|NCT00911534|58668830|FG000|Overall Study|Lack of Efficacy|4|||
30769244|NCT00277355|58778173|FG000|Overall Study|Withdrawal by Subject|3|||
30655805|NCT00911534|58668831|FG001|Overall Study|Lack of Efficacy|1|||
30655806|NCT00911534|58668830|FG000|Overall Study|Withdrawal of consent|1|||
30655807|NCT00911534|58668831|FG001|Overall Study|Withdrawal of consent|4|||
30655808|NCT00911534|58668830|FG000|Overall Study|Other|2|||
30655809|NCT00911534|58668831|FG001|Overall Study|Other|2|||
30655810|NCT00911300|58668839|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
30655811|NCT00911300|58668840|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
30655812|NCT00911300|58668839|FG000|Overall Study|Death|1|||
30655813|NCT00911300|58668840|FG001|Overall Study|Death|0|||
30655814|NCT00911300|58668839|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
30655815|NCT00911300|58668840|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
30655816|NCT00911300|58668839|FG000|Overall Study|Adverse Event|14|||
30769245|NCT00277355|58778174|FG001|Overall Study|Withdrawal by Subject|3|||
30769246|NCT00277355|58778173|FG000|Overall Study|Lost to Follow-up|2|||
30848827|NCT02848651|58875464|FG000|Overall Study|Withdrawal by Subject|14|||
30848828|NCT00709059|58875484|FG000|Overall Study|Lost to Follow-up|34|||
30848829|NCT00709059|58875484|FG000|Overall Study|Withdrawal by Subject|19|||
30655817|NCT00911300|58668840|FG001|Overall Study|Adverse Event|6|||
30655818|NCT00911300|58668839|FG000|Overall Study|Protocol Violation|3|||
30655819|NCT00911300|58668840|FG001|Overall Study|Protocol Violation|2|||
30655820|NCT00911300|58668839|FG000|Overall Study|Consent Withdrawn|4|||
30655821|NCT00911300|58668840|FG001|Overall Study|Consent Withdrawn|12|||
30769247|NCT00277355|58778174|FG001|Overall Study|Lost to Follow-up|2|||
30769248|NCT00277355|58778173|FG000|Overall Study|Adverse Event|5|||
30655822|NCT00911300|58668839|FG000|Overall Study|Coronary Angiography Performed|1|||
30655823|NCT00911300|58668840|FG001|Overall Study|Coronary Angiography Performed|0|||
30655824|NCT00911300|58668839|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
30655825|NCT00911300|58668840|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
30655826|NCT00911300|58668839|FG000|Overall Study|Received Commercial Treatment|1|||
30769249|NCT00277355|58778174|FG001|Overall Study|Adverse Event|0|||
30655827|NCT00911300|58668840|FG001|Overall Study|Received Commercial Treatment|0|||
30655828|NCT00911300|58668839|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
30655829|NCT00911300|58668840|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
30655830|NCT00911300|58668839|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
30655831|NCT00911300|58668840|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
30655832|NCT00911300|58668839|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
30655833|NCT00911300|58668840|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
30655834|NCT00911300|58668839|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
30655835|NCT00911300|58668840|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
30655836|NCT00911300|58668839|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
30655837|NCT00911300|58668840|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
30655838|NCT00911300|58668839|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
30655839|NCT00911300|58668840|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
30655840|NCT00911300|58668839|FG000|Overall Study|International Normalized Ratio Too High|0|||
30655841|NCT00911300|58668840|FG001|Overall Study|International Normalized Ratio Too High|1|||
30655842|NCT00911300|58668839|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
30655843|NCT00911300|58668840|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
30655844|NCT00911300|58668839|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
30655845|NCT00911300|58668840|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
30655846|NCT00911300|58668839|FG000|Overall Study|Physician Decision|0|||
30655847|NCT00911300|58668840|FG001|Overall Study|Physician Decision|1|||
30655848|NCT00911300|58668839|FG000|Overall Study|Treatment Stopped by Mistake|0|||
30655849|NCT00911300|58668840|FG001|Overall Study|Treatment Stopped by Mistake|1|||
30655850|NCT00911300|58668839|FG000|Overall Study|Randomized; No Study Medication Received|0|||
30655851|NCT00911300|58668840|FG001|Overall Study|Randomized; No Study Medication Received|2|||
30655852|NCT00911144|58668849|FG000|Overall Study|Withdrawal by Subject|16|||
30655853|NCT00911144|58668850|FG001|Overall Study|Withdrawal by Subject|5|||
30655854|NCT00910988|58668860|FG000|Overall Study|Lost to Follow-up|2|||
30655855|NCT00910988|58668861|FG001|Overall Study|Lost to Follow-up|4|||
30655856|NCT00910988|58668862|FG002|Overall Study|Lost to Follow-up|3|||
30655857|NCT00910988|58668863|FG003|Overall Study|Lost to Follow-up|0|||
30655858|NCT00644059|58668892|FG000|Overall Study|Lost to Follow-up|37|||
30655859|NCT00644059|58668893|FG001|Overall Study|Lost to Follow-up|34|||
30655860|NCT00644059|58668894|FG002|Overall Study|Lost to Follow-up|16|||
30655861|NCT00644059|58668892|FG000|Overall Study|Withdrawal by Subject|52|||
30655862|NCT00644059|58668893|FG001|Overall Study|Withdrawal by Subject|60|||
30655863|NCT00644059|58668894|FG002|Overall Study|Withdrawal by Subject|30|||
30655864|NCT00644059|58668892|FG000|Overall Study|Adverse Event|8|||
30655865|NCT00644059|58668893|FG001|Overall Study|Adverse Event|5|||
30655866|NCT00644059|58668894|FG002|Overall Study|Adverse Event|1|||
30769250|NCT00277355|58778173|FG000|Overall Study|Death|3|||
30769251|NCT00277355|58778174|FG001|Overall Study|Death|0|||
30769252|NCT00277355|58778173|FG000|Overall Study|Physician Decision|1|||
30769253|NCT00277355|58778174|FG001|Overall Study|Physician Decision|0|||
30769254|NCT00262223|58778183|FG000|Treatment Phase|Withdrawal by Subject|3|||
30769255|NCT00262223|58778184|FG001|Treatment Phase|Withdrawal by Subject|6|||
30769256|NCT00262223|58778183|FG000|Treatment Phase|Adverse Event|1|||
30769257|NCT00262223|58778184|FG001|Treatment Phase|Adverse Event|2|||
30769258|NCT00262223|58778183|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
30769259|NCT00262223|58778184|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
30769260|NCT00262223|58778183|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
30769261|NCT00262223|58778184|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
30769262|NCT00262223|58778183|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
30655867|NCT00644059|58668892|FG000|Overall Study|Inappropriate Enrollment|1|||
30655868|NCT00644059|58668893|FG001|Overall Study|Inappropriate Enrollment|3|||
30655869|NCT00644059|58668894|FG002|Overall Study|Inappropriate Enrollment|0|||
30655870|NCT00644059|58668892|FG000|Overall Study|Protocol Deviation/violation|20|||
30655871|NCT00644059|58668893|FG001|Overall Study|Protocol Deviation/violation|19|||
30655872|NCT00644059|58668894|FG002|Overall Study|Protocol Deviation/violation|15|||
30655873|NCT00644059|58668892|FG000|Overall Study|Unable to classify|6|||
30655874|NCT00644059|58668893|FG001|Overall Study|Unable to classify|2|||
30655875|NCT00644059|58668894|FG002|Overall Study|Unable to classify|3|||
30655876|NCT00643279|58668945|FG000|Overall Study|Death|13|||
30655877|NCT00643279|58668946|FG001|Overall Study|Death|11|||
30655878|NCT00643279|58668945|FG000|Overall Study|Withdrawal by Subject|3|||
30655879|NCT00643279|58668946|FG001|Overall Study|Withdrawal by Subject|0|||
30655880|NCT00643279|58668945|FG000|Overall Study|Lost to Follow-up|0|||
30655881|NCT00643279|58668946|FG001|Overall Study|Lost to Follow-up|1|||
30655882|NCT00643279|58668945|FG000|Overall Study|Physician Decision|0|||
30655883|NCT00643279|58668946|FG001|Overall Study|Physician Decision|1|||
30655884|NCT00910910|58668956|FG000|Overall Study|Adverse Event|63|||
30769263|NCT00262223|58778184|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
30655885|NCT00910910|58668957|FG001|Overall Study|Adverse Event|35|||
30769264|NCT00276419|58778193|FG000|First Intervention|Adverse Event|1|||
30769265|NCT00276419|58778194|FG001|First Intervention|Adverse Event|0|||
30769266|NCT00276419|58778193|FG000|First Intervention|Withdrawal by Subject|0|||
30769267|NCT00276419|58778194|FG001|First Intervention|Withdrawal by Subject|2|||
30769268|NCT00262067|58778215|FG000|Overall Study|Death|190|||
30769269|NCT00262067|58778216|FG001|Overall Study|Death|89|||
30769270|NCT00262067|58778217|FG002|Overall Study|Death|186|||
30769271|NCT00262067|58778218|FG003|Overall Study|Death|99|||
30769272|NCT00262067|58778215|FG000|Overall Study|Lost to Follow-up|5|||
30769273|NCT00262067|58778216|FG001|Overall Study|Lost to Follow-up|4|||
30769274|NCT00262067|58778217|FG002|Overall Study|Lost to Follow-up|7|||
30769275|NCT00262067|58778218|FG003|Overall Study|Lost to Follow-up|5|||
30769276|NCT00262067|58778215|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
30769277|NCT00262067|58778216|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
30769278|NCT00262067|58778217|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
30769279|NCT00262067|58778218|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
30769280|NCT00262067|58778215|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
30769281|NCT00262067|58778216|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
30769282|NCT00262067|58778217|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
30769283|NCT00262067|58778218|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
30769284|NCT00275561|58778230|FG000|Overall Study|Withdrawal by Subject|0|||
30769285|NCT00275561|58778231|FG001|Overall Study|Withdrawal by Subject|1|||
30769286|NCT00275561|58778230|FG000|Overall Study|Travel|1|||
30769287|NCT00275561|58778231|FG001|Overall Study|Travel|1|||
30769288|NCT00275561|58778230|FG000|Overall Study|Scheduling|1|||
30769289|NCT00275561|58778231|FG001|Overall Study|Scheduling|2|||
30769290|NCT00275561|58778230|FG000|Overall Study|Family Issues|0|||
30769291|NCT00275561|58778231|FG001|Overall Study|Family Issues|2|||
30769292|NCT00274937|58778241|FG000|Overall Study|Physician Decision|10|||
30769293|NCT00274937|58778241|FG000|Overall Study|Withdrawal by Subject|6|||
30769294|NCT00274937|58778241|FG000|Overall Study|Progressive Disease|4|||
30769295|NCT00251693|58778248|FG000|Overall Study|Adverse Event|17|||
30769296|NCT00251693|58778249|FG001|Overall Study|Adverse Event|9|||
30769297|NCT00251693|58778250|FG002|Overall Study|Adverse Event|9|||
30769298|NCT00251693|58778248|FG000|Overall Study|Protocol Violation|2|||
30769299|NCT00251693|58778249|FG001|Overall Study|Protocol Violation|0|||
30769300|NCT00251693|58778250|FG002|Overall Study|Protocol Violation|2|||
30769301|NCT00251693|58778248|FG000|Overall Study|Lost to Follow-up|12|||
30769302|NCT00251693|58778249|FG001|Overall Study|Lost to Follow-up|7|||
30769303|NCT00251693|58778250|FG002|Overall Study|Lost to Follow-up|8|||
30769304|NCT00251693|58778248|FG000|Overall Study|Withdrawal by Subject|11|||
30769305|NCT00251693|58778249|FG001|Overall Study|Withdrawal by Subject|17|||
30769306|NCT00251693|58778250|FG002|Overall Study|Withdrawal by Subject|14|||
30769307|NCT00251693|58778248|FG000|Overall Study|Lack of Efficacy|0|||
30769308|NCT00251693|58778249|FG001|Overall Study|Lack of Efficacy|1|||
30769309|NCT00251693|58778250|FG002|Overall Study|Lack of Efficacy|0|||
30769310|NCT00251693|58778248|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
30769311|NCT00251693|58778249|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
30769312|NCT00251693|58778250|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
30769313|NCT00251693|58778248|FG000|Overall Study|Noncompliant|0|||
30769314|NCT00251693|58778249|FG001|Overall Study|Noncompliant|0|||
30769315|NCT00251693|58778250|FG002|Overall Study|Noncompliant|2|||
30769316|NCT00251693|58778248|FG000|Overall Study|Possible Barrett's esophagus|3|||
30769317|NCT00251693|58778249|FG001|Overall Study|Possible Barrett's esophagus|5|||
30769318|NCT00251693|58778250|FG002|Overall Study|Possible Barrett's esophagus|2|||
30769319|NCT00251693|58778248|FG000|Overall Study|Subject request/subject unavailable|1|||
30769320|NCT00251693|58778249|FG001|Overall Study|Subject request/subject unavailable|2|||
30769321|NCT00251693|58778250|FG002|Overall Study|Subject request/subject unavailable|0|||
30769322|NCT00251693|58778248|FG000|Overall Study|Abnormal laboratory findings|0|||
30769323|NCT00251693|58778249|FG001|Overall Study|Abnormal laboratory findings|0|||
30769324|NCT00251693|58778250|FG002|Overall Study|Abnormal laboratory findings|1|||
30769325|NCT00250835|58778258|FG000|Overall Study|Withdrawal by Subject|1|||
30769326|NCT03716024|58778268|FG000|Overall Study|Randomized, not Treated|7|||
30769327|NCT03716024|58778269|FG001|Overall Study|Randomized, not Treated|8|||
30769328|NCT03716024|58778268|FG000|Overall Study|Adverse Event|1|||
30769329|NCT03716024|58778269|FG001|Overall Study|Adverse Event|2|||
30848830|NCT00709059|58875484|FG000|Overall Study|Physician Decision|7|||
30655886|NCT00910910|58668956|FG000|Overall Study|PD without histologic change|27|||
30769330|NCT03716024|58778268|FG000|Overall Study|Treatment Failure|1|||
30848831|NCT00709059|58875484|FG000|Overall Study|Disease complication|3|||
30769331|NCT03716024|58778269|FG001|Overall Study|Treatment Failure|0|||
30769332|NCT03716024|58778268|FG000|Overall Study|Lost to Follow-up|2|||
30769333|NCT03716024|58778269|FG001|Overall Study|Lost to Follow-up|6|||
30769334|NCT03716024|58778268|FG000|Overall Study|Withdrawal by Subject|0|||
30769335|NCT03716024|58778269|FG001|Overall Study|Withdrawal by Subject|1|||
30769336|NCT03716024|58778268|FG000|Overall Study|Missing Reason|0|||
30769337|NCT03716024|58778269|FG001|Overall Study|Missing Reason|1|||
30769338|NCT00250679|58778278|FG000|Overall Study|Adverse Event|12|||
30769339|NCT00250679|58778279|FG001|Overall Study|Adverse Event|15|||
30769340|NCT00250679|58778280|FG002|Overall Study|Adverse Event|16|||
30769341|NCT00250679|58778278|FG000|Overall Study|Protocol Violation|2|||
30769342|NCT00250679|58778279|FG001|Overall Study|Protocol Violation|4|||
30769343|NCT00250679|58778280|FG002|Overall Study|Protocol Violation|3|||
30769344|NCT00250679|58778278|FG000|Overall Study|Withdrawal by Subject|15|||
30769345|NCT00250679|58778279|FG001|Overall Study|Withdrawal by Subject|18|||
30769346|NCT00250679|58778280|FG002|Overall Study|Withdrawal by Subject|15|||
30769347|NCT00250679|58778278|FG000|Overall Study|Lost to Follow-up|3|||
30769348|NCT00250679|58778279|FG001|Overall Study|Lost to Follow-up|4|||
30769349|NCT00250679|58778280|FG002|Overall Study|Lost to Follow-up|2|||
30769350|NCT00250679|58778278|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
30769351|NCT00250679|58778279|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
30769352|NCT00250679|58778280|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
30769353|NCT00250679|58778278|FG000|Overall Study|Lack of Efficacy|0|||
30769354|NCT00250679|58778279|FG001|Overall Study|Lack of Efficacy|1|||
30769355|NCT00250679|58778280|FG002|Overall Study|Lack of Efficacy|3|||
30769356|NCT00250679|58778278|FG000|Overall Study|Technical Holter issues|1|||
30769357|NCT00250679|58778279|FG001|Overall Study|Technical Holter issues|0|||
30769358|NCT00250679|58778280|FG002|Overall Study|Technical Holter issues|2|||
30769359|NCT00250679|58778278|FG000|Overall Study|Moved|1|||
30769360|NCT00250679|58778279|FG001|Overall Study|Moved|1|||
30769361|NCT00250679|58778280|FG002|Overall Study|Moved|0|||
30769362|NCT00250679|58778278|FG000|Overall Study|Non-compliance|1|||
30769363|NCT00250679|58778279|FG001|Overall Study|Non-compliance|1|||
30769364|NCT00250679|58778280|FG002|Overall Study|Non-compliance|0|||
30769365|NCT00250679|58778278|FG000|Overall Study|various single events: hip surgery,diary|3|||
30769366|NCT00250679|58778279|FG001|Overall Study|various single events: hip surgery,diary|1|||
30769367|NCT00250679|58778280|FG002|Overall Study|various single events: hip surgery,diary|1|||
30769368|NCT00261833|58778290|FG000|Overall Study|Death|1|||
30769369|NCT00261833|58778291|FG001|Overall Study|Death|3|||
30769370|NCT00261833|58778290|FG000|Overall Study|Adverse Event|1|||
30769371|NCT00261833|58778291|FG001|Overall Study|Adverse Event|4|||
30769372|NCT00261833|58778290|FG000|Overall Study|Withdrawal by Subject|5|||
30769373|NCT00261833|58778291|FG001|Overall Study|Withdrawal by Subject|7|||
30769374|NCT00261833|58778290|FG000|Overall Study|Protocol Violation|0|||
30769375|NCT00261833|58778291|FG001|Overall Study|Protocol Violation|1|||
30769376|NCT00261833|58778290|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
30769377|NCT00261833|58778291|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
30769378|NCT00261833|58778290|FG000|Overall Study|Lung transplantation|1|||
30769379|NCT00261833|58778291|FG001|Overall Study|Lung transplantation|1|||
30769380|NCT00261833|58778290|FG000|Overall Study|Missing reason|1|||
30769381|NCT00261833|58778291|FG001|Overall Study|Missing reason|0|||
30769382|NCT00261833|58778290|FG000|Overall Study|Not interested in being participant|0|||
30769383|NCT00261833|58778291|FG001|Overall Study|Not interested in being participant|1|||
30769384|NCT03713684|58778302|FG000|Overall Study|Adverse Event|1|||
30769385|NCT03713684|58778303|FG001|Overall Study|Adverse Event|3|||
30769386|NCT03713684|58778304|FG002|Overall Study|Adverse Event|1|||
30769387|NCT03713684|58778305|FG003|Overall Study|Adverse Event|0|||
30769388|NCT03713684|58778302|FG000|Overall Study|Poor compliance to protocol|2|||
30769389|NCT03713684|58778303|FG001|Overall Study|Poor compliance to protocol|1|||
30769390|NCT03713684|58778304|FG002|Overall Study|Poor compliance to protocol|0|||
30769391|NCT03713684|58778305|FG003|Overall Study|Poor compliance to protocol|1|||
30769392|NCT03713684|58778302|FG000|Overall Study|Withdrawal by Subject|14|||
30769393|NCT03713684|58778303|FG001|Overall Study|Withdrawal by Subject|6|||
30769394|NCT03713684|58778304|FG002|Overall Study|Withdrawal by Subject|14|||
30769395|NCT03713684|58778305|FG003|Overall Study|Withdrawal by Subject|16|||
30769396|NCT03713684|58778302|FG000|Overall Study|Other than specified|69|||
30769397|NCT03713684|58778303|FG001|Overall Study|Other than specified|77|||
30769398|NCT03713684|58778304|FG002|Overall Study|Other than specified|73|||
30769399|NCT03713684|58778305|FG003|Overall Study|Other than specified|70|||
30769400|NCT03711266|58778315|FG000|Overall Study|Lost to Follow-up|10|||
30769401|NCT03150862|58778327|FG000|Overall Study|Death|2|||
30769402|NCT03150862|58778328|FG001|Overall Study|Death|7|||
30769403|NCT03150862|58778329|FG002|Overall Study|Death|8|||
30769404|NCT03150862|58778330|FG003|Overall Study|Death|27|||
30848832|NCT00709059|58875484|FG000|Overall Study|Side effects|20|||
30848833|NCT00709059|58875484|FG000|Overall Study|Serious side effects|11|||
30769405|NCT03150862|58778331|FG004|Overall Study|Death|4|||
30769406|NCT03150862|58778332|FG005|Overall Study|Death|8|||
30769407|NCT03150862|58778333|FG006|Overall Study|Death|6|||
30769408|NCT03150862|58778334|FG007|Overall Study|Death|21|||
30769409|NCT03150862|58778327|FG000|Overall Study|Withdrawal by Subject|1|||
30769410|NCT03150862|58778328|FG001|Overall Study|Withdrawal by Subject|1|||
30769411|NCT03150862|58778329|FG002|Overall Study|Withdrawal by Subject|0|||
30769412|NCT03150862|58778330|FG003|Overall Study|Withdrawal by Subject|3|||
30769413|NCT03150862|58778331|FG004|Overall Study|Withdrawal by Subject|1|||
30769414|NCT03150862|58778332|FG005|Overall Study|Withdrawal by Subject|1|||
30769415|NCT03150862|58778333|FG006|Overall Study|Withdrawal by Subject|1|||
30769416|NCT03150862|58778334|FG007|Overall Study|Withdrawal by Subject|3|||
30769417|NCT03150862|58778327|FG000|Overall Study|Lost to Follow-up|0|||
30769418|NCT03150862|58778328|FG001|Overall Study|Lost to Follow-up|0|||
30769419|NCT03150862|58778329|FG002|Overall Study|Lost to Follow-up|1|||
30769420|NCT03150862|58778330|FG003|Overall Study|Lost to Follow-up|0|||
30769421|NCT03150862|58778331|FG004|Overall Study|Lost to Follow-up|0|||
30769422|NCT03150862|58778332|FG005|Overall Study|Lost to Follow-up|0|||
30769423|NCT03150862|58778333|FG006|Overall Study|Lost to Follow-up|0|||
30769424|NCT03150862|58778334|FG007|Overall Study|Lost to Follow-up|2|||
30769425|NCT03150862|58778327|FG000|Overall Study|Sponsor's decision|0|||
30769426|NCT03150862|58778328|FG001|Overall Study|Sponsor's decision|0|||
30769427|NCT03150862|58778329|FG002|Overall Study|Sponsor's decision|0|||
30769428|NCT03150862|58778330|FG003|Overall Study|Sponsor's decision|10|||
30769429|NCT03150862|58778331|FG004|Overall Study|Sponsor's decision|3|||
30769430|NCT03150862|58778332|FG005|Overall Study|Sponsor's decision|0|||
30769431|NCT03150862|58778333|FG006|Overall Study|Sponsor's decision|1|||
30769432|NCT03150862|58778334|FG007|Overall Study|Sponsor's decision|1|||
30769433|NCT03150862|58778327|FG000|Overall Study|Change in Methylation status|0|||
30769434|NCT03150862|58778328|FG001|Overall Study|Change in Methylation status|0|||
30769435|NCT03150862|58778329|FG002|Overall Study|Change in Methylation status|0|||
30769436|NCT03150862|58778330|FG003|Overall Study|Change in Methylation status|0|||
30769437|NCT03150862|58778331|FG004|Overall Study|Change in Methylation status|1|||
30769438|NCT03150862|58778332|FG005|Overall Study|Change in Methylation status|0|||
30769439|NCT03150862|58778333|FG006|Overall Study|Change in Methylation status|0|||
30769440|NCT03150862|58778334|FG007|Overall Study|Change in Methylation status|0|||
30848834|NCT01678898|58875491|FG000|PB-102-F01|Adverse Event|0|||
30655887|NCT00910910|58668957|FG001|Overall Study|PD without histologic change|23|||
30655888|NCT00910910|58668956|FG000|Overall Study|PD with histologic change|0|||
30655889|NCT00910910|58668957|FG001|Overall Study|PD with histologic change|2|||
30655890|NCT00910910|58668956|FG000|Overall Study|Withdrawal by Subject|7|||
30655891|NCT00910910|58668957|FG001|Overall Study|Withdrawal by Subject|5|||
30655892|NCT00910910|58668956|FG000|Overall Study|Lost to Follow-up|2|||
30655893|NCT00910910|58668957|FG001|Overall Study|Lost to Follow-up|2|||
30655894|NCT00910910|58668956|FG000|Overall Study|Death|9|||
30655895|NCT00910910|58668957|FG001|Overall Study|Death|3|||
30655896|NCT00910910|58668956|FG000|Overall Study|Protocol Violation|2|||
30655897|NCT00910910|58668957|FG001|Overall Study|Protocol Violation|2|||
30655898|NCT00910910|58668956|FG000|Overall Study|Completed 13 cycles of treatment|0|||
30655899|NCT00910910|58668957|FG001|Overall Study|Completed 13 cycles of treatment|118|||
30655900|NCT00910910|58668956|FG000|Overall Study|Other|114|||
30655901|NCT00910910|58668957|FG001|Overall Study|Other|32|||
30655902|NCT00910910|58668956|FG000|Overall Study|Untreated before cycle 1|1|||
30655903|NCT00910910|58668957|FG001|Overall Study|Untreated before cycle 1|2|||
30655904|NCT00911768|58668965|FG000|Overall Study|Protocol Violation|5|||
30655905|NCT00911768|58668966|FG001|Overall Study|Protocol Violation|4|||
30655906|NCT00911768|58668965|FG000|Overall Study|Withdrawal by Subject|1|||
30655907|NCT00911768|58668966|FG001|Overall Study|Withdrawal by Subject|0|||
30655908|NCT00909038|58668972|FG000|Overall Study|Protocol Violation|187|||
30655909|NCT00909038|58668972|FG000|Overall Study|Non-evaluable Subjects|230|||
30655910|NCT00909428|58668979|FG000|Overall Study|Lost to Follow-up|13|||
30655911|NCT00909428|58668980|FG001|Overall Study|Lost to Follow-up|10|||
30655912|NCT00909428|58668981|FG002|Overall Study|Lost to Follow-up|9|||
30655913|NCT00908960|58668991|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
30655914|NCT00908960|58668992|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
30655915|NCT00908960|58668993|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
30655916|NCT00650767|58669011|FG000|Overall Study|Adverse Event|0|||
30655917|NCT00650767|58669012|FG001|Overall Study|Adverse Event|3|||
30655918|NCT00650767|58669013|FG002|Overall Study|Adverse Event|10|||
30655919|NCT00650767|58669014|FG003|Overall Study|Adverse Event|8|||
30655920|NCT00650767|58669011|FG000|Overall Study|Death|1|||
30769441|NCT03150862|58778327|FG000|Overall Study|Roll over in to Long Term Extension|0|||
30769442|NCT03150862|58778328|FG001|Overall Study|Roll over in to Long Term Extension|0|||
30769443|NCT03150862|58778329|FG002|Overall Study|Roll over in to Long Term Extension|0|||
30655921|NCT00650767|58669012|FG001|Overall Study|Death|0|||
30655922|NCT00650767|58669013|FG002|Overall Study|Death|0|||
30655923|NCT00650767|58669014|FG003|Overall Study|Death|0|||
30655924|NCT00650767|58669011|FG000|Overall Study|Withdrawal by Subject|2|||
30769444|NCT03150862|58778330|FG003|Overall Study|Roll over in to Long Term Extension|0|||
30769445|NCT03150862|58778331|FG004|Overall Study|Roll over in to Long Term Extension|0|||
30848835|NCT01678898|58875492|FG001|PB-102-F01|Adverse Event|1|||
30769446|NCT03150862|58778332|FG005|Overall Study|Roll over in to Long Term Extension|0|||
30769447|NCT03150862|58778333|FG006|Overall Study|Roll over in to Long Term Extension|0|||
30769448|NCT03150862|58778334|FG007|Overall Study|Roll over in to Long Term Extension|1|||
30655925|NCT00650767|58669012|FG001|Overall Study|Withdrawal by Subject|4|||
30655926|NCT00650767|58669013|FG002|Overall Study|Withdrawal by Subject|3|||
30655927|NCT00650767|58669014|FG003|Overall Study|Withdrawal by Subject|3|||
30655928|NCT00650767|58669011|FG000|Overall Study|Lost to Follow-up|1|||
30655929|NCT00650767|58669012|FG001|Overall Study|Lost to Follow-up|1|||
30655930|NCT00650767|58669013|FG002|Overall Study|Lost to Follow-up|1|||
30655931|NCT00650767|58669014|FG003|Overall Study|Lost to Follow-up|0|||
30655932|NCT00650767|58669011|FG000|Overall Study|Other|1|||
30655933|NCT00650767|58669012|FG001|Overall Study|Other|1|||
30655934|NCT00650767|58669013|FG002|Overall Study|Other|0|||
30655935|NCT00650767|58669014|FG003|Overall Study|Other|0|||
30655936|NCT00973349|58669040|FG000|Overall Study|Adverse Event|0|||
30655937|NCT00973349|58669041|FG001|Overall Study|Adverse Event|0|||
30655938|NCT00973349|58669042|FG002|Overall Study|Adverse Event|0|||
30655939|NCT00973349|58669043|FG003|Overall Study|Adverse Event|0|||
30655940|NCT00973349|58669044|FG004|Overall Study|Adverse Event|1|||
30655941|NCT00973349|58669045|FG005|Overall Study|Adverse Event|0|||
30655942|NCT00973349|58669046|FG006|Overall Study|Adverse Event|0|||
30655943|NCT00973349|58669047|FG007|Overall Study|Adverse Event|0|||
30655944|NCT00973349|58669048|FG008|Overall Study|Adverse Event|1|||
30655945|NCT00973349|58669049|FG009|Overall Study|Adverse Event|0|||
30655946|NCT00973349|58669050|FG010|Overall Study|Adverse Event|0|||
30952420|NCT00081159|59000528|FG000|Overall Study|Lost to Follow-up|2|||
30952421|NCT00081159|59000529|FG001|Overall Study|Lost to Follow-up|1|||
30952422|NCT00080223|59000544|FG000|Overall Study|Adverse Event|23|||
30952423|NCT00080223|59000544|FG000|Overall Study|Death|21|||
30952424|NCT00080223|59000544|FG000|Overall Study|Withdrawal by Subject|13|||
30952425|NCT00080223|59000544|FG000|Overall Study|Lung Transplantation|9|||
30952426|NCT00080223|59000544|FG000|Overall Study|Non-compliance With Study Treatment|7|||
30952427|NCT00080223|59000544|FG000|Overall Study|Participant unwilling to continue|2|||
30952428|NCT00080223|59000544|FG000|Overall Study|Physician Decision|1|||
30952429|NCT01899053|59001155|FG000|Overall Study|Progressive Disease|4|||
30952430|NCT01899053|59001156|FG001|Overall Study|Progressive Disease|0|||
30952431|NCT01899053|59001157|FG002|Overall Study|Progressive Disease|3|||
30952432|NCT01899053|59001158|FG003|Overall Study|Progressive Disease|0|||
30952433|NCT01899053|59001159|FG004|Overall Study|Progressive Disease|3|||
30952434|NCT01899053|59001160|FG005|Overall Study|Progressive Disease|1|||
30952435|NCT01899053|59001161|FG006|Overall Study|Progressive Disease|1|||
30952436|NCT01899053|59001162|FG007|Overall Study|Progressive Disease|1|||
30952437|NCT01899053|59001163|FG008|Overall Study|Progressive Disease|4|||
30952438|NCT01899053|59001164|FG009|Overall Study|Progressive Disease|3|||
30952439|NCT01899053|59001165|FG010|Overall Study|Progressive Disease|12|||
30655947|NCT00973349|58669051|FG011|Overall Study|Adverse Event|0|||
30952440|NCT01899053|59001166|FG011|Overall Study|Progressive Disease|5|||
30952441|NCT01899053|59001167|FG012|Overall Study|Progressive Disease|8|||
30952442|NCT01899053|59001168|FG013|Overall Study|Progressive Disease|17|||
30952443|NCT01899053|59001155|FG000|Overall Study|Adverse Event|1|||
30952444|NCT01899053|59001156|FG001|Overall Study|Adverse Event|1|||
30952445|NCT01899053|59001157|FG002|Overall Study|Adverse Event|1|||
30952446|NCT01899053|59001158|FG003|Overall Study|Adverse Event|3|||
30952447|NCT01899053|59001159|FG004|Overall Study|Adverse Event|1|||
30952448|NCT01899053|59001160|FG005|Overall Study|Adverse Event|1|||
30655948|NCT00973349|58669052|FG012|Overall Study|Adverse Event|0|||
30655949|NCT00973349|58669053|FG013|Overall Study|Adverse Event|0|||
30655950|NCT00973349|58669054|FG014|Overall Study|Adverse Event|1|||
30952449|NCT01899053|59001161|FG006|Overall Study|Adverse Event|1|||
30952450|NCT01899053|59001162|FG007|Overall Study|Adverse Event|0|||
30952451|NCT01899053|59001163|FG008|Overall Study|Adverse Event|2|||
30952452|NCT01899053|59001164|FG009|Overall Study|Adverse Event|0|||
30952453|NCT01899053|59001165|FG010|Overall Study|Adverse Event|3|||
30952454|NCT01899053|59001166|FG011|Overall Study|Adverse Event|1|||
30952455|NCT01899053|59001167|FG012|Overall Study|Adverse Event|2|||
30952456|NCT01899053|59001168|FG013|Overall Study|Adverse Event|2|||
30952457|NCT01899053|59001155|FG000|Overall Study|Reason Not Specified|0|||
30952458|NCT01899053|59001156|FG001|Overall Study|Reason Not Specified|0|||
30952459|NCT01899053|59001157|FG002|Overall Study|Reason Not Specified|0|||
30952460|NCT01899053|59001158|FG003|Overall Study|Reason Not Specified|0|||
30952461|NCT01899053|59001159|FG004|Overall Study|Reason Not Specified|0|||
30952462|NCT01899053|59001160|FG005|Overall Study|Reason Not Specified|0|||
30952463|NCT01899053|59001161|FG006|Overall Study|Reason Not Specified|1|||
30952464|NCT01899053|59001162|FG007|Overall Study|Reason Not Specified|0|||
30952465|NCT01899053|59001163|FG008|Overall Study|Reason Not Specified|0|||
30952466|NCT01899053|59001164|FG009|Overall Study|Reason Not Specified|0|||
30655951|NCT00973349|58669055|FG015|Overall Study|Adverse Event|0|||
30655952|NCT00973349|58669040|FG000|Overall Study|Withdrawal by Subject|1|||
30952467|NCT01899053|59001165|FG010|Overall Study|Reason Not Specified|0|||
30952468|NCT01899053|59001166|FG011|Overall Study|Reason Not Specified|0|||
30952469|NCT01899053|59001167|FG012|Overall Study|Reason Not Specified|1|||
30655953|NCT00973349|58669041|FG001|Overall Study|Withdrawal by Subject|2|||
30655954|NCT00973349|58669042|FG002|Overall Study|Withdrawal by Subject|2|||
30655955|NCT00973349|58669043|FG003|Overall Study|Withdrawal by Subject|3|||
30655956|NCT00973349|58669044|FG004|Overall Study|Withdrawal by Subject|2|||
30655957|NCT00973349|58669045|FG005|Overall Study|Withdrawal by Subject|0|||
30655958|NCT00973349|58669046|FG006|Overall Study|Withdrawal by Subject|2|||
30655959|NCT00973349|58669047|FG007|Overall Study|Withdrawal by Subject|2|||
30655960|NCT00973349|58669048|FG008|Overall Study|Withdrawal by Subject|0|||
30655961|NCT00973349|58669049|FG009|Overall Study|Withdrawal by Subject|2|||
30655962|NCT00973349|58669050|FG010|Overall Study|Withdrawal by Subject|0|||
30655963|NCT00973349|58669051|FG011|Overall Study|Withdrawal by Subject|1|||
30655964|NCT00973349|58669052|FG012|Overall Study|Withdrawal by Subject|0|||
30655965|NCT00973349|58669053|FG013|Overall Study|Withdrawal by Subject|0|||
30655966|NCT00973349|58669054|FG014|Overall Study|Withdrawal by Subject|0|||
30655967|NCT00973349|58669055|FG015|Overall Study|Withdrawal by Subject|0|||
30655968|NCT00973349|58669040|FG000|Overall Study|Lost to Follow-up|3|||
30655969|NCT00973349|58669041|FG001|Overall Study|Lost to Follow-up|1|||
30655970|NCT00973349|58669042|FG002|Overall Study|Lost to Follow-up|2|||
30655971|NCT00973349|58669043|FG003|Overall Study|Lost to Follow-up|2|||
30655972|NCT00973349|58669044|FG004|Overall Study|Lost to Follow-up|1|||
30655973|NCT00973349|58669045|FG005|Overall Study|Lost to Follow-up|3|||
30655974|NCT00973349|58669046|FG006|Overall Study|Lost to Follow-up|0|||
30655975|NCT00973349|58669047|FG007|Overall Study|Lost to Follow-up|1|||
30655976|NCT00973349|58669048|FG008|Overall Study|Lost to Follow-up|2|||
30655977|NCT00973349|58669049|FG009|Overall Study|Lost to Follow-up|1|||
30655978|NCT00973349|58669050|FG010|Overall Study|Lost to Follow-up|0|||
30655979|NCT00973349|58669051|FG011|Overall Study|Lost to Follow-up|1|||
30655980|NCT00973349|58669052|FG012|Overall Study|Lost to Follow-up|0|||
30655981|NCT00973349|58669053|FG013|Overall Study|Lost to Follow-up|0|||
30655982|NCT00973349|58669054|FG014|Overall Study|Lost to Follow-up|0|||
30655983|NCT00973349|58669055|FG015|Overall Study|Lost to Follow-up|1|||
30655984|NCT00973349|58669040|FG000|Overall Study|Inappropriate enrolment|0|||
30655985|NCT00973349|58669041|FG001|Overall Study|Inappropriate enrolment|0|||
30655986|NCT00973349|58669042|FG002|Overall Study|Inappropriate enrolment|1|||
30655987|NCT00973349|58669043|FG003|Overall Study|Inappropriate enrolment|0|||
30655988|NCT00973349|58669044|FG004|Overall Study|Inappropriate enrolment|0|||
30655989|NCT00973349|58669045|FG005|Overall Study|Inappropriate enrolment|0|||
30655990|NCT00973349|58669046|FG006|Overall Study|Inappropriate enrolment|0|||
30655991|NCT00973349|58669047|FG007|Overall Study|Inappropriate enrolment|0|||
30655992|NCT00973349|58669048|FG008|Overall Study|Inappropriate enrolment|0|||
30655993|NCT00973349|58669049|FG009|Overall Study|Inappropriate enrolment|2|||
30655994|NCT00973349|58669050|FG010|Overall Study|Inappropriate enrolment|0|||
30655995|NCT00973349|58669051|FG011|Overall Study|Inappropriate enrolment|0|||
30655996|NCT00973349|58669052|FG012|Overall Study|Inappropriate enrolment|1|||
30769449|NCT03150862|58778327|FG000|Overall Study|Progressive Disease|0|||
30769450|NCT03150862|58778328|FG001|Overall Study|Progressive Disease|0|||
30769451|NCT03150862|58778329|FG002|Overall Study|Progressive Disease|0|||
30769452|NCT03150862|58778330|FG003|Overall Study|Progressive Disease|0|||
30769453|NCT03150862|58778331|FG004|Overall Study|Progressive Disease|0|||
30769454|NCT03150862|58778332|FG005|Overall Study|Progressive Disease|0|||
30769455|NCT03150862|58778333|FG006|Overall Study|Progressive Disease|0|||
30769456|NCT03150862|58778334|FG007|Overall Study|Progressive Disease|2|||
30769457|NCT00260429|58778363|FG000|Overall Study|failure to follow appointments|1|||
30769458|NCT00260429|58778364|FG001|Overall Study|failure to follow appointments|0|||
30769459|NCT00260429|58778363|FG000|Overall Study|scheduled hand surgery|1|||
30769460|NCT00260429|58778364|FG001|Overall Study|scheduled hand surgery|0|||
30769461|NCT00379288|58778374|FG000|Overall Study|Adverse Event|5|||
30769462|NCT00379288|58778375|FG001|Overall Study|Adverse Event|6|||
30769463|NCT00379288|58778376|FG002|Overall Study|Adverse Event|2|||
30848836|NCT01678898|58875493|FG002|PB-102-F01|Adverse Event|0|||
30655997|NCT00973349|58669053|FG013|Overall Study|Inappropriate enrolment|0|||
30655998|NCT00973349|58669054|FG014|Overall Study|Inappropriate enrolment|1|||
30655999|NCT00973349|58669055|FG015|Overall Study|Inappropriate enrolment|1|||
30656000|NCT00973349|58669040|FG000|Overall Study|Protocol Violation|0|||
30656001|NCT00973349|58669041|FG001|Overall Study|Protocol Violation|0|||
30656002|NCT00973349|58669042|FG002|Overall Study|Protocol Violation|0|||
30656003|NCT00973349|58669043|FG003|Overall Study|Protocol Violation|0|||
30656004|NCT00973349|58669044|FG004|Overall Study|Protocol Violation|0|||
30656005|NCT00973349|58669045|FG005|Overall Study|Protocol Violation|0|||
30656006|NCT00973349|58669046|FG006|Overall Study|Protocol Violation|0|||
30656007|NCT00973349|58669047|FG007|Overall Study|Protocol Violation|0|||
30656008|NCT00973349|58669048|FG008|Overall Study|Protocol Violation|1|||
30769464|NCT00379288|58778377|FG003|Overall Study|Adverse Event|0|||
30656009|NCT00973349|58669049|FG009|Overall Study|Protocol Violation|0|||
30848837|NCT01678898|58875491|FG000|PB-102-F01|Physician Decision|0|||
30769465|NCT00379288|58778374|FG000|Overall Study|Treatment Failure|0|||
30769466|NCT00379288|58778375|FG001|Overall Study|Treatment Failure|1|||
30656010|NCT00973349|58669050|FG010|Overall Study|Protocol Violation|0|||
30656011|NCT00973349|58669051|FG011|Overall Study|Protocol Violation|0|||
30656012|NCT00973349|58669052|FG012|Overall Study|Protocol Violation|0|||
30656013|NCT00973349|58669053|FG013|Overall Study|Protocol Violation|0|||
30656014|NCT00973349|58669054|FG014|Overall Study|Protocol Violation|0|||
30656015|NCT00973349|58669055|FG015|Overall Study|Protocol Violation|0|||
30656016|NCT00973349|58669040|FG000|Overall Study|Unable to classify|0|||
30656017|NCT00973349|58669041|FG001|Overall Study|Unable to classify|0|||
30656018|NCT00973349|58669042|FG002|Overall Study|Unable to classify|0|||
30656019|NCT00973349|58669043|FG003|Overall Study|Unable to classify|0|||
30656020|NCT00973349|58669044|FG004|Overall Study|Unable to classify|1|||
30656021|NCT00973349|58669045|FG005|Overall Study|Unable to classify|1|||
30952470|NCT01899053|59001168|FG013|Overall Study|Reason Not Specified|0|||
30952471|NCT01899053|59001155|FG000|Overall Study|Withdrawal by Subject|1|||
30952472|NCT01899053|59001156|FG001|Overall Study|Withdrawal by Subject|1|||
30952473|NCT01899053|59001157|FG002|Overall Study|Withdrawal by Subject|2|||
30952474|NCT01899053|59001158|FG003|Overall Study|Withdrawal by Subject|0|||
30952475|NCT01899053|59001159|FG004|Overall Study|Withdrawal by Subject|2|||
30952476|NCT01899053|59001160|FG005|Overall Study|Withdrawal by Subject|0|||
30952477|NCT01899053|59001161|FG006|Overall Study|Withdrawal by Subject|0|||
30952478|NCT01899053|59001162|FG007|Overall Study|Withdrawal by Subject|1|||
30952479|NCT01899053|59001163|FG008|Overall Study|Withdrawal by Subject|0|||
30952480|NCT01899053|59001164|FG009|Overall Study|Withdrawal by Subject|0|||
30952481|NCT01899053|59001165|FG010|Overall Study|Withdrawal by Subject|0|||
30952482|NCT01899053|59001166|FG011|Overall Study|Withdrawal by Subject|0|||
30952483|NCT01899053|59001167|FG012|Overall Study|Withdrawal by Subject|1|||
30952484|NCT01899053|59001168|FG013|Overall Study|Withdrawal by Subject|1|||
30952485|NCT01899053|59001155|FG000|Overall Study|Protocol Violation|0|||
30769467|NCT00379288|58778376|FG002|Overall Study|Treatment Failure|0|||
30769468|NCT00379288|58778377|FG003|Overall Study|Treatment Failure|1|||
30769469|NCT00379288|58778374|FG000|Overall Study|Lost to Follow-up|3|||
30769470|NCT00379288|58778375|FG001|Overall Study|Lost to Follow-up|3|||
30769471|NCT00379288|58778376|FG002|Overall Study|Lost to Follow-up|2|||
30769472|NCT00379288|58778377|FG003|Overall Study|Lost to Follow-up|0|||
30769473|NCT00379288|58778374|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
30769474|NCT00379288|58778375|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
30769475|NCT00379288|58778376|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
30769476|NCT00379288|58778377|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
30952486|NCT01899053|59001156|FG001|Overall Study|Protocol Violation|0|||
30952487|NCT01899053|59001157|FG002|Overall Study|Protocol Violation|1|||
30952488|NCT01899053|59001158|FG003|Overall Study|Protocol Violation|0|||
30656022|NCT00973349|58669046|FG006|Overall Study|Unable to classify|0|||
30656023|NCT00973349|58669047|FG007|Overall Study|Unable to classify|0|||
30656024|NCT00973349|58669048|FG008|Overall Study|Unable to classify|0|||
30656025|NCT00973349|58669049|FG009|Overall Study|Unable to classify|1|||
30656026|NCT00973349|58669050|FG010|Overall Study|Unable to classify|0|||
30656027|NCT00973349|58669051|FG011|Overall Study|Unable to classify|0|||
30656028|NCT00973349|58669052|FG012|Overall Study|Unable to classify|0|||
30656029|NCT00973349|58669053|FG013|Overall Study|Unable to classify|0|||
30656030|NCT00973349|58669054|FG014|Overall Study|Unable to classify|0|||
30656031|NCT00973349|58669055|FG015|Overall Study|Unable to classify|0|||
30656032|NCT00643201|58669083|FG000|Randomized, Completed 6 Months of Study|Death|20|||
30656033|NCT00643201|58669084|FG001|Randomized, Completed 6 Months of Study|Death|26|||
30656034|NCT00643201|58669083|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
30656035|NCT00643201|58669084|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
30656036|NCT00643201|58669083|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
30656037|NCT00643201|58669084|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
30656038|NCT00643201|58669083|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
30656039|NCT00643201|58669084|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
30769477|NCT00379288|58778374|FG000|Overall Study|Subject withdrew-related to study drug|1|||
30769478|NCT00379288|58778375|FG001|Overall Study|Subject withdrew-related to study drug|0|||
30952489|NCT01899053|59001159|FG004|Overall Study|Protocol Violation|0|||
30952490|NCT01899053|59001160|FG005|Overall Study|Protocol Violation|0|||
30952491|NCT01899053|59001161|FG006|Overall Study|Protocol Violation|0|||
30656040|NCT00643201|58669083|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
30656041|NCT00643201|58669084|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
30656042|NCT00643201|58669083|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
30656043|NCT00643201|58669084|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
30769479|NCT00379288|58778376|FG002|Overall Study|Subject withdrew-related to study drug|0|||
30769480|NCT00379288|58778377|FG003|Overall Study|Subject withdrew-related to study drug|1|||
30952492|NCT01899053|59001162|FG007|Overall Study|Protocol Violation|0|||
30952493|NCT01899053|59001163|FG008|Overall Study|Protocol Violation|0|||
30656044|NCT00643201|58669083|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
30656045|NCT00643201|58669084|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
30656046|NCT00643201|58669083|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
30656047|NCT00643201|58669084|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
30656048|NCT00643201|58669083|FG000|Randomized, Completed 6 Months of Study|Other|107|||
30656049|NCT00643201|58669084|FG001|Randomized, Completed 6 Months of Study|Other|107|||
30656050|NCT00643201|58669083|FG000|Completed Study Follow Up|Death|28|||
30656051|NCT00643201|58669084|FG001|Completed Study Follow Up|Death|34|||
30656052|NCT00643201|58669083|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
30656053|NCT00643201|58669084|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
30656054|NCT00643201|58669083|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
30656055|NCT00643201|58669084|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
30656056|NCT00643201|58669083|FG000|Completed Study Follow Up|non-specified|1|||
30656057|NCT00643201|58669084|FG001|Completed Study Follow Up|non-specified|0|||
30656058|NCT00643123|58669094|FG000|Overall Study|Lost to Follow-up|4|||
30656059|NCT00643123|58669095|FG001|Overall Study|Lost to Follow-up|0|||
30656060|NCT00643123|58669094|FG000|Overall Study|Withdrawal by Subject|1|||
30656061|NCT00643123|58669095|FG001|Overall Study|Withdrawal by Subject|1|||
30656062|NCT00968981|58669104|FG000|Overall Study|Adverse Event|2|||
30656063|NCT00968981|58669105|FG001|Overall Study|Adverse Event|0|||
30769481|NCT00379288|58778374|FG000|Overall Study|Noncompliance with protocol|8|||
30769482|NCT00379288|58778375|FG001|Overall Study|Noncompliance with protocol|6|||
30769483|NCT00379288|58778376|FG002|Overall Study|Noncompliance with protocol|2|||
30769484|NCT00379288|58778377|FG003|Overall Study|Noncompliance with protocol|1|||
30769485|NCT00379288|58778374|FG000|Overall Study|Did not meet protocol eligibility|0|||
30769486|NCT00379288|58778375|FG001|Overall Study|Did not meet protocol eligibility|1|||
30769487|NCT00379288|58778376|FG002|Overall Study|Did not meet protocol eligibility|0|||
30769488|NCT00379288|58778377|FG003|Overall Study|Did not meet protocol eligibility|2|||
30769489|NCT00379288|58778374|FG000|Overall Study|Administrative|2|||
30769490|NCT00379288|58778375|FG001|Overall Study|Administrative|2|||
30769491|NCT00379288|58778376|FG002|Overall Study|Administrative|0|||
30769492|NCT00379288|58778377|FG003|Overall Study|Administrative|1|||
30769493|NCT00243503|58778387|FG000|Overall Study|Adverse Event|11|||
30769494|NCT00243503|58778387|FG000|Overall Study|Withdrawal by Subject|1|||
30769495|NCT00243503|58778387|FG000|Overall Study|Lack of Efficacy|44|||
30769496|NCT00243503|58778387|FG000|Overall Study|Death|1|||
30769497|NCT00243503|58778387|FG000|Overall Study|Other|1|||
30769498|NCT00239837|58778394|FG000|Overall Study|Lost to Follow-up|3|||
30769499|NCT00239837|58778395|FG001|Overall Study|Lost to Follow-up|7|||
30769500|NCT00259649|58778403|FG000|Overall Study|Lost to Follow-up|7|||
30769501|NCT00259649|58778403|FG000|Overall Study|irregular menses|3|||
30656064|NCT00968981|58669106|FG002|Overall Study|Adverse Event|0|||
30656065|NCT00968981|58669104|FG000|Overall Study|Disease Progression|14|||
30656066|NCT00968981|58669105|FG001|Overall Study|Disease Progression|16|||
30656067|NCT00968981|58669106|FG002|Overall Study|Disease Progression|13|||
30769502|NCT03712280|58778411|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
30769503|NCT03712280|58778412|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
30769504|NCT03712280|58778413|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
30769505|NCT03712280|58778414|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
30769506|NCT03712280|58778411|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
30769507|NCT03712280|58778412|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
30769508|NCT03712280|58778413|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
30769509|NCT03712280|58778414|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
30769510|NCT03712280|58778411|FG000|Overall Study|Adverse Event|0|||
30769511|NCT03712280|58778412|FG001|Overall Study|Adverse Event|0|||
30769512|NCT03712280|58778413|FG002|Overall Study|Adverse Event|1|||
30769513|NCT03712280|58778414|FG003|Overall Study|Adverse Event|0|||
30769514|NCT01345240|58778429|FG000|Overall Study|Adverse Event|3|||
30769515|NCT01345240|58778430|FG001|Overall Study|Adverse Event|5|||
30769516|NCT01345240|58778431|FG002|Overall Study|Adverse Event|4|||
30769517|NCT01345240|58778432|FG003|Overall Study|Adverse Event|2|||
30769518|NCT01345240|58778433|FG004|Overall Study|Adverse Event|1|||
30769519|NCT01345240|58778429|FG000|Overall Study|Lost to Follow-up|8|||
30769520|NCT01345240|58778430|FG001|Overall Study|Lost to Follow-up|9|||
30769521|NCT01345240|58778431|FG002|Overall Study|Lost to Follow-up|14|||
30769522|NCT01345240|58778432|FG003|Overall Study|Lost to Follow-up|7|||
30769523|NCT01345240|58778433|FG004|Overall Study|Lost to Follow-up|9|||
30769524|NCT03707912|58778465|FG000|Overall Study|Violation of inclusion criteria|1|||
30769525|NCT03707912|58778466|FG001|Overall Study|Violation of inclusion criteria|0|||
30848838|NCT01678898|58875492|FG001|PB-102-F01|Physician Decision|1|||
30769526|NCT02883244|58778474|FG000|Overall Study|Lost to Follow-up|0|||
30769527|NCT02883244|58778475|FG001|Overall Study|Lost to Follow-up|1|||
30769528|NCT02882854|58778483|FG000|Overall Study|Lost to Follow-up|1|||
30769529|NCT02882854|58778484|FG001|Overall Study|Lost to Follow-up|2|||
30656068|NCT00968981|58669104|FG000|Overall Study|Lost to Follow-up|0|||
30656069|NCT00968981|58669105|FG001|Overall Study|Lost to Follow-up|0|||
30656070|NCT00968981|58669106|FG002|Overall Study|Lost to Follow-up|1|||
30656071|NCT00968981|58669104|FG000|Overall Study|Physician Decision|5|||
30656072|NCT00968981|58669105|FG001|Overall Study|Physician Decision|3|||
30656073|NCT00968981|58669106|FG002|Overall Study|Physician Decision|5|||
30656074|NCT00968981|58669104|FG000|Overall Study|Withdrawal by Subject|1|||
30656075|NCT00968981|58669105|FG001|Overall Study|Withdrawal by Subject|3|||
30656076|NCT00968981|58669106|FG002|Overall Study|Withdrawal by Subject|3|||
30656077|NCT00641719|58669117|FG000|Overall Study|Lack of Efficacy|1|||
30656078|NCT00641719|58669118|FG001|Overall Study|Lack of Efficacy|2|||
30656079|NCT00641719|58669117|FG000|Overall Study|Adverse Event|24|||
30656080|NCT00641719|58669118|FG001|Overall Study|Adverse Event|29|||
30769530|NCT02882854|58778483|FG000|Overall Study|Physician Decision|0|||
30769531|NCT02882854|58778484|FG001|Overall Study|Physician Decision|1|||
30769532|NCT03707522|58778494|FG000|Overall Study|Lost to Follow-up|24|||
30769533|NCT03707522|58778495|FG001|Overall Study|Lost to Follow-up|27|||
30769534|NCT03707522|58778496|FG002|Overall Study|Lost to Follow-up|41|||
30769535|NCT03707522|58778497|FG003|Overall Study|Lost to Follow-up|36|||
30769536|NCT03150082|58778507|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
30769537|NCT03150082|58778508|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
30769538|NCT03142750|58778536|FG000|Overall Study|Lost to Follow-up|4|||
30769539|NCT03142750|58778537|FG001|Overall Study|Lost to Follow-up|1|||
30769540|NCT03149848|58778547|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
30769541|NCT03149848|58778547|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
30769542|NCT03706040|58778557|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
30769543|NCT03706040|58778558|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
30769544|NCT03706040|58778559|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
30769545|NCT03706040|58778560|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
30769546|NCT03706040|58778561|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
30769547|NCT03706040|58778562|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
30769548|NCT03706040|58778563|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
30769549|NCT03706040|58778557|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
30769550|NCT03706040|58778558|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
30769551|NCT03706040|58778559|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
30769552|NCT03706040|58778560|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
30769553|NCT03706040|58778561|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
30769554|NCT03706040|58778562|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
30769555|NCT03706040|58778563|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
30769556|NCT03706040|58778557|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
30769557|NCT03706040|58778558|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
30769558|NCT03706040|58778559|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
30769559|NCT03706040|58778560|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
30769560|NCT03706040|58778561|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
30769561|NCT03706040|58778562|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
30769562|NCT03706040|58778563|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
30769563|NCT03706040|58778557|FG000|Period A (Week 0 to Week 16)|Other|2|||
30769564|NCT03706040|58778558|FG001|Period A (Week 0 to Week 16)|Other|0|||
30769565|NCT03706040|58778559|FG002|Period A (Week 0 to Week 16)|Other|2|||
30769566|NCT03706040|58778560|FG003|Period A (Week 0 to Week 16)|Other|0|||
30769567|NCT03706040|58778561|FG004|Period A (Week 0 to Week 16)|Other|0|||
30769568|NCT03706040|58778562|FG005|Period A (Week 0 to Week 16)|Other|0|||
30769569|NCT03706040|58778563|FG006|Period A (Week 0 to Week 16)|Other|0|||
30769570|NCT03706040|58778557|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
30769571|NCT03706040|58778558|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
30769572|NCT03706040|58778559|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
30769573|NCT03706040|58778560|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
30769574|NCT03706040|58778561|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
30769575|NCT03706040|58778562|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
30769576|NCT03706040|58778563|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
30769577|NCT03706040|58778557|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
30769578|NCT03706040|58778558|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
30769579|NCT03706040|58778559|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
30769580|NCT03706040|58778560|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
30769581|NCT03706040|58778561|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
30769582|NCT03706040|58778562|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
30769583|NCT03706040|58778563|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
30769584|NCT03706040|58778557|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
30769585|NCT03706040|58778558|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
30769586|NCT03706040|58778559|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
30952494|NCT01899053|59001164|FG009|Overall Study|Protocol Violation|0|||
30656081|NCT00641719|58669117|FG000|Overall Study|Withdrawal by Subject|4|||
30656082|NCT00641719|58669118|FG001|Overall Study|Withdrawal by Subject|4|||
30656083|NCT00641719|58669117|FG000|Overall Study|Reason Not Specified|1|||
30656084|NCT00641719|58669118|FG001|Overall Study|Reason Not Specified|2|||
30656085|NCT00648895|58669126|FG000|Overall Study|Lack of Efficacy|0|||
30656086|NCT00648895|58669127|FG001|Overall Study|Lack of Efficacy|1|||
30656087|NCT00975221|58669135|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
30656088|NCT00975221|58669136|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
30656089|NCT00975221|58669135|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
30656090|NCT00975221|58669136|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
30656091|NCT00975221|58669135|FG000|Titration Phase (Weeks 1-12)|Other|0|||
30656092|NCT00975221|58669136|FG001|Titration Phase (Weeks 1-12)|Other|1|||
30656093|NCT00975221|58669135|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
30656094|NCT00975221|58669136|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
30656095|NCT00975221|58669135|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
30656096|NCT00975221|58669136|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
30656097|NCT00975221|58669135|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
30656098|NCT00975221|58669136|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
30656099|NCT00972179|58669151|FG000|Overall Study|Noncompliance|1|||
30656100|NCT00972179|58669152|FG001|Overall Study|Noncompliance|0|||
30656101|NCT00972179|58669153|FG002|Overall Study|Noncompliance|0|||
30656102|NCT00972179|58669154|FG003|Overall Study|Noncompliance|0|||
30656103|NCT00972179|58669155|FG004|Overall Study|Noncompliance|1|||
30656104|NCT00972179|58669156|FG005|Overall Study|Noncompliance|0|||
30656105|NCT00972179|58669157|FG006|Overall Study|Noncompliance|1|||
30656106|NCT00972179|58669151|FG000|Overall Study|Withdrawal by Subject|0|||
30656107|NCT00972179|58669152|FG001|Overall Study|Withdrawal by Subject|3|||
30656108|NCT00972179|58669153|FG002|Overall Study|Withdrawal by Subject|0|||
30656109|NCT00972179|58669154|FG003|Overall Study|Withdrawal by Subject|1|||
30656110|NCT00972179|58669155|FG004|Overall Study|Withdrawal by Subject|0|||
30656111|NCT00972179|58669156|FG005|Overall Study|Withdrawal by Subject|0|||
30656112|NCT00972179|58669157|FG006|Overall Study|Withdrawal by Subject|2|||
30656113|NCT00972179|58669151|FG000|Overall Study|Administrative Decision|0|||
30656114|NCT00972179|58669152|FG001|Overall Study|Administrative Decision|0|||
30656115|NCT00972179|58669153|FG002|Overall Study|Administrative Decision|0|||
30656116|NCT00972179|58669154|FG003|Overall Study|Administrative Decision|0|||
30656117|NCT00972179|58669155|FG004|Overall Study|Administrative Decision|1|||
30656118|NCT00972179|58669156|FG005|Overall Study|Administrative Decision|0|||
30656119|NCT00972179|58669157|FG006|Overall Study|Administrative Decision|0|||
30656120|NCT00972179|58669151|FG000|Overall Study|Lost to Follow-up|0|||
30656121|NCT00972179|58669152|FG001|Overall Study|Lost to Follow-up|0|||
30656122|NCT00972179|58669153|FG002|Overall Study|Lost to Follow-up|1|||
30656123|NCT00972179|58669154|FG003|Overall Study|Lost to Follow-up|0|||
30656124|NCT00972179|58669155|FG004|Overall Study|Lost to Follow-up|0|||
30656125|NCT00972179|58669156|FG005|Overall Study|Lost to Follow-up|3|||
30656126|NCT00972179|58669157|FG006|Overall Study|Lost to Follow-up|1|||
30656127|NCT00906698|58669183|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
30656128|NCT00906698|58669184|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
30656129|NCT00906698|58669185|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
30656130|NCT00906698|58669186|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
30656131|NCT00906698|58669187|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
30656132|NCT00906698|58669188|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
30656133|NCT00906698|58669183|FG000|Overall Study|Adverse Event|0|||
30656134|NCT00906698|58669184|FG001|Overall Study|Adverse Event|0|||
30656135|NCT00906698|58669185|FG002|Overall Study|Adverse Event|2|||
30656136|NCT00906698|58669186|FG003|Overall Study|Adverse Event|0|||
30656137|NCT00906698|58669187|FG004|Overall Study|Adverse Event|4|||
30656138|NCT00906698|58669188|FG005|Overall Study|Adverse Event|1|||
30656139|NCT00906698|58669183|FG000|Overall Study|Disease progression|3|||
30656140|NCT00906698|58669184|FG001|Overall Study|Disease progression|12|||
30656141|NCT00906698|58669185|FG002|Overall Study|Disease progression|4|||
30656142|NCT00906698|58669186|FG003|Overall Study|Disease progression|4|||
30656143|NCT00906698|58669187|FG004|Overall Study|Disease progression|12|||
30656144|NCT00906698|58669188|FG005|Overall Study|Disease progression|4|||
30656145|NCT00906698|58669183|FG000|Overall Study|Withdrawal by Subject|0|||
30952495|NCT01899053|59001165|FG010|Overall Study|Protocol Violation|0|||
30952496|NCT01899053|59001166|FG011|Overall Study|Protocol Violation|0|||
30656146|NCT00906698|58669184|FG001|Overall Study|Withdrawal by Subject|0|||
30656147|NCT00906698|58669185|FG002|Overall Study|Withdrawal by Subject|0|||
30656148|NCT00906698|58669186|FG003|Overall Study|Withdrawal by Subject|0|||
30656149|NCT00906698|58669187|FG004|Overall Study|Withdrawal by Subject|1|||
30656150|NCT00906698|58669188|FG005|Overall Study|Withdrawal by Subject|0|||
30656151|NCT00906698|58669183|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
30656152|NCT00906698|58669184|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
30656153|NCT00906698|58669185|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
30656154|NCT00906698|58669186|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
30656155|NCT00906698|58669187|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
30656156|NCT00906698|58669188|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
30656157|NCT00972023|58669220|FG000|Overall Study|Withdrawal by Subject|1|||
30656158|NCT00971945|58669226|FG000|Overall Study|Progressive Disease|3|||
30656159|NCT00971945|58669226|FG000|Overall Study|Change in treatment policy|1|||
30656160|NCT00971945|58669226|FG000|Overall Study|Other reasons|2|||
30656161|NCT00971867|58669230|FG000|Overall Study|Adverse Event|4|||
30656162|NCT00971867|58669230|FG000|Overall Study|Participant Withdrew Consent|1|||
30656163|NCT00971867|58669230|FG000|Overall Study|Disease Progression|6|||
30656164|NCT00971321|58669236|FG000|Up to Month 7|Withdrawal by Subject|1|||
30656165|NCT00971321|58669237|FG001|Up to Month 7|Withdrawal by Subject|0|||
30656166|NCT00971321|58669236|FG000|Up to Month 7|Migrated/moved from study area|3|||
30656167|NCT00971321|58669237|FG001|Up to Month 7|Migrated/moved from study area|2|||
30656168|NCT00971321|58669236|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
30656169|NCT00971321|58669237|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
30656170|NCT00971321|58669236|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
30656171|NCT00971321|58669237|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
30656172|NCT00971321|58669236|FG000|Up to Month 11-12|Lost to Follow-up|1|||
30656173|NCT00971321|58669237|FG001|Up to Month 11-12|Lost to Follow-up|0|||
30656174|NCT00648739|58669243|FG000|Overall Study|Adverse Event|1|||
30656175|NCT00648739|58669244|FG001|Overall Study|Adverse Event|0|||
30656176|NCT00648739|58669245|FG002|Overall Study|Adverse Event|1|||
30656177|NCT00648739|58669246|FG003|Overall Study|Adverse Event|2|||
30656178|NCT00648739|58669247|FG004|Overall Study|Adverse Event|1|||
30656179|NCT00648739|58669248|FG005|Overall Study|Adverse Event|0|||
30656180|NCT00648739|58669249|FG006|Overall Study|Adverse Event|0|||
30656181|NCT00648739|58669243|FG000|Overall Study|Withdrawal by Subject|1|||
30656182|NCT00648739|58669244|FG001|Overall Study|Withdrawal by Subject|0|||
30656183|NCT00648739|58669245|FG002|Overall Study|Withdrawal by Subject|1|||
30656184|NCT00648739|58669246|FG003|Overall Study|Withdrawal by Subject|0|||
30656185|NCT00648739|58669247|FG004|Overall Study|Withdrawal by Subject|0|||
30656186|NCT00648739|58669248|FG005|Overall Study|Withdrawal by Subject|2|||
30656187|NCT00648739|58669249|FG006|Overall Study|Withdrawal by Subject|0|||
30656188|NCT00648739|58669243|FG000|Overall Study|Lack of Efficacy|0|||
30656189|NCT00648739|58669244|FG001|Overall Study|Lack of Efficacy|0|||
30656190|NCT00648739|58669245|FG002|Overall Study|Lack of Efficacy|0|||
30656191|NCT00648739|58669246|FG003|Overall Study|Lack of Efficacy|0|||
30656192|NCT00648739|58669247|FG004|Overall Study|Lack of Efficacy|1|||
30656193|NCT00648739|58669248|FG005|Overall Study|Lack of Efficacy|2|||
30656194|NCT00648739|58669249|FG006|Overall Study|Lack of Efficacy|0|||
30656195|NCT00648739|58669243|FG000|Overall Study|Investigator Considered it Advisable|0|||
30656196|NCT00648739|58669244|FG001|Overall Study|Investigator Considered it Advisable|0|||
30656197|NCT00648739|58669245|FG002|Overall Study|Investigator Considered it Advisable|0|||
30656198|NCT00648739|58669246|FG003|Overall Study|Investigator Considered it Advisable|0|||
30656199|NCT00648739|58669247|FG004|Overall Study|Investigator Considered it Advisable|0|||
30656200|NCT00648739|58669248|FG005|Overall Study|Investigator Considered it Advisable|1|||
30656201|NCT00648739|58669249|FG006|Overall Study|Investigator Considered it Advisable|1|||
30656202|NCT00648739|58669243|FG000|Overall Study|Death|0|||
30656203|NCT00648739|58669244|FG001|Overall Study|Death|1|||
30769587|NCT03706040|58778560|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
30769588|NCT03706040|58778561|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
30769589|NCT03706040|58778562|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
30769590|NCT03706040|58778563|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
30769591|NCT03706040|58778557|FG000|Period B (Week 16 to Week 52)|Other|0|||
30769592|NCT03706040|58778558|FG001|Period B (Week 16 to Week 52)|Other|0|||
30769593|NCT03706040|58778559|FG002|Period B (Week 16 to Week 52)|Other|0|||
30769594|NCT03706040|58778560|FG003|Period B (Week 16 to Week 52)|Other|4|||
30769595|NCT03706040|58778561|FG004|Period B (Week 16 to Week 52)|Other|5|||
30769596|NCT03706040|58778562|FG005|Period B (Week 16 to Week 52)|Other|23|||
30769597|NCT03706040|58778563|FG006|Period B (Week 16 to Week 52)|Other|17|||
30769598|NCT03770000|58778584|FG000|Overall Study|Premature discontinuation due to PD|0|||
30848839|NCT01678898|58875493|FG002|PB-102-F01|Physician Decision|0|||
30848840|NCT01678820|58875513|FG000|Overall Study|Study Terminated by Sponsor|45|||
30848841|NCT01678820|58875514|FG001|Overall Study|Study Terminated by Sponsor|43|||
30848842|NCT01678820|58875515|FG002|Overall Study|Study Terminated by Sponsor|43|||
30848843|NCT01678820|58875513|FG000|Overall Study|Withdrawal by Subject|2|||
30656204|NCT00648739|58669245|FG002|Overall Study|Death|0|||
30656205|NCT00648739|58669246|FG003|Overall Study|Death|0|||
30656206|NCT00648739|58669247|FG004|Overall Study|Death|0|||
30656207|NCT00648739|58669248|FG005|Overall Study|Death|0|||
30656208|NCT00648739|58669249|FG006|Overall Study|Death|0|||
30656209|NCT00648739|58669243|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
30656210|NCT00648739|58669244|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
30656211|NCT00648739|58669245|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
30656212|NCT00648739|58669246|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
30656213|NCT00648739|58669247|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
30769599|NCT03770000|58778585|FG001|Overall Study|Premature discontinuation due to PD|0|||
30769600|NCT03770000|58778586|FG002|Overall Study|Premature discontinuation due to PD|1|||
30769601|NCT03770000|58778587|FG003|Overall Study|Premature discontinuation due to PD|3|||
30769602|NCT03770000|58778588|FG004|Overall Study|Premature discontinuation due to PD|2|||
30769603|NCT03158272|58778607|FG000|Overall Study|Disease progression|3|||
30769604|NCT03158272|58778608|FG001|Overall Study|Disease progression|3|||
30769605|NCT03158272|58778609|FG002|Overall Study|Disease progression|4|||
30769606|NCT03158272|58778610|FG003|Overall Study|Disease progression|6|||
30769607|NCT03158272|58778607|FG000|Overall Study|Death|0|||
30769608|NCT03158272|58778608|FG001|Overall Study|Death|0|||
30769609|NCT03158272|58778609|FG002|Overall Study|Death|1|||
30769610|NCT03158272|58778610|FG003|Overall Study|Death|0|||
30769611|NCT03158272|58778607|FG000|Overall Study|Other reasons|0|||
30769612|NCT03158272|58778608|FG001|Overall Study|Other reasons|0|||
30769613|NCT03158272|58778609|FG002|Overall Study|Other reasons|1|||
30769614|NCT03158272|58778610|FG003|Overall Study|Other reasons|0|||
30769615|NCT03158272|58778607|FG000|Overall Study|Adverse event unrelated to the drug|0|||
30769616|NCT03158272|58778608|FG001|Overall Study|Adverse event unrelated to the drug|1|||
30769617|NCT03158272|58778609|FG002|Overall Study|Adverse event unrelated to the drug|0|||
30769618|NCT03158272|58778610|FG003|Overall Study|Adverse event unrelated to the drug|0|||
30769619|NCT03705494|58778624|FG000|Overall Study|Lost to Follow-up|2|||
30769620|NCT03705494|58778625|FG001|Overall Study|Lost to Follow-up|1|||
30769621|NCT03705494|58778624|FG000|Overall Study|Withdrawal by Subject|5|||
30769622|NCT03705494|58778625|FG001|Overall Study|Withdrawal by Subject|2|||
30769623|NCT01431508|58778631|FG000|Overall Study|Lack of Efficacy|1|||
30769624|NCT01431508|58778631|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
30769625|NCT00654628|58778635|FG000|6-week Active Treatment Period|Adverse Event|9|||
30769626|NCT00654628|58778635|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
30769627|NCT00654628|58778635|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
30769628|NCT00654628|58778635|FG000|6-week Active Treatment Period|Out of window period|1|||
30769629|NCT00654628|58778635|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
30769630|NCT00654628|58778635|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
30769631|NCT00536380|58778642|FG000|Overall Study|Adverse Event|0|||
30656214|NCT00648739|58669248|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
30656215|NCT00648739|58669249|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
30656216|NCT00648739|58669243|FG000|Overall Study|Follow-up Visits Not Completed|0|||
30656217|NCT00648739|58669244|FG001|Overall Study|Follow-up Visits Not Completed|1|||
30656218|NCT00648739|58669245|FG002|Overall Study|Follow-up Visits Not Completed|0|||
30656219|NCT00648739|58669246|FG003|Overall Study|Follow-up Visits Not Completed|0|||
30656220|NCT00648739|58669247|FG004|Overall Study|Follow-up Visits Not Completed|0|||
30656221|NCT00648739|58669248|FG005|Overall Study|Follow-up Visits Not Completed|0|||
30656222|NCT00648739|58669249|FG006|Overall Study|Follow-up Visits Not Completed|0|||
30656223|NCT00648037|58669270|FG000|Overall Study|Not Treated|1|||
30656224|NCT00648037|58669270|FG000|Overall Study|Withdrawal by Subject|1|||
30656225|NCT00648037|58669270|FG000|Overall Study|Adverse Event|11|||
30656226|NCT00648037|58669270|FG000|Overall Study|Relapse|2|||
30656227|NCT00648037|58669270|FG000|Overall Study|Other|1|||
30656228|NCT00627523|58669276|FG000|Overall Study|Lack of Efficacy|1|||
30656229|NCT00627523|58669277|FG001|Overall Study|Lack of Efficacy|0|||
30656230|NCT00627523|58669276|FG000|Overall Study|Withdrawal by Subject|0|||
30656231|NCT00627523|58669277|FG001|Overall Study|Withdrawal by Subject|2|||
30656232|NCT00627523|58669276|FG000|Overall Study|Other|1|||
30769632|NCT00536380|58778643|FG001|Overall Study|Adverse Event|2|||
30769633|NCT00536380|58778644|FG002|Overall Study|Adverse Event|2|||
30769634|NCT00536380|58778642|FG000|Overall Study|Lost to Follow-up|0|||
30769635|NCT00536380|58778643|FG001|Overall Study|Lost to Follow-up|0|||
30769636|NCT00536380|58778644|FG002|Overall Study|Lost to Follow-up|1|||
30769637|NCT00536380|58778642|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
30769638|NCT00536380|58778643|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
30769639|NCT00536380|58778644|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
30769640|NCT00536380|58778642|FG000|Overall Study|Withdrawal related to study drug|7|||
30769641|NCT00536380|58778643|FG001|Overall Study|Withdrawal related to study drug|5|||
30769642|NCT00536380|58778644|FG002|Overall Study|Withdrawal related to study drug|2|||
30769643|NCT00536380|58778642|FG000|Overall Study|Noncompliance with protocol|3|||
30769644|NCT00536380|58778643|FG001|Overall Study|Noncompliance with protocol|2|||
30769645|NCT00536380|58778644|FG002|Overall Study|Noncompliance with protocol|2|||
30769646|NCT00536380|58778642|FG000|Overall Study|Did not meet protocol eligibility|0|||
30769647|NCT00536380|58778643|FG001|Overall Study|Did not meet protocol eligibility|0|||
30769648|NCT00536380|58778644|FG002|Overall Study|Did not meet protocol eligibility|1|||
30769649|NCT00536380|58778642|FG000|Overall Study|Administrative|0|||
30769650|NCT00536380|58778643|FG001|Overall Study|Administrative|0|||
30769651|NCT00536380|58778644|FG002|Overall Study|Administrative|1|||
30769652|NCT00496834|58778654|FG000|Overall Study|Withdrawal by Subject|4|||
30656233|NCT00627523|58669277|FG001|Overall Study|Other|0|||
30656234|NCT00640393|58669283|FG000|Part 1|Lost to Follow-up|2|||
30769653|NCT00496834|58778655|FG001|Overall Study|Withdrawal by Subject|6|||
30769654|NCT00496834|58778654|FG000|Overall Study|Contraindicated medication administered|0|||
30769655|NCT00496834|58778655|FG001|Overall Study|Contraindicated medication administered|1|||
30769656|NCT00496834|58778654|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
30769657|NCT00496834|58778655|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
30769658|NCT00496834|58778654|FG000|Overall Study|Adverse Event|5|||
30769659|NCT00496834|58778655|FG001|Overall Study|Adverse Event|3|||
30769660|NCT00496834|58778654|FG000|Overall Study|IP administration violation|2|||
30769661|NCT00496834|58778655|FG001|Overall Study|IP administration violation|0|||
30769662|NCT00496834|58778654|FG000|Overall Study|Lost to Follow-up|2|||
30769663|NCT00496834|58778655|FG001|Overall Study|Lost to Follow-up|0|||
30769664|NCT00496834|58778654|FG000|Overall Study|Blood Pressure control failure|2|||
30769665|NCT00496834|58778655|FG001|Overall Study|Blood Pressure control failure|1|||
30769666|NCT05244122|58778663|FG000|Overall Study|Withdrawal by Subject|318|||
30769667|NCT00166504|58778684|FG000|Overall Study|Adverse Event|3|||
30769668|NCT00166504|58778685|FG001|Overall Study|Adverse Event|3|||
30769669|NCT00166504|58778684|FG000|Overall Study|Lost to Follow-up|1|||
30769670|NCT00166504|58778685|FG001|Overall Study|Lost to Follow-up|1|||
30769671|NCT00166504|58778684|FG000|Overall Study|Withdrawal by Subject|1|||
30769672|NCT00166504|58778685|FG001|Overall Study|Withdrawal by Subject|0|||
30769673|NCT03137992|58778691|FG000|Washout Period 1|Adverse Event|1|||
30769674|NCT03137992|58778692|FG001|Washout Period 1|Adverse Event|1|||
30769675|NCT03137992|58778693|FG002|Washout Period 1|Adverse Event|0|||
30769676|NCT03137992|58778694|FG003|Washout Period 1|Adverse Event|0|||
30769677|NCT03137992|58778695|FG004|Washout Period 1|Adverse Event|0|||
30769678|NCT03137992|58778696|FG005|Washout Period 1|Adverse Event|1|||
30769679|NCT03137992|58778691|FG000|Washout Period 1|Withdrawal by Subject|0|||
30769680|NCT03137992|58778692|FG001|Washout Period 1|Withdrawal by Subject|1|||
30769681|NCT03137992|58778693|FG002|Washout Period 1|Withdrawal by Subject|1|||
30769682|NCT03137992|58778694|FG003|Washout Period 1|Withdrawal by Subject|0|||
30769683|NCT03137992|58778695|FG004|Washout Period 1|Withdrawal by Subject|0|||
30769684|NCT03137992|58778696|FG005|Washout Period 1|Withdrawal by Subject|0|||
30769685|NCT03137992|58778691|FG000|Washout Period 1|Principal Investigator Discretion|0|||
30769686|NCT03137992|58778692|FG001|Washout Period 1|Principal Investigator Discretion|1|||
30769687|NCT03137992|58778693|FG002|Washout Period 1|Principal Investigator Discretion|0|||
30769688|NCT03137992|58778694|FG003|Washout Period 1|Principal Investigator Discretion|0|||
30769689|NCT03137992|58778695|FG004|Washout Period 1|Principal Investigator Discretion|0|||
30769690|NCT03137992|58778696|FG005|Washout Period 1|Principal Investigator Discretion|0|||
30769691|NCT03137992|58778691|FG000|Washout Period 1|COPD Exacerbation|1|||
30769692|NCT03137992|58778692|FG001|Washout Period 1|COPD Exacerbation|1|||
30769693|NCT03137992|58778693|FG002|Washout Period 1|COPD Exacerbation|1|||
30769694|NCT03137992|58778694|FG003|Washout Period 1|COPD Exacerbation|0|||
30769695|NCT03137992|58778695|FG004|Washout Period 1|COPD Exacerbation|1|||
30769696|NCT03137992|58778696|FG005|Washout Period 1|COPD Exacerbation|1|||
30769697|NCT03137992|58778691|FG000|Washout Period 1|Subject Noncompliance|1|||
30769698|NCT03137992|58778692|FG001|Washout Period 1|Subject Noncompliance|0|||
30769699|NCT03137992|58778693|FG002|Washout Period 1|Subject Noncompliance|0|||
30769700|NCT03137992|58778694|FG003|Washout Period 1|Subject Noncompliance|0|||
30769701|NCT03137992|58778695|FG004|Washout Period 1|Subject Noncompliance|1|||
30769702|NCT03137992|58778696|FG005|Washout Period 1|Subject Noncompliance|0|||
30848844|NCT01678820|58875514|FG001|Overall Study|Withdrawal by Subject|5|||
30848845|NCT01678820|58875515|FG002|Overall Study|Withdrawal by Subject|2|||
30848846|NCT01678820|58875513|FG000|Overall Study|Protocol Specified Criteria|2|||
30848847|NCT01678820|58875514|FG001|Overall Study|Protocol Specified Criteria|3|||
30848848|NCT01678820|58875515|FG002|Overall Study|Protocol Specified Criteria|1|||
30848849|NCT01678820|58875513|FG000|Overall Study|Adverse Event|2|||
30848850|NCT01678820|58875514|FG001|Overall Study|Adverse Event|2|||
30656235|NCT00640393|58669284|FG001|Part 1|Lost to Follow-up|0|||
30656236|NCT00640393|58669285|FG002|Part 1|Lost to Follow-up|0|||
30656237|NCT00640393|58669283|FG000|Part 1|Withdrawal by Subject|3|||
30656238|NCT00640393|58669284|FG001|Part 1|Withdrawal by Subject|0|||
30656239|NCT00640393|58669285|FG002|Part 1|Withdrawal by Subject|0|||
30656240|NCT00640393|58669283|FG000|Randomization|Withdrawn per protocol|17|||
30656241|NCT00640393|58669284|FG001|Randomization|Withdrawn per protocol|0|||
30656242|NCT00640393|58669285|FG002|Randomization|Withdrawn per protocol|0|||
30656243|NCT00640393|58669283|FG000|Randomization|Never randomized by site|2|||
30656244|NCT00640393|58669284|FG001|Randomization|Never randomized by site|0|||
30656245|NCT00640393|58669285|FG002|Randomization|Never randomized by site|0|||
30769703|NCT03137992|58778691|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
30769704|NCT03137992|58778692|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
30769705|NCT03137992|58778693|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
30769706|NCT03137992|58778694|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
30769707|NCT03137992|58778695|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
30656246|NCT00640393|58669283|FG000|Part 2|Lost to Follow-up|0|||
30656247|NCT00640393|58669284|FG001|Part 2|Lost to Follow-up|2|||
30656248|NCT00640393|58669285|FG002|Part 2|Lost to Follow-up|2|||
30656249|NCT00640393|58669283|FG000|Part 2|Withdrawal by Subject|0|||
30656250|NCT00640393|58669284|FG001|Part 2|Withdrawal by Subject|6|||
30656251|NCT00640393|58669285|FG002|Part 2|Withdrawal by Subject|1|||
30656252|NCT00640393|58669283|FG000|Part 2|Non-adherence|0|||
30656253|NCT00640393|58669284|FG001|Part 2|Non-adherence|1|||
30656254|NCT00640393|58669285|FG002|Part 2|Non-adherence|0|||
30656255|NCT00640393|58669283|FG000|Part 2|Adverse Event|0|||
30656256|NCT00640393|58669284|FG001|Part 2|Adverse Event|1|||
30656257|NCT00640393|58669285|FG002|Part 2|Adverse Event|0|||
30656258|NCT00907478|58669296|FG000|Overall Study|Ineligibility determined|0|||
30656259|NCT00907478|58669297|FG001|Overall Study|Ineligibility determined|0|||
30656260|NCT00907478|58669298|FG002|Overall Study|Ineligibility determined|1|||
30656261|NCT00907478|58669296|FG000|Overall Study|Noncompliance|0|||
30656262|NCT00907478|58669297|FG001|Overall Study|Noncompliance|0|||
30656263|NCT00907478|58669298|FG002|Overall Study|Noncompliance|1|||
30656264|NCT00907478|58669296|FG000|Overall Study|Adverse Event|3|||
30656265|NCT00907478|58669297|FG001|Overall Study|Adverse Event|1|||
30656266|NCT00907478|58669298|FG002|Overall Study|Adverse Event|2|||
30656267|NCT00907478|58669296|FG000|Overall Study|Withdrawal by Subject|8|||
30656268|NCT00907478|58669297|FG001|Overall Study|Withdrawal by Subject|9|||
30656269|NCT00907478|58669298|FG002|Overall Study|Withdrawal by Subject|6|||
30656270|NCT00907478|58669296|FG000|Overall Study|Requirement for alternative therapy|1|||
30656271|NCT00907478|58669297|FG001|Overall Study|Requirement for alternative therapy|2|||
30769708|NCT03137992|58778696|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
30769709|NCT03137992|58778691|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
30769710|NCT03137992|58778692|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
30769711|NCT03137992|58778693|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
30769712|NCT03137992|58778694|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
30656272|NCT00907478|58669298|FG002|Overall Study|Requirement for alternative therapy|3|||
30656273|NCT00907478|58669296|FG000|Overall Study|Physician Decision|2|||
30656274|NCT00907478|58669297|FG001|Overall Study|Physician Decision|0|||
30656275|NCT00907478|58669298|FG002|Overall Study|Physician Decision|3|||
30656276|NCT00907478|58669296|FG000|Overall Study|Death|4|||
30656277|NCT00907478|58669297|FG001|Overall Study|Death|2|||
30656278|NCT00907478|58669298|FG002|Overall Study|Death|1|||
30656279|NCT00907478|58669296|FG000|Overall Study|Protocol-specified criteria|5|||
30656280|NCT00907478|58669297|FG001|Overall Study|Protocol-specified criteria|2|||
30656281|NCT00907478|58669298|FG002|Overall Study|Protocol-specified criteria|3|||
30656282|NCT00907478|58669296|FG000|Overall Study|Pregnancy|0|||
30656283|NCT00907478|58669297|FG001|Overall Study|Pregnancy|1|||
30656284|NCT00907478|58669298|FG002|Overall Study|Pregnancy|1|||
30656285|NCT00907478|58669296|FG000|Overall Study|Lost to Follow-up|1|||
30656286|NCT00907478|58669297|FG001|Overall Study|Lost to Follow-up|0|||
30656287|NCT00907478|58669298|FG002|Overall Study|Lost to Follow-up|0|||
30656288|NCT00907478|58669296|FG000|Overall Study|Other|3|||
30656289|NCT00907478|58669297|FG001|Overall Study|Other|0|||
30656290|NCT00907478|58669298|FG002|Overall Study|Other|1|||
30656291|NCT00627445|58669310|FG000|Overall Study|Adverse Event|3|||
30656292|NCT00627445|58669311|FG001|Overall Study|Adverse Event|3|||
30656293|NCT00627445|58669310|FG000|Overall Study|Lack of Efficacy|0|||
30656294|NCT00627445|58669311|FG001|Overall Study|Lack of Efficacy|1|||
30656295|NCT00627445|58669310|FG000|Overall Study|Other|6|||
30656296|NCT00627445|58669311|FG001|Overall Study|Other|8|||
30656297|NCT00905840|58669319|FG000|Overall Study|Lost to Follow-up|11|||
30656298|NCT00905840|58669319|FG000|Overall Study|Death|3|||
30656299|NCT00905840|58669319|FG000|Overall Study|Withdrawal by Subject|1|||
30656300|NCT00905840|58669319|FG000|Overall Study|Adverse Event|1|||
30656301|NCT00626821|58669326|FG000|Overall Study|Adverse Event|44|||
30656302|NCT00626821|58669326|FG000|Overall Study|Protocol Violation|33|||
30656303|NCT00626821|58669326|FG000|Overall Study|Withdrawal by Subject|10|||
30656304|NCT00626821|58669326|FG000|Overall Study|Physician Decision|9|||
30769713|NCT03137992|58778695|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
30656305|NCT00626821|58669326|FG000|Overall Study|Product dysfunction|21|||
30656306|NCT00626821|58669326|FG000|Overall Study|other/unknown reason|104|||
30656307|NCT00625183|58669330|FG000|Overall Study|Disease Progression|1|||
30656308|NCT00904982|58669340|FG000|Overall Study|Withdrawal by Subject|2|||
30656309|NCT00904982|58669341|FG001|Overall Study|Withdrawal by Subject|0|||
30656310|NCT00904982|58669342|FG002|Overall Study|Withdrawal by Subject|0|||
30656311|NCT00904982|58669343|FG003|Overall Study|Withdrawal by Subject|0|||
30656312|NCT00640315|58669355|FG000|Overall Study|Withdrawal by Subject|0|||
30656313|NCT00640315|58669356|FG001|Overall Study|Withdrawal by Subject|1|||
30656314|NCT00904748|58669362|FG000|Overall Study|Withdrawal by Subject|1|||
30656315|NCT00904748|58669363|FG001|Overall Study|Withdrawal by Subject|1|||
30656316|NCT00904748|58669364|FG002|Overall Study|Withdrawal by Subject|1|||
30656317|NCT00904748|58669365|FG003|Overall Study|Withdrawal by Subject|2|||
30656318|NCT00904748|58669366|FG004|Overall Study|Withdrawal by Subject|0|||
30656319|NCT00904748|58669367|FG005|Overall Study|Withdrawal by Subject|0|||
30656320|NCT00904748|58669362|FG000|Overall Study|Adverse Event|0|||
30656321|NCT00904748|58669363|FG001|Overall Study|Adverse Event|0|||
30656322|NCT00904748|58669364|FG002|Overall Study|Adverse Event|0|||
30656323|NCT00904748|58669365|FG003|Overall Study|Adverse Event|0|||
30656324|NCT00904748|58669366|FG004|Overall Study|Adverse Event|1|||
30656325|NCT00904748|58669367|FG005|Overall Study|Adverse Event|0|||
30656326|NCT00574405|58669378|FG000|Overall Study|Withdrawal by Subject|3|||
30656327|NCT00574405|58669379|FG001|Overall Study|Withdrawal by Subject|2|||
30656328|NCT00971243|58669390|FG000|Double Blind Period|Adverse Event|2|||
30656329|NCT00971243|58669391|FG001|Double Blind Period|Adverse Event|3|||
30656330|NCT00971243|58669392|FG002|Double Blind Period|Adverse Event|2|||
30656331|NCT00971243|58669393|FG003|Double Blind Period|Adverse Event|2|||
30656332|NCT00971243|58669394|FG004|Double Blind Period|Adverse Event|3|||
30656333|NCT00971243|58669390|FG000|Double Blind Period|Lost to Follow-up|0|||
30656334|NCT00971243|58669391|FG001|Double Blind Period|Lost to Follow-up|1|||
30656335|NCT00971243|58669392|FG002|Double Blind Period|Lost to Follow-up|1|||
30656336|NCT00971243|58669393|FG003|Double Blind Period|Lost to Follow-up|0|||
30656337|NCT00971243|58669394|FG004|Double Blind Period|Lost to Follow-up|1|||
30656338|NCT00971243|58669390|FG000|Double Blind Period|Physician Decision|10|||
30656339|NCT00971243|58669391|FG001|Double Blind Period|Physician Decision|6|||
30656340|NCT00971243|58669392|FG002|Double Blind Period|Physician Decision|7|||
30656341|NCT00971243|58669393|FG003|Double Blind Period|Physician Decision|6|||
30656342|NCT00971243|58669394|FG004|Double Blind Period|Physician Decision|7|||
30656343|NCT00971243|58669390|FG000|Double Blind Period|Protocol Violation|2|||
30656344|NCT00971243|58669391|FG001|Double Blind Period|Protocol Violation|0|||
30656345|NCT00971243|58669392|FG002|Double Blind Period|Protocol Violation|3|||
30656346|NCT00971243|58669393|FG003|Double Blind Period|Protocol Violation|2|||
30656347|NCT00971243|58669394|FG004|Double Blind Period|Protocol Violation|2|||
30656348|NCT00971243|58669390|FG000|Double Blind Period|Withdrawal by Subject|4|||
30656349|NCT00971243|58669391|FG001|Double Blind Period|Withdrawal by Subject|1|||
30656350|NCT00971243|58669392|FG002|Double Blind Period|Withdrawal by Subject|4|||
30656351|NCT00971243|58669393|FG003|Double Blind Period|Withdrawal by Subject|4|||
30656352|NCT00971243|58669394|FG004|Double Blind Period|Withdrawal by Subject|4|||
30656353|NCT00971243|58669390|FG000|Double Blind Period|Other reasons|1|||
30656354|NCT00971243|58669391|FG001|Double Blind Period|Other reasons|0|||
30656355|NCT00971243|58669392|FG002|Double Blind Period|Other reasons|2|||
30656356|NCT00971243|58669393|FG003|Double Blind Period|Other reasons|0|||
30656357|NCT00971243|58669394|FG004|Double Blind Period|Other reasons|1|||
30656358|NCT00971243|58669390|FG000|Open-label Period|Adverse Event|1|||
30656359|NCT00971243|58669391|FG001|Open-label Period|Adverse Event|0|||
30769714|NCT03137992|58778696|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
30769715|NCT03137992|58778691|FG000|Period 2 (Visit 3)|Adverse Event|0|||
30769716|NCT03137992|58778692|FG001|Period 2 (Visit 3)|Adverse Event|1|||
30769717|NCT03137992|58778693|FG002|Period 2 (Visit 3)|Adverse Event|0|||
30769718|NCT03137992|58778694|FG003|Period 2 (Visit 3)|Adverse Event|0|||
30769719|NCT03137992|58778695|FG004|Period 2 (Visit 3)|Adverse Event|0|||
30769720|NCT03137992|58778696|FG005|Period 2 (Visit 3)|Adverse Event|0|||
30769721|NCT03137992|58778691|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
30769722|NCT03137992|58778692|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
30769723|NCT03137992|58778693|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
30769724|NCT03137992|58778694|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
30769725|NCT03137992|58778695|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
30769726|NCT03137992|58778696|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
30769727|NCT03137992|58778691|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
30769728|NCT03137992|58778692|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
30769729|NCT03137992|58778693|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
30769730|NCT03137992|58778694|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
30769731|NCT03137992|58778695|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
30769732|NCT03137992|58778696|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
30769733|NCT03137992|58778691|FG000|Washout Period 2|COPD Exacerbation|1|||
30769734|NCT03137992|58778692|FG001|Washout Period 2|COPD Exacerbation|1|||
30769735|NCT03137992|58778693|FG002|Washout Period 2|COPD Exacerbation|0|||
30769736|NCT03137992|58778694|FG003|Washout Period 2|COPD Exacerbation|0|||
30769737|NCT03137992|58778695|FG004|Washout Period 2|COPD Exacerbation|1|||
30769738|NCT03137992|58778696|FG005|Washout Period 2|COPD Exacerbation|0|||
30769739|NCT03137992|58778691|FG000|Washout Period 2|Subject Non-compliance|0|||
30848851|NCT01678820|58875515|FG002|Overall Study|Adverse Event|2|||
30656360|NCT00971243|58669392|FG002|Open-label Period|Adverse Event|1|||
30656361|NCT00971243|58669393|FG003|Open-label Period|Adverse Event|1|||
30656362|NCT00971243|58669394|FG004|Open-label Period|Adverse Event|0|||
30656363|NCT00971243|58669390|FG000|Open-label Period|Physician Decision|5|||
30656364|NCT00971243|58669391|FG001|Open-label Period|Physician Decision|9|||
30656365|NCT00971243|58669392|FG002|Open-label Period|Physician Decision|3|||
30656366|NCT00971243|58669393|FG003|Open-label Period|Physician Decision|7|||
30656367|NCT00971243|58669394|FG004|Open-label Period|Physician Decision|2|||
30656368|NCT00971243|58669390|FG000|Open-label Period|Protocol Violation|1|||
30656369|NCT00971243|58669391|FG001|Open-label Period|Protocol Violation|1|||
30656370|NCT00971243|58669392|FG002|Open-label Period|Protocol Violation|1|||
30769740|NCT03137992|58778692|FG001|Washout Period 2|Subject Non-compliance|1|||
30769741|NCT03137992|58778693|FG002|Washout Period 2|Subject Non-compliance|0|||
30656371|NCT00971243|58669393|FG003|Open-label Period|Protocol Violation|0|||
30656372|NCT00971243|58669394|FG004|Open-label Period|Protocol Violation|1|||
30656373|NCT00971243|58669390|FG000|Open-label Period|Withdrawal by Subject|1|||
30656374|NCT00971243|58669391|FG001|Open-label Period|Withdrawal by Subject|0|||
30656375|NCT00971243|58669392|FG002|Open-label Period|Withdrawal by Subject|0|||
30656376|NCT00971243|58669393|FG003|Open-label Period|Withdrawal by Subject|2|||
30656377|NCT00971243|58669394|FG004|Open-label Period|Withdrawal by Subject|1|||
30656378|NCT00971243|58669390|FG000|Open-label Period|Other reason|0|||
30656379|NCT00971243|58669391|FG001|Open-label Period|Other reason|0|||
30656380|NCT00971243|58669392|FG002|Open-label Period|Other reason|0|||
30656381|NCT00971243|58669393|FG003|Open-label Period|Other reason|0|||
30656382|NCT00971243|58669394|FG004|Open-label Period|Other reason|2|||
30656383|NCT00568555|58669408|FG000|Overall Study|Withdrawal by Subject|1|||
30656384|NCT00568555|58669409|FG001|Overall Study|Withdrawal by Subject|1|||
30656385|NCT00904670|58669417|FG000|Open Label Phase|Withdrawal by Subject|2|||
30656386|NCT00904670|58669418|FG001|Open Label Phase|Withdrawal by Subject|0|||
30656387|NCT00904670|58669417|FG000|Open Label Phase|Adverse Event|2|||
30952497|NCT01899053|59001167|FG012|Overall Study|Protocol Violation|0|||
30952498|NCT01899053|59001168|FG013|Overall Study|Protocol Violation|0|||
30952499|NCT01899053|59001155|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
30952500|NCT01899053|59001156|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
30656388|NCT00904670|58669418|FG001|Open Label Phase|Adverse Event|0|||
30656389|NCT00904670|58669417|FG000|Open Label Phase|Lack of Efficacy|1|||
30656390|NCT00904670|58669418|FG001|Open Label Phase|Lack of Efficacy|0|||
30656391|NCT00904670|58669417|FG000|Open Label Phase|Lost to Follow-up|1|||
30656392|NCT00904670|58669418|FG001|Open Label Phase|Lost to Follow-up|0|||
30656393|NCT00638443|58669426|FG000|First Intervention|Adverse Event|2|||
30656394|NCT00638443|58669427|FG001|First Intervention|Adverse Event|1|||
30656395|NCT00636181|58669438|FG000|Overall Study|Withdrawal by Subject|8|||
30656396|NCT00636181|58669439|FG001|Overall Study|Withdrawal by Subject|6|||
30656397|NCT00636181|58669440|FG002|Overall Study|Withdrawal by Subject|10|||
30656398|NCT00968669|58669452|FG000|Overall Study|Lost to Follow-up|5|||
30656399|NCT00968669|58669453|FG001|Overall Study|Lost to Follow-up|2|||
30656400|NCT00968669|58669454|FG002|Overall Study|Lost to Follow-up|1|||
30656401|NCT00968669|58669455|FG003|Overall Study|Lost to Follow-up|4|||
30656402|NCT00968669|58669452|FG000|Overall Study|Withdrawal by Subject|9|||
30656403|NCT00968669|58669453|FG001|Overall Study|Withdrawal by Subject|7|||
30656404|NCT00968669|58669454|FG002|Overall Study|Withdrawal by Subject|5|||
30656405|NCT00968669|58669455|FG003|Overall Study|Withdrawal by Subject|3|||
30656406|NCT00968669|58669452|FG000|Overall Study|Pregnancy|0|||
30656407|NCT00968669|58669453|FG001|Overall Study|Pregnancy|0|||
30656408|NCT00968669|58669454|FG002|Overall Study|Pregnancy|2|||
30656409|NCT00968669|58669455|FG003|Overall Study|Pregnancy|0|||
30656410|NCT00968669|58669452|FG000|Overall Study|AE|1|||
30656411|NCT00968669|58669453|FG001|Overall Study|AE|0|||
30656412|NCT00968669|58669454|FG002|Overall Study|AE|0|||
30656413|NCT00968669|58669455|FG003|Overall Study|AE|0|||
30656414|NCT00968669|58669452|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
30656415|NCT00968669|58669453|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
30656416|NCT00968669|58669454|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
30656417|NCT00968669|58669455|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
30656418|NCT00968669|58669452|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
30656419|NCT00968669|58669453|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
30656420|NCT00968669|58669454|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
30656421|NCT00968669|58669455|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
30656422|NCT00968669|58669452|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
30769742|NCT03137992|58778694|FG003|Washout Period 2|Subject Non-compliance|0|||
30769743|NCT03137992|58778695|FG004|Washout Period 2|Subject Non-compliance|0|||
30769744|NCT03137992|58778696|FG005|Washout Period 2|Subject Non-compliance|0|||
30769745|NCT03137992|58778691|FG000|Washout Period 2|Adverse Event|0|||
30769746|NCT03137992|58778692|FG001|Washout Period 2|Adverse Event|0|||
30769747|NCT03137992|58778693|FG002|Washout Period 2|Adverse Event|0|||
30769748|NCT03137992|58778694|FG003|Washout Period 2|Adverse Event|1|||
30769749|NCT03137992|58778695|FG004|Washout Period 2|Adverse Event|1|||
30769750|NCT03137992|58778696|FG005|Washout Period 2|Adverse Event|0|||
30769751|NCT03137992|58778691|FG000|Washout Period 2|Withdrawal by Subject|1|||
30769752|NCT03137992|58778692|FG001|Washout Period 2|Withdrawal by Subject|0|||
30769753|NCT03137992|58778693|FG002|Washout Period 2|Withdrawal by Subject|0|||
30656423|NCT00968669|58669453|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
30656424|NCT00968669|58669454|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
30656425|NCT00968669|58669455|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
30656426|NCT00968669|58669452|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
30656427|NCT00968669|58669453|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
30656428|NCT00968669|58669454|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
30769754|NCT03137992|58778694|FG003|Washout Period 2|Withdrawal by Subject|0|||
30769755|NCT03137992|58778695|FG004|Washout Period 2|Withdrawal by Subject|1|||
30769756|NCT03137992|58778696|FG005|Washout Period 2|Withdrawal by Subject|0|||
30769757|NCT03137992|58778691|FG000|Washout Period 2|Sponsor Decision|0|||
30769758|NCT03137992|58778692|FG001|Washout Period 2|Sponsor Decision|0|||
30769759|NCT03137992|58778693|FG002|Washout Period 2|Sponsor Decision|0|||
30769760|NCT03137992|58778694|FG003|Washout Period 2|Sponsor Decision|0|||
30769761|NCT03137992|58778695|FG004|Washout Period 2|Sponsor Decision|0|||
30769762|NCT03137992|58778696|FG005|Washout Period 2|Sponsor Decision|1|||
30769763|NCT03137992|58778691|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
30656429|NCT00968669|58669455|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
30656430|NCT00968669|58669452|FG000|Overall Study|EARLY WITHDRAWAL|0|||
30656431|NCT00968669|58669453|FG001|Overall Study|EARLY WITHDRAWAL|1|||
30656432|NCT00968669|58669454|FG002|Overall Study|EARLY WITHDRAWAL|0|||
30656433|NCT00968669|58669455|FG003|Overall Study|EARLY WITHDRAWAL|0|||
30656434|NCT00968669|58669452|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
30656435|NCT00968669|58669453|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
30656436|NCT00968669|58669454|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
30656437|NCT00968669|58669455|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
30656438|NCT00968669|58669452|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
30656439|NCT00968669|58669453|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
30656440|NCT00968669|58669454|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
30656441|NCT00968669|58669455|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
30656442|NCT00968669|58669452|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
30656443|NCT00968669|58669453|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
30656444|NCT00968669|58669454|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
30656445|NCT00968669|58669455|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
30656446|NCT00968669|58669452|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
30656447|NCT00968669|58669453|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
30656448|NCT00968669|58669454|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
30656449|NCT00968669|58669455|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
30656450|NCT00968669|58669452|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
30656451|NCT00968669|58669453|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
30656452|NCT00968669|58669454|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
30656453|NCT00968669|58669455|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
30656454|NCT00968669|58669452|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
30656455|NCT00968669|58669453|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
30656456|NCT00968669|58669454|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
30656457|NCT00968669|58669455|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
30656458|NCT00968669|58669452|FG000|Overall Study|SPONSOR DECISION|0|||
30656459|NCT00968669|58669453|FG001|Overall Study|SPONSOR DECISION|1|||
30656460|NCT00968669|58669454|FG002|Overall Study|SPONSOR DECISION|0|||
30656461|NCT00968669|58669455|FG003|Overall Study|SPONSOR DECISION|0|||
30656462|NCT00968669|58669452|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
30656463|NCT00968669|58669453|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
30656464|NCT00968669|58669454|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
30656465|NCT00968669|58669455|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
30656466|NCT00968669|58669452|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
30656467|NCT00968669|58669453|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
30656468|NCT00968669|58669454|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
30656469|NCT00968669|58669455|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
30656470|NCT00968669|58669452|FG000|Overall Study|SUBJECT INCARCERATED|0|||
30656471|NCT00968669|58669453|FG001|Overall Study|SUBJECT INCARCERATED|1|||
30656472|NCT00968669|58669454|FG002|Overall Study|SUBJECT INCARCERATED|0|||
30656473|NCT00968669|58669455|FG003|Overall Study|SUBJECT INCARCERATED|0|||
30656474|NCT00968669|58669452|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
30656475|NCT00968669|58669453|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
30656476|NCT00968669|58669454|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
30656477|NCT00968669|58669455|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
30769764|NCT03137992|58778692|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
30769765|NCT03137992|58778693|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
30769766|NCT03137992|58778694|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
30769767|NCT03137992|58778695|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
30769768|NCT03137992|58778696|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
30769769|NCT03137992|58778691|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
30769770|NCT03137992|58778692|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
30848852|NCT01678820|58875513|FG000|Overall Study|Lost to Follow-up|7|||
30656478|NCT00968669|58669452|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
30656479|NCT00968669|58669453|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
30656480|NCT00968669|58669454|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
30656481|NCT00968669|58669455|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
30848853|NCT01678820|58875514|FG001|Overall Study|Lost to Follow-up|2|||
30769771|NCT03137992|58778693|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
30769772|NCT03137992|58778694|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
30769773|NCT03137992|58778695|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
30769774|NCT03137992|58778696|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
30769775|NCT03137992|58778691|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
30769776|NCT03137992|58778692|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
30769777|NCT03137992|58778693|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
30769778|NCT03137992|58778694|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
30769779|NCT03137992|58778695|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
30769780|NCT03137992|58778696|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
30769781|NCT03137992|58778691|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
30769782|NCT03137992|58778692|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
30769783|NCT03137992|58778693|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
30769784|NCT03137992|58778694|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
30769785|NCT03137992|58778695|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
30769786|NCT03137992|58778696|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
30769787|NCT03137992|58778691|FG000|Part 2 (Open-label Extension)|Per study team|1|||
30656482|NCT00568399|58669465|FG000|Overall Study|Death|2|||
30656483|NCT00568399|58669465|FG000|Overall Study|Adverse Event|5|||
30656484|NCT00568399|58669465|FG000|Overall Study|Withdrawal by Subject|8|||
30656485|NCT00975143|58669471|FG000|Overall Study|Adverse Event|19|||
30656486|NCT00975143|58669472|FG001|Overall Study|Adverse Event|15|||
30769788|NCT03137992|58778692|FG001|Part 2 (Open-label Extension)|Per study team|0|||
30769789|NCT03137992|58778693|FG002|Part 2 (Open-label Extension)|Per study team|0|||
30769790|NCT03137992|58778694|FG003|Part 2 (Open-label Extension)|Per study team|0|||
30769791|NCT03137992|58778695|FG004|Part 2 (Open-label Extension)|Per study team|0|||
30769792|NCT03137992|58778696|FG005|Part 2 (Open-label Extension)|Per study team|0|||
30769793|NCT03137992|58778691|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
30769794|NCT03137992|58778692|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
30769795|NCT03137992|58778693|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
30769796|NCT03137992|58778694|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
30769797|NCT03137992|58778695|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
30769798|NCT03137992|58778696|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
30769799|NCT03704636|58778704|FG000|Overall Study|Inadequate Venous Flow|3|||
30769800|NCT05096312|58778719|FG000|Overall Study|Lost to Follow-up|2|||
30769801|NCT05096312|58778720|FG001|Overall Study|Lost to Follow-up|4|||
30769802|NCT05096312|58778719|FG000|Overall Study|Adverse Event|1|||
30769803|NCT05096312|58778720|FG001|Overall Study|Adverse Event|0|||
30769804|NCT04908488|58778728|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
30769805|NCT04908488|58778729|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
30769806|NCT04908488|58778728|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
30769807|NCT04908488|58778729|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
30769808|NCT04876274|58778740|FG000|Overall Study|Lost to Follow-up|9|||
30769809|NCT04876274|58778741|FG001|Overall Study|Lost to Follow-up|12|||
30769810|NCT04865354|58778749|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
30769811|NCT04865354|58778750|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
30769812|NCT04865354|58778749|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
30769813|NCT04865354|58778750|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
30769814|NCT04865354|58778749|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
30769815|NCT04865354|58778750|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
30769816|NCT04860518|58778761|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
30769817|NCT04860518|58778762|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
30769818|NCT03110380|58778770|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
30769819|NCT03110380|58778771|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
30769820|NCT03110380|58778772|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
30769821|NCT03110380|58778773|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
30769822|NCT03110380|58778770|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
30769823|NCT03110380|58778771|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
30769824|NCT03110380|58778772|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
30769825|NCT03110380|58778773|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
30769826|NCT03110380|58778770|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
30769827|NCT03110380|58778771|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
30769828|NCT03110380|58778772|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
30769829|NCT03110380|58778773|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
30769830|NCT03110380|58778770|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
30769831|NCT03110380|58778771|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
30848854|NCT01678820|58875515|FG002|Overall Study|Lost to Follow-up|2|||
30848855|NCT01678820|58875513|FG000|Overall Study|Non-compliance with study drug|0|||
30848856|NCT01678820|58875514|FG001|Overall Study|Non-compliance with study drug|1|||
30656487|NCT00975143|58669471|FG000|Overall Study|Withdrawal by Subject|15|||
30656488|NCT00975143|58669472|FG001|Overall Study|Withdrawal by Subject|15|||
30656489|NCT00975143|58669471|FG000|Overall Study|Lost to Follow-up|20|||
30656490|NCT00975143|58669472|FG001|Overall Study|Lost to Follow-up|16|||
30656491|NCT00975143|58669471|FG000|Overall Study|Non-compliance|5|||
30656492|NCT00975143|58669472|FG001|Overall Study|Non-compliance|8|||
30656493|NCT00975143|58669471|FG000|Overall Study|Physician Decision|1|||
30656494|NCT00975143|58669472|FG001|Overall Study|Physician Decision|2|||
30656495|NCT00975143|58669471|FG000|Overall Study|Details not available|10|||
30656496|NCT00975143|58669472|FG001|Overall Study|Details not available|4|||
30656497|NCT00974675|58669495|FG000|Overall Study|Adverse Event|2|||
30656498|NCT00974675|58669496|FG001|Overall Study|Adverse Event|1|||
30656499|NCT00974675|58669497|FG002|Overall Study|Adverse Event|1|||
30656500|NCT00974675|58669498|FG003|Overall Study|Adverse Event|1|||
30656501|NCT00974675|58669495|FG000|Overall Study|Physician Decision|0|||
30656502|NCT00974675|58669496|FG001|Overall Study|Physician Decision|0|||
30656503|NCT00974675|58669497|FG002|Overall Study|Physician Decision|1|||
30656504|NCT00974675|58669498|FG003|Overall Study|Physician Decision|0|||
30656505|NCT00974675|58669495|FG000|Overall Study|Participant on holiday; unable to attend|0|||
30656506|NCT00974675|58669496|FG001|Overall Study|Participant on holiday; unable to attend|0|||
30769832|NCT03110380|58778772|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
30769833|NCT03110380|58778773|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
30769834|NCT03110380|58778770|FG000|Double-Blind Treatment Phase|Death|2|||
30656507|NCT00974675|58669497|FG002|Overall Study|Participant on holiday; unable to attend|0|||
30656508|NCT00974675|58669498|FG003|Overall Study|Participant on holiday; unable to attend|1|||
30656509|NCT00634933|58669511|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
30656510|NCT00634933|58669512|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
30656511|NCT00634933|58669513|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
30656512|NCT00634933|58669514|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
30769835|NCT03110380|58778771|FG001|Double-Blind Treatment Phase|Death|1|||
30769836|NCT03110380|58778772|FG002|Double-Blind Treatment Phase|Death|0|||
30769837|NCT03110380|58778773|FG003|Double-Blind Treatment Phase|Death|0|||
30769838|NCT03110380|58778770|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
30769839|NCT03110380|58778771|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
30769840|NCT03110380|58778772|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
30769841|NCT03110380|58778773|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
30769842|NCT03110380|58778770|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
30769843|NCT03110380|58778771|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
30769844|NCT03110380|58778772|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
30769845|NCT03110380|58778773|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
30769846|NCT03110380|58778770|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
30656513|NCT00634933|58669515|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
30656514|NCT00634933|58669511|FG000|Part A: Baseline to Week 24|Death|1|||
30656515|NCT00634933|58669512|FG001|Part A: Baseline to Week 24|Death|0|||
30656516|NCT00634933|58669513|FG002|Part A: Baseline to Week 24|Death|0|||
30656517|NCT00634933|58669514|FG003|Part A: Baseline to Week 24|Death|0|||
30656518|NCT00634933|58669515|FG004|Part A: Baseline to Week 24|Death|0|||
30656519|NCT00634933|58669511|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
30656520|NCT00634933|58669512|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
30656521|NCT00634933|58669513|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
30656522|NCT00634933|58669514|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
30656523|NCT00634933|58669515|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
30656524|NCT00634933|58669511|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
30656525|NCT00634933|58669512|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
30656526|NCT00634933|58669513|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
30656527|NCT00634933|58669514|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
30656528|NCT00634933|58669515|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
30656529|NCT00634933|58669511|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
30656530|NCT00634933|58669512|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
30656531|NCT00634933|58669513|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
30656532|NCT00634933|58669514|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
30656533|NCT00634933|58669515|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
30656534|NCT00634933|58669511|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
30656535|NCT00634933|58669512|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
30656536|NCT00634933|58669513|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
30656537|NCT00634933|58669514|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
30656538|NCT00634933|58669515|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
30656539|NCT00634933|58669511|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
30656540|NCT00634933|58669512|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
30656541|NCT00634933|58669513|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
30656542|NCT00634933|58669514|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
30769847|NCT03110380|58778771|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
30848857|NCT01678820|58875515|FG002|Overall Study|Non-compliance with study drug|0|||
30656543|NCT00634933|58669515|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
30656544|NCT00634933|58669511|FG000|Part A: Baseline to Week 24|Other|1|||
30656545|NCT00634933|58669512|FG001|Part A: Baseline to Week 24|Other|8|||
30656546|NCT00634933|58669513|FG002|Part A: Baseline to Week 24|Other|5|||
30656547|NCT00634933|58669514|FG003|Part A: Baseline to Week 24|Other|0|||
30656548|NCT00634933|58669515|FG004|Part A: Baseline to Week 24|Other|0|||
30656549|NCT00634933|58669511|FG000|Between Part A and Part B|Physician Decision|0|||
30656550|NCT00634933|58669512|FG001|Between Part A and Part B|Physician Decision|1|||
30656551|NCT00634933|58669513|FG002|Between Part A and Part B|Physician Decision|0|||
30656552|NCT00634933|58669514|FG003|Between Part A and Part B|Physician Decision|0|||
30656553|NCT00634933|58669515|FG004|Between Part A and Part B|Physician Decision|0|||
30656554|NCT00634933|58669511|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
30656555|NCT00634933|58669512|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
30656556|NCT00634933|58669513|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
30656557|NCT00634933|58669514|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
30656558|NCT00634933|58669515|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
30656559|NCT00634933|58669511|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
30656560|NCT00634933|58669512|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
30656561|NCT00634933|58669513|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
30656562|NCT00634933|58669514|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
30656563|NCT00634933|58669515|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
30656564|NCT00634933|58669511|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
30656565|NCT00634933|58669512|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
30656566|NCT00634933|58669513|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
30656567|NCT00634933|58669514|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
30656568|NCT00634933|58669515|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
30656569|NCT00634933|58669511|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
30656570|NCT00634933|58669512|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
30656571|NCT00634933|58669513|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
30656572|NCT00634933|58669514|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
30656573|NCT00634933|58669515|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
30656574|NCT00634933|58669511|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
30656575|NCT00634933|58669512|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
30656576|NCT00634933|58669513|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
30656577|NCT00634933|58669514|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
30656578|NCT00634933|58669515|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
30656579|NCT00634933|58669511|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
30656580|NCT00634933|58669512|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
30656581|NCT00634933|58669513|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
30656582|NCT00634933|58669514|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
30656583|NCT00634933|58669515|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
30656584|NCT00634933|58669511|FG000|Part B: Week 24 to Week 52|Other|0|||
30656585|NCT00634933|58669512|FG001|Part B: Week 24 to Week 52|Other|0|||
30656586|NCT00634933|58669513|FG002|Part B: Week 24 to Week 52|Other|5|||
30656587|NCT00634933|58669514|FG003|Part B: Week 24 to Week 52|Other|0|||
30656588|NCT00634933|58669515|FG004|Part B: Week 24 to Week 52|Other|1|||
30656589|NCT00967499|58669529|FG000|Overall Study|Adverse Event|0|||
30656590|NCT00967499|58669530|FG001|Overall Study|Adverse Event|1|||
30656591|NCT00967499|58669529|FG000|Overall Study|Protocol Violation|1|||
30656592|NCT00967499|58669530|FG001|Overall Study|Protocol Violation|0|||
30656593|NCT00967499|58669529|FG000|Overall Study|Sponsor Decision|1|||
30656594|NCT00967499|58669530|FG001|Overall Study|Sponsor Decision|0|||
30656595|NCT00967499|58669529|FG000|Overall Study|Randomized but not treated|63|||
30656596|NCT00967499|58669530|FG001|Overall Study|Randomized but not treated|59|||
30656597|NCT03909971|58669538|FG000|Overall Study|Other Reasons Not Specified|0|||
30656598|NCT03909971|58669539|FG001|Overall Study|Other Reasons Not Specified|1|||
30656599|NCT03909971|58669538|FG000|Overall Study|Global Deterioration of Health Status|2|||
30656600|NCT03909971|58669539|FG001|Overall Study|Global Deterioration of Health Status|1|||
30656601|NCT03909971|58669538|FG000|Overall Study|Progressive Disease|6|||
30656602|NCT03909971|58669539|FG001|Overall Study|Progressive Disease|14|||
30656603|NCT03909971|58669538|FG000|Overall Study|Death|2|||
30769848|NCT03110380|58778772|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
30769849|NCT03110380|58778773|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
30656604|NCT03909971|58669539|FG001|Overall Study|Death|6|||
30656605|NCT00967343|58669546|FG000|Overall Study|Study termination by sponsor|12|||
30769850|NCT03110380|58778770|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
30769851|NCT03110380|58778771|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
30769852|NCT03110380|58778772|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
30656606|NCT00967343|58669546|FG000|Overall Study|Death|24|||
30656607|NCT00967343|58669546|FG000|Overall Study|Relapse|1|||
30656608|NCT00967343|58669546|FG000|Overall Study|Lost to Follow-up|1|||
30656609|NCT00973973|58669552|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
30656610|NCT00973973|58669553|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
30656611|NCT00973973|58669552|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
30656612|NCT00973973|58669553|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
30656613|NCT00973973|58669552|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
30656614|NCT00973973|58669553|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
30656615|NCT00973973|58669552|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
30656616|NCT00973973|58669553|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
30656617|NCT00973973|58669552|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
30656618|NCT00973973|58669553|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
30656619|NCT00973973|58669552|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
30656620|NCT00973973|58669553|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
30656621|NCT00973973|58669552|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
30656622|NCT00973973|58669553|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
30656623|NCT00973973|58669552|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
30656624|NCT00973973|58669553|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
30656625|NCT00973973|58669552|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
30656626|NCT00973973|58669553|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
30656627|NCT00973973|58669552|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
30656628|NCT00973973|58669553|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
30656629|NCT00973973|58669552|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
30656630|NCT00973973|58669553|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
30656631|NCT00973973|58669552|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
30656632|NCT00973973|58669553|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
30656633|NCT00633139|58669562|FG000|Overall Study|Non compliance|0|||
30656634|NCT00633139|58669563|FG001|Overall Study|Non compliance|0|||
30656635|NCT00633139|58669564|FG002|Overall Study|Non compliance|1|||
30656636|NCT00633139|58669562|FG000|Overall Study|Withdrawal by Subject|0|||
30656637|NCT00633139|58669563|FG001|Overall Study|Withdrawal by Subject|1|||
30656638|NCT00633139|58669564|FG002|Overall Study|Withdrawal by Subject|0|||
30656639|NCT00965081|58669574|FG000|Overall Study|Adverse Event|14|||
30656640|NCT00965081|58669575|FG001|Overall Study|Adverse Event|9|||
30656641|NCT00965081|58669574|FG000|Overall Study|Lack of Efficacy|2|||
30656642|NCT00965081|58669575|FG001|Overall Study|Lack of Efficacy|5|||
30656643|NCT00965081|58669574|FG000|Overall Study|Lost to Follow-up|4|||
30656644|NCT00965081|58669575|FG001|Overall Study|Lost to Follow-up|5|||
30656645|NCT00965081|58669574|FG000|Overall Study|Physician Decision|2|||
30656646|NCT00965081|58669575|FG001|Overall Study|Physician Decision|0|||
30656647|NCT00965081|58669574|FG000|Overall Study|Protocol Violation|2|||
30656648|NCT00965081|58669575|FG001|Overall Study|Protocol Violation|5|||
30656649|NCT00965081|58669574|FG000|Overall Study|Sponsor Decision|1|||
30656650|NCT00965081|58669575|FG001|Overall Study|Sponsor Decision|0|||
30656651|NCT00965081|58669574|FG000|Overall Study|Withdrawal by Subject|4|||
30656652|NCT00965081|58669575|FG001|Overall Study|Withdrawal by Subject|7|||
30656653|NCT00965081|58669574|FG000|Overall Study|Switched to Rescue Arm|5|||
30656654|NCT00965081|58669575|FG001|Overall Study|Switched to Rescue Arm|12|||
30656655|NCT00961649|58669586|FG000|Overall Study|Adverse Event|4|||
30656656|NCT00961649|58669587|FG001|Overall Study|Adverse Event|0|||
30656657|NCT00961649|58669588|FG002|Overall Study|Adverse Event|0|||
30656658|NCT00961649|58669589|FG003|Overall Study|Adverse Event|2|||
30656659|NCT00961649|58669586|FG000|Overall Study|Inadequate control of IOP|0|||
30656660|NCT00961649|58669587|FG001|Overall Study|Inadequate control of IOP|0|||
30656661|NCT00961649|58669588|FG002|Overall Study|Inadequate control of IOP|0|||
30769853|NCT03110380|58778773|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
30769854|NCT03110380|58778770|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
30769855|NCT03110380|58778771|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
30769856|NCT03110380|58778772|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
30769857|NCT03110380|58778773|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
30769858|NCT03110380|58778770|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
30769859|NCT03110380|58778771|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
30769860|NCT03110380|58778772|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
30656662|NCT00961649|58669589|FG003|Overall Study|Inadequate control of IOP|1|||
30656663|NCT00961649|58669586|FG000|Overall Study|Patient has travel plans during holidays|0|||
30656664|NCT00961649|58669587|FG001|Overall Study|Patient has travel plans during holidays|0|||
30656665|NCT00961649|58669588|FG002|Overall Study|Patient has travel plans during holidays|1|||
30769861|NCT03110380|58778773|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
30769862|NCT04851314|58778783|FG000|Overall Study|Unable to complete research set-up procedures|0|||
30769863|NCT04851314|58778784|FG001|Overall Study|Unable to complete research set-up procedures|2|||
30769864|NCT04851314|58778783|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
30656666|NCT00961649|58669589|FG003|Overall Study|Patient has travel plans during holidays|0|||
30656667|NCT00961649|58669586|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
30656668|NCT00961649|58669587|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
30656669|NCT00961649|58669588|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
30656670|NCT00961649|58669589|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
30656671|NCT00961649|58669586|FG000|Overall Study|Study terminated by sponsor|4|||
30656672|NCT00961649|58669587|FG001|Overall Study|Study terminated by sponsor|4|||
30656673|NCT00961649|58669588|FG002|Overall Study|Study terminated by sponsor|4|||
30656674|NCT00961649|58669589|FG003|Overall Study|Study terminated by sponsor|1|||
30848858|NCT01678820|58875513|FG000|Overall Study|Physician Decision|0|||
30848859|NCT01678820|58875514|FG001|Overall Study|Physician Decision|0|||
30848860|NCT01678820|58875515|FG002|Overall Study|Physician Decision|1|||
30848861|NCT01678820|58875513|FG000|Overall Study|Protocol Violation|4|||
30848862|NCT01678820|58875514|FG001|Overall Study|Protocol Violation|5|||
30848863|NCT01678820|58875515|FG002|Overall Study|Protocol Violation|4|||
30656675|NCT00632125|58669599|FG000|Overall Study|Death|82|||
30656676|NCT00632125|58669599|FG000|Overall Study|Withdrawal by Subject|44|||
30656677|NCT00632125|58669599|FG000|Overall Study|Adverse Event|36|||
30656678|NCT00632125|58669599|FG000|Overall Study|Renal transplantation|17|||
30656679|NCT00632125|58669599|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
30656680|NCT00632125|58669599|FG000|Overall Study|Non-compliance|8|||
30656681|NCT00632125|58669599|FG000|Overall Study|Development of uncontrolled hypertension|5|||
30656682|NCT00632125|58669599|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
30656683|NCT00903968|58669605|FG000|Overall Study|Adverse Event|0|||
30656684|NCT00903968|58669606|FG001|Overall Study|Adverse Event|0|||
30656685|NCT00903968|58669607|FG002|Overall Study|Adverse Event|0|||
30656686|NCT00903968|58669608|FG003|Overall Study|Adverse Event|0|||
30656687|NCT00903968|58669609|FG004|Overall Study|Adverse Event|0|||
30656688|NCT00903968|58669610|FG005|Overall Study|Adverse Event|0|||
30656689|NCT00903968|58669611|FG006|Overall Study|Adverse Event|1|||
30656690|NCT00903968|58669612|FG007|Overall Study|Adverse Event|8|||
30656691|NCT00903968|58669605|FG000|Overall Study|DLT|0|||
30656692|NCT00903968|58669606|FG001|Overall Study|DLT|0|||
30656693|NCT00903968|58669607|FG002|Overall Study|DLT|0|||
30656694|NCT00903968|58669608|FG003|Overall Study|DLT|0|||
30656695|NCT00903968|58669609|FG004|Overall Study|DLT|0|||
30656696|NCT00903968|58669610|FG005|Overall Study|DLT|0|||
30656697|NCT00903968|58669611|FG006|Overall Study|DLT|2|||
30656698|NCT00903968|58669612|FG007|Overall Study|DLT|0|||
30656699|NCT00903968|58669605|FG000|Overall Study|Withdrawal by Subject|1|||
30656700|NCT00903968|58669606|FG001|Overall Study|Withdrawal by Subject|0|||
30656701|NCT00903968|58669607|FG002|Overall Study|Withdrawal by Subject|1|||
30656702|NCT00903968|58669608|FG003|Overall Study|Withdrawal by Subject|0|||
30656703|NCT00903968|58669609|FG004|Overall Study|Withdrawal by Subject|1|||
30656704|NCT00903968|58669610|FG005|Overall Study|Withdrawal by Subject|1|||
30656705|NCT00903968|58669611|FG006|Overall Study|Withdrawal by Subject|0|||
30656706|NCT00903968|58669612|FG007|Overall Study|Withdrawal by Subject|4|||
30656707|NCT00903968|58669605|FG000|Overall Study|Non-Compliance|0|||
30656708|NCT00903968|58669606|FG001|Overall Study|Non-Compliance|0|||
30656709|NCT00903968|58669607|FG002|Overall Study|Non-Compliance|0|||
30656710|NCT00903968|58669608|FG003|Overall Study|Non-Compliance|0|||
30656711|NCT00903968|58669609|FG004|Overall Study|Non-Compliance|0|||
30656712|NCT00903968|58669610|FG005|Overall Study|Non-Compliance|1|||
30656713|NCT00903968|58669611|FG006|Overall Study|Non-Compliance|0|||
30656714|NCT00903968|58669612|FG007|Overall Study|Non-Compliance|0|||
30656715|NCT00903968|58669605|FG000|Overall Study|Physician Decision|0|||
30656716|NCT00903968|58669606|FG001|Overall Study|Physician Decision|0|||
30656717|NCT00903968|58669607|FG002|Overall Study|Physician Decision|0|||
30656718|NCT00903968|58669608|FG003|Overall Study|Physician Decision|0|||
30656719|NCT00903968|58669609|FG004|Overall Study|Physician Decision|0|||
30656720|NCT00903968|58669610|FG005|Overall Study|Physician Decision|1|||
30656721|NCT00903968|58669611|FG006|Overall Study|Physician Decision|0|||
30656722|NCT00903968|58669612|FG007|Overall Study|Physician Decision|0|||
30656723|NCT00903968|58669605|FG000|Overall Study|Progressive Disease|2|||
30656724|NCT00903968|58669606|FG001|Overall Study|Progressive Disease|3|||
30656725|NCT00903968|58669607|FG002|Overall Study|Progressive Disease|2|||
30656726|NCT00903968|58669608|FG003|Overall Study|Progressive Disease|3|||
30656727|NCT00903968|58669609|FG004|Overall Study|Progressive Disease|3|||
30656728|NCT00903968|58669610|FG005|Overall Study|Progressive Disease|3|||
30656729|NCT00903968|58669611|FG006|Overall Study|Progressive Disease|0|||
30656730|NCT00903968|58669612|FG007|Overall Study|Progressive Disease|18|||
30656731|NCT00903968|58669605|FG000|Overall Study|Lack of Efficacy|0|||
30656732|NCT00903968|58669606|FG001|Overall Study|Lack of Efficacy|0|||
30656733|NCT00903968|58669607|FG002|Overall Study|Lack of Efficacy|0|||
30656734|NCT00903968|58669608|FG003|Overall Study|Lack of Efficacy|0|||
30656735|NCT00903968|58669609|FG004|Overall Study|Lack of Efficacy|0|||
30656736|NCT00903968|58669610|FG005|Overall Study|Lack of Efficacy|0|||
30656737|NCT00903968|58669611|FG006|Overall Study|Lack of Efficacy|0|||
30656738|NCT00903968|58669612|FG007|Overall Study|Lack of Efficacy|3|||
30656739|NCT00903344|58669635|FG000|Overall Study|Pregnancy|2|||
30656740|NCT00903344|58669636|FG001|Overall Study|Pregnancy|3|||
30848864|NCT01678820|58875513|FG000|Overall Study|Not treated with double-blind study drug|0|||
30848865|NCT01678820|58875514|FG001|Overall Study|Not treated with double-blind study drug|2|||
30848866|NCT01678820|58875515|FG002|Overall Study|Not treated with double-blind study drug|2|||
30848867|NCT02660138|58875527|FG000|Overall Study|Adverse Event|0|||
30848868|NCT02660138|58875528|FG001|Overall Study|Adverse Event|3|||
30848869|NCT02660138|58875529|FG002|Overall Study|Adverse Event|2|||
30848870|NCT02660138|58875527|FG000|Overall Study|Lack of Efficacy|1|||
30848871|NCT02660138|58875528|FG001|Overall Study|Lack of Efficacy|2|||
30848872|NCT02660138|58875529|FG002|Overall Study|Lack of Efficacy|1|||
30848873|NCT02660138|58875527|FG000|Overall Study|Withdrawal by Subject|7|||
30848874|NCT02660138|58875528|FG001|Overall Study|Withdrawal by Subject|6|||
30848875|NCT02660138|58875529|FG002|Overall Study|Withdrawal by Subject|6|||
30848876|NCT02660138|58875527|FG000|Overall Study|Lost to Follow-up|4|||
30656741|NCT00903344|58669635|FG000|Overall Study|Lost to Follow-up|3|||
30656742|NCT00903344|58669636|FG001|Overall Study|Lost to Follow-up|0|||
30656743|NCT00903032|58669644|FG000|Overall Study|Withdrawal by Subject|5|||
30656744|NCT00903032|58669645|FG001|Overall Study|Withdrawal by Subject|3|||
30656745|NCT00903032|58669644|FG000|Overall Study|Lost to Follow-up|2|||
30656746|NCT00903032|58669645|FG001|Overall Study|Lost to Follow-up|2|||
30656747|NCT00902564|58669660|FG000|Overall Study|Withdrawal by Subject|2|||
30656748|NCT00626197|58669667|FG000|Overall Study|Did not cooperate|2|||
30656749|NCT00626197|58669668|FG001|Overall Study|Did not cooperate|6|||
30656750|NCT00626197|58669669|FG002|Overall Study|Did not cooperate|1|||
30656751|NCT00626197|58669667|FG000|Overall Study|Failure to return|6|||
30656752|NCT00626197|58669668|FG001|Overall Study|Failure to return|5|||
30656753|NCT00626197|58669669|FG002|Overall Study|Failure to return|6|||
30656754|NCT00626197|58669667|FG000|Overall Study|Adverse event, serious fatal|3|||
30656755|NCT00626197|58669668|FG001|Overall Study|Adverse event, serious fatal|6|||
30656756|NCT00626197|58669669|FG002|Overall Study|Adverse event, serious fatal|6|||
30656757|NCT00626197|58669667|FG000|Overall Study|Adverse Event|1|||
30656758|NCT00626197|58669668|FG001|Overall Study|Adverse Event|1|||
30656759|NCT00626197|58669669|FG002|Overall Study|Adverse Event|2|||
30656760|NCT00626197|58669667|FG000|Overall Study|Withdrawal by Subject|17|||
30656761|NCT00626197|58669668|FG001|Overall Study|Withdrawal by Subject|17|||
30656762|NCT00626197|58669669|FG002|Overall Study|Withdrawal by Subject|7|||
30656763|NCT00626197|58669667|FG000|Overall Study|Administrative reasons|15|||
30656764|NCT00626197|58669668|FG001|Overall Study|Administrative reasons|19|||
30656765|NCT00626197|58669669|FG002|Overall Study|Administrative reasons|55|||
30656766|NCT00626275|58669683|FG000|Part A - Treatment Period 1|Adverse Event|1|||
30656767|NCT00626275|58669684|FG001|Part A - Treatment Period 1|Adverse Event|0|||
30656768|NCT00626275|58669685|FG002|Part A - Treatment Period 1|Adverse Event|0|||
30656769|NCT00626275|58669686|FG003|Part A - Treatment Period 1|Adverse Event|0|||
30656770|NCT00626275|58669687|FG004|Part A - Treatment Period 1|Adverse Event|0|||
30656771|NCT00626275|58669688|FG005|Part A - Treatment Period 1|Adverse Event|0|||
30656772|NCT00626275|58669689|FG006|Part A - Treatment Period 1|Adverse Event|0|||
30656773|NCT00626275|58669690|FG007|Part A - Treatment Period 1|Adverse Event|0|||
30656774|NCT00626275|58669683|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
30656775|NCT00626275|58669684|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
30656776|NCT00626275|58669685|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
30656777|NCT00626275|58669686|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
30656778|NCT00626275|58669687|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
30656779|NCT00626275|58669688|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
30656780|NCT00626275|58669689|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
30656781|NCT00626275|58669690|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
30769865|NCT04851314|58778784|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
30769866|NCT04848662|58778792|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
30769867|NCT04848662|58778793|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
30769868|NCT03701516|58778799|FG000|Period 1|Lost to Follow-up|0|||
30769869|NCT03701516|58778800|FG001|Period 1|Lost to Follow-up|1|||
30769870|NCT03701516|58778799|FG000|Period 1|Adverse Event|0|||
30769871|NCT03701516|58778800|FG001|Period 1|Adverse Event|2|||
30769872|NCT03701516|58778799|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
30769873|NCT03701516|58778800|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
30769874|NCT03701516|58778799|FG000|Period 1|Non Compliance to Protocol|2|||
30769875|NCT03701516|58778800|FG001|Period 1|Non Compliance to Protocol|1|||
30769876|NCT03701516|58778799|FG000|Period 1|Withdrawal by Subject|0|||
30848877|NCT02660138|58875528|FG001|Overall Study|Lost to Follow-up|4|||
30656782|NCT00626275|58669683|FG000|Part B|Lost to Follow-up|0|||
30656783|NCT00626275|58669684|FG001|Part B|Lost to Follow-up|0|||
30769877|NCT03701516|58778800|FG001|Period 1|Withdrawal by Subject|1|||
30769878|NCT03701516|58778799|FG000|Period 2|failed to meet all eligibility creiteria|1|||
30656784|NCT00626275|58669685|FG002|Part B|Lost to Follow-up|0|||
30656785|NCT00626275|58669686|FG003|Part B|Lost to Follow-up|0|||
30656786|NCT00626275|58669687|FG004|Part B|Lost to Follow-up|0|||
30848878|NCT02660138|58875529|FG002|Overall Study|Lost to Follow-up|1|||
30848879|NCT02660138|58875527|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
30848880|NCT02660138|58875528|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
30656787|NCT00626275|58669688|FG005|Part B|Lost to Follow-up|0|||
30656788|NCT00626275|58669689|FG006|Part B|Lost to Follow-up|1|||
30656789|NCT00626275|58669690|FG007|Part B|Lost to Follow-up|0|||
30656790|NCT00626275|58669683|FG000|Part B|Withdrawal by Subject|0|||
30656791|NCT00626275|58669684|FG001|Part B|Withdrawal by Subject|0|||
30656792|NCT00626275|58669685|FG002|Part B|Withdrawal by Subject|0|||
30656793|NCT00626275|58669686|FG003|Part B|Withdrawal by Subject|0|||
30656794|NCT00626275|58669687|FG004|Part B|Withdrawal by Subject|0|||
30656795|NCT00626275|58669688|FG005|Part B|Withdrawal by Subject|0|||
30656796|NCT00626275|58669689|FG006|Part B|Withdrawal by Subject|0|||
30656797|NCT00626275|58669690|FG007|Part B|Withdrawal by Subject|1|||
30656798|NCT00623935|58669704|FG000|Overall Study|Death|1|||
30656799|NCT00623935|58669704|FG000|Overall Study|Patient Declined Transplant|1|||
30656800|NCT00623779|58669711|FG000|Overall Study|Adverse Event|1|||
30656801|NCT00623779|58669712|FG001|Overall Study|Adverse Event|3|||
30769879|NCT03701516|58778800|FG001|Period 2|failed to meet all eligibility creiteria|0|||
30769880|NCT03701516|58778799|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
30769881|NCT03701516|58778800|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
30769882|NCT03700892|58778808|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
30769883|NCT03700892|58778809|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
30769884|NCT03700892|58778810|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
30769885|NCT03700736|58778821|FG000|Overall Study|Pregnancy|1|||
30769886|NCT03700736|58778822|FG001|Overall Study|Pregnancy|1|||
30952501|NCT01899053|59001157|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
30952502|NCT01899053|59001158|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
30952503|NCT01899053|59001159|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
30952504|NCT01899053|59001160|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
30952505|NCT01899053|59001161|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
30952506|NCT01899053|59001162|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
30952507|NCT01899053|59001163|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
30952508|NCT01899053|59001164|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
30952509|NCT01899053|59001165|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
30952510|NCT01899053|59001166|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
30952511|NCT01899053|59001167|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
30952512|NCT01899053|59001168|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
30952513|NCT01899053|59001155|FG000|Overall Study|Symptomatic Deterioration|0|||
30952514|NCT01899053|59001156|FG001|Overall Study|Symptomatic Deterioration|0|||
30952515|NCT01899053|59001157|FG002|Overall Study|Symptomatic Deterioration|0|||
30952516|NCT01899053|59001158|FG003|Overall Study|Symptomatic Deterioration|0|||
30952517|NCT01899053|59001159|FG004|Overall Study|Symptomatic Deterioration|0|||
30952518|NCT01899053|59001160|FG005|Overall Study|Symptomatic Deterioration|1|||
30952519|NCT01899053|59001161|FG006|Overall Study|Symptomatic Deterioration|0|||
30952520|NCT01899053|59001162|FG007|Overall Study|Symptomatic Deterioration|1|||
30952521|NCT01899053|59001163|FG008|Overall Study|Symptomatic Deterioration|0|||
30952522|NCT01899053|59001164|FG009|Overall Study|Symptomatic Deterioration|0|||
30952523|NCT01899053|59001165|FG010|Overall Study|Symptomatic Deterioration|0|||
30952524|NCT01899053|59001166|FG011|Overall Study|Symptomatic Deterioration|1|||
30952525|NCT01899053|59001167|FG012|Overall Study|Symptomatic Deterioration|2|||
30952526|NCT01899053|59001168|FG013|Overall Study|Symptomatic Deterioration|0|||
30952527|NCT01888367|59001273|FG000|Overall Study|Physician Decision|3|||
30952528|NCT01888367|59001274|FG001|Overall Study|Physician Decision|4|||
30952529|NCT01888367|59001275|FG002|Overall Study|Physician Decision|2|||
30952530|NCT01888367|59001273|FG000|Overall Study|Death|2|||
30952531|NCT01888367|59001274|FG001|Overall Study|Death|0|||
30952532|NCT01888367|59001275|FG002|Overall Study|Death|1|||
30952533|NCT01888367|59001273|FG000|Overall Study|Withdrawal by Subject|1|||
30952534|NCT01888367|59001274|FG001|Overall Study|Withdrawal by Subject|0|||
30952535|NCT01888367|59001275|FG002|Overall Study|Withdrawal by Subject|1|||
30952536|NCT01888367|59001273|FG000|Overall Study|Lost to Follow-up|1|||
30952537|NCT01888367|59001274|FG001|Overall Study|Lost to Follow-up|1|||
30952538|NCT01888367|59001275|FG002|Overall Study|Lost to Follow-up|0|||
30952539|NCT01888367|59001273|FG000|Overall Study|Protocol Violation|0|||
30952540|NCT01888367|59001274|FG001|Overall Study|Protocol Violation|0|||
30952541|NCT01888367|59001275|FG002|Overall Study|Protocol Violation|1|||
30769887|NCT03700736|58778821|FG000|Overall Study|Withdrawal by Subject|2|||
30769888|NCT03700736|58778822|FG001|Overall Study|Withdrawal by Subject|6|||
30769889|NCT04737278|58778833|FG000|Overall Study|Lost to Follow-up|1|||
30656802|NCT00623779|58669713|FG002|Overall Study|Adverse Event|0|||
30952542|NCT01888367|59001273|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
30952543|NCT01888367|59001274|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
30952544|NCT01888367|59001275|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
30952545|NCT01898195|59001301|FG000|Smoking Abstinence|Did not have good measurements|35|||
30952546|NCT01898195|59001302|FG001|Smoking Abstinence|Did not have good measurements|38|||
30656803|NCT00623779|58669711|FG000|Overall Study|Criteria from CSR|2|||
30656804|NCT00623779|58669712|FG001|Overall Study|Criteria from CSR|0|||
30952547|NCT01898195|59001303|FG002|Smoking Abstinence|Did not have good measurements|36|||
30656805|NCT00623779|58669713|FG002|Overall Study|Criteria from CSR|1|||
30656806|NCT00629707|58669744|FG000|Overall Study|Withdrawal by Subject|0|||
30656807|NCT00629707|58669745|FG001|Overall Study|Withdrawal by Subject|1|||
30656808|NCT00629707|58669744|FG000|Overall Study|Physician Decision|0|||
30656809|NCT00629707|58669745|FG001|Overall Study|Physician Decision|1|||
30656810|NCT00902330|58669753|FG000|Overall Study|Too overwhelmed by treatment|2|||
30656811|NCT00902330|58669754|FG001|Overall Study|Too overwhelmed by treatment|5|||
30656812|NCT00902330|58669753|FG000|Overall Study|Adverse Event|1|||
30656813|NCT00902330|58669754|FG001|Overall Study|Adverse Event|0|||
30656814|NCT00902330|58669753|FG000|Overall Study|No post baseline data|1|||
30656815|NCT00902330|58669754|FG001|Overall Study|No post baseline data|0|||
30656816|NCT00901394|58669791|FG000|Overall Study|Physician Decision|1|||
30656817|NCT00901394|58669792|FG001|Overall Study|Physician Decision|1|||
30656818|NCT00901394|58669793|FG002|Overall Study|Physician Decision|2|||
30656819|NCT00896532|58669809|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656820|NCT00896532|58669810|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656821|NCT00896532|58669811|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656822|NCT00896532|58669812|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
30656823|NCT00896532|58669813|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656824|NCT00896532|58669814|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
30656825|NCT00896532|58669815|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656826|NCT00896532|58669816|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656827|NCT00896532|58669817|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656828|NCT00896532|58669818|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656829|NCT00896532|58669819|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656830|NCT00896532|58669820|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656831|NCT00896532|58669821|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656832|NCT00896532|58669822|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656833|NCT00896532|58669823|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656834|NCT00896532|58669824|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656835|NCT00896532|58669825|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656836|NCT00896532|58669826|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656837|NCT00896532|58669827|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656838|NCT00896532|58669828|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656839|NCT00896532|58669829|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656840|NCT00896532|58669830|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656841|NCT00896532|58669831|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
30656842|NCT00896532|58669809|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
30656843|NCT00896532|58669810|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
30656844|NCT00896532|58669811|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
30656845|NCT00896532|58669812|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
30656846|NCT00896532|58669813|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
30656847|NCT00896532|58669814|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
30656848|NCT00896532|58669815|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
30656849|NCT00896532|58669816|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656850|NCT00896532|58669817|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656851|NCT00896532|58669818|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656852|NCT00896532|58669819|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656853|NCT00896532|58669820|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656854|NCT00896532|58669821|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656855|NCT00896532|58669822|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656856|NCT00896532|58669823|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656857|NCT00896532|58669824|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656858|NCT00896532|58669825|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656859|NCT00896532|58669826|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656860|NCT00896532|58669827|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656861|NCT00896532|58669828|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656862|NCT00896532|58669829|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656863|NCT00896532|58669830|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656864|NCT00896532|58669831|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
30656865|NCT00896532|58669809|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
30656866|NCT00896532|58669810|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
30656867|NCT00896532|58669811|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
30656868|NCT00896532|58669812|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
30656869|NCT00896532|58669813|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
30848881|NCT02660138|58875529|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
30656870|NCT00896532|58669814|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
30656871|NCT00896532|58669815|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
30656872|NCT00896532|58669816|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
30656873|NCT00896532|58669817|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656874|NCT00896532|58669818|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656875|NCT00896532|58669819|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656876|NCT00896532|58669820|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656877|NCT00896532|58669821|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656878|NCT00896532|58669822|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656879|NCT00896532|58669823|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656880|NCT00896532|58669824|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656881|NCT00896532|58669825|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656882|NCT00896532|58669826|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656883|NCT00896532|58669827|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656884|NCT00896532|58669828|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656885|NCT00896532|58669829|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656886|NCT00896532|58669830|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656887|NCT00896532|58669831|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
30656888|NCT00896532|58669809|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656889|NCT00896532|58669810|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656890|NCT00896532|58669811|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
30656891|NCT00896532|58669812|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656892|NCT00896532|58669813|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
30656893|NCT00896532|58669814|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656894|NCT00896532|58669815|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656895|NCT00896532|58669816|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656896|NCT00896532|58669817|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656897|NCT00896532|58669818|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656898|NCT00896532|58669819|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656899|NCT00896532|58669820|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656900|NCT00896532|58669821|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656901|NCT00896532|58669822|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656902|NCT00896532|58669823|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656903|NCT00896532|58669824|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656904|NCT00896532|58669825|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656905|NCT00896532|58669826|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656906|NCT00896532|58669827|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656907|NCT00896532|58669828|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656908|NCT00896532|58669829|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656909|NCT00896532|58669830|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656910|NCT00896532|58669831|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
30656911|NCT00896532|58669809|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
30656912|NCT00896532|58669810|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656913|NCT00896532|58669811|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656914|NCT00896532|58669812|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
30656915|NCT00896532|58669813|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656916|NCT00896532|58669814|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656917|NCT00896532|58669815|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656918|NCT00896532|58669816|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656919|NCT00896532|58669817|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656920|NCT00896532|58669818|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656921|NCT00896532|58669819|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656922|NCT00896532|58669820|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656923|NCT00896532|58669821|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656924|NCT00896532|58669822|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656925|NCT00896532|58669823|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656926|NCT00896532|58669824|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656927|NCT00896532|58669825|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656928|NCT00896532|58669826|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656929|NCT00896532|58669827|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656930|NCT00896532|58669828|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656931|NCT00896532|58669829|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656932|NCT00896532|58669830|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656933|NCT00896532|58669831|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
30656934|NCT00896532|58669809|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656935|NCT00896532|58669810|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656936|NCT00896532|58669811|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
30656937|NCT00896532|58669812|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656938|NCT00896532|58669813|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656939|NCT00896532|58669814|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656940|NCT00896532|58669815|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656941|NCT00896532|58669816|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656942|NCT00896532|58669817|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656943|NCT00896532|58669818|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656944|NCT00896532|58669819|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656945|NCT00896532|58669820|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656946|NCT00896532|58669821|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656947|NCT00896532|58669822|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656948|NCT00896532|58669823|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30769890|NCT04737278|58778834|FG001|Overall Study|Lost to Follow-up|1|||
30769891|NCT04737278|58778833|FG000|Overall Study|Withdrawal by Subject|1|||
30769892|NCT04737278|58778834|FG001|Overall Study|Withdrawal by Subject|0|||
30769893|NCT04737278|58778833|FG000|Overall Study|Protocol Violation|1|||
30769894|NCT04737278|58778834|FG001|Overall Study|Protocol Violation|1|||
30656949|NCT00896532|58669824|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656950|NCT00896532|58669825|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656951|NCT00896532|58669826|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656952|NCT00896532|58669827|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656953|NCT00896532|58669828|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656954|NCT00896532|58669829|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656955|NCT00896532|58669830|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656956|NCT00896532|58669831|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
30656957|NCT00896532|58669809|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656958|NCT00896532|58669810|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656959|NCT00896532|58669811|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
30656960|NCT00896532|58669812|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656961|NCT00896532|58669813|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656962|NCT00896532|58669814|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656963|NCT00896532|58669815|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656964|NCT00896532|58669816|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656965|NCT00896532|58669817|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656966|NCT00896532|58669818|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656967|NCT00896532|58669819|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656968|NCT00896532|58669820|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656969|NCT00896532|58669821|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30769895|NCT04737278|58778833|FG000|Overall Study|failure to complete questionnaire|1|||
30769896|NCT04737278|58778834|FG001|Overall Study|failure to complete questionnaire|1|||
30769897|NCT04725500|58778840|FG000|Screening|Screen Failure|26|||
30769898|NCT04725500|58778840|FG000|Screening|Withdrawal by Subject|1|||
30769899|NCT04725500|58778840|FG000|2 Week Take Home|Screen Fail|5|||
30769900|NCT04684394|58778846|FG000|Overall Study|Death|1|||
30848882|NCT02660138|58875527|FG000|Overall Study|Other|1|||
30848883|NCT02660138|58875528|FG001|Overall Study|Other|1|||
30848884|NCT02660138|58875529|FG002|Overall Study|Other|0|||
30848885|NCT02660138|58875527|FG000|Overall Study|Not treated|0|||
30848886|NCT02660138|58875528|FG001|Overall Study|Not treated|1|||
30848887|NCT02660138|58875529|FG002|Overall Study|Not treated|0|||
30848888|NCT01603394|58875540|FG000|Overall Study|Adverse Event|1|||
30848889|NCT02729025|58875546|FG000|Overall Study|Sponsor Decision|0|||
30848890|NCT02729025|58875547|FG001|Overall Study|Sponsor Decision|1|||
30848891|NCT01603082|58875555|FG000|Overall Study|Adverse Event|0|||
30656970|NCT00896532|58669822|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30769901|NCT04684394|58778847|FG001|Overall Study|Death|2|||
30848892|NCT01603082|58875556|FG001|Overall Study|Adverse Event|1|||
30848893|NCT01603082|58875555|FG000|Overall Study|Withdrawal by Subject|1|||
30848894|NCT01603082|58875556|FG001|Overall Study|Withdrawal by Subject|0|||
30848895|NCT01603082|58875555|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
30848896|NCT01603082|58875556|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
30848897|NCT02846779|58875569|FG000|Overall Study|Lost Enrollment|83|||
30769902|NCT04684394|58778846|FG000|Overall Study|Lost to Follow-up|1|||
30769903|NCT04684394|58778847|FG001|Overall Study|Lost to Follow-up|0|||
30769904|NCT04684394|58778846|FG000|Overall Study|Withdrawal by Subject|2|||
30769905|NCT04684394|58778847|FG001|Overall Study|Withdrawal by Subject|0|||
30769906|NCT04684394|58778846|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
30769907|NCT04684394|58778847|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
30656971|NCT00896532|58669823|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656972|NCT00896532|58669824|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656973|NCT00896532|58669825|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656974|NCT00896532|58669826|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656975|NCT00896532|58669827|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656976|NCT00896532|58669828|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656977|NCT00896532|58669829|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656978|NCT00896532|58669830|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656979|NCT00896532|58669831|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
30656980|NCT00896532|58669809|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656981|NCT00896532|58669810|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656982|NCT00896532|58669811|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656983|NCT00896532|58669812|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
30656984|NCT00896532|58669813|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656985|NCT00896532|58669814|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656986|NCT00896532|58669815|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656987|NCT00896532|58669816|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656988|NCT00896532|58669817|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656989|NCT00896532|58669818|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656990|NCT00896532|58669819|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656991|NCT00896532|58669820|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656992|NCT00896532|58669821|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656993|NCT00896532|58669822|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656994|NCT00896532|58669823|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656995|NCT00896532|58669824|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656996|NCT00896532|58669825|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656997|NCT00896532|58669826|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656998|NCT00896532|58669827|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30656999|NCT00896532|58669828|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30657000|NCT00896532|58669829|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30657001|NCT00896532|58669830|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30657002|NCT00896532|58669831|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
30657003|NCT00896532|58669809|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657004|NCT00896532|58669810|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
30657005|NCT00896532|58669811|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657006|NCT00896532|58669812|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
30657007|NCT00896532|58669813|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
30657008|NCT00896532|58669814|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657009|NCT00896532|58669815|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657010|NCT00896532|58669816|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30769908|NCT04674644|58778853|FG000|Overall Study|with missing data|37|||
30769909|NCT04668950|58778860|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
30769910|NCT04668950|58778861|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
30769911|NCT04668950|58778860|FG000|Overall Study|Could not confirm started study medication|15|||
30769912|NCT04668950|58778861|FG001|Overall Study|Could not confirm started study medication|15|||
30769913|NCT04668950|58778860|FG000|Overall Study|Could not confirm baseline status|6|||
30769914|NCT04668950|58778861|FG001|Overall Study|Could not confirm baseline status|2|||
30769915|NCT04668950|58778860|FG000|Overall Study|Drop out and did not start medication|15|||
30769916|NCT04668950|58778861|FG001|Overall Study|Drop out and did not start medication|17|||
30848898|NCT02846779|58875570|FG001|Overall Study|Lost Enrollment|82|||
30848899|NCT02846779|58875571|FG002|Overall Study|Lost Enrollment|86|||
30848900|NCT02846779|58875569|FG000|Overall Study|Less than 31 days of follow-up|56|||
30848901|NCT02846779|58875570|FG001|Overall Study|Less than 31 days of follow-up|45|||
30848902|NCT02846779|58875571|FG002|Overall Study|Less than 31 days of follow-up|52|||
30848903|NCT00406393|58875581|FG000|Overall Study|Did not undergo transplantation|2|||
30848904|NCT00406393|58875582|FG001|Overall Study|Did not undergo transplantation|1|||
30848905|NCT02845375|58875591|FG000|Overall Study|upper airway obstruction|1|||
30848906|NCT02845375|58875592|FG001|Overall Study|upper airway obstruction|2|||
30848907|NCT02845375|58875593|FG002|Overall Study|upper airway obstruction|1|||
30657011|NCT00896532|58669817|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657012|NCT00896532|58669818|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657013|NCT00896532|58669819|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657014|NCT00896532|58669820|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657015|NCT00896532|58669821|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657016|NCT00896532|58669822|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657017|NCT00896532|58669823|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657018|NCT00896532|58669824|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657019|NCT00896532|58669825|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657020|NCT00896532|58669826|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657021|NCT00896532|58669827|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657022|NCT00896532|58669828|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657023|NCT00896532|58669829|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657024|NCT00896532|58669830|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657025|NCT00896532|58669831|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
30657026|NCT00896532|58669809|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657027|NCT00896532|58669810|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657028|NCT00896532|58669811|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657029|NCT00896532|58669812|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657030|NCT00896532|58669813|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657031|NCT00896532|58669814|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657032|NCT00896532|58669815|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657033|NCT00896532|58669816|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657034|NCT00896532|58669817|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
30657035|NCT00896532|58669818|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657036|NCT00896532|58669819|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30769917|NCT04668950|58778860|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
30769918|NCT04668950|58778861|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
30769919|NCT04668950|58778860|FG000|Overall Study|Other|2|||
30769920|NCT04668950|58778861|FG001|Overall Study|Other|4|||
30769921|NCT03078478|58778869|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
30769922|NCT03078478|58778870|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
30769923|NCT03078478|58778869|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
30769924|NCT03078478|58778870|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
30848908|NCT02658734|58875601|FG000|Overall Study|Adverse Event|2|||
30769925|NCT03078478|58778869|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
30769926|NCT03078478|58778870|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
30769927|NCT03078478|58778869|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
30769928|NCT03078478|58778870|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
30769929|NCT03078478|58778869|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
30769930|NCT03078478|58778870|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
30769931|NCT03078478|58778869|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
30769932|NCT03078478|58778870|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
30769933|NCT03078478|58778869|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
30769934|NCT03078478|58778870|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
30769935|NCT03078478|58778869|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
30769936|NCT03078478|58778870|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
30769937|NCT03539458|58778876|FG000|Overall Study|Death|1|||
30769938|NCT02879578|58778883|FG000|Overall Study|Adverse Event|1|||
30769939|NCT02879578|58778884|FG001|Overall Study|Adverse Event|2|||
30769940|NCT02879578|58778885|FG002|Overall Study|Adverse Event|14|||
30769941|NCT02879578|58778883|FG000|Overall Study|Protocol Violation|0|||
30769942|NCT02879578|58778884|FG001|Overall Study|Protocol Violation|1|||
30769943|NCT02879578|58778885|FG002|Overall Study|Protocol Violation|1|||
30769944|NCT02879578|58778883|FG000|Overall Study|Withdrawal by Subject|8|||
30769945|NCT02879578|58778884|FG001|Overall Study|Withdrawal by Subject|6|||
30769946|NCT02879578|58778885|FG002|Overall Study|Withdrawal by Subject|9|||
30769947|NCT02879578|58778883|FG000|Overall Study|Lost to Follow-up|1|||
30848909|NCT02658734|58875601|FG000|Overall Study|Death|4|||
30848910|NCT02658734|58875601|FG000|Overall Study|Lost to Follow-up|7|||
30848911|NCT02658734|58875601|FG000|Overall Study|Withdrawal of Consent|16|||
30848912|NCT02658734|58875601|FG000|Overall Study|Disease Progression|28|||
30848913|NCT02844439|58875605|FG000|Overall Study|Withdrawal by Subject|1|||
30769948|NCT02879578|58778884|FG001|Overall Study|Lost to Follow-up|0|||
30769949|NCT02879578|58778885|FG002|Overall Study|Lost to Follow-up|4|||
30848914|NCT02844439|58875605|FG000|Overall Study|Lost to Follow-up|2|||
30848915|NCT02844439|58875605|FG000|Overall Study|Termination by Sponsor|4|||
30769950|NCT02879578|58778883|FG000|Overall Study|Physician Decision|0|||
30848916|NCT02844439|58875605|FG000|Overall Study|Death|28|||
30848917|NCT02844439|58875605|FG000|Overall Study|Other|5|||
30848918|NCT01677182|58875619|FG000|Overall Study|Adverse Event|2|||
30848919|NCT01677182|58875620|FG001|Overall Study|Adverse Event|1|||
30657037|NCT00896532|58669820|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30769951|NCT02879578|58778884|FG001|Overall Study|Physician Decision|0|||
30769952|NCT02879578|58778885|FG002|Overall Study|Physician Decision|4|||
30848920|NCT01677182|58875621|FG002|Overall Study|Adverse Event|8|||
30848921|NCT01677182|58875619|FG000|Overall Study|Protocol Violation|5|||
30848922|NCT01677182|58875620|FG001|Overall Study|Protocol Violation|1|||
30848923|NCT01677182|58875621|FG002|Overall Study|Protocol Violation|4|||
30848924|NCT01677182|58875619|FG000|Overall Study|Lost to Follow-up|4|||
30848925|NCT01677182|58875620|FG001|Overall Study|Lost to Follow-up|0|||
30848926|NCT01677182|58875621|FG002|Overall Study|Lost to Follow-up|3|||
30848927|NCT01677182|58875619|FG000|Overall Study|Withdrawal by Subject|7|||
30848928|NCT01677182|58875620|FG001|Overall Study|Withdrawal by Subject|12|||
30848929|NCT01677182|58875621|FG002|Overall Study|Withdrawal by Subject|10|||
30848930|NCT01677182|58875619|FG000|Overall Study|Study termination|12|||
30848931|NCT01677182|58875620|FG001|Overall Study|Study termination|9|||
30848932|NCT01677182|58875621|FG002|Overall Study|Study termination|11|||
30848933|NCT01677182|58875619|FG000|Overall Study|Lack of Efficacy|3|||
30848934|NCT01677182|58875620|FG001|Overall Study|Lack of Efficacy|0|||
30848935|NCT01677182|58875621|FG002|Overall Study|Lack of Efficacy|1|||
30848936|NCT01677182|58875619|FG000|Overall Study|Other reasons|1|||
30848937|NCT01677182|58875620|FG001|Overall Study|Other reasons|5|||
30848938|NCT01677182|58875621|FG002|Overall Study|Other reasons|2|||
30848939|NCT02843659|58875632|FG000|Overall Study|Subject Withdrew Consent|0|||
30848940|NCT02843659|58875633|FG001|Overall Study|Subject Withdrew Consent|0|||
30848941|NCT02843659|58875634|FG002|Overall Study|Subject Withdrew Consent|1|||
30848942|NCT02843659|58875632|FG000|Overall Study|Administrative Reason by Sponsor|4|||
30848943|NCT02843659|58875633|FG001|Overall Study|Administrative Reason by Sponsor|5|||
30848944|NCT02843659|58875634|FG002|Overall Study|Administrative Reason by Sponsor|4|||
30848945|NCT02843659|58875632|FG000|Overall Study|Adverse Event|0|||
30848946|NCT02843659|58875633|FG001|Overall Study|Adverse Event|1|||
30848947|NCT02843659|58875634|FG002|Overall Study|Adverse Event|0|||
30848948|NCT00708435|58875644|FG000|Overall Study|Death / Serious Adverse Event|10|||
30848949|NCT00708435|58875645|FG001|Overall Study|Death / Serious Adverse Event|5|||
30848950|NCT00708435|58875644|FG000|Overall Study|Lost to Follow-up|9|||
30848951|NCT00708435|58875645|FG001|Overall Study|Lost to Follow-up|4|||
30848952|NCT00708435|58875644|FG000|Overall Study|Withdrawal by Subject|3|||
30848953|NCT00708435|58875645|FG001|Overall Study|Withdrawal by Subject|7|||
30848954|NCT00708435|58875644|FG000|Overall Study|Adverse Event|1|||
30848955|NCT00708435|58875645|FG001|Overall Study|Adverse Event|0|||
30848956|NCT00708435|58875644|FG000|Overall Study|Protocol Violation|0|||
30848957|NCT00708435|58875645|FG001|Overall Study|Protocol Violation|1|||
30848958|NCT00708435|58875644|FG000|Overall Study|Intervention by primary care physician|1|||
30848959|NCT00708435|58875645|FG001|Overall Study|Intervention by primary care physician|0|||
30848960|NCT00708435|58875644|FG000|Overall Study|Refused hospitalization|1|||
30848961|NCT00708435|58875645|FG001|Overall Study|Refused hospitalization|0|||
30848962|NCT02841787|58875656|FG000|Overall Study|Lost to Follow-up|1|||
30848963|NCT02841787|58875657|FG001|Overall Study|Lost to Follow-up|0|||
30769953|NCT00045942|58778902|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
30769954|NCT00045942|58778903|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
30769955|NCT00045942|58778904|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
30769956|NCT00045942|58778905|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
30769957|NCT00045942|58778906|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
30769958|NCT00045942|58778907|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
30769959|NCT00045942|58778908|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
30769960|NCT00045942|58778909|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
30769961|NCT00045942|58778910|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
30769962|NCT00045942|58778902|FG000|PKC412A2104 (Core)|Adverse Event|5|||
30769963|NCT00045942|58778903|FG001|PKC412A2104 (Core)|Adverse Event|0|||
30769964|NCT00045942|58778904|FG002|PKC412A2104 (Core)|Adverse Event|0|||
30769965|NCT00045942|58778905|FG003|PKC412A2104 (Core)|Adverse Event|0|||
30769966|NCT00045942|58778906|FG004|PKC412A2104 (Core)|Adverse Event|0|||
30769967|NCT00045942|58778907|FG005|PKC412A2104 (Core)|Adverse Event|0|||
30769968|NCT00045942|58778908|FG006|PKC412A2104 (Core)|Adverse Event|0|||
30769969|NCT00045942|58778909|FG007|PKC412A2104 (Core)|Adverse Event|0|||
30769970|NCT00045942|58778910|FG008|PKC412A2104 (Core)|Adverse Event|0|||
30769971|NCT00045942|58778902|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
30848964|NCT02841787|58875658|FG002|Overall Study|Lost to Follow-up|0|||
30848965|NCT02841787|58875656|FG000|Overall Study|Symptoms dropped below threshold|1|||
30848966|NCT02841787|58875657|FG001|Overall Study|Symptoms dropped below threshold|0|||
30848967|NCT02841787|58875658|FG002|Overall Study|Symptoms dropped below threshold|0|||
30848968|NCT02841787|58875656|FG000|Overall Study|Withdrawal by Subject|1|||
30848969|NCT02841787|58875657|FG001|Overall Study|Withdrawal by Subject|4|||
30848970|NCT02841787|58875658|FG002|Overall Study|Withdrawal by Subject|0|||
30848971|NCT01376037|58875668|FG000|Overall Study|Lost to Follow-up|0|||
30848972|NCT01376037|58875669|FG001|Overall Study|Lost to Follow-up|2|||
30657038|NCT00896532|58669821|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657039|NCT00896532|58669822|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657040|NCT00896532|58669823|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657041|NCT00896532|58669824|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657042|NCT00896532|58669825|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657043|NCT00896532|58669826|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657044|NCT00896532|58669827|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657045|NCT00896532|58669828|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657046|NCT00896532|58669829|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657047|NCT00896532|58669830|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657048|NCT00896532|58669831|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
30657049|NCT00896532|58669809|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657050|NCT00896532|58669810|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657051|NCT00896532|58669811|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657052|NCT00896532|58669812|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657053|NCT00896532|58669813|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657054|NCT00896532|58669814|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657055|NCT00896532|58669815|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657056|NCT00896532|58669816|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657057|NCT00896532|58669817|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657058|NCT00896532|58669818|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657059|NCT00896532|58669819|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657060|NCT00896532|58669820|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657061|NCT00896532|58669821|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
30657062|NCT00896532|58669822|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657063|NCT00896532|58669823|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657064|NCT00896532|58669824|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657065|NCT00896532|58669825|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657066|NCT00896532|58669826|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657067|NCT00896532|58669827|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657068|NCT00896532|58669828|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657069|NCT00896532|58669829|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657070|NCT00896532|58669830|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30657071|NCT00896532|58669831|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
30769972|NCT00045942|58778903|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
30769973|NCT00045942|58778904|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
30769974|NCT00045942|58778905|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
30769975|NCT00045942|58778906|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
30769976|NCT00045942|58778907|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
30769977|NCT00045942|58778908|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
30769978|NCT00045942|58778909|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
30769979|NCT00045942|58778910|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
30657072|NCT00896532|58669809|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657073|NCT00896532|58669810|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657074|NCT00896532|58669811|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657075|NCT00896532|58669812|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657076|NCT00896532|58669813|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657077|NCT00896532|58669814|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657078|NCT00896532|58669815|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657079|NCT00896532|58669816|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657080|NCT00896532|58669817|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657081|NCT00896532|58669818|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657082|NCT00896532|58669819|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
30657083|NCT00896532|58669820|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657084|NCT00896532|58669821|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
30657085|NCT00896532|58669822|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657086|NCT00896532|58669823|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657087|NCT00896532|58669824|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657088|NCT00896532|58669825|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657089|NCT00896532|58669826|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657090|NCT00896532|58669827|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30769980|NCT00045942|58778902|FG000|PKC412A2104 (Core)|Death|1|||
30769981|NCT00045942|58778903|FG001|PKC412A2104 (Core)|Death|0|||
30769982|NCT00045942|58778904|FG002|PKC412A2104 (Core)|Death|0|||
30769983|NCT00045942|58778905|FG003|PKC412A2104 (Core)|Death|0|||
30769984|NCT00045942|58778906|FG004|PKC412A2104 (Core)|Death|0|||
30848973|NCT02657408|58875677|FG000|Overall Study|Adverse Event|3|||
30657091|NCT00896532|58669828|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657092|NCT00896532|58669829|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657093|NCT00896532|58669830|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657094|NCT00896532|58669831|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
30657095|NCT00896532|58669809|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657096|NCT00896532|58669810|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657097|NCT00896532|58669811|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657098|NCT00896532|58669812|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657099|NCT00896532|58669813|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657100|NCT00896532|58669814|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657101|NCT00896532|58669815|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657102|NCT00896532|58669816|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657103|NCT00896532|58669817|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657104|NCT00896532|58669818|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657105|NCT00896532|58669819|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657106|NCT00896532|58669820|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657107|NCT00896532|58669821|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
30657108|NCT00896532|58669822|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
30657109|NCT00896532|58669823|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657110|NCT00896532|58669824|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657111|NCT00896532|58669825|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657112|NCT00896532|58669826|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657113|NCT00896532|58669827|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657114|NCT00896532|58669828|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657115|NCT00896532|58669829|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657116|NCT00896532|58669830|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657117|NCT00896532|58669831|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
30657118|NCT00896532|58669809|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
30657119|NCT00896532|58669810|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
30657120|NCT00896532|58669811|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
30657121|NCT00896532|58669812|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
30657122|NCT00896532|58669813|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
30657123|NCT00896532|58669814|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
30657124|NCT00896532|58669815|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
30657125|NCT00896532|58669816|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
30657126|NCT00896532|58669817|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
30657127|NCT00896532|58669818|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
30657128|NCT00896532|58669819|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
30657129|NCT00896532|58669820|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
30657130|NCT00896532|58669821|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
30657131|NCT00896532|58669822|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
30657132|NCT00896532|58669823|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
30657133|NCT00896532|58669824|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
30657134|NCT00896532|58669825|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
30657135|NCT00896532|58669826|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
30657136|NCT00896532|58669827|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
30657137|NCT00896532|58669828|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
30657138|NCT00896532|58669829|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
30657139|NCT00896532|58669830|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
30657140|NCT00896532|58669831|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
30657141|NCT00896532|58669809|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657142|NCT00896532|58669810|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657143|NCT00896532|58669811|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657144|NCT00896532|58669812|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657145|NCT00896532|58669813|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657146|NCT00896532|58669814|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657147|NCT00896532|58669815|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657148|NCT00896532|58669816|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657149|NCT00896532|58669817|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30769985|NCT00045942|58778907|FG005|PKC412A2104 (Core)|Death|0|||
30657150|NCT00896532|58669818|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657151|NCT00896532|58669819|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657152|NCT00896532|58669820|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657153|NCT00896532|58669821|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657154|NCT00896532|58669822|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657155|NCT00896532|58669823|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657156|NCT00896532|58669824|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
30657157|NCT00896532|58669825|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
30657158|NCT00896532|58669826|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657159|NCT00896532|58669827|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657160|NCT00896532|58669828|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657161|NCT00896532|58669829|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657162|NCT00896532|58669830|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657163|NCT00896532|58669831|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
30657164|NCT00896532|58669809|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657165|NCT00896532|58669810|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657166|NCT00896532|58669811|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657167|NCT00896532|58669812|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657168|NCT00896532|58669813|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657169|NCT00896532|58669814|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657170|NCT00896532|58669815|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657171|NCT00896532|58669816|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657172|NCT00896532|58669817|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657173|NCT00896532|58669818|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657174|NCT00896532|58669819|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657175|NCT00896532|58669820|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657176|NCT00896532|58669821|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657177|NCT00896532|58669822|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657178|NCT00896532|58669823|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657179|NCT00896532|58669824|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
30657180|NCT00896532|58669825|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
30657181|NCT00896532|58669826|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
30657182|NCT00896532|58669827|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657183|NCT00896532|58669828|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657184|NCT00896532|58669829|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657185|NCT00896532|58669830|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657186|NCT00896532|58669831|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
30657187|NCT00896532|58669809|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657188|NCT00896532|58669810|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657189|NCT00896532|58669811|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657190|NCT00896532|58669812|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657191|NCT00896532|58669813|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657192|NCT00896532|58669814|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657193|NCT00896532|58669815|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657194|NCT00896532|58669816|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657195|NCT00896532|58669817|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657196|NCT00896532|58669818|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657197|NCT00896532|58669819|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657198|NCT00896532|58669820|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657199|NCT00896532|58669821|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657200|NCT00896532|58669822|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657201|NCT00896532|58669823|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657202|NCT00896532|58669824|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657203|NCT00896532|58669825|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
30769986|NCT00045942|58778908|FG006|PKC412A2104 (Core)|Death|0|||
30769987|NCT00045942|58778909|FG007|PKC412A2104 (Core)|Death|0|||
30769988|NCT00045942|58778910|FG008|PKC412A2104 (Core)|Death|0|||
30769989|NCT00045942|58778902|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
30769990|NCT00045942|58778903|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
30769991|NCT00045942|58778904|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
30769992|NCT00045942|58778905|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
30769993|NCT00045942|58778906|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
30769994|NCT00045942|58778907|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
30769995|NCT00045942|58778908|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
30769996|NCT00045942|58778909|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
30657204|NCT00896532|58669826|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657205|NCT00896532|58669827|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657206|NCT00896532|58669828|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657207|NCT00896532|58669829|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30769997|NCT00045942|58778910|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
30769998|NCT00045942|58778902|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
30769999|NCT00045942|58778903|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
30657208|NCT00896532|58669830|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657209|NCT00896532|58669831|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
30657210|NCT00896532|58669809|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
30770000|NCT00045942|58778904|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
30770001|NCT00045942|58778905|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
30770002|NCT00045942|58778906|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
30770003|NCT00045942|58778907|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
30770004|NCT00045942|58778908|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
30770005|NCT00045942|58778909|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
30770006|NCT00045942|58778910|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
30770007|NCT00045942|58778902|FG000|PKC412A2104E1|Lack of Efficacy|0|||
30657211|NCT00896532|58669810|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
30657212|NCT00896532|58669811|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
30770008|NCT00045942|58778903|FG001|PKC412A2104E1|Lack of Efficacy|11|||
30770009|NCT00045942|58778904|FG002|PKC412A2104E1|Lack of Efficacy|11|||
30770010|NCT00045942|58778905|FG003|PKC412A2104E1|Lack of Efficacy|23|||
30770011|NCT00045942|58778906|FG004|PKC412A2104E1|Lack of Efficacy|17|||
30770012|NCT00045942|58778907|FG005|PKC412A2104E1|Lack of Efficacy|0|||
30770013|NCT00045942|58778908|FG006|PKC412A2104E1|Lack of Efficacy|0|||
30770014|NCT00045942|58778909|FG007|PKC412A2104E1|Lack of Efficacy|0|||
30770015|NCT00045942|58778910|FG008|PKC412A2104E1|Lack of Efficacy|0|||
30770016|NCT00045942|58778902|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
30770017|NCT00045942|58778903|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
30770018|NCT00045942|58778904|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
30770019|NCT00045942|58778905|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
30770020|NCT00045942|58778906|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
30770021|NCT00045942|58778907|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
30770022|NCT00045942|58778908|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
30770023|NCT00045942|58778909|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
30770024|NCT00045942|58778910|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
30770025|NCT00045942|58778902|FG000|PKC412A2104E1|Adverse Event|0|||
30770026|NCT00045942|58778903|FG001|PKC412A2104E1|Adverse Event|1|||
30770027|NCT00045942|58778904|FG002|PKC412A2104E1|Adverse Event|1|||
30770028|NCT00045942|58778905|FG003|PKC412A2104E1|Adverse Event|3|||
30770029|NCT00045942|58778906|FG004|PKC412A2104E1|Adverse Event|6|||
30770030|NCT00045942|58778907|FG005|PKC412A2104E1|Adverse Event|0|||
30770031|NCT00045942|58778908|FG006|PKC412A2104E1|Adverse Event|0|||
30770032|NCT00045942|58778909|FG007|PKC412A2104E1|Adverse Event|0|||
30657213|NCT00896532|58669812|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
30657214|NCT00896532|58669813|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
30657215|NCT00896532|58669814|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
30657216|NCT00896532|58669815|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
30657217|NCT00896532|58669816|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
30657218|NCT00896532|58669817|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
30657219|NCT00896532|58669818|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
30657220|NCT00896532|58669819|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
30657221|NCT00896532|58669820|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
30657222|NCT00896532|58669821|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
30657223|NCT00896532|58669822|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
30657224|NCT00896532|58669823|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
30657225|NCT00896532|58669824|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
30657226|NCT00896532|58669825|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
30657227|NCT00896532|58669826|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
30657228|NCT00896532|58669827|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
30657229|NCT00896532|58669828|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
30657230|NCT00896532|58669829|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
30770033|NCT00045942|58778910|FG008|PKC412A2104E1|Adverse Event|0|||
30770034|NCT00045942|58778902|FG000|PKC412A2104E1|Death|0|||
30770035|NCT00045942|58778903|FG001|PKC412A2104E1|Death|4|||
30770036|NCT00045942|58778904|FG002|PKC412A2104E1|Death|1|||
30770037|NCT00045942|58778905|FG003|PKC412A2104E1|Death|1|||
30657231|NCT00896532|58669830|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
30657232|NCT00896532|58669831|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
30657233|NCT00896532|58669809|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30770038|NCT00045942|58778906|FG004|PKC412A2104E1|Death|1|||
30770039|NCT00045942|58778907|FG005|PKC412A2104E1|Death|0|||
30770040|NCT00045942|58778908|FG006|PKC412A2104E1|Death|0|||
30770041|NCT00045942|58778909|FG007|PKC412A2104E1|Death|0|||
30770042|NCT00045942|58778910|FG008|PKC412A2104E1|Death|0|||
30770043|NCT00045942|58778902|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
30770044|NCT00045942|58778903|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
30770045|NCT00045942|58778904|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
30770046|NCT00045942|58778905|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
30770047|NCT00045942|58778906|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
30770048|NCT00045942|58778907|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
30770049|NCT00045942|58778908|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
30770050|NCT00045942|58778909|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
30770051|NCT00045942|58778910|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
30770052|NCT00045942|58778902|FG000|PKC412A2104E2|Lost to Follow-up|0|||
30770053|NCT00045942|58778903|FG001|PKC412A2104E2|Lost to Follow-up|0|||
30770054|NCT00045942|58778904|FG002|PKC412A2104E2|Lost to Follow-up|0|||
30770055|NCT00045942|58778905|FG003|PKC412A2104E2|Lost to Follow-up|0|||
30770056|NCT00045942|58778906|FG004|PKC412A2104E2|Lost to Follow-up|0|||
30770057|NCT00045942|58778907|FG005|PKC412A2104E2|Lost to Follow-up|0|||
30657234|NCT00896532|58669810|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657235|NCT00896532|58669811|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657236|NCT00896532|58669812|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657237|NCT00896532|58669813|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657238|NCT00896532|58669814|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657239|NCT00896532|58669815|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657240|NCT00896532|58669816|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657241|NCT00896532|58669817|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657242|NCT00896532|58669818|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657243|NCT00896532|58669819|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657244|NCT00896532|58669820|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657245|NCT00896532|58669821|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657246|NCT00896532|58669822|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657247|NCT00896532|58669823|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657248|NCT00896532|58669824|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657249|NCT00896532|58669825|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
30657250|NCT00896532|58669826|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657251|NCT00896532|58669827|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657252|NCT00896532|58669828|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657253|NCT00896532|58669829|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657254|NCT00896532|58669830|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657255|NCT00896532|58669831|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
30657256|NCT00896532|58669809|FG000|Months 48-72: Follow-on Phase|Death|0|||
30657257|NCT00896532|58669810|FG001|Months 48-72: Follow-on Phase|Death|0|||
30657258|NCT00896532|58669811|FG002|Months 48-72: Follow-on Phase|Death|0|||
30657259|NCT00896532|58669812|FG003|Months 48-72: Follow-on Phase|Death|0|||
30657260|NCT00896532|58669813|FG004|Months 48-72: Follow-on Phase|Death|0|||
30657261|NCT00896532|58669814|FG005|Months 48-72: Follow-on Phase|Death|0|||
30657262|NCT00896532|58669815|FG006|Months 48-72: Follow-on Phase|Death|0|||
30657263|NCT00896532|58669816|FG007|Months 48-72: Follow-on Phase|Death|0|||
30657264|NCT00896532|58669817|FG008|Months 48-72: Follow-on Phase|Death|0|||
30657265|NCT00896532|58669818|FG009|Months 48-72: Follow-on Phase|Death|0|||
30657266|NCT00896532|58669819|FG010|Months 48-72: Follow-on Phase|Death|0|||
30657267|NCT00896532|58669820|FG011|Months 48-72: Follow-on Phase|Death|0|||
30657268|NCT00896532|58669821|FG012|Months 48-72: Follow-on Phase|Death|0|||
30657269|NCT00896532|58669822|FG013|Months 48-72: Follow-on Phase|Death|0|||
30657270|NCT00896532|58669823|FG014|Months 48-72: Follow-on Phase|Death|0|||
30657271|NCT00896532|58669824|FG015|Months 48-72: Follow-on Phase|Death|0|||
30657272|NCT00896532|58669825|FG016|Months 48-72: Follow-on Phase|Death|0|||
30657273|NCT00896532|58669826|FG017|Months 48-72: Follow-on Phase|Death|0|||
30657274|NCT00896532|58669827|FG018|Months 48-72: Follow-on Phase|Death|1|||
30657275|NCT00896532|58669828|FG019|Months 48-72: Follow-on Phase|Death|0|||
30657276|NCT00896532|58669829|FG020|Months 48-72: Follow-on Phase|Death|0|||
30657277|NCT00896532|58669830|FG021|Months 48-72: Follow-on Phase|Death|0|||
30657278|NCT00896532|58669831|FG022|Months 48-72: Follow-on Phase|Death|0|||
30657279|NCT00896532|58669809|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657280|NCT00896532|58669810|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657281|NCT00896532|58669811|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657282|NCT00896532|58669812|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657283|NCT00896532|58669813|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30770058|NCT00045942|58778908|FG006|PKC412A2104E2|Lost to Follow-up|0|||
30770059|NCT00045942|58778909|FG007|PKC412A2104E2|Lost to Follow-up|3|||
30770060|NCT00045942|58778910|FG008|PKC412A2104E2|Lost to Follow-up|0|||
30770061|NCT00045942|58778902|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
30770062|NCT00045942|58778903|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
30770063|NCT00045942|58778904|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
30770064|NCT00045942|58778905|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
30770065|NCT00045942|58778906|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
30657284|NCT00896532|58669814|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657285|NCT00896532|58669815|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657286|NCT00896532|58669816|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657287|NCT00896532|58669817|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657288|NCT00896532|58669818|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657289|NCT00896532|58669819|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657290|NCT00896532|58669820|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657291|NCT00896532|58669821|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657292|NCT00896532|58669822|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657293|NCT00896532|58669823|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657294|NCT00896532|58669824|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657295|NCT00896532|58669825|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657296|NCT00896532|58669826|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657297|NCT00896532|58669827|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657298|NCT00896532|58669828|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657299|NCT00896532|58669829|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657300|NCT00896532|58669830|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
30657301|NCT00896532|58669831|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
30657302|NCT00896532|58669809|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657303|NCT00896532|58669810|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657304|NCT00896532|58669811|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657305|NCT00896532|58669812|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657306|NCT00896532|58669813|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657307|NCT00896532|58669814|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657308|NCT00896532|58669815|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657309|NCT00896532|58669816|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657310|NCT00896532|58669817|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657311|NCT00896532|58669818|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657312|NCT00896532|58669819|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657313|NCT00896532|58669820|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657314|NCT00896532|58669821|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657315|NCT00896532|58669822|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657316|NCT00896532|58669823|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657317|NCT00896532|58669824|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657318|NCT00896532|58669825|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657319|NCT00896532|58669826|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657320|NCT00896532|58669827|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657321|NCT00896532|58669828|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657322|NCT00896532|58669829|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657323|NCT00896532|58669830|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
30657324|NCT00896532|58669831|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
30657325|NCT00574873|58669880|FG000|Overall Study|Withdrawal by Subject|18|||
30657326|NCT00574873|58669881|FG001|Overall Study|Withdrawal by Subject|19|||
30657327|NCT00574873|58669880|FG000|Overall Study|Investigator request|18|||
30657328|NCT00574873|58669881|FG001|Overall Study|Investigator request|8|||
30657329|NCT00574873|58669880|FG000|Overall Study|Death|15|||
30657330|NCT00574873|58669881|FG001|Overall Study|Death|14|||
30657331|NCT00574873|58669880|FG000|Overall Study|Lost to Follow-up|14|||
30657332|NCT00574873|58669881|FG001|Overall Study|Lost to Follow-up|5|||
30657333|NCT00574873|58669880|FG000|Overall Study|Other|40|||
30657334|NCT00574873|58669881|FG001|Overall Study|Other|4|||
30657335|NCT00574873|58669880|FG000|Overall Study|Discontinuation of study by sponsor|5|||
30657336|NCT00574873|58669881|FG001|Overall Study|Discontinuation of study by sponsor|199|||
30657337|NCT00574873|58669880|FG000|Overall Study|Blank, site closed per local regulations|2|||
30657338|NCT00574873|58669881|FG001|Overall Study|Blank, site closed per local regulations|2|||
30657339|NCT00574873|58669880|FG000|Overall Study|Extension Study|126|||
30657340|NCT00574873|58669881|FG001|Overall Study|Extension Study|0|||
30657341|NCT00902174|58669889|FG000|Overall Study|Adverse Event|27|||
30657342|NCT00902174|58669890|FG001|Overall Study|Adverse Event|7|||
30657343|NCT00902174|58669889|FG000|Overall Study|Lack of Efficacy|1|||
30657344|NCT00902174|58669890|FG001|Overall Study|Lack of Efficacy|5|||
30657345|NCT00902174|58669889|FG000|Overall Study|Death|2|||
30657346|NCT00902174|58669890|FG001|Overall Study|Death|2|||
30657347|NCT00902174|58669889|FG000|Overall Study|Withdrawal by Subject|2|||
30657348|NCT00902174|58669890|FG001|Overall Study|Withdrawal by Subject|1|||
30657349|NCT00902174|58669889|FG000|Overall Study|Abnormal labs|1|||
30657350|NCT00902174|58669890|FG001|Overall Study|Abnormal labs|1|||
30657351|NCT00902174|58669889|FG000|Overall Study|Protocol Violation|1|||
30657352|NCT00902174|58669890|FG001|Overall Study|Protocol Violation|1|||
30657353|NCT00902174|58669889|FG000|Overall Study|Administration problem|0|||
30657354|NCT00902174|58669890|FG001|Overall Study|Administration problem|1|||
30657355|NCT00623623|58669914|FG000|Overall Study|Previous enrolment into this study|1|||
30657356|NCT00623623|58669915|FG001|Overall Study|Previous enrolment into this study|1|||
30657357|NCT00896454|58669921|FG000|Overall Study|Death|10|||
30657358|NCT00896454|58669921|FG000|Overall Study|Adverse Event|8|||
30657359|NCT00896454|58669921|FG000|Overall Study|Disease Progression|5|||
30657360|NCT00896454|58669921|FG000|Overall Study|Other|4|||
30657361|NCT00896454|58669921|FG000|Overall Study|Requirement for alternative therapy|3|||
30657362|NCT00896454|58669921|FG000|Overall Study|Ongoing in study|2|||
30657363|NCT00896454|58669921|FG000|Overall Study|Withdrawal by Subject|1|||
30657364|NCT00629239|58669927|FG000|Overall Study|Adverse Event|7|||
30657365|NCT00629239|58669928|FG001|Overall Study|Adverse Event|4|||
30657366|NCT00629239|58669927|FG000|Overall Study|Physician Decision|1|||
30657367|NCT00629239|58669928|FG001|Overall Study|Physician Decision|0|||
30657368|NCT00625807|58669936|FG000|Overall Study|schedule conflict|2|||
30657369|NCT00625807|58669937|FG001|Overall Study|schedule conflict|8|||
30657370|NCT00629083|58669947|FG000|Overall Study|Adverse Event|0|||
30848974|NCT02657408|58875678|FG001|Overall Study|Adverse Event|7|||
30952548|NCT01897727|59001317|FG000|Overall Study|Exclusion: central sleep apnea|0|||
30657371|NCT00629083|58669948|FG001|Overall Study|Adverse Event|2|||
30657372|NCT00629083|58669947|FG000|Overall Study|Lack of Efficacy|3|||
30657373|NCT00629083|58669948|FG001|Overall Study|Lack of Efficacy|1|||
30657374|NCT00629083|58669947|FG000|Overall Study|Withdrawal by Subject|10|||
30657375|NCT00629083|58669948|FG001|Overall Study|Withdrawal by Subject|2|||
30657376|NCT00629083|58669947|FG000|Overall Study|Lost to Follow-up|12|||
30657377|NCT00629083|58669948|FG001|Overall Study|Lost to Follow-up|8|||
30657378|NCT00629083|58669947|FG000|Overall Study|Moved out of country/state|2|||
30657379|NCT00629083|58669948|FG001|Overall Study|Moved out of country/state|1|||
30657380|NCT00629083|58669947|FG000|Overall Study|Refused to return for 12 month visit|1|||
30657381|NCT00629083|58669948|FG001|Overall Study|Refused to return for 12 month visit|0|||
30657382|NCT00901628|58669958|FG000|Overall Study|disconnection of catheter|4|||
30657383|NCT00901628|58669959|FG001|Overall Study|disconnection of catheter|8|||
30657384|NCT00901628|58669958|FG000|Overall Study|disconnection of drain|0|||
30657385|NCT00901628|58669959|FG001|Overall Study|disconnection of drain|1|||
30657386|NCT00901628|58669958|FG000|Overall Study|peroneal nerve palsy|0|||
30657387|NCT00901628|58669959|FG001|Overall Study|peroneal nerve palsy|1|||
30657388|NCT00623545|58669965|FG000|Overall Study|Adverse Event|6|||
30657389|NCT00623545|58669965|FG000|Overall Study|Withdrawal by Subject|4|||
30657390|NCT00628927|58669972|FG000|Overall Study|Problems performing blood draw|6|||
30657391|NCT00628927|58669973|FG001|Overall Study|Problems performing blood draw|0|||
30657392|NCT00628927|58669972|FG000|Overall Study|Lost to Follow-up|1|||
30657393|NCT00628927|58669973|FG001|Overall Study|Lost to Follow-up|0|||
30657394|NCT00628927|58669972|FG000|Overall Study|Equipment failure|1|||
30657395|NCT00628927|58669973|FG001|Overall Study|Equipment failure|0|||
30657396|NCT00623467|58669984|FG000|Overall Study|Lost to Follow-up|1|||
30657397|NCT00623467|58669984|FG000|Overall Study|Protocol Violation|4|||
30657398|NCT00623467|58669984|FG000|Overall Study|Withdrawal by Subject|2|||
30657399|NCT00838539|58670002|FG000|Overall Study|Disease Progression|2|||
30657400|NCT00838539|58670003|FG001|Overall Study|Disease Progression|4|||
30657401|NCT00838539|58670004|FG002|Overall Study|Disease Progression|3|||
30657402|NCT00838539|58670005|FG003|Overall Study|Disease Progression|2|||
30657403|NCT00838539|58670006|FG004|Overall Study|Disease Progression|4|||
30657404|NCT00838539|58670007|FG005|Overall Study|Disease Progression|2|||
30657405|NCT00838539|58670008|FG006|Overall Study|Disease Progression|3|||
30657406|NCT00838539|58670009|FG007|Overall Study|Disease Progression|4|||
30657407|NCT00838539|58670010|FG008|Overall Study|Disease Progression|4|||
30657408|NCT00838539|58670011|FG009|Overall Study|Disease Progression|5|||
30657409|NCT00838539|58670012|FG010|Overall Study|Disease Progression|1|||
30657410|NCT00838539|58670013|FG011|Overall Study|Disease Progression|4|||
30657411|NCT00838539|58670002|FG000|Overall Study|Adverse Event|1|||
30657412|NCT00838539|58670003|FG001|Overall Study|Adverse Event|1|||
30657413|NCT00838539|58670004|FG002|Overall Study|Adverse Event|1|||
30657414|NCT00838539|58670005|FG003|Overall Study|Adverse Event|1|||
30657415|NCT00838539|58670006|FG004|Overall Study|Adverse Event|2|||
30657416|NCT00838539|58670007|FG005|Overall Study|Adverse Event|1|||
30657417|NCT00838539|58670008|FG006|Overall Study|Adverse Event|0|||
30657418|NCT00838539|58670009|FG007|Overall Study|Adverse Event|2|||
30657419|NCT00838539|58670010|FG008|Overall Study|Adverse Event|0|||
30657420|NCT00838539|58670011|FG009|Overall Study|Adverse Event|1|||
30657421|NCT00838539|58670012|FG010|Overall Study|Adverse Event|2|||
30952549|NCT01897727|59001318|FG001|Overall Study|Exclusion: central sleep apnea|1|||
30657422|NCT00838539|58670013|FG011|Overall Study|Adverse Event|0|||
30657423|NCT00838539|58670002|FG000|Overall Study|Withdrawal by Subject|0|||
30657424|NCT00838539|58670003|FG001|Overall Study|Withdrawal by Subject|1|||
30657425|NCT00838539|58670004|FG002|Overall Study|Withdrawal by Subject|0|||
30657426|NCT00838539|58670005|FG003|Overall Study|Withdrawal by Subject|0|||
30657427|NCT00838539|58670006|FG004|Overall Study|Withdrawal by Subject|0|||
30657428|NCT00838539|58670007|FG005|Overall Study|Withdrawal by Subject|0|||
30657429|NCT00838539|58670008|FG006|Overall Study|Withdrawal by Subject|0|||
30657430|NCT00838539|58670009|FG007|Overall Study|Withdrawal by Subject|0|||
30657431|NCT00838539|58670010|FG008|Overall Study|Withdrawal by Subject|0|||
30657432|NCT00838539|58670011|FG009|Overall Study|Withdrawal by Subject|1|||
30770066|NCT00045942|58778907|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
30770067|NCT00045942|58778908|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
30657433|NCT00838539|58670012|FG010|Overall Study|Withdrawal by Subject|2|||
30657434|NCT00838539|58670013|FG011|Overall Study|Withdrawal by Subject|0|||
30657435|NCT00838539|58670002|FG000|Overall Study|Death|0|||
30657436|NCT00838539|58670003|FG001|Overall Study|Death|0|||
30657437|NCT00838539|58670004|FG002|Overall Study|Death|0|||
30657438|NCT00838539|58670005|FG003|Overall Study|Death|0|||
30657439|NCT00838539|58670006|FG004|Overall Study|Death|0|||
30657440|NCT00838539|58670007|FG005|Overall Study|Death|0|||
30657441|NCT00838539|58670008|FG006|Overall Study|Death|1|||
30657442|NCT00838539|58670009|FG007|Overall Study|Death|0|||
30657443|NCT00838539|58670010|FG008|Overall Study|Death|0|||
30657444|NCT00838539|58670011|FG009|Overall Study|Death|0|||
30770068|NCT00045942|58778909|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
30770069|NCT00045942|58778910|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
30770070|NCT00045942|58778902|FG000|PKC412A2104E2|Lack of Efficacy|0|||
30770071|NCT00045942|58778903|FG001|PKC412A2104E2|Lack of Efficacy|0|||
30770072|NCT00045942|58778904|FG002|PKC412A2104E2|Lack of Efficacy|0|||
30770073|NCT00045942|58778905|FG003|PKC412A2104E2|Lack of Efficacy|0|||
30770074|NCT00045942|58778906|FG004|PKC412A2104E2|Lack of Efficacy|0|||
30770075|NCT00045942|58778907|FG005|PKC412A2104E2|Lack of Efficacy|3|||
30770076|NCT00045942|58778908|FG006|PKC412A2104E2|Lack of Efficacy|2|||
30770077|NCT00045942|58778909|FG007|PKC412A2104E2|Lack of Efficacy|2|||
30770078|NCT00045942|58778910|FG008|PKC412A2104E2|Lack of Efficacy|6|||
30770079|NCT00045942|58778902|FG000|PKC412A2104E2|Adverse Event|0|||
30770080|NCT00045942|58778903|FG001|PKC412A2104E2|Adverse Event|0|||
30770081|NCT00045942|58778904|FG002|PKC412A2104E2|Adverse Event|0|||
30770082|NCT00045942|58778905|FG003|PKC412A2104E2|Adverse Event|0|||
30770083|NCT00045942|58778906|FG004|PKC412A2104E2|Adverse Event|0|||
30770084|NCT00045942|58778907|FG005|PKC412A2104E2|Adverse Event|4|||
30770085|NCT00045942|58778908|FG006|PKC412A2104E2|Adverse Event|3|||
30770086|NCT00045942|58778909|FG007|PKC412A2104E2|Adverse Event|1|||
30770087|NCT00045942|58778910|FG008|PKC412A2104E2|Adverse Event|0|||
30770088|NCT00045942|58778902|FG000|PKC412A2104E2|Death|0|||
30770089|NCT00045942|58778903|FG001|PKC412A2104E2|Death|0|||
30657445|NCT00838539|58670012|FG010|Overall Study|Death|0|||
30657446|NCT00838539|58670013|FG011|Overall Study|Death|0|||
30657447|NCT00838539|58670002|FG000|Overall Study|Physician Decision|0|||
30657448|NCT00838539|58670003|FG001|Overall Study|Physician Decision|0|||
30657449|NCT00838539|58670004|FG002|Overall Study|Physician Decision|0|||
30657450|NCT00838539|58670005|FG003|Overall Study|Physician Decision|0|||
30657451|NCT00838539|58670006|FG004|Overall Study|Physician Decision|0|||
30657452|NCT00838539|58670007|FG005|Overall Study|Physician Decision|0|||
30657453|NCT00838539|58670008|FG006|Overall Study|Physician Decision|0|||
30770090|NCT00045942|58778904|FG002|PKC412A2104E2|Death|0|||
30770091|NCT00045942|58778905|FG003|PKC412A2104E2|Death|0|||
30770092|NCT00045942|58778906|FG004|PKC412A2104E2|Death|0|||
30770093|NCT00045942|58778907|FG005|PKC412A2104E2|Death|1|||
30848975|NCT02841709|58875684|FG000|5th Intervention|Adverse Event|2|||
30848976|NCT02841709|58875685|FG001|5th Intervention|Adverse Event|0|||
30848977|NCT02841709|58875686|FG002|5th Intervention|Adverse Event|0|||
30848978|NCT02841709|58875687|FG003|5th Intervention|Adverse Event|0|||
30848979|NCT02841709|58875688|FG004|5th Intervention|Adverse Event|2|||
30848980|NCT01353859|58875701|FG000|Overall Study|Adverse Event|3|||
30657454|NCT00838539|58670009|FG007|Overall Study|Physician Decision|0|||
30770094|NCT00045942|58778908|FG006|PKC412A2104E2|Death|2|||
30657455|NCT00838539|58670010|FG008|Overall Study|Physician Decision|1|||
30657456|NCT00838539|58670011|FG009|Overall Study|Physician Decision|0|||
30657457|NCT00838539|58670012|FG010|Overall Study|Physician Decision|0|||
30657458|NCT00838539|58670013|FG011|Overall Study|Physician Decision|0|||
30657459|NCT00838539|58670002|FG000|Overall Study|Clinical Progression|0|||
30657460|NCT00838539|58670003|FG001|Overall Study|Clinical Progression|0|||
30657461|NCT00838539|58670004|FG002|Overall Study|Clinical Progression|0|||
30657462|NCT00838539|58670005|FG003|Overall Study|Clinical Progression|0|||
30657463|NCT00838539|58670006|FG004|Overall Study|Clinical Progression|0|||
30657464|NCT00838539|58670007|FG005|Overall Study|Clinical Progression|0|||
30770095|NCT00045942|58778909|FG007|PKC412A2104E2|Death|0|||
30770096|NCT00045942|58778910|FG008|PKC412A2104E2|Death|0|||
30657465|NCT00838539|58670008|FG006|Overall Study|Clinical Progression|1|||
30770097|NCT04386616|58778937|FG000|Overall Study|Death|22|||
30770098|NCT04386616|58778938|FG001|Overall Study|Death|22|||
30770099|NCT04386616|58778939|FG002|Overall Study|Death|21|||
30770100|NCT04386616|58778937|FG000|Overall Study|Lost to Follow-up|5|||
30770101|NCT04386616|58778938|FG001|Overall Study|Lost to Follow-up|8|||
30770102|NCT04386616|58778939|FG002|Overall Study|Lost to Follow-up|6|||
30848981|NCT01353859|58875701|FG000|Overall Study|Lack of Efficacy|1|||
30848982|NCT02850965|58875707|FG000|Overall Study|Other than listed|3|||
30657466|NCT00838539|58670009|FG007|Overall Study|Clinical Progression|0|||
30657467|NCT00838539|58670010|FG008|Overall Study|Clinical Progression|0|||
30657468|NCT00838539|58670011|FG009|Overall Study|Clinical Progression|0|||
30657469|NCT00838539|58670012|FG010|Overall Study|Clinical Progression|0|||
30770103|NCT04386616|58778937|FG000|Overall Study|Withdrawal by Subject|2|||
30770104|NCT04386616|58778938|FG001|Overall Study|Withdrawal by Subject|4|||
30770105|NCT04386616|58778939|FG002|Overall Study|Withdrawal by Subject|1|||
30657470|NCT00838539|58670013|FG011|Overall Study|Clinical Progression|0|||
30657471|NCT00838539|58670002|FG000|Overall Study|Symptomatic Deterioration|0|||
30657472|NCT00838539|58670003|FG001|Overall Study|Symptomatic Deterioration|0|||
30657473|NCT00838539|58670004|FG002|Overall Study|Symptomatic Deterioration|1|||
30657474|NCT00838539|58670005|FG003|Overall Study|Symptomatic Deterioration|1|||
30657475|NCT00838539|58670006|FG004|Overall Study|Symptomatic Deterioration|0|||
30657476|NCT00838539|58670007|FG005|Overall Study|Symptomatic Deterioration|1|||
30657477|NCT00838539|58670008|FG006|Overall Study|Symptomatic Deterioration|0|||
30657478|NCT00838539|58670009|FG007|Overall Study|Symptomatic Deterioration|0|||
30657479|NCT00838539|58670010|FG008|Overall Study|Symptomatic Deterioration|0|||
30657480|NCT00838539|58670011|FG009|Overall Study|Symptomatic Deterioration|1|||
30657481|NCT00838539|58670012|FG010|Overall Study|Symptomatic Deterioration|0|||
30657482|NCT00838539|58670013|FG011|Overall Study|Symptomatic Deterioration|0|||
30657483|NCT00837759|58670053|FG000|Overall Study|Protocol Violation|3|||
30657484|NCT00837759|58670053|FG000|Overall Study|Lost to Follow-up|1|||
30657485|NCT00891774|58670057|FG000|Overall Study|Lost to Follow-up|5|||
30657486|NCT00891774|58670057|FG000|Overall Study|Illness (Self/Mother)|3|||
30657487|NCT00891774|58670057|FG000|Overall Study|Withdrawal by Subject|2|||
30657488|NCT00891774|58670057|FG000|Overall Study|Protocol Violation|4|||
30657489|NCT05421754|58670061|FG000|Overall Study|Technical issue with sensor|1|||
30657490|NCT04644276|58670083|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
30657491|NCT04644276|58670084|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
30657492|NCT04644276|58670085|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
30657493|NCT03845296|58670114|FG000|Overall Study|On Treatment|2|||
30657494|NCT03845296|58670115|FG001|Overall Study|On Treatment|1|||
30657495|NCT03845296|58670114|FG000|Overall Study|Adverse Event|4|||
30657496|NCT03845296|58670115|FG001|Overall Study|Adverse Event|11|||
30657497|NCT03845296|58670114|FG000|Overall Study|Refusal unrelated to adverse event|0|||
30657498|NCT03845296|58670115|FG001|Overall Study|Refusal unrelated to adverse event|1|||
30657499|NCT03845296|58670114|FG000|Overall Study|Progression/relapse|14|||
30657500|NCT03845296|58670115|FG001|Overall Study|Progression/relapse|18|||
30657501|NCT03845296|58670114|FG000|Overall Study|Death|4|||
30657502|NCT03845296|58670115|FG001|Overall Study|Death|0|||
30657503|NCT03845296|58670114|FG000|Overall Study|Other - not protocol specified|1|||
30657504|NCT03845296|58670115|FG001|Overall Study|Other - not protocol specified|3|||
30657505|NCT02115282|58670162|FG000|Overall Study|Disease progression during treatment|216|||
30657506|NCT02115282|58670163|FG001|Overall Study|Disease progression during treatment|229|||
30657507|NCT02115282|58670162|FG000|Overall Study|Adverse Event|49|||
30657508|NCT02115282|58670163|FG001|Overall Study|Adverse Event|23|||
30657509|NCT02115282|58670162|FG000|Overall Study|Death|1|||
30657510|NCT02115282|58670163|FG001|Overall Study|Death|3|||
30657511|NCT02115282|58670162|FG000|Overall Study|Alternative therapy|1|||
30657512|NCT02115282|58670163|FG001|Overall Study|Alternative therapy|1|||
30657513|NCT02115282|58670162|FG000|Overall Study|Complicating disease|0|||
30657514|NCT02115282|58670163|FG001|Overall Study|Complicating disease|3|||
30657515|NCT02115282|58670162|FG000|Overall Study|Withdrawal by Subject|12|||
30657516|NCT02115282|58670163|FG001|Overall Study|Withdrawal by Subject|10|||
30657517|NCT02115282|58670162|FG000|Overall Study|Symptomatic progression/deterioration|7|||
30657518|NCT02115282|58670163|FG001|Overall Study|Symptomatic progression/deterioration|18|||
30657519|NCT02115282|58670162|FG000|Overall Study|Non-compliance|5|||
30657520|NCT02115282|58670163|FG001|Overall Study|Non-compliance|1|||
30657521|NCT02115282|58670162|FG000|Overall Study|Protocol Violation|2|||
30770106|NCT04386616|58778937|FG000|Overall Study|Adverse Event|1|||
30770107|NCT04386616|58778938|FG001|Overall Study|Adverse Event|1|||
30657522|NCT02115282|58670163|FG001|Overall Study|Protocol Violation|2|||
30657523|NCT02115282|58670162|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
30657524|NCT02115282|58670163|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
30657525|NCT02115282|58670162|FG000|Overall Study|Not start protocol therapy|9|||
30657526|NCT02115282|58670163|FG001|Overall Study|Not start protocol therapy|10|||
30770108|NCT04386616|58778939|FG002|Overall Study|Adverse Event|0|||
30657527|NCT01596621|58670171|FG000|Overall Study|Death|4|||
30657528|NCT01596621|58670171|FG000|Overall Study|Withdrawal by Subject|9|||
30657529|NCT01596621|58670171|FG000|Overall Study|Disease Progression|49|||
30657530|NCT01596621|58670171|FG000|Overall Study|Lost to Follow-up|3|||
30657531|NCT01596621|58670171|FG000|Overall Study|Other than specified|13|||
30657532|NCT01337245|58670175|FG000|Overall Study|Lost to Follow-up|1|||
30657533|NCT00566098|58670185|FG000|Collection of MILs|Withdrawal by Subject|1|||
30657534|NCT00566098|58670185|FG000|Collection of MILs|Relapsed|1|||
30657535|NCT00566098|58670185|FG000|Generation of MILs Product|Relapsed|1|||
30657536|NCT00566098|58670185|FG000|Administration of ASCT+MILs|Death|10|||
30657537|NCT00566098|58670185|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
30657538|NCT00248287|58670192|FG000|Overall Study|Adverse Event|11|||
30657539|NCT00248287|58670193|FG001|Overall Study|Adverse Event|10|||
30657540|NCT00248287|58670192|FG000|Overall Study|Death|1|||
30657541|NCT00248287|58670193|FG001|Overall Study|Death|0|||
30657542|NCT00248287|58670192|FG000|Overall Study|Lost to Follow-up|0|||
30657543|NCT00248287|58670193|FG001|Overall Study|Lost to Follow-up|1|||
30657544|NCT00248287|58670192|FG000|Overall Study|Investigator Request|4|||
30657545|NCT00248287|58670193|FG001|Overall Study|Investigator Request|3|||
30657546|NCT00248287|58670192|FG000|Overall Study|Patient Request|5|||
30657547|NCT00248287|58670193|FG001|Overall Study|Patient Request|3|||
30657548|NCT00248287|58670192|FG000|Overall Study|Other|3|||
30657549|NCT00248287|58670193|FG001|Overall Study|Other|2|||
30657550|NCT00837213|58670201|FG000|Overall Study|Lost to Follow-up|3|||
30657551|NCT00837213|58670202|FG001|Overall Study|Lost to Follow-up|2|||
30657552|NCT00837213|58670201|FG000|Overall Study|Withdrawal by Subject|2|||
30657553|NCT00837213|58670202|FG001|Overall Study|Withdrawal by Subject|2|||
30657554|NCT00837213|58670201|FG000|Overall Study|not stated|1|||
30657555|NCT00837213|58670202|FG001|Overall Study|not stated|1|||
30657556|NCT00902486|58670212|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
30657557|NCT00902486|58670213|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
30657558|NCT00902486|58670214|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
30657559|NCT00902486|58670215|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
30657560|NCT00902486|58670216|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
30657561|NCT00902486|58670217|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
30657562|NCT00902486|58670212|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
30657563|NCT00902486|58670213|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
30657564|NCT00902486|58670214|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
30657565|NCT00902486|58670215|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
30657566|NCT00902486|58670216|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
30657567|NCT00902486|58670217|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
30657568|NCT00902486|58670212|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
30657569|NCT00902486|58670213|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
30657570|NCT00902486|58670214|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
30657571|NCT00902486|58670215|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
30657572|NCT00902486|58670216|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
30657573|NCT00902486|58670217|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
30657574|NCT00902486|58670212|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
30657575|NCT00902486|58670213|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
30657576|NCT00902486|58670214|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
30657577|NCT00902486|58670215|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
30657578|NCT00902486|58670216|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
30657579|NCT00902486|58670217|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
30657580|NCT00902486|58670212|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
30657581|NCT00902486|58670213|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
30657582|NCT00902486|58670214|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
30657583|NCT00902486|58670215|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
30657584|NCT00902486|58670216|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
30657585|NCT00902486|58670217|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
30657586|NCT00902486|58670212|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
30657587|NCT00902486|58670213|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
30657588|NCT00902486|58670214|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
30657589|NCT00902486|58670215|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
30657590|NCT00902486|58670216|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
30657591|NCT00902486|58670217|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
30657592|NCT00902486|58670212|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
30657593|NCT00902486|58670213|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
30770109|NCT00045708|58778959|FG000|Phase 1|early progressive disease|0|||
30770110|NCT00045708|58778960|FG001|Phase 1|early progressive disease|1|||
30770111|NCT00045708|58778961|FG002|Phase 1|early progressive disease|0|||
30770112|NCT00045630|58778978|FG000|Overall Study|Adverse Event|1|||
30770113|NCT00045630|58778978|FG000|Overall Study|Refusal unrelated to adverse event|1|||
30657594|NCT00902486|58670214|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
30657595|NCT00902486|58670215|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
30657596|NCT00902486|58670216|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
30657597|NCT00902486|58670217|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
30657598|NCT00902486|58670212|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
30657599|NCT00902486|58670213|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
30657600|NCT00902486|58670214|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
30657601|NCT00902486|58670215|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
30657602|NCT00902486|58670216|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
30657603|NCT00902486|58670217|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
30657604|NCT00902486|58670212|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
30657605|NCT00902486|58670213|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
30657606|NCT00902486|58670214|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
30657607|NCT00902486|58670215|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
30657608|NCT00902486|58670216|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
30657609|NCT00902486|58670217|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
30657610|NCT00902486|58670212|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
30657611|NCT00902486|58670213|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
30657612|NCT00902486|58670214|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
30657613|NCT00902486|58670215|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
30657614|NCT00902486|58670216|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
30657615|NCT00902486|58670217|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
30657616|NCT00902486|58670212|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
30657617|NCT00902486|58670213|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
30657618|NCT00902486|58670214|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
30657619|NCT00902486|58670215|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
30657620|NCT00902486|58670216|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
30657621|NCT00902486|58670217|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
30657622|NCT00836745|58670247|FG000|Overall Study|Death|2|||
30657623|NCT00836745|58670247|FG000|Overall Study|Lost to Follow-up|10|||
30657624|NCT00836745|58670247|FG000|Overall Study|Adverse Event|3|||
30657625|NCT00836745|58670247|FG000|Overall Study|Objective progression or relapse|4|||
30657626|NCT00836745|58670247|FG000|Overall Study|Other|2|||
30657627|NCT00891618|58670251|FG000|Overall Study|Withdrawal by Subject|1|||
30657628|NCT00836589|58670255|FG000|Overall Study|Lost to Follow-up|246|||
30657629|NCT00836589|58670255|FG000|Overall Study|Death|429|||
30657630|NCT00836589|58670255|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
30657631|NCT00574795|58670267|FG000|Infant Series|Withdrawal by Subject|2|||
30657632|NCT00574795|58670267|FG000|Infant Series|Protocol Violation|2|||
30657633|NCT00574795|58670267|FG000|Infant Series|Adverse Event|1|||
30657634|NCT00574795|58670267|FG000|After Infant Series|Withdrawal by Subject|1|||
30657635|NCT00574795|58670267|FG000|After Infant Series|Adverse Event|2|||
30657636|NCT00574795|58670267|FG000|Toddler Dose|Withdrawal by Subject|1|||
30657637|NCT02297516|58670284|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
30657638|NCT02297516|58670285|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
30657639|NCT02297516|58670284|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
30657640|NCT02297516|58670285|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
30657641|NCT02297516|58670284|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
30657642|NCT02297516|58670285|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
30657643|NCT00836277|58670298|FG000|Overall Study|Not evaluable for response|6|||
30657644|NCT00835731|58670304|FG000|Overall Study|Withdrawal by Subject|1|||
30657645|NCT00835731|58670305|FG001|Overall Study|Withdrawal by Subject|0|||
30657646|NCT00835731|58670304|FG000|Overall Study|Physician Decision|1|||
30657647|NCT00835731|58670305|FG001|Overall Study|Physician Decision|1|||
30657648|NCT00835341|58670313|FG000|Overall Study|Lost to Follow-up|3|||
30657649|NCT00835341|58670314|FG001|Overall Study|Lost to Follow-up|12|||
30657650|NCT00574249|58670322|FG000|Overall Study|Adverse Event|6|||
30657651|NCT00574249|58670323|FG001|Overall Study|Adverse Event|18|||
30657652|NCT00574249|58670322|FG000|Overall Study|Lack of Efficacy|5|||
30657653|NCT00574249|58670323|FG001|Overall Study|Lack of Efficacy|3|||
30657654|NCT00574249|58670322|FG000|Overall Study|Lost to Follow-up|4|||
30657655|NCT00574249|58670323|FG001|Overall Study|Lost to Follow-up|3|||
30657656|NCT00574249|58670322|FG000|Overall Study|Protocol Violation|5|||
30657657|NCT00574249|58670323|FG001|Overall Study|Protocol Violation|2|||
30657658|NCT00574249|58670322|FG000|Overall Study|History of carcinoma|1|||
30657659|NCT00574249|58670323|FG001|Overall Study|History of carcinoma|0|||
30657660|NCT00574249|58670322|FG000|Overall Study|Withdrawal by Subject|3|||
30657661|NCT00574249|58670323|FG001|Overall Study|Withdrawal by Subject|0|||
30657662|NCT00574249|58670322|FG000|Overall Study|Physician Decision|1|||
30657663|NCT00574249|58670323|FG001|Overall Study|Physician Decision|0|||
30657664|NCT00574249|58670322|FG000|Overall Study|Pregnancy|1|||
30657665|NCT00574249|58670323|FG001|Overall Study|Pregnancy|0|||
30657666|NCT00574249|58670322|FG000|Overall Study|Excluded by company|0|||
30657667|NCT00574249|58670323|FG001|Overall Study|Excluded by company|1|||
30657668|NCT00574249|58670322|FG000|Overall Study|PPD test taken twice|0|||
30657669|NCT00574249|58670323|FG001|Overall Study|PPD test taken twice|1|||
30657670|NCT00891228|58670332|FG000|Overall Study|Adverse Event|0|||
30657671|NCT00891228|58670333|FG001|Overall Study|Adverse Event|2|||
30657672|NCT00891228|58670334|FG002|Overall Study|Adverse Event|3|||
30657673|NCT00891228|58670332|FG000|Overall Study|Withdrawal by Subject|2|||
30657674|NCT00891228|58670333|FG001|Overall Study|Withdrawal by Subject|4|||
30657675|NCT00891228|58670334|FG002|Overall Study|Withdrawal by Subject|5|||
30657676|NCT00891228|58670332|FG000|Overall Study|Protocol Violation|3|||
30657677|NCT00891228|58670333|FG001|Overall Study|Protocol Violation|1|||
30657678|NCT00891228|58670334|FG002|Overall Study|Protocol Violation|2|||
30657679|NCT00891228|58670332|FG000|Overall Study|Physician Decision|2|||
30657680|NCT00891228|58670333|FG001|Overall Study|Physician Decision|1|||
30657681|NCT00891228|58670334|FG002|Overall Study|Physician Decision|0|||
30657682|NCT00891228|58670332|FG000|Overall Study|Lost to Follow-up|4|||
30657683|NCT00891228|58670333|FG001|Overall Study|Lost to Follow-up|4|||
30657684|NCT00891228|58670334|FG002|Overall Study|Lost to Follow-up|5|||
30657685|NCT00891228|58670332|FG000|Overall Study|Pregnancy|0|||
30657686|NCT00891228|58670333|FG001|Overall Study|Pregnancy|1|||
30657687|NCT00891228|58670334|FG002|Overall Study|Pregnancy|0|||
30657688|NCT00896168|58670344|FG000|Overall Study|Adverse Event|4|||
30657689|NCT00896168|58670345|FG001|Overall Study|Adverse Event|7|||
30657690|NCT00896168|58670344|FG000|Overall Study|Treatment failure|8|||
30657691|NCT00896168|58670345|FG001|Overall Study|Treatment failure|10|||
30657692|NCT00896168|58670344|FG000|Overall Study|Lost to Follow-up|1|||
30657693|NCT00896168|58670345|FG001|Overall Study|Lost to Follow-up|1|||
30657694|NCT00896168|58670344|FG000|Overall Study|Other|1|||
30657695|NCT00896168|58670345|FG001|Overall Study|Other|1|||
30657696|NCT00833703|58670353|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
30657697|NCT00833703|58670354|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
30657698|NCT00833547|58670362|FG000|Overall Study|Withdrawal by Subject|2|||
30657699|NCT00833547|58670363|FG001|Overall Study|Withdrawal by Subject|2|||
30657700|NCT00833469|58670369|FG000|Overall Study|Withdrawal by Subject|1|||
30657701|NCT00833469|58670369|FG000|Overall Study|Lost to Follow-up|1|||
30657702|NCT00832377|58670373|FG000|Overall Study|Protocol Violation|1|||
30657703|NCT00892008|58670377|FG000|Overall Study|Death|5|||
30657704|NCT00892008|58670377|FG000|Overall Study|Lack of Efficacy|3|||
30657705|NCT00892008|58670377|FG000|Overall Study|Lost to Follow-up|142|||
30657706|NCT00892008|58670377|FG000|Overall Study|Other|378|||
30657707|NCT00892008|58670377|FG000|Overall Study|Adverse Event|37|||
30657708|NCT00623233|58670381|FG000|Overall Study|Adverse Event|10|||
30657709|NCT00623233|58670381|FG000|Overall Study|Physician Decision|10|||
30657710|NCT00623233|58670381|FG000|Overall Study|Lost to Follow-up|1|||
30657711|NCT00623233|58670381|FG000|Overall Study|Withdrawal by Subject|3|||
30657712|NCT03369236|58670396|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
30657713|NCT03369236|58670397|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
30657714|NCT03369236|58670396|FG000|Open-label Extension Period|Lack of Efficacy|2|||
30657715|NCT03369236|58670397|FG001|Open-label Extension Period|Lack of Efficacy|1|||
30657716|NCT03369236|58670396|FG000|Open-label Extension Period|Adverse Event|0|||
30657717|NCT03369236|58670397|FG001|Open-label Extension Period|Adverse Event|1|||
30657718|NCT03369236|58670396|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
30657719|NCT03369236|58670397|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
30657720|NCT00621751|58670411|FG000|Overall Study|Adverse Event|0|||
30657721|NCT00621751|58670412|FG001|Overall Study|Adverse Event|1|||
30657722|NCT00891930|58670429|FG000|Part 1: Panitumumab +Irinotecan|Death|38|||
30657723|NCT00891930|58670429|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1|||
30657724|NCT00891930|58670429|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1|||
30657725|NCT00891930|58670429|FG000|Part 2: Panitumumab + Ganitumab|Death|30|||
30657726|NCT00891930|58670429|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1|||
30657727|NCT00895622|58670440|FG000|Overall Study|Protocol Violation|5|||
30657728|NCT00895622|58670441|FG001|Overall Study|Protocol Violation|4|||
30657729|NCT00895622|58670442|FG002|Overall Study|Protocol Violation|4|||
30657730|NCT00891462|58670461|FG000|Overall Study|Withdrawal by Subject|9|||
30657731|NCT00891462|58670462|FG001|Overall Study|Withdrawal by Subject|6|||
30657732|NCT00891462|58670463|FG002|Overall Study|Withdrawal by Subject|7|||
30657733|NCT00891462|58670461|FG000|Overall Study|Adverse Event|7|||
30657734|NCT00891462|58670462|FG001|Overall Study|Adverse Event|8|||
30657735|NCT00891462|58670463|FG002|Overall Study|Adverse Event|7|||
30657736|NCT00891462|58670461|FG000|Overall Study|Lack of Efficacy|10|||
30657737|NCT00891462|58670462|FG001|Overall Study|Lack of Efficacy|5|||
30657738|NCT00891462|58670463|FG002|Overall Study|Lack of Efficacy|1|||
30657739|NCT00891462|58670461|FG000|Overall Study|COPD exacerbation|7|||
30657740|NCT00891462|58670462|FG001|Overall Study|COPD exacerbation|4|||
30657741|NCT00891462|58670463|FG002|Overall Study|COPD exacerbation|1|||
30657742|NCT00891462|58670461|FG000|Overall Study|Other Reason|2|||
30657743|NCT00891462|58670462|FG001|Overall Study|Other Reason|5|||
30657744|NCT00891462|58670463|FG002|Overall Study|Other Reason|3|||
30657745|NCT00891462|58670461|FG000|Overall Study|Protocol Violation|2|||
30657746|NCT00891462|58670462|FG001|Overall Study|Protocol Violation|1|||
30657747|NCT00891462|58670463|FG002|Overall Study|Protocol Violation|3|||
30657748|NCT00891462|58670461|FG000|Overall Study|Inclusion/exclusion criteria|0|||
30657749|NCT00891462|58670462|FG001|Overall Study|Inclusion/exclusion criteria|2|||
30657750|NCT00891462|58670463|FG002|Overall Study|Inclusion/exclusion criteria|2|||
30657751|NCT00891462|58670461|FG000|Overall Study|Lost to Follow-up|0|||
30657752|NCT00891462|58670462|FG001|Overall Study|Lost to Follow-up|2|||
30657753|NCT00891462|58670463|FG002|Overall Study|Lost to Follow-up|0|||
30657754|NCT00900146|58670478|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
30657755|NCT00900146|58670479|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
30657756|NCT00900146|58670480|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
30657757|NCT00900146|58670481|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
30657758|NCT00900146|58670482|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
30657759|NCT00900146|58670478|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
30657760|NCT00900146|58670479|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
30657761|NCT00900146|58670480|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
30657762|NCT00900146|58670481|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
30657763|NCT00900146|58670482|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
30657764|NCT00900146|58670478|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
30657765|NCT00900146|58670479|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
30657766|NCT00900146|58670480|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
30657767|NCT00900146|58670481|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
30657768|NCT00900146|58670482|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
30657769|NCT00900146|58670478|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
30657770|NCT00900146|58670479|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
30657771|NCT00900146|58670480|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
30657772|NCT00900146|58670481|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
30657773|NCT00900146|58670482|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
30657774|NCT00900146|58670478|FG000|Intermediate: Period III|Lost to Follow-up|2|||
30657775|NCT00900146|58670479|FG001|Intermediate: Period III|Lost to Follow-up|0|||
30657776|NCT00900146|58670480|FG002|Intermediate: Period III|Lost to Follow-up|0|||
30657777|NCT00900146|58670481|FG003|Intermediate: Period III|Lost to Follow-up|0|||
30657778|NCT00900146|58670482|FG004|Intermediate: Period III|Lost to Follow-up|1|||
30657779|NCT00900146|58670478|FG000|Intermediate: Period III|Administrative problems|85|||
30657780|NCT00900146|58670479|FG001|Intermediate: Period III|Administrative problems|92|||
30657781|NCT00900146|58670480|FG002|Intermediate: Period III|Administrative problems|84|||
30657782|NCT00900146|58670481|FG003|Intermediate: Period III|Administrative problems|90|||
30657783|NCT00900146|58670482|FG004|Intermediate: Period III|Administrative problems|163|||
30657784|NCT00895310|58670494|FG000|Overall Study|Withdrawal by Subject|1|||
30657785|NCT00895154|58670500|FG000|Overall Study|Lost to Follow-up|1|||
30657786|NCT00895154|58670501|FG001|Overall Study|Lost to Follow-up|1|||
30657787|NCT00895154|58670500|FG000|Overall Study|Withdrawal by Subject|0|||
30657788|NCT00895154|58670501|FG001|Overall Study|Withdrawal by Subject|1|||
30657789|NCT00888654|58670507|FG000|Overall Study|Problems swallowing oral meds.|1|||
30657790|NCT00888654|58670507|FG000|Overall Study|Not enough oral meds before surgery|3|||
30657791|NCT00888654|58670507|FG000|Overall Study|Surgery aborted|2|||
30657792|NCT00888654|58670507|FG000|Overall Study|Withdrawal by Subject|1|||
30657793|NCT00888654|58670507|FG000|Overall Study|Inelig. due to contraindication of med|1|||
30657794|NCT00888654|58670507|FG000|Overall Study|Change in surg date|1|||
30657795|NCT00888654|58670507|FG000|Overall Study|Stopped meds due to headaches|1|||
30657796|NCT00899678|58670514|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
30657797|NCT00899678|58670515|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
30657798|NCT00899678|58670516|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
30657799|NCT00899678|58670514|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
30657800|NCT00899678|58670515|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
30657801|NCT00899678|58670516|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
30657802|NCT00899678|58670514|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
30657803|NCT00899678|58670515|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
30657804|NCT00899678|58670516|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
30657805|NCT00899678|58670514|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
30657806|NCT00899678|58670515|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
30657807|NCT00899678|58670516|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
30657808|NCT00899678|58670514|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
30657809|NCT00899678|58670515|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
30657810|NCT00899678|58670516|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
30657811|NCT00899678|58670514|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
30657812|NCT00899678|58670515|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
30657813|NCT00899678|58670516|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
30657814|NCT00899678|58670514|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
30657815|NCT00899678|58670515|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
30657816|NCT00899678|58670516|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
30657817|NCT00899678|58670514|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
30657818|NCT00899678|58670515|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
30657819|NCT00899678|58670516|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
30657820|NCT00899678|58670514|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
30657821|NCT00899678|58670515|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
30657822|NCT00899678|58670516|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
30770114|NCT00045630|58778978|FG000|Overall Study|Progression/relapse|1|||
30770115|NCT00045630|58778978|FG000|Overall Study|Death|1|||
30770116|NCT00045630|58778978|FG000|Overall Study|Ineligible|2|||
30770117|NCT00003702|58778984|FG000|Overall Study|Ineligible cell types|2|||
30657823|NCT00887484|58670524|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
30657824|NCT00887484|58670524|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
30657825|NCT00887484|58670524|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
30657826|NCT00886938|58670533|FG000|Overall Study|Adverse Event|1|||
30657827|NCT00886938|58670533|FG000|Overall Study|Withdrawal by Subject|1|||
30657828|NCT00620659|58670537|FG000|Treatment Period 1|Adverse Event|1|||
30657829|NCT00620659|58670538|FG001|Treatment Period 1|Adverse Event|0|||
30657830|NCT00620659|58670539|FG002|Treatment Period 1|Adverse Event|0|||
30657831|NCT00620659|58670540|FG003|Treatment Period 1|Adverse Event|3|||
30657832|NCT00620659|58670541|FG004|Treatment Period 1|Adverse Event|0|||
30657833|NCT00620659|58670542|FG005|Treatment Period 1|Adverse Event|0|||
30770118|NCT00003702|58778985|FG001|Overall Study|Ineligible cell types|2|||
30770119|NCT00003702|58778984|FG000|Overall Study|Did not meet criteria for persistence|8|||
30770120|NCT00003702|58778985|FG001|Overall Study|Did not meet criteria for persistence|5|||
30848983|NCT02850965|58875708|FG001|Overall Study|Other than listed|4|||
30848984|NCT02850965|58875707|FG000|Overall Study|Protocol Violation|0|||
30848985|NCT02850965|58875708|FG001|Overall Study|Protocol Violation|2|||
30848986|NCT02850965|58875707|FG000|Overall Study|Lost to Follow-up|5|||
30952550|NCT01897493|59001324|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
30952551|NCT01887353|59001333|FG000|Overall Study|Study stopped early|4|||
30952552|NCT01887353|59001334|FG001|Overall Study|Study stopped early|3|||
30952553|NCT01896869|59001356|FG000|Overall Study|Withdrawal by Subject|0|||
30952554|NCT01896869|59001357|FG001|Overall Study|Withdrawal by Subject|6|||
30952555|NCT01896869|59001356|FG000|Overall Study|Lost to Follow-up|1|||
30952556|NCT01896869|59001357|FG001|Overall Study|Lost to Follow-up|0|||
30952557|NCT01896557|59001367|FG000|Clopidogrel Alone|Adverse Event|1|||
30952558|NCT01896557|59001368|FG001|Clopidogrel Alone|Adverse Event|0|||
30952559|NCT01896557|59001367|FG000|Clopidogrel + GI Protector|low adherence|1|||
30952560|NCT01896557|59001368|FG001|Clopidogrel + GI Protector|low adherence|1|||
30952561|NCT01896557|59001367|FG000|Clopidogrel + GI Protector|Reading error|1|||
30657834|NCT00620659|58670537|FG000|Treatment Period 1|Protocol Violation|1|||
30770121|NCT00003702|58778984|FG000|Overall Study|WHO score > 6|2|||
30770122|NCT00003702|58778985|FG001|Overall Study|WHO score > 6|1|||
30848987|NCT02850965|58875708|FG001|Overall Study|Lost to Follow-up|3|||
30848988|NCT02850965|58875707|FG000|Overall Study|Lack of Efficacy|4|||
30848989|NCT02850965|58875708|FG001|Overall Study|Lack of Efficacy|8|||
30848990|NCT02850965|58875707|FG000|Overall Study|Adverse Event|3|||
30848991|NCT02850965|58875708|FG001|Overall Study|Adverse Event|2|||
30848992|NCT02850965|58875707|FG000|Overall Study|Withdrawal by Subject|3|||
30848993|NCT02850965|58875708|FG001|Overall Study|Withdrawal by Subject|4|||
30848994|NCT02850965|58875707|FG000|Overall Study|Physician Decision|0|||
30848995|NCT02850965|58875708|FG001|Overall Study|Physician Decision|1|||
30848996|NCT02850965|58875707|FG000|Overall Study|Randomized but not treated|0|||
30848997|NCT02850965|58875708|FG001|Overall Study|Randomized but not treated|1|||
30848998|NCT01375959|58875716|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
30848999|NCT01375959|58875717|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
30849000|NCT01375959|58875716|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
30849001|NCT01375959|58875717|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
30849002|NCT01375959|58875716|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
30849003|NCT01375959|58875717|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
30849004|NCT00708201|58875727|FG000|Overall Study|Adverse Event|4|||
30849005|NCT00708201|58875728|FG001|Overall Study|Adverse Event|4|||
30849006|NCT00708201|58875727|FG000|Overall Study|Withdrawal by Subject|1|||
30849007|NCT00708201|58875728|FG001|Overall Study|Withdrawal by Subject|1|||
30849008|NCT00708201|58875727|FG000|Overall Study|Lost to Follow-up|2|||
30849009|NCT00708201|58875728|FG001|Overall Study|Lost to Follow-up|0|||
30849010|NCT00708201|58875727|FG000|Overall Study|Protocol Violation|0|||
30849011|NCT00708201|58875728|FG001|Overall Study|Protocol Violation|1|||
30849012|NCT02848313|58875736|FG000|Overall Study|Adverse Event|1|||
30849013|NCT02848313|58875737|FG001|Overall Study|Adverse Event|2|||
30952562|NCT01896557|59001368|FG001|Clopidogrel + GI Protector|Reading error|3|||
30952563|NCT01886105|59001383|FG000|Overall Study|Lack of Efficacy|3|||
30952564|NCT01895777|59001412|FG000|Overall Study|Adverse Event|1|||
30657835|NCT00620659|58670538|FG001|Treatment Period 1|Protocol Violation|0|||
30657836|NCT00620659|58670539|FG002|Treatment Period 1|Protocol Violation|0|||
30657837|NCT00620659|58670540|FG003|Treatment Period 1|Protocol Violation|0|||
30657838|NCT00620659|58670541|FG004|Treatment Period 1|Protocol Violation|0|||
30657839|NCT00620659|58670542|FG005|Treatment Period 1|Protocol Violation|0|||
30657840|NCT00620659|58670537|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30657841|NCT00620659|58670538|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30657842|NCT00620659|58670539|FG002|Treatment Period 1|Withdrawal by Subject|1|||
30657843|NCT00620659|58670540|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30657844|NCT00620659|58670541|FG004|Treatment Period 1|Withdrawal by Subject|1|||
30657845|NCT00620659|58670542|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30657846|NCT00620659|58670537|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
30657847|NCT00620659|58670538|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
30657848|NCT00620659|58670539|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
30657849|NCT00620659|58670540|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
30657850|NCT00620659|58670541|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
30657851|NCT00620659|58670542|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
30657852|NCT00620659|58670537|FG000|Treatment Period 2|Adverse Event|0|||
30657853|NCT00620659|58670538|FG001|Treatment Period 2|Adverse Event|3|||
30657854|NCT00620659|58670539|FG002|Treatment Period 2|Adverse Event|0|||
30657855|NCT00620659|58670540|FG003|Treatment Period 2|Adverse Event|0|||
30657856|NCT00620659|58670541|FG004|Treatment Period 2|Adverse Event|2|||
30657857|NCT00620659|58670542|FG005|Treatment Period 2|Adverse Event|0|||
30657858|NCT00620659|58670537|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30657859|NCT00620659|58670538|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30657860|NCT00620659|58670539|FG002|Treatment Period 2|Withdrawal by Subject|1|||
30657861|NCT00620659|58670540|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30657862|NCT00620659|58670541|FG004|Treatment Period 2|Withdrawal by Subject|3|||
30657863|NCT00620659|58670542|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30657864|NCT00620659|58670537|FG000|Placebo Washout Period 2|Adverse Event|2|||
30657865|NCT00620659|58670538|FG001|Placebo Washout Period 2|Adverse Event|0|||
30657866|NCT00620659|58670539|FG002|Placebo Washout Period 2|Adverse Event|0|||
30657867|NCT00620659|58670540|FG003|Placebo Washout Period 2|Adverse Event|0|||
30657868|NCT00620659|58670541|FG004|Placebo Washout Period 2|Adverse Event|0|||
30657869|NCT00620659|58670542|FG005|Placebo Washout Period 2|Adverse Event|0|||
30657870|NCT00620659|58670537|FG000|Treatment Period 3|Adverse Event|0|||
30657871|NCT00620659|58670538|FG001|Treatment Period 3|Adverse Event|2|||
30657872|NCT00620659|58670539|FG002|Treatment Period 3|Adverse Event|0|||
30657873|NCT00620659|58670540|FG003|Treatment Period 3|Adverse Event|0|||
30657874|NCT00620659|58670541|FG004|Treatment Period 3|Adverse Event|0|||
30657875|NCT00620659|58670542|FG005|Treatment Period 3|Adverse Event|0|||
30657876|NCT00620659|58670537|FG000|Treatment Period 3|Withdrawal by Subject|0|||
30657877|NCT00620659|58670538|FG001|Treatment Period 3|Withdrawal by Subject|0|||
30657878|NCT00620659|58670539|FG002|Treatment Period 3|Withdrawal by Subject|0|||
30657879|NCT00620659|58670540|FG003|Treatment Period 3|Withdrawal by Subject|1|||
30657880|NCT00620659|58670541|FG004|Treatment Period 3|Withdrawal by Subject|0|||
30657881|NCT00620659|58670542|FG005|Treatment Period 3|Withdrawal by Subject|0|||
30657882|NCT00894686|58670555|FG000|Overall Study|Withdrawal by Subject|50|||
30657883|NCT00894686|58670555|FG000|Overall Study|Physician Decision|1|||
30657884|NCT00894686|58670555|FG000|Overall Study|Other|5|||
30657885|NCT00885846|58670562|FG000|Overall Study|Withdrawal by Subject|2|||
30657886|NCT00885846|58670563|FG001|Overall Study|Withdrawal by Subject|5|||
30657887|NCT00885846|58670564|FG002|Overall Study|Withdrawal by Subject|2|||
30657888|NCT00621517|58670574|FG000|Overall Study|Lost to Follow-up|3|||
30657889|NCT00621517|58670575|FG001|Overall Study|Lost to Follow-up|3|||
30657890|NCT00621517|58670574|FG000|Overall Study|Withdrawal by Subject|3|||
30657891|NCT00621517|58670575|FG001|Overall Study|Withdrawal by Subject|4|||
30657892|NCT00621517|58670574|FG000|Overall Study|Adverse Event|1|||
30657893|NCT00621517|58670575|FG001|Overall Study|Adverse Event|0|||
30657894|NCT00573937|58670583|FG000|Overall Study|Study Terminated|0|||
30657895|NCT00573937|58670584|FG001|Overall Study|Study Terminated|1|||
30657896|NCT00573859|58670590|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
30657897|NCT00573859|58670590|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
30657898|NCT00831441|58670596|FG000|Randomized|Death|82|||
30657899|NCT00831441|58670597|FG001|Randomized|Death|81|||
30657900|NCT00831441|58670596|FG000|Randomized|Adverse Event|248|||
30657901|NCT00831441|58670597|FG001|Randomized|Adverse Event|321|||
30657902|NCT00831441|58670596|FG000|Randomized|Emergency procedure|2|||
30657903|NCT00831441|58670597|FG001|Randomized|Emergency procedure|2|||
30657904|NCT00831441|58670596|FG000|Randomized|Elective procedure|26|||
30657905|NCT00831441|58670597|FG001|Randomized|Elective procedure|25|||
30657906|NCT00831441|58670596|FG000|Randomized|Physician Decision|26|||
30657907|NCT00831441|58670597|FG001|Randomized|Physician Decision|35|||
30657908|NCT00831441|58670596|FG000|Randomized|No longer met criteria|13|||
30657909|NCT00831441|58670597|FG001|Randomized|No longer met criteria|19|||
30657910|NCT00831441|58670596|FG000|Randomized|Withdrawal by Subject|178|||
30657911|NCT00831441|58670597|FG001|Randomized|Withdrawal by Subject|212|||
30657912|NCT00831441|58670596|FG000|Randomized|Lost to Follow-up|26|||
30657913|NCT00831441|58670597|FG001|Randomized|Lost to Follow-up|35|||
30657914|NCT00831441|58670596|FG000|Randomized|Administrative reason by sponsor|2780|||
30657915|NCT00831441|58670597|FG001|Randomized|Administrative reason by sponsor|2671|||
30657916|NCT00831441|58670596|FG000|Randomized|poor/non-compliance|30|||
30657917|NCT00831441|58670597|FG001|Randomized|poor/non-compliance|38|||
30657918|NCT00831441|58670596|FG000|Randomized|non-specified|276|||
30657919|NCT00831441|58670597|FG001|Randomized|non-specified|266|||
30657920|NCT00831441|58670596|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
30657921|NCT00831441|58670597|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
30657922|NCT00831441|58670596|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
30657923|NCT00831441|58670597|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
30657924|NCT00831441|58670596|FG000|Follow Up (30 Days)|Death|63|||
30657925|NCT00831441|58670597|FG001|Follow Up (30 Days)|Death|86|||
30657926|NCT00831441|58670596|FG000|Follow Up (30 Days)|non-specified|16|||
30657927|NCT00831441|58670597|FG001|Follow Up (30 Days)|non-specified|26|||
30657928|NCT00831441|58670596|FG000|Follow Up (30 Days)|missing end of study status|0|||
30657929|NCT00831441|58670597|FG001|Follow Up (30 Days)|missing end of study status|1|||
30657930|NCT00831129|58670606|FG000|Overall Study|Adverse Event|0|||
30657931|NCT00831129|58670607|FG001|Overall Study|Adverse Event|1|||
30657932|NCT00831129|58670606|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
30657933|NCT00831129|58670607|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
30657934|NCT00620113|58670617|FG000|Overall Study|Adverse Event|3|||
30657935|NCT00620113|58670618|FG001|Overall Study|Adverse Event|2|||
30657936|NCT00620113|58670619|FG002|Overall Study|Adverse Event|2|||
30657937|NCT00620113|58670620|FG003|Overall Study|Adverse Event|1|||
30657938|NCT00620113|58670617|FG000|Overall Study|Lack of Efficacy|2|||
30657939|NCT00620113|58670618|FG001|Overall Study|Lack of Efficacy|3|||
30657940|NCT00620113|58670619|FG002|Overall Study|Lack of Efficacy|0|||
30657941|NCT00620113|58670620|FG003|Overall Study|Lack of Efficacy|2|||
30657942|NCT00620113|58670617|FG000|Overall Study|Physician Decision|1|||
30657943|NCT00620113|58670618|FG001|Overall Study|Physician Decision|0|||
30657944|NCT00620113|58670619|FG002|Overall Study|Physician Decision|0|||
30657945|NCT00620113|58670620|FG003|Overall Study|Physician Decision|2|||
30657946|NCT00620113|58670617|FG000|Overall Study|Protocol Violation|2|||
30657947|NCT00620113|58670618|FG001|Overall Study|Protocol Violation|1|||
30657948|NCT00620113|58670619|FG002|Overall Study|Protocol Violation|0|||
30657949|NCT00620113|58670620|FG003|Overall Study|Protocol Violation|0|||
30657950|NCT00620113|58670617|FG000|Overall Study|Withdrawal by Subject|5|||
30657951|NCT00620113|58670618|FG001|Overall Study|Withdrawal by Subject|1|||
30657952|NCT00620113|58670619|FG002|Overall Study|Withdrawal by Subject|3|||
30657953|NCT00620113|58670620|FG003|Overall Study|Withdrawal by Subject|5|||
30657954|NCT00830115|58670630|FG000|Overall Study|Adverse Event|2|||
30657955|NCT00830115|58670630|FG000|Overall Study|Improvement/recovery|1|||
30657956|NCT00830037|58670638|FG000|Overall Study|Withdrawal by Subject|2|||
30657957|NCT00830037|58670639|FG001|Overall Study|Withdrawal by Subject|3|||
30657958|NCT00830037|58670638|FG000|Overall Study|Lost to Follow-up|1|||
30657959|NCT00830037|58670639|FG001|Overall Study|Lost to Follow-up|2|||
30657960|NCT00830037|58670638|FG000|Overall Study|Active when terminated by DSMB|15|||
30657961|NCT00830037|58670639|FG001|Overall Study|Active when terminated by DSMB|14|||
30657962|NCT00829413|58670645|FG000|Overall Study|No study drug admimnistered|13|||
30657963|NCT00829413|58670645|FG000|Overall Study|Training Patients|67|||
30657964|NCT00829413|58670645|FG000|Overall Study|No truth standard procedure available|9|||
30770123|NCT00003702|58778984|FG000|Overall Study|Inadequate documentation of disease|1|||
30770124|NCT00003702|58778985|FG001|Overall Study|Inadequate documentation of disease|3|||
30770125|NCT00031590|58778992|FG000|Overall Study|Adverse Event|1|||
30770126|NCT00031590|58778992|FG000|Overall Study|Withdrawal by parents|2|||
30770127|NCT00239681|58778999|FG000|Overall Study|Adverse Event|100|||
30657965|NCT00829413|58670645|FG000|Overall Study|Technically inadequate truth standard|2|||
30657966|NCT00829413|58670645|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
30657967|NCT00829179|58670656|FG000|Overall Study|Withdrawal by Subject|1|||
30657968|NCT00591591|58670662|FG000|Overall Study|Withdrawal by Subject|1|||
30657969|NCT00591591|58670663|FG001|Overall Study|Withdrawal by Subject|37|||
30657970|NCT00591591|58670662|FG000|Overall Study|Lack of Efficacy|10|||
30657971|NCT00591591|58670663|FG001|Overall Study|Lack of Efficacy|2|||
30849014|NCT02848313|58875736|FG000|Overall Study|Lack of Efficacy|0|||
30657972|NCT00828945|58670669|FG000|Overall Study|Death|4|||
30657973|NCT00828945|58670669|FG000|Overall Study|Participant was missing|1|||
30657974|NCT00828945|58670669|FG000|Overall Study|Other|36|||
30657975|NCT00966875|58670682|FG000|Part A|Adverse Event|2|||
30657976|NCT00966875|58670683|FG001|Part A|Adverse Event|1|||
30657977|NCT00966875|58670684|FG002|Part A|Adverse Event|0|||
30657978|NCT00966875|58670685|FG003|Part A|Adverse Event|1|||
30657979|NCT00966875|58670686|FG004|Part A|Adverse Event|0|||
30770128|NCT00239681|58779000|FG001|Overall Study|Adverse Event|99|||
30657980|NCT00966875|58670687|FG005|Part A|Adverse Event|1|||
30657981|NCT00966875|58670688|FG006|Part A|Adverse Event|0|||
30657982|NCT00966875|58670689|FG007|Part A|Adverse Event|3|||
30657983|NCT00966875|58670690|FG008|Part A|Adverse Event|3|||
30657984|NCT00966875|58670682|FG000|Part A|Entry Criteria|0|||
30657985|NCT00966875|58670683|FG001|Part A|Entry Criteria|0|||
30657986|NCT00966875|58670684|FG002|Part A|Entry Criteria|0|||
30657987|NCT00966875|58670685|FG003|Part A|Entry Criteria|0|||
30657988|NCT00966875|58670686|FG004|Part A|Entry Criteria|0|||
30657989|NCT00966875|58670687|FG005|Part A|Entry Criteria|2|||
30657990|NCT00966875|58670688|FG006|Part A|Entry Criteria|0|||
30657991|NCT00966875|58670689|FG007|Part A|Entry Criteria|0|||
30657992|NCT00966875|58670690|FG008|Part A|Entry Criteria|0|||
30657993|NCT00966875|58670682|FG000|Part A|Lack of Efficacy|0|||
30657994|NCT00966875|58670683|FG001|Part A|Lack of Efficacy|1|||
30657995|NCT00966875|58670684|FG002|Part A|Lack of Efficacy|0|||
30657996|NCT00966875|58670685|FG003|Part A|Lack of Efficacy|0|||
30657997|NCT00966875|58670686|FG004|Part A|Lack of Efficacy|0|||
30657998|NCT00966875|58670687|FG005|Part A|Lack of Efficacy|0|||
30657999|NCT00966875|58670688|FG006|Part A|Lack of Efficacy|4|||
30658000|NCT00966875|58670689|FG007|Part A|Lack of Efficacy|0|||
30658001|NCT00966875|58670690|FG008|Part A|Lack of Efficacy|0|||
30658002|NCT00966875|58670682|FG000|Part A|Lost to Follow-up|2|||
30658003|NCT00966875|58670683|FG001|Part A|Lost to Follow-up|0|||
30658004|NCT00966875|58670684|FG002|Part A|Lost to Follow-up|0|||
30658005|NCT00966875|58670685|FG003|Part A|Lost to Follow-up|0|||
30658006|NCT00966875|58670686|FG004|Part A|Lost to Follow-up|0|||
30658007|NCT00966875|58670687|FG005|Part A|Lost to Follow-up|1|||
30658008|NCT00966875|58670688|FG006|Part A|Lost to Follow-up|0|||
30658009|NCT00966875|58670689|FG007|Part A|Lost to Follow-up|0|||
30658010|NCT00966875|58670690|FG008|Part A|Lost to Follow-up|0|||
30658011|NCT00966875|58670682|FG000|Part A|Parent/Caregiver Decision|0|||
30658012|NCT00966875|58670683|FG001|Part A|Parent/Caregiver Decision|0|||
30658013|NCT00966875|58670684|FG002|Part A|Parent/Caregiver Decision|0|||
30658014|NCT00966875|58670685|FG003|Part A|Parent/Caregiver Decision|1|||
30658015|NCT00966875|58670686|FG004|Part A|Parent/Caregiver Decision|0|||
30658016|NCT00966875|58670687|FG005|Part A|Parent/Caregiver Decision|0|||
30658017|NCT00966875|58670688|FG006|Part A|Parent/Caregiver Decision|0|||
30658018|NCT00966875|58670689|FG007|Part A|Parent/Caregiver Decision|0|||
30658019|NCT00966875|58670690|FG008|Part A|Parent/Caregiver Decision|0|||
30658020|NCT00966875|58670682|FG000|Part A|Physician Decision|0|||
30658021|NCT00966875|58670683|FG001|Part A|Physician Decision|0|||
30770129|NCT00239681|58778999|FG000|Overall Study|Withdrawal by Subject|458|||
30770130|NCT00239681|58779000|FG001|Overall Study|Withdrawal by Subject|489|||
30770131|NCT00239681|58778999|FG000|Overall Study|Lost to Follow-up|28|||
30770132|NCT00239681|58779000|FG001|Overall Study|Lost to Follow-up|22|||
30770133|NCT00239681|58778999|FG000|Overall Study|Protocol Violation|4|||
30770134|NCT00239681|58779000|FG001|Overall Study|Protocol Violation|4|||
30658022|NCT00966875|58670684|FG002|Part A|Physician Decision|0|||
30658023|NCT00966875|58670685|FG003|Part A|Physician Decision|0|||
30658024|NCT00966875|58670686|FG004|Part A|Physician Decision|1|||
30770135|NCT00239681|58778999|FG000|Overall Study|Physician Decision|13|||
30770136|NCT00239681|58779000|FG001|Overall Study|Physician Decision|17|||
30770137|NCT00239681|58778999|FG000|Overall Study|No information chacked on CaseReportForm|90|||
30770138|NCT00239681|58779000|FG001|Overall Study|No information chacked on CaseReportForm|84|||
30770139|NCT02878330|58779008|FG000|Overall Study|Death|3|||
30770140|NCT02878330|58779009|FG001|Overall Study|Death|2|||
30770141|NCT02878330|58779008|FG000|Overall Study|Lost to Follow-up|11|||
30770142|NCT02878330|58779009|FG001|Overall Study|Lost to Follow-up|26|||
30770143|NCT02878330|58779008|FG000|Overall Study|Withdrawal by Subject|11|||
30770144|NCT02878330|58779009|FG001|Overall Study|Withdrawal by Subject|21|||
30658025|NCT00966875|58670687|FG005|Part A|Physician Decision|0|||
30658026|NCT00966875|58670688|FG006|Part A|Physician Decision|1|||
30658027|NCT00966875|58670689|FG007|Part A|Physician Decision|0|||
30658028|NCT00966875|58670690|FG008|Part A|Physician Decision|2|||
30770145|NCT02878330|58779008|FG000|Overall Study|Other|4|||
30770146|NCT02878330|58779009|FG001|Overall Study|Other|7|||
30770147|NCT00238433|58779016|FG000|Overall Study|Screen failure|1|||
30658029|NCT00966875|58670682|FG000|Part A|Sponsor Decision|0|||
30658030|NCT00966875|58670683|FG001|Part A|Sponsor Decision|0|||
30658031|NCT00966875|58670684|FG002|Part A|Sponsor Decision|1|||
30658032|NCT00966875|58670685|FG003|Part A|Sponsor Decision|0|||
30658033|NCT00966875|58670686|FG004|Part A|Sponsor Decision|1|||
30658034|NCT00966875|58670687|FG005|Part A|Sponsor Decision|0|||
30658035|NCT00966875|58670688|FG006|Part A|Sponsor Decision|0|||
30658036|NCT00966875|58670689|FG007|Part A|Sponsor Decision|2|||
30658037|NCT00966875|58670690|FG008|Part A|Sponsor Decision|1|||
30658038|NCT00966875|58670682|FG000|Part A|Withdrawal by Subject|2|||
30658039|NCT00966875|58670683|FG001|Part A|Withdrawal by Subject|2|||
30658040|NCT00966875|58670684|FG002|Part A|Withdrawal by Subject|1|||
30658041|NCT00966875|58670685|FG003|Part A|Withdrawal by Subject|1|||
30658042|NCT00966875|58670686|FG004|Part A|Withdrawal by Subject|3|||
30658043|NCT00966875|58670687|FG005|Part A|Withdrawal by Subject|0|||
30658044|NCT00966875|58670688|FG006|Part A|Withdrawal by Subject|5|||
30658045|NCT00966875|58670689|FG007|Part A|Withdrawal by Subject|1|||
30658046|NCT00966875|58670690|FG008|Part A|Withdrawal by Subject|1|||
30658047|NCT00966875|58670682|FG000|Part A|Protocol Violation|0|||
30658048|NCT00966875|58670683|FG001|Part A|Protocol Violation|0|||
30658049|NCT00966875|58670684|FG002|Part A|Protocol Violation|0|||
30658050|NCT00966875|58670685|FG003|Part A|Protocol Violation|0|||
30658051|NCT00966875|58670686|FG004|Part A|Protocol Violation|0|||
30658052|NCT00966875|58670687|FG005|Part A|Protocol Violation|0|||
30658053|NCT00966875|58670688|FG006|Part A|Protocol Violation|2|||
30658054|NCT00966875|58670689|FG007|Part A|Protocol Violation|1|||
30658055|NCT00966875|58670690|FG008|Part A|Protocol Violation|1|||
30658056|NCT00966875|58670682|FG000|Part B|Adverse Event|0|||
30658057|NCT00966875|58670683|FG001|Part B|Adverse Event|1|||
30658058|NCT00966875|58670684|FG002|Part B|Adverse Event|1|||
30658059|NCT00966875|58670685|FG003|Part B|Adverse Event|0|||
30658060|NCT00966875|58670686|FG004|Part B|Adverse Event|1|||
30658061|NCT00966875|58670687|FG005|Part B|Adverse Event|0|||
30658062|NCT00966875|58670688|FG006|Part B|Adverse Event|5|||
30658063|NCT00966875|58670689|FG007|Part B|Adverse Event|2|||
30658064|NCT00966875|58670690|FG008|Part B|Adverse Event|2|||
30658065|NCT00966875|58670682|FG000|Part B|Death|0|||
30658066|NCT00966875|58670683|FG001|Part B|Death|0|||
30658067|NCT00966875|58670684|FG002|Part B|Death|1|||
30658068|NCT00966875|58670685|FG003|Part B|Death|0|||
30658069|NCT00966875|58670686|FG004|Part B|Death|0|||
30658070|NCT00966875|58670687|FG005|Part B|Death|0|||
30658071|NCT00966875|58670688|FG006|Part B|Death|0|||
30658072|NCT00966875|58670689|FG007|Part B|Death|1|||
30658073|NCT00966875|58670690|FG008|Part B|Death|0|||
30658074|NCT00966875|58670682|FG000|Part B|Lack of Efficacy|2|||
30658075|NCT00966875|58670683|FG001|Part B|Lack of Efficacy|1|||
30658076|NCT00966875|58670684|FG002|Part B|Lack of Efficacy|1|||
30658077|NCT00966875|58670685|FG003|Part B|Lack of Efficacy|1|||
30658078|NCT00966875|58670686|FG004|Part B|Lack of Efficacy|2|||
30658079|NCT00966875|58670687|FG005|Part B|Lack of Efficacy|3|||
30658080|NCT00966875|58670688|FG006|Part B|Lack of Efficacy|12|||
30658081|NCT00966875|58670689|FG007|Part B|Lack of Efficacy|9|||
30658082|NCT00966875|58670690|FG008|Part B|Lack of Efficacy|6|||
30658083|NCT00966875|58670682|FG000|Part B|Lost to Follow-up|0|||
30658084|NCT00966875|58670683|FG001|Part B|Lost to Follow-up|0|||
30658085|NCT00966875|58670684|FG002|Part B|Lost to Follow-up|0|||
30658086|NCT00966875|58670685|FG003|Part B|Lost to Follow-up|1|||
30658087|NCT00966875|58670686|FG004|Part B|Lost to Follow-up|0|||
30658088|NCT00966875|58670687|FG005|Part B|Lost to Follow-up|0|||
30658089|NCT00966875|58670688|FG006|Part B|Lost to Follow-up|0|||
30658090|NCT00966875|58670689|FG007|Part B|Lost to Follow-up|0|||
30658091|NCT00966875|58670690|FG008|Part B|Lost to Follow-up|1|||
30658092|NCT00966875|58670682|FG000|Part B|Physician Decision|0|||
30658093|NCT00966875|58670683|FG001|Part B|Physician Decision|0|||
30658094|NCT00966875|58670684|FG002|Part B|Physician Decision|1|||
30658095|NCT00966875|58670685|FG003|Part B|Physician Decision|0|||
30658096|NCT00966875|58670686|FG004|Part B|Physician Decision|2|||
30658097|NCT00966875|58670687|FG005|Part B|Physician Decision|1|||
30658098|NCT00966875|58670688|FG006|Part B|Physician Decision|0|||
30658099|NCT00966875|58670689|FG007|Part B|Physician Decision|0|||
30658100|NCT00966875|58670690|FG008|Part B|Physician Decision|2|||
30658101|NCT00966875|58670682|FG000|Part B|Sponsor Decision|1|||
30658102|NCT00966875|58670683|FG001|Part B|Sponsor Decision|0|||
30658103|NCT00966875|58670684|FG002|Part B|Sponsor Decision|0|||
30658104|NCT00966875|58670685|FG003|Part B|Sponsor Decision|0|||
30658105|NCT00966875|58670686|FG004|Part B|Sponsor Decision|0|||
30658106|NCT00966875|58670687|FG005|Part B|Sponsor Decision|1|||
30658107|NCT00966875|58670688|FG006|Part B|Sponsor Decision|0|||
30658108|NCT00966875|58670689|FG007|Part B|Sponsor Decision|2|||
30658109|NCT00966875|58670690|FG008|Part B|Sponsor Decision|1|||
30658110|NCT00966875|58670682|FG000|Part B|Withdrawal by Subject|2|||
30658111|NCT00966875|58670683|FG001|Part B|Withdrawal by Subject|1|||
30658112|NCT00966875|58670684|FG002|Part B|Withdrawal by Subject|2|||
30658113|NCT00966875|58670685|FG003|Part B|Withdrawal by Subject|1|||
30658114|NCT00966875|58670686|FG004|Part B|Withdrawal by Subject|2|||
30658115|NCT00966875|58670687|FG005|Part B|Withdrawal by Subject|1|||
30658116|NCT00966875|58670688|FG006|Part B|Withdrawal by Subject|4|||
30658117|NCT00966875|58670689|FG007|Part B|Withdrawal by Subject|5|||
30658118|NCT00966875|58670690|FG008|Part B|Withdrawal by Subject|5|||
30658119|NCT00966875|58670682|FG000|Part B|Entry Criteria|0|||
30658120|NCT00966875|58670683|FG001|Part B|Entry Criteria|0|||
30658121|NCT00966875|58670684|FG002|Part B|Entry Criteria|0|||
30658122|NCT00966875|58670685|FG003|Part B|Entry Criteria|0|||
30658123|NCT00966875|58670686|FG004|Part B|Entry Criteria|0|||
30658124|NCT00966875|58670687|FG005|Part B|Entry Criteria|0|||
30658125|NCT00966875|58670688|FG006|Part B|Entry Criteria|1|||
30658126|NCT00966875|58670689|FG007|Part B|Entry Criteria|0|||
30658127|NCT00966875|58670690|FG008|Part B|Entry Criteria|1|||
30658128|NCT00828711|58670766|FG000|Overall Study|Lost to Follow-up|1|||
30658129|NCT00828711|58670767|FG001|Overall Study|Lost to Follow-up|0|||
30658130|NCT00828711|58670768|FG002|Overall Study|Lost to Follow-up|0|||
30658131|NCT00966719|58670778|FG000|Overall Study|Lost to Follow-up|6|||
30658132|NCT00966719|58670779|FG001|Overall Study|Lost to Follow-up|11|||
30658133|NCT00818649|58670785|FG000|Overall Study|Declining performance status|2|||
30658134|NCT00818649|58670785|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
30658135|NCT00818649|58670785|FG000|Overall Study|Adverse Event|1|||
30658136|NCT00961571|58670790|FG000|Overall Study|Physician Decision|39|||
30658137|NCT00964223|58670794|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
30658138|NCT00620815|58670802|FG000|Overall Study|Adverse Event|1|||
30658139|NCT00620815|58670803|FG001|Overall Study|Adverse Event|1|||
30658140|NCT00620815|58670804|FG002|Overall Study|Adverse Event|2|||
30658141|NCT00620815|58670802|FG000|Overall Study|Withdrawal by Subject|1|||
30658142|NCT00620815|58670803|FG001|Overall Study|Withdrawal by Subject|2|||
30658143|NCT00620815|58670804|FG002|Overall Study|Withdrawal by Subject|0|||
30658144|NCT00620815|58670802|FG000|Overall Study|Lost to Follow-up|1|||
30658145|NCT00620815|58670803|FG001|Overall Study|Lost to Follow-up|6|||
30658146|NCT00620815|58670804|FG002|Overall Study|Lost to Follow-up|3|||
30770148|NCT00238433|58779016|FG000|Overall Study|Lost to Follow-up|1|||
30770149|NCT00238433|58779016|FG000|Overall Study|Death|1|||
30658147|NCT00620815|58670802|FG000|Overall Study|Inappropriate enrolment|0|||
30658148|NCT00620815|58670803|FG001|Overall Study|Inappropriate enrolment|0|||
30658149|NCT00620815|58670804|FG002|Overall Study|Inappropriate enrolment|1|||
30658150|NCT00620815|58670802|FG000|Overall Study|Protocol Violation|1|||
30658151|NCT00620815|58670803|FG001|Overall Study|Protocol Violation|2|||
30658152|NCT00620815|58670804|FG002|Overall Study|Protocol Violation|1|||
30658153|NCT03372941|58670830|FG000|Overall Study|Lost to Follow-up|2|||
30658154|NCT03372941|58670831|FG001|Overall Study|Lost to Follow-up|4|||
30658155|NCT00619957|58670839|FG000|Month 24 Double-Blind|Adverse Event|9|||
30658156|NCT00619957|58670840|FG001|Month 24 Double-Blind|Adverse Event|7|||
30658157|NCT00619957|58670839|FG000|Month 24 Double-Blind|Protocol Violation|1|||
30658158|NCT00619957|58670840|FG001|Month 24 Double-Blind|Protocol Violation|0|||
30658159|NCT00619957|58670839|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
30658160|NCT00619957|58670840|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
30658161|NCT00619957|58670839|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
30658162|NCT00619957|58670840|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
30658163|NCT00619957|58670839|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
30658164|NCT00619957|58670840|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
30658165|NCT00619957|58670839|FG000|Month 48 Open-Label|Adverse Event|4|||
30658166|NCT00619957|58670840|FG001|Month 48 Open-Label|Adverse Event|4|||
30658167|NCT00619957|58670839|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
30658168|NCT00619957|58670840|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
30658169|NCT00619957|58670839|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
30658170|NCT00619957|58670840|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
30658171|NCT00961415|58670850|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
30658172|NCT00961415|58670851|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
30658173|NCT00961415|58670852|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
30658174|NCT00961415|58670850|FG000|Induction Treatment Phase|Death|77|||
30658175|NCT00961415|58670851|FG001|Induction Treatment Phase|Death|0|||
30658176|NCT00961415|58670852|FG002|Induction Treatment Phase|Death|0|||
30658177|NCT00961415|58670850|FG000|Induction Treatment Phase|Protocol Violation|1|||
30658178|NCT00961415|58670851|FG001|Induction Treatment Phase|Protocol Violation|0|||
30658179|NCT00961415|58670852|FG002|Induction Treatment Phase|Protocol Violation|0|||
30658180|NCT00961415|58670850|FG000|Induction Treatment Phase|Physician Decision|2|||
30658181|NCT00961415|58670851|FG001|Induction Treatment Phase|Physician Decision|0|||
30658182|NCT00961415|58670852|FG002|Induction Treatment Phase|Physician Decision|0|||
30658183|NCT00961415|58670850|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
30658184|NCT00961415|58670851|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
30658185|NCT00961415|58670852|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
30658186|NCT00961415|58670850|FG000|Induction Treatment Phase|Other Reason|5|||
30658187|NCT00961415|58670851|FG001|Induction Treatment Phase|Other Reason|0|||
30658188|NCT00961415|58670852|FG002|Induction Treatment Phase|Other Reason|0|||
30658189|NCT00961415|58670850|FG000|Maintenance Treatment Phase|Death|0|||
30658190|NCT00961415|58670851|FG001|Maintenance Treatment Phase|Death|42|||
30658191|NCT00961415|58670852|FG002|Maintenance Treatment Phase|Death|34|||
30658192|NCT00961415|58670850|FG000|Maintenance Treatment Phase|Investigators decision|0|||
30658193|NCT00961415|58670851|FG001|Maintenance Treatment Phase|Investigators decision|2|||
30658194|NCT00961415|58670852|FG002|Maintenance Treatment Phase|Investigators decision|0|||
30658195|NCT00961415|58670850|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
30658196|NCT00961415|58670851|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
30658197|NCT00961415|58670852|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
30770150|NCT00045162|58779023|FG000|Overall Study|Ineligible|12|||
30770151|NCT00045162|58779024|FG001|Overall Study|Ineligible|8|||
30658198|NCT00961415|58670850|FG000|Maintenance Treatment Phase|Other reason|0|||
30658199|NCT00961415|58670851|FG001|Maintenance Treatment Phase|Other reason|1|||
30658200|NCT00961415|58670852|FG002|Maintenance Treatment Phase|Other reason|3|||
30770152|NCT00045162|58779023|FG000|Overall Study|Not treated|7|||
30658201|NCT00963599|58670870|FG000|Overall Study|Adverse Event|2|||
30658202|NCT00963599|58670871|FG001|Overall Study|Adverse Event|0|||
30658203|NCT00963599|58670872|FG002|Overall Study|Adverse Event|1|||
30658204|NCT00963599|58670873|FG003|Overall Study|Adverse Event|2|||
30658205|NCT00963599|58670870|FG000|Overall Study|Lack of Efficacy|0|||
30658206|NCT00963599|58670871|FG001|Overall Study|Lack of Efficacy|2|||
30658207|NCT00963599|58670872|FG002|Overall Study|Lack of Efficacy|1|||
30658208|NCT00963599|58670873|FG003|Overall Study|Lack of Efficacy|4|||
30658209|NCT00963599|58670870|FG000|Overall Study|Lost to Follow-up|0|||
30658210|NCT00963599|58670871|FG001|Overall Study|Lost to Follow-up|1|||
30658211|NCT00963599|58670872|FG002|Overall Study|Lost to Follow-up|1|||
30770153|NCT00045162|58779024|FG001|Overall Study|Not treated|2|||
30770154|NCT00045162|58779023|FG000|Overall Study|Adverse Event|55|||
30770155|NCT00045162|58779024|FG001|Overall Study|Adverse Event|50|||
30770156|NCT00045162|58779023|FG000|Overall Study|Lack of Efficacy|32|||
30770157|NCT00045162|58779024|FG001|Overall Study|Lack of Efficacy|29|||
30770158|NCT00045162|58779023|FG000|Overall Study|Death|10|||
30770159|NCT00045162|58779024|FG001|Overall Study|Death|10|||
30770160|NCT00045162|58779023|FG000|Overall Study|Withdrawal by Subject|5|||
30770161|NCT00045162|58779024|FG001|Overall Study|Withdrawal by Subject|3|||
30770162|NCT00045162|58779023|FG000|Overall Study|Other|21|||
30849015|NCT02848313|58875737|FG001|Overall Study|Lack of Efficacy|1|||
30658212|NCT00963599|58670873|FG003|Overall Study|Lost to Follow-up|1|||
30658213|NCT00963599|58670870|FG000|Overall Study|Protocol Violation|2|||
30658214|NCT00963599|58670871|FG001|Overall Study|Protocol Violation|2|||
30658215|NCT00963599|58670872|FG002|Overall Study|Protocol Violation|3|||
30658216|NCT00963599|58670873|FG003|Overall Study|Protocol Violation|4|||
30658217|NCT00963599|58670870|FG000|Overall Study|Withdrawal by Subject|2|||
30658218|NCT00963599|58670871|FG001|Overall Study|Withdrawal by Subject|1|||
30658219|NCT00963599|58670872|FG002|Overall Study|Withdrawal by Subject|3|||
30658220|NCT00963599|58670873|FG003|Overall Study|Withdrawal by Subject|3|||
30658221|NCT00619801|58670885|FG000|Overall Study|Lack of Efficacy|0|||
30658222|NCT00619801|58670886|FG001|Overall Study|Lack of Efficacy|1|||
30658223|NCT00619801|58670885|FG000|Overall Study|Withdrawal by Subject|1|||
30658224|NCT00619801|58670886|FG001|Overall Study|Withdrawal by Subject|1|||
30658225|NCT00619801|58670885|FG000|Overall Study|Loss of efficacy|0|||
30658226|NCT00619801|58670886|FG001|Overall Study|Loss of efficacy|1|||
30658227|NCT00962741|58670892|FG000|Overall Study|Failed to return|3|||
30658228|NCT00962741|58670892|FG000|Overall Study|Lost to Follow-up|2|||
30658229|NCT00962741|58670892|FG000|Overall Study|Withdrawal by Subject|1|||
30658230|NCT00962741|58670892|FG000|Overall Study|Lack of Efficacy|1|||
30658231|NCT00962741|58670892|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
30658232|NCT00619645|58670896|FG000|Overall Study|Adverse Event|1|||
30658233|NCT00619177|58670900|FG000|Overall Study|Adverse Event|18|||
30658234|NCT00619177|58670900|FG000|Overall Study|Lost to Follow-up|2|||
30658235|NCT00619177|58670900|FG000|Overall Study|Lack of Efficacy|1|||
30658236|NCT00619177|58670900|FG000|Overall Study|Missing termination information|481|||
30658237|NCT00619177|58670900|FG000|Overall Study|Not specified reasons|6|||
30658238|NCT00818259|58670911|FG000|Part I|Withdrawal by Subject|1|||
30658239|NCT00818259|58670912|FG001|Part I|Withdrawal by Subject|0|||
30658240|NCT00818259|58670913|FG002|Part I|Withdrawal by Subject|0|||
30658241|NCT00818259|58670914|FG003|Part I|Withdrawal by Subject|0|||
30658242|NCT00818259|58670915|FG004|Part I|Withdrawal by Subject|0|||
30658243|NCT00818259|58670916|FG005|Part I|Withdrawal by Subject|0|||
30658244|NCT00818259|58670917|FG006|Part I|Withdrawal by Subject|0|||
30658245|NCT00818259|58670918|FG007|Part I|Withdrawal by Subject|0|||
30658246|NCT00818259|58670919|FG008|Part I|Withdrawal by Subject|0|||
30658247|NCT00818259|58670911|FG000|Part II|Physician Decision|0|||
30658248|NCT00818259|58670912|FG001|Part II|Physician Decision|0|||
30658249|NCT00818259|58670913|FG002|Part II|Physician Decision|1|||
30658250|NCT00818259|58670914|FG003|Part II|Physician Decision|0|||
30658251|NCT00818259|58670915|FG004|Part II|Physician Decision|0|||
30658252|NCT00818259|58670916|FG005|Part II|Physician Decision|0|||
30658253|NCT00818259|58670917|FG006|Part II|Physician Decision|0|||
30658254|NCT00818259|58670918|FG007|Part II|Physician Decision|0|||
30658255|NCT00818259|58670919|FG008|Part II|Physician Decision|0|||
30658256|NCT00818259|58670911|FG000|Part II|Lack of Efficacy|0|||
30658257|NCT00818259|58670912|FG001|Part II|Lack of Efficacy|0|||
30658258|NCT00818259|58670913|FG002|Part II|Lack of Efficacy|0|||
30770163|NCT00045162|58779024|FG001|Overall Study|Other|16|||
30770164|NCT02748616|58779030|FG000|Overall Study|Lost to Follow-up|1|||
30770165|NCT02748616|58779030|FG000|Overall Study|Withdrawal by Subject|2|||
30770166|NCT02748616|58779030|FG000|Overall Study|Physician Decision|2|||
30770167|NCT02748616|58779030|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
30849016|NCT02848313|58875736|FG000|Overall Study|Withdrawal by Subject|1|||
30849017|NCT02848313|58875737|FG001|Overall Study|Withdrawal by Subject|1|||
30849018|NCT02848313|58875736|FG000|Overall Study|Lost to follow up|1|||
30849019|NCT02848313|58875737|FG001|Overall Study|Lost to follow up|0|||
30849020|NCT02728089|58875743|FG000|Overall Study|Physician Decision|2|||
30849021|NCT02728089|58875743|FG000|Overall Study|Withdrawal by Subject|1|||
30658259|NCT00818259|58670914|FG003|Part II|Lack of Efficacy|1|||
30658260|NCT00818259|58670915|FG004|Part II|Lack of Efficacy|0|||
30658261|NCT00818259|58670916|FG005|Part II|Lack of Efficacy|0|||
30658262|NCT00818259|58670917|FG006|Part II|Lack of Efficacy|0|||
30658263|NCT00818259|58670918|FG007|Part II|Lack of Efficacy|0|||
30658264|NCT00818259|58670919|FG008|Part II|Lack of Efficacy|0|||
30658265|NCT00818259|58670911|FG000|Part II|Not Treated|0|||
30658266|NCT00818259|58670912|FG001|Part II|Not Treated|0|||
30658267|NCT00818259|58670913|FG002|Part II|Not Treated|0|||
30658268|NCT00818259|58670914|FG003|Part II|Not Treated|1|||
30658269|NCT00818259|58670915|FG004|Part II|Not Treated|0|||
30658270|NCT00818259|58670916|FG005|Part II|Not Treated|0|||
30658271|NCT00818259|58670917|FG006|Part II|Not Treated|0|||
30658272|NCT00818259|58670918|FG007|Part II|Not Treated|0|||
30658273|NCT00818259|58670919|FG008|Part II|Not Treated|0|||
30658274|NCT00818259|58670911|FG000|Part IV|Physician Decision|0|||
30658275|NCT00818259|58670912|FG001|Part IV|Physician Decision|0|||
30658276|NCT00818259|58670913|FG002|Part IV|Physician Decision|0|||
30658277|NCT00818259|58670914|FG003|Part IV|Physician Decision|0|||
30658278|NCT00818259|58670915|FG004|Part IV|Physician Decision|0|||
30658279|NCT00818259|58670916|FG005|Part IV|Physician Decision|1|||
30658280|NCT00818259|58670917|FG006|Part IV|Physician Decision|0|||
30658281|NCT00818259|58670918|FG007|Part IV|Physician Decision|0|||
30658282|NCT00818259|58670919|FG008|Part IV|Physician Decision|0|||
30658283|NCT00818259|58670911|FG000|Part V|Adverse Event|0|||
30658284|NCT00818259|58670912|FG001|Part V|Adverse Event|0|||
30658285|NCT00818259|58670913|FG002|Part V|Adverse Event|0|||
30658286|NCT00818259|58670914|FG003|Part V|Adverse Event|0|||
30658287|NCT00818259|58670915|FG004|Part V|Adverse Event|0|||
30658288|NCT00818259|58670916|FG005|Part V|Adverse Event|0|||
30658289|NCT00818259|58670917|FG006|Part V|Adverse Event|0|||
30658290|NCT00818259|58670918|FG007|Part V|Adverse Event|1|||
30658291|NCT00818259|58670919|FG008|Part V|Adverse Event|0|||
30658292|NCT00619099|58670937|FG000|Overall Study|Progressive Disease|7|||
30658293|NCT00619099|58670938|FG001|Overall Study|Progressive Disease|5|||
30658294|NCT00619099|58670937|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
30658295|NCT00619099|58670938|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
30658296|NCT00619099|58670937|FG000|Overall Study|Adverse Event|4|||
30658297|NCT00619099|58670938|FG001|Overall Study|Adverse Event|3|||
30658298|NCT00619099|58670937|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
30658299|NCT00619099|58670938|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
30658300|NCT00619099|58670937|FG000|Overall Study|Withdrawal by Subject|10|||
30658301|NCT00619099|58670938|FG001|Overall Study|Withdrawal by Subject|2|||
30658302|NCT00619099|58670937|FG000|Overall Study|Physician Decision|9|||
30658303|NCT00619099|58670938|FG001|Overall Study|Physician Decision|6|||
30658304|NCT00962585|58670948|FG000|Overall Study|Adverse Event|0|||
30658305|NCT00962585|58670949|FG001|Overall Study|Adverse Event|2|||
30658306|NCT00962585|58670950|FG002|Overall Study|Adverse Event|1|||
30658307|NCT00962585|58670951|FG003|Overall Study|Adverse Event|0|||
30658308|NCT00962585|58670948|FG000|Overall Study|Lost to Follow-up|3|||
30658309|NCT00962585|58670949|FG001|Overall Study|Lost to Follow-up|0|||
30658310|NCT00962585|58670950|FG002|Overall Study|Lost to Follow-up|1|||
30658311|NCT00962585|58670951|FG003|Overall Study|Lost to Follow-up|0|||
30658312|NCT00962585|58670948|FG000|Overall Study|Protocol Violation|0|||
30658313|NCT00962585|58670949|FG001|Overall Study|Protocol Violation|0|||
30658314|NCT00962585|58670950|FG002|Overall Study|Protocol Violation|1|||
30658315|NCT00962585|58670951|FG003|Overall Study|Protocol Violation|0|||
30658316|NCT00962585|58670948|FG000|Overall Study|Withdrawal by Subject|1|||
30658317|NCT00962585|58670949|FG001|Overall Study|Withdrawal by Subject|0|||
30658318|NCT00962585|58670950|FG002|Overall Study|Withdrawal by Subject|0|||
30658319|NCT00962585|58670951|FG003|Overall Study|Withdrawal by Subject|0|||
30658320|NCT00962585|58670948|FG000|Overall Study|Withdrew Consent|2|||
30658321|NCT00962585|58670949|FG001|Overall Study|Withdrew Consent|0|||
30658322|NCT00962585|58670950|FG002|Overall Study|Withdrew Consent|0|||
30658323|NCT00962585|58670951|FG003|Overall Study|Withdrew Consent|0|||
30658324|NCT00621985|58670963|FG000|Dexamethasone Admission|Adverse Event|1|||
30658325|NCT00961259|58670973|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
30658326|NCT00961259|58670974|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
30658327|NCT00961259|58670975|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
30658328|NCT00961181|58670984|FG000|Overall Study|Death|2|||
30658329|NCT00961181|58670984|FG000|Overall Study|Withdrawal by Subject|2|||
30770168|NCT00238121|58779036|FG000|Overall Study|Withdrawal by Subject|1|||
30770169|NCT00238121|58779037|FG001|Overall Study|Withdrawal by Subject|1|||
30658330|NCT00961181|58670984|FG000|Overall Study|Lost to Follow-up|1|||
30658331|NCT00817635|58670993|FG000|Overall Study|Adverse Event|1|||
30658332|NCT00817635|58670994|FG001|Overall Study|Adverse Event|0|||
30658333|NCT00817635|58670995|FG002|Overall Study|Adverse Event|0|||
30658334|NCT00817635|58670996|FG003|Overall Study|Adverse Event|1|||
30658335|NCT00817635|58670997|FG004|Overall Study|Adverse Event|1|||
30658336|NCT00817635|58670993|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
30658337|NCT00817635|58670994|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
30658338|NCT00817635|58670995|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
30658339|NCT00817635|58670996|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
30658340|NCT00817635|58670997|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
30658341|NCT00817635|58670993|FG000|Overall Study|Withdrawal by Subject|2|||
30658342|NCT00817635|58670994|FG001|Overall Study|Withdrawal by Subject|1|||
30658343|NCT00817635|58670995|FG002|Overall Study|Withdrawal by Subject|0|||
30658344|NCT00817635|58670996|FG003|Overall Study|Withdrawal by Subject|1|||
30658345|NCT00817635|58670997|FG004|Overall Study|Withdrawal by Subject|2|||
30658346|NCT00817635|58670993|FG000|Overall Study|Lost to Follow-up|0|||
30658347|NCT00817635|58670994|FG001|Overall Study|Lost to Follow-up|1|||
30658348|NCT00817635|58670995|FG002|Overall Study|Lost to Follow-up|0|||
30658349|NCT00817635|58670996|FG003|Overall Study|Lost to Follow-up|1|||
30658350|NCT00817635|58670997|FG004|Overall Study|Lost to Follow-up|0|||
30658351|NCT00817635|58670993|FG000|Overall Study|Administrative Problems|0|||
30658352|NCT00817635|58670994|FG001|Overall Study|Administrative Problems|0|||
30658353|NCT00817635|58670995|FG002|Overall Study|Administrative Problems|0|||
30658354|NCT00817635|58670996|FG003|Overall Study|Administrative Problems|0|||
30658355|NCT00817635|58670997|FG004|Overall Study|Administrative Problems|1|||
30658356|NCT00817635|58670993|FG000|Overall Study|Protocol Violation|5|||
30658357|NCT00817635|58670994|FG001|Overall Study|Protocol Violation|1|||
30658358|NCT00817635|58670995|FG002|Overall Study|Protocol Violation|3|||
30658359|NCT00817635|58670996|FG003|Overall Study|Protocol Violation|2|||
30658360|NCT00817635|58670997|FG004|Overall Study|Protocol Violation|3|||
30658361|NCT00817479|58671018|FG000|Overall Study|Physician Decision|1|||
30658362|NCT00817479|58671019|FG001|Overall Study|Physician Decision|1|||
30658363|NCT00961961|58671029|FG000|Phase I|Withdrawal by Subject|7|||
30658364|NCT00961961|58671030|FG001|Phase I|Withdrawal by Subject|0|||
30658365|NCT00961961|58671031|FG002|Phase I|Withdrawal by Subject|0|||
30658366|NCT00961961|58671032|FG003|Phase I|Withdrawal by Subject|0|||
30658367|NCT00961961|58671029|FG000|Phase I|Lost to Follow-up|10|||
30658368|NCT00961961|58671030|FG001|Phase I|Lost to Follow-up|0|||
30658369|NCT00961961|58671031|FG002|Phase I|Lost to Follow-up|0|||
30658370|NCT00961961|58671032|FG003|Phase I|Lost to Follow-up|0|||
30658371|NCT00961961|58671029|FG000|Phase I|Lack of Efficacy|94|||
30658372|NCT00961961|58671030|FG001|Phase I|Lack of Efficacy|0|||
30658373|NCT00961961|58671031|FG002|Phase I|Lack of Efficacy|0|||
30658374|NCT00961961|58671032|FG003|Phase I|Lack of Efficacy|0|||
30658375|NCT00961961|58671029|FG000|Phase I|Adverse Event|7|||
30658376|NCT00961961|58671030|FG001|Phase I|Adverse Event|0|||
30658377|NCT00961961|58671031|FG002|Phase I|Adverse Event|0|||
30658378|NCT00961961|58671032|FG003|Phase I|Adverse Event|0|||
30658379|NCT00961961|58671029|FG000|Phase I|Physician Decision|8|||
30658380|NCT00961961|58671030|FG001|Phase I|Physician Decision|0|||
30658381|NCT00961961|58671031|FG002|Phase I|Physician Decision|0|||
30658382|NCT00961961|58671032|FG003|Phase I|Physician Decision|0|||
30658383|NCT00961961|58671029|FG000|Phase II|Lost to Follow-up|0|||
30658384|NCT00961961|58671030|FG001|Phase II|Lost to Follow-up|0|||
30658385|NCT00961961|58671031|FG002|Phase II|Lost to Follow-up|10|||
30658386|NCT00961961|58671032|FG003|Phase II|Lost to Follow-up|7|||
30658387|NCT00961961|58671029|FG000|Phase II|Adverse Event|0|||
30658388|NCT00961961|58671030|FG001|Phase II|Adverse Event|0|||
30658389|NCT00961961|58671031|FG002|Phase II|Adverse Event|0|||
30658390|NCT00961961|58671032|FG003|Phase II|Adverse Event|1|||
30658391|NCT00961961|58671029|FG000|Phase II|Physician Decision|0|||
30658392|NCT00961961|58671030|FG001|Phase II|Physician Decision|0|||
30658393|NCT00961961|58671031|FG002|Phase II|Physician Decision|1|||
30658394|NCT00961961|58671032|FG003|Phase II|Physician Decision|0|||
30658395|NCT00961961|58671029|FG000|Phase II|Withdrawal by Subject|0|||
30658396|NCT00961961|58671030|FG001|Phase II|Withdrawal by Subject|0|||
30658397|NCT00961961|58671031|FG002|Phase II|Withdrawal by Subject|1|||
30658398|NCT00961961|58671032|FG003|Phase II|Withdrawal by Subject|0|||
30658399|NCT00817089|58671056|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
30658400|NCT00817089|58671057|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
30658401|NCT00817089|58671058|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
30658402|NCT00817089|58671059|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
30658403|NCT00817089|58671056|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
30658404|NCT00817089|58671057|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
30658405|NCT00817089|58671058|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
30658406|NCT00817089|58671059|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
30658407|NCT00815919|58671073|FG000|Overall Study|Unrelated Fungal Infection|1|||
30658408|NCT00815919|58671073|FG000|Overall Study|AML Relapse|1|||
30658409|NCT00815919|58671073|FG000|Overall Study|Lack of Efficacy|2|||
30658410|NCT00957905|58671079|FG000|Part B|Not Treated|0|||
30658411|NCT00957905|58671080|FG001|Part B|Not Treated|1|||
30658412|NCT00957905|58671079|FG000|Part B|Physician Decision|0|||
30658413|NCT00957905|58671080|FG001|Part B|Physician Decision|1|||
30658414|NCT00957905|58671079|FG000|Part B|Death|0|||
30658415|NCT00957905|58671080|FG001|Part B|Death|1|||
30658416|NCT00957905|58671079|FG000|Part B|Protocol Violation|0|||
30658417|NCT00957905|58671080|FG001|Part B|Protocol Violation|1|||
30658418|NCT00960323|58671086|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
30658419|NCT00617929|58671094|FG000|Overall Study|Physician Decision|1|||
30658420|NCT00815295|58671101|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
30658421|NCT00815295|58671102|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
30658422|NCT00815295|58671103|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
30658423|NCT00814983|58671113|FG000|Overall Study|Screen failure|1|||
30658424|NCT00814983|58671114|FG001|Overall Study|Screen failure|0|||
30658425|NCT00814983|58671113|FG000|Overall Study|Withdrawal by Subject|1|||
30658426|NCT00814983|58671114|FG001|Overall Study|Withdrawal by Subject|0|||
30658427|NCT00814983|58671113|FG000|Overall Study|Graft failure|1|||
30658428|NCT00814983|58671114|FG001|Overall Study|Graft failure|0|||
30658429|NCT00960869|58671122|FG000|Overall Study|Adverse Event|17|||
30658430|NCT00960869|58671123|FG001|Overall Study|Adverse Event|26|||
30658431|NCT00960869|58671122|FG000|Overall Study|Withdrawal by Subject|16|||
30658432|NCT00960869|58671123|FG001|Overall Study|Withdrawal by Subject|14|||
30658433|NCT00960869|58671122|FG000|Overall Study|Lost to Follow-up|1|||
30658434|NCT00960869|58671123|FG001|Overall Study|Lost to Follow-up|4|||
30658435|NCT00960869|58671122|FG000|Overall Study|Misc|19|||
30658436|NCT00960869|58671123|FG001|Overall Study|Misc|18|||
30658437|NCT00618787|58671131|FG000|Overall Study|Adverse Event|0|||
30658438|NCT00618787|58671132|FG001|Overall Study|Adverse Event|1|||
30658439|NCT00618787|58671131|FG000|Overall Study|Withdrawal by Subject|2|||
30658440|NCT00618787|58671132|FG001|Overall Study|Withdrawal by Subject|1|||
30658441|NCT00618787|58671131|FG000|Overall Study|Lost to Follow-up|1|||
30658442|NCT00618787|58671132|FG001|Overall Study|Lost to Follow-up|0|||
30658443|NCT00813813|58671140|FG000|Overall Study|Withdrawal by Subject|1|||
30658444|NCT00813813|58671141|FG001|Overall Study|Withdrawal by Subject|1|||
30658445|NCT00813813|58671140|FG000|Overall Study|Lost to Follow-up|2|||
30658446|NCT00813813|58671141|FG001|Overall Study|Lost to Follow-up|7|||
30658447|NCT00813813|58671140|FG000|Overall Study|Other|0|||
30658448|NCT00813813|58671141|FG001|Overall Study|Other|1|||
30658449|NCT05317312|58671151|FG000|Overall Study|Withdrawal by Subject|0|||
30658450|NCT05317312|58671152|FG001|Overall Study|Withdrawal by Subject|1|||
30658451|NCT05317312|58671153|FG002|Overall Study|Withdrawal by Subject|0|||
30658452|NCT05317312|58671154|FG003|Overall Study|Withdrawal by Subject|0|||
30658453|NCT05317312|58671151|FG000|Overall Study|Lost to Follow-up|0|||
30658454|NCT05317312|58671152|FG001|Overall Study|Lost to Follow-up|0|||
30658455|NCT05317312|58671153|FG002|Overall Study|Lost to Follow-up|0|||
30658456|NCT05317312|58671154|FG003|Overall Study|Lost to Follow-up|1|||
30658457|NCT05317312|58671151|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
30658458|NCT05317312|58671152|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
30658459|NCT05317312|58671153|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
30658460|NCT05317312|58671154|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
30658461|NCT04644315|58671164|FG000|Overall Study|Subject withdrawal of consent|1|||
30658462|NCT04566692|58671170|FG000|Overall Study|Adverse Event|2|||
30658463|NCT04566692|58671171|FG001|Overall Study|Adverse Event|0|||
30658464|NCT04566692|58671170|FG000|Overall Study|Withdrawal by Subject|1|||
30658465|NCT04566692|58671171|FG001|Overall Study|Withdrawal by Subject|1|||
30658466|NCT04410523|58671189|FG000|Overall Study|Study terminated by sponsor|1|||
30658467|NCT04410523|58671190|FG001|Overall Study|Study terminated by sponsor|3|||
30658468|NCT04410523|58671191|FG002|Overall Study|Study terminated by sponsor|2|||
30658469|NCT04410523|58671192|FG003|Overall Study|Study terminated by sponsor|6|||
30658470|NCT04410523|58671193|FG004|Overall Study|Study terminated by sponsor|3|||
30658471|NCT04410523|58671194|FG005|Overall Study|Study terminated by sponsor|4|||
30658472|NCT04410523|58671189|FG000|Overall Study|Adverse Event|1|||
30658473|NCT04410523|58671190|FG001|Overall Study|Adverse Event|0|||
30658474|NCT04410523|58671191|FG002|Overall Study|Adverse Event|0|||
30658475|NCT04410523|58671192|FG003|Overall Study|Adverse Event|0|||
30658476|NCT04410523|58671193|FG004|Overall Study|Adverse Event|0|||
30658477|NCT04410523|58671194|FG005|Overall Study|Adverse Event|2|||
30658478|NCT04410523|58671189|FG000|Overall Study|Lost to Follow-up|0|||
30658479|NCT04410523|58671190|FG001|Overall Study|Lost to Follow-up|1|||
30658480|NCT04410523|58671191|FG002|Overall Study|Lost to Follow-up|0|||
30658481|NCT04410523|58671192|FG003|Overall Study|Lost to Follow-up|0|||
30658482|NCT04410523|58671193|FG004|Overall Study|Lost to Follow-up|0|||
30658483|NCT04410523|58671194|FG005|Overall Study|Lost to Follow-up|0|||
30658484|NCT04410523|58671189|FG000|Overall Study|Physician Decision|0|||
30658485|NCT04410523|58671190|FG001|Overall Study|Physician Decision|1|||
30658486|NCT04410523|58671191|FG002|Overall Study|Physician Decision|0|||
30658487|NCT04410523|58671192|FG003|Overall Study|Physician Decision|0|||
30658488|NCT04410523|58671193|FG004|Overall Study|Physician Decision|0|||
30658489|NCT04410523|58671194|FG005|Overall Study|Physician Decision|0|||
30658490|NCT04410523|58671189|FG000|Overall Study|Pregnancy|0|||
30658491|NCT04410523|58671190|FG001|Overall Study|Pregnancy|0|||
30658492|NCT04410523|58671191|FG002|Overall Study|Pregnancy|0|||
30658493|NCT04410523|58671192|FG003|Overall Study|Pregnancy|0|||
30658494|NCT04410523|58671193|FG004|Overall Study|Pregnancy|0|||
30658495|NCT04410523|58671194|FG005|Overall Study|Pregnancy|1|||
30658496|NCT04410523|58671189|FG000|Overall Study|Protocol deviation|0|||
30658497|NCT04410523|58671190|FG001|Overall Study|Protocol deviation|0|||
30658498|NCT04410523|58671191|FG002|Overall Study|Protocol deviation|0|||
30658499|NCT04410523|58671192|FG003|Overall Study|Protocol deviation|0|||
30658500|NCT04410523|58671193|FG004|Overall Study|Protocol deviation|0|||
30770170|NCT00238121|58779036|FG000|Overall Study|Adverse Event|2|||
30770171|NCT00238121|58779037|FG001|Overall Study|Adverse Event|1|||
30770172|NCT03139552|58779042|FG000|Overall Study|unable to attend tasting due to schedule|3|||
30770173|NCT03804918|58779053|FG000|Overall Study|Participant did not use the app|1|||
30770174|NCT03139240|58779061|FG000|Overall Study|Lost to Follow-up|0|||
30658501|NCT04410523|58671194|FG005|Overall Study|Protocol deviation|2|||
30658502|NCT04410523|58671189|FG000|Overall Study|Subject decision|2|||
30658503|NCT04410523|58671190|FG001|Overall Study|Subject decision|0|||
30770175|NCT03139240|58779062|FG001|Overall Study|Lost to Follow-up|1|||
30770176|NCT03139240|58779063|FG002|Overall Study|Lost to Follow-up|1|||
30770177|NCT03139240|58779064|FG003|Overall Study|Lost to Follow-up|0|||
30770178|NCT00237809|58779076|FG000|Overall Study|Lost to Follow-up|11|||
30770179|NCT00237809|58779077|FG001|Overall Study|Lost to Follow-up|10|||
30770180|NCT00237809|58779078|FG002|Overall Study|Lost to Follow-up|9|||
30770181|NCT00237809|58779079|FG003|Overall Study|Lost to Follow-up|9|||
30770182|NCT00003498|58779089|FG000|Overall Study|Not evaluable.|4|||
30770183|NCT00003492|58779093|FG000|Overall Study|Not evaluable|6|||
30770184|NCT03136198|58779099|FG000|Overall Study|Withdrawal by Subject|0|||
30770185|NCT03136198|58779100|FG001|Overall Study|Withdrawal by Subject|1|||
30770186|NCT00042666|58779106|FG000|Overall Study|Adverse Event|2|||
30770187|NCT00042666|58779106|FG000|Overall Study|Death|4|||
30770188|NCT00042666|58779106|FG000|Overall Study|Protocol Violation|1|||
30849022|NCT02840461|58875750|FG000|Overall Study|Adverse Event|1|||
30849023|NCT02840461|58875751|FG001|Overall Study|Adverse Event|5|||
30658504|NCT04410523|58671191|FG002|Overall Study|Subject decision|0|||
30658505|NCT04410523|58671192|FG003|Overall Study|Subject decision|1|||
30658506|NCT04410523|58671193|FG004|Overall Study|Subject decision|0|||
30658507|NCT04410523|58671194|FG005|Overall Study|Subject decision|1|||
30658508|NCT04154189|58671233|FG000|Overall Study|Death|16|||
30658509|NCT04154189|58671234|FG001|Overall Study|Death|15|||
30658510|NCT04154189|58671233|FG000|Overall Study|Withdrawal by Subject|4|||
30658511|NCT04154189|58671234|FG001|Overall Study|Withdrawal by Subject|6|||
30658512|NCT04154189|58671233|FG000|Overall Study|Ongoing|20|||
30658513|NCT04154189|58671234|FG001|Overall Study|Ongoing|20|||
30658514|NCT03749109|58671244|FG000|Overall Study|Adverse Event|2|||
30658515|NCT03749109|58671245|FG001|Overall Study|Adverse Event|0|||
30658516|NCT03726879|58671254|FG000|Overall Study|Death|6|||
30658517|NCT03726879|58671255|FG001|Overall Study|Death|4|||
30658518|NCT03726879|58671254|FG000|Overall Study|Physician Decision|0|||
30658519|NCT03726879|58671255|FG001|Overall Study|Physician Decision|2|||
30658520|NCT03726879|58671254|FG000|Overall Study|Protocol Violation|0|||
30658521|NCT03726879|58671255|FG001|Overall Study|Protocol Violation|1|||
30658522|NCT03726879|58671254|FG000|Overall Study|Withdrawal by Subject|5|||
30658523|NCT03726879|58671255|FG001|Overall Study|Withdrawal by Subject|5|||
30658524|NCT03726879|58671254|FG000|Overall Study|TSH result is unstable|0|||
30658525|NCT03726879|58671255|FG001|Overall Study|TSH result is unstable|1|||
30658526|NCT03726879|58671254|FG000|Overall Study|Continuing on Study|215|||
30658527|NCT03726879|58671255|FG001|Overall Study|Continuing on Study|215|||
30658528|NCT03709706|58671263|FG000|Overall Study|Adverse Event|0|||
30658529|NCT03709706|58671264|FG001|Overall Study|Adverse Event|1|||
30658530|NCT03709706|58671263|FG000|Overall Study|Physician Decision|14|||
30658531|NCT03709706|58671264|FG001|Overall Study|Physician Decision|8|||
30658532|NCT03709706|58671263|FG000|Overall Study|Withdrawal by Subject|2|||
30658533|NCT03709706|58671264|FG001|Overall Study|Withdrawal by Subject|1|||
30658534|NCT03709706|58671263|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
30658535|NCT03709706|58671264|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
30658536|NCT03565991|58671273|FG000|Overall Study|Other|6|||
30658537|NCT03565991|58671274|FG001|Overall Study|Other|0|||
30658538|NCT03565991|58671273|FG000|Overall Study|Global deterioration of health status|14|||
30658539|NCT03565991|58671274|FG001|Overall Study|Global deterioration of health status|4|||
30658540|NCT03565991|58671273|FG000|Overall Study|Withdrawal by Subject|2|||
30658541|NCT03565991|58671274|FG001|Overall Study|Withdrawal by Subject|6|||
30658542|NCT03565991|58671273|FG000|Overall Study|Progressive disease|118|||
30658543|NCT03565991|58671274|FG001|Overall Study|Progressive disease|29|||
30658544|NCT03565991|58671273|FG000|Overall Study|Death|3|||
30658545|NCT03565991|58671274|FG001|Overall Study|Death|0|||
30658546|NCT03565991|58671273|FG000|Overall Study|Adverse Event|7|||
30658547|NCT03565991|58671274|FG001|Overall Study|Adverse Event|2|||
30658548|NCT03565991|58671273|FG000|Overall Study|Ongoing|9|||
30658549|NCT03565991|58671274|FG001|Overall Study|Ongoing|0|||
30658550|NCT03497689|58671282|FG000|Overall Study|Adverse Event|2|||
30658551|NCT03497689|58671282|FG000|Overall Study|Death|1|||
30849024|NCT02840461|58875752|FG002|Overall Study|Adverse Event|3|||
30658552|NCT03497689|58671282|FG000|Overall Study|Physician Decision|1|||
30658553|NCT03497689|58671282|FG000|Overall Study|Withdrawal by Subject|1|||
30658554|NCT03497689|58671282|FG000|Overall Study|Protocol Violation|2|||
30658555|NCT03492437|58671286|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30658556|NCT03492437|58671287|FG001|Treatment Period 2|Withdrawal by Subject|1|||
30658557|NCT03193853|58671293|FG000|Overall Study|Death|6|||
30658558|NCT03100149|58671300|FG000|Overall Study|Adverse Event|0|||
30658559|NCT03100149|58671301|FG001|Overall Study|Adverse Event|1|||
30658560|NCT03100149|58671302|FG002|Overall Study|Adverse Event|0|||
30658561|NCT03100149|58671300|FG000|Overall Study|Participant Moved out of Country|0|||
30658562|NCT03100149|58671301|FG001|Overall Study|Participant Moved out of Country|0|||
30658563|NCT03100149|58671302|FG002|Overall Study|Participant Moved out of Country|1|||
30658564|NCT03100149|58671300|FG000|Overall Study|Withdrawal by Subject|0|||
30658565|NCT03100149|58671301|FG001|Overall Study|Withdrawal by Subject|3|||
30658566|NCT03100149|58671302|FG002|Overall Study|Withdrawal by Subject|1|||
30658567|NCT02756637|58671312|FG000|Overall Study|Not eligible for initial SWOG study|10|||
30658568|NCT02756637|58671313|FG001|Overall Study|Not eligible for initial SWOG study|10|||
30658569|NCT02756637|58671312|FG000|Overall Study|No available NLR value|44|||
30658570|NCT02756637|58671313|FG001|Overall Study|No available NLR value|44|||
30658571|NCT02756637|58671312|FG000|Overall Study|Did not complete curative therapy|33|||
30658572|NCT02756637|58671313|FG001|Overall Study|Did not complete curative therapy|0|||
30658573|NCT02041195|58671327|FG000|Overall Study|Adverse Event|1|||
30658574|NCT02041195|58671328|FG001|Overall Study|Adverse Event|2|||
30658575|NCT02041195|58671329|FG002|Overall Study|Adverse Event|0|||
30658576|NCT02041195|58671330|FG003|Overall Study|Adverse Event|0|||
30658577|NCT02041195|58671331|FG004|Overall Study|Adverse Event|0|||
30658578|NCT02041195|58671332|FG005|Overall Study|Adverse Event|0|||
30658579|NCT02041195|58671333|FG006|Overall Study|Adverse Event|3|||
30658580|NCT02041195|58671334|FG007|Overall Study|Adverse Event|0|||
30658581|NCT02041195|58671327|FG000|Overall Study|Withdrawal by Subject|1|||
30658582|NCT02041195|58671328|FG001|Overall Study|Withdrawal by Subject|0|||
30658583|NCT02041195|58671329|FG002|Overall Study|Withdrawal by Subject|0|||
30658584|NCT02041195|58671330|FG003|Overall Study|Withdrawal by Subject|0|||
30658585|NCT02041195|58671331|FG004|Overall Study|Withdrawal by Subject|0|||
30658586|NCT02041195|58671332|FG005|Overall Study|Withdrawal by Subject|0|||
30658587|NCT02041195|58671333|FG006|Overall Study|Withdrawal by Subject|4|||
30658588|NCT02041195|58671334|FG007|Overall Study|Withdrawal by Subject|3|||
30658589|NCT02041195|58671327|FG000|Overall Study|Unable to comply with study visits|0|||
30658590|NCT02041195|58671328|FG001|Overall Study|Unable to comply with study visits|1|||
30658591|NCT02041195|58671329|FG002|Overall Study|Unable to comply with study visits|0|||
30658592|NCT02041195|58671330|FG003|Overall Study|Unable to comply with study visits|0|||
30658593|NCT02041195|58671331|FG004|Overall Study|Unable to comply with study visits|1|||
30658594|NCT02041195|58671332|FG005|Overall Study|Unable to comply with study visits|0|||
30658595|NCT02041195|58671333|FG006|Overall Study|Unable to comply with study visits|0|||
30658596|NCT02041195|58671334|FG007|Overall Study|Unable to comply with study visits|0|||
30658597|NCT01771107|58671364|FG000|Overall Study|Adverse Event|1|||
30658598|NCT01771107|58671365|FG001|Overall Study|Adverse Event|3|||
30658599|NCT01771107|58671364|FG000|Overall Study|Withdrawal by Subject|0|||
30658600|NCT01771107|58671365|FG001|Overall Study|Withdrawal by Subject|2|||
30658601|NCT01771107|58671364|FG000|Overall Study|Lost to Follow-up|0|||
30658602|NCT01771107|58671365|FG001|Overall Study|Lost to Follow-up|1|||
30658603|NCT01771107|58671364|FG000|Overall Study|participant moved|0|||
30658604|NCT01771107|58671365|FG001|Overall Study|participant moved|1|||
30658605|NCT01771107|58671364|FG000|Overall Study|Other|0|||
30658606|NCT01771107|58671365|FG001|Overall Study|Other|1|||
30658607|NCT01583218|58671404|FG000|Overall Study|Withdrawal by Subject|43|||
30658608|NCT01583218|58671405|FG001|Overall Study|Withdrawal by Subject|29|||
30658609|NCT01583218|58671404|FG000|Overall Study|Death|206|||
30658610|NCT01583218|58671405|FG001|Overall Study|Death|211|||
30658611|NCT01583218|58671404|FG000|Overall Study|Lost to Follow-up|11|||
30658612|NCT01583218|58671405|FG001|Overall Study|Lost to Follow-up|17|||
30658613|NCT01583218|58671404|FG000|Overall Study|Adverse event or serious adverse event|3|||
30658614|NCT01583218|58671405|FG001|Overall Study|Adverse event or serious adverse event|3|||
30658615|NCT01583218|58671404|FG000|Overall Study|Patient /Family decision|3|||
30658616|NCT01583218|58671405|FG001|Overall Study|Patient /Family decision|0|||
30658617|NCT01583218|58671404|FG000|Overall Study|Cannot contact patient directly|1|||
30658618|NCT01583218|58671405|FG001|Overall Study|Cannot contact patient directly|2|||
30658619|NCT01583218|58671404|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
30658620|NCT01583218|58671405|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
30658621|NCT01583218|58671404|FG000|Overall Study|Patient did not wish to attend visits|0|||
30658622|NCT01583218|58671405|FG001|Overall Study|Patient did not wish to attend visits|1|||
30658623|NCT01583218|58671404|FG000|Overall Study|Patient randomized but not dosed|17|||
30658624|NCT01583218|58671405|FG001|Overall Study|Patient randomized but not dosed|16|||
30658625|NCT01583218|58671404|FG000|Overall Study|Patient was assessed via phone in person|1|||
30658626|NCT01583218|58671405|FG001|Overall Study|Patient was assessed via phone in person|0|||
30770189|NCT00042666|58779106|FG000|Overall Study|Participant/Physician Perception|1|||
30770190|NCT00042666|58779106|FG000|Overall Study|Progressive Disease|41|||
30770191|NCT00042666|58779106|FG000|Overall Study|Other|1|||
30770192|NCT00042666|58779106|FG000|Overall Study|Other|4|||
30770193|NCT00042432|58779113|FG000|Overall Study|Adverse Event|4|||
30770194|NCT00042432|58779114|FG001|Overall Study|Adverse Event|1|||
30770195|NCT00042432|58779113|FG000|Overall Study|Withdrawal by Subject|1|||
30770196|NCT00042432|58779114|FG001|Overall Study|Withdrawal by Subject|3|||
30770197|NCT00042432|58779113|FG000|Overall Study|Death|0|||
30770198|NCT00042432|58779114|FG001|Overall Study|Death|2|||
30770199|NCT00042432|58779113|FG000|Overall Study|Ineligibility determined|1|||
30770200|NCT00042432|58779114|FG001|Overall Study|Ineligibility determined|0|||
30770201|NCT00042432|58779113|FG000|Overall Study|Initiation of maintenance dialysis|1|||
30770202|NCT00042432|58779114|FG001|Overall Study|Initiation of maintenance dialysis|1|||
30770203|NCT00042432|58779113|FG000|Overall Study|Other|2|||
30770204|NCT00042432|58779114|FG001|Overall Study|Other|0|||
30658627|NCT01583218|58671404|FG000|Overall Study|Patient deemed ineligible after random|2|||
30658628|NCT01583218|58671405|FG001|Overall Study|Patient deemed ineligible after random|0|||
30658629|NCT01583218|58671404|FG000|Overall Study|Patient was early terminated from study|0|||
30658630|NCT01583218|58671405|FG001|Overall Study|Patient was early terminated from study|1|||
30658631|NCT01583218|58671404|FG000|Overall Study|Patient was randomized due to mistake|1|||
30658632|NCT01583218|58671405|FG001|Overall Study|Patient was randomized due to mistake|0|||
30658633|NCT01583218|58671404|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
30658634|NCT01583218|58671405|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
30658635|NCT01583218|58671404|FG000|Overall Study|Withdraw of consent on day of random|1|||
30658636|NCT01583218|58671405|FG001|Overall Study|Withdraw of consent on day of random|0|||
30658637|NCT00742859|58671415|FG000|Overall Study|Adverse Event|5|||
30658638|NCT00742859|58671416|FG001|Overall Study|Adverse Event|6|||
30658639|NCT00742859|58671417|FG002|Overall Study|Adverse Event|3|||
30658640|NCT00742859|58671418|FG003|Overall Study|Adverse Event|1|||
30658641|NCT00742859|58671415|FG000|Overall Study|Death|1|||
30658642|NCT00742859|58671416|FG001|Overall Study|Death|0|||
30658643|NCT00742859|58671417|FG002|Overall Study|Death|0|||
30658644|NCT00742859|58671418|FG003|Overall Study|Death|1|||
30658645|NCT00742859|58671415|FG000|Overall Study|Physician Decision|1|||
30658646|NCT00742859|58671416|FG001|Overall Study|Physician Decision|2|||
30658647|NCT00742859|58671417|FG002|Overall Study|Physician Decision|0|||
30658648|NCT00742859|58671418|FG003|Overall Study|Physician Decision|0|||
30658649|NCT00742859|58671415|FG000|Overall Study|Withdrawal by Subject|4|||
30770205|NCT00003474|58779120|FG000|Overall Study|Not Evaluable|14|||
30770206|NCT01542736|58779124|FG000|Overall Study|Death|1|||
30770207|NCT01346410|58779128|FG000|Overall Study|Death|1|||
30770208|NCT00003456|58779132|FG000|Overall Study|Not evaluable|8|||
30770209|NCT02719522|58779136|FG000|Overall Study|Implant Failure|4|||
30770210|NCT02719522|58779136|FG000|Overall Study|Death|2|||
30770211|NCT02719522|58779136|FG000|Overall Study|Lost to Follow-up|5|||
30770212|NCT00237185|58779142|FG000|Core|Adverse Event|3|||
30770213|NCT00237185|58779143|FG001|Core|Adverse Event|4|||
30770214|NCT00237185|58779142|FG000|Core|Abnormal laboratory value|0|||
30770215|NCT00237185|58779143|FG001|Core|Abnormal laboratory value|4|||
30770216|NCT00237185|58779142|FG000|Core|Abnormal test procedure results|1|||
30770217|NCT00237185|58779143|FG001|Core|Abnormal test procedure results|0|||
30770218|NCT00237185|58779142|FG000|Core|Lack of Efficacy|30|||
30770219|NCT00237185|58779143|FG001|Core|Lack of Efficacy|23|||
30770220|NCT00237185|58779142|FG000|Core|Protocol Violation|1|||
30770221|NCT00237185|58779143|FG001|Core|Protocol Violation|1|||
30770222|NCT00237185|58779142|FG000|Core|Withdrawal by Subject|4|||
30770223|NCT00237185|58779143|FG001|Core|Withdrawal by Subject|4|||
30770224|NCT00237185|58779142|FG000|Core|Administrative problems|0|||
30770225|NCT00237185|58779143|FG001|Core|Administrative problems|1|||
30770226|NCT00237185|58779142|FG000|Core|Death|4|||
30770227|NCT00237185|58779143|FG001|Core|Death|0|||
30770228|NCT00237185|58779142|FG000|Core|Determined ineligible post randomization|1|||
30770229|NCT00237185|58779143|FG001|Core|Determined ineligible post randomization|0|||
30658650|NCT00742859|58671416|FG001|Overall Study|Withdrawal by Subject|2|||
30770230|NCT00237185|58779142|FG000|Extension|Adverse Event|1|||
30770231|NCT00237185|58779143|FG001|Extension|Adverse Event|0|||
30770232|NCT00237185|58779142|FG000|Extension|Abnormal laboratory value|0|||
30770233|NCT00237185|58779143|FG001|Extension|Abnormal laboratory value|1|||
30770234|NCT00237185|58779142|FG000|Extension|Lack of Efficacy|9|||
30658651|NCT00742859|58671417|FG002|Overall Study|Withdrawal by Subject|4|||
30658652|NCT00742859|58671418|FG003|Overall Study|Withdrawal by Subject|1|||
30770235|NCT00237185|58779143|FG001|Extension|Lack of Efficacy|14|||
30849025|NCT02840461|58875750|FG000|Overall Study|Lost to Follow-up|10|||
30658653|NCT00742859|58671415|FG000|Overall Study|Endpoint|0|||
30658654|NCT00742859|58671416|FG001|Overall Study|Endpoint|1|||
30770236|NCT00237185|58779142|FG000|Extension|Condition no longer required study drug|0|||
30770237|NCT00237185|58779143|FG001|Extension|Condition no longer required study drug|1|||
30770238|NCT00237185|58779142|FG000|Extension|Withdrawal by Subject|3|||
30770239|NCT00237185|58779143|FG001|Extension|Withdrawal by Subject|2|||
30658655|NCT00742859|58671417|FG002|Overall Study|Endpoint|1|||
30658656|NCT00742859|58671418|FG003|Overall Study|Endpoint|2|||
30658657|NCT00742859|58671415|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
30770240|NCT00237185|58779142|FG000|Extension|Lost to Follow-up|1|||
30770241|NCT00237185|58779143|FG001|Extension|Lost to Follow-up|0|||
30770242|NCT00237185|58779142|FG000|Extension|Administrative problems|1|||
30770243|NCT00237185|58779143|FG001|Extension|Administrative problems|0|||
30770244|NCT00237185|58779142|FG000|Extension|Death|1|||
30770245|NCT00237185|58779143|FG001|Extension|Death|1|||
30770246|NCT00003222|58779151|FG000|Overall Study|Physician Decision|0|||
30770247|NCT00003222|58779152|FG001|Overall Study|Physician Decision|1|||
30770248|NCT02877082|58779158|FG000|Overall Study|Trial was closed early|5|||
30770249|NCT02875834|58779166|FG000|Open-label Phase|Withdrawal by Subject|3|||
30770250|NCT02875834|58779167|FG001|Open-label Phase|Withdrawal by Subject|0|||
30770251|NCT02875834|58779168|FG002|Open-label Phase|Withdrawal by Subject|0|||
30770252|NCT02875834|58779169|FG003|Open-label Phase|Withdrawal by Subject|0|||
30770253|NCT02875834|58779166|FG000|Open-label Phase|(Not collected)|4|||
30770254|NCT02875834|58779167|FG001|Open-label Phase|(Not collected)|0|||
30770255|NCT02875834|58779168|FG002|Open-label Phase|(Not collected)|0|||
30770256|NCT02875834|58779169|FG003|Open-label Phase|(Not collected)|0|||
30770257|NCT02875834|58779166|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
30770258|NCT02875834|58779167|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
30770259|NCT02875834|58779168|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
30770260|NCT02875834|58779169|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
30770261|NCT02875834|58779166|FG000|Randomized Treatment Phase|Protocol Violation|0|||
30770262|NCT02875834|58779167|FG001|Randomized Treatment Phase|Protocol Violation|2|||
30770263|NCT02875834|58779168|FG002|Randomized Treatment Phase|Protocol Violation|0|||
30770264|NCT02875834|58779169|FG003|Randomized Treatment Phase|Protocol Violation|0|||
30770265|NCT02875834|58779166|FG000|Randomized Treatment Phase|(Not collected)|0|||
30770266|NCT02875834|58779167|FG001|Randomized Treatment Phase|(Not collected)|9|||
30770267|NCT02875834|58779168|FG002|Randomized Treatment Phase|(Not collected)|10|||
30770268|NCT02875834|58779169|FG003|Randomized Treatment Phase|(Not collected)|9|||
30770269|NCT02875366|58779181|FG000|Overall Study|Adverse Event|0|||
30770270|NCT02875366|58779182|FG001|Overall Study|Adverse Event|2|||
30770271|NCT02875366|58779181|FG000|Overall Study|Noncompliance|0|||
30770272|NCT02875366|58779182|FG001|Overall Study|Noncompliance|1|||
30770273|NCT00003102|58779191|FG000|Overall Study|Physician Decision|1|||
30770274|NCT00003102|58779192|FG001|Overall Study|Physician Decision|1|||
30658658|NCT00742859|58671416|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
30658659|NCT00742859|58671417|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
30658660|NCT00742859|58671418|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
30658661|NCT00742859|58671415|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
30658662|NCT00742859|58671416|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
30658663|NCT00742859|58671417|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
30658664|NCT00742859|58671418|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
30658665|NCT00742859|58671415|FG000|Overall Study|Sponsor request patient out of town|0|||
30658666|NCT00742859|58671416|FG001|Overall Study|Sponsor request patient out of town|0|||
30658667|NCT00742859|58671417|FG002|Overall Study|Sponsor request patient out of town|1|||
30658668|NCT00742859|58671418|FG003|Overall Study|Sponsor request patient out of town|1|||
30658669|NCT00742859|58671415|FG000|Overall Study|Site error|0|||
30658670|NCT00742859|58671416|FG001|Overall Study|Site error|0|||
30658671|NCT00742859|58671417|FG002|Overall Study|Site error|1|||
30658672|NCT00742859|58671418|FG003|Overall Study|Site error|1|||
30658673|NCT00667342|58671431|FG000|Overall Study|Protocol Violation|1|||
30658674|NCT00667342|58671432|FG001|Overall Study|Protocol Violation|0|||
30658675|NCT00667342|58671433|FG002|Overall Study|Protocol Violation|0|||
30658676|NCT00667342|58671431|FG000|Overall Study|Withdrawal by Subject|1|||
30658677|NCT00667342|58671432|FG001|Overall Study|Withdrawal by Subject|0|||
30658678|NCT00667342|58671433|FG002|Overall Study|Withdrawal by Subject|0|||
30658679|NCT00667342|58671431|FG000|Overall Study|Physician Decision|3|||
30658680|NCT00667342|58671432|FG001|Overall Study|Physician Decision|0|||
30770275|NCT00003102|58779193|FG002|Overall Study|Physician Decision|0|||
30770276|NCT00003102|58779191|FG000|Overall Study|Progressive Disease|0|||
30770277|NCT00003102|58779192|FG001|Overall Study|Progressive Disease|1|||
30770278|NCT00003102|58779193|FG002|Overall Study|Progressive Disease|0|||
30770279|NCT00003102|58779191|FG000|Overall Study|Adverse Event|0|||
30658681|NCT00667342|58671433|FG002|Overall Study|Physician Decision|0|||
30658682|NCT00667342|58671431|FG000|Overall Study|Relapse or tumor progression|9|||
30658683|NCT00667342|58671432|FG001|Overall Study|Relapse or tumor progression|0|||
30658684|NCT00667342|58671433|FG002|Overall Study|Relapse or tumor progression|7|||
30658685|NCT00667342|58671431|FG000|Overall Study|Adverse Event|0|||
30658686|NCT00667342|58671432|FG001|Overall Study|Adverse Event|0|||
30658687|NCT00667342|58671433|FG002|Overall Study|Adverse Event|1|||
30658688|NCT00667342|58671431|FG000|Overall Study|Ineligible|0|||
30658689|NCT00667342|58671432|FG001|Overall Study|Ineligible|0|||
30658690|NCT00667342|58671433|FG002|Overall Study|Ineligible|1|||
30658691|NCT00375609|58671450|FG000|Overall Study|Did not receive treatment|1|||
30658692|NCT00375609|58671451|FG001|Overall Study|Did not receive treatment|0|||
30658693|NCT00375609|58671452|FG002|Overall Study|Did not receive treatment|0|||
30658694|NCT00375609|58671450|FG000|Overall Study|Adverse Event|0|||
30658695|NCT00375609|58671451|FG001|Overall Study|Adverse Event|3|||
30658696|NCT00375609|58671452|FG002|Overall Study|Adverse Event|0|||
30658697|NCT00375609|58671450|FG000|Overall Study|Lost to Follow-up|1|||
30658698|NCT00375609|58671451|FG001|Overall Study|Lost to Follow-up|0|||
30658699|NCT00375609|58671452|FG002|Overall Study|Lost to Follow-up|0|||
30658700|NCT00375609|58671450|FG000|Overall Study|Physician Decision|0|||
30658701|NCT00375609|58671451|FG001|Overall Study|Physician Decision|0|||
30658702|NCT00375609|58671452|FG002|Overall Study|Physician Decision|1|||
30658703|NCT00375609|58671450|FG000|Overall Study|Withdrawal by Subject|1|||
30658704|NCT00375609|58671451|FG001|Overall Study|Withdrawal by Subject|4|||
30658705|NCT00375609|58671452|FG002|Overall Study|Withdrawal by Subject|0|||
30658706|NCT00375609|58671450|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
30658707|NCT00375609|58671451|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
30658708|NCT00375609|58671452|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
30658709|NCT00960011|58671462|FG000|Overall Study|Death|5|||
30658710|NCT00960011|58671463|FG001|Overall Study|Death|0|||
30658711|NCT00960011|58671462|FG000|Overall Study|Lost to Follow-up|6|||
30658712|NCT00960011|58671463|FG001|Overall Study|Lost to Follow-up|2|||
30658713|NCT00617851|58671507|FG000|Overall Study|Death|0|||
30658714|NCT00617851|58671508|FG001|Overall Study|Death|0|||
30658715|NCT00617851|58671509|FG002|Overall Study|Death|0|||
30658716|NCT00617851|58671510|FG003|Overall Study|Death|1|||
30658717|NCT00617851|58671507|FG000|Overall Study|Withdrawal by Subject|14|||
30658718|NCT00617851|58671508|FG001|Overall Study|Withdrawal by Subject|7|||
30658719|NCT00617851|58671509|FG002|Overall Study|Withdrawal by Subject|12|||
30658720|NCT00617851|58671510|FG003|Overall Study|Withdrawal by Subject|4|||
30658721|NCT00617851|58671507|FG000|Overall Study|Lost to Follow-up|27|||
30658722|NCT00617851|58671508|FG001|Overall Study|Lost to Follow-up|29|||
30658723|NCT00617851|58671509|FG002|Overall Study|Lost to Follow-up|31|||
30658724|NCT00617851|58671510|FG003|Overall Study|Lost to Follow-up|19|||
30658725|NCT00617851|58671507|FG000|Overall Study|Inappropriate Enrollment|5|||
30658726|NCT00617851|58671508|FG001|Overall Study|Inappropriate Enrollment|4|||
30658727|NCT00617851|58671509|FG002|Overall Study|Inappropriate Enrollment|1|||
30658728|NCT00617851|58671510|FG003|Overall Study|Inappropriate Enrollment|1|||
30658729|NCT00617851|58671507|FG000|Overall Study|Unable to classify|1|||
30658730|NCT00617851|58671508|FG001|Overall Study|Unable to classify|0|||
30658731|NCT00617851|58671509|FG002|Overall Study|Unable to classify|1|||
30658732|NCT00617851|58671510|FG003|Overall Study|Unable to classify|0|||
30658733|NCT00812955|58671534|FG000|Overall Study|Adverse Event|7|||
30658734|NCT00812955|58671535|FG001|Overall Study|Adverse Event|6|||
30658735|NCT00812955|58671536|FG002|Overall Study|Adverse Event|3|||
30658736|NCT00812955|58671537|FG003|Overall Study|Adverse Event|4|||
30658737|NCT00812955|58671534|FG000|Overall Study|Lost to Follow-up|2|||
30658738|NCT00812955|58671535|FG001|Overall Study|Lost to Follow-up|1|||
30658739|NCT00812955|58671536|FG002|Overall Study|Lost to Follow-up|1|||
30658740|NCT00812955|58671537|FG003|Overall Study|Lost to Follow-up|2|||
30658741|NCT00812955|58671534|FG000|Overall Study|Withdrawal by Subject|1|||
30658742|NCT00812955|58671535|FG001|Overall Study|Withdrawal by Subject|0|||
30658743|NCT00812955|58671536|FG002|Overall Study|Withdrawal by Subject|1|||
30952565|NCT01895777|59001413|FG001|Overall Study|Adverse Event|2|||
30658744|NCT00812955|58671537|FG003|Overall Study|Withdrawal by Subject|2|||
30658745|NCT00812955|58671534|FG000|Overall Study|randomized in error|0|||
30658746|NCT00812955|58671535|FG001|Overall Study|randomized in error|0|||
30658747|NCT00812955|58671536|FG002|Overall Study|randomized in error|1|||
30658748|NCT00812955|58671537|FG003|Overall Study|randomized in error|0|||
30658749|NCT00619489|58671553|FG000|Overall Study|Adverse Event|0|||
30658750|NCT00619489|58671554|FG001|Overall Study|Adverse Event|7|||
30658751|NCT00619489|58671553|FG000|Overall Study|Withdrawal by Subject|1|||
30658752|NCT00619489|58671554|FG001|Overall Study|Withdrawal by Subject|1|||
30658753|NCT00619489|58671553|FG000|Overall Study|Lack of Efficacy|0|||
30658754|NCT00619489|58671554|FG001|Overall Study|Lack of Efficacy|11|||
30658755|NCT00619489|58671553|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
30770280|NCT00003102|58779192|FG001|Overall Study|Adverse Event|1|||
30658756|NCT00619489|58671554|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
30658757|NCT00959699|58671562|FG000|Treatment Period|Adverse Event|3|||
30658758|NCT00959699|58671563|FG001|Treatment Period|Adverse Event|13|||
30658759|NCT00959699|58671562|FG000|Treatment Period|Lack of Efficacy|15|||
30658760|NCT00959699|58671563|FG001|Treatment Period|Lack of Efficacy|6|||
30658761|NCT00959699|58671562|FG000|Treatment Period|Lost to Follow-up|0|||
30658762|NCT00959699|58671563|FG001|Treatment Period|Lost to Follow-up|1|||
30658763|NCT00959699|58671562|FG000|Treatment Period|Withdrawal by Subject|1|||
30658764|NCT00959699|58671563|FG001|Treatment Period|Withdrawal by Subject|3|||
30658765|NCT00959699|58671562|FG000|Treatment Period|Non-Compliance with Protocol|0|||
30658766|NCT00959699|58671563|FG001|Treatment Period|Non-Compliance with Protocol|1|||
30658767|NCT00959699|58671562|FG000|Treatment Period|Did not receive treatment|0|||
30658768|NCT00959699|58671563|FG001|Treatment Period|Did not receive treatment|1|||
30658769|NCT00959699|58671562|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
30658770|NCT00959699|58671563|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
30658771|NCT00959699|58671562|FG000|Follow-up Period|Lost to Follow-up|3|||
30658772|NCT00959699|58671563|FG001|Follow-up Period|Lost to Follow-up|2|||
30658773|NCT00959699|58671562|FG000|Follow-up Period|Withdrawal by Subject|3|||
30658774|NCT00959699|58671563|FG001|Follow-up Period|Withdrawal by Subject|4|||
30658775|NCT00617773|58671570|FG000|Overall Study|Physician Decision|1|||
30658776|NCT00617773|58671570|FG000|Overall Study|Lack of compliance with the protocol|1|||
30658777|NCT00617773|58671570|FG000|Overall Study|Withdrawal by Subject|1|||
30658778|NCT00617773|58671570|FG000|Overall Study|Death|1|||
30658779|NCT00617773|58671570|FG000|Overall Study|Progressive disease|19|||
30658780|NCT00617773|58671570|FG000|Overall Study|Protocol Violation|1|||
30658781|NCT00956813|58671576|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
30658782|NCT00956813|58671577|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
30658783|NCT00956813|58671576|FG000|Flaxseed and Placebo|Ineligible|3|||
30658784|NCT00956813|58671577|FG001|Flaxseed and Placebo|Ineligible|1|||
30658785|NCT00955955|58671587|FG000|Overall Study|Lost to Follow-up|2|||
30658786|NCT00955955|58671588|FG001|Overall Study|Lost to Follow-up|0|||
30658787|NCT00955955|58671589|FG002|Overall Study|Lost to Follow-up|0|||
30658788|NCT00955721|58671605|FG000|Overall Study|Physician Decision|1|||
30658789|NCT00955721|58671606|FG001|Overall Study|Physician Decision|0|||
30658790|NCT00955721|58671605|FG000|Overall Study|Death|1|||
30658791|NCT00955721|58671606|FG001|Overall Study|Death|0|||
30658792|NCT00955721|58671605|FG000|Overall Study|Withdrawal by Subject|1|||
30658793|NCT00955721|58671606|FG001|Overall Study|Withdrawal by Subject|0|||
30658794|NCT00573469|58671616|FG000|Overall Study|Adverse Event|1|||
30658795|NCT00573469|58671617|FG001|Overall Study|Adverse Event|1|||
30658796|NCT00573469|58671618|FG002|Overall Study|Adverse Event|1|||
30658797|NCT00573469|58671616|FG000|Overall Study|Withdrawal by Subject|0|||
30658798|NCT00573469|58671617|FG001|Overall Study|Withdrawal by Subject|2|||
30658799|NCT00573469|58671618|FG002|Overall Study|Withdrawal by Subject|0|||
30658800|NCT00573469|58671616|FG000|Overall Study|Other|5|||
30658801|NCT00573469|58671617|FG001|Overall Study|Other|1|||
30658802|NCT00573469|58671618|FG002|Overall Study|Other|3|||
30658803|NCT00812565|58671634|FG000|Overall Study|Did Not Receive Study Medication|1|||
30658804|NCT00812565|58671635|FG001|Overall Study|Did Not Receive Study Medication|1|||
30658805|NCT00812565|58671636|FG002|Overall Study|Did Not Receive Study Medication|0|||
30658806|NCT00812565|58671637|FG003|Overall Study|Did Not Receive Study Medication|0|||
30658807|NCT00812565|58671638|FG004|Overall Study|Did Not Receive Study Medication|0|||
30658808|NCT00812565|58671639|FG005|Overall Study|Did Not Receive Study Medication|0|||
30658809|NCT00812565|58671640|FG006|Overall Study|Did Not Receive Study Medication|0|||
30658810|NCT00812565|58671641|FG007|Overall Study|Did Not Receive Study Medication|0|||
30658811|NCT00812565|58671634|FG000|Overall Study|Adverse Event|0|||
30658812|NCT00812565|58671635|FG001|Overall Study|Adverse Event|0|||
30658813|NCT00812565|58671636|FG002|Overall Study|Adverse Event|0|||
30658814|NCT00812565|58671637|FG003|Overall Study|Adverse Event|2|||
30658815|NCT00812565|58671638|FG004|Overall Study|Adverse Event|0|||
30658816|NCT00812565|58671639|FG005|Overall Study|Adverse Event|0|||
30658817|NCT00812565|58671640|FG006|Overall Study|Adverse Event|0|||
30658818|NCT00812565|58671641|FG007|Overall Study|Adverse Event|1|||
30658819|NCT00812565|58671634|FG000|Overall Study|Did Not Come to Study Visit|1|||
30658820|NCT00812565|58671635|FG001|Overall Study|Did Not Come to Study Visit|0|||
30849026|NCT02840461|58875751|FG001|Overall Study|Lost to Follow-up|7|||
30658821|NCT00812565|58671636|FG002|Overall Study|Did Not Come to Study Visit|0|||
30658822|NCT00812565|58671637|FG003|Overall Study|Did Not Come to Study Visit|0|||
30658823|NCT00812565|58671638|FG004|Overall Study|Did Not Come to Study Visit|0|||
30658824|NCT00812565|58671639|FG005|Overall Study|Did Not Come to Study Visit|0|||
30658825|NCT00812565|58671640|FG006|Overall Study|Did Not Come to Study Visit|0|||
30658826|NCT00812565|58671641|FG007|Overall Study|Did Not Come to Study Visit|0|||
30658827|NCT00812565|58671634|FG000|Overall Study|Withdrawal of Consent|1|||
30658828|NCT00812565|58671635|FG001|Overall Study|Withdrawal of Consent|0|||
30658829|NCT00812565|58671636|FG002|Overall Study|Withdrawal of Consent|0|||
30658830|NCT00812565|58671637|FG003|Overall Study|Withdrawal of Consent|0|||
30849027|NCT02840461|58875752|FG002|Overall Study|Lost to Follow-up|6|||
30658831|NCT00812565|58671638|FG004|Overall Study|Withdrawal of Consent|1|||
30658832|NCT00812565|58671639|FG005|Overall Study|Withdrawal of Consent|0|||
30658833|NCT00812565|58671640|FG006|Overall Study|Withdrawal of Consent|0|||
30658834|NCT00812565|58671641|FG007|Overall Study|Withdrawal of Consent|0|||
30658835|NCT00812565|58671634|FG000|Overall Study|Reason Not Specified|0|||
30658836|NCT00812565|58671635|FG001|Overall Study|Reason Not Specified|0|||
30658837|NCT00812565|58671636|FG002|Overall Study|Reason Not Specified|0|||
30658838|NCT00812565|58671637|FG003|Overall Study|Reason Not Specified|0|||
30658839|NCT00812565|58671638|FG004|Overall Study|Reason Not Specified|0|||
30658840|NCT00812565|58671639|FG005|Overall Study|Reason Not Specified|1|||
30658841|NCT00812565|58671640|FG006|Overall Study|Reason Not Specified|0|||
30658842|NCT00812565|58671641|FG007|Overall Study|Reason Not Specified|0|||
30658843|NCT00812487|58671661|FG000|Overall Study|Lost to Follow-up|2|||
30658844|NCT00812487|58671662|FG001|Overall Study|Lost to Follow-up|0|||
30658845|NCT00812487|58671661|FG000|Overall Study|Withdrawal by Subject|3|||
30658846|NCT00812487|58671662|FG001|Overall Study|Withdrawal by Subject|2|||
30658847|NCT00812487|58671661|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
30658848|NCT00812487|58671662|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
30658849|NCT00812487|58671661|FG000|Overall Study|Protocol Violation|0|||
30658850|NCT00812487|58671662|FG001|Overall Study|Protocol Violation|1|||
30658851|NCT00617461|58671672|FG000|First Treatment Intervention Period|Adverse Event|2|||
30658852|NCT00617461|58671673|FG001|First Treatment Intervention Period|Adverse Event|0|||
30658853|NCT00617461|58671672|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
30658854|NCT00617461|58671673|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
30658855|NCT00617461|58671672|FG000|First Treatment Intervention Period|Protocol Violation|2|||
30658856|NCT00617461|58671673|FG001|First Treatment Intervention Period|Protocol Violation|1|||
30658857|NCT00617461|58671672|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
30658858|NCT00617461|58671673|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
30658859|NCT00617461|58671672|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
30658860|NCT00617461|58671673|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
30658861|NCT00617461|58671672|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
30658862|NCT00617461|58671673|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
30658863|NCT00617461|58671672|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
30658864|NCT00617461|58671673|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
30658865|NCT00617461|58671672|FG000|Second Treatment Intervention Period|Adverse Event|0|||
30658866|NCT00617461|58671673|FG001|Second Treatment Intervention Period|Adverse Event|1|||
30658867|NCT00617461|58671672|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
30658868|NCT00617461|58671673|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
30658869|NCT00617461|58671672|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
30658870|NCT00617461|58671673|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
30658871|NCT00617461|58671672|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
30658872|NCT00617461|58671673|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
30658873|NCT00812331|58671700|FG000|Overall Study|Adverse Event|1|||
30658874|NCT00812331|58671701|FG001|Overall Study|Adverse Event|0|||
30770281|NCT00003102|58779193|FG002|Overall Study|Adverse Event|1|||
30770282|NCT00003102|58779191|FG000|Overall Study|Death|0|||
30770283|NCT00003102|58779192|FG001|Overall Study|Death|0|||
30770284|NCT00003102|58779193|FG002|Overall Study|Death|1|||
30770285|NCT00002850|58779204|FG000|Overall Study|Death|4|||
30770286|NCT00002850|58779205|FG001|Overall Study|Death|1|||
30770287|NCT00002850|58779206|FG002|Overall Study|Death|3|||
30770288|NCT00002850|58779204|FG000|Overall Study|Protocol Violation|1|||
30770289|NCT00002850|58779205|FG001|Overall Study|Protocol Violation|0|||
30770290|NCT00002850|58779206|FG002|Overall Study|Protocol Violation|1|||
30770291|NCT00002850|58779204|FG000|Overall Study|Withdrawal by Subject|0|||
30770292|NCT00002850|58779205|FG001|Overall Study|Withdrawal by Subject|1|||
30770293|NCT00002850|58779206|FG002|Overall Study|Withdrawal by Subject|0|||
30770294|NCT00002766|58779216|FG000|Overall Study|Withdrawal by Subject|0|||
30658875|NCT00812331|58671702|FG002|Overall Study|Adverse Event|0|||
30658876|NCT00812331|58671703|FG003|Overall Study|Adverse Event|0|||
30658877|NCT00812331|58671704|FG004|Overall Study|Adverse Event|0|||
30658878|NCT00812253|58671714|FG000|Overall Study|Withdrawal by Subject|3|||
30658879|NCT00812253|58671715|FG001|Overall Study|Withdrawal by Subject|2|||
30658880|NCT00812253|58671714|FG000|Overall Study|Protocol Violation|1|||
30658881|NCT00812253|58671715|FG001|Overall Study|Protocol Violation|1|||
30658882|NCT00812253|58671714|FG000|Overall Study|Lost to Follow-up|2|||
30658883|NCT00812253|58671715|FG001|Overall Study|Lost to Follow-up|0|||
30658884|NCT00616759|58671723|FG000|Overall Study|Physician Decision|2|||
30658885|NCT00616759|58671724|FG001|Overall Study|Physician Decision|0|||
30658886|NCT00616759|58671723|FG000|Overall Study|Withdrawal by Subject|1|||
30770295|NCT00002766|58779217|FG001|Overall Study|Withdrawal by Subject|1|||
30770296|NCT00002766|58779216|FG000|Overall Study|Patient Not Treated|1|||
30770297|NCT00002766|58779217|FG001|Overall Study|Patient Not Treated|2|||
30770298|NCT00002766|58779216|FG000|Overall Study|Adverse Event|1|||
30658887|NCT00616759|58671724|FG001|Overall Study|Withdrawal by Subject|2|||
30658888|NCT00812097|58671734|FG000|Overall Study|Death|3|||
30658889|NCT00812097|58671735|FG001|Overall Study|Death|10|||
30658890|NCT00812097|58671736|FG002|Overall Study|Death|3|||
30658891|NCT00812097|58671737|FG003|Overall Study|Death|3|||
30658892|NCT00812097|58671734|FG000|Overall Study|Withdrawal by Subject|14|||
30658893|NCT00812097|58671735|FG001|Overall Study|Withdrawal by Subject|12|||
30658894|NCT00812097|58671736|FG002|Overall Study|Withdrawal by Subject|8|||
30658895|NCT00812097|58671737|FG003|Overall Study|Withdrawal by Subject|2|||
30658896|NCT00812097|58671734|FG000|Overall Study|Lost to Follow-up|90|||
30658897|NCT00812097|58671735|FG001|Overall Study|Lost to Follow-up|14|||
30658898|NCT00812097|58671736|FG002|Overall Study|Lost to Follow-up|17|||
30658899|NCT00812097|58671737|FG003|Overall Study|Lost to Follow-up|5|||
30658900|NCT00812097|58671734|FG000|Overall Study|Explantation of study device(s)|27|||
30658901|NCT00812097|58671735|FG001|Overall Study|Explantation of study device(s)|29|||
30658902|NCT00812097|58671736|FG002|Overall Study|Explantation of study device(s)|14|||
30658903|NCT00812097|58671737|FG003|Overall Study|Explantation of study device(s)|20|||
30658904|NCT00812097|58671734|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
30658905|NCT00812097|58671735|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
30658906|NCT00812097|58671736|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
30658907|NCT00812097|58671737|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
30658908|NCT00811941|58671749|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
30658909|NCT00811941|58671750|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
30658910|NCT00811941|58671749|FG000|All Treated Patients|Adverse Event|2|||
30658911|NCT00811941|58671750|FG001|All Treated Patients|Adverse Event|43|||
30658912|NCT00811941|58671749|FG000|All Treated Patients|Lack of Efficacy|2|||
30658913|NCT00811941|58671750|FG001|All Treated Patients|Lack of Efficacy|3|||
30658914|NCT00811941|58671749|FG000|All Treated Patients|Non-compliance|1|||
30658915|NCT00811941|58671750|FG001|All Treated Patients|Non-compliance|8|||
30770299|NCT00002766|58779217|FG001|Overall Study|Adverse Event|1|||
30770300|NCT00002766|58779216|FG000|Overall Study|Protocol Violation|1|||
30770301|NCT00002766|58779217|FG001|Overall Study|Protocol Violation|0|||
30770302|NCT02306122|58779230|FG000|Initial Physician Randomization|Physician Decision|0|||
30770303|NCT02306122|58779231|FG001|Initial Physician Randomization|Physician Decision|0|||
30770304|NCT02306122|58779232|FG002|Initial Physician Randomization|Physician Decision|0|||
30770305|NCT02306122|58779233|FG003|Initial Physician Randomization|Physician Decision|0|||
30770306|NCT02306122|58779234|FG004|Initial Physician Randomization|Physician Decision|0|||
30770307|NCT02306122|58779235|FG005|Initial Physician Randomization|Physician Decision|0|||
30770308|NCT02306122|58779236|FG006|Initial Physician Randomization|Physician Decision|0|||
30770309|NCT02306122|58779237|FG007|Initial Physician Randomization|Physician Decision|0|||
30770310|NCT02306122|58779238|FG008|Initial Physician Randomization|Physician Decision|1|||
30770311|NCT02306122|58779239|FG009|Initial Physician Randomization|Physician Decision|0|||
30770312|NCT02306122|58779240|FG010|Initial Physician Randomization|Physician Decision|0|||
30770313|NCT00001962|58779258|FG000|Overall Study|Lack of Efficacy|18|||
30770314|NCT00001962|58779258|FG000|Overall Study|Lack of Accrual|6|||
30770315|NCT00001962|58779258|FG000|Overall Study|Death|1|||
30770316|NCT00001962|58779258|FG000|Overall Study|Lost to Follow-up|2|||
30770317|NCT00001962|58779258|FG000|Overall Study|Adverse Event|1|||
30770318|NCT00028002|58779262|FG000|Overall Study|Withdrawal by Subject|3|||
30770319|NCT00028002|58779262|FG000|Overall Study|Ineligible|8|||
30770320|NCT00256997|58779269|FG000|Overall Study|Protocol Violation|1|||
30770321|NCT00256997|58779270|FG001|Overall Study|Protocol Violation|4|||
30770322|NCT00256997|58779269|FG000|Overall Study|Lack of Efficacy|1|||
30770323|NCT00256997|58779270|FG001|Overall Study|Lack of Efficacy|4|||
30770324|NCT00256997|58779269|FG000|Overall Study|Death|2|||
30770325|NCT00256997|58779270|FG001|Overall Study|Death|0|||
30770326|NCT00256997|58779269|FG000|Overall Study|Adverse Event|4|||
30770327|NCT00256997|58779270|FG001|Overall Study|Adverse Event|0|||
30770328|NCT00256997|58779269|FG000|Overall Study|Lost to Follow-up|3|||
30770329|NCT00256997|58779270|FG001|Overall Study|Lost to Follow-up|5|||
30770330|NCT00256997|58779269|FG000|Overall Study|Withdrawal by Subject|13|||
30770331|NCT00256997|58779270|FG001|Overall Study|Withdrawal by Subject|3|||
30658916|NCT00811941|58671749|FG000|All Treated Patients|Protocol Violation|5|||
30658917|NCT00811941|58671750|FG001|All Treated Patients|Protocol Violation|17|||
30658918|NCT00811941|58671749|FG000|All Treated Patients|Withdrawal by Subject|35|||
30770332|NCT00256997|58779269|FG000|Overall Study|Started but not treated|2|||
30770333|NCT00256997|58779270|FG001|Overall Study|Started but not treated|0|||
30849028|NCT02840461|58875750|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
30658919|NCT00811941|58671750|FG001|All Treated Patients|Withdrawal by Subject|94|||
30658920|NCT00811941|58671749|FG000|All Treated Patients|Lost to Follow-up|3|||
30658921|NCT00811941|58671750|FG001|All Treated Patients|Lost to Follow-up|12|||
30658922|NCT00811941|58671749|FG000|All Treated Patients|Other Reason|4|||
30770334|NCT00256997|58779269|FG000|Overall Study|Other|5|||
30770335|NCT00256997|58779270|FG001|Overall Study|Other|8|||
30770336|NCT00256997|58779269|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
30770337|NCT00256997|58779270|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
30770338|NCT00256997|58779269|FG000|Overall Study|Participant Non-compliant|3|||
30770339|NCT00256997|58779270|FG001|Overall Study|Participant Non-compliant|6|||
30770340|NCT00256997|58779269|FG000|Overall Study|Investigator Withdrew Participant|2|||
30770341|NCT00256997|58779270|FG001|Overall Study|Investigator Withdrew Participant|1|||
30770342|NCT00027846|58779280|FG000|Overall Study|Lost to Follow-up|0|||
30770343|NCT00027846|58779281|FG001|Overall Study|Lost to Follow-up|41|||
30770344|NCT00027846|58779282|FG002|Overall Study|Lost to Follow-up|9|||
30770345|NCT00027846|58779280|FG000|Overall Study|Withdrawal by Subject|0|||
30770346|NCT00027846|58779281|FG001|Overall Study|Withdrawal by Subject|14|||
30770347|NCT00027846|58779282|FG002|Overall Study|Withdrawal by Subject|7|||
30770348|NCT00027846|58779280|FG000|Overall Study|Ineligible for study|2|||
30770349|NCT00027846|58779281|FG001|Overall Study|Ineligible for study|6|||
30770350|NCT00027846|58779282|FG002|Overall Study|Ineligible for study|14|||
30770351|NCT00027846|58779280|FG000|Overall Study|Entry into another COG therapeutic study|0|||
30770352|NCT00027846|58779281|FG001|Overall Study|Entry into another COG therapeutic study|5|||
30770353|NCT00027846|58779282|FG002|Overall Study|Entry into another COG therapeutic study|2|||
30770354|NCT00027846|58779280|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
30770355|NCT00027846|58779281|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
30770356|NCT00027846|58779282|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
30770357|NCT00027378|58779294|FG000|Overall Study|Physician Decision|0|||
30770358|NCT00027378|58779295|FG001|Overall Study|Physician Decision|3|||
30770359|NCT00235391|58779307|FG000|Overall Study|Adverse Event|4|||
30770360|NCT00235391|58779308|FG001|Overall Study|Adverse Event|5|||
30770361|NCT00235391|58779309|FG002|Overall Study|Adverse Event|10|||
30770362|NCT00235391|58779310|FG003|Overall Study|Adverse Event|72|||
30770363|NCT00235391|58779311|FG004|Overall Study|Adverse Event|5|||
30770364|NCT00235391|58779312|FG005|Overall Study|Adverse Event|2|||
30770365|NCT00235391|58779307|FG000|Overall Study|Abnormal laboratory value(s)|3|||
30770366|NCT00235391|58779308|FG001|Overall Study|Abnormal laboratory value(s)|5|||
30770367|NCT00235391|58779309|FG002|Overall Study|Abnormal laboratory value(s)|4|||
30770368|NCT00235391|58779310|FG003|Overall Study|Abnormal laboratory value(s)|27|||
30770369|NCT00235391|58779311|FG004|Overall Study|Abnormal laboratory value(s)|1|||
30770370|NCT00235391|58779312|FG005|Overall Study|Abnormal laboratory value(s)|2|||
30770371|NCT00235391|58779307|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30770372|NCT00235391|58779308|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30770373|NCT00235391|58779309|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
30770374|NCT00235391|58779310|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
30770375|NCT00235391|58779311|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
30770376|NCT00235391|58779312|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
30770377|NCT00235391|58779307|FG000|Overall Study|Condition no longer requires treatment|3|||
30770378|NCT00235391|58779308|FG001|Overall Study|Condition no longer requires treatment|0|||
30770379|NCT00235391|58779309|FG002|Overall Study|Condition no longer requires treatment|0|||
30770380|NCT00235391|58779310|FG003|Overall Study|Condition no longer requires treatment|11|||
30849029|NCT02840461|58875751|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
30849030|NCT02840461|58875752|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
30849031|NCT02840461|58875750|FG000|Overall Study|Protocol Violation|2|||
30849032|NCT02840461|58875751|FG001|Overall Study|Protocol Violation|3|||
30849033|NCT02840461|58875752|FG002|Overall Study|Protocol Violation|1|||
30658923|NCT00811941|58671750|FG001|All Treated Patients|Other Reason|14|||
30658924|NCT00811473|58671758|FG000|Overall Study|Adverse Event|3|||
30658925|NCT00811473|58671759|FG001|Overall Study|Adverse Event|12|||
30658926|NCT00811473|58671758|FG000|Overall Study|Lost to Follow-up|5|||
30658927|NCT00811473|58671759|FG001|Overall Study|Lost to Follow-up|1|||
30658928|NCT00811473|58671758|FG000|Overall Study|Withdrawal by Subject|2|||
30658929|NCT00811473|58671759|FG001|Overall Study|Withdrawal by Subject|4|||
30658930|NCT00811473|58671758|FG000|Overall Study|Severe non-compliance to protocol|2|||
30658931|NCT00811473|58671759|FG001|Overall Study|Severe non-compliance to protocol|4|||
30658932|NCT00811473|58671758|FG000|Overall Study|Lack of therapeutic response|4|||
30770381|NCT00235391|58779311|FG004|Overall Study|Condition no longer requires treatment|1|||
30770382|NCT00235391|58779312|FG005|Overall Study|Condition no longer requires treatment|0|||
30770383|NCT00235391|58779307|FG000|Overall Study|Protocol deviation|0|||
30770384|NCT00235391|58779308|FG001|Overall Study|Protocol deviation|0|||
30770385|NCT00235391|58779309|FG002|Overall Study|Protocol deviation|1|||
30658933|NCT00811473|58671759|FG001|Overall Study|Lack of therapeutic response|1|||
30658934|NCT00811473|58671758|FG000|Overall Study|Condition under investigation worsened|1|||
30770386|NCT00235391|58779310|FG003|Overall Study|Protocol deviation|11|||
30770387|NCT00235391|58779311|FG004|Overall Study|Protocol deviation|0|||
30770388|NCT00235391|58779312|FG005|Overall Study|Protocol deviation|0|||
30770389|NCT00235391|58779307|FG000|Overall Study|Withdrawal by Subject|2|||
30770390|NCT00235391|58779308|FG001|Overall Study|Withdrawal by Subject|3|||
30770391|NCT00235391|58779309|FG002|Overall Study|Withdrawal by Subject|3|||
30952566|NCT01895777|59001412|FG000|Overall Study|Lost to Follow-up|2|||
30952567|NCT01895777|59001413|FG001|Overall Study|Lost to Follow-up|0|||
30658935|NCT00811473|58671759|FG001|Overall Study|Condition under investigation worsened|3|||
30658936|NCT00811473|58671758|FG000|Overall Study|Other 2|4|||
30658937|NCT00811473|58671759|FG001|Overall Study|Other 2|1|||
30658938|NCT00811473|58671758|FG000|Overall Study|Incorrect Enrollment|1|||
30658939|NCT00811473|58671759|FG001|Overall Study|Incorrect Enrollment|0|||
30658940|NCT00811473|58671758|FG000|Overall Study|Safety Reasons|1|||
30658941|NCT00811473|58671759|FG001|Overall Study|Safety Reasons|0|||
30658942|NCT00617305|58671772|FG000|Overall Study|Adverse Event|4|||
30658943|NCT00617305|58671773|FG001|Overall Study|Adverse Event|0|||
30658944|NCT00617305|58671774|FG002|Overall Study|Adverse Event|0|||
30658945|NCT00617305|58671772|FG000|Overall Study|Death|1|||
30658946|NCT00617305|58671773|FG001|Overall Study|Death|0|||
30658947|NCT00617305|58671774|FG002|Overall Study|Death|0|||
30658948|NCT00617305|58671772|FG000|Overall Study|Physician Decision|1|||
30658949|NCT00617305|58671773|FG001|Overall Study|Physician Decision|0|||
30658950|NCT00617305|58671774|FG002|Overall Study|Physician Decision|0|||
30658951|NCT00617305|58671772|FG000|Overall Study|Protocol Violation|1|||
30658952|NCT00617305|58671773|FG001|Overall Study|Protocol Violation|0|||
30658953|NCT00617305|58671774|FG002|Overall Study|Protocol Violation|1|||
30658954|NCT00617305|58671772|FG000|Overall Study|Withdrawal by Subject|1|||
30658955|NCT00617305|58671773|FG001|Overall Study|Withdrawal by Subject|0|||
30658956|NCT00617305|58671774|FG002|Overall Study|Withdrawal by Subject|0|||
30658957|NCT00811395|58671791|FG000|Extension Treatment|Adverse Event|1|||
30658958|NCT00811395|58671792|FG001|Extension Treatment|Adverse Event|2|||
30658959|NCT00811395|58671793|FG002|Extension Treatment|Adverse Event|2|||
30658960|NCT00811395|58671794|FG003|Extension Treatment|Adverse Event|2|||
30658961|NCT00811395|58671795|FG004|Extension Treatment|Adverse Event|0|||
30658962|NCT00811395|58671796|FG005|Extension Treatment|Adverse Event|1|||
30658963|NCT00811395|58671791|FG000|Extension Treatment|Progressive disease|1|||
30658964|NCT00811395|58671792|FG001|Extension Treatment|Progressive disease|1|||
30658965|NCT00811395|58671793|FG002|Extension Treatment|Progressive disease|0|||
30658966|NCT00811395|58671794|FG003|Extension Treatment|Progressive disease|0|||
30658967|NCT00811395|58671795|FG004|Extension Treatment|Progressive disease|0|||
30658968|NCT00811395|58671796|FG005|Extension Treatment|Progressive disease|0|||
30658969|NCT00811395|58671791|FG000|Extension Treatment|Participant did not wish to continue|0|||
30658970|NCT00811395|58671792|FG001|Extension Treatment|Participant did not wish to continue|3|||
30658971|NCT00811395|58671793|FG002|Extension Treatment|Participant did not wish to continue|0|||
30658972|NCT00811395|58671794|FG003|Extension Treatment|Participant did not wish to continue|1|||
30658973|NCT00811395|58671795|FG004|Extension Treatment|Participant did not wish to continue|0|||
30658974|NCT00811395|58671796|FG005|Extension Treatment|Participant did not wish to continue|1|||
30658975|NCT00811395|58671791|FG000|Extension Treatment|Other than above|0|||
30658976|NCT00811395|58671792|FG001|Extension Treatment|Other than above|0|||
30658977|NCT00811395|58671793|FG002|Extension Treatment|Other than above|1|||
30658978|NCT00811395|58671794|FG003|Extension Treatment|Other than above|0|||
30658979|NCT00811395|58671795|FG004|Extension Treatment|Other than above|0|||
30658980|NCT00811395|58671796|FG005|Extension Treatment|Other than above|0|||
30658981|NCT00955409|58671823|FG000|Overall Study|Lack of Efficacy|1|||
30658982|NCT00955409|58671824|FG001|Overall Study|Lack of Efficacy|0|||
30658983|NCT00955409|58671825|FG002|Overall Study|Lack of Efficacy|0|||
30658984|NCT00955409|58671826|FG003|Overall Study|Lack of Efficacy|0|||
30658985|NCT00955409|58671827|FG004|Overall Study|Lack of Efficacy|0|||
30658986|NCT00955409|58671828|FG005|Overall Study|Lack of Efficacy|0|||
30658987|NCT00955409|58671829|FG006|Overall Study|Lack of Efficacy|0|||
30658988|NCT00955409|58671830|FG007|Overall Study|Lack of Efficacy|0|||
30658989|NCT00955409|58671831|FG008|Overall Study|Lack of Efficacy|0|||
30658990|NCT00955409|58671832|FG009|Overall Study|Lack of Efficacy|0|||
30658991|NCT00955409|58671823|FG000|Overall Study|Withdrawal by Subject|1|||
30658992|NCT00955409|58671824|FG001|Overall Study|Withdrawal by Subject|0|||
30658993|NCT00955409|58671825|FG002|Overall Study|Withdrawal by Subject|5|||
30658994|NCT00955409|58671826|FG003|Overall Study|Withdrawal by Subject|2|||
30658995|NCT00955409|58671827|FG004|Overall Study|Withdrawal by Subject|0|||
30658996|NCT00955409|58671828|FG005|Overall Study|Withdrawal by Subject|0|||
30658997|NCT00955409|58671829|FG006|Overall Study|Withdrawal by Subject|2|||
30658998|NCT00955409|58671830|FG007|Overall Study|Withdrawal by Subject|0|||
30658999|NCT00955409|58671831|FG008|Overall Study|Withdrawal by Subject|1|||
30659000|NCT00955409|58671832|FG009|Overall Study|Withdrawal by Subject|0|||
30659001|NCT00955409|58671823|FG000|Overall Study|Caregiver Request|2|||
30659002|NCT00955409|58671824|FG001|Overall Study|Caregiver Request|0|||
30659003|NCT00955409|58671825|FG002|Overall Study|Caregiver Request|6|||
30659004|NCT00955409|58671826|FG003|Overall Study|Caregiver Request|5|||
30659005|NCT00955409|58671827|FG004|Overall Study|Caregiver Request|0|||
30659006|NCT00955409|58671828|FG005|Overall Study|Caregiver Request|2|||
30659007|NCT00955409|58671829|FG006|Overall Study|Caregiver Request|3|||
30659008|NCT00955409|58671830|FG007|Overall Study|Caregiver Request|1|||
30659009|NCT00955409|58671831|FG008|Overall Study|Caregiver Request|3|||
30659010|NCT00955409|58671832|FG009|Overall Study|Caregiver Request|0|||
30659011|NCT00955409|58671823|FG000|Overall Study|Investigator Request|0|||
30659012|NCT00955409|58671824|FG001|Overall Study|Investigator Request|0|||
30659013|NCT00955409|58671825|FG002|Overall Study|Investigator Request|1|||
30659014|NCT00955409|58671826|FG003|Overall Study|Investigator Request|0|||
30659015|NCT00955409|58671827|FG004|Overall Study|Investigator Request|0|||
30659016|NCT00955409|58671828|FG005|Overall Study|Investigator Request|0|||
30659017|NCT00955409|58671829|FG006|Overall Study|Investigator Request|0|||
30659018|NCT00955409|58671830|FG007|Overall Study|Investigator Request|0|||
30659019|NCT00955409|58671831|FG008|Overall Study|Investigator Request|0|||
30659020|NCT00955409|58671832|FG009|Overall Study|Investigator Request|0|||
30659021|NCT00955409|58671823|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
30659022|NCT00955409|58671824|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
30659023|NCT00955409|58671825|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
30659024|NCT00955409|58671826|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
30659025|NCT00955409|58671827|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
30659026|NCT00955409|58671828|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
30659027|NCT00955409|58671829|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
30659028|NCT00955409|58671830|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
30659029|NCT00955409|58671831|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
30659030|NCT00955409|58671832|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
30659031|NCT00955409|58671823|FG000|Overall Study|Lost to Follow-up|0|||
30659032|NCT00955409|58671824|FG001|Overall Study|Lost to Follow-up|0|||
30659033|NCT00955409|58671825|FG002|Overall Study|Lost to Follow-up|1|||
30659034|NCT00955409|58671826|FG003|Overall Study|Lost to Follow-up|0|||
30659035|NCT00955409|58671827|FG004|Overall Study|Lost to Follow-up|0|||
30659036|NCT00955409|58671828|FG005|Overall Study|Lost to Follow-up|0|||
30659037|NCT00955409|58671829|FG006|Overall Study|Lost to Follow-up|1|||
30659038|NCT00955409|58671830|FG007|Overall Study|Lost to Follow-up|0|||
30659039|NCT00955409|58671831|FG008|Overall Study|Lost to Follow-up|0|||
30659040|NCT00955409|58671832|FG009|Overall Study|Lost to Follow-up|0|||
30659041|NCT00955409|58671823|FG000|Overall Study|Failed to Return|2|||
30659042|NCT00955409|58671824|FG001|Overall Study|Failed to Return|0|||
30659043|NCT00955409|58671825|FG002|Overall Study|Failed to Return|0|||
30659044|NCT00955409|58671826|FG003|Overall Study|Failed to Return|0|||
30659045|NCT00955409|58671827|FG004|Overall Study|Failed to Return|0|||
30659046|NCT00955409|58671828|FG005|Overall Study|Failed to Return|0|||
30659047|NCT00955409|58671829|FG006|Overall Study|Failed to Return|0|||
30659048|NCT00955409|58671830|FG007|Overall Study|Failed to Return|2|||
30659049|NCT00955409|58671831|FG008|Overall Study|Failed to Return|0|||
30659050|NCT00955409|58671832|FG009|Overall Study|Failed to Return|0|||
30659051|NCT00955409|58671823|FG000|Overall Study|Adverse Event (AE)|2|||
30659052|NCT00955409|58671824|FG001|Overall Study|Adverse Event (AE)|0|||
30659053|NCT00955409|58671825|FG002|Overall Study|Adverse Event (AE)|0|||
30659054|NCT00955409|58671826|FG003|Overall Study|Adverse Event (AE)|0|||
30659055|NCT00955409|58671827|FG004|Overall Study|Adverse Event (AE)|0|||
30659056|NCT00955409|58671828|FG005|Overall Study|Adverse Event (AE)|1|||
30659057|NCT00955409|58671829|FG006|Overall Study|Adverse Event (AE)|2|||
30659058|NCT00955409|58671830|FG007|Overall Study|Adverse Event (AE)|0|||
30659059|NCT00955409|58671831|FG008|Overall Study|Adverse Event (AE)|2|||
30659060|NCT00955409|58671832|FG009|Overall Study|Adverse Event (AE)|0|||
30659061|NCT00955409|58671823|FG000|Overall Study|Reason not Specified|2|||
30659062|NCT00955409|58671824|FG001|Overall Study|Reason not Specified|1|||
30659063|NCT00955409|58671825|FG002|Overall Study|Reason not Specified|13|||
30659064|NCT00955409|58671826|FG003|Overall Study|Reason not Specified|1|||
30659065|NCT00955409|58671827|FG004|Overall Study|Reason not Specified|2|||
30659066|NCT00955409|58671828|FG005|Overall Study|Reason not Specified|0|||
30659067|NCT00955409|58671829|FG006|Overall Study|Reason not Specified|16|||
30659068|NCT00955409|58671830|FG007|Overall Study|Reason not Specified|0|||
30659069|NCT00955409|58671831|FG008|Overall Study|Reason not Specified|8|||
30659070|NCT00955409|58671832|FG009|Overall Study|Reason not Specified|1|||
30659071|NCT00615901|58671858|FG000|Overall Study|Withdrawal by Subject|2|||
30849034|NCT02840461|58875750|FG000|Overall Study|Withdrawal by Subject|10|||
30849035|NCT02840461|58875751|FG001|Overall Study|Withdrawal by Subject|6|||
30849036|NCT02840461|58875752|FG002|Overall Study|Withdrawal by Subject|2|||
30849037|NCT02840461|58875750|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
30659072|NCT00615901|58671858|FG000|Overall Study|Adverse Event|7|||
30659073|NCT00616603|58671870|FG000|Overall Study|Physician Decision|2|||
30659074|NCT00616603|58671871|FG001|Overall Study|Physician Decision|0|||
30659075|NCT00616603|58671872|FG002|Overall Study|Physician Decision|2|||
30659076|NCT00810693|58671883|FG000|Treatment Period|Adverse Event|8|||
30659077|NCT00810693|58671884|FG001|Treatment Period|Adverse Event|1|||
30849038|NCT02840461|58875751|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
30659078|NCT00810693|58671885|FG002|Treatment Period|Adverse Event|7|||
30659079|NCT00810693|58671883|FG000|Treatment Period|Death|0|||
30659080|NCT00810693|58671884|FG001|Treatment Period|Death|1|||
30659081|NCT00810693|58671885|FG002|Treatment Period|Death|2|||
30659082|NCT00810693|58671883|FG000|Treatment Period|Lack of Efficacy|0|||
30659083|NCT00810693|58671884|FG001|Treatment Period|Lack of Efficacy|0|||
30659084|NCT00810693|58671885|FG002|Treatment Period|Lack of Efficacy|1|||
30659085|NCT00810693|58671883|FG000|Treatment Period|Lost to Follow-up|1|||
30659086|NCT00810693|58671884|FG001|Treatment Period|Lost to Follow-up|0|||
30659087|NCT00810693|58671885|FG002|Treatment Period|Lost to Follow-up|0|||
30659088|NCT00810693|58671883|FG000|Treatment Period|Non-compliance|1|||
30659089|NCT00810693|58671884|FG001|Treatment Period|Non-compliance|0|||
30659090|NCT00810693|58671885|FG002|Treatment Period|Non-compliance|0|||
30659091|NCT00810693|58671883|FG000|Treatment Period|Protocol Violation|1|||
30659092|NCT00810693|58671884|FG001|Treatment Period|Protocol Violation|2|||
30659093|NCT00810693|58671885|FG002|Treatment Period|Protocol Violation|2|||
30659094|NCT00810693|58671883|FG000|Treatment Period|Withdrawal by Subject|6|||
30659095|NCT00810693|58671884|FG001|Treatment Period|Withdrawal by Subject|2|||
30659096|NCT00810693|58671885|FG002|Treatment Period|Withdrawal by Subject|3|||
30659097|NCT00810693|58671883|FG000|Treatment Period|Not treated|0|||
30659098|NCT00810693|58671884|FG001|Treatment Period|Not treated|1|||
30659099|NCT00810693|58671885|FG002|Treatment Period|Not treated|1|||
30659100|NCT00810693|58671883|FG000|Follow-up Period (FUP)|Adverse Event|3|||
30659101|NCT00810693|58671884|FG001|Follow-up Period (FUP)|Adverse Event|1|||
30659102|NCT00810693|58671885|FG002|Follow-up Period (FUP)|Adverse Event|1|||
30659103|NCT00810693|58671883|FG000|Follow-up Period (FUP)|Death|2|||
30659104|NCT00810693|58671884|FG001|Follow-up Period (FUP)|Death|0|||
30659105|NCT00810693|58671885|FG002|Follow-up Period (FUP)|Death|1|||
30659106|NCT00810693|58671883|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
30659107|NCT00810693|58671884|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
30659108|NCT00810693|58671885|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
30659109|NCT00810693|58671883|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
30659110|NCT00810693|58671884|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
30659111|NCT00810693|58671885|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
30659112|NCT00810693|58671883|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
30659113|NCT00810693|58671884|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
30659114|NCT00810693|58671885|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
30659115|NCT00573313|58671897|FG000|Overall Study|Protocol Violation|5|||
30659116|NCT00573313|58671898|FG001|Overall Study|Protocol Violation|0|||
30659117|NCT00573313|58671899|FG002|Overall Study|Protocol Violation|6|||
30659118|NCT00573313|58671900|FG003|Overall Study|Protocol Violation|0|||
30659119|NCT00953615|58671907|FG000|Overall Study|Adverse Event|1|||
30659120|NCT00810615|58671913|FG000|Overall Study|Withdrawal by Subject|1|||
30659121|NCT00810615|58671914|FG001|Overall Study|Withdrawal by Subject|1|||
30659122|NCT00573391|58671934|FG000|Overall Study|study stopped|2|||
30659123|NCT00573391|58671935|FG001|Overall Study|study stopped|2|||
30659124|NCT00573391|58671934|FG000|Overall Study|Death|1|||
30659125|NCT00573391|58671935|FG001|Overall Study|Death|0|||
30659126|NCT00590967|58671943|FG000|Overall Study|Withdrawal by Subject|1|||
30659127|NCT00590967|58671944|FG001|Overall Study|Withdrawal by Subject|1|||
30659128|NCT00590967|58671943|FG000|Overall Study|Ineligible|1|||
30659129|NCT00590967|58671944|FG001|Overall Study|Ineligible|0|||
30659130|NCT00590967|58671943|FG000|Overall Study|Poor performance status|0|||
30659131|NCT00590967|58671944|FG001|Overall Study|Poor performance status|1|||
30659132|NCT00590967|58671943|FG000|Overall Study|Non-compliant|0|||
30659133|NCT00590967|58671944|FG001|Overall Study|Non-compliant|2|||
30659134|NCT00590967|58671943|FG000|Overall Study|Did not sign consent form|0|||
30659135|NCT00590967|58671944|FG001|Overall Study|Did not sign consent form|1|||
30659136|NCT00590967|58671943|FG000|Overall Study|Did not receive chemo per protocol|1|||
30659137|NCT00590967|58671944|FG001|Overall Study|Did not receive chemo per protocol|0|||
30659138|NCT00590577|58671954|FG000|Overall Study|Lack of Efficacy|31|||
30659139|NCT00590577|58671955|FG001|Overall Study|Lack of Efficacy|28|||
30659140|NCT00590577|58671956|FG002|Overall Study|Lack of Efficacy|23|||
30659141|NCT00590577|58671957|FG003|Overall Study|Lack of Efficacy|45|||
30849039|NCT02840461|58875752|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
30952568|NCT01895777|59001412|FG000|Overall Study|Not treated|1|||
30952569|NCT01895777|59001413|FG001|Overall Study|Not treated|0|||
30659142|NCT00590577|58671954|FG000|Overall Study|Withdrawal by Subject|23|||
30659143|NCT00590577|58671955|FG001|Overall Study|Withdrawal by Subject|28|||
30659144|NCT00590577|58671956|FG002|Overall Study|Withdrawal by Subject|30|||
30659145|NCT00590577|58671957|FG003|Overall Study|Withdrawal by Subject|26|||
30659146|NCT00590577|58671954|FG000|Overall Study|Adverse Event|10|||
30659147|NCT00590577|58671955|FG001|Overall Study|Adverse Event|10|||
30659148|NCT00590577|58671956|FG002|Overall Study|Adverse Event|13|||
30659149|NCT00590577|58671957|FG003|Overall Study|Adverse Event|11|||
30659150|NCT00590577|58671954|FG000|Overall Study|Lost to Follow-up|12|||
30659151|NCT00590577|58671955|FG001|Overall Study|Lost to Follow-up|6|||
30659152|NCT00590577|58671956|FG002|Overall Study|Lost to Follow-up|6|||
30659153|NCT00590577|58671957|FG003|Overall Study|Lost to Follow-up|9|||
30659154|NCT00590577|58671954|FG000|Overall Study|Pregnancy|0|||
30659155|NCT00590577|58671955|FG001|Overall Study|Pregnancy|1|||
30659156|NCT00590577|58671956|FG002|Overall Study|Pregnancy|0|||
30659157|NCT00590577|58671957|FG003|Overall Study|Pregnancy|0|||
30952570|NCT01895777|59001412|FG000|Overall Study|Other reasons|3|||
30659158|NCT00590577|58671954|FG000|Overall Study|Various reasons|1|||
30659159|NCT00590577|58671955|FG001|Overall Study|Various reasons|3|||
30659160|NCT00590577|58671956|FG002|Overall Study|Various reasons|1|||
30659161|NCT00590577|58671957|FG003|Overall Study|Various reasons|2|||
30659162|NCT00614575|58671967|FG000|Overall Study|Adverse Event|106|||
30659163|NCT00614575|58671967|FG000|Overall Study|Lost to Follow-up|55|||
30659164|NCT00614575|58671967|FG000|Overall Study|Lack of Efficacy|14|||
30659165|NCT00614575|58671967|FG000|Overall Study|Withdrawal by Subject|6|||
30659166|NCT00614575|58671967|FG000|Overall Study|Death|3|||
30659167|NCT00614575|58671967|FG000|Overall Study|Physician Decision|2|||
30659168|NCT00614575|58671967|FG000|Overall Study|No data were collected.|18|||
30659169|NCT00614575|58671967|FG000|Overall Study|Irregularly enrolled patients|23|||
30659170|NCT00614575|58671967|FG000|Overall Study|No treatment|1|||
30659171|NCT00805935|58671975|FG000|Overall Study|Stimulation Failure|1|||
30659172|NCT00805935|58671976|FG001|Overall Study|Stimulation Failure|5|||
30659173|NCT00805935|58671977|FG002|Overall Study|Stimulation Failure|2|||
30659174|NCT00805935|58671978|FG003|Overall Study|Stimulation Failure|2|||
30659175|NCT00805935|58671975|FG000|Overall Study|Cycle cancelled|0|||
30659176|NCT00805935|58671976|FG001|Overall Study|Cycle cancelled|0|||
30659177|NCT00805935|58671977|FG002|Overall Study|Cycle cancelled|2|||
30659178|NCT00805935|58671978|FG003|Overall Study|Cycle cancelled|0|||
30659179|NCT00805935|58671975|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
30770392|NCT00235391|58779310|FG003|Overall Study|Withdrawal by Subject|61|||
30770393|NCT00235391|58779311|FG004|Overall Study|Withdrawal by Subject|5|||
30770394|NCT00235391|58779312|FG005|Overall Study|Withdrawal by Subject|0|||
30770395|NCT00235391|58779307|FG000|Overall Study|Lost to Follow-up|0|||
30770396|NCT00235391|58779308|FG001|Overall Study|Lost to Follow-up|3|||
30770397|NCT00235391|58779309|FG002|Overall Study|Lost to Follow-up|3|||
30770398|NCT00235391|58779310|FG003|Overall Study|Lost to Follow-up|16|||
30770399|NCT00235391|58779311|FG004|Overall Study|Lost to Follow-up|0|||
30770400|NCT00235391|58779312|FG005|Overall Study|Lost to Follow-up|0|||
30770401|NCT00235391|58779307|FG000|Overall Study|Administrative problems|0|||
30770402|NCT00235391|58779308|FG001|Overall Study|Administrative problems|0|||
30770403|NCT00235391|58779309|FG002|Overall Study|Administrative problems|0|||
30770404|NCT00235391|58779310|FG003|Overall Study|Administrative problems|1|||
30770405|NCT00235391|58779311|FG004|Overall Study|Administrative problems|0|||
30770406|NCT00235391|58779312|FG005|Overall Study|Administrative problems|0|||
30770407|NCT00235391|58779307|FG000|Overall Study|Death|0|||
30659180|NCT00805935|58671976|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
30659181|NCT00805935|58671977|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
30659182|NCT00805935|58671978|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
30659183|NCT00805935|58671975|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
30659184|NCT00805935|58671976|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
30659185|NCT00805935|58671977|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
30659186|NCT00805935|58671978|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
30659187|NCT00805935|58671975|FG000|Overall Study|Lost to Follow-up|1|||
30659188|NCT00805935|58671976|FG001|Overall Study|Lost to Follow-up|0|||
30659189|NCT00805935|58671977|FG002|Overall Study|Lost to Follow-up|0|||
30659190|NCT00805935|58671978|FG003|Overall Study|Lost to Follow-up|0|||
30659191|NCT00805935|58671975|FG000|Overall Study|No positive serum pregnancy|8|||
30659192|NCT00805935|58671976|FG001|Overall Study|No positive serum pregnancy|7|||
30659193|NCT00805935|58671977|FG002|Overall Study|No positive serum pregnancy|6|||
30659194|NCT00805935|58671978|FG003|Overall Study|No positive serum pregnancy|5|||
30659195|NCT00805935|58671975|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
30659196|NCT00805935|58671976|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
30659197|NCT00805935|58671977|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
30659198|NCT00805935|58671978|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
30659199|NCT00805935|58671975|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
30659200|NCT00805935|58671976|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
30659201|NCT00805935|58671977|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
30659202|NCT00805935|58671978|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
30659203|NCT00805935|58671975|FG000|Overall Study|Biochemical pregnancy|0|||
30659204|NCT00805935|58671976|FG001|Overall Study|Biochemical pregnancy|1|||
30770408|NCT00235391|58779308|FG001|Overall Study|Death|0|||
30849040|NCT02839681|58875761|FG000|Overall Study|Death|2|||
30659205|NCT00805935|58671977|FG002|Overall Study|Biochemical pregnancy|0|||
30770409|NCT00235391|58779309|FG002|Overall Study|Death|1|||
30659206|NCT00805935|58671978|FG003|Overall Study|Biochemical pregnancy|0|||
30659207|NCT00805935|58671975|FG000|Overall Study|Chemical pregnancy|0|||
30659208|NCT00805935|58671976|FG001|Overall Study|Chemical pregnancy|5|||
30659209|NCT00805935|58671977|FG002|Overall Study|Chemical pregnancy|3|||
30659210|NCT00805935|58671978|FG003|Overall Study|Chemical pregnancy|2|||
30659211|NCT00805935|58671975|FG000|Overall Study|Ectopic pregnancy|0|||
30770410|NCT00235391|58779310|FG003|Overall Study|Death|4|||
30770411|NCT00235391|58779311|FG004|Overall Study|Death|0|||
30770412|NCT00235391|58779312|FG005|Overall Study|Death|0|||
30770413|NCT00234533|58779356|FG000|Overall Study|Withdrawal by Subject|6|||
30659212|NCT00805935|58671976|FG001|Overall Study|Ectopic pregnancy|0|||
30659213|NCT00805935|58671977|FG002|Overall Study|Ectopic pregnancy|1|||
30659214|NCT00805935|58671978|FG003|Overall Study|Ectopic pregnancy|0|||
30659215|NCT00805935|58671975|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
30659216|NCT00805935|58671976|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
30659217|NCT00805935|58671977|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
30659218|NCT00805935|58671978|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
30659219|NCT00805545|58671992|FG000|Overall Study|Protocol Violation|3|||
30659220|NCT00805545|58671993|FG001|Overall Study|Protocol Violation|2|||
30659221|NCT00805545|58671992|FG000|Overall Study|Protocol Violation|3|||
30659222|NCT00805545|58671993|FG001|Overall Study|Protocol Violation|1|||
30659223|NCT00590031|58672025|FG000|Overall Study|Adverse Event|3|||
30659224|NCT00590031|58672025|FG000|Overall Study|Withdrawal by Subject|1|||
30659225|NCT00590031|58672025|FG000|Overall Study|Metastatic Disease|1|||
30659226|NCT00590031|58672025|FG000|Overall Study|Admin Hold|1|||
30659227|NCT00615199|58672033|FG000|Overall Study|Adverse Event|3|||
30659228|NCT00615199|58672034|FG001|Overall Study|Adverse Event|1|||
30659229|NCT00615199|58672035|FG002|Overall Study|Adverse Event|1|||
30659230|NCT00615199|58672036|FG003|Overall Study|Adverse Event|0|||
30659231|NCT00615199|58672033|FG000|Overall Study|Lack of Efficacy|2|||
30659232|NCT00615199|58672034|FG001|Overall Study|Lack of Efficacy|0|||
30659233|NCT00615199|58672035|FG002|Overall Study|Lack of Efficacy|0|||
30659234|NCT00615199|58672036|FG003|Overall Study|Lack of Efficacy|1|||
30659235|NCT00615199|58672033|FG000|Overall Study|Lost to Follow-up|1|||
30659236|NCT00615199|58672034|FG001|Overall Study|Lost to Follow-up|0|||
30659237|NCT00615199|58672035|FG002|Overall Study|Lost to Follow-up|0|||
30659238|NCT00615199|58672036|FG003|Overall Study|Lost to Follow-up|0|||
30659239|NCT00615199|58672033|FG000|Overall Study|Other|0|||
30659240|NCT00615199|58672034|FG001|Overall Study|Other|0|||
30659241|NCT00615199|58672035|FG002|Overall Study|Other|0|||
30659242|NCT00615199|58672036|FG003|Overall Study|Other|1|||
30659243|NCT00615199|58672033|FG000|Overall Study|Withdrawal by Subject|2|||
30659244|NCT00615199|58672034|FG001|Overall Study|Withdrawal by Subject|1|||
30659245|NCT00615199|58672035|FG002|Overall Study|Withdrawal by Subject|0|||
30659246|NCT00615199|58672036|FG003|Overall Study|Withdrawal by Subject|0|||
30659247|NCT00613951|58672049|FG000|Overall Study|Adverse Event|1|||
30659248|NCT00613951|58672050|FG001|Overall Study|Adverse Event|0|||
30659249|NCT00613951|58672051|FG002|Overall Study|Adverse Event|1|||
30659250|NCT00613951|58672049|FG000|Overall Study|Lack of Efficacy|0|||
30659251|NCT00613951|58672050|FG001|Overall Study|Lack of Efficacy|1|||
30659252|NCT00613951|58672051|FG002|Overall Study|Lack of Efficacy|1|||
30659253|NCT00613951|58672049|FG000|Overall Study|Protocol Violation|1|||
30659254|NCT00613951|58672050|FG001|Overall Study|Protocol Violation|1|||
30659255|NCT00613951|58672051|FG002|Overall Study|Protocol Violation|1|||
30659256|NCT00613951|58672049|FG000|Overall Study|Unclassified|5|||
30659257|NCT00613951|58672050|FG001|Overall Study|Unclassified|3|||
30659258|NCT00613951|58672051|FG002|Overall Study|Unclassified|2|||
30659259|NCT00805467|58672066|FG000|Overall Study|Lack of Efficacy|0|||
30659260|NCT00805467|58672067|FG001|Overall Study|Lack of Efficacy|8|||
30659261|NCT00805467|58672068|FG002|Overall Study|Lack of Efficacy|13|||
30659262|NCT00805467|58672069|FG003|Overall Study|Lack of Efficacy|86|||
30659263|NCT00805467|58672066|FG000|Overall Study|Lost to Follow-up|0|||
30659264|NCT00805467|58672067|FG001|Overall Study|Lost to Follow-up|1|||
30659265|NCT00805467|58672068|FG002|Overall Study|Lost to Follow-up|7|||
30659266|NCT00805467|58672069|FG003|Overall Study|Lost to Follow-up|21|||
30659267|NCT00805467|58672066|FG000|Overall Study|Withdrawal by Subject|0|||
30659268|NCT00805467|58672067|FG001|Overall Study|Withdrawal by Subject|6|||
30659269|NCT00805467|58672068|FG002|Overall Study|Withdrawal by Subject|45|||
30659270|NCT00805467|58672069|FG003|Overall Study|Withdrawal by Subject|50|||
30659271|NCT00805467|58672066|FG000|Overall Study|Protocol Violation|0|||
30659272|NCT00805467|58672067|FG001|Overall Study|Protocol Violation|3|||
30659273|NCT00805467|58672068|FG002|Overall Study|Protocol Violation|0|||
30659274|NCT00805467|58672069|FG003|Overall Study|Protocol Violation|5|||
30659275|NCT00805467|58672066|FG000|Overall Study|Adverse Event|0|||
30659276|NCT00805467|58672067|FG001|Overall Study|Adverse Event|13|||
30659277|NCT00805467|58672068|FG002|Overall Study|Adverse Event|26|||
30659278|NCT00805467|58672069|FG003|Overall Study|Adverse Event|57|||
30770414|NCT00234533|58779356|FG000|Overall Study|Adverse Event|2|||
30659279|NCT00805467|58672066|FG000|Overall Study|Death|0|||
30659280|NCT00805467|58672067|FG001|Overall Study|Death|2|||
30659281|NCT00805467|58672068|FG002|Overall Study|Death|7|||
30659282|NCT00805467|58672069|FG003|Overall Study|Death|5|||
30659283|NCT00805467|58672066|FG000|Overall Study|Physician Decision|0|||
30659284|NCT00805467|58672067|FG001|Overall Study|Physician Decision|1|||
30659285|NCT00805467|58672068|FG002|Overall Study|Physician Decision|2|||
30659286|NCT00805467|58672069|FG003|Overall Study|Physician Decision|6|||
30659287|NCT00805467|58672066|FG000|Overall Study|Not reported|0|||
30659288|NCT00805467|58672067|FG001|Overall Study|Not reported|0|||
30659289|NCT00805467|58672068|FG002|Overall Study|Not reported|3|||
30659290|NCT00805467|58672069|FG003|Overall Study|Not reported|7|||
30659291|NCT00958841|58672079|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30659292|NCT00958841|58672079|FG000|Overall Study|Abnormal test procedure result(s)|3|||
30659293|NCT00958841|58672079|FG000|Overall Study|Administrative problems|1|||
30659294|NCT00958841|58672079|FG000|Overall Study|Adverse Event|8|||
30659295|NCT00958841|58672079|FG000|Overall Study|New cancer therapy|5|||
30659296|NCT00958841|58672079|FG000|Overall Study|Withdrawal by Subject|1|||
30659297|NCT00958841|58672079|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
30659298|NCT00958841|58672079|FG000|Overall Study|Completed M6/did not enter extension|27|||
30659299|NCT00958841|58672079|FG000|Overall Study|Discontinued prior to M*|28|||
30659300|NCT03927105|58672142|FG000|Overall Study|Death|1|||
30659301|NCT03927105|58672142|FG000|Overall Study|In observation for potential re-treatment|2|||
30659302|NCT03927105|58672142|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
30659303|NCT00613327|58672146|FG000|Overall Study|Adverse Event|38|||
30659304|NCT00613327|58672146|FG000|Overall Study|Lost to Follow-up|8|||
30659305|NCT00613327|58672146|FG000|Overall Study|Withdrawal by Subject|6|||
30659306|NCT00613327|58672146|FG000|Overall Study|Protocol Violation|2|||
30659307|NCT00613327|58672146|FG000|Overall Study|Other|47|||
30659308|NCT00954941|58672152|FG000|Overall Study|Received treatment at home|1|||
30659309|NCT00954941|58672153|FG001|Overall Study|Received treatment at home|0|||
30659310|NCT00954941|58672152|FG000|Overall Study|Withdrawal by Subject|1|||
30659311|NCT00954941|58672153|FG001|Overall Study|Withdrawal by Subject|0|||
30659312|NCT00954941|58672152|FG000|Overall Study|Insurance Denial|2|||
30659313|NCT00954941|58672153|FG001|Overall Study|Insurance Denial|2|||
30659314|NCT00954941|58672152|FG000|Overall Study|Physician Decision|2|||
30659315|NCT00954941|58672153|FG001|Overall Study|Physician Decision|2|||
30659316|NCT00954941|58672152|FG000|Overall Study|Ineligible|2|||
30659317|NCT00954941|58672153|FG001|Overall Study|Ineligible|2|||
30659318|NCT00954941|58672152|FG000|Overall Study|Adverse Event|0|||
30659319|NCT00954941|58672153|FG001|Overall Study|Adverse Event|1|||
30659320|NCT00954707|58672159|FG000|Overall Study|Death|34|||
30659321|NCT00954707|58672159|FG000|Overall Study|Withdrawal by Subject|100|||
30659322|NCT00954707|58672159|FG000|Overall Study|Lost to Follow-up|33|||
30659323|NCT00589797|58672165|FG000|Overall Study|Death|1|||
30659324|NCT00589797|58672166|FG001|Overall Study|Death|0|||
30659325|NCT00589797|58672165|FG000|Overall Study|Lost to Follow-up|12|||
30659326|NCT00589797|58672166|FG001|Overall Study|Lost to Follow-up|9|||
30659327|NCT00589797|58672165|FG000|Overall Study|Physician Decision|8|||
30659328|NCT00589797|58672166|FG001|Overall Study|Physician Decision|3|||
30659329|NCT00589797|58672165|FG000|Overall Study|Withdrawal by Subject|6|||
30659330|NCT00589797|58672166|FG001|Overall Study|Withdrawal by Subject|5|||
30659331|NCT00589797|58672165|FG000|Overall Study|Non-Randomized Training Subjects|46|||
30659332|NCT00589797|58672166|FG001|Overall Study|Non-Randomized Training Subjects|6|||
30659333|NCT00613171|58672172|FG000|Overall Study|Adverse Event|7|||
30659334|NCT00613171|58672172|FG000|Overall Study|Withdrawal by Subject|3|||
30659335|NCT00613171|58672172|FG000|Overall Study|Reason not Specified|4|||
30659336|NCT00896480|58672177|FG000|Overall Study|Disease progression/recurrence|21|||
30659337|NCT00953225|58672186|FG000|Overall Study|Withdrawal by Subject|2|||
30659338|NCT00953225|58672187|FG001|Overall Study|Withdrawal by Subject|0|||
30659339|NCT00613015|58672199|FG000|Overall Study|Lost to Follow-up|0|||
30659340|NCT00613015|58672200|FG001|Overall Study|Lost to Follow-up|1|||
30659341|NCT00613015|58672201|FG002|Overall Study|Lost to Follow-up|3|||
30659342|NCT00613015|58672202|FG003|Overall Study|Lost to Follow-up|3|||
30659343|NCT00613015|58672203|FG004|Overall Study|Lost to Follow-up|2|||
30659344|NCT00613015|58672204|FG005|Overall Study|Lost to Follow-up|3|||
30659345|NCT00803595|58672221|FG000|Overall Study|Adverse Event|3|||
30659346|NCT00803595|58672222|FG001|Overall Study|Adverse Event|4|||
30659347|NCT00803595|58672223|FG002|Overall Study|Adverse Event|1|||
30659348|NCT00803595|58672221|FG000|Overall Study|Protocol Violation|7|||
30659349|NCT00803595|58672222|FG001|Overall Study|Protocol Violation|2|||
30659350|NCT00803595|58672223|FG002|Overall Study|Protocol Violation|12|||
30659351|NCT00803595|58672221|FG000|Overall Study|Withdrawal by Subject|5|||
30659352|NCT00803595|58672222|FG001|Overall Study|Withdrawal by Subject|2|||
30659353|NCT00803595|58672223|FG002|Overall Study|Withdrawal by Subject|3|||
30659354|NCT00953927|58672233|FG000|Overall Study|Lost to Follow-up|61|||
30659355|NCT00953927|58672234|FG001|Overall Study|Lost to Follow-up|65|||
30659356|NCT00953927|58672233|FG000|Overall Study|Withdrawal by Subject|36|||
30659357|NCT00953927|58672234|FG001|Overall Study|Withdrawal by Subject|25|||
30659358|NCT00953927|58672233|FG000|Overall Study|Death|7|||
30659359|NCT00953927|58672234|FG001|Overall Study|Death|4|||
30659360|NCT00953927|58672233|FG000|Overall Study|Other study discontinuation|1|||
30659361|NCT00953927|58672234|FG001|Overall Study|Other study discontinuation|1|||
30659362|NCT00611767|58672242|FG000|Overall Study|Withdrawal by Subject|4|||
30659363|NCT00611767|58672243|FG001|Overall Study|Withdrawal by Subject|1|||
30659364|NCT00611767|58672242|FG000|Overall Study|Thiopental not available|3|||
30659365|NCT00611767|58672243|FG001|Overall Study|Thiopental not available|0|||
30659366|NCT00611767|58672242|FG000|Overall Study|didn't like the medication|1|||
30659367|NCT00611767|58672243|FG001|Overall Study|didn't like the medication|1|||
30659368|NCT00611767|58672242|FG000|Overall Study|Physician Decision|1|||
30659369|NCT00611767|58672243|FG001|Overall Study|Physician Decision|0|||
30952571|NCT01895777|59001413|FG001|Overall Study|Other reasons|2|||
30952572|NCT01895777|59001412|FG000|Overall Study|Non-compliance with the CTP|2|||
30952573|NCT01895777|59001413|FG001|Overall Study|Non-compliance with the CTP|1|||
30659370|NCT00803361|58672251|FG000|Overall Study|Adverse Event|13|||
30659371|NCT00803361|58672252|FG001|Overall Study|Adverse Event|3|||
30659372|NCT00803361|58672251|FG000|Overall Study|Lack of Efficacy|4|||
30659373|NCT00803361|58672252|FG001|Overall Study|Lack of Efficacy|13|||
30659374|NCT00803361|58672251|FG000|Overall Study|Lost to Follow-up|1|||
30659375|NCT00803361|58672252|FG001|Overall Study|Lost to Follow-up|2|||
30659376|NCT00803361|58672251|FG000|Overall Study|Physician Decision|1|||
30659377|NCT00803361|58672252|FG001|Overall Study|Physician Decision|0|||
30659378|NCT00803361|58672251|FG000|Overall Study|Protocol Violation|2|||
30659379|NCT00803361|58672252|FG001|Overall Study|Protocol Violation|4|||
30659380|NCT00803361|58672251|FG000|Overall Study|Withdrawal by Subject|5|||
30659381|NCT00803361|58672252|FG001|Overall Study|Withdrawal by Subject|6|||
30659382|NCT00611533|58672258|FG000|First Intervention (6 Weeks)|Never started study|0|||
30659383|NCT00611533|58672259|FG001|First Intervention (6 Weeks)|Never started study|1|||
30659384|NCT00611533|58672258|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
30659385|NCT00611533|58672259|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
30659386|NCT00611533|58672258|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
30659387|NCT00611533|58672259|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
30659388|NCT00953147|58672278|FG000|Overall Study|Adverse Event|8|||
30659389|NCT00953147|58672279|FG001|Overall Study|Adverse Event|16|||
30659390|NCT00953147|58672280|FG002|Overall Study|Adverse Event|6|||
30659391|NCT00953147|58672278|FG000|Overall Study|Protocol Violation|2|||
30659392|NCT00953147|58672279|FG001|Overall Study|Protocol Violation|8|||
30659393|NCT00953147|58672280|FG002|Overall Study|Protocol Violation|4|||
30659394|NCT00953147|58672278|FG000|Overall Study|Withdrawal by Subject|13|||
30659395|NCT00953147|58672279|FG001|Overall Study|Withdrawal by Subject|15|||
30659396|NCT00953147|58672280|FG002|Overall Study|Withdrawal by Subject|12|||
30659397|NCT00953147|58672278|FG000|Overall Study|Lost to Follow-up|8|||
30659398|NCT00953147|58672279|FG001|Overall Study|Lost to Follow-up|9|||
30659399|NCT00953147|58672280|FG002|Overall Study|Lost to Follow-up|4|||
30659400|NCT00953147|58672278|FG000|Overall Study|Physician Decision|2|||
30659401|NCT00953147|58672279|FG001|Overall Study|Physician Decision|7|||
30659402|NCT00953147|58672280|FG002|Overall Study|Physician Decision|3|||
30659403|NCT00953147|58672278|FG000|Overall Study|Other|4|||
30659404|NCT00953147|58672279|FG001|Overall Study|Other|11|||
30659405|NCT00953147|58672280|FG002|Overall Study|Other|13|||
30659406|NCT00803205|58672290|FG000|Overall Study|Adverse Event|7|||
30659407|NCT00803205|58672291|FG001|Overall Study|Adverse Event|2|||
30659408|NCT00803205|58672290|FG000|Overall Study|Lost to Follow-up|1|||
30659409|NCT00803205|58672291|FG001|Overall Study|Lost to Follow-up|0|||
30659410|NCT00803205|58672290|FG000|Overall Study|Withdrawal by Subject|9|||
30659411|NCT00803205|58672291|FG001|Overall Study|Withdrawal by Subject|9|||
30659412|NCT00803205|58672290|FG000|Overall Study|Physician Decision|1|||
30952574|NCT01885559|59001441|FG000|Overall Study|Lost to Follow-up|15|||
30952575|NCT01885559|59001442|FG001|Overall Study|Lost to Follow-up|16|||
30952576|NCT01885559|59001441|FG000|Overall Study|Less than full participation|9|||
30952577|NCT01885559|59001442|FG001|Overall Study|Less than full participation|19|||
30952578|NCT01885559|59001441|FG000|Overall Study|Protocol Violation|0|||
30952579|NCT01885559|59001442|FG001|Overall Study|Protocol Violation|1|||
30952580|NCT01884545|59001452|FG000|Overall Study|Lost to Follow-up|6|||
30952581|NCT01884545|59001453|FG001|Overall Study|Lost to Follow-up|4|||
30952582|NCT01884545|59001454|FG002|Overall Study|Lost to Follow-up|9|||
30952583|NCT01884545|59001455|FG003|Overall Study|Lost to Follow-up|4|||
30952584|NCT01884545|59001452|FG000|Overall Study|Patient withdrawn|7|||
30952585|NCT01884545|59001453|FG001|Overall Study|Patient withdrawn|12|||
30952586|NCT01884545|59001454|FG002|Overall Study|Patient withdrawn|5|||
30952587|NCT01884545|59001455|FG003|Overall Study|Patient withdrawn|5|||
30952588|NCT01884545|59001452|FG000|Overall Study|Non-adherence|0|||
30659413|NCT00803205|58672291|FG001|Overall Study|Physician Decision|0|||
30659414|NCT00803205|58672290|FG000|Overall Study|Protocol Violation|1|||
30952589|NCT01884545|59001453|FG001|Overall Study|Non-adherence|2|||
30952590|NCT01884545|59001454|FG002|Overall Study|Non-adherence|0|||
30952591|NCT01884545|59001455|FG003|Overall Study|Non-adherence|0|||
30659415|NCT00803205|58672291|FG001|Overall Study|Protocol Violation|1|||
30659416|NCT00803205|58672290|FG000|Overall Study|Medical Monitor Decision|1|||
30659417|NCT00803205|58672291|FG001|Overall Study|Medical Monitor Decision|0|||
30659418|NCT00803205|58672290|FG000|Overall Study|Acquired a Lung Infection|0|||
30659419|NCT00803205|58672291|FG001|Overall Study|Acquired a Lung Infection|1|||
30659420|NCT00803205|58672290|FG000|Overall Study|Sponsor Decision|0|||
30659421|NCT00803205|58672291|FG001|Overall Study|Sponsor Decision|1|||
30952592|NCT01895543|59001465|FG000|Overall Study|Withdrawal by Subject|43|||
30952593|NCT01895543|59001465|FG000|Overall Study|Lost to Follow-up|25|||
30952594|NCT01895543|59001465|FG000|Overall Study|Adverse Event|28|||
30952595|NCT01895543|59001465|FG000|Overall Study|Subject's substantial non-compliance|6|||
30770415|NCT00234533|58779356|FG000|Overall Study|Enrolled but not treated|3|||
30770416|NCT00026208|58779363|FG000|Overall Study|Complications of auto accident|1|||
30659422|NCT00952523|58672297|FG000|Overall Study|Withdrawal by Subject|7|||
30659423|NCT02232737|58672306|FG000|Overall Study|Lost to Follow-up|18|||
30659424|NCT02232737|58672307|FG001|Overall Study|Lost to Follow-up|28|||
30659425|NCT02232737|58672308|FG002|Overall Study|Lost to Follow-up|33|||
30659426|NCT02232737|58672306|FG000|Overall Study|Personal reasons|7|||
30659427|NCT02232737|58672307|FG001|Overall Study|Personal reasons|8|||
30659428|NCT02232737|58672308|FG002|Overall Study|Personal reasons|14|||
30659429|NCT02232737|58672306|FG000|Overall Study|Adverse Event|6|||
30659430|NCT02232737|58672307|FG001|Overall Study|Adverse Event|3|||
30659431|NCT02232737|58672308|FG002|Overall Study|Adverse Event|8|||
30659432|NCT02232737|58672306|FG000|Overall Study|Incarcerated|2|||
30659433|NCT02232737|58672307|FG001|Overall Study|Incarcerated|1|||
30659434|NCT02232737|58672308|FG002|Overall Study|Incarcerated|2|||
30659435|NCT02232737|58672306|FG000|Overall Study|Withdrawal by Subject|0|||
30659436|NCT02232737|58672307|FG001|Overall Study|Withdrawal by Subject|1|||
30659437|NCT02232737|58672308|FG002|Overall Study|Withdrawal by Subject|2|||
30659438|NCT02232737|58672306|FG000|Overall Study|Death|0|||
30659439|NCT02232737|58672307|FG001|Overall Study|Death|1|||
30659440|NCT02232737|58672308|FG002|Overall Study|Death|1|||
30659441|NCT02232737|58672306|FG000|Overall Study|Physician Decision|1|||
30659442|NCT02232737|58672307|FG001|Overall Study|Physician Decision|3|||
30659443|NCT02232737|58672308|FG002|Overall Study|Physician Decision|1|||
30659444|NCT02232737|58672306|FG000|Overall Study|Protocol Violation|1|||
30659445|NCT02232737|58672307|FG001|Overall Study|Protocol Violation|0|||
30659446|NCT02232737|58672308|FG002|Overall Study|Protocol Violation|1|||
30659447|NCT02232737|58672306|FG000|Overall Study|Reason unknown|1|||
30659448|NCT02232737|58672307|FG001|Overall Study|Reason unknown|0|||
30659449|NCT02232737|58672308|FG002|Overall Study|Reason unknown|0|||
30659450|NCT00952367|58672316|FG000|Overall Study|Withdrawal by Subject|2|||
30659451|NCT00952367|58672316|FG000|Overall Study|Noncoordination|1|||
30659452|NCT00952367|58672316|FG000|Overall Study|Protocol Violation|3|||
30659453|NCT00948857|58672322|FG000|Overall Study|Lost to Follow-up|1|||
30659454|NCT00948857|58672323|FG001|Overall Study|Lost to Follow-up|0|||
30659455|NCT00948389|58672338|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
30659456|NCT00948389|58672339|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
30659457|NCT00948389|58672340|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
30659458|NCT00948389|58672341|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
30659459|NCT00948389|58672342|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
30659460|NCT00948389|58672338|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
30659461|NCT00948389|58672339|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
30659462|NCT00948389|58672340|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
30659463|NCT00948389|58672341|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
30659464|NCT00948389|58672342|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
30659465|NCT00948389|58672338|FG000|Overall Study|Both Progression and Toxicity|1|||
30659466|NCT00948389|58672339|FG001|Overall Study|Both Progression and Toxicity|0|||
30659467|NCT00948389|58672340|FG002|Overall Study|Both Progression and Toxicity|0|||
30659468|NCT00948389|58672341|FG003|Overall Study|Both Progression and Toxicity|0|||
30659469|NCT00948389|58672342|FG004|Overall Study|Both Progression and Toxicity|0|||
30659470|NCT00948155|58672358|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
30659471|NCT00948155|58672359|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
30659472|NCT00948155|58672358|FG000|Washout 14 Days|Lost to Follow-up|1|||
30659473|NCT00948155|58672359|FG001|Washout 14 Days|Lost to Follow-up|2|||
30659474|NCT00958217|58672369|FG000|Overall Study|Death|2|||
30659475|NCT00958217|58672370|FG001|Overall Study|Death|1|||
30659476|NCT00958217|58672369|FG000|Overall Study|Withdrawal by Subject|4|||
30659477|NCT00958217|58672370|FG001|Overall Study|Withdrawal by Subject|3|||
30659478|NCT00958217|58672369|FG000|Overall Study|Lost to Follow-up|17|||
30659479|NCT00958217|58672370|FG001|Overall Study|Lost to Follow-up|19|||
30659480|NCT00958217|58672369|FG000|Overall Study|Moved out of area|1|||
30659481|NCT00958217|58672370|FG001|Overall Study|Moved out of area|1|||
30659482|NCT00958217|58672369|FG000|Overall Study|Inpatient hospitalization|0|||
30770417|NCT00026208|58779364|FG001|Overall Study|Complications of auto accident|0|||
30770418|NCT00025662|58779370|FG000|Overall Study|Withdrawal by Subject|2|||
30659483|NCT00958217|58672370|FG001|Overall Study|Inpatient hospitalization|1|||
30770419|NCT00025662|58779370|FG000|Overall Study|Technical failure of manipulation|1|||
30770420|NCT00025506|58779374|FG000|Overall Study|Ineligible: clerical error|1|||
30770421|NCT00025506|58779374|FG000|Overall Study|Ineligible: wrong cell type|5|||
30770422|NCT00025506|58779374|FG000|Overall Study|Ineligible: inadequate pathology|2|||
30770423|NCT00025506|58779374|FG000|Overall Study|Never Treated|2|||
30770424|NCT00024258|58779383|FG000|Overall Study|Withdrawal by Subject|1|||
30770425|NCT00024258|58779383|FG000|Overall Study|Disease Progression|8|||
30770426|NCT00023712|58779389|FG000|Overall Study|Not platinum sensitive|1|||
30770427|NCT00023712|58779390|FG001|Overall Study|Not platinum sensitive|0|||
30770428|NCT00023712|58779389|FG000|Overall Study|Never treated|1|||
30770429|NCT00023712|58779390|FG001|Overall Study|Never treated|1|||
30659484|NCT00891020|58672380|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
30659485|NCT00891020|58672381|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
30659486|NCT00891020|58672382|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
30659487|NCT00891020|58672380|FG000|24 Week Treatment Period|Death|0|||
30659488|NCT00891020|58672381|FG001|24 Week Treatment Period|Death|2|||
30659489|NCT00891020|58672382|FG002|24 Week Treatment Period|Death|0|||
30659490|NCT00891020|58672380|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
30659491|NCT00891020|58672381|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
30659492|NCT00891020|58672382|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
30659493|NCT00891020|58672380|FG000|24 Week Treatment Period|Failure to return|4|||
30659494|NCT00891020|58672381|FG001|24 Week Treatment Period|Failure to return|5|||
30659495|NCT00891020|58672382|FG002|24 Week Treatment Period|Failure to return|5|||
30659496|NCT00891020|58672380|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
30659497|NCT00891020|58672381|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
30659498|NCT00891020|58672382|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
30659499|NCT00891020|58672380|FG000|24 Week Treatment Period|Other protocol violation|1|||
30659500|NCT00891020|58672381|FG001|24 Week Treatment Period|Other protocol violation|1|||
30659501|NCT00891020|58672382|FG002|24 Week Treatment Period|Other protocol violation|2|||
30659502|NCT00891020|58672380|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
30659503|NCT00891020|58672381|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
30659504|NCT00891020|58672382|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
30659505|NCT00891020|58672380|FG000|24 Week Treatment Period|Withdrew consent|6|||
30659506|NCT00891020|58672381|FG001|24 Week Treatment Period|Withdrew consent|3|||
30659507|NCT00891020|58672382|FG002|24 Week Treatment Period|Withdrew consent|15|||
30659508|NCT00891020|58672380|FG000|24 Week Treatment Period|Administrative/Other|5|||
30659509|NCT00891020|58672381|FG001|24 Week Treatment Period|Administrative/Other|6|||
30659510|NCT00891020|58672382|FG002|24 Week Treatment Period|Administrative/Other|1|||
30659511|NCT00891020|58672380|FG000|Long-term Extension Period|Adverse Event|1|||
30659512|NCT00891020|58672381|FG001|Long-term Extension Period|Adverse Event|11|||
30659513|NCT00891020|58672382|FG002|Long-term Extension Period|Adverse Event|10|||
30659514|NCT00891020|58672380|FG000|Long-term Extension Period|Death|0|||
30659515|NCT00891020|58672381|FG001|Long-term Extension Period|Death|0|||
30659516|NCT00891020|58672382|FG002|Long-term Extension Period|Death|1|||
30659517|NCT00891020|58672380|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
30659518|NCT00891020|58672381|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
30659519|NCT00891020|58672382|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
30659520|NCT00891020|58672380|FG000|Long-term Extension Period|Protocol Violation|0|||
30659521|NCT00891020|58672381|FG001|Long-term Extension Period|Protocol Violation|1|||
30659522|NCT00891020|58672382|FG002|Long-term Extension Period|Protocol Violation|1|||
30659523|NCT00891020|58672380|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
30659524|NCT00891020|58672381|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
30659525|NCT00891020|58672382|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
30659526|NCT00891020|58672380|FG000|Long-term Extension Period|Failure to return|0|||
30659527|NCT00891020|58672381|FG001|Long-term Extension Period|Failure to return|2|||
30659528|NCT00891020|58672382|FG002|Long-term Extension Period|Failure to return|3|||
30659529|NCT00891020|58672380|FG000|Long-term Extension Period|Administrative|1|||
30659530|NCT00891020|58672381|FG001|Long-term Extension Period|Administrative|2|||
30659531|NCT00891020|58672382|FG002|Long-term Extension Period|Administrative|2|||
30770430|NCT00023322|58779406|FG000|Overall Study|Lost to Follow-up|1|||
30770431|NCT04640168|58779412|FG000|Overall Study|Withdrawal by Subject|8|||
30770432|NCT04640168|58779413|FG001|Overall Study|Withdrawal by Subject|7|||
30770433|NCT04640168|58779412|FG000|Overall Study|Lost to Follow-up|1|||
30770434|NCT04640168|58779413|FG001|Overall Study|Lost to Follow-up|0|||
30770435|NCT04640168|58779412|FG000|Overall Study|Enrolled but not treated|12|||
30770436|NCT04640168|58779413|FG001|Overall Study|Enrolled but not treated|12|||
30770437|NCT00022698|58779421|FG000|Overall Study|Adverse Event|5|||
30770438|NCT00022698|58779422|FG001|Overall Study|Adverse Event|9|||
30770439|NCT00022698|58779421|FG000|Overall Study|Death|0|||
30770440|NCT00022698|58779422|FG001|Overall Study|Death|2|||
30770441|NCT00022698|58779421|FG000|Overall Study|Failure to return|0|||
30770442|NCT00022698|58779422|FG001|Overall Study|Failure to return|1|||
30770443|NCT00022698|58779421|FG000|Overall Study|Refused treatment|0|||
30849041|NCT01676012|58875765|FG000|Overall Study|Adverse Event|2|||
30849042|NCT01676012|58875765|FG000|Overall Study|incomplete set of videos|1|||
30770444|NCT00022698|58779422|FG001|Overall Study|Refused treatment|2|||
30849043|NCT02727777|58875781|FG000|Overall Study|Screen Failure|2|||
30849044|NCT02727777|58875782|FG001|Overall Study|Screen Failure|0|||
30659532|NCT00611455|58672394|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
30770445|NCT00022698|58779421|FG000|Overall Study|Insufficient therapeutic response|2|||
30770446|NCT00022698|58779422|FG001|Overall Study|Insufficient therapeutic response|14|||
30849045|NCT02727777|58875783|FG002|Overall Study|Screen Failure|0|||
30849046|NCT02727777|58875781|FG000|Overall Study|Progressive disease|2|||
30659533|NCT00611455|58672395|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
30659534|NCT00611455|58672396|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
30659535|NCT00611455|58672394|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
30659536|NCT00611455|58672395|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
30659537|NCT00611455|58672396|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
30659538|NCT00611455|58672394|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
30659539|NCT00611455|58672395|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
30659540|NCT00611455|58672396|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
30659541|NCT00611455|58672394|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
30659542|NCT00611455|58672395|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
30659543|NCT00611455|58672396|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
30659544|NCT00611455|58672394|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
30659545|NCT00611455|58672395|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
30659546|NCT00611455|58672396|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
30659547|NCT00611455|58672394|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
30659548|NCT00611455|58672395|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
30659549|NCT00611455|58672396|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
30659550|NCT00611455|58672394|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
30659551|NCT00611455|58672395|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
30659552|NCT00611455|58672396|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
30659553|NCT00611455|58672394|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
30952596|NCT01895543|59001465|FG000|Overall Study|Protocol Violation|1|||
30952597|NCT01895543|59001465|FG000|Overall Study|Physician Decision|2|||
30659554|NCT00611455|58672395|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
30659555|NCT00611455|58672396|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
30659556|NCT00611455|58672394|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
30659557|NCT00611455|58672395|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
30659558|NCT00611455|58672396|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
30659559|NCT00611455|58672394|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
30659560|NCT00611455|58672395|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
30659561|NCT00611455|58672396|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
30659562|NCT00611455|58672394|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
30659563|NCT00611455|58672395|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
30659564|NCT00611455|58672396|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
30659565|NCT00611455|58672394|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
30659566|NCT00611455|58672395|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
30659567|NCT00611455|58672396|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
30659568|NCT00611455|58672394|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
30659569|NCT00611455|58672395|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
30659570|NCT00611455|58672396|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
30659571|NCT00611455|58672394|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
30659572|NCT00611455|58672395|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
30659573|NCT00611455|58672396|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
30659574|NCT00611455|58672394|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
30659575|NCT00611455|58672395|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
30659576|NCT00611455|58672396|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
30659577|NCT00611455|58672394|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
30659578|NCT00611455|58672395|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
30659579|NCT00611455|58672396|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
30659580|NCT00611455|58672394|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
30659581|NCT00611455|58672395|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
30659582|NCT00611455|58672396|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
30659583|NCT00611455|58672394|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
30659584|NCT00611455|58672395|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
30770447|NCT00022698|58779421|FG000|Overall Study|Administrative /other|1|||
30770448|NCT00022698|58779422|FG001|Overall Study|Administrative /other|7|||
30770449|NCT04625972|58779432|FG000|Overall Study|Physician Decision|1|||
30770450|NCT04625972|58779433|FG001|Overall Study|Physician Decision|0|||
30770451|NCT04625972|58779432|FG000|Overall Study|Protocol Violation|0|||
30770452|NCT04625972|58779433|FG001|Overall Study|Protocol Violation|1|||
30770453|NCT04625972|58779432|FG000|Overall Study|Ongoing in Study|741|||
30770454|NCT04625972|58779433|FG001|Overall Study|Ongoing in Study|369|||
30770455|NCT04625972|58779432|FG000|Overall Study|Lost to Follow-up|2|||
30770456|NCT04625972|58779433|FG001|Overall Study|Lost to Follow-up|0|||
30770457|NCT04625972|58779432|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|5|||
30659585|NCT00611455|58672396|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
30659586|NCT00611455|58672394|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
30659587|NCT00611455|58672395|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
30659588|NCT00611455|58672396|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
30659589|NCT00611455|58672394|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
30659590|NCT00611455|58672395|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
30659591|NCT00611455|58672396|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
30659592|NCT00611455|58672394|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
30659593|NCT00611455|58672395|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
30659594|NCT00611455|58672396|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
30659595|NCT00952289|58672408|FG000|All Participants|Death|9|||
30659596|NCT00952289|58672409|FG001|All Participants|Death|9|||
30659597|NCT00952289|58672408|FG000|All Participants|Adverse Event|8|||
30659598|NCT00952289|58672409|FG001|All Participants|Adverse Event|8|||
30659599|NCT00952289|58672408|FG000|All Participants|Disease progression|3|||
30659600|NCT00952289|58672409|FG001|All Participants|Disease progression|12|||
30659601|NCT00952289|58672408|FG000|All Participants|Withdrawal by Subject|1|||
30659602|NCT00952289|58672409|FG001|All Participants|Withdrawal by Subject|10|||
30659603|NCT00952289|58672408|FG000|All Participants|Data lost during site relocation|0|||
30659604|NCT00952289|58672409|FG001|All Participants|Data lost during site relocation|1|||
30659605|NCT00952289|58672408|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
30659606|NCT00952289|58672409|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
30659607|NCT00952289|58672408|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
30659608|NCT00952289|58672409|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
30659609|NCT00952289|58672408|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
30659610|NCT00952289|58672409|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
30659611|NCT00952289|58672408|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
30659612|NCT00952289|58672409|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
30659613|NCT00952289|58672408|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
30659614|NCT00952289|58672409|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
30659615|NCT00947531|58672417|FG000|Overall Study|Withdrawal by Subject|10|||
30659616|NCT00947531|58672418|FG001|Overall Study|Withdrawal by Subject|7|||
30659617|NCT00947531|58672417|FG000|Overall Study|Administrative Reason|0|||
30659618|NCT00947531|58672418|FG001|Overall Study|Administrative Reason|1|||
30659619|NCT00947531|58672417|FG000|Overall Study|Adverse Event|2|||
30659620|NCT00947531|58672418|FG001|Overall Study|Adverse Event|2|||
30659621|NCT00947531|58672417|FG000|Overall Study|Lack of Efficacy|1|||
30659622|NCT00947531|58672418|FG001|Overall Study|Lack of Efficacy|0|||
30659623|NCT00947531|58672417|FG000|Overall Study|Other|1|||
30659624|NCT00947531|58672418|FG001|Overall Study|Other|1|||
30659625|NCT00612313|58672426|FG000|Overall Study|Withdrawal by Subject|6|||
30659626|NCT00612313|58672427|FG001|Overall Study|Withdrawal by Subject|9|||
30659627|NCT00612313|58672426|FG000|Overall Study|Lost to Follow-up|11|||
30659628|NCT00612313|58672427|FG001|Overall Study|Lost to Follow-up|4|||
30659629|NCT00890552|58672439|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
30659630|NCT00890552|58672439|FG000|On-treatment|Early prog disease/ death|10|||
30659631|NCT00946985|58672443|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
30659632|NCT00946985|58672443|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
30659633|NCT00946985|58672443|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
30659634|NCT00946985|58672443|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
30659635|NCT00946985|58672443|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
30659636|NCT00946985|58672443|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
30659637|NCT00946985|58672443|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
30659638|NCT00946985|58672443|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
30770458|NCT04625972|58779433|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|2|||
30770459|NCT04625972|58779432|FG000|Overall Study|Withdrawal by Subject|7|||
30770460|NCT04625972|58779433|FG001|Overall Study|Withdrawal by Subject|3|||
30770461|NCT00234065|58779441|FG000|Overall Study|Adverse Event|268|||
30770462|NCT00234065|58779442|FG001|Overall Study|Adverse Event|166|||
30770463|NCT00234065|58779441|FG000|Overall Study|Withdrawal by Subject|73|||
30770464|NCT00234065|58779442|FG001|Overall Study|Withdrawal by Subject|56|||
30770465|NCT00234065|58779441|FG000|Overall Study|Physician Decision|23|||
30770466|NCT00234065|58779442|FG001|Overall Study|Physician Decision|22|||
30770467|NCT00234065|58779441|FG000|Overall Study|Not Classified|111|||
30659639|NCT00946985|58672443|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
30659640|NCT00611923|58672449|FG000|Overall Study|Withdrawal by Subject|2|||
30659641|NCT00611923|58672450|FG001|Overall Study|Withdrawal by Subject|2|||
30659642|NCT00609973|58672460|FG000|Overall Study|Adverse Event|2|||
30659643|NCT00609973|58672461|FG001|Overall Study|Adverse Event|1|||
30659644|NCT00609973|58672460|FG000|Overall Study|Protocol Violation|4|||
30659645|NCT00609973|58672461|FG001|Overall Study|Protocol Violation|3|||
30659646|NCT00609973|58672460|FG000|Overall Study|Lost to Follow-up|2|||
30659647|NCT00609973|58672461|FG001|Overall Study|Lost to Follow-up|1|||
30659648|NCT00609973|58672460|FG000|Overall Study|Withdrawal by Subject|0|||
30659649|NCT00609973|58672461|FG001|Overall Study|Withdrawal by Subject|1|||
30659650|NCT00803049|58672471|FG000|Overall Study|Adverse Event|21|||
30659651|NCT00803049|58672472|FG001|Overall Study|Adverse Event|33|||
30659652|NCT00803049|58672473|FG002|Overall Study|Adverse Event|13|||
30659653|NCT00803049|58672474|FG003|Overall Study|Adverse Event|27|||
30659654|NCT00803049|58672471|FG000|Overall Study|Lack of Efficacy|10|||
30659655|NCT00803049|58672472|FG001|Overall Study|Lack of Efficacy|19|||
30659656|NCT00803049|58672473|FG002|Overall Study|Lack of Efficacy|6|||
30659657|NCT00803049|58672474|FG003|Overall Study|Lack of Efficacy|13|||
30659658|NCT00803049|58672471|FG000|Overall Study|Lost to Follow-up|0|||
30659659|NCT00803049|58672472|FG001|Overall Study|Lost to Follow-up|2|||
30659660|NCT00803049|58672473|FG002|Overall Study|Lost to Follow-up|0|||
30659661|NCT00803049|58672474|FG003|Overall Study|Lost to Follow-up|3|||
30659662|NCT00803049|58672471|FG000|Overall Study|Death|2|||
30659663|NCT00803049|58672472|FG001|Overall Study|Death|1|||
30659664|NCT00803049|58672473|FG002|Overall Study|Death|0|||
30659665|NCT00803049|58672474|FG003|Overall Study|Death|2|||
30659666|NCT00803049|58672471|FG000|Overall Study|Progressive Disease|6|||
30659667|NCT00803049|58672472|FG001|Overall Study|Progressive Disease|10|||
30659668|NCT00803049|58672473|FG002|Overall Study|Progressive Disease|6|||
30659669|NCT00803049|58672474|FG003|Overall Study|Progressive Disease|6|||
30659670|NCT00803049|58672471|FG000|Overall Study|Withdrawal by Subject|19|||
30659671|NCT00803049|58672472|FG001|Overall Study|Withdrawal by Subject|43|||
30659672|NCT00803049|58672473|FG002|Overall Study|Withdrawal by Subject|16|||
30659673|NCT00803049|58672474|FG003|Overall Study|Withdrawal by Subject|44|||
30659674|NCT00803049|58672471|FG000|Overall Study|Protocol Violation|0|||
30659675|NCT00803049|58672472|FG001|Overall Study|Protocol Violation|1|||
30659676|NCT00803049|58672473|FG002|Overall Study|Protocol Violation|1|||
30659677|NCT00803049|58672474|FG003|Overall Study|Protocol Violation|0|||
30659678|NCT00803049|58672471|FG000|Overall Study|Randomized and Not Treated|0|||
30659679|NCT00803049|58672472|FG001|Overall Study|Randomized and Not Treated|0|||
30659680|NCT00803049|58672473|FG002|Overall Study|Randomized and Not Treated|0|||
30659681|NCT00803049|58672474|FG003|Overall Study|Randomized and Not Treated|2|||
30659682|NCT00803049|58672471|FG000|Overall Study|Other than Specified Above|3|||
30659683|NCT00803049|58672472|FG001|Overall Study|Other than Specified Above|9|||
30659684|NCT00803049|58672473|FG002|Overall Study|Other than Specified Above|2|||
30659685|NCT00803049|58672474|FG003|Overall Study|Other than Specified Above|5|||
30659686|NCT00890084|58672484|FG000|Overall Study|Adverse Event|16|||
30659687|NCT00890084|58672484|FG000|Overall Study|Lost to Follow-up|126|||
30659688|NCT00802893|58672497|FG000|Overall Study|study terminated|3|||
30659689|NCT00608569|58672518|FG000|Overall Study|Death|4|||
30659690|NCT00608569|58672519|FG001|Overall Study|Death|3|||
30659691|NCT00608569|58672518|FG000|Overall Study|Lost to Follow-up|4|||
30659692|NCT00608569|58672519|FG001|Overall Study|Lost to Follow-up|5|||
30659693|NCT00608569|58672518|FG000|Overall Study|Withdrawal by Subject|1|||
30659694|NCT00608569|58672519|FG001|Overall Study|Withdrawal by Subject|0|||
30659695|NCT00608569|58672518|FG000|Overall Study|Adverse Event|1|||
30659696|NCT00608569|58672519|FG001|Overall Study|Adverse Event|0|||
30659697|NCT00608569|58672518|FG000|Overall Study|Unable to adhere with study requirements|0|||
30659698|NCT00608569|58672519|FG001|Overall Study|Unable to adhere with study requirements|1|||
30659699|NCT00610675|58672525|FG000|Overall Study|Untreated|4|||
30659700|NCT00610675|58672525|FG000|Overall Study|Adverse Event|67|||
30659701|NCT00610675|58672525|FG000|Overall Study|Insufficient Effect|31|||
30659702|NCT00610675|58672525|FG000|Overall Study|Withdrawal by Subject|28|||
30659703|NCT00610675|58672525|FG000|Overall Study|Reasons unrelated to trial|27|||
30659704|NCT00610675|58672525|FG000|Overall Study|Lack of Compliance|7|||
30659705|NCT00610675|58672525|FG000|Overall Study|Lost to Follow-up|31|||
30659706|NCT00610675|58672525|FG000|Overall Study|Other reason (not specified)|25|||
30659707|NCT00888134|58672529|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
30659708|NCT00888134|58672529|FG000|Follow-up|being followed for long-term survival|1|||
30659709|NCT00573157|58672536|FG000|Overall Study|Adverse Event|3|||
30659710|NCT00573157|58672537|FG001|Overall Study|Adverse Event|1|||
30659711|NCT00573157|58672536|FG000|Overall Study|Other|1|||
30659712|NCT00573157|58672537|FG001|Overall Study|Other|1|||
30659713|NCT00802737|58672546|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
30659714|NCT00802737|58672547|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
30659715|NCT00802737|58672548|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
30659716|NCT00802737|58672546|FG000|Overall Study|Death|6|||
30770468|NCT00234065|58779442|FG001|Overall Study|Not Classified|112|||
30659717|NCT00802737|58672547|FG001|Overall Study|Death|5|||
30659718|NCT00802737|58672548|FG002|Overall Study|Death|1|||
30659719|NCT00802737|58672546|FG000|Overall Study|Adverse Event|1|||
30659720|NCT00802737|58672547|FG001|Overall Study|Adverse Event|0|||
30659721|NCT00802737|58672548|FG002|Overall Study|Adverse Event|0|||
30659722|NCT00802737|58672546|FG000|Overall Study|Received Prohibited Therapy|1|||
30659723|NCT00802737|58672547|FG001|Overall Study|Received Prohibited Therapy|0|||
30659724|NCT00802737|58672548|FG002|Overall Study|Received Prohibited Therapy|0|||
30659725|NCT00802737|58672546|FG000|Overall Study|Ongoing CLL-Treatment|0|||
30659726|NCT00802737|58672547|FG001|Overall Study|Ongoing CLL-Treatment|1|||
30659727|NCT00802737|58672548|FG002|Overall Study|Ongoing CLL-Treatment|0|||
30659728|NCT00802737|58672546|FG000|Overall Study|Participant too Unwell|0|||
30659729|NCT00802737|58672547|FG001|Overall Study|Participant too Unwell|2|||
30659730|NCT00802737|58672548|FG002|Overall Study|Participant too Unwell|0|||
30659731|NCT00588861|58672559|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
30659732|NCT00588861|58672560|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
30659733|NCT00588861|58672559|FG000|6 Months|Patients did not return for follow-up|98|||
30659734|NCT00588861|58672560|FG001|6 Months|Patients did not return for follow-up|73|||
30659735|NCT00588861|58672559|FG000|1 Year|Patients did not return for follow-up|89|||
30659736|NCT00588861|58672560|FG001|1 Year|Patients did not return for follow-up|82|||
30770469|NCT00233987|58779448|FG000|Overall Study|Withdrawal by Subject|1|||
30770470|NCT00233987|58779448|FG000|Overall Study|Lack of Efficacy|2|||
30770471|NCT00233987|58779448|FG000|Overall Study|Reason Under Review|1|||
30770472|NCT00233987|58779448|FG000|Overall Study|Other - Not Protocol Specified|5|||
30770473|NCT00233987|58779448|FG000|Overall Study|Eligible but No Treatment Received|2|||
30770474|NCT00233987|58779448|FG000|Overall Study|Ineligible|4|||
30770475|NCT04623242|58779457|FG000|Overall Study|Withdrawal by Subject|7|||
30770476|NCT04623242|58779458|FG001|Overall Study|Withdrawal by Subject|12|||
30659737|NCT00588861|58672559|FG000|2 Years|Patients did not return for follow-up|92|||
30659738|NCT00588861|58672560|FG001|2 Years|Patients did not return for follow-up|87|||
30659739|NCT00588861|58672559|FG000|4 Years|Patients did not return for follow-up|91|||
30659740|NCT00588861|58672560|FG001|4 Years|Patients did not return for follow-up|103|||
30659741|NCT00588861|58672559|FG000|6 Years|Patients did not return for follow-up|104|||
30659742|NCT00588861|58672560|FG001|6 Years|Patients did not return for follow-up|109|||
30659743|NCT00588861|58672559|FG000|8 Years|Patients did not return for follow-up|105|||
30659744|NCT00588861|58672560|FG001|8 Years|Patients did not return for follow-up|114|||
30659745|NCT00588861|58672559|FG000|10 Years|Incomplete due to study termination|107|||
30659746|NCT00588861|58672560|FG001|10 Years|Incomplete due to study termination|114|||
30659747|NCT00887978|58672568|FG000|Overall Study|Adverse Event|18|||
30659748|NCT00887978|58672569|FG001|Overall Study|Adverse Event|5|||
30659749|NCT00887978|58672568|FG000|Overall Study|Clinical Worsening|4|||
30659750|NCT00887978|58672569|FG001|Overall Study|Clinical Worsening|4|||
30659751|NCT00887978|58672568|FG000|Overall Study|Death|2|||
30659752|NCT00887978|58672569|FG001|Overall Study|Death|3|||
30659753|NCT00887978|58672568|FG000|Overall Study|Withdrawal by Subject|1|||
30659754|NCT00887978|58672569|FG001|Overall Study|Withdrawal by Subject|2|||
30659755|NCT00887978|58672568|FG000|Overall Study|Lost to Follow-up|0|||
30659756|NCT00887978|58672569|FG001|Overall Study|Lost to Follow-up|1|||
30659757|NCT00608023|58672578|FG000|Overall Study|Withdrawal by Subject|8|||
30659758|NCT00608023|58672579|FG001|Overall Study|Withdrawal by Subject|10|||
30659759|NCT00608023|58672580|FG002|Overall Study|Withdrawal by Subject|7|||
30659760|NCT00608023|58672578|FG000|Overall Study|Adverse Event|1|||
30659761|NCT00608023|58672579|FG001|Overall Study|Adverse Event|4|||
30659762|NCT00608023|58672580|FG002|Overall Study|Adverse Event|5|||
30659763|NCT00608023|58672578|FG000|Overall Study|Lost to Follow-up|2|||
30659764|NCT00608023|58672579|FG001|Overall Study|Lost to Follow-up|2|||
30659765|NCT00608023|58672580|FG002|Overall Study|Lost to Follow-up|1|||
30659766|NCT00608023|58672578|FG000|Overall Study|Protocol Violation|1|||
30659767|NCT00608023|58672579|FG001|Overall Study|Protocol Violation|3|||
30659768|NCT00608023|58672580|FG002|Overall Study|Protocol Violation|1|||
30659769|NCT00608023|58672578|FG000|Overall Study|Unknown reason|0|||
30659770|NCT00608023|58672579|FG001|Overall Study|Unknown reason|3|||
30659771|NCT00608023|58672580|FG002|Overall Study|Unknown reason|0|||
30659772|NCT00802659|58672595|FG000|Overall Study|Physician Decision|0|||
30659773|NCT00802659|58672596|FG001|Overall Study|Physician Decision|1|||
30770477|NCT04623242|58779459|FG002|Overall Study|Withdrawal by Subject|5|||
30659774|NCT00802659|58672597|FG002|Overall Study|Physician Decision|0|||
30659775|NCT00802659|58672598|FG003|Overall Study|Physician Decision|0|||
30659776|NCT00607789|58672610|FG000|Overall Study|Adverse Event|3|||
30770478|NCT04623242|58779460|FG003|Overall Study|Withdrawal by Subject|7|||
30770479|NCT04623242|58779461|FG004|Overall Study|Withdrawal by Subject|0|||
30659777|NCT00607789|58672611|FG001|Overall Study|Adverse Event|0|||
30659778|NCT00607789|58672610|FG000|Overall Study|Lack of Efficacy|0|||
30659779|NCT00607789|58672611|FG001|Overall Study|Lack of Efficacy|1|||
30659780|NCT00607789|58672610|FG000|Overall Study|Inadequate adherence|3|||
30659781|NCT00607789|58672611|FG001|Overall Study|Inadequate adherence|0|||
30770480|NCT04623242|58779457|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
30659782|NCT00607789|58672610|FG000|Overall Study|Lost to Follow-up|0|||
30659783|NCT00607789|58672611|FG001|Overall Study|Lost to Follow-up|5|||
30659784|NCT00607789|58672610|FG000|Overall Study|Withdrawal by Subject|1|||
30659785|NCT00607789|58672611|FG001|Overall Study|Withdrawal by Subject|0|||
30659786|NCT00887822|58672619|FG000|Overall Study|Insufficient therapeutic response|53|||
30659787|NCT00887822|58672620|FG001|Overall Study|Insufficient therapeutic response|55|||
30659788|NCT00887822|58672619|FG000|Overall Study|Adverse Event|14|||
30659789|NCT00887822|58672620|FG001|Overall Study|Adverse Event|17|||
30659790|NCT00887822|58672619|FG000|Overall Study|Failure to return|11|||
30659791|NCT00887822|58672620|FG001|Overall Study|Failure to return|11|||
30659792|NCT00887822|58672619|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
30659793|NCT00887822|58672620|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
30659794|NCT00887822|58672619|FG000|Overall Study|Administrative/Other than specified|5|||
30659795|NCT00887822|58672620|FG001|Overall Study|Administrative/Other than specified|4|||
30659796|NCT00887822|58672619|FG000|Overall Study|Death|2|||
30659797|NCT00887822|58672620|FG001|Overall Study|Death|3|||
30659798|NCT00887822|58672619|FG000|Overall Study|Protocol Violation|0|||
30659799|NCT00887822|58672620|FG001|Overall Study|Protocol Violation|1|||
30659800|NCT00887822|58672619|FG000|Overall Study|Randomized but not treated|0|||
30659801|NCT00887822|58672620|FG001|Overall Study|Randomized but not treated|1|||
30659802|NCT00951665|58672632|FG000|Phase 1b|Adverse Event|2|||
30659803|NCT00951665|58672633|FG001|Phase 1b|Adverse Event|1|||
30659804|NCT00951665|58672634|FG002|Phase 1b|Adverse Event|0|||
30659805|NCT00951665|58672635|FG003|Phase 1b|Adverse Event|1|||
30659806|NCT00951665|58672636|FG004|Phase 1b|Adverse Event|0|||
30659807|NCT00951665|58672637|FG005|Phase 1b|Adverse Event|0|||
30659808|NCT00951665|58672632|FG000|Phase 1b|Death|1|||
30659809|NCT00951665|58672633|FG001|Phase 1b|Death|0|||
30659810|NCT00951665|58672634|FG002|Phase 1b|Death|2|||
30659811|NCT00951665|58672635|FG003|Phase 1b|Death|0|||
30659812|NCT00951665|58672636|FG004|Phase 1b|Death|0|||
30659813|NCT00951665|58672637|FG005|Phase 1b|Death|0|||
30659814|NCT00951665|58672632|FG000|Phase 1b|Physician Decision|4|||
30659815|NCT00951665|58672633|FG001|Phase 1b|Physician Decision|0|||
30659816|NCT00951665|58672634|FG002|Phase 1b|Physician Decision|1|||
30659817|NCT00951665|58672635|FG003|Phase 1b|Physician Decision|0|||
30659818|NCT00951665|58672636|FG004|Phase 1b|Physician Decision|0|||
30659819|NCT00951665|58672637|FG005|Phase 1b|Physician Decision|0|||
30659820|NCT00951665|58672632|FG000|Phase 1b|Withdrawal by Subject|0|||
30659821|NCT00951665|58672633|FG001|Phase 1b|Withdrawal by Subject|1|||
30659822|NCT00951665|58672634|FG002|Phase 1b|Withdrawal by Subject|0|||
30659823|NCT00951665|58672635|FG003|Phase 1b|Withdrawal by Subject|0|||
30659824|NCT00951665|58672636|FG004|Phase 1b|Withdrawal by Subject|0|||
30659825|NCT00951665|58672637|FG005|Phase 1b|Withdrawal by Subject|0|||
30659826|NCT00951665|58672632|FG000|Phase 1b|Disease Progression|13|||
30659827|NCT00951665|58672633|FG001|Phase 1b|Disease Progression|2|||
30659828|NCT00951665|58672634|FG002|Phase 1b|Disease Progression|14|||
30659829|NCT00951665|58672635|FG003|Phase 1b|Disease Progression|0|||
30659830|NCT00951665|58672636|FG004|Phase 1b|Disease Progression|0|||
30659831|NCT00951665|58672637|FG005|Phase 1b|Disease Progression|0|||
30659832|NCT00951665|58672632|FG000|Phase 1b|Protocol Violation|2|||
30659833|NCT00951665|58672633|FG001|Phase 1b|Protocol Violation|0|||
30659834|NCT00951665|58672634|FG002|Phase 1b|Protocol Violation|0|||
30849047|NCT02727777|58875782|FG001|Overall Study|Progressive disease|0|||
30659835|NCT00951665|58672635|FG003|Phase 1b|Protocol Violation|0|||
30659836|NCT00951665|58672636|FG004|Phase 1b|Protocol Violation|0|||
30659837|NCT00951665|58672637|FG005|Phase 1b|Protocol Violation|0|||
30659838|NCT00951665|58672632|FG000|Phase 2a|Adverse Event|0|||
30659839|NCT00951665|58672633|FG001|Phase 2a|Adverse Event|0|||
30659840|NCT00951665|58672634|FG002|Phase 2a|Adverse Event|0|||
30659841|NCT00951665|58672635|FG003|Phase 2a|Adverse Event|0|||
30659842|NCT00951665|58672636|FG004|Phase 2a|Adverse Event|2|||
30659843|NCT00951665|58672637|FG005|Phase 2a|Adverse Event|0|||
30659844|NCT00951665|58672632|FG000|Phase 2a|Death|0|||
30659845|NCT00951665|58672633|FG001|Phase 2a|Death|0|||
30659846|NCT00951665|58672634|FG002|Phase 2a|Death|0|||
30659847|NCT00951665|58672635|FG003|Phase 2a|Death|0|||
30659848|NCT00951665|58672636|FG004|Phase 2a|Death|1|||
30659849|NCT00951665|58672637|FG005|Phase 2a|Death|1|||
30659850|NCT00951665|58672632|FG000|Phase 2a|Lost to Follow-up|0|||
30659851|NCT00951665|58672633|FG001|Phase 2a|Lost to Follow-up|0|||
30659852|NCT00951665|58672634|FG002|Phase 2a|Lost to Follow-up|0|||
30659853|NCT00951665|58672635|FG003|Phase 2a|Lost to Follow-up|0|||
30659854|NCT00951665|58672636|FG004|Phase 2a|Lost to Follow-up|1|||
30659855|NCT00951665|58672637|FG005|Phase 2a|Lost to Follow-up|0|||
30659856|NCT00951665|58672632|FG000|Phase 2a|Physician Decision|0|||
30659857|NCT00951665|58672633|FG001|Phase 2a|Physician Decision|0|||
30659858|NCT00951665|58672634|FG002|Phase 2a|Physician Decision|0|||
30659859|NCT00951665|58672635|FG003|Phase 2a|Physician Decision|0|||
30659860|NCT00951665|58672636|FG004|Phase 2a|Physician Decision|0|||
30659861|NCT00951665|58672637|FG005|Phase 2a|Physician Decision|1|||
30659862|NCT00951665|58672632|FG000|Phase 2a|Withdrawal by Subject|0|||
30659863|NCT00951665|58672633|FG001|Phase 2a|Withdrawal by Subject|0|||
30659864|NCT00951665|58672634|FG002|Phase 2a|Withdrawal by Subject|0|||
30659865|NCT00951665|58672635|FG003|Phase 2a|Withdrawal by Subject|0|||
30659866|NCT00951665|58672636|FG004|Phase 2a|Withdrawal by Subject|2|||
30659867|NCT00951665|58672637|FG005|Phase 2a|Withdrawal by Subject|0|||
30659868|NCT00951665|58672632|FG000|Phase 2a|Disease Progression|0|||
30659869|NCT00951665|58672633|FG001|Phase 2a|Disease Progression|0|||
30659870|NCT00951665|58672634|FG002|Phase 2a|Disease Progression|0|||
30659871|NCT00951665|58672635|FG003|Phase 2a|Disease Progression|0|||
30659872|NCT00951665|58672636|FG004|Phase 2a|Disease Progression|6|||
30659873|NCT00951665|58672637|FG005|Phase 2a|Disease Progression|5|||
30659874|NCT00801099|58672671|FG000|Overall Study|Lost to Follow-up|101|||
30659875|NCT00887744|58672675|FG000|Overall Study|Adverse Event|3|||
30659876|NCT00887744|58672675|FG000|Overall Study|Death|1|||
30659877|NCT00887744|58672675|FG000|Overall Study|Lost to Follow-up|3|||
30659878|NCT00887744|58672675|FG000|Overall Study|Withdrawal by Subject|18|||
30659879|NCT00887744|58672675|FG000|Overall Study|Various reasons|9|||
30659880|NCT00951509|58672679|FG000|Overall Study|Withdrawal by Subject|2|||
30659881|NCT00610441|58672691|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
30659882|NCT00610441|58672692|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
30659883|NCT00610441|58672693|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
30659884|NCT00610441|58672694|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
30659885|NCT00610441|58672691|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
30849048|NCT02727777|58875783|FG002|Overall Study|Progressive disease|0|||
30659886|NCT00610441|58672692|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
30659887|NCT00610441|58672693|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
30659888|NCT00610441|58672694|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
30659889|NCT00610441|58672691|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
30659890|NCT00610441|58672692|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
30659891|NCT00610441|58672693|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
30659892|NCT00610441|58672694|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
30659893|NCT00610441|58672691|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
30659894|NCT00610441|58672692|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
30659895|NCT00610441|58672693|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
30659896|NCT00610441|58672694|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
30659897|NCT00610441|58672691|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
30659898|NCT00610441|58672692|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
30659899|NCT00610441|58672693|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
30659900|NCT00610441|58672694|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
30659901|NCT00610441|58672691|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
30659902|NCT00610441|58672692|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
30659903|NCT00610441|58672693|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
30659904|NCT00610441|58672694|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
30659905|NCT00610441|58672691|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
30659906|NCT00610441|58672692|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
30659907|NCT00610441|58672693|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
30659908|NCT00610441|58672694|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
30659909|NCT00610441|58672691|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
30659910|NCT00610441|58672692|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
30659911|NCT00610441|58672693|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
30659912|NCT00610441|58672694|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
30659913|NCT00610441|58672691|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
30659914|NCT00610441|58672692|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
30659915|NCT00610441|58672693|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
30659916|NCT00610441|58672694|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
30659917|NCT00799617|58672708|FG000|Main Testosterone Trial|Randomized in error|1|||
30659918|NCT00799617|58672709|FG001|Main Testosterone Trial|Randomized in error|1|||
30659919|NCT00799617|58672708|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
30659920|NCT00799617|58672709|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
30659921|NCT00799617|58672708|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
30659922|NCT00799617|58672709|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
30659923|NCT00799617|58672708|FG000|Sexual Funtion Trial|No Baseline Data|4|||
30659924|NCT00799617|58672709|FG001|Sexual Funtion Trial|No Baseline Data|7|||
30659925|NCT00799617|58672708|FG000|Physical Function Trial|Lost to Follow-up|6|||
30659926|NCT00799617|58672709|FG001|Physical Function Trial|Lost to Follow-up|11|||
30659927|NCT00799617|58672708|FG000|Vitality Trial|Lost to Follow-up|7|||
30659928|NCT00799617|58672709|FG001|Vitality Trial|Lost to Follow-up|22|||
30659929|NCT00799617|58672708|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
30659930|NCT00799617|58672709|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
30659931|NCT00799617|58672708|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
30770481|NCT04623242|58779458|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
30770482|NCT04623242|58779459|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
30770483|NCT04623242|58779460|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
30770484|NCT04623242|58779461|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
30770485|NCT04623242|58779457|FG000|Overall Study|Subject unblinded to mutation status|0|||
30770486|NCT04623242|58779458|FG001|Overall Study|Subject unblinded to mutation status|0|||
30770487|NCT04623242|58779459|FG002|Overall Study|Subject unblinded to mutation status|0|||
30770488|NCT04623242|58779460|FG003|Overall Study|Subject unblinded to mutation status|13|||
30770489|NCT04623242|58779461|FG004|Overall Study|Subject unblinded to mutation status|0|||
30770490|NCT00233363|58779478|FG000|Overall Study|Adverse Event|1|||
30770491|NCT00233363|58779479|FG001|Overall Study|Adverse Event|2|||
30770492|NCT00233363|58779478|FG000|Overall Study|Lack of Efficacy|0|||
30770493|NCT00233363|58779479|FG001|Overall Study|Lack of Efficacy|2|||
30770494|NCT00233363|58779478|FG000|Overall Study|Withdrawal by Subject|1|||
30770495|NCT00233363|58779479|FG001|Overall Study|Withdrawal by Subject|1|||
30770496|NCT00233363|58779478|FG000|Overall Study|Aggravation of complication|1|||
30770497|NCT00233363|58779479|FG001|Overall Study|Aggravation of complication|0|||
30770498|NCT01147666|58779500|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
30659932|NCT00799617|58672709|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
30659933|NCT00799617|58672708|FG000|Bone Trial|Month 12 scan not available|6|||
30659934|NCT00799617|58672709|FG001|Bone Trial|Month 12 scan not available|16|||
30659935|NCT00799617|58672708|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
30849049|NCT00707577|58875793|FG000|Overall Study|Withdrawal by Subject|3|||
30849050|NCT00707577|58875794|FG001|Overall Study|Withdrawal by Subject|2|||
30659936|NCT00799617|58672709|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
30659937|NCT00799617|58672708|FG000|Anemia Trial|Withdrawal by Subject|3|||
30659938|NCT00799617|58672709|FG001|Anemia Trial|Withdrawal by Subject|3|||
30659939|NCT00607087|58672718|FG000|Overall Study|Withdrawal by Subject|9|||
30659940|NCT00607087|58672719|FG001|Overall Study|Withdrawal by Subject|4|||
30659941|NCT00607087|58672720|FG002|Overall Study|Withdrawal by Subject|4|||
30659942|NCT00607087|58672718|FG000|Overall Study|Adverse Event|3|||
30659943|NCT00607087|58672719|FG001|Overall Study|Adverse Event|2|||
30659944|NCT00607087|58672720|FG002|Overall Study|Adverse Event|3|||
30659945|NCT00607087|58672718|FG000|Overall Study|Other reason|1|||
30659946|NCT00607087|58672719|FG001|Overall Study|Other reason|5|||
30659947|NCT00607087|58672720|FG002|Overall Study|Other reason|2|||
30659948|NCT00607087|58672718|FG000|Overall Study|Poor compliance to protocol|1|||
30659949|NCT00607087|58672719|FG001|Overall Study|Poor compliance to protocol|0|||
30659950|NCT00607087|58672720|FG002|Overall Study|Poor compliance to protocol|1|||
30659951|NCT00607087|58672718|FG000|Overall Study|Lost to Follow-up|1|||
30849051|NCT00707577|58875793|FG000|Overall Study|Lost to Follow-up|34|||
30849052|NCT00707577|58875794|FG001|Overall Study|Lost to Follow-up|25|||
30659952|NCT00607087|58672719|FG001|Overall Study|Lost to Follow-up|0|||
30659953|NCT00607087|58672720|FG002|Overall Study|Lost to Follow-up|0|||
30659954|NCT00607087|58672718|FG000|Period 1|Withdrawal by Subject|7|||
30659955|NCT00607087|58672719|FG001|Period 1|Withdrawal by Subject|2|||
30659956|NCT00607087|58672720|FG002|Period 1|Withdrawal by Subject|3|||
30659957|NCT00607087|58672718|FG000|Period 1|Adverse Event|3|||
30659958|NCT00607087|58672719|FG001|Period 1|Adverse Event|0|||
30659959|NCT00607087|58672720|FG002|Period 1|Adverse Event|0|||
30659960|NCT00607087|58672718|FG000|Period 1|Poor compliance to protocol|1|||
30659961|NCT00607087|58672719|FG001|Period 1|Poor compliance to protocol|0|||
30659962|NCT00607087|58672720|FG002|Period 1|Poor compliance to protocol|0|||
30659963|NCT00607087|58672718|FG000|Period 1|Lost to Follow-up|1|||
30659964|NCT00607087|58672719|FG001|Period 1|Lost to Follow-up|0|||
30659965|NCT00607087|58672720|FG002|Period 1|Lost to Follow-up|0|||
30659966|NCT00607087|58672718|FG000|Period 1|Other reason|0|||
30659967|NCT00607087|58672719|FG001|Period 1|Other reason|4|||
30659968|NCT00607087|58672720|FG002|Period 1|Other reason|2|||
30659969|NCT00607087|58672718|FG000|Period 2|Withdrawal by Subject|0|||
30659970|NCT00607087|58672719|FG001|Period 2|Withdrawal by Subject|1|||
30659971|NCT00607087|58672720|FG002|Period 2|Withdrawal by Subject|1|||
30659972|NCT00607087|58672718|FG000|Period 2|Other reason|1|||
30659973|NCT00607087|58672719|FG001|Period 2|Other reason|1|||
30659974|NCT00607087|58672720|FG002|Period 2|Other reason|0|||
30659975|NCT00607087|58672718|FG000|Period 2|Adverse Event|0|||
30659976|NCT00607087|58672719|FG001|Period 2|Adverse Event|1|||
30659977|NCT00607087|58672720|FG002|Period 2|Adverse Event|3|||
30659978|NCT00607087|58672718|FG000|Period 2|Poor compliance to protocol|0|||
30659979|NCT00607087|58672719|FG001|Period 2|Poor compliance to protocol|0|||
30659980|NCT00607087|58672720|FG002|Period 2|Poor compliance to protocol|1|||
30659981|NCT00607087|58672718|FG000|Period 3|Withdrawal by Subject|2|||
30659982|NCT00607087|58672719|FG001|Period 3|Withdrawal by Subject|1|||
30659983|NCT00607087|58672720|FG002|Period 3|Withdrawal by Subject|0|||
30659984|NCT00607087|58672718|FG000|Period 3|Adverse Event|0|||
30659985|NCT00607087|58672719|FG001|Period 3|Adverse Event|1|||
30659986|NCT00607087|58672720|FG002|Period 3|Adverse Event|0|||
30659987|NCT00610363|58672730|FG000|Overall Study|Non-compliance with protocol|0|||
30659988|NCT00610363|58672731|FG001|Overall Study|Non-compliance with protocol|1|||
30659989|NCT00610363|58672730|FG000|Overall Study|Adverse Event|3|||
30659990|NCT00610363|58672731|FG001|Overall Study|Adverse Event|1|||
30659991|NCT00610363|58672730|FG000|Overall Study|Lack of Efficacy|2|||
30659992|NCT00610363|58672731|FG001|Overall Study|Lack of Efficacy|0|||
30659993|NCT00610363|58672730|FG000|Overall Study|Lost to Follow-up|4|||
30659994|NCT00610363|58672731|FG001|Overall Study|Lost to Follow-up|0|||
30770499|NCT01147666|58779501|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
30770500|NCT01147666|58779502|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
30770501|NCT01147666|58779503|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
30770502|NCT01147666|58779504|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
30770503|NCT01147666|58779505|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
30770504|NCT01147666|58779506|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
30770505|NCT01147666|58779507|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
30770506|NCT01147666|58779508|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
30659995|NCT00610363|58672730|FG000|Overall Study|Withdrawal by Subject|1|||
30659996|NCT00610363|58672731|FG001|Overall Study|Withdrawal by Subject|0|||
30659997|NCT00610363|58672730|FG000|Overall Study|Other than specified above|1|||
30659998|NCT00610363|58672731|FG001|Overall Study|Other than specified above|1|||
30659999|NCT00887588|58672740|FG000|Core Period|Death|1|||
30660000|NCT00887588|58672741|FG001|Core Period|Death|1|||
30660001|NCT00887588|58672740|FG000|Core Period|Lost to Follow-up|3|||
30660002|NCT00887588|58672741|FG001|Core Period|Lost to Follow-up|1|||
30660003|NCT00887588|58672740|FG000|Core Period|Withdrawal by Subject|6|||
30660004|NCT00887588|58672741|FG001|Core Period|Withdrawal by Subject|8|||
30849053|NCT00707577|58875793|FG000|Overall Study|Left employment|13|||
30660005|NCT00887588|58672740|FG000|Core Period|Adverse Event|9|||
30660006|NCT00887588|58672741|FG001|Core Period|Adverse Event|11|||
30660007|NCT00887588|58672740|FG000|Extension Period|Adverse Event|4|||
30660008|NCT00887588|58672741|FG001|Extension Period|Adverse Event|4|||
30660009|NCT00887588|58672740|FG000|Extension Period|Death|0|||
30660010|NCT00887588|58672741|FG001|Extension Period|Death|1|||
30660011|NCT00887588|58672740|FG000|Extension Period|Protocol deviation|1|||
30660012|NCT00887588|58672741|FG001|Extension Period|Protocol deviation|0|||
30660013|NCT00887588|58672740|FG000|Extension Period|Lost to Follow-up|1|||
30660014|NCT00887588|58672741|FG001|Extension Period|Lost to Follow-up|0|||
30660015|NCT00945893|58672749|FG000|Overall Study|Lost to Follow-up|2|||
30660016|NCT00945893|58672750|FG001|Overall Study|Lost to Follow-up|8|||
30660017|NCT00945893|58672749|FG000|Overall Study|Withdrawal of consent|1|||
30660018|NCT00945893|58672750|FG001|Overall Study|Withdrawal of consent|2|||
30660019|NCT00799383|58672762|FG000|Overall Study|Protocol Violation|1|||
30660020|NCT00799383|58672763|FG001|Overall Study|Protocol Violation|1|||
30660021|NCT00799383|58672762|FG000|Overall Study|Adverse Event|0|||
30660022|NCT00799383|58672763|FG001|Overall Study|Adverse Event|1|||
30660023|NCT00799383|58672762|FG000|Overall Study|Lost to Follow-up|1|||
30660024|NCT00799383|58672763|FG001|Overall Study|Lost to Follow-up|2|||
30660025|NCT00799383|58672762|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
30660026|NCT00799383|58672763|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
30660027|NCT00799383|58672762|FG000|Overall Study|Withdrawal by Subject|0|||
30660028|NCT00799383|58672763|FG001|Overall Study|Withdrawal by Subject|1|||
30660029|NCT00610207|58672769|FG000|Overall Study|Lost to Follow-up|3|||
30660030|NCT00798759|58672775|FG000|Overall Study|Adverse Event|3|||
30660031|NCT00798759|58672776|FG001|Overall Study|Adverse Event|3|||
30660032|NCT00798759|58672775|FG000|Overall Study|Lost to Follow-up|1|||
30660033|NCT00798759|58672776|FG001|Overall Study|Lost to Follow-up|1|||
30660034|NCT00798759|58672775|FG000|Overall Study|Protocol Violation|4|||
30660035|NCT00798759|58672776|FG001|Overall Study|Protocol Violation|8|||
30660036|NCT00798759|58672775|FG000|Overall Study|Other|0|||
30660037|NCT00798759|58672776|FG001|Overall Study|Other|1|||
30660038|NCT00887432|58672784|FG000|Overall Study|Start Excluded Therapy|3|||
30660039|NCT00887432|58672785|FG001|Overall Study|Start Excluded Therapy|0|||
30660040|NCT00887432|58672784|FG000|Overall Study|Did not complete treatment|6|||
30660041|NCT00887432|58672785|FG001|Overall Study|Did not complete treatment|8|||
30660042|NCT00887432|58672784|FG000|Overall Study|Protocol Violation|2|||
30660043|NCT00887432|58672785|FG001|Overall Study|Protocol Violation|3|||
30660044|NCT00887432|58672784|FG000|Overall Study|Withdrawal by Subject|3|||
30660045|NCT00887432|58672785|FG001|Overall Study|Withdrawal by Subject|2|||
30660046|NCT00887432|58672784|FG000|Overall Study|Lost to Follow-up|1|||
30660047|NCT00887432|58672785|FG001|Overall Study|Lost to Follow-up|0|||
30660048|NCT00887432|58672784|FG000|Overall Study|No reason provided|0|||
30660049|NCT00887432|58672785|FG001|Overall Study|No reason provided|1|||
30660050|NCT00951275|58672791|FG000|Overall Study|Administrative Reason|1|||
30660051|NCT00951275|58672791|FG000|Overall Study|Adverse Event|7|||
30660052|NCT00951275|58672791|FG000|Overall Study|Withdrawal by Subject|4|||
30660053|NCT00951275|58672791|FG000|Overall Study|Protocol Violation|1|||
30660054|NCT00798603|58672795|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
30660055|NCT00798603|58672795|FG000|Overall Study|Withdrawal by Subject|10|||
30660056|NCT00798603|58672795|FG000|Overall Study|Adverse Event|22|||
30660057|NCT00798603|58672795|FG000|Overall Study|Physician Decision|1|||
30660058|NCT00798603|58672795|FG000|Overall Study|Lack of insurance coverage|1|||
30660059|NCT00887354|58672801|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
30660060|NCT00887354|58672802|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
30660061|NCT00887354|58672801|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
30660062|NCT00887354|58672802|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
30660063|NCT00887354|58672801|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
30660064|NCT00887354|58672802|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
30849054|NCT00707577|58875794|FG001|Overall Study|Left employment|10|||
30849055|NCT00707577|58875793|FG000|Overall Study|Pregnancy|4|||
30660065|NCT00887354|58672801|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
30660066|NCT00887354|58672802|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
30660067|NCT00887354|58672801|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
30660068|NCT00887354|58672802|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
30660069|NCT00887354|58672801|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
30660070|NCT00887354|58672802|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
30660071|NCT00887354|58672801|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
30660072|NCT00887354|58672802|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
30660073|NCT00887354|58672801|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
30660074|NCT00887354|58672802|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
30660075|NCT00887354|58672801|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
30660076|NCT00887354|58672802|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
30660077|NCT00887354|58672801|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
30849056|NCT00707577|58875794|FG001|Overall Study|Pregnancy|1|||
30660078|NCT00887354|58672802|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
30660079|NCT00887354|58672801|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
30660080|NCT00887354|58672802|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
30660081|NCT00887354|58672801|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
30660082|NCT00887354|58672802|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
30660083|NCT00887354|58672801|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
30660084|NCT00887354|58672802|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
30660085|NCT00887354|58672801|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
30660086|NCT00887354|58672802|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
30660087|NCT00887354|58672801|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
30660088|NCT00887354|58672802|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
30660089|NCT00951041|58672811|FG000|Overall Study|Withdrawal by Subject|1|||
30660090|NCT00951041|58672812|FG001|Overall Study|Withdrawal by Subject|1|||
30770507|NCT01147666|58779509|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
30770508|NCT01147666|58779510|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
30770509|NCT01147666|58779511|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
30770510|NCT01147666|58779512|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
30770511|NCT01147666|58779513|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
30770512|NCT01147666|58779514|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
30770513|NCT01147666|58779500|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
30770514|NCT01147666|58779501|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
30770515|NCT01147666|58779502|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
30770516|NCT01147666|58779503|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
30770517|NCT01147666|58779504|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
30770518|NCT01147666|58779505|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
30770519|NCT01147666|58779506|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
30770520|NCT01147666|58779507|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
30770521|NCT01147666|58779508|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
30770522|NCT01147666|58779509|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
30770523|NCT01147666|58779510|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
30770524|NCT01147666|58779511|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
30770525|NCT01147666|58779512|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
30770526|NCT01147666|58779513|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
30770527|NCT01147666|58779514|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
30770528|NCT01147666|58779500|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
30770529|NCT01147666|58779501|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
30770530|NCT01147666|58779502|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
30770531|NCT01147666|58779503|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
30770532|NCT01147666|58779504|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
30770533|NCT01147666|58779505|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
30770534|NCT01147666|58779506|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
30770535|NCT01147666|58779507|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
30770536|NCT01147666|58779508|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
30770537|NCT01147666|58779509|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
30770538|NCT01147666|58779510|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
30770539|NCT01147666|58779511|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
30770540|NCT01147666|58779512|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
30770541|NCT01147666|58779513|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
30770542|NCT01147666|58779514|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
30770543|NCT01147666|58779500|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
30770544|NCT01147666|58779501|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30849057|NCT01675622|58875802|FG000|Overall Study|Withdrawal by Subject|2|||
30849058|NCT01675622|58875803|FG001|Overall Study|Withdrawal by Subject|2|||
30849059|NCT01675622|58875802|FG000|Overall Study|Adverse Event|12|||
30849060|NCT01675622|58875803|FG001|Overall Study|Adverse Event|10|||
30849061|NCT01675622|58875802|FG000|Overall Study|Protocol Violation|4|||
30849062|NCT01675622|58875803|FG001|Overall Study|Protocol Violation|1|||
30849063|NCT01675622|58875802|FG000|Overall Study|Lack of Efficacy|2|||
30849064|NCT01675622|58875803|FG001|Overall Study|Lack of Efficacy|4|||
30849065|NCT01675622|58875802|FG000|Overall Study|Lost to Follow-up|1|||
30849066|NCT01675622|58875803|FG001|Overall Study|Lost to Follow-up|3|||
30849067|NCT01675622|58875802|FG000|Overall Study|Other|5|||
30849068|NCT01675622|58875803|FG001|Overall Study|Other|4|||
30952598|NCT01895543|59001465|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
30770545|NCT01147666|58779502|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30770546|NCT01147666|58779503|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
30770547|NCT01147666|58779504|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30849069|NCT02655224|58875811|FG000|Overall Study|Adverse Event|1|||
30849070|NCT02655224|58875812|FG001|Overall Study|Adverse Event|1|||
30849071|NCT01675544|58875818|FG000|Overall Study|Withdrawal by Subject|2|||
30849072|NCT02838901|58875861|FG000|Overall Study|Withdrawal by Subject|1|||
30849073|NCT02838901|58875862|FG001|Overall Study|Withdrawal by Subject|1|||
30770548|NCT01147666|58779505|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30770549|NCT01147666|58779506|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30770550|NCT01147666|58779507|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30770551|NCT01147666|58779508|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30849074|NCT02838901|58875861|FG000|Overall Study|Lost to Follow-up|1|||
30770552|NCT01147666|58779509|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30770553|NCT01147666|58779510|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
30770554|NCT01147666|58779511|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30770555|NCT01147666|58779512|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30770556|NCT01147666|58779513|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30770557|NCT01147666|58779514|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
30770558|NCT01147666|58779500|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
30770559|NCT01147666|58779501|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
30770560|NCT01147666|58779502|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
30770561|NCT01147666|58779503|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
30770562|NCT01147666|58779504|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
30770563|NCT01147666|58779505|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
30770564|NCT01147666|58779506|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
30770565|NCT01147666|58779507|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
30770566|NCT01147666|58779508|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
30770567|NCT01147666|58779509|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
30770568|NCT01147666|58779510|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
30770569|NCT01147666|58779511|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
30770570|NCT01147666|58779512|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
30770571|NCT01147666|58779513|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
30770572|NCT01147666|58779514|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
30770573|NCT01147666|58779500|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770574|NCT01147666|58779501|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770575|NCT01147666|58779502|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770576|NCT01147666|58779503|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
30770577|NCT01147666|58779504|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770578|NCT01147666|58779505|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770579|NCT01147666|58779506|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770580|NCT01147666|58779507|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770581|NCT01147666|58779508|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770582|NCT01147666|58779509|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770583|NCT01147666|58779510|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
30770584|NCT01147666|58779511|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770585|NCT01147666|58779512|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770586|NCT01147666|58779513|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770587|NCT01147666|58779514|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
30770588|NCT01147666|58779500|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770589|NCT01147666|58779501|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770590|NCT01147666|58779502|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770591|NCT01147666|58779503|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770592|NCT01147666|58779504|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770593|NCT01147666|58779505|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770594|NCT01147666|58779506|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770595|NCT01147666|58779507|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770596|NCT01147666|58779508|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770597|NCT01147666|58779509|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770598|NCT01147666|58779510|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770599|NCT01147666|58779511|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
30770600|NCT01147666|58779512|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
30770601|NCT01147666|58779513|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
30770602|NCT01147666|58779514|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
30770603|NCT01147666|58779500|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
30770604|NCT01147666|58779501|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
30770605|NCT01147666|58779502|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
30770606|NCT01147666|58779503|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
30770607|NCT01147666|58779504|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
30849075|NCT02838901|58875862|FG001|Overall Study|Lost to Follow-up|1|||
30849076|NCT00706797|58875890|FG000|Overall Study|Lack of Efficacy|3|||
30849077|NCT00706797|58875891|FG001|Overall Study|Lack of Efficacy|0|||
30660091|NCT00951041|58672811|FG000|Overall Study|Lost to Follow-up|1|||
30660092|NCT00951041|58672812|FG001|Overall Study|Lost to Follow-up|0|||
30660093|NCT00951041|58672811|FG000|Overall Study|Other|3|||
30660094|NCT00951041|58672812|FG001|Overall Study|Other|0|||
30660095|NCT02763462|58672819|FG000|Overall Study|Protocol Violation|6|||
30660096|NCT00610129|58672833|FG000|Overall Study|Not treated since patients ineligible|3|||
30660097|NCT00945815|58672837|FG000|Overall Study|Death|3|||
30660098|NCT00945815|58672837|FG000|Overall Study|Not protocol specified|1|||
30660099|NCT00945815|58672837|FG000|Overall Study|Ineligible|3|||
30660100|NCT00945815|58672837|FG000|Overall Study|Did not begin protocol therapy|1|||
30660101|NCT00606307|58672841|FG000|Overall Study|Adverse Event|2|||
30660102|NCT00606307|58672841|FG000|Overall Study|Withdrawal by Subject|2|||
30660103|NCT00606307|58672841|FG000|Overall Study|Disease progression|6|||
30660104|NCT00606307|58672841|FG000|Overall Study|QTc prolongation|1|||
30660105|NCT00798369|58672851|FG000|Overall Study|Subject withdrew consent|0|||
30660106|NCT00798369|58672852|FG001|Overall Study|Subject withdrew consent|0|||
30660107|NCT00798369|58672853|FG002|Overall Study|Subject withdrew consent|1|||
30660108|NCT00798369|58672854|FG003|Overall Study|Subject withdrew consent|1|||
30660109|NCT00798369|58672855|FG004|Overall Study|Subject withdrew consent|0|||
30660110|NCT00798369|58672856|FG005|Overall Study|Subject withdrew consent|2|||
30660111|NCT00798369|58672851|FG000|Overall Study|Lost to Follow-up|1|||
30660112|NCT00798369|58672852|FG001|Overall Study|Lost to Follow-up|1|||
30660113|NCT00798369|58672853|FG002|Overall Study|Lost to Follow-up|1|||
30660114|NCT00798369|58672854|FG003|Overall Study|Lost to Follow-up|0|||
30660115|NCT00798369|58672855|FG004|Overall Study|Lost to Follow-up|1|||
30660116|NCT00798369|58672856|FG005|Overall Study|Lost to Follow-up|0|||
30660117|NCT00798369|58672851|FG000|Overall Study|Adminstrative problems|0|||
30660118|NCT00798369|58672852|FG001|Overall Study|Adminstrative problems|0|||
30660119|NCT00798369|58672853|FG002|Overall Study|Adminstrative problems|0|||
30660120|NCT00798369|58672854|FG003|Overall Study|Adminstrative problems|0|||
30660121|NCT00798369|58672855|FG004|Overall Study|Adminstrative problems|0|||
30660122|NCT00798369|58672856|FG005|Overall Study|Adminstrative problems|1|||
30660123|NCT00950963|58672873|FG000|Overall Study|Lost to Follow-up|29|||
30660124|NCT00950963|58672874|FG001|Overall Study|Lost to Follow-up|24|||
30660125|NCT00608959|58672882|FG000|Part 1|Did not meet eligibility criteria|1|||
30660126|NCT00945659|58672895|FG000|Overall Study|Lost to Follow-up|7|||
30660127|NCT00945659|58672896|FG001|Overall Study|Lost to Follow-up|20|||
30660128|NCT00945659|58672897|FG002|Overall Study|Lost to Follow-up|17|||
30770608|NCT01147666|58779505|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
30770609|NCT01147666|58779506|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
30660129|NCT00798135|58672905|FG000|Overall Study|Disease progression, relapse|11|||
30660130|NCT00798135|58672905|FG000|Overall Study|Disease progression, refractory|1|||
30660131|NCT00798135|58672905|FG000|Overall Study|Physician Decision|1|||
30660132|NCT00941603|58672915|FG000|Overall Study|Adverse Event|10|||
30770610|NCT01147666|58779507|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
30770611|NCT01147666|58779508|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
30770612|NCT01147666|58779509|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
30770613|NCT01147666|58779510|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
30770614|NCT01147666|58779511|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
30770615|NCT01147666|58779512|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
30770616|NCT01147666|58779513|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
30770617|NCT01147666|58779514|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
30660133|NCT00941603|58672916|FG001|Overall Study|Adverse Event|15|||
30660134|NCT00941603|58672917|FG002|Overall Study|Adverse Event|5|||
30660135|NCT00941603|58672918|FG003|Overall Study|Adverse Event|1|||
30660136|NCT00941603|58672919|FG004|Overall Study|Adverse Event|4|||
30660137|NCT00941603|58672920|FG005|Overall Study|Adverse Event|0|||
30660138|NCT00941603|58672915|FG000|Overall Study|Lost to Follow-up|0|||
30660139|NCT00941603|58672916|FG001|Overall Study|Lost to Follow-up|0|||
30660140|NCT00941603|58672917|FG002|Overall Study|Lost to Follow-up|0|||
30660141|NCT00941603|58672918|FG003|Overall Study|Lost to Follow-up|1|||
30660142|NCT00941603|58672919|FG004|Overall Study|Lost to Follow-up|0|||
30770618|NCT01147666|58779500|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
30660143|NCT00941603|58672920|FG005|Overall Study|Lost to Follow-up|2|||
30660144|NCT00941603|58672915|FG000|Overall Study|Withdrawal by Subject|0|||
30660145|NCT00941603|58672916|FG001|Overall Study|Withdrawal by Subject|0|||
30660146|NCT00941603|58672917|FG002|Overall Study|Withdrawal by Subject|0|||
30660147|NCT00941603|58672918|FG003|Overall Study|Withdrawal by Subject|2|||
30770619|NCT01147666|58779501|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
30770620|NCT01147666|58779502|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
30660148|NCT00941603|58672919|FG004|Overall Study|Withdrawal by Subject|0|||
30660149|NCT00941603|58672920|FG005|Overall Study|Withdrawal by Subject|1|||
30660150|NCT00941603|58672915|FG000|Overall Study|Protocol Violation|0|||
30660151|NCT00941603|58672916|FG001|Overall Study|Protocol Violation|1|||
30660152|NCT00941603|58672917|FG002|Overall Study|Protocol Violation|0|||
30849078|NCT00706797|58875890|FG000|Overall Study|Adverse Event|0|||
30660153|NCT00941603|58672918|FG003|Overall Study|Protocol Violation|0|||
30660154|NCT00941603|58672919|FG004|Overall Study|Protocol Violation|0|||
30660155|NCT00941603|58672920|FG005|Overall Study|Protocol Violation|0|||
30660156|NCT00941603|58672915|FG000|Overall Study|Did not meet protocol eligibility|1|||
30660157|NCT00941603|58672916|FG001|Overall Study|Did not meet protocol eligibility|0|||
30660158|NCT00941603|58672917|FG002|Overall Study|Did not meet protocol eligibility|0|||
30660159|NCT00941603|58672918|FG003|Overall Study|Did not meet protocol eligibility|0|||
30660160|NCT00941603|58672919|FG004|Overall Study|Did not meet protocol eligibility|0|||
30660161|NCT00941603|58672920|FG005|Overall Study|Did not meet protocol eligibility|0|||
30660162|NCT00797823|58672937|FG000|First Period (Initial Randomization)|Physician Decision|1|||
30660163|NCT00797823|58672938|FG001|First Period (Initial Randomization)|Physician Decision|0|||
30660164|NCT00797823|58672939|FG002|First Period (Initial Randomization)|Physician Decision|0|||
30660165|NCT00797667|58672949|FG000|Overall Study|Lack of Efficacy|0|||
30660166|NCT00797667|58672950|FG001|Overall Study|Lack of Efficacy|1|||
30660167|NCT00797667|58672951|FG002|Overall Study|Lack of Efficacy|0|||
30660168|NCT00797667|58672949|FG000|Overall Study|Lost to Follow-up|8|||
30660169|NCT00797667|58672950|FG001|Overall Study|Lost to Follow-up|12|||
30660170|NCT00797667|58672951|FG002|Overall Study|Lost to Follow-up|2|||
30660171|NCT00797667|58672949|FG000|Overall Study|Physician Decision|3|||
30660172|NCT00797667|58672950|FG001|Overall Study|Physician Decision|1|||
30660173|NCT00797667|58672951|FG002|Overall Study|Physician Decision|0|||
30660174|NCT00797667|58672949|FG000|Overall Study|Pregnancy|2|||
30660175|NCT00797667|58672950|FG001|Overall Study|Pregnancy|0|||
30660176|NCT00797667|58672951|FG002|Overall Study|Pregnancy|0|||
30660177|NCT00797667|58672949|FG000|Overall Study|Protocol Violation|2|||
30660178|NCT00797667|58672950|FG001|Overall Study|Protocol Violation|7|||
30660179|NCT00797667|58672951|FG002|Overall Study|Protocol Violation|0|||
30660180|NCT00797667|58672949|FG000|Overall Study|Study Terminated by Sponsor|217|||
30660181|NCT00797667|58672950|FG001|Overall Study|Study Terminated by Sponsor|216|||
30660182|NCT00797667|58672951|FG002|Overall Study|Study Terminated by Sponsor|115|||
30660183|NCT00797667|58672949|FG000|Overall Study|Withdrawal by Subject|9|||
30770621|NCT01147666|58779503|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
30770622|NCT01147666|58779504|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
30770623|NCT01147666|58779505|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
30660184|NCT00797667|58672950|FG001|Overall Study|Withdrawal by Subject|14|||
30660185|NCT00797667|58672951|FG002|Overall Study|Withdrawal by Subject|2|||
30660186|NCT00797667|58672949|FG000|Overall Study|Adverse Event|19|||
30660187|NCT00797667|58672950|FG001|Overall Study|Adverse Event|8|||
30660188|NCT00797667|58672951|FG002|Overall Study|Adverse Event|8|||
30660189|NCT00950807|58672959|FG000|Treatment Period 1|Lack of Efficacy|1|||
30660190|NCT00950807|58672960|FG001|Treatment Period 1|Lack of Efficacy|0|||
30660191|NCT00950807|58672961|FG002|Treatment Period 1|Lack of Efficacy|0|||
30660192|NCT00950807|58672962|FG003|Treatment Period 1|Lack of Efficacy|0|||
30660193|NCT00950807|58672963|FG004|Treatment Period 1|Lack of Efficacy|0|||
30660194|NCT00950807|58672964|FG005|Treatment Period 1|Lack of Efficacy|1|||
30660195|NCT00950807|58672965|FG006|Treatment Period 1|Lack of Efficacy|0|||
30660196|NCT00950807|58672966|FG007|Treatment Period 1|Lack of Efficacy|0|||
30660197|NCT00950807|58672967|FG008|Treatment Period 1|Lack of Efficacy|0|||
30660198|NCT00950807|58672968|FG009|Treatment Period 1|Lack of Efficacy|0|||
30660199|NCT00950807|58672959|FG000|Treatment Period 1|Protocol Violation|1|||
30660200|NCT00950807|58672960|FG001|Treatment Period 1|Protocol Violation|0|||
30660201|NCT00950807|58672961|FG002|Treatment Period 1|Protocol Violation|0|||
30660202|NCT00950807|58672962|FG003|Treatment Period 1|Protocol Violation|0|||
30660203|NCT00950807|58672963|FG004|Treatment Period 1|Protocol Violation|0|||
30660204|NCT00950807|58672964|FG005|Treatment Period 1|Protocol Violation|0|||
30660205|NCT00950807|58672965|FG006|Treatment Period 1|Protocol Violation|0|||
30770624|NCT01147666|58779506|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
30770625|NCT01147666|58779507|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
30770626|NCT01147666|58779508|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
30770627|NCT01147666|58779509|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
30770628|NCT01147666|58779510|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
30770629|NCT01147666|58779511|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
30660206|NCT00950807|58672966|FG007|Treatment Period 1|Protocol Violation|0|||
30660207|NCT00950807|58672967|FG008|Treatment Period 1|Protocol Violation|0|||
30660208|NCT00950807|58672968|FG009|Treatment Period 1|Protocol Violation|0|||
30660209|NCT00950807|58672959|FG000|Treatment Period 1|Lost to Follow-up|0|||
30660210|NCT00950807|58672960|FG001|Treatment Period 1|Lost to Follow-up|0|||
30660211|NCT00950807|58672961|FG002|Treatment Period 1|Lost to Follow-up|1|||
30660212|NCT00950807|58672962|FG003|Treatment Period 1|Lost to Follow-up|0|||
30660213|NCT00950807|58672963|FG004|Treatment Period 1|Lost to Follow-up|0|||
30849079|NCT00706797|58875891|FG001|Overall Study|Adverse Event|3|||
30660214|NCT00950807|58672964|FG005|Treatment Period 1|Lost to Follow-up|0|||
30660215|NCT00950807|58672965|FG006|Treatment Period 1|Lost to Follow-up|0|||
30660216|NCT00950807|58672966|FG007|Treatment Period 1|Lost to Follow-up|0|||
30660217|NCT00950807|58672967|FG008|Treatment Period 1|Lost to Follow-up|0|||
30660218|NCT00950807|58672968|FG009|Treatment Period 1|Lost to Follow-up|0|||
30660219|NCT00950807|58672959|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30660220|NCT00950807|58672960|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30660221|NCT00950807|58672961|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30660222|NCT00950807|58672962|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30660223|NCT00950807|58672963|FG004|Treatment Period 1|Withdrawal by Subject|1|||
30660224|NCT00950807|58672964|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30660225|NCT00950807|58672965|FG006|Treatment Period 1|Withdrawal by Subject|0|||
30660226|NCT00950807|58672966|FG007|Treatment Period 1|Withdrawal by Subject|0|||
30660227|NCT00950807|58672967|FG008|Treatment Period 1|Withdrawal by Subject|1|||
30770630|NCT01147666|58779512|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
30770631|NCT01147666|58779513|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
30770632|NCT01147666|58779514|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
30770633|NCT01147666|58779500|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770634|NCT01147666|58779501|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770635|NCT01147666|58779502|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770636|NCT01147666|58779503|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
30770637|NCT01147666|58779504|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770638|NCT01147666|58779505|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770639|NCT01147666|58779506|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770640|NCT01147666|58779507|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770641|NCT01147666|58779508|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770642|NCT01147666|58779509|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770643|NCT01147666|58779510|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770644|NCT01147666|58779511|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770645|NCT01147666|58779512|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770646|NCT01147666|58779513|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770647|NCT01147666|58779514|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
30770648|NCT01147666|58779500|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
30770649|NCT01147666|58779501|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
30770650|NCT01147666|58779502|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
30770651|NCT01147666|58779503|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
30770652|NCT01147666|58779504|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
30770653|NCT01147666|58779505|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
30770654|NCT01147666|58779506|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
30660228|NCT00950807|58672968|FG009|Treatment Period 1|Withdrawal by Subject|0|||
30660229|NCT00950807|58672959|FG000|Treatment Period 1|Adverse Event|0|||
30660230|NCT00950807|58672960|FG001|Treatment Period 1|Adverse Event|0|||
30660231|NCT00950807|58672961|FG002|Treatment Period 1|Adverse Event|0|||
30660232|NCT00950807|58672962|FG003|Treatment Period 1|Adverse Event|0|||
30660233|NCT00950807|58672963|FG004|Treatment Period 1|Adverse Event|0|||
30660234|NCT00950807|58672964|FG005|Treatment Period 1|Adverse Event|1|||
30660235|NCT00950807|58672965|FG006|Treatment Period 1|Adverse Event|0|||
30660236|NCT00950807|58672966|FG007|Treatment Period 1|Adverse Event|0|||
30660237|NCT00950807|58672967|FG008|Treatment Period 1|Adverse Event|0|||
30660238|NCT00950807|58672968|FG009|Treatment Period 1|Adverse Event|0|||
30660239|NCT00950807|58672959|FG000|Washout Period 1|Lack of Efficacy|0|||
30660240|NCT00950807|58672960|FG001|Washout Period 1|Lack of Efficacy|0|||
30660241|NCT00950807|58672961|FG002|Washout Period 1|Lack of Efficacy|0|||
30660242|NCT00950807|58672962|FG003|Washout Period 1|Lack of Efficacy|0|||
30660243|NCT00950807|58672963|FG004|Washout Period 1|Lack of Efficacy|0|||
30660244|NCT00950807|58672964|FG005|Washout Period 1|Lack of Efficacy|0|||
30660245|NCT00950807|58672965|FG006|Washout Period 1|Lack of Efficacy|1|||
30660246|NCT00950807|58672966|FG007|Washout Period 1|Lack of Efficacy|0|||
30660247|NCT00950807|58672967|FG008|Washout Period 1|Lack of Efficacy|0|||
30660248|NCT00950807|58672968|FG009|Washout Period 1|Lack of Efficacy|0|||
30660249|NCT00950807|58672959|FG000|Washout Period 1|Withdrawal by Subject|0|||
30660250|NCT00950807|58672960|FG001|Washout Period 1|Withdrawal by Subject|0|||
30660251|NCT00950807|58672961|FG002|Washout Period 1|Withdrawal by Subject|0|||
30660252|NCT00950807|58672962|FG003|Washout Period 1|Withdrawal by Subject|0|||
30660253|NCT00950807|58672963|FG004|Washout Period 1|Withdrawal by Subject|0|||
30660254|NCT00950807|58672964|FG005|Washout Period 1|Withdrawal by Subject|0|||
30770655|NCT01147666|58779507|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
30770656|NCT01147666|58779508|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
30660255|NCT00950807|58672965|FG006|Washout Period 1|Withdrawal by Subject|0|||
30660256|NCT00950807|58672966|FG007|Washout Period 1|Withdrawal by Subject|0|||
30660257|NCT00950807|58672967|FG008|Washout Period 1|Withdrawal by Subject|1|||
30660258|NCT00950807|58672968|FG009|Washout Period 1|Withdrawal by Subject|0|||
30660259|NCT00950807|58672959|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
30660260|NCT00950807|58672960|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
30660261|NCT00950807|58672961|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
30660262|NCT00950807|58672962|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
30660263|NCT00950807|58672963|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
30660264|NCT00950807|58672964|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
30660265|NCT00950807|58672965|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
30660266|NCT00950807|58672966|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
30660267|NCT00950807|58672967|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
30660268|NCT00950807|58672968|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
30660269|NCT00950807|58672959|FG000|Washout Period 1|Adverse Event|2|||
30660270|NCT00950807|58672960|FG001|Washout Period 1|Adverse Event|0|||
30660271|NCT00950807|58672961|FG002|Washout Period 1|Adverse Event|0|||
30660272|NCT00950807|58672962|FG003|Washout Period 1|Adverse Event|1|||
30660273|NCT00950807|58672963|FG004|Washout Period 1|Adverse Event|1|||
30660274|NCT00950807|58672964|FG005|Washout Period 1|Adverse Event|0|||
30660275|NCT00950807|58672965|FG006|Washout Period 1|Adverse Event|0|||
30660276|NCT00950807|58672966|FG007|Washout Period 1|Adverse Event|0|||
30660277|NCT00950807|58672967|FG008|Washout Period 1|Adverse Event|0|||
30660278|NCT00950807|58672968|FG009|Washout Period 1|Adverse Event|0|||
30660279|NCT00950807|58672959|FG000|Treatment Period 2|Lack of Efficacy|1|||
30660280|NCT00950807|58672960|FG001|Treatment Period 2|Lack of Efficacy|0|||
30660281|NCT00950807|58672961|FG002|Treatment Period 2|Lack of Efficacy|0|||
30660282|NCT00950807|58672962|FG003|Treatment Period 2|Lack of Efficacy|0|||
30660283|NCT00950807|58672963|FG004|Treatment Period 2|Lack of Efficacy|0|||
30660284|NCT00950807|58672964|FG005|Treatment Period 2|Lack of Efficacy|0|||
30660285|NCT00950807|58672965|FG006|Treatment Period 2|Lack of Efficacy|0|||
30660286|NCT00950807|58672966|FG007|Treatment Period 2|Lack of Efficacy|0|||
30660287|NCT00950807|58672967|FG008|Treatment Period 2|Lack of Efficacy|0|||
30660288|NCT00950807|58672968|FG009|Treatment Period 2|Lack of Efficacy|0|||
30660289|NCT00950807|58672959|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30660290|NCT00950807|58672960|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30660291|NCT00950807|58672961|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30660292|NCT00950807|58672962|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30660293|NCT00950807|58672963|FG004|Treatment Period 2|Withdrawal by Subject|0|||
30770657|NCT01147666|58779509|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
30770658|NCT01147666|58779510|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
30770659|NCT01147666|58779511|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
30770660|NCT01147666|58779512|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
30770661|NCT01147666|58779513|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
30770662|NCT01147666|58779514|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
30770663|NCT01147666|58779500|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770664|NCT01147666|58779501|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770665|NCT01147666|58779502|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770666|NCT01147666|58779503|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
30770667|NCT01147666|58779504|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770668|NCT01147666|58779505|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30952599|NCT04828161|59001562|FG000|Overall Study|Withdrawal by Subject|0|||
30952600|NCT04828161|59001563|FG001|Overall Study|Withdrawal by Subject|3|||
30952601|NCT04828161|59001564|FG002|Overall Study|Withdrawal by Subject|3|||
30770669|NCT01147666|58779506|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770670|NCT01147666|58779507|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770671|NCT01147666|58779508|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770672|NCT01147666|58779509|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770673|NCT01147666|58779510|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
30770674|NCT01147666|58779511|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770675|NCT01147666|58779512|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770676|NCT01147666|58779513|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770677|NCT01147666|58779514|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
30770678|NCT01147666|58779500|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30770679|NCT01147666|58779501|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30952602|NCT04828161|59001565|FG003|Overall Study|Withdrawal by Subject|4|||
30952603|NCT04828161|59001562|FG000|Overall Study|Lost to Follow-up|1|||
30660294|NCT00950807|58672964|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30660295|NCT00950807|58672965|FG006|Treatment Period 2|Withdrawal by Subject|1|||
30770680|NCT01147666|58779502|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30770681|NCT01147666|58779503|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30952604|NCT04828161|59001563|FG001|Overall Study|Lost to Follow-up|4|||
30660296|NCT00950807|58672966|FG007|Treatment Period 2|Withdrawal by Subject|2|||
30660297|NCT00950807|58672967|FG008|Treatment Period 2|Withdrawal by Subject|0|||
30660298|NCT00950807|58672968|FG009|Treatment Period 2|Withdrawal by Subject|0|||
30660299|NCT00950807|58672959|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
30660300|NCT00950807|58672960|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30660301|NCT00950807|58672961|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30770682|NCT01147666|58779504|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30660302|NCT00950807|58672962|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30660303|NCT00950807|58672963|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30660304|NCT00950807|58672964|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30660305|NCT00950807|58672965|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30660306|NCT00950807|58672966|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30660307|NCT00950807|58672967|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30660308|NCT00950807|58672968|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
30660309|NCT00950807|58672959|FG000|Treatment Period 2|Adverse Event|0|||
30660310|NCT00950807|58672960|FG001|Treatment Period 2|Adverse Event|1|||
30660311|NCT00950807|58672961|FG002|Treatment Period 2|Adverse Event|0|||
30660312|NCT00950807|58672962|FG003|Treatment Period 2|Adverse Event|1|||
30660313|NCT00950807|58672963|FG004|Treatment Period 2|Adverse Event|0|||
30660314|NCT00950807|58672964|FG005|Treatment Period 2|Adverse Event|1|||
30660315|NCT00950807|58672965|FG006|Treatment Period 2|Adverse Event|0|||
30660316|NCT00950807|58672966|FG007|Treatment Period 2|Adverse Event|1|||
30660317|NCT00950807|58672967|FG008|Treatment Period 2|Adverse Event|0|||
30660318|NCT00950807|58672968|FG009|Treatment Period 2|Adverse Event|0|||
30660319|NCT00950807|58672959|FG000|Washout Period 2|Lack of Efficacy|1|||
30660320|NCT00950807|58672960|FG001|Washout Period 2|Lack of Efficacy|0|||
30660321|NCT00950807|58672961|FG002|Washout Period 2|Lack of Efficacy|0|||
30660322|NCT00950807|58672962|FG003|Washout Period 2|Lack of Efficacy|0|||
30660323|NCT00950807|58672963|FG004|Washout Period 2|Lack of Efficacy|0|||
30660324|NCT00950807|58672964|FG005|Washout Period 2|Lack of Efficacy|0|||
30660325|NCT00950807|58672965|FG006|Washout Period 2|Lack of Efficacy|0|||
30660326|NCT00950807|58672966|FG007|Washout Period 2|Lack of Efficacy|0|||
30660327|NCT00950807|58672967|FG008|Washout Period 2|Lack of Efficacy|0|||
30660328|NCT00950807|58672968|FG009|Washout Period 2|Lack of Efficacy|0|||
30660329|NCT00950807|58672959|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
30660330|NCT00950807|58672960|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
30660331|NCT00950807|58672961|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
30660332|NCT00950807|58672962|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
30660333|NCT00950807|58672963|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
30660334|NCT00950807|58672964|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
30660335|NCT00950807|58672965|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
30660336|NCT00950807|58672966|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
30660337|NCT00950807|58672967|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
30660338|NCT00950807|58672968|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
30660339|NCT00950807|58672959|FG000|Washout Period 2|Adverse Event|3|||
30660340|NCT00950807|58672960|FG001|Washout Period 2|Adverse Event|0|||
30660341|NCT00950807|58672961|FG002|Washout Period 2|Adverse Event|0|||
30660342|NCT00950807|58672962|FG003|Washout Period 2|Adverse Event|1|||
30660343|NCT00950807|58672963|FG004|Washout Period 2|Adverse Event|0|||
30660344|NCT00950807|58672964|FG005|Washout Period 2|Adverse Event|0|||
30660345|NCT00950807|58672965|FG006|Washout Period 2|Adverse Event|0|||
30660346|NCT00950807|58672966|FG007|Washout Period 2|Adverse Event|0|||
30660347|NCT00950807|58672967|FG008|Washout Period 2|Adverse Event|0|||
30660348|NCT00950807|58672968|FG009|Washout Period 2|Adverse Event|0|||
30660349|NCT00950807|58672959|FG000|Treatment Period 3|Withdrawal by Subject|0|||
30660350|NCT00950807|58672960|FG001|Treatment Period 3|Withdrawal by Subject|0|||
30660351|NCT00950807|58672961|FG002|Treatment Period 3|Withdrawal by Subject|0|||
30660352|NCT00950807|58672962|FG003|Treatment Period 3|Withdrawal by Subject|0|||
30660353|NCT00950807|58672963|FG004|Treatment Period 3|Withdrawal by Subject|0|||
30660354|NCT00950807|58672964|FG005|Treatment Period 3|Withdrawal by Subject|0|||
30660355|NCT00950807|58672965|FG006|Treatment Period 3|Withdrawal by Subject|0|||
30660356|NCT00950807|58672966|FG007|Treatment Period 3|Withdrawal by Subject|0|||
30660357|NCT00950807|58672967|FG008|Treatment Period 3|Withdrawal by Subject|0|||
30660358|NCT00950807|58672968|FG009|Treatment Period 3|Withdrawal by Subject|1|||
30660359|NCT00950807|58672959|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
30660360|NCT00950807|58672960|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30660361|NCT00950807|58672961|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30660362|NCT00950807|58672962|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30660363|NCT00950807|58672963|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30660364|NCT00950807|58672964|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30660365|NCT00950807|58672965|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30660366|NCT00950807|58672966|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
30660367|NCT00950807|58672967|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30660368|NCT00950807|58672968|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
30660369|NCT00950807|58672959|FG000|Treatment Period 3|Adverse Event|0|||
30660370|NCT00950807|58672960|FG001|Treatment Period 3|Adverse Event|0|||
30660371|NCT00950807|58672961|FG002|Treatment Period 3|Adverse Event|0|||
30660372|NCT00950807|58672962|FG003|Treatment Period 3|Adverse Event|0|||
30660373|NCT00950807|58672963|FG004|Treatment Period 3|Adverse Event|0|||
30660374|NCT00950807|58672964|FG005|Treatment Period 3|Adverse Event|0|||
30660375|NCT00950807|58672965|FG006|Treatment Period 3|Adverse Event|1|||
30660376|NCT00950807|58672966|FG007|Treatment Period 3|Adverse Event|0|||
30660377|NCT00950807|58672967|FG008|Treatment Period 3|Adverse Event|0|||
30660378|NCT00950807|58672968|FG009|Treatment Period 3|Adverse Event|0|||
30660379|NCT00797511|58672990|FG000|Overall Study|Withdrawal by Subject|1|||
30660380|NCT00608881|58672997|FG000|Overall Study|Death|22|||
30660381|NCT00608881|58672998|FG001|Overall Study|Death|13|||
30660382|NCT00608881|58672997|FG000|Overall Study|Adverse Event|5|||
30660383|NCT00608881|58672998|FG001|Overall Study|Adverse Event|3|||
30660384|NCT00608881|58672997|FG000|Overall Study|Lost to Follow-up|28|||
30660385|NCT00608881|58672998|FG001|Overall Study|Lost to Follow-up|14|||
30660386|NCT00608881|58672997|FG000|Overall Study|Withdrawal by Subject|18|||
30660387|NCT00608881|58672998|FG001|Overall Study|Withdrawal by Subject|29|||
30660388|NCT00608881|58672997|FG000|Overall Study|Physician Decision|5|||
30660389|NCT00608881|58672998|FG001|Overall Study|Physician Decision|5|||
30660390|NCT00608881|58672997|FG000|Overall Study|Institutionalized|1|||
30660391|NCT00608881|58672998|FG001|Overall Study|Institutionalized|2|||
30660392|NCT00945191|58673004|FG000|Overall Study|Did not achieve a complete response|18|||
30660393|NCT00945191|58673004|FG000|Overall Study|Participant relocated to another state|1|||
30660394|NCT00945191|58673004|FG000|Overall Study|Disease progression|3|||
30660395|NCT00945191|58673004|FG000|Overall Study|Serious adverse event or adverse event|1|||
30660396|NCT00945191|58673004|FG000|Overall Study|Investigator's discretion|1|||
30660397|NCT00606931|58673008|FG000|Overall Study|Withdrawal by Subject|3|||
30660398|NCT00792909|58673015|FG000|Overall Study|Withdrawal by Subject|0|||
30660399|NCT00792909|58673016|FG001|Overall Study|Withdrawal by Subject|1|||
30660400|NCT00792909|58673017|FG002|Overall Study|Withdrawal by Subject|0|||
30660401|NCT00944645|58673028|FG000|Period 2|Adverse Event|1|||
30660402|NCT00944645|58673029|FG001|Period 2|Adverse Event|0|||
30660403|NCT00944645|58673028|FG000|Period 2|Lost to Follow-up|0|||
30660404|NCT00944645|58673029|FG001|Period 2|Lost to Follow-up|3|||
30660405|NCT00944645|58673028|FG000|Period 2|Withdrawal by Subject|7|||
30660406|NCT00944645|58673029|FG001|Period 2|Withdrawal by Subject|6|||
30660407|NCT00606229|58673035|FG000|Overall Study|Adverse Event|11|||
30660408|NCT00606229|58673035|FG000|Overall Study|Lack of Efficacy|1|||
30660409|NCT00606229|58673035|FG000|Overall Study|Withdrawal by Subject|4|||
30660410|NCT00606229|58673035|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
30660411|NCT00606229|58673035|FG000|Overall Study|change of residence or other commitments|2|||
30660412|NCT00950651|58673041|FG000|Overall Study|Adverse Event|17|||
30660413|NCT00950651|58673042|FG001|Overall Study|Adverse Event|20|||
30660414|NCT00950651|58673041|FG000|Overall Study|Death|1|||
30660415|NCT00950651|58673042|FG001|Overall Study|Death|0|||
30660416|NCT00950651|58673041|FG000|Overall Study|Lack of Efficacy|2|||
30660417|NCT00950651|58673042|FG001|Overall Study|Lack of Efficacy|2|||
30660418|NCT00950651|58673041|FG000|Overall Study|Protocol Violation|3|||
30660419|NCT00950651|58673042|FG001|Overall Study|Protocol Violation|4|||
30660420|NCT00950651|58673041|FG000|Overall Study|Withdrawal by Subject|8|||
30660421|NCT00950651|58673042|FG001|Overall Study|Withdrawal by Subject|9|||
30660422|NCT00605293|58673050|FG000|Overall Study|Death|2|||
30660423|NCT00605293|58673051|FG001|Overall Study|Death|1|||
30660424|NCT00605293|58673050|FG000|Overall Study|Insufficient Therapeutic Response|2|||
30660425|NCT00605293|58673051|FG001|Overall Study|Insufficient Therapeutic Response|0|||
30660426|NCT00605293|58673050|FG000|Overall Study|Adverse Event|1|||
30660427|NCT00605293|58673051|FG001|Overall Study|Adverse Event|0|||
30660428|NCT00605293|58673050|FG000|Overall Study|Holidays Dialysis Out|1|||
30660429|NCT00605293|58673051|FG001|Overall Study|Holidays Dialysis Out|0|||
30660430|NCT00605293|58673050|FG000|Overall Study|Blood Transfusion|7|||
30660431|NCT00605293|58673051|FG001|Overall Study|Blood Transfusion|1|||
30660432|NCT00605293|58673050|FG000|Overall Study|Renal Transplantation|3|||
30660433|NCT00605293|58673051|FG001|Overall Study|Renal Transplantation|1|||
30660434|NCT00605293|58673050|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
30660435|NCT00605293|58673051|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
30660436|NCT00605293|58673050|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
30660437|NCT00605293|58673051|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
30660438|NCT00605293|58673050|FG000|Overall Study|Principal Investigator Decision|0|||
30660439|NCT00605293|58673051|FG001|Overall Study|Principal Investigator Decision|1|||
30660440|NCT00572533|58673059|FG000|Overall Study|Death|4|||
30660441|NCT00572533|58673060|FG001|Overall Study|Death|1|||
30660442|NCT00572533|58673059|FG000|Overall Study|Received Kidney Transplant|2|||
30660443|NCT00572533|58673060|FG001|Overall Study|Received Kidney Transplant|1|||
30660444|NCT00572533|58673059|FG000|Overall Study|Social Issues|1|||
30660445|NCT00572533|58673060|FG001|Overall Study|Social Issues|0|||
30660446|NCT00572533|58673059|FG000|Overall Study|Transfer out of Facility|0|||
30660447|NCT00572533|58673060|FG001|Overall Study|Transfer out of Facility|1|||
30660448|NCT00949715|58673068|FG000|Overall Study|Physician Decision|1|||
30660449|NCT00949715|58673069|FG001|Overall Study|Physician Decision|0|||
30660450|NCT00949715|58673068|FG000|Overall Study|Lost to Follow-up|1|||
30660451|NCT00949715|58673069|FG001|Overall Study|Lost to Follow-up|0|||
30660452|NCT00949715|58673068|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
30660453|NCT00949715|58673069|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
30660454|NCT00791661|58673077|FG000|7 Day Wash-out|Adverse Event|0|||
30660455|NCT00791661|58673078|FG001|7 Day Wash-out|Adverse Event|0|||
30660456|NCT00791661|58673079|FG002|7 Day Wash-out|Adverse Event|1|||
30660457|NCT00791661|58673077|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
30660458|NCT00791661|58673078|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
30660459|NCT00791661|58673079|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
30660460|NCT00943787|58673103|FG000|Overall Study|Physician Decision|4|||
30770683|NCT01147666|58779505|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30770684|NCT01147666|58779506|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30770685|NCT01147666|58779507|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30770686|NCT01147666|58779508|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30770687|NCT01147666|58779509|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30770688|NCT01147666|58779510|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30770689|NCT01147666|58779511|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30770690|NCT01147666|58779512|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
30770691|NCT01147666|58779513|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30770692|NCT01147666|58779514|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
30770693|NCT01147666|58779500|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770694|NCT01147666|58779501|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770695|NCT01147666|58779502|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770696|NCT01147666|58779503|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770697|NCT01147666|58779504|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770698|NCT01147666|58779505|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770699|NCT01147666|58779506|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770700|NCT01147666|58779507|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770701|NCT01147666|58779508|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770702|NCT01147666|58779509|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770703|NCT01147666|58779510|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770704|NCT01147666|58779511|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770705|NCT01147666|58779512|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
30770706|NCT01147666|58779513|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
30770707|NCT01147666|58779514|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
30770708|NCT00256295|58779576|FG000|Overall Study|Withdrawal by Subject|3|||
30770709|NCT00256295|58779576|FG000|Overall Study|Death|1|||
30770710|NCT02877004|58779583|FG000|Overall Study|Pregnancy|0|||
30770711|NCT02877004|58779584|FG001|Overall Study|Pregnancy|0|||
30770712|NCT02877004|58779585|FG002|Overall Study|Pregnancy|1|||
30770713|NCT04617860|58779615|FG000|Overall Study|Adverse Event|0|||
30770714|NCT04617860|58779616|FG001|Overall Study|Adverse Event|2|||
30770715|NCT04617860|58779617|FG002|Overall Study|Adverse Event|2|||
30770716|NCT04617860|58779615|FG000|Overall Study|Withdrawal by Subject|0|||
30770717|NCT04617860|58779616|FG001|Overall Study|Withdrawal by Subject|0|||
30770718|NCT04617860|58779617|FG002|Overall Study|Withdrawal by Subject|2|||
30770719|NCT04617860|58779615|FG000|Overall Study|Physician Decision|0|||
30770720|NCT04617860|58779616|FG001|Overall Study|Physician Decision|1|||
30770721|NCT04617860|58779617|FG002|Overall Study|Physician Decision|0|||
30770722|NCT04617860|58779615|FG000|Overall Study|Sponsor Decision|0|||
30770723|NCT04617860|58779616|FG001|Overall Study|Sponsor Decision|3|||
30660461|NCT00943787|58673103|FG000|Overall Study|Withdrawal by Subject|3|||
30660462|NCT00949325|58673107|FG000|Overall Study|Adverse Event|0|||
30660463|NCT00949325|58673108|FG001|Overall Study|Adverse Event|2|||
30660464|NCT00949325|58673109|FG002|Overall Study|Adverse Event|0|||
30660465|NCT00943319|58673125|FG000|Overall Study|Death|1|||
30660466|NCT00790647|58673129|FG000|Overall Study|Adverse Event|1|||
30660467|NCT00790569|58673138|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
30660468|NCT00790569|58673139|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
30770724|NCT04617860|58779617|FG002|Overall Study|Sponsor Decision|1|||
30770725|NCT04617860|58779615|FG000|Overall Study|Termination of Study by Sponsor|8|||
30770726|NCT04617860|58779616|FG001|Overall Study|Termination of Study by Sponsor|4|||
30770727|NCT04617860|58779617|FG002|Overall Study|Termination of Study by Sponsor|13|||
30770728|NCT04608500|58779629|FG000|Overall Study|Adverse Event|2|||
30952605|NCT04828161|59001564|FG002|Overall Study|Lost to Follow-up|2|||
30952606|NCT04828161|59001565|FG003|Overall Study|Lost to Follow-up|2|||
30952607|NCT04828161|59001562|FG000|Overall Study|Other|2|||
30952608|NCT04828161|59001563|FG001|Overall Study|Other|0|||
30952609|NCT04828161|59001564|FG002|Overall Study|Other|2|||
30952610|NCT04828161|59001565|FG003|Overall Study|Other|0|||
30952611|NCT04828161|59001562|FG000|Overall Study|Death|0|||
30952612|NCT04828161|59001563|FG001|Overall Study|Death|0|||
30952613|NCT04828161|59001564|FG002|Overall Study|Death|0|||
30952614|NCT04828161|59001565|FG003|Overall Study|Death|2|||
30952615|NCT01895309|59001663|FG000|Overall Study|Adverse Event|13|||
30952616|NCT01895309|59001664|FG001|Overall Study|Adverse Event|17|||
30952617|NCT01895309|59001663|FG000|Overall Study|Protocol Violation|1|||
30952618|NCT01895309|59001664|FG001|Overall Study|Protocol Violation|0|||
30952619|NCT01895309|59001663|FG000|Overall Study|Lack of Efficacy|1|||
30952620|NCT01895309|59001664|FG001|Overall Study|Lack of Efficacy|3|||
30952621|NCT01895309|59001663|FG000|Overall Study|Lost to Follow-up|1|||
30952622|NCT01895309|59001664|FG001|Overall Study|Lost to Follow-up|3|||
30952623|NCT01895309|59001663|FG000|Overall Study|Physician Decision|15|||
30952624|NCT01895309|59001664|FG001|Overall Study|Physician Decision|10|||
30952625|NCT01895309|59001663|FG000|Overall Study|Withdrawal by Subject|9|||
30952626|NCT01895309|59001664|FG001|Overall Study|Withdrawal by Subject|18|||
30952627|NCT01884311|59001674|FG000|Overall Study|Withdrawal by Subject|3|||
30952628|NCT01884311|59001674|FG000|Overall Study|withdrew consent due to AEs|1|||
30952629|NCT01884311|59001674|FG000|Overall Study|Precautionary measure|1|||
30952630|NCT01884077|59001714|FG000|Overall Study|screen fail|0|||
30952631|NCT01884077|59001715|FG001|Overall Study|screen fail|2|||
30952632|NCT01884077|59001714|FG000|Overall Study|canceled surgery|2|||
30952633|NCT01884077|59001715|FG001|Overall Study|canceled surgery|0|||
30952634|NCT01884077|59001714|FG000|Overall Study|Lost to Follow-up|0|||
30952635|NCT01884077|59001715|FG001|Overall Study|Lost to Follow-up|4|||
30952636|NCT01884077|59001714|FG000|Overall Study|study closed|6|||
30952637|NCT01884077|59001715|FG001|Overall Study|study closed|4|||
30952638|NCT01894919|59001734|FG000|Overall Study|Withdrawal by Subject|1|||
30952639|NCT01894919|59001735|FG001|Overall Study|Withdrawal by Subject|0|||
30952640|NCT01894919|59001736|FG002|Overall Study|Withdrawal by Subject|0|||
30952641|NCT01894919|59001737|FG003|Overall Study|Withdrawal by Subject|0|||
30952642|NCT01894919|59001738|FG004|Overall Study|Withdrawal by Subject|1|||
30952643|NCT01894919|59001739|FG005|Overall Study|Withdrawal by Subject|0|||
30952644|NCT01894919|59001740|FG006|Overall Study|Withdrawal by Subject|0|||
30952645|NCT01894919|59001741|FG007|Overall Study|Withdrawal by Subject|0|||
30952646|NCT01894919|59001742|FG008|Overall Study|Withdrawal by Subject|0|||
30952647|NCT01894919|59001743|FG009|Overall Study|Withdrawal by Subject|1|||
30952648|NCT01894919|59001744|FG010|Overall Study|Withdrawal by Subject|1|||
30952649|NCT01894919|59001745|FG011|Overall Study|Withdrawal by Subject|0|||
30952650|NCT01894919|59001746|FG012|Overall Study|Withdrawal by Subject|0|||
30952651|NCT01894919|59001734|FG000|Overall Study|Adverse Event|0|||
30952652|NCT01894919|59001735|FG001|Overall Study|Adverse Event|0|||
30952653|NCT01894919|59001736|FG002|Overall Study|Adverse Event|0|||
30952654|NCT01894919|59001737|FG003|Overall Study|Adverse Event|0|||
30952655|NCT01894919|59001738|FG004|Overall Study|Adverse Event|0|||
30952656|NCT01894919|59001739|FG005|Overall Study|Adverse Event|0|||
30952657|NCT01894919|59001740|FG006|Overall Study|Adverse Event|0|||
30952658|NCT01894919|59001741|FG007|Overall Study|Adverse Event|0|||
30952659|NCT01894919|59001742|FG008|Overall Study|Adverse Event|0|||
30952660|NCT01894919|59001743|FG009|Overall Study|Adverse Event|0|||
30952661|NCT01894919|59001744|FG010|Overall Study|Adverse Event|1|||
30952662|NCT01894919|59001745|FG011|Overall Study|Adverse Event|0|||
30952663|NCT01894919|59001746|FG012|Overall Study|Adverse Event|0|||
30952664|NCT01894919|59001734|FG000|Overall Study|Other-Unspecified|1|||
30952665|NCT01894919|59001735|FG001|Overall Study|Other-Unspecified|0|||
30952666|NCT01894919|59001736|FG002|Overall Study|Other-Unspecified|0|||
30952667|NCT01894919|59001737|FG003|Overall Study|Other-Unspecified|0|||
30952668|NCT01894919|59001738|FG004|Overall Study|Other-Unspecified|0|||
30952669|NCT01894919|59001739|FG005|Overall Study|Other-Unspecified|0|||
30952670|NCT01894919|59001740|FG006|Overall Study|Other-Unspecified|0|||
30952671|NCT01894919|59001741|FG007|Overall Study|Other-Unspecified|0|||
30952672|NCT01894919|59001742|FG008|Overall Study|Other-Unspecified|0|||
30952673|NCT01894919|59001743|FG009|Overall Study|Other-Unspecified|0|||
30952674|NCT01894919|59001744|FG010|Overall Study|Other-Unspecified|0|||
30770729|NCT04608500|58779630|FG001|Overall Study|Adverse Event|0|||
30952675|NCT01894919|59001745|FG011|Overall Study|Other-Unspecified|0|||
30952676|NCT01894919|59001746|FG012|Overall Study|Other-Unspecified|0|||
30952677|NCT01894919|59001734|FG000|Overall Study|Lost to Follow-up|0|||
30952678|NCT01894919|59001735|FG001|Overall Study|Lost to Follow-up|0|||
30770730|NCT04608500|58779629|FG000|Overall Study|Lost to Follow-up|15|||
30770731|NCT04608500|58779630|FG001|Overall Study|Lost to Follow-up|9|||
30770732|NCT04608500|58779629|FG000|Overall Study|Participant request|11|||
30849080|NCT00706797|58875890|FG000|Overall Study|Withdrawal by Subject|8|||
30849081|NCT00706797|58875891|FG001|Overall Study|Withdrawal by Subject|1|||
30849082|NCT00706797|58875890|FG000|Overall Study|Death|1|||
30849083|NCT00706797|58875891|FG001|Overall Study|Death|0|||
30849084|NCT00706797|58875890|FG000|Overall Study|Discontinuation of study by sponsor|52|||
30849085|NCT00706797|58875891|FG001|Overall Study|Discontinuation of study by sponsor|63|||
30849086|NCT00706797|58875890|FG000|Overall Study|Protocol Violation|3|||
30849087|NCT00706797|58875891|FG001|Overall Study|Protocol Violation|2|||
30849088|NCT00706797|58875890|FG000|Overall Study|Lost to Follow-up|1|||
30849089|NCT00706797|58875891|FG001|Overall Study|Lost to Follow-up|2|||
30660469|NCT00790569|58673140|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
30660470|NCT00790569|58673138|FG000|End of Treatment (6 Month Interview)|Death|0|||
30660471|NCT00790569|58673139|FG001|End of Treatment (6 Month Interview)|Death|2|||
30770733|NCT04608500|58779630|FG001|Overall Study|Participant request|7|||
30770734|NCT04608500|58779629|FG000|Overall Study|Protocol Violation|1|||
30770735|NCT04608500|58779630|FG001|Overall Study|Protocol Violation|0|||
30770736|NCT04608500|58779629|FG000|Overall Study|Other|6|||
30770737|NCT04608500|58779630|FG001|Overall Study|Other|2|||
30770738|NCT04585646|58779636|FG000|First Intervention|Physician Decision|1|||
30770739|NCT04585646|58779637|FG001|First Intervention|Physician Decision|0|||
30770740|NCT04585646|58779636|FG000|First Intervention|Lost to Follow-up|0|||
30660472|NCT00790569|58673140|FG002|End of Treatment (6 Month Interview)|Death|1|||
30660473|NCT00790569|58673138|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
30660474|NCT00790569|58673139|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
30660475|NCT00790569|58673140|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
30660476|NCT00790569|58673138|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
30660477|NCT00790569|58673139|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
30660478|NCT00790569|58673140|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
30660479|NCT00790569|58673138|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
30660480|NCT00790569|58673139|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
30660481|NCT00790569|58673140|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
30660482|NCT00790569|58673138|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
30660483|NCT00790569|58673139|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
30770741|NCT04585646|58779637|FG001|First Intervention|Lost to Follow-up|3|||
30770742|NCT04585646|58779636|FG000|First Intervention|Withdrawal by Subject|0|||
30770743|NCT04585646|58779637|FG001|First Intervention|Withdrawal by Subject|1|||
30770744|NCT04584788|58779653|FG000|Overall Study|Physician Decision|8|||
30770745|NCT04584788|58779653|FG000|Overall Study|Withdrawal by Subject|1|||
30770746|NCT04584788|58779653|FG000|Overall Study|Adverse Event|3|||
30660484|NCT00790569|58673140|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
30660485|NCT00939029|58673150|FG000|Overall Study|Withdrawal by Subject|3|||
30660486|NCT00939029|58673151|FG001|Overall Study|Withdrawal by Subject|7|||
30660487|NCT00939029|58673150|FG000|Overall Study|Lost to Follow-up|3|||
30660488|NCT00939029|58673151|FG001|Overall Study|Lost to Follow-up|4|||
30660489|NCT00939029|58673150|FG000|Overall Study|Adverse Event|0|||
30660490|NCT00939029|58673151|FG001|Overall Study|Adverse Event|1|||
30660491|NCT00587847|58673157|FG000|Overall Study|Lack of Efficacy|5|||
30660492|NCT00587847|58673157|FG000|Overall Study|Adverse Event|2|||
30660493|NCT00784563|58673165|FG000|Years 1 & 2|Withdrawal by Subject|3|||
30660494|NCT00784563|58673166|FG001|Years 1 & 2|Withdrawal by Subject|2|||
30660495|NCT00784563|58673167|FG002|Years 1 & 2|Withdrawal by Subject|0|||
30660496|NCT00784563|58673165|FG000|Years 1 & 2|Adverse Event|0|||
30660497|NCT00784563|58673166|FG001|Years 1 & 2|Adverse Event|3|||
30660498|NCT00784563|58673167|FG002|Years 1 & 2|Adverse Event|0|||
30660499|NCT00784563|58673165|FG000|Year 3|Withdrawal by Subject|0|||
30660500|NCT00784563|58673166|FG001|Year 3|Withdrawal by Subject|0|||
30770747|NCT04575038|58779659|FG000|Overall Study|Withdrawal by Subject|1|||
30770748|NCT04575038|58779660|FG001|Overall Study|Withdrawal by Subject|1|||
30770749|NCT03066622|58779668|FG000|Overall Study|Lost to Follow-up|24|||
30770750|NCT03066622|58779669|FG001|Overall Study|Lost to Follow-up|25|||
30849090|NCT00706797|58875890|FG000|Overall Study|Other|1|||
30849091|NCT00706797|58875891|FG001|Overall Study|Other|0|||
30849092|NCT00706641|58875897|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
30660501|NCT00784563|58673167|FG002|Year 3|Withdrawal by Subject|2|||
30660502|NCT00784563|58673165|FG000|Year 3|Adverse Event|0|||
30660503|NCT00784563|58673166|FG001|Year 3|Adverse Event|0|||
30660504|NCT00784563|58673167|FG002|Year 3|Adverse Event|1|||
30660505|NCT00938717|58673175|FG000|Overall Study|Adverse Event|10|||
30660506|NCT00938717|58673176|FG001|Overall Study|Adverse Event|41|||
30770751|NCT03066622|58779668|FG000|Overall Study|Withdrawal by Subject|2|||
30770752|NCT03066622|58779669|FG001|Overall Study|Withdrawal by Subject|1|||
30770753|NCT04501952|58779701|FG000|Overall Study|Adverse Event|0|||
30770754|NCT04501952|58779702|FG001|Overall Study|Adverse Event|3|||
30770755|NCT04501952|58779701|FG000|Overall Study|Investigator's Discretion|0|||
30660507|NCT00938717|58673175|FG000|Overall Study|Protocol Violation|11|||
30660508|NCT00938717|58673176|FG001|Overall Study|Protocol Violation|8|||
30660509|NCT00938717|58673175|FG000|Overall Study|Withdrawal by Subject|26|||
30660510|NCT00938717|58673176|FG001|Overall Study|Withdrawal by Subject|24|||
30660511|NCT00938717|58673175|FG000|Overall Study|Lost to Follow-up|13|||
30660512|NCT00938717|58673176|FG001|Overall Study|Lost to Follow-up|18|||
30660513|NCT00938717|58673175|FG000|Overall Study|Lack of Efficacy|33|||
30660514|NCT00938717|58673176|FG001|Overall Study|Lack of Efficacy|15|||
30660515|NCT00938717|58673175|FG000|Overall Study|Other reason|5|||
30660516|NCT00938717|58673176|FG001|Overall Study|Other reason|2|||
30660517|NCT00587223|58673182|FG000|Overall Study|Adverse Event|1|||
30660518|NCT00938639|58673191|FG000|Overall Study|Moved away from study area|0|||
30660519|NCT00938639|58673192|FG001|Overall Study|Moved away from study area|1|||
30660520|NCT00938639|58673191|FG000|Overall Study|Lost to Follow-up|1|||
30660521|NCT00938639|58673192|FG001|Overall Study|Lost to Follow-up|2|||
30660522|NCT00938639|58673191|FG000|Overall Study|Family issues|1|||
30660523|NCT00938639|58673192|FG001|Overall Study|Family issues|1|||
30660524|NCT00938639|58673191|FG000|Overall Study|Participant noncompliance|1|||
30660525|NCT00938639|58673192|FG001|Overall Study|Participant noncompliance|0|||
30660526|NCT00783705|58673204|FG000|Overall Study|Adverse Event|2|||
30660527|NCT00783705|58673205|FG001|Overall Study|Adverse Event|0|||
30660528|NCT00783705|58673204|FG000|Overall Study|Withdrawal by Subject|3|||
30660529|NCT00783705|58673205|FG001|Overall Study|Withdrawal by Subject|2|||
30660530|NCT00783705|58673204|FG000|Overall Study|Lost to Follow-up|1|||
30660531|NCT00783705|58673205|FG001|Overall Study|Lost to Follow-up|3|||
30660532|NCT00604669|58673211|FG000|Overall Study|lack of information in chart|7|||
30660533|NCT00938327|58673215|FG000|Overall Study|Adverse Event|2|||
30660534|NCT00938327|58673215|FG000|Overall Study|Protocol Violation|1|||
30660535|NCT00938327|58673215|FG000|Overall Study|Withdrawal by Subject|4|||
30660536|NCT00938327|58673215|FG000|Overall Study|Lost to Follow-up|37|||
30660537|NCT00938327|58673215|FG000|Overall Study|2nd dose received outside of the study|7|||
30660538|NCT00938327|58673215|FG000|Overall Study|Vaccine not received as out of stock|9|||
30660539|NCT00887198|58673221|FG000|Randomized Period|Ongoing|42|||
30660540|NCT00887198|58673222|FG001|Randomized Period|Ongoing|0|||
30660541|NCT00887198|58673223|FG002|Randomized Period|Ongoing|0|||
30660542|NCT00887198|58673221|FG000|Randomized Period|Adverse Event|50|||
30660543|NCT00887198|58673222|FG001|Randomized Period|Adverse Event|33|||
30660544|NCT00887198|58673223|FG002|Randomized Period|Adverse Event|0|||
30660545|NCT00887198|58673221|FG000|Randomized Period|Lost to Follow-up|1|||
30660546|NCT00887198|58673222|FG001|Randomized Period|Lost to Follow-up|0|||
30660547|NCT00887198|58673223|FG002|Randomized Period|Lost to Follow-up|0|||
30660548|NCT00887198|58673221|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
30660549|NCT00887198|58673222|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
30660550|NCT00887198|58673223|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
30660551|NCT00887198|58673221|FG000|Randomized Period|Withdrawal by Subject|41|||
30660552|NCT00887198|58673222|FG001|Randomized Period|Withdrawal by Subject|56|||
30660553|NCT00887198|58673223|FG002|Randomized Period|Withdrawal by Subject|0|||
30660554|NCT00887198|58673221|FG000|Randomized Period|Progressive disease|366|||
30660555|NCT00887198|58673222|FG001|Randomized Period|Progressive disease|370|||
30660556|NCT00887198|58673223|FG002|Randomized Period|Progressive disease|0|||
30660557|NCT00887198|58673221|FG000|Randomized Period|Other|42|||
30660558|NCT00887198|58673222|FG001|Randomized Period|Other|30|||
30660559|NCT00887198|58673223|FG002|Randomized Period|Other|0|||
30660560|NCT00887198|58673221|FG000|Randomized Period|Randomized, Not treated|4|||
30660561|NCT00887198|58673222|FG001|Randomized Period|Randomized, Not treated|2|||
30660562|NCT00887198|58673223|FG002|Randomized Period|Randomized, Not treated|0|||
30660563|NCT00887198|58673221|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
30660564|NCT00887198|58673222|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
30660565|NCT00887198|58673223|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
30660566|NCT00887198|58673221|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
30660567|NCT00887198|58673222|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
30660568|NCT00887198|58673223|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
30660569|NCT00887198|58673221|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
30660570|NCT00887198|58673222|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
30660571|NCT00887198|58673223|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
30770756|NCT04501952|58779702|FG001|Overall Study|Investigator's Discretion|1|||
30660572|NCT00887198|58673221|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
30660573|NCT00887198|58673222|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
30660574|NCT00887198|58673223|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
30660575|NCT00887198|58673221|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
30660576|NCT00887198|58673222|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
30660577|NCT00887198|58673223|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
30660578|NCT00887198|58673221|FG000|Cross Over (Placebo to AA)|Other|0|||
30660579|NCT00887198|58673222|FG001|Cross Over (Placebo to AA)|Other|0|||
30770757|NCT04501952|58779701|FG000|Overall Study|Protocol Violation|1|||
30660580|NCT00887198|58673223|FG002|Cross Over (Placebo to AA)|Other|19|||
30660581|NCT00782067|58673231|FG000|Overall Study|Adverse Event|35|||
30660582|NCT00782067|58673231|FG000|Overall Study|Subject withdrew consent|11|||
30660583|NCT00782067|58673231|FG000|Overall Study|Lost to Follow-up|2|||
30660584|NCT00782067|58673231|FG000|Overall Study|Administrative problems|14|||
30660585|NCT00782067|58673231|FG000|Overall Study|Death|9|||
30660586|NCT00782067|58673231|FG000|Overall Study|Disease progression|43|||
30660587|NCT00782067|58673231|FG000|Overall Study|Protocol deviation|2|||
30660588|NCT00886340|58673237|FG000|Overall Study|Withdrawal by Subject|0|||
30660589|NCT00886340|58673238|FG001|Overall Study|Withdrawal by Subject|7|||
30660590|NCT00605215|58673247|FG000|Overall Study|Death|0|||
30660591|NCT00605215|58673248|FG001|Overall Study|Death|0|||
30660592|NCT00605215|58673249|FG002|Overall Study|Death|1|||
30660593|NCT00605215|58673247|FG000|Overall Study|Adverse Event|19|||
30660594|NCT00605215|58673248|FG001|Overall Study|Adverse Event|21|||
30660595|NCT00605215|58673249|FG002|Overall Study|Adverse Event|26|||
30660596|NCT00605215|58673247|FG000|Overall Study|Refusal to sign the re-consent form|8|||
30660597|NCT00605215|58673248|FG001|Overall Study|Refusal to sign the re-consent form|3|||
30660598|NCT00605215|58673249|FG002|Overall Study|Refusal to sign the re-consent form|3|||
30660599|NCT00605215|58673247|FG000|Overall Study|Withdrawal by Subject|39|||
30660600|NCT00605215|58673248|FG001|Overall Study|Withdrawal by Subject|37|||
30660601|NCT00605215|58673249|FG002|Overall Study|Withdrawal by Subject|27|||
30660602|NCT00605215|58673247|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
30660603|NCT00605215|58673248|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
30660604|NCT00605215|58673249|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
30660605|NCT00605215|58673247|FG000|Overall Study|Protocol Violation|3|||
30660606|NCT00605215|58673248|FG001|Overall Study|Protocol Violation|4|||
30660607|NCT00605215|58673249|FG002|Overall Study|Protocol Violation|1|||
30660608|NCT00605215|58673247|FG000|Overall Study|Pregnancy|8|||
30660609|NCT00605215|58673248|FG001|Overall Study|Pregnancy|5|||
30660610|NCT00605215|58673249|FG002|Overall Study|Pregnancy|4|||
30660611|NCT00605215|58673247|FG000|Overall Study|Lost to Follow-up|8|||
30660612|NCT00605215|58673248|FG001|Overall Study|Lost to Follow-up|5|||
30660613|NCT00605215|58673249|FG002|Overall Study|Lost to Follow-up|2|||
30660614|NCT00605215|58673247|FG000|Overall Study|Other than specified|0|||
30660615|NCT00605215|58673248|FG001|Overall Study|Other than specified|2|||
30660616|NCT00605215|58673249|FG002|Overall Study|Other than specified|1|||
30660617|NCT00604279|58673259|FG000|Overall Study|Lack of Efficacy|22|||
30660618|NCT00604279|58673260|FG001|Overall Study|Lack of Efficacy|9|||
30660619|NCT00604279|58673259|FG000|Overall Study|Lost to Follow-up|9|||
30660620|NCT00604279|58673260|FG001|Overall Study|Lost to Follow-up|14|||
30660621|NCT00604279|58673259|FG000|Overall Study|Pregnancy|2|||
30660622|NCT00604279|58673260|FG001|Overall Study|Pregnancy|0|||
30660623|NCT00604279|58673259|FG000|Overall Study|Protocol Violation|3|||
30770758|NCT04501952|58779702|FG001|Overall Study|Protocol Violation|1|||
30770759|NCT04501952|58779701|FG000|Overall Study|Withdrew Consent|5|||
30770760|NCT04501952|58779702|FG001|Overall Study|Withdrew Consent|4|||
30770761|NCT04501952|58779701|FG000|Overall Study|Lost to Follow-up|7|||
30770762|NCT04501952|58779702|FG001|Overall Study|Lost to Follow-up|2|||
30770763|NCT04501952|58779701|FG000|Overall Study|Randomized and Never Treated|13|||
30770764|NCT04501952|58779702|FG001|Overall Study|Randomized and Never Treated|9|||
30770765|NCT02930122|58779720|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
30770766|NCT02930122|58779721|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
30770767|NCT03697460|58779728|FG000|Overall Study|Withdrawal by Subject|3|||
30770768|NCT00070018|58779732|FG000|Overall Study|Adverse Event|2|||
30770769|NCT00070018|58779732|FG000|Overall Study|Lack of Efficacy|1|||
30770770|NCT00070018|58779732|FG000|Overall Study|Withdrawal by Subject|1|||
30770771|NCT00231413|58779743|FG000|Overall Study|Non-serious AE|0|||
30770772|NCT00231413|58779744|FG001|Overall Study|Non-serious AE|0|||
30770773|NCT00231413|58779745|FG002|Overall Study|Non-serious AE|1|||
30660624|NCT00604279|58673260|FG001|Overall Study|Protocol Violation|1|||
30660625|NCT00604279|58673259|FG000|Overall Study|Withdrawal by Subject|16|||
30660626|NCT00604279|58673260|FG001|Overall Study|Withdrawal by Subject|5|||
30660627|NCT00604279|58673259|FG000|Overall Study|Adverse Event|4|||
30660628|NCT00604279|58673260|FG001|Overall Study|Adverse Event|5|||
30849093|NCT00706641|58875897|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
30660629|NCT00604279|58673259|FG000|Overall Study|Other|8|||
30660630|NCT00604279|58673260|FG001|Overall Study|Other|4|||
30660631|NCT00938015|58673266|FG000|Overall Study|Death|2|||
30660632|NCT00938015|58673266|FG000|Overall Study|Lost to Follow-up|32|||
30770774|NCT00231413|58779746|FG003|Overall Study|Non-serious AE|0|||
30660633|NCT00938015|58673266|FG000|Overall Study|Adverse Event|32|||
30660634|NCT00938015|58673266|FG000|Overall Study|Non-responder|52|||
30660635|NCT00938015|58673266|FG000|Overall Study|Reason not related to Etanercept|29|||
30660636|NCT00781911|58673272|FG000|Overall Study|Adverse Event|4|||
30660637|NCT00781911|58673273|FG001|Overall Study|Adverse Event|4|||
30660638|NCT00781911|58673272|FG000|Overall Study|Withdrawal by Subject|1|||
30660639|NCT00781911|58673273|FG001|Overall Study|Withdrawal by Subject|2|||
30770775|NCT00231413|58779747|FG004|Overall Study|Non-serious AE|0|||
30770776|NCT00231413|58779748|FG005|Overall Study|Non-serious AE|0|||
30770777|NCT00231413|58779749|FG006|Overall Study|Non-serious AE|1|||
30770778|NCT00231413|58779743|FG000|Overall Study|Withdrawal by Subject|3|||
30770779|NCT00231413|58779744|FG001|Overall Study|Withdrawal by Subject|1|||
30770780|NCT00231413|58779745|FG002|Overall Study|Withdrawal by Subject|4|||
30770781|NCT00231413|58779746|FG003|Overall Study|Withdrawal by Subject|2|||
30770782|NCT00231413|58779747|FG004|Overall Study|Withdrawal by Subject|2|||
30770783|NCT00231413|58779748|FG005|Overall Study|Withdrawal by Subject|0|||
30770784|NCT00231413|58779749|FG006|Overall Study|Withdrawal by Subject|3|||
30770785|NCT00231413|58779743|FG000|Overall Study|Migrated/moved from study area|0|||
30770786|NCT00231413|58779744|FG001|Overall Study|Migrated/moved from study area|0|||
30770787|NCT00231413|58779745|FG002|Overall Study|Migrated/moved from study area|1|||
30770788|NCT00231413|58779746|FG003|Overall Study|Migrated/moved from study area|0|||
30770789|NCT00231413|58779747|FG004|Overall Study|Migrated/moved from study area|0|||
30770790|NCT00231413|58779748|FG005|Overall Study|Migrated/moved from study area|1|||
30952679|NCT01894919|59001736|FG002|Overall Study|Lost to Follow-up|0|||
30660640|NCT00781911|58673272|FG000|Overall Study|Physician Decision|0|||
30660641|NCT00781911|58673273|FG001|Overall Study|Physician Decision|2|||
30660642|NCT00781911|58673272|FG000|Overall Study|Sponsor Decision|1|||
30660643|NCT00781911|58673273|FG001|Overall Study|Sponsor Decision|0|||
30660644|NCT00605917|58673281|FG000|Overall Study|Protocol Violation|79|||
30660645|NCT00781599|58673318|FG000|Overall Study|Lost to Follow-up|7|||
30660646|NCT00781599|58673319|FG001|Overall Study|Lost to Follow-up|4|||
30660647|NCT00605839|58673337|FG000|Overall Study|Protocol Violation|1|||
30660648|NCT00605839|58673338|FG001|Overall Study|Protocol Violation|0|||
30660649|NCT00605839|58673339|FG002|Overall Study|Protocol Violation|0|||
30660650|NCT00781365|58673349|FG000|Overall Study|Withdrawal by Subject|13|||
30660651|NCT00781365|58673350|FG001|Overall Study|Withdrawal by Subject|8|||
30660652|NCT00781365|58673349|FG000|Overall Study|Did Not Attend Visit|20|||
30660653|NCT00781365|58673350|FG001|Overall Study|Did Not Attend Visit|28|||
30660654|NCT00781365|58673349|FG000|Overall Study|Language barrier|1|||
30660655|NCT00781365|58673350|FG001|Overall Study|Language barrier|0|||
30660656|NCT00937547|58673359|FG000|Overall Study|misdiagnosis|1|||
30660657|NCT00937547|58673360|FG001|Overall Study|misdiagnosis|6|||
30660658|NCT00937547|58673361|FG002|Overall Study|misdiagnosis|7|||
30660659|NCT00780975|58673369|FG000|Overall Study|Progressive disease|3|||
30660660|NCT00780975|58673369|FG000|Overall Study|Toxicity|5|||
30660661|NCT00780273|58673373|FG000|Overall Study|Death|1|||
30660662|NCT00780273|58673373|FG000|Overall Study|Lost to Follow-up|1|||
30660663|NCT00779259|58673378|FG000|Quinine Alone|Adverse Event|2|||
30660664|NCT00779025|58673396|FG000|Overall Study|Withdrawal by Subject|1|||
30660665|NCT00936065|58673404|FG000|Overall Study|Adverse Event|1|||
30660666|NCT00936065|58673405|FG001|Overall Study|Adverse Event|0|||
30660667|NCT00936065|58673406|FG002|Overall Study|Adverse Event|1|||
30660668|NCT00936065|58673404|FG000|Overall Study|Lack of Efficacy|1|||
30660669|NCT00936065|58673405|FG001|Overall Study|Lack of Efficacy|0|||
30660670|NCT00936065|58673406|FG002|Overall Study|Lack of Efficacy|1|||
30660671|NCT00936065|58673404|FG000|Overall Study|Lost to Follow-up|1|||
30660672|NCT00936065|58673405|FG001|Overall Study|Lost to Follow-up|0|||
30660673|NCT00936065|58673406|FG002|Overall Study|Lost to Follow-up|0|||
30660674|NCT00936065|58673404|FG000|Overall Study|Protocol Violation|1|||
30660675|NCT00936065|58673405|FG001|Overall Study|Protocol Violation|2|||
30660676|NCT00936065|58673406|FG002|Overall Study|Protocol Violation|1|||
30660677|NCT00936065|58673404|FG000|Overall Study|Withdrawal by Subject|0|||
30660678|NCT00936065|58673405|FG001|Overall Study|Withdrawal by Subject|2|||
30660679|NCT00936065|58673406|FG002|Overall Study|Withdrawal by Subject|4|||
30660680|NCT04441788|58673417|FG000|Overall Study|Voluntary Withdrawl|0|||
30660681|NCT04441788|58673418|FG001|Overall Study|Voluntary Withdrawl|1|||
30660682|NCT04441788|58673419|FG002|Overall Study|Voluntary Withdrawl|0|||
30660683|NCT04441788|58673417|FG000|Overall Study|Ineligibility|1|||
30660684|NCT04441788|58673418|FG001|Overall Study|Ineligibility|0|||
30660685|NCT04441788|58673419|FG002|Overall Study|Ineligibility|0|||
30660686|NCT04441788|58673417|FG000|Overall Study|Adverse Event|0|||
30660687|NCT04441788|58673418|FG001|Overall Study|Adverse Event|0|||
30660688|NCT04441788|58673419|FG002|Overall Study|Adverse Event|4|||
30770791|NCT00231413|58779749|FG006|Overall Study|Migrated/moved from study area|0|||
30660689|NCT04441788|58673417|FG000|Overall Study|Study Terminated by Sponsor|16|||
30660690|NCT04441788|58673418|FG001|Overall Study|Study Terminated by Sponsor|16|||
30660691|NCT04441788|58673419|FG002|Overall Study|Study Terminated by Sponsor|12|||
30660692|NCT00604825|58673435|FG000|Overall Study|Adverse Event|2|||
30660693|NCT00604825|58673436|FG001|Overall Study|Adverse Event|6|||
30660694|NCT00604825|58673437|FG002|Overall Study|Adverse Event|7|||
30660695|NCT00604825|58673438|FG003|Overall Study|Adverse Event|4|||
30660696|NCT00604825|58673435|FG000|Overall Study|Lost to Follow-up|0|||
30660697|NCT00604825|58673436|FG001|Overall Study|Lost to Follow-up|3|||
30660698|NCT00604825|58673437|FG002|Overall Study|Lost to Follow-up|1|||
30660699|NCT00604825|58673438|FG003|Overall Study|Lost to Follow-up|0|||
30660700|NCT00604825|58673435|FG000|Overall Study|Protocol Violation|0|||
30660701|NCT00604825|58673436|FG001|Overall Study|Protocol Violation|1|||
30660702|NCT00604825|58673437|FG002|Overall Study|Protocol Violation|0|||
30660703|NCT00604825|58673438|FG003|Overall Study|Protocol Violation|0|||
30660704|NCT00604825|58673435|FG000|Overall Study|Withdrawal by Subject|4|||
30660705|NCT00604825|58673436|FG001|Overall Study|Withdrawal by Subject|3|||
30660706|NCT00604825|58673437|FG002|Overall Study|Withdrawal by Subject|5|||
30660707|NCT00604825|58673438|FG003|Overall Study|Withdrawal by Subject|5|||
30660708|NCT00604825|58673435|FG000|Overall Study|Lack of Efficacy|3|||
30660709|NCT00604825|58673436|FG001|Overall Study|Lack of Efficacy|2|||
30660710|NCT00604825|58673437|FG002|Overall Study|Lack of Efficacy|1|||
30660711|NCT00604825|58673438|FG003|Overall Study|Lack of Efficacy|0|||
30660712|NCT00604825|58673435|FG000|Overall Study|Did not meet eligibility criteria|0|||
30660713|NCT00604825|58673436|FG001|Overall Study|Did not meet eligibility criteria|0|||
30660714|NCT00604825|58673437|FG002|Overall Study|Did not meet eligibility criteria|2|||
30660715|NCT00604825|58673438|FG003|Overall Study|Did not meet eligibility criteria|0|||
30660716|NCT00604825|58673435|FG000|Overall Study|Physician Decision|0|||
30660717|NCT00604825|58673436|FG001|Overall Study|Physician Decision|0|||
30660718|NCT00604825|58673437|FG002|Overall Study|Physician Decision|0|||
30660719|NCT00604825|58673438|FG003|Overall Study|Physician Decision|1|||
30660720|NCT00604825|58673435|FG000|Overall Study|Exclusion criterion met|0|||
30660721|NCT00604825|58673436|FG001|Overall Study|Exclusion criterion met|0|||
30660722|NCT00604825|58673437|FG002|Overall Study|Exclusion criterion met|0|||
30770792|NCT00231413|58779743|FG000|Overall Study|Lost to Follow-up|4|||
30770793|NCT00231413|58779744|FG001|Overall Study|Lost to Follow-up|4|||
30770794|NCT00231413|58779745|FG002|Overall Study|Lost to Follow-up|1|||
30770795|NCT00231413|58779746|FG003|Overall Study|Lost to Follow-up|1|||
30770796|NCT00231413|58779747|FG004|Overall Study|Lost to Follow-up|1|||
30770797|NCT00231413|58779748|FG005|Overall Study|Lost to Follow-up|4|||
30770798|NCT00231413|58779749|FG006|Overall Study|Lost to Follow-up|0|||
30770799|NCT00231413|58779743|FG000|Overall Study|Pregnancy|1|||
30770800|NCT00231413|58779744|FG001|Overall Study|Pregnancy|0|||
30770801|NCT00231413|58779745|FG002|Overall Study|Pregnancy|0|||
30849094|NCT00706641|58875897|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
30849095|NCT01362530|58875903|FG000|Base Study (Cycle 1)|Adverse Event|2|||
30849096|NCT01362530|58875904|FG001|Base Study (Cycle 1)|Adverse Event|0|||
30849097|NCT01362530|58875903|FG000|Base Study (Cycle 1)|Physician Decision|0|||
30849098|NCT01362530|58875904|FG001|Base Study (Cycle 1)|Physician Decision|1|||
30849099|NCT01362530|58875903|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
30849100|NCT01362530|58875904|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
30849101|NCT01362530|58875903|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
30849102|NCT01362530|58875904|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
30849103|NCT01362530|58875903|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
30849104|NCT01362530|58875904|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
30770802|NCT00231413|58779746|FG003|Overall Study|Pregnancy|0|||
30770803|NCT00231413|58779747|FG004|Overall Study|Pregnancy|0|||
30770804|NCT00231413|58779748|FG005|Overall Study|Pregnancy|0|||
30770805|NCT00231413|58779749|FG006|Overall Study|Pregnancy|0|||
30770806|NCT04494646|58779767|FG000|Overall Study|Adverse Event|0|||
30770807|NCT04494646|58779768|FG001|Overall Study|Adverse Event|1|||
30770808|NCT04494646|58779767|FG000|Overall Study|Withdrawal by Subject|0|||
30770809|NCT04494646|58779768|FG001|Overall Study|Withdrawal by Subject|1|||
30770810|NCT04529096|58779776|FG000|Overall Study|Adverse Event|6|||
30770811|NCT04529096|58779777|FG001|Overall Study|Adverse Event|1|||
30770812|NCT04529096|58779776|FG000|Overall Study|Lack of Efficacy|1|||
30770813|NCT04529096|58779777|FG001|Overall Study|Lack of Efficacy|0|||
30770814|NCT04529096|58779776|FG000|Overall Study|Lost to Follow-up|1|||
30770815|NCT04529096|58779777|FG001|Overall Study|Lost to Follow-up|1|||
30770816|NCT04529096|58779776|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30770817|NCT04529096|58779777|FG001|Overall Study|Non-Compliance With Study Drug|1|||
30770818|NCT04529096|58779776|FG000|Overall Study|Physician Decision|1|||
30770819|NCT04529096|58779777|FG001|Overall Study|Physician Decision|3|||
30770820|NCT04529096|58779776|FG000|Overall Study|Withdrawal by Subject|5|||
30770821|NCT04529096|58779777|FG001|Overall Study|Withdrawal by Subject|0|||
30770822|NCT00231179|58779785|FG000|Overall Study|Lost to Follow-up|21|||
30770823|NCT00231179|58779786|FG001|Overall Study|Lost to Follow-up|21|||
30770824|NCT00231179|58779785|FG000|Overall Study|Withdrawal by Subject|3|||
30770825|NCT00231179|58779786|FG001|Overall Study|Withdrawal by Subject|3|||
30849105|NCT01362530|58875903|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
30770826|NCT00229931|58779794|FG000|Overall Study|Death|1|||
30660723|NCT00604825|58673438|FG003|Overall Study|Exclusion criterion met|1|||
30770827|NCT00229931|58779795|FG001|Overall Study|Death|0|||
30770828|NCT00229931|58779794|FG000|Overall Study|Lost to Follow-up|3|||
30660724|NCT00937391|58673450|FG000|Stage 2|Withdrawal by Subject|1|||
30660725|NCT00937157|58673467|FG000|Overall Study|Pregnancy|1|||
30660726|NCT00937157|58673467|FG000|Overall Study|Lost to Follow-up|3|||
30660727|NCT00777153|58673474|FG000|Overall Study|Lost to Follow-up|1|||
30660728|NCT00777153|58673475|FG001|Overall Study|Lost to Follow-up|1|||
30660729|NCT00777153|58673476|FG002|Overall Study|Lost to Follow-up|0|||
30660730|NCT00777153|58673474|FG000|Overall Study|Death|85|||
30660731|NCT00777153|58673475|FG001|Overall Study|Death|73|||
30660732|NCT00777153|58673476|FG002|Overall Study|Death|33|||
30660733|NCT00777153|58673474|FG000|Overall Study|Withdrawal by Subject|3|||
30660734|NCT00777153|58673475|FG001|Overall Study|Withdrawal by Subject|4|||
30660735|NCT00777153|58673476|FG002|Overall Study|Withdrawal by Subject|3|||
30660736|NCT00777153|58673474|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
30660737|NCT00777153|58673475|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
30660738|NCT00777153|58673476|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
30660739|NCT00567541|58673490|FG000|Overall Study|Adverse Event|0|||
30660740|NCT00567541|58673491|FG001|Overall Study|Adverse Event|1|||
30660741|NCT00776997|58673497|FG000|Overall Study|Adverse Event|2|||
30660742|NCT00940823|58673503|FG000|Overall Study|Death|8|||
30660743|NCT00940823|58673504|FG001|Overall Study|Death|12|||
30660744|NCT00940823|58673503|FG000|Overall Study|Lost to Follow-up|27|||
30660745|NCT00940823|58673504|FG001|Overall Study|Lost to Follow-up|20|||
30660746|NCT00936611|58673512|FG000|Overall Study|Progressive Disease|3|||
30660747|NCT00936611|58673512|FG000|Overall Study|New Systemic Therapy|22|||
30660748|NCT00936611|58673512|FG000|Overall Study|Lost to Follow-up|1|||
30660749|NCT00936611|58673512|FG000|Overall Study|Withdrawal by Subject|2|||
30660750|NCT00936611|58673512|FG000|Overall Study|Still on Follow-up|1|||
30660751|NCT00936611|58673512|FG000|Overall Study|Still on Active Therapy|7|||
30660752|NCT00936611|58673512|FG000|Overall Study|Ineligible for Study Drug|3|||
30660753|NCT00936221|58673535|FG000|Overall Study|Withdrawal by Subject|1|||
30660754|NCT00936221|58673536|FG001|Overall Study|Withdrawal by Subject|1|||
30660755|NCT00776919|58673546|FG000|Overall Study|Withdrawal by Subject|16|||
30660756|NCT00776919|58673547|FG001|Overall Study|Withdrawal by Subject|14|||
30770829|NCT00229931|58779795|FG001|Overall Study|Lost to Follow-up|2|||
30770830|NCT03135028|58779801|FG000|Overall Study|Death|6|||
30770831|NCT03135028|58779801|FG000|Overall Study|Study Terminated by Sponsor|2|||
30770832|NCT03135028|58779801|FG000|Overall Study|Withdrew Consent|1|||
30770833|NCT00228917|58779813|FG000|Overall Study|Migrated/moved from study area|0|||
30770834|NCT00228917|58779814|FG001|Overall Study|Migrated/moved from study area|0|||
30770835|NCT00228917|58779815|FG002|Overall Study|Migrated/moved from study area|0|||
30770836|NCT00228917|58779816|FG003|Overall Study|Migrated/moved from study area|0|||
30770837|NCT00228917|58779817|FG004|Overall Study|Migrated/moved from study area|0|||
30770838|NCT00228917|58779818|FG005|Overall Study|Migrated/moved from study area|2|||
30770839|NCT00228917|58779819|FG006|Overall Study|Migrated/moved from study area|0|||
30770840|NCT00228917|58779820|FG007|Overall Study|Migrated/moved from study area|0|||
30849106|NCT01362530|58875904|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
30849107|NCT01362530|58875903|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
30849108|NCT01362530|58875904|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
30660757|NCT00776919|58673548|FG002|Overall Study|Withdrawal by Subject|15|||
30660758|NCT00776919|58673549|FG003|Overall Study|Withdrawal by Subject|26|||
30660759|NCT00776919|58673546|FG000|Overall Study|Lost to Follow-up|8|||
30660760|NCT00776919|58673547|FG001|Overall Study|Lost to Follow-up|12|||
30660761|NCT00776919|58673548|FG002|Overall Study|Lost to Follow-up|11|||
30660762|NCT00776919|58673549|FG003|Overall Study|Lost to Follow-up|8|||
30660763|NCT00776919|58673546|FG000|Overall Study|Adverse Event|1|||
30660764|NCT00776919|58673547|FG001|Overall Study|Adverse Event|0|||
30660765|NCT00776919|58673548|FG002|Overall Study|Adverse Event|2|||
30660766|NCT00776919|58673549|FG003|Overall Study|Adverse Event|2|||
30660767|NCT00776919|58673546|FG000|Overall Study|Protocol Violation|1|||
30660768|NCT00776919|58673547|FG001|Overall Study|Protocol Violation|2|||
30660769|NCT00776919|58673548|FG002|Overall Study|Protocol Violation|0|||
30660770|NCT00776919|58673549|FG003|Overall Study|Protocol Violation|1|||
30660771|NCT00776919|58673546|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
30660772|NCT00776919|58673547|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
30660773|NCT00776919|58673548|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
30660774|NCT00776919|58673549|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
30660775|NCT00775983|58673576|FG000|Overall Study|Protocol Violation|1|||
30660776|NCT00775983|58673577|FG001|Overall Study|Protocol Violation|2|||
30660777|NCT00775593|58673583|FG000|Overall Study|Unmet eligibility criteria|6|||
30660778|NCT00775593|58673583|FG000|Overall Study|Death|1|||
30660779|NCT00939809|58673587|FG000|Overall Study|Adverse Event|2|||
30660780|NCT00939809|58673587|FG000|Overall Study|Death|1|||
30660781|NCT00934661|58673593|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
30660782|NCT00934661|58673594|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
30660783|NCT00775437|58673600|FG000|Overall Study|Loss of efficacy|2|||
30660784|NCT00775437|58673600|FG000|Overall Study|Withdrawal by Subject|3|||
30660785|NCT00775437|58673600|FG000|Overall Study|Lost to Follow-up|1|||
30660786|NCT00775203|58673606|FG000|Overall Study|Adverse Event|25|||
30660787|NCT00775203|58673607|FG001|Overall Study|Adverse Event|6|||
30770841|NCT00227903|58779836|FG000|Overall Study|Withdrawal by Subject|2|||
30770842|NCT00227903|58779837|FG001|Overall Study|Withdrawal by Subject|5|||
30770843|NCT00227903|58779836|FG000|Overall Study|Subject moved out of area|1|||
30952680|NCT01894919|59001737|FG003|Overall Study|Lost to Follow-up|0|||
30952681|NCT01894919|59001738|FG004|Overall Study|Lost to Follow-up|2|||
30952682|NCT01894919|59001739|FG005|Overall Study|Lost to Follow-up|0|||
30660788|NCT00775203|58673606|FG000|Overall Study|Lack of Efficacy|8|||
30660789|NCT00775203|58673607|FG001|Overall Study|Lack of Efficacy|9|||
30660790|NCT00775203|58673606|FG000|Overall Study|Withdrawal by Subject|11|||
30660791|NCT00775203|58673607|FG001|Overall Study|Withdrawal by Subject|9|||
30660792|NCT00775203|58673606|FG000|Overall Study|Lost to Follow-up|11|||
30660793|NCT00775203|58673607|FG001|Overall Study|Lost to Follow-up|15|||
30660794|NCT00775203|58673606|FG000|Overall Study|Administrative reason|2|||
30660795|NCT00775203|58673607|FG001|Overall Study|Administrative reason|0|||
30660796|NCT00775203|58673606|FG000|Overall Study|Noncompliance|4|||
30660797|NCT00775203|58673607|FG001|Overall Study|Noncompliance|2|||
30660798|NCT00775203|58673606|FG000|Overall Study|Protocol Violation|0|||
30660799|NCT00775203|58673607|FG001|Overall Study|Protocol Violation|1|||
30660800|NCT00775203|58673606|FG000|Overall Study|Entered other study|1|||
30660801|NCT00775203|58673607|FG001|Overall Study|Entered other study|0|||
30660802|NCT00775203|58673606|FG000|Overall Study|Physician Decision|0|||
30660803|NCT00775203|58673607|FG001|Overall Study|Physician Decision|1|||
30660804|NCT00568321|58673616|FG000|Overall Study|Adverse Event|1|||
30660805|NCT00568321|58673617|FG001|Overall Study|Adverse Event|0|||
30660806|NCT00568321|58673618|FG002|Overall Study|Adverse Event|0|||
30660807|NCT00568321|58673616|FG000|Overall Study|Lack of Efficacy|8|||
30660808|NCT00568321|58673617|FG001|Overall Study|Lack of Efficacy|5|||
30660809|NCT00568321|58673618|FG002|Overall Study|Lack of Efficacy|6|||
30660810|NCT00568321|58673616|FG000|Overall Study|Lost to Follow-up|0|||
30660811|NCT00568321|58673617|FG001|Overall Study|Lost to Follow-up|0|||
30660812|NCT00568321|58673618|FG002|Overall Study|Lost to Follow-up|1|||
30660813|NCT00568321|58673616|FG000|Overall Study|Withdrawal by Subject|2|||
30660814|NCT00568321|58673617|FG001|Overall Study|Withdrawal by Subject|0|||
30660815|NCT00568321|58673618|FG002|Overall Study|Withdrawal by Subject|0|||
30660816|NCT00568321|58673616|FG000|Overall Study|Protocol Violation|0|||
30660817|NCT00568321|58673617|FG001|Overall Study|Protocol Violation|0|||
30660818|NCT00568321|58673618|FG002|Overall Study|Protocol Violation|1|||
30660819|NCT00568321|58673616|FG000|Overall Study|Randomized, not treated|2|||
30660820|NCT00568321|58673617|FG001|Overall Study|Randomized, not treated|0|||
30660821|NCT00568321|58673618|FG002|Overall Study|Randomized, not treated|1|||
30660822|NCT00774345|58673630|FG000|Pre-treatment|Other reasons|2|||
30660823|NCT00774345|58673631|FG001|Pre-treatment|Other reasons|0|||
30660824|NCT00774345|58673630|FG000|Treatment|Adverse Event|61|||
30660825|NCT00774345|58673631|FG001|Treatment|Adverse Event|15|||
30660826|NCT00774345|58673630|FG000|Treatment|Progressive Disease without histologic transformation|51|||
30660827|NCT00774345|58673631|FG001|Treatment|Progressive Disease without histologic transformation|111|||
30660828|NCT00774345|58673630|FG000|Treatment|Progressive Disease with histologic transformation|4|||
30660829|NCT00774345|58673631|FG001|Treatment|Progressive Disease with histologic transformation|2|||
30660830|NCT00774345|58673630|FG000|Treatment|Withdrawal by Subject|5|||
30660831|NCT00774345|58673631|FG001|Treatment|Withdrawal by Subject|2|||
30660832|NCT00774345|58673630|FG000|Treatment|Lost to Follow-up|1|||
30660833|NCT00774345|58673631|FG001|Treatment|Lost to Follow-up|1|||
30660834|NCT00774345|58673630|FG000|Treatment|Death|4|||
30660835|NCT00774345|58673631|FG001|Treatment|Death|0|||
30660836|NCT00774345|58673630|FG000|Treatment|Other Reasons|32|||
30660837|NCT00774345|58673631|FG001|Treatment|Other Reasons|26|||
30660838|NCT00773253|58673643|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
30660839|NCT00773253|58673644|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
30660840|NCT00773175|58673654|FG000|Overall Study|Adverse Event|2|||
30660841|NCT00773175|58673655|FG001|Overall Study|Adverse Event|0|||
30660842|NCT00773175|58673654|FG000|Overall Study|Consent Withdrawn|0|||
30660843|NCT00773175|58673655|FG001|Overall Study|Consent Withdrawn|2|||
30660844|NCT00566527|58673669|FG000|Overall Study|Reason not provided|3|||
30660845|NCT00566527|58673670|FG001|Overall Study|Reason not provided|11|||
30660846|NCT00566527|58673671|FG002|Overall Study|Reason not provided|10|||
30660847|NCT00566527|58673669|FG000|Overall Study|Adverse Event|2|||
30660848|NCT00566527|58673670|FG001|Overall Study|Adverse Event|0|||
30660849|NCT00566527|58673671|FG002|Overall Study|Adverse Event|1|||
30660850|NCT00566527|58673669|FG000|Overall Study|Physician Decision|3|||
30660851|NCT00566527|58673670|FG001|Overall Study|Physician Decision|8|||
30660852|NCT00566527|58673671|FG002|Overall Study|Physician Decision|20|||
30660853|NCT00566527|58673669|FG000|Overall Study|Lost to Follow-up|3|||
30660854|NCT00566527|58673670|FG001|Overall Study|Lost to Follow-up|4|||
30770844|NCT00227903|58779837|FG001|Overall Study|Subject moved out of area|2|||
30770845|NCT00227903|58779836|FG000|Overall Study|Lost to Follow-up|1|||
30952683|NCT01894919|59001740|FG006|Overall Study|Lost to Follow-up|0|||
30660855|NCT00566527|58673671|FG002|Overall Study|Lost to Follow-up|4|||
30770846|NCT00227903|58779837|FG001|Overall Study|Lost to Follow-up|3|||
30770847|NCT00227903|58779836|FG000|Overall Study|Miscarriage|1|||
30770848|NCT00227903|58779837|FG001|Overall Study|Miscarriage|0|||
30770849|NCT04411628|58779847|FG000|Overall Study|Withdrawal by Subject|1|||
30770850|NCT04411628|58779848|FG001|Overall Study|Withdrawal by Subject|1|||
30770851|NCT04411628|58779849|FG002|Overall Study|Withdrawal by Subject|2|||
30770852|NCT04411628|58779850|FG003|Overall Study|Withdrawal by Subject|0|||
30770853|NCT04411628|58779847|FG000|Overall Study|Lost to Follow-up|0|||
30770854|NCT04411628|58779848|FG001|Overall Study|Lost to Follow-up|1|||
30770855|NCT04411628|58779849|FG002|Overall Study|Lost to Follow-up|0|||
30770856|NCT04411628|58779850|FG003|Overall Study|Lost to Follow-up|0|||
30770857|NCT00227591|58779863|FG000|Overall Study|Withdrawal by Subject|1|||
30770858|NCT04512482|58779869|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
30770859|NCT04512482|58779870|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
30770860|NCT00226811|58779876|FG000|Overall Study|Death|8|||
30660856|NCT00566527|58673669|FG000|Overall Study|Withdrawal by Subject|6|||
30660857|NCT00566527|58673670|FG001|Overall Study|Withdrawal by Subject|43|||
30660858|NCT00566527|58673671|FG002|Overall Study|Withdrawal by Subject|43|||
30660859|NCT00773097|58673681|FG000|Overall Study|Withdrawal by Subject|1|||
30660860|NCT00773097|58673681|FG000|Overall Study|Physician Decision|6|||
30660861|NCT00933335|58673687|FG000|Overall Study|Lost to Follow-up|1|||
30660862|NCT00933335|58673688|FG001|Overall Study|Lost to Follow-up|3|||
30660863|NCT00933335|58673687|FG000|Overall Study|Withdrawal by Subject|0|||
30660864|NCT00933335|58673688|FG001|Overall Study|Withdrawal by Subject|1|||
30660865|NCT00933335|58673687|FG000|Overall Study|Progressive Disease|0|||
30660866|NCT00933335|58673688|FG001|Overall Study|Progressive Disease|11|||
30660867|NCT00933335|58673687|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
30660868|NCT00933335|58673688|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
30660869|NCT00933335|58673687|FG000|Overall Study|Co-morbid Illness|1|||
30660870|NCT00933335|58673688|FG001|Overall Study|Co-morbid Illness|0|||
30660871|NCT00772941|58673700|FG000|Overall Study|CRFs not available|195|||
30660872|NCT00772941|58673700|FG000|Overall Study|Study not completed|16|||
30660873|NCT00772941|58673700|FG000|Overall Study|Missed Visits|374|||
30660874|NCT00772941|58673700|FG000|Overall Study|Poor Compliance|7|||
30660875|NCT00772941|58673700|FG000|Overall Study|GPSP Violation|90|||
30660876|NCT00772707|58673727|FG000|Overall Study|Withdrawn|3|||
30660877|NCT00772629|58673733|FG000|Overall Study|Subject was not vaccinated|1|||
30660878|NCT00772629|58673734|FG001|Overall Study|Subject was not vaccinated|0|||
30660879|NCT00939341|58673740|FG000|Overall Study|Adverse Event|15|||
30660880|NCT00939341|58673740|FG000|Overall Study|Pregnancy|1|||
30660881|NCT00939341|58673740|FG000|Overall Study|Lost to Follow-up|23|||
30660882|NCT00939341|58673740|FG000|Overall Study|Withdrawal by Subject|13|||
30660883|NCT00939341|58673740|FG000|Overall Study|Protocol Violation|6|||
30660884|NCT00939341|58673740|FG000|Overall Study|Incorrect enrolment|8|||
30660885|NCT04292470|58673769|FG000|Overall Study|Withdrawal by Subject|0|||
30660886|NCT04292470|58673770|FG001|Overall Study|Withdrawal by Subject|1|||
30660887|NCT04217590|58673778|FG000|Overall Study|Other|1|||
30660888|NCT04217590|58673779|FG001|Overall Study|Other|1|||
30660889|NCT04217590|58673778|FG000|Overall Study|Withdrawal by Subject|3|||
30660890|NCT04217590|58673779|FG001|Overall Study|Withdrawal by Subject|1|||
30660891|NCT04217590|58673778|FG000|Overall Study|Death|0|||
30660892|NCT04217590|58673779|FG001|Overall Study|Death|1|||
30660893|NCT03963232|58673787|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
30660894|NCT03963232|58673788|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
30660895|NCT03963232|58673787|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
30660896|NCT03963232|58673788|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
30660897|NCT03963232|58673787|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
30660898|NCT03963232|58673788|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
30660899|NCT03963232|58673787|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
30660900|NCT03963232|58673788|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
30660901|NCT03963232|58673787|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
30660902|NCT03963232|58673788|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
30660903|NCT03963232|58673787|FG000|Open-Label Treatment Phase|Adverse Event|1|||
30660904|NCT03963232|58673788|FG001|Open-Label Treatment Phase|Adverse Event|2|||
30770861|NCT00226811|58779876|FG000|Overall Study|Adverse Event|11|||
30660905|NCT03963232|58673787|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
30660906|NCT03963232|58673788|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
30660907|NCT03963232|58673787|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
30660908|NCT03963232|58673788|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
30660909|NCT03963232|58673787|FG000|Open-Label Treatment Phase|Pregnancy|1|||
30660910|NCT03963232|58673788|FG001|Open-Label Treatment Phase|Pregnancy|0|||
30660911|NCT03963232|58673787|FG000|Follow-up Phase|Withdrawal by Subject|7|||
30660912|NCT03963232|58673788|FG001|Follow-up Phase|Withdrawal by Subject|5|||
30770862|NCT00226811|58779876|FG000|Overall Study|Lack of Efficacy|55|||
30770863|NCT00226811|58779876|FG000|Overall Study|Withdrawal by Subject|2|||
30770864|NCT02951052|58779882|FG000|Overall Study|Adverse Event|13|||
30660913|NCT03963232|58673787|FG000|Follow-up Phase|Protocol Violation|0|||
30660914|NCT03963232|58673788|FG001|Follow-up Phase|Protocol Violation|2|||
30660915|NCT03963232|58673787|FG000|Follow-up Phase|Adverse Event|0|||
30770865|NCT02951052|58779883|FG001|Overall Study|Adverse Event|5|||
30770866|NCT02951052|58779882|FG000|Overall Study|Withdrawal by Subject|1|||
30770867|NCT02951052|58779883|FG001|Overall Study|Withdrawal by Subject|5|||
30770868|NCT02951052|58779882|FG000|Overall Study|Physician Decision|2|||
30770869|NCT02951052|58779883|FG001|Overall Study|Physician Decision|0|||
30770870|NCT02951052|58779882|FG000|Overall Study|Lost to Follow-up|1|||
30770871|NCT02951052|58779883|FG001|Overall Study|Lost to Follow-up|1|||
30770872|NCT02951052|58779882|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
30770873|NCT02951052|58779883|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
30770874|NCT02951052|58779882|FG000|Overall Study|Protocol Violation|5|||
30770875|NCT02951052|58779883|FG001|Overall Study|Protocol Violation|3|||
30770876|NCT02951052|58779882|FG000|Overall Study|Lack of Efficacy|3|||
30770877|NCT02951052|58779883|FG001|Overall Study|Lack of Efficacy|4|||
30770878|NCT02951052|58779882|FG000|Overall Study|Ongoing|1|||
30770879|NCT02951052|58779883|FG001|Overall Study|Ongoing|0|||
30770880|NCT00226655|58779893|FG000|Overall Study|Death|13|||
30770881|NCT00226655|58779893|FG000|Overall Study|Withdrawal by Subject|15|||
30770882|NCT00226655|58779893|FG000|Overall Study|Adverse Event|35|||
30770883|NCT00226655|58779893|FG000|Overall Study|Physician Decision|6|||
30770884|NCT00226655|58779893|FG000|Overall Study|Clinical deterioration|10|||
30770885|NCT03124108|58779909|FG000|Overall Study|Adverse Event|0|||
30770886|NCT03124108|58779910|FG001|Overall Study|Adverse Event|1|||
30770887|NCT03124108|58779911|FG002|Overall Study|Adverse Event|0|||
30770888|NCT04475588|58779923|FG000|Overall Study|Adverse Event|2|||
30770889|NCT04475588|58779924|FG001|Overall Study|Adverse Event|0|||
30770890|NCT04353596|58779933|FG000|Overall Study|Protocol Violation|4|||
30770891|NCT04353596|58779934|FG001|Overall Study|Protocol Violation|4|||
30770892|NCT04353596|58779933|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
30770893|NCT04353596|58779934|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
30770894|NCT04350788|58779942|FG000|Overall Study|Lost to Follow-up|6|||
30770895|NCT04350788|58779943|FG001|Overall Study|Lost to Follow-up|2|||
30770896|NCT04350788|58779942|FG000|Overall Study|Withdrawal by Subject|2|||
30770897|NCT04350788|58779943|FG001|Overall Study|Withdrawal by Subject|4|||
30770898|NCT04350788|58779942|FG000|Overall Study|Protocol Violation|4|||
30770899|NCT04350788|58779943|FG001|Overall Study|Protocol Violation|0|||
30770900|NCT03852316|58779954|FG000|Overall Study|Protocol Violation|1|||
30770901|NCT03852316|58779954|FG000|Overall Study|Withdrawal by Subject|2|||
30770902|NCT03852316|58779954|FG000|Overall Study|Enrolled but Device not Utilized|1|||
30770903|NCT04335812|58779960|FG000|Overall Study|Withdrawal by Subject|1|||
30770904|NCT04335812|58779961|FG001|Overall Study|Withdrawal by Subject|3|||
30770905|NCT04335812|58779960|FG000|Overall Study|Lost to Follow-up|12|||
30770906|NCT04335812|58779961|FG001|Overall Study|Lost to Follow-up|12|||
30770907|NCT04335812|58779960|FG000|Overall Study|Did not engage in the intervention|22|||
30770908|NCT04335812|58779961|FG001|Overall Study|Did not engage in the intervention|18|||
30770909|NCT03127384|58779967|FG000|Overall Study|Lost to Follow-up|4|||
30770910|NCT03127384|58779967|FG000|Overall Study|Subject request|2|||
30770911|NCT04398134|58779994|FG000|Overall Study|Adverse Event|0|||
30849109|NCT01362530|58875903|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
30849110|NCT01362530|58875904|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
30849111|NCT01362530|58875903|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
30849112|NCT01362530|58875904|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
30849113|NCT01362530|58875903|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
30849114|NCT01362530|58875904|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
30849115|NCT01362530|58875903|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
30849116|NCT01362530|58875904|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
30770912|NCT04398134|58779995|FG001|Overall Study|Adverse Event|0|||
30770913|NCT04398134|58779996|FG002|Overall Study|Adverse Event|1|||
30770914|NCT04398134|58779997|FG003|Overall Study|Adverse Event|0|||
30770915|NCT04398134|58779994|FG000|Overall Study|Withdrawal by Subject|2|||
30770916|NCT04398134|58779995|FG001|Overall Study|Withdrawal by Subject|0|||
30770917|NCT04398134|58779996|FG002|Overall Study|Withdrawal by Subject|0|||
30770918|NCT04398134|58779997|FG003|Overall Study|Withdrawal by Subject|1|||
30770919|NCT04398134|58779994|FG000|Overall Study|Study Terminated by Sponsor|30|||
30770920|NCT04398134|58779995|FG001|Overall Study|Study Terminated by Sponsor|11|||
30770921|NCT04398134|58779996|FG002|Overall Study|Study Terminated by Sponsor|32|||
30660916|NCT03963232|58673788|FG001|Follow-up Phase|Adverse Event|1|||
30660917|NCT03963232|58673787|FG000|Follow-up Phase|Lost to Follow-up|0|||
30660918|NCT03963232|58673788|FG001|Follow-up Phase|Lost to Follow-up|1|||
30660919|NCT03856593|58673812|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
30660920|NCT03856593|58673813|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
30660921|NCT03785925|58673821|FG000|Overall Study|Withdrawal by Subject|15|||
30660922|NCT03785925|58673821|FG000|Overall Study|Lost to Follow-up|1|||
30660923|NCT03427411|58673832|FG000|Overall Study|Screen failure - platelets too low|0|||
30660924|NCT03427411|58673833|FG001|Overall Study|Screen failure - platelets too low|1|||
30660925|NCT03330106|58673841|FG000|Part A|Withdrawal by Subject|1|||
30660926|NCT03330106|58673842|FG001|Part A|Withdrawal by Subject|1|||
30660927|NCT03330106|58673843|FG002|Part A|Withdrawal by Subject|0|||
30660928|NCT03330106|58673844|FG003|Part A|Withdrawal by Subject|0|||
30660929|NCT03330106|58673841|FG000|Part A|Death|2|||
30660930|NCT03330106|58673842|FG001|Part A|Death|1|||
30660931|NCT03330106|58673843|FG002|Part A|Death|0|||
30660932|NCT03330106|58673844|FG003|Part A|Death|0|||
30660933|NCT03330106|58673841|FG000|Part A|Adverse Event|0|||
30660934|NCT03330106|58673842|FG001|Part A|Adverse Event|1|||
30660935|NCT03330106|58673843|FG002|Part A|Adverse Event|0|||
30660936|NCT03330106|58673844|FG003|Part A|Adverse Event|0|||
30660937|NCT03330106|58673841|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
30660938|NCT03330106|58673842|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
30660939|NCT03330106|58673843|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
30660940|NCT03330106|58673844|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
30660941|NCT03330106|58673841|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
30660942|NCT03330106|58673842|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
30660943|NCT03330106|58673843|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
30660944|NCT03330106|58673844|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
30660945|NCT03330106|58673841|FG000|Part A|Progressive Disease|0|||
30660946|NCT03330106|58673842|FG001|Part A|Progressive Disease|1|||
30660947|NCT03330106|58673843|FG002|Part A|Progressive Disease|0|||
30660948|NCT03330106|58673844|FG003|Part A|Progressive Disease|0|||
30660949|NCT03330106|58673841|FG000|Part B|Lost to Follow-up|0|||
30660950|NCT03330106|58673842|FG001|Part B|Lost to Follow-up|0|||
30660951|NCT03330106|58673843|FG002|Part B|Lost to Follow-up|0|||
30660952|NCT03330106|58673844|FG003|Part B|Lost to Follow-up|1|||
30660953|NCT03330106|58673841|FG000|Part B|Withdrawal by Subject|0|||
30660954|NCT03330106|58673842|FG001|Part B|Withdrawal by Subject|0|||
30660955|NCT03330106|58673843|FG002|Part B|Withdrawal by Subject|4|||
30660956|NCT03330106|58673844|FG003|Part B|Withdrawal by Subject|0|||
30660957|NCT03330106|58673841|FG000|Part B|Death|0|||
30660958|NCT03330106|58673842|FG001|Part B|Death|0|||
30660959|NCT03330106|58673843|FG002|Part B|Death|2|||
30660960|NCT03330106|58673844|FG003|Part B|Death|0|||
30660961|NCT03330106|58673841|FG000|Part B|Clinical Progression|0|||
30660962|NCT03330106|58673842|FG001|Part B|Clinical Progression|0|||
30660963|NCT03330106|58673843|FG002|Part B|Clinical Progression|1|||
30660964|NCT03330106|58673844|FG003|Part B|Clinical Progression|1|||
30660965|NCT03330106|58673841|FG000|Part B|Symptomatic Deterioration|0|||
30660966|NCT03330106|58673842|FG001|Part B|Symptomatic Deterioration|0|||
30660967|NCT03330106|58673843|FG002|Part B|Symptomatic Deterioration|0|||
30660968|NCT03330106|58673844|FG003|Part B|Symptomatic Deterioration|1|||
30660969|NCT03330106|58673841|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
30660970|NCT03330106|58673842|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
30660971|NCT03330106|58673843|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
30660972|NCT03330106|58673844|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
30660973|NCT03330106|58673841|FG000|Part B|Progressive Disease|0|||
30660974|NCT03330106|58673842|FG001|Part B|Progressive Disease|0|||
30770922|NCT04398134|58779997|FG003|Overall Study|Study Terminated by Sponsor|11|||
30770923|NCT03122860|58780013|FG000|Overall Study|Discontinued Before Treatment|1|||
30770924|NCT03122860|58780014|FG001|Overall Study|Discontinued Before Treatment|1|||
30770925|NCT03122860|58780015|FG002|Overall Study|Discontinued Before Treatment|2|||
30770926|NCT03122860|58780016|FG003|Overall Study|Discontinued Before Treatment|0|||
30770927|NCT03122860|58780017|FG004|Overall Study|Discontinued Before Treatment|1|||
30770928|NCT03122860|58780018|FG005|Overall Study|Discontinued Before Treatment|0|||
30770929|NCT03122860|58780013|FG000|Overall Study|Adverse Event|1|||
30770930|NCT03122860|58780014|FG001|Overall Study|Adverse Event|0|||
30770931|NCT03122860|58780015|FG002|Overall Study|Adverse Event|1|||
30660975|NCT03330106|58673843|FG002|Part B|Progressive Disease|11|||
30660976|NCT03330106|58673844|FG003|Part B|Progressive Disease|4|||
30660977|NCT03164564|58673856|FG000|Overall Study|Death|3|||
30770932|NCT03122860|58780016|FG003|Overall Study|Adverse Event|1|||
30770933|NCT03122860|58780017|FG004|Overall Study|Adverse Event|0|||
30849117|NCT01362530|58875903|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
30849118|NCT01362530|58875904|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
30849119|NCT01362530|58875903|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
30849120|NCT01362530|58875904|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
30849121|NCT02654054|58875914|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
30849122|NCT02654054|58875915|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
30849123|NCT02654054|58875916|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
30849124|NCT02654054|58875914|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
30849125|NCT02654054|58875915|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30849126|NCT02654054|58875916|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
30849127|NCT02654054|58875914|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
30849128|NCT02654054|58875915|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
30849129|NCT02654054|58875916|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
30849130|NCT02654054|58875914|FG000|Post-Treatment Follow-Up Period|Other|1|||
30849131|NCT02654054|58875915|FG001|Post-Treatment Follow-Up Period|Other|0|||
30849132|NCT02654054|58875916|FG002|Post-Treatment Follow-Up Period|Other|4|||
30849133|NCT02654054|58875914|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
30849134|NCT02654054|58875915|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
30849135|NCT02654054|58875916|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
30849136|NCT02653664|58875937|FG000|Post-Treatment|Withdrawal by Subject|6|||
30849137|NCT02653664|58875938|FG001|Post-Treatment|Withdrawal by Subject|5|||
30849138|NCT02653664|58875939|FG002|Post-Treatment|Withdrawal by Subject|7|||
30849139|NCT02653664|58875937|FG000|Post-Treatment|Lost to Follow-up|8|||
30849140|NCT02653664|58875938|FG001|Post-Treatment|Lost to Follow-up|1|||
30660978|NCT03164564|58673857|FG001|Overall Study|Death|0|||
30849141|NCT02653664|58875939|FG002|Post-Treatment|Lost to Follow-up|7|||
30849142|NCT02653664|58875937|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
30660979|NCT03164564|58673856|FG000|Overall Study|Withdrawal by Subject|20|||
30660980|NCT03164564|58673857|FG001|Overall Study|Withdrawal by Subject|15|||
30660981|NCT03164564|58673856|FG000|Overall Study|Lost to Follow-up|2|||
30660982|NCT03164564|58673857|FG001|Overall Study|Lost to Follow-up|0|||
30770934|NCT03122860|58780018|FG005|Overall Study|Adverse Event|0|||
30770935|NCT03122860|58780013|FG000|Overall Study|Lost to Follow-up|5|||
30770936|NCT03122860|58780014|FG001|Overall Study|Lost to Follow-up|2|||
30660983|NCT03164564|58673856|FG000|Overall Study|Physician Decision|0|||
30770937|NCT03122860|58780015|FG002|Overall Study|Lost to Follow-up|3|||
30770938|NCT03122860|58780016|FG003|Overall Study|Lost to Follow-up|3|||
30770939|NCT03122860|58780017|FG004|Overall Study|Lost to Follow-up|5|||
30660984|NCT03164564|58673857|FG001|Overall Study|Physician Decision|1|||
30660985|NCT03164564|58673856|FG000|Overall Study|Adverse Event|0|||
30660986|NCT03164564|58673857|FG001|Overall Study|Adverse Event|1|||
30660987|NCT03164564|58673856|FG000|Overall Study|Ongoing|1586|||
30660988|NCT03164564|58673857|FG001|Overall Study|Ongoing|1586|||
30660989|NCT02821754|58673877|FG000|Overall Study|Procedure not required prior to amendment change|13|||
30660990|NCT02821754|58673878|FG001|Overall Study|Procedure not required prior to amendment change|11|||
30660991|NCT02821754|58673879|FG002|Overall Study|Procedure not required prior to amendment change|0|||
30660992|NCT02821754|58673877|FG000|Overall Study|Participant's Clinical status|2|||
30660993|NCT02821754|58673878|FG001|Overall Study|Participant's Clinical status|0|||
30660994|NCT02821754|58673879|FG002|Overall Study|Participant's Clinical status|0|||
30660995|NCT02821754|58673877|FG000|Overall Study|Participant removed for noncompliance|1|||
30660996|NCT02821754|58673878|FG001|Overall Study|Participant removed for noncompliance|0|||
30660997|NCT02821754|58673879|FG002|Overall Study|Participant removed for noncompliance|0|||
30660998|NCT02821754|58673877|FG000|Overall Study|Drug not available.|0|||
30660999|NCT02821754|58673878|FG001|Overall Study|Drug not available.|0|||
30661000|NCT02821754|58673879|FG002|Overall Study|Drug not available.|1|||
30661001|NCT02821754|58673877|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
30661002|NCT02821754|58673878|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
30661003|NCT02821754|58673879|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
30661004|NCT02742246|58673888|FG000|Overall Study|Never initiated treatment|5|||
30661005|NCT02742246|58673889|FG001|Overall Study|Never initiated treatment|3|||
30661006|NCT02742246|58673890|FG002|Overall Study|Never initiated treatment|1|||
30661007|NCT02742246|58673888|FG000|Overall Study|dropped out during treatment|14|||
30661008|NCT02742246|58673889|FG001|Overall Study|dropped out during treatment|14|||
30661009|NCT02742246|58673890|FG002|Overall Study|dropped out during treatment|11|||
30661010|NCT02742246|58673888|FG000|Overall Study|Death|1|||
30661011|NCT02742246|58673889|FG001|Overall Study|Death|0|||
30770940|NCT03122860|58780018|FG005|Overall Study|Lost to Follow-up|4|||
30770941|NCT03122860|58780013|FG000|Overall Study|Subject Non-Compliance|0|||
30661012|NCT02742246|58673890|FG002|Overall Study|Death|0|||
30661013|NCT02708108|58673900|FG000|Overall Study|Death|1|||
30661014|NCT02708108|58673901|FG001|Overall Study|Death|2|||
30770942|NCT03122860|58780014|FG001|Overall Study|Subject Non-Compliance|0|||
30770943|NCT03122860|58780015|FG002|Overall Study|Subject Non-Compliance|1|||
30661015|NCT02708108|58673900|FG000|Overall Study|Regimen change|1|||
30661016|NCT02708108|58673901|FG001|Overall Study|Regimen change|0|||
30770944|NCT03122860|58780016|FG003|Overall Study|Subject Non-Compliance|0|||
30770945|NCT03122860|58780017|FG004|Overall Study|Subject Non-Compliance|0|||
30770946|NCT03122860|58780018|FG005|Overall Study|Subject Non-Compliance|0|||
30770947|NCT03122860|58780013|FG000|Overall Study|Withdrawal by Subject|3|||
30770948|NCT03122860|58780014|FG001|Overall Study|Withdrawal by Subject|2|||
30770949|NCT03122860|58780015|FG002|Overall Study|Withdrawal by Subject|5|||
30770950|NCT03122860|58780016|FG003|Overall Study|Withdrawal by Subject|7|||
30770951|NCT03122860|58780017|FG004|Overall Study|Withdrawal by Subject|9|||
30770952|NCT03122860|58780018|FG005|Overall Study|Withdrawal by Subject|8|||
30770953|NCT03798366|58780035|FG000|Overall Study|Lost to Follow-up|0|||
30770954|NCT03798366|58780036|FG001|Overall Study|Lost to Follow-up|1|||
30770955|NCT04327388|58780045|FG000|Overall Study|Adverse Event|17|||
30770956|NCT04327388|58780046|FG001|Overall Study|Adverse Event|18|||
30770957|NCT04327388|58780047|FG002|Overall Study|Adverse Event|9|||
30770958|NCT04327388|58780045|FG000|Overall Study|Other|1|||
30770959|NCT04327388|58780046|FG001|Overall Study|Other|2|||
30770960|NCT04327388|58780047|FG002|Overall Study|Other|0|||
30770961|NCT04327388|58780045|FG000|Overall Study|Randomized and not treated|2|||
30661017|NCT02708108|58673900|FG000|Overall Study|No MRD and no imaging available|0|||
30661018|NCT02708108|58673901|FG001|Overall Study|No MRD and no imaging available|1|||
30661019|NCT02619682|58673908|FG000|Overall Study|Withdrawal by Subject|3|||
30770962|NCT04327388|58780046|FG001|Overall Study|Randomized and not treated|0|||
30661020|NCT02619682|58673908|FG000|Overall Study|Lack of Efficacy|8|||
30770963|NCT04327388|58780047|FG002|Overall Study|Randomized and not treated|2|||
30770964|NCT03796728|58780055|FG000|Overall Study|Lost to Follow-up|8|||
30770965|NCT03796728|58780055|FG000|Overall Study|Reason not Specified|16|||
30849143|NCT02653664|58875938|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
30770966|NCT00352534|58780061|FG000|Initial Staging|Ineligible|8|||
30770967|NCT00352534|58780062|FG001|Initial Staging|Ineligible|9|||
30661021|NCT02619682|58673908|FG000|Overall Study|new secondary cancer|1|||
30661022|NCT02619682|58673908|FG000|Overall Study|post surgery complications|2|||
30661023|NCT02617589|58673914|FG000|Randomization|Request to Discontinue Study Treatment|1|||
30661024|NCT02617589|58673915|FG001|Randomization|Request to Discontinue Study Treatment|3|||
30661025|NCT02617589|58673914|FG000|Randomization|Participant Withdrew Consent|1|||
30661026|NCT02617589|58673915|FG001|Randomization|Participant Withdrew Consent|2|||
30661027|NCT02617589|58673914|FG000|Treatment|Other Reasons|3|||
30661028|NCT02617589|58673915|FG001|Treatment|Other Reasons|3|||
30661029|NCT02617589|58673914|FG000|Treatment|Poor/Non Compliance|1|||
30661030|NCT02617589|58673915|FG001|Treatment|Poor/Non Compliance|1|||
30661031|NCT02617589|58673914|FG000|Treatment|Maximum Clinical Benefit|0|||
30661032|NCT02617589|58673915|FG001|Treatment|Maximum Clinical Benefit|2|||
30661033|NCT02617589|58673914|FG000|Treatment|Participant Withdrew Consent|2|||
30661034|NCT02617589|58673915|FG001|Treatment|Participant Withdrew Consent|6|||
30661035|NCT02617589|58673914|FG000|Treatment|Participant Request to Discontinue|12|||
30661036|NCT02617589|58673915|FG001|Treatment|Participant Request to Discontinue|21|||
30661037|NCT02617589|58673914|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
30661038|NCT02617589|58673915|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
30661039|NCT02617589|58673914|FG000|Treatment|Death|1|||
30661040|NCT02617589|58673915|FG001|Treatment|Death|1|||
30661041|NCT02617589|58673914|FG000|Treatment|Study Drug Toxicity|27|||
30661042|NCT02617589|58673915|FG001|Treatment|Study Drug Toxicity|20|||
30661043|NCT02617589|58673914|FG000|Treatment|Disease Progression|216|||
30661044|NCT02617589|58673915|FG001|Treatment|Disease Progression|136|||
30661045|NCT02471807|58673921|FG000|Overall Study|Death|14|||
30661046|NCT02471807|58673921|FG000|Overall Study|Withdrawal by Subject|2|||
30661047|NCT02471807|58673921|FG000|Overall Study|Explant|5|||
30661048|NCT02471807|58673921|FG000|Overall Study|Lost to Follow-up|1|||
30661049|NCT02364557|58673927|FG000|Overall Study|Protocol Violation|3|||
30661050|NCT02364557|58673928|FG001|Overall Study|Protocol Violation|1|||
30661051|NCT02337829|58673964|FG000|Overall Study|Death|0|||
30661052|NCT02337829|58673965|FG001|Overall Study|Death|1|||
30661053|NCT02337829|58673966|FG002|Overall Study|Death|0|||
30661054|NCT02337829|58673967|FG003|Overall Study|Death|0|||
30661055|NCT02337829|58673964|FG000|Overall Study|Study terminated by sponsor|12|||
30661056|NCT02337829|58673965|FG001|Overall Study|Study terminated by sponsor|10|||
30661057|NCT02337829|58673966|FG002|Overall Study|Study terminated by sponsor|5|||
30661058|NCT02337829|58673967|FG003|Overall Study|Study terminated by sponsor|6|||
30661059|NCT02337829|58673964|FG000|Overall Study|discontinued for other reasons|6|||
30661060|NCT02337829|58673965|FG001|Overall Study|discontinued for other reasons|3|||
30661061|NCT02337829|58673966|FG002|Overall Study|discontinued for other reasons|1|||
30661062|NCT02337829|58673967|FG003|Overall Study|discontinued for other reasons|4|||
30661063|NCT02257528|58673979|FG000|Overall Study|Never received study treatment|1|||
30661064|NCT01899326|58673990|FG000|Overall Study|Withdrawal by Subject|1|||
30661065|NCT01899326|58673990|FG000|Overall Study|Adverse Event|2|||
30661066|NCT01899326|58673990|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
30661067|NCT01572480|58673995|FG000|Participants Enrolled|Withdrawal by Subject|1|||
30770968|NCT00352534|58780063|FG002|Initial Staging|Ineligible|0|||
30770969|NCT00352534|58780064|FG003|Initial Staging|Ineligible|0|||
30770970|NCT00352534|58780065|FG004|Initial Staging|Ineligible|0|||
30770971|NCT00352534|58780066|FG005|Initial Staging|Ineligible|0|||
30770972|NCT00352534|58780067|FG006|Initial Staging|Ineligible|0|||
30770973|NCT00352534|58780061|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
30770974|NCT00352534|58780062|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
30770975|NCT00352534|58780063|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
30770976|NCT00352534|58780064|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
30952684|NCT01894919|59001741|FG007|Overall Study|Lost to Follow-up|0|||
30952685|NCT01894919|59001742|FG008|Overall Study|Lost to Follow-up|0|||
30952686|NCT01894919|59001743|FG009|Overall Study|Lost to Follow-up|0|||
30952687|NCT01894919|59001744|FG010|Overall Study|Lost to Follow-up|0|||
30952688|NCT01894919|59001745|FG011|Overall Study|Lost to Follow-up|0|||
30952689|NCT01894919|59001746|FG012|Overall Study|Lost to Follow-up|0|||
30661068|NCT01572480|58673995|FG000|Drug Administration|Discontinued drug/Off Study|1|||
30661069|NCT01572480|58673995|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
30661070|NCT01572480|58673995|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
30661071|NCT01126190|58674002|FG000|Double-Blind Phase|Death|0|||
30661072|NCT01126190|58674003|FG001|Double-Blind Phase|Death|1|||
30661073|NCT01126190|58674004|FG002|Double-Blind Phase|Death|0|||
30661074|NCT01126190|58674002|FG000|Double-Blind Phase|Adverse Event|1|||
30661075|NCT01126190|58674003|FG001|Double-Blind Phase|Adverse Event|2|||
30661076|NCT01126190|58674004|FG002|Double-Blind Phase|Adverse Event|0|||
30770977|NCT00352534|58780065|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
30770978|NCT00352534|58780066|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
30770979|NCT00352534|58780067|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
30952690|NCT01894841|59001790|FG000|Overall Study|Withdrawal by Subject|9|||
30952691|NCT01894841|59001791|FG001|Overall Study|Withdrawal by Subject|4|||
30661077|NCT01126190|58674002|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
30661078|NCT01126190|58674003|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
30661079|NCT01126190|58674004|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
30661080|NCT01126190|58674002|FG000|Double-Blind Phase|Request of Investigator|1|||
30661081|NCT01126190|58674003|FG001|Double-Blind Phase|Request of Investigator|0|||
30661082|NCT01126190|58674004|FG002|Double-Blind Phase|Request of Investigator|0|||
30661083|NCT01126190|58674002|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
30661084|NCT01126190|58674003|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
30770980|NCT00352534|58780061|FG000|Final Risk Group Assignment|Physician Decision|0|||
30770981|NCT00352534|58780062|FG001|Final Risk Group Assignment|Physician Decision|0|||
30661085|NCT01126190|58674004|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
30661086|NCT01126190|58674002|FG000|Double-Blind Phase|Non-compliance|1|||
30661087|NCT01126190|58674003|FG001|Double-Blind Phase|Non-compliance|0|||
30661088|NCT01126190|58674004|FG002|Double-Blind Phase|Non-compliance|0|||
30661089|NCT01126190|58674002|FG000|Double-Blind Phase|Lost to Follow-up|1|||
30661090|NCT01126190|58674003|FG001|Double-Blind Phase|Lost to Follow-up|3|||
30661091|NCT01126190|58674004|FG002|Double-Blind Phase|Lost to Follow-up|0|||
30661092|NCT01126190|58674002|FG000|Open-Label Phase|Death|0|||
30770982|NCT00352534|58780063|FG002|Final Risk Group Assignment|Physician Decision|0|||
30770983|NCT00352534|58780064|FG003|Final Risk Group Assignment|Physician Decision|0|||
30770984|NCT00352534|58780065|FG004|Final Risk Group Assignment|Physician Decision|0|||
30770985|NCT00352534|58780066|FG005|Final Risk Group Assignment|Physician Decision|8|||
30770986|NCT00352534|58780067|FG006|Final Risk Group Assignment|Physician Decision|0|||
30770987|NCT00352534|58780061|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
30770988|NCT00352534|58780062|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
30770989|NCT00352534|58780063|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
30770990|NCT00352534|58780064|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
30770991|NCT00352534|58780065|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
30770992|NCT00352534|58780066|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
30770993|NCT00352534|58780067|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
30770994|NCT00352534|58780061|FG000|Final Risk Group Assignment|Ineligible|0|||
30770995|NCT00352534|58780062|FG001|Final Risk Group Assignment|Ineligible|0|||
30770996|NCT00352534|58780063|FG002|Final Risk Group Assignment|Ineligible|3|||
30770997|NCT00352534|58780064|FG003|Final Risk Group Assignment|Ineligible|1|||
30770998|NCT00352534|58780065|FG004|Final Risk Group Assignment|Ineligible|0|||
30770999|NCT00352534|58780066|FG005|Final Risk Group Assignment|Ineligible|13|||
30771000|NCT00352534|58780067|FG006|Final Risk Group Assignment|Ineligible|0|||
30771001|NCT00352534|58780061|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
30771002|NCT00352534|58780062|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
30771003|NCT00352534|58780063|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
30771004|NCT00352534|58780064|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
30952692|NCT01894841|59001790|FG000|Overall Study|Withdrawn by investigator|2|||
30661093|NCT01126190|58674003|FG001|Open-Label Phase|Death|0|||
30661094|NCT01126190|58674004|FG002|Open-Label Phase|Death|1|||
30661095|NCT01126190|58674002|FG000|Open-Label Phase|Adverse Event|0|||
30661096|NCT01126190|58674003|FG001|Open-Label Phase|Adverse Event|0|||
30661097|NCT01126190|58674004|FG002|Open-Label Phase|Adverse Event|4|||
30661098|NCT01126190|58674002|FG000|Open-Label Phase|Withdrawal by Subject|0|||
30661099|NCT01126190|58674003|FG001|Open-Label Phase|Withdrawal by Subject|0|||
30661100|NCT01126190|58674004|FG002|Open-Label Phase|Withdrawal by Subject|6|||
30661101|NCT00939185|58674037|FG000|Overall Study|Adverse Event|3|||
30661102|NCT00939185|58674037|FG000|Overall Study|Lack of Efficacy|1|||
30661103|NCT00939185|58674037|FG000|Overall Study|Lost to Follow-up|6|||
30661104|NCT00939185|58674037|FG000|Overall Study|Other|3|||
30661105|NCT00939185|58674037|FG000|Overall Study|Withdrawal by Subject|2|||
30661106|NCT00939185|58674037|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
30661107|NCT03977155|58674044|FG000|Overall Study|Adverse Event|3|||
30661108|NCT03977155|58674045|FG001|Overall Study|Adverse Event|0|||
30661109|NCT03977155|58674046|FG002|Overall Study|Adverse Event|0|||
30661110|NCT03977155|58674044|FG000|Overall Study|Lost to Follow-up|0|||
30661111|NCT03977155|58674045|FG001|Overall Study|Lost to Follow-up|1|||
30661112|NCT03977155|58674046|FG002|Overall Study|Lost to Follow-up|0|||
30661113|NCT03977155|58674044|FG000|Overall Study|Withdrawal by Subject|1|||
30661114|NCT03977155|58674045|FG001|Overall Study|Withdrawal by Subject|1|||
30661115|NCT03977155|58674046|FG002|Overall Study|Withdrawal by Subject|2|||
30771005|NCT00352534|58780065|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
30771006|NCT00352534|58780066|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
30771007|NCT00352534|58780067|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
30771008|NCT00352534|58780061|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
30661116|NCT03977155|58674044|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
30661117|NCT03977155|58674045|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
30661118|NCT03977155|58674046|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
30661119|NCT00930059|58674071|FG000|Overall Study|Death|1|||
30661120|NCT00930059|58674072|FG001|Overall Study|Death|0|||
30661121|NCT00930059|58674071|FG000|Overall Study|Did not meet entrance criteria|1|||
30661122|NCT00930059|58674072|FG001|Overall Study|Did not meet entrance criteria|1|||
30661123|NCT00930059|58674071|FG000|Overall Study|Withdrawal by Subject|3|||
30661124|NCT00930059|58674072|FG001|Overall Study|Withdrawal by Subject|4|||
30661125|NCT00930059|58674071|FG000|Overall Study|Other|1|||
30661126|NCT00930059|58674072|FG001|Overall Study|Other|0|||
30661127|NCT00930059|58674071|FG000|Overall Study|1 site terminated by sponsor|1|||
30661128|NCT00930059|58674072|FG001|Overall Study|1 site terminated by sponsor|1|||
30661129|NCT00930059|58674071|FG000|Overall Study|Adverse Event|1|||
30661130|NCT00930059|58674072|FG001|Overall Study|Adverse Event|6|||
30661131|NCT00772005|58674091|FG000|Overall Study|Adverse Event|9|||
30661132|NCT00772005|58674092|FG001|Overall Study|Adverse Event|14|||
30661133|NCT00772005|58674093|FG002|Overall Study|Adverse Event|10|||
30661134|NCT00772005|58674094|FG003|Overall Study|Adverse Event|13|||
30661135|NCT00772005|58674091|FG000|Overall Study|Lack of Efficacy|0|||
30661136|NCT00772005|58674092|FG001|Overall Study|Lack of Efficacy|1|||
30661137|NCT00772005|58674093|FG002|Overall Study|Lack of Efficacy|0|||
30661138|NCT00772005|58674094|FG003|Overall Study|Lack of Efficacy|0|||
30661139|NCT00772005|58674091|FG000|Overall Study|Withdrawal by Subject|3|||
30661140|NCT00772005|58674092|FG001|Overall Study|Withdrawal by Subject|7|||
30661141|NCT00772005|58674093|FG002|Overall Study|Withdrawal by Subject|10|||
30661142|NCT00772005|58674094|FG003|Overall Study|Withdrawal by Subject|2|||
30661143|NCT00772005|58674091|FG000|Overall Study|Protocol Violation|2|||
30661144|NCT00772005|58674092|FG001|Overall Study|Protocol Violation|4|||
30661145|NCT00772005|58674093|FG002|Overall Study|Protocol Violation|1|||
30661146|NCT00772005|58674094|FG003|Overall Study|Protocol Violation|6|||
30661147|NCT00772005|58674091|FG000|Overall Study|Lost to Follow-up|7|||
30661148|NCT00772005|58674092|FG001|Overall Study|Lost to Follow-up|3|||
30661149|NCT00772005|58674093|FG002|Overall Study|Lost to Follow-up|6|||
30661150|NCT00772005|58674094|FG003|Overall Study|Lost to Follow-up|3|||
30661151|NCT00772005|58674091|FG000|Overall Study|Non-compliance with study procedures|1|||
30661152|NCT00772005|58674092|FG001|Overall Study|Non-compliance with study procedures|1|||
30661153|NCT00772005|58674093|FG002|Overall Study|Non-compliance with study procedures|0|||
30661154|NCT00772005|58674094|FG003|Overall Study|Non-compliance with study procedures|1|||
30661155|NCT00772005|58674091|FG000|Overall Study|Non-compliance with drug administration|3|||
30661156|NCT00772005|58674092|FG001|Overall Study|Non-compliance with drug administration|0|||
30661157|NCT00772005|58674093|FG002|Overall Study|Non-compliance with drug administration|1|||
30661158|NCT00772005|58674094|FG003|Overall Study|Non-compliance with drug administration|1|||
30661159|NCT00939107|58674106|FG000|Overall Study|Lost to Follow-up|14|||
30661160|NCT00939107|58674107|FG001|Overall Study|Lost to Follow-up|12|||
30661161|NCT00927485|58674115|FG000|Overall Study|Adverse Event|4|||
30661162|NCT00927485|58674116|FG001|Overall Study|Adverse Event|2|||
30661163|NCT00927485|58674115|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
30661164|NCT00927485|58674116|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
30661165|NCT00927251|58674122|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
30661166|NCT00927095|58674129|FG000|Overall Study|Adverse Event|3|||
30661167|NCT00927095|58674130|FG001|Overall Study|Adverse Event|1|||
30661168|NCT00927095|58674131|FG002|Overall Study|Adverse Event|0|||
30661169|NCT00927095|58674129|FG000|Overall Study|Withdrawal by Subject|2|||
30661170|NCT00927095|58674130|FG001|Overall Study|Withdrawal by Subject|1|||
30661171|NCT00927095|58674131|FG002|Overall Study|Withdrawal by Subject|1|||
30661172|NCT00927095|58674129|FG000|Overall Study|Physician Decision|1|||
30661173|NCT00927095|58674130|FG001|Overall Study|Physician Decision|2|||
30661174|NCT00927095|58674131|FG002|Overall Study|Physician Decision|1|||
30661175|NCT00932165|58674139|FG000|Overall Study|Lost to Follow-up|1|||
30661176|NCT04888494|58674146|FG000|Overall Study|Lost to Follow-up|2|||
30661177|NCT04888494|58674147|FG001|Overall Study|Lost to Follow-up|3|||
30661178|NCT04888494|58674146|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
30661179|NCT04888494|58674147|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
30661180|NCT04761822|58674207|FG000|Overall Study|Adverse Event|3|||
30661181|NCT04761822|58674208|FG001|Overall Study|Adverse Event|1|||
30661182|NCT04761822|58674209|FG002|Overall Study|Adverse Event|1|||
30661183|NCT04761822|58674210|FG003|Overall Study|Adverse Event|3|||
30661184|NCT04761822|58674207|FG000|Overall Study|Lost to Follow-up|1|||
30661185|NCT04761822|58674208|FG001|Overall Study|Lost to Follow-up|0|||
30661186|NCT04761822|58674209|FG002|Overall Study|Lost to Follow-up|2|||
30661187|NCT04761822|58674210|FG003|Overall Study|Lost to Follow-up|3|||
30661188|NCT04761822|58674207|FG000|Overall Study|Physician Decision|0|||
30661189|NCT04761822|58674208|FG001|Overall Study|Physician Decision|1|||
30661190|NCT04761822|58674209|FG002|Overall Study|Physician Decision|0|||
30661191|NCT04761822|58674210|FG003|Overall Study|Physician Decision|0|||
30661192|NCT04761822|58674207|FG000|Overall Study|Withdrawal by Subject|3|||
30661193|NCT04761822|58674208|FG001|Overall Study|Withdrawal by Subject|8|||
30661194|NCT04761822|58674209|FG002|Overall Study|Withdrawal by Subject|1|||
30661195|NCT04761822|58674210|FG003|Overall Study|Withdrawal by Subject|11|||
30661196|NCT04761822|58674207|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
30661197|NCT04761822|58674208|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
30661198|NCT04761822|58674209|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
30661199|NCT04761822|58674210|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
30661200|NCT04761822|58674207|FG000|Overall Study|Participant requested unblinding|0|||
30661201|NCT04761822|58674208|FG001|Overall Study|Participant requested unblinding|0|||
30661202|NCT04761822|58674209|FG002|Overall Study|Participant requested unblinding|0|||
30661203|NCT04761822|58674210|FG003|Overall Study|Participant requested unblinding|1|||
30661204|NCT04573972|58674239|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
30661205|NCT04573972|58674240|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
30661206|NCT04476043|58674261|FG000|Overall Study|Withdrawal by Subject|1|||
30661207|NCT04476043|58674262|FG001|Overall Study|Withdrawal by Subject|3|||
30661208|NCT04476043|58674263|FG002|Overall Study|Withdrawal by Subject|4|||
30661209|NCT04476043|58674264|FG003|Overall Study|Withdrawal by Subject|1|||
30661210|NCT04476043|58674261|FG000|Overall Study|Lost to Follow-up|1|||
30661211|NCT04476043|58674262|FG001|Overall Study|Lost to Follow-up|1|||
30661212|NCT04476043|58674263|FG002|Overall Study|Lost to Follow-up|2|||
30661213|NCT04476043|58674264|FG003|Overall Study|Lost to Follow-up|1|||
30661214|NCT04476043|58674261|FG000|Overall Study|Adverse Event|2|||
30661215|NCT04476043|58674262|FG001|Overall Study|Adverse Event|0|||
30661216|NCT04476043|58674263|FG002|Overall Study|Adverse Event|1|||
30661217|NCT04476043|58674264|FG003|Overall Study|Adverse Event|0|||
30661218|NCT04476043|58674261|FG000|Overall Study|Protocol Violation|0|||
30661219|NCT04476043|58674262|FG001|Overall Study|Protocol Violation|1|||
30661220|NCT04476043|58674263|FG002|Overall Study|Protocol Violation|0|||
30661221|NCT04476043|58674264|FG003|Overall Study|Protocol Violation|0|||
30661222|NCT04391309|58674285|FG000|Overall Study|Death|1|||
30661223|NCT04391309|58674286|FG001|Overall Study|Death|1|||
30661224|NCT04391309|58674285|FG000|Overall Study|Lost to Follow-up|3|||
30661225|NCT04391309|58674286|FG001|Overall Study|Lost to Follow-up|2|||
30661226|NCT04391309|58674285|FG000|Overall Study|Withdrawal by Subject|2|||
30661227|NCT04391309|58674286|FG001|Overall Study|Withdrawal by Subject|2|||
30661228|NCT04202965|58674314|FG000|Overall Study|Adverse Event|3|||
30661229|NCT04202965|58674314|FG000|Overall Study|Did not meet inclusion criteria|1|||
30661230|NCT04056624|58674322|FG000|Overall Study|Withdrawal by Subject|0|||
30661231|NCT04056624|58674323|FG001|Overall Study|Withdrawal by Subject|0|||
30661232|NCT04056624|58674324|FG002|Overall Study|Withdrawal by Subject|1|||
30661233|NCT04056624|58674322|FG000|Overall Study|Protocol Violation|1|||
30661234|NCT04056624|58674323|FG001|Overall Study|Protocol Violation|2|||
30661235|NCT04056624|58674324|FG002|Overall Study|Protocol Violation|0|||
30661236|NCT03870763|58674344|FG000|Overall Study|Study terminated by sponsor|0|||
30661237|NCT03870763|58674345|FG001|Overall Study|Study terminated by sponsor|2|||
30661238|NCT03870763|58674346|FG002|Overall Study|Study terminated by sponsor|0|||
30661239|NCT03870763|58674344|FG000|Overall Study|Withdrawal by Subject|0|||
30661240|NCT03870763|58674345|FG001|Overall Study|Withdrawal by Subject|1|||
30661241|NCT03870763|58674346|FG002|Overall Study|Withdrawal by Subject|0|||
30661242|NCT03870763|58674344|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
30661243|NCT03870763|58674345|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
30661244|NCT03870763|58674346|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
30661245|NCT03647501|58674356|FG000|Overall Study|Lost to Follow-up|1|||
30771009|NCT00352534|58780062|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
30771010|NCT00352534|58780063|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
30771011|NCT00352534|58780064|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
30771012|NCT00352534|58780065|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
30771013|NCT00352534|58780066|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
30771014|NCT00352534|58780067|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
30771015|NCT00352534|58780061|FG000|Final Risk Group Assignment|Death|0|||
30661246|NCT03647501|58674357|FG001|Overall Study|Lost to Follow-up|1|||
30661247|NCT03647501|58674356|FG000|Overall Study|Withdrawal by Subject|0|||
30661248|NCT03647501|58674357|FG001|Overall Study|Withdrawal by Subject|1|||
30661249|NCT03587142|58674389|FG000|Overall Study|Lost to Follow-up|5|||
30661250|NCT03587142|58674390|FG001|Overall Study|Lost to Follow-up|3|||
30661251|NCT03587142|58674389|FG000|Overall Study|Did not complete the f4 visit|3|||
30661252|NCT03587142|58674390|FG001|Overall Study|Did not complete the f4 visit|7|||
30661253|NCT03493854|58674398|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
30661254|NCT03493854|58674399|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
30771016|NCT00352534|58780062|FG001|Final Risk Group Assignment|Death|0|||
30771017|NCT00352534|58780063|FG002|Final Risk Group Assignment|Death|0|||
30661255|NCT03493854|58674398|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
30661256|NCT03493854|58674399|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
30661257|NCT03493854|58674398|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
30661258|NCT03493854|58674399|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
30661259|NCT03493854|58674398|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
30661260|NCT03493854|58674399|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
30661261|NCT03493854|58674398|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
30661262|NCT03493854|58674399|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
30661263|NCT03493854|58674398|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
30661264|NCT03493854|58674399|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
30661265|NCT03493854|58674398|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
30661266|NCT03493854|58674399|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
30661267|NCT03493854|58674398|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229|||
30661268|NCT03493854|58674399|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228|||
30661269|NCT03493854|58674398|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
30661270|NCT03493854|58674399|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
30661271|NCT03493854|58674398|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
30661272|NCT03493854|58674399|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1|||
30661273|NCT03493854|58674398|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3|||
30661274|NCT03493854|58674399|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
30661275|NCT03493854|58674398|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1|||
30661276|NCT03493854|58674399|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0|||
30661277|NCT03493854|58674398|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
30661278|NCT03493854|58674399|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0|||
30661279|NCT03493854|58674398|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5|||
30661280|NCT03493854|58674399|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3|||
30661281|NCT03493854|58674398|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
30661282|NCT03493854|58674399|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
30661283|NCT03493854|58674398|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18|||
30661284|NCT03493854|58674399|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16|||
30661285|NCT03188705|58674405|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
30661286|NCT03188705|58674405|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
30661287|NCT03072238|58674412|FG000|Overall Study|Withdrawal by Subject|30|||
30661288|NCT03072238|58674413|FG001|Overall Study|Withdrawal by Subject|51|||
30661289|NCT03072238|58674412|FG000|Overall Study|Lost to Follow-up|7|||
30661290|NCT03072238|58674413|FG001|Overall Study|Lost to Follow-up|4|||
30661291|NCT03072238|58674412|FG000|Overall Study|Physician Decision|1|||
30661292|NCT03072238|58674413|FG001|Overall Study|Physician Decision|3|||
30661293|NCT03072238|58674412|FG000|Overall Study|Death|139|||
30661294|NCT03072238|58674413|FG001|Overall Study|Death|121|||
30661295|NCT03072238|58674412|FG000|Overall Study|Other|0|||
30661296|NCT03072238|58674413|FG001|Overall Study|Other|1|||
30661297|NCT03072238|58674412|FG000|Overall Study|Ongoing on study|377|||
30661298|NCT03072238|58674413|FG001|Overall Study|Ongoing on study|367|||
30661299|NCT03032484|58674420|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
30661300|NCT03032484|58674421|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
30661301|NCT03032484|58674420|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
30661302|NCT03032484|58674421|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
30661303|NCT02975349|58674430|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
30661304|NCT02975349|58674431|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
30661305|NCT02975349|58674432|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
30661306|NCT02975349|58674433|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
30661307|NCT02975349|58674434|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
30661308|NCT02975349|58674435|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
30661309|NCT02975349|58674430|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
30661310|NCT02975349|58674431|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30661311|NCT02975349|58674432|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30661312|NCT02975349|58674433|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30661313|NCT02975349|58674434|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30661314|NCT02975349|58674435|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
30661315|NCT02975349|58674430|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
30661316|NCT02975349|58674431|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
30661317|NCT02975349|58674432|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
30661318|NCT02975349|58674433|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
30771018|NCT00352534|58780064|FG003|Final Risk Group Assignment|Death|0|||
30771019|NCT00352534|58780065|FG004|Final Risk Group Assignment|Death|0|||
30771020|NCT00352534|58780066|FG005|Final Risk Group Assignment|Death|2|||
30771021|NCT00352534|58780067|FG006|Final Risk Group Assignment|Death|0|||
30771022|NCT04323800|58780079|FG000|Overall Study|Withdrawal by Subject|4|||
30661319|NCT02975349|58674434|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
30661320|NCT02975349|58674435|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
30661321|NCT02975349|58674430|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
30661322|NCT02975349|58674431|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
30661323|NCT02975349|58674432|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
30661324|NCT02975349|58674433|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
30661325|NCT02975349|58674434|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
30661326|NCT02975349|58674435|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
30661327|NCT02975349|58674430|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
30661328|NCT02975349|58674431|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
30661329|NCT02975349|58674432|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
30661330|NCT02975349|58674433|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
30661331|NCT02975349|58674434|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
30661332|NCT02975349|58674435|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
30661333|NCT02975349|58674430|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
30661334|NCT02975349|58674431|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
30661335|NCT02975349|58674432|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
30661336|NCT02975349|58674433|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
30661337|NCT02975349|58674434|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
30661338|NCT02975349|58674435|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
30661339|NCT02975349|58674430|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
30661340|NCT02975349|58674431|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
30661341|NCT02975349|58674432|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
30661342|NCT02975349|58674433|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
30661343|NCT02975349|58674434|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
30661344|NCT02975349|58674435|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
30661345|NCT02975349|58674430|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
30661346|NCT02975349|58674431|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
30661347|NCT02975349|58674432|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
30661348|NCT02975349|58674433|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
30661349|NCT02975349|58674434|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
30661350|NCT02975349|58674435|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
30661351|NCT02975349|58674430|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
30661352|NCT02975349|58674431|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
30661353|NCT02975349|58674432|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
30661354|NCT02975349|58674433|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
30661355|NCT02975349|58674434|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
30661356|NCT02975349|58674435|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
30661357|NCT02520141|58674506|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
30661358|NCT02513394|58674514|FG000|Overall Study|Withdrawal by Subject|11|||
30661359|NCT02513394|58674515|FG001|Overall Study|Withdrawal by Subject|23|||
30661360|NCT02513394|58674514|FG000|Overall Study|Ineligible|1|||
30661361|NCT02513394|58674515|FG001|Overall Study|Ineligible|0|||
30661362|NCT02329847|58674527|FG000|Overall Study|Death|4|||
30661363|NCT02329847|58674528|FG001|Overall Study|Death|4|||
30661364|NCT02329847|58674529|FG002|Overall Study|Death|22|||
30661365|NCT02329847|58674530|FG003|Overall Study|Death|12|||
30661366|NCT02329847|58674531|FG004|Overall Study|Death|20|||
30661367|NCT02329847|58674532|FG005|Overall Study|Death|13|||
30661368|NCT02329847|58674527|FG000|Overall Study|Lost to Follow-up|0|||
30661369|NCT02329847|58674528|FG001|Overall Study|Lost to Follow-up|0|||
30661370|NCT02329847|58674529|FG002|Overall Study|Lost to Follow-up|2|||
30661371|NCT02329847|58674530|FG003|Overall Study|Lost to Follow-up|3|||
30661372|NCT02329847|58674531|FG004|Overall Study|Lost to Follow-up|0|||
30661373|NCT02329847|58674532|FG005|Overall Study|Lost to Follow-up|1|||
30661374|NCT02329847|58674527|FG000|Overall Study|Physician Decision|0|||
30661375|NCT02329847|58674528|FG001|Overall Study|Physician Decision|0|||
30661376|NCT02329847|58674529|FG002|Overall Study|Physician Decision|0|||
30661377|NCT02329847|58674530|FG003|Overall Study|Physician Decision|0|||
30661378|NCT02329847|58674531|FG004|Overall Study|Physician Decision|1|||
30661379|NCT02329847|58674532|FG005|Overall Study|Physician Decision|0|||
30661380|NCT02329847|58674527|FG000|Overall Study|Withdrawal by Subject|2|||
30771023|NCT04323800|58780080|FG001|Overall Study|Withdrawal by Subject|4|||
30771024|NCT04323800|58780079|FG000|Overall Study|Incomplete transfusion|1|||
30771025|NCT04323800|58780080|FG001|Overall Study|Incomplete transfusion|0|||
30771026|NCT04323800|58780079|FG000|Overall Study|Other|0|||
30771027|NCT04323800|58780080|FG001|Overall Study|Other|1|||
30661381|NCT02329847|58674528|FG001|Overall Study|Withdrawal by Subject|1|||
30661382|NCT02329847|58674529|FG002|Overall Study|Withdrawal by Subject|5|||
30661383|NCT02329847|58674530|FG003|Overall Study|Withdrawal by Subject|7|||
30661384|NCT02329847|58674531|FG004|Overall Study|Withdrawal by Subject|8|||
30771028|NCT04323800|58780079|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
30771029|NCT04323800|58780080|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
30661385|NCT02329847|58674532|FG005|Overall Study|Withdrawal by Subject|3|||
30661386|NCT02329847|58674527|FG000|Overall Study|Other|1|||
30849144|NCT02653664|58875939|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
30661387|NCT02329847|58674528|FG001|Overall Study|Other|2|||
30661388|NCT02329847|58674529|FG002|Overall Study|Other|6|||
30661389|NCT02329847|58674530|FG003|Overall Study|Other|13|||
30661390|NCT02329847|58674531|FG004|Overall Study|Other|10|||
30661391|NCT02329847|58674532|FG005|Overall Study|Other|3|||
30661392|NCT02314624|58674553|FG000|Overall Study|No participating patient|16|||
30661393|NCT02314624|58674554|FG001|Overall Study|No participating patient|13|||
30661394|NCT02314624|58674553|FG000|Overall Study|Participant withdrew|7|||
30661395|NCT02314624|58674554|FG001|Overall Study|Participant withdrew|2|||
30661396|NCT02314624|58674553|FG000|Overall Study|Lost to Follow-up|2|||
30661397|NCT02314624|58674554|FG001|Overall Study|Lost to Follow-up|5|||
30661398|NCT02314624|58674553|FG000|Overall Study|Dropped/Excluded by PI|6|||
30661399|NCT02314624|58674554|FG001|Overall Study|Dropped/Excluded by PI|6|||
30661400|NCT02017717|58674579|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
30661401|NCT02017717|58674580|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
30661402|NCT02017717|58674581|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
30661403|NCT02017717|58674582|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
30661404|NCT02017717|58674583|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
30661405|NCT02017717|58674584|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
30661406|NCT02017717|58674585|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
30661407|NCT02017717|58674586|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
30661408|NCT02017717|58674587|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
30661409|NCT02017717|58674579|FG000|Before Treatment Period|Participant request to stop therapy|0|||
30661410|NCT02017717|58674580|FG001|Before Treatment Period|Participant request to stop therapy|0|||
30661411|NCT02017717|58674581|FG002|Before Treatment Period|Participant request to stop therapy|0|||
30661412|NCT02017717|58674582|FG003|Before Treatment Period|Participant request to stop therapy|0|||
30661413|NCT02017717|58674583|FG004|Before Treatment Period|Participant request to stop therapy|5|||
30661414|NCT02017717|58674584|FG005|Before Treatment Period|Participant request to stop therapy|0|||
30661415|NCT02017717|58674585|FG006|Before Treatment Period|Participant request to stop therapy|0|||
30661416|NCT02017717|58674586|FG007|Before Treatment Period|Participant request to stop therapy|0|||
30661417|NCT02017717|58674587|FG008|Before Treatment Period|Participant request to stop therapy|0|||
30661418|NCT02017717|58674579|FG000|Before Treatment Period|Participant withdrew consent|0|||
30661419|NCT02017717|58674580|FG001|Before Treatment Period|Participant withdrew consent|0|||
30661420|NCT02017717|58674581|FG002|Before Treatment Period|Participant withdrew consent|0|||
30661421|NCT02017717|58674582|FG003|Before Treatment Period|Participant withdrew consent|0|||
30661422|NCT02017717|58674583|FG004|Before Treatment Period|Participant withdrew consent|11|||
30661423|NCT02017717|58674584|FG005|Before Treatment Period|Participant withdrew consent|0|||
30661424|NCT02017717|58674585|FG006|Before Treatment Period|Participant withdrew consent|0|||
30661425|NCT02017717|58674586|FG007|Before Treatment Period|Participant withdrew consent|0|||
30661426|NCT02017717|58674587|FG008|Before Treatment Period|Participant withdrew consent|2|||
30661427|NCT02017717|58674579|FG000|Before Treatment Period|Lost to Follow-up|0|||
30661428|NCT02017717|58674580|FG001|Before Treatment Period|Lost to Follow-up|0|||
30661429|NCT02017717|58674581|FG002|Before Treatment Period|Lost to Follow-up|0|||
30661430|NCT02017717|58674582|FG003|Before Treatment Period|Lost to Follow-up|0|||
30661431|NCT02017717|58674583|FG004|Before Treatment Period|Lost to Follow-up|1|||
30661432|NCT02017717|58674584|FG005|Before Treatment Period|Lost to Follow-up|0|||
30661433|NCT02017717|58674585|FG006|Before Treatment Period|Lost to Follow-up|0|||
30661434|NCT02017717|58674586|FG007|Before Treatment Period|Lost to Follow-up|0|||
30661435|NCT02017717|58674587|FG008|Before Treatment Period|Lost to Follow-up|0|||
30661436|NCT02017717|58674579|FG000|Before Treatment Period|Participant no longer met criteria|0|||
30661437|NCT02017717|58674580|FG001|Before Treatment Period|Participant no longer met criteria|0|||
30661438|NCT02017717|58674581|FG002|Before Treatment Period|Participant no longer met criteria|0|||
30661439|NCT02017717|58674582|FG003|Before Treatment Period|Participant no longer met criteria|1|||
30661440|NCT02017717|58674583|FG004|Before Treatment Period|Participant no longer met criteria|2|||
30661441|NCT02017717|58674584|FG005|Before Treatment Period|Participant no longer met criteria|0|||
30661442|NCT02017717|58674585|FG006|Before Treatment Period|Participant no longer met criteria|0|||
30661443|NCT02017717|58674586|FG007|Before Treatment Period|Participant no longer met criteria|1|||
30661444|NCT02017717|58674587|FG008|Before Treatment Period|Participant no longer met criteria|0|||
30661445|NCT02017717|58674579|FG000|Before Treatment Period|other reason|0|||
30661446|NCT02017717|58674580|FG001|Before Treatment Period|other reason|0|||
30661447|NCT02017717|58674581|FG002|Before Treatment Period|other reason|0|||
30661448|NCT02017717|58674582|FG003|Before Treatment Period|other reason|0|||
30661449|NCT02017717|58674583|FG004|Before Treatment Period|other reason|1|||
30661450|NCT02017717|58674584|FG005|Before Treatment Period|other reason|0|||
30661451|NCT02017717|58674585|FG006|Before Treatment Period|other reason|0|||
30661452|NCT02017717|58674586|FG007|Before Treatment Period|other reason|0|||
30661453|NCT02017717|58674587|FG008|Before Treatment Period|other reason|0|||
30661454|NCT02017717|58674579|FG000|Treatment Period|Disease progression|7|||
30661455|NCT02017717|58674580|FG001|Treatment Period|Disease progression|9|||
30661456|NCT02017717|58674581|FG002|Treatment Period|Disease progression|12|||
30661457|NCT02017717|58674582|FG003|Treatment Period|Disease progression|165|||
30661458|NCT02017717|58674583|FG004|Treatment Period|Disease progression|134|||
30661459|NCT02017717|58674584|FG005|Treatment Period|Disease progression|20|||
30661460|NCT02017717|58674585|FG006|Treatment Period|Disease progression|26|||
30661461|NCT02017717|58674586|FG007|Treatment Period|Disease progression|17|||
30661462|NCT02017717|58674587|FG008|Treatment Period|Disease progression|22|||
30661463|NCT02017717|58674579|FG000|Treatment Period|Study drug toxicity|3|||
30661464|NCT02017717|58674580|FG001|Treatment Period|Study drug toxicity|0|||
30661465|NCT02017717|58674581|FG002|Treatment Period|Study drug toxicity|1|||
30661466|NCT02017717|58674582|FG003|Treatment Period|Study drug toxicity|7|||
30661467|NCT02017717|58674583|FG004|Treatment Period|Study drug toxicity|11|||
30661468|NCT02017717|58674584|FG005|Treatment Period|Study drug toxicity|4|||
30661469|NCT02017717|58674585|FG006|Treatment Period|Study drug toxicity|4|||
30661470|NCT02017717|58674586|FG007|Treatment Period|Study drug toxicity|5|||
30661471|NCT02017717|58674587|FG008|Treatment Period|Study drug toxicity|3|||
30661472|NCT02017717|58674579|FG000|Treatment Period|Death|0|||
30661473|NCT02017717|58674580|FG001|Treatment Period|Death|0|||
30661474|NCT02017717|58674581|FG002|Treatment Period|Death|1|||
30661475|NCT02017717|58674582|FG003|Treatment Period|Death|0|||
30661476|NCT02017717|58674583|FG004|Treatment Period|Death|0|||
30661477|NCT02017717|58674584|FG005|Treatment Period|Death|0|||
30661478|NCT02017717|58674585|FG006|Treatment Period|Death|0|||
30661479|NCT02017717|58674586|FG007|Treatment Period|Death|1|||
30661480|NCT02017717|58674587|FG008|Treatment Period|Death|0|||
30661481|NCT02017717|58674579|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
30661482|NCT02017717|58674580|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
30661483|NCT02017717|58674581|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
30661484|NCT02017717|58674582|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
30661485|NCT02017717|58674583|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
30661486|NCT02017717|58674584|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
30661487|NCT02017717|58674585|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
30661488|NCT02017717|58674586|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
30661489|NCT02017717|58674587|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
30661490|NCT02017717|58674579|FG000|Treatment Period|Participant request to stop therapy|0|||
30661491|NCT02017717|58674580|FG001|Treatment Period|Participant request to stop therapy|0|||
30661492|NCT02017717|58674581|FG002|Treatment Period|Participant request to stop therapy|3|||
30661493|NCT02017717|58674582|FG003|Treatment Period|Participant request to stop therapy|4|||
30661494|NCT02017717|58674583|FG004|Treatment Period|Participant request to stop therapy|7|||
30661495|NCT02017717|58674584|FG005|Treatment Period|Participant request to stop therapy|5|||
30661496|NCT02017717|58674585|FG006|Treatment Period|Participant request to stop therapy|0|||
30661497|NCT02017717|58674586|FG007|Treatment Period|Participant request to stop therapy|2|||
30661498|NCT02017717|58674587|FG008|Treatment Period|Participant request to stop therapy|1|||
30661499|NCT02017717|58674579|FG000|Treatment Period|Participant withdrew consent|0|||
30661500|NCT02017717|58674580|FG001|Treatment Period|Participant withdrew consent|0|||
30661501|NCT02017717|58674581|FG002|Treatment Period|Participant withdrew consent|1|||
30661502|NCT02017717|58674582|FG003|Treatment Period|Participant withdrew consent|1|||
30661503|NCT02017717|58674583|FG004|Treatment Period|Participant withdrew consent|4|||
30661504|NCT02017717|58674584|FG005|Treatment Period|Participant withdrew consent|0|||
30661505|NCT02017717|58674585|FG006|Treatment Period|Participant withdrew consent|0|||
30661506|NCT02017717|58674586|FG007|Treatment Period|Participant withdrew consent|2|||
30661507|NCT02017717|58674587|FG008|Treatment Period|Participant withdrew consent|0|||
30661508|NCT02017717|58674579|FG000|Treatment Period|Participant no longer met criteria|0|||
30661509|NCT02017717|58674580|FG001|Treatment Period|Participant no longer met criteria|0|||
30661510|NCT02017717|58674581|FG002|Treatment Period|Participant no longer met criteria|0|||
30661511|NCT02017717|58674582|FG003|Treatment Period|Participant no longer met criteria|0|||
30661512|NCT02017717|58674583|FG004|Treatment Period|Participant no longer met criteria|1|||
30661513|NCT02017717|58674584|FG005|Treatment Period|Participant no longer met criteria|0|||
30661514|NCT02017717|58674585|FG006|Treatment Period|Participant no longer met criteria|0|||
30661515|NCT02017717|58674586|FG007|Treatment Period|Participant no longer met criteria|0|||
30661516|NCT02017717|58674587|FG008|Treatment Period|Participant no longer met criteria|0|||
30661517|NCT02017717|58674579|FG000|Treatment Period|other reasons|0|||
30952693|NCT01894841|59001791|FG001|Overall Study|Withdrawn by investigator|2|||
30952694|NCT01894841|59001790|FG000|Overall Study|Lost to Follow-up|7|||
30661518|NCT02017717|58674580|FG001|Treatment Period|other reasons|0|||
30661519|NCT02017717|58674581|FG002|Treatment Period|other reasons|0|||
30661520|NCT02017717|58674582|FG003|Treatment Period|other reasons|0|||
30661521|NCT02017717|58674583|FG004|Treatment Period|other reasons|1|||
30952695|NCT01894841|59001791|FG001|Overall Study|Lost to Follow-up|3|||
30661522|NCT02017717|58674584|FG005|Treatment Period|other reasons|0|||
30661523|NCT02017717|58674585|FG006|Treatment Period|other reasons|0|||
30661524|NCT02017717|58674586|FG007|Treatment Period|other reasons|1|||
30661525|NCT02017717|58674587|FG008|Treatment Period|other reasons|1|||
30661526|NCT02017717|58674579|FG000|Treatment Period|Maximum clinical benefit|0|||
30661527|NCT02017717|58674580|FG001|Treatment Period|Maximum clinical benefit|0|||
30661528|NCT02017717|58674581|FG002|Treatment Period|Maximum clinical benefit|0|||
30661529|NCT02017717|58674582|FG003|Treatment Period|Maximum clinical benefit|0|||
30661530|NCT02017717|58674583|FG004|Treatment Period|Maximum clinical benefit|1|||
30661531|NCT02017717|58674584|FG005|Treatment Period|Maximum clinical benefit|0|||
30661532|NCT02017717|58674585|FG006|Treatment Period|Maximum clinical benefit|0|||
30661533|NCT02017717|58674586|FG007|Treatment Period|Maximum clinical benefit|0|||
30661534|NCT02017717|58674587|FG008|Treatment Period|Maximum clinical benefit|0|||
30661535|NCT01419080|58674624|FG000|Overall Study|Withdrawal by Subject|75|||
30661536|NCT01419080|58674624|FG000|Overall Study|Death|30|||
30661537|NCT01419080|58674624|FG000|Overall Study|Lost to Follow-up|23|||
30661538|NCT01419080|58674624|FG000|Overall Study|Too Ill|3|||
30661539|NCT01164228|58674632|FG000|Overall Study|Progression|24|||
30661540|NCT01164228|58674633|FG001|Overall Study|Progression|25|||
30661541|NCT01164228|58674632|FG000|Overall Study|Adverse Event|13|||
30661542|NCT01164228|58674633|FG001|Overall Study|Adverse Event|7|||
30661543|NCT01164228|58674632|FG000|Overall Study|Death|1|||
30661544|NCT01164228|58674633|FG001|Overall Study|Death|1|||
30661545|NCT01164228|58674632|FG000|Overall Study|Withdrawal by Subject|2|||
30661546|NCT01164228|58674633|FG001|Overall Study|Withdrawal by Subject|0|||
30771030|NCT04321460|58780088|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
30771031|NCT04321460|58780089|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
30771032|NCT03122548|58780095|FG000|Overall Study|Death|2|||
30771033|NCT03122548|58780095|FG000|Overall Study|Progression - subject went into hospice|1|||
30771034|NCT03122548|58780095|FG000|Overall Study|Study Terminated by Sponsor|2|||
30771035|NCT04459598|58780101|FG000|Overall Study|Adverse Event|1|||
30771036|NCT04459598|58780102|FG001|Overall Study|Adverse Event|1|||
30771037|NCT02929498|58780111|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
30771038|NCT02929498|58780112|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
30771039|NCT02929498|58780113|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
30661547|NCT01164228|58674632|FG000|Overall Study|Physician Decision|1|||
30661548|NCT01164228|58674633|FG001|Overall Study|Physician Decision|2|||
30661549|NCT01164228|58674632|FG000|Overall Study|Symptomatic deterioration|1|||
30661550|NCT01164228|58674633|FG001|Overall Study|Symptomatic deterioration|0|||
30661551|NCT01164228|58674632|FG000|Overall Study|Never started treatment|1|||
30661552|NCT01164228|58674633|FG001|Overall Study|Never started treatment|3|||
30661553|NCT01164228|58674632|FG000|Overall Study|Ineligible|1|||
30661554|NCT01164228|58674633|FG001|Overall Study|Ineligible|0|||
30661555|NCT00554515|58674639|FG000|Overall Study|Withdrawal by Subject|3|||
30661556|NCT00554515|58674639|FG000|Overall Study|Disease progression|52|||
30661557|NCT00554515|58674639|FG000|Overall Study|Physician Decision|18|||
30661558|NCT00554515|58674639|FG000|Overall Study|Withdrawal by Subject|11|||
30661559|NCT00554515|58674639|FG000|Overall Study|Adverse Event|9|||
30661560|NCT00554515|58674639|FG000|Overall Study|Death|2|||
30661561|NCT00554515|58674639|FG000|Overall Study|Achieved Stable Disease|7|||
30661562|NCT00554515|58674639|FG000|Overall Study|Other|1|||
30661563|NCT00554515|58674639|FG000|Overall Study|Misc|15|||
30661564|NCT00049517|58674666|FG000|Induction|Disease progression|0|||
30661565|NCT00049517|58674667|FG001|Induction|Disease progression|0|||
30661566|NCT00049517|58674668|FG002|Induction|Disease progression|0|||
30661567|NCT00049517|58674669|FG003|Induction|Disease progression|0|||
30661568|NCT00049517|58674670|FG004|Induction|Disease progression|18|||
30661569|NCT00049517|58674671|FG005|Induction|Disease progression|11|||
30661570|NCT00049517|58674666|FG000|Induction|Adverse Event|0|||
30661571|NCT00049517|58674667|FG001|Induction|Adverse Event|0|||
30661572|NCT00049517|58674668|FG002|Induction|Adverse Event|0|||
30661573|NCT00049517|58674669|FG003|Induction|Adverse Event|0|||
30661574|NCT00049517|58674670|FG004|Induction|Adverse Event|5|||
30771040|NCT02929498|58780111|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
30771041|NCT02929498|58780112|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
30849145|NCT02653664|58875937|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
30849146|NCT02653664|58875938|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
30661575|NCT00049517|58674671|FG005|Induction|Adverse Event|7|||
30771042|NCT02929498|58780113|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
30771043|NCT03792672|58780119|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
30849147|NCT02653664|58875939|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
30849148|NCT02653664|58875937|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
30661576|NCT00049517|58674666|FG000|Induction|Death|0|||
30771044|NCT03792672|58780120|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
30771045|NCT03792672|58780121|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
30661577|NCT00049517|58674667|FG001|Induction|Death|0|||
30661578|NCT00049517|58674668|FG002|Induction|Death|0|||
30661579|NCT00049517|58674669|FG003|Induction|Death|0|||
30661580|NCT00049517|58674670|FG004|Induction|Death|9|||
30661581|NCT00049517|58674671|FG005|Induction|Death|6|||
30661582|NCT00049517|58674666|FG000|Induction|Withdrawal by Subject|0|||
30661583|NCT00049517|58674667|FG001|Induction|Withdrawal by Subject|0|||
30771046|NCT03792672|58780122|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
30771047|NCT03792672|58780123|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
30771048|NCT03792672|58780124|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
30771049|NCT03792672|58780119|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
30771050|NCT03792672|58780120|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
30771051|NCT03792672|58780121|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
30771052|NCT03792672|58780122|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
30771053|NCT03792672|58780123|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
30771054|NCT03792672|58780124|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
30771055|NCT03792672|58780119|FG000|Treatment Period 4 (2 Days)|Other|1|||
30771056|NCT03792672|58780120|FG001|Treatment Period 4 (2 Days)|Other|0|||
30771057|NCT03792672|58780121|FG002|Treatment Period 4 (2 Days)|Other|0|||
30771058|NCT03792672|58780122|FG003|Treatment Period 4 (2 Days)|Other|0|||
30771059|NCT03792672|58780123|FG004|Treatment Period 4 (2 Days)|Other|0|||
30771060|NCT03792672|58780124|FG005|Treatment Period 4 (2 Days)|Other|0|||
30771061|NCT03120676|58780139|FG000|Overall Study|Not treated|1|||
30771062|NCT03120520|58780147|FG000|Overall Study|Lost to Follow-up|1|||
30771063|NCT03120520|58780148|FG001|Overall Study|Lost to Follow-up|1|||
30771064|NCT03120520|58780149|FG002|Overall Study|Lost to Follow-up|1|||
30661584|NCT00049517|58674668|FG002|Induction|Withdrawal by Subject|0|||
30771065|NCT03120520|58780150|FG003|Overall Study|Lost to Follow-up|1|||
30771066|NCT03120520|58780147|FG000|Overall Study|Withdrawal by Subject|3|||
30771067|NCT03120520|58780148|FG001|Overall Study|Withdrawal by Subject|2|||
30849149|NCT02653664|58875938|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
30661585|NCT00049517|58674669|FG003|Induction|Withdrawal by Subject|0|||
30661586|NCT00049517|58674670|FG004|Induction|Withdrawal by Subject|1|||
30661587|NCT00049517|58674671|FG005|Induction|Withdrawal by Subject|3|||
30661588|NCT00049517|58674666|FG000|Induction|Alternative therapy|0|||
30661589|NCT00049517|58674667|FG001|Induction|Alternative therapy|0|||
30661590|NCT00049517|58674668|FG002|Induction|Alternative therapy|0|||
30661591|NCT00049517|58674669|FG003|Induction|Alternative therapy|0|||
30661592|NCT00049517|58674670|FG004|Induction|Alternative therapy|2|||
30661593|NCT00049517|58674671|FG005|Induction|Alternative therapy|2|||
30661594|NCT00049517|58674666|FG000|Induction|Other complicating disease|0|||
30661595|NCT00049517|58674667|FG001|Induction|Other complicating disease|0|||
30661596|NCT00049517|58674668|FG002|Induction|Other complicating disease|0|||
30661597|NCT00049517|58674669|FG003|Induction|Other complicating disease|0|||
30661598|NCT00049517|58674670|FG004|Induction|Other complicating disease|3|||
30661599|NCT00049517|58674671|FG005|Induction|Other complicating disease|0|||
30661600|NCT00049517|58674666|FG000|Induction|Reasons not reported|0|||
30661601|NCT00049517|58674667|FG001|Induction|Reasons not reported|0|||
30661602|NCT00049517|58674668|FG002|Induction|Reasons not reported|0|||
30661603|NCT00049517|58674669|FG003|Induction|Reasons not reported|0|||
30661604|NCT00049517|58674670|FG004|Induction|Reasons not reported|22|||
30661605|NCT00049517|58674671|FG005|Induction|Reasons not reported|25|||
30661606|NCT00049517|58674666|FG000|Conditioning/Transplant|Disease progression|14|||
30661607|NCT00049517|58674667|FG001|Conditioning/Transplant|Disease progression|6|||
30661608|NCT00049517|58674668|FG002|Conditioning/Transplant|Disease progression|10|||
30661609|NCT00049517|58674669|FG003|Conditioning/Transplant|Disease progression|6|||
30661610|NCT00049517|58674670|FG004|Conditioning/Transplant|Disease progression|0|||
30661611|NCT00049517|58674671|FG005|Conditioning/Transplant|Disease progression|0|||
30661612|NCT00049517|58674666|FG000|Conditioning/Transplant|Adverse Event|2|||
30661613|NCT00049517|58674667|FG001|Conditioning/Transplant|Adverse Event|1|||
30661614|NCT00049517|58674668|FG002|Conditioning/Transplant|Adverse Event|4|||
30661615|NCT00049517|58674669|FG003|Conditioning/Transplant|Adverse Event|8|||
30661616|NCT00049517|58674670|FG004|Conditioning/Transplant|Adverse Event|0|||
30661617|NCT00049517|58674671|FG005|Conditioning/Transplant|Adverse Event|0|||
30661618|NCT00049517|58674666|FG000|Conditioning/Transplant|Death|1|||
30661619|NCT00049517|58674667|FG001|Conditioning/Transplant|Death|0|||
30661620|NCT00049517|58674668|FG002|Conditioning/Transplant|Death|0|||
30661621|NCT00049517|58674669|FG003|Conditioning/Transplant|Death|2|||
30661622|NCT00049517|58674670|FG004|Conditioning/Transplant|Death|0|||
30661623|NCT00049517|58674671|FG005|Conditioning/Transplant|Death|0|||
30661624|NCT00049517|58674666|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
30661625|NCT00049517|58674667|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
30661626|NCT00049517|58674668|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
30661627|NCT00049517|58674669|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
30661628|NCT00049517|58674670|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
30661629|NCT00049517|58674671|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
30661630|NCT00049517|58674666|FG000|Conditioning/Transplant|Alternative therapy|4|||
30661631|NCT00049517|58674667|FG001|Conditioning/Transplant|Alternative therapy|4|||
30661632|NCT00049517|58674668|FG002|Conditioning/Transplant|Alternative therapy|2|||
30661633|NCT00049517|58674669|FG003|Conditioning/Transplant|Alternative therapy|1|||
30661634|NCT00049517|58674670|FG004|Conditioning/Transplant|Alternative therapy|1|||
30661635|NCT00049517|58674671|FG005|Conditioning/Transplant|Alternative therapy|0|||
30661636|NCT00049517|58674666|FG000|Conditioning/Transplant|Other complicating disease|2|||
30661637|NCT00049517|58674667|FG001|Conditioning/Transplant|Other complicating disease|0|||
30661638|NCT00049517|58674668|FG002|Conditioning/Transplant|Other complicating disease|0|||
30661639|NCT00049517|58674669|FG003|Conditioning/Transplant|Other complicating disease|4|||
30661640|NCT00049517|58674670|FG004|Conditioning/Transplant|Other complicating disease|0|||
30661641|NCT00049517|58674671|FG005|Conditioning/Transplant|Other complicating disease|1|||
30661642|NCT00049517|58674666|FG000|Conditioning/Transplant|Reasons not reported|25|||
30661643|NCT00049517|58674667|FG001|Conditioning/Transplant|Reasons not reported|31|||
30661644|NCT00049517|58674668|FG002|Conditioning/Transplant|Reasons not reported|18|||
30661645|NCT00049517|58674669|FG003|Conditioning/Transplant|Reasons not reported|15|||
30661646|NCT00049517|58674670|FG004|Conditioning/Transplant|Reasons not reported|5|||
30661647|NCT00049517|58674671|FG005|Conditioning/Transplant|Reasons not reported|5|||
30661648|NCT00926783|58674681|FG000|Overall Study|Incomplete CFAE Procedures|3|||
30661649|NCT00926783|58674682|FG001|Overall Study|Incomplete CFAE Procedures|3|||
30661650|NCT00929669|58674688|FG000|Overall Study|elevated glucose levels|1|||
30661651|NCT00566995|58674692|FG000|Overall Study|Toxicity|4|||
30661652|NCT00566995|58674692|FG000|Overall Study|Withdrew consent|3|||
30952696|NCT01894607|59001801|FG000|Overall Study|Ineligible|1|||
30661653|NCT00926393|58674698|FG000|Overall Study|Withdrawal by Subject|1|||
30661654|NCT00926393|58674699|FG001|Overall Study|Withdrawal by Subject|2|||
30661655|NCT00926393|58674698|FG000|Overall Study|Adverse Event|1|||
30661656|NCT00926393|58674699|FG001|Overall Study|Adverse Event|1|||
30661657|NCT00926237|58674705|FG000|Overall Study|Withdrawal by Subject|2|||
30661658|NCT00926237|58674706|FG001|Overall Study|Withdrawal by Subject|1|||
30661659|NCT00931463|58674718|FG000|Overall Study|Death|8|||
30661660|NCT00931463|58674719|FG001|Overall Study|Death|4|||
30661661|NCT00931463|58674718|FG000|Overall Study|Withdrawal by Subject|5|||
30661662|NCT00931463|58674719|FG001|Overall Study|Withdrawal by Subject|0|||
30661663|NCT00931463|58674718|FG000|Overall Study|Lost to Follow-up|4|||
30661664|NCT00931463|58674719|FG001|Overall Study|Lost to Follow-up|1|||
30661665|NCT00929201|58674725|FG000|Period 1|Withdrawal by Subject|0|||
30661666|NCT00929201|58674726|FG001|Period 1|Withdrawal by Subject|1|||
30661667|NCT00926003|58674736|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
30661668|NCT00926003|58674737|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
30661669|NCT00926003|58674738|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
30661670|NCT00926003|58674736|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
30661671|NCT00926003|58674737|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
30661672|NCT00926003|58674738|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
30661673|NCT00928889|58674748|FG000|Overall Study|Lost to Follow-up|3|||
30661674|NCT00928889|58674749|FG001|Overall Study|Lost to Follow-up|1|||
30661675|NCT00928889|58674748|FG000|Overall Study|Protocol Violation|0|||
30661676|NCT00928889|58674749|FG001|Overall Study|Protocol Violation|1|||
30661677|NCT00928889|58674748|FG000|Overall Study|Adverse Event|1|||
30661678|NCT00928889|58674749|FG001|Overall Study|Adverse Event|0|||
30661679|NCT00928889|58674748|FG000|Overall Study|Other|1|||
30661680|NCT00928889|58674749|FG001|Overall Study|Other|0|||
30661681|NCT03978091|58674761|FG000|Overall Study|Lost to Follow-up|0|||
30661682|NCT03978091|58674762|FG001|Overall Study|Lost to Follow-up|0|||
30661683|NCT03978091|58674763|FG002|Overall Study|Lost to Follow-up|1|||
30661684|NCT03978091|58674764|FG003|Overall Study|Lost to Follow-up|0|||
30661685|NCT03978091|58674765|FG004|Overall Study|Lost to Follow-up|0|||
30661686|NCT03978091|58674766|FG005|Overall Study|Lost to Follow-up|0|||
30661687|NCT03978091|58674761|FG000|Overall Study|Withdrawal by Subject|0|||
30661688|NCT03978091|58674762|FG001|Overall Study|Withdrawal by Subject|0|||
30661689|NCT03978091|58674763|FG002|Overall Study|Withdrawal by Subject|0|||
30661690|NCT03978091|58674764|FG003|Overall Study|Withdrawal by Subject|1|||
30661691|NCT03978091|58674765|FG004|Overall Study|Withdrawal by Subject|1|||
30771068|NCT03120520|58780149|FG002|Overall Study|Withdrawal by Subject|3|||
30771069|NCT03120520|58780150|FG003|Overall Study|Withdrawal by Subject|2|||
30771070|NCT03120520|58780147|FG000|Overall Study|Other|0|||
30771071|NCT03120520|58780148|FG001|Overall Study|Other|1|||
30771072|NCT03120520|58780149|FG002|Overall Study|Other|0|||
30771073|NCT03120520|58780150|FG003|Overall Study|Other|0|||
30771074|NCT03787212|58780160|FG000|Period 1|Study Termination|2|||
30771075|NCT03787212|58780161|FG001|Period 1|Study Termination|2|||
30771076|NCT03125200|58780174|FG000|Overall Study|Study Termination|0|||
30771077|NCT03125200|58780175|FG001|Overall Study|Study Termination|0|||
30771078|NCT03125200|58780176|FG002|Overall Study|Study Termination|0|||
30771079|NCT03125200|58780177|FG003|Overall Study|Study Termination|1|||
30771080|NCT03125200|58780178|FG004|Overall Study|Study Termination|1|||
30771081|NCT03125200|58780179|FG005|Overall Study|Study Termination|2|||
30771082|NCT03125200|58780180|FG006|Overall Study|Study Termination|1|||
30771083|NCT03125200|58780174|FG000|Overall Study|Clinical Progression|0|||
30771084|NCT03125200|58780175|FG001|Overall Study|Clinical Progression|0|||
30771085|NCT03125200|58780176|FG002|Overall Study|Clinical Progression|0|||
30771086|NCT03125200|58780177|FG003|Overall Study|Clinical Progression|1|||
30771087|NCT03125200|58780178|FG004|Overall Study|Clinical Progression|0|||
30771088|NCT03125200|58780179|FG005|Overall Study|Clinical Progression|1|||
30771089|NCT03125200|58780180|FG006|Overall Study|Clinical Progression|0|||
30661692|NCT03978091|58674766|FG005|Overall Study|Withdrawal by Subject|0|||
30661693|NCT00564733|58674789|FG000|Overall Study|Withdrawal by Subject|4|||
30661694|NCT00564733|58674789|FG000|Overall Study|Ineligible|5|||
30661695|NCT00931385|58674793|FG000|Overall Study|Adverse Event|2|||
30661696|NCT00931385|58674794|FG001|Overall Study|Adverse Event|1|||
30661697|NCT00931385|58674795|FG002|Overall Study|Adverse Event|0|||
30661698|NCT00931385|58674796|FG003|Overall Study|Adverse Event|3|||
30771090|NCT03125200|58780174|FG000|Overall Study|Progressive Disease|2|||
30771091|NCT03125200|58780175|FG001|Overall Study|Progressive Disease|1|||
30771092|NCT03125200|58780176|FG002|Overall Study|Progressive Disease|2|||
30771093|NCT03125200|58780177|FG003|Overall Study|Progressive Disease|1|||
30771094|NCT03125200|58780178|FG004|Overall Study|Progressive Disease|2|||
30771095|NCT03125200|58780179|FG005|Overall Study|Progressive Disease|0|||
30661699|NCT00931385|58674793|FG000|Overall Study|Protocol Violation|0|||
30661700|NCT00931385|58674794|FG001|Overall Study|Protocol Violation|0|||
30661701|NCT00931385|58674795|FG002|Overall Study|Protocol Violation|1|||
30661702|NCT00931385|58674796|FG003|Overall Study|Protocol Violation|0|||
30661703|NCT00931385|58674793|FG000|Overall Study|Withdrawal by Subject|0|||
30771096|NCT03125200|58780180|FG006|Overall Study|Progressive Disease|1|||
30771097|NCT03125200|58780174|FG000|Overall Study|Lack of Efficacy|0|||
30771098|NCT03125200|58780175|FG001|Overall Study|Lack of Efficacy|0|||
30771099|NCT03125200|58780176|FG002|Overall Study|Lack of Efficacy|0|||
30661704|NCT00931385|58674794|FG001|Overall Study|Withdrawal by Subject|1|||
30661705|NCT00931385|58674795|FG002|Overall Study|Withdrawal by Subject|0|||
30661706|NCT00931385|58674796|FG003|Overall Study|Withdrawal by Subject|1|||
30661707|NCT00931385|58674793|FG000|Overall Study|Lost to Follow-up|0|||
30661708|NCT00931385|58674794|FG001|Overall Study|Lost to Follow-up|0|||
30661709|NCT00931385|58674795|FG002|Overall Study|Lost to Follow-up|0|||
30661710|NCT00931385|58674796|FG003|Overall Study|Lost to Follow-up|1|||
30661711|NCT00565747|58674812|FG000|Overall Study|No embryo transfer|67|||
30661712|NCT00565747|58674813|FG001|Overall Study|No embryo transfer|73|||
30661713|NCT00563797|58674821|FG000|Overall Study|Lost to Follow-up|7|||
30661714|NCT00563797|58674822|FG001|Overall Study|Lost to Follow-up|2|||
30661715|NCT00771927|58674841|FG000|Overall Study|Adverse Event|100|||
30661716|NCT00771927|58674842|FG001|Overall Study|Adverse Event|105|||
30661717|NCT00771927|58674841|FG000|Overall Study|Lack of Efficacy|70|||
30661718|NCT00771927|58674842|FG001|Overall Study|Lack of Efficacy|42|||
30661719|NCT00771927|58674841|FG000|Overall Study|Lost to Follow-up|46|||
30661720|NCT00771927|58674842|FG001|Overall Study|Lost to Follow-up|46|||
30661721|NCT00771927|58674841|FG000|Overall Study|Withdrawal by Subject|16|||
30661722|NCT00771927|58674842|FG001|Overall Study|Withdrawal by Subject|17|||
30661723|NCT00771927|58674841|FG000|Overall Study|Other reason|23|||
30661724|NCT00771927|58674842|FG001|Overall Study|Other reason|27|||
30661725|NCT00771849|58674850|FG000|Overall Study|Lost to Follow-up|1|||
30661726|NCT00771849|58674851|FG001|Overall Study|Lost to Follow-up|2|||
30661727|NCT00771849|58674850|FG000|Overall Study|Withdrawal by Subject|1|||
30661728|NCT00771849|58674851|FG001|Overall Study|Withdrawal by Subject|1|||
30661729|NCT00771849|58674850|FG000|Overall Study|Not vaccinated|0|||
30661730|NCT00771849|58674851|FG001|Overall Study|Not vaccinated|1|||
30661731|NCT00564889|58674857|FG000|Overall Study|Death|7|||
30661732|NCT00564889|58674857|FG000|Overall Study|Adverse Event|12|||
30661733|NCT00564889|58674857|FG000|Overall Study|Alternative treatment|3|||
30661734|NCT00564889|58674857|FG000|Overall Study|Disease progression|3|||
30661735|NCT00564889|58674857|FG000|Overall Study|Other, not specified|4|||
30661736|NCT00560833|58674875|FG000|Overall Study|Adverse Event|16|||
30661737|NCT00560833|58674876|FG001|Overall Study|Adverse Event|10|||
30661738|NCT00560833|58674877|FG002|Overall Study|Adverse Event|25|||
30661739|NCT00560833|58674878|FG003|Overall Study|Adverse Event|23|||
30661740|NCT00560833|58674879|FG004|Overall Study|Adverse Event|35|||
30661741|NCT00560833|58674875|FG000|Overall Study|Lost to Follow-up|0|||
30661742|NCT00560833|58674876|FG001|Overall Study|Lost to Follow-up|0|||
30661743|NCT00560833|58674877|FG002|Overall Study|Lost to Follow-up|1|||
30661744|NCT00560833|58674878|FG003|Overall Study|Lost to Follow-up|0|||
30661745|NCT00560833|58674879|FG004|Overall Study|Lost to Follow-up|0|||
30661746|NCT00560833|58674875|FG000|Overall Study|Lack of Efficacy|22|||
30661747|NCT00560833|58674876|FG001|Overall Study|Lack of Efficacy|9|||
30661748|NCT00560833|58674877|FG002|Overall Study|Lack of Efficacy|6|||
30661749|NCT00560833|58674878|FG003|Overall Study|Lack of Efficacy|4|||
30661750|NCT00560833|58674879|FG004|Overall Study|Lack of Efficacy|4|||
30661751|NCT00560833|58674875|FG000|Overall Study|Participant uncooperative|5|||
30661752|NCT00560833|58674876|FG001|Overall Study|Participant uncooperative|5|||
30661753|NCT00560833|58674877|FG002|Overall Study|Participant uncooperative|4|||
30661754|NCT00560833|58674878|FG003|Overall Study|Participant uncooperative|4|||
30661755|NCT00560833|58674879|FG004|Overall Study|Participant uncooperative|2|||
30661756|NCT00560833|58674875|FG000|Overall Study|Other|1|||
30661757|NCT00560833|58674876|FG001|Overall Study|Other|1|||
30661758|NCT00560833|58674877|FG002|Overall Study|Other|3|||
30661759|NCT00560833|58674878|FG003|Overall Study|Other|0|||
30661760|NCT00560833|58674879|FG004|Overall Study|Other|0|||
30771100|NCT03125200|58780177|FG003|Overall Study|Lack of Efficacy|1|||
30771101|NCT03125200|58780178|FG004|Overall Study|Lack of Efficacy|0|||
30771102|NCT03125200|58780179|FG005|Overall Study|Lack of Efficacy|0|||
30661761|NCT00560833|58674875|FG000|Overall Study|Never received drug|0|||
30952697|NCT01883453|59001807|FG000|Overall Study|No episode of common cold|25|||
30952698|NCT01883453|59001808|FG001|Overall Study|No episode of common cold|23|||
30952699|NCT01882985|59001842|FG000|Overall Study|Lost to Follow-up|1|||
30952700|NCT01882985|59001842|FG000|Overall Study|Withdrawal by Subject|1|||
30952701|NCT01893905|59001855|FG000|Overall Study|Withdrawal by Subject|1|||
30661762|NCT00560833|58674876|FG001|Overall Study|Never received drug|1|||
30661763|NCT00560833|58674877|FG002|Overall Study|Never received drug|0|||
30771103|NCT03125200|58780180|FG006|Overall Study|Lack of Efficacy|0|||
30771104|NCT03125200|58780174|FG000|Overall Study|Toxicity|0|||
30661764|NCT00560833|58674878|FG003|Overall Study|Never received drug|0|||
30661765|NCT00560833|58674879|FG004|Overall Study|Never received drug|1|||
30661766|NCT00771615|58674900|FG000|Overall Study|Withdrawal by Subject|0|||
30661767|NCT00771615|58674901|FG001|Overall Study|Withdrawal by Subject|1|||
30661768|NCT00771615|58674902|FG002|Overall Study|Withdrawal by Subject|0|||
30661769|NCT00771615|58674903|FG003|Overall Study|Withdrawal by Subject|0|||
30952702|NCT01893905|59001856|FG001|Overall Study|Withdrawal by Subject|0|||
30952703|NCT01893905|59001855|FG000|Overall Study|Adverse Event|9|||
30661770|NCT00771615|58674904|FG004|Overall Study|Withdrawal by Subject|0|||
30661771|NCT00771615|58674905|FG005|Overall Study|Withdrawal by Subject|0|||
30661772|NCT00771615|58674906|FG006|Overall Study|Withdrawal by Subject|0|||
30661773|NCT00771615|58674907|FG007|Overall Study|Withdrawal by Subject|1|||
30661774|NCT00771615|58674908|FG008|Overall Study|Withdrawal by Subject|0|||
30661775|NCT00771615|58674900|FG000|Overall Study|Lost to Follow-up|1|||
30661776|NCT00771615|58674901|FG001|Overall Study|Lost to Follow-up|1|||
30661777|NCT00771615|58674902|FG002|Overall Study|Lost to Follow-up|1|||
30952704|NCT01893905|59001856|FG001|Overall Study|Adverse Event|3|||
30952705|NCT01893905|59001855|FG000|Overall Study|Lack of Efficacy|5|||
30661778|NCT00771615|58674903|FG003|Overall Study|Lost to Follow-up|1|||
30661779|NCT00771615|58674904|FG004|Overall Study|Lost to Follow-up|0|||
30661780|NCT00771615|58674905|FG005|Overall Study|Lost to Follow-up|1|||
30661781|NCT00771615|58674906|FG006|Overall Study|Lost to Follow-up|1|||
30661782|NCT00771615|58674907|FG007|Overall Study|Lost to Follow-up|0|||
30661783|NCT00771615|58674908|FG008|Overall Study|Lost to Follow-up|0|||
30661784|NCT02723604|58674937|FG000|Overall Study|ineligible|1|||
30661785|NCT02723604|58674937|FG000|Overall Study|never received treatment|1|||
30661786|NCT00560755|58674941|FG000|Overall Study|Protocol Violation|15|||
30661787|NCT00560755|58674941|FG000|Overall Study|Withdrawal by Subject|26|||
30661788|NCT00560755|58674941|FG000|Overall Study|Lost to Follow-up|9|||
30661789|NCT00560755|58674941|FG000|Overall Study|Adverse Event|8|||
30661790|NCT00560755|58674941|FG000|Overall Study|Physician Decision|2|||
30661791|NCT00770991|58674948|FG000|Overall Study|Physician Decision|2|||
30661792|NCT00770991|58674949|FG001|Overall Study|Physician Decision|0|||
30661793|NCT00770991|58674948|FG000|Overall Study|Withdrawal by Subject|1|||
30661794|NCT00770991|58674949|FG001|Overall Study|Withdrawal by Subject|0|||
30661795|NCT00770991|58674948|FG000|Overall Study|Adverse Event|1|||
30661796|NCT00770991|58674949|FG001|Overall Study|Adverse Event|5|||
30661797|NCT00770991|58674948|FG000|Overall Study|Pregnancy|1|||
30661798|NCT00770991|58674949|FG001|Overall Study|Pregnancy|0|||
30661799|NCT00925769|58674960|FG000|Overall Study|Major toxicity|1|||
30661800|NCT00925769|58674961|FG001|Overall Study|Major toxicity|0|||
30661801|NCT00925769|58674962|FG002|Overall Study|Major toxicity|1|||
30661802|NCT00925769|58674963|FG003|Overall Study|Major toxicity|1|||
30661803|NCT00925769|58674964|FG004|Overall Study|Major toxicity|0|||
30661804|NCT00925769|58674965|FG005|Overall Study|Major toxicity|0|||
30661805|NCT00925769|58674960|FG000|Overall Study|Disease progression|4|||
30661806|NCT00925769|58674961|FG001|Overall Study|Disease progression|5|||
30661807|NCT00925769|58674962|FG002|Overall Study|Disease progression|3|||
30661808|NCT00925769|58674963|FG003|Overall Study|Disease progression|4|||
30661809|NCT00925769|58674964|FG004|Overall Study|Disease progression|2|||
30661810|NCT00925769|58674965|FG005|Overall Study|Disease progression|3|||
30661811|NCT00925769|58674960|FG000|Overall Study|Death|0|||
30661812|NCT00925769|58674961|FG001|Overall Study|Death|0|||
30661813|NCT00925769|58674962|FG002|Overall Study|Death|1|||
30661814|NCT00925769|58674963|FG003|Overall Study|Death|0|||
30661815|NCT00925769|58674964|FG004|Overall Study|Death|0|||
30661816|NCT00925769|58674965|FG005|Overall Study|Death|0|||
30661817|NCT00925769|58674960|FG000|Overall Study|Physician Decision|1|||
30661818|NCT00925769|58674961|FG001|Overall Study|Physician Decision|0|||
30661819|NCT00925769|58674962|FG002|Overall Study|Physician Decision|0|||
30661820|NCT00925769|58674963|FG003|Overall Study|Physician Decision|0|||
30661821|NCT00925769|58674964|FG004|Overall Study|Physician Decision|0|||
30661822|NCT00925769|58674965|FG005|Overall Study|Physician Decision|0|||
30661823|NCT00925769|58674960|FG000|Overall Study|Missing documentation|0|||
30661824|NCT00925769|58674961|FG001|Overall Study|Missing documentation|1|||
30661825|NCT00925769|58674962|FG002|Overall Study|Missing documentation|0|||
30661826|NCT00925769|58674963|FG003|Overall Study|Missing documentation|0|||
30661827|NCT00925769|58674964|FG004|Overall Study|Missing documentation|0|||
30661828|NCT00925769|58674965|FG005|Overall Study|Missing documentation|0|||
30661829|NCT00925769|58674960|FG000|Overall Study|End of study visit not done|0|||
30661830|NCT00925769|58674961|FG001|Overall Study|End of study visit not done|0|||
30661831|NCT00925769|58674962|FG002|Overall Study|End of study visit not done|1|||
30661832|NCT00925769|58674963|FG003|Overall Study|End of study visit not done|0|||
30661833|NCT00925769|58674964|FG004|Overall Study|End of study visit not done|0|||
30661834|NCT00925769|58674965|FG005|Overall Study|End of study visit not done|0|||
30661835|NCT00925769|58674960|FG000|Overall Study|Participant is unable to swallow drug|0|||
30952706|NCT01893905|59001856|FG001|Overall Study|Lack of Efficacy|7|||
30661836|NCT00925769|58674961|FG001|Overall Study|Participant is unable to swallow drug|0|||
30661837|NCT00925769|58674962|FG002|Overall Study|Participant is unable to swallow drug|0|||
30661838|NCT00925769|58674963|FG003|Overall Study|Participant is unable to swallow drug|1|||
30952707|NCT01893905|59001855|FG000|Overall Study|Lost to Follow-up|1|||
30661839|NCT00925769|58674964|FG004|Overall Study|Participant is unable to swallow drug|0|||
30661840|NCT00925769|58674965|FG005|Overall Study|Participant is unable to swallow drug|0|||
30661841|NCT00925769|58674960|FG000|Overall Study|Adverse Event|0|||
30661842|NCT00925769|58674961|FG001|Overall Study|Adverse Event|0|||
30661843|NCT00925769|58674962|FG002|Overall Study|Adverse Event|0|||
30661844|NCT00925769|58674963|FG003|Overall Study|Adverse Event|0|||
30661845|NCT00925769|58674964|FG004|Overall Study|Adverse Event|1|||
30661846|NCT00925769|58674965|FG005|Overall Study|Adverse Event|0|||
30661847|NCT00770913|58674984|FG000|Overall Study|Adverse Event|1|||
30661848|NCT00770913|58674985|FG001|Overall Study|Adverse Event|3|||
30661849|NCT00770913|58674986|FG002|Overall Study|Adverse Event|6|||
30661850|NCT00770913|58674984|FG000|Overall Study|Refusal to continue participation|6|||
30661851|NCT00770913|58674985|FG001|Overall Study|Refusal to continue participation|4|||
30661852|NCT00770913|58674986|FG002|Overall Study|Refusal to continue participation|5|||
30661853|NCT00770913|58674984|FG000|Overall Study|Physician Decision|0|||
30661854|NCT00770913|58674985|FG001|Overall Study|Physician Decision|1|||
30771105|NCT03125200|58780175|FG001|Overall Study|Toxicity|0|||
30771106|NCT03125200|58780176|FG002|Overall Study|Toxicity|0|||
30771107|NCT03125200|58780177|FG003|Overall Study|Toxicity|1|||
30771108|NCT03125200|58780178|FG004|Overall Study|Toxicity|0|||
30771109|NCT03125200|58780179|FG005|Overall Study|Toxicity|0|||
30771110|NCT03125200|58780180|FG006|Overall Study|Toxicity|0|||
30771111|NCT03125200|58780174|FG000|Overall Study|Consent Withdrawn by Subject|0|||
30771112|NCT03125200|58780175|FG001|Overall Study|Consent Withdrawn by Subject|1|||
30771113|NCT03125200|58780176|FG002|Overall Study|Consent Withdrawn by Subject|0|||
30771114|NCT03125200|58780177|FG003|Overall Study|Consent Withdrawn by Subject|0|||
30771115|NCT03125200|58780178|FG004|Overall Study|Consent Withdrawn by Subject|1|||
30771116|NCT03125200|58780179|FG005|Overall Study|Consent Withdrawn by Subject|0|||
30771117|NCT03125200|58780180|FG006|Overall Study|Consent Withdrawn by Subject|1|||
30771118|NCT03132220|58780201|FG000|Overall Study|Lost to Follow-up|17|||
30771119|NCT03132220|58780202|FG001|Overall Study|Lost to Follow-up|8|||
30771120|NCT03132220|58780201|FG000|Overall Study|Withdrawal by Subject|1|||
30771121|NCT03132220|58780202|FG001|Overall Study|Withdrawal by Subject|4|||
30771122|NCT03119662|58780210|FG000|Overall Study|Withdrawal by Subject|0|||
30771123|NCT03119662|58780211|FG001|Overall Study|Withdrawal by Subject|1|||
30771124|NCT02728804|58780217|FG000|Overall Study|Ineligible|3|||
30771125|NCT02728804|58780217|FG000|Overall Study|Did not complete baseline questionnaire|9|||
30849150|NCT02653664|58875939|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
30849151|NCT02653664|58875937|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
30849152|NCT02653664|58875938|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
30849153|NCT02653664|58875939|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
30849154|NCT02653664|58875937|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
30849155|NCT02653664|58875938|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
30849156|NCT02653664|58875939|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
30849157|NCT02653664|58875937|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
30849158|NCT02653664|58875938|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
30849159|NCT02653664|58875939|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
30849160|NCT02653664|58875937|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
30849161|NCT02653664|58875938|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
30849162|NCT02653664|58875939|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
30849163|NCT02653664|58875937|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
30849164|NCT02653664|58875938|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
30849165|NCT02653664|58875939|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
30849166|NCT02488629|58875957|FG000|Overall Study|Lack of Efficacy|3|||
30849167|NCT02488629|58875958|FG001|Overall Study|Lack of Efficacy|1|||
30849168|NCT02488629|58875959|FG002|Overall Study|Lack of Efficacy|0|||
30849169|NCT02488629|58875960|FG003|Overall Study|Lack of Efficacy|0|||
30849170|NCT02488629|58875957|FG000|Overall Study|Withdrawal by Subject|0|||
30849171|NCT02488629|58875958|FG001|Overall Study|Withdrawal by Subject|1|||
30849172|NCT02488629|58875959|FG002|Overall Study|Withdrawal by Subject|0|||
30849173|NCT02488629|58875960|FG003|Overall Study|Withdrawal by Subject|0|||
30849174|NCT02727699|58875971|FG000|Overall Study|Adverse Event|2|||
30849175|NCT02727699|58875972|FG001|Overall Study|Adverse Event|0|||
30849176|NCT02727699|58875971|FG000|Overall Study|Withdrawal by Subject|5|||
30849177|NCT02727699|58875972|FG001|Overall Study|Withdrawal by Subject|3|||
30952708|NCT01893905|59001856|FG001|Overall Study|Lost to Follow-up|0|||
30661855|NCT00770913|58674986|FG002|Overall Study|Physician Decision|1|||
30661856|NCT00770913|58674984|FG000|Overall Study|Protocol Violation|3|||
30661857|NCT00770913|58674985|FG001|Overall Study|Protocol Violation|0|||
30661858|NCT00770913|58674986|FG002|Overall Study|Protocol Violation|1|||
30661859|NCT00770913|58674984|FG000|Overall Study|Incorrect drug was allocated|1|||
30771126|NCT02728804|58780217|FG000|Overall Study|Death|99|||
30771127|NCT02699554|58780233|FG000|Overall Study|Lost to Follow-up|9|||
30771128|NCT03783780|58780247|FG000|Overall Study|Withdrawn prior to completion|1|||
30771129|NCT03783702|58780254|FG000|Overall Study|Lost to Follow-up|6|||
30661860|NCT00770913|58674985|FG001|Overall Study|Incorrect drug was allocated|0|||
30771130|NCT03783702|58780255|FG001|Overall Study|Lost to Follow-up|8|||
30849178|NCT02727699|58875971|FG000|Overall Study|Protocol Violation|0|||
30849179|NCT02727699|58875972|FG001|Overall Study|Protocol Violation|1|||
30661861|NCT00770913|58674986|FG002|Overall Study|Incorrect drug was allocated|0|||
30661862|NCT00562861|58674996|FG000|Overall Study|Adverse Event|1|||
30661863|NCT00562861|58674997|FG001|Overall Study|Adverse Event|1|||
30661864|NCT00562861|58674996|FG000|Overall Study|Lack of Efficacy|5|||
30661865|NCT00562861|58674997|FG001|Overall Study|Lack of Efficacy|5|||
30661866|NCT00562861|58674996|FG000|Overall Study|noncompliance, moved|7|||
30661867|NCT00562861|58674997|FG001|Overall Study|noncompliance, moved|2|||
30849180|NCT02727699|58875971|FG000|Overall Study|Physician Decision|0|||
30661868|NCT00562861|58674996|FG000|Overall Study|Lost to Follow-up|7|||
30661869|NCT00562861|58674997|FG001|Overall Study|Lost to Follow-up|3|||
30661870|NCT00770679|58675003|FG000|Overall Study|Lost to Follow-up|3|||
30661871|NCT00770679|58675003|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
30661872|NCT00770601|58675007|FG000|Overall Study|Withdrawal by Subject|1|||
30661873|NCT00770367|58675013|FG000|First Intervention|Withdrawal by Subject|0|||
30661874|NCT00770367|58675014|FG001|First Intervention|Withdrawal by Subject|2|||
30661875|NCT00770367|58675013|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
30661876|NCT00770367|58675014|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
30661877|NCT00770367|58675013|FG000|Second Intervention|Lost to Follow-up|2|||
30661878|NCT00770367|58675014|FG001|Second Intervention|Lost to Follow-up|0|||
30661879|NCT00931307|58675022|FG000|Overall Study|Lack of Efficacy|12|||
30661880|NCT00931307|58675022|FG000|Overall Study|Biomicroscopy|1|||
30661881|NCT00930761|58675028|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
30661882|NCT00930761|58675029|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
30661883|NCT00930761|58675028|FG000|Overall Study|less than 3 music therapy sessions|0|||
30661884|NCT00930761|58675029|FG001|Overall Study|less than 3 music therapy sessions|3|||
30661885|NCT00770289|58675035|FG000|Overall Study|Other|6|||
30661886|NCT00556933|58675048|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
30661887|NCT00556933|58675049|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
30661888|NCT00556933|58675050|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
30661889|NCT00556933|58675051|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
30661890|NCT00556933|58675048|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
30661891|NCT00556933|58675049|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
30661892|NCT00556933|58675050|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
30661893|NCT00556933|58675051|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
30661894|NCT00556933|58675048|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
30661895|NCT00556933|58675049|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
30661896|NCT00556933|58675050|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
30661897|NCT00556933|58675051|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
30661898|NCT00556933|58675048|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
30661899|NCT00556933|58675049|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
30661900|NCT00556933|58675050|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
30661901|NCT00556933|58675051|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
30661902|NCT00556933|58675048|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
30661903|NCT00556933|58675049|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
30661904|NCT00556933|58675050|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
30661905|NCT00556933|58675051|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
30661906|NCT00556933|58675048|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
30661907|NCT00556933|58675049|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
30661908|NCT00556933|58675050|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
30661909|NCT00556933|58675051|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
30661910|NCT00556933|58675048|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
30661911|NCT00556933|58675049|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
30661912|NCT00556933|58675050|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
30661913|NCT00556933|58675051|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
30661914|NCT00556933|58675048|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
30661915|NCT00556933|58675049|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
30661916|NCT00556933|58675050|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
30661917|NCT00556933|58675051|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
30661918|NCT00556933|58675048|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
30661919|NCT00556933|58675049|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
30661920|NCT00556933|58675050|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
30661921|NCT00556933|58675051|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
30661922|NCT00556933|58675048|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
30661923|NCT00556933|58675049|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
30661924|NCT00556933|58675050|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
30661925|NCT00556933|58675051|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
30661926|NCT00556933|58675048|FG000|CNI Withdrawal vs. Minimization|Death|0|||
30771131|NCT03783702|58780254|FG000|Overall Study|Protocol Violation|1|||
30849181|NCT02727699|58875972|FG001|Overall Study|Physician Decision|1|||
30661927|NCT00556933|58675049|FG001|CNI Withdrawal vs. Minimization|Death|0|||
30661928|NCT00556933|58675050|FG002|CNI Withdrawal vs. Minimization|Death|0|||
30661929|NCT00556933|58675051|FG003|CNI Withdrawal vs. Minimization|Death|1|||
30661930|NCT00770211|58675072|FG000|Overall Study|Lost to Follow-up|1|||
30661931|NCT00770211|58675073|FG001|Overall Study|Lost to Follow-up|0|||
30661932|NCT00770211|58675072|FG000|Overall Study|Withdrawal by Subject|0|||
30661933|NCT00770211|58675073|FG001|Overall Study|Withdrawal by Subject|2|||
30661934|NCT00928187|58675082|FG000|Overall Study|Death|1|||
30661935|NCT00928187|58675083|FG001|Overall Study|Death|2|||
30661936|NCT00928187|58675084|FG002|Overall Study|Death|3|||
30661937|NCT00928187|58675082|FG000|Overall Study|Lost to Follow-up|1|||
30661938|NCT00928187|58675083|FG001|Overall Study|Lost to Follow-up|2|||
30661939|NCT00928187|58675084|FG002|Overall Study|Lost to Follow-up|1|||
30661940|NCT00928187|58675082|FG000|Overall Study|Withdrawal by Subject|0|||
30661941|NCT00928187|58675083|FG001|Overall Study|Withdrawal by Subject|1|||
30661942|NCT00928187|58675084|FG002|Overall Study|Withdrawal by Subject|1|||
30661943|NCT00928187|58675082|FG000|Overall Study|Protocol Violation|0|||
30661944|NCT00928187|58675083|FG001|Overall Study|Protocol Violation|1|||
30661945|NCT00928187|58675084|FG002|Overall Study|Protocol Violation|0|||
30661946|NCT00769119|58675094|FG000|Overall Study|Voluntary discontinuation|0|||
30661947|NCT00769119|58675095|FG001|Overall Study|Voluntary discontinuation|2|||
30661948|NCT00769119|58675094|FG000|Overall Study|Adverse Event|1|||
30661949|NCT00769119|58675095|FG001|Overall Study|Adverse Event|1|||
30661950|NCT00769119|58675094|FG000|Overall Study|Disallowed medication|1|||
30661951|NCT00769119|58675095|FG001|Overall Study|Disallowed medication|0|||
30661952|NCT00927953|58675103|FG000|Overall Study|Death|2|||
30661953|NCT00927953|58675104|FG001|Overall Study|Death|1|||
30661954|NCT00768651|58675111|FG000|Overall Study|Withdrawal by Subject|1|||
30661955|NCT00756717|58675116|FG000|Overall Study|Withdrawal by Subject|2|||
30661956|NCT04987762|58675130|FG000|Overall Study|Study was Terminated by Sponsor|103|||
30661957|NCT04817332|58675157|FG000|Overall Study|Lost to Follow-up|3|||
30661958|NCT04817332|58675158|FG001|Overall Study|Lost to Follow-up|3|||
30661959|NCT04817332|58675157|FG000|Overall Study|Protocol Violation|2|||
30661960|NCT04817332|58675158|FG001|Overall Study|Protocol Violation|0|||
30661961|NCT04797637|58675166|FG000|Overall Study|Lost to Follow-up|23|||
30661962|NCT04797637|58675167|FG001|Overall Study|Lost to Follow-up|32|||
30661963|NCT04797637|58675166|FG000|Overall Study|Withdrawal by Subject|0|||
30661964|NCT04797637|58675167|FG001|Overall Study|Withdrawal by Subject|1|||
30661965|NCT04779489|58675173|FG000|Overall Study|Physician Decision|1|||
30661966|NCT04300296|58675204|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
30661967|NCT04300296|58675205|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
30661968|NCT04300296|58675206|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
30661969|NCT04300296|58675207|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
30661970|NCT04300296|58675208|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
30661971|NCT04300296|58675209|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
30661972|NCT04300296|58675204|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
30661973|NCT04300296|58675205|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
30661974|NCT04300296|58675206|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
30661975|NCT04300296|58675207|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
30661976|NCT04300296|58675208|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
30661977|NCT04300296|58675209|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
30661978|NCT04300296|58675204|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
30661979|NCT04300296|58675205|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
30661980|NCT04300296|58675206|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
30661981|NCT04300296|58675207|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
30661982|NCT04300296|58675208|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
30661983|NCT04300296|58675209|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
30661984|NCT04300296|58675204|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
30661985|NCT04300296|58675205|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
30661986|NCT04300296|58675206|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
30661987|NCT04300296|58675207|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
30661988|NCT04300296|58675208|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
30661989|NCT04300296|58675209|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
30661990|NCT04300296|58675204|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
30661991|NCT04300296|58675205|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
30661992|NCT04300296|58675206|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
30661993|NCT04300296|58675207|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
30661994|NCT04300296|58675208|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
30661995|NCT04300296|58675209|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
30661996|NCT04300296|58675204|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
30661997|NCT04300296|58675205|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
30771132|NCT03783702|58780255|FG001|Overall Study|Protocol Violation|3|||
30661998|NCT04300296|58675206|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
30661999|NCT04300296|58675207|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
30662000|NCT04300296|58675208|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
30662001|NCT04300296|58675209|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
30662002|NCT04300296|58675204|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
30662003|NCT04300296|58675205|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
30662004|NCT04300296|58675206|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
30662005|NCT04300296|58675207|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
30662006|NCT04300296|58675208|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
30662007|NCT04300296|58675209|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
30662008|NCT03989440|58675257|FG000|Overall Study|COVID-19 travel restrictions|0|||
30662009|NCT03989440|58675258|FG001|Overall Study|COVID-19 travel restrictions|0|||
30662010|NCT03989440|58675259|FG002|Overall Study|COVID-19 travel restrictions|1|||
30662011|NCT03989440|58675260|FG003|Overall Study|COVID-19 travel restrictions|0|||
30662012|NCT03989440|58675261|FG004|Overall Study|COVID-19 travel restrictions|0|||
30662013|NCT03989440|58675262|FG005|Overall Study|COVID-19 travel restrictions|0|||
30662014|NCT03989440|58675257|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
30662015|NCT03989440|58675258|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
30662016|NCT03989440|58675259|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
30662017|NCT03989440|58675260|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
30662018|NCT03989440|58675261|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
30662019|NCT03989440|58675262|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
30662020|NCT03908437|58675280|FG000|Overall Study|Death|0|||
30662021|NCT03908437|58675281|FG001|Overall Study|Death|1|||
30662022|NCT03908437|58675280|FG000|Overall Study|Lost to Follow-up|31|||
30662023|NCT03908437|58675281|FG001|Overall Study|Lost to Follow-up|24|||
30662024|NCT03382561|58675306|FG000|Overall Study|Disease progression|47|||
30662025|NCT03382561|58675307|FG001|Overall Study|Disease progression|6|||
30662026|NCT03382561|58675306|FG000|Overall Study|Adverse Event|10|||
30662027|NCT03382561|58675307|FG001|Overall Study|Adverse Event|2|||
30662028|NCT03382561|58675306|FG000|Overall Study|Death|8|||
30662029|NCT03382561|58675307|FG001|Overall Study|Death|3|||
30662030|NCT03382561|58675306|FG000|Overall Study|Withdrawal by Subject|6|||
30662031|NCT03382561|58675307|FG001|Overall Study|Withdrawal by Subject|5|||
30662032|NCT03382561|58675306|FG000|Overall Study|Alternative therapy|2|||
30662033|NCT03382561|58675307|FG001|Overall Study|Alternative therapy|8|||
30662034|NCT03382561|58675306|FG000|Overall Study|Never started treatment|3|||
30662035|NCT03382561|58675307|FG001|Overall Study|Never started treatment|6|||
30771133|NCT03575572|58780263|FG000|Overall Study|Withdrawal by Subject|2|||
30771134|NCT03575572|58780263|FG000|Overall Study|Physician Decision|2|||
30771135|NCT03116698|58780289|FG000|Overall Study|Adverse Event|1|||
30771136|NCT03116698|58780290|FG001|Overall Study|Adverse Event|1|||
30771137|NCT03116698|58780291|FG002|Overall Study|Adverse Event|1|||
30771138|NCT03116698|58780292|FG003|Overall Study|Adverse Event|0|||
30771139|NCT03116698|58780289|FG000|Overall Study|Withdrawal by Subject|1|||
30771140|NCT03116698|58780290|FG001|Overall Study|Withdrawal by Subject|4|||
30771141|NCT03116698|58780291|FG002|Overall Study|Withdrawal by Subject|5|||
30771142|NCT03116698|58780292|FG003|Overall Study|Withdrawal by Subject|2|||
30771143|NCT03116698|58780289|FG000|Overall Study|Lost to Follow-up|2|||
30771144|NCT03116698|58780290|FG001|Overall Study|Lost to Follow-up|0|||
30771145|NCT03116698|58780291|FG002|Overall Study|Lost to Follow-up|0|||
30771146|NCT03116698|58780292|FG003|Overall Study|Lost to Follow-up|0|||
30771147|NCT03116698|58780289|FG000|Overall Study|Physician Decision|1|||
30771148|NCT03116698|58780290|FG001|Overall Study|Physician Decision|1|||
30771149|NCT03116698|58780291|FG002|Overall Study|Physician Decision|0|||
30849182|NCT02727699|58875971|FG000|Overall Study|Lost to Follow-up|1|||
30849183|NCT02727699|58875972|FG001|Overall Study|Lost to Follow-up|0|||
30849184|NCT02727699|58875971|FG000|Overall Study|Sponsor Decision|1|||
30849185|NCT02727699|58875972|FG001|Overall Study|Sponsor Decision|0|||
30662036|NCT03382561|58675306|FG000|Overall Study|Lack of Efficacy|0|||
30662037|NCT03382561|58675307|FG001|Overall Study|Lack of Efficacy|1|||
30662038|NCT03382561|58675306|FG000|Overall Study|Physician Decision|0|||
30662039|NCT03382561|58675307|FG001|Overall Study|Physician Decision|1|||
30662040|NCT03382561|58675306|FG000|Overall Study|Other complicating disease|0|||
30771150|NCT03116698|58780292|FG003|Overall Study|Physician Decision|0|||
30771151|NCT03116698|58780289|FG000|Overall Study|Protocol Violation|1|||
30771152|NCT03116698|58780290|FG001|Overall Study|Protocol Violation|0|||
30771153|NCT03116698|58780291|FG002|Overall Study|Protocol Violation|0|||
30771154|NCT03116698|58780292|FG003|Overall Study|Protocol Violation|0|||
30771155|NCT03116698|58780289|FG000|Overall Study|Death|0|||
30771156|NCT03116698|58780290|FG001|Overall Study|Death|0|||
30771157|NCT03116698|58780291|FG002|Overall Study|Death|2|||
30771158|NCT03116698|58780292|FG003|Overall Study|Death|0|||
30771159|NCT03116152|58780304|FG000|Overall Study|Disease Progression|49|||
30771160|NCT03116152|58780305|FG001|Overall Study|Disease Progression|47|||
30849186|NCT03576716|58875980|FG000|Overall Study|Withdrawal by Subject|0|||
30771161|NCT03116152|58780304|FG000|Overall Study|Death|5|||
30771162|NCT03116152|58780305|FG001|Overall Study|Death|2|||
30771163|NCT03116152|58780304|FG000|Overall Study|Adverse Event|21|||
30771164|NCT03116152|58780305|FG001|Overall Study|Adverse Event|7|||
30771165|NCT03116152|58780304|FG000|Overall Study|Protocol Violation|2|||
30771166|NCT03116152|58780305|FG001|Overall Study|Protocol Violation|2|||
30771167|NCT03116152|58780304|FG000|Overall Study|Withdrawal by Subject|0|||
30771168|NCT03116152|58780305|FG001|Overall Study|Withdrawal by Subject|1|||
30771169|NCT03116152|58780304|FG000|Overall Study|Physician Decision|3|||
30771170|NCT03116152|58780305|FG001|Overall Study|Physician Decision|2|||
30771171|NCT03116152|58780304|FG000|Overall Study|other|11|||
30771172|NCT03116152|58780305|FG001|Overall Study|other|34|||
30771173|NCT00226499|58780316|FG000|Overall Study|Adverse Event|10|||
30771174|NCT00226499|58780317|FG001|Overall Study|Adverse Event|6|||
30849187|NCT03576716|58875981|FG001|Overall Study|Withdrawal by Subject|1|||
30849188|NCT02847637|58876000|FG000|Overall Study|Withdrawal by Subject|0|||
30771175|NCT00226499|58780318|FG002|Overall Study|Adverse Event|3|||
30771176|NCT00226499|58780316|FG000|Overall Study|Others|1064|||
30771177|NCT00226499|58780317|FG001|Overall Study|Others|1066|||
30771178|NCT00226499|58780318|FG002|Overall Study|Others|356|||
30771179|NCT01400776|58780332|FG000|Overall Study|Adverse Event|7|||
30771180|NCT01400776|58780333|FG001|Overall Study|Adverse Event|2|||
30771181|NCT01400776|58780334|FG002|Overall Study|Adverse Event|9|||
30771182|NCT01400776|58780335|FG003|Overall Study|Adverse Event|2|||
30771183|NCT01400776|58780332|FG000|Overall Study|Lost to Follow-up|1|||
30771184|NCT01400776|58780333|FG001|Overall Study|Lost to Follow-up|0|||
30771185|NCT01400776|58780334|FG002|Overall Study|Lost to Follow-up|4|||
30771186|NCT01400776|58780335|FG003|Overall Study|Lost to Follow-up|1|||
30771187|NCT01400776|58780332|FG000|Overall Study|Withdrew Consent|4|||
30771188|NCT01400776|58780333|FG001|Overall Study|Withdrew Consent|2|||
30771189|NCT01400776|58780334|FG002|Overall Study|Withdrew Consent|6|||
30771190|NCT01400776|58780335|FG003|Overall Study|Withdrew Consent|1|||
30771191|NCT01400776|58780332|FG000|Overall Study|Protocol Deviation|6|||
30771192|NCT01400776|58780333|FG001|Overall Study|Protocol Deviation|1|||
30771193|NCT01400776|58780334|FG002|Overall Study|Protocol Deviation|5|||
30771194|NCT01400776|58780335|FG003|Overall Study|Protocol Deviation|2|||
30771195|NCT01400776|58780332|FG000|Overall Study|Reason not Specified|3|||
30771196|NCT01400776|58780333|FG001|Overall Study|Reason not Specified|0|||
30849189|NCT02847637|58876001|FG001|Overall Study|Withdrawal by Subject|1|||
30849190|NCT02847637|58876002|FG002|Overall Study|Withdrawal by Subject|1|||
30849191|NCT02847637|58876003|FG003|Overall Study|Withdrawal by Subject|0|||
30849192|NCT02847637|58876000|FG000|Overall Study|Lost to Follow-up|1|||
30849193|NCT02847637|58876001|FG001|Overall Study|Lost to Follow-up|1|||
30849194|NCT02847637|58876002|FG002|Overall Study|Lost to Follow-up|0|||
30849195|NCT02847637|58876003|FG003|Overall Study|Lost to Follow-up|0|||
30849196|NCT02652260|58876029|FG000|Overall Study|Pregnancy|0|||
30849197|NCT02652260|58876030|FG001|Overall Study|Pregnancy|1|||
30849198|NCT02652260|58876029|FG000|Overall Study|Withdrawal by Subject|0|||
30849199|NCT02652260|58876030|FG001|Overall Study|Withdrawal by Subject|1|||
30849200|NCT00706095|58876042|FG000|Overall Study|Progressive Disease|4|||
30849201|NCT00706095|58876043|FG001|Overall Study|Progressive Disease|5|||
30849202|NCT00706095|58876044|FG002|Overall Study|Progressive Disease|3|||
30849203|NCT00706095|58876042|FG000|Overall Study|Clinical Progression|1|||
30849204|NCT00706095|58876043|FG001|Overall Study|Clinical Progression|2|||
30771197|NCT01400776|58780334|FG002|Overall Study|Reason not Specified|4|||
30771198|NCT01400776|58780335|FG003|Overall Study|Reason not Specified|3|||
30771199|NCT03131596|58780347|FG000|Overall Study|Protocol Violation|3|||
30771200|NCT03131596|58780348|FG001|Overall Study|Protocol Violation|3|||
30771201|NCT03131596|58780347|FG000|Overall Study|Lost to Follow-up|3|||
30771202|NCT03131596|58780348|FG001|Overall Study|Lost to Follow-up|0|||
30771203|NCT00255047|58780362|FG000|Overall Study|Serious Adverse Events|2|||
30771204|NCT00255047|58780363|FG001|Overall Study|Serious Adverse Events|1|||
30771205|NCT00255047|58780364|FG002|Overall Study|Serious Adverse Events|2|||
30771206|NCT00255047|58780365|FG003|Overall Study|Serious Adverse Events|1|||
30771207|NCT00255047|58780362|FG000|Overall Study|Adverse Event|0|||
30771208|NCT00255047|58780363|FG001|Overall Study|Adverse Event|3|||
30849205|NCT00706095|58876044|FG002|Overall Study|Clinical Progression|2|||
30849206|NCT00706095|58876042|FG000|Overall Study|Withdrawal by Subject|1|||
30849207|NCT00706095|58876043|FG001|Overall Study|Withdrawal by Subject|0|||
30849208|NCT00706095|58876044|FG002|Overall Study|Withdrawal by Subject|0|||
30771209|NCT00255047|58780364|FG002|Overall Study|Adverse Event|2|||
30771210|NCT00255047|58780365|FG003|Overall Study|Adverse Event|1|||
30771211|NCT00255047|58780362|FG000|Overall Study|Protocol Violation|13|||
30771212|NCT00255047|58780363|FG001|Overall Study|Protocol Violation|13|||
30771213|NCT00255047|58780364|FG002|Overall Study|Protocol Violation|16|||
30849209|NCT02837731|58876054|FG000|Allocation|Admitted to General Floor|3|||
30849210|NCT02837731|58876055|FG001|Allocation|Admitted to General Floor|4|||
30849211|NCT02837731|58876054|FG000|Allocation|Immediate surgery/withdrew|2|||
30849212|NCT02837731|58876055|FG001|Allocation|Immediate surgery/withdrew|0|||
30849213|NCT02837731|58876054|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
30849214|NCT02837731|58876055|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
30849215|NCT02837731|58876054|FG000|Allocation|Withdrawal by Subject|2|||
30849216|NCT02837731|58876055|FG001|Allocation|Withdrawal by Subject|0|||
30849217|NCT02837731|58876054|FG000|Allocation|Device not available|1|||
30849218|NCT02837731|58876055|FG001|Allocation|Device not available|0|||
30771214|NCT00255047|58780365|FG003|Overall Study|Protocol Violation|20|||
30771215|NCT00255047|58780362|FG000|Overall Study|Lost to Follow-up|9|||
30771216|NCT00255047|58780363|FG001|Overall Study|Lost to Follow-up|8|||
30771217|NCT00255047|58780364|FG002|Overall Study|Lost to Follow-up|5|||
30771218|NCT00255047|58780365|FG003|Overall Study|Lost to Follow-up|6|||
30849219|NCT02837731|58876054|FG000|Allocation|Protocol not implemented|7|||
30849220|NCT02837731|58876055|FG001|Allocation|Protocol not implemented|0|||
30849221|NCT02837731|58876054|FG000|Allocation|Moribund/Do not resuscitate|2|||
30849222|NCT02837731|58876055|FG001|Allocation|Moribund/Do not resuscitate|0|||
30771219|NCT00255047|58780362|FG000|Overall Study|Withdrawal by Subject|24|||
30771220|NCT00255047|58780363|FG001|Overall Study|Withdrawal by Subject|23|||
30771221|NCT00255047|58780364|FG002|Overall Study|Withdrawal by Subject|25|||
30771222|NCT00255047|58780365|FG003|Overall Study|Withdrawal by Subject|18|||
30771223|NCT00225251|58780377|FG000|Overall Study|Withdrawal by Subject|1|||
30771224|NCT00225251|58780378|FG001|Overall Study|Withdrawal by Subject|1|||
30771225|NCT00254501|58780386|FG000|Overall Study|Lost to Follow-up|1|||
30771226|NCT00254501|58780387|FG001|Overall Study|Lost to Follow-up|1|||
30771227|NCT00253643|58780399|FG000|Overall Study|Withdrawal by Subject|0|||
30771228|NCT00253643|58780400|FG001|Overall Study|Withdrawal by Subject|0|||
30771229|NCT00253643|58780401|FG002|Overall Study|Withdrawal by Subject|1|||
30771230|NCT00253643|58780402|FG003|Overall Study|Withdrawal by Subject|1|||
30771231|NCT00253643|58780399|FG000|Overall Study|Non-Compliance|0|||
30771232|NCT00253643|58780400|FG001|Overall Study|Non-Compliance|0|||
30849223|NCT02837731|58876054|FG000|Allocation|Did not meet sepsis criteria|1|||
30849224|NCT02837731|58876055|FG001|Allocation|Did not meet sepsis criteria|2|||
30849225|NCT02837731|58876054|FG000|Allocation|Known aortic abnormalities|0|||
30849226|NCT02837731|58876055|FG001|Allocation|Known aortic abnormalities|1|||
30849227|NCT02836873|58876063|FG000|Overall Study|Protocol Violation|0|||
30849228|NCT02836873|58876064|FG001|Overall Study|Protocol Violation|1|||
30849229|NCT02836873|58876063|FG000|Overall Study|Adverse Event|1|||
30952709|NCT01893905|59001855|FG000|Overall Study|Protocol Violation|6|||
30771233|NCT00253643|58780401|FG002|Overall Study|Non-Compliance|0|||
30771234|NCT00253643|58780402|FG003|Overall Study|Non-Compliance|2|||
30771235|NCT00221195|58780414|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
30771236|NCT00221195|58780415|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
30771237|NCT00221195|58780414|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
30771238|NCT00221195|58780415|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
30771239|NCT00221195|58780414|FG000|Washout Period (Months 7-9)|Death|0|||
30771240|NCT00221195|58780415|FG001|Washout Period (Months 7-9)|Death|1|||
30771241|NCT00221195|58780414|FG000|Therapy 2 (Months 10-15)|Death|1|||
30771242|NCT00221195|58780415|FG001|Therapy 2 (Months 10-15)|Death|0|||
30771243|NCT00221195|58780414|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
30771244|NCT00221195|58780415|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
30771245|NCT00220805|58780424|FG000|Overall Study|Adverse Event|1|||
30771246|NCT00220805|58780425|FG001|Overall Study|Adverse Event|3|||
30771247|NCT00220805|58780424|FG000|Overall Study|Withdrawal by Subject|3|||
30771248|NCT00220805|58780425|FG001|Overall Study|Withdrawal by Subject|0|||
30771249|NCT00220805|58780424|FG000|Overall Study|Lack of Efficacy|1|||
30771250|NCT00220805|58780425|FG001|Overall Study|Lack of Efficacy|0|||
30771251|NCT00220805|58780424|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
30771252|NCT00220805|58780425|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
30952710|NCT01893905|59001856|FG001|Overall Study|Protocol Violation|1|||
30952711|NCT01893905|59001855|FG000|Overall Study|Lack of adherence to treatment|2|||
30771253|NCT00220727|58780433|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
30771254|NCT00220727|58780434|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
30771255|NCT04495816|58780444|FG000|Overall Study|Lost to Follow-up|10|||
30771256|NCT04495816|58780445|FG001|Overall Study|Lost to Follow-up|4|||
30771257|NCT04495816|58780444|FG000|Overall Study|Withdrawal by Subject|3|||
30849230|NCT02836873|58876064|FG001|Overall Study|Adverse Event|4|||
30849231|NCT02836873|58876063|FG000|Overall Study|Withdrawal by Subject|2|||
30849232|NCT02836873|58876064|FG001|Overall Study|Withdrawal by Subject|2|||
30849233|NCT02836873|58876063|FG000|Overall Study|Lost to Follow-up|1|||
30771258|NCT04495816|58780445|FG001|Overall Study|Withdrawal by Subject|5|||
30771259|NCT03971357|58780453|FG000|Overall Study|Lack of Efficacy|0|||
30771260|NCT03971357|58780454|FG001|Overall Study|Lack of Efficacy|1|||
30771261|NCT04310566|58780460|FG000|Period 1|Study Termination due to COVID-19|15|||
30771262|NCT04310566|58780461|FG001|Period 1|Study Termination due to COVID-19|17|||
30771263|NCT04310566|58780460|FG000|Period 1|Protocol Violation|0|||
30771264|NCT04310566|58780461|FG001|Period 1|Protocol Violation|1|||
30771265|NCT04310566|58780460|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
30771266|NCT04310566|58780461|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
30771267|NCT04310566|58780460|FG000|Period 1|Lost to Follow-up|1|||
30771268|NCT04310566|58780461|FG001|Period 1|Lost to Follow-up|0|||
30771269|NCT04310566|58780460|FG000|Period 1|Withdrawal by Subject|0|||
30771270|NCT04310566|58780461|FG001|Period 1|Withdrawal by Subject|1|||
30771271|NCT04310566|58780460|FG000|Period 2|Study Termination|7|||
30771272|NCT04310566|58780461|FG001|Period 2|Study Termination|5|||
30771273|NCT00252239|58780471|FG000|Overall Study|Withdrawal by Subject|1|||
30771274|NCT00252239|58780472|FG001|Overall Study|Withdrawal by Subject|0|||
30771275|NCT00252239|58780473|FG002|Overall Study|Withdrawal by Subject|0|||
30771276|NCT00252239|58780474|FG003|Overall Study|Withdrawal by Subject|1|||
30771277|NCT00252239|58780471|FG000|Overall Study|Lost to Follow-up|0|||
30771278|NCT00252239|58780472|FG001|Overall Study|Lost to Follow-up|0|||
30771279|NCT00252239|58780473|FG002|Overall Study|Lost to Follow-up|2|||
30771280|NCT00252239|58780474|FG003|Overall Study|Lost to Follow-up|0|||
30771281|NCT03103906|58780486|FG000|Overall Study|Adverse Event|2|||
30771282|NCT03103906|58780487|FG001|Overall Study|Adverse Event|3|||
30771283|NCT03103906|58780486|FG000|Overall Study|Other|2|||
30771284|NCT03103906|58780487|FG001|Overall Study|Other|0|||
30771285|NCT04799158|58780497|FG000|Run-In Period|Adverse Event|6|||
30771286|NCT04799158|58780498|FG001|Run-In Period|Adverse Event|0|||
30771287|NCT04799158|58780499|FG002|Run-In Period|Adverse Event|0|||
30771288|NCT04799158|58780500|FG003|Run-In Period|Adverse Event|0|||
30771289|NCT04799158|58780501|FG004|Run-In Period|Adverse Event|0|||
30771290|NCT04799158|58780497|FG000|Run-In Period|Lost to Follow-up|4|||
30771291|NCT04799158|58780498|FG001|Run-In Period|Lost to Follow-up|0|||
30771292|NCT04799158|58780499|FG002|Run-In Period|Lost to Follow-up|0|||
30771293|NCT04799158|58780500|FG003|Run-In Period|Lost to Follow-up|0|||
30771294|NCT04799158|58780501|FG004|Run-In Period|Lost to Follow-up|0|||
30771295|NCT04799158|58780497|FG000|Run-In Period|Significant Protocol Deviation|1|||
30771296|NCT04799158|58780498|FG001|Run-In Period|Significant Protocol Deviation|0|||
30771297|NCT04799158|58780499|FG002|Run-In Period|Significant Protocol Deviation|0|||
30771298|NCT04799158|58780500|FG003|Run-In Period|Significant Protocol Deviation|0|||
30771299|NCT04799158|58780501|FG004|Run-In Period|Significant Protocol Deviation|0|||
30771300|NCT04799158|58780497|FG000|Run-In Period|Withdrawal by Subject|11|||
30771301|NCT04799158|58780498|FG001|Run-In Period|Withdrawal by Subject|0|||
30771302|NCT04799158|58780499|FG002|Run-In Period|Withdrawal by Subject|0|||
30771303|NCT04799158|58780500|FG003|Run-In Period|Withdrawal by Subject|0|||
30771304|NCT04799158|58780501|FG004|Run-In Period|Withdrawal by Subject|0|||
30771305|NCT04799158|58780497|FG000|Run-In Period|Miscellaneous|3|||
30771306|NCT04799158|58780498|FG001|Run-In Period|Miscellaneous|0|||
30771307|NCT04799158|58780499|FG002|Run-In Period|Miscellaneous|0|||
30771308|NCT04799158|58780500|FG003|Run-In Period|Miscellaneous|0|||
30771309|NCT04799158|58780501|FG004|Run-In Period|Miscellaneous|0|||
30771310|NCT04799158|58780497|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
30771311|NCT04799158|58780498|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
30771312|NCT04799158|58780499|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
30771313|NCT04799158|58780500|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
30771314|NCT04799158|58780501|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
30771315|NCT04799158|58780497|FG000|On-Demand Treatment Period|Adverse Event|0|||
30771316|NCT04799158|58780498|FG001|On-Demand Treatment Period|Adverse Event|1|||
30771317|NCT04799158|58780499|FG002|On-Demand Treatment Period|Adverse Event|0|||
30771318|NCT04799158|58780500|FG003|On-Demand Treatment Period|Adverse Event|0|||
30771319|NCT04799158|58780501|FG004|On-Demand Treatment Period|Adverse Event|1|||
30771320|NCT04799158|58780497|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
30771321|NCT04799158|58780498|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
30771322|NCT04799158|58780499|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
30771323|NCT04799158|58780500|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
30771324|NCT04799158|58780501|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
30771325|NCT04799158|58780497|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
30771326|NCT04799158|58780498|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
30771327|NCT04799158|58780499|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
30771328|NCT04799158|58780500|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
30771329|NCT04799158|58780501|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
30771330|NCT04799158|58780497|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
30771331|NCT04799158|58780498|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
30771332|NCT04799158|58780499|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
30771333|NCT04799158|58780500|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
30771334|NCT04799158|58780501|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
30771335|NCT04799158|58780497|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
30771336|NCT04799158|58780498|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
30771337|NCT04799158|58780499|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
30771338|NCT04799158|58780500|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
30771339|NCT04799158|58780501|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
30771340|NCT04799158|58780497|FG000|On-Demand Treatment Period|Miscellaneous|0|||
30771341|NCT04799158|58780498|FG001|On-Demand Treatment Period|Miscellaneous|0|||
30771342|NCT04799158|58780499|FG002|On-Demand Treatment Period|Miscellaneous|0|||
30771343|NCT04799158|58780500|FG003|On-Demand Treatment Period|Miscellaneous|0|||
30771344|NCT04799158|58780501|FG004|On-Demand Treatment Period|Miscellaneous|1|||
30771345|NCT01319422|58780514|FG000|Overall Study|Withdrawal by Subject|1|||
30771346|NCT01319422|58780515|FG001|Overall Study|Withdrawal by Subject|0|||
30771347|NCT03102034|58780523|FG000|Overall Study|Withdrawal by Subject|1|||
30771348|NCT03102034|58780524|FG001|Overall Study|Withdrawal by Subject|0|||
30771349|NCT03774576|58780530|FG000|Period 2|Adverse Event|1|||
30771350|NCT02928952|58780541|FG000|Overall Study|Lost to Follow-up|5|||
30771351|NCT02928952|58780542|FG001|Overall Study|Lost to Follow-up|5|||
30771352|NCT02928952|58780541|FG000|Overall Study|Withdrawal by Subject|5|||
30771353|NCT02928952|58780542|FG001|Overall Study|Withdrawal by Subject|1|||
30771354|NCT02928952|58780541|FG000|Overall Study|Physician Decision|0|||
30771355|NCT02928952|58780542|FG001|Overall Study|Physician Decision|1|||
30771356|NCT03773796|58780548|FG000|Overall Study|Adverse Event|1|||
30771357|NCT03773796|58780548|FG000|Overall Study|Withdrawal by Subject|1|||
30771358|NCT03773796|58780548|FG000|Overall Study|Lack of Efficacy|1|||
30771359|NCT02927938|58780556|FG000|Overall Study|Death|0|||
30771360|NCT02927938|58780557|FG001|Overall Study|Death|1|||
30771361|NCT02927938|58780558|FG002|Overall Study|Death|0|||
30771362|NCT02927938|58780559|FG003|Overall Study|Death|4|||
30771363|NCT02927938|58780556|FG000|Overall Study|Early Study Termination|1|||
30771364|NCT02927938|58780557|FG001|Overall Study|Early Study Termination|5|||
30771365|NCT02927938|58780558|FG002|Overall Study|Early Study Termination|4|||
30771366|NCT02927938|58780559|FG003|Overall Study|Early Study Termination|3|||
30771367|NCT03765138|58780567|FG000|Overall Study|Lost to Follow-up|1|||
30771368|NCT03768726|58780574|FG000|Treatment Phase|Adverse Event|2|||
30771369|NCT03768726|58780575|FG001|Treatment Phase|Adverse Event|2|||
30771370|NCT03768726|58780574|FG000|Treatment Phase|Lost to Follow-up|1|||
30771371|NCT03768726|58780575|FG001|Treatment Phase|Lost to Follow-up|0|||
30771372|NCT03768726|58780574|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
30771373|NCT03768726|58780575|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
30771374|NCT03768726|58780574|FG000|Treatment Phase|Withdrawal by Subject|3|||
30771375|NCT03768726|58780575|FG001|Treatment Phase|Withdrawal by Subject|1|||
30771376|NCT03768726|58780574|FG000|Follow-Up|Adverse Event|2|||
30771377|NCT03768726|58780575|FG001|Follow-Up|Adverse Event|2|||
30771378|NCT03768726|58780574|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
30771379|NCT03768726|58780575|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
30771380|NCT03768726|58780574|FG000|Follow-Up|Withdrawal by Subject|2|||
30849234|NCT02836873|58876064|FG001|Overall Study|Lost to Follow-up|3|||
30849235|NCT02836873|58876063|FG000|Overall Study|Physician Decision|0|||
30771381|NCT03768726|58780575|FG001|Follow-Up|Withdrawal by Subject|0|||
30771382|NCT03768726|58780574|FG000|Follow-Up|Other|1|||
30771383|NCT03768726|58780575|FG001|Follow-Up|Other|0|||
30771384|NCT03769896|58780583|FG000|Open-label Phase|Lack of Efficacy|5|||
30771385|NCT03769896|58780584|FG001|Open-label Phase|Lack of Efficacy|0|||
30771386|NCT03769896|58780583|FG000|Open-label Phase|Adverse Event|3|||
30771387|NCT03769896|58780584|FG001|Open-label Phase|Adverse Event|0|||
30771388|NCT03769896|58780583|FG000|Open-label Phase|Withdrawal by Subject|1|||
30771389|NCT03769896|58780584|FG001|Open-label Phase|Withdrawal by Subject|0|||
30771390|NCT05047601|58780594|FG000|Overall Study|Lost to Follow-up|9|||
30771391|NCT05047601|58780595|FG001|Overall Study|Lost to Follow-up|11|||
30771392|NCT05047601|58780596|FG002|Overall Study|Lost to Follow-up|7|||
30771393|NCT05047601|58780594|FG000|Overall Study|Withdrawal by Subject|25|||
30771394|NCT05047601|58780595|FG001|Overall Study|Withdrawal by Subject|36|||
30771395|NCT05047601|58780596|FG002|Overall Study|Withdrawal by Subject|23|||
30771396|NCT05047601|58780594|FG000|Overall Study|Other|10|||
30771397|NCT05047601|58780595|FG001|Overall Study|Other|6|||
30952712|NCT01893905|59001856|FG001|Overall Study|Lack of adherence to treatment|0|||
30952713|NCT01893905|59001855|FG000|Overall Study|Other reason|1|||
30771398|NCT05047601|58780596|FG002|Overall Study|Other|5|||
30771399|NCT04658784|58780610|FG000|6-month Follow-up|Lost to Follow-up|2|||
30771400|NCT04658784|58780611|FG001|6-month Follow-up|Lost to Follow-up|5|||
30771401|NCT04606394|58780617|FG000|Overall Study|Withdrawal by Subject|3|||
30771402|NCT04606394|58780617|FG000|Overall Study|Exclusion criteria screen failure|12|||
30771403|NCT04585451|58780631|FG000|Overall Study|Withdrawal by Subject|26|||
30771404|NCT04585451|58780632|FG001|Overall Study|Withdrawal by Subject|0|||
30771405|NCT04576988|58780639|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
30771406|NCT04576988|58780640|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
30771407|NCT04576988|58780639|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
30771408|NCT04576988|58780640|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
30771409|NCT04576988|58780639|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
30771410|NCT04576988|58780640|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
30771411|NCT04576988|58780639|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
30771412|NCT04576988|58780640|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
30771413|NCT04576988|58780639|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
30771414|NCT04576988|58780640|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
30771415|NCT04576988|58780639|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
30849236|NCT02836873|58876064|FG001|Overall Study|Physician Decision|1|||
30849237|NCT02836873|58876063|FG000|Overall Study|Other|1|||
30849238|NCT02836873|58876064|FG001|Overall Study|Other|0|||
30849239|NCT01342081|58876082|FG000|Overall Study|Did not receive allocated intervention|0|||
30849240|NCT01342081|58876083|FG001|Overall Study|Did not receive allocated intervention|0|||
30771416|NCT04576988|58780640|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
30771417|NCT04576988|58780639|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
30771418|NCT04576988|58780640|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
30771419|NCT04576988|58780639|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
30771420|NCT04576988|58780640|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
30771421|NCT04576988|58780639|FG000|Long Term Double Blind (LTDB)|Death|2|||
30771422|NCT04576988|58780640|FG001|Long Term Double Blind (LTDB)|Death|1|||
30771423|NCT04576988|58780639|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
30771424|NCT04576988|58780640|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
30771425|NCT04362189|58780672|FG000|Overall Study|Lost to Follow-up|0|||
30771426|NCT04362189|58780673|FG001|Overall Study|Lost to Follow-up|1|||
30771427|NCT04362189|58780672|FG000|Overall Study|Withdrawal by Subject|1|||
30771428|NCT04362189|58780673|FG001|Overall Study|Withdrawal by Subject|0|||
30771429|NCT04362189|58780672|FG000|Overall Study|FDA Clinical Hold|7|||
30771430|NCT04362189|58780673|FG001|Overall Study|FDA Clinical Hold|2|||
30771431|NCT04362189|58780672|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
30771432|NCT04362189|58780673|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
30771433|NCT04362189|58780672|FG000|Overall Study|Adverse Event|0|||
30771434|NCT04362189|58780673|FG001|Overall Study|Adverse Event|2|||
30849241|NCT01342081|58876084|FG002|Overall Study|Did not receive allocated intervention|1|||
30849242|NCT01342081|58876082|FG000|Overall Study|Adverse Event|1|||
30849243|NCT01342081|58876083|FG001|Overall Study|Adverse Event|0|||
30849244|NCT01342081|58876084|FG002|Overall Study|Adverse Event|0|||
30849245|NCT01342081|58876082|FG000|Overall Study|Physician Decision|0|||
30849246|NCT01342081|58876083|FG001|Overall Study|Physician Decision|1|||
30849247|NCT01342081|58876084|FG002|Overall Study|Physician Decision|0|||
30849248|NCT01342081|58876082|FG000|Overall Study|Withdrawal by Subject|1|||
30849249|NCT01342081|58876083|FG001|Overall Study|Withdrawal by Subject|1|||
30849250|NCT01342081|58876084|FG002|Overall Study|Withdrawal by Subject|0|||
30849251|NCT01341457|58876094|FG000|Overall Study|Adverse Event|2|||
30952714|NCT01893905|59001856|FG001|Overall Study|Other reason|3|||
30771435|NCT04362189|58780672|FG000|Overall Study|Death|4|||
30771436|NCT04362189|58780673|FG001|Overall Study|Death|1|||
30771437|NCT04181788|58780747|FG000|TREATMENT|Adverse Event|0|||
30771438|NCT04181788|58780748|FG001|TREATMENT|Adverse Event|2|||
30771439|NCT04181788|58780749|FG002|TREATMENT|Adverse Event|1|||
30771440|NCT04181788|58780750|FG003|TREATMENT|Adverse Event|0|||
30771441|NCT04181788|58780751|FG004|TREATMENT|Adverse Event|1|||
30771442|NCT04181788|58780752|FG005|TREATMENT|Adverse Event|3|||
30771443|NCT04181788|58780747|FG000|TREATMENT|Death|0|||
30771444|NCT04181788|58780748|FG001|TREATMENT|Death|0|||
30771445|NCT04181788|58780749|FG002|TREATMENT|Death|0|||
30771446|NCT04181788|58780750|FG003|TREATMENT|Death|0|||
30771447|NCT04181788|58780751|FG004|TREATMENT|Death|8|||
30771448|NCT04181788|58780752|FG005|TREATMENT|Death|8|||
30771449|NCT04181788|58780747|FG000|TREATMENT|Physician Decision|0|||
30771450|NCT04181788|58780748|FG001|TREATMENT|Physician Decision|0|||
30771451|NCT04181788|58780749|FG002|TREATMENT|Physician Decision|0|||
30849252|NCT01341457|58876095|FG001|Overall Study|Adverse Event|0|||
30849253|NCT02832037|58876107|FG000|Overall Study|Administrative reasons|0|||
30849254|NCT02832037|58876108|FG001|Overall Study|Administrative reasons|0|||
30771452|NCT04181788|58780750|FG003|TREATMENT|Physician Decision|0|||
30771453|NCT04181788|58780751|FG004|TREATMENT|Physician Decision|0|||
30771454|NCT04181788|58780752|FG005|TREATMENT|Physician Decision|1|||
30771455|NCT04181788|58780747|FG000|TREATMENT|Progressive disease|3|||
30771456|NCT04181788|58780748|FG001|TREATMENT|Progressive disease|3|||
30849255|NCT02832037|58876109|FG002|Overall Study|Administrative reasons|1|||
30849256|NCT02832037|58876110|FG003|Overall Study|Administrative reasons|0|||
30771457|NCT04181788|58780749|FG002|TREATMENT|Progressive disease|5|||
30849257|NCT02832037|58876111|FG004|Overall Study|Administrative reasons|0|||
30849258|NCT02832037|58876107|FG000|Overall Study|Protocol Violation|3|||
30849259|NCT02832037|58876108|FG001|Overall Study|Protocol Violation|0|||
30849260|NCT02832037|58876109|FG002|Overall Study|Protocol Violation|4|||
30849261|NCT02832037|58876110|FG003|Overall Study|Protocol Violation|1|||
30849262|NCT02832037|58876111|FG004|Overall Study|Protocol Violation|2|||
30849263|NCT02832037|58876107|FG000|Overall Study|Lost to Follow-up|2|||
30849264|NCT02832037|58876108|FG001|Overall Study|Lost to Follow-up|0|||
30849265|NCT02832037|58876109|FG002|Overall Study|Lost to Follow-up|3|||
30849266|NCT02832037|58876110|FG003|Overall Study|Lost to Follow-up|0|||
30849267|NCT02832037|58876111|FG004|Overall Study|Lost to Follow-up|5|||
30849268|NCT02832037|58876107|FG000|Overall Study|Withdrawal by Subject|9|||
30849269|NCT02832037|58876108|FG001|Overall Study|Withdrawal by Subject|8|||
30849270|NCT02832037|58876109|FG002|Overall Study|Withdrawal by Subject|0|||
30849271|NCT02832037|58876110|FG003|Overall Study|Withdrawal by Subject|4|||
30849272|NCT02832037|58876111|FG004|Overall Study|Withdrawal by Subject|8|||
30849273|NCT02832037|58876107|FG000|Overall Study|Adverse Event|5|||
30849274|NCT02832037|58876108|FG001|Overall Study|Adverse Event|4|||
30849275|NCT02832037|58876109|FG002|Overall Study|Adverse Event|0|||
30849276|NCT02832037|58876110|FG003|Overall Study|Adverse Event|2|||
30849277|NCT02832037|58876111|FG004|Overall Study|Adverse Event|4|||
30849278|NCT01675154|58876127|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
30952715|NCT01893827|59001869|FG000|Overall Study|Lost to Follow-up|19|||
30771458|NCT04181788|58780750|FG003|TREATMENT|Progressive disease|7|||
30771459|NCT04181788|58780751|FG004|TREATMENT|Progressive disease|20|||
30771460|NCT04181788|58780752|FG005|TREATMENT|Progressive disease|38|||
30771461|NCT04181788|58780747|FG000|TREATMENT|Global deterioration of health status|0|||
30771462|NCT04181788|58780748|FG001|TREATMENT|Global deterioration of health status|2|||
30771463|NCT04181788|58780749|FG002|TREATMENT|Global deterioration of health status|0|||
30771464|NCT04181788|58780750|FG003|TREATMENT|Global deterioration of health status|0|||
30771465|NCT04181788|58780751|FG004|TREATMENT|Global deterioration of health status|2|||
30771466|NCT04181788|58780752|FG005|TREATMENT|Global deterioration of health status|8|||
30771467|NCT04181788|58780747|FG000|TREATMENT|Withdrawal by Subject|1|||
30771468|NCT04181788|58780748|FG001|TREATMENT|Withdrawal by Subject|2|||
30771469|NCT04181788|58780749|FG002|TREATMENT|Withdrawal by Subject|0|||
30771470|NCT04181788|58780750|FG003|TREATMENT|Withdrawal by Subject|0|||
30771471|NCT04181788|58780751|FG004|TREATMENT|Withdrawal by Subject|3|||
30849279|NCT01675154|58876128|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
30662041|NCT03382561|58675307|FG001|Overall Study|Other complicating disease|1|||
30662042|NCT03274895|58675324|FG000|Overall Study|Lack of Efficacy|1|||
30662043|NCT03274895|58675325|FG001|Overall Study|Lack of Efficacy|0|||
30662044|NCT03274895|58675324|FG000|Overall Study|Adverse Event|8|||
30662045|NCT03274895|58675325|FG001|Overall Study|Adverse Event|7|||
30662046|NCT03274895|58675324|FG000|Overall Study|Lost to Follow-up|1|||
30662047|NCT03274895|58675325|FG001|Overall Study|Lost to Follow-up|0|||
30662048|NCT03274895|58675324|FG000|Overall Study|Diagnosis not confirmed|3|||
30662049|NCT03274895|58675325|FG001|Overall Study|Diagnosis not confirmed|4|||
30662050|NCT03035201|58675347|FG000|Overall Study|Death|9|||
30662051|NCT03035201|58675348|FG001|Overall Study|Death|12|||
30662052|NCT03035201|58675349|FG002|Overall Study|Death|9|||
30662053|NCT03035201|58675350|FG003|Overall Study|Death|10|||
30662054|NCT03035201|58675347|FG000|Overall Study|Withdrawal by Subject|51|||
30662055|NCT03035201|58675348|FG001|Overall Study|Withdrawal by Subject|49|||
30662056|NCT03035201|58675349|FG002|Overall Study|Withdrawal by Subject|37|||
30662057|NCT03035201|58675350|FG003|Overall Study|Withdrawal by Subject|46|||
30662058|NCT03035201|58675347|FG000|Overall Study|Lost to Follow-up|67|||
30662059|NCT03035201|58675348|FG001|Overall Study|Lost to Follow-up|51|||
30662060|NCT03035201|58675349|FG002|Overall Study|Lost to Follow-up|64|||
30662061|NCT03035201|58675350|FG003|Overall Study|Lost to Follow-up|69|||
30662062|NCT02969915|58675372|FG000|Overall Study|Death|104|||
30662063|NCT02969915|58675373|FG001|Overall Study|Death|125|||
30662064|NCT02969915|58675372|FG000|Overall Study|Lost to Follow-up|108|||
30662065|NCT02969915|58675373|FG001|Overall Study|Lost to Follow-up|112|||
30662066|NCT02969915|58675372|FG000|Overall Study|Censored due to COVID-19|481|||
30849280|NCT01675154|58876129|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
30662067|NCT02969915|58675373|FG001|Overall Study|Censored due to COVID-19|471|||
30662068|NCT02906332|58675379|FG000|Overall Study|Withdrawal by Subject|1|||
30662069|NCT02827877|58675402|FG000|Overall Study|Withdrawal by Subject|1|||
30849281|NCT01675154|58876130|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
30849282|NCT02744755|58876154|FG000|Study Period 1|Protocol Violation|2|||
30662070|NCT02755597|58675408|FG000|Overall Study|Withdrew consent|27|||
30662071|NCT02755597|58675409|FG001|Overall Study|Withdrew consent|11|||
30662072|NCT02755597|58675408|FG000|Overall Study|Lost to Follow-up|1|||
30662073|NCT02755597|58675409|FG001|Overall Study|Lost to Follow-up|0|||
30771472|NCT04181788|58780752|FG005|TREATMENT|Withdrawal by Subject|5|||
30771473|NCT04181788|58780747|FG000|TREATMENT|Other unspecified|0|||
30662074|NCT02755597|58675408|FG000|Overall Study|Death|78|||
30662075|NCT02755597|58675409|FG001|Overall Study|Death|36|||
30662076|NCT02755597|58675408|FG000|Overall Study|Study terminated by Sponsor|67|||
30662077|NCT02755597|58675409|FG001|Overall Study|Study terminated by Sponsor|47|||
30662078|NCT02755597|58675408|FG000|Overall Study|Other, not specified|20|||
30771474|NCT04181788|58780748|FG001|TREATMENT|Other unspecified|0|||
30771475|NCT04181788|58780749|FG002|TREATMENT|Other unspecified|0|||
30771476|NCT04181788|58780750|FG003|TREATMENT|Other unspecified|0|||
30771477|NCT04181788|58780751|FG004|TREATMENT|Other unspecified|0|||
30771478|NCT04181788|58780752|FG005|TREATMENT|Other unspecified|2|||
30771479|NCT04181788|58780747|FG000|TREATMENT|Ongoing|0|||
30771480|NCT04181788|58780748|FG001|TREATMENT|Ongoing|3|||
30771481|NCT04181788|58780749|FG002|TREATMENT|Ongoing|0|||
30771482|NCT04181788|58780750|FG003|TREATMENT|Ongoing|5|||
30771483|NCT04181788|58780751|FG004|TREATMENT|Ongoing|7|||
30771484|NCT04181788|58780752|FG005|TREATMENT|Ongoing|15|||
30771485|NCT04181788|58780747|FG000|FOLLOW-UP|Death|0|||
30771486|NCT04181788|58780748|FG001|FOLLOW-UP|Death|0|||
30771487|NCT04181788|58780749|FG002|FOLLOW-UP|Death|1|||
30771488|NCT04181788|58780750|FG003|FOLLOW-UP|Death|2|||
30771489|NCT04181788|58780751|FG004|FOLLOW-UP|Death|8|||
30771490|NCT04181788|58780752|FG005|FOLLOW-UP|Death|20|||
30771491|NCT04181788|58780747|FG000|FOLLOW-UP|Lost to Follow-up|0|||
30771492|NCT04181788|58780748|FG001|FOLLOW-UP|Lost to Follow-up|0|||
30771493|NCT04181788|58780749|FG002|FOLLOW-UP|Lost to Follow-up|0|||
30771494|NCT04181788|58780750|FG003|FOLLOW-UP|Lost to Follow-up|0|||
30771495|NCT04181788|58780751|FG004|FOLLOW-UP|Lost to Follow-up|0|||
30771496|NCT04181788|58780752|FG005|FOLLOW-UP|Lost to Follow-up|2|||
30771497|NCT04181788|58780747|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
30771498|NCT04181788|58780748|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
30771499|NCT04181788|58780749|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
30771500|NCT04181788|58780750|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
30771501|NCT04181788|58780751|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
30771502|NCT04181788|58780752|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
30771503|NCT04181788|58780747|FG000|FOLLOW-UP|Other unspecified|0|||
30771504|NCT04181788|58780748|FG001|FOLLOW-UP|Other unspecified|1|||
30771505|NCT04181788|58780749|FG002|FOLLOW-UP|Other unspecified|0|||
30771506|NCT04181788|58780750|FG003|FOLLOW-UP|Other unspecified|0|||
30771507|NCT04181788|58780751|FG004|FOLLOW-UP|Other unspecified|0|||
30771508|NCT04181788|58780752|FG005|FOLLOW-UP|Other unspecified|3|||
30771509|NCT04181788|58780747|FG000|FOLLOW-UP|Ongoing|0|||
30771510|NCT04181788|58780748|FG001|FOLLOW-UP|Ongoing|0|||
30771511|NCT04181788|58780749|FG002|FOLLOW-UP|Ongoing|1|||
30771512|NCT04181788|58780750|FG003|FOLLOW-UP|Ongoing|3|||
30771513|NCT04181788|58780751|FG004|FOLLOW-UP|Ongoing|2|||
30771514|NCT04181788|58780752|FG005|FOLLOW-UP|Ongoing|2|||
30771515|NCT04120194|58780775|FG000|Overall Study|Lost to Follow-up|11|||
30771516|NCT04120194|58780776|FG001|Overall Study|Lost to Follow-up|8|||
30771517|NCT04120194|58780775|FG000|Overall Study|Adverse Event|4|||
30771518|NCT04120194|58780776|FG001|Overall Study|Adverse Event|5|||
30771519|NCT04120194|58780775|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
30771520|NCT04120194|58780776|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
30771521|NCT04120194|58780775|FG000|Overall Study|Miscellaneous|4|||
30771522|NCT04120194|58780776|FG001|Overall Study|Miscellaneous|5|||
30771523|NCT04050670|58780782|FG000|Period 3|Physician Decision|0|||
30771524|NCT04050670|58780783|FG001|Period 3|Physician Decision|1|||
30771525|NCT04050670|58780784|FG002|Period 3|Physician Decision|0|||
30771526|NCT04016714|58780807|FG000|Overall Study|Death|1|||
30771527|NCT04016714|58780808|FG001|Overall Study|Death|0|||
30771528|NCT04016714|58780807|FG000|Overall Study|Lost to Follow-up|3|||
30771529|NCT04016714|58780808|FG001|Overall Study|Lost to Follow-up|1|||
30771530|NCT04016714|58780807|FG000|Overall Study|Physician Decision|3|||
30771531|NCT04016714|58780808|FG001|Overall Study|Physician Decision|3|||
30771532|NCT04016714|58780807|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
30771533|NCT04016714|58780808|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
30771534|NCT03997409|58780817|FG000|Overall Study|Protocol Violation|1|||
30771535|NCT03997409|58780818|FG001|Overall Study|Protocol Violation|1|||
30771536|NCT03997409|58780819|FG002|Overall Study|Protocol Violation|0|||
30771537|NCT03997409|58780817|FG000|Overall Study|Withdrawal by Subject|3|||
30662079|NCT02755597|58675409|FG001|Overall Study|Other, not specified|3|||
30771538|NCT03997409|58780818|FG001|Overall Study|Withdrawal by Subject|0|||
30771539|NCT03997409|58780819|FG002|Overall Study|Withdrawal by Subject|0|||
30771540|NCT03997409|58780817|FG000|Overall Study|Lost to Follow-up|0|||
30771541|NCT03997409|58780818|FG001|Overall Study|Lost to Follow-up|0|||
30771542|NCT03997409|58780819|FG002|Overall Study|Lost to Follow-up|1|||
30771543|NCT03946124|58780827|FG000|Overall Study|Withdrawal by Subject|19|||
30771544|NCT03812029|58780836|FG000|Overall Study|Protocol Violation|1|||
30771545|NCT03812029|58780837|FG001|Overall Study|Protocol Violation|0|||
30771546|NCT03812029|58780838|FG002|Overall Study|Protocol Violation|0|||
30771547|NCT03812029|58780839|FG003|Overall Study|Protocol Violation|1|||
30771548|NCT03812029|58780840|FG004|Overall Study|Protocol Violation|0|||
30771549|NCT03812029|58780836|FG000|Overall Study|Withdrawal by Subject|1|||
30771550|NCT03812029|58780837|FG001|Overall Study|Withdrawal by Subject|0|||
30771551|NCT03812029|58780838|FG002|Overall Study|Withdrawal by Subject|0|||
30771552|NCT03812029|58780839|FG003|Overall Study|Withdrawal by Subject|2|||
30771553|NCT03812029|58780840|FG004|Overall Study|Withdrawal by Subject|2|||
30771554|NCT03812029|58780836|FG000|Overall Study|Stopping rules|0|||
30771555|NCT03812029|58780837|FG001|Overall Study|Stopping rules|1|||
30771556|NCT03812029|58780838|FG002|Overall Study|Stopping rules|0|||
30771557|NCT03812029|58780839|FG003|Overall Study|Stopping rules|0|||
30771558|NCT03812029|58780840|FG004|Overall Study|Stopping rules|0|||
30771559|NCT03812029|58780836|FG000|Overall Study|Adverse Event|0|||
30771560|NCT03812029|58780837|FG001|Overall Study|Adverse Event|9|||
30771561|NCT03812029|58780838|FG002|Overall Study|Adverse Event|0|||
30771562|NCT03812029|58780839|FG003|Overall Study|Adverse Event|3|||
30771563|NCT03812029|58780840|FG004|Overall Study|Adverse Event|5|||
30771564|NCT03812029|58780836|FG000|Overall Study|Lost to Follow-up|0|||
30771565|NCT03812029|58780837|FG001|Overall Study|Lost to Follow-up|0|||
30771566|NCT03812029|58780838|FG002|Overall Study|Lost to Follow-up|0|||
30771567|NCT03812029|58780839|FG003|Overall Study|Lost to Follow-up|0|||
30771568|NCT03812029|58780840|FG004|Overall Study|Lost to Follow-up|3|||
30771569|NCT03747575|58780858|FG000|Overall Study|Withdrawal by Subject|6|||
30771570|NCT03747575|58780859|FG001|Overall Study|Withdrawal by Subject|3|||
30771571|NCT03747575|58780858|FG000|Overall Study|Lost to Follow-up|3|||
30771572|NCT03747575|58780859|FG001|Overall Study|Lost to Follow-up|3|||
30771573|NCT03747575|58780858|FG000|Overall Study|Adverse Event|0|||
30771574|NCT03747575|58780859|FG001|Overall Study|Adverse Event|1|||
30771575|NCT03657043|58780868|FG000|Overall Study|Withdrawal by Subject|1|||
30771576|NCT03657043|58780869|FG001|Overall Study|Withdrawal by Subject|1|||
30771577|NCT03657043|58780870|FG002|Overall Study|Withdrawal by Subject|0|||
30771578|NCT03657043|58780871|FG003|Overall Study|Withdrawal by Subject|0|||
30771579|NCT03657043|58780872|FG004|Overall Study|Withdrawal by Subject|4|||
30771580|NCT03657043|58780868|FG000|Overall Study|Study closure by Sponsor|0|||
30849283|NCT02744755|58876155|FG001|Study Period 1|Protocol Violation|1|||
30849284|NCT02744755|58876154|FG000|Study Period 1|not defined|0|||
30849285|NCT02744755|58876155|FG001|Study Period 1|not defined|1|||
30849286|NCT02744755|58876154|FG000|Study Period 1|Pregnancy|1|||
30849287|NCT02744755|58876155|FG001|Study Period 1|Pregnancy|0|||
30849288|NCT02744755|58876154|FG000|Study Period 1|Adverse Event|1|||
30849289|NCT02744755|58876155|FG001|Study Period 1|Adverse Event|1|||
30849290|NCT02744755|58876154|FG000|Study Period 1|Lost to Follow-up|1|||
30849291|NCT02744755|58876155|FG001|Study Period 1|Lost to Follow-up|1|||
30849292|NCT02744755|58876154|FG000|Study Period 1|Lack of Efficacy|1|||
30849293|NCT02744755|58876155|FG001|Study Period 1|Lack of Efficacy|0|||
30849294|NCT02744755|58876154|FG000|Study Period 1|Withdrawal by Subject|8|||
30849295|NCT02744755|58876155|FG001|Study Period 1|Withdrawal by Subject|4|||
30849296|NCT02744755|58876154|FG000|Study Period 2|Adverse Event|5|||
30849297|NCT02744755|58876155|FG001|Study Period 2|Adverse Event|0|||
30849298|NCT02744755|58876154|FG000|Study Period 2|Protocol Violation|1|||
30849299|NCT02744755|58876155|FG001|Study Period 2|Protocol Violation|0|||
30849300|NCT02744755|58876154|FG000|Study Period 2|not defined|3|||
30849301|NCT02744755|58876155|FG001|Study Period 2|not defined|2|||
30849302|NCT02744755|58876154|FG000|Study Period 2|Lost to Follow-up|0|||
30849303|NCT02744755|58876155|FG001|Study Period 2|Lost to Follow-up|2|||
30849304|NCT02744755|58876154|FG000|Study Period 2|Withdrawal by Subject|2|||
30849305|NCT02744755|58876155|FG001|Study Period 2|Withdrawal by Subject|2|||
30849306|NCT02744755|58876154|FG000|Study Period 2|Lack of Efficacy|3|||
30849307|NCT02744755|58876155|FG001|Study Period 2|Lack of Efficacy|2|||
30849308|NCT01356589|58876173|FG000|Overall Study|Enrolled, but not treated|3|||
30849309|NCT01356589|58876173|FG000|Overall Study|Dose data not recorded|2|||
30849310|NCT02830087|58876183|FG000|Overall Study|No study staff to follow-up patients|4|||
30849311|NCT02830087|58876184|FG001|Overall Study|No study staff to follow-up patients|4|||
30849312|NCT02830087|58876185|FG002|Overall Study|No study staff to follow-up patients|4|||
30849313|NCT02830087|58876186|FG003|Overall Study|No study staff to follow-up patients|3|||
30849314|NCT02830087|58876187|FG004|Overall Study|No study staff to follow-up patients|3|||
30849315|NCT02830087|58876188|FG005|Overall Study|No study staff to follow-up patients|3|||
30849316|NCT02829775|58876202|FG000|Overall Study|Death|1|||
30849317|NCT02829775|58876202|FG000|Overall Study|Withdrawal by Subject|3|||
30849318|NCT02829775|58876202|FG000|Overall Study|Disease remission|1|||
30849319|NCT01355497|58876223|FG000|Overall Study|Death|19|||
30849320|NCT01355497|58876224|FG001|Overall Study|Death|18|||
30849321|NCT01355497|58876223|FG000|Overall Study|Lost to Follow-up|3|||
30849322|NCT01355497|58876224|FG001|Overall Study|Lost to Follow-up|0|||
30849323|NCT01355497|58876223|FG000|Overall Study|Protocol Violation|0|||
30849324|NCT01355497|58876224|FG001|Overall Study|Protocol Violation|1|||
30849325|NCT01355497|58876223|FG000|Overall Study|other-not provided|9|||
30849326|NCT01355497|58876224|FG001|Overall Study|other-not provided|4|||
30849327|NCT01355497|58876223|FG000|Overall Study|Withdrawal by Subject|12|||
30771581|NCT03657043|58780869|FG001|Overall Study|Study closure by Sponsor|2|||
30771582|NCT03657043|58780870|FG002|Overall Study|Study closure by Sponsor|0|||
30849328|NCT01355497|58876224|FG001|Overall Study|Withdrawal by Subject|20|||
30771583|NCT03657043|58780871|FG003|Overall Study|Study closure by Sponsor|0|||
30771584|NCT03657043|58780872|FG004|Overall Study|Study closure by Sponsor|17|||
30771585|NCT03657043|58780868|FG000|Overall Study|Lost to Follow-up|0|||
30771586|NCT03657043|58780869|FG001|Overall Study|Lost to Follow-up|0|||
30771587|NCT03657043|58780870|FG002|Overall Study|Lost to Follow-up|0|||
30771588|NCT03657043|58780871|FG003|Overall Study|Lost to Follow-up|0|||
30771589|NCT03657043|58780872|FG004|Overall Study|Lost to Follow-up|4|||
30771590|NCT03657043|58780868|FG000|Overall Study|Death|6|||
30952716|NCT01893827|59001870|FG001|Overall Study|Lost to Follow-up|26|||
30849329|NCT01355497|58876223|FG000|Overall Study|noncompliance|1|||
30849330|NCT01355497|58876224|FG001|Overall Study|noncompliance|2|||
30849331|NCT01355497|58876223|FG000|Overall Study|progressive disease|11|||
30849332|NCT01355497|58876224|FG001|Overall Study|progressive disease|8|||
30849333|NCT01355497|58876223|FG000|Overall Study|Adverse Event|11|||
30849334|NCT01355497|58876224|FG001|Overall Study|Adverse Event|10|||
30952717|NCT01882907|59001878|FG000|Overall Study|Adverse Event|3|||
30952718|NCT01882907|59001879|FG001|Overall Study|Adverse Event|1|||
30952719|NCT01882907|59001878|FG000|Overall Study|Lack of Efficacy|0|||
30952720|NCT01882907|59001879|FG001|Overall Study|Lack of Efficacy|3|||
30952721|NCT01882907|59001878|FG000|Overall Study|Lost to Follow-up|1|||
30952722|NCT01882907|59001879|FG001|Overall Study|Lost to Follow-up|4|||
30952723|NCT01882907|59001878|FG000|Overall Study|Protocol Violation|10|||
30952724|NCT01882907|59001879|FG001|Overall Study|Protocol Violation|14|||
30952725|NCT01882907|59001878|FG000|Overall Study|Withdrawal by Subject|0|||
30952726|NCT01882907|59001879|FG001|Overall Study|Withdrawal by Subject|6|||
30952727|NCT01893281|59001901|FG000|Overall Study|Adverse Event|1|||
30952728|NCT01893281|59001901|FG000|Overall Study|Protocol Violation|1|||
30952729|NCT01893281|59001901|FG000|Overall Study|Withdrawal by Subject|1|||
30952730|NCT01893203|59001905|FG000|Overall Study|Withdrawal by Subject|1|||
30952731|NCT01882829|59001909|FG000|Overall Study|Adverse Event|4|||
30952732|NCT01882829|59001909|FG000|Overall Study|Protocol Violation|1|||
30952733|NCT01882829|59001909|FG000|Overall Study|Withdrawal by Subject|1|||
30952734|NCT01882439|59001993|FG000|Overall Study|Adverse event related to study drug|3|||
30952735|NCT01882439|59001994|FG001|Overall Study|Adverse event related to study drug|8|||
30952736|NCT01882439|59001995|FG002|Overall Study|Adverse event related to study drug|1|||
30952737|NCT01882439|59001996|FG003|Overall Study|Adverse event related to study drug|2|||
30952738|NCT01882439|59001993|FG000|Overall Study|Pregnancy|0|||
30952739|NCT01882439|59001994|FG001|Overall Study|Pregnancy|1|||
30952740|NCT01882439|59001995|FG002|Overall Study|Pregnancy|0|||
30952741|NCT01882439|59001996|FG003|Overall Study|Pregnancy|0|||
30952742|NCT01882439|59001993|FG000|Overall Study|Protocol Violation|2|||
30952743|NCT01882439|59001994|FG001|Overall Study|Protocol Violation|2|||
30952744|NCT01882439|59001995|FG002|Overall Study|Protocol Violation|0|||
30952745|NCT01882439|59001996|FG003|Overall Study|Protocol Violation|1|||
30952746|NCT01882439|59001993|FG000|Overall Study|No longer willing to participate|1|||
30952747|NCT01882439|59001994|FG001|Overall Study|No longer willing to participate|4|||
30952748|NCT01882439|59001995|FG002|Overall Study|No longer willing to participate|2|||
30952749|NCT01882439|59001996|FG003|Overall Study|No longer willing to participate|3|||
30952750|NCT01882439|59001993|FG000|Overall Study|Medication error with no associated AE|0|||
30952751|NCT01882439|59001994|FG001|Overall Study|Medication error with no associated AE|0|||
30952752|NCT01882439|59001995|FG002|Overall Study|Medication error with no associated AE|2|||
30952753|NCT01882439|59001996|FG003|Overall Study|Medication error with no associated AE|0|||
30849335|NCT01355575|58876230|FG000|Overall Study|Withdrawal by Subject|2|||
30849336|NCT02826421|58876242|FG000|Overall Study|Adverse Event|1|||
30849337|NCT02826421|58876243|FG001|Overall Study|Adverse Event|0|||
30849338|NCT02826421|58876244|FG002|Overall Study|Adverse Event|0|||
30849339|NCT02826421|58876245|FG003|Overall Study|Adverse Event|1|||
30849340|NCT02826421|58876242|FG000|Overall Study|Withdrawal by Subject|1|||
30952754|NCT01882439|59001993|FG000|Overall Study|Insufficient clinical response|1|||
30952755|NCT01882439|59001994|FG001|Overall Study|Insufficient clinical response|4|||
30849341|NCT02826421|58876243|FG001|Overall Study|Withdrawal by Subject|3|||
30849342|NCT02826421|58876244|FG002|Overall Study|Withdrawal by Subject|1|||
30849343|NCT02826421|58876245|FG003|Overall Study|Withdrawal by Subject|1|||
30849344|NCT02826421|58876242|FG000|Overall Study|Reason not given|1|||
30849345|NCT02826421|58876243|FG001|Overall Study|Reason not given|0|||
30849346|NCT02826421|58876244|FG002|Overall Study|Reason not given|1|||
30952756|NCT01882439|59001995|FG002|Overall Study|Insufficient clinical response|4|||
30952757|NCT01882439|59001996|FG003|Overall Study|Insufficient clinical response|2|||
30952758|NCT01882439|59001993|FG000|Overall Study|Adverse event unrelated to study drug|2|||
30952759|NCT01882439|59001994|FG001|Overall Study|Adverse event unrelated to study drug|2|||
30952760|NCT01882439|59001995|FG002|Overall Study|Adverse event unrelated to study drug|1|||
30952761|NCT01882439|59001996|FG003|Overall Study|Adverse event unrelated to study drug|1|||
30952762|NCT01892657|59002043|FG000|Overall Study|Withdrawal by Subject|6|||
30952763|NCT01892657|59002043|FG000|Overall Study|Protocol Violation|12|||
30771591|NCT03657043|58780869|FG001|Overall Study|Death|5|||
30771592|NCT03657043|58780870|FG002|Overall Study|Death|0|||
30771593|NCT03657043|58780871|FG003|Overall Study|Death|0|||
30771594|NCT03657043|58780872|FG004|Overall Study|Death|53|||
30771595|NCT03657043|58780868|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
30771596|NCT03657043|58780869|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
30771597|NCT03657043|58780870|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
30771598|NCT03657043|58780871|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
30771599|NCT03657043|58780872|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
30771600|NCT03657043|58780868|FG000|Overall Study|Adverse Event|0|||
30771601|NCT03657043|58780869|FG001|Overall Study|Adverse Event|0|||
30771602|NCT03657043|58780870|FG002|Overall Study|Adverse Event|0|||
30771603|NCT03657043|58780871|FG003|Overall Study|Adverse Event|0|||
30771604|NCT03657043|58780872|FG004|Overall Study|Adverse Event|2|||
30771605|NCT03657043|58780868|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
30771606|NCT03657043|58780869|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
30771607|NCT03657043|58780870|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
30771608|NCT03657043|58780871|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
30771609|NCT03657043|58780872|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
30771610|NCT03657043|58780868|FG000|Overall Study|Withdrawal - declined follow-up|0|||
30771611|NCT03657043|58780869|FG001|Overall Study|Withdrawal - declined follow-up|0|||
30771612|NCT03657043|58780870|FG002|Overall Study|Withdrawal - declined follow-up|0|||
30771613|NCT03657043|58780871|FG003|Overall Study|Withdrawal - declined follow-up|0|||
30771614|NCT03657043|58780872|FG004|Overall Study|Withdrawal - declined follow-up|1|||
30771615|NCT03646669|58780882|FG000|Overall Study|Withdrawal by Subject|5|||
30771616|NCT03646669|58780883|FG001|Overall Study|Withdrawal by Subject|0|||
30771617|NCT03631706|58780891|FG000|Overall Study|Randomized, not treated|1|||
30771618|NCT03631706|58780892|FG001|Overall Study|Randomized, not treated|0|||
30771619|NCT03631706|58780891|FG000|Overall Study|Treatment ongoing|26|||
30771620|NCT03631706|58780892|FG001|Overall Study|Treatment ongoing|57|||
30771621|NCT03631706|58780891|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
30771622|NCT03631706|58780892|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
30771623|NCT03619876|58780900|FG000|Overall Study|Withdrawal by Subject|1|||
30771624|NCT03619876|58780901|FG001|Overall Study|Withdrawal by Subject|2|||
30771625|NCT03619876|58780900|FG000|Overall Study|Withdrawal due to incidental finding|0|||
30771626|NCT03619876|58780901|FG001|Overall Study|Withdrawal due to incidental finding|2|||
30771627|NCT03526861|58780923|FG000|Initial Treatment Period|Not dosed|1|||
30771628|NCT03526861|58780924|FG001|Initial Treatment Period|Not dosed|1|||
30771629|NCT03526861|58780925|FG002|Initial Treatment Period|Not dosed|1|||
30771630|NCT03526861|58780926|FG003|Initial Treatment Period|Not dosed|0|||
30771631|NCT03526861|58780927|FG004|Initial Treatment Period|Not dosed|0|||
30771632|NCT03526861|58780928|FG005|Initial Treatment Period|Not dosed|0|||
30771633|NCT03526861|58780929|FG006|Initial Treatment Period|Not dosed|0|||
30771634|NCT03526861|58780930|FG007|Initial Treatment Period|Not dosed|0|||
30771635|NCT03526861|58780931|FG008|Initial Treatment Period|Not dosed|0|||
30771636|NCT03526861|58780923|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
30771637|NCT03526861|58780924|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
30771638|NCT03526861|58780925|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
30771639|NCT03526861|58780926|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771640|NCT03526861|58780927|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771641|NCT03526861|58780928|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771642|NCT03526861|58780929|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771643|NCT03526861|58780930|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771644|NCT03526861|58780931|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771645|NCT03526861|58780923|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
30771646|NCT03526861|58780924|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
30771647|NCT03526861|58780925|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
30771648|NCT03526861|58780926|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
30771649|NCT03526861|58780927|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
30771650|NCT03526861|58780928|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
30771651|NCT03526861|58780929|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
30771652|NCT03526861|58780930|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
30771653|NCT03526861|58780931|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
30771654|NCT03526861|58780923|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771655|NCT03526861|58780924|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771656|NCT03526861|58780925|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771657|NCT03526861|58780926|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
30662080|NCT02755597|58675408|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
30662081|NCT02755597|58675409|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
30662082|NCT02598557|58675418|FG000|Overall Study|Withdrawal by Subject|1|||
30662083|NCT02598557|58675419|FG001|Overall Study|Withdrawal by Subject|0|||
30662084|NCT02598557|58675420|FG002|Overall Study|Withdrawal by Subject|1|||
30662085|NCT02598557|58675418|FG000|Overall Study|Participant did not start treatment|2|||
30662086|NCT02598557|58675419|FG001|Overall Study|Participant did not start treatment|1|||
30662087|NCT02598557|58675420|FG002|Overall Study|Participant did not start treatment|1|||
30662088|NCT02598557|58675418|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
30662089|NCT02598557|58675419|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
30662090|NCT02598557|58675420|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
30662091|NCT02598557|58675418|FG000|Overall Study|Adverse Event|1|||
30662092|NCT02598557|58675419|FG001|Overall Study|Adverse Event|1|||
30662093|NCT02598557|58675420|FG002|Overall Study|Adverse Event|0|||
30771658|NCT03526861|58780927|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
30771659|NCT03526861|58780928|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771660|NCT03526861|58780929|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
30771661|NCT03526861|58780930|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771662|NCT03526861|58780931|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771663|NCT03526861|58780923|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
30771664|NCT03526861|58780924|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
30771665|NCT03526861|58780925|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
30771666|NCT03526861|58780926|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
30771667|NCT03526861|58780927|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
30771668|NCT03526861|58780928|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
30771669|NCT03526861|58780929|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
30771670|NCT03526861|58780930|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
30771671|NCT03526861|58780931|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
30771672|NCT03526861|58780923|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771673|NCT03526861|58780924|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771674|NCT03526861|58780925|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771675|NCT03526861|58780926|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
30771676|NCT03526861|58780927|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771677|NCT03526861|58780928|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771678|NCT03526861|58780929|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771679|NCT03526861|58780930|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771680|NCT03526861|58780931|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771681|NCT03526861|58780923|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771682|NCT03526861|58780924|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771683|NCT03526861|58780925|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30849347|NCT02826421|58876245|FG003|Overall Study|Reason not given|0|||
30849348|NCT02825251|58876258|FG000|Overall Study|Adverse Event|0|||
30849349|NCT02825251|58876259|FG001|Overall Study|Adverse Event|1|||
30849350|NCT02825251|58876258|FG000|Overall Study|Lost to Follow-up|0|||
30849351|NCT02825251|58876259|FG001|Overall Study|Lost to Follow-up|1|||
30849352|NCT02825251|58876258|FG000|Overall Study|Withdrawal by Subject|1|||
30849353|NCT02825251|58876259|FG001|Overall Study|Withdrawal by Subject|4|||
30849354|NCT02825251|58876258|FG000|Overall Study|Unclassified|2|||
30849355|NCT02825251|58876259|FG001|Overall Study|Unclassified|0|||
30849356|NCT02824627|58876267|FG000|Overall Study|Adverse Event|1|||
30849357|NCT02824627|58876268|FG001|Overall Study|Adverse Event|2|||
30849358|NCT02824627|58876267|FG000|Overall Study|Lost to Follow-up|2|||
30849359|NCT02824627|58876268|FG001|Overall Study|Lost to Follow-up|1|||
30849360|NCT04860505|58876274|FG000|Overall Study|Lost to Follow-up|2|||
30849361|NCT04063865|58876280|FG000|Overall Study|Physician Decision|1|||
30849362|NCT04063865|58876281|FG001|Overall Study|Physician Decision|3|||
30849363|NCT04063865|58876280|FG000|Overall Study|Study Closed Prior to Completion|4|||
30849364|NCT04063865|58876281|FG001|Overall Study|Study Closed Prior to Completion|4|||
30849365|NCT04063865|58876280|FG000|Overall Study|Withdrawal by Subject|1|||
30849366|NCT04063865|58876281|FG001|Overall Study|Withdrawal by Subject|1|||
30849367|NCT03994211|58876289|FG000|Core Phase|Adverse Event|0|||
30849368|NCT03994211|58876290|FG001|Core Phase|Adverse Event|1|||
30849369|NCT03994211|58876291|FG002|Core Phase|Adverse Event|0|||
30849370|NCT03994211|58876289|FG000|Extension Phase|Adverse Event|0|||
30849371|NCT03994211|58876290|FG001|Extension Phase|Adverse Event|0|||
30849372|NCT03994211|58876291|FG002|Extension Phase|Adverse Event|1|||
30849373|NCT03994211|58876289|FG000|Extension Phase|Physician Decision|0|||
30849374|NCT03994211|58876290|FG001|Extension Phase|Physician Decision|0|||
30849375|NCT03994211|58876291|FG002|Extension Phase|Physician Decision|1|||
30849376|NCT03994211|58876289|FG000|Extension Phase|Progressive Disease|0|||
30849377|NCT03994211|58876290|FG001|Extension Phase|Progressive Disease|0|||
30849378|NCT03994211|58876291|FG002|Extension Phase|Progressive Disease|20|||
30849379|NCT03994211|58876289|FG000|Extension Phase|Withdrawal by Subject|0|||
30849380|NCT03994211|58876290|FG001|Extension Phase|Withdrawal by Subject|0|||
30849381|NCT03994211|58876291|FG002|Extension Phase|Withdrawal by Subject|2|||
30849382|NCT03818607|58876306|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
30849383|NCT03818607|58876307|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
30849384|NCT03818607|58876306|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
30849385|NCT03818607|58876307|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
30849386|NCT03818607|58876306|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
30849387|NCT03818607|58876307|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
30849388|NCT03300817|58876345|FG000|Overall Study|Withdrawal by Subject|1|||
30849389|NCT03300817|58876345|FG000|Overall Study|Adverse Event|1|||
30849390|NCT03300817|58876345|FG000|Overall Study|Subject Found to be Ineligible|2|||
30849391|NCT03144674|58876357|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
30849392|NCT03144674|58876358|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
30849393|NCT03144674|58876359|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
30849394|NCT03144674|58876360|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
30849395|NCT03144674|58876357|FG000|Overall Study|Death|3|||
30849396|NCT03144674|58876358|FG001|Overall Study|Death|1|||
30849397|NCT03144674|58876359|FG002|Overall Study|Death|1|||
30849398|NCT03144674|58876360|FG003|Overall Study|Death|10|||
30849399|NCT03144674|58876357|FG000|Overall Study|Lost to Follow-up|0|||
30662094|NCT02576574|58675431|FG000|Overall Study|still ongoing|65|||
30662095|NCT02576574|58675432|FG001|Overall Study|still ongoing|66|||
30662096|NCT02576574|58675433|FG002|Overall Study|still ongoing|73|||
30662097|NCT02576574|58675431|FG000|Overall Study|Randomized, not treated|5|||
30662098|NCT02576574|58675432|FG001|Overall Study|Randomized, not treated|4|||
30662099|NCT02576574|58675433|FG002|Overall Study|Randomized, not treated|26|||
30662100|NCT02340780|58675443|FG000|Overall Study|Ineligible|1|||
30662101|NCT02091960|58675447|FG000|Overall Study|Death|7|||
30662102|NCT02091960|58675447|FG000|Overall Study|Withdrawal by Subject|1|||
30662103|NCT02091960|58675447|FG000|Overall Study|Miscellaneous Reasons|31|||
30662104|NCT02091960|58675447|FG000|Overall Study|On Study at Data Cut-off|12|||
30662105|NCT01772472|58675462|FG000|Overall Study|Death|56|||
30662106|NCT01772472|58675463|FG001|Overall Study|Death|42|||
30662107|NCT01772472|58675462|FG000|Overall Study|Physician Decision|1|||
30662108|NCT01772472|58675463|FG001|Overall Study|Physician Decision|3|||
30662109|NCT01772472|58675462|FG000|Overall Study|Other|5|||
30662110|NCT01772472|58675463|FG001|Overall Study|Other|5|||
30662111|NCT01772472|58675462|FG000|Overall Study|Lost to Follow-up|12|||
30662112|NCT01772472|58675463|FG001|Overall Study|Lost to Follow-up|8|||
30662113|NCT01772472|58675462|FG000|Overall Study|Withdrawal by Subject|72|||
30662114|NCT01772472|58675463|FG001|Overall Study|Withdrawal by Subject|50|||
30662115|NCT01772472|58675462|FG000|Overall Study|Ongoing|597|||
30662116|NCT01772472|58675463|FG001|Overall Study|Ongoing|635|||
30662117|NCT01470417|58675471|FG000|Overall Study|Disease progression|0|||
30662118|NCT01470417|58675472|FG001|Overall Study|Disease progression|2|||
30849400|NCT03144674|58876358|FG001|Overall Study|Lost to Follow-up|1|||
30849401|NCT03144674|58876359|FG002|Overall Study|Lost to Follow-up|1|||
30849402|NCT03144674|58876360|FG003|Overall Study|Lost to Follow-up|1|||
30849403|NCT03144674|58876357|FG000|Overall Study|Withdrawal by Participant|0|||
30849404|NCT03144674|58876358|FG001|Overall Study|Withdrawal by Participant|0|||
30849405|NCT03144674|58876359|FG002|Overall Study|Withdrawal by Participant|0|||
30849406|NCT03144674|58876360|FG003|Overall Study|Withdrawal by Participant|3|||
30849407|NCT03144674|58876357|FG000|Overall Study|Reason not Specified|0|||
30662119|NCT00820248|58675510|FG000|Overall Study|No treated|4|||
30662120|NCT00820248|58675511|FG001|Overall Study|No treated|1|||
30662121|NCT00668642|58675532|FG000|First Off-cycle|Cancer progression|1|||
30662122|NCT00668642|58675533|FG001|First Off-cycle|Cancer progression|0|||
30662123|NCT00668642|58675532|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
30662124|NCT00668642|58675533|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
30849408|NCT03144674|58876358|FG001|Overall Study|Reason not Specified|0|||
30849409|NCT03144674|58876359|FG002|Overall Study|Reason not Specified|2|||
30849410|NCT03144674|58876360|FG003|Overall Study|Reason not Specified|4|||
30849411|NCT02521285|58876377|FG000|Overall Study|Lost to Follow-up|1|||
30849412|NCT02521285|58876378|FG001|Overall Study|Lost to Follow-up|1|||
30849413|NCT02521285|58876377|FG000|Overall Study|Withdrawal by Subject|1|||
30849414|NCT02521285|58876378|FG001|Overall Study|Withdrawal by Subject|1|||
30849415|NCT02521285|58876377|FG000|Overall Study|Adverse Event|0|||
30849416|NCT02521285|58876378|FG001|Overall Study|Adverse Event|1|||
30849417|NCT02422615|58876386|FG000|Overall Study|Progressive disease|193|||
30849418|NCT02422615|58876387|FG001|Overall Study|Progressive disease|142|||
30849419|NCT02422615|58876386|FG000|Overall Study|Adverse Event|41|||
30849420|NCT02422615|58876387|FG001|Overall Study|Adverse Event|10|||
30849421|NCT02422615|58876386|FG000|Overall Study|Physician Decision|22|||
30849422|NCT02422615|58876387|FG001|Overall Study|Physician Decision|7|||
30849423|NCT02422615|58876386|FG000|Overall Study|Subject/guardian decision|21|||
30849424|NCT02422615|58876387|FG001|Overall Study|Subject/guardian decision|5|||
30849425|NCT02422615|58876386|FG000|Overall Study|Death|2|||
30849426|NCT02422615|58876387|FG001|Overall Study|Death|0|||
30849427|NCT02422615|58876386|FG000|Overall Study|Protocol Violation|1|||
30849428|NCT02422615|58876387|FG001|Overall Study|Protocol Violation|1|||
30849429|NCT02422615|58876386|FG000|Overall Study|Technical problems|0|||
30849430|NCT02422615|58876387|FG001|Overall Study|Technical problems|1|||
30849431|NCT02382406|58876396|FG000|Study Treatment|Disease Progression|8|||
30849432|NCT02382406|58876397|FG001|Study Treatment|Disease Progression|0|||
30849433|NCT02382406|58876398|FG002|Study Treatment|Disease Progression|20|||
30849434|NCT02382406|58876396|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
30849435|NCT02382406|58876397|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
30849436|NCT02382406|58876398|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
30849437|NCT02382406|58876396|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
30849438|NCT02382406|58876397|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
30849439|NCT02382406|58876398|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
30849440|NCT02382406|58876396|FG000|Study Treatment|symptomatic deterioration|1|||
30849441|NCT02382406|58876397|FG001|Study Treatment|symptomatic deterioration|0|||
30849442|NCT02382406|58876398|FG002|Study Treatment|symptomatic deterioration|1|||
30849443|NCT02382406|58876396|FG000|Study Treatment|Death|0|||
30849444|NCT02382406|58876397|FG001|Study Treatment|Death|0|||
30849445|NCT02382406|58876398|FG002|Study Treatment|Death|2|||
30849446|NCT02382406|58876396|FG000|Follow up|Death|11|||
30849447|NCT02382406|58876397|FG001|Follow up|Death|0|||
30849448|NCT02382406|58876398|FG002|Follow up|Death|19|||
30849449|NCT02382406|58876396|FG000|Follow up|Symptomatic deterioration|1|||
30849450|NCT02382406|58876397|FG001|Follow up|Symptomatic deterioration|0|||
30849451|NCT02382406|58876398|FG002|Follow up|Symptomatic deterioration|1|||
30662125|NCT00609791|58675539|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
30662126|NCT00101101|58675552|FG000|Overall Study|never received vaccine|20|||
30662127|NCT03962101|58675556|FG000|Overall Study|Adverse Event|1|||
30662128|NCT03962101|58675556|FG000|Overall Study|Physician Decision|2|||
30662129|NCT03962101|58675556|FG000|Overall Study|Not related to medical events|1|||
30662130|NCT00923351|58675563|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
30662131|NCT00923351|58675564|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
30662132|NCT00923351|58675565|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
30662133|NCT00755937|58675571|FG000|Recruitment|Unknown if infliximab received|164|||
30662134|NCT00755937|58675571|FG000|Observational Follow-up|Lost to Follow-up|148|||
30662135|NCT00755079|58675577|FG000|Overall Study|Lost to Follow-up|1|||
30662136|NCT00755079|58675578|FG001|Overall Study|Lost to Follow-up|3|||
30662137|NCT00755079|58675577|FG000|Overall Study|Adverse Event|0|||
30662138|NCT00755079|58675578|FG001|Overall Study|Adverse Event|1|||
30662139|NCT00755079|58675577|FG000|Overall Study|Withdrawal by Subject|0|||
30662140|NCT00755079|58675578|FG001|Overall Study|Withdrawal by Subject|2|||
30662141|NCT00925301|58675586|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
30849452|NCT02382406|58876396|FG000|Follow up|Patient Refused Follow-up|1|||
30849453|NCT02382406|58876397|FG001|Follow up|Patient Refused Follow-up|0|||
30849454|NCT02382406|58876398|FG002|Follow up|Patient Refused Follow-up|0|||
30849455|NCT02382406|58876396|FG000|Follow up|Study Terminated|1|||
30849456|NCT02382406|58876397|FG001|Follow up|Study Terminated|0|||
30849457|NCT02382406|58876398|FG002|Follow up|Study Terminated|8|||
30849458|NCT02382406|58876396|FG000|Follow up|Withdrawal by Subject|0|||
30662142|NCT00925301|58675587|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
30849459|NCT02382406|58876397|FG001|Follow up|Withdrawal by Subject|0|||
30849460|NCT02382406|58876398|FG002|Follow up|Withdrawal by Subject|2|||
30662143|NCT00925301|58675588|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
30662144|NCT00925301|58675589|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
30849461|NCT02101268|58876418|FG000|Randomized Treatment Phase|Subject Decision|8|||
30849462|NCT02101268|58876419|FG001|Randomized Treatment Phase|Subject Decision|4|||
30849463|NCT02101268|58876420|FG002|Randomized Treatment Phase|Subject Decision|0|||
30849464|NCT02101268|58876421|FG003|Randomized Treatment Phase|Subject Decision|0|||
30849465|NCT02101268|58876418|FG000|Randomized Treatment Phase|Physician Decision|4|||
30849466|NCT02101268|58876419|FG001|Randomized Treatment Phase|Physician Decision|1|||
30849467|NCT02101268|58876420|FG002|Randomized Treatment Phase|Physician Decision|0|||
30849468|NCT02101268|58876421|FG003|Randomized Treatment Phase|Physician Decision|0|||
30849469|NCT02101268|58876418|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
30849470|NCT02101268|58876419|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
30849471|NCT02101268|58876420|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
30849472|NCT02101268|58876421|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
30849473|NCT02101268|58876418|FG000|Randomized Treatment Phase|Adverse Event|6|||
30849474|NCT02101268|58876419|FG001|Randomized Treatment Phase|Adverse Event|0|||
30849475|NCT02101268|58876420|FG002|Randomized Treatment Phase|Adverse Event|0|||
30849476|NCT02101268|58876421|FG003|Randomized Treatment Phase|Adverse Event|0|||
30849477|NCT02101268|58876418|FG000|Randomized Treatment Phase|Death|5|||
30849478|NCT02101268|58876419|FG001|Randomized Treatment Phase|Death|4|||
30849479|NCT02101268|58876420|FG002|Randomized Treatment Phase|Death|0|||
30849480|NCT02101268|58876421|FG003|Randomized Treatment Phase|Death|0|||
30849481|NCT02101268|58876418|FG000|Randomized Treatment Phase|Disease Progression|4|||
30849482|NCT02101268|58876419|FG001|Randomized Treatment Phase|Disease Progression|1|||
30849483|NCT02101268|58876420|FG002|Randomized Treatment Phase|Disease Progression|0|||
30849484|NCT02101268|58876421|FG003|Randomized Treatment Phase|Disease Progression|0|||
30849485|NCT02101268|58876418|FG000|Extended Treatment Phase|Subject Decision|0|||
30849486|NCT02101268|58876419|FG001|Extended Treatment Phase|Subject Decision|0|||
30849487|NCT02101268|58876420|FG002|Extended Treatment Phase|Subject Decision|3|||
30849488|NCT02101268|58876421|FG003|Extended Treatment Phase|Subject Decision|2|||
30849489|NCT02101268|58876418|FG000|Extended Treatment Phase|Physician Decision|0|||
30849490|NCT02101268|58876419|FG001|Extended Treatment Phase|Physician Decision|0|||
30849491|NCT02101268|58876420|FG002|Extended Treatment Phase|Physician Decision|5|||
30849492|NCT02101268|58876421|FG003|Extended Treatment Phase|Physician Decision|2|||
30849493|NCT02101268|58876418|FG000|Extended Treatment Phase|Adverse Event|0|||
30849494|NCT02101268|58876419|FG001|Extended Treatment Phase|Adverse Event|0|||
30849495|NCT02101268|58876420|FG002|Extended Treatment Phase|Adverse Event|14|||
30849496|NCT02101268|58876421|FG003|Extended Treatment Phase|Adverse Event|18|||
30849497|NCT02101268|58876418|FG000|Extended Treatment Phase|Death|0|||
30849498|NCT02101268|58876419|FG001|Extended Treatment Phase|Death|0|||
30849499|NCT02101268|58876420|FG002|Extended Treatment Phase|Death|5|||
30849500|NCT02101268|58876421|FG003|Extended Treatment Phase|Death|1|||
30849501|NCT02101268|58876418|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
30849502|NCT02101268|58876419|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
30849503|NCT02101268|58876420|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
30849504|NCT02101268|58876421|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
30849505|NCT02101268|58876418|FG000|Extended Treatment Phase|Disease Progression|0|||
30849506|NCT02101268|58876419|FG001|Extended Treatment Phase|Disease Progression|0|||
30849507|NCT02101268|58876420|FG002|Extended Treatment Phase|Disease Progression|13|||
30849508|NCT02101268|58876421|FG003|Extended Treatment Phase|Disease Progression|6|||
30849509|NCT02101268|58876418|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
30849510|NCT02101268|58876419|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
30849511|NCT02101268|58876420|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
30849512|NCT02101268|58876421|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
30849513|NCT01898650|58876438|FG000|Overall Study|the subject would not lie still for imaging|1|||
30849514|NCT01880515|58876444|FG000|Overall Study|Lost to Follow-up|3|||
30849515|NCT01880515|58876445|FG001|Overall Study|Lost to Follow-up|2|||
30849516|NCT01880515|58876444|FG000|Overall Study|Disease Progression|5|||
30849517|NCT01880515|58876445|FG001|Overall Study|Disease Progression|7|||
30849518|NCT01668719|58876455|FG000|Phase I|On treatment|1|||
30849519|NCT01668719|58876456|FG001|Phase I|On treatment|0|||
30849520|NCT01668719|58876457|FG002|Phase I|On treatment|0|||
30849521|NCT01668719|58876455|FG000|Phase I|Adverse Event|2|||
30849522|NCT01668719|58876456|FG001|Phase I|Adverse Event|0|||
30849523|NCT01668719|58876457|FG002|Phase I|Adverse Event|0|||
30849524|NCT01668719|58876455|FG000|Phase I|Progression/relapse|1|||
30849525|NCT01668719|58876456|FG001|Phase I|Progression/relapse|0|||
30849526|NCT01668719|58876457|FG002|Phase I|Progression/relapse|0|||
30849527|NCT01668719|58876455|FG000|Phase I|not protocol specified|2|||
30952764|NCT01881737|59002070|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
30849528|NCT01668719|58876456|FG001|Phase I|not protocol specified|0|||
30849529|NCT01668719|58876457|FG002|Phase I|not protocol specified|0|||
30849530|NCT01668719|58876455|FG000|Phase II|On treatment|0|||
30849531|NCT01668719|58876456|FG001|Phase II|On treatment|4|||
30849532|NCT01668719|58876457|FG002|Phase II|On treatment|3|||
30849533|NCT01668719|58876455|FG000|Phase II|Adverse Event|0|||
30849534|NCT01668719|58876456|FG001|Phase II|Adverse Event|18|||
30849535|NCT01668719|58876457|FG002|Phase II|Adverse Event|18|||
30849536|NCT01668719|58876455|FG000|Phase II|Refusal unrelated to adverse event|0|||
30849537|NCT01668719|58876456|FG001|Phase II|Refusal unrelated to adverse event|4|||
30849538|NCT01668719|58876457|FG002|Phase II|Refusal unrelated to adverse event|1|||
30849539|NCT01668719|58876455|FG000|Phase II|Progression/relapse|0|||
30849540|NCT01668719|58876456|FG001|Phase II|Progression/relapse|13|||
30849541|NCT01668719|58876457|FG002|Phase II|Progression/relapse|17|||
30849542|NCT01668719|58876455|FG000|Phase II|Death|0|||
30849543|NCT01668719|58876456|FG001|Phase II|Death|0|||
30849544|NCT01668719|58876457|FG002|Phase II|Death|2|||
30849545|NCT01668719|58876455|FG000|Phase II|not protocol specified|0|||
30849546|NCT01668719|58876456|FG001|Phase II|not protocol specified|13|||
30849547|NCT01668719|58876457|FG002|Phase II|not protocol specified|7|||
30849548|NCT01642901|58876469|FG000|12-month Follow-up|Withdrawal by Subject|1|||
30849549|NCT01642901|58876470|FG001|12-month Follow-up|Withdrawal by Subject|0|||
30849550|NCT01488045|58876478|FG000|Overall Study|Withdrawal by Subject|6|||
30849551|NCT01488045|58876479|FG001|Overall Study|Withdrawal by Subject|11|||
30849552|NCT01488045|58876478|FG000|Overall Study|Failure to present for colonoscopy|3|||
30849553|NCT01488045|58876479|FG001|Overall Study|Failure to present for colonoscopy|6|||
30849554|NCT01488045|58876478|FG000|Overall Study|Failure to report exclusion criteria|0|||
30849555|NCT01488045|58876479|FG001|Overall Study|Failure to report exclusion criteria|1|||
30849556|NCT00946712|58876498|FG000|Overall Study|Adverse Event|118|||
30849557|NCT00946712|58876499|FG001|Overall Study|Adverse Event|124|||
30849558|NCT00946712|58876498|FG000|Overall Study|Disease progression|308|||
30849559|NCT00946712|58876499|FG001|Overall Study|Disease progression|404|||
30849560|NCT00946712|58876498|FG000|Overall Study|Death|21|||
30849561|NCT00946712|58876499|FG001|Overall Study|Death|22|||
30849562|NCT00946712|58876498|FG000|Overall Study|No treatment given|25|||
30849563|NCT00946712|58876499|FG001|Overall Study|No treatment given|29|||
30849564|NCT00946712|58876498|FG000|Overall Study|Other reasons|61|||
30849565|NCT00946712|58876499|FG001|Overall Study|Other reasons|73|||
30849566|NCT00946712|58876498|FG000|Overall Study|On Treatment|0|||
30849567|NCT00946712|58876499|FG001|Overall Study|On Treatment|4|||
30849568|NCT00946712|58876498|FG000|Overall Study|Ineligible|14|||
30849569|NCT00946712|58876499|FG001|Overall Study|Ineligible|6|||
30849570|NCT00656669|58876506|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
30849571|NCT00656669|58876506|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
30849572|NCT00656669|58876506|FG000|AC (Cycles 6-9)|Adverse Event|1|||
30849573|NCT00656669|58876506|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
30849574|NCT00470704|58876517|FG000|Overall Study|Withdrawal by Subject|4|||
30849575|NCT00470704|58876518|FG001|Overall Study|Withdrawal by Subject|3|||
30849576|NCT00470704|58876517|FG000|Overall Study|Relapse/Progression|37|||
30849577|NCT00470704|58876518|FG001|Overall Study|Relapse/Progression|42|||
30849578|NCT00470704|58876517|FG000|Overall Study|toxicity|0|||
30849579|NCT00470704|58876518|FG001|Overall Study|toxicity|1|||
30849580|NCT01338493|58876524|FG000|Enrolled|Withdrawal by Subject|1|||
30849581|NCT01338493|58876524|FG000|Enrolled|Patient not implanted|4|||
30849582|NCT01338493|58876524|FG000|Discharge|Death|1|||
30849583|NCT01338493|58876524|FG000|Discharge|Missed visit|1|||
30849584|NCT01338493|58876524|FG000|6 Months Follow up|Lost to Follow-up|11|||
30849585|NCT01338493|58876524|FG000|6 Months Follow up|Missed visit|8|||
30952765|NCT01881737|59002070|FG000|Overall Study|Withdrawal by Subject|1|||
30952766|NCT01881737|59002070|FG000|Overall Study|Worsening of baseline behavior|1|||
30771684|NCT03526861|58780926|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771685|NCT03526861|58780927|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771686|NCT03526861|58780928|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771687|NCT03526861|58780929|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771688|NCT03526861|58780930|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
30771689|NCT03526861|58780931|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
30771690|NCT03526861|58780923|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
30771691|NCT03526861|58780924|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
30771692|NCT03526861|58780925|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
30771693|NCT03526861|58780926|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
30771694|NCT03526861|58780927|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
30771695|NCT03526861|58780928|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
30849586|NCT01338493|58876524|FG000|12 Months Follow up|Lost to Follow-up|9|||
30849587|NCT01362296|58876530|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
30849588|NCT01362296|58876531|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
30849589|NCT01362296|58876532|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
30849590|NCT01362296|58876533|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
30849591|NCT01362296|58876530|FG000|Randomized Phase (RP)|Physician Decision|1|||
30849592|NCT01362296|58876531|FG001|Randomized Phase (RP)|Physician Decision|9|||
30849593|NCT01362296|58876532|FG002|Randomized Phase (RP)|Physician Decision|0|||
30849594|NCT01362296|58876533|FG003|Randomized Phase (RP)|Physician Decision|0|||
30849595|NCT01362296|58876530|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
30849596|NCT01362296|58876531|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
30849597|NCT01362296|58876532|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
30849598|NCT01362296|58876533|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
30849599|NCT01362296|58876530|FG000|Randomized Phase (RP)|Adverse Event|20|||
30849600|NCT01362296|58876531|FG001|Randomized Phase (RP)|Adverse Event|4|||
30849601|NCT01362296|58876532|FG002|Randomized Phase (RP)|Adverse Event|0|||
30849602|NCT01362296|58876533|FG003|Randomized Phase (RP)|Adverse Event|0|||
30849603|NCT01362296|58876530|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
30662145|NCT00925301|58675586|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
30662146|NCT00925301|58675587|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
30662147|NCT00925301|58675588|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
30662148|NCT00925301|58675589|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
30662149|NCT00925301|58675586|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
30662150|NCT00925301|58675587|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
30662151|NCT00925301|58675588|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
30662152|NCT00925301|58675589|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
30662153|NCT00925301|58675586|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
30662154|NCT00925301|58675587|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
30849604|NCT01362296|58876531|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
30849605|NCT01362296|58876532|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
30849606|NCT01362296|58876533|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
30849607|NCT01362296|58876530|FG000|Crossover Phase|PD including Death due to PD|0|||
30662155|NCT00925301|58675588|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
30662156|NCT00925301|58675589|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
30662157|NCT00925301|58675586|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
30662158|NCT00925301|58675587|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
30662159|NCT00925301|58675588|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
30662160|NCT00925301|58675589|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
30662161|NCT00925301|58675586|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
30662162|NCT00925301|58675587|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
30662163|NCT00925301|58675588|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
30662164|NCT00925301|58675589|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
30849608|NCT01362296|58876531|FG001|Crossover Phase|PD including Death due to PD|0|||
30952767|NCT01892501|59002106|FG000|Overall Study|Protocol Violation|2|||
30952768|NCT01892501|59002106|FG000|Overall Study|Puncture not carried out|9|||
30952769|NCT01892501|59002106|FG000|Overall Study|Radiological monitoring not carried out|5|||
30952770|NCT01892501|59002106|FG000|Overall Study|Non-contributory histological result|12|||
30952771|NCT01892345|59002121|FG000|Overall Study|Adverse Event|0|||
30952772|NCT01892345|59002122|FG001|Overall Study|Adverse Event|2|||
30952773|NCT01892345|59002121|FG000|Overall Study|Death|1|||
30952774|NCT01892345|59002122|FG001|Overall Study|Death|0|||
30952775|NCT01892345|59002121|FG000|Overall Study|Lost to Follow-up|3|||
30952776|NCT01892345|59002122|FG001|Overall Study|Lost to Follow-up|0|||
30952777|NCT01892345|59002121|FG000|Overall Study|Withdrawal by Subject|12|||
30952778|NCT01892345|59002122|FG001|Overall Study|Withdrawal by Subject|1|||
30952779|NCT01892189|59002199|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
30952780|NCT01892189|59002200|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
30952781|NCT01892189|59002201|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
30952782|NCT01892189|59002202|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
30952783|NCT01892189|59002203|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
30662165|NCT00925301|58675586|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
30662166|NCT00925301|58675587|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
30662167|NCT00925301|58675588|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
30849609|NCT01362296|58876532|FG002|Crossover Phase|PD including Death due to PD|16|||
30849610|NCT01362296|58876533|FG003|Crossover Phase|PD including Death due to PD|1|||
30849611|NCT01362296|58876530|FG000|Crossover Phase|Withdrawal by Subject|0|||
30952784|NCT01892189|59002204|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
30952785|NCT01892189|59002205|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
30952786|NCT01892189|59002206|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
30952787|NCT01892189|59002207|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
30952788|NCT01892189|59002199|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30849612|NCT01362296|58876531|FG001|Crossover Phase|Withdrawal by Subject|0|||
30662168|NCT00925301|58675589|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
30662169|NCT00754065|58675602|FG000|Overall Study|Never received treatment|12|||
30662170|NCT00754065|58675603|FG001|Overall Study|Never received treatment|2|||
30662171|NCT00754065|58675602|FG000|Overall Study|Adverse Event|19|||
30662172|NCT00754065|58675603|FG001|Overall Study|Adverse Event|25|||
30662173|NCT00754065|58675602|FG000|Overall Study|Lost to Follow-up|7|||
30662174|NCT00754065|58675603|FG001|Overall Study|Lost to Follow-up|11|||
30662175|NCT00754065|58675602|FG000|Overall Study|Protocol Violation|12|||
30662176|NCT00754065|58675603|FG001|Overall Study|Protocol Violation|10|||
30849613|NCT01362296|58876532|FG002|Crossover Phase|Withdrawal by Subject|2|||
30849614|NCT01362296|58876533|FG003|Crossover Phase|Withdrawal by Subject|1|||
30849615|NCT01362296|58876530|FG000|Crossover Phase|Adverse Event|0|||
30849616|NCT01362296|58876531|FG001|Crossover Phase|Adverse Event|0|||
30849617|NCT01362296|58876532|FG002|Crossover Phase|Adverse Event|4|||
30849618|NCT01362296|58876533|FG003|Crossover Phase|Adverse Event|0|||
30849619|NCT01362296|58876530|FG000|Crossover Phase|Study Closed/Terminated|0|||
30849620|NCT01362296|58876531|FG001|Crossover Phase|Study Closed/Terminated|0|||
30849621|NCT01362296|58876532|FG002|Crossover Phase|Study Closed/Terminated|1|||
30849622|NCT01362296|58876533|FG003|Crossover Phase|Study Closed/Terminated|0|||
30849623|NCT01338415|58876545|FG000|Core + Extension|Adverse Event|8|||
30849624|NCT01338415|58876546|FG001|Core + Extension|Adverse Event|6|||
30849625|NCT01338415|58876547|FG002|Core + Extension|Adverse Event|0|||
30849626|NCT01338415|58876545|FG000|Core + Extension|Withdrawal by Subject|1|||
30662177|NCT00754065|58675602|FG000|Overall Study|Withdrawal by Subject|4|||
30662178|NCT00754065|58675603|FG001|Overall Study|Withdrawal by Subject|5|||
30662179|NCT00754065|58675602|FG000|Overall Study|Pregnancy|6|||
30662180|NCT00754065|58675603|FG001|Overall Study|Pregnancy|0|||
30662181|NCT00754065|58675602|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
30662182|NCT00754065|58675603|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
30662183|NCT04138056|58675623|FG000|Primary Study|Lost to Follow-up|3|||
30662184|NCT04138056|58675624|FG001|Primary Study|Lost to Follow-up|4|||
30662185|NCT04138056|58675625|FG002|Primary Study|Lost to Follow-up|1|||
30662186|NCT04138056|58675626|FG003|Primary Study|Lost to Follow-up|1|||
30662187|NCT04138056|58675627|FG004|Primary Study|Lost to Follow-up|4|||
30662188|NCT04138056|58675623|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
30662189|NCT04138056|58675624|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
30662190|NCT04138056|58675625|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
30662191|NCT04138056|58675626|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
30662192|NCT04138056|58675627|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
30662193|NCT04138056|58675623|FG000|Extension Study|Lost to Follow-up|1|||
30662194|NCT04138056|58675624|FG001|Extension Study|Lost to Follow-up|2|||
30662195|NCT04138056|58675625|FG002|Extension Study|Lost to Follow-up|1|||
30662196|NCT04138056|58675626|FG003|Extension Study|Lost to Follow-up|0|||
30662197|NCT04138056|58675627|FG004|Extension Study|Lost to Follow-up|1|||
30662198|NCT00753675|58675673|FG000|Overall Study|other reason|11|||
30662199|NCT00753675|58675674|FG001|Overall Study|other reason|12|||
30662200|NCT00753675|58675675|FG002|Overall Study|other reason|13|||
30662201|NCT00753675|58675673|FG000|Overall Study|Death|1|||
30662202|NCT00753675|58675674|FG001|Overall Study|Death|2|||
30662203|NCT00753675|58675675|FG002|Overall Study|Death|4|||
30662204|NCT00753675|58675673|FG000|Overall Study|Adverse Event|11|||
30662205|NCT00753675|58675674|FG001|Overall Study|Adverse Event|9|||
30662206|NCT00753675|58675675|FG002|Overall Study|Adverse Event|4|||
30662207|NCT00753675|58675673|FG000|Overall Study|Objective progression of disease|35|||
30662208|NCT00753675|58675674|FG001|Overall Study|Objective progression of disease|35|||
30662209|NCT00753675|58675675|FG002|Overall Study|Objective progression of disease|35|||
30662210|NCT00753675|58675673|FG000|Overall Study|Withdrawal by Subject|0|||
30662211|NCT00753675|58675674|FG001|Overall Study|Withdrawal by Subject|1|||
30662212|NCT00753675|58675675|FG002|Overall Study|Withdrawal by Subject|0|||
30662213|NCT00753675|58675673|FG000|Overall Study|Lost to Follow-up|1|||
30662214|NCT00753675|58675674|FG001|Overall Study|Lost to Follow-up|0|||
30662215|NCT00753675|58675675|FG002|Overall Study|Lost to Follow-up|0|||
30662216|NCT00586521|58675683|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
30849627|NCT01338415|58876546|FG001|Core + Extension|Withdrawal by Subject|1|||
30662217|NCT00923273|58675692|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
30849628|NCT01338415|58876547|FG002|Core + Extension|Withdrawal by Subject|0|||
30662218|NCT00923273|58675693|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
30662219|NCT00923273|58675694|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
30662220|NCT00923273|58675695|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
30662221|NCT00923273|58675696|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
30849629|NCT01338415|58876545|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
30849630|NCT01338415|58876546|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
30849631|NCT01338415|58876547|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
30662222|NCT00923273|58675692|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
30662223|NCT00923273|58675693|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
30662224|NCT00923273|58675694|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
30662225|NCT00923273|58675695|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
30662226|NCT00923273|58675696|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
30662227|NCT00923195|58675716|FG000|Overall Study|Death|0|||
30662228|NCT00923195|58675717|FG001|Overall Study|Death|1|||
30662229|NCT00753519|58675725|FG000|Overall Study|Withdrawal by Subject|0|||
30662230|NCT00753519|58675726|FG001|Overall Study|Withdrawal by Subject|2|||
30662231|NCT00919061|58675734|FG000|Overall Study|Adverse Event|1|||
30662232|NCT00919061|58675734|FG000|Overall Study|Withdrawal by Subject|1|||
30662233|NCT00747435|58675738|FG000|Overall Study|Lost to Follow-up|2|||
30662234|NCT00747435|58675738|FG000|Overall Study|Withdrawal by Subject|3|||
30662235|NCT00747435|58675738|FG000|Overall Study|Still undergoing follow up|1|||
30662236|NCT00918749|58675745|FG000|Overall Study|Adverse Event|1|||
30662237|NCT00918749|58675746|FG001|Overall Study|Adverse Event|0|||
30662238|NCT00918749|58675747|FG002|Overall Study|Adverse Event|1|||
30662239|NCT00918749|58675745|FG000|Overall Study|Lost to Follow-up|0|||
30662240|NCT00918749|58675746|FG001|Overall Study|Lost to Follow-up|0|||
30662241|NCT00918749|58675747|FG002|Overall Study|Lost to Follow-up|1|||
30662242|NCT00918749|58675745|FG000|Overall Study|Withdrawal by Subject|5|||
30662243|NCT00918749|58675746|FG001|Overall Study|Withdrawal by Subject|3|||
30662244|NCT00918749|58675747|FG002|Overall Study|Withdrawal by Subject|5|||
30662245|NCT00918749|58675745|FG000|Overall Study|No Study Medication Taken|1|||
30662246|NCT00918749|58675746|FG001|Overall Study|No Study Medication Taken|0|||
30662247|NCT00918749|58675747|FG002|Overall Study|No Study Medication Taken|0|||
30662248|NCT00746733|58675755|FG000|Second Intervention|Adverse Event|1|||
30662249|NCT00746733|58675756|FG001|Second Intervention|Adverse Event|0|||
30662250|NCT00746733|58675755|FG000|Third Intervention|Withdrawal by Subject|1|||
30662251|NCT00746733|58675756|FG001|Third Intervention|Withdrawal by Subject|1|||
30662252|NCT00745875|58675771|FG000|Overall Study|Continuing study treatment|4|||
30662253|NCT00745875|58675772|FG001|Overall Study|Continuing study treatment|4|||
30662254|NCT00555217|58675780|FG000|Overall Study|Withdrawal by Subject|35|||
30662255|NCT00555217|58675781|FG001|Overall Study|Withdrawal by Subject|31|||
30662256|NCT00555217|58675780|FG000|Overall Study|Lost to Follow-up|19|||
30662257|NCT00555217|58675781|FG001|Overall Study|Lost to Follow-up|20|||
30662258|NCT00555217|58675780|FG000|Overall Study|close out sites|21|||
30662259|NCT00555217|58675781|FG001|Overall Study|close out sites|17|||
30662260|NCT00745251|58675789|FG000|Overall Study|Adverse Event|1|||
30662261|NCT00745251|58675790|FG001|Overall Study|Adverse Event|2|||
30662262|NCT00745251|58675789|FG000|Overall Study|Withdrawal by Subject|1|||
30662263|NCT00745251|58675790|FG001|Overall Study|Withdrawal by Subject|1|||
30662264|NCT00745095|58675802|FG000|Overall Study|Declined to participate|1|||
30662265|NCT00745095|58675803|FG001|Overall Study|Declined to participate|0|||
30662266|NCT00745095|58675804|FG002|Overall Study|Declined to participate|0|||
30662267|NCT00745095|58675805|FG003|Overall Study|Declined to participate|0|||
30662268|NCT00745095|58675806|FG004|Overall Study|Declined to participate|92|||
30771696|NCT03526861|58780929|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
30771697|NCT03526861|58780930|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
30771698|NCT03526861|58780931|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
30771699|NCT03526861|58780923|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771700|NCT03526861|58780924|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771701|NCT03526861|58780925|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30849632|NCT01338415|58876545|FG000|Core + Extension|Other (administrative reason)|1|||
30849633|NCT01338415|58876546|FG001|Core + Extension|Other (administrative reason)|0|||
30849634|NCT01338415|58876547|FG002|Core + Extension|Other (administrative reason)|0|||
30849635|NCT01338415|58876545|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
30849636|NCT01338415|58876546|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
30662269|NCT00745095|58675807|FG005|Overall Study|Declined to participate|95|||
30662270|NCT00745095|58675802|FG000|Overall Study|Ineligible due to GFR criteria|0|||
30662271|NCT00745095|58675803|FG001|Overall Study|Ineligible due to GFR criteria|2|||
30662272|NCT00745095|58675804|FG002|Overall Study|Ineligible due to GFR criteria|3|||
30662273|NCT00745095|58675805|FG003|Overall Study|Ineligible due to GFR criteria|3|||
30662274|NCT00745095|58675806|FG004|Overall Study|Ineligible due to GFR criteria|30|||
30662275|NCT00745095|58675807|FG005|Overall Study|Ineligible due to GFR criteria|28|||
30662276|NCT00744939|58675828|FG000|Overall Study|Withdrawal by Subject|9|||
30662277|NCT00744939|58675828|FG000|Overall Study|Protocol Violation|13|||
30662278|NCT00744939|58675828|FG000|Overall Study|Death|24|||
30662279|NCT00744939|58675828|FG000|Overall Study|distance|4|||
30662280|NCT00744939|58675828|FG000|Overall Study|Lost to Follow-up|12|||
30771702|NCT03526861|58780926|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771703|NCT03526861|58780927|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771704|NCT03526861|58780928|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771705|NCT03526861|58780929|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771706|NCT03526861|58780930|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
30771707|NCT03526861|58780931|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
30771708|NCT03515811|58780953|FG000|Overall Study|Lost to Follow-up|2|||
30771709|NCT03515811|58780954|FG001|Overall Study|Lost to Follow-up|1|||
30771710|NCT03515811|58780953|FG000|Overall Study|Protocol Violation|1|||
30771711|NCT03515811|58780954|FG001|Overall Study|Protocol Violation|1|||
30771712|NCT03515811|58780953|FG000|Overall Study|Death|1|||
30771713|NCT03515811|58780954|FG001|Overall Study|Death|1|||
30771714|NCT03515811|58780953|FG000|Overall Study|Withdrawal by Subject|0|||
30771715|NCT03515811|58780954|FG001|Overall Study|Withdrawal by Subject|2|||
30771716|NCT03515811|58780953|FG000|Overall Study|Technical Problems|1|||
30771717|NCT03515811|58780954|FG001|Overall Study|Technical Problems|0|||
30771718|NCT03515811|58780953|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
30771719|NCT03515811|58780954|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
30771720|NCT03515811|58780953|FG000|Overall Study|COVID-19|0|||
30771721|NCT03515811|58780954|FG001|Overall Study|COVID-19|1|||
30771722|NCT03510884|58780967|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
30771723|NCT03510884|58780968|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
30771724|NCT03510884|58780969|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
30771725|NCT03510884|58780970|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
30849637|NCT01338415|58876547|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
30849638|NCT01338415|58876545|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
30849639|NCT01338415|58876546|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
30662281|NCT00744939|58675828|FG000|Overall Study|Medical history exclusionary|1|||
30662282|NCT00744939|58675828|FG000|Overall Study|Did not receive Magnevist|7|||
30849640|NCT01338415|58876547|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
30849641|NCT01338415|58876545|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
30849642|NCT01338415|58876546|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
30849643|NCT01338415|58876547|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
30952789|NCT01892189|59002200|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30952790|NCT01892189|59002201|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
30952791|NCT01892189|59002202|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
30952792|NCT01892189|59002203|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30952793|NCT01892189|59002204|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30952794|NCT01892189|59002205|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
30952795|NCT01892189|59002206|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30952796|NCT01892189|59002207|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
30952797|NCT01892189|59002199|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
30952798|NCT01892189|59002200|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
30952799|NCT01892189|59002201|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
30952800|NCT01892189|59002202|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
30952801|NCT01892189|59002203|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
30849644|NCT01338415|58876545|FG000|Exceptional Use Treatment Period|Death|0|||
30849645|NCT01338415|58876546|FG001|Exceptional Use Treatment Period|Death|0|||
30849646|NCT01338415|58876547|FG002|Exceptional Use Treatment Period|Death|1|||
30849647|NCT05258149|58876557|FG000|Period 1|Protocol Deviation|1|||
30849648|NCT05258149|58876558|FG001|Period 1|Protocol Deviation|0|||
30849649|NCT05258149|58876557|FG000|Period 1|Adverse Event|0|||
30849650|NCT05258149|58876558|FG001|Period 1|Adverse Event|1|||
30849651|NCT05258149|58876557|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
30849652|NCT05258149|58876558|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
30849653|NCT05258149|58876557|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
30849654|NCT05258149|58876558|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
30849655|NCT05258149|58876557|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
30849656|NCT05258149|58876558|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
30849657|NCT01371643|58876566|FG000|Overall Study|Withdrawal by Subject|3|||
30849658|NCT01371643|58876567|FG001|Overall Study|Withdrawal by Subject|0|||
30952802|NCT01892189|59002204|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
30952803|NCT01892189|59002205|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
30952804|NCT01892189|59002206|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
30771726|NCT03510884|58780967|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
30771727|NCT03510884|58780968|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
30771728|NCT03510884|58780969|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
30771729|NCT03510884|58780970|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
30771730|NCT03510884|58780967|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
30771731|NCT03510884|58780968|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
30771732|NCT03510884|58780969|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
30771733|NCT03510884|58780970|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
30771734|NCT03510884|58780967|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
30771735|NCT03510884|58780968|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
30771736|NCT03510884|58780969|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
30771737|NCT03510884|58780970|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
30771738|NCT03510884|58780967|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
30771739|NCT03510884|58780968|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
30771740|NCT03510884|58780969|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
30771741|NCT03510884|58780970|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
30771742|NCT03510884|58780967|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
30771743|NCT03510884|58780968|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
30771744|NCT03510884|58780969|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
30771745|NCT03510884|58780970|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
30771746|NCT03510884|58780967|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
30771747|NCT03510884|58780968|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
30771748|NCT03510884|58780969|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
30771749|NCT03510884|58780970|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
30771750|NCT03510884|58780967|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
30771751|NCT03510884|58780968|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
30771752|NCT03510884|58780969|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
30771753|NCT03510884|58780970|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
30771754|NCT03510884|58780967|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
30771755|NCT03510884|58780968|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
30771756|NCT03510884|58780969|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
30771757|NCT03510884|58780970|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
30771758|NCT03510884|58780967|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
30771759|NCT03510884|58780968|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
30771760|NCT03510884|58780969|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
30771761|NCT03510884|58780970|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
30771762|NCT03488472|58781008|FG000|Overall Study|disease progression additional mets|1|||
30771763|NCT03456453|58781014|FG000|Overall Study|Withdrawal by Subject|2|||
30771764|NCT03456453|58781015|FG001|Overall Study|Withdrawal by Subject|0|||
30771765|NCT03456453|58781014|FG000|Overall Study|Not released to community|1|||
30771766|NCT03456453|58781015|FG001|Overall Study|Not released to community|5|||
30771767|NCT03456453|58781014|FG000|Overall Study|Lost to Follow-up|0|||
30771768|NCT03456453|58781015|FG001|Overall Study|Lost to Follow-up|2|||
30771769|NCT03455829|58781026|FG000|Overall Study|Death|2|||
30771770|NCT03455829|58781027|FG001|Overall Study|Death|3|||
30771771|NCT03455829|58781028|FG002|Overall Study|Death|2|||
30771772|NCT03455829|58781029|FG003|Overall Study|Death|4|||
30771773|NCT03455829|58781030|FG004|Overall Study|Death|2|||
30771774|NCT03455829|58781026|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
30771775|NCT03455829|58781027|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
30771776|NCT03455829|58781028|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
30849659|NCT01371565|58876573|FG000|Overall Study|Withdrawal by Subject|1|||
30849660|NCT01371565|58876573|FG000|Overall Study|Death|1|||
30849661|NCT01371565|58876573|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
30849662|NCT02821819|58876581|FG000|Overall Study|Protocol Violation|1|||
30771777|NCT03455829|58781029|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
30771778|NCT03455829|58781030|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
30771779|NCT03455829|58781026|FG000|Overall Study|Disease progression|0|||
30771780|NCT03455829|58781027|FG001|Overall Study|Disease progression|0|||
30771781|NCT03455829|58781028|FG002|Overall Study|Disease progression|0|||
30771782|NCT03455829|58781029|FG003|Overall Study|Disease progression|1|||
30771783|NCT03455829|58781030|FG004|Overall Study|Disease progression|1|||
30771784|NCT03441334|58781044|FG000|Overall Study|Withdrawal by Subject|1|||
30771785|NCT03441334|58781045|FG001|Overall Study|Withdrawal by Subject|0|||
30771786|NCT03429244|58781076|FG000|Overall Study|Withdrawal by Subject|2|||
30771787|NCT03429244|58781077|FG001|Overall Study|Withdrawal by Subject|1|||
30771788|NCT03429244|58781078|FG002|Overall Study|Withdrawal by Subject|1|||
30771789|NCT03370276|58781094|FG000|Overall Study|Death|0|||
30771790|NCT03370276|58781095|FG001|Overall Study|Death|2|||
30771791|NCT03370276|58781096|FG002|Overall Study|Death|5|||
30771792|NCT03250117|58781104|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
30771793|NCT03250117|58781105|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
30771794|NCT03250117|58781106|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
30771795|NCT03250117|58781107|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
30771796|NCT03230838|58781113|FG000|Overall Study|Withdrawal by Subject|3|||
30771797|NCT03230838|58781114|FG001|Overall Study|Withdrawal by Subject|0|||
30771798|NCT03230838|58781113|FG000|Overall Study|Temperature excursion|1|||
30771799|NCT03230838|58781114|FG001|Overall Study|Temperature excursion|0|||
30771800|NCT03217136|58781122|FG000|Overall Study|Lost to Follow-up|2|||
30771801|NCT03217136|58781123|FG001|Overall Study|Lost to Follow-up|1|||
30771802|NCT03217136|58781122|FG000|Overall Study|Site Randomized Participant in Error|0|||
30771803|NCT03217136|58781123|FG001|Overall Study|Site Randomized Participant in Error|1|||
30771804|NCT03217136|58781122|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
30771805|NCT03217136|58781123|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
30771806|NCT03217136|58781122|FG000|Overall Study|Dispensing Error|1|||
30771807|NCT03217136|58781123|FG001|Overall Study|Dispensing Error|0|||
30771808|NCT03217136|58781122|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
30771809|NCT03217136|58781123|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
30771810|NCT03213665|58781129|FG000|Overall Study|Adverse Event|1|||
30771811|NCT03213665|58781129|FG000|Overall Study|Physician Decision|2|||
30771812|NCT03213665|58781129|FG000|Overall Study|Withdrawal by Subject|3|||
30771813|NCT03213665|58781129|FG000|Overall Study|Progressive Disease|13|||
30771814|NCT03179761|58781135|FG000|Overall Study|Death|2|||
30771815|NCT03179761|58781136|FG001|Overall Study|Death|5|||
30771816|NCT03179761|58781135|FG000|Overall Study|Lost to Follow-up|2|||
30771817|NCT03179761|58781136|FG001|Overall Study|Lost to Follow-up|2|||
30771818|NCT03179761|58781135|FG000|Overall Study|Protocol Violation|1|||
30771819|NCT03179761|58781136|FG001|Overall Study|Protocol Violation|0|||
30771820|NCT03179761|58781135|FG000|Overall Study|Withdrawal by Subject|1|||
30771821|NCT03179761|58781136|FG001|Overall Study|Withdrawal by Subject|4|||
30771822|NCT03179761|58781135|FG000|Overall Study|Investigator Request|0|||
30771823|NCT03179761|58781136|FG001|Overall Study|Investigator Request|2|||
30771824|NCT03173248|58781144|FG000|Overall Study|Death|28|||
30771825|NCT03173248|58781145|FG001|Overall Study|Death|46|||
30771826|NCT03173248|58781144|FG000|Overall Study|Lost to Follow-up|0|||
30771827|NCT03173248|58781145|FG001|Overall Study|Lost to Follow-up|1|||
30771828|NCT03173248|58781144|FG000|Overall Study|Withdrawal by Subject|6|||
30771829|NCT03173248|58781145|FG001|Overall Study|Withdrawal by Subject|4|||
30771830|NCT03173248|58781144|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
30771831|NCT03173248|58781145|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
30771832|NCT03155841|58781153|FG000|Overall Study|Protocol Violation|3|||
30771833|NCT03155841|58781154|FG001|Overall Study|Protocol Violation|4|||
30771834|NCT03122886|58781162|FG000|Overall Study|Withdrawal by Subject|1|||
30771835|NCT03122886|58781163|FG001|Overall Study|Withdrawal by Subject|2|||
30771836|NCT03114891|58781173|FG000|First Treatment Round|Lost to Follow-up|0|||
30771837|NCT03114891|58781174|FG001|First Treatment Round|Lost to Follow-up|1|||
30771838|NCT03114891|58781175|FG002|First Treatment Round|Lost to Follow-up|1|||
30771839|NCT03114891|58781176|FG003|First Treatment Round|Lost to Follow-up|0|||
30771840|NCT03114891|58781173|FG000|First Treatment Round|Withdrawal by Subject|0|||
30771841|NCT03114891|58781174|FG001|First Treatment Round|Withdrawal by Subject|2|||
30771842|NCT03114891|58781175|FG002|First Treatment Round|Withdrawal by Subject|0|||
30771843|NCT03114891|58781176|FG003|First Treatment Round|Withdrawal by Subject|1|||
30771844|NCT03114891|58781173|FG000|3 Week Break|Lost to Follow-up|1|||
30771845|NCT03114891|58781174|FG001|3 Week Break|Lost to Follow-up|0|||
30771846|NCT03114891|58781175|FG002|3 Week Break|Lost to Follow-up|0|||
30771847|NCT03114891|58781176|FG003|3 Week Break|Lost to Follow-up|1|||
30771848|NCT03114891|58781173|FG000|3 Week Break|Withdrawal by Subject|0|||
30771849|NCT03114891|58781174|FG001|3 Week Break|Withdrawal by Subject|1|||
30771850|NCT03114891|58781175|FG002|3 Week Break|Withdrawal by Subject|0|||
30771851|NCT03114891|58781176|FG003|3 Week Break|Withdrawal by Subject|0|||
30771852|NCT03114891|58781173|FG000|Second Treatment Round|Lost to Follow-up|1|||
30771853|NCT03114891|58781174|FG001|Second Treatment Round|Lost to Follow-up|0|||
30771854|NCT03114891|58781175|FG002|Second Treatment Round|Lost to Follow-up|0|||
30662283|NCT00744939|58675828|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
30662284|NCT00744939|58675828|FG000|Overall Study|coma|1|||
30662285|NCT00744939|58675828|FG000|Overall Study|incorrect race|1|||
30771855|NCT03114891|58781176|FG003|Second Treatment Round|Lost to Follow-up|0|||
30771856|NCT03114891|58781173|FG000|Second Treatment Round|Physician Decision|1|||
30771857|NCT03114891|58781174|FG001|Second Treatment Round|Physician Decision|0|||
30771858|NCT03114891|58781175|FG002|Second Treatment Round|Physician Decision|0|||
30771859|NCT03114891|58781176|FG003|Second Treatment Round|Physician Decision|0|||
30771860|NCT03057847|58781218|FG000|Overall Study|Lost to Follow-up|16|||
30771861|NCT02946463|58781246|FG000|Primary Evaluation Period|Physician Decision|0|||
30771862|NCT02946463|58781247|FG001|Primary Evaluation Period|Physician Decision|1|||
30771863|NCT02946463|58781246|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
30771864|NCT02946463|58781247|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
30771865|NCT02928224|58781257|FG000|Overall Study|Randomized, Not Treated|0|||
30771866|NCT02928224|58781258|FG001|Overall Study|Randomized, Not Treated|2|||
30771867|NCT02928224|58781259|FG002|Overall Study|Randomized, Not Treated|4|||
30771868|NCT02928224|58781260|FG003|Overall Study|Randomized, Not Treated|28|||
30771869|NCT02928224|58781257|FG000|Overall Study|Treatment Ongoing|6|||
30771870|NCT02928224|58781258|FG001|Overall Study|Treatment Ongoing|78|||
30771871|NCT02928224|58781259|FG002|Overall Study|Treatment Ongoing|78|||
30771872|NCT02928224|58781260|FG003|Overall Study|Treatment Ongoing|37|||
30771873|NCT02928224|58781257|FG000|Overall Study|Progressive Disease|23|||
30771874|NCT02928224|58781258|FG001|Overall Study|Progressive Disease|104|||
30771875|NCT02928224|58781259|FG002|Overall Study|Progressive Disease|101|||
30771876|NCT02928224|58781260|FG003|Overall Study|Progressive Disease|103|||
30771877|NCT02928224|58781257|FG000|Overall Study|Adverse Event|2|||
30771878|NCT02928224|58781258|FG001|Overall Study|Adverse Event|11|||
30771879|NCT02928224|58781259|FG002|Overall Study|Adverse Event|11|||
30771880|NCT02928224|58781260|FG003|Overall Study|Adverse Event|10|||
30771881|NCT02928224|58781257|FG000|Overall Study|Changes in Patient's Condition|3|||
30771882|NCT02928224|58781258|FG001|Overall Study|Changes in Patient's Condition|9|||
30771883|NCT02928224|58781259|FG002|Overall Study|Changes in Patient's Condition|9|||
30771884|NCT02928224|58781260|FG003|Overall Study|Changes in Patient's Condition|13|||
30771885|NCT02928224|58781257|FG000|Overall Study|Death|1|||
30771886|NCT02928224|58781258|FG001|Overall Study|Death|7|||
30771887|NCT02928224|58781259|FG002|Overall Study|Death|5|||
30771888|NCT02928224|58781260|FG003|Overall Study|Death|11|||
30771889|NCT02928224|58781257|FG000|Overall Study|Withdrawal by Subject|1|||
30771890|NCT02928224|58781258|FG001|Overall Study|Withdrawal by Subject|4|||
30771891|NCT02928224|58781259|FG002|Overall Study|Withdrawal by Subject|3|||
30771892|NCT02928224|58781260|FG003|Overall Study|Withdrawal by Subject|9|||
30771893|NCT02928224|58781257|FG000|Overall Study|Dose Interruptions>28|1|||
30771894|NCT02928224|58781258|FG001|Overall Study|Dose Interruptions>28|2|||
30771895|NCT02928224|58781259|FG002|Overall Study|Dose Interruptions>28|2|||
30662286|NCT00744861|58675844|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
30662287|NCT00744861|58675845|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
30662288|NCT00744861|58675846|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
30662289|NCT00744861|58675847|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
30662290|NCT00744861|58675844|FG000|Feasibility Stage 1|Pregnancy|0|||
30662291|NCT00744861|58675845|FG001|Feasibility Stage 1|Pregnancy|1|||
30662292|NCT00744861|58675846|FG002|Feasibility Stage 1|Pregnancy|0|||
30662293|NCT00744861|58675847|FG003|Feasibility Stage 1|Pregnancy|0|||
30662294|NCT00744861|58675844|FG000|Pivotal Stage 2|Adverse Event|0|||
30662295|NCT00744861|58675845|FG001|Pivotal Stage 2|Adverse Event|0|||
30662296|NCT00744861|58675846|FG002|Pivotal Stage 2|Adverse Event|6|||
30662297|NCT00744861|58675847|FG003|Pivotal Stage 2|Adverse Event|11|||
30662298|NCT00744861|58675844|FG000|Pivotal Stage 2|Death|0|||
30662299|NCT00744861|58675845|FG001|Pivotal Stage 2|Death|0|||
30771896|NCT02928224|58781260|FG003|Overall Study|Dose Interruptions>28|4|||
30771897|NCT02928224|58781257|FG000|Overall Study|Patient Decision to Discontinue Drug|0|||
30771898|NCT02928224|58781258|FG001|Overall Study|Patient Decision to Discontinue Drug|2|||
30771899|NCT02928224|58781259|FG002|Overall Study|Patient Decision to Discontinue Drug|2|||
30771900|NCT02928224|58781260|FG003|Overall Study|Patient Decision to Discontinue Drug|4|||
30771901|NCT02928224|58781257|FG000|Overall Study|Physician Decision|0|||
30771902|NCT02928224|58781258|FG001|Overall Study|Physician Decision|2|||
30662300|NCT00744861|58675846|FG002|Pivotal Stage 2|Death|0|||
30662301|NCT00744861|58675847|FG003|Pivotal Stage 2|Death|1|||
30662302|NCT00744861|58675844|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
30662303|NCT00744861|58675845|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
30662304|NCT00744861|58675846|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
30662305|NCT00744861|58675847|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
30771903|NCT02928224|58781259|FG002|Overall Study|Physician Decision|4|||
30771904|NCT02928224|58781260|FG003|Overall Study|Physician Decision|2|||
30771905|NCT02928224|58781257|FG000|Overall Study|not listed|0|||
30771906|NCT02928224|58781258|FG001|Overall Study|not listed|3|||
30771907|NCT02928224|58781259|FG002|Overall Study|not listed|1|||
30771908|NCT02928224|58781260|FG003|Overall Study|not listed|0|||
30771909|NCT02872116|58781301|FG000|Pre-Treatment|Disease Progression|0|||
30771910|NCT02872116|58781302|FG001|Pre-Treatment|Disease Progression|1|||
30771911|NCT02872116|58781303|FG002|Pre-Treatment|Disease Progression|0|||
30771912|NCT02872116|58781301|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
30771913|NCT02872116|58781302|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
30771914|NCT02872116|58781303|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
30771915|NCT02872116|58781301|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
30771916|NCT02872116|58781302|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
30771917|NCT02872116|58781303|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
30771918|NCT02872116|58781301|FG000|Pre-Treatment|Participant withdrew consent|2|||
30771919|NCT02872116|58781302|FG001|Pre-Treatment|Participant withdrew consent|20|||
30771920|NCT02872116|58781303|FG002|Pre-Treatment|Participant withdrew consent|3|||
30771921|NCT02872116|58781301|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
30771922|NCT02872116|58781302|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
30771923|NCT02872116|58781303|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
30771924|NCT02872116|58781301|FG000|Pre-Treatment|Other reasons|1|||
30771925|NCT02872116|58781302|FG001|Pre-Treatment|Other reasons|2|||
30771926|NCT02872116|58781303|FG002|Pre-Treatment|Other reasons|2|||
30771927|NCT02872116|58781301|FG000|Treatment|Death|122|||
30771928|NCT02872116|58781302|FG001|Treatment|Death|94|||
30771929|NCT02872116|58781303|FG002|Treatment|Death|68|||
30771930|NCT02872116|58781301|FG000|Treatment|Lost to Follow-up|5|||
30771931|NCT02872116|58781302|FG001|Treatment|Lost to Follow-up|7|||
30771932|NCT02872116|58781303|FG002|Treatment|Lost to Follow-up|3|||
30771933|NCT02872116|58781301|FG000|Treatment|Participant withdrew consent|20|||
30771934|NCT02872116|58781302|FG001|Treatment|Participant withdrew consent|40|||
30771935|NCT02872116|58781303|FG002|Treatment|Participant withdrew consent|8|||
30771936|NCT02872116|58781301|FG000|Treatment|Other reasons|12|||
30771937|NCT02872116|58781302|FG001|Treatment|Other reasons|12|||
30771938|NCT02872116|58781303|FG002|Treatment|Other reasons|5|||
30771939|NCT02860039|58781317|FG000|Overall Study|Death|4|||
30771940|NCT02860039|58781318|FG001|Overall Study|Death|0|||
30771941|NCT02860039|58781317|FG000|Overall Study|Lost to Follow-up|2|||
30771942|NCT02860039|58781318|FG001|Overall Study|Lost to Follow-up|2|||
30771943|NCT02860039|58781317|FG000|Overall Study|Protocol Violation|3|||
30771944|NCT02860039|58781318|FG001|Overall Study|Protocol Violation|1|||
30771945|NCT02860039|58781317|FG000|Overall Study|Withdrawal by Subject|1|||
30771946|NCT02860039|58781318|FG001|Overall Study|Withdrawal by Subject|0|||
30771947|NCT02860039|58781317|FG000|Overall Study|Not otherwise eligible|1|||
30771948|NCT02860039|58781318|FG001|Overall Study|Not otherwise eligible|1|||
30771949|NCT02761694|58781348|FG000|Overall Study|Lack of Efficacy|0|||
30771950|NCT02761694|58781349|FG001|Overall Study|Lack of Efficacy|0|||
30771951|NCT02761694|58781350|FG002|Overall Study|Lack of Efficacy|0|||
30771952|NCT02761694|58781351|FG003|Overall Study|Lack of Efficacy|0|||
30771953|NCT02761694|58781352|FG004|Overall Study|Lack of Efficacy|0|||
30771954|NCT02761694|58781353|FG005|Overall Study|Lack of Efficacy|0|||
30771955|NCT02761694|58781354|FG006|Overall Study|Lack of Efficacy|6|||
30771956|NCT02761694|58781355|FG007|Overall Study|Lack of Efficacy|0|||
30771957|NCT02761694|58781356|FG008|Overall Study|Lack of Efficacy|0|||
30771958|NCT02761694|58781357|FG009|Overall Study|Lack of Efficacy|1|||
30771959|NCT02761694|58781358|FG010|Overall Study|Lack of Efficacy|1|||
30771960|NCT02761694|58781359|FG011|Overall Study|Lack of Efficacy|4|||
30771961|NCT02761694|58781348|FG000|Overall Study|Death|0|||
30771962|NCT02761694|58781349|FG001|Overall Study|Death|0|||
30771963|NCT02761694|58781350|FG002|Overall Study|Death|0|||
30771964|NCT02761694|58781351|FG003|Overall Study|Death|0|||
30771965|NCT02761694|58781352|FG004|Overall Study|Death|0|||
30771966|NCT02761694|58781353|FG005|Overall Study|Death|0|||
30771967|NCT02761694|58781354|FG006|Overall Study|Death|2|||
30771968|NCT02761694|58781355|FG007|Overall Study|Death|0|||
30771969|NCT02761694|58781356|FG008|Overall Study|Death|2|||
30771970|NCT02761694|58781357|FG009|Overall Study|Death|2|||
30771971|NCT02761694|58781358|FG010|Overall Study|Death|1|||
30771972|NCT02761694|58781359|FG011|Overall Study|Death|0|||
30771973|NCT02761694|58781348|FG000|Overall Study|Physician Decision|0|||
30771974|NCT02761694|58781349|FG001|Overall Study|Physician Decision|0|||
30771975|NCT02761694|58781350|FG002|Overall Study|Physician Decision|0|||
30771976|NCT02761694|58781351|FG003|Overall Study|Physician Decision|0|||
30771977|NCT02761694|58781352|FG004|Overall Study|Physician Decision|0|||
30771978|NCT02761694|58781353|FG005|Overall Study|Physician Decision|0|||
30771979|NCT02761694|58781354|FG006|Overall Study|Physician Decision|1|||
30771980|NCT02761694|58781355|FG007|Overall Study|Physician Decision|0|||
30771981|NCT02761694|58781356|FG008|Overall Study|Physician Decision|0|||
30771982|NCT02761694|58781357|FG009|Overall Study|Physician Decision|0|||
30771983|NCT02761694|58781358|FG010|Overall Study|Physician Decision|0|||
30771984|NCT02761694|58781359|FG011|Overall Study|Physician Decision|0|||
30771985|NCT02761694|58781348|FG000|Overall Study|Withdrawal by Subject|0|||
30771986|NCT02761694|58781349|FG001|Overall Study|Withdrawal by Subject|0|||
30771987|NCT02761694|58781350|FG002|Overall Study|Withdrawal by Subject|0|||
30771988|NCT02761694|58781351|FG003|Overall Study|Withdrawal by Subject|1|||
30771989|NCT02761694|58781352|FG004|Overall Study|Withdrawal by Subject|0|||
30771990|NCT02761694|58781353|FG005|Overall Study|Withdrawal by Subject|0|||
30771991|NCT02761694|58781354|FG006|Overall Study|Withdrawal by Subject|4|||
30771992|NCT02761694|58781355|FG007|Overall Study|Withdrawal by Subject|0|||
30771993|NCT02761694|58781356|FG008|Overall Study|Withdrawal by Subject|2|||
30771994|NCT02761694|58781357|FG009|Overall Study|Withdrawal by Subject|1|||
30771995|NCT02761694|58781358|FG010|Overall Study|Withdrawal by Subject|0|||
30771996|NCT02761694|58781359|FG011|Overall Study|Withdrawal by Subject|0|||
30771997|NCT02761694|58781348|FG000|Overall Study|Lost to Follow-up|0|||
30771998|NCT02761694|58781349|FG001|Overall Study|Lost to Follow-up|0|||
30771999|NCT02761694|58781350|FG002|Overall Study|Lost to Follow-up|0|||
30772000|NCT02761694|58781351|FG003|Overall Study|Lost to Follow-up|0|||
30772001|NCT02761694|58781352|FG004|Overall Study|Lost to Follow-up|0|||
30772002|NCT02761694|58781353|FG005|Overall Study|Lost to Follow-up|0|||
30772003|NCT02761694|58781354|FG006|Overall Study|Lost to Follow-up|1|||
30772004|NCT02761694|58781355|FG007|Overall Study|Lost to Follow-up|0|||
30772005|NCT02761694|58781356|FG008|Overall Study|Lost to Follow-up|0|||
30772006|NCT02761694|58781357|FG009|Overall Study|Lost to Follow-up|0|||
30772007|NCT02761694|58781358|FG010|Overall Study|Lost to Follow-up|0|||
30772008|NCT02761694|58781359|FG011|Overall Study|Lost to Follow-up|1|||
30772009|NCT02761694|58781348|FG000|Overall Study|Adverse Event|0|||
30772010|NCT02761694|58781349|FG001|Overall Study|Adverse Event|0|||
30772011|NCT02761694|58781350|FG002|Overall Study|Adverse Event|0|||
30772012|NCT02761694|58781351|FG003|Overall Study|Adverse Event|0|||
30772013|NCT02761694|58781352|FG004|Overall Study|Adverse Event|0|||
30772014|NCT02761694|58781353|FG005|Overall Study|Adverse Event|0|||
30772015|NCT02761694|58781354|FG006|Overall Study|Adverse Event|1|||
30772016|NCT02761694|58781355|FG007|Overall Study|Adverse Event|0|||
30772017|NCT02761694|58781356|FG008|Overall Study|Adverse Event|1|||
30772018|NCT02761694|58781357|FG009|Overall Study|Adverse Event|0|||
30772019|NCT02761694|58781358|FG010|Overall Study|Adverse Event|0|||
30772020|NCT02761694|58781359|FG011|Overall Study|Adverse Event|1|||
30772021|NCT02761694|58781348|FG000|Overall Study|Other|4|||
30772022|NCT02761694|58781349|FG001|Overall Study|Other|4|||
30772023|NCT02761694|58781350|FG002|Overall Study|Other|1|||
30772024|NCT02761694|58781351|FG003|Overall Study|Other|2|||
30772025|NCT02761694|58781352|FG004|Overall Study|Other|3|||
30772026|NCT02761694|58781353|FG005|Overall Study|Other|3|||
30772027|NCT02761694|58781354|FG006|Overall Study|Other|18|||
30772028|NCT02761694|58781355|FG007|Overall Study|Other|8|||
30952805|NCT01892189|59002207|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
30952806|NCT01881425|59002238|FG000|Overall Study|Death|5|||
30952807|NCT01881425|59002239|FG001|Overall Study|Death|1|||
30952808|NCT01881425|59002238|FG000|Overall Study|Withdrawal by Subject|8|||
30952809|NCT01881425|59002239|FG001|Overall Study|Withdrawal by Subject|3|||
30952810|NCT01881425|59002238|FG000|Overall Study|Physician Decision|2|||
30952811|NCT01881425|59002239|FG001|Overall Study|Physician Decision|1|||
30952812|NCT01881425|59002238|FG000|Overall Study|Adverse Event|3|||
30952813|NCT01881425|59002239|FG001|Overall Study|Adverse Event|0|||
30952814|NCT01881425|59002238|FG000|Overall Study|General Anesthesia panic attack|0|||
30952815|NCT01881425|59002239|FG001|Overall Study|General Anesthesia panic attack|1|||
30952816|NCT01881425|59002238|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
30952817|NCT01881425|59002239|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
30952818|NCT01881425|59002238|FG000|Overall Study|Lost to Follow-up|7|||
30772029|NCT02761694|58781356|FG008|Overall Study|Other|0|||
30772030|NCT02761694|58781357|FG009|Overall Study|Other|1|||
30772031|NCT02761694|58781358|FG010|Overall Study|Other|1|||
30772032|NCT02761694|58781359|FG011|Overall Study|Other|0|||
30772033|NCT02726386|58781388|FG000|Overall Study|Adverse Event|17|||
30772034|NCT02726386|58781389|FG001|Overall Study|Adverse Event|20|||
30772035|NCT02726386|58781388|FG000|Overall Study|Withdrawal by Subject|14|||
30772036|NCT02726386|58781389|FG001|Overall Study|Withdrawal by Subject|28|||
30772037|NCT02726386|58781388|FG000|Overall Study|Other reasons|7|||
30952819|NCT01881425|59002239|FG001|Overall Study|Lost to Follow-up|2|||
30952820|NCT01891721|59002258|FG000|Overall Study|Lost to Follow-up|10|||
30952821|NCT01891721|59002259|FG001|Overall Study|Lost to Follow-up|5|||
30952822|NCT01891721|59002260|FG002|Overall Study|Lost to Follow-up|1|||
30952823|NCT01880957|59002279|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
30849663|NCT03926611|58876592|FG000|Overall Study|Adverse Event|0|||
30772038|NCT02726386|58781389|FG001|Overall Study|Other reasons|8|||
30772039|NCT02574481|58781411|FG000|Overall Study|Withdrawal by Subject|29|||
30772040|NCT02574481|58781412|FG001|Overall Study|Withdrawal by Subject|15|||
30772041|NCT02574481|58781413|FG002|Overall Study|Withdrawal by Subject|4|||
30772042|NCT02574481|58781414|FG003|Overall Study|Withdrawal by Subject|1|||
30772043|NCT02574481|58781411|FG000|Overall Study|Adverse Event|5|||
30772044|NCT02574481|58781412|FG001|Overall Study|Adverse Event|1|||
30772045|NCT02574481|58781413|FG002|Overall Study|Adverse Event|1|||
30772046|NCT02574481|58781414|FG003|Overall Study|Adverse Event|0|||
30772047|NCT02574481|58781411|FG000|Overall Study|Visit Missed|15|||
30772048|NCT02574481|58781412|FG001|Overall Study|Visit Missed|7|||
30772049|NCT02574481|58781413|FG002|Overall Study|Visit Missed|5|||
30772050|NCT02574481|58781414|FG003|Overall Study|Visit Missed|0|||
30772051|NCT02574481|58781411|FG000|Overall Study|Other|7|||
30772052|NCT02574481|58781412|FG001|Overall Study|Other|2|||
30772053|NCT02574481|58781413|FG002|Overall Study|Other|0|||
30772054|NCT02574481|58781414|FG003|Overall Study|Other|0|||
30772055|NCT02574481|58781411|FG000|Overall Study|Death|48|||
30772056|NCT02574481|58781412|FG001|Overall Study|Death|26|||
30772057|NCT02574481|58781413|FG002|Overall Study|Death|12|||
30772058|NCT02574481|58781414|FG003|Overall Study|Death|4|||
30772059|NCT02574481|58781411|FG000|Overall Study|Physician Decision|5|||
30772060|NCT02574481|58781412|FG001|Overall Study|Physician Decision|2|||
30772061|NCT02574481|58781413|FG002|Overall Study|Physician Decision|0|||
30772062|NCT02574481|58781414|FG003|Overall Study|Physician Decision|0|||
30772063|NCT02574481|58781411|FG000|Overall Study|Lost to Follow-up|5|||
30772064|NCT02574481|58781412|FG001|Overall Study|Lost to Follow-up|1|||
30772065|NCT02574481|58781413|FG002|Overall Study|Lost to Follow-up|3|||
30772066|NCT02574481|58781414|FG003|Overall Study|Lost to Follow-up|0|||
30772067|NCT02438722|58781429|FG000|Overall Study|Adverse Event|12|||
30772068|NCT02438722|58781430|FG001|Overall Study|Adverse Event|9|||
30772069|NCT02438722|58781429|FG000|Overall Study|Refusal unrelated to AE|2|||
30662306|NCT00744861|58675844|FG000|Pivotal Stage 2|Physician Decision|0|||
30662307|NCT00744861|58675845|FG001|Pivotal Stage 2|Physician Decision|0|||
30662308|NCT00744861|58675846|FG002|Pivotal Stage 2|Physician Decision|3|||
30662309|NCT00744861|58675847|FG003|Pivotal Stage 2|Physician Decision|1|||
30662310|NCT00744861|58675844|FG000|Pivotal Stage 2|Protocol Violation|0|||
30662311|NCT00744861|58675845|FG001|Pivotal Stage 2|Protocol Violation|0|||
30662312|NCT00744861|58675846|FG002|Pivotal Stage 2|Protocol Violation|0|||
30662313|NCT00744861|58675847|FG003|Pivotal Stage 2|Protocol Violation|1|||
30662314|NCT00744861|58675844|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
30772070|NCT02438722|58781430|FG001|Overall Study|Refusal unrelated to AE|5|||
30772071|NCT02438722|58781429|FG000|Overall Study|Disease progression/relapse|46|||
30772072|NCT02438722|58781430|FG001|Overall Study|Disease progression/relapse|51|||
30772073|NCT02438722|58781429|FG000|Overall Study|Death|0|||
30772074|NCT02438722|58781430|FG001|Overall Study|Death|3|||
30772075|NCT02438722|58781429|FG000|Overall Study|Physician Decision|2|||
30772076|NCT02438722|58781430|FG001|Overall Study|Physician Decision|2|||
30772077|NCT02438722|58781429|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
30772078|NCT02438722|58781430|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
30772079|NCT02438722|58781429|FG000|Overall Study|Withdrawal by Subject|0|||
30772080|NCT02438722|58781430|FG001|Overall Study|Withdrawal by Subject|1|||
30772081|NCT02438722|58781429|FG000|Overall Study|On protocol treatment|15|||
30772082|NCT02438722|58781430|FG001|Overall Study|On protocol treatment|14|||
30772083|NCT02438722|58781429|FG000|Overall Study|Did not receive protocol treatment|5|||
30772084|NCT02438722|58781430|FG001|Overall Study|Did not receive protocol treatment|0|||
30772087|NCT02376829|58781451|FG000|Overall Study|Withdrawal by Subject|27|||
30772088|NCT02376829|58781452|FG001|Overall Study|Withdrawal by Subject|44|||
30772089|NCT02297438|58781461|FG000|Overall Study|Death|79|||
30772090|NCT02297438|58781462|FG001|Overall Study|Death|86|||
30772091|NCT02297438|58781461|FG000|Overall Study|Lost to Follow-up|9|||
30772092|NCT02297438|58781462|FG001|Overall Study|Lost to Follow-up|7|||
30772093|NCT02297438|58781461|FG000|Overall Study|Withdrawal by Subject|7|||
30772094|NCT02297438|58781462|FG001|Overall Study|Withdrawal by Subject|0|||
30772095|NCT02297438|58781461|FG000|Overall Study|Other|9|||
30772096|NCT02297438|58781462|FG001|Overall Study|Other|5|||
30772097|NCT02297438|58781461|FG000|Overall Study|Ongoing|65|||
30772098|NCT02297438|58781462|FG001|Overall Study|Ongoing|73|||
30772099|NCT02297139|58781470|FG000|Overall Study|Disease progression|0|||
30772100|NCT02297139|58781471|FG001|Overall Study|Disease progression|1|||
30772101|NCT02297139|58781470|FG000|Overall Study|Study drug toxicity|0|||
30772102|NCT02297139|58781471|FG001|Overall Study|Study drug toxicity|4|||
30772103|NCT02297139|58781470|FG000|Overall Study|Participant request to discontinue study treatment|0|||
30772104|NCT02297139|58781471|FG001|Overall Study|Participant request to discontinue study treatment|1|||
30772105|NCT02297139|58781470|FG000|Overall Study|Maximum clinical benefit|1|||
30662315|NCT00744861|58675845|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
30772106|NCT02297139|58781471|FG001|Overall Study|Maximum clinical benefit|0|||
30772107|NCT02297139|58781470|FG000|Overall Study|Administrative reason by sponsor|0|||
30662316|NCT00744861|58675846|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
30662317|NCT00744861|58675847|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
30772108|NCT02297139|58781471|FG001|Overall Study|Administrative reason by sponsor|2|||
30772109|NCT02297139|58781470|FG000|Overall Study|Other reasons|0|||
30772110|NCT02297139|58781471|FG001|Overall Study|Other reasons|8|||
30772111|NCT02142959|58781480|FG000|Overall Study|Adverse Event|1|||
30772112|NCT02142959|58781481|FG001|Overall Study|Adverse Event|0|||
30772113|NCT02142959|58781482|FG002|Overall Study|Adverse Event|0|||
30772114|NCT02142959|58781480|FG000|Overall Study|Death|0|||
30772115|NCT02142959|58781481|FG001|Overall Study|Death|1|||
30952824|NCT01880957|59002280|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
30952825|NCT01880957|59002279|FG000|Overall Study|Lost to Follow-up|11|||
30952826|NCT01880957|59002280|FG001|Overall Study|Lost to Follow-up|0|||
30952827|NCT01880957|59002279|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
30952828|NCT01880957|59002280|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
30662318|NCT00744861|58675844|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
30772116|NCT02142959|58781482|FG002|Overall Study|Death|0|||
30772117|NCT02142959|58781480|FG000|Overall Study|Withdrawal by Subject|3|||
30772118|NCT02142959|58781481|FG001|Overall Study|Withdrawal by Subject|1|||
30772119|NCT02142959|58781482|FG002|Overall Study|Withdrawal by Subject|3|||
30772120|NCT02142959|58781480|FG000|Overall Study|Administrative Reasons|1|||
30772121|NCT02142959|58781481|FG001|Overall Study|Administrative Reasons|0|||
30772122|NCT02142959|58781482|FG002|Overall Study|Administrative Reasons|1|||
30772123|NCT02142959|58781480|FG000|Overall Study|Missing|0|||
30772124|NCT02142959|58781481|FG001|Overall Study|Missing|1|||
30772125|NCT02142959|58781482|FG002|Overall Study|Missing|0|||
30772126|NCT02142959|58781480|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
30772127|NCT02142959|58781481|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
30772128|NCT02142959|58781482|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
30772129|NCT02142959|58781480|FG000|Overall Study|Patient didn't complete end of study visit|0|||
30772130|NCT02142959|58781481|FG001|Overall Study|Patient didn't complete end of study visit|0|||
30772131|NCT02142959|58781482|FG002|Overall Study|Patient didn't complete end of study visit|1|||
30772132|NCT02100722|58781501|FG000|Overall Study|Withdrawal pre-procedure|4|||
30772133|NCT02100722|58781502|FG001|Overall Study|Withdrawal pre-procedure|9|||
30772134|NCT02100722|58781501|FG000|Overall Study|Withdrawal post-procedure|0|||
30772135|NCT02100722|58781502|FG001|Overall Study|Withdrawal post-procedure|3|||
30772136|NCT02100722|58781501|FG000|Overall Study|Lost to Follow-up|2|||
30772137|NCT02100722|58781502|FG001|Overall Study|Lost to Follow-up|2|||
30952829|NCT04152837|59002295|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
30662319|NCT00744861|58675845|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
30662320|NCT00744861|58675846|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
30662321|NCT00744861|58675847|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
30662322|NCT03969589|58675857|FG000|Overall Study|Lost to Follow-up|3|||
30662323|NCT03969589|58675858|FG001|Overall Study|Lost to Follow-up|2|||
30662324|NCT03969589|58675857|FG000|Overall Study|Declined Follow-Up|0|||
30662325|NCT03969589|58675858|FG001|Overall Study|Declined Follow-Up|1|||
30662326|NCT00744627|58675866|FG000|Overall Study|Adverse Event|6|||
30662327|NCT00744627|58675867|FG001|Overall Study|Adverse Event|9|||
30662328|NCT00744627|58675866|FG000|Overall Study|Lack of Efficacy|7|||
30662329|NCT00744627|58675867|FG001|Overall Study|Lack of Efficacy|3|||
30662330|NCT00744627|58675866|FG000|Overall Study|Noncompliance|0|||
30662331|NCT00744627|58675867|FG001|Overall Study|Noncompliance|1|||
30662332|NCT00744627|58675866|FG000|Overall Study|Protocol Deviations|0|||
30662333|NCT00744627|58675867|FG001|Overall Study|Protocol Deviations|2|||
30662334|NCT00744627|58675866|FG000|Overall Study|Voluntary Withdrawal|9|||
30662335|NCT00744627|58675867|FG001|Overall Study|Voluntary Withdrawal|6|||
30662336|NCT00744627|58675866|FG000|Overall Study|Lost to Follow-up|2|||
30662337|NCT00744627|58675867|FG001|Overall Study|Lost to Follow-up|1|||
30662338|NCT00744627|58675866|FG000|Overall Study|Other|1|||
30662339|NCT00744627|58675867|FG001|Overall Study|Other|0|||
30662340|NCT03959137|58675873|FG000|Overall Study|Protocol Violation|6|||
30662341|NCT00562627|58675880|FG000|Overall Study|Protocol Violation|1|||
30662342|NCT00562627|58675881|FG001|Overall Study|Protocol Violation|1|||
30662343|NCT00562627|58675882|FG002|Overall Study|Protocol Violation|1|||
30662344|NCT00562159|58675892|FG000|Overall Study|Adverse Event|11|||
30662345|NCT00562159|58675893|FG001|Overall Study|Adverse Event|8|||
30662346|NCT00562159|58675892|FG000|Overall Study|Lost to Follow-up|5|||
30772138|NCT02100722|58781501|FG000|Overall Study|Continuing on study|751|||
30772139|NCT02100722|58781502|FG001|Overall Study|Continuing on study|729|||
30952830|NCT04152837|59002295|FG000|Maintenance Period|Adverse Event|1|||
30662347|NCT00562159|58675893|FG001|Overall Study|Lost to Follow-up|4|||
30662348|NCT00562159|58675892|FG000|Overall Study|Withdrawal by Subject|9|||
30662349|NCT00562159|58675893|FG001|Overall Study|Withdrawal by Subject|8|||
30662350|NCT00562159|58675892|FG000|Overall Study|Protocol Violation|12|||
30662351|NCT00562159|58675893|FG001|Overall Study|Protocol Violation|12|||
30662352|NCT00562159|58675892|FG000|Overall Study|Did not meet protocol eligibility|1|||
30662353|NCT00562159|58675893|FG001|Overall Study|Did not meet protocol eligibility|1|||
30662354|NCT04223778|58675902|FG000|Overall Study|Ongoing|322|||
30662355|NCT04223778|58675903|FG001|Overall Study|Ongoing|326|||
30662356|NCT04223778|58675902|FG000|Overall Study|Death|0|||
30662357|NCT04223778|58675903|FG001|Overall Study|Death|1|||
30662358|NCT04223778|58675902|FG000|Overall Study|Lost to Follow-up|1|||
30662359|NCT04223778|58675903|FG001|Overall Study|Lost to Follow-up|5|||
30662360|NCT04223778|58675902|FG000|Overall Study|Physician Decision|3|||
30662361|NCT04223778|58675903|FG001|Overall Study|Physician Decision|1|||
30662362|NCT04223778|58675902|FG000|Overall Study|Withdrawal by Subject|10|||
30772140|NCT02028988|58781518|FG000|Overall Study|Withdrawal by Subject|2|||
30772141|NCT02004236|58781525|FG000|Overall Study|Lack of Efficacy|0|||
30772142|NCT02004236|58781526|FG001|Overall Study|Lack of Efficacy|0|||
30772143|NCT02004236|58781527|FG002|Overall Study|Lack of Efficacy|16|||
30772144|NCT01974440|58781538|FG000|Overall Study|Lost to Follow-up|8|||
30772145|NCT01974440|58781539|FG001|Overall Study|Lost to Follow-up|7|||
30772146|NCT01974440|58781538|FG000|Overall Study|Withdrawal by Subject|20|||
30772147|NCT01974440|58781539|FG001|Overall Study|Withdrawal by Subject|19|||
30772148|NCT01974440|58781538|FG000|Overall Study|Ongoing|112|||
30772149|NCT01974440|58781539|FG001|Overall Study|Ongoing|116|||
30772150|NCT01959139|58781549|FG000|Phase II|Disease progression|0|||
30772151|NCT01959139|58781550|FG001|Phase II|Disease progression|0|||
30772152|NCT01959139|58781551|FG002|Phase II|Disease progression|26|||
30772153|NCT01959139|58781552|FG003|Phase II|Disease progression|34|||
30772154|NCT01959139|58781549|FG000|Phase II|Adverse Event|0|||
30772155|NCT01959139|58781550|FG001|Phase II|Adverse Event|0|||
30772156|NCT01959139|58781551|FG002|Phase II|Adverse Event|10|||
30772157|NCT01959139|58781552|FG003|Phase II|Adverse Event|11|||
30772158|NCT01959139|58781549|FG000|Phase II|Patient Refusal|0|||
30772159|NCT01959139|58781550|FG001|Phase II|Patient Refusal|0|||
30772160|NCT01959139|58781551|FG002|Phase II|Patient Refusal|5|||
30772161|NCT01959139|58781552|FG003|Phase II|Patient Refusal|4|||
30772162|NCT01959139|58781549|FG000|Phase II|Death|0|||
30772163|NCT01959139|58781550|FG001|Phase II|Death|0|||
30772164|NCT01959139|58781551|FG002|Phase II|Death|3|||
30772165|NCT01959139|58781552|FG003|Phase II|Death|1|||
30772166|NCT01959139|58781549|FG000|Phase II|Other/Unknown|0|||
30772167|NCT01959139|58781550|FG001|Phase II|Other/Unknown|0|||
30772168|NCT01959139|58781551|FG002|Phase II|Other/Unknown|8|||
30772169|NCT01959139|58781552|FG003|Phase II|Other/Unknown|5|||
30772170|NCT01959139|58781549|FG000|Phase II|On treatment|0|||
30772171|NCT01959139|58781550|FG001|Phase II|On treatment|0|||
30772172|NCT01959139|58781551|FG002|Phase II|On treatment|4|||
30772173|NCT01959139|58781552|FG003|Phase II|On treatment|0|||
30772174|NCT01784068|58781585|FG000|NTCS Phase|Adverse Event|5|||
30772175|NCT01784068|58781586|FG001|NTCS Phase|Adverse Event|0|||
30772176|NCT01784068|58781585|FG000|NTCS Phase|Physician Decision|2|||
30772177|NCT01784068|58781586|FG001|NTCS Phase|Physician Decision|0|||
30772178|NCT01784068|58781585|FG000|NTCS Phase|Patient/guardian decision|3|||
30772179|NCT01784068|58781586|FG001|NTCS Phase|Patient/guardian decision|0|||
30772180|NCT01784068|58781585|FG000|NTCS Phase|Death|2|||
30772181|NCT01784068|58781586|FG001|NTCS Phase|Death|0|||
30772182|NCT01784068|58781585|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
30772183|NCT01784068|58781586|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
30772184|NCT01784068|58781585|FG000|TFR Phase|Physician Decision|0|||
30772185|NCT01784068|58781586|FG001|TFR Phase|Physician Decision|1|||
30772186|NCT01784068|58781585|FG000|TFR Phase|Patient/guardian decision|0|||
30772187|NCT01784068|58781586|FG001|TFR Phase|Patient/guardian decision|3|||
30772188|NCT01784068|58781585|FG000|TFR Phase|Death|0|||
30772189|NCT01784068|58781586|FG001|TFR Phase|Death|1|||
30772190|NCT01784068|58781585|FG000|TFR Phase|Lack of Efficacy|0|||
30772191|NCT01784068|58781586|FG001|TFR Phase|Lack of Efficacy|88|||
30772192|NCT01642251|58781600|FG000|Overall Study|Progressive disease|0|||
30662363|NCT04223778|58675903|FG001|Overall Study|Withdrawal by Subject|1|||
30662364|NCT04223778|58675902|FG000|Overall Study|Lack of Efficacy|0|||
30662365|NCT04223778|58675903|FG001|Overall Study|Lack of Efficacy|2|||
30772193|NCT01642251|58781601|FG001|Overall Study|Progressive disease|0|||
30772194|NCT01642251|58781602|FG002|Overall Study|Progressive disease|3|||
30772195|NCT01642251|58781603|FG003|Overall Study|Progressive disease|3|||
30772196|NCT01642251|58781600|FG000|Overall Study|Adverse Event|0|||
30772197|NCT01642251|58781601|FG001|Overall Study|Adverse Event|0|||
30772198|NCT01642251|58781602|FG002|Overall Study|Adverse Event|5|||
30772199|NCT01642251|58781603|FG003|Overall Study|Adverse Event|4|||
30772200|NCT01642251|58781600|FG000|Overall Study|Death|0|||
30772201|NCT01642251|58781601|FG001|Overall Study|Death|0|||
30772202|NCT01642251|58781602|FG002|Overall Study|Death|1|||
30772203|NCT01642251|58781603|FG003|Overall Study|Death|3|||
30772204|NCT01642251|58781600|FG000|Overall Study|Withdrawal by Subject|0|||
30772205|NCT01642251|58781601|FG001|Overall Study|Withdrawal by Subject|0|||
30772206|NCT01642251|58781602|FG002|Overall Study|Withdrawal by Subject|1|||
30772207|NCT01642251|58781603|FG003|Overall Study|Withdrawal by Subject|3|||
30662366|NCT00921557|58675912|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
30662367|NCT00921557|58675913|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
30662368|NCT00921557|58675914|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
30662369|NCT00921557|58675912|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
30662370|NCT00921557|58675913|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
30662371|NCT00921557|58675914|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
30662372|NCT00921557|58675912|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
30662373|NCT00921557|58675913|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
30662374|NCT00921557|58675914|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
30662375|NCT00921557|58675912|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
30662376|NCT00921557|58675913|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
30662377|NCT00921557|58675914|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
30662378|NCT00921557|58675912|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
30662379|NCT00921557|58675913|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
30662380|NCT00921557|58675914|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
30662381|NCT00550615|58675929|FG000|Overall Study|Withdrawal by Subject|0|||
30662382|NCT00550615|58675930|FG001|Overall Study|Withdrawal by Subject|0|||
30662383|NCT00550615|58675931|FG002|Overall Study|Withdrawal by Subject|2|||
30772208|NCT01642251|58781600|FG000|Overall Study|Alternative therapy|0|||
30772209|NCT01642251|58781601|FG001|Overall Study|Alternative therapy|0|||
30772210|NCT01642251|58781602|FG002|Overall Study|Alternative therapy|0|||
30662384|NCT00550615|58675932|FG003|Overall Study|Withdrawal by Subject|3|||
30772211|NCT01642251|58781603|FG003|Overall Study|Alternative therapy|2|||
30849664|NCT03926611|58876593|FG001|Overall Study|Adverse Event|0|||
30772212|NCT01642251|58781600|FG000|Overall Study|Other complicating disease|0|||
30772213|NCT01642251|58781601|FG001|Overall Study|Other complicating disease|0|||
30849665|NCT03926611|58876594|FG002|Overall Study|Adverse Event|0|||
30772214|NCT01642251|58781602|FG002|Overall Study|Other complicating disease|1|||
30772215|NCT01642251|58781603|FG003|Overall Study|Other complicating disease|0|||
30662385|NCT00550615|58675929|FG000|Overall Study|Not evaluable|0|||
30662386|NCT00550615|58675930|FG001|Overall Study|Not evaluable|0|||
30662387|NCT00550615|58675931|FG002|Overall Study|Not evaluable|2|||
30849666|NCT03926611|58876595|FG003|Overall Study|Adverse Event|3|||
30849667|NCT03926611|58876596|FG004|Overall Study|Adverse Event|1|||
30849668|NCT03926611|58876597|FG005|Overall Study|Adverse Event|3|||
30952831|NCT04152837|59002295|FG000|Maintenance Period|Withdrawal by Subject|1|||
30952832|NCT04152837|59002295|FG000|Maintenance Period|Sponsor Termination of Study|2|||
30952833|NCT01879553|59002314|FG000|Overall Study|Withdrawal by Subject|1|||
30952834|NCT01879553|59002315|FG001|Overall Study|Withdrawal by Subject|0|||
30952835|NCT01890785|59002336|FG000|Third Intervention|Withdrawal by Subject|0|||
30952836|NCT01890785|59002337|FG001|Third Intervention|Withdrawal by Subject|1|||
30952837|NCT01890785|59002338|FG002|Third Intervention|Withdrawal by Subject|0|||
30952838|NCT01890785|59002339|FG003|Third Intervention|Withdrawal by Subject|0|||
30952839|NCT01890785|59002340|FG004|Third Intervention|Withdrawal by Subject|0|||
30952840|NCT01890785|59002341|FG005|Third Intervention|Withdrawal by Subject|0|||
30952841|NCT01878383|59002365|FG000|Overall Study|Lost to Follow-up|0|||
30952842|NCT01878383|59002366|FG001|Overall Study|Lost to Follow-up|1499|||
30952843|NCT01878149|59002374|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
30952844|NCT01878149|59002375|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
30952845|NCT01863953|59002397|FG000|Overall Study|Adverse Event|0|||
30952846|NCT01863953|59002398|FG001|Overall Study|Adverse Event|0|||
30952847|NCT01863953|59002399|FG002|Overall Study|Adverse Event|1|||
30952848|NCT03049449|59002675|FG000|Overall Study|Did not receive treatment.|0|||
30952849|NCT03049449|59002676|FG001|Overall Study|Did not receive treatment.|0|||
30952850|NCT03049449|59002677|FG002|Overall Study|Did not receive treatment.|0|||
30952851|NCT03049449|59002678|FG003|Overall Study|Did not receive treatment.|0|||
30952852|NCT03049449|59002679|FG004|Overall Study|Did not receive treatment.|0|||
30952853|NCT03049449|59002680|FG005|Overall Study|Did not receive treatment.|0|||
30952854|NCT03049449|59002681|FG006|Overall Study|Did not receive treatment.|0|||
30952855|NCT03049449|59002682|FG007|Overall Study|Did not receive treatment.|0|||
30952856|NCT03049449|59002683|FG008|Overall Study|Did not receive treatment.|1|||
30952857|NCT03049449|59002684|FG009|Overall Study|Did not receive treatment.|0|||
30952858|NCT03049449|59002675|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
30952859|NCT03049449|59002676|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
30952860|NCT03049449|59002677|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
30952861|NCT03049449|59002678|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
30952862|NCT03049449|59002679|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
30952863|NCT03049449|59002680|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
30952864|NCT03049449|59002681|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
30952865|NCT03049449|59002682|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
30952866|NCT03049449|59002683|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
30849669|NCT03926611|58876598|FG006|Overall Study|Adverse Event|0|||
30849670|NCT03926611|58876592|FG000|Overall Study|Lack of Efficacy|1|||
30849671|NCT03926611|58876593|FG001|Overall Study|Lack of Efficacy|2|||
30952867|NCT03049449|59002684|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
30952868|NCT03049449|59002675|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
30952869|NCT03049449|59002676|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
30662388|NCT00550615|58675932|FG003|Overall Study|Not evaluable|7|||
30662389|NCT00744471|58675942|FG000|Overall Study|Randomized but not treated|1|||
30662390|NCT00744471|58675943|FG001|Overall Study|Randomized but not treated|1|||
30952870|NCT03049449|59002677|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
30662391|NCT00744471|58675944|FG002|Overall Study|Randomized but not treated|4|||
30849672|NCT03926611|58876594|FG002|Overall Study|Lack of Efficacy|0|||
30849673|NCT03926611|58876595|FG003|Overall Study|Lack of Efficacy|0|||
30772216|NCT01642251|58781600|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
30772217|NCT01642251|58781601|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
30772218|NCT01642251|58781602|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
30772219|NCT01642251|58781603|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
30772220|NCT01606137|58781612|FG000|Overall Study|Adverse Event|85|||
30772221|NCT01606137|58781612|FG000|Overall Study|Withdrawal by Subject|74|||
30772222|NCT01606137|58781612|FG000|Overall Study|Lack of Efficacy|56|||
30849674|NCT03926611|58876596|FG004|Overall Study|Lack of Efficacy|1|||
30849675|NCT03926611|58876597|FG005|Overall Study|Lack of Efficacy|0|||
30849676|NCT03926611|58876598|FG006|Overall Study|Lack of Efficacy|1|||
30849677|NCT03926611|58876592|FG000|Overall Study|Physician Decision|0|||
30849678|NCT03926611|58876593|FG001|Overall Study|Physician Decision|0|||
30849679|NCT03926611|58876594|FG002|Overall Study|Physician Decision|0|||
30849680|NCT03926611|58876595|FG003|Overall Study|Physician Decision|0|||
30849681|NCT03926611|58876596|FG004|Overall Study|Physician Decision|0|||
30952871|NCT03049449|59002678|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
30952872|NCT03049449|59002679|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
30952873|NCT03049449|59002680|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
30952874|NCT03049449|59002681|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
30952875|NCT03049449|59002682|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
30952876|NCT03049449|59002683|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
30952877|NCT03049449|59002684|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
30952878|NCT02989857|59002807|FG000|Randomization Phase|Not Treated|3|||
30952879|NCT02989857|59002808|FG001|Randomization Phase|Not Treated|2|||
30952880|NCT02989857|59002809|FG002|Randomization Phase|Not Treated|0|||
30952881|NCT01877915|59002820|FG000|Overall Study|Lost to Follow-up|10|||
30952882|NCT01877915|59002821|FG001|Overall Study|Lost to Follow-up|9|||
30952883|NCT01877915|59002820|FG000|Overall Study|Withdrawal by Subject|42|||
30952884|NCT01877915|59002821|FG001|Overall Study|Withdrawal by Subject|55|||
30952885|NCT01877915|59002820|FG000|Overall Study|Other|2|||
30952886|NCT01877915|59002821|FG001|Overall Study|Other|4|||
30952887|NCT01876979|59002829|FG000|Overall Study|Physician Decision|2|||
30952888|NCT01876979|59002830|FG001|Overall Study|Physician Decision|3|||
30952889|NCT01860989|59002836|FG000|Overall Study|Unsatisfactory therapeutic|5|||
30952890|NCT01860677|59002852|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
30952891|NCT01860677|59002853|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
30952892|NCT01876901|59002871|FG000|Overall Study|Protocol Violation|10|||
30952893|NCT01876901|59002872|FG001|Overall Study|Protocol Violation|2|||
30952894|NCT01876901|59002871|FG000|Overall Study|No or other surgical intervention|7|||
30952895|NCT01876901|59002872|FG001|Overall Study|No or other surgical intervention|5|||
30952896|NCT01876823|59002879|FG000|Overall Study|Withdrawal by Subject|5|||
30952897|NCT01876823|59002879|FG000|Overall Study|Physician Decision|2|||
30952898|NCT01876823|59002879|FG000|Overall Study|Patients moved|2|||
30952899|NCT01876511|59002886|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
30952900|NCT01876511|59002887|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
30952901|NCT01876511|59002888|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
30952902|NCT01876511|59002886|FG000|Overall Study|Death (unrelated)|3|||
30952903|NCT01876511|59002887|FG001|Overall Study|Death (unrelated)|0|||
30952904|NCT01876511|59002888|FG002|Overall Study|Death (unrelated)|2|||
30952905|NCT01876511|59002886|FG000|Overall Study|Drug-related Toxicity|5|||
30952906|NCT01876511|59002887|FG001|Overall Study|Drug-related Toxicity|1|||
30952907|NCT01876511|59002888|FG002|Overall Study|Drug-related Toxicity|6|||
30952908|NCT01876511|59002886|FG000|Overall Study|Patient Decision|3|||
30952909|NCT01876511|59002887|FG001|Overall Study|Patient Decision|0|||
30952910|NCT01876511|59002888|FG002|Overall Study|Patient Decision|6|||
30952911|NCT01876511|59002886|FG000|Overall Study|Physician Decision|1|||
30952912|NCT01876511|59002887|FG001|Overall Study|Physician Decision|0|||
30952913|NCT01876511|59002888|FG002|Overall Study|Physician Decision|1|||
30952914|NCT01993719|59002903|FG000|First Drug Administration|Not treated|1|||
30952915|NCT01993719|59002904|FG001|First Drug Administration|Not treated|0|||
30952916|NCT01993719|59002905|FG002|First Drug Administration|Not treated|0|||
30952917|NCT01993719|59002906|FG003|First Drug Administration|Not treated|0|||
30772223|NCT01606137|58781612|FG000|Overall Study|Lost to Follow-up|15|||
30772224|NCT01606137|58781612|FG000|Overall Study|Protocol Violation|1|||
30849682|NCT03926611|58876597|FG005|Overall Study|Physician Decision|1|||
30849683|NCT03926611|58876598|FG006|Overall Study|Physician Decision|0|||
30952918|NCT01993719|59002907|FG004|First Drug Administration|Not treated|0|||
30952919|NCT00638235|59002949|FG000|Overall Study|Lost to Follow-up|31|||
30772225|NCT01606137|58781612|FG000|Overall Study|Patient non-compliance|9|||
30772226|NCT01606137|58781612|FG000|Overall Study|Death|1|||
30849684|NCT03926611|58876592|FG000|Overall Study|Protocol Violation|1|||
30849685|NCT03926611|58876593|FG001|Overall Study|Protocol Violation|0|||
30772227|NCT01606137|58781612|FG000|Overall Study|Decreased/no pain|4|||
30772228|NCT01606137|58781612|FG000|Overall Study|Issues with driving|4|||
30772229|NCT01606137|58781612|FG000|Overall Study|multiple sclerosis less stable|1|||
30772230|NCT01606137|58781612|FG000|Overall Study|Increased bilirubin|1|||
30772231|NCT01606137|58781612|FG000|Overall Study|Spray causes nausea|1|||
30772232|NCT01606137|58781612|FG000|Overall Study|Not enough improvement|4|||
30772233|NCT01606137|58781612|FG000|Overall Study|Wanted to try another treatment|1|||
30772234|NCT01606137|58781612|FG000|Overall Study|Patient leaving country|1|||
30772235|NCT01606137|58781612|FG000|Overall Study|Personal reasons|1|||
30772236|NCT01606137|58781612|FG000|Overall Study|Unable to tolerate study med. taste|1|||
30772237|NCT01606137|58781612|FG000|Overall Study|Patient moving|1|||
30772238|NCT01606137|58781612|FG000|Overall Study|Unable to collect consistent data|1|||
30772239|NCT01532518|58781619|FG000|Overall Study|Withdrawal by Subject|0|||
30772240|NCT01532518|58781620|FG001|Overall Study|Withdrawal by Subject|0|||
30772241|NCT01532518|58781621|FG002|Overall Study|Withdrawal by Subject|1|||
30772242|NCT00844285|58781649|FG000|Overall Study|Other|0|||
30772243|NCT00844285|58781650|FG001|Overall Study|Other|1|||
30772244|NCT00844285|58781651|FG002|Overall Study|Other|0|||
30772245|NCT00844285|58781649|FG000|Overall Study|Other than specified|95|||
30772246|NCT00844285|58781650|FG001|Overall Study|Other than specified|129|||
30772247|NCT00844285|58781651|FG002|Overall Study|Other than specified|12|||
30772248|NCT00844285|58781649|FG000|Overall Study|Site closure|256|||
30772249|NCT00844285|58781650|FG001|Overall Study|Site closure|450|||
30772250|NCT00844285|58781651|FG002|Overall Study|Site closure|50|||
30772251|NCT00844285|58781649|FG000|Overall Study|Follow-up < 8 years|16|||
30772252|NCT00844285|58781650|FG001|Overall Study|Follow-up < 8 years|23|||
30772253|NCT00844285|58781651|FG002|Overall Study|Follow-up < 8 years|4|||
30772254|NCT00844285|58781649|FG000|Overall Study|Protocol Violation|26|||
30772255|NCT00844285|58781650|FG001|Overall Study|Protocol Violation|28|||
30772256|NCT00844285|58781651|FG002|Overall Study|Protocol Violation|54|||
30849686|NCT03926611|58876594|FG002|Overall Study|Protocol Violation|0|||
30849687|NCT03926611|58876595|FG003|Overall Study|Protocol Violation|1|||
30849688|NCT03926611|58876596|FG004|Overall Study|Protocol Violation|1|||
30849689|NCT03926611|58876597|FG005|Overall Study|Protocol Violation|1|||
30772257|NCT00844285|58781649|FG000|Overall Study|Death|22|||
30772258|NCT00844285|58781650|FG001|Overall Study|Death|21|||
30772259|NCT00844285|58781651|FG002|Overall Study|Death|8|||
30772260|NCT00844285|58781649|FG000|Overall Study|Withdrew Consent|344|||
30772261|NCT00844285|58781650|FG001|Overall Study|Withdrew Consent|466|||
30772262|NCT00844285|58781651|FG002|Overall Study|Withdrew Consent|70|||
30772263|NCT00844285|58781649|FG000|Overall Study|Lost to Follow-up|330|||
30772264|NCT00844285|58781650|FG001|Overall Study|Lost to Follow-up|486|||
30772265|NCT00844285|58781651|FG002|Overall Study|Lost to Follow-up|74|||
30772266|NCT00711646|58781679|FG000|Overall Study|Adverse Event|6|||
30772267|NCT00711646|58781680|FG001|Overall Study|Adverse Event|1|||
30772268|NCT00711646|58781679|FG000|Overall Study|Withdrawal by Subject|4|||
30772269|NCT00711646|58781680|FG001|Overall Study|Withdrawal by Subject|0|||
30772270|NCT00711646|58781679|FG000|Overall Study|Protocol Violation|0|||
30772271|NCT00711646|58781680|FG001|Overall Study|Protocol Violation|1|||
30772272|NCT00711646|58781679|FG000|Overall Study|Lost to Follow-up|1|||
30772273|NCT00711646|58781680|FG001|Overall Study|Lost to Follow-up|0|||
30772274|NCT00711646|58781679|FG000|Overall Study|administrative decision|0|||
30772275|NCT00711646|58781680|FG001|Overall Study|administrative decision|1|||
30849690|NCT03926611|58876598|FG006|Overall Study|Protocol Violation|1|||
30849691|NCT03926611|58876592|FG000|Overall Study|Technical problems|0|||
30849692|NCT03926611|58876593|FG001|Overall Study|Technical problems|0|||
30849693|NCT03926611|58876594|FG002|Overall Study|Technical problems|0|||
30849694|NCT03926611|58876595|FG003|Overall Study|Technical problems|0|||
30849695|NCT03926611|58876596|FG004|Overall Study|Technical problems|0|||
30849696|NCT03926611|58876597|FG005|Overall Study|Technical problems|1|||
30849697|NCT03926611|58876598|FG006|Overall Study|Technical problems|0|||
30849698|NCT03926611|58876592|FG000|Overall Study|Withdrawal by Subject|1|||
30849699|NCT03926611|58876593|FG001|Overall Study|Withdrawal by Subject|1|||
30849700|NCT03926611|58876594|FG002|Overall Study|Withdrawal by Subject|1|||
30849701|NCT03926611|58876595|FG003|Overall Study|Withdrawal by Subject|0|||
30849702|NCT03926611|58876596|FG004|Overall Study|Withdrawal by Subject|0|||
30849703|NCT03926611|58876597|FG005|Overall Study|Withdrawal by Subject|1|||
30849704|NCT03926611|58876598|FG006|Overall Study|Withdrawal by Subject|3|||
30849705|NCT03926611|58876592|FG000|Overall Study|Covid-19 pandemic|0|||
30849706|NCT03926611|58876593|FG001|Overall Study|Covid-19 pandemic|0|||
30849707|NCT03926611|58876594|FG002|Overall Study|Covid-19 pandemic|1|||
30849708|NCT03926611|58876595|FG003|Overall Study|Covid-19 pandemic|0|||
30849709|NCT03926611|58876596|FG004|Overall Study|Covid-19 pandemic|1|||
30849710|NCT03926611|58876597|FG005|Overall Study|Covid-19 pandemic|2|||
30849711|NCT03926611|58876598|FG006|Overall Study|Covid-19 pandemic|0|||
30849712|NCT02818777|58876627|FG000|Overall Study|Adverse Event|3|||
30849713|NCT02817841|58876641|FG000|Overall Study|Lost to Follow-up|287|||
30849714|NCT02817841|58876641|FG000|Overall Study|Withdrawal by Subject|183|||
30849715|NCT02817841|58876641|FG000|Overall Study|Adverse event not related to bleeding|131|||
30772276|NCT00711646|58781679|FG000|Overall Study|patient non-compliance|1|||
30772277|NCT00711646|58781680|FG001|Overall Study|patient non-compliance|0|||
30772278|NCT00640133|58781706|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
30772279|NCT00640133|58781707|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
30772280|NCT00640133|58781706|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
30772281|NCT00640133|58781707|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
30772282|NCT00640133|58781706|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
30772283|NCT00640133|58781707|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
30772284|NCT00379340|58781734|FG000|Overall Study|Death|0|||
30772285|NCT00379340|58781735|FG001|Overall Study|Death|0|||
30772286|NCT00379340|58781736|FG002|Overall Study|Death|0|||
30772287|NCT00379340|58781737|FG003|Overall Study|Death|2|||
30772288|NCT00379340|58781738|FG004|Overall Study|Death|0|||
30772289|NCT00379340|58781734|FG000|Overall Study|Lack of Efficacy|6|||
30772290|NCT00379340|58781735|FG001|Overall Study|Lack of Efficacy|1|||
30772291|NCT00379340|58781736|FG002|Overall Study|Lack of Efficacy|0|||
30772292|NCT00379340|58781737|FG003|Overall Study|Lack of Efficacy|4|||
30772293|NCT00379340|58781738|FG004|Overall Study|Lack of Efficacy|3|||
30772294|NCT00379340|58781734|FG000|Overall Study|Physician Decision|6|||
30772295|NCT00379340|58781735|FG001|Overall Study|Physician Decision|2|||
30772296|NCT00379340|58781736|FG002|Overall Study|Physician Decision|1|||
30772297|NCT00379340|58781737|FG003|Overall Study|Physician Decision|2|||
30772298|NCT00379340|58781738|FG004|Overall Study|Physician Decision|3|||
30772299|NCT00379340|58781734|FG000|Overall Study|Withdrawal by Subject|0|||
30772300|NCT00379340|58781735|FG001|Overall Study|Withdrawal by Subject|0|||
30772301|NCT00379340|58781736|FG002|Overall Study|Withdrawal by Subject|0|||
30772302|NCT00379340|58781737|FG003|Overall Study|Withdrawal by Subject|1|||
30772303|NCT00379340|58781738|FG004|Overall Study|Withdrawal by Subject|0|||
30772304|NCT00379340|58781734|FG000|Overall Study|Refusal of further protocol therapy|1|||
30772305|NCT00379340|58781735|FG001|Overall Study|Refusal of further protocol therapy|0|||
30772306|NCT00379340|58781736|FG002|Overall Study|Refusal of further protocol therapy|1|||
30772307|NCT00379340|58781737|FG003|Overall Study|Refusal of further protocol therapy|1|||
30772308|NCT00379340|58781738|FG004|Overall Study|Refusal of further protocol therapy|7|||
30772309|NCT00379340|58781734|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
30772310|NCT00379340|58781735|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
30772311|NCT00379340|58781736|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
30772312|NCT00379340|58781737|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
30772313|NCT00379340|58781738|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
30772314|NCT00379340|58781734|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
30772315|NCT00379340|58781735|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
30772316|NCT00379340|58781736|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
30772317|NCT00379340|58781737|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
30772318|NCT00379340|58781738|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
30772319|NCT00301808|58781751|FG000|Overall Study|Adverse Event|5|||
30772320|NCT00301808|58781751|FG000|Overall Study|Death|3|||
30772321|NCT00301808|58781751|FG000|Overall Study|Lack of Efficacy|4|||
30772322|NCT04979858|58781779|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
30772323|NCT04979858|58781780|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
30772324|NCT04030598|58781828|FG000|Overall Study|Voluntary Withdrawal|0|||
30772325|NCT04030598|58781829|FG001|Overall Study|Voluntary Withdrawal|1|||
30772326|NCT04030598|58781830|FG002|Overall Study|Voluntary Withdrawal|0|||
30772327|NCT03830164|58781850|FG000|Overall Study|Adverse Event|0|||
30772328|NCT03830164|58781851|FG001|Overall Study|Adverse Event|2|||
30772329|NCT03830164|58781852|FG002|Overall Study|Adverse Event|0|||
30772330|NCT03830164|58781850|FG000|Overall Study|Lack of Efficacy|1|||
30772331|NCT03830164|58781851|FG001|Overall Study|Lack of Efficacy|5|||
30772332|NCT03830164|58781852|FG002|Overall Study|Lack of Efficacy|0|||
30772333|NCT03830164|58781850|FG000|Overall Study|Lost to Follow-up|0|||
30772334|NCT03830164|58781851|FG001|Overall Study|Lost to Follow-up|1|||
30772335|NCT03830164|58781852|FG002|Overall Study|Lost to Follow-up|0|||
30772336|NCT03830164|58781850|FG000|Overall Study|Withdrawal by Subject|1|||
30772337|NCT03830164|58781851|FG001|Overall Study|Withdrawal by Subject|0|||
30772338|NCT03830164|58781852|FG002|Overall Study|Withdrawal by Subject|0|||
30662392|NCT00744471|58675945|FG003|Overall Study|Randomized but not treated|0|||
30772339|NCT03777436|58781862|FG000|Placebo-controlled Phase|Adverse Event|8|||
30772340|NCT03777436|58781863|FG001|Placebo-controlled Phase|Adverse Event|10|||
30772341|NCT03777436|58781864|FG002|Placebo-controlled Phase|Adverse Event|0|||
30772342|NCT03777436|58781862|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
30772343|NCT03777436|58781863|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
30772344|NCT03777436|58781864|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
30772345|NCT03777436|58781862|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
30772346|NCT03777436|58781863|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
30662393|NCT00744471|58675942|FG000|Overall Study|Death|0|||
30662394|NCT00744471|58675943|FG001|Overall Study|Death|0|||
30772347|NCT03777436|58781864|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
30772348|NCT03777436|58781862|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
30772349|NCT03777436|58781863|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
30772350|NCT03777436|58781864|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
30772351|NCT03777436|58781862|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
30772352|NCT03777436|58781863|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
30772353|NCT03777436|58781864|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
30772354|NCT03777436|58781862|FG000|Placebo-controlled Phase|Physician Decision|0|||
30772355|NCT03777436|58781863|FG001|Placebo-controlled Phase|Physician Decision|1|||
30772356|NCT03777436|58781864|FG002|Placebo-controlled Phase|Physician Decision|0|||
30772357|NCT03777436|58781862|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
30772358|NCT03777436|58781863|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
30772359|NCT03777436|58781864|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
30772360|NCT03777436|58781862|FG000|Apremilast Extension Phase|Adverse Event|0|||
30772361|NCT03777436|58781863|FG001|Apremilast Extension Phase|Adverse Event|0|||
30772362|NCT03777436|58781864|FG002|Apremilast Extension Phase|Adverse Event|6|||
30772363|NCT03777436|58781862|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
30772364|NCT03777436|58781863|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
30772365|NCT03777436|58781864|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
30772366|NCT03777436|58781862|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
30772367|NCT03777436|58781863|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
30772368|NCT03777436|58781864|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
30772369|NCT03777436|58781862|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
30772370|NCT03777436|58781863|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
30772371|NCT03777436|58781864|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
30772372|NCT03777436|58781862|FG000|Apremilast Extension Phase|Miscellaneous|0|||
30772373|NCT03777436|58781863|FG001|Apremilast Extension Phase|Miscellaneous|0|||
30772374|NCT03777436|58781864|FG002|Apremilast Extension Phase|Miscellaneous|1|||
30772375|NCT03156023|58781880|FG000|Overall Study|Withdrawal by Subject|1|||
30772376|NCT03156023|58781881|FG001|Overall Study|Withdrawal by Subject|0|||
30772377|NCT03156023|58781882|FG002|Overall Study|Withdrawal by Subject|2|||
30772378|NCT03156023|58781883|FG003|Overall Study|Withdrawal by Subject|1|||
30772379|NCT03156023|58781884|FG004|Overall Study|Withdrawal by Subject|1|||
30772380|NCT03156023|58781880|FG000|Overall Study|Lost to Follow-up|0|||
30772381|NCT03156023|58781881|FG001|Overall Study|Lost to Follow-up|0|||
30772382|NCT03156023|58781882|FG002|Overall Study|Lost to Follow-up|0|||
30772383|NCT03156023|58781883|FG003|Overall Study|Lost to Follow-up|0|||
30772384|NCT03156023|58781884|FG004|Overall Study|Lost to Follow-up|1|||
30772385|NCT03025880|58781902|FG000|Overall Study|Adverse Event|1|||
30772386|NCT03025880|58781903|FG001|Overall Study|Adverse Event|0|||
30772387|NCT03025880|58781902|FG000|Overall Study|Death|1|||
30772388|NCT03025880|58781903|FG001|Overall Study|Death|1|||
30772389|NCT03025880|58781902|FG000|Overall Study|Withdrawal by Subject|0|||
30772390|NCT03025880|58781903|FG001|Overall Study|Withdrawal by Subject|1|||
30772391|NCT03025880|58781902|FG000|Overall Study|Physician Decision|0|||
30772392|NCT03025880|58781903|FG001|Overall Study|Physician Decision|1|||
30772393|NCT03025880|58781902|FG000|Overall Study|Progressive Disease|12|||
30772394|NCT03025880|58781903|FG001|Overall Study|Progressive Disease|19|||
30772395|NCT02027376|58781920|FG000|Overall Study|Death|1|||
30772396|NCT02027376|58781921|FG001|Overall Study|Death|0|||
30772397|NCT02027376|58781922|FG002|Overall Study|Death|0|||
30772398|NCT01924533|58781934|FG000|Overall Study|Death|181|||
30772399|NCT01924533|58781935|FG001|Overall Study|Death|200|||
30772400|NCT01924533|58781934|FG000|Overall Study|Lost to Follow-up|0|||
30772401|NCT01924533|58781935|FG001|Overall Study|Lost to Follow-up|1|||
30772402|NCT01924533|58781934|FG000|Overall Study|Withdrawal by Subject|7|||
30772403|NCT01924533|58781935|FG001|Overall Study|Withdrawal by Subject|3|||
30772404|NCT01924533|58781934|FG000|Overall Study|Other Eligibility criteria|1|||
30772405|NCT01924533|58781935|FG001|Overall Study|Other Eligibility criteria|1|||
30772406|NCT01606436|58781941|FG000|Overall Study|Withdrawal by Subject|0|||
30772407|NCT01606436|58781942|FG001|Overall Study|Withdrawal by Subject|0|||
30772408|NCT01606436|58781943|FG002|Overall Study|Withdrawal by Subject|1|||
30772409|NCT01606436|58781944|FG003|Overall Study|Withdrawal by Subject|1|||
30772410|NCT01606436|58781945|FG004|Overall Study|Withdrawal by Subject|1|||
30849716|NCT02817841|58876641|FG000|Overall Study|Adverse event related to bleeding|51|||
30772411|NCT01606436|58781946|FG005|Overall Study|Withdrawal by Subject|0|||
30772412|NCT01606436|58781941|FG000|Overall Study|Adverse Event|0|||
30772413|NCT01606436|58781942|FG001|Overall Study|Adverse Event|0|||
30772414|NCT01606436|58781943|FG002|Overall Study|Adverse Event|1|||
30849717|NCT02817841|58876641|FG000|Overall Study|Pregnancy|32|||
30772415|NCT01606436|58781944|FG003|Overall Study|Adverse Event|0|||
30772416|NCT01606436|58781945|FG004|Overall Study|Adverse Event|0|||
30772417|NCT01606436|58781946|FG005|Overall Study|Adverse Event|0|||
30772418|NCT01606436|58781941|FG000|Overall Study|Sponsor Decision|0|||
30772419|NCT01606436|58781942|FG001|Overall Study|Sponsor Decision|0|||
30772420|NCT01606436|58781943|FG002|Overall Study|Sponsor Decision|0|||
30772421|NCT01606436|58781944|FG003|Overall Study|Sponsor Decision|1|||
30772422|NCT01606436|58781945|FG004|Overall Study|Sponsor Decision|0|||
30772423|NCT01606436|58781946|FG005|Overall Study|Sponsor Decision|0|||
30772424|NCT00219557|58781957|FG000|Phase 1|Lack of Efficacy|3|||
30772425|NCT00219557|58781958|FG001|Phase 1|Lack of Efficacy|0|||
30772426|NCT00219557|58781959|FG002|Phase 1|Lack of Efficacy|0|||
30772427|NCT00219557|58781957|FG000|Phase 1|Adverse Event|2|||
30772428|NCT00219557|58781958|FG001|Phase 1|Adverse Event|0|||
30772429|NCT00219557|58781959|FG002|Phase 1|Adverse Event|0|||
30772430|NCT00219557|58781957|FG000|Phase 1|Withdrawal by Subject|1|||
30772431|NCT00219557|58781958|FG001|Phase 1|Withdrawal by Subject|0|||
30772432|NCT00219557|58781959|FG002|Phase 1|Withdrawal by Subject|0|||
30772433|NCT00219557|58781957|FG000|Phase 1|Started chemotherapy at other institute|1|||
30772434|NCT00219557|58781958|FG001|Phase 1|Started chemotherapy at other institute|0|||
30772435|NCT00219557|58781959|FG002|Phase 1|Started chemotherapy at other institute|0|||
30772436|NCT00219557|58781957|FG000|Phase 2|Lack of Efficacy|0|||
30772437|NCT00219557|58781958|FG001|Phase 2|Lack of Efficacy|21|||
30772438|NCT00219557|58781959|FG002|Phase 2|Lack of Efficacy|15|||
30772439|NCT00219557|58781957|FG000|Phase 2|Adverse Event|0|||
30772440|NCT00219557|58781958|FG001|Phase 2|Adverse Event|22|||
30772441|NCT00219557|58781959|FG002|Phase 2|Adverse Event|2|||
30772442|NCT00219557|58781957|FG000|Phase 2|Death|0|||
30772443|NCT00219557|58781958|FG001|Phase 2|Death|8|||
30772444|NCT00219557|58781959|FG002|Phase 2|Death|2|||
30772445|NCT00219557|58781957|FG000|Phase 2|Other|0|||
30772446|NCT00219557|58781958|FG001|Phase 2|Other|8|||
30772447|NCT00219557|58781959|FG002|Phase 2|Other|6|||
30772448|NCT00219557|58781957|FG000|Phase 2|Withdrawal by Subject|0|||
30772449|NCT00219557|58781958|FG001|Phase 2|Withdrawal by Subject|9|||
30772450|NCT00219557|58781959|FG002|Phase 2|Withdrawal by Subject|5|||
30772451|NCT00219557|58781957|FG000|Phase 2|Treatment not received|0|||
30772452|NCT00219557|58781958|FG001|Phase 2|Treatment not received|1|||
30772453|NCT00219557|58781959|FG002|Phase 2|Treatment not received|3|||
30772454|NCT00251927|58781974|FG000|Overall Study|Adverse Event|3|||
30772455|NCT00251927|58781975|FG001|Overall Study|Adverse Event|15|||
30772456|NCT00251927|58781974|FG000|Overall Study|Lack of Efficacy|22|||
30772457|NCT00251927|58781975|FG001|Overall Study|Lack of Efficacy|16|||
30772458|NCT00251927|58781974|FG000|Overall Study|Lost to Follow-up|22|||
30772459|NCT00251927|58781975|FG001|Overall Study|Lost to Follow-up|8|||
30772460|NCT00251927|58781974|FG000|Overall Study|Protocol Violation|1|||
30772461|NCT00251927|58781975|FG001|Overall Study|Protocol Violation|2|||
30772462|NCT00251927|58781974|FG000|Overall Study|Pregnancy|2|||
30772463|NCT00251927|58781975|FG001|Overall Study|Pregnancy|0|||
30772464|NCT00251927|58781974|FG000|Overall Study|Withdrawal by Subject|40|||
30772465|NCT00251927|58781975|FG001|Overall Study|Withdrawal by Subject|25|||
30772466|NCT00251927|58781974|FG000|Overall Study|Study-specific discont. achieved|13|||
30772467|NCT00251927|58781975|FG001|Overall Study|Study-specific discont. achieved|2|||
30772468|NCT00251927|58781974|FG000|Overall Study|Study procedure non-compliance|5|||
30772469|NCT00251927|58781975|FG001|Overall Study|Study procedure non-compliance|6|||
30772470|NCT00165503|58781982|FG000|Overall Study|Death|1|||
30772471|NCT00165503|58781982|FG000|Overall Study|Lost to Follow-up|12|||
30772472|NCT00165503|58781982|FG000|Overall Study|Unresectable|3|||
30772473|NCT00162773|58781986|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
30772474|NCT00209339|58781990|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
30772475|NCT00209339|58781990|FG000|At 12 Months Follow-up|Death|1|||
30772476|NCT00209339|58781990|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
30772477|NCT00209339|58781990|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
30772478|NCT00209339|58781990|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
30772479|NCT00209339|58781990|FG000|At 24 Months Follow-up|Death|1|||
30772480|NCT00209339|58781990|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
30772481|NCT00209339|58781990|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
30772482|NCT00209339|58781990|FG000|At 4 Years Follow-up|Death|1|||
30772483|NCT00209339|58781990|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
30772484|NCT00209339|58781990|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
30772485|NCT00209339|58781990|FG000|At 5 Years Follow-up|Death|1|||
30772486|NCT03823391|58781996|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
30772487|NCT03823391|58781997|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
30772488|NCT03823391|58781996|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
30772489|NCT03823391|58781997|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
30772490|NCT00209027|58782007|FG000|Overall Study|study terminated|10|||
30772491|NCT00209027|58782008|FG001|Overall Study|study terminated|0|||
30772492|NCT00208325|58782018|FG000|Overall Study|Death|18|||
30772493|NCT00208325|58782019|FG001|Overall Study|Death|19|||
30849718|NCT02817841|58876641|FG000|Overall Study|Pregnancy wish|17|||
30772494|NCT00208325|58782020|FG002|Overall Study|Death|7|||
30772495|NCT00208325|58782021|FG003|Overall Study|Death|5|||
30772496|NCT00208325|58782018|FG000|Overall Study|Withdrawal by Subject|0|||
30772497|NCT00208325|58782019|FG001|Overall Study|Withdrawal by Subject|1|||
30772498|NCT00208325|58782020|FG002|Overall Study|Withdrawal by Subject|0|||
30772499|NCT00208325|58782021|FG003|Overall Study|Withdrawal by Subject|0|||
30772500|NCT00208325|58782018|FG000|Overall Study|Revision|4|||
30772501|NCT00208325|58782019|FG001|Overall Study|Revision|1|||
30772502|NCT00208325|58782020|FG002|Overall Study|Revision|0|||
30772503|NCT00208325|58782021|FG003|Overall Study|Revision|4|||
30772504|NCT00208325|58782018|FG000|Overall Study|Lost to Follow-up|1|||
30772505|NCT00208325|58782019|FG001|Overall Study|Lost to Follow-up|0|||
30772506|NCT00208325|58782020|FG002|Overall Study|Lost to Follow-up|2|||
30772507|NCT00208325|58782021|FG003|Overall Study|Lost to Follow-up|0|||
30772508|NCT00208325|58782018|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
30772509|NCT00208325|58782019|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
30772510|NCT00208325|58782020|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
30772511|NCT00208325|58782021|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
30772512|NCT00208325|58782018|FG000|Overall Study|Does not wish to Continue in Study|5|||
30772513|NCT00208325|58782019|FG001|Overall Study|Does not wish to Continue in Study|8|||
30772514|NCT00208325|58782020|FG002|Overall Study|Does not wish to Continue in Study|3|||
30772515|NCT00208325|58782021|FG003|Overall Study|Does not wish to Continue in Study|2|||
30772516|NCT00208325|58782018|FG000|Overall Study|Other|2|||
30772517|NCT00208325|58782019|FG001|Overall Study|Other|1|||
30772518|NCT00208325|58782020|FG002|Overall Study|Other|1|||
30772519|NCT00208325|58782021|FG003|Overall Study|Other|0|||
30772520|NCT00208325|58782018|FG000|Overall Study|Mis-Randomized|17|||
30772521|NCT00208325|58782019|FG001|Overall Study|Mis-Randomized|20|||
30772522|NCT00208325|58782020|FG002|Overall Study|Mis-Randomized|0|||
30772523|NCT00208325|58782021|FG003|Overall Study|Mis-Randomized|0|||
30772524|NCT00160667|58782034|FG000|Overall Study|Adverse Event|3|||
30772525|NCT00160667|58782035|FG001|Overall Study|Adverse Event|1|||
30772526|NCT00160667|58782036|FG002|Overall Study|Adverse Event|4|||
30772527|NCT00160667|58782034|FG000|Overall Study|Withdrawal by Subject|2|||
30772528|NCT00160667|58782035|FG001|Overall Study|Withdrawal by Subject|0|||
30772529|NCT00160667|58782036|FG002|Overall Study|Withdrawal by Subject|1|||
30772530|NCT00160667|58782034|FG000|Overall Study|Lack of Efficacy|0|||
30772531|NCT00160667|58782035|FG001|Overall Study|Lack of Efficacy|1|||
30772532|NCT00160667|58782036|FG002|Overall Study|Lack of Efficacy|0|||
30772533|NCT00160667|58782034|FG000|Overall Study|Protocol Violation|0|||
30772534|NCT00160667|58782035|FG001|Overall Study|Protocol Violation|1|||
30772535|NCT00160667|58782036|FG002|Overall Study|Protocol Violation|0|||
30772536|NCT00160667|58782034|FG000|Overall Study|Patient decision|0|||
30772537|NCT00160667|58782035|FG001|Overall Study|Patient decision|0|||
30772538|NCT00160667|58782036|FG002|Overall Study|Patient decision|1|||
30772539|NCT00206375|58782048|FG000|Overall Study|Lost to Follow-up|1|||
30772540|NCT00206375|58782049|FG001|Overall Study|Lost to Follow-up|0|||
30772541|NCT00206375|58782050|FG002|Overall Study|Lost to Follow-up|0|||
30772542|NCT00206375|58782048|FG000|Overall Study|Withdrawal by Subject|2|||
30772543|NCT00206375|58782049|FG001|Overall Study|Withdrawal by Subject|1|||
30849719|NCT02817841|58876641|FG000|Overall Study|Other reasons|53|||
30849720|NCT02817841|58876641|FG000|Overall Study|Protocol Violation|94|||
30849721|NCT02814565|58876651|FG000|Overall Study|Lack of Efficacy|0|||
30849722|NCT02814565|58876652|FG001|Overall Study|Lack of Efficacy|1|||
30849723|NCT02814565|58876651|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
30849724|NCT02814565|58876652|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
30849725|NCT02650466|58876658|FG000|Overall Study|Physician Decision|1|||
30849726|NCT02650466|58876658|FG000|Overall Study|Withdrawal by Subject|5|||
30849727|NCT02650466|58876658|FG000|Overall Study|Lost to Follow-up|1|||
30849728|NCT02815735|58876664|FG000|First Intervention (4 Weeks)|Discomfort|1|||
30849729|NCT02815735|58876665|FG001|First Intervention (4 Weeks)|Discomfort|0|||
30849730|NCT02815735|58876664|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
30772544|NCT00206375|58782050|FG002|Overall Study|Withdrawal by Subject|3|||
30772545|NCT00206375|58782048|FG000|Overall Study|Study terminated due to lack of funds|0|||
30772546|NCT00206375|58782049|FG001|Overall Study|Study terminated due to lack of funds|1|||
30772547|NCT00206375|58782050|FG002|Overall Study|Study terminated due to lack of funds|1|||
30772548|NCT00160199|58782060|FG000|Overall Study|Adverse Event|5|||
30849731|NCT02815735|58876665|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
30849732|NCT02815735|58876664|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
30849733|NCT02815735|58876665|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
30772549|NCT00160199|58782061|FG001|Overall Study|Adverse Event|14|||
30849734|NCT02815735|58876664|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
30849735|NCT02815735|58876665|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
30772550|NCT00160199|58782060|FG000|Overall Study|Lack of Efficacy|0|||
30772551|NCT00160199|58782061|FG001|Overall Study|Lack of Efficacy|1|||
30772552|NCT00160199|58782060|FG000|Overall Study|Lost to Follow-up|7|||
30772553|NCT00160199|58782061|FG001|Overall Study|Lost to Follow-up|7|||
30772554|NCT00160199|58782060|FG000|Overall Study|Withdrawal by Subject|4|||
30772555|NCT00160199|58782061|FG001|Overall Study|Withdrawal by Subject|6|||
30772556|NCT00160199|58782060|FG000|Overall Study|Administrative|0|||
30772557|NCT00160199|58782061|FG001|Overall Study|Administrative|1|||
30772558|NCT00160199|58782060|FG000|Overall Study|Protocol Violation|8|||
30772559|NCT00160199|58782061|FG001|Overall Study|Protocol Violation|8|||
30772560|NCT00157157|58782067|FG000|Overall Study|Withdrawal by Subject|6|||
30772561|NCT00157157|58782067|FG000|Overall Study|Physician Decision|1|||
30772562|NCT00157157|58782067|FG000|Overall Study|Lost to Follow-up|1|||
30772563|NCT00157157|58782067|FG000|Overall Study|Enrolled in another study|1|||
30772564|NCT00157157|58782067|FG000|Overall Study|Met exclusion criteria|1|||
30772565|NCT00157157|58782067|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
30772566|NCT00203411|58782078|FG000|Follow-up|Progressive Disease|4|||
30772567|NCT00203021|58782085|FG000|Overall Study|Death|4|||
30772568|NCT00203021|58782086|FG001|Overall Study|Death|1|||
30772569|NCT00203021|58782085|FG000|Overall Study|Adverse Event|10|||
30772570|NCT00203021|58782086|FG001|Overall Study|Adverse Event|5|||
30772571|NCT00203021|58782085|FG000|Overall Study|Withdrawal by Subject|45|||
30772572|NCT00203021|58782086|FG001|Overall Study|Withdrawal by Subject|48|||
30772573|NCT00203021|58782085|FG000|Overall Study|Lost to Follow-up|9|||
30772574|NCT00203021|58782086|FG001|Overall Study|Lost to Follow-up|7|||
30772575|NCT00203021|58782085|FG000|Overall Study|Other than specified|11|||
30772576|NCT00203021|58782086|FG001|Overall Study|Other than specified|16|||
30772577|NCT00201851|58782095|FG000|Overall Study|Lost to Follow-up|2|||
30772578|NCT00201851|58782096|FG001|Overall Study|Lost to Follow-up|1|||
30772579|NCT00201851|58782097|FG002|Overall Study|Lost to Follow-up|0|||
30772580|NCT00201851|58782095|FG000|Overall Study|Ineligible post enrollment|6|||
30772581|NCT00201851|58782096|FG001|Overall Study|Ineligible post enrollment|1|||
30772582|NCT00201851|58782097|FG002|Overall Study|Ineligible post enrollment|1|||
30772583|NCT00200057|58782105|FG000|Overall Study|Lack of Efficacy|3|||
30772584|NCT00200057|58782105|FG000|Overall Study|Exited due to terminal illness of PI|2|||
30772585|NCT00200057|58782105|FG000|Overall Study|Withdrawal by Subject|1|||
30772586|NCT00200057|58782105|FG000|Overall Study|Change in medical condition|1|||
30772587|NCT00200057|58782105|FG000|Overall Study|Infection|1|||
30772588|NCT00200057|58782105|FG000|Overall Study|Death|1|||
30772589|NCT03129100|58782114|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
30772590|NCT03129100|58782115|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
30772591|NCT03129100|58782116|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
30772592|NCT03129100|58782117|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
30772593|NCT03129100|58782118|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
30772594|NCT03129100|58782119|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
30772595|NCT03129100|58782120|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
30772596|NCT03129100|58782121|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
30772597|NCT03129100|58782122|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
30772598|NCT03129100|58782123|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
30772599|NCT03129100|58782124|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
30772600|NCT03129100|58782125|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
30772601|NCT03129100|58782126|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
30772602|NCT03129100|58782127|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
30772603|NCT03129100|58782128|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
30772604|NCT03129100|58782129|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
30772605|NCT03129100|58782130|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
30772606|NCT03129100|58782131|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
30772607|NCT03129100|58782132|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
30772608|NCT03129100|58782133|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
30772609|NCT03129100|58782134|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
30772610|NCT03129100|58782135|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
30772611|NCT03129100|58782136|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
30772612|NCT03129100|58782137|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
30772613|NCT03129100|58782138|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
30772614|NCT03129100|58782139|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
30772615|NCT03129100|58782114|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
30772616|NCT03129100|58782115|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772617|NCT03129100|58782116|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772618|NCT03129100|58782117|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772619|NCT03129100|58782118|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772620|NCT03129100|58782119|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772621|NCT03129100|58782120|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772622|NCT03129100|58782121|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772623|NCT03129100|58782122|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772624|NCT03129100|58782123|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772625|NCT03129100|58782124|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772626|NCT03129100|58782125|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772627|NCT03129100|58782126|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772628|NCT03129100|58782127|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772629|NCT03129100|58782128|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772630|NCT03129100|58782129|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772631|NCT03129100|58782130|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772632|NCT03129100|58782131|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772633|NCT03129100|58782132|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772634|NCT03129100|58782133|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772635|NCT03129100|58782134|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772636|NCT03129100|58782135|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772637|NCT03129100|58782136|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772638|NCT03129100|58782137|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772639|NCT03129100|58782138|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30662395|NCT00744471|58675944|FG002|Overall Study|Death|0|||
30662396|NCT00744471|58675945|FG003|Overall Study|Death|1|||
30662397|NCT00744471|58675942|FG000|Overall Study|Adverse Event|6|||
30662398|NCT00744471|58675943|FG001|Overall Study|Adverse Event|7|||
30662399|NCT00744471|58675944|FG002|Overall Study|Adverse Event|5|||
30662400|NCT00744471|58675945|FG003|Overall Study|Adverse Event|9|||
30772640|NCT03129100|58782139|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
30772641|NCT03129100|58782114|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
30772642|NCT03129100|58782115|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
30772643|NCT03129100|58782116|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772644|NCT03129100|58782117|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772645|NCT03129100|58782118|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772646|NCT03129100|58782119|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772647|NCT03129100|58782120|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772648|NCT03129100|58782121|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772649|NCT03129100|58782122|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772650|NCT03129100|58782123|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772651|NCT03129100|58782124|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772652|NCT03129100|58782125|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772653|NCT03129100|58782126|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772654|NCT03129100|58782127|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772655|NCT03129100|58782128|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772656|NCT03129100|58782129|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772657|NCT03129100|58782130|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772658|NCT03129100|58782131|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772659|NCT03129100|58782132|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772660|NCT03129100|58782133|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772661|NCT03129100|58782134|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772662|NCT03129100|58782135|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772663|NCT03129100|58782136|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772664|NCT03129100|58782137|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772665|NCT03129100|58782138|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772666|NCT03129100|58782139|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
30772667|NCT03129100|58782114|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
30772668|NCT03129100|58782115|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
30772669|NCT03129100|58782116|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772670|NCT03129100|58782117|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772671|NCT03129100|58782118|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772672|NCT03129100|58782119|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772673|NCT03129100|58782120|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772674|NCT03129100|58782121|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772675|NCT03129100|58782122|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772676|NCT03129100|58782123|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772677|NCT03129100|58782124|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772678|NCT03129100|58782125|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772679|NCT03129100|58782126|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772680|NCT03129100|58782127|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772681|NCT03129100|58782128|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772682|NCT03129100|58782129|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772683|NCT03129100|58782130|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772684|NCT03129100|58782131|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772685|NCT03129100|58782132|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772686|NCT03129100|58782133|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772687|NCT03129100|58782134|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772688|NCT03129100|58782135|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772689|NCT03129100|58782136|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30662401|NCT00744471|58675942|FG000|Overall Study|Withdrawal by Subject|9|||
30662402|NCT00744471|58675943|FG001|Overall Study|Withdrawal by Subject|9|||
30662403|NCT00744471|58675944|FG002|Overall Study|Withdrawal by Subject|15|||
30772690|NCT03129100|58782137|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772691|NCT03129100|58782138|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772692|NCT03129100|58782139|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
30772693|NCT03129100|58782114|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772694|NCT03129100|58782115|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
30772695|NCT03129100|58782116|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772696|NCT03129100|58782117|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772697|NCT03129100|58782118|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772698|NCT03129100|58782119|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772699|NCT03129100|58782120|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772700|NCT03129100|58782121|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772701|NCT03129100|58782122|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772702|NCT03129100|58782123|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772703|NCT03129100|58782124|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772704|NCT03129100|58782125|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772705|NCT03129100|58782126|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772706|NCT03129100|58782127|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772707|NCT03129100|58782128|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772708|NCT03129100|58782129|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772709|NCT03129100|58782130|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772710|NCT03129100|58782131|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772711|NCT03129100|58782132|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772712|NCT03129100|58782133|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772713|NCT03129100|58782134|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772714|NCT03129100|58782135|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772715|NCT03129100|58782136|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772716|NCT03129100|58782137|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772717|NCT03129100|58782138|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772718|NCT03129100|58782139|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
30772719|NCT03129100|58782114|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772720|NCT03129100|58782115|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772721|NCT03129100|58782116|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
30772722|NCT03129100|58782117|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
30772723|NCT03129100|58782118|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772724|NCT03129100|58782119|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
30772725|NCT03129100|58782120|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772726|NCT03129100|58782121|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772727|NCT03129100|58782122|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772728|NCT03129100|58782123|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772729|NCT03129100|58782124|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772730|NCT03129100|58782125|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772731|NCT03129100|58782126|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772732|NCT03129100|58782127|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772733|NCT03129100|58782128|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772734|NCT03129100|58782129|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772735|NCT03129100|58782130|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772736|NCT03129100|58782131|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772737|NCT03129100|58782132|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772738|NCT03129100|58782133|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772739|NCT03129100|58782134|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772740|NCT03129100|58782135|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772741|NCT03129100|58782136|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30662404|NCT00744471|58675945|FG003|Overall Study|Withdrawal by Subject|12|||
30662405|NCT00744471|58675942|FG000|Overall Study|Protocol Violation|1|||
30662406|NCT00744471|58675943|FG001|Overall Study|Protocol Violation|4|||
30662407|NCT00744471|58675944|FG002|Overall Study|Protocol Violation|1|||
30662408|NCT00744471|58675945|FG003|Overall Study|Protocol Violation|2|||
30662409|NCT00744471|58675942|FG000|Overall Study|Entered extension study|41|||
30662410|NCT00744471|58675943|FG001|Overall Study|Entered extension study|84|||
30662411|NCT00744471|58675944|FG002|Overall Study|Entered extension study|100|||
30662412|NCT00744471|58675945|FG003|Overall Study|Entered extension study|91|||
30662413|NCT00744471|58675942|FG000|Overall Study|Other|2|||
30662414|NCT00744471|58675943|FG001|Overall Study|Other|3|||
30662415|NCT00744471|58675944|FG002|Overall Study|Other|6|||
30662416|NCT00744471|58675945|FG003|Overall Study|Other|2|||
30662417|NCT00744471|58675942|FG000|Overall Study|Lack of Efficacy|83|||
30772742|NCT03129100|58782137|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772743|NCT03129100|58782138|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30772744|NCT03129100|58782139|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
30662418|NCT00744471|58675943|FG001|Overall Study|Lack of Efficacy|37|||
30662419|NCT00744471|58675944|FG002|Overall Study|Lack of Efficacy|19|||
30662420|NCT00744471|58675945|FG003|Overall Study|Lack of Efficacy|31|||
30662421|NCT00744471|58675942|FG000|Overall Study|Lost to Follow-up|0|||
30662422|NCT00744471|58675943|FG001|Overall Study|Lost to Follow-up|0|||
30662423|NCT00744471|58675944|FG002|Overall Study|Lost to Follow-up|2|||
30772745|NCT03129100|58782114|FG000|Period2 Extension Period (Group A and B)|Death|0|||
30772746|NCT03129100|58782115|FG001|Period2 Extension Period (Group A and B)|Death|0|||
30772747|NCT03129100|58782116|FG002|Period2 Extension Period (Group A and B)|Death|1|||
30772748|NCT03129100|58782117|FG003|Period2 Extension Period (Group A and B)|Death|0|||
30772749|NCT03129100|58782118|FG004|Period2 Extension Period (Group A and B)|Death|0|||
30772750|NCT03129100|58782119|FG005|Period2 Extension Period (Group A and B)|Death|0|||
30772751|NCT03129100|58782120|FG006|Period2 Extension Period (Group A and B)|Death|0|||
30772752|NCT03129100|58782121|FG007|Period2 Extension Period (Group A and B)|Death|0|||
30772753|NCT03129100|58782122|FG008|Period2 Extension Period (Group A and B)|Death|0|||
30772754|NCT03129100|58782123|FG009|Period2 Extension Period (Group A and B)|Death|0|||
30772755|NCT03129100|58782124|FG010|Period2 Extension Period (Group A and B)|Death|0|||
30772756|NCT03129100|58782125|FG011|Period2 Extension Period (Group A and B)|Death|0|||
30772757|NCT03129100|58782126|FG012|Period2 Extension Period (Group A and B)|Death|0|||
30772758|NCT03129100|58782127|FG013|Period2 Extension Period (Group A and B)|Death|0|||
30772759|NCT03129100|58782128|FG014|Period2 Extension Period (Group A and B)|Death|0|||
30772760|NCT03129100|58782129|FG015|Period2 Extension Period (Group A and B)|Death|0|||
30772761|NCT03129100|58782130|FG016|Period2 Extension Period (Group A and B)|Death|0|||
30772762|NCT03129100|58782131|FG017|Period2 Extension Period (Group A and B)|Death|0|||
30772763|NCT03129100|58782132|FG018|Period2 Extension Period (Group A and B)|Death|0|||
30772764|NCT03129100|58782133|FG019|Period2 Extension Period (Group A and B)|Death|0|||
30772765|NCT03129100|58782134|FG020|Period2 Extension Period (Group A and B)|Death|0|||
30772766|NCT03129100|58782135|FG021|Period2 Extension Period (Group A and B)|Death|0|||
30952920|NCT00638235|59002950|FG001|Overall Study|Lost to Follow-up|3|||
30952921|NCT00638235|59002951|FG002|Overall Study|Lost to Follow-up|18|||
30952922|NCT00638235|59002952|FG003|Overall Study|Lost to Follow-up|10|||
30952923|NCT00638235|59002953|FG004|Overall Study|Lost to Follow-up|13|||
30952924|NCT00638235|59002954|FG005|Overall Study|Lost to Follow-up|26|||
30952925|NCT00638235|59002955|FG006|Overall Study|Lost to Follow-up|0|||
30952926|NCT00638235|59002956|FG007|Overall Study|Lost to Follow-up|1|||
30952927|NCT00638235|59002957|FG008|Overall Study|Lost to Follow-up|18|||
30952928|NCT00638157|59002986|FG000|Overall Study|Adverse Event|0|||
30952929|NCT00638157|59002987|FG001|Overall Study|Adverse Event|1|||
30952930|NCT00638157|59002986|FG000|Overall Study|Clinical (symptomatic) failure|1|||
30952931|NCT00638157|59002987|FG001|Overall Study|Clinical (symptomatic) failure|1|||
30952932|NCT00638157|59002986|FG000|Overall Study|Microbiological failure|1|||
30952933|NCT00638157|59002987|FG001|Overall Study|Microbiological failure|0|||
30952934|NCT00638157|59002986|FG000|Overall Study|Lost to Follow-up|1|||
30952935|NCT00638157|59002987|FG001|Overall Study|Lost to Follow-up|0|||
30952936|NCT00638157|59002986|FG000|Overall Study|Physician Decision|1|||
30952937|NCT00638157|59002987|FG001|Overall Study|Physician Decision|0|||
30952938|NCT00638157|59002986|FG000|Overall Study|Other|1|||
30952939|NCT00638157|59002987|FG001|Overall Study|Other|2|||
30952940|NCT00638157|59002986|FG000|Overall Study|Randomized, not treated|2|||
30952941|NCT00638157|59002987|FG001|Overall Study|Randomized, not treated|0|||
30662424|NCT00744471|58675945|FG003|Overall Study|Lost to Follow-up|0|||
30662425|NCT00744237|58675958|FG000|Overall Study|Lack of Efficacy|1|||
30662426|NCT00744237|58675959|FG001|Overall Study|Lack of Efficacy|1|||
30662427|NCT00744237|58675960|FG002|Overall Study|Lack of Efficacy|0|||
30662428|NCT00744237|58675958|FG000|Overall Study|Withdrawal by Subject|9|||
30662429|NCT00744237|58675959|FG001|Overall Study|Withdrawal by Subject|5|||
30662430|NCT00744237|58675960|FG002|Overall Study|Withdrawal by Subject|3|||
30662431|NCT00744237|58675958|FG000|Overall Study|Lost to Follow-up|1|||
30662432|NCT00744237|58675959|FG001|Overall Study|Lost to Follow-up|1|||
30662433|NCT00744237|58675960|FG002|Overall Study|Lost to Follow-up|1|||
30662434|NCT00744237|58675958|FG000|Overall Study|Protocol Violation|3|||
30662435|NCT00744237|58675959|FG001|Overall Study|Protocol Violation|4|||
30662436|NCT00744237|58675960|FG002|Overall Study|Protocol Violation|3|||
30662437|NCT00744237|58675958|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
30662438|NCT00744237|58675959|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
30662439|NCT00744237|58675960|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
30662440|NCT00744237|58675958|FG000|Overall Study|Dosing Error|1|||
30662441|NCT00744237|58675959|FG001|Overall Study|Dosing Error|0|||
30662442|NCT00744237|58675960|FG002|Overall Study|Dosing Error|1|||
30662443|NCT00744237|58675958|FG000|Overall Study|Study Drug Error|1|||
30662444|NCT00744237|58675959|FG001|Overall Study|Study Drug Error|0|||
30772767|NCT03129100|58782136|FG022|Period2 Extension Period (Group A and B)|Death|0|||
30772768|NCT03129100|58782137|FG023|Period2 Extension Period (Group A and B)|Death|0|||
30662445|NCT00744237|58675960|FG002|Overall Study|Study Drug Error|0|||
30772769|NCT03129100|58782138|FG024|Period2 Extension Period (Group A and B)|Death|0|||
30952942|NCT00637377|59002998|FG000|Overall Study|Adverse Event|2|||
30952943|NCT00637377|59002999|FG001|Overall Study|Adverse Event|6|||
30662446|NCT00744237|58675958|FG000|Overall Study|Prohibited Concomitant Medication|0|||
30952944|NCT00637377|59003000|FG002|Overall Study|Adverse Event|8|||
30662447|NCT00744237|58675959|FG001|Overall Study|Prohibited Concomitant Medication|0|||
30952945|NCT00637377|59003001|FG003|Overall Study|Adverse Event|9|||
30952946|NCT00637377|59002998|FG000|Overall Study|Death|1|||
30772770|NCT03129100|58782139|FG025|Period2 Extension Period (Group A and B)|Death|0|||
30772771|NCT03129100|58782114|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772772|NCT03129100|58782115|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772773|NCT03129100|58782116|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
30772774|NCT03129100|58782117|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
30772775|NCT03129100|58782118|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
30772776|NCT03129100|58782119|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
30772777|NCT03129100|58782120|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
30772778|NCT03129100|58782121|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30952947|NCT00637377|59002999|FG001|Overall Study|Death|3|||
30952948|NCT00637377|59003000|FG002|Overall Study|Death|2|||
30952949|NCT00637377|59003001|FG003|Overall Study|Death|1|||
30952950|NCT00637377|59002998|FG000|Overall Study|Lack of Efficacy|0|||
30952951|NCT00637377|59002999|FG001|Overall Study|Lack of Efficacy|0|||
30952952|NCT00637377|59003000|FG002|Overall Study|Lack of Efficacy|1|||
30952953|NCT00637377|59003001|FG003|Overall Study|Lack of Efficacy|1|||
30952954|NCT00637377|59002998|FG000|Overall Study|Lost to Follow-up|4|||
30952955|NCT00637377|59002999|FG001|Overall Study|Lost to Follow-up|1|||
30952956|NCT00637377|59003000|FG002|Overall Study|Lost to Follow-up|2|||
30952957|NCT00637377|59003001|FG003|Overall Study|Lost to Follow-up|2|||
30772779|NCT03129100|58782122|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772780|NCT03129100|58782123|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772781|NCT03129100|58782124|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772782|NCT03129100|58782125|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772783|NCT03129100|58782126|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772784|NCT03129100|58782127|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772785|NCT03129100|58782128|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772786|NCT03129100|58782129|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772787|NCT03129100|58782130|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772788|NCT03129100|58782131|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772789|NCT03129100|58782132|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772790|NCT03129100|58782133|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772791|NCT03129100|58782134|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772792|NCT03129100|58782135|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772793|NCT03129100|58782136|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772794|NCT03129100|58782137|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772795|NCT03129100|58782138|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772796|NCT03129100|58782139|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
30772797|NCT03129100|58782114|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772798|NCT03129100|58782115|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772799|NCT03129100|58782116|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
30772800|NCT03129100|58782117|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772801|NCT03129100|58782118|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772802|NCT03129100|58782119|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772803|NCT03129100|58782120|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772804|NCT03129100|58782121|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772805|NCT03129100|58782122|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772806|NCT03129100|58782123|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772807|NCT03129100|58782124|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30849736|NCT02814643|58876682|FG000|Overall Study|Lost to Follow-up|0|||
30849737|NCT02814643|58876683|FG001|Overall Study|Lost to Follow-up|1|||
30849738|NCT02814643|58876682|FG000|Overall Study|Withdrawal by Subject|1|||
30849739|NCT02814643|58876683|FG001|Overall Study|Withdrawal by Subject|2|||
30849740|NCT02724111|58876691|FG000|Overall Study|Protocol Violation|2|||
30849741|NCT02724111|58876692|FG001|Overall Study|Protocol Violation|5|||
30849742|NCT02649218|58876698|FG000|Overall Study|Adverse Event|8|||
30952958|NCT00637377|59002998|FG000|Overall Study|Protocol Violation|2|||
30952959|NCT00637377|59002999|FG001|Overall Study|Protocol Violation|1|||
30952960|NCT00637377|59003000|FG002|Overall Study|Protocol Violation|1|||
30952961|NCT00637377|59003001|FG003|Overall Study|Protocol Violation|0|||
30952962|NCT00637377|59002998|FG000|Overall Study|Withdrawal by Subject|11|||
30952963|NCT00637377|59002999|FG001|Overall Study|Withdrawal by Subject|15|||
30952964|NCT00637377|59003000|FG002|Overall Study|Withdrawal by Subject|13|||
30952965|NCT00637377|59003001|FG003|Overall Study|Withdrawal by Subject|11|||
30952966|NCT00637377|59002998|FG000|Overall Study|Other (no further information available)|7|||
30952967|NCT00637377|59002999|FG001|Overall Study|Other (no further information available)|6|||
30772808|NCT03129100|58782125|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772809|NCT03129100|58782126|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772810|NCT03129100|58782127|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772811|NCT03129100|58782128|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772812|NCT03129100|58782129|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772813|NCT03129100|58782130|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772814|NCT03129100|58782131|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772815|NCT03129100|58782132|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772816|NCT03129100|58782133|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772817|NCT03129100|58782134|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772818|NCT03129100|58782135|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772819|NCT03129100|58782136|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772820|NCT03129100|58782137|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772821|NCT03129100|58782138|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772822|NCT03129100|58782139|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
30772823|NCT03129100|58782114|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772824|NCT03129100|58782115|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772825|NCT03129100|58782116|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
30772826|NCT03129100|58782117|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772827|NCT03129100|58782118|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772828|NCT03129100|58782119|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772829|NCT03129100|58782120|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772830|NCT03129100|58782121|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772831|NCT03129100|58782122|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30849743|NCT02649218|58876698|FG000|Overall Study|Lack of Efficacy|8|||
30849744|NCT02649218|58876698|FG000|Overall Study|Pregnancy|3|||
30849745|NCT02649218|58876698|FG000|Overall Study|Protocol Violation|3|||
30849746|NCT02649218|58876698|FG000|Overall Study|Physician Decision|1|||
30849747|NCT02649218|58876698|FG000|Overall Study|Withdrawal by Subject|2|||
30849748|NCT02814175|58876705|FG000|Part 1|Adverse Event|2|||
30849749|NCT02814175|58876706|FG001|Part 1|Adverse Event|3|||
30849750|NCT02814175|58876707|FG002|Part 1|Adverse Event|0|||
30849751|NCT02814175|58876708|FG003|Part 1|Adverse Event|0|||
30849752|NCT02814175|58876709|FG004|Part 1|Adverse Event|0|||
30849753|NCT02814175|58876710|FG005|Part 1|Adverse Event|0|||
30849754|NCT02814175|58876705|FG000|Part 1|Withdrawal Consent|8|||
30849755|NCT02814175|58876706|FG001|Part 1|Withdrawal Consent|1|||
30849756|NCT02814175|58876707|FG002|Part 1|Withdrawal Consent|0|||
30849757|NCT02814175|58876708|FG003|Part 1|Withdrawal Consent|0|||
30849758|NCT02814175|58876709|FG004|Part 1|Withdrawal Consent|0|||
30849759|NCT02814175|58876710|FG005|Part 1|Withdrawal Consent|0|||
30849760|NCT02814175|58876705|FG000|Part 1|Lost to Follow-up|1|||
30849761|NCT02814175|58876706|FG001|Part 1|Lost to Follow-up|0|||
30849762|NCT02814175|58876707|FG002|Part 1|Lost to Follow-up|0|||
30849763|NCT02814175|58876708|FG003|Part 1|Lost to Follow-up|0|||
30849764|NCT02814175|58876709|FG004|Part 1|Lost to Follow-up|0|||
30849765|NCT02814175|58876710|FG005|Part 1|Lost to Follow-up|0|||
30849766|NCT02814175|58876705|FG000|Part 1|Lack of Efficacy|1|||
30849767|NCT02814175|58876706|FG001|Part 1|Lack of Efficacy|2|||
30849768|NCT02814175|58876707|FG002|Part 1|Lack of Efficacy|0|||
30849769|NCT02814175|58876708|FG003|Part 1|Lack of Efficacy|0|||
30849770|NCT02814175|58876709|FG004|Part 1|Lack of Efficacy|0|||
30849771|NCT02814175|58876710|FG005|Part 1|Lack of Efficacy|0|||
30772832|NCT03129100|58782123|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772833|NCT03129100|58782124|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772834|NCT03129100|58782125|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772835|NCT03129100|58782126|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772836|NCT03129100|58782127|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772837|NCT03129100|58782128|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30849772|NCT02814175|58876705|FG000|Part 2|Adverse Event|0|||
30772838|NCT03129100|58782129|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772839|NCT03129100|58782130|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30849773|NCT02814175|58876706|FG001|Part 2|Adverse Event|0|||
30849774|NCT02814175|58876707|FG002|Part 2|Adverse Event|0|||
30849775|NCT02814175|58876708|FG003|Part 2|Adverse Event|1|||
30849776|NCT02814175|58876709|FG004|Part 2|Adverse Event|1|||
30849777|NCT02814175|58876710|FG005|Part 2|Adverse Event|2|||
30849778|NCT02814175|58876705|FG000|Part 2|Withdrawal Consent|0|||
30849779|NCT02814175|58876706|FG001|Part 2|Withdrawal Consent|0|||
30849780|NCT02814175|58876707|FG002|Part 2|Withdrawal Consent|0|||
30849781|NCT02814175|58876708|FG003|Part 2|Withdrawal Consent|2|||
30849782|NCT02814175|58876709|FG004|Part 2|Withdrawal Consent|1|||
30849783|NCT02814175|58876710|FG005|Part 2|Withdrawal Consent|1|||
30849784|NCT02814175|58876705|FG000|Part 2|Lost to Follow-up|0|||
30849785|NCT02814175|58876706|FG001|Part 2|Lost to Follow-up|0|||
30772840|NCT03129100|58782131|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772841|NCT03129100|58782132|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772842|NCT03129100|58782133|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772843|NCT03129100|58782134|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772844|NCT03129100|58782135|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772845|NCT03129100|58782136|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772846|NCT03129100|58782137|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772847|NCT03129100|58782138|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772848|NCT03129100|58782139|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
30772849|NCT03129100|58782114|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772850|NCT03129100|58782115|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772851|NCT03129100|58782116|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
30772852|NCT03129100|58782117|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772853|NCT03129100|58782118|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772854|NCT03129100|58782119|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772855|NCT03129100|58782120|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772856|NCT03129100|58782121|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772857|NCT03129100|58782122|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772858|NCT03129100|58782123|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772859|NCT03129100|58782124|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772860|NCT03129100|58782125|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772861|NCT03129100|58782126|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772862|NCT03129100|58782127|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772863|NCT03129100|58782128|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772864|NCT03129100|58782129|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772865|NCT03129100|58782130|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772866|NCT03129100|58782131|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772867|NCT03129100|58782132|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772868|NCT03129100|58782133|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772869|NCT03129100|58782134|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772870|NCT03129100|58782135|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772871|NCT03129100|58782136|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772872|NCT03129100|58782137|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772873|NCT03129100|58782138|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772874|NCT03129100|58782139|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
30772875|NCT03129100|58782114|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772876|NCT03129100|58782115|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772877|NCT03129100|58782116|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772878|NCT03129100|58782117|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772879|NCT03129100|58782118|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
30772880|NCT03129100|58782119|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
30772881|NCT03129100|58782120|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
30772882|NCT03129100|58782121|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772883|NCT03129100|58782122|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772884|NCT03129100|58782123|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772885|NCT03129100|58782124|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772886|NCT03129100|58782125|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772887|NCT03129100|58782126|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772888|NCT03129100|58782127|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772889|NCT03129100|58782128|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772890|NCT03129100|58782129|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772891|NCT03129100|58782130|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30662448|NCT00744237|58675960|FG002|Overall Study|Prohibited Concomitant Medication|1|||
30662449|NCT00744237|58675958|FG000|Overall Study|Poor Compliance|0|||
30662450|NCT00744237|58675959|FG001|Overall Study|Poor Compliance|2|||
30662451|NCT00744237|58675960|FG002|Overall Study|Poor Compliance|0|||
30662452|NCT00744237|58675958|FG000|Overall Study|Administrative. Site Closed|1|||
30662453|NCT00744237|58675959|FG001|Overall Study|Administrative. Site Closed|1|||
30662454|NCT00744237|58675960|FG002|Overall Study|Administrative. Site Closed|1|||
30662455|NCT00744237|58675958|FG000|Overall Study|Adverse Event|9|||
30662456|NCT00744237|58675959|FG001|Overall Study|Adverse Event|13|||
30662457|NCT00744237|58675960|FG002|Overall Study|Adverse Event|5|||
30662458|NCT00743145|58675968|FG000|Overall Study|Withdrawal by Subject|1|||
30662459|NCT00743145|58675968|FG000|Overall Study|Adverse Event|2|||
30662460|NCT00743145|58675968|FG000|Overall Study|Pregnancy|1|||
30772892|NCT03129100|58782131|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772893|NCT03129100|58782132|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772894|NCT03129100|58782133|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772895|NCT03129100|58782134|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772896|NCT03129100|58782135|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772897|NCT03129100|58782136|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772898|NCT03129100|58782137|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772899|NCT03129100|58782138|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772900|NCT03129100|58782139|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
30772901|NCT03129100|58782114|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772902|NCT03129100|58782115|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772903|NCT03129100|58782116|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772904|NCT03129100|58782117|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772905|NCT03129100|58782118|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772906|NCT03129100|58782119|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772907|NCT03129100|58782120|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772908|NCT03129100|58782121|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772909|NCT03129100|58782122|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772910|NCT03129100|58782123|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
30772911|NCT03129100|58782124|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772912|NCT03129100|58782125|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772913|NCT03129100|58782126|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772914|NCT03129100|58782127|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772915|NCT03129100|58782128|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772916|NCT03129100|58782129|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772917|NCT03129100|58782130|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772918|NCT03129100|58782131|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772919|NCT03129100|58782132|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772920|NCT03129100|58782133|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772921|NCT03129100|58782134|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772922|NCT03129100|58782135|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772923|NCT03129100|58782136|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772924|NCT03129100|58782137|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772925|NCT03129100|58782138|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772926|NCT03129100|58782139|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
30772927|NCT03129100|58782114|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772928|NCT03129100|58782115|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772929|NCT03129100|58782116|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772930|NCT03129100|58782117|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772931|NCT03129100|58782118|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772932|NCT03129100|58782119|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772933|NCT03129100|58782120|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772934|NCT03129100|58782121|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772935|NCT03129100|58782122|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772936|NCT03129100|58782123|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772937|NCT03129100|58782124|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772938|NCT03129100|58782125|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
30772939|NCT03129100|58782126|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772940|NCT03129100|58782127|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772941|NCT03129100|58782128|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772942|NCT03129100|58782129|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772943|NCT03129100|58782130|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772944|NCT03129100|58782131|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772945|NCT03129100|58782132|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772946|NCT03129100|58782133|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772947|NCT03129100|58782134|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772948|NCT03129100|58782135|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772949|NCT03129100|58782136|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772950|NCT03129100|58782137|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30849786|NCT02814175|58876707|FG002|Part 2|Lost to Follow-up|0|||
30849787|NCT02814175|58876708|FG003|Part 2|Lost to Follow-up|1|||
30952968|NCT00637377|59003000|FG002|Overall Study|Other (no further information available)|10|||
30952969|NCT00637377|59003001|FG003|Overall Study|Other (no further information available)|5|||
30849788|NCT02814175|58876709|FG004|Part 2|Lost to Follow-up|0|||
30772951|NCT03129100|58782138|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772952|NCT03129100|58782139|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
30772953|NCT03129100|58782114|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772954|NCT03129100|58782115|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772955|NCT03129100|58782116|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772956|NCT03129100|58782117|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772957|NCT03129100|58782118|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772958|NCT03129100|58782119|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772959|NCT03129100|58782120|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772960|NCT03129100|58782121|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772961|NCT03129100|58782122|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772962|NCT03129100|58782123|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772963|NCT03129100|58782124|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772964|NCT03129100|58782125|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
30772965|NCT03129100|58782126|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
30772966|NCT03129100|58782127|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
30772967|NCT03129100|58782128|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
30772968|NCT03129100|58782129|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30662461|NCT00920855|58675985|FG000|Overall Study|Adverse Event|1|||
30662462|NCT00920855|58675986|FG001|Overall Study|Adverse Event|1|||
30662463|NCT00920855|58675987|FG002|Overall Study|Adverse Event|4|||
30772969|NCT03129100|58782130|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772970|NCT03129100|58782131|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772971|NCT03129100|58782132|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772972|NCT03129100|58782133|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772973|NCT03129100|58782134|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772974|NCT03129100|58782135|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772975|NCT03129100|58782136|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772976|NCT03129100|58782137|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772977|NCT03129100|58782138|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772978|NCT03129100|58782139|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
30772979|NCT03129100|58782114|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772980|NCT03129100|58782115|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772981|NCT03129100|58782116|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772982|NCT03129100|58782117|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772983|NCT03129100|58782118|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772984|NCT03129100|58782119|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772985|NCT03129100|58782120|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772986|NCT03129100|58782121|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772987|NCT03129100|58782122|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30849789|NCT02814175|58876710|FG005|Part 2|Lost to Follow-up|0|||
30849790|NCT02814175|58876705|FG000|Part 2|Lack of Efficacy|0|||
30849791|NCT02814175|58876706|FG001|Part 2|Lack of Efficacy|0|||
30849792|NCT02814175|58876707|FG002|Part 2|Lack of Efficacy|0|||
30849793|NCT02814175|58876708|FG003|Part 2|Lack of Efficacy|0|||
30849794|NCT02814175|58876709|FG004|Part 2|Lack of Efficacy|0|||
30849795|NCT02814175|58876710|FG005|Part 2|Lack of Efficacy|3|||
30849796|NCT01335997|58876726|FG000|Period I and II|Adverse Event|63|||
30849797|NCT01335997|58876727|FG001|Period I and II|Adverse Event|43|||
30849798|NCT01335997|58876726|FG000|Period I and II|Noncompliance with Study Drug|1|||
30849799|NCT01335997|58876727|FG001|Period I and II|Noncompliance with Study Drug|1|||
30849800|NCT01335997|58876726|FG000|Period I and II|Lost to Follow-up|3|||
30849801|NCT01335997|58876727|FG001|Period I and II|Lost to Follow-up|5|||
30849802|NCT01335997|58876726|FG000|Period I and II|Withdrawal by Subject|9|||
30849803|NCT01335997|58876727|FG001|Period I and II|Withdrawal by Subject|4|||
30849804|NCT01335997|58876726|FG000|Period I and II|Study Terminated by Sponsor|406|||
30849805|NCT01335997|58876727|FG001|Period I and II|Study Terminated by Sponsor|415|||
30849806|NCT01335997|58876726|FG000|Period I and II|Protocol Violation|9|||
30849807|NCT01335997|58876727|FG001|Period I and II|Protocol Violation|10|||
30849808|NCT01335997|58876726|FG000|Period I and II|Physician Decision|2|||
30662464|NCT00920855|58675985|FG000|Overall Study|Withdrawal by Subject|2|||
30849809|NCT01335997|58876727|FG001|Period I and II|Physician Decision|1|||
30849810|NCT01335997|58876726|FG000|Period III|Adverse Event|0|||
30849811|NCT01335997|58876727|FG001|Period III|Adverse Event|2|||
30849812|NCT01335997|58876726|FG000|Period III|Study Terminated by Sponsor|77|||
30952970|NCT00636987|59003011|FG000|Overall Study|Death|44|||
30662465|NCT00920855|58675986|FG001|Overall Study|Withdrawal by Subject|1|||
30772988|NCT03129100|58782123|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772989|NCT03129100|58782124|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772990|NCT03129100|58782125|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
30772991|NCT03129100|58782126|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772992|NCT03129100|58782127|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
30772993|NCT03129100|58782128|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
30772994|NCT03129100|58782129|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772995|NCT03129100|58782130|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772996|NCT03129100|58782131|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772997|NCT03129100|58782132|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772998|NCT03129100|58782133|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30772999|NCT03129100|58782134|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30773000|NCT03129100|58782135|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30773001|NCT03129100|58782136|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30773002|NCT03129100|58782137|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30773003|NCT03129100|58782138|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30773004|NCT03129100|58782139|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
30773005|NCT03129100|58782114|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773006|NCT03129100|58782115|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773007|NCT03129100|58782116|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773008|NCT03129100|58782117|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773009|NCT03129100|58782118|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773010|NCT03129100|58782119|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773011|NCT03129100|58782120|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773012|NCT03129100|58782121|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773013|NCT03129100|58782122|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773014|NCT03129100|58782123|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773015|NCT03129100|58782124|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773016|NCT03129100|58782125|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773017|NCT03129100|58782126|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773018|NCT03129100|58782127|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773019|NCT03129100|58782128|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773020|NCT03129100|58782129|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
30773021|NCT03129100|58782130|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773022|NCT03129100|58782131|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773023|NCT03129100|58782132|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773024|NCT03129100|58782133|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773025|NCT03129100|58782134|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773026|NCT03129100|58782135|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773027|NCT03129100|58782136|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773028|NCT03129100|58782137|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773029|NCT03129100|58782138|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773030|NCT03129100|58782139|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
30773031|NCT03129100|58782114|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773032|NCT03129100|58782115|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773033|NCT03129100|58782116|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773034|NCT03129100|58782117|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773035|NCT03129100|58782118|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773036|NCT03129100|58782119|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773037|NCT03129100|58782120|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773038|NCT03129100|58782121|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773039|NCT03129100|58782122|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773040|NCT03129100|58782123|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773041|NCT03129100|58782124|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773042|NCT03129100|58782125|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773043|NCT03129100|58782126|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
30773044|NCT03129100|58782127|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30849813|NCT01335997|58876727|FG001|Period III|Study Terminated by Sponsor|76|||
30849814|NCT01335997|58876726|FG000|Period III|Protocol Violation|0|||
30849815|NCT01335997|58876727|FG001|Period III|Protocol Violation|1|||
30849816|NCT01335997|58876726|FG000|Period III|Lost to Follow-up|1|||
30849817|NCT01335997|58876727|FG001|Period III|Lost to Follow-up|0|||
30849818|NCT02725671|58876735|FG000|Overall Study|Lost to Follow-up|1|||
30849819|NCT02446990|58876743|FG000|Overall Study|Death|485|||
30662466|NCT00920855|58675987|FG002|Overall Study|Withdrawal by Subject|6|||
30773045|NCT03129100|58782128|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
30773046|NCT03129100|58782129|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
30773047|NCT03129100|58782130|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773048|NCT03129100|58782131|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773049|NCT03129100|58782132|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773050|NCT03129100|58782133|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773051|NCT03129100|58782134|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773052|NCT03129100|58782135|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773053|NCT03129100|58782136|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773054|NCT03129100|58782137|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773055|NCT03129100|58782138|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773056|NCT03129100|58782139|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
30773057|NCT03129100|58782114|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773058|NCT03129100|58782115|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773059|NCT03129100|58782116|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773060|NCT03129100|58782117|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773061|NCT03129100|58782118|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773062|NCT03129100|58782119|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773063|NCT03129100|58782120|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773064|NCT03129100|58782121|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773065|NCT03129100|58782122|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773066|NCT03129100|58782123|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773067|NCT03129100|58782124|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773068|NCT03129100|58782125|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773069|NCT03129100|58782126|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773070|NCT03129100|58782127|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773071|NCT03129100|58782128|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773072|NCT03129100|58782129|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773073|NCT03129100|58782130|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773074|NCT03129100|58782131|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
30773075|NCT03129100|58782132|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773076|NCT03129100|58782133|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
30773077|NCT03129100|58782134|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773078|NCT03129100|58782135|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773079|NCT03129100|58782136|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773080|NCT03129100|58782137|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773081|NCT03129100|58782138|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773082|NCT03129100|58782139|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
30773083|NCT03129100|58782114|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773084|NCT03129100|58782115|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773085|NCT03129100|58782116|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773086|NCT03129100|58782117|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773087|NCT03129100|58782118|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773088|NCT03129100|58782119|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773089|NCT03129100|58782120|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773090|NCT03129100|58782121|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773091|NCT03129100|58782122|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773092|NCT03129100|58782123|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773093|NCT03129100|58782124|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773094|NCT03129100|58782125|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773095|NCT03129100|58782126|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773096|NCT03129100|58782127|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773097|NCT03129100|58782128|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773098|NCT03129100|58782129|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773099|NCT03129100|58782130|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773100|NCT03129100|58782131|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773101|NCT03129100|58782132|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773102|NCT03129100|58782133|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773103|NCT03129100|58782134|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
30773104|NCT03129100|58782135|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773105|NCT03129100|58782136|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773106|NCT03129100|58782137|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773107|NCT03129100|58782138|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773108|NCT03129100|58782139|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
30773109|NCT03129100|58782114|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
30773110|NCT03129100|58782115|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
30773111|NCT03129100|58782116|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
30773112|NCT03129100|58782117|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
30773113|NCT03129100|58782118|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
30773114|NCT03129100|58782119|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
30773115|NCT03129100|58782120|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
30773116|NCT03129100|58782121|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
30773117|NCT03129100|58782122|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
30773118|NCT03129100|58782123|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
30773119|NCT03129100|58782124|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
30773120|NCT03129100|58782125|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
30773121|NCT03129100|58782126|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
30773122|NCT03129100|58782127|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
30773123|NCT03129100|58782128|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
30773124|NCT03129100|58782129|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
30773125|NCT03129100|58782130|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
30773126|NCT03129100|58782131|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
30773127|NCT03129100|58782132|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
30773128|NCT03129100|58782133|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
30773129|NCT03129100|58782134|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
30773130|NCT03129100|58782135|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
30773131|NCT03129100|58782136|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
30773132|NCT03129100|58782137|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
30773133|NCT03129100|58782138|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
30773134|NCT03129100|58782139|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
30773135|NCT03129100|58782114|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773136|NCT03129100|58782115|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773137|NCT03129100|58782116|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773138|NCT03129100|58782117|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773139|NCT03129100|58782118|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773140|NCT03129100|58782119|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773141|NCT03129100|58782120|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773142|NCT03129100|58782121|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773143|NCT03129100|58782122|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773144|NCT03129100|58782123|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773145|NCT03129100|58782124|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773146|NCT03129100|58782125|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773147|NCT03129100|58782126|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773148|NCT03129100|58782127|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773149|NCT03129100|58782128|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773150|NCT03129100|58782129|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773151|NCT03129100|58782130|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773152|NCT03129100|58782131|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773153|NCT03129100|58782132|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773154|NCT03129100|58782133|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773155|NCT03129100|58782134|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
30773156|NCT03129100|58782135|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773157|NCT03129100|58782136|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773158|NCT03129100|58782137|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773159|NCT03129100|58782138|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773160|NCT03129100|58782139|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
30773161|NCT03129100|58782114|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
30773162|NCT03129100|58782115|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
30773163|NCT03129100|58782116|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
30773164|NCT03129100|58782117|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
30773165|NCT03129100|58782118|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
30773166|NCT03129100|58782119|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
30773167|NCT03129100|58782120|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
30773168|NCT03129100|58782121|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
30773169|NCT03129100|58782122|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
30773170|NCT03129100|58782123|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
30773171|NCT03129100|58782124|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
30773172|NCT03129100|58782125|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
30773173|NCT03129100|58782126|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
30773174|NCT03129100|58782127|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
30773175|NCT03129100|58782128|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
30773176|NCT03129100|58782129|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
30773177|NCT03129100|58782130|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
30773178|NCT03129100|58782131|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
30773179|NCT03129100|58782132|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
30773180|NCT03129100|58782133|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
30773181|NCT03129100|58782134|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
30773182|NCT03129100|58782135|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
30773183|NCT03129100|58782136|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
30662467|NCT00920855|58675985|FG000|Overall Study|Disease progression|2|||
30662468|NCT00920855|58675986|FG001|Overall Study|Disease progression|1|||
30773184|NCT03129100|58782137|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
30773185|NCT03129100|58782138|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
30773186|NCT03129100|58782139|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
30773187|NCT03129100|58782114|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773188|NCT03129100|58782115|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773189|NCT03129100|58782116|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773190|NCT03129100|58782117|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773191|NCT03129100|58782118|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773192|NCT03129100|58782119|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773193|NCT03129100|58782120|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773194|NCT03129100|58782121|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773195|NCT03129100|58782122|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773196|NCT03129100|58782123|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773197|NCT03129100|58782124|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773198|NCT03129100|58782125|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773199|NCT03129100|58782126|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30849820|NCT02446990|58876744|FG001|Overall Study|Death|458|||
30849821|NCT02446990|58876743|FG000|Overall Study|Lost to Follow-up|3|||
30849822|NCT02446990|58876744|FG001|Overall Study|Lost to Follow-up|1|||
30849823|NCT02446990|58876743|FG000|Overall Study|Physician Decision|1|||
30849824|NCT02446990|58876744|FG001|Overall Study|Physician Decision|0|||
30849825|NCT02446990|58876743|FG000|Overall Study|Withdrawal by Subject|231|||
30849826|NCT02446990|58876744|FG001|Overall Study|Withdrawal by Subject|199|||
30849827|NCT02725515|58876752|FG000|Overall Study|Refused infusion (no study treatment)|1|||
30849828|NCT02725515|58876753|FG001|Overall Study|Refused infusion (no study treatment)|0|||
30849829|NCT02725515|58876752|FG000|Overall Study|Loss of Improvement per Protocol|14|||
30849830|NCT02725515|58876753|FG001|Overall Study|Loss of Improvement per Protocol|25|||
30849831|NCT02725515|58876752|FG000|Overall Study|Withdrawal by Subject|2|||
30849832|NCT02725515|58876753|FG001|Overall Study|Withdrawal by Subject|1|||
30849833|NCT02725515|58876752|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30849834|NCT02725515|58876753|FG001|Overall Study|Non-Compliance With Study Drug|3|||
30849835|NCT02725515|58876752|FG000|Overall Study|Lost to Follow-up|1|||
30849836|NCT02725515|58876753|FG001|Overall Study|Lost to Follow-up|1|||
30849837|NCT02725515|58876752|FG000|Overall Study|Adverse Event|7|||
30849838|NCT02725515|58876753|FG001|Overall Study|Adverse Event|2|||
30849839|NCT02725515|58876752|FG000|Overall Study|No Documented Disease Improvement|0|||
30849840|NCT02725515|58876753|FG001|Overall Study|No Documented Disease Improvement|1|||
30849841|NCT02725515|58876752|FG000|Overall Study|Completed Study Under Original Protocol|0|||
30849842|NCT02725515|58876753|FG001|Overall Study|Completed Study Under Original Protocol|1|||
30849843|NCT02725515|58876752|FG000|Overall Study|Lack of Response|0|||
30849844|NCT02725515|58876753|FG001|Overall Study|Lack of Response|1|||
30849845|NCT02416180|58876759|FG000|Overall Study|Withdrawal by Subject|1|||
30849846|NCT02473510|58876765|FG000|Overall Study|Lost to Follow-up|1|||
30849847|NCT02473510|58876766|FG001|Overall Study|Lost to Follow-up|2|||
30849848|NCT02445586|58876772|FG000|Overall Study|Death|14|||
30849849|NCT02445586|58876772|FG000|Overall Study|Withdrawal by Subject|13|||
30849850|NCT02445586|58876772|FG000|Overall Study|Disease Progression|10|||
30849851|NCT02445586|58876772|FG000|Overall Study|Protocol Violation|1|||
30849852|NCT02445586|58876772|FG000|Overall Study|Medical Condition|1|||
30849853|NCT01674062|58876778|FG000|Overall Study|Insufficient Therapeutic Response|56|||
30849854|NCT01674062|58876779|FG001|Overall Study|Insufficient Therapeutic Response|26|||
30849855|NCT01674062|58876778|FG000|Overall Study|Other|8|||
30849856|NCT01674062|58876779|FG001|Overall Study|Other|1|||
30849857|NCT01674062|58876778|FG000|Overall Study|Adverse Event|1|||
30849858|NCT01674062|58876779|FG001|Overall Study|Adverse Event|1|||
30849859|NCT01674062|58876778|FG000|Overall Study|Death|0|||
30849860|NCT01674062|58876779|FG001|Overall Study|Death|1|||
30849861|NCT01674062|58876778|FG000|Overall Study|Programming Error|1|||
30849862|NCT01674062|58876779|FG001|Overall Study|Programming Error|0|||
30849863|NCT02472886|58876788|FG000|Overall Study|Lack of Efficacy|0|||
30952971|NCT00636987|59003011|FG000|Overall Study|Explanted|13|||
30952972|NCT00636987|59003011|FG000|Overall Study|Lost to Follow-up|63|||
30952973|NCT00636987|59003011|FG000|Overall Study|5 year visit window not complete|69|||
30849864|NCT02472886|58876789|FG001|Overall Study|Lack of Efficacy|2|||
30849865|NCT02472886|58876790|FG002|Overall Study|Lack of Efficacy|1|||
30849866|NCT02472652|58876803|FG000|Overall Study|Lost to Follow-up|1|||
30849867|NCT02807857|58876807|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
30849868|NCT02807857|58876807|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
30849869|NCT02807857|58876807|FG000|Follow-Up Set|Withdrawal by Subject|8|||
30952974|NCT00636441|59003166|FG000|Overall Study|Adverse Event|0|||
30849870|NCT02807857|58876807|FG000|Follow-Up Set|Lost to Follow-up|7|||
30849871|NCT02807857|58876807|FG000|Follow-Up Set|Physician Decision|6|||
30849872|NCT02807857|58876807|FG000|Follow-Up Set|Adverse Event|3|||
30849873|NCT02807857|58876807|FG000|Follow-Up Set|Death|27|||
30849874|NCT02807857|58876807|FG000|Follow-Up Set|Relocation|2|||
30773200|NCT03129100|58782127|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773201|NCT03129100|58782128|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773202|NCT03129100|58782129|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773203|NCT03129100|58782130|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773204|NCT03129100|58782131|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773205|NCT03129100|58782132|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773206|NCT03129100|58782133|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773207|NCT03129100|58782134|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773208|NCT03129100|58782135|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773209|NCT03129100|58782136|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773210|NCT03129100|58782137|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
30773211|NCT03129100|58782138|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
30773212|NCT03129100|58782139|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
30773213|NCT03129100|58782114|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773214|NCT03129100|58782115|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773215|NCT03129100|58782116|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773216|NCT03129100|58782117|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30849875|NCT02648438|58876820|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30849876|NCT02648438|58876821|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
30849877|NCT02648438|58876822|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
30849878|NCT02648438|58876820|FG000|Overall Study|Protocol Violation|2|||
30849879|NCT02648438|58876821|FG001|Overall Study|Protocol Violation|0|||
30849880|NCT02648438|58876822|FG002|Overall Study|Protocol Violation|0|||
30849881|NCT02648438|58876820|FG000|Overall Study|Withdrawal by Subject|1|||
30849882|NCT02648438|58876821|FG001|Overall Study|Withdrawal by Subject|1|||
30849883|NCT02648438|58876822|FG002|Overall Study|Withdrawal by Subject|0|||
30849884|NCT02415556|58876842|FG000|Overall Study|Adverse Event|3|||
30849885|NCT02415556|58876843|FG001|Overall Study|Adverse Event|4|||
30849886|NCT02415556|58876844|FG002|Overall Study|Adverse Event|2|||
30849887|NCT02415556|58876845|FG003|Overall Study|Adverse Event|4|||
30849888|NCT02415556|58876842|FG000|Overall Study|Lost to Follow-up|4|||
30849889|NCT02415556|58876843|FG001|Overall Study|Lost to Follow-up|5|||
30849890|NCT02415556|58876844|FG002|Overall Study|Lost to Follow-up|4|||
30849891|NCT02415556|58876845|FG003|Overall Study|Lost to Follow-up|1|||
30849892|NCT02415556|58876842|FG000|Overall Study|Withdrawal by Subject|13|||
30849893|NCT02415556|58876843|FG001|Overall Study|Withdrawal by Subject|4|||
30849894|NCT02415556|58876844|FG002|Overall Study|Withdrawal by Subject|14|||
30849895|NCT02415556|58876845|FG003|Overall Study|Withdrawal by Subject|12|||
30849896|NCT02415556|58876842|FG000|Overall Study|Physician Decision|1|||
30849897|NCT02415556|58876843|FG001|Overall Study|Physician Decision|3|||
30849898|NCT02415556|58876844|FG002|Overall Study|Physician Decision|1|||
30849899|NCT02415556|58876845|FG003|Overall Study|Physician Decision|2|||
30849900|NCT02415556|58876842|FG000|Overall Study|Censored - study completion|4|||
30849901|NCT02415556|58876843|FG001|Overall Study|Censored - study completion|5|||
30849902|NCT02415556|58876844|FG002|Overall Study|Censored - study completion|1|||
30849903|NCT02415556|58876845|FG003|Overall Study|Censored - study completion|0|||
30849904|NCT02415556|58876842|FG000|Overall Study|Family-related issues|0|||
30849905|NCT02415556|58876843|FG001|Overall Study|Family-related issues|0|||
30849906|NCT02415556|58876844|FG002|Overall Study|Family-related issues|0|||
30849907|NCT02415556|58876845|FG003|Overall Study|Family-related issues|1|||
30849908|NCT02807623|58876858|FG000|Overall Study|Lost to Follow-up|23|||
30849909|NCT02807623|58876859|FG001|Overall Study|Lost to Follow-up|18|||
30849910|NCT02807623|58876860|FG002|Overall Study|Lost to Follow-up|22|||
30849911|NCT02807623|58876858|FG000|Overall Study|Drug intolerance|0|||
30849912|NCT02807623|58876859|FG001|Overall Study|Drug intolerance|1|||
30849913|NCT02807623|58876860|FG002|Overall Study|Drug intolerance|0|||
30849914|NCT02807623|58876858|FG000|Overall Study|incomplete blood draw|0|||
30849915|NCT02807623|58876859|FG001|Overall Study|incomplete blood draw|2|||
30849916|NCT02807623|58876860|FG002|Overall Study|incomplete blood draw|1|||
30849917|NCT02805907|58876879|FG000|Overall Study|Lost to Follow-up|3|||
30849918|NCT02805907|58876880|FG001|Overall Study|Lost to Follow-up|3|||
30849919|NCT02723175|58876888|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
30849920|NCT02723175|58876889|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
30849921|NCT02723175|58876888|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
30849922|NCT02723175|58876889|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
30849923|NCT02801617|58876897|FG000|Overall Study|Protocol Violation|2|||
30849924|NCT02801617|58876898|FG001|Overall Study|Protocol Violation|6|||
30849925|NCT01334515|58876910|FG000|Overall Study|Adverse Event|1|||
30849926|NCT01334515|58876911|FG001|Overall Study|Adverse Event|6|||
30849927|NCT01334515|58876910|FG000|Overall Study|Death|1|||
30849928|NCT01334515|58876911|FG001|Overall Study|Death|0|||
30849929|NCT01334515|58876910|FG000|Overall Study|Lack of Efficacy|8|||
30849930|NCT01334515|58876911|FG001|Overall Study|Lack of Efficacy|21|||
30849931|NCT01334515|58876910|FG000|Overall Study|Physician Decision|1|||
30849932|NCT01334515|58876911|FG001|Overall Study|Physician Decision|1|||
30773217|NCT03129100|58782118|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773218|NCT03129100|58782119|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773219|NCT03129100|58782120|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773220|NCT03129100|58782121|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773221|NCT03129100|58782122|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773222|NCT03129100|58782123|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773223|NCT03129100|58782124|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773224|NCT03129100|58782125|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773225|NCT03129100|58782126|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773226|NCT03129100|58782127|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773227|NCT03129100|58782128|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773228|NCT03129100|58782129|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773229|NCT03129100|58782130|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773230|NCT03129100|58782131|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773231|NCT03129100|58782132|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773232|NCT03129100|58782133|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773233|NCT03129100|58782134|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773234|NCT03129100|58782135|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773235|NCT03129100|58782136|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
30773236|NCT03129100|58782137|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
30773237|NCT03129100|58782138|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
30773238|NCT03129100|58782139|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
30773239|NCT03129100|58782114|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773240|NCT03129100|58782115|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773241|NCT03129100|58782116|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773242|NCT03129100|58782117|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773243|NCT03129100|58782118|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773244|NCT03129100|58782119|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773245|NCT03129100|58782120|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773246|NCT03129100|58782121|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773247|NCT03129100|58782122|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773248|NCT03129100|58782123|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773249|NCT03129100|58782124|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773250|NCT03129100|58782125|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773251|NCT03129100|58782126|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773252|NCT03129100|58782127|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773253|NCT03129100|58782128|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773254|NCT03129100|58782129|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773255|NCT03129100|58782130|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773256|NCT03129100|58782131|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773257|NCT03129100|58782132|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773258|NCT03129100|58782133|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773259|NCT03129100|58782134|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773260|NCT03129100|58782135|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773261|NCT03129100|58782136|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773262|NCT03129100|58782137|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773263|NCT03129100|58782138|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
30773264|NCT03129100|58782139|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
30773265|NCT03129100|58782114|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773266|NCT03129100|58782115|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773267|NCT03129100|58782116|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773268|NCT03129100|58782117|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773269|NCT03129100|58782118|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773270|NCT03129100|58782119|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773271|NCT03129100|58782120|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773272|NCT03129100|58782121|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773273|NCT03129100|58782122|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773274|NCT03129100|58782123|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773275|NCT03129100|58782124|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773276|NCT03129100|58782125|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773277|NCT03129100|58782126|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30849933|NCT01334515|58876910|FG000|Overall Study|Withdrawal by Subject|1|||
30849934|NCT01334515|58876911|FG001|Overall Study|Withdrawal by Subject|1|||
30662469|NCT00920855|58675987|FG002|Overall Study|Disease progression|10|||
30662470|NCT00920855|58675985|FG000|Overall Study|Noncompliance to study medication|0|||
30773278|NCT03129100|58782127|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773279|NCT03129100|58782128|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773280|NCT03129100|58782129|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773281|NCT03129100|58782130|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773282|NCT03129100|58782131|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773283|NCT03129100|58782132|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773284|NCT03129100|58782133|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773285|NCT03129100|58782134|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773286|NCT03129100|58782135|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773287|NCT03129100|58782136|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773288|NCT03129100|58782137|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773289|NCT03129100|58782138|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
30773290|NCT03129100|58782139|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
30773291|NCT03129100|58782114|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
30773292|NCT03129100|58782115|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
30773293|NCT03129100|58782116|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
30773294|NCT03129100|58782117|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
30773295|NCT03129100|58782118|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
30773296|NCT03129100|58782119|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
30773297|NCT03129100|58782120|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
30773298|NCT03129100|58782121|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
30773299|NCT03129100|58782122|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
30773300|NCT03129100|58782123|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
30773301|NCT03129100|58782124|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
30773302|NCT03129100|58782125|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
30773303|NCT03129100|58782126|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
30773304|NCT03129100|58782127|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
30773305|NCT03129100|58782128|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
30773306|NCT03129100|58782129|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
30773307|NCT03129100|58782130|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
30773308|NCT03129100|58782131|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
30773309|NCT03129100|58782132|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
30773310|NCT03129100|58782133|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
30773311|NCT03129100|58782134|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
30773312|NCT03129100|58782135|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
30773313|NCT03129100|58782136|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
30773314|NCT03129100|58782137|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
30773315|NCT03129100|58782138|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
30773316|NCT03129100|58782139|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
30773317|NCT03101020|58782178|FG000|Overall Study|Lack of time to participate|1|||
30773318|NCT03101020|58782179|FG001|Overall Study|Lack of time to participate|0|||
30773319|NCT03101020|58782178|FG000|Overall Study|Ran over by a car|0|||
30773320|NCT03101020|58782179|FG001|Overall Study|Ran over by a car|1|||
30773321|NCT03101020|58782178|FG000|Overall Study|Withdrawal by Subject|0|||
30773322|NCT03101020|58782179|FG001|Overall Study|Withdrawal by Subject|2|||
30773323|NCT03100942|58782189|FG000|Randomized Treatment Period|Withdrew Consent|4|||
30773324|NCT03100942|58782190|FG001|Randomized Treatment Period|Withdrew Consent|5|||
30773325|NCT03100942|58782191|FG002|Randomized Treatment Period|Withdrew Consent|3|||
30773326|NCT03100942|58782192|FG003|Randomized Treatment Period|Withdrew Consent|3|||
30773327|NCT03100942|58782193|FG004|Randomized Treatment Period|Withdrew Consent|0|||
30773328|NCT03100942|58782194|FG005|Randomized Treatment Period|Withdrew Consent|0|||
30773329|NCT03100942|58782195|FG006|Randomized Treatment Period|Withdrew Consent|0|||
30773330|NCT03100942|58782189|FG000|Randomized Treatment Period|Adverse Event|5|||
30773331|NCT03100942|58782190|FG001|Randomized Treatment Period|Adverse Event|2|||
30773332|NCT03100942|58782191|FG002|Randomized Treatment Period|Adverse Event|1|||
30773333|NCT03100942|58782192|FG003|Randomized Treatment Period|Adverse Event|0|||
30773334|NCT03100942|58782193|FG004|Randomized Treatment Period|Adverse Event|0|||
30773335|NCT03100942|58782194|FG005|Randomized Treatment Period|Adverse Event|0|||
30773336|NCT03100942|58782195|FG006|Randomized Treatment Period|Adverse Event|0|||
30773337|NCT03100942|58782189|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
30773338|NCT03100942|58782190|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
30773339|NCT03100942|58782191|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
30773340|NCT03100942|58782192|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
30773341|NCT03100942|58782193|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
30773342|NCT03100942|58782194|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
30773343|NCT03100942|58782195|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
30773344|NCT03100942|58782189|FG000|Randomized Treatment Period|Protocol Violation|0|||
30773345|NCT03100942|58782190|FG001|Randomized Treatment Period|Protocol Violation|1|||
30773346|NCT03100942|58782191|FG002|Randomized Treatment Period|Protocol Violation|1|||
30773347|NCT03100942|58782192|FG003|Randomized Treatment Period|Protocol Violation|1|||
30773348|NCT03100942|58782193|FG004|Randomized Treatment Period|Protocol Violation|0|||
30849935|NCT02802319|58876919|FG000|Overall Study|Physician Decision|2|||
30773349|NCT03100942|58782194|FG005|Randomized Treatment Period|Protocol Violation|0|||
30773350|NCT03100942|58782195|FG006|Randomized Treatment Period|Protocol Violation|0|||
30773351|NCT03100942|58782189|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
30773352|NCT03100942|58782190|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
30773353|NCT03100942|58782191|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
30773354|NCT03100942|58782192|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
30773355|NCT03100942|58782193|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
30773356|NCT03100942|58782194|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
30849936|NCT02802319|58876920|FG001|Overall Study|Physician Decision|1|||
30849937|NCT02802319|58876919|FG000|Overall Study|Lost to Follow-up|0|||
30849938|NCT02802319|58876920|FG001|Overall Study|Lost to Follow-up|4|||
30849939|NCT02415400|58876930|FG000|Overall Study|Adverse Event|0|||
30849940|NCT02415400|58876931|FG001|Overall Study|Adverse Event|1|||
30773357|NCT03100942|58782195|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
30773358|NCT03100942|58782189|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
30773359|NCT03100942|58782190|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
30773360|NCT03100942|58782191|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
30773361|NCT03100942|58782192|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
30773362|NCT03100942|58782193|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
30773363|NCT03100942|58782194|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
30773364|NCT03100942|58782195|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
30773365|NCT03100942|58782189|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
30773366|NCT03100942|58782190|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
30773367|NCT03100942|58782191|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
30773368|NCT03100942|58782192|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
30773369|NCT03100942|58782193|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
30773370|NCT03100942|58782194|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
30773371|NCT03100942|58782195|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
30773372|NCT03099694|58782210|FG000|Overall Study|Withdrawal by Subject|11|||
30773373|NCT03099694|58782211|FG001|Overall Study|Withdrawal by Subject|13|||
30773374|NCT03099694|58782210|FG000|Overall Study|Lost to Follow-up|9|||
30773375|NCT03099694|58782211|FG001|Overall Study|Lost to Follow-up|5|||
30773376|NCT03099538|58782218|FG000|Overall Study|Lack of Efficacy|3|||
30773377|NCT03099304|58782227|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
30773378|NCT03099304|58782228|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
30773379|NCT03099304|58782229|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
30773380|NCT03099304|58782230|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
30773381|NCT03099304|58782231|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
30773382|NCT03099304|58782232|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
30773383|NCT03099304|58782227|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
30773384|NCT03099304|58782228|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
30773385|NCT03099304|58782229|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
30773386|NCT03099304|58782230|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
30773387|NCT03099304|58782231|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
30773388|NCT03099304|58782232|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
30773389|NCT03099304|58782227|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
30773390|NCT03099304|58782228|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
30773391|NCT03099304|58782229|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
30773392|NCT03099304|58782230|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
30773393|NCT03099304|58782231|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
30773394|NCT03099304|58782232|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
30773395|NCT03099304|58782227|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
30773396|NCT03099304|58782228|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
30849941|NCT02415400|58876932|FG002|Overall Study|Adverse Event|1|||
30849942|NCT02415400|58876933|FG003|Overall Study|Adverse Event|2|||
30952975|NCT00636441|59003167|FG001|Overall Study|Adverse Event|1|||
30773397|NCT03099304|58782229|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
30773398|NCT03099304|58782230|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
30849943|NCT02415400|58876930|FG000|Overall Study|Participant request to stop therapy|4|||
30773399|NCT03099304|58782231|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
30773400|NCT03099304|58782232|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
30773401|NCT03099304|58782227|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
30773402|NCT03099304|58782228|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
30773403|NCT03099304|58782229|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
30773404|NCT03099304|58782230|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
30773405|NCT03099304|58782231|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
30773406|NCT03099304|58782232|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
30773407|NCT03099304|58782227|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
30773408|NCT03099304|58782228|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
30773409|NCT03099304|58782229|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
30773410|NCT03099304|58782230|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
30773411|NCT03099304|58782231|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
30773412|NCT03099304|58782232|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
30773413|NCT03099304|58782227|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
30773414|NCT03099304|58782228|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
30773415|NCT03099304|58782229|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
30773416|NCT03099304|58782230|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
30773417|NCT03099304|58782231|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
30773418|NCT03099304|58782232|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
30773419|NCT03099304|58782227|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
30773420|NCT03099304|58782228|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
30773421|NCT03099304|58782229|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
30773422|NCT03099304|58782230|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
30773423|NCT03099304|58782231|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
30773424|NCT03099304|58782232|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
30773425|NCT03099304|58782227|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
30773426|NCT03099304|58782228|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
30773427|NCT03099304|58782229|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
30773428|NCT03099304|58782230|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
30773429|NCT03099304|58782231|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
30773430|NCT03099304|58782232|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
30773431|NCT03099304|58782227|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
30773432|NCT03099304|58782228|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
30773433|NCT03099304|58782229|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
30773434|NCT03099304|58782230|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
30773435|NCT03099304|58782231|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
30773436|NCT03099304|58782232|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
30773437|NCT03099304|58782227|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
30773438|NCT03099304|58782228|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
30773439|NCT03099304|58782229|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
30773440|NCT03099304|58782230|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
30773441|NCT03099304|58782231|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
30773442|NCT03099304|58782232|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
30773443|NCT03099304|58782227|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
30773444|NCT03099304|58782228|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
30849944|NCT02415400|58876931|FG001|Overall Study|Participant request to stop therapy|3|||
30849945|NCT02415400|58876932|FG002|Overall Study|Participant request to stop therapy|8|||
30849946|NCT02415400|58876933|FG003|Overall Study|Participant request to stop therapy|6|||
30849947|NCT02415400|58876930|FG000|Overall Study|Participant withdrew consent|14|||
30849948|NCT02415400|58876931|FG001|Overall Study|Participant withdrew consent|12|||
30849949|NCT02415400|58876932|FG002|Overall Study|Participant withdrew consent|30|||
30849950|NCT02415400|58876933|FG003|Overall Study|Participant withdrew consent|21|||
30849951|NCT02415400|58876930|FG000|Overall Study|Death|39|||
30849952|NCT02415400|58876931|FG001|Overall Study|Death|41|||
30849953|NCT02415400|58876932|FG002|Overall Study|Death|35|||
30773445|NCT03099304|58782229|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
30773446|NCT03099304|58782230|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
30773447|NCT03099304|58782231|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
30773448|NCT03099304|58782232|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
30773449|NCT03099304|58782227|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
30773450|NCT03099304|58782228|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
30773451|NCT03099304|58782229|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
30773452|NCT03099304|58782230|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
30849954|NCT02415400|58876933|FG003|Overall Study|Death|42|||
30773453|NCT03099304|58782231|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
30773454|NCT03099304|58782232|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
30773455|NCT03099304|58782227|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
30773456|NCT03099304|58782228|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
30773457|NCT03099304|58782229|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
30849955|NCT02415400|58876930|FG000|Overall Study|Lost to Follow-up|3|||
30662471|NCT00920855|58675986|FG001|Overall Study|Noncompliance to study medication|0|||
30662472|NCT00920855|58675987|FG002|Overall Study|Noncompliance to study medication|1|||
30662473|NCT00920855|58675985|FG000|Overall Study|Response plateau; started maintenance|0|||
30662474|NCT00920855|58675986|FG001|Overall Study|Response plateau; started maintenance|0|||
30773458|NCT03099304|58782230|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
30849956|NCT02415400|58876931|FG001|Overall Study|Lost to Follow-up|3|||
30849957|NCT02415400|58876932|FG002|Overall Study|Lost to Follow-up|2|||
30849958|NCT02415400|58876933|FG003|Overall Study|Lost to Follow-up|5|||
30849959|NCT02415400|58876930|FG000|Overall Study|Poor/Non-Compliance|0|||
30849960|NCT02415400|58876931|FG001|Overall Study|Poor/Non-Compliance|1|||
30849961|NCT02415400|58876932|FG002|Overall Study|Poor/Non-Compliance|3|||
30849962|NCT02415400|58876933|FG003|Overall Study|Poor/Non-Compliance|4|||
30849963|NCT02415400|58876930|FG000|Overall Study|Participant no longer meets criteria|2|||
30849964|NCT02415400|58876931|FG001|Overall Study|Participant no longer meets criteria|0|||
30849965|NCT02415400|58876932|FG002|Overall Study|Participant no longer meets criteria|0|||
30849966|NCT02415400|58876933|FG003|Overall Study|Participant no longer meets criteria|1|||
30849967|NCT02415400|58876930|FG000|Overall Study|Participant doesn't answer phone|1|||
30849968|NCT02415400|58876931|FG001|Overall Study|Participant doesn't answer phone|0|||
30849969|NCT02415400|58876932|FG002|Overall Study|Participant doesn't answer phone|0|||
30849970|NCT02415400|58876933|FG003|Overall Study|Participant doesn't answer phone|0|||
30849971|NCT02415400|58876930|FG000|Overall Study|Participant wanted home visits|1|||
30952976|NCT00636441|59003168|FG002|Overall Study|Adverse Event|1|||
30952977|NCT00636441|59003169|FG003|Overall Study|Adverse Event|0|||
30952978|NCT00636441|59003170|FG004|Overall Study|Adverse Event|0|||
30952979|NCT00636441|59003171|FG005|Overall Study|Adverse Event|1|||
30952980|NCT00636441|59003172|FG006|Overall Study|Adverse Event|0|||
30952981|NCT00636441|59003166|FG000|Overall Study|Late, ineligible|0|||
30952982|NCT00636441|59003167|FG001|Overall Study|Late, ineligible|0|||
30952983|NCT00636441|59003168|FG002|Overall Study|Late, ineligible|0|||
30952984|NCT00636441|59003169|FG003|Overall Study|Late, ineligible|0|||
30952985|NCT00636441|59003170|FG004|Overall Study|Late, ineligible|0|||
30952986|NCT00636441|59003171|FG005|Overall Study|Late, ineligible|0|||
30952987|NCT00636441|59003172|FG006|Overall Study|Late, ineligible|1|||
30952988|NCT00636441|59003166|FG000|Overall Study|Screen Failure|0|||
30952989|NCT00636441|59003167|FG001|Overall Study|Screen Failure|0|||
30952990|NCT00636441|59003168|FG002|Overall Study|Screen Failure|0|||
30952991|NCT00636441|59003169|FG003|Overall Study|Screen Failure|0|||
30952992|NCT00636441|59003170|FG004|Overall Study|Screen Failure|0|||
30952993|NCT00636441|59003171|FG005|Overall Study|Screen Failure|0|||
30952994|NCT00636441|59003172|FG006|Overall Study|Screen Failure|17|||
30952995|NCT00636363|59003195|FG000|Overall Study|Conjunctivitis|0|||
30952996|NCT00636363|59003196|FG001|Overall Study|Conjunctivitis|0|||
30952997|NCT00636363|59003197|FG002|Overall Study|Conjunctivitis|1|||
30773459|NCT03099304|58782231|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
30773460|NCT03099304|58782232|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
30773461|NCT03099304|58782227|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
30773462|NCT03099304|58782228|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
30773463|NCT03099304|58782229|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
30773464|NCT03099304|58782230|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
30773465|NCT03099304|58782231|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
30773466|NCT03099304|58782232|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
30849972|NCT02415400|58876931|FG001|Overall Study|Participant wanted home visits|0|||
30849973|NCT02415400|58876932|FG002|Overall Study|Participant wanted home visits|0|||
30773467|NCT03099304|58782227|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
30773468|NCT03099304|58782228|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
30849974|NCT02415400|58876933|FG003|Overall Study|Participant wanted home visits|0|||
30849975|NCT02415400|58876930|FG000|Overall Study|Randomized in error|2|||
30849976|NCT02415400|58876931|FG001|Overall Study|Randomized in error|0|||
30849977|NCT02415400|58876932|FG002|Overall Study|Randomized in error|0|||
30849978|NCT02415400|58876933|FG003|Overall Study|Randomized in error|0|||
30849979|NCT02415400|58876930|FG000|Overall Study|No study drug on site|0|||
30952998|NCT00636363|59003195|FG000|Overall Study|Adverse Event|0|||
30952999|NCT00636363|59003196|FG001|Overall Study|Adverse Event|0|||
30953000|NCT00636363|59003197|FG002|Overall Study|Adverse Event|1|||
30953001|NCT00636363|59003195|FG000|Overall Study|Positive slit lamp finding|0|||
30953002|NCT00636363|59003196|FG001|Overall Study|Positive slit lamp finding|2|||
30953003|NCT00636363|59003197|FG002|Overall Study|Positive slit lamp finding|1|||
30953004|NCT00636363|59003195|FG000|Overall Study|Study related symptoms/complaints|8|||
30849980|NCT02415400|58876931|FG001|Overall Study|No study drug on site|1|||
30849981|NCT02415400|58876932|FG002|Overall Study|No study drug on site|0|||
30849982|NCT02415400|58876933|FG003|Overall Study|No study drug on site|0|||
30849983|NCT02415400|58876930|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
30849984|NCT02415400|58876931|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
30849985|NCT02415400|58876932|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
30849986|NCT02415400|58876933|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
30849987|NCT02415400|58876930|FG000|Overall Study|Coagulation values cannot be set|0|||
30849988|NCT02415400|58876931|FG001|Overall Study|Coagulation values cannot be set|0|||
30849989|NCT02415400|58876932|FG002|Overall Study|Coagulation values cannot be set|1|||
30849990|NCT02415400|58876933|FG003|Overall Study|Coagulation values cannot be set|0|||
30849991|NCT02415400|58876930|FG000|Overall Study|State regulations prevent participation|0|||
30849992|NCT02415400|58876931|FG001|Overall Study|State regulations prevent participation|0|||
30849993|NCT02415400|58876932|FG002|Overall Study|State regulations prevent participation|1|||
30849994|NCT02415400|58876933|FG003|Overall Study|State regulations prevent participation|0|||
30773469|NCT03099304|58782229|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
30662475|NCT00920855|58675987|FG002|Overall Study|Response plateau; started maintenance|1|||
30662476|NCT03738228|58675998|FG000|Overall Study|Never received study treatment|2|||
30662477|NCT03738228|58675999|FG001|Overall Study|Never received study treatment|2|||
30662478|NCT00742209|58676010|FG000|Overall Study|Adverse Event|11|||
30773470|NCT03099304|58782230|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
30773471|NCT03099304|58782231|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
30773472|NCT03099304|58782232|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
30773473|NCT03099304|58782227|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
30773474|NCT03099304|58782228|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
30773475|NCT03099304|58782229|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
30773476|NCT03099304|58782230|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
30773477|NCT03099304|58782231|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
30773478|NCT03099304|58782232|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
30773479|NCT03097588|58782259|FG000|Overall Study|Adverse Event|1|||
30773480|NCT01631214|58782265|FG000|Overall Study|Withdrawal by Subject|276|||
30773481|NCT01631214|58782266|FG001|Overall Study|Withdrawal by Subject|290|||
30773482|NCT01631214|58782265|FG000|Overall Study|Death|113|||
30773483|NCT01631214|58782266|FG001|Overall Study|Death|106|||
30773484|NCT01631214|58782265|FG000|Overall Study|Lost to Follow-up|54|||
30773485|NCT01631214|58782266|FG001|Overall Study|Lost to Follow-up|40|||
30773486|NCT01631214|58782265|FG000|Overall Study|Adverse Event|45|||
30773487|NCT01631214|58782266|FG001|Overall Study|Adverse Event|45|||
30773488|NCT01631214|58782265|FG000|Overall Study|Other|22|||
30773489|NCT01631214|58782266|FG001|Overall Study|Other|19|||
30773490|NCT01631214|58782265|FG000|Overall Study|Noncompliance|16|||
30773491|NCT01631214|58782266|FG001|Overall Study|Noncompliance|15|||
30773492|NCT01631214|58782265|FG000|Overall Study|Requirement for Alternative Therapy|8|||
30773493|NCT01631214|58782266|FG001|Overall Study|Requirement for Alternative Therapy|3|||
30773494|NCT01631214|58782265|FG000|Overall Study|Protocol Deviation|4|||
30773495|NCT01631214|58782266|FG001|Overall Study|Protocol Deviation|3|||
30773496|NCT01631214|58782265|FG000|Overall Study|Ineligibility determined|5|||
30773497|NCT01631214|58782266|FG001|Overall Study|Ineligibility determined|2|||
30773498|NCT01631214|58782265|FG000|Overall Study|Administrative Decision|1|||
30773499|NCT01631214|58782266|FG001|Overall Study|Administrative Decision|0|||
30773500|NCT03093454|58782276|FG000|Overall Study|Withdrawal by Subject|1|||
30773501|NCT03093454|58782277|FG001|Overall Study|Withdrawal by Subject|1|||
30773502|NCT03093454|58782276|FG000|Overall Study|Scheduling conflict|3|||
30773503|NCT03093454|58782277|FG001|Overall Study|Scheduling conflict|1|||
30773504|NCT03093454|58782276|FG000|Overall Study|Physician Decision|2|||
30773505|NCT03093454|58782277|FG001|Overall Study|Physician Decision|1|||
30773506|NCT00468130|58782298|FG000|Overall Study|Adverse Event|2|||
30849995|NCT02415400|58876930|FG000|Overall Study|Poor treatment monitoring|0|||
30849996|NCT02415400|58876931|FG001|Overall Study|Poor treatment monitoring|0|||
30662479|NCT00742209|58676011|FG001|Overall Study|Adverse Event|4|||
30773507|NCT00468130|58782299|FG001|Overall Study|Adverse Event|1|||
30773508|NCT00468130|58782298|FG000|Overall Study|Withdrawal by Subject|0|||
30773509|NCT00468130|58782299|FG001|Overall Study|Withdrawal by Subject|1|||
30773510|NCT00911820|58782309|FG000|Overall Study|RECIST progression|12|||
30773511|NCT00911820|58782310|FG001|Overall Study|RECIST progression|8|||
30849997|NCT02415400|58876932|FG002|Overall Study|Poor treatment monitoring|1|||
30773512|NCT00911820|58782309|FG000|Overall Study|Adverse Event|8|||
30773513|NCT00911820|58782310|FG001|Overall Study|Adverse Event|8|||
30773514|NCT00911820|58782309|FG000|Overall Study|Clinical Progression|7|||
30773515|NCT00911820|58782310|FG001|Overall Study|Clinical Progression|5|||
30953005|NCT00636363|59003196|FG001|Overall Study|Study related symptoms/complaints|7|||
30773516|NCT00911820|58782309|FG000|Overall Study|Physician Decision|5|||
30773517|NCT00911820|58782310|FG001|Overall Study|Physician Decision|9|||
30773518|NCT00911820|58782309|FG000|Overall Study|Decline in Performance Status|4|||
30773519|NCT00911820|58782310|FG001|Overall Study|Decline in Performance Status|2|||
30773520|NCT00911820|58782309|FG000|Overall Study|Withdrawal by Subject|3|||
30773521|NCT00911820|58782310|FG001|Overall Study|Withdrawal by Subject|4|||
30773522|NCT00911820|58782309|FG000|Overall Study|Death|1|||
30773523|NCT00911820|58782310|FG001|Overall Study|Death|2|||
30773524|NCT00911820|58782309|FG000|Overall Study|Pursue surgery|1|||
30773525|NCT00911820|58782310|FG001|Overall Study|Pursue surgery|1|||
30773526|NCT00911820|58782309|FG000|Overall Study|Pursue Radiation|1|||
30773527|NCT00911820|58782310|FG001|Overall Study|Pursue Radiation|0|||
30773528|NCT00911820|58782309|FG000|Overall Study|Still on Therapy|2|||
30773529|NCT00911820|58782310|FG001|Overall Study|Still on Therapy|2|||
30849998|NCT02415400|58876933|FG003|Overall Study|Poor treatment monitoring|0|||
30849999|NCT02415400|58876930|FG000|Overall Study|Participant in jail|0|||
30850000|NCT02415400|58876931|FG001|Overall Study|Participant in jail|0|||
30850001|NCT02415400|58876932|FG002|Overall Study|Participant in jail|1|||
30850002|NCT02415400|58876933|FG003|Overall Study|Participant in jail|0|||
30850003|NCT02415400|58876930|FG000|Overall Study|Investigator decision|0|||
30850004|NCT02415400|58876931|FG001|Overall Study|Investigator decision|0|||
30850005|NCT02415400|58876932|FG002|Overall Study|Investigator decision|1|||
30850006|NCT02415400|58876933|FG003|Overall Study|Investigator decision|1|||
30850007|NCT02415400|58876930|FG000|Overall Study|Site closure; participant won't transfer|0|||
30850008|NCT02415400|58876931|FG001|Overall Study|Site closure; participant won't transfer|0|||
30850009|NCT02415400|58876932|FG002|Overall Study|Site closure; participant won't transfer|0|||
30850010|NCT02415400|58876933|FG003|Overall Study|Site closure; participant won't transfer|1|||
30850011|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
30850012|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
30850013|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
30850014|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
30850015|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
30850016|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
30850017|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
30850018|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
30850019|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
30850020|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
30850021|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
30850022|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
30850023|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
30850024|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
30850025|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
30850026|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
30850027|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
30850028|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
30850029|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
30850030|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
30850031|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
30850032|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
30850033|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
30850034|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
30850035|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
30850036|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
30850037|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
30850038|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
30850039|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
30850040|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
30850041|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
30850042|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
30850043|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
30850044|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
30850045|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
30850046|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
30850047|NCT04194801|58876950|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
30773530|NCT00911820|58782309|FG000|Overall Study|Pathology Not Confirmed|1|||
30850048|NCT04194801|58876951|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
30850049|NCT04194801|58876952|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
30850050|NCT04194801|58876950|FG000|Part Ib/II End of Study|Death|2|||
30850051|NCT04194801|58876951|FG001|Part Ib/II End of Study|Death|3|||
30850052|NCT04194801|58876952|FG002|Part Ib/II End of Study|Death|3|||
30773531|NCT00911820|58782310|FG001|Overall Study|Pathology Not Confirmed|0|||
30773532|NCT00911820|58782309|FG000|Overall Study|Withdraw before Receive Treatment|0|||
30773533|NCT00911820|58782310|FG001|Overall Study|Withdraw before Receive Treatment|2|||
30773534|NCT00246324|58782325|FG000|Overall Study|Withdrawal by Subject|1|||
30773535|NCT04234984|58782331|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
30773536|NCT04234984|58782331|FG000|Follow-up at the Second Time Point|Death|1|||
30773537|NCT04234984|58782331|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
30773538|NCT03922750|58782345|FG000|Overall Study|Unclassified|0|||
30773539|NCT03922750|58782346|FG001|Overall Study|Unclassified|0|||
30773540|NCT03922750|58782347|FG002|Overall Study|Unclassified|1|||
30773541|NCT03922750|58782345|FG000|Overall Study|Adverse Event|0|||
30773542|NCT03922750|58782346|FG001|Overall Study|Adverse Event|1|||
30773543|NCT03922750|58782347|FG002|Overall Study|Adverse Event|0|||
30773544|NCT04634253|58782369|FG000|Overall Study|Adverse Event|1|||
30773545|NCT04634253|58782370|FG001|Overall Study|Adverse Event|1|||
30850053|NCT04194801|58876950|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
30850054|NCT04194801|58876951|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
30850055|NCT04194801|58876952|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
30850056|NCT04194801|58876950|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
30850057|NCT04194801|58876951|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
30850058|NCT04194801|58876952|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
30850059|NCT04194801|58876950|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
30850060|NCT04194801|58876951|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
30773546|NCT04634253|58782371|FG002|Overall Study|Adverse Event|0|||
30773547|NCT04634253|58782369|FG000|Overall Study|Physician Decision|0|||
30773548|NCT04634253|58782370|FG001|Overall Study|Physician Decision|1|||
30773549|NCT04634253|58782371|FG002|Overall Study|Physician Decision|0|||
30773550|NCT04634253|58782369|FG000|Overall Study|Withdrawal by Subject|1|||
30773551|NCT04634253|58782370|FG001|Overall Study|Withdrawal by Subject|0|||
30773552|NCT04634253|58782371|FG002|Overall Study|Withdrawal by Subject|3|||
30773553|NCT03725982|58782477|FG000|First Intervention|Withdrawal by Subject|0|||
30773554|NCT03725982|58782478|FG001|First Intervention|Withdrawal by Subject|1|||
30773555|NCT03725982|58782477|FG000|First Intervention|Physician Decision|1|||
30773556|NCT03725982|58782478|FG001|First Intervention|Physician Decision|1|||
30850061|NCT04194801|58876952|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
30850062|NCT04194801|58876950|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
30773557|NCT03354273|58782548|FG000|Overall Study|Adverse Event|5|||
30773558|NCT03354273|58782548|FG000|Overall Study|Screen Failure|21|||
30773559|NCT03354273|58782548|FG000|Overall Study|Withdrawal by Subject|34|||
30773560|NCT03354273|58782548|FG000|Overall Study|Technical Problems|30|||
30773561|NCT03354273|58782548|FG000|Overall Study|Lost to Follow-up|4|||
30773562|NCT03354273|58782548|FG000|Overall Study|Investigator Decision|3|||
30773563|NCT03354273|58782548|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
30773564|NCT03354273|58782548|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
30773565|NCT03354273|58782548|FG000|Overall Study|COVID-19 Restrictions|9|||
30773566|NCT03354273|58782548|FG000|Overall Study|Other|5|||
30773567|NCT03282123|58782559|FG000|Overall Study|Withdrawal by Subject|5|||
30773568|NCT02759185|58782587|FG000|Stage 1|Adverse Event|0|||
30850063|NCT04194801|58876951|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
30850064|NCT04194801|58876952|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
30850065|NCT02802865|58876976|FG000|Overall Study|Pregnancy|1|||
30850066|NCT02802865|58876977|FG001|Overall Study|Pregnancy|1|||
30850067|NCT02802865|58876976|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
30850068|NCT02802865|58876977|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
30953006|NCT00636363|59003197|FG002|Overall Study|Study related symptoms/complaints|4|||
30953007|NCT00636363|59003195|FG000|Overall Study|Met ineligibility criteria|0|||
30662480|NCT00742209|58676012|FG002|Overall Study|Adverse Event|17|||
30662481|NCT00742209|58676013|FG003|Overall Study|Adverse Event|16|||
30662482|NCT00742209|58676014|FG004|Overall Study|Adverse Event|13|||
30662483|NCT00742209|58676010|FG000|Overall Study|Participant Withdrew Consent|8|||
30662484|NCT00742209|58676011|FG001|Overall Study|Participant Withdrew Consent|4|||
30773569|NCT02759185|58782588|FG001|Stage 1|Adverse Event|1|||
30773570|NCT02759185|58782589|FG002|Stage 1|Adverse Event|3|||
30773571|NCT02759185|58782590|FG003|Stage 1|Adverse Event|0|||
30773572|NCT02759185|58782591|FG004|Stage 1|Adverse Event|0|||
30773573|NCT02759185|58782592|FG005|Stage 1|Adverse Event|0|||
30773574|NCT02759185|58782593|FG006|Stage 1|Adverse Event|0|||
30773575|NCT02759185|58782587|FG000|Stage 1|Withdrawal by Subject|1|||
30773576|NCT02759185|58782588|FG001|Stage 1|Withdrawal by Subject|0|||
30773577|NCT02759185|58782589|FG002|Stage 1|Withdrawal by Subject|0|||
30773578|NCT02759185|58782590|FG003|Stage 1|Withdrawal by Subject|0|||
30773579|NCT02759185|58782591|FG004|Stage 1|Withdrawal by Subject|0|||
30773580|NCT02759185|58782592|FG005|Stage 1|Withdrawal by Subject|0|||
30773581|NCT02759185|58782593|FG006|Stage 1|Withdrawal by Subject|0|||
30850069|NCT02414932|58876985|FG000|Overall Study|Withdrawal by Subject|2|||
30850070|NCT02414932|58876986|FG001|Overall Study|Withdrawal by Subject|3|||
30662485|NCT00742209|58676012|FG002|Overall Study|Participant Withdrew Consent|14|||
30662486|NCT00742209|58676013|FG003|Overall Study|Participant Withdrew Consent|7|||
30662487|NCT00742209|58676014|FG004|Overall Study|Participant Withdrew Consent|4|||
30662488|NCT00742209|58676010|FG000|Overall Study|Protocol Violation|6|||
30662489|NCT00742209|58676011|FG001|Overall Study|Protocol Violation|5|||
30662490|NCT00742209|58676012|FG002|Overall Study|Protocol Violation|4|||
30662491|NCT00742209|58676013|FG003|Overall Study|Protocol Violation|5|||
30662492|NCT00742209|58676014|FG004|Overall Study|Protocol Violation|3|||
30662493|NCT00742209|58676010|FG000|Overall Study|Lost to Follow-up|3|||
30773582|NCT02759185|58782587|FG000|Stage 2|Adverse Event|0|||
30773583|NCT02759185|58782588|FG001|Stage 2|Adverse Event|0|||
30773584|NCT02759185|58782589|FG002|Stage 2|Adverse Event|0|||
30773585|NCT02759185|58782590|FG003|Stage 2|Adverse Event|0|||
30773586|NCT02759185|58782591|FG004|Stage 2|Adverse Event|1|||
30850071|NCT02414932|58876985|FG000|Overall Study|Adverse Event|1|||
30850072|NCT02414932|58876986|FG001|Overall Study|Adverse Event|0|||
30850073|NCT00704535|58876992|FG000|Overall Study|Adverse Event|2|||
30850074|NCT00704535|58876992|FG000|Overall Study|Death|2|||
30850075|NCT00704535|58876992|FG000|Overall Study|Lost to Follow-up|8|||
30850076|NCT00704535|58876992|FG000|Overall Study|Protocol Violation|10|||
30850077|NCT00704535|58876992|FG000|Overall Study|Completed status not on Case Report Form|124|||
30850078|NCT01740687|58876996|FG000|Overall Study|Lost to Follow-up|11|||
30850079|NCT01740687|58876996|FG000|Overall Study|Withdrawal by Subject|2|||
30850080|NCT01740687|58876996|FG000|Overall Study|other reason|22|||
30850081|NCT01740687|58876996|FG000|Overall Study|treatment not received|2|||
30850082|NCT02648204|58877004|FG000|Overall Study|Withdrawal by Subject|12|||
30850083|NCT02648204|58877005|FG001|Overall Study|Withdrawal by Subject|8|||
30850084|NCT02648204|58877006|FG002|Overall Study|Withdrawal by Subject|2|||
30850085|NCT02648204|58877007|FG003|Overall Study|Withdrawal by Subject|6|||
30850086|NCT02648204|58877004|FG000|Overall Study|Lost to Follow-up|5|||
30850087|NCT02648204|58877005|FG001|Overall Study|Lost to Follow-up|8|||
30850088|NCT02648204|58877006|FG002|Overall Study|Lost to Follow-up|4|||
30850089|NCT02648204|58877007|FG003|Overall Study|Lost to Follow-up|6|||
30850090|NCT02648204|58877004|FG000|Overall Study|Missing follow-up information|4|||
30850091|NCT02648204|58877005|FG001|Overall Study|Missing follow-up information|4|||
30850092|NCT02648204|58877006|FG002|Overall Study|Missing follow-up information|4|||
30850093|NCT02648204|58877007|FG003|Overall Study|Missing follow-up information|2|||
30850094|NCT02648204|58877004|FG000|Overall Study|Death|1|||
30773587|NCT02759185|58782592|FG005|Stage 2|Adverse Event|2|||
30773588|NCT02759185|58782593|FG006|Stage 2|Adverse Event|0|||
30850095|NCT02648204|58877005|FG001|Overall Study|Death|1|||
30850096|NCT02648204|58877006|FG002|Overall Study|Death|2|||
30850097|NCT02648204|58877007|FG003|Overall Study|Death|2|||
30850098|NCT02648204|58877004|FG000|Overall Study|Adverse Event|0|||
30850099|NCT02648204|58877005|FG001|Overall Study|Adverse Event|0|||
30850100|NCT02648204|58877006|FG002|Overall Study|Adverse Event|1|||
30850101|NCT02648204|58877007|FG003|Overall Study|Adverse Event|0|||
30850102|NCT02799745|58877019|FG000|Overall Study|Participant moved out of state|1|||
30850103|NCT02799745|58877020|FG001|Overall Study|Participant moved out of state|0|||
30850104|NCT02799745|58877019|FG000|Overall Study|Discontinued due to planned surgery|1|||
30850105|NCT02799745|58877020|FG001|Overall Study|Discontinued due to planned surgery|0|||
30850106|NCT02799745|58877019|FG000|Overall Study|Withdrawal by Subject|16|||
30850107|NCT02799745|58877020|FG001|Overall Study|Withdrawal by Subject|25|||
30850108|NCT02799745|58877019|FG000|Overall Study|Protocol Deviation|4|||
30662494|NCT00742209|58676011|FG001|Overall Study|Lost to Follow-up|4|||
30662495|NCT00742209|58676012|FG002|Overall Study|Lost to Follow-up|5|||
30662496|NCT00742209|58676013|FG003|Overall Study|Lost to Follow-up|5|||
30773589|NCT02759185|58782587|FG000|Stage 2|Withdrawal by Subject|0|||
30773590|NCT02759185|58782588|FG001|Stage 2|Withdrawal by Subject|0|||
30773591|NCT02759185|58782589|FG002|Stage 2|Withdrawal by Subject|0|||
30773592|NCT02759185|58782590|FG003|Stage 2|Withdrawal by Subject|0|||
30773593|NCT02759185|58782591|FG004|Stage 2|Withdrawal by Subject|1|||
30773594|NCT02759185|58782592|FG005|Stage 2|Withdrawal by Subject|1|||
30773595|NCT02759185|58782593|FG006|Stage 2|Withdrawal by Subject|1|||
30773596|NCT02008396|58782630|FG000|Overall Study|Protocol Violation|0|||
30773597|NCT02008396|58782631|FG001|Overall Study|Protocol Violation|1|||
30773598|NCT01844518|58782649|FG000|Overall Study|Adverse Event|7|||
30773599|NCT01844518|58782650|FG001|Overall Study|Adverse Event|1|||
30773600|NCT01844518|58782649|FG000|Overall Study|Lack of Efficacy|17|||
30850109|NCT02799745|58877020|FG001|Overall Study|Protocol Deviation|5|||
30850110|NCT02799745|58877019|FG000|Overall Study|Progressive Disease|28|||
30850111|NCT02799745|58877020|FG001|Overall Study|Progressive Disease|38|||
30850112|NCT02799745|58877019|FG000|Overall Study|Lost to Follow-up|3|||
30850113|NCT02799745|58877020|FG001|Overall Study|Lost to Follow-up|2|||
30850114|NCT02799745|58877019|FG000|Overall Study|Death|3|||
30850115|NCT02799745|58877020|FG001|Overall Study|Death|0|||
30850116|NCT02799745|58877019|FG000|Overall Study|Adverse Event|0|||
30850117|NCT02799745|58877020|FG001|Overall Study|Adverse Event|1|||
30773601|NCT01844518|58782650|FG001|Overall Study|Lack of Efficacy|5|||
30850118|NCT00705159|58877030|FG000|Overall Study|Withdrawal by Subject|0|||
30773602|NCT01844518|58782649|FG000|Overall Study|Participant's request to discontinue|4|||
30773603|NCT01844518|58782650|FG001|Overall Study|Participant's request to discontinue|1|||
30773604|NCT01844518|58782649|FG000|Overall Study|Poor/Non-compliance|1|||
30773605|NCT01844518|58782650|FG001|Overall Study|Poor/Non-compliance|0|||
30773606|NCT01844518|58782649|FG000|Overall Study|No Longer Met Study Criteria|2|||
30773607|NCT01844518|58782650|FG001|Overall Study|No Longer Met Study Criteria|0|||
30773608|NCT01844518|58782649|FG000|Overall Study|Withdrawal by Subject|9|||
30773609|NCT01844518|58782650|FG001|Overall Study|Withdrawal by Subject|0|||
30773610|NCT01844518|58782649|FG000|Overall Study|Pregnancy|1|||
30773611|NCT01844518|58782650|FG001|Overall Study|Pregnancy|0|||
30773612|NCT01793610|58782686|FG000|Overall Study|Withdrawal by Subject|1|||
30773613|NCT01793610|58782687|FG001|Overall Study|Withdrawal by Subject|0|||
30773614|NCT01793610|58782688|FG002|Overall Study|Withdrawal by Subject|1|||
30773615|NCT01039584|58782736|FG000|Overall Study|Withdrawal by Subject|4|||
30773616|NCT01039584|58782737|FG001|Overall Study|Withdrawal by Subject|2|||
30773617|NCT01039584|58782738|FG002|Overall Study|Withdrawal by Subject|1|||
30773618|NCT01039584|58782736|FG000|Overall Study|Protocol Violation|10|||
30773619|NCT01039584|58782737|FG001|Overall Study|Protocol Violation|4|||
30773620|NCT01039584|58782738|FG002|Overall Study|Protocol Violation|6|||
30773621|NCT01039584|58782736|FG000|Overall Study|Lost to Follow-up|5|||
30773622|NCT01039584|58782737|FG001|Overall Study|Lost to Follow-up|3|||
30773623|NCT01039584|58782738|FG002|Overall Study|Lost to Follow-up|4|||
30773624|NCT01039584|58782736|FG000|Overall Study|Negative Baseline culture for Candida|59|||
30773625|NCT01039584|58782737|FG001|Overall Study|Negative Baseline culture for Candida|59|||
30773626|NCT01039584|58782738|FG002|Overall Study|Negative Baseline culture for Candida|24|||
30773627|NCT01039584|58782736|FG000|Overall Study|Lack of Efficacy|7|||
30773628|NCT01039584|58782737|FG001|Overall Study|Lack of Efficacy|6|||
30773629|NCT01039584|58782738|FG002|Overall Study|Lack of Efficacy|10|||
30773630|NCT01039584|58782736|FG000|Overall Study|other|1|||
30773631|NCT01039584|58782737|FG001|Overall Study|other|3|||
30773632|NCT01039584|58782738|FG002|Overall Study|other|1|||
30773633|NCT01039584|58782736|FG000|Overall Study|Pap smear with significant pathology|10|||
30773634|NCT01039584|58782737|FG001|Overall Study|Pap smear with significant pathology|10|||
30773635|NCT01039584|58782738|FG002|Overall Study|Pap smear with significant pathology|3|||
30773636|NCT01039584|58782736|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
30773637|NCT01039584|58782737|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
30773638|NCT01039584|58782738|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
30773639|NCT00920387|58782748|FG000|Stage 1|Adverse Event|1|||
30773640|NCT00920387|58782749|FG001|Stage 1|Adverse Event|0|||
30773641|NCT00920387|58782750|FG002|Stage 1|Adverse Event|0|||
30773642|NCT00679783|58782775|FG000|Overall Study|Adverse Event|0|||
30773643|NCT00679783|58782776|FG001|Overall Study|Adverse Event|0|||
30773644|NCT00679783|58782777|FG002|Overall Study|Adverse Event|0|||
30773645|NCT00679783|58782778|FG003|Overall Study|Adverse Event|3|||
30773646|NCT00679783|58782779|FG004|Overall Study|Adverse Event|0|||
30773647|NCT00679783|58782780|FG005|Overall Study|Adverse Event|0|||
30773648|NCT00679783|58782781|FG006|Overall Study|Adverse Event|1|||
30773649|NCT00679783|58782775|FG000|Overall Study|Lack of Efficacy|0|||
30773650|NCT00679783|58782776|FG001|Overall Study|Lack of Efficacy|1|||
30773651|NCT00679783|58782777|FG002|Overall Study|Lack of Efficacy|0|||
30773652|NCT00679783|58782778|FG003|Overall Study|Lack of Efficacy|2|||
30773653|NCT00679783|58782779|FG004|Overall Study|Lack of Efficacy|0|||
30773654|NCT00679783|58782780|FG005|Overall Study|Lack of Efficacy|0|||
30773655|NCT00679783|58782781|FG006|Overall Study|Lack of Efficacy|0|||
30773656|NCT00679783|58782775|FG000|Overall Study|Withdrawal by Subject|0|||
30773657|NCT00679783|58782776|FG001|Overall Study|Withdrawal by Subject|0|||
30773658|NCT00679783|58782777|FG002|Overall Study|Withdrawal by Subject|1|||
30773659|NCT00679783|58782778|FG003|Overall Study|Withdrawal by Subject|1|||
30773660|NCT00679783|58782779|FG004|Overall Study|Withdrawal by Subject|0|||
30773661|NCT00679783|58782780|FG005|Overall Study|Withdrawal by Subject|0|||
30850119|NCT00705159|58877031|FG001|Overall Study|Withdrawal by Subject|1|||
30773662|NCT00679783|58782781|FG006|Overall Study|Withdrawal by Subject|0|||
30773663|NCT00679783|58782775|FG000|Overall Study|Not Captured|0|||
30773664|NCT00679783|58782776|FG001|Overall Study|Not Captured|0|||
30773665|NCT00679783|58782777|FG002|Overall Study|Not Captured|0|||
30773666|NCT00679783|58782778|FG003|Overall Study|Not Captured|5|||
30773667|NCT00679783|58782779|FG004|Overall Study|Not Captured|0|||
30773668|NCT00679783|58782780|FG005|Overall Study|Not Captured|0|||
30773669|NCT00679783|58782781|FG006|Overall Study|Not Captured|0|||
30773670|NCT00679783|58782775|FG000|Overall Study|Ongoing at data cut-off|2|||
30850120|NCT00705159|58877032|FG002|Overall Study|Withdrawal by Subject|1|||
30773671|NCT00679783|58782776|FG001|Overall Study|Ongoing at data cut-off|2|||
30773672|NCT00679783|58782777|FG002|Overall Study|Ongoing at data cut-off|0|||
30773673|NCT00679783|58782778|FG003|Overall Study|Ongoing at data cut-off|9|||
30773674|NCT00679783|58782779|FG004|Overall Study|Ongoing at data cut-off|1|||
30773675|NCT00679783|58782780|FG005|Overall Study|Ongoing at data cut-off|0|||
30773676|NCT00679783|58782781|FG006|Overall Study|Ongoing at data cut-off|0|||
30773677|NCT03896490|58782803|FG000|Overall Study|Withdrawal by Subject|1|||
30773678|NCT03896490|58782804|FG001|Overall Study|Withdrawal by Subject|1|||
30773679|NCT03617172|58782812|FG000|Overall Study|Lost to Follow-up|1|||
30773680|NCT03617172|58782813|FG001|Overall Study|Lost to Follow-up|0|||
30850121|NCT00705159|58877033|FG003|Overall Study|Withdrawal by Subject|1|||
30850122|NCT00705159|58877030|FG000|Overall Study|Protocol Violation|0|||
30850123|NCT00705159|58877031|FG001|Overall Study|Protocol Violation|1|||
30850124|NCT00705159|58877032|FG002|Overall Study|Protocol Violation|0|||
30850125|NCT00705159|58877033|FG003|Overall Study|Protocol Violation|0|||
30850126|NCT00705159|58877030|FG000|Overall Study|Adverse Event|0|||
30850127|NCT00705159|58877031|FG001|Overall Study|Adverse Event|0|||
30850128|NCT00705159|58877032|FG002|Overall Study|Adverse Event|1|||
30850129|NCT00705159|58877033|FG003|Overall Study|Adverse Event|0|||
30850130|NCT00705159|58877030|FG000|Overall Study|Lost to Follow-up|0|||
30850131|NCT00705159|58877031|FG001|Overall Study|Lost to Follow-up|0|||
30850132|NCT00705159|58877032|FG002|Overall Study|Lost to Follow-up|3|||
30850133|NCT00705159|58877033|FG003|Overall Study|Lost to Follow-up|2|||
30850134|NCT00705159|58877030|FG000|Overall Study|Screen Failure|0|||
30850135|NCT00705159|58877031|FG001|Overall Study|Screen Failure|0|||
30850136|NCT00705159|58877032|FG002|Overall Study|Screen Failure|0|||
30850137|NCT00705159|58877033|FG003|Overall Study|Screen Failure|1|||
30850138|NCT01673984|58877045|FG000|Overall Study|Adverse Event|1|||
30850139|NCT01673984|58877046|FG001|Overall Study|Adverse Event|0|||
30850140|NCT01673984|58877045|FG000|Overall Study|Study termination|9|||
30850141|NCT01673984|58877046|FG001|Overall Study|Study termination|6|||
30850142|NCT02332928|58877065|FG000|Overall Study|Withdrawal by Subject|0|||
30850143|NCT02332928|58877066|FG001|Overall Study|Withdrawal by Subject|2|||
30953008|NCT00636363|59003196|FG001|Overall Study|Met ineligibility criteria|0|||
30953009|NCT00636363|59003197|FG002|Overall Study|Met ineligibility criteria|3|||
30953010|NCT00636363|59003195|FG000|Overall Study|Missed > 1 visit|0|||
30953011|NCT00636363|59003196|FG001|Overall Study|Missed > 1 visit|1|||
30953012|NCT00636363|59003197|FG002|Overall Study|Missed > 1 visit|3|||
30953013|NCT00636363|59003195|FG000|Overall Study|Lack of motivation|1|||
30953014|NCT00636363|59003196|FG001|Overall Study|Lack of motivation|0|||
30953015|NCT00636363|59003197|FG002|Overall Study|Lack of motivation|1|||
30953016|NCT00636363|59003195|FG000|Overall Study|Protocol Violation|0|||
30953017|NCT00636363|59003196|FG001|Overall Study|Protocol Violation|3|||
30953018|NCT00636363|59003197|FG002|Overall Study|Protocol Violation|0|||
30953019|NCT00636363|59003195|FG000|Overall Study|Lost to Follow-up|3|||
30953020|NCT00636363|59003196|FG001|Overall Study|Lost to Follow-up|4|||
30953021|NCT00636363|59003197|FG002|Overall Study|Lost to Follow-up|2|||
30953022|NCT00636363|59003195|FG000|Overall Study|Withdrawal by Subject|1|||
30953023|NCT00636363|59003196|FG001|Overall Study|Withdrawal by Subject|3|||
30953024|NCT00636363|59003197|FG002|Overall Study|Withdrawal by Subject|2|||
30953025|NCT00636207|59003239|FG000|Overall Study|Adverse Event|1|||
30953026|NCT00636207|59003240|FG001|Overall Study|Adverse Event|0|||
30953027|NCT00636207|59003241|FG002|Overall Study|Adverse Event|0|||
30953028|NCT00636207|59003242|FG003|Overall Study|Adverse Event|0|||
30953029|NCT00636207|59003243|FG004|Overall Study|Adverse Event|0|||
30953030|NCT00636207|59003244|FG005|Overall Study|Adverse Event|0|||
30953031|NCT00636207|59003245|FG006|Overall Study|Adverse Event|0|||
30953032|NCT00636207|59003239|FG000|Overall Study|Withdrawal by Subject|0|||
30953033|NCT00636207|59003240|FG001|Overall Study|Withdrawal by Subject|1|||
30953034|NCT00636207|59003241|FG002|Overall Study|Withdrawal by Subject|0|||
30953035|NCT00636207|59003242|FG003|Overall Study|Withdrawal by Subject|0|||
30773681|NCT03760146|58782825|FG000|Overall Study|Adverse Event|11|||
30850144|NCT02332928|58877065|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
30850145|NCT02332928|58877066|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
30850146|NCT02647658|58877074|FG000|Overall Study|Consent refusal|15|||
30850147|NCT02647658|58877075|FG001|Overall Study|Consent refusal|24|||
30850148|NCT00703677|58877081|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
30953036|NCT00636207|59003243|FG004|Overall Study|Withdrawal by Subject|1|||
30773682|NCT03760146|58782826|FG001|Overall Study|Adverse Event|8|||
30773683|NCT03760146|58782827|FG002|Overall Study|Adverse Event|0|||
30773684|NCT03760146|58782828|FG003|Overall Study|Adverse Event|0|||
30850149|NCT00703911|58877089|FG000|Overall Study|Death|1|||
30850150|NCT00703911|58877089|FG000|Overall Study|Physician Decision|6|||
30850151|NCT00703911|58877089|FG000|Overall Study|Lost to Follow-up|1|||
30953037|NCT00636207|59003244|FG005|Overall Study|Withdrawal by Subject|0|||
30953038|NCT00636207|59003245|FG006|Overall Study|Withdrawal by Subject|0|||
30953039|NCT00635661|59003266|FG000|Overall Study|Withdrawal by Subject|4|||
30953040|NCT00635427|59003355|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
30773685|NCT03760146|58782829|FG004|Overall Study|Adverse Event|0|||
30773686|NCT03760146|58782830|FG005|Overall Study|Adverse Event|0|||
30773687|NCT03760146|58782825|FG000|Overall Study|Death|1|||
30773688|NCT03760146|58782826|FG001|Overall Study|Death|0|||
30773689|NCT03760146|58782827|FG002|Overall Study|Death|0|||
30773690|NCT03760146|58782828|FG003|Overall Study|Death|0|||
30773691|NCT03760146|58782829|FG004|Overall Study|Death|0|||
30773692|NCT03760146|58782830|FG005|Overall Study|Death|0|||
30773693|NCT03760146|58782825|FG000|Overall Study|Lost to Follow-up|41|||
30773694|NCT03760146|58782826|FG001|Overall Study|Lost to Follow-up|28|||
30773695|NCT03760146|58782827|FG002|Overall Study|Lost to Follow-up|9|||
30773696|NCT03760146|58782828|FG003|Overall Study|Lost to Follow-up|2|||
30773697|NCT03760146|58782829|FG004|Overall Study|Lost to Follow-up|14|||
30773698|NCT03760146|58782830|FG005|Overall Study|Lost to Follow-up|8|||
30773699|NCT03760146|58782825|FG000|Overall Study|No longer met eligibility criteria|3|||
30773700|NCT03760146|58782826|FG001|Overall Study|No longer met eligibility criteria|9|||
30773701|NCT03760146|58782827|FG002|Overall Study|No longer met eligibility criteria|0|||
30773702|NCT03760146|58782828|FG003|Overall Study|No longer met eligibility criteria|0|||
30773703|NCT03760146|58782829|FG004|Overall Study|No longer met eligibility criteria|1|||
30773704|NCT03760146|58782830|FG005|Overall Study|No longer met eligibility criteria|0|||
30773705|NCT03760146|58782825|FG000|Overall Study|Protocol Violation|21|||
30773706|NCT03760146|58782826|FG001|Overall Study|Protocol Violation|13|||
30773707|NCT03760146|58782827|FG002|Overall Study|Protocol Violation|1|||
30773708|NCT03760146|58782828|FG003|Overall Study|Protocol Violation|0|||
30773709|NCT03760146|58782829|FG004|Overall Study|Protocol Violation|1|||
30773710|NCT03760146|58782830|FG005|Overall Study|Protocol Violation|0|||
30773711|NCT03760146|58782825|FG000|Overall Study|Withdrawal by Subject|19|||
30773712|NCT03760146|58782826|FG001|Overall Study|Withdrawal by Subject|20|||
30773713|NCT03760146|58782827|FG002|Overall Study|Withdrawal by Subject|1|||
30773714|NCT03760146|58782828|FG003|Overall Study|Withdrawal by Subject|0|||
30773715|NCT03760146|58782829|FG004|Overall Study|Withdrawal by Subject|1|||
30773716|NCT03760146|58782830|FG005|Overall Study|Withdrawal by Subject|0|||
30773717|NCT03760068|58782850|FG000|Overall Study|Withdrawal by Subject|7|||
30773718|NCT03760068|58782851|FG001|Overall Study|Withdrawal by Subject|8|||
30773719|NCT03760068|58782850|FG000|Overall Study|Adverse Event|1|||
30773720|NCT03760068|58782851|FG001|Overall Study|Adverse Event|2|||
30773721|NCT03760068|58782850|FG000|Overall Study|Administrative Decision by Sponsor|0|||
30773722|NCT03760068|58782851|FG001|Overall Study|Administrative Decision by Sponsor|2|||
30773723|NCT03760068|58782850|FG000|Overall Study|Physician Decision|1|||
30773724|NCT03760068|58782851|FG001|Overall Study|Physician Decision|2|||
30773725|NCT03760068|58782850|FG000|Overall Study|Lost to Follow-up|4|||
30773726|NCT03760068|58782851|FG001|Overall Study|Lost to Follow-up|9|||
30773727|NCT03760068|58782850|FG000|Overall Study|Subject Moved Out of State|1|||
30773728|NCT03760068|58782851|FG001|Overall Study|Subject Moved Out of State|0|||
30773729|NCT03759600|58782858|FG000|Overall Study|Ongoing at Data Cut-off|16|||
30773730|NCT03759600|58782858|FG000|Overall Study|Adverse Event|1|||
30773731|NCT03759600|58782858|FG000|Overall Study|Progressive Disease|3|||
30773732|NCT04724733|58782865|FG000|Overall Study|Lost to Follow-up|1|||
30773733|NCT04724733|58782866|FG001|Overall Study|Lost to Follow-up|1|||
30773734|NCT04724733|58782867|FG002|Overall Study|Lost to Follow-up|1|||
30773735|NCT04635839|58782877|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
30773736|NCT04635839|58782878|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
30773737|NCT04493502|58782886|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
30773738|NCT04493502|58782887|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
30773739|NCT04493502|58782886|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
30773740|NCT04493502|58782887|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
30773741|NCT04493502|58782886|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
30773742|NCT04493502|58782887|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
30773743|NCT04493502|58782886|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
30773744|NCT04493502|58782887|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
30773745|NCT04493502|58782886|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
30773746|NCT04493502|58782887|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
30773747|NCT04493502|58782886|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
30773748|NCT04493502|58782887|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
30953041|NCT00635427|59003356|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
30953042|NCT00635427|59003357|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
30773749|NCT04493502|58782886|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
30773750|NCT04493502|58782887|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
30773751|NCT04493502|58782886|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
30773752|NCT04493502|58782887|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
30773753|NCT04493502|58782886|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
30773754|NCT04493502|58782887|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
30773755|NCT04493502|58782886|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
30773756|NCT04493502|58782887|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
30773757|NCT04493502|58782886|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
30773758|NCT04493502|58782887|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
30773759|NCT04493502|58782886|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
30773760|NCT04493502|58782887|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
30773761|NCT04493502|58782886|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
30773762|NCT04493502|58782887|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
30773763|NCT04147858|58782898|FG000|Overall Study|Adverse Event|6|||
30773764|NCT04147858|58782899|FG001|Overall Study|Adverse Event|6|||
30773765|NCT04147858|58782900|FG002|Overall Study|Adverse Event|6|||
30773766|NCT04147858|58782898|FG000|Overall Study|Lack of Efficacy|3|||
30773767|NCT04147858|58782899|FG001|Overall Study|Lack of Efficacy|3|||
30773768|NCT04147858|58782900|FG002|Overall Study|Lack of Efficacy|1|||
30773769|NCT04147858|58782898|FG000|Overall Study|Lost to Follow-up|1|||
30773770|NCT04147858|58782899|FG001|Overall Study|Lost to Follow-up|6|||
30773771|NCT04147858|58782900|FG002|Overall Study|Lost to Follow-up|2|||
30773772|NCT04147858|58782898|FG000|Overall Study|Withdrawal by Subject|3|||
30773773|NCT04147858|58782899|FG001|Overall Study|Withdrawal by Subject|4|||
30773774|NCT04147858|58782900|FG002|Overall Study|Withdrawal by Subject|10|||
30773775|NCT04147858|58782898|FG000|Overall Study|Subject Noncompliance, Other|4|||
30773776|NCT04147858|58782899|FG001|Overall Study|Subject Noncompliance, Other|3|||
30773777|NCT04147858|58782900|FG002|Overall Study|Subject Noncompliance, Other|1|||
30773778|NCT04146896|58782910|FG000|Overall Study|Adverse Event|5|||
30773779|NCT04146896|58782911|FG001|Overall Study|Adverse Event|8|||
30773780|NCT04146896|58782910|FG000|Overall Study|Lack of Efficacy|3|||
30773781|NCT04146896|58782911|FG001|Overall Study|Lack of Efficacy|2|||
30773782|NCT04146896|58782910|FG000|Overall Study|Lost to Follow-up|0|||
30773783|NCT04146896|58782911|FG001|Overall Study|Lost to Follow-up|1|||
30773784|NCT04146896|58782910|FG000|Overall Study|Non-compliance|5|||
30773785|NCT04146896|58782911|FG001|Overall Study|Non-compliance|4|||
30773786|NCT04146896|58782910|FG000|Overall Study|Withdrawal by Subject|3|||
30773787|NCT04146896|58782911|FG001|Overall Study|Withdrawal by Subject|5|||
30773788|NCT04146896|58782910|FG000|Overall Study|Randomized in error|1|||
30773789|NCT04146896|58782911|FG001|Overall Study|Randomized in error|2|||
30773790|NCT04072887|58782923|FG000|Overall Study|Withdrawal by Subject|3|||
30773791|NCT04072887|58782924|FG001|Overall Study|Withdrawal by Subject|8|||
30773792|NCT04072887|58782925|FG002|Overall Study|Withdrawal by Subject|1|||
30773793|NCT04072887|58782926|FG003|Overall Study|Withdrawal by Subject|3|||
30773794|NCT04072887|58782927|FG004|Overall Study|Withdrawal by Subject|3|||
30773795|NCT04072887|58782928|FG005|Overall Study|Withdrawal by Subject|13|||
30773796|NCT04072887|58782923|FG000|Overall Study|Adverse Event|2|||
30773797|NCT04072887|58782924|FG001|Overall Study|Adverse Event|4|||
30773798|NCT04072887|58782925|FG002|Overall Study|Adverse Event|1|||
30773799|NCT04072887|58782926|FG003|Overall Study|Adverse Event|4|||
30773800|NCT04072887|58782927|FG004|Overall Study|Adverse Event|0|||
30773801|NCT04072887|58782928|FG005|Overall Study|Adverse Event|1|||
30773802|NCT04072887|58782923|FG000|Overall Study|Physician Decision|2|||
30773803|NCT04072887|58782924|FG001|Overall Study|Physician Decision|0|||
30773804|NCT04072887|58782925|FG002|Overall Study|Physician Decision|0|||
30773805|NCT04072887|58782926|FG003|Overall Study|Physician Decision|0|||
30773806|NCT04072887|58782927|FG004|Overall Study|Physician Decision|0|||
30773807|NCT04072887|58782928|FG005|Overall Study|Physician Decision|1|||
30773808|NCT04072887|58782923|FG000|Overall Study|Lost to Follow-up|1|||
30773809|NCT04072887|58782924|FG001|Overall Study|Lost to Follow-up|3|||
30773810|NCT04072887|58782925|FG002|Overall Study|Lost to Follow-up|0|||
30773811|NCT04072887|58782926|FG003|Overall Study|Lost to Follow-up|0|||
30773812|NCT04072887|58782927|FG004|Overall Study|Lost to Follow-up|0|||
30773813|NCT04072887|58782928|FG005|Overall Study|Lost to Follow-up|0|||
30773814|NCT04072887|58782923|FG000|Overall Study|Death|0|||
30773815|NCT04072887|58782924|FG001|Overall Study|Death|2|||
30773816|NCT04072887|58782925|FG002|Overall Study|Death|0|||
30773817|NCT04072887|58782926|FG003|Overall Study|Death|2|||
30773818|NCT04072887|58782927|FG004|Overall Study|Death|3|||
30662497|NCT00742209|58676014|FG004|Overall Study|Lost to Follow-up|3|||
30773819|NCT04072887|58782928|FG005|Overall Study|Death|0|||
30773820|NCT03516812|58783021|FG000|Overall Study|Adverse Event|4|||
30773821|NCT03516812|58783021|FG000|Overall Study|Lack of Efficacy|2|||
30773822|NCT03122119|58783061|FG000|Overall Study|Did not meet eligibility critria|1|||
30662498|NCT00742209|58676010|FG000|Overall Study|Lack of Efficacy|6|||
30662499|NCT00742209|58676011|FG001|Overall Study|Lack of Efficacy|1|||
30773823|NCT02613169|58783067|FG000|Overall Study|Withdrawal by Subject|4|||
30662500|NCT00742209|58676012|FG002|Overall Study|Lack of Efficacy|1|||
30662501|NCT00742209|58676013|FG003|Overall Study|Lack of Efficacy|3|||
30773824|NCT02613169|58783068|FG001|Overall Study|Withdrawal by Subject|1|||
30773825|NCT02613169|58783067|FG000|Overall Study|Lost to Follow-up|0|||
30773826|NCT02613169|58783068|FG001|Overall Study|Lost to Follow-up|5|||
30773827|NCT02613169|58783067|FG000|Overall Study|HIV|0|||
30773828|NCT02613169|58783068|FG001|Overall Study|HIV|2|||
30773829|NCT02613169|58783067|FG000|Overall Study|No TB infection endpoint|14|||
30773830|NCT02613169|58783068|FG001|Overall Study|No TB infection endpoint|9|||
30773831|NCT02362464|58783074|FG000|Overall Study|Switched to alternative therapy|1|||
30773832|NCT02362464|58783074|FG000|Overall Study|Refused further treatment|1|||
30773833|NCT02362464|58783074|FG000|Overall Study|Physician Decision|4|||
30773834|NCT02352948|58783084|FG000|Overall Study|Death|47|||
30773835|NCT02352948|58783085|FG001|Overall Study|Death|48|||
30773836|NCT02352948|58783086|FG002|Overall Study|Death|114|||
30773837|NCT02352948|58783087|FG003|Overall Study|Death|74|||
30773838|NCT02352948|58783088|FG004|Overall Study|Death|77|||
30773839|NCT02352948|58783089|FG005|Overall Study|Death|44|||
30773840|NCT02352948|58783084|FG000|Overall Study|Lost to Follow-up|1|||
30773841|NCT02352948|58783085|FG001|Overall Study|Lost to Follow-up|0|||
30773842|NCT02352948|58783086|FG002|Overall Study|Lost to Follow-up|2|||
30773843|NCT02352948|58783087|FG003|Overall Study|Lost to Follow-up|1|||
30773844|NCT02352948|58783088|FG004|Overall Study|Lost to Follow-up|2|||
30773845|NCT02352948|58783089|FG005|Overall Study|Lost to Follow-up|1|||
30773846|NCT02352948|58783084|FG000|Overall Study|Withdrawal by Subject|1|||
30773847|NCT02352948|58783085|FG001|Overall Study|Withdrawal by Subject|10|||
30773848|NCT02352948|58783086|FG002|Overall Study|Withdrawal by Subject|11|||
30773849|NCT02352948|58783087|FG003|Overall Study|Withdrawal by Subject|23|||
30773850|NCT02352948|58783088|FG004|Overall Study|Withdrawal by Subject|9|||
30773851|NCT02352948|58783089|FG005|Overall Study|Withdrawal by Subject|4|||
30773852|NCT02352948|58783084|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30773853|NCT02352948|58783085|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
30773854|NCT02352948|58783086|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
30773855|NCT02352948|58783087|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
30773856|NCT02352948|58783088|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
30773857|NCT02352948|58783089|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
30773858|NCT02352948|58783084|FG000|Overall Study|Other|0|||
30773859|NCT02352948|58783085|FG001|Overall Study|Other|0|||
30773860|NCT02352948|58783086|FG002|Overall Study|Other|2|||
30773861|NCT02352948|58783087|FG003|Overall Study|Other|0|||
30773862|NCT02352948|58783088|FG004|Overall Study|Other|0|||
30773863|NCT02352948|58783089|FG005|Overall Study|Other|0|||
30773864|NCT01974765|58783109|FG000|Overall Study|Withdrawal by Subject|1|||
30773865|NCT01974765|58783109|FG000|Overall Study|Death|1|||
30773866|NCT01974765|58783109|FG000|Overall Study|Adverse Event|2|||
30773867|NCT01802281|58783115|FG000|Overall Study|Death|1|||
30773868|NCT01802281|58783116|FG001|Overall Study|Death|2|||
30773869|NCT01802281|58783115|FG000|Overall Study|Withdrawal by Subject|2|||
30773870|NCT01802281|58783116|FG001|Overall Study|Withdrawal by Subject|1|||
30773871|NCT01802281|58783115|FG000|Overall Study|Ineligible|5|||
30773872|NCT01802281|58783116|FG001|Overall Study|Ineligible|3|||
30773873|NCT01725217|58783125|FG000|Overall Study|Withdrawal by Subject|1|||
30773874|NCT01725217|58783126|FG001|Overall Study|Withdrawal by Subject|0|||
30773875|NCT01725217|58783127|FG002|Overall Study|Withdrawal by Subject|0|||
30773876|NCT01344057|58783153|FG000|Overall Study|Premature Withdrawal|1|||
30773877|NCT00886782|58783160|FG000|Overall Study|Disease progression|3|||
30773878|NCT00886782|58783161|FG001|Overall Study|Disease progression|3|||
30773879|NCT00886782|58783162|FG002|Overall Study|Disease progression|3|||
30773880|NCT00886782|58783160|FG000|Overall Study|Study drug toxicity|0|||
30773881|NCT00886782|58783161|FG001|Overall Study|Study drug toxicity|0|||
30773882|NCT00886782|58783162|FG002|Overall Study|Study drug toxicity|1|||
30773883|NCT00886782|58783160|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
30773884|NCT00886782|58783161|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
30773885|NCT00886782|58783162|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
30773886|NCT00583024|58783170|FG000|Overall Study|Lost to Follow-up|4|||
30773887|NCT03435640|58783185|FG000|Overall Study|Withdrawal by Subject|0|||
30773888|NCT03435640|58783186|FG001|Overall Study|Withdrawal by Subject|1|||
30773889|NCT03435640|58783187|FG002|Overall Study|Withdrawal by Subject|0|||
30773890|NCT03435640|58783188|FG003|Overall Study|Withdrawal by Subject|2|||
30773891|NCT03435640|58783189|FG004|Overall Study|Withdrawal by Subject|0|||
30773892|NCT03435640|58783190|FG005|Overall Study|Withdrawal by Subject|0|||
30773893|NCT03435640|58783191|FG006|Overall Study|Withdrawal by Subject|3|||
30773894|NCT03435640|58783192|FG007|Overall Study|Withdrawal by Subject|0|||
30773895|NCT03435640|58783193|FG008|Overall Study|Withdrawal by Subject|0|||
30773896|NCT03435640|58783194|FG009|Overall Study|Withdrawal by Subject|2|||
30773897|NCT03435640|58783195|FG010|Overall Study|Withdrawal by Subject|3|||
30773898|NCT03435640|58783185|FG000|Overall Study|Lost to Follow-up|0|||
30773899|NCT03435640|58783186|FG001|Overall Study|Lost to Follow-up|0|||
30773900|NCT03435640|58783187|FG002|Overall Study|Lost to Follow-up|1|||
30773901|NCT03435640|58783188|FG003|Overall Study|Lost to Follow-up|0|||
30953043|NCT00635427|59003358|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
30773902|NCT03435640|58783189|FG004|Overall Study|Lost to Follow-up|0|||
30773903|NCT03435640|58783190|FG005|Overall Study|Lost to Follow-up|0|||
30773904|NCT03435640|58783191|FG006|Overall Study|Lost to Follow-up|0|||
30773905|NCT03435640|58783192|FG007|Overall Study|Lost to Follow-up|0|||
30773906|NCT03435640|58783193|FG008|Overall Study|Lost to Follow-up|0|||
30773907|NCT03435640|58783194|FG009|Overall Study|Lost to Follow-up|0|||
30773908|NCT03435640|58783195|FG010|Overall Study|Lost to Follow-up|0|||
30773909|NCT00655876|58783223|FG000|Overall Study|Protocol Violation|9|||
30773910|NCT00655876|58783224|FG001|Overall Study|Protocol Violation|7|||
30773911|NCT03092752|58783230|FG000|Overall Study|Aged <40 years|14209|||
30773912|NCT03092752|58783230|FG000|Overall Study|At least one claim with T2DM|61299|||
30773913|NCT03092752|58783230|FG000|Overall Study|Having no claim of study drugs|29282|||
30773914|NCT03092752|58783230|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
30773915|NCT03092752|58783230|FG000|Overall Study|<6 month history|245900|||
30773916|NCT03750552|58783253|FG000|Overall Study|Adverse Event|5|||
30773917|NCT03750552|58783254|FG001|Overall Study|Adverse Event|1|||
30773918|NCT03750552|58783253|FG000|Overall Study|Withdrawal by Subject|1|||
30773919|NCT03750552|58783254|FG001|Overall Study|Withdrawal by Subject|1|||
30773920|NCT03750552|58783253|FG000|Overall Study|Other|2|||
30773921|NCT03750552|58783254|FG001|Overall Study|Other|0|||
30773922|NCT03750240|58783261|FG000|Overall Study|Technical Difficulties|2|||
30773923|NCT03091738|58783265|FG000|Overall Study|Adverse Event|1|||
30773924|NCT03091738|58783265|FG000|Overall Study|Lost to Follow-up|1|||
30773925|NCT03193216|58783271|FG000|Overall Study|Lost to Follow-up|1|||
30773926|NCT03193216|58783272|FG001|Overall Study|Lost to Follow-up|0|||
30773927|NCT03193216|58783271|FG000|Overall Study|Withdrawal by Subject|5|||
30773928|NCT03193216|58783272|FG001|Overall Study|Withdrawal by Subject|0|||
30773929|NCT03193216|58783271|FG000|Overall Study|Physician Decision|4|||
30773930|NCT03193216|58783272|FG001|Overall Study|Physician Decision|0|||
30773931|NCT03091348|58783280|FG000|Overall Study|Lost to Follow-up|2|||
30773932|NCT03091348|58783281|FG001|Overall Study|Lost to Follow-up|1|||
30773933|NCT03751098|58783288|FG000|Overall Study|Withdrawal by Subject|0|||
30773934|NCT03751098|58783289|FG001|Overall Study|Withdrawal by Subject|1|||
30773935|NCT03751020|58783300|FG000|Overall Study|Withdrawal by Subject|2|||
30773936|NCT03751020|58783301|FG001|Overall Study|Withdrawal by Subject|0|||
30773937|NCT03751020|58783302|FG002|Overall Study|Withdrawal by Subject|0|||
30773938|NCT03751020|58783300|FG000|Overall Study|Lost to Follow-up|7|||
30773939|NCT03751020|58783301|FG001|Overall Study|Lost to Follow-up|4|||
30773940|NCT03751020|58783302|FG002|Overall Study|Lost to Follow-up|10|||
30773941|NCT03090100|58783312|FG000|Overall Study|Adverse Event|9|||
30773942|NCT03090100|58783313|FG001|Overall Study|Adverse Event|11|||
30773943|NCT03090100|58783312|FG000|Overall Study|Pregnancy|1|||
30773944|NCT03090100|58783313|FG001|Overall Study|Pregnancy|1|||
30773945|NCT03090100|58783312|FG000|Overall Study|Lack of Efficacy|2|||
30773946|NCT03090100|58783313|FG001|Overall Study|Lack of Efficacy|7|||
30773947|NCT03090100|58783312|FG000|Overall Study|Lost to Follow-up|2|||
30773948|NCT03090100|58783313|FG001|Overall Study|Lost to Follow-up|2|||
30773949|NCT03090100|58783312|FG000|Overall Study|Withdrawal by Subject|7|||
30773950|NCT03090100|58783313|FG001|Overall Study|Withdrawal by Subject|19|||
30773951|NCT03090100|58783312|FG000|Overall Study|Protocol Violation|2|||
30773952|NCT03090100|58783313|FG001|Overall Study|Protocol Violation|6|||
30773953|NCT03090100|58783312|FG000|Overall Study|Non-compliance|2|||
30773954|NCT03090100|58783313|FG001|Overall Study|Non-compliance|0|||
30773955|NCT03090100|58783312|FG000|Overall Study|Other|2|||
30773956|NCT03090100|58783313|FG001|Overall Study|Other|2|||
30773957|NCT03089944|58783319|FG000|Overall Study|Lost to Follow-up|8|||
30773958|NCT03089944|58783319|FG000|Overall Study|Withdrew Consent|2|||
30773959|NCT03089944|58783319|FG000|Overall Study|Adverse Event|1|||
30773960|NCT03089944|58783319|FG000|Overall Study|Other|1|||
30773961|NCT03739866|58783342|FG000|Overall Study|Lost to Follow-up|0|||
30773962|NCT03739866|58783343|FG001|Overall Study|Lost to Follow-up|0|||
30773963|NCT03739866|58783344|FG002|Overall Study|Lost to Follow-up|0|||
30850152|NCT00703911|58877089|FG000|Overall Study|Withdrawal by Subject|2|||
30850153|NCT02055547|58877093|FG000|Overall Study|Protocol Violation|0|||
30850154|NCT02055547|58877094|FG001|Overall Study|Protocol Violation|0|||
30850155|NCT02055547|58877095|FG002|Overall Study|Protocol Violation|1|||
30773964|NCT03739866|58783345|FG003|Overall Study|Lost to Follow-up|1|||
30773965|NCT03739866|58783346|FG004|Overall Study|Lost to Follow-up|0|||
30850156|NCT02055547|58877096|FG003|Overall Study|Protocol Violation|0|||
30773966|NCT03739866|58783347|FG005|Overall Study|Lost to Follow-up|0|||
30773967|NCT03739866|58783348|FG006|Overall Study|Lost to Follow-up|0|||
30773968|NCT03739866|58783349|FG007|Overall Study|Lost to Follow-up|0|||
30773969|NCT03739866|58783342|FG000|Overall Study|Enrolled but not treated|0|||
30773970|NCT03739866|58783343|FG001|Overall Study|Enrolled but not treated|0|||
30773971|NCT03739866|58783344|FG002|Overall Study|Enrolled but not treated|1|||
30773972|NCT03739866|58783345|FG003|Overall Study|Enrolled but not treated|0|||
30773973|NCT03739866|58783346|FG004|Overall Study|Enrolled but not treated|1|||
30773974|NCT03739866|58783347|FG005|Overall Study|Enrolled but not treated|0|||
30850157|NCT02055547|58877097|FG004|Overall Study|Protocol Violation|0|||
30773975|NCT03739866|58783348|FG006|Overall Study|Enrolled but not treated|0|||
30773976|NCT03739866|58783349|FG007|Overall Study|Enrolled but not treated|0|||
30850158|NCT02055547|58877098|FG005|Overall Study|Protocol Violation|0|||
30850159|NCT02055547|58877099|FG006|Overall Study|Protocol Violation|1|||
30773977|NCT03739242|58783373|FG000|Overall Study|Withdrawal by Subject|1|||
30773978|NCT03739242|58783374|FG001|Overall Study|Withdrawal by Subject|1|||
30773979|NCT03739242|58783373|FG000|Overall Study|Protocol Violation|0|||
30773980|NCT03739242|58783374|FG001|Overall Study|Protocol Violation|1|||
30773981|NCT02849626|58783431|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
30773982|NCT02849626|58783432|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
30773983|NCT02849626|58783433|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
30773984|NCT02849626|58783434|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
30773985|NCT02849626|58783431|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
30773986|NCT02849626|58783432|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
30773987|NCT02849626|58783433|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
30850160|NCT02055547|58877100|FG007|Overall Study|Protocol Violation|0|||
30773988|NCT02849626|58783434|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
30773989|NCT02849626|58783431|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
30773990|NCT02849626|58783432|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
30773991|NCT02849626|58783433|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
30773992|NCT02849626|58783434|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
30773993|NCT02849626|58783431|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
30773994|NCT02849626|58783432|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
30773995|NCT02849626|58783433|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
30850161|NCT02055547|58877101|FG008|Overall Study|Protocol Violation|0|||
30850162|NCT02055547|58877102|FG009|Overall Study|Protocol Violation|0|||
30850163|NCT02055547|58877103|FG010|Overall Study|Protocol Violation|0|||
30850164|NCT02055547|58877104|FG011|Overall Study|Protocol Violation|0|||
30850165|NCT02055547|58877105|FG012|Overall Study|Protocol Violation|0|||
30773996|NCT02849626|58783434|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
30773997|NCT02849626|58783431|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
30773998|NCT02849626|58783432|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
30773999|NCT02849626|58783433|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
30774000|NCT02849626|58783434|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
30774001|NCT02849626|58783431|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
30850166|NCT02055547|58877106|FG013|Overall Study|Protocol Violation|0|||
30850167|NCT02055547|58877107|FG014|Overall Study|Protocol Violation|0|||
30850168|NCT02055547|58877108|FG015|Overall Study|Protocol Violation|0|||
30953044|NCT00635427|59003359|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
30774002|NCT02849626|58783432|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
30774003|NCT02849626|58783433|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
30774004|NCT02849626|58783434|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
30774005|NCT02849626|58783431|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
30774006|NCT02849626|58783432|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
30774007|NCT02849626|58783433|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
30774008|NCT02849626|58783434|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
30774009|NCT02849626|58783431|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
30774010|NCT02849626|58783432|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
30774011|NCT02849626|58783433|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
30774012|NCT02849626|58783434|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
30953045|NCT00635427|59003355|FG000|Overall Study|Death|0|||
30953046|NCT00635427|59003356|FG001|Overall Study|Death|0|||
30662502|NCT00742209|58676014|FG004|Overall Study|Lack of Efficacy|1|||
30662503|NCT00742209|58676010|FG000|Overall Study|Investigator Discretion|0|||
30662504|NCT00742209|58676011|FG001|Overall Study|Investigator Discretion|0|||
30662505|NCT00742209|58676012|FG002|Overall Study|Investigator Discretion|5|||
30774013|NCT02849626|58783431|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
30774014|NCT02849626|58783432|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
30953047|NCT00635427|59003357|FG002|Overall Study|Death|0|||
30953048|NCT00635427|59003358|FG003|Overall Study|Death|1|||
30953049|NCT00635427|59003359|FG004|Overall Study|Death|0|||
30953050|NCT00635427|59003355|FG000|Overall Study|Termination Of Study By Sponsor|12|||
30953051|NCT00635427|59003356|FG001|Overall Study|Termination Of Study By Sponsor|6|||
30953052|NCT00635427|59003357|FG002|Overall Study|Termination Of Study By Sponsor|10|||
30953053|NCT00635427|59003358|FG003|Overall Study|Termination Of Study By Sponsor|6|||
30953054|NCT00635427|59003359|FG004|Overall Study|Termination Of Study By Sponsor|6|||
30850169|NCT02055547|58877109|FG016|Overall Study|Protocol Violation|0|||
30850170|NCT02055547|58877110|FG017|Overall Study|Protocol Violation|0|||
30850171|NCT02055547|58877111|FG018|Overall Study|Protocol Violation|0|||
30662506|NCT00742209|58676013|FG003|Overall Study|Investigator Discretion|1|||
30953055|NCT00635427|59003355|FG000|Overall Study|Withdrawal Of Consent|0|||
30774015|NCT02849626|58783433|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
30774016|NCT02849626|58783434|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
30774017|NCT02849626|58783431|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
30774018|NCT02849626|58783432|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
30774019|NCT02849626|58783433|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
30774020|NCT02849626|58783434|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
30774021|NCT02849626|58783431|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
30774022|NCT02849626|58783432|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
30774023|NCT02849626|58783433|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
30774024|NCT02849626|58783434|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
30774025|NCT03735498|58783452|FG000|Overall Study|Withdrawal by Subject|5|||
30774026|NCT03735498|58783452|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
30774027|NCT02659540|58783458|FG000|Overall Study|Adverse Event|3|||
30774028|NCT02659540|58783459|FG001|Overall Study|Adverse Event|2|||
30774029|NCT02659540|58783458|FG000|Overall Study|Death|1|||
30774030|NCT02659540|58783459|FG001|Overall Study|Death|0|||
30774031|NCT02659540|58783458|FG000|Overall Study|Progressive disease|2|||
30774032|NCT02659540|58783459|FG001|Overall Study|Progressive disease|6|||
30774033|NCT01097746|58783465|FG000|Overall Study|Adverse Event|4|||
30774034|NCT01097746|58783465|FG000|Overall Study|taken off study before any treatment given|1|||
30774035|NCT03733470|58783495|FG000|Overall Study|PI Decision|1|||
30774036|NCT03733470|58783496|FG001|Overall Study|PI Decision|1|||
30850172|NCT02055547|58877093|FG000|Overall Study|Physician Decision|0|||
30850173|NCT02055547|58877094|FG001|Overall Study|Physician Decision|1|||
30850174|NCT02055547|58877095|FG002|Overall Study|Physician Decision|1|||
30850175|NCT02055547|58877096|FG003|Overall Study|Physician Decision|0|||
30850176|NCT02055547|58877097|FG004|Overall Study|Physician Decision|1|||
30850177|NCT02055547|58877098|FG005|Overall Study|Physician Decision|0|||
30850178|NCT02055547|58877099|FG006|Overall Study|Physician Decision|0|||
30774037|NCT03732534|58783502|FG000|Overall Study|Study terminated by Sponsor|6|||
30774038|NCT03087058|58783508|FG000|Overall Study|Withdrawal by Subject|2|||
30774039|NCT03087058|58783509|FG001|Overall Study|Withdrawal by Subject|0|||
30774040|NCT03087058|58783510|FG002|Overall Study|Withdrawal by Subject|0|||
30774041|NCT03726996|58783517|FG000|Overall Study|Parent's decision|2|||
30774042|NCT03726996|58783517|FG000|Overall Study|Study early termination|2|||
30774043|NCT03882970|58783525|FG000|Overall Study|Adverse Event|5|||
30774044|NCT03882970|58783526|FG001|Overall Study|Adverse Event|7|||
30774045|NCT03882970|58783527|FG002|Overall Study|Adverse Event|3|||
30774046|NCT03882970|58783528|FG003|Overall Study|Adverse Event|1|||
30774047|NCT03882970|58783525|FG000|Overall Study|Death|1|||
30774048|NCT03882970|58783526|FG001|Overall Study|Death|2|||
30774049|NCT03882970|58783527|FG002|Overall Study|Death|1|||
30774050|NCT03882970|58783528|FG003|Overall Study|Death|1|||
30774051|NCT03882970|58783525|FG000|Overall Study|Lost to Follow-up|8|||
30774052|NCT03882970|58783526|FG001|Overall Study|Lost to Follow-up|9|||
30774053|NCT03882970|58783527|FG002|Overall Study|Lost to Follow-up|5|||
30774054|NCT03882970|58783528|FG003|Overall Study|Lost to Follow-up|5|||
30774055|NCT03882970|58783525|FG000|Overall Study|Physician Decision|0|||
30774056|NCT03882970|58783526|FG001|Overall Study|Physician Decision|2|||
30774057|NCT03882970|58783527|FG002|Overall Study|Physician Decision|2|||
30850179|NCT02055547|58877100|FG007|Overall Study|Physician Decision|0|||
30850180|NCT02055547|58877101|FG008|Overall Study|Physician Decision|0|||
30850181|NCT02055547|58877102|FG009|Overall Study|Physician Decision|1|||
30850182|NCT02055547|58877103|FG010|Overall Study|Physician Decision|1|||
30850183|NCT02055547|58877104|FG011|Overall Study|Physician Decision|0|||
30850184|NCT02055547|58877105|FG012|Overall Study|Physician Decision|0|||
30850185|NCT02055547|58877106|FG013|Overall Study|Physician Decision|0|||
30850186|NCT02055547|58877107|FG014|Overall Study|Physician Decision|0|||
30850187|NCT02055547|58877108|FG015|Overall Study|Physician Decision|0|||
30850188|NCT02055547|58877109|FG016|Overall Study|Physician Decision|0|||
30850189|NCT02055547|58877110|FG017|Overall Study|Physician Decision|0|||
30850190|NCT02055547|58877111|FG018|Overall Study|Physician Decision|0|||
30850191|NCT02055547|58877093|FG000|Overall Study|Adverse Event|0|||
30850192|NCT02055547|58877094|FG001|Overall Study|Adverse Event|0|||
30850193|NCT02055547|58877095|FG002|Overall Study|Adverse Event|0|||
30953056|NCT00635427|59003356|FG001|Overall Study|Withdrawal Of Consent|0|||
30774058|NCT03882970|58783528|FG003|Overall Study|Physician Decision|2|||
30774059|NCT03882970|58783525|FG000|Overall Study|Protocol Violation|2|||
30774060|NCT03882970|58783526|FG001|Overall Study|Protocol Violation|0|||
30850194|NCT02055547|58877096|FG003|Overall Study|Adverse Event|0|||
30850195|NCT02055547|58877097|FG004|Overall Study|Adverse Event|0|||
30850196|NCT02055547|58877098|FG005|Overall Study|Adverse Event|0|||
30850197|NCT02055547|58877099|FG006|Overall Study|Adverse Event|1|||
30774061|NCT03882970|58783527|FG002|Overall Study|Protocol Violation|0|||
30774062|NCT03882970|58783528|FG003|Overall Study|Protocol Violation|0|||
30774063|NCT03882970|58783525|FG000|Overall Study|Withdrawal by Subject|8|||
30850198|NCT02055547|58877100|FG007|Overall Study|Adverse Event|0|||
30850199|NCT02055547|58877101|FG008|Overall Study|Adverse Event|1|||
30953057|NCT00635427|59003357|FG002|Overall Study|Withdrawal Of Consent|0|||
30774064|NCT03882970|58783526|FG001|Overall Study|Withdrawal by Subject|17|||
30774065|NCT03882970|58783527|FG002|Overall Study|Withdrawal by Subject|7|||
30774066|NCT03882970|58783528|FG003|Overall Study|Withdrawal by Subject|22|||
30774067|NCT03882970|58783525|FG000|Overall Study|Personal Reason|2|||
30774068|NCT03882970|58783526|FG001|Overall Study|Personal Reason|3|||
30774069|NCT03882970|58783527|FG002|Overall Study|Personal Reason|1|||
30774070|NCT03882970|58783528|FG003|Overall Study|Personal Reason|3|||
30774071|NCT03730480|58783542|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
30774072|NCT03674112|58783549|FG000|Overall Study|Adverse Event|1|||
30774073|NCT03674112|58783550|FG001|Overall Study|Adverse Event|0|||
30774074|NCT03674112|58783549|FG000|Overall Study|Ongoing in the Study|79|||
30774075|NCT03674112|58783550|FG001|Overall Study|Ongoing in the Study|80|||
30774076|NCT03668808|58783576|FG000|First Intervention|Withdrawal by Subject|2|||
30774077|NCT03668808|58783577|FG001|First Intervention|Withdrawal by Subject|2|||
30774078|NCT02982954|58783589|FG000|Overall Study|Death|55|||
30774079|NCT02982954|58783590|FG001|Overall Study|Death|29|||
30774080|NCT02982954|58783591|FG002|Overall Study|Death|15|||
30774081|NCT02982954|58783592|FG003|Overall Study|Death|20|||
30774082|NCT02982954|58783589|FG000|Overall Study|Lost to Follow-up|2|||
30774083|NCT02982954|58783590|FG001|Overall Study|Lost to Follow-up|1|||
30774084|NCT02982954|58783591|FG002|Overall Study|Lost to Follow-up|0|||
30774085|NCT02982954|58783592|FG003|Overall Study|Lost to Follow-up|0|||
30774086|NCT02982954|58783589|FG000|Overall Study|Participant withdrew consent|7|||
30774087|NCT02982954|58783590|FG001|Overall Study|Participant withdrew consent|5|||
30774088|NCT02982954|58783591|FG002|Overall Study|Participant withdrew consent|1|||
30774089|NCT02982954|58783592|FG003|Overall Study|Participant withdrew consent|1|||
30774090|NCT02982954|58783589|FG000|Overall Study|Other reasons|42|||
30774091|NCT02982954|58783590|FG001|Overall Study|Other reasons|17|||
30774092|NCT02982954|58783591|FG002|Overall Study|Other reasons|12|||
30774093|NCT02982954|58783592|FG003|Overall Study|Other reasons|3|||
30774094|NCT02982954|58783589|FG000|Overall Study|Premature site closure|0|||
30774095|NCT02982954|58783590|FG001|Overall Study|Premature site closure|0|||
30774096|NCT02982954|58783591|FG002|Overall Study|Premature site closure|0|||
30774097|NCT02982954|58783592|FG003|Overall Study|Premature site closure|1|||
30774098|NCT03724968|58783604|FG000|Overall Study|Insurance issues|0|||
30774099|NCT03724968|58783605|FG001|Overall Study|Insurance issues|1|||
30774100|NCT03724968|58783604|FG000|Overall Study|Study closed|0|||
30774101|NCT03724968|58783605|FG001|Overall Study|Study closed|1|||
30774102|NCT03724812|58783611|FG000|Overall Study|Missed Visit|1|||
30774103|NCT03724812|58783611|FG000|Overall Study|Death|2|||
30774104|NCT03724812|58783611|FG000|Overall Study|Withdrawal by Subject|1|||
30774105|NCT03722784|58783618|FG000|Overall Study|Withdrawal by Subject|1|||
30774106|NCT03722784|58783619|FG001|Overall Study|Withdrawal by Subject|0|||
30774107|NCT03722784|58783618|FG000|Overall Study|Physician Decision|1|||
30774108|NCT03722784|58783619|FG001|Overall Study|Physician Decision|1|||
30774109|NCT03722784|58783618|FG000|Overall Study|Protocol Violation|0|||
30774110|NCT03722784|58783619|FG001|Overall Study|Protocol Violation|1|||
30774111|NCT03722238|58783628|FG000|Overall Study|Protocol Violation|1|||
30774112|NCT03722238|58783629|FG001|Overall Study|Protocol Violation|0|||
30774113|NCT03722238|58783628|FG000|Overall Study|Physician Decision|1|||
30774114|NCT03722238|58783629|FG001|Overall Study|Physician Decision|0|||
30953058|NCT00635427|59003358|FG003|Overall Study|Withdrawal Of Consent|2|||
30953059|NCT00635427|59003359|FG004|Overall Study|Withdrawal Of Consent|2|||
30953060|NCT00635349|59003371|FG000|Overall Study|Other|8|||
30953061|NCT00635349|59003372|FG001|Overall Study|Other|6|||
30953062|NCT00635349|59003371|FG000|Overall Study|Protocol Violation|18|||
30953063|NCT00635349|59003372|FG001|Overall Study|Protocol Violation|22|||
30953064|NCT00635349|59003371|FG000|Overall Study|Withdrawal by Subject|3|||
30953065|NCT00635349|59003372|FG001|Overall Study|Withdrawal by Subject|8|||
30774115|NCT03722238|58783628|FG000|Overall Study|Death|1|||
30774116|NCT03722238|58783629|FG001|Overall Study|Death|0|||
30774117|NCT03722238|58783628|FG000|Overall Study|Lost to Follow-up|6|||
30774118|NCT03722238|58783629|FG001|Overall Study|Lost to Follow-up|0|||
30953066|NCT00635349|59003371|FG000|Overall Study|Lost to Follow-up|4|||
30774119|NCT03722238|58783628|FG000|Overall Study|Partial missing data|44|||
30774120|NCT03722238|58783629|FG001|Overall Study|Partial missing data|1|||
30774121|NCT03722238|58783628|FG000|Overall Study|Withdrawal by Subject|2|||
30774122|NCT03722238|58783629|FG001|Overall Study|Withdrawal by Subject|0|||
30953067|NCT00635349|59003372|FG001|Overall Study|Lost to Follow-up|3|||
30953068|NCT00635349|59003371|FG000|Overall Study|Adverse Event|11|||
30774123|NCT03722238|58783628|FG000|Overall Study|Other|4|||
30774124|NCT03722238|58783629|FG001|Overall Study|Other|0|||
30774125|NCT03722238|58783628|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
30774126|NCT03722238|58783629|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
30774127|NCT03722238|58783628|FG000|Overall Study|Did not meet risk classification group criteria|90|||
30953069|NCT00635349|59003372|FG001|Overall Study|Adverse Event|9|||
30953070|NCT00634803|59003381|FG000|Overall Study|Lost to Follow-up|6|||
30774128|NCT03722238|58783629|FG001|Overall Study|Did not meet risk classification group criteria|0|||
30774129|NCT03722238|58783628|FG000|Overall Study|Did not sign consent|17|||
30774130|NCT03722238|58783629|FG001|Overall Study|Did not sign consent|0|||
30774131|NCT03722238|58783628|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
30774132|NCT03722238|58783629|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
30774133|NCT03722238|58783628|FG000|Overall Study|Not willing to purchase study medication|142|||
30774134|NCT03722238|58783629|FG001|Overall Study|Not willing to purchase study medication|0|||
30774135|NCT03722238|58783628|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
30774136|NCT03722238|58783629|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
30774137|NCT02927080|58783645|FG000|Overall Study|Withdrawal by Subject|0|||
30774138|NCT02927080|58783646|FG001|Overall Study|Withdrawal by Subject|0|||
30774139|NCT02927080|58783647|FG002|Overall Study|Withdrawal by Subject|0|||
30774140|NCT02927080|58783648|FG003|Overall Study|Withdrawal by Subject|0|||
30774141|NCT02927080|58783649|FG004|Overall Study|Withdrawal by Subject|1|||
30774142|NCT02927080|58783650|FG005|Overall Study|Withdrawal by Subject|0|||
30774143|NCT02927080|58783651|FG006|Overall Study|Withdrawal by Subject|1|||
30774144|NCT02927080|58783652|FG007|Overall Study|Withdrawal by Subject|1|||
30774145|NCT02927080|58783653|FG008|Overall Study|Withdrawal by Subject|0|||
30774146|NCT02927080|58783654|FG009|Overall Study|Withdrawal by Subject|2|||
30774147|NCT02927080|58783645|FG000|Overall Study|Willingness to comply with protocol|0|||
30774148|NCT02927080|58783646|FG001|Overall Study|Willingness to comply with protocol|0|||
30774149|NCT02927080|58783647|FG002|Overall Study|Willingness to comply with protocol|0|||
30774150|NCT02927080|58783648|FG003|Overall Study|Willingness to comply with protocol|0|||
30774151|NCT02927080|58783649|FG004|Overall Study|Willingness to comply with protocol|0|||
30774152|NCT02927080|58783650|FG005|Overall Study|Willingness to comply with protocol|0|||
30774153|NCT02927080|58783651|FG006|Overall Study|Willingness to comply with protocol|0|||
30774154|NCT02927080|58783652|FG007|Overall Study|Willingness to comply with protocol|0|||
30774155|NCT02927080|58783653|FG008|Overall Study|Willingness to comply with protocol|0|||
30774156|NCT02927080|58783654|FG009|Overall Study|Willingness to comply with protocol|1|||
30774157|NCT02927080|58783645|FG000|Overall Study|Study terminated by Sponsor|0|||
30774158|NCT02927080|58783646|FG001|Overall Study|Study terminated by Sponsor|0|||
30774159|NCT02927080|58783647|FG002|Overall Study|Study terminated by Sponsor|0|||
30774160|NCT02927080|58783648|FG003|Overall Study|Study terminated by Sponsor|0|||
30774161|NCT02927080|58783649|FG004|Overall Study|Study terminated by Sponsor|0|||
30774162|NCT02927080|58783650|FG005|Overall Study|Study terminated by Sponsor|0|||
30774163|NCT02927080|58783651|FG006|Overall Study|Study terminated by Sponsor|6|||
30774164|NCT02927080|58783652|FG007|Overall Study|Study terminated by Sponsor|7|||
30774165|NCT02927080|58783653|FG008|Overall Study|Study terminated by Sponsor|2|||
30774166|NCT02927080|58783654|FG009|Overall Study|Study terminated by Sponsor|3|||
30774167|NCT02927080|58783645|FG000|Overall Study|Adverse Event|0|||
30774168|NCT02927080|58783646|FG001|Overall Study|Adverse Event|1|||
30774169|NCT02927080|58783647|FG002|Overall Study|Adverse Event|0|||
30774170|NCT02927080|58783648|FG003|Overall Study|Adverse Event|0|||
30774171|NCT02927080|58783649|FG004|Overall Study|Adverse Event|0|||
30774172|NCT02927080|58783650|FG005|Overall Study|Adverse Event|0|||
30774173|NCT02927080|58783651|FG006|Overall Study|Adverse Event|0|||
30774174|NCT02927080|58783652|FG007|Overall Study|Adverse Event|1|||
30774175|NCT02927080|58783653|FG008|Overall Study|Adverse Event|0|||
30774176|NCT02927080|58783654|FG009|Overall Study|Adverse Event|1|||
30774177|NCT02927080|58783645|FG000|Overall Study|Other|0|||
30774178|NCT02927080|58783646|FG001|Overall Study|Other|0|||
30774179|NCT02927080|58783647|FG002|Overall Study|Other|0|||
30774180|NCT02927080|58783648|FG003|Overall Study|Other|0|||
30774181|NCT02927080|58783649|FG004|Overall Study|Other|0|||
30774182|NCT02927080|58783650|FG005|Overall Study|Other|0|||
30774183|NCT02927080|58783651|FG006|Overall Study|Other|1|||
30774184|NCT02927080|58783652|FG007|Overall Study|Other|0|||
30774185|NCT02927080|58783653|FG008|Overall Study|Other|1|||
30774186|NCT02927080|58783654|FG009|Overall Study|Other|0|||
30774187|NCT02374476|58783701|FG000|VT Induced Ablation|Screening Failures|36|||
30774188|NCT02374476|58783702|FG001|VT Induced Ablation|Screening Failures|0|||
30774189|NCT02374476|58783703|FG002|VT Induced Ablation|Screening Failures|0|||
30774190|NCT02374476|58783701|FG000|Arm Assignment|Withdrawal by Subject|0|||
30774191|NCT02374476|58783702|FG001|Arm Assignment|Withdrawal by Subject|0|||
30774192|NCT02374476|58783703|FG002|Arm Assignment|Withdrawal by Subject|1|||
30774193|NCT02918292|58783710|FG000|Study Enrollment Prior to Transplant|Death|1|||
30774194|NCT02918292|58783710|FG000|Study Follow up After Transplant|Death|6|||
30774195|NCT03720210|58783714|FG000|Overall Study|Lost to Follow-up|1|||
30774196|NCT03719586|58783722|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
30774197|NCT03719586|58783723|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
30774198|NCT03719586|58783724|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
30850200|NCT02055547|58877102|FG009|Overall Study|Adverse Event|0|||
30774199|NCT03719586|58783725|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
30774200|NCT03353350|58783751|FG000|30-week Core Treatment Period|Protocol Violation|1|||
30774201|NCT03353350|58783752|FG001|30-week Core Treatment Period|Protocol Violation|1|||
30774202|NCT03353350|58783753|FG002|30-week Core Treatment Period|Protocol Violation|1|||
30774203|NCT03353350|58783754|FG003|30-week Core Treatment Period|Protocol Violation|0|||
30774204|NCT03353350|58783751|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
30774205|NCT03353350|58783752|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
30774206|NCT03353350|58783753|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
30774207|NCT03353350|58783754|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
30774208|NCT03353350|58783751|FG000|30-week Core Treatment Period|Adverse Event|0|||
30774209|NCT03353350|58783752|FG001|30-week Core Treatment Period|Adverse Event|4|||
30774210|NCT03353350|58783753|FG002|30-week Core Treatment Period|Adverse Event|2|||
30774211|NCT03353350|58783754|FG003|30-week Core Treatment Period|Adverse Event|3|||
30774212|NCT03353350|58783751|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
30774213|NCT03353350|58783752|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
30774214|NCT03353350|58783753|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
30774215|NCT03353350|58783754|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
30774216|NCT03353350|58783751|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
30774217|NCT03353350|58783752|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
30774218|NCT03353350|58783753|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
30774219|NCT03353350|58783754|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
30774220|NCT03353350|58783751|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
30774221|NCT03353350|58783752|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
30774222|NCT03353350|58783753|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
30774223|NCT03353350|58783754|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
30774224|NCT03353350|58783751|FG000|26-week Treatment Extension Period|Adverse Event|1|||
30774225|NCT03353350|58783752|FG001|26-week Treatment Extension Period|Adverse Event|0|||
30774226|NCT03353350|58783753|FG002|26-week Treatment Extension Period|Adverse Event|0|||
30774227|NCT03353350|58783754|FG003|26-week Treatment Extension Period|Adverse Event|1|||
30774228|NCT03353350|58783751|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
30774229|NCT03353350|58783752|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
30774230|NCT03353350|58783753|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
30774231|NCT03353350|58783754|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
30774232|NCT03032068|58783768|FG000|Overall Study|Adverse Event|1|||
30774233|NCT02674516|58783788|FG000|Overall Study|Lost to Follow-up|3|||
30774234|NCT02674516|58783789|FG001|Overall Study|Lost to Follow-up|0|||
30774235|NCT02674516|58783788|FG000|Overall Study|Protocol Violation|0|||
30774236|NCT02674516|58783789|FG001|Overall Study|Protocol Violation|4|||
30774237|NCT02674516|58783788|FG000|Overall Study|Knowledge of study hypothesis|1|||
30774238|NCT02674516|58783789|FG001|Overall Study|Knowledge of study hypothesis|0|||
30774239|NCT02463448|58783795|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
30774240|NCT02463448|58783795|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
30774241|NCT02463448|58783795|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
30774242|NCT02463448|58783795|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
30774243|NCT03794544|58783803|FG000|Overall Study|Withdrawal by Subject|1|||
30774244|NCT03794544|58783804|FG001|Overall Study|Withdrawal by Subject|1|||
30774245|NCT03794544|58783805|FG002|Overall Study|Withdrawal by Subject|0|||
30774246|NCT03794544|58783806|FG003|Overall Study|Withdrawal by Subject|0|||
30774247|NCT03794544|58783803|FG000|Overall Study|Death|0|||
30774248|NCT03794544|58783804|FG001|Overall Study|Death|0|||
30774249|NCT03794544|58783805|FG002|Overall Study|Death|0|||
30774250|NCT03794544|58783806|FG003|Overall Study|Death|1|||
30850201|NCT02055547|58877103|FG010|Overall Study|Adverse Event|0|||
30850202|NCT02055547|58877104|FG011|Overall Study|Adverse Event|0|||
30774251|NCT03794544|58783803|FG000|Overall Study|Lost to Follow-up|0|||
30774252|NCT03794544|58783804|FG001|Overall Study|Lost to Follow-up|1|||
30774253|NCT03794544|58783805|FG002|Overall Study|Lost to Follow-up|1|||
30774254|NCT03794544|58783806|FG003|Overall Study|Lost to Follow-up|0|||
30774255|NCT03794544|58783803|FG000|Overall Study|Other|0|||
30774256|NCT03794544|58783804|FG001|Overall Study|Other|1|||
30774257|NCT03794544|58783805|FG002|Overall Study|Other|0|||
30774258|NCT03794544|58783806|FG003|Overall Study|Other|0|||
30774259|NCT01804270|58783818|FG000|Overall Study|Withdrawal by Subject|1|||
30774260|NCT01804270|58783819|FG001|Overall Study|Withdrawal by Subject|1|||
30774261|NCT03107026|58783828|FG000|Overall Study|Adverse Event|2|||
30774262|NCT03107026|58783829|FG001|Overall Study|Adverse Event|14|||
30774263|NCT03107026|58783830|FG002|Overall Study|Adverse Event|23|||
30774264|NCT03107026|58783828|FG000|Overall Study|Lost to Follow-up|12|||
30774265|NCT03107026|58783829|FG001|Overall Study|Lost to Follow-up|12|||
30774266|NCT03107026|58783830|FG002|Overall Study|Lost to Follow-up|13|||
30774267|NCT03107026|58783828|FG000|Overall Study|Protocol Violation|1|||
30850203|NCT02055547|58877105|FG012|Overall Study|Adverse Event|0|||
30850204|NCT02055547|58877106|FG013|Overall Study|Adverse Event|0|||
30850205|NCT02055547|58877107|FG014|Overall Study|Adverse Event|0|||
30850206|NCT02055547|58877108|FG015|Overall Study|Adverse Event|0|||
30850207|NCT02055547|58877109|FG016|Overall Study|Adverse Event|0|||
30850208|NCT02055547|58877110|FG017|Overall Study|Adverse Event|0|||
30850209|NCT02055547|58877111|FG018|Overall Study|Adverse Event|0|||
30850210|NCT02055547|58877093|FG000|Overall Study|Withdrawal by Subject|0|||
30850211|NCT02055547|58877094|FG001|Overall Study|Withdrawal by Subject|0|||
30850212|NCT02055547|58877095|FG002|Overall Study|Withdrawal by Subject|0|||
30850213|NCT02055547|58877096|FG003|Overall Study|Withdrawal by Subject|0|||
30774268|NCT03107026|58783829|FG001|Overall Study|Protocol Violation|2|||
30774269|NCT03107026|58783830|FG002|Overall Study|Protocol Violation|0|||
30774270|NCT03107026|58783828|FG000|Overall Study|Pregnancy|1|||
30774271|NCT03107026|58783829|FG001|Overall Study|Pregnancy|0|||
30774272|NCT03107026|58783830|FG002|Overall Study|Pregnancy|0|||
30774273|NCT03107026|58783828|FG000|Overall Study|Withdrawal by Subject|13|||
30774274|NCT03107026|58783829|FG001|Overall Study|Withdrawal by Subject|5|||
30774275|NCT03107026|58783830|FG002|Overall Study|Withdrawal by Subject|17|||
30774276|NCT03107026|58783828|FG000|Overall Study|non compliance with study visits|1|||
30774277|NCT03107026|58783829|FG001|Overall Study|non compliance with study visits|2|||
30774278|NCT03107026|58783830|FG002|Overall Study|non compliance with study visits|0|||
30774279|NCT03107026|58783828|FG000|Overall Study|non-compliance with study drug|2|||
30774280|NCT03107026|58783829|FG001|Overall Study|non-compliance with study drug|2|||
30774281|NCT03107026|58783830|FG002|Overall Study|non-compliance with study drug|3|||
30774282|NCT03107026|58783828|FG000|Overall Study|Physician Decision|0|||
30774283|NCT03107026|58783829|FG001|Overall Study|Physician Decision|1|||
30774284|NCT03107026|58783830|FG002|Overall Study|Physician Decision|0|||
30774285|NCT03717480|58783838|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
30774286|NCT00005044|58783844|FG000|Overall Study|Protocol Violation|37|||
30774287|NCT00005044|58783845|FG001|Overall Study|Protocol Violation|46|||
30774288|NCT00005044|58783844|FG000|Overall Study|Withdrawal by Subject|1|||
30774289|NCT00005044|58783845|FG001|Overall Study|Withdrawal by Subject|5|||
30774290|NCT00005044|58783844|FG000|Overall Study|No protocol treatment|0|||
30774291|NCT00005044|58783845|FG001|Overall Study|No protocol treatment|1|||
30774292|NCT03084796|58783857|FG000|Overall Study|Adverse Event|4|||
30774293|NCT03084796|58783858|FG001|Overall Study|Adverse Event|5|||
30774294|NCT03084796|58783859|FG002|Overall Study|Adverse Event|6|||
30774295|NCT03084796|58783860|FG003|Overall Study|Adverse Event|2|||
30774296|NCT03084796|58783861|FG004|Overall Study|Adverse Event|3|||
30774297|NCT03084796|58783862|FG005|Overall Study|Adverse Event|5|||
30774298|NCT03084796|58783857|FG000|Overall Study|Withdrawal by Subject|3|||
30774299|NCT03084796|58783858|FG001|Overall Study|Withdrawal by Subject|5|||
30774300|NCT03084796|58783859|FG002|Overall Study|Withdrawal by Subject|2|||
30850214|NCT02055547|58877097|FG004|Overall Study|Withdrawal by Subject|0|||
30850215|NCT02055547|58877098|FG005|Overall Study|Withdrawal by Subject|1|||
30850216|NCT02055547|58877099|FG006|Overall Study|Withdrawal by Subject|0|||
30850217|NCT02055547|58877100|FG007|Overall Study|Withdrawal by Subject|0|||
30850218|NCT02055547|58877101|FG008|Overall Study|Withdrawal by Subject|1|||
30850219|NCT02055547|58877102|FG009|Overall Study|Withdrawal by Subject|0|||
30850220|NCT02055547|58877103|FG010|Overall Study|Withdrawal by Subject|0|||
30850221|NCT02055547|58877104|FG011|Overall Study|Withdrawal by Subject|0|||
30850222|NCT02055547|58877105|FG012|Overall Study|Withdrawal by Subject|0|||
30850223|NCT02055547|58877106|FG013|Overall Study|Withdrawal by Subject|1|||
30850224|NCT02055547|58877107|FG014|Overall Study|Withdrawal by Subject|0|||
30850225|NCT02055547|58877108|FG015|Overall Study|Withdrawal by Subject|1|||
30850226|NCT02055547|58877109|FG016|Overall Study|Withdrawal by Subject|0|||
30850227|NCT02055547|58877110|FG017|Overall Study|Withdrawal by Subject|0|||
30850228|NCT02055547|58877111|FG018|Overall Study|Withdrawal by Subject|0|||
30850229|NCT02055547|58877093|FG000|Overall Study|Lost to Follow-up|0|||
30850230|NCT02055547|58877094|FG001|Overall Study|Lost to Follow-up|0|||
30850231|NCT02055547|58877095|FG002|Overall Study|Lost to Follow-up|1|||
30850232|NCT02055547|58877096|FG003|Overall Study|Lost to Follow-up|0|||
30850233|NCT02055547|58877097|FG004|Overall Study|Lost to Follow-up|0|||
30850234|NCT02055547|58877098|FG005|Overall Study|Lost to Follow-up|0|||
30850235|NCT02055547|58877099|FG006|Overall Study|Lost to Follow-up|0|||
30850236|NCT02055547|58877100|FG007|Overall Study|Lost to Follow-up|0|||
30953071|NCT00634803|59003382|FG001|Overall Study|Lost to Follow-up|7|||
30774301|NCT03084796|58783860|FG003|Overall Study|Withdrawal by Subject|1|||
30774302|NCT03084796|58783861|FG004|Overall Study|Withdrawal by Subject|3|||
30850237|NCT02055547|58877101|FG008|Overall Study|Lost to Follow-up|0|||
30850238|NCT02055547|58877102|FG009|Overall Study|Lost to Follow-up|0|||
30850239|NCT02055547|58877103|FG010|Overall Study|Lost to Follow-up|0|||
30850240|NCT02055547|58877104|FG011|Overall Study|Lost to Follow-up|0|||
30774303|NCT03084796|58783862|FG005|Overall Study|Withdrawal by Subject|0|||
30774304|NCT03084796|58783857|FG000|Overall Study|Protocol Violation|0|||
30850241|NCT02055547|58877105|FG012|Overall Study|Lost to Follow-up|0|||
30850242|NCT02055547|58877106|FG013|Overall Study|Lost to Follow-up|0|||
30774305|NCT03084796|58783858|FG001|Overall Study|Protocol Violation|0|||
30774306|NCT03084796|58783859|FG002|Overall Study|Protocol Violation|1|||
30774307|NCT03084796|58783860|FG003|Overall Study|Protocol Violation|0|||
30774308|NCT03084796|58783861|FG004|Overall Study|Protocol Violation|1|||
30774309|NCT03084796|58783862|FG005|Overall Study|Protocol Violation|1|||
30774310|NCT03084796|58783857|FG000|Overall Study|Lack of Efficacy|0|||
30774311|NCT03084796|58783858|FG001|Overall Study|Lack of Efficacy|0|||
30774312|NCT03084796|58783859|FG002|Overall Study|Lack of Efficacy|1|||
30774313|NCT03084796|58783860|FG003|Overall Study|Lack of Efficacy|0|||
30774314|NCT03084796|58783861|FG004|Overall Study|Lack of Efficacy|1|||
30774315|NCT03084796|58783862|FG005|Overall Study|Lack of Efficacy|0|||
30774316|NCT03084796|58783857|FG000|Overall Study|Lost to Follow-up|0|||
30774317|NCT03084796|58783858|FG001|Overall Study|Lost to Follow-up|0|||
30774318|NCT03084796|58783859|FG002|Overall Study|Lost to Follow-up|1|||
30774319|NCT03084796|58783860|FG003|Overall Study|Lost to Follow-up|1|||
30774320|NCT03084796|58783861|FG004|Overall Study|Lost to Follow-up|3|||
30774321|NCT03084796|58783862|FG005|Overall Study|Lost to Follow-up|1|||
30774322|NCT03084796|58783857|FG000|Overall Study|Randomization error|0|||
30774323|NCT03084796|58783858|FG001|Overall Study|Randomization error|0|||
30774324|NCT03084796|58783859|FG002|Overall Study|Randomization error|1|||
30774325|NCT03084796|58783860|FG003|Overall Study|Randomization error|0|||
30774326|NCT03084796|58783861|FG004|Overall Study|Randomization error|0|||
30774327|NCT03084796|58783862|FG005|Overall Study|Randomization error|0|||
30774328|NCT03717012|58783878|FG000|Overall Study|Due to trial termination|1|||
30774329|NCT03717012|58783879|FG001|Overall Study|Due to trial termination|2|||
30774330|NCT03717012|58783878|FG000|Overall Study|Protocol Violation|0|||
30774331|NCT03717012|58783879|FG001|Overall Study|Protocol Violation|2|||
30774332|NCT03717012|58783878|FG000|Overall Study|Adverse Event|0|||
30774333|NCT03717012|58783879|FG001|Overall Study|Adverse Event|1|||
30774334|NCT03717012|58783878|FG000|Overall Study|Lung transplant|0|||
30774335|NCT03717012|58783879|FG001|Overall Study|Lung transplant|1|||
30774336|NCT03078556|58783892|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
30774337|NCT03078556|58783893|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
30774338|NCT03078556|58783894|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
30774339|NCT03078556|58783895|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
30774340|NCT03078556|58783892|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
30774341|NCT03078556|58783893|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
30850243|NCT02055547|58877107|FG014|Overall Study|Lost to Follow-up|0|||
30850244|NCT02055547|58877108|FG015|Overall Study|Lost to Follow-up|0|||
30774342|NCT03078556|58783894|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
30774343|NCT03078556|58783895|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
30774344|NCT03078556|58783892|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
30774345|NCT03078556|58783893|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
30774346|NCT03078556|58783894|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
30774347|NCT03078556|58783895|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
30774348|NCT03078556|58783892|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
30774349|NCT03078556|58783893|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
30774350|NCT03078556|58783894|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
30774351|NCT03078556|58783895|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
30774352|NCT03714672|58783924|FG000|Overall Study|Adverse Event|0|||
30774353|NCT03714672|58783925|FG001|Overall Study|Adverse Event|0|||
30774354|NCT03714672|58783926|FG002|Overall Study|Adverse Event|3|||
30774355|NCT03714672|58783927|FG003|Overall Study|Adverse Event|0|||
30774356|NCT03714672|58783924|FG000|Overall Study|Physician Decision|0|||
30774357|NCT03714672|58783925|FG001|Overall Study|Physician Decision|1|||
30774358|NCT03714672|58783926|FG002|Overall Study|Physician Decision|0|||
30774359|NCT03714672|58783927|FG003|Overall Study|Physician Decision|0|||
30774360|NCT03714672|58783924|FG000|Overall Study|Other Reason|1|||
30774361|NCT03714672|58783925|FG001|Overall Study|Other Reason|2|||
30774362|NCT03714672|58783926|FG002|Overall Study|Other Reason|1|||
30774363|NCT03714672|58783927|FG003|Overall Study|Other Reason|1|||
30774364|NCT03714672|58783924|FG000|Overall Study|Lost to Follow-up|1|||
30774365|NCT03714672|58783925|FG001|Overall Study|Lost to Follow-up|1|||
30774366|NCT03714672|58783926|FG002|Overall Study|Lost to Follow-up|0|||
30774367|NCT03714672|58783927|FG003|Overall Study|Lost to Follow-up|0|||
30774368|NCT03083470|58783943|FG000|Overall Study|Lost to Follow-up|0|||
30774369|NCT03083470|58783944|FG001|Overall Study|Lost to Follow-up|0|||
30850245|NCT02055547|58877109|FG016|Overall Study|Lost to Follow-up|0|||
30774370|NCT03083470|58783945|FG002|Overall Study|Lost to Follow-up|0|||
30774371|NCT03083470|58783946|FG003|Overall Study|Lost to Follow-up|0|||
30774372|NCT03083470|58783947|FG004|Overall Study|Lost to Follow-up|1|||
30774373|NCT03083470|58783943|FG000|Overall Study|Withdrawal by Subject|0|||
30774374|NCT03083470|58783944|FG001|Overall Study|Withdrawal by Subject|0|||
30774375|NCT03083470|58783945|FG002|Overall Study|Withdrawal by Subject|0|||
30774376|NCT03083470|58783946|FG003|Overall Study|Withdrawal by Subject|0|||
30850246|NCT02055547|58877110|FG017|Overall Study|Lost to Follow-up|0|||
30850247|NCT02055547|58877111|FG018|Overall Study|Lost to Follow-up|0|||
30850248|NCT02414854|58877149|FG000|Overall Study|Adverse Event|9|||
30850249|NCT02414854|58877150|FG001|Overall Study|Adverse Event|7|||
30774377|NCT03083470|58783947|FG004|Overall Study|Withdrawal by Subject|1|||
30774378|NCT05405244|58783959|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
30774379|NCT05405244|58783960|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
30774380|NCT05405244|58783959|FG000|Washout (2 Weeks)|Adverse Event|2|||
30774381|NCT05405244|58783960|FG001|Washout (2 Weeks)|Adverse Event|0|||
30774382|NCT05405244|58783959|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
30774383|NCT05405244|58783960|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
30774384|NCT03074500|58783973|FG000|Overall Study|Lost to Follow-up|1|||
30774385|NCT03074500|58783974|FG001|Overall Study|Lost to Follow-up|0|||
30774386|NCT03074500|58783975|FG002|Overall Study|Lost to Follow-up|0|||
30774387|NCT03074500|58783973|FG000|Overall Study|Lack of Efficacy|0|||
30774388|NCT03074500|58783974|FG001|Overall Study|Lack of Efficacy|1|||
30774389|NCT03074500|58783975|FG002|Overall Study|Lack of Efficacy|0|||
30774390|NCT03074500|58783973|FG000|Overall Study|Adverse Event|0|||
30774391|NCT03074500|58783974|FG001|Overall Study|Adverse Event|0|||
30774392|NCT03074500|58783975|FG002|Overall Study|Adverse Event|1|||
30774393|NCT03715530|58783988|FG000|Overall Study|Lost to Follow-up|3|||
30774394|NCT03715530|58783989|FG001|Overall Study|Lost to Follow-up|1|||
30774395|NCT03715530|58783990|FG002|Overall Study|Lost to Follow-up|2|||
30774396|NCT03077698|58784000|FG000|Progestin Monotherapy|Stable Disease|8|||
30774397|NCT03077698|58784001|FG001|Progestin Monotherapy|Stable Disease|0|||
30774398|NCT03077698|58784000|FG000|Progestin Monotherapy|Adverse Event|1|||
30774399|NCT03077698|58784001|FG001|Progestin Monotherapy|Adverse Event|0|||
30774400|NCT03077698|58784000|FG000|Progestin Monotherapy|Death|1|||
30774401|NCT03077698|58784001|FG001|Progestin Monotherapy|Death|0|||
30774402|NCT03077698|58784000|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
30774403|NCT03077698|58784001|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
30774404|NCT03077698|58784000|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
30774405|NCT03077698|58784001|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
30774406|NCT03077698|58784000|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
30774407|NCT03077698|58784001|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
30774408|NCT03077698|58784000|FG000|Safety Follow Up|Withdrawal by Subject|2|||
30774409|NCT03077698|58784001|FG001|Safety Follow Up|Withdrawal by Subject|1|||
30774410|NCT03077698|58784000|FG000|Safety Follow Up|Transfer of care to hospice|1|||
30774411|NCT03077698|58784001|FG001|Safety Follow Up|Transfer of care to hospice|0|||
30850250|NCT02414854|58877151|FG002|Overall Study|Adverse Event|1|||
30850251|NCT02414854|58877152|FG003|Overall Study|Adverse Event|12|||
30850252|NCT02414854|58877149|FG000|Overall Study|Poor compliance to protocol|1|||
30850253|NCT02414854|58877150|FG001|Overall Study|Poor compliance to protocol|1|||
30850254|NCT02414854|58877151|FG002|Overall Study|Poor compliance to protocol|2|||
30850255|NCT02414854|58877152|FG003|Overall Study|Poor compliance to protocol|2|||
30850256|NCT02414854|58877149|FG000|Overall Study|Other than specified above|12|||
30850257|NCT02414854|58877150|FG001|Overall Study|Other than specified above|37|||
30850258|NCT02414854|58877151|FG002|Overall Study|Other than specified above|17|||
30850259|NCT02414854|58877152|FG003|Overall Study|Other than specified above|37|||
30850260|NCT03332498|58877165|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
30850261|NCT03332498|58877166|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
30850262|NCT03332498|58877167|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
30850263|NCT01334125|58877176|FG000|Overall Study|Lost to Follow-up|3|||
30850264|NCT01334125|58877177|FG001|Overall Study|Lost to Follow-up|3|||
30850265|NCT02414152|58877184|FG000|Overall Study|Withdrawal by Subject|1|||
30850266|NCT02414152|58877184|FG000|Overall Study|Lack of Efficacy|1|||
30850267|NCT02413996|58877190|FG000|Overall Study|not comfortable with the intervention|9|||
30850268|NCT02413996|58877191|FG001|Overall Study|not comfortable with the intervention|2|||
30850269|NCT01333501|58877199|FG000|Overall Study|Adverse Event|3|||
30953072|NCT00634803|59003383|FG002|Overall Study|Lost to Follow-up|7|||
30953073|NCT01217385|59003399|FG000|Overall Study|Withdrawal by Subject|3|||
30953074|NCT01217385|59003399|FG000|Overall Study|DOSI not performed/not eval|12|||
30953075|NCT01217385|59003399|FG000|Overall Study|Central Path not Available|1|||
30953076|NCT01217385|59003399|FG000|Overall Study|Normal Breast TOI not available|10|||
30953077|NCT01378104|59003751|FG000|Overall Study|Adverse Event|8|||
30953078|NCT01378104|59003752|FG001|Overall Study|Adverse Event|8|||
30953079|NCT01378104|59003751|FG000|Overall Study|Lack of Efficacy|7|||
30953080|NCT01378104|59003752|FG001|Overall Study|Lack of Efficacy|5|||
30953081|NCT01378104|59003751|FG000|Overall Study|Withdrawal by Subject|12|||
30953082|NCT01378104|59003752|FG001|Overall Study|Withdrawal by Subject|13|||
30953083|NCT01379274|59003793|FG000|Overall Study|funding withdrawn|1|||
30662507|NCT00742209|58676014|FG004|Overall Study|Investigator Discretion|1|||
30850270|NCT01333501|58877200|FG001|Overall Study|Adverse Event|1|||
30850271|NCT01333501|58877199|FG000|Overall Study|Abnormal laboratory value|2|||
30850272|NCT01333501|58877200|FG001|Overall Study|Abnormal laboratory value|1|||
30850273|NCT01333501|58877199|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30850274|NCT01333501|58877200|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
30953084|NCT00634569|59003994|FG000|Overall Study|Withdrawal by Subject|0|||
30774412|NCT03079102|58784019|FG000|Overall Study|Physician Decision|0|||
30774413|NCT03079102|58784020|FG001|Overall Study|Physician Decision|1|||
30774414|NCT02434354|58784026|FG000|Overall Study|screen fail|3|||
30774415|NCT03076996|58784030|FG000|Overall Study|Withdrawal by Subject|2|||
30662508|NCT00741819|58676027|FG000|Overall Study|Adverse Event|3|||
30662509|NCT00741819|58676027|FG000|Overall Study|Withdrawal by Subject|3|||
30662510|NCT00741819|58676027|FG000|Overall Study|Death|1|||
30662511|NCT00741819|58676027|FG000|Overall Study|Disease progression|1|||
30662512|NCT00924443|58676033|FG000|Overall Study|Physician Decision|2|||
30662513|NCT00924443|58676033|FG000|Overall Study|Protocol Violation|1|||
30850275|NCT01333501|58877199|FG000|Overall Study|Withdrawn consent|3|||
30850276|NCT01333501|58877200|FG001|Overall Study|Withdrawn consent|12|||
30850277|NCT01362140|58877208|FG000|Overall Study|Noncompliance|1|||
30850278|NCT01362140|58877209|FG001|Overall Study|Noncompliance|0|||
30850279|NCT01362140|58877208|FG000|Overall Study|Adverse Event|2|||
30850280|NCT01362140|58877209|FG001|Overall Study|Adverse Event|2|||
30850281|NCT01362140|58877208|FG000|Overall Study|Withdrawal by Subject|3|||
30850282|NCT01362140|58877209|FG001|Overall Study|Withdrawal by Subject|3|||
30850283|NCT01362140|58877208|FG000|Overall Study|Administrative Decision|0|||
30850284|NCT01362140|58877209|FG001|Overall Study|Administrative Decision|1|||
30850285|NCT01362140|58877208|FG000|Overall Study|Death|2|||
30850286|NCT01362140|58877209|FG001|Overall Study|Death|1|||
30850287|NCT01362140|58877208|FG000|Overall Study|Other|1|||
30850288|NCT01362140|58877209|FG001|Overall Study|Other|1|||
30850289|NCT01362140|58877208|FG000|Overall Study|Protocol-specified Criteria|1|||
30850290|NCT01362140|58877209|FG001|Overall Study|Protocol-specified Criteria|2|||
30850291|NCT01362140|58877208|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
30850292|NCT01362140|58877209|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
30850293|NCT01333189|58877217|FG000|Overall Study|Time constraints|1|||
30850294|NCT01333189|58877218|FG001|Overall Study|Time constraints|0|||
30850295|NCT01333189|58877217|FG000|Overall Study|Adverse Event|1|||
30850296|NCT01333189|58877218|FG001|Overall Study|Adverse Event|0|||
30850297|NCT01333189|58877217|FG000|Overall Study|Transportation difficulties|0|||
30850298|NCT01333189|58877218|FG001|Overall Study|Transportation difficulties|1|||
30774416|NCT03076996|58784030|FG000|Overall Study|Lost to Follow-up|3|||
30774417|NCT03076996|58784030|FG000|Overall Study|Literacy precluded participation|1|||
30774418|NCT03078868|58784034|FG000|Overall Study|Physician Decision|3|||
30774419|NCT04524598|58784042|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
30774420|NCT04524598|58784043|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
30774421|NCT04524598|58784044|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
30850299|NCT01333189|58877217|FG000|Overall Study|Moved from region|0|||
30850300|NCT01333189|58877218|FG001|Overall Study|Moved from region|1|||
30850301|NCT01333111|58877227|FG000|Overall Study|patient undergoing major surgery|0|||
30850302|NCT01333111|58877228|FG001|Overall Study|patient undergoing major surgery|2|||
30850303|NCT01333111|58877229|FG002|Overall Study|patient undergoing major surgery|0|||
30850304|NCT01333111|58877227|FG000|Overall Study|personal reasons|0|||
30850305|NCT01333111|58877228|FG001|Overall Study|personal reasons|0|||
30850306|NCT01333111|58877229|FG002|Overall Study|personal reasons|1|||
30850307|NCT01333111|58877227|FG000|Overall Study|unclassified|1|||
30850308|NCT01333111|58877228|FG001|Overall Study|unclassified|0|||
30850309|NCT01333111|58877229|FG002|Overall Study|unclassified|0|||
30850310|NCT01333111|58877227|FG000|Overall Study|withdrawal criteria|0|||
30850311|NCT01333111|58877228|FG001|Overall Study|withdrawal criteria|1|||
30850312|NCT01333111|58877229|FG002|Overall Study|withdrawal criteria|0|||
30850313|NCT01333111|58877227|FG000|Overall Study|Non-compliance|1|||
30850314|NCT01333111|58877228|FG001|Overall Study|Non-compliance|0|||
30850315|NCT01333111|58877229|FG002|Overall Study|Non-compliance|0|||
30850316|NCT01333111|58877227|FG000|Overall Study|Ineffective therapy|0|||
30850317|NCT01333111|58877228|FG001|Overall Study|Ineffective therapy|0|||
30850318|NCT01333111|58877229|FG002|Overall Study|Ineffective therapy|1|||
30850319|NCT00702507|58877237|FG000|Initial Treatment Phase|Adverse Event|2|||
30850320|NCT00702507|58877237|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
30850321|NCT00702507|58877237|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
30774422|NCT04524598|58784045|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
30774423|NCT04524598|58784046|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
30774424|NCT04524598|58784042|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
30774425|NCT04524598|58784043|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
30774426|NCT04524598|58784044|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
30850322|NCT00702507|58877237|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
30850323|NCT00702507|58877237|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
30850324|NCT00702507|58877237|FG000|Follow-up Phase|Protocol Violation|2|||
30662514|NCT00924287|58676037|FG000|Overall Study|Death|1|||
30850325|NCT00702507|58877237|FG000|Follow-up Phase|Lost to Follow-up|23|||
30850326|NCT00702507|58877237|FG000|Follow-up Phase|Late Enrollment|1|||
30850327|NCT01673594|58877253|FG000|Overall Study|Adverse Event|3|||
30850328|NCT01673594|58877254|FG001|Overall Study|Adverse Event|1|||
30850329|NCT01673594|58877253|FG000|Overall Study|Lost to Follow-up|1|||
30850330|NCT01673594|58877254|FG001|Overall Study|Lost to Follow-up|0|||
30850331|NCT01673594|58877253|FG000|Overall Study|Physician Decision|2|||
30850332|NCT01673594|58877254|FG001|Overall Study|Physician Decision|4|||
30850333|NCT01673594|58877253|FG000|Overall Study|Withdrawal by Subject|0|||
30850334|NCT01673594|58877254|FG001|Overall Study|Withdrawal by Subject|1|||
30850335|NCT02721147|58877263|FG000|Overall Study|Lost to Follow-up|2|||
30850336|NCT02721147|58877264|FG001|Overall Study|Lost to Follow-up|0|||
30850337|NCT02721147|58877265|FG002|Overall Study|Lost to Follow-up|0|||
30850338|NCT02720757|58877273|FG000|Overall Study|Other reason|5|||
30850339|NCT02720757|58877273|FG000|Overall Study|Loss of contact|4|||
30850340|NCT02720757|58877273|FG000|Overall Study|Informed consent withdrawal|1|||
30850341|NCT02720757|58877273|FG000|Overall Study|Patients wish to withdraw|2|||
30850342|NCT02720757|58877273|FG000|Overall Study|Missing|3|||
30850343|NCT02720757|58877273|FG000|Overall Study|General exclusion|3|||
30850344|NCT02646566|58877303|FG000|Overall Study|Lost to Follow-up|5|||
30850345|NCT02646566|58877304|FG001|Overall Study|Lost to Follow-up|4|||
30850346|NCT02646566|58877305|FG002|Overall Study|Lost to Follow-up|5|||
30850347|NCT02646566|58877303|FG000|Overall Study|Treatment failure|1|||
30850348|NCT02646566|58877304|FG001|Overall Study|Treatment failure|0|||
30850349|NCT02646566|58877305|FG002|Overall Study|Treatment failure|0|||
30850350|NCT02720523|58877321|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
30850351|NCT02720523|58877322|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
30850352|NCT02720523|58877323|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
30850353|NCT02720523|58877324|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
30850354|NCT02720523|58877325|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
30850355|NCT02720523|58877326|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
30850356|NCT02720523|58877327|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
30850357|NCT02720523|58877321|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
30850358|NCT02720523|58877322|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
30850359|NCT02720523|58877323|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
30850360|NCT02720523|58877324|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
30850361|NCT02720523|58877325|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
30850362|NCT02720523|58877326|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
30850363|NCT02720523|58877327|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
30850364|NCT02720523|58877321|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
30850365|NCT02720523|58877322|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
30850366|NCT02720523|58877323|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
30850367|NCT02720523|58877324|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
30850368|NCT02720523|58877325|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
30850369|NCT02720523|58877326|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
30850370|NCT02720523|58877327|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
30850371|NCT02720523|58877321|FG000|Period 1: Placebo-controlled Period|Other|0|||
30850372|NCT02720523|58877322|FG001|Period 1: Placebo-controlled Period|Other|0|||
30850373|NCT02720523|58877323|FG002|Period 1: Placebo-controlled Period|Other|1|||
30850374|NCT02720523|58877324|FG003|Period 1: Placebo-controlled Period|Other|1|||
30850375|NCT02720523|58877325|FG004|Period 1: Placebo-controlled Period|Other|0|||
30850376|NCT02720523|58877326|FG005|Period 1: Placebo-controlled Period|Other|0|||
30850377|NCT02720523|58877327|FG006|Period 1: Placebo-controlled Period|Other|0|||
30850378|NCT02720523|58877321|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
30850379|NCT02720523|58877322|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
30850380|NCT02720523|58877323|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
30850381|NCT02720523|58877324|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
30850382|NCT02720523|58877325|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
30850383|NCT02720523|58877326|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
30850384|NCT02720523|58877327|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
30850385|NCT02720523|58877321|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
30850386|NCT02720523|58877322|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
30850387|NCT02720523|58877323|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
30850388|NCT02720523|58877324|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
30850389|NCT02720523|58877325|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
30850390|NCT02720523|58877326|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
30850391|NCT02720523|58877327|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
30850392|NCT02720523|58877321|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
30850393|NCT02720523|58877322|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
30850394|NCT02720523|58877323|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
30850395|NCT02720523|58877324|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
30850396|NCT02720523|58877325|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
30850397|NCT02720523|58877326|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
30850398|NCT02720523|58877327|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
30850399|NCT02720523|58877321|FG000|Period 2: Long-term Extension Period|Other|0|||
30850400|NCT02720523|58877322|FG001|Period 2: Long-term Extension Period|Other|0|||
30850401|NCT02720523|58877323|FG002|Period 2: Long-term Extension Period|Other|0|||
30850402|NCT02720523|58877324|FG003|Period 2: Long-term Extension Period|Other|0|||
30850403|NCT02720523|58877325|FG004|Period 2: Long-term Extension Period|Other|2|||
30850404|NCT02720523|58877326|FG005|Period 2: Long-term Extension Period|Other|0|||
30850405|NCT02720523|58877327|FG006|Period 2: Long-term Extension Period|Other|3|||
30850406|NCT02646332|58877342|FG000|Overall Study|Lost to Follow-up|0|||
30850407|NCT02646332|58877343|FG001|Overall Study|Lost to Follow-up|3|||
30850408|NCT02471716|58877354|FG000|Overall Study|Withdrawal by Subject|0|||
30850409|NCT02471716|58877355|FG001|Overall Study|Withdrawal by Subject|1|||
30850410|NCT02471716|58877356|FG002|Overall Study|Withdrawal by Subject|0|||
30850411|NCT02471716|58877357|FG003|Overall Study|Withdrawal by Subject|2|||
30850412|NCT02471716|58877358|FG004|Overall Study|Withdrawal by Subject|5|||
30850413|NCT02471716|58877354|FG000|Overall Study|Study Terminiated by sponsor|0|||
30850414|NCT02471716|58877355|FG001|Overall Study|Study Terminiated by sponsor|0|||
30850415|NCT02471716|58877356|FG002|Overall Study|Study Terminiated by sponsor|0|||
30850416|NCT02471716|58877357|FG003|Overall Study|Study Terminiated by sponsor|1|||
30850417|NCT02471716|58877358|FG004|Overall Study|Study Terminiated by sponsor|0|||
30850418|NCT02471716|58877354|FG000|Overall Study|Lost to Follow-up|0|||
30850419|NCT02471716|58877355|FG001|Overall Study|Lost to Follow-up|0|||
30850420|NCT02471716|58877356|FG002|Overall Study|Lost to Follow-up|0|||
30850421|NCT02471716|58877357|FG003|Overall Study|Lost to Follow-up|3|||
30850422|NCT02471716|58877358|FG004|Overall Study|Lost to Follow-up|2|||
30850423|NCT02471716|58877354|FG000|Overall Study|Death|0|||
30850424|NCT02471716|58877355|FG001|Overall Study|Death|0|||
30850425|NCT02471716|58877356|FG002|Overall Study|Death|0|||
30850426|NCT02471716|58877357|FG003|Overall Study|Death|1|||
30850427|NCT02471716|58877358|FG004|Overall Study|Death|0|||
30850428|NCT02471716|58877354|FG000|Overall Study|Other|0|||
30850429|NCT02471716|58877355|FG001|Overall Study|Other|0|||
30850430|NCT02471716|58877356|FG002|Overall Study|Other|0|||
30850431|NCT02471716|58877357|FG003|Overall Study|Other|8|||
30850432|NCT02471716|58877358|FG004|Overall Study|Other|9|||
30850433|NCT01370863|58877374|FG000|Overall Study|Adverse Event|1|||
30850434|NCT01370863|58877375|FG001|Overall Study|Adverse Event|1|||
30850435|NCT01370863|58877374|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
30850436|NCT01370863|58877375|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
30850437|NCT01370863|58877374|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
30850438|NCT01370863|58877375|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
30850439|NCT02444182|58877383|FG000|Overall Study|non-compliance|2|||
30850440|NCT02444182|58877384|FG001|Overall Study|non-compliance|1|||
30850441|NCT02444182|58877383|FG000|Overall Study|Lost to Follow-up|0|||
30850442|NCT02444182|58877384|FG001|Overall Study|Lost to Follow-up|4|||
30850443|NCT02471404|58877393|FG000|Overall Study|Adverse Event|7|||
30850444|NCT02471404|58877394|FG001|Overall Study|Adverse Event|1|||
30850445|NCT02471404|58877395|FG002|Overall Study|Adverse Event|2|||
30850446|NCT02471404|58877393|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
30850447|NCT02471404|58877394|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
30850448|NCT02471404|58877395|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
30850449|NCT02471404|58877393|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
30850450|NCT02471404|58877394|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
30850451|NCT02471404|58877395|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
30850452|NCT02471404|58877393|FG000|Overall Study|Lost to Follow-up|1|||
30850453|NCT02471404|58877394|FG001|Overall Study|Lost to Follow-up|1|||
30850454|NCT02471404|58877395|FG002|Overall Study|Lost to Follow-up|3|||
30850455|NCT02471404|58877393|FG000|Overall Study|Protocol Violation|1|||
30850456|NCT02471404|58877394|FG001|Overall Study|Protocol Violation|0|||
30850457|NCT02471404|58877395|FG002|Overall Study|Protocol Violation|0|||
30850458|NCT02471404|58877393|FG000|Overall Study|Withdrawal by Subject|8|||
30850459|NCT02471404|58877394|FG001|Overall Study|Withdrawal by Subject|4|||
30850460|NCT02471404|58877395|FG002|Overall Study|Withdrawal by Subject|5|||
30850461|NCT02471404|58877393|FG000|Overall Study|Other reasons not specified|10|||
30850462|NCT02471404|58877394|FG001|Overall Study|Other reasons not specified|7|||
30850463|NCT02471404|58877395|FG002|Overall Study|Other reasons not specified|12|||
30850464|NCT02471014|58877405|FG000|Overall Study|Lost to Follow-up|2|||
30850465|NCT02471014|58877406|FG001|Overall Study|Lost to Follow-up|2|||
30850466|NCT02413372|58877415|FG000|Treatment|Lost to Follow-up|0|||
30850467|NCT02413372|58877416|FG001|Treatment|Lost to Follow-up|2|||
30850468|NCT02413372|58877417|FG002|Treatment|Lost to Follow-up|1|||
30850469|NCT02413372|58877415|FG000|Treatment|Withdrawal by Subject|1|||
30850470|NCT02413372|58877416|FG001|Treatment|Withdrawal by Subject|0|||
30850471|NCT02413372|58877417|FG002|Treatment|Withdrawal by Subject|0|||
30850472|NCT02413372|58877415|FG000|Follow-up|Lost to Follow-up|1|||
30850473|NCT02413372|58877416|FG001|Follow-up|Lost to Follow-up|1|||
30850474|NCT02413372|58877417|FG002|Follow-up|Lost to Follow-up|0|||
30850475|NCT02413372|58877415|FG000|Follow-up|Subject Withdrew Consent|1|||
30850476|NCT02413372|58877416|FG001|Follow-up|Subject Withdrew Consent|0|||
30850477|NCT02413372|58877417|FG002|Follow-up|Subject Withdrew Consent|1|||
30850478|NCT02413372|58877415|FG000|Follow-up|Subject unable to return for visit|0|||
30850479|NCT02413372|58877416|FG001|Follow-up|Subject unable to return for visit|0|||
30850480|NCT02413372|58877417|FG002|Follow-up|Subject unable to return for visit|1|||
30850481|NCT02413294|58877425|FG000|Overall Study|Withdrawal by Subject|1|||
30850482|NCT02719353|58877438|FG000|First Intervention|Physician Decision|0|||
30850483|NCT02719353|58877439|FG001|First Intervention|Physician Decision|1|||
30850484|NCT01362062|58877448|FG000|Overall Study|Adverse Event|1|||
30850485|NCT01362062|58877449|FG001|Overall Study|Adverse Event|0|||
30850486|NCT01362062|58877448|FG000|Overall Study|Lost to Follow-up|11|||
30850487|NCT01362062|58877449|FG001|Overall Study|Lost to Follow-up|0|||
30850488|NCT01362062|58877448|FG000|Overall Study|Withdrawal by Subject|2|||
30850489|NCT01362062|58877449|FG001|Overall Study|Withdrawal by Subject|0|||
30850490|NCT01362062|58877448|FG000|Overall Study|Non-compliant participant|2|||
30850491|NCT01362062|58877449|FG001|Overall Study|Non-compliant participant|0|||
30850492|NCT01362062|58877448|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
30850493|NCT01362062|58877449|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
30850494|NCT01362062|58877448|FG000|Overall Study|Had significant improvement|9|||
30850495|NCT01362062|58877449|FG001|Overall Study|Had significant improvement|0|||
30850496|NCT01361594|58877456|FG000|Overall Study|Withdrawal by Subject|1|||
30850497|NCT01361594|58877457|FG001|Overall Study|Withdrawal by Subject|2|||
30850498|NCT02642432|58877463|FG000|Overall Study|Adverse Event|2|||
30850499|NCT02642432|58877463|FG000|Overall Study|Withdrew Consent|1|||
30850500|NCT02642432|58877463|FG000|Overall Study|Lost to Follow-up|2|||
30850501|NCT02642432|58877463|FG000|Overall Study|Other|3|||
30850502|NCT02640482|58877469|FG000|Overall Study|Lost to Follow-up|3|||
30850503|NCT02640482|58877470|FG001|Overall Study|Lost to Follow-up|0|||
30850504|NCT02719743|58877481|FG000|Overall Study|Consent withdrawal|0|||
30850505|NCT02719743|58877482|FG001|Overall Study|Consent withdrawal|2|||
30850506|NCT02719743|58877483|FG002|Overall Study|Consent withdrawal|0|||
30850507|NCT02719743|58877484|FG003|Overall Study|Consent withdrawal|1|||
30850508|NCT02719743|58877485|FG004|Overall Study|Consent withdrawal|0|||
30850509|NCT02719743|58877481|FG000|Overall Study|Migrated/moved from study area|0|||
30850510|NCT02719743|58877482|FG001|Overall Study|Migrated/moved from study area|0|||
30850511|NCT02719743|58877483|FG002|Overall Study|Migrated/moved from study area|0|||
30850512|NCT02719743|58877484|FG003|Overall Study|Migrated/moved from study area|0|||
30850513|NCT02719743|58877485|FG004|Overall Study|Migrated/moved from study area|2|||
30850514|NCT02719743|58877481|FG000|Overall Study|Lost to Follow-up|1|||
30850515|NCT02719743|58877482|FG001|Overall Study|Lost to Follow-up|1|||
30850516|NCT02719743|58877483|FG002|Overall Study|Lost to Follow-up|0|||
30850517|NCT02719743|58877484|FG003|Overall Study|Lost to Follow-up|0|||
30850518|NCT02719743|58877485|FG004|Overall Study|Lost to Follow-up|0|||
30850519|NCT02641730|58877500|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
30850520|NCT02641730|58877501|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
30774427|NCT04524598|58784045|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
30774428|NCT04524598|58784046|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
30774429|NCT04524598|58784042|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
30774430|NCT04524598|58784043|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
30774431|NCT04524598|58784044|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
30774432|NCT04524598|58784045|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
30774433|NCT04524598|58784046|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
30774434|NCT04524598|58784042|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
30774435|NCT04524598|58784043|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
30774436|NCT04524598|58784044|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
30774437|NCT04524598|58784045|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
30774438|NCT04524598|58784046|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
30774439|NCT04524598|58784042|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
30774440|NCT04524598|58784043|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
30774441|NCT04524598|58784044|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
30850521|NCT02641730|58877502|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
30850522|NCT02641730|58877503|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
30850523|NCT02641730|58877504|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
30850524|NCT02641730|58877500|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
30850525|NCT02641730|58877501|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
30850526|NCT02641730|58877502|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
30850527|NCT02641730|58877503|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
30850528|NCT02641730|58877504|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
30850529|NCT02641730|58877500|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
30850530|NCT02641730|58877501|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
30850531|NCT02641730|58877502|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
30850532|NCT02641730|58877503|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
30850533|NCT02641730|58877504|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
30850534|NCT02641730|58877500|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
30850535|NCT02641730|58877501|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
30850536|NCT02641730|58877502|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
30850537|NCT02641730|58877503|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
30850538|NCT02641730|58877504|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
30850539|NCT02641730|58877500|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
30850540|NCT02641730|58877501|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
30850541|NCT02641730|58877502|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
30850542|NCT02641730|58877503|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
30850543|NCT02641730|58877504|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
30850544|NCT02641730|58877500|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
30850545|NCT02641730|58877501|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
30850546|NCT02641730|58877502|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
30850547|NCT02641730|58877503|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
30850548|NCT02641730|58877504|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
30850549|NCT02797171|58877524|FG000|Overall Study|Lost to Follow-up|2|||
30850550|NCT02797171|58877525|FG001|Overall Study|Lost to Follow-up|0|||
30850551|NCT02797171|58877526|FG002|Overall Study|Lost to Follow-up|2|||
30850552|NCT02797171|58877527|FG003|Overall Study|Lost to Follow-up|1|||
30850553|NCT02797171|58877528|FG004|Overall Study|Lost to Follow-up|2|||
30774442|NCT04524598|58784045|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
30774443|NCT04524598|58784046|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
30774444|NCT04524598|58784042|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
30774445|NCT04524598|58784043|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
30774446|NCT04524598|58784044|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
30774447|NCT04524598|58784045|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
30774448|NCT04524598|58784046|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
30774449|NCT04524598|58784042|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
30774450|NCT04524598|58784043|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
30774451|NCT04524598|58784044|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
30774452|NCT04524598|58784045|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
30774453|NCT04524598|58784046|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
30774454|NCT03075904|58784060|FG000|Overall Study|Physician Decision|3|||
30774455|NCT03075904|58784060|FG000|Overall Study|Need for Medication not Permitted|1|||
30774456|NCT03073798|58784064|FG000|Overall Study|Adverse Event|1|||
30774457|NCT03073798|58784064|FG000|Overall Study|Withdrawal by Subject|1|||
30774458|NCT03075826|58784069|FG000|Overall Study|Withdrawal by Subject|1|||
30774459|NCT03075826|58784069|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
30774460|NCT02865850|58784084|FG000|Overall Study|Death|15|||
30774461|NCT02865850|58784085|FG001|Overall Study|Death|19|||
30774462|NCT02865850|58784084|FG000|Overall Study|Withdrawal by Subject|3|||
30774463|NCT02865850|58784085|FG001|Overall Study|Withdrawal by Subject|2|||
30774464|NCT02865850|58784084|FG000|Overall Study|Lost to Follow-up|3|||
30774465|NCT02865850|58784085|FG001|Overall Study|Lost to Follow-up|2|||
30774466|NCT03711162|58784094|FG000|Overall Study|Adverse Event|5|||
30774467|NCT03711162|58784095|FG001|Overall Study|Adverse Event|2|||
30774468|NCT03711162|58784096|FG002|Overall Study|Adverse Event|4|||
30774469|NCT03711162|58784094|FG000|Overall Study|Death|11|||
30774470|NCT03711162|58784095|FG001|Overall Study|Death|7|||
30774471|NCT03711162|58784096|FG002|Overall Study|Death|8|||
30774472|NCT03711162|58784094|FG000|Overall Study|Lost to Follow-up|1|||
30774473|NCT03711162|58784095|FG001|Overall Study|Lost to Follow-up|0|||
30774474|NCT03711162|58784096|FG002|Overall Study|Lost to Follow-up|1|||
30774475|NCT03711162|58784094|FG000|Overall Study|Study Terminated by Sponsor|139|||
30774476|NCT03711162|58784095|FG001|Overall Study|Study Terminated by Sponsor|152|||
30774477|NCT03711162|58784096|FG002|Overall Study|Study Terminated by Sponsor|146|||
30850554|NCT02797171|58877529|FG005|Overall Study|Lost to Follow-up|0|||
30850555|NCT02797171|58877524|FG000|Overall Study|Withdrawal by Subject|1|||
30850556|NCT02797171|58877525|FG001|Overall Study|Withdrawal by Subject|1|||
30850557|NCT02797171|58877526|FG002|Overall Study|Withdrawal by Subject|0|||
30850558|NCT02797171|58877527|FG003|Overall Study|Withdrawal by Subject|0|||
30850559|NCT02797171|58877528|FG004|Overall Study|Withdrawal by Subject|0|||
30850560|NCT02797171|58877529|FG005|Overall Study|Withdrawal by Subject|0|||
30850561|NCT02797171|58877524|FG000|Overall Study|Protocol Violation|1|||
30850562|NCT02797171|58877525|FG001|Overall Study|Protocol Violation|0|||
30850563|NCT02797171|58877526|FG002|Overall Study|Protocol Violation|0|||
30774478|NCT03711162|58784094|FG000|Overall Study|Withdrawal by Subject|17|||
30774479|NCT03711162|58784095|FG001|Overall Study|Withdrawal by Subject|10|||
30774480|NCT03711162|58784096|FG002|Overall Study|Withdrawal by Subject|10|||
30774481|NCT03711162|58784094|FG000|Overall Study|Miscellaneous|1|||
30774482|NCT03711162|58784095|FG001|Overall Study|Miscellaneous|2|||
30774483|NCT03711162|58784096|FG002|Overall Study|Miscellaneous|2|||
30774484|NCT03711162|58784094|FG000|Overall Study|Not Treated|1|||
30774485|NCT03711162|58784095|FG001|Overall Study|Not Treated|0|||
30774486|NCT03711162|58784096|FG002|Overall Study|Not Treated|1|||
30774487|NCT03711162|58784094|FG000|Overall Study|Physician Decision|0|||
30774488|NCT03711162|58784095|FG001|Overall Study|Physician Decision|2|||
30774489|NCT03711162|58784096|FG002|Overall Study|Physician Decision|0|||
30774490|NCT03711162|58784094|FG000|Overall Study|Lack of Efficacy|0|||
30774491|NCT03711162|58784095|FG001|Overall Study|Lack of Efficacy|0|||
30774492|NCT03711162|58784096|FG002|Overall Study|Lack of Efficacy|2|||
30774493|NCT03711162|58784094|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
30774494|NCT03711162|58784095|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
30774495|NCT03711162|58784096|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
30774496|NCT03072160|58784112|FG000|Overall Study|Adverse Event|3|||
30774497|NCT03072160|58784113|FG001|Overall Study|Adverse Event|1|||
30774498|NCT03072160|58784112|FG000|Overall Study|Refused further treatment|6|||
30774499|NCT03072160|58784113|FG001|Overall Study|Refused further treatment|1|||
30774500|NCT03072160|58784112|FG000|Overall Study|Physician Decision|1|||
30774501|NCT03072160|58784113|FG001|Overall Study|Physician Decision|0|||
30774502|NCT03072160|58784112|FG000|Overall Study|Disease progression on study|1|||
30774503|NCT03072160|58784113|FG001|Overall Study|Disease progression on study|1|||
30774504|NCT03072160|58784112|FG000|Overall Study|No contact|0|||
30774505|NCT03072160|58784113|FG001|Overall Study|No contact|1|||
30774506|NCT00407602|58784151|FG000|Overall Study|Death - unrelated to device|1|||
30774507|NCT00407602|58784151|FG000|Overall Study|Device explanted|5|||
30774508|NCT00407602|58784151|FG000|Overall Study|Withdrawal by Subject|1|||
30774509|NCT03057496|58784158|FG000|Overall Study|Withdrawal by Subject|8|||
30774510|NCT03057496|58784158|FG000|Overall Study|Lost to Follow-up|5|||
30774511|NCT03057496|58784158|FG000|Overall Study|Did not use device during home trial|3|||
30774512|NCT03057496|58784158|FG000|Overall Study|Device failure|2|||
30774513|NCT03708744|58784168|FG000|Overall Study|Withdrawal by Subject|0|||
30774514|NCT03708744|58784169|FG001|Overall Study|Withdrawal by Subject|0|||
30774515|NCT03708744|58784170|FG002|Overall Study|Withdrawal by Subject|1|||
30774516|NCT03708744|58784171|FG003|Overall Study|Withdrawal by Subject|0|||
30774517|NCT02574286|58784185|FG000|Overall Study|Adverse Event|3|||
30774518|NCT02574286|58784185|FG000|Overall Study|Withdrawal by Subject|2|||
30662515|NCT00923975|58676041|FG000|Overall Study|Did not meet inclusion criteria|1|||
30662516|NCT00918203|58676077|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
30662517|NCT00918203|58676078|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
30662518|NCT00918203|58676079|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
30662519|NCT00918203|58676077|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
30662520|NCT00918203|58676078|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
30662521|NCT00918203|58676079|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
30662522|NCT00918203|58676077|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
30662523|NCT00918203|58676078|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
30662524|NCT00918203|58676079|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
30662525|NCT00918203|58676077|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
30662526|NCT00918203|58676078|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
30662527|NCT00918203|58676079|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
30662528|NCT00918281|58676091|FG000|Overall Study|Physician Decision|29|||
30662529|NCT02770716|58676100|FG000|Overall Study|Death|101|||
30774519|NCT02083354|58784193|FG000|Overall Study|Withdrawal by Subject|9|||
30774520|NCT02083354|58784193|FG000|Overall Study|Lost to Follow-up|1|||
30774521|NCT02083354|58784193|FG000|Overall Study|Adverse Event|3|||
30774522|NCT02083354|58784193|FG000|Overall Study|Disease progression|46|||
30774523|NCT02083354|58784193|FG000|Overall Study|Study closed/terminated|5|||
30774524|NCT04230486|58784197|FG000|Overall Study|Screen Failure|1|||
30774525|NCT01399918|58784203|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
30774526|NCT00112840|58784210|FG000|Overall Study|Physician Decision|1|||
30662530|NCT02770716|58676101|FG001|Overall Study|Death|45|||
30774527|NCT00112840|58784211|FG001|Overall Study|Physician Decision|0|||
30774528|NCT00112840|58784212|FG002|Overall Study|Physician Decision|0|||
30774529|NCT00112840|58784210|FG000|Overall Study|Withdrawal by Subject|1|||
30774530|NCT00112840|58784211|FG001|Overall Study|Withdrawal by Subject|0|||
30774531|NCT00112840|58784212|FG002|Overall Study|Withdrawal by Subject|1|||
30774532|NCT00112840|58784210|FG000|Overall Study|Protocol Violation|0|||
30774533|NCT00112840|58784211|FG001|Overall Study|Protocol Violation|0|||
30774534|NCT00112840|58784212|FG002|Overall Study|Protocol Violation|5|||
30774535|NCT02197572|58784225|FG000|Overall Study|Progressive Disease|28|||
30774536|NCT02197572|58784225|FG000|Overall Study|Withdrawal by Subject|9|||
30774537|NCT02197572|58784225|FG000|Overall Study|Adverse Event|3|||
30774538|NCT02197572|58784225|FG000|Overall Study|Reason Not Specified|4|||
30774539|NCT03176784|58784233|FG000|Overall Study|Lost to Follow-up|77|||
30774540|NCT03176784|58784234|FG001|Overall Study|Lost to Follow-up|79|||
30774541|NCT03176784|58784235|FG002|Overall Study|Lost to Follow-up|79|||
30774542|NCT03176784|58784236|FG003|Overall Study|Lost to Follow-up|49|||
30774543|NCT03176784|58784233|FG000|Overall Study|Withdrawal by Subject|28|||
30774544|NCT03176784|58784234|FG001|Overall Study|Withdrawal by Subject|34|||
30774545|NCT03176784|58784235|FG002|Overall Study|Withdrawal by Subject|34|||
30774546|NCT03176784|58784236|FG003|Overall Study|Withdrawal by Subject|21|||
30774547|NCT03049852|58784249|FG000|Overall Study|Lost to Follow-up|0|||
30774548|NCT03049852|58784250|FG001|Overall Study|Lost to Follow-up|1|||
30850564|NCT02797171|58877527|FG003|Overall Study|Protocol Violation|0|||
30850565|NCT02797171|58877528|FG004|Overall Study|Protocol Violation|0|||
30850566|NCT02797171|58877529|FG005|Overall Study|Protocol Violation|0|||
30850567|NCT02797171|58877524|FG000|Overall Study|Participant unable to adhere|0|||
30850568|NCT02797171|58877525|FG001|Overall Study|Participant unable to adhere|1|||
30850569|NCT02797171|58877526|FG002|Overall Study|Participant unable to adhere|0|||
30850570|NCT02797171|58877527|FG003|Overall Study|Participant unable to adhere|0|||
30850571|NCT02797171|58877528|FG004|Overall Study|Participant unable to adhere|0|||
30774549|NCT03049852|58784251|FG002|Overall Study|Lost to Follow-up|0|||
30774550|NCT05091528|58784263|FG000|Overall Study|Study Termination by Sponsor|0|||
30774551|NCT05091528|58784264|FG001|Overall Study|Study Termination by Sponsor|1|||
30774552|NCT05091528|58784265|FG002|Overall Study|Study Termination by Sponsor|0|||
30774553|NCT05091528|58784266|FG003|Overall Study|Study Termination by Sponsor|1|||
30774554|NCT01317160|58784276|FG000|Overall Study|Incorrect inclusion|1|||
30774555|NCT01317160|58784277|FG001|Overall Study|Incorrect inclusion|1|||
30774556|NCT01317160|58784276|FG000|Overall Study|Lost to Follow-up|3|||
30774557|NCT01317160|58784277|FG001|Overall Study|Lost to Follow-up|3|||
30774558|NCT01317160|58784276|FG000|Overall Study|Withdrawal by Subject|0|||
30774559|NCT01317160|58784277|FG001|Overall Study|Withdrawal by Subject|2|||
30774560|NCT01317004|58784298|FG000|Overall Study|Withdrawal by Subject|1|||
30774561|NCT01317004|58784299|FG001|Overall Study|Withdrawal by Subject|4|||
30774562|NCT01317004|58784298|FG000|Overall Study|Protocol Violation|0|||
30774563|NCT01317004|58784299|FG001|Overall Study|Protocol Violation|2|||
30774564|NCT01317004|58784298|FG000|Overall Study|Adverse Event|3|||
30774565|NCT01317004|58784299|FG001|Overall Study|Adverse Event|3|||
30774566|NCT01343056|58784309|FG000|Overall Study|Lost to Follow-up|7|||
30774567|NCT01343056|58784310|FG001|Overall Study|Lost to Follow-up|5|||
30774568|NCT01343056|58784311|FG002|Overall Study|Lost to Follow-up|3|||
30774569|NCT01343056|58784312|FG003|Overall Study|Lost to Follow-up|9|||
30774570|NCT01316692|58784326|FG000|Overall Study|Adverse Event|5|||
30774571|NCT01316692|58784326|FG000|Overall Study|Disease Progression|7|||
30774572|NCT01316380|58784333|FG000|Overall Study|Adverse Event|0|||
30774573|NCT01316380|58784334|FG001|Overall Study|Adverse Event|2|||
30774574|NCT01316380|58784335|FG002|Overall Study|Adverse Event|1|||
30774575|NCT01316380|58784333|FG000|Overall Study|Protocol Violation|0|||
30774576|NCT01316380|58784334|FG001|Overall Study|Protocol Violation|0|||
30774577|NCT01316380|58784335|FG002|Overall Study|Protocol Violation|1|||
30774578|NCT01316380|58784333|FG000|Overall Study|Withdrawal by Subject|1|||
30774579|NCT01316380|58784334|FG001|Overall Study|Withdrawal by Subject|2|||
30774580|NCT01316380|58784335|FG002|Overall Study|Withdrawal by Subject|0|||
30774581|NCT01316380|58784333|FG000|Overall Study|Other|0|||
30774582|NCT01316380|58784334|FG001|Overall Study|Other|1|||
30774583|NCT01316380|58784335|FG002|Overall Study|Other|1|||
30850572|NCT02797171|58877529|FG005|Overall Study|Participant unable to adhere|0|||
30850573|NCT02797171|58877524|FG000|Overall Study|Not Randomized|0|||
30850574|NCT02797171|58877525|FG001|Overall Study|Not Randomized|0|||
30850575|NCT02797171|58877526|FG002|Overall Study|Not Randomized|0|||
30850576|NCT02797171|58877527|FG003|Overall Study|Not Randomized|0|||
30850577|NCT02797171|58877528|FG004|Overall Study|Not Randomized|0|||
30850578|NCT02797171|58877529|FG005|Overall Study|Not Randomized|1|||
30850579|NCT02797951|58877543|FG000|Overall Study|Adverse Event|4|||
30850580|NCT02797951|58877543|FG000|Overall Study|Death|1|||
30850581|NCT02797951|58877543|FG000|Overall Study|Lack of Efficacy|19|||
30850582|NCT02797951|58877543|FG000|Overall Study|Lost to Follow-up|4|||
30850583|NCT02797951|58877543|FG000|Overall Study|Physician Decision|6|||
30774584|NCT01316380|58784333|FG000|Overall Study|Not treated|1|||
30850584|NCT02797951|58877543|FG000|Overall Study|Withdrawal by Subject|15|||
30774585|NCT01316380|58784334|FG001|Overall Study|Not treated|0|||
30774586|NCT01316380|58784335|FG002|Overall Study|Not treated|0|||
30850585|NCT00701805|58877551|FG000|Overall Study|Withdrawal by Subject|3|||
30774587|NCT01316224|58784343|FG000|Overall Study|Protocol Violation|3|||
30774588|NCT01316224|58784343|FG000|Overall Study|Adverse Event|3|||
30774589|NCT01316224|58784343|FG000|Overall Study|Lack of Efficacy|1|||
30850586|NCT00701805|58877552|FG001|Overall Study|Withdrawal by Subject|1|||
30850587|NCT00701805|58877553|FG002|Overall Study|Withdrawal by Subject|4|||
30774590|NCT01316224|58784343|FG000|Overall Study|Withdrawal by Subject|1|||
30774591|NCT01316224|58784343|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
30850588|NCT00701805|58877554|FG003|Overall Study|Withdrawal by Subject|3|||
30850589|NCT00701805|58877551|FG000|Overall Study|Adverse Event|0|||
30774592|NCT01316224|58784343|FG000|Overall Study|Other|1|||
30774593|NCT04315298|58784366|FG000|Overall Study|Withdrawal by Subject|0|||
30774594|NCT04315298|58784367|FG001|Overall Study|Withdrawal by Subject|0|||
30774595|NCT04315298|58784368|FG002|Overall Study|Withdrawal by Subject|0|||
30774596|NCT04315298|58784369|FG003|Overall Study|Withdrawal by Subject|2|||
30850590|NCT00701805|58877552|FG001|Overall Study|Adverse Event|1|||
30850591|NCT00701805|58877553|FG002|Overall Study|Adverse Event|1|||
30850592|NCT00701805|58877554|FG003|Overall Study|Adverse Event|0|||
30850593|NCT00701805|58877551|FG000|Overall Study|Missed 7 consecutive doses|0|||
30850594|NCT00701805|58877552|FG001|Overall Study|Missed 7 consecutive doses|1|||
30850595|NCT00701805|58877553|FG002|Overall Study|Missed 7 consecutive doses|0|||
30850596|NCT00701805|58877554|FG003|Overall Study|Missed 7 consecutive doses|0|||
30850597|NCT00701805|58877551|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
30850598|NCT00701805|58877552|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
30850599|NCT00701805|58877553|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
30850600|NCT00701805|58877554|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
30850601|NCT00701805|58877551|FG000|Overall Study|Physician decision, change of therapy|0|||
30850602|NCT00701805|58877552|FG001|Overall Study|Physician decision, change of therapy|0|||
30850603|NCT00701805|58877553|FG002|Overall Study|Physician decision, change of therapy|0|||
30850604|NCT00701805|58877554|FG003|Overall Study|Physician decision, change of therapy|1|||
30850605|NCT00701805|58877551|FG000|Overall Study|Difficult to travel to dialysis site|0|||
30850606|NCT00701805|58877552|FG001|Overall Study|Difficult to travel to dialysis site|0|||
30850607|NCT00701805|58877553|FG002|Overall Study|Difficult to travel to dialysis site|1|||
30850608|NCT00701805|58877554|FG003|Overall Study|Difficult to travel to dialysis site|0|||
30850609|NCT00701805|58877551|FG000|Overall Study|Resumption criteria were not met|0|||
30850610|NCT00701805|58877552|FG001|Overall Study|Resumption criteria were not met|1|||
30850611|NCT00701805|58877553|FG002|Overall Study|Resumption criteria were not met|0|||
30850612|NCT00701805|58877554|FG003|Overall Study|Resumption criteria were not met|0|||
30850613|NCT02715765|58877567|FG000|Overall Study|Study Termination|3|||
30850614|NCT02715765|58877568|FG001|Overall Study|Study Termination|0|||
30850615|NCT02715765|58877569|FG002|Overall Study|Study Termination|0|||
30850616|NCT04542291|58877577|FG000|Overall Study|Adverse Event|1|||
30850617|NCT04542291|58877577|FG000|Overall Study|Physician Decision|2|||
30850618|NCT02795767|58877584|FG000|Overall Study|Received Commercial Emicizumab|1|||
30850619|NCT02795767|58877585|FG001|Overall Study|Received Commercial Emicizumab|0|||
30850620|NCT02795767|58877586|FG002|Overall Study|Received Commercial Emicizumab|0|||
30850621|NCT02639559|58877600|FG000|Overall Study|Mobilization failure|0|||
30850622|NCT02639559|58877601|FG001|Overall Study|Mobilization failure|3|||
30850623|NCT02639559|58877600|FG000|Overall Study|Issues with vascular acess|1|||
30850624|NCT02639559|58877601|FG001|Overall Study|Issues with vascular acess|0|||
30850625|NCT02796391|58877622|FG000|Overall Study|Lost to Follow-up|2|||
30850626|NCT02796391|58877623|FG001|Overall Study|Lost to Follow-up|2|||
30850627|NCT02796391|58877624|FG002|Overall Study|Lost to Follow-up|13|||
30850628|NCT02796391|58877625|FG003|Overall Study|Lost to Follow-up|8|||
30850629|NCT02796391|58877626|FG004|Overall Study|Lost to Follow-up|14|||
30850630|NCT02796391|58877627|FG005|Overall Study|Lost to Follow-up|13|||
30850631|NCT02796391|58877622|FG000|Overall Study|COVID|0|||
30850632|NCT02796391|58877623|FG001|Overall Study|COVID|0|||
30850633|NCT02796391|58877624|FG002|Overall Study|COVID|5|||
30850634|NCT02796391|58877625|FG003|Overall Study|COVID|5|||
30774597|NCT04315298|58784370|FG004|Overall Study|Withdrawal by Subject|2|||
30774598|NCT04315298|58784371|FG005|Overall Study|Withdrawal by Subject|2|||
30774599|NCT04315298|58784372|FG006|Overall Study|Withdrawal by Subject|0|||
30774600|NCT04315298|58784373|FG007|Overall Study|Withdrawal by Subject|1|||
30774601|NCT04315298|58784374|FG008|Overall Study|Withdrawal by Subject|1|||
30774602|NCT04315298|58784375|FG009|Overall Study|Withdrawal by Subject|1|||
30774603|NCT04315298|58784376|FG010|Overall Study|Withdrawal by Subject|0|||
30774604|NCT04315298|58784377|FG011|Overall Study|Withdrawal by Subject|0|||
30774605|NCT04315298|58784378|FG012|Overall Study|Withdrawal by Subject|0|||
30774606|NCT04315298|58784379|FG013|Overall Study|Withdrawal by Subject|0|||
30774607|NCT04315298|58784380|FG014|Overall Study|Withdrawal by Subject|0|||
30774608|NCT04315298|58784381|FG015|Overall Study|Withdrawal by Subject|0|||
30774609|NCT04315298|58784382|FG016|Overall Study|Withdrawal by Subject|0|||
30774610|NCT04315298|58784383|FG017|Overall Study|Withdrawal by Subject|0|||
30774611|NCT04315298|58784384|FG018|Overall Study|Withdrawal by Subject|0|||
30774612|NCT04315298|58784366|FG000|Overall Study|Physician Decision|0|||
30774613|NCT04315298|58784367|FG001|Overall Study|Physician Decision|0|||
30774614|NCT04315298|58784368|FG002|Overall Study|Physician Decision|0|||
30850635|NCT02796391|58877626|FG004|Overall Study|COVID|2|||
30850636|NCT02796391|58877627|FG005|Overall Study|COVID|4|||
30850637|NCT02796391|58877622|FG000|Overall Study|Participant did not like study cigarettes|0|||
30850638|NCT02796391|58877623|FG001|Overall Study|Participant did not like study cigarettes|0|||
30850639|NCT02796391|58877624|FG002|Overall Study|Participant did not like study cigarettes|3|||
30774615|NCT04315298|58784369|FG003|Overall Study|Physician Decision|0|||
30774616|NCT04315298|58784370|FG004|Overall Study|Physician Decision|1|||
30774617|NCT04315298|58784371|FG005|Overall Study|Physician Decision|0|||
30774618|NCT04315298|58784372|FG006|Overall Study|Physician Decision|0|||
30774619|NCT04315298|58784373|FG007|Overall Study|Physician Decision|0|||
30774620|NCT04315298|58784374|FG008|Overall Study|Physician Decision|0|||
30774621|NCT04315298|58784375|FG009|Overall Study|Physician Decision|0|||
30774622|NCT04315298|58784376|FG010|Overall Study|Physician Decision|0|||
30774623|NCT04315298|58784377|FG011|Overall Study|Physician Decision|0|||
30774624|NCT04315298|58784378|FG012|Overall Study|Physician Decision|0|||
30774625|NCT04315298|58784379|FG013|Overall Study|Physician Decision|0|||
30774626|NCT04315298|58784380|FG014|Overall Study|Physician Decision|0|||
30774627|NCT04315298|58784381|FG015|Overall Study|Physician Decision|0|||
30774628|NCT04315298|58784382|FG016|Overall Study|Physician Decision|0|||
30774629|NCT04315298|58784383|FG017|Overall Study|Physician Decision|0|||
30774630|NCT04315298|58784384|FG018|Overall Study|Physician Decision|0|||
30774631|NCT04315298|58784366|FG000|Overall Study|Lost to Follow-up|5|||
30774632|NCT04315298|58784367|FG001|Overall Study|Lost to Follow-up|10|||
30774633|NCT04315298|58784368|FG002|Overall Study|Lost to Follow-up|6|||
30774634|NCT04315298|58784369|FG003|Overall Study|Lost to Follow-up|8|||
30774635|NCT04315298|58784370|FG004|Overall Study|Lost to Follow-up|12|||
30774636|NCT04315298|58784371|FG005|Overall Study|Lost to Follow-up|13|||
30774637|NCT04315298|58784372|FG006|Overall Study|Lost to Follow-up|9|||
30774638|NCT04315298|58784373|FG007|Overall Study|Lost to Follow-up|16|||
30774639|NCT04315298|58784374|FG008|Overall Study|Lost to Follow-up|14|||
30774640|NCT04315298|58784375|FG009|Overall Study|Lost to Follow-up|0|||
30774641|NCT04315298|58784376|FG010|Overall Study|Lost to Follow-up|2|||
30774642|NCT04315298|58784377|FG011|Overall Study|Lost to Follow-up|1|||
30774643|NCT04315298|58784378|FG012|Overall Study|Lost to Follow-up|0|||
30774644|NCT04315298|58784379|FG013|Overall Study|Lost to Follow-up|0|||
30774645|NCT04315298|58784380|FG014|Overall Study|Lost to Follow-up|0|||
30774646|NCT04315298|58784381|FG015|Overall Study|Lost to Follow-up|2|||
30774647|NCT04315298|58784382|FG016|Overall Study|Lost to Follow-up|0|||
30774648|NCT04315298|58784383|FG017|Overall Study|Lost to Follow-up|0|||
30774649|NCT04315298|58784384|FG018|Overall Study|Lost to Follow-up|0|||
30774650|NCT04315298|58784366|FG000|Overall Study|Death|24|||
30774651|NCT04315298|58784367|FG001|Overall Study|Death|60|||
30774652|NCT04315298|58784368|FG002|Overall Study|Death|49|||
30774653|NCT04315298|58784369|FG003|Overall Study|Death|59|||
30774654|NCT04315298|58784370|FG004|Overall Study|Death|70|||
30774655|NCT04315298|58784371|FG005|Overall Study|Death|114|||
30774656|NCT04315298|58784372|FG006|Overall Study|Death|9|||
30774657|NCT04315298|58784373|FG007|Overall Study|Death|12|||
30774658|NCT04315298|58784374|FG008|Overall Study|Death|21|||
30774659|NCT04315298|58784375|FG009|Overall Study|Death|16|||
30774660|NCT04315298|58784376|FG010|Overall Study|Death|40|||
30774661|NCT04315298|58784377|FG011|Overall Study|Death|40|||
30774662|NCT04315298|58784378|FG012|Overall Study|Death|3|||
30774663|NCT04315298|58784379|FG013|Overall Study|Death|4|||
30774664|NCT04315298|58784380|FG014|Overall Study|Death|6|||
30774665|NCT04315298|58784381|FG015|Overall Study|Death|4|||
30774666|NCT04315298|58784382|FG016|Overall Study|Death|3|||
30774667|NCT04315298|58784383|FG017|Overall Study|Death|1|||
30774668|NCT04315298|58784384|FG018|Overall Study|Death|0|||
30774669|NCT04308668|58784453|FG000|Overall Study|Lost to Follow-up|32|||
30774670|NCT04308668|58784454|FG001|Overall Study|Lost to Follow-up|38|||
30774671|NCT04308668|58784453|FG000|Overall Study|Withdrawal by Subject|4|||
30774672|NCT04308668|58784454|FG001|Overall Study|Withdrawal by Subject|4|||
30774673|NCT04451330|58784462|FG000|Overall Study|Adverse Event|1|||
30774674|NCT04451330|58784463|FG001|Overall Study|Adverse Event|2|||
30774675|NCT04451330|58784462|FG000|Overall Study|Lost to Follow-up|5|||
30774676|NCT04451330|58784463|FG001|Overall Study|Lost to Follow-up|0|||
30774677|NCT04451330|58784462|FG000|Overall Study|Withdrawal by Subject|3|||
30774678|NCT04451330|58784463|FG001|Overall Study|Withdrawal by Subject|1|||
30774679|NCT04451330|58784462|FG000|Overall Study|Withdrawal by parent/guardian|1|||
30774680|NCT04451330|58784463|FG001|Overall Study|Withdrawal by parent/guardian|0|||
30774681|NCT04451330|58784462|FG000|Overall Study|Other than specified|0|||
30774682|NCT04451330|58784463|FG001|Overall Study|Other than specified|1|||
30774683|NCT02493426|58784469|FG000|Overall Study|Withdrawal by Subject|0|||
30774684|NCT02493426|58784470|FG001|Overall Study|Withdrawal by Subject|1|||
30774685|NCT04448756|58784479|FG000|Overall Study|Adverse Event|0|||
30850640|NCT02796391|58877625|FG003|Overall Study|Participant did not like study cigarettes|0|||
30774686|NCT04448756|58784480|FG001|Overall Study|Adverse Event|1|||
30774687|NCT04448756|58784481|FG002|Overall Study|Adverse Event|0|||
30774688|NCT04448756|58784479|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
30774689|NCT04448756|58784480|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
30774690|NCT04448756|58784481|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
30774691|NCT04448756|58784479|FG000|Overall Study|Withdrawal by Subject|0|||
30774692|NCT04448756|58784480|FG001|Overall Study|Withdrawal by Subject|3|||
30774693|NCT04448756|58784481|FG002|Overall Study|Withdrawal by Subject|1|||
30774694|NCT04448756|58784479|FG000|Overall Study|Death|2|||
30774695|NCT04448756|58784480|FG001|Overall Study|Death|1|||
30774696|NCT04448756|58784481|FG002|Overall Study|Death|0|||
30774697|NCT04274192|58784491|FG000|Overall Study|Protocol Violation|1|||
30774698|NCT04274192|58784492|FG001|Overall Study|Protocol Violation|0|||
30774699|NCT04387136|58784502|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
30774700|NCT04387136|58784503|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
30774701|NCT04252586|58784509|FG000|Overall Study|Withdrawal by parent/guardian|3|||
30774702|NCT04252586|58784509|FG000|Overall Study|Adverse Event|1|||
30774703|NCT04252586|58784509|FG000|Overall Study|Death|2|||
30774704|NCT04252586|58784509|FG000|Overall Study|Study terminated by sponsor|4|||
30774705|NCT04252586|58784509|FG000|Overall Study|Sponsor request|10|||
30774706|NCT04252586|58784509|FG000|Overall Study|Did not complete treatment period|1|||
30774707|NCT04247828|58784514|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
30774708|NCT04507776|58784518|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
30774709|NCT04386902|58784527|FG000|Overall Study|Withdrawal by Subject|5|||
30850641|NCT02796391|58877626|FG004|Overall Study|Participant did not like study cigarettes|0|||
30850642|NCT02796391|58877627|FG005|Overall Study|Participant did not like study cigarettes|0|||
30850643|NCT02796391|58877622|FG000|Overall Study|Withdrawal by Subject|1|||
30850644|NCT02796391|58877623|FG001|Overall Study|Withdrawal by Subject|1|||
30850645|NCT02796391|58877624|FG002|Overall Study|Withdrawal by Subject|4|||
30850646|NCT02796391|58877625|FG003|Overall Study|Withdrawal by Subject|3|||
30774710|NCT04386902|58784527|FG000|Overall Study|Technical problems in the recording|5|||
30774711|NCT04232540|58784533|FG000|Overall Study|Lost to Follow-up|1|||
30774712|NCT04232540|58784534|FG001|Overall Study|Lost to Follow-up|0|||
30774713|NCT04504032|58784542|FG000|Overall Study|Adverse Event|1|||
30774714|NCT04504032|58784543|FG001|Overall Study|Adverse Event|2|||
30774715|NCT04504032|58784542|FG000|Overall Study|Lost to Follow-up|6|||
30774716|NCT04504032|58784543|FG001|Overall Study|Lost to Follow-up|9|||
30774717|NCT04504032|58784542|FG000|Overall Study|Protocol Violation|2|||
30774718|NCT04504032|58784543|FG001|Overall Study|Protocol Violation|0|||
30774719|NCT04504032|58784542|FG000|Overall Study|Study terminated by sponsor|1|||
30774720|NCT04504032|58784543|FG001|Overall Study|Study terminated by sponsor|2|||
30774721|NCT04504032|58784542|FG000|Overall Study|Withdrawal by Subject|9|||
30774722|NCT04504032|58784543|FG001|Overall Study|Withdrawal by Subject|11|||
30850647|NCT02796391|58877626|FG004|Overall Study|Withdrawal by Subject|4|||
30850648|NCT02796391|58877627|FG005|Overall Study|Withdrawal by Subject|3|||
30850649|NCT02796391|58877622|FG000|Overall Study|Adverse Event|0|||
30850650|NCT02796391|58877623|FG001|Overall Study|Adverse Event|0|||
30850651|NCT02796391|58877624|FG002|Overall Study|Adverse Event|0|||
30850652|NCT02796391|58877625|FG003|Overall Study|Adverse Event|1|||
30850653|NCT02796391|58877626|FG004|Overall Study|Adverse Event|0|||
30850654|NCT02796391|58877627|FG005|Overall Study|Adverse Event|0|||
30850655|NCT02796391|58877622|FG000|Overall Study|Protocol Violation|0|||
30850656|NCT02796391|58877623|FG001|Overall Study|Protocol Violation|0|||
30774723|NCT04504032|58784542|FG000|Overall Study|Disease progression prior to dosing|15|||
30774724|NCT04504032|58784543|FG001|Overall Study|Disease progression prior to dosing|3|||
30774725|NCT04504032|58784542|FG000|Overall Study|Drug supply issues|1|||
30774726|NCT04504032|58784543|FG001|Overall Study|Drug supply issues|1|||
30774727|NCT04504032|58784542|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
30774728|NCT04504032|58784543|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
30774729|NCT04439240|58784549|FG000|Overall Study|Ineligible|2|||
30774730|NCT04439240|58784549|FG000|Overall Study|Never started treatment|2|||
30774731|NCT04439240|58784549|FG000|Overall Study|Adverse Event|12|||
30774732|NCT04439240|58784549|FG000|Overall Study|Death|2|||
30774733|NCT04439240|58784549|FG000|Overall Study|Disease progression|25|||
30774734|NCT04439240|58784549|FG000|Overall Study|Other diseases|2|||
30774735|NCT04439240|58784549|FG000|Overall Study|Withdrawal by Subject|3|||
30774736|NCT04439240|58784549|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
30774737|NCT04439240|58784549|FG000|Overall Study|Symptomatic decline|1|||
30850657|NCT02796391|58877624|FG002|Overall Study|Protocol Violation|0|||
30850658|NCT02796391|58877625|FG003|Overall Study|Protocol Violation|1|||
30774738|NCT04439240|58784549|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
30774739|NCT04439240|58784549|FG000|Overall Study|Clinical progression|1|||
30774740|NCT04605588|58784555|FG000|Overall Study|Withdrawal by Subject|1|||
30774741|NCT04605588|58784556|FG001|Overall Study|Withdrawal by Subject|0|||
30774742|NCT04885296|58784562|FG000|Period 1|Covid-19 Related|1|||
30774743|NCT04885296|58784563|FG001|Period 1|Covid-19 Related|0|||
30774744|NCT04885296|58784562|FG000|Period 1|Adverse Event|0|||
30774745|NCT04885296|58784563|FG001|Period 1|Adverse Event|1|||
30850659|NCT02796391|58877626|FG004|Overall Study|Protocol Violation|0|||
30850660|NCT02796391|58877627|FG005|Overall Study|Protocol Violation|0|||
30850661|NCT01370317|58877643|FG000|Overall Study|Participant withdrew consent|1|||
30774746|NCT04885296|58784562|FG000|Period 1|Withdrawal by Subject|1|||
30774747|NCT04885296|58784563|FG001|Period 1|Withdrawal by Subject|1|||
30774748|NCT04885296|58784562|FG000|Period 1|Test Article No Longer Available|1|||
30774749|NCT04885296|58784563|FG001|Period 1|Test Article No Longer Available|0|||
30774750|NCT04885296|58784562|FG000|Period 1|Dispensed Study lens in Error|1|||
30774751|NCT04885296|58784563|FG001|Period 1|Dispensed Study lens in Error|0|||
30774752|NCT04885296|58784562|FG000|Period 1|Lost to Follow-up|1|||
30774753|NCT04885296|58784563|FG001|Period 1|Lost to Follow-up|0|||
30774754|NCT04885296|58784562|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
30774755|NCT04885296|58784563|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
30774756|NCT04602000|58784574|FG000|Overall Study|Withdrawal by Subject|3|||
30774757|NCT04602000|58784575|FG001|Overall Study|Withdrawal by Subject|6|||
30774758|NCT04602000|58784576|FG002|Overall Study|Withdrawal by Subject|3|||
30774759|NCT04602000|58784577|FG003|Overall Study|Withdrawal by Subject|27|||
30774760|NCT04602000|58784578|FG004|Overall Study|Withdrawal by Subject|39|||
30774761|NCT04602000|58784574|FG000|Overall Study|Physician Decision|1|||
30774762|NCT04602000|58784575|FG001|Overall Study|Physician Decision|0|||
30774763|NCT04602000|58784576|FG002|Overall Study|Physician Decision|0|||
30774764|NCT04602000|58784577|FG003|Overall Study|Physician Decision|2|||
30774765|NCT04602000|58784578|FG004|Overall Study|Physician Decision|2|||
30774766|NCT04602000|58784574|FG000|Overall Study|Death|0|||
30774767|NCT04602000|58784575|FG001|Overall Study|Death|1|||
30850662|NCT01370317|58877644|FG001|Overall Study|Participant withdrew consent|0|||
30850663|NCT01370317|58877643|FG000|Overall Study|Protocol deviation|0|||
30850664|NCT01370317|58877644|FG001|Overall Study|Protocol deviation|1|||
30850665|NCT01370083|58877652|FG000|Overall Study|Lost to Follow-up|2|||
30850666|NCT01370083|58877653|FG001|Overall Study|Lost to Follow-up|0|||
30850667|NCT01370083|58877652|FG000|Overall Study|Adverse Event|0|||
30850668|NCT01370083|58877653|FG001|Overall Study|Adverse Event|1|||
30850669|NCT03350815|58877659|FG000|Period 1|Adverse Event|10|||
30850670|NCT03350815|58877660|FG001|Period 1|Adverse Event|0|||
30850671|NCT03350815|58877661|FG002|Period 1|Adverse Event|0|||
30850672|NCT03350815|58877662|FG003|Period 1|Adverse Event|0|||
30850673|NCT03350815|58877659|FG000|Period 1|Technical problems|1|||
30850674|NCT03350815|58877660|FG001|Period 1|Technical problems|0|||
30850675|NCT03350815|58877661|FG002|Period 1|Technical problems|0|||
30850676|NCT03350815|58877662|FG003|Period 1|Technical problems|0|||
30850677|NCT03350815|58877659|FG000|Period 1|Lost to Follow-up|3|||
30850678|NCT03350815|58877660|FG001|Period 1|Lost to Follow-up|0|||
30850679|NCT03350815|58877661|FG002|Period 1|Lost to Follow-up|0|||
30850680|NCT03350815|58877662|FG003|Period 1|Lost to Follow-up|0|||
30850681|NCT03350815|58877659|FG000|Period 1|Physician Decision|1|||
30850682|NCT03350815|58877660|FG001|Period 1|Physician Decision|0|||
30850683|NCT03350815|58877661|FG002|Period 1|Physician Decision|0|||
30850684|NCT03350815|58877662|FG003|Period 1|Physician Decision|0|||
30850685|NCT03350815|58877659|FG000|Period 1|Withdrawal by Subject|8|||
30850686|NCT03350815|58877660|FG001|Period 1|Withdrawal by Subject|0|||
30850687|NCT03350815|58877661|FG002|Period 1|Withdrawal by Subject|0|||
30850688|NCT03350815|58877662|FG003|Period 1|Withdrawal by Subject|0|||
30850689|NCT03350815|58877659|FG000|Period 1|Lack of Efficacy|15|||
30850690|NCT03350815|58877660|FG001|Period 1|Lack of Efficacy|0|||
30850691|NCT03350815|58877661|FG002|Period 1|Lack of Efficacy|0|||
30850692|NCT03350815|58877662|FG003|Period 1|Lack of Efficacy|0|||
30850693|NCT03350815|58877659|FG000|Period 1|Non-compliance with study treatment|2|||
30850694|NCT03350815|58877660|FG001|Period 1|Non-compliance with study treatment|0|||
30850695|NCT03350815|58877661|FG002|Period 1|Non-compliance with study treatment|0|||
30850696|NCT03350815|58877662|FG003|Period 1|Non-compliance with study treatment|0|||
30850697|NCT03350815|58877659|FG000|Period 1|Protocol Violation|3|||
30850698|NCT03350815|58877660|FG001|Period 1|Protocol Violation|0|||
30850699|NCT03350815|58877661|FG002|Period 1|Protocol Violation|0|||
30850700|NCT03350815|58877662|FG003|Period 1|Protocol Violation|0|||
30850701|NCT03350815|58877659|FG000|Period 2|Adverse Event|0|||
30850702|NCT03350815|58877660|FG001|Period 2|Adverse Event|3|||
30774768|NCT04602000|58784576|FG002|Overall Study|Death|0|||
30850703|NCT03350815|58877661|FG002|Period 2|Adverse Event|5|||
30774769|NCT04602000|58784577|FG003|Overall Study|Death|1|||
30774770|NCT04602000|58784578|FG004|Overall Study|Death|2|||
30774771|NCT04602000|58784574|FG000|Overall Study|Lost to Follow-up|0|||
30850704|NCT03350815|58877662|FG003|Period 2|Adverse Event|0|||
30850705|NCT03350815|58877659|FG000|Period 2|Technical problem|0|||
30850706|NCT03350815|58877660|FG001|Period 2|Technical problem|1|||
30850707|NCT03350815|58877661|FG002|Period 2|Technical problem|0|||
30850708|NCT03350815|58877662|FG003|Period 2|Technical problem|0|||
30850709|NCT03350815|58877659|FG000|Period 2|Lost to Follow-up|0|||
30850710|NCT03350815|58877660|FG001|Period 2|Lost to Follow-up|3|||
30850711|NCT03350815|58877661|FG002|Period 2|Lost to Follow-up|3|||
30850712|NCT03350815|58877662|FG003|Period 2|Lost to Follow-up|0|||
30850713|NCT03350815|58877659|FG000|Period 2|Physician Decision|0|||
30850714|NCT03350815|58877660|FG001|Period 2|Physician Decision|0|||
30850715|NCT03350815|58877661|FG002|Period 2|Physician Decision|1|||
30850716|NCT03350815|58877662|FG003|Period 2|Physician Decision|0|||
30774772|NCT04602000|58784575|FG001|Overall Study|Lost to Follow-up|0|||
30774773|NCT04602000|58784576|FG002|Overall Study|Lost to Follow-up|0|||
30774774|NCT04602000|58784577|FG003|Overall Study|Lost to Follow-up|3|||
30774775|NCT04602000|58784578|FG004|Overall Study|Lost to Follow-up|4|||
30774776|NCT04602000|58784574|FG000|Overall Study|Other|4|||
30774777|NCT04602000|58784575|FG001|Overall Study|Other|1|||
30774778|NCT04602000|58784576|FG002|Overall Study|Other|2|||
30774779|NCT04602000|58784577|FG003|Overall Study|Other|5|||
30774780|NCT04602000|58784578|FG004|Overall Study|Other|4|||
30774781|NCT04602000|58784574|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
30774782|NCT04602000|58784575|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
30774783|NCT04602000|58784576|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
30774784|NCT04602000|58784577|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
30774785|NCT04602000|58784578|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
30774786|NCT03041116|58784594|FG000|Double-blind|Death|0|||
30774787|NCT03041116|58784595|FG001|Double-blind|Death|2|||
30774788|NCT03041116|58784594|FG000|Double-blind|Withdrawal by Subject|0|||
30774789|NCT03041116|58784595|FG001|Double-blind|Withdrawal by Subject|4|||
30774790|NCT03041116|58784594|FG000|Open-label|Death|1|||
30774791|NCT03041116|58784595|FG001|Open-label|Death|0|||
30774792|NCT03041116|58784594|FG000|Open-label|Termination of the study by Sponsor|39|||
30774793|NCT03041116|58784595|FG001|Open-label|Termination of the study by Sponsor|37|||
30774794|NCT03041116|58784594|FG000|Open-label|Withdrawal by Subject|1|||
30662531|NCT02770716|58676100|FG000|Overall Study|Withdrawal by Subject|4|||
30662532|NCT02770716|58676101|FG001|Overall Study|Withdrawal by Subject|2|||
30662533|NCT02770716|58676100|FG000|Overall Study|Lost to Follow-up|1|||
30662534|NCT02770716|58676101|FG001|Overall Study|Lost to Follow-up|0|||
30774795|NCT03041116|58784595|FG001|Open-label|Withdrawal by Subject|0|||
30774796|NCT04860258|58784612|FG000|Overall Study|Withdrawal by Subject|0|||
30774797|NCT04860258|58784613|FG001|Overall Study|Withdrawal by Subject|0|||
30774798|NCT04860258|58784614|FG002|Overall Study|Withdrawal by Subject|4|||
30774799|NCT04860258|58784615|FG003|Overall Study|Withdrawal by Subject|1|||
30774800|NCT04860258|58784616|FG004|Overall Study|Withdrawal by Subject|4|||
30774801|NCT04860258|58784617|FG005|Overall Study|Withdrawal by Subject|1|||
30774802|NCT04860258|58784618|FG006|Overall Study|Withdrawal by Subject|0|||
30774803|NCT03041038|58784636|FG000|Overall Study|Withdrawal by Subject|4|||
30774804|NCT03041038|58784637|FG001|Overall Study|Withdrawal by Subject|0|||
30774805|NCT03041038|58784636|FG000|Overall Study|Lost to Follow-up|1|||
30774806|NCT03041038|58784637|FG001|Overall Study|Lost to Follow-up|1|||
30774807|NCT03041038|58784636|FG000|Overall Study|Protocol Violation|1|||
30774808|NCT03041038|58784637|FG001|Overall Study|Protocol Violation|1|||
30774809|NCT04382066|58784648|FG000|Overall Study|Adverse Event|1|||
30774810|NCT04382066|58784649|FG001|Overall Study|Adverse Event|0|||
30774811|NCT04382066|58784650|FG002|Overall Study|Adverse Event|0|||
30774812|NCT04382066|58784648|FG000|Overall Study|Death|1|||
30774813|NCT04382066|58784649|FG001|Overall Study|Death|0|||
30774814|NCT04382066|58784650|FG002|Overall Study|Death|1|||
30774815|NCT04435184|58784666|FG000|Overall Study|follow-up blood draws missing|3|||
30774816|NCT04435184|58784667|FG001|Overall Study|follow-up blood draws missing|5|||
30774817|NCT04432376|58784676|FG000|Double-blind Treatment Period|Adverse Event|2|||
30774818|NCT04432376|58784677|FG001|Double-blind Treatment Period|Adverse Event|6|||
30774819|NCT04432376|58784678|FG002|Double-blind Treatment Period|Adverse Event|0|||
30774820|NCT04432376|58784676|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
30774821|NCT04432376|58784677|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
30774822|NCT04432376|58784678|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
30774823|NCT04432376|58784676|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
30774824|NCT04432376|58784677|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
30774825|NCT04432376|58784678|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
30774826|NCT04432376|58784676|FG000|Double-blind Treatment Period|Protocol Violation|0|||
30774827|NCT04432376|58784677|FG001|Double-blind Treatment Period|Protocol Violation|1|||
30774828|NCT04432376|58784678|FG002|Double-blind Treatment Period|Protocol Violation|0|||
30774829|NCT04432376|58784676|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
30774830|NCT04432376|58784677|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
30774831|NCT04432376|58784678|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
30774832|NCT03693404|58784687|FG000|Overall Study|Withdrawal by Subject|1|||
30774833|NCT03693404|58784688|FG001|Overall Study|Withdrawal by Subject|0|||
30774834|NCT03693404|58784687|FG000|Overall Study|Lost to Follow-up|0|||
30774835|NCT03693404|58784688|FG001|Overall Study|Lost to Follow-up|5|||
30774836|NCT03693404|58784687|FG000|Overall Study|Excluded from Analysis|0|||
30774837|NCT03693404|58784688|FG001|Overall Study|Excluded from Analysis|1|||
30662535|NCT02770716|58676100|FG000|Overall Study|Various reasons|6|||
30662536|NCT02770716|58676101|FG001|Overall Study|Various reasons|2|||
30662537|NCT00917579|58676107|FG000|Washout >= 2 Weeks|Adverse Event|1|||
30662538|NCT00917579|58676108|FG001|Washout >= 2 Weeks|Adverse Event|0|||
30774838|NCT03696108|58784696|FG000|Overall Study|Physician Decision|1|||
30774839|NCT03696108|58784697|FG001|Overall Study|Physician Decision|0|||
30774840|NCT03696108|58784696|FG000|Overall Study|Withdrawal by Subject|3|||
30774841|NCT03696108|58784697|FG001|Overall Study|Withdrawal by Subject|6|||
30774842|NCT04218110|58784707|FG000|Overall Study|Withdrawal by Subject|0|||
30662539|NCT00917579|58676107|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
30662540|NCT00917579|58676108|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
30662541|NCT00915551|58676116|FG000|Overall Study|Withdrawal by Subject|0|||
30662542|NCT00915551|58676117|FG001|Overall Study|Withdrawal by Subject|1|||
30662543|NCT00915473|58676125|FG000|Screening|Withdrawal by Subject|1|||
30662544|NCT00915473|58676126|FG001|Screening|Withdrawal by Subject|0|||
30662545|NCT00915473|58676125|FG000|4-week Follow Up|Lost to Follow-up|1|||
30662546|NCT00915473|58676126|FG001|4-week Follow Up|Lost to Follow-up|5|||
30774843|NCT04218110|58784708|FG001|Overall Study|Withdrawal by Subject|0|||
30774844|NCT04218110|58784709|FG002|Overall Study|Withdrawal by Subject|0|||
30774845|NCT04218110|58784710|FG003|Overall Study|Withdrawal by Subject|1|||
30774846|NCT04214600|58784722|FG000|Overall Study|Lost to Follow-up|9|||
30774847|NCT04214600|58784723|FG001|Overall Study|Lost to Follow-up|14|||
30774848|NCT04210310|58784732|FG000|Overall Study|Lost to Follow-up|32|||
30953085|NCT00634569|59003995|FG001|Overall Study|Withdrawal by Subject|4|||
30953086|NCT00634569|59003994|FG000|Overall Study|Physician Decision|0|||
30953087|NCT00634569|59003995|FG001|Overall Study|Physician Decision|1|||
30953088|NCT00634179|59004040|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
30953089|NCT03877926|59004115|FG000|Overall Study|Adverse Event|1|||
30953090|NCT03877926|59004116|FG001|Overall Study|Adverse Event|0|||
30953091|NCT03877926|59004117|FG002|Overall Study|Adverse Event|0|||
30953092|NCT03877926|59004118|FG003|Overall Study|Adverse Event|0|||
30953093|NCT03877926|59004115|FG000|Overall Study|Death|2|||
30774849|NCT04210310|58784733|FG001|Overall Study|Lost to Follow-up|1|||
30774850|NCT04209530|58784741|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
30774851|NCT04209530|58784742|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
30774852|NCT04209530|58784741|FG000|Overall Study|Withdrawal by Subject|0|||
30774853|NCT04209530|58784742|FG001|Overall Study|Withdrawal by Subject|1|||
30774854|NCT04349098|58784750|FG000|Overall Study|Death|16|||
30774855|NCT04349098|58784751|FG001|Overall Study|Death|8|||
30774856|NCT04349098|58784750|FG000|Overall Study|Lost to Follow-up|11|||
30774857|NCT04349098|58784751|FG001|Overall Study|Lost to Follow-up|8|||
30774858|NCT04349098|58784750|FG000|Overall Study|Withdrawal by Subject|8|||
30774859|NCT04349098|58784751|FG001|Overall Study|Withdrawal by Subject|5|||
30774860|NCT04349098|58784750|FG000|Overall Study|Other|3|||
30774861|NCT04349098|58784751|FG001|Overall Study|Other|5|||
30774862|NCT04208750|58784759|FG000|Overall Study|Lost to Follow-up|16|||
30850717|NCT03350815|58877659|FG000|Period 2|Withdrawal by Subject|0|||
30850718|NCT03350815|58877660|FG001|Period 2|Withdrawal by Subject|3|||
30850719|NCT03350815|58877661|FG002|Period 2|Withdrawal by Subject|4|||
30850720|NCT03350815|58877662|FG003|Period 2|Withdrawal by Subject|0|||
30850721|NCT03350815|58877659|FG000|Period 2|Lack of Efficacy|0|||
30850722|NCT03350815|58877660|FG001|Period 2|Lack of Efficacy|6|||
30850723|NCT03350815|58877661|FG002|Period 2|Lack of Efficacy|2|||
30850724|NCT03350815|58877662|FG003|Period 2|Lack of Efficacy|0|||
30850725|NCT03350815|58877659|FG000|Period 2|Protocol Violation|0|||
30662547|NCT00917501|58676134|FG000|Overall Study|Lost to Follow-up|4|||
30662548|NCT00917501|58676135|FG001|Overall Study|Lost to Follow-up|1|||
30662549|NCT00917501|58676134|FG000|Overall Study|Withdrawal by Subject|3|||
30662550|NCT00917501|58676135|FG001|Overall Study|Withdrawal by Subject|1|||
30774863|NCT04208750|58784760|FG001|Overall Study|Lost to Follow-up|15|||
30774864|NCT04381988|58784768|FG000|Overall Study|The study was terminated|4|||
30774865|NCT04381988|58784769|FG001|Overall Study|The study was terminated|0|||
30850726|NCT03350815|58877660|FG001|Period 2|Protocol Violation|0|||
30774866|NCT04333498|58784777|FG000|Overall Study|Lost to Follow-up|1|||
30774867|NCT04333498|58784778|FG001|Overall Study|Lost to Follow-up|0|||
30774868|NCT04333498|58784777|FG000|Overall Study|Lost to Follow-up|0|||
30850727|NCT03350815|58877661|FG002|Period 2|Protocol Violation|1|||
30953094|NCT03877926|59004116|FG001|Overall Study|Death|2|||
30953095|NCT03877926|59004117|FG002|Overall Study|Death|2|||
30774869|NCT04333498|58784778|FG001|Overall Study|Lost to Follow-up|1|||
30774870|NCT03355664|58784786|FG000|Overall Study|Adverse Event|1|||
30774871|NCT03355664|58784787|FG001|Overall Study|Adverse Event|2|||
30774872|NCT03355664|58784786|FG000|Overall Study|Lost to Follow-up|11|||
30774873|NCT03355664|58784787|FG001|Overall Study|Lost to Follow-up|7|||
30774874|NCT03355664|58784786|FG000|Overall Study|Protocol Violation|1|||
30774875|NCT03355664|58784787|FG001|Overall Study|Protocol Violation|2|||
30774876|NCT03355664|58784786|FG000|Overall Study|Withdrawal by Subject|2|||
30774877|NCT03355664|58784787|FG001|Overall Study|Withdrawal by Subject|1|||
30774878|NCT04170686|58784795|FG000|Screening|Physician Decision|12|||
30774879|NCT04170686|58784796|FG001|Screening|Physician Decision|13|||
30774880|NCT04170686|58784795|FG000|Randomization and Treatment|Lost to Follow-up|26|||
30774881|NCT04170686|58784796|FG001|Randomization and Treatment|Lost to Follow-up|15|||
30774882|NCT03695094|58784804|FG000|Overall Study|Adverse Event|1|||
30774883|NCT03695094|58784805|FG001|Overall Study|Adverse Event|1|||
30774884|NCT03695094|58784804|FG000|Overall Study|Withdrawal by Subject|1|||
30774885|NCT03695094|58784805|FG001|Overall Study|Withdrawal by Subject|0|||
30774886|NCT04497948|58784813|FG000|Overall Study|Death|2|||
30774887|NCT04495374|58784823|FG000|Overall Study|Protocol Violation|2|||
30774888|NCT04495374|58784824|FG001|Overall Study|Protocol Violation|1|||
30774889|NCT04794270|58784830|FG000|Period 1|Non Compliance|1|||
30850728|NCT03350815|58877662|FG003|Period 2|Protocol Violation|0|||
30850729|NCT03350815|58877659|FG000|Period 2|New therapy for study indication|0|||
30850730|NCT03350815|58877660|FG001|Period 2|New therapy for study indication|0|||
30850731|NCT03350815|58877661|FG002|Period 2|New therapy for study indication|1|||
30850732|NCT03350815|58877662|FG003|Period 2|New therapy for study indication|0|||
30850733|NCT00854295|58877677|FG000|Overall Study|Death|7|||
30850734|NCT00854295|58877678|FG001|Overall Study|Death|0|||
30850735|NCT00854295|58877679|FG002|Overall Study|Death|1|||
30850736|NCT00854295|58877680|FG003|Overall Study|Death|1|||
30850737|NCT00854295|58877677|FG000|Overall Study|Adverse Event|6|||
30850738|NCT00854295|58877678|FG001|Overall Study|Adverse Event|1|||
30850739|NCT00854295|58877679|FG002|Overall Study|Adverse Event|1|||
30850740|NCT00854295|58877680|FG003|Overall Study|Adverse Event|3|||
30850741|NCT00854295|58877677|FG000|Overall Study|Lost to Follow-up|18|||
30850742|NCT00854295|58877678|FG001|Overall Study|Lost to Follow-up|5|||
30850743|NCT00854295|58877679|FG002|Overall Study|Lost to Follow-up|21|||
30850744|NCT00854295|58877680|FG003|Overall Study|Lost to Follow-up|21|||
30850745|NCT00854295|58877677|FG000|Overall Study|Physician Decision|10|||
30850746|NCT00854295|58877678|FG001|Overall Study|Physician Decision|0|||
30850747|NCT00854295|58877679|FG002|Overall Study|Physician Decision|0|||
30850748|NCT00854295|58877680|FG003|Overall Study|Physician Decision|0|||
30850749|NCT02792959|58877691|FG000|Overall Study|Protocol Violation|1|||
30850750|NCT01652872|58877697|FG000|Overall Study|Death|36|||
30850751|NCT01652872|58877698|FG001|Overall Study|Death|39|||
30850752|NCT01652872|58877697|FG000|Overall Study|Lost to Follow-up|28|||
30850753|NCT01652872|58877698|FG001|Overall Study|Lost to Follow-up|23|||
30850754|NCT01652872|58877697|FG000|Overall Study|Decision by sponsor|5|||
30850755|NCT01652872|58877698|FG001|Overall Study|Decision by sponsor|7|||
30850756|NCT01652872|58877697|FG000|Overall Study|Withdrawal by Subject|76|||
30850757|NCT01652872|58877698|FG001|Overall Study|Withdrawal by Subject|84|||
30850758|NCT04251273|58877706|FG000|Overall Study|Lost to Follow-up|331|||
30850759|NCT04251273|58877707|FG001|Overall Study|Lost to Follow-up|290|||
30850760|NCT02443402|58877715|FG000|Overall Study|Withdrawal by Subject|3|||
30850761|NCT02443402|58877716|FG001|Overall Study|Withdrawal by Subject|1|||
30850762|NCT02443402|58877715|FG000|Overall Study|Screen Failure|1|||
30850763|NCT02443402|58877716|FG001|Overall Study|Screen Failure|2|||
30850764|NCT01370005|58877725|FG000|Overall Study|Not treated|1|||
30850765|NCT01370005|58877726|FG001|Overall Study|Not treated|0|||
30850766|NCT01370005|58877727|FG002|Overall Study|Not treated|0|||
30850767|NCT01370005|58877725|FG000|Overall Study|Adverse Event|5|||
30850768|NCT01370005|58877726|FG001|Overall Study|Adverse Event|5|||
30850769|NCT01370005|58877727|FG002|Overall Study|Adverse Event|6|||
30850770|NCT01370005|58877725|FG000|Overall Study|Lack of Efficacy|1|||
30850771|NCT01370005|58877726|FG001|Overall Study|Lack of Efficacy|0|||
30850772|NCT01370005|58877727|FG002|Overall Study|Lack of Efficacy|0|||
30953096|NCT03877926|59004118|FG003|Overall Study|Death|0|||
30774890|NCT04794270|58784831|FG001|Period 1|Non Compliance|0|||
30774891|NCT04794270|58784830|FG000|Period 1|Adverse Event|1|||
30850773|NCT01370005|58877725|FG000|Overall Study|Non compliant with protocol|0|||
30850774|NCT01370005|58877726|FG001|Overall Study|Non compliant with protocol|1|||
30774892|NCT04794270|58784831|FG001|Period 1|Adverse Event|0|||
30850775|NCT01370005|58877727|FG002|Overall Study|Non compliant with protocol|2|||
30850776|NCT01370005|58877725|FG000|Overall Study|Lost to Follow-up|1|||
30850777|NCT01370005|58877726|FG001|Overall Study|Lost to Follow-up|1|||
30850778|NCT01370005|58877727|FG002|Overall Study|Lost to Follow-up|1|||
30850779|NCT01370005|58877725|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
30850780|NCT01370005|58877726|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
30774893|NCT04794270|58784830|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
30774894|NCT04794270|58784831|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
30774895|NCT04567186|58784837|FG000|Period 1|COVID-19 related|1|||
30774896|NCT04567186|58784838|FG001|Period 1|COVID-19 related|0|||
30774897|NCT04567186|58784837|FG000|Period 1|Protocol Violation|0|||
30774898|NCT04567186|58784838|FG001|Period 1|Protocol Violation|1|||
30774899|NCT04567186|58784837|FG000|Period 1|Adverse Event|0|||
30774900|NCT04567186|58784838|FG001|Period 1|Adverse Event|2|||
30774901|NCT04567186|58784837|FG000|Period 2|COVID-19 Related|0|||
30774902|NCT04567186|58784838|FG001|Period 2|COVID-19 Related|1|||
30774903|NCT04567186|58784837|FG000|Period 2|Protocol Violation|0|||
30774904|NCT04567186|58784838|FG001|Period 2|Protocol Violation|1|||
30774905|NCT04567186|58784837|FG000|Period 2|Lost to Follow-up|0|||
30774906|NCT04567186|58784838|FG001|Period 2|Lost to Follow-up|1|||
30774907|NCT04567186|58784837|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
30774908|NCT04567186|58784838|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
30774909|NCT04168190|58784849|FG000|Overall Study|Lost to Follow-up|0|||
30774910|NCT04168190|58784850|FG001|Overall Study|Lost to Follow-up|1|||
30774911|NCT04168190|58784851|FG002|Overall Study|Lost to Follow-up|0|||
30774912|NCT04168190|58784852|FG003|Overall Study|Lost to Follow-up|7|||
30774913|NCT04168190|58784853|FG004|Overall Study|Lost to Follow-up|5|||
30774914|NCT04168190|58784849|FG000|Overall Study|Withdrawal by Subject|1|||
30774915|NCT04168190|58784850|FG001|Overall Study|Withdrawal by Subject|0|||
30774916|NCT04168190|58784851|FG002|Overall Study|Withdrawal by Subject|0|||
30774917|NCT04168190|58784852|FG003|Overall Study|Withdrawal by Subject|2|||
30774918|NCT04168190|58784853|FG004|Overall Study|Withdrawal by Subject|4|||
30774919|NCT04168190|58784849|FG000|Overall Study|Death|0|||
30774920|NCT04168190|58784850|FG001|Overall Study|Death|0|||
30774921|NCT04168190|58784851|FG002|Overall Study|Death|0|||
30774922|NCT04168190|58784852|FG003|Overall Study|Death|1|||
30774923|NCT04168190|58784853|FG004|Overall Study|Death|0|||
30774924|NCT04476108|58784867|FG000|Overall Study|Adverse Event|4|||
30774925|NCT04476108|58784868|FG001|Overall Study|Adverse Event|1|||
30774926|NCT04476108|58784867|FG000|Overall Study|Lost to Follow-up|1|||
30774927|NCT04476108|58784868|FG001|Overall Study|Lost to Follow-up|0|||
30774928|NCT04476108|58784867|FG000|Overall Study|Inadvertent Enrollment|1|||
30774929|NCT04476108|58784868|FG001|Overall Study|Inadvertent Enrollment|0|||
30774930|NCT04476108|58784867|FG000|Overall Study|Protocol Violation|1|||
30774931|NCT04476108|58784868|FG001|Overall Study|Protocol Violation|1|||
30774932|NCT04476108|58784867|FG000|Overall Study|Withdrawal by Subject|1|||
30774933|NCT04476108|58784868|FG001|Overall Study|Withdrawal by Subject|1|||
30774934|NCT03529942|58784874|FG000|Overall Study|Withdrawal by Subject|13|||
30774935|NCT03529942|58784874|FG000|Overall Study|Physician Decision|1|||
30774936|NCT03529942|58784874|FG000|Overall Study|Lost to Follow-up|7|||
30774937|NCT03529942|58784874|FG000|Overall Study|Needle inserted but no drug administered|1|||
30774938|NCT03529942|58784874|FG000|Overall Study|Personal reasons|1|||
30774939|NCT04732338|58784883|FG000|Overall Study|Lost to Follow-up|3|||
30774940|NCT04732338|58784884|FG001|Overall Study|Lost to Follow-up|3|||
30774941|NCT04194008|58784890|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
30774942|NCT04194008|58784890|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
30774943|NCT04194008|58784890|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
30774944|NCT04194008|58784890|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
30774945|NCT04194008|58784890|FG000|Treatment Phase With Nerivio|Missing data|4|||
30774946|NCT04194008|58784890|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
30774947|NCT04189952|58784903|FG000|Follow-up Period|Death|1|||
30774948|NCT04189952|58784903|FG000|Follow-up Period|Withdrawal by Subject|1|||
30774949|NCT04716426|58784909|FG000|Overall Study|Vaccination|1|||
30774950|NCT04716426|58784910|FG001|Overall Study|Vaccination|1|||
30774951|NCT04716426|58784909|FG000|Overall Study|Contamination|1|||
30774952|NCT04716426|58784910|FG001|Overall Study|Contamination|0|||
30774953|NCT03694548|58784918|FG000|Part A Survey|Protocol Violation|3|||
30774954|NCT03694548|58784919|FG001|Part A Survey|Protocol Violation|3|||
30774955|NCT03694548|58784920|FG002|Part A Survey|Protocol Violation|0|||
30774956|NCT03694548|58784918|FG000|Part B Yoga Program|Protocol Violation|0|||
30774957|NCT03694548|58784919|FG001|Part B Yoga Program|Protocol Violation|0|||
30774958|NCT03694548|58784920|FG002|Part B Yoga Program|Protocol Violation|3|||
30774959|NCT03694548|58784918|FG000|Part B Yoga Program|Did not attend intervention|0|||
30774960|NCT03694548|58784919|FG001|Part B Yoga Program|Did not attend intervention|0|||
30774961|NCT03694548|58784920|FG002|Part B Yoga Program|Did not attend intervention|8|||
30774962|NCT04166630|58784932|FG000|Overall Study|Withdrawal by Subject|0|||
30953097|NCT03877926|59004115|FG000|Overall Study|Lost to Follow-up|41|||
30774963|NCT04166630|58784933|FG001|Overall Study|Withdrawal by Subject|1|||
30774964|NCT04164758|58784942|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
30774965|NCT04164758|58784943|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
30774966|NCT04164758|58784944|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
30774967|NCT04164758|58784942|FG000|Overall Study|Adverse Event|0|||
30774968|NCT04164758|58784943|FG001|Overall Study|Adverse Event|1|||
30774969|NCT04164758|58784944|FG002|Overall Study|Adverse Event|0|||
30774970|NCT04178720|58784954|FG000|Overall Study|Withdrawal by Subject|2|||
30774971|NCT04178720|58784955|FG001|Overall Study|Withdrawal by Subject|0|||
30774972|NCT04178720|58784954|FG000|Overall Study|Relocation|0|||
30774973|NCT04178720|58784955|FG001|Overall Study|Relocation|1|||
30774974|NCT04177862|58784966|FG000|Overall Study|Protocol Violation|2|||
30774975|NCT04177862|58784967|FG001|Overall Study|Protocol Violation|7|||
30774976|NCT04173572|58784976|FG000|Overall Study|Withdrawal by Subject|1|||
30774977|NCT04173572|58784977|FG001|Overall Study|Withdrawal by Subject|5|||
30774978|NCT04173572|58784976|FG000|Overall Study|Lost to Follow-up|3|||
30774979|NCT04173572|58784977|FG001|Overall Study|Lost to Follow-up|1|||
30774980|NCT04157738|58784985|FG000|Overall Study|Moved out of state|0|||
30774981|NCT04157738|58784986|FG001|Overall Study|Moved out of state|2|||
30774982|NCT04157738|58784985|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
30774983|NCT04157738|58784986|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
30774984|NCT04156646|58784994|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
30774985|NCT04156646|58784995|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
30774986|NCT04676412|58785006|FG000|Overall Study|Death|17|||
30774987|NCT04676412|58785007|FG001|Overall Study|Death|23|||
30774988|NCT04676412|58785006|FG000|Overall Study|Withdrawal by Subject|0|||
30774989|NCT04676412|58785007|FG001|Overall Study|Withdrawal by Subject|2|||
30774990|NCT04676412|58785006|FG000|Overall Study|Participants ongoing|32|||
30774991|NCT04676412|58785007|FG001|Overall Study|Participants ongoing|33|||
30774992|NCT04150250|58785015|FG000|Overall Study|Lost to Follow-up|0|||
30774993|NCT04150250|58785016|FG001|Overall Study|Lost to Follow-up|2|||
30774994|NCT04537806|58785024|FG000|Overall Study|Randomized but not treated|1|||
30774995|NCT04537806|58785025|FG001|Overall Study|Randomized but not treated|0|||
30774996|NCT04537806|58785024|FG000|Overall Study|Adverse Event|1|||
30774997|NCT04537806|58785025|FG001|Overall Study|Adverse Event|1|||
30774998|NCT04015232|58785033|FG000|Overall Study|Withdrawal by Subject|7|||
30774999|NCT04015232|58785034|FG001|Overall Study|Withdrawal by Subject|4|||
30775000|NCT04015232|58785033|FG000|Overall Study|Protocol Violation|1|||
30775001|NCT04015232|58785034|FG001|Overall Study|Protocol Violation|0|||
30775002|NCT04015232|58785033|FG000|Overall Study|Medical Grounds|3|||
30775003|NCT04015232|58785034|FG001|Overall Study|Medical Grounds|3|||
30775004|NCT04533204|58785046|FG000|Overall Study|Unable to understand training instructions|1|||
30775005|NCT04533204|58785047|FG001|Overall Study|Unable to understand training instructions|1|||
30775006|NCT04465422|58785055|FG000|Overall Study|Lost to Follow-up|0|||
30775007|NCT04465422|58785056|FG001|Overall Study|Lost to Follow-up|2|||
30850781|NCT01370005|58877727|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
30850782|NCT01370005|58877725|FG000|Overall Study|Other reason not defined above|3|||
30850783|NCT01370005|58877726|FG001|Overall Study|Other reason not defined above|0|||
30850784|NCT01370005|58877727|FG002|Overall Study|Other reason not defined above|2|||
30850785|NCT02442778|58877738|FG000|Overall Study|Adverse Event|2|||
30850786|NCT02442778|58877739|FG001|Overall Study|Adverse Event|6|||
30850787|NCT02442778|58877740|FG002|Overall Study|Adverse Event|6|||
30850788|NCT02442778|58877738|FG000|Overall Study|Death|0|||
30850789|NCT02442778|58877739|FG001|Overall Study|Death|2|||
30850790|NCT02442778|58877740|FG002|Overall Study|Death|0|||
30850791|NCT02442778|58877738|FG000|Overall Study|Lack of Efficacy|1|||
30850792|NCT02442778|58877739|FG001|Overall Study|Lack of Efficacy|0|||
30850793|NCT02442778|58877740|FG002|Overall Study|Lack of Efficacy|0|||
30850794|NCT02442778|58877738|FG000|Overall Study|Lost to Follow-up|1|||
30850795|NCT02442778|58877739|FG001|Overall Study|Lost to Follow-up|1|||
30850796|NCT02442778|58877740|FG002|Overall Study|Lost to Follow-up|1|||
30850797|NCT02442778|58877738|FG000|Overall Study|Non-compliance with study drug|2|||
30850798|NCT02442778|58877739|FG001|Overall Study|Non-compliance with study drug|0|||
30850799|NCT02442778|58877740|FG002|Overall Study|Non-compliance with study drug|1|||
30850800|NCT02442778|58877738|FG000|Overall Study|Physician Decision|1|||
30850801|NCT02442778|58877739|FG001|Overall Study|Physician Decision|1|||
30850802|NCT02442778|58877740|FG002|Overall Study|Physician Decision|1|||
30850803|NCT02442778|58877738|FG000|Overall Study|Protocol Deviation|3|||
30775008|NCT04014062|58785066|FG000|Period I: Dosing|Medical Grounds|4|||
30775009|NCT04014062|58785067|FG001|Period I: Dosing|Medical Grounds|5|||
30775010|NCT04014062|58785066|FG000|Period I: Dosing|Withdrawal by Subject|3|||
30775011|NCT04014062|58785067|FG001|Period I: Dosing|Withdrawal by Subject|1|||
30775012|NCT04531098|58785081|FG000|Stage I|Adverse Event|0|||
30775013|NCT04531098|58785082|FG001|Stage I|Adverse Event|0|||
30775014|NCT04531098|58785083|FG002|Stage I|Adverse Event|3|||
30775015|NCT04531098|58785081|FG000|Stage I|Protocol Violation|0|||
30850804|NCT02442778|58877739|FG001|Overall Study|Protocol Deviation|0|||
30850805|NCT02442778|58877740|FG002|Overall Study|Protocol Deviation|1|||
30850806|NCT02442778|58877738|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
30775016|NCT04531098|58785082|FG001|Stage I|Protocol Violation|0|||
30775017|NCT04531098|58785083|FG002|Stage I|Protocol Violation|5|||
30775018|NCT04531098|58785081|FG000|Stage I|Withdrawal by Subject|0|||
30775019|NCT04531098|58785082|FG001|Stage I|Withdrawal by Subject|5|||
30775020|NCT04531098|58785083|FG002|Stage I|Withdrawal by Subject|10|||
30775021|NCT04531098|58785081|FG000|Stage II|Adverse Event|1|||
30850807|NCT02442778|58877739|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
30775022|NCT04531098|58785082|FG001|Stage II|Adverse Event|2|||
30775023|NCT04531098|58785083|FG002|Stage II|Adverse Event|0|||
30775024|NCT04531098|58785081|FG000|Stage II|Protocol Violation|1|||
30775025|NCT04531098|58785082|FG001|Stage II|Protocol Violation|2|||
30775026|NCT04531098|58785083|FG002|Stage II|Protocol Violation|0|||
30775027|NCT04531098|58785081|FG000|Stage II|Withdrawal by Subject|3|||
30775028|NCT04531098|58785082|FG001|Stage II|Withdrawal by Subject|1|||
30775029|NCT04531098|58785083|FG002|Stage II|Withdrawal by Subject|0|||
30775030|NCT04531098|58785081|FG000|Stage II|Moved from study area|8|||
30775031|NCT04531098|58785082|FG001|Stage II|Moved from study area|5|||
30775032|NCT04531098|58785083|FG002|Stage II|Moved from study area|0|||
30775033|NCT04144166|58785091|FG000|Overall Study|Discharged before study start|1|||
30775034|NCT04144166|58785091|FG000|Overall Study|Pregnancy|1|||
30775035|NCT04144166|58785091|FG000|Overall Study|Nail polish could not be removed from finger|1|||
30775036|NCT04142450|58785100|FG000|Overall Study|Screen Failure|1|||
30775037|NCT04142450|58785100|FG000|Overall Study|Lost to Follow-up|1|||
30775038|NCT04529850|58785104|FG000|Overall Study|Death|2|||
30775039|NCT04529850|58785104|FG000|Overall Study|Physician Decision|1|||
30775040|NCT04529850|58785104|FG000|Overall Study|Withdrawal by Subject|2|||
30775041|NCT04225676|58785108|FG000|Overall Study|Physician Decision|1|||
30775042|NCT04225676|58785108|FG000|Overall Study|Lack of Efficacy|1|||
30775043|NCT04225676|58785108|FG000|Overall Study|Study terminated by sponsor|3|||
30775044|NCT04142216|58785116|FG000|Overall Study|Hospitalization|0|||
30775045|NCT04142216|58785117|FG001|Overall Study|Hospitalization|2|||
30775046|NCT04142216|58785116|FG000|Overall Study|Death|3|||
30775047|NCT04142216|58785117|FG001|Overall Study|Death|1|||
30775048|NCT04142216|58785116|FG000|Overall Study|Referral to another hemodialysis unit|3|||
30775049|NCT04142216|58785117|FG001|Overall Study|Referral to another hemodialysis unit|2|||
30775050|NCT04142216|58785116|FG000|Overall Study|Use of clove|0|||
30775051|NCT04142216|58785117|FG001|Overall Study|Use of clove|1|||
30775052|NCT04140890|58785125|FG000|Overall Study|Withdrawal by Subject|0|||
30775053|NCT04140890|58785126|FG001|Overall Study|Withdrawal by Subject|1|||
30775054|NCT03700320|58785137|FG000|Overall Study|Adverse Event|5|||
30775055|NCT03700320|58785138|FG001|Overall Study|Adverse Event|31|||
30775056|NCT03700320|58785137|FG000|Overall Study|Lack of Efficacy|2|||
30775057|NCT03700320|58785138|FG001|Overall Study|Lack of Efficacy|5|||
30775058|NCT03700320|58785137|FG000|Overall Study|Withdrawal by Subject|29|||
30775059|NCT03700320|58785138|FG001|Overall Study|Withdrawal by Subject|75|||
30775060|NCT03700320|58785137|FG000|Overall Study|Lost to Follow-up|16|||
30775061|NCT03700320|58785138|FG001|Overall Study|Lost to Follow-up|23|||
30775062|NCT03700320|58785137|FG000|Overall Study|Pregnancy|2|||
30775063|NCT03700320|58785138|FG001|Overall Study|Pregnancy|4|||
30775064|NCT03700320|58785137|FG000|Overall Study|Protocol Deviation|7|||
30775065|NCT03700320|58785138|FG001|Overall Study|Protocol Deviation|31|||
30775066|NCT03700320|58785137|FG000|Overall Study|Non-compliance with Study Drug|1|||
30775067|NCT03700320|58785138|FG001|Overall Study|Non-compliance with Study Drug|3|||
30775068|NCT03700320|58785137|FG000|Overall Study|Reason not Specified|0|||
30775069|NCT03700320|58785138|FG001|Overall Study|Reason not Specified|1|||
30775070|NCT04139018|58785146|FG000|Overall Study|Screen fail|1|||
30775071|NCT04139018|58785147|FG001|Overall Study|Screen fail|0|||
30775072|NCT04139018|58785146|FG000|Overall Study|Withdrawal by Subject|2|||
30775073|NCT04139018|58785147|FG001|Overall Study|Withdrawal by Subject|0|||
30775074|NCT04139018|58785146|FG000|Overall Study|Lost to Follow-up|0|||
30775075|NCT04139018|58785147|FG001|Overall Study|Lost to Follow-up|1|||
30775076|NCT04456686|58785155|FG000|Overall Study|Adverse Event|2|||
30775077|NCT04456686|58785156|FG001|Overall Study|Adverse Event|1|||
30775078|NCT04456686|58785155|FG000|Overall Study|Lack of Efficacy|3|||
30775079|NCT04456686|58785156|FG001|Overall Study|Lack of Efficacy|1|||
30775080|NCT04456686|58785155|FG000|Overall Study|Withdrew consent|3|||
30775081|NCT04456686|58785156|FG001|Overall Study|Withdrew consent|1|||
30775082|NCT04456686|58785155|FG000|Overall Study|Physician Decision|2|||
30775083|NCT04456686|58785156|FG001|Overall Study|Physician Decision|2|||
30775084|NCT04456686|58785155|FG000|Overall Study|Withdrawal by Subject|5|||
30775085|NCT04456686|58785156|FG001|Overall Study|Withdrawal by Subject|1|||
30775086|NCT04456686|58785155|FG000|Overall Study|Protocol Violation|0|||
30775087|NCT04456686|58785156|FG001|Overall Study|Protocol Violation|1|||
30775088|NCT04527978|58785164|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
30775089|NCT04527978|58785165|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
30775090|NCT04136444|58785176|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
30775091|NCT04136444|58785177|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
30775092|NCT04425252|58785191|FG000|Overall Study|Withdrawal by Subject|2|||
30775093|NCT04425252|58785192|FG001|Overall Study|Withdrawal by Subject|1|||
30775094|NCT04425252|58785191|FG000|Overall Study|Lost to Follow-up|1|||
30775095|NCT04425252|58785192|FG001|Overall Study|Lost to Follow-up|0|||
30775096|NCT04425252|58785191|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
30775097|NCT04425252|58785192|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
30775098|NCT03696576|58785203|FG000|Overall Study|Soreness of throat after therapy|1|||
30775099|NCT03696576|58785204|FG001|Overall Study|Soreness of throat after therapy|1|||
30775100|NCT03696576|58785203|FG000|Overall Study|Lost to Follow-up|2|||
30775101|NCT03696576|58785204|FG001|Overall Study|Lost to Follow-up|4|||
30775102|NCT04003610|58785213|FG000|Overall Study|Lost to Follow-up|0|||
30775103|NCT04003610|58785214|FG001|Overall Study|Lost to Follow-up|1|||
30775104|NCT04003610|58785215|FG002|Overall Study|Lost to Follow-up|0|||
30775105|NCT04003610|58785213|FG000|Overall Study|Death|0|||
30775106|NCT04003610|58785214|FG001|Overall Study|Death|0|||
30775107|NCT04003610|58785215|FG002|Overall Study|Death|3|||
30662551|NCT00917501|58676134|FG000|Overall Study|Lack of Efficacy|1|||
30662552|NCT00917501|58676135|FG001|Overall Study|Lack of Efficacy|2|||
30662553|NCT00917501|58676134|FG000|Overall Study|trouble swollowing capsules|0|||
30662554|NCT00917501|58676135|FG001|Overall Study|trouble swollowing capsules|1|||
30662555|NCT00917267|58676154|FG000|Overall Study|Adverse Event|15|||
30662556|NCT00917267|58676155|FG001|Overall Study|Adverse Event|36|||
30662557|NCT00917267|58676154|FG000|Overall Study|Physician Decision|2|||
30662558|NCT00917267|58676155|FG001|Overall Study|Physician Decision|4|||
30662559|NCT00917267|58676154|FG000|Overall Study|Protocol Violation|9|||
30662560|NCT00917267|58676155|FG001|Overall Study|Protocol Violation|18|||
30662561|NCT00917267|58676154|FG000|Overall Study|Withdrawal by Subject|5|||
30775108|NCT04003610|58785213|FG000|Overall Study|Study Terminated by Sponsor|0|||
30775109|NCT04003610|58785214|FG001|Overall Study|Study Terminated by Sponsor|0|||
30775110|NCT04003610|58785215|FG002|Overall Study|Study Terminated by Sponsor|3|||
30775111|NCT03999554|58785229|FG000|Overall Study|Lost to Follow-up|4|||
30775112|NCT03999554|58785230|FG001|Overall Study|Lost to Follow-up|5|||
30775113|NCT03999554|58785231|FG002|Overall Study|Lost to Follow-up|4|||
30775114|NCT03999554|58785232|FG003|Overall Study|Lost to Follow-up|5|||
30775115|NCT03999554|58785233|FG004|Overall Study|Lost to Follow-up|8|||
30775116|NCT03999554|58785229|FG000|Overall Study|Protocol Violation|0|||
30775117|NCT03999554|58785230|FG001|Overall Study|Protocol Violation|0|||
30775118|NCT03999554|58785231|FG002|Overall Study|Protocol Violation|5|||
30775119|NCT03999554|58785232|FG003|Overall Study|Protocol Violation|0|||
30775120|NCT03999554|58785233|FG004|Overall Study|Protocol Violation|0|||
30775121|NCT03999554|58785229|FG000|Overall Study|Pregnancy|0|||
30775122|NCT03999554|58785230|FG001|Overall Study|Pregnancy|0|||
30850808|NCT02442778|58877740|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
30850809|NCT02442778|58877738|FG000|Overall Study|Withdrawal by Subject|4|||
30850810|NCT02442778|58877739|FG001|Overall Study|Withdrawal by Subject|4|||
30850811|NCT02442778|58877740|FG002|Overall Study|Withdrawal by Subject|3|||
30850812|NCT02442778|58877738|FG000|Overall Study|Reason not specified|1|||
30850813|NCT02442778|58877739|FG001|Overall Study|Reason not specified|4|||
30850814|NCT02442778|58877740|FG002|Overall Study|Reason not specified|0|||
30850815|NCT02412436|58877748|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
30850816|NCT02412436|58877748|FG000|Overall Study|Lost to Follow-up|6|||
30850817|NCT02412436|58877748|FG000|Overall Study|Unable to get to clinic|3|||
30850818|NCT02412436|58877748|FG000|Overall Study|Death|1|||
30850819|NCT02412436|58877748|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
30850820|NCT01651000|58877754|FG000|Overall Study|Adverse Event|2|||
30850821|NCT01651000|58877755|FG001|Overall Study|Adverse Event|8|||
30850822|NCT01651000|58877754|FG000|Overall Study|Lost to Follow-up|3|||
30850823|NCT01651000|58877755|FG001|Overall Study|Lost to Follow-up|2|||
30850824|NCT01651000|58877754|FG000|Overall Study|Protocol Violation|0|||
30850825|NCT01651000|58877755|FG001|Overall Study|Protocol Violation|3|||
30850826|NCT01651000|58877754|FG000|Overall Study|Withdrawal by Subject|2|||
30850827|NCT01651000|58877755|FG001|Overall Study|Withdrawal by Subject|10|||
30850828|NCT01651000|58877754|FG000|Overall Study|Subject noncompliance|0|||
30850829|NCT01651000|58877755|FG001|Overall Study|Subject noncompliance|3|||
30850830|NCT01651000|58877754|FG000|Overall Study|Lack of Efficacy|1|||
30850831|NCT01651000|58877755|FG001|Overall Study|Lack of Efficacy|1|||
30850832|NCT01651000|58877754|FG000|Overall Study|Physician Decision|1|||
30850833|NCT01651000|58877755|FG001|Overall Study|Physician Decision|0|||
30850834|NCT01651000|58877754|FG000|Overall Study|Administrative reason|1|||
30953098|NCT03877926|59004116|FG001|Overall Study|Lost to Follow-up|52|||
30953099|NCT03877926|59004117|FG002|Overall Study|Lost to Follow-up|45|||
30775123|NCT03999554|58785231|FG002|Overall Study|Pregnancy|1|||
30850835|NCT01651000|58877755|FG001|Overall Study|Administrative reason|0|||
30850836|NCT01651000|58877754|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
30850837|NCT01651000|58877755|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
30662562|NCT00917267|58676155|FG001|Overall Study|Withdrawal by Subject|12|||
30662563|NCT00917267|58676154|FG000|Overall Study|Lost to follow up|0|||
30775124|NCT03999554|58785232|FG003|Overall Study|Pregnancy|0|||
30775125|NCT03999554|58785233|FG004|Overall Study|Pregnancy|0|||
30775126|NCT03999554|58785229|FG000|Overall Study|Withdrawal by Subject|2|||
30775127|NCT03999554|58785230|FG001|Overall Study|Withdrawal by Subject|2|||
30775128|NCT03999554|58785231|FG002|Overall Study|Withdrawal by Subject|2|||
30775129|NCT03999554|58785232|FG003|Overall Study|Withdrawal by Subject|1|||
30775130|NCT03999554|58785233|FG004|Overall Study|Withdrawal by Subject|1|||
30662564|NCT00917267|58676155|FG001|Overall Study|Lost to follow up|2|||
30775131|NCT03999554|58785229|FG000|Overall Study|failure to comply with protocol requirements|0|||
30775132|NCT03999554|58785230|FG001|Overall Study|failure to comply with protocol requirements|0|||
30775133|NCT03999554|58785231|FG002|Overall Study|failure to comply with protocol requirements|0|||
30775134|NCT03999554|58785232|FG003|Overall Study|failure to comply with protocol requirements|1|||
30775135|NCT03999554|58785233|FG004|Overall Study|failure to comply with protocol requirements|0|||
30775136|NCT04129346|58785248|FG000|Overall Study|Death|1|||
30775137|NCT04129346|58785249|FG001|Overall Study|Death|0|||
30775138|NCT04526574|58785257|FG000|Overall Study|Protocol Violation|3|||
30775139|NCT04526574|58785258|FG001|Overall Study|Protocol Violation|1|||
30775140|NCT04526574|58785257|FG000|Overall Study|Withdrawal by Subject|12|||
30775141|NCT04526574|58785258|FG001|Overall Study|Withdrawal by Subject|9|||
30775142|NCT04526574|58785257|FG000|Overall Study|Other|1|||
30775143|NCT04526574|58785258|FG001|Overall Study|Other|2|||
30775144|NCT04526574|58785257|FG000|Overall Study|Adverse Event|1|||
30775145|NCT04526574|58785258|FG001|Overall Study|Adverse Event|1|||
30775146|NCT04526574|58785257|FG000|Overall Study|Death|2|||
30775147|NCT04526574|58785258|FG001|Overall Study|Death|3|||
30775148|NCT04526574|58785257|FG000|Overall Study|Lost to Follow-up|9|||
30775149|NCT04526574|58785258|FG001|Overall Study|Lost to Follow-up|9|||
30775150|NCT04526574|58785257|FG000|Overall Study|No longer meets eligibility criteria|8|||
30775151|NCT04526574|58785258|FG001|Overall Study|No longer meets eligibility criteria|8|||
30775152|NCT03993392|58785268|FG000|Overall Study|Withdrawal by Subject|3|||
30775153|NCT03993392|58785268|FG000|Overall Study|Lost to Follow-up|2|||
30775154|NCT03993392|58785268|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
30775155|NCT04422990|58785275|FG000|Overall Study|Withdrawal by Subject|0|||
30775156|NCT04422990|58785276|FG001|Overall Study|Withdrawal by Subject|1|||
30775157|NCT04422990|58785275|FG000|Overall Study|Travel|3|||
30775158|NCT04422990|58785276|FG001|Overall Study|Travel|0|||
30775159|NCT04377308|58785287|FG000|Overall Study|Withdrawal by Subject|0|||
30775160|NCT04377308|58785288|FG001|Overall Study|Withdrawal by Subject|1|||
30775161|NCT04447404|58785296|FG000|Overall Study|Death|2|||
30775162|NCT04447404|58785297|FG001|Overall Study|Death|0|||
30775163|NCT03988166|58785303|FG000|Overall Study|Lost to Follow-up|2|||
30775164|NCT03988166|58785303|FG000|Overall Study|Death|1|||
30775165|NCT03988088|58785312|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
30775166|NCT03988088|58785313|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
30775167|NCT03988088|58785314|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
30775168|NCT03988088|58785315|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
30775169|NCT03988088|58785312|FG000|Open-Label Addendum|Lost to Follow-up|0|||
30775170|NCT03988088|58785313|FG001|Open-Label Addendum|Lost to Follow-up|0|||
30775171|NCT03988088|58785314|FG002|Open-Label Addendum|Lost to Follow-up|1|||
30775172|NCT03988088|58785315|FG003|Open-Label Addendum|Lost to Follow-up|0|||
30775173|NCT03987932|58785326|FG000|Overall Study|Lost to Follow-up|2|||
30775174|NCT03987932|58785327|FG001|Overall Study|Lost to Follow-up|1|||
30775175|NCT03987932|58785328|FG002|Overall Study|Lost to Follow-up|1|||
30775176|NCT03987932|58785326|FG000|Overall Study|Non-study related elective surgery|0|||
30775177|NCT03987932|58785327|FG001|Overall Study|Non-study related elective surgery|0|||
30775178|NCT03987932|58785328|FG002|Overall Study|Non-study related elective surgery|1|||
30775179|NCT03987620|58785338|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
30775180|NCT03987620|58785339|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
30775181|NCT03987620|58785338|FG000|Overall Study|Adverse Event|3|||
30775182|NCT03987620|58785339|FG001|Overall Study|Adverse Event|0|||
30775183|NCT03987620|58785338|FG000|Overall Study|Lost to Follow-up|1|||
30775184|NCT03987620|58785339|FG001|Overall Study|Lost to Follow-up|2|||
30775185|NCT03987620|58785338|FG000|Overall Study|Physician Decision|0|||
30775186|NCT03987620|58785339|FG001|Overall Study|Physician Decision|1|||
30775187|NCT03987620|58785338|FG000|Overall Study|Pregnancy|1|||
30775188|NCT03987620|58785339|FG001|Overall Study|Pregnancy|0|||
30775189|NCT03987620|58785338|FG000|Overall Study|Withdrawal by Subject|7|||
30775190|NCT03987620|58785339|FG001|Overall Study|Withdrawal by Subject|1|||
30775191|NCT03987620|58785338|FG000|Overall Study|Other|2|||
30775192|NCT03987620|58785339|FG001|Overall Study|Other|5|||
30775193|NCT04376060|58785345|FG000|Overall Study|Physician Decision|1|||
30775194|NCT04413552|58785359|FG000|Overall Study|Adverse Event|0|||
30775195|NCT04413552|58785360|FG001|Overall Study|Adverse Event|0|||
30775196|NCT04413552|58785361|FG002|Overall Study|Adverse Event|0|||
30775197|NCT04413552|58785362|FG003|Overall Study|Adverse Event|0|||
30775198|NCT04413552|58785363|FG004|Overall Study|Adverse Event|0|||
30775199|NCT04413552|58785364|FG005|Overall Study|Adverse Event|0|||
30775200|NCT04413552|58785365|FG006|Overall Study|Adverse Event|1|||
30775201|NCT04413552|58785366|FG007|Overall Study|Adverse Event|0|||
30775202|NCT04413552|58785367|FG008|Overall Study|Adverse Event|0|||
30775203|NCT04413552|58785368|FG009|Overall Study|Adverse Event|0|||
30775204|NCT03987074|58785399|FG000|Overall Study|Withdrew Consent|1|||
30775205|NCT03987074|58785400|FG001|Overall Study|Withdrew Consent|1|||
30775206|NCT03987074|58785401|FG002|Overall Study|Withdrew Consent|0|||
30775207|NCT03987074|58785402|FG003|Overall Study|Withdrew Consent|2|||
30775208|NCT03987074|58785403|FG004|Overall Study|Withdrew Consent|1|||
30775209|NCT03987074|58785399|FG000|Overall Study|Adverse Event|2|||
30775210|NCT03987074|58785400|FG001|Overall Study|Adverse Event|1|||
30775211|NCT03987074|58785401|FG002|Overall Study|Adverse Event|0|||
30775212|NCT03987074|58785402|FG003|Overall Study|Adverse Event|0|||
30775213|NCT03987074|58785403|FG004|Overall Study|Adverse Event|1|||
30775214|NCT03987074|58785399|FG000|Overall Study|Lost to Follow-up|0|||
30775215|NCT03987074|58785400|FG001|Overall Study|Lost to Follow-up|0|||
30775216|NCT03987074|58785401|FG002|Overall Study|Lost to Follow-up|1|||
30775217|NCT03987074|58785402|FG003|Overall Study|Lost to Follow-up|1|||
30775218|NCT03987074|58785403|FG004|Overall Study|Lost to Follow-up|0|||
30775219|NCT03987074|58785399|FG000|Overall Study|Investigator's Discretion|0|||
30775220|NCT03987074|58785400|FG001|Overall Study|Investigator's Discretion|0|||
30775221|NCT03987074|58785401|FG002|Overall Study|Investigator's Discretion|0|||
30775222|NCT03987074|58785402|FG003|Overall Study|Investigator's Discretion|1|||
30775223|NCT03987074|58785403|FG004|Overall Study|Investigator's Discretion|0|||
30775224|NCT04439214|58785415|FG000|Overall Study|Adverse Event|13|||
30775225|NCT04439214|58785415|FG000|Overall Study|Disease progression|16|||
30775226|NCT04439214|58785415|FG000|Overall Study|Death|1|||
30775227|NCT04439214|58785415|FG000|Overall Study|Withdrawal by Subject|2|||
30775228|NCT04439214|58785415|FG000|Overall Study|Declining health|1|||
30775229|NCT04439214|58785415|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
30775230|NCT04439214|58785415|FG000|Overall Study|Ineligible|5|||
30775231|NCT03696342|58785421|FG000|Overall Study|Lost to Follow-up|1|||
30775232|NCT03696342|58785422|FG001|Overall Study|Lost to Follow-up|0|||
30775233|NCT04411680|58785430|FG000|Treatment Period|Adverse Event|3|||
30775234|NCT04411680|58785431|FG001|Treatment Period|Adverse Event|0|||
30775235|NCT04411680|58785430|FG000|Treatment Period|Discharged from hospital|18|||
30775236|NCT04411680|58785431|FG001|Treatment Period|Discharged from hospital|7|||
30775237|NCT04411680|58785430|FG000|Treatment Period|Missed 1 or more doses|8|||
30775238|NCT04411680|58785431|FG001|Treatment Period|Missed 1 or more doses|0|||
30775239|NCT04411680|58785430|FG000|Treatment Period|Transferred to another hospital|0|||
30775240|NCT04411680|58785431|FG001|Treatment Period|Transferred to another hospital|1|||
30775241|NCT04411680|58785430|FG000|Follow up Period|Withdrawal by Subject|2|||
30775242|NCT04411680|58785431|FG001|Follow up Period|Withdrawal by Subject|0|||
30775243|NCT04411680|58785430|FG000|Follow up Period|Lost to Follow-up|5|||
30775244|NCT04411680|58785431|FG001|Follow up Period|Lost to Follow-up|6|||
30775245|NCT04411680|58785430|FG000|Follow up Period|Death|11|||
30775246|NCT04411680|58785431|FG001|Follow up Period|Death|8|||
30775247|NCT04410198|58785437|FG000|Overall Study|Death|10|||
30775248|NCT04410198|58785437|FG000|Overall Study|Withdrawal by Subject|7|||
30775249|NCT04410198|58785437|FG000|Overall Study|Transferred/Relocation|4|||
30775250|NCT04410198|58785437|FG000|Overall Study|Kidney Transplant|9|||
30775251|NCT04410198|58785437|FG000|Overall Study|Adverse Event|4|||
30775252|NCT04410198|58785437|FG000|Overall Study|Physician Decision|2|||
30775253|NCT04410198|58785437|FG000|Overall Study|Other than specified|1|||
30775254|NCT04161144|58785443|FG000|Overall Study|Withdrawal by Subject|0|||
30775255|NCT04161144|58785444|FG001|Overall Study|Withdrawal by Subject|1|||
30775256|NCT04161144|58785443|FG000|Overall Study|Protocol Violation|1|||
30775257|NCT04161144|58785444|FG001|Overall Study|Protocol Violation|0|||
30775258|NCT03984812|58785461|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
30775259|NCT03984812|58785462|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
30775260|NCT03984812|58785463|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
30775261|NCT03984812|58785464|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
30775262|NCT03984812|58785465|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
30775263|NCT03984812|58785466|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
30775264|NCT03984812|58785467|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
30775265|NCT03984812|58785468|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
30775266|NCT03984812|58785469|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
30775267|NCT03984812|58785470|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
30775268|NCT03984812|58785471|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
30775269|NCT04160988|58785498|FG000|Overall Study|poor image quality|28|||
30775270|NCT04153188|58785519|FG000|Overall Study|Lost to Follow-up|1|||
30775271|NCT04153188|58785520|FG001|Overall Study|Lost to Follow-up|1|||
30850838|NCT02469610|58877763|FG000|Overall Study|Death|1|||
30850839|NCT02469610|58877764|FG001|Overall Study|Death|0|||
30775272|NCT04153188|58785519|FG000|Overall Study|Withdrawal by Subject|2|||
30775273|NCT04153188|58785520|FG001|Overall Study|Withdrawal by Subject|0|||
30775274|NCT04153188|58785519|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
30775275|NCT04153188|58785520|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
30775276|NCT04113746|58785528|FG000|Overall Study|Lost to Follow-up|4|||
30775277|NCT04113746|58785529|FG001|Overall Study|Lost to Follow-up|4|||
30775278|NCT03611010|58785539|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
30775279|NCT03611010|58785540|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
30775280|NCT03611010|58785541|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
30775281|NCT03611010|58785542|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
30775282|NCT04357782|58785557|FG000|Overall Study|Discharged from hospital|1|||
30775283|NCT04357782|58785558|FG001|Overall Study|Discharged from hospital|0|||
30775284|NCT04357782|58785557|FG000|Overall Study|Death|0|||
30775285|NCT04357782|58785558|FG001|Overall Study|Death|2|||
30775286|NCT03980522|58785569|FG000|Treatment Period|Adverse Event|1|||
30775287|NCT03980522|58785570|FG001|Treatment Period|Adverse Event|0|||
30775288|NCT03980522|58785571|FG002|Treatment Period|Adverse Event|0|||
30775289|NCT03980522|58785572|FG003|Treatment Period|Adverse Event|0|||
30775290|NCT03980522|58785573|FG004|Treatment Period|Adverse Event|0|||
30775291|NCT04402866|58785591|FG000|Overall Study|Discontinued Prior to Treatment|0|||
30775292|NCT04402866|58785592|FG001|Overall Study|Discontinued Prior to Treatment|0|||
30775293|NCT04402866|58785593|FG002|Overall Study|Discontinued Prior to Treatment|0|||
30775294|NCT04402866|58785594|FG003|Overall Study|Discontinued Prior to Treatment|0|||
30775295|NCT04402866|58785595|FG004|Overall Study|Discontinued Prior to Treatment|2|||
30775296|NCT04402866|58785596|FG005|Overall Study|Discontinued Prior to Treatment|3|||
30775297|NCT04402866|58785591|FG000|Overall Study|Adverse Event|2|||
30775298|NCT04402866|58785592|FG001|Overall Study|Adverse Event|1|||
30775299|NCT04402866|58785593|FG002|Overall Study|Adverse Event|0|||
30775300|NCT04402866|58785594|FG003|Overall Study|Adverse Event|0|||
30775301|NCT04402866|58785595|FG004|Overall Study|Adverse Event|13|||
30775302|NCT04402866|58785596|FG005|Overall Study|Adverse Event|8|||
30775303|NCT04402866|58785591|FG000|Overall Study|Miscellaneous|0|||
30775304|NCT04402866|58785592|FG001|Overall Study|Miscellaneous|0|||
30775305|NCT04402866|58785593|FG002|Overall Study|Miscellaneous|1|||
30775306|NCT04402866|58785594|FG003|Overall Study|Miscellaneous|0|||
30775307|NCT04402866|58785595|FG004|Overall Study|Miscellaneous|0|||
30775308|NCT04402866|58785596|FG005|Overall Study|Miscellaneous|0|||
30775309|NCT04402866|58785591|FG000|Overall Study|Lost to Follow-up|0|||
30775310|NCT04402866|58785592|FG001|Overall Study|Lost to Follow-up|0|||
30775311|NCT04402866|58785593|FG002|Overall Study|Lost to Follow-up|0|||
30775312|NCT04402866|58785594|FG003|Overall Study|Lost to Follow-up|0|||
30775313|NCT04402866|58785595|FG004|Overall Study|Lost to Follow-up|0|||
30775314|NCT04402866|58785596|FG005|Overall Study|Lost to Follow-up|1|||
30775315|NCT04402866|58785591|FG000|Overall Study|Withdrawal by Subject|0|||
30775316|NCT04402866|58785592|FG001|Overall Study|Withdrawal by Subject|0|||
30775317|NCT04402866|58785593|FG002|Overall Study|Withdrawal by Subject|0|||
30775318|NCT04402866|58785594|FG003|Overall Study|Withdrawal by Subject|0|||
30775319|NCT04402866|58785595|FG004|Overall Study|Withdrawal by Subject|0|||
30775320|NCT04402866|58785596|FG005|Overall Study|Withdrawal by Subject|2|||
30775321|NCT04400682|58785608|FG000|Period 1|Withdrawal by Subject|1|||
30775322|NCT04400682|58785609|FG001|Period 1|Withdrawal by Subject|4|||
30775323|NCT03066778|58785617|FG000|Overall Study|Death|195|||
30775324|NCT03066778|58785618|FG001|Overall Study|Death|205|||
30775325|NCT03066778|58785617|FG000|Overall Study|Withdrawal by Subject|5|||
30775326|NCT03066778|58785618|FG001|Overall Study|Withdrawal by Subject|7|||
30775327|NCT04348656|58785627|FG000|Overall Study|Withdrawal by Subject|2|||
30775328|NCT04348656|58785628|FG001|Overall Study|Withdrawal by Subject|0|||
30775329|NCT04348656|58785627|FG000|Overall Study|Lost to Follow-up|11|||
30775330|NCT04348656|58785628|FG001|Overall Study|Lost to Follow-up|6|||
30850840|NCT02469610|58877763|FG000|Overall Study|Lost to Follow-up|1|||
30850841|NCT02469610|58877764|FG001|Overall Study|Lost to Follow-up|0|||
30850842|NCT02469610|58877763|FG000|Overall Study|exclusion criteria|2|||
30775331|NCT04348500|58785643|FG000|Overall Study|Death|2|||
30775332|NCT04348500|58785644|FG001|Overall Study|Death|2|||
30775333|NCT04348500|58785643|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
30775334|NCT04348500|58785644|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
30775335|NCT04347954|58785653|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
30775336|NCT04347954|58785654|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
30850843|NCT02469610|58877764|FG001|Overall Study|exclusion criteria|1|||
30850844|NCT02469298|58877774|FG000|Overall Study|Protocol Violation|0|||
30850845|NCT02469298|58877775|FG001|Overall Study|Protocol Violation|1|||
30850846|NCT02469298|58877776|FG002|Overall Study|Protocol Violation|1|||
30850847|NCT02469298|58877777|FG003|Overall Study|Protocol Violation|0|||
30850848|NCT02469298|58877774|FG000|Overall Study|Lost to Follow-up|1|||
30850849|NCT02469298|58877775|FG001|Overall Study|Lost to Follow-up|0|||
30850850|NCT02469298|58877776|FG002|Overall Study|Lost to Follow-up|1|||
30850851|NCT02469298|58877777|FG003|Overall Study|Lost to Follow-up|0|||
30850852|NCT02469298|58877774|FG000|Overall Study|Physician Decision|0|||
30850853|NCT02469298|58877775|FG001|Overall Study|Physician Decision|0|||
30775337|NCT04347954|58785655|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
30775338|NCT04347954|58785653|FG000|Overall Study|Lost to Follow-up|0|||
30775339|NCT04347954|58785654|FG001|Overall Study|Lost to Follow-up|1|||
30775340|NCT04347954|58785655|FG002|Overall Study|Lost to Follow-up|0|||
30775341|NCT03065530|58785667|FG000|Overall Study|Lack of Efficacy|1|||
30775342|NCT03065530|58785668|FG001|Overall Study|Lack of Efficacy|1|||
30850854|NCT02469298|58877776|FG002|Overall Study|Physician Decision|0|||
30850855|NCT02469298|58877777|FG003|Overall Study|Physician Decision|1|||
30775343|NCT03065530|58785669|FG002|Overall Study|Lack of Efficacy|0|||
30775344|NCT03065530|58785670|FG003|Overall Study|Lack of Efficacy|1|||
30775345|NCT03065530|58785667|FG000|Overall Study|Protocol Violation|1|||
30775346|NCT03065530|58785668|FG001|Overall Study|Protocol Violation|0|||
30775347|NCT03065530|58785669|FG002|Overall Study|Protocol Violation|1|||
30775348|NCT03065530|58785670|FG003|Overall Study|Protocol Violation|1|||
30775349|NCT03979820|58785692|FG000|Overall Study|Protocol Violation|1|||
30775350|NCT03979820|58785693|FG001|Overall Study|Protocol Violation|0|||
30850856|NCT02469298|58877774|FG000|Overall Study|Withdrawal by Subject|0|||
30850857|NCT02469298|58877775|FG001|Overall Study|Withdrawal by Subject|0|||
30850858|NCT02469298|58877776|FG002|Overall Study|Withdrawal by Subject|0|||
30850859|NCT02469298|58877777|FG003|Overall Study|Withdrawal by Subject|1|||
30850860|NCT04163991|58877799|FG000|Overall Study|Adverse Event|0|||
30850861|NCT04163991|58877800|FG001|Overall Study|Adverse Event|0|||
30850862|NCT04163991|58877801|FG002|Overall Study|Adverse Event|0|||
30850863|NCT04163991|58877802|FG003|Overall Study|Adverse Event|1|||
30850864|NCT04163991|58877803|FG004|Overall Study|Adverse Event|0|||
30850865|NCT04163991|58877799|FG000|Overall Study|Death|0|||
30850866|NCT04163991|58877800|FG001|Overall Study|Death|0|||
30850867|NCT04163991|58877801|FG002|Overall Study|Death|1|||
30850868|NCT04163991|58877802|FG003|Overall Study|Death|0|||
30850869|NCT04163991|58877803|FG004|Overall Study|Death|0|||
30850870|NCT04163991|58877799|FG000|Overall Study|Lost to Follow-up|0|||
30850871|NCT04163991|58877800|FG001|Overall Study|Lost to Follow-up|1|||
30850872|NCT04163991|58877801|FG002|Overall Study|Lost to Follow-up|0|||
30850873|NCT04163991|58877802|FG003|Overall Study|Lost to Follow-up|0|||
30953100|NCT03877926|59004118|FG003|Overall Study|Lost to Follow-up|17|||
30953101|NCT03877926|59004115|FG000|Overall Study|Physician Decision|2|||
30953102|NCT03877926|59004116|FG001|Overall Study|Physician Decision|0|||
30953103|NCT03877926|59004117|FG002|Overall Study|Physician Decision|2|||
30953104|NCT03877926|59004118|FG003|Overall Study|Physician Decision|0|||
30953105|NCT03877926|59004115|FG000|Overall Study|Withdrawal by Subject|18|||
30953106|NCT03877926|59004116|FG001|Overall Study|Withdrawal by Subject|21|||
30953107|NCT03877926|59004117|FG002|Overall Study|Withdrawal by Subject|12|||
30953108|NCT03877926|59004118|FG003|Overall Study|Withdrawal by Subject|4|||
30953109|NCT03877926|59004115|FG000|Overall Study|Other - Various|4|||
30953110|NCT03877926|59004116|FG001|Overall Study|Other - Various|1|||
30953111|NCT03877926|59004117|FG002|Overall Study|Other - Various|1|||
30953112|NCT03877926|59004118|FG003|Overall Study|Other - Various|0|||
30953113|NCT03877926|59004115|FG000|Overall Study|Not Treated|3|||
30953114|NCT03877926|59004116|FG001|Overall Study|Not Treated|1|||
30953115|NCT03877926|59004117|FG002|Overall Study|Not Treated|1|||
30953116|NCT03877926|59004118|FG003|Overall Study|Not Treated|0|||
30953117|NCT02874144|59004341|FG000|Overall Study|Lost to Follow-up|3|||
30953118|NCT02874144|59004342|FG001|Overall Study|Lost to Follow-up|5|||
30953119|NCT02611830|59004372|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
30953120|NCT02611830|59004373|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
30953121|NCT02611830|59004374|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
30953122|NCT02611830|59004375|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
30953123|NCT02611830|59004372|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
30953124|NCT02611830|59004373|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
30953125|NCT02611830|59004374|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
30953126|NCT02611830|59004375|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
30953127|NCT02611830|59004372|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
30953128|NCT02611830|59004373|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
30953129|NCT02611830|59004374|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
30953130|NCT02611830|59004375|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
30953131|NCT02611830|59004372|FG000|OL Induction Phase|Lack of Efficacy|9|||
30953132|NCT02611830|59004373|FG001|OL Induction Phase|Lack of Efficacy|0|||
30953133|NCT02611830|59004374|FG002|OL Induction Phase|Lack of Efficacy|0|||
30953134|NCT02611830|59004375|FG003|OL Induction Phase|Lack of Efficacy|0|||
30953135|NCT02611830|59004372|FG000|OL Induction Phase|Reason not specified|3|||
30953136|NCT02611830|59004373|FG001|OL Induction Phase|Reason not specified|0|||
30953137|NCT02611830|59004374|FG002|OL Induction Phase|Reason not specified|0|||
30953138|NCT02611830|59004375|FG003|OL Induction Phase|Reason not specified|0|||
30775351|NCT03979820|58785694|FG002|Overall Study|Protocol Violation|0|||
30850874|NCT04163991|58877803|FG004|Overall Study|Lost to Follow-up|0|||
30775352|NCT03979820|58785695|FG003|Overall Study|Protocol Violation|0|||
30775353|NCT03979820|58785692|FG000|Overall Study|Withdrawal by Subject|0|||
30850875|NCT04163991|58877799|FG000|Overall Study|Withdrawal by Subject|1|||
30953139|NCT02611830|59004372|FG000|Maintenance Phase|Lack of Efficacy|0|||
30953140|NCT02611830|59004373|FG001|Maintenance Phase|Lack of Efficacy|29|||
30953141|NCT02611830|59004374|FG002|Maintenance Phase|Lack of Efficacy|18|||
30953142|NCT02611830|59004375|FG003|Maintenance Phase|Lack of Efficacy|6|||
30775354|NCT03979820|58785693|FG001|Overall Study|Withdrawal by Subject|0|||
30775355|NCT03979820|58785694|FG002|Overall Study|Withdrawal by Subject|1|||
30850876|NCT04163991|58877800|FG001|Overall Study|Withdrawal by Subject|1|||
30850877|NCT04163991|58877801|FG002|Overall Study|Withdrawal by Subject|3|||
30775356|NCT03979820|58785695|FG003|Overall Study|Withdrawal by Subject|0|||
30775357|NCT03979820|58785692|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
30775358|NCT03979820|58785693|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
30775359|NCT03979820|58785694|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
30775360|NCT03979820|58785695|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
30775361|NCT03647488|58785712|FG000|Overall Study|Progressive disease|10|||
30775362|NCT03647488|58785713|FG001|Overall Study|Progressive disease|0|||
30775363|NCT03647488|58785714|FG002|Overall Study|Progressive disease|0|||
30775364|NCT03647488|58785712|FG000|Overall Study|Adverse Event|5|||
30775365|NCT03647488|58785713|FG001|Overall Study|Adverse Event|0|||
30775366|NCT03647488|58785714|FG002|Overall Study|Adverse Event|0|||
30775367|NCT03647488|58785712|FG000|Overall Study|Clinical progression|2|||
30775368|NCT03647488|58785713|FG001|Overall Study|Clinical progression|0|||
30775369|NCT03647488|58785714|FG002|Overall Study|Clinical progression|0|||
30775370|NCT03647488|58785712|FG000|Overall Study|Participant refused to take investigational product|1|||
30775371|NCT03647488|58785713|FG001|Overall Study|Participant refused to take investigational product|0|||
30775372|NCT03647488|58785714|FG002|Overall Study|Participant refused to take investigational product|0|||
30775373|NCT03693950|58785722|FG000|Overall Study|Withdrawal by Subject|1|||
30775374|NCT03693950|58785723|FG001|Overall Study|Withdrawal by Subject|0|||
30775375|NCT04110314|58785735|FG000|Overall Study|Did not meet inclusion criteria|35255|||
30775376|NCT04110314|58785736|FG001|Overall Study|Did not meet inclusion criteria|35104|||
30775377|NCT04110314|58785737|FG002|Overall Study|Did not meet inclusion criteria|35636|||
30775378|NCT04110314|58785738|FG003|Overall Study|Did not meet inclusion criteria|35135|||
30775379|NCT04110314|58785739|FG004|Overall Study|Did not meet inclusion criteria|35247|||
30775380|NCT04110314|58785740|FG005|Overall Study|Did not meet inclusion criteria|35727|||
30775381|NCT04109222|58785755|FG000|Overall Study|Adverse Event|1|||
30775382|NCT04109222|58785756|FG001|Overall Study|Adverse Event|0|||
30775383|NCT04109222|58785757|FG002|Overall Study|Adverse Event|0|||
30775384|NCT04098458|58785765|FG000|Overall Study|Death|1|||
30775385|NCT04098458|58785765|FG000|Overall Study|did not meet study inclusion criteria|3|||
30775386|NCT03447262|58785770|FG000|Overall Study|Adverse Event|7|||
30775387|NCT03447262|58785770|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
30775388|NCT03447262|58785770|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
30775389|NCT03447262|58785770|FG000|Overall Study|Death|2|||
30775390|NCT03447262|58785770|FG000|Overall Study|Study Termination by Sponsor|455|||
30775391|NCT03447262|58785770|FG000|Overall Study|Other|4|||
30775392|NCT04094870|58785779|FG000|Overall Study|Lost to Follow-up|1|||
30775393|NCT04094870|58785780|FG001|Overall Study|Lost to Follow-up|1|||
30775394|NCT04399356|58785795|FG000|Overall Study|Lost to Follow-up|1|||
30775395|NCT04399356|58785796|FG001|Overall Study|Lost to Follow-up|1|||
30775396|NCT04399356|58785795|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
30775397|NCT04399356|58785796|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
30775398|NCT04399356|58785795|FG000|Overall Study|Withdrawal by Subject|1|||
30775399|NCT04399356|58785796|FG001|Overall Study|Withdrawal by Subject|0|||
30775400|NCT03692676|58785806|FG000|Overall Study|exclude patients with prior use|4424|||
30775401|NCT03692676|58785807|FG001|Overall Study|exclude patients with prior use|24726|||
30775402|NCT03692676|58785808|FG002|Overall Study|exclude patients with prior use|0|||
30775403|NCT03692676|58785809|FG003|Overall Study|exclude patients with prior use|0|||
30775404|NCT03692676|58785806|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
30775405|NCT03692676|58785807|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
30775406|NCT03692676|58785808|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
30775407|NCT03692676|58785809|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
30775408|NCT03692676|58785806|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
30775409|NCT03692676|58785807|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
30775410|NCT03692676|58785808|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
30775411|NCT03692676|58785809|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
30775412|NCT03692676|58785806|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
30775413|NCT03692676|58785807|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
30775414|NCT03692676|58785808|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
30775415|NCT03692676|58785809|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
30775416|NCT03692676|58785806|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
30775417|NCT03692676|58785807|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
30775418|NCT03692676|58785808|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
30775419|NCT03692676|58785809|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
30850878|NCT04163991|58877802|FG003|Overall Study|Withdrawal by Subject|1|||
30953143|NCT02611830|59004372|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
30775420|NCT03692676|58785806|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
30775421|NCT03692676|58785807|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
30775422|NCT03692676|58785808|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
30775423|NCT03692676|58785809|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
30775424|NCT03692676|58785806|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
30775425|NCT03692676|58785807|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
30775426|NCT03692676|58785808|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
30775427|NCT03692676|58785809|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
30953144|NCT02611830|59004373|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
30953145|NCT02611830|59004374|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
30953146|NCT02611830|59004375|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
30953147|NCT02611830|59004372|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
30953148|NCT02611830|59004373|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
30953149|NCT02611830|59004374|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
30953150|NCT02611830|59004375|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
30953151|NCT02611830|59004372|FG000|Maintenance Phase|Lost to Follow-up|0|||
30953152|NCT02611830|59004373|FG001|Maintenance Phase|Lost to Follow-up|0|||
30953153|NCT02611830|59004374|FG002|Maintenance Phase|Lost to Follow-up|0|||
30953154|NCT02611830|59004375|FG003|Maintenance Phase|Lost to Follow-up|1|||
30953155|NCT02611830|59004372|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
30953156|NCT02611830|59004373|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
30953157|NCT02611830|59004374|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
30953158|NCT02611830|59004375|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
30953159|NCT02611830|59004372|FG000|Maintenance Phase|Pregnancy|0|||
30953160|NCT02611830|59004373|FG001|Maintenance Phase|Pregnancy|0|||
30953161|NCT02611830|59004374|FG002|Maintenance Phase|Pregnancy|1|||
30953162|NCT02611830|59004375|FG003|Maintenance Phase|Pregnancy|0|||
30953163|NCT02611830|59004372|FG000|Maintenance Phase|Reason not specified|0|||
30953164|NCT02611830|59004373|FG001|Maintenance Phase|Reason not specified|1|||
30953165|NCT02611830|59004374|FG002|Maintenance Phase|Reason not specified|4|||
30953166|NCT02611830|59004375|FG003|Maintenance Phase|Reason not specified|0|||
30953167|NCT01328574|59004561|FG000|Overall Study|Refused further treatment|1|||
30953168|NCT01328496|59004683|FG000|Overall Study|Significant Change in Health Status|1|||
30953169|NCT01328496|59004684|FG001|Overall Study|Significant Change in Health Status|0|||
30953170|NCT02734212|59004804|FG000|Overall Study|Lost to Follow-up|5|||
30953171|NCT02734212|59004805|FG001|Overall Study|Lost to Follow-up|10|||
30953172|NCT03786432|59004851|FG000|Overall Study|Screen Failure after consent|1|||
30953173|NCT03786432|59004851|FG000|Overall Study|Lost to Follow-up|4|||
30953174|NCT03786432|59004851|FG000|Overall Study|did not complete 12 month CT scan|1|||
30953175|NCT04604184|59004887|FG000|Overall Study|Adverse Event|5|||
30953176|NCT04604184|59004888|FG001|Overall Study|Adverse Event|5|||
30953177|NCT04604184|59004887|FG000|Overall Study|Death|2|||
30953178|NCT04604184|59004888|FG001|Overall Study|Death|1|||
30953179|NCT04604184|59004887|FG000|Overall Study|Withdrawal by Subject|1|||
30953180|NCT04604184|59004888|FG001|Overall Study|Withdrawal by Subject|3|||
30953181|NCT04604184|59004887|FG000|Overall Study|Not treated|2|||
30953182|NCT04604184|59004888|FG001|Overall Study|Not treated|2|||
30953183|NCT04604184|59004887|FG000|Overall Study|Due to sponsor decision|9|||
30953184|NCT04604184|59004888|FG001|Overall Study|Due to sponsor decision|7|||
30953185|NCT04604184|59004887|FG000|Overall Study|Physician Decision|0|||
30953186|NCT04604184|59004888|FG001|Overall Study|Physician Decision|1|||
30953187|NCT04604184|59004887|FG000|Overall Study|Transfer to healthcare|1|||
30953188|NCT04604184|59004888|FG001|Overall Study|Transfer to healthcare|0|||
30953189|NCT01859741|59005059|FG000|Overall Study|Death|3|||
30953190|NCT01859741|59005060|FG001|Overall Study|Death|2|||
30953191|NCT01859741|59005061|FG002|Overall Study|Death|4|||
30953192|NCT01859741|59005062|FG003|Overall Study|Death|3|||
30953193|NCT01859741|59005063|FG004|Overall Study|Death|5|||
30953194|NCT01859741|59005064|FG005|Overall Study|Death|4|||
30953195|NCT01859741|59005065|FG006|Overall Study|Death|51|||
30953196|NCT01859741|59005066|FG007|Overall Study|Death|51|||
30953197|NCT01859741|59005059|FG000|Overall Study|Lost to Follow-up|0|||
30953198|NCT01859741|59005060|FG001|Overall Study|Lost to Follow-up|0|||
30953199|NCT01859741|59005061|FG002|Overall Study|Lost to Follow-up|0|||
30953200|NCT01859741|59005062|FG003|Overall Study|Lost to Follow-up|0|||
30953201|NCT01859741|59005063|FG004|Overall Study|Lost to Follow-up|0|||
30953202|NCT01859741|59005064|FG005|Overall Study|Lost to Follow-up|1|||
30953203|NCT01859741|59005065|FG006|Overall Study|Lost to Follow-up|0|||
30953204|NCT01859741|59005066|FG007|Overall Study|Lost to Follow-up|4|||
30953205|NCT01859741|59005059|FG000|Overall Study|Withdrawal by Subject|0|||
30953206|NCT01859741|59005060|FG001|Overall Study|Withdrawal by Subject|1|||
30953207|NCT01859741|59005061|FG002|Overall Study|Withdrawal by Subject|2|||
30953208|NCT01859741|59005062|FG003|Overall Study|Withdrawal by Subject|0|||
30953209|NCT01859741|59005063|FG004|Overall Study|Withdrawal by Subject|0|||
30953210|NCT01859741|59005064|FG005|Overall Study|Withdrawal by Subject|1|||
30775428|NCT03692676|58785806|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
30775429|NCT03692676|58785807|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
30775430|NCT03692676|58785808|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
30775431|NCT03692676|58785809|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
30775432|NCT03692676|58785806|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
30775433|NCT03692676|58785807|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
30775434|NCT03692676|58785808|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
30775435|NCT03692676|58785809|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
30775436|NCT03692676|58785806|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
30775437|NCT03692676|58785807|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
30775438|NCT03692676|58785808|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
30775439|NCT03692676|58785809|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
30775440|NCT03692676|58785806|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
30775441|NCT03692676|58785807|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
30775442|NCT03692676|58785808|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
30775443|NCT03692676|58785809|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
30775444|NCT03692676|58785806|FG000|Overall Study|Other|0|||
30775445|NCT03692676|58785807|FG001|Overall Study|Other|805|||
30775446|NCT03692676|58785808|FG002|Overall Study|Other|758|||
30775447|NCT03692676|58785809|FG003|Overall Study|Other|277|||
30775448|NCT03692676|58785806|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
30775449|NCT03692676|58785807|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
30775450|NCT03692676|58785808|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
30775451|NCT03692676|58785809|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
30775452|NCT03691428|58785821|FG000|Overall Study|Withdrawal by Subject|6|||
30775453|NCT03691428|58785822|FG001|Overall Study|Withdrawal by Subject|8|||
30775454|NCT04124952|58785828|FG000|Overall Study|Lost to Follow-up|1|||
30775455|NCT04122534|58785832|FG000|Overall Study|Lost to Follow-up|4|||
30775456|NCT04091360|58785842|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
30775457|NCT04091360|58785843|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
30775458|NCT04091360|58785844|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
30775459|NCT04091360|58785845|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
30775460|NCT04091360|58785846|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
30775461|NCT04091360|58785847|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
30850879|NCT04163991|58877803|FG004|Overall Study|Withdrawal by Subject|1|||
30850880|NCT04163991|58877799|FG000|Overall Study|Other, Not Specified|0|||
30850881|NCT04163991|58877800|FG001|Overall Study|Other, Not Specified|1|||
30850882|NCT04163991|58877801|FG002|Overall Study|Other, Not Specified|1|||
30850883|NCT04163991|58877802|FG003|Overall Study|Other, Not Specified|1|||
30850884|NCT04163991|58877803|FG004|Overall Study|Other, Not Specified|0|||
30850885|NCT02442622|58877821|FG000|Overall Study|Withdrawal by Subject|3|||
30850886|NCT02442622|58877822|FG001|Overall Study|Withdrawal by Subject|1|||
30850887|NCT02411578|58877830|FG000|Crossover Trial Phase|Pregnancy|0|||
30850888|NCT02411578|58877831|FG001|Crossover Trial Phase|Pregnancy|1|||
30850889|NCT02442310|58877839|FG000|Overall Study|Adverse Event|2|||
30850890|NCT02442310|58877839|FG000|Overall Study|Withdrawal by Subject|1|||
30850891|NCT02411110|58877851|FG000|Treatment Period 1|Adverse Event|4|||
30850892|NCT02411110|58877852|FG001|Treatment Period 1|Adverse Event|2|||
30953211|NCT01859741|59005065|FG006|Overall Study|Withdrawal by Subject|1|||
30953212|NCT01859741|59005066|FG007|Overall Study|Withdrawal by Subject|1|||
30953213|NCT01859741|59005059|FG000|Overall Study|Study Terminated by Sponsor|0|||
30953214|NCT01859741|59005060|FG001|Overall Study|Study Terminated by Sponsor|0|||
30953215|NCT01859741|59005061|FG002|Overall Study|Study Terminated by Sponsor|0|||
30953216|NCT01859741|59005062|FG003|Overall Study|Study Terminated by Sponsor|0|||
30850893|NCT02411110|58877851|FG000|Treatment Period 1|Lost to Follow-up|1|||
30953217|NCT01859741|59005063|FG004|Overall Study|Study Terminated by Sponsor|1|||
30953218|NCT01859741|59005064|FG005|Overall Study|Study Terminated by Sponsor|0|||
30953219|NCT01859741|59005065|FG006|Overall Study|Study Terminated by Sponsor|16|||
30850894|NCT02411110|58877852|FG001|Treatment Period 1|Lost to Follow-up|0|||
30850895|NCT02411110|58877851|FG000|Treatment Period 1|Personal Reasons|2|||
30850896|NCT02411110|58877852|FG001|Treatment Period 1|Personal Reasons|5|||
30953220|NCT01859741|59005066|FG007|Overall Study|Study Terminated by Sponsor|14|||
30953221|NCT01859741|59005059|FG000|Overall Study|Other|0|||
30775462|NCT04091360|58785848|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
30775463|NCT04091360|58785849|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
30775464|NCT04091360|58785850|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
30775465|NCT04091360|58785851|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
30775466|NCT04091360|58785842|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
30775467|NCT04091360|58785843|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
30775468|NCT04091360|58785844|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
30775469|NCT04091360|58785845|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
30775470|NCT04091360|58785846|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
30775471|NCT04091360|58785847|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
30775472|NCT04091360|58785848|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
30775473|NCT04091360|58785849|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
30775474|NCT04091360|58785850|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
30775475|NCT04091360|58785851|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
30775476|NCT04091360|58785842|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
30775477|NCT04091360|58785843|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
30775478|NCT04091360|58785844|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
30775479|NCT04091360|58785845|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
30775480|NCT04091360|58785846|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
30775481|NCT04091360|58785847|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
30775482|NCT04091360|58785848|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
30775483|NCT04091360|58785849|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
30775484|NCT04091360|58785850|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
30775485|NCT04091360|58785851|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
30775486|NCT04118166|58785873|FG000|Overall Study|Adverse Event|1|||
30775487|NCT04346628|58785880|FG000|Overall Study|Lost to Follow-up|4|||
30775488|NCT04346628|58785881|FG001|Overall Study|Lost to Follow-up|4|||
30775489|NCT04346628|58785880|FG000|Overall Study|Withdrew (had personal reasons)|2|||
30775490|NCT04346628|58785881|FG001|Overall Study|Withdrew (had personal reasons)|5|||
30775491|NCT04346628|58785880|FG000|Overall Study|Withdrew (medication intolerant)|0|||
30775492|NCT04346628|58785881|FG001|Overall Study|Withdrew (medication intolerant)|3|||
30775493|NCT04346628|58785880|FG000|Overall Study|Withdrew (declined intervention)|0|||
30775494|NCT04346628|58785881|FG001|Overall Study|Withdrew (declined intervention)|1|||
30775495|NCT03681470|58785887|FG000|Overall Study|Lack of Efficacy|3|||
30775496|NCT03681470|58785887|FG000|Overall Study|Lost to Follow-up|1|||
30775497|NCT03681470|58785887|FG000|Overall Study|Protocol Violation|3|||
30775498|NCT03681470|58785887|FG000|Overall Study|Withdrawal by Subject|1|||
30775499|NCT04343976|58785893|FG000|Overall Study|Withdrawal by Subject|0|||
30775500|NCT04343976|58785894|FG001|Overall Study|Withdrawal by Subject|1|||
30775501|NCT03322540|58785902|FG000|Overall Study|Death|21|||
30775502|NCT03322540|58785903|FG001|Overall Study|Death|28|||
30775503|NCT03322540|58785902|FG000|Overall Study|Lost to Follow-up|0|||
30775504|NCT03322540|58785903|FG001|Overall Study|Lost to Follow-up|1|||
30775505|NCT03322540|58785902|FG000|Overall Study|Physician Decision|7|||
30775506|NCT03322540|58785903|FG001|Overall Study|Physician Decision|6|||
30775507|NCT03322540|58785902|FG000|Overall Study|Withdrawal by Subject|3|||
30775508|NCT03322540|58785903|FG001|Overall Study|Withdrawal by Subject|1|||
30775509|NCT03322540|58785902|FG000|Overall Study|Study terminated by sponsor|0|||
30775510|NCT03322540|58785903|FG001|Overall Study|Study terminated by sponsor|1|||
30775511|NCT04339296|58785913|FG000|Overall Study|Refuse to participate after allocation|1|||
30775512|NCT04339296|58785914|FG001|Overall Study|Refuse to participate after allocation|1|||
30775513|NCT04339296|58785913|FG000|Overall Study|Withdrew after completion of baseline|2|||
30775514|NCT04339296|58785914|FG001|Overall Study|Withdrew after completion of baseline|1|||
30775515|NCT04339296|58785913|FG000|Overall Study|Lost to Follow-up|0|||
30775516|NCT04339296|58785914|FG001|Overall Study|Lost to Follow-up|4|||
30775517|NCT04339296|58785913|FG000|Overall Study|Discontinued intervention|5|||
30775518|NCT04339296|58785914|FG001|Overall Study|Discontinued intervention|3|||
30775519|NCT02025556|58785923|FG000|Overall Study|Adverse Event|0|||
30775520|NCT02025556|58785924|FG001|Overall Study|Adverse Event|4|||
30775521|NCT02025556|58785925|FG002|Overall Study|Adverse Event|2|||
30953222|NCT01859741|59005060|FG001|Overall Study|Other|0|||
30775522|NCT02025556|58785923|FG000|Overall Study|Lack of Efficacy|2|||
30775523|NCT02025556|58785924|FG001|Overall Study|Lack of Efficacy|1|||
30775524|NCT02025556|58785925|FG002|Overall Study|Lack of Efficacy|0|||
30775525|NCT02025556|58785923|FG000|Overall Study|Protocol Violation|2|||
30775526|NCT02025556|58785924|FG001|Overall Study|Protocol Violation|1|||
30775527|NCT02025556|58785925|FG002|Overall Study|Protocol Violation|0|||
30775528|NCT02025556|58785923|FG000|Overall Study|Withdrawal by Subject|0|||
30953223|NCT01859741|59005061|FG002|Overall Study|Other|0|||
30775529|NCT02025556|58785924|FG001|Overall Study|Withdrawal by Subject|3|||
30775530|NCT02025556|58785925|FG002|Overall Study|Withdrawal by Subject|6|||
30775531|NCT02025556|58785923|FG000|Overall Study|Lost to Follow-up|2|||
30775532|NCT02025556|58785924|FG001|Overall Study|Lost to Follow-up|4|||
30775533|NCT02025556|58785925|FG002|Overall Study|Lost to Follow-up|0|||
30775534|NCT02025556|58785923|FG000|Overall Study|Reason not reported|0|||
30775535|NCT02025556|58785924|FG001|Overall Study|Reason not reported|0|||
30850897|NCT02411110|58877851|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
30850898|NCT02411110|58877852|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
30850899|NCT02411110|58877851|FG000|Treatment Period 2|Adverse Event|1|||
30850900|NCT02411110|58877852|FG001|Treatment Period 2|Adverse Event|0|||
30850901|NCT02411110|58877851|FG000|Treatment Period 2|Lost to Follow-up|0|||
30850902|NCT02411110|58877852|FG001|Treatment Period 2|Lost to Follow-up|2|||
30850903|NCT02411110|58877851|FG000|Treatment Period 2|Personal Reasons|0|||
30850904|NCT02411110|58877852|FG001|Treatment Period 2|Personal Reasons|2|||
30850905|NCT01369849|58877863|FG000|Overall Study|Ineligible prior to treatment|0|||
30850906|NCT01369849|58877864|FG001|Overall Study|Ineligible prior to treatment|0|||
30850907|NCT01369849|58877865|FG002|Overall Study|Ineligible prior to treatment|1|||
30850908|NCT01369849|58877863|FG000|Overall Study|Ineligible after receiving treatment|0|||
30850909|NCT01369849|58877864|FG001|Overall Study|Ineligible after receiving treatment|1|||
30850910|NCT01369849|58877865|FG002|Overall Study|Ineligible after receiving treatment|0|||
30850911|NCT02716779|58877878|FG000|Monotherapy|Adverse Event|0|||
30850912|NCT02716779|58877879|FG001|Monotherapy|Adverse Event|1|||
30850913|NCT02716779|58877880|FG002|Monotherapy|Adverse Event|1|||
30850914|NCT02716779|58877878|FG000|Combination Therapy|Adverse Event|0|||
30953224|NCT01859741|59005062|FG003|Overall Study|Other|0|||
30953225|NCT01859741|59005063|FG004|Overall Study|Other|0|||
30953226|NCT01859741|59005064|FG005|Overall Study|Other|0|||
30953227|NCT01859741|59005065|FG006|Overall Study|Other|2|||
30953228|NCT01859741|59005066|FG007|Overall Study|Other|0|||
30953229|NCT01859507|59005112|FG000|Overall Study|left the country|4|||
30953230|NCT01876043|59005117|FG000|Overall Study|Death|1|||
30953231|NCT01876043|59005117|FG000|Overall Study|Withdrawal by Subject|1|||
30953232|NCT01875731|59005123|FG000|Overall Study|Fail to obtain lab sample|1|||
30953233|NCT01875731|59005124|FG001|Overall Study|Fail to obtain lab sample|0|||
30953234|NCT01873859|59005132|FG000|Overall Study|Withdrawal by Subject|0|||
30953235|NCT01873859|59005133|FG001|Overall Study|Withdrawal by Subject|4|||
30953236|NCT01857869|59005150|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
30953237|NCT01857869|59005151|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
30953238|NCT01857869|59005152|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
30953239|NCT01857869|59005153|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
30953240|NCT01857869|59005154|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
30953241|NCT01857869|59005155|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
30953242|NCT01857869|59005156|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
30953243|NCT01857869|59005157|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
30953244|NCT01857869|59005158|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
30953245|NCT01857869|59005159|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
30953246|NCT01857869|59005150|FG000|Primary/Challenge Phase|Pregnancy|1|||
30953247|NCT01857869|59005151|FG001|Primary/Challenge Phase|Pregnancy|0|||
30953248|NCT01857869|59005152|FG002|Primary/Challenge Phase|Pregnancy|0|||
30953249|NCT01857869|59005153|FG003|Primary/Challenge Phase|Pregnancy|0|||
30953250|NCT01857869|59005154|FG004|Primary/Challenge Phase|Pregnancy|0|||
30953251|NCT01857869|59005155|FG005|Primary/Challenge Phase|Pregnancy|0|||
30953252|NCT01857869|59005156|FG006|Primary/Challenge Phase|Pregnancy|0|||
30953253|NCT01857869|59005157|FG007|Primary/Challenge Phase|Pregnancy|0|||
30953254|NCT01857869|59005158|FG008|Primary/Challenge Phase|Pregnancy|0|||
30953255|NCT01857869|59005159|FG009|Primary/Challenge Phase|Pregnancy|0|||
30953256|NCT01857869|59005150|FG000|Primary/Challenge Phase|Protocol Violation|1|||
30953257|NCT01857869|59005151|FG001|Primary/Challenge Phase|Protocol Violation|0|||
30775536|NCT02025556|58785925|FG002|Overall Study|Reason not reported|1|||
30850915|NCT02716779|58877879|FG001|Combination Therapy|Adverse Event|2|||
30850916|NCT02716779|58877880|FG002|Combination Therapy|Adverse Event|1|||
30850917|NCT01369615|58877896|FG000|Overall Study|Withdrawal by Subject|0|||
30953258|NCT01857869|59005152|FG002|Primary/Challenge Phase|Protocol Violation|0|||
30953259|NCT01857869|59005153|FG003|Primary/Challenge Phase|Protocol Violation|0|||
30953260|NCT01857869|59005154|FG004|Primary/Challenge Phase|Protocol Violation|0|||
30953261|NCT01857869|59005155|FG005|Primary/Challenge Phase|Protocol Violation|0|||
30953262|NCT01857869|59005156|FG006|Primary/Challenge Phase|Protocol Violation|0|||
30953263|NCT01857869|59005157|FG007|Primary/Challenge Phase|Protocol Violation|0|||
30953264|NCT01857869|59005158|FG008|Primary/Challenge Phase|Protocol Violation|0|||
30850918|NCT01369615|58877897|FG001|Overall Study|Withdrawal by Subject|1|||
30850919|NCT01369615|58877896|FG000|Overall Study|Lost to Follow-up|0|||
30775537|NCT04334460|58785935|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
30775538|NCT04334460|58785936|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
30775539|NCT04334460|58785935|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
30775540|NCT04334460|58785936|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
30775541|NCT04334148|58785945|FG000|Overall Study|positive nasal swab at baseline|0|||
30953265|NCT01857869|59005159|FG009|Primary/Challenge Phase|Protocol Violation|0|||
30953266|NCT01857869|59005150|FG000|Primary/Challenge Phase|Other|1|||
30953267|NCT01857869|59005151|FG001|Primary/Challenge Phase|Other|1|||
30953268|NCT01857869|59005152|FG002|Primary/Challenge Phase|Other|0|||
30953269|NCT01857869|59005153|FG003|Primary/Challenge Phase|Other|0|||
30953270|NCT01857869|59005154|FG004|Primary/Challenge Phase|Other|0|||
30953271|NCT01857869|59005155|FG005|Primary/Challenge Phase|Other|0|||
30953272|NCT01857869|59005156|FG006|Primary/Challenge Phase|Other|0|||
30953273|NCT01857869|59005157|FG007|Primary/Challenge Phase|Other|0|||
30953274|NCT01857869|59005158|FG008|Primary/Challenge Phase|Other|0|||
30953275|NCT01857869|59005159|FG009|Primary/Challenge Phase|Other|0|||
30953276|NCT01857869|59005150|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
30953277|NCT01857869|59005151|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
30953278|NCT01857869|59005152|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
30953279|NCT01857869|59005153|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
30953280|NCT01857869|59005154|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
30953281|NCT01857869|59005155|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
30953282|NCT01857869|59005156|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
30953283|NCT01857869|59005157|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
30850920|NCT01369615|58877897|FG001|Overall Study|Lost to Follow-up|1|||
30850921|NCT02468674|58877921|FG000|Overall Study|Adverse Event|0|||
30850922|NCT02468674|58877922|FG001|Overall Study|Adverse Event|0|||
30850923|NCT02468674|58877923|FG002|Overall Study|Adverse Event|0|||
30850924|NCT02468674|58877924|FG003|Overall Study|Adverse Event|1|||
30850925|NCT02468674|58877925|FG004|Overall Study|Adverse Event|0|||
30953284|NCT01857869|59005158|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
30953285|NCT01857869|59005159|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
30850926|NCT02468674|58877926|FG005|Overall Study|Adverse Event|1|||
30850927|NCT02468674|58877927|FG006|Overall Study|Adverse Event|0|||
30850928|NCT02468674|58877928|FG007|Overall Study|Adverse Event|0|||
30850929|NCT02468674|58877929|FG008|Overall Study|Adverse Event|0|||
30850930|NCT02468674|58877921|FG000|Overall Study|Lost to Follow-up|1|||
30850931|NCT02468674|58877922|FG001|Overall Study|Lost to Follow-up|0|||
30850932|NCT02468674|58877923|FG002|Overall Study|Lost to Follow-up|0|||
30850933|NCT02468674|58877924|FG003|Overall Study|Lost to Follow-up|0|||
30850934|NCT02468674|58877925|FG004|Overall Study|Lost to Follow-up|0|||
30850935|NCT02468674|58877926|FG005|Overall Study|Lost to Follow-up|0|||
30850936|NCT02468674|58877927|FG006|Overall Study|Lost to Follow-up|0|||
30850937|NCT02468674|58877928|FG007|Overall Study|Lost to Follow-up|1|||
30850938|NCT02468674|58877929|FG008|Overall Study|Lost to Follow-up|1|||
30850939|NCT02468674|58877921|FG000|Overall Study|Physician Decision|0|||
30662565|NCT00917267|58676154|FG000|Overall Study|Entry Criteria Not Met|1|||
30775542|NCT04334148|58785946|FG001|Overall Study|positive nasal swab at baseline|1|||
30775543|NCT04399122|58785954|FG000|Overall Study|Lost to Follow-up|2|||
30775544|NCT04399122|58785955|FG001|Overall Study|Lost to Follow-up|0|||
30775545|NCT04399122|58785954|FG000|Overall Study|Withdrawal by Subject|1|||
30775546|NCT04399122|58785955|FG001|Overall Study|Withdrawal by Subject|0|||
30775547|NCT04398732|58785976|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
30775548|NCT04398030|58785982|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
30775549|NCT04398030|58785983|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
30850940|NCT02468674|58877922|FG001|Overall Study|Physician Decision|0|||
30850941|NCT02468674|58877923|FG002|Overall Study|Physician Decision|0|||
30850942|NCT02468674|58877924|FG003|Overall Study|Physician Decision|0|||
30850943|NCT02468674|58877925|FG004|Overall Study|Physician Decision|0|||
30850944|NCT02468674|58877926|FG005|Overall Study|Physician Decision|0|||
30850945|NCT02468674|58877927|FG006|Overall Study|Physician Decision|1|||
30850946|NCT02468674|58877928|FG007|Overall Study|Physician Decision|0|||
30850947|NCT02468674|58877929|FG008|Overall Study|Physician Decision|0|||
30850948|NCT02468674|58877921|FG000|Overall Study|Patient/Guardian Decision|0|||
30850949|NCT02468674|58877922|FG001|Overall Study|Patient/Guardian Decision|0|||
30850950|NCT02468674|58877923|FG002|Overall Study|Patient/Guardian Decision|0|||
30850951|NCT02468674|58877924|FG003|Overall Study|Patient/Guardian Decision|0|||
30850952|NCT02468674|58877925|FG004|Overall Study|Patient/Guardian Decision|1|||
30850953|NCT02468674|58877926|FG005|Overall Study|Patient/Guardian Decision|0|||
30850954|NCT02468674|58877927|FG006|Overall Study|Patient/Guardian Decision|0|||
30850955|NCT02468674|58877928|FG007|Overall Study|Patient/Guardian Decision|2|||
30850956|NCT02468674|58877929|FG008|Overall Study|Patient/Guardian Decision|1|||
30850957|NCT02468674|58877921|FG000|Overall Study|Protocol Deviation|0|||
30775550|NCT04398030|58785982|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
30775551|NCT04398030|58785983|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
30775552|NCT03064438|58785991|FG000|Overall Study|Lost to Follow-up|1|||
30775553|NCT03064438|58785992|FG001|Overall Study|Lost to Follow-up|0|||
30775554|NCT03064438|58785991|FG000|Overall Study|Withdrawal by Subject|0|||
30775555|NCT03064438|58785992|FG001|Overall Study|Withdrawal by Subject|1|||
30775556|NCT04327986|58785998|FG000|Overall Study|Physician Decision|2|||
30775557|NCT04327986|58785999|FG001|Overall Study|Physician Decision|0|||
30775558|NCT04327986|58786000|FG002|Overall Study|Physician Decision|0|||
30775559|NCT04327986|58785998|FG000|Overall Study|Death|1|||
30850958|NCT02468674|58877922|FG001|Overall Study|Protocol Deviation|0|||
30850959|NCT02468674|58877923|FG002|Overall Study|Protocol Deviation|0|||
30850960|NCT02468674|58877924|FG003|Overall Study|Protocol Deviation|0|||
30850961|NCT02468674|58877925|FG004|Overall Study|Protocol Deviation|0|||
30850962|NCT02468674|58877926|FG005|Overall Study|Protocol Deviation|0|||
30850963|NCT02468674|58877927|FG006|Overall Study|Protocol Deviation|0|||
30850964|NCT02468674|58877928|FG007|Overall Study|Protocol Deviation|1|||
30850965|NCT02468674|58877929|FG008|Overall Study|Protocol Deviation|1|||
30850966|NCT02467192|58877949|FG000|Overall Study|Death|1|||
30850967|NCT02467192|58877949|FG000|Overall Study|revealed to have pneumonia before|2|||
30850968|NCT02410954|58877959|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
30850969|NCT02410954|58877960|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
30850970|NCT02410954|58877959|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
30850971|NCT02410954|58877960|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
30850972|NCT02689453|58877969|FG000|Overall Study|Progressive disease|0|||
30850973|NCT02689453|58877970|FG001|Overall Study|Progressive disease|1|||
30850974|NCT02689453|58877971|FG002|Overall Study|Progressive disease|1|||
30850975|NCT00701103|58878006|FG000|Overall Study|Adverse Event|0|||
30850976|NCT00701103|58878007|FG001|Overall Study|Adverse Event|0|||
30850977|NCT00701103|58878008|FG002|Overall Study|Adverse Event|1|||
30850978|NCT00701103|58878009|FG003|Overall Study|Adverse Event|1|||
30850979|NCT00701103|58878010|FG004|Overall Study|Adverse Event|0|||
30850980|NCT00701103|58878011|FG005|Overall Study|Adverse Event|1|||
30850981|NCT00701103|58878012|FG006|Overall Study|Adverse Event|1|||
30850982|NCT00701103|58878013|FG007|Overall Study|Adverse Event|0|||
30850983|NCT00701103|58878014|FG008|Overall Study|Adverse Event|0|||
30850984|NCT00701103|58878015|FG009|Overall Study|Adverse Event|2|||
30850985|NCT00701103|58878016|FG010|Overall Study|Adverse Event|0|||
30850986|NCT00701103|58878006|FG000|Overall Study|Progressive Disease|5|||
30850987|NCT00701103|58878007|FG001|Overall Study|Progressive Disease|2|||
30850988|NCT00701103|58878008|FG002|Overall Study|Progressive Disease|6|||
30850989|NCT00701103|58878009|FG003|Overall Study|Progressive Disease|5|||
30850990|NCT00701103|58878010|FG004|Overall Study|Progressive Disease|6|||
30850991|NCT00701103|58878011|FG005|Overall Study|Progressive Disease|5|||
30850992|NCT00701103|58878012|FG006|Overall Study|Progressive Disease|7|||
30850993|NCT00701103|58878013|FG007|Overall Study|Progressive Disease|7|||
30850994|NCT00701103|58878014|FG008|Overall Study|Progressive Disease|8|||
30850995|NCT00701103|58878015|FG009|Overall Study|Progressive Disease|8|||
30850996|NCT00701103|58878016|FG010|Overall Study|Progressive Disease|11|||
30850997|NCT00701103|58878006|FG000|Overall Study|Withdrawal by Subject|0|||
30850998|NCT00701103|58878007|FG001|Overall Study|Withdrawal by Subject|1|||
30850999|NCT00701103|58878008|FG002|Overall Study|Withdrawal by Subject|1|||
30851000|NCT00701103|58878009|FG003|Overall Study|Withdrawal by Subject|0|||
30851001|NCT00701103|58878010|FG004|Overall Study|Withdrawal by Subject|0|||
30851002|NCT00701103|58878011|FG005|Overall Study|Withdrawal by Subject|0|||
30851003|NCT00701103|58878012|FG006|Overall Study|Withdrawal by Subject|0|||
30851004|NCT00701103|58878013|FG007|Overall Study|Withdrawal by Subject|0|||
30851005|NCT00701103|58878014|FG008|Overall Study|Withdrawal by Subject|0|||
30851006|NCT00701103|58878015|FG009|Overall Study|Withdrawal by Subject|0|||
30851007|NCT00701103|58878016|FG010|Overall Study|Withdrawal by Subject|0|||
30851008|NCT00701103|58878006|FG000|Overall Study|Other|0|||
30851009|NCT00701103|58878007|FG001|Overall Study|Other|0|||
30851010|NCT00701103|58878008|FG002|Overall Study|Other|0|||
30851011|NCT00701103|58878009|FG003|Overall Study|Other|0|||
30851012|NCT00701103|58878010|FG004|Overall Study|Other|0|||
30851013|NCT00701103|58878011|FG005|Overall Study|Other|0|||
30775560|NCT04327986|58785999|FG001|Overall Study|Death|0|||
30851014|NCT00701103|58878012|FG006|Overall Study|Other|0|||
30851015|NCT00701103|58878013|FG007|Overall Study|Other|0|||
30851016|NCT00701103|58878014|FG008|Overall Study|Other|1|||
30851017|NCT00701103|58878015|FG009|Overall Study|Other|1|||
30851018|NCT00701103|58878016|FG010|Overall Study|Other|0|||
30851019|NCT01369225|58878050|FG000|Overall Study|Withdrawal by Subject|1|||
30851020|NCT01369225|58878051|FG001|Overall Study|Withdrawal by Subject|0|||
30851021|NCT01369225|58878052|FG002|Overall Study|Withdrawal by Subject|2|||
30851022|NCT01369225|58878053|FG003|Overall Study|Withdrawal by Subject|1|||
30775561|NCT04327986|58786000|FG002|Overall Study|Death|0|||
30851023|NCT01369225|58878054|FG004|Overall Study|Withdrawal by Subject|0|||
30851024|NCT01369225|58878055|FG005|Overall Study|Withdrawal by Subject|0|||
30775562|NCT04322682|58786006|FG000|Overall Study|Withdrawal by Subject|33|||
30775563|NCT04322682|58786007|FG001|Overall Study|Withdrawal by Subject|47|||
30775564|NCT04322682|58786006|FG000|Overall Study|Death|5|||
30775565|NCT04322682|58786007|FG001|Overall Study|Death|9|||
30775566|NCT04322682|58786006|FG000|Overall Study|Lost to Follow-up|4|||
30775567|NCT04322682|58786007|FG001|Overall Study|Lost to Follow-up|8|||
30775568|NCT04322682|58786006|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
30775569|NCT04322682|58786007|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
30775570|NCT04322526|58786015|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
30775571|NCT04322526|58786016|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
30775572|NCT04322526|58786015|FG000|Washout (1 Week)|Lost to Follow-up|1|||
30775573|NCT04322526|58786016|FG001|Washout (1 Week)|Lost to Follow-up|2|||
30775574|NCT04115358|58786025|FG000|Overall Study|exfoliation|0|||
30775575|NCT04115358|58786026|FG001|Overall Study|exfoliation|0|||
30775576|NCT04115358|58786027|FG002|Overall Study|exfoliation|1|||
30775577|NCT04109118|58786036|FG000|Overall Study|Lost to Follow-up|3|||
30775578|NCT04105998|58786043|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
30775579|NCT04105998|58786044|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
30775580|NCT04397718|58786052|FG000|Overall Study|Death|7|||
30775581|NCT04397718|58786053|FG001|Overall Study|Death|11|||
30775582|NCT04397718|58786052|FG000|Overall Study|Lost to Follow-up|0|||
30775583|NCT04397718|58786053|FG001|Overall Study|Lost to Follow-up|4|||
30775584|NCT04105218|58786061|FG000|Overall Study|Withdrawal by Subject|3|||
30775585|NCT04105218|58786062|FG001|Overall Study|Withdrawal by Subject|2|||
30775586|NCT04105218|58786061|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
30775587|NCT04105218|58786062|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
30775588|NCT04105218|58786061|FG000|Overall Study|Failed screening tests|2|||
30775589|NCT04105218|58786062|FG001|Overall Study|Failed screening tests|1|||
30775590|NCT04317690|58786073|FG000|Overall Study|did not have complete information for primary outcome|0|||
30775591|NCT04317690|58786074|FG001|Overall Study|did not have complete information for primary outcome|4|||
30775592|NCT04317690|58786075|FG002|Overall Study|did not have complete information for primary outcome|0|||
30775593|NCT04317690|58786076|FG003|Overall Study|did not have complete information for primary outcome|2|||
30775594|NCT04317690|58786077|FG004|Overall Study|did not have complete information for primary outcome|0|||
30775595|NCT03721276|58786104|FG000|Overall Study|Lost to Follow-up|5|||
30775596|NCT03721276|58786105|FG001|Overall Study|Lost to Follow-up|3|||
30775597|NCT03721276|58786104|FG000|Overall Study|Adverse Event|0|||
30775598|NCT03721276|58786105|FG001|Overall Study|Adverse Event|1|||
30775599|NCT03269344|58786120|FG000|Overall Study|Protocol Violation|4|||
30775600|NCT03269344|58786121|FG001|Overall Study|Protocol Violation|3|||
30775601|NCT04389840|58786133|FG000|Overall Study|Adverse Event|0|||
30775602|NCT04389840|58786134|FG001|Overall Study|Adverse Event|0|||
30775603|NCT04389840|58786135|FG002|Overall Study|Adverse Event|0|||
30775604|NCT04389840|58786136|FG003|Overall Study|Adverse Event|1|||
30775605|NCT04389840|58786137|FG004|Overall Study|Adverse Event|0|||
30775606|NCT04389840|58786138|FG005|Overall Study|Adverse Event|0|||
30775607|NCT04389840|58786133|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
30775608|NCT04389840|58786134|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
30775609|NCT04389840|58786135|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
30775610|NCT04389840|58786136|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
30775611|NCT04389840|58786137|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
30775612|NCT04389840|58786138|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
30775613|NCT04389840|58786133|FG000|Overall Study|Death|0|||
30775614|NCT04389840|58786134|FG001|Overall Study|Death|1|||
30775615|NCT04389840|58786135|FG002|Overall Study|Death|0|||
30775616|NCT04389840|58786136|FG003|Overall Study|Death|0|||
30775617|NCT04389840|58786137|FG004|Overall Study|Death|0|||
30775618|NCT04389840|58786138|FG005|Overall Study|Death|0|||
30775619|NCT04307940|58786161|FG000|Overall Study|Adverse Event|1|||
30775620|NCT04307940|58786162|FG001|Overall Study|Adverse Event|0|||
30775621|NCT04307940|58786163|FG002|Overall Study|Adverse Event|0|||
30775622|NCT04307940|58786161|FG000|Overall Study|Withdrawal by Subject|2|||
30775623|NCT04307940|58786162|FG001|Overall Study|Withdrawal by Subject|3|||
30775624|NCT04307940|58786163|FG002|Overall Study|Withdrawal by Subject|1|||
30775625|NCT04307940|58786161|FG000|Overall Study|Lost to Follow-up|2|||
30775626|NCT04307940|58786162|FG001|Overall Study|Lost to Follow-up|0|||
30775627|NCT04307940|58786163|FG002|Overall Study|Lost to Follow-up|1|||
30775628|NCT02054104|58786173|FG000|Overall Study|Did not want to continue due to college classes|1|||
30775629|NCT02054104|58786174|FG001|Overall Study|Did not want to continue due to college classes|0|||
30775630|NCT02054104|58786173|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
30775631|NCT02054104|58786174|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
30775632|NCT02054104|58786173|FG000|Overall Study|No evidence of immunologic response|2|||
30775633|NCT02054104|58786174|FG001|Overall Study|No evidence of immunologic response|2|||
30851025|NCT01369225|58878050|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
30851026|NCT01369225|58878051|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
30851027|NCT01369225|58878052|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
30851028|NCT01369225|58878053|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
30851029|NCT01369225|58878054|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
30775634|NCT02054104|58786173|FG000|Overall Study|Disease Progression On Study|4|||
30775635|NCT02054104|58786174|FG001|Overall Study|Disease Progression On Study|5|||
30851030|NCT01369225|58878055|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
30851031|NCT01369225|58878050|FG000|Overall Study|Other|1|||
30851032|NCT01369225|58878051|FG001|Overall Study|Other|0|||
30851033|NCT01369225|58878052|FG002|Overall Study|Other|0|||
30775636|NCT02054104|58786173|FG000|Overall Study|Diagnosis of lymphoma|0|||
30775637|NCT02054104|58786174|FG001|Overall Study|Diagnosis of lymphoma|1|||
30775638|NCT02054104|58786173|FG000|Overall Study|Inconclusive response|0|||
30775639|NCT02054104|58786174|FG001|Overall Study|Inconclusive response|1|||
30775640|NCT04090242|58786182|FG000|Overall Study|Withdrawal by Subject|1|||
30775641|NCT04090242|58786183|FG001|Overall Study|Withdrawal by Subject|0|||
30775642|NCT04090164|58786192|FG000|Overall Study|incomplete data on file|245|||
30775643|NCT04090164|58786193|FG001|Overall Study|incomplete data on file|0|||
30775644|NCT04292730|58786222|FG000|Overall Study|Lost to Follow-up|8|||
30775645|NCT04292730|58786223|FG001|Overall Study|Lost to Follow-up|12|||
30775646|NCT04292730|58786224|FG002|Overall Study|Lost to Follow-up|12|||
30775647|NCT04292730|58786225|FG003|Overall Study|Lost to Follow-up|48|||
30775648|NCT04292730|58786222|FG000|Overall Study|Death|2|||
30775649|NCT04292730|58786223|FG001|Overall Study|Death|2|||
30775650|NCT04292730|58786224|FG002|Overall Study|Death|4|||
30775651|NCT04292730|58786225|FG003|Overall Study|Death|12|||
30775652|NCT04292730|58786222|FG000|Overall Study|Withdrew Consent|2|||
30775653|NCT04292730|58786223|FG001|Overall Study|Withdrew Consent|2|||
30775654|NCT04292730|58786224|FG002|Overall Study|Withdrew Consent|5|||
30775655|NCT04292730|58786225|FG003|Overall Study|Withdrew Consent|6|||
30775656|NCT04292730|58786222|FG000|Overall Study|Non-Compliance with Study Drug|0|||
30775657|NCT04292730|58786223|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30775658|NCT04292730|58786224|FG002|Overall Study|Non-Compliance with Study Drug|0|||
30775659|NCT04292730|58786225|FG003|Overall Study|Non-Compliance with Study Drug|0|||
30775660|NCT04292730|58786222|FG000|Overall Study|Protocol Violation|0|||
30775661|NCT04292730|58786223|FG001|Overall Study|Protocol Violation|0|||
30775662|NCT04292730|58786224|FG002|Overall Study|Protocol Violation|1|||
30775663|NCT04292730|58786225|FG003|Overall Study|Protocol Violation|0|||
30775664|NCT04292730|58786222|FG000|Overall Study|Randomized but not Treated|8|||
30775665|NCT04292730|58786223|FG001|Overall Study|Randomized but not Treated|4|||
30775666|NCT04292730|58786224|FG002|Overall Study|Randomized but not Treated|0|||
30775667|NCT04292730|58786225|FG003|Overall Study|Randomized but not Treated|14|||
30775668|NCT02861014|58786234|FG000|Primary Analysis|Adverse Event|7|||
30775669|NCT02861014|58786234|FG000|Primary Analysis|Death|1|||
30775670|NCT02861014|58786234|FG000|Primary Analysis|Lack of Efficacy|3|||
30775671|NCT02861014|58786234|FG000|Primary Analysis|Physician Decision|2|||
30775672|NCT02861014|58786234|FG000|Primary Analysis|Pregnancy|4|||
30775673|NCT02861014|58786234|FG000|Primary Analysis|Protocol Violation|2|||
30775674|NCT02861014|58786234|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
30775675|NCT02861014|58786234|FG000|Primary Analysis|Withdrawal by Subject|14|||
30775676|NCT02861014|58786234|FG000|Primary Analysis|Commercial ocrelizumab|3|||
30775677|NCT02861014|58786234|FG000|Safety Follow-up|Adverse Event|1|||
30775678|NCT02861014|58786234|FG000|Safety Follow-up|Pregnancy|1|||
30775679|NCT02861014|58786234|FG000|Safety Follow-up|Withdrawal by Subject|9|||
30775680|NCT02861014|58786234|FG000|Safety Follow-up|Study terminated by sponsor|1|||
30775681|NCT02861014|58786234|FG000|Safety Follow-up|Physician Decision|1|||
30775682|NCT02861014|58786234|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
30775683|NCT02861014|58786234|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
30775684|NCT04382586|58786242|FG000|Overall Study|Death|3|||
30775685|NCT04382586|58786243|FG001|Overall Study|Death|4|||
30775686|NCT04382586|58786242|FG000|Overall Study|Lost to Follow-up|11|||
30775687|NCT04382586|58786243|FG001|Overall Study|Lost to Follow-up|8|||
30775688|NCT04382586|58786242|FG000|Overall Study|Withdrawal by Subject|3|||
30775689|NCT04382586|58786243|FG001|Overall Study|Withdrawal by Subject|1|||
30775690|NCT04382586|58786242|FG000|Overall Study|Physician Decision|0|||
30775691|NCT04382586|58786243|FG001|Overall Study|Physician Decision|3|||
30775692|NCT04275336|58786252|FG000|Overall Study|First venipuncture failed|4|||
30851034|NCT01369225|58878053|FG003|Overall Study|Other|0|||
30851035|NCT01369225|58878054|FG004|Overall Study|Other|1|||
30851036|NCT01369225|58878055|FG005|Overall Study|Other|0|||
30851037|NCT01369225|58878050|FG000|Overall Study|Adverse Event|0|||
30851038|NCT01369225|58878051|FG001|Overall Study|Adverse Event|0|||
30851039|NCT01369225|58878052|FG002|Overall Study|Adverse Event|0|||
30851040|NCT01369225|58878053|FG003|Overall Study|Adverse Event|1|||
30851041|NCT01369225|58878054|FG004|Overall Study|Adverse Event|1|||
30851042|NCT01369225|58878055|FG005|Overall Study|Adverse Event|0|||
30851043|NCT02639546|58878077|FG000|Overall Study|Death|2|||
30775693|NCT04275336|58786253|FG001|Overall Study|First venipuncture failed|6|||
30775694|NCT04275336|58786254|FG002|Overall Study|First venipuncture failed|5|||
30775695|NCT04275336|58786252|FG000|Overall Study|Unscheduled venipuncture|9|||
30775696|NCT04275336|58786253|FG001|Overall Study|Unscheduled venipuncture|13|||
30775697|NCT04275336|58786254|FG002|Overall Study|Unscheduled venipuncture|7|||
30851044|NCT02639546|58878078|FG001|Overall Study|Death|2|||
30775698|NCT04275336|58786252|FG000|Overall Study|Failed specimen of saliva|4|||
30775699|NCT04275336|58786253|FG001|Overall Study|Failed specimen of saliva|3|||
30775700|NCT04275336|58786254|FG002|Overall Study|Failed specimen of saliva|4|||
30775701|NCT04480710|58786269|FG000|Overall Study|Adverse Event|0|||
30775702|NCT04480710|58786270|FG001|Overall Study|Adverse Event|2|||
30775703|NCT04480710|58786271|FG002|Overall Study|Adverse Event|0|||
30775704|NCT04480710|58786272|FG003|Overall Study|Adverse Event|0|||
30775705|NCT04480710|58786269|FG000|Overall Study|Withdrawal by Subject|0|||
30775706|NCT04480710|58786270|FG001|Overall Study|Withdrawal by Subject|1|||
30775707|NCT04480710|58786271|FG002|Overall Study|Withdrawal by Subject|0|||
30775708|NCT04480710|58786272|FG003|Overall Study|Withdrawal by Subject|0|||
30775709|NCT04480710|58786269|FG000|Overall Study|Physician Decision|0|||
30775710|NCT04480710|58786270|FG001|Overall Study|Physician Decision|0|||
30775711|NCT04480710|58786271|FG002|Overall Study|Physician Decision|1|||
30775712|NCT04480710|58786272|FG003|Overall Study|Physician Decision|0|||
30775713|NCT04268316|58786291|FG000|Overall Study|Withdrawal by Subject|2|||
30775714|NCT04268316|58786292|FG001|Overall Study|Withdrawal by Subject|1|||
30775715|NCT04268316|58786293|FG002|Overall Study|Withdrawal by Subject|0|||
30775716|NCT01971970|58786303|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
30775717|NCT01971970|58786304|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
30775718|NCT01971970|58786303|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
30775719|NCT01971970|58786304|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
30775720|NCT01971970|58786303|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
30775721|NCT01971970|58786304|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
30775722|NCT01971970|58786303|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
30775723|NCT01971970|58786304|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
30775724|NCT01971970|58786303|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
30775725|NCT01971970|58786304|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
30775726|NCT01971970|58786303|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
30775727|NCT01971970|58786304|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
30775728|NCT01971970|58786303|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
30775729|NCT01971970|58786304|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
30775730|NCT04079790|58786319|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
30775731|NCT04079790|58786320|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
30775732|NCT04079790|58786321|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
30775733|NCT04079790|58786322|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
30775734|NCT04079790|58786319|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
30775735|NCT04079790|58786320|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
30775736|NCT04079790|58786321|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
30775737|NCT04079790|58786322|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
30775738|NCT04079790|58786319|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
30775739|NCT04079790|58786320|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
30775740|NCT04079790|58786321|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
30775741|NCT04079790|58786322|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
30775742|NCT04259346|58786350|FG000|Overall Study|Lost to Follow-up|1|||
30775743|NCT04259346|58786351|FG001|Overall Study|Lost to Follow-up|3|||
30775744|NCT04259346|58786350|FG000|Overall Study|Protocol Violation|1|||
30775745|NCT04259346|58786351|FG001|Overall Study|Protocol Violation|0|||
30775746|NCT04259346|58786350|FG000|Overall Study|Withdrawal by Subject|1|||
30775747|NCT04259346|58786351|FG001|Overall Study|Withdrawal by Subject|0|||
30775748|NCT04259346|58786350|FG000|Overall Study|Adverse Event|1|||
30775749|NCT04259346|58786351|FG001|Overall Study|Adverse Event|1|||
30775750|NCT04230876|58786359|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
30775751|NCT04230876|58786360|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
30775752|NCT04228302|58786372|FG000|Overall Study|Adverse Event|0|||
30775753|NCT04228302|58786373|FG001|Overall Study|Adverse Event|0|||
30775754|NCT04228302|58786374|FG002|Overall Study|Adverse Event|0|||
30775755|NCT04228302|58786375|FG003|Overall Study|Adverse Event|0|||
30775756|NCT04228302|58786376|FG004|Overall Study|Adverse Event|1|||
30775757|NCT04228302|58786377|FG005|Overall Study|Adverse Event|0|||
30851045|NCT02639546|58878079|FG002|Overall Study|Death|1|||
30851046|NCT02639546|58878080|FG003|Overall Study|Death|2|||
30851047|NCT02639546|58878081|FG004|Overall Study|Death|2|||
30851048|NCT02639546|58878082|FG005|Overall Study|Death|2|||
30851049|NCT02639546|58878083|FG006|Overall Study|Death|0|||
30851050|NCT02639546|58878084|FG007|Overall Study|Death|0|||
30851051|NCT02639546|58878077|FG000|Overall Study|Lost to Follow-up|0|||
30953286|NCT01857869|59005150|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
30775758|NCT01348100|58786398|FG000|Overall Study|Subject Withdrew Consent|0|||
30775759|NCT01348100|58786399|FG001|Overall Study|Subject Withdrew Consent|0|||
30775760|NCT01348100|58786400|FG002|Overall Study|Subject Withdrew Consent|2|||
30851052|NCT02639546|58878078|FG001|Overall Study|Lost to Follow-up|0|||
30851053|NCT02639546|58878079|FG002|Overall Study|Lost to Follow-up|1|||
30953287|NCT01857869|59005151|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
30775761|NCT01348100|58786401|FG003|Overall Study|Subject Withdrew Consent|0|||
30851054|NCT02639546|58878080|FG003|Overall Study|Lost to Follow-up|0|||
30775762|NCT01348100|58786402|FG004|Overall Study|Subject Withdrew Consent|1|||
30775763|NCT01348100|58786403|FG005|Overall Study|Subject Withdrew Consent|0|||
30775764|NCT01348100|58786404|FG006|Overall Study|Subject Withdrew Consent|1|||
30775765|NCT01348100|58786398|FG000|Overall Study|Protocol Deviation|0|||
30775766|NCT01348100|58786399|FG001|Overall Study|Protocol Deviation|0|||
30775767|NCT01348100|58786400|FG002|Overall Study|Protocol Deviation|0|||
30775768|NCT01348100|58786401|FG003|Overall Study|Protocol Deviation|1|||
30775769|NCT01348100|58786402|FG004|Overall Study|Protocol Deviation|0|||
30775770|NCT01348100|58786403|FG005|Overall Study|Protocol Deviation|0|||
30775771|NCT01348100|58786404|FG006|Overall Study|Protocol Deviation|0|||
30775772|NCT01348100|58786398|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
30775773|NCT01348100|58786399|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
30775774|NCT01348100|58786400|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
30775775|NCT01348100|58786401|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
30775776|NCT01348100|58786402|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
30775777|NCT01348100|58786403|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
30775778|NCT01348100|58786404|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
30775779|NCT01348100|58786398|FG000|Overall Study|Lost to Follow-up|0|||
30775780|NCT01348100|58786399|FG001|Overall Study|Lost to Follow-up|0|||
30775781|NCT01348100|58786400|FG002|Overall Study|Lost to Follow-up|0|||
30775782|NCT01348100|58786401|FG003|Overall Study|Lost to Follow-up|0|||
30775783|NCT01348100|58786402|FG004|Overall Study|Lost to Follow-up|0|||
30851055|NCT02639546|58878081|FG004|Overall Study|Lost to Follow-up|1|||
30851056|NCT02639546|58878082|FG005|Overall Study|Lost to Follow-up|1|||
30851057|NCT02639546|58878083|FG006|Overall Study|Lost to Follow-up|0|||
30851058|NCT02639546|58878084|FG007|Overall Study|Lost to Follow-up|1|||
30851059|NCT02639546|58878077|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
30851060|NCT02639546|58878078|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
30851061|NCT02639546|58878079|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
30851062|NCT02639546|58878080|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
30851063|NCT02639546|58878081|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
30851064|NCT02639546|58878082|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
30851065|NCT02639546|58878083|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
30851066|NCT02639546|58878084|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
30851067|NCT02639546|58878077|FG000|Overall Study|Study Terminated By Sponsor|0|||
30851068|NCT02639546|58878078|FG001|Overall Study|Study Terminated By Sponsor|2|||
30851069|NCT02639546|58878079|FG002|Overall Study|Study Terminated By Sponsor|3|||
30851070|NCT02639546|58878080|FG003|Overall Study|Study Terminated By Sponsor|4|||
30851071|NCT02639546|58878081|FG004|Overall Study|Study Terminated By Sponsor|4|||
30851072|NCT02639546|58878082|FG005|Overall Study|Study Terminated By Sponsor|3|||
30851073|NCT02639546|58878083|FG006|Overall Study|Study Terminated By Sponsor|3|||
30851074|NCT02639546|58878084|FG007|Overall Study|Study Terminated By Sponsor|9|||
30775784|NCT01348100|58786403|FG005|Overall Study|Lost to Follow-up|0|||
30775785|NCT01348100|58786404|FG006|Overall Study|Lost to Follow-up|1|||
30775786|NCT01348100|58786398|FG000|Overall Study|Administrative Problems|0|||
30775787|NCT01348100|58786399|FG001|Overall Study|Administrative Problems|0|||
30775788|NCT01348100|58786400|FG002|Overall Study|Administrative Problems|0|||
30775789|NCT01348100|58786401|FG003|Overall Study|Administrative Problems|0|||
30775790|NCT01348100|58786402|FG004|Overall Study|Administrative Problems|0|||
30775791|NCT01348100|58786403|FG005|Overall Study|Administrative Problems|1|||
30775792|NCT01348100|58786404|FG006|Overall Study|Administrative Problems|1|||
30851075|NCT02639546|58878077|FG000|Overall Study|Withdrawal by Subject|2|||
30851076|NCT02639546|58878078|FG001|Overall Study|Withdrawal by Subject|2|||
30851077|NCT02639546|58878079|FG002|Overall Study|Withdrawal by Subject|1|||
30851078|NCT02639546|58878080|FG003|Overall Study|Withdrawal by Subject|0|||
30851079|NCT02639546|58878081|FG004|Overall Study|Withdrawal by Subject|0|||
30851080|NCT02639546|58878082|FG005|Overall Study|Withdrawal by Subject|1|||
30851081|NCT02639546|58878083|FG006|Overall Study|Withdrawal by Subject|2|||
30851082|NCT02639546|58878084|FG007|Overall Study|Withdrawal by Subject|1|||
30953288|NCT01857869|59005152|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
30775793|NCT03676634|58786425|FG000|Overall Study|Red blood cell loss|1|||
30775794|NCT03676634|58786425|FG000|Overall Study|Out-of-limit pulse|2|||
30775795|NCT03675776|58786432|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
30851083|NCT02639390|58878118|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
30851084|NCT02639390|58878119|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
30851085|NCT02718417|58878128|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
30851086|NCT02718417|58878129|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
30851087|NCT02718417|58878130|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
30851088|NCT02718417|58878128|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
30775796|NCT03675776|58786433|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
30775797|NCT03675776|58786434|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
30775798|NCT03675776|58786432|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
30851089|NCT02718417|58878129|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
30851090|NCT02718417|58878130|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
30851091|NCT02718417|58878128|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
30851092|NCT02718417|58878129|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
30851093|NCT02718417|58878130|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
30851094|NCT02718417|58878128|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
30662566|NCT00917267|58676155|FG001|Overall Study|Entry Criteria Not Met|0|||
30662567|NCT00917267|58676154|FG000|Overall Study|Sponsor Decision|5|||
30662568|NCT00917267|58676155|FG001|Overall Study|Sponsor Decision|5|||
30662569|NCT00917267|58676154|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
30662570|NCT00917267|58676155|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
30662571|NCT00920699|58676168|FG000|Overall Study|Withdrawal by Subject|2|||
30662572|NCT00920699|58676169|FG001|Overall Study|Withdrawal by Subject|0|||
30662573|NCT00920699|58676170|FG002|Overall Study|Withdrawal by Subject|2|||
30662574|NCT00920699|58676168|FG000|Overall Study|no longer met eligibility|0|||
30662575|NCT00920699|58676169|FG001|Overall Study|no longer met eligibility|1|||
30775799|NCT03675776|58786433|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
30775800|NCT03675776|58786434|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
30851095|NCT02718417|58878129|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
30851096|NCT02718417|58878130|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
30851097|NCT02718417|58878128|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
30851098|NCT02718417|58878129|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
30851099|NCT02718417|58878130|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
30775801|NCT03673670|58786448|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
30775802|NCT03673670|58786449|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
30775803|NCT03673670|58786450|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
30775804|NCT03673670|58786451|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
30775805|NCT03673670|58786452|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
30775806|NCT03673670|58786453|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
30775807|NCT03673670|58786448|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
30775808|NCT03673670|58786449|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
30775809|NCT03673670|58786450|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
30775810|NCT03673670|58786451|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
30775811|NCT03673670|58786452|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
30775812|NCT03673670|58786453|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
30775813|NCT03673670|58786448|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
30775814|NCT03673670|58786449|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
30775815|NCT03673670|58786450|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
30775816|NCT03673670|58786451|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
30775817|NCT03673670|58786452|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
30775818|NCT03673670|58786453|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
30775819|NCT03673670|58786448|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
30775820|NCT03673670|58786449|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
30775821|NCT03673670|58786450|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
30775822|NCT03673670|58786451|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
30775823|NCT03673670|58786452|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
30775824|NCT03673670|58786453|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
30775825|NCT03673670|58786448|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
30775826|NCT03673670|58786449|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
30851100|NCT02718417|58878128|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
30851101|NCT02718417|58878129|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
30851102|NCT02718417|58878130|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
30851103|NCT02718417|58878128|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
30851104|NCT02718417|58878129|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
30851105|NCT02718417|58878130|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
30851106|NCT02718417|58878128|FG000|Chemotherapy Phase (CP)|Other|2|||
30851107|NCT02718417|58878129|FG001|Chemotherapy Phase (CP)|Other|0|||
30851108|NCT02718417|58878130|FG002|Chemotherapy Phase (CP)|Other|1|||
30851109|NCT02718417|58878128|FG000|Maintenance Phase (MP)|Adverse Event|21|||
30851110|NCT02718417|58878129|FG001|Maintenance Phase (MP)|Adverse Event|26|||
30953289|NCT01857869|59005153|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
30953290|NCT01857869|59005154|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
30953291|NCT01857869|59005155|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
30953292|NCT01857869|59005156|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
30775827|NCT03673670|58786450|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
30775828|NCT03673670|58786451|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
30851111|NCT02718417|58878130|FG002|Maintenance Phase (MP)|Adverse Event|0|||
30953293|NCT01857869|59005157|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
30662576|NCT00920699|58676170|FG002|Overall Study|no longer met eligibility|0|||
30662577|NCT00920699|58676168|FG000|Overall Study|Lost to Follow-up|0|||
30851112|NCT02718417|58878128|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
30851113|NCT02718417|58878129|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
30851114|NCT02718417|58878130|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
30851115|NCT02718417|58878128|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
30851116|NCT02718417|58878129|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
30851117|NCT02718417|58878130|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
30851118|NCT02718417|58878128|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
30851119|NCT02718417|58878129|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
30851120|NCT02718417|58878130|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
30851121|NCT02718417|58878128|FG000|Maintenance Phase (MP)|Physician's decision|6|||
30851122|NCT02718417|58878129|FG001|Maintenance Phase (MP)|Physician's decision|7|||
30851123|NCT02718417|58878130|FG002|Maintenance Phase (MP)|Physician's decision|0|||
30851124|NCT02718417|58878128|FG000|Maintenance Phase (MP)|Progressive disease|100|||
30851125|NCT02718417|58878129|FG001|Maintenance Phase (MP)|Progressive disease|88|||
30851126|NCT02718417|58878130|FG002|Maintenance Phase (MP)|Progressive disease|0|||
30851127|NCT02718417|58878128|FG000|Maintenance Phase (MP)|Other|2|||
30851128|NCT02718417|58878129|FG001|Maintenance Phase (MP)|Other|1|||
30851129|NCT02718417|58878130|FG002|Maintenance Phase (MP)|Other|0|||
30851130|NCT02718417|58878128|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
30851131|NCT02718417|58878129|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
30851132|NCT02718417|58878130|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
30775829|NCT03673670|58786452|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
30775830|NCT03673670|58786453|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
30775831|NCT03673670|58786448|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
30775832|NCT03673670|58786449|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
30775833|NCT03673670|58786450|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
30775834|NCT03673670|58786451|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
30775835|NCT03673670|58786452|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
30775836|NCT03673670|58786453|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
30775837|NCT03673670|58786448|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
30775838|NCT03673670|58786449|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
30775839|NCT03673670|58786450|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
30775840|NCT03673670|58786451|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
30775841|NCT03673670|58786452|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
30775842|NCT03673670|58786453|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
30775843|NCT04369742|58786472|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
30851133|NCT02718417|58878128|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
30851134|NCT02718417|58878129|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
30851135|NCT02718417|58878130|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
30851136|NCT02718417|58878128|FG000|Observation Phase (OP)|Adverse Event|0|||
30851137|NCT02718417|58878129|FG001|Observation Phase (OP)|Adverse Event|0|||
30851138|NCT02718417|58878130|FG002|Observation Phase (OP)|Adverse Event|1|||
30851139|NCT02718417|58878128|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
30851140|NCT02718417|58878129|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
30851141|NCT02718417|58878130|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
30851142|NCT02718417|58878128|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
30851143|NCT02718417|58878129|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
30851144|NCT02718417|58878130|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
30851145|NCT02718417|58878128|FG000|Observation Phase (OP)|Physician Decision|0|||
30851146|NCT02718417|58878129|FG001|Observation Phase (OP)|Physician Decision|0|||
30851147|NCT02718417|58878130|FG002|Observation Phase (OP)|Physician Decision|9|||
30851148|NCT02718417|58878128|FG000|Observation Phase (OP)|Progressive disease|0|||
30851149|NCT02718417|58878129|FG001|Observation Phase (OP)|Progressive disease|0|||
30851150|NCT02718417|58878130|FG002|Observation Phase (OP)|Progressive disease|92|||
30851151|NCT02718417|58878128|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
30851152|NCT02718417|58878129|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
30851153|NCT02718417|58878130|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
30851154|NCT02718417|58878128|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
30851155|NCT02718417|58878129|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
30851156|NCT02718417|58878130|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
30851157|NCT02718417|58878128|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
30851158|NCT02718417|58878129|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
30775844|NCT04369742|58786473|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
30775845|NCT04369742|58786472|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
30851159|NCT02718417|58878130|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
30851160|NCT02718417|58878128|FG000|Observation Phase (OP)|Other|0|||
30775846|NCT04369742|58786473|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
30775847|NCT04369430|58786481|FG000|Overall Study|Adverse Event|2|||
30775848|NCT04369430|58786482|FG001|Overall Study|Adverse Event|3|||
30775849|NCT04369430|58786481|FG000|Overall Study|Death|1|||
30775850|NCT04369430|58786482|FG001|Overall Study|Death|0|||
30775851|NCT04369430|58786481|FG000|Overall Study|Withdrawal by Subject|4|||
30851161|NCT02718417|58878129|FG001|Observation Phase (OP)|Other|0|||
30851162|NCT02718417|58878130|FG002|Observation Phase (OP)|Other|7|||
30851163|NCT02718417|58878128|FG000|Follow-up Phase|Adverse Event|3|||
30851164|NCT02718417|58878129|FG001|Follow-up Phase|Adverse Event|1|||
30775852|NCT04369430|58786482|FG001|Overall Study|Withdrawal by Subject|3|||
30775853|NCT04369430|58786481|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
30775854|NCT04369430|58786482|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
30775855|NCT04369430|58786481|FG000|Overall Study|Lost to Follow-up|0|||
30775856|NCT04369430|58786482|FG001|Overall Study|Lost to Follow-up|1|||
30775857|NCT04363736|58786490|FG000|Overall Study|Withdrawal by Subject|1|||
30775858|NCT04363736|58786491|FG001|Overall Study|Withdrawal by Subject|0|||
30775859|NCT04363736|58786490|FG000|Overall Study|Lost to Follow-up|10|||
30775860|NCT04363736|58786491|FG001|Overall Study|Lost to Follow-up|7|||
30775861|NCT04363736|58786490|FG000|Overall Study|Death|8|||
30775862|NCT04363736|58786491|FG001|Overall Study|Death|6|||
30775863|NCT04362176|58786499|FG000|Overall Study|Lost to Follow-up|5|||
30775864|NCT04362176|58786500|FG001|Overall Study|Lost to Follow-up|8|||
30851165|NCT02718417|58878130|FG002|Follow-up Phase|Adverse Event|1|||
30851166|NCT02718417|58878128|FG000|Follow-up Phase|Other|4|||
30851167|NCT02718417|58878129|FG001|Follow-up Phase|Other|6|||
30851168|NCT02718417|58878130|FG002|Follow-up Phase|Other|4|||
30851169|NCT02718417|58878128|FG000|Follow-up Phase|Withdrawal by Subject|19|||
30851170|NCT02718417|58878129|FG001|Follow-up Phase|Withdrawal by Subject|17|||
30851171|NCT02718417|58878130|FG002|Follow-up Phase|Withdrawal by Subject|5|||
30851172|NCT02718417|58878128|FG000|Follow-up Phase|Study terminated by sponsor|100|||
30851173|NCT02718417|58878129|FG001|Follow-up Phase|Study terminated by sponsor|138|||
30851174|NCT02718417|58878130|FG002|Follow-up Phase|Study terminated by sponsor|6|||
30851175|NCT02718417|58878128|FG000|Follow-up Phase|Lost to Follow-up|2|||
30851176|NCT02718417|58878129|FG001|Follow-up Phase|Lost to Follow-up|3|||
30851177|NCT02718417|58878130|FG002|Follow-up Phase|Lost to Follow-up|0|||
30851178|NCT02718417|58878128|FG000|Follow-up Phase|Death leading to discontinuation|7|||
30851179|NCT02718417|58878129|FG001|Follow-up Phase|Death leading to discontinuation|7|||
30851180|NCT02718417|58878130|FG002|Follow-up Phase|Death leading to discontinuation|3|||
30851181|NCT02718417|58878128|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
30851182|NCT02718417|58878129|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
30851183|NCT02718417|58878130|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
30851184|NCT02718417|58878128|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
30851185|NCT02718417|58878129|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
30851186|NCT02718417|58878130|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
30851187|NCT02718417|58878128|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
30851188|NCT02718417|58878129|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
30851189|NCT02718417|58878130|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
30851190|NCT02718417|58878128|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
30851191|NCT02718417|58878129|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
30851192|NCT02718417|58878130|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
30775865|NCT04362176|58786499|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
30775866|NCT04362176|58786500|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
30775867|NCT04079816|58786506|FG000|Overall Study|Request of Subject|2|||
30775868|NCT04079816|58786506|FG000|Overall Study|Unable to draw samples|1|||
30775869|NCT04079114|58786510|FG000|Overall Study|Study prematuely terminated.|166|||
30775870|NCT03055936|58786518|FG000|Overall Study|Adverse Event|0|||
30775871|NCT03055936|58786519|FG001|Overall Study|Adverse Event|1|||
30775872|NCT03055936|58786520|FG002|Overall Study|Adverse Event|1|||
30775873|NCT03055936|58786521|FG003|Overall Study|Adverse Event|1|||
30851193|NCT02718417|58878128|FG000|Long-term Follow-up Phase|Other|0|||
30851194|NCT02718417|58878129|FG001|Long-term Follow-up Phase|Other|2|||
30851195|NCT02718417|58878130|FG002|Long-term Follow-up Phase|Other|0|||
30851196|NCT02640404|58878147|FG000|Overall Study|Protocol Violation|1|||
30775874|NCT03055936|58786518|FG000|Overall Study|Personal reason|2|||
30775875|NCT03055936|58786519|FG001|Overall Study|Personal reason|0|||
30775876|NCT03055936|58786520|FG002|Overall Study|Personal reason|1|||
30851197|NCT02640404|58878148|FG001|Overall Study|Protocol Violation|0|||
30851198|NCT02640404|58878147|FG000|Overall Study|Withdrawal by Subject|1|||
30775877|NCT03055936|58786521|FG003|Overall Study|Personal reason|0|||
30775878|NCT03891524|58786563|FG000|Overall Study|Death|0|||
30775879|NCT03891524|58786564|FG001|Overall Study|Death|0|||
30775880|NCT03891524|58786565|FG002|Overall Study|Death|0|||
30851199|NCT02640404|58878148|FG001|Overall Study|Withdrawal by Subject|0|||
30851200|NCT00701727|58878154|FG000|First Treatment Period|Adverse Event|0|||
30775881|NCT03891524|58786566|FG003|Overall Study|Death|0|||
30775882|NCT03891524|58786567|FG004|Overall Study|Death|0|||
30775883|NCT03891524|58786568|FG005|Overall Study|Death|0|||
30775884|NCT03891524|58786569|FG006|Overall Study|Death|0|||
30953294|NCT01857869|59005158|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
30953295|NCT01857869|59005159|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
30953296|NCT04452318|59005247|FG000|Overall Study|Physician Decision|1|||
30953297|NCT04452318|59005248|FG001|Overall Study|Physician Decision|2|||
30953298|NCT04452318|59005249|FG002|Overall Study|Physician Decision|0|||
30851201|NCT00701727|58878155|FG001|First Treatment Period|Adverse Event|0|||
30851202|NCT00701727|58878154|FG000|First Treatment Period|Withdrawal by Subject|1|||
30953299|NCT04452318|59005250|FG003|Overall Study|Physician Decision|2|||
30953300|NCT04452318|59005251|FG004|Overall Study|Physician Decision|0|||
30953301|NCT04452318|59005252|FG005|Overall Study|Physician Decision|2|||
30953302|NCT04452318|59005253|FG006|Overall Study|Physician Decision|5|||
30953303|NCT04452318|59005247|FG000|Overall Study|Death|2|||
30953304|NCT04452318|59005248|FG001|Overall Study|Death|3|||
30953305|NCT04452318|59005249|FG002|Overall Study|Death|0|||
30953306|NCT04452318|59005250|FG003|Overall Study|Death|0|||
30953307|NCT04452318|59005251|FG004|Overall Study|Death|0|||
30953308|NCT04452318|59005252|FG005|Overall Study|Death|0|||
30953309|NCT04452318|59005253|FG006|Overall Study|Death|0|||
30953310|NCT04452318|59005247|FG000|Overall Study|Lost to Follow-up|38|||
30953311|NCT04452318|59005248|FG001|Overall Study|Lost to Follow-up|28|||
30953312|NCT04452318|59005249|FG002|Overall Study|Lost to Follow-up|0|||
30953313|NCT04452318|59005250|FG003|Overall Study|Lost to Follow-up|3|||
30953314|NCT04452318|59005251|FG004|Overall Study|Lost to Follow-up|3|||
30953315|NCT04452318|59005252|FG005|Overall Study|Lost to Follow-up|2|||
30953316|NCT04452318|59005253|FG006|Overall Study|Lost to Follow-up|1|||
30953317|NCT04452318|59005247|FG000|Overall Study|Withdrawal by Subject|46|||
30953318|NCT04452318|59005248|FG001|Overall Study|Withdrawal by Subject|40|||
30953319|NCT04452318|59005249|FG002|Overall Study|Withdrawal by Subject|0|||
30953320|NCT04452318|59005250|FG003|Overall Study|Withdrawal by Subject|18|||
30953321|NCT04452318|59005251|FG004|Overall Study|Withdrawal by Subject|6|||
30953322|NCT04452318|59005252|FG005|Overall Study|Withdrawal by Subject|8|||
30851203|NCT00701727|58878155|FG001|First Treatment Period|Withdrawal by Subject|0|||
30851204|NCT00701727|58878154|FG000|First Treatment Period|sponsor decision|0|||
30851205|NCT00701727|58878155|FG001|First Treatment Period|sponsor decision|1|||
30851206|NCT00701727|58878154|FG000|First Treatment Period|Lost to Follow-up|0|||
30953323|NCT04452318|59005253|FG006|Overall Study|Withdrawal by Subject|6|||
30953324|NCT00634101|59005430|FG000|Overall Study|Study Terminated|3|||
30953325|NCT00634101|59005431|FG001|Overall Study|Study Terminated|3|||
30953326|NCT00634101|59005430|FG000|Overall Study|Lost to Follow-up|2|||
30953327|NCT00634101|59005431|FG001|Overall Study|Lost to Follow-up|0|||
30953328|NCT00633477|59005448|FG000|Overall Study|Death|1|||
30953329|NCT00633477|59005449|FG001|Overall Study|Death|0|||
30953330|NCT00633477|59005448|FG000|Overall Study|Randomized but not treated|1|||
30953331|NCT00633477|59005449|FG001|Overall Study|Randomized but not treated|0|||
30953332|NCT00331773|59005474|FG000|Overall Study|Withdrawal by Subject|6|||
30953333|NCT00331773|59005475|FG001|Overall Study|Withdrawal by Subject|4|||
30953334|NCT00331773|59005474|FG000|Overall Study|Protocol Violation|10|||
30953335|NCT00331773|59005475|FG001|Overall Study|Protocol Violation|3|||
30953336|NCT00633243|59005508|FG000|Overall Study|Withdrawal by Subject|0|||
30662578|NCT00920699|58676169|FG001|Overall Study|Lost to Follow-up|0|||
30775885|NCT03891524|58786570|FG007|Overall Study|Death|1|||
30775886|NCT03891524|58786563|FG000|Overall Study|Withdrawal by Subject|0|||
30775887|NCT03891524|58786564|FG001|Overall Study|Withdrawal by Subject|1|||
30775888|NCT03891524|58786565|FG002|Overall Study|Withdrawal by Subject|2|||
30775889|NCT03891524|58786566|FG003|Overall Study|Withdrawal by Subject|1|||
30775890|NCT03891524|58786567|FG004|Overall Study|Withdrawal by Subject|2|||
30851207|NCT00701727|58878155|FG001|First Treatment Period|Lost to Follow-up|1|||
30851208|NCT00701727|58878154|FG000|Second Treatment Period|Withdrawal by Subject|2|||
30851209|NCT00701727|58878155|FG001|Second Treatment Period|Withdrawal by Subject|0|||
30953337|NCT00633243|59005509|FG001|Overall Study|Withdrawal by Subject|1|||
30953338|NCT00633243|59005508|FG000|Overall Study|incarceration|0|||
30953339|NCT00633243|59005509|FG001|Overall Study|incarceration|2|||
30953340|NCT00633243|59005508|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
30953341|NCT00633243|59005509|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
30953342|NCT00633243|59005508|FG000|Overall Study|Not comfortable with self-injecting|0|||
30953343|NCT00633243|59005509|FG001|Overall Study|Not comfortable with self-injecting|1|||
30953344|NCT00633243|59005508|FG000|Overall Study|Mental Health--Depression|0|||
30953345|NCT00633243|59005509|FG001|Overall Study|Mental Health--Depression|1|||
30953346|NCT00633243|59005508|FG000|Overall Study|Couldn't tolerate side-effects|1|||
30775891|NCT03891524|58786568|FG005|Overall Study|Withdrawal by Subject|2|||
30953347|NCT00633243|59005509|FG001|Overall Study|Couldn't tolerate side-effects|1|||
30953348|NCT01872689|59005519|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
30953349|NCT01872689|59005520|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
30775892|NCT03891524|58786569|FG006|Overall Study|Withdrawal by Subject|2|||
30775893|NCT03891524|58786570|FG007|Overall Study|Withdrawal by Subject|1|||
30775894|NCT03055624|58786605|FG000|Overall Study|Study closed|9|||
30775895|NCT01346176|58786612|FG000|Recruited|Protocol Violation|1|||
30775896|NCT01346176|58786613|FG001|Recruited|Protocol Violation|0|||
30775897|NCT01346176|58786614|FG002|Recruited|Protocol Violation|0|||
30775898|NCT01346176|58786612|FG000|Completed Advance Directive|Death|3|||
30775899|NCT01346176|58786613|FG001|Completed Advance Directive|Death|2|||
30775900|NCT01346176|58786614|FG002|Completed Advance Directive|Death|2|||
30851210|NCT01369069|58878172|FG000|Overall Study|Lost to Follow-up|8|||
30851211|NCT01369069|58878173|FG001|Overall Study|Lost to Follow-up|9|||
30851212|NCT01369069|58878172|FG000|Overall Study|Withdrawal by Subject|9|||
30851213|NCT01369069|58878173|FG001|Overall Study|Withdrawal by Subject|7|||
30851214|NCT02441218|58878181|FG000|Overall Study|Death|503|||
30851215|NCT02441218|58878182|FG001|Overall Study|Death|553|||
30851216|NCT02441218|58878181|FG000|Overall Study|Withdrawal by Subject|73|||
30851217|NCT02441218|58878182|FG001|Overall Study|Withdrawal by Subject|58|||
30851218|NCT02441218|58878181|FG000|Overall Study|Lost to Follow-up|2|||
30851219|NCT02441218|58878182|FG001|Overall Study|Lost to Follow-up|1|||
30851220|NCT02410252|58878188|FG000|Overall Study|Withdrawal by Subject|4|||
30851221|NCT02410252|58878188|FG000|Overall Study|Physician Decision|2|||
30851222|NCT02440594|58878202|FG000|Overall Study|Lost to Follow-up|34|||
30851223|NCT02440594|58878203|FG001|Overall Study|Lost to Follow-up|33|||
30851224|NCT02440594|58878204|FG002|Overall Study|Lost to Follow-up|54|||
30851225|NCT02440594|58878205|FG003|Overall Study|Lost to Follow-up|47|||
30851226|NCT02440594|58878206|FG004|Overall Study|Lost to Follow-up|5|||
30851227|NCT02440594|58878207|FG005|Overall Study|Lost to Follow-up|4|||
30775901|NCT01346176|58786612|FG000|Completed Advance Directive|Became Ineligible|3|||
30775902|NCT01346176|58786613|FG001|Completed Advance Directive|Became Ineligible|0|||
30775903|NCT01346176|58786614|FG002|Completed Advance Directive|Became Ineligible|1|||
30775904|NCT01346176|58786612|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
30775905|NCT01346176|58786613|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
30775906|NCT01346176|58786614|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
30775907|NCT01346176|58786612|FG000|Completed Satisfaction Survey|Death|3|||
30775908|NCT01346176|58786613|FG001|Completed Satisfaction Survey|Death|0|||
30775909|NCT01346176|58786614|FG002|Completed Satisfaction Survey|Death|2|||
30775910|NCT01346176|58786612|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
30775911|NCT01346176|58786613|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
30775912|NCT01346176|58786614|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
30775913|NCT04075604|58786625|FG000|Overall Study|Adverse Event|0|||
30775914|NCT04075604|58786626|FG001|Overall Study|Adverse Event|0|||
30775915|NCT04075604|58786627|FG002|Overall Study|Adverse Event|3|||
30775916|NCT04075604|58786625|FG000|Overall Study|Participant request to discontinue study treatment|0|||
30775917|NCT04075604|58786626|FG001|Overall Study|Participant request to discontinue study treatment|0|||
30775918|NCT04075604|58786627|FG002|Overall Study|Participant request to discontinue study treatment|1|||
30775919|NCT04075604|58786625|FG000|Overall Study|Participant withdrew consent|0|||
30775920|NCT04075604|58786626|FG001|Overall Study|Participant withdrew consent|0|||
30775921|NCT04075604|58786627|FG002|Overall Study|Participant withdrew consent|1|||
30775922|NCT04075604|58786625|FG000|Overall Study|Other reasons|1|||
30775923|NCT04075604|58786626|FG001|Overall Study|Other reasons|0|||
30775924|NCT04075604|58786627|FG002|Overall Study|Other reasons|0|||
30851228|NCT02440594|58878208|FG006|Overall Study|Lost to Follow-up|28|||
30851229|NCT02440594|58878209|FG007|Overall Study|Lost to Follow-up|48|||
30775925|NCT04075604|58786625|FG000|Overall Study|Disease progression|0|||
30775926|NCT04075604|58786626|FG001|Overall Study|Disease progression|1|||
30775927|NCT04075604|58786627|FG002|Overall Study|Disease progression|0|||
30775928|NCT04075604|58786625|FG000|Overall Study|Study drug toxicity|0|||
30775929|NCT04075604|58786626|FG001|Overall Study|Study drug toxicity|5|||
30775930|NCT04075604|58786627|FG002|Overall Study|Study drug toxicity|1|||
30775931|NCT03796208|58786646|FG000|Overall Study|Withdrawal by Subject|3|||
30775932|NCT03796208|58786647|FG001|Overall Study|Withdrawal by Subject|0|||
30775933|NCT03796208|58786646|FG000|Overall Study|Loss of pregnancy|1|||
30775934|NCT03796208|58786647|FG001|Overall Study|Loss of pregnancy|1|||
30775935|NCT03796208|58786646|FG000|Overall Study|Changed prenatal clinics|0|||
30775936|NCT03796208|58786647|FG001|Overall Study|Changed prenatal clinics|5|||
30775937|NCT03796208|58786646|FG000|Overall Study|Lost to Follow-up|20|||
30775938|NCT03796208|58786647|FG001|Overall Study|Lost to Follow-up|16|||
30775939|NCT01318876|58786653|FG000|Day 8 Survey|email address invalid|96|||
30851230|NCT02440594|58878202|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
30851231|NCT02440594|58878203|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
30851232|NCT02440594|58878204|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
30851233|NCT02440594|58878205|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
30775940|NCT01318876|58786653|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
30775941|NCT01318876|58786653|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
30775942|NCT03668600|58786657|FG000|Overall Study|Study Terminated by the Sponsor|157|||
30775943|NCT03668600|58786657|FG000|Overall Study|Protocol Violation|1|||
30851234|NCT02440594|58878206|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
30775944|NCT03668600|58786657|FG000|Overall Study|Pregnancy|1|||
30775945|NCT03668600|58786657|FG000|Overall Study|Lost to Follow-up|7|||
30775946|NCT03668600|58786657|FG000|Overall Study|Withdrawal by Subject|56|||
30775947|NCT03668600|58786657|FG000|Overall Study|Lack of Efficacy|7|||
30775948|NCT03668600|58786657|FG000|Overall Study|Adverse Event|1|||
30775949|NCT04073186|58786661|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
30851235|NCT02440594|58878207|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
30851236|NCT02440594|58878208|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
30851237|NCT02440594|58878209|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
30851238|NCT02440594|58878202|FG000|Overall Study|Withdrawal by Subject|81|||
30851239|NCT02440594|58878203|FG001|Overall Study|Withdrawal by Subject|67|||
30851240|NCT02440594|58878204|FG002|Overall Study|Withdrawal by Subject|59|||
30851241|NCT02440594|58878205|FG003|Overall Study|Withdrawal by Subject|38|||
30851242|NCT02440594|58878206|FG004|Overall Study|Withdrawal by Subject|2|||
30851243|NCT02440594|58878207|FG005|Overall Study|Withdrawal by Subject|2|||
30851244|NCT02440594|58878208|FG006|Overall Study|Withdrawal by Subject|7|||
30851245|NCT02440594|58878209|FG007|Overall Study|Withdrawal by Subject|7|||
30851246|NCT02440594|58878202|FG000|Overall Study|Administratively w/drawn|3|||
30851247|NCT02440594|58878203|FG001|Overall Study|Administratively w/drawn|2|||
30851248|NCT02440594|58878204|FG002|Overall Study|Administratively w/drawn|0|||
30851249|NCT02440594|58878205|FG003|Overall Study|Administratively w/drawn|0|||
30851250|NCT02440594|58878206|FG004|Overall Study|Administratively w/drawn|0|||
30851251|NCT02440594|58878207|FG005|Overall Study|Administratively w/drawn|0|||
30775950|NCT04073186|58786661|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
30775951|NCT04073186|58786661|FG000|First Wearing Cycle|Protocol Violation|1|||
30775952|NCT04073186|58786661|FG000|First Wearing Cycle|Lens Discomfort|2|||
30953350|NCT01872689|59005521|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
30953351|NCT01872689|59005522|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
30953352|NCT01872689|59005519|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
30953353|NCT01872689|59005520|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
30953354|NCT01872689|59005521|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
30953355|NCT01872689|59005522|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
30953356|NCT01872689|59005519|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
30953357|NCT01872689|59005520|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
30953358|NCT01872689|59005521|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
30953359|NCT01872689|59005522|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
30953360|NCT01872689|59005519|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
30953361|NCT01872689|59005520|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
30953362|NCT01872689|59005521|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
30953363|NCT01872689|59005522|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
30953364|NCT01872689|59005519|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
30953365|NCT01872689|59005520|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
30953366|NCT01872689|59005521|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
30953367|NCT01872689|59005522|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
30953368|NCT01872689|59005519|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
30953369|NCT01872689|59005520|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
30953370|NCT01872689|59005521|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
30662579|NCT00920699|58676170|FG002|Overall Study|Lost to Follow-up|2|||
30662580|NCT03462576|58676181|FG000|Overall Study|Protocol Violation|5|||
30662581|NCT03462576|58676182|FG001|Overall Study|Protocol Violation|11|||
30851252|NCT02440594|58878208|FG006|Overall Study|Administratively w/drawn|2|||
30851253|NCT02440594|58878209|FG007|Overall Study|Administratively w/drawn|1|||
30851254|NCT03836001|58878236|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
30851255|NCT03836001|58878237|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
30851256|NCT03836001|58878238|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
30851257|NCT03836001|58878236|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
30851258|NCT03836001|58878237|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
30851259|NCT03836001|58878238|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
30851260|NCT03836001|58878236|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
30851261|NCT03836001|58878237|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
30851262|NCT03836001|58878238|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
30851263|NCT03836001|58878236|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
30851264|NCT03836001|58878237|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
30851265|NCT03836001|58878238|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
30851266|NCT02465866|58878245|FG000|Period 3|Withdrawal by Subject|0|||
30851267|NCT02465866|58878246|FG001|Period 3|Withdrawal by Subject|1|||
30851268|NCT02465866|58878247|FG002|Period 3|Withdrawal by Subject|0|||
30851269|NCT02465866|58878248|FG003|Period 3|Withdrawal by Subject|0|||
30775953|NCT04073186|58786661|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
30775954|NCT04073186|58786661|FG000|Second Wearing Cycle|Adverse Event|1|||
30775955|NCT03054064|58786666|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
30775956|NCT03054064|58786666|FG000|Overall Study|Investigator Decision|2|||
30775957|NCT03054064|58786666|FG000|Overall Study|Bladder Issue|1|||
30775958|NCT03054064|58786666|FG000|Overall Study|High Blood Pressure|1|||
30775959|NCT03054064|58786666|FG000|Overall Study|Change in Status|1|||
30851270|NCT02439970|58878260|FG000|Overall Study|Study Terminated|2|||
30851271|NCT02439970|58878261|FG001|Overall Study|Study Terminated|3|||
30851272|NCT02437864|58878269|FG000|Overall Study|Protocol Violation|4|||
30851273|NCT02437864|58878270|FG001|Overall Study|Protocol Violation|0|||
30851274|NCT02408068|58878276|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
30851275|NCT02408068|58878277|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
30851276|NCT02408068|58878278|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
30851277|NCT02408068|58878279|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
30851278|NCT02408068|58878280|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
30851279|NCT02408068|58878281|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
30851280|NCT01361126|58878294|FG000|Overall Study|Sponsor decision|0|||
30851281|NCT01361126|58878295|FG001|Overall Study|Sponsor decision|2|||
30851282|NCT04428645|58878302|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
30851283|NCT01368835|58878306|FG000|Overall Study|Inclusion criteria/photography quality|22|||
30953371|NCT01872689|59005522|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
30953372|NCT01872689|59005519|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
30953373|NCT01872689|59005520|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
30953374|NCT01872689|59005521|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
30953375|NCT01872689|59005522|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
30851284|NCT01368835|58878306|FG000|Overall Study|Lost to Follow-up|11|||
30851285|NCT02407990|58878325|FG000|Overall Study|Death|2|||
30851286|NCT02407990|58878326|FG001|Overall Study|Death|22|||
30851287|NCT02407990|58878327|FG002|Overall Study|Death|23|||
30851288|NCT02407990|58878328|FG003|Overall Study|Death|7|||
30851289|NCT02407990|58878329|FG004|Overall Study|Death|17|||
30953376|NCT01872689|59005519|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
30953377|NCT01872689|59005520|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
30953378|NCT01872689|59005521|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
30953379|NCT01872689|59005522|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
30953380|NCT01872689|59005519|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
30953381|NCT01872689|59005520|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
30953382|NCT01872689|59005521|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
30953383|NCT01872689|59005522|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
30953384|NCT01872689|59005519|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
30953385|NCT01872689|59005520|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
30953386|NCT01872689|59005521|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
30953387|NCT01872689|59005522|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
30953388|NCT01872689|59005519|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
30953389|NCT01872689|59005520|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
30953390|NCT01872689|59005521|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
30953391|NCT01872689|59005522|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
30953392|NCT01872689|59005519|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
30953393|NCT01872689|59005520|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
30953394|NCT01872689|59005521|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
30953395|NCT01872689|59005522|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
30953396|NCT01872689|59005519|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
30775960|NCT03053518|58786670|FG000|Overall Study|Withdrawal by Subject|3|||
30851290|NCT02407990|58878330|FG005|Overall Study|Death|16|||
30851291|NCT02407990|58878331|FG006|Overall Study|Death|10|||
30775961|NCT03053518|58786670|FG000|Overall Study|Lost to Follow-up|2|||
30775962|NCT03053518|58786670|FG000|Overall Study|Ineligible|5|||
30851292|NCT02407990|58878332|FG007|Overall Study|Death|248|||
30851293|NCT02407990|58878325|FG000|Overall Study|Lost to Follow-up|0|||
30851294|NCT02407990|58878326|FG001|Overall Study|Lost to Follow-up|1|||
30851295|NCT02407990|58878327|FG002|Overall Study|Lost to Follow-up|0|||
30851296|NCT02407990|58878328|FG003|Overall Study|Lost to Follow-up|0|||
30851297|NCT02407990|58878329|FG004|Overall Study|Lost to Follow-up|0|||
30851298|NCT02407990|58878330|FG005|Overall Study|Lost to Follow-up|0|||
30851299|NCT02407990|58878331|FG006|Overall Study|Lost to Follow-up|0|||
30851300|NCT02407990|58878332|FG007|Overall Study|Lost to Follow-up|17|||
30775963|NCT04015336|58786674|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
30851301|NCT02407990|58878325|FG000|Overall Study|Progressive Disease|0|||
30851302|NCT02407990|58878326|FG001|Overall Study|Progressive Disease|0|||
30851303|NCT02407990|58878327|FG002|Overall Study|Progressive Disease|0|||
30775964|NCT04071158|58786697|FG000|Overall Study|Lost to Follow-up|1|||
30775965|NCT04071158|58786698|FG001|Overall Study|Lost to Follow-up|2|||
30775966|NCT04071158|58786699|FG002|Overall Study|Lost to Follow-up|3|||
30775967|NCT04071158|58786700|FG003|Overall Study|Lost to Follow-up|3|||
30775968|NCT04071158|58786701|FG004|Overall Study|Lost to Follow-up|5|||
30775969|NCT04071158|58786697|FG000|Overall Study|Randomized but not treated|2|||
30775970|NCT04071158|58786698|FG001|Overall Study|Randomized but not treated|2|||
30775971|NCT04071158|58786699|FG002|Overall Study|Randomized but not treated|0|||
30775972|NCT04071158|58786700|FG003|Overall Study|Randomized but not treated|0|||
30775973|NCT04071158|58786701|FG004|Overall Study|Randomized but not treated|0|||
30775974|NCT01317940|58786725|FG000|Overall Study|Death|1|||
30775975|NCT01317940|58786726|FG001|Overall Study|Death|0|||
30775976|NCT01317940|58786727|FG002|Overall Study|Death|1|||
30775977|NCT01317940|58786728|FG003|Overall Study|Death|0|||
30775978|NCT01317940|58786729|FG004|Overall Study|Death|0|||
30775979|NCT01317940|58786730|FG005|Overall Study|Death|0|||
30775980|NCT01317940|58786725|FG000|Overall Study|Lost to Follow-up|0|||
30775981|NCT01317940|58786726|FG001|Overall Study|Lost to Follow-up|0|||
30775982|NCT01317940|58786727|FG002|Overall Study|Lost to Follow-up|1|||
30775983|NCT01317940|58786728|FG003|Overall Study|Lost to Follow-up|1|||
30775984|NCT01317940|58786729|FG004|Overall Study|Lost to Follow-up|1|||
30775985|NCT01317940|58786730|FG005|Overall Study|Lost to Follow-up|0|||
30775986|NCT01317940|58786725|FG000|Overall Study|Change in therapy plan|0|||
30775987|NCT01317940|58786726|FG001|Overall Study|Change in therapy plan|0|||
30775988|NCT01317940|58786727|FG002|Overall Study|Change in therapy plan|3|||
30775989|NCT01317940|58786728|FG003|Overall Study|Change in therapy plan|0|||
30775990|NCT01317940|58786729|FG004|Overall Study|Change in therapy plan|0|||
30775991|NCT01317940|58786730|FG005|Overall Study|Change in therapy plan|0|||
30775992|NCT01345786|58786749|FG000|Overall Study|Adverse Event|0|||
30775993|NCT01345786|58786750|FG001|Overall Study|Adverse Event|1|||
30775994|NCT01345786|58786751|FG002|Overall Study|Adverse Event|3|||
30775995|NCT01345786|58786752|FG003|Overall Study|Adverse Event|1|||
30775996|NCT01345786|58786749|FG000|Overall Study|Subject withdrew consent|2|||
30775997|NCT01345786|58786750|FG001|Overall Study|Subject withdrew consent|2|||
30775998|NCT01345786|58786751|FG002|Overall Study|Subject withdrew consent|1|||
30775999|NCT01345786|58786752|FG003|Overall Study|Subject withdrew consent|0|||
30776000|NCT01345786|58786749|FG000|Overall Study|Noncompliance with protocol|1|||
30776001|NCT01345786|58786750|FG001|Overall Study|Noncompliance with protocol|0|||
30776002|NCT01345786|58786751|FG002|Overall Study|Noncompliance with protocol|1|||
30776003|NCT01345786|58786752|FG003|Overall Study|Noncompliance with protocol|0|||
30776004|NCT01345786|58786749|FG000|Overall Study|Administrative|3|||
30776005|NCT01345786|58786750|FG001|Overall Study|Administrative|5|||
30776006|NCT01345786|58786751|FG002|Overall Study|Administrative|0|||
30776007|NCT01345786|58786752|FG003|Overall Study|Administrative|0|||
30776008|NCT01345786|58786749|FG000|Overall Study|Lost to Follow-up|0|||
30776009|NCT01345786|58786750|FG001|Overall Study|Lost to Follow-up|0|||
30776010|NCT01345786|58786751|FG002|Overall Study|Lost to Follow-up|0|||
30776011|NCT01345786|58786752|FG003|Overall Study|Lost to Follow-up|2|||
30776012|NCT01317550|58786766|FG000|Overall Study|Withdrawal by Subject|1|||
30776013|NCT01317550|58786767|FG001|Overall Study|Withdrawal by Subject|0|||
30776014|NCT01317550|58786768|FG002|Overall Study|Withdrawal by Subject|0|||
30776015|NCT01317550|58786769|FG003|Overall Study|Withdrawal by Subject|0|||
30776016|NCT01317550|58786766|FG000|Overall Study|Lack of compliance study med|1|||
30776017|NCT01317550|58786767|FG001|Overall Study|Lack of compliance study med|0|||
30776018|NCT01317550|58786768|FG002|Overall Study|Lack of compliance study med|0|||
30776019|NCT01317550|58786769|FG003|Overall Study|Lack of compliance study med|0|||
30776020|NCT01317472|58786781|FG000|Overall Study|Withdrawal by Subject|1|||
30776021|NCT01317472|58786782|FG001|Overall Study|Withdrawal by Subject|0|||
30776022|NCT01317472|58786781|FG000|Overall Study|Unrelated hospitalization|1|||
30776023|NCT01317472|58786782|FG001|Overall Study|Unrelated hospitalization|0|||
30776024|NCT01345630|58786790|FG000|Overall Study|Adverse Event|22|||
30776025|NCT01345630|58786791|FG001|Overall Study|Adverse Event|23|||
30776026|NCT01345630|58786790|FG000|Overall Study|Lost to Follow-up|17|||
30776027|NCT01345630|58786791|FG001|Overall Study|Lost to Follow-up|16|||
30776028|NCT01345630|58786790|FG000|Overall Study|Protocol Violation|4|||
30776029|NCT01345630|58786791|FG001|Overall Study|Protocol Violation|1|||
30776030|NCT01345630|58786790|FG000|Overall Study|Medication error without associated AE|0|||
30776031|NCT01345630|58786791|FG001|Overall Study|Medication error without associated AE|1|||
30776032|NCT01345630|58786790|FG000|Overall Study|Study terminated by sponsor|254|||
30776033|NCT01345630|58786791|FG001|Overall Study|Study terminated by sponsor|285|||
30776034|NCT01345630|58786790|FG000|Overall Study|Other reasons|6|||
30776035|NCT01345630|58786791|FG001|Overall Study|Other reasons|8|||
30776036|NCT01345630|58786790|FG000|Overall Study|Withdrawn due to pregnancy|1|||
30776037|NCT01345630|58786791|FG001|Overall Study|Withdrawn due to pregnancy|2|||
30776038|NCT01345630|58786790|FG000|Overall Study|No longer willing to participate|9|||
30776039|NCT01345630|58786791|FG001|Overall Study|No longer willing to participate|12|||
30776040|NCT01345630|58786790|FG000|Overall Study|Insufficient clinical response|48|||
30851304|NCT02407990|58878328|FG003|Overall Study|Progressive Disease|0|||
30776041|NCT01345630|58786791|FG001|Overall Study|Insufficient clinical response|11|||
30776042|NCT03693612|58786808|FG000|Overall Study|Lost to Follow-up|0|||
30776043|NCT03693612|58786809|FG001|Overall Study|Lost to Follow-up|0|||
30776044|NCT03693612|58786810|FG002|Overall Study|Lost to Follow-up|0|||
30776045|NCT03693612|58786811|FG003|Overall Study|Lost to Follow-up|0|||
30776046|NCT03693612|58786812|FG004|Overall Study|Lost to Follow-up|1|||
30776047|NCT03693612|58786813|FG005|Overall Study|Lost to Follow-up|0|||
30776048|NCT03693612|58786814|FG006|Overall Study|Lost to Follow-up|0|||
30776049|NCT03693612|58786808|FG000|Overall Study|Withdrawal by Subject|0|||
30776050|NCT03693612|58786809|FG001|Overall Study|Withdrawal by Subject|0|||
30776051|NCT03693612|58786810|FG002|Overall Study|Withdrawal by Subject|1|||
30776052|NCT03693612|58786811|FG003|Overall Study|Withdrawal by Subject|0|||
30776053|NCT03693612|58786812|FG004|Overall Study|Withdrawal by Subject|2|||
30851305|NCT02407990|58878329|FG004|Overall Study|Progressive Disease|0|||
30851306|NCT02407990|58878330|FG005|Overall Study|Progressive Disease|0|||
30851307|NCT02407990|58878331|FG006|Overall Study|Progressive Disease|0|||
30851308|NCT02407990|58878332|FG007|Overall Study|Progressive Disease|1|||
30851309|NCT02407990|58878325|FG000|Overall Study|Withdrawal by Subject|0|||
30851310|NCT02407990|58878326|FG001|Overall Study|Withdrawal by Subject|0|||
30851311|NCT02407990|58878327|FG002|Overall Study|Withdrawal by Subject|0|||
30851312|NCT02407990|58878328|FG003|Overall Study|Withdrawal by Subject|0|||
30851313|NCT02407990|58878329|FG004|Overall Study|Withdrawal by Subject|1|||
30851314|NCT02407990|58878330|FG005|Overall Study|Withdrawal by Subject|0|||
30851315|NCT02407990|58878331|FG006|Overall Study|Withdrawal by Subject|0|||
30851316|NCT02407990|58878332|FG007|Overall Study|Withdrawal by Subject|30|||
30851317|NCT02407990|58878325|FG000|Overall Study|Study Terminated by Sponsor|1|||
30851318|NCT02407990|58878326|FG001|Overall Study|Study Terminated by Sponsor|3|||
30851319|NCT02407990|58878327|FG002|Overall Study|Study Terminated by Sponsor|3|||
30851320|NCT02407990|58878328|FG003|Overall Study|Study Terminated by Sponsor|0|||
30851321|NCT02407990|58878329|FG004|Overall Study|Study Terminated by Sponsor|3|||
30851322|NCT02407990|58878330|FG005|Overall Study|Study Terminated by Sponsor|4|||
30851323|NCT02407990|58878331|FG006|Overall Study|Study Terminated by Sponsor|3|||
30851324|NCT02407990|58878332|FG007|Overall Study|Study Terminated by Sponsor|37|||
30851325|NCT02407990|58878325|FG000|Overall Study|Logistics|0|||
30851326|NCT02407990|58878326|FG001|Overall Study|Logistics|0|||
30851327|NCT02407990|58878327|FG002|Overall Study|Logistics|0|||
30851328|NCT02407990|58878328|FG003|Overall Study|Logistics|0|||
30851329|NCT02407990|58878329|FG004|Overall Study|Logistics|0|||
30851330|NCT02407990|58878330|FG005|Overall Study|Logistics|0|||
30776054|NCT03693612|58786813|FG005|Overall Study|Withdrawal by Subject|0|||
30776055|NCT03693612|58786814|FG006|Overall Study|Withdrawal by Subject|0|||
30776056|NCT03693612|58786808|FG000|Overall Study|Study Terminated by Sponsor|0|||
30776057|NCT03693612|58786809|FG001|Overall Study|Study Terminated by Sponsor|1|||
30776058|NCT03693612|58786810|FG002|Overall Study|Study Terminated by Sponsor|0|||
30776059|NCT03693612|58786811|FG003|Overall Study|Study Terminated by Sponsor|0|||
30776060|NCT03693612|58786812|FG004|Overall Study|Study Terminated by Sponsor|3|||
30776061|NCT03693612|58786813|FG005|Overall Study|Study Terminated by Sponsor|0|||
30776062|NCT03693612|58786814|FG006|Overall Study|Study Terminated by Sponsor|0|||
30776063|NCT03692910|58786830|FG000|Overall Study|Lost to Follow-up|4|||
30776064|NCT03692910|58786831|FG001|Overall Study|Lost to Follow-up|0|||
30776065|NCT03692910|58786832|FG002|Overall Study|Lost to Follow-up|0|||
30776066|NCT03692910|58786830|FG000|Overall Study|Withdrawal by Subject|2|||
30776067|NCT03692910|58786831|FG001|Overall Study|Withdrawal by Subject|0|||
30776068|NCT03692910|58786832|FG002|Overall Study|Withdrawal by Subject|0|||
30776069|NCT04223232|58786838|FG000|Overall Study|Withdrawal by Subject|1|||
30776070|NCT04206384|58786842|FG000|Overall Study|Withdrawal by Subject|8|||
30776071|NCT04206384|58786842|FG000|Overall Study|Adverse Event|2|||
30776072|NCT04051944|58786848|FG000|Overall Study|Study ending|1|||
30776073|NCT04051944|58786849|FG001|Overall Study|Study ending|1|||
30776074|NCT04051944|58786848|FG000|Overall Study|Early study termination by participant|1|||
30776075|NCT04051944|58786849|FG001|Overall Study|Early study termination by participant|0|||
30776076|NCT04051944|58786848|FG000|Overall Study|Withdrawal by Subject|2|||
30851331|NCT02407990|58878331|FG006|Overall Study|Logistics|0|||
30851332|NCT02407990|58878332|FG007|Overall Study|Logistics|1|||
30851333|NCT02407990|58878325|FG000|Overall Study|Rolled into long-term extension study|0|||
30851334|NCT02407990|58878326|FG001|Overall Study|Rolled into long-term extension study|0|||
30851335|NCT02407990|58878327|FG002|Overall Study|Rolled into long-term extension study|0|||
30851336|NCT02407990|58878328|FG003|Overall Study|Rolled into long-term extension study|0|||
30851337|NCT02407990|58878329|FG004|Overall Study|Rolled into long-term extension study|0|||
30776077|NCT04051944|58786849|FG001|Overall Study|Withdrawal by Subject|2|||
30776078|NCT04051944|58786848|FG000|Overall Study|Lack of Efficacy|3|||
30776079|NCT04051944|58786849|FG001|Overall Study|Lack of Efficacy|0|||
30776080|NCT04051944|58786848|FG000|Overall Study|Adverse event, non- fatal|1|||
30851338|NCT02407990|58878330|FG005|Overall Study|Rolled into long-term extension study|0|||
30851339|NCT02407990|58878331|FG006|Overall Study|Rolled into long-term extension study|0|||
30776081|NCT04051944|58786849|FG001|Overall Study|Adverse event, non- fatal|1|||
30776082|NCT04050618|58786857|FG000|First Intervention|Withdrawal by Subject|2|||
30776083|NCT04050618|58786858|FG001|First Intervention|Withdrawal by Subject|0|||
30776084|NCT04050618|58786857|FG000|Second Intervention|Withdrawal by Subject|1|||
30776085|NCT04050618|58786858|FG001|Second Intervention|Withdrawal by Subject|0|||
30776086|NCT04067492|58786875|FG000|Overall Study|Lost to Follow-up|0|||
30851340|NCT02407990|58878332|FG007|Overall Study|Rolled into long-term extension study|1|||
30851341|NCT03288129|58878356|FG000|Overall Study|Adverse Event|10|||
30851342|NCT03288129|58878356|FG000|Overall Study|Lost to Follow-up|3|||
30851343|NCT03288129|58878356|FG000|Overall Study|Withdrawal by Subject|3|||
30851344|NCT03288129|58878356|FG000|Overall Study|Withdrawal of consent/assent|1|||
30851345|NCT03288129|58878356|FG000|Overall Study|Other|5|||
30851346|NCT01673282|58878362|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
30851347|NCT01673282|58878363|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
30851348|NCT01673282|58878362|FG000|Overall Study|Lack of Efficacy|9|||
30851349|NCT01673282|58878363|FG001|Overall Study|Lack of Efficacy|2|||
30851350|NCT01673282|58878362|FG000|Overall Study|Lost to Follow-up|11|||
30851351|NCT01673282|58878363|FG001|Overall Study|Lost to Follow-up|10|||
30851352|NCT01673282|58878362|FG000|Overall Study|Withdrawal by Subject|3|||
30851353|NCT01673282|58878363|FG001|Overall Study|Withdrawal by Subject|3|||
30851354|NCT01673282|58878362|FG000|Overall Study|Other|1|||
30851355|NCT01673282|58878363|FG001|Overall Study|Other|6|||
30851356|NCT04157751|58878371|FG000|Overall Study|Withdrawal by Subject|12|||
30851357|NCT04157751|58878372|FG001|Overall Study|Withdrawal by Subject|17|||
30851358|NCT04157751|58878371|FG000|Overall Study|Lost to Follow-up|6|||
30851359|NCT04157751|58878372|FG001|Overall Study|Lost to Follow-up|2|||
30953397|NCT01872689|59005520|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
30953398|NCT01872689|59005521|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
30953399|NCT01872689|59005522|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
30953400|NCT01872689|59005519|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
30953401|NCT01872689|59005520|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
30953402|NCT01872689|59005521|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
30953403|NCT01872689|59005522|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
30953404|NCT00632931|59005535|FG000|Part 1, Period 1|Protocol Violation|1|||
30953405|NCT00632931|59005536|FG001|Part 1, Period 1|Protocol Violation|0|||
30953406|NCT00632931|59005537|FG002|Part 1, Period 1|Protocol Violation|0|||
30953407|NCT00632931|59005535|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
30953408|NCT00632931|59005536|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
30776087|NCT04067492|58786876|FG001|Overall Study|Lost to Follow-up|0|||
30953409|NCT00632931|59005537|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
30953410|NCT00632931|59005535|FG000|Part 2|Adverse Event|0|||
30953411|NCT00632931|59005536|FG001|Part 2|Adverse Event|0|||
30953412|NCT00632931|59005537|FG002|Part 2|Adverse Event|3|||
30953413|NCT00632931|59005535|FG000|Part 2|Death|0|||
30953414|NCT00632931|59005536|FG001|Part 2|Death|0|||
30953415|NCT00632931|59005537|FG002|Part 2|Death|1|||
30953416|NCT00632931|59005535|FG000|Part 2|Lack of Efficacy|0|||
30953417|NCT00632931|59005536|FG001|Part 2|Lack of Efficacy|0|||
30953418|NCT00632931|59005537|FG002|Part 2|Lack of Efficacy|17|||
30953419|NCT00632931|59005535|FG000|Part 2|Withdrawal by Subject|0|||
30953420|NCT00632931|59005536|FG001|Part 2|Withdrawal by Subject|0|||
30953421|NCT00632931|59005537|FG002|Part 2|Withdrawal by Subject|3|||
30953422|NCT01857323|59005542|FG000|Overall Study|Adverse Event|1|||
30953423|NCT01857323|59005542|FG000|Overall Study|Withdrawal by Subject|3|||
30953424|NCT01857323|59005542|FG000|Overall Study|Non-compliance|1|||
30953425|NCT01857323|59005542|FG000|Overall Study|Protocol Violation|6|||
30953426|NCT01857323|59005542|FG000|Overall Study|Lost to Follow-up|1|||
30953427|NCT01857323|59005542|FG000|Overall Study|Other|4|||
30953428|NCT01857323|59005542|FG000|Overall Study|Did not complete 180 doses|48|||
30953429|NCT00632541|59005546|FG000|Overall Study|Adverse Event|7|||
30953430|NCT01872611|59005552|FG000|Overall Study|Adverse Event|3|||
30953431|NCT01872611|59005553|FG001|Overall Study|Adverse Event|1|||
30953432|NCT01872611|59005552|FG000|Overall Study|Adverse Event, prior to treatment|0|||
30953433|NCT01872611|59005553|FG001|Overall Study|Adverse Event, prior to treatment|1|||
30776088|NCT04067492|58786877|FG002|Overall Study|Lost to Follow-up|0|||
30776089|NCT04067492|58786878|FG003|Overall Study|Lost to Follow-up|0|||
30776090|NCT04067492|58786879|FG004|Overall Study|Lost to Follow-up|0|||
30851360|NCT04157751|58878371|FG000|Overall Study|Adverse Event|34|||
30851361|NCT04157751|58878372|FG001|Overall Study|Adverse Event|23|||
30776091|NCT04067492|58786880|FG005|Overall Study|Lost to Follow-up|1|||
30851362|NCT04157751|58878371|FG000|Overall Study|Not treated|1|||
30851363|NCT04157751|58878372|FG001|Overall Study|Not treated|5|||
30851364|NCT04157751|58878371|FG000|Overall Study|Other reason not stated above|10|||
30851365|NCT04157751|58878372|FG001|Overall Study|Other reason not stated above|10|||
30851366|NCT01673126|58878380|FG000|Overall Study|change of diagnosis|4|||
30953434|NCT01872611|59005552|FG000|Overall Study|Death|0|||
30953435|NCT01872611|59005553|FG001|Overall Study|Death|1|||
30953436|NCT01872611|59005552|FG000|Overall Study|Death, prior to treatment|0|||
30953437|NCT01872611|59005553|FG001|Overall Study|Death, prior to treatment|1|||
30776092|NCT04067492|58786875|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
30776093|NCT04067492|58786876|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
30776094|NCT04067492|58786877|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
30776095|NCT04067492|58786878|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
30776096|NCT04067492|58786879|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
30776097|NCT04067492|58786880|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
30776098|NCT04067492|58786875|FG000|Overall Study|COVID-19 epidemiological situation|0|||
30776099|NCT04067492|58786876|FG001|Overall Study|COVID-19 epidemiological situation|0|||
30776100|NCT04067492|58786877|FG002|Overall Study|COVID-19 epidemiological situation|0|||
30776101|NCT04067492|58786878|FG003|Overall Study|COVID-19 epidemiological situation|1|||
30776102|NCT04067492|58786879|FG004|Overall Study|COVID-19 epidemiological situation|0|||
30776103|NCT04067492|58786880|FG005|Overall Study|COVID-19 epidemiological situation|0|||
30776104|NCT04375878|58786898|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
30776105|NCT04375878|58786899|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
30776106|NCT04375878|58786900|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
30851367|NCT01673126|58878381|FG001|Overall Study|change of diagnosis|3|||
30851368|NCT02407054|58878390|FG000|Overall Study|Adverse Event|1|||
30851369|NCT02407054|58878391|FG001|Overall Study|Adverse Event|4|||
30851370|NCT02407054|58878392|FG002|Overall Study|Adverse Event|1|||
30851371|NCT02407054|58878390|FG000|Overall Study|Non-compliance with Study|0|||
30851372|NCT02407054|58878391|FG001|Overall Study|Non-compliance with Study|2|||
30851373|NCT02407054|58878392|FG002|Overall Study|Non-compliance with Study|1|||
30776107|NCT04375878|58786901|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
30776108|NCT04375878|58786902|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
30776109|NCT04375878|58786903|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
30776110|NCT04375878|58786898|FG000|Crossover First and Second Interventions|Adverse Event|0|||
30776111|NCT04375878|58786899|FG001|Crossover First and Second Interventions|Adverse Event|0|||
30776112|NCT04375878|58786900|FG002|Crossover First and Second Interventions|Adverse Event|1|||
30776113|NCT04375878|58786901|FG003|Crossover First and Second Interventions|Adverse Event|0|||
30776114|NCT04375878|58786902|FG004|Crossover First and Second Interventions|Adverse Event|0|||
30776115|NCT04375878|58786903|FG005|Crossover First and Second Interventions|Adverse Event|0|||
30776116|NCT04375878|58786898|FG000|Extension Phase|Withdrawal by Subject|0|||
30776117|NCT04375878|58786899|FG001|Extension Phase|Withdrawal by Subject|0|||
30851374|NCT02407054|58878390|FG000|Overall Study|Physician Decision|1|||
30851375|NCT02407054|58878391|FG001|Overall Study|Physician Decision|3|||
30953438|NCT01872611|59005552|FG000|Overall Study|Lost to Follow-up|8|||
30776118|NCT04375878|58786900|FG002|Extension Phase|Withdrawal by Subject|0|||
30776119|NCT04375878|58786901|FG003|Extension Phase|Withdrawal by Subject|0|||
30776120|NCT04375878|58786902|FG004|Extension Phase|Withdrawal by Subject|1|||
30776121|NCT04375878|58786903|FG005|Extension Phase|Withdrawal by Subject|0|||
30776122|NCT04189224|58786923|FG000|Period 2|Adverse Event|0|||
30776123|NCT04189224|58786924|FG001|Period 2|Adverse Event|1|||
30776124|NCT04186806|58786932|FG000|Period 1: 7 Days|Adverse Event|1|||
30776125|NCT04186806|58786933|FG001|Period 1: 7 Days|Adverse Event|0|||
30776126|NCT04041414|58786942|FG000|Overall Study|Lost to Follow-up|1|||
30776127|NCT04041414|58786943|FG001|Overall Study|Lost to Follow-up|2|||
30776128|NCT04370028|58786952|FG000|Overall Study|Withdrawal by Subject|695|||
30776129|NCT04370028|58786952|FG000|Overall Study|Protocol Violation|9|||
30776130|NCT04370028|58786952|FG000|Overall Study|Adverse Event|3|||
30776131|NCT04037748|58786965|FG000|Treatment Period 1|Withdrawal by Subject|3|||
30776132|NCT04037748|58786966|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30776133|NCT04037748|58786965|FG000|Treatment Period 1|Adverse Event|1|||
30776134|NCT04037748|58786966|FG001|Treatment Period 1|Adverse Event|1|||
30776135|NCT04037748|58786965|FG000|Treatment Period 1|Protocol Violation|4|||
30776136|NCT04037748|58786966|FG001|Treatment Period 1|Protocol Violation|5|||
30776137|NCT04037748|58786965|FG000|Treatment Period 2|Adverse Event|0|||
30776138|NCT04037748|58786966|FG001|Treatment Period 2|Adverse Event|1|||
30776139|NCT04037748|58786965|FG000|Treatment Period 2|Protocol Violation|2|||
30776140|NCT04037748|58786966|FG001|Treatment Period 2|Protocol Violation|0|||
30953439|NCT01872611|59005553|FG001|Overall Study|Lost to Follow-up|1|||
30776141|NCT04036110|58786975|FG000|Overall Study|Lost to Follow-up|3|||
30776142|NCT04036110|58786976|FG001|Overall Study|Lost to Follow-up|2|||
30776143|NCT04036110|58786977|FG002|Overall Study|Lost to Follow-up|1|||
30776144|NCT04036110|58786975|FG000|Overall Study|Study Suspended|4|||
30776145|NCT04036110|58786976|FG001|Overall Study|Study Suspended|5|||
30776146|NCT04036110|58786977|FG002|Overall Study|Study Suspended|1|||
30776147|NCT03053050|58786988|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
30776148|NCT03053050|58786989|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
30851376|NCT02407054|58878392|FG002|Overall Study|Physician Decision|3|||
30851377|NCT02407054|58878390|FG000|Overall Study|Withdrawal by Subject|5|||
30851378|NCT02407054|58878391|FG001|Overall Study|Withdrawal by Subject|9|||
30851379|NCT02407054|58878392|FG002|Overall Study|Withdrawal by Subject|2|||
30851380|NCT01652716|58878403|FG000|Overall Study|Loss of glucose control|1|||
30776149|NCT03053050|58786990|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
30776150|NCT03053050|58786991|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
30776151|NCT03053050|58786988|FG000|Randomized Phase|Withdrew Consent|16|||
30776152|NCT03053050|58786989|FG001|Randomized Phase|Withdrew Consent|8|||
30776153|NCT03053050|58786990|FG002|Randomized Phase|Withdrew Consent|9|||
30776154|NCT03053050|58786991|FG003|Randomized Phase|Withdrew Consent|0|||
30776155|NCT03053050|58786988|FG000|Randomized Phase|Investigator's Discretion|6|||
30776156|NCT03053050|58786989|FG001|Randomized Phase|Investigator's Discretion|6|||
30776157|NCT03053050|58786990|FG002|Randomized Phase|Investigator's Discretion|3|||
30776158|NCT03053050|58786991|FG003|Randomized Phase|Investigator's Discretion|0|||
30776159|NCT03053050|58786988|FG000|Randomized Phase|Lost to Follow-up|5|||
30776160|NCT03053050|58786989|FG001|Randomized Phase|Lost to Follow-up|1|||
30776161|NCT03053050|58786990|FG002|Randomized Phase|Lost to Follow-up|1|||
30776162|NCT03053050|58786991|FG003|Randomized Phase|Lost to Follow-up|0|||
30776163|NCT03053050|58786988|FG000|Randomized Phase|Adverse Event|0|||
30776164|NCT03053050|58786989|FG001|Randomized Phase|Adverse Event|1|||
30776165|NCT03053050|58786990|FG002|Randomized Phase|Adverse Event|0|||
30776166|NCT03053050|58786991|FG003|Randomized Phase|Adverse Event|0|||
30776167|NCT03053050|58786988|FG000|Randomized Phase|Randomized but Never Treated|2|||
30776168|NCT03053050|58786989|FG001|Randomized Phase|Randomized but Never Treated|2|||
30776169|NCT03053050|58786990|FG002|Randomized Phase|Randomized but Never Treated|2|||
30776170|NCT03053050|58786991|FG003|Randomized Phase|Randomized but Never Treated|0|||
30776171|NCT03053050|58786988|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
30776172|NCT03053050|58786989|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
30776173|NCT03053050|58786990|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
30851381|NCT01652716|58878404|FG001|Overall Study|Loss of glucose control|0|||
30851382|NCT01652716|58878403|FG000|Overall Study|Administrative|0|||
30851383|NCT01652716|58878404|FG001|Overall Study|Administrative|2|||
30851384|NCT01652716|58878403|FG000|Overall Study|Investigator decision|1|||
30851385|NCT01652716|58878404|FG001|Overall Study|Investigator decision|4|||
30851386|NCT01652716|58878403|FG000|Overall Study|Lost to Follow-up|12|||
30851387|NCT01652716|58878404|FG001|Overall Study|Lost to Follow-up|11|||
30851388|NCT01652716|58878403|FG000|Overall Study|Protocol Violation|2|||
30851389|NCT01652716|58878404|FG001|Overall Study|Protocol Violation|1|||
30851390|NCT01652716|58878403|FG000|Overall Study|Adverse Event|7|||
30851391|NCT01652716|58878404|FG001|Overall Study|Adverse Event|10|||
30851392|NCT01652716|58878403|FG000|Overall Study|Withdrawal by Subject|33|||
30851393|NCT01652716|58878404|FG001|Overall Study|Withdrawal by Subject|18|||
30776174|NCT03053050|58786991|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
30776175|NCT03053050|58786988|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
30776176|NCT03053050|58786989|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
30776177|NCT03053050|58786990|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
30776178|NCT03053050|58786991|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
30776179|NCT03053050|58786988|FG000|Open-label Phase|Withdrew Consent|0|||
30776180|NCT03053050|58786989|FG001|Open-label Phase|Withdrew Consent|0|||
30776181|NCT03053050|58786990|FG002|Open-label Phase|Withdrew Consent|0|||
30851394|NCT02790073|58878410|FG000|Overall Study|Death|1|||
30851395|NCT02790073|58878410|FG000|Overall Study|Withdrawal from HD|1|||
30851396|NCT02790073|58878410|FG000|Overall Study|Withdrawal by Subject|1|||
30851397|NCT02789137|58878414|FG000|Overall Study|Dropped out/Died|58|||
30851398|NCT01672970|58878419|FG000|Overall Study|Lack of Efficacy|12|||
30851399|NCT01672970|58878419|FG000|Overall Study|Adverse Event|18|||
30851400|NCT01672970|58878419|FG000|Overall Study|Withdrawal by Subject|2|||
30662582|NCT03462576|58676183|FG002|Overall Study|Protocol Violation|7|||
30662583|NCT03462576|58676181|FG000|Overall Study|Device Malfunction|0|||
30662584|NCT03462576|58676182|FG001|Overall Study|Device Malfunction|0|||
30776182|NCT03053050|58786991|FG003|Open-label Phase|Withdrew Consent|6|||
30776183|NCT03053050|58786988|FG000|Open-label Phase|Investigator's Discretion|0|||
30776184|NCT03053050|58786989|FG001|Open-label Phase|Investigator's Discretion|0|||
30776185|NCT03053050|58786990|FG002|Open-label Phase|Investigator's Discretion|0|||
30776186|NCT03053050|58786991|FG003|Open-label Phase|Investigator's Discretion|4|||
30776187|NCT04369950|58787002|FG000|Overall Study|Protocol Violation|2|||
30776188|NCT04369950|58787003|FG001|Overall Study|Protocol Violation|2|||
30776189|NCT04035564|58787011|FG000|Overall Study|Protocol Violation|1|||
30776190|NCT04035564|58787012|FG001|Overall Study|Protocol Violation|2|||
30776191|NCT04035564|58787011|FG000|Overall Study|No laboratory available|2|||
30776192|NCT04035564|58787012|FG001|Overall Study|No laboratory available|2|||
30662585|NCT03462576|58676183|FG002|Overall Study|Device Malfunction|1|||
30662586|NCT00916721|58676193|FG000|Overall Study|Lost to Follow-up|0|||
30776193|NCT04035564|58787011|FG000|Overall Study|Guardian declined consent|1|||
30776194|NCT04035564|58787012|FG001|Overall Study|Guardian declined consent|2|||
30776195|NCT02955602|58787021|FG000|Overall Study|Adverse Event|0|||
30776196|NCT02955602|58787022|FG001|Overall Study|Adverse Event|3|||
30776197|NCT02955602|58787023|FG002|Overall Study|Adverse Event|0|||
30776198|NCT02955602|58787021|FG000|Overall Study|Withdrawal of informed consent|1|||
30662587|NCT00916721|58676194|FG001|Overall Study|Lost to Follow-up|1|||
30776199|NCT02955602|58787022|FG001|Overall Study|Withdrawal of informed consent|3|||
30776200|NCT02955602|58787023|FG002|Overall Study|Withdrawal of informed consent|2|||
30776201|NCT02955602|58787021|FG000|Overall Study|Lost to Follow-up|0|||
30776202|NCT02955602|58787022|FG001|Overall Study|Lost to Follow-up|0|||
30776203|NCT02955602|58787023|FG002|Overall Study|Lost to Follow-up|1|||
30776204|NCT02955602|58787021|FG000|Overall Study|Other|0|||
30776205|NCT02955602|58787022|FG001|Overall Study|Other|1|||
30776206|NCT02955602|58787023|FG002|Overall Study|Other|3|||
30776207|NCT04179786|58787031|FG000|Overall Study|Withdrawal by Subject|8|||
30776208|NCT04175808|58787035|FG000|Part A|Miscellaneous|2|||
30776209|NCT04175808|58787036|FG001|Part A|Miscellaneous|0|||
30776210|NCT04175808|58787037|FG002|Part A|Miscellaneous|0|||
30776211|NCT04175808|58787038|FG003|Part A|Miscellaneous|0|||
30776212|NCT04175808|58787039|FG004|Part A|Miscellaneous|0|||
30776213|NCT04175808|58787040|FG005|Part A|Miscellaneous|0|||
30776214|NCT04175808|58787041|FG006|Part A|Miscellaneous|0|||
30776215|NCT04057196|58787057|FG000|Overall Study|Withdrawal by Subject|3|||
30776216|NCT04057196|58787057|FG000|Overall Study|Death|3|||
30776217|NCT04027686|58787063|FG000|Overall Study|Lost to Follow-up|2|||
30776218|NCT04027686|58787064|FG001|Overall Study|Lost to Follow-up|0|||
30851401|NCT01672970|58878419|FG000|Overall Study|Lost to Follow-up|5|||
30851402|NCT01672970|58878419|FG000|Overall Study|Other|9|||
30851403|NCT01672970|58878419|FG000|Overall Study|Enrolled but not treated|1|||
30851404|NCT02788747|58878443|FG000|Overall Study|Adverse Event|1|||
30851405|NCT02788747|58878444|FG001|Overall Study|Adverse Event|0|||
30851406|NCT02788747|58878445|FG002|Overall Study|Adverse Event|0|||
30851407|NCT02406742|58878459|FG000|Overall Study|Progression of Disease|5|||
30851408|NCT02406742|58878460|FG001|Overall Study|Progression of Disease|1|||
30851409|NCT02406742|58878461|FG002|Overall Study|Progression of Disease|6|||
30851410|NCT02406742|58878459|FG000|Overall Study|Adverse Event|3|||
30851411|NCT02406742|58878460|FG001|Overall Study|Adverse Event|0|||
30851412|NCT02406742|58878461|FG002|Overall Study|Adverse Event|2|||
30851413|NCT02406742|58878459|FG000|Overall Study|Death|1|||
30851414|NCT02406742|58878460|FG001|Overall Study|Death|0|||
30851415|NCT02406742|58878461|FG002|Overall Study|Death|0|||
30851416|NCT02406742|58878459|FG000|Overall Study|Lack of Efficacy|0|||
30776219|NCT04027686|58787063|FG000|Overall Study|Withdrawal by Subject|0|||
30776220|NCT04027686|58787064|FG001|Overall Study|Withdrawal by Subject|1|||
30776221|NCT03052426|58787077|FG000|Overall Study|Withdrawal by Subject|0|||
30776222|NCT03052426|58787078|FG001|Overall Study|Withdrawal by Subject|1|||
30851417|NCT02406742|58878460|FG001|Overall Study|Lack of Efficacy|0|||
30851418|NCT02406742|58878461|FG002|Overall Study|Lack of Efficacy|1|||
30851419|NCT02406742|58878459|FG000|Overall Study|Withdrawal by Participant|1|||
30851420|NCT02406742|58878460|FG001|Overall Study|Withdrawal by Participant|2|||
30851421|NCT02406742|58878461|FG002|Overall Study|Withdrawal by Participant|0|||
30851422|NCT02406742|58878459|FG000|Overall Study|Physician Decision|1|||
30851423|NCT02406742|58878460|FG001|Overall Study|Physician Decision|2|||
30851424|NCT02406742|58878461|FG002|Overall Study|Physician Decision|1|||
30851425|NCT02406742|58878459|FG000|Overall Study|Transition to other treatment|2|||
30851426|NCT02406742|58878460|FG001|Overall Study|Transition to other treatment|0|||
30851427|NCT02406742|58878461|FG002|Overall Study|Transition to other treatment|1|||
30851428|NCT02406742|58878459|FG000|Overall Study|Other Reasons|1|||
30662588|NCT00916721|58676193|FG000|Overall Study|Adverse Event|6|||
30851429|NCT02406742|58878460|FG001|Overall Study|Other Reasons|11|||
30776223|NCT03052426|58787079|FG002|Overall Study|Withdrawal by Subject|0|||
30776224|NCT03052426|58787077|FG000|Overall Study|Lost to Follow-up|2|||
30662589|NCT00916721|58676194|FG001|Overall Study|Adverse Event|3|||
30776225|NCT03052426|58787078|FG001|Overall Study|Lost to Follow-up|0|||
30776226|NCT03052426|58787079|FG002|Overall Study|Lost to Follow-up|1|||
30776227|NCT03688880|58787094|FG000|Overall Study|Withdrawal by Subject|0|||
30776228|NCT03688880|58787095|FG001|Overall Study|Withdrawal by Subject|2|||
30776229|NCT03688880|58787094|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
30776230|NCT03688880|58787095|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
30776231|NCT03688880|58787094|FG000|Overall Study|Lost to Follow-up|4|||
30851430|NCT02406742|58878461|FG002|Overall Study|Other Reasons|5|||
30851431|NCT02714595|58878471|FG000|Overall Study|Lost to Follow-up|1|||
30851432|NCT02714595|58878472|FG001|Overall Study|Lost to Follow-up|0|||
30776232|NCT03688880|58787095|FG001|Overall Study|Lost to Follow-up|7|||
30776233|NCT03688880|58787094|FG000|Overall Study|Adverse Event|0|||
30776234|NCT03688880|58787095|FG001|Overall Study|Adverse Event|2|||
30776235|NCT03688880|58787094|FG000|Overall Study|Device deficiencies|0|||
30776236|NCT03688880|58787095|FG001|Overall Study|Device deficiencies|2|||
30776237|NCT03688880|58787094|FG000|Overall Study|Other|10|||
30776238|NCT03688880|58787095|FG001|Overall Study|Other|16|||
30776239|NCT03051178|58787101|FG000|Overall Study|Withdrawal by Subject|5|||
30776240|NCT03051100|58787107|FG000|Overall Study|Withdrawal by Subject|1|||
30776241|NCT03051100|58787108|FG001|Overall Study|Withdrawal by Subject|0|||
30776242|NCT01343368|58787116|FG000|Overall Study|Death|1|||
30776243|NCT01343368|58787117|FG001|Overall Study|Death|0|||
30851433|NCT02714595|58878471|FG000|Overall Study|Withdrawal by Subject|1|||
30851434|NCT02714595|58878472|FG001|Overall Study|Withdrawal by Subject|2|||
30851435|NCT02714595|58878471|FG000|Overall Study|Lack of Efficacy|0|||
30851436|NCT02714595|58878472|FG001|Overall Study|Lack of Efficacy|1|||
30851437|NCT02714595|58878471|FG000|Overall Study|Death|30|||
30851438|NCT02714595|58878472|FG001|Overall Study|Death|9|||
30851439|NCT02714595|58878471|FG000|Overall Study|Other-Miscellaneous|0|||
30851440|NCT02714595|58878472|FG001|Overall Study|Other-Miscellaneous|1|||
30851441|NCT02437162|58878499|FG000|Overall Study|Protocol Violation|0|||
30851442|NCT02437162|58878500|FG001|Overall Study|Protocol Violation|1|||
30851443|NCT02437162|58878501|FG002|Overall Study|Protocol Violation|0|||
30851444|NCT02437162|58878499|FG000|Overall Study|Randomized but not treated|0|||
30851445|NCT02437162|58878500|FG001|Overall Study|Randomized but not treated|0|||
30851446|NCT02437162|58878501|FG002|Overall Study|Randomized but not treated|1|||
30851447|NCT02437162|58878499|FG000|Overall Study|Study discontinued by Sponsor|93|||
30851448|NCT02437162|58878500|FG001|Overall Study|Study discontinued by Sponsor|98|||
30851449|NCT02437162|58878501|FG002|Overall Study|Study discontinued by Sponsor|97|||
30851450|NCT02437162|58878499|FG000|Overall Study|Withdrawal by Subject|13|||
30851451|NCT02437162|58878500|FG001|Overall Study|Withdrawal by Subject|7|||
30851452|NCT02437162|58878501|FG002|Overall Study|Withdrawal by Subject|9|||
30851453|NCT02437162|58878499|FG000|Overall Study|Adverse Event|0|||
30851454|NCT02437162|58878500|FG001|Overall Study|Adverse Event|1|||
30851455|NCT02437162|58878501|FG002|Overall Study|Adverse Event|0|||
30851456|NCT02437162|58878499|FG000|Overall Study|Lost to Follow-up|1|||
30851457|NCT02437162|58878500|FG001|Overall Study|Lost to Follow-up|0|||
30851458|NCT02437162|58878501|FG002|Overall Study|Lost to Follow-up|1|||
30851459|NCT02437162|58878499|FG000|Overall Study|Death|0|||
30851460|NCT02437162|58878500|FG001|Overall Study|Death|1|||
30851461|NCT02437162|58878501|FG002|Overall Study|Death|0|||
30851462|NCT02437162|58878499|FG000|Overall Study|Other|0|||
30851463|NCT02437162|58878500|FG001|Overall Study|Other|0|||
30851464|NCT02437162|58878501|FG002|Overall Study|Other|1|||
30851465|NCT01368211|58878516|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
30851466|NCT01368211|58878517|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
30851467|NCT02437084|58878523|FG000|Overall Study|Withdrawal by Subject|2|||
30851468|NCT02437084|58878523|FG000|Overall Study|Physician Decision|1|||
30851469|NCT02406586|58878530|FG000|Overall Study|Lost to Follow-up|0|||
30851470|NCT02406586|58878531|FG001|Overall Study|Lost to Follow-up|4|||
30851471|NCT02406586|58878532|FG002|Overall Study|Lost to Follow-up|2|||
30851472|NCT02406586|58878530|FG000|Overall Study|Withdrawal by Subject|1|||
30851473|NCT02406586|58878531|FG001|Overall Study|Withdrawal by Subject|0|||
30851474|NCT02406586|58878532|FG002|Overall Study|Withdrawal by Subject|0|||
30851475|NCT02460562|58878545|FG000|Overall Study|Lost to Follow-up|15|||
30851476|NCT02460562|58878546|FG001|Overall Study|Lost to Follow-up|16|||
30851477|NCT02788357|58878554|FG000|Overall Study|Lost to Follow-up|3|||
30851478|NCT02788357|58878555|FG001|Overall Study|Lost to Follow-up|0|||
30851479|NCT02457910|58878567|FG000|Overall Study|Withdrawal by Subject|0|||
30851480|NCT02457910|58878568|FG001|Overall Study|Withdrawal by Subject|0|||
30851481|NCT02457910|58878569|FG002|Overall Study|Withdrawal by Subject|0|||
30851482|NCT02457910|58878570|FG003|Overall Study|Withdrawal by Subject|0|||
30851483|NCT02457910|58878571|FG004|Overall Study|Withdrawal by Subject|0|||
30851484|NCT02457910|58878572|FG005|Overall Study|Withdrawal by Subject|1|||
30851485|NCT02457910|58878567|FG000|Overall Study|Adverse Event|0|||
30851486|NCT02457910|58878568|FG001|Overall Study|Adverse Event|2|||
30851487|NCT02457910|58878569|FG002|Overall Study|Adverse Event|1|||
30851488|NCT02457910|58878570|FG003|Overall Study|Adverse Event|1|||
30851489|NCT02457910|58878571|FG004|Overall Study|Adverse Event|1|||
30851490|NCT02457910|58878572|FG005|Overall Study|Adverse Event|3|||
30851491|NCT02457910|58878567|FG000|Overall Study|Disease progression|3|||
30851492|NCT02457910|58878568|FG001|Overall Study|Disease progression|3|||
30851493|NCT02457910|58878569|FG002|Overall Study|Disease progression|1|||
30776244|NCT01343368|58787116|FG000|Overall Study|Lost to Follow-up|1|||
30776245|NCT01343368|58787117|FG001|Overall Study|Lost to Follow-up|0|||
30776246|NCT02955212|58787125|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
30851494|NCT02457910|58878570|FG003|Overall Study|Disease progression|1|||
30851495|NCT02457910|58878571|FG004|Overall Study|Disease progression|4|||
30851496|NCT02457910|58878572|FG005|Overall Study|Disease progression|6|||
30776247|NCT02955212|58787126|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
30776248|NCT02955212|58787125|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
30776249|NCT02955212|58787126|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
30776250|NCT02955212|58787125|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
30776251|NCT02955212|58787126|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
30776252|NCT02955212|58787125|FG000|Period 1: Double-blind Treatment Period|Other|3|||
30776253|NCT02955212|58787126|FG001|Period 1: Double-blind Treatment Period|Other|2|||
30776254|NCT02955212|58787125|FG000|Period 2: Open-label Extension|Adverse Event|11|||
30776255|NCT02955212|58787126|FG001|Period 2: Open-label Extension|Adverse Event|7|||
30776256|NCT02955212|58787125|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
30776257|NCT02955212|58787126|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
30776258|NCT02955212|58787125|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
30776259|NCT02955212|58787126|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
30776260|NCT02955212|58787125|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
30776261|NCT02955212|58787126|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
30776262|NCT02955212|58787125|FG000|Period 2: Open-label Extension|Other|2|||
30776263|NCT02955212|58787126|FG001|Period 2: Open-label Extension|Other|4|||
30776264|NCT03050398|58787133|FG000|Overall Study|Study terminated by sponsor|8|||
30776265|NCT03662750|58787137|FG000|Overall Study|Withdrawal by Subject|1|||
30776266|NCT04052204|58787141|FG000|Overall Study|Death|1|||
30776267|NCT04052204|58787142|FG001|Overall Study|Death|0|||
30776268|NCT04052204|58787143|FG002|Overall Study|Death|0|||
30776269|NCT04052204|58787141|FG000|Overall Study|Progressive disease|1|||
30776270|NCT04052204|58787142|FG001|Overall Study|Progressive disease|0|||
30776271|NCT04052204|58787143|FG002|Overall Study|Progressive disease|0|||
30776272|NCT04052204|58787141|FG000|Overall Study|Other|1|||
30776273|NCT04052204|58787142|FG001|Overall Study|Other|0|||
30776274|NCT04052204|58787143|FG002|Overall Study|Other|0|||
30776275|NCT04050722|58787149|FG000|Overall Study|Withdrawal by Subject|1|||
30776276|NCT04050722|58787150|FG001|Overall Study|Withdrawal by Subject|0|||
30776277|NCT04049552|58787156|FG000|Overall Study|Lost to Follow-up|1|||
30776278|NCT03048058|58787164|FG000|Overall Study|Lost to Follow-up|4|||
30776279|NCT03048058|58787165|FG001|Overall Study|Lost to Follow-up|0|||
30776280|NCT03048058|58787164|FG000|Overall Study|Withdrawal by Subject|0|||
30851497|NCT02457910|58878567|FG000|Overall Study|Other complicating illness|0|||
30851498|NCT02457910|58878568|FG001|Overall Study|Other complicating illness|0|||
30851499|NCT02457910|58878569|FG002|Overall Study|Other complicating illness|0|||
30851500|NCT02457910|58878570|FG003|Overall Study|Other complicating illness|0|||
30851501|NCT02457910|58878571|FG004|Overall Study|Other complicating illness|0|||
30851502|NCT02457910|58878572|FG005|Overall Study|Other complicating illness|1|||
30851503|NCT02457910|58878567|FG000|Overall Study|Death|0|||
30851504|NCT02457910|58878568|FG001|Overall Study|Death|0|||
30953440|NCT01872611|59005552|FG000|Overall Study|Physician Decision|1|||
30953441|NCT01872611|59005553|FG001|Overall Study|Physician Decision|0|||
30953442|NCT01872611|59005552|FG000|Overall Study|Withdrawal by Subject|6|||
30776281|NCT03048058|58787165|FG001|Overall Study|Withdrawal by Subject|4|||
30776282|NCT03047980|58787171|FG000|Overall Study|Adverse Event|1|||
30776283|NCT04048382|58787177|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
30776284|NCT04048382|58787178|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
30776285|NCT04048382|58787177|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
30776286|NCT04048382|58787178|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
30776287|NCT04048382|58787177|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
30776288|NCT04048382|58787178|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
30776289|NCT04047446|58787186|FG000|Overall Study|Physician Decision|1|||
30776290|NCT04047446|58787187|FG001|Overall Study|Physician Decision|0|||
30776291|NCT03655106|58787195|FG000|Overall Study|Withdrawal by Subject|3|||
30776292|NCT03655106|58787196|FG001|Overall Study|Withdrawal by Subject|2|||
30776293|NCT03655106|58787195|FG000|Overall Study|Lost to Follow-up|2|||
30776294|NCT03655106|58787196|FG001|Overall Study|Lost to Follow-up|1|||
30776295|NCT03655106|58787195|FG000|Overall Study|Duplicate Enrollment|1|||
30776296|NCT03655106|58787196|FG001|Overall Study|Duplicate Enrollment|1|||
30776297|NCT03655106|58787195|FG000|Overall Study|Protocol Violation|3|||
30776298|NCT03655106|58787196|FG001|Overall Study|Protocol Violation|0|||
30776299|NCT03630302|58787202|FG000|Surgery|hardware issue prevented LFP recordings|1|||
30776300|NCT03630302|58787202|FG000|3 Month Visit|Adverse Event|2|||
30776301|NCT03630302|58787202|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
30776302|NCT04041440|58787208|FG000|Overall Study|Withdrawal by Subject|0|||
30776303|NCT04041440|58787209|FG001|Overall Study|Withdrawal by Subject|1|||
30776304|NCT04041440|58787208|FG000|Overall Study|Lost to Follow-up|0|||
30776305|NCT04041440|58787209|FG001|Overall Study|Lost to Follow-up|1|||
30776306|NCT03654560|58787218|FG000|Overall Study|Death|3|||
30776307|NCT03654560|58787219|FG001|Overall Study|Death|1|||
30851505|NCT02457910|58878569|FG002|Overall Study|Death|1|||
30851506|NCT02457910|58878570|FG003|Overall Study|Death|0|||
30851507|NCT02457910|58878571|FG004|Overall Study|Death|0|||
30776308|NCT03654560|58787218|FG000|Overall Study|Lost to Follow-up|1|||
30776309|NCT03654560|58787219|FG001|Overall Study|Lost to Follow-up|0|||
30776310|NCT03629054|58787227|FG000|Period 2 (4 Days)|Not treated|0|||
30776311|NCT03629054|58787228|FG001|Period 2 (4 Days)|Not treated|1|||
30776312|NCT03628898|58787234|FG000|Overall Study|Device deficiency|1|||
30776313|NCT03628508|58787238|FG000|Overall Study|Lost to Follow-up|1|||
30776314|NCT03045328|58787242|FG000|Overall Study|Withdrawal by Subject|2|||
30776315|NCT02154490|58787248|FG000|Overall Study|No tissue submitted|23|||
30776316|NCT02154490|58787248|FG000|Overall Study|No biomarker results|167|||
30776317|NCT02154490|58787248|FG000|Overall Study|Not assigned to a sub-study|270|||
30851508|NCT02457910|58878572|FG005|Overall Study|Death|0|||
30851509|NCT02405962|58878591|FG000|Overall Study|Lost to Follow-up|1|||
30851510|NCT02405962|58878592|FG001|Overall Study|Lost to Follow-up|4|||
30851511|NCT02405962|58878591|FG000|Overall Study|A participant has moved to another place|0|||
30851512|NCT02405962|58878592|FG001|Overall Study|A participant has moved to another place|1|||
30851513|NCT02436304|58878601|FG000|Overall Study|Lost to Follow-up|0|||
30776318|NCT02154490|58787248|FG000|Overall Study|Did not register to a sub-study|749|||
30776319|NCT03627494|58787264|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
30776320|NCT03627494|58787265|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
30776321|NCT03627494|58787266|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
30776322|NCT03627494|58787267|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
30776323|NCT03627494|58787268|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
30776324|NCT03627494|58787269|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
30776325|NCT03627494|58787270|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
30776326|NCT03627494|58787271|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
30776327|NCT03627494|58787272|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
30776328|NCT03627494|58787273|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
30776329|NCT03627494|58787274|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
30776330|NCT03627494|58787275|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
30776331|NCT03627494|58787264|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
30776332|NCT03627494|58787265|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
30776333|NCT03627494|58787266|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
30776334|NCT03627494|58787267|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
30776335|NCT03627494|58787268|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
30851514|NCT02436304|58878602|FG001|Overall Study|Lost to Follow-up|1|||
30851515|NCT02436304|58878603|FG002|Overall Study|Lost to Follow-up|0|||
30851516|NCT02436304|58878601|FG000|Overall Study|Withdrawal by Subject|0|||
30851517|NCT02436304|58878602|FG001|Overall Study|Withdrawal by Subject|1|||
30851518|NCT02436304|58878603|FG002|Overall Study|Withdrawal by Subject|0|||
30851519|NCT02436304|58878601|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
30776336|NCT03627494|58787269|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
30851520|NCT02436304|58878602|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
30851521|NCT02436304|58878603|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
30851522|NCT02402218|58878615|FG000|Overall Study|Did not pickup study medication|12|||
30851523|NCT02402218|58878616|FG001|Overall Study|Did not pickup study medication|9|||
30776337|NCT03627494|58787270|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
30776338|NCT03627494|58787271|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
30776339|NCT03627494|58787272|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
30776340|NCT03627494|58787273|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
30776341|NCT03627494|58787274|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
30776342|NCT03627494|58787275|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
30776343|NCT03627494|58787264|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
30776344|NCT03627494|58787265|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
30776345|NCT03627494|58787266|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
30776346|NCT03627494|58787267|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
30776347|NCT03627494|58787268|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
30776348|NCT03627494|58787269|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
30776349|NCT03627494|58787270|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
30776350|NCT03627494|58787271|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
30776351|NCT03627494|58787272|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
30776352|NCT03627494|58787273|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
30776353|NCT03627494|58787274|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
30776354|NCT03627494|58787275|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
30851524|NCT02402218|58878617|FG002|Overall Study|Did not pickup study medication|13|||
30776355|NCT03627416|58787316|FG000|Overall Study|Adverse Event|0|||
30776356|NCT03627416|58787317|FG001|Overall Study|Adverse Event|1|||
30776357|NCT00972478|58787325|FG000|Overall Study|Adverse Event|3|||
30776358|NCT00972478|58787326|FG001|Overall Study|Adverse Event|16|||
30776359|NCT00972478|58787325|FG000|Overall Study|Withdrawal by Subject|1|||
30776360|NCT00972478|58787326|FG001|Overall Study|Withdrawal by Subject|8|||
30776361|NCT00972478|58787325|FG000|Overall Study|Progression/Relapse|0|||
30776362|NCT00972478|58787326|FG001|Overall Study|Progression/Relapse|2|||
30776363|NCT00972478|58787325|FG000|Overall Study|Death|0|||
30851525|NCT02402218|58878615|FG000|Overall Study|Lack of Efficacy|0|||
30851526|NCT02402218|58878616|FG001|Overall Study|Lack of Efficacy|1|||
30851527|NCT02402218|58878617|FG002|Overall Study|Lack of Efficacy|1|||
30776364|NCT00972478|58787326|FG001|Overall Study|Death|2|||
30776365|NCT00972478|58787325|FG000|Overall Study|Not protocol specified|1|||
30776366|NCT00972478|58787326|FG001|Overall Study|Not protocol specified|1|||
30776367|NCT00972478|58787325|FG000|Overall Study|Ineligible|1|||
30776368|NCT00972478|58787326|FG001|Overall Study|Ineligible|7|||
30776369|NCT00972478|58787325|FG000|Overall Study|Not start protocol treatment|1|||
30776370|NCT00972478|58787326|FG001|Overall Study|Not start protocol treatment|2|||
30776371|NCT00097539|58787340|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
30776372|NCT00097539|58787341|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
30776373|NCT00097539|58787342|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
30776374|NCT00097539|58787343|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
30776375|NCT00097539|58787344|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
30776376|NCT00097539|58787345|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
30776377|NCT00097539|58787346|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
30776378|NCT00097539|58787340|FG000|Overall Study|Withdrawal by Subject|925|||
30776379|NCT00097539|58787341|FG001|Overall Study|Withdrawal by Subject|323|||
30776380|NCT00097539|58787342|FG002|Overall Study|Withdrawal by Subject|346|||
30776381|NCT00097539|58787343|FG003|Overall Study|Withdrawal by Subject|217|||
30776382|NCT00097539|58787344|FG004|Overall Study|Withdrawal by Subject|68|||
30776383|NCT00097539|58787345|FG005|Overall Study|Withdrawal by Subject|229|||
30776384|NCT00097539|58787346|FG006|Overall Study|Withdrawal by Subject|3|||
30776385|NCT00097539|58787340|FG000|Overall Study|Participant Non-compliant|2140|||
30776386|NCT00097539|58787341|FG001|Overall Study|Participant Non-compliant|567|||
30776387|NCT00097539|58787342|FG002|Overall Study|Participant Non-compliant|1067|||
30776388|NCT00097539|58787343|FG003|Overall Study|Participant Non-compliant|353|||
30776389|NCT00097539|58787344|FG004|Overall Study|Participant Non-compliant|136|||
30776390|NCT00097539|58787345|FG005|Overall Study|Participant Non-compliant|543|||
30776391|NCT00097539|58787346|FG006|Overall Study|Participant Non-compliant|18|||
30776392|NCT00097539|58787340|FG000|Overall Study|Lack of Efficacy|249|||
30776393|NCT00097539|58787341|FG001|Overall Study|Lack of Efficacy|122|||
30776394|NCT00097539|58787342|FG002|Overall Study|Lack of Efficacy|202|||
30851528|NCT02402218|58878615|FG000|Overall Study|Death|1|||
30851529|NCT02402218|58878616|FG001|Overall Study|Death|0|||
30851530|NCT02402218|58878617|FG002|Overall Study|Death|0|||
30851531|NCT02402218|58878615|FG000|Overall Study|Reinfection|0|||
30851532|NCT02402218|58878616|FG001|Overall Study|Reinfection|0|||
30851533|NCT02402218|58878617|FG002|Overall Study|Reinfection|1|||
30851534|NCT02402218|58878615|FG000|Overall Study|Adverse Event|0|||
30851535|NCT02402218|58878616|FG001|Overall Study|Adverse Event|2|||
30851536|NCT02402218|58878617|FG002|Overall Study|Adverse Event|1|||
30851537|NCT02402218|58878615|FG000|Overall Study|Withdrawal by Subject|1|||
30851538|NCT02402218|58878616|FG001|Overall Study|Withdrawal by Subject|1|||
30851539|NCT02402218|58878617|FG002|Overall Study|Withdrawal by Subject|1|||
30851540|NCT02457520|58878625|FG000|Active Treatment Phase|Adverse Event|10|||
30851541|NCT02457520|58878625|FG000|Active Treatment Phase|Lost to Follow-up|8|||
30851542|NCT02457520|58878625|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
30851543|NCT02457520|58878625|FG000|Active Treatment Phase|other|4|||
30851544|NCT02457520|58878625|FG000|Active Treatment Phase|Physician Decision|1|||
30851545|NCT02457520|58878625|FG000|Active Treatment Phase|Protocol Violation|1|||
30851546|NCT02457520|58878625|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
30851547|NCT02457520|58878625|FG000|Post-treatment Period|Other: Retreatment Required|7|||
30851548|NCT02457520|58878625|FG000|Post-treatment Period|Lost to Follow-up|23|||
30851549|NCT02457520|58878625|FG000|Post-treatment Period|Other|3|||
30851550|NCT02457520|58878625|FG000|Post-treatment Period|Physician Decision|1|||
30851551|NCT02457520|58878625|FG000|Post-treatment Period|Withdrawal by Subject|14|||
30851552|NCT02788279|58878658|FG000|Overall Study|Death|62|||
30851553|NCT02788279|58878659|FG001|Overall Study|Death|136|||
30953443|NCT01872611|59005553|FG001|Overall Study|Withdrawal by Subject|1|||
30776395|NCT00097539|58787343|FG003|Overall Study|Lack of Efficacy|105|||
30776396|NCT00097539|58787344|FG004|Overall Study|Lack of Efficacy|45|||
30851554|NCT02788279|58878660|FG002|Overall Study|Death|72|||
30851555|NCT02788279|58878658|FG000|Overall Study|Withdrawal by Subject|10|||
30851556|NCT02788279|58878659|FG001|Overall Study|Withdrawal by Subject|15|||
30851557|NCT02788279|58878660|FG002|Overall Study|Withdrawal by Subject|5|||
30851558|NCT02788279|58878658|FG000|Overall Study|Lost to Follow-up|0|||
30851559|NCT02788279|58878659|FG001|Overall Study|Lost to Follow-up|3|||
30776397|NCT00097539|58787345|FG005|Overall Study|Lack of Efficacy|228|||
30776398|NCT00097539|58787346|FG006|Overall Study|Lack of Efficacy|5|||
30776399|NCT00097539|58787340|FG000|Overall Study|Adverse Event|78|||
30776400|NCT00097539|58787341|FG001|Overall Study|Adverse Event|133|||
30851560|NCT02788279|58878660|FG002|Overall Study|Lost to Follow-up|2|||
30776401|NCT00097539|58787342|FG002|Overall Study|Adverse Event|37|||
30776402|NCT00097539|58787343|FG003|Overall Study|Adverse Event|27|||
30776403|NCT00097539|58787344|FG004|Overall Study|Adverse Event|30|||
30776404|NCT00097539|58787345|FG005|Overall Study|Adverse Event|59|||
30776405|NCT00097539|58787346|FG006|Overall Study|Adverse Event|1|||
30776406|NCT00097539|58787340|FG000|Overall Study|Death|2|||
30776407|NCT00097539|58787341|FG001|Overall Study|Death|7|||
30776408|NCT00097539|58787342|FG002|Overall Study|Death|0|||
30776409|NCT00097539|58787343|FG003|Overall Study|Death|0|||
30776410|NCT00097539|58787344|FG004|Overall Study|Death|1|||
30776411|NCT00097539|58787345|FG005|Overall Study|Death|3|||
30776412|NCT00097539|58787346|FG006|Overall Study|Death|0|||
30776413|NCT00097539|58787340|FG000|Overall Study|Reasons Other Than Above|3602|||
30776414|NCT00097539|58787341|FG001|Overall Study|Reasons Other Than Above|1382|||
30776415|NCT00097539|58787342|FG002|Overall Study|Reasons Other Than Above|1757|||
30851561|NCT02788279|58878658|FG000|Overall Study|Sponsor decision|18|||
30851562|NCT02788279|58878659|FG001|Overall Study|Sponsor decision|29|||
30776416|NCT00097539|58787343|FG003|Overall Study|Reasons Other Than Above|692|||
30776417|NCT00097539|58787344|FG004|Overall Study|Reasons Other Than Above|361|||
30776418|NCT00097539|58787345|FG005|Overall Study|Reasons Other Than Above|1244|||
30776419|NCT00097539|58787346|FG006|Overall Study|Reasons Other Than Above|34|||
30776420|NCT00097539|58787340|FG000|Overall Study|Reason not Specified|111|||
30776421|NCT00097539|58787341|FG001|Overall Study|Reason not Specified|49|||
30776422|NCT00097539|58787342|FG002|Overall Study|Reason not Specified|53|||
30851563|NCT02788279|58878660|FG002|Overall Study|Sponsor decision|11|||
30851564|NCT02435992|58878676|FG000|Overall Study|non compliance with protocol|2|||
30851565|NCT02435992|58878677|FG001|Overall Study|non compliance with protocol|0|||
30851566|NCT02435992|58878678|FG002|Overall Study|non compliance with protocol|1|||
30851567|NCT02435992|58878679|FG003|Overall Study|non compliance with protocol|0|||
30851568|NCT02435992|58878680|FG004|Overall Study|non compliance with protocol|0|||
30851569|NCT02435992|58878676|FG000|Overall Study|Adverse Event|11|||
30851570|NCT02435992|58878677|FG001|Overall Study|Adverse Event|6|||
30851571|NCT02435992|58878678|FG002|Overall Study|Adverse Event|12|||
30851572|NCT02435992|58878679|FG003|Overall Study|Adverse Event|0|||
30851573|NCT02435992|58878680|FG004|Overall Study|Adverse Event|0|||
30851574|NCT02435992|58878676|FG000|Overall Study|Lack of Efficacy|4|||
30851575|NCT02435992|58878677|FG001|Overall Study|Lack of Efficacy|10|||
30851576|NCT02435992|58878678|FG002|Overall Study|Lack of Efficacy|9|||
30851577|NCT02435992|58878679|FG003|Overall Study|Lack of Efficacy|0|||
30851578|NCT02435992|58878680|FG004|Overall Study|Lack of Efficacy|0|||
30776423|NCT00097539|58787343|FG003|Overall Study|Reason not Specified|21|||
30776424|NCT00097539|58787344|FG004|Overall Study|Reason not Specified|11|||
30776425|NCT00097539|58787345|FG005|Overall Study|Reason not Specified|40|||
30776426|NCT00097539|58787346|FG006|Overall Study|Reason not Specified|2|||
30776427|NCT03925324|58787364|FG000|Overall Study|Death|1|||
30776428|NCT03925324|58787365|FG001|Overall Study|Death|1|||
30953444|NCT01872611|59005552|FG000|Overall Study|Reason not provided|6|||
30953445|NCT01872611|59005553|FG001|Overall Study|Reason not provided|6|||
30953446|NCT03089853|59005563|FG000|Overall Study|Lost to Follow-up|2|||
30953447|NCT03089853|59005564|FG001|Overall Study|Lost to Follow-up|1|||
30776429|NCT03042910|58787371|FG000|Overall Study|Adverse Event|1|||
30776430|NCT03042910|58787371|FG000|Overall Study|Disease Progression|2|||
30776431|NCT03042910|58787371|FG000|Overall Study|Withdrawal by Subject|3|||
30776432|NCT03042910|58787371|FG000|Overall Study|Enrolled but not treated|1|||
30776433|NCT03059446|58787375|FG000|Overall Study|Adverse Event|11|||
30776434|NCT03059446|58787375|FG000|Overall Study|Withdrawal of Consent|16|||
30776435|NCT03059446|58787375|FG000|Overall Study|Lost to Follow-up|3|||
30776436|NCT03059446|58787375|FG000|Overall Study|Protocol Violation|1|||
30953448|NCT03086967|59005572|FG000|Overall Study|Screen Failure|2|||
30953449|NCT03086967|59005573|FG001|Overall Study|Screen Failure|2|||
30776437|NCT03059446|58787375|FG000|Overall Study|Study Terminated by Sponsor|131|||
30953450|NCT01856543|59005581|FG000|Overall Study|Treatment discontinued|6|||
30953451|NCT01856543|59005582|FG001|Overall Study|Treatment discontinued|3|||
30953452|NCT01856543|59005581|FG000|Overall Study|Withdrawn before start|7|||
30776438|NCT03059446|58787375|FG000|Overall Study|Reason not Specified|5|||
30776439|NCT00090519|58787381|FG000|Overall Study|Adverse Event|5|||
30851579|NCT02435992|58878676|FG000|Overall Study|Withdrawal by Subject|10|||
30851580|NCT02435992|58878677|FG001|Overall Study|Withdrawal by Subject|8|||
30851581|NCT02435992|58878678|FG002|Overall Study|Withdrawal by Subject|20|||
30851582|NCT02435992|58878679|FG003|Overall Study|Withdrawal by Subject|0|||
30776440|NCT00090519|58787382|FG001|Overall Study|Adverse Event|4|||
30776441|NCT00090519|58787381|FG000|Overall Study|Death|9|||
30776442|NCT00090519|58787382|FG001|Overall Study|Death|9|||
30953453|NCT01856543|59005582|FG001|Overall Study|Withdrawn before start|3|||
30776443|NCT00090519|58787381|FG000|Overall Study|Lost to Follow-up|26|||
30776444|NCT00090519|58787382|FG001|Overall Study|Lost to Follow-up|29|||
30776445|NCT00090519|58787381|FG000|Overall Study|Withdrawal by Subject|28|||
30776446|NCT00090519|58787382|FG001|Overall Study|Withdrawal by Subject|29|||
30851583|NCT02435992|58878680|FG004|Overall Study|Withdrawal by Subject|0|||
30851584|NCT02435992|58878676|FG000|Overall Study|Other Reason|1|||
30851585|NCT02435992|58878677|FG001|Overall Study|Other Reason|0|||
30851586|NCT02435992|58878678|FG002|Overall Study|Other Reason|0|||
30851587|NCT02435992|58878679|FG003|Overall Study|Other Reason|0|||
30851588|NCT02435992|58878680|FG004|Overall Study|Other Reason|0|||
30851589|NCT02435992|58878676|FG000|Overall Study|Physician Decision|0|||
30851590|NCT02435992|58878677|FG001|Overall Study|Physician Decision|0|||
30851591|NCT02435992|58878678|FG002|Overall Study|Physician Decision|1|||
30851592|NCT02435992|58878679|FG003|Overall Study|Physician Decision|0|||
30851593|NCT02435992|58878680|FG004|Overall Study|Physician Decision|0|||
30953454|NCT00632463|59005592|FG000|Overall Study|Adverse Event|0|||
30953455|NCT00632463|59005593|FG001|Overall Study|Adverse Event|1|||
30953456|NCT00632463|59005594|FG002|Overall Study|Adverse Event|0|||
30953457|NCT00632229|59005604|FG000|Overall Study|Adverse Event|6|||
30953458|NCT00632229|59005605|FG001|Overall Study|Adverse Event|0|||
30953459|NCT00632229|59005604|FG000|Overall Study|Lost to Follow-up|0|||
30953460|NCT00632229|59005605|FG001|Overall Study|Lost to Follow-up|3|||
30953461|NCT00632229|59005604|FG000|Overall Study|Lack of Efficacy|0|||
30953462|NCT00632229|59005605|FG001|Overall Study|Lack of Efficacy|2|||
30953463|NCT00632229|59005604|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
30776447|NCT00090519|58787381|FG000|Overall Study|Physician Decision|2|||
30953464|NCT00632229|59005605|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
30953465|NCT00631137|59005613|FG000|Overall Study|Withdrawal by Subject|1|||
30953466|NCT00631137|59005614|FG001|Overall Study|Withdrawal by Subject|0|||
30953467|NCT00630825|59005633|FG000|Overall Study|Adverse Event|4|||
30953468|NCT00630825|59005634|FG001|Overall Study|Adverse Event|4|||
30953469|NCT00630825|59005635|FG002|Overall Study|Adverse Event|3|||
30953470|NCT00630825|59005636|FG003|Overall Study|Adverse Event|1|||
30953471|NCT00630825|59005633|FG000|Overall Study|Entry Criteria Not Met|1|||
30953472|NCT00630825|59005634|FG001|Overall Study|Entry Criteria Not Met|0|||
30953473|NCT00630825|59005635|FG002|Overall Study|Entry Criteria Not Met|2|||
30953474|NCT00630825|59005636|FG003|Overall Study|Entry Criteria Not Met|1|||
30953475|NCT00630825|59005633|FG000|Overall Study|Lost to Follow-up|1|||
30953476|NCT00630825|59005634|FG001|Overall Study|Lost to Follow-up|1|||
30953477|NCT00630825|59005635|FG002|Overall Study|Lost to Follow-up|1|||
30953478|NCT00630825|59005636|FG003|Overall Study|Lost to Follow-up|1|||
30953479|NCT00630825|59005633|FG000|Overall Study|Physician Decision|1|||
30953480|NCT00630825|59005634|FG001|Overall Study|Physician Decision|0|||
30953481|NCT00630825|59005635|FG002|Overall Study|Physician Decision|0|||
30953482|NCT00630825|59005636|FG003|Overall Study|Physician Decision|0|||
30953483|NCT00630825|59005633|FG000|Overall Study|Withdrawal by Subject|2|||
30776448|NCT00090519|58787382|FG001|Overall Study|Physician Decision|3|||
30776449|NCT00090519|58787381|FG000|Overall Study|Sponsor Decision|3|||
30776450|NCT00090519|58787382|FG001|Overall Study|Sponsor Decision|1|||
30776451|NCT00096993|58787412|FG000|Overall Study|Death|1|||
30776452|NCT00096993|58787413|FG001|Overall Study|Death|0|||
30776453|NCT00096993|58787412|FG000|Overall Study|Disease progression|56|||
30776454|NCT00096993|58787413|FG001|Overall Study|Disease progression|53|||
30776455|NCT00096993|58787412|FG000|Overall Study|Adverse Event|2|||
30776456|NCT00096993|58787413|FG001|Overall Study|Adverse Event|8|||
30776457|NCT00096993|58787412|FG000|Overall Study|Subject's decision|3|||
30776458|NCT00096993|58787413|FG001|Overall Study|Subject's decision|1|||
30776459|NCT00096993|58787412|FG000|Overall Study|Physician Decision|2|||
30776460|NCT00096993|58787413|FG001|Overall Study|Physician Decision|1|||
30776461|NCT00096993|58787412|FG000|Overall Study|Non-compliance|0|||
30776462|NCT00096993|58787413|FG001|Overall Study|Non-compliance|1|||
30776463|NCT00096993|58787412|FG000|Overall Study|Other unspecified|1|||
30776464|NCT00096993|58787413|FG001|Overall Study|Other unspecified|1|||
30776465|NCT03040336|58787421|FG000|Overall Study|Death|1|||
30851594|NCT02788513|58878697|FG000|Overall Study|Withdrawal by Subject|3|||
30851595|NCT02788513|58878698|FG001|Overall Study|Withdrawal by Subject|0|||
30851596|NCT02788513|58878699|FG002|Overall Study|Withdrawal by Subject|2|||
30851597|NCT02788513|58878700|FG003|Overall Study|Withdrawal by Subject|3|||
30851598|NCT02788513|58878701|FG004|Overall Study|Withdrawal by Subject|1|||
30851599|NCT02788513|58878697|FG000|Overall Study|Lost to Follow-up|1|||
30953484|NCT00630825|59005634|FG001|Overall Study|Withdrawal by Subject|2|||
30953485|NCT00630825|59005635|FG002|Overall Study|Withdrawal by Subject|2|||
30953486|NCT00630825|59005636|FG003|Overall Study|Withdrawal by Subject|3|||
30851600|NCT02788513|58878698|FG001|Overall Study|Lost to Follow-up|0|||
30953487|NCT04075734|59005933|FG000|Overall Study|Lost to Follow-up|1|||
30953488|NCT04075734|59005934|FG001|Overall Study|Lost to Follow-up|1|||
30953489|NCT04075734|59005935|FG002|Overall Study|Lost to Follow-up|0|||
30953490|NCT04075734|59005933|FG000|Overall Study|Withdrawal by Subject|3|||
30776466|NCT03040336|58787422|FG001|Overall Study|Death|0|||
30776467|NCT03040336|58787421|FG000|Overall Study|Withdrawal by Subject|2|||
30776468|NCT03040336|58787422|FG001|Overall Study|Withdrawal by Subject|3|||
30776469|NCT00072189|58787429|FG000|Overall Study|Withdrawal by Subject|1|||
30851601|NCT02788513|58878699|FG002|Overall Study|Lost to Follow-up|0|||
30776470|NCT03040024|58787436|FG000|Overall Study|Adverse Event|0|||
30776471|NCT03040024|58787437|FG001|Overall Study|Adverse Event|1|||
30776472|NCT03040024|58787438|FG002|Overall Study|Adverse Event|0|||
30776473|NCT03040024|58787436|FG000|Overall Study|Death|0|||
30776474|NCT03040024|58787437|FG001|Overall Study|Death|1|||
30776475|NCT03040024|58787438|FG002|Overall Study|Death|0|||
30776476|NCT03040024|58787436|FG000|Overall Study|Physician Decision|0|||
30776477|NCT03040024|58787437|FG001|Overall Study|Physician Decision|0|||
30776478|NCT03040024|58787438|FG002|Overall Study|Physician Decision|1|||
30776479|NCT03039790|58787466|FG000|Overall Study|Lost to Follow-up|2|||
30776480|NCT03039790|58787467|FG001|Overall Study|Lost to Follow-up|0|||
30776481|NCT03039790|58787468|FG002|Overall Study|Lost to Follow-up|1|||
30776482|NCT03039790|58787469|FG003|Overall Study|Lost to Follow-up|1|||
30776483|NCT03039790|58787470|FG004|Overall Study|Lost to Follow-up|0|||
30776484|NCT03039790|58787471|FG005|Overall Study|Lost to Follow-up|1|||
30776485|NCT03039790|58787472|FG006|Overall Study|Lost to Follow-up|1|||
30776486|NCT03039790|58787473|FG007|Overall Study|Lost to Follow-up|1|||
30776487|NCT03039790|58787474|FG008|Overall Study|Lost to Follow-up|0|||
30776488|NCT03039790|58787475|FG009|Overall Study|Lost to Follow-up|1|||
30776489|NCT03039790|58787476|FG010|Overall Study|Lost to Follow-up|1|||
30776490|NCT03039790|58787477|FG011|Overall Study|Lost to Follow-up|0|||
30776491|NCT03039790|58787478|FG012|Overall Study|Lost to Follow-up|1|||
30776492|NCT03039790|58787479|FG013|Overall Study|Lost to Follow-up|0|||
30776493|NCT03039790|58787480|FG014|Overall Study|Lost to Follow-up|3|||
30776494|NCT03039790|58787481|FG015|Overall Study|Lost to Follow-up|1|||
30851602|NCT02788513|58878700|FG003|Overall Study|Lost to Follow-up|0|||
30851603|NCT02788513|58878701|FG004|Overall Study|Lost to Follow-up|1|||
30851604|NCT02788513|58878697|FG000|Overall Study|Adverse Event|5|||
30851605|NCT02788513|58878698|FG001|Overall Study|Adverse Event|8|||
30776495|NCT03039790|58787482|FG016|Overall Study|Lost to Follow-up|2|||
30776496|NCT03039790|58787483|FG017|Overall Study|Lost to Follow-up|2|||
30776497|NCT03039790|58787484|FG018|Overall Study|Lost to Follow-up|1|||
30851606|NCT02788513|58878699|FG002|Overall Study|Adverse Event|4|||
30851607|NCT02788513|58878700|FG003|Overall Study|Adverse Event|2|||
30851608|NCT02788513|58878701|FG004|Overall Study|Adverse Event|2|||
30851609|NCT02788513|58878697|FG000|Overall Study|Protocol Violation|0|||
30851610|NCT02788513|58878698|FG001|Overall Study|Protocol Violation|0|||
30953491|NCT04075734|59005934|FG001|Overall Study|Withdrawal by Subject|0|||
30776498|NCT03039790|58787485|FG019|Overall Study|Lost to Follow-up|3|||
30776499|NCT03039790|58787466|FG000|Overall Study|Withdrawal of Consent|1|||
30776500|NCT03039790|58787467|FG001|Overall Study|Withdrawal of Consent|0|||
30776501|NCT03039790|58787468|FG002|Overall Study|Withdrawal of Consent|0|||
30776502|NCT03039790|58787469|FG003|Overall Study|Withdrawal of Consent|1|||
30776503|NCT03039790|58787470|FG004|Overall Study|Withdrawal of Consent|0|||
30776504|NCT03039790|58787471|FG005|Overall Study|Withdrawal of Consent|0|||
30776505|NCT03039790|58787472|FG006|Overall Study|Withdrawal of Consent|0|||
30776506|NCT03039790|58787473|FG007|Overall Study|Withdrawal of Consent|0|||
30776507|NCT03039790|58787474|FG008|Overall Study|Withdrawal of Consent|0|||
30776508|NCT03039790|58787475|FG009|Overall Study|Withdrawal of Consent|1|||
30776509|NCT03039790|58787476|FG010|Overall Study|Withdrawal of Consent|0|||
30953492|NCT04075734|59005935|FG002|Overall Study|Withdrawal by Subject|0|||
30953493|NCT00989781|59005980|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
30953494|NCT00989781|59005981|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
30953495|NCT00989235|59006022|FG000|Overall Study|Death|0|||
30953496|NCT00989235|59006023|FG001|Overall Study|Death|1|||
30953497|NCT00989235|59006022|FG000|Overall Study|Adverse Event|0|||
30953498|NCT00989235|59006023|FG001|Overall Study|Adverse Event|1|||
30953499|NCT00989235|59006022|FG000|Overall Study|Lack of Efficacy|1|||
30953500|NCT00989235|59006023|FG001|Overall Study|Lack of Efficacy|0|||
30953501|NCT00989235|59006022|FG000|Overall Study|Withdrawal of Consent|1|||
30776510|NCT03039790|58787477|FG011|Overall Study|Withdrawal of Consent|0|||
30776511|NCT03039790|58787478|FG012|Overall Study|Withdrawal of Consent|2|||
30776512|NCT03039790|58787479|FG013|Overall Study|Withdrawal of Consent|0|||
30851611|NCT02788513|58878699|FG002|Overall Study|Protocol Violation|1|||
30851612|NCT02788513|58878700|FG003|Overall Study|Protocol Violation|1|||
30851613|NCT02788513|58878701|FG004|Overall Study|Protocol Violation|0|||
30851614|NCT02788513|58878697|FG000|Overall Study|Subject decided to stop taking treatment|0|||
30851615|NCT02788513|58878698|FG001|Overall Study|Subject decided to stop taking treatment|0|||
30776513|NCT03039790|58787480|FG014|Overall Study|Withdrawal of Consent|1|||
30776514|NCT03039790|58787481|FG015|Overall Study|Withdrawal of Consent|5|||
30776515|NCT03039790|58787482|FG016|Overall Study|Withdrawal of Consent|3|||
30776516|NCT03039790|58787483|FG017|Overall Study|Withdrawal of Consent|0|||
30776517|NCT03039790|58787484|FG018|Overall Study|Withdrawal of Consent|2|||
30953502|NCT00989235|59006023|FG001|Overall Study|Withdrawal of Consent|1|||
30776518|NCT03039790|58787485|FG019|Overall Study|Withdrawal of Consent|5|||
30776519|NCT03039790|58787466|FG000|Overall Study|Death|0|||
30776520|NCT03039790|58787467|FG001|Overall Study|Death|0|||
30776521|NCT03039790|58787468|FG002|Overall Study|Death|0|||
30953503|NCT00989235|59006022|FG000|Overall Study|Desire to Become Pregnant|1|||
30776522|NCT03039790|58787469|FG003|Overall Study|Death|0|||
30776523|NCT03039790|58787470|FG004|Overall Study|Death|0|||
30953504|NCT00989235|59006023|FG001|Overall Study|Desire to Become Pregnant|0|||
30953505|NCT00989235|59006022|FG000|Overall Study|Randomized by Mistake|0|||
30953506|NCT00989235|59006023|FG001|Overall Study|Randomized by Mistake|2|||
30953507|NCT00989235|59006022|FG000|Overall Study|Lost to Follow-up|0|||
30851616|NCT02788513|58878699|FG002|Overall Study|Subject decided to stop taking treatment|1|||
30953508|NCT00989235|59006023|FG001|Overall Study|Lost to Follow-up|1|||
30953509|NCT00988533|59006063|FG000|Overall Study|Lost to Follow-up|3|||
30953510|NCT03633396|59006095|FG000|Overall Study|Withdrawal by Subject|4|||
30953511|NCT03633396|59006096|FG001|Overall Study|Withdrawal by Subject|4|||
30953512|NCT03633396|59006095|FG000|Overall Study|Adverse Event|1|||
30953513|NCT03633396|59006096|FG001|Overall Study|Adverse Event|1|||
30953514|NCT03633396|59006095|FG000|Overall Study|Lack of Efficacy|1|||
30953515|NCT03633396|59006096|FG001|Overall Study|Lack of Efficacy|0|||
30953516|NCT03633396|59006095|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
30953517|NCT03633396|59006096|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
30953518|NCT00988065|59006109|FG000|Overall Study|Adverse Event|4|||
30953519|NCT00988065|59006110|FG001|Overall Study|Adverse Event|10|||
30851617|NCT02788513|58878700|FG003|Overall Study|Subject decided to stop taking treatment|0|||
30851618|NCT02788513|58878701|FG004|Overall Study|Subject decided to stop taking treatment|0|||
30953520|NCT00988065|59006111|FG002|Overall Study|Adverse Event|2|||
30953521|NCT00988065|59006109|FG000|Overall Study|Lost to Follow-up|1|||
30953522|NCT00988065|59006110|FG001|Overall Study|Lost to Follow-up|2|||
30953523|NCT00988065|59006111|FG002|Overall Study|Lost to Follow-up|2|||
30953524|NCT00988065|59006109|FG000|Overall Study|Subject withdrew consent|3|||
30953525|NCT00988065|59006110|FG001|Overall Study|Subject withdrew consent|5|||
30953526|NCT00988065|59006111|FG002|Overall Study|Subject withdrew consent|2|||
30953527|NCT00988065|59006109|FG000|Overall Study|Noncompliance with protocol|5|||
30953528|NCT00988065|59006110|FG001|Overall Study|Noncompliance with protocol|6|||
30953529|NCT00988065|59006111|FG002|Overall Study|Noncompliance with protocol|9|||
30953530|NCT00987831|59006135|FG000|Overall Study|Never flared in 12 months|1|||
30953531|NCT00987831|59006136|FG001|Overall Study|Never flared in 12 months|0|||
30953532|NCT00987831|59006137|FG002|Overall Study|Never flared in 12 months|0|||
30953533|NCT00987831|59006135|FG000|Overall Study|Lost to Follow-up|0|||
30953534|NCT00987831|59006136|FG001|Overall Study|Lost to Follow-up|3|||
30953535|NCT00987831|59006137|FG002|Overall Study|Lost to Follow-up|0|||
30953536|NCT00986973|59006168|FG000|Overall Study|Withdrawn by study team|1|||
30953537|NCT00986427|59006175|FG000|Overall Study|Lost to Follow-up|2|||
30953538|NCT00986427|59006176|FG001|Overall Study|Lost to Follow-up|0|||
30953539|NCT00986427|59006175|FG000|Overall Study|Lack of Efficacy|1|||
30953540|NCT00986427|59006176|FG001|Overall Study|Lack of Efficacy|0|||
30953541|NCT00986427|59006175|FG000|Overall Study|Withdrawal by Subject|1|||
30953542|NCT00986427|59006176|FG001|Overall Study|Withdrawal by Subject|0|||
30953543|NCT00986349|59006186|FG000|Overall Study|Unsuccessful implant procedure|3|||
30953544|NCT00986349|59006186|FG000|Overall Study|Adverse Event|2|||
30953545|NCT00986349|59006186|FG000|Overall Study|Physician Decision|1|||
30953546|NCT00986349|59006186|FG000|Overall Study|device migration|1|||
30953547|NCT00985959|59006209|FG000|Overall Study|Adverse Event|0|||
30776524|NCT03039790|58787471|FG005|Overall Study|Death|0|||
30776525|NCT03039790|58787472|FG006|Overall Study|Death|0|||
30776526|NCT03039790|58787473|FG007|Overall Study|Death|0|||
30776527|NCT03039790|58787474|FG008|Overall Study|Death|0|||
30776528|NCT03039790|58787475|FG009|Overall Study|Death|0|||
30776529|NCT03039790|58787476|FG010|Overall Study|Death|0|||
30851619|NCT02788513|58878697|FG000|Overall Study|Decision by the study team|0|||
30851620|NCT02788513|58878698|FG001|Overall Study|Decision by the study team|0|||
30851621|NCT02788513|58878699|FG002|Overall Study|Decision by the study team|0|||
30851622|NCT02788513|58878700|FG003|Overall Study|Decision by the study team|0|||
30851623|NCT02788513|58878701|FG004|Overall Study|Decision by the study team|1|||
30851624|NCT03077828|58878713|FG000|Treatment Cycles|Death|1|||
30851625|NCT03077828|58878713|FG000|Treatment Cycles|Withdrawal by Subject|1|||
30851626|NCT03077828|58878713|FG000|Treatment Cycles|Screen Fail|2|||
30851627|NCT03077828|58878713|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
30953548|NCT00985959|59006210|FG001|Overall Study|Adverse Event|0|||
30953549|NCT00985959|59006211|FG002|Overall Study|Adverse Event|19|||
30953550|NCT00985959|59006209|FG000|Overall Study|Withdrawal by Subject|0|||
30953551|NCT00985959|59006210|FG001|Overall Study|Withdrawal by Subject|0|||
30953552|NCT00985959|59006211|FG002|Overall Study|Withdrawal by Subject|8|||
30953553|NCT00985959|59006209|FG000|Overall Study|Progressive disease|1|||
30953554|NCT00985959|59006210|FG001|Overall Study|Progressive disease|2|||
30953555|NCT00985959|59006211|FG002|Overall Study|Progressive disease|8|||
30953556|NCT00985959|59006209|FG000|Overall Study|Unrecovered toxicity|0|||
30953557|NCT00985959|59006210|FG001|Overall Study|Unrecovered toxicity|0|||
30953558|NCT00985959|59006211|FG002|Overall Study|Unrecovered toxicity|7|||
30776530|NCT03039790|58787477|FG011|Overall Study|Death|0|||
30776531|NCT03039790|58787478|FG012|Overall Study|Death|0|||
30776532|NCT03039790|58787479|FG013|Overall Study|Death|0|||
30776533|NCT03039790|58787480|FG014|Overall Study|Death|0|||
30776534|NCT03039790|58787481|FG015|Overall Study|Death|1|||
30776535|NCT03039790|58787482|FG016|Overall Study|Death|3|||
30776536|NCT03039790|58787483|FG017|Overall Study|Death|0|||
30776537|NCT03039790|58787484|FG018|Overall Study|Death|2|||
30776538|NCT03039790|58787485|FG019|Overall Study|Death|0|||
30776539|NCT03039790|58787466|FG000|Overall Study|Reason, not Specified|1|||
30776540|NCT03039790|58787467|FG001|Overall Study|Reason, not Specified|0|||
30776541|NCT03039790|58787468|FG002|Overall Study|Reason, not Specified|0|||
30776542|NCT03039790|58787469|FG003|Overall Study|Reason, not Specified|0|||
30776543|NCT03039790|58787470|FG004|Overall Study|Reason, not Specified|0|||
30776544|NCT03039790|58787471|FG005|Overall Study|Reason, not Specified|0|||
30776545|NCT03039790|58787472|FG006|Overall Study|Reason, not Specified|0|||
30776546|NCT03039790|58787473|FG007|Overall Study|Reason, not Specified|0|||
30776547|NCT03039790|58787474|FG008|Overall Study|Reason, not Specified|0|||
30776548|NCT03039790|58787475|FG009|Overall Study|Reason, not Specified|0|||
30776549|NCT03039790|58787476|FG010|Overall Study|Reason, not Specified|0|||
30776550|NCT03039790|58787477|FG011|Overall Study|Reason, not Specified|0|||
30776551|NCT03039790|58787478|FG012|Overall Study|Reason, not Specified|0|||
30851628|NCT03077828|58878713|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
30851629|NCT03077828|58878713|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
30851630|NCT03077828|58878713|FG000|Follow-up|Patients still in follow-up|15|||
30851631|NCT02401672|58878719|FG000|Overall Study|Withdrawal by Subject|1|||
30851632|NCT02401672|58878720|FG001|Overall Study|Withdrawal by Subject|3|||
30851633|NCT02435914|58878730|FG000|Overall Study|Ocular Adverse Event|1|||
30851634|NCT02435914|58878731|FG001|Overall Study|Ocular Adverse Event|0|||
30851635|NCT02435914|58878732|FG002|Overall Study|Ocular Adverse Event|0|||
30776552|NCT03039790|58787479|FG013|Overall Study|Reason, not Specified|0|||
30776553|NCT03039790|58787480|FG014|Overall Study|Reason, not Specified|0|||
30776554|NCT03039790|58787481|FG015|Overall Study|Reason, not Specified|0|||
30776555|NCT03039790|58787482|FG016|Overall Study|Reason, not Specified|2|||
30776556|NCT03039790|58787483|FG017|Overall Study|Reason, not Specified|0|||
30776557|NCT03039790|58787484|FG018|Overall Study|Reason, not Specified|1|||
30776558|NCT03039790|58787485|FG019|Overall Study|Reason, not Specified|0|||
30776559|NCT03038620|58787558|FG000|Overall Study|Lost to Follow-up|18|||
30776560|NCT03038620|58787559|FG001|Overall Study|Lost to Follow-up|23|||
30776561|NCT03038620|58787558|FG000|Overall Study|Withdrawal by Subject|0|||
30776562|NCT03038620|58787559|FG001|Overall Study|Withdrawal by Subject|15|||
30776563|NCT03038620|58787558|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
30776564|NCT03038620|58787559|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
30776565|NCT01350934|58787580|FG000|Base Study|Adverse Event|6|||
30776566|NCT01350934|58787581|FG001|Base Study|Adverse Event|0|||
30776567|NCT01350934|58787580|FG000|Base Study|Lost to Follow-up|1|||
30776568|NCT01350934|58787581|FG001|Base Study|Lost to Follow-up|0|||
30776569|NCT01350934|58787580|FG000|Base Study|Protocol Violation|1|||
30851636|NCT02435914|58878733|FG003|Overall Study|Ocular Adverse Event|0|||
30851637|NCT02435914|58878730|FG000|Overall Study|Withdrawal by Subject|0|||
30851638|NCT02435914|58878731|FG001|Overall Study|Withdrawal by Subject|1|||
30776570|NCT01350934|58787581|FG001|Base Study|Protocol Violation|1|||
30776571|NCT01350934|58787580|FG000|Base Study|Withdrawal by Subject|1|||
30776572|NCT01350934|58787581|FG001|Base Study|Withdrawal by Subject|2|||
30776573|NCT01350934|58787580|FG000|Base Study|Non-Compliance With Study Drug|2|||
30776574|NCT01350934|58787581|FG001|Base Study|Non-Compliance With Study Drug|0|||
30776575|NCT01350934|58787580|FG000|Extension Study|Adverse Event|2|||
30776576|NCT01350934|58787581|FG001|Extension Study|Adverse Event|1|||
30776577|NCT01350934|58787580|FG000|Extension Study|Lost to Follow-up|2|||
30776578|NCT01350934|58787581|FG001|Extension Study|Lost to Follow-up|0|||
30851639|NCT02435914|58878732|FG002|Overall Study|Withdrawal by Subject|0|||
30851640|NCT02435914|58878733|FG003|Overall Study|Withdrawal by Subject|0|||
30851641|NCT02435914|58878730|FG000|Overall Study|Other Miscellaneous Reason|0|||
30851642|NCT02435914|58878731|FG001|Overall Study|Other Miscellaneous Reason|0|||
30776579|NCT01350934|58787580|FG000|Extension Study|Protocol Violation|1|||
30776580|NCT01350934|58787581|FG001|Extension Study|Protocol Violation|1|||
30776581|NCT01350934|58787580|FG000|Extension Study|Lack of Efficacy|0|||
30776582|NCT01350934|58787581|FG001|Extension Study|Lack of Efficacy|1|||
30776583|NCT01350934|58787580|FG000|Extension Study|Withdrawal by Subject|0|||
30776584|NCT01350934|58787581|FG001|Extension Study|Withdrawal by Subject|1|||
30776585|NCT03622580|58787605|FG000|Overall Study|Death|16|||
30776586|NCT03622580|58787606|FG001|Overall Study|Death|21|||
30776587|NCT03622580|58787607|FG002|Overall Study|Death|13|||
30776588|NCT03622580|58787605|FG000|Overall Study|Adverse Event|6|||
30776589|NCT03622580|58787606|FG001|Overall Study|Adverse Event|6|||
30953559|NCT00985959|59006209|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
30953560|NCT00985959|59006210|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
30953561|NCT00985959|59006211|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
30953562|NCT00985959|59006209|FG000|Overall Study|Complete response observed over 2 cycles|0|||
30953563|NCT00985959|59006210|FG001|Overall Study|Complete response observed over 2 cycles|1|||
30953564|NCT00985959|59006211|FG002|Overall Study|Complete response observed over 2 cycles|4|||
30953565|NCT00985959|59006209|FG000|Overall Study|Other|0|||
30953566|NCT00985959|59006210|FG001|Overall Study|Other|0|||
30953567|NCT00985959|59006211|FG002|Overall Study|Other|11|||
30953568|NCT00985725|59006227|FG000|Overall Study|Adverse Event|4|||
30953569|NCT00985725|59006228|FG001|Overall Study|Adverse Event|1|||
30953570|NCT00985725|59006227|FG000|Overall Study|Protocol Violation|1|||
30953571|NCT00985725|59006228|FG001|Overall Study|Protocol Violation|3|||
30953572|NCT00985725|59006227|FG000|Overall Study|Withdrawal by Subject|4|||
30953573|NCT00985725|59006228|FG001|Overall Study|Withdrawal by Subject|4|||
30953574|NCT00985725|59006227|FG000|Overall Study|Lost to Follow-up|1|||
30953575|NCT00985725|59006228|FG001|Overall Study|Lost to Follow-up|1|||
30953576|NCT00985725|59006227|FG000|Overall Study|Lack of Efficacy|0|||
30953577|NCT00985725|59006228|FG001|Overall Study|Lack of Efficacy|1|||
30953578|NCT00985725|59006227|FG000|Overall Study|Non-compliance|1|||
30953579|NCT00985725|59006228|FG001|Overall Study|Non-compliance|2|||
30953580|NCT00985725|59006227|FG000|Overall Study|Out-of-window visits|0|||
30953581|NCT00985725|59006228|FG001|Overall Study|Out-of-window visits|1|||
30953582|NCT00985491|59006243|FG000|Overall Study|Adverse Event|8|||
30953583|NCT00985491|59006243|FG000|Overall Study|device migration|7|||
30953584|NCT00985491|59006243|FG000|Overall Study|Withdrawal by Subject|1|||
30953585|NCT00985491|59006243|FG000|Overall Study|implant failure|3|||
30953586|NCT00984867|59006278|FG000|Overall Study|Adverse Event|3|||
30953587|NCT00984867|59006279|FG001|Overall Study|Adverse Event|7|||
30953588|NCT00984867|59006278|FG000|Overall Study|Death|1|||
30953589|NCT00984867|59006279|FG001|Overall Study|Death|0|||
30953590|NCT00984867|59006278|FG000|Overall Study|Withdrawal by Subject|13|||
30953591|NCT00984867|59006279|FG001|Overall Study|Withdrawal by Subject|4|||
30953592|NCT00984867|59006278|FG000|Overall Study|Lost to Follow-up|3|||
30953593|NCT00984867|59006279|FG001|Overall Study|Lost to Follow-up|4|||
30953594|NCT00984867|59006278|FG000|Overall Study|Poor/non-compliance|0|||
30953595|NCT00984867|59006279|FG001|Overall Study|Poor/non-compliance|1|||
30953596|NCT00984867|59006278|FG000|Overall Study|Subject no longer meets study criteria|1|||
30953597|NCT00984867|59006279|FG001|Overall Study|Subject no longer meets study criteria|1|||
30953598|NCT00984867|59006278|FG000|Overall Study|site closing|1|||
30953599|NCT00984867|59006279|FG001|Overall Study|site closing|0|||
30953600|NCT00984867|59006278|FG000|Overall Study|lack of efficacy and subject compliance|1|||
30953601|NCT00984867|59006279|FG001|Overall Study|lack of efficacy and subject compliance|0|||
30953602|NCT00984009|59006319|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
30953603|NCT00983931|59006326|FG000|14 Day Washout Period|Physician Decision|1|||
30953604|NCT00983853|59006338|FG000|Overall Study|Lost to Follow-up|1|||
30953605|NCT00983853|59006339|FG001|Overall Study|Lost to Follow-up|1|||
30953606|NCT00983853|59006340|FG002|Overall Study|Lost to Follow-up|2|||
30953607|NCT00983853|59006341|FG003|Overall Study|Lost to Follow-up|2|||
30953608|NCT00983853|59006342|FG004|Overall Study|Lost to Follow-up|2|||
30953609|NCT00983853|59006343|FG005|Overall Study|Lost to Follow-up|1|||
30953610|NCT00983853|59006338|FG000|Overall Study|Withdrawal by Subject|0|||
30953611|NCT00983853|59006339|FG001|Overall Study|Withdrawal by Subject|0|||
30953612|NCT00983853|59006340|FG002|Overall Study|Withdrawal by Subject|1|||
30953613|NCT00983853|59006341|FG003|Overall Study|Withdrawal by Subject|0|||
30953614|NCT00983853|59006342|FG004|Overall Study|Withdrawal by Subject|1|||
30953615|NCT00983853|59006343|FG005|Overall Study|Withdrawal by Subject|0|||
30953616|NCT00983853|59006338|FG000|Overall Study|Unable to come to study follow-up visits|0|||
30953617|NCT00983853|59006339|FG001|Overall Study|Unable to come to study follow-up visits|1|||
30953618|NCT00983853|59006340|FG002|Overall Study|Unable to come to study follow-up visits|0|||
30953619|NCT00983853|59006341|FG003|Overall Study|Unable to come to study follow-up visits|0|||
30953620|NCT00983853|59006342|FG004|Overall Study|Unable to come to study follow-up visits|0|||
30953621|NCT00983853|59006343|FG005|Overall Study|Unable to come to study follow-up visits|0|||
30953622|NCT00983073|59006359|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
30953623|NCT00983073|59006359|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
30953624|NCT00983073|59006359|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
30953625|NCT00983073|59006359|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
30953626|NCT00983073|59006359|FG000|Titration and Optimal Dose Period|Other reason|4|||
30953627|NCT00983073|59006359|FG000|Maintenance Period|Adverse Event|5|||
30953628|NCT00983073|59006359|FG000|Maintenance Period|Withdrawal by Subject|2|||
30953629|NCT00983073|59006359|FG000|Maintenance Period|Lack of Efficacy|2|||
30953630|NCT00983073|59006359|FG000|Maintenance Period|Other Reason|7|||
30953631|NCT00982137|59006368|FG000|Overall Study|Lost to Follow-up|0|||
30776590|NCT03622580|58787607|FG002|Overall Study|Adverse Event|5|||
30776591|NCT03622580|58787605|FG000|Overall Study|Withdrawal by Subject|12|||
30776592|NCT03622580|58787606|FG001|Overall Study|Withdrawal by Subject|7|||
30776593|NCT03622580|58787607|FG002|Overall Study|Withdrawal by Subject|19|||
30776594|NCT03622580|58787605|FG000|Overall Study|Lost to Follow-up|12|||
30851643|NCT02435914|58878732|FG002|Overall Study|Other Miscellaneous Reason|1|||
30851644|NCT02435914|58878733|FG003|Overall Study|Other Miscellaneous Reason|0|||
30851645|NCT02786953|58878745|FG000|Overall Study|Withdrawal by Subject|3|||
30776595|NCT03622580|58787606|FG001|Overall Study|Lost to Follow-up|9|||
30776596|NCT03622580|58787607|FG002|Overall Study|Lost to Follow-up|9|||
30776597|NCT03622580|58787605|FG000|Overall Study|Protocol Violation|1|||
30776598|NCT03622580|58787606|FG001|Overall Study|Protocol Violation|0|||
30776599|NCT03622580|58787607|FG002|Overall Study|Protocol Violation|1|||
30776600|NCT03622580|58787605|FG000|Overall Study|Physician Decision|3|||
30776601|NCT03622580|58787606|FG001|Overall Study|Physician Decision|0|||
30776602|NCT03622580|58787607|FG002|Overall Study|Physician Decision|1|||
30776603|NCT03622580|58787605|FG000|Overall Study|Pregnancy|0|||
30851646|NCT02786953|58878746|FG001|Overall Study|Withdrawal by Subject|0|||
30851647|NCT02786953|58878745|FG000|Overall Study|Physician Decision|0|||
30851648|NCT02786953|58878746|FG001|Overall Study|Physician Decision|1|||
30851649|NCT02435836|58878752|FG000|Overall Study|Lost to Follow-up|21|||
30851650|NCT02435836|58878752|FG000|Overall Study|Lack of Efficacy|1|||
30851651|NCT02435836|58878752|FG000|Overall Study|Withdrawal by Subject|236|||
30851652|NCT02435836|58878752|FG000|Overall Study|Insufficient Clinical Response|26|||
30851653|NCT02435836|58878752|FG000|Overall Study|Adverse Event|44|||
30851654|NCT02435836|58878752|FG000|Overall Study|Sponsor discontinued trial|167|||
30851655|NCT02435836|58878752|FG000|Overall Study|Noncompliance|27|||
30851656|NCT02435836|58878752|FG000|Overall Study|Protocol Violation|6|||
30851657|NCT02435836|58878752|FG000|Overall Study|Met Withdrawal Criteria|7|||
30851658|NCT02435836|58878752|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
30851659|NCT02788201|58878762|FG000|Overall Study|Death|1|||
30776604|NCT03622580|58787606|FG001|Overall Study|Pregnancy|1|||
30776605|NCT03622580|58787607|FG002|Overall Study|Pregnancy|0|||
30776606|NCT03622580|58787605|FG000|Overall Study|Lack of Efficacy|0|||
30776607|NCT03622580|58787606|FG001|Overall Study|Lack of Efficacy|0|||
30776608|NCT03622580|58787607|FG002|Overall Study|Lack of Efficacy|1|||
30776609|NCT03622580|58787605|FG000|Overall Study|Other|2|||
30776610|NCT03622580|58787606|FG001|Overall Study|Other|0|||
30776611|NCT03622580|58787607|FG002|Overall Study|Other|3|||
30776612|NCT00461032|58787618|FG000|Overall Study|Adverse Event|5|||
30776613|NCT00461032|58787619|FG001|Overall Study|Adverse Event|6|||
30776614|NCT00461032|58787618|FG000|Overall Study|Lack of Efficacy|5|||
30851660|NCT02788201|58878763|FG001|Overall Study|Death|1|||
30851661|NCT02788201|58878764|FG002|Overall Study|Death|1|||
30953632|NCT00982137|59006369|FG001|Overall Study|Lost to Follow-up|0|||
30953633|NCT00982137|59006370|FG002|Overall Study|Lost to Follow-up|0|||
30953634|NCT00982137|59006371|FG003|Overall Study|Lost to Follow-up|1|||
30953635|NCT00982137|59006368|FG000|Overall Study|Withdrawal by Subject|0|||
30953636|NCT00982137|59006369|FG001|Overall Study|Withdrawal by Subject|1|||
30953637|NCT00982137|59006370|FG002|Overall Study|Withdrawal by Subject|0|||
30953638|NCT00982137|59006371|FG003|Overall Study|Withdrawal by Subject|0|||
30953639|NCT00981747|59006388|FG000|Losartan|Withdrawal by Subject|1|||
30953640|NCT00981747|59006388|FG000|Losartan|Death|1|||
30953641|NCT00981747|59006388|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
30953642|NCT01856309|59006543|FG000|Overall Study|Death|4|||
30953643|NCT01856309|59006544|FG001|Overall Study|Death|6|||
30953644|NCT01856309|59006545|FG002|Overall Study|Death|11|||
30953645|NCT01856309|59006546|FG003|Overall Study|Death|6|||
30953646|NCT01856309|59006543|FG000|Overall Study|Lost to Follow-up|6|||
30953647|NCT01856309|59006544|FG001|Overall Study|Lost to Follow-up|2|||
30953648|NCT01856309|59006545|FG002|Overall Study|Lost to Follow-up|4|||
30953649|NCT01856309|59006546|FG003|Overall Study|Lost to Follow-up|8|||
30776615|NCT00461032|58787619|FG001|Overall Study|Lack of Efficacy|1|||
30776616|NCT00461032|58787618|FG000|Overall Study|Lost to Follow-up|7|||
30776617|NCT00461032|58787619|FG001|Overall Study|Lost to Follow-up|12|||
30776618|NCT00461032|58787618|FG000|Overall Study|Protocol Violation|4|||
30851662|NCT02788201|58878765|FG003|Overall Study|Death|1|||
30851663|NCT02788201|58878766|FG004|Overall Study|Death|0|||
30851664|NCT02788201|58878767|FG005|Overall Study|Death|1|||
30953650|NCT01856309|59006543|FG000|Overall Study|Withdrawal by Subject|11|||
30953651|NCT01856309|59006544|FG001|Overall Study|Withdrawal by Subject|13|||
30953652|NCT01856309|59006545|FG002|Overall Study|Withdrawal by Subject|28|||
30953653|NCT01856309|59006546|FG003|Overall Study|Withdrawal by Subject|26|||
30953654|NCT01856309|59006543|FG000|Overall Study|Other|227|||
30776619|NCT00461032|58787619|FG001|Overall Study|Protocol Violation|4|||
30776620|NCT00461032|58787618|FG000|Overall Study|Withdrawal by Subject|7|||
30776621|NCT00461032|58787619|FG001|Overall Study|Withdrawal by Subject|15|||
30776622|NCT00461032|58787618|FG000|Overall Study|Patient Moved or Relocated|2|||
30776623|NCT00461032|58787619|FG001|Overall Study|Patient Moved or Relocated|1|||
30851665|NCT02788201|58878762|FG000|Overall Study|Ineligible|0|||
30953655|NCT01856309|59006544|FG001|Overall Study|Other|225|||
30851666|NCT02788201|58878763|FG001|Overall Study|Ineligible|0|||
30851667|NCT02788201|58878764|FG002|Overall Study|Ineligible|0|||
30851668|NCT02788201|58878765|FG003|Overall Study|Ineligible|0|||
30851669|NCT02788201|58878766|FG004|Overall Study|Ineligible|0|||
30851670|NCT02788201|58878767|FG005|Overall Study|Ineligible|1|||
30851671|NCT02788201|58878762|FG000|Overall Study|Withdrawal by Subject|0|||
30851672|NCT02788201|58878763|FG001|Overall Study|Withdrawal by Subject|0|||
30851673|NCT02788201|58878764|FG002|Overall Study|Withdrawal by Subject|0|||
30776624|NCT00461032|58787618|FG000|Overall Study|Other|7|||
30776625|NCT00461032|58787619|FG001|Overall Study|Other|5|||
30776626|NCT00090142|58787625|FG000|Treatment Period I|Lost to Follow-up|1|||
30776627|NCT00090142|58787626|FG001|Treatment Period I|Lost to Follow-up|2|||
30776628|NCT00090142|58787625|FG000|Treatment Period I|Protocol Violation|2|||
30776629|NCT00090142|58787626|FG001|Treatment Period I|Protocol Violation|0|||
30776630|NCT00090142|58787625|FG000|Treatment Period I|Withdrawal by Subject|2|||
30851674|NCT02788201|58878765|FG003|Overall Study|Withdrawal by Subject|0|||
30851675|NCT02788201|58878766|FG004|Overall Study|Withdrawal by Subject|0|||
30851676|NCT02788201|58878767|FG005|Overall Study|Withdrawal by Subject|1|||
30851677|NCT02456740|58878786|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
30851678|NCT02456740|58878787|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
30851679|NCT02456740|58878788|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
30851680|NCT02456740|58878789|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
30851681|NCT02456740|58878790|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
30851682|NCT02456740|58878791|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
30851683|NCT02456740|58878792|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
30851684|NCT02456740|58878793|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
30851685|NCT02456740|58878794|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
30851686|NCT02456740|58878786|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
30851687|NCT02456740|58878787|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
30851688|NCT02456740|58878788|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
30851689|NCT02456740|58878789|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
30851690|NCT02456740|58878790|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
30776631|NCT00090142|58787626|FG001|Treatment Period I|Withdrawal by Subject|0|||
30776632|NCT00090142|58787625|FG000|Treatment Period I|Other|0|||
30776633|NCT00090142|58787626|FG001|Treatment Period I|Other|1|||
30776634|NCT00090142|58787625|FG000|Treatment Period II|Other|1|||
30776635|NCT00090142|58787626|FG001|Treatment Period II|Other|0|||
30953656|NCT01856309|59006545|FG002|Overall Study|Other|447|||
30851691|NCT02456740|58878791|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
30953657|NCT01856309|59006546|FG003|Overall Study|Other|469|||
30953658|NCT01856309|59006543|FG000|Overall Study|Lack of Efficacy|14|||
30953659|NCT01856309|59006544|FG001|Overall Study|Lack of Efficacy|9|||
30953660|NCT01856309|59006545|FG002|Overall Study|Lack of Efficacy|40|||
30953661|NCT01856309|59006546|FG003|Overall Study|Lack of Efficacy|25|||
30953662|NCT01856309|59006543|FG000|Overall Study|Adverse Event|31|||
30953663|NCT01856309|59006544|FG001|Overall Study|Adverse Event|31|||
30953664|NCT01856309|59006545|FG002|Overall Study|Adverse Event|55|||
30953665|NCT01856309|59006546|FG003|Overall Study|Adverse Event|65|||
30953666|NCT01856309|59006543|FG000|Overall Study|Pregnancy|0|||
30953667|NCT01856309|59006544|FG001|Overall Study|Pregnancy|0|||
30953668|NCT01856309|59006545|FG002|Overall Study|Pregnancy|0|||
30953669|NCT01856309|59006546|FG003|Overall Study|Pregnancy|1|||
30953670|NCT01856309|59006543|FG000|Overall Study|Physician Decision|6|||
30953671|NCT01856309|59006544|FG001|Overall Study|Physician Decision|1|||
30953672|NCT01856309|59006545|FG002|Overall Study|Physician Decision|6|||
30953673|NCT01856309|59006546|FG003|Overall Study|Physician Decision|8|||
30953674|NCT01856309|59006543|FG000|Overall Study|Noncompliance With Study Drug|0|||
30953675|NCT01856309|59006544|FG001|Overall Study|Noncompliance With Study Drug|1|||
30953676|NCT01856309|59006545|FG002|Overall Study|Noncompliance With Study Drug|4|||
30953677|NCT01856309|59006546|FG003|Overall Study|Noncompliance With Study Drug|1|||
30776636|NCT03622112|58787643|FG000|Overall Study|Withdrawal by Subject|6|||
30851692|NCT02456740|58878792|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
30851693|NCT02456740|58878793|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
30851694|NCT02456740|58878794|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
30953678|NCT01855919|59006744|FG000|Overall Study|Adverse Event|16|||
30953679|NCT01855919|59006745|FG001|Overall Study|Adverse Event|8|||
30953680|NCT01855919|59006744|FG000|Overall Study|Lack of Efficacy|1|||
30776637|NCT03622112|58787644|FG001|Overall Study|Withdrawal by Subject|2|||
30851695|NCT02456740|58878786|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
30851696|NCT02456740|58878787|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
30953681|NCT01855919|59006745|FG001|Overall Study|Lack of Efficacy|3|||
30953682|NCT01855919|59006744|FG000|Overall Study|Withdrawal by Subject|4|||
30776638|NCT03622112|58787645|FG002|Overall Study|Withdrawal by Subject|4|||
30776639|NCT03622112|58787646|FG003|Overall Study|Withdrawal by Subject|2|||
30776640|NCT03622112|58787647|FG004|Overall Study|Withdrawal by Subject|1|||
30776641|NCT03622112|58787648|FG005|Overall Study|Withdrawal by Subject|2|||
30776642|NCT03622112|58787649|FG006|Overall Study|Withdrawal by Subject|2|||
30776643|NCT03622112|58787643|FG000|Overall Study|Death|0|||
30776644|NCT03622112|58787644|FG001|Overall Study|Death|0|||
30953683|NCT01855919|59006745|FG001|Overall Study|Withdrawal by Subject|10|||
30953684|NCT01855919|59006744|FG000|Overall Study|Entry Criteria Not Met|1|||
30953685|NCT01855919|59006745|FG001|Overall Study|Entry Criteria Not Met|1|||
30953686|NCT01855919|59006744|FG000|Overall Study|Protocol Violation|1|||
30953687|NCT01855919|59006745|FG001|Overall Study|Protocol Violation|4|||
30953688|NCT01871519|59006761|FG000|Overall Study|Death|26|||
30953689|NCT01871519|59006761|FG000|Overall Study|Lost to Follow-up|15|||
30953690|NCT01871519|59006761|FG000|Overall Study|Withdrawal by Subject|49|||
30953691|NCT01871285|59006768|FG000|First Intervention (1 Day)|Adverse Event|1|||
30953692|NCT01871285|59006769|FG001|First Intervention (1 Day)|Adverse Event|0|||
30953693|NCT01871285|59006770|FG002|First Intervention (1 Day)|Adverse Event|0|||
30953694|NCT01871285|59006771|FG003|First Intervention (1 Day)|Adverse Event|0|||
30953695|NCT01871285|59006768|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
30953696|NCT01871285|59006769|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
30953697|NCT01871285|59006770|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
30953698|NCT01871285|59006771|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
30953699|NCT01870973|59006797|FG000|Overall Study|Lost to Follow-up|10|||
30953700|NCT01870973|59006798|FG001|Overall Study|Lost to Follow-up|3|||
30953701|NCT01854827|59006817|FG000|Overall Study|Death|1|||
30953702|NCT01854047|59006960|FG000|Overall Study|Lack of Efficacy|1|||
30953703|NCT01854047|59006961|FG001|Overall Study|Lack of Efficacy|0|||
30953704|NCT01854047|59006962|FG002|Overall Study|Lack of Efficacy|0|||
30953705|NCT01854047|59006963|FG003|Overall Study|Lack of Efficacy|0|||
30953706|NCT01854047|59006964|FG004|Overall Study|Lack of Efficacy|0|||
30953707|NCT01854047|59006960|FG000|Overall Study|Poor compliance to protocol|3|||
30953708|NCT01854047|59006961|FG001|Overall Study|Poor compliance to protocol|0|||
30953709|NCT01854047|59006962|FG002|Overall Study|Poor compliance to protocol|2|||
30953710|NCT01854047|59006963|FG003|Overall Study|Poor compliance to protocol|0|||
30953711|NCT01854047|59006964|FG004|Overall Study|Poor compliance to protocol|0|||
30953712|NCT01854047|59006960|FG000|Overall Study|Adverse Event|5|||
30953713|NCT01854047|59006961|FG001|Overall Study|Adverse Event|4|||
30953714|NCT01854047|59006962|FG002|Overall Study|Adverse Event|6|||
30953715|NCT01854047|59006963|FG003|Overall Study|Adverse Event|10|||
30953716|NCT01854047|59006964|FG004|Overall Study|Adverse Event|7|||
30953717|NCT01854047|59006960|FG000|Overall Study|Randomized but not treated|0|||
30953718|NCT01854047|59006961|FG001|Overall Study|Randomized but not treated|1|||
30953719|NCT01854047|59006962|FG002|Overall Study|Randomized but not treated|2|||
30953720|NCT01854047|59006963|FG003|Overall Study|Randomized but not treated|0|||
30953721|NCT01854047|59006964|FG004|Overall Study|Randomized but not treated|4|||
30953722|NCT01854047|59006960|FG000|Overall Study|Other than specified above|3|||
30953723|NCT01854047|59006961|FG001|Overall Study|Other than specified above|3|||
30953724|NCT01854047|59006962|FG002|Overall Study|Other than specified above|3|||
30953725|NCT01854047|59006963|FG003|Overall Study|Other than specified above|5|||
30953726|NCT01854047|59006964|FG004|Overall Study|Other than specified above|8|||
30953727|NCT01870739|59007014|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
30953728|NCT01870739|59007015|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
30953729|NCT01870739|59007014|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
30953730|NCT01870739|59007015|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
30953731|NCT01870739|59007014|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
30953732|NCT01870739|59007015|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
30953733|NCT01870739|59007014|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
30953734|NCT01870739|59007015|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
30953735|NCT01870739|59007014|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
30953736|NCT01870739|59007015|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
30776645|NCT03622112|58787645|FG002|Overall Study|Death|0|||
30953737|NCT01870739|59007014|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
30953738|NCT01870739|59007015|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
30953739|NCT01870739|59007014|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
30953740|NCT01870739|59007015|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
30953741|NCT01613417|59007042|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
30953742|NCT01613417|59007043|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
30953743|NCT01870583|59007071|FG000|Overall Study|Protocol Violation|0|||
30953744|NCT01870583|59007072|FG001|Overall Study|Protocol Violation|5|||
30953745|NCT01870583|59007073|FG002|Overall Study|Protocol Violation|3|||
30953746|NCT01870583|59007071|FG000|Overall Study|Lost to Follow-up|11|||
30776646|NCT03622112|58787646|FG003|Overall Study|Death|1|||
30851697|NCT02456740|58878788|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
30953747|NCT01870583|59007072|FG001|Overall Study|Lost to Follow-up|13|||
30953748|NCT01870583|59007073|FG002|Overall Study|Lost to Follow-up|5|||
30953749|NCT01869959|59007131|FG000|Randomization Period|Physician Decision|0|||
30953750|NCT01869959|59007132|FG001|Randomization Period|Physician Decision|0|||
30953751|NCT01869959|59007133|FG002|Randomization Period|Physician Decision|0|||
30953752|NCT01869959|59007134|FG003|Randomization Period|Physician Decision|0|||
30953753|NCT01869959|59007135|FG004|Randomization Period|Physician Decision|1|||
30953754|NCT01869959|59007131|FG000|Treatment Period|Adverse Event|1|||
30953755|NCT01869959|59007132|FG001|Treatment Period|Adverse Event|0|||
30953756|NCT01869959|59007133|FG002|Treatment Period|Adverse Event|3|||
30953757|NCT01869959|59007134|FG003|Treatment Period|Adverse Event|1|||
30953758|NCT01869959|59007135|FG004|Treatment Period|Adverse Event|0|||
30953759|NCT01869959|59007131|FG000|Treatment Period|Sponsor decision|0|||
30953760|NCT01869959|59007132|FG001|Treatment Period|Sponsor decision|1|||
30953761|NCT01869959|59007133|FG002|Treatment Period|Sponsor decision|0|||
30953762|NCT01869959|59007134|FG003|Treatment Period|Sponsor decision|1|||
30953763|NCT01869959|59007135|FG004|Treatment Period|Sponsor decision|0|||
30953764|NCT01869959|59007131|FG000|Treatment Period|Withdrawal by Subject|0|||
30953765|NCT01869959|59007132|FG001|Treatment Period|Withdrawal by Subject|1|||
30953766|NCT01869959|59007133|FG002|Treatment Period|Withdrawal by Subject|0|||
30953767|NCT01869959|59007134|FG003|Treatment Period|Withdrawal by Subject|0|||
30953768|NCT01869959|59007135|FG004|Treatment Period|Withdrawal by Subject|0|||
30953769|NCT01613027|59007196|FG000|Overall Study|Lost to Follow-up|5|||
30953770|NCT01613027|59007196|FG000|Overall Study|Switched Physician|1|||
30953771|NCT01613027|59007196|FG000|Overall Study|Lack of Efficacy|1|||
30953772|NCT01613027|59007196|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
30953773|NCT01869725|59007214|FG000|Overall Study|ineligible after registration|1|||
30953774|NCT01869725|59007214|FG000|Overall Study|Death|1|||
30953775|NCT01869725|59007214|FG000|Overall Study|Lost to Follow-up|2|||
30953776|NCT01851863|59007235|FG000|Overall Study|Did not receive study medication|2|||
30953777|NCT01851863|59007236|FG001|Overall Study|Did not receive study medication|5|||
30953778|NCT01851863|59007237|FG002|Overall Study|Did not receive study medication|3|||
30953779|NCT01851863|59007238|FG003|Overall Study|Did not receive study medication|0|||
30953780|NCT01851863|59007235|FG000|Overall Study|Lost to Follow-up|3|||
30953781|NCT01851863|59007236|FG001|Overall Study|Lost to Follow-up|4|||
30953782|NCT01851863|59007237|FG002|Overall Study|Lost to Follow-up|2|||
30953783|NCT01851863|59007238|FG003|Overall Study|Lost to Follow-up|3|||
30953784|NCT01850615|59007266|FG000|Overall Study|Protocol Violation|4|||
30953785|NCT01850615|59007267|FG001|Overall Study|Protocol Violation|1|||
30953786|NCT01850615|59007266|FG000|Overall Study|Adverse Event|2|||
30953787|NCT01850615|59007267|FG001|Overall Study|Adverse Event|1|||
30953788|NCT01850615|59007266|FG000|Overall Study|Withdrawal by Subject|3|||
30953789|NCT01850615|59007267|FG001|Overall Study|Withdrawal by Subject|1|||
30953790|NCT01850615|59007266|FG000|Overall Study|Lost to Follow-up|0|||
30776647|NCT03622112|58787647|FG004|Overall Study|Death|0|||
30776648|NCT03622112|58787648|FG005|Overall Study|Death|0|||
30776649|NCT03622112|58787649|FG006|Overall Study|Death|0|||
30776650|NCT03622112|58787643|FG000|Overall Study|Lost to Follow-up|1|||
30776651|NCT03622112|58787644|FG001|Overall Study|Lost to Follow-up|1|||
30776652|NCT03622112|58787645|FG002|Overall Study|Lost to Follow-up|0|||
30776653|NCT03622112|58787646|FG003|Overall Study|Lost to Follow-up|0|||
30776654|NCT03622112|58787647|FG004|Overall Study|Lost to Follow-up|0|||
30776655|NCT03622112|58787648|FG005|Overall Study|Lost to Follow-up|0|||
30776656|NCT03622112|58787649|FG006|Overall Study|Lost to Follow-up|0|||
30776657|NCT03622112|58787643|FG000|Overall Study|Study-specific withdrawal criteria|10|||
30776658|NCT03622112|58787644|FG001|Overall Study|Study-specific withdrawal criteria|8|||
30776659|NCT03622112|58787645|FG002|Overall Study|Study-specific withdrawal criteria|7|||
30953791|NCT01850615|59007267|FG001|Overall Study|Lost to Follow-up|1|||
30953792|NCT01850615|59007266|FG000|Overall Study|Unclassified|0|||
30953793|NCT01850615|59007267|FG001|Overall Study|Unclassified|1|||
30953794|NCT01868477|59007352|FG000|Overall Study|Adverse Event|2|||
30953795|NCT01868477|59007353|FG001|Overall Study|Adverse Event|4|||
30953796|NCT01868477|59007352|FG000|Overall Study|Disease progression|1|||
30953797|NCT01868477|59007353|FG001|Overall Study|Disease progression|1|||
30953798|NCT01868477|59007352|FG000|Overall Study|Withdrawal by Subject|1|||
30953799|NCT01868477|59007353|FG001|Overall Study|Withdrawal by Subject|0|||
30953800|NCT01849289|59007368|FG000|Overall Study|Adverse Event|3|||
30776660|NCT03622112|58787646|FG003|Overall Study|Study-specific withdrawal criteria|6|||
30953801|NCT01849289|59007369|FG001|Overall Study|Adverse Event|3|||
30953802|NCT01849289|59007368|FG000|Overall Study|Protocol Violation|3|||
30776661|NCT03622112|58787647|FG004|Overall Study|Study-specific withdrawal criteria|4|||
30776662|NCT03622112|58787648|FG005|Overall Study|Study-specific withdrawal criteria|18|||
30776663|NCT03622112|58787649|FG006|Overall Study|Study-specific withdrawal criteria|4|||
30776664|NCT03622112|58787643|FG000|Overall Study|Protocol Violation|2|||
30776665|NCT03622112|58787644|FG001|Overall Study|Protocol Violation|0|||
30851698|NCT02456740|58878789|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
30776666|NCT03622112|58787645|FG002|Overall Study|Protocol Violation|1|||
30776667|NCT03622112|58787646|FG003|Overall Study|Protocol Violation|1|||
30776668|NCT03622112|58787647|FG004|Overall Study|Protocol Violation|0|||
30776669|NCT03622112|58787648|FG005|Overall Study|Protocol Violation|0|||
30776670|NCT03622112|58787649|FG006|Overall Study|Protocol Violation|0|||
30776671|NCT03622112|58787643|FG000|Overall Study|Adverse Event|6|||
30776672|NCT03622112|58787644|FG001|Overall Study|Adverse Event|8|||
30776673|NCT03622112|58787645|FG002|Overall Study|Adverse Event|4|||
30776674|NCT03622112|58787646|FG003|Overall Study|Adverse Event|11|||
30776675|NCT03622112|58787647|FG004|Overall Study|Adverse Event|4|||
30776676|NCT03622112|58787648|FG005|Overall Study|Adverse Event|20|||
30776677|NCT03622112|58787649|FG006|Overall Study|Adverse Event|2|||
30776678|NCT03622112|58787643|FG000|Overall Study|Reason not specified|0|||
30776679|NCT03622112|58787644|FG001|Overall Study|Reason not specified|1|||
30851699|NCT02456740|58878790|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
30851700|NCT02456740|58878791|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
30851701|NCT02456740|58878792|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
30851702|NCT02456740|58878793|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
30851703|NCT02456740|58878794|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
30851704|NCT02456740|58878786|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
30851705|NCT02456740|58878787|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
30953803|NCT01849289|59007369|FG001|Overall Study|Protocol Violation|3|||
30953804|NCT01849289|59007368|FG000|Overall Study|Withdrawal criteria|1|||
30953805|NCT01849289|59007369|FG001|Overall Study|Withdrawal criteria|0|||
30776680|NCT03622112|58787645|FG002|Overall Study|Reason not specified|0|||
30776681|NCT03622112|58787646|FG003|Overall Study|Reason not specified|1|||
30776682|NCT03622112|58787647|FG004|Overall Study|Reason not specified|1|||
30776683|NCT03622112|58787648|FG005|Overall Study|Reason not specified|2|||
30851706|NCT02456740|58878788|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
30851707|NCT02456740|58878789|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
30851708|NCT02456740|58878790|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
30851709|NCT02456740|58878791|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
30851710|NCT02456740|58878792|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
30851711|NCT02456740|58878793|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
30851712|NCT02456740|58878794|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
30851713|NCT02456740|58878786|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
30851714|NCT02456740|58878787|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
30851715|NCT02456740|58878788|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
30851716|NCT02456740|58878789|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
30851717|NCT02456740|58878790|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
30851718|NCT02456740|58878791|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
30851719|NCT02456740|58878792|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
30851720|NCT02456740|58878793|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
30851721|NCT02456740|58878794|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
30851722|NCT02456740|58878786|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
30851723|NCT02456740|58878787|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
30851724|NCT02456740|58878788|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
30851725|NCT02456740|58878789|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
30851726|NCT02456740|58878790|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
30851727|NCT02456740|58878791|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
30851728|NCT02456740|58878792|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
30851729|NCT02456740|58878793|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
30851730|NCT02456740|58878794|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
30851731|NCT02456740|58878786|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
30851732|NCT02456740|58878787|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
30851733|NCT02456740|58878788|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
30851734|NCT02456740|58878789|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
30851735|NCT02456740|58878790|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
30851736|NCT02456740|58878791|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
30851737|NCT02456740|58878792|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
30851738|NCT02456740|58878793|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
30851739|NCT02456740|58878794|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
30851740|NCT02400580|58878806|FG000|Overall Study|Withdrawal by Subject|1|||
30776684|NCT03622112|58787649|FG006|Overall Study|Reason not specified|1|||
30776685|NCT04032158|58787667|FG000|Overall Study|Study Termination|2|||
30776686|NCT04032158|58787668|FG001|Overall Study|Study Termination|1|||
30776687|NCT03620708|58787677|FG000|Overall Study|Lost to Follow-up|1|||
30776688|NCT03620708|58787678|FG001|Overall Study|Lost to Follow-up|1|||
30776689|NCT03620708|58787679|FG002|Overall Study|Lost to Follow-up|2|||
30776690|NCT03620708|58787677|FG000|Overall Study|Withdrawal by Subject|0|||
30776691|NCT03620708|58787678|FG001|Overall Study|Withdrawal by Subject|0|||
30776692|NCT03620708|58787679|FG002|Overall Study|Withdrawal by Subject|1|||
30776693|NCT03654326|58787689|FG000|Overall Study|Withdrawal by Subject|5|||
30776694|NCT03654326|58787690|FG001|Overall Study|Withdrawal by Subject|3|||
30776695|NCT03654326|58787689|FG000|Overall Study|Physician Decision|0|||
30776696|NCT03654326|58787690|FG001|Overall Study|Physician Decision|1|||
30776697|NCT03654326|58787689|FG000|Overall Study|Unable to adhere to study schedule|0|||
30776698|NCT03654326|58787690|FG001|Overall Study|Unable to adhere to study schedule|1|||
30776699|NCT03654326|58787689|FG000|Overall Study|Lost to Follow-up|1|||
30776700|NCT03654326|58787690|FG001|Overall Study|Lost to Follow-up|1|||
30776701|NCT04025684|58787700|FG000|Overall Study|Withdrawal by Subject|1|||
30776702|NCT04025684|58787701|FG001|Overall Study|Withdrawal by Subject|1|||
30776703|NCT04025684|58787702|FG002|Overall Study|Withdrawal by Subject|0|||
30776704|NCT04025684|58787703|FG003|Overall Study|Withdrawal by Subject|0|||
30776705|NCT04025684|58787700|FG000|Overall Study|Multiple reasons|1|||
30776706|NCT04025684|58787701|FG001|Overall Study|Multiple reasons|3|||
30776707|NCT04025684|58787702|FG002|Overall Study|Multiple reasons|0|||
30776708|NCT04025684|58787703|FG003|Overall Study|Multiple reasons|1|||
30776709|NCT03617588|58787715|FG000|Overall Study|Withdrawal by Subject|1|||
30776710|NCT03617588|58787716|FG001|Overall Study|Withdrawal by Subject|0|||
30776711|NCT03616106|58787728|FG000|Overall Study|Removed by PI|6|||
30776712|NCT03616106|58787729|FG001|Overall Study|Removed by PI|0|||
30776713|NCT03616106|58787728|FG000|Overall Study|Withdrawal by Subject|1|||
30776714|NCT03616106|58787729|FG001|Overall Study|Withdrawal by Subject|1|||
30851741|NCT02400580|58878807|FG001|Overall Study|Withdrawal by Subject|1|||
30851742|NCT02400580|58878806|FG000|Overall Study|Adverse Event|1|||
30851743|NCT02400580|58878807|FG001|Overall Study|Adverse Event|0|||
30851744|NCT01367119|58878815|FG000|Overall Study|Adverse Event|1|||
30776715|NCT03616106|58787728|FG000|Overall Study|Lost to Follow-up|7|||
30776716|NCT03616106|58787729|FG001|Overall Study|Lost to Follow-up|0|||
30776717|NCT04019054|58787736|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
30776718|NCT04019054|58787737|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
30776719|NCT04019054|58787736|FG000|Overall Study|Withdrawal by Subject|3|||
30776720|NCT04019054|58787737|FG001|Overall Study|Withdrawal by Subject|1|||
30776721|NCT00071799|58787745|FG000|Overall Study|Adverse Event|19|||
30776722|NCT00071799|58787746|FG001|Overall Study|Adverse Event|10|||
30776723|NCT00071799|58787745|FG000|Overall Study|Protocol Violation|1|||
30776724|NCT00071799|58787746|FG001|Overall Study|Protocol Violation|7|||
30776725|NCT00071799|58787745|FG000|Overall Study|Lost to Follow-up|1|||
30776726|NCT00071799|58787746|FG001|Overall Study|Lost to Follow-up|1|||
30776727|NCT00071799|58787745|FG000|Overall Study|Withdrawal by Subject|15|||
30776728|NCT00071799|58787746|FG001|Overall Study|Withdrawal by Subject|37|||
30776729|NCT00071799|58787745|FG000|Overall Study|Physician Decision|0|||
30776730|NCT00071799|58787746|FG001|Overall Study|Physician Decision|2|||
30776731|NCT00071799|58787745|FG000|Overall Study|Lack of Efficacy|11|||
30851745|NCT01367119|58878816|FG001|Overall Study|Adverse Event|0|||
30851746|NCT01367119|58878815|FG000|Overall Study|Withdrawal by Subject|1|||
30851747|NCT01367119|58878816|FG001|Overall Study|Withdrawal by Subject|1|||
30851748|NCT02635724|58878825|FG000|Overall Study|Withdrawal by Subject|0|||
30851749|NCT02635724|58878826|FG001|Overall Study|Withdrawal by Subject|1|||
30851750|NCT02635724|58878827|FG002|Overall Study|Withdrawal by Subject|0|||
30851751|NCT02635646|58878837|FG000|Overall Study|Lost to Follow-up|24|||
30851752|NCT02635646|58878838|FG001|Overall Study|Lost to Follow-up|25|||
30851753|NCT02635646|58878837|FG000|Overall Study|Pregnancy|1|||
30851754|NCT02635646|58878838|FG001|Overall Study|Pregnancy|1|||
30851755|NCT02634788|58878854|FG000|Overall Study|Adverse Event|0|||
30851756|NCT02634788|58878855|FG001|Overall Study|Adverse Event|8|||
30953806|NCT01849289|59007368|FG000|Overall Study|Unclassified|25|||
30776732|NCT00071799|58787746|FG001|Overall Study|Lack of Efficacy|18|||
30776733|NCT00071799|58787745|FG000|Overall Study|Disease Progression|23|||
30776734|NCT00071799|58787746|FG001|Overall Study|Disease Progression|20|||
30776735|NCT00071799|58787745|FG000|Overall Study|Different Central+Local Pathology Review|0|||
30776736|NCT00071799|58787746|FG001|Overall Study|Different Central+Local Pathology Review|1|||
30776737|NCT00071799|58787745|FG000|Overall Study|Not Documented|0|||
30776738|NCT00071799|58787746|FG001|Overall Study|Not Documented|2|||
30776739|NCT03615482|58787760|FG000|Overall Study|Death|1|||
30851757|NCT02634788|58878856|FG002|Overall Study|Adverse Event|3|||
30851758|NCT02634788|58878857|FG003|Overall Study|Adverse Event|1|||
30851759|NCT02634788|58878854|FG000|Overall Study|Lack of Efficacy|4|||
30851760|NCT02634788|58878855|FG001|Overall Study|Lack of Efficacy|0|||
30851761|NCT02634788|58878856|FG002|Overall Study|Lack of Efficacy|1|||
30851762|NCT02634788|58878857|FG003|Overall Study|Lack of Efficacy|4|||
30851763|NCT02634788|58878854|FG000|Overall Study|Lost to Follow-up|0|||
30851764|NCT02634788|58878855|FG001|Overall Study|Lost to Follow-up|1|||
30851765|NCT02634788|58878856|FG002|Overall Study|Lost to Follow-up|0|||
30776740|NCT03615482|58787761|FG001|Overall Study|Death|0|||
30851766|NCT02634788|58878857|FG003|Overall Study|Lost to Follow-up|0|||
30851767|NCT02634788|58878854|FG000|Overall Study|Withdrawal by Subject|0|||
30851768|NCT02634788|58878855|FG001|Overall Study|Withdrawal by Subject|1|||
30851769|NCT02634788|58878856|FG002|Overall Study|Withdrawal by Subject|1|||
30851770|NCT02634788|58878857|FG003|Overall Study|Withdrawal by Subject|0|||
30851771|NCT02785939|58878869|FG000|Overall Study|Progression|25|||
30851772|NCT02785939|58878870|FG001|Overall Study|Progression|8|||
30851773|NCT02785939|58878869|FG000|Overall Study|Adverse Event|3|||
30851774|NCT02785939|58878870|FG001|Overall Study|Adverse Event|1|||
30851775|NCT02785939|58878869|FG000|Overall Study|Death|1|||
30953807|NCT01849289|59007369|FG001|Overall Study|Unclassified|18|||
30953808|NCT01868243|59007377|FG000|Overall Study|Death|0|||
30953809|NCT01868243|59007378|FG001|Overall Study|Death|1|||
30953810|NCT01611935|59007386|FG000|Overall Study|Family Declined Participation|1|||
30953811|NCT01611935|59007387|FG001|Overall Study|Family Declined Participation|0|||
30953812|NCT01868165|59007393|FG000|Overall Study|Withdrawal by Subject|36|||
30953813|NCT01868165|59007393|FG000|Overall Study|Physician Decision|2|||
30776741|NCT03615482|58787760|FG000|Overall Study|Lost to Follow-up|7|||
30776742|NCT03615482|58787761|FG001|Overall Study|Lost to Follow-up|7|||
30953814|NCT01868165|59007393|FG000|Overall Study|Lost to Follow-up|3|||
30953815|NCT01868165|59007393|FG000|Overall Study|Death|4|||
30953816|NCT01868009|59007432|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
30953817|NCT01868009|59007433|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
30953818|NCT01868009|59007432|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
30953819|NCT01868009|59007433|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
30953820|NCT01868009|59007432|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
30953821|NCT01868009|59007433|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
30953822|NCT01849055|59007487|FG000|Overall Study|Withdrawal by Subject|0|||
30953823|NCT01849055|59007488|FG001|Overall Study|Withdrawal by Subject|0|||
30953824|NCT01849055|59007489|FG002|Overall Study|Withdrawal by Subject|1|||
30953825|NCT01849055|59007490|FG003|Overall Study|Withdrawal by Subject|0|||
30953826|NCT01849055|59007491|FG004|Overall Study|Withdrawal by Subject|0|||
30953827|NCT01849055|59007492|FG005|Overall Study|Withdrawal by Subject|0|||
30953828|NCT01848353|59007518|FG000|Phase 1|Withdrawal by Subject|3|||
30953829|NCT01848353|59007519|FG001|Phase 1|Withdrawal by Subject|1|||
30953830|NCT01848353|59007520|FG002|Phase 1|Withdrawal by Subject|0|||
30953831|NCT01848353|59007521|FG003|Phase 1|Withdrawal by Subject|0|||
30953832|NCT01848353|59007518|FG000|Phase 2|Withdrawal by Subject|3|||
30953833|NCT01848353|59007519|FG001|Phase 2|Withdrawal by Subject|2|||
30953834|NCT01848353|59007520|FG002|Phase 2|Withdrawal by Subject|0|||
30953835|NCT01848353|59007521|FG003|Phase 2|Withdrawal by Subject|0|||
30953836|NCT01848353|59007518|FG000|Phase 3|Withdrawal by Subject|1|||
30953837|NCT01848353|59007519|FG001|Phase 3|Withdrawal by Subject|1|||
30953838|NCT01848353|59007520|FG002|Phase 3|Withdrawal by Subject|0|||
30953839|NCT01848353|59007521|FG003|Phase 3|Withdrawal by Subject|0|||
30953840|NCT01847885|59007550|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
30953841|NCT01847885|59007551|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
30953842|NCT01847885|59007552|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
30662590|NCT00916721|58676193|FG000|Overall Study|Withdrawal by Subject|2|||
30776743|NCT03615482|58787760|FG000|Overall Study|Physician Decision|2|||
30776744|NCT03615482|58787761|FG001|Overall Study|Physician Decision|3|||
30776745|NCT03615482|58787760|FG000|Overall Study|Withdrawal by Subject|7|||
30776746|NCT03615482|58787761|FG001|Overall Study|Withdrawal by Subject|7|||
30776747|NCT03688620|58787770|FG000|Overall Study|Other|0|||
30776748|NCT03688620|58787771|FG001|Overall Study|Other|0|||
30776749|NCT03688620|58787772|FG002|Overall Study|Other|1|||
30953843|NCT01847885|59007550|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
30953844|NCT01847885|59007551|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
30953845|NCT01847885|59007552|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
30953846|NCT01847885|59007550|FG000|Initial Enrollment (Consented)|Screen failure|39|||
30953847|NCT01847885|59007551|FG001|Initial Enrollment (Consented)|Screen failure|0|||
30776750|NCT03688620|58787770|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
30776751|NCT03688620|58787771|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
30776752|NCT03688620|58787772|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
30851776|NCT02785939|58878870|FG001|Overall Study|Death|0|||
30851777|NCT02785939|58878869|FG000|Overall Study|Refusal|1|||
30851778|NCT02785939|58878870|FG001|Overall Study|Refusal|0|||
30851779|NCT02785939|58878869|FG000|Overall Study|Deteriorating health|1|||
30953848|NCT01847885|59007552|FG002|Initial Enrollment (Consented)|Screen failure|0|||
30851780|NCT02785939|58878870|FG001|Overall Study|Deteriorating health|0|||
30953849|NCT01847885|59007550|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
30776753|NCT03688620|58787770|FG000|Overall Study|Lost to Follow-up|16|||
30776754|NCT03688620|58787771|FG001|Overall Study|Lost to Follow-up|0|||
30776755|NCT03688620|58787772|FG002|Overall Study|Lost to Follow-up|1|||
30851781|NCT02785939|58878869|FG000|Overall Study|Not protocol specified|0|||
30851782|NCT02785939|58878870|FG001|Overall Study|Not protocol specified|1|||
30851783|NCT02634320|58878884|FG000|Overall Study|Adverse Event|2|||
30851784|NCT02634320|58878884|FG000|Overall Study|Lost to Follow-up|3|||
30851785|NCT02634320|58878884|FG000|Overall Study|Moved out of area|2|||
30851786|NCT02634320|58878884|FG000|Overall Study|Out of window for study visits|1|||
30776756|NCT03688620|58787770|FG000|Overall Study|Withdrawal by Subject|0|||
30776757|NCT03688620|58787771|FG001|Overall Study|Withdrawal by Subject|0|||
30776758|NCT03688620|58787772|FG002|Overall Study|Withdrawal by Subject|6|||
30776759|NCT00090363|58787785|FG000|Overall Study|Lost to Follow-up|1|||
30851787|NCT02634320|58878884|FG000|Overall Study|Protocol Violation|1|||
30851788|NCT02634320|58878884|FG000|Overall Study|Withdrawal by Subject|5|||
30851789|NCT02634320|58878884|FG000|Overall Study|Lack of Efficacy|2|||
30851790|NCT02435680|58878891|FG000|Overall Study|Physician Decision|3|||
30851791|NCT02435680|58878892|FG001|Overall Study|Physician Decision|0|||
30851792|NCT02435680|58878893|FG002|Overall Study|Physician Decision|0|||
30851793|NCT02435680|58878891|FG000|Overall Study|subject / guardian decision|0|||
30851794|NCT02435680|58878892|FG001|Overall Study|subject / guardian decision|3|||
30851795|NCT02435680|58878893|FG002|Overall Study|subject / guardian decision|2|||
30851796|NCT02435680|58878891|FG000|Overall Study|Adverse Event|8|||
30776760|NCT00090363|58787786|FG001|Overall Study|Lost to Follow-up|2|||
30776761|NCT00090363|58787787|FG002|Overall Study|Lost to Follow-up|1|||
30776762|NCT00090363|58787785|FG000|Overall Study|Withdrawal by Subject|7|||
30851797|NCT02435680|58878892|FG001|Overall Study|Adverse Event|3|||
30851798|NCT02435680|58878893|FG002|Overall Study|Adverse Event|2|||
30851799|NCT02435680|58878891|FG000|Overall Study|progressive disease|10|||
30851800|NCT02435680|58878892|FG001|Overall Study|progressive disease|7|||
30851801|NCT02435680|58878893|FG002|Overall Study|progressive disease|11|||
30851802|NCT02435680|58878891|FG000|Overall Study|not treated|0|||
30851803|NCT02435680|58878892|FG001|Overall Study|not treated|0|||
30851804|NCT02435680|58878893|FG002|Overall Study|not treated|1|||
30851805|NCT03371732|58878907|FG000|Overall Study|Withdrawal by Subject|9|||
30851806|NCT03371732|58878908|FG001|Overall Study|Withdrawal by Subject|3|||
30851807|NCT03371732|58878907|FG000|Overall Study|Refusal to continue|3|||
30851808|NCT03371732|58878908|FG001|Overall Study|Refusal to continue|4|||
30851809|NCT02745119|58878920|FG000|Overall Study|Adverse Event|1|||
30851810|NCT02745119|58878921|FG001|Overall Study|Adverse Event|0|||
30953850|NCT01847885|59007551|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
30953851|NCT01847885|59007552|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
30953852|NCT01847885|59007550|FG000|Randomization|Protocol Violation|0|||
30953853|NCT01847885|59007551|FG001|Randomization|Protocol Violation|1|||
30953854|NCT01847885|59007552|FG002|Randomization|Protocol Violation|0|||
30953855|NCT01847885|59007550|FG000|Randomization|Withdrawal by Subject|0|||
30953856|NCT01847885|59007551|FG001|Randomization|Withdrawal by Subject|0|||
30953857|NCT01847885|59007552|FG002|Randomization|Withdrawal by Subject|2|||
30953858|NCT01847885|59007550|FG000|Randomization|Screen Failure|0|||
30953859|NCT01847885|59007551|FG001|Randomization|Screen Failure|3|||
30953860|NCT01847885|59007552|FG002|Randomization|Screen Failure|0|||
30953861|NCT01867307|59007590|FG000|Overall Study|Protocol Violation|2|||
30953862|NCT01867307|59007591|FG001|Overall Study|Protocol Violation|0|||
30953863|NCT01867307|59007590|FG000|Overall Study|Other Adverse Event|1|||
30953864|NCT01867307|59007591|FG001|Overall Study|Other Adverse Event|3|||
30953865|NCT01845077|59007600|FG000|Washout Period|Lost to Follow-up|0|||
30953866|NCT01845077|59007601|FG001|Washout Period|Lost to Follow-up|1|||
30953867|NCT01845077|59007602|FG002|Washout Period|Lost to Follow-up|0|||
30953868|NCT01845077|59007603|FG003|Washout Period|Lost to Follow-up|1|||
30953869|NCT01845077|59007604|FG004|Washout Period|Lost to Follow-up|0|||
30953870|NCT01845077|59007605|FG005|Washout Period|Lost to Follow-up|1|||
30953871|NCT01845077|59007600|FG000|Washout Period|Adverse Event|1|||
30953872|NCT01845077|59007601|FG001|Washout Period|Adverse Event|0|||
30953873|NCT01845077|59007602|FG002|Washout Period|Adverse Event|0|||
30776763|NCT00090363|58787786|FG001|Overall Study|Withdrawal by Subject|7|||
30776764|NCT00090363|58787787|FG002|Overall Study|Withdrawal by Subject|6|||
30776765|NCT00090363|58787785|FG000|Overall Study|Study-specific discontinuation criteria|75|||
30851811|NCT02745119|58878922|FG002|Overall Study|Adverse Event|1|||
30851812|NCT02745119|58878923|FG003|Overall Study|Adverse Event|3|||
30851813|NCT02745119|58878920|FG000|Overall Study|Death|3|||
30851814|NCT02745119|58878921|FG001|Overall Study|Death|3|||
30851815|NCT02745119|58878922|FG002|Overall Study|Death|0|||
30851816|NCT02745119|58878923|FG003|Overall Study|Death|4|||
30851817|NCT02745119|58878920|FG000|Overall Study|Lost to Follow-up|0|||
30851818|NCT02745119|58878921|FG001|Overall Study|Lost to Follow-up|0|||
30851819|NCT02745119|58878922|FG002|Overall Study|Lost to Follow-up|0|||
30953874|NCT01845077|59007603|FG003|Washout Period|Adverse Event|0|||
30953875|NCT01845077|59007604|FG004|Washout Period|Adverse Event|0|||
30953876|NCT01845077|59007605|FG005|Washout Period|Adverse Event|0|||
30776766|NCT00090363|58787786|FG001|Overall Study|Study-specific discontinuation criteria|74|||
30776767|NCT00090363|58787787|FG002|Overall Study|Study-specific discontinuation criteria|62|||
30776768|NCT00090363|58787785|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30776769|NCT00090363|58787786|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30776770|NCT00090363|58787787|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
30776771|NCT00090363|58787785|FG000|Overall Study|Consent expired|7|||
30776772|NCT00090363|58787786|FG001|Overall Study|Consent expired|10|||
30776773|NCT00090363|58787787|FG002|Overall Study|Consent expired|9|||
30953877|NCT01845077|59007600|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
30953878|NCT01845077|59007601|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
30953879|NCT01845077|59007602|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
30953880|NCT01845077|59007603|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
30953881|NCT01845077|59007604|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
30953882|NCT01845077|59007605|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
30953883|NCT01845077|59007600|FG000|Washout Period|Protocol Violation|0|||
30953884|NCT01845077|59007601|FG001|Washout Period|Protocol Violation|0|||
30953885|NCT01845077|59007602|FG002|Washout Period|Protocol Violation|0|||
30953886|NCT01845077|59007603|FG003|Washout Period|Protocol Violation|1|||
30953887|NCT01845077|59007604|FG004|Washout Period|Protocol Violation|1|||
30953888|NCT01845077|59007605|FG005|Washout Period|Protocol Violation|0|||
30953889|NCT01866917|59007622|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
30953890|NCT01866917|59007623|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
30953891|NCT01844765|59007758|FG000|Overall Study|Adverse Event|6|||
30953892|NCT01844765|59007759|FG001|Overall Study|Adverse Event|8|||
30953893|NCT01844765|59007758|FG000|Overall Study|Withdrawal by Subject|2|||
30953894|NCT01844765|59007759|FG001|Overall Study|Withdrawal by Subject|3|||
30953895|NCT01844765|59007758|FG000|Overall Study|Disease progression|1|||
30953896|NCT01844765|59007759|FG001|Overall Study|Disease progression|0|||
30953897|NCT01844765|59007758|FG000|Overall Study|Administrative problems|3|||
30953898|NCT01844765|59007759|FG001|Overall Study|Administrative problems|4|||
30953899|NCT01844765|59007758|FG000|Overall Study|Protocol deviation|2|||
30953900|NCT01844765|59007759|FG001|Overall Study|Protocol deviation|0|||
30953901|NCT01844765|59007758|FG000|Overall Study|Untreated|1|||
30953902|NCT01844765|59007759|FG001|Overall Study|Untreated|0|||
30953903|NCT01866293|59007774|FG000|Overall Study|Adverse Event|2|||
30953904|NCT01844687|59007778|FG000|Visit 1|Protocol Violation|3|||
30953905|NCT01844687|59007778|FG000|Visit 1|Lost to Follow-up|5|||
30776774|NCT00090363|58787785|FG000|Overall Study|Reasons not specified|2|||
30776775|NCT00090363|58787786|FG001|Overall Study|Reasons not specified|1|||
30776776|NCT00090363|58787787|FG002|Overall Study|Reasons not specified|1|||
30776777|NCT00090363|58787785|FG000|Overall Study|Continuing on study off treatment|14|||
30776778|NCT00090363|58787786|FG001|Overall Study|Continuing on study off treatment|13|||
30776779|NCT00090363|58787787|FG002|Overall Study|Continuing on study off treatment|16|||
30776780|NCT03652610|58787797|FG000|Overall Study|Lost to Follow-up|1|||
30776781|NCT03652610|58787798|FG001|Overall Study|Lost to Follow-up|0|||
30776782|NCT03652610|58787797|FG000|Overall Study|Withdrawal by Subject|3|||
30776783|NCT03652610|58787798|FG001|Overall Study|Withdrawal by Subject|5|||
30776784|NCT03615404|58787804|FG000|Overall Study|Death|1|||
30776785|NCT03615404|58787804|FG000|Overall Study|vaccine did not pass quality assurance|1|||
30776786|NCT03614156|58787811|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
30851820|NCT02745119|58878923|FG003|Overall Study|Lost to Follow-up|1|||
30851821|NCT02745119|58878920|FG000|Overall Study|Protocol Deviation|0|||
30851822|NCT02745119|58878921|FG001|Overall Study|Protocol Deviation|0|||
30851823|NCT02745119|58878922|FG002|Overall Study|Protocol Deviation|0|||
30851824|NCT02745119|58878923|FG003|Overall Study|Protocol Deviation|1|||
30851825|NCT02745119|58878920|FG000|Overall Study|Withdrawal by Subject|7|||
30851826|NCT02745119|58878921|FG001|Overall Study|Withdrawal by Subject|15|||
30851827|NCT02745119|58878922|FG002|Overall Study|Withdrawal by Subject|8|||
30851828|NCT02745119|58878923|FG003|Overall Study|Withdrawal by Subject|14|||
30953906|NCT01844687|59007778|FG000|Visit 2|Withdrawal by Subject|1|||
30776787|NCT03614156|58787812|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
30776788|NCT03614156|58787813|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
30851829|NCT02745119|58878920|FG000|Overall Study|Study Terminated by Sponsor|134|||
30851830|NCT02745119|58878921|FG001|Overall Study|Study Terminated by Sponsor|252|||
30851831|NCT02745119|58878922|FG002|Overall Study|Study Terminated by Sponsor|135|||
30851832|NCT02745119|58878923|FG003|Overall Study|Study Terminated by Sponsor|251|||
30851833|NCT02745119|58878920|FG000|Overall Study|Physician Decision|0|||
30851834|NCT02745119|58878921|FG001|Overall Study|Physician Decision|2|||
30776789|NCT03614156|58787814|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
30851835|NCT02745119|58878922|FG002|Overall Study|Physician Decision|2|||
30851836|NCT02745119|58878923|FG003|Overall Study|Physician Decision|2|||
30953907|NCT01844687|59007778|FG000|Visit 2|Protocol Violation|1|||
30953908|NCT01844687|59007778|FG000|Visit 3|Lost to Follow-up|1|||
30953909|NCT01844687|59007778|FG000|Visit 3|Withdrawal by Subject|3|||
30776790|NCT03614156|58787811|FG000|Open-Label Treatment Period|Adverse Event|7|||
30776791|NCT03614156|58787812|FG001|Open-Label Treatment Period|Adverse Event|0|||
30776792|NCT03614156|58787813|FG002|Open-Label Treatment Period|Adverse Event|0|||
30776793|NCT03614156|58787814|FG003|Open-Label Treatment Period|Adverse Event|0|||
30776794|NCT03614156|58787811|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
30851837|NCT02745119|58878920|FG000|Overall Study|Reason Not Specified|0|||
30851838|NCT02745119|58878921|FG001|Overall Study|Reason Not Specified|2|||
30851839|NCT02745119|58878922|FG002|Overall Study|Reason Not Specified|0|||
30851840|NCT02745119|58878923|FG003|Overall Study|Reason Not Specified|1|||
30851841|NCT01367665|58878937|FG000|Overall Study|Death|102|||
30851842|NCT01367665|58878938|FG001|Overall Study|Death|19|||
30851843|NCT01367665|58878937|FG000|Overall Study|Lost to Follow-up|222|||
30851844|NCT01367665|58878938|FG001|Overall Study|Lost to Follow-up|22|||
30851845|NCT01367665|58878937|FG000|Overall Study|Not Done|118|||
30662591|NCT00916721|58676194|FG001|Overall Study|Withdrawal by Subject|2|||
30662592|NCT00916721|58676193|FG000|Overall Study|Protocol Violation|2|||
30662593|NCT00916721|58676194|FG001|Overall Study|Protocol Violation|4|||
30662594|NCT00915005|58676202|FG000|Overall Study|Withdrawal by Subject|4|||
30662595|NCT00915005|58676203|FG001|Overall Study|Withdrawal by Subject|4|||
30776795|NCT03614156|58787812|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
30776796|NCT03614156|58787813|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
30776797|NCT03614156|58787814|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
30851846|NCT01367665|58878938|FG001|Overall Study|Not Done|14|||
30851847|NCT02576847|58878945|FG000|Overall Study|Adverse Event|27|||
30851848|NCT02576847|58878945|FG000|Overall Study|Lost to Follow-up|22|||
30851849|NCT02576847|58878945|FG000|Overall Study|Physician Decision|1|||
30851850|NCT02576847|58878945|FG000|Overall Study|Pregnancy|1|||
30851851|NCT02576847|58878945|FG000|Overall Study|Protocol Violation|3|||
30851852|NCT02576847|58878945|FG000|Overall Study|Withdrawal by Subject|78|||
30851853|NCT02576847|58878945|FG000|Overall Study|Other|5|||
30851854|NCT02135029|58878961|FG000|Overall Study|Adverse Event|2|||
30851855|NCT02135029|58878962|FG001|Overall Study|Adverse Event|2|||
30851856|NCT02135029|58878963|FG002|Overall Study|Adverse Event|2|||
30851857|NCT02135029|58878961|FG000|Overall Study|Lost to Follow-up|0|||
30851858|NCT02135029|58878962|FG001|Overall Study|Lost to Follow-up|1|||
30851859|NCT02135029|58878963|FG002|Overall Study|Lost to Follow-up|0|||
30851860|NCT02135029|58878961|FG000|Overall Study|Withdrawal by Subject|2|||
30851861|NCT02135029|58878962|FG001|Overall Study|Withdrawal by Subject|0|||
30851862|NCT02135029|58878963|FG002|Overall Study|Withdrawal by Subject|1|||
30851863|NCT02135029|58878961|FG000|Overall Study|Other|0|||
30851864|NCT02135029|58878962|FG001|Overall Study|Other|1|||
30851865|NCT02135029|58878963|FG002|Overall Study|Other|0|||
30851866|NCT02135029|58878961|FG000|Overall Study|Death|0|||
30851867|NCT02135029|58878962|FG001|Overall Study|Death|1|||
30851868|NCT02135029|58878963|FG002|Overall Study|Death|0|||
30851869|NCT02842151|58878972|FG000|Overall Study|Adverse Event|1|||
30851870|NCT02842151|58878972|FG000|Overall Study|Subject moved too far away|1|||
30851871|NCT02842073|58878978|FG000|Overall Study|Withdrawal by Subject|1|||
30851872|NCT02784535|58878982|FG000|Overall Study|Adverse Event|1|||
30851873|NCT02784535|58878983|FG001|Overall Study|Adverse Event|0|||
30953910|NCT01844687|59007778|FG000|Visit 3|child care problems|1|||
30953911|NCT01844687|59007778|FG000|Visit 4|Pregnancy|1|||
30953912|NCT01844687|59007778|FG000|Visit 4|Lost to Follow-up|1|||
30953913|NCT01844687|59007778|FG000|Visit 4|Withdrawal by Subject|2|||
30776798|NCT03614156|58787811|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
30776799|NCT03614156|58787812|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
30776800|NCT03614156|58787813|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
30776801|NCT03614156|58787814|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
30776802|NCT03614156|58787811|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
30776803|NCT03614156|58787812|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
30776804|NCT03614156|58787813|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
30776805|NCT03614156|58787814|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
30851874|NCT02784535|58878982|FG000|Overall Study|Withdrawal by Subject|0|||
30851875|NCT02784535|58878983|FG001|Overall Study|Withdrawal by Subject|1|||
30953914|NCT01844531|59007804|FG000|Overall Study|Withdrawal by Subject|0|||
30662596|NCT00915005|58676202|FG000|Overall Study|Patient preferred protons therapy|6|||
30953915|NCT01844531|59007805|FG001|Overall Study|Withdrawal by Subject|1|||
30851876|NCT02784535|58878982|FG000|Overall Study|Physician Decision|0|||
30851877|NCT02784535|58878983|FG001|Overall Study|Physician Decision|1|||
30851878|NCT01367275|58878992|FG000|Overall Study|Ineligible|1|||
30851879|NCT01367275|58878992|FG000|Overall Study|Disease Progression|2|||
30851880|NCT02842853|58879000|FG000|Overall Study|Non-compliance with the protocol|3|||
30953916|NCT01844531|59007806|FG002|Overall Study|Withdrawal by Subject|0|||
30662597|NCT00915005|58676203|FG001|Overall Study|Patient preferred protons therapy|0|||
30851881|NCT02842853|58879001|FG001|Overall Study|Non-compliance with the protocol|7|||
30851882|NCT02842853|58879002|FG002|Overall Study|Non-compliance with the protocol|2|||
30776806|NCT03614156|58787811|FG000|Open-Label Treatment Period|Protocol Violation|2|||
30776807|NCT03614156|58787812|FG001|Open-Label Treatment Period|Protocol Violation|0|||
30776808|NCT03614156|58787813|FG002|Open-Label Treatment Period|Protocol Violation|0|||
30776809|NCT03614156|58787814|FG003|Open-Label Treatment Period|Protocol Violation|0|||
30776810|NCT03614156|58787811|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
30776811|NCT03614156|58787812|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
30776812|NCT03614156|58787813|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
30776813|NCT03614156|58787814|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
30776814|NCT03614156|58787811|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
30776815|NCT03614156|58787812|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
30776816|NCT03614156|58787813|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
30776817|NCT03614156|58787814|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
30776818|NCT03614156|58787811|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
30776819|NCT03614156|58787812|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
30776820|NCT03614156|58787813|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
30776821|NCT03614156|58787814|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
30776822|NCT03614156|58787811|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
30776823|NCT03614156|58787812|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
30776824|NCT03614156|58787813|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
30776825|NCT03614156|58787814|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
30776826|NCT03614156|58787811|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
30776827|NCT03614156|58787812|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
30776828|NCT03614156|58787813|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
30776829|NCT03614156|58787814|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
30776830|NCT03614156|58787811|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
30776831|NCT03614156|58787812|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
30776832|NCT03614156|58787813|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
30776833|NCT03614156|58787814|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
30776834|NCT03614156|58787811|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
30776835|NCT03614156|58787812|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
30776836|NCT03614156|58787813|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
30776837|NCT03614156|58787814|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
30851883|NCT02842853|58879003|FG003|Overall Study|Non-compliance with the protocol|5|||
30851884|NCT02842853|58879000|FG000|Overall Study|Subject met exclusion criteria|0|||
30851885|NCT02842853|58879001|FG001|Overall Study|Subject met exclusion criteria|1|||
30953917|NCT01844531|59007807|FG003|Overall Study|Withdrawal by Subject|0|||
30953918|NCT01844375|59007819|FG000|Overall Study|Protocol Violation|1|||
30953919|NCT01844375|59007820|FG001|Overall Study|Protocol Violation|1|||
30953920|NCT02367456|59007829|FG000|Overall Study|Death|8|||
30953921|NCT02367456|59007830|FG001|Overall Study|Death|21|||
30953922|NCT02367456|59007831|FG002|Overall Study|Death|14|||
30953923|NCT02367456|59007829|FG000|Overall Study|Lost to Follow-up|1|||
30953924|NCT02367456|59007830|FG001|Overall Study|Lost to Follow-up|3|||
30953925|NCT02367456|59007831|FG002|Overall Study|Lost to Follow-up|1|||
30953926|NCT02367456|59007829|FG000|Overall Study|Ongoing|0|||
30953927|NCT02367456|59007830|FG001|Overall Study|Ongoing|6|||
30953928|NCT02367456|59007831|FG002|Overall Study|Ongoing|15|||
30953929|NCT02367456|59007829|FG000|Overall Study|Other reason|3|||
30953930|NCT02367456|59007830|FG001|Overall Study|Other reason|0|||
30953931|NCT02367456|59007831|FG002|Overall Study|Other reason|0|||
30953932|NCT01865747|59007862|FG000|Overall Study (ITT)|Adverse Event|32|||
30953933|NCT01865747|59007863|FG001|Overall Study (ITT)|Adverse Event|31|||
30953934|NCT01865747|59007862|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
30953935|NCT01865747|59007863|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
30953936|NCT01865747|59007862|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
30953937|NCT01865747|59007863|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
30953938|NCT01865747|59007862|FG000|Overall Study (ITT)|Protocol Violation|1|||
30953939|NCT01865747|59007863|FG001|Overall Study (ITT)|Protocol Violation|1|||
30851886|NCT02842853|58879002|FG002|Overall Study|Subject met exclusion criteria|0|||
30851887|NCT02842853|58879003|FG003|Overall Study|Subject met exclusion criteria|0|||
30851888|NCT02842853|58879000|FG000|Overall Study|Withdrawal by Subject|11|||
30851889|NCT02842853|58879001|FG001|Overall Study|Withdrawal by Subject|13|||
30953940|NCT01865747|59007862|FG000|Overall Study (ITT)|Physician Decision|5|||
30953941|NCT01865747|59007863|FG001|Overall Study (ITT)|Physician Decision|2|||
30953942|NCT01865747|59007862|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
30953943|NCT01865747|59007863|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
30953944|NCT01865747|59007862|FG000|Overall Study (ITT)|Sponsor Decision|0|||
30953945|NCT01865747|59007863|FG001|Overall Study (ITT)|Sponsor Decision|1|||
30851890|NCT02842853|58879002|FG002|Overall Study|Withdrawal by Subject|9|||
30953946|NCT01865747|59007862|FG000|Overall Study (ITT)|Progressive Disease|122|||
30953947|NCT01865747|59007863|FG001|Overall Study (ITT)|Progressive Disease|158|||
30776838|NCT03614156|58787811|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
30776839|NCT03614156|58787812|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
30776840|NCT03614156|58787813|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
30776841|NCT03614156|58787814|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
30776842|NCT03614156|58787811|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
30776843|NCT03614156|58787812|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
30851891|NCT02842853|58879003|FG003|Overall Study|Withdrawal by Subject|8|||
30953948|NCT01865747|59007862|FG000|Overall Study (ITT)|Reason Not Provided|0|||
30953949|NCT01865747|59007863|FG001|Overall Study (ITT)|Reason Not Provided|1|||
30953950|NCT01865747|59007862|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
30953951|NCT01865747|59007863|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
30953952|NCT01865747|59007862|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
30953953|NCT01865747|59007863|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
30953954|NCT01865747|59007862|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
30953955|NCT01865747|59007863|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
30953956|NCT01865747|59007862|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
30953957|NCT01865747|59007863|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
30953958|NCT01865747|59007862|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
30953959|NCT01865747|59007863|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
30953960|NCT01865747|59007862|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
30953961|NCT01865747|59007863|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
30953962|NCT01865747|59007862|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
30953963|NCT01865747|59007863|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
30953964|NCT01865747|59007862|FG000|Primary Intent to Treat (PITT)|Other|0|||
30953965|NCT01865747|59007863|FG001|Primary Intent to Treat (PITT)|Other|1|||
30953966|NCT01843673|59007904|FG000|Overall Study|Lack of Efficacy|2|||
30953967|NCT01843673|59007904|FG000|Overall Study|Withdrawal by Subject|4|||
30953968|NCT01843205|59007923|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
30953969|NCT01843205|59007924|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
30953970|NCT01835015|59008011|FG000|Overall Study|Adverse Event|0|||
30953971|NCT01835015|59008012|FG001|Overall Study|Adverse Event|0|||
30953972|NCT01835015|59008013|FG002|Overall Study|Adverse Event|1|||
30953973|NCT01835015|59008014|FG003|Overall Study|Adverse Event|0|||
30953974|NCT01835015|59008015|FG004|Overall Study|Adverse Event|0|||
30953975|NCT01842581|59008043|FG000|Overall Study|Adverse Event|6|||
30953976|NCT01842581|59008044|FG001|Overall Study|Adverse Event|4|||
30953977|NCT01842581|59008043|FG000|Overall Study|HE breakthrough|26|||
30953978|NCT01842581|59008044|FG001|Overall Study|HE breakthrough|13|||
30953979|NCT01842581|59008043|FG000|Overall Study|Liver transplant|2|||
30953980|NCT01842581|59008044|FG001|Overall Study|Liver transplant|0|||
30953981|NCT01842581|59008043|FG000|Overall Study|Lost to Follow-up|2|||
30953982|NCT01842581|59008044|FG001|Overall Study|Lost to Follow-up|5|||
30953983|NCT01842581|59008043|FG000|Overall Study|Withdrawal by Subject|5|||
30953984|NCT01842581|59008044|FG001|Overall Study|Withdrawal by Subject|7|||
30953985|NCT01842581|59008043|FG000|Overall Study|Other than specified|3|||
30953986|NCT01842581|59008044|FG001|Overall Study|Other than specified|1|||
30953987|NCT01833533|59008052|FG000|Overall Study|Adverse Event|0|||
30953988|NCT01833533|59008053|FG001|Overall Study|Adverse Event|1|||
30953989|NCT01833533|59008052|FG000|Overall Study|Lost to Follow-up|4|||
30953990|NCT01833533|59008053|FG001|Overall Study|Lost to Follow-up|9|||
30953991|NCT01833533|59008052|FG000|Overall Study|To Enter an Extension Study|0|||
30953992|NCT01833533|59008053|FG001|Overall Study|To Enter an Extension Study|4|||
30953993|NCT01833533|59008052|FG000|Overall Study|Other|2|||
30953994|NCT01833533|59008053|FG001|Overall Study|Other|7|||
30953995|NCT01833455|59008061|FG000|Overall Study|Withdrawal by Subject|1|||
30776844|NCT03614156|58787813|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
30776845|NCT03614156|58787814|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
30776846|NCT03614156|58787811|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
30776847|NCT03614156|58787812|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
30776848|NCT03614156|58787813|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
30776849|NCT03614156|58787814|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
30776850|NCT03614156|58787811|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
30776851|NCT03614156|58787812|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
30776852|NCT03614156|58787813|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
30776853|NCT03614156|58787814|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
30776854|NCT03614078|58787826|FG000|Overall Study|Withdrawal by Subject|2|||
30776855|NCT03614078|58787827|FG001|Overall Study|Withdrawal by Subject|2|||
30776856|NCT03614078|58787828|FG002|Overall Study|Withdrawal by Subject|3|||
30953996|NCT01833455|59008062|FG001|Overall Study|Withdrawal by Subject|0|||
30953997|NCT01833143|59008080|FG000|Overall Study|Not Treated|1|||
30953998|NCT01841567|59008084|FG000|Overall Study|Adverse Event|3|||
30953999|NCT01833065|59008091|FG000|Overall Study|Adverse Event|6|||
30954000|NCT01833065|59008092|FG001|Overall Study|Adverse Event|1|||
30954001|NCT01833065|59008093|FG002|Overall Study|Adverse Event|0|||
30851892|NCT02842853|58879000|FG000|Overall Study|Lost to Follow-up|9|||
30851893|NCT02842853|58879001|FG001|Overall Study|Lost to Follow-up|13|||
30851894|NCT02842853|58879002|FG002|Overall Study|Lost to Follow-up|10|||
30851895|NCT02842853|58879003|FG003|Overall Study|Lost to Follow-up|11|||
30851896|NCT02433340|58879019|FG000|Overall Study|Adverse Event|0|||
30851897|NCT02433340|58879020|FG001|Overall Study|Adverse Event|0|||
30851898|NCT02433340|58879021|FG002|Overall Study|Adverse Event|1|||
30851899|NCT02433340|58879022|FG003|Overall Study|Adverse Event|0|||
30851900|NCT02433340|58879019|FG000|Overall Study|Withdrawal by Subject|1|||
30851901|NCT02433340|58879020|FG001|Overall Study|Withdrawal by Subject|0|||
30851902|NCT02433340|58879021|FG002|Overall Study|Withdrawal by Subject|1|||
30851903|NCT02433340|58879022|FG003|Overall Study|Withdrawal by Subject|2|||
30954002|NCT01833065|59008094|FG003|Overall Study|Adverse Event|2|||
30954003|NCT01833065|59008095|FG004|Overall Study|Adverse Event|3|||
30954004|NCT01833065|59008091|FG000|Overall Study|Protocol Violation|1|||
30954005|NCT01833065|59008092|FG001|Overall Study|Protocol Violation|0|||
30954006|NCT01833065|59008093|FG002|Overall Study|Protocol Violation|0|||
30954007|NCT01833065|59008094|FG003|Overall Study|Protocol Violation|0|||
30954008|NCT01833065|59008095|FG004|Overall Study|Protocol Violation|2|||
30954009|NCT01833065|59008091|FG000|Overall Study|Lost to Follow-up|1|||
30954010|NCT01833065|59008092|FG001|Overall Study|Lost to Follow-up|0|||
30954011|NCT01833065|59008093|FG002|Overall Study|Lost to Follow-up|0|||
30954012|NCT01833065|59008094|FG003|Overall Study|Lost to Follow-up|0|||
30954013|NCT01833065|59008095|FG004|Overall Study|Lost to Follow-up|3|||
30954014|NCT01833065|59008091|FG000|Overall Study|Withdrawal by Subject|6|||
30954015|NCT01833065|59008092|FG001|Overall Study|Withdrawal by Subject|2|||
30954016|NCT01833065|59008093|FG002|Overall Study|Withdrawal by Subject|4|||
30954017|NCT01833065|59008094|FG003|Overall Study|Withdrawal by Subject|3|||
30954018|NCT01833065|59008095|FG004|Overall Study|Withdrawal by Subject|11|||
30954019|NCT01833065|59008091|FG000|Overall Study|Subject's substantial non-compliance|0|||
30954020|NCT01833065|59008092|FG001|Overall Study|Subject's substantial non-compliance|1|||
30954021|NCT01833065|59008093|FG002|Overall Study|Subject's substantial non-compliance|0|||
30954022|NCT01833065|59008094|FG003|Overall Study|Subject's substantial non-compliance|0|||
30954023|NCT01833065|59008095|FG004|Overall Study|Subject's substantial non-compliance|0|||
30954024|NCT01833065|59008091|FG000|Overall Study|Trial terminated by sponsor|8|||
30954025|NCT01833065|59008092|FG001|Overall Study|Trial terminated by sponsor|8|||
30954026|NCT01833065|59008093|FG002|Overall Study|Trial terminated by sponsor|7|||
30954027|NCT01833065|59008094|FG003|Overall Study|Trial terminated by sponsor|3|||
30954028|NCT01833065|59008095|FG004|Overall Study|Trial terminated by sponsor|13|||
30954029|NCT01833065|59008091|FG000|Overall Study|Others|2|||
30954030|NCT01833065|59008092|FG001|Overall Study|Others|1|||
30954031|NCT01833065|59008093|FG002|Overall Study|Others|1|||
30954032|NCT01833065|59008094|FG003|Overall Study|Others|1|||
30954033|NCT01833065|59008095|FG004|Overall Study|Others|4|||
30954034|NCT01831817|59008109|FG000|Overall Study|Lost to Follow-up|1|||
30954035|NCT01831817|59008110|FG001|Overall Study|Lost to Follow-up|0|||
30954036|NCT01831817|59008111|FG002|Overall Study|Lost to Follow-up|0|||
30954037|NCT01831817|59008112|FG003|Overall Study|Lost to Follow-up|0|||
30776857|NCT03614078|58787826|FG000|Overall Study|Participant Did Not Return for Visit|0|||
30776858|NCT03614078|58787827|FG001|Overall Study|Participant Did Not Return for Visit|1|||
30776859|NCT03614078|58787828|FG002|Overall Study|Participant Did Not Return for Visit|0|||
30776860|NCT03614078|58787826|FG000|Overall Study|High Neutrophils|0|||
30776861|NCT03614078|58787827|FG001|Overall Study|High Neutrophils|0|||
30776862|NCT03614078|58787828|FG002|Overall Study|High Neutrophils|2|||
30776863|NCT03614078|58787826|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
30776864|NCT03614078|58787827|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
30776865|NCT03614078|58787828|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
30776866|NCT03614078|58787826|FG000|Overall Study|Exacerbation of Psoriasis|0|||
30776867|NCT03614078|58787827|FG001|Overall Study|Exacerbation of Psoriasis|1|||
30954038|NCT01831817|59008109|FG000|Overall Study|Withdrawl of Consent|3|||
30954039|NCT01831817|59008110|FG001|Overall Study|Withdrawl of Consent|0|||
30954040|NCT01831817|59008111|FG002|Overall Study|Withdrawl of Consent|0|||
30954041|NCT01831817|59008112|FG003|Overall Study|Withdrawl of Consent|0|||
30851904|NCT02433340|58879019|FG000|Overall Study|Lost to Follow-up|0|||
30851905|NCT02433340|58879020|FG001|Overall Study|Lost to Follow-up|1|||
30851906|NCT02433340|58879021|FG002|Overall Study|Lost to Follow-up|0|||
30851907|NCT02433340|58879022|FG003|Overall Study|Lost to Follow-up|0|||
30954042|NCT01840943|59008137|FG000|Overall Study|Withdrawal by Subject|5|||
30954043|NCT01840943|59008138|FG001|Overall Study|Withdrawal by Subject|6|||
30954044|NCT01840943|59008137|FG000|Overall Study|Physician Decision|4|||
30954045|NCT01840943|59008138|FG001|Overall Study|Physician Decision|2|||
30954046|NCT01840943|59008137|FG000|Overall Study|Lost to Follow-up|4|||
30954047|NCT01840943|59008138|FG001|Overall Study|Lost to Follow-up|4|||
30954048|NCT01840163|59008146|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
30851908|NCT02433340|58879019|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
30851909|NCT02433340|58879020|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
30851910|NCT02433340|58879021|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
30851911|NCT02433340|58879022|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
30851912|NCT02433340|58879019|FG000|Overall Study|Other|0|||
30851913|NCT02433340|58879020|FG001|Overall Study|Other|1|||
30851914|NCT02433340|58879021|FG002|Overall Study|Other|0|||
30851915|NCT02433340|58879022|FG003|Overall Study|Other|0|||
30851916|NCT02400346|58879034|FG000|Overall Study|Adverse Event|24|||
30662598|NCT00915005|58676202|FG000|Overall Study|Insurance denial|3|||
30662599|NCT00915005|58676203|FG001|Overall Study|Insurance denial|15|||
30662600|NCT01143246|58676211|FG000|Overall Study|Adverse Event|24|||
30662601|NCT01143246|58676212|FG001|Overall Study|Adverse Event|28|||
30662602|NCT01143246|58676211|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
30662603|NCT01143246|58676212|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
30662604|NCT01143246|58676211|FG000|Overall Study|Lost to Follow-up|0|||
30662605|NCT01143246|58676212|FG001|Overall Study|Lost to Follow-up|1|||
30662606|NCT01143246|58676211|FG000|Overall Study|Death|16|||
30662607|NCT01143246|58676212|FG001|Overall Study|Death|15|||
30776868|NCT03614078|58787828|FG002|Overall Study|Exacerbation of Psoriasis|0|||
30776869|NCT03614078|58787826|FG000|Overall Study|Adverse Event|0|||
30776870|NCT03614078|58787827|FG001|Overall Study|Adverse Event|2|||
30776871|NCT03614078|58787828|FG002|Overall Study|Adverse Event|0|||
30776872|NCT03614078|58787826|FG000|Overall Study|Dizziness and Rash|0|||
30776873|NCT03614078|58787827|FG001|Overall Study|Dizziness and Rash|1|||
30776874|NCT03614078|58787828|FG002|Overall Study|Dizziness and Rash|0|||
30776875|NCT03613454|58787838|FG000|Overall Study|Protocol Violation|1|||
30776876|NCT03613454|58787839|FG001|Overall Study|Protocol Violation|0|||
30776877|NCT03613454|58787838|FG000|Overall Study|Protocol Violation|0|||
30776878|NCT03613454|58787839|FG001|Overall Study|Protocol Violation|1|||
30776879|NCT03581786|58787847|FG000|Overall Study|Death|17|||
30776880|NCT03581786|58787848|FG001|Overall Study|Death|12|||
30776881|NCT03581786|58787847|FG000|Overall Study|Withdrawal by Subject|2|||
30776882|NCT03581786|58787848|FG001|Overall Study|Withdrawal by Subject|4|||
30776883|NCT03581786|58787847|FG000|Overall Study|Lost to Follow-up|1|||
30776884|NCT03581786|58787848|FG001|Overall Study|Lost to Follow-up|0|||
30776885|NCT03581786|58787847|FG000|Overall Study|reason other than specified above|0|||
30776886|NCT03581786|58787848|FG001|Overall Study|reason other than specified above|1|||
30776887|NCT03581786|58787847|FG000|Overall Study|Ongoing in the study|123|||
30776888|NCT03581786|58787848|FG001|Overall Study|Ongoing in the study|129|||
30776889|NCT03580382|58787856|FG000|Overall Study|Early Termination of Study|0|||
30776890|NCT03580382|58787857|FG001|Overall Study|Early Termination of Study|3|||
30776891|NCT03579290|58787862|FG000|Overall Study|Lost to Follow-up|9|||
30776892|NCT03611582|58787868|FG000|Overall Study|Adverse Event|26|||
30776893|NCT03611582|58787869|FG001|Overall Study|Adverse Event|6|||
30776894|NCT03611582|58787868|FG000|Overall Study|Protocol Violation|0|||
30776895|NCT03611582|58787869|FG001|Overall Study|Protocol Violation|1|||
30776896|NCT03611582|58787868|FG000|Overall Study|Pregnancy|1|||
30776897|NCT03611582|58787869|FG001|Overall Study|Pregnancy|2|||
30776898|NCT03611582|58787868|FG000|Overall Study|Lack of Efficacy|0|||
30776899|NCT03611582|58787869|FG001|Overall Study|Lack of Efficacy|1|||
30776900|NCT03611582|58787868|FG000|Overall Study|At the discretion of the investigator|1|||
30776901|NCT03611582|58787869|FG001|Overall Study|At the discretion of the investigator|0|||
30776902|NCT03611582|58787868|FG000|Overall Study|Safety concern as judged by the investigator|1|||
30776903|NCT03611582|58787869|FG001|Overall Study|Safety concern as judged by the investigator|2|||
30776904|NCT03611582|58787868|FG000|Overall Study|Withdrawal by Subject|4|||
30776905|NCT03611582|58787869|FG001|Overall Study|Withdrawal by Subject|3|||
30776906|NCT03611582|58787868|FG000|Overall Study|Lost to Follow-up|18|||
30776907|NCT03611582|58787869|FG001|Overall Study|Lost to Follow-up|7|||
30776908|NCT03611582|58787868|FG000|Overall Study|other|17|||
30776909|NCT03611582|58787869|FG001|Overall Study|other|16|||
30776910|NCT04015518|58787880|FG000|Overall Study|Adverse Event|6|||
30776911|NCT04015518|58787881|FG001|Overall Study|Adverse Event|1|||
30776912|NCT04015518|58787882|FG002|Overall Study|Adverse Event|1|||
30776913|NCT04015518|58787883|FG003|Overall Study|Adverse Event|3|||
30851917|NCT02400346|58879034|FG000|Overall Study|Lack of Efficacy|9|||
30851918|NCT02400346|58879034|FG000|Overall Study|Non-compliance with IMP|1|||
30851919|NCT02400346|58879034|FG000|Overall Study|Withdrawal by Subject|7|||
30776914|NCT04015518|58787884|FG004|Overall Study|Adverse Event|3|||
30776915|NCT04015518|58787880|FG000|Overall Study|Lack of Efficacy|1|||
30776916|NCT04015518|58787881|FG001|Overall Study|Lack of Efficacy|0|||
30776917|NCT04015518|58787882|FG002|Overall Study|Lack of Efficacy|1|||
30851920|NCT02400346|58879034|FG000|Overall Study|Administrative or other reason(s)|2|||
30851921|NCT02400346|58879034|FG000|Overall Study|Lost to Follow-up|1|||
30851922|NCT02399254|58879038|FG000|Overall Study|Physician Decision|2|||
30662608|NCT01143246|58676211|FG000|Overall Study|Reason not Specified|3|||
30662609|NCT01143246|58676212|FG001|Overall Study|Reason not Specified|5|||
30776918|NCT04015518|58787883|FG003|Overall Study|Lack of Efficacy|0|||
30851923|NCT02456662|58879045|FG000|Overall Study|Lost to Follow-up|2|||
30851924|NCT02456662|58879046|FG001|Overall Study|Lost to Follow-up|1|||
30851925|NCT01653262|58879052|FG000|Overall Study|Lack of Efficacy|1|||
30851926|NCT01653262|58879052|FG000|Overall Study|SAE, non-fatal|1|||
30851927|NCT01653262|58879052|FG000|Overall Study|AE, non-serious non-fatal|1|||
30851928|NCT02455336|58879058|FG000|Overall Study|Withdrawal by Subject|0|||
30851929|NCT02455336|58879059|FG001|Overall Study|Withdrawal by Subject|2|||
30851930|NCT02455336|58879058|FG000|Overall Study|Adverse Event|3|||
30776919|NCT04015518|58787884|FG004|Overall Study|Lack of Efficacy|4|||
30776920|NCT04015518|58787880|FG000|Overall Study|Lost to Follow-up|0|||
30776921|NCT04015518|58787881|FG001|Overall Study|Lost to Follow-up|0|||
30776922|NCT04015518|58787882|FG002|Overall Study|Lost to Follow-up|0|||
30776923|NCT04015518|58787883|FG003|Overall Study|Lost to Follow-up|0|||
30776924|NCT04015518|58787884|FG004|Overall Study|Lost to Follow-up|1|||
30776925|NCT04015518|58787880|FG000|Overall Study|Withdrawal by Subject|0|||
30776926|NCT04015518|58787881|FG001|Overall Study|Withdrawal by Subject|1|||
30776927|NCT04015518|58787882|FG002|Overall Study|Withdrawal by Subject|0|||
30776928|NCT04015518|58787883|FG003|Overall Study|Withdrawal by Subject|1|||
30776929|NCT04015518|58787884|FG004|Overall Study|Withdrawal by Subject|1|||
30776930|NCT04015518|58787880|FG000|Overall Study|Patient did not come for consecutive visits|0|||
30776931|NCT04015518|58787881|FG001|Overall Study|Patient did not come for consecutive visits|1|||
30776932|NCT04015518|58787882|FG002|Overall Study|Patient did not come for consecutive visits|0|||
30776933|NCT04015518|58787883|FG003|Overall Study|Patient did not come for consecutive visits|0|||
30776934|NCT04015518|58787884|FG004|Overall Study|Patient did not come for consecutive visits|0|||
30776935|NCT04015518|58787880|FG000|Overall Study|not willing to travel due to Covid-19|0|||
30851931|NCT02455336|58879059|FG001|Overall Study|Adverse Event|0|||
30851932|NCT02455336|58879058|FG000|Overall Study|Non-responder to treatment|2|||
30851933|NCT02455336|58879059|FG001|Overall Study|Non-responder to treatment|0|||
30851934|NCT04525703|58879086|FG000|Overall Study|Lost to Follow-up|6|||
30851935|NCT04525703|58879087|FG001|Overall Study|Lost to Follow-up|15|||
30851936|NCT04525703|58879088|FG002|Overall Study|Lost to Follow-up|8|||
30851937|NCT04509076|58879101|FG000|Overall Study|Withdrawal by Subject|1|||
30851938|NCT04509076|58879102|FG001|Overall Study|Withdrawal by Subject|2|||
30851939|NCT04509076|58879101|FG000|Overall Study|Lost to Follow-up|1|||
30851940|NCT04509076|58879102|FG001|Overall Study|Lost to Follow-up|2|||
30851941|NCT04267614|58879116|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
30851942|NCT04267614|58879116|FG000|Overall Study|Lost to Follow-up|115|||
30851943|NCT03735680|58879127|FG000|Overall Study|Withdrawal by Subject|0|||
30851944|NCT03735680|58879128|FG001|Overall Study|Withdrawal by Subject|1|||
30851945|NCT03735680|58879129|FG002|Overall Study|Withdrawal by Subject|0|||
30851946|NCT03735680|58879130|FG003|Overall Study|Withdrawal by Subject|0|||
30851947|NCT03735680|58879131|FG004|Overall Study|Withdrawal by Subject|0|||
30851948|NCT03735680|58879132|FG005|Overall Study|Withdrawal by Subject|1|||
30954049|NCT01840163|59008147|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
30954050|NCT01840163|59008146|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
30954051|NCT01840163|59008147|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
30954052|NCT01840163|59008146|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
30954053|NCT01840163|59008147|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
30954054|NCT01831427|59008300|FG000|Overall Study|Adverse Event|0|||
30954055|NCT01831427|59008301|FG001|Overall Study|Adverse Event|1|||
30954056|NCT01831427|59008302|FG002|Overall Study|Adverse Event|0|||
30954057|NCT01831427|59008303|FG003|Overall Study|Adverse Event|0|||
30954058|NCT01831427|59008304|FG004|Overall Study|Adverse Event|0|||
30954059|NCT01831427|59008305|FG005|Overall Study|Adverse Event|1|||
30954060|NCT01831427|59008306|FG006|Overall Study|Adverse Event|0|||
30954061|NCT01831427|59008307|FG007|Overall Study|Adverse Event|1|||
30954062|NCT01831427|59008308|FG008|Overall Study|Adverse Event|0|||
30954063|NCT01831427|59008309|FG009|Overall Study|Adverse Event|0|||
30954064|NCT01831427|59008310|FG010|Overall Study|Adverse Event|2|||
30954065|NCT01831427|59008300|FG000|Overall Study|Investigator's Discretion|0|||
30776936|NCT04015518|58787881|FG001|Overall Study|not willing to travel due to Covid-19|0|||
30776937|NCT04015518|58787882|FG002|Overall Study|not willing to travel due to Covid-19|1|||
30776938|NCT04015518|58787883|FG003|Overall Study|not willing to travel due to Covid-19|0|||
30954066|NCT01831427|59008301|FG001|Overall Study|Investigator's Discretion|0|||
30776939|NCT04015518|58787884|FG004|Overall Study|not willing to travel due to Covid-19|0|||
30776940|NCT04015518|58787880|FG000|Overall Study|Patient wants to discontinue treatment|0|||
30851949|NCT03735680|58879127|FG000|Overall Study|Patient unable or unwilling to continue|0|||
30851950|NCT03735680|58879128|FG001|Overall Study|Patient unable or unwilling to continue|0|||
30851951|NCT03735680|58879129|FG002|Overall Study|Patient unable or unwilling to continue|1|||
30851952|NCT03735680|58879130|FG003|Overall Study|Patient unable or unwilling to continue|0|||
30851953|NCT03735680|58879131|FG004|Overall Study|Patient unable or unwilling to continue|0|||
30851954|NCT03735680|58879132|FG005|Overall Study|Patient unable or unwilling to continue|0|||
30954067|NCT01831427|59008302|FG002|Overall Study|Investigator's Discretion|0|||
30954068|NCT01831427|59008303|FG003|Overall Study|Investigator's Discretion|1|||
30776941|NCT04015518|58787881|FG001|Overall Study|Patient wants to discontinue treatment|0|||
30776942|NCT04015518|58787882|FG002|Overall Study|Patient wants to discontinue treatment|0|||
30776943|NCT04015518|58787883|FG003|Overall Study|Patient wants to discontinue treatment|1|||
30776944|NCT04015518|58787884|FG004|Overall Study|Patient wants to discontinue treatment|0|||
30776945|NCT04015518|58787880|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
30776946|NCT04015518|58787881|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
30776947|NCT04015518|58787882|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
30776948|NCT04015518|58787883|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
30776949|NCT04015518|58787884|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
30851955|NCT03726658|58879168|FG000|Overall Study|Lost to Follow-up|0|||
30851956|NCT03726658|58879169|FG001|Overall Study|Lost to Follow-up|0|||
30851957|NCT03726658|58879170|FG002|Overall Study|Lost to Follow-up|2|||
30851958|NCT03726658|58879171|FG003|Overall Study|Lost to Follow-up|0|||
30776950|NCT04015518|58787880|FG000|Overall Study|Pregnancy|0|||
30776951|NCT04015518|58787881|FG001|Overall Study|Pregnancy|0|||
30776952|NCT04015518|58787882|FG002|Overall Study|Pregnancy|0|||
30776953|NCT04015518|58787883|FG003|Overall Study|Pregnancy|0|||
30776954|NCT04015518|58787884|FG004|Overall Study|Pregnancy|1|||
30776955|NCT04015518|58787880|FG000|Overall Study|Personal reasons|1|||
30776956|NCT04015518|58787881|FG001|Overall Study|Personal reasons|0|||
30776957|NCT04015518|58787882|FG002|Overall Study|Personal reasons|0|||
30776958|NCT04015518|58787883|FG003|Overall Study|Personal reasons|0|||
30776959|NCT04015518|58787884|FG004|Overall Study|Personal reasons|1|||
30851959|NCT03726658|58879172|FG004|Overall Study|Lost to Follow-up|0|||
30851960|NCT03726658|58879173|FG005|Overall Study|Lost to Follow-up|1|||
30851961|NCT03726658|58879174|FG006|Overall Study|Lost to Follow-up|1|||
30851962|NCT03726658|58879168|FG000|Overall Study|Withdrawal by Subject|1|||
30851963|NCT03726658|58879169|FG001|Overall Study|Withdrawal by Subject|0|||
30851964|NCT03726658|58879170|FG002|Overall Study|Withdrawal by Subject|0|||
30776960|NCT04015518|58787880|FG000|Overall Study|Withdrew consent|1|||
30776961|NCT04015518|58787881|FG001|Overall Study|Withdrew consent|0|||
30776962|NCT04015518|58787882|FG002|Overall Study|Withdrew consent|0|||
30776963|NCT04015518|58787883|FG003|Overall Study|Withdrew consent|0|||
30776964|NCT04015518|58787884|FG004|Overall Study|Withdrew consent|0|||
30776965|NCT04015518|58787880|FG000|Overall Study|Prostate carcinoma|1|||
30851965|NCT03726658|58879171|FG003|Overall Study|Withdrawal by Subject|0|||
30851966|NCT03726658|58879172|FG004|Overall Study|Withdrawal by Subject|6|||
30851967|NCT03726658|58879173|FG005|Overall Study|Withdrawal by Subject|4|||
30851968|NCT03726658|58879174|FG006|Overall Study|Withdrawal by Subject|2|||
30954069|NCT01831427|59008304|FG004|Overall Study|Investigator's Discretion|0|||
30954070|NCT01831427|59008305|FG005|Overall Study|Investigator's Discretion|0|||
30954071|NCT01831427|59008306|FG006|Overall Study|Investigator's Discretion|0|||
30954072|NCT01831427|59008307|FG007|Overall Study|Investigator's Discretion|0|||
30954073|NCT01831427|59008308|FG008|Overall Study|Investigator's Discretion|0|||
30954074|NCT01831427|59008309|FG009|Overall Study|Investigator's Discretion|0|||
30954075|NCT01831427|59008310|FG010|Overall Study|Investigator's Discretion|0|||
30954076|NCT01831427|59008300|FG000|Overall Study|Withdrew Consent|0|||
30954077|NCT01831427|59008301|FG001|Overall Study|Withdrew Consent|0|||
30954078|NCT01831427|59008302|FG002|Overall Study|Withdrew Consent|0|||
30954079|NCT01831427|59008303|FG003|Overall Study|Withdrew Consent|0|||
30954080|NCT01831427|59008304|FG004|Overall Study|Withdrew Consent|0|||
30954081|NCT01831427|59008305|FG005|Overall Study|Withdrew Consent|0|||
30954082|NCT01831427|59008306|FG006|Overall Study|Withdrew Consent|2|||
30954083|NCT01831427|59008307|FG007|Overall Study|Withdrew Consent|0|||
30954084|NCT01831427|59008308|FG008|Overall Study|Withdrew Consent|0|||
30954085|NCT01831427|59008309|FG009|Overall Study|Withdrew Consent|1|||
30954086|NCT01831427|59008310|FG010|Overall Study|Withdrew Consent|1|||
30954087|NCT01830881|59008356|FG000|Overall Study|Changed decision to have an abortion|0|||
30954088|NCT01830881|59008357|FG001|Overall Study|Changed decision to have an abortion|1|||
30954089|NCT01838681|59008393|FG000|Period A|Adverse Event|39|||
30954090|NCT01838681|59008394|FG001|Period A|Adverse Event|0|||
30954091|NCT01838681|59008395|FG002|Period A|Adverse Event|0|||
30954092|NCT01838681|59008396|FG003|Period A|Adverse Event|0|||
30954093|NCT01838681|59008393|FG000|Period A|Lack of Efficacy|21|||
30954094|NCT01838681|59008394|FG001|Period A|Lack of Efficacy|0|||
30954095|NCT01838681|59008395|FG002|Period A|Lack of Efficacy|0|||
30776966|NCT04015518|58787881|FG001|Overall Study|Prostate carcinoma|0|||
30776967|NCT04015518|58787882|FG002|Overall Study|Prostate carcinoma|0|||
30776968|NCT04015518|58787883|FG003|Overall Study|Prostate carcinoma|0|||
30776969|NCT04015518|58787884|FG004|Overall Study|Prostate carcinoma|0|||
30851969|NCT03726658|58879168|FG000|Overall Study|Pregnancy|0|||
30851970|NCT03726658|58879169|FG001|Overall Study|Pregnancy|0|||
30851971|NCT03726658|58879170|FG002|Overall Study|Pregnancy|0|||
30851972|NCT03726658|58879171|FG003|Overall Study|Pregnancy|0|||
30851973|NCT03726658|58879172|FG004|Overall Study|Pregnancy|0|||
30851974|NCT03726658|58879173|FG005|Overall Study|Pregnancy|0|||
30954096|NCT01838681|59008396|FG003|Period A|Lack of Efficacy|0|||
30954097|NCT01838681|59008393|FG000|Period A|Early response|148|||
30954098|NCT01838681|59008394|FG001|Period A|Early response|0|||
30776970|NCT04015518|58787880|FG000|Overall Study|Could not keep appointments due to work|1|||
30776971|NCT04015518|58787881|FG001|Overall Study|Could not keep appointments due to work|0|||
30776972|NCT04015518|58787882|FG002|Overall Study|Could not keep appointments due to work|0|||
30776973|NCT04015518|58787883|FG003|Overall Study|Could not keep appointments due to work|0|||
30776974|NCT04015518|58787884|FG004|Overall Study|Could not keep appointments due to work|0|||
30776975|NCT03577730|58787901|FG000|Overall Study|Physician Decision|3|||
30776976|NCT03577730|58787902|FG001|Overall Study|Physician Decision|1|||
30776977|NCT03577730|58787901|FG000|Overall Study|Did not receive allocated intervention|1|||
30776978|NCT03577730|58787902|FG001|Overall Study|Did not receive allocated intervention|0|||
30851975|NCT03726658|58879174|FG006|Overall Study|Pregnancy|1|||
30851976|NCT03726658|58879168|FG000|Overall Study|Not Reported|0|||
30851977|NCT03726658|58879169|FG001|Overall Study|Not Reported|0|||
30776979|NCT03608774|58787910|FG000|Overall Study|Lost to Follow-up|5|||
30776980|NCT03608774|58787911|FG001|Overall Study|Lost to Follow-up|5|||
30776981|NCT03608774|58787910|FG000|Overall Study|Withdrawal by Subject|1|||
30776982|NCT03608774|58787911|FG001|Overall Study|Withdrawal by Subject|0|||
30776983|NCT03608774|58787910|FG000|Overall Study|Protocol Violation|1|||
30776984|NCT03608774|58787911|FG001|Overall Study|Protocol Violation|0|||
30776985|NCT03608774|58787910|FG000|Overall Study|Not eligible at enrollment|0|||
30776986|NCT03608774|58787911|FG001|Overall Study|Not eligible at enrollment|1|||
30776987|NCT03608774|58787910|FG000|Overall Study|Health related event|0|||
30776988|NCT03608774|58787911|FG001|Overall Study|Health related event|1|||
30776989|NCT04021524|58787919|FG000|Overall Study|Change in surgical intervention|0|||
30776990|NCT04021524|58787920|FG001|Overall Study|Change in surgical intervention|1|||
30776991|NCT03607682|58787926|FG000|Overall Study|Withdrawal by Subject|1|||
30776992|NCT03607682|58787926|FG000|Overall Study|Disease progression|1|||
30776993|NCT03606668|58787930|FG000|Overall Study|Screen Failure|1|||
30776994|NCT03606668|58787930|FG000|Overall Study|Lost to Follow-up|1|||
30776995|NCT03601052|58787934|FG000|Overall Study|Lost to Follow-up|2|||
30776996|NCT03600740|58787943|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
30776997|NCT03600428|58787949|FG000|Overall Study|Not eligible|0|||
30776998|NCT03600428|58787950|FG001|Overall Study|Not eligible|1|||
30776999|NCT03600428|58787949|FG000|Overall Study|Lost to Follow-up|5|||
30777000|NCT03600428|58787950|FG001|Overall Study|Lost to Follow-up|4|||
30851978|NCT03726658|58879170|FG002|Overall Study|Not Reported|0|||
30851979|NCT03726658|58879171|FG003|Overall Study|Not Reported|0|||
30851980|NCT03726658|58879172|FG004|Overall Study|Not Reported|0|||
30851981|NCT03726658|58879173|FG005|Overall Study|Not Reported|0|||
30851982|NCT03726658|58879174|FG006|Overall Study|Not Reported|1|||
30851983|NCT03106779|58879234|FG000|Overall Study|Lack of Efficacy|33|||
30851984|NCT03106779|58879235|FG001|Overall Study|Lack of Efficacy|24|||
30851985|NCT03106779|58879234|FG000|Overall Study|Adverse Event|8|||
30851986|NCT03106779|58879235|FG001|Overall Study|Adverse Event|16|||
30954099|NCT01838681|59008395|FG002|Period A|Early response|0|||
30954100|NCT01838681|59008396|FG003|Period A|Early response|0|||
30954101|NCT01838681|59008393|FG000|Period A|Withdrawal by Subject|70|||
30954102|NCT01838681|59008394|FG001|Period A|Withdrawal by Subject|0|||
30954103|NCT01838681|59008395|FG002|Period A|Withdrawal by Subject|0|||
30954104|NCT01838681|59008396|FG003|Period A|Withdrawal by Subject|0|||
30954105|NCT01838681|59008393|FG000|Period A|Protocol Violation|16|||
30954106|NCT01838681|59008394|FG001|Period A|Protocol Violation|0|||
30954107|NCT01838681|59008395|FG002|Period A|Protocol Violation|0|||
30954108|NCT01838681|59008396|FG003|Period A|Protocol Violation|0|||
30954109|NCT01838681|59008393|FG000|Period A|Non-compliance with IMP|6|||
30954110|NCT01838681|59008394|FG001|Period A|Non-compliance with IMP|0|||
30954111|NCT01838681|59008395|FG002|Period A|Non-compliance with IMP|0|||
30954112|NCT01838681|59008396|FG003|Period A|Non-compliance with IMP|0|||
30954113|NCT01838681|59008393|FG000|Period A|Lost to Follow-up|4|||
30954114|NCT01838681|59008394|FG001|Period A|Lost to Follow-up|0|||
30954115|NCT01838681|59008395|FG002|Period A|Lost to Follow-up|0|||
30954116|NCT01838681|59008396|FG003|Period A|Lost to Follow-up|0|||
30954117|NCT01838681|59008393|FG000|Period A|Withdrawal before treatment|4|||
30777001|NCT03575702|58787958|FG000|Overall Study|Withdrawal by Subject|1|||
30777002|NCT03575702|58787959|FG001|Overall Study|Withdrawal by Subject|1|||
30777003|NCT03575702|58787958|FG000|Overall Study|Lost to Follow-up|1|||
30777004|NCT03575702|58787959|FG001|Overall Study|Lost to Follow-up|2|||
30777005|NCT03575702|58787958|FG000|Overall Study|Protocol Violation|0|||
30851987|NCT03106779|58879234|FG000|Overall Study|Physician Decision|10|||
30954118|NCT01838681|59008394|FG001|Period A|Withdrawal before treatment|0|||
30851988|NCT03106779|58879235|FG001|Overall Study|Physician Decision|6|||
30851989|NCT03106779|58879234|FG000|Overall Study|Patient/guardian decision|4|||
30954119|NCT01838681|59008395|FG002|Period A|Withdrawal before treatment|0|||
30851990|NCT03106779|58879235|FG001|Overall Study|Patient/guardian decision|3|||
30851991|NCT03106779|58879234|FG000|Overall Study|Progressive disease|1|||
30954120|NCT01838681|59008396|FG003|Period A|Withdrawal before treatment|0|||
30954121|NCT01838681|59008393|FG000|Period A|Administrative or other reasons|17|||
30954122|NCT01838681|59008394|FG001|Period A|Administrative or other reasons|0|||
30777006|NCT03575702|58787959|FG001|Overall Study|Protocol Violation|1|||
30777007|NCT03575702|58787958|FG000|Overall Study|Patient non compliance|4|||
30777008|NCT03575702|58787959|FG001|Overall Study|Patient non compliance|0|||
30777009|NCT03575468|58787967|FG000|Overall Study|Withdrawal by Subject|3|||
30954123|NCT01838681|59008395|FG002|Period A|Administrative or other reasons|0|||
30954124|NCT01838681|59008396|FG003|Period A|Administrative or other reasons|0|||
30954125|NCT01838681|59008393|FG000|Period B/A+|Adverse Event|0|||
30851992|NCT03106779|58879235|FG001|Overall Study|Progressive disease|3|||
30851993|NCT03106779|58879234|FG000|Overall Study|Lost to Follow-up|1|||
30851994|NCT03106779|58879235|FG001|Overall Study|Lost to Follow-up|2|||
30851995|NCT03106779|58879234|FG000|Overall Study|Death|1|||
30851996|NCT03106779|58879235|FG001|Overall Study|Death|0|||
30851997|NCT03106779|58879234|FG000|Overall Study|Protocol Violation|1|||
30851998|NCT03106779|58879235|FG001|Overall Study|Protocol Violation|0|||
30851999|NCT03106779|58879234|FG000|Overall Study|Not treated|1|||
30852000|NCT03106779|58879235|FG001|Overall Study|Not treated|0|||
30954126|NCT01838681|59008394|FG001|Period B/A+|Adverse Event|13|||
30954127|NCT01838681|59008395|FG002|Period B/A+|Adverse Event|27|||
30954128|NCT01838681|59008396|FG003|Period B/A+|Adverse Event|16|||
30954129|NCT01838681|59008393|FG000|Period B/A+|Lack of Efficacy|0|||
30954130|NCT01838681|59008394|FG001|Period B/A+|Lack of Efficacy|9|||
30954131|NCT01838681|59008395|FG002|Period B/A+|Lack of Efficacy|11|||
30954132|NCT01838681|59008396|FG003|Period B/A+|Lack of Efficacy|6|||
30954133|NCT01838681|59008393|FG000|Period B/A+|Withdrawal by Subject|0|||
30777010|NCT03575468|58787968|FG001|Overall Study|Withdrawal by Subject|0|||
30777011|NCT03575468|58787967|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
30777012|NCT03575468|58787968|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
30777013|NCT03575468|58787967|FG000|Overall Study|Lost to Follow-up|13|||
30777014|NCT03575468|58787968|FG001|Overall Study|Lost to Follow-up|17|||
30777015|NCT03573908|58787976|FG000|Treatment Period|Adverse Event|4|||
30777016|NCT03573908|58787977|FG001|Treatment Period|Adverse Event|9|||
30777017|NCT03573908|58787978|FG002|Treatment Period|Adverse Event|0|||
30777018|NCT03573908|58787979|FG003|Treatment Period|Adverse Event|0|||
30777019|NCT03573908|58787980|FG004|Treatment Period|Adverse Event|0|||
30777020|NCT03573908|58787976|FG000|Treatment Period|Protocol Violation|1|||
30777021|NCT03573908|58787977|FG001|Treatment Period|Protocol Violation|0|||
30852001|NCT03062358|58879252|FG000|Overall Study|Death|220|||
30852002|NCT03062358|58879253|FG001|Overall Study|Death|127|||
30852003|NCT03062358|58879252|FG000|Overall Study|Withdrawal by Subject|2|||
30852004|NCT03062358|58879253|FG001|Overall Study|Withdrawal by Subject|1|||
30852005|NCT03062358|58879252|FG000|Overall Study|Ongoing in Trial|78|||
30852006|NCT03062358|58879253|FG001|Overall Study|Ongoing in Trial|25|||
30852007|NCT02706873|58879264|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
30852008|NCT02706873|58879265|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
30852009|NCT02706873|58879266|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
30852010|NCT02706873|58879267|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
30852011|NCT02706873|58879264|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
30852012|NCT02706873|58879265|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
30852013|NCT02706873|58879266|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
30852014|NCT02706873|58879267|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
30852015|NCT02706873|58879264|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
30852016|NCT02706873|58879265|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
30852017|NCT02706873|58879266|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
30852018|NCT02706873|58879267|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
30852019|NCT02706873|58879264|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
30852020|NCT02706873|58879265|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
30852021|NCT02706873|58879266|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
30852022|NCT02706873|58879267|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
30852023|NCT02706873|58879264|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
30852024|NCT02706873|58879265|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
30852025|NCT02706873|58879266|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
30852026|NCT02706873|58879267|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
30852027|NCT02706873|58879264|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
30852028|NCT02706873|58879265|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
30852029|NCT02706873|58879266|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
30852030|NCT02706873|58879267|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
30852031|NCT02706873|58879264|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
30852032|NCT02706873|58879265|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
30852033|NCT02706873|58879266|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
30852034|NCT02706873|58879267|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
30852035|NCT02706873|58879264|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
30662610|NCT00561925|58676226|FG000|14 Day Lead-In Period|Adverse Event|38|||
30852036|NCT02706873|58879265|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
30852037|NCT02706873|58879266|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
30954134|NCT01838681|59008394|FG001|Period B/A+|Withdrawal by Subject|28|||
30954135|NCT01838681|59008395|FG002|Period B/A+|Withdrawal by Subject|35|||
30777022|NCT03573908|58787978|FG002|Treatment Period|Protocol Violation|0|||
30777023|NCT03573908|58787979|FG003|Treatment Period|Protocol Violation|0|||
30777024|NCT03573908|58787980|FG004|Treatment Period|Protocol Violation|0|||
30777025|NCT03573908|58787976|FG000|Treatment Period|Withdrawal by Subject|7|||
30777026|NCT03573908|58787977|FG001|Treatment Period|Withdrawal by Subject|5|||
30777027|NCT03573908|58787978|FG002|Treatment Period|Withdrawal by Subject|0|||
30777028|NCT03573908|58787979|FG003|Treatment Period|Withdrawal by Subject|0|||
30777029|NCT03573908|58787980|FG004|Treatment Period|Withdrawal by Subject|0|||
30777030|NCT03573908|58787976|FG000|Treatment Period|Lost to Follow-up|7|||
30777031|NCT03573908|58787977|FG001|Treatment Period|Lost to Follow-up|6|||
30777032|NCT03573908|58787978|FG002|Treatment Period|Lost to Follow-up|0|||
30777033|NCT03573908|58787979|FG003|Treatment Period|Lost to Follow-up|0|||
30777034|NCT03573908|58787980|FG004|Treatment Period|Lost to Follow-up|0|||
30777035|NCT03573908|58787976|FG000|Treatment Period|Pregnancy|1|||
30777036|NCT03573908|58787977|FG001|Treatment Period|Pregnancy|0|||
30777037|NCT03573908|58787978|FG002|Treatment Period|Pregnancy|0|||
30777038|NCT03573908|58787979|FG003|Treatment Period|Pregnancy|0|||
30777039|NCT03573908|58787980|FG004|Treatment Period|Pregnancy|0|||
30777040|NCT03573908|58787976|FG000|Treatment Period|Other, Not Specified|4|||
30777041|NCT03573908|58787977|FG001|Treatment Period|Other, Not Specified|6|||
30777042|NCT03573908|58787978|FG002|Treatment Period|Other, Not Specified|0|||
30777043|NCT03573908|58787979|FG003|Treatment Period|Other, Not Specified|0|||
30777044|NCT03573908|58787980|FG004|Treatment Period|Other, Not Specified|0|||
30777045|NCT03573908|58787976|FG000|Randomized Withdrawal Period|Adverse Event|0|||
30777046|NCT03573908|58787977|FG001|Randomized Withdrawal Period|Adverse Event|0|||
30777047|NCT03573908|58787978|FG002|Randomized Withdrawal Period|Adverse Event|3|||
30777048|NCT03573908|58787979|FG003|Randomized Withdrawal Period|Adverse Event|0|||
30777049|NCT03573908|58787980|FG004|Randomized Withdrawal Period|Adverse Event|0|||
30777050|NCT03573908|58787976|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30777051|NCT03573908|58787977|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30777052|NCT03573908|58787978|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30777053|NCT03573908|58787979|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
30777054|NCT03573908|58787980|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
30777055|NCT03573908|58787976|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
30777056|NCT03573908|58787977|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
30777057|NCT03573908|58787978|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
30777058|NCT03573908|58787979|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
30777059|NCT03573908|58787980|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
30777060|NCT03573908|58787976|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
30777061|NCT03573908|58787977|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
30777062|NCT03573908|58787978|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
30777063|NCT03573908|58787979|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
30777064|NCT03573908|58787980|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
30777065|NCT03573830|58787991|FG000|Overall Study|Dropped without completing treatment|0|||
30777066|NCT03573830|58787992|FG001|Overall Study|Dropped without completing treatment|7|||
30777067|NCT03573830|58787991|FG000|Overall Study|Lost to Follow-up|4|||
30777068|NCT03573830|58787992|FG001|Overall Study|Lost to Follow-up|0|||
30777069|NCT03595904|58787999|FG000|Overall Study|Protocol Violation|3|||
30777070|NCT03595904|58788000|FG001|Overall Study|Protocol Violation|1|||
30777071|NCT03595904|58787999|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
30777072|NCT03595904|58788000|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
30777073|NCT03595904|58787999|FG000|Overall Study|Insurance complications|1|||
30777074|NCT03595904|58788000|FG001|Overall Study|Insurance complications|0|||
30777075|NCT03595904|58787999|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
30852038|NCT02706873|58879267|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
30852039|NCT02706873|58879264|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
30852040|NCT02706873|58879265|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
30852041|NCT02706873|58879266|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
30852042|NCT02706873|58879267|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
30852043|NCT02706873|58879264|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
30852044|NCT02706873|58879265|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
30852045|NCT02706873|58879266|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
30852046|NCT02706873|58879267|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
30852047|NCT02706873|58879264|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
30852048|NCT02706873|58879265|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
30852049|NCT02706873|58879266|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
30777076|NCT03595904|58788000|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
30777077|NCT03595280|58788009|FG000|Overall Study|Lost to Follow-up|6|||
30777078|NCT03595280|58788010|FG001|Overall Study|Lost to Follow-up|9|||
30777079|NCT03595280|58788011|FG002|Overall Study|Lost to Follow-up|15|||
30954136|NCT01838681|59008396|FG003|Period B/A+|Withdrawal by Subject|47|||
30777080|NCT03593876|58788019|FG000|Overall Study|Withdrawal by Subject|1|||
30777081|NCT03593876|58788019|FG000|Overall Study|Discharged home before intervention completion|2|||
30777082|NCT00071487|58788027|FG000|52-Week Double-Blind Period|Adverse Event|5|||
30777083|NCT00071487|58788028|FG001|52-Week Double-Blind Period|Adverse Event|8|||
30777084|NCT00071487|58788029|FG002|52-Week Double-Blind Period|Adverse Event|4|||
30777085|NCT00071487|58788030|FG003|52-Week Double-Blind Period|Adverse Event|8|||
30777086|NCT00071487|58788027|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
30777087|NCT00071487|58788028|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
30777088|NCT00071487|58788029|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
30777089|NCT00071487|58788030|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
30777090|NCT00071487|58788027|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
30954137|NCT01838681|59008393|FG000|Period B/A+|Protocol Violation|0|||
30954138|NCT01838681|59008394|FG001|Period B/A+|Protocol Violation|1|||
30954139|NCT01838681|59008395|FG002|Period B/A+|Protocol Violation|4|||
30954140|NCT01838681|59008396|FG003|Period B/A+|Protocol Violation|6|||
30954141|NCT01838681|59008393|FG000|Period B/A+|Non-compliance with IMP|0|||
30954142|NCT01838681|59008394|FG001|Period B/A+|Non-compliance with IMP|2|||
30954143|NCT01838681|59008395|FG002|Period B/A+|Non-compliance with IMP|3|||
30954144|NCT01838681|59008396|FG003|Period B/A+|Non-compliance with IMP|3|||
30954145|NCT01838681|59008393|FG000|Period B/A+|Lost to Follow-up|0|||
30954146|NCT01838681|59008394|FG001|Period B/A+|Lost to Follow-up|2|||
30954147|NCT01838681|59008395|FG002|Period B/A+|Lost to Follow-up|5|||
30954148|NCT01838681|59008396|FG003|Period B/A+|Lost to Follow-up|11|||
30954149|NCT01838681|59008393|FG000|Period B/A+|Withdrawal before treatment|0|||
30954150|NCT01838681|59008394|FG001|Period B/A+|Withdrawal before treatment|1|||
30954151|NCT01838681|59008395|FG002|Period B/A+|Withdrawal before treatment|0|||
30954152|NCT01838681|59008396|FG003|Period B/A+|Withdrawal before treatment|0|||
30954153|NCT01838681|59008393|FG000|Period B/A+|Administrative or other reasons|0|||
30954154|NCT01838681|59008394|FG001|Period B/A+|Administrative or other reasons|6|||
30954155|NCT01838681|59008395|FG002|Period B/A+|Administrative or other reasons|10|||
30954156|NCT01838681|59008396|FG003|Period B/A+|Administrative or other reasons|28|||
30954157|NCT01611857|59008454|FG000|Overall Study|Withdrawal by Subject|0|||
30954158|NCT01611857|59008455|FG001|Overall Study|Withdrawal by Subject|2|||
30954159|NCT01829477|59008478|FG000|Overall Study|Study Terminated by Sponsor|15|||
30954160|NCT01829477|59008479|FG001|Overall Study|Study Terminated by Sponsor|15|||
30954161|NCT01829477|59008478|FG000|Overall Study|Withdrawal by Subject|1|||
30954162|NCT01829477|59008479|FG001|Overall Study|Withdrawal by Subject|0|||
30954163|NCT01611155|59008495|FG000|Overall Study|Adverse Event|1|||
30954164|NCT01611155|59008496|FG001|Overall Study|Adverse Event|1|||
30954165|NCT01611155|59008495|FG000|Overall Study|Refused further treatment|6|||
30954166|NCT01611155|59008496|FG001|Overall Study|Refused further treatment|4|||
30954167|NCT01611155|59008495|FG000|Overall Study|Disease progression|1|||
30954168|NCT01611155|59008496|FG001|Overall Study|Disease progression|0|||
30954169|NCT01611155|59008495|FG000|Overall Study|Withdrawal by Subject|1|||
30954170|NCT01611155|59008496|FG001|Overall Study|Withdrawal by Subject|0|||
30954171|NCT01611155|59008495|FG000|Overall Study|Alternative treatment|0|||
30954172|NCT01611155|59008496|FG001|Overall Study|Alternative treatment|1|||
30954173|NCT01611155|59008495|FG000|Overall Study|Ineligible patient|0|||
30954174|NCT01611155|59008496|FG001|Overall Study|Ineligible patient|1|||
30954175|NCT01829243|59008511|FG000|First Intervention|Screen Failure|4|||
30954176|NCT01829243|59008512|FG001|First Intervention|Screen Failure|2|||
30954177|NCT01838447|59008522|FG000|Overall Study|Change in surgical plan|1|||
30954178|NCT01838447|59008523|FG001|Overall Study|Change in surgical plan|2|||
30954179|NCT01838447|59008522|FG000|Overall Study|Withdrawal by Subject|1|||
30954180|NCT01838447|59008523|FG001|Overall Study|Withdrawal by Subject|1|||
30954181|NCT01829165|59008531|FG000|Overall Study|Did not complete intervention|2|||
30954182|NCT01829165|59008532|FG001|Overall Study|Did not complete intervention|0|||
30954183|NCT01838213|59008540|FG000|Overall Study|Ineligible|166|||
30954184|NCT01838213|59008541|FG001|Overall Study|Ineligible|191|||
30954185|NCT01837823|59008547|FG000|Overall Study|Lost to Follow-up|6|||
30954186|NCT01828073|59008557|FG000|Overall Study|Lost to Follow-up|1|||
30954187|NCT01828073|59008558|FG001|Overall Study|Lost to Follow-up|2|||
30954188|NCT03819114|59008578|FG000|Overall Study|Protocol Violation|0|||
30954189|NCT03819114|59008579|FG001|Overall Study|Protocol Violation|1|||
30777091|NCT00071487|58788028|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
30777092|NCT00071487|58788029|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
30954190|NCT03819114|59008580|FG002|Overall Study|Protocol Violation|1|||
30954191|NCT03819114|59008581|FG003|Overall Study|Protocol Violation|0|||
30954192|NCT03819114|59008578|FG000|Overall Study|Lost to Follow-up|0|||
30777093|NCT00071487|58788030|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
30954193|NCT03819114|59008579|FG001|Overall Study|Lost to Follow-up|0|||
30954194|NCT03819114|59008580|FG002|Overall Study|Lost to Follow-up|1|||
30954195|NCT03819114|59008581|FG003|Overall Study|Lost to Follow-up|0|||
30954196|NCT01827839|59008593|FG000|Overall Study|Adverse Event|1|||
30954197|NCT01827839|59008593|FG000|Overall Study|Consent Withdrawal|2|||
30954198|NCT01827371|59008608|FG000|Overall Study|Adverse Event|0|||
30777094|NCT00071487|58788027|FG000|52-Week Double-Blind Period|Physician Decision|1|||
30777095|NCT00071487|58788028|FG001|52-Week Double-Blind Period|Physician Decision|0|||
30852050|NCT02706873|58879267|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
30852051|NCT02706873|58879264|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
30852052|NCT02706873|58879265|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
30852053|NCT02706873|58879266|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
30852054|NCT02706873|58879267|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
30852055|NCT02706873|58879264|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
30852056|NCT02706873|58879265|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
30852057|NCT02706873|58879266|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
30777096|NCT00071487|58788029|FG002|52-Week Double-Blind Period|Physician Decision|0|||
30852058|NCT02706873|58879267|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
30852059|NCT02584634|58879290|FG000|Overall Study|Adverse Event|3|||
30852060|NCT02584634|58879291|FG001|Overall Study|Adverse Event|5|||
30852061|NCT02584634|58879290|FG000|Overall Study|Death|0|||
30777097|NCT00071487|58788030|FG003|52-Week Double-Blind Period|Physician Decision|0|||
30777098|NCT00071487|58788027|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
30777099|NCT00071487|58788028|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
30777100|NCT00071487|58788029|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
30777101|NCT00071487|58788030|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
30777102|NCT00071487|58788027|FG000|52-Week Double-Blind Period|Pregnancy|0|||
30777103|NCT00071487|58788028|FG001|52-Week Double-Blind Period|Pregnancy|1|||
30777104|NCT00071487|58788029|FG002|52-Week Double-Blind Period|Pregnancy|0|||
30777105|NCT00071487|58788030|FG003|52-Week Double-Blind Period|Pregnancy|0|||
30777106|NCT00071487|58788027|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
30777107|NCT00071487|58788028|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
30777108|NCT00071487|58788029|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
30777109|NCT00071487|58788030|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
30777110|NCT00071487|58788027|FG000|52-Week Double-Blind Period|Death|0|||
30777111|NCT00071487|58788028|FG001|52-Week Double-Blind Period|Death|1|||
30777112|NCT00071487|58788029|FG002|52-Week Double-Blind Period|Death|0|||
30777113|NCT00071487|58788030|FG003|52-Week Double-Blind Period|Death|0|||
30777114|NCT00071487|58788027|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
30777115|NCT00071487|58788028|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
30777116|NCT00071487|58788029|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
30777117|NCT00071487|58788030|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
30777118|NCT00071487|58788027|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
30777119|NCT00071487|58788028|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
30777120|NCT00071487|58788029|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
30777121|NCT00071487|58788030|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
30777122|NCT00071487|58788027|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
30777123|NCT00071487|58788028|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
30777124|NCT00071487|58788029|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
30777125|NCT00071487|58788030|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
30777126|NCT00071487|58788027|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
30777127|NCT00071487|58788028|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
30777128|NCT00071487|58788029|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
30777129|NCT00071487|58788030|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
30777130|NCT00071487|58788027|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
30777131|NCT00071487|58788028|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
30954199|NCT01827371|59008609|FG001|Overall Study|Adverse Event|0|||
30852062|NCT02584634|58879291|FG001|Overall Study|Death|1|||
30852063|NCT02584634|58879290|FG000|Overall Study|Lost to Follow-up|0|||
30852064|NCT02584634|58879291|FG001|Overall Study|Lost to Follow-up|1|||
30852065|NCT02584634|58879290|FG000|Overall Study|Physician Decision|1|||
30852066|NCT02584634|58879291|FG001|Overall Study|Physician Decision|2|||
30954200|NCT01827371|59008610|FG002|Overall Study|Adverse Event|4|||
30954201|NCT01827371|59008611|FG003|Overall Study|Adverse Event|2|||
30954202|NCT01827371|59008608|FG000|Overall Study|Lost to Follow-up|0|||
30954203|NCT01827371|59008609|FG001|Overall Study|Lost to Follow-up|2|||
30954204|NCT01827371|59008610|FG002|Overall Study|Lost to Follow-up|0|||
30662611|NCT00561925|58676227|FG001|14 Day Lead-In Period|Adverse Event|0|||
30777132|NCT00071487|58788029|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
30777133|NCT00071487|58788030|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
30777134|NCT00071487|58788027|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
30777135|NCT00071487|58788028|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
30852067|NCT02584634|58879290|FG000|Overall Study|Progressive disease|7|||
30852068|NCT02584634|58879291|FG001|Overall Study|Progressive disease|15|||
30852069|NCT02584634|58879290|FG000|Overall Study|Withdrawal by Subject|1|||
30954205|NCT01827371|59008611|FG003|Overall Study|Lost to Follow-up|4|||
30954206|NCT01827371|59008608|FG000|Overall Study|Protocol Violation|1|||
30777136|NCT00071487|58788029|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
30777137|NCT00071487|58788030|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
30777138|NCT00071487|58788027|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
30777139|NCT00071487|58788028|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
30777140|NCT00071487|58788029|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
30777141|NCT00071487|58788030|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
30777142|NCT03591146|58788047|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
30777143|NCT03591146|58788048|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
30777144|NCT03591146|58788049|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
30777145|NCT03591146|58788050|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
30777146|NCT03591146|58788051|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
30777147|NCT03591146|58788047|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
30777148|NCT03591146|58788048|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
30777149|NCT03591146|58788049|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
30777150|NCT03591146|58788050|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
30777151|NCT03591146|58788051|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
30777152|NCT03591146|58788047|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
30777153|NCT03591146|58788048|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
30777154|NCT03591146|58788049|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
30777155|NCT03591146|58788050|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
30777156|NCT03591146|58788051|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
30777157|NCT03591146|58788047|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
30777158|NCT03591146|58788048|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
30777159|NCT03591146|58788049|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
30777160|NCT03591146|58788050|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
30777161|NCT03591146|58788051|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
30777162|NCT00096447|58788063|FG000|Overall Study|Never treated|1|||
30777163|NCT03590366|58788074|FG000|Overall Study|Adverse Event|0|||
30777164|NCT03590366|58788075|FG001|Overall Study|Adverse Event|3|||
30777165|NCT03590366|58788074|FG000|Overall Study|Lost to Follow-up|3|||
30777166|NCT03590366|58788075|FG001|Overall Study|Lost to Follow-up|3|||
30777167|NCT03590366|58788074|FG000|Overall Study|Withdrawal by Subject|0|||
30777168|NCT03590366|58788075|FG001|Overall Study|Withdrawal by Subject|2|||
30777169|NCT03588572|58788083|FG000|Visitation 1|Lack of Efficacy|1|||
30777170|NCT03588572|58788084|FG001|Visitation 1|Lack of Efficacy|1|||
30777171|NCT03588572|58788083|FG000|Visitation 2|Lost to Follow-up|1|||
30777172|NCT03588572|58788084|FG001|Visitation 2|Lost to Follow-up|1|||
30777173|NCT03588572|58788083|FG000|Visitation 2|Lack of Efficacy|0|||
30777174|NCT03588572|58788084|FG001|Visitation 2|Lack of Efficacy|1|||
30777175|NCT03588572|58788083|FG000|Visitation 2|Withdrawal by Subject|1|||
30777176|NCT03588572|58788084|FG001|Visitation 2|Withdrawal by Subject|0|||
30777177|NCT03588572|58788083|FG000|Visitation 3|Lost to Follow-up|1|||
30777178|NCT03588572|58788084|FG001|Visitation 3|Lost to Follow-up|1|||
30777179|NCT03588572|58788083|FG000|Visitation 3|Physician Decision|1|||
30777180|NCT03588572|58788084|FG001|Visitation 3|Physician Decision|1|||
30777181|NCT03588572|58788083|FG000|Visitation 3|Withdrawal by Subject|1|||
30777182|NCT03588572|58788084|FG001|Visitation 3|Withdrawal by Subject|0|||
30777183|NCT00090285|58788092|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
30777184|NCT00090285|58788093|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
30777185|NCT00090285|58788094|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
30777186|NCT00090285|58788095|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
30777187|NCT00090285|58788096|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
30777188|NCT00090285|58788097|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
30777189|NCT00090285|58788092|FG000|Base Study Vaccination Period|Adverse Event|2|||
30777190|NCT00090285|58788093|FG001|Base Study Vaccination Period|Adverse Event|4|||
30777191|NCT00090285|58788094|FG002|Base Study Vaccination Period|Adverse Event|0|||
30852070|NCT02584634|58879291|FG001|Overall Study|Withdrawal by Subject|1|||
30852071|NCT02584634|58879290|FG000|Overall Study|Other|0|||
30852072|NCT02584634|58879291|FG001|Overall Study|Other|6|||
30852073|NCT02000622|58879301|FG000|Overall Study|Withdrawal by Subject|5|||
30852074|NCT02000622|58879302|FG001|Overall Study|Withdrawal by Subject|7|||
30852075|NCT02000622|58879301|FG000|Overall Study|Lost to Follow-up|4|||
30852076|NCT02000622|58879302|FG001|Overall Study|Lost to Follow-up|0|||
30852077|NCT02000622|58879301|FG000|Overall Study|Death|159|||
30852078|NCT02000622|58879302|FG001|Overall Study|Death|73|||
30777192|NCT00090285|58788095|FG003|Base Study Vaccination Period|Adverse Event|0|||
30777193|NCT00090285|58788096|FG004|Base Study Vaccination Period|Adverse Event|0|||
30852079|NCT02000622|58879301|FG000|Overall Study|Withdrawn due to site closure|1|||
30852080|NCT02000622|58879302|FG001|Overall Study|Withdrawn due to site closure|0|||
30777194|NCT00090285|58788097|FG005|Base Study Vaccination Period|Adverse Event|0|||
30777195|NCT00090285|58788092|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
30777196|NCT00090285|58788093|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
30777197|NCT00090285|58788094|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
30777198|NCT00090285|58788095|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
30777199|NCT00090285|58788096|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
30777200|NCT00090285|58788097|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
30777201|NCT00090285|58788092|FG000|Base Study Vaccination Period|Protocol Violation|2|||
30777202|NCT00090285|58788093|FG001|Base Study Vaccination Period|Protocol Violation|3|||
30777203|NCT00090285|58788094|FG002|Base Study Vaccination Period|Protocol Violation|0|||
30777204|NCT00090285|58788095|FG003|Base Study Vaccination Period|Protocol Violation|0|||
30777205|NCT00090285|58788096|FG004|Base Study Vaccination Period|Protocol Violation|0|||
30777206|NCT00090285|58788097|FG005|Base Study Vaccination Period|Protocol Violation|0|||
30777207|NCT00090285|58788092|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
30777208|NCT00090285|58788093|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
30777209|NCT00090285|58788094|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
30777210|NCT00090285|58788095|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
30777211|NCT00090285|58788096|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
30777212|NCT00090285|58788097|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
30777213|NCT00090285|58788092|FG000|Base Study Vaccination Period|Uncooperative|2|||
30777214|NCT00090285|58788093|FG001|Base Study Vaccination Period|Uncooperative|2|||
30852081|NCT01275729|58879368|FG000|Overall Study|Death|3|||
30852082|NCT01275729|58879368|FG000|Overall Study|Withdrawal by Subject|1|||
30852083|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
30852084|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
30954207|NCT01827371|59008609|FG001|Overall Study|Protocol Violation|0|||
30954208|NCT01827371|59008610|FG002|Overall Study|Protocol Violation|0|||
30954209|NCT01827371|59008611|FG003|Overall Study|Protocol Violation|0|||
30954210|NCT01827371|59008608|FG000|Overall Study|Withdrawal by Subject|1|||
30954211|NCT01827371|59008609|FG001|Overall Study|Withdrawal by Subject|2|||
30954212|NCT01827371|59008610|FG002|Overall Study|Withdrawal by Subject|2|||
30954213|NCT01827371|59008611|FG003|Overall Study|Withdrawal by Subject|3|||
30852085|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
30852086|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
30852087|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Adverse Event|198|||
30852088|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Adverse Event|0|||
30852089|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Adverse Event|0|||
30852090|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Adverse Event|0|||
30852091|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Death|62|||
30852092|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Death|0|||
30852093|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Death|0|||
30852094|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Death|0|||
30852095|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
30852096|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
30852097|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
30852098|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
30852099|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Complicating disease|13|||
30852100|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Complicating disease|0|||
30954214|NCT01827371|59008608|FG000|Overall Study|Physician Decision|0|||
30954215|NCT01827371|59008609|FG001|Overall Study|Physician Decision|1|||
30954216|NCT01827371|59008610|FG002|Overall Study|Physician Decision|0|||
30954217|NCT01827371|59008611|FG003|Overall Study|Physician Decision|1|||
30954218|NCT01827371|59008608|FG000|Overall Study|Temporary study halt to vaccinations|11|||
30954219|NCT01827371|59008609|FG001|Overall Study|Temporary study halt to vaccinations|2|||
30954220|NCT01827371|59008610|FG002|Overall Study|Temporary study halt to vaccinations|5|||
30954221|NCT01827371|59008611|FG003|Overall Study|Temporary study halt to vaccinations|13|||
30954222|NCT04409262|59008790|FG000|Overall Study|Adverse Event|0|||
30954223|NCT04409262|59008791|FG001|Overall Study|Adverse Event|2|||
30954224|NCT04409262|59008790|FG000|Overall Study|Death|55|||
30954225|NCT04409262|59008791|FG001|Overall Study|Death|97|||
30954226|NCT04409262|59008790|FG000|Overall Study|Lost to Follow-up|12|||
30954227|NCT04409262|59008791|FG001|Overall Study|Lost to Follow-up|23|||
30954228|NCT04409262|59008790|FG000|Overall Study|Lack of Staff|0|||
30777215|NCT00090285|58788094|FG002|Base Study Vaccination Period|Uncooperative|0|||
30777216|NCT00090285|58788095|FG003|Base Study Vaccination Period|Uncooperative|0|||
30662612|NCT00561925|58676228|FG002|14 Day Lead-In Period|Adverse Event|0|||
30662613|NCT00561925|58676229|FG003|14 Day Lead-In Period|Adverse Event|0|||
30777217|NCT00090285|58788096|FG004|Base Study Vaccination Period|Uncooperative|0|||
30852101|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Complicating disease|0|||
30852102|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Complicating disease|0|||
30852103|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
30852104|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
30954229|NCT04409262|59008791|FG001|Overall Study|Lack of Staff|1|||
30777218|NCT00090285|58788097|FG005|Base Study Vaccination Period|Uncooperative|0|||
30777219|NCT00090285|58788092|FG000|Base Study Vaccination Period|Moved|20|||
30777220|NCT00090285|58788093|FG001|Base Study Vaccination Period|Moved|21|||
30777221|NCT00090285|58788094|FG002|Base Study Vaccination Period|Moved|0|||
30777222|NCT00090285|58788095|FG003|Base Study Vaccination Period|Moved|0|||
30777223|NCT00090285|58788096|FG004|Base Study Vaccination Period|Moved|0|||
30777224|NCT00090285|58788097|FG005|Base Study Vaccination Period|Moved|0|||
30777225|NCT00090285|58788092|FG000|Base Study Vaccination Period|Site Terminated|1|||
30852105|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
30852106|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
30852107|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
30852108|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
30852109|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
30852110|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
30852111|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Non-compliance|4|||
30852112|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Non-compliance|0|||
30852113|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Non-compliance|0|||
30852114|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Non-compliance|0|||
30852115|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Pain|4|||
30852116|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Pain|0|||
30852117|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Pain|0|||
30852118|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Pain|0|||
30852119|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
30852120|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
30852121|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
30852122|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
30852123|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Hospice care|1|||
30852124|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Hospice care|0|||
30852125|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Hospice care|0|||
30852126|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Hospice care|0|||
30852127|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Physician Decision|1|||
30852128|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Physician Decision|0|||
30852129|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Physician Decision|0|||
30852130|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Physician Decision|0|||
30852131|NCT01107626|58879376|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
30852132|NCT01107626|58879377|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
30852133|NCT01107626|58879378|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
30852134|NCT01107626|58879379|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
30852135|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
30852136|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
30852137|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
30852138|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
30852139|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
30852140|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
30852141|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
30852142|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
30852143|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Death|0|||
30852144|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Death|8|||
30852145|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Death|2|||
30852146|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Death|13|||
30852147|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
30777226|NCT00090285|58788093|FG001|Base Study Vaccination Period|Site Terminated|0|||
30777227|NCT00090285|58788094|FG002|Base Study Vaccination Period|Site Terminated|0|||
30852148|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
30852149|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
30852150|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
30777228|NCT00090285|58788095|FG003|Base Study Vaccination Period|Site Terminated|0|||
30777229|NCT00090285|58788096|FG004|Base Study Vaccination Period|Site Terminated|0|||
30852151|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
30954230|NCT04409262|59008790|FG000|Overall Study|Protocol Violation|3|||
30777230|NCT00090285|58788097|FG005|Base Study Vaccination Period|Site Terminated|0|||
30777231|NCT00090285|58788092|FG000|Base Study Vaccination Period|Other|2|||
30777232|NCT00090285|58788093|FG001|Base Study Vaccination Period|Other|2|||
30777233|NCT00090285|58788094|FG002|Base Study Vaccination Period|Other|0|||
30777234|NCT00090285|58788095|FG003|Base Study Vaccination Period|Other|0|||
30777235|NCT00090285|58788096|FG004|Base Study Vaccination Period|Other|0|||
30777236|NCT00090285|58788097|FG005|Base Study Vaccination Period|Other|0|||
30954231|NCT04409262|59008791|FG001|Overall Study|Protocol Violation|1|||
30954232|NCT04409262|59008790|FG000|Overall Study|Withdrawal by Subject|5|||
30954233|NCT04409262|59008791|FG001|Overall Study|Withdrawal by Subject|10|||
30954234|NCT04305912|59008835|FG000|First Intervention|COVID-19 Suspension|2|||
30954235|NCT04305912|59008836|FG001|First Intervention|COVID-19 Suspension|0|||
30954236|NCT04305912|59008835|FG000|First Intervention|Withdrawal by Subject|0|||
30954237|NCT04305912|59008836|FG001|First Intervention|Withdrawal by Subject|1|||
30954238|NCT04305912|59008835|FG000|Second Intervention|Adverse Event|0|||
30954239|NCT04305912|59008836|FG001|Second Intervention|Adverse Event|1|||
30954240|NCT00782184|59009065|FG000|Overall Study|Adverse Event|1|||
30954241|NCT00782184|59009066|FG001|Overall Study|Adverse Event|2|||
30954242|NCT00782184|59009065|FG000|Overall Study|Protocol Violation|0|||
30954243|NCT00782184|59009066|FG001|Overall Study|Protocol Violation|1|||
30954244|NCT00782184|59009065|FG000|Overall Study|Withdrawal by Subject|3|||
30954245|NCT00782184|59009066|FG001|Overall Study|Withdrawal by Subject|2|||
30852152|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
30852153|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
30852154|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
30852155|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
30852156|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
30852157|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
30852158|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
30852159|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
30852160|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
30852161|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
30852162|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
30852163|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
30954246|NCT02731638|59009102|FG000|Overall Study|Lost to Follow-up|6|||
30954247|NCT02731638|59009103|FG001|Overall Study|Lost to Follow-up|9|||
30852164|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
30852165|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
30852166|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
30852167|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
30852168|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
30852169|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
30852170|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
30852171|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
30852172|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
30852173|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
30852174|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
30852175|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
30852176|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
30852177|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
30852178|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
30852179|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
30852180|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
30852181|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
30852182|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
30852183|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
30852184|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
30852185|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
30954248|NCT03730662|59009550|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
30954249|NCT03730662|59009551|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
30954250|NCT03730662|59009552|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
30777237|NCT00090285|58788092|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
30777238|NCT00090285|58788093|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
30777239|NCT00090285|58788094|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
30954251|NCT03730662|59009553|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
30777240|NCT00090285|58788095|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
30777241|NCT00090285|58788096|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
30777242|NCT00090285|58788097|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
30777243|NCT00090285|58788092|FG000|Base Study Vaccination Period|HIV positive|1|||
30852186|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
30852187|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Pain|0|||
30852188|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Pain|0|||
30852189|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Pain|0|||
30852190|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Pain|1|||
30852191|NCT01107626|58879376|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
30852192|NCT01107626|58879377|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
30852193|NCT01107626|58879378|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
30852194|NCT01107626|58879379|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
30852195|NCT00828009|58879388|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
30852196|NCT00828009|58879388|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
30852197|NCT00828009|58879388|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
30777244|NCT00090285|58788093|FG001|Base Study Vaccination Period|HIV positive|1|||
30777245|NCT00090285|58788094|FG002|Base Study Vaccination Period|HIV positive|0|||
30777246|NCT00090285|58788095|FG003|Base Study Vaccination Period|HIV positive|0|||
30777247|NCT00090285|58788096|FG004|Base Study Vaccination Period|HIV positive|0|||
30777248|NCT00090285|58788097|FG005|Base Study Vaccination Period|HIV positive|0|||
30777249|NCT00090285|58788092|FG000|Base Study Follow-up Period|Adverse Event|3|||
30777250|NCT00090285|58788093|FG001|Base Study Follow-up Period|Adverse Event|10|||
30777251|NCT00090285|58788094|FG002|Base Study Follow-up Period|Adverse Event|0|||
30852198|NCT00828009|58879388|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
30852199|NCT00828009|58879388|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
30852200|NCT00828009|58879388|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
30852201|NCT00828009|58879388|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
30852202|NCT00828009|58879388|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
30852203|NCT00828009|58879388|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
30852204|NCT00828009|58879388|FG000|Step 2 - Maintenance Therapy|Death|1|||
30852205|NCT00828009|58879388|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
30852206|NCT00828009|58879388|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
30777252|NCT00090285|58788095|FG003|Base Study Follow-up Period|Adverse Event|0|||
30777253|NCT00090285|58788096|FG004|Base Study Follow-up Period|Adverse Event|0|||
30777254|NCT00090285|58788097|FG005|Base Study Follow-up Period|Adverse Event|0|||
30777255|NCT00090285|58788092|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
30777256|NCT00090285|58788093|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
30777257|NCT00090285|58788094|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
30777258|NCT00090285|58788095|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
30777259|NCT00090285|58788096|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
30777260|NCT00090285|58788097|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
30777261|NCT00090285|58788092|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
30777262|NCT00090285|58788093|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
30777263|NCT00090285|58788094|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
30777264|NCT00090285|58788095|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
30777265|NCT00090285|58788096|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
30777266|NCT00090285|58788097|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
30777267|NCT00090285|58788092|FG000|Base Study Follow-up Period|Moved|41|||
30777268|NCT00090285|58788093|FG001|Base Study Follow-up Period|Moved|36|||
30777269|NCT00090285|58788094|FG002|Base Study Follow-up Period|Moved|0|||
30777270|NCT00090285|58788095|FG003|Base Study Follow-up Period|Moved|0|||
30777271|NCT00090285|58788096|FG004|Base Study Follow-up Period|Moved|0|||
30852207|NCT00828009|58879388|FG000|Step 2 - Maintenance Therapy|Other|1|||
30852208|NCT00539591|58879400|FG000|Overall Study|Toxicity|3|||
30852209|NCT00539591|58879401|FG001|Overall Study|Toxicity|0|||
30852210|NCT00539591|58879402|FG002|Overall Study|Toxicity|0|||
30852211|NCT00539591|58879400|FG000|Overall Study|Disease progression|2|||
30954252|NCT03730662|59009550|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
30954253|NCT03730662|59009551|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
30954254|NCT03730662|59009552|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
30954255|NCT03730662|59009553|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
30954256|NCT03730662|59009550|FG000|Treatment Period (52 Weeks)|Death|6|||
30954257|NCT03730662|59009551|FG001|Treatment Period (52 Weeks)|Death|2|||
30954258|NCT03730662|59009552|FG002|Treatment Period (52 Weeks)|Death|2|||
30954259|NCT03730662|59009553|FG003|Treatment Period (52 Weeks)|Death|9|||
30954260|NCT03730662|59009550|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
30954261|NCT03730662|59009551|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
30954262|NCT03730662|59009552|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
30954263|NCT03730662|59009553|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
30954264|NCT03730662|59009550|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
30954265|NCT03730662|59009551|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
30954266|NCT03730662|59009552|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
30954267|NCT03730662|59009553|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
30954268|NCT03730662|59009550|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
30954269|NCT03730662|59009551|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
30954270|NCT03730662|59009552|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
30954271|NCT03730662|59009553|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
30954272|NCT03730662|59009550|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
30954273|NCT03730662|59009551|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
30954274|NCT03730662|59009552|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
30777272|NCT00090285|58788097|FG005|Base Study Follow-up Period|Moved|0|||
30777273|NCT00090285|58788092|FG000|Base Study Follow-up Period|Other|2|||
30852212|NCT00539591|58879401|FG001|Overall Study|Disease progression|2|||
30852213|NCT00539591|58879402|FG002|Overall Study|Disease progression|3|||
30852214|NCT00068393|58879449|FG000|Overall Study|Adverse Event|2|||
30852215|NCT00068393|58879449|FG000|Overall Study|Death|3|||
30954275|NCT03730662|59009553|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
30954276|NCT03730662|59009550|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
30954277|NCT03730662|59009551|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
30954278|NCT03730662|59009552|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
30777274|NCT00090285|58788093|FG001|Base Study Follow-up Period|Other|0|||
30852216|NCT00068393|58879449|FG000|Overall Study|Withdrawal by Subject|3|||
30852217|NCT00068393|58879449|FG000|Overall Study|Alternative treatment|1|||
30852218|NCT00068393|58879449|FG000|Overall Study|Quality of life worsening|1|||
30852219|NCT00062010|58879453|FG000|Overall Study|Ineligible|3|||
30852220|NCT00047008|58879459|FG000|Overall Study|Withdrawn consent|2|||
30852221|NCT00047008|58879460|FG001|Overall Study|Withdrawn consent|3|||
30852222|NCT00047008|58879459|FG000|Overall Study|Ineligible|9|||
30852223|NCT00047008|58879460|FG001|Overall Study|Ineligible|8|||
30777275|NCT00090285|58788094|FG002|Base Study Follow-up Period|Other|0|||
30777276|NCT00090285|58788095|FG003|Base Study Follow-up Period|Other|0|||
30852224|NCT02397694|58879468|FG000|Double-Blinded Phase|Adverse Event|1|||
30777277|NCT00090285|58788096|FG004|Base Study Follow-up Period|Other|0|||
30777278|NCT00090285|58788097|FG005|Base Study Follow-up Period|Other|0|||
30777279|NCT00090285|58788092|FG000|Base Study Follow-up Period|Protocol Violation|1|||
30777280|NCT00090285|58788093|FG001|Base Study Follow-up Period|Protocol Violation|0|||
30777281|NCT00090285|58788094|FG002|Base Study Follow-up Period|Protocol Violation|0|||
30777282|NCT00090285|58788095|FG003|Base Study Follow-up Period|Protocol Violation|0|||
30777283|NCT00090285|58788096|FG004|Base Study Follow-up Period|Protocol Violation|0|||
30777284|NCT00090285|58788097|FG005|Base Study Follow-up Period|Protocol Violation|0|||
30852225|NCT02397694|58879469|FG001|Double-Blinded Phase|Adverse Event|0|||
30852226|NCT02397694|58879468|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
30852227|NCT02397694|58879469|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
30852228|NCT02397694|58879468|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
30852229|NCT02397694|58879469|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
30852230|NCT02397694|58879468|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
30852231|NCT02397694|58879469|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
30852232|NCT02397694|58879468|FG000|Open Label Extension Phase|Protocol Violation|1|||
30852233|NCT02397694|58879469|FG001|Open Label Extension Phase|Protocol Violation|0|||
30852234|NCT02397694|58879468|FG000|Open Label Extension Phase|Withdrew Consent|3|||
30852235|NCT02397694|58879469|FG001|Open Label Extension Phase|Withdrew Consent|1|||
30852236|NCT02397694|58879468|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
30852237|NCT02397694|58879469|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
30852238|NCT02783599|58879479|FG000|Overall Study|Progressive disease|23|||
30852239|NCT02783599|58879479|FG000|Overall Study|Surgical Resection|10|||
30852240|NCT02783599|58879479|FG000|Overall Study|Adverse Event|4|||
30852241|NCT02783599|58879479|FG000|Overall Study|Physician Decision|2|||
30852242|NCT02783599|58879479|FG000|Overall Study|Death|1|||
30852243|NCT02838017|58879492|FG000|Overall Study|Lost to Follow-up|14|||
30852244|NCT02838017|58879493|FG001|Overall Study|Lost to Follow-up|11|||
30852245|NCT03188666|58879501|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
30852246|NCT03188666|58879502|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
30852247|NCT03188666|58879503|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
30852248|NCT03188666|58879504|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
30852249|NCT03188666|58879501|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
30852250|NCT03188666|58879502|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
30662614|NCT00561925|58676230|FG004|14 Day Lead-In Period|Adverse Event|0|||
30777285|NCT00090285|58788092|FG000|Base Study Follow-up Period|Uncooperative|3|||
30852251|NCT03188666|58879503|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
30852252|NCT03188666|58879504|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
30852253|NCT03188666|58879501|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
30852254|NCT03188666|58879502|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
30852255|NCT03188666|58879503|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
30852256|NCT03188666|58879504|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
30852257|NCT03188666|58879501|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
30852258|NCT03188666|58879502|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
30852259|NCT03188666|58879503|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
30852260|NCT03188666|58879504|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
30852261|NCT02836769|58879518|FG000|Overall Study|Lost to Follow-up|10|||
30852262|NCT02836769|58879518|FG000|Overall Study|Medical withdrawal|2|||
30852263|NCT02836769|58879518|FG000|Overall Study|Withdrawal by Subject|3|||
30852264|NCT02836613|58879524|FG000|Overall Study|Accidental drowning|1|||
30852265|NCT02836613|58879525|FG001|Overall Study|Accidental drowning|0|||
30852266|NCT02836613|58879524|FG000|Overall Study|Lost to Follow-up|0|||
30852267|NCT02836613|58879525|FG001|Overall Study|Lost to Follow-up|1|||
30852268|NCT02836613|58879524|FG000|Overall Study|Withdrawal by Subject|0|||
30852269|NCT02836613|58879525|FG001|Overall Study|Withdrawal by Subject|2|||
30777286|NCT00090285|58788093|FG001|Base Study Follow-up Period|Uncooperative|4|||
30777287|NCT00090285|58788094|FG002|Base Study Follow-up Period|Uncooperative|0|||
30852270|NCT02397460|58879539|FG000|Treatment Period 2|Adverse Event|0|||
30777288|NCT00090285|58788095|FG003|Base Study Follow-up Period|Uncooperative|0|||
30852271|NCT02397460|58879540|FG001|Treatment Period 2|Adverse Event|0|||
30852272|NCT02397460|58879541|FG002|Treatment Period 2|Adverse Event|0|||
30852273|NCT02397460|58879542|FG003|Treatment Period 2|Adverse Event|0|||
30777289|NCT00090285|58788096|FG004|Base Study Follow-up Period|Uncooperative|0|||
30777290|NCT00090285|58788097|FG005|Base Study Follow-up Period|Uncooperative|0|||
30777291|NCT00090285|58788092|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
30777292|NCT00090285|58788093|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
30777293|NCT00090285|58788094|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
30777294|NCT00090285|58788095|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
30777295|NCT00090285|58788096|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
30777296|NCT00090285|58788097|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
30852274|NCT02397460|58879543|FG004|Treatment Period 2|Adverse Event|0|||
30777297|NCT00090285|58788092|FG000|Extension 1|Adverse Event|0|||
30777298|NCT00090285|58788093|FG001|Extension 1|Adverse Event|0|||
30777299|NCT00090285|58788094|FG002|Extension 1|Adverse Event|2|||
30777300|NCT00090285|58788095|FG003|Extension 1|Adverse Event|0|||
30852275|NCT02397460|58879544|FG005|Treatment Period 2|Adverse Event|0|||
30852276|NCT02397460|58879545|FG006|Treatment Period 2|Adverse Event|0|||
30852277|NCT02397460|58879546|FG007|Treatment Period 2|Adverse Event|1|||
30852278|NCT02397460|58879539|FG000|Treatment Period 4|Adverse Event|0|||
30852279|NCT02397460|58879540|FG001|Treatment Period 4|Adverse Event|1|||
30852280|NCT02397460|58879541|FG002|Treatment Period 4|Adverse Event|0|||
30777301|NCT00090285|58788096|FG004|Extension 1|Adverse Event|0|||
30777302|NCT00090285|58788097|FG005|Extension 1|Adverse Event|0|||
30777303|NCT00090285|58788092|FG000|Extension 1|Lost to Follow-up|0|||
30777304|NCT00090285|58788093|FG001|Extension 1|Lost to Follow-up|0|||
30777305|NCT00090285|58788094|FG002|Extension 1|Lost to Follow-up|35|||
30777306|NCT00090285|58788095|FG003|Extension 1|Lost to Follow-up|0|||
30777307|NCT00090285|58788096|FG004|Extension 1|Lost to Follow-up|0|||
30777308|NCT00090285|58788097|FG005|Extension 1|Lost to Follow-up|0|||
30777309|NCT00090285|58788092|FG000|Extension 1|Withdrawal by Subject|0|||
30777310|NCT00090285|58788093|FG001|Extension 1|Withdrawal by Subject|0|||
30777311|NCT00090285|58788094|FG002|Extension 1|Withdrawal by Subject|13|||
30777312|NCT00090285|58788095|FG003|Extension 1|Withdrawal by Subject|1|||
30777313|NCT00090285|58788096|FG004|Extension 1|Withdrawal by Subject|0|||
30777314|NCT00090285|58788097|FG005|Extension 1|Withdrawal by Subject|0|||
30852281|NCT02397460|58879542|FG003|Treatment Period 4|Adverse Event|0|||
30852282|NCT02397460|58879543|FG004|Treatment Period 4|Adverse Event|0|||
30852283|NCT02397460|58879544|FG005|Treatment Period 4|Adverse Event|0|||
30852284|NCT02397460|58879545|FG006|Treatment Period 4|Adverse Event|0|||
30852285|NCT02397460|58879546|FG007|Treatment Period 4|Adverse Event|0|||
30852286|NCT02397460|58879539|FG000|Treatment Period 4|Physician Decision|0|||
30852287|NCT02397460|58879540|FG001|Treatment Period 4|Physician Decision|0|||
30852288|NCT02397460|58879541|FG002|Treatment Period 4|Physician Decision|0|||
30852289|NCT02397460|58879542|FG003|Treatment Period 4|Physician Decision|0|||
30852290|NCT02397460|58879543|FG004|Treatment Period 4|Physician Decision|1|||
30852291|NCT02397460|58879544|FG005|Treatment Period 4|Physician Decision|0|||
30852292|NCT02397460|58879545|FG006|Treatment Period 4|Physician Decision|0|||
30954279|NCT03730662|59009553|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
30954280|NCT03730662|59009550|FG000|Variable Treatment Period|Adverse Event|1|||
30954281|NCT03730662|59009551|FG001|Variable Treatment Period|Adverse Event|2|||
30954282|NCT03730662|59009552|FG002|Variable Treatment Period|Adverse Event|0|||
30954283|NCT03730662|59009553|FG003|Variable Treatment Period|Adverse Event|7|||
30954284|NCT03730662|59009550|FG000|Variable Treatment Period|Death|9|||
30954285|NCT03730662|59009551|FG001|Variable Treatment Period|Death|0|||
30954286|NCT03730662|59009552|FG002|Variable Treatment Period|Death|6|||
30954287|NCT03730662|59009553|FG003|Variable Treatment Period|Death|26|||
30954288|NCT03730662|59009550|FG000|Variable Treatment Period|Lost to Follow-up|2|||
30954289|NCT03730662|59009551|FG001|Variable Treatment Period|Lost to Follow-up|1|||
30954290|NCT03730662|59009552|FG002|Variable Treatment Period|Lost to Follow-up|4|||
30777315|NCT00090285|58788092|FG000|Extension 1|Other|0|||
30777316|NCT00090285|58788093|FG001|Extension 1|Other|0|||
30777317|NCT00090285|58788094|FG002|Extension 1|Other|4|||
30954291|NCT03730662|59009553|FG003|Variable Treatment Period|Lost to Follow-up|11|||
30777318|NCT00090285|58788095|FG003|Extension 1|Other|0|||
30777319|NCT00090285|58788096|FG004|Extension 1|Other|0|||
30777320|NCT00090285|58788097|FG005|Extension 1|Other|0|||
30777321|NCT00090285|58788092|FG000|Extension 1|Moved|0|||
30777322|NCT00090285|58788093|FG001|Extension 1|Moved|0|||
30777323|NCT00090285|58788094|FG002|Extension 1|Moved|3|||
30777324|NCT00090285|58788095|FG003|Extension 1|Moved|0|||
30777325|NCT00090285|58788096|FG004|Extension 1|Moved|0|||
30777326|NCT00090285|58788097|FG005|Extension 1|Moved|0|||
30852293|NCT02397460|58879546|FG007|Treatment Period 4|Physician Decision|0|||
30852294|NCT02834819|58879622|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
30852295|NCT02834819|58879623|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
30954292|NCT03730662|59009550|FG000|Variable Treatment Period|Personal Reason|0|||
30954293|NCT03730662|59009551|FG001|Variable Treatment Period|Personal Reason|2|||
30777327|NCT00090285|58788092|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
30777328|NCT00090285|58788093|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
30852296|NCT02454478|58879629|FG000|Overall Study|Incomplete DLT Evaluation|1|||
30954294|NCT03730662|59009552|FG002|Variable Treatment Period|Personal Reason|1|||
30954295|NCT03730662|59009553|FG003|Variable Treatment Period|Personal Reason|6|||
30954296|NCT03730662|59009550|FG000|Variable Treatment Period|Physician Decision|0|||
30954297|NCT03730662|59009551|FG001|Variable Treatment Period|Physician Decision|0|||
30954298|NCT03730662|59009552|FG002|Variable Treatment Period|Physician Decision|0|||
30954299|NCT03730662|59009553|FG003|Variable Treatment Period|Physician Decision|3|||
30954300|NCT03730662|59009550|FG000|Variable Treatment Period|Protocol Violation|0|||
30954301|NCT03730662|59009551|FG001|Variable Treatment Period|Protocol Violation|1|||
30954302|NCT03730662|59009552|FG002|Variable Treatment Period|Protocol Violation|1|||
30954303|NCT03730662|59009553|FG003|Variable Treatment Period|Protocol Violation|1|||
30954304|NCT03730662|59009550|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
30954305|NCT03730662|59009551|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
30954306|NCT03730662|59009552|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
30954307|NCT03730662|59009553|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
30954308|NCT03185832|59009655|FG000|Overall Study|Death|9|||
30954309|NCT03185832|59009656|FG001|Overall Study|Death|14|||
30954310|NCT03185832|59009657|FG002|Overall Study|Death|9|||
30954311|NCT03185832|59009658|FG003|Overall Study|Death|7|||
30954312|NCT03185832|59009655|FG000|Overall Study|Withdrawn - vital status available|0|||
30954313|NCT03185832|59009656|FG001|Overall Study|Withdrawn - vital status available|1|||
30954314|NCT03185832|59009657|FG002|Overall Study|Withdrawn - vital status available|1|||
30954315|NCT03185832|59009658|FG003|Overall Study|Withdrawn - vital status available|4|||
30662615|NCT00561925|58676226|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
30777329|NCT00090285|58788094|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
30777330|NCT00090285|58788095|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
30777331|NCT00090285|58788096|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
30777332|NCT00090285|58788097|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
30777333|NCT00090285|58788092|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
30777334|NCT00090285|58788093|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
30852297|NCT01341587|58879635|FG000|Overall Study|Lost to Follow-up|2|||
30852298|NCT01341587|58879636|FG001|Overall Study|Lost to Follow-up|0|||
30852299|NCT01341587|58879635|FG000|Overall Study|stopped using the meters|2|||
30852300|NCT01341587|58879636|FG001|Overall Study|stopped using the meters|10|||
30852301|NCT01358825|58879644|FG000|Overall Study|Blood sample not drawn|0|||
30852302|NCT01358825|58879645|FG001|Overall Study|Blood sample not drawn|1|||
30852303|NCT02453386|58879654|FG000|Overall Study|Adverse Event|22|||
30852304|NCT02453386|58879655|FG001|Overall Study|Adverse Event|30|||
30852305|NCT02453386|58879656|FG002|Overall Study|Adverse Event|15|||
30852306|NCT02453386|58879654|FG000|Overall Study|Protocol Violation|1|||
30852307|NCT02453386|58879655|FG001|Overall Study|Protocol Violation|0|||
30852308|NCT02453386|58879656|FG002|Overall Study|Protocol Violation|1|||
30852309|NCT02453386|58879654|FG000|Overall Study|Withdrawal by Subject|10|||
30852310|NCT02453386|58879655|FG001|Overall Study|Withdrawal by Subject|9|||
30852311|NCT02453386|58879656|FG002|Overall Study|Withdrawal by Subject|9|||
30777335|NCT00090285|58788094|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
30777336|NCT00090285|58788095|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
30777337|NCT00090285|58788096|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
30777338|NCT00090285|58788097|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
30777339|NCT00090285|58788092|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
30777340|NCT00090285|58788093|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
30777341|NCT00090285|58788094|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
30777342|NCT00090285|58788095|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
30777343|NCT00090285|58788096|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
30777344|NCT00090285|58788097|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
30777345|NCT00090285|58788092|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
30777346|NCT00090285|58788093|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
30777347|NCT00090285|58788094|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
30777348|NCT00090285|58788095|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
30777349|NCT00090285|58788096|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
30852312|NCT02453386|58879654|FG000|Overall Study|Sponsor Terminated Study|14|||
30852313|NCT02453386|58879655|FG001|Overall Study|Sponsor Terminated Study|8|||
30852314|NCT02453386|58879656|FG002|Overall Study|Sponsor Terminated Study|11|||
30852315|NCT02453386|58879654|FG000|Overall Study|Subject Terminated by Sponsor|1|||
30954316|NCT04569786|59009710|FG000|Overall Study|Lost to Follow-up|1|||
30954317|NCT04569786|59009711|FG001|Overall Study|Lost to Follow-up|0|||
30954318|NCT04569786|59009712|FG002|Overall Study|Lost to Follow-up|4|||
30954319|NCT04569786|59009713|FG003|Overall Study|Lost to Follow-up|1|||
30954320|NCT04569786|59009714|FG004|Overall Study|Lost to Follow-up|0|||
30954321|NCT04569786|59009710|FG000|Overall Study|Withdrawal by Subject|0|||
30954322|NCT04569786|59009711|FG001|Overall Study|Withdrawal by Subject|0|||
30954323|NCT04569786|59009712|FG002|Overall Study|Withdrawal by Subject|0|||
30954324|NCT04569786|59009713|FG003|Overall Study|Withdrawal by Subject|5|||
30954325|NCT04569786|59009714|FG004|Overall Study|Withdrawal by Subject|1|||
30954326|NCT04569786|59009710|FG000|Overall Study|Physician Decision|0|||
30954327|NCT04569786|59009711|FG001|Overall Study|Physician Decision|0|||
30954328|NCT04569786|59009712|FG002|Overall Study|Physician Decision|0|||
30954329|NCT04569786|59009713|FG003|Overall Study|Physician Decision|1|||
30852316|NCT02453386|58879655|FG001|Overall Study|Subject Terminated by Sponsor|1|||
30852317|NCT02453386|58879656|FG002|Overall Study|Subject Terminated by Sponsor|1|||
30852318|NCT02453386|58879654|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
30852319|NCT02453386|58879655|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
30852320|NCT02453386|58879656|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
30852321|NCT02453386|58879654|FG000|Overall Study|Lost to Follow-up|0|||
30852322|NCT02453386|58879655|FG001|Overall Study|Lost to Follow-up|0|||
30852323|NCT02453386|58879656|FG002|Overall Study|Lost to Follow-up|1|||
30852324|NCT02453386|58879654|FG000|Overall Study|Other|1|||
30852325|NCT02453386|58879655|FG001|Overall Study|Other|0|||
30852326|NCT02453386|58879656|FG002|Overall Study|Other|1|||
30852327|NCT02431468|58879674|FG000|Overall Study|Adverse Event|2|||
30852328|NCT02431468|58879675|FG001|Overall Study|Adverse Event|4|||
30852329|NCT02431468|58879676|FG002|Overall Study|Adverse Event|5|||
30852330|NCT02431468|58879674|FG000|Overall Study|Withdrawal by Subject|4|||
30852331|NCT02431468|58879675|FG001|Overall Study|Withdrawal by Subject|12|||
30852332|NCT02431468|58879676|FG002|Overall Study|Withdrawal by Subject|2|||
30852333|NCT02431468|58879674|FG000|Overall Study|noncompliance, investigator termination,|2|||
30852334|NCT02431468|58879675|FG001|Overall Study|noncompliance, investigator termination,|2|||
30852335|NCT02431468|58879676|FG002|Overall Study|noncompliance, investigator termination,|2|||
30852336|NCT02452762|58879692|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
30852337|NCT02452762|58879693|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
30852338|NCT02452762|58879692|FG000|Overall Study|Withdrawal by Subject|1|||
30852339|NCT02452762|58879693|FG001|Overall Study|Withdrawal by Subject|0|||
30852340|NCT02631746|58879700|FG000|Overall Study|Lack of Efficacy|3|||
30852341|NCT02633306|58879704|FG000|Overall Study|Withdrawal by Subject|3|||
30852342|NCT02396758|58879713|FG000|Overall Study|Withdrawal by Subject|2|||
30852343|NCT02396758|58879714|FG001|Overall Study|Withdrawal by Subject|0|||
30852344|NCT02396758|58879715|FG002|Overall Study|Withdrawal by Subject|0|||
30852345|NCT02396758|58879716|FG003|Overall Study|Withdrawal by Subject|1|||
30954330|NCT04569786|59009714|FG004|Overall Study|Physician Decision|0|||
30954331|NCT01826981|59009890|FG000|Overall Study|Lack of Efficacy|0|||
30777350|NCT00090285|58788097|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
30777351|NCT00070941|58788115|FG000|Overall Study|Adverse Event|10|||
30777352|NCT00070941|58788116|FG001|Overall Study|Adverse Event|8|||
30852346|NCT02396758|58879713|FG000|Overall Study|Lost to Follow-up|8|||
30852347|NCT02396758|58879714|FG001|Overall Study|Lost to Follow-up|5|||
30852348|NCT02396758|58879715|FG002|Overall Study|Lost to Follow-up|3|||
30852349|NCT02396758|58879716|FG003|Overall Study|Lost to Follow-up|3|||
30852350|NCT02396758|58879713|FG000|Overall Study|Death|1|||
30777353|NCT00070941|58788117|FG002|Overall Study|Adverse Event|4|||
30777354|NCT00070707|58788127|FG000|Overall Study|Adverse Event|1|||
30777355|NCT00070707|58788128|FG001|Overall Study|Adverse Event|2|||
30777356|NCT00070707|58788127|FG000|Overall Study|Lack of Efficacy|4|||
30777357|NCT00070707|58788128|FG001|Overall Study|Lack of Efficacy|1|||
30777358|NCT00070707|58788127|FG000|Overall Study|Protocol Violation|8|||
30777359|NCT00070707|58788128|FG001|Overall Study|Protocol Violation|4|||
30777360|NCT00070707|58788127|FG000|Overall Study|Unrelated to Study Medication|1|||
30777361|NCT00070707|58788128|FG001|Overall Study|Unrelated to Study Medication|0|||
30777362|NCT03036124|58788136|FG000|Overall Study|Lost to Follow-up|0|||
30777363|NCT03036124|58788137|FG001|Overall Study|Lost to Follow-up|2|||
30777364|NCT03036124|58788136|FG000|Overall Study|Withdrawal by Subject|5|||
30777365|NCT03036124|58788137|FG001|Overall Study|Withdrawal by Subject|4|||
30777366|NCT00070317|58788143|FG000|Overall Study|Inevaluable (Never Treated)|1|||
30777367|NCT00070317|58788143|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
30777368|NCT00070317|58788143|FG000|Overall Study|Ineligible required test not done|1|||
30777369|NCT00070317|58788143|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
30777370|NCT00070317|58788143|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
30777371|NCT03649412|58788149|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
30777372|NCT03649412|58788150|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
30777373|NCT03649412|58788149|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
30777374|NCT03649412|58788150|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
30777375|NCT03649412|58788149|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
30777376|NCT03649412|58788150|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
30777377|NCT03649412|58788149|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
30777378|NCT03649412|58788150|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
30777379|NCT03649412|58788149|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
30777380|NCT03649412|58788150|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
30777381|NCT03649412|58788149|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
30777382|NCT03649412|58788150|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
30777383|NCT03587636|58788195|FG000|Overall Study|Lost to Follow-up|2|||
30777384|NCT03587636|58788196|FG001|Overall Study|Lost to Follow-up|5|||
30777385|NCT03586544|58788214|FG000|First Intervention|Adverse Event|0|||
30777386|NCT03586544|58788215|FG001|First Intervention|Adverse Event|1|||
30777387|NCT03586544|58788214|FG000|Second Intervention|Withdrawal by Subject|0|||
30777388|NCT03586544|58788215|FG001|Second Intervention|Withdrawal by Subject|1|||
30777389|NCT03585296|58788221|FG000|Overall Study|Adverse Event|1|||
30777390|NCT03585296|58788221|FG000|Overall Study|Lost to Follow-up|2|||
30777391|NCT03585296|58788221|FG000|Overall Study|Withdrawal by Subject|2|||
30777392|NCT03589768|58788229|FG000|Overall Study|Death|1|||
30777393|NCT03589768|58788230|FG001|Overall Study|Death|0|||
30777394|NCT03589768|58788231|FG002|Overall Study|Death|8|||
30777395|NCT03589768|58788232|FG003|Overall Study|Death|3|||
30777396|NCT03589768|58788229|FG000|Overall Study|Withdrawal by Subject|2|||
30777397|NCT03589768|58788230|FG001|Overall Study|Withdrawal by Subject|0|||
30777398|NCT03589768|58788231|FG002|Overall Study|Withdrawal by Subject|0|||
30777399|NCT03589768|58788232|FG003|Overall Study|Withdrawal by Subject|0|||
30777400|NCT03589768|58788229|FG000|Overall Study|Protocol Violation|1|||
30777401|NCT03589768|58788230|FG001|Overall Study|Protocol Violation|0|||
30777402|NCT03589768|58788231|FG002|Overall Study|Protocol Violation|0|||
30777403|NCT03589768|58788232|FG003|Overall Study|Protocol Violation|0|||
30777404|NCT02892422|58788242|FG000|Overall Study|Enrolled not treated|4|||
30777405|NCT02892422|58788242|FG000|Overall Study|Adverse Event|38|||
30777406|NCT02892422|58788242|FG000|Overall Study|Lack of Efficacy|32|||
30777407|NCT02892422|58788242|FG000|Overall Study|Non-compliance with study drug|11|||
30777408|NCT02892422|58788242|FG000|Overall Study|Protocol Violation|4|||
30777409|NCT02892422|58788242|FG000|Overall Study|Withdrawal by Subject|56|||
30777410|NCT02892422|58788242|FG000|Overall Study|Lost to Follow-up|5|||
30777411|NCT02892422|58788242|FG000|Overall Study|sponsor information 16159A results|21|||
30777412|NCT02892422|58788242|FG000|Overall Study|withdrawal of consent|13|||
30662616|NCT00561925|58676227|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
30777413|NCT02892422|58788242|FG000|Overall Study|exclusion criteria met|3|||
30777414|NCT02892422|58788242|FG000|Overall Study|moving elsewhere|4|||
30777415|NCT02892422|58788242|FG000|Overall Study|non-compliance|10|||
30777416|NCT02892422|58788242|FG000|Overall Study|patient legally incapable|1|||
30777417|NCT02892422|58788242|FG000|Overall Study|patient decision|7|||
30777418|NCT02892422|58788242|FG000|Overall Study|Investigator decision|1|||
30777419|NCT03571646|58788248|FG000|Overall Study|Adverse Event|1|||
30777420|NCT03571646|58788249|FG001|Overall Study|Adverse Event|0|||
30777421|NCT03571646|58788248|FG000|Overall Study|Withdrawal by Subject|1|||
30777422|NCT03571646|58788249|FG001|Overall Study|Withdrawal by Subject|1|||
30777423|NCT03645434|58788255|FG000|Period 1|Adverse Event|0|||
30777424|NCT03645434|58788256|FG001|Period 1|Adverse Event|0|||
30777425|NCT03645434|58788257|FG002|Period 1|Adverse Event|0|||
30777426|NCT03645434|58788258|FG003|Period 1|Adverse Event|1|||
30777427|NCT03645434|58788259|FG004|Period 1|Adverse Event|0|||
30777428|NCT03645434|58788260|FG005|Period 1|Adverse Event|0|||
30777429|NCT03645434|58788255|FG000|Period 1|COPD exacerbation|0|||
30662617|NCT00561925|58676228|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
30662618|NCT00561925|58676229|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
30954332|NCT01826981|59009891|FG001|Overall Study|Lack of Efficacy|1|||
30954333|NCT01826981|59009892|FG002|Overall Study|Lack of Efficacy|0|||
30954334|NCT01826981|59009893|FG003|Overall Study|Lack of Efficacy|0|||
30954335|NCT01826981|59009894|FG004|Overall Study|Lack of Efficacy|5|||
30954336|NCT01826981|59009895|FG005|Overall Study|Lack of Efficacy|0|||
30954337|NCT01826981|59009896|FG006|Overall Study|Lack of Efficacy|0|||
30954338|NCT01826981|59009897|FG007|Overall Study|Lack of Efficacy|8|||
30954339|NCT01826981|59009898|FG008|Overall Study|Lack of Efficacy|7|||
30954340|NCT01826981|59009899|FG009|Overall Study|Lack of Efficacy|0|||
30954341|NCT01826981|59009900|FG010|Overall Study|Lack of Efficacy|1|||
30954342|NCT01826981|59009901|FG011|Overall Study|Lack of Efficacy|0|||
30954343|NCT01826981|59009902|FG012|Overall Study|Lack of Efficacy|0|||
30954344|NCT01826981|59009903|FG013|Overall Study|Lack of Efficacy|3|||
30954345|NCT01826981|59009904|FG014|Overall Study|Lack of Efficacy|0|||
30954346|NCT01826981|59009890|FG000|Overall Study|Lost to Follow-up|0|||
30954347|NCT01826981|59009891|FG001|Overall Study|Lost to Follow-up|0|||
30954348|NCT01826981|59009892|FG002|Overall Study|Lost to Follow-up|0|||
30954349|NCT01826981|59009893|FG003|Overall Study|Lost to Follow-up|0|||
30954350|NCT01826981|59009894|FG004|Overall Study|Lost to Follow-up|1|||
30954351|NCT01826981|59009895|FG005|Overall Study|Lost to Follow-up|1|||
30954352|NCT01826981|59009896|FG006|Overall Study|Lost to Follow-up|0|||
30954353|NCT01826981|59009897|FG007|Overall Study|Lost to Follow-up|1|||
30954354|NCT01826981|59009898|FG008|Overall Study|Lost to Follow-up|0|||
30954355|NCT01826981|59009899|FG009|Overall Study|Lost to Follow-up|1|||
30954356|NCT01826981|59009900|FG010|Overall Study|Lost to Follow-up|1|||
30954357|NCT01826981|59009901|FG011|Overall Study|Lost to Follow-up|1|||
30954358|NCT01826981|59009902|FG012|Overall Study|Lost to Follow-up|1|||
30954359|NCT01826981|59009903|FG013|Overall Study|Lost to Follow-up|0|||
30954360|NCT01826981|59009904|FG014|Overall Study|Lost to Follow-up|0|||
30954361|NCT01826981|59009890|FG000|Overall Study|Withdrew Consent|0|||
30954362|NCT01826981|59009891|FG001|Overall Study|Withdrew Consent|0|||
30954363|NCT01826981|59009892|FG002|Overall Study|Withdrew Consent|0|||
30954364|NCT01826981|59009893|FG003|Overall Study|Withdrew Consent|0|||
30954365|NCT01826981|59009894|FG004|Overall Study|Withdrew Consent|0|||
30954366|NCT01826981|59009895|FG005|Overall Study|Withdrew Consent|0|||
30954367|NCT01826981|59009896|FG006|Overall Study|Withdrew Consent|1|||
30954368|NCT01826981|59009897|FG007|Overall Study|Withdrew Consent|1|||
30954369|NCT01826981|59009898|FG008|Overall Study|Withdrew Consent|0|||
30954370|NCT01826981|59009899|FG009|Overall Study|Withdrew Consent|0|||
30954371|NCT01826981|59009900|FG010|Overall Study|Withdrew Consent|0|||
30954372|NCT01826981|59009901|FG011|Overall Study|Withdrew Consent|1|||
30954373|NCT01826981|59009902|FG012|Overall Study|Withdrew Consent|0|||
30954374|NCT01826981|59009903|FG013|Overall Study|Withdrew Consent|1|||
30954375|NCT01826981|59009904|FG014|Overall Study|Withdrew Consent|0|||
30954376|NCT01826981|59009890|FG000|Overall Study|Adverse Event|0|||
30954377|NCT01826981|59009891|FG001|Overall Study|Adverse Event|0|||
30954378|NCT01826981|59009892|FG002|Overall Study|Adverse Event|0|||
30954379|NCT01826981|59009893|FG003|Overall Study|Adverse Event|0|||
30954380|NCT01826981|59009894|FG004|Overall Study|Adverse Event|1|||
30954381|NCT01826981|59009895|FG005|Overall Study|Adverse Event|0|||
30954382|NCT01826981|59009896|FG006|Overall Study|Adverse Event|0|||
30954383|NCT01826981|59009897|FG007|Overall Study|Adverse Event|0|||
30954384|NCT01826981|59009898|FG008|Overall Study|Adverse Event|0|||
30662619|NCT00561925|58676230|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
30777430|NCT03645434|58788256|FG001|Period 1|COPD exacerbation|0|||
30777431|NCT03645434|58788257|FG002|Period 1|COPD exacerbation|0|||
30777432|NCT03645434|58788258|FG003|Period 1|COPD exacerbation|0|||
30954385|NCT01826981|59009899|FG009|Overall Study|Adverse Event|0|||
30777433|NCT03645434|58788259|FG004|Period 1|COPD exacerbation|1|||
30777434|NCT03645434|58788260|FG005|Period 1|COPD exacerbation|0|||
30954386|NCT01826981|59009900|FG010|Overall Study|Adverse Event|0|||
30954387|NCT01826981|59009901|FG011|Overall Study|Adverse Event|0|||
30954388|NCT01826981|59009902|FG012|Overall Study|Adverse Event|0|||
30954389|NCT01826981|59009903|FG013|Overall Study|Adverse Event|0|||
30954390|NCT01826981|59009904|FG014|Overall Study|Adverse Event|0|||
30954391|NCT01826981|59009890|FG000|Overall Study|Upper G-I Haemorrhage|0|||
30954392|NCT01826981|59009891|FG001|Overall Study|Upper G-I Haemorrhage|0|||
30954393|NCT01826981|59009892|FG002|Overall Study|Upper G-I Haemorrhage|0|||
30777435|NCT00089505|58788272|FG000|Overall Study|Death|4|||
30954394|NCT01826981|59009893|FG003|Overall Study|Upper G-I Haemorrhage|0|||
30852351|NCT02396758|58879714|FG001|Overall Study|Death|1|||
30852352|NCT02396758|58879715|FG002|Overall Study|Death|0|||
30852353|NCT02396758|58879716|FG003|Overall Study|Death|1|||
30852354|NCT02396758|58879713|FG000|Overall Study|Randomized but not treated|1|||
30852355|NCT02396758|58879714|FG001|Overall Study|Randomized but not treated|0|||
30852356|NCT02396758|58879715|FG002|Overall Study|Randomized but not treated|1|||
30852357|NCT02396758|58879716|FG003|Overall Study|Randomized but not treated|0|||
30852358|NCT02632838|58879728|FG000|Overall Study|Withdrawal by Subject|3|||
30852359|NCT02632838|58879729|FG001|Overall Study|Withdrawal by Subject|0|||
30852360|NCT02632838|58879728|FG000|Overall Study|Lost to Follow-up|0|||
30852361|NCT02632838|58879729|FG001|Overall Study|Lost to Follow-up|2|||
30852362|NCT02396212|58879739|FG000|Overall Study|Adverse Event|1|||
30852363|NCT02396212|58879739|FG000|Overall Study|Lack of Efficacy|2|||
30852364|NCT02395822|58879743|FG000|Overall Study|Withdrawal by Subject|1|||
30852365|NCT02395822|58879743|FG000|Overall Study|Death|1|||
30852366|NCT01651936|58879749|FG000|Base Study|Adverse Event|3|||
30852367|NCT01651936|58879750|FG001|Base Study|Adverse Event|0|||
30852368|NCT01651936|58879751|FG002|Base Study|Adverse Event|0|||
30852369|NCT01651936|58879749|FG000|Base Study|Withdrawal by Subject|1|||
30954395|NCT01826981|59009894|FG004|Overall Study|Upper G-I Haemorrhage|0|||
30662620|NCT00561925|58676226|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
30954396|NCT01826981|59009895|FG005|Overall Study|Upper G-I Haemorrhage|0|||
30852370|NCT01651936|58879750|FG001|Base Study|Withdrawal by Subject|1|||
30852371|NCT01651936|58879751|FG002|Base Study|Withdrawal by Subject|0|||
30852372|NCT01651936|58879749|FG000|Base Study|Early Escape|2|||
30852373|NCT01651936|58879750|FG001|Base Study|Early Escape|8|||
30852374|NCT01651936|58879751|FG002|Base Study|Early Escape|0|||
30852375|NCT01651936|58879749|FG000|Base Study|Study terminated by sponsor|21|||
30662621|NCT00561925|58676227|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
30777436|NCT00089505|58788273|FG001|Overall Study|Death|1|||
30777437|NCT00089505|58788274|FG002|Overall Study|Death|5|||
30777438|NCT00089505|58788275|FG003|Overall Study|Death|8|||
30777439|NCT00089505|58788272|FG000|Overall Study|Withdrawal by Subject|3|||
30777440|NCT00089505|58788273|FG001|Overall Study|Withdrawal by Subject|0|||
30777441|NCT00089505|58788274|FG002|Overall Study|Withdrawal by Subject|6|||
30777442|NCT00089505|58788275|FG003|Overall Study|Withdrawal by Subject|6|||
30777443|NCT00089505|58788272|FG000|Overall Study|Lost to Follow-up|1|||
30777444|NCT00089505|58788273|FG001|Overall Study|Lost to Follow-up|1|||
30954397|NCT01826981|59009896|FG006|Overall Study|Upper G-I Haemorrhage|0|||
30954398|NCT01826981|59009897|FG007|Overall Study|Upper G-I Haemorrhage|0|||
30954399|NCT01826981|59009898|FG008|Overall Study|Upper G-I Haemorrhage|0|||
30954400|NCT01826981|59009899|FG009|Overall Study|Upper G-I Haemorrhage|0|||
30954401|NCT01826981|59009900|FG010|Overall Study|Upper G-I Haemorrhage|0|||
30954402|NCT01826981|59009901|FG011|Overall Study|Upper G-I Haemorrhage|0|||
30954403|NCT01826981|59009902|FG012|Overall Study|Upper G-I Haemorrhage|0|||
30954404|NCT01826981|59009903|FG013|Overall Study|Upper G-I Haemorrhage|1|||
30954405|NCT01826981|59009904|FG014|Overall Study|Upper G-I Haemorrhage|0|||
30954406|NCT01826981|59009890|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954407|NCT01826981|59009891|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954408|NCT01826981|59009892|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954409|NCT01826981|59009893|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954410|NCT01826981|59009894|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954411|NCT01826981|59009895|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954412|NCT01826981|59009896|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954413|NCT01826981|59009897|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
30954414|NCT01826981|59009898|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954415|NCT01826981|59009899|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954416|NCT01826981|59009900|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954417|NCT01826981|59009901|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954418|NCT01826981|59009902|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954419|NCT01826981|59009903|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954420|NCT01826981|59009904|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
30954421|NCT01804049|59009976|FG000|Overall Study|Adverse Event|2|||
30954422|NCT01804049|59009977|FG001|Overall Study|Adverse Event|10|||
30954423|NCT01804049|59009976|FG000|Overall Study|Lost to Follow-up|2|||
30954424|NCT01804049|59009977|FG001|Overall Study|Lost to Follow-up|1|||
30954425|NCT01804049|59009976|FG000|Overall Study|Decreased interest/personal|4|||
30954426|NCT01804049|59009977|FG001|Overall Study|Decreased interest/personal|5|||
30954427|NCT01804049|59009976|FG000|Overall Study|Other health concerns|2|||
30777445|NCT00089505|58788274|FG002|Overall Study|Lost to Follow-up|9|||
30777446|NCT00089505|58788275|FG003|Overall Study|Lost to Follow-up|7|||
30777447|NCT00089505|58788272|FG000|Overall Study|Physician Decision|1|||
30777448|NCT00089505|58788273|FG001|Overall Study|Physician Decision|0|||
30777449|NCT00089505|58788274|FG002|Overall Study|Physician Decision|0|||
30777450|NCT00089505|58788275|FG003|Overall Study|Physician Decision|0|||
30777451|NCT00089505|58788272|FG000|Overall Study|Protocol Violation|0|||
30777452|NCT00089505|58788273|FG001|Overall Study|Protocol Violation|0|||
30954428|NCT01804049|59009977|FG001|Overall Study|Other health concerns|7|||
30954429|NCT01804049|59009976|FG000|Overall Study|Moved out of area|0|||
30777453|NCT00089505|58788274|FG002|Overall Study|Protocol Violation|1|||
30954430|NCT01804049|59009977|FG001|Overall Study|Moved out of area|7|||
30954431|NCT01804049|59009976|FG000|Overall Study|other MD recommended|1|||
30954432|NCT01804049|59009977|FG001|Overall Study|other MD recommended|1|||
30954433|NCT01804049|59009976|FG000|Overall Study|Enrollment in dual studies|0|||
30954434|NCT01804049|59009977|FG001|Overall Study|Enrollment in dual studies|1|||
30852376|NCT01651936|58879750|FG001|Base Study|Study terminated by sponsor|16|||
30852377|NCT01651936|58879751|FG002|Base Study|Study terminated by sponsor|0|||
30852378|NCT01651936|58879749|FG000|Extension Study|Lack of Efficacy|0|||
30954435|NCT01826825|59009987|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
30954436|NCT01826825|59009988|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
30954437|NCT01803737|59009998|FG000|Overall Study|Lack of Time|1|||
30954438|NCT01803737|59009999|FG001|Overall Study|Lack of Time|0|||
30852379|NCT01651936|58879750|FG001|Extension Study|Lack of Efficacy|0|||
30852380|NCT01651936|58879751|FG002|Extension Study|Lack of Efficacy|1|||
30852381|NCT01651936|58879749|FG000|Extension Study|Study terminated by sponsor|0|||
30852382|NCT01651936|58879750|FG001|Extension Study|Study terminated by sponsor|0|||
30852383|NCT01651936|58879751|FG002|Extension Study|Study terminated by sponsor|13|||
30852384|NCT02395042|58879761|FG000|Treatment 1 Period|Adverse Event|1|||
30954439|NCT01803737|59009998|FG000|Overall Study|Medical Reason|0|||
30954440|NCT01803737|59009999|FG001|Overall Study|Medical Reason|1|||
30954441|NCT01803737|59009998|FG000|Overall Study|Lost to Follow-up|0|||
30954442|NCT01803737|59009999|FG001|Overall Study|Lost to Follow-up|2|||
30954443|NCT01826201|59010005|FG000|Overall Study|Non compliance with protocol|4|||
30954444|NCT01803269|59010036|FG000|Overall Study|Withdrawal by Subject|3|||
30954445|NCT01803269|59010037|FG001|Overall Study|Withdrawal by Subject|0|||
30954446|NCT01803269|59010038|FG002|Overall Study|Withdrawal by Subject|0|||
30954447|NCT01802879|59010046|FG000|Overall Study|Administrative problems|2|||
30954448|NCT01802879|59010046|FG000|Overall Study|Disease progression|6|||
30954449|NCT01825577|59010050|FG000|Overall Study|Physician Decision|2|||
30954450|NCT01825577|59010050|FG000|Overall Study|Withdrawal by Subject|1|||
30954451|NCT01825577|59010050|FG000|Overall Study|Withdrawn by family members|2|||
30954452|NCT01825577|59010050|FG000|Overall Study|Lack of Efficacy|3|||
30954453|NCT01802411|59010056|FG000|Overall Study|Death|2|||
30954454|NCT01802411|59010057|FG001|Overall Study|Death|1|||
30954455|NCT01802411|59010056|FG000|Overall Study|Adverse Event|2|||
30954456|NCT01802411|59010057|FG001|Overall Study|Adverse Event|7|||
30954457|NCT01802411|59010056|FG000|Overall Study|Lack of Efficacy|8|||
30954458|NCT01802411|59010057|FG001|Overall Study|Lack of Efficacy|10|||
30954459|NCT01802411|59010056|FG000|Overall Study|Withdrawal by Subject|0|||
30954460|NCT01802411|59010057|FG001|Overall Study|Withdrawal by Subject|2|||
30954461|NCT01802411|59010056|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
30954462|NCT01802411|59010057|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
30954463|NCT01802411|59010056|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
30954464|NCT01802411|59010057|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
30954465|NCT01802411|59010056|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
30954466|NCT01802411|59010057|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
30954467|NCT02963610|59010098|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
30954468|NCT02606136|59010180|FG000|Overall Study|Participant/Legal Guardian Decision|5|||
30954469|NCT02606136|59010180|FG000|Overall Study|Withdrawal by Subject|1|||
30954470|NCT01802333|59010323|FG000|Overall Study|Ineligible|2|||
30954471|NCT01802333|59010324|FG001|Overall Study|Ineligible|6|||
30954472|NCT01802333|59010325|FG002|Overall Study|Ineligible|8|||
30954473|NCT01802333|59010323|FG000|Overall Study|Adverse Event|1|||
30954474|NCT01802333|59010324|FG001|Overall Study|Adverse Event|8|||
30954475|NCT01802333|59010325|FG002|Overall Study|Adverse Event|8|||
30954476|NCT01802333|59010323|FG000|Overall Study|Withdrawal by Subject|6|||
30954477|NCT01802333|59010324|FG001|Overall Study|Withdrawal by Subject|6|||
30954478|NCT01802333|59010325|FG002|Overall Study|Withdrawal by Subject|5|||
30954479|NCT01802333|59010323|FG000|Overall Study|Progression/relapse|1|||
30954480|NCT01802333|59010324|FG001|Overall Study|Progression/relapse|3|||
30954481|NCT01802333|59010325|FG002|Overall Study|Progression/relapse|0|||
30954482|NCT01802333|59010323|FG000|Overall Study|Death|7|||
30954483|NCT01802333|59010324|FG001|Overall Study|Death|14|||
30954484|NCT01802333|59010325|FG002|Overall Study|Death|13|||
30852385|NCT02395042|58879762|FG001|Treatment 1 Period|Adverse Event|3|||
30852386|NCT02395042|58879763|FG002|Treatment 1 Period|Adverse Event|1|||
30954485|NCT01802333|59010323|FG000|Overall Study|Other - not protocol specified|32|||
30954486|NCT01802333|59010324|FG001|Overall Study|Other - not protocol specified|22|||
30954487|NCT01802333|59010325|FG002|Overall Study|Other - not protocol specified|24|||
30852387|NCT02395042|58879761|FG000|Treatment 1 Period|Lack of Efficacy|1|||
30954488|NCT01802333|59010323|FG000|Overall Study|Did not start treatment|0|||
30954489|NCT01802333|59010324|FG001|Overall Study|Did not start treatment|2|||
30954490|NCT01802333|59010325|FG002|Overall Study|Did not start treatment|5|||
30954491|NCT00980655|59010370|FG000|Overall Study|Adverse Event|13|||
30954492|NCT00980655|59010371|FG001|Overall Study|Adverse Event|31|||
30954493|NCT00980655|59010370|FG000|Overall Study|Death|0|||
30954494|NCT00980655|59010371|FG001|Overall Study|Death|7|||
30954495|NCT00980655|59010370|FG000|Overall Study|Protocol Violation|2|||
30954496|NCT00980655|59010371|FG001|Overall Study|Protocol Violation|7|||
30954497|NCT00980655|59010370|FG000|Overall Study|Withdrawal by Subject|0|||
30954498|NCT00980655|59010371|FG001|Overall Study|Withdrawal by Subject|4|||
30954499|NCT00980655|59010370|FG000|Overall Study|Lost to Follow-up|0|||
30662622|NCT00561925|58676228|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
30777454|NCT00089505|58788275|FG003|Overall Study|Protocol Violation|0|||
30777455|NCT04009824|58788290|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
30777456|NCT04009824|58788291|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
30777457|NCT04009824|58788292|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
30777458|NCT04009824|58788293|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
30777459|NCT04009824|58788294|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
30777460|NCT03555890|58788310|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
30777461|NCT03555890|58788311|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
30777462|NCT03555890|58788312|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
30777463|NCT03555890|58788313|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
30777464|NCT03688074|58788325|FG000|Overall Study|Adverse Event|0|||
30777465|NCT03688074|58788326|FG001|Overall Study|Adverse Event|1|||
30852388|NCT02395042|58879762|FG001|Treatment 1 Period|Lack of Efficacy|1|||
30852389|NCT02395042|58879763|FG002|Treatment 1 Period|Lack of Efficacy|0|||
30852390|NCT02395042|58879761|FG000|Treatment 1 Period|Lost to Follow-up|1|||
30852391|NCT02395042|58879762|FG001|Treatment 1 Period|Lost to Follow-up|0|||
30852392|NCT02395042|58879763|FG002|Treatment 1 Period|Lost to Follow-up|0|||
30852393|NCT02395042|58879761|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
30852394|NCT02395042|58879762|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
30852395|NCT02395042|58879763|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
30852396|NCT02395042|58879761|FG000|Treatment 2 Period|Lack of Efficacy|1|||
30852397|NCT02395042|58879762|FG001|Treatment 2 Period|Lack of Efficacy|1|||
30852398|NCT02395042|58879763|FG002|Treatment 2 Period|Lack of Efficacy|0|||
30852399|NCT02394808|58879774|FG000|Period 1|Unsatisfactory lens fitting|0|||
30852400|NCT02394808|58879775|FG001|Period 1|Unsatisfactory lens fitting|1|||
30852401|NCT02394808|58879774|FG000|Period 2|Lost to Follow-up|1|||
30852402|NCT02394808|58879775|FG001|Period 2|Lost to Follow-up|0|||
30852403|NCT02630966|58879783|FG000|Overall Study|Adverse Event|1|||
30852404|NCT02630966|58879784|FG001|Overall Study|Adverse Event|3|||
30852405|NCT02630966|58879783|FG000|Overall Study|Significant Protocol Deviation|0|||
30852406|NCT02630966|58879784|FG001|Overall Study|Significant Protocol Deviation|2|||
30852407|NCT02630966|58879783|FG000|Overall Study|Voluntary Withdrawal|1|||
30852408|NCT02630966|58879784|FG001|Overall Study|Voluntary Withdrawal|1|||
30852409|NCT02630966|58879783|FG000|Overall Study|Lack of Efficacy|0|||
30852410|NCT02630966|58879784|FG001|Overall Study|Lack of Efficacy|2|||
30852411|NCT01651780|58879792|FG000|Overall Study|Physician decision: No 30-day visit|2|||
30852412|NCT01651780|58879793|FG001|Overall Study|Physician decision: No 30-day visit|1|||
30852413|NCT01651780|58879792|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
30852414|NCT01651780|58879793|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
30852415|NCT01651780|58879792|FG000|Overall Study|Withdrawal by Subject|2|||
30852416|NCT01651780|58879793|FG001|Overall Study|Withdrawal by Subject|0|||
30852417|NCT01651780|58879792|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
30852418|NCT01651780|58879793|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30852419|NCT01651780|58879792|FG000|Overall Study|Lost to Follow-up|1|||
30777466|NCT03688074|58788325|FG000|Overall Study|Other|1|||
30852420|NCT01651780|58879793|FG001|Overall Study|Lost to Follow-up|2|||
30852421|NCT01651780|58879792|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
30662623|NCT00561925|58676229|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
30662624|NCT00561925|58676230|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
30662625|NCT00561925|58676226|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
30852422|NCT01651780|58879793|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
30852423|NCT02394730|58879805|FG000|Overall Study|Lost to Follow-up|1|||
30852424|NCT02394730|58879806|FG001|Overall Study|Lost to Follow-up|0|||
30777467|NCT03688074|58788326|FG001|Overall Study|Other|0|||
30954500|NCT00980655|59010371|FG001|Overall Study|Lost to Follow-up|1|||
30954501|NCT00980655|59010370|FG000|Overall Study|Parent/legal guardian request|1|||
30954502|NCT00980655|59010371|FG001|Overall Study|Parent/legal guardian request|0|||
30954503|NCT00980655|59010370|FG000|Overall Study|Other|0|||
30954504|NCT00980655|59010371|FG001|Overall Study|Other|1|||
30954505|NCT01801865|59010413|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
30954506|NCT01801865|59010413|FG000|Overall Study|Physician Decision|7|||
30954507|NCT00980343|59010423|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
30954508|NCT00980343|59010424|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
30954509|NCT01801475|59010434|FG000|Overall Study|Withdrawal by Subject|0|||
30954510|NCT01801475|59010435|FG001|Overall Study|Withdrawal by Subject|0|||
30954511|NCT01801475|59010436|FG002|Overall Study|Withdrawal by Subject|0|||
30954512|NCT01801475|59010437|FG003|Overall Study|Withdrawal by Subject|0|||
30954513|NCT01801475|59010438|FG004|Overall Study|Withdrawal by Subject|1|||
30954514|NCT01822925|59010497|FG000|Overall Study|Adverse Event|1|||
30954515|NCT01822925|59010498|FG001|Overall Study|Adverse Event|1|||
30954516|NCT01822925|59010499|FG002|Overall Study|Adverse Event|1|||
30954517|NCT01822925|59010500|FG003|Overall Study|Adverse Event|1|||
30954518|NCT01822925|59010497|FG000|Overall Study|Lost to Follow-up|0|||
30954519|NCT01822925|59010498|FG001|Overall Study|Lost to Follow-up|1|||
30954520|NCT01822925|59010499|FG002|Overall Study|Lost to Follow-up|0|||
30954521|NCT01822925|59010500|FG003|Overall Study|Lost to Follow-up|0|||
30954522|NCT01822925|59010497|FG000|Overall Study|Protocol Violation|1|||
30954523|NCT01822925|59010498|FG001|Overall Study|Protocol Violation|0|||
30954524|NCT01822925|59010499|FG002|Overall Study|Protocol Violation|0|||
30954525|NCT01822925|59010500|FG003|Overall Study|Protocol Violation|1|||
30954526|NCT01822925|59010497|FG000|Overall Study|Withdrawal by Subject|2|||
30954527|NCT01822925|59010498|FG001|Overall Study|Withdrawal by Subject|0|||
30954528|NCT01822925|59010499|FG002|Overall Study|Withdrawal by Subject|2|||
30954529|NCT01822925|59010500|FG003|Overall Study|Withdrawal by Subject|2|||
30954530|NCT01822925|59010497|FG000|Overall Study|Taking prohibited medication|2|||
30852425|NCT02394730|58879805|FG000|Overall Study|Withdrawal by Subject|0|||
30852426|NCT02394730|58879806|FG001|Overall Study|Withdrawal by Subject|1|||
30852427|NCT02430532|58879814|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
30852428|NCT02430532|58879815|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
30852429|NCT02430532|58879814|FG000|Overall Study|Consent Withdrawn|0|||
30852430|NCT02430532|58879815|FG001|Overall Study|Consent Withdrawn|2|||
30852431|NCT02430532|58879814|FG000|Overall Study|Adverse Event|0|||
30852432|NCT02430532|58879815|FG001|Overall Study|Adverse Event|1|||
30852433|NCT02394340|58879823|FG000|Overall Study|Failed drug screen test|1|||
30852434|NCT02394340|58879823|FG000|Overall Study|Adverse Event|1|||
30852435|NCT01672736|58879827|FG000|Overall Study|Available drug expired on 31 May 16|3|||
30852436|NCT01560637|58879831|FG000|Overall Study|Adverse Event|63|||
30852437|NCT01560637|58879831|FG000|Overall Study|Death|69|||
30852438|NCT01560637|58879831|FG000|Overall Study|Lost to Follow-up|8|||
30852439|NCT01560637|58879831|FG000|Overall Study|Protocol Violation|8|||
30852440|NCT01560637|58879831|FG000|Overall Study|Withdrawal by Subject|24|||
30852441|NCT01560637|58879831|FG000|Overall Study|Progressive Disease|20|||
30852442|NCT01560637|58879831|FG000|Overall Study|Other Reason Not Specified|6|||
30852443|NCT01353911|58879843|FG000|Overall Study|Lost to Follow-up|2|||
30852444|NCT01353911|58879844|FG001|Overall Study|Lost to Follow-up|6|||
30852445|NCT01353911|58879845|FG002|Overall Study|Lost to Follow-up|4|||
30852446|NCT01353911|58879846|FG003|Overall Study|Lost to Follow-up|0|||
30852447|NCT01353911|58879847|FG004|Overall Study|Lost to Follow-up|4|||
30852448|NCT01353911|58879848|FG005|Overall Study|Lost to Follow-up|4|||
30852449|NCT01353911|58879849|FG006|Overall Study|Lost to Follow-up|3|||
30852450|NCT01353911|58879850|FG007|Overall Study|Lost to Follow-up|6|||
30852451|NCT01353911|58879843|FG000|Overall Study|Withdrawal by Subject|2|||
30852452|NCT01353911|58879844|FG001|Overall Study|Withdrawal by Subject|3|||
30852453|NCT01353911|58879845|FG002|Overall Study|Withdrawal by Subject|4|||
30852454|NCT01353911|58879846|FG003|Overall Study|Withdrawal by Subject|2|||
30852455|NCT01353911|58879847|FG004|Overall Study|Withdrawal by Subject|2|||
30852456|NCT01353911|58879848|FG005|Overall Study|Withdrawal by Subject|3|||
30852457|NCT01353911|58879849|FG006|Overall Study|Withdrawal by Subject|3|||
30852458|NCT01353911|58879850|FG007|Overall Study|Withdrawal by Subject|9|||
30954531|NCT01822925|59010498|FG001|Overall Study|Taking prohibited medication|0|||
30954532|NCT01822925|59010499|FG002|Overall Study|Taking prohibited medication|0|||
30852459|NCT01353911|58879843|FG000|Overall Study|Status Not Recorded|4|||
30852460|NCT01353911|58879844|FG001|Overall Study|Status Not Recorded|0|||
30852461|NCT01353911|58879845|FG002|Overall Study|Status Not Recorded|1|||
30852462|NCT01353911|58879846|FG003|Overall Study|Status Not Recorded|0|||
30852463|NCT01353911|58879847|FG004|Overall Study|Status Not Recorded|0|||
30954533|NCT01822925|59010500|FG003|Overall Study|Taking prohibited medication|1|||
30954534|NCT01801007|59010533|FG000|Overall Study|Adverse Event|2|||
30954535|NCT01801007|59010533|FG000|Overall Study|Lost to Follow-up|4|||
30954536|NCT01801007|59010533|FG000|Overall Study|Withdrawal by Subject|5|||
30954537|NCT01822691|59010537|FG000|Overall Study|Withdrawal by Subject|2|||
30954538|NCT01822535|59010543|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
30954539|NCT01822535|59010544|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
30954540|NCT01822535|59010543|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
30954541|NCT01822535|59010544|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
30954542|NCT01822535|59010543|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
30954543|NCT01822535|59010544|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
30954544|NCT01799993|59010630|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
30954545|NCT01799993|59010631|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
30954546|NCT01799993|59010630|FG000|Overall Study|Death|61|||
30954547|NCT01799993|59010631|FG001|Overall Study|Death|45|||
30954548|NCT01799993|59010630|FG000|Overall Study|Withdrawal by Subject|23|||
30954549|NCT01799993|59010631|FG001|Overall Study|Withdrawal by Subject|24|||
30954550|NCT01799993|59010630|FG000|Overall Study|Lost to Follow-up|5|||
30954551|NCT01799993|59010631|FG001|Overall Study|Lost to Follow-up|8|||
30954552|NCT01799993|59010630|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
30954553|NCT01799993|59010631|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
30954554|NCT01799993|59010630|FG000|Overall Study|Protocol driven decision point|0|||
30954555|NCT01799993|59010631|FG001|Overall Study|Protocol driven decision point|3|||
30954556|NCT01799993|59010630|FG000|Overall Study|Protocol Violation|1|||
30954557|NCT01799993|59010631|FG001|Overall Study|Protocol Violation|1|||
30954558|NCT01799993|59010630|FG000|Overall Study|Deterioration of general conditions|2|||
30954559|NCT01799993|59010631|FG001|Overall Study|Deterioration of general conditions|0|||
30954560|NCT01799993|59010630|FG000|Overall Study|Screen failure|0|||
30954561|NCT01799993|59010631|FG001|Overall Study|Screen failure|1|||
30852464|NCT01353911|58879848|FG005|Overall Study|Status Not Recorded|0|||
30852465|NCT01353911|58879849|FG006|Overall Study|Status Not Recorded|0|||
30852466|NCT01353911|58879850|FG007|Overall Study|Status Not Recorded|0|||
30852467|NCT01671488|58879868|FG000|Overall Study|Withdrawal by Subject|1|||
30852468|NCT02783911|58879874|FG000|Overall Study|Lost to Follow-up|3|||
30852469|NCT02783911|58879875|FG001|Overall Study|Lost to Follow-up|32|||
30852470|NCT01358357|58879883|FG000|Open Label Phase|Adverse Event|0|||
30852471|NCT01358357|58879884|FG001|Open Label Phase|Adverse Event|0|||
30852472|NCT01358357|58879885|FG002|Open Label Phase|Adverse Event|59|||
30954562|NCT01799993|59010630|FG000|Overall Study|Adverse Event|1|||
30954563|NCT01799993|59010631|FG001|Overall Study|Adverse Event|0|||
30954564|NCT01799993|59010630|FG000|Overall Study|Lack of Efficacy|1|||
30954565|NCT01799993|59010631|FG001|Overall Study|Lack of Efficacy|0|||
30954566|NCT01799993|59010630|FG000|Overall Study|Recovery|0|||
30954567|NCT01799993|59010631|FG001|Overall Study|Recovery|1|||
30954568|NCT01799993|59010630|FG000|Overall Study|Logistical difficulties|1|||
30954569|NCT01799993|59010631|FG001|Overall Study|Logistical difficulties|0|||
30954570|NCT01799993|59010630|FG000|Overall Study|Protocol deviation|1|||
30954571|NCT01799993|59010631|FG001|Overall Study|Protocol deviation|0|||
30954572|NCT01799993|59010630|FG000|Overall Study|Non-compliance with medical device|1|||
30954573|NCT01799993|59010631|FG001|Overall Study|Non-compliance with medical device|0|||
30954574|NCT01799993|59010630|FG000|Overall Study|Withdrawal by parent/guardian|0|||
30954575|NCT01799993|59010631|FG001|Overall Study|Withdrawal by parent/guardian|1|||
30954576|NCT01799993|59010630|FG000|Overall Study|Other|1|||
30954577|NCT01799993|59010631|FG001|Overall Study|Other|0|||
30954578|NCT01799993|59010630|FG000|Overall Study|Subject didn't return for follow-up|0|||
30954579|NCT01799993|59010631|FG001|Overall Study|Subject didn't return for follow-up|1|||
30954580|NCT01822223|59010648|FG000|Overall Study|Death|0|||
30954581|NCT01822223|59010649|FG001|Overall Study|Death|1|||
30954582|NCT02228382|59010735|FG000|Overall Study|Death|5|||
30954583|NCT02228382|59010736|FG001|Overall Study|Death|7|||
30954584|NCT02228382|59010737|FG002|Overall Study|Death|5|||
30954585|NCT02228382|59010738|FG003|Overall Study|Death|0|||
30954586|NCT02228382|59010739|FG004|Overall Study|Death|2|||
30954587|NCT02228382|59010735|FG000|Overall Study|Participant refused further follow-up|0|||
30954588|NCT02228382|59010736|FG001|Overall Study|Participant refused further follow-up|0|||
30954589|NCT02228382|59010737|FG002|Overall Study|Participant refused further follow-up|1|||
30954590|NCT02228382|59010738|FG003|Overall Study|Participant refused further follow-up|0|||
30954591|NCT02228382|59010739|FG004|Overall Study|Participant refused further follow-up|0|||
30954592|NCT02228382|59010735|FG000|Overall Study|Study terminated by sponsor|3|||
30954593|NCT02228382|59010736|FG001|Overall Study|Study terminated by sponsor|5|||
30954594|NCT02228382|59010737|FG002|Overall Study|Study terminated by sponsor|7|||
30954595|NCT02228382|59010738|FG003|Overall Study|Study terminated by sponsor|0|||
30954596|NCT02228382|59010739|FG004|Overall Study|Study terminated by sponsor|0|||
30954597|NCT02228382|59010735|FG000|Overall Study|Lost to Follow-up|0|||
30852473|NCT01358357|58879883|FG000|Open Label Phase|Lack of Efficacy|0|||
30852474|NCT01358357|58879884|FG001|Open Label Phase|Lack of Efficacy|0|||
30852475|NCT01358357|58879885|FG002|Open Label Phase|Lack of Efficacy|107|||
30954598|NCT02228382|59010736|FG001|Overall Study|Lost to Follow-up|0|||
30954599|NCT02228382|59010737|FG002|Overall Study|Lost to Follow-up|3|||
30954600|NCT02228382|59010738|FG003|Overall Study|Lost to Follow-up|1|||
30954601|NCT02228382|59010739|FG004|Overall Study|Lost to Follow-up|0|||
30954602|NCT02228382|59010735|FG000|Overall Study|Withdrawal by Subject|0|||
30954603|NCT02228382|59010736|FG001|Overall Study|Withdrawal by Subject|3|||
30954604|NCT02228382|59010737|FG002|Overall Study|Withdrawal by Subject|2|||
30954605|NCT02228382|59010738|FG003|Overall Study|Withdrawal by Subject|1|||
30954606|NCT02228382|59010739|FG004|Overall Study|Withdrawal by Subject|0|||
30954607|NCT02228382|59010735|FG000|Overall Study|Other|2|||
30954608|NCT02228382|59010736|FG001|Overall Study|Other|3|||
30954609|NCT02228382|59010737|FG002|Overall Study|Other|3|||
30954610|NCT02228382|59010738|FG003|Overall Study|Other|0|||
30954611|NCT02228382|59010739|FG004|Overall Study|Other|0|||
30954612|NCT01900002|59010783|FG000|Overall Study|Withdrawal by Subject|2|||
30954613|NCT01900002|59010783|FG000|Overall Study|ineligible for Y-90|4|||
30954614|NCT01377012|59010813|FG000|Core Study|Study terminated by Sponsor|47|||
30954615|NCT01377012|59010814|FG001|Core Study|Study terminated by Sponsor|54|||
30954616|NCT01377012|59010815|FG002|Core Study|Study terminated by Sponsor|46|||
30954617|NCT01377012|59010813|FG000|Core Study|Technical problems|1|||
30954618|NCT01377012|59010814|FG001|Core Study|Technical problems|0|||
30954619|NCT01377012|59010815|FG002|Core Study|Technical problems|0|||
30954620|NCT01377012|59010813|FG000|Core Study|Withdrawal by Subject|15|||
30954621|NCT01377012|59010814|FG001|Core Study|Withdrawal by Subject|23|||
30954622|NCT01377012|59010815|FG002|Core Study|Withdrawal by Subject|18|||
30954623|NCT01377012|59010813|FG000|Core Study|Protocol Violation|7|||
30954624|NCT01377012|59010814|FG001|Core Study|Protocol Violation|3|||
30954625|NCT01377012|59010815|FG002|Core Study|Protocol Violation|2|||
30954626|NCT01377012|59010813|FG000|Core Study|Pregnancy|0|||
30954627|NCT01377012|59010814|FG001|Core Study|Pregnancy|0|||
30954628|NCT01377012|59010815|FG002|Core Study|Pregnancy|1|||
30954629|NCT01377012|59010813|FG000|Core Study|Physician Decision|5|||
30954630|NCT01377012|59010814|FG001|Core Study|Physician Decision|4|||
30954631|NCT01377012|59010815|FG002|Core Study|Physician Decision|10|||
30954632|NCT01377012|59010813|FG000|Core Study|Non-Compliant with study treatment|0|||
30954633|NCT01377012|59010814|FG001|Core Study|Non-Compliant with study treatment|0|||
30954634|NCT01377012|59010815|FG002|Core Study|Non-Compliant with study treatment|1|||
30954635|NCT01377012|59010813|FG000|Core Study|No Longer require treatment|0|||
30954636|NCT01377012|59010814|FG001|Core Study|No Longer require treatment|0|||
30852476|NCT01358357|58879883|FG000|Open Label Phase|Lost to Follow-up|0|||
30852477|NCT01358357|58879884|FG001|Open Label Phase|Lost to Follow-up|0|||
30852478|NCT01358357|58879885|FG002|Open Label Phase|Lost to Follow-up|76|||
30852479|NCT01358357|58879883|FG000|Open Label Phase|Protocol Violation|0|||
30852480|NCT01358357|58879884|FG001|Open Label Phase|Protocol Violation|0|||
30852481|NCT01358357|58879885|FG002|Open Label Phase|Protocol Violation|45|||
30852482|NCT01358357|58879883|FG000|Open Label Phase|Withdrawal by Subject|0|||
30852483|NCT01358357|58879884|FG001|Open Label Phase|Withdrawal by Subject|0|||
30852484|NCT01358357|58879885|FG002|Open Label Phase|Withdrawal by Subject|112|||
30852485|NCT01358357|58879883|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
30852486|NCT01358357|58879884|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
30954637|NCT01377012|59010815|FG002|Core Study|No Longer require treatment|1|||
30954638|NCT01377012|59010813|FG000|Core Study|Lost to Follow-up|7|||
30954639|NCT01377012|59010814|FG001|Core Study|Lost to Follow-up|5|||
30954640|NCT01377012|59010815|FG002|Core Study|Lost to Follow-up|4|||
30954641|NCT01377012|59010813|FG000|Core Study|Lack of Efficacy|41|||
30954642|NCT01377012|59010814|FG001|Core Study|Lack of Efficacy|28|||
30954643|NCT01377012|59010815|FG002|Core Study|Lack of Efficacy|37|||
30954644|NCT01377012|59010813|FG000|Core Study|Death|1|||
30954645|NCT01377012|59010814|FG001|Core Study|Death|1|||
30954646|NCT01377012|59010815|FG002|Core Study|Death|1|||
30954647|NCT01377012|59010813|FG000|Core Study|Adverse Event|10|||
30954648|NCT01377012|59010814|FG001|Core Study|Adverse Event|14|||
30954649|NCT01377012|59010815|FG002|Core Study|Adverse Event|13|||
30954650|NCT01377012|59010813|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
30954651|NCT01377012|59010814|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
30954652|NCT01377012|59010815|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
30954653|NCT01377012|59010813|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
30954654|NCT01377012|59010814|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
30954655|NCT01377012|59010815|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
30954656|NCT01377012|59010813|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
30954657|NCT01377012|59010814|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
30954658|NCT01377012|59010815|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
30852487|NCT01358357|58879885|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
30852488|NCT01358357|58879883|FG000|Open Label Phase|Terminated at study completion|0|||
30954659|NCT01377012|59010813|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
30954660|NCT01377012|59010814|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
30954661|NCT01377012|59010815|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
30954662|NCT01377012|59010813|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
30954663|NCT01377012|59010814|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
30954664|NCT01377012|59010815|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
30954665|NCT01377012|59010813|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
30954666|NCT01377012|59010814|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
30954667|NCT01377012|59010815|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
30954668|NCT01376310|59011064|FG000|Overall Study|Study closed/terminated|1|||
30954669|NCT01376310|59011065|FG001|Overall Study|Study closed/terminated|2|||
30954670|NCT01376310|59011064|FG000|Overall Study|Withdrawal by Subject|8|||
30954671|NCT01376310|59011065|FG001|Overall Study|Withdrawal by Subject|2|||
30954672|NCT01376310|59011064|FG000|Overall Study|Physician Decision|26|||
30954673|NCT01376310|59011065|FG001|Overall Study|Physician Decision|7|||
30954674|NCT01376310|59011064|FG000|Overall Study|Lost to Follow-up|1|||
30954675|NCT01376310|59011065|FG001|Overall Study|Lost to Follow-up|0|||
30954676|NCT01949506|59011071|FG000|Overall Study|Physician Decision|1|||
30954677|NCT00709098|59011168|FG000|Double-blind Period|Withdrawal of consent|3|||
30954678|NCT00709098|59011169|FG001|Double-blind Period|Withdrawal of consent|3|||
30954679|NCT00709098|59011170|FG002|Double-blind Period|Withdrawal of consent|0|||
30954680|NCT00709098|59011168|FG000|Double-blind Period|Administrative reason|1|||
30954681|NCT00709098|59011169|FG001|Double-blind Period|Administrative reason|3|||
30954682|NCT00709098|59011170|FG002|Double-blind Period|Administrative reason|0|||
30954683|NCT00709098|59011168|FG000|Double-blind Period|Death|1|||
30852489|NCT01358357|58879884|FG001|Open Label Phase|Terminated at study completion|0|||
30852490|NCT01358357|58879885|FG002|Open Label Phase|Terminated at study completion|5|||
30852491|NCT01358357|58879883|FG000|Open Label Phase|Mood episode|0|||
30852492|NCT01358357|58879884|FG001|Open Label Phase|Mood episode|0|||
30852493|NCT01358357|58879885|FG002|Open Label Phase|Mood episode|42|||
30852494|NCT01358357|58879883|FG000|Double-Blind Phase|Adverse Event|8|||
30852495|NCT01358357|58879884|FG001|Double-Blind Phase|Adverse Event|5|||
30852496|NCT01358357|58879885|FG002|Double-Blind Phase|Adverse Event|0|||
30852497|NCT01358357|58879883|FG000|Double-Blind Phase|Lost to Follow-up|5|||
30852498|NCT01358357|58879884|FG001|Double-Blind Phase|Lost to Follow-up|7|||
30852499|NCT01358357|58879885|FG002|Double-Blind Phase|Lost to Follow-up|0|||
30852500|NCT01358357|58879883|FG000|Double-Blind Phase|Protocol Violation|1|||
30852501|NCT01358357|58879884|FG001|Double-Blind Phase|Protocol Violation|11|||
30852502|NCT01358357|58879885|FG002|Double-Blind Phase|Protocol Violation|0|||
30852503|NCT01358357|58879883|FG000|Double-Blind Phase|Protocol Violation|16|||
30852504|NCT01358357|58879884|FG001|Double-Blind Phase|Protocol Violation|12|||
30852505|NCT01358357|58879885|FG002|Double-Blind Phase|Protocol Violation|0|||
30852506|NCT01358357|58879883|FG000|Double-Blind Phase|Terminated at study completion|2|||
30852507|NCT01358357|58879884|FG001|Double-Blind Phase|Terminated at study completion|0|||
30852508|NCT01358357|58879885|FG002|Double-Blind Phase|Terminated at study completion|0|||
30852509|NCT01358357|58879883|FG000|Double-Blind Phase|Recurrence of mood event|48|||
30852510|NCT01358357|58879884|FG001|Double-Blind Phase|Recurrence of mood event|64|||
30852511|NCT01358357|58879885|FG002|Double-Blind Phase|Recurrence of mood event|0|||
30852512|NCT01358357|58879883|FG000|Double-Blind Phase|Administrative|0|||
30852513|NCT01358357|58879884|FG001|Double-Blind Phase|Administrative|1|||
30852514|NCT01358357|58879885|FG002|Double-Blind Phase|Administrative|0|||
30852515|NCT02831387|58879894|FG000|Overall Study|Withdrawal by Subject|1|||
30852516|NCT02831387|58879895|FG001|Overall Study|Withdrawal by Subject|1|||
30852517|NCT02831387|58879894|FG000|Overall Study|Discontinued due to stock recovery|0|||
30852518|NCT02831387|58879895|FG001|Overall Study|Discontinued due to stock recovery|1|||
30852519|NCT02831855|58879901|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
30852520|NCT02831855|58879902|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
30852521|NCT02831855|58879903|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
30852522|NCT02831855|58879901|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
30852523|NCT02831855|58879902|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
30852524|NCT02831855|58879903|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
30852525|NCT02831855|58879901|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
30852526|NCT02831855|58879902|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
30852527|NCT02831855|58879903|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
30852528|NCT02831855|58879901|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
30852529|NCT02831855|58879902|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
30852530|NCT02831855|58879903|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
30852531|NCT02831855|58879901|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
30954684|NCT00709098|59011169|FG001|Double-blind Period|Death|1|||
30954685|NCT00709098|59011170|FG002|Double-blind Period|Death|0|||
30954686|NCT00709098|59011168|FG000|Double-blind Period|Lost to Follow-up|1|||
30852532|NCT02831855|58879902|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
30954687|NCT00709098|59011169|FG001|Double-blind Period|Lost to Follow-up|1|||
30954688|NCT00709098|59011170|FG002|Double-blind Period|Lost to Follow-up|0|||
30954689|NCT00709098|59011168|FG000|Open-label Period|Withdrawal of consent|0|||
30954690|NCT00709098|59011169|FG001|Open-label Period|Withdrawal of consent|0|||
30662626|NCT00561925|58676227|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
30852533|NCT02831855|58879903|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
30954691|NCT00709098|59011170|FG002|Open-label Period|Withdrawal of consent|7|||
30954692|NCT00709098|59011168|FG000|Open-label Period|Administrative reason|0|||
30954693|NCT00709098|59011169|FG001|Open-label Period|Administrative reason|0|||
30954694|NCT00709098|59011170|FG002|Open-label Period|Administrative reason|5|||
30954695|NCT00709098|59011168|FG000|Open-label Period|Death|0|||
30954696|NCT00709098|59011169|FG001|Open-label Period|Death|0|||
30954697|NCT00709098|59011170|FG002|Open-label Period|Death|1|||
30954698|NCT00709098|59011168|FG000|Open-label Period|Lost to Follow-up|0|||
30954699|NCT00709098|59011169|FG001|Open-label Period|Lost to Follow-up|0|||
30954700|NCT00709098|59011170|FG002|Open-label Period|Lost to Follow-up|1|||
30954701|NCT01376700|59011179|FG000|Overall Study|Sponsor terminated study early|8|||
30954702|NCT01376700|59011179|FG000|Overall Study|Low or high titer inhibitor|8|||
30954703|NCT01797965|59011190|FG000|Overall Study|Adverse Event|104|||
30954704|NCT01797965|59011191|FG001|Overall Study|Adverse Event|129|||
30954705|NCT01797965|59011192|FG002|Overall Study|Adverse Event|4|||
30954706|NCT01797965|59011193|FG003|Overall Study|Adverse Event|21|||
30954707|NCT01797965|59011190|FG000|Overall Study|Lost to Follow-up|9|||
30954708|NCT01797965|59011191|FG001|Overall Study|Lost to Follow-up|8|||
30954709|NCT01797965|59011192|FG002|Overall Study|Lost to Follow-up|1|||
30954710|NCT01797965|59011193|FG003|Overall Study|Lost to Follow-up|2|||
30954711|NCT01797965|59011190|FG000|Overall Study|Consent withdrawn|130|||
30954712|NCT01797965|59011191|FG001|Overall Study|Consent withdrawn|117|||
30954713|NCT01797965|59011192|FG002|Overall Study|Consent withdrawn|3|||
30777468|NCT03630120|58788336|FG000|Overall Study|Disease progression|0|||
30777469|NCT03630120|58788337|FG001|Overall Study|Disease progression|1|||
30777470|NCT03630120|58788338|FG002|Overall Study|Disease progression|1|||
30777471|NCT03630120|58788339|FG003|Overall Study|Disease progression|1|||
30954714|NCT01797965|59011193|FG003|Overall Study|Consent withdrawn|35|||
30954715|NCT01797965|59011190|FG000|Overall Study|Investigator decision|21|||
30954716|NCT01797965|59011191|FG001|Overall Study|Investigator decision|15|||
30954717|NCT01797965|59011192|FG002|Overall Study|Investigator decision|0|||
30954718|NCT01797965|59011193|FG003|Overall Study|Investigator decision|0|||
30954719|NCT01797965|59011190|FG000|Overall Study|Death|2|||
30954720|NCT01797965|59011191|FG001|Overall Study|Death|4|||
30954721|NCT01797965|59011192|FG002|Overall Study|Death|0|||
30954722|NCT01797965|59011193|FG003|Overall Study|Death|0|||
30954723|NCT01797965|59011190|FG000|Overall Study|Disease progression, defined by protocol|3|||
30954724|NCT01797965|59011191|FG001|Overall Study|Disease progression, defined by protocol|1|||
30954725|NCT01797965|59011192|FG002|Overall Study|Disease progression, defined by protocol|0|||
30954726|NCT01797965|59011193|FG003|Overall Study|Disease progression, defined by protocol|0|||
30954727|NCT01797965|59011190|FG000|Overall Study|Reason Not Specified|280|||
30954728|NCT01797965|59011191|FG001|Overall Study|Reason Not Specified|295|||
30954729|NCT01797965|59011192|FG002|Overall Study|Reason Not Specified|0|||
30954730|NCT01797965|59011193|FG003|Overall Study|Reason Not Specified|15|||
30954731|NCT01376388|59011238|FG000|Overall Study|Adverse Event|13|||
30954732|NCT01376388|59011238|FG000|Overall Study|Lack of Efficacy|2|||
30954733|NCT01376388|59011238|FG000|Overall Study|Withdrawal by Subject|3|||
30954734|NCT01821677|59011259|FG000|Overall Study|Adverse Event|4|||
30954735|NCT01821677|59011260|FG001|Overall Study|Adverse Event|6|||
30954736|NCT01821677|59011261|FG002|Overall Study|Adverse Event|5|||
30954737|NCT01821677|59011259|FG000|Overall Study|Physician Decision|1|||
30954738|NCT01821677|59011260|FG001|Overall Study|Physician Decision|4|||
30954739|NCT01821677|59011261|FG002|Overall Study|Physician Decision|1|||
30954740|NCT01821677|59011259|FG000|Overall Study|Non-compliance|0|||
30954741|NCT01821677|59011260|FG001|Overall Study|Non-compliance|1|||
30954742|NCT01821677|59011261|FG002|Overall Study|Non-compliance|2|||
30954743|NCT01821677|59011259|FG000|Overall Study|Lost to Follow-up|2|||
30954744|NCT01821677|59011260|FG001|Overall Study|Lost to Follow-up|1|||
30954745|NCT01821677|59011261|FG002|Overall Study|Lost to Follow-up|3|||
30777472|NCT03555266|58788351|FG000|Overall Study|Protocol Violation|6|||
30777473|NCT03555266|58788352|FG001|Overall Study|Protocol Violation|4|||
30777474|NCT03629886|58788360|FG000|Overall Study|Migrated / moved from the study area|0|||
30777475|NCT03629886|58788361|FG001|Overall Study|Migrated / moved from the study area|55|||
30777476|NCT03629886|58788360|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
30954746|NCT01821677|59011259|FG000|Overall Study|Protocol Violation|0|||
30954747|NCT01821677|59011260|FG001|Overall Study|Protocol Violation|0|||
30954748|NCT01821677|59011261|FG002|Overall Study|Protocol Violation|2|||
30954749|NCT01821677|59011259|FG000|Overall Study|Withdrawal by Subject|7|||
30954750|NCT01821677|59011260|FG001|Overall Study|Withdrawal by Subject|3|||
30954751|NCT01821677|59011261|FG002|Overall Study|Withdrawal by Subject|2|||
30777477|NCT03629886|58788361|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
30852534|NCT02831855|58879901|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
30852535|NCT02831855|58879902|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
30954752|NCT01821677|59011259|FG000|Overall Study|Other|9|||
30954753|NCT01821677|59011260|FG001|Overall Study|Other|0|||
30954754|NCT01821677|59011261|FG002|Overall Study|Other|0|||
30954755|NCT01797731|59011272|FG000|Overall Study|Didn't have proper radiographs required|3|||
30954756|NCT01797731|59011273|FG001|Overall Study|Didn't have proper radiographs required|3|||
30954757|NCT00709722|59011279|FG000|Overall Study|Adverse Event|1|||
30954758|NCT01820585|59011300|FG000|Overall Study|Adverse Event|9|||
30954759|NCT01820585|59011301|FG001|Overall Study|Adverse Event|13|||
30954760|NCT01820585|59011302|FG002|Overall Study|Adverse Event|23|||
30954761|NCT01820585|59011303|FG003|Overall Study|Adverse Event|34|||
30954762|NCT01820585|59011300|FG000|Overall Study|Lack of Efficacy|9|||
30954763|NCT01820585|59011301|FG001|Overall Study|Lack of Efficacy|7|||
30954764|NCT01820585|59011302|FG002|Overall Study|Lack of Efficacy|5|||
30954765|NCT01820585|59011303|FG003|Overall Study|Lack of Efficacy|1|||
30954766|NCT01820585|59011300|FG000|Overall Study|Withdrawal by Subject|3|||
30954767|NCT01820585|59011301|FG001|Overall Study|Withdrawal by Subject|7|||
30954768|NCT01820585|59011302|FG002|Overall Study|Withdrawal by Subject|3|||
30954769|NCT01820585|59011303|FG003|Overall Study|Withdrawal by Subject|8|||
30954770|NCT01820585|59011300|FG000|Overall Study|Lost to Follow-up|3|||
30954771|NCT01820585|59011301|FG001|Overall Study|Lost to Follow-up|3|||
30954772|NCT01820585|59011302|FG002|Overall Study|Lost to Follow-up|0|||
30954773|NCT01820585|59011303|FG003|Overall Study|Lost to Follow-up|3|||
30954774|NCT01820585|59011300|FG000|Overall Study|Protocol Violation|3|||
30954775|NCT01820585|59011301|FG001|Overall Study|Protocol Violation|1|||
30954776|NCT01820585|59011302|FG002|Overall Study|Protocol Violation|1|||
30954777|NCT01820585|59011303|FG003|Overall Study|Protocol Violation|1|||
30954778|NCT01820585|59011300|FG000|Overall Study|Subject non-compliance|0|||
30954779|NCT01820585|59011301|FG001|Overall Study|Subject non-compliance|0|||
30954780|NCT01820585|59011302|FG002|Overall Study|Subject non-compliance|1|||
30954781|NCT01820585|59011303|FG003|Overall Study|Subject non-compliance|2|||
30954782|NCT01820585|59011300|FG000|Overall Study|at sponsor request|0|||
30954783|NCT01820585|59011301|FG001|Overall Study|at sponsor request|0|||
30954784|NCT01820585|59011302|FG002|Overall Study|at sponsor request|1|||
30954785|NCT01820585|59011303|FG003|Overall Study|at sponsor request|0|||
30954786|NCT01820585|59011300|FG000|Overall Study|Pregnancy|0|||
30954787|NCT01820585|59011301|FG001|Overall Study|Pregnancy|1|||
30954788|NCT01820585|59011302|FG002|Overall Study|Pregnancy|0|||
30954789|NCT01820585|59011303|FG003|Overall Study|Pregnancy|0|||
30954790|NCT01797263|59011315|FG000|Overall Study|Withdrawal by Subject|21|||
30954791|NCT01797263|59011316|FG001|Overall Study|Withdrawal by Subject|25|||
30954792|NCT01797263|59011315|FG000|Overall Study|Death|1|||
30954793|NCT01797263|59011316|FG001|Overall Study|Death|0|||
30954794|NCT01797263|59011315|FG000|Overall Study|Lost to Follow-up|15|||
30954795|NCT01797263|59011316|FG001|Overall Study|Lost to Follow-up|15|||
30954796|NCT01797185|59011371|FG000|Overall Study|Adverse Event|5|||
30954797|NCT01797185|59011372|FG001|Overall Study|Adverse Event|15|||
30954798|NCT01797185|59011373|FG002|Overall Study|Adverse Event|6|||
30954799|NCT01797185|59011371|FG000|Overall Study|Withdrawal by Subject|6|||
30954800|NCT01797185|59011372|FG001|Overall Study|Withdrawal by Subject|9|||
30954801|NCT01797185|59011373|FG002|Overall Study|Withdrawal by Subject|5|||
30954802|NCT01797185|59011371|FG000|Overall Study|Site terminated|8|||
30954803|NCT01797185|59011372|FG001|Overall Study|Site terminated|4|||
30954804|NCT01797185|59011373|FG002|Overall Study|Site terminated|0|||
30954805|NCT01797185|59011371|FG000|Overall Study|Lost to Follow-up|2|||
30954806|NCT01797185|59011372|FG001|Overall Study|Lost to Follow-up|6|||
30954807|NCT01797185|59011373|FG002|Overall Study|Lost to Follow-up|1|||
30954808|NCT01797185|59011371|FG000|Overall Study|Withdrawn per sponsor|5|||
30954809|NCT01797185|59011372|FG001|Overall Study|Withdrawn per sponsor|0|||
30954810|NCT01797185|59011373|FG002|Overall Study|Withdrawn per sponsor|0|||
30954811|NCT01797185|59011371|FG000|Overall Study|Physician Decision|1|||
30954812|NCT01797185|59011372|FG001|Overall Study|Physician Decision|3|||
30954813|NCT01797185|59011373|FG002|Overall Study|Physician Decision|0|||
30954814|NCT01797185|59011371|FG000|Overall Study|Protocol Violation|1|||
30954815|NCT01797185|59011372|FG001|Overall Study|Protocol Violation|1|||
30954816|NCT01797185|59011373|FG002|Overall Study|Protocol Violation|0|||
30954817|NCT01819727|59011429|FG000|Overall Study|Adverse Event|8|||
30954818|NCT01819727|59011430|FG001|Overall Study|Adverse Event|9|||
30954819|NCT01819727|59011429|FG000|Overall Study|Death|1|||
30954820|NCT01819727|59011430|FG001|Overall Study|Death|0|||
30954821|NCT01819727|59011429|FG000|Overall Study|Lost to Follow-up|1|||
30954822|NCT01819727|59011430|FG001|Overall Study|Lost to Follow-up|1|||
30954823|NCT01819727|59011429|FG000|Overall Study|Physician Decision|3|||
30954824|NCT01819727|59011430|FG001|Overall Study|Physician Decision|2|||
30954825|NCT01819727|59011429|FG000|Overall Study|Pregnancy|1|||
30954826|NCT01819727|59011430|FG001|Overall Study|Pregnancy|0|||
30954827|NCT01819727|59011429|FG000|Overall Study|Protocol Violation|0|||
30954828|NCT01819727|59011430|FG001|Overall Study|Protocol Violation|2|||
30954829|NCT01819727|59011429|FG000|Overall Study|Study Terminated by Sponsor|0|||
30662627|NCT00561925|58676228|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
30954830|NCT01819727|59011430|FG001|Overall Study|Study Terminated by Sponsor|1|||
30954831|NCT01819727|59011429|FG000|Overall Study|Withdrawal by Subject|6|||
30954832|NCT01819727|59011430|FG001|Overall Study|Withdrawal by Subject|11|||
30954833|NCT01819727|59011429|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
30954834|NCT01819727|59011430|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
30954835|NCT01819727|59011429|FG000|Overall Study|Quit due to lack of health benifits|0|||
30954836|NCT01819727|59011430|FG001|Overall Study|Quit due to lack of health benifits|1|||
30954837|NCT01795937|59011489|FG000|Overall Study|Withdrawal by Subject|1|||
30954838|NCT01795937|59011490|FG001|Overall Study|Withdrawal by Subject|0|||
30954839|NCT01795937|59011491|FG002|Overall Study|Withdrawal by Subject|0|||
30954840|NCT01795937|59011489|FG000|Overall Study|Physician Decision|0|||
30954841|NCT01795937|59011490|FG001|Overall Study|Physician Decision|1|||
30954842|NCT01795937|59011491|FG002|Overall Study|Physician Decision|0|||
30954843|NCT01817777|59011533|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
30954844|NCT01817777|59011534|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
30954845|NCT01817777|59011535|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
30954846|NCT01817777|59011533|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
30954847|NCT01817777|59011534|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
30954848|NCT01817777|59011535|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
30954849|NCT01817777|59011533|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
30954850|NCT01817777|59011534|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
30954851|NCT01817777|59011535|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
30954852|NCT01817777|59011533|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
30954853|NCT01817777|59011534|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
30954854|NCT01817777|59011535|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
30954855|NCT01817777|59011533|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
30954856|NCT01817777|59011534|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
30954857|NCT01817777|59011535|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
30954858|NCT01795547|59011561|FG000|Overall Study|Adverse Event|16|||
30954859|NCT01795547|59011562|FG001|Overall Study|Adverse Event|27|||
30954860|NCT01795547|59011561|FG000|Overall Study|Lack of Efficacy|8|||
30954861|NCT01795547|59011562|FG001|Overall Study|Lack of Efficacy|3|||
30954862|NCT01795547|59011561|FG000|Overall Study|Protocol Violation|6|||
30954863|NCT01795547|59011562|FG001|Overall Study|Protocol Violation|4|||
30954864|NCT01795547|59011561|FG000|Overall Study|Lost to Follow-up|2|||
30954865|NCT01795547|59011562|FG001|Overall Study|Lost to Follow-up|5|||
30954866|NCT01795547|59011561|FG000|Overall Study|Withdrawal of consent|7|||
30954867|NCT01795547|59011562|FG001|Overall Study|Withdrawal of consent|12|||
30954868|NCT01795547|59011561|FG000|Overall Study|Not Treated|4|||
30954869|NCT01795547|59011562|FG001|Overall Study|Not Treated|10|||
30852536|NCT02831855|58879903|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
30852537|NCT02831855|58879901|FG000|Open Label Phase (24 Weeks)|Other|4|||
30954870|NCT01795547|59011561|FG000|Overall Study|Non-compliance with IMP|1|||
30954871|NCT01795547|59011562|FG001|Overall Study|Non-compliance with IMP|1|||
30954872|NCT01795547|59011561|FG000|Overall Study|Others|4|||
30954873|NCT01795547|59011562|FG001|Overall Study|Others|1|||
30954874|NCT01795547|59011561|FG000|Overall Study|Not stated|0|||
30954875|NCT01795547|59011562|FG001|Overall Study|Not stated|1|||
30954876|NCT01794923|59011588|FG000|Overall Study|Adverse Event|0|||
30852538|NCT02831855|58879902|FG001|Open Label Phase (24 Weeks)|Other|0|||
30852539|NCT02831855|58879903|FG002|Open Label Phase (24 Weeks)|Other|0|||
30852540|NCT02831855|58879901|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
30852541|NCT02831855|58879902|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
30852542|NCT02831855|58879903|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
30852543|NCT02831855|58879901|FG000|Double Blind Phase (24 Weeks)|Death|0|||
30852544|NCT02831855|58879902|FG001|Double Blind Phase (24 Weeks)|Death|0|||
30852545|NCT02831855|58879903|FG002|Double Blind Phase (24 Weeks)|Death|2|||
30954877|NCT01794923|59011589|FG001|Overall Study|Adverse Event|0|||
30954878|NCT01794923|59011590|FG002|Overall Study|Adverse Event|1|||
30954879|NCT01794845|59011598|FG000|Overall Study|Withdrawal by Subject|1|||
30954880|NCT01794689|59011606|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
30954881|NCT01794689|59011607|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
30954882|NCT01794689|59011608|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
30954883|NCT01794689|59011609|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
30954884|NCT01794689|59011606|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
30954885|NCT01794689|59011607|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
30954886|NCT01794689|59011608|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
30777478|NCT03629886|58788360|FG000|Overall Study|Study vaccine not administrated|0|||
30777479|NCT03629886|58788361|FG001|Overall Study|Study vaccine not administrated|3|||
30777480|NCT03629886|58788360|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
30777481|NCT03629886|58788361|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
30777482|NCT03629886|58788360|FG000|Overall Study|Refused vaccination step of the study|0|||
30777483|NCT03629886|58788361|FG001|Overall Study|Refused vaccination step of the study|44|||
30777484|NCT03656874|58788370|FG000|Overall Study|Lost to Follow-up|3|||
30777485|NCT03656874|58788371|FG001|Overall Study|Lost to Follow-up|17|||
30954887|NCT01794689|59011609|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
30954888|NCT01794689|59011606|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
30777486|NCT03554486|58788379|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
30777487|NCT03554486|58788380|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
30954889|NCT01794689|59011607|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
30954890|NCT01794689|59011608|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
30954891|NCT01794689|59011609|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
30954892|NCT01794689|59011606|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
30954893|NCT01794689|59011607|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
30954894|NCT01794689|59011608|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
30954895|NCT01794689|59011609|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
30954896|NCT01794299|59011625|FG000|Overall Study|ATIR manufacturing not possible|1|||
30954897|NCT01794299|59011625|FG000|Overall Study|Death|14|||
30954898|NCT01794299|59011625|FG000|Overall Study|Graft failure|1|||
30954899|NCT01794299|59011625|FG000|Overall Study|ATIR batch rejected|2|||
30954900|NCT01794299|59011625|FG000|Overall Study|Relapse|2|||
30954901|NCT01794299|59011625|FG000|Overall Study|Discontinued from active follow-up|1|||
30954902|NCT01794299|59011625|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
30954903|NCT01817075|59011631|FG000|Overall Study|Adverse Event|7|||
30954904|NCT01817075|59011632|FG001|Overall Study|Adverse Event|5|||
30954905|NCT01817075|59011631|FG000|Overall Study|Physician Decision|9|||
30954906|NCT01817075|59011632|FG001|Overall Study|Physician Decision|12|||
30954907|NCT01817075|59011631|FG000|Overall Study|Withdrawal by Subject|31|||
30954908|NCT01817075|59011632|FG001|Overall Study|Withdrawal by Subject|15|||
30954909|NCT01817075|59011631|FG000|Overall Study|Received Sorafenib after enrollment|0|||
30954910|NCT01817075|59011632|FG001|Overall Study|Received Sorafenib after enrollment|1|||
30954911|NCT01817075|59011631|FG000|Overall Study|Ineligible|0|||
30954912|NCT01817075|59011632|FG001|Overall Study|Ineligible|2|||
30954913|NCT01816763|59011641|FG000|Overall Study|The main reason for an incomplete survey|4|||
30954914|NCT01816763|59011642|FG001|Overall Study|The main reason for an incomplete survey|15|||
30954915|NCT01816763|59011643|FG002|Overall Study|The main reason for an incomplete survey|11|||
30954916|NCT01816685|59011656|FG000|Overall Study|Lost to Follow-up|7|||
30954917|NCT01816685|59011657|FG001|Overall Study|Lost to Follow-up|9|||
30954918|NCT01816685|59011656|FG000|Overall Study|Surgery Cancelled|3|||
30954919|NCT01816685|59011657|FG001|Overall Study|Surgery Cancelled|2|||
30954920|NCT00708552|59011688|FG000|Overall Study|Adverse Event|10|||
30954921|NCT00708552|59011689|FG001|Overall Study|Adverse Event|3|||
30954922|NCT00708552|59011690|FG002|Overall Study|Adverse Event|4|||
30954923|NCT00708552|59011691|FG003|Overall Study|Adverse Event|6|||
30954924|NCT00708552|59011688|FG000|Overall Study|Lack of Efficacy|0|||
30954925|NCT00708552|59011689|FG001|Overall Study|Lack of Efficacy|4|||
30954926|NCT00708552|59011690|FG002|Overall Study|Lack of Efficacy|1|||
30954927|NCT00708552|59011691|FG003|Overall Study|Lack of Efficacy|0|||
30954928|NCT00708552|59011688|FG000|Overall Study|Protocol Violation|0|||
30954929|NCT00708552|59011689|FG001|Overall Study|Protocol Violation|0|||
30954930|NCT00708552|59011690|FG002|Overall Study|Protocol Violation|2|||
30954931|NCT00708552|59011691|FG003|Overall Study|Protocol Violation|4|||
30954932|NCT00708552|59011688|FG000|Overall Study|Lost to Follow-up|4|||
30954933|NCT00708552|59011689|FG001|Overall Study|Lost to Follow-up|2|||
30954934|NCT00708552|59011690|FG002|Overall Study|Lost to Follow-up|0|||
30954935|NCT00708552|59011691|FG003|Overall Study|Lost to Follow-up|1|||
30954936|NCT00708552|59011688|FG000|Overall Study|Physician Decision|1|||
30954937|NCT00708552|59011689|FG001|Overall Study|Physician Decision|2|||
30954938|NCT00708552|59011690|FG002|Overall Study|Physician Decision|0|||
30954939|NCT00708552|59011691|FG003|Overall Study|Physician Decision|0|||
30954940|NCT00708552|59011688|FG000|Overall Study|Withdrawal by Subject|12|||
30954941|NCT00708552|59011689|FG001|Overall Study|Withdrawal by Subject|7|||
30954942|NCT00708552|59011690|FG002|Overall Study|Withdrawal by Subject|8|||
30954943|NCT00708552|59011691|FG003|Overall Study|Withdrawal by Subject|10|||
30954944|NCT01816295|59011821|FG000|Double Blind Phase|Adverse Event|11|||
30954945|NCT01816295|59011822|FG001|Double Blind Phase|Adverse Event|8|||
30954946|NCT01816295|59011821|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
30777488|NCT03554486|58788381|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
30777489|NCT03554486|58788379|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
30662628|NCT00561925|58676229|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
30662629|NCT00561925|58676230|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
30777490|NCT03554486|58788380|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
30777491|NCT03554486|58788381|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
30954947|NCT01816295|59011822|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
30954948|NCT01816295|59011821|FG000|Double Blind Phase|Lost to Follow-up|3|||
30954949|NCT01816295|59011822|FG001|Double Blind Phase|Lost to Follow-up|5|||
30954950|NCT01816295|59011821|FG000|Double Blind Phase|Physician Decision|2|||
30954951|NCT01816295|59011822|FG001|Double Blind Phase|Physician Decision|2|||
30954952|NCT01816295|59011821|FG000|Double Blind Phase|Protocol Violation|17|||
30954953|NCT01816295|59011822|FG001|Double Blind Phase|Protocol Violation|11|||
30954954|NCT01816295|59011821|FG000|Double Blind Phase|Sponsor Decision|8|||
30954955|NCT01816295|59011822|FG001|Double Blind Phase|Sponsor Decision|8|||
30954956|NCT01816295|59011821|FG000|Double Blind Phase|Withdrawal by Subject|22|||
30954957|NCT01816295|59011822|FG001|Double Blind Phase|Withdrawal by Subject|20|||
30954958|NCT01816295|59011821|FG000|OLE Phase|Adverse Event|17|||
30954959|NCT01816295|59011822|FG001|OLE Phase|Adverse Event|15|||
30954960|NCT01816295|59011821|FG000|OLE Phase|Death|1|||
30954961|NCT01816295|59011822|FG001|OLE Phase|Death|0|||
30954962|NCT01816295|59011821|FG000|OLE Phase|Entry Criteria Not Met|3|||
30954963|NCT01816295|59011822|FG001|OLE Phase|Entry Criteria Not Met|5|||
30852546|NCT02831855|58879901|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
30852547|NCT02831855|58879902|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
30852548|NCT02831855|58879903|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
30852549|NCT02831855|58879901|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
30954964|NCT01816295|59011821|FG000|OLE Phase|Lost to Follow-up|5|||
30954965|NCT01816295|59011822|FG001|OLE Phase|Lost to Follow-up|5|||
30954966|NCT01816295|59011821|FG000|OLE Phase|Physician Decision|3|||
30954967|NCT01816295|59011822|FG001|OLE Phase|Physician Decision|1|||
30852550|NCT02831855|58879902|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
30852551|NCT02831855|58879903|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
30852552|NCT02831855|58879901|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
30852553|NCT02831855|58879902|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
30852554|NCT02831855|58879903|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
30852555|NCT02831855|58879901|FG000|Double Blind Phase (24 Weeks)|Other|0|||
30954968|NCT01816295|59011821|FG000|OLE Phase|Protocol Violation|4|||
30954969|NCT01816295|59011822|FG001|OLE Phase|Protocol Violation|4|||
30954970|NCT01816295|59011821|FG000|OLE Phase|Sponsor Decision|7|||
30954971|NCT01816295|59011822|FG001|OLE Phase|Sponsor Decision|9|||
30954972|NCT01816295|59011821|FG000|OLE Phase|Withdrawal by Subject|10|||
30954973|NCT01816295|59011822|FG001|OLE Phase|Withdrawal by Subject|10|||
30954974|NCT01816295|59011821|FG000|OLE Phase|Lack of Efficacy|3|||
30954975|NCT01816295|59011822|FG001|OLE Phase|Lack of Efficacy|7|||
30954976|NCT01610297|59011847|FG000|Overall Study|Lost to Follow-up|1|||
30954977|NCT01793051|59011858|FG000|Overall Study|Withdrawal by Subject|6|||
30954978|NCT01793051|59011859|FG001|Overall Study|Withdrawal by Subject|4|||
30954979|NCT01793051|59011858|FG000|Overall Study|Adverse Event|0|||
30954980|NCT01793051|59011859|FG001|Overall Study|Adverse Event|2|||
30954981|NCT01793051|59011858|FG000|Overall Study|Too ill to continue|1|||
30954982|NCT01793051|59011859|FG001|Overall Study|Too ill to continue|0|||
30954983|NCT01793051|59011858|FG000|Overall Study|Switched chemo|1|||
30954984|NCT01793051|59011859|FG001|Overall Study|Switched chemo|1|||
30954985|NCT01793051|59011858|FG000|Overall Study|Lack of compliance|1|||
30954986|NCT01793051|59011859|FG001|Overall Study|Lack of compliance|0|||
30852556|NCT02831855|58879902|FG001|Double Blind Phase (24 Weeks)|Other|2|||
30954987|NCT01793051|59011858|FG000|Overall Study|Requested to be removed from the study|1|||
30954988|NCT01793051|59011859|FG001|Overall Study|Requested to be removed from the study|1|||
30954989|NCT01816061|59011892|FG000|Overall Study|Lost to Follow-up|13|||
30954990|NCT01816061|59011893|FG001|Overall Study|Lost to Follow-up|24|||
30954991|NCT01792115|59011919|FG000|Overall Study|Lost to Follow-up|0|||
30954992|NCT01792115|59011920|FG001|Overall Study|Lost to Follow-up|1|||
30954993|NCT01792115|59011921|FG002|Overall Study|Lost to Follow-up|0|||
30954994|NCT01791803|59011933|FG000|Overall Study|Withdrawal by Subject|0|||
30954995|NCT01791803|59011934|FG001|Overall Study|Withdrawal by Subject|0|||
30954996|NCT01791803|59011935|FG002|Overall Study|Withdrawal by Subject|0|||
30954997|NCT01791803|59011936|FG003|Overall Study|Withdrawal by Subject|2|||
30954998|NCT01791803|59011933|FG000|Overall Study|Physician Decision|0|||
30954999|NCT01791803|59011934|FG001|Overall Study|Physician Decision|2|||
30955000|NCT01791803|59011935|FG002|Overall Study|Physician Decision|0|||
30955001|NCT01791803|59011936|FG003|Overall Study|Physician Decision|1|||
30955002|NCT01791803|59011933|FG000|Overall Study|Death|0|||
30955003|NCT01791803|59011934|FG001|Overall Study|Death|0|||
30955004|NCT01791803|59011935|FG002|Overall Study|Death|2|||
30955005|NCT01791803|59011936|FG003|Overall Study|Death|2|||
30955006|NCT01791725|59011961|FG000|Overall Study|Withdrawal by Subject|0|||
30955007|NCT01791725|59011962|FG001|Overall Study|Withdrawal by Subject|1|||
30955008|NCT01791725|59011963|FG002|Overall Study|Withdrawal by Subject|0|||
30852557|NCT02831855|58879903|FG002|Double Blind Phase (24 Weeks)|Other|5|||
30955009|NCT01791413|59011973|FG000|Overall Study|Lost to Follow-up|5|||
30955010|NCT01791413|59011974|FG001|Overall Study|Lost to Follow-up|1|||
30955011|NCT01610063|59011987|FG000|Overall Study|Lost to Follow-up|42|||
30955012|NCT01610063|59011988|FG001|Overall Study|Lost to Follow-up|20|||
30955013|NCT01813721|59011994|FG000|Overall Study|Ineligibility determined|63|||
30955014|NCT01813721|59011994|FG000|Overall Study|Withdrawal by Subject|1|||
30955015|NCT01790633|59012018|FG000|Overall Study|Protocol Violation|1|||
30955016|NCT01790633|59012019|FG001|Overall Study|Protocol Violation|2|||
30955017|NCT01790633|59012018|FG000|Overall Study|Did not have serology performed|47|||
30955018|NCT01790633|59012019|FG001|Overall Study|Did not have serology performed|0|||
30955019|NCT01790633|59012018|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
30955020|NCT01790633|59012019|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
30955021|NCT01788215|59012028|FG000|Overall Study|Withdrawal by Subject|0|||
30955022|NCT01788215|59012029|FG001|Overall Study|Withdrawal by Subject|1|||
30955023|NCT01788215|59012028|FG000|Overall Study|Lost to Follow-up|2|||
30955024|NCT01788215|59012029|FG001|Overall Study|Lost to Follow-up|0|||
30955025|NCT01787825|59012035|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
30777492|NCT03554486|58788379|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
30777493|NCT03554486|58788380|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
30852558|NCT02831855|58879901|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
30852559|NCT02831855|58879902|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
30852560|NCT02831855|58879903|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
30852561|NCT02831855|58879901|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
30852562|NCT02831855|58879902|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
30852563|NCT02831855|58879903|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
30852564|NCT02831855|58879901|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
30852565|NCT02831855|58879902|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
30852566|NCT02831855|58879903|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
30852567|NCT02628938|58879916|FG000|Overall Study|Did not attend the follow up recall|2|||
30852568|NCT02628938|58879917|FG001|Overall Study|Did not attend the follow up recall|2|||
30852569|NCT02628938|58879918|FG002|Overall Study|Did not attend the follow up recall|1|||
30852570|NCT02628938|58879916|FG000|Overall Study|Failure to comply with the instructions|3|||
30852571|NCT02628938|58879917|FG001|Overall Study|Failure to comply with the instructions|0|||
30852572|NCT02628938|58879918|FG002|Overall Study|Failure to comply with the instructions|3|||
30852573|NCT01356407|58879932|FG000|Overall Study|Lost to Follow-up|2|||
30852574|NCT01356407|58879933|FG001|Overall Study|Lost to Follow-up|0|||
30852575|NCT01356407|58879932|FG000|Overall Study|Patient Withdrew Consent|2|||
30852576|NCT01356407|58879933|FG001|Overall Study|Patient Withdrew Consent|1|||
30852577|NCT01356407|58879932|FG000|Overall Study|Could not afford IMP administration|0|||
30852578|NCT01356407|58879933|FG001|Overall Study|Could not afford IMP administration|1|||
30852579|NCT01356407|58879932|FG000|Overall Study|Not complete Endoscopy|2|||
30852580|NCT01356407|58879933|FG001|Overall Study|Not complete Endoscopy|2|||
30852581|NCT00109837|58879939|FG000|Overall Study|Adverse Event|2|||
30852582|NCT00109837|58879939|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
30852583|NCT00109837|58879939|FG000|Overall Study|Death|1|||
30852584|NCT00109837|58879939|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
30852585|NCT00109837|58879939|FG000|Overall Study|Not treated|1|||
30852586|NCT00109837|58879939|FG000|Overall Study|Ineligible|1|||
30852587|NCT02828111|58879952|FG000|Overall Study|Withdrawal by Subject|0|||
30852588|NCT02828111|58879953|FG001|Overall Study|Withdrawal by Subject|0|||
30852589|NCT02828111|58879954|FG002|Overall Study|Withdrawal by Subject|2|||
30852590|NCT02828111|58879955|FG003|Overall Study|Withdrawal by Subject|0|||
30852591|NCT02828111|58879956|FG004|Overall Study|Withdrawal by Subject|0|||
30852592|NCT02828111|58879952|FG000|Overall Study|Lost to Follow-up|0|||
30852593|NCT02828111|58879953|FG001|Overall Study|Lost to Follow-up|0|||
30852594|NCT02828111|58879954|FG002|Overall Study|Lost to Follow-up|0|||
30852595|NCT02828111|58879955|FG003|Overall Study|Lost to Follow-up|1|||
30852596|NCT02828111|58879956|FG004|Overall Study|Lost to Follow-up|1|||
30777494|NCT03554486|58788381|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
30777495|NCT03554018|58788390|FG000|Overall Study|Lost to Follow-up|3|||
30777496|NCT03554018|58788391|FG001|Overall Study|Lost to Follow-up|7|||
30777497|NCT03571256|58788400|FG000|Overall Study|Adverse Event|3|||
30777498|NCT03571256|58788401|FG001|Overall Study|Adverse Event|0|||
30852597|NCT01671332|58879979|FG000|Overall Study|Withdrawal by Subject|1|||
30852598|NCT01671332|58879980|FG001|Overall Study|Withdrawal by Subject|1|||
30852599|NCT01355627|58879988|FG000|Overall Study|Request By the Patient to Discontinue|5|||
30852600|NCT01355627|58879989|FG001|Overall Study|Request By the Patient to Discontinue|7|||
30777499|NCT03571256|58788402|FG002|Overall Study|Adverse Event|1|||
30777500|NCT03571256|58788400|FG000|Overall Study|Withdrawal by Subject|3|||
30852601|NCT01355627|58879988|FG000|Overall Study|Lost to Follow-up|8|||
30852602|NCT01355627|58879989|FG001|Overall Study|Lost to Follow-up|7|||
30852603|NCT01355627|58879988|FG000|Overall Study|Fatal Adverse Event|19|||
30852604|NCT01355627|58879989|FG001|Overall Study|Fatal Adverse Event|23|||
30852605|NCT01355627|58879988|FG000|Overall Study|Other|1|||
30852606|NCT01355627|58879989|FG001|Overall Study|Other|1|||
30852607|NCT00100802|58879995|FG000|Overall Study|Adverse Event|9|||
30852608|NCT00100802|58879995|FG000|Overall Study|Death|1|||
30955026|NCT01787825|59012036|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
30955027|NCT01787825|59012035|FG000|Overall Study|Data Not Analyzable|5|||
30955028|NCT01787825|59012036|FG001|Overall Study|Data Not Analyzable|1|||
30955029|NCT01813019|59012045|FG000|Overall Study|Adverse Event|0|||
30955030|NCT01813019|59012046|FG001|Overall Study|Adverse Event|3|||
30955031|NCT01813019|59012045|FG000|Overall Study|Withdrawal by Subject|3|||
30955032|NCT01813019|59012046|FG001|Overall Study|Withdrawal by Subject|2|||
30955033|NCT01813019|59012045|FG000|Overall Study|administrative problems|2|||
30955034|NCT01813019|59012046|FG001|Overall Study|administrative problems|0|||
30955035|NCT01813019|59012045|FG000|Overall Study|Protocol Deviation|2|||
30955036|NCT01813019|59012046|FG001|Overall Study|Protocol Deviation|1|||
30955037|NCT01787591|59012054|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
30955038|NCT01787591|59012055|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
30955039|NCT01787591|59012056|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
30955040|NCT01787591|59012057|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
30955041|NCT01812707|59012072|FG000|Overall Study|Adverse Event|0|||
30955042|NCT01812707|59012073|FG001|Overall Study|Adverse Event|0|||
30955043|NCT01812707|59012074|FG002|Overall Study|Adverse Event|0|||
30955044|NCT01812707|59012075|FG003|Overall Study|Adverse Event|2|||
30955045|NCT01812707|59012072|FG000|Overall Study|Poor compliance to protocol|1|||
30955046|NCT01812707|59012073|FG001|Overall Study|Poor compliance to protocol|0|||
30955047|NCT01812707|59012074|FG002|Overall Study|Poor compliance to protocol|0|||
30955048|NCT01812707|59012075|FG003|Overall Study|Poor compliance to protocol|0|||
30955049|NCT01812707|59012072|FG000|Overall Study|Consent withdrawn by participant|1|||
30955050|NCT01812707|59012073|FG001|Overall Study|Consent withdrawn by participant|0|||
30955051|NCT01812707|59012074|FG002|Overall Study|Consent withdrawn by participant|0|||
30955052|NCT01812707|59012075|FG003|Overall Study|Consent withdrawn by participant|0|||
30955053|NCT01787279|59012086|FG000|Overall Study|Lost to Follow-up|2|||
30955054|NCT01787279|59012086|FG000|Overall Study|Lack of Efficacy|1|||
30955055|NCT02728206|59012090|FG000|Overall Study|Death|1|||
30955056|NCT01811225|59012094|FG000|Treatment Period 1|Adverse Event|2|||
30955057|NCT01811225|59012095|FG001|Treatment Period 1|Adverse Event|3|||
30955058|NCT01811225|59012094|FG000|Treatment Period 1|Lost to Follow-up|12|||
30955059|NCT01811225|59012095|FG001|Treatment Period 1|Lost to Follow-up|8|||
30955060|NCT01811225|59012094|FG000|Treatment Period 1|transporation|1|||
30955061|NCT01811225|59012095|FG001|Treatment Period 1|transporation|0|||
30955062|NCT01811225|59012094|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
30955063|NCT01811225|59012095|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
30955064|NCT01811225|59012094|FG000|Treatment Period 2|Lost to Follow-up|1|||
30955065|NCT01811225|59012095|FG001|Treatment Period 2|Lost to Follow-up|2|||
30777501|NCT03571256|58788401|FG001|Overall Study|Withdrawal by Subject|1|||
30777502|NCT03571256|58788402|FG002|Overall Study|Withdrawal by Subject|1|||
30777503|NCT03571256|58788400|FG000|Overall Study|Other than specified|0|||
30777504|NCT03571256|58788401|FG001|Overall Study|Other than specified|1|||
30777505|NCT03571256|58788402|FG002|Overall Study|Other than specified|1|||
30777506|NCT03571256|58788400|FG000|Overall Study|Protocol Violation|0|||
30777507|NCT03571256|58788401|FG001|Overall Study|Protocol Violation|1|||
30777508|NCT03571256|58788402|FG002|Overall Study|Protocol Violation|1|||
30777509|NCT03570554|58788416|FG000|Overall Study|Non-compliance with study drug|0|||
30777510|NCT03570554|58788417|FG001|Overall Study|Non-compliance with study drug|0|||
30777511|NCT03570554|58788418|FG002|Overall Study|Non-compliance with study drug|1|||
30777512|NCT03570554|58788419|FG003|Overall Study|Non-compliance with study drug|0|||
30777513|NCT03570554|58788416|FG000|Overall Study|Adverse Event|0|||
30777514|NCT03570554|58788417|FG001|Overall Study|Adverse Event|0|||
30777515|NCT03570554|58788418|FG002|Overall Study|Adverse Event|0|||
30777516|NCT03570554|58788419|FG003|Overall Study|Adverse Event|1|||
30777517|NCT04004208|58788431|FG000|Overall Study|Withdrawal by parent/guardian|1|||
30777518|NCT04004208|58788432|FG001|Overall Study|Withdrawal by parent/guardian|1|||
30777519|NCT04004208|58788431|FG000|Overall Study|Death|3|||
30777520|NCT04004208|58788432|FG001|Overall Study|Death|0|||
30777521|NCT04004208|58788431|FG000|Overall Study|COVID-19 pandemic|1|||
30777522|NCT04004208|58788432|FG001|Overall Study|COVID-19 pandemic|0|||
30777523|NCT04004208|58788431|FG000|Overall Study|Physician Decision|1|||
30777524|NCT04004208|58788432|FG001|Overall Study|Physician Decision|0|||
30777525|NCT04004208|58788431|FG000|Overall Study|Adverse Event|1|||
30777526|NCT04004208|58788432|FG001|Overall Study|Adverse Event|1|||
30777527|NCT03643952|58788438|FG000|Overall Study|Lack of Efficacy|1|||
30777528|NCT03035032|58788450|FG000|Overall Study|Adverse Event|2|||
30777529|NCT03035032|58788450|FG000|Overall Study|Death|9|||
30777530|NCT03035032|58788450|FG000|Overall Study|Lost to Follow-up|1|||
30777531|NCT03035032|58788450|FG000|Overall Study|Progressive Disease|22|||
30777532|NCT03035032|58788450|FG000|Overall Study|Protocol Violation|2|||
30777533|NCT03035032|58788450|FG000|Overall Study|Withdrawal by Subject|2|||
30777534|NCT03035032|58788450|FG000|Overall Study|Physician Decision|5|||
30777535|NCT03629184|58788456|FG000|Overall Study|Withdrawal by Subject|2|||
30777536|NCT03629184|58788457|FG001|Overall Study|Withdrawal by Subject|1|||
30955066|NCT01811225|59012094|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
30852609|NCT00100802|58879995|FG000|Overall Study|Lack of Efficacy|47|||
30852610|NCT00100802|58879995|FG000|Overall Study|Physician Decision|5|||
30852611|NCT00100802|58879995|FG000|Overall Study|Protocol Violation|1|||
30852612|NCT00100802|58879995|FG000|Overall Study|Withdrawal by Subject|5|||
30955067|NCT01811225|59012095|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
30955068|NCT01809197|59012103|FG000|Overall Study|Lost to Follow-up|4|||
30955069|NCT01809197|59012104|FG001|Overall Study|Lost to Follow-up|2|||
30955070|NCT01809197|59012103|FG000|Overall Study|Adverse Event|2|||
30955071|NCT01809197|59012104|FG001|Overall Study|Adverse Event|3|||
30955072|NCT01809197|59012103|FG000|Overall Study|Failed slit lamp exam|1|||
30955073|NCT01809197|59012104|FG001|Overall Study|Failed slit lamp exam|0|||
30955074|NCT01809197|59012103|FG000|Overall Study|Non-Compliance|1|||
30955075|NCT01809197|59012104|FG001|Overall Study|Non-Compliance|1|||
30955076|NCT01809197|59012103|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
30955077|NCT01809197|59012104|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
30955078|NCT01809197|59012103|FG000|Overall Study|Withdrawal by Subject|1|||
30955079|NCT01809197|59012104|FG001|Overall Study|Withdrawal by Subject|1|||
30955080|NCT01809197|59012103|FG000|Overall Study|Product not available|0|||
30955081|NCT01809197|59012104|FG001|Overall Study|Product not available|1|||
30955082|NCT01786109|59012113|FG000|Overall Study|fail manometry barostat tube placement|1|||
30955083|NCT01786109|59012114|FG001|Overall Study|fail manometry barostat tube placement|0|||
30955084|NCT01786109|59012115|FG002|Overall Study|fail manometry barostat tube placement|0|||
30955085|NCT01786109|59012113|FG000|Overall Study|unrelated illness|0|||
30955086|NCT01786109|59012114|FG001|Overall Study|unrelated illness|0|||
30852613|NCT00100802|58879995|FG000|Overall Study|Ineligible|12|||
30852614|NCT01355159|58880001|FG000|Overall Study|Withdrew consent|39|||
30852615|NCT01355159|58880002|FG001|Overall Study|Withdrew consent|47|||
30955087|NCT01786109|59012115|FG002|Overall Study|unrelated illness|1|||
30955088|NCT01786109|59012113|FG000|Overall Study|adverse effects colon preparation|0|||
30955089|NCT01786109|59012114|FG001|Overall Study|adverse effects colon preparation|0|||
30955090|NCT01786109|59012115|FG002|Overall Study|adverse effects colon preparation|1|||
30955091|NCT02728830|59012199|FG000|Overall Study|Exclusionary Surgery|9|||
30955092|NCT02728830|59012199|FG000|Overall Study|Exclusionary Pathology|6|||
30955093|NCT02728830|59012199|FG000|Overall Study|Physician Decision|3|||
30955094|NCT02728830|59012199|FG000|Overall Study|Withdrawal by Subject|2|||
30955095|NCT02728830|59012199|FG000|Overall Study|Lost to Follow-up|1|||
30955096|NCT02728830|59012199|FG000|Overall Study|Exclusionary Lab Values|1|||
30955097|NCT02728830|59012199|FG000|Overall Study|Contraindicated Illness|1|||
30955098|NCT02728830|59012199|FG000|Overall Study|Language Barrier|1|||
30955099|NCT02728596|59012253|FG000|Overall Study|Refusal unrelated to adverse event|3|||
30955100|NCT02728596|59012254|FG001|Overall Study|Refusal unrelated to adverse event|6|||
30955101|NCT02728596|59012255|FG002|Overall Study|Refusal unrelated to adverse event|7|||
30955102|NCT02728596|59012256|FG003|Overall Study|Refusal unrelated to adverse event|7|||
30955103|NCT02728596|59012253|FG000|Overall Study|Death|44|||
30955104|NCT02728596|59012254|FG001|Overall Study|Death|42|||
30955105|NCT02728596|59012255|FG002|Overall Study|Death|123|||
30955106|NCT02728596|59012256|FG003|Overall Study|Death|68|||
30955107|NCT00708162|59012630|FG000|Randomized Phase|Randomized but Not Treated|7|||
30955108|NCT00708162|59012631|FG001|Randomized Phase|Randomized but Not Treated|5|||
30955109|NCT00708162|59012630|FG000|Randomized Phase|Participant Noncompliance|40|||
30955110|NCT00708162|59012631|FG001|Randomized Phase|Participant Noncompliance|32|||
30955111|NCT00708162|59012630|FG000|Randomized Phase|Lost to Follow-up|34|||
30777537|NCT03629184|58788456|FG000|Overall Study|Physician Decision|1|||
30777538|NCT03629184|58788457|FG001|Overall Study|Physician Decision|0|||
30777539|NCT03549338|58788475|FG000|Overall Study|Progressive Disease|1|||
30777540|NCT03549338|58788476|FG001|Overall Study|Progressive Disease|0|||
30777541|NCT03549338|58788477|FG002|Overall Study|Progressive Disease|0|||
30777542|NCT03549338|58788475|FG000|Overall Study|Clinical Progression|0|||
30777543|NCT03549338|58788476|FG001|Overall Study|Clinical Progression|1|||
30777544|NCT03549338|58788477|FG002|Overall Study|Clinical Progression|0|||
30777545|NCT03629028|58788485|FG000|Overall Study|Lost to Follow-up|26|||
30852616|NCT01355159|58880001|FG000|Overall Study|No primary outcome data|17|||
30955112|NCT00708162|59012631|FG001|Randomized Phase|Lost to Follow-up|34|||
30955113|NCT00708162|59012630|FG000|Randomized Phase|Withdrew Consent|31|||
30777546|NCT03629028|58788486|FG001|Overall Study|Lost to Follow-up|23|||
30955114|NCT00708162|59012631|FG001|Randomized Phase|Withdrew Consent|22|||
30955115|NCT00708162|59012630|FG000|Randomized Phase|Lack of Efficacy|14|||
30955116|NCT00708162|59012631|FG001|Randomized Phase|Lack of Efficacy|19|||
30955117|NCT00708162|59012630|FG000|Randomized Phase|Protocol Violation|10|||
30777547|NCT03629028|58788485|FG000|Overall Study|Pregnancy|4|||
30777548|NCT03629028|58788486|FG001|Overall Study|Pregnancy|2|||
30852617|NCT01355159|58880002|FG001|Overall Study|No primary outcome data|11|||
30852618|NCT01355159|58880001|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
30852619|NCT01355159|58880002|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
30852620|NCT01355159|58880001|FG000|Overall Study|Early intrauterine fetal death|6|||
30852621|NCT01355159|58880002|FG001|Overall Study|Early intrauterine fetal death|6|||
30852622|NCT02630186|58880008|FG000|Overall Study|Withdrawal by Subject|1|||
30852623|NCT01669928|58880014|FG000|First Intervention|Withdrawal by Subject|3|||
30852624|NCT01669928|58880015|FG001|First Intervention|Withdrawal by Subject|5|||
30852625|NCT01355081|58880026|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
30852626|NCT01355081|58880027|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
30852627|NCT01355081|58880028|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
30852628|NCT01355081|58880026|FG000|Overall Study|Major Protocol Deviation|0|||
30852629|NCT01355081|58880027|FG001|Overall Study|Major Protocol Deviation|1|||
30852630|NCT01355081|58880028|FG002|Overall Study|Major Protocol Deviation|0|||
30852631|NCT01355081|58880026|FG000|Overall Study|Lost to Follow-up|0|||
30852632|NCT01355081|58880027|FG001|Overall Study|Lost to Follow-up|0|||
30852633|NCT01355081|58880028|FG002|Overall Study|Lost to Follow-up|1|||
30852634|NCT01355081|58880026|FG000|Overall Study|Withdrawal of Consent|2|||
30852635|NCT01355081|58880027|FG001|Overall Study|Withdrawal of Consent|3|||
30852636|NCT01355081|58880028|FG002|Overall Study|Withdrawal of Consent|3|||
30852637|NCT01355081|58880026|FG000|Overall Study|Lack of Efficacy|2|||
30852638|NCT01355081|58880027|FG001|Overall Study|Lack of Efficacy|1|||
30852639|NCT01355081|58880028|FG002|Overall Study|Lack of Efficacy|1|||
30852640|NCT01355081|58880026|FG000|Overall Study|Non Compliance with Study Medication|0|||
30852641|NCT01355081|58880027|FG001|Overall Study|Non Compliance with Study Medication|1|||
30852642|NCT01355081|58880028|FG002|Overall Study|Non Compliance with Study Medication|0|||
30852643|NCT01354223|58880038|FG000|Overall Study|Withdrawal by Subject|3|||
30852644|NCT01354223|58880039|FG001|Overall Study|Withdrawal by Subject|1|||
30852645|NCT04043455|58880049|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
30852646|NCT04043455|58880050|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
30852647|NCT04043455|58880051|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
30852648|NCT04043455|58880052|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
30852649|NCT04043455|58880053|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
30852650|NCT04043455|58880054|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
30852651|NCT04043455|58880049|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
30852652|NCT04043455|58880050|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
30852653|NCT04043455|58880051|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
30852654|NCT04043455|58880052|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
30852655|NCT04043455|58880053|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
30852656|NCT04043455|58880054|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
30852657|NCT04043455|58880049|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
30852658|NCT04043455|58880050|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
30852659|NCT04043455|58880051|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
30852660|NCT04043455|58880052|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
30852661|NCT04043455|58880053|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
30852662|NCT04043455|58880054|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
30777549|NCT03629028|58788485|FG000|Overall Study|intolerance to examination|2|||
30777550|NCT03629028|58788486|FG001|Overall Study|intolerance to examination|0|||
30777551|NCT03549104|58788504|FG000|Overall Study|Physician Decision|2|||
30777552|NCT03549104|58788505|FG001|Overall Study|Physician Decision|0|||
30777553|NCT03549104|58788504|FG000|Overall Study|Withdrawal by Subject|5|||
30777554|NCT03549104|58788505|FG001|Overall Study|Withdrawal by Subject|2|||
30777555|NCT03549104|58788504|FG000|Overall Study|Covid shelter in place|1|||
30777556|NCT03549104|58788505|FG001|Overall Study|Covid shelter in place|2|||
30777557|NCT02892344|58788513|FG000|Overall Study|Protocol deviation|3|||
30777558|NCT02892344|58788514|FG001|Overall Study|Protocol deviation|4|||
30777559|NCT02892344|58788513|FG000|Overall Study|Adverse Event|1|||
30777560|NCT02892344|58788514|FG001|Overall Study|Adverse Event|8|||
30777561|NCT02892344|58788513|FG000|Overall Study|Lost to Follow-up|0|||
30777562|NCT02892344|58788514|FG001|Overall Study|Lost to Follow-up|1|||
30777563|NCT02892344|58788513|FG000|Overall Study|Non-compliance with study treatment|0|||
30777564|NCT02892344|58788514|FG001|Overall Study|Non-compliance with study treatment|1|||
30777565|NCT02892344|58788513|FG000|Overall Study|Physician Decision|0|||
30777566|NCT02892344|58788514|FG001|Overall Study|Physician Decision|2|||
30777567|NCT02892344|58788513|FG000|Overall Study|Subject/guardian decision|0|||
30777568|NCT02892344|58788514|FG001|Overall Study|Subject/guardian decision|4|||
30777569|NCT02892344|58788513|FG000|Overall Study|Technical problems|0|||
30777570|NCT02892344|58788514|FG001|Overall Study|Technical problems|1|||
30852663|NCT04043455|58880049|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
30852664|NCT04043455|58880050|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
30852665|NCT04043455|58880051|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
30852666|NCT04043455|58880052|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
30852667|NCT04043455|58880053|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
30955118|NCT00708162|59012631|FG001|Randomized Phase|Protocol Violation|11|||
30955119|NCT00708162|59012630|FG000|Randomized Phase|Adverse Event|8|||
30955120|NCT00708162|59012631|FG001|Randomized Phase|Adverse Event|12|||
30955121|NCT00708162|59012630|FG000|Randomized Phase|Investigator's Discretion|7|||
30955122|NCT00708162|59012631|FG001|Randomized Phase|Investigator's Discretion|10|||
30955123|NCT00708162|59012630|FG000|Randomized Phase|Death|2|||
30955124|NCT00708162|59012631|FG001|Randomized Phase|Death|9|||
30955125|NCT00708162|59012630|FG000|Randomized Phase|Pregnancy|3|||
30955126|NCT00708162|59012631|FG001|Randomized Phase|Pregnancy|0|||
30955127|NCT00708162|59012630|FG000|Open-Label Phase|Lost to Follow-up|10|||
30955128|NCT00708162|59012631|FG001|Open-Label Phase|Lost to Follow-up|8|||
30777571|NCT03567980|58788520|FG000|Overall Study|Adverse Event|1|||
30777572|NCT02894840|58788528|FG000|Overall Study|Lost to Follow-up|1|||
30777573|NCT02894840|58788529|FG001|Overall Study|Lost to Follow-up|0|||
30777574|NCT02894840|58788530|FG002|Overall Study|Lost to Follow-up|3|||
30777575|NCT02894840|58788531|FG003|Overall Study|Lost to Follow-up|0|||
30955129|NCT00708162|59012630|FG000|Open-Label Phase|Withdrew Consent|12|||
30955130|NCT00708162|59012631|FG001|Open-Label Phase|Withdrew Consent|6|||
30955131|NCT00708162|59012630|FG000|Open-Label Phase|Participant Noncompliance|7|||
30955132|NCT00708162|59012631|FG001|Open-Label Phase|Participant Noncompliance|7|||
30955133|NCT00708162|59012630|FG000|Open-Label Phase|Lack of Efficacy|7|||
30955134|NCT00708162|59012631|FG001|Open-Label Phase|Lack of Efficacy|4|||
30955135|NCT00708162|59012630|FG000|Open-Label Phase|Investigator's Discretion|3|||
30955136|NCT00708162|59012631|FG001|Open-Label Phase|Investigator's Discretion|2|||
30955137|NCT00708162|59012630|FG000|Open-Label Phase|Death|3|||
30852668|NCT04043455|58880054|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
30852669|NCT04043455|58880049|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
30852670|NCT04043455|58880050|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
30852671|NCT04043455|58880051|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
30955138|NCT00708162|59012631|FG001|Open-Label Phase|Death|1|||
30955139|NCT00708162|59012630|FG000|Open-Label Phase|Adverse Event|1|||
30955140|NCT00708162|59012631|FG001|Open-Label Phase|Adverse Event|2|||
30955141|NCT00708162|59012630|FG000|Open-Label Phase|Other|1|||
30955142|NCT00708162|59012631|FG001|Open-Label Phase|Other|0|||
30955143|NCT02245672|59012716|FG000|Overall Study|Adverse Event|4|||
30955144|NCT02245672|59012717|FG001|Overall Study|Adverse Event|4|||
30955145|NCT02245672|59012718|FG002|Overall Study|Adverse Event|4|||
30955146|NCT02245672|59012716|FG000|Overall Study|Lost to Follow-up|3|||
30955147|NCT02245672|59012717|FG001|Overall Study|Lost to Follow-up|5|||
30955148|NCT02245672|59012718|FG002|Overall Study|Lost to Follow-up|1|||
30955149|NCT02245672|59012716|FG000|Overall Study|Withdrawal by Subject|6|||
30955150|NCT02245672|59012717|FG001|Overall Study|Withdrawal by Subject|3|||
30955151|NCT02245672|59012718|FG002|Overall Study|Withdrawal by Subject|0|||
30955152|NCT02245672|59012716|FG000|Overall Study|Randomized in error (not treated)|0|||
30955153|NCT02245672|59012717|FG001|Overall Study|Randomized in error (not treated)|1|||
30955154|NCT02245672|59012718|FG002|Overall Study|Randomized in error (not treated)|0|||
30955155|NCT00706992|59012863|FG000|Overall Study|Study termination|5|||
30852672|NCT04043455|58880052|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
30852673|NCT04043455|58880053|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
30852674|NCT04043455|58880054|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
30852675|NCT04043455|58880049|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
30852676|NCT04043455|58880050|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
30852677|NCT04043455|58880051|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
30852678|NCT04043455|58880052|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
30955156|NCT00706992|59012864|FG001|Overall Study|Study termination|5|||
30955157|NCT00706992|59012865|FG002|Overall Study|Study termination|6|||
30955158|NCT00706992|59012866|FG003|Overall Study|Study termination|2|||
30955159|NCT00706992|59012867|FG004|Overall Study|Study termination|3|||
30955160|NCT00706992|59012868|FG005|Overall Study|Study termination|2|||
30955161|NCT00706992|59012869|FG006|Overall Study|Study termination|3|||
30955162|NCT00706992|59012863|FG000|Overall Study|Disease progression before treatment|0|||
30955163|NCT00706992|59012864|FG001|Overall Study|Disease progression before treatment|0|||
30955164|NCT00706992|59012865|FG002|Overall Study|Disease progression before treatment|0|||
30955165|NCT00706992|59012866|FG003|Overall Study|Disease progression before treatment|0|||
30777576|NCT03358030|58788550|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
30777577|NCT03358030|58788551|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
30777578|NCT03358030|58788552|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
30955166|NCT00706992|59012867|FG004|Overall Study|Disease progression before treatment|1|||
30955167|NCT00706992|59012868|FG005|Overall Study|Disease progression before treatment|0|||
30955168|NCT00706992|59012869|FG006|Overall Study|Disease progression before treatment|0|||
30955169|NCT01785875|59012922|FG000|Overall Study|Withdrawal by Subject|41|||
30955170|NCT01785875|59012923|FG001|Overall Study|Withdrawal by Subject|34|||
30955171|NCT01785875|59012924|FG002|Overall Study|Withdrawal by Subject|36|||
30955172|NCT01785875|59012922|FG000|Overall Study|Lost to Follow-up|19|||
30955173|NCT01785875|59012923|FG001|Overall Study|Lost to Follow-up|22|||
30955174|NCT01785875|59012924|FG002|Overall Study|Lost to Follow-up|6|||
30955175|NCT01785875|59012922|FG000|Overall Study|Death|27|||
30955176|NCT01785875|59012923|FG001|Overall Study|Death|16|||
30955177|NCT01785875|59012924|FG002|Overall Study|Death|7|||
30955178|NCT01785875|59012922|FG000|Overall Study|Sponsor Decision|0|||
30955179|NCT01785875|59012923|FG001|Overall Study|Sponsor Decision|2|||
30955180|NCT01785875|59012924|FG002|Overall Study|Sponsor Decision|0|||
30955181|NCT01785875|59012922|FG000|Overall Study|Protocol Specified Criteria|207|||
30955182|NCT01785875|59012923|FG001|Overall Study|Protocol Specified Criteria|214|||
30955183|NCT01785875|59012924|FG002|Overall Study|Protocol Specified Criteria|55|||
30955184|NCT01785875|59012922|FG000|Overall Study|Missing|0|||
30955185|NCT01785875|59012923|FG001|Overall Study|Missing|1|||
30955186|NCT01785875|59012924|FG002|Overall Study|Missing|3|||
30955187|NCT00706914|59012977|FG000|Overall Study|Lack of Efficacy|0|||
30955188|NCT00706914|59012978|FG001|Overall Study|Lack of Efficacy|1|||
30955189|NCT00706914|59012979|FG002|Overall Study|Lack of Efficacy|0|||
30955190|NCT00706914|59012977|FG000|Overall Study|Lost to Follow-up|1|||
30955191|NCT00706914|59012978|FG001|Overall Study|Lost to Follow-up|0|||
30955192|NCT00706914|59012979|FG002|Overall Study|Lost to Follow-up|0|||
30955193|NCT00706914|59012977|FG000|Overall Study|Adverse Event|2|||
30955194|NCT00706914|59012978|FG001|Overall Study|Adverse Event|2|||
30955195|NCT00706914|59012979|FG002|Overall Study|Adverse Event|0|||
30955196|NCT00706914|59012977|FG000|Overall Study|Protocol Violation|3|||
30955197|NCT00706914|59012978|FG001|Overall Study|Protocol Violation|1|||
30955198|NCT00706914|59012979|FG002|Overall Study|Protocol Violation|1|||
30955199|NCT01808651|59013086|FG000|Study Period 1|Lost to Follow-up|1|||
30955200|NCT01808651|59013087|FG001|Study Period 1|Lost to Follow-up|3|||
30955201|NCT01808651|59013088|FG002|Study Period 1|Lost to Follow-up|0|||
30955202|NCT01808651|59013086|FG000|Study Period 1|Protocol Violation|1|||
30955203|NCT01808651|59013087|FG001|Study Period 1|Protocol Violation|0|||
30955204|NCT01808651|59013088|FG002|Study Period 1|Protocol Violation|1|||
30955205|NCT01808651|59013086|FG000|Study Period 1|Physician Decision|3|||
30955206|NCT01808651|59013087|FG001|Study Period 1|Physician Decision|2|||
30955207|NCT01808651|59013088|FG002|Study Period 1|Physician Decision|0|||
30955208|NCT01808651|59013086|FG000|Study Period 1|Lack of Efficacy|2|||
30955209|NCT01808651|59013087|FG001|Study Period 1|Lack of Efficacy|1|||
30955210|NCT01808651|59013088|FG002|Study Period 1|Lack of Efficacy|0|||
30955211|NCT01808651|59013086|FG000|Study Period 1|Adverse Event|10|||
30955212|NCT01808651|59013087|FG001|Study Period 1|Adverse Event|4|||
30955213|NCT01808651|59013088|FG002|Study Period 1|Adverse Event|1|||
30955214|NCT01808651|59013086|FG000|Study Period 1|Participant Decision|9|||
30955215|NCT01808651|59013087|FG001|Study Period 1|Participant Decision|7|||
30955216|NCT01808651|59013088|FG002|Study Period 1|Participant Decision|3|||
30955217|NCT00706134|59013153|FG000|Overall Study|Adverse Event|8|||
30955218|NCT00706134|59013154|FG001|Overall Study|Adverse Event|7|||
30955219|NCT00706134|59013155|FG002|Overall Study|Adverse Event|2|||
30955220|NCT00706134|59013156|FG003|Overall Study|Adverse Event|3|||
30955221|NCT00706134|59013153|FG000|Overall Study|Lost to Follow-up|0|||
30955222|NCT00706134|59013154|FG001|Overall Study|Lost to Follow-up|1|||
30955223|NCT00706134|59013155|FG002|Overall Study|Lost to Follow-up|0|||
30955224|NCT00706134|59013156|FG003|Overall Study|Lost to Follow-up|0|||
30955225|NCT00706134|59013153|FG000|Overall Study|Protocol Violation|0|||
30955226|NCT00706134|59013154|FG001|Overall Study|Protocol Violation|6|||
30955227|NCT00706134|59013155|FG002|Overall Study|Protocol Violation|0|||
30955228|NCT00706134|59013156|FG003|Overall Study|Protocol Violation|3|||
30955229|NCT00706134|59013153|FG000|Overall Study|Withdrawal by Subject|1|||
30955230|NCT00706134|59013154|FG001|Overall Study|Withdrawal by Subject|2|||
30955231|NCT00706134|59013155|FG002|Overall Study|Withdrawal by Subject|1|||
30955232|NCT00706134|59013156|FG003|Overall Study|Withdrawal by Subject|0|||
30955233|NCT00706134|59013153|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
30955234|NCT00706134|59013154|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
30955235|NCT00706134|59013155|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
30955236|NCT00706134|59013156|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
30955237|NCT00706134|59013153|FG000|Overall Study|Did not meet study criteria|2|||
30955238|NCT00706134|59013154|FG001|Overall Study|Did not meet study criteria|0|||
30955239|NCT00706134|59013155|FG002|Overall Study|Did not meet study criteria|0|||
30955240|NCT00706134|59013156|FG003|Overall Study|Did not meet study criteria|0|||
30955241|NCT01808573|59013168|FG000|Overall Study|Death|212|||
30955242|NCT01808573|59013169|FG001|Overall Study|Death|240|||
30955243|NCT01808573|59013168|FG000|Overall Study|Withdrawal by Subject|12|||
30955244|NCT01808573|59013169|FG001|Overall Study|Withdrawal by Subject|10|||
30955245|NCT01808573|59013168|FG000|Overall Study|Lost to Follow-up|3|||
30955246|NCT01808573|59013169|FG001|Overall Study|Lost to Follow-up|0|||
30955247|NCT01808573|59013168|FG000|Overall Study|Discontinuation of study by sponsor|79|||
30955248|NCT01808573|59013169|FG001|Overall Study|Discontinuation of study by sponsor|64|||
30955249|NCT01808573|59013168|FG000|Overall Study|Randomized in Error|1|||
30955250|NCT01808573|59013169|FG001|Overall Study|Randomized in Error|0|||
30955251|NCT02246530|59013196|FG000|Overall Study|Lost to Follow-up|4|||
30955252|NCT02246530|59013197|FG001|Overall Study|Lost to Follow-up|0|||
30955253|NCT01808339|59013203|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
30955254|NCT01808339|59013204|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
30955255|NCT01808339|59013205|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
30955256|NCT01808339|59013206|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
30955257|NCT01808339|59013207|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
30955258|NCT01808339|59013208|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
30955259|NCT01808339|59013203|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30955260|NCT01808339|59013204|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
30955261|NCT01808339|59013205|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30955262|NCT01808339|59013206|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
30955263|NCT01808339|59013207|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30955264|NCT01808339|59013208|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30955265|NCT01808339|59013203|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
30955266|NCT01808339|59013204|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
30955267|NCT01808339|59013205|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
30955268|NCT01808339|59013206|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
30955269|NCT01808339|59013207|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
30955270|NCT01808339|59013208|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
30955271|NCT02727660|59013258|FG000|Overall Study|Lack of Efficacy|40|||
30955272|NCT02727660|59013259|FG001|Overall Study|Lack of Efficacy|40|||
30955273|NCT02727660|59013260|FG002|Overall Study|Lack of Efficacy|70|||
30955274|NCT02727660|59013258|FG000|Overall Study|Adverse Event|28|||
30955275|NCT02727660|59013259|FG001|Overall Study|Adverse Event|21|||
30955276|NCT02727660|59013260|FG002|Overall Study|Adverse Event|32|||
30955277|NCT02727660|59013258|FG000|Overall Study|Withdrawal by Subject|26|||
30955278|NCT02727660|59013259|FG001|Overall Study|Withdrawal by Subject|25|||
30955279|NCT02727660|59013260|FG002|Overall Study|Withdrawal by Subject|30|||
30955280|NCT02727660|59013258|FG000|Overall Study|Physician Decision|3|||
30955281|NCT02727660|59013259|FG001|Overall Study|Physician Decision|8|||
30955282|NCT02727660|59013260|FG002|Overall Study|Physician Decision|14|||
30955283|NCT02727660|59013258|FG000|Overall Study|Lost to Follow-up|5|||
30955284|NCT02727660|59013259|FG001|Overall Study|Lost to Follow-up|9|||
30955285|NCT02727660|59013260|FG002|Overall Study|Lost to Follow-up|8|||
30955286|NCT02727660|59013258|FG000|Overall Study|Protocol Violation|7|||
30955287|NCT02727660|59013259|FG001|Overall Study|Protocol Violation|5|||
30955288|NCT02727660|59013260|FG002|Overall Study|Protocol Violation|5|||
30955289|NCT02727660|59013258|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
30955290|NCT02727660|59013259|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
30662630|NCT00561925|58676226|FG000|14 Day Lead-In Period|Other|5|||
30662631|NCT00561925|58676227|FG001|14 Day Lead-In Period|Other|0|||
30662632|NCT00561925|58676228|FG002|14 Day Lead-In Period|Other|0|||
30955291|NCT02727660|59013260|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
30955292|NCT02727660|59013258|FG000|Overall Study|Administrative Reasons|2|||
30955293|NCT02727660|59013259|FG001|Overall Study|Administrative Reasons|3|||
30662633|NCT00561925|58676229|FG003|14 Day Lead-In Period|Other|0|||
30955294|NCT02727660|59013260|FG002|Overall Study|Administrative Reasons|4|||
30955295|NCT01784861|59013274|FG000|Overall Study|Adverse Event|0|||
30955296|NCT01784861|59013275|FG001|Overall Study|Adverse Event|0|||
30955297|NCT01784861|59013276|FG002|Overall Study|Adverse Event|1|||
30955298|NCT01784861|59013277|FG003|Overall Study|Adverse Event|2|||
30955299|NCT01784861|59013278|FG004|Overall Study|Adverse Event|1|||
30955300|NCT01784861|59013279|FG005|Overall Study|Adverse Event|0|||
30955301|NCT01784861|59013274|FG000|Overall Study|Withdrawal by Subject|0|||
30955302|NCT01784861|59013275|FG001|Overall Study|Withdrawal by Subject|0|||
30955303|NCT01784861|59013276|FG002|Overall Study|Withdrawal by Subject|0|||
30955304|NCT01784861|59013277|FG003|Overall Study|Withdrawal by Subject|1|||
30955305|NCT01784861|59013278|FG004|Overall Study|Withdrawal by Subject|0|||
30955306|NCT01784861|59013279|FG005|Overall Study|Withdrawal by Subject|0|||
30955307|NCT01784861|59013274|FG000|Overall Study|Physician Decision|0|||
30955308|NCT01784861|59013275|FG001|Overall Study|Physician Decision|0|||
30955309|NCT01784861|59013276|FG002|Overall Study|Physician Decision|0|||
30955310|NCT01784861|59013277|FG003|Overall Study|Physician Decision|2|||
30955311|NCT01784861|59013278|FG004|Overall Study|Physician Decision|0|||
30955312|NCT01784861|59013279|FG005|Overall Study|Physician Decision|1|||
30955313|NCT02727192|59013353|FG000|Overall Study|Lost to Follow-up|1|||
30955314|NCT02727192|59013354|FG001|Overall Study|Lost to Follow-up|0|||
30955315|NCT02727192|59013355|FG002|Overall Study|Lost to Follow-up|0|||
30955316|NCT00705666|59013375|FG000|Overall Study|No post-treatment questionnaire|279|||
30955317|NCT00705666|59013375|FG000|Overall Study|Withdrawal by Subject|21|||
30955318|NCT00705666|59013375|FG000|Overall Study|Physician Decision|7|||
30955319|NCT00705666|59013375|FG000|Overall Study|Lost to Follow-up|5|||
30955320|NCT00705666|59013375|FG000|Overall Study|Death|1|||
30955321|NCT00705666|59013375|FG000|Overall Study|Adverse Event|4|||
30955322|NCT00705666|59013375|FG000|Overall Study|Other|12|||
30955323|NCT00705666|59013375|FG000|Overall Study|Other|2|||
30955324|NCT00705666|59013375|FG000|Overall Study|Lack of data|3|||
30955325|NCT00705666|59013375|FG000|Overall Study|Untreated|5|||
30955326|NCT02725866|59013534|FG000|Overall Study|Failure to return|6|||
30955327|NCT02725866|59013534|FG000|Overall Study|Withdrew consent|3|||
30955328|NCT02725866|59013534|FG000|Overall Study|Insufficient virological response|1|||
30955329|NCT02725866|59013534|FG000|Overall Study|Other, not specified|4|||
30955330|NCT02726022|59013570|FG000|Overall Study|Adverse Event|14|||
30955331|NCT02726022|59013570|FG000|Overall Study|Treatment Failure|8|||
30955332|NCT02726022|59013570|FG000|Overall Study|Poor Compliance|13|||
30955333|NCT02726022|59013570|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
30955334|NCT02725788|59013585|FG000|Overall Study|Lost to Follow-up|1|||
30955335|NCT02725788|59013586|FG001|Overall Study|Lost to Follow-up|1|||
30852679|NCT04043455|58880053|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
30852680|NCT04043455|58880054|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
30852681|NCT04043455|58880049|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
30852682|NCT04043455|58880050|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
30852683|NCT04043455|58880051|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
30852684|NCT04043455|58880052|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
30852685|NCT04043455|58880053|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
30852686|NCT04043455|58880054|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
30852687|NCT04043455|58880049|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
30852688|NCT04043455|58880050|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
30852689|NCT04043455|58880051|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
30852690|NCT04043455|58880052|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
30852691|NCT04043455|58880053|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
30852692|NCT04043455|58880054|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
30852693|NCT04043455|58880049|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
30955336|NCT02725788|59013585|FG000|Overall Study|Protocol Violation|0|||
30955337|NCT02725788|59013586|FG001|Overall Study|Protocol Violation|1|||
30955338|NCT02725710|59013725|FG000|Overall Study|Lost to Follow-up|1|||
30955339|NCT02725710|59013726|FG001|Overall Study|Lost to Follow-up|0|||
30955340|NCT02724462|59013757|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
30662634|NCT00561925|58676230|FG004|14 Day Lead-In Period|Other|0|||
30955341|NCT02724462|59013758|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
30955342|NCT02724462|59013757|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
30955343|NCT02724462|59013758|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
30955344|NCT02724462|59013757|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
30955345|NCT02724462|59013758|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
30662635|NCT00561925|58676226|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
30955346|NCT02724462|59013757|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
30955347|NCT02724462|59013758|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
30955348|NCT02724462|59013757|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
30852694|NCT04043455|58880050|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
30852695|NCT04043455|58880051|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
30852696|NCT04043455|58880052|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
30852697|NCT04043455|58880053|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
30852698|NCT04043455|58880054|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
30852699|NCT04043455|58880049|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
30852700|NCT04043455|58880050|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
30852701|NCT04043455|58880051|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
30852702|NCT04043455|58880052|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
30852703|NCT04043455|58880053|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
30852704|NCT04043455|58880054|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
30852705|NCT04043455|58880049|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
30852706|NCT04043455|58880050|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
30852707|NCT04043455|58880051|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
30852708|NCT04043455|58880052|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
30662636|NCT00561925|58676227|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
30852709|NCT04043455|58880053|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
30852710|NCT04043455|58880054|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
30852711|NCT02627144|58880072|FG000|Overall Study|Serious adverse event|32|||
30852712|NCT02627144|58880072|FG000|Overall Study|Cancer progression|171|||
30852713|NCT02627144|58880072|FG000|Overall Study|Death from cancer|20|||
30852714|NCT02627144|58880072|FG000|Overall Study|Death from other cause|8|||
30852715|NCT02627144|58880072|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
30852716|NCT02627144|58880072|FG000|Overall Study|Administrative reasons|65|||
30852717|NCT02627144|58880072|FG000|Overall Study|Lost to Follow-up|8|||
30852718|NCT02627144|58880072|FG000|Overall Study|Enrolled, not treated|6|||
30852719|NCT02627144|58880072|FG000|Overall Study|Other|17|||
30852720|NCT02626520|58880078|FG000|Overall Study|Physician Decision|1|||
30852721|NCT02626520|58880079|FG001|Overall Study|Physician Decision|1|||
30852722|NCT02626520|58880078|FG000|Overall Study|Adverse Event|0|||
30852723|NCT02626520|58880079|FG001|Overall Study|Adverse Event|4|||
30852724|NCT02626520|58880078|FG000|Overall Study|Lack of Efficacy|0|||
30852725|NCT02626520|58880079|FG001|Overall Study|Lack of Efficacy|2|||
30852726|NCT02626520|58880078|FG000|Overall Study|Did not start protocol therapy|0|||
30852727|NCT02626520|58880079|FG001|Overall Study|Did not start protocol therapy|2|||
30852728|NCT02626520|58880078|FG000|Overall Study|Study terminated|0|||
30852729|NCT02626520|58880079|FG001|Overall Study|Study terminated|1|||
30852730|NCT04522141|58880087|FG000|Overall Study|Withdrawal by Subject|1|||
30955349|NCT02724462|59013758|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
30955350|NCT02724462|59013757|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
30955351|NCT02724462|59013758|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
30955352|NCT02725476|59013815|FG000|Overall Study|Physician Decision|2|||
30955353|NCT02725476|59013816|FG001|Overall Study|Physician Decision|0|||
30955354|NCT02725476|59013815|FG000|Overall Study|Adverse Event|1|||
30955355|NCT02725476|59013816|FG001|Overall Study|Adverse Event|1|||
30955356|NCT02725008|59013921|FG000|Overall Study|Lost to Follow-up|7|||
30955357|NCT02725008|59013922|FG001|Overall Study|Lost to Follow-up|9|||
30955358|NCT02725008|59013921|FG000|Overall Study|Withdrawal by Subject|2|||
30955359|NCT02725008|59013922|FG001|Overall Study|Withdrawal by Subject|2|||
30955360|NCT02725008|59013921|FG000|Overall Study|Admitted to hospital|0|||
30955361|NCT02725008|59013922|FG001|Overall Study|Admitted to hospital|1|||
30955362|NCT01807949|59014194|FG000|Overall Study|Adverse Event|1|||
30955363|NCT01807949|59014195|FG001|Overall Study|Adverse Event|2|||
30955364|NCT01807949|59014196|FG002|Overall Study|Adverse Event|2|||
30955365|NCT01807949|59014194|FG000|Overall Study|Withdrawal by Subject|1|||
30955366|NCT01807949|59014195|FG001|Overall Study|Withdrawal by Subject|2|||
30955367|NCT01807949|59014196|FG002|Overall Study|Withdrawal by Subject|2|||
30955368|NCT01807949|59014194|FG000|Overall Study|Non-Compliance|0|||
30955369|NCT01807949|59014195|FG001|Overall Study|Non-Compliance|0|||
30852731|NCT04522141|58880088|FG001|Overall Study|Withdrawal by Subject|0|||
30852732|NCT01329029|58880111|FG000|Overall Study|Withdrawal by Subject|117|||
30852733|NCT01329029|58880112|FG001|Overall Study|Withdrawal by Subject|87|||
30852734|NCT01329029|58880111|FG000|Overall Study|Adverse Event|82|||
30852735|NCT01329029|58880112|FG001|Overall Study|Adverse Event|29|||
30852736|NCT01329029|58880111|FG000|Overall Study|Death|16|||
30852737|NCT01329029|58880112|FG001|Overall Study|Death|19|||
30852738|NCT01329029|58880111|FG000|Overall Study|Other|14|||
30955370|NCT01807949|59014196|FG002|Overall Study|Non-Compliance|1|||
30955371|NCT01807949|59014194|FG000|Overall Study|Undefined|0|||
30955372|NCT01807949|59014195|FG001|Overall Study|Undefined|1|||
30955373|NCT01807949|59014196|FG002|Overall Study|Undefined|2|||
30955374|NCT01807949|59014194|FG000|Overall Study|Randomized But Not Treated|0|||
30955375|NCT01807949|59014195|FG001|Overall Study|Randomized But Not Treated|2|||
30955376|NCT01807949|59014196|FG002|Overall Study|Randomized But Not Treated|2|||
30955377|NCT01806779|59014208|FG000|Overall Study|Physician Decision|2|||
30955378|NCT01806779|59014209|FG001|Overall Study|Physician Decision|0|||
30852739|NCT01329029|58880112|FG001|Overall Study|Other|20|||
30852740|NCT01329029|58880111|FG000|Overall Study|COPD Exacerbation|11|||
30955379|NCT01806779|59014210|FG002|Overall Study|Physician Decision|1|||
30955380|NCT01806779|59014208|FG000|Overall Study|Lack of Efficacy|1|||
30955381|NCT01806779|59014209|FG001|Overall Study|Lack of Efficacy|1|||
30955382|NCT01806779|59014210|FG002|Overall Study|Lack of Efficacy|0|||
30955383|NCT01806779|59014208|FG000|Overall Study|Lost to Follow-up|19|||
30955384|NCT01806779|59014209|FG001|Overall Study|Lost to Follow-up|20|||
30955385|NCT01806779|59014210|FG002|Overall Study|Lost to Follow-up|0|||
30852741|NCT01329029|58880112|FG001|Overall Study|COPD Exacerbation|18|||
30852742|NCT01329029|58880111|FG000|Overall Study|Physician Decision|16|||
30777579|NCT03358030|58788553|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
30777580|NCT03358030|58788550|FG000|Overall Study|Ineligibility|0|||
30777581|NCT03358030|58788551|FG001|Overall Study|Ineligibility|0|||
30777582|NCT03358030|58788552|FG002|Overall Study|Ineligibility|0|||
30777583|NCT03358030|58788553|FG003|Overall Study|Ineligibility|2|||
30777584|NCT03358030|58788550|FG000|Overall Study|Voluntary Withdrawal|1|||
30852743|NCT01329029|58880112|FG001|Overall Study|Physician Decision|13|||
30852744|NCT01329029|58880111|FG000|Overall Study|Lost to Follow-up|8|||
30852745|NCT01329029|58880112|FG001|Overall Study|Lost to Follow-up|5|||
30852746|NCT01329029|58880111|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
30852747|NCT01329029|58880112|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
30777585|NCT03358030|58788551|FG001|Overall Study|Voluntary Withdrawal|1|||
30777586|NCT03358030|58788552|FG002|Overall Study|Voluntary Withdrawal|3|||
30777587|NCT03358030|58788553|FG003|Overall Study|Voluntary Withdrawal|1|||
30777588|NCT03358030|58788550|FG000|Overall Study|Other|0|||
30852748|NCT01372085|58880128|FG000|Washout Period 2|Physician Decision|0|||
30955386|NCT01806779|59014208|FG000|Overall Study|Withdrawal by Subject|20|||
30955387|NCT01806779|59014209|FG001|Overall Study|Withdrawal by Subject|23|||
30955388|NCT01806779|59014210|FG002|Overall Study|Withdrawal by Subject|22|||
30955389|NCT01607957|59014284|FG000|Overall Study|Not treated|1|||
30955390|NCT01607957|59014285|FG001|Overall Study|Not treated|1|||
30955391|NCT01607957|59014284|FG000|Overall Study|Death|367|||
30955392|NCT01607957|59014285|FG001|Overall Study|Death|211|||
30955393|NCT01607957|59014284|FG000|Overall Study|Lost to Follow-up|3|||
30955394|NCT01607957|59014285|FG001|Overall Study|Lost to Follow-up|3|||
30955395|NCT01607957|59014284|FG000|Overall Study|Participant refusal|1|||
30955396|NCT01607957|59014285|FG001|Overall Study|Participant refusal|0|||
30955397|NCT01806623|59014305|FG000|Overall Study|Withdrawal by Subject|1|||
30955398|NCT01806623|59014305|FG000|Overall Study|Adverse Event|1|||
30955399|NCT01806623|59014305|FG000|Overall Study|Did not meet the inclusion criteria|56|||
30955400|NCT01806545|59014311|FG000|Overall Study|Adverse Event|2|||
30955401|NCT01806545|59014312|FG001|Overall Study|Adverse Event|3|||
30955402|NCT01806545|59014311|FG000|Overall Study|Lost to Follow-up|1|||
30955403|NCT01806545|59014312|FG001|Overall Study|Lost to Follow-up|0|||
30955404|NCT01806545|59014311|FG000|Overall Study|Withdrawal by Subject|3|||
30955405|NCT01806545|59014312|FG001|Overall Study|Withdrawal by Subject|2|||
30955406|NCT01806389|59014318|FG000|Overall Study|Withdrawal by Subject|4|||
30955407|NCT01782131|59014574|FG000|Overall Study|Death|93|||
30955408|NCT01782131|59014575|FG001|Overall Study|Death|96|||
30955409|NCT01782131|59014574|FG000|Overall Study|Lost to Follow-up|1|||
30955410|NCT01782131|59014575|FG001|Overall Study|Lost to Follow-up|3|||
30955411|NCT01782131|59014574|FG000|Overall Study|Withdrawal by Subject|10|||
30955412|NCT01782131|59014575|FG001|Overall Study|Withdrawal by Subject|10|||
30955413|NCT01782131|59014574|FG000|Overall Study|Randomized but not treated|5|||
30955414|NCT01782131|59014575|FG001|Overall Study|Randomized but not treated|5|||
30955415|NCT01782131|59014574|FG000|Overall Study|Reason not provided|0|||
30955416|NCT01782131|59014575|FG001|Overall Study|Reason not provided|1|||
30955417|NCT01781975|59014596|FG000|Overall Study|Death|1|||
30955418|NCT01781975|59014597|FG001|Overall Study|Death|0|||
30955419|NCT01781975|59014596|FG000|Overall Study|Withdrawal by Subject|1|||
30955420|NCT01781975|59014597|FG001|Overall Study|Withdrawal by Subject|1|||
30955421|NCT01804673|59014618|FG000|Overall Study|Adverse Event|4|||
30777589|NCT03358030|58788551|FG001|Overall Study|Other|0|||
30955422|NCT01804673|59014618|FG000|Overall Study|Withdrawal by Subject|1|||
30955423|NCT01804673|59014618|FG000|Overall Study|Lack of Efficacy|9|||
30955424|NCT01804673|59014618|FG000|Overall Study|Change to Oral Therapy|37|||
30955425|NCT01804673|59014618|FG000|Overall Study|No Further Therapy Required|84|||
30955426|NCT01804673|59014618|FG000|Overall Study|Use of Prohibited Medication|1|||
30955427|NCT01804673|59014618|FG000|Overall Study|Other|4|||
30955428|NCT01774097|59014628|FG000|Overall Study|Withdrawal by Subject|1|||
30955429|NCT01774097|59014629|FG001|Overall Study|Withdrawal by Subject|1|||
30955430|NCT01774097|59014628|FG000|Overall Study|Adverse Event|1|||
30955431|NCT01774097|59014629|FG001|Overall Study|Adverse Event|1|||
30777590|NCT03358030|58788552|FG002|Overall Study|Other|1|||
30777591|NCT03358030|58788553|FG003|Overall Study|Other|0|||
30777592|NCT03566810|58788567|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
30777593|NCT03566810|58788568|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
30777594|NCT03566810|58788569|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
30852749|NCT01372085|58880129|FG001|Washout Period 2|Physician Decision|0|||
30852750|NCT01372085|58880130|FG002|Washout Period 2|Physician Decision|0|||
30852751|NCT01372085|58880131|FG003|Washout Period 2|Physician Decision|0|||
30852752|NCT01372085|58880132|FG004|Washout Period 2|Physician Decision|1|||
30852753|NCT01372085|58880133|FG005|Washout Period 2|Physician Decision|0|||
30852754|NCT01372085|58880134|FG006|Washout Period 2|Physician Decision|0|||
30852755|NCT01372085|58880135|FG007|Washout Period 2|Physician Decision|0|||
30852756|NCT01372085|58880136|FG008|Washout Period 2|Physician Decision|0|||
30852757|NCT01372085|58880137|FG009|Washout Period 2|Physician Decision|0|||
30852758|NCT01372085|58880128|FG000|Washout Period 3|Withdrawal by Subject|0|||
30852759|NCT01372085|58880129|FG001|Washout Period 3|Withdrawal by Subject|0|||
30852760|NCT01372085|58880130|FG002|Washout Period 3|Withdrawal by Subject|0|||
30852761|NCT01372085|58880131|FG003|Washout Period 3|Withdrawal by Subject|0|||
30852762|NCT01372085|58880132|FG004|Washout Period 3|Withdrawal by Subject|0|||
30852763|NCT01372085|58880133|FG005|Washout Period 3|Withdrawal by Subject|2|||
30852764|NCT01372085|58880134|FG006|Washout Period 3|Withdrawal by Subject|0|||
30852765|NCT01372085|58880135|FG007|Washout Period 3|Withdrawal by Subject|0|||
30852766|NCT01372085|58880136|FG008|Washout Period 3|Withdrawal by Subject|0|||
30852767|NCT01372085|58880137|FG009|Washout Period 3|Withdrawal by Subject|0|||
30852768|NCT04012853|58880163|FG000|Overall Study|Withdrawal by Subject|1|||
30852769|NCT04012853|58880164|FG001|Overall Study|Withdrawal by Subject|1|||
30852770|NCT04012853|58880163|FG000|Overall Study|Protocol Violation|1|||
30852771|NCT04012853|58880164|FG001|Overall Study|Protocol Violation|0|||
30852772|NCT04012853|58880163|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
30852773|NCT04012853|58880164|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
30852774|NCT02941549|58880173|FG000|Overall Study|Adverse Event|1|||
30852775|NCT02941549|58880174|FG001|Overall Study|Adverse Event|0|||
30852776|NCT02941549|58880175|FG002|Overall Study|Adverse Event|0|||
30852777|NCT02941549|58880173|FG000|Overall Study|Withdrawal by Subject|2|||
30852778|NCT02941549|58880174|FG001|Overall Study|Withdrawal by Subject|1|||
30852779|NCT02941549|58880175|FG002|Overall Study|Withdrawal by Subject|2|||
30852780|NCT02394028|58880197|FG000|Induction Phase|Adverse Event|2|||
30852781|NCT02394028|58880198|FG001|Induction Phase|Adverse Event|4|||
30852782|NCT02394028|58880199|FG002|Induction Phase|Adverse Event|1|||
30852783|NCT02394028|58880200|FG003|Induction Phase|Adverse Event|2|||
30852784|NCT02394028|58880201|FG004|Induction Phase|Adverse Event|5|||
30852785|NCT02394028|58880202|FG005|Induction Phase|Adverse Event|2|||
30852786|NCT02394028|58880203|FG006|Induction Phase|Adverse Event|0|||
30852787|NCT02394028|58880204|FG007|Induction Phase|Adverse Event|0|||
30852788|NCT02394028|58880205|FG008|Induction Phase|Adverse Event|0|||
30852789|NCT02394028|58880206|FG009|Induction Phase|Adverse Event|0|||
30852790|NCT02394028|58880207|FG010|Induction Phase|Adverse Event|0|||
30852791|NCT02394028|58880197|FG000|Induction Phase|Lack of Efficacy|3|||
30852792|NCT02394028|58880198|FG001|Induction Phase|Lack of Efficacy|6|||
30852793|NCT02394028|58880199|FG002|Induction Phase|Lack of Efficacy|2|||
30852794|NCT02394028|58880200|FG003|Induction Phase|Lack of Efficacy|17|||
30852795|NCT02394028|58880201|FG004|Induction Phase|Lack of Efficacy|14|||
30852796|NCT02394028|58880202|FG005|Induction Phase|Lack of Efficacy|8|||
30852797|NCT02394028|58880203|FG006|Induction Phase|Lack of Efficacy|17|||
30777595|NCT03566810|58788570|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
30777596|NCT03628716|58788593|FG000|Overall Study|Adverse Event|1|||
30852798|NCT02394028|58880204|FG007|Induction Phase|Lack of Efficacy|23|||
30852799|NCT02394028|58880205|FG008|Induction Phase|Lack of Efficacy|0|||
30777597|NCT03628716|58788594|FG001|Overall Study|Adverse Event|1|||
30852800|NCT02394028|58880206|FG009|Induction Phase|Lack of Efficacy|0|||
30852801|NCT02394028|58880207|FG010|Induction Phase|Lack of Efficacy|0|||
30852802|NCT02394028|58880197|FG000|Induction Phase|Lost to Follow-up|1|||
30852803|NCT02394028|58880198|FG001|Induction Phase|Lost to Follow-up|0|||
30852804|NCT02394028|58880199|FG002|Induction Phase|Lost to Follow-up|0|||
30852805|NCT02394028|58880200|FG003|Induction Phase|Lost to Follow-up|1|||
30955432|NCT02859558|59014703|FG000|Step 1|Not Eligible|0|||
30955433|NCT02859558|59014704|FG001|Step 1|Not Eligible|0|||
30955434|NCT02859558|59014705|FG002|Step 1|Not Eligible|0|||
30955435|NCT02859558|59014706|FG003|Step 1|Not Eligible|0|||
30955436|NCT02859558|59014707|FG004|Step 1|Not Eligible|3|||
30955437|NCT02859558|59014703|FG000|Step 1|Lost to Follow-up|1|||
30955438|NCT02859558|59014704|FG001|Step 1|Lost to Follow-up|3|||
30955439|NCT02859558|59014705|FG002|Step 1|Lost to Follow-up|3|||
30955440|NCT02859558|59014706|FG003|Step 1|Lost to Follow-up|0|||
30955441|NCT02859558|59014707|FG004|Step 1|Lost to Follow-up|0|||
30955442|NCT02859558|59014703|FG000|Step 1|Did Not Return to Clinic|2|||
30955443|NCT02859558|59014704|FG001|Step 1|Did Not Return to Clinic|3|||
30955444|NCT02859558|59014705|FG002|Step 1|Did Not Return to Clinic|4|||
30955445|NCT02859558|59014706|FG003|Step 1|Did Not Return to Clinic|0|||
30955446|NCT02859558|59014707|FG004|Step 1|Did Not Return to Clinic|0|||
30955447|NCT02859558|59014703|FG000|Step 1|Moved|0|||
30955448|NCT02859558|59014704|FG001|Step 1|Moved|1|||
30955449|NCT02859558|59014705|FG002|Step 1|Moved|1|||
30955450|NCT02859558|59014706|FG003|Step 1|Moved|0|||
30955451|NCT02859558|59014707|FG004|Step 1|Moved|0|||
30777598|NCT03628716|58788593|FG000|Overall Study|Death|1|||
30955452|NCT02859558|59014703|FG000|Step 1|Withdrawal By Participant|1|||
30955453|NCT02859558|59014704|FG001|Step 1|Withdrawal By Participant|2|||
30955454|NCT02859558|59014705|FG002|Step 1|Withdrawal By Participant|1|||
30955455|NCT02859558|59014706|FG003|Step 1|Withdrawal By Participant|0|||
30955456|NCT02859558|59014707|FG004|Step 1|Withdrawal By Participant|0|||
30955457|NCT02859558|59014703|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
30955458|NCT02859558|59014704|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
30955459|NCT02859558|59014705|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
30955460|NCT02859558|59014706|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
30955461|NCT02859558|59014707|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
30955462|NCT02859558|59014703|FG000|Step 1|Incarceration|0|||
30955463|NCT02859558|59014704|FG001|Step 1|Incarceration|1|||
30955464|NCT02859558|59014705|FG002|Step 1|Incarceration|0|||
30955465|NCT02859558|59014706|FG003|Step 1|Incarceration|0|||
30955466|NCT02859558|59014707|FG004|Step 1|Incarceration|0|||
30955467|NCT02859558|59014703|FG000|Step 1|Non-Adherence to Study Drug|2|||
30955468|NCT02859558|59014704|FG001|Step 1|Non-Adherence to Study Drug|0|||
30955469|NCT02859558|59014705|FG002|Step 1|Non-Adherence to Study Drug|1|||
30955470|NCT02859558|59014706|FG003|Step 1|Non-Adherence to Study Drug|0|||
30955471|NCT02859558|59014707|FG004|Step 1|Non-Adherence to Study Drug|0|||
30955472|NCT02859558|59014703|FG000|Step 1|Non-Adherence to Study Requirements|3|||
30955473|NCT02859558|59014704|FG001|Step 1|Non-Adherence to Study Requirements|1|||
30955474|NCT02859558|59014705|FG002|Step 1|Non-Adherence to Study Requirements|0|||
30955475|NCT02859558|59014706|FG003|Step 1|Non-Adherence to Study Requirements|0|||
30955476|NCT02859558|59014707|FG004|Step 1|Non-Adherence to Study Requirements|0|||
30955477|NCT02859558|59014703|FG000|Step 1|Virologic Failure|2|||
30955478|NCT02859558|59014704|FG001|Step 1|Virologic Failure|1|||
30955479|NCT02859558|59014705|FG002|Step 1|Virologic Failure|1|||
30955480|NCT02859558|59014706|FG003|Step 1|Virologic Failure|0|||
30955481|NCT02859558|59014707|FG004|Step 1|Virologic Failure|0|||
30955482|NCT02859558|59014703|FG000|Step 2|Active On Study|23|||
30955483|NCT02859558|59014704|FG001|Step 2|Active On Study|38|||
30955484|NCT02859558|59014705|FG002|Step 2|Active On Study|20|||
30955485|NCT02859558|59014706|FG003|Step 2|Active On Study|0|||
30955486|NCT02859558|59014707|FG004|Step 2|Active On Study|0|||
30955487|NCT02859558|59014703|FG000|Step 2|Did Not Return to Clinic|2|||
30955488|NCT02859558|59014704|FG001|Step 2|Did Not Return to Clinic|0|||
30955489|NCT02859558|59014705|FG002|Step 2|Did Not Return to Clinic|0|||
30955490|NCT02859558|59014706|FG003|Step 2|Did Not Return to Clinic|0|||
30662637|NCT00561925|58676228|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
30955491|NCT02859558|59014707|FG004|Step 2|Did Not Return to Clinic|0|||
30955492|NCT02859558|59014703|FG000|Step 2|Unexpected Closure of Site|0|||
30955493|NCT02859558|59014704|FG001|Step 2|Unexpected Closure of Site|1|||
30955494|NCT02859558|59014705|FG002|Step 2|Unexpected Closure of Site|1|||
30955495|NCT02859558|59014706|FG003|Step 2|Unexpected Closure of Site|0|||
30955496|NCT02859558|59014707|FG004|Step 2|Unexpected Closure of Site|0|||
30955497|NCT00705432|59014758|FG000|Treatment Period|Adverse Event|45|||
30955498|NCT00705432|59014759|FG001|Treatment Period|Adverse Event|37|||
30955499|NCT00705432|59014760|FG002|Treatment Period|Adverse Event|51|||
30955500|NCT00705432|59014761|FG003|Treatment Period|Adverse Event|12|||
30662638|NCT00561925|58676229|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
30955501|NCT00705432|59014762|FG004|Treatment Period|Adverse Event|8|||
30955502|NCT00705432|59014763|FG005|Treatment Period|Adverse Event|9|||
30955503|NCT00705432|59014758|FG000|Treatment Period|Treatment failure|92|||
30955504|NCT00705432|59014759|FG001|Treatment Period|Treatment failure|42|||
30955505|NCT00705432|59014760|FG002|Treatment Period|Treatment failure|33|||
30955506|NCT00705432|59014761|FG003|Treatment Period|Treatment failure|25|||
30955507|NCT00705432|59014762|FG004|Treatment Period|Treatment failure|13|||
30955508|NCT00705432|59014763|FG005|Treatment Period|Treatment failure|14|||
30955509|NCT00705432|59014758|FG000|Treatment Period|Non medical reason|26|||
30955510|NCT00705432|59014759|FG001|Treatment Period|Non medical reason|32|||
30955511|NCT00705432|59014760|FG002|Treatment Period|Non medical reason|37|||
30955512|NCT00705432|59014761|FG003|Treatment Period|Non medical reason|4|||
30955513|NCT00705432|59014762|FG004|Treatment Period|Non medical reason|7|||
30955514|NCT00705432|59014763|FG005|Treatment Period|Non medical reason|7|||
30955515|NCT00705432|59014758|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
30955516|NCT00705432|59014759|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
30955517|NCT00705432|59014760|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
30955518|NCT00705432|59014761|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
30955519|NCT00705432|59014762|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
30955520|NCT00705432|59014763|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
30955521|NCT00705432|59014758|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
30955522|NCT00705432|59014759|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
30955523|NCT00705432|59014760|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
30955524|NCT00705432|59014761|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
30955525|NCT00705432|59014762|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
30955526|NCT00705432|59014763|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
30955527|NCT00704964|59014774|FG000|Overall Study|Not completed on time|328|||
30955528|NCT00704808|59014790|FG000|Overall Study|Discontinued prior to starting treatment|14|||
30955529|NCT00704808|59014790|FG000|Overall Study|Death|7|||
30955530|NCT00704808|59014790|FG000|Overall Study|Tumor progression|80|||
30955531|NCT00704808|59014790|FG000|Overall Study|Patient's decision|11|||
30955532|NCT00704808|59014790|FG000|Overall Study|Early therapy discontinuation|16|||
30955533|NCT00704808|59014790|FG000|Overall Study|Adverse Event|1|||
30955534|NCT00704808|59014790|FG000|Overall Study|Lost to Follow-up|1|||
30955535|NCT00704808|59014790|FG000|Overall Study|Treatment change|1|||
30955536|NCT05166876|59014824|FG000|Overall Study|Withdrawal by Subject|1|||
30955537|NCT05166876|59014825|FG001|Overall Study|Withdrawal by Subject|0|||
30955538|NCT05166876|59014826|FG002|Overall Study|Withdrawal by Subject|0|||
30955539|NCT01375608|59014838|FG000|Overall Study|Withdrawal by Subject|2|||
30955540|NCT00704418|59014853|FG000|Overall Study|Withdrawal by Subject|2|||
30955541|NCT00704418|59014854|FG001|Overall Study|Withdrawal by Subject|0|||
30955542|NCT00704418|59014853|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
30955543|NCT00704418|59014854|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
30955544|NCT00704340|59014923|FG000|Overall Study|Lost to Follow-up|2|||
30955545|NCT00704340|59014924|FG001|Overall Study|Lost to Follow-up|1|||
30955546|NCT00704340|59014923|FG000|Overall Study|Death|0|||
30955547|NCT00704340|59014924|FG001|Overall Study|Death|1|||
30955548|NCT00552058|59014932|FG000|Overall Study|Adverse Event|8|||
30955549|NCT00552058|59014933|FG001|Overall Study|Adverse Event|7|||
30955550|NCT00552058|59014932|FG000|Overall Study|Lack of Efficacy|1|||
30955551|NCT00552058|59014933|FG001|Overall Study|Lack of Efficacy|5|||
30955552|NCT00552058|59014932|FG000|Overall Study|Lost to Follow-up|1|||
30955553|NCT00552058|59014933|FG001|Overall Study|Lost to Follow-up|0|||
30955554|NCT00552058|59014932|FG000|Overall Study|Withdrawal by Subject|4|||
30955555|NCT00552058|59014933|FG001|Overall Study|Withdrawal by Subject|4|||
30955556|NCT00552058|59014932|FG000|Overall Study|Other: Protocol Violation|0|||
30955557|NCT00552058|59014933|FG001|Overall Study|Other: Protocol Violation|1|||
30955558|NCT00552058|59014932|FG000|Overall Study|Other: Non Compliance|1|||
30955559|NCT00552058|59014933|FG001|Overall Study|Other: Non Compliance|2|||
30955560|NCT00552058|59014932|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
30955561|NCT00552058|59014933|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
30955562|NCT00552058|59014932|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
30955563|NCT00552058|59014933|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
30955564|NCT00552058|59014932|FG000|Overall Study|Other: Positive Stool Result|0|||
30662639|NCT00561925|58676230|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
30777599|NCT03628716|58788594|FG001|Overall Study|Death|0|||
30777600|NCT03628716|58788593|FG000|Overall Study|Lack of Efficacy|15|||
30777601|NCT03628716|58788594|FG001|Overall Study|Lack of Efficacy|20|||
30777602|NCT03628716|58788593|FG000|Overall Study|Withdrawal by Subject|1|||
30777603|NCT03628716|58788594|FG001|Overall Study|Withdrawal by Subject|2|||
30777604|NCT03628716|58788593|FG000|Overall Study|Study Terminated by Sponsor|1|||
30777605|NCT03628716|58788594|FG001|Overall Study|Study Terminated by Sponsor|0|||
30777606|NCT04002960|58788602|FG000|Overall Study|Withdrawn prior to Completion|2|||
30777607|NCT04002648|58788608|FG000|Overall Study|Lost to Follow-up|2|||
30955565|NCT00552058|59014933|FG001|Overall Study|Other: Positive Stool Result|1|||
30955566|NCT00552058|59014932|FG000|Overall Study|Other: Randomized in error|0|||
30955567|NCT00552058|59014933|FG001|Overall Study|Other: Randomized in error|1|||
30955568|NCT00552058|59014932|FG000|Overall Study|Other: Sponsors Decision|0|||
30955569|NCT00552058|59014933|FG001|Overall Study|Other: Sponsors Decision|1|||
30955570|NCT00552058|59014932|FG000|Overall Study|Other: Early Roll Over|1|||
30955571|NCT00552058|59014933|FG001|Overall Study|Other: Early Roll Over|0|||
30955572|NCT00550732|59014962|FG000|Overall Study|Death|4|||
30955573|NCT00550732|59014962|FG000|Overall Study|Withdrawal by Subject|2|||
30955574|NCT00550732|59014962|FG000|Overall Study|Physician Decision|2|||
30955575|NCT00550732|59014962|FG000|Overall Study|Lost to Follow-up|1|||
30955576|NCT00550732|59014962|FG000|Overall Study|Palliative care|1|||
30955577|NCT00550732|59014962|FG000|Overall Study|Adverse Event|1|||
30955578|NCT00550420|59014976|FG000|Overall Study|Adverse Event|28|||
30955579|NCT00550420|59014976|FG000|Overall Study|Lost to Follow-up|8|||
30955580|NCT00550420|59014976|FG000|Overall Study|Protocol Violation|11|||
30955581|NCT00550420|59014976|FG000|Overall Study|Withdrawal by Subject|30|||
30955582|NCT00550420|59014976|FG000|Overall Study|Still in study at termination|206|||
30955583|NCT00550420|59014976|FG000|Overall Study|Missing|2|||
30955584|NCT00550420|59014976|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
30955585|NCT00550420|59014976|FG000|Overall Study|Investigators opinion|1|||
30955586|NCT00550420|59014976|FG000|Overall Study|Lack of curative effect|1|||
30955587|NCT00550420|59014976|FG000|Overall Study|Unethical stop of enrollment|2|||
30955588|NCT00550420|59014976|FG000|Overall Study|Caregiver's decision to withdraw|1|||
30955589|NCT00550420|59014976|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
30955590|NCT00550420|59014976|FG000|Overall Study|Exclusion criteria|1|||
30955591|NCT00550420|59014976|FG000|Overall Study|Prohibited medicine|1|||
30955592|NCT00558064|59014988|FG000|Overall Study|Adverse Event|3|||
30955593|NCT00558064|59014989|FG001|Overall Study|Adverse Event|2|||
30955594|NCT00558064|59014988|FG000|Overall Study|Lack of Efficacy|0|||
30955595|NCT00558064|59014989|FG001|Overall Study|Lack of Efficacy|1|||
30955596|NCT00558064|59014988|FG000|Overall Study|Protocol Violation|1|||
30955597|NCT00558064|59014989|FG001|Overall Study|Protocol Violation|0|||
30955598|NCT00558064|59014988|FG000|Overall Study|Lost to Follow-up|0|||
30955599|NCT00558064|59014989|FG001|Overall Study|Lost to Follow-up|1|||
30955600|NCT00558064|59014988|FG000|Overall Study|Withdrawal by Subject|0|||
30777608|NCT04002648|58788609|FG001|Overall Study|Lost to Follow-up|0|||
30777609|NCT00088413|58788630|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
30777610|NCT00088413|58788631|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
30777611|NCT00088413|58788632|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
30777612|NCT00088413|58788633|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
30777613|NCT00088413|58788630|FG000|Overall Study|Adverse Events/Side Effects|0|||
30777614|NCT00088413|58788631|FG001|Overall Study|Adverse Events/Side Effects|1|||
30777615|NCT00088413|58788632|FG002|Overall Study|Adverse Events/Side Effects|1|||
30777616|NCT00088413|58788633|FG003|Overall Study|Adverse Events/Side Effects|0|||
30852806|NCT02394028|58880201|FG004|Induction Phase|Lost to Follow-up|0|||
30955601|NCT00558064|59014989|FG001|Overall Study|Withdrawal by Subject|1|||
30955602|NCT00558064|59014988|FG000|Overall Study|No visit within allowance period|1|||
30955603|NCT00558064|59014989|FG001|Overall Study|No visit within allowance period|0|||
30955604|NCT00557830|59014998|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
30955605|NCT00557830|59014999|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
30955606|NCT00557830|59015000|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
30955607|NCT00557830|59014998|FG000|Screening Treatment Phase|Adverse Event|2|||
30955608|NCT00557830|59014999|FG001|Screening Treatment Phase|Adverse Event|0|||
30955609|NCT00557830|59015000|FG002|Screening Treatment Phase|Adverse Event|0|||
30955610|NCT00557830|59014998|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
30955611|NCT00557830|59014999|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
30662640|NCT00561925|58676226|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
30662641|NCT00561925|58676227|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
30955612|NCT00557830|59015000|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
30955613|NCT00557440|59015011|FG000|Treatment Period 1|Adverse Event|0|||
30955614|NCT00557440|59015012|FG001|Treatment Period 1|Adverse Event|0|||
30955615|NCT00557440|59015013|FG002|Treatment Period 1|Adverse Event|1|||
30955616|NCT00556894|59015024|FG000|Overall Study|Adverse Event|2|||
30955617|NCT00556894|59015025|FG001|Overall Study|Adverse Event|3|||
30955618|NCT00556894|59015026|FG002|Overall Study|Adverse Event|3|||
30955619|NCT00556894|59015024|FG000|Overall Study|Death|1|||
30955620|NCT00556894|59015025|FG001|Overall Study|Death|0|||
30955621|NCT00556894|59015026|FG002|Overall Study|Death|0|||
30955622|NCT00556894|59015024|FG000|Overall Study|regulatory decision in Bulgaria|10|||
30955623|NCT00556894|59015025|FG001|Overall Study|regulatory decision in Bulgaria|14|||
30955624|NCT00556894|59015026|FG002|Overall Study|regulatory decision in Bulgaria|13|||
30955625|NCT00556894|59015024|FG000|Overall Study|Change in therapy|2|||
30955626|NCT00556894|59015025|FG001|Overall Study|Change in therapy|1|||
30955627|NCT00556894|59015026|FG002|Overall Study|Change in therapy|2|||
30955628|NCT00556894|59015024|FG000|Overall Study|Withdrawal by Subject|1|||
30662642|NCT00561925|58676228|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
30662643|NCT00561925|58676229|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
30852807|NCT02394028|58880202|FG005|Induction Phase|Lost to Follow-up|0|||
30955629|NCT00556894|59015025|FG001|Overall Study|Withdrawal by Subject|1|||
30955630|NCT00556894|59015026|FG002|Overall Study|Withdrawal by Subject|1|||
30955631|NCT02722044|59015034|FG000|Overall Study|Adverse Event|2|||
30955632|NCT02722044|59015034|FG000|Overall Study|Physician Decision|1|||
30955633|NCT02722044|59015034|FG000|Overall Study|Withdrawal by Subject|1|||
30955634|NCT02722044|59015034|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
30955635|NCT00556426|59015039|FG000|Overall Study|Withdrawal by Subject|3|||
30955636|NCT00556426|59015039|FG000|Overall Study|Death|6|||
30955637|NCT00555568|59015047|FG000|Overall Study|Lost to Follow-up|26|||
30955638|NCT00555568|59015048|FG001|Overall Study|Lost to Follow-up|16|||
30955639|NCT00555568|59015049|FG002|Overall Study|Lost to Follow-up|16|||
30955640|NCT00702702|59015060|FG000|Overall Study|Study prematurely terminated|56|||
30955641|NCT02721966|59015071|FG000|Overall Study|Protocol Violation|1|||
30955642|NCT02721966|59015072|FG001|Overall Study|Protocol Violation|0|||
30955643|NCT02721966|59015073|FG002|Overall Study|Protocol Violation|0|||
30955644|NCT02721966|59015074|FG003|Overall Study|Protocol Violation|0|||
30955645|NCT02721966|59015075|FG004|Overall Study|Protocol Violation|0|||
30955646|NCT02721966|59015071|FG000|Overall Study|Withdrawal by Subject|9|||
30955647|NCT02721966|59015072|FG001|Overall Study|Withdrawal by Subject|2|||
30955648|NCT02721966|59015073|FG002|Overall Study|Withdrawal by Subject|3|||
30852808|NCT02394028|58880203|FG006|Induction Phase|Lost to Follow-up|1|||
30852809|NCT02394028|58880204|FG007|Induction Phase|Lost to Follow-up|0|||
30852810|NCT02394028|58880205|FG008|Induction Phase|Lost to Follow-up|0|||
30852811|NCT02394028|58880206|FG009|Induction Phase|Lost to Follow-up|0|||
30852812|NCT02394028|58880207|FG010|Induction Phase|Lost to Follow-up|0|||
30852813|NCT02394028|58880197|FG000|Induction Phase|Non-compliance|0|||
30852814|NCT02394028|58880198|FG001|Induction Phase|Non-compliance|1|||
30852815|NCT02394028|58880199|FG002|Induction Phase|Non-compliance|3|||
30852816|NCT02394028|58880200|FG003|Induction Phase|Non-compliance|1|||
30852817|NCT02394028|58880201|FG004|Induction Phase|Non-compliance|3|||
30852818|NCT02394028|58880202|FG005|Induction Phase|Non-compliance|0|||
30955649|NCT02721966|59015074|FG003|Overall Study|Withdrawal by Subject|7|||
30955650|NCT02721966|59015075|FG004|Overall Study|Withdrawal by Subject|0|||
30955651|NCT02721966|59015071|FG000|Overall Study|Adverse Event|4|||
30955652|NCT02721966|59015072|FG001|Overall Study|Adverse Event|4|||
30852819|NCT02394028|58880203|FG006|Induction Phase|Non-compliance|1|||
30852820|NCT02394028|58880204|FG007|Induction Phase|Non-compliance|1|||
30852821|NCT02394028|58880205|FG008|Induction Phase|Non-compliance|0|||
30852822|NCT02394028|58880206|FG009|Induction Phase|Non-compliance|0|||
30852823|NCT02394028|58880207|FG010|Induction Phase|Non-compliance|0|||
30852824|NCT02394028|58880197|FG000|Induction Phase|Physician Decision|0|||
30852825|NCT02394028|58880198|FG001|Induction Phase|Physician Decision|0|||
30955653|NCT02721966|59015073|FG002|Overall Study|Adverse Event|3|||
30955654|NCT02721966|59015074|FG003|Overall Study|Adverse Event|0|||
30955655|NCT02721966|59015075|FG004|Overall Study|Adverse Event|0|||
30955656|NCT02721966|59015071|FG000|Overall Study|Death|1|||
30955657|NCT02721966|59015072|FG001|Overall Study|Death|0|||
30955658|NCT02721966|59015073|FG002|Overall Study|Death|0|||
30955659|NCT02721966|59015074|FG003|Overall Study|Death|0|||
30955660|NCT02721966|59015075|FG004|Overall Study|Death|0|||
30852826|NCT02394028|58880199|FG002|Induction Phase|Physician Decision|1|||
30852827|NCT02394028|58880200|FG003|Induction Phase|Physician Decision|4|||
30852828|NCT02394028|58880201|FG004|Induction Phase|Physician Decision|0|||
30852829|NCT02394028|58880202|FG005|Induction Phase|Physician Decision|2|||
30852830|NCT02394028|58880203|FG006|Induction Phase|Physician Decision|1|||
30852831|NCT02394028|58880204|FG007|Induction Phase|Physician Decision|0|||
30852832|NCT02394028|58880205|FG008|Induction Phase|Physician Decision|0|||
30852833|NCT02394028|58880206|FG009|Induction Phase|Physician Decision|0|||
30852834|NCT02394028|58880207|FG010|Induction Phase|Physician Decision|0|||
30852835|NCT02394028|58880197|FG000|Induction Phase|Protocol Violation|0|||
30955661|NCT02721966|59015071|FG000|Overall Study|Lack of Efficacy|7|||
30955662|NCT02721966|59015072|FG001|Overall Study|Lack of Efficacy|4|||
30955663|NCT02721966|59015073|FG002|Overall Study|Lack of Efficacy|0|||
30955664|NCT02721966|59015074|FG003|Overall Study|Lack of Efficacy|0|||
30852836|NCT02394028|58880198|FG001|Induction Phase|Protocol Violation|2|||
30852837|NCT02394028|58880199|FG002|Induction Phase|Protocol Violation|0|||
30955665|NCT02721966|59015075|FG004|Overall Study|Lack of Efficacy|0|||
30955666|NCT02721966|59015071|FG000|Overall Study|Lost to Follow-up|0|||
30955667|NCT02721966|59015072|FG001|Overall Study|Lost to Follow-up|0|||
30955668|NCT02721966|59015073|FG002|Overall Study|Lost to Follow-up|3|||
30852838|NCT02394028|58880200|FG003|Induction Phase|Protocol Violation|3|||
30852839|NCT02394028|58880201|FG004|Induction Phase|Protocol Violation|0|||
30852840|NCT02394028|58880202|FG005|Induction Phase|Protocol Violation|1|||
30852841|NCT02394028|58880203|FG006|Induction Phase|Protocol Violation|1|||
30852842|NCT02394028|58880204|FG007|Induction Phase|Protocol Violation|0|||
30852843|NCT02394028|58880205|FG008|Induction Phase|Protocol Violation|0|||
30852844|NCT02394028|58880206|FG009|Induction Phase|Protocol Violation|0|||
30955669|NCT02721966|59015074|FG003|Overall Study|Lost to Follow-up|0|||
30955670|NCT02721966|59015075|FG004|Overall Study|Lost to Follow-up|0|||
30955671|NCT02721966|59015071|FG000|Overall Study|Physician Decision|1|||
30955672|NCT02721966|59015072|FG001|Overall Study|Physician Decision|1|||
30955673|NCT02721966|59015073|FG002|Overall Study|Physician Decision|0|||
30955674|NCT02721966|59015074|FG003|Overall Study|Physician Decision|0|||
30955675|NCT02721966|59015075|FG004|Overall Study|Physician Decision|0|||
30955676|NCT02721966|59015071|FG000|Overall Study|Pregnancy|1|||
30955677|NCT02721966|59015072|FG001|Overall Study|Pregnancy|0|||
30777617|NCT00088413|58788630|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
30777618|NCT00088413|58788631|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
30777619|NCT00088413|58788632|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
30777620|NCT00088413|58788633|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
30777621|NCT00088413|58788630|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
30777622|NCT00088413|58788631|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
30777623|NCT00088413|58788632|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
30777624|NCT00088413|58788633|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
30777625|NCT00088413|58788630|FG000|Overall Study|Death|0|||
30777626|NCT00088413|58788631|FG001|Overall Study|Death|1|||
30777627|NCT00088413|58788632|FG002|Overall Study|Death|0|||
30777628|NCT00088413|58788633|FG003|Overall Study|Death|0|||
30777629|NCT00088413|58788630|FG000|Overall Study|Progressive disease|9|||
30777630|NCT00088413|58788631|FG001|Overall Study|Progressive disease|11|||
30852845|NCT02394028|58880207|FG010|Induction Phase|Protocol Violation|0|||
30852846|NCT02394028|58880197|FG000|Induction Phase|Withdrawal by Subject|1|||
30852847|NCT02394028|58880198|FG001|Induction Phase|Withdrawal by Subject|2|||
30852848|NCT02394028|58880199|FG002|Induction Phase|Withdrawal by Subject|4|||
30955678|NCT02721966|59015073|FG002|Overall Study|Pregnancy|0|||
30955679|NCT02721966|59015074|FG003|Overall Study|Pregnancy|0|||
30955680|NCT02721966|59015075|FG004|Overall Study|Pregnancy|0|||
30955681|NCT02721966|59015071|FG000|Overall Study|Did not continue to period 2|5|||
30955682|NCT02721966|59015072|FG001|Overall Study|Did not continue to period 2|12|||
30955683|NCT02721966|59015073|FG002|Overall Study|Did not continue to period 2|0|||
30955684|NCT02721966|59015074|FG003|Overall Study|Did not continue to period 2|0|||
30955685|NCT02721966|59015075|FG004|Overall Study|Did not continue to period 2|5|||
30955686|NCT00553462|59015083|FG000|Overall Study|Adverse Event|4|||
30955687|NCT00553462|59015083|FG000|Overall Study|Progression|4|||
30955688|NCT00553462|59015083|FG000|Overall Study|Withdrawal by Subject|5|||
30777631|NCT00088413|58788632|FG002|Overall Study|Progressive disease|8|||
30777632|NCT00088413|58788633|FG003|Overall Study|Progressive disease|14|||
30852849|NCT02394028|58880200|FG003|Induction Phase|Withdrawal by Subject|6|||
30852850|NCT02394028|58880201|FG004|Induction Phase|Withdrawal by Subject|7|||
30955689|NCT00553462|59015083|FG000|Overall Study|Physician Decision|1|||
30955690|NCT00553150|59015089|FG000|Overall Study|Withdrawal by Subject|0|||
30955691|NCT00553150|59015090|FG001|Overall Study|Withdrawal by Subject|0|||
30955692|NCT00553150|59015091|FG002|Overall Study|Withdrawal by Subject|0|||
30955693|NCT00553150|59015092|FG003|Overall Study|Withdrawal by Subject|2|||
30955694|NCT00553150|59015089|FG000|Overall Study|Protocol Violation|0|||
30852851|NCT02394028|58880202|FG005|Induction Phase|Withdrawal by Subject|4|||
30852852|NCT02394028|58880203|FG006|Induction Phase|Withdrawal by Subject|3|||
30852853|NCT02394028|58880204|FG007|Induction Phase|Withdrawal by Subject|6|||
30852854|NCT02394028|58880205|FG008|Induction Phase|Withdrawal by Subject|0|||
30852855|NCT02394028|58880206|FG009|Induction Phase|Withdrawal by Subject|0|||
30852856|NCT02394028|58880207|FG010|Induction Phase|Withdrawal by Subject|0|||
30852857|NCT02394028|58880197|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
30955695|NCT00553150|59015090|FG001|Overall Study|Protocol Violation|0|||
30777633|NCT00088413|58788630|FG000|Overall Study|Other|0|||
30777634|NCT00088413|58788631|FG001|Overall Study|Other|1|||
30777635|NCT00088413|58788632|FG002|Overall Study|Other|0|||
30777636|NCT00088413|58788633|FG003|Overall Study|Other|0|||
30777637|NCT00088413|58788630|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
30777638|NCT00088413|58788631|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
30777639|NCT00088413|58788632|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
30852858|NCT02394028|58880198|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
30852859|NCT02394028|58880199|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
30852860|NCT02394028|58880200|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
30852861|NCT02394028|58880201|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
30955696|NCT00553150|59015091|FG002|Overall Study|Protocol Violation|0|||
30955697|NCT00553150|59015092|FG003|Overall Study|Protocol Violation|1|||
30955698|NCT00553150|59015089|FG000|Overall Study|Ineligible|0|||
30955699|NCT00553150|59015090|FG001|Overall Study|Ineligible|0|||
30852862|NCT02394028|58880202|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
30955700|NCT00553150|59015091|FG002|Overall Study|Ineligible|0|||
30955701|NCT00553150|59015092|FG003|Overall Study|Ineligible|1|||
30955702|NCT03301350|59015100|FG000|Overall Study|Withdrawal by Subject|4|||
30955703|NCT03301350|59015100|FG000|Overall Study|Adverse Event|1|||
30955704|NCT03301350|59015100|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
30955705|NCT03301350|59015100|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
30955706|NCT03301350|59015100|FG000|Overall Study|no detail provided|1|||
30955707|NCT04735432|59015107|FG000|Overall Study|Other - due to personal reason|1|||
30955708|NCT04735432|59015108|FG001|Overall Study|Other - due to personal reason|0|||
30955709|NCT04735432|59015107|FG000|Overall Study|Adverse Event|2|||
30955710|NCT04735432|59015108|FG001|Overall Study|Adverse Event|0|||
30955711|NCT02722278|59015117|FG000|Overall Study|Withdrawal by Subject|5|||
30955712|NCT02722278|59015118|FG001|Overall Study|Withdrawal by Subject|3|||
30955713|NCT02722278|59015117|FG000|Overall Study|Adverse Event|4|||
30852863|NCT02394028|58880203|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
30852864|NCT02394028|58880204|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
30852865|NCT02394028|58880205|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
30852866|NCT02394028|58880206|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
30955714|NCT02722278|59015118|FG001|Overall Study|Adverse Event|1|||
30955715|NCT02722278|59015117|FG000|Overall Study|Lost to Follow-up|2|||
30955716|NCT02722278|59015118|FG001|Overall Study|Lost to Follow-up|0|||
30955717|NCT02722278|59015117|FG000|Overall Study|Protocol Violation|1|||
30955718|NCT02722278|59015118|FG001|Overall Study|Protocol Violation|0|||
30955719|NCT02722278|59015117|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
30955720|NCT02722278|59015118|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
30955721|NCT02722278|59015117|FG000|Overall Study|Subject declined after tx assignment|0|||
30955722|NCT02722278|59015118|FG001|Overall Study|Subject declined after tx assignment|1|||
30955723|NCT02722278|59015117|FG000|Overall Study|Site closure not study related|0|||
30955724|NCT02722278|59015118|FG001|Overall Study|Site closure not study related|1|||
30955725|NCT00703092|59015126|FG000|Overall Study|Withdrawal by Subject|2|||
30955726|NCT02720484|59015130|FG000|Treatment on Study|Adverse Event|1|||
30955727|NCT02720484|59015130|FG000|Treatment on Study|Withdrawal by Subject|1|||
30955728|NCT02720484|59015130|FG000|Treatment on Study|Progressive Disease|4|||
30955729|NCT02720484|59015130|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
30955730|NCT02720484|59015130|FG000|Follow Up for 2 Years|Death|3|||
30955731|NCT02720484|59015130|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
30955732|NCT02715804|59015136|FG000|Overall Study|Death|222|||
30852867|NCT02394028|58880207|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
30852868|NCT02394028|58880197|FG000|Induction Phase|Sponsor decision|0|||
30852869|NCT02394028|58880198|FG001|Induction Phase|Sponsor decision|1|||
30852870|NCT02394028|58880199|FG002|Induction Phase|Sponsor decision|2|||
30852871|NCT02394028|58880200|FG003|Induction Phase|Sponsor decision|0|||
30955733|NCT02715804|59015137|FG001|Overall Study|Death|106|||
30955734|NCT02715804|59015136|FG000|Overall Study|Withdrawal by Subject|5|||
30955735|NCT02715804|59015137|FG001|Overall Study|Withdrawal by Subject|4|||
30955736|NCT02715804|59015136|FG000|Overall Study|Other than specified|2|||
30955737|NCT02715804|59015137|FG001|Overall Study|Other than specified|3|||
30955738|NCT02717832|59015143|FG000|Overall Study|Inability to place IV|3|||
30955739|NCT02717754|59015154|FG000|Overall Study|Incorrect Infusion Duration|0|||
30955740|NCT02717754|59015155|FG001|Overall Study|Incorrect Infusion Duration|0|||
30777640|NCT00088413|58788633|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
30777641|NCT03995784|58788645|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
30777642|NCT00086385|58788660|FG000|Overall Study|Death|2|||
30777643|NCT00086385|58788661|FG001|Overall Study|Death|2|||
30777644|NCT00086385|58788662|FG002|Overall Study|Death|1|||
30777645|NCT00086385|58788663|FG003|Overall Study|Death|1|||
30777646|NCT03993288|58788675|FG000|Overall Study|Lost to Follow-up|2|||
30777647|NCT03993288|58788676|FG001|Overall Study|Lost to Follow-up|1|||
30777648|NCT03993288|58788675|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
30777649|NCT03993288|58788676|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
30777650|NCT03993288|58788675|FG000|Overall Study|wrong randomization|0|||
30777651|NCT03993288|58788676|FG001|Overall Study|wrong randomization|1|||
30777652|NCT03993288|58788675|FG000|Overall Study|improper enrollment|0|||
30777653|NCT03993288|58788676|FG001|Overall Study|improper enrollment|1|||
30955741|NCT02717754|59015156|FG002|Overall Study|Incorrect Infusion Duration|0|||
30955742|NCT02717754|59015157|FG003|Overall Study|Incorrect Infusion Duration|10|||
30955743|NCT02717754|59015158|FG004|Overall Study|Incorrect Infusion Duration|20|||
30955744|NCT02717754|59015159|FG005|Overall Study|Incorrect Infusion Duration|20|||
30955745|NCT02717130|59015169|FG000|Overall Study|Withdrawal by Subject|1|||
30955746|NCT02717130|59015169|FG000|Overall Study|Adverse Event|1|||
30852872|NCT02394028|58880201|FG004|Induction Phase|Sponsor decision|0|||
30955747|NCT02717130|59015169|FG000|Overall Study|Physician Decision|1|||
30955748|NCT02717130|59015169|FG000|Overall Study|Study Closure|4|||
30852873|NCT02394028|58880202|FG005|Induction Phase|Sponsor decision|0|||
30852874|NCT02394028|58880203|FG006|Induction Phase|Sponsor decision|0|||
30852875|NCT02394028|58880204|FG007|Induction Phase|Sponsor decision|0|||
30852876|NCT02394028|58880205|FG008|Induction Phase|Sponsor decision|0|||
30852877|NCT02394028|58880206|FG009|Induction Phase|Sponsor decision|0|||
30852878|NCT02394028|58880207|FG010|Induction Phase|Sponsor decision|0|||
30852879|NCT02394028|58880197|FG000|Induction Phase|Technical reason|0|||
30852880|NCT02394028|58880198|FG001|Induction Phase|Technical reason|0|||
30852881|NCT02394028|58880199|FG002|Induction Phase|Technical reason|0|||
30852882|NCT02394028|58880200|FG003|Induction Phase|Technical reason|1|||
30852883|NCT02394028|58880201|FG004|Induction Phase|Technical reason|0|||
30852884|NCT02394028|58880202|FG005|Induction Phase|Technical reason|0|||
30852885|NCT02394028|58880203|FG006|Induction Phase|Technical reason|0|||
30852886|NCT02394028|58880204|FG007|Induction Phase|Technical reason|0|||
30852887|NCT02394028|58880205|FG008|Induction Phase|Technical reason|0|||
30852888|NCT02394028|58880206|FG009|Induction Phase|Technical reason|0|||
30852889|NCT02394028|58880207|FG010|Induction Phase|Technical reason|0|||
30852890|NCT02394028|58880197|FG000|Induction Phase|:ack of calculation|0|||
30852891|NCT02394028|58880198|FG001|Induction Phase|:ack of calculation|0|||
30852892|NCT02394028|58880199|FG002|Induction Phase|:ack of calculation|0|||
30852893|NCT02394028|58880200|FG003|Induction Phase|:ack of calculation|0|||
30852894|NCT02394028|58880201|FG004|Induction Phase|:ack of calculation|0|||
30852895|NCT02394028|58880202|FG005|Induction Phase|:ack of calculation|0|||
30852896|NCT02394028|58880203|FG006|Induction Phase|:ack of calculation|0|||
30852897|NCT02394028|58880204|FG007|Induction Phase|:ack of calculation|1|||
30955749|NCT02192502|59015189|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
30955750|NCT02192502|59015190|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
30777654|NCT03993288|58788675|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
30777655|NCT03993288|58788676|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
30777656|NCT03993288|58788675|FG000|Overall Study|developed SAE|2|||
30777657|NCT03993288|58788676|FG001|Overall Study|developed SAE|0|||
30777658|NCT03993288|58788675|FG000|Overall Study|consent withdrawal|1|||
30777659|NCT03993288|58788676|FG001|Overall Study|consent withdrawal|0|||
30777660|NCT03993288|58788675|FG000|Overall Study|did not follow the treatment schedule|1|||
30777661|NCT03993288|58788676|FG001|Overall Study|did not follow the treatment schedule|0|||
30852898|NCT02394028|58880205|FG008|Induction Phase|:ack of calculation|0|||
30852899|NCT02394028|58880206|FG009|Induction Phase|:ack of calculation|0|||
30852900|NCT02394028|58880207|FG010|Induction Phase|:ack of calculation|0|||
30955751|NCT02192502|59015189|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
30955752|NCT02192502|59015190|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
30955753|NCT02192502|59015189|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
30955754|NCT02192502|59015190|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
30955755|NCT01781429|59015211|FG000|Overall Study|Death|0|||
30955756|NCT01781429|59015212|FG001|Overall Study|Death|0|||
30955757|NCT01781429|59015213|FG002|Overall Study|Death|0|||
30955758|NCT01781429|59015214|FG003|Overall Study|Death|0|||
30955759|NCT01781429|59015215|FG004|Overall Study|Death|0|||
30955760|NCT01781429|59015216|FG005|Overall Study|Death|0|||
30955761|NCT01781429|59015217|FG006|Overall Study|Death|0|||
30955762|NCT01781429|59015218|FG007|Overall Study|Death|0|||
30955763|NCT01781429|59015219|FG008|Overall Study|Death|0|||
30955764|NCT01781429|59015220|FG009|Overall Study|Death|1|||
30955765|NCT01781429|59015221|FG010|Overall Study|Death|0|||
30955766|NCT01781429|59015222|FG011|Overall Study|Death|0|||
30955767|NCT01781429|59015223|FG012|Overall Study|Death|1|||
30955768|NCT01781429|59015224|FG013|Overall Study|Death|0|||
30955769|NCT01781429|59015225|FG014|Overall Study|Death|1|||
30955770|NCT01781429|59015226|FG015|Overall Study|Death|0|||
30955771|NCT01781429|59015211|FG000|Overall Study|Withdrawal by Subject|0|||
30955772|NCT01781429|59015212|FG001|Overall Study|Withdrawal by Subject|0|||
30955773|NCT01781429|59015213|FG002|Overall Study|Withdrawal by Subject|0|||
30955774|NCT01781429|59015214|FG003|Overall Study|Withdrawal by Subject|0|||
30955775|NCT01781429|59015215|FG004|Overall Study|Withdrawal by Subject|0|||
30955776|NCT01781429|59015216|FG005|Overall Study|Withdrawal by Subject|0|||
30955777|NCT01781429|59015217|FG006|Overall Study|Withdrawal by Subject|0|||
30955778|NCT01781429|59015218|FG007|Overall Study|Withdrawal by Subject|0|||
30955779|NCT01781429|59015219|FG008|Overall Study|Withdrawal by Subject|1|||
30955780|NCT01781429|59015220|FG009|Overall Study|Withdrawal by Subject|3|||
30955781|NCT01781429|59015221|FG010|Overall Study|Withdrawal by Subject|1|||
30955782|NCT01781429|59015222|FG011|Overall Study|Withdrawal by Subject|1|||
30955783|NCT01781429|59015223|FG012|Overall Study|Withdrawal by Subject|5|||
30955784|NCT01781429|59015224|FG013|Overall Study|Withdrawal by Subject|2|||
30955785|NCT01781429|59015225|FG014|Overall Study|Withdrawal by Subject|3|||
30955786|NCT01781429|59015226|FG015|Overall Study|Withdrawal by Subject|0|||
30955787|NCT01781429|59015211|FG000|Overall Study|Disease Progression|1|||
30852901|NCT02394028|58880197|FG000|Maintenance Phase|Protocol Violation|0|||
30852902|NCT02394028|58880198|FG001|Maintenance Phase|Protocol Violation|0|||
30955788|NCT01781429|59015212|FG001|Overall Study|Disease Progression|0|||
30955789|NCT01781429|59015213|FG002|Overall Study|Disease Progression|1|||
30955790|NCT01781429|59015214|FG003|Overall Study|Disease Progression|1|||
30955791|NCT01781429|59015215|FG004|Overall Study|Disease Progression|1|||
30955792|NCT01781429|59015216|FG005|Overall Study|Disease Progression|4|||
30955793|NCT01781429|59015217|FG006|Overall Study|Disease Progression|7|||
30955794|NCT01781429|59015218|FG007|Overall Study|Disease Progression|4|||
30955795|NCT01781429|59015219|FG008|Overall Study|Disease Progression|6|||
30955796|NCT01781429|59015220|FG009|Overall Study|Disease Progression|15|||
30955797|NCT01781429|59015221|FG010|Overall Study|Disease Progression|15|||
30955798|NCT01781429|59015222|FG011|Overall Study|Disease Progression|15|||
30955799|NCT01781429|59015223|FG012|Overall Study|Disease Progression|15|||
30662644|NCT00561925|58676230|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
30662645|NCT00561925|58676226|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
30777662|NCT03993288|58788675|FG000|Overall Study|did not follow the treatment regimen|1|||
30777663|NCT03993288|58788676|FG001|Overall Study|did not follow the treatment regimen|0|||
30777664|NCT03993288|58788675|FG000|Overall Study|Adverse Event|1|||
30777665|NCT03993288|58788676|FG001|Overall Study|Adverse Event|0|||
30777666|NCT03993288|58788675|FG000|Overall Study|Withdrawal by Subject|1|||
30777667|NCT03993288|58788676|FG001|Overall Study|Withdrawal by Subject|1|||
30777668|NCT03991494|58788682|FG000|Overall Study|Progressive Disease|4|||
30777669|NCT00086307|58788691|FG000|Overall Study|Lack of Efficacy|1|||
30777670|NCT00086307|58788692|FG001|Overall Study|Lack of Efficacy|1|||
30777671|NCT00086307|58788693|FG002|Overall Study|Lack of Efficacy|2|||
30852903|NCT02394028|58880199|FG002|Maintenance Phase|Protocol Violation|0|||
30955800|NCT01781429|59015224|FG013|Overall Study|Disease Progression|4|||
30955801|NCT01781429|59015225|FG014|Overall Study|Disease Progression|11|||
30955802|NCT01781429|59015226|FG015|Overall Study|Disease Progression|0|||
30955803|NCT01781429|59015211|FG000|Overall Study|Unacceptable Toxicity|0|||
30955804|NCT01781429|59015212|FG001|Overall Study|Unacceptable Toxicity|0|||
30955805|NCT01781429|59015213|FG002|Overall Study|Unacceptable Toxicity|0|||
30955806|NCT01781429|59015214|FG003|Overall Study|Unacceptable Toxicity|0|||
30955807|NCT01781429|59015215|FG004|Overall Study|Unacceptable Toxicity|0|||
30955808|NCT01781429|59015216|FG005|Overall Study|Unacceptable Toxicity|0|||
30955809|NCT01781429|59015217|FG006|Overall Study|Unacceptable Toxicity|0|||
30955810|NCT01781429|59015218|FG007|Overall Study|Unacceptable Toxicity|0|||
30662646|NCT00561925|58676227|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
30852904|NCT02394028|58880200|FG003|Maintenance Phase|Protocol Violation|0|||
30852905|NCT02394028|58880201|FG004|Maintenance Phase|Protocol Violation|0|||
30852906|NCT02394028|58880202|FG005|Maintenance Phase|Protocol Violation|0|||
30852907|NCT02394028|58880203|FG006|Maintenance Phase|Protocol Violation|0|||
30852908|NCT02394028|58880204|FG007|Maintenance Phase|Protocol Violation|0|||
30852909|NCT02394028|58880205|FG008|Maintenance Phase|Protocol Violation|0|||
30852910|NCT02394028|58880206|FG009|Maintenance Phase|Protocol Violation|0|||
30852911|NCT02394028|58880207|FG010|Maintenance Phase|Protocol Violation|1|||
30852912|NCT02394028|58880197|FG000|Maintenance Phase|Physician Decision|0|||
30852913|NCT02394028|58880198|FG001|Maintenance Phase|Physician Decision|0|||
30852914|NCT02394028|58880199|FG002|Maintenance Phase|Physician Decision|0|||
30852915|NCT02394028|58880200|FG003|Maintenance Phase|Physician Decision|0|||
30852916|NCT02394028|58880201|FG004|Maintenance Phase|Physician Decision|0|||
30852917|NCT02394028|58880202|FG005|Maintenance Phase|Physician Decision|0|||
30852918|NCT02394028|58880203|FG006|Maintenance Phase|Physician Decision|0|||
30852919|NCT02394028|58880204|FG007|Maintenance Phase|Physician Decision|0|||
30852920|NCT02394028|58880205|FG008|Maintenance Phase|Physician Decision|1|||
30955811|NCT01781429|59015219|FG008|Overall Study|Unacceptable Toxicity|0|||
30955812|NCT01781429|59015220|FG009|Overall Study|Unacceptable Toxicity|0|||
30955813|NCT01781429|59015221|FG010|Overall Study|Unacceptable Toxicity|0|||
30955814|NCT01781429|59015222|FG011|Overall Study|Unacceptable Toxicity|2|||
30955815|NCT01781429|59015223|FG012|Overall Study|Unacceptable Toxicity|0|||
30955816|NCT01781429|59015224|FG013|Overall Study|Unacceptable Toxicity|0|||
30955817|NCT01781429|59015225|FG014|Overall Study|Unacceptable Toxicity|0|||
30955818|NCT01781429|59015226|FG015|Overall Study|Unacceptable Toxicity|0|||
30955819|NCT01781429|59015211|FG000|Overall Study|Patient Condition Changed|0|||
30955820|NCT01781429|59015212|FG001|Overall Study|Patient Condition Changed|0|||
30955821|NCT01781429|59015213|FG002|Overall Study|Patient Condition Changed|0|||
30955822|NCT01781429|59015214|FG003|Overall Study|Patient Condition Changed|0|||
30955823|NCT01781429|59015215|FG004|Overall Study|Patient Condition Changed|0|||
30955824|NCT01781429|59015216|FG005|Overall Study|Patient Condition Changed|0|||
30955825|NCT01781429|59015217|FG006|Overall Study|Patient Condition Changed|0|||
30955826|NCT01781429|59015218|FG007|Overall Study|Patient Condition Changed|0|||
30955827|NCT01781429|59015219|FG008|Overall Study|Patient Condition Changed|0|||
30955828|NCT01781429|59015220|FG009|Overall Study|Patient Condition Changed|4|||
30955829|NCT01781429|59015221|FG010|Overall Study|Patient Condition Changed|0|||
30955830|NCT01781429|59015222|FG011|Overall Study|Patient Condition Changed|1|||
30955831|NCT01781429|59015223|FG012|Overall Study|Patient Condition Changed|0|||
30955832|NCT01781429|59015224|FG013|Overall Study|Patient Condition Changed|1|||
30955833|NCT01781429|59015225|FG014|Overall Study|Patient Condition Changed|0|||
30955834|NCT01781429|59015226|FG015|Overall Study|Patient Condition Changed|0|||
30955835|NCT01781429|59015211|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
30955836|NCT01781429|59015212|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
30955837|NCT01781429|59015213|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
30777672|NCT00086307|58788691|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
30777673|NCT00086307|58788692|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
30777674|NCT00086307|58788693|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
30777675|NCT00086307|58788691|FG000|Overall Study|Nausea and headaches|0|||
30777676|NCT00086307|58788692|FG001|Overall Study|Nausea and headaches|0|||
30777677|NCT00086307|58788693|FG002|Overall Study|Nausea and headaches|1|||
30777678|NCT00086307|58788691|FG000|Overall Study|Constipation and sleepiness|0|||
30852921|NCT02394028|58880206|FG009|Maintenance Phase|Physician Decision|3|||
30955838|NCT01781429|59015214|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
30955839|NCT01781429|59015215|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
30955840|NCT01781429|59015216|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
30777679|NCT00086307|58788692|FG001|Overall Study|Constipation and sleepiness|0|||
30777680|NCT00086307|58788693|FG002|Overall Study|Constipation and sleepiness|1|||
30777681|NCT00086307|58788691|FG000|Overall Study|Suicidal ideation|0|||
30777682|NCT00086307|58788692|FG001|Overall Study|Suicidal ideation|0|||
30777683|NCT00086307|58788693|FG002|Overall Study|Suicidal ideation|1|||
30852922|NCT02394028|58880207|FG010|Maintenance Phase|Physician Decision|2|||
30852923|NCT02394028|58880197|FG000|Maintenance Phase|Lack of Efficacy|0|||
30852924|NCT02394028|58880198|FG001|Maintenance Phase|Lack of Efficacy|0|||
30852925|NCT02394028|58880199|FG002|Maintenance Phase|Lack of Efficacy|0|||
30852926|NCT02394028|58880200|FG003|Maintenance Phase|Lack of Efficacy|0|||
30852927|NCT02394028|58880201|FG004|Maintenance Phase|Lack of Efficacy|0|||
30852928|NCT02394028|58880202|FG005|Maintenance Phase|Lack of Efficacy|0|||
30955841|NCT01781429|59015217|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
30955842|NCT01781429|59015218|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
30955843|NCT01781429|59015219|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
30955844|NCT01781429|59015220|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
30955845|NCT01781429|59015221|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
30955846|NCT01781429|59015222|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
30955847|NCT01781429|59015223|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
30955848|NCT01781429|59015224|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
30955849|NCT01781429|59015225|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
30955850|NCT01781429|59015226|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
30955851|NCT01781429|59015211|FG000|Overall Study|Enrolled, but not treated|0|||
30955852|NCT01781429|59015212|FG001|Overall Study|Enrolled, but not treated|0|||
30955853|NCT01781429|59015213|FG002|Overall Study|Enrolled, but not treated|0|||
30955854|NCT01781429|59015214|FG003|Overall Study|Enrolled, but not treated|0|||
30955855|NCT01781429|59015215|FG004|Overall Study|Enrolled, but not treated|0|||
30955856|NCT01781429|59015216|FG005|Overall Study|Enrolled, but not treated|0|||
30955857|NCT01781429|59015217|FG006|Overall Study|Enrolled, but not treated|0|||
30955858|NCT01781429|59015218|FG007|Overall Study|Enrolled, but not treated|0|||
30955859|NCT01781429|59015219|FG008|Overall Study|Enrolled, but not treated|0|||
30955860|NCT01781429|59015220|FG009|Overall Study|Enrolled, but not treated|0|||
30955861|NCT01781429|59015221|FG010|Overall Study|Enrolled, but not treated|1|||
30955862|NCT01781429|59015222|FG011|Overall Study|Enrolled, but not treated|0|||
30955863|NCT01781429|59015223|FG012|Overall Study|Enrolled, but not treated|0|||
30955864|NCT01781429|59015224|FG013|Overall Study|Enrolled, but not treated|0|||
30955865|NCT01781429|59015225|FG014|Overall Study|Enrolled, but not treated|0|||
30955866|NCT01781429|59015226|FG015|Overall Study|Enrolled, but not treated|0|||
30955867|NCT01773473|59015261|FG000|Overall Study|Adverse Event|3|||
30955868|NCT01773473|59015262|FG001|Overall Study|Adverse Event|2|||
30955869|NCT01773473|59015261|FG000|Overall Study|Protocol Violation|0|||
30955870|NCT01773473|59015262|FG001|Overall Study|Protocol Violation|4|||
30955871|NCT01773473|59015261|FG000|Overall Study|Physician Decision|3|||
30955872|NCT01773473|59015262|FG001|Overall Study|Physician Decision|5|||
30662647|NCT00561925|58676228|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
30662648|NCT00561925|58676229|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
30955873|NCT01773473|59015261|FG000|Overall Study|Sponsor Decision|2|||
30955874|NCT01773473|59015262|FG001|Overall Study|Sponsor Decision|0|||
30955875|NCT01773473|59015261|FG000|Overall Study|Lack of Efficacy|0|||
30955876|NCT01773473|59015262|FG001|Overall Study|Lack of Efficacy|1|||
30955877|NCT01773473|59015261|FG000|Overall Study|Non-Compliance with study drug|1|||
30955878|NCT01773473|59015262|FG001|Overall Study|Non-Compliance with study drug|4|||
30852929|NCT02394028|58880203|FG006|Maintenance Phase|Lack of Efficacy|0|||
30955879|NCT01773473|59015261|FG000|Overall Study|Withdrawal by Subject|5|||
30955880|NCT01773473|59015262|FG001|Overall Study|Withdrawal by Subject|3|||
30852930|NCT02394028|58880204|FG007|Maintenance Phase|Lack of Efficacy|0|||
30852931|NCT02394028|58880205|FG008|Maintenance Phase|Lack of Efficacy|7|||
30955881|NCT01773473|59015261|FG000|Overall Study|Lost to Follow-up|2|||
30955882|NCT01773473|59015262|FG001|Overall Study|Lost to Follow-up|0|||
30955883|NCT01772693|59015270|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
30955884|NCT01772693|59015271|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
30955885|NCT01772693|59015270|FG000|Overall Study|Withdrawal by Subject|2|||
30955886|NCT01772693|59015271|FG001|Overall Study|Withdrawal by Subject|0|||
30955887|NCT01772693|59015270|FG000|Overall Study|Alternative Treatment|2|||
30955888|NCT01772693|59015271|FG001|Overall Study|Alternative Treatment|0|||
30955889|NCT01779869|59015277|FG000|Overall Study|Physician Decision|2|||
30955890|NCT01772537|59015284|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
30955891|NCT01772537|59015285|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
30955892|NCT01772537|59015286|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
30955893|NCT01772147|59015299|FG000|Overall Study|Adverse Event|13|||
30955894|NCT01772147|59015300|FG001|Overall Study|Adverse Event|10|||
30955895|NCT01772147|59015301|FG002|Overall Study|Adverse Event|6|||
30955896|NCT01772147|59015299|FG000|Overall Study|Withdrew Consent|7|||
30955897|NCT01772147|59015300|FG001|Overall Study|Withdrew Consent|8|||
30955898|NCT01772147|59015301|FG002|Overall Study|Withdrew Consent|4|||
30955899|NCT01772147|59015299|FG000|Overall Study|Lost to Follow-up|1|||
30955900|NCT01772147|59015300|FG001|Overall Study|Lost to Follow-up|0|||
30955901|NCT01772147|59015301|FG002|Overall Study|Lost to Follow-up|1|||
30955902|NCT01772147|59015299|FG000|Overall Study|Protocol Deviation|2|||
30955903|NCT01772147|59015300|FG001|Overall Study|Protocol Deviation|1|||
30955904|NCT01772147|59015301|FG002|Overall Study|Protocol Deviation|1|||
30955905|NCT01772147|59015299|FG000|Overall Study|Lack of Efficacy|8|||
30955906|NCT01772147|59015300|FG001|Overall Study|Lack of Efficacy|6|||
30955907|NCT01772147|59015301|FG002|Overall Study|Lack of Efficacy|6|||
30955908|NCT01771913|59015311|FG000|Overall Study|Withdrawal by Subject|1|||
30955909|NCT01771913|59015312|FG001|Overall Study|Withdrawal by Subject|0|||
30955910|NCT01606787|59015320|FG000|Overall Study|Withdrawal by Subject|4|||
30955911|NCT01606787|59015321|FG001|Overall Study|Withdrawal by Subject|5|||
30955912|NCT01606787|59015320|FG000|Overall Study|Surgery canceled|0|||
30955913|NCT01606787|59015321|FG001|Overall Study|Surgery canceled|2|||
30955914|NCT01778855|59015329|FG000|Overall Study|Death|0|||
30955915|NCT01778855|59015330|FG001|Overall Study|Death|1|||
30955916|NCT01777997|59015336|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
30955917|NCT01777997|59015336|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
30955918|NCT01777997|59015336|FG000|Weeks 48 to 72/96 on ART|Death|1|||
30955919|NCT01777997|59015336|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
30955920|NCT01770509|59015342|FG000|Overall Study|Injury|0|||
30955921|NCT01770509|59015343|FG001|Overall Study|Injury|1|||
30955922|NCT01770509|59015342|FG000|Overall Study|Lost to Follow-up|1|||
30955923|NCT01770509|59015343|FG001|Overall Study|Lost to Follow-up|2|||
30955924|NCT01770353|59015351|FG000|Overall Study|Progressive disease|2|||
30955925|NCT01770353|59015352|FG001|Overall Study|Progressive disease|1|||
30955926|NCT01770353|59015351|FG000|Overall Study|Adverse Event|0|||
30955927|NCT01770353|59015352|FG001|Overall Study|Adverse Event|1|||
30955928|NCT01770353|59015351|FG000|Overall Study|Protocol Violation|1|||
30955929|NCT01770353|59015352|FG001|Overall Study|Protocol Violation|0|||
30955930|NCT01770353|59015351|FG000|Overall Study|Physician Decision|0|||
30955931|NCT01770353|59015352|FG001|Overall Study|Physician Decision|3|||
30777684|NCT00086307|58788691|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
30777685|NCT00086307|58788692|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
30777686|NCT00086307|58788693|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
30777687|NCT00086307|58788691|FG000|Overall Study|Withdrawal by Subject|0|||
30777688|NCT00086307|58788692|FG001|Overall Study|Withdrawal by Subject|0|||
30777689|NCT00086307|58788693|FG002|Overall Study|Withdrawal by Subject|2|||
30777690|NCT03624972|58788704|FG000|Overall Study|Lost to Follow-up|2|||
30955932|NCT01770353|59015351|FG000|Overall Study|Clinical deterioration|3|||
30955933|NCT01770353|59015352|FG001|Overall Study|Clinical deterioration|6|||
30955934|NCT01770353|59015351|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
30955935|NCT01770353|59015352|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
30955936|NCT01777763|59015368|FG000|Overall Study|Adverse Event|2|||
30777691|NCT03624972|58788705|FG001|Overall Study|Lost to Follow-up|0|||
30777692|NCT03624972|58788706|FG002|Overall Study|Lost to Follow-up|0|||
30955937|NCT01777763|59015369|FG001|Overall Study|Adverse Event|32|||
30955938|NCT01777763|59015368|FG000|Overall Study|Protocol Violation|1|||
30955939|NCT01777763|59015369|FG001|Overall Study|Protocol Violation|7|||
30955940|NCT01777763|59015368|FG000|Overall Study|Withdrawal by Subject|0|||
30955941|NCT01777763|59015369|FG001|Overall Study|Withdrawal by Subject|2|||
30955942|NCT01777763|59015368|FG000|Overall Study|Treatment Failure|1|||
30955943|NCT01777763|59015369|FG001|Overall Study|Treatment Failure|6|||
30955944|NCT01769339|59015375|FG000|Overall Study|Lost to Follow-up|42|||
30955945|NCT01769339|59015375|FG000|Overall Study|Adverse Event|1|||
30955946|NCT01769105|59015381|FG000|First Intervention|Protocol Violation|2|||
30955947|NCT01769105|59015382|FG001|First Intervention|Protocol Violation|2|||
30955948|NCT01769105|59015381|FG000|Cross-over|Lost to Follow-up|5|||
30955949|NCT01769105|59015382|FG001|Cross-over|Lost to Follow-up|0|||
30852932|NCT02394028|58880206|FG009|Maintenance Phase|Lack of Efficacy|25|||
30955950|NCT01777139|59015390|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
30955951|NCT01777139|59015391|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
30662649|NCT00561925|58676230|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
30662650|NCT00561925|58676226|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
30662651|NCT00561925|58676227|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
30662652|NCT00561925|58676228|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
30662653|NCT00561925|58676229|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
30662654|NCT00561925|58676230|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
30662655|NCT00561925|58676226|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
30662656|NCT00561925|58676227|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
30662657|NCT00561925|58676228|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
30662658|NCT00561925|58676229|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
30662659|NCT00561925|58676230|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
30662660|NCT00561925|58676226|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
30662661|NCT00561925|58676227|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
30662662|NCT00561925|58676228|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
30662663|NCT00561925|58676229|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
30662664|NCT00561925|58676230|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
30662665|NCT00561925|58676226|FG000|144-week Double-blind, Double-dummy|Death|0|||
30662666|NCT00561925|58676227|FG001|144-week Double-blind, Double-dummy|Death|6|||
30662667|NCT00561925|58676228|FG002|144-week Double-blind, Double-dummy|Death|3|||
30662668|NCT00561925|58676229|FG003|144-week Double-blind, Double-dummy|Death|0|||
30662669|NCT00561925|58676230|FG004|144-week Double-blind, Double-dummy|Death|0|||
30662670|NCT00561925|58676226|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
30662671|NCT00561925|58676227|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
30662672|NCT00561925|58676228|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
30777693|NCT03624972|58788704|FG000|Overall Study|Withdrawal by Subject|0|||
30777694|NCT03624972|58788705|FG001|Overall Study|Withdrawal by Subject|2|||
30777695|NCT03624972|58788706|FG002|Overall Study|Withdrawal by Subject|0|||
30777696|NCT03988842|58788715|FG000|Overall Study|Death|1|||
30777697|NCT02668822|58788722|FG000|Overall Study|Protocol Violation|2|||
30777698|NCT02668822|58788723|FG001|Overall Study|Protocol Violation|0|||
30777699|NCT02668822|58788722|FG000|Overall Study|Study Terminated by Sponsor|7|||
30777700|NCT02668822|58788723|FG001|Overall Study|Study Terminated by Sponsor|9|||
30777701|NCT02524288|58788729|FG000|Overall Study|Adverse Event|115|||
30777702|NCT02524288|58788729|FG000|Overall Study|Lost to Follow-up|216|||
30777703|NCT02524288|58788729|FG000|Overall Study|Non-Compliance With Protocol|32|||
30777704|NCT02524288|58788729|FG000|Overall Study|Non-Compliance With Study Drug|14|||
30777705|NCT02524288|58788729|FG000|Overall Study|Pregnancy Wish|6|||
30955952|NCT01777139|59015390|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
30955953|NCT01777139|59015391|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
30955954|NCT01777139|59015390|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
30955955|NCT01777139|59015391|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
30955956|NCT01777139|59015390|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
30955957|NCT01777139|59015391|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
30852933|NCT02394028|58880207|FG010|Maintenance Phase|Lack of Efficacy|33|||
30852934|NCT02394028|58880197|FG000|Maintenance Phase|Death|0|||
30852935|NCT02394028|58880198|FG001|Maintenance Phase|Death|0|||
30852936|NCT02394028|58880199|FG002|Maintenance Phase|Death|0|||
30852937|NCT02394028|58880200|FG003|Maintenance Phase|Death|0|||
30852938|NCT02394028|58880201|FG004|Maintenance Phase|Death|0|||
30852939|NCT02394028|58880202|FG005|Maintenance Phase|Death|0|||
30852940|NCT02394028|58880203|FG006|Maintenance Phase|Death|0|||
30852941|NCT02394028|58880204|FG007|Maintenance Phase|Death|0|||
30852942|NCT02394028|58880205|FG008|Maintenance Phase|Death|0|||
30852943|NCT02394028|58880206|FG009|Maintenance Phase|Death|0|||
30852944|NCT02394028|58880207|FG010|Maintenance Phase|Death|1|||
30852945|NCT02394028|58880197|FG000|Maintenance Phase|Adverse Event|0|||
30852946|NCT02394028|58880198|FG001|Maintenance Phase|Adverse Event|0|||
30955958|NCT01777139|59015390|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
30852947|NCT02394028|58880199|FG002|Maintenance Phase|Adverse Event|0|||
30852948|NCT02394028|58880200|FG003|Maintenance Phase|Adverse Event|0|||
30852949|NCT02394028|58880201|FG004|Maintenance Phase|Adverse Event|0|||
30852950|NCT02394028|58880202|FG005|Maintenance Phase|Adverse Event|0|||
30852951|NCT02394028|58880203|FG006|Maintenance Phase|Adverse Event|0|||
30852952|NCT02394028|58880204|FG007|Maintenance Phase|Adverse Event|0|||
30852953|NCT02394028|58880205|FG008|Maintenance Phase|Adverse Event|1|||
30852954|NCT02394028|58880206|FG009|Maintenance Phase|Adverse Event|1|||
30852955|NCT02394028|58880207|FG010|Maintenance Phase|Adverse Event|3|||
30852956|NCT02394028|58880197|FG000|Maintenance Phase|Site closure|0|||
30852957|NCT02394028|58880198|FG001|Maintenance Phase|Site closure|0|||
30852958|NCT02394028|58880199|FG002|Maintenance Phase|Site closure|0|||
30852959|NCT02394028|58880200|FG003|Maintenance Phase|Site closure|0|||
30852960|NCT02394028|58880201|FG004|Maintenance Phase|Site closure|0|||
30852961|NCT02394028|58880202|FG005|Maintenance Phase|Site closure|0|||
30852962|NCT02394028|58880203|FG006|Maintenance Phase|Site closure|0|||
30852963|NCT02394028|58880204|FG007|Maintenance Phase|Site closure|0|||
30852964|NCT02394028|58880205|FG008|Maintenance Phase|Site closure|0|||
30852965|NCT02394028|58880206|FG009|Maintenance Phase|Site closure|1|||
30852966|NCT02394028|58880207|FG010|Maintenance Phase|Site closure|0|||
30852967|NCT02394028|58880197|FG000|Maintenance Phase|Withdrawal by Subject|0|||
30852968|NCT02394028|58880198|FG001|Maintenance Phase|Withdrawal by Subject|0|||
30955959|NCT01777139|59015391|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
30955960|NCT01777139|59015390|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
30955961|NCT01777139|59015391|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
30662673|NCT00561925|58676229|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
30662674|NCT00561925|58676230|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
30777706|NCT02524288|58788729|FG000|Overall Study|Protocol Violation|6|||
30777707|NCT02524288|58788729|FG000|Overall Study|Screen Failure|2|||
30777708|NCT02524288|58788729|FG000|Overall Study|Site Discontinued Study Participation|1|||
30777709|NCT02524288|58788729|FG000|Overall Study|Study Terminated By Sponsor|1417|||
30777710|NCT02524288|58788729|FG000|Overall Study|Subject Moved|32|||
30777711|NCT02524288|58788729|FG000|Overall Study|Withdrawal by Subject|76|||
30777712|NCT02524288|58788729|FG000|Overall Study|Pregnancy|22|||
30777713|NCT02524288|58788729|FG000|Overall Study|Physician Decision|2|||
30777714|NCT03624504|58788733|FG000|Overall Study|Unsuccessful Implant|1|||
30777715|NCT02954952|58788740|FG000|Overall Study|Withdrawal by Subject|1|||
30777716|NCT02954952|58788741|FG001|Overall Study|Withdrawal by Subject|0|||
30852969|NCT02394028|58880199|FG002|Maintenance Phase|Withdrawal by Subject|0|||
30852970|NCT02394028|58880200|FG003|Maintenance Phase|Withdrawal by Subject|0|||
30852971|NCT02394028|58880201|FG004|Maintenance Phase|Withdrawal by Subject|0|||
30852972|NCT02394028|58880202|FG005|Maintenance Phase|Withdrawal by Subject|0|||
30777717|NCT02954952|58788742|FG002|Overall Study|Withdrawal by Subject|0|||
30777718|NCT02954952|58788740|FG000|Overall Study|No data collected|0|||
30852973|NCT02394028|58880203|FG006|Maintenance Phase|Withdrawal by Subject|0|||
30852974|NCT02394028|58880204|FG007|Maintenance Phase|Withdrawal by Subject|0|||
30852975|NCT02394028|58880205|FG008|Maintenance Phase|Withdrawal by Subject|3|||
30852976|NCT02394028|58880206|FG009|Maintenance Phase|Withdrawal by Subject|12|||
30852977|NCT02394028|58880207|FG010|Maintenance Phase|Withdrawal by Subject|12|||
30852978|NCT01371539|58880261|FG000|Period One: One Week|Lost to Follow-up|0|||
30852979|NCT01371539|58880262|FG001|Period One: One Week|Lost to Follow-up|1|||
30852980|NCT01371539|58880261|FG000|Period Two: One Week|Lost to Follow-up|0|||
30852981|NCT01371539|58880262|FG001|Period Two: One Week|Lost to Follow-up|1|||
30852982|NCT01371539|58880261|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
30955962|NCT01777139|59015390|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
30955963|NCT01777139|59015391|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
30852983|NCT01371539|58880262|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
30852984|NCT01371539|58880261|FG000|Period Two: One Week|Time/job conflict|0|||
30852985|NCT01371539|58880262|FG001|Period Two: One Week|Time/job conflict|1|||
30852986|NCT03320330|58880271|FG000|Overall Study|Lack of Efficacy|5|||
30852987|NCT03320330|58880272|FG001|Overall Study|Lack of Efficacy|5|||
30852988|NCT03320330|58880273|FG002|Overall Study|Lack of Efficacy|14|||
30852989|NCT03320330|58880271|FG000|Overall Study|Physician Decision|1|||
30852990|NCT03320330|58880272|FG001|Overall Study|Physician Decision|0|||
30852991|NCT03320330|58880273|FG002|Overall Study|Physician Decision|0|||
30852992|NCT02819297|58880284|FG000|Overall Study|Withdrawal by Subject|25|||
30852993|NCT02819297|58880285|FG001|Overall Study|Withdrawal by Subject|13|||
30852994|NCT02819297|58880284|FG000|Overall Study|Lost to Follow-up|12|||
30852995|NCT02819297|58880285|FG001|Overall Study|Lost to Follow-up|14|||
30852996|NCT02819297|58880284|FG000|Overall Study|Adverse Event|12|||
30852997|NCT02819297|58880285|FG001|Overall Study|Adverse Event|10|||
30852998|NCT02819297|58880284|FG000|Overall Study|Physician Decision|5|||
30852999|NCT02819297|58880285|FG001|Overall Study|Physician Decision|5|||
30853000|NCT02819297|58880284|FG000|Overall Study|Lack of Efficacy|5|||
30853001|NCT02819297|58880285|FG001|Overall Study|Lack of Efficacy|8|||
30853002|NCT02819297|58880284|FG000|Overall Study|Protocol Violation|1|||
30853003|NCT02819297|58880285|FG001|Overall Study|Protocol Violation|2|||
30955964|NCT01777139|59015390|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
30955965|NCT01777139|59015391|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
30955966|NCT01768637|59015400|FG000|Overall Study|Lost to Follow-up|2|||
30955967|NCT01768637|59015401|FG001|Overall Study|Lost to Follow-up|7|||
30955968|NCT01768637|59015400|FG000|Overall Study|Difficult blood draw|1|||
30955969|NCT01768637|59015401|FG001|Overall Study|Difficult blood draw|0|||
30955970|NCT01768559|59015410|FG000|Overall Study|Randomized but not treated|0|||
30777719|NCT02954952|58788741|FG001|Overall Study|No data collected|1|||
30777720|NCT02954952|58788742|FG002|Overall Study|No data collected|0|||
30777721|NCT03547154|58788752|FG000|Overall Study|Disease Progression/Recurrence|6|||
30777722|NCT03547154|58788753|FG001|Overall Study|Disease Progression/Recurrence|14|||
30777723|NCT03547154|58788752|FG000|Overall Study|Adverse Event|26|||
30777724|NCT03547154|58788753|FG001|Overall Study|Adverse Event|31|||
30777725|NCT03547154|58788752|FG000|Overall Study|Protocol Violation|6|||
30777726|NCT03547154|58788753|FG001|Overall Study|Protocol Violation|1|||
30777727|NCT03547154|58788752|FG000|Overall Study|Physician Decision|4|||
30777728|NCT03547154|58788753|FG001|Overall Study|Physician Decision|3|||
30777729|NCT03547154|58788752|FG000|Overall Study|Insufficient Therapeutic Response|13|||
30777730|NCT03547154|58788753|FG001|Overall Study|Insufficient Therapeutic Response|10|||
30853004|NCT02429830|58880291|FG000|Overall Study|Lost to Follow-up|1|||
30853005|NCT02429830|58880291|FG000|Overall Study|Device Explant|2|||
30853006|NCT02821715|58880295|FG000|Overall Study|Protocol Violation|1|||
30853007|NCT02821715|58880296|FG001|Overall Study|Protocol Violation|0|||
30853008|NCT02821715|58880297|FG002|Overall Study|Protocol Violation|0|||
30853009|NCT02821715|58880298|FG003|Overall Study|Protocol Violation|0|||
30853010|NCT02821715|58880299|FG004|Overall Study|Protocol Violation|0|||
30853011|NCT02821715|58880300|FG005|Overall Study|Protocol Violation|0|||
30853012|NCT02813681|58880311|FG000|Overall Study|Physician Decision|5|||
30853013|NCT02813681|58880312|FG001|Overall Study|Physician Decision|5|||
30853014|NCT02813681|58880313|FG002|Overall Study|Physician Decision|0|||
30853015|NCT02813681|58880311|FG000|Overall Study|Lost to Follow-up|0|||
30853016|NCT02813681|58880312|FG001|Overall Study|Lost to Follow-up|1|||
30777731|NCT03547154|58788752|FG000|Overall Study|Withdrawal by Subject|10|||
30777732|NCT03547154|58788753|FG001|Overall Study|Withdrawal by Subject|6|||
30777733|NCT03547154|58788752|FG000|Overall Study|Not Selected|0|||
30777734|NCT03547154|58788753|FG001|Overall Study|Not Selected|1|||
30853017|NCT02813681|58880313|FG002|Overall Study|Lost to Follow-up|0|||
30777735|NCT03547154|58788752|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
30853018|NCT02393950|58880325|FG000|Overall Study|Adverse Event|1|||
30853019|NCT02393950|58880326|FG001|Overall Study|Adverse Event|0|||
30853020|NCT02393950|58880325|FG000|Overall Study|Withdrawal by Subject|0|||
30853021|NCT02393950|58880326|FG001|Overall Study|Withdrawal by Subject|1|||
30853022|NCT02815397|58880361|FG000|Overall Study|Physician Decision|2|||
30853023|NCT02427958|58880365|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
30853024|NCT02427958|58880365|FG000|Overall Study|Lost to Follow-up|6|||
30853025|NCT02427958|58880365|FG000|Overall Study|Withdrawal by Subject|14|||
30853026|NCT02427958|58880365|FG000|Overall Study|Lack of Efficacy|1|||
30853027|NCT02392624|58880372|FG000|Overall Study|Withdrawal by Subject|15|||
30955971|NCT01768559|59015411|FG001|Overall Study|Randomized but not treated|0|||
30955972|NCT01768559|59015412|FG002|Overall Study|Randomized but not treated|1|||
30955973|NCT01768559|59015410|FG000|Overall Study|Adverse Event|15|||
30777736|NCT03547154|58788753|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
30777737|NCT02275546|58788759|FG000|Treatment Period 2|Withdrawal by Subject|2|||
30777738|NCT02275546|58788760|FG001|Treatment Period 2|Withdrawal by Subject|1|||
30955974|NCT01768559|59015411|FG001|Overall Study|Adverse Event|2|||
30955975|NCT01768559|59015412|FG002|Overall Study|Adverse Event|5|||
30955976|NCT01768559|59015410|FG000|Overall Study|Lack of Efficacy|6|||
30955977|NCT01768559|59015411|FG001|Overall Study|Lack of Efficacy|4|||
30955978|NCT01768559|59015412|FG002|Overall Study|Lack of Efficacy|0|||
30955979|NCT01768559|59015410|FG000|Overall Study|Poor compliance to protocol|0|||
30955980|NCT01768559|59015411|FG001|Overall Study|Poor compliance to protocol|3|||
30955981|NCT01768559|59015412|FG002|Overall Study|Poor compliance to protocol|2|||
30955982|NCT01768559|59015410|FG000|Overall Study|Other than specified|9|||
30853028|NCT02392624|58880373|FG001|Overall Study|Withdrawal by Subject|12|||
30853029|NCT02392624|58880374|FG002|Overall Study|Withdrawal by Subject|9|||
30853030|NCT02392624|58880372|FG000|Overall Study|Adverse Event|4|||
30853031|NCT02392624|58880373|FG001|Overall Study|Adverse Event|1|||
30853032|NCT02392624|58880374|FG002|Overall Study|Adverse Event|2|||
30853033|NCT02392624|58880372|FG000|Overall Study|Pregnancy|1|||
30853034|NCT02392624|58880373|FG001|Overall Study|Pregnancy|0|||
30853035|NCT02392624|58880374|FG002|Overall Study|Pregnancy|0|||
30853036|NCT02392624|58880372|FG000|Overall Study|Protocol Violation|0|||
30853037|NCT02392624|58880373|FG001|Overall Study|Protocol Violation|0|||
30853038|NCT02392624|58880374|FG002|Overall Study|Protocol Violation|1|||
30853039|NCT02392624|58880372|FG000|Overall Study|Sponsor/Investigator Decision|2|||
30853040|NCT02392624|58880373|FG001|Overall Study|Sponsor/Investigator Decision|1|||
30853041|NCT02392624|58880374|FG002|Overall Study|Sponsor/Investigator Decision|0|||
30853042|NCT02392624|58880372|FG000|Overall Study|Other|49|||
30853043|NCT02392624|58880373|FG001|Overall Study|Other|1|||
30853044|NCT02392624|58880374|FG002|Overall Study|Other|1|||
30853045|NCT02387164|58880384|FG000|Overall Study|Lost to Follow-up|2|||
30955983|NCT01768559|59015411|FG001|Overall Study|Other than specified|8|||
30955984|NCT01768559|59015412|FG002|Overall Study|Other than specified|5|||
30955985|NCT00983619|59015436|FG000|Overall Study|Lost to Follow-up|0|||
30955986|NCT00983619|59015437|FG001|Overall Study|Lost to Follow-up|1|||
30955987|NCT00983619|59015438|FG002|Overall Study|Lost to Follow-up|0|||
30955988|NCT00983619|59015439|FG003|Overall Study|Lost to Follow-up|0|||
30955989|NCT00983619|59015440|FG004|Overall Study|Lost to Follow-up|0|||
30955990|NCT00983619|59015441|FG005|Overall Study|Lost to Follow-up|2|||
30955991|NCT00983619|59015442|FG006|Overall Study|Lost to Follow-up|0|||
30955992|NCT00983619|59015443|FG007|Overall Study|Lost to Follow-up|0|||
30955993|NCT00983619|59015444|FG008|Overall Study|Lost to Follow-up|0|||
30955994|NCT00983619|59015445|FG009|Overall Study|Lost to Follow-up|0|||
30955995|NCT00983619|59015446|FG010|Overall Study|Lost to Follow-up|0|||
30955996|NCT00983619|59015447|FG011|Overall Study|Lost to Follow-up|2|||
30955997|NCT00983619|59015436|FG000|Overall Study|Withdrawal by Subject|2|||
30955998|NCT00983619|59015437|FG001|Overall Study|Withdrawal by Subject|1|||
30955999|NCT00983619|59015438|FG002|Overall Study|Withdrawal by Subject|1|||
30956000|NCT00983619|59015439|FG003|Overall Study|Withdrawal by Subject|3|||
30956001|NCT00983619|59015440|FG004|Overall Study|Withdrawal by Subject|1|||
30956002|NCT00983619|59015441|FG005|Overall Study|Withdrawal by Subject|23|||
30956003|NCT00983619|59015442|FG006|Overall Study|Withdrawal by Subject|0|||
30956004|NCT00983619|59015443|FG007|Overall Study|Withdrawal by Subject|0|||
30956005|NCT00983619|59015444|FG008|Overall Study|Withdrawal by Subject|0|||
30956006|NCT00983619|59015445|FG009|Overall Study|Withdrawal by Subject|0|||
30956007|NCT00983619|59015446|FG010|Overall Study|Withdrawal by Subject|1|||
30956008|NCT00983619|59015447|FG011|Overall Study|Withdrawal by Subject|1|||
30956009|NCT00983619|59015436|FG000|Overall Study|Death|0|||
30956010|NCT00983619|59015437|FG001|Overall Study|Death|2|||
30956011|NCT00983619|59015438|FG002|Overall Study|Death|2|||
30956012|NCT00983619|59015439|FG003|Overall Study|Death|1|||
30956013|NCT00983619|59015440|FG004|Overall Study|Death|2|||
30777739|NCT02275546|58788759|FG000|Treatment Period 2|Protocol Violation|0|||
30777740|NCT02275546|58788760|FG001|Treatment Period 2|Protocol Violation|1|||
30777741|NCT03624192|58788766|FG000|Overall Study|Lost to Follow-up|1|||
30777742|NCT03624192|58788767|FG001|Overall Study|Lost to Follow-up|1|||
30777743|NCT03034954|58788777|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
30777744|NCT03034954|58788778|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
30853046|NCT02387164|58880385|FG001|Overall Study|Lost to Follow-up|0|||
30956014|NCT00983619|59015441|FG005|Overall Study|Death|30|||
30956015|NCT00983619|59015442|FG006|Overall Study|Death|1|||
30956016|NCT00983619|59015443|FG007|Overall Study|Death|0|||
30777745|NCT03546842|58788784|FG000|Overall Study|Protocol Violation|1|||
30777746|NCT03546842|58788784|FG000|Overall Study|Withdrawal by Subject|2|||
30777747|NCT03640052|58788788|FG000|Overall Study|Lost to Follow-up|0|||
30956017|NCT00983619|59015444|FG008|Overall Study|Death|1|||
30956018|NCT00983619|59015445|FG009|Overall Study|Death|2|||
30956019|NCT00983619|59015446|FG010|Overall Study|Death|9|||
30956020|NCT00983619|59015447|FG011|Overall Study|Death|8|||
30853047|NCT02387164|58880384|FG000|Overall Study|Diagnosed|1|||
30853048|NCT02387164|58880385|FG001|Overall Study|Diagnosed|2|||
30853049|NCT02392234|58880403|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
30956021|NCT00983619|59015436|FG000|Overall Study|Other|1|||
30853050|NCT02392234|58880404|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
30853051|NCT02392234|58880405|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
30956022|NCT00983619|59015437|FG001|Overall Study|Other|0|||
30956023|NCT00983619|59015438|FG002|Overall Study|Other|0|||
30956024|NCT00983619|59015439|FG003|Overall Study|Other|1|||
30956025|NCT00983619|59015440|FG004|Overall Study|Other|0|||
30956026|NCT00983619|59015441|FG005|Overall Study|Other|12|||
30956027|NCT00983619|59015442|FG006|Overall Study|Other|2|||
30956028|NCT00983619|59015443|FG007|Overall Study|Other|2|||
30956029|NCT00983619|59015444|FG008|Overall Study|Other|0|||
30956030|NCT00983619|59015445|FG009|Overall Study|Other|1|||
30956031|NCT00983619|59015446|FG010|Overall Study|Other|1|||
30956032|NCT00983619|59015447|FG011|Overall Study|Other|0|||
30956033|NCT00653068|59015497|FG000|Overall Study|Death|9|||
30956034|NCT00653068|59015497|FG000|Overall Study|Lack of Efficacy|34|||
30956035|NCT00653068|59015497|FG000|Overall Study|Physician Decision|4|||
30777748|NCT03640052|58788789|FG001|Overall Study|Lost to Follow-up|1|||
30777749|NCT03640052|58788790|FG002|Overall Study|Lost to Follow-up|0|||
30956036|NCT00653068|59015497|FG000|Overall Study|Withdrawal by Subject|1|||
30956037|NCT00653068|59015497|FG000|Overall Study|Ineligible|2|||
30956038|NCT01767857|59015506|FG000|Overall Study|Adverse Event|27|||
30956039|NCT01767857|59015507|FG001|Overall Study|Adverse Event|7|||
30956040|NCT01767857|59015506|FG000|Overall Study|Death|28|||
30956041|NCT01767857|59015507|FG001|Overall Study|Death|13|||
30956042|NCT01767857|59015506|FG000|Overall Study|Lack of Efficacy|299|||
30956043|NCT01767857|59015507|FG001|Overall Study|Lack of Efficacy|151|||
30956044|NCT01767857|59015506|FG000|Overall Study|Lost to Follow-up|1|||
30956045|NCT01767857|59015507|FG001|Overall Study|Lost to Follow-up|1|||
30956046|NCT01767857|59015506|FG000|Overall Study|Withdrawal by Subject|38|||
30956047|NCT01767857|59015507|FG001|Overall Study|Withdrawal by Subject|18|||
30956048|NCT01767857|59015506|FG000|Overall Study|Physician Decision|17|||
30777750|NCT03640052|58788791|FG003|Overall Study|Lost to Follow-up|0|||
30777751|NCT03640052|58788792|FG004|Overall Study|Lost to Follow-up|0|||
30777752|NCT00068601|58788806|FG000|Overall Study|Ineligible|11|||
30777753|NCT00068601|58788807|FG001|Overall Study|Ineligible|13|||
30777754|NCT00068601|58788806|FG000|Overall Study|Not evaluable: withdrew consent|5|||
30777755|NCT00068601|58788807|FG001|Overall Study|Not evaluable: withdrew consent|4|||
30777756|NCT00068601|58788806|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
30777757|NCT00068601|58788807|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
30777758|NCT00068601|58788806|FG000|Overall Study|Death|11|||
30777759|NCT00068601|58788807|FG001|Overall Study|Death|3|||
30777760|NCT00068601|58788806|FG000|Overall Study|Lost to Follow-up|3|||
30777761|NCT00068601|58788807|FG001|Overall Study|Lost to Follow-up|2|||
30777762|NCT00068601|58788806|FG000|Overall Study|Missing primary outcome data|30|||
30777763|NCT00068601|58788807|FG001|Overall Study|Missing primary outcome data|34|||
30777764|NCT03638258|58788816|FG000|Overall Study|Adverse Event|1|||
30777765|NCT03638258|58788817|FG001|Overall Study|Adverse Event|0|||
30777766|NCT03638258|58788818|FG002|Overall Study|Adverse Event|2|||
30777767|NCT03638258|58788816|FG000|Overall Study|Lost to Follow-up|2|||
30777768|NCT03638258|58788817|FG001|Overall Study|Lost to Follow-up|4|||
30777769|NCT03638258|58788818|FG002|Overall Study|Lost to Follow-up|5|||
30777770|NCT03638258|58788816|FG000|Overall Study|Pregnancy|0|||
30777771|NCT03638258|58788817|FG001|Overall Study|Pregnancy|0|||
30956049|NCT01767857|59015507|FG001|Overall Study|Physician Decision|10|||
30956050|NCT01767857|59015506|FG000|Overall Study|Protocol Terminated|1|||
30956051|NCT01767857|59015507|FG001|Overall Study|Protocol Terminated|0|||
30956052|NCT01767857|59015506|FG000|Overall Study|Randomized But Never Treated|19|||
30956053|NCT01767857|59015507|FG001|Overall Study|Randomized But Never Treated|13|||
30956054|NCT01775501|59015514|FG000|Overall Study|Discontinued prior to treatment|1|||
30956055|NCT01775189|59015543|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30956056|NCT01775189|59015544|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
30777772|NCT03638258|58788818|FG002|Overall Study|Pregnancy|1|||
30777773|NCT03638258|58788816|FG000|Overall Study|Protocol Violation|0|||
30777774|NCT03638258|58788817|FG001|Overall Study|Protocol Violation|0|||
30777775|NCT03638258|58788818|FG002|Overall Study|Protocol Violation|1|||
30777776|NCT03638258|58788816|FG000|Overall Study|Withdrawal by Subject|4|||
30956057|NCT01775189|59015545|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30956058|NCT01775189|59015546|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30956059|NCT01775189|59015547|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30956060|NCT01775189|59015548|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30956061|NCT01775189|59015549|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
30956062|NCT01775189|59015543|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30956063|NCT01775189|59015544|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
30956064|NCT01775189|59015545|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30956065|NCT01775189|59015546|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30956066|NCT01775189|59015547|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30956067|NCT01775189|59015548|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30956068|NCT01775189|59015549|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
30956069|NCT01775189|59015543|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
30956070|NCT01775189|59015544|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
30956071|NCT01775189|59015545|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
30956072|NCT01775189|59015546|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
30956073|NCT01775189|59015547|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
30853052|NCT02392234|58880406|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
30853053|NCT02392234|58880407|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
30853054|NCT02392234|58880408|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
30956074|NCT01775189|59015548|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
30956075|NCT01775189|59015549|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
30956076|NCT01775189|59015543|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
30956077|NCT01775189|59015544|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
30956078|NCT01775189|59015545|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
30956079|NCT01775189|59015546|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
30956080|NCT01775189|59015547|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
30956081|NCT01775189|59015548|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
30853055|NCT02392234|58880403|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
30853056|NCT02392234|58880404|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
30853057|NCT02392234|58880405|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
30853058|NCT02392234|58880406|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
30956082|NCT01775189|59015549|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
30956083|NCT01775189|59015543|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
30956084|NCT01775189|59015544|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
30956085|NCT01775189|59015545|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
30956086|NCT01775189|59015546|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
30956087|NCT01775189|59015547|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
30956088|NCT01775189|59015548|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
30956089|NCT01775189|59015549|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
30956090|NCT01775189|59015543|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
30956091|NCT01775189|59015544|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
30956092|NCT01775189|59015545|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
30956093|NCT01775189|59015546|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
30956094|NCT01775189|59015547|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
30956095|NCT01775189|59015548|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
30956096|NCT01775189|59015549|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
30956097|NCT01770743|59015615|FG000|Overall Study|Adverse Event|1|||
30956098|NCT01770743|59015616|FG001|Overall Study|Adverse Event|0|||
30956099|NCT01770743|59015617|FG002|Overall Study|Adverse Event|0|||
30956100|NCT01770743|59015618|FG003|Overall Study|Adverse Event|0|||
30956101|NCT01770743|59015619|FG004|Overall Study|Adverse Event|0|||
30956102|NCT01770743|59015615|FG000|Overall Study|Withdrawal by Subject|0|||
30853059|NCT02392234|58880407|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
30956103|NCT01770743|59015616|FG001|Overall Study|Withdrawal by Subject|0|||
30956104|NCT01770743|59015617|FG002|Overall Study|Withdrawal by Subject|1|||
30956105|NCT01770743|59015618|FG003|Overall Study|Withdrawal by Subject|1|||
30956106|NCT01770743|59015619|FG004|Overall Study|Withdrawal by Subject|1|||
30956107|NCT01770743|59015615|FG000|Overall Study|Lost to Follow-up|0|||
30956108|NCT01770743|59015616|FG001|Overall Study|Lost to Follow-up|2|||
30956109|NCT01770743|59015617|FG002|Overall Study|Lost to Follow-up|0|||
30956110|NCT01770743|59015618|FG003|Overall Study|Lost to Follow-up|0|||
30956111|NCT01770743|59015619|FG004|Overall Study|Lost to Follow-up|1|||
30956112|NCT01770743|59015615|FG000|Overall Study|Sponsor Terminated Subject|1|||
30956113|NCT01770743|59015616|FG001|Overall Study|Sponsor Terminated Subject|0|||
30956114|NCT01770743|59015617|FG002|Overall Study|Sponsor Terminated Subject|0|||
30956115|NCT01770743|59015618|FG003|Overall Study|Sponsor Terminated Subject|1|||
30956116|NCT01770743|59015619|FG004|Overall Study|Sponsor Terminated Subject|0|||
30956117|NCT01770743|59015615|FG000|Overall Study|Moving Out of State|0|||
30956118|NCT01770743|59015616|FG001|Overall Study|Moving Out of State|1|||
30853060|NCT02392234|58880408|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
30956119|NCT01770743|59015617|FG002|Overall Study|Moving Out of State|0|||
30956120|NCT01770743|59015618|FG003|Overall Study|Moving Out of State|0|||
30853061|NCT02392234|58880403|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
30853062|NCT02392234|58880404|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
30853063|NCT02392234|58880405|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
30853064|NCT02392234|58880406|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
30853065|NCT02392234|58880407|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
30853066|NCT02392234|58880408|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
30853067|NCT02392234|58880403|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
30853068|NCT02392234|58880404|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
30853069|NCT02392234|58880405|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
30853070|NCT02392234|58880406|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
30853071|NCT02392234|58880407|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
30853072|NCT02392234|58880408|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
30853073|NCT02392234|58880403|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
30853074|NCT02392234|58880404|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
30853075|NCT02392234|58880405|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
30853076|NCT02392234|58880406|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
30853077|NCT02392234|58880407|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
30853078|NCT02392234|58880408|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
30853079|NCT02392234|58880403|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
30853080|NCT02392234|58880404|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
30853081|NCT02392234|58880405|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
30853082|NCT02392234|58880406|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
30853083|NCT02392234|58880407|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
30853084|NCT02392234|58880408|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
30853085|NCT02392234|58880403|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
30853086|NCT02392234|58880404|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
30853087|NCT02392234|58880405|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
30853088|NCT02392234|58880406|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
30853089|NCT02392234|58880407|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
30853090|NCT02392234|58880408|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
30853091|NCT02392234|58880403|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
30853092|NCT02392234|58880404|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
30853093|NCT02392234|58880405|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
30853094|NCT02392234|58880406|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
30853095|NCT02392234|58880407|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
30853096|NCT02392234|58880408|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
30853097|NCT02963090|58880422|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
30956121|NCT01770743|59015619|FG004|Overall Study|Moving Out of State|0|||
30956122|NCT01767467|59015715|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
30956123|NCT01767467|59015716|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
30956124|NCT01767467|59015715|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
30956125|NCT01767467|59015716|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
30956126|NCT01767467|59015715|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
30956127|NCT01767467|59015716|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
30853098|NCT02963090|58880423|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
30853099|NCT02427802|58880435|FG000|Overall Study|Adverse Event|11|||
30853100|NCT02427802|58880436|FG001|Overall Study|Adverse Event|3|||
30853101|NCT02427802|58880437|FG002|Overall Study|Adverse Event|7|||
30956128|NCT01767467|59015715|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
30956129|NCT01767467|59015716|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
30956130|NCT01767467|59015715|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
30956131|NCT01767467|59015716|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
30956132|NCT01767467|59015715|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
30662675|NCT00561925|58676226|FG000|144-week Double-blind, Double-dummy|Other|0|||
30853102|NCT02427802|58880435|FG000|Overall Study|Death|0|||
30853103|NCT02427802|58880436|FG001|Overall Study|Death|4|||
30853104|NCT02427802|58880437|FG002|Overall Study|Death|1|||
30853105|NCT02427802|58880435|FG000|Overall Study|Lost to Follow-up|13|||
30853106|NCT02427802|58880436|FG001|Overall Study|Lost to Follow-up|8|||
30853107|NCT02427802|58880437|FG002|Overall Study|Lost to Follow-up|8|||
30853108|NCT02427802|58880435|FG000|Overall Study|Physician Decision|4|||
30853109|NCT02427802|58880436|FG001|Overall Study|Physician Decision|2|||
30853110|NCT02427802|58880437|FG002|Overall Study|Physician Decision|4|||
30853111|NCT02427802|58880435|FG000|Overall Study|Withdrawal by Subject|10|||
30853112|NCT02427802|58880436|FG001|Overall Study|Withdrawal by Subject|5|||
30853113|NCT02427802|58880437|FG002|Overall Study|Withdrawal by Subject|11|||
30853114|NCT02427802|58880435|FG000|Overall Study|Protocol Violation|3|||
30853115|NCT02427802|58880436|FG001|Overall Study|Protocol Violation|1|||
30853116|NCT02427802|58880437|FG002|Overall Study|Protocol Violation|1|||
30853117|NCT02427802|58880435|FG000|Overall Study|protocol specific treatment unrelated|18|||
30853118|NCT02427802|58880436|FG001|Overall Study|protocol specific treatment unrelated|11|||
30853119|NCT02427802|58880437|FG002|Overall Study|protocol specific treatment unrelated|11|||
30956133|NCT01767467|59015716|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
30956134|NCT01767467|59015715|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
30956135|NCT01767467|59015716|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
30956136|NCT01767467|59015715|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
30956137|NCT01767467|59015716|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
30956138|NCT01767467|59015715|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
30956139|NCT01767467|59015716|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
30956140|NCT01767467|59015715|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
30956141|NCT01767467|59015716|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
30956142|NCT01767467|59015715|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
30956143|NCT01767467|59015716|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
30853120|NCT02427646|58880447|FG000|Overall Study|Lack of Efficacy|2|||
30853121|NCT02427646|58880448|FG001|Overall Study|Lack of Efficacy|3|||
30853122|NCT02427646|58880447|FG000|Overall Study|Physician Decision|1|||
30853123|NCT02427646|58880448|FG001|Overall Study|Physician Decision|4|||
30853124|NCT02427646|58880447|FG000|Overall Study|Protocol Violation|3|||
30853125|NCT02427646|58880448|FG001|Overall Study|Protocol Violation|3|||
30853126|NCT02427646|58880447|FG000|Overall Study|Bothersome hand weakness|2|||
30853127|NCT02427646|58880448|FG001|Overall Study|Bothersome hand weakness|4|||
30662676|NCT00561925|58676227|FG001|144-week Double-blind, Double-dummy|Other|8|||
30662677|NCT00561925|58676228|FG002|144-week Double-blind, Double-dummy|Other|11|||
30662678|NCT00561925|58676229|FG003|144-week Double-blind, Double-dummy|Other|0|||
30662679|NCT00561925|58676230|FG004|144-week Double-blind, Double-dummy|Other|0|||
30662680|NCT00561925|58676226|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
30662681|NCT00561925|58676227|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
30662682|NCT00561925|58676228|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
30662683|NCT00561925|58676229|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
30662684|NCT00561925|58676230|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
30662685|NCT00549445|58676250|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
30662686|NCT00549445|58676251|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
30853128|NCT02392000|58880456|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
30853129|NCT02392000|58880456|FG000|Overall Study|Withdrawal by Subject|1|||
30853130|NCT02392000|58880456|FG000|Overall Study|Lost to Follow-up|8|||
30853131|NCT02385526|58880464|FG000|Overall Study|Withdrawal by Subject|0|||
30853132|NCT02385526|58880465|FG001|Overall Study|Withdrawal by Subject|2|||
30853133|NCT02385526|58880466|FG002|Overall Study|Withdrawal by Subject|0|||
30853134|NCT02385526|58880464|FG000|Overall Study|Lost to Follow-up|0|||
30853135|NCT02385526|58880465|FG001|Overall Study|Lost to Follow-up|1|||
30853136|NCT02385526|58880466|FG002|Overall Study|Lost to Follow-up|0|||
30853137|NCT02385526|58880464|FG000|Overall Study|Physician Decision|1|||
30853138|NCT02385526|58880465|FG001|Overall Study|Physician Decision|0|||
30853139|NCT02385526|58880466|FG002|Overall Study|Physician Decision|0|||
30853140|NCT02385526|58880464|FG000|Overall Study|Protocol Violation|1|||
30853141|NCT02385526|58880465|FG001|Overall Study|Protocol Violation|0|||
30853142|NCT02385526|58880466|FG002|Overall Study|Protocol Violation|0|||
30956144|NCT01767467|59015715|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
30853143|NCT02808143|58880476|FG000|Maintenance Phase|Disease recurrence|1|||
30853144|NCT02808143|58880477|FG001|Maintenance Phase|Disease recurrence|3|||
30853145|NCT02808143|58880476|FG000|Maintenance Phase|Disease progression|1|||
30853146|NCT02808143|58880477|FG001|Maintenance Phase|Disease progression|2|||
30853147|NCT02808143|58880476|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
30853148|NCT02808143|58880477|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
30853149|NCT02808143|58880476|FG000|Survival Follow-Up|Disease recurrence|0|||
30853150|NCT02808143|58880477|FG001|Survival Follow-Up|Disease recurrence|2|||
30853151|NCT02808143|58880476|FG000|Survival Follow-Up|Adverse Event|0|||
30956145|NCT01767467|59015716|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
30956146|NCT01767467|59015715|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
30956147|NCT01767467|59015716|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
30956148|NCT01767467|59015715|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
30956149|NCT01767467|59015716|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
30956150|NCT04126083|59015789|FG000|Overall Study|Withdrawal by Subject|1|||
30956151|NCT01766921|59015829|FG000|Overall Study|Administrative Reason|5|||
30956152|NCT01766921|59015830|FG001|Overall Study|Administrative Reason|5|||
30956153|NCT01766921|59015829|FG000|Overall Study|Death|1|||
30956154|NCT01766921|59015830|FG001|Overall Study|Death|1|||
30956155|NCT01766921|59015829|FG000|Overall Study|Lost to Follow-up|1|||
30956156|NCT01766921|59015830|FG001|Overall Study|Lost to Follow-up|3|||
30956157|NCT01766921|59015829|FG000|Overall Study|Unclassified|2|||
30956158|NCT01766921|59015830|FG001|Overall Study|Unclassified|2|||
30956159|NCT01766921|59015829|FG000|Overall Study|Protocol Violation|1|||
30956160|NCT01766921|59015830|FG001|Overall Study|Protocol Violation|1|||
30956161|NCT01766921|59015829|FG000|Overall Study|Withdrawal by Subject|14|||
30956162|NCT01766921|59015830|FG001|Overall Study|Withdrawal by Subject|5|||
30956163|NCT01774799|59015848|FG000|Overall Study|Lost to Follow-up|1|||
30956164|NCT01774799|59015849|FG001|Overall Study|Lost to Follow-up|1|||
30956165|NCT01774799|59015850|FG002|Overall Study|Lost to Follow-up|0|||
30956166|NCT01774799|59015851|FG003|Overall Study|Lost to Follow-up|0|||
30956167|NCT01774253|59015857|FG000|Overall Study|Lack of Efficacy|4|||
30956168|NCT01774253|59015857|FG000|Overall Study|Physician Decision|2|||
30956169|NCT01774253|59015857|FG000|Overall Study|Withdrawal by Subject|2|||
30956170|NCT01774253|59015857|FG000|Overall Study|Death|1|||
30956171|NCT01765751|59015897|FG000|Overall Study|Lost to Follow-up|0|||
30956172|NCT01765751|59015898|FG001|Overall Study|Lost to Follow-up|2|||
30956173|NCT01765751|59015899|FG002|Overall Study|Lost to Follow-up|1|||
30956174|NCT01736657|59015919|FG000|Overall Study|insufficient vascular access|1|||
30956175|NCT01736579|59015934|FG000|Overall Study|Termination of Study by Sponsor|2|||
30956176|NCT01736579|59015935|FG001|Overall Study|Termination of Study by Sponsor|2|||
30956177|NCT01765673|59015966|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
30956178|NCT01764659|59015973|FG000|Overall Study|Death|1|||
30956179|NCT01764659|59015973|FG000|Overall Study|Physician Decision|1|||
30956180|NCT01736189|59015979|FG000|Overall Study|Violation of registration criteria|41|||
30956181|NCT01736189|59015979|FG000|Overall Study|Protocol Violation|4|||
30777777|NCT03638258|58788817|FG001|Overall Study|Withdrawal by Subject|5|||
30777778|NCT03638258|58788818|FG002|Overall Study|Withdrawal by Subject|12|||
30777779|NCT03638258|58788816|FG000|Overall Study|Lack of Efficacy|0|||
30777780|NCT03638258|58788817|FG001|Overall Study|Lack of Efficacy|0|||
30777781|NCT03638258|58788818|FG002|Overall Study|Lack of Efficacy|2|||
30777782|NCT01670656|58788832|FG000|Overall Study|Non-compliance with study drug|0|||
30777783|NCT01670656|58788833|FG001|Overall Study|Non-compliance with study drug|0|||
30777784|NCT01670656|58788834|FG002|Overall Study|Non-compliance with study drug|3|||
30777785|NCT01670656|58788835|FG003|Overall Study|Non-compliance with study drug|0|||
30777786|NCT01670656|58788836|FG004|Overall Study|Non-compliance with study drug|1|||
30777787|NCT01670656|58788832|FG000|Overall Study|Pregnancy|0|||
30777788|NCT01670656|58788833|FG001|Overall Study|Pregnancy|0|||
30777789|NCT01670656|58788834|FG002|Overall Study|Pregnancy|0|||
30777790|NCT01670656|58788835|FG003|Overall Study|Pregnancy|0|||
30777791|NCT01670656|58788836|FG004|Overall Study|Pregnancy|1|||
30777792|NCT01670656|58788832|FG000|Overall Study|Withdrawal by Subject|1|||
30777793|NCT01670656|58788833|FG001|Overall Study|Withdrawal by Subject|1|||
30956182|NCT01736189|59015979|FG000|Overall Study|Criteria and protocol violations|1|||
30956183|NCT01735175|59016011|FG000|Overall Study|Withdrawal by Subject|9|||
30956184|NCT01735175|59016012|FG001|Overall Study|Withdrawal by Subject|2|||
30777794|NCT01670656|58788834|FG002|Overall Study|Withdrawal by Subject|0|||
30956185|NCT01735175|59016011|FG000|Overall Study|Lost to Follow-up|4|||
30956186|NCT01735175|59016012|FG001|Overall Study|Lost to Follow-up|2|||
30956187|NCT01735175|59016011|FG000|Overall Study|Death|3|||
30956188|NCT01735175|59016012|FG001|Overall Study|Death|2|||
30956189|NCT01735175|59016011|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
30956190|NCT01735175|59016012|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
30956191|NCT01762943|59016024|FG000|Overall Study|Physician Decision|1|||
30956192|NCT01762943|59016025|FG001|Overall Study|Physician Decision|1|||
30956193|NCT01762943|59016024|FG000|Overall Study|Protocol Violation|1|||
30662687|NCT00601107|58676261|FG000|Overall Study|Adverse Event|0|||
30662688|NCT00601107|58676262|FG001|Overall Study|Adverse Event|1|||
30662689|NCT00601107|58676263|FG002|Overall Study|Adverse Event|3|||
30777795|NCT01670656|58788835|FG003|Overall Study|Withdrawal by Subject|0|||
30777796|NCT01670656|58788836|FG004|Overall Study|Withdrawal by Subject|0|||
30777797|NCT01670656|58788832|FG000|Overall Study|Non-compliance with protocol|0|||
30777798|NCT01670656|58788833|FG001|Overall Study|Non-compliance with protocol|3|||
30777799|NCT01670656|58788834|FG002|Overall Study|Non-compliance with protocol|1|||
30777800|NCT01670656|58788835|FG003|Overall Study|Non-compliance with protocol|1|||
30777801|NCT01670656|58788836|FG004|Overall Study|Non-compliance with protocol|2|||
30777802|NCT01670656|58788832|FG000|Overall Study|Adverse Event|2|||
30777803|NCT01670656|58788833|FG001|Overall Study|Adverse Event|2|||
30777804|NCT01670656|58788834|FG002|Overall Study|Adverse Event|2|||
30777805|NCT01670656|58788835|FG003|Overall Study|Adverse Event|3|||
30777806|NCT01670656|58788836|FG004|Overall Study|Adverse Event|3|||
30662690|NCT00601107|58676264|FG003|Overall Study|Adverse Event|0|||
30662691|NCT00601107|58676261|FG000|Overall Study|Withdrawal by Subject|5|||
30662692|NCT00601107|58676262|FG001|Overall Study|Withdrawal by Subject|4|||
30662693|NCT00601107|58676263|FG002|Overall Study|Withdrawal by Subject|7|||
30662694|NCT00601107|58676264|FG003|Overall Study|Withdrawal by Subject|4|||
30662695|NCT00601107|58676261|FG000|Overall Study|Lost to Follow-up|3|||
30662696|NCT00601107|58676262|FG001|Overall Study|Lost to Follow-up|3|||
30662697|NCT00601107|58676263|FG002|Overall Study|Lost to Follow-up|0|||
30662698|NCT00601107|58676264|FG003|Overall Study|Lost to Follow-up|3|||
30662699|NCT00601107|58676261|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
30662700|NCT00601107|58676262|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
30662701|NCT00601107|58676263|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
30662702|NCT00601107|58676264|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
30662703|NCT00601107|58676261|FG000|Overall Study|Worsening of Psoriasis|4|||
30662704|NCT00601107|58676262|FG001|Overall Study|Worsening of Psoriasis|1|||
30662705|NCT00601107|58676263|FG002|Overall Study|Worsening of Psoriasis|1|||
30662706|NCT00601107|58676264|FG003|Overall Study|Worsening of Psoriasis|4|||
30662707|NCT00601107|58676261|FG000|Overall Study|Undefined|1|||
30662708|NCT00601107|58676262|FG001|Overall Study|Undefined|0|||
30662709|NCT00601107|58676263|FG002|Overall Study|Undefined|1|||
30662710|NCT00601107|58676264|FG003|Overall Study|Undefined|0|||
30662711|NCT00914927|58676281|FG000|Overall Study|Adverse Event|0|||
30662712|NCT00914927|58676282|FG001|Overall Study|Adverse Event|0|||
30662713|NCT00914927|58676283|FG002|Overall Study|Adverse Event|0|||
30662714|NCT00914927|58676284|FG003|Overall Study|Adverse Event|0|||
30662715|NCT00914927|58676285|FG004|Overall Study|Adverse Event|1|||
30662716|NCT00914927|58676286|FG005|Overall Study|Adverse Event|0|||
30662717|NCT00914927|58676287|FG006|Overall Study|Adverse Event|0|||
30662718|NCT00914927|58676281|FG000|Overall Study|Withdrawal by Subject|0|||
30662719|NCT00914927|58676282|FG001|Overall Study|Withdrawal by Subject|1|||
30662720|NCT00914927|58676283|FG002|Overall Study|Withdrawal by Subject|0|||
30662721|NCT00914927|58676284|FG003|Overall Study|Withdrawal by Subject|1|||
30662722|NCT00914927|58676285|FG004|Overall Study|Withdrawal by Subject|0|||
30662723|NCT00914927|58676286|FG005|Overall Study|Withdrawal by Subject|0|||
30662724|NCT00914927|58676287|FG006|Overall Study|Withdrawal by Subject|0|||
30662725|NCT00914927|58676281|FG000|Overall Study|Lost to Follow-up|0|||
30662726|NCT00914927|58676282|FG001|Overall Study|Lost to Follow-up|0|||
30662727|NCT00914927|58676283|FG002|Overall Study|Lost to Follow-up|0|||
30662728|NCT00914927|58676284|FG003|Overall Study|Lost to Follow-up|1|||
30662729|NCT00914927|58676285|FG004|Overall Study|Lost to Follow-up|0|||
30662730|NCT00914927|58676286|FG005|Overall Study|Lost to Follow-up|0|||
30662731|NCT00914927|58676287|FG006|Overall Study|Lost to Follow-up|0|||
30662732|NCT00914927|58676281|FG000|Overall Study|Administrative/Other|2|||
30777807|NCT01670656|58788832|FG000|Overall Study|Subject withdrew consent|0|||
30777808|NCT01670656|58788833|FG001|Overall Study|Subject withdrew consent|1|||
30777809|NCT01670656|58788834|FG002|Overall Study|Subject withdrew consent|2|||
30662733|NCT00914927|58676282|FG001|Overall Study|Administrative/Other|1|||
30662734|NCT00914927|58676283|FG002|Overall Study|Administrative/Other|0|||
30662735|NCT00914927|58676284|FG003|Overall Study|Administrative/Other|0|||
30662736|NCT00914927|58676285|FG004|Overall Study|Administrative/Other|1|||
30662737|NCT00914927|58676286|FG005|Overall Study|Administrative/Other|0|||
30662738|NCT00914927|58676287|FG006|Overall Study|Administrative/Other|0|||
30662739|NCT00914849|58676314|FG000|Overall Study|Withdrawal by Subject|1|||
30777810|NCT01670656|58788835|FG003|Overall Study|Subject withdrew consent|1|||
30777811|NCT01670656|58788836|FG004|Overall Study|Subject withdrew consent|1|||
30956194|NCT01762943|59016025|FG001|Overall Study|Protocol Violation|0|||
30956195|NCT01762943|59016024|FG000|Overall Study|Withdrawal by Subject|2|||
30956196|NCT01762943|59016025|FG001|Overall Study|Withdrawal by Subject|1|||
30956197|NCT01734785|59016088|FG000|Open-Label Period|Adverse Event|0|||
30956198|NCT01734785|59016089|FG001|Open-Label Period|Adverse Event|0|||
30956199|NCT01734785|59016090|FG002|Open-Label Period|Adverse Event|0|||
30956200|NCT01734785|59016091|FG003|Open-Label Period|Adverse Event|9|||
30956201|NCT01734785|59016088|FG000|Open-Label Period|Lack of Efficacy|0|||
30956202|NCT01734785|59016089|FG001|Open-Label Period|Lack of Efficacy|0|||
30956203|NCT01734785|59016090|FG002|Open-Label Period|Lack of Efficacy|0|||
30956204|NCT01734785|59016091|FG003|Open-Label Period|Lack of Efficacy|1|||
30956205|NCT01734785|59016088|FG000|Open-Label Period|Protocol Violation|0|||
30956206|NCT01734785|59016089|FG001|Open-Label Period|Protocol Violation|0|||
30956207|NCT01734785|59016090|FG002|Open-Label Period|Protocol Violation|0|||
30956208|NCT01734785|59016091|FG003|Open-Label Period|Protocol Violation|13|||
30956209|NCT01734785|59016088|FG000|Open-Label Period|Lost to Follow-up|0|||
30956210|NCT01734785|59016089|FG001|Open-Label Period|Lost to Follow-up|0|||
30956211|NCT01734785|59016090|FG002|Open-Label Period|Lost to Follow-up|0|||
30956212|NCT01734785|59016091|FG003|Open-Label Period|Lost to Follow-up|14|||
30956213|NCT01734785|59016088|FG000|Open-Label Period|Withdrawal by Subject|0|||
30956214|NCT01734785|59016089|FG001|Open-Label Period|Withdrawal by Subject|0|||
30956215|NCT01734785|59016090|FG002|Open-Label Period|Withdrawal by Subject|0|||
30956216|NCT01734785|59016091|FG003|Open-Label Period|Withdrawal by Subject|12|||
30956217|NCT01734785|59016088|FG000|Open-Label Period|Other Reasons|0|||
30956218|NCT01734785|59016089|FG001|Open-Label Period|Other Reasons|0|||
30956219|NCT01734785|59016090|FG002|Open-Label Period|Other Reasons|0|||
30956220|NCT01734785|59016091|FG003|Open-Label Period|Other Reasons|224|||
30956221|NCT01734785|59016088|FG000|Double-Blind Period|Adverse Event|0|||
30956222|NCT01734785|59016089|FG001|Double-Blind Period|Adverse Event|3|||
30956223|NCT01734785|59016090|FG002|Double-Blind Period|Adverse Event|2|||
30956224|NCT01734785|59016091|FG003|Double-Blind Period|Adverse Event|0|||
30956225|NCT01734785|59016088|FG000|Double-Blind Period|Lack of Efficacy|0|||
30956226|NCT01734785|59016089|FG001|Double-Blind Period|Lack of Efficacy|1|||
30956227|NCT01734785|59016090|FG002|Double-Blind Period|Lack of Efficacy|0|||
30956228|NCT01734785|59016091|FG003|Double-Blind Period|Lack of Efficacy|0|||
30956229|NCT01734785|59016088|FG000|Double-Blind Period|Protocol Violation|0|||
30956230|NCT01734785|59016089|FG001|Double-Blind Period|Protocol Violation|1|||
30956231|NCT01734785|59016090|FG002|Double-Blind Period|Protocol Violation|1|||
30956232|NCT01734785|59016091|FG003|Double-Blind Period|Protocol Violation|0|||
30956233|NCT01734785|59016088|FG000|Double-Blind Period|Lost to Follow-up|2|||
30956234|NCT01734785|59016089|FG001|Double-Blind Period|Lost to Follow-up|4|||
30956235|NCT01734785|59016090|FG002|Double-Blind Period|Lost to Follow-up|2|||
30956236|NCT01734785|59016091|FG003|Double-Blind Period|Lost to Follow-up|0|||
30956237|NCT01734785|59016088|FG000|Double-Blind Period|Withdrawal by Subject|2|||
30956238|NCT01734785|59016089|FG001|Double-Blind Period|Withdrawal by Subject|0|||
30956239|NCT01734785|59016090|FG002|Double-Blind Period|Withdrawal by Subject|0|||
30956240|NCT01734785|59016091|FG003|Double-Blind Period|Withdrawal by Subject|0|||
30956241|NCT01734785|59016088|FG000|Double-Blind Period|Not treated|1|||
30956242|NCT01734785|59016089|FG001|Double-Blind Period|Not treated|0|||
30956243|NCT01734785|59016090|FG002|Double-Blind Period|Not treated|0|||
30956244|NCT01734785|59016091|FG003|Double-Blind Period|Not treated|0|||
30956245|NCT01734395|59016100|FG000|Overall Study|Other|65|||
30956246|NCT01734395|59016100|FG000|Overall Study|Lost to Follow-up|287|||
30956247|NCT01734395|59016100|FG000|Overall Study|Lack of Efficacy|5|||
30956248|NCT01734395|59016100|FG000|Overall Study|Adverse Event|40|||
30956249|NCT01734395|59016100|FG000|Overall Study|Withdrawal by Subject|10|||
30956250|NCT01734395|59016100|FG000|Overall Study|Missing the reasons for not completed|3|||
30956251|NCT01597505|59016134|FG000|Overall Study|Physician Decision|5|||
30956252|NCT01597505|59016135|FG001|Overall Study|Physician Decision|0|||
30956253|NCT01597505|59016134|FG000|Overall Study|Adverse Event|19|||
30853152|NCT02808143|58880477|FG001|Survival Follow-Up|Adverse Event|1|||
30956254|NCT01597505|59016135|FG001|Overall Study|Adverse Event|7|||
30956255|NCT01597505|59016134|FG000|Overall Study|Lost to Follow-up|4|||
30956256|NCT01597505|59016135|FG001|Overall Study|Lost to Follow-up|2|||
30956257|NCT01597505|59016134|FG000|Overall Study|Withdrawal by Subject|10|||
30956258|NCT01597505|59016135|FG001|Overall Study|Withdrawal by Subject|18|||
30956259|NCT01597505|59016134|FG000|Overall Study|Other|5|||
30956260|NCT01597505|59016135|FG001|Overall Study|Other|6|||
30956261|NCT01597505|59016134|FG000|Overall Study|Missing|1|||
30956262|NCT01597505|59016135|FG001|Overall Study|Missing|0|||
30956263|NCT01760447|59016174|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
30956264|NCT01760447|59016175|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
30956265|NCT01760447|59016176|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
30956266|NCT01760447|59016177|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
30956267|NCT01760447|59016174|FG000|Weeks 0-20|Withdrawal by Subject|2|||
30956268|NCT01760447|59016175|FG001|Weeks 0-20|Withdrawal by Subject|0|||
30956269|NCT01760447|59016176|FG002|Weeks 0-20|Withdrawal by Subject|1|||
30956270|NCT01760447|59016177|FG003|Weeks 0-20|Withdrawal by Subject|0|||
30956271|NCT01760447|59016174|FG000|Weeks 0-20|Lost to Follow-up|1|||
30956272|NCT01760447|59016175|FG001|Weeks 0-20|Lost to Follow-up|0|||
30956273|NCT01760447|59016176|FG002|Weeks 0-20|Lost to Follow-up|1|||
30956274|NCT01760447|59016177|FG003|Weeks 0-20|Lost to Follow-up|1|||
30956275|NCT01760447|59016174|FG000|Weeks 0-20|Randomized but not treated|0|||
30956276|NCT01760447|59016175|FG001|Weeks 0-20|Randomized but not treated|0|||
30956277|NCT01760447|59016176|FG002|Weeks 0-20|Randomized but not treated|2|||
30956278|NCT01760447|59016177|FG003|Weeks 0-20|Randomized but not treated|0|||
30956279|NCT01760447|59016174|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
30956280|NCT01760447|59016175|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
30956281|NCT01760447|59016176|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
30956282|NCT01760447|59016177|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
30956283|NCT01760447|59016174|FG000|Weeks 20-54|Withdrawal by Subject|2|||
30956284|NCT01760447|59016175|FG001|Weeks 20-54|Withdrawal by Subject|1|||
30956285|NCT01760447|59016176|FG002|Weeks 20-54|Withdrawal by Subject|1|||
30956286|NCT01760447|59016177|FG003|Weeks 20-54|Withdrawal by Subject|2|||
30956287|NCT01760447|59016174|FG000|Weeks 20-54|Lost to Follow-up|0|||
30956288|NCT01760447|59016175|FG001|Weeks 20-54|Lost to Follow-up|0|||
30777812|NCT01670656|58788832|FG000|Overall Study|Lost to Follow-up|0|||
30777813|NCT01670656|58788833|FG001|Overall Study|Lost to Follow-up|0|||
30777814|NCT01670656|58788834|FG002|Overall Study|Lost to Follow-up|0|||
30777815|NCT01670656|58788835|FG003|Overall Study|Lost to Follow-up|0|||
30777816|NCT01670656|58788836|FG004|Overall Study|Lost to Follow-up|3|||
30853153|NCT02808143|58880476|FG000|Survival Follow-Up|Death|1|||
30853154|NCT02808143|58880477|FG001|Survival Follow-Up|Death|0|||
30853155|NCT02427100|58880487|FG000|Overall Study|Lost to Follow-up|0|||
30853156|NCT02427100|58880488|FG001|Overall Study|Lost to Follow-up|2|||
30853157|NCT02806973|58880494|FG000|Period 1|Withdrawal by Subject|0|||
30853158|NCT02806973|58880495|FG001|Period 1|Withdrawal by Subject|2|||
30853159|NCT02806973|58880496|FG002|Period 1|Withdrawal by Subject|1|||
30853160|NCT02806973|58880497|FG003|Period 1|Withdrawal by Subject|1|||
30853161|NCT02806973|58880494|FG000|Period 1|Adverse Event|0|||
30853162|NCT02806973|58880495|FG001|Period 1|Adverse Event|0|||
30853163|NCT02806973|58880496|FG002|Period 1|Adverse Event|0|||
30853164|NCT02806973|58880497|FG003|Period 1|Adverse Event|1|||
30853165|NCT02806973|58880494|FG000|Period 3|Withdrawal by Subject|0|||
30853166|NCT02806973|58880495|FG001|Period 3|Withdrawal by Subject|0|||
30853167|NCT02806973|58880496|FG002|Period 3|Withdrawal by Subject|0|||
30853168|NCT02806973|58880497|FG003|Period 3|Withdrawal by Subject|3|||
30853169|NCT02806973|58880494|FG000|Period 3|Adverse Event|0|||
30853170|NCT02806973|58880495|FG001|Period 3|Adverse Event|0|||
30853171|NCT02806973|58880496|FG002|Period 3|Adverse Event|1|||
30853172|NCT02806973|58880497|FG003|Period 3|Adverse Event|0|||
30853173|NCT02806505|58880509|FG000|Overall Study|Adverse event/intercurrent illness|1|||
30853174|NCT02806505|58880510|FG001|Overall Study|Adverse event/intercurrent illness|3|||
30853175|NCT02806505|58880509|FG000|Overall Study|Death|4|||
30853176|NCT02806505|58880510|FG001|Overall Study|Death|0|||
30853177|NCT02806505|58880509|FG000|Overall Study|Did not cooperate/refused treatment|3|||
30853178|NCT02806505|58880510|FG001|Overall Study|Did not cooperate/refused treatment|3|||
30853179|NCT02806505|58880509|FG000|Overall Study|Failure to return|0|||
30853180|NCT02806505|58880510|FG001|Overall Study|Failure to return|1|||
30853181|NCT02806505|58880509|FG000|Overall Study|Insufficient therapeutic response|2|||
30853182|NCT02806505|58880510|FG001|Overall Study|Insufficient therapeutic response|4|||
30853183|NCT02807363|58880520|FG000|Dosing Period|Adverse Event|0|||
30853184|NCT02807363|58880521|FG001|Dosing Period|Adverse Event|1|||
30853185|NCT02807363|58880522|FG002|Dosing Period|Adverse Event|0|||
30853186|NCT02807363|58880523|FG003|Dosing Period|Adverse Event|0|||
30853187|NCT02383966|58880537|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
30853188|NCT02383966|58880538|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
30777817|NCT01670656|58788832|FG000|Overall Study|Subject moved|0|||
30777818|NCT01670656|58788833|FG001|Overall Study|Subject moved|0|||
30777819|NCT01670656|58788834|FG002|Overall Study|Subject moved|0|||
30777820|NCT01670656|58788835|FG003|Overall Study|Subject moved|1|||
30777821|NCT01670656|58788836|FG004|Overall Study|Subject moved|0|||
30853189|NCT02383966|58880537|FG000|Overall Study|Randomized, but not treated|1|||
30853190|NCT02383966|58880538|FG001|Overall Study|Randomized, but not treated|3|||
30853191|NCT02383576|58880546|FG000|Overall Study|Death|53|||
30853192|NCT02383576|58880547|FG001|Overall Study|Death|33|||
30853193|NCT02383576|58880546|FG000|Overall Study|Lost to Follow-up|7|||
30853194|NCT02383576|58880547|FG001|Overall Study|Lost to Follow-up|1|||
30853195|NCT02383576|58880546|FG000|Overall Study|Withdrew Consent|1|||
30956289|NCT01760447|59016176|FG002|Weeks 20-54|Lost to Follow-up|1|||
30956290|NCT01760447|59016177|FG003|Weeks 20-54|Lost to Follow-up|2|||
30777822|NCT03621696|58788852|FG000|Overall Study|Not eligible|0|||
30956291|NCT01732913|59016266|FG000|Overall Study|Study Terminated by Sponsor|105|||
30777823|NCT03621696|58788853|FG001|Overall Study|Not eligible|0|||
30777824|NCT03621696|58788854|FG002|Overall Study|Not eligible|0|||
30853196|NCT02383576|58880547|FG001|Overall Study|Withdrew Consent|6|||
30853197|NCT02383576|58880546|FG000|Overall Study|Investigator's Decision|0|||
30853198|NCT02383576|58880547|FG001|Overall Study|Investigator's Decision|1|||
30853199|NCT02383576|58880546|FG000|Overall Study|Administrative/Other|2|||
30853200|NCT02383576|58880547|FG001|Overall Study|Administrative/Other|4|||
30777825|NCT03621696|58788855|FG003|Overall Study|Not eligible|5|||
30853201|NCT02748317|58880553|FG000|Overall Study|Withdrawal by Subject|14|||
30853202|NCT02748317|58880553|FG000|Overall Study|Lost to Follow-up|8|||
30853203|NCT02748317|58880553|FG000|Overall Study|Death|1|||
30853204|NCT02426086|58880559|FG000|Overall Study|Death|33|||
30853205|NCT02426086|58880560|FG001|Overall Study|Death|36|||
30853206|NCT02426086|58880559|FG000|Overall Study|Lost to Follow-up|2|||
30853207|NCT02426086|58880560|FG001|Overall Study|Lost to Follow-up|0|||
30853208|NCT02426086|58880559|FG000|Overall Study|Study Terminated by Sponsor|5|||
30853209|NCT02426086|58880560|FG001|Overall Study|Study Terminated by Sponsor|14|||
30853210|NCT02426086|58880559|FG000|Overall Study|Withdrawal by Subject|8|||
30853211|NCT02426086|58880560|FG001|Overall Study|Withdrawal by Subject|9|||
30853212|NCT02422264|58880573|FG000|Overall Study|Serious Adverse Event|1|||
30853213|NCT02422264|58880574|FG001|Overall Study|Serious Adverse Event|0|||
30853214|NCT02422264|58880573|FG000|Overall Study|Withdrawal by Subject|1|||
30853215|NCT02422264|58880574|FG001|Overall Study|Withdrawal by Subject|2|||
30853216|NCT02422264|58880573|FG000|Overall Study|Migrated/moved from study area|3|||
30853217|NCT02422264|58880574|FG001|Overall Study|Migrated/moved from study area|1|||
30853218|NCT02422264|58880573|FG000|Overall Study|Subject vaccinated outside of the study|0|||
30853219|NCT02422264|58880574|FG001|Overall Study|Subject vaccinated outside of the study|1|||
30853220|NCT02390362|58880582|FG000|Overall Study|Withdrawal by Subject|0|||
30853221|NCT02390362|58880583|FG001|Overall Study|Withdrawal by Subject|1|||
30853222|NCT02389894|58880592|FG000|Overall Study|Death|4|||
30853223|NCT02389894|58880593|FG001|Overall Study|Death|5|||
30853224|NCT02389894|58880594|FG002|Overall Study|Death|3|||
30853225|NCT02389894|58880592|FG000|Overall Study|Withdrawal by Subject|2|||
30853226|NCT02389894|58880593|FG001|Overall Study|Withdrawal by Subject|4|||
30853227|NCT02389894|58880594|FG002|Overall Study|Withdrawal by Subject|5|||
30853228|NCT02389894|58880592|FG000|Overall Study|Lost to Follow-up|2|||
30956292|NCT01732913|59016267|FG001|Overall Study|Study Terminated by Sponsor|55|||
30956293|NCT01732913|59016266|FG000|Overall Study|Withdrawal by Subject|27|||
30777826|NCT03621696|58788852|FG000|Overall Study|Withdrawal by Subject|1|||
30777827|NCT03621696|58788853|FG001|Overall Study|Withdrawal by Subject|1|||
30777828|NCT03621696|58788854|FG002|Overall Study|Withdrawal by Subject|1|||
30777829|NCT03621696|58788855|FG003|Overall Study|Withdrawal by Subject|0|||
30777830|NCT03621696|58788852|FG000|Overall Study|Physician Decision|0|||
30777831|NCT03621696|58788853|FG001|Overall Study|Physician Decision|0|||
30777832|NCT03621696|58788854|FG002|Overall Study|Physician Decision|1|||
30777833|NCT03621696|58788855|FG003|Overall Study|Physician Decision|0|||
30777834|NCT00068445|58788865|FG000|Randomization|Cancel|1|||
30777835|NCT00068445|58788866|FG001|Randomization|Cancel|3|||
30777836|NCT00068445|58788865|FG000|Randomization|Ineligible|1|||
30777837|NCT00068445|58788866|FG001|Randomization|Ineligible|1|||
30777838|NCT00068445|58788865|FG000|Treatment|Refused Further Treatment|13|||
30777839|NCT00068445|58788866|FG001|Treatment|Refused Further Treatment|10|||
30777840|NCT00068445|58788865|FG000|Treatment|Adverse Event|7|||
30777841|NCT00068445|58788866|FG001|Treatment|Adverse Event|1|||
30777842|NCT00068445|58788865|FG000|Treatment|Other (Specifics not available)|9|||
30853229|NCT02389894|58880593|FG001|Overall Study|Lost to Follow-up|1|||
30853230|NCT02389894|58880594|FG002|Overall Study|Lost to Follow-up|1|||
30853231|NCT02389816|58880605|FG000|Overall Study|Randomized but Not Treated|1|||
30853232|NCT02389816|58880606|FG001|Overall Study|Randomized but Not Treated|0|||
30853233|NCT02389816|58880607|FG002|Overall Study|Randomized but Not Treated|0|||
30853234|NCT02389816|58880605|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
30853235|NCT02389816|58880606|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
30777843|NCT00068445|58788866|FG001|Treatment|Other (Specifics not available)|5|||
30777844|NCT03653208|58788881|FG000|Overall Study|Withdrawal by Subject|0|||
30777845|NCT03653208|58788882|FG001|Overall Study|Withdrawal by Subject|0|||
30777846|NCT03653208|58788883|FG002|Overall Study|Withdrawal by Subject|0|||
30777847|NCT03653208|58788884|FG003|Overall Study|Withdrawal by Subject|0|||
30956294|NCT01732913|59016267|FG001|Overall Study|Withdrawal by Subject|4|||
30956295|NCT01732913|59016266|FG000|Overall Study|Physician Decision|14|||
30956296|NCT01732913|59016267|FG001|Overall Study|Physician Decision|7|||
30956297|NCT01732913|59016266|FG000|Overall Study|Other|7|||
30956298|NCT01732913|59016267|FG001|Overall Study|Other|1|||
30956299|NCT01732913|59016266|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
30956300|NCT01732913|59016267|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
30956301|NCT01732835|59016298|FG000|6-month Primary Endpoint|Did not receive device|19|||
30956302|NCT01732835|59016298|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
30956303|NCT01732835|59016298|FG000|6-month Primary Endpoint|Adverse Event|3|||
30956304|NCT01732835|59016298|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
30956305|NCT01732835|59016298|FG000|2-year Extended Follow-up|Adverse Event|3|||
30956306|NCT01732835|59016298|FG000|2-year Extended Follow-up|Death|1|||
30777848|NCT03653208|58788885|FG004|Overall Study|Withdrawal by Subject|1|||
30777849|NCT03653208|58788886|FG005|Overall Study|Withdrawal by Subject|0|||
30777850|NCT03653208|58788887|FG006|Overall Study|Withdrawal by Subject|0|||
30777851|NCT03653208|58788888|FG007|Overall Study|Withdrawal by Subject|1|||
30777852|NCT03653208|58788889|FG008|Overall Study|Withdrawal by Subject|1|||
30777853|NCT03545984|58788911|FG000|Overall Study|CSF cases not present during rotation|11|||
30777854|NCT03545984|58788912|FG001|Overall Study|CSF cases not present during rotation|9|||
30777855|NCT03033784|58788920|FG000|Overall Study|Anxiety related to MRI scanner|0|||
30777856|NCT03033784|58788921|FG001|Overall Study|Anxiety related to MRI scanner|1|||
30777857|NCT03033784|58788922|FG002|Overall Study|Anxiety related to MRI scanner|0|||
30777858|NCT03033784|58788923|FG003|Overall Study|Anxiety related to MRI scanner|0|||
30777859|NCT03033784|58788924|FG004|Overall Study|Anxiety related to MRI scanner|0|||
30777860|NCT03033784|58788925|FG005|Overall Study|Anxiety related to MRI scanner|0|||
30777861|NCT03033784|58788926|FG006|Overall Study|Anxiety related to MRI scanner|0|||
30777862|NCT03033784|58788927|FG007|Overall Study|Anxiety related to MRI scanner|0|||
30777863|NCT03033784|58788928|FG008|Overall Study|Anxiety related to MRI scanner|0|||
30777864|NCT03033784|58788929|FG009|Overall Study|Anxiety related to MRI scanner|0|||
30777865|NCT03033784|58788930|FG010|Overall Study|Anxiety related to MRI scanner|0|||
30777866|NCT03033784|58788931|FG011|Overall Study|Anxiety related to MRI scanner|0|||
30777867|NCT03033784|58788932|FG012|Overall Study|Anxiety related to MRI scanner|0|||
30777868|NCT03033784|58788920|FG000|Overall Study|Withdrawal by Subject|0|||
30777869|NCT03033784|58788921|FG001|Overall Study|Withdrawal by Subject|0|||
30777870|NCT03033784|58788922|FG002|Overall Study|Withdrawal by Subject|0|||
30777871|NCT03033784|58788923|FG003|Overall Study|Withdrawal by Subject|0|||
30777872|NCT03033784|58788924|FG004|Overall Study|Withdrawal by Subject|0|||
30777873|NCT03033784|58788925|FG005|Overall Study|Withdrawal by Subject|0|||
30777874|NCT03033784|58788926|FG006|Overall Study|Withdrawal by Subject|0|||
30777875|NCT03033784|58788927|FG007|Overall Study|Withdrawal by Subject|0|||
30777876|NCT03033784|58788928|FG008|Overall Study|Withdrawal by Subject|0|||
30777877|NCT03033784|58788929|FG009|Overall Study|Withdrawal by Subject|0|||
30777878|NCT03033784|58788930|FG010|Overall Study|Withdrawal by Subject|0|||
30777879|NCT03033784|58788931|FG011|Overall Study|Withdrawal by Subject|0|||
30777880|NCT03033784|58788932|FG012|Overall Study|Withdrawal by Subject|2|||
30777881|NCT00038649|58788943|FG000|Overall Study|Adverse Event|9|||
30777882|NCT03544268|58788949|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
30777883|NCT03544268|58788950|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
30777884|NCT03652818|58788961|FG000|Overall Study|Adverse Event|1|||
30956307|NCT01759511|59016352|FG000|Overall Study|Adverse Event|4|||
30956308|NCT01759511|59016352|FG000|Overall Study|Death|2|||
30956309|NCT01759511|59016352|FG000|Overall Study|Lack of Efficacy|2|||
30956310|NCT01759511|59016352|FG000|Overall Study|Physician Decision|1|||
30956311|NCT01759511|59016352|FG000|Overall Study|Progressive Disease|5|||
30777885|NCT03652818|58788962|FG001|Overall Study|Adverse Event|0|||
30777886|NCT03652818|58788963|FG002|Overall Study|Adverse Event|0|||
30777887|NCT03652818|58788964|FG003|Overall Study|Adverse Event|0|||
30956312|NCT01759511|59016352|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
30956313|NCT01759511|59016352|FG000|Overall Study|Study Terminated by Sponsor|13|||
30956314|NCT01759511|59016352|FG000|Overall Study|Withdrawal by Subject|3|||
30956315|NCT01732757|59016370|FG000|Overall Study|Lost to Follow-up|1|||
30956316|NCT01732757|59016371|FG001|Overall Study|Lost to Follow-up|0|||
30956317|NCT01732757|59016372|FG002|Overall Study|Lost to Follow-up|0|||
30956318|NCT01758731|59016380|FG000|Overall Study|Physician Decision|1|||
30956319|NCT01606319|59016390|FG000|Overall Study|Lost to Follow-up|17|||
30956320|NCT01606319|59016391|FG001|Overall Study|Lost to Follow-up|14|||
30956321|NCT01606319|59016390|FG000|Overall Study|Withdrawal by Subject|9|||
30956322|NCT01606319|59016391|FG001|Overall Study|Withdrawal by Subject|12|||
30853236|NCT02389816|58880607|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
30853237|NCT02389816|58880605|FG000|Overall Study|Major Protocol Deviation|1|||
30853238|NCT02389816|58880606|FG001|Overall Study|Major Protocol Deviation|0|||
30853239|NCT02389816|58880607|FG002|Overall Study|Major Protocol Deviation|0|||
30853240|NCT02389816|58880605|FG000|Overall Study|Lost to Follow-up|1|||
30853241|NCT02389816|58880606|FG001|Overall Study|Lost to Follow-up|0|||
30853242|NCT02389816|58880607|FG002|Overall Study|Lost to Follow-up|0|||
30853243|NCT02389816|58880605|FG000|Overall Study|Withdrawal of Consent|6|||
30853244|NCT02389816|58880606|FG001|Overall Study|Withdrawal of Consent|4|||
30853245|NCT02389816|58880607|FG002|Overall Study|Withdrawal of Consent|4|||
30853246|NCT02389816|58880605|FG000|Overall Study|Lack of Efficacy|1|||
30853247|NCT02389816|58880606|FG001|Overall Study|Lack of Efficacy|0|||
30853248|NCT02389816|58880607|FG002|Overall Study|Lack of Efficacy|0|||
30853249|NCT02389816|58880605|FG000|Overall Study|Non Compliance with Study Drug|1|||
30853250|NCT02389816|58880606|FG001|Overall Study|Non Compliance with Study Drug|1|||
30853251|NCT02389816|58880607|FG002|Overall Study|Non Compliance with Study Drug|1|||
30853252|NCT02389816|58880605|FG000|Overall Study|Reason not Specified|0|||
30853253|NCT02389816|58880606|FG001|Overall Study|Reason not Specified|2|||
30853254|NCT02389816|58880607|FG002|Overall Study|Reason not Specified|0|||
30853255|NCT02388724|58880617|FG000|Overall Study|Reason not Specified|0|||
30853256|NCT02388724|58880618|FG001|Overall Study|Reason not Specified|1|||
30853257|NCT02388724|58880617|FG000|Overall Study|Major Protocol Deviation|3|||
30853258|NCT02388724|58880618|FG001|Overall Study|Major Protocol Deviation|3|||
30853259|NCT02388724|58880617|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
30853260|NCT02388724|58880618|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
30853261|NCT02388724|58880617|FG000|Overall Study|Voluntary Withdrawal|6|||
30853262|NCT02388724|58880618|FG001|Overall Study|Voluntary Withdrawal|5|||
30956323|NCT01606319|59016390|FG000|Overall Study|Physician Decision|1|||
30956324|NCT01606319|59016391|FG001|Overall Study|Physician Decision|2|||
30662740|NCT00914849|58676315|FG001|Overall Study|Withdrawal by Subject|0|||
30662741|NCT00914849|58676314|FG000|Overall Study|Not eligible|0|||
30956325|NCT01606319|59016390|FG000|Overall Study|Lack of Efficacy|6|||
30956326|NCT01606319|59016391|FG001|Overall Study|Lack of Efficacy|8|||
30956327|NCT01606319|59016390|FG000|Overall Study|Adverse Event|1|||
30956328|NCT01606319|59016391|FG001|Overall Study|Adverse Event|4|||
30662742|NCT00914849|58676315|FG001|Overall Study|Not eligible|1|||
30956329|NCT01757405|59016399|FG000|Overall Study|Lost to Follow-up|1|||
30956330|NCT01757405|59016400|FG001|Overall Study|Lost to Follow-up|1|||
30956331|NCT01757405|59016399|FG000|Overall Study|Withdrawal by Subject|0|||
30956332|NCT01757405|59016400|FG001|Overall Study|Withdrawal by Subject|1|||
30956333|NCT01455597|59016406|FG000|Overall Study|Adverse Event|7|||
30956334|NCT01455597|59016407|FG001|Overall Study|Adverse Event|0|||
30956335|NCT01455597|59016408|FG002|Overall Study|Adverse Event|5|||
30662743|NCT00912743|58676323|FG000|Overall Study|Adverse Event|3|||
30662744|NCT00912743|58676324|FG001|Overall Study|Adverse Event|1|||
30956336|NCT01455597|59016409|FG003|Overall Study|Adverse Event|1|||
30956337|NCT01455597|59016406|FG000|Overall Study|Lack of Efficacy|0|||
30956338|NCT01455597|59016407|FG001|Overall Study|Lack of Efficacy|1|||
30956339|NCT01455597|59016408|FG002|Overall Study|Lack of Efficacy|2|||
30956340|NCT01455597|59016409|FG003|Overall Study|Lack of Efficacy|0|||
30956341|NCT01455597|59016406|FG000|Overall Study|Lost to Follow-up|3|||
30956342|NCT01455597|59016407|FG001|Overall Study|Lost to Follow-up|0|||
30956343|NCT01455597|59016408|FG002|Overall Study|Lost to Follow-up|2|||
30956344|NCT01455597|59016409|FG003|Overall Study|Lost to Follow-up|1|||
30956345|NCT01455597|59016406|FG000|Overall Study|Withdrew Consent|6|||
30956346|NCT01455597|59016407|FG001|Overall Study|Withdrew Consent|5|||
30956347|NCT01455597|59016408|FG002|Overall Study|Withdrew Consent|8|||
30956348|NCT01455597|59016409|FG003|Overall Study|Withdrew Consent|5|||
30956349|NCT01455597|59016406|FG000|Overall Study|Reason not Specified|1|||
30956350|NCT01455597|59016407|FG001|Overall Study|Reason not Specified|2|||
30956351|NCT01455597|59016408|FG002|Overall Study|Reason not Specified|3|||
30956352|NCT01455597|59016409|FG003|Overall Study|Reason not Specified|3|||
30956353|NCT01757171|59016432|FG000|Overall Study|Adverse Event|5|||
30853263|NCT02388724|58880617|FG000|Overall Study|Randomized but not Treated|0|||
30853264|NCT02388724|58880618|FG001|Overall Study|Randomized but not Treated|2|||
30853265|NCT02382796|58880624|FG000|Overall Study|Global deterioration of health status|1|||
30853266|NCT02382796|58880624|FG000|Overall Study|Objective progression or relapse|3|||
30853267|NCT02382796|58880624|FG000|Overall Study|Commercial dacomitinib became available|3|||
30853268|NCT02382640|58880632|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
30853269|NCT02382640|58880633|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
30853270|NCT02382640|58880634|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
30853271|NCT02382640|58880635|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
30853272|NCT02801669|58880647|FG000|Overall Study|Death|66|||
30853273|NCT02801669|58880648|FG001|Overall Study|Death|69|||
30853274|NCT02801669|58880647|FG000|Overall Study|Withdrawal by Subject|81|||
30853275|NCT02801669|58880648|FG001|Overall Study|Withdrawal by Subject|77|||
30853276|NCT02801669|58880647|FG000|Overall Study|Other|4|||
30853277|NCT02801669|58880648|FG001|Overall Study|Other|6|||
30853278|NCT02804399|58880654|FG000|Period 2|Adverse Event|0|||
30853279|NCT02804399|58880655|FG001|Period 2|Adverse Event|1|||
30853280|NCT01333943|58880666|FG000|Overall Study|Known neuropathy|1|||
30853281|NCT01333943|58880667|FG001|Overall Study|Known neuropathy|0|||
30853282|NCT01333865|58880673|FG000|Overall Study|Adverse Event|2|||
30956354|NCT01757171|59016433|FG001|Overall Study|Adverse Event|1|||
30956355|NCT01757171|59016432|FG000|Overall Study|Disease Progression|1|||
30956356|NCT01757171|59016433|FG001|Overall Study|Disease Progression|0|||
30956357|NCT01757171|59016432|FG000|Overall Study|Hospitalization|1|||
30956358|NCT01757171|59016433|FG001|Overall Study|Hospitalization|0|||
30956359|NCT01757171|59016432|FG000|Overall Study|ECOG decline|1|||
30956360|NCT01757171|59016433|FG001|Overall Study|ECOG decline|0|||
30956361|NCT01756235|59016439|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
30956362|NCT01730729|59016443|FG000|Overall Study|Adverse Event|1|||
30956363|NCT01730729|59016443|FG000|Overall Study|Death|1|||
30956364|NCT01730729|59016443|FG000|Overall Study|Progressive Disease|12|||
30956365|NCT01756157|59016447|FG000|First Intervention Period|Withdrawal by Subject|1|||
30956366|NCT01756157|59016448|FG001|First Intervention Period|Withdrawal by Subject|0|||
30956367|NCT01756157|59016447|FG000|First Intervention Period|Lost to Follow-up|0|||
30956368|NCT01756157|59016448|FG001|First Intervention Period|Lost to Follow-up|2|||
30956369|NCT01756079|59016454|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
30956370|NCT01756079|59016454|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
30956371|NCT01756079|59016454|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
30956372|NCT01756079|59016454|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
30956373|NCT01756079|59016454|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
30777888|NCT03652818|58788965|FG004|Overall Study|Adverse Event|0|||
30777889|NCT03652818|58788961|FG000|Overall Study|Physician Decision|1|||
30777890|NCT03652818|58788962|FG001|Overall Study|Physician Decision|0|||
30777891|NCT03652818|58788963|FG002|Overall Study|Physician Decision|0|||
30777892|NCT03652818|58788964|FG003|Overall Study|Physician Decision|0|||
30777893|NCT03652818|58788965|FG004|Overall Study|Physician Decision|0|||
30853283|NCT01333475|58880679|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
30853284|NCT01333475|58880680|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
30956374|NCT04967885|59016461|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
30777894|NCT03652818|58788961|FG000|Overall Study|Lost to Follow-up|0|||
30777895|NCT03652818|58788962|FG001|Overall Study|Lost to Follow-up|1|||
30956375|NCT04967885|59016462|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
30777896|NCT03652818|58788963|FG002|Overall Study|Lost to Follow-up|2|||
30956376|NCT04967885|59016461|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
30956377|NCT04967885|59016462|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
30956378|NCT04967885|59016461|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
30956379|NCT04967885|59016462|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
30956380|NCT04967885|59016461|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
30956381|NCT04967885|59016462|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
30853285|NCT01333475|58880679|FG000|Overall Study|Toxicity|1|||
30853286|NCT01333475|58880680|FG001|Overall Study|Toxicity|3|||
30853287|NCT01333397|58880692|FG000|Overall Study|Lost to Follow-up|1|||
30853288|NCT01333397|58880693|FG001|Overall Study|Lost to Follow-up|0|||
30853289|NCT01333397|58880694|FG002|Overall Study|Lost to Follow-up|0|||
30853290|NCT01333397|58880695|FG003|Overall Study|Lost to Follow-up|1|||
30853291|NCT01333397|58880696|FG004|Overall Study|Lost to Follow-up|0|||
30853292|NCT02798861|58880717|FG000|Overall Study|Lost to Follow-up|22|||
30853293|NCT02798861|58880717|FG000|Overall Study|Withdrawal by Subject|1|||
30956382|NCT04967885|59016461|FG000|EMI-II Intervention|Lost to Follow-up|14|||
30956383|NCT04967885|59016462|FG001|EMI-II Intervention|Lost to Follow-up|10|||
30956384|NCT04571060|59016479|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
30956385|NCT04571060|59016480|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
30956386|NCT04571060|59016479|FG000|Overall Study|Never treated migraine|47|||
30956387|NCT04571060|59016480|FG001|Overall Study|Never treated migraine|36|||
30956388|NCT04571060|59016479|FG000|Overall Study|Protocol Violation|4|||
30956389|NCT04571060|59016480|FG001|Overall Study|Protocol Violation|2|||
30956390|NCT04571060|59016479|FG000|Overall Study|Withdrawal by Subject|6|||
30956391|NCT04571060|59016480|FG001|Overall Study|Withdrawal by Subject|2|||
30956392|NCT04571060|59016479|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
30956393|NCT04571060|59016480|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
30956394|NCT04426318|59016488|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
30956395|NCT04426318|59016489|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
30956396|NCT04356963|59016504|FG000|First Session|Withdrawal by Subject|1|||
30956397|NCT04356963|59016504|FG000|Second Session|Withdrawal by Subject|3|||
30956398|NCT04356963|59016504|FG000|Second Session|Lost to Follow-up|1|||
30956399|NCT04356963|59016504|FG000|Third Session|Lost to Follow-up|6|||
30956400|NCT04356963|59016504|FG000|Third Session|Withdrawal by Subject|1|||
30956401|NCT03941483|59016517|FG000|Overall Study|Miscellaneous|2|||
30956402|NCT03941483|59016518|FG001|Overall Study|Miscellaneous|3|||
30956403|NCT03941483|59016519|FG002|Overall Study|Miscellaneous|0|||
30956404|NCT03941483|59016517|FG000|Overall Study|Study Terminated by Sponsor|1|||
30956405|NCT03941483|59016518|FG001|Overall Study|Study Terminated by Sponsor|0|||
30956406|NCT03941483|59016519|FG002|Overall Study|Study Terminated by Sponsor|0|||
30956407|NCT03941483|59016517|FG000|Overall Study|Withdrawal by Subject|1|||
30956408|NCT03941483|59016518|FG001|Overall Study|Withdrawal by Subject|4|||
30956409|NCT03941483|59016519|FG002|Overall Study|Withdrawal by Subject|1|||
30956410|NCT03941483|59016517|FG000|Overall Study|Lost to Follow-up|2|||
30956411|NCT03941483|59016518|FG001|Overall Study|Lost to Follow-up|1|||
30956412|NCT03941483|59016519|FG002|Overall Study|Lost to Follow-up|8|||
30956413|NCT03941483|59016517|FG000|Overall Study|Death|3|||
30956414|NCT03941483|59016518|FG001|Overall Study|Death|2|||
30956415|NCT03941483|59016519|FG002|Overall Study|Death|6|||
30777897|NCT03652818|58788964|FG003|Overall Study|Lost to Follow-up|1|||
30777898|NCT03652818|58788965|FG004|Overall Study|Lost to Follow-up|1|||
30777899|NCT03619902|58788977|FG000|Overall Study|Termination of Study by Investigator|1|||
30777900|NCT03619902|58788977|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
30777901|NCT00620464|58788983|FG000|Overall Study|Adverse Event|15|||
30777902|NCT00620464|58788984|FG001|Overall Study|Adverse Event|17|||
30777903|NCT00620464|58788983|FG000|Overall Study|Lost to Follow-up|1|||
30777904|NCT00620464|58788984|FG001|Overall Study|Lost to Follow-up|1|||
30777905|NCT00620464|58788983|FG000|Overall Study|Planning Pregnancy|1|||
30777906|NCT00620464|58788984|FG001|Overall Study|Planning Pregnancy|4|||
30777907|NCT00620464|58788983|FG000|Overall Study|Personal|2|||
30777908|NCT00620464|58788984|FG001|Overall Study|Personal|2|||
30777909|NCT00620464|58788983|FG000|Overall Study|Used prohibited medication|1|||
30853294|NCT02798315|58880721|FG000|Overall Study|Failure to return|1|||
30853295|NCT02796755|58880727|FG000|Overall Study|Adverse Event|2|||
30853296|NCT02796755|58880728|FG001|Overall Study|Adverse Event|0|||
30853297|NCT02382016|58880736|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
30853298|NCT02382016|58880737|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
30956416|NCT03689855|59016555|FG000|Overall Study|Adverse Event|3|||
30956417|NCT03689855|59016555|FG000|Overall Study|Withdrawal by Subject|1|||
30956418|NCT03635996|59016568|FG000|Overall Study|Study terminated by Sponsor|94|||
30956419|NCT03635996|59016568|FG000|Overall Study|Withdrawal by Subject|20|||
30956420|NCT03635996|59016568|FG000|Overall Study|Ablation|26|||
30956421|NCT03635996|59016568|FG000|Overall Study|Adverse Event|7|||
30956422|NCT03635996|59016568|FG000|Overall Study|Physician Decision|3|||
30956423|NCT03635996|59016568|FG000|Overall Study|Prohibited medication|5|||
30853299|NCT02382016|58880736|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
30853300|NCT02382016|58880737|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
30853301|NCT02382016|58880736|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
30853302|NCT02382016|58880737|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
30853303|NCT02382016|58880736|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
30853304|NCT02382016|58880737|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
30853305|NCT02382016|58880736|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
30853306|NCT02382016|58880737|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
30853307|NCT02382016|58880736|FG000|Open-label (OL) Treatment Period|Death|4|||
30853308|NCT02382016|58880737|FG001|Open-label (OL) Treatment Period|Death|0|||
30853309|NCT02382016|58880736|FG000|OL Extension Period|Physician Decision|3|||
30853310|NCT02382016|58880737|FG001|OL Extension Period|Physician Decision|0|||
30853311|NCT02382016|58880736|FG000|OL Extension Period|Death|2|||
30853312|NCT02382016|58880737|FG001|OL Extension Period|Death|0|||
30853313|NCT02382016|58880736|FG000|OL Extension Period|Withdrawal by Subject|1|||
30853314|NCT02382016|58880737|FG001|OL Extension Period|Withdrawal by Subject|0|||
30853315|NCT02422186|58880747|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
30853316|NCT02422186|58880748|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
30853317|NCT02422186|58880747|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
30853318|NCT02422186|58880748|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
30853319|NCT02422186|58880747|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
30853320|NCT02422186|58880748|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
30853321|NCT02422186|58880747|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
30853322|NCT02422186|58880748|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
30853323|NCT02422186|58880747|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
30853324|NCT02422186|58880748|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
30853325|NCT02422186|58880747|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
30853326|NCT02422186|58880748|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
30853327|NCT02422186|58880747|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
30853328|NCT02422186|58880748|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
30853329|NCT02422186|58880747|FG000|Follow-up Phase (2 Weeks)|Other|3|||
30853330|NCT02422186|58880748|FG001|Follow-up Phase (2 Weeks)|Other|0|||
30853331|NCT02421952|58880756|FG000|Overall Study|Diary Not Returned|93|||
30853332|NCT02421952|58880756|FG000|Overall Study|Failed seriation task|13|||
30853333|NCT02421952|58880756|FG000|Overall Study|Subject uncooperative for baseline test|2|||
30853334|NCT02421952|58880756|FG000|Overall Study|Surgery cancelled|1|||
30853335|NCT02796677|58880767|FG000|Overall Study|Adverse Event|11|||
30853336|NCT02796677|58880768|FG001|Overall Study|Adverse Event|22|||
30853337|NCT02796677|58880769|FG002|Overall Study|Adverse Event|14|||
30853338|NCT02796677|58880770|FG003|Overall Study|Adverse Event|14|||
30853339|NCT02796677|58880767|FG000|Overall Study|Protocol Violation|7|||
30853340|NCT02796677|58880768|FG001|Overall Study|Protocol Violation|5|||
30853341|NCT02796677|58880769|FG002|Overall Study|Protocol Violation|4|||
30853342|NCT02796677|58880770|FG003|Overall Study|Protocol Violation|8|||
30853343|NCT02796677|58880767|FG000|Overall Study|Lost to Follow-up|1|||
30853344|NCT02796677|58880768|FG001|Overall Study|Lost to Follow-up|5|||
30853345|NCT02796677|58880769|FG002|Overall Study|Lost to Follow-up|2|||
30853346|NCT02796677|58880770|FG003|Overall Study|Lost to Follow-up|2|||
30853347|NCT02796677|58880767|FG000|Overall Study|Lack of Efficacy|7|||
30853348|NCT02796677|58880768|FG001|Overall Study|Lack of Efficacy|9|||
30853349|NCT02796677|58880769|FG002|Overall Study|Lack of Efficacy|14|||
30662745|NCT00912743|58676323|FG000|Overall Study|Lack of Efficacy|9|||
30662746|NCT00912743|58676324|FG001|Overall Study|Lack of Efficacy|18|||
30662747|NCT00912743|58676323|FG000|Overall Study|Toxicity|0|||
30662748|NCT00912743|58676324|FG001|Overall Study|Toxicity|1|||
30777910|NCT00620464|58788984|FG001|Overall Study|Used prohibited medication|0|||
30777911|NCT03652662|58788992|FG000|Overall Study|Withdrawal by Subject|2|||
30777912|NCT03652662|58788993|FG001|Overall Study|Withdrawal by Subject|1|||
30777913|NCT03652662|58788992|FG000|Overall Study|Lost to Follow-up|1|||
30777914|NCT03652662|58788993|FG001|Overall Study|Lost to Follow-up|0|||
30777915|NCT03560258|58789002|FG000|Overall Study|Lost to Follow-up|3|||
30777916|NCT03560258|58789003|FG001|Overall Study|Lost to Follow-up|0|||
30777917|NCT03560258|58789004|FG002|Overall Study|Lost to Follow-up|0|||
30853350|NCT02796677|58880770|FG003|Overall Study|Lack of Efficacy|20|||
30853351|NCT02796677|58880767|FG000|Overall Study|Withdrawal by Subject|4|||
30853352|NCT02796677|58880768|FG001|Overall Study|Withdrawal by Subject|14|||
30853353|NCT02796677|58880769|FG002|Overall Study|Withdrawal by Subject|6|||
30853354|NCT02796677|58880770|FG003|Overall Study|Withdrawal by Subject|7|||
30662749|NCT00912743|58676323|FG000|Overall Study|End of treatment form was not collected|1|||
30662750|NCT00912743|58676324|FG001|Overall Study|End of treatment form was not collected|0|||
30777918|NCT03560258|58789002|FG000|Overall Study|Protocol Violation|0|||
30853355|NCT02796677|58880767|FG000|Overall Study|Progressive disease|6|||
30956424|NCT03635996|59016568|FG000|Overall Study|Did not meet eligibility criteria|5|||
30777919|NCT03560258|58789003|FG001|Overall Study|Protocol Violation|1|||
30956425|NCT03635996|59016568|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
30956426|NCT03635996|59016568|FG000|Overall Study|Protocol Violation|1|||
30956427|NCT03635996|59016568|FG000|Overall Study|Lost to Follow-up|1|||
30956428|NCT03595878|59016575|FG000|Overall Study|Death|2|||
30956429|NCT03595878|59016576|FG001|Overall Study|Death|1|||
30956430|NCT03595878|59016577|FG002|Overall Study|Death|0|||
30956431|NCT03595878|59016575|FG000|Overall Study|Disease progression|2|||
30956432|NCT03595878|59016576|FG001|Overall Study|Disease progression|1|||
30956433|NCT03595878|59016577|FG002|Overall Study|Disease progression|2|||
30956434|NCT03168464|59016623|FG000|Overall Study|Death|9|||
30956435|NCT03168464|59016623|FG000|Overall Study|Progression of disease|6|||
30956436|NCT02818920|59016627|FG000|Overall Study|Unresectable|4|||
30956437|NCT02818920|59016627|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
30956438|NCT02818920|59016627|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
30956439|NCT02818920|59016627|FG000|Overall Study|Adverse Event|3|||
30956440|NCT02818920|59016627|FG000|Overall Study|Developed Other Disease|1|||
30956441|NCT02818920|59016627|FG000|Overall Study|Refused Further Treatment|1|||
30956442|NCT01454401|59016653|FG000|Overall Study|Death|1|||
30956443|NCT01454401|59016653|FG000|Overall Study|hospitalised|1|||
30956444|NCT01454401|59016653|FG000|Overall Study|osteomyelitis|2|||
30956445|NCT01454401|59016653|FG000|Overall Study|non-adherence|1|||
30956446|NCT01344018|59016659|FG000|Overall Study|Death|22|||
30956447|NCT01344018|59016660|FG001|Overall Study|Death|25|||
30956448|NCT01344018|59016659|FG000|Overall Study|Lost to Follow-up|4|||
30956449|NCT01344018|59016660|FG001|Overall Study|Lost to Follow-up|7|||
30956450|NCT01755767|59016693|FG000|Overall Study|Progressive Disease|8|||
30956451|NCT01755767|59016694|FG001|Overall Study|Progressive Disease|7|||
30956452|NCT01755767|59016695|FG002|Overall Study|Progressive Disease|91|||
30956453|NCT01755767|59016696|FG003|Overall Study|Progressive Disease|43|||
30956454|NCT01755767|59016693|FG000|Overall Study|Clinical Disease Progression|4|||
30956455|NCT01755767|59016694|FG001|Overall Study|Clinical Disease Progression|2|||
30956456|NCT01755767|59016695|FG002|Overall Study|Clinical Disease Progression|29|||
30956457|NCT01755767|59016696|FG003|Overall Study|Clinical Disease Progression|20|||
30956458|NCT01755767|59016693|FG000|Overall Study|Radiographic Disease Progression|9|||
30956459|NCT01755767|59016694|FG001|Overall Study|Radiographic Disease Progression|4|||
30956460|NCT01755767|59016695|FG002|Overall Study|Radiographic Disease Progression|44|||
30956461|NCT01755767|59016696|FG003|Overall Study|Radiographic Disease Progression|27|||
30956462|NCT01755767|59016693|FG000|Overall Study|Adverse Event|6|||
30956463|NCT01755767|59016694|FG001|Overall Study|Adverse Event|0|||
30956464|NCT01755767|59016695|FG002|Overall Study|Adverse Event|28|||
30956465|NCT01755767|59016696|FG003|Overall Study|Adverse Event|11|||
30956466|NCT01755767|59016693|FG000|Overall Study|Death|1|||
30956467|NCT01755767|59016694|FG001|Overall Study|Death|2|||
30956468|NCT01755767|59016695|FG002|Overall Study|Death|15|||
30956469|NCT01755767|59016696|FG003|Overall Study|Death|4|||
30956470|NCT01755767|59016693|FG000|Overall Study|Subject Decision|0|||
30956471|NCT01755767|59016694|FG001|Overall Study|Subject Decision|0|||
30956472|NCT01755767|59016695|FG002|Overall Study|Subject Decision|10|||
30956473|NCT01755767|59016696|FG003|Overall Study|Subject Decision|3|||
30956474|NCT01755767|59016693|FG000|Overall Study|Withdrawal by Subject|0|||
30956475|NCT01755767|59016694|FG001|Overall Study|Withdrawal by Subject|0|||
30956476|NCT01755767|59016695|FG002|Overall Study|Withdrawal by Subject|2|||
30956477|NCT01755767|59016696|FG003|Overall Study|Withdrawal by Subject|1|||
30956478|NCT01755767|59016693|FG000|Overall Study|Other|0|||
30956479|NCT01755767|59016694|FG001|Overall Study|Other|0|||
30956480|NCT01755767|59016695|FG002|Overall Study|Other|2|||
30956481|NCT01755767|59016696|FG003|Overall Study|Other|3|||
30956482|NCT01755767|59016693|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
30956483|NCT01755767|59016694|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
30956484|NCT01755767|59016695|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
30956485|NCT01755767|59016696|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
30956486|NCT01730339|59016792|FG000|Overall Study|Withdrawal by Subject|3|||
30956487|NCT01730339|59016793|FG001|Overall Study|Withdrawal by Subject|2|||
30956488|NCT01730339|59016792|FG000|Overall Study|Lost to Follow-up|1|||
30956489|NCT01730339|59016793|FG001|Overall Study|Lost to Follow-up|1|||
30777920|NCT03560258|58789004|FG002|Overall Study|Protocol Violation|0|||
30956490|NCT01730339|59016792|FG000|Overall Study|Un-specified|1|||
30956491|NCT01730339|59016793|FG001|Overall Study|Un-specified|0|||
30956492|NCT01754753|59016850|FG000|Overall Study|Study close|43|||
30956493|NCT01754753|59016851|FG001|Overall Study|Study close|44|||
30956494|NCT01754753|59016850|FG000|Overall Study|Lost to Follow-up|9|||
30956495|NCT01754753|59016851|FG001|Overall Study|Lost to Follow-up|5|||
30956496|NCT01729871|59016859|FG000|Overall Study|Adverse Event|7|||
30956497|NCT01729871|59016860|FG001|Overall Study|Adverse Event|7|||
30956498|NCT01729871|59016859|FG000|Overall Study|Death|0|||
30956499|NCT01729871|59016860|FG001|Overall Study|Death|1|||
30956500|NCT01729871|59016859|FG000|Overall Study|Lack of Efficacy|0|||
30956501|NCT01729871|59016860|FG001|Overall Study|Lack of Efficacy|1|||
30956502|NCT01729871|59016859|FG000|Overall Study|Physician Decision|0|||
30956503|NCT01729871|59016860|FG001|Overall Study|Physician Decision|2|||
30956504|NCT01729871|59016859|FG000|Overall Study|Protocol Violation|1|||
30956505|NCT01729871|59016860|FG001|Overall Study|Protocol Violation|0|||
30956506|NCT01729871|59016859|FG000|Overall Study|Withdrawal by Subject|0|||
30956507|NCT01729871|59016860|FG001|Overall Study|Withdrawal by Subject|3|||
30956508|NCT01729871|59016859|FG000|Overall Study|Other|4|||
30956509|NCT01729871|59016860|FG001|Overall Study|Other|9|||
30956510|NCT01729559|59016868|FG000|Overall Study|Protocol Violation|31|||
30956511|NCT01729559|59016869|FG001|Overall Study|Protocol Violation|28|||
30956512|NCT01728779|59016888|FG000|Overall Study|Withdrawal by Subject|1|||
30956513|NCT01728623|59016899|FG000|Overall Study|Disease progression|26|||
30956514|NCT01728623|59016899|FG000|Overall Study|Adverse Event|1|||
30956515|NCT01728623|59016899|FG000|Overall Study|Withdrawal by Subject|1|||
30956516|NCT01754129|59016906|FG000|Overall Study|Death|13|||
30956517|NCT01754129|59016906|FG000|Overall Study|Duodopa discontinuation|9|||
30956518|NCT01754129|59016906|FG000|Overall Study|Lost to Follow-up|7|||
30956519|NCT01754129|59016906|FG000|Overall Study|Withdrew consent|1|||
30956520|NCT01754129|59016906|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
30956521|NCT01728077|59016919|FG000|Overall Study|Lack of Efficacy|3|||
30956522|NCT01728077|59016920|FG001|Overall Study|Lack of Efficacy|1|||
30956523|NCT01728077|59016919|FG000|Overall Study|Lost to Follow-up|1|||
30956524|NCT01728077|59016920|FG001|Overall Study|Lost to Follow-up|0|||
30956525|NCT01728077|59016919|FG000|Overall Study|Subject choice|2|||
30956526|NCT01728077|59016920|FG001|Overall Study|Subject choice|3|||
30956527|NCT01728077|59016919|FG000|Overall Study|Death|0|||
30956528|NCT01728077|59016920|FG001|Overall Study|Death|1|||
30956529|NCT01728077|59016919|FG000|Overall Study|Patient moving|1|||
30956530|NCT01728077|59016920|FG001|Overall Study|Patient moving|0|||
30956531|NCT01728077|59016919|FG000|Overall Study|Non compliance|1|||
30956532|NCT01728077|59016920|FG001|Overall Study|Non compliance|0|||
30956533|NCT01606007|59016939|FG000|Overall Study|Reason 'Other' in the protocol|0|||
30956534|NCT01606007|59016940|FG001|Overall Study|Reason 'Other' in the protocol|1|||
30956535|NCT01606007|59016941|FG002|Overall Study|Reason 'Other' in the protocol|1|||
30956536|NCT01606007|59016939|FG000|Overall Study|Pregnancy|0|||
30777921|NCT03560258|58789002|FG000|Overall Study|Withdrawal by Subject|0|||
30777922|NCT03560258|58789003|FG001|Overall Study|Withdrawal by Subject|0|||
30777923|NCT03560258|58789004|FG002|Overall Study|Withdrawal by Subject|1|||
30777924|NCT02768662|58789012|FG000|Overall Study|Adverse Event|1|||
30777925|NCT02768662|58789012|FG000|Overall Study|Lost to Follow-up|4|||
30777926|NCT02768662|58789012|FG000|Overall Study|Withdrawal by Subject|3|||
30777927|NCT02768662|58789012|FG000|Overall Study|Study terminated by Sponsor|78|||
30777928|NCT03539432|58789018|FG000|Overall Study|Lost to Follow-up|0|||
30853356|NCT02796677|58880768|FG001|Overall Study|Progressive disease|15|||
30956537|NCT01606007|59016940|FG001|Overall Study|Pregnancy|1|||
30956538|NCT01606007|59016941|FG002|Overall Study|Pregnancy|1|||
30956539|NCT01606007|59016939|FG000|Overall Study|Withdrawal by Subject|8|||
30956540|NCT01606007|59016940|FG001|Overall Study|Withdrawal by Subject|6|||
30956541|NCT01606007|59016941|FG002|Overall Study|Withdrawal by Subject|1|||
30956542|NCT01606007|59016939|FG000|Overall Study|Adverse Event|0|||
30956543|NCT01606007|59016940|FG001|Overall Study|Adverse Event|1|||
30956544|NCT01606007|59016941|FG002|Overall Study|Adverse Event|1|||
30956545|NCT01606007|59016939|FG000|Overall Study|discontinue study treatment|0|||
30956546|NCT01606007|59016940|FG001|Overall Study|discontinue study treatment|2|||
30956547|NCT01606007|59016941|FG002|Overall Study|discontinue study treatment|1|||
30956548|NCT01606007|59016939|FG000|Overall Study|Lost to Follow-up|6|||
30956549|NCT01606007|59016940|FG001|Overall Study|Lost to Follow-up|8|||
30956550|NCT01606007|59016941|FG002|Overall Study|Lost to Follow-up|5|||
30956551|NCT01606007|59016939|FG000|Overall Study|Poor/Non-compliance|1|||
30956552|NCT01606007|59016940|FG001|Overall Study|Poor/Non-compliance|0|||
30956553|NCT01606007|59016941|FG002|Overall Study|Poor/Non-compliance|0|||
30956554|NCT01753193|59017020|FG000|Overall Study|Withdrawal by Subject|23|||
30956555|NCT01753193|59017020|FG000|Overall Study|Lost to Follow-up|6|||
30956556|NCT01753193|59017020|FG000|Overall Study|Death|1|||
30777929|NCT03539432|58789019|FG001|Overall Study|Lost to Follow-up|1|||
30777930|NCT03615924|58789027|FG000|Overall Study|Withdrawal by Subject|2|||
30956557|NCT01753193|59017020|FG000|Overall Study|Other|16|||
30956558|NCT01727297|59017067|FG000|Overall Study|Death|13|||
30956559|NCT01727297|59017068|FG001|Overall Study|Death|0|||
30956560|NCT01727297|59017067|FG000|Overall Study|Protocol Violation|1|||
30956561|NCT01727297|59017068|FG001|Overall Study|Protocol Violation|10|||
30956562|NCT01727297|59017067|FG000|Overall Study|Adverse Event|3|||
30956563|NCT01727297|59017068|FG001|Overall Study|Adverse Event|1|||
30956564|NCT01727297|59017067|FG000|Overall Study|Lost to Follow-up|11|||
30956565|NCT01727297|59017068|FG001|Overall Study|Lost to Follow-up|0|||
30956566|NCT01727297|59017067|FG000|Overall Study|Withdrawal by Subject|26|||
30956567|NCT01727297|59017068|FG001|Overall Study|Withdrawal by Subject|27|||
30956568|NCT01727297|59017067|FG000|Overall Study|Physician Decision|19|||
30956569|NCT01727297|59017068|FG001|Overall Study|Physician Decision|5|||
30956570|NCT01727297|59017067|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
30956571|NCT01727297|59017068|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
30956572|NCT01753115|59017084|FG000|Overall Study|Lost to Follow-up|3|||
30956573|NCT01753115|59017085|FG001|Overall Study|Lost to Follow-up|6|||
30956574|NCT01753115|59017086|FG002|Overall Study|Lost to Follow-up|8|||
30956575|NCT01753115|59017084|FG000|Overall Study|Withdrawal by Subject|6|||
30777931|NCT03615924|58789028|FG001|Overall Study|Withdrawal by Subject|5|||
30777932|NCT03615924|58789027|FG000|Overall Study|Death|3|||
30777933|NCT03615924|58789028|FG001|Overall Study|Death|1|||
30777934|NCT03615924|58789027|FG000|Overall Study|Lost to Follow-up|1|||
30777935|NCT03615924|58789028|FG001|Overall Study|Lost to Follow-up|0|||
30777936|NCT03615924|58789027|FG000|Overall Study|Randomized in error|1|||
30777937|NCT03615924|58789028|FG001|Overall Study|Randomized in error|0|||
30777938|NCT03615924|58789027|FG000|Overall Study|Study termination by Sponsor|94|||
30777939|NCT03615924|58789028|FG001|Overall Study|Study termination by Sponsor|86|||
30777940|NCT03535844|58789036|FG000|Overall Study|Withdrawal by Subject|0|||
30777941|NCT03535844|58789037|FG001|Overall Study|Withdrawal by Subject|1|||
30777942|NCT03533114|58789054|FG000|Overall|Adverse Event|16|||
30777943|NCT03533114|58789055|FG001|Overall|Adverse Event|11|||
30777944|NCT03533114|58789054|FG000|Overall|Consent Withdrawal by Participant|7|||
30777945|NCT03533114|58789055|FG001|Overall|Consent Withdrawal by Participant|6|||
30777946|NCT03533114|58789054|FG000|Overall|Lack of Efficacy|5|||
30777947|NCT03533114|58789055|FG001|Overall|Lack of Efficacy|3|||
30777948|NCT03533114|58789054|FG000|Overall|Lost to Follow-up|1|||
30777949|NCT03533114|58789055|FG001|Overall|Lost to Follow-up|1|||
30777950|NCT03533114|58789054|FG000|Overall|Physician Decision|0|||
30777951|NCT03533114|58789055|FG001|Overall|Physician Decision|2|||
30777952|NCT03533114|58789054|FG000|Overall|Protocol deviation|1|||
30777953|NCT03533114|58789055|FG001|Overall|Protocol deviation|1|||
30777954|NCT03533114|58789054|FG000|Overall|Failure to meet randomization criteria|1|||
30777955|NCT03533114|58789055|FG001|Overall|Failure to meet randomization criteria|2|||
30777956|NCT03533114|58789054|FG000|Overall|Non-Compliance with study drug|0|||
30777957|NCT03533114|58789055|FG001|Overall|Non-Compliance with study drug|1|||
30777958|NCT03533114|58789054|FG000|Overall|Other|0|||
30777959|NCT03533114|58789055|FG001|Overall|Other|1|||
30777960|NCT03533114|58789054|FG000|Open Label Titration and Optimization|Adverse Event|11|||
30777961|NCT03533114|58789055|FG001|Open Label Titration and Optimization|Adverse Event|8|||
30777962|NCT03533114|58789054|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
30777963|NCT03533114|58789055|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
30777964|NCT03533114|58789054|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
30777965|NCT03533114|58789055|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
30777966|NCT03533114|58789054|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
30777967|NCT03533114|58789055|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
30777968|NCT03533114|58789054|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
30777969|NCT03533114|58789055|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
30777970|NCT03533114|58789054|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
30777971|NCT03533114|58789055|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
30777972|NCT03533114|58789054|FG000|Stable Dose|Adverse Event|0|||
30777973|NCT03533114|58789055|FG001|Stable Dose|Adverse Event|2|||
30777974|NCT03533114|58789054|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
30777975|NCT03533114|58789055|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
30956576|NCT01753115|59017085|FG001|Overall Study|Withdrawal by Subject|5|||
30956577|NCT01753115|59017086|FG002|Overall Study|Withdrawal by Subject|6|||
30956578|NCT01753115|59017084|FG000|Overall Study|Subject non-compliant|3|||
30956579|NCT01753115|59017085|FG001|Overall Study|Subject non-compliant|3|||
30956580|NCT01753115|59017086|FG002|Overall Study|Subject non-compliant|0|||
30956581|NCT01753115|59017084|FG000|Overall Study|Used excluded drug|0|||
30956582|NCT01753115|59017085|FG001|Overall Study|Used excluded drug|1|||
30956583|NCT01753115|59017086|FG002|Overall Study|Used excluded drug|0|||
30956584|NCT01727141|59017107|FG000|Overall Study|Physician Decision|0|||
30956585|NCT01727141|59017108|FG001|Overall Study|Physician Decision|1|||
30956586|NCT01727141|59017109|FG002|Overall Study|Physician Decision|0|||
30777976|NCT03533114|58789054|FG000|Stable Dose|Lack of Efficacy|1|||
30777977|NCT03533114|58789055|FG001|Stable Dose|Lack of Efficacy|0|||
30777978|NCT03533114|58789054|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
30777979|NCT03533114|58789055|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
30956587|NCT01727141|59017110|FG003|Overall Study|Physician Decision|2|||
30777980|NCT03533114|58789054|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
30956588|NCT01727141|59017107|FG000|Overall Study|Lost to Follow-up|0|||
30956589|NCT01727141|59017108|FG001|Overall Study|Lost to Follow-up|2|||
30956590|NCT01727141|59017109|FG002|Overall Study|Lost to Follow-up|0|||
30956591|NCT01727141|59017110|FG003|Overall Study|Lost to Follow-up|0|||
30956592|NCT01727141|59017107|FG000|Overall Study|Death|0|||
30956593|NCT01727141|59017108|FG001|Overall Study|Death|1|||
30956594|NCT01727141|59017109|FG002|Overall Study|Death|1|||
30956595|NCT01727141|59017110|FG003|Overall Study|Death|1|||
30956596|NCT01727141|59017107|FG000|Overall Study|Protocol deviation|1|||
30956597|NCT01727141|59017108|FG001|Overall Study|Protocol deviation|1|||
30956598|NCT01727141|59017109|FG002|Overall Study|Protocol deviation|0|||
30956599|NCT01727141|59017110|FG003|Overall Study|Protocol deviation|1|||
30956600|NCT01727141|59017107|FG000|Overall Study|Withdrawal by Subject|4|||
30956601|NCT01727141|59017108|FG001|Overall Study|Withdrawal by Subject|4|||
30956602|NCT01727141|59017109|FG002|Overall Study|Withdrawal by Subject|2|||
30956603|NCT01727141|59017110|FG003|Overall Study|Withdrawal by Subject|11|||
30956604|NCT01726517|59017134|FG000|Overall Study|Withdrawal by Subject|0|||
30956605|NCT01726517|59017135|FG001|Overall Study|Withdrawal by Subject|0|||
30956606|NCT01726517|59017136|FG002|Overall Study|Withdrawal by Subject|1|||
30956607|NCT01726517|59017137|FG003|Overall Study|Withdrawal by Subject|0|||
30956608|NCT01726517|59017138|FG004|Overall Study|Withdrawal by Subject|0|||
30956609|NCT01752023|59017152|FG000|Overall Study|Physician Decision|2|||
30956610|NCT01752023|59017153|FG001|Overall Study|Physician Decision|1|||
30956611|NCT01726049|59017165|FG000|Overall Study|Death|1|||
30956612|NCT01726049|59017166|FG001|Overall Study|Death|1|||
30956613|NCT01726049|59017165|FG000|Overall Study|Adverse Event|4|||
30956614|NCT01726049|59017166|FG001|Overall Study|Adverse Event|1|||
30956615|NCT01726049|59017165|FG000|Overall Study|refused second HC|0|||
30956616|NCT01726049|59017166|FG001|Overall Study|refused second HC|2|||
30956617|NCT01605617|59017187|FG000|First Intervention|Adverse Event|0|||
30956618|NCT01605617|59017188|FG001|First Intervention|Adverse Event|1|||
30956619|NCT01605617|59017187|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
30956620|NCT01605617|59017188|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
30777981|NCT03533114|58789055|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
30777982|NCT03533114|58789054|FG000|Open-Label Safety Extension|Adverse Event|3|||
30777983|NCT03533114|58789055|FG001|Open-Label Safety Extension|Adverse Event|0|||
30777984|NCT03533114|58789054|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
30777985|NCT03533114|58789055|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
30777986|NCT03533114|58789054|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
30777987|NCT03533114|58789055|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
30777988|NCT03533114|58789054|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
30777989|NCT03533114|58789055|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
30777990|NCT03533114|58789054|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
30777991|NCT03533114|58789055|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
30777992|NCT03033394|58789063|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
30777993|NCT03033394|58789063|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
30777994|NCT03033394|58789063|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
30777995|NCT03033394|58789063|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
30777996|NCT03033394|58789063|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
30777997|NCT03981822|58789080|FG000|Overall Study|Lost to Follow-up|0|||
30777998|NCT03981822|58789081|FG001|Overall Study|Lost to Follow-up|1|||
30777999|NCT03981822|58789082|FG002|Overall Study|Lost to Follow-up|1|||
30778000|NCT03981822|58789083|FG003|Overall Study|Lost to Follow-up|0|||
30778001|NCT03981822|58789084|FG004|Overall Study|Lost to Follow-up|6|||
30778002|NCT03981822|58789085|FG005|Overall Study|Lost to Follow-up|4|||
30778003|NCT03981822|58789086|FG006|Overall Study|Lost to Follow-up|4|||
30778004|NCT03981822|58789087|FG007|Overall Study|Lost to Follow-up|2|||
30778005|NCT03981822|58789080|FG000|Overall Study|Withdrawal by Subject|0|||
30778006|NCT03981822|58789081|FG001|Overall Study|Withdrawal by Subject|1|||
30778007|NCT03981822|58789082|FG002|Overall Study|Withdrawal by Subject|0|||
30778008|NCT03981822|58789083|FG003|Overall Study|Withdrawal by Subject|0|||
30853357|NCT02796677|58880769|FG002|Overall Study|Progressive disease|13|||
30853358|NCT02796677|58880770|FG003|Overall Study|Progressive disease|18|||
30956621|NCT01751867|59017205|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
30956622|NCT01751867|59017206|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
30956623|NCT01751867|59017205|FG000|Overall Study|Diease Progression|4|||
30956624|NCT01751867|59017206|FG001|Overall Study|Diease Progression|18|||
30956625|NCT01751867|59017205|FG000|Overall Study|Adverse Event|8|||
30662751|NCT00914459|58676332|FG000|Overall Study|Protocol Violation|0|||
30778009|NCT03981822|58789084|FG004|Overall Study|Withdrawal by Subject|0|||
30778010|NCT03981822|58789085|FG005|Overall Study|Withdrawal by Subject|1|||
30956626|NCT01751867|59017206|FG001|Overall Study|Adverse Event|15|||
30956627|NCT01751867|59017205|FG000|Overall Study|Poor Compliance|0|||
30956628|NCT01751867|59017206|FG001|Overall Study|Poor Compliance|5|||
30956629|NCT01751867|59017205|FG000|Overall Study|Withdrawal by Subject|3|||
30956630|NCT01751867|59017206|FG001|Overall Study|Withdrawal by Subject|1|||
30778011|NCT03981822|58789086|FG006|Overall Study|Withdrawal by Subject|0|||
30778012|NCT03981822|58789087|FG007|Overall Study|Withdrawal by Subject|2|||
30778013|NCT03981822|58789080|FG000|Overall Study|COVID-19 Related|0|||
30778014|NCT03981822|58789081|FG001|Overall Study|COVID-19 Related|0|||
30778015|NCT03981822|58789082|FG002|Overall Study|COVID-19 Related|0|||
30778016|NCT03981822|58789083|FG003|Overall Study|COVID-19 Related|0|||
30778017|NCT03981822|58789084|FG004|Overall Study|COVID-19 Related|2|||
30778018|NCT03981822|58789085|FG005|Overall Study|COVID-19 Related|1|||
30778019|NCT03981822|58789086|FG006|Overall Study|COVID-19 Related|2|||
30778020|NCT03981822|58789087|FG007|Overall Study|COVID-19 Related|1|||
30778021|NCT03650556|58789099|FG000|Overall Study|Death|2|||
30778022|NCT03650556|58789099|FG000|Overall Study|Withdrawal by Subject|20|||
30778023|NCT03650556|58789099|FG000|Overall Study|Physician Decision|2|||
30778024|NCT03650556|58789099|FG000|Overall Study|Lost to Follow-up|8|||
30778025|NCT03650556|58789099|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
30778026|NCT03650556|58789099|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
30778027|NCT03531632|58789107|FG000|Overall Study|Adverse Event|0|||
30778028|NCT03531632|58789108|FG001|Overall Study|Adverse Event|0|||
30778029|NCT03531632|58789109|FG002|Overall Study|Adverse Event|1|||
30778030|NCT03531632|58789107|FG000|Overall Study|Death|4|||
30778031|NCT03531632|58789108|FG001|Overall Study|Death|0|||
30778032|NCT03531632|58789109|FG002|Overall Study|Death|14|||
30778033|NCT03531632|58789107|FG000|Overall Study|Study Terminated|1|||
30778034|NCT03531632|58789108|FG001|Overall Study|Study Terminated|3|||
30778035|NCT03531632|58789109|FG002|Overall Study|Study Terminated|11|||
30778036|NCT03979638|58789120|FG000|Period 1|Physician Decision|1|||
30778037|NCT03979638|58789121|FG001|Period 1|Physician Decision|1|||
30778038|NCT03979638|58789120|FG000|Period 1|Withdrawal by Subject|4|||
30778039|NCT03979638|58789121|FG001|Period 1|Withdrawal by Subject|3|||
30853359|NCT02796677|58880767|FG000|Overall Study|Reason not mentioned|2|||
30853360|NCT02796677|58880768|FG001|Overall Study|Reason not mentioned|3|||
30956631|NCT01751867|59017205|FG000|Overall Study|Physician Decision|4|||
30956632|NCT01751867|59017206|FG001|Overall Study|Physician Decision|7|||
30956633|NCT01751867|59017205|FG000|Overall Study|Protocol Violation|0|||
30956634|NCT01751867|59017206|FG001|Overall Study|Protocol Violation|2|||
30853361|NCT02796677|58880769|FG002|Overall Study|Reason not mentioned|0|||
30853362|NCT02796677|58880770|FG003|Overall Study|Reason not mentioned|5|||
30853363|NCT02421172|58880784|FG000|Period 1|Adverse Event|1|||
30853364|NCT02421172|58880785|FG001|Period 1|Adverse Event|0|||
30853365|NCT02421172|58880786|FG002|Period 1|Adverse Event|0|||
30853366|NCT02421172|58880787|FG003|Period 1|Adverse Event|0|||
30853367|NCT02421172|58880788|FG004|Period 1|Adverse Event|0|||
30853368|NCT02421172|58880784|FG000|Period 1|Lost to Follow-up|3|||
30853369|NCT02421172|58880785|FG001|Period 1|Lost to Follow-up|1|||
30956635|NCT01751867|59017205|FG000|Overall Study|Death|0|||
30662752|NCT00914459|58676333|FG001|Overall Study|Protocol Violation|1|||
30778040|NCT03979638|58789120|FG000|Period 1|Study terminated by Sponsor|1|||
30778041|NCT03979638|58789121|FG001|Period 1|Study terminated by Sponsor|3|||
30778042|NCT03979638|58789120|FG000|Period 1|Protocol Violation|1|||
30778043|NCT03979638|58789121|FG001|Period 1|Protocol Violation|0|||
30778044|NCT03979638|58789120|FG000|Period 2|Study terminated by Sponsor|1|||
30778045|NCT03979638|58789121|FG001|Period 2|Study terminated by Sponsor|1|||
30853370|NCT02421172|58880786|FG002|Period 1|Lost to Follow-up|0|||
30853371|NCT02421172|58880787|FG003|Period 1|Lost to Follow-up|0|||
30853372|NCT02421172|58880788|FG004|Period 1|Lost to Follow-up|0|||
30853373|NCT02421172|58880784|FG000|Period 1|Patient/guardian decision|0|||
30853374|NCT02421172|58880785|FG001|Period 1|Patient/guardian decision|1|||
30853375|NCT02421172|58880786|FG002|Period 1|Patient/guardian decision|0|||
30853376|NCT02421172|58880787|FG003|Period 1|Patient/guardian decision|0|||
30853377|NCT02421172|58880788|FG004|Period 1|Patient/guardian decision|0|||
30956636|NCT01751867|59017206|FG001|Overall Study|Death|5|||
30956637|NCT01751867|59017205|FG000|Overall Study|Other|11|||
30956638|NCT01751867|59017206|FG001|Overall Study|Other|37|||
30956639|NCT01751867|59017205|FG000|Overall Study|Randomized but not treated.|2|||
30956640|NCT01751867|59017206|FG001|Overall Study|Randomized but not treated.|1|||
30956641|NCT01751165|59017232|FG000|Overall Study|Adverse event, serious fatal|1|||
30956642|NCT01751165|59017233|FG001|Overall Study|Adverse event, serious fatal|0|||
30956643|NCT01751165|59017234|FG002|Overall Study|Adverse event, serious fatal|1|||
30956644|NCT01751165|59017232|FG000|Overall Study|Withdrawal by Subject|0|||
30956645|NCT01751165|59017233|FG001|Overall Study|Withdrawal by Subject|0|||
30956646|NCT01751165|59017234|FG002|Overall Study|Withdrawal by Subject|1|||
30662753|NCT00914459|58676332|FG000|Overall Study|Parent/Legal guardian request|1|||
30662754|NCT00914459|58676333|FG001|Overall Study|Parent/Legal guardian request|0|||
30956647|NCT01751165|59017232|FG000|Overall Study|Serious adverse event|0|||
30956648|NCT01751165|59017233|FG001|Overall Study|Serious adverse event|2|||
30956649|NCT01751165|59017234|FG002|Overall Study|Serious adverse event|0|||
30956650|NCT01751165|59017232|FG000|Overall Study|Lost to Follow-up|1|||
30956651|NCT01751165|59017233|FG001|Overall Study|Lost to Follow-up|1|||
30956652|NCT01751165|59017234|FG002|Overall Study|Lost to Follow-up|1|||
30956653|NCT01751087|59017259|FG000|Overall Study|Withdrawal by Subject|1|||
30956654|NCT01751087|59017260|FG001|Overall Study|Withdrawal by Subject|0|||
30956655|NCT01751087|59017261|FG002|Overall Study|Withdrawal by Subject|0|||
30956656|NCT01751087|59017259|FG000|Overall Study|Physician Decision|0|||
30956657|NCT01751087|59017260|FG001|Overall Study|Physician Decision|0|||
30956658|NCT01751087|59017261|FG002|Overall Study|Physician Decision|1|||
30956659|NCT01750697|59017269|FG000|Overall Study|Transferred Back to Local Hospital|1|||
30956660|NCT01750697|59017269|FG000|Overall Study|Physician and Family Decision|1|||
30956661|NCT01750697|59017269|FG000|Overall Study|Transferred to Adult Services|5|||
30956662|NCT01750697|59017269|FG000|Overall Study|Physician Decision|1|||
30956663|NCT01750697|59017269|FG000|Overall Study|Withdrawal by Subject|1|||
30956664|NCT01750229|59017280|FG000|Randomized Crossover Phase|Adverse Event|1|||
30662755|NCT00912509|58676343|FG000|Overall Study|Lost to Follow-up|1|||
30662756|NCT00912509|58676344|FG001|Overall Study|Lost to Follow-up|0|||
30662757|NCT00912509|58676343|FG000|Overall Study|Lack of Efficacy|4|||
30662758|NCT00912509|58676344|FG001|Overall Study|Lack of Efficacy|3|||
30956665|NCT01750229|59017280|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
30956666|NCT01750229|59017280|FG000|Long-term Follow-up Phase|Adverse Event|2|||
30956667|NCT01750229|59017280|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
30956668|NCT01724489|59017292|FG000|Overall Study|Adverse Event|8|||
30956669|NCT01724489|59017293|FG001|Overall Study|Adverse Event|3|||
30956670|NCT01724489|59017292|FG000|Overall Study|Surgery, medication|1|||
30956671|NCT01724489|59017293|FG001|Overall Study|Surgery, medication|1|||
30956672|NCT01724489|59017292|FG000|Overall Study|Lost to Follow-up|1|||
30956673|NCT01724489|59017293|FG001|Overall Study|Lost to Follow-up|2|||
30662759|NCT00913835|58676364|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
30662760|NCT00913835|58676365|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
30662761|NCT00913835|58676364|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
30662762|NCT00913835|58676365|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
30956674|NCT01724489|59017292|FG000|Overall Study|Withdrawal by Subject|6|||
30956675|NCT01724489|59017293|FG001|Overall Study|Withdrawal by Subject|6|||
30956676|NCT01724177|59017308|FG000|Overall Study|Adverse Event|8|||
30956677|NCT01724177|59017308|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
30956678|NCT01724177|59017308|FG000|Overall Study|Nervous participant|1|||
30956679|NCT01724177|59017308|FG000|Overall Study|Serious Adverse Event Related|1|||
30956680|NCT04378270|59017327|FG000|Overall Study|Lack of Efficacy|1|||
30662763|NCT00913835|58676364|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
30662764|NCT00913835|58676365|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
30662765|NCT00913835|58676364|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
30956681|NCT04378270|59017327|FG000|Overall Study|Withdrawal by Subject|1|||
30956682|NCT04378270|59017327|FG000|Overall Study|Screen Failure|1|||
30956683|NCT04378270|59017327|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
30956684|NCT01724021|59017333|FG000|Overall Study|Adverse Event|11|||
30956685|NCT01724021|59017334|FG001|Overall Study|Adverse Event|6|||
30956686|NCT01724021|59017333|FG000|Overall Study|Death|46|||
30956687|NCT01724021|59017334|FG001|Overall Study|Death|58|||
30662766|NCT00913835|58676365|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
30956688|NCT01724021|59017333|FG000|Overall Study|Participant request/ Withdrew consent|18|||
30956689|NCT01724021|59017334|FG001|Overall Study|Participant request/ Withdrew consent|14|||
30662767|NCT00913835|58676364|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
30662768|NCT00913835|58676365|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
30662769|NCT00913523|58676390|FG000|Overall Study|Withdrawal by Subject|3|||
30662770|NCT00913523|58676391|FG001|Overall Study|Withdrawal by Subject|2|||
30662771|NCT00913523|58676392|FG002|Overall Study|Withdrawal by Subject|2|||
30662772|NCT00913523|58676390|FG000|Overall Study|Lost to Follow-up|1|||
30662773|NCT00913523|58676391|FG001|Overall Study|Lost to Follow-up|1|||
30662774|NCT00913523|58676392|FG002|Overall Study|Lost to Follow-up|1|||
30662775|NCT00913523|58676390|FG000|Overall Study|Adverse Event|1|||
30662776|NCT00913523|58676391|FG001|Overall Study|Adverse Event|0|||
30662777|NCT00913523|58676392|FG002|Overall Study|Adverse Event|0|||
30662778|NCT00913523|58676390|FG000|Overall Study|Protocol Violation|5|||
30662779|NCT00913523|58676391|FG001|Overall Study|Protocol Violation|8|||
30662780|NCT00913523|58676392|FG002|Overall Study|Protocol Violation|8|||
30956690|NCT01724021|59017333|FG000|Overall Study|Lost to Follow-up|15|||
30956691|NCT01724021|59017334|FG001|Overall Study|Lost to Follow-up|15|||
30956692|NCT01724021|59017333|FG000|Overall Study|Reason Not Specified|36|||
30956693|NCT01724021|59017334|FG001|Overall Study|Reason Not Specified|39|||
30956694|NCT01724021|59017333|FG000|Overall Study|Missing|1|||
30956695|NCT01724021|59017334|FG001|Overall Study|Missing|1|||
30956696|NCT01723397|59017348|FG000|Study Period 1|Protocol Violation|0|||
30956697|NCT01723397|59017349|FG001|Study Period 1|Protocol Violation|1|||
30956698|NCT01723397|59017348|FG000|Study Period 2|Protocol Violation|0|||
30956699|NCT01723397|59017349|FG001|Study Period 2|Protocol Violation|1|||
30956700|NCT01723163|59017357|FG000|Treatment Phase|Withdrawal by Subject|14|||
30956701|NCT01723163|59017358|FG001|Treatment Phase|Withdrawal by Subject|6|||
30956702|NCT01723163|59017357|FG000|Treatment Phase|Withdrawal by PI|5|||
30956703|NCT01723163|59017358|FG001|Treatment Phase|Withdrawal by PI|1|||
30956704|NCT01723163|59017357|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
30956705|NCT01723163|59017358|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
30956706|NCT01723163|59017357|FG000|3-Month Follow-up|Unable to Contact|12|||
30956707|NCT01723163|59017358|FG001|3-Month Follow-up|Unable to Contact|19|||
30956708|NCT01723163|59017357|FG000|6-Month Follow-up|Death|1|||
30956709|NCT01723163|59017358|FG001|6-Month Follow-up|Death|0|||
30956710|NCT01723163|59017357|FG000|6-Month Follow-up|Unable to Contact|17|||
30956711|NCT01723163|59017358|FG001|6-Month Follow-up|Unable to Contact|15|||
30956712|NCT01723163|59017357|FG000|12-Month Follow-up|Death|1|||
30662781|NCT00913523|58676390|FG000|Overall Study|Pregnancy|1|||
30662782|NCT00913523|58676391|FG001|Overall Study|Pregnancy|3|||
30662783|NCT00913523|58676392|FG002|Overall Study|Pregnancy|0|||
30662784|NCT00913523|58676390|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
30778046|NCT03655054|58789136|FG000|Overall Study|Lost to Follow-up|1|||
30853378|NCT02421172|58880784|FG000|Period 2|Adverse Event|0|||
30853379|NCT02421172|58880785|FG001|Period 2|Adverse Event|0|||
30956713|NCT01723163|59017358|FG001|12-Month Follow-up|Death|0|||
30956714|NCT01723163|59017357|FG000|12-Month Follow-up|Unable to Contact|23|||
30778047|NCT03615144|58789142|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
30778048|NCT03615144|58789143|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
30778049|NCT03682302|58789153|FG000|Overall Study|Lost to Follow-up|1|||
30778050|NCT03682302|58789154|FG001|Overall Study|Lost to Follow-up|2|||
30956715|NCT01723163|59017358|FG001|12-Month Follow-up|Unable to Contact|28|||
30956716|NCT01722071|59017368|FG000|Overall Study|Protocol Violation|1|||
30778051|NCT03682302|58789155|FG002|Overall Study|Lost to Follow-up|0|||
30778052|NCT03682302|58789156|FG003|Overall Study|Lost to Follow-up|1|||
30778053|NCT03682302|58789153|FG000|Overall Study|Study drug was not administered|0|||
30778054|NCT03682302|58789154|FG001|Overall Study|Study drug was not administered|0|||
30778055|NCT03682302|58789155|FG002|Overall Study|Study drug was not administered|1|||
30778056|NCT03682302|58789156|FG003|Overall Study|Study drug was not administered|1|||
30778057|NCT03522506|58789170|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30853380|NCT02421172|58880786|FG002|Period 2|Adverse Event|4|||
30956717|NCT01722071|59017369|FG001|Overall Study|Protocol Violation|0|||
30956718|NCT01721759|59017375|FG000|Treatment Period|Disease Progression|85|||
30956719|NCT01721759|59017375|FG000|Treatment Period|Study drug toxicity|14|||
30662785|NCT00913523|58676391|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
30853381|NCT02421172|58880787|FG003|Period 2|Adverse Event|0|||
30853382|NCT02421172|58880788|FG004|Period 2|Adverse Event|0|||
30853383|NCT02421172|58880784|FG000|Period 2|Lost to Follow-up|0|||
30662786|NCT00913523|58676392|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
30662787|NCT00912197|58676402|FG000|Overall Study|Withdrawal by Subject|3|||
30853384|NCT02421172|58880785|FG001|Period 2|Lost to Follow-up|0|||
30853385|NCT02421172|58880786|FG002|Period 2|Lost to Follow-up|0|||
30853386|NCT02421172|58880787|FG003|Period 2|Lost to Follow-up|1|||
30956720|NCT01721759|59017375|FG000|Treatment Period|Death|1|||
30956721|NCT01721759|59017375|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
30956722|NCT01721759|59017375|FG000|Treatment Period|Participant request to withdraw|3|||
30956723|NCT01721759|59017375|FG000|Treatment Period|Other Reasons|3|||
30956724|NCT01721759|59017375|FG000|End of Study Period|Participant Withdrew Consent|5|||
30956725|NCT01721759|59017375|FG000|End of Study Period|Death|101|||
30956726|NCT01721759|59017375|FG000|End of Study Period|Lost to Follow-up|1|||
30956727|NCT01721759|59017375|FG000|End of Study Period|Other Reasons|10|||
30956728|NCT01721369|59017384|FG000|Overall Study|Not initial etiological diagnosis|12|||
30956729|NCT01721057|59017446|FG000|Treatment Period|Withdrawal by Subject|11|||
30956730|NCT01721057|59017447|FG001|Treatment Period|Withdrawal by Subject|5|||
30853387|NCT02421172|58880788|FG004|Period 2|Lost to Follow-up|0|||
30853388|NCT02421172|58880784|FG000|Period 2|Patient/guardian decision|0|||
30853389|NCT02421172|58880785|FG001|Period 2|Patient/guardian decision|0|||
30853390|NCT02421172|58880786|FG002|Period 2|Patient/guardian decision|3|||
30853391|NCT02421172|58880787|FG003|Period 2|Patient/guardian decision|2|||
30853392|NCT02421172|58880788|FG004|Period 2|Patient/guardian decision|1|||
30853393|NCT02379052|58880801|FG000|Overall Study|Protocol Violation|0|||
30853394|NCT02379052|58880802|FG001|Overall Study|Protocol Violation|1|||
30853395|NCT02379052|58880801|FG000|Overall Study|Adverse Event|0|||
30853396|NCT02379052|58880802|FG001|Overall Study|Adverse Event|1|||
30853397|NCT02379052|58880801|FG000|Overall Study|Physician Decision|1|||
30853398|NCT02379052|58880802|FG001|Overall Study|Physician Decision|1|||
30853399|NCT02379052|58880801|FG000|Overall Study|Withdrawal by Subject|2|||
30853400|NCT02379052|58880802|FG001|Overall Study|Withdrawal by Subject|0|||
30853401|NCT02379052|58880801|FG000|Overall Study|Lost to Follow-up|2|||
30853402|NCT02379052|58880802|FG001|Overall Study|Lost to Follow-up|1|||
30853403|NCT02379052|58880801|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
30853404|NCT02379052|58880802|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
30956731|NCT01721057|59017448|FG002|Treatment Period|Withdrawal by Subject|8|||
30956732|NCT01721057|59017449|FG003|Treatment Period|Withdrawal by Subject|0|||
30956733|NCT01721057|59017450|FG004|Treatment Period|Withdrawal by Subject|0|||
30956734|NCT01721057|59017451|FG005|Treatment Period|Withdrawal by Subject|0|||
30956735|NCT01721057|59017452|FG006|Treatment Period|Withdrawal by Subject|0|||
30956736|NCT01721057|59017446|FG000|Treatment Period|Adverse Event|7|||
30956737|NCT01721057|59017447|FG001|Treatment Period|Adverse Event|10|||
30956738|NCT01721057|59017448|FG002|Treatment Period|Adverse Event|12|||
30956739|NCT01721057|59017449|FG003|Treatment Period|Adverse Event|0|||
30956740|NCT01721057|59017450|FG004|Treatment Period|Adverse Event|0|||
30956741|NCT01721057|59017451|FG005|Treatment Period|Adverse Event|0|||
30956742|NCT01721057|59017452|FG006|Treatment Period|Adverse Event|0|||
30956743|NCT01721057|59017446|FG000|Treatment Period|Lack of Efficacy|7|||
30956744|NCT01721057|59017447|FG001|Treatment Period|Lack of Efficacy|3|||
30956745|NCT01721057|59017448|FG002|Treatment Period|Lack of Efficacy|0|||
30956746|NCT01721057|59017449|FG003|Treatment Period|Lack of Efficacy|0|||
30956747|NCT01721057|59017450|FG004|Treatment Period|Lack of Efficacy|0|||
30956748|NCT01721057|59017451|FG005|Treatment Period|Lack of Efficacy|0|||
30956749|NCT01721057|59017452|FG006|Treatment Period|Lack of Efficacy|0|||
30956750|NCT01721057|59017446|FG000|Treatment Period|Lost to Follow-up|1|||
30956751|NCT01721057|59017447|FG001|Treatment Period|Lost to Follow-up|0|||
30956752|NCT01721057|59017448|FG002|Treatment Period|Lost to Follow-up|0|||
30956753|NCT01721057|59017449|FG003|Treatment Period|Lost to Follow-up|0|||
30853405|NCT02379052|58880801|FG000|Overall Study|Subject was Incarcerated|0|||
30853406|NCT02379052|58880802|FG001|Overall Study|Subject was Incarcerated|1|||
30853407|NCT02378662|58880810|FG000|Overall Study|Early Discontinuation|2|||
30853408|NCT02378662|58880811|FG001|Overall Study|Early Discontinuation|0|||
30853409|NCT02378506|58880817|FG000|Overall Study|Lack of Efficacy|3|||
30853410|NCT02378506|58880817|FG000|Overall Study|Withdrawal by Subject|4|||
30853411|NCT02378506|58880817|FG000|Overall Study|Protocol Violation|2|||
30853412|NCT02378506|58880817|FG000|Overall Study|Death|1|||
30853413|NCT02378506|58880817|FG000|Overall Study|Adverse Event|14|||
30853414|NCT02378506|58880817|FG000|Overall Study|Randomized But Not Treated|1|||
30853415|NCT02347774|58880824|FG000|Study Participation|Lost to Follow-up|3|||
30853416|NCT02347774|58880825|FG001|Study Participation|Lost to Follow-up|6|||
30853417|NCT02347774|58880826|FG002|Study Participation|Lost to Follow-up|2|||
30853418|NCT02347774|58880824|FG000|Study Participation|Withdrawal by Subject|8|||
30853419|NCT02347774|58880825|FG001|Study Participation|Withdrawal by Subject|9|||
30853420|NCT02347774|58880826|FG002|Study Participation|Withdrawal by Subject|15|||
30853421|NCT02347774|58880824|FG000|Study Participation|Adverse Event|1|||
30853422|NCT02347774|58880825|FG001|Study Participation|Adverse Event|4|||
30853423|NCT02347774|58880826|FG002|Study Participation|Adverse Event|6|||
30853424|NCT02347774|58880824|FG000|Study Participation|withdrew consent|1|||
30853425|NCT02347774|58880825|FG001|Study Participation|withdrew consent|1|||
30853426|NCT02347774|58880826|FG002|Study Participation|withdrew consent|1|||
30853427|NCT02347774|58880824|FG000|Study Participation|Met Prolonged QT criteria|1|||
30853428|NCT02347774|58880825|FG001|Study Participation|Met Prolonged QT criteria|0|||
30853429|NCT02347774|58880826|FG002|Study Participation|Met Prolonged QT criteria|0|||
30853430|NCT02347774|58880824|FG000|Study Participation|non-compliance with study drug|0|||
30956754|NCT01721057|59017450|FG004|Treatment Period|Lost to Follow-up|0|||
30956755|NCT01721057|59017451|FG005|Treatment Period|Lost to Follow-up|0|||
30956756|NCT01721057|59017452|FG006|Treatment Period|Lost to Follow-up|0|||
30956757|NCT01721057|59017446|FG000|Treatment Period|Physician Decision|0|||
30956758|NCT01721057|59017447|FG001|Treatment Period|Physician Decision|1|||
30956759|NCT01721057|59017448|FG002|Treatment Period|Physician Decision|3|||
30956760|NCT01721057|59017449|FG003|Treatment Period|Physician Decision|0|||
30956761|NCT01721057|59017450|FG004|Treatment Period|Physician Decision|0|||
30956762|NCT01721057|59017451|FG005|Treatment Period|Physician Decision|0|||
30956763|NCT01721057|59017452|FG006|Treatment Period|Physician Decision|0|||
30956764|NCT01721057|59017446|FG000|Treatment Period|Death|2|||
30956765|NCT01721057|59017447|FG001|Treatment Period|Death|0|||
30956766|NCT01721057|59017448|FG002|Treatment Period|Death|0|||
30853431|NCT02347774|58880825|FG001|Study Participation|non-compliance with study drug|1|||
30853432|NCT02347774|58880826|FG002|Study Participation|non-compliance with study drug|0|||
30853433|NCT02347774|58880824|FG000|Study Participation|incarceration|1|||
30853434|NCT02347774|58880825|FG001|Study Participation|incarceration|0|||
30956767|NCT01721057|59017449|FG003|Treatment Period|Death|0|||
30956768|NCT01721057|59017450|FG004|Treatment Period|Death|0|||
30956769|NCT01721057|59017451|FG005|Treatment Period|Death|0|||
30956770|NCT01721057|59017452|FG006|Treatment Period|Death|0|||
30778058|NCT03522506|58789171|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30853435|NCT02347774|58880826|FG002|Study Participation|incarceration|0|||
30853436|NCT02347774|58880824|FG000|Study Participation|randomized in error|0|||
30853437|NCT02347774|58880825|FG001|Study Participation|randomized in error|0|||
30853438|NCT02347774|58880826|FG002|Study Participation|randomized in error|1|||
30853439|NCT02347774|58880824|FG000|On Study Treatment|Adverse Event|9|||
30853440|NCT02347774|58880825|FG001|On Study Treatment|Adverse Event|15|||
30853441|NCT02347774|58880826|FG002|On Study Treatment|Adverse Event|19|||
30853442|NCT02347774|58880824|FG000|On Study Treatment|Lack of Efficacy|3|||
30853443|NCT02347774|58880825|FG001|On Study Treatment|Lack of Efficacy|0|||
30853444|NCT02347774|58880826|FG002|On Study Treatment|Lack of Efficacy|2|||
30853445|NCT02347774|58880824|FG000|On Study Treatment|non-complicance with study medication|0|||
30778059|NCT03522506|58789172|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30778060|NCT03522506|58789173|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
30778061|NCT03522506|58789170|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
30778062|NCT03522506|58789171|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
30853446|NCT02347774|58880825|FG001|On Study Treatment|non-complicance with study medication|2|||
30778063|NCT03522506|58789172|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
30778064|NCT03522506|58789173|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
30778065|NCT02892734|58789204|FG000|Treatment on Study|Progressive Disease|2|||
30778066|NCT02892734|58789204|FG000|Follow up for 2 Years|Death|2|||
30778067|NCT02892734|58789204|FG000|Follow up for 2 Years|Study closed early|1|||
30778068|NCT00055497|58789212|FG000|Overall Study|Adverse Event|1|||
30778069|NCT00055497|58789213|FG001|Overall Study|Adverse Event|1|||
30778070|NCT00055497|58789214|FG002|Overall Study|Adverse Event|1|||
30778071|NCT00055497|58789215|FG003|Overall Study|Adverse Event|28|||
30778072|NCT00055497|58789212|FG000|Overall Study|Withdrawal by Subject|3|||
30778073|NCT00055497|58789213|FG001|Overall Study|Withdrawal by Subject|1|||
30778074|NCT00055497|58789214|FG002|Overall Study|Withdrawal by Subject|1|||
30778075|NCT00055497|58789215|FG003|Overall Study|Withdrawal by Subject|15|||
30778076|NCT00055497|58789212|FG000|Overall Study|Lost to Follow-up|0|||
30778077|NCT00055497|58789213|FG001|Overall Study|Lost to Follow-up|1|||
30778078|NCT00055497|58789214|FG002|Overall Study|Lost to Follow-up|0|||
30778079|NCT00055497|58789215|FG003|Overall Study|Lost to Follow-up|5|||
30778080|NCT00055497|58789212|FG000|Overall Study|Protocol Violation|0|||
30778081|NCT00055497|58789213|FG001|Overall Study|Protocol Violation|0|||
30778082|NCT00055497|58789214|FG002|Overall Study|Protocol Violation|0|||
30778083|NCT00055497|58789215|FG003|Overall Study|Protocol Violation|3|||
30778084|NCT00055497|58789212|FG000|Overall Study|Lack of Efficacy|1|||
30778085|NCT00055497|58789213|FG001|Overall Study|Lack of Efficacy|0|||
30778086|NCT00055497|58789214|FG002|Overall Study|Lack of Efficacy|0|||
30778087|NCT00055497|58789215|FG003|Overall Study|Lack of Efficacy|27|||
30778088|NCT00055497|58789212|FG000|Overall Study|Administrative Reasons|0|||
30853447|NCT02347774|58880826|FG002|On Study Treatment|non-complicance with study medication|0|||
30853448|NCT02347774|58880824|FG000|On Study Treatment|Protocol Violation|0|||
30956771|NCT01721057|59017446|FG000|Rescue Period|Adverse Event|0|||
30956772|NCT01721057|59017447|FG001|Rescue Period|Adverse Event|0|||
30956773|NCT01721057|59017448|FG002|Rescue Period|Adverse Event|0|||
30778089|NCT00055497|58789213|FG001|Overall Study|Administrative Reasons|0|||
30778090|NCT00055497|58789214|FG002|Overall Study|Administrative Reasons|0|||
30853449|NCT02347774|58880825|FG001|On Study Treatment|Protocol Violation|0|||
30853450|NCT02347774|58880826|FG002|On Study Treatment|Protocol Violation|1|||
30956774|NCT01721057|59017449|FG003|Rescue Period|Adverse Event|1|||
30956775|NCT01721057|59017450|FG004|Rescue Period|Adverse Event|0|||
30956776|NCT01721057|59017451|FG005|Rescue Period|Adverse Event|0|||
30956777|NCT01721057|59017452|FG006|Rescue Period|Adverse Event|0|||
30956778|NCT01721057|59017446|FG000|Rescue Period|Lack of Efficacy|0|||
30956779|NCT01721057|59017447|FG001|Rescue Period|Lack of Efficacy|0|||
30956780|NCT01721057|59017448|FG002|Rescue Period|Lack of Efficacy|0|||
30956781|NCT01721057|59017449|FG003|Rescue Period|Lack of Efficacy|2|||
30662788|NCT00912197|58676403|FG001|Overall Study|Withdrawal by Subject|3|||
30662789|NCT00910247|58676411|FG000|Overall Study|Adverse Event|15|||
30662790|NCT00910247|58676411|FG000|Overall Study|Death|2|||
30662791|NCT00910247|58676411|FG000|Overall Study|Lost to Follow-up|10|||
30662792|NCT00910247|58676411|FG000|Overall Study|Physician Decision|3|||
30662793|NCT00910247|58676411|FG000|Overall Study|Protocol Violation|10|||
30662794|NCT00910247|58676411|FG000|Overall Study|Withdrawal by Subject|25|||
30662795|NCT00910247|58676411|FG000|Overall Study|Not collected|4|||
30853451|NCT02347774|58880824|FG000|On Study Treatment|withdrew consent|9|||
30853452|NCT02347774|58880825|FG001|On Study Treatment|withdrew consent|8|||
30853453|NCT02347774|58880826|FG002|On Study Treatment|withdrew consent|12|||
30853454|NCT02347774|58880824|FG000|On Study Treatment|Lost to Follow-up|2|||
30853455|NCT02347774|58880825|FG001|On Study Treatment|Lost to Follow-up|6|||
30853456|NCT02347774|58880826|FG002|On Study Treatment|Lost to Follow-up|1|||
30853457|NCT02347774|58880824|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
30853458|NCT02347774|58880825|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
30853459|NCT02347774|58880826|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
30853460|NCT02347774|58880824|FG000|On Study Treatment|ranomized in error|0|||
30853461|NCT02347774|58880825|FG001|On Study Treatment|ranomized in error|0|||
30662796|NCT00659334|58676422|FG000|Overall Study|Screen Failure|8|||
30853462|NCT02347774|58880826|FG002|On Study Treatment|ranomized in error|1|||
30853463|NCT02794883|58880837|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
30853464|NCT02794883|58880838|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
30853465|NCT02794883|58880839|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
30853466|NCT02794883|58880837|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
30853467|NCT02794883|58880838|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
30662797|NCT00659334|58676423|FG001|Overall Study|Screen Failure|5|||
30662798|NCT00659334|58676424|FG002|Overall Study|Screen Failure|0|||
30662799|NCT00659334|58676425|FG003|Overall Study|Screen Failure|0|||
30662800|NCT00659334|58676426|FG004|Overall Study|Screen Failure|0|||
30662801|NCT00659334|58676427|FG005|Overall Study|Screen Failure|0|||
30662802|NCT00659334|58676428|FG006|Overall Study|Screen Failure|1|||
30662803|NCT00910091|58676450|FG000|Pre-assignment|Withdrawal by Subject|0|||
30662804|NCT00910091|58676451|FG001|Pre-assignment|Withdrawal by Subject|2|||
30662805|NCT00910091|58676450|FG000|Treatment and Survival|Withdrawal by Subject|3|||
30662806|NCT00910091|58676451|FG001|Treatment and Survival|Withdrawal by Subject|4|||
30662807|NCT00910091|58676450|FG000|Treatment and Survival|Adverse Event|1|||
30662808|NCT00910091|58676451|FG001|Treatment and Survival|Adverse Event|0|||
30662809|NCT00909857|58676460|FG000|Overall Study|Withdrawal by Subject|6|||
30662810|NCT00909857|58676461|FG001|Overall Study|Withdrawal by Subject|10|||
30662811|NCT00909857|58676460|FG000|Overall Study|Adverse Event|5|||
30662812|NCT00909857|58676461|FG001|Overall Study|Adverse Event|5|||
30662813|NCT00909857|58676460|FG000|Overall Study|Lost to Follow-up|2|||
30662814|NCT00909857|58676461|FG001|Overall Study|Lost to Follow-up|5|||
30662815|NCT00909857|58676460|FG000|Overall Study|Protocol Violation|2|||
30662816|NCT00909857|58676461|FG001|Overall Study|Protocol Violation|1|||
30662817|NCT00909857|58676460|FG000|Overall Study|Pregnancy|1|||
30662818|NCT00909857|58676461|FG001|Overall Study|Pregnancy|0|||
30662819|NCT00909857|58676460|FG000|Overall Study|Other|1|||
30853468|NCT02794883|58880839|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
30853469|NCT02794883|58880837|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
30853470|NCT02794883|58880838|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
30853471|NCT02794883|58880839|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
30853472|NCT02794883|58880837|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
30853473|NCT02794883|58880838|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
30853474|NCT02794883|58880839|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
30662820|NCT00909857|58676461|FG001|Overall Study|Other|0|||
30662821|NCT00909857|58676460|FG000|Overall Study|Did not receive study medication|19|||
30853475|NCT02794883|58880837|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
30853476|NCT02794883|58880838|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
30853477|NCT02794883|58880839|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
30956782|NCT01721057|59017450|FG004|Rescue Period|Lack of Efficacy|0|||
30956783|NCT01721057|59017451|FG005|Rescue Period|Lack of Efficacy|0|||
30662822|NCT00909857|58676461|FG001|Overall Study|Did not receive study medication|24|||
30662823|NCT00911807|58676470|FG000|Overall Study|Adverse Event|2|||
30662824|NCT00911807|58676471|FG001|Overall Study|Adverse Event|1|||
30778091|NCT00055497|58789215|FG003|Overall Study|Administrative Reasons|1|||
30778092|NCT00055497|58789212|FG000|Overall Study|Other|0|||
30778093|NCT00055497|58789213|FG001|Overall Study|Other|0|||
30778094|NCT00055497|58789214|FG002|Overall Study|Other|0|||
30778095|NCT00055497|58789215|FG003|Overall Study|Other|11|||
30778096|NCT03520400|58789232|FG000|Overall Study|Physician Decision|15|||
30778097|NCT03520400|58789233|FG001|Overall Study|Physician Decision|7|||
30778098|NCT03615066|58789242|FG000|Main Study|Withdrew Consent|0|||
30778099|NCT03615066|58789243|FG001|Main Study|Withdrew Consent|1|||
30853478|NCT02794883|58880837|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
30853479|NCT02794883|58880838|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
30853480|NCT02794883|58880839|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
30853481|NCT02794883|58880837|FG000|Follow-up Period (up to 2 Years)|Death|12|||
30853482|NCT02794883|58880838|FG001|Follow-up Period (up to 2 Years)|Death|10|||
30853483|NCT02794883|58880839|FG002|Follow-up Period (up to 2 Years)|Death|10|||
30853484|NCT01370603|58880849|FG000|Period 1|Adverse Event|5|||
30853485|NCT01370603|58880850|FG001|Period 1|Adverse Event|3|||
30853486|NCT01370603|58880849|FG000|Period 1|Lost to Follow-up|2|||
30853487|NCT01370603|58880850|FG001|Period 1|Lost to Follow-up|0|||
30853488|NCT01370603|58880849|FG000|Period 1|Protocol Violation|2|||
30853489|NCT01370603|58880850|FG001|Period 1|Protocol Violation|2|||
30853490|NCT01370603|58880849|FG000|Period 1|Withdrawal by Subject|5|||
30853491|NCT01370603|58880850|FG001|Period 1|Withdrawal by Subject|5|||
30853492|NCT01370603|58880849|FG000|Crossover Washout|Adverse Event|2|||
30853493|NCT01370603|58880850|FG001|Crossover Washout|Adverse Event|1|||
30853494|NCT01370603|58880849|FG000|Crossover Washout|Lost to Follow-up|2|||
30853495|NCT01370603|58880850|FG001|Crossover Washout|Lost to Follow-up|0|||
30853496|NCT01370603|58880849|FG000|Crossover Washout|Protocol Violation|1|||
30853497|NCT01370603|58880850|FG001|Crossover Washout|Protocol Violation|0|||
30853498|NCT01370603|58880849|FG000|Crossover Washout|Withdrawal by Subject|4|||
30853499|NCT01370603|58880850|FG001|Crossover Washout|Withdrawal by Subject|1|||
30853500|NCT01370603|58880849|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
30853501|NCT01370603|58880850|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
30853502|NCT01370603|58880849|FG000|Period 2|Adverse Event|1|||
30853503|NCT01370603|58880850|FG001|Period 2|Adverse Event|4|||
30853504|NCT01370603|58880849|FG000|Period 2|Lost to Follow-up|1|||
30853505|NCT01370603|58880850|FG001|Period 2|Lost to Follow-up|0|||
30853506|NCT01370603|58880849|FG000|Period 2|Withdrawal by Subject|1|||
30853507|NCT01370603|58880850|FG001|Period 2|Withdrawal by Subject|0|||
30853508|NCT02312206|58880858|FG000|Overall Study|Adverse Event|3|||
30853509|NCT02312206|58880859|FG001|Overall Study|Adverse Event|6|||
30853510|NCT02312206|58880858|FG000|Overall Study|Withdrawal by Subject|7|||
30853511|NCT02312206|58880859|FG001|Overall Study|Withdrawal by Subject|6|||
30853512|NCT02312206|58880858|FG000|Overall Study|Physician Decision|7|||
30853513|NCT02312206|58880859|FG001|Overall Study|Physician Decision|6|||
30853514|NCT02312206|58880858|FG000|Overall Study|Death|30|||
30853515|NCT02312206|58880859|FG001|Overall Study|Death|36|||
30956784|NCT01721057|59017452|FG006|Rescue Period|Lack of Efficacy|0|||
30956785|NCT04570384|59017481|FG000|Overall Study|Adverse Event|2|||
30956786|NCT04570384|59017482|FG001|Overall Study|Adverse Event|1|||
30956787|NCT04570384|59017481|FG000|Overall Study|Death|2|||
30956788|NCT04570384|59017482|FG001|Overall Study|Death|5|||
30956789|NCT04570384|59017481|FG000|Overall Study|Lost to Follow-up|1|||
30956790|NCT04570384|59017482|FG001|Overall Study|Lost to Follow-up|0|||
30956791|NCT04570384|59017481|FG000|Overall Study|Other|1|||
30956792|NCT04570384|59017482|FG001|Overall Study|Other|0|||
30778100|NCT03615066|58789244|FG002|Main Study|Withdrew Consent|1|||
30778101|NCT03615066|58789242|FG000|Main Study|Lost to Follow-up|0|||
30778102|NCT03615066|58789243|FG001|Main Study|Lost to Follow-up|0|||
30778103|NCT03615066|58789244|FG002|Main Study|Lost to Follow-up|1|||
30778104|NCT03615066|58789242|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
30853516|NCT02312206|58880858|FG000|Overall Study|Study Terminated by Sponsor|81|||
30853517|NCT02312206|58880859|FG001|Overall Study|Study Terminated by Sponsor|74|||
30853518|NCT02312206|58880858|FG000|Overall Study|Disease Progression|1|||
30853519|NCT02312206|58880859|FG001|Overall Study|Disease Progression|0|||
30853520|NCT02312206|58880858|FG000|Overall Study|Patient progression and new therapy|1|||
30853521|NCT02312206|58880859|FG001|Overall Study|Patient progression and new therapy|0|||
30853522|NCT02312206|58880858|FG000|Overall Study|Patient transferred to hospice|0|||
30853523|NCT02312206|58880859|FG001|Overall Study|Patient transferred to hospice|1|||
30853524|NCT02312206|58880858|FG000|Overall Study|Subject missed 3 consecutive tx visits|0|||
30853525|NCT02312206|58880859|FG001|Overall Study|Subject missed 3 consecutive tx visits|1|||
30778105|NCT03615066|58789243|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
30778106|NCT03615066|58789244|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
30853526|NCT02347072|58880865|FG000|Overall Study|Adverse Event|2|||
30956793|NCT04570384|59017481|FG000|Overall Study|Protocol Violation|0|||
30778107|NCT03615066|58789242|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
30778108|NCT03615066|58789243|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
30956794|NCT04570384|59017482|FG001|Overall Study|Protocol Violation|1|||
30853527|NCT02347072|58880865|FG000|Overall Study|Withdrawal by Subject|6|||
30853528|NCT02347072|58880865|FG000|Overall Study|Physician Decision|1|||
30853529|NCT02347072|58880865|FG000|Overall Study|Lost to Follow-up|2|||
30853530|NCT02347072|58880865|FG000|Overall Study|Protocol Violation|1|||
30956795|NCT04570384|59017481|FG000|Overall Study|Sponsor Decision|1|||
30956796|NCT04570384|59017482|FG001|Overall Study|Sponsor Decision|0|||
30956797|NCT04570384|59017481|FG000|Overall Study|Withdrawal by Subject|4|||
30956798|NCT04570384|59017482|FG001|Overall Study|Withdrawal by Subject|2|||
30956799|NCT02563522|59017535|FG000|Overall Study|Adverse Event|2|||
30956800|NCT02563522|59017536|FG001|Overall Study|Adverse Event|3|||
30956801|NCT02563522|59017535|FG000|Overall Study|Lost to Follow-up|1|||
30956802|NCT02563522|59017536|FG001|Overall Study|Lost to Follow-up|0|||
30956803|NCT02563522|59017535|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
30956804|NCT02563522|59017536|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
30956805|NCT03578146|59017557|FG000|Overall Study|Did Not Receive Treatment|1|||
30956806|NCT03578146|59017558|FG001|Overall Study|Did Not Receive Treatment|0|||
30956807|NCT03578146|59017559|FG002|Overall Study|Did Not Receive Treatment|0|||
30956808|NCT03578146|59017560|FG003|Overall Study|Did Not Receive Treatment|0|||
30956809|NCT03578146|59017561|FG004|Overall Study|Did Not Receive Treatment|0|||
30956810|NCT03578146|59017562|FG005|Overall Study|Did Not Receive Treatment|2|||
30956811|NCT03578146|59017557|FG000|Overall Study|Lost to Follow-up|0|||
30956812|NCT03578146|59017558|FG001|Overall Study|Lost to Follow-up|1|||
30956813|NCT03578146|59017559|FG002|Overall Study|Lost to Follow-up|1|||
30956814|NCT03578146|59017560|FG003|Overall Study|Lost to Follow-up|0|||
30956815|NCT03578146|59017561|FG004|Overall Study|Lost to Follow-up|0|||
30956816|NCT03578146|59017562|FG005|Overall Study|Lost to Follow-up|1|||
30956817|NCT02716896|59017578|FG000|Overall Study|Physician Decision|0|||
30956818|NCT02716896|59017579|FG001|Overall Study|Physician Decision|1|||
30956819|NCT02715726|59017634|FG000|Overall Study|Adverse Event|2|||
30956820|NCT02715726|59017635|FG001|Overall Study|Adverse Event|6|||
30956821|NCT02715726|59017634|FG000|Overall Study|Protocol Violation|1|||
30956822|NCT02715726|59017635|FG001|Overall Study|Protocol Violation|0|||
30956823|NCT02715726|59017634|FG000|Overall Study|Death|2|||
30956824|NCT02715726|59017635|FG001|Overall Study|Death|1|||
30956825|NCT02715726|59017634|FG000|Overall Study|Participant moved|1|||
30956826|NCT02715726|59017635|FG001|Overall Study|Participant moved|3|||
30956827|NCT02715726|59017634|FG000|Overall Study|Other than specified above|11|||
30662825|NCT00911807|58676472|FG002|Overall Study|Adverse Event|5|||
30662826|NCT00911807|58676470|FG000|Overall Study|Death|0|||
30662827|NCT00911807|58676471|FG001|Overall Study|Death|0|||
30778109|NCT03615066|58789244|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
30956828|NCT02715726|59017635|FG001|Overall Study|Other than specified above|15|||
30956829|NCT02715726|59017634|FG000|Overall Study|Randomized but not treated|1|||
30956830|NCT02715726|59017635|FG001|Overall Study|Randomized but not treated|2|||
30956831|NCT04248816|59017648|FG000|Overall Study|Ineligible post-randomization|7|||
30956832|NCT04248816|59017649|FG001|Overall Study|Ineligible post-randomization|21|||
30956833|NCT04248816|59017650|FG002|Overall Study|Ineligible post-randomization|25|||
30956834|NCT02314156|59017687|FG000|Overall Study|Adverse Event|1|||
30956835|NCT02314156|59017688|FG001|Overall Study|Adverse Event|0|||
30956836|NCT02314156|59017687|FG000|Overall Study|Withdrawal by Subject|1|||
30956837|NCT02314156|59017688|FG001|Overall Study|Withdrawal by Subject|0|||
30956838|NCT02716584|59017908|FG000|Overall Study|Lost to Follow-up|8|||
30956839|NCT02716584|59017909|FG001|Overall Study|Lost to Follow-up|5|||
30956840|NCT02716194|59017990|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
30956841|NCT02716194|59017991|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
30956842|NCT02716194|59017992|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
30956843|NCT03773484|59018062|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
30778110|NCT03615066|58789242|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
30778111|NCT03615066|58789243|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
30778112|NCT03615066|58789244|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
30778113|NCT03527966|58789258|FG000|Overall Study|Lost to Follow-up|3|||
30778114|NCT03527966|58789259|FG001|Overall Study|Lost to Follow-up|0|||
30778115|NCT03808545|58789267|FG000|Overall Study|Withdrawal by Subject|1|||
30778116|NCT03808545|58789268|FG001|Overall Study|Withdrawal by Subject|1|||
30778117|NCT03807843|58789277|FG000|Overall Study|Lost to Follow-up|1|||
30853531|NCT02347072|58880865|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
30853532|NCT02794103|58880873|FG000|Overall Study|Loss to follow up due to high sedation|3|||
30853533|NCT02346370|58880880|FG000|Overall Study|Not treated|1|||
30956844|NCT02715258|59018245|FG000|Overall Study|Withdrawal by Subject|6|||
30956845|NCT02715258|59018246|FG001|Overall Study|Withdrawal by Subject|1|||
30956846|NCT02715258|59018245|FG000|Overall Study|Lost to Follow-up|7|||
30662828|NCT00911807|58676472|FG002|Overall Study|Death|1|||
30778118|NCT03807843|58789278|FG001|Overall Study|Lost to Follow-up|0|||
30778119|NCT03519932|58789284|FG000|First Intervention|Adverse Event|1|||
30778120|NCT03519932|58789285|FG001|First Intervention|Adverse Event|3|||
30853534|NCT02346370|58880881|FG001|Overall Study|Not treated|0|||
30853535|NCT02346370|58880882|FG002|Overall Study|Not treated|0|||
30853536|NCT02346370|58880880|FG000|Overall Study|Withdrawal of consent|1|||
30853537|NCT02346370|58880881|FG001|Overall Study|Withdrawal of consent|0|||
30853538|NCT02346370|58880882|FG002|Overall Study|Withdrawal of consent|0|||
30853539|NCT02346370|58880880|FG000|Overall Study|Death|1|||
30853540|NCT02346370|58880881|FG001|Overall Study|Death|3|||
30778121|NCT03806127|58789298|FG000|Overall Study|Withdrawal by Subject|4|||
30778122|NCT03806127|58789299|FG001|Overall Study|Withdrawal by Subject|5|||
30778123|NCT03806127|58789298|FG000|Overall Study|Protocol Violation|3|||
30778124|NCT03806127|58789299|FG001|Overall Study|Protocol Violation|1|||
30778125|NCT03806127|58789298|FG000|Overall Study|Adverse Event|3|||
30778126|NCT03806127|58789299|FG001|Overall Study|Adverse Event|0|||
30778127|NCT03806127|58789298|FG000|Overall Study|Unable to Complete Procedures|0|||
30662829|NCT00911807|58676470|FG000|Overall Study|Protocol Violation|6|||
30662830|NCT00911807|58676471|FG001|Overall Study|Protocol Violation|4|||
30778128|NCT03806127|58789299|FG001|Overall Study|Unable to Complete Procedures|1|||
30778129|NCT03806127|58789298|FG000|Overall Study|Pregnancy|0|||
30778130|NCT03806127|58789299|FG001|Overall Study|Pregnancy|1|||
30778131|NCT03806127|58789298|FG000|Overall Study|Lost to Follow-up|5|||
30778132|NCT03806127|58789299|FG001|Overall Study|Lost to Follow-up|1|||
30778133|NCT03806127|58789298|FG000|Overall Study|Physician Decision|1|||
30778134|NCT03806127|58789299|FG001|Overall Study|Physician Decision|1|||
30778135|NCT03806127|58789298|FG000|Overall Study|Could Not Come Due to Covid|1|||
30778136|NCT03806127|58789299|FG001|Overall Study|Could Not Come Due to Covid|0|||
30778137|NCT03806127|58789298|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
30778138|NCT03806127|58789299|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
30778139|NCT03806127|58789298|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
30778140|NCT03806127|58789299|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
30778141|NCT03806127|58789298|FG000|Overall Study|Covid 19 Restrictions|2|||
30853541|NCT02346370|58880882|FG002|Overall Study|Death|1|||
30778142|NCT03806127|58789299|FG001|Overall Study|Covid 19 Restrictions|0|||
30778143|NCT03806127|58789298|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
30778144|NCT03806127|58789299|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
30853542|NCT02346370|58880880|FG000|Overall Study|Sponsor discontinued study|5|||
30853543|NCT02346370|58880881|FG001|Overall Study|Sponsor discontinued study|0|||
30853544|NCT02346370|58880882|FG002|Overall Study|Sponsor discontinued study|2|||
30853545|NCT02346370|58880880|FG000|Overall Study|Radiologic progression|0|||
30853546|NCT02346370|58880881|FG001|Overall Study|Radiologic progression|0|||
30956847|NCT02715258|59018246|FG001|Overall Study|Lost to Follow-up|1|||
30853547|NCT02346370|58880882|FG002|Overall Study|Radiologic progression|1|||
30853548|NCT02346370|58880880|FG000|Overall Study|Physician Decision|0|||
30853549|NCT02346370|58880881|FG001|Overall Study|Physician Decision|1|||
30853550|NCT02346370|58880882|FG002|Overall Study|Physician Decision|0|||
30853551|NCT02346136|58880894|FG000|Overall Study|Withdrawal by Subject|7|||
30853552|NCT02346136|58880895|FG001|Overall Study|Withdrawal by Subject|5|||
30853553|NCT02346136|58880894|FG000|Overall Study|Death|1|||
30853554|NCT02346136|58880895|FG001|Overall Study|Death|0|||
30853555|NCT02346136|58880894|FG000|Overall Study|Study termination|14|||
30853556|NCT02346136|58880895|FG001|Overall Study|Study termination|18|||
30853557|NCT02793947|58880903|FG000|Overall Study|Death|1|||
30853558|NCT02793947|58880904|FG001|Overall Study|Death|0|||
30853559|NCT02793947|58880903|FG000|Overall Study|Physician Decision|1|||
30853560|NCT02793947|58880904|FG001|Overall Study|Physician Decision|5|||
30853561|NCT02345512|58880910|FG000|Overall Study|Adverse Event|1|||
30853562|NCT02345512|58880910|FG000|Overall Study|Withdrawal by Subject|1|||
30853563|NCT02345434|58880921|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
30853564|NCT02345434|58880922|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
30853565|NCT01370213|58880931|FG000|Overall Study|Early Death|1|||
30853566|NCT01370213|58880932|FG001|Overall Study|Early Death|0|||
30956848|NCT02715258|59018245|FG000|Overall Study|Terminated by Sponsor|0|||
30956849|NCT02715258|59018246|FG001|Overall Study|Terminated by Sponsor|1|||
30956850|NCT02715258|59018245|FG000|Overall Study|Death|0|||
30956851|NCT02715258|59018246|FG001|Overall Study|Death|1|||
30956852|NCT02715258|59018245|FG000|Overall Study|Subject non-compliant|1|||
30956853|NCT02715258|59018246|FG001|Overall Study|Subject non-compliant|1|||
30956854|NCT02715258|59018245|FG000|Overall Study|GCP violation|2|||
30956855|NCT02715258|59018246|FG001|Overall Study|GCP violation|1|||
30956856|NCT02714868|59018271|FG000|Overall Study|Withdrawal by Subject|3|||
30956857|NCT02714868|59018272|FG001|Overall Study|Withdrawal by Subject|0|||
30956858|NCT02714868|59018271|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
30956859|NCT02714868|59018272|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
30956860|NCT02714868|59018271|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
30956861|NCT02714868|59018272|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
30853567|NCT01370213|58880933|FG002|Overall Study|Early Death|0|||
30853568|NCT01370213|58880931|FG000|Overall Study|Not evaluable|0|||
30853569|NCT01370213|58880932|FG001|Overall Study|Not evaluable|2|||
30853570|NCT01370213|58880933|FG002|Overall Study|Not evaluable|0|||
30853571|NCT01370525|58880942|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
30778145|NCT03806127|58789298|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
30778146|NCT03806127|58789299|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
30778147|NCT02843074|58789305|FG000|Overall Study|Withdrawal by Subject|5|||
30778148|NCT02843074|58789305|FG000|Overall Study|Progressive disease|1|||
30778149|NCT02843074|58789305|FG000|Overall Study|Physician Decision|1|||
30778150|NCT02843074|58789305|FG000|Overall Study|Lost to Follow-up|1|||
30778151|NCT02843074|58789305|FG000|Overall Study|Death|9|||
30778152|NCT03650400|58789311|FG000|Overall Study|Study terminated by sponsor|0|||
30778153|NCT03650400|58789312|FG001|Overall Study|Study terminated by sponsor|5|||
30778154|NCT00038103|58789320|FG000|Overall Study|Adverse Event|5|||
30778155|NCT00038103|58789321|FG001|Overall Study|Adverse Event|6|||
30853572|NCT01370525|58880943|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
30956862|NCT02713542|59018587|FG000|Overall Study|Use of prohibited medication|14|||
30778156|NCT00038103|58789320|FG000|Overall Study|Lack of Efficacy|48|||
30778157|NCT00038103|58789321|FG001|Overall Study|Lack of Efficacy|41|||
30853573|NCT01370525|58880942|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
30853574|NCT01370525|58880943|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30853575|NCT01370525|58880942|FG000|Overall Study|Adverse Event|0|||
30853576|NCT01370525|58880943|FG001|Overall Study|Adverse Event|1|||
30853577|NCT01370525|58880942|FG000|Overall Study|Protocol Violation|2|||
30853578|NCT01370525|58880943|FG001|Overall Study|Protocol Violation|1|||
30853579|NCT01370525|58880942|FG000|Overall Study|Lost to follow up|2|||
30956863|NCT02713542|59018588|FG001|Overall Study|Use of prohibited medication|5|||
30853580|NCT01370525|58880943|FG001|Overall Study|Lost to follow up|6|||
30956864|NCT02713542|59018587|FG000|Overall Study|Withdrawal by Subject|4|||
30956865|NCT02713542|59018588|FG001|Overall Study|Withdrawal by Subject|1|||
30956866|NCT03548220|59018672|FG000|Overall Study|Lost to Follow-up|1|||
30956867|NCT03548220|59018673|FG001|Overall Study|Lost to Follow-up|0|||
30956868|NCT03548220|59018674|FG002|Overall Study|Lost to Follow-up|0|||
30956869|NCT03548220|59018675|FG003|Overall Study|Lost to Follow-up|0|||
30956870|NCT02712996|59018710|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
30956871|NCT02712996|59018711|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
30956872|NCT00701064|59018818|FG000|Overall Study|Protocol Violation|1|||
30956873|NCT00701064|59018819|FG001|Overall Study|Protocol Violation|1|||
30956874|NCT00701064|59018818|FG000|Overall Study|Withdrawal by Subject|1|||
30956875|NCT00701064|59018819|FG001|Overall Study|Withdrawal by Subject|1|||
30956876|NCT00701064|59018818|FG000|Overall Study|initiated other PTSD treatment|2|||
30956877|NCT00701064|59018819|FG001|Overall Study|initiated other PTSD treatment|2|||
30956878|NCT01748825|59018958|FG000|Dose Escalation|Refused further treatment|2|||
30956879|NCT01748825|59018959|FG001|Dose Escalation|Refused further treatment|2|||
30956880|NCT01748825|59018960|FG002|Dose Escalation|Refused further treatment|0|||
30956881|NCT01748825|59018961|FG003|Dose Escalation|Refused further treatment|0|||
30956882|NCT01748825|59018962|FG004|Dose Escalation|Refused further treatment|1|||
30956883|NCT01748825|59018963|FG005|Dose Escalation|Refused further treatment|2|||
30956884|NCT01748825|59018964|FG006|Dose Escalation|Refused further treatment|0|||
30956885|NCT01748825|59018965|FG007|Dose Escalation|Refused further treatment|0|||
30956886|NCT01748825|59018966|FG008|Dose Escalation|Refused further treatment|0|||
30956887|NCT01748825|59018967|FG009|Dose Escalation|Refused further treatment|0|||
30956888|NCT01748825|59018958|FG000|Dose Escalation|Switched to alternative treatment|0|||
30956889|NCT01748825|59018959|FG001|Dose Escalation|Switched to alternative treatment|0|||
30956890|NCT01748825|59018960|FG002|Dose Escalation|Switched to alternative treatment|0|||
30956891|NCT01748825|59018961|FG003|Dose Escalation|Switched to alternative treatment|1|||
30956892|NCT01748825|59018962|FG004|Dose Escalation|Switched to alternative treatment|0|||
30956893|NCT01748825|59018963|FG005|Dose Escalation|Switched to alternative treatment|0|||
30956894|NCT01748825|59018964|FG006|Dose Escalation|Switched to alternative treatment|0|||
30956895|NCT01748825|59018965|FG007|Dose Escalation|Switched to alternative treatment|0|||
30956896|NCT01748825|59018966|FG008|Dose Escalation|Switched to alternative treatment|0|||
30956897|NCT01748825|59018967|FG009|Dose Escalation|Switched to alternative treatment|0|||
30956898|NCT01748825|59018958|FG000|Dose Escalation|Adverse Event|0|||
30956899|NCT01748825|59018959|FG001|Dose Escalation|Adverse Event|0|||
30956900|NCT01748825|59018960|FG002|Dose Escalation|Adverse Event|0|||
30956901|NCT01748825|59018961|FG003|Dose Escalation|Adverse Event|0|||
30956902|NCT01748825|59018962|FG004|Dose Escalation|Adverse Event|0|||
30956903|NCT01748825|59018963|FG005|Dose Escalation|Adverse Event|0|||
30956904|NCT01748825|59018964|FG006|Dose Escalation|Adverse Event|1|||
30956905|NCT01748825|59018965|FG007|Dose Escalation|Adverse Event|0|||
30956906|NCT01748825|59018966|FG008|Dose Escalation|Adverse Event|0|||
30956907|NCT01748825|59018967|FG009|Dose Escalation|Adverse Event|0|||
30956908|NCT01748825|59018958|FG000|Dose Expansion|Refused further treatment|0|||
30956909|NCT01748825|59018959|FG001|Dose Expansion|Refused further treatment|0|||
30956910|NCT01748825|59018960|FG002|Dose Expansion|Refused further treatment|0|||
30956911|NCT01748825|59018961|FG003|Dose Expansion|Refused further treatment|0|||
30956912|NCT01748825|59018962|FG004|Dose Expansion|Refused further treatment|0|||
30956913|NCT01748825|59018963|FG005|Dose Expansion|Refused further treatment|0|||
30956914|NCT01748825|59018964|FG006|Dose Expansion|Refused further treatment|0|||
30956915|NCT01748825|59018965|FG007|Dose Expansion|Refused further treatment|0|||
30956916|NCT01748825|59018966|FG008|Dose Expansion|Refused further treatment|1|||
30778158|NCT00038103|58789320|FG000|Overall Study|Withdrawal by Subject|0|||
30778159|NCT00038103|58789321|FG001|Overall Study|Withdrawal by Subject|3|||
30778160|NCT00038103|58789320|FG000|Overall Study|Lost to Follow-up|0|||
30778161|NCT00038103|58789321|FG001|Overall Study|Lost to Follow-up|3|||
30778162|NCT00038103|58789320|FG000|Overall Study|Protocol Violation|0|||
30778163|NCT00038103|58789321|FG001|Overall Study|Protocol Violation|2|||
30778164|NCT00038103|58789320|FG000|Overall Study|Sponsor Decision|0|||
30778165|NCT00038103|58789321|FG001|Overall Study|Sponsor Decision|1|||
30778166|NCT00038103|58789320|FG000|Overall Study|Randomized/never treated|2|||
30778167|NCT00038103|58789321|FG001|Overall Study|Randomized/never treated|0|||
30778168|NCT03680742|58789327|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
30778169|NCT03678870|58789333|FG000|Overall Study|prescribed non- protocol medications|10|||
30778170|NCT03678870|58789334|FG001|Overall Study|prescribed non- protocol medications|6|||
30853581|NCT02792777|58880951|FG000|Overall Study|Withdrawal by Subject|2|||
30853582|NCT02792777|58880952|FG001|Overall Study|Withdrawal by Subject|0|||
30956917|NCT01748825|59018967|FG009|Dose Expansion|Refused further treatment|1|||
30956918|NCT01748825|59018958|FG000|Dose Expansion|Switched to alternative treatment|0|||
30956919|NCT01748825|59018959|FG001|Dose Expansion|Switched to alternative treatment|0|||
30778171|NCT03678870|58789333|FG000|Overall Study|Lost to Follow-up|3|||
30778172|NCT03678870|58789334|FG001|Overall Study|Lost to Follow-up|2|||
30956920|NCT01748825|59018960|FG002|Dose Expansion|Switched to alternative treatment|0|||
30956921|NCT01748825|59018961|FG003|Dose Expansion|Switched to alternative treatment|0|||
30956922|NCT01748825|59018962|FG004|Dose Expansion|Switched to alternative treatment|0|||
30956923|NCT01748825|59018963|FG005|Dose Expansion|Switched to alternative treatment|0|||
30956924|NCT01748825|59018964|FG006|Dose Expansion|Switched to alternative treatment|0|||
30956925|NCT01748825|59018965|FG007|Dose Expansion|Switched to alternative treatment|0|||
30956926|NCT01748825|59018966|FG008|Dose Expansion|Switched to alternative treatment|0|||
30956927|NCT01748825|59018967|FG009|Dose Expansion|Switched to alternative treatment|1|||
30956928|NCT01748825|59018958|FG000|Dose Expansion|Adverse Event|0|||
30956929|NCT01748825|59018959|FG001|Dose Expansion|Adverse Event|0|||
30956930|NCT01748825|59018960|FG002|Dose Expansion|Adverse Event|0|||
30956931|NCT01748825|59018961|FG003|Dose Expansion|Adverse Event|0|||
30956932|NCT01748825|59018962|FG004|Dose Expansion|Adverse Event|0|||
30778173|NCT03805971|58789340|FG000|Overall Study|Withdrawal by Subject|1|||
30778174|NCT03805971|58789340|FG000|Overall Study|Protocol Violation|2|||
30778175|NCT03032380|58789347|FG000|Overall Study|Adverse Event|0|||
30778176|NCT03032380|58789348|FG001|Overall Study|Adverse Event|1|||
30778177|NCT03032380|58789347|FG000|Overall Study|Lack of Efficacy|1|||
30778178|NCT03032380|58789348|FG001|Overall Study|Lack of Efficacy|0|||
30778179|NCT03032380|58789347|FG000|Overall Study|Withdrawal by Subject|2|||
30778180|NCT03032380|58789348|FG001|Overall Study|Withdrawal by Subject|3|||
30778181|NCT03032380|58789347|FG000|Overall Study|Recovery|0|||
30778182|NCT03032380|58789348|FG001|Overall Study|Recovery|1|||
30778183|NCT03032380|58789347|FG000|Overall Study|Death|39|||
30778184|NCT03032380|58789348|FG001|Overall Study|Death|34|||
30778185|NCT03032380|58789347|FG000|Overall Study|Other - Miscellaneous|0|||
30778186|NCT03032380|58789348|FG001|Overall Study|Other - Miscellaneous|1|||
30778187|NCT03519854|58789372|FG000|Overall Study|Technical Error|0|||
30778188|NCT03519854|58789373|FG001|Overall Study|Technical Error|0|||
30778189|NCT03519854|58789374|FG002|Overall Study|Technical Error|1|||
30778190|NCT03519854|58789375|FG003|Overall Study|Technical Error|0|||
30778191|NCT03519854|58789376|FG004|Overall Study|Technical Error|0|||
30778192|NCT03519854|58789377|FG005|Overall Study|Technical Error|0|||
30778193|NCT03519854|58789378|FG006|Overall Study|Technical Error|0|||
30778194|NCT03519854|58789379|FG007|Overall Study|Technical Error|0|||
30778195|NCT03519854|58789380|FG008|Overall Study|Technical Error|0|||
30778196|NCT03519854|58789381|FG009|Overall Study|Technical Error|0|||
30778197|NCT03519854|58789382|FG010|Overall Study|Technical Error|0|||
30778198|NCT03519854|58789383|FG011|Overall Study|Technical Error|0|||
30778199|NCT03519854|58789384|FG012|Overall Study|Technical Error|0|||
30778200|NCT03519854|58789385|FG013|Overall Study|Technical Error|0|||
30778201|NCT03519854|58789386|FG014|Overall Study|Technical Error|0|||
30778202|NCT03519854|58789387|FG015|Overall Study|Technical Error|0|||
30778203|NCT03519854|58789388|FG016|Overall Study|Technical Error|0|||
30778204|NCT03519854|58789389|FG017|Overall Study|Technical Error|0|||
30778205|NCT03479216|58789429|FG000|Overall Study|Withdrawal by Subject|3|||
30778206|NCT03479216|58789430|FG001|Overall Study|Withdrawal by Subject|2|||
30778207|NCT03479216|58789429|FG000|Overall Study|Physician Decision|2|||
30778208|NCT03479216|58789430|FG001|Overall Study|Physician Decision|3|||
30778209|NCT03518840|58789436|FG000|Overall Study|Lost to Follow-up|6|||
30778210|NCT03436082|58789445|FG000|Overall Study|Did not undergo procedure|1|||
30778211|NCT03436082|58789446|FG001|Overall Study|Did not undergo procedure|0|||
30778212|NCT03677934|58789454|FG000|Overall Study|Adverse Event|1|||
30778213|NCT03677934|58789455|FG001|Overall Study|Adverse Event|1|||
30778214|NCT03677934|58789454|FG000|Overall Study|Death|8|||
30778215|NCT03677934|58789455|FG001|Overall Study|Death|4|||
30778216|NCT03677934|58789454|FG000|Overall Study|Lost to Follow-up|3|||
30778217|NCT03677934|58789455|FG001|Overall Study|Lost to Follow-up|0|||
30853583|NCT02792777|58880951|FG000|Overall Study|Recording malfunction|2|||
30956933|NCT01748825|59018963|FG005|Dose Expansion|Adverse Event|0|||
30778218|NCT03677934|58789454|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30778219|NCT03677934|58789455|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30778220|NCT03677934|58789454|FG000|Overall Study|Physician Decision|0|||
30778221|NCT03677934|58789455|FG001|Overall Study|Physician Decision|1|||
30778222|NCT03677934|58789454|FG000|Overall Study|Withdrawal by Subject|1|||
30778223|NCT03677934|58789455|FG001|Overall Study|Withdrawal by Subject|7|||
30778224|NCT03435692|58789467|FG000|Overall Study|Lack of Efficacy|2|||
30778225|NCT03435692|58789468|FG001|Overall Study|Lack of Efficacy|2|||
30778226|NCT03435692|58789469|FG002|Overall Study|Lack of Efficacy|0|||
30956934|NCT01748825|59018964|FG006|Dose Expansion|Adverse Event|0|||
30956935|NCT01748825|59018965|FG007|Dose Expansion|Adverse Event|0|||
30778227|NCT03475316|58789483|FG000|6 Month Intervention|Adverse Event|2|||
30778228|NCT03475316|58789484|FG001|6 Month Intervention|Adverse Event|1|||
30778229|NCT03475316|58789483|FG000|6 Month Intervention|Withdrawal by Subject|2|||
30956936|NCT01748825|59018966|FG008|Dose Expansion|Adverse Event|0|||
30956937|NCT01748825|59018967|FG009|Dose Expansion|Adverse Event|3|||
30956938|NCT01748825|59018958|FG000|Dose Expansion|Physician Decision|0|||
30956939|NCT01748825|59018959|FG001|Dose Expansion|Physician Decision|0|||
30956940|NCT01748825|59018960|FG002|Dose Expansion|Physician Decision|0|||
30956941|NCT01748825|59018961|FG003|Dose Expansion|Physician Decision|0|||
30956942|NCT01748825|59018962|FG004|Dose Expansion|Physician Decision|0|||
30956943|NCT01748825|59018963|FG005|Dose Expansion|Physician Decision|0|||
30956944|NCT01748825|59018964|FG006|Dose Expansion|Physician Decision|0|||
30956945|NCT01748825|59018965|FG007|Dose Expansion|Physician Decision|0|||
30956946|NCT01748825|59018966|FG008|Dose Expansion|Physician Decision|1|||
30956947|NCT01748825|59018967|FG009|Dose Expansion|Physician Decision|0|||
30956948|NCT01720667|59019029|FG000|Overall Study|Adverse Event|1|||
30956949|NCT01720667|59019030|FG001|Overall Study|Adverse Event|1|||
30956950|NCT01720667|59019029|FG000|Overall Study|Withdrawal by Subject|3|||
30956951|NCT01720667|59019030|FG001|Overall Study|Withdrawal by Subject|0|||
30956952|NCT01720043|59019038|FG000|Overall Study|Withdrawal by Subject|1|||
30956953|NCT00700752|59019042|FG000|First Intervention|Withdrawal by Subject|0|||
30956954|NCT00700752|59019043|FG001|First Intervention|Withdrawal by Subject|2|||
30956955|NCT01747811|59019060|FG000|Overall Study|Lack of Efficacy|2|||
30956956|NCT01747811|59019061|FG001|Overall Study|Lack of Efficacy|4|||
30956957|NCT01747655|59019069|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
30956958|NCT01747655|59019070|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
30956959|NCT01747655|59019069|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
30956960|NCT01747655|59019070|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
30956961|NCT01747655|59019069|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
30956962|NCT01747655|59019070|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
30956963|NCT01718483|59019078|FG000|Overall Study|Withdrawal by Subject|14|||
30956964|NCT01718483|59019079|FG001|Overall Study|Withdrawal by Subject|12|||
30956965|NCT01718483|59019078|FG000|Overall Study|Adverse Event|5|||
30956966|NCT01718483|59019079|FG001|Overall Study|Adverse Event|12|||
30956967|NCT01718483|59019078|FG000|Overall Study|Lost to Follow-up|8|||
30956968|NCT01718483|59019079|FG001|Overall Study|Lost to Follow-up|3|||
30956969|NCT01718483|59019078|FG000|Overall Study|Protocol Violation|4|||
30956970|NCT01718483|59019079|FG001|Overall Study|Protocol Violation|2|||
30956971|NCT01718483|59019078|FG000|Overall Study|Other|1|||
30956972|NCT01718483|59019079|FG001|Overall Study|Other|4|||
30956973|NCT01718483|59019078|FG000|Overall Study|Pregnancy|1|||
30956974|NCT01718483|59019079|FG001|Overall Study|Pregnancy|1|||
30956975|NCT01718483|59019078|FG000|Overall Study|Lack of Efficacy|1|||
30956976|NCT01718483|59019079|FG001|Overall Study|Lack of Efficacy|0|||
30956977|NCT01717859|59019085|FG000|Overall Study|Adverse Event|5|||
30956978|NCT01717859|59019085|FG000|Overall Study|Moved out of state|1|||
30956979|NCT01717859|59019085|FG000|Overall Study|Patient concerned about mental health|1|||
30956980|NCT01717859|59019085|FG000|Overall Study|Lost to Follow-up|1|||
30956981|NCT01717859|59019085|FG000|Overall Study|Withdrawal by Subject|2|||
30956982|NCT01747499|59019378|FG000|Overall Study|Steroid refractory aGvHD|1|||
30956983|NCT01747499|59019379|FG001|Overall Study|Steroid refractory aGvHD|0|||
30956984|NCT01747499|59019380|FG002|Overall Study|Steroid refractory aGvHD|0|||
30956985|NCT01747499|59019381|FG003|Overall Study|Steroid refractory aGvHD|1|||
30956986|NCT01747499|59019382|FG004|Overall Study|Steroid refractory aGvHD|4|||
30956987|NCT01747499|59019378|FG000|Overall Study|Physician Decision|0|||
30956988|NCT01747499|59019379|FG001|Overall Study|Physician Decision|1|||
30956989|NCT01747499|59019380|FG002|Overall Study|Physician Decision|0|||
30956990|NCT01747499|59019381|FG003|Overall Study|Physician Decision|0|||
30956991|NCT01747499|59019382|FG004|Overall Study|Physician Decision|2|||
30956992|NCT01747499|59019378|FG000|Overall Study|Death|0|||
30956993|NCT01747499|59019379|FG001|Overall Study|Death|0|||
30956994|NCT01747499|59019380|FG002|Overall Study|Death|0|||
30956995|NCT01747499|59019381|FG003|Overall Study|Death|1|||
30956996|NCT01747499|59019382|FG004|Overall Study|Death|1|||
30956997|NCT01747499|59019378|FG000|Overall Study|Withdrawal by Subject|0|||
30956998|NCT01747499|59019379|FG001|Overall Study|Withdrawal by Subject|0|||
30956999|NCT01747499|59019380|FG002|Overall Study|Withdrawal by Subject|0|||
30957000|NCT01747499|59019381|FG003|Overall Study|Withdrawal by Subject|0|||
30957001|NCT01747499|59019382|FG004|Overall Study|Withdrawal by Subject|6|||
30957002|NCT01747499|59019378|FG000|Overall Study|Developed AML and death|0|||
30662831|NCT00911807|58676472|FG002|Overall Study|Protocol Violation|9|||
30957003|NCT01747499|59019379|FG001|Overall Study|Developed AML and death|0|||
30957004|NCT01747499|59019380|FG002|Overall Study|Developed AML and death|0|||
30957005|NCT01747499|59019381|FG003|Overall Study|Developed AML and death|0|||
30957006|NCT01747499|59019382|FG004|Overall Study|Developed AML and death|1|||
30957007|NCT01747499|59019378|FG000|Overall Study|Determined not to be eligible|0|||
30957008|NCT01747499|59019379|FG001|Overall Study|Determined not to be eligible|0|||
30957009|NCT01747499|59019380|FG002|Overall Study|Determined not to be eligible|0|||
30957010|NCT01747499|59019381|FG003|Overall Study|Determined not to be eligible|0|||
30957011|NCT01747499|59019382|FG004|Overall Study|Determined not to be eligible|1|||
30853584|NCT02792777|58880952|FG001|Overall Study|Recording malfunction|0|||
30957012|NCT01717391|59019414|FG000|Overall Study|Withdrawal by Subject|5|||
30957013|NCT01717391|59019414|FG000|Overall Study|Physician Decision|1|||
30957014|NCT01717391|59019414|FG000|Overall Study|FLT technical failure|3|||
30957015|NCT01746017|59019557|FG000|Period 1|Withdrawal by Subject|0|||
30957016|NCT01746017|59019558|FG001|Period 1|Withdrawal by Subject|0|||
30957017|NCT01746017|59019559|FG002|Period 1|Withdrawal by Subject|0|||
30957018|NCT01746017|59019560|FG003|Period 1|Withdrawal by Subject|0|||
30778230|NCT03475316|58789484|FG001|6 Month Intervention|Withdrawal by Subject|0|||
30778231|NCT03475316|58789483|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
30778232|NCT03475316|58789484|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
30778233|NCT03475316|58789483|FG000|9 Months|Study stopped due to COVID pandemic|3|||
30778234|NCT03475316|58789484|FG001|9 Months|Study stopped due to COVID pandemic|4|||
30778235|NCT03673956|58789494|FG000|Overall Study|Lost to Follow-up|1|||
30778236|NCT03673956|58789495|FG001|Overall Study|Lost to Follow-up|0|||
30778237|NCT03673956|58789496|FG002|Overall Study|Lost to Follow-up|0|||
30778238|NCT03673956|58789497|FG003|Overall Study|Lost to Follow-up|0|||
30778239|NCT03673956|58789494|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
30778240|NCT03673956|58789495|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
30778241|NCT03673956|58789496|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
30778242|NCT03673956|58789497|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
30778243|NCT03517436|58789507|FG000|Overall Study|Death|3|||
30778244|NCT03517436|58789507|FG000|Overall Study|Withdrawal by Subject|4|||
30853585|NCT02792777|58880951|FG000|Overall Study|Later determined to be ineligible|2|||
30853586|NCT02792777|58880952|FG001|Overall Study|Later determined to be ineligible|0|||
30853587|NCT02792777|58880951|FG000|Overall Study|Participant interviewed twice|1|||
30853588|NCT02792777|58880952|FG001|Overall Study|Participant interviewed twice|0|||
30853589|NCT02625974|58880961|FG000|Overall Study|Adverse Event|12|||
30853590|NCT02625974|58880962|FG001|Overall Study|Adverse Event|2|||
30853591|NCT02625974|58880961|FG000|Overall Study|Withdrawal by Subject|3|||
30853592|NCT02625974|58880962|FG001|Overall Study|Withdrawal by Subject|1|||
30853593|NCT02625974|58880961|FG000|Overall Study|positive parasitemia|1|||
30853594|NCT02625974|58880962|FG001|Overall Study|positive parasitemia|0|||
30853595|NCT02625974|58880961|FG000|Overall Study|non-compliance with study drug|0|||
30853596|NCT02625974|58880962|FG001|Overall Study|non-compliance with study drug|2|||
30853597|NCT02625974|58880961|FG000|Overall Study|Protocol Violation|0|||
30853598|NCT02625974|58880962|FG001|Overall Study|Protocol Violation|1|||
30853599|NCT02792699|58881007|FG000|Overall Study|Adverse Event|1|||
30853600|NCT02792699|58881008|FG001|Overall Study|Adverse Event|2|||
30853601|NCT02792699|58881009|FG002|Overall Study|Adverse Event|4|||
30853602|NCT02792699|58881007|FG000|Overall Study|Withdrawal by Subject|4|||
30853603|NCT02792699|58881008|FG001|Overall Study|Withdrawal by Subject|4|||
30853604|NCT02792699|58881009|FG002|Overall Study|Withdrawal by Subject|3|||
30853605|NCT02792699|58881007|FG000|Overall Study|Lost to Follow-up|0|||
30853606|NCT02792699|58881008|FG001|Overall Study|Lost to Follow-up|1|||
30853607|NCT02792699|58881009|FG002|Overall Study|Lost to Follow-up|2|||
30853608|NCT02792699|58881007|FG000|Overall Study|Physician Decision|2|||
30853609|NCT02792699|58881008|FG001|Overall Study|Physician Decision|0|||
30853610|NCT02792699|58881009|FG002|Overall Study|Physician Decision|0|||
30853611|NCT02792699|58881007|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
30853612|NCT02792699|58881008|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
30853613|NCT02792699|58881009|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
30957019|NCT01746017|59019561|FG004|Period 1|Withdrawal by Subject|0|||
30853614|NCT02792699|58881007|FG000|Overall Study|Other|1|||
30853615|NCT02792699|58881008|FG001|Overall Study|Other|0|||
30853616|NCT02792699|58881009|FG002|Overall Study|Other|0|||
30957020|NCT01746017|59019562|FG005|Period 1|Withdrawal by Subject|0|||
30957021|NCT01746017|59019563|FG006|Period 1|Withdrawal by Subject|1|||
30778245|NCT03517436|58789507|FG000|Overall Study|Did not receive study valve.|1|||
30778246|NCT03673098|58789513|FG000|Overall Study|Lost to Follow-up|2|||
30853617|NCT03010319|58881026|FG000|Overall Study|Adverse Event|15|||
30853618|NCT03010319|58881027|FG001|Overall Study|Adverse Event|9|||
30853619|NCT03010319|58881026|FG000|Overall Study|Withdrawal by Subject|1|||
30853620|NCT03010319|58881027|FG001|Overall Study|Withdrawal by Subject|6|||
30853621|NCT03010319|58881026|FG000|Overall Study|Physician Decision|2|||
30853622|NCT03010319|58881027|FG001|Overall Study|Physician Decision|4|||
30853623|NCT03010319|58881026|FG000|Overall Study|Sponsor requested withdrawal|2|||
30853624|NCT03010319|58881027|FG001|Overall Study|Sponsor requested withdrawal|2|||
30853625|NCT03010319|58881026|FG000|Overall Study|Death|1|||
30853626|NCT03010319|58881027|FG001|Overall Study|Death|0|||
30853627|NCT03010319|58881026|FG000|Overall Study|Lost to Follow-up|0|||
30853628|NCT03010319|58881027|FG001|Overall Study|Lost to Follow-up|1|||
30853629|NCT03010319|58881026|FG000|Overall Study|Other Reason|5|||
30957022|NCT01746017|59019564|FG007|Period 1|Withdrawal by Subject|0|||
30957023|NCT01746017|59019565|FG008|Period 1|Withdrawal by Subject|0|||
30957024|NCT01746017|59019566|FG009|Period 1|Withdrawal by Subject|0|||
30957025|NCT01746017|59019567|FG010|Period 1|Withdrawal by Subject|0|||
30853630|NCT03010319|58881027|FG001|Overall Study|Other Reason|7|||
30853631|NCT01369511|58881037|FG000|Overall Study|Adverse Event|1|||
30853632|NCT01369511|58881038|FG001|Overall Study|Adverse Event|1|||
30853633|NCT01369511|58881039|FG002|Overall Study|Adverse Event|5|||
30853634|NCT01369511|58881040|FG003|Overall Study|Adverse Event|0|||
30853635|NCT01369511|58881037|FG000|Overall Study|Entry criteria not met|2|||
30957026|NCT01746017|59019557|FG000|Period 3|Withdrawal by Subject|0|||
30957027|NCT01746017|59019558|FG001|Period 3|Withdrawal by Subject|0|||
30957028|NCT01746017|59019559|FG002|Period 3|Withdrawal by Subject|0|||
30957029|NCT01746017|59019560|FG003|Period 3|Withdrawal by Subject|0|||
30957030|NCT01746017|59019561|FG004|Period 3|Withdrawal by Subject|0|||
30957031|NCT01746017|59019562|FG005|Period 3|Withdrawal by Subject|1|||
30957032|NCT01746017|59019563|FG006|Period 3|Withdrawal by Subject|0|||
30957033|NCT01746017|59019564|FG007|Period 3|Withdrawal by Subject|0|||
30957034|NCT01746017|59019565|FG008|Period 3|Withdrawal by Subject|0|||
30957035|NCT01746017|59019566|FG009|Period 3|Withdrawal by Subject|0|||
30957036|NCT01746017|59019567|FG010|Period 3|Withdrawal by Subject|0|||
30957037|NCT01717313|59019629|FG000|Phase A (Weeks 0 to 24)|Death|0|||
30957038|NCT01717313|59019630|FG001|Phase A (Weeks 0 to 24)|Death|1|||
30957039|NCT01717313|59019629|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
30853636|NCT01369511|58881038|FG001|Overall Study|Entry criteria not met|0|||
30853637|NCT01369511|58881039|FG002|Overall Study|Entry criteria not met|0|||
30853638|NCT01369511|58881040|FG003|Overall Study|Entry criteria not met|1|||
30853639|NCT01369511|58881037|FG000|Overall Study|Lost to Follow-up|0|||
30853640|NCT01369511|58881038|FG001|Overall Study|Lost to Follow-up|1|||
30853641|NCT01369511|58881039|FG002|Overall Study|Lost to Follow-up|1|||
30957040|NCT01717313|59019630|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
30957041|NCT01717313|59019629|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
30957042|NCT01717313|59019630|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
30957043|NCT01717313|59019629|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
30853642|NCT01369511|58881040|FG003|Overall Study|Lost to Follow-up|2|||
30957044|NCT01717313|59019630|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
30957045|NCT01717313|59019629|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
30957046|NCT01717313|59019630|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
30957047|NCT01717313|59019629|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
30957048|NCT01717313|59019630|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
30957049|NCT01717313|59019629|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
30778247|NCT03673098|58789514|FG001|Overall Study|Lost to Follow-up|3|||
30778248|NCT03673098|58789513|FG000|Overall Study|Withdrawal by Subject|6|||
30778249|NCT03673098|58789514|FG001|Overall Study|Withdrawal by Subject|1|||
30778250|NCT03673098|58789513|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
30778251|NCT03673098|58789514|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
30778252|NCT03435224|58789527|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
30778253|NCT03672396|58789531|FG000|Overall Study|Withdrawal by Subject|4|||
30778254|NCT03672396|58789531|FG000|Overall Study|Physician Decision|1|||
30778255|NCT03672396|58789531|FG000|Overall Study|Adverse Event|1|||
30778256|NCT03434834|58789535|FG000|Overall Study|unable to swallow OCT probe|16|||
30778257|NCT03605862|58789541|FG000|Overall Study|Withdrawal by Subject|12|||
30778258|NCT03605862|58789542|FG001|Overall Study|Withdrawal by Subject|9|||
30778259|NCT03605862|58789541|FG000|Overall Study|Adverse Event|2|||
30778260|NCT03605862|58789542|FG001|Overall Study|Adverse Event|1|||
30778261|NCT03605862|58789541|FG000|Overall Study|Physician Decision|3|||
30778262|NCT03605862|58789542|FG001|Overall Study|Physician Decision|1|||
30778263|NCT03605862|58789541|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
30778264|NCT03605862|58789542|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
30778265|NCT03672006|58789551|FG000|Overall Study|exclusion criteria met|0|||
30778266|NCT03672006|58789552|FG001|Overall Study|exclusion criteria met|1|||
30778267|NCT03512288|58789562|FG000|Overall Study|Adverse Event|1|||
30778268|NCT03512288|58789563|FG001|Overall Study|Adverse Event|0|||
30778269|NCT03512288|58789562|FG000|Overall Study|Lost to Follow-up|12|||
30778270|NCT03512288|58789563|FG001|Overall Study|Lost to Follow-up|15|||
30778271|NCT03512288|58789562|FG000|Overall Study|Physician Decision|0|||
30853643|NCT01369511|58881037|FG000|Overall Study|Protocol Violation|0|||
30853644|NCT01369511|58881038|FG001|Overall Study|Protocol Violation|1|||
30853645|NCT01369511|58881039|FG002|Overall Study|Protocol Violation|0|||
30853646|NCT01369511|58881040|FG003|Overall Study|Protocol Violation|2|||
30853647|NCT01369511|58881037|FG000|Overall Study|Physician Decision|3|||
30853648|NCT01369511|58881038|FG001|Overall Study|Physician Decision|4|||
30957050|NCT01717313|59019630|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
30957051|NCT01717313|59019629|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
30957052|NCT01717313|59019630|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
30957053|NCT01717313|59019629|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
30957054|NCT01717313|59019630|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
30957055|NCT01745393|59019642|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
30957056|NCT01745393|59019643|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
30957057|NCT01745393|59019642|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
30853649|NCT01369511|58881039|FG002|Overall Study|Physician Decision|0|||
30853650|NCT01369511|58881040|FG003|Overall Study|Physician Decision|0|||
30853651|NCT01369511|58881037|FG000|Overall Study|Sponsor decision|2|||
30853652|NCT01369511|58881038|FG001|Overall Study|Sponsor decision|0|||
30853653|NCT01369511|58881039|FG002|Overall Study|Sponsor decision|1|||
30853654|NCT01369511|58881040|FG003|Overall Study|Sponsor decision|0|||
30957058|NCT01745393|59019643|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
30957059|NCT01745393|59019642|FG000|12-month Follow-up|Lost to Follow-up|6|||
30957060|NCT01745393|59019643|FG001|12-month Follow-up|Lost to Follow-up|5|||
30957061|NCT01744691|59019674|FG000|Overall Study|Progressive Disease|18|||
30957062|NCT01744691|59019674|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
30957063|NCT01744691|59019674|FG000|Overall Study|Withdrawal of consent for treatment|3|||
30957064|NCT01744691|59019674|FG000|Overall Study|Physician Decision|4|||
30957065|NCT01716533|59019709|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
30957066|NCT01716533|59019710|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
30957067|NCT01716533|59019711|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
30957068|NCT01716533|59019712|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
30957069|NCT01716533|59019709|FG000|Overall Study|Withdrawal by Subject|0|||
30957070|NCT01716533|59019710|FG001|Overall Study|Withdrawal by Subject|0|||
30957071|NCT01716533|59019711|FG002|Overall Study|Withdrawal by Subject|0|||
30957072|NCT01716533|59019712|FG003|Overall Study|Withdrawal by Subject|5|||
30957073|NCT01716533|59019709|FG000|Overall Study|Death|0|||
30957074|NCT01716533|59019710|FG001|Overall Study|Death|0|||
30957075|NCT01716533|59019711|FG002|Overall Study|Death|0|||
30957076|NCT01716533|59019712|FG003|Overall Study|Death|2|||
30957077|NCT01716533|59019709|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
30957078|NCT01716533|59019710|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
30957079|NCT01716533|59019711|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
30957080|NCT01716533|59019712|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
30957081|NCT01375374|59019726|FG000|Overall Study|Adverse Event|1|||
30957082|NCT01743989|59020334|FG000|Treatment Phase|Unstable MR4.0|0|||
30957083|NCT01743989|59020335|FG001|Treatment Phase|Unstable MR4.0|6|||
30957084|NCT01743989|59020336|FG002|Treatment Phase|Unstable MR4.0|263|||
30957085|NCT01743989|59020334|FG000|Treatment Phase|Adverse Event|0|||
30957086|NCT01743989|59020335|FG001|Treatment Phase|Adverse Event|4|||
30778272|NCT03512288|58789563|FG001|Overall Study|Physician Decision|2|||
30778273|NCT03512288|58789562|FG000|Overall Study|Protocol Violation|6|||
30778274|NCT03512288|58789563|FG001|Overall Study|Protocol Violation|4|||
30853655|NCT01369511|58881037|FG000|Overall Study|Withdrawal by Subject|5|||
30853656|NCT01369511|58881038|FG001|Overall Study|Withdrawal by Subject|6|||
30853657|NCT01369511|58881039|FG002|Overall Study|Withdrawal by Subject|4|||
30853658|NCT01369511|58881040|FG003|Overall Study|Withdrawal by Subject|6|||
30853659|NCT01369433|58881052|FG000|Overall Study|Adverse Event|31|||
30853660|NCT01369433|58881053|FG001|Overall Study|Adverse Event|1|||
30853661|NCT01369433|58881052|FG000|Overall Study|Required significant surgical procedure|1|||
30853662|NCT01369433|58881053|FG001|Overall Study|Required significant surgical procedure|0|||
30853663|NCT01369433|58881052|FG000|Overall Study|Non-compliance|1|||
30853664|NCT01369433|58881053|FG001|Overall Study|Non-compliance|0|||
30853665|NCT01369433|58881052|FG000|Overall Study|Withdrawal by Subject|5|||
30853666|NCT01369433|58881053|FG001|Overall Study|Withdrawal by Subject|2|||
30853667|NCT01369433|58881052|FG000|Overall Study|Study terminated by Sponsor|67|||
30853668|NCT01369433|58881053|FG001|Overall Study|Study terminated by Sponsor|0|||
30853669|NCT01369433|58881052|FG000|Overall Study|Lost to Follow-up|1|||
30853670|NCT01369433|58881053|FG001|Overall Study|Lost to Follow-up|0|||
30778275|NCT03512288|58789562|FG000|Overall Study|Medication error without associated adverse event|1|||
30778276|NCT03512288|58789563|FG001|Overall Study|Medication error without associated adverse event|0|||
30778277|NCT03512288|58789562|FG000|Overall Study|No longer met eligibility criteria|5|||
30778278|NCT03512288|58789563|FG001|Overall Study|No longer met eligibility criteria|2|||
30778279|NCT03512288|58789562|FG000|Overall Study|Withdrawal by parent/guardian|14|||
30778280|NCT03512288|58789563|FG001|Overall Study|Withdrawal by parent/guardian|18|||
30853671|NCT01369433|58881052|FG000|Overall Study|Death|5|||
30853672|NCT01369433|58881053|FG001|Overall Study|Death|0|||
30853673|NCT01369433|58881052|FG000|Overall Study|Investigator discretion|6|||
30957087|NCT01743989|59020336|FG002|Treatment Phase|Adverse Event|67|||
30957088|NCT01743989|59020334|FG000|Treatment Phase|Withdrawal by Subject|1|||
30957089|NCT01743989|59020335|FG001|Treatment Phase|Withdrawal by Subject|3|||
30957090|NCT01743989|59020336|FG002|Treatment Phase|Withdrawal by Subject|28|||
30957091|NCT01743989|59020334|FG000|Treatment Phase|Death|0|||
30957092|NCT01743989|59020335|FG001|Treatment Phase|Death|1|||
30957093|NCT01743989|59020336|FG002|Treatment Phase|Death|3|||
30957094|NCT01743989|59020334|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
30957095|NCT01743989|59020335|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
30957096|NCT01743989|59020336|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
30957097|NCT01743989|59020334|FG000|Treatment Phase|Protocol deviation|0|||
30957098|NCT01743989|59020335|FG001|Treatment Phase|Protocol deviation|0|||
30957099|NCT01743989|59020336|FG002|Treatment Phase|Protocol deviation|3|||
30957100|NCT01743989|59020334|FG000|Treatment Phase|Pregnancy|0|||
30957101|NCT01743989|59020335|FG001|Treatment Phase|Pregnancy|0|||
30957102|NCT01743989|59020336|FG002|Treatment Phase|Pregnancy|2|||
30662832|NCT00911807|58676470|FG000|Overall Study|Withdrawal by Subject|8|||
30662833|NCT00911807|58676471|FG001|Overall Study|Withdrawal by Subject|10|||
30662834|NCT00911807|58676472|FG002|Overall Study|Withdrawal by Subject|7|||
30662835|NCT00911807|58676470|FG000|Overall Study|Organizational reasons|1|||
30662836|NCT00911807|58676471|FG001|Overall Study|Organizational reasons|3|||
30662837|NCT00911807|58676472|FG002|Overall Study|Organizational reasons|1|||
30778281|NCT03512288|58789562|FG000|Overall Study|Other|1|||
30778282|NCT03512288|58789563|FG001|Overall Study|Other|1|||
30662838|NCT04287920|58676499|FG000|Overall Study|Lost to Follow-up|1|||
30662839|NCT04287920|58676500|FG001|Overall Study|Lost to Follow-up|1|||
30662840|NCT04287920|58676499|FG000|Overall Study|Withdrawal by Subject|0|||
30662841|NCT04287920|58676500|FG001|Overall Study|Withdrawal by Subject|3|||
30778283|NCT03512288|58789562|FG000|Overall Study|Randomized but not treated|1|||
30778284|NCT03512288|58789563|FG001|Overall Study|Randomized but not treated|1|||
30778285|NCT03031678|58789569|FG000|Overall Study|Study closed prior to completion|1|||
30778286|NCT03669588|58789579|FG000|Overall Study|Adverse Event|1|||
30778287|NCT03669588|58789580|FG001|Overall Study|Adverse Event|0|||
30778288|NCT03669588|58789579|FG000|Overall Study|Physician Decision|0|||
30778289|NCT03669588|58789580|FG001|Overall Study|Physician Decision|1|||
30778290|NCT03669588|58789579|FG000|Overall Study|Protocol Violation|1|||
30778291|NCT03669588|58789580|FG001|Overall Study|Protocol Violation|0|||
30778292|NCT03669588|58789579|FG000|Overall Study|Sponsor Decision|1|||
30662842|NCT00909779|58676508|FG000|Overall Study|Adverse Event|53|||
30957103|NCT01743989|59020334|FG000|Treatment Phase|Lost to Follow-up|0|||
30957104|NCT01743989|59020335|FG001|Treatment Phase|Lost to Follow-up|0|||
30957105|NCT01743989|59020336|FG002|Treatment Phase|Lost to Follow-up|2|||
30957106|NCT01743989|59020334|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
30957107|NCT01743989|59020335|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
30957108|NCT01743989|59020336|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
30957109|NCT01743989|59020334|FG000|Treatment Phase|Administrative problems|0|||
30853674|NCT01369433|58881053|FG001|Overall Study|Investigator discretion|1|||
30853675|NCT01369433|58881052|FG000|Overall Study|Progressive Disease|92|||
30853676|NCT01369433|58881053|FG001|Overall Study|Progressive Disease|12|||
30853677|NCT02624492|58881062|FG000|Overall Study|Adverse Event|2|||
30853678|NCT02624492|58881063|FG001|Overall Study|Adverse Event|2|||
30853679|NCT02624492|58881064|FG002|Overall Study|Adverse Event|2|||
30853680|NCT02624492|58881062|FG000|Overall Study|Progressive disease|0|||
30778293|NCT03669588|58789580|FG001|Overall Study|Sponsor Decision|1|||
30778294|NCT03669588|58789579|FG000|Overall Study|Withdrawal by Subject|1|||
30853681|NCT02624492|58881063|FG001|Overall Study|Progressive disease|2|||
30853682|NCT02624492|58881064|FG002|Overall Study|Progressive disease|3|||
30853683|NCT01975831|58881081|FG000|Overall Study|Adverse Event|1|||
30853684|NCT01975831|58881082|FG001|Overall Study|Adverse Event|2|||
30853685|NCT01975831|58881083|FG002|Overall Study|Adverse Event|2|||
30853686|NCT01975831|58881084|FG003|Overall Study|Adverse Event|0|||
30853687|NCT01975831|58881085|FG004|Overall Study|Adverse Event|1|||
30853688|NCT01975831|58881086|FG005|Overall Study|Adverse Event|1|||
30778295|NCT03669588|58789580|FG001|Overall Study|Withdrawal by Subject|4|||
30778296|NCT03669588|58789579|FG000|Overall Study|Rescue Therapy Needed|0|||
30778297|NCT03669588|58789580|FG001|Overall Study|Rescue Therapy Needed|1|||
30778298|NCT03598140|58789588|FG000|Overall Study|enrolled but didn't start|1|||
30778299|NCT03598140|58789589|FG001|Overall Study|enrolled but didn't start|0|||
30778300|NCT03644550|58789595|FG000|Overall Study|Withdrawal by Subject|3|||
30778301|NCT03644550|58789595|FG000|Overall Study|Progressive disease|15|||
30778302|NCT03511664|58789602|FG000|Overall Study|Treatment ongoing|49|||
30778303|NCT03511664|58789603|FG001|Overall Study|Treatment ongoing|5|||
30778304|NCT03511664|58789602|FG000|Overall Study|Entered long-term follow-up|140|||
30778305|NCT03511664|58789603|FG001|Overall Study|Entered long-term follow-up|50|||
30778306|NCT03511664|58789602|FG000|Overall Study|Withdrawal by Subject|29|||
30778307|NCT03511664|58789603|FG001|Overall Study|Withdrawal by Subject|53|||
30778308|NCT03511664|58789602|FG000|Overall Study|Lost to Follow-up|4|||
30778309|NCT03511664|58789603|FG001|Overall Study|Lost to Follow-up|4|||
30778310|NCT03511664|58789602|FG000|Overall Study|Physician Decision|0|||
30778311|NCT03511664|58789603|FG001|Overall Study|Physician Decision|1|||
30778312|NCT00054717|58789611|FG000|Overall Study|Randomized but not treated|2|||
30778313|NCT00054717|58789612|FG001|Overall Study|Randomized but not treated|8|||
30778314|NCT00054717|58789611|FG000|Overall Study|Adverse Event|70|||
30778315|NCT00054717|58789612|FG001|Overall Study|Adverse Event|22|||
30778316|NCT00054717|58789611|FG000|Overall Study|Protocol Violation|18|||
30778317|NCT00054717|58789612|FG001|Overall Study|Protocol Violation|19|||
30778318|NCT00054717|58789611|FG000|Overall Study|Lost to Follow-up|23|||
30778319|NCT00054717|58789612|FG001|Overall Study|Lost to Follow-up|13|||
30778320|NCT00054717|58789611|FG000|Overall Study|Withdrawal by Subject|32|||
30778321|NCT00054717|58789612|FG001|Overall Study|Withdrawal by Subject|20|||
30778322|NCT00054717|58789611|FG000|Overall Study|Other reason not defined above|117|||
30778323|NCT00054717|58789612|FG001|Overall Study|Other reason not defined above|217|||
30778324|NCT03430856|58789621|FG000|Overall Study|Adverse Event|0|||
30778325|NCT03430856|58789622|FG001|Overall Study|Adverse Event|1|||
30778326|NCT03430856|58789623|FG002|Overall Study|Adverse Event|0|||
30778327|NCT03430856|58789621|FG000|Overall Study|Rescue criteria|1|||
30778328|NCT03430856|58789622|FG001|Overall Study|Rescue criteria|1|||
30957110|NCT01743989|59020335|FG001|Treatment Phase|Administrative problems|0|||
30957111|NCT01743989|59020336|FG002|Treatment Phase|Administrative problems|1|||
30778329|NCT03430856|58789623|FG002|Overall Study|Rescue criteria|0|||
30778330|NCT03430856|58789621|FG000|Overall Study|Voluntary withdrawal of consent|1|||
30778331|NCT03430856|58789622|FG001|Overall Study|Voluntary withdrawal of consent|1|||
30778332|NCT03430856|58789623|FG002|Overall Study|Voluntary withdrawal of consent|1|||
30778333|NCT03731364|58789639|FG000|Overall Study|Adverse Event|0|||
30778334|NCT03731364|58789640|FG001|Overall Study|Adverse Event|0|||
30853689|NCT01975831|58881087|FG006|Overall Study|Adverse Event|3|||
30853690|NCT01975831|58881088|FG007|Overall Study|Adverse Event|4|||
30853691|NCT01975831|58881089|FG008|Overall Study|Adverse Event|1|||
30957112|NCT01743989|59020334|FG000|Treatment Phase|New cancer (CML) therapy|0|||
30853692|NCT01975831|58881081|FG000|Overall Study|Death|1|||
30853693|NCT01975831|58881082|FG001|Overall Study|Death|1|||
30853694|NCT01975831|58881083|FG002|Overall Study|Death|0|||
30853695|NCT01975831|58881084|FG003|Overall Study|Death|0|||
30853696|NCT01975831|58881085|FG004|Overall Study|Death|1|||
30853697|NCT01975831|58881086|FG005|Overall Study|Death|0|||
30853698|NCT01975831|58881087|FG006|Overall Study|Death|1|||
30853699|NCT01975831|58881088|FG007|Overall Study|Death|0|||
30853700|NCT01975831|58881089|FG008|Overall Study|Death|0|||
30853701|NCT01975831|58881081|FG000|Overall Study|Progressive Disease|1|||
30853702|NCT01975831|58881082|FG001|Overall Study|Progressive Disease|3|||
30853703|NCT01975831|58881083|FG002|Overall Study|Progressive Disease|2|||
30853704|NCT01975831|58881084|FG003|Overall Study|Progressive Disease|4|||
30853705|NCT01975831|58881085|FG004|Overall Study|Progressive Disease|13|||
30853706|NCT01975831|58881086|FG005|Overall Study|Progressive Disease|9|||
30853707|NCT01975831|58881087|FG006|Overall Study|Progressive Disease|10|||
30853708|NCT01975831|58881088|FG007|Overall Study|Progressive Disease|8|||
30853709|NCT01975831|58881089|FG008|Overall Study|Progressive Disease|10|||
30853710|NCT01975831|58881081|FG000|Overall Study|Withdrawal by Subject|0|||
30853711|NCT01975831|58881082|FG001|Overall Study|Withdrawal by Subject|3|||
30853712|NCT01975831|58881083|FG002|Overall Study|Withdrawal by Subject|0|||
30853713|NCT01975831|58881084|FG003|Overall Study|Withdrawal by Subject|0|||
30853714|NCT01975831|58881085|FG004|Overall Study|Withdrawal by Subject|3|||
30853715|NCT01975831|58881086|FG005|Overall Study|Withdrawal by Subject|1|||
30853716|NCT01975831|58881087|FG006|Overall Study|Withdrawal by Subject|1|||
30853717|NCT01975831|58881088|FG007|Overall Study|Withdrawal by Subject|0|||
30853718|NCT01975831|58881089|FG008|Overall Study|Withdrawal by Subject|0|||
30853719|NCT01975831|58881081|FG000|Overall Study|Physician Decision|0|||
30853720|NCT01975831|58881082|FG001|Overall Study|Physician Decision|0|||
30853721|NCT01975831|58881083|FG002|Overall Study|Physician Decision|0|||
30853722|NCT01975831|58881084|FG003|Overall Study|Physician Decision|0|||
30853723|NCT01975831|58881085|FG004|Overall Study|Physician Decision|0|||
30853724|NCT01975831|58881086|FG005|Overall Study|Physician Decision|1|||
30853725|NCT01975831|58881087|FG006|Overall Study|Physician Decision|0|||
30853726|NCT01975831|58881088|FG007|Overall Study|Physician Decision|1|||
30853727|NCT01975831|58881089|FG008|Overall Study|Physician Decision|0|||
30853728|NCT01975831|58881081|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
30853729|NCT01975831|58881082|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
30853730|NCT01975831|58881083|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
30853731|NCT01975831|58881084|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
30853732|NCT01975831|58881085|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
30853733|NCT01975831|58881086|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
30957113|NCT01743989|59020335|FG001|Treatment Phase|New cancer (CML) therapy|1|||
30957114|NCT01743989|59020336|FG002|Treatment Phase|New cancer (CML) therapy|0|||
30957115|NCT01743989|59020334|FG000|Treatment Phase|Physician Decision|0|||
30957116|NCT01743989|59020335|FG001|Treatment Phase|Physician Decision|0|||
30957117|NCT01743989|59020336|FG002|Treatment Phase|Physician Decision|3|||
30957118|NCT01743989|59020334|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
30957119|NCT01743989|59020335|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
30778335|NCT03731364|58789641|FG002|Overall Study|Adverse Event|1|||
30778336|NCT03731364|58789642|FG003|Overall Study|Adverse Event|2|||
30778337|NCT03731364|58789643|FG004|Overall Study|Adverse Event|1|||
30778338|NCT03510182|58789655|FG000|Overall Study|Withdrawal by Subject|2|||
30778339|NCT00066807|58789661|FG000|Overall Study|Study was terminated early|14|||
30778340|NCT00066807|58789662|FG001|Overall Study|Study was terminated early|15|||
30778341|NCT03428750|58789670|FG000|Overall Study|Withdrawal by Subject|11|||
30778342|NCT03428750|58789671|FG001|Overall Study|Withdrawal by Subject|10|||
30778343|NCT03428750|58789670|FG000|Overall Study|Lost to Follow-up|3|||
30778344|NCT03428750|58789671|FG001|Overall Study|Lost to Follow-up|9|||
30778345|NCT03428750|58789670|FG000|Overall Study|Adverse Event|9|||
30778346|NCT03428750|58789671|FG001|Overall Study|Adverse Event|1|||
30778347|NCT03428750|58789670|FG000|Overall Study|Protocol Violation|1|||
30853734|NCT01975831|58881087|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
30853735|NCT01975831|58881088|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
30853736|NCT01975831|58881089|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
30853737|NCT01975831|58881081|FG000|Overall Study|Entered Hospice|0|||
30853738|NCT01975831|58881082|FG001|Overall Study|Entered Hospice|0|||
30853739|NCT01975831|58881083|FG002|Overall Study|Entered Hospice|0|||
30853740|NCT01975831|58881084|FG003|Overall Study|Entered Hospice|0|||
30853741|NCT01975831|58881085|FG004|Overall Study|Entered Hospice|0|||
30853742|NCT01975831|58881086|FG005|Overall Study|Entered Hospice|1|||
30853743|NCT01975831|58881087|FG006|Overall Study|Entered Hospice|0|||
30853744|NCT01975831|58881088|FG007|Overall Study|Entered Hospice|0|||
30853745|NCT01975831|58881089|FG008|Overall Study|Entered Hospice|0|||
30957120|NCT01743989|59020336|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
30778348|NCT03428750|58789671|FG001|Overall Study|Protocol Violation|0|||
30778349|NCT03428750|58789670|FG000|Overall Study|Administrative|0|||
30853746|NCT01975831|58881081|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
30957121|NCT01743989|59020334|FG000|Treatment Phase|Not randomized by mistake|0|||
30957122|NCT01743989|59020335|FG001|Treatment Phase|Not randomized by mistake|0|||
30957123|NCT01743989|59020336|FG002|Treatment Phase|Not randomized by mistake|1|||
30957124|NCT01743989|59020334|FG000|Treatment Phase|Included by mistake|0|||
30957125|NCT01743989|59020335|FG001|Treatment Phase|Included by mistake|0|||
30957126|NCT01743989|59020336|FG002|Treatment Phase|Included by mistake|1|||
30853747|NCT01975831|58881082|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
30853748|NCT01975831|58881083|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
30853749|NCT01975831|58881084|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
30853750|NCT01975831|58881085|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
30853751|NCT01975831|58881086|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
30853752|NCT01975831|58881087|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
30853753|NCT01975831|58881088|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
30853754|NCT01975831|58881089|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
30853755|NCT00700713|58881112|FG000|Overall Study|Protocol Violation|1|||
30853756|NCT00700713|58881113|FG001|Overall Study|Protocol Violation|0|||
30853757|NCT00700713|58881114|FG002|Overall Study|Protocol Violation|1|||
30853758|NCT00700713|58881112|FG000|Overall Study|Withdrawal by Subject|0|||
30957127|NCT01743989|59020334|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
30957128|NCT01743989|59020335|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
30957129|NCT01743989|59020336|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
30957130|NCT01743989|59020334|FG000|TFR Phase|Adverse Event|0|||
30957131|NCT01743989|59020335|FG001|TFR Phase|Adverse Event|1|||
30957132|NCT01743989|59020336|FG002|TFR Phase|Adverse Event|0|||
30957133|NCT01743989|59020334|FG000|TFR Phase|Lost to Follow-up|0|||
30957134|NCT01743989|59020335|FG001|TFR Phase|Lost to Follow-up|2|||
30957135|NCT01743989|59020336|FG002|TFR Phase|Lost to Follow-up|0|||
30957136|NCT01743989|59020334|FG000|TFR Phase|Physician Decision|0|||
30957137|NCT01743989|59020335|FG001|TFR Phase|Physician Decision|1|||
30957138|NCT01743989|59020336|FG002|TFR Phase|Physician Decision|0|||
30957139|NCT01743989|59020334|FG000|TFR Phase|Logistical problems|0|||
30957140|NCT01743989|59020335|FG001|TFR Phase|Logistical problems|2|||
30957141|NCT01743989|59020336|FG002|TFR Phase|Logistical problems|0|||
30957142|NCT01743989|59020334|FG000|TFR Phase|Protocol deviation|0|||
30957143|NCT01743989|59020335|FG001|TFR Phase|Protocol deviation|1|||
30957144|NCT01743989|59020336|FG002|TFR Phase|Protocol deviation|0|||
30957145|NCT01743989|59020334|FG000|TFR Phase|Withdrawal by Subject|0|||
30957146|NCT01743989|59020335|FG001|TFR Phase|Withdrawal by Subject|2|||
30957147|NCT01743989|59020336|FG002|TFR Phase|Withdrawal by Subject|0|||
30957148|NCT01743989|59020334|FG000|Re-treatment Phase|Adverse Event|8|||
30957149|NCT01743989|59020335|FG001|Re-treatment Phase|Adverse Event|4|||
30957150|NCT01743989|59020336|FG002|Re-treatment Phase|Adverse Event|0|||
30957151|NCT01743989|59020334|FG000|Re-treatment Phase|Death|1|||
30957152|NCT01743989|59020335|FG001|Re-treatment Phase|Death|1|||
30957153|NCT01743989|59020336|FG002|Re-treatment Phase|Death|0|||
30957154|NCT01743989|59020334|FG000|Re-treatment Phase|Administrative problems|1|||
30957155|NCT01743989|59020335|FG001|Re-treatment Phase|Administrative problems|1|||
30957156|NCT01743989|59020336|FG002|Re-treatment Phase|Administrative problems|0|||
30957157|NCT01743989|59020334|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
30957158|NCT01743989|59020335|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
30957159|NCT01743989|59020336|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
30957160|NCT01743989|59020334|FG000|Re-treatment Phase|Unstable MR|1|||
30957161|NCT01743989|59020335|FG001|Re-treatment Phase|Unstable MR|0|||
30957162|NCT01743989|59020336|FG002|Re-treatment Phase|Unstable MR|0|||
30957163|NCT01743989|59020334|FG000|Re-treatment Phase|Physician Decision|0|||
30957164|NCT01743989|59020335|FG001|Re-treatment Phase|Physician Decision|1|||
30957165|NCT01743989|59020336|FG002|Re-treatment Phase|Physician Decision|0|||
30957166|NCT01743989|59020334|FG000|Re-treatment Phase|Lost to Follow-up|0|||
30778350|NCT03428750|58789671|FG001|Overall Study|Administrative|1|||
30778351|NCT03666858|58789700|FG000|Cohort 1|Adverse Event|1|||
30778352|NCT03666858|58789701|FG001|Cohort 1|Adverse Event|0|||
30778353|NCT03666858|58789700|FG000|Cohort 2|Adverse Event|0|||
30778354|NCT03666858|58789701|FG001|Cohort 2|Adverse Event|1|||
30778355|NCT00054639|58789707|FG000|Overall Study|Lack of Efficacy|1|||
30778356|NCT00054639|58789707|FG000|Overall Study|Physician Decision|1|||
30778357|NCT03428360|58789711|FG000|Overall Study|Informed consent withdrawn|5|||
30957167|NCT01743989|59020335|FG001|Re-treatment Phase|Lost to Follow-up|1|||
30778358|NCT03428360|58789711|FG000|Overall Study|Withdrawal by Subject|4|||
30778359|NCT03428360|58789711|FG000|Overall Study|Lost to Follow-up|5|||
30778360|NCT03428360|58789711|FG000|Overall Study|Physician Decision|2|||
30778361|NCT03428360|58789711|FG000|Overall Study|Informed consent withdrawn|5|||
30778362|NCT03428360|58789711|FG000|Overall Study|Study terminated by sponsor|10|||
30778363|NCT03428360|58789711|FG000|Overall Study|Non-compliant with study|1|||
30957168|NCT01743989|59020336|FG002|Re-treatment Phase|Lost to Follow-up|0|||
30957169|NCT01605461|59020369|FG000|Overall Study|Lost to Follow-up|3|||
30957170|NCT01605461|59020369|FG000|Overall Study|Withdrawal by Subject|1|||
30957171|NCT01742897|59020373|FG000|Overall Study|Adverse Event|3|||
30957172|NCT01742897|59020373|FG000|Overall Study|Withdrawal by Subject|1|||
30957173|NCT01742897|59020373|FG000|Overall Study|Other|1|||
30957174|NCT01715831|59020377|FG000|Overall Study|Adverse Event|1|||
30957175|NCT01741259|59020383|FG000|Overall Study|Protocol Violation|6|||
30957176|NCT01741259|59020384|FG001|Overall Study|Protocol Violation|4|||
30957177|NCT01741259|59020383|FG000|Overall Study|Withdrawal by Subject|0|||
30957178|NCT01741259|59020384|FG001|Overall Study|Withdrawal by Subject|2|||
30957179|NCT01715129|59020390|FG000|Overall Study|Adverse Event, fatal|1|||
30957180|NCT01715129|59020390|FG000|Overall Study|Lack of Efficacy|3|||
30957181|NCT01715129|59020390|FG000|Overall Study|Protocol Violation|1|||
30957182|NCT01715129|59020390|FG000|Overall Study|Consent Withdrawn|2|||
30957183|NCT01715129|59020390|FG000|Overall Study|Lost to Follow-up|1|||
30957184|NCT01715129|59020390|FG000|Overall Study|Other|1|||
30957185|NCT01740791|59020483|FG000|Overall Study|Randomized but never treated|5|||
30957186|NCT01740791|59020484|FG001|Overall Study|Randomized but never treated|3|||
30957187|NCT01740791|59020485|FG002|Overall Study|Randomized but never treated|2|||
30957188|NCT01740791|59020486|FG003|Overall Study|Randomized but never treated|2|||
30957189|NCT01740791|59020487|FG004|Overall Study|Randomized but never treated|1|||
30957190|NCT01740791|59020488|FG005|Overall Study|Randomized but never treated|3|||
30957191|NCT01740791|59020483|FG000|Overall Study|Lost to Follow-up|2|||
30957192|NCT01740791|59020484|FG001|Overall Study|Lost to Follow-up|0|||
30957193|NCT01740791|59020485|FG002|Overall Study|Lost to Follow-up|2|||
30957194|NCT01740791|59020486|FG003|Overall Study|Lost to Follow-up|3|||
30957195|NCT01740791|59020487|FG004|Overall Study|Lost to Follow-up|2|||
30957196|NCT01740791|59020488|FG005|Overall Study|Lost to Follow-up|3|||
30957197|NCT01740791|59020483|FG000|Overall Study|Withdrew Consent|4|||
30957198|NCT01740791|59020484|FG001|Overall Study|Withdrew Consent|0|||
30853759|NCT00700713|58881113|FG001|Overall Study|Withdrawal by Subject|0|||
30853760|NCT00700713|58881114|FG002|Overall Study|Withdrawal by Subject|1|||
30853761|NCT02622386|58881122|FG000|First Assignment|Withdrawal by Subject|3|||
30853762|NCT02622386|58881123|FG001|First Assignment|Withdrawal by Subject|2|||
30957199|NCT01740791|59020485|FG002|Overall Study|Withdrew Consent|1|||
30662843|NCT00909779|58676509|FG001|Overall Study|Adverse Event|55|||
30662844|NCT00909779|58676508|FG000|Overall Study|Lack of Efficacy|7|||
30662845|NCT00909779|58676509|FG001|Overall Study|Lack of Efficacy|4|||
30662846|NCT00909779|58676508|FG000|Overall Study|Lost to Follow-up|19|||
30662847|NCT00909779|58676509|FG001|Overall Study|Lost to Follow-up|15|||
30662848|NCT00909779|58676508|FG000|Overall Study|Physician Decision|8|||
30662849|NCT00909779|58676509|FG001|Overall Study|Physician Decision|2|||
30662850|NCT00909779|58676508|FG000|Overall Study|Protocol Violation|2|||
30957200|NCT01740791|59020486|FG003|Overall Study|Withdrew Consent|2|||
30957201|NCT01740791|59020487|FG004|Overall Study|Withdrew Consent|0|||
30778364|NCT03428360|58789711|FG000|Overall Study|Non-compliant with study drug|3|||
30778365|NCT03428360|58789711|FG000|Overall Study|Death|3|||
30778366|NCT03428360|58789711|FG000|Overall Study|Adverse Event|1|||
30778367|NCT03428360|58789711|FG000|Overall Study|Not on antiepileptic drug|1|||
30778368|NCT03427892|58789719|FG000|Overall Study|Lost to Follow-up|2|||
30778369|NCT03595332|58789725|FG000|Overall Study|Lost to Follow-up|16|||
30778370|NCT03595332|58789726|FG001|Overall Study|Lost to Follow-up|22|||
30853763|NCT02622386|58881122|FG000|Washout|Withdrawal by Subject|4|||
30853764|NCT02622386|58881123|FG001|Washout|Withdrawal by Subject|4|||
30853765|NCT02622386|58881122|FG000|Second Assignment|Withdrawal by Subject|0|||
30853766|NCT02622386|58881123|FG001|Second Assignment|Withdrawal by Subject|2|||
30853767|NCT02792231|58881131|FG000|Overall Study|Patient/guardian decision|32|||
30853768|NCT02792231|58881132|FG001|Overall Study|Patient/guardian decision|42|||
30853769|NCT02792231|58881131|FG000|Overall Study|Adverse Event|15|||
30853770|NCT02792231|58881132|FG001|Overall Study|Adverse Event|11|||
30853771|NCT02792231|58881131|FG000|Overall Study|Physician Decision|14|||
30957202|NCT01740791|59020488|FG005|Overall Study|Withdrew Consent|3|||
30957203|NCT01740791|59020483|FG000|Overall Study|Investigator's discretion|1|||
30957204|NCT01740791|59020484|FG001|Overall Study|Investigator's discretion|0|||
30957205|NCT01740791|59020485|FG002|Overall Study|Investigator's discretion|1|||
30957206|NCT01740791|59020486|FG003|Overall Study|Investigator's discretion|0|||
30957207|NCT01740791|59020487|FG004|Overall Study|Investigator's discretion|0|||
30957208|NCT01740791|59020488|FG005|Overall Study|Investigator's discretion|1|||
30957209|NCT01740791|59020483|FG000|Overall Study|Adverse Event|0|||
30778371|NCT03595332|58789725|FG000|Overall Study|Unable to retrieve ID from school|0|||
30778372|NCT03595332|58789726|FG001|Overall Study|Unable to retrieve ID from school|2|||
30957210|NCT01740791|59020484|FG001|Overall Study|Adverse Event|0|||
30957211|NCT01740791|59020485|FG002|Overall Study|Adverse Event|0|||
30662851|NCT00909779|58676509|FG001|Overall Study|Protocol Violation|5|||
30778373|NCT03427268|58789735|FG000|Overall Study|Progressive disease|25|||
30853772|NCT02792231|58881132|FG001|Overall Study|Physician Decision|12|||
30853773|NCT02792231|58881131|FG000|Overall Study|Lack of Efficacy|7|||
30853774|NCT02792231|58881132|FG001|Overall Study|Lack of Efficacy|9|||
30778374|NCT03427268|58789735|FG000|Overall Study|Never treated|2|||
30957212|NCT01740791|59020486|FG003|Overall Study|Adverse Event|0|||
30957213|NCT01740791|59020487|FG004|Overall Study|Adverse Event|0|||
30853775|NCT02792231|58881131|FG000|Overall Study|Lost to Follow-up|9|||
30853776|NCT02792231|58881132|FG001|Overall Study|Lost to Follow-up|5|||
30853777|NCT02792231|58881131|FG000|Overall Study|Pregnancy|1|||
30853778|NCT02792231|58881132|FG001|Overall Study|Pregnancy|3|||
30853779|NCT02792231|58881131|FG000|Overall Study|Non-compliance with study treatment|2|||
30853780|NCT02792231|58881132|FG001|Overall Study|Non-compliance with study treatment|1|||
30853781|NCT02792231|58881131|FG000|Overall Study|Protocol deviation|2|||
30853782|NCT02792231|58881132|FG001|Overall Study|Protocol deviation|0|||
30853783|NCT02792231|58881131|FG000|Overall Study|Technical problems|0|||
30853784|NCT02792231|58881132|FG001|Overall Study|Technical problems|1|||
30853785|NCT00700401|58881138|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
30853786|NCT00700401|58881138|FG000|Overall Study|Adverse Event|5|||
30853787|NCT00700401|58881138|FG000|Overall Study|Refused Treatment|2|||
30853788|NCT00700401|58881138|FG000|Overall Study|Lost to Follow-up|1|||
30853789|NCT00700401|58881138|FG000|Overall Study|Treatment never started|1|||
30853790|NCT00700401|58881138|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
30853791|NCT00700401|58881138|FG000|Overall Study|Withdrawal by Subject|2|||
30853792|NCT02621606|58881145|FG000|Overall Study|Withdrawal by Subject|0|||
30853793|NCT02621606|58881146|FG001|Overall Study|Withdrawal by Subject|1|||
30853794|NCT02621606|58881147|FG002|Overall Study|Withdrawal by Subject|0|||
30853795|NCT02871401|58881157|FG000|Overall Study|Adverse Event|1|||
30853796|NCT02871401|58881158|FG001|Overall Study|Adverse Event|0|||
30853797|NCT02619812|58881168|FG000|Overall Study|Withdrawal by Subject|0|||
30853798|NCT02619812|58881169|FG001|Overall Study|Withdrawal by Subject|0|||
30853799|NCT02619812|58881170|FG002|Overall Study|Withdrawal by Subject|1|||
30778375|NCT03427268|58789735|FG000|Overall Study|Compassionate use|1|||
30778376|NCT03427268|58789735|FG000|Overall Study|Withdrawal by Subject|1|||
30778377|NCT03427268|58789735|FG000|Overall Study|Adverse Event|3|||
30778378|NCT03509948|58789739|FG000|Overall Study|Protocol Violation|0|||
30778379|NCT03509948|58789740|FG001|Overall Study|Protocol Violation|1|||
30853800|NCT02619812|58881171|FG003|Overall Study|Withdrawal by Subject|2|||
30662852|NCT00909779|58676508|FG000|Overall Study|Withdrawal by Subject|116|||
30778380|NCT03466658|58789746|FG000|Overall Study|Withdrawal by Subject|3|||
30778381|NCT03425396|58789757|FG000|Overall Study|Lost to Follow-up|2|||
30778382|NCT03425396|58789758|FG001|Overall Study|Lost to Follow-up|5|||
30778383|NCT03425396|58789759|FG002|Overall Study|Lost to Follow-up|2|||
30778384|NCT03425396|58789760|FG003|Overall Study|Lost to Follow-up|0|||
30778385|NCT03425396|58789761|FG004|Overall Study|Lost to Follow-up|0|||
30778386|NCT03425396|58789757|FG000|Overall Study|Withdrawal by Subject|0|||
30778387|NCT03425396|58789758|FG001|Overall Study|Withdrawal by Subject|1|||
30778388|NCT03425396|58789759|FG002|Overall Study|Withdrawal by Subject|0|||
30778389|NCT03425396|58789760|FG003|Overall Study|Withdrawal by Subject|1|||
30778390|NCT03425396|58789761|FG004|Overall Study|Withdrawal by Subject|0|||
30778391|NCT03425396|58789757|FG000|Overall Study|Other|0|||
30778392|NCT03425396|58789758|FG001|Overall Study|Other|1|||
30778393|NCT03425396|58789759|FG002|Overall Study|Other|1|||
30778394|NCT03425396|58789760|FG003|Overall Study|Other|0|||
30778395|NCT03425396|58789761|FG004|Overall Study|Other|1|||
30778396|NCT00066729|58789773|FG000|Overall Study|Lost to Follow-up|1|||
30778397|NCT00066729|58789773|FG000|Overall Study|Disease progression|1|||
30778398|NCT00032487|58789779|FG000|Overall Study|Withdrawal by Subject|67|||
30778399|NCT00032487|58789780|FG001|Overall Study|Withdrawal by Subject|43|||
30778400|NCT00032487|58789779|FG000|Overall Study|Adverse Event|3|||
30778401|NCT00032487|58789780|FG001|Overall Study|Adverse Event|7|||
30778402|NCT00032487|58789779|FG000|Overall Study|Lost to Follow-up|57|||
30778403|NCT00032487|58789780|FG001|Overall Study|Lost to Follow-up|58|||
30778404|NCT00032487|58789779|FG000|Overall Study|Had other reason|12|||
30778405|NCT00032487|58789780|FG001|Overall Study|Had other reason|12|||
30778406|NCT03641508|58789788|FG000|First Injection|Lost to Follow-up|2|||
30778407|NCT03641508|58789789|FG001|First Injection|Lost to Follow-up|0|||
30778408|NCT03465878|58789797|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
30778409|NCT03465878|58789798|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
30778410|NCT03465878|58789799|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
30778411|NCT03465878|58789800|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
30778412|NCT03465878|58789797|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
30853801|NCT02623322|58881184|FG000|Overall Study|Lost to Follow-up|2|||
30662853|NCT00909779|58676509|FG001|Overall Study|Withdrawal by Subject|80|||
30853802|NCT02623322|58881185|FG001|Overall Study|Lost to Follow-up|1|||
30853803|NCT02623322|58881186|FG002|Overall Study|Lost to Follow-up|0|||
30853804|NCT00105157|58881200|FG000|Double-Blind (DB)|Never Treated|1|||
30662854|NCT00909779|58676508|FG000|Overall Study|Site Ceasing Operation|2|||
30778413|NCT03465878|58789798|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
30778414|NCT03465878|58789799|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
30778415|NCT03465878|58789800|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
30853805|NCT00105157|58881201|FG001|Double-Blind (DB)|Never Treated|0|||
30853806|NCT00105157|58881202|FG002|Double-Blind (DB)|Never Treated|0|||
30853807|NCT00105157|58881203|FG003|Double-Blind (DB)|Never Treated|0|||
30853808|NCT00105157|58881200|FG000|Double-Blind (DB)|Adverse Event|2|||
30853809|NCT00105157|58881201|FG001|Double-Blind (DB)|Adverse Event|0|||
30853810|NCT00105157|58881202|FG002|Double-Blind (DB)|Adverse Event|1|||
30853811|NCT00105157|58881203|FG003|Double-Blind (DB)|Adverse Event|1|||
30853812|NCT00105157|58881200|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
30778416|NCT03465878|58789797|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
30778417|NCT03465878|58789798|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
30778418|NCT03465878|58789799|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
30778419|NCT03465878|58789800|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
30778420|NCT03637374|58789828|FG000|Overall Study|Death|2|||
30778421|NCT03637374|58789829|FG001|Overall Study|Death|0|||
30778422|NCT03421730|58789835|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
30778423|NCT03421730|58789836|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
30778424|NCT03421730|58789837|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
30778425|NCT03421730|58789838|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
30778426|NCT03421730|58789839|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
30778427|NCT03421730|58789840|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
30778428|NCT03421730|58789841|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
30778429|NCT03421730|58789842|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
30778430|NCT03421730|58789843|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
30778431|NCT03421730|58789844|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
30778432|NCT03421730|58789845|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
30778433|NCT03421730|58789846|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
30778434|NCT03421730|58789835|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
30778435|NCT03421730|58789836|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
30778436|NCT03421730|58789837|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
30778437|NCT03421730|58789838|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
30778438|NCT03421730|58789839|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
30778439|NCT03421730|58789840|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
30778440|NCT03421730|58789841|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
30778441|NCT03421730|58789842|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
30778442|NCT03421730|58789843|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
30778443|NCT03421730|58789844|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
30778444|NCT03421730|58789845|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
30778445|NCT03421730|58789846|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
30778446|NCT00054327|58789866|FG000|Overall Study|Engraftment failure|1|||
30778447|NCT00054327|58789867|FG001|Overall Study|Engraftment failure|0|||
30778448|NCT00054327|58789868|FG002|Overall Study|Engraftment failure|0|||
30778449|NCT00054327|58789869|FG003|Overall Study|Engraftment failure|0|||
30778450|NCT00054327|58789870|FG004|Overall Study|Engraftment failure|0|||
30778451|NCT00054327|58789871|FG005|Overall Study|Engraftment failure|0|||
30778452|NCT03503162|58789885|FG000|Overall Study|did not meet eligibility|1|||
30778453|NCT03029650|58789889|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
30778454|NCT03029650|58789890|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
30778455|NCT03029650|58789889|FG000|Washout (1 Week)|Physician Decision|0|||
30778456|NCT03029650|58789890|FG001|Washout (1 Week)|Physician Decision|1|||
30778457|NCT03462680|58789902|FG000|Overall Study|Withdrawal by Subject|3|||
30778458|NCT03462680|58789903|FG001|Overall Study|Withdrawal by Subject|5|||
30778459|NCT03636906|58789912|FG000|Overall Study|Adverse Event|0|||
30778460|NCT03636906|58789913|FG001|Overall Study|Adverse Event|0|||
30778461|NCT03636906|58789914|FG002|Overall Study|Adverse Event|1|||
30853813|NCT00105157|58881201|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
30853814|NCT00105157|58881202|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
30778462|NCT03636906|58789912|FG000|Overall Study|Lost to Follow-up|1|||
30778463|NCT03636906|58789913|FG001|Overall Study|Lost to Follow-up|0|||
30778464|NCT03636906|58789914|FG002|Overall Study|Lost to Follow-up|0|||
30778465|NCT03636906|58789912|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
30778466|NCT03636906|58789913|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
30778467|NCT03636906|58789914|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
30778468|NCT03636906|58789912|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
30853815|NCT00105157|58881203|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
30853816|NCT00105157|58881200|FG000|Open-Label Continuation of DB|Adverse Event|3|||
30853817|NCT00105157|58881201|FG001|Open-Label Continuation of DB|Adverse Event|1|||
30853818|NCT00105157|58881202|FG002|Open-Label Continuation of DB|Adverse Event|0|||
30853819|NCT00105157|58881203|FG003|Open-Label Continuation of DB|Adverse Event|0|||
30853820|NCT00105157|58881200|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
30853821|NCT00105157|58881201|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
30853822|NCT00105157|58881202|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
30853823|NCT00105157|58881203|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
30853824|NCT00105157|58881200|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
30853825|NCT00105157|58881201|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
30853826|NCT00105157|58881202|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
30853827|NCT00105157|58881203|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
30853828|NCT00105157|58881200|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
30853829|NCT00105157|58881201|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
30853830|NCT00105157|58881202|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
30853831|NCT00105157|58881203|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
30853832|NCT00105157|58881200|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
30853833|NCT00105157|58881201|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
30853834|NCT00105157|58881202|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
30853835|NCT00105157|58881203|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
30853836|NCT00105157|58881200|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
30853837|NCT00105157|58881201|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
30853838|NCT00105157|58881202|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
30853839|NCT00105157|58881203|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
30853840|NCT00105157|58881200|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
30853841|NCT00105157|58881201|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
30853842|NCT00105157|58881202|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
30853843|NCT00105157|58881203|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
30853844|NCT00105157|58881200|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
30853845|NCT00105157|58881201|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
30853846|NCT00105157|58881202|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
30853847|NCT00105157|58881203|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
30853848|NCT00105157|58881200|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
30853849|NCT00105157|58881201|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
30853850|NCT00105157|58881202|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
30853851|NCT00105157|58881203|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
30853852|NCT00105157|58881200|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
30853853|NCT00105157|58881201|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
30853854|NCT00105157|58881202|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
30853855|NCT00105157|58881203|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
30853856|NCT00105157|58881200|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
30853857|NCT00105157|58881201|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
30853858|NCT00105157|58881202|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
30853859|NCT00105157|58881203|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
30853860|NCT02148133|58881224|FG000|Overall Study|Investigator discretion|1|||
30853861|NCT02148133|58881224|FG000|Overall Study|Lack of Efficacy|1|||
30778469|NCT03636906|58789913|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
30778470|NCT03636906|58789914|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
30778471|NCT03636906|58789912|FG000|Overall Study|Other|0|||
30778472|NCT03636906|58789913|FG001|Overall Study|Other|0|||
30778473|NCT03636906|58789914|FG002|Overall Study|Other|1|||
30778474|NCT03028870|58789932|FG000|Overall Study|Adverse Event|7|||
30778475|NCT03028870|58789933|FG001|Overall Study|Adverse Event|4|||
30778476|NCT03028870|58789934|FG002|Overall Study|Adverse Event|3|||
30778477|NCT03028870|58789935|FG003|Overall Study|Adverse Event|3|||
30778478|NCT03028870|58789932|FG000|Overall Study|Withdrawal by Subject|1|||
30778479|NCT03028870|58789933|FG001|Overall Study|Withdrawal by Subject|1|||
30778480|NCT03028870|58789934|FG002|Overall Study|Withdrawal by Subject|1|||
30778481|NCT03028870|58789935|FG003|Overall Study|Withdrawal by Subject|2|||
30778482|NCT03028870|58789932|FG000|Overall Study|Lost to Follow-up|1|||
30778483|NCT03028870|58789933|FG001|Overall Study|Lost to Follow-up|0|||
30778484|NCT03028870|58789934|FG002|Overall Study|Lost to Follow-up|0|||
30778485|NCT03028870|58789935|FG003|Overall Study|Lost to Follow-up|0|||
30778486|NCT03028870|58789932|FG000|Overall Study|Lack of Efficacy|3|||
30778487|NCT03028870|58789933|FG001|Overall Study|Lack of Efficacy|0|||
30778488|NCT03028870|58789934|FG002|Overall Study|Lack of Efficacy|0|||
30778489|NCT03028870|58789935|FG003|Overall Study|Lack of Efficacy|0|||
30778490|NCT03028870|58789932|FG000|Overall Study|Administrative|5|||
30778491|NCT03028870|58789933|FG001|Overall Study|Administrative|5|||
30778492|NCT03028870|58789934|FG002|Overall Study|Administrative|12|||
30957214|NCT01740791|59020488|FG005|Overall Study|Adverse Event|1|||
30853862|NCT02148133|58881224|FG000|Overall Study|Protocol deviation|1|||
30853863|NCT02148133|58881224|FG000|Overall Study|Protocol-defined stopping criteria|2|||
30853864|NCT00803569|58881228|FG000|Overall Study|Progressive Disease|3|||
30853865|NCT00803569|58881228|FG000|Overall Study|Noncompliance|1|||
30853866|NCT00112957|58881232|FG000|Overall Study|Progressive disease|18|||
30853867|NCT00112957|58881232|FG000|Overall Study|Physician Decision|1|||
30853868|NCT02376790|58881239|FG000|Overall Study|Withdrawal by Subject|43|||
30853869|NCT02376790|58881240|FG001|Overall Study|Withdrawal by Subject|36|||
30853870|NCT02376790|58881241|FG002|Overall Study|Withdrawal by Subject|37|||
30853871|NCT02376790|58881239|FG000|Overall Study|Decision by Sponsor|2|||
30957215|NCT01740323|59020545|FG000|Overall Study|Adverse Event|1|||
30957216|NCT01740323|59020546|FG001|Overall Study|Adverse Event|0|||
30853872|NCT02376790|58881240|FG001|Overall Study|Decision by Sponsor|1|||
30853873|NCT02376790|58881241|FG002|Overall Study|Decision by Sponsor|4|||
30853874|NCT02376790|58881239|FG000|Overall Study|Lost to Follow-up|15|||
30853875|NCT02376790|58881240|FG001|Overall Study|Lost to Follow-up|10|||
30853876|NCT02376790|58881241|FG002|Overall Study|Lost to Follow-up|12|||
30662855|NCT00909779|58676509|FG001|Overall Study|Site Ceasing Operation|2|||
30662856|NCT00909779|58676508|FG000|Overall Study|Medical Monitor Decision|1|||
30662857|NCT00909779|58676509|FG001|Overall Study|Medical Monitor Decision|0|||
30957217|NCT01740323|59020545|FG000|Overall Study|Randomized but did not take study drug|1|||
30957218|NCT01740323|59020546|FG001|Overall Study|Randomized but did not take study drug|0|||
30957219|NCT01740089|59020564|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
30957220|NCT01740089|59020565|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
30957221|NCT01740089|59020566|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
30957222|NCT01740089|59020564|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
30957223|NCT01740089|59020565|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
30957224|NCT01740089|59020566|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
30957225|NCT01740089|59020564|FG000|After 12 Weeks|Lack of Efficacy|3|||
30957226|NCT01740089|59020565|FG001|After 12 Weeks|Lack of Efficacy|1|||
30957227|NCT01740089|59020566|FG002|After 12 Weeks|Lack of Efficacy|4|||
30853877|NCT02376166|58881249|FG000|Overall Study|Adverse Event|1|||
30957228|NCT01740089|59020564|FG000|After 12 Weeks|Adverse Event|2|||
30957229|NCT01740089|59020565|FG001|After 12 Weeks|Adverse Event|0|||
30957230|NCT01740089|59020566|FG002|After 12 Weeks|Adverse Event|5|||
30957231|NCT01740089|59020564|FG000|After 12 Weeks|Protocol Violation|1|||
30957232|NCT01740089|59020565|FG001|After 12 Weeks|Protocol Violation|1|||
30957233|NCT01740089|59020566|FG002|After 12 Weeks|Protocol Violation|1|||
30957234|NCT01740089|59020564|FG000|After 12 Weeks|Withdrawal by Subject|1|||
30957235|NCT01740089|59020565|FG001|After 12 Weeks|Withdrawal by Subject|1|||
30853878|NCT02376166|58881249|FG000|Overall Study|Discontinued metformin early|2|||
30853879|NCT02311894|58881253|FG000|Overall Study|Discontinued in error|1|||
30853880|NCT02311894|58881253|FG000|Overall Study|Lost to Follow-up|1|||
30853881|NCT02311894|58881253|FG000|Overall Study|Adverse Event|1|||
30853882|NCT02311894|58881253|FG000|Overall Study|Withdrawal by Subject|1|||
30853883|NCT02310646|58881259|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
30853884|NCT02310646|58881260|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
30853885|NCT02310646|58881259|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
30957236|NCT01740089|59020566|FG002|After 12 Weeks|Withdrawal by Subject|1|||
30957237|NCT01739933|59020577|FG000|Overall Study|Death|89|||
30662858|NCT00909779|58676508|FG000|Overall Study|Noncompliance|1|||
30662859|NCT00909779|58676509|FG001|Overall Study|Noncompliance|1|||
30957238|NCT01739933|59020578|FG001|Overall Study|Death|86|||
30957239|NCT01739933|59020577|FG000|Overall Study|Withdrawal by Subject|10|||
30957240|NCT01739933|59020578|FG001|Overall Study|Withdrawal by Subject|8|||
30957241|NCT01739933|59020577|FG000|Overall Study|Lost to Follow-up|3|||
30957242|NCT01739933|59020578|FG001|Overall Study|Lost to Follow-up|10|||
30957243|NCT01739933|59020577|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
30957244|NCT01739933|59020578|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
30957245|NCT01738919|59020595|FG000|Overall Study|Lost to Follow-up|1|||
30662860|NCT00909779|58676508|FG000|Overall Study|Randomized in error|1|||
30662861|NCT00909779|58676509|FG001|Overall Study|Randomized in error|1|||
30662862|NCT00910871|58676517|FG000|Overall Study|Adverse Event|5|||
30662863|NCT00910871|58676517|FG000|Overall Study|Death|12|||
30853886|NCT02310646|58881260|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
30853887|NCT02375698|58881284|FG000|Overall Study|Withdrawal by Subject|0|||
30853888|NCT02375698|58881285|FG001|Overall Study|Withdrawal by Subject|2|||
30853889|NCT02375698|58881284|FG000|Overall Study|Physician Decision|2|||
30957246|NCT01738919|59020596|FG001|Overall Study|Lost to Follow-up|0|||
30957247|NCT01738919|59020595|FG000|Overall Study|Immigrated|0|||
30957248|NCT01738919|59020596|FG001|Overall Study|Immigrated|1|||
30957249|NCT01738919|59020595|FG000|Overall Study|Withdrawal by Subject|0|||
30957250|NCT01738919|59020596|FG001|Overall Study|Withdrawal by Subject|1|||
30662864|NCT00910871|58676517|FG000|Overall Study|Lost to Follow-up|8|||
30853890|NCT02375698|58881285|FG001|Overall Study|Physician Decision|0|||
30957251|NCT01738919|59020595|FG000|Overall Study|Not treated in accordance to guidelines|0|||
30957252|NCT01738919|59020596|FG001|Overall Study|Not treated in accordance to guidelines|1|||
30957253|NCT01712399|59020617|FG000|Overall Study|Lost to Follow-up|1|||
30957254|NCT01712399|59020617|FG000|Overall Study|Withdrawal by Subject|39|||
30957255|NCT01712399|59020617|FG000|Overall Study|Death|1|||
30957256|NCT01712399|59020617|FG000|Overall Study|Adverse Event|11|||
30957257|NCT01712399|59020617|FG000|Overall Study|Study closure|345|||
30957258|NCT03225846|59020724|FG000|Overall Study|Adverse Event|0|||
30957259|NCT03225846|59020725|FG001|Overall Study|Adverse Event|0|||
30957260|NCT03225846|59020726|FG002|Overall Study|Adverse Event|0|||
30957261|NCT03225846|59020727|FG003|Overall Study|Adverse Event|0|||
30957262|NCT03225846|59020728|FG004|Overall Study|Adverse Event|0|||
30957263|NCT03225846|59020729|FG005|Overall Study|Adverse Event|0|||
30957264|NCT03225846|59020730|FG006|Overall Study|Adverse Event|6|||
30957265|NCT03225846|59020724|FG000|Overall Study|Withdrawal by Subject|0|||
30957266|NCT03225846|59020725|FG001|Overall Study|Withdrawal by Subject|1|||
30957267|NCT03225846|59020726|FG002|Overall Study|Withdrawal by Subject|0|||
30957268|NCT03225846|59020727|FG003|Overall Study|Withdrawal by Subject|0|||
30778493|NCT03028870|58789935|FG003|Overall Study|Administrative|4|||
30778494|NCT03663582|58789945|FG000|Overall Study|Physician Decision|1|||
30778495|NCT03502616|58789951|FG000|Up to Week 16|Withdrawal by Subject|1|||
30778496|NCT03502616|58789952|FG001|Up to Week 16|Withdrawal by Subject|2|||
30778497|NCT03502616|58789951|FG000|Up to Week 16|Lost to Follow-up|0|||
30957269|NCT03225846|59020728|FG004|Overall Study|Withdrawal by Subject|0|||
30957270|NCT03225846|59020729|FG005|Overall Study|Withdrawal by Subject|0|||
30957271|NCT03225846|59020730|FG006|Overall Study|Withdrawal by Subject|0|||
30957272|NCT03225846|59020724|FG000|Overall Study|Death|0|||
30778498|NCT03502616|58789952|FG001|Up to Week 16|Lost to Follow-up|1|||
30957273|NCT03225846|59020725|FG001|Overall Study|Death|1|||
30957274|NCT03225846|59020726|FG002|Overall Study|Death|0|||
30957275|NCT03225846|59020727|FG003|Overall Study|Death|0|||
30957276|NCT03225846|59020728|FG004|Overall Study|Death|0|||
30957277|NCT03225846|59020729|FG005|Overall Study|Death|0|||
30957278|NCT03225846|59020730|FG006|Overall Study|Death|0|||
30957279|NCT03225846|59020724|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
30957280|NCT03225846|59020725|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
30957281|NCT03225846|59020726|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
30957282|NCT03225846|59020727|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
30957283|NCT03225846|59020728|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
30957284|NCT03225846|59020729|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
30957285|NCT03225846|59020730|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
30957286|NCT03225846|59020724|FG000|Overall Study|Patient decision|0|||
30957287|NCT03225846|59020725|FG001|Overall Study|Patient decision|0|||
30957288|NCT03225846|59020726|FG002|Overall Study|Patient decision|0|||
30957289|NCT03225846|59020727|FG003|Overall Study|Patient decision|0|||
30957290|NCT03225846|59020728|FG004|Overall Study|Patient decision|0|||
30957291|NCT03225846|59020729|FG005|Overall Study|Patient decision|0|||
30957292|NCT03225846|59020730|FG006|Overall Study|Patient decision|1|||
30957293|NCT01712009|59020795|FG000|Overall Study|Withdrawal by Subject|24|||
30957294|NCT01712009|59020796|FG001|Overall Study|Withdrawal by Subject|15|||
30957295|NCT01712009|59020797|FG002|Overall Study|Withdrawal by Subject|8|||
30957296|NCT01712009|59020795|FG000|Overall Study|Lost to Follow-up|2|||
30957297|NCT01712009|59020796|FG001|Overall Study|Lost to Follow-up|0|||
30662865|NCT00910871|58676517|FG000|Overall Study|Protocol Violation|11|||
30778499|NCT03502616|58789951|FG000|Up to Week 16|Randomized, but not treated|1|||
30778500|NCT03502616|58789952|FG001|Up to Week 16|Randomized, but not treated|0|||
30778501|NCT03502616|58789951|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
30778502|NCT03502616|58789952|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
30957298|NCT01712009|59020797|FG002|Overall Study|Lost to Follow-up|1|||
30662866|NCT00910871|58676517|FG000|Overall Study|Withdrawal by Subject|12|||
30662867|NCT00910871|58676517|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
30957299|NCT01712009|59020795|FG000|Overall Study|Decision by Sponsor|12|||
30662868|NCT00910871|58676517|FG000|Overall Study|Undefined|1|||
30662869|NCT02631941|58676542|FG000|Overall Study|Physician Decision|0|||
30662870|NCT02631941|58676543|FG001|Overall Study|Physician Decision|1|||
30778503|NCT03502616|58789951|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
30778504|NCT03502616|58789952|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
30778505|NCT03028012|58789973|FG000|Overall Study|Lost to Follow-up|2|||
30778506|NCT03028012|58789974|FG001|Overall Study|Lost to Follow-up|3|||
30778507|NCT03028012|58789975|FG002|Overall Study|Lost to Follow-up|3|||
30778508|NCT03635190|58789984|FG000|Overall Study|Lost to Follow-up|4|||
30778509|NCT03635190|58789984|FG000|Overall Study|Death|3|||
30778510|NCT03635190|58789984|FG000|Overall Study|Withdrawal by Subject|1|||
30778511|NCT03635190|58789984|FG000|Overall Study|Patient moved and did not return for follow up|1|||
30957300|NCT01712009|59020796|FG001|Overall Study|Decision by Sponsor|14|||
30957301|NCT01712009|59020797|FG002|Overall Study|Decision by Sponsor|12|||
30957302|NCT01711853|59020826|FG000|Overall Study|Not treated|3|||
30957303|NCT01708187|59020832|FG000|Overall Study|Lost to Follow-up|0|||
30957304|NCT01708187|59020833|FG001|Overall Study|Lost to Follow-up|1|||
30778512|NCT03634800|58789991|FG000|Overall Study|Adverse Event|1|||
30778513|NCT03634800|58789991|FG000|Overall Study|Disease Progression|4|||
30778514|NCT03634800|58789991|FG000|Overall Study|Withdrawal by Subject|1|||
30778515|NCT03027466|58789999|FG000|Overall Study|Opting out of the app|1869|||
30957305|NCT01740401|59020909|FG000|Overall Study|Progression of disease|6|||
30957306|NCT01740401|59020909|FG000|Overall Study|Adverse Event|2|||
30957307|NCT01740401|59020909|FG000|Overall Study|Did not reach primary endpoint|2|||
30957308|NCT01711619|59020930|FG000|Overall Study|Early study termination|10|||
30957309|NCT01711619|59020931|FG001|Overall Study|Early study termination|14|||
30957310|NCT01711619|59020930|FG000|Overall Study|Withdrawal by Subject|3|||
30957311|NCT01711619|59020931|FG001|Overall Study|Withdrawal by Subject|7|||
30957312|NCT01711619|59020930|FG000|Overall Study|Protocol Violation|2|||
30957313|NCT01711619|59020931|FG001|Overall Study|Protocol Violation|3|||
30957314|NCT01711619|59020930|FG000|Overall Study|Adverse Event|2|||
30957315|NCT01711619|59020931|FG001|Overall Study|Adverse Event|0|||
30957316|NCT01711619|59020930|FG000|Overall Study|Lost to Follow-up|1|||
30957317|NCT01711619|59020931|FG001|Overall Study|Lost to Follow-up|0|||
30957318|NCT01710527|59020946|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
30957319|NCT01710527|59020947|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
30957320|NCT01706939|59020955|FG000|Pre Randomization|Screen Failure|1|||
30957321|NCT01706939|59020956|FG001|Pre Randomization|Screen Failure|0|||
30957322|NCT01706939|59020957|FG002|Pre Randomization|Screen Failure|0|||
30957323|NCT01706939|59020955|FG000|Pre Randomization|Ineligible for Randomization|1|||
30957324|NCT01706939|59020956|FG001|Pre Randomization|Ineligible for Randomization|0|||
30957325|NCT01706939|59020957|FG002|Pre Randomization|Ineligible for Randomization|0|||
30957326|NCT01706939|59020955|FG000|Pre Randomization|Withdrawal by Subject|1|||
30957327|NCT01706939|59020956|FG001|Pre Randomization|Withdrawal by Subject|0|||
30957328|NCT01706939|59020957|FG002|Pre Randomization|Withdrawal by Subject|0|||
30957329|NCT01706939|59020955|FG000|Randomization|Insufficient QoL survey compliance|0|||
30957330|NCT01706939|59020956|FG001|Randomization|Insufficient QoL survey compliance|1|||
30957331|NCT01706939|59020957|FG002|Randomization|Insufficient QoL survey compliance|1|||
30957332|NCT01706939|59020955|FG000|Randomization|Progression of disease|0|||
30957333|NCT01706939|59020956|FG001|Randomization|Progression of disease|2|||
30957334|NCT01706939|59020957|FG002|Randomization|Progression of disease|1|||
30957335|NCT01709903|59020966|FG000|Overall Study|administrative problems|2|||
30957336|NCT01709903|59020967|FG001|Overall Study|administrative problems|6|||
30957337|NCT01709903|59020966|FG000|Overall Study|Abnormal test procedure results|1|||
30957338|NCT01709903|59020967|FG001|Overall Study|Abnormal test procedure results|0|||
30957339|NCT01709903|59020966|FG000|Overall Study|In ability to use device|1|||
30957340|NCT01709903|59020967|FG001|Overall Study|In ability to use device|1|||
30957341|NCT01709903|59020966|FG000|Overall Study|no longer needed study drug|0|||
30957342|NCT01709903|59020967|FG001|Overall Study|no longer needed study drug|1|||
30957343|NCT01709903|59020966|FG000|Overall Study|Lost to Follow-up|0|||
30957344|NCT01709903|59020967|FG001|Overall Study|Lost to Follow-up|2|||
30957345|NCT01709903|59020966|FG000|Overall Study|Death|2|||
30957346|NCT01709903|59020967|FG001|Overall Study|Death|0|||
30957347|NCT01709903|59020966|FG000|Overall Study|Protocol Violation|3|||
30957348|NCT01709903|59020967|FG001|Overall Study|Protocol Violation|2|||
30957349|NCT01709903|59020966|FG000|Overall Study|Lack of Efficacy|3|||
30957350|NCT01709903|59020967|FG001|Overall Study|Lack of Efficacy|3|||
30957351|NCT01709903|59020966|FG000|Overall Study|Withdrawal by Subject|6|||
30957352|NCT01709903|59020967|FG001|Overall Study|Withdrawal by Subject|6|||
30957353|NCT01709903|59020966|FG000|Overall Study|Adverse Event|11|||
30957354|NCT01709903|59020967|FG001|Overall Study|Adverse Event|18|||
30957355|NCT04492618|59020973|FG000|Overall Study|Withdrawal by Subject|1|||
30957356|NCT01605227|59020979|FG000|Overall Study|Did not receive study treatment|2|||
30957357|NCT01605227|59020980|FG001|Overall Study|Did not receive study treatment|3|||
30957358|NCT01605227|59020979|FG000|Overall Study|Adverse Event|228|||
30853891|NCT02374918|58881295|FG000|Overall Study|Protocol Violation|2|||
30853892|NCT02374918|58881296|FG001|Overall Study|Protocol Violation|0|||
30853893|NCT02374918|58881297|FG002|Overall Study|Protocol Violation|2|||
30853894|NCT02374918|58881298|FG003|Overall Study|Protocol Violation|1|||
30853895|NCT02374918|58881295|FG000|Overall Study|Withdrawal by Subject|1|||
30853896|NCT02374918|58881296|FG001|Overall Study|Withdrawal by Subject|1|||
30853897|NCT02374918|58881297|FG002|Overall Study|Withdrawal by Subject|1|||
30853898|NCT02374918|58881298|FG003|Overall Study|Withdrawal by Subject|0|||
30853899|NCT02374918|58881295|FG000|Overall Study|Lack of Efficacy|0|||
30853900|NCT02374918|58881296|FG001|Overall Study|Lack of Efficacy|0|||
30957359|NCT01605227|59020980|FG001|Overall Study|Adverse Event|42|||
30957360|NCT01605227|59020979|FG000|Overall Study|Progressive Disease|132|||
30957361|NCT01605227|59020980|FG001|Overall Study|Progressive Disease|128|||
30957362|NCT01605227|59020979|FG000|Overall Study|Clinical Deterioration|227|||
30957363|NCT01605227|59020980|FG001|Overall Study|Clinical Deterioration|133|||
30957364|NCT01605227|59020979|FG000|Overall Study|Lost to Follow-up|1|||
30957365|NCT01605227|59020980|FG001|Overall Study|Lost to Follow-up|0|||
30957366|NCT01605227|59020979|FG000|Overall Study|Protocol Violation|1|||
30853901|NCT02374918|58881297|FG002|Overall Study|Lack of Efficacy|1|||
30853902|NCT02374918|58881298|FG003|Overall Study|Lack of Efficacy|1|||
30957367|NCT01605227|59020980|FG001|Overall Study|Protocol Violation|0|||
30957368|NCT01605227|59020979|FG000|Overall Study|Physician Decision|9|||
30957369|NCT01605227|59020980|FG001|Overall Study|Physician Decision|7|||
30957370|NCT01605227|59020979|FG000|Overall Study|Withdrawal by Subject|18|||
30957371|NCT01605227|59020980|FG001|Overall Study|Withdrawal by Subject|14|||
30957372|NCT01605227|59020979|FG000|Overall Study|Sponsor Decision|2|||
30957373|NCT01605227|59020980|FG001|Overall Study|Sponsor Decision|0|||
30957374|NCT01605227|59020979|FG000|Overall Study|Started New Therapy|1|||
30957375|NCT01605227|59020980|FG001|Overall Study|Started New Therapy|0|||
30957376|NCT01605227|59020979|FG000|Overall Study|Subject Decision|0|||
30957377|NCT01605227|59020980|FG001|Overall Study|Subject Decision|1|||
30957378|NCT01605227|59020979|FG000|Overall Study|Dose Held >6 weeks|0|||
30957379|NCT01605227|59020980|FG001|Overall Study|Dose Held >6 weeks|1|||
30957380|NCT01709513|59020989|FG000|Overall Study|Randomized but not treated|0|||
30957381|NCT01709513|59020990|FG001|Overall Study|Randomized but not treated|1|||
30957382|NCT01709513|59020991|FG002|Overall Study|Randomized but not treated|0|||
30957383|NCT01709513|59020989|FG000|Overall Study|Adverse Event|16|||
30957384|NCT01709513|59020990|FG001|Overall Study|Adverse Event|31|||
30778516|NCT03027466|58790000|FG001|Overall Study|Opting out of the app|1819|||
30778517|NCT03027466|58790001|FG002|Overall Study|Opting out of the app|1743|||
30778518|NCT03027466|58790002|FG003|Overall Study|Opting out of the app|1821|||
30778519|NCT03662334|58790014|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
30957385|NCT01709513|59020991|FG002|Overall Study|Adverse Event|23|||
30778520|NCT03662334|58790015|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
30778521|NCT02955186|58790023|FG000|Overall Study|Withdrawal by Subject|6|||
30778522|NCT02955186|58790024|FG001|Overall Study|Withdrawal by Subject|2|||
30778523|NCT02955186|58790023|FG000|Overall Study|Protocol Violation|1|||
30853903|NCT02344576|58881310|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
30957386|NCT01709513|59020989|FG000|Overall Study|Poor compliance to protocol|2|||
30957387|NCT01709513|59020990|FG001|Overall Study|Poor compliance to protocol|0|||
30957388|NCT01709513|59020991|FG002|Overall Study|Poor compliance to protocol|0|||
30957389|NCT01709513|59020989|FG000|Overall Study|Other|3|||
30778524|NCT02955186|58790024|FG001|Overall Study|Protocol Violation|0|||
30957390|NCT01709513|59020990|FG001|Overall Study|Other|11|||
30957391|NCT01709513|59020991|FG002|Overall Study|Other|7|||
30853904|NCT02344576|58881311|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
30853905|NCT02344576|58881312|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
30853906|NCT02344576|58881313|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
30853907|NCT02344576|58881310|FG000|1-Month Follow-Up|Death|13|||
30853908|NCT02344576|58881311|FG001|1-Month Follow-Up|Death|8|||
30853909|NCT02344576|58881312|FG002|1-Month Follow-Up|Death|0|||
30853910|NCT02344576|58881313|FG003|1-Month Follow-Up|Death|0|||
30853911|NCT02344576|58881310|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
30853912|NCT02344576|58881311|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
30853913|NCT02344576|58881312|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
30853914|NCT02344576|58881313|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
30853915|NCT02344576|58881310|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
30853916|NCT02344576|58881311|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
30853917|NCT02344576|58881312|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
30853918|NCT02344576|58881313|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
30853919|NCT02344576|58881310|FG000|6-Month Follow-Up|Death|14|||
30957392|NCT01605071|59021004|FG000|Overall Study|Withdrawal by Subject|3|||
30662871|NCT02631941|58676544|FG002|Overall Study|Physician Decision|0|||
30853920|NCT02344576|58881311|FG001|6-Month Follow-Up|Death|14|||
30853921|NCT02344576|58881312|FG002|6-Month Follow-Up|Death|0|||
30853922|NCT02344576|58881313|FG003|6-Month Follow-Up|Death|0|||
30957393|NCT01605071|59021005|FG001|Overall Study|Withdrawal by Subject|2|||
30853923|NCT02344576|58881310|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
30957394|NCT02710422|59021015|FG000|Overall Study|Termination of study|9|||
30957395|NCT02710422|59021016|FG001|Overall Study|Termination of study|9|||
30957396|NCT01706159|59021026|FG000|Overall Study|Withdrawal Criteria|2|||
30957397|NCT01706159|59021027|FG001|Overall Study|Withdrawal Criteria|1|||
30957398|NCT01706159|59021026|FG000|Overall Study|Unclassified|6|||
30957399|NCT01706159|59021027|FG001|Overall Study|Unclassified|1|||
30957400|NCT01706003|59021035|FG000|Overall Study|Withdrawal by Subject|2|||
30957401|NCT01706003|59021036|FG001|Overall Study|Withdrawal by Subject|0|||
30957402|NCT01706003|59021035|FG000|Overall Study|Not scheduled|3|||
30957403|NCT01706003|59021036|FG001|Overall Study|Not scheduled|0|||
30957404|NCT01706003|59021035|FG000|Overall Study|Lost to Follow-up|6|||
30957405|NCT01706003|59021036|FG001|Overall Study|Lost to Follow-up|4|||
30957406|NCT01705691|59021044|FG000|Overall Study|Death|1|||
30853924|NCT02344576|58881311|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
30853925|NCT02344576|58881312|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
30853926|NCT02344576|58881313|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
30853927|NCT02344576|58881310|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
30853928|NCT02344576|58881311|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
30853929|NCT02344576|58881312|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
30853930|NCT02344576|58881313|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
30853931|NCT02344342|58881329|FG000|Overall Study|Industry partner dropped out|11|||
30853932|NCT02344342|58881330|FG001|Overall Study|Industry partner dropped out|9|||
30853933|NCT02344342|58881331|FG002|Overall Study|Industry partner dropped out|14|||
30853934|NCT02344342|58881332|FG003|Overall Study|Industry partner dropped out|10|||
30853935|NCT02343952|58881346|FG000|Study Treatment|Disease Progression|23|||
30853936|NCT02343952|58881346|FG000|Study Treatment|Death|3|||
30853937|NCT02343952|58881346|FG000|Study Treatment|Adverse Event|19|||
30853938|NCT02343952|58881346|FG000|Study Treatment|Withdrawal by Subject|7|||
30853939|NCT02343952|58881346|FG000|Study Treatment|other complicating Diseases|1|||
30853940|NCT02343952|58881346|FG000|Follow up|Withdrawal by Subject|3|||
30853941|NCT02343952|58881346|FG000|Follow up|Death|33|||
30853942|NCT02343952|58881346|FG000|Follow up|Patient does not meet eligibility for study.|1|||
30853943|NCT02343952|58881346|FG000|Follow up|Research department closed by the practice.|5|||
30853944|NCT02343952|58881346|FG000|Follow up|Patient went home to Russia|1|||
30853945|NCT02343952|58881346|FG000|Follow up|Disease Progression|1|||
30853946|NCT02343952|58881346|FG000|Follow up|study terminated|1|||
30853947|NCT02310568|58881355|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
30853948|NCT02310568|58881356|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
30853949|NCT02310568|58881357|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
30853950|NCT02310568|58881358|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
30853951|NCT02310568|58881359|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
30853952|NCT02310568|58881355|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
30853953|NCT02310568|58881356|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
30853954|NCT02310568|58881357|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
30853955|NCT02310568|58881358|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
30853956|NCT02310568|58881359|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
30853957|NCT02310568|58881355|FG000|Stage 1 ( 4 Weeks)|Other|1|||
30853958|NCT02310568|58881356|FG001|Stage 1 ( 4 Weeks)|Other|1|||
30853959|NCT02310568|58881357|FG002|Stage 1 ( 4 Weeks)|Other|0|||
30853960|NCT02310568|58881358|FG003|Stage 1 ( 4 Weeks)|Other|0|||
30853961|NCT02310568|58881359|FG004|Stage 1 ( 4 Weeks)|Other|0|||
30853962|NCT02310568|58881355|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
30853963|NCT02310568|58881356|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
30853964|NCT02310568|58881357|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
30853965|NCT02310568|58881358|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
30853966|NCT02310568|58881359|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
30853967|NCT02310568|58881355|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
30853968|NCT02310568|58881356|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
30853969|NCT02310568|58881357|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
30853970|NCT02310568|58881358|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
30853971|NCT02310568|58881359|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
30853972|NCT02310568|58881355|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
30853973|NCT02310568|58881356|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
30853974|NCT02310568|58881357|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
30853975|NCT02310568|58881358|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
30853976|NCT02310568|58881359|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
30853977|NCT02310568|58881355|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
30853978|NCT02310568|58881356|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
30957407|NCT01705691|59021045|FG001|Overall Study|Death|2|||
30957408|NCT01705691|59021044|FG000|Overall Study|Withdrawal by Subject|1|||
30957409|NCT01705691|59021045|FG001|Overall Study|Withdrawal by Subject|2|||
30853979|NCT02310568|58881357|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
30853980|NCT02310568|58881358|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
30853981|NCT02310568|58881359|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
30853982|NCT02310568|58881355|FG000|Stage 2 (4 Weeks)|Other|0|||
30957410|NCT01705691|59021044|FG000|Overall Study|Lost to Follow-up|1|||
30853983|NCT02310568|58881356|FG001|Stage 2 (4 Weeks)|Other|1|||
30853984|NCT02310568|58881357|FG002|Stage 2 (4 Weeks)|Other|1|||
30957411|NCT01705691|59021045|FG001|Overall Study|Lost to Follow-up|1|||
30957412|NCT01705691|59021044|FG000|Overall Study|Other|0|||
30957413|NCT01705691|59021045|FG001|Overall Study|Other|1|||
30957414|NCT03766906|59021051|FG000|Overall Study|Withdrawal by Subject|6|||
30957415|NCT01705145|59021055|FG000|Part B|Adverse Event|1|||
30957416|NCT01704755|59021073|FG000|Overall Study|Adverse Event|4|||
30957417|NCT01704755|59021074|FG001|Overall Study|Adverse Event|1|||
30957418|NCT01704755|59021073|FG000|Overall Study|Lost to Follow-up|3|||
30957419|NCT01704755|59021074|FG001|Overall Study|Lost to Follow-up|4|||
30957420|NCT01704755|59021073|FG000|Overall Study|Withdrew consent|1|||
30957421|NCT01704755|59021074|FG001|Overall Study|Withdrew consent|1|||
30957422|NCT01704755|59021073|FG000|Overall Study|Other (not specified)|3|||
30957423|NCT01704755|59021074|FG001|Overall Study|Other (not specified)|1|||
30957424|NCT01704755|59021073|FG000|Overall Study|Withdrew consent and personal issues|1|||
30957425|NCT01704755|59021074|FG001|Overall Study|Withdrew consent and personal issues|0|||
30957426|NCT01704599|59021080|FG000|Overall Study|Adverse Event|1|||
30957427|NCT03599518|59021112|FG000|Overall Study|Clinical progression|0|||
30957428|NCT03599518|59021113|FG001|Overall Study|Clinical progression|0|||
30957429|NCT03599518|59021114|FG002|Overall Study|Clinical progression|0|||
30957430|NCT03599518|59021115|FG003|Overall Study|Clinical progression|0|||
30957431|NCT03599518|59021116|FG004|Overall Study|Clinical progression|1|||
30957432|NCT03599518|59021112|FG000|Overall Study|Adverse Event|0|||
30957433|NCT03599518|59021113|FG001|Overall Study|Adverse Event|0|||
30957434|NCT03599518|59021114|FG002|Overall Study|Adverse Event|0|||
30957435|NCT03599518|59021115|FG003|Overall Study|Adverse Event|0|||
30957436|NCT03599518|59021116|FG004|Overall Study|Adverse Event|1|||
30957437|NCT03599518|59021112|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
30957438|NCT03599518|59021113|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
30957439|NCT03599518|59021114|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
30957440|NCT03599518|59021115|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
30957441|NCT03599518|59021116|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
30957442|NCT03599518|59021112|FG000|Overall Study|Participant withdrawal from study treatment|0|||
30957443|NCT03599518|59021113|FG001|Overall Study|Participant withdrawal from study treatment|0|||
30957444|NCT03599518|59021114|FG002|Overall Study|Participant withdrawal from study treatment|1|||
30957445|NCT03599518|59021115|FG003|Overall Study|Participant withdrawal from study treatment|0|||
30957446|NCT03599518|59021116|FG004|Overall Study|Participant withdrawal from study treatment|0|||
30957447|NCT02709486|59021193|FG000|Overall Study|Adverse Event|2|||
30778525|NCT03502070|58790030|FG000|Overall Study|Withdrawal by Subject|1|||
30778526|NCT03502070|58790030|FG000|Overall Study|Screen Failure|1|||
30778527|NCT03586830|58790038|FG000|Overall Study|Site terminated by Sponsor|1|||
30778528|NCT03586830|58790039|FG001|Overall Study|Site terminated by Sponsor|4|||
30778529|NCT03586830|58790040|FG002|Overall Study|Site terminated by Sponsor|3|||
30778530|NCT03586830|58790041|FG003|Overall Study|Site terminated by Sponsor|3|||
30853985|NCT02310568|58881358|FG003|Stage 2 (4 Weeks)|Other|0|||
30853986|NCT02310568|58881359|FG004|Stage 2 (4 Weeks)|Other|0|||
30853987|NCT02310568|58881355|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
30853988|NCT02310568|58881356|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
30853989|NCT02310568|58881357|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
30853990|NCT02310568|58881358|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
30853991|NCT02310568|58881359|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
30853992|NCT02310568|58881355|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
30853993|NCT02310568|58881356|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
30853994|NCT02310568|58881357|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
30853995|NCT02310568|58881358|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
30853996|NCT02310568|58881359|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
30853997|NCT02310568|58881355|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
30957448|NCT02709486|59021194|FG001|Overall Study|Adverse Event|5|||
30957449|NCT02709486|59021195|FG002|Overall Study|Adverse Event|3|||
30957450|NCT02709486|59021193|FG000|Overall Study|Death|0|||
30957451|NCT02709486|59021194|FG001|Overall Study|Death|0|||
30957452|NCT02709486|59021195|FG002|Overall Study|Death|2|||
30853998|NCT02310568|58881356|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
30853999|NCT02310568|58881357|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
30854000|NCT02310568|58881358|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
30854001|NCT02310568|58881359|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
30957453|NCT02709486|59021193|FG000|Overall Study|Insufficient clinical response|7|||
30778531|NCT03586830|58790038|FG000|Overall Study|Lost to Follow-up|0|||
30778532|NCT03586830|58790039|FG001|Overall Study|Lost to Follow-up|2|||
30778533|NCT03586830|58790040|FG002|Overall Study|Lost to Follow-up|2|||
30957454|NCT02709486|59021194|FG001|Overall Study|Insufficient clinical response|3|||
30957455|NCT02709486|59021195|FG002|Overall Study|Insufficient clinical response|3|||
30957456|NCT02709486|59021193|FG000|Overall Study|Lost to Follow-up|3|||
30957457|NCT02709486|59021194|FG001|Overall Study|Lost to Follow-up|2|||
30957458|NCT02709486|59021195|FG002|Overall Study|Lost to Follow-up|2|||
30854002|NCT02310100|58881377|FG000|Overall Study|Physician Decision|3|||
30854003|NCT02310100|58881377|FG000|Overall Study|Withdrawal by Subject|10|||
30854004|NCT02310100|58881377|FG000|Overall Study|Enrollment closure|1|||
30854005|NCT02310100|58881377|FG000|Overall Study|Unapproved ablation operator|1|||
30854006|NCT02310100|58881377|FG000|Overall Study|Visit compliance|1|||
30854007|NCT02310100|58881377|FG000|Overall Study|Lost to Follow-up|2|||
30854008|NCT02780167|58881387|FG000|Overall Study|Adverse Event|9|||
30957459|NCT02709486|59021193|FG000|Overall Study|Other|0|||
30957460|NCT02709486|59021194|FG001|Overall Study|Other|2|||
30957461|NCT02709486|59021195|FG002|Overall Study|Other|3|||
30957462|NCT02709486|59021193|FG000|Overall Study|Withdrawal by Subject|32|||
30957463|NCT02709486|59021194|FG001|Overall Study|Withdrawal by Subject|22|||
30957464|NCT02709486|59021195|FG002|Overall Study|Withdrawal by Subject|32|||
30957465|NCT03110770|59021212|FG000|Overall Study|Death|1|||
30957466|NCT03110770|59021213|FG001|Overall Study|Death|0|||
30957467|NCT03110770|59021214|FG002|Overall Study|Death|0|||
30957468|NCT03110770|59021215|FG003|Overall Study|Death|1|||
30957469|NCT03110770|59021216|FG004|Overall Study|Death|0|||
30957470|NCT03110770|59021212|FG000|Overall Study|Enrolled but did not receive product|0|||
30957471|NCT03110770|59021213|FG001|Overall Study|Enrolled but did not receive product|0|||
30957472|NCT03110770|59021214|FG002|Overall Study|Enrolled but did not receive product|0|||
30957473|NCT03110770|59021215|FG003|Overall Study|Enrolled but did not receive product|8|||
30957474|NCT03110770|59021216|FG004|Overall Study|Enrolled but did not receive product|7|||
30957475|NCT03110770|59021212|FG000|Overall Study|Lost to Follow-up|0|||
30957476|NCT03110770|59021213|FG001|Overall Study|Lost to Follow-up|0|||
30957477|NCT03110770|59021214|FG002|Overall Study|Lost to Follow-up|0|||
30957478|NCT03110770|59021215|FG003|Overall Study|Lost to Follow-up|53|||
30957479|NCT03110770|59021216|FG004|Overall Study|Lost to Follow-up|45|||
30957480|NCT03110770|59021212|FG000|Overall Study|Investigator Decision|0|||
30957481|NCT03110770|59021213|FG001|Overall Study|Investigator Decision|0|||
30957482|NCT03110770|59021214|FG002|Overall Study|Investigator Decision|0|||
30957483|NCT03110770|59021215|FG003|Overall Study|Investigator Decision|5|||
30957484|NCT03110770|59021216|FG004|Overall Study|Investigator Decision|3|||
30957485|NCT03110770|59021212|FG000|Overall Study|Withdrawal by Subject|0|||
30957486|NCT03110770|59021213|FG001|Overall Study|Withdrawal by Subject|0|||
30957487|NCT03110770|59021214|FG002|Overall Study|Withdrawal by Subject|0|||
30957488|NCT03110770|59021215|FG003|Overall Study|Withdrawal by Subject|24|||
30957489|NCT03110770|59021216|FG004|Overall Study|Withdrawal by Subject|24|||
30957490|NCT03110770|59021212|FG000|Overall Study|Moved from area|5|||
30957491|NCT03110770|59021213|FG001|Overall Study|Moved from area|0|||
30957492|NCT03110770|59021214|FG002|Overall Study|Moved from area|2|||
30957493|NCT03110770|59021215|FG003|Overall Study|Moved from area|42|||
30957494|NCT03110770|59021216|FG004|Overall Study|Moved from area|43|||
30957495|NCT03110770|59021212|FG000|Overall Study|Illness/Injury unrelated to product|0|||
30957496|NCT03110770|59021213|FG001|Overall Study|Illness/Injury unrelated to product|0|||
30957497|NCT03110770|59021214|FG002|Overall Study|Illness/Injury unrelated to product|0|||
30957498|NCT03110770|59021215|FG003|Overall Study|Illness/Injury unrelated to product|0|||
30957499|NCT03110770|59021216|FG004|Overall Study|Illness/Injury unrelated to product|1|||
30957500|NCT00703326|59021422|FG000|Overall Study|Lost to Follow-up|47|||
30957501|NCT00703326|59021423|FG001|Overall Study|Lost to Follow-up|18|||
30957502|NCT00703326|59021422|FG000|Overall Study|Withdrawal by Subject|54|||
30957503|NCT00703326|59021423|FG001|Overall Study|Withdrawal by Subject|20|||
30957504|NCT00703326|59021422|FG000|Overall Study|Adverse Event|1|||
30957505|NCT00703326|59021423|FG001|Overall Study|Adverse Event|0|||
30957506|NCT04868500|59021476|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
30854009|NCT02780167|58881388|FG001|Overall Study|Adverse Event|8|||
30957507|NCT04868500|59021477|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
30957508|NCT04868500|59021476|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
30957509|NCT04868500|59021477|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
30957510|NCT04372186|59021485|FG000|Overall Study|Death|24|||
30957511|NCT04372186|59021486|FG001|Overall Study|Death|11|||
30957512|NCT04372186|59021485|FG000|Overall Study|Transferred to a different facility for care|0|||
30957513|NCT04372186|59021486|FG001|Overall Study|Transferred to a different facility for care|2|||
30957514|NCT04317040|59021516|FG000|Overall Study|Lost to Follow-up|2|||
30957515|NCT04317040|59021517|FG001|Overall Study|Lost to Follow-up|0|||
30957516|NCT04317040|59021516|FG000|Overall Study|Death|16|||
30957517|NCT04317040|59021517|FG001|Overall Study|Death|18|||
30957518|NCT04317040|59021516|FG000|Overall Study|Withdrawal by Subject|0|||
30957519|NCT04317040|59021517|FG001|Overall Study|Withdrawal by Subject|1|||
30957520|NCT04317040|59021516|FG000|Overall Study|Incomplete assessments|0|||
30957521|NCT04317040|59021517|FG001|Overall Study|Incomplete assessments|1|||
30957522|NCT00703014|59021597|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
30957523|NCT00703014|59021598|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
30957524|NCT00703014|59021599|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
30957525|NCT00703014|59021600|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
30957526|NCT00703014|59021597|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
30957527|NCT00703014|59021598|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
30957528|NCT00703014|59021599|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
30957529|NCT00703014|59021600|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
30957530|NCT03915496|59021648|FG000|Overall Study|Adverse Event|2|||
30957531|NCT03915496|59021649|FG001|Overall Study|Adverse Event|1|||
30957532|NCT03915496|59021650|FG002|Overall Study|Adverse Event|2|||
30957533|NCT02709330|59021667|FG000|Overall Study|Death|5|||
30957534|NCT02709330|59021668|FG001|Overall Study|Death|0|||
30957535|NCT02709330|59021667|FG000|Overall Study|Lost to Follow-up|2|||
30957536|NCT02709330|59021668|FG001|Overall Study|Lost to Follow-up|0|||
30957537|NCT02709330|59021667|FG000|Overall Study|Physician Decision|2|||
30957538|NCT02709330|59021668|FG001|Overall Study|Physician Decision|0|||
30957539|NCT02709330|59021667|FG000|Overall Study|Withdrawal by Subject|4|||
30957540|NCT02709330|59021668|FG001|Overall Study|Withdrawal by Subject|0|||
30957541|NCT02709096|59021676|FG000|Overall Study|non-compliance|1|||
30957542|NCT02709096|59021677|FG001|Overall Study|non-compliance|1|||
30957543|NCT01372410|59021683|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
30957544|NCT01372410|59021684|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
30957545|NCT01372410|59021685|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
30957546|NCT01372410|59021686|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
30957547|NCT01372410|59021687|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
30957548|NCT01372410|59021688|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
30957549|NCT01372410|59021689|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
30957550|NCT01372410|59021690|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
30957551|NCT01372410|59021683|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
30662872|NCT02631941|58676545|FG003|Overall Study|Physician Decision|0|||
30778534|NCT03586830|58790041|FG003|Overall Study|Lost to Follow-up|1|||
30778535|NCT03586830|58790038|FG000|Overall Study|Withdrawal by Subject|1|||
30778536|NCT03586830|58790039|FG001|Overall Study|Withdrawal by Subject|0|||
30778537|NCT03586830|58790040|FG002|Overall Study|Withdrawal by Subject|3|||
30778538|NCT03586830|58790041|FG003|Overall Study|Withdrawal by Subject|1|||
30778539|NCT03026530|58790053|FG000|Overall Study|Lost to Follow-up|19|||
30957552|NCT01372410|59021684|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
30957553|NCT01372410|59021685|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
30957554|NCT01372410|59021686|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
30778540|NCT03026530|58790054|FG001|Overall Study|Lost to Follow-up|24|||
30778541|NCT03026530|58790053|FG000|Overall Study|Protocol Violation|2|||
30778542|NCT03026530|58790054|FG001|Overall Study|Protocol Violation|5|||
30957555|NCT01372410|59021687|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
30957556|NCT01372410|59021688|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
30957557|NCT01372410|59021689|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
30957558|NCT01372410|59021690|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
30957559|NCT01372410|59021683|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30957560|NCT01372410|59021684|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30957561|NCT01372410|59021685|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30957562|NCT01372410|59021686|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30957563|NCT01372410|59021687|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
30957564|NCT01372410|59021688|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30854010|NCT02780167|58881389|FG002|Overall Study|Adverse Event|8|||
30854011|NCT02780167|58881390|FG003|Overall Study|Adverse Event|12|||
30854012|NCT02780167|58881391|FG004|Overall Study|Adverse Event|8|||
30854013|NCT02780167|58881387|FG000|Overall Study|Lack of Efficacy|6|||
30854014|NCT02780167|58881388|FG001|Overall Study|Lack of Efficacy|5|||
30854015|NCT02780167|58881389|FG002|Overall Study|Lack of Efficacy|6|||
30854016|NCT02780167|58881390|FG003|Overall Study|Lack of Efficacy|1|||
30854017|NCT02780167|58881391|FG004|Overall Study|Lack of Efficacy|0|||
30854018|NCT02780167|58881387|FG000|Overall Study|Lost to Follow-up|2|||
30854019|NCT02780167|58881388|FG001|Overall Study|Lost to Follow-up|0|||
30854020|NCT02780167|58881389|FG002|Overall Study|Lost to Follow-up|1|||
30854021|NCT02780167|58881390|FG003|Overall Study|Lost to Follow-up|0|||
30957565|NCT01372410|59021689|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30957566|NCT01372410|59021690|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
30957567|NCT01372410|59021683|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
30957568|NCT01372410|59021684|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
30957569|NCT01372410|59021685|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
30957570|NCT01372410|59021686|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
30957571|NCT01372410|59021687|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
30957572|NCT01372410|59021688|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
30957573|NCT01372410|59021689|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
30957574|NCT01372410|59021690|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
30957575|NCT01372410|59021683|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
30957576|NCT01372410|59021684|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
30957577|NCT01372410|59021685|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
30957578|NCT01372410|59021686|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
30957579|NCT01372410|59021687|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
30957580|NCT01372410|59021688|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
30957581|NCT01372410|59021689|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
30957582|NCT01372410|59021690|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
30957583|NCT01372410|59021683|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
30957584|NCT01372410|59021684|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
30957585|NCT01372410|59021685|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
30957586|NCT01372410|59021686|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
30957587|NCT01372410|59021687|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
30957588|NCT01372410|59021688|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
30957589|NCT01372410|59021689|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
30957590|NCT01372410|59021690|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
30957591|NCT01372410|59021683|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
30957592|NCT01372410|59021684|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
30957593|NCT01372410|59021685|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
30957594|NCT01372410|59021686|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
30957595|NCT01372410|59021687|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
30957596|NCT01372410|59021688|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
30957597|NCT01372410|59021689|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
30957598|NCT01372410|59021690|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
30957599|NCT01372410|59021683|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
30957600|NCT01372410|59021684|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
30957601|NCT01372410|59021685|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
30957602|NCT01372410|59021686|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
30957603|NCT01372410|59021687|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
30957604|NCT01372410|59021688|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
30957605|NCT01372410|59021689|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
30662873|NCT02631941|58676546|FG004|Overall Study|Physician Decision|0|||
30854022|NCT02780167|58881391|FG004|Overall Study|Lost to Follow-up|0|||
30854023|NCT02780167|58881387|FG000|Overall Study|Does not meet entrance criteria|0|||
30854024|NCT02780167|58881388|FG001|Overall Study|Does not meet entrance criteria|0|||
30854025|NCT02780167|58881389|FG002|Overall Study|Does not meet entrance criteria|1|||
30854026|NCT02780167|58881390|FG003|Overall Study|Does not meet entrance criteria|0|||
30957606|NCT01372410|59021690|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
30957607|NCT01372410|59021683|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
30957608|NCT01372410|59021684|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
30957609|NCT01372410|59021685|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
30957610|NCT01372410|59021686|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
30957611|NCT01372410|59021687|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
30957612|NCT01372410|59021688|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
30957613|NCT01372410|59021689|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
30957614|NCT01372410|59021690|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
30957615|NCT01372410|59021683|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
30957616|NCT01372410|59021684|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
30957617|NCT01372410|59021685|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
30957618|NCT01372410|59021686|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
30957619|NCT01372410|59021687|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
30957620|NCT01372410|59021688|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
30957621|NCT01372410|59021689|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
30957622|NCT01372410|59021690|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
30957623|NCT04624672|59021711|FG000|Overall Study|Early Study Closure|2|||
30957624|NCT04624672|59021712|FG001|Overall Study|Early Study Closure|1|||
30957625|NCT01704287|59021737|FG000|Initial Treatment Period|Death|139|||
30957626|NCT01704287|59021738|FG001|Initial Treatment Period|Death|129|||
30957627|NCT01704287|59021739|FG002|Initial Treatment Period|Death|71|||
30957628|NCT01704287|59021740|FG003|Initial Treatment Period|Death|0|||
30957629|NCT01704287|59021741|FG004|Initial Treatment Period|Death|0|||
30957630|NCT01704287|59021737|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
30957631|NCT01704287|59021738|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
30957632|NCT01704287|59021739|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
30957633|NCT01704287|59021740|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
30854027|NCT02780167|58881391|FG004|Overall Study|Does not meet entrance criteria|0|||
30957634|NCT01704287|59021741|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
30957635|NCT01704287|59021737|FG000|Initial Treatment Period|Lost to Follow-up|5|||
30662874|NCT02631941|58676547|FG005|Overall Study|Physician Decision|0|||
30957636|NCT01704287|59021738|FG001|Initial Treatment Period|Lost to Follow-up|3|||
30957637|NCT01704287|59021739|FG002|Initial Treatment Period|Lost to Follow-up|0|||
30957638|NCT01704287|59021740|FG003|Initial Treatment Period|Lost to Follow-up|0|||
30957639|NCT01704287|59021741|FG004|Initial Treatment Period|Lost to Follow-up|0|||
30957640|NCT01704287|59021737|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
30778543|NCT03418376|58790064|FG000|Overall Study|Musculoskeletal injury|1|||
30778544|NCT03418376|58790065|FG001|Overall Study|Musculoskeletal injury|2|||
30778545|NCT03418376|58790066|FG002|Overall Study|Musculoskeletal injury|1|||
30778546|NCT03418376|58790067|FG003|Overall Study|Musculoskeletal injury|0|||
30778547|NCT03418376|58790064|FG000|Overall Study|Personal reasons|0|||
30778548|NCT03418376|58790065|FG001|Overall Study|Personal reasons|2|||
30778549|NCT03418376|58790066|FG002|Overall Study|Personal reasons|2|||
30778550|NCT03418376|58790067|FG003|Overall Study|Personal reasons|1|||
30778551|NCT03418376|58790064|FG000|Overall Study|Exacerbation|0|||
30778552|NCT03418376|58790065|FG001|Overall Study|Exacerbation|1|||
30778553|NCT03418376|58790066|FG002|Overall Study|Exacerbation|0|||
30778554|NCT03418376|58790067|FG003|Overall Study|Exacerbation|0|||
30778555|NCT03585504|58790079|FG000|Overall Study|Lost to Follow-up|26|||
30778556|NCT03585504|58790080|FG001|Overall Study|Lost to Follow-up|29|||
30778557|NCT03417830|58790088|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
30778558|NCT03417830|58790089|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
30778559|NCT03576768|58790100|FG000|Overall Study|Lost to Follow-up|3|||
30778560|NCT03576768|58790101|FG001|Overall Study|Lost to Follow-up|3|||
30957641|NCT01704287|59021738|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
30778561|NCT03576768|58790102|FG002|Overall Study|Lost to Follow-up|0|||
30778562|NCT03576768|58790103|FG003|Overall Study|Lost to Follow-up|0|||
30778563|NCT03576066|58790115|FG000|Overall Study|Noncompliance with study drug|0|||
30957642|NCT01704287|59021739|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
30957643|NCT01704287|59021740|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
30957644|NCT01704287|59021741|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
30957645|NCT01704287|59021737|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
30957646|NCT01704287|59021738|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
30957647|NCT01704287|59021739|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
30957648|NCT01704287|59021740|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
30957649|NCT01704287|59021741|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
30957650|NCT01704287|59021737|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
30957651|NCT01704287|59021738|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
30957652|NCT01704287|59021739|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
30957653|NCT01704287|59021740|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
30957654|NCT01704287|59021741|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
30957655|NCT01704287|59021737|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
30957656|NCT01704287|59021738|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
30957657|NCT01704287|59021739|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
30957658|NCT01704287|59021740|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
30957659|NCT01704287|59021741|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
30957660|NCT01682837|59021769|FG000|Baseline|Withdrawal by Subject|5|||
30957661|NCT01703819|59021806|FG000|Overall Study|Adverse Event|0|||
30957662|NCT01703819|59021807|FG001|Overall Study|Adverse Event|1|||
30957663|NCT01703819|59021806|FG000|Overall Study|Withdrawal by Subject|0|||
30957664|NCT01703819|59021807|FG001|Overall Study|Withdrawal by Subject|1|||
30957665|NCT01682759|59021819|FG000|Overall Study|Death|2|||
30957666|NCT01682759|59021820|FG001|Overall Study|Death|1|||
30957667|NCT01682759|59021819|FG000|Overall Study|Lost to Follow-up|10|||
30957668|NCT01682759|59021820|FG001|Overall Study|Lost to Follow-up|13|||
30957669|NCT01682759|59021819|FG000|Overall Study|Physician Decision|1|||
30957670|NCT01682759|59021820|FG001|Overall Study|Physician Decision|1|||
30957671|NCT01682759|59021819|FG000|Overall Study|Withdrawal by Subject|56|||
30957672|NCT01682759|59021820|FG001|Overall Study|Withdrawal by Subject|55|||
30854028|NCT02780167|58881387|FG000|Overall Study|No longer meets eligibility criteria|0|||
30854029|NCT02780167|58881388|FG001|Overall Study|No longer meets eligibility criteria|0|||
30854030|NCT02780167|58881389|FG002|Overall Study|No longer meets eligibility criteria|0|||
30854031|NCT02780167|58881390|FG003|Overall Study|No longer meets eligibility criteria|1|||
30854032|NCT02780167|58881391|FG004|Overall Study|No longer meets eligibility criteria|1|||
30854033|NCT02780167|58881387|FG000|Overall Study|Protocol Violation|5|||
30854034|NCT02780167|58881388|FG001|Overall Study|Protocol Violation|5|||
30854035|NCT02780167|58881389|FG002|Overall Study|Protocol Violation|1|||
30854036|NCT02780167|58881390|FG003|Overall Study|Protocol Violation|1|||
30854037|NCT02780167|58881391|FG004|Overall Study|Protocol Violation|2|||
30854038|NCT02780167|58881387|FG000|Overall Study|Withdrawal by Subject|6|||
30854039|NCT02780167|58881388|FG001|Overall Study|Withdrawal by Subject|4|||
30854040|NCT02780167|58881389|FG002|Overall Study|Withdrawal by Subject|4|||
30854041|NCT02780167|58881390|FG003|Overall Study|Withdrawal by Subject|3|||
30778564|NCT03576066|58790116|FG001|Overall Study|Noncompliance with study drug|1|||
30778565|NCT03557034|58790128|FG000|Overall Study|Withdrawal by Subject|1|||
30778566|NCT03557034|58790129|FG001|Overall Study|Withdrawal by Subject|0|||
30778567|NCT03583554|58790135|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
30778568|NCT03583554|58790136|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
30778569|NCT03583554|58790137|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
30778570|NCT03948178|58790148|FG000|Overall Study|Protocol Violation|1|||
30778571|NCT03948178|58790148|FG000|Overall Study|Lost to Follow-up|2|||
30778572|NCT03948178|58790148|FG000|Overall Study|Withdrawal by Subject|2|||
30778573|NCT03948178|58790148|FG000|Overall Study|Reason not known|2|||
30778574|NCT03948178|58790148|FG000|Overall Study|Personal reason|14|||
30778575|NCT03948178|58790148|FG000|Overall Study|Disease progression|30|||
30778576|NCT03948178|58790148|FG000|Overall Study|Adverse Event|12|||
30778577|NCT03948178|58790148|FG000|Overall Study|Sponsor terminated study|164|||
30778578|NCT03520920|58790155|FG000|Overall Study|Death|13|||
30778579|NCT03520920|58790156|FG001|Overall Study|Death|1|||
30778580|NCT03520920|58790157|FG002|Overall Study|Death|0|||
30778581|NCT03520920|58790155|FG000|Overall Study|Withdrawal by Subject|2|||
30778582|NCT03520920|58790156|FG001|Overall Study|Withdrawal by Subject|1|||
30854042|NCT02780167|58881391|FG004|Overall Study|Withdrawal by Subject|4|||
30854043|NCT02780167|58881387|FG000|Overall Study|Other|0|||
30957673|NCT01682681|59021830|FG000|Overall Study|Lack of Efficacy|62|||
30778583|NCT03520920|58790157|FG002|Overall Study|Withdrawal by Subject|0|||
30778584|NCT03520920|58790155|FG000|Overall Study|Study Terminated by the Sponsor|5|||
30778585|NCT03520920|58790156|FG001|Overall Study|Study Terminated by the Sponsor|14|||
30778586|NCT03520920|58790157|FG002|Overall Study|Study Terminated by the Sponsor|5|||
30854044|NCT02780167|58881388|FG001|Overall Study|Other|0|||
30854045|NCT02780167|58881389|FG002|Overall Study|Other|3|||
30854046|NCT02780167|58881390|FG003|Overall Study|Other|1|||
30854047|NCT02780167|58881391|FG004|Overall Study|Other|2|||
30854048|NCT02779075|58881403|FG000|Overall Study|Withdrawal by Subject|1|||
30854049|NCT02779075|58881404|FG001|Overall Study|Withdrawal by Subject|3|||
30854050|NCT02779075|58881403|FG000|Overall Study|IV lost during 2nd study|1|||
30854051|NCT02779075|58881404|FG001|Overall Study|IV lost during 2nd study|0|||
30854052|NCT00105079|58881416|FG000|Overall Study|Adverse Event|5|||
30854053|NCT00105079|58881417|FG001|Overall Study|Adverse Event|12|||
30854054|NCT00105079|58881416|FG000|Overall Study|Death|3|||
30854055|NCT00105079|58881417|FG001|Overall Study|Death|1|||
30854056|NCT00105079|58881416|FG000|Overall Study|Lost to Follow-up|12|||
30854057|NCT00105079|58881417|FG001|Overall Study|Lost to Follow-up|12|||
30854058|NCT00105079|58881416|FG000|Overall Study|Lack of Efficacy|9|||
30854059|NCT00105079|58881417|FG001|Overall Study|Lack of Efficacy|3|||
30854060|NCT00105079|58881416|FG000|Overall Study|Refused treatment|6|||
30854061|NCT00105079|58881417|FG001|Overall Study|Refused treatment|4|||
30854062|NCT00105079|58881416|FG000|Overall Study|Violation of selection criteria at entry|0|||
30854063|NCT00105079|58881417|FG001|Overall Study|Violation of selection criteria at entry|2|||
30854064|NCT00105079|58881416|FG000|Overall Study|Protocol Violation|1|||
30854065|NCT00105079|58881417|FG001|Overall Study|Protocol Violation|0|||
30854066|NCT00105079|58881416|FG000|Overall Study|Other|3|||
30778587|NCT02953340|58790173|FG000|Overall Study|Death|0|||
30778588|NCT02953340|58790174|FG001|Overall Study|Death|1|||
30778589|NCT02953340|58790173|FG000|Overall Study|Investigator Decision|3|||
30778590|NCT02953340|58790174|FG001|Overall Study|Investigator Decision|3|||
30778591|NCT02953340|58790173|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
30778592|NCT02953340|58790174|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
30778593|NCT02953340|58790173|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
30778594|NCT02953340|58790174|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
30778595|NCT02953340|58790173|FG000|Overall Study|Withdrawal by Subject|9|||
30778596|NCT02953340|58790174|FG001|Overall Study|Withdrawal by Subject|9|||
30778597|NCT02953340|58790173|FG000|Overall Study|Sponsor decision|0|||
30778598|NCT02953340|58790174|FG001|Overall Study|Sponsor decision|2|||
30778599|NCT02953340|58790173|FG000|Overall Study|Lost to Follow-up|3|||
30778600|NCT02953340|58790174|FG001|Overall Study|Lost to Follow-up|2|||
30778601|NCT02953340|58790173|FG000|Overall Study|Reason not specified|2|||
30778602|NCT02953340|58790174|FG001|Overall Study|Reason not specified|2|||
30778603|NCT03554772|58790190|FG000|Overall Study|Lost to Follow-up|0|||
30778604|NCT03554772|58790191|FG001|Overall Study|Lost to Follow-up|0|||
30778605|NCT03554772|58790192|FG002|Overall Study|Lost to Follow-up|0|||
30778606|NCT03554772|58790193|FG003|Overall Study|Lost to Follow-up|2|||
30778607|NCT03573804|58790203|FG000|Overall Study|claustrophobia or MRI table problems|10|||
30778608|NCT03417440|58790221|FG000|Overall Study|Lost to Follow-up|0|||
30778609|NCT03417440|58790222|FG001|Overall Study|Lost to Follow-up|1|||
30778610|NCT03417440|58790223|FG002|Overall Study|Lost to Follow-up|0|||
30778611|NCT03417440|58790224|FG003|Overall Study|Lost to Follow-up|0|||
30778612|NCT03417440|58790225|FG004|Overall Study|Lost to Follow-up|1|||
30778613|NCT03417440|58790226|FG005|Overall Study|Lost to Follow-up|0|||
30778614|NCT03417440|58790227|FG006|Overall Study|Lost to Follow-up|0|||
30778615|NCT03417440|58790228|FG007|Overall Study|Lost to Follow-up|0|||
30778616|NCT03417440|58790221|FG000|Overall Study|Withdrawal by Subject|2|||
30778617|NCT03417440|58790222|FG001|Overall Study|Withdrawal by Subject|0|||
30778618|NCT03417440|58790223|FG002|Overall Study|Withdrawal by Subject|2|||
30778619|NCT03417440|58790224|FG003|Overall Study|Withdrawal by Subject|1|||
30778620|NCT03417440|58790225|FG004|Overall Study|Withdrawal by Subject|1|||
30778621|NCT03417440|58790226|FG005|Overall Study|Withdrawal by Subject|0|||
30778622|NCT03417440|58790227|FG006|Overall Study|Withdrawal by Subject|0|||
30778623|NCT03417440|58790228|FG007|Overall Study|Withdrawal by Subject|1|||
30778624|NCT03458702|58790251|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
30778625|NCT03458702|58790252|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
30778626|NCT03458702|58790251|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
30778627|NCT03458702|58790252|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
30778628|NCT03454412|58790258|FG000|Baseline Assesment|Physician Decision|12|||
30778629|NCT03452540|58790262|FG000|Overall Study|Adverse Event|1|||
30854067|NCT00105079|58881417|FG001|Overall Study|Other|1|||
30854068|NCT02777827|58881423|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
30854069|NCT02777827|58881424|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
30854070|NCT02777827|58881425|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
30854071|NCT02777827|58881426|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
30778630|NCT03452540|58790262|FG000|Overall Study|Withdrawal by Subject|1|||
30778631|NCT03452540|58790262|FG000|Overall Study|Other SAE and AE|2|||
30778632|NCT03573336|58790269|FG000|Overall Study|Study terminated|2|||
30854072|NCT02777827|58881427|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
30854073|NCT02777827|58881428|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
30854074|NCT02712333|58881444|FG000|First Period|Withdrawal by Subject|3|||
30854075|NCT02712333|58881445|FG001|First Period|Withdrawal by Subject|2|||
30854076|NCT02343406|58881461|FG000|Overall Study|Progressive disease|72|||
30854077|NCT02343406|58881462|FG001|Overall Study|Progressive disease|70|||
30854078|NCT02343406|58881463|FG002|Overall Study|Progressive disease|43|||
30854079|NCT02343406|58881464|FG003|Overall Study|Progressive disease|15|||
30854080|NCT02343406|58881465|FG004|Overall Study|Progressive disease|5|||
30957674|NCT01682681|59021830|FG000|Overall Study|Withdrawal by Subject|1|||
30957675|NCT01682681|59021830|FG000|Overall Study|Moved to other hospital|10|||
30957676|NCT01682681|59021830|FG000|Overall Study|Lost to Follow-up|174|||
30854081|NCT02343406|58881461|FG000|Overall Study|Adverse Event|6|||
30957677|NCT01682681|59021830|FG000|Overall Study|Adverse Event|46|||
30957678|NCT01682681|59021830|FG000|Overall Study|tapering of topiramate|5|||
30854082|NCT02343406|58881462|FG001|Overall Study|Adverse Event|8|||
30854083|NCT02343406|58881463|FG002|Overall Study|Adverse Event|6|||
30957679|NCT01682681|59021830|FG000|Overall Study|Other|21|||
30957680|NCT01682681|59021830|FG000|Overall Study|Low compliance|13|||
30957681|NCT01682603|59021834|FG000|Overall Study|Lost to Follow-up|3|||
30957682|NCT01682213|59021850|FG000|Overall Study|Withdrawal by Subject|2|||
30957683|NCT01703741|59021859|FG000|Overall Study|Withdrawal by Subject|6|||
30957684|NCT01703741|59021859|FG000|Overall Study|Adverse Event|2|||
30957685|NCT01703741|59021859|FG000|Overall Study|Physician Decision|2|||
30957686|NCT01703741|59021859|FG000|Overall Study|Protocol Violation|1|||
30957687|NCT01703741|59021859|FG000|Overall Study|Lost to Follow-up|3|||
30957688|NCT01703741|59021859|FG000|Overall Study|Subject did not want to continue|2|||
30957689|NCT01703741|59021859|FG000|Overall Study|Subject cannot comply with study visits|1|||
30957690|NCT01703741|59021859|FG000|Overall Study|Subject started testosterone injections|1|||
30957691|NCT01681511|59021865|FG000|Overall Study|No Treatment Received|1|||
30957692|NCT01681511|59021866|FG001|Overall Study|No Treatment Received|3|||
30957693|NCT01681511|59021865|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
30957694|NCT01681511|59021866|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
30957695|NCT01681511|59021865|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
30957696|NCT01681511|59021866|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
30957697|NCT01681511|59021865|FG000|Overall Study|No Daily Urine Sample Collected|0|||
30957698|NCT01681511|59021866|FG001|Overall Study|No Daily Urine Sample Collected|1|||
30957699|NCT01681511|59021865|FG000|Overall Study|No post-catheter sample collected|11|||
30957700|NCT01681511|59021866|FG001|Overall Study|No post-catheter sample collected|4|||
30957701|NCT02175004|59021874|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
30957702|NCT02175004|59021875|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
30957703|NCT02175004|59021874|FG000|Overall Study|Investigator Judgment|1|||
30957704|NCT02175004|59021875|FG001|Overall Study|Investigator Judgment|4|||
30957705|NCT02175004|59021874|FG000|Overall Study|Voluntary Withdrawal|6|||
30854084|NCT02343406|58881464|FG003|Overall Study|Adverse Event|3|||
30854085|NCT02343406|58881465|FG004|Overall Study|Adverse Event|0|||
30854086|NCT02343406|58881461|FG000|Overall Study|Withdrawal by Subject|6|||
30854087|NCT02343406|58881462|FG001|Overall Study|Withdrawal by Subject|4|||
30854088|NCT02343406|58881463|FG002|Overall Study|Withdrawal by Subject|8|||
30854089|NCT02343406|58881464|FG003|Overall Study|Withdrawal by Subject|3|||
30854090|NCT02343406|58881465|FG004|Overall Study|Withdrawal by Subject|0|||
30854091|NCT02343406|58881461|FG000|Overall Study|Death|2|||
30854092|NCT02343406|58881462|FG001|Overall Study|Death|1|||
30854093|NCT02343406|58881463|FG002|Overall Study|Death|0|||
30854094|NCT02343406|58881464|FG003|Overall Study|Death|0|||
30854095|NCT02343406|58881465|FG004|Overall Study|Death|0|||
30854096|NCT02343406|58881461|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
30854097|NCT02343406|58881462|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
30854098|NCT02343406|58881463|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
30854099|NCT02343406|58881464|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
30854100|NCT02343406|58881465|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
30854101|NCT02343406|58881461|FG000|Overall Study|Other primary malignancy|0|||
30854102|NCT02343406|58881462|FG001|Overall Study|Other primary malignancy|1|||
30957706|NCT02175004|59021875|FG001|Overall Study|Voluntary Withdrawal|19|||
30957707|NCT02175004|59021874|FG000|Overall Study|Liver Transplant|1|||
30854103|NCT02343406|58881463|FG002|Overall Study|Other primary malignancy|0|||
30854104|NCT02343406|58881464|FG003|Overall Study|Other primary malignancy|0|||
30854105|NCT02343406|58881465|FG004|Overall Study|Other primary malignancy|0|||
30854106|NCT02343406|58881461|FG000|Overall Study|Other, not specified|2|||
30854107|NCT02343406|58881462|FG001|Overall Study|Other, not specified|1|||
30854108|NCT02343406|58881463|FG002|Overall Study|Other, not specified|1|||
30854109|NCT02343406|58881464|FG003|Overall Study|Other, not specified|4|||
30957708|NCT02175004|59021875|FG001|Overall Study|Liver Transplant|0|||
30957709|NCT02175004|59021874|FG000|Overall Study|Disease Progression|1|||
30854110|NCT02343406|58881465|FG004|Overall Study|Other, not specified|0|||
30854111|NCT02710071|58881478|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
30854112|NCT02710071|58881479|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
30854113|NCT02710071|58881478|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
30854114|NCT02710071|58881479|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
30854115|NCT02373202|58881490|FG000|Overall Study|Adverse Event|2|||
30854116|NCT02373202|58881491|FG001|Overall Study|Adverse Event|5|||
30854117|NCT02373202|58881492|FG002|Overall Study|Adverse Event|2|||
30778633|NCT03573336|58790270|FG001|Overall Study|Study terminated|4|||
30778634|NCT03573336|58790271|FG002|Overall Study|Study terminated|2|||
30778635|NCT03500198|58790281|FG000|Overall Study|Lost to Follow-up|0|||
30778636|NCT03500198|58790282|FG001|Overall Study|Lost to Follow-up|1|||
30778637|NCT03553758|58790290|FG000|Overall Study|Lost to Follow-up|1|||
30778638|NCT03552198|58790300|FG000|Overall Study|Lost to Follow-up|42|||
30778639|NCT03552198|58790301|FG001|Overall Study|Lost to Follow-up|48|||
30778640|NCT03552198|58790302|FG002|Overall Study|Lost to Follow-up|15|||
30778641|NCT03552198|58790303|FG003|Overall Study|Lost to Follow-up|19|||
30778642|NCT03552198|58790300|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
30778643|NCT03552198|58790301|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
30854118|NCT02373202|58881493|FG003|Overall Study|Adverse Event|1|||
30854119|NCT02373202|58881490|FG000|Overall Study|Lack of Efficacy|0|||
30854120|NCT02373202|58881491|FG001|Overall Study|Lack of Efficacy|0|||
30854121|NCT02373202|58881492|FG002|Overall Study|Lack of Efficacy|1|||
30854122|NCT02373202|58881493|FG003|Overall Study|Lack of Efficacy|0|||
30854123|NCT02373202|58881490|FG000|Overall Study|Other|0|||
30854124|NCT02373202|58881491|FG001|Overall Study|Other|1|||
30854125|NCT02373202|58881492|FG002|Overall Study|Other|0|||
30854126|NCT02373202|58881493|FG003|Overall Study|Other|0|||
30854127|NCT02622074|58881509|FG000|Overall Study|Death|4|||
30854128|NCT02622074|58881510|FG001|Overall Study|Death|0|||
30854129|NCT02622074|58881511|FG002|Overall Study|Death|0|||
30854130|NCT02622074|58881512|FG003|Overall Study|Death|1|||
30854131|NCT02622074|58881513|FG004|Overall Study|Death|1|||
30854132|NCT02622074|58881514|FG005|Overall Study|Death|0|||
30854133|NCT02622074|58881509|FG000|Overall Study|Withdrawal by Subject|0|||
30854134|NCT02622074|58881510|FG001|Overall Study|Withdrawal by Subject|1|||
30854135|NCT02622074|58881511|FG002|Overall Study|Withdrawal by Subject|0|||
30854136|NCT02622074|58881512|FG003|Overall Study|Withdrawal by Subject|0|||
30854137|NCT02622074|58881513|FG004|Overall Study|Withdrawal by Subject|0|||
30854138|NCT02622074|58881514|FG005|Overall Study|Withdrawal by Subject|0|||
30854139|NCT02308696|58881530|FG000|Overall Study|Lost to Follow-up|28|||
30854140|NCT02308696|58881531|FG001|Overall Study|Lost to Follow-up|21|||
30854141|NCT02308696|58881530|FG000|Overall Study|Death|8|||
30854142|NCT02308696|58881531|FG001|Overall Study|Death|4|||
30854143|NCT02308696|58881530|FG000|Overall Study|Moved to a Higher Level of Care|17|||
30854144|NCT02308696|58881531|FG001|Overall Study|Moved to a Higher Level of Care|6|||
30854145|NCT02342704|58881539|FG000|Overall Study|Physician Decision|0|||
30854146|NCT02342704|58881540|FG001|Overall Study|Physician Decision|3|||
30854147|NCT02342704|58881539|FG000|Overall Study|Sponsor Termination|49|||
30854148|NCT02342704|58881540|FG001|Overall Study|Sponsor Termination|43|||
30778644|NCT03552198|58790302|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
30778645|NCT03552198|58790303|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
30778646|NCT03552198|58790300|FG000|Overall Study|Did not receive air alerts|1|||
30778647|NCT03552198|58790301|FG001|Overall Study|Did not receive air alerts|0|||
30778648|NCT03552198|58790302|FG002|Overall Study|Did not receive air alerts|0|||
30854149|NCT02342704|58881539|FG000|Overall Study|Other|0|||
30854150|NCT02342704|58881540|FG001|Overall Study|Other|1|||
30778649|NCT03552198|58790303|FG003|Overall Study|Did not receive air alerts|1|||
30778650|NCT02954354|58790316|FG000|Overall Study|Adverse Event|2|||
30778651|NCT02954354|58790317|FG001|Overall Study|Adverse Event|2|||
30854151|NCT02342704|58881539|FG000|Overall Study|Withdrawal by Subject|1|||
30854152|NCT02342704|58881540|FG001|Overall Study|Withdrawal by Subject|0|||
30778652|NCT02954354|58790318|FG002|Overall Study|Adverse Event|4|||
30778653|NCT02954354|58790316|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
30778654|NCT02954354|58790317|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
30778655|NCT02954354|58790318|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
30778656|NCT02954354|58790316|FG000|Overall Study|Lack of Efficacy|0|||
30854153|NCT02342704|58881539|FG000|Overall Study|Lost to Follow-up|2|||
30854154|NCT02342704|58881540|FG001|Overall Study|Lost to Follow-up|1|||
30854155|NCT02342704|58881539|FG000|Overall Study|Adverse Event|1|||
30854156|NCT02342704|58881540|FG001|Overall Study|Adverse Event|3|||
30854157|NCT02342548|58881549|FG000|Overall Study|Adverse Event|12|||
30854158|NCT02342548|58881550|FG001|Overall Study|Adverse Event|17|||
30854159|NCT02342548|58881551|FG002|Overall Study|Adverse Event|13|||
30854160|NCT02342548|58881549|FG000|Overall Study|Lost to Follow-up|0|||
30854161|NCT02342548|58881550|FG001|Overall Study|Lost to Follow-up|1|||
30854162|NCT02342548|58881551|FG002|Overall Study|Lost to Follow-up|0|||
30854163|NCT02342548|58881549|FG000|Overall Study|Study terminated by sponsor|20|||
30854164|NCT02342548|58881550|FG001|Overall Study|Study terminated by sponsor|39|||
30854165|NCT02342548|58881551|FG002|Overall Study|Study terminated by sponsor|25|||
30854166|NCT02342548|58881549|FG000|Overall Study|Protocol Violation|0|||
30854167|NCT02342548|58881550|FG001|Overall Study|Protocol Violation|1|||
30854168|NCT02342548|58881551|FG002|Overall Study|Protocol Violation|0|||
30854169|NCT02342548|58881549|FG000|Overall Study|Withdrawal by Subject|1|||
30854170|NCT02342548|58881550|FG001|Overall Study|Withdrawal by Subject|3|||
30854171|NCT02342548|58881551|FG002|Overall Study|Withdrawal by Subject|4|||
30854172|NCT02342548|58881549|FG000|Overall Study|Other|1|||
30854173|NCT02342548|58881550|FG001|Overall Study|Other|1|||
30854174|NCT02342548|58881551|FG002|Overall Study|Other|1|||
30854175|NCT03142191|58881564|FG000|Placebo Controlled Period|Death|0|||
30854176|NCT03142191|58881565|FG001|Placebo Controlled Period|Death|1|||
30854177|NCT03142191|58881566|FG002|Placebo Controlled Period|Death|1|||
30854178|NCT03142191|58881567|FG003|Placebo Controlled Period|Death|0|||
30662875|NCT02631941|58676548|FG006|Overall Study|Physician Decision|0|||
30662876|NCT02631941|58676549|FG007|Overall Study|Physician Decision|0|||
30662877|NCT02631941|58676550|FG008|Overall Study|Physician Decision|0|||
30662878|NCT02631941|58676551|FG009|Overall Study|Physician Decision|0|||
30662879|NCT02631941|58676542|FG000|Overall Study|Adverse Event|0|||
30662880|NCT02631941|58676543|FG001|Overall Study|Adverse Event|1|||
30662881|NCT02631941|58676544|FG002|Overall Study|Adverse Event|0|||
30662882|NCT02631941|58676545|FG003|Overall Study|Adverse Event|0|||
30662883|NCT02631941|58676546|FG004|Overall Study|Adverse Event|0|||
30662884|NCT02631941|58676547|FG005|Overall Study|Adverse Event|0|||
30662885|NCT02631941|58676548|FG006|Overall Study|Adverse Event|0|||
30662886|NCT02631941|58676549|FG007|Overall Study|Adverse Event|0|||
30662887|NCT02631941|58676550|FG008|Overall Study|Adverse Event|0|||
30662888|NCT02631941|58676551|FG009|Overall Study|Adverse Event|0|||
30662889|NCT02631941|58676542|FG000|Overall Study|Withdrawal by Subject|0|||
30778657|NCT02954354|58790317|FG001|Overall Study|Lack of Efficacy|2|||
30778658|NCT02954354|58790318|FG002|Overall Study|Lack of Efficacy|0|||
30778659|NCT02954354|58790316|FG000|Overall Study|Withdrawal by Subject|17|||
30778660|NCT02954354|58790317|FG001|Overall Study|Withdrawal by Subject|9|||
30778661|NCT02954354|58790318|FG002|Overall Study|Withdrawal by Subject|11|||
30778662|NCT02954354|58790316|FG000|Overall Study|Lost to Follow-up|12|||
30778663|NCT02954354|58790317|FG001|Overall Study|Lost to Follow-up|5|||
30662890|NCT02631941|58676543|FG001|Overall Study|Withdrawal by Subject|0|||
30662891|NCT02631941|58676544|FG002|Overall Study|Withdrawal by Subject|0|||
30662892|NCT02631941|58676545|FG003|Overall Study|Withdrawal by Subject|0|||
30662893|NCT02631941|58676546|FG004|Overall Study|Withdrawal by Subject|1|||
30662894|NCT02631941|58676547|FG005|Overall Study|Withdrawal by Subject|0|||
30778664|NCT02954354|58790318|FG002|Overall Study|Lost to Follow-up|0|||
30778665|NCT02954354|58790316|FG000|Overall Study|Miscellaneous|2|||
30778666|NCT02954354|58790317|FG001|Overall Study|Miscellaneous|2|||
30778667|NCT02954354|58790318|FG002|Overall Study|Miscellaneous|1|||
30778668|NCT03519516|58790330|FG000|Overall Study|Adverse Event|0|||
30854179|NCT03142191|58881568|FG004|Placebo Controlled Period|Death|0|||
30854180|NCT03142191|58881564|FG000|Placebo Controlled Period|Adverse Event|4|||
30854181|NCT03142191|58881565|FG001|Placebo Controlled Period|Adverse Event|5|||
30662895|NCT02631941|58676548|FG006|Overall Study|Withdrawal by Subject|0|||
30662896|NCT02631941|58676549|FG007|Overall Study|Withdrawal by Subject|1|||
30778669|NCT03519516|58790331|FG001|Overall Study|Adverse Event|1|||
30854182|NCT03142191|58881566|FG002|Placebo Controlled Period|Adverse Event|1|||
30662897|NCT02631941|58676550|FG008|Overall Study|Withdrawal by Subject|0|||
30662898|NCT02631941|58676551|FG009|Overall Study|Withdrawal by Subject|0|||
30662899|NCT02631941|58676542|FG000|Overall Study|Lost to Follow-up|0|||
30662900|NCT02631941|58676543|FG001|Overall Study|Lost to Follow-up|0|||
30662901|NCT02631941|58676544|FG002|Overall Study|Lost to Follow-up|0|||
30662902|NCT02631941|58676545|FG003|Overall Study|Lost to Follow-up|0|||
30662903|NCT02631941|58676546|FG004|Overall Study|Lost to Follow-up|0|||
30778670|NCT03519204|58790339|FG000|Overall Study|Lost to Follow-up|3|||
30778671|NCT03519204|58790340|FG001|Overall Study|Lost to Follow-up|8|||
30854183|NCT03142191|58881567|FG003|Placebo Controlled Period|Adverse Event|0|||
30778672|NCT03519204|58790339|FG000|Overall Study|Withdrawal by Subject|9|||
30778673|NCT03519204|58790340|FG001|Overall Study|Withdrawal by Subject|7|||
30778674|NCT03519204|58790339|FG000|Overall Study|Other Miscellaneous Reasons|1|||
30854184|NCT03142191|58881568|FG004|Placebo Controlled Period|Adverse Event|0|||
30854185|NCT03142191|58881564|FG000|Placebo Controlled Period|Progressive Disease|1|||
30854186|NCT03142191|58881565|FG001|Placebo Controlled Period|Progressive Disease|0|||
30854187|NCT03142191|58881566|FG002|Placebo Controlled Period|Progressive Disease|1|||
30854188|NCT03142191|58881567|FG003|Placebo Controlled Period|Progressive Disease|0|||
30854189|NCT03142191|58881568|FG004|Placebo Controlled Period|Progressive Disease|0|||
30854190|NCT03142191|58881564|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
30854191|NCT03142191|58881565|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
30854192|NCT03142191|58881566|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
30854193|NCT03142191|58881567|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
30778675|NCT03519204|58790340|FG001|Overall Study|Other Miscellaneous Reasons|0|||
30778676|NCT03518658|58790352|FG000|Overall Study|Other|51|||
30778677|NCT03518658|58790353|FG001|Overall Study|Other|0|||
30778678|NCT03518112|58790361|FG000|Overall Study|Withdrawal by Subject|1|||
30778679|NCT03706456|58790365|FG000|Overall Study|Lack of Efficacy|1|||
30778680|NCT03706456|58790365|FG000|Overall Study|Ongoing|21|||
30778681|NCT03517566|58790374|FG000|Overall Study|Adverse Event|5|||
30778682|NCT03517566|58790375|FG001|Overall Study|Adverse Event|2|||
30778683|NCT03517566|58790376|FG002|Overall Study|Adverse Event|2|||
30778684|NCT03517566|58790377|FG003|Overall Study|Adverse Event|8|||
30778685|NCT03517566|58790378|FG004|Overall Study|Adverse Event|7|||
30778686|NCT03517566|58790374|FG000|Overall Study|Lack of Efficacy|3|||
30778687|NCT03517566|58790375|FG001|Overall Study|Lack of Efficacy|2|||
30778688|NCT03517566|58790376|FG002|Overall Study|Lack of Efficacy|1|||
30778689|NCT03517566|58790377|FG003|Overall Study|Lack of Efficacy|1|||
30778690|NCT03517566|58790378|FG004|Overall Study|Lack of Efficacy|4|||
30778691|NCT03517566|58790374|FG000|Overall Study|Lost to Follow-up|3|||
30778692|NCT03517566|58790375|FG001|Overall Study|Lost to Follow-up|1|||
30778693|NCT03517566|58790376|FG002|Overall Study|Lost to Follow-up|1|||
30778694|NCT03517566|58790377|FG003|Overall Study|Lost to Follow-up|1|||
30778695|NCT03517566|58790378|FG004|Overall Study|Lost to Follow-up|0|||
30778696|NCT03517566|58790374|FG000|Overall Study|Physician Decision|1|||
30778697|NCT03517566|58790375|FG001|Overall Study|Physician Decision|1|||
30778698|NCT03517566|58790376|FG002|Overall Study|Physician Decision|0|||
30854194|NCT03142191|58881568|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
30854195|NCT03142191|58881564|FG000|Placebo Controlled Period|Other Reasons|1|||
30778699|NCT03517566|58790377|FG003|Overall Study|Physician Decision|1|||
30778700|NCT03517566|58790378|FG004|Overall Study|Physician Decision|0|||
30778701|NCT03517566|58790374|FG000|Overall Study|Pregnancy|0|||
30778702|NCT03517566|58790375|FG001|Overall Study|Pregnancy|1|||
30854196|NCT03142191|58881565|FG001|Placebo Controlled Period|Other Reasons|0|||
30854197|NCT03142191|58881566|FG002|Placebo Controlled Period|Other Reasons|0|||
30854198|NCT03142191|58881567|FG003|Placebo Controlled Period|Other Reasons|0|||
30854199|NCT03142191|58881568|FG004|Placebo Controlled Period|Other Reasons|0|||
30854200|NCT03142191|58881564|FG000|Active Treatment Extension Period|Death|2|||
30662904|NCT02631941|58676547|FG005|Overall Study|Lost to Follow-up|0|||
30662905|NCT02631941|58676548|FG006|Overall Study|Lost to Follow-up|0|||
30662906|NCT02631941|58676549|FG007|Overall Study|Lost to Follow-up|0|||
30662907|NCT02631941|58676550|FG008|Overall Study|Lost to Follow-up|1|||
30662908|NCT02631941|58676551|FG009|Overall Study|Lost to Follow-up|0|||
30662909|NCT00908375|58676563|FG000|Overall Study|Withdrawal by Subject|2|||
30778703|NCT03517566|58790376|FG002|Overall Study|Pregnancy|0|||
30778704|NCT03517566|58790377|FG003|Overall Study|Pregnancy|0|||
30854201|NCT03142191|58881565|FG001|Active Treatment Extension Period|Death|1|||
30854202|NCT03142191|58881566|FG002|Active Treatment Extension Period|Death|1|||
30854203|NCT03142191|58881567|FG003|Active Treatment Extension Period|Death|1|||
30662910|NCT00908375|58676564|FG001|Overall Study|Withdrawal by Subject|4|||
30662911|NCT00908375|58676563|FG000|Overall Study|Lost to Follow-up|8|||
30662912|NCT00908375|58676564|FG001|Overall Study|Lost to Follow-up|6|||
30778705|NCT03517566|58790378|FG004|Overall Study|Pregnancy|0|||
30778706|NCT03517566|58790374|FG000|Overall Study|Protocol Deviation|0|||
30778707|NCT03517566|58790375|FG001|Overall Study|Protocol Deviation|1|||
30778708|NCT03517566|58790376|FG002|Overall Study|Protocol Deviation|0|||
30778709|NCT03517566|58790377|FG003|Overall Study|Protocol Deviation|1|||
30854204|NCT03142191|58881568|FG004|Active Treatment Extension Period|Death|0|||
30854205|NCT03142191|58881564|FG000|Active Treatment Extension Period|Adverse Event|6|||
30854206|NCT03142191|58881565|FG001|Active Treatment Extension Period|Adverse Event|5|||
30854207|NCT03142191|58881566|FG002|Active Treatment Extension Period|Adverse Event|4|||
30854208|NCT03142191|58881567|FG003|Active Treatment Extension Period|Adverse Event|1|||
30854209|NCT03142191|58881568|FG004|Active Treatment Extension Period|Adverse Event|0|||
30854210|NCT03142191|58881564|FG000|Active Treatment Extension Period|Progressive Disease|10|||
30854211|NCT03142191|58881565|FG001|Active Treatment Extension Period|Progressive Disease|5|||
30854212|NCT03142191|58881566|FG002|Active Treatment Extension Period|Progressive Disease|4|||
30854213|NCT03142191|58881567|FG003|Active Treatment Extension Period|Progressive Disease|1|||
30854214|NCT03142191|58881568|FG004|Active Treatment Extension Period|Progressive Disease|2|||
30854215|NCT03142191|58881564|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
30854216|NCT03142191|58881565|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
30854217|NCT03142191|58881566|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
30854218|NCT03142191|58881567|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
30854219|NCT03142191|58881568|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
30854220|NCT03142191|58881564|FG000|Active Treatment Extension Period|Physician Decision|2|||
30854221|NCT03142191|58881565|FG001|Active Treatment Extension Period|Physician Decision|0|||
30854222|NCT03142191|58881566|FG002|Active Treatment Extension Period|Physician Decision|0|||
30778710|NCT03517566|58790378|FG004|Overall Study|Protocol Deviation|1|||
30778711|NCT03517566|58790374|FG000|Overall Study|Study terminated by Sponsor|11|||
30778712|NCT03517566|58790375|FG001|Overall Study|Study terminated by Sponsor|5|||
30778713|NCT03517566|58790376|FG002|Overall Study|Study terminated by Sponsor|6|||
30778714|NCT03517566|58790377|FG003|Overall Study|Study terminated by Sponsor|14|||
30778715|NCT03517566|58790378|FG004|Overall Study|Study terminated by Sponsor|12|||
30778716|NCT03517566|58790374|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
30778717|NCT03517566|58790375|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
30778718|NCT03517566|58790376|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
30778719|NCT03517566|58790377|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
30778720|NCT03517566|58790378|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
30778721|NCT03916744|58790394|FG000|Overall Study|Withdrawal by Subject|0|||
30778722|NCT03916744|58790395|FG001|Overall Study|Withdrawal by Subject|1|||
30778723|NCT03916744|58790396|FG002|Overall Study|Withdrawal by Subject|2|||
30778724|NCT03639610|58790411|FG000|Overall Study|Adverse Event|7|||
30778725|NCT03639610|58790412|FG001|Overall Study|Adverse Event|1|||
30778726|NCT03639610|58790413|FG002|Overall Study|Adverse Event|0|||
30778727|NCT03639610|58790411|FG000|Overall Study|Physician Decision|3|||
30778728|NCT03639610|58790412|FG001|Overall Study|Physician Decision|1|||
30778729|NCT03639610|58790413|FG002|Overall Study|Physician Decision|0|||
30778730|NCT03639610|58790411|FG000|Overall Study|Disease progression|8|||
30778731|NCT03639610|58790412|FG001|Overall Study|Disease progression|5|||
30778732|NCT03639610|58790413|FG002|Overall Study|Disease progression|3|||
30778733|NCT03639610|58790411|FG000|Overall Study|Study terminated by sponsor|2|||
30778734|NCT03639610|58790412|FG001|Overall Study|Study terminated by sponsor|1|||
30778735|NCT03639610|58790413|FG002|Overall Study|Study terminated by sponsor|1|||
30778736|NCT03639610|58790411|FG000|Overall Study|Patient request to stop treatment|1|||
30778737|NCT03639610|58790412|FG001|Overall Study|Patient request to stop treatment|2|||
30778738|NCT03639610|58790413|FG002|Overall Study|Patient request to stop treatment|0|||
30778739|NCT02954406|58790431|FG000|Overall Study|Adverse Event|0|||
30957710|NCT02175004|59021875|FG001|Overall Study|Disease Progression|0|||
30957711|NCT02175004|59021874|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
30957712|NCT02175004|59021875|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
30957713|NCT01681433|59021883|FG000|Overall Study|Lack of Efficacy|23|||
30957714|NCT01681433|59021884|FG001|Overall Study|Lack of Efficacy|23|||
30778740|NCT02954406|58790432|FG001|Overall Study|Adverse Event|1|||
30778741|NCT02954406|58790433|FG002|Overall Study|Adverse Event|0|||
30778742|NCT02954406|58790434|FG003|Overall Study|Adverse Event|0|||
30778743|NCT02954406|58790435|FG004|Overall Study|Adverse Event|1|||
30778744|NCT02954406|58790436|FG005|Overall Study|Adverse Event|0|||
30778745|NCT02954406|58790437|FG006|Overall Study|Adverse Event|0|||
30778746|NCT02954406|58790438|FG007|Overall Study|Adverse Event|0|||
30778747|NCT02954406|58790439|FG008|Overall Study|Adverse Event|1|||
30778748|NCT02954406|58790440|FG009|Overall Study|Adverse Event|1|||
30778749|NCT02954406|58790441|FG010|Overall Study|Adverse Event|0|||
30778750|NCT02954406|58790431|FG000|Overall Study|Progressive Disease|3|||
30778751|NCT02954406|58790432|FG001|Overall Study|Progressive Disease|4|||
30778752|NCT02954406|58790433|FG002|Overall Study|Progressive Disease|3|||
30778753|NCT02954406|58790434|FG003|Overall Study|Progressive Disease|4|||
30778754|NCT02954406|58790435|FG004|Overall Study|Progressive Disease|3|||
30778755|NCT02954406|58790436|FG005|Overall Study|Progressive Disease|3|||
30778756|NCT02954406|58790437|FG006|Overall Study|Progressive Disease|2|||
30778757|NCT02954406|58790438|FG007|Overall Study|Progressive Disease|2|||
30778758|NCT02954406|58790439|FG008|Overall Study|Progressive Disease|1|||
30778759|NCT02954406|58790440|FG009|Overall Study|Progressive Disease|1|||
30778760|NCT02954406|58790441|FG010|Overall Study|Progressive Disease|0|||
30778761|NCT02954406|58790431|FG000|Overall Study|Symptomatic Deterioration|0|||
30778762|NCT02954406|58790432|FG001|Overall Study|Symptomatic Deterioration|1|||
30778763|NCT02954406|58790433|FG002|Overall Study|Symptomatic Deterioration|0|||
30778764|NCT02954406|58790434|FG003|Overall Study|Symptomatic Deterioration|0|||
30778765|NCT02954406|58790435|FG004|Overall Study|Symptomatic Deterioration|0|||
30778766|NCT02954406|58790436|FG005|Overall Study|Symptomatic Deterioration|0|||
30778767|NCT02954406|58790437|FG006|Overall Study|Symptomatic Deterioration|0|||
30778768|NCT02954406|58790438|FG007|Overall Study|Symptomatic Deterioration|0|||
30778769|NCT02954406|58790439|FG008|Overall Study|Symptomatic Deterioration|0|||
30778770|NCT02954406|58790440|FG009|Overall Study|Symptomatic Deterioration|0|||
30778771|NCT02954406|58790441|FG010|Overall Study|Symptomatic Deterioration|0|||
30778772|NCT02954406|58790431|FG000|Overall Study|Death|0|||
30778773|NCT02954406|58790432|FG001|Overall Study|Death|0|||
30778774|NCT02954406|58790433|FG002|Overall Study|Death|0|||
30778775|NCT02954406|58790434|FG003|Overall Study|Death|0|||
30778776|NCT02954406|58790435|FG004|Overall Study|Death|1|||
30778777|NCT02954406|58790436|FG005|Overall Study|Death|0|||
30778778|NCT02954406|58790437|FG006|Overall Study|Death|0|||
30778779|NCT02954406|58790438|FG007|Overall Study|Death|0|||
30778780|NCT02954406|58790439|FG008|Overall Study|Death|1|||
30778781|NCT02954406|58790440|FG009|Overall Study|Death|1|||
30778782|NCT02954406|58790441|FG010|Overall Study|Death|0|||
30778783|NCT02954406|58790431|FG000|Overall Study|Reason Not Specified|0|||
30778784|NCT02954406|58790432|FG001|Overall Study|Reason Not Specified|0|||
30778785|NCT02954406|58790433|FG002|Overall Study|Reason Not Specified|3|||
30957715|NCT01681433|59021883|FG000|Overall Study|Withdrawal by Subject|5|||
30957716|NCT01681433|59021884|FG001|Overall Study|Withdrawal by Subject|5|||
30778786|NCT02954406|58790434|FG003|Overall Study|Reason Not Specified|2|||
30778787|NCT02954406|58790435|FG004|Overall Study|Reason Not Specified|2|||
30778788|NCT02954406|58790436|FG005|Overall Study|Reason Not Specified|0|||
30778789|NCT02954406|58790437|FG006|Overall Study|Reason Not Specified|1|||
30778790|NCT02954406|58790438|FG007|Overall Study|Reason Not Specified|0|||
30778791|NCT02954406|58790439|FG008|Overall Study|Reason Not Specified|1|||
30778792|NCT02954406|58790440|FG009|Overall Study|Reason Not Specified|0|||
30778793|NCT02954406|58790441|FG010|Overall Study|Reason Not Specified|0|||
30778794|NCT03514914|58790471|FG000|Overall Study|Death|3|||
30778795|NCT03514914|58790472|FG001|Overall Study|Death|3|||
30778796|NCT03514914|58790471|FG000|Overall Study|Lost to Follow-up|117|||
30957717|NCT01681433|59021883|FG000|Overall Study|Protocol Violation|2|||
30957718|NCT01681433|59021884|FG001|Overall Study|Protocol Violation|0|||
30957719|NCT01681433|59021883|FG000|Overall Study|Adverse Event|2|||
30957720|NCT01681433|59021884|FG001|Overall Study|Adverse Event|4|||
30957721|NCT01681433|59021883|FG000|Overall Study|Lost to Follow-up|0|||
30957722|NCT01681433|59021884|FG001|Overall Study|Lost to Follow-up|1|||
30957723|NCT01681277|59021895|FG000|Overall Study|Adverse Event|1|||
30957724|NCT01681277|59021896|FG001|Overall Study|Adverse Event|0|||
30957725|NCT01681277|59021897|FG002|Overall Study|Adverse Event|0|||
30957726|NCT01681277|59021898|FG003|Overall Study|Adverse Event|0|||
30957727|NCT01681277|59021899|FG004|Overall Study|Adverse Event|0|||
30957728|NCT01703117|59021917|FG000|Overall Study|Adverse Event|4|||
30957729|NCT01703117|59021918|FG001|Overall Study|Adverse Event|3|||
30957730|NCT01703117|59021917|FG000|Overall Study|Withdrawal by Subject|0|||
30957731|NCT01703117|59021918|FG001|Overall Study|Withdrawal by Subject|1|||
30778797|NCT03514914|58790472|FG001|Overall Study|Lost to Follow-up|89|||
30778798|NCT03513588|58790481|FG000|Overall Study|Lost to Follow-up|0|||
30778799|NCT03513588|58790482|FG001|Overall Study|Lost to Follow-up|1|||
30854223|NCT03142191|58881567|FG003|Active Treatment Extension Period|Physician Decision|0|||
30854224|NCT03142191|58881568|FG004|Active Treatment Extension Period|Physician Decision|0|||
30957732|NCT01702961|59021926|FG000|Overall Study|Additional treatment|3|||
30957733|NCT01702961|59021926|FG000|Overall Study|Progressive disease|5|||
30957734|NCT01702961|59021926|FG000|Overall Study|Relapse|20|||
30957735|NCT01702961|59021926|FG000|Overall Study|Death|6|||
30957736|NCT01702961|59021926|FG000|Overall Study|Lost to Follow-up|2|||
30957737|NCT01702961|59021926|FG000|Overall Study|Ongoing|11|||
30957738|NCT01593917|59021930|FG000|Overall Study|Death|67|||
30957739|NCT01593917|59021930|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
30957740|NCT01593917|59021930|FG000|Overall Study|Withdrawal by Subject|23|||
30957741|NCT01593917|59021930|FG000|Overall Study|Lost to Follow-up|12|||
30957742|NCT01593917|59021930|FG000|Overall Study|Protocol Violation|5|||
30957743|NCT01593917|59021930|FG000|Overall Study|Physician Decision|3|||
30957744|NCT01593761|59021934|FG000|Overall Study|Lost to Follow-up|1|||
30957745|NCT01593761|59021934|FG000|Overall Study|culture negative for MRSA at baseline|5|||
30957746|NCT01593761|59021934|FG000|Overall Study|positive for hepatitis C virus|1|||
30957747|NCT01593761|59021934|FG000|Overall Study|secondary cellulitis|1|||
30957748|NCT02706834|59021955|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
30957749|NCT02706834|59021956|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
30957750|NCT02706834|59021957|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
30957751|NCT02706834|59021958|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
30778800|NCT03513588|58790483|FG002|Overall Study|Lost to Follow-up|1|||
30778801|NCT03513588|58790481|FG000|Overall Study|Study dosing paused by sponsor|1|||
30778802|NCT03513588|58790482|FG001|Overall Study|Study dosing paused by sponsor|1|||
30778803|NCT03513588|58790483|FG002|Overall Study|Study dosing paused by sponsor|0|||
30854225|NCT03142191|58881564|FG000|Active Treatment Extension Period|Other Reasons|3|||
30854226|NCT03142191|58881565|FG001|Active Treatment Extension Period|Other Reasons|3|||
30854227|NCT03142191|58881566|FG002|Active Treatment Extension Period|Other Reasons|3|||
30854228|NCT03142191|58881567|FG003|Active Treatment Extension Period|Other Reasons|8|||
30854229|NCT03142191|58881568|FG004|Active Treatment Extension Period|Other Reasons|3|||
30957752|NCT02706834|59021959|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
30957753|NCT02706834|59021960|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
30854230|NCT03142191|58881564|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
30957754|NCT02706834|59021961|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
30957755|NCT02706834|59021962|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
30957756|NCT02706834|59021963|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
30957757|NCT02706834|59021964|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
30778804|NCT03513588|58790481|FG000|Overall Study|Death|0|||
30854231|NCT03142191|58881565|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
30957758|NCT02706834|59021965|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
30957759|NCT02706834|59021955|FG000|Overall Study|Lost to Follow-up|0|||
30957760|NCT02706834|59021956|FG001|Overall Study|Lost to Follow-up|0|||
30957761|NCT02706834|59021957|FG002|Overall Study|Lost to Follow-up|1|||
30957762|NCT02706834|59021958|FG003|Overall Study|Lost to Follow-up|0|||
30957763|NCT02706834|59021959|FG004|Overall Study|Lost to Follow-up|0|||
30957764|NCT02706834|59021960|FG005|Overall Study|Lost to Follow-up|0|||
30957765|NCT02706834|59021961|FG006|Overall Study|Lost to Follow-up|0|||
30957766|NCT02706834|59021962|FG007|Overall Study|Lost to Follow-up|0|||
30957767|NCT02706834|59021963|FG008|Overall Study|Lost to Follow-up|0|||
30957768|NCT02706834|59021964|FG009|Overall Study|Lost to Follow-up|0|||
30957769|NCT02706834|59021965|FG010|Overall Study|Lost to Follow-up|0|||
30957770|NCT02706834|59021955|FG000|Overall Study|Voluntary Withdrawal|1|||
30778805|NCT03513588|58790482|FG001|Overall Study|Death|0|||
30778806|NCT03513588|58790483|FG002|Overall Study|Death|1|||
30778807|NCT03512028|58790495|FG000|Overall Study|Withdrawal by Subject|2|||
30778808|NCT03512028|58790496|FG001|Overall Study|Withdrawal by Subject|0|||
30778809|NCT03512028|58790495|FG000|Overall Study|Protocol Violation|2|||
30778810|NCT03512028|58790496|FG001|Overall Study|Protocol Violation|0|||
30778811|NCT03511326|58790502|FG000|Overall Study|Withdrawal by Subject|1|||
30778812|NCT03508830|58790508|FG000|Overall Study|Withdrawal by Subject|3|||
30778813|NCT03508830|58790509|FG001|Overall Study|Withdrawal by Subject|4|||
30778814|NCT03508830|58790508|FG000|Overall Study|Physician Decision|2|||
30778815|NCT03508830|58790509|FG001|Overall Study|Physician Decision|2|||
30778816|NCT03508050|58790517|FG000|Overall Study|Pleural adhesions|1|||
30778817|NCT03508050|58790518|FG001|Overall Study|Pleural adhesions|0|||
30778818|NCT03508050|58790517|FG000|Overall Study|Mucus plug|1|||
30778819|NCT03508050|58790518|FG001|Overall Study|Mucus plug|0|||
30778820|NCT03508050|58790517|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
30778821|NCT03508050|58790518|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
30778822|NCT03508050|58790517|FG000|Overall Study|Sustained desaturation|0|||
30778823|NCT03508050|58790518|FG001|Overall Study|Sustained desaturation|1|||
30778824|NCT03569202|58790527|FG000|Part 3|Physician Decision|1|||
30778825|NCT03569202|58790528|FG001|Part 3|Physician Decision|0|||
30854232|NCT03142191|58881566|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
30854233|NCT03142191|58881567|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
30854234|NCT03142191|58881568|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
30854235|NCT02617628|58881597|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
30854236|NCT02617628|58881598|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
30854237|NCT02308540|58881614|FG000|Overall Study|Lost to Follow-up|0|||
30854238|NCT02308540|58881615|FG001|Overall Study|Lost to Follow-up|0|||
30854239|NCT02308540|58881616|FG002|Overall Study|Lost to Follow-up|0|||
30854240|NCT02308540|58881617|FG003|Overall Study|Lost to Follow-up|0|||
30854241|NCT02308540|58881618|FG004|Overall Study|Lost to Follow-up|0|||
30854242|NCT02308540|58881619|FG005|Overall Study|Lost to Follow-up|1|||
30854243|NCT02308228|58881670|FG000|Overall Study|Adverse Event|3|||
30854244|NCT02308228|58881671|FG001|Overall Study|Adverse Event|4|||
30854245|NCT02308228|58881670|FG000|Overall Study|Withdrawal by Subject|5|||
30854246|NCT02308228|58881671|FG001|Overall Study|Withdrawal by Subject|3|||
30854247|NCT02616614|58881689|FG000|Overall Study|Withdrawal by Subject|10|||
30778826|NCT03569202|58790527|FG000|Part 3|Other|1|||
30778827|NCT03569202|58790528|FG001|Part 3|Other|1|||
30778828|NCT03568500|58790537|FG000|Overall Study|Lost to Follow-up|1|||
30778829|NCT03568500|58790538|FG001|Overall Study|Lost to Follow-up|1|||
30778830|NCT03568500|58790539|FG002|Overall Study|Lost to Follow-up|2|||
30778831|NCT03568500|58790537|FG000|Overall Study|Adverse Event|1|||
30778832|NCT03568500|58790538|FG001|Overall Study|Adverse Event|1|||
30778833|NCT03568500|58790539|FG002|Overall Study|Adverse Event|2|||
30778834|NCT03568500|58790537|FG000|Overall Study|Physician Decision|1|||
30778835|NCT03568500|58790538|FG001|Overall Study|Physician Decision|0|||
30778836|NCT03568500|58790539|FG002|Overall Study|Physician Decision|0|||
30854248|NCT02616614|58881690|FG001|Overall Study|Withdrawal by Subject|5|||
30854249|NCT02616614|58881691|FG002|Overall Study|Withdrawal by Subject|6|||
30957771|NCT02706834|59021956|FG001|Overall Study|Voluntary Withdrawal|0|||
30957772|NCT02706834|59021957|FG002|Overall Study|Voluntary Withdrawal|0|||
30957773|NCT02706834|59021958|FG003|Overall Study|Voluntary Withdrawal|0|||
30778837|NCT03568500|58790537|FG000|Overall Study|Withdrawal by Subject|4|||
30778838|NCT03568500|58790538|FG001|Overall Study|Withdrawal by Subject|2|||
30778839|NCT03568500|58790539|FG002|Overall Study|Withdrawal by Subject|0|||
30778840|NCT03568500|58790537|FG000|Overall Study|Technical Problems|2|||
30854250|NCT02616614|58881689|FG000|Overall Study|Physician Decision|2|||
30854251|NCT02616614|58881690|FG001|Overall Study|Physician Decision|1|||
30957774|NCT02706834|59021959|FG004|Overall Study|Voluntary Withdrawal|0|||
30778841|NCT03568500|58790538|FG001|Overall Study|Technical Problems|1|||
30778842|NCT03568500|58790539|FG002|Overall Study|Technical Problems|0|||
30778843|NCT03568500|58790537|FG000|Overall Study|Participant Noncompliance|1|||
30957775|NCT02706834|59021960|FG005|Overall Study|Voluntary Withdrawal|0|||
30854252|NCT02616614|58881691|FG002|Overall Study|Physician Decision|0|||
30854253|NCT02616614|58881689|FG000|Overall Study|Adverse Event|1|||
30854254|NCT02616614|58881690|FG001|Overall Study|Adverse Event|4|||
30854255|NCT02616614|58881691|FG002|Overall Study|Adverse Event|1|||
30854256|NCT02616614|58881689|FG000|Overall Study|Protocol Violation|0|||
30854257|NCT02616614|58881690|FG001|Overall Study|Protocol Violation|3|||
30854258|NCT02616614|58881691|FG002|Overall Study|Protocol Violation|1|||
30854259|NCT02616614|58881689|FG000|Overall Study|Prohibited Medication|12|||
30854260|NCT02616614|58881690|FG001|Overall Study|Prohibited Medication|9|||
30854261|NCT02616614|58881691|FG002|Overall Study|Prohibited Medication|5|||
30854262|NCT02616614|58881689|FG000|Overall Study|More than 3 applications missed|6|||
30854263|NCT02616614|58881690|FG001|Overall Study|More than 3 applications missed|8|||
30854264|NCT02616614|58881691|FG002|Overall Study|More than 3 applications missed|1|||
30854265|NCT02616614|58881689|FG000|Overall Study|Lost to Follow-up|31|||
30854266|NCT02616614|58881690|FG001|Overall Study|Lost to Follow-up|28|||
30854267|NCT02616614|58881691|FG002|Overall Study|Lost to Follow-up|13|||
30854268|NCT02616614|58881689|FG000|Overall Study|Pregnancy|2|||
30854269|NCT02616614|58881690|FG001|Overall Study|Pregnancy|0|||
30854270|NCT02616614|58881691|FG002|Overall Study|Pregnancy|1|||
30854271|NCT02616614|58881689|FG000|Overall Study|Other|1|||
30957776|NCT02706834|59021961|FG006|Overall Study|Voluntary Withdrawal|0|||
30957777|NCT02706834|59021962|FG007|Overall Study|Voluntary Withdrawal|0|||
30957778|NCT02706834|59021963|FG008|Overall Study|Voluntary Withdrawal|0|||
30957779|NCT02706834|59021964|FG009|Overall Study|Voluntary Withdrawal|1|||
30957780|NCT02706834|59021965|FG010|Overall Study|Voluntary Withdrawal|0|||
30957781|NCT02706834|59021955|FG000|Overall Study|Other Reason Not Specified|1|||
30854272|NCT02616614|58881690|FG001|Overall Study|Other|2|||
30854273|NCT02616614|58881691|FG002|Overall Study|Other|1|||
30854274|NCT02616380|58881717|FG000|Overall Study|Lost to Follow-up|1|||
30957782|NCT02706834|59021956|FG001|Overall Study|Other Reason Not Specified|0|||
30957783|NCT02706834|59021957|FG002|Overall Study|Other Reason Not Specified|0|||
30957784|NCT02706834|59021958|FG003|Overall Study|Other Reason Not Specified|0|||
30957785|NCT02706834|59021959|FG004|Overall Study|Other Reason Not Specified|1|||
30957786|NCT02706834|59021960|FG005|Overall Study|Other Reason Not Specified|0|||
30957787|NCT02706834|59021961|FG006|Overall Study|Other Reason Not Specified|0|||
30957788|NCT02706834|59021962|FG007|Overall Study|Other Reason Not Specified|0|||
30957789|NCT02706834|59021963|FG008|Overall Study|Other Reason Not Specified|0|||
30957790|NCT02706834|59021964|FG009|Overall Study|Other Reason Not Specified|0|||
30957791|NCT02706834|59021965|FG010|Overall Study|Other Reason Not Specified|0|||
30957792|NCT01702025|59022014|FG000|Overall Study|Equipment failure|1|||
30957793|NCT01702025|59022015|FG001|Overall Study|Equipment failure|0|||
30957794|NCT01702025|59022016|FG002|Overall Study|Equipment failure|0|||
30957795|NCT01702025|59022017|FG003|Overall Study|Equipment failure|0|||
30957796|NCT01702025|59022014|FG000|Overall Study|Adverse Event|1|||
30957797|NCT01702025|59022015|FG001|Overall Study|Adverse Event|1|||
30957798|NCT01702025|59022016|FG002|Overall Study|Adverse Event|1|||
30957799|NCT01702025|59022017|FG003|Overall Study|Adverse Event|0|||
30957800|NCT01592747|59022034|FG000|Overall Study|Loss of Therapeutic Response|107|||
30957801|NCT01592747|59022035|FG001|Overall Study|Loss of Therapeutic Response|108|||
30957802|NCT01592747|59022036|FG002|Overall Study|Loss of Therapeutic Response|100|||
30957803|NCT01592747|59022034|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
30957804|NCT01592747|59022035|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
30957805|NCT01592747|59022036|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
30957806|NCT01592747|59022034|FG000|Overall Study|Adverse Event|1|||
30957807|NCT01592747|59022035|FG001|Overall Study|Adverse Event|0|||
30957808|NCT01592747|59022036|FG002|Overall Study|Adverse Event|0|||
30957809|NCT01592747|59022034|FG000|Overall Study|Protocol Violation|4|||
30957810|NCT01592747|59022035|FG001|Overall Study|Protocol Violation|0|||
30957811|NCT01592747|59022036|FG002|Overall Study|Protocol Violation|4|||
30957812|NCT01592747|59022034|FG000|Overall Study|Lack of Efficacy|0|||
30957813|NCT01592747|59022035|FG001|Overall Study|Lack of Efficacy|1|||
30957814|NCT01592747|59022036|FG002|Overall Study|Lack of Efficacy|0|||
30957815|NCT01592747|59022034|FG000|Overall Study|Withdrawal by Subject|2|||
30957816|NCT01592747|59022035|FG001|Overall Study|Withdrawal by Subject|0|||
30957817|NCT01592747|59022036|FG002|Overall Study|Withdrawal by Subject|2|||
30854275|NCT02616380|58881717|FG000|Overall Study|Other|2|||
30854276|NCT04436822|58881727|FG000|Overall Study|Physician Decision|2|||
30957818|NCT01592747|59022034|FG000|Overall Study|Lost to Follow-up|1|||
30854277|NCT04436822|58881728|FG001|Overall Study|Physician Decision|0|||
30854278|NCT04436822|58881727|FG000|Overall Study|Sponsor request|1|||
30957819|NCT01592747|59022035|FG001|Overall Study|Lost to Follow-up|0|||
30957820|NCT01592747|59022036|FG002|Overall Study|Lost to Follow-up|1|||
30957821|NCT01592747|59022034|FG000|Overall Study|Other Reasons|1|||
30957822|NCT01592747|59022035|FG001|Overall Study|Other Reasons|1|||
30854279|NCT04436822|58881728|FG001|Overall Study|Sponsor request|0|||
30854280|NCT04436822|58881727|FG000|Overall Study|Withdrawal by parent/guardian|0|||
30957823|NCT01592747|59022036|FG002|Overall Study|Other Reasons|0|||
30957824|NCT02051608|59022049|FG000|Part 1: Double Blind Treatment|Death|3|||
30957825|NCT02051608|59022050|FG001|Part 1: Double Blind Treatment|Death|3|||
30957826|NCT02051608|59022051|FG002|Part 1: Double Blind Treatment|Death|0|||
30957827|NCT02051608|59022052|FG003|Part 1: Double Blind Treatment|Death|0|||
30957828|NCT02051608|59022049|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
30957829|NCT02051608|59022050|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
30957830|NCT02051608|59022051|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
30957831|NCT02051608|59022052|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
30957832|NCT02051608|59022049|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
30957833|NCT02051608|59022050|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
30957834|NCT02051608|59022051|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
30957835|NCT02051608|59022052|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
30957836|NCT02051608|59022049|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
30957837|NCT02051608|59022050|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
30957838|NCT02051608|59022051|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
30957839|NCT02051608|59022052|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
30957840|NCT02051608|59022049|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
30957841|NCT02051608|59022050|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
30778844|NCT03568500|58790538|FG001|Overall Study|Participant Noncompliance|1|||
30778845|NCT03568500|58790539|FG002|Overall Study|Participant Noncompliance|0|||
30778846|NCT03504852|58790564|FG000|Overall Study|Withdrawal of informed consent|2|||
30778847|NCT03504852|58790565|FG001|Overall Study|Withdrawal of informed consent|1|||
30778848|NCT03504852|58790566|FG002|Overall Study|Withdrawal of informed consent|0|||
30778849|NCT03504852|58790564|FG000|Overall Study|Withdrawal by Subject|5|||
30778850|NCT03504852|58790565|FG001|Overall Study|Withdrawal by Subject|5|||
30778851|NCT03504852|58790566|FG002|Overall Study|Withdrawal by Subject|1|||
30778852|NCT03504852|58790564|FG000|Overall Study|Lost to Follow-up|4|||
30778853|NCT03504852|58790565|FG001|Overall Study|Lost to Follow-up|1|||
30778854|NCT03504852|58790566|FG002|Overall Study|Lost to Follow-up|0|||
30778855|NCT03504852|58790564|FG000|Overall Study|New therapy for study indication|1|||
30778856|NCT03504852|58790565|FG001|Overall Study|New therapy for study indication|0|||
30854281|NCT04436822|58881728|FG001|Overall Study|Withdrawal by parent/guardian|3|||
30854282|NCT04436822|58881727|FG000|Overall Study|Unsuccessful procedure|0|||
30854283|NCT04436822|58881728|FG001|Overall Study|Unsuccessful procedure|1|||
30854284|NCT04436822|58881727|FG000|Overall Study|Withdrawal due to Covid-19|8|||
30854285|NCT04436822|58881728|FG001|Overall Study|Withdrawal due to Covid-19|1|||
30854286|NCT04436822|58881727|FG000|Overall Study|Withdrawal by Subject|1|||
30854287|NCT04436822|58881728|FG001|Overall Study|Withdrawal by Subject|0|||
30854288|NCT04436822|58881727|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
30854289|NCT04436822|58881728|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
30854290|NCT01596062|58881738|FG000|Overall Study|Adverse Event|1|||
30854291|NCT01596062|58881739|FG001|Overall Study|Adverse Event|0|||
30854292|NCT01596062|58881740|FG002|Overall Study|Adverse Event|2|||
30854293|NCT01596062|58881738|FG000|Overall Study|Lack of Efficacy|0|||
30854294|NCT01596062|58881739|FG001|Overall Study|Lack of Efficacy|0|||
30854295|NCT01596062|58881740|FG002|Overall Study|Lack of Efficacy|1|||
30854296|NCT02614898|58881759|FG000|Overall Study|Participated until study termination|10|||
30854297|NCT02614898|58881760|FG001|Overall Study|Participated until study termination|26|||
30957842|NCT02051608|59022051|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
30778857|NCT03504852|58790566|FG002|Overall Study|New therapy for study indication|0|||
30778858|NCT03504852|58790564|FG000|Overall Study|Lack of Efficacy|1|||
30778859|NCT03504852|58790565|FG001|Overall Study|Lack of Efficacy|2|||
30778860|NCT03504852|58790566|FG002|Overall Study|Lack of Efficacy|0|||
30778861|NCT03504852|58790564|FG000|Overall Study|Death|0|||
30778862|NCT03504852|58790565|FG001|Overall Study|Death|1|||
30778863|NCT03504852|58790566|FG002|Overall Study|Death|0|||
30778864|NCT03504852|58790564|FG000|Overall Study|Adverse Event|4|||
30854298|NCT02614898|58881759|FG000|Overall Study|Lost to Follow-up|0|||
30854299|NCT02614898|58881760|FG001|Overall Study|Lost to Follow-up|2|||
30957843|NCT02051608|59022052|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
30957844|NCT02051608|59022049|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
30778865|NCT03504852|58790565|FG001|Overall Study|Adverse Event|8|||
30778866|NCT03504852|58790566|FG002|Overall Study|Adverse Event|2|||
30778867|NCT03025828|58790576|FG000|Overall Study|Lost to Follow-up|1|||
30778868|NCT03546816|58790582|FG000|Overall Study|Adverse Event|5|||
30957845|NCT02051608|59022050|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
30957846|NCT02051608|59022051|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
30957847|NCT02051608|59022052|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
30957848|NCT02051608|59022049|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
30957849|NCT02051608|59022050|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
30957850|NCT02051608|59022051|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
30957851|NCT02051608|59022052|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
30957852|NCT02051608|59022049|FG000|Part 1: Double Blind Treatment|Other|6|||
30957853|NCT02051608|59022050|FG001|Part 1: Double Blind Treatment|Other|3|||
30957854|NCT02051608|59022051|FG002|Part 1: Double Blind Treatment|Other|0|||
30957855|NCT02051608|59022052|FG003|Part 1: Double Blind Treatment|Other|0|||
30957856|NCT02051608|59022049|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
30957857|NCT02051608|59022050|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
30957858|NCT02051608|59022051|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
30957859|NCT02051608|59022052|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
30957860|NCT02051608|59022049|FG000|Part 2: Open-label Extension|Adverse Event|0|||
30957861|NCT02051608|59022050|FG001|Part 2: Open-label Extension|Adverse Event|0|||
30957862|NCT02051608|59022051|FG002|Part 2: Open-label Extension|Adverse Event|6|||
30957863|NCT02051608|59022052|FG003|Part 2: Open-label Extension|Adverse Event|8|||
30957864|NCT02051608|59022049|FG000|Part 2: Open-label Extension|Death|0|||
30957865|NCT02051608|59022050|FG001|Part 2: Open-label Extension|Death|0|||
30854300|NCT02614898|58881759|FG000|Overall Study|Physician Decision|1|||
30854301|NCT02614898|58881760|FG001|Overall Study|Physician Decision|8|||
30854302|NCT02614898|58881759|FG000|Overall Study|Study Terminated by Sponsor|3|||
30854303|NCT02614898|58881760|FG001|Overall Study|Study Terminated by Sponsor|0|||
30854304|NCT02614898|58881759|FG000|Overall Study|Withdrawal by Subject|0|||
30854305|NCT02614898|58881760|FG001|Overall Study|Withdrawal by Subject|2|||
30854306|NCT02614898|58881759|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
30957866|NCT02051608|59022051|FG002|Part 2: Open-label Extension|Death|7|||
30957867|NCT02051608|59022052|FG003|Part 2: Open-label Extension|Death|4|||
30957868|NCT02051608|59022049|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
30957869|NCT02051608|59022050|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
30957870|NCT02051608|59022051|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
30957871|NCT02051608|59022052|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
30957872|NCT02051608|59022049|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
30957873|NCT02051608|59022050|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
30957874|NCT02051608|59022051|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
30957875|NCT02051608|59022052|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
30957876|NCT02051608|59022049|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
30957877|NCT02051608|59022050|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
30957878|NCT02051608|59022051|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
30957879|NCT02051608|59022052|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
30957880|NCT02051608|59022049|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
30957881|NCT02051608|59022050|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
30957882|NCT02051608|59022051|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
30957883|NCT02051608|59022052|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
30957884|NCT02051608|59022049|FG000|Part 2: Open-label Extension|Physician Decision|0|||
30957885|NCT02051608|59022050|FG001|Part 2: Open-label Extension|Physician Decision|0|||
30957886|NCT02051608|59022051|FG002|Part 2: Open-label Extension|Physician Decision|8|||
30957887|NCT02051608|59022052|FG003|Part 2: Open-label Extension|Physician Decision|5|||
30957888|NCT02051608|59022049|FG000|Part 2: Open-label Extension|Other|0|||
30957889|NCT02051608|59022050|FG001|Part 2: Open-label Extension|Other|0|||
30957890|NCT02051608|59022051|FG002|Part 2: Open-label Extension|Other|9|||
30957891|NCT02051608|59022052|FG003|Part 2: Open-label Extension|Other|9|||
30957892|NCT02705586|59022065|FG000|Overall Study|Health Issues|2|||
30957893|NCT02705586|59022065|FG000|Overall Study|Transportation Difficulties|5|||
30957894|NCT02705586|59022065|FG000|Overall Study|Vacation/Planned Absence|1|||
30957895|NCT01592045|59022071|FG000|Overall Study|Disease Progression|1|||
30957896|NCT01592045|59022072|FG001|Overall Study|Disease Progression|1|||
30854307|NCT02614898|58881760|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
30957897|NCT01592045|59022071|FG000|Overall Study|Adverse Event|1|||
30957898|NCT01592045|59022072|FG001|Overall Study|Adverse Event|1|||
30854308|NCT02614898|58881759|FG000|Overall Study|Other-Additional Information Unavailable|0|||
30957899|NCT01592045|59022071|FG000|Overall Study|Withdrawal by Subject|1|||
30854309|NCT02614898|58881760|FG001|Overall Study|Other-Additional Information Unavailable|11|||
30854310|NCT02614898|58881759|FG000|Overall Study|Missing|0|||
30854311|NCT02614898|58881760|FG001|Overall Study|Missing|1|||
30854312|NCT02777593|58881772|FG000|Overall Study|Still in study|66|||
30854313|NCT02777593|58881773|FG001|Overall Study|Still in study|105|||
30854314|NCT02777593|58881774|FG002|Overall Study|Still in study|10|||
30854315|NCT02777593|58881775|FG003|Overall Study|Still in study|8|||
30854316|NCT02777593|58881776|FG004|Overall Study|Still in study|6|||
30662913|NCT00909389|58676570|FG000|Overall Study|Adverse Event|6|||
30662914|NCT00909389|58676570|FG000|Overall Study|Death|4|||
30854317|NCT02777593|58881772|FG000|Overall Study|Death|11|||
30854318|NCT02777593|58881773|FG001|Overall Study|Death|19|||
30854319|NCT02777593|58881774|FG002|Overall Study|Death|0|||
30854320|NCT02777593|58881775|FG003|Overall Study|Death|4|||
30854321|NCT02777593|58881776|FG004|Overall Study|Death|0|||
30854322|NCT02777593|58881772|FG000|Overall Study|Withdrawal by Subject|5|||
30854323|NCT02777593|58881773|FG001|Overall Study|Withdrawal by Subject|1|||
30854324|NCT02777593|58881774|FG002|Overall Study|Withdrawal by Subject|0|||
30854325|NCT02777593|58881775|FG003|Overall Study|Withdrawal by Subject|1|||
30854326|NCT02777593|58881776|FG004|Overall Study|Withdrawal by Subject|0|||
30854327|NCT02777593|58881772|FG000|Overall Study|Lost to Follow-up|1|||
30854328|NCT02777593|58881773|FG001|Overall Study|Lost to Follow-up|6|||
30854329|NCT02777593|58881774|FG002|Overall Study|Lost to Follow-up|0|||
30854330|NCT02777593|58881775|FG003|Overall Study|Lost to Follow-up|0|||
30854331|NCT02777593|58881776|FG004|Overall Study|Lost to Follow-up|0|||
30854332|NCT02777593|58881772|FG000|Overall Study|Physician Decision|0|||
30854333|NCT02777593|58881773|FG001|Overall Study|Physician Decision|1|||
30854334|NCT02777593|58881774|FG002|Overall Study|Physician Decision|0|||
30854335|NCT02777593|58881775|FG003|Overall Study|Physician Decision|0|||
30957900|NCT01592045|59022072|FG001|Overall Study|Withdrawal by Subject|0|||
30957901|NCT01592045|59022071|FG000|Overall Study|Moved out of country|2|||
30957902|NCT01592045|59022072|FG001|Overall Study|Moved out of country|0|||
30957903|NCT01591499|59022080|FG000|Baseline Visit|Withdrawal by Subject|0|||
30957904|NCT01591499|59022081|FG001|Baseline Visit|Withdrawal by Subject|2|||
30957905|NCT01591499|59022082|FG002|Baseline Visit|Withdrawal by Subject|0|||
30957906|NCT01591499|59022083|FG003|Baseline Visit|Withdrawal by Subject|2|||
30957907|NCT01591499|59022080|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
30957908|NCT01591499|59022081|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
30957909|NCT01591499|59022082|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
30957910|NCT01591499|59022083|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
30957911|NCT01591499|59022080|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
30957912|NCT01591499|59022081|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
30957913|NCT01591499|59022082|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
30957914|NCT01591499|59022083|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
30957915|NCT01981720|59022107|FG000|Overall Study|Adverse Event|1|||
30957916|NCT01981720|59022107|FG000|Overall Study|Withdrawal by Subject|3|||
30957917|NCT01981720|59022107|FG000|Overall Study|Pregnancy|1|||
30957918|NCT01590797|59022117|FG000|Overall Study|Adverse Event|4|||
30957919|NCT01590797|59022118|FG001|Overall Study|Adverse Event|3|||
30957920|NCT01590797|59022117|FG000|Overall Study|Lack of Efficacy|0|||
30957921|NCT01590797|59022118|FG001|Overall Study|Lack of Efficacy|2|||
30957922|NCT01590797|59022117|FG000|Overall Study|Lost to Follow-up|0|||
30957923|NCT01590797|59022118|FG001|Overall Study|Lost to Follow-up|1|||
30854336|NCT02777593|58881776|FG004|Overall Study|Physician Decision|0|||
30854337|NCT02777593|58881772|FG000|Overall Study|Discontinued due to Other|2|||
30957924|NCT01590797|59022117|FG000|Overall Study|Protocol Violation|4|||
30957925|NCT01590797|59022118|FG001|Overall Study|Protocol Violation|1|||
30957926|NCT01590797|59022117|FG000|Overall Study|Withdrawal by Subject|7|||
30957927|NCT01590797|59022118|FG001|Overall Study|Withdrawal by Subject|5|||
30957928|NCT01590797|59022117|FG000|Overall Study|Other Protocol Specified Criteria|2|||
30957929|NCT01590797|59022118|FG001|Overall Study|Other Protocol Specified Criteria|4|||
30957930|NCT01590563|59022124|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
30957931|NCT01701401|59022133|FG000|Overall Study|Randomized But Not Treated|3|||
30957932|NCT01701401|59022134|FG001|Overall Study|Randomized But Not Treated|1|||
30957933|NCT01701401|59022135|FG002|Overall Study|Randomized But Not Treated|0|||
30957934|NCT01701401|59022136|FG003|Overall Study|Randomized But Not Treated|1|||
30957935|NCT01701401|59022133|FG000|Overall Study|Lost to Follow-up|5|||
30957936|NCT01701401|59022134|FG001|Overall Study|Lost to Follow-up|5|||
30957937|NCT01701401|59022135|FG002|Overall Study|Lost to Follow-up|1|||
30957938|NCT01701401|59022136|FG003|Overall Study|Lost to Follow-up|3|||
30957939|NCT01701401|59022133|FG000|Overall Study|Withdrew Consent|0|||
30957940|NCT01701401|59022134|FG001|Overall Study|Withdrew Consent|3|||
30957941|NCT01701401|59022135|FG002|Overall Study|Withdrew Consent|1|||
30957942|NCT01701401|59022136|FG003|Overall Study|Withdrew Consent|2|||
30957943|NCT01701401|59022133|FG000|Overall Study|Lack of Efficacy|1|||
30957944|NCT01701401|59022134|FG001|Overall Study|Lack of Efficacy|0|||
30854338|NCT02777593|58881773|FG001|Overall Study|Discontinued due to Other|0|||
30854339|NCT02777593|58881774|FG002|Overall Study|Discontinued due to Other|0|||
30957945|NCT01701401|59022135|FG002|Overall Study|Lack of Efficacy|2|||
30957946|NCT01701401|59022136|FG003|Overall Study|Lack of Efficacy|0|||
30957947|NCT01701401|59022133|FG000|Overall Study|Adverse Event|1|||
30854340|NCT02777593|58881775|FG003|Overall Study|Discontinued due to Other|0|||
30854341|NCT02777593|58881776|FG004|Overall Study|Discontinued due to Other|0|||
30854342|NCT02776033|58881801|FG000|Overall Study|Withdrawal by Subject|0|||
30957948|NCT01701401|59022134|FG001|Overall Study|Adverse Event|0|||
30957949|NCT01701401|59022135|FG002|Overall Study|Adverse Event|0|||
30957950|NCT01701401|59022136|FG003|Overall Study|Adverse Event|0|||
30854343|NCT02776033|58881802|FG001|Overall Study|Withdrawal by Subject|0|||
30854344|NCT02776033|58881803|FG002|Overall Study|Withdrawal by Subject|2|||
30854345|NCT02776033|58881801|FG000|Overall Study|Physician Decision|2|||
30957951|NCT01701401|59022133|FG000|Overall Study|Protocol Violation|0|||
30957952|NCT01701401|59022134|FG001|Overall Study|Protocol Violation|0|||
30957953|NCT01701401|59022135|FG002|Overall Study|Protocol Violation|1|||
30957954|NCT01701401|59022136|FG003|Overall Study|Protocol Violation|0|||
30854346|NCT02776033|58881802|FG001|Overall Study|Physician Decision|0|||
30957955|NCT01701245|59022148|FG000|Overall Study|Protocol Violation|1|||
30957956|NCT01701245|59022149|FG001|Overall Study|Protocol Violation|3|||
30957957|NCT01701245|59022148|FG000|Overall Study|Did not complete the open label period|11|||
30957958|NCT01701245|59022149|FG001|Overall Study|Did not complete the open label period|12|||
30957959|NCT01590017|59022155|FG000|Overall Study|Adverse Event|1|||
30957960|NCT01590017|59022155|FG000|Overall Study|Withdrawal by Subject|1|||
30957961|NCT01590017|59022155|FG000|Overall Study|Lack of Efficacy|1|||
30854347|NCT02776033|58881803|FG002|Overall Study|Physician Decision|0|||
30854348|NCT02776033|58881801|FG000|Overall Study|Lost to Follow-up|1|||
30854349|NCT02776033|58881802|FG001|Overall Study|Lost to Follow-up|0|||
30854350|NCT02776033|58881803|FG002|Overall Study|Lost to Follow-up|0|||
30957962|NCT01590017|59022155|FG000|Overall Study|Physician Decision|1|||
30957963|NCT01700621|59022161|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
30957964|NCT01700621|59022162|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
30957965|NCT01700621|59022161|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
30778869|NCT03546816|58790583|FG001|Overall Study|Adverse Event|3|||
30778870|NCT03546816|58790582|FG000|Overall Study|Lack of Efficacy|2|||
30778871|NCT03546816|58790583|FG001|Overall Study|Lack of Efficacy|4|||
30778872|NCT03546816|58790582|FG000|Overall Study|Pregnancy|1|||
30778873|NCT03546816|58790583|FG001|Overall Study|Pregnancy|0|||
30778874|NCT03546816|58790582|FG000|Overall Study|Physician Decision|2|||
30778875|NCT03546816|58790583|FG001|Overall Study|Physician Decision|0|||
30778876|NCT03546816|58790582|FG000|Overall Study|Withdrawal by Subject|8|||
30778877|NCT03546816|58790583|FG001|Overall Study|Withdrawal by Subject|10|||
30778878|NCT03546816|58790582|FG000|Overall Study|Lost to Follow-up|3|||
30957966|NCT01700621|59022162|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
30957967|NCT01700621|59022161|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
30957968|NCT01700621|59022162|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
30854351|NCT02776033|58881801|FG000|Overall Study|Adverse Event|1|||
30854352|NCT02776033|58881802|FG001|Overall Study|Adverse Event|2|||
30778879|NCT03546816|58790583|FG001|Overall Study|Lost to Follow-up|2|||
30778880|NCT03024970|58790591|FG000|First Intervention|Adverse Event|1|||
30778881|NCT03024970|58790592|FG001|First Intervention|Adverse Event|0|||
30778882|NCT03024970|58790591|FG000|Second Intervention|Lost to Follow-up|1|||
30778883|NCT03024970|58790592|FG001|Second Intervention|Lost to Follow-up|0|||
30778884|NCT03500094|58790598|FG000|Overall Study|Withdrawal by Subject|1|||
30778885|NCT03500094|58790598|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
30778886|NCT03500094|58790598|FG000|Overall Study|Lost to Follow-up|1|||
30778887|NCT03566550|58790606|FG000|Overall Study|Withdrawal by Subject|0|||
30778888|NCT03566550|58790607|FG001|Overall Study|Withdrawal by Subject|1|||
30778889|NCT03566238|58790616|FG000|Overall Study|Adverse Event|0|||
30778890|NCT03566238|58790617|FG001|Overall Study|Adverse Event|1|||
30778891|NCT03566238|58790618|FG002|Overall Study|Adverse Event|0|||
30778892|NCT03566238|58790616|FG000|Overall Study|Lack of Efficacy|4|||
30957969|NCT01589237|59022173|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
30957970|NCT01589237|59022174|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
30957971|NCT01589237|59022175|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
30957972|NCT01589237|59022176|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
30957973|NCT01589237|59022173|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
30957974|NCT01589237|59022174|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
30957975|NCT01589237|59022175|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
30957976|NCT01589237|59022176|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
30957977|NCT01589237|59022173|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
30957978|NCT01589237|59022174|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
30957979|NCT01589237|59022175|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
30957980|NCT01589237|59022176|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
30957981|NCT01589237|59022173|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
30957982|NCT01589237|59022174|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
30957983|NCT01589237|59022175|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
30957984|NCT01589237|59022176|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
30957985|NCT01700387|59022192|FG000|Overall Study|Withdrawal by Subject|1|||
30957986|NCT01700387|59022193|FG001|Overall Study|Withdrawal by Subject|2|||
30957987|NCT01700387|59022192|FG000|Overall Study|Adverse Event|1|||
30957988|NCT01700387|59022193|FG001|Overall Study|Adverse Event|1|||
30957989|NCT01700387|59022192|FG000|Overall Study|Lost to Follow-up|2|||
30957990|NCT01700387|59022193|FG001|Overall Study|Lost to Follow-up|1|||
30957991|NCT01699685|59022205|FG000|Period 1|Adverse Event|1|||
30957992|NCT01699685|59022206|FG001|Period 1|Adverse Event|1|||
30957993|NCT01699685|59022205|FG000|Period 1|Medical or ethical, noncompliance|2|||
30957994|NCT01699685|59022206|FG001|Period 1|Medical or ethical, noncompliance|0|||
30957995|NCT01699685|59022205|FG000|Period 1|Other|0|||
30957996|NCT01699685|59022206|FG001|Period 1|Other|1|||
30957997|NCT01699685|59022205|FG000|Period 1|Patient request|0|||
30957998|NCT01699685|59022206|FG001|Period 1|Patient request|1|||
30957999|NCT01699685|59022205|FG000|Period 2|Lost to Follow-up|1|||
30958000|NCT01699685|59022206|FG001|Period 2|Lost to Follow-up|0|||
30958001|NCT01587989|59022214|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
30778893|NCT03566238|58790617|FG001|Overall Study|Lack of Efficacy|2|||
30778894|NCT03566238|58790618|FG002|Overall Study|Lack of Efficacy|5|||
30778895|NCT03566238|58790616|FG000|Overall Study|Other|1|||
30778896|NCT03566238|58790617|FG001|Overall Study|Other|0|||
30854353|NCT02776033|58881803|FG002|Overall Study|Adverse Event|0|||
30854354|NCT02777125|58881819|FG000|Overall Study|Consent form violation|14|||
30854355|NCT02777125|58881820|FG001|Overall Study|Consent form violation|12|||
30854356|NCT02777125|58881819|FG000|Overall Study|Assent form violation|21|||
30854357|NCT02777125|58881820|FG001|Overall Study|Assent form violation|23|||
30854358|NCT02777125|58881819|FG000|Overall Study|Protocol Violation|8|||
30854359|NCT02777125|58881820|FG001|Overall Study|Protocol Violation|12|||
30854360|NCT02769481|58881845|FG000|Overall Study|Protocol Violation|1|||
30854361|NCT02769481|58881846|FG001|Overall Study|Protocol Violation|0|||
30778897|NCT03566238|58790618|FG002|Overall Study|Other|0|||
30778898|NCT02894502|58790629|FG000|Baseline|Withdrawal by Subject|24|||
30778899|NCT02894502|58790630|FG001|Baseline|Withdrawal by Subject|31|||
30778900|NCT02894502|58790631|FG002|Baseline|Withdrawal by Subject|36|||
30778901|NCT02894502|58790629|FG000|Baseline|Death|3|||
30778902|NCT02894502|58790630|FG001|Baseline|Death|1|||
30778903|NCT02894502|58790631|FG002|Baseline|Death|9|||
30854362|NCT02769481|58881845|FG000|Overall Study|Adverse Event|3|||
30854363|NCT02769481|58881846|FG001|Overall Study|Adverse Event|6|||
30958002|NCT01587989|59022215|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
30958003|NCT01587989|59022216|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
30778904|NCT02894502|58790629|FG000|First Follow up|Withdrawal by Subject|32|||
30778905|NCT02894502|58790630|FG001|First Follow up|Withdrawal by Subject|29|||
30854364|NCT02769481|58881845|FG000|Overall Study|Entry Criteria Not Met|1|||
30958004|NCT01587989|59022214|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
30958005|NCT01587989|59022215|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
30958006|NCT01587989|59022216|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
30778906|NCT02894502|58790631|FG002|First Follow up|Withdrawal by Subject|37|||
30778907|NCT02894502|58790629|FG000|First Follow up|Death|2|||
30958007|NCT01587989|59022214|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
30958008|NCT01587989|59022215|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
30958009|NCT01587989|59022216|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
30958010|NCT01587989|59022214|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
30958011|NCT01587989|59022215|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
30958012|NCT01587989|59022216|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
30958013|NCT01587989|59022214|FG000|Randomized Study Treatment|Screening failure|0|||
30958014|NCT01587989|59022215|FG001|Randomized Study Treatment|Screening failure|1|||
30958015|NCT01587989|59022216|FG002|Randomized Study Treatment|Screening failure|0|||
30958016|NCT01587989|59022214|FG000|Randomized Study Treatment|Physician Decision|0|||
30958017|NCT01587989|59022215|FG001|Randomized Study Treatment|Physician Decision|0|||
30958018|NCT01587989|59022216|FG002|Randomized Study Treatment|Physician Decision|1|||
30958019|NCT01697969|59022222|FG000|Overall Study|Did not meet inc/exc criteria|3|||
30958020|NCT01586819|59022229|FG000|Overall Study|Withdrawal by Subject|1|||
30958021|NCT01586819|59022230|FG001|Overall Study|Withdrawal by Subject|0|||
30958022|NCT01697579|59022241|FG000|Base Study-Cycle 1|Adverse Event|1|||
30958023|NCT01697579|59022242|FG001|Base Study-Cycle 1|Adverse Event|0|||
30958024|NCT01697579|59022243|FG002|Base Study-Cycle 1|Adverse Event|0|||
30958025|NCT01697579|59022244|FG003|Base Study-Cycle 1|Adverse Event|0|||
30958026|NCT01697579|59022245|FG004|Base Study-Cycle 1|Adverse Event|0|||
30854365|NCT02769481|58881846|FG001|Overall Study|Entry Criteria Not Met|2|||
30854366|NCT02769481|58881845|FG000|Overall Study|Withdrawal by Subject|14|||
30854367|NCT02769481|58881846|FG001|Overall Study|Withdrawal by Subject|16|||
30854368|NCT02769481|58881845|FG000|Overall Study|Lost to Follow-up|9|||
30854369|NCT02769481|58881846|FG001|Overall Study|Lost to Follow-up|9|||
30854370|NCT02769481|58881845|FG000|Overall Study|Physician Decision|0|||
30854371|NCT02769481|58881846|FG001|Overall Study|Physician Decision|1|||
30854372|NCT02769481|58881845|FG000|Overall Study|Terminated by Sponsor|1|||
30854373|NCT02769481|58881846|FG001|Overall Study|Terminated by Sponsor|0|||
30854374|NCT02769481|58881845|FG000|Overall Study|Death|0|||
30854375|NCT02769481|58881846|FG001|Overall Study|Death|1|||
30854376|NCT02769481|58881845|FG000|Overall Study|Undefined|4|||
30854377|NCT02769481|58881846|FG001|Overall Study|Undefined|1|||
30854378|NCT02769247|58881856|FG000|Overall Study|Withdrawal by Subject|1|||
30854379|NCT02769247|58881857|FG001|Overall Study|Withdrawal by Subject|0|||
30854380|NCT02769247|58881858|FG002|Overall Study|Withdrawal by Subject|0|||
30854381|NCT02769247|58881859|FG003|Overall Study|Withdrawal by Subject|1|||
30854382|NCT02769247|58881856|FG000|Overall Study|Protocol Violation|0|||
30854383|NCT02769247|58881857|FG001|Overall Study|Protocol Violation|0|||
30854384|NCT02769247|58881858|FG002|Overall Study|Protocol Violation|1|||
30854385|NCT02769247|58881859|FG003|Overall Study|Protocol Violation|0|||
30958027|NCT01697579|59022246|FG005|Base Study-Cycle 1|Adverse Event|0|||
30854386|NCT02769247|58881856|FG000|Overall Study|Physician Decision|1|||
30958028|NCT01697579|59022247|FG006|Base Study-Cycle 1|Adverse Event|0|||
30854387|NCT02769247|58881857|FG001|Overall Study|Physician Decision|0|||
30854388|NCT02769247|58881858|FG002|Overall Study|Physician Decision|0|||
30854389|NCT02769247|58881859|FG003|Overall Study|Physician Decision|0|||
30958029|NCT01697579|59022241|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
30854390|NCT02773537|58881876|FG000|Overall Study|Lost to Follow-up|0|||
30778908|NCT02894502|58790630|FG001|First Follow up|Death|2|||
30778909|NCT02894502|58790631|FG002|First Follow up|Death|3|||
30778910|NCT02894502|58790629|FG000|Second Follow up|Withdrawal by Subject|13|||
30854391|NCT02773537|58881877|FG001|Overall Study|Lost to Follow-up|1|||
30854392|NCT02773537|58881878|FG002|Overall Study|Lost to Follow-up|4|||
30854393|NCT02780713|58881886|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
30854394|NCT02780713|58881887|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
30854395|NCT02780713|58881888|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
30854396|NCT02780713|58881889|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
30854397|NCT02780713|58881890|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
30958030|NCT01697579|59022242|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
30958031|NCT01697579|59022243|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
30958032|NCT01697579|59022244|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
30958033|NCT01697579|59022245|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
30958034|NCT01697579|59022246|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
30958035|NCT01697579|59022247|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
30958036|NCT01697579|59022241|FG000|Base Study-Cycle 1|Protocol Violation|0|||
30958037|NCT01697579|59022242|FG001|Base Study-Cycle 1|Protocol Violation|0|||
30958038|NCT01697579|59022243|FG002|Base Study-Cycle 1|Protocol Violation|0|||
30958039|NCT01697579|59022244|FG003|Base Study-Cycle 1|Protocol Violation|0|||
30958040|NCT01697579|59022245|FG004|Base Study-Cycle 1|Protocol Violation|3|||
30958041|NCT01697579|59022246|FG005|Base Study-Cycle 1|Protocol Violation|0|||
30958042|NCT01697579|59022247|FG006|Base Study-Cycle 1|Protocol Violation|0|||
30958043|NCT01697579|59022241|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
30958044|NCT01697579|59022242|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
30958045|NCT01697579|59022243|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
30958046|NCT01697579|59022244|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
30958047|NCT01697579|59022245|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
30958048|NCT01697579|59022246|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
30958049|NCT01697579|59022247|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
30958050|NCT01697579|59022241|FG000|Base Study-Cycle 1|Technical Problems|0|||
30958051|NCT01697579|59022242|FG001|Base Study-Cycle 1|Technical Problems|0|||
30958052|NCT01697579|59022243|FG002|Base Study-Cycle 1|Technical Problems|1|||
30958053|NCT01697579|59022244|FG003|Base Study-Cycle 1|Technical Problems|1|||
30958054|NCT01697579|59022245|FG004|Base Study-Cycle 1|Technical Problems|0|||
30958055|NCT01697579|59022246|FG005|Base Study-Cycle 1|Technical Problems|0|||
30958056|NCT01697579|59022247|FG006|Base Study-Cycle 1|Technical Problems|0|||
30958057|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Death|0|||
30958058|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Death|0|||
30958059|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Death|0|||
30958060|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Death|0|||
30958061|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Death|0|||
30958062|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Death|0|||
30958063|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Death|2|||
30778911|NCT02894502|58790630|FG001|Second Follow up|Withdrawal by Subject|15|||
30778912|NCT02894502|58790631|FG002|Second Follow up|Withdrawal by Subject|13|||
30778913|NCT02894502|58790629|FG000|Second Follow up|Death|2|||
30778914|NCT02894502|58790630|FG001|Second Follow up|Death|3|||
30778915|NCT02894502|58790631|FG002|Second Follow up|Death|1|||
30778916|NCT02894502|58790629|FG000|Third Follow up|Withdrawal by Subject|5|||
30778917|NCT02894502|58790630|FG001|Third Follow up|Withdrawal by Subject|6|||
30778918|NCT02894502|58790631|FG002|Third Follow up|Withdrawal by Subject|3|||
30778919|NCT02894502|58790629|FG000|Third Follow up|Death|1|||
30778920|NCT02894502|58790630|FG001|Third Follow up|Death|1|||
30958064|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
30958065|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
30958066|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
30958067|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
30778921|NCT02894502|58790631|FG002|Third Follow up|Death|0|||
30778922|NCT03449030|58790652|FG000|Overall Study|Withdrawal by Subject|0|||
30778923|NCT03449030|58790653|FG001|Overall Study|Withdrawal by Subject|0|||
30778924|NCT03449030|58790654|FG002|Overall Study|Withdrawal by Subject|0|||
30854398|NCT02767765|58881909|FG000|Overall Study|Adverse Event|4|||
30662915|NCT00909389|58676570|FG000|Overall Study|Poor Compliance|16|||
30662916|NCT00909389|58676570|FG000|Overall Study|Lost to Follow-up|4|||
30662917|NCT00909389|58676570|FG000|Overall Study|No Information|103|||
30662918|NCT00910715|58676577|FG000|Overall Study|Lost to Follow-up|22|||
30778925|NCT03449030|58790655|FG003|Overall Study|Withdrawal by Subject|1|||
30778926|NCT03449030|58790656|FG004|Overall Study|Withdrawal by Subject|1|||
30778927|NCT03449030|58790657|FG005|Overall Study|Withdrawal by Subject|1|||
30854399|NCT02767765|58881909|FG000|Overall Study|Death|1|||
30854400|NCT02767765|58881909|FG000|Overall Study|Insufficient response|1|||
30854401|NCT02767765|58881909|FG000|Overall Study|Lost to Follow-up|2|||
30854402|NCT02767765|58881909|FG000|Overall Study|Investigator decision|1|||
30854403|NCT02767765|58881909|FG000|Overall Study|Non-Compliance|1|||
30854404|NCT02767765|58881909|FG000|Overall Study|Withdrawal by Subject|1|||
30854405|NCT02772757|58881916|FG000|Overall Study|Withdrawal by Subject|1|||
30854406|NCT02772757|58881917|FG001|Overall Study|Withdrawal by Subject|0|||
30854407|NCT02772757|58881918|FG002|Overall Study|Withdrawal by Subject|1|||
30854408|NCT02772757|58881916|FG000|Overall Study|Protocol Violation|0|||
30854409|NCT02772757|58881917|FG001|Overall Study|Protocol Violation|0|||
30854410|NCT02772757|58881918|FG002|Overall Study|Protocol Violation|1|||
30854411|NCT02772757|58881916|FG000|Overall Study|Physician Decision|0|||
30854412|NCT02772757|58881917|FG001|Overall Study|Physician Decision|3|||
30854413|NCT02772757|58881918|FG002|Overall Study|Physician Decision|3|||
30854414|NCT00103207|58881927|FG000|Overall Study|Adverse Event|3|||
30854415|NCT00103207|58881927|FG000|Overall Study|Death|1|||
30854416|NCT00103207|58881927|FG000|Overall Study|Withdrawal by Subject|2|||
30854417|NCT00103207|58881927|FG000|Overall Study|Other complicating disease|1|||
30854418|NCT00103207|58881927|FG000|Overall Study|Ineligible|4|||
30854419|NCT00103207|58881927|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
30854420|NCT01369355|58881939|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
30854421|NCT01369355|58881940|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
30854422|NCT01369355|58881941|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
30854423|NCT01369355|58881942|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
30854424|NCT01369355|58881943|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
30854425|NCT01369355|58881944|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
30854426|NCT01369355|58881945|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
30854427|NCT01369355|58881946|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
30854428|NCT01369355|58881947|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
30854429|NCT01369355|58881939|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
30854430|NCT01369355|58881940|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
30854431|NCT01369355|58881941|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
30854432|NCT01369355|58881942|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
30854433|NCT01369355|58881943|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
30854434|NCT01369355|58881944|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
30854435|NCT01369355|58881945|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
30854436|NCT01369355|58881946|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
30854437|NCT01369355|58881947|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
30778928|NCT03449030|58790658|FG006|Overall Study|Withdrawal by Subject|1|||
30778929|NCT03449030|58790659|FG007|Overall Study|Withdrawal by Subject|2|||
30778930|NCT03449030|58790660|FG008|Overall Study|Withdrawal by Subject|0|||
30778931|NCT03449030|58790661|FG009|Overall Study|Withdrawal by Subject|0|||
30778932|NCT03449030|58790652|FG000|Overall Study|Symptomatic Deterioration|0|||
30778933|NCT03449030|58790653|FG001|Overall Study|Symptomatic Deterioration|1|||
30778934|NCT03449030|58790654|FG002|Overall Study|Symptomatic Deterioration|0|||
30854438|NCT01369355|58881939|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
30854439|NCT01369355|58881940|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
30854440|NCT01369355|58881941|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
30854441|NCT01369355|58881942|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
30854442|NCT01369355|58881943|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
30854443|NCT01369355|58881944|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
30854444|NCT01369355|58881945|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
30854445|NCT01369355|58881946|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
30854446|NCT01369355|58881947|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
30854447|NCT01369355|58881939|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
30854448|NCT01369355|58881940|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
30958068|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
30958069|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
30778935|NCT03449030|58790655|FG003|Overall Study|Symptomatic Deterioration|0|||
30778936|NCT03449030|58790656|FG004|Overall Study|Symptomatic Deterioration|0|||
30854449|NCT01369355|58881941|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
30854450|NCT01369355|58881942|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
30854451|NCT01369355|58881943|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
30854452|NCT01369355|58881944|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
30662919|NCT00910715|58676578|FG001|Overall Study|Lost to Follow-up|26|||
30854453|NCT01369355|58881945|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
30854454|NCT01369355|58881946|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
30854455|NCT01369355|58881947|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
30854456|NCT01369355|58881939|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
30854457|NCT01369355|58881940|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
30854458|NCT01369355|58881941|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
30854459|NCT01369355|58881942|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
30854460|NCT01369355|58881943|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
30854461|NCT01369355|58881944|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
30854462|NCT01369355|58881945|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
30854463|NCT01369355|58881946|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
30854464|NCT01369355|58881947|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
30854465|NCT01369355|58881939|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
30854466|NCT01369355|58881940|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
30854467|NCT01369355|58881941|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
30854468|NCT01369355|58881942|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
30854469|NCT01369355|58881943|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
30854470|NCT01369355|58881944|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
30854471|NCT01369355|58881945|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
30854472|NCT01369355|58881946|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
30854473|NCT01369355|58881947|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
30854474|NCT01369355|58881939|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
30958070|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
30958071|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
30662920|NCT00910715|58676579|FG002|Overall Study|Lost to Follow-up|0|||
30662921|NCT00600483|58676659|FG000|Overall Study|Lost to Follow-up|26|||
30662922|NCT00600483|58676660|FG001|Overall Study|Lost to Follow-up|47|||
30662923|NCT00600483|58676659|FG000|Overall Study|Randomized but not treated|10|||
30662924|NCT00600483|58676660|FG001|Overall Study|Randomized but not treated|0|||
30662925|NCT00600171|58676672|FG000|Overall Study|Adverse Event|0|||
30662926|NCT00600171|58676673|FG001|Overall Study|Adverse Event|1|||
30662927|NCT00600171|58676674|FG002|Overall Study|Adverse Event|0|||
30662928|NCT00600171|58676675|FG003|Overall Study|Adverse Event|0|||
30662929|NCT00600171|58676676|FG004|Overall Study|Adverse Event|1|||
30662930|NCT00600171|58676677|FG005|Overall Study|Adverse Event|0|||
30778937|NCT03449030|58790657|FG005|Overall Study|Symptomatic Deterioration|1|||
30778938|NCT03449030|58790658|FG006|Overall Study|Symptomatic Deterioration|1|||
30778939|NCT03449030|58790659|FG007|Overall Study|Symptomatic Deterioration|0|||
30778940|NCT03449030|58790660|FG008|Overall Study|Symptomatic Deterioration|2|||
30778941|NCT03449030|58790661|FG009|Overall Study|Symptomatic Deterioration|0|||
30778942|NCT03449030|58790652|FG000|Overall Study|Progressive Disease|1|||
30778943|NCT03449030|58790653|FG001|Overall Study|Progressive Disease|0|||
30778944|NCT03449030|58790654|FG002|Overall Study|Progressive Disease|1|||
30662931|NCT00600171|58676672|FG000|Overall Study|Lack of Efficacy|9|||
30778945|NCT03449030|58790655|FG003|Overall Study|Progressive Disease|4|||
30854475|NCT01369355|58881940|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
30958072|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
30958073|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
30958074|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
30958075|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
30958076|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
30958077|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
30662932|NCT00600171|58676673|FG001|Overall Study|Lack of Efficacy|12|||
30662933|NCT00600171|58676674|FG002|Overall Study|Lack of Efficacy|3|||
30662934|NCT00600171|58676675|FG003|Overall Study|Lack of Efficacy|5|||
30662935|NCT00600171|58676676|FG004|Overall Study|Lack of Efficacy|4|||
30662936|NCT00600171|58676677|FG005|Overall Study|Lack of Efficacy|0|||
30778946|NCT03449030|58790656|FG004|Overall Study|Progressive Disease|5|||
30778947|NCT03449030|58790657|FG005|Overall Study|Progressive Disease|3|||
30778948|NCT03449030|58790658|FG006|Overall Study|Progressive Disease|0|||
30778949|NCT03449030|58790659|FG007|Overall Study|Progressive Disease|1|||
30778950|NCT03449030|58790660|FG008|Overall Study|Progressive Disease|1|||
30778951|NCT03449030|58790661|FG009|Overall Study|Progressive Disease|1|||
30778952|NCT03449030|58790652|FG000|Overall Study|Adverse Event|0|||
30778953|NCT03449030|58790653|FG001|Overall Study|Adverse Event|0|||
30778954|NCT03449030|58790654|FG002|Overall Study|Adverse Event|0|||
30778955|NCT03449030|58790655|FG003|Overall Study|Adverse Event|0|||
30778956|NCT03449030|58790656|FG004|Overall Study|Adverse Event|0|||
30778957|NCT03449030|58790657|FG005|Overall Study|Adverse Event|2|||
30778958|NCT03449030|58790658|FG006|Overall Study|Adverse Event|0|||
30778959|NCT03449030|58790659|FG007|Overall Study|Adverse Event|0|||
30778960|NCT03449030|58790660|FG008|Overall Study|Adverse Event|0|||
30778961|NCT03449030|58790661|FG009|Overall Study|Adverse Event|0|||
30778962|NCT03449030|58790652|FG000|Overall Study|Death|0|||
30778963|NCT03449030|58790653|FG001|Overall Study|Death|0|||
30854476|NCT01369355|58881941|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
30854477|NCT01369355|58881942|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
30854478|NCT01369355|58881943|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
30854479|NCT01369355|58881944|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
30854480|NCT01369355|58881945|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
30854481|NCT01369355|58881946|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
30854482|NCT01369355|58881947|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
30854483|NCT01369355|58881939|FG000|Long-term Extension (Week 44-272)|Death|0|||
30854484|NCT01369355|58881940|FG001|Long-term Extension (Week 44-272)|Death|0|||
30854485|NCT01369355|58881941|FG002|Long-term Extension (Week 44-272)|Death|0|||
30854486|NCT01369355|58881942|FG003|Long-term Extension (Week 44-272)|Death|0|||
30854487|NCT01369355|58881943|FG004|Long-term Extension (Week 44-272)|Death|0|||
30854488|NCT01369355|58881944|FG005|Long-term Extension (Week 44-272)|Death|0|||
30854489|NCT01369355|58881945|FG006|Long-term Extension (Week 44-272)|Death|0|||
30854490|NCT01369355|58881946|FG007|Long-term Extension (Week 44-272)|Death|1|||
30854491|NCT01369355|58881947|FG008|Long-term Extension (Week 44-272)|Death|3|||
30854492|NCT01369355|58881939|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
30854493|NCT01369355|58881940|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
30854494|NCT01369355|58881941|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
30854495|NCT01369355|58881942|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
30854496|NCT01369355|58881943|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
30854497|NCT01369355|58881944|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
30854498|NCT01369355|58881945|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
30854499|NCT01369355|58881946|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
30854500|NCT01369355|58881947|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
30854501|NCT01369355|58881939|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
30854502|NCT01369355|58881940|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
30854503|NCT01369355|58881941|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
30854504|NCT01369355|58881942|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
30958078|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
30958079|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
30958080|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
30958081|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
30958082|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
30958083|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
30958084|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
30958085|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
30958086|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
30958087|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
30662937|NCT00600171|58676672|FG000|Overall Study|Protocol Violation|1|||
30778964|NCT03449030|58790654|FG002|Overall Study|Death|0|||
30778965|NCT03449030|58790655|FG003|Overall Study|Death|0|||
30778966|NCT03449030|58790656|FG004|Overall Study|Death|1|||
30778967|NCT03449030|58790657|FG005|Overall Study|Death|0|||
30778968|NCT03449030|58790658|FG006|Overall Study|Death|0|||
30778969|NCT03449030|58790659|FG007|Overall Study|Death|0|||
30778970|NCT03449030|58790660|FG008|Overall Study|Death|0|||
30778971|NCT03449030|58790661|FG009|Overall Study|Death|0|||
30778972|NCT03448406|58790686|FG000|Overall Study|Noncompliance of scheduled visits|1|||
30778973|NCT03448406|58790687|FG001|Overall Study|Noncompliance of scheduled visits|2|||
30778974|NCT03448406|58790686|FG000|Overall Study|Withdrawal by Subject|1|||
30778975|NCT03448406|58790687|FG001|Overall Study|Withdrawal by Subject|2|||
30778976|NCT03448406|58790686|FG000|Overall Study|Protocol Violation|1|||
30778977|NCT03448406|58790687|FG001|Overall Study|Protocol Violation|0|||
30778978|NCT03448406|58790686|FG000|Overall Study|Adverse Event|8|||
30778979|NCT03448406|58790687|FG001|Overall Study|Adverse Event|9|||
30778980|NCT03499028|58790695|FG000|Overall Study|Lost to Follow-up|12|||
30778981|NCT03499028|58790696|FG001|Overall Study|Lost to Follow-up|9|||
30778982|NCT03499028|58790695|FG000|Overall Study|Withdrawal by Subject|5|||
30778983|NCT03499028|58790696|FG001|Overall Study|Withdrawal by Subject|8|||
30778984|NCT03499028|58790695|FG000|Overall Study|Unplanned SNF discharge|5|||
30854505|NCT01369355|58881943|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
30854506|NCT01369355|58881944|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
30958088|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
30778985|NCT03499028|58790696|FG001|Overall Study|Unplanned SNF discharge|8|||
30778986|NCT03498560|58790704|FG000|Overall Study|Found Ineligible|2|||
30778987|NCT03498560|58790704|FG000|Overall Study|Withdrawal by Subject|14|||
30778988|NCT03498560|58790704|FG000|Overall Study|Lost to Follow-up|4|||
30778989|NCT03498560|58790704|FG000|Overall Study|Death|1|||
30778990|NCT00064701|58790712|FG000|One Year Post-transplant|Did not receive study drug|7|||
30778991|NCT00064701|58790713|FG001|One Year Post-transplant|Did not receive study drug|12|||
30778992|NCT00064701|58790714|FG002|One Year Post-transplant|Did not receive study drug|11|||
30778993|NCT00064701|58790712|FG000|One Year Post-transplant|Adverse Event|23|||
30778994|NCT00064701|58790713|FG001|One Year Post-transplant|Adverse Event|19|||
30778995|NCT00064701|58790714|FG002|One Year Post-transplant|Adverse Event|37|||
30778996|NCT00064701|58790712|FG000|One Year Post-transplant|Rejection|0|||
30778997|NCT00064701|58790713|FG001|One Year Post-transplant|Rejection|1|||
30778998|NCT00064701|58790714|FG002|One Year Post-transplant|Rejection|16|||
30778999|NCT00064701|58790712|FG000|One Year Post-transplant|Non-compliance|4|||
30958089|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
30958090|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
30958091|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
30958092|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
30958093|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
30958094|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
30958095|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
30958096|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
30958097|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
30958098|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
30958099|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
30958100|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
30958101|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
30958102|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
30958103|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
30958104|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
30958105|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
30958106|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
30958107|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
30958108|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
30958109|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
30958110|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
30662938|NCT00600171|58676673|FG001|Overall Study|Protocol Violation|2|||
30779000|NCT00064701|58790713|FG001|One Year Post-transplant|Non-compliance|2|||
30779001|NCT00064701|58790714|FG002|One Year Post-transplant|Non-compliance|5|||
30779002|NCT00064701|58790712|FG000|One Year Post-transplant|Graft Failure|3|||
30779003|NCT00064701|58790713|FG001|One Year Post-transplant|Graft Failure|2|||
30779004|NCT00064701|58790714|FG002|One Year Post-transplant|Graft Failure|1|||
30779005|NCT00064701|58790712|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
30779006|NCT00064701|58790713|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
30779007|NCT00064701|58790714|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
30779008|NCT00064701|58790712|FG000|One Year Post-transplant|Lost to Follow-up|1|||
30779009|NCT00064701|58790713|FG001|One Year Post-transplant|Lost to Follow-up|0|||
30779010|NCT00064701|58790714|FG002|One Year Post-transplant|Lost to Follow-up|0|||
30854507|NCT01369355|58881945|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
30854508|NCT01369355|58881946|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
30854509|NCT01369355|58881947|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
30854510|NCT01369355|58881939|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
30854511|NCT01369355|58881940|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
30854512|NCT01369355|58881941|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
30854513|NCT01369355|58881942|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
30854514|NCT01369355|58881943|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
30662939|NCT00600171|58676674|FG002|Overall Study|Protocol Violation|0|||
30662940|NCT00600171|58676675|FG003|Overall Study|Protocol Violation|1|||
30662941|NCT00600171|58676676|FG004|Overall Study|Protocol Violation|0|||
30662942|NCT00600171|58676677|FG005|Overall Study|Protocol Violation|0|||
30662943|NCT00600171|58676672|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
30662944|NCT00600171|58676673|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
30662945|NCT00600171|58676674|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
30662946|NCT00600171|58676675|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
30662947|NCT00600171|58676676|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
30662948|NCT00600171|58676677|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
30854515|NCT01369355|58881944|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
30662949|NCT00600171|58676672|FG000|Overall Study|Withdrawal by Subject|3|||
30662950|NCT00600171|58676673|FG001|Overall Study|Withdrawal by Subject|0|||
30662951|NCT00600171|58676674|FG002|Overall Study|Withdrawal by Subject|0|||
30779011|NCT00064701|58790712|FG000|One Year Post-transplant|Converted to rapamycin|1|||
30779012|NCT00064701|58790713|FG001|One Year Post-transplant|Converted to rapamycin|0|||
30854516|NCT01369355|58881945|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
30854517|NCT01369355|58881946|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
30854518|NCT01369355|58881947|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
30854519|NCT01369355|58881939|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
30854520|NCT01369355|58881940|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
30854521|NCT01369355|58881941|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
30854522|NCT01369355|58881942|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
30854523|NCT01369355|58881943|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
30779013|NCT00064701|58790714|FG002|One Year Post-transplant|Converted to rapamycin|0|||
30779014|NCT00064701|58790712|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
30779015|NCT00064701|58790713|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
30779016|NCT00064701|58790714|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
30854524|NCT01369355|58881944|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
30854525|NCT01369355|58881945|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
30854526|NCT01369355|58881946|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
30854527|NCT01369355|58881947|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
30854528|NCT01369355|58881939|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
30854529|NCT01369355|58881940|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
30854530|NCT01369355|58881941|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
30854531|NCT01369355|58881942|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
30854532|NCT01369355|58881943|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
30854533|NCT01369355|58881944|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
30854534|NCT01369355|58881945|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
30854535|NCT01369355|58881946|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
30854536|NCT01369355|58881947|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
30854537|NCT01369355|58881939|FG000|Long-term Extension (Week 44-272)|Other|0|||
30854538|NCT01369355|58881940|FG001|Long-term Extension (Week 44-272)|Other|0|||
30854539|NCT01369355|58881941|FG002|Long-term Extension (Week 44-272)|Other|0|||
30854540|NCT01369355|58881942|FG003|Long-term Extension (Week 44-272)|Other|0|||
30854541|NCT01369355|58881943|FG004|Long-term Extension (Week 44-272)|Other|0|||
30854542|NCT01369355|58881944|FG005|Long-term Extension (Week 44-272)|Other|0|||
30854543|NCT01369355|58881945|FG006|Long-term Extension (Week 44-272)|Other|110|||
30854544|NCT01369355|58881946|FG007|Long-term Extension (Week 44-272)|Other|9|||
30854545|NCT01369355|58881947|FG008|Long-term Extension (Week 44-272)|Other|17|||
30854546|NCT02614196|58881970|FG000|Double Blind Treatment Phase|Adverse Event|8|||
30854547|NCT02614196|58881971|FG001|Double Blind Treatment Phase|Adverse Event|5|||
30958111|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
30958112|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
30958113|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
30958114|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
30958115|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
30958116|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
30958117|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
30958118|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
30958119|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
30958120|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
30958121|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
30958122|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
30958123|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
30958124|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
30958125|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
30779017|NCT00064701|58790712|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
30779018|NCT00064701|58790713|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
30854548|NCT02614196|58881972|FG002|Double Blind Treatment Phase|Adverse Event|9|||
30854549|NCT02614196|58881973|FG003|Double Blind Treatment Phase|Adverse Event|0|||
30854550|NCT02614196|58881974|FG004|Double Blind Treatment Phase|Adverse Event|0|||
30958126|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
30779019|NCT00064701|58790714|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
30779020|NCT00064701|58790712|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
30779021|NCT00064701|58790713|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
30779022|NCT00064701|58790714|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
30779023|NCT00064701|58790712|FG000|One Year Post-transplant|Poor absorption|0|||
30779024|NCT00064701|58790713|FG001|One Year Post-transplant|Poor absorption|1|||
30779025|NCT00064701|58790714|FG002|One Year Post-transplant|Poor absorption|0|||
30779026|NCT00064701|58790712|FG000|One Year Post-transplant|Pancreas transplant|0|||
30779027|NCT00064701|58790713|FG001|One Year Post-transplant|Pancreas transplant|0|||
30779028|NCT00064701|58790714|FG002|One Year Post-transplant|Pancreas transplant|1|||
30779029|NCT00064701|58790712|FG000|Clinical Continuation Phase|Adverse Event|12|||
30779030|NCT00064701|58790713|FG001|Clinical Continuation Phase|Adverse Event|21|||
30779031|NCT00064701|58790714|FG002|Clinical Continuation Phase|Adverse Event|14|||
30779032|NCT00064701|58790712|FG000|Clinical Continuation Phase|Non-compliance|8|||
30779033|NCT00064701|58790713|FG001|Clinical Continuation Phase|Non-compliance|6|||
30779034|NCT00064701|58790714|FG002|Clinical Continuation Phase|Non-compliance|7|||
30779035|NCT00064701|58790712|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
30779036|NCT00064701|58790713|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
30779037|NCT00064701|58790714|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
30779038|NCT00064701|58790712|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
30779039|NCT00064701|58790713|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
30779040|NCT00064701|58790714|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
30779041|NCT00064701|58790712|FG000|Clinical Continuation Phase|Graft Failure|5|||
30779042|NCT00064701|58790713|FG001|Clinical Continuation Phase|Graft Failure|5|||
30779043|NCT00064701|58790714|FG002|Clinical Continuation Phase|Graft Failure|2|||
30779044|NCT00064701|58790712|FG000|Clinical Continuation Phase|Rejection|1|||
30779045|NCT00064701|58790713|FG001|Clinical Continuation Phase|Rejection|2|||
30779046|NCT00064701|58790714|FG002|Clinical Continuation Phase|Rejection|2|||
30779047|NCT00064701|58790712|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
30779048|NCT00064701|58790713|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
30779049|NCT00064701|58790714|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
30779050|NCT00064701|58790712|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
30779051|NCT00064701|58790713|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
30779052|NCT00064701|58790714|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
30779053|NCT00064701|58790712|FG000|Clinical Continuation Phase|Physician Decision|1|||
30779054|NCT00064701|58790713|FG001|Clinical Continuation Phase|Physician Decision|3|||
30779055|NCT00064701|58790714|FG002|Clinical Continuation Phase|Physician Decision|0|||
30854551|NCT02614196|58881975|FG005|Double Blind Treatment Phase|Adverse Event|0|||
30779056|NCT00064701|58790712|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
30779057|NCT00064701|58790713|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
30779058|NCT00064701|58790714|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
30779059|NCT00064701|58790712|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
30779060|NCT00064701|58790713|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
30779061|NCT00064701|58790714|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
30779062|NCT00064701|58790712|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
30779063|NCT00064701|58790713|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
30779064|NCT00064701|58790714|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
30779065|NCT00064701|58790712|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
30779066|NCT00064701|58790713|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
30779067|NCT00064701|58790714|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
30779068|NCT00064701|58790712|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
30779069|NCT00064701|58790713|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
30779070|NCT00064701|58790714|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
30779071|NCT00064701|58790712|FG000|Clinical Continuation Phase|Patient opted out|0|||
30779072|NCT00064701|58790713|FG001|Clinical Continuation Phase|Patient opted out|0|||
30779073|NCT00064701|58790714|FG002|Clinical Continuation Phase|Patient opted out|1|||
30779074|NCT00064077|58790726|FG000|Overall Study|Improper prior treatment|1|||
30779075|NCT00064077|58790727|FG001|Overall Study|Improper prior treatment|0|||
30779076|NCT00064077|58790728|FG002|Overall Study|Improper prior treatment|0|||
30779077|NCT00064077|58790729|FG003|Overall Study|Improper prior treatment|0|||
30779078|NCT00064077|58790726|FG000|Overall Study|Poor risk|2|||
30779079|NCT00064077|58790727|FG001|Overall Study|Poor risk|0|||
30779080|NCT00064077|58790728|FG002|Overall Study|Poor risk|1|||
30779081|NCT00064077|58790729|FG003|Overall Study|Poor risk|1|||
30779082|NCT00064077|58790726|FG000|Overall Study|Pathology|10|||
30779083|NCT00064077|58790727|FG001|Overall Study|Pathology|7|||
30779084|NCT00064077|58790728|FG002|Overall Study|Pathology|3|||
30779085|NCT00064077|58790729|FG003|Overall Study|Pathology|4|||
30779086|NCT00064077|58790726|FG000|Overall Study|No surgery|0|||
30779087|NCT00064077|58790727|FG001|Overall Study|No surgery|0|||
30779088|NCT00064077|58790728|FG002|Overall Study|No surgery|1|||
30779089|NCT00064077|58790729|FG003|Overall Study|No surgery|0|||
30779090|NCT00064077|58790726|FG000|Overall Study|No tumor|0|||
30779091|NCT00064077|58790727|FG001|Overall Study|No tumor|0|||
30779092|NCT00064077|58790728|FG002|Overall Study|No tumor|1|||
30779093|NCT00064077|58790729|FG003|Overall Study|No tumor|0|||
30779094|NCT00064077|58790726|FG000|Overall Study|Other reasons|2|||
30779095|NCT00064077|58790727|FG001|Overall Study|Other reasons|2|||
30779096|NCT00064077|58790728|FG002|Overall Study|Other reasons|1|||
30779097|NCT00064077|58790729|FG003|Overall Study|Other reasons|2|||
30779098|NCT00063999|58790741|FG000|Overall Study|Withdrawal by Subject|1|||
30779099|NCT00063999|58790742|FG001|Overall Study|Withdrawal by Subject|0|||
30779100|NCT00063999|58790741|FG000|Overall Study|Ineligible|44|||
30779101|NCT00063999|58790742|FG001|Overall Study|Ineligible|24|||
30779102|NCT03131440|58790787|FG000|Overall Study|Withdrawal by Subject|1|||
30779103|NCT03131440|58790788|FG001|Overall Study|Withdrawal by Subject|3|||
30779104|NCT03131440|58790789|FG002|Overall Study|Withdrawal by Subject|0|||
30779105|NCT03131440|58790790|FG003|Overall Study|Withdrawal by Subject|0|||
30854552|NCT02614196|58881970|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
30854553|NCT02614196|58881971|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
30854554|NCT02614196|58881972|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
30854555|NCT02614196|58881973|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
30854556|NCT02614196|58881974|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
30854557|NCT02614196|58881975|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
30854558|NCT02614196|58881970|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
30854559|NCT02614196|58881971|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
30854560|NCT02614196|58881972|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
30854561|NCT02614196|58881973|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
30854562|NCT02614196|58881974|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
30854563|NCT02614196|58881975|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
30854564|NCT02614196|58881970|FG000|Double Blind Treatment Phase|Physician Decision|4|||
30854565|NCT02614196|58881971|FG001|Double Blind Treatment Phase|Physician Decision|0|||
30854566|NCT02614196|58881972|FG002|Double Blind Treatment Phase|Physician Decision|2|||
30854567|NCT02614196|58881973|FG003|Double Blind Treatment Phase|Physician Decision|0|||
30854568|NCT02614196|58881974|FG004|Double Blind Treatment Phase|Physician Decision|0|||
30779106|NCT03131440|58790791|FG004|Overall Study|Withdrawal by Subject|1|||
30779107|NCT03131440|58790792|FG005|Overall Study|Withdrawal by Subject|0|||
30779108|NCT03131440|58790793|FG006|Overall Study|Withdrawal by Subject|0|||
30779109|NCT03131440|58790794|FG007|Overall Study|Withdrawal by Subject|1|||
30779110|NCT03131440|58790795|FG008|Overall Study|Withdrawal by Subject|1|||
30779111|NCT03131440|58790796|FG009|Overall Study|Withdrawal by Subject|1|||
30854569|NCT02614196|58881975|FG005|Double Blind Treatment Phase|Physician Decision|0|||
30854570|NCT02614196|58881970|FG000|Double Blind Treatment Phase|Pregnancy|1|||
30854571|NCT02614196|58881971|FG001|Double Blind Treatment Phase|Pregnancy|2|||
30854572|NCT02614196|58881972|FG002|Double Blind Treatment Phase|Pregnancy|0|||
30854573|NCT02614196|58881973|FG003|Double Blind Treatment Phase|Pregnancy|0|||
30854574|NCT02614196|58881974|FG004|Double Blind Treatment Phase|Pregnancy|0|||
30854575|NCT02614196|58881975|FG005|Double Blind Treatment Phase|Pregnancy|0|||
30854576|NCT02614196|58881970|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
30854577|NCT02614196|58881971|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
30854578|NCT02614196|58881972|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
30854579|NCT02614196|58881973|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
30854580|NCT02614196|58881974|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
30854581|NCT02614196|58881975|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
30854582|NCT02614196|58881970|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
30958127|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
30958128|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
30779112|NCT03131440|58790797|FG010|Overall Study|Withdrawal by Subject|0|||
30779113|NCT03131440|58790798|FG011|Overall Study|Withdrawal by Subject|1|||
30779114|NCT03131440|58790799|FG012|Overall Study|Withdrawal by Subject|1|||
30779115|NCT03131440|58790800|FG013|Overall Study|Withdrawal by Subject|0|||
30779116|NCT03131440|58790801|FG014|Overall Study|Withdrawal by Subject|1|||
30779117|NCT03131440|58790802|FG015|Overall Study|Withdrawal by Subject|0|||
30958129|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
30779118|NCT03131440|58790803|FG016|Overall Study|Withdrawal by Subject|0|||
30779119|NCT03131440|58790804|FG017|Overall Study|Withdrawal by Subject|0|||
30779120|NCT03131440|58790805|FG018|Overall Study|Withdrawal by Subject|1|||
30779121|NCT03131440|58790806|FG019|Overall Study|Withdrawal by Subject|0|||
30779122|NCT03131440|58790807|FG020|Overall Study|Withdrawal by Subject|1|||
30779123|NCT03131440|58790808|FG021|Overall Study|Withdrawal by Subject|1|||
30779124|NCT03131440|58790809|FG022|Overall Study|Withdrawal by Subject|1|||
30779125|NCT03131440|58790810|FG023|Overall Study|Withdrawal by Subject|0|||
30779126|NCT03131440|58790811|FG024|Overall Study|Withdrawal by Subject|0|||
30779127|NCT03131440|58790812|FG025|Overall Study|Withdrawal by Subject|0|||
30779128|NCT03131440|58790813|FG026|Overall Study|Withdrawal by Subject|0|||
30779129|NCT03131440|58790814|FG027|Overall Study|Withdrawal by Subject|0|||
30779130|NCT03131440|58790815|FG028|Overall Study|Withdrawal by Subject|0|||
30779131|NCT03131440|58790816|FG029|Overall Study|Withdrawal by Subject|0|||
30779132|NCT03131440|58790817|FG030|Overall Study|Withdrawal by Subject|1|||
30779133|NCT03131440|58790818|FG031|Overall Study|Withdrawal by Subject|0|||
30779134|NCT03131440|58790787|FG000|Overall Study|Lost to Follow-up|0|||
30779135|NCT03131440|58790788|FG001|Overall Study|Lost to Follow-up|0|||
30779136|NCT03131440|58790789|FG002|Overall Study|Lost to Follow-up|0|||
30779137|NCT03131440|58790790|FG003|Overall Study|Lost to Follow-up|0|||
30779138|NCT03131440|58790791|FG004|Overall Study|Lost to Follow-up|0|||
30779139|NCT03131440|58790792|FG005|Overall Study|Lost to Follow-up|1|||
30779140|NCT03131440|58790793|FG006|Overall Study|Lost to Follow-up|0|||
30779141|NCT03131440|58790794|FG007|Overall Study|Lost to Follow-up|0|||
30779142|NCT03131440|58790795|FG008|Overall Study|Lost to Follow-up|0|||
30779143|NCT03131440|58790796|FG009|Overall Study|Lost to Follow-up|0|||
30779144|NCT03131440|58790797|FG010|Overall Study|Lost to Follow-up|0|||
30779145|NCT03131440|58790798|FG011|Overall Study|Lost to Follow-up|0|||
30779146|NCT03131440|58790799|FG012|Overall Study|Lost to Follow-up|0|||
30779147|NCT03131440|58790800|FG013|Overall Study|Lost to Follow-up|0|||
30779148|NCT03131440|58790801|FG014|Overall Study|Lost to Follow-up|0|||
30779149|NCT03131440|58790802|FG015|Overall Study|Lost to Follow-up|0|||
30779150|NCT03131440|58790803|FG016|Overall Study|Lost to Follow-up|0|||
30779151|NCT03131440|58790804|FG017|Overall Study|Lost to Follow-up|0|||
30779152|NCT03131440|58790805|FG018|Overall Study|Lost to Follow-up|0|||
30779153|NCT03131440|58790806|FG019|Overall Study|Lost to Follow-up|2|||
30779154|NCT03131440|58790807|FG020|Overall Study|Lost to Follow-up|1|||
30779155|NCT03131440|58790808|FG021|Overall Study|Lost to Follow-up|0|||
30779156|NCT03131440|58790809|FG022|Overall Study|Lost to Follow-up|1|||
30779157|NCT03131440|58790810|FG023|Overall Study|Lost to Follow-up|0|||
30779158|NCT03131440|58790811|FG024|Overall Study|Lost to Follow-up|1|||
30854583|NCT02614196|58881971|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
30779159|NCT03131440|58790812|FG025|Overall Study|Lost to Follow-up|0|||
30854584|NCT02614196|58881972|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
30854585|NCT02614196|58881973|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
30779160|NCT03131440|58790813|FG026|Overall Study|Lost to Follow-up|0|||
30779161|NCT03131440|58790814|FG027|Overall Study|Lost to Follow-up|2|||
30779162|NCT03131440|58790815|FG028|Overall Study|Lost to Follow-up|0|||
30779163|NCT03131440|58790816|FG029|Overall Study|Lost to Follow-up|2|||
30779164|NCT03131440|58790817|FG030|Overall Study|Lost to Follow-up|0|||
30779165|NCT03131440|58790818|FG031|Overall Study|Lost to Follow-up|0|||
30779166|NCT03131440|58790787|FG000|Overall Study|Death|0|||
30779167|NCT03131440|58790788|FG001|Overall Study|Death|0|||
30779168|NCT03131440|58790789|FG002|Overall Study|Death|0|||
30779169|NCT03131440|58790790|FG003|Overall Study|Death|0|||
30779170|NCT03131440|58790791|FG004|Overall Study|Death|0|||
30779171|NCT03131440|58790792|FG005|Overall Study|Death|0|||
30779172|NCT03131440|58790793|FG006|Overall Study|Death|0|||
30779173|NCT03131440|58790794|FG007|Overall Study|Death|0|||
30779174|NCT03131440|58790795|FG008|Overall Study|Death|0|||
30779175|NCT03131440|58790796|FG009|Overall Study|Death|0|||
30779176|NCT03131440|58790797|FG010|Overall Study|Death|0|||
30779177|NCT03131440|58790798|FG011|Overall Study|Death|0|||
30779178|NCT03131440|58790799|FG012|Overall Study|Death|0|||
30779179|NCT03131440|58790800|FG013|Overall Study|Death|0|||
30779180|NCT03131440|58790801|FG014|Overall Study|Death|0|||
30779181|NCT03131440|58790802|FG015|Overall Study|Death|0|||
30779182|NCT03131440|58790803|FG016|Overall Study|Death|0|||
30779183|NCT03131440|58790804|FG017|Overall Study|Death|0|||
30779184|NCT03131440|58790805|FG018|Overall Study|Death|0|||
30779185|NCT03131440|58790806|FG019|Overall Study|Death|0|||
30779186|NCT03131440|58790807|FG020|Overall Study|Death|0|||
30779187|NCT03131440|58790808|FG021|Overall Study|Death|0|||
30779188|NCT03131440|58790809|FG022|Overall Study|Death|0|||
30779189|NCT03131440|58790810|FG023|Overall Study|Death|0|||
30779190|NCT03131440|58790811|FG024|Overall Study|Death|0|||
30779191|NCT03131440|58790812|FG025|Overall Study|Death|1|||
30779192|NCT03131440|58790813|FG026|Overall Study|Death|0|||
30779193|NCT03131440|58790814|FG027|Overall Study|Death|0|||
30779194|NCT03131440|58790815|FG028|Overall Study|Death|0|||
30779195|NCT03131440|58790816|FG029|Overall Study|Death|0|||
30779196|NCT03131440|58790817|FG030|Overall Study|Death|0|||
30779197|NCT03131440|58790818|FG031|Overall Study|Death|0|||
30779198|NCT02915302|58790863|FG000|Overall Study|Adverse Event|3|||
30779199|NCT02915302|58790864|FG001|Overall Study|Adverse Event|0|||
30779200|NCT02915302|58790863|FG000|Overall Study|Protocol Violation|20|||
30779201|NCT02915302|58790864|FG001|Overall Study|Protocol Violation|27|||
30779202|NCT02915302|58790863|FG000|Overall Study|Lost to Follow-up|19|||
30779203|NCT02915302|58790864|FG001|Overall Study|Lost to Follow-up|22|||
30779204|NCT02915302|58790863|FG000|Overall Study|Withdrawal by Subject|22|||
30779205|NCT02915302|58790864|FG001|Overall Study|Withdrawal by Subject|29|||
30779206|NCT02915302|58790863|FG000|Overall Study|Other|1|||
30779207|NCT02915302|58790864|FG001|Overall Study|Other|0|||
30779208|NCT03023878|58790870|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
30779209|NCT03023878|58790870|FG000|Pre-Study Run-In Period|Death|1|||
30779210|NCT03023878|58790870|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
30779211|NCT03023878|58790870|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
30779212|NCT03023878|58790870|FG000|Treatment Period|Disease Progression|1|||
30854586|NCT02614196|58881974|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
30854587|NCT02614196|58881975|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
30854588|NCT02614196|58881970|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
30854589|NCT02614196|58881971|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
30854590|NCT02614196|58881972|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
30854591|NCT02614196|58881973|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
30854592|NCT02614196|58881974|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
30854593|NCT02614196|58881975|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
30854594|NCT02614196|58881970|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
30854595|NCT02614196|58881971|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
30854596|NCT02614196|58881972|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
30854597|NCT02614196|58881973|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
30854598|NCT02614196|58881974|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
30854599|NCT02614196|58881975|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
30854600|NCT02614196|58881970|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
30854601|NCT02614196|58881971|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
30779213|NCT03023878|58790870|FG000|Treatment Period|Withdrawal by Subject|1|||
30779214|NCT03023878|58790870|FG000|Treatment Period|Adverse Event|1|||
30779215|NCT03023878|58790870|FG000|Long Term Follow-Up Period|Death|2|||
30779216|NCT03022630|58790876|FG000|Overall Study|Death|9|||
30779217|NCT03022630|58790877|FG001|Overall Study|Death|7|||
30779218|NCT03022630|58790876|FG000|Overall Study|Withdrawal by Subject|0|||
30779219|NCT03022630|58790877|FG001|Overall Study|Withdrawal by Subject|5|||
30779220|NCT03023722|58790888|FG000|Overall Study|No follow-up assessment|4|||
30779221|NCT03022084|58790894|FG000|Overall Study|Lost to Follow-up|2|||
30779222|NCT03022084|58790895|FG001|Overall Study|Lost to Follow-up|3|||
30779223|NCT03021304|58790901|FG000|Overall Study|Lack of Efficacy|1|||
30779224|NCT01979536|58790907|FG000|Overall Study|Physician Decision|2|||
30779225|NCT01979536|58790908|FG001|Overall Study|Physician Decision|3|||
30779226|NCT01979536|58790907|FG000|Overall Study|Withdrawal by Subject|0|||
30779227|NCT01979536|58790908|FG001|Overall Study|Withdrawal by Subject|1|||
30854602|NCT02614196|58881972|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
30854603|NCT02614196|58881973|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
30854604|NCT02614196|58881974|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
30854605|NCT02614196|58881975|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
30779228|NCT01979536|58790907|FG000|Overall Study|Refusal|0|||
30779229|NCT01979536|58790908|FG001|Overall Study|Refusal|1|||
30779230|NCT01979536|58790907|FG000|Overall Study|Relapse|0|||
30779231|NCT01979536|58790908|FG001|Overall Study|Relapse|1|||
30779232|NCT01979536|58790907|FG000|Overall Study|Study terminated by Sponsor|0|||
30779233|NCT01979536|58790908|FG001|Overall Study|Study terminated by Sponsor|1|||
30779234|NCT01979536|58790907|FG000|Overall Study|Did not start treatment|0|||
30779235|NCT01979536|58790908|FG001|Overall Study|Did not start treatment|1|||
30779236|NCT03496298|58790925|FG000|Overall Study|Adverse Event|49|||
30779237|NCT03496298|58790926|FG001|Overall Study|Adverse Event|68|||
30779238|NCT03496298|58790927|FG002|Overall Study|Adverse Event|79|||
30779239|NCT03496298|58790925|FG000|Overall Study|Study terminated by Sponsor|1050|||
30779240|NCT03496298|58790926|FG001|Overall Study|Study terminated by Sponsor|1063|||
30779241|NCT03496298|58790927|FG002|Overall Study|Study terminated by Sponsor|1071|||
30779242|NCT03496298|58790925|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
30779243|NCT03496298|58790926|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
30779244|NCT03496298|58790927|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
30779245|NCT03496298|58790925|FG000|Overall Study|Withdrawal by Subject|176|||
30779246|NCT03496298|58790926|FG001|Overall Study|Withdrawal by Subject|154|||
30779247|NCT03496298|58790927|FG002|Overall Study|Withdrawal by Subject|151|||
30779248|NCT03496298|58790925|FG000|Overall Study|Other|29|||
30779249|NCT03496298|58790926|FG001|Overall Study|Other|20|||
30779250|NCT03496298|58790927|FG002|Overall Study|Other|23|||
30779251|NCT03496298|58790925|FG000|Overall Study|Randomized and not treated|1|||
30779252|NCT03496298|58790926|FG001|Overall Study|Randomized and not treated|1|||
30779253|NCT03496298|58790927|FG002|Overall Study|Randomized and not treated|1|||
30779254|NCT02914522|58790940|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
30779255|NCT02914522|58790941|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
30779256|NCT02914522|58790942|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
30779257|NCT02914522|58790943|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
30779258|NCT02914522|58790944|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
30779259|NCT02914522|58790945|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
30779260|NCT02914522|58790946|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
30779261|NCT02914522|58790947|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
30779262|NCT02914522|58790948|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
30779263|NCT02914522|58790949|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
30779264|NCT02914522|58790950|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
30779265|NCT02914522|58790940|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
30779266|NCT02914522|58790941|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
30779267|NCT02914522|58790942|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
30779268|NCT02914522|58790943|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
30779269|NCT02914522|58790944|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
30854606|NCT02614196|58881970|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
30854607|NCT02614196|58881971|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
30854608|NCT02614196|58881972|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
30854609|NCT02614196|58881973|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
30854610|NCT02614196|58881974|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
30854611|NCT02614196|58881975|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
30854612|NCT02614196|58881970|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
30854613|NCT02614196|58881971|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
30779270|NCT02914522|58790945|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
30779271|NCT02914522|58790946|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
30779272|NCT02914522|58790947|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
30958130|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
30958131|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
30779273|NCT02914522|58790948|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
30779274|NCT02914522|58790949|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
30779275|NCT02914522|58790950|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
30779276|NCT02914522|58790940|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
30779277|NCT02914522|58790941|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
30779278|NCT02914522|58790942|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
30779279|NCT02914522|58790943|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
30779280|NCT02914522|58790944|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
30779281|NCT02914522|58790945|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
30779282|NCT02914522|58790946|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
30779283|NCT02914522|58790947|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
30779284|NCT02914522|58790948|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
30854614|NCT02614196|58881972|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
30854615|NCT02614196|58881973|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
30854616|NCT02614196|58881974|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
30854617|NCT02614196|58881975|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
30854618|NCT02614196|58881970|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
30854619|NCT02614196|58881971|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
30854620|NCT02614196|58881972|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
30854621|NCT02614196|58881973|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
30854622|NCT02614196|58881974|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
30958132|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
30958133|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
30779285|NCT02914522|58790949|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
30779286|NCT02914522|58790950|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
30779287|NCT02914522|58790940|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
30779288|NCT02914522|58790941|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
30779289|NCT02914522|58790942|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
30779290|NCT02914522|58790943|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
30779291|NCT02914522|58790944|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
30779292|NCT02914522|58790945|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
30779293|NCT02914522|58790946|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
30779294|NCT02914522|58790947|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
30779295|NCT02914522|58790948|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
30779296|NCT02914522|58790949|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
30779297|NCT02914522|58790950|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
30779298|NCT02914522|58790940|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
30779299|NCT02914522|58790941|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
30779300|NCT02914522|58790942|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
30779301|NCT02914522|58790943|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
30779302|NCT02914522|58790944|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
30779303|NCT02914522|58790945|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
30958134|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
30958135|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
30958136|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
30958137|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
30958138|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
30958139|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
30958140|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
30958141|NCT01697579|59022241|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
30958142|NCT01697579|59022242|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
30958143|NCT01697579|59022243|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
30958144|NCT01697579|59022244|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
30779304|NCT02914522|58790946|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
30779305|NCT02914522|58790947|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
30854623|NCT02614196|58881975|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
30854624|NCT02765035|58882005|FG000|First Intervention (90 Days)|Adverse Event|1|||
30662952|NCT00600171|58676675|FG003|Overall Study|Withdrawal by Subject|1|||
30662953|NCT00600171|58676676|FG004|Overall Study|Withdrawal by Subject|1|||
30662954|NCT00600171|58676677|FG005|Overall Study|Withdrawal by Subject|1|||
30662955|NCT00600171|58676672|FG000|Overall Study|Physician Decision|0|||
30662956|NCT00600171|58676673|FG001|Overall Study|Physician Decision|1|||
30662957|NCT00600171|58676674|FG002|Overall Study|Physician Decision|0|||
30662958|NCT00600171|58676675|FG003|Overall Study|Physician Decision|1|||
30779306|NCT02914522|58790948|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
30779307|NCT02914522|58790949|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
30779308|NCT02914522|58790950|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
30779309|NCT02914522|58790940|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
30779310|NCT02914522|58790941|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
30662959|NCT00600171|58676676|FG004|Overall Study|Physician Decision|0|||
30958145|NCT01697579|59022245|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
30958146|NCT01697579|59022246|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
30958147|NCT01697579|59022247|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
30958148|NCT01586195|59022275|FG000|Overall Study|Death|11|||
30958149|NCT01586195|59022275|FG000|Overall Study|Withdrawal of Consent|5|||
30958150|NCT01586195|59022275|FG000|Overall Study|Started new anti-melanoma therapy|1|||
30958151|NCT01586195|59022275|FG000|Overall Study|Reason not specified|9|||
30662960|NCT00600171|58676677|FG005|Overall Study|Physician Decision|2|||
30662961|NCT00600171|58676672|FG000|Overall Study|Lost to Follow-up|0|||
30662962|NCT00600171|58676673|FG001|Overall Study|Lost to Follow-up|0|||
30662963|NCT00600171|58676674|FG002|Overall Study|Lost to Follow-up|0|||
30662964|NCT00600171|58676675|FG003|Overall Study|Lost to Follow-up|1|||
30662965|NCT00600171|58676676|FG004|Overall Study|Lost to Follow-up|0|||
30662966|NCT00600171|58676677|FG005|Overall Study|Lost to Follow-up|0|||
30662967|NCT04035668|58676696|FG000|Overall Study|Adverse Event|3|||
30662968|NCT04035668|58676697|FG001|Overall Study|Adverse Event|4|||
30662969|NCT04035668|58676698|FG002|Overall Study|Adverse Event|2|||
30662970|NCT04035668|58676696|FG000|Overall Study|Lost to Follow-up|0|||
30662971|NCT04035668|58676697|FG001|Overall Study|Lost to Follow-up|1|||
30662972|NCT04035668|58676698|FG002|Overall Study|Lost to Follow-up|0|||
30662973|NCT04035668|58676696|FG000|Overall Study|Physician Decision|2|||
30662974|NCT04035668|58676697|FG001|Overall Study|Physician Decision|1|||
30662975|NCT04035668|58676698|FG002|Overall Study|Physician Decision|1|||
30662976|NCT04035668|58676696|FG000|Overall Study|Subject Decision|2|||
30662977|NCT04035668|58676697|FG001|Overall Study|Subject Decision|2|||
30662978|NCT04035668|58676698|FG002|Overall Study|Subject Decision|0|||
30662979|NCT00885495|58676718|FG000|Overall Study|Adverse Event|1|||
30662980|NCT00885495|58676719|FG001|Overall Study|Adverse Event|2|||
30958152|NCT01585961|59022279|FG000|Overall Study|Death|6|||
30958153|NCT01585961|59022279|FG000|Overall Study|Physician Decision|1|||
30958154|NCT01585961|59022279|FG000|Overall Study|Decision to use non-study catheter|1|||
30662981|NCT00885495|58676718|FG000|Overall Study|Protocol Violation|0|||
30662982|NCT00885495|58676719|FG001|Overall Study|Protocol Violation|1|||
30662983|NCT00885495|58676718|FG000|Overall Study|Withdrawal by Subject|1|||
30958155|NCT01585961|59022279|FG000|Overall Study|Withdrawal by Subject|1|||
30662984|NCT00885495|58676719|FG001|Overall Study|Withdrawal by Subject|0|||
30662985|NCT00885105|58676732|FG000|Overall Study|Withdrawal by Subject|0|||
30662986|NCT00885105|58676733|FG001|Overall Study|Withdrawal by Subject|8|||
30662987|NCT00885105|58676732|FG000|Overall Study|Adverse Event|1|||
30662988|NCT00885105|58676733|FG001|Overall Study|Adverse Event|0|||
30854625|NCT02765035|58882006|FG001|First Intervention (90 Days)|Adverse Event|1|||
30854626|NCT02765035|58882005|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
30854627|NCT02765035|58882006|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
30854628|NCT02307682|58882016|FG000|Overall Study|Adverse Event|9|||
30958156|NCT01585961|59022279|FG000|Overall Study|Lost to Follow-up|23|||
30662989|NCT00885105|58676732|FG000|Overall Study|Protocol Violation|0|||
30854629|NCT02307682|58882017|FG001|Overall Study|Adverse Event|8|||
30662990|NCT00885105|58676733|FG001|Overall Study|Protocol Violation|2|||
30662991|NCT03945188|58676741|FG000|Overall Study|Protocol Violation|1|||
30662992|NCT03945188|58676742|FG001|Overall Study|Protocol Violation|0|||
30958157|NCT01585961|59022279|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
30662993|NCT03945188|58676741|FG000|Overall Study|Disease worsening|79|||
30779311|NCT02914522|58790942|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
30779312|NCT02914522|58790943|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
30779313|NCT02914522|58790944|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
30854630|NCT02307682|58882018|FG002|Overall Study|Adverse Event|12|||
30854631|NCT02307682|58882016|FG000|Overall Study|Lack of Efficacy|1|||
30854632|NCT02307682|58882017|FG001|Overall Study|Lack of Efficacy|0|||
30662994|NCT03945188|58676742|FG001|Overall Study|Disease worsening|73|||
30662995|NCT03945188|58676741|FG000|Overall Study|Physician Decision|2|||
30662996|NCT03945188|58676742|FG001|Overall Study|Physician Decision|2|||
30662997|NCT03945188|58676741|FG000|Overall Study|Lack of Efficacy|7|||
30662998|NCT03945188|58676742|FG001|Overall Study|Lack of Efficacy|4|||
30662999|NCT03945188|58676741|FG000|Overall Study|Pregnancy|2|||
30854633|NCT02307682|58882018|FG002|Overall Study|Lack of Efficacy|1|||
30854634|NCT02307682|58882016|FG000|Overall Study|Physician Decision|2|||
30854635|NCT02307682|58882017|FG001|Overall Study|Physician Decision|2|||
30854636|NCT02307682|58882018|FG002|Overall Study|Physician Decision|8|||
30663000|NCT03945188|58676742|FG001|Overall Study|Pregnancy|0|||
30663001|NCT03945188|58676741|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
30663002|NCT03945188|58676742|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
30663003|NCT03945188|58676741|FG000|Overall Study|Adverse Event|10|||
30663004|NCT03945188|58676742|FG001|Overall Study|Adverse Event|5|||
30663005|NCT03945188|58676741|FG000|Overall Study|Other|2|||
30854637|NCT02307682|58882016|FG000|Overall Study|Progressive Disease|1|||
30854638|NCT02307682|58882017|FG001|Overall Study|Progressive Disease|0|||
30854639|NCT02307682|58882018|FG002|Overall Study|Progressive Disease|0|||
30854640|NCT02307682|58882016|FG000|Overall Study|Withdrawal by Subject|26|||
30854641|NCT02307682|58882017|FG001|Overall Study|Withdrawal by Subject|34|||
30854642|NCT02307682|58882018|FG002|Overall Study|Withdrawal by Subject|23|||
30854643|NCT02307682|58882016|FG000|Overall Study|Death|9|||
30854644|NCT02307682|58882017|FG001|Overall Study|Death|7|||
30854645|NCT02307682|58882018|FG002|Overall Study|Death|12|||
30854646|NCT02307682|58882016|FG000|Overall Study|Lost to Follow-up|1|||
30854647|NCT02307682|58882017|FG001|Overall Study|Lost to Follow-up|5|||
30854648|NCT02307682|58882018|FG002|Overall Study|Lost to Follow-up|6|||
30854649|NCT02307682|58882016|FG000|Overall Study|Protocol Deviation|0|||
30854650|NCT02307682|58882017|FG001|Overall Study|Protocol Deviation|0|||
30854651|NCT02307682|58882018|FG002|Overall Study|Protocol Deviation|2|||
30854652|NCT02307682|58882016|FG000|Overall Study|Other|1|||
30854653|NCT02307682|58882017|FG001|Overall Study|Other|1|||
30854654|NCT02307682|58882018|FG002|Overall Study|Other|0|||
30854655|NCT02615990|58882028|FG000|Overall Study|study terminated|1|||
30854656|NCT02615990|58882029|FG001|Overall Study|study terminated|1|||
30854657|NCT02613884|58882035|FG000|Overall Study|Death|1|||
30854658|NCT02613884|58882035|FG000|Overall Study|Lost to Follow-up|1|||
30854659|NCT02791763|58882043|FG000|Overall Study|Protocol Violation|0|||
30854660|NCT02791763|58882044|FG001|Overall Study|Protocol Violation|0|||
30854661|NCT02791763|58882045|FG002|Overall Study|Protocol Violation|1|||
30854662|NCT02791763|58882043|FG000|Overall Study|Withdrawal by Subject|5|||
30854663|NCT02791763|58882044|FG001|Overall Study|Withdrawal by Subject|1|||
30854664|NCT02791763|58882045|FG002|Overall Study|Withdrawal by Subject|0|||
30854665|NCT02791763|58882043|FG000|Overall Study|Physician Decision|0|||
30854666|NCT02791763|58882044|FG001|Overall Study|Physician Decision|1|||
30958158|NCT01697501|59022283|FG000|Overall Study|Protocol Violation|2|||
30663006|NCT03945188|58676742|FG001|Overall Study|Other|2|||
30854667|NCT02791763|58882045|FG002|Overall Study|Physician Decision|0|||
30958159|NCT01697345|59022296|FG000|Overall Study|Withdrawal by Subject|1|||
30854668|NCT02791763|58882043|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
30854669|NCT02791763|58882044|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
30854670|NCT02791763|58882045|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
30854671|NCT02791763|58882043|FG000|Overall Study|Cancer event|1|||
30854672|NCT02791763|58882044|FG001|Overall Study|Cancer event|3|||
30958160|NCT01697267|59022365|FG000|Overall Study|Death|3|||
30854673|NCT02791763|58882045|FG002|Overall Study|Cancer event|0|||
30854674|NCT02791763|58882043|FG000|Overall Study|Participant had renal transplant|3|||
30854675|NCT02791763|58882044|FG001|Overall Study|Participant had renal transplant|0|||
30854676|NCT02791763|58882045|FG002|Overall Study|Participant had renal transplant|0|||
30854677|NCT02791763|58882043|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
30854678|NCT02791763|58882044|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
30854679|NCT02791763|58882045|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
30854680|NCT02791763|58882043|FG000|Overall Study|Adverse Event|12|||
30854681|NCT02791763|58882044|FG001|Overall Study|Adverse Event|13|||
30854682|NCT02791763|58882045|FG002|Overall Study|Adverse Event|7|||
30854683|NCT02613572|58882065|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
30854684|NCT02613572|58882066|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
30854685|NCT02613572|58882067|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
30854686|NCT02613572|58882065|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
30854687|NCT02613572|58882066|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
30854688|NCT02613572|58882067|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
30779314|NCT02914522|58790945|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
30779315|NCT02914522|58790946|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
30779316|NCT02914522|58790947|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
30779317|NCT02914522|58790948|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
30779318|NCT02914522|58790949|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
30779319|NCT02914522|58790950|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
30779320|NCT02914522|58790940|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
30779321|NCT02914522|58790941|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
30779322|NCT02914522|58790942|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
30779323|NCT02914522|58790943|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
30779324|NCT02914522|58790944|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
30854689|NCT02087189|58882079|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
30854690|NCT02341456|58882086|FG000|Overall Study|Disease progression|2|||
30854691|NCT02341456|58882087|FG001|Overall Study|Disease progression|3|||
30663007|NCT03945188|58676741|FG000|Overall Study|Lost to Follow-up|1|||
30663008|NCT03945188|58676742|FG001|Overall Study|Lost to Follow-up|2|||
30663009|NCT00884949|58676748|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
30958161|NCT01697267|59022366|FG001|Overall Study|Death|1|||
30958162|NCT01697267|59022365|FG000|Overall Study|Withdrawal by Subject|5|||
30958163|NCT01697267|59022366|FG001|Overall Study|Withdrawal by Subject|5|||
30779325|NCT02914522|58790945|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
30779326|NCT02914522|58790946|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
30779327|NCT02914522|58790947|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
30779328|NCT02914522|58790948|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
30779329|NCT02914522|58790949|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
30958164|NCT01697267|59022365|FG000|Overall Study|Adverse Event|2|||
30779330|NCT02914522|58790950|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
30663010|NCT00884949|58676748|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
30663011|NCT00884793|58676761|FG000|Overall Study|Withdrawal by Subject|1|||
30663012|NCT00884325|58676767|FG000|Overall Study|Lost to Follow-up|1|||
30663013|NCT00884325|58676768|FG001|Overall Study|Lost to Follow-up|2|||
30663014|NCT00884325|58676767|FG000|Overall Study|Lack of Efficacy|0|||
30663015|NCT00884325|58676768|FG001|Overall Study|Lack of Efficacy|1|||
30779331|NCT02914522|58790940|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
30779332|NCT02914522|58790941|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
30854692|NCT02341456|58882088|FG002|Overall Study|Disease progression|1|||
30854693|NCT02341456|58882086|FG000|Overall Study|Death|1|||
30663016|NCT00884325|58676767|FG000|Overall Study|Withdrawal by Subject|1|||
30663017|NCT00884325|58676768|FG001|Overall Study|Withdrawal by Subject|1|||
30663018|NCT00884325|58676767|FG000|Overall Study|Not provided|1|||
30779333|NCT02914522|58790942|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
30779334|NCT02914522|58790943|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
30779335|NCT02914522|58790944|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
30779336|NCT02914522|58790945|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
30779337|NCT02914522|58790946|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
30854694|NCT02341456|58882087|FG001|Overall Study|Death|1|||
30854695|NCT02341456|58882088|FG002|Overall Study|Death|1|||
30663019|NCT00884325|58676768|FG001|Overall Study|Not provided|0|||
30663020|NCT00883779|58676776|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
30663021|NCT00883779|58676777|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
30854696|NCT02341456|58882086|FG000|Overall Study|Withdrawal by Subject|0|||
30854697|NCT02341456|58882087|FG001|Overall Study|Withdrawal by Subject|1|||
30663022|NCT00883779|58676776|FG000|Primary Study Treatment Phase|Disease progression|75|||
30663023|NCT00883779|58676777|FG001|Primary Study Treatment Phase|Disease progression|59|||
30663024|NCT00883779|58676776|FG000|Primary Study Treatment Phase|Adverse Event|16|||
30663025|NCT00883779|58676777|FG001|Primary Study Treatment Phase|Adverse Event|16|||
30663026|NCT00883779|58676776|FG000|Primary Study Treatment Phase|Death|2|||
30663027|NCT00883779|58676777|FG001|Primary Study Treatment Phase|Death|3|||
30663028|NCT00883779|58676776|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
30663029|NCT00883779|58676777|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
30663030|NCT00883779|58676776|FG000|Primary Study Treatment Phase|Other|3|||
30663031|NCT00883779|58676777|FG001|Primary Study Treatment Phase|Other|0|||
30663032|NCT00883779|58676776|FG000|Post-Study Treatment Phase|Adverse Event|2|||
30663033|NCT00883779|58676777|FG001|Post-Study Treatment Phase|Adverse Event|3|||
30663034|NCT00883779|58676776|FG000|Post-Study Treatment Phase|Death|1|||
30663035|NCT00883779|58676777|FG001|Post-Study Treatment Phase|Death|3|||
30663036|NCT00883779|58676776|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
30663037|NCT00883779|58676777|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
30663038|NCT00883779|58676776|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
30663039|NCT00883779|58676777|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
30663040|NCT00883779|58676776|FG000|Post-Study Treatment Phase|Disease progression|103|||
30663041|NCT00883779|58676777|FG001|Post-Study Treatment Phase|Disease progression|122|||
30663042|NCT00883779|58676776|FG000|Post-Study Treatment Phase|Other|3|||
30663043|NCT00883779|58676777|FG001|Post-Study Treatment Phase|Other|0|||
30663044|NCT00883779|58676776|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
30958165|NCT01697267|59022366|FG001|Overall Study|Adverse Event|1|||
30958166|NCT01697267|59022365|FG000|Overall Study|Lost to Follow-up|2|||
30958167|NCT01697267|59022366|FG001|Overall Study|Lost to Follow-up|4|||
30663045|NCT00883779|58676777|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
30663046|NCT00883779|58676776|FG000|Off-study Phase|Death|185|||
30958168|NCT01697267|59022365|FG000|Overall Study|Physician Decision|2|||
30663047|NCT00883779|58676777|FG001|Off-study Phase|Death|174|||
30663048|NCT00883779|58676776|FG000|Off-study Phase|Refused treatment|1|||
30958169|NCT01697267|59022366|FG001|Overall Study|Physician Decision|4|||
30663049|NCT00883779|58676777|FG001|Off-study Phase|Refused treatment|1|||
30663050|NCT00883779|58676776|FG000|Off-study Phase|Failure to return|5|||
30663051|NCT00883779|58676777|FG001|Off-study Phase|Failure to return|6|||
30663052|NCT00883779|58676776|FG000|Off-study Phase|Other|18|||
30663053|NCT00883779|58676777|FG001|Off-study Phase|Other|21|||
30663054|NCT04159701|58676785|FG000|Period 1: Treatment Period|Pregnancy|1|||
30663055|NCT04159701|58676786|FG001|Period 1: Treatment Period|Pregnancy|0|||
30663056|NCT04159701|58676785|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
30663057|NCT04159701|58676786|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
30663058|NCT04159701|58676785|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
30663059|NCT04159701|58676786|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
30663060|NCT04159701|58676785|FG000|Washout Period|site terminated by sponsor|0|||
30663061|NCT04159701|58676786|FG001|Washout Period|site terminated by sponsor|1|||
30663062|NCT04159701|58676785|FG000|Washout Period|study terminated by sponsor|10|||
30663063|NCT04159701|58676786|FG001|Washout Period|study terminated by sponsor|3|||
30663064|NCT04159701|58676785|FG000|Washout Period|Withdrawal by Subject|1|||
30663065|NCT04159701|58676786|FG001|Washout Period|Withdrawal by Subject|0|||
30663066|NCT04159701|58676785|FG000|Washout Period|Inadvertent Enrollment|1|||
30663067|NCT04159701|58676786|FG001|Washout Period|Inadvertent Enrollment|0|||
30663068|NCT04159701|58676785|FG000|Washout Period|Miscellaneous|1|||
30663069|NCT04159701|58676786|FG001|Washout Period|Miscellaneous|0|||
30663070|NCT04159701|58676785|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
30663071|NCT04159701|58676786|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
30663072|NCT04159701|58676785|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
30663073|NCT04159701|58676786|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
30663074|NCT04159701|58676785|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
30663075|NCT04159701|58676786|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
30958170|NCT01696955|59022428|FG000|Main Study|Protocol Violation|1|||
30958171|NCT01696955|59022429|FG001|Main Study|Protocol Violation|0|||
30663076|NCT04159701|58676785|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
30663077|NCT04159701|58676786|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
30663078|NCT04159701|58676785|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
30663079|NCT04159701|58676786|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
30663080|NCT00880269|58676798|FG000|Overall Study|Protocol Violation|1|||
30958172|NCT01696955|59022428|FG000|Main Study|Withdrawal by Subject|1|||
30854698|NCT02341456|58882088|FG002|Overall Study|Withdrawal by Subject|1|||
30854699|NCT02341456|58882086|FG000|Overall Study|Moved to local access programme.|0|||
30663081|NCT00880269|58676799|FG001|Overall Study|Protocol Violation|0|||
30663082|NCT00880269|58676798|FG000|Overall Study|Disease Progression|13|||
30663083|NCT00880269|58676799|FG001|Overall Study|Disease Progression|11|||
30663084|NCT00880269|58676798|FG000|Overall Study|New Cancer Therapy|1|||
30779338|NCT02914522|58790947|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
30779339|NCT02914522|58790948|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
30779340|NCT02914522|58790949|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
30663085|NCT00880269|58676799|FG001|Overall Study|New Cancer Therapy|0|||
30663086|NCT00880269|58676798|FG000|Overall Study|Death|4|||
30663087|NCT00880269|58676799|FG001|Overall Study|Death|2|||
30663088|NCT00880269|58676798|FG000|Overall Study|Lost to Follow-up|0|||
30663089|NCT00880269|58676799|FG001|Overall Study|Lost to Follow-up|1|||
30663090|NCT00880269|58676798|FG000|Overall Study|Withdrawal by Subject|3|||
30663091|NCT00880269|58676799|FG001|Overall Study|Withdrawal by Subject|4|||
30663092|NCT00880269|58676798|FG000|Overall Study|Adverse Event|10|||
30663093|NCT00880269|58676799|FG001|Overall Study|Adverse Event|9|||
30663094|NCT00880191|58676807|FG000|Overall Study|Refused further treatment|4|||
30663095|NCT00880191|58676808|FG001|Overall Study|Refused further treatment|1|||
30663096|NCT00880191|58676807|FG000|Overall Study|Adverse Event|8|||
30663097|NCT00880191|58676808|FG001|Overall Study|Adverse Event|6|||
30663098|NCT00880191|58676807|FG000|Overall Study|Hospitalization/efficacy|1|||
30663099|NCT00880191|58676808|FG001|Overall Study|Hospitalization/efficacy|1|||
30663100|NCT00597519|58676814|FG000|Overall Study|Death|1|||
30958173|NCT01696955|59022429|FG001|Main Study|Withdrawal by Subject|1|||
30663101|NCT00879333|58676820|FG000|Overall Study|Adverse Event|94|||
30663102|NCT00879333|58676821|FG001|Overall Study|Adverse Event|34|||
30663103|NCT00879333|58676820|FG000|Overall Study|Abnormal Laboratory Value|1|||
30663104|NCT00879333|58676821|FG001|Overall Study|Abnormal Laboratory Value|0|||
30663105|NCT00879333|58676820|FG000|Overall Study|Withdrawal by Subject|20|||
30663106|NCT00879333|58676821|FG001|Overall Study|Withdrawal by Subject|7|||
30663107|NCT00879333|58676820|FG000|Overall Study|Lost to Follow-up|2|||
30663108|NCT00879333|58676821|FG001|Overall Study|Lost to Follow-up|1|||
30663109|NCT00879333|58676820|FG000|Overall Study|Administrative Problems|2|||
30663110|NCT00879333|58676821|FG001|Overall Study|Administrative Problems|0|||
30663111|NCT00879333|58676820|FG000|Overall Study|Death|16|||
30779341|NCT02914522|58790950|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
30779342|NCT02914522|58790940|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
30779343|NCT02914522|58790941|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
30779344|NCT02914522|58790942|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
30779345|NCT02914522|58790943|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
30779346|NCT02914522|58790944|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
30779347|NCT02914522|58790945|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
30779348|NCT02914522|58790946|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
30779349|NCT02914522|58790947|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
30779350|NCT02914522|58790948|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
30779351|NCT02914522|58790949|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
30779352|NCT02914522|58790950|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
30779353|NCT02914522|58790940|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
30779354|NCT02914522|58790941|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
30779355|NCT02914522|58790942|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
30779356|NCT02914522|58790943|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
30779357|NCT02914522|58790944|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
30779358|NCT02914522|58790945|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
30779359|NCT02914522|58790946|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
30779360|NCT02914522|58790947|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
30779361|NCT02914522|58790948|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
30779362|NCT02914522|58790949|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
30779363|NCT02914522|58790950|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
30779364|NCT02914522|58790940|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
30779365|NCT02914522|58790941|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
30779366|NCT02914522|58790942|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
30779367|NCT02914522|58790943|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
30958174|NCT02702388|59022453|FG000|Overall Study|Disease Progression|18|||
30958175|NCT02702388|59022454|FG001|Overall Study|Disease Progression|25|||
30663112|NCT00879333|58676821|FG001|Overall Study|Death|5|||
30663113|NCT00879333|58676820|FG000|Overall Study|Disease Progression|292|||
30663114|NCT00879333|58676821|FG001|Overall Study|Disease Progression|169|||
30663115|NCT00879333|58676820|FG000|Overall Study|Protocol Violation|1|||
30663116|NCT00879333|58676821|FG001|Overall Study|Protocol Violation|1|||
30854700|NCT02341456|58882087|FG001|Overall Study|Moved to local access programme.|1|||
30854701|NCT02341456|58882088|FG002|Overall Study|Moved to local access programme.|1|||
30854702|NCT02341456|58882086|FG000|Overall Study|Physician Decision|1|||
30854703|NCT02341456|58882087|FG001|Overall Study|Physician Decision|0|||
30854704|NCT02341456|58882088|FG002|Overall Study|Physician Decision|0|||
30779368|NCT02914522|58790944|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
30779369|NCT02914522|58790945|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
30779370|NCT02914522|58790946|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
30779371|NCT02914522|58790947|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
30779372|NCT02914522|58790948|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
30779373|NCT02914522|58790949|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
30779374|NCT02914522|58790950|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
30663117|NCT03481556|58676833|FG000|Overall Study|Adverse Event|1|||
30663118|NCT03481556|58676834|FG001|Overall Study|Adverse Event|0|||
30663119|NCT03481556|58676835|FG002|Overall Study|Adverse Event|0|||
30663120|NCT03481556|58676836|FG003|Overall Study|Adverse Event|0|||
30663121|NCT03481556|58676833|FG000|Overall Study|Death|4|||
30779375|NCT02914522|58790940|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
30779376|NCT02914522|58790941|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
30854705|NCT02370784|58882098|FG000|Overall Study|Patient started prohibited medication|0|||
30663122|NCT03481556|58676834|FG001|Overall Study|Death|2|||
30663123|NCT03481556|58676835|FG002|Overall Study|Death|3|||
30663124|NCT03481556|58676836|FG003|Overall Study|Death|16|||
30663125|NCT03481556|58676833|FG000|Overall Study|Study Terminated by Sponsor|10|||
30663126|NCT03481556|58676834|FG001|Overall Study|Study Terminated by Sponsor|5|||
30663127|NCT03481556|58676835|FG002|Overall Study|Study Terminated by Sponsor|2|||
30663128|NCT03481556|58676836|FG003|Overall Study|Study Terminated by Sponsor|9|||
30663129|NCT00596427|58676854|FG000|Overall Study|Withdrawal by Subject|2|||
30663130|NCT00596427|58676855|FG001|Overall Study|Withdrawal by Subject|2|||
30779377|NCT02914522|58790942|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
30779378|NCT02914522|58790943|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
30779379|NCT02914522|58790944|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
30854706|NCT02370784|58882099|FG001|Overall Study|Patient started prohibited medication|1|||
30663131|NCT00596427|58676854|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
30663132|NCT00596427|58676855|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
30663133|NCT00596427|58676854|FG000|Overall Study|Protocol Violation|1|||
30663134|NCT00596427|58676855|FG001|Overall Study|Protocol Violation|0|||
30779380|NCT02914522|58790945|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
30779381|NCT02914522|58790946|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
30779382|NCT02914522|58790947|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
30779383|NCT02914522|58790948|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
30779384|NCT02914522|58790949|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
30779385|NCT02914522|58790950|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
30779386|NCT02914522|58790940|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
30779387|NCT02914522|58790941|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
30663135|NCT02732210|58676864|FG000|Overall Study|Site Closed|0|||
30779388|NCT02914522|58790942|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
30779389|NCT02914522|58790943|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
30779390|NCT02914522|58790944|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
30779391|NCT02914522|58790945|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
30779392|NCT02914522|58790946|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
30779393|NCT02914522|58790947|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
30779394|NCT02914522|58790948|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
30779395|NCT02914522|58790949|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
30779396|NCT02914522|58790950|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
30779397|NCT02914522|58790940|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
30779398|NCT02914522|58790941|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
30779399|NCT02914522|58790942|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
30663136|NCT02732210|58676865|FG001|Overall Study|Site Closed|11|||
30663137|NCT02732210|58676864|FG000|Overall Study|Study Ended|13|||
30663138|NCT02732210|58676865|FG001|Overall Study|Study Ended|13|||
30663139|NCT02732210|58676864|FG000|Overall Study|Withdrawal by Subject|28|||
30663140|NCT02732210|58676865|FG001|Overall Study|Withdrawal by Subject|87|||
30663141|NCT02732210|58676864|FG000|Overall Study|Lost to Follow-up|5|||
30663142|NCT02732210|58676865|FG001|Overall Study|Lost to Follow-up|57|||
30663143|NCT02732210|58676864|FG000|Overall Study|Death|4|||
30663144|NCT02732210|58676865|FG001|Overall Study|Death|15|||
30779400|NCT02914522|58790943|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
30779401|NCT02914522|58790944|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
30779402|NCT02914522|58790945|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
30663145|NCT02732210|58676864|FG000|Overall Study|Other|35|||
30663146|NCT02732210|58676865|FG001|Overall Study|Other|103|||
30663147|NCT02732210|58676864|FG000|Overall Study|Missing|0|||
30663148|NCT02732210|58676865|FG001|Overall Study|Missing|8|||
30958176|NCT02702388|59022453|FG000|Overall Study|Withdrawal by Subject|9|||
30958177|NCT02702388|59022454|FG001|Overall Study|Withdrawal by Subject|7|||
30958178|NCT02702388|59022453|FG000|Overall Study|Adverse Event|11|||
30958179|NCT02702388|59022454|FG001|Overall Study|Adverse Event|15|||
30958180|NCT02702388|59022453|FG000|Overall Study|Other|2|||
30958181|NCT02702388|59022454|FG001|Overall Study|Other|4|||
30958182|NCT01696877|59022480|FG000|Overall Study|Adverse Event|0|||
30958183|NCT01696877|59022481|FG001|Overall Study|Adverse Event|1|||
30958184|NCT02703636|59022677|FG000|Overall Study|Adverse Event|14|||
30958185|NCT02703636|59022677|FG000|Overall Study|Study stopped by sponsor|1|||
30958186|NCT02703636|59022677|FG000|Overall Study|Withdrawal by Subject|1|||
30958187|NCT02703324|59022905|FG000|Period Two|Withdrawal by Subject|0|||
30958188|NCT02703324|59022906|FG001|Period Two|Withdrawal by Subject|0|||
30663149|NCT00595959|58676871|FG000|Overall Study|Withdrawal by Subject|1|||
30663150|NCT00595959|58676871|FG000|Overall Study|Lost to Follow-up|1|||
30663151|NCT00436748|58676909|FG000|Overall Study|Ineligibility Determined|1|||
30663152|NCT00436748|58676910|FG001|Overall Study|Ineligibility Determined|1|||
30663153|NCT00436748|58676909|FG000|Overall Study|Adverse Event|0|||
30779403|NCT02914522|58790946|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
30779404|NCT02914522|58790947|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
30854707|NCT02307370|58882107|FG000|Overall Study|Death|5|||
30663154|NCT00436748|58676910|FG001|Overall Study|Adverse Event|2|||
30663155|NCT00436748|58676909|FG000|Overall Study|Consent Withdrawn|1|||
30663156|NCT00436748|58676910|FG001|Overall Study|Consent Withdrawn|4|||
30663157|NCT00436748|58676909|FG000|Overall Study|Administrative Decision|1|||
30663158|NCT00436748|58676910|FG001|Overall Study|Administrative Decision|0|||
30663159|NCT00436748|58676909|FG000|Overall Study|Lost to Follow-up|0|||
30779405|NCT02914522|58790948|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
30779406|NCT02914522|58790949|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
30779407|NCT02914522|58790950|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
30779408|NCT02914522|58790940|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
30779409|NCT02914522|58790941|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
30779410|NCT02914522|58790942|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
30779411|NCT02914522|58790943|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
30779412|NCT02914522|58790944|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
30779413|NCT02914522|58790945|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
30779414|NCT02914522|58790946|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
30779415|NCT02914522|58790947|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
30779416|NCT02914522|58790948|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
30779417|NCT02914522|58790949|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
30779418|NCT02914522|58790950|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
30779419|NCT02914522|58790940|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
30779420|NCT02914522|58790941|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
30779421|NCT02914522|58790942|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
30779422|NCT02914522|58790943|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
30779423|NCT02914522|58790944|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
30779424|NCT02914522|58790945|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
30663160|NCT00436748|58676910|FG001|Overall Study|Lost to Follow-up|1|||
30663161|NCT00436748|58676909|FG000|Overall Study|Protocol-specified Criteria|5|||
30663162|NCT00436748|58676910|FG001|Overall Study|Protocol-specified Criteria|4|||
30663163|NCT00436748|58676909|FG000|Overall Study|Other|3|||
30663164|NCT00436748|58676910|FG001|Overall Study|Other|0|||
30663165|NCT03342404|58676918|FG000|Overall Study|Withdrawal by Subject|9|||
30779425|NCT02914522|58790946|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
30854708|NCT02307370|58882107|FG000|Overall Study|Lost to Follow-up|1|||
30663166|NCT03342404|58676919|FG001|Overall Study|Withdrawal by Subject|10|||
30663167|NCT03342404|58676918|FG000|Overall Study|Lack of Efficacy|1|||
30663168|NCT03342404|58676919|FG001|Overall Study|Lack of Efficacy|17|||
30779426|NCT02914522|58790947|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
30779427|NCT02914522|58790948|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
30779428|NCT02914522|58790949|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
30779429|NCT02914522|58790950|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
30779430|NCT02924428|58790979|FG000|Overall Study|Adverse Event|1|||
30779431|NCT02924428|58790980|FG001|Overall Study|Adverse Event|0|||
30779432|NCT02924428|58790979|FG000|Overall Study|Physician Decision|1|||
30779433|NCT02924428|58790980|FG001|Overall Study|Physician Decision|0|||
30779434|NCT02924428|58790979|FG000|Overall Study|Lost to Follow-up|2|||
30779435|NCT02924428|58790980|FG001|Overall Study|Lost to Follow-up|4|||
30779436|NCT02924428|58790979|FG000|Overall Study|Pregnancy|0|||
30779437|NCT02924428|58790980|FG001|Overall Study|Pregnancy|1|||
30958189|NCT02703324|59022907|FG002|Period Two|Withdrawal by Subject|1|||
30663169|NCT03342404|58676918|FG000|Overall Study|Adverse Event|3|||
30779438|NCT00062751|58790991|FG000|Overall Study|Disease progression|24|||
30779439|NCT00062751|58790992|FG001|Overall Study|Disease progression|17|||
30779440|NCT00062751|58790993|FG002|Overall Study|Disease progression|24|||
30779441|NCT00062751|58790994|FG003|Overall Study|Disease progression|2|||
30779442|NCT00062751|58790995|FG004|Overall Study|Disease progression|2|||
30779443|NCT00062751|58790991|FG000|Overall Study|Adverse Event|4|||
30779444|NCT00062751|58790992|FG001|Overall Study|Adverse Event|7|||
30779445|NCT00062751|58790993|FG002|Overall Study|Adverse Event|2|||
30779446|NCT00062751|58790994|FG003|Overall Study|Adverse Event|2|||
30779447|NCT00062751|58790995|FG004|Overall Study|Adverse Event|2|||
30779448|NCT00062751|58790991|FG000|Overall Study|Other|2|||
30779449|NCT00062751|58790992|FG001|Overall Study|Other|3|||
30779450|NCT00062751|58790993|FG002|Overall Study|Other|1|||
30779451|NCT00062751|58790994|FG003|Overall Study|Other|0|||
30779452|NCT00062751|58790995|FG004|Overall Study|Other|1|||
30779453|NCT00062751|58790991|FG000|Overall Study|Withdrawal by Subject|1|||
30779454|NCT00062751|58790992|FG001|Overall Study|Withdrawal by Subject|2|||
30779455|NCT00062751|58790993|FG002|Overall Study|Withdrawal by Subject|2|||
30779456|NCT00062751|58790994|FG003|Overall Study|Withdrawal by Subject|1|||
30779457|NCT00062751|58790995|FG004|Overall Study|Withdrawal by Subject|0|||
30958190|NCT02703324|59022908|FG003|Period Two|Withdrawal by Subject|0|||
30779458|NCT00062751|58790991|FG000|Overall Study|Symptomatic deterioration|1|||
30779459|NCT00062751|58790992|FG001|Overall Study|Symptomatic deterioration|1|||
30663170|NCT03342404|58676919|FG001|Overall Study|Adverse Event|4|||
30779460|NCT00062751|58790993|FG002|Overall Study|Symptomatic deterioration|0|||
30779461|NCT00062751|58790994|FG003|Overall Study|Symptomatic deterioration|0|||
30779462|NCT00062751|58790995|FG004|Overall Study|Symptomatic deterioration|1|||
30779463|NCT00062751|58790991|FG000|Overall Study|Death|1|||
30779464|NCT00062751|58790992|FG001|Overall Study|Death|0|||
30779465|NCT00062751|58790993|FG002|Overall Study|Death|1|||
30779466|NCT00062751|58790994|FG003|Overall Study|Death|0|||
30779467|NCT00062751|58790995|FG004|Overall Study|Death|0|||
30779468|NCT00062439|58791012|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
30854709|NCT02307370|58882107|FG000|Overall Study|Withdrawal by Subject|1|||
30854710|NCT02307370|58882107|FG000|Overall Study|Declined Addendum ICF|6|||
30958191|NCT02703324|59022909|FG004|Period Two|Withdrawal by Subject|0|||
30958192|NCT02703324|59022910|FG005|Period Two|Withdrawal by Subject|0|||
30958193|NCT02701764|59022921|FG000|Overall Study|Lost to Follow-up|0|||
30958194|NCT02701764|59022922|FG001|Overall Study|Lost to Follow-up|1|||
30958195|NCT01696643|59023103|FG000|Overall Study|Adverse Event|15|||
30958196|NCT01696643|59023104|FG001|Overall Study|Adverse Event|7|||
30958197|NCT01696643|59023103|FG000|Overall Study|Death|1|||
30958198|NCT01696643|59023104|FG001|Overall Study|Death|2|||
30958199|NCT01696643|59023103|FG000|Overall Study|Lack of Efficacy|3|||
30663171|NCT03342404|58676918|FG000|Overall Study|Noncompliance with study drug|1|||
30663172|NCT03342404|58676919|FG001|Overall Study|Noncompliance with study drug|0|||
30663173|NCT03342404|58676918|FG000|Overall Study|Other reasons|1|||
30663174|NCT03342404|58676919|FG001|Overall Study|Other reasons|0|||
30663175|NCT02703272|58676929|FG000|Overall Study|Death|4|||
30663176|NCT02703272|58676930|FG001|Overall Study|Death|9|||
30958200|NCT01696643|59023104|FG001|Overall Study|Lack of Efficacy|0|||
30663177|NCT02703272|58676931|FG002|Overall Study|Death|19|||
30663178|NCT02703272|58676932|FG003|Overall Study|Death|10|||
30663179|NCT02703272|58676929|FG000|Overall Study|Withdrawal by Subject|0|||
30663180|NCT02703272|58676930|FG001|Overall Study|Withdrawal by Subject|0|||
30663181|NCT02703272|58676931|FG002|Overall Study|Withdrawal by Subject|4|||
30663182|NCT02703272|58676932|FG003|Overall Study|Withdrawal by Subject|2|||
30663183|NCT02703272|58676929|FG000|Overall Study|Study Terminated by Sponsor|6|||
30663184|NCT02703272|58676930|FG001|Overall Study|Study Terminated by Sponsor|1|||
30663185|NCT02703272|58676931|FG002|Overall Study|Study Terminated by Sponsor|12|||
30663186|NCT02703272|58676932|FG003|Overall Study|Study Terminated by Sponsor|4|||
30958201|NCT01696643|59023103|FG000|Overall Study|Lost to Follow-up|67|||
30663187|NCT02703272|58676929|FG000|Overall Study|Other|1|||
30663188|NCT02703272|58676930|FG001|Overall Study|Other|0|||
30663189|NCT02703272|58676931|FG002|Overall Study|Other|0|||
30663190|NCT02703272|58676932|FG003|Overall Study|Other|0|||
30663191|NCT02568215|58676972|FG000|Overall Study|Death|1|||
30663192|NCT02568215|58676973|FG001|Overall Study|Death|2|||
30663193|NCT02568215|58676974|FG002|Overall Study|Death|0|||
30663194|NCT02568215|58676972|FG000|Overall Study|Physician Decision|2|||
30663195|NCT02568215|58676973|FG001|Overall Study|Physician Decision|2|||
30663196|NCT02568215|58676974|FG002|Overall Study|Physician Decision|2|||
30663197|NCT02568215|58676972|FG000|Overall Study|Lost to Follow-up|29|||
30663198|NCT02568215|58676973|FG001|Overall Study|Lost to Follow-up|32|||
30663199|NCT02568215|58676974|FG002|Overall Study|Lost to Follow-up|41|||
30663200|NCT02568215|58676972|FG000|Overall Study|Withdrawal by Subject|21|||
30663201|NCT02568215|58676973|FG001|Overall Study|Withdrawal by Subject|19|||
30663202|NCT02568215|58676974|FG002|Overall Study|Withdrawal by Subject|22|||
30663203|NCT02568215|58676972|FG000|Overall Study|Protocol Violation|1|||
30663204|NCT02568215|58676973|FG001|Overall Study|Protocol Violation|1|||
30663205|NCT02568215|58676974|FG002|Overall Study|Protocol Violation|0|||
30663206|NCT02568215|58676972|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
30663207|NCT02568215|58676973|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
30663208|NCT02568215|58676974|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
30663209|NCT02568215|58676972|FG000|Overall Study|Other|0|||
30663210|NCT02568215|58676973|FG001|Overall Study|Other|1|||
30663211|NCT02568215|58676974|FG002|Overall Study|Other|4|||
30663212|NCT00908141|58677011|FG000|Overall Study|Withdrawal by Subject|0|||
30663213|NCT00908141|58677012|FG001|Overall Study|Withdrawal by Subject|1|||
30663214|NCT00906347|58677020|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
30663215|NCT00906347|58677021|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
30779469|NCT00062439|58791012|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
30958202|NCT01696643|59023104|FG001|Overall Study|Lost to Follow-up|67|||
30958203|NCT01696643|59023103|FG000|Overall Study|Physician Decision|3|||
30958204|NCT01696643|59023104|FG001|Overall Study|Physician Decision|2|||
30958205|NCT01696643|59023103|FG000|Overall Study|Pregnancy|0|||
30958206|NCT01696643|59023104|FG001|Overall Study|Pregnancy|1|||
30958207|NCT01696643|59023103|FG000|Overall Study|Protocol Violation|7|||
30958208|NCT01696643|59023104|FG001|Overall Study|Protocol Violation|7|||
30958209|NCT01696643|59023103|FG000|Overall Study|Study Terminated by Sponsor|286|||
30958210|NCT01696643|59023104|FG001|Overall Study|Study Terminated by Sponsor|294|||
30958211|NCT01696643|59023103|FG000|Overall Study|Withdrawal by Subject|142|||
30663216|NCT00906347|58677020|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
30958212|NCT01696643|59023104|FG001|Overall Study|Withdrawal by Subject|149|||
30958213|NCT01696643|59023103|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
30958214|NCT01696643|59023104|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
30958215|NCT01696643|59023103|FG000|Overall Study|Site Error|2|||
30958216|NCT01696643|59023104|FG001|Overall Study|Site Error|1|||
30958217|NCT01696643|59023103|FG000|Overall Study|Participant Incarcerated|0|||
30958218|NCT01696643|59023104|FG001|Overall Study|Participant Incarcerated|1|||
30663217|NCT00906347|58677021|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
30663218|NCT00906347|58677020|FG000|Received Study Drug|Refused study drug|1|||
30663219|NCT00906347|58677021|FG001|Received Study Drug|Refused study drug|0|||
30663220|NCT00906347|58677020|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
30663221|NCT00906347|58677021|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
30958219|NCT01696643|59023103|FG000|Overall Study|Medical Monitor Decision|0|||
30958220|NCT01696643|59023104|FG001|Overall Study|Medical Monitor Decision|2|||
30663222|NCT00906035|58677030|FG000|Overall Study|Withdrawal by Subject|2|||
30663223|NCT00906035|58677031|FG001|Overall Study|Withdrawal by Subject|3|||
30663224|NCT00906035|58677032|FG002|Overall Study|Withdrawal by Subject|0|||
30663225|NCT00905489|58677040|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
30663226|NCT00905489|58677040|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
30663227|NCT00905489|58677040|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
30663228|NCT02704754|58677051|FG000|Overall Study|Lost to Follow-up|1|||
30663229|NCT02704754|58677052|FG001|Overall Study|Lost to Follow-up|1|||
30663230|NCT02704754|58677051|FG000|Overall Study|Lack of Efficacy|1|||
30663231|NCT02704754|58677052|FG001|Overall Study|Lack of Efficacy|0|||
30663232|NCT02704754|58677051|FG000|Overall Study|Withdrawal by Subject|1|||
30663233|NCT02704754|58677052|FG001|Overall Study|Withdrawal by Subject|0|||
30663234|NCT03170882|58677060|FG000|Overall Study|Death|17|||
30663235|NCT03170882|58677061|FG001|Overall Study|Death|29|||
30663236|NCT03170882|58677060|FG000|Overall Study|Lost to Follow-up|0|||
30663237|NCT03170882|58677061|FG001|Overall Study|Lost to Follow-up|1|||
30663238|NCT03170882|58677060|FG000|Overall Study|Withdrawal by Subject|4|||
30663239|NCT03170882|58677061|FG001|Overall Study|Withdrawal by Subject|7|||
30663240|NCT03170882|58677060|FG000|Overall Study|Reason not Specified|28|||
30663241|NCT03170882|58677061|FG001|Overall Study|Reason not Specified|36|||
30663242|NCT00907517|58677072|FG000|Overall Study|Progressive Disease|3|||
30663243|NCT00907517|58677073|FG001|Overall Study|Progressive Disease|3|||
30663244|NCT00907517|58677074|FG002|Overall Study|Progressive Disease|4|||
30663245|NCT00907517|58677075|FG003|Overall Study|Progressive Disease|4|||
30663246|NCT00907517|58677076|FG004|Overall Study|Progressive Disease|4|||
30663247|NCT00907517|58677072|FG000|Overall Study|Symptomatic Deterioration|0|||
30663248|NCT00907517|58677073|FG001|Overall Study|Symptomatic Deterioration|0|||
30663249|NCT00907517|58677074|FG002|Overall Study|Symptomatic Deterioration|0|||
30663250|NCT00907517|58677075|FG003|Overall Study|Symptomatic Deterioration|0|||
30663251|NCT00907517|58677076|FG004|Overall Study|Symptomatic Deterioration|1|||
30663252|NCT00905255|58677090|FG000|Overall Study|Adverse Event|7|||
30663253|NCT00905255|58677091|FG001|Overall Study|Adverse Event|5|||
30663254|NCT00905255|58677090|FG000|Overall Study|Withdrawal by Subject|5|||
30663255|NCT00905255|58677091|FG001|Overall Study|Withdrawal by Subject|4|||
30663256|NCT00905255|58677090|FG000|Overall Study|Familial and Personal Reasons|1|||
30663257|NCT00905255|58677091|FG001|Overall Study|Familial and Personal Reasons|0|||
30779470|NCT00062439|58791012|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
30779471|NCT00062439|58791012|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
30663258|NCT00905021|58677098|FG000|Overall Study|Adverse Event|2|||
30663259|NCT00906971|58677105|FG000|Overall Study|Withdrawal by Subject|8|||
30663260|NCT00906971|58677106|FG001|Overall Study|Withdrawal by Subject|2|||
30663261|NCT00906971|58677105|FG000|Overall Study|Lost to Follow-up|0|||
30663262|NCT00906971|58677106|FG001|Overall Study|Lost to Follow-up|1|||
30663263|NCT00903929|58677112|FG000|Overall Study|Withdrawal by Subject|0|||
30663264|NCT00903929|58677113|FG001|Overall Study|Withdrawal by Subject|0|||
30663265|NCT00903929|58677114|FG002|Overall Study|Withdrawal by Subject|1|||
30663266|NCT00903929|58677115|FG003|Overall Study|Withdrawal by Subject|2|||
30663267|NCT00903929|58677112|FG000|Overall Study|Adverse Event|0|||
30663268|NCT00903929|58677113|FG001|Overall Study|Adverse Event|0|||
30663269|NCT00903929|58677114|FG002|Overall Study|Adverse Event|0|||
30663270|NCT00903929|58677115|FG003|Overall Study|Adverse Event|1|||
30663271|NCT00903695|58677122|FG000|Overall Study|medical exclusion after 1st testing|1|||
30663272|NCT00903695|58677123|FG001|Overall Study|medical exclusion after 1st testing|0|||
30663273|NCT00903695|58677122|FG000|Overall Study|lung cancer|1|||
30663274|NCT00903695|58677123|FG001|Overall Study|lung cancer|0|||
30663275|NCT00903617|58677135|FG000|Overall Study|Adverse Event|0|||
30663276|NCT00903617|58677136|FG001|Overall Study|Adverse Event|1|||
30663277|NCT00903617|58677137|FG002|Overall Study|Adverse Event|1|||
30663278|NCT00903617|58677138|FG003|Overall Study|Adverse Event|0|||
30663279|NCT00903617|58677135|FG000|Overall Study|Protocol-defined stopping criteria|0|||
30663280|NCT00903617|58677136|FG001|Overall Study|Protocol-defined stopping criteria|2|||
30663281|NCT00903617|58677137|FG002|Overall Study|Protocol-defined stopping criteria|0|||
30663282|NCT00903617|58677138|FG003|Overall Study|Protocol-defined stopping criteria|0|||
30663283|NCT00903617|58677135|FG000|Overall Study|Lost to Follow-up|2|||
30663284|NCT00903617|58677136|FG001|Overall Study|Lost to Follow-up|0|||
30663285|NCT00903617|58677137|FG002|Overall Study|Lost to Follow-up|1|||
30663286|NCT00903617|58677138|FG003|Overall Study|Lost to Follow-up|1|||
30663287|NCT00903617|58677135|FG000|Overall Study|Withdrawal by Subject|1|||
30958221|NCT01696643|59023103|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
30958222|NCT01696643|59023104|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
30663288|NCT00903617|58677136|FG001|Overall Study|Withdrawal by Subject|2|||
30663289|NCT00903617|58677137|FG002|Overall Study|Withdrawal by Subject|3|||
30663290|NCT00903617|58677138|FG003|Overall Study|Withdrawal by Subject|0|||
30663291|NCT00903383|58677153|FG000|Overall Study|Adverse Event|1|||
30663292|NCT00903383|58677154|FG001|Overall Study|Adverse Event|2|||
30663293|NCT00903383|58677155|FG002|Overall Study|Adverse Event|3|||
30663294|NCT00903383|58677156|FG003|Overall Study|Adverse Event|1|||
30663295|NCT00903383|58677153|FG000|Overall Study|Physician Decision|1|||
30663296|NCT00903383|58677154|FG001|Overall Study|Physician Decision|2|||
30663297|NCT00903383|58677155|FG002|Overall Study|Physician Decision|0|||
30663298|NCT00903383|58677156|FG003|Overall Study|Physician Decision|0|||
30663299|NCT00903383|58677153|FG000|Overall Study|Lost to Follow-up|0|||
30663300|NCT00903383|58677154|FG001|Overall Study|Lost to Follow-up|0|||
30663301|NCT00903383|58677155|FG002|Overall Study|Lost to Follow-up|0|||
30663302|NCT00903383|58677156|FG003|Overall Study|Lost to Follow-up|1|||
30663303|NCT00903383|58677153|FG000|Overall Study|Decision of Sponsor|1|||
30663304|NCT00903383|58677154|FG001|Overall Study|Decision of Sponsor|0|||
30663305|NCT00903383|58677155|FG002|Overall Study|Decision of Sponsor|0|||
30663306|NCT00903383|58677156|FG003|Overall Study|Decision of Sponsor|0|||
30663307|NCT00903383|58677153|FG000|Overall Study|Withdrawal by Subject|4|||
30663308|NCT00903383|58677154|FG001|Overall Study|Withdrawal by Subject|1|||
30663309|NCT00903383|58677155|FG002|Overall Study|Withdrawal by Subject|0|||
30958223|NCT01695317|59023116|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
30958224|NCT01695317|59023117|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
30958225|NCT01695317|59023116|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
30958226|NCT01695317|59023117|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
30663310|NCT00903383|58677156|FG003|Overall Study|Withdrawal by Subject|2|||
30663311|NCT00903383|58677153|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
30663312|NCT00903383|58677154|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
30854711|NCT02307370|58882107|FG000|Overall Study|No response during telephone contact|5|||
30854712|NCT02307370|58882107|FG000|Overall Study|Protocol Violation|1|||
30663313|NCT00903383|58677155|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
30663314|NCT00903383|58677156|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
30663315|NCT00903383|58677153|FG000|Overall Study|Patient Decision|0|||
30663316|NCT00903383|58677154|FG001|Overall Study|Patient Decision|0|||
30663317|NCT00903383|58677155|FG002|Overall Study|Patient Decision|0|||
30663318|NCT00903383|58677156|FG003|Overall Study|Patient Decision|1|||
30663319|NCT02314026|58677166|FG000|Overall Study|Protocol Violation|28|||
30663320|NCT01617096|58677176|FG000|Overall Study|Withdrawal by Subject|96|||
30663321|NCT01617096|58677177|FG001|Overall Study|Withdrawal by Subject|81|||
30663322|NCT01617096|58677176|FG000|Overall Study|Lost to Follow-up|37|||
30663323|NCT01617096|58677177|FG001|Overall Study|Lost to Follow-up|32|||
30663324|NCT01617096|58677176|FG000|Overall Study|Physician Decision|10|||
30663325|NCT01617096|58677177|FG001|Overall Study|Physician Decision|18|||
30663326|NCT01617096|58677176|FG000|Overall Study|Death|4|||
30663327|NCT01617096|58677177|FG001|Overall Study|Death|3|||
30663328|NCT01617096|58677176|FG000|Overall Study|Other|1|||
30663329|NCT01617096|58677177|FG001|Overall Study|Other|3|||
30663330|NCT00900731|58677206|FG000|Overall Study|Adverse Event|31|||
30663331|NCT00900731|58677207|FG001|Overall Study|Adverse Event|27|||
30663332|NCT00900731|58677206|FG000|Overall Study|Withdrawal by Subject|8|||
30663333|NCT00900731|58677207|FG001|Overall Study|Withdrawal by Subject|7|||
30663334|NCT00900731|58677206|FG000|Overall Study|Protocol Deviation|8|||
30663335|NCT00900731|58677207|FG001|Overall Study|Protocol Deviation|11|||
30663336|NCT00900731|58677206|FG000|Overall Study|Administrative Problems|5|||
30663337|NCT00900731|58677207|FG001|Overall Study|Administrative Problems|4|||
30663338|NCT00900731|58677206|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
30663339|NCT00900731|58677207|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
30663340|NCT00900731|58677206|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
30663341|NCT00900731|58677207|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
30663342|NCT00900731|58677206|FG000|Overall Study|Lost to Follow-up|2|||
30663343|NCT00900731|58677207|FG001|Overall Study|Lost to Follow-up|3|||
30663344|NCT00900731|58677206|FG000|Overall Study|Lack of Efficacy|1|||
30663345|NCT00900731|58677207|FG001|Overall Study|Lack of Efficacy|3|||
30663346|NCT00900731|58677206|FG000|Overall Study|Death|0|||
30663347|NCT00900731|58677207|FG001|Overall Study|Death|2|||
30663348|NCT03842436|58677213|FG000|Overall Study|Lost to Follow-up|1|||
30663349|NCT00602472|58677253|FG000|Overall Study|Adverse Event|5|||
30663350|NCT00602472|58677254|FG001|Overall Study|Adverse Event|23|||
30663351|NCT00602472|58677253|FG000|Overall Study|Protocol Violation|4|||
30663352|NCT00602472|58677254|FG001|Overall Study|Protocol Violation|19|||
30663353|NCT00602472|58677253|FG000|Overall Study|Withdrawal by Subject|8|||
30663354|NCT00602472|58677254|FG001|Overall Study|Withdrawal by Subject|14|||
30663355|NCT00602472|58677253|FG000|Overall Study|Other incl. lack of efficacy|4|||
30663356|NCT00602472|58677254|FG001|Overall Study|Other incl. lack of efficacy|2|||
30663357|NCT00901901|58677289|FG000|Treatment Period|Adverse Event|120|||
30663358|NCT00901901|58677290|FG001|Treatment Period|Adverse Event|128|||
30663359|NCT00901901|58677289|FG000|Treatment Period|Withdrawal by Subject|26|||
30663360|NCT00901901|58677290|FG001|Treatment Period|Withdrawal by Subject|24|||
30663361|NCT00901901|58677289|FG000|Treatment Period|Physician Decision|2|||
30663362|NCT00901901|58677290|FG001|Treatment Period|Physician Decision|2|||
30663363|NCT00901901|58677289|FG000|Treatment Period|Lost to Follow-up|3|||
30663364|NCT00901901|58677290|FG001|Treatment Period|Lost to Follow-up|5|||
30663365|NCT00901901|58677289|FG000|Treatment Period|Noncompliance with study medication|4|||
30663366|NCT00901901|58677290|FG001|Treatment Period|Noncompliance with study medication|1|||
30663367|NCT00901901|58677289|FG000|Treatment Period|Missing|1|||
30663368|NCT00901901|58677290|FG001|Treatment Period|Missing|0|||
30663369|NCT00901901|58677289|FG000|Treatment Period|Never treated|0|||
30663370|NCT00901901|58677290|FG001|Treatment Period|Never treated|3|||
30663371|NCT00901901|58677289|FG000|Treatment Period|Protocol driven decision point|0|||
30663372|NCT00901901|58677290|FG001|Treatment Period|Protocol driven decision point|2|||
30663373|NCT00901901|58677289|FG000|Treatment Period|Study terminated by sponsor|2|||
30663374|NCT00901901|58677290|FG001|Treatment Period|Study terminated by sponsor|0|||
30663375|NCT00901901|58677289|FG000|Treatment Period|Protocol Violation|5|||
30663376|NCT00901901|58677290|FG001|Treatment Period|Protocol Violation|9|||
30663377|NCT00901901|58677289|FG000|Treatment Period|Switch to commercial drug|1|||
30663378|NCT00901901|58677290|FG001|Treatment Period|Switch to commercial drug|1|||
30663379|NCT00901901|58677289|FG000|Treatment Period|Transfer to treatment continuation study|5|||
30663380|NCT00901901|58677290|FG001|Treatment Period|Transfer to treatment continuation study|2|||
30663381|NCT00901901|58677289|FG000|Follow-up Period|Death|181|||
30663382|NCT00901901|58677290|FG001|Follow-up Period|Death|208|||
30663383|NCT00901901|58677289|FG000|Follow-up Period|Protocol driven decision point|47|||
30663384|NCT00901901|58677290|FG001|Follow-up Period|Protocol driven decision point|36|||
30663385|NCT00901901|58677289|FG000|Follow-up Period|Withdrawal by Subject|6|||
30663386|NCT00901901|58677290|FG001|Follow-up Period|Withdrawal by Subject|9|||
30663387|NCT00901901|58677289|FG000|Follow-up Period|Lost to Follow-up|12|||
30663388|NCT00901901|58677290|FG001|Follow-up Period|Lost to Follow-up|8|||
30663389|NCT00901901|58677289|FG000|Follow-up Period|Missing|94|||
30663390|NCT00901901|58677290|FG001|Follow-up Period|Missing|80|||
30663391|NCT02143778|58677298|FG000|Overall Study|Withdrawal by Subject|2|||
30663392|NCT02143778|58677298|FG000|Overall Study|Device malfunction|1|||
30663393|NCT00896363|58677342|FG000|Overall Study|Adverse Event|3|||
30663394|NCT00896363|58677343|FG001|Overall Study|Adverse Event|4|||
30663395|NCT00896363|58677344|FG002|Overall Study|Adverse Event|2|||
30663396|NCT00896363|58677342|FG000|Overall Study|Lack of Efficacy|0|||
30663397|NCT00896363|58677343|FG001|Overall Study|Lack of Efficacy|2|||
30663398|NCT00896363|58677344|FG002|Overall Study|Lack of Efficacy|1|||
30663399|NCT00896363|58677342|FG000|Overall Study|Withdrawal by Subject|3|||
30663400|NCT00896363|58677343|FG001|Overall Study|Withdrawal by Subject|5|||
30663401|NCT00896363|58677344|FG002|Overall Study|Withdrawal by Subject|5|||
30663402|NCT00900029|58677360|FG000|Overall Study|Lost to Follow-up|0|||
30663403|NCT00900029|58677361|FG001|Overall Study|Lost to Follow-up|2|||
30663404|NCT00900029|58677362|FG002|Overall Study|Lost to Follow-up|1|||
30663405|NCT00900029|58677363|FG003|Overall Study|Lost to Follow-up|4|||
30663406|NCT00900029|58677364|FG004|Overall Study|Lost to Follow-up|4|||
30663407|NCT00900029|58677360|FG000|Overall Study|Withdrawal by Subject|2|||
30663408|NCT00900029|58677361|FG001|Overall Study|Withdrawal by Subject|2|||
30854713|NCT02370394|58882115|FG000|Overall Study|Lost to Follow-up|2|||
30663409|NCT00900029|58677362|FG002|Overall Study|Withdrawal by Subject|1|||
30663410|NCT00900029|58677363|FG003|Overall Study|Withdrawal by Subject|1|||
30663411|NCT00900029|58677364|FG004|Overall Study|Withdrawal by Subject|1|||
30663412|NCT00900029|58677360|FG000|Overall Study|Adverse Event|0|||
30663413|NCT00900029|58677361|FG001|Overall Study|Adverse Event|0|||
30663414|NCT00900029|58677362|FG002|Overall Study|Adverse Event|1|||
30663415|NCT00900029|58677363|FG003|Overall Study|Adverse Event|1|||
30663416|NCT00900029|58677364|FG004|Overall Study|Adverse Event|1|||
30663417|NCT00900029|58677360|FG000|Overall Study|Death|1|||
30663418|NCT00900029|58677361|FG001|Overall Study|Death|0|||
30663419|NCT00900029|58677362|FG002|Overall Study|Death|0|||
30663420|NCT00900029|58677363|FG003|Overall Study|Death|1|||
30663421|NCT00900029|58677364|FG004|Overall Study|Death|0|||
30663422|NCT00896051|58677382|FG000|Overall Study|Adverse Event|2|||
30663423|NCT00896051|58677383|FG001|Overall Study|Adverse Event|1|||
30663424|NCT00896051|58677382|FG000|Overall Study|Lost to Follow-up|3|||
30663425|NCT00896051|58677383|FG001|Overall Study|Lost to Follow-up|2|||
30663426|NCT00896051|58677382|FG000|Overall Study|Withdrawal by Subject|3|||
30663427|NCT00896051|58677383|FG001|Overall Study|Withdrawal by Subject|2|||
30663428|NCT00896051|58677382|FG000|Overall Study|Subject noncompliant|1|||
30663429|NCT00896051|58677383|FG001|Overall Study|Subject noncompliant|3|||
30663430|NCT00896051|58677382|FG000|Overall Study|Other|1|||
30663431|NCT00896051|58677383|FG001|Overall Study|Other|1|||
30663432|NCT00894647|58677400|FG000|Overall Study|Adverse Event|5|||
30663433|NCT00894647|58677401|FG001|Overall Study|Adverse Event|4|||
30663434|NCT00894647|58677400|FG000|Overall Study|Withdrawal by Subject|4|||
30663435|NCT00894647|58677401|FG001|Overall Study|Withdrawal by Subject|4|||
30663436|NCT00894647|58677400|FG000|Overall Study|Lost to Follow-up|0|||
30663437|NCT00894647|58677401|FG001|Overall Study|Lost to Follow-up|2|||
30663438|NCT00894647|58677400|FG000|Overall Study|Non-compliance with study procedures|0|||
30663439|NCT00894647|58677401|FG001|Overall Study|Non-compliance with study procedures|2|||
30663440|NCT00894647|58677400|FG000|Overall Study|Other, not due to AE|1|||
30663441|NCT00894647|58677401|FG001|Overall Study|Other, not due to AE|2|||
30958227|NCT02701296|59023173|FG000|Overall Study|Incomplete Data|0|||
30663442|NCT00892775|58677409|FG000|Overall Study|Protocol Violation|1|||
30663443|NCT00892775|58677410|FG001|Overall Study|Protocol Violation|0|||
30663444|NCT00892775|58677409|FG000|Overall Study|Subject difficulties with blood drawing|1|||
30663445|NCT00892775|58677410|FG001|Overall Study|Subject difficulties with blood drawing|0|||
30663446|NCT00892775|58677409|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
30663447|NCT00892775|58677410|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
30663448|NCT00892775|58677409|FG000|Overall Study|Migrated/ moved from study area|1|||
30663449|NCT00892775|58677410|FG001|Overall Study|Migrated/ moved from study area|0|||
30663450|NCT00892775|58677409|FG000|Overall Study|Withdrawal by Subject|0|||
30663451|NCT00892775|58677410|FG001|Overall Study|Withdrawal by Subject|1|||
30663452|NCT00892775|58677409|FG000|Overall Study|Lost to Follow-up|1|||
30663453|NCT00892775|58677410|FG001|Overall Study|Lost to Follow-up|0|||
30663454|NCT00895895|58677421|FG000|Period 1|Adverse Event|7|||
30663455|NCT00895895|58677422|FG001|Period 1|Adverse Event|6|||
30663456|NCT00895895|58677423|FG002|Period 1|Adverse Event|4|||
30663457|NCT00895895|58677424|FG003|Period 1|Adverse Event|6|||
30663458|NCT00895895|58677425|FG004|Period 1|Adverse Event|7|||
30663459|NCT00895895|58677421|FG000|Period 1|Death|0|||
30663460|NCT00895895|58677422|FG001|Period 1|Death|0|||
30663461|NCT00895895|58677423|FG002|Period 1|Death|0|||
30663462|NCT00895895|58677424|FG003|Period 1|Death|0|||
30663463|NCT00895895|58677425|FG004|Period 1|Death|1|||
30663464|NCT00895895|58677421|FG000|Period 1|discontinued by sponsor|2|||
30663465|NCT00895895|58677422|FG001|Period 1|discontinued by sponsor|1|||
30663466|NCT00895895|58677423|FG002|Period 1|discontinued by sponsor|2|||
30663467|NCT00895895|58677424|FG003|Period 1|discontinued by sponsor|1|||
30663468|NCT00895895|58677425|FG004|Period 1|discontinued by sponsor|1|||
30663469|NCT00895895|58677421|FG000|Period 1|failed to return|0|||
30663470|NCT00895895|58677422|FG001|Period 1|failed to return|0|||
30663471|NCT00895895|58677423|FG002|Period 1|failed to return|1|||
30663472|NCT00895895|58677424|FG003|Period 1|failed to return|0|||
30663473|NCT00895895|58677425|FG004|Period 1|failed to return|1|||
30663474|NCT00895895|58677421|FG000|Period 1|investigator request|0|||
30663475|NCT00895895|58677422|FG001|Period 1|investigator request|1|||
30663476|NCT00895895|58677423|FG002|Period 1|investigator request|0|||
30663477|NCT00895895|58677424|FG003|Period 1|investigator request|0|||
30663478|NCT00895895|58677425|FG004|Period 1|investigator request|0|||
30663479|NCT00895895|58677421|FG000|Period 1|Lost to Follow-up|2|||
30663480|NCT00895895|58677422|FG001|Period 1|Lost to Follow-up|1|||
30663481|NCT00895895|58677423|FG002|Period 1|Lost to Follow-up|3|||
30663482|NCT00895895|58677424|FG003|Period 1|Lost to Follow-up|2|||
30663483|NCT00895895|58677425|FG004|Period 1|Lost to Follow-up|3|||
30663484|NCT00895895|58677421|FG000|Period 1|Other|1|||
30663485|NCT00895895|58677422|FG001|Period 1|Other|2|||
30663486|NCT00895895|58677423|FG002|Period 1|Other|1|||
30779472|NCT00062439|58791012|FG000|Post Chemoradiation Assessment|Death|1|||
30779473|NCT00062439|58791012|FG000|Post Chemoradiation Assessment|Disease progression|2|||
30779474|NCT00062439|58791012|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
30779475|NCT00062439|58791012|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
30779476|NCT00062439|58791012|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
30779477|NCT00062439|58791012|FG000|Surgery|Physician Decision|4|||
30779478|NCT00062439|58791012|FG000|Surgery|Death|1|||
30779479|NCT00062439|58791012|FG000|Surgery|Adverse Event|2|||
30958228|NCT02701296|59023174|FG001|Overall Study|Incomplete Data|2|||
30663487|NCT00895895|58677424|FG003|Period 1|Other|1|||
30663488|NCT00895895|58677425|FG004|Period 1|Other|1|||
30663489|NCT00895895|58677421|FG000|Period 1|Protocol Violation|0|||
30663490|NCT00895895|58677422|FG001|Period 1|Protocol Violation|1|||
30663491|NCT00895895|58677423|FG002|Period 1|Protocol Violation|0|||
30663492|NCT00895895|58677424|FG003|Period 1|Protocol Violation|0|||
30663493|NCT00895895|58677425|FG004|Period 1|Protocol Violation|0|||
30779480|NCT00062439|58791012|FG000|Consolidation Chemotherapy|Adverse Event|2|||
30854714|NCT02370394|58882116|FG001|Overall Study|Lost to Follow-up|1|||
30779481|NCT00051363|58791023|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
30779482|NCT00051363|58791024|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
30779483|NCT00051363|58791023|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
30779484|NCT00051363|58791024|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
30779485|NCT00051363|58791023|FG000|Overall Study|Death|2|||
30779486|NCT00051363|58791024|FG001|Overall Study|Death|2|||
30958229|NCT01582451|59023191|FG000|Overall Study|Adverse Event|1|||
30958230|NCT01582451|59023192|FG001|Overall Study|Adverse Event|3|||
30779487|NCT00051363|58791023|FG000|Overall Study|Excluded Pre-Randomization|2|||
30779488|NCT00051363|58791024|FG001|Overall Study|Excluded Pre-Randomization|5|||
30958231|NCT01582451|59023191|FG000|Overall Study|Death|3|||
30958232|NCT01582451|59023192|FG001|Overall Study|Death|3|||
30958233|NCT01582451|59023191|FG000|Overall Study|Lost to Follow-up|0|||
30958234|NCT01582451|59023192|FG001|Overall Study|Lost to Follow-up|2|||
30958235|NCT01582451|59023191|FG000|Overall Study|Protocol Violation|11|||
30779489|NCT00031551|58791032|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
30663494|NCT00895895|58677421|FG000|Period 1|Withdrawal by Subject|6|||
30663495|NCT00895895|58677422|FG001|Period 1|Withdrawal by Subject|6|||
30663496|NCT00895895|58677423|FG002|Period 1|Withdrawal by Subject|8|||
30958236|NCT01582451|59023192|FG001|Overall Study|Protocol Violation|3|||
30958237|NCT01582451|59023191|FG000|Overall Study|Withdrawal by Subject|13|||
30958238|NCT01582451|59023192|FG001|Overall Study|Withdrawal by Subject|9|||
30958239|NCT01582451|59023191|FG000|Overall Study|Physician Decision|3|||
30958240|NCT01582451|59023192|FG001|Overall Study|Physician Decision|0|||
30958241|NCT01582451|59023191|FG000|Overall Study|Sponsor Decision|1|||
30958242|NCT01582451|59023192|FG001|Overall Study|Sponsor Decision|0|||
30958243|NCT02700984|59023276|FG000|Overall Study|Death|2|||
30958244|NCT02700984|59023277|FG001|Overall Study|Death|1|||
30958245|NCT02700984|59023276|FG000|Overall Study|Lost to Follow-up|2|||
30663497|NCT00895895|58677424|FG003|Period 1|Withdrawal by Subject|2|||
30663498|NCT00895895|58677425|FG004|Period 1|Withdrawal by Subject|4|||
30663499|NCT00895895|58677421|FG000|Period 1|unsatisfactory response-efficacy|2|||
30663500|NCT00895895|58677422|FG001|Period 1|unsatisfactory response-efficacy|0|||
30663501|NCT00895895|58677423|FG002|Period 1|unsatisfactory response-efficacy|0|||
30663502|NCT00895895|58677424|FG003|Period 1|unsatisfactory response-efficacy|0|||
30663503|NCT00895895|58677425|FG004|Period 1|unsatisfactory response-efficacy|0|||
30663504|NCT00895895|58677421|FG000|Period 1|randomized and not treated|1|||
30663505|NCT00895895|58677422|FG001|Period 1|randomized and not treated|3|||
30663506|NCT00895895|58677423|FG002|Period 1|randomized and not treated|1|||
30663507|NCT00895895|58677424|FG003|Period 1|randomized and not treated|1|||
30663508|NCT00895895|58677425|FG004|Period 1|randomized and not treated|2|||
30663509|NCT00895895|58677421|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
30663510|NCT00895895|58677422|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
30663511|NCT00895895|58677423|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
30663512|NCT00895895|58677424|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
30663513|NCT00895895|58677425|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
30958246|NCT02700984|59023277|FG001|Overall Study|Lost to Follow-up|1|||
30958247|NCT02700984|59023276|FG000|Overall Study|Physician Decision|0|||
30958248|NCT02700984|59023277|FG001|Overall Study|Physician Decision|1|||
30663514|NCT00895895|58677421|FG000|After Period 1, Prior to Period 2|Other|0|||
30663515|NCT00895895|58677422|FG001|After Period 1, Prior to Period 2|Other|0|||
30663516|NCT00895895|58677423|FG002|After Period 1, Prior to Period 2|Other|1|||
30663517|NCT00895895|58677424|FG003|After Period 1, Prior to Period 2|Other|0|||
30663518|NCT00895895|58677425|FG004|After Period 1, Prior to Period 2|Other|0|||
30663519|NCT00895895|58677421|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
30663520|NCT00895895|58677422|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
30663521|NCT00895895|58677423|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
30663522|NCT00895895|58677424|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
30663523|NCT00895895|58677425|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
30663524|NCT00895895|58677421|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
30663525|NCT00895895|58677422|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
30663526|NCT00895895|58677423|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
30663527|NCT00895895|58677424|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
30663528|NCT00895895|58677425|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
30663529|NCT00895895|58677421|FG000|Period 2|Adverse Event|3|||
30663530|NCT00895895|58677422|FG001|Period 2|Adverse Event|3|||
30663531|NCT00895895|58677423|FG002|Period 2|Adverse Event|5|||
30663532|NCT00895895|58677424|FG003|Period 2|Adverse Event|2|||
30663533|NCT00895895|58677425|FG004|Period 2|Adverse Event|5|||
30663534|NCT00895895|58677421|FG000|Period 2|Death|0|||
30663535|NCT00895895|58677422|FG001|Period 2|Death|0|||
30663536|NCT00895895|58677423|FG002|Period 2|Death|1|||
30663537|NCT00895895|58677424|FG003|Period 2|Death|0|||
30663538|NCT00895895|58677425|FG004|Period 2|Death|0|||
30663539|NCT00895895|58677421|FG000|Period 2|discontinued by sponsor|44|||
30663540|NCT00895895|58677422|FG001|Period 2|discontinued by sponsor|44|||
30663541|NCT00895895|58677423|FG002|Period 2|discontinued by sponsor|38|||
30663542|NCT00895895|58677424|FG003|Period 2|discontinued by sponsor|46|||
30663543|NCT00895895|58677425|FG004|Period 2|discontinued by sponsor|37|||
30663544|NCT00895895|58677421|FG000|Period 2|failed to return|2|||
30663545|NCT00895895|58677422|FG001|Period 2|failed to return|0|||
30663546|NCT00895895|58677423|FG002|Period 2|failed to return|0|||
30663547|NCT00895895|58677424|FG003|Period 2|failed to return|0|||
30663548|NCT00895895|58677425|FG004|Period 2|failed to return|0|||
30663549|NCT00895895|58677421|FG000|Period 2|investigator request|2|||
30663550|NCT00895895|58677422|FG001|Period 2|investigator request|0|||
30663551|NCT00895895|58677423|FG002|Period 2|investigator request|0|||
30663552|NCT00895895|58677424|FG003|Period 2|investigator request|0|||
30663553|NCT00895895|58677425|FG004|Period 2|investigator request|0|||
30663554|NCT00895895|58677421|FG000|Period 2|Lost to Follow-up|1|||
30663555|NCT00895895|58677422|FG001|Period 2|Lost to Follow-up|2|||
30663556|NCT00895895|58677423|FG002|Period 2|Lost to Follow-up|1|||
30663557|NCT00895895|58677424|FG003|Period 2|Lost to Follow-up|1|||
30663558|NCT00895895|58677425|FG004|Period 2|Lost to Follow-up|0|||
30663559|NCT00895895|58677421|FG000|Period 2|Other|1|||
30663560|NCT00895895|58677422|FG001|Period 2|Other|1|||
30663561|NCT00895895|58677423|FG002|Period 2|Other|3|||
30663562|NCT00895895|58677424|FG003|Period 2|Other|1|||
30663563|NCT00895895|58677425|FG004|Period 2|Other|1|||
30663564|NCT00895895|58677421|FG000|Period 2|Protocol Violation|1|||
30663565|NCT00895895|58677422|FG001|Period 2|Protocol Violation|0|||
30663566|NCT00895895|58677423|FG002|Period 2|Protocol Violation|1|||
30663567|NCT00895895|58677424|FG003|Period 2|Protocol Violation|1|||
30663568|NCT00895895|58677425|FG004|Period 2|Protocol Violation|1|||
30663569|NCT00895895|58677421|FG000|Period 2|Withdrawal by Subject|0|||
30663570|NCT00895895|58677422|FG001|Period 2|Withdrawal by Subject|2|||
30663571|NCT00895895|58677423|FG002|Period 2|Withdrawal by Subject|0|||
30663572|NCT00895895|58677424|FG003|Period 2|Withdrawal by Subject|3|||
30663573|NCT00895895|58677425|FG004|Period 2|Withdrawal by Subject|5|||
30663574|NCT00895895|58677421|FG000|Period 2|unsatisfactory response-efficacy|2|||
30663575|NCT00895895|58677422|FG001|Period 2|unsatisfactory response-efficacy|1|||
30663576|NCT00895895|58677423|FG002|Period 2|unsatisfactory response-efficacy|0|||
30663577|NCT00895895|58677424|FG003|Period 2|unsatisfactory response-efficacy|0|||
30663578|NCT00895895|58677425|FG004|Period 2|unsatisfactory response-efficacy|0|||
30663579|NCT00895661|58677443|FG000|Overall Study|Death|1|||
30663580|NCT00895661|58677443|FG000|Overall Study|reason unknown|2|||
30663581|NCT00895583|58677449|FG000|Overall Study|Adverse Event|28|||
30663582|NCT00895583|58677450|FG001|Overall Study|Adverse Event|4|||
30663583|NCT00895583|58677449|FG000|Overall Study|Death|2|||
30663584|NCT00895583|58677450|FG001|Overall Study|Death|1|||
30663585|NCT00895583|58677449|FG000|Overall Study|Physician Decision|3|||
30663586|NCT00895583|58677450|FG001|Overall Study|Physician Decision|1|||
30663587|NCT00895583|58677449|FG000|Overall Study|Lost to Follow-up|1|||
30663588|NCT00895583|58677450|FG001|Overall Study|Lost to Follow-up|3|||
30663589|NCT00895583|58677449|FG000|Overall Study|Protocol Violation|1|||
30663590|NCT00895583|58677450|FG001|Overall Study|Protocol Violation|0|||
30663591|NCT00895583|58677449|FG000|Overall Study|Withdrawal by Subject|4|||
30663592|NCT00895583|58677450|FG001|Overall Study|Withdrawal by Subject|2|||
30663593|NCT00895583|58677449|FG000|Overall Study|Lack of Efficacy|5|||
30663594|NCT00895583|58677450|FG001|Overall Study|Lack of Efficacy|0|||
30779490|NCT00031551|58791033|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
30779491|NCT00049257|58791043|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
30779492|NCT00049257|58791043|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
30779493|NCT00049257|58791043|FG000|Carboplatin, Paclitaxel|Death|2|||
30779494|NCT00049257|58791043|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
30779495|NCT03020992|58791047|FG000|Overall Study|Adverse Event|5|||
30854715|NCT02370394|58882115|FG000|Overall Study|Withdrawal by Subject|0|||
30854716|NCT02370394|58882116|FG001|Overall Study|Withdrawal by Subject|1|||
30779496|NCT03020992|58791047|FG000|Overall Study|Withdrawal by Subject|1|||
30779497|NCT03020914|58791054|FG000|Overall Study|Surgery Cancelled|1|||
30779498|NCT03020914|58791055|FG001|Overall Study|Surgery Cancelled|0|||
30779499|NCT03018340|58791063|FG000|Overall Study|Adverse Event|1|||
30854717|NCT01595438|58882125|FG000|Overall Study|Lost to Follow-up|20|||
30854718|NCT01595438|58882126|FG001|Overall Study|Lost to Follow-up|20|||
30958249|NCT02700984|59023276|FG000|Overall Study|Withdrawal by Subject|8|||
30958250|NCT02700984|59023277|FG001|Overall Study|Withdrawal by Subject|9|||
30958251|NCT02700984|59023276|FG000|Overall Study|Reason not specified|3|||
30958252|NCT02700984|59023277|FG001|Overall Study|Reason not specified|2|||
30958253|NCT02696850|59023351|FG000|Overall Study|Withdrawal by Subject|3|||
30958254|NCT02696850|59023352|FG001|Overall Study|Withdrawal by Subject|3|||
30958255|NCT02696850|59023351|FG000|Overall Study|Lost to Follow-up|8|||
30958256|NCT02696850|59023352|FG001|Overall Study|Lost to Follow-up|5|||
30958257|NCT02698410|59023515|FG000|Overall Study|Adverse Event|2|||
30958258|NCT02698410|59023515|FG000|Overall Study|Withdrawal by Subject|1|||
30958259|NCT02698410|59023515|FG000|Overall Study|Other|1|||
30958260|NCT02699892|59023519|FG000|Overall Study|Other|36|||
30958261|NCT02698176|59023526|FG000|Overall Study|Progressive disease|4|||
30958262|NCT02698176|59023527|FG001|Overall Study|Progressive disease|3|||
30958263|NCT02698176|59023528|FG002|Overall Study|Progressive disease|1|||
30958264|NCT02698176|59023529|FG003|Overall Study|Progressive disease|0|||
30958265|NCT02698176|59023526|FG000|Overall Study|Adverse Event|2|||
30958266|NCT02698176|59023527|FG001|Overall Study|Adverse Event|0|||
30958267|NCT02698176|59023528|FG002|Overall Study|Adverse Event|0|||
30958268|NCT02698176|59023529|FG003|Overall Study|Adverse Event|0|||
30663595|NCT00895583|58677449|FG000|Overall Study|Other|0|||
30779500|NCT03018340|58791064|FG001|Overall Study|Adverse Event|2|||
30779501|NCT03018340|58791063|FG000|Overall Study|Withdrawal by Subject|0|||
30854719|NCT01595438|58882125|FG000|Overall Study|Withdrawal by Subject|12|||
30854720|NCT01595438|58882126|FG001|Overall Study|Withdrawal by Subject|12|||
30854721|NCT01595438|58882125|FG000|Overall Study|Other Eligibility criteria|11|||
30854722|NCT01595438|58882126|FG001|Overall Study|Other Eligibility criteria|9|||
30854723|NCT02340520|58882132|FG000|Overall Study|Lost to Follow-up|1|||
30854724|NCT02340520|58882132|FG000|Overall Study|Patient did not take drug as specified|1|||
30854725|NCT02340520|58882132|FG000|Overall Study|Withdrawal by Subject|1|||
30854726|NCT02339584|58882138|FG000|Overall Study|Adverse Event|11|||
30958269|NCT02698176|59023526|FG000|Overall Study|Clinical progression|3|||
30958270|NCT02698176|59023527|FG001|Overall Study|Clinical progression|0|||
30958271|NCT02698176|59023528|FG002|Overall Study|Clinical progression|0|||
30958272|NCT02698176|59023529|FG003|Overall Study|Clinical progression|0|||
30958273|NCT02693418|59023545|FG000|Overall Study|Lost to Follow-up|1|||
30958274|NCT02693418|59023546|FG001|Overall Study|Lost to Follow-up|2|||
30958275|NCT02693418|59023547|FG002|Overall Study|Lost to Follow-up|0|||
30663596|NCT00895583|58677450|FG001|Overall Study|Other|1|||
30663597|NCT00894413|58677467|FG000|Overall Study|Physician Decision|0|||
30663598|NCT00894413|58677468|FG001|Overall Study|Physician Decision|2|||
30663599|NCT00894413|58677467|FG000|Overall Study|Adverse Event|0|||
30663600|NCT00894413|58677468|FG001|Overall Study|Adverse Event|2|||
30663601|NCT00894413|58677467|FG000|Overall Study|Withdrawal by Subject|0|||
30663602|NCT00894413|58677468|FG001|Overall Study|Withdrawal by Subject|4|||
30663603|NCT00895037|58677477|FG000|Overall Study|Death|0|||
30663604|NCT00895037|58677478|FG001|Overall Study|Death|2|||
30663605|NCT00895037|58677479|FG002|Overall Study|Death|1|||
30663606|NCT00892151|58677487|FG000|Overall Study|Protocol Violation|1|||
30663607|NCT01706705|58677491|FG000|Overall Study|Death|1|||
30663608|NCT01706705|58677491|FG000|Overall Study|Lack of Efficacy|13|||
30663609|NCT01706705|58677491|FG000|Overall Study|Non-clinical|6|||
30663610|NCT00894803|58677507|FG000|Overall Study|Death|20|||
30663611|NCT00894803|58677508|FG001|Overall Study|Death|4|||
30663612|NCT00894803|58677507|FG000|Overall Study|Lost to Follow-up|0|||
30663613|NCT00894803|58677508|FG001|Overall Study|Lost to Follow-up|1|||
30663614|NCT00601458|58677517|FG000|Overall Study|Dosing Error|1|||
30663615|NCT00601458|58677518|FG001|Overall Study|Dosing Error|0|||
30663616|NCT00601458|58677519|FG002|Overall Study|Dosing Error|0|||
30663617|NCT00601458|58677517|FG000|Overall Study|Incomplete Data|0|||
30663618|NCT00601458|58677518|FG001|Overall Study|Incomplete Data|2|||
30663619|NCT00601458|58677519|FG002|Overall Study|Incomplete Data|0|||
30663620|NCT00601458|58677517|FG000|Overall Study|Protocol Violation|3|||
30663621|NCT00601458|58677518|FG001|Overall Study|Protocol Violation|2|||
30663622|NCT00601458|58677519|FG002|Overall Study|Protocol Violation|1|||
30663623|NCT00601458|58677517|FG000|Overall Study|Early Termination|0|||
30663624|NCT00601458|58677518|FG001|Overall Study|Early Termination|1|||
30663625|NCT00601458|58677519|FG002|Overall Study|Early Termination|1|||
30663626|NCT02141282|58677531|FG000|Overall Study|Adverse event, not related to progression|8|||
30663627|NCT02141282|58677532|FG001|Overall Study|Adverse event, not related to progression|1|||
30663628|NCT02141282|58677533|FG002|Overall Study|Adverse event, not related to progression|3|||
30663629|NCT02141282|58677534|FG003|Overall Study|Adverse event, not related to progression|1|||
30663630|NCT02141282|58677531|FG000|Overall Study|Adverse event, related to progression|1|||
30663631|NCT02141282|58677532|FG001|Overall Study|Adverse event, related to progression|0|||
30663632|NCT02141282|58677533|FG002|Overall Study|Adverse event, related to progression|2|||
30663633|NCT02141282|58677534|FG003|Overall Study|Adverse event, related to progression|0|||
30663634|NCT02141282|58677531|FG000|Overall Study|COVID-19 infection|1|||
30663635|NCT02141282|58677532|FG001|Overall Study|COVID-19 infection|0|||
30663636|NCT02141282|58677533|FG002|Overall Study|COVID-19 infection|0|||
30663637|NCT02141282|58677534|FG003|Overall Study|COVID-19 infection|0|||
30663638|NCT02141282|58677531|FG000|Overall Study|Lost to Follow-up|0|||
30663639|NCT02141282|58677532|FG001|Overall Study|Lost to Follow-up|0|||
30663640|NCT02141282|58677533|FG002|Overall Study|Lost to Follow-up|4|||
30663641|NCT02141282|58677534|FG003|Overall Study|Lost to Follow-up|2|||
30663642|NCT02141282|58677531|FG000|Overall Study|Other, not specified|14|||
30663643|NCT02141282|58677532|FG001|Overall Study|Other, not specified|11|||
30663644|NCT02141282|58677533|FG002|Overall Study|Other, not specified|23|||
30663645|NCT02141282|58677534|FG003|Overall Study|Other, not specified|9|||
30663646|NCT02141282|58677531|FG000|Overall Study|Progressive disease, Richter's|4|||
30663647|NCT02141282|58677532|FG001|Overall Study|Progressive disease, Richter's|1|||
30663648|NCT02141282|58677533|FG002|Overall Study|Progressive disease, Richter's|1|||
30663649|NCT02141282|58677534|FG003|Overall Study|Progressive disease, Richter's|1|||
30663650|NCT02141282|58677531|FG000|Overall Study|Progressive disease per protocol|12|||
30663651|NCT02141282|58677532|FG001|Overall Study|Progressive disease per protocol|7|||
30663652|NCT02141282|58677533|FG002|Overall Study|Progressive disease per protocol|9|||
30663653|NCT02141282|58677534|FG003|Overall Study|Progressive disease per protocol|2|||
30663654|NCT02141282|58677531|FG000|Overall Study|Stem cell transplant|1|||
30663655|NCT02141282|58677532|FG001|Overall Study|Stem cell transplant|0|||
30663656|NCT02141282|58677533|FG002|Overall Study|Stem cell transplant|1|||
30663657|NCT02141282|58677534|FG003|Overall Study|Stem cell transplant|0|||
30663658|NCT02141282|58677531|FG000|Overall Study|Study terminated by Sponsor|0|||
30663659|NCT02141282|58677532|FG001|Overall Study|Study terminated by Sponsor|1|||
30663660|NCT02141282|58677533|FG002|Overall Study|Study terminated by Sponsor|0|||
30958276|NCT02693418|59023548|FG003|Overall Study|Lost to Follow-up|0|||
30958277|NCT02693418|59023549|FG004|Overall Study|Lost to Follow-up|0|||
30958278|NCT02693418|59023545|FG000|Overall Study|Menses during study period|0|||
30958279|NCT02693418|59023546|FG001|Overall Study|Menses during study period|0|||
30663661|NCT02141282|58677534|FG003|Overall Study|Study terminated by Sponsor|0|||
30663662|NCT02141282|58677531|FG000|Overall Study|Subject non-compliance|0|||
30663663|NCT02141282|58677532|FG001|Overall Study|Subject non-compliance|0|||
30663664|NCT02141282|58677533|FG002|Overall Study|Subject non-compliance|1|||
30663665|NCT02141282|58677534|FG003|Overall Study|Subject non-compliance|0|||
30663666|NCT02141282|58677531|FG000|Overall Study|Withdrew consent|2|||
30663667|NCT02141282|58677532|FG001|Overall Study|Withdrew consent|0|||
30663668|NCT02141282|58677533|FG002|Overall Study|Withdrew consent|4|||
30958280|NCT02693418|59023547|FG002|Overall Study|Menses during study period|2|||
30958281|NCT02693418|59023548|FG003|Overall Study|Menses during study period|0|||
30958282|NCT02693418|59023549|FG004|Overall Study|Menses during study period|0|||
30663669|NCT02141282|58677534|FG003|Overall Study|Withdrew consent|0|||
30779502|NCT03018340|58791064|FG001|Overall Study|Withdrawal by Subject|8|||
30779503|NCT03018340|58791063|FG000|Overall Study|Lack of Efficacy|0|||
30779504|NCT03018340|58791064|FG001|Overall Study|Lack of Efficacy|1|||
30779505|NCT03018340|58791063|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
30779506|NCT03018340|58791064|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
30854727|NCT02339584|58882139|FG001|Overall Study|Adverse Event|7|||
30854728|NCT02339584|58882138|FG000|Overall Study|Lack of Efficacy|0|||
30854729|NCT02339584|58882139|FG001|Overall Study|Lack of Efficacy|1|||
30854730|NCT02339584|58882138|FG000|Overall Study|Physician Decision|1|||
30854731|NCT02339584|58882139|FG001|Overall Study|Physician Decision|2|||
30663670|NCT00003479|58677547|FG000|Overall Study|Not evaluable|3|||
30663671|NCT00891839|58677551|FG000|Overall Study|Adverse Event|2|||
30779507|NCT03018340|58791063|FG000|Overall Study|Lost to Follow-up|1|||
30779508|NCT03018340|58791064|FG001|Overall Study|Lost to Follow-up|7|||
30779509|NCT03018340|58791063|FG000|Overall Study|Protocol Violation|3|||
30779510|NCT03018340|58791064|FG001|Overall Study|Protocol Violation|7|||
30779511|NCT03018340|58791063|FG000|Overall Study|Not further specified|0|||
30779512|NCT03018340|58791064|FG001|Overall Study|Not further specified|1|||
30779513|NCT03016078|58791074|FG000|Overall Study|Protocol Violation|1|||
30779514|NCT03016078|58791074|FG000|Overall Study|Protocol Violation|1|||
30779515|NCT00048165|58791080|FG000|Completed 6 Months Study|Administration/Other|8|||
30779516|NCT00048165|58791081|FG001|Completed 6 Months Study|Administration/Other|8|||
30779517|NCT00048165|58791080|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
30779518|NCT00048165|58791081|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
30779519|NCT00048165|58791080|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
30779520|NCT00048165|58791081|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
30854732|NCT02339584|58882138|FG000|Overall Study|Protocol Violation|1|||
30854733|NCT02339584|58882139|FG001|Overall Study|Protocol Violation|1|||
30958283|NCT02693106|59023582|FG000|Overall Study|No time|3|||
30854734|NCT02339584|58882138|FG000|Overall Study|Withdrawal by Subject|2|||
30958284|NCT02546986|59023594|FG000|Treatment Period|Progressive Disease|20|||
30958285|NCT02546986|59023595|FG001|Treatment Period|Progressive Disease|22|||
30663672|NCT00891839|58677551|FG000|Overall Study|Withdrawal by Subject|2|||
30779521|NCT00048165|58791080|FG000|Completed 6 Months Study|Death|12|||
30779522|NCT00048165|58791081|FG001|Completed 6 Months Study|Death|6|||
30779523|NCT00048165|58791080|FG000|Completed 6 Months Study|Insufficient therapy|1|||
30854735|NCT02339584|58882139|FG001|Overall Study|Withdrawal by Subject|4|||
30854736|NCT02339506|58882145|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
30663673|NCT00891839|58677551|FG000|Overall Study|Disease progression|3|||
30663674|NCT00600756|58677557|FG000|Analysis After 6 Months|Adverse Event|43|||
30663675|NCT00600756|58677558|FG001|Analysis After 6 Months|Adverse Event|33|||
30663676|NCT00600756|58677557|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
30663677|NCT00600756|58677558|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
30663678|NCT00600756|58677557|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
30663679|NCT00600756|58677558|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
30663680|NCT00600756|58677557|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
30663681|NCT00600756|58677558|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
30663682|NCT00600756|58677557|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
30663683|NCT00600756|58677558|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
30779524|NCT00048165|58791081|FG001|Completed 6 Months Study|Insufficient therapy|4|||
30779525|NCT00048165|58791080|FG000|Completed 6 Months Study|Other violation|4|||
30663684|NCT00600756|58677557|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
30663685|NCT00600756|58677558|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
30663686|NCT00600756|58677557|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
30663687|NCT00600756|58677558|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
30663688|NCT00600756|58677557|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
30958286|NCT02546986|59023594|FG000|Treatment Period|Adverse Event|14|||
30663689|NCT00600756|58677558|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
30663690|NCT00600756|58677557|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
30663691|NCT00600756|58677558|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
30779526|NCT00048165|58791081|FG001|Completed 6 Months Study|Other violation|6|||
30958287|NCT02546986|59023595|FG001|Treatment Period|Adverse Event|6|||
30779527|NCT00048165|58791080|FG000|Completed 6 Months Study|Refused treatment|5|||
30663692|NCT00600756|58677557|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
30663693|NCT00600756|58677558|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
30663694|NCT00600756|58677557|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
30779528|NCT00048165|58791081|FG001|Completed 6 Months Study|Refused treatment|5|||
30958288|NCT02546986|59023594|FG000|Treatment Period|Symptomatic Deterioration|4|||
30854737|NCT02339506|58882146|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
30854738|NCT02339506|58882145|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
30854739|NCT02339506|58882146|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
30854740|NCT02305888|58882155|FG000|Overall Study|Lost to Follow-up|0|||
30854741|NCT02305888|58882156|FG001|Overall Study|Lost to Follow-up|0|||
30854742|NCT02305888|58882157|FG002|Overall Study|Lost to Follow-up|1|||
30854743|NCT02305888|58882155|FG000|Overall Study|Adverse Event|0|||
30854744|NCT02305888|58882156|FG001|Overall Study|Adverse Event|1|||
30663695|NCT00600756|58677558|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
30663696|NCT00600756|58677557|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
30779529|NCT00048165|58791080|FG000|Completed 6 Months Study|Violation criteria|0|||
30779530|NCT00048165|58791081|FG001|Completed 6 Months Study|Violation criteria|2|||
30779531|NCT00048165|58791080|FG000|Completed 6 Months Study|Did not receive study drug|6|||
30779532|NCT00048165|58791081|FG001|Completed 6 Months Study|Did not receive study drug|6|||
30779533|NCT00048165|58791080|FG000|Completed 12 Months Study|Administration/Other|0|||
30779534|NCT00048165|58791081|FG001|Completed 12 Months Study|Administration/Other|2|||
30779535|NCT00048165|58791080|FG000|Completed 12 Months Study|Death|2|||
30779536|NCT00048165|58791081|FG001|Completed 12 Months Study|Death|1|||
30779537|NCT00048165|58791080|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
30854745|NCT02305888|58882157|FG002|Overall Study|Adverse Event|0|||
30663697|NCT00600756|58677558|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
30854746|NCT02338882|58882167|FG000|Overall Study|Death|1|||
30854747|NCT02338882|58882168|FG001|Overall Study|Death|0|||
30663698|NCT00600756|58677557|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
30663699|NCT00600756|58677558|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
30663700|NCT00600756|58677557|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
30663701|NCT00600756|58677558|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
30663702|NCT00890825|58677570|FG000|Overall Study|Withdrawal by Subject|1|||
30663703|NCT00890825|58677571|FG001|Overall Study|Withdrawal by Subject|0|||
30663704|NCT00890825|58677570|FG000|Overall Study|Alive at data cut off (DCO)|13|||
30663705|NCT00890825|58677571|FG001|Overall Study|Alive at data cut off (DCO)|14|||
30663706|NCT00890201|58677579|FG000|Overall Study|Protocol Violation|5|||
30663707|NCT00890201|58677580|FG001|Overall Study|Protocol Violation|56|||
30663708|NCT00891527|58677586|FG000|Overall Study|Withdrawal by Subject|2|||
30663709|NCT03861078|58677591|FG000|Overall Study|COVID-19 shut down|4|||
30663710|NCT03861078|58677591|FG000|Overall Study|Lost to Follow-up|1|||
30663711|NCT03861078|58677591|FG000|Overall Study|Protocol Violation|2|||
30663712|NCT03861078|58677591|FG000|Overall Study|lack of venous access|1|||
30663713|NCT00891371|58677599|FG000|Pre-assignment|Inclusion/exclusion|5|||
30663714|NCT00891371|58677599|FG000|Pre-assignment|Consent withdrawal|1|||
30663715|NCT00891371|58677599|FG000|Treatment|Lack of Efficacy|5|||
30663716|NCT00891371|58677599|FG000|Treatment|Adverse Event|2|||
30663717|NCT00891371|58677599|FG000|Treatment|Death|1|||
30663718|NCT00891371|58677599|FG000|Treatment|Lost to Follow-up|1|||
30663719|NCT00890045|58677605|FG000|Overall Study|Death|0|||
30663720|NCT00890045|58677606|FG001|Overall Study|Death|1|||
30663721|NCT00890045|58677605|FG000|Overall Study|Did not receive HeRO Graft|0|||
30663722|NCT00890045|58677606|FG001|Overall Study|Did not receive HeRO Graft|2|||
30663723|NCT00890045|58677605|FG000|Overall Study|Lost to Follow-up|5|||
30663724|NCT00890045|58677606|FG001|Overall Study|Lost to Follow-up|7|||
30663725|NCT00891293|58677612|FG000|Overall Study|Adverse Event|2|||
30663726|NCT00891293|58677612|FG000|Overall Study|Protocol Violation|2|||
30663727|NCT00891293|58677612|FG000|Overall Study|Laboratory abnormality|4|||
30663728|NCT00891293|58677612|FG000|Overall Study|Lost to Follow-up|7|||
30663729|NCT00891293|58677612|FG000|Overall Study|Subject withdrew consent|7|||
30663730|NCT00891293|58677612|FG000|Overall Study|Sponsor termination|62|||
30663731|NCT00889421|58677616|FG000|Overall Study|Lack of Efficacy|3|||
30663732|NCT00889265|58677620|FG000|Overall Study|Adverse Event|1|||
30663733|NCT00889265|58677620|FG000|Overall Study|Lost to Follow-up|5|||
30663734|NCT00889265|58677620|FG000|Overall Study|Protocol Violation|1|||
30663735|NCT00603746|58677630|FG000|Overall Study|Adverse Event|2|||
30663736|NCT00603746|58677631|FG001|Overall Study|Adverse Event|3|||
30663737|NCT00603746|58677632|FG002|Overall Study|Adverse Event|0|||
30779538|NCT00048165|58791081|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
30779539|NCT00059787|58791089|FG000|Overall Study|Adverse Event|13|||
30663738|NCT00603746|58677633|FG003|Overall Study|Adverse Event|1|||
30663739|NCT00603746|58677634|FG004|Overall Study|Adverse Event|0|||
30663740|NCT00603746|58677635|FG005|Overall Study|Adverse Event|4|||
30663741|NCT00603746|58677630|FG000|Overall Study|Lack of Efficacy|34|||
30663742|NCT00603746|58677631|FG001|Overall Study|Lack of Efficacy|11|||
30663743|NCT00603746|58677632|FG002|Overall Study|Lack of Efficacy|6|||
30663744|NCT00603746|58677633|FG003|Overall Study|Lack of Efficacy|11|||
30663745|NCT00603746|58677634|FG004|Overall Study|Lack of Efficacy|12|||
30663746|NCT00603746|58677635|FG005|Overall Study|Lack of Efficacy|8|||
30663747|NCT00603746|58677630|FG000|Overall Study|Protocol Violation|0|||
30663748|NCT00603746|58677631|FG001|Overall Study|Protocol Violation|3|||
30854748|NCT02338882|58882167|FG000|Overall Study|Lost to Follow-up|6|||
30663749|NCT00603746|58677632|FG002|Overall Study|Protocol Violation|1|||
30779540|NCT00059787|58791089|FG000|Overall Study|disease progression|2|||
30663750|NCT00603746|58677633|FG003|Overall Study|Protocol Violation|0|||
30663751|NCT00603746|58677634|FG004|Overall Study|Protocol Violation|1|||
30663752|NCT00603746|58677635|FG005|Overall Study|Protocol Violation|0|||
30663753|NCT00603746|58677630|FG000|Overall Study|Lost to Follow-up|0|||
30663754|NCT00603746|58677631|FG001|Overall Study|Lost to Follow-up|1|||
30663755|NCT00603746|58677632|FG002|Overall Study|Lost to Follow-up|1|||
30663756|NCT00603746|58677633|FG003|Overall Study|Lost to Follow-up|0|||
30663757|NCT00603746|58677634|FG004|Overall Study|Lost to Follow-up|0|||
30663758|NCT00603746|58677635|FG005|Overall Study|Lost to Follow-up|0|||
30663759|NCT00603746|58677630|FG000|Overall Study|Physician Decision|1|||
30663760|NCT00603746|58677631|FG001|Overall Study|Physician Decision|0|||
30663761|NCT00603746|58677632|FG002|Overall Study|Physician Decision|0|||
30663762|NCT00603746|58677633|FG003|Overall Study|Physician Decision|0|||
30663763|NCT00603746|58677634|FG004|Overall Study|Physician Decision|1|||
30663764|NCT00603746|58677635|FG005|Overall Study|Physician Decision|0|||
30663765|NCT00603746|58677630|FG000|Overall Study|Withdrawal by Subject|1|||
30663766|NCT00603746|58677631|FG001|Overall Study|Withdrawal by Subject|0|||
30663767|NCT00603746|58677632|FG002|Overall Study|Withdrawal by Subject|0|||
30663768|NCT00603746|58677633|FG003|Overall Study|Withdrawal by Subject|1|||
30663769|NCT00603746|58677634|FG004|Overall Study|Withdrawal by Subject|3|||
30663770|NCT00603746|58677635|FG005|Overall Study|Withdrawal by Subject|1|||
30663771|NCT00888329|58677651|FG000|Overall Study|Physician Decision|6|||
30663772|NCT00888329|58677652|FG001|Overall Study|Physician Decision|9|||
30663773|NCT00603590|58677660|FG000|Overall Study|Did not attend study clinic|39|||
30663774|NCT00603590|58677661|FG001|Overall Study|Did not attend study clinic|30|||
30663775|NCT00603590|58677660|FG000|Overall Study|Refused blood test|5|||
30663776|NCT00603590|58677661|FG001|Overall Study|Refused blood test|1|||
30779541|NCT00059787|58791089|FG000|Overall Study|ineligible|1|||
30663777|NCT00603590|58677660|FG000|Overall Study|Patient discontinued study drug|22|||
30779542|NCT00059787|58791089|FG000|Overall Study|Other|4|||
30779543|NCT00058539|58791094|FG000|Overall Study|Disease progression|24|||
30779544|NCT00058539|58791094|FG000|Overall Study|Adverse Event|3|||
30779545|NCT00058539|58791094|FG000|Overall Study|Withdrawal by Subject|5|||
30779546|NCT00058539|58791094|FG000|Overall Study|Physician Decision|9|||
30779547|NCT00058539|58791094|FG000|Overall Study|Death|1|||
30779548|NCT03015532|58791106|FG000|Overall Study|Adverse Event|0|||
30779549|NCT03015532|58791107|FG001|Overall Study|Adverse Event|0|||
30779550|NCT03015532|58791108|FG002|Overall Study|Adverse Event|0|||
30779551|NCT03015532|58791109|FG003|Overall Study|Adverse Event|0|||
30779552|NCT03015532|58791110|FG004|Overall Study|Adverse Event|0|||
30779553|NCT03015532|58791111|FG005|Overall Study|Adverse Event|2|||
30779554|NCT03015532|58791112|FG006|Overall Study|Adverse Event|1|||
30779555|NCT03015532|58791113|FG007|Overall Study|Adverse Event|0|||
30663778|NCT00603590|58677661|FG001|Overall Study|Patient discontinued study drug|15|||
30663779|NCT00603590|58677660|FG000|Overall Study|Adverse Event|2|||
30663780|NCT00603590|58677661|FG001|Overall Study|Adverse Event|0|||
30663781|NCT00603590|58677660|FG000|Overall Study|Lost to Follow-up|8|||
30663782|NCT00603590|58677661|FG001|Overall Study|Lost to Follow-up|4|||
30663783|NCT00603590|58677660|FG000|Overall Study|Cardiovascular event|0|||
30663784|NCT00603590|58677661|FG001|Overall Study|Cardiovascular event|1|||
30663785|NCT00888173|58677667|FG000|Overall Study|Wrong Primary|1|||
30663786|NCT00888173|58677667|FG000|Overall Study|Ineligible: required test not done|1|||
30663787|NCT00887549|58677680|FG000|Induction Therapy|Adverse Event|8|||
30779556|NCT03015532|58791106|FG000|Overall Study|Withdrawal by Subject|0|||
30854749|NCT02338882|58882168|FG001|Overall Study|Lost to Follow-up|3|||
30854750|NCT01594970|58882180|FG000|Overall Study|Non-Adverse Event Related|4|||
30854751|NCT01594970|58882181|FG001|Overall Study|Non-Adverse Event Related|5|||
30854752|NCT01594970|58882182|FG002|Overall Study|Non-Adverse Event Related|6|||
30854753|NCT01594970|58882180|FG000|Overall Study|Adverse Event|17|||
30854754|NCT01594970|58882181|FG001|Overall Study|Adverse Event|23|||
30854755|NCT01594970|58882182|FG002|Overall Study|Adverse Event|23|||
30779557|NCT03015532|58791107|FG001|Overall Study|Withdrawal by Subject|0|||
30779558|NCT03015532|58791108|FG002|Overall Study|Withdrawal by Subject|0|||
30779559|NCT03015532|58791109|FG003|Overall Study|Withdrawal by Subject|0|||
30779560|NCT03015532|58791110|FG004|Overall Study|Withdrawal by Subject|0|||
30779561|NCT03015532|58791111|FG005|Overall Study|Withdrawal by Subject|0|||
30779562|NCT03015532|58791112|FG006|Overall Study|Withdrawal by Subject|1|||
30779563|NCT03015532|58791113|FG007|Overall Study|Withdrawal by Subject|0|||
30779564|NCT00047463|58791135|FG000|Overall Study|Withdrawal by Subject|0|||
30779565|NCT00047463|58791136|FG001|Overall Study|Withdrawal by Subject|3|||
30779566|NCT03015220|58791149|FG000|Overall Study|Withdrawal by Subject|3|||
30779567|NCT03015220|58791150|FG001|Overall Study|Withdrawal by Subject|2|||
30779568|NCT03015220|58791151|FG002|Overall Study|Withdrawal by Subject|2|||
30779569|NCT03015220|58791152|FG003|Overall Study|Withdrawal by Subject|2|||
30779570|NCT03015220|58791149|FG000|Overall Study|Lost to Follow-up|0|||
30779571|NCT03015220|58791150|FG001|Overall Study|Lost to Follow-up|0|||
30779572|NCT03015220|58791151|FG002|Overall Study|Lost to Follow-up|1|||
30779573|NCT03015220|58791152|FG003|Overall Study|Lost to Follow-up|0|||
30779574|NCT00022659|58791162|FG000|Overall Study|Ineligible: wrong primary|1|||
30779575|NCT00022659|58791162|FG000|Overall Study|Never treated|1|||
30779576|NCT03014674|58791173|FG000|Overall Study|Withdrawal by Subject|1|||
30779577|NCT03014674|58791174|FG001|Overall Study|Withdrawal by Subject|0|||
30779578|NCT03014674|58791175|FG002|Overall Study|Withdrawal by Subject|0|||
30779579|NCT03018106|58791185|FG000|Overall Study|Lost to Follow-up|0|||
30779580|NCT03018106|58791186|FG001|Overall Study|Lost to Follow-up|1|||
30779581|NCT03018028|58791195|FG000|Overall Study|Withdrawal by Subject|3|||
30779582|NCT03018028|58791196|FG001|Overall Study|Withdrawal by Subject|0|||
30779583|NCT03018028|58791197|FG002|Overall Study|Withdrawal by Subject|1|||
30779584|NCT03018028|58791198|FG003|Overall Study|Withdrawal by Subject|2|||
30779585|NCT03018028|58791199|FG004|Overall Study|Withdrawal by Subject|0|||
30854756|NCT01594970|58882180|FG000|Overall Study|Lost to Follow-up|54|||
30854757|NCT01594970|58882181|FG001|Overall Study|Lost to Follow-up|54|||
30663788|NCT00887549|58677680|FG000|Induction Therapy|Physician Decision|1|||
30663789|NCT00887549|58677680|FG000|Induction Therapy|Progressive Disease|13|||
30663790|NCT00887549|58677680|FG000|Induction Therapy|Death due to Study Disease|4|||
30663791|NCT00887549|58677680|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
30663792|NCT00887549|58677680|FG000|Maintenance Therapy|Adverse Event|16|||
30663793|NCT00887549|58677680|FG000|Maintenance Therapy|Physician Decision|1|||
30663794|NCT00887549|58677680|FG000|Maintenance Therapy|Progressive Disease|25|||
30663795|NCT00887549|58677680|FG000|Maintenance Therapy|Death due to adverse event|1|||
30663796|NCT00887315|58677686|FG000|Overall Study|Study termination|7|||
30663797|NCT00887315|58677687|FG001|Overall Study|Study termination|4|||
30663798|NCT03608826|58677693|FG000|Overall Study|Death|3|||
30663799|NCT03608826|58677693|FG000|Overall Study|Heart Transplant|3|||
30663800|NCT03608826|58677693|FG000|Overall Study|Physician Decision|4|||
30663801|NCT00887159|58677700|FG000|Overall Study|Disease progression|6|||
30663802|NCT00887159|58677701|FG001|Overall Study|Disease progression|39|||
30663803|NCT00887159|58677702|FG002|Overall Study|Disease progression|33|||
30663804|NCT00887159|58677700|FG000|Overall Study|Adverse Event|3|||
30663805|NCT00887159|58677701|FG001|Overall Study|Adverse Event|4|||
30663806|NCT00887159|58677702|FG002|Overall Study|Adverse Event|17|||
30663807|NCT00887159|58677700|FG000|Overall Study|Death|2|||
30663808|NCT00887159|58677701|FG001|Overall Study|Death|2|||
30663809|NCT00887159|58677702|FG002|Overall Study|Death|0|||
30663810|NCT00887159|58677700|FG000|Overall Study|Withdrawal by Subject|4|||
30663811|NCT00887159|58677701|FG001|Overall Study|Withdrawal by Subject|4|||
30663812|NCT00887159|58677702|FG002|Overall Study|Withdrawal by Subject|2|||
30663813|NCT00887159|58677700|FG000|Overall Study|Alternative therapy|2|||
30663814|NCT00887159|58677701|FG001|Overall Study|Alternative therapy|0|||
30663815|NCT00887159|58677702|FG002|Overall Study|Alternative therapy|0|||
30663816|NCT00887159|58677700|FG000|Overall Study|Physician Decision|1|||
30663817|NCT00887159|58677701|FG001|Overall Study|Physician Decision|1|||
30663818|NCT00887159|58677702|FG002|Overall Study|Physician Decision|0|||
30663819|NCT00887159|58677700|FG000|Overall Study|Sympomatic deterioration|1|||
30663820|NCT00887159|58677701|FG001|Overall Study|Sympomatic deterioration|0|||
30663821|NCT00887159|58677702|FG002|Overall Study|Sympomatic deterioration|0|||
30663822|NCT00887159|58677700|FG000|Overall Study|Treatment delayed|1|||
30663823|NCT00887159|58677701|FG001|Overall Study|Treatment delayed|1|||
30663824|NCT00887159|58677702|FG002|Overall Study|Treatment delayed|0|||
30663825|NCT00887159|58677700|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
30663826|NCT00887159|58677701|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
30663827|NCT00887159|58677702|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
30663828|NCT00887159|58677700|FG000|Overall Study|Received more tx instead of observation|1|||
30663829|NCT00887159|58677701|FG001|Overall Study|Received more tx instead of observation|0|||
30663830|NCT00887159|58677702|FG002|Overall Study|Received more tx instead of observation|0|||
30663831|NCT00887159|58677700|FG000|Overall Study|Ineligible|5|||
30663832|NCT00887159|58677701|FG001|Overall Study|Ineligible|1|||
30663833|NCT00887159|58677702|FG002|Overall Study|Ineligible|0|||
30663834|NCT00887159|58677700|FG000|Overall Study|Never started assigned therapy|3|||
30663835|NCT00887159|58677701|FG001|Overall Study|Never started assigned therapy|3|||
30663836|NCT00887159|58677702|FG002|Overall Study|Never started assigned therapy|4|||
30663837|NCT00886769|58677714|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
30663838|NCT00886769|58677715|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
30663839|NCT00886613|58677724|FG000|Overall Study|Protocol deviation (Part B)|1|||
30779586|NCT03014206|58791211|FG000|Overall Study|Registration Violation|12|||
30779587|NCT03010462|58791217|FG000|Overall Study|Withdrawal by Subject|3|||
30779588|NCT03010462|58791218|FG001|Overall Study|Withdrawal by Subject|1|||
30779589|NCT00021255|58791227|FG000|Overall Study|Death|1|||
30779590|NCT00021255|58791228|FG001|Overall Study|Death|0|||
30779591|NCT00021255|58791229|FG002|Overall Study|Death|2|||
30779592|NCT00021255|58791227|FG000|Overall Study|Breast cancer relapse|5|||
30779593|NCT00021255|58791228|FG001|Overall Study|Breast cancer relapse|18|||
30779594|NCT00021255|58791229|FG002|Overall Study|Breast cancer relapse|11|||
30663840|NCT00886613|58677725|FG001|Overall Study|Protocol deviation (Part B)|0|||
30663841|NCT00886613|58677726|FG002|Overall Study|Protocol deviation (Part B)|0|||
30663842|NCT00886613|58677724|FG000|Overall Study|Lost to follow-up (Part B)|1|||
30663843|NCT00886613|58677725|FG001|Overall Study|Lost to follow-up (Part B)|0|||
30663844|NCT00886613|58677726|FG002|Overall Study|Lost to follow-up (Part B)|1|||
30663845|NCT00886613|58677724|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
30663846|NCT00886613|58677725|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
30663847|NCT00886613|58677726|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
30663848|NCT00886379|58677742|FG000|Overall Study|Transferred Schools|0|||
30663849|NCT00886379|58677743|FG001|Overall Study|Transferred Schools|0|||
30663850|NCT00886379|58677744|FG002|Overall Study|Transferred Schools|2|||
30779595|NCT00021255|58791227|FG000|Overall Study|Second primary malignancy|0|||
30663851|NCT00886379|58677745|FG003|Overall Study|Transferred Schools|1|||
30779596|NCT00021255|58791228|FG001|Overall Study|Second primary malignancy|4|||
30779597|NCT00021255|58791229|FG002|Overall Study|Second primary malignancy|1|||
30663852|NCT00886379|58677746|FG004|Overall Study|Transferred Schools|1|||
30779598|NCT00021255|58791227|FG000|Overall Study|Withdrawal by Subject|41|||
30779599|NCT00021255|58791228|FG001|Overall Study|Withdrawal by Subject|64|||
30779600|NCT00021255|58791229|FG002|Overall Study|Withdrawal by Subject|26|||
30779601|NCT00021255|58791227|FG000|Overall Study|Lost to Follow-up|0|||
30779602|NCT00021255|58791228|FG001|Overall Study|Lost to Follow-up|2|||
30779603|NCT00021255|58791229|FG002|Overall Study|Lost to Follow-up|3|||
30779604|NCT00021255|58791227|FG000|Overall Study|Cardiac toxicity|0|||
30779605|NCT00021255|58791228|FG001|Overall Study|Cardiac toxicity|61|||
30779606|NCT00021255|58791229|FG002|Overall Study|Cardiac toxicity|32|||
30779607|NCT00021255|58791227|FG000|Overall Study|Herceptin toxicity|0|||
30779608|NCT00021255|58791228|FG001|Overall Study|Herceptin toxicity|22|||
30779609|NCT00021255|58791229|FG002|Overall Study|Herceptin toxicity|6|||
30779610|NCT00021255|58791227|FG000|Overall Study|Adverse Event|46|||
30779611|NCT00021255|58791228|FG001|Overall Study|Adverse Event|30|||
30663853|NCT00886379|58677742|FG000|Overall Study|Final blood draw not obtained|3|||
30663854|NCT00886379|58677743|FG001|Overall Study|Final blood draw not obtained|3|||
30663855|NCT00886379|58677744|FG002|Overall Study|Final blood draw not obtained|4|||
30663856|NCT00886379|58677745|FG003|Overall Study|Final blood draw not obtained|2|||
30663857|NCT00886379|58677746|FG004|Overall Study|Final blood draw not obtained|2|||
30663858|NCT00599196|58677758|FG000|Overall Study|Lack of Efficacy|22|||
30663859|NCT00599196|58677758|FG000|Overall Study|Adverse Event|93|||
30663860|NCT00599196|58677758|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
30779612|NCT00021255|58791229|FG002|Overall Study|Adverse Event|18|||
30663861|NCT00599196|58677758|FG000|Overall Study|Subject withdrew consent|43|||
30663862|NCT00599196|58677758|FG000|Overall Study|Study ended per sponsor|197|||
30663863|NCT00599196|58677758|FG000|Overall Study|Lost to Follow-up|17|||
30663864|NCT00599196|58677758|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
30663865|NCT00599196|58677758|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
30663866|NCT00599196|58677758|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
30663867|NCT00599196|58677758|FG000|Overall Study|Other: Pt Moved To Australia|1|||
30663868|NCT00599196|58677758|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
30663869|NCT00599196|58677758|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
30663870|NCT00603512|58677767|FG000|Overall Study|Adverse Event|0|||
30663871|NCT00603512|58677768|FG001|Overall Study|Adverse Event|2|||
30663872|NCT00603512|58677769|FG002|Overall Study|Adverse Event|4|||
30663873|NCT00603512|58677770|FG003|Overall Study|Adverse Event|4|||
30663874|NCT00603512|58677771|FG004|Overall Study|Adverse Event|2|||
30663875|NCT00603512|58677767|FG000|Overall Study|Lack of Efficacy|0|||
30663876|NCT00603512|58677768|FG001|Overall Study|Lack of Efficacy|1|||
30663877|NCT00603512|58677769|FG002|Overall Study|Lack of Efficacy|0|||
30663878|NCT00603512|58677770|FG003|Overall Study|Lack of Efficacy|0|||
30663879|NCT00603512|58677771|FG004|Overall Study|Lack of Efficacy|1|||
30663880|NCT00603512|58677767|FG000|Overall Study|Other|2|||
30663881|NCT00603512|58677768|FG001|Overall Study|Other|1|||
30663882|NCT00603512|58677769|FG002|Overall Study|Other|0|||
30663883|NCT00603512|58677770|FG003|Overall Study|Other|1|||
30663884|NCT00603512|58677771|FG004|Overall Study|Other|1|||
30663885|NCT00603512|58677767|FG000|Overall Study|Withdrawal by Subject|0|||
30663886|NCT00603512|58677768|FG001|Overall Study|Withdrawal by Subject|0|||
30779613|NCT00021255|58791227|FG000|Overall Study|Protocol Violation|0|||
30779614|NCT00021255|58791228|FG001|Overall Study|Protocol Violation|2|||
30663887|NCT00603512|58677769|FG002|Overall Study|Withdrawal by Subject|0|||
30663888|NCT00603512|58677770|FG003|Overall Study|Withdrawal by Subject|0|||
30663889|NCT00603512|58677771|FG004|Overall Study|Withdrawal by Subject|1|||
30663890|NCT00603512|58677767|FG000|Overall Study|Randomized but not treated|0|||
30663891|NCT00603512|58677768|FG001|Overall Study|Randomized but not treated|1|||
30663892|NCT00603512|58677769|FG002|Overall Study|Randomized but not treated|1|||
30663893|NCT00603512|58677770|FG003|Overall Study|Randomized but not treated|2|||
30663894|NCT00603512|58677771|FG004|Overall Study|Randomized but not treated|0|||
30663895|NCT04242875|58677783|FG000|Overall Study|Adverse Event|2|||
30663896|NCT00603278|58677797|FG000|Overall Study|Lack of Efficacy|35|||
30663897|NCT00603278|58677798|FG001|Overall Study|Lack of Efficacy|10|||
30779615|NCT00021255|58791229|FG002|Overall Study|Protocol Violation|0|||
30854758|NCT01594970|58882182|FG002|Overall Study|Lost to Follow-up|37|||
30958289|NCT02546986|59023595|FG001|Treatment Period|Symptomatic Deterioration|3|||
30958290|NCT02546986|59023594|FG000|Treatment Period|Death|3|||
30663898|NCT00603278|58677799|FG002|Overall Study|Lack of Efficacy|11|||
30663899|NCT00603278|58677800|FG003|Overall Study|Lack of Efficacy|8|||
30663900|NCT00603278|58677801|FG004|Overall Study|Lack of Efficacy|7|||
30663901|NCT00603278|58677802|FG005|Overall Study|Lack of Efficacy|14|||
30663902|NCT00603278|58677797|FG000|Overall Study|Adverse Event|0|||
30663903|NCT00603278|58677798|FG001|Overall Study|Adverse Event|3|||
30663904|NCT00603278|58677799|FG002|Overall Study|Adverse Event|1|||
30663905|NCT00603278|58677800|FG003|Overall Study|Adverse Event|0|||
30663906|NCT00603278|58677801|FG004|Overall Study|Adverse Event|2|||
30663907|NCT00603278|58677802|FG005|Overall Study|Adverse Event|1|||
30663908|NCT00603278|58677797|FG000|Overall Study|Withdrawal by Subject|2|||
30663909|NCT00603278|58677798|FG001|Overall Study|Withdrawal by Subject|3|||
30663910|NCT00603278|58677799|FG002|Overall Study|Withdrawal by Subject|1|||
30663911|NCT00603278|58677800|FG003|Overall Study|Withdrawal by Subject|2|||
30663912|NCT00603278|58677801|FG004|Overall Study|Withdrawal by Subject|1|||
30663913|NCT00603278|58677802|FG005|Overall Study|Withdrawal by Subject|2|||
30663914|NCT00603278|58677797|FG000|Overall Study|Protocol Violation|3|||
30663915|NCT00603278|58677798|FG001|Overall Study|Protocol Violation|0|||
30663916|NCT00603278|58677799|FG002|Overall Study|Protocol Violation|1|||
30663917|NCT00603278|58677800|FG003|Overall Study|Protocol Violation|1|||
30663918|NCT00603278|58677801|FG004|Overall Study|Protocol Violation|0|||
30663919|NCT00603278|58677802|FG005|Overall Study|Protocol Violation|1|||
30663920|NCT00603278|58677797|FG000|Overall Study|Physician Decision|0|||
30663921|NCT00603278|58677798|FG001|Overall Study|Physician Decision|1|||
30663922|NCT00603278|58677799|FG002|Overall Study|Physician Decision|0|||
30663923|NCT00603278|58677800|FG003|Overall Study|Physician Decision|0|||
30663924|NCT00603278|58677801|FG004|Overall Study|Physician Decision|2|||
30663925|NCT00603278|58677802|FG005|Overall Study|Physician Decision|1|||
30663926|NCT00603278|58677797|FG000|Overall Study|Lost to Follow-up|1|||
30663927|NCT00603278|58677798|FG001|Overall Study|Lost to Follow-up|0|||
30663928|NCT00603278|58677799|FG002|Overall Study|Lost to Follow-up|0|||
30663929|NCT00603278|58677800|FG003|Overall Study|Lost to Follow-up|0|||
30663930|NCT00603278|58677801|FG004|Overall Study|Lost to Follow-up|1|||
30663931|NCT00603278|58677802|FG005|Overall Study|Lost to Follow-up|0|||
30663932|NCT00876447|58677818|FG000|Overall Study|Other miscellaneous reasons|3|||
30663933|NCT00876447|58677819|FG001|Overall Study|Other miscellaneous reasons|8|||
30663934|NCT00876447|58677818|FG000|Overall Study|Site closure|19|||
30663935|NCT00876447|58677819|FG001|Overall Study|Site closure|14|||
30663936|NCT00876447|58677818|FG000|Overall Study|Protocol Violation|9|||
30663937|NCT00876447|58677819|FG001|Overall Study|Protocol Violation|3|||
30663938|NCT00876447|58677818|FG000|Overall Study|Personal reasons|30|||
30663939|NCT00876447|58677819|FG001|Overall Study|Personal reasons|28|||
30663940|NCT00876447|58677818|FG000|Overall Study|Lost to Follow-up|6|||
30663941|NCT00876447|58677819|FG001|Overall Study|Lost to Follow-up|15|||
30663942|NCT00876447|58677818|FG000|Overall Study|Pregnancy|4|||
30663943|NCT00876447|58677819|FG001|Overall Study|Pregnancy|2|||
30663944|NCT00876447|58677818|FG000|Overall Study|Lack of Efficacy|5|||
30663945|NCT00876447|58677819|FG001|Overall Study|Lack of Efficacy|3|||
30663946|NCT00876447|58677818|FG000|Overall Study|Adverse Event|4|||
30663947|NCT00876447|58677819|FG001|Overall Study|Adverse Event|8|||
30663948|NCT00598650|58677849|FG000|Overall Study|Withdrawal by Subject|3|||
30663949|NCT00598650|58677849|FG000|Overall Study|Adverse Event|18|||
30663950|NCT00598650|58677849|FG000|Overall Study|No treatment for 3 weeks|1|||
30663951|NCT00598650|58677849|FG000|Overall Study|Not eligible|1|||
30663952|NCT00598650|58677849|FG000|Overall Study|Prohibited Concomitant Medication|2|||
30663953|NCT00598650|58677849|FG000|Overall Study|Physician Decision|2|||
30663954|NCT04249076|58677856|FG000|Overall Study|Adverse Event|1|||
30663955|NCT04249076|58677857|FG001|Overall Study|Adverse Event|1|||
30663956|NCT04249076|58677856|FG000|Overall Study|Protocol Violation|1|||
30663957|NCT04249076|58677857|FG001|Overall Study|Protocol Violation|2|||
30663958|NCT04249076|58677856|FG000|Overall Study|Lack of Efficacy|0|||
30663959|NCT04249076|58677857|FG001|Overall Study|Lack of Efficacy|1|||
30663960|NCT04249076|58677856|FG000|Overall Study|Withdrawal by Subject|0|||
30663961|NCT04249076|58677857|FG001|Overall Study|Withdrawal by Subject|1|||
30663962|NCT04150107|58677865|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
30663963|NCT04150107|58677866|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
30663964|NCT04150107|58677865|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
30663965|NCT04150107|58677866|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
30663966|NCT04173494|58677876|FG000|Randomized Double-Blind Treatment Period|Adverse Event|16|||
30663967|NCT04173494|58677877|FG001|Randomized Double-Blind Treatment Period|Adverse Event|11|||
30663968|NCT04173494|58677876|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|6|||
30663969|NCT04173494|58677877|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|5|||
30663970|NCT04173494|58677876|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|6|||
30663971|NCT04173494|58677877|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|3|||
30663972|NCT04173494|58677876|FG000|Randomized Double-Blind Treatment Period|Death|4|||
30663973|NCT04173494|58677877|FG001|Randomized Double-Blind Treatment Period|Death|3|||
30663974|NCT04173494|58677876|FG000|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
30663975|NCT04173494|58677877|FG001|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
30663976|NCT04173494|58677876|FG000|Randomized Double-Blind Treatment Period|Disease Progression|1|||
30663977|NCT04173494|58677877|FG001|Randomized Double-Blind Treatment Period|Disease Progression|2|||
30663978|NCT04173494|58677876|FG000|Randomized Double-Blind Treatment Period|Lost to Follow-up|1|||
30663979|NCT04173494|58677877|FG001|Randomized Double-Blind Treatment Period|Lost to Follow-up|0|||
30854759|NCT02338492|58882190|FG000|Overall Study|Death|32|||
30663980|NCT04173494|58677876|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
30663981|NCT04173494|58677877|FG001|Randomized Double-Blind Treatment Period|Physician Decision|1|||
30663982|NCT04173494|58677876|FG000|Open-Label Extended Treatment Period|Open-label treatment ongoing|52|||
30663983|NCT04173494|58677877|FG001|Open-Label Extended Treatment Period|Open-label treatment ongoing|22|||
30663984|NCT04173494|58677876|FG000|Open-Label Extended Treatment Period|Continuing in MMB extension study|24|||
30663985|NCT04173494|58677877|FG001|Open-Label Extended Treatment Period|Continuing in MMB extension study|9|||
30663986|NCT04173494|58677876|FG000|Open-Label Extended Treatment Period|Adverse Event|8|||
30663987|NCT04173494|58677877|FG001|Open-Label Extended Treatment Period|Adverse Event|1|||
30663988|NCT04173494|58677876|FG000|Open-Label Extended Treatment Period|Withdrawal by Subject|2|||
30663989|NCT04173494|58677877|FG001|Open-Label Extended Treatment Period|Withdrawal by Subject|3|||
30663990|NCT04173494|58677876|FG000|Open-Label Extended Treatment Period|Death|3|||
30663991|NCT04173494|58677877|FG001|Open-Label Extended Treatment Period|Death|1|||
30663992|NCT04173494|58677876|FG000|Open-Label Extended Treatment Period|Physician Decision|2|||
30663993|NCT04173494|58677877|FG001|Open-Label Extended Treatment Period|Physician Decision|2|||
30663994|NCT04173494|58677876|FG000|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
30663995|NCT04173494|58677877|FG001|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
30663996|NCT04173494|58677876|FG000|Open-Label Extended Treatment Period|Leukemic transformation|0|||
30663997|NCT04173494|58677877|FG001|Open-Label Extended Treatment Period|Leukemic transformation|1|||
30663998|NCT00875979|58677885|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
30663999|NCT00875979|58677886|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
30664000|NCT00875979|58677885|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
30664001|NCT00875979|58677886|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
30664002|NCT00875979|58677885|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
30664003|NCT00875979|58677886|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
30664004|NCT00875979|58677885|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
30664005|NCT00875979|58677886|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
30664006|NCT00875979|58677885|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
30664007|NCT00875979|58677886|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
30664008|NCT00875979|58677885|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
30664009|NCT00875979|58677886|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
30664010|NCT00875979|58677885|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
30664011|NCT00875979|58677886|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
30664012|NCT00875979|58677885|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
30664013|NCT00875979|58677886|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
30779616|NCT00021255|58791227|FG000|Overall Study|Other than specified above|0|||
30779617|NCT00021255|58791228|FG001|Overall Study|Other than specified above|38|||
30779618|NCT00021255|58791229|FG002|Overall Study|Other than specified above|19|||
30779619|NCT00021255|58791227|FG000|Overall Study|Missing|0|||
30779620|NCT00021255|58791228|FG001|Overall Study|Missing|27|||
30664014|NCT00875979|58677885|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
30664015|NCT00875979|58677886|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
30664016|NCT00602420|58677894|FG000|Overall Study|Death|1|||
30664017|NCT00602420|58677895|FG001|Overall Study|Death|4|||
30664018|NCT00602420|58677894|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
30664019|NCT00602420|58677895|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
30664020|NCT00602420|58677894|FG000|Overall Study|Withdrawal by Subject|18|||
30664021|NCT00602420|58677895|FG001|Overall Study|Withdrawal by Subject|17|||
30664022|NCT00602420|58677894|FG000|Overall Study|Adverse Event|1|||
30664023|NCT00602420|58677895|FG001|Overall Study|Adverse Event|0|||
30664024|NCT00875667|58677909|FG000|Overall Study|Adverse Event|29|||
30664025|NCT00875667|58677910|FG001|Overall Study|Adverse Event|10|||
30664026|NCT00875667|58677909|FG000|Overall Study|Withdrawal by Subject|17|||
30664027|NCT00875667|58677910|FG001|Overall Study|Withdrawal by Subject|5|||
30664028|NCT00875667|58677909|FG000|Overall Study|Death|7|||
30664029|NCT00875667|58677910|FG001|Overall Study|Death|2|||
30664030|NCT00875667|58677909|FG000|Overall Study|Protocol Violation|2|||
30664031|NCT00875667|58677910|FG001|Overall Study|Protocol Violation|0|||
30664032|NCT00875667|58677909|FG000|Overall Study|Disease Progression|100|||
30664033|NCT00875667|58677910|FG001|Overall Study|Disease Progression|49|||
30664034|NCT00875667|58677909|FG000|Overall Study|Miscellaneous|12|||
30779621|NCT00021255|58791229|FG002|Overall Study|Missing|13|||
30779622|NCT00021255|58791227|FG000|Overall Study|Randomized but not treated|28|||
30779623|NCT00021255|58791228|FG001|Overall Study|Randomized but not treated|2|||
30664035|NCT00875667|58677910|FG001|Overall Study|Miscellaneous|6|||
30664036|NCT00875667|58677909|FG000|Overall Study|Randomized but no Study Drug Given|3|||
30664037|NCT00875667|58677910|FG001|Overall Study|Randomized but no Study Drug Given|1|||
30664038|NCT00602030|58677920|FG000|Lead-in Phase|Disease Progression|2|||
30779624|NCT00021255|58791229|FG002|Overall Study|Randomized but not treated|18|||
30779625|NCT03012334|58791247|FG000|Period 1|Withdrawal by Subject|0|||
30779626|NCT03012334|58791248|FG001|Period 1|Withdrawal by Subject|0|||
30779627|NCT03012334|58791249|FG002|Period 1|Withdrawal by Subject|0|||
30779628|NCT03012334|58791250|FG003|Period 1|Withdrawal by Subject|0|||
30779629|NCT03012334|58791251|FG004|Period 1|Withdrawal by Subject|0|||
30779630|NCT03012334|58791252|FG005|Period 1|Withdrawal by Subject|0|||
30779631|NCT03012334|58791253|FG006|Period 1|Withdrawal by Subject|0|||
30779632|NCT03012334|58791254|FG007|Period 1|Withdrawal by Subject|0|||
30779633|NCT03012334|58791255|FG008|Period 1|Withdrawal by Subject|0|||
30779634|NCT03012334|58791256|FG009|Period 1|Withdrawal by Subject|1|||
30779635|NCT03012334|58791247|FG000|Period 2|Withdrawal by Subject|0|||
30664039|NCT00602030|58677921|FG001|Lead-in Phase|Disease Progression|3|||
30664040|NCT00602030|58677922|FG002|Lead-in Phase|Disease Progression|0|||
30854760|NCT02338492|58882190|FG000|Overall Study|Adverse Event|3|||
30854761|NCT02338492|58882190|FG000|Overall Study|Lost to Follow-up|4|||
30664041|NCT00602030|58677923|FG003|Lead-in Phase|Disease Progression|0|||
30958291|NCT02546986|59023595|FG001|Treatment Period|Death|4|||
30664042|NCT00602030|58677924|FG004|Lead-in Phase|Disease Progression|0|||
30664043|NCT00602030|58677920|FG000|Lead-in Phase|Adverse Event|0|||
30664044|NCT00602030|58677921|FG001|Lead-in Phase|Adverse Event|2|||
30664045|NCT00602030|58677922|FG002|Lead-in Phase|Adverse Event|0|||
30664046|NCT00602030|58677923|FG003|Lead-in Phase|Adverse Event|0|||
30664047|NCT00602030|58677924|FG004|Lead-in Phase|Adverse Event|0|||
30664048|NCT00602030|58677920|FG000|Double-blind Phase|Disease progression|0|||
30664049|NCT00602030|58677921|FG001|Double-blind Phase|Disease progression|0|||
30664050|NCT00602030|58677922|FG002|Double-blind Phase|Disease progression|33|||
30664051|NCT00602030|58677923|FG003|Double-blind Phase|Disease progression|30|||
30664052|NCT00602030|58677924|FG004|Double-blind Phase|Disease progression|0|||
30664053|NCT00602030|58677920|FG000|Double-blind Phase|Adverse Event|0|||
30664054|NCT00602030|58677921|FG001|Double-blind Phase|Adverse Event|0|||
30664055|NCT00602030|58677922|FG002|Double-blind Phase|Adverse Event|9|||
30664056|NCT00602030|58677923|FG003|Double-blind Phase|Adverse Event|18|||
30664057|NCT00602030|58677924|FG004|Double-blind Phase|Adverse Event|0|||
30664058|NCT00602030|58677920|FG000|Double-blind Phase|Consent withdrawal|0|||
30664059|NCT00602030|58677921|FG001|Double-blind Phase|Consent withdrawal|0|||
30664060|NCT00602030|58677922|FG002|Double-blind Phase|Consent withdrawal|4|||
30664061|NCT00602030|58677923|FG003|Double-blind Phase|Consent withdrawal|3|||
30664062|NCT00602030|58677924|FG004|Double-blind Phase|Consent withdrawal|0|||
30664063|NCT00602030|58677920|FG000|Double-blind Phase|Death|0|||
30664064|NCT00602030|58677921|FG001|Double-blind Phase|Death|0|||
30664065|NCT00602030|58677922|FG002|Double-blind Phase|Death|3|||
30664066|NCT00602030|58677923|FG003|Double-blind Phase|Death|3|||
30664067|NCT00602030|58677924|FG004|Double-blind Phase|Death|0|||
30664068|NCT00602030|58677920|FG000|Double-blind Phase|Administrative decision|0|||
30664069|NCT00602030|58677921|FG001|Double-blind Phase|Administrative decision|0|||
30664070|NCT00602030|58677922|FG002|Double-blind Phase|Administrative decision|0|||
30664071|NCT00602030|58677923|FG003|Double-blind Phase|Administrative decision|2|||
30664072|NCT00602030|58677924|FG004|Double-blind Phase|Administrative decision|0|||
30664073|NCT00602030|58677920|FG000|Double-blind Phase|Ineligibility|0|||
30664074|NCT00602030|58677921|FG001|Double-blind Phase|Ineligibility|0|||
30664075|NCT00602030|58677922|FG002|Double-blind Phase|Ineligibility|0|||
30664076|NCT00602030|58677923|FG003|Double-blind Phase|Ineligibility|1|||
30664077|NCT00602030|58677924|FG004|Double-blind Phase|Ineligibility|0|||
30664078|NCT00602030|58677920|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
30664079|NCT00602030|58677921|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
30664080|NCT00602030|58677922|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
30664081|NCT00602030|58677923|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
30664082|NCT00602030|58677924|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
30664083|NCT00602030|58677920|FG000|Double-blind Phase|Reason not specified|0|||
30854762|NCT02338492|58882190|FG000|Overall Study|Reason not captured above|6|||
30664084|NCT00602030|58677921|FG001|Double-blind Phase|Reason not specified|0|||
30664085|NCT00602030|58677922|FG002|Double-blind Phase|Reason not specified|4|||
30664086|NCT00602030|58677923|FG003|Double-blind Phase|Reason not specified|2|||
30664087|NCT00602030|58677924|FG004|Double-blind Phase|Reason not specified|0|||
30664088|NCT00602030|58677920|FG000|Crossover Phase|Disease Progression|0|||
30664089|NCT00602030|58677921|FG001|Crossover Phase|Disease Progression|0|||
30664090|NCT00602030|58677922|FG002|Crossover Phase|Disease Progression|0|||
30664091|NCT00602030|58677923|FG003|Crossover Phase|Disease Progression|0|||
30664092|NCT00602030|58677924|FG004|Crossover Phase|Disease Progression|11|||
30664093|NCT00602030|58677920|FG000|Crossover Phase|Adverse Event|0|||
30779636|NCT03012334|58791248|FG001|Period 2|Withdrawal by Subject|1|||
30779637|NCT03012334|58791249|FG002|Period 2|Withdrawal by Subject|0|||
30779638|NCT03012334|58791250|FG003|Period 2|Withdrawal by Subject|0|||
30779639|NCT03012334|58791251|FG004|Period 2|Withdrawal by Subject|0|||
30779640|NCT03012334|58791252|FG005|Period 2|Withdrawal by Subject|0|||
30779641|NCT03012334|58791253|FG006|Period 2|Withdrawal by Subject|0|||
30779642|NCT03012334|58791254|FG007|Period 2|Withdrawal by Subject|0|||
30779643|NCT03012334|58791255|FG008|Period 2|Withdrawal by Subject|0|||
30779644|NCT03012334|58791256|FG009|Period 2|Withdrawal by Subject|0|||
30779645|NCT03012334|58791247|FG000|Period 2|Protocol Violation|0|||
30779646|NCT03012334|58791248|FG001|Period 2|Protocol Violation|0|||
30779647|NCT03012334|58791249|FG002|Period 2|Protocol Violation|1|||
30779648|NCT03012334|58791250|FG003|Period 2|Protocol Violation|0|||
30958292|NCT02546986|59023594|FG000|Treatment Period|Physician Decision|1|||
30958293|NCT02546986|59023595|FG001|Treatment Period|Physician Decision|2|||
30958294|NCT02546986|59023594|FG000|Treatment Period|Protocol Violation|1|||
30854763|NCT02337946|58882194|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
30854764|NCT02337946|58882195|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
30854765|NCT02337946|58882196|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
30854766|NCT02337946|58882194|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
30854767|NCT02337946|58882195|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
30664094|NCT00602030|58677921|FG001|Crossover Phase|Adverse Event|0|||
30664095|NCT00602030|58677922|FG002|Crossover Phase|Adverse Event|0|||
30664096|NCT00602030|58677923|FG003|Crossover Phase|Adverse Event|0|||
30779649|NCT03012334|58791251|FG004|Period 2|Protocol Violation|0|||
30958295|NCT02546986|59023595|FG001|Treatment Period|Protocol Violation|0|||
30664097|NCT00602030|58677924|FG004|Crossover Phase|Adverse Event|3|||
30664098|NCT00602030|58677920|FG000|Crossover Phase|Consent withdrawal|0|||
30664099|NCT00602030|58677921|FG001|Crossover Phase|Consent withdrawal|0|||
30664100|NCT00602030|58677922|FG002|Crossover Phase|Consent withdrawal|0|||
30664101|NCT00602030|58677923|FG003|Crossover Phase|Consent withdrawal|0|||
30664102|NCT00602030|58677924|FG004|Crossover Phase|Consent withdrawal|2|||
30664103|NCT00549757|58677938|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
30664104|NCT00549757|58677939|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
30664105|NCT00549757|58677938|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
30664106|NCT00549757|58677939|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
30664107|NCT00549757|58677938|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
30664108|NCT00549757|58677939|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
30664109|NCT00549757|58677938|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
30664110|NCT00549757|58677939|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
30664111|NCT00549757|58677938|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
30664112|NCT00549757|58677939|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
30664113|NCT00549757|58677938|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
30664114|NCT00549757|58677939|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
30664115|NCT00549757|58677938|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
30664116|NCT00549757|58677939|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
30779650|NCT03012334|58791252|FG005|Period 2|Protocol Violation|0|||
30958296|NCT02546986|59023594|FG000|Treatment Period|Withdrawal by Subject|1|||
30958297|NCT02546986|59023595|FG001|Treatment Period|Withdrawal by Subject|1|||
30779651|NCT03012334|58791253|FG006|Period 2|Protocol Violation|0|||
30779652|NCT03012334|58791254|FG007|Period 2|Protocol Violation|1|||
30779653|NCT03012334|58791255|FG008|Period 2|Protocol Violation|0|||
30779654|NCT03012334|58791256|FG009|Period 2|Protocol Violation|0|||
30779655|NCT03012334|58791247|FG000|Period 4|Non-Compliance|0|||
30779656|NCT03012334|58791248|FG001|Period 4|Non-Compliance|0|||
30779657|NCT03012334|58791249|FG002|Period 4|Non-Compliance|0|||
30779658|NCT03012334|58791250|FG003|Period 4|Non-Compliance|0|||
30779659|NCT03012334|58791251|FG004|Period 4|Non-Compliance|0|||
30779660|NCT03012334|58791252|FG005|Period 4|Non-Compliance|0|||
30779661|NCT03012334|58791253|FG006|Period 4|Non-Compliance|1|||
30779662|NCT03012334|58791254|FG007|Period 4|Non-Compliance|0|||
30779663|NCT03012334|58791255|FG008|Period 4|Non-Compliance|0|||
30779664|NCT03012334|58791256|FG009|Period 4|Non-Compliance|0|||
30779665|NCT03012334|58791247|FG000|Period 4|Adverse Event|0|||
30779666|NCT03012334|58791248|FG001|Period 4|Adverse Event|0|||
30779667|NCT03012334|58791249|FG002|Period 4|Adverse Event|0|||
30779668|NCT03012334|58791250|FG003|Period 4|Adverse Event|0|||
30779669|NCT03012334|58791251|FG004|Period 4|Adverse Event|0|||
30779670|NCT03012334|58791252|FG005|Period 4|Adverse Event|0|||
30664117|NCT00549757|58677938|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
30779671|NCT03012334|58791253|FG006|Period 4|Adverse Event|0|||
30779672|NCT03012334|58791254|FG007|Period 4|Adverse Event|0|||
30779673|NCT03012334|58791255|FG008|Period 4|Adverse Event|1|||
30779674|NCT03012334|58791256|FG009|Period 4|Adverse Event|0|||
30779675|NCT03565068|58791278|FG000|Overall Study|Protocol Violation|0|||
30779676|NCT03565068|58791279|FG001|Overall Study|Protocol Violation|0|||
30779677|NCT03565068|58791280|FG002|Overall Study|Protocol Violation|0|||
30779678|NCT03565068|58791281|FG003|Overall Study|Protocol Violation|0|||
30779679|NCT03565068|58791282|FG004|Overall Study|Protocol Violation|1|||
30779680|NCT03565068|58791283|FG005|Overall Study|Protocol Violation|0|||
30779681|NCT03565068|58791284|FG006|Overall Study|Protocol Violation|0|||
30779682|NCT03565068|58791285|FG007|Overall Study|Protocol Violation|1|||
30779683|NCT03565068|58791286|FG008|Overall Study|Protocol Violation|0|||
30779684|NCT03565068|58791278|FG000|Overall Study|Sponsor decision|0|||
30779685|NCT03565068|58791279|FG001|Overall Study|Sponsor decision|0|||
30664118|NCT00549757|58677939|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
30664119|NCT00549757|58677938|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
30664120|NCT00549757|58677939|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
30664121|NCT00549757|58677938|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
30779686|NCT03565068|58791280|FG002|Overall Study|Sponsor decision|0|||
30779687|NCT03565068|58791281|FG003|Overall Study|Sponsor decision|0|||
30779688|NCT03565068|58791282|FG004|Overall Study|Sponsor decision|1|||
30664122|NCT00549757|58677939|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
30664123|NCT00549757|58677938|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
30779689|NCT03565068|58791283|FG005|Overall Study|Sponsor decision|1|||
30779690|NCT03565068|58791284|FG006|Overall Study|Sponsor decision|0|||
30779691|NCT03565068|58791285|FG007|Overall Study|Sponsor decision|0|||
30779692|NCT03565068|58791286|FG008|Overall Study|Sponsor decision|0|||
30779693|NCT03565068|58791278|FG000|Overall Study|Withdrawal by Subject|0|||
30779694|NCT03565068|58791279|FG001|Overall Study|Withdrawal by Subject|0|||
30664124|NCT00549757|58677939|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
30664125|NCT00549757|58677938|FG000|Extension Period (in Average 9 Months)|Death|143|||
30664126|NCT00549757|58677939|FG001|Extension Period (in Average 9 Months)|Death|136|||
30664127|NCT00549757|58677938|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
30664128|NCT00549757|58677939|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
30664129|NCT00549757|58677938|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
30664130|NCT00549757|58677939|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
30664131|NCT00549757|58677938|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
30664132|NCT00549757|58677939|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
30664133|NCT00549601|58677954|FG000|Randomized|Protocol Violation|0|||
30664134|NCT00549601|58677955|FG001|Randomized|Protocol Violation|0|||
30664135|NCT00549601|58677956|FG002|Randomized|Protocol Violation|1|||
30664136|NCT00549601|58677954|FG000|Randomized|Withdrawal by Subject|0|||
30664137|NCT00549601|58677955|FG001|Randomized|Withdrawal by Subject|1|||
30664138|NCT00549601|58677956|FG002|Randomized|Withdrawal by Subject|1|||
30664139|NCT00549601|58677954|FG000|Received Study Drug|Adverse Event|2|||
30664140|NCT00549601|58677955|FG001|Received Study Drug|Adverse Event|5|||
30664141|NCT00549601|58677956|FG002|Received Study Drug|Adverse Event|1|||
30664142|NCT00549601|58677954|FG000|Received Study Drug|Death|0|||
30664143|NCT00549601|58677955|FG001|Received Study Drug|Death|1|||
30664144|NCT00549601|58677956|FG002|Received Study Drug|Death|0|||
30664145|NCT00549601|58677954|FG000|Received Study Drug|Lost to Follow-up|0|||
30664146|NCT00549601|58677955|FG001|Received Study Drug|Lost to Follow-up|1|||
30664147|NCT00549601|58677956|FG002|Received Study Drug|Lost to Follow-up|1|||
30664148|NCT00549601|58677954|FG000|Received Study Drug|Protocol Violation|3|||
30664149|NCT00549601|58677955|FG001|Received Study Drug|Protocol Violation|4|||
30779695|NCT03565068|58791280|FG002|Overall Study|Withdrawal by Subject|1|||
30664150|NCT00549601|58677956|FG002|Received Study Drug|Protocol Violation|1|||
30664151|NCT00549601|58677954|FG000|Received Study Drug|Withdrawal by Subject|2|||
30664152|NCT00549601|58677955|FG001|Received Study Drug|Withdrawal by Subject|0|||
30854768|NCT02337946|58882196|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
30664153|NCT00549601|58677956|FG002|Received Study Drug|Withdrawal by Subject|1|||
30664154|NCT00601640|58677982|FG000|Overall Study|Withdrawal by Subject|3|||
30664155|NCT00601640|58677983|FG001|Overall Study|Withdrawal by Subject|0|||
30664156|NCT00601640|58677984|FG002|Overall Study|Withdrawal by Subject|7|||
30664157|NCT00601640|58677982|FG000|Overall Study|Death|1|||
30664158|NCT00601640|58677983|FG001|Overall Study|Death|0|||
30664159|NCT00601640|58677984|FG002|Overall Study|Death|0|||
30664160|NCT00601640|58677982|FG000|Overall Study|Adverse Event|0|||
30664161|NCT00601640|58677983|FG001|Overall Study|Adverse Event|4|||
30664162|NCT00601640|58677984|FG002|Overall Study|Adverse Event|2|||
30664163|NCT00601640|58677982|FG000|Overall Study|intercurrent illness|1|||
30664164|NCT00601640|58677983|FG001|Overall Study|intercurrent illness|0|||
30664165|NCT00601640|58677984|FG002|Overall Study|intercurrent illness|0|||
30664166|NCT00601640|58677982|FG000|Overall Study|change in eligibility status|0|||
30664167|NCT00601640|58677983|FG001|Overall Study|change in eligibility status|1|||
30664168|NCT00601640|58677984|FG002|Overall Study|change in eligibility status|1|||
30664169|NCT02805725|58677999|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
30664170|NCT02805725|58678000|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
30664171|NCT02805725|58678001|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
30664172|NCT02805725|58678002|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
30664173|NCT02805725|58678003|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
30664174|NCT02805725|58677999|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
30664175|NCT02805725|58678000|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
30664176|NCT02805725|58678001|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
30664177|NCT02805725|58678002|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
30664178|NCT02805725|58678003|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
30664179|NCT02805725|58677999|FG000|Phase II|Protocol Violation|0|||
30664180|NCT02805725|58678000|FG001|Phase II|Protocol Violation|0|||
30664181|NCT02805725|58678001|FG002|Phase II|Protocol Violation|0|||
30664182|NCT02805725|58678002|FG003|Phase II|Protocol Violation|0|||
30664183|NCT02805725|58678003|FG004|Phase II|Protocol Violation|6|||
30664184|NCT00546871|58678020|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
30664185|NCT00546871|58678021|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
30664186|NCT00546871|58678020|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
30664187|NCT00546871|58678021|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
30664188|NCT00546871|58678020|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
30664189|NCT00546871|58678021|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
30664190|NCT00546871|58678020|FG000|Study Extension Period|Protocol Violation|1|||
30664191|NCT00546871|58678021|FG001|Study Extension Period|Protocol Violation|0|||
30664192|NCT00546871|58678020|FG000|Study Extension Period|Withdrawal by Subject|0|||
30664193|NCT00546871|58678021|FG001|Study Extension Period|Withdrawal by Subject|1|||
30664194|NCT03951805|58678054|FG000|Overall Study|Adverse Event|1|||
30664195|NCT03951805|58678055|FG001|Overall Study|Adverse Event|0|||
30664196|NCT03951805|58678056|FG002|Overall Study|Adverse Event|0|||
30664197|NCT03951805|58678057|FG003|Overall Study|Adverse Event|0|||
30664198|NCT03944707|58678069|FG000|Overall Study|Adverse Event|0|||
30664199|NCT03944707|58678070|FG001|Overall Study|Adverse Event|2|||
30664200|NCT03944707|58678069|FG000|Overall Study|Study terminated by sponsor|12|||
30664201|NCT03944707|58678070|FG001|Overall Study|Study terminated by sponsor|7|||
30664202|NCT03944707|58678069|FG000|Overall Study|Subject decision|0|||
30664203|NCT03944707|58678070|FG001|Overall Study|Subject decision|1|||
30664204|NCT00549055|58678076|FG000|Overall Study|Adverse Event|4|||
30664205|NCT00549055|58678076|FG000|Overall Study|Lack of Efficacy|18|||
30664206|NCT00549055|58678076|FG000|Overall Study|Stabilization|5|||
30664207|NCT00549055|58678076|FG000|Overall Study|Progression to fibrosis|2|||
30664208|NCT00549055|58678076|FG000|Overall Study|Decrease of size|1|||
30664209|NCT00549055|58678076|FG000|Overall Study|Active choroidal neovascula increased|1|||
30664210|NCT00549055|58678076|FG000|Overall Study|Vitreous hemorrhage|1|||
30664211|NCT00549055|58678076|FG000|Overall Study|Growth choroidal neovascularisation|1|||
30664212|NCT00549055|58678076|FG000|Overall Study|Choroidal neovascularization|1|||
30664213|NCT00549055|58678076|FG000|Overall Study|Very low visual acuity (VA)|1|||
30664214|NCT00883116|58678082|FG000|Overall Study|Adverse event unrelated to study drug|5|||
30664215|NCT00883116|58678083|FG001|Overall Study|Adverse event unrelated to study drug|10|||
30664216|NCT00883116|58678082|FG000|Overall Study|Death|6|||
30664217|NCT00883116|58678083|FG001|Overall Study|Death|2|||
30664218|NCT00883116|58678082|FG000|Overall Study|Disease progression|130|||
30664219|NCT00883116|58678083|FG001|Overall Study|Disease progression|128|||
30664220|NCT00883116|58678082|FG000|Overall Study|Lost to Follow-up|0|||
30664221|NCT00883116|58678083|FG001|Overall Study|Lost to Follow-up|1|||
30664222|NCT00883116|58678082|FG000|Overall Study|Maximum clinical benefit|13|||
30779696|NCT03565068|58791281|FG003|Overall Study|Withdrawal by Subject|0|||
30779697|NCT03565068|58791282|FG004|Overall Study|Withdrawal by Subject|2|||
30664223|NCT00883116|58678083|FG001|Overall Study|Maximum clinical benefit|46|||
30664224|NCT00883116|58678082|FG000|Overall Study|Not identified|3|||
30664225|NCT00883116|58678083|FG001|Overall Study|Not identified|6|||
30664226|NCT00883116|58678082|FG000|Overall Study|Study drug toxicity|36|||
30664227|NCT00883116|58678083|FG001|Overall Study|Study drug toxicity|16|||
30664228|NCT00883116|58678082|FG000|Overall Study|Withdrawal by Subject|14|||
30664229|NCT00883116|58678083|FG001|Overall Study|Withdrawal by Subject|8|||
30664230|NCT00883116|58678082|FG000|Overall Study|No longer meets study criteria|2|||
30664231|NCT00883116|58678083|FG001|Overall Study|No longer meets study criteria|2|||
30664232|NCT00594399|58678102|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
30664233|NCT00594399|58678103|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
30664234|NCT00594399|58678104|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
30664235|NCT00594399|58678102|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
30664236|NCT00594399|58678103|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
30664237|NCT00594399|58678104|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
30664238|NCT00594399|58678102|FG000|Initial 3 Month Counseling|Personal issues|2|||
30664239|NCT00594399|58678103|FG001|Initial 3 Month Counseling|Personal issues|0|||
30664240|NCT00594399|58678104|FG002|Initial 3 Month Counseling|Personal issues|0|||
30664241|NCT00594399|58678102|FG000|Initial 3 Month Counseling|Too busy|7|||
30664242|NCT00594399|58678103|FG001|Initial 3 Month Counseling|Too busy|1|||
30664243|NCT00594399|58678104|FG002|Initial 3 Month Counseling|Too busy|0|||
30664244|NCT00594399|58678102|FG000|Initial 3 Month Counseling|Pain|2|||
30664245|NCT00594399|58678103|FG001|Initial 3 Month Counseling|Pain|0|||
30664246|NCT00594399|58678104|FG002|Initial 3 Month Counseling|Pain|0|||
30664247|NCT00594399|58678102|FG000|Initial 3 Month Counseling|Moved|1|||
30664248|NCT00594399|58678103|FG001|Initial 3 Month Counseling|Moved|0|||
30664249|NCT00594399|58678104|FG002|Initial 3 Month Counseling|Moved|0|||
30664250|NCT00594399|58678102|FG000|Initial 3 Month Counseling|Family illness|1|||
30779698|NCT03565068|58791283|FG005|Overall Study|Withdrawal by Subject|0|||
30779699|NCT03565068|58791284|FG006|Overall Study|Withdrawal by Subject|1|||
30779700|NCT03565068|58791285|FG007|Overall Study|Withdrawal by Subject|5|||
30779701|NCT03565068|58791286|FG008|Overall Study|Withdrawal by Subject|1|||
30779702|NCT03565068|58791278|FG000|Overall Study|Physician Decision|0|||
30779703|NCT03565068|58791279|FG001|Overall Study|Physician Decision|0|||
30779704|NCT03565068|58791280|FG002|Overall Study|Physician Decision|0|||
30779705|NCT03565068|58791281|FG003|Overall Study|Physician Decision|0|||
30779706|NCT03565068|58791282|FG004|Overall Study|Physician Decision|0|||
30779707|NCT03565068|58791283|FG005|Overall Study|Physician Decision|0|||
30779708|NCT03565068|58791284|FG006|Overall Study|Physician Decision|0|||
30779709|NCT03565068|58791285|FG007|Overall Study|Physician Decision|1|||
30779710|NCT03565068|58791286|FG008|Overall Study|Physician Decision|0|||
30779711|NCT03565068|58791278|FG000|Overall Study|Lost to Follow-up|0|||
30779712|NCT03565068|58791279|FG001|Overall Study|Lost to Follow-up|0|||
30779713|NCT03565068|58791280|FG002|Overall Study|Lost to Follow-up|0|||
30779714|NCT03565068|58791281|FG003|Overall Study|Lost to Follow-up|0|||
30779715|NCT03565068|58791282|FG004|Overall Study|Lost to Follow-up|0|||
30664251|NCT00594399|58678103|FG001|Initial 3 Month Counseling|Family illness|0|||
30664252|NCT00594399|58678104|FG002|Initial 3 Month Counseling|Family illness|0|||
30664253|NCT00594399|58678102|FG000|Rerandomization Arm 1 Only|Death|2|||
30664254|NCT00594399|58678103|FG001|Rerandomization Arm 1 Only|Death|1|||
30664255|NCT00594399|58678104|FG002|Rerandomization Arm 1 Only|Death|0|||
30779716|NCT03565068|58791283|FG005|Overall Study|Lost to Follow-up|0|||
30779717|NCT03565068|58791284|FG006|Overall Study|Lost to Follow-up|0|||
30779718|NCT03565068|58791285|FG007|Overall Study|Lost to Follow-up|1|||
30779719|NCT03565068|58791286|FG008|Overall Study|Lost to Follow-up|0|||
30779720|NCT00010803|58791345|FG000|Overall Study|Withdrawal by Subject|97|||
30779721|NCT00010803|58791346|FG001|Overall Study|Withdrawal by Subject|98|||
30779722|NCT02914834|58791354|FG000|Overall Study|Study halted due to COVID|1|||
30779723|NCT02914834|58791355|FG001|Overall Study|Study halted due to COVID|1|||
30779724|NCT02914834|58791354|FG000|Overall Study|1 subject withdrew|0|||
30779725|NCT02914834|58791355|FG001|Overall Study|1 subject withdrew|1|||
30664256|NCT00594399|58678102|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
30779726|NCT03497130|58791363|FG000|Overall Study|Lost to Follow-up|1|||
30664257|NCT00594399|58678103|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
30664258|NCT00594399|58678104|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
30664259|NCT00546715|58678114|FG000|Overall Study|Withdrawal by Subject|0|||
30664260|NCT00546715|58678115|FG001|Overall Study|Withdrawal by Subject|1|||
30779727|NCT03497130|58791364|FG001|Overall Study|Lost to Follow-up|1|||
30779728|NCT03006562|58791372|FG000|Overall Study|Lost to Follow-up|0|||
30779729|NCT03006562|58791373|FG001|Overall Study|Lost to Follow-up|1|||
30779730|NCT03007966|58791381|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
30779731|NCT03007966|58791382|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
30664261|NCT00546715|58678116|FG002|Overall Study|Withdrawal by Subject|0|||
30779732|NCT03007888|58791389|FG000|First Intervention (14 Days)|Adverse Event|1|||
30779733|NCT03007888|58791390|FG001|First Intervention (14 Days)|Adverse Event|0|||
30779734|NCT03541044|58791399|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
30779735|NCT03541044|58791400|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
30779736|NCT03541044|58791399|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
30779737|NCT03541044|58791400|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
30779738|NCT00009945|58791410|FG000|Overall Study|no follow up data|7|||
30779739|NCT00009945|58791411|FG001|Overall Study|no follow up data|5|||
30854769|NCT02337946|58882194|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
30854770|NCT02337946|58882195|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
30854771|NCT02337946|58882196|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
30854772|NCT02337946|58882194|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
30958298|NCT02546986|59023594|FG000|Treatment Period|Non-compliance with Study Drug|0|||
30958299|NCT02546986|59023595|FG001|Treatment Period|Non-compliance with Study Drug|1|||
30958300|NCT02546986|59023594|FG000|Treatment Period|Study Terminated by Sponsor|0|||
30958301|NCT02546986|59023595|FG001|Treatment Period|Study Terminated by Sponsor|1|||
30854773|NCT02337946|58882195|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
30854774|NCT02337946|58882196|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
30779740|NCT03540030|58791419|FG000|Overall Study|Withdrawal by Subject|2|||
30779741|NCT03540030|58791420|FG001|Overall Study|Withdrawal by Subject|1|||
30779742|NCT03540030|58791419|FG000|Overall Study|screen fail|7|||
30779743|NCT03540030|58791420|FG001|Overall Study|screen fail|1|||
30779744|NCT03540030|58791419|FG000|Overall Study|never had surgery after signing consent|9|||
30779745|NCT03540030|58791420|FG001|Overall Study|never had surgery after signing consent|1|||
30664262|NCT00546715|58678117|FG003|Overall Study|Withdrawal by Subject|0|||
30664263|NCT00874029|58678127|FG000|Overall Study|Withdrawal by Subject|10|||
30664264|NCT00874029|58678127|FG000|Overall Study|Pregnancy|4|||
30779746|NCT03003676|58791428|FG000|Overall Study|Lack of Efficacy|5|||
30664265|NCT00874029|58678127|FG000|Overall Study|Physician Decision|1|||
30958302|NCT02546986|59023594|FG000|Treatment Period|Miscellaneous|7|||
30664266|NCT00874029|58678127|FG000|Overall Study|Adverse Event|1|||
30664267|NCT00874029|58678127|FG000|Overall Study|Lost to Follow-up|5|||
30664268|NCT00546637|58678143|FG000|Overall Study|Adverse Event|46|||
30664269|NCT00546637|58678144|FG001|Overall Study|Adverse Event|20|||
30664270|NCT00546637|58678143|FG000|Overall Study|Lack of Efficacy|5|||
30664271|NCT00546637|58678144|FG001|Overall Study|Lack of Efficacy|5|||
30664272|NCT00546637|58678143|FG000|Overall Study|Lost to Follow-up|2|||
30664273|NCT00546637|58678144|FG001|Overall Study|Lost to Follow-up|2|||
30664274|NCT00546637|58678143|FG000|Overall Study|Other|10|||
30664275|NCT00546637|58678144|FG001|Overall Study|Other|12|||
30664276|NCT00546637|58678143|FG000|Overall Study|Withdrawal by Subject|7|||
30664277|NCT00546637|58678144|FG001|Overall Study|Withdrawal by Subject|9|||
30664278|NCT00546637|58678143|FG000|Overall Study|Randomized, but not treated|3|||
30664279|NCT00546637|58678144|FG001|Overall Study|Randomized, but not treated|1|||
30664280|NCT00546481|58678152|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
30664281|NCT00546481|58678153|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
30664282|NCT00546481|58678154|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
30664283|NCT00546481|58678152|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
30664284|NCT00546481|58678153|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
30664285|NCT00546481|58678154|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
30664286|NCT00546481|58678152|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
30664287|NCT00546481|58678153|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
30664288|NCT00546481|58678154|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
30664289|NCT00546481|58678152|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
30664290|NCT00546481|58678153|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
30664291|NCT00546481|58678154|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
30664292|NCT00546481|58678152|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
30664293|NCT00546481|58678153|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
30958303|NCT02546986|59023595|FG001|Treatment Period|Miscellaneous|9|||
30958304|NCT02546986|59023594|FG000|Survival Follow-Up Phase|Missing Status|3|||
30958305|NCT02546986|59023595|FG001|Survival Follow-Up Phase|Missing Status|5|||
30958306|NCT02546986|59023594|FG000|Survival Follow-Up Phase|Death|18|||
30958307|NCT02546986|59023595|FG001|Survival Follow-Up Phase|Death|12|||
30664294|NCT00546481|58678154|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
30664295|NCT00546481|58678152|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
30664296|NCT00546481|58678153|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
30664297|NCT00546481|58678154|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
30779747|NCT03003676|58791429|FG001|Overall Study|Lack of Efficacy|7|||
30779748|NCT03003676|58791428|FG000|Overall Study|Withdrawal by Subject|0|||
30664298|NCT00546481|58678152|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
30664299|NCT00546481|58678153|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
30779749|NCT03003676|58791429|FG001|Overall Study|Withdrawal by Subject|1|||
30779750|NCT03003676|58791428|FG000|Overall Study|Hepatitis B infection|1|||
30779751|NCT03003676|58791429|FG001|Overall Study|Hepatitis B infection|0|||
30958308|NCT02546986|59023594|FG000|Survival Follow-Up Phase|Alive|13|||
30958309|NCT02546986|59023595|FG001|Survival Follow-Up Phase|Alive|16|||
30664300|NCT00546481|58678154|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
30958310|NCT02546986|59023594|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
30958311|NCT02546986|59023595|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
30958312|NCT02689206|59023606|FG000|Overall Study|Adverse Event|0|||
30664301|NCT00546481|58678152|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
30664302|NCT00546481|58678153|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
30664303|NCT00546481|58678154|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
30664304|NCT00546481|58678152|FG000|Maintenance Phase (CERA)|Other Reason|0|||
30664305|NCT00546481|58678153|FG001|Maintenance Phase (CERA)|Other Reason|0|||
30664306|NCT00546481|58678154|FG002|Maintenance Phase (CERA)|Other Reason|1|||
30664307|NCT00880698|58678166|FG000|Overall Study|Death|0|||
30664308|NCT00880698|58678167|FG001|Overall Study|Death|0|||
30664309|NCT00880698|58678168|FG002|Overall Study|Death|1|||
30664310|NCT00880698|58678169|FG003|Overall Study|Death|2|||
30664311|NCT00880698|58678166|FG000|Overall Study|Lost to Follow-up|1|||
30664312|NCT00880698|58678167|FG001|Overall Study|Lost to Follow-up|3|||
30664313|NCT00880698|58678168|FG002|Overall Study|Lost to Follow-up|0|||
30664314|NCT00880698|58678169|FG003|Overall Study|Lost to Follow-up|1|||
30664315|NCT00880620|58678185|FG000|Overall Study|Adverse Event|4|||
30664316|NCT00880620|58678186|FG001|Overall Study|Adverse Event|5|||
30664317|NCT00880620|58678187|FG002|Overall Study|Adverse Event|15|||
30664318|NCT00880620|58678188|FG003|Overall Study|Adverse Event|15|||
30664319|NCT00880620|58678185|FG000|Overall Study|Death|0|||
30664320|NCT00880620|58678186|FG001|Overall Study|Death|0|||
30664321|NCT00880620|58678187|FG002|Overall Study|Death|1|||
30664322|NCT00880620|58678188|FG003|Overall Study|Death|0|||
30664323|NCT00880620|58678185|FG000|Overall Study|Lack of Efficacy|12|||
30664324|NCT00880620|58678186|FG001|Overall Study|Lack of Efficacy|4|||
30664325|NCT00880620|58678187|FG002|Overall Study|Lack of Efficacy|0|||
30664326|NCT00880620|58678188|FG003|Overall Study|Lack of Efficacy|1|||
30664327|NCT00880620|58678185|FG000|Overall Study|Lost to Follow-up|0|||
30664328|NCT00880620|58678186|FG001|Overall Study|Lost to Follow-up|1|||
30664329|NCT00880620|58678187|FG002|Overall Study|Lost to Follow-up|1|||
30664330|NCT00880620|58678188|FG003|Overall Study|Lost to Follow-up|0|||
30664331|NCT00880620|58678185|FG000|Overall Study|Protocol Violation|0|||
30664332|NCT00880620|58678186|FG001|Overall Study|Protocol Violation|1|||
30664333|NCT00880620|58678187|FG002|Overall Study|Protocol Violation|0|||
30779752|NCT00047385|58791439|FG000|Overall Study|Death before any screening|2|||
30779753|NCT00047385|58791440|FG001|Overall Study|Death before any screening|5|||
30779754|NCT00047385|58791439|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
30779755|NCT00047385|58791440|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
30779756|NCT00047385|58791439|FG000|Overall Study|Eligible for screening but had no screen|260|||
30779757|NCT00047385|58791440|FG001|Overall Study|Eligible for screening but had no screen|492|||
30664334|NCT00880620|58678188|FG003|Overall Study|Protocol Violation|2|||
30779758|NCT03002818|58791446|FG000|Overall Study|Decision of the investigator|1|||
30779759|NCT03002194|58791450|FG000|Overall Study|Lost to Follow-up|6|||
30779760|NCT03002194|58791450|FG000|Overall Study|Adverse Event|1|||
30779761|NCT03002194|58791450|FG000|Overall Study|Lack of Efficacy|1|||
30779762|NCT03002194|58791450|FG000|Overall Study|Withdrawal by Subject|2|||
30779763|NCT02912650|58791458|FG000|Overall Study|Withdrawal by Subject|1|||
30779764|NCT02912650|58791459|FG001|Overall Study|Withdrawal by Subject|0|||
30779765|NCT02912650|58791460|FG002|Overall Study|Withdrawal by Subject|1|||
30779766|NCT02912650|58791461|FG003|Overall Study|Withdrawal by Subject|5|||
30779767|NCT02912650|58791458|FG000|Overall Study|Adverse Event|0|||
30779768|NCT02912650|58791459|FG001|Overall Study|Adverse Event|0|||
30779769|NCT02912650|58791460|FG002|Overall Study|Adverse Event|1|||
30779770|NCT02912650|58791461|FG003|Overall Study|Adverse Event|0|||
30779771|NCT03004924|58791474|FG000|Overall Study|Adverse Event|6|||
30779772|NCT03004924|58791475|FG001|Overall Study|Adverse Event|5|||
30779773|NCT03004924|58791476|FG002|Overall Study|Adverse Event|10|||
30779774|NCT03004924|58791474|FG000|Overall Study|Protocol Violation|4|||
30664335|NCT00880620|58678185|FG000|Overall Study|Withdrawal by Subject|4|||
30779775|NCT03004924|58791475|FG001|Overall Study|Protocol Violation|0|||
30779776|NCT03004924|58791476|FG002|Overall Study|Protocol Violation|1|||
30779777|NCT03004924|58791474|FG000|Overall Study|Withdrawal by Subject|5|||
30779778|NCT03004924|58791475|FG001|Overall Study|Withdrawal by Subject|3|||
30958313|NCT02689206|59023607|FG001|Overall Study|Adverse Event|0|||
30779779|NCT03004924|58791476|FG002|Overall Study|Withdrawal by Subject|5|||
30779780|NCT03004924|58791474|FG000|Overall Study|Lost to Follow-up|6|||
30779781|NCT03004924|58791475|FG001|Overall Study|Lost to Follow-up|1|||
30854775|NCT02337946|58882194|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
30854776|NCT02337946|58882195|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
30958314|NCT02689206|59023608|FG002|Overall Study|Adverse Event|1|||
30854777|NCT02337946|58882196|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
30958315|NCT02689206|59023609|FG003|Overall Study|Adverse Event|0|||
30664336|NCT00880620|58678186|FG001|Overall Study|Withdrawal by Subject|3|||
30664337|NCT00880620|58678187|FG002|Overall Study|Withdrawal by Subject|1|||
30664338|NCT00880620|58678188|FG003|Overall Study|Withdrawal by Subject|3|||
30664339|NCT00880620|58678185|FG000|Overall Study|Noncompliance|0|||
30854778|NCT02337946|58882194|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
30854779|NCT02337946|58882195|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
30854780|NCT02337946|58882196|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
30664340|NCT00880620|58678186|FG001|Overall Study|Noncompliance|0|||
30664341|NCT00880620|58678187|FG002|Overall Study|Noncompliance|1|||
30664342|NCT00880620|58678188|FG003|Overall Study|Noncompliance|1|||
30664343|NCT00880620|58678185|FG000|Overall Study|Other|1|||
30664344|NCT00880620|58678186|FG001|Overall Study|Other|1|||
30958316|NCT02689206|59023610|FG004|Overall Study|Adverse Event|2|||
30958317|NCT02689206|59023606|FG000|Overall Study|Protocol Violation|1|||
30664345|NCT00880620|58678187|FG002|Overall Study|Other|2|||
30664346|NCT00880620|58678188|FG003|Overall Study|Other|2|||
30958318|NCT02689206|59023607|FG001|Overall Study|Protocol Violation|0|||
30958319|NCT02689206|59023608|FG002|Overall Study|Protocol Violation|0|||
30958320|NCT02689206|59023609|FG003|Overall Study|Protocol Violation|1|||
30958321|NCT02689206|59023610|FG004|Overall Study|Protocol Violation|2|||
30958322|NCT02689206|59023606|FG000|Overall Study|Other: Reached stopping criteria|0|||
30958323|NCT02689206|59023607|FG001|Overall Study|Other: Reached stopping criteria|1|||
30958324|NCT02689206|59023608|FG002|Overall Study|Other: Reached stopping criteria|2|||
30958325|NCT02689206|59023609|FG003|Overall Study|Other: Reached stopping criteria|3|||
30958326|NCT02689206|59023610|FG004|Overall Study|Other: Reached stopping criteria|4|||
30779782|NCT03004924|58791476|FG002|Overall Study|Lost to Follow-up|4|||
30779783|NCT03004924|58791474|FG000|Overall Study|Lack of Efficacy|2|||
30779784|NCT03004924|58791475|FG001|Overall Study|Lack of Efficacy|4|||
30779785|NCT03004924|58791476|FG002|Overall Study|Lack of Efficacy|2|||
30779786|NCT03004924|58791474|FG000|Overall Study|Physician Decision|1|||
30779787|NCT03004924|58791475|FG001|Overall Study|Physician Decision|0|||
30779788|NCT03004924|58791476|FG002|Overall Study|Physician Decision|1|||
30779789|NCT03004924|58791474|FG000|Overall Study|Withdrawal by parent/guardian|1|||
30779790|NCT03004924|58791475|FG001|Overall Study|Withdrawal by parent/guardian|0|||
30854781|NCT02337946|58882194|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
30854782|NCT02337946|58882195|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
30854783|NCT02337946|58882196|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
30854784|NCT02337946|58882194|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
30854785|NCT02337946|58882195|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
30854786|NCT02337946|58882196|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
30854787|NCT02337946|58882194|FG000|In-between Period|Without Informed Consent|1|||
30854788|NCT02337946|58882195|FG001|In-between Period|Without Informed Consent|0|||
30854789|NCT02337946|58882196|FG002|In-between Period|Without Informed Consent|0|||
30854790|NCT02337946|58882194|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
30854791|NCT02337946|58882195|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
30958327|NCT02689206|59023606|FG000|Overall Study|Physician Decision|1|||
30779791|NCT03004924|58791476|FG002|Overall Study|Withdrawal by parent/guardian|2|||
30779792|NCT03004924|58791474|FG000|Overall Study|Screen Failure|1|||
30958328|NCT02689206|59023607|FG001|Overall Study|Physician Decision|0|||
30958329|NCT02689206|59023608|FG002|Overall Study|Physician Decision|0|||
30779793|NCT03004924|58791475|FG001|Overall Study|Screen Failure|0|||
30779794|NCT03004924|58791476|FG002|Overall Study|Screen Failure|0|||
30779795|NCT03004924|58791474|FG000|Overall Study|Pregnancy|0|||
30779796|NCT03004924|58791475|FG001|Overall Study|Pregnancy|1|||
30779797|NCT03004924|58791476|FG002|Overall Study|Pregnancy|0|||
30958330|NCT02689206|59023609|FG003|Overall Study|Physician Decision|0|||
30958331|NCT02689206|59023610|FG004|Overall Study|Physician Decision|0|||
30779798|NCT03004924|58791474|FG000|Overall Study|Terminated by Sponsor|0|||
30779799|NCT03004924|58791475|FG001|Overall Study|Terminated by Sponsor|0|||
30779800|NCT03004924|58791476|FG002|Overall Study|Terminated by Sponsor|1|||
30779801|NCT03004924|58791474|FG000|Overall Study|Missed Study Visit|0|||
30779802|NCT03004924|58791475|FG001|Overall Study|Missed Study Visit|0|||
30958332|NCT02689206|59023606|FG000|Overall Study|Withdrawal by Subject|1|||
30664347|NCT00881868|58678214|FG000|Overall Study|Adverse Event|0|||
30664348|NCT00881868|58678215|FG001|Overall Study|Adverse Event|1|||
30664349|NCT00881868|58678214|FG000|Overall Study|Lost to Follow-up|2|||
30664350|NCT00881868|58678215|FG001|Overall Study|Lost to Follow-up|1|||
30664351|NCT00881868|58678214|FG000|Overall Study|Physician Decision|4|||
30664352|NCT00881868|58678215|FG001|Overall Study|Physician Decision|0|||
30664353|NCT00881868|58678214|FG000|Overall Study|Protocol Violation|2|||
30664354|NCT00881868|58678215|FG001|Overall Study|Protocol Violation|0|||
30664355|NCT00881712|58678224|FG000|Overall Study|Death|1|||
30664356|NCT00881712|58678225|FG001|Overall Study|Death|0|||
30664357|NCT00881712|58678226|FG002|Overall Study|Death|0|||
30664358|NCT00881712|58678224|FG000|Overall Study|Withdrawal by Subject|1|||
30664359|NCT00881712|58678225|FG001|Overall Study|Withdrawal by Subject|0|||
30664360|NCT00881712|58678226|FG002|Overall Study|Withdrawal by Subject|0|||
30664361|NCT03955471|58678234|FG000|Overall Study|Death|22|||
30664362|NCT03955471|58678234|FG000|Overall Study|Lost to Follow-up|1|||
30664363|NCT03955471|58678234|FG000|Overall Study|Withdrawal by Subject|6|||
30664364|NCT03955471|58678234|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
30664365|NCT00880542|58678238|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
30664366|NCT00880542|58678238|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
30664367|NCT00880542|58678238|FG000|REP: Surgical Resection|progressive disease|1|||
30664368|NCT00885534|58678242|FG000|Overall Study|Patient deemed ineligible|1|||
30664369|NCT00885378|58678248|FG000|Overall Study|Lack of Efficacy|2|||
30664370|NCT00885378|58678249|FG001|Overall Study|Lack of Efficacy|2|||
30664371|NCT00885378|58678248|FG000|Overall Study|Withdrawal by Subject|1|||
30664372|NCT00885378|58678249|FG001|Overall Study|Withdrawal by Subject|2|||
30664373|NCT00885378|58678248|FG000|Overall Study|Lost to Follow-up|1|||
30664374|NCT00885378|58678249|FG001|Overall Study|Lost to Follow-up|2|||
30664375|NCT00885378|58678248|FG000|Overall Study|Poor/Noncompliance|2|||
30664376|NCT00885378|58678249|FG001|Overall Study|Poor/Noncompliance|2|||
30664377|NCT00885378|58678248|FG000|Overall Study|Protocol Violation|2|||
30664378|NCT00885378|58678249|FG001|Overall Study|Protocol Violation|0|||
30664379|NCT00545779|58678255|FG000|Overall Study|Violation of selection criteria at entry|8|||
30664380|NCT00545779|58678255|FG000|Overall Study|Other protocol violation|1|||
30664381|NCT00545779|58678255|FG000|Overall Study|Did not cooperate|7|||
30664382|NCT00545779|58678255|FG000|Overall Study|Withdrawal by Subject|20|||
30664383|NCT00545779|58678255|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
30664384|NCT00545779|58678255|FG000|Overall Study|Failure to return|3|||
30664385|NCT00597714|58678265|FG000|Overall Study|Death|56|||
30664386|NCT00597714|58678266|FG001|Overall Study|Death|46|||
30664387|NCT00597714|58678267|FG002|Overall Study|Death|0|||
30664388|NCT00597714|58678265|FG000|Overall Study|Recipient death|0|||
30664389|NCT00597714|58678266|FG001|Overall Study|Recipient death|0|||
30664390|NCT00597714|58678267|FG002|Overall Study|Recipient death|10|||
30664391|NCT03938857|58678280|FG000|Overall Study|Physician Decision|1|||
30664392|NCT03938857|58678281|FG001|Overall Study|Physician Decision|0|||
30664393|NCT03938857|58678282|FG002|Overall Study|Physician Decision|0|||
30664394|NCT03938857|58678283|FG003|Overall Study|Physician Decision|0|||
30664395|NCT00884832|58678295|FG000|Overall Study|Withdrawal by Subject|0|||
30664396|NCT00884832|58678296|FG001|Overall Study|Withdrawal by Subject|1|||
30664397|NCT03938545|58678306|FG000|Overall Study|Lost to Follow-up|0|||
30664398|NCT03938545|58678307|FG001|Overall Study|Lost to Follow-up|0|||
30664399|NCT03938545|58678308|FG002|Overall Study|Lost to Follow-up|0|||
30664400|NCT03938545|58678309|FG003|Overall Study|Lost to Follow-up|1|||
30664401|NCT03938545|58678306|FG000|Overall Study|Non-compliance with study drug|0|||
30779803|NCT03004924|58791476|FG002|Overall Study|Missed Study Visit|2|||
30779804|NCT03004924|58791474|FG000|Overall Study|HSV1 Positive|1|||
30779805|NCT03004924|58791475|FG001|Overall Study|HSV1 Positive|0|||
30779806|NCT03004924|58791476|FG002|Overall Study|HSV1 Positive|0|||
30779807|NCT03002038|58791487|FG000|Overall Study|Adverse Event|3|||
30779808|NCT03002038|58791488|FG001|Overall Study|Adverse Event|1|||
30958333|NCT02689206|59023607|FG001|Overall Study|Withdrawal by Subject|0|||
30664402|NCT03938545|58678307|FG001|Overall Study|Non-compliance with study drug|0|||
30854792|NCT02337946|58882196|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
30854793|NCT02337946|58882194|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
30854794|NCT02337946|58882195|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
30854795|NCT02337946|58882196|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
30854796|NCT02337946|58882194|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
30854797|NCT02337946|58882195|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
30854798|NCT02337946|58882196|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
30854799|NCT02337946|58882194|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
30779809|NCT03002038|58791487|FG000|Overall Study|Withdrawal by Subject|8|||
30779810|NCT03002038|58791488|FG001|Overall Study|Withdrawal by Subject|4|||
30779811|NCT03002038|58791487|FG000|Overall Study|Immigration to another region|0|||
30779812|NCT03002038|58791488|FG001|Overall Study|Immigration to another region|2|||
30779813|NCT02911948|58791496|FG000|Overall Study|Protocol Violation|0|||
30779814|NCT02911948|58791497|FG001|Overall Study|Protocol Violation|1|||
30779815|NCT02911948|58791496|FG000|Overall Study|Withdrawal by Subject|0|||
30779816|NCT02911948|58791497|FG001|Overall Study|Withdrawal by Subject|2|||
30854800|NCT02337946|58882195|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
30854801|NCT02337946|58882196|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
30854802|NCT02337946|58882194|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
30854803|NCT02337946|58882195|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
30779817|NCT02911948|58791496|FG000|Overall Study|Lack of Efficacy|0|||
30664403|NCT03938545|58678308|FG002|Overall Study|Non-compliance with study drug|1|||
30664404|NCT03938545|58678309|FG003|Overall Study|Non-compliance with study drug|0|||
30664405|NCT03938545|58678306|FG000|Overall Study|Pregnancy|1|||
30779818|NCT02911948|58791497|FG001|Overall Study|Lack of Efficacy|1|||
30779819|NCT02911948|58791496|FG000|Overall Study|Unclassified|0|||
30779820|NCT02911948|58791497|FG001|Overall Study|Unclassified|3|||
30779821|NCT02996968|58791505|FG000|Overall Study|Withdrawal by Subject|1|||
30779822|NCT02996968|58791506|FG001|Overall Study|Withdrawal by Subject|0|||
30779823|NCT00027027|58791517|FG000|Overall Study|Adverse Event|0|||
30779824|NCT00027027|58791518|FG001|Overall Study|Adverse Event|0|||
30664406|NCT03938545|58678307|FG001|Overall Study|Pregnancy|0|||
30664407|NCT03938545|58678308|FG002|Overall Study|Pregnancy|0|||
30779825|NCT00027027|58791519|FG002|Overall Study|Adverse Event|1|||
30779826|NCT00027027|58791520|FG003|Overall Study|Adverse Event|0|||
30664408|NCT03938545|58678309|FG003|Overall Study|Pregnancy|0|||
30664409|NCT03938545|58678306|FG000|Overall Study|Study terminated by sponsor|6|||
30664410|NCT03938545|58678307|FG001|Overall Study|Study terminated by sponsor|4|||
30664411|NCT03938545|58678308|FG002|Overall Study|Study terminated by sponsor|2|||
30664412|NCT03938545|58678309|FG003|Overall Study|Study terminated by sponsor|4|||
30779827|NCT00027027|58791521|FG004|Overall Study|Adverse Event|1|||
30779828|NCT00027027|58791517|FG000|Overall Study|Admitted for Signs of PD|0|||
30779829|NCT00027027|58791518|FG001|Overall Study|Admitted for Signs of PD|0|||
30779830|NCT00027027|58791519|FG002|Overall Study|Admitted for Signs of PD|0|||
30779831|NCT00027027|58791520|FG003|Overall Study|Admitted for Signs of PD|0|||
30779832|NCT00027027|58791521|FG004|Overall Study|Admitted for Signs of PD|1|||
30779833|NCT00027027|58791517|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
30854804|NCT02337946|58882196|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
30854805|NCT02337946|58882194|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
30664413|NCT03938545|58678306|FG000|Overall Study|Withdrawal by Subject|0|||
30664414|NCT03938545|58678307|FG001|Overall Study|Withdrawal by Subject|1|||
30664415|NCT03938545|58678308|FG002|Overall Study|Withdrawal by Subject|0|||
30664416|NCT03938545|58678309|FG003|Overall Study|Withdrawal by Subject|0|||
30664417|NCT03938545|58678306|FG000|Overall Study|Adverse Event|1|||
30664418|NCT03938545|58678307|FG001|Overall Study|Adverse Event|0|||
30664419|NCT03938545|58678308|FG002|Overall Study|Adverse Event|0|||
30664420|NCT03938545|58678309|FG003|Overall Study|Adverse Event|0|||
30664421|NCT00879996|58678321|FG000|Overall Study|Lost to Follow-up|7|||
30664422|NCT00879996|58678322|FG001|Overall Study|Lost to Follow-up|6|||
30664423|NCT00879996|58678321|FG000|Overall Study|non-compliance|6|||
30664424|NCT00879996|58678322|FG001|Overall Study|non-compliance|4|||
30664425|NCT00879996|58678321|FG000|Overall Study|Physician Decision|1|||
30664426|NCT00879996|58678322|FG001|Overall Study|Physician Decision|2|||
30664427|NCT00879996|58678321|FG000|Overall Study|psychiatric problem|0|||
30664428|NCT00879996|58678322|FG001|Overall Study|psychiatric problem|1|||
30664429|NCT00879996|58678321|FG000|Overall Study|put on parole|1|||
30664430|NCT00879996|58678322|FG001|Overall Study|put on parole|0|||
30664431|NCT00873093|58678335|FG000|Overall Study|Adverse Event|0|||
30664432|NCT00873093|58678336|FG001|Overall Study|Adverse Event|2|||
30664433|NCT00873093|58678337|FG002|Overall Study|Adverse Event|0|||
30664434|NCT00873093|58678338|FG003|Overall Study|Adverse Event|0|||
30664435|NCT00873093|58678339|FG004|Overall Study|Adverse Event|0|||
30664436|NCT00873093|58678335|FG000|Overall Study|Death|0|||
30664437|NCT00873093|58678336|FG001|Overall Study|Death|3|||
30664438|NCT00873093|58678337|FG002|Overall Study|Death|2|||
30664439|NCT00873093|58678338|FG003|Overall Study|Death|0|||
30664440|NCT00873093|58678339|FG004|Overall Study|Death|0|||
30664441|NCT00873093|58678335|FG000|Overall Study|Physician Decision|0|||
30664442|NCT00873093|58678336|FG001|Overall Study|Physician Decision|17|||
30664443|NCT00873093|58678337|FG002|Overall Study|Physician Decision|10|||
30664444|NCT00873093|58678338|FG003|Overall Study|Physician Decision|10|||
30664445|NCT00873093|58678339|FG004|Overall Study|Physician Decision|2|||
30664446|NCT00873093|58678335|FG000|Overall Study|Withdrawal by Subject|1|||
30664447|NCT00873093|58678336|FG001|Overall Study|Withdrawal by Subject|4|||
30664448|NCT00873093|58678337|FG002|Overall Study|Withdrawal by Subject|4|||
30664449|NCT00873093|58678338|FG003|Overall Study|Withdrawal by Subject|0|||
30664450|NCT00873093|58678339|FG004|Overall Study|Withdrawal by Subject|0|||
30664451|NCT00873093|58678335|FG000|Overall Study|Ineligible|0|||
30664452|NCT00873093|58678336|FG001|Overall Study|Ineligible|1|||
30664453|NCT00873093|58678337|FG002|Overall Study|Ineligible|0|||
30664454|NCT00873093|58678338|FG003|Overall Study|Ineligible|1|||
30854806|NCT02337946|58882195|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
30854807|NCT02337946|58882196|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
30664455|NCT00873093|58678339|FG004|Overall Study|Ineligible|0|||
30664456|NCT00884286|58678363|FG000|Overall Study|Progressive disease|21|||
30664457|NCT00884286|58678364|FG001|Overall Study|Progressive disease|28|||
30958334|NCT02689206|59023608|FG002|Overall Study|Withdrawal by Subject|1|||
30958335|NCT02689206|59023609|FG003|Overall Study|Withdrawal by Subject|0|||
30958336|NCT02689206|59023610|FG004|Overall Study|Withdrawal by Subject|0|||
30958337|NCT01695239|59023630|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
30958338|NCT01695239|59023631|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
30958339|NCT01695239|59023632|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
30958340|NCT01695239|59023633|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
30958341|NCT01695239|59023634|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
30958342|NCT01695239|59023635|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
30958343|NCT01695239|59023636|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
30958344|NCT01695239|59023637|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
30958345|NCT01695239|59023638|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
30958346|NCT01695239|59023639|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
30958347|NCT01695239|59023640|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
30958348|NCT01695239|59023641|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
30664458|NCT00884286|58678363|FG000|Overall Study|Toxicity|4|||
30958349|NCT01695239|59023642|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
30958350|NCT01695239|59023643|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
30958351|NCT01695239|59023630|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
30958352|NCT01695239|59023631|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
30958353|NCT01695239|59023632|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
30958354|NCT01695239|59023633|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
30958355|NCT01695239|59023634|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
30958356|NCT01695239|59023635|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
30958357|NCT01695239|59023636|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
30958358|NCT01695239|59023637|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
30958359|NCT01695239|59023638|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
30958360|NCT01695239|59023639|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
30958361|NCT01695239|59023640|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
30664459|NCT00884286|58678364|FG001|Overall Study|Toxicity|1|||
30664460|NCT00884286|58678363|FG000|Overall Study|Death|2|||
30664461|NCT00884286|58678364|FG001|Overall Study|Death|2|||
30664462|NCT00884286|58678363|FG000|Overall Study|Physician Decision|1|||
30664463|NCT00884286|58678364|FG001|Overall Study|Physician Decision|0|||
30664464|NCT00884286|58678363|FG000|Overall Study|Septic shock|1|||
30664465|NCT00884286|58678364|FG001|Overall Study|Septic shock|0|||
30664466|NCT00884286|58678363|FG000|Overall Study|Thrombus in right auricle|1|||
30664467|NCT00884286|58678364|FG001|Overall Study|Thrombus in right auricle|0|||
30664468|NCT00884286|58678363|FG000|Overall Study|Not treated|2|||
30664469|NCT00884286|58678364|FG001|Overall Study|Not treated|1|||
30664470|NCT00884286|58678363|FG000|Overall Study|Comprised lung carcinoma|0|||
30664471|NCT00884286|58678364|FG001|Overall Study|Comprised lung carcinoma|1|||
30664472|NCT00873015|58678375|FG000|Overall Study|Withdrawal by Subject|0|||
30664473|NCT00873015|58678376|FG001|Overall Study|Withdrawal by Subject|1|||
30664474|NCT00873015|58678377|FG002|Overall Study|Withdrawal by Subject|0|||
30664475|NCT00873015|58678378|FG003|Overall Study|Withdrawal by Subject|0|||
30779834|NCT00027027|58791518|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
30779835|NCT00027027|58791519|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
30779836|NCT00027027|58791520|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
30664476|NCT03921151|58678393|FG000|Overall Study|Withdrawal by Subject|11|||
30664477|NCT03921151|58678394|FG001|Overall Study|Withdrawal by Subject|16|||
30779837|NCT00027027|58791521|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
30958362|NCT01695239|59023641|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
30664478|NCT00872001|58678406|FG000|Overall Study|Adverse Event|34|||
30664479|NCT00872001|58678407|FG001|Overall Study|Adverse Event|23|||
30664480|NCT00872001|58678406|FG000|Overall Study|Protocol Defined Clinical Event|5|||
30664481|NCT00872001|58678407|FG001|Overall Study|Protocol Defined Clinical Event|7|||
30958363|NCT01695239|59023642|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
30854808|NCT01369199|58882202|FG000|Overall Study|Withdrawal by Subject|1|||
30854809|NCT01369199|58882202|FG000|Overall Study|Lost to Follow-up|2|||
30958364|NCT01695239|59023643|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
30854810|NCT01368965|58882206|FG000|Overall Study|Lost to Follow-up|12|||
30958365|NCT01695239|59023630|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
30779838|NCT00027027|58791517|FG000|Overall Study|PD Requiring Surgery|0|||
30854811|NCT02610140|58882214|FG000|Randomization and Treatment Period|Radiological progression|23|||
30854812|NCT02610140|58882215|FG001|Randomization and Treatment Period|Radiological progression|15|||
30664482|NCT00872001|58678406|FG000|Overall Study|Lost to Follow-up|13|||
30664483|NCT00872001|58678407|FG001|Overall Study|Lost to Follow-up|12|||
30664484|NCT00872001|58678406|FG000|Overall Study|Withdrawal by Subject|18|||
30664485|NCT00872001|58678407|FG001|Overall Study|Withdrawal by Subject|30|||
30664486|NCT00872001|58678406|FG000|Overall Study|Protocol Violation|5|||
30664487|NCT00872001|58678407|FG001|Overall Study|Protocol Violation|8|||
30664488|NCT00872001|58678406|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
30664489|NCT00872001|58678407|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
30664490|NCT00872001|58678406|FG000|Overall Study|Administrative|23|||
30664491|NCT00872001|58678407|FG001|Overall Study|Administrative|15|||
30958366|NCT01695239|59023631|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30958367|NCT01695239|59023632|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
30958368|NCT01695239|59023633|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30958369|NCT01695239|59023634|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30958370|NCT01695239|59023635|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30664492|NCT00871923|58678415|FG000|Overall Study|Death|1|||
30664493|NCT00871923|58678415|FG000|Overall Study|Withdrawal by Subject|1|||
30664494|NCT03922945|58678422|FG000|Overall Study|Adverse Event|1|||
30664495|NCT03922945|58678423|FG001|Overall Study|Adverse Event|1|||
30664496|NCT03922945|58678424|FG002|Overall Study|Adverse Event|2|||
30664497|NCT03922945|58678422|FG000|Overall Study|Lost to Follow-up|13|||
30664498|NCT03922945|58678423|FG001|Overall Study|Lost to Follow-up|9|||
30664499|NCT03922945|58678424|FG002|Overall Study|Lost to Follow-up|20|||
30664500|NCT03922945|58678422|FG000|Overall Study|Lack of Efficacy|2|||
30664501|NCT03922945|58678423|FG001|Overall Study|Lack of Efficacy|0|||
30664502|NCT03922945|58678424|FG002|Overall Study|Lack of Efficacy|1|||
30664503|NCT03922945|58678422|FG000|Overall Study|Protocol Non-Compliance|0|||
30664504|NCT03922945|58678423|FG001|Overall Study|Protocol Non-Compliance|0|||
30664505|NCT03922945|58678424|FG002|Overall Study|Protocol Non-Compliance|1|||
30664506|NCT03922945|58678422|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
30664507|NCT03922945|58678423|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
30664508|NCT03922945|58678424|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
30664509|NCT03922945|58678422|FG000|Overall Study|All Other Personal Reasons|1|||
30664510|NCT03922945|58678423|FG001|Overall Study|All Other Personal Reasons|1|||
30664511|NCT03922945|58678424|FG002|Overall Study|All Other Personal Reasons|2|||
30664512|NCT03922477|58678435|FG000|Overall Study|Death|9|||
30664513|NCT03922477|58678435|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
30664514|NCT03922477|58678435|FG000|Overall Study|Physician Decision|1|||
30664515|NCT03922477|58678435|FG000|Overall Study|Withdrawal by Subject|2|||
30664516|NCT00867165|58678441|FG000|Overall Study|Adverse Event|3|||
30958371|NCT01695239|59023636|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30664517|NCT00867165|58678442|FG001|Overall Study|Adverse Event|0|||
30664518|NCT00867165|58678441|FG000|Overall Study|Withdrawal by Subject|1|||
30664519|NCT00867165|58678442|FG001|Overall Study|Withdrawal by Subject|0|||
30958372|NCT01695239|59023637|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30664520|NCT00867087|58678448|FG000|Overall Study|Other|1|||
30664521|NCT00867087|58678448|FG000|Overall Study|Withdrawal by Subject|4|||
30664522|NCT00867087|58678448|FG000|Overall Study|Death|37|||
30664523|NCT00545233|58678454|FG000|Overall Study|Adverse Event|10|||
30664524|NCT00545233|58678455|FG001|Overall Study|Adverse Event|5|||
30664525|NCT00545233|58678454|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
30664526|NCT00545233|58678455|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
30664527|NCT00545233|58678454|FG000|Overall Study|Protocol Violation|2|||
30664528|NCT00545233|58678455|FG001|Overall Study|Protocol Violation|0|||
30664529|NCT00545233|58678454|FG000|Overall Study|Refused Treatment|9|||
30664530|NCT00545233|58678455|FG001|Overall Study|Refused Treatment|7|||
30664531|NCT00545233|58678454|FG000|Overall Study|Failure to Return|4|||
30664532|NCT00545233|58678455|FG001|Overall Study|Failure to Return|6|||
30664533|NCT00545233|58678454|FG000|Overall Study|Insufficient response|14|||
30664534|NCT00545233|58678455|FG001|Overall Study|Insufficient response|15|||
30664535|NCT00545233|58678454|FG000|Overall Study|Physician Decision|2|||
30664536|NCT00545233|58678455|FG001|Overall Study|Physician Decision|1|||
30664537|NCT02393248|58678487|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664538|NCT02393248|58678488|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
30664539|NCT02393248|58678489|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664540|NCT02393248|58678490|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664541|NCT02393248|58678491|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664542|NCT02393248|58678492|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
30664543|NCT02393248|58678493|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
30664544|NCT02393248|58678494|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664545|NCT02393248|58678495|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664546|NCT02393248|58678496|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664547|NCT02393248|58678497|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664548|NCT02393248|58678498|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664549|NCT02393248|58678499|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664550|NCT02393248|58678500|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664551|NCT02393248|58678501|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664552|NCT02393248|58678502|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664553|NCT02393248|58678503|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664554|NCT02393248|58678504|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664555|NCT02393248|58678505|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664556|NCT02393248|58678506|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664557|NCT02393248|58678507|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664558|NCT02393248|58678508|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664559|NCT02393248|58678509|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664560|NCT02393248|58678510|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664561|NCT02393248|58678511|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
30664562|NCT02393248|58678487|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664563|NCT02393248|58678488|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
30664564|NCT02393248|58678489|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664565|NCT02393248|58678490|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664566|NCT02393248|58678491|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664567|NCT02393248|58678492|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664568|NCT02393248|58678493|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664569|NCT02393248|58678494|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664570|NCT02393248|58678495|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664571|NCT02393248|58678496|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664572|NCT02393248|58678497|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664573|NCT02393248|58678498|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664574|NCT02393248|58678499|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664575|NCT02393248|58678500|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664576|NCT02393248|58678501|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664577|NCT02393248|58678502|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664578|NCT02393248|58678503|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664579|NCT02393248|58678504|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664580|NCT02393248|58678505|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664581|NCT02393248|58678506|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664582|NCT02393248|58678507|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30779839|NCT00027027|58791518|FG001|Overall Study|PD Requiring Surgery|0|||
30779840|NCT00027027|58791519|FG002|Overall Study|PD Requiring Surgery|1|||
30779841|NCT00027027|58791520|FG003|Overall Study|PD Requiring Surgery|0|||
30779842|NCT00027027|58791521|FG004|Overall Study|PD Requiring Surgery|0|||
30779843|NCT00027027|58791517|FG000|Overall Study|Physician Decision Due To PD|2|||
30664583|NCT02393248|58678508|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664584|NCT02393248|58678509|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664585|NCT02393248|58678510|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664586|NCT02393248|58678511|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
30664587|NCT02393248|58678487|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
30664588|NCT02393248|58678488|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
30664589|NCT02393248|58678489|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
30664590|NCT02393248|58678490|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
30664591|NCT02393248|58678491|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
30664592|NCT02393248|58678492|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
30664593|NCT02393248|58678493|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
30664594|NCT02393248|58678494|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
30664595|NCT02393248|58678495|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
30664596|NCT02393248|58678496|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
30664597|NCT02393248|58678497|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
30664598|NCT02393248|58678498|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
30664599|NCT02393248|58678499|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
30664600|NCT02393248|58678500|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
30664601|NCT02393248|58678501|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
30664602|NCT02393248|58678502|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
30664603|NCT02393248|58678503|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
30664604|NCT02393248|58678504|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
30664605|NCT02393248|58678505|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
30664606|NCT02393248|58678506|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
30664607|NCT02393248|58678507|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
30664608|NCT02393248|58678508|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
30664609|NCT02393248|58678509|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
30664610|NCT02393248|58678510|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
30664611|NCT02393248|58678511|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
30664612|NCT02393248|58678487|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
30664613|NCT02393248|58678488|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664614|NCT02393248|58678489|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664615|NCT02393248|58678490|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664616|NCT02393248|58678491|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664617|NCT02393248|58678492|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664618|NCT02393248|58678493|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30958373|NCT01695239|59023638|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30958374|NCT01695239|59023639|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30958375|NCT01695239|59023640|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30958376|NCT01695239|59023641|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30958377|NCT01695239|59023642|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30958378|NCT01695239|59023643|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30958379|NCT01695239|59023630|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
30958380|NCT01695239|59023631|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
30958381|NCT01695239|59023632|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
30958382|NCT01695239|59023633|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30958383|NCT01695239|59023634|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30958384|NCT01695239|59023635|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30958385|NCT01695239|59023636|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30958386|NCT01695239|59023637|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30958387|NCT01695239|59023638|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30958388|NCT01695239|59023639|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30958389|NCT01695239|59023640|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30958390|NCT01695239|59023641|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30958391|NCT01695239|59023642|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30958392|NCT01695239|59023643|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30958393|NCT01695239|59023630|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
30958394|NCT01695239|59023631|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30664619|NCT02393248|58678494|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664620|NCT02393248|58678495|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664621|NCT02393248|58678496|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30854813|NCT02610140|58882214|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
30854814|NCT02610140|58882215|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
30854815|NCT02610140|58882214|FG000|Randomization and Treatment Period|Protocol Violation|1|||
30664622|NCT02393248|58678497|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664623|NCT02393248|58678498|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664624|NCT02393248|58678499|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664625|NCT02393248|58678500|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664626|NCT02393248|58678501|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664627|NCT02393248|58678502|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664628|NCT02393248|58678503|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664629|NCT02393248|58678504|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664630|NCT02393248|58678505|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664631|NCT02393248|58678506|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664632|NCT02393248|58678507|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664633|NCT02393248|58678508|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664634|NCT02393248|58678509|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664635|NCT02393248|58678510|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664636|NCT02393248|58678511|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
30664637|NCT02393248|58678487|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664638|NCT02393248|58678488|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664639|NCT02393248|58678489|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664640|NCT02393248|58678490|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664641|NCT02393248|58678491|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664642|NCT02393248|58678492|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
30664643|NCT02393248|58678493|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
30664644|NCT02393248|58678494|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664645|NCT02393248|58678495|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664646|NCT02393248|58678496|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
30664647|NCT02393248|58678497|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664648|NCT02393248|58678498|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664649|NCT02393248|58678499|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664650|NCT02393248|58678500|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30958395|NCT01695239|59023632|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
30958396|NCT01695239|59023633|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30779844|NCT00027027|58791518|FG001|Overall Study|Physician Decision Due To PD|3|||
30854816|NCT02610140|58882215|FG001|Randomization and Treatment Period|Protocol Violation|0|||
30854817|NCT02610140|58882214|FG000|Randomization and Treatment Period|Physician Decision|0|||
30854818|NCT02610140|58882215|FG001|Randomization and Treatment Period|Physician Decision|1|||
30664651|NCT02393248|58678501|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664652|NCT02393248|58678502|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664653|NCT02393248|58678503|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664654|NCT02393248|58678504|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664655|NCT02393248|58678505|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664656|NCT02393248|58678506|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664657|NCT02393248|58678507|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664658|NCT02393248|58678508|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664659|NCT02393248|58678509|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664660|NCT02393248|58678510|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664661|NCT02393248|58678511|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
30664662|NCT02393248|58678487|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664663|NCT02393248|58678488|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664664|NCT02393248|58678489|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664665|NCT02393248|58678490|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664666|NCT02393248|58678491|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664667|NCT02393248|58678492|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664668|NCT02393248|58678493|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
30664669|NCT02393248|58678494|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664670|NCT02393248|58678495|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664671|NCT02393248|58678496|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664672|NCT02393248|58678497|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664673|NCT02393248|58678498|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664674|NCT02393248|58678499|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664675|NCT02393248|58678500|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664676|NCT02393248|58678501|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664677|NCT02393248|58678502|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664678|NCT02393248|58678503|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664679|NCT02393248|58678504|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664680|NCT02393248|58678505|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664681|NCT02393248|58678506|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664682|NCT02393248|58678507|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664683|NCT02393248|58678508|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664684|NCT02393248|58678509|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664685|NCT02393248|58678510|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664686|NCT02393248|58678511|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
30664687|NCT02393248|58678487|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664688|NCT02393248|58678488|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664689|NCT02393248|58678489|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664690|NCT02393248|58678490|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664691|NCT02393248|58678491|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664692|NCT02393248|58678492|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664693|NCT02393248|58678493|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664694|NCT02393248|58678494|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664695|NCT02393248|58678495|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664696|NCT02393248|58678496|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30779845|NCT00027027|58791519|FG002|Overall Study|Physician Decision Due To PD|2|||
30664697|NCT02393248|58678497|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664698|NCT02393248|58678498|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
30854819|NCT02610140|58882214|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
30854820|NCT02610140|58882215|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
30854821|NCT02610140|58882214|FG000|Randomization and Treatment Period|Death|7|||
30854822|NCT02610140|58882215|FG001|Randomization and Treatment Period|Death|1|||
30854823|NCT02610140|58882214|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
30854824|NCT02610140|58882215|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
30854825|NCT02610140|58882214|FG000|Randomization and Treatment Period|Adverse Event|44|||
30854826|NCT02610140|58882215|FG001|Randomization and Treatment Period|Adverse Event|13|||
30854827|NCT02610140|58882214|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
30854828|NCT02610140|58882215|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
30854829|NCT02610140|58882214|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
30854830|NCT02610140|58882215|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
30854831|NCT02610140|58882214|FG000|Randomization and Treatment Period|Not treated|3|||
30854832|NCT02610140|58882215|FG001|Randomization and Treatment Period|Not treated|10|||
30854833|NCT02610140|58882214|FG000|Safety Follow-up|Other|0|||
30854834|NCT02610140|58882215|FG001|Safety Follow-up|Other|2|||
30854835|NCT02610140|58882214|FG000|Safety Follow-up|Lost to Follow-up|1|||
30854836|NCT02610140|58882215|FG001|Safety Follow-up|Lost to Follow-up|0|||
30854837|NCT02610140|58882214|FG000|Safety Follow-up|No follow-up|5|||
30854838|NCT02610140|58882215|FG001|Safety Follow-up|No follow-up|3|||
30854839|NCT02610140|58882214|FG000|Safety Follow-up|Death|12|||
30854840|NCT02610140|58882215|FG001|Safety Follow-up|Death|2|||
30854841|NCT02610140|58882214|FG000|Safety Follow-up|Deterioration of general conditions|15|||
30854842|NCT02610140|58882215|FG001|Safety Follow-up|Deterioration of general conditions|5|||
30854843|NCT02610140|58882214|FG000|Safety Follow-up|Withdrawal by Subject|12|||
30854844|NCT02610140|58882215|FG001|Safety Follow-up|Withdrawal by Subject|12|||
30854845|NCT02610140|58882214|FG000|Active Follow-up|Progressive disease - radiological|30|||
30854846|NCT02610140|58882215|FG001|Active Follow-up|Progressive disease - radiological|22|||
30854847|NCT02610140|58882214|FG000|Active Follow-up|Death|8|||
30854848|NCT02610140|58882215|FG001|Active Follow-up|Death|1|||
30854849|NCT02610140|58882214|FG000|Active Follow-up|Withdrawal by Subject|4|||
30854850|NCT02610140|58882215|FG001|Active Follow-up|Withdrawal by Subject|0|||
30854851|NCT02610140|58882214|FG000|Active Follow-up|Progressive disease - clinical|1|||
30854852|NCT02610140|58882215|FG001|Active Follow-up|Progressive disease - clinical|2|||
30854853|NCT02610140|58882214|FG000|Active Follow-up|Deterioration of general conditions|1|||
30854854|NCT02610140|58882215|FG001|Active Follow-up|Deterioration of general conditions|0|||
30854855|NCT02610140|58882214|FG000|Active Follow-up|Ongoing but not completed|4|||
30854856|NCT02610140|58882215|FG001|Active Follow-up|Ongoing but not completed|1|||
30854857|NCT02610140|58882214|FG000|Long-term Follow-up|Death|86|||
30854858|NCT02610140|58882215|FG001|Long-term Follow-up|Death|44|||
30854859|NCT02610140|58882214|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
30854860|NCT02610140|58882215|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
30854861|NCT02610140|58882214|FG000|Long-term Follow-up|Lost to Follow-up|1|||
30854862|NCT02610140|58882215|FG001|Long-term Follow-up|Lost to Follow-up|2|||
30854863|NCT02610140|58882214|FG000|Long-term Follow-up|Ongoing but not completed|30|||
30854864|NCT02610140|58882215|FG001|Long-term Follow-up|Ongoing but not completed|17|||
30854865|NCT02789657|58882225|FG000|Overall Study|Withdrawal by Subject|2|||
30854866|NCT02789657|58882226|FG001|Overall Study|Withdrawal by Subject|0|||
30958397|NCT01695239|59023634|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30958398|NCT01695239|59023635|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30854867|NCT02789657|58882227|FG002|Overall Study|Withdrawal by Subject|0|||
30854868|NCT02789657|58882228|FG003|Overall Study|Withdrawal by Subject|0|||
30854869|NCT02609984|58882239|FG000|Overall Study|Death|29|||
30854870|NCT02609984|58882240|FG001|Overall Study|Death|26|||
30854871|NCT02609984|58882239|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
30854872|NCT02609984|58882240|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
30854873|NCT02609984|58882239|FG000|Overall Study|Lost to Follow-up|1|||
30854874|NCT02609984|58882240|FG001|Overall Study|Lost to Follow-up|2|||
30854875|NCT02609984|58882239|FG000|Overall Study|Withdrawal by Subject|0|||
30854876|NCT02609984|58882240|FG001|Overall Study|Withdrawal by Subject|1|||
30854877|NCT02609984|58882239|FG000|Overall Study|Disease Progression|2|||
30958399|NCT01695239|59023636|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30854878|NCT02609984|58882240|FG001|Overall Study|Disease Progression|0|||
30854879|NCT02609672|58882248|FG000|Overall Study|Lost to Follow-up|3|||
30854880|NCT02609672|58882249|FG001|Overall Study|Lost to Follow-up|1|||
30854881|NCT02611778|58882257|FG000|Overall Study|Withdrawal by Subject|2|||
30854882|NCT02611778|58882258|FG001|Overall Study|Withdrawal by Subject|8|||
30854883|NCT02611778|58882257|FG000|Overall Study|Adverse Event|1|||
30854884|NCT02611778|58882258|FG001|Overall Study|Adverse Event|2|||
30854885|NCT02611778|58882257|FG000|Overall Study|Death|2|||
30854886|NCT02611778|58882258|FG001|Overall Study|Death|1|||
30854887|NCT02611778|58882257|FG000|Overall Study|Protocol Violation|1|||
30854888|NCT02611778|58882258|FG001|Overall Study|Protocol Violation|0|||
30854889|NCT02611778|58882257|FG000|Overall Study|Lost to Follow-up|3|||
30854890|NCT02611778|58882258|FG001|Overall Study|Lost to Follow-up|1|||
30854891|NCT02611778|58882257|FG000|Overall Study|Need for alternative treatment|1|||
30854892|NCT02611778|58882258|FG001|Overall Study|Need for alternative treatment|0|||
30854893|NCT02611778|58882257|FG000|Overall Study|Other Reason|2|||
30854894|NCT02611778|58882258|FG001|Overall Study|Other Reason|1|||
30854895|NCT02711553|58882269|FG000|Overall Study|Withdrawal by Subject|2|||
30854896|NCT02711553|58882270|FG001|Overall Study|Withdrawal by Subject|1|||
30854897|NCT02711553|58882271|FG002|Overall Study|Withdrawal by Subject|1|||
30854898|NCT02711553|58882272|FG003|Overall Study|Withdrawal by Subject|0|||
30854899|NCT02711553|58882269|FG000|Overall Study|Lost to Follow-up|3|||
30854900|NCT02711553|58882270|FG001|Overall Study|Lost to Follow-up|3|||
30854901|NCT02711553|58882271|FG002|Overall Study|Lost to Follow-up|6|||
30854902|NCT02711553|58882272|FG003|Overall Study|Lost to Follow-up|3|||
30854903|NCT02711553|58882269|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
30854904|NCT02711553|58882270|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
30854905|NCT02711553|58882271|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
30854906|NCT02711553|58882272|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
30854907|NCT02709369|58882284|FG000|Overall Study|Lost to Follow-up|15|||
30854908|NCT02709369|58882284|FG000|Overall Study|Withdrawal by Subject|10|||
30854909|NCT02709369|58882284|FG000|Overall Study|Did not received intervention|2|||
30854910|NCT02613182|58882288|FG000|Overall Study|Death|6|||
30854911|NCT02613182|58882288|FG000|Overall Study|Physician Decision|1|||
30854912|NCT02613182|58882288|FG000|Overall Study|Study Terminated by Sponsor|21|||
30854913|NCT02613182|58882288|FG000|Overall Study|Withdrawal by Subject|6|||
30854914|NCT02610842|58882292|FG000|Overall Study|Lost to Follow-up|5|||
30854915|NCT01648582|58882301|FG000|Overall Study|Adverse Event|6|||
30854916|NCT01648582|58882302|FG001|Overall Study|Adverse Event|11|||
30854917|NCT01648582|58882303|FG002|Overall Study|Adverse Event|2|||
30854918|NCT01648582|58882301|FG000|Overall Study|Lost to Follow-up|9|||
30854919|NCT01648582|58882302|FG001|Overall Study|Lost to Follow-up|6|||
30854920|NCT01648582|58882303|FG002|Overall Study|Lost to Follow-up|8|||
30779846|NCT00027027|58791520|FG003|Overall Study|Physician Decision Due To PD|3|||
30779847|NCT00027027|58791521|FG004|Overall Study|Physician Decision Due To PD|5|||
30779848|NCT00027027|58791517|FG000|Overall Study|Withdrawal by Subject|0|||
30779849|NCT00027027|58791518|FG001|Overall Study|Withdrawal by Subject|0|||
30779850|NCT00027027|58791519|FG002|Overall Study|Withdrawal by Subject|0|||
30779851|NCT00027027|58791520|FG003|Overall Study|Withdrawal by Subject|0|||
30779852|NCT00027027|58791521|FG004|Overall Study|Withdrawal by Subject|1|||
30779853|NCT00046839|58791539|FG000|Overall Study|Ineligible / No protocol treatment|0|||
30779854|NCT00046839|58791540|FG001|Overall Study|Ineligible / No protocol treatment|2|||
30779855|NCT00046839|58791539|FG000|Overall Study|Withdrawal of consent|1|||
30779856|NCT00046839|58791540|FG001|Overall Study|Withdrawal of consent|0|||
30854921|NCT01648582|58882301|FG000|Overall Study|Protocol Violation|1|||
30854922|NCT01648582|58882302|FG001|Overall Study|Protocol Violation|2|||
30779857|NCT00006903|58791549|FG000|Overall Study|Still receiving treatment|0|||
30779858|NCT00006903|58791550|FG001|Overall Study|Still receiving treatment|0|||
30854923|NCT01648582|58882303|FG002|Overall Study|Protocol Violation|1|||
30958400|NCT01695239|59023637|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30854924|NCT01648582|58882301|FG000|Overall Study|Withdrawal by Subject|15|||
30854925|NCT01648582|58882302|FG001|Overall Study|Withdrawal by Subject|17|||
30854926|NCT01648582|58882303|FG002|Overall Study|Withdrawal by Subject|17|||
30854927|NCT01648582|58882301|FG000|Overall Study|Physician Decision|0|||
30664699|NCT02393248|58678499|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
30854928|NCT01648582|58882302|FG001|Overall Study|Physician Decision|1|||
30854929|NCT01648582|58882303|FG002|Overall Study|Physician Decision|3|||
30854930|NCT01648582|58882301|FG000|Overall Study|Death|1|||
30854931|NCT01648582|58882302|FG001|Overall Study|Death|0|||
30854932|NCT01648582|58882303|FG002|Overall Study|Death|0|||
30854933|NCT01648582|58882301|FG000|Overall Study|Sponsor Decision|0|||
30854934|NCT01648582|58882302|FG001|Overall Study|Sponsor Decision|1|||
30854935|NCT01648582|58882303|FG002|Overall Study|Sponsor Decision|1|||
30854936|NCT02607800|58882316|FG000|Overall Study|Lost to Follow-up|7|||
30854937|NCT02607800|58882317|FG001|Overall Study|Lost to Follow-up|10|||
30854938|NCT02607800|58882316|FG000|Overall Study|Withdrew Consent|2|||
30854939|NCT02607800|58882317|FG001|Overall Study|Withdrew Consent|0|||
30854940|NCT02607800|58882316|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
30854941|NCT02607800|58882317|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
30854942|NCT02304484|58882324|FG000|Overall Study|Death|9|||
30854943|NCT02304484|58882324|FG000|Overall Study|Withdrawal by Subject|14|||
30854944|NCT02304484|58882324|FG000|Overall Study|Lost to Follow-up|2|||
30854945|NCT02708355|58882331|FG000|Overall Study|Adverse Event|1|||
30854946|NCT02708355|58882332|FG001|Overall Study|Adverse Event|0|||
30854947|NCT02708355|58882333|FG002|Overall Study|Adverse Event|0|||
30854948|NCT02708277|58882343|FG000|Overall Study|Lost to Follow-up|7|||
30664700|NCT02393248|58678500|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
30664701|NCT02393248|58678501|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
30664702|NCT02393248|58678502|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664703|NCT02393248|58678503|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664704|NCT02393248|58678504|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664705|NCT02393248|58678505|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664706|NCT02393248|58678506|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664707|NCT02393248|58678507|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664708|NCT02393248|58678508|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664709|NCT02393248|58678509|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664710|NCT02393248|58678510|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664711|NCT02393248|58678511|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
30664712|NCT02393248|58678487|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664713|NCT02393248|58678488|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664714|NCT02393248|58678489|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664715|NCT02393248|58678490|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664716|NCT02393248|58678491|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664717|NCT02393248|58678492|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664718|NCT02393248|58678493|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664719|NCT02393248|58678494|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664720|NCT02393248|58678495|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664721|NCT02393248|58678496|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664722|NCT02393248|58678497|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
30664723|NCT02393248|58678498|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
30664724|NCT02393248|58678499|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664725|NCT02393248|58678500|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664726|NCT02393248|58678501|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664727|NCT02393248|58678502|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664728|NCT02393248|58678503|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664729|NCT02393248|58678504|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664730|NCT02393248|58678505|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664731|NCT02393248|58678506|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664732|NCT02393248|58678507|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664733|NCT02393248|58678508|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664734|NCT02393248|58678509|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664735|NCT02393248|58678510|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664736|NCT02393248|58678511|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
30664737|NCT02393248|58678487|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
30664738|NCT02393248|58678488|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
30664739|NCT02393248|58678489|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
30664740|NCT02393248|58678490|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
30664741|NCT02393248|58678491|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
30664742|NCT02393248|58678492|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
30664743|NCT02393248|58678493|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
30664744|NCT02393248|58678494|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
30664745|NCT02393248|58678495|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
30664746|NCT02393248|58678496|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
30664747|NCT02393248|58678497|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
30664748|NCT02393248|58678498|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
30664749|NCT02393248|58678499|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
30664750|NCT02393248|58678500|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
30664751|NCT02393248|58678501|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
30664752|NCT02393248|58678502|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
30664753|NCT02393248|58678503|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
30664754|NCT02393248|58678504|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
30664755|NCT02393248|58678505|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
30664756|NCT02393248|58678506|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
30664757|NCT02393248|58678507|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
30664758|NCT02393248|58678508|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
30664759|NCT02393248|58678509|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
30854949|NCT02708277|58882344|FG001|Overall Study|Lost to Follow-up|4|||
30664760|NCT02393248|58678510|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
30664761|NCT02393248|58678511|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
30664762|NCT02393248|58678487|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664763|NCT02393248|58678488|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664764|NCT02393248|58678489|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664765|NCT02393248|58678490|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664766|NCT02393248|58678491|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664767|NCT02393248|58678492|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664768|NCT02393248|58678493|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664769|NCT02393248|58678494|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664770|NCT02393248|58678495|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664771|NCT02393248|58678496|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664772|NCT02393248|58678497|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664773|NCT02393248|58678498|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
30664774|NCT02393248|58678499|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664775|NCT02393248|58678500|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
30664776|NCT02393248|58678501|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664777|NCT02393248|58678502|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30854950|NCT02337478|58882350|FG000|Overall Study|Lack of Efficacy|5|||
30854951|NCT02303704|58882356|FG000|Overall Study|Protocol Violation|5|||
30854952|NCT02303704|58882357|FG001|Overall Study|Protocol Violation|9|||
30854953|NCT02608892|58882365|FG000|Overall Study|Lost to Follow-up|1|||
30854954|NCT02608892|58882366|FG001|Overall Study|Lost to Follow-up|0|||
30854955|NCT02706951|58882376|FG000|Overall Study|Adverse Event|1|||
30854956|NCT02706951|58882377|FG001|Overall Study|Adverse Event|5|||
30854957|NCT02706951|58882378|FG002|Overall Study|Adverse Event|3|||
30854958|NCT02706951|58882376|FG000|Overall Study|Withdrawal by Subject|11|||
30854959|NCT02706951|58882377|FG001|Overall Study|Withdrawal by Subject|6|||
30854960|NCT02706951|58882378|FG002|Overall Study|Withdrawal by Subject|6|||
30854961|NCT02706951|58882376|FG000|Overall Study|Lost to Follow-up|0|||
30854962|NCT02706951|58882377|FG001|Overall Study|Lost to Follow-up|4|||
30854963|NCT02706951|58882378|FG002|Overall Study|Lost to Follow-up|1|||
30854964|NCT02706951|58882376|FG000|Overall Study|Other|2|||
30854965|NCT02706951|58882377|FG001|Overall Study|Other|1|||
30854966|NCT02706951|58882378|FG002|Overall Study|Other|0|||
30664778|NCT02393248|58678503|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664779|NCT02393248|58678504|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30854967|NCT02708121|58882388|FG000|Overall Study|Withdrawn by Study Team|1|||
30854968|NCT02708121|58882389|FG001|Overall Study|Withdrawn by Study Team|1|||
30854969|NCT02708121|58882388|FG000|Overall Study|Withdrawal by Subject|0|||
30854970|NCT02708121|58882389|FG001|Overall Study|Withdrawal by Subject|4|||
30664780|NCT02393248|58678505|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664781|NCT02393248|58678506|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664782|NCT02393248|58678507|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30854971|NCT02707965|58882404|FG000|Overall Study|Withdrawal by Subject|0|||
30854972|NCT02707965|58882405|FG001|Overall Study|Withdrawal by Subject|0|||
30854973|NCT02707965|58882406|FG002|Overall Study|Withdrawal by Subject|1|||
30854974|NCT02707965|58882407|FG003|Overall Study|Withdrawal by Subject|0|||
30854975|NCT02707965|58882408|FG004|Overall Study|Withdrawal by Subject|0|||
30854976|NCT02707965|58882409|FG005|Overall Study|Withdrawal by Subject|0|||
30664783|NCT02393248|58678508|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664784|NCT02393248|58678509|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30779859|NCT00006903|58791551|FG002|Overall Study|Still receiving treatment|1|||
30664785|NCT02393248|58678510|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664786|NCT02393248|58678511|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
30664787|NCT02393248|58678487|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30779860|NCT00006903|58791549|FG000|Overall Study|Refused further treatment|0|||
30779861|NCT00006903|58791550|FG001|Overall Study|Refused further treatment|2|||
30779862|NCT00006903|58791551|FG002|Overall Study|Refused further treatment|1|||
30958401|NCT01695239|59023638|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30958402|NCT01695239|59023639|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30664788|NCT02393248|58678488|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30779863|NCT00006903|58791549|FG000|Overall Study|Adverse Event|0|||
30779864|NCT00006903|58791550|FG001|Overall Study|Adverse Event|0|||
30779865|NCT00006903|58791551|FG002|Overall Study|Adverse Event|1|||
30779866|NCT00006903|58791549|FG000|Overall Study|Death|0|||
30779867|NCT00006903|58791550|FG001|Overall Study|Death|1|||
30779868|NCT00006903|58791551|FG002|Overall Study|Death|0|||
30779869|NCT00006903|58791549|FG000|Overall Study|Patient never treated|0|||
30958403|NCT01695239|59023640|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30854977|NCT02707965|58882410|FG006|Overall Study|Withdrawal by Subject|0|||
30854978|NCT02707965|58882411|FG007|Overall Study|Withdrawal by Subject|2|||
30958404|NCT01695239|59023641|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30958405|NCT01695239|59023642|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30958406|NCT01695239|59023643|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
30958407|NCT01695239|59023630|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
30958408|NCT01695239|59023631|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958409|NCT01695239|59023632|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
30958410|NCT01695239|59023633|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958411|NCT01695239|59023634|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958412|NCT01695239|59023635|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958413|NCT01695239|59023636|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958414|NCT01695239|59023637|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958415|NCT01695239|59023638|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958416|NCT01695239|59023639|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958417|NCT01695239|59023640|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958418|NCT01695239|59023641|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958419|NCT01695239|59023642|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958420|NCT01695239|59023643|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30958421|NCT01695239|59023630|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
30958422|NCT01695239|59023631|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958423|NCT01695239|59023632|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958424|NCT01695239|59023633|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958425|NCT01695239|59023634|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958426|NCT01695239|59023635|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958427|NCT01695239|59023636|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958428|NCT01695239|59023637|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958429|NCT01695239|59023638|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958430|NCT01695239|59023639|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958431|NCT01695239|59023640|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958432|NCT01695239|59023641|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958433|NCT01695239|59023642|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958434|NCT01695239|59023643|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30958435|NCT01695239|59023630|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958436|NCT01695239|59023631|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958437|NCT01695239|59023632|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958438|NCT01695239|59023633|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958439|NCT01695239|59023634|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958440|NCT01695239|59023635|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958441|NCT01695239|59023636|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958442|NCT01695239|59023637|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
30958443|NCT01695239|59023638|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958444|NCT01695239|59023639|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958445|NCT01695239|59023640|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958446|NCT01695239|59023641|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958447|NCT01695239|59023642|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958448|NCT01695239|59023643|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
30958449|NCT01695239|59023630|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958450|NCT01695239|59023631|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30854979|NCT02707965|58882412|FG008|Overall Study|Withdrawal by Subject|0|||
30854980|NCT02707965|58882413|FG009|Overall Study|Withdrawal by Subject|0|||
30854981|NCT02707965|58882414|FG010|Overall Study|Withdrawal by Subject|0|||
30854982|NCT02707965|58882415|FG011|Overall Study|Withdrawal by Subject|0|||
30854983|NCT02707965|58882416|FG012|Overall Study|Withdrawal by Subject|0|||
30854984|NCT02707965|58882417|FG013|Overall Study|Withdrawal by Subject|0|||
30854985|NCT02707965|58882418|FG014|Overall Study|Withdrawal by Subject|0|||
30854986|NCT02707965|58882419|FG015|Overall Study|Withdrawal by Subject|0|||
30854987|NCT02707965|58882404|FG000|Overall Study|PI decisions|0|||
30854988|NCT02707965|58882405|FG001|Overall Study|PI decisions|0|||
30854989|NCT02707965|58882406|FG002|Overall Study|PI decisions|0|||
30958451|NCT01695239|59023632|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958452|NCT01695239|59023633|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958453|NCT01695239|59023634|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958454|NCT01695239|59023635|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958455|NCT01695239|59023636|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958456|NCT01695239|59023637|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
30958457|NCT01695239|59023638|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958458|NCT01695239|59023639|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958459|NCT01695239|59023640|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958460|NCT01695239|59023641|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958461|NCT01695239|59023642|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958462|NCT01695239|59023643|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
30958463|NCT01695239|59023630|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958464|NCT01695239|59023631|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958465|NCT01695239|59023632|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958466|NCT01695239|59023633|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958467|NCT01695239|59023634|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958468|NCT01695239|59023635|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958469|NCT01695239|59023636|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958470|NCT01695239|59023637|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
30958471|NCT01695239|59023638|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958472|NCT01695239|59023639|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958473|NCT01695239|59023640|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958474|NCT01695239|59023641|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958475|NCT01695239|59023642|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958476|NCT01695239|59023643|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
30958477|NCT01695239|59023630|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958478|NCT01695239|59023631|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958479|NCT01695239|59023632|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958480|NCT01695239|59023633|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958481|NCT01695239|59023634|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958482|NCT01695239|59023635|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958483|NCT01695239|59023636|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958484|NCT01695239|59023637|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958485|NCT01695239|59023638|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
30958486|NCT01695239|59023639|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
30958487|NCT01695239|59023640|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958488|NCT01695239|59023641|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958489|NCT01695239|59023642|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958490|NCT01695239|59023643|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
30958491|NCT01695239|59023630|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
30958492|NCT01695239|59023631|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
30958493|NCT01695239|59023632|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
30958494|NCT01695239|59023633|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
30958495|NCT01695239|59023634|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
30958496|NCT01695239|59023635|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
30958497|NCT01695239|59023636|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
30958498|NCT01695239|59023637|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
30958499|NCT01695239|59023638|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
30779870|NCT00006903|58791550|FG001|Overall Study|Patient never treated|0|||
30779871|NCT00006903|58791551|FG002|Overall Study|Patient never treated|1|||
30779872|NCT00006903|58791549|FG000|Overall Study|Ineligible|10|||
30958500|NCT01695239|59023639|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
30958501|NCT01695239|59023640|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
30958502|NCT01695239|59023641|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
30958503|NCT01695239|59023642|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
30958504|NCT01695239|59023643|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
30958505|NCT01695239|59023630|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30958506|NCT01695239|59023631|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30958507|NCT01695239|59023632|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30664789|NCT02393248|58678489|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30779873|NCT00006903|58791550|FG001|Overall Study|Ineligible|1|||
30779874|NCT00006903|58791551|FG002|Overall Study|Ineligible|2|||
30779875|NCT00026793|58791559|FG000|Overall Study|Death on study due to underlying disease|4|||
30779876|NCT00026793|58791559|FG000|Overall Study|Physician Decision|2|||
30958508|NCT01695239|59023633|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30958509|NCT01695239|59023634|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30958510|NCT01695239|59023635|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30958511|NCT01695239|59023636|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30958512|NCT01695239|59023637|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30958513|NCT01695239|59023638|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
30958514|NCT01695239|59023639|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
30958515|NCT01695239|59023640|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30958516|NCT01695239|59023641|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30958517|NCT01695239|59023642|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30958518|NCT01695239|59023643|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
30958519|NCT01695239|59023630|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
30958520|NCT01695239|59023631|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
30958521|NCT01695239|59023632|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
30958522|NCT01695239|59023633|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
30958523|NCT01695239|59023634|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
30664790|NCT02393248|58678490|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664791|NCT02393248|58678491|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664792|NCT02393248|58678492|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30958524|NCT01695239|59023635|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
30958525|NCT01695239|59023636|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
30958526|NCT01695239|59023637|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
30958527|NCT01695239|59023638|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
30958528|NCT01695239|59023639|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
30958529|NCT01695239|59023640|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
30958530|NCT01695239|59023641|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
30958531|NCT01695239|59023642|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
30958532|NCT01695239|59023643|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
30958533|NCT01695239|59023630|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30958534|NCT01695239|59023631|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30958535|NCT01695239|59023632|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30958536|NCT01695239|59023633|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30958537|NCT01695239|59023634|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30958538|NCT01695239|59023635|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30958539|NCT01695239|59023636|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30958540|NCT01695239|59023637|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30958541|NCT01695239|59023638|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
30779877|NCT00026793|58791559|FG000|Overall Study|Off study|2|||
30779878|NCT03539484|58791570|FG000|Overall Study|Death|1|||
30779879|NCT03539484|58791571|FG001|Overall Study|Death|0|||
30779880|NCT03539484|58791572|FG002|Overall Study|Death|0|||
30779881|NCT03539484|58791573|FG003|Overall Study|Death|2|||
30779882|NCT03539484|58791574|FG004|Overall Study|Death|8|||
30779883|NCT03539484|58791575|FG005|Overall Study|Death|3|||
30779884|NCT03539484|58791576|FG006|Overall Study|Death|0|||
30779885|NCT03539484|58791570|FG000|Overall Study|Lost to Follow-up|0|||
30779886|NCT03539484|58791571|FG001|Overall Study|Lost to Follow-up|1|||
30779887|NCT03539484|58791572|FG002|Overall Study|Lost to Follow-up|0|||
30779888|NCT03539484|58791573|FG003|Overall Study|Lost to Follow-up|0|||
30779889|NCT03539484|58791574|FG004|Overall Study|Lost to Follow-up|1|||
30779890|NCT03539484|58791575|FG005|Overall Study|Lost to Follow-up|0|||
30779891|NCT03539484|58791576|FG006|Overall Study|Lost to Follow-up|0|||
30779892|NCT03539484|58791570|FG000|Overall Study|Withdrawal by Subject|0|||
30779893|NCT03539484|58791571|FG001|Overall Study|Withdrawal by Subject|0|||
30779894|NCT03539484|58791572|FG002|Overall Study|Withdrawal by Subject|0|||
30779895|NCT03539484|58791573|FG003|Overall Study|Withdrawal by Subject|0|||
30958542|NCT01695239|59023639|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
30958543|NCT01695239|59023640|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30664793|NCT02393248|58678493|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664794|NCT02393248|58678494|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664795|NCT02393248|58678495|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30958544|NCT01695239|59023641|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30664796|NCT02393248|58678496|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30958545|NCT01695239|59023642|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30854990|NCT02707965|58882407|FG003|Overall Study|PI decisions|0|||
30854991|NCT02707965|58882408|FG004|Overall Study|PI decisions|0|||
30854992|NCT02707965|58882409|FG005|Overall Study|PI decisions|0|||
30854993|NCT02707965|58882410|FG006|Overall Study|PI decisions|0|||
30958546|NCT01695239|59023643|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
30958547|NCT01695239|59023630|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30779896|NCT03539484|58791574|FG004|Overall Study|Withdrawal by Subject|2|||
30779897|NCT03539484|58791575|FG005|Overall Study|Withdrawal by Subject|0|||
30854994|NCT02707965|58882411|FG007|Overall Study|PI decisions|0|||
30854995|NCT02707965|58882412|FG008|Overall Study|PI decisions|0|||
30664797|NCT02393248|58678497|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664798|NCT02393248|58678498|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664799|NCT02393248|58678499|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664800|NCT02393248|58678500|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664801|NCT02393248|58678501|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664802|NCT02393248|58678502|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664803|NCT02393248|58678503|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664804|NCT02393248|58678504|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664805|NCT02393248|58678505|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
30664806|NCT02393248|58678506|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664807|NCT02393248|58678507|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
30664808|NCT02393248|58678508|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
30664809|NCT02393248|58678509|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664810|NCT02393248|58678510|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
30664811|NCT02393248|58678511|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
30664812|NCT02393248|58678487|FG000|Part 3: Combination Therapy|Death|0|||
30664813|NCT02393248|58678488|FG001|Part 3: Combination Therapy|Death|0|||
30664814|NCT02393248|58678489|FG002|Part 3: Combination Therapy|Death|0|||
30664815|NCT02393248|58678490|FG003|Part 3: Combination Therapy|Death|0|||
30664816|NCT02393248|58678491|FG004|Part 3: Combination Therapy|Death|0|||
30664817|NCT02393248|58678492|FG005|Part 3: Combination Therapy|Death|0|||
30664818|NCT02393248|58678493|FG006|Part 3: Combination Therapy|Death|0|||
30664819|NCT02393248|58678494|FG007|Part 3: Combination Therapy|Death|0|||
30664820|NCT02393248|58678495|FG008|Part 3: Combination Therapy|Death|0|||
30664821|NCT02393248|58678496|FG009|Part 3: Combination Therapy|Death|0|||
30664822|NCT02393248|58678497|FG010|Part 3: Combination Therapy|Death|0|||
30664823|NCT02393248|58678498|FG011|Part 3: Combination Therapy|Death|0|||
30779898|NCT03539484|58791576|FG006|Overall Study|Withdrawal by Subject|1|||
30779899|NCT03539484|58791570|FG000|Overall Study|Study Terminated by Sponsor|0|||
30779900|NCT03539484|58791571|FG001|Overall Study|Study Terminated by Sponsor|0|||
30779901|NCT03539484|58791572|FG002|Overall Study|Study Terminated by Sponsor|1|||
30664824|NCT02393248|58678499|FG012|Part 3: Combination Therapy|Death|0|||
30664825|NCT02393248|58678500|FG013|Part 3: Combination Therapy|Death|0|||
30664826|NCT02393248|58678501|FG014|Part 3: Combination Therapy|Death|0|||
30664827|NCT02393248|58678502|FG015|Part 3: Combination Therapy|Death|1|||
30664828|NCT02393248|58678503|FG016|Part 3: Combination Therapy|Death|7|||
30664829|NCT02393248|58678504|FG017|Part 3: Combination Therapy|Death|5|||
30664830|NCT02393248|58678505|FG018|Part 3: Combination Therapy|Death|5|||
30664831|NCT02393248|58678506|FG019|Part 3: Combination Therapy|Death|3|||
30664832|NCT02393248|58678507|FG020|Part 3: Combination Therapy|Death|7|||
30664833|NCT02393248|58678508|FG021|Part 3: Combination Therapy|Death|5|||
30664834|NCT02393248|58678509|FG022|Part 3: Combination Therapy|Death|6|||
30664835|NCT02393248|58678510|FG023|Part 3: Combination Therapy|Death|3|||
30664836|NCT02393248|58678511|FG024|Part 3: Combination Therapy|Death|0|||
30664837|NCT02393248|58678487|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664838|NCT02393248|58678488|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664839|NCT02393248|58678489|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664840|NCT02393248|58678490|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664841|NCT02393248|58678491|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664842|NCT02393248|58678492|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664843|NCT02393248|58678493|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664844|NCT02393248|58678494|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664845|NCT02393248|58678495|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664846|NCT02393248|58678496|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664847|NCT02393248|58678497|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664848|NCT02393248|58678498|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664849|NCT02393248|58678499|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664850|NCT02393248|58678500|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664851|NCT02393248|58678501|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664852|NCT02393248|58678502|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664853|NCT02393248|58678503|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664854|NCT02393248|58678504|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
30664855|NCT02393248|58678505|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
30664856|NCT02393248|58678506|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
30664857|NCT02393248|58678507|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
30664858|NCT02393248|58678508|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
30664859|NCT02393248|58678509|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
30664860|NCT02393248|58678510|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
30664861|NCT02393248|58678511|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
30664862|NCT02393248|58678487|FG000|Part 3: Combination Therapy|Disease Progression|0|||
30664863|NCT02393248|58678488|FG001|Part 3: Combination Therapy|Disease Progression|0|||
30664864|NCT02393248|58678489|FG002|Part 3: Combination Therapy|Disease Progression|0|||
30664865|NCT02393248|58678490|FG003|Part 3: Combination Therapy|Disease Progression|0|||
30664866|NCT02393248|58678491|FG004|Part 3: Combination Therapy|Disease Progression|0|||
30664867|NCT02393248|58678492|FG005|Part 3: Combination Therapy|Disease Progression|0|||
30664868|NCT02393248|58678493|FG006|Part 3: Combination Therapy|Disease Progression|0|||
30664869|NCT02393248|58678494|FG007|Part 3: Combination Therapy|Disease Progression|0|||
30664870|NCT02393248|58678495|FG008|Part 3: Combination Therapy|Disease Progression|0|||
30664871|NCT02393248|58678496|FG009|Part 3: Combination Therapy|Disease Progression|0|||
30664872|NCT02393248|58678497|FG010|Part 3: Combination Therapy|Disease Progression|0|||
30664873|NCT02393248|58678498|FG011|Part 3: Combination Therapy|Disease Progression|0|||
30664874|NCT02393248|58678499|FG012|Part 3: Combination Therapy|Disease Progression|0|||
30664875|NCT02393248|58678500|FG013|Part 3: Combination Therapy|Disease Progression|0|||
30664876|NCT02393248|58678501|FG014|Part 3: Combination Therapy|Disease Progression|0|||
30664877|NCT02393248|58678502|FG015|Part 3: Combination Therapy|Disease Progression|0|||
30664878|NCT02393248|58678503|FG016|Part 3: Combination Therapy|Disease Progression|0|||
30664879|NCT02393248|58678504|FG017|Part 3: Combination Therapy|Disease Progression|0|||
30664880|NCT02393248|58678505|FG018|Part 3: Combination Therapy|Disease Progression|0|||
30664881|NCT02393248|58678506|FG019|Part 3: Combination Therapy|Disease Progression|0|||
30664882|NCT02393248|58678507|FG020|Part 3: Combination Therapy|Disease Progression|2|||
30664883|NCT02393248|58678508|FG021|Part 3: Combination Therapy|Disease Progression|1|||
30779902|NCT03539484|58791573|FG003|Overall Study|Study Terminated by Sponsor|1|||
30664884|NCT02393248|58678509|FG022|Part 3: Combination Therapy|Disease Progression|0|||
30779903|NCT03539484|58791574|FG004|Overall Study|Study Terminated by Sponsor|2|||
30854996|NCT02707965|58882413|FG009|Overall Study|PI decisions|0|||
30779904|NCT03539484|58791575|FG005|Overall Study|Study Terminated by Sponsor|2|||
30779905|NCT03539484|58791576|FG006|Overall Study|Study Terminated by Sponsor|1|||
30779906|NCT03561090|58791599|FG000|Overall Study|Adverse Event|11|||
30779907|NCT03561090|58791600|FG001|Overall Study|Adverse Event|7|||
30664885|NCT02393248|58678510|FG023|Part 3: Combination Therapy|Disease Progression|0|||
30779908|NCT03561090|58791599|FG000|Overall Study|Non-Compliance With Study Drug|2|||
30664886|NCT02393248|58678511|FG024|Part 3: Combination Therapy|Disease Progression|0|||
30664887|NCT02393248|58678487|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664888|NCT02393248|58678488|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664889|NCT02393248|58678489|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664890|NCT02393248|58678490|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664891|NCT02393248|58678491|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664892|NCT02393248|58678492|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664893|NCT02393248|58678493|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664894|NCT02393248|58678494|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664895|NCT02393248|58678495|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664896|NCT02393248|58678496|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664897|NCT02393248|58678497|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
30779909|NCT03561090|58791600|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30958548|NCT01695239|59023631|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30958549|NCT01695239|59023632|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30958550|NCT01695239|59023633|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30664898|NCT02393248|58678498|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664899|NCT02393248|58678499|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664900|NCT02393248|58678500|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
30779910|NCT03561090|58791599|FG000|Overall Study|Protocol Violation|2|||
30779911|NCT03561090|58791600|FG001|Overall Study|Protocol Violation|2|||
30779912|NCT03561090|58791599|FG000|Overall Study|Withdrawal by Subject|7|||
30779913|NCT03561090|58791600|FG001|Overall Study|Withdrawal by Subject|7|||
30664901|NCT02393248|58678501|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664902|NCT02393248|58678502|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664903|NCT02393248|58678503|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664904|NCT02393248|58678504|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664905|NCT02393248|58678505|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664906|NCT02393248|58678506|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664907|NCT02393248|58678507|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
30664908|NCT02393248|58678508|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
30664909|NCT02393248|58678509|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664910|NCT02393248|58678510|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664911|NCT02393248|58678511|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
30664912|NCT02393248|58678487|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664913|NCT02393248|58678488|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664914|NCT02393248|58678489|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664915|NCT02393248|58678490|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664916|NCT02393248|58678491|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664917|NCT02393248|58678492|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664918|NCT02393248|58678493|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664919|NCT02393248|58678494|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664920|NCT02393248|58678495|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664921|NCT02393248|58678496|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30779914|NCT03561090|58791599|FG000|Overall Study|Lost to Follow-up|7|||
30779915|NCT03561090|58791600|FG001|Overall Study|Lost to Follow-up|2|||
30779916|NCT03561090|58791599|FG000|Overall Study|Study Terminated by Sponsor|10|||
30779917|NCT03561090|58791600|FG001|Overall Study|Study Terminated by Sponsor|15|||
30779918|NCT03561090|58791599|FG000|Overall Study|Randomized by Mistake|1|||
30779919|NCT03561090|58791600|FG001|Overall Study|Randomized by Mistake|1|||
30958551|NCT01695239|59023634|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30664922|NCT02393248|58678497|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664923|NCT02393248|58678498|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664924|NCT02393248|58678499|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664925|NCT02393248|58678500|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664926|NCT02393248|58678501|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664927|NCT02393248|58678502|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664928|NCT02393248|58678503|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664929|NCT02393248|58678504|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664930|NCT02393248|58678505|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664931|NCT02393248|58678506|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664932|NCT02393248|58678507|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
30664933|NCT02393248|58678508|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664934|NCT02393248|58678509|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664935|NCT02393248|58678510|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664936|NCT02393248|58678511|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
30664937|NCT02393248|58678487|FG000|Part 3: Combination Therapy|Adverse Event|0|||
30664938|NCT02393248|58678488|FG001|Part 3: Combination Therapy|Adverse Event|0|||
30664939|NCT02393248|58678489|FG002|Part 3: Combination Therapy|Adverse Event|0|||
30664940|NCT02393248|58678490|FG003|Part 3: Combination Therapy|Adverse Event|0|||
30664941|NCT02393248|58678491|FG004|Part 3: Combination Therapy|Adverse Event|0|||
30664942|NCT02393248|58678492|FG005|Part 3: Combination Therapy|Adverse Event|0|||
30664943|NCT02393248|58678493|FG006|Part 3: Combination Therapy|Adverse Event|0|||
30664944|NCT02393248|58678494|FG007|Part 3: Combination Therapy|Adverse Event|0|||
30664945|NCT02393248|58678495|FG008|Part 3: Combination Therapy|Adverse Event|0|||
30664946|NCT02393248|58678496|FG009|Part 3: Combination Therapy|Adverse Event|0|||
30664947|NCT02393248|58678497|FG010|Part 3: Combination Therapy|Adverse Event|0|||
30664948|NCT02393248|58678498|FG011|Part 3: Combination Therapy|Adverse Event|0|||
30664949|NCT02393248|58678499|FG012|Part 3: Combination Therapy|Adverse Event|0|||
30664950|NCT02393248|58678500|FG013|Part 3: Combination Therapy|Adverse Event|0|||
30664951|NCT02393248|58678501|FG014|Part 3: Combination Therapy|Adverse Event|0|||
30664952|NCT02393248|58678502|FG015|Part 3: Combination Therapy|Adverse Event|0|||
30664953|NCT02393248|58678503|FG016|Part 3: Combination Therapy|Adverse Event|0|||
30664954|NCT02393248|58678504|FG017|Part 3: Combination Therapy|Adverse Event|0|||
30664955|NCT02393248|58678505|FG018|Part 3: Combination Therapy|Adverse Event|0|||
30664956|NCT02393248|58678506|FG019|Part 3: Combination Therapy|Adverse Event|0|||
30664957|NCT02393248|58678507|FG020|Part 3: Combination Therapy|Adverse Event|0|||
30664958|NCT02393248|58678508|FG021|Part 3: Combination Therapy|Adverse Event|0|||
30664959|NCT02393248|58678509|FG022|Part 3: Combination Therapy|Adverse Event|0|||
30664960|NCT02393248|58678510|FG023|Part 3: Combination Therapy|Adverse Event|1|||
30664961|NCT02393248|58678511|FG024|Part 3: Combination Therapy|Adverse Event|0|||
30664962|NCT02393248|58678487|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664963|NCT02393248|58678488|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664964|NCT02393248|58678489|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664965|NCT02393248|58678490|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30779920|NCT03561090|58791599|FG000|Overall Study|Other Not Specified|0|||
30779921|NCT03561090|58791600|FG001|Overall Study|Other Not Specified|2|||
30779922|NCT02996500|58791614|FG000|Overall Study|Adverse Event|1|||
30779923|NCT02996500|58791615|FG001|Overall Study|Adverse Event|1|||
30779924|NCT02996500|58791616|FG002|Overall Study|Adverse Event|4|||
30958552|NCT01695239|59023635|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30958553|NCT01695239|59023636|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30958554|NCT01695239|59023637|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30958555|NCT01695239|59023638|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
30958556|NCT01695239|59023639|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
30958557|NCT01695239|59023640|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30958558|NCT01695239|59023641|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30958559|NCT01695239|59023642|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30958560|NCT01695239|59023643|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
30664966|NCT02393248|58678491|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664967|NCT02393248|58678492|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664968|NCT02393248|58678493|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664969|NCT02393248|58678494|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664970|NCT02393248|58678495|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664971|NCT02393248|58678496|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664972|NCT02393248|58678497|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664973|NCT02393248|58678498|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664974|NCT02393248|58678499|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30779925|NCT02996500|58791617|FG003|Overall Study|Adverse Event|3|||
30779926|NCT02996500|58791618|FG004|Overall Study|Adverse Event|1|||
30779927|NCT02996500|58791619|FG005|Overall Study|Adverse Event|2|||
30958561|NCT01695239|59023630|FG000|Extension Long-Term Extension Periods|Death|0|||
30958562|NCT01695239|59023631|FG001|Extension Long-Term Extension Periods|Death|0|||
30779928|NCT02996500|58791614|FG000|Overall Study|Lack of Efficacy|0|||
30854997|NCT02707965|58882414|FG010|Overall Study|PI decisions|0|||
30854998|NCT02707965|58882415|FG011|Overall Study|PI decisions|0|||
30854999|NCT02707965|58882416|FG012|Overall Study|PI decisions|0|||
30855000|NCT02707965|58882417|FG013|Overall Study|PI decisions|0|||
30855001|NCT02707965|58882418|FG014|Overall Study|PI decisions|2|||
30855002|NCT02707965|58882419|FG015|Overall Study|PI decisions|0|||
30855003|NCT02707965|58882404|FG000|Overall Study|Protocol deviation|1|||
30855004|NCT02707965|58882405|FG001|Overall Study|Protocol deviation|1|||
30855005|NCT02707965|58882406|FG002|Overall Study|Protocol deviation|0|||
30855006|NCT02707965|58882407|FG003|Overall Study|Protocol deviation|0|||
30855007|NCT02707965|58882408|FG004|Overall Study|Protocol deviation|0|||
30855008|NCT02707965|58882409|FG005|Overall Study|Protocol deviation|0|||
30779929|NCT02996500|58791615|FG001|Overall Study|Lack of Efficacy|0|||
30779930|NCT02996500|58791616|FG002|Overall Study|Lack of Efficacy|0|||
30779931|NCT02996500|58791617|FG003|Overall Study|Lack of Efficacy|0|||
30779932|NCT02996500|58791618|FG004|Overall Study|Lack of Efficacy|2|||
30779933|NCT02996500|58791619|FG005|Overall Study|Lack of Efficacy|0|||
30779934|NCT02996500|58791614|FG000|Overall Study|Lost to Follow-up|1|||
30779935|NCT02996500|58791615|FG001|Overall Study|Lost to Follow-up|0|||
30779936|NCT02996500|58791616|FG002|Overall Study|Lost to Follow-up|0|||
30779937|NCT02996500|58791617|FG003|Overall Study|Lost to Follow-up|0|||
30779938|NCT02996500|58791618|FG004|Overall Study|Lost to Follow-up|0|||
30779939|NCT02996500|58791619|FG005|Overall Study|Lost to Follow-up|1|||
30779940|NCT02996500|58791614|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
30779941|NCT02996500|58791615|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
30779942|NCT02996500|58791616|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
30779943|NCT02996500|58791617|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
30779944|NCT02996500|58791618|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
30779945|NCT02996500|58791619|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
30855009|NCT02707965|58882410|FG006|Overall Study|Protocol deviation|0|||
30855010|NCT02707965|58882411|FG007|Overall Study|Protocol deviation|1|||
30855011|NCT02707965|58882412|FG008|Overall Study|Protocol deviation|0|||
30664975|NCT02393248|58678500|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664976|NCT02393248|58678501|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664977|NCT02393248|58678502|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664978|NCT02393248|58678503|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664979|NCT02393248|58678504|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664980|NCT02393248|58678505|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664981|NCT02393248|58678506|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664982|NCT02393248|58678507|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664983|NCT02393248|58678508|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664984|NCT02393248|58678509|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664985|NCT02393248|58678510|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
30664986|NCT02393248|58678511|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
30664987|NCT00601484|58678574|FG000|Overall Study|Adverse Event|0|||
30664988|NCT00601484|58678575|FG001|Overall Study|Adverse Event|1|||
30664989|NCT00601484|58678574|FG000|Overall Study|Lost to Follow-up|4|||
30664990|NCT00601484|58678575|FG001|Overall Study|Lost to Follow-up|3|||
30664991|NCT00601484|58678574|FG000|Overall Study|Lack of Efficacy|0|||
30664992|NCT00601484|58678575|FG001|Overall Study|Lack of Efficacy|2|||
30664993|NCT00601484|58678574|FG000|Overall Study|Withdrawal by Subject|1|||
30664994|NCT00601484|58678575|FG001|Overall Study|Withdrawal by Subject|1|||
30664995|NCT00601484|58678574|FG000|Overall Study|Randomized, but not treated|0|||
30664996|NCT00601484|58678575|FG001|Overall Study|Randomized, but not treated|1|||
30664997|NCT00883896|58678585|FG000|Overall Study|Lost to Follow-up|0|||
30664998|NCT00883896|58678586|FG001|Overall Study|Lost to Follow-up|0|||
30664999|NCT00883896|58678587|FG002|Overall Study|Lost to Follow-up|0|||
30665000|NCT00883896|58678588|FG003|Overall Study|Lost to Follow-up|2|||
30665001|NCT00883896|58678585|FG000|Overall Study|Withdrawal by Subject|5|||
30665002|NCT00883896|58678586|FG001|Overall Study|Withdrawal by Subject|0|||
30665003|NCT00883896|58678587|FG002|Overall Study|Withdrawal by Subject|1|||
30665004|NCT00883896|58678588|FG003|Overall Study|Withdrawal by Subject|3|||
30665005|NCT00883896|58678585|FG000|Overall Study|Lack of Efficacy|0|||
30665006|NCT00883896|58678586|FG001|Overall Study|Lack of Efficacy|0|||
30665007|NCT00883896|58678587|FG002|Overall Study|Lack of Efficacy|0|||
30665008|NCT00883896|58678588|FG003|Overall Study|Lack of Efficacy|2|||
30665009|NCT00883896|58678585|FG000|Overall Study|Other|1|||
30665010|NCT00883896|58678586|FG001|Overall Study|Other|0|||
30665011|NCT00883896|58678587|FG002|Overall Study|Other|0|||
30665012|NCT00883896|58678588|FG003|Overall Study|Other|0|||
30665027|NCT00867009|58678607|FG000|Induction Period|Nonserious Adverse Event|5|||
30665028|NCT00867009|58678607|FG000|Induction Period|Serious Adverse Event|10|||
30665029|NCT00867009|58678607|FG000|Induction Period|Death due to serious adverse event|6|||
30665030|NCT00867009|58678607|FG000|Induction Period|Death due to Study Disease|4|||
30665031|NCT00867009|58678607|FG000|Induction Period|Protocol Violation|1|||
30665032|NCT00867009|58678607|FG000|Induction Period|Withdrawal by Subject|8|||
30855012|NCT02707965|58882413|FG009|Overall Study|Protocol deviation|0|||
30855013|NCT02707965|58882414|FG010|Overall Study|Protocol deviation|0|||
30855014|NCT02707965|58882415|FG011|Overall Study|Protocol deviation|0|||
30855015|NCT02707965|58882416|FG012|Overall Study|Protocol deviation|0|||
30855016|NCT02707965|58882417|FG013|Overall Study|Protocol deviation|0|||
30855017|NCT02707965|58882418|FG014|Overall Study|Protocol deviation|0|||
30855018|NCT02707965|58882419|FG015|Overall Study|Protocol deviation|0|||
30855019|NCT01667900|58882457|FG000|Part B|Death|0|||
30855020|NCT01667900|58882458|FG001|Part B|Death|0|||
30855021|NCT01667900|58882459|FG002|Part B|Death|0|||
30855022|NCT01667900|58882460|FG003|Part B|Death|0|||
30855023|NCT01667900|58882461|FG004|Part B|Death|0|||
30855024|NCT01667900|58882462|FG005|Part B|Death|0|||
30855025|NCT01667900|58882463|FG006|Part B|Death|0|||
30855026|NCT01667900|58882464|FG007|Part B|Death|0|||
30855027|NCT01667900|58882465|FG008|Part B|Death|0|||
30958563|NCT01695239|59023632|FG002|Extension Long-Term Extension Periods|Death|0|||
30665033|NCT00867009|58678607|FG000|Induction Period|Physician Decision|3|||
30665034|NCT00867009|58678607|FG000|Induction Period|Progressive Disease (PD)|25|||
30665035|NCT00867009|58678607|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
30665036|NCT00601250|58678613|FG000|Overall Study|Adverse Event|3|||
30665037|NCT00601250|58678614|FG001|Overall Study|Adverse Event|9|||
30665038|NCT00601250|58678613|FG000|Overall Study|Protocol Violation|3|||
30665039|NCT00601250|58678614|FG001|Overall Study|Protocol Violation|2|||
30665040|NCT00601250|58678613|FG000|Overall Study|Lost to Follow-up|2|||
30665041|NCT00601250|58678614|FG001|Overall Study|Lost to Follow-up|6|||
30665042|NCT00601250|58678613|FG000|Overall Study|Withdrawal by Subject|4|||
30665043|NCT00601250|58678614|FG001|Overall Study|Withdrawal by Subject|13|||
30665044|NCT00601250|58678613|FG000|Overall Study|Other incl. lack of efficacy|2|||
30665045|NCT00601250|58678614|FG001|Overall Study|Other incl. lack of efficacy|9|||
30665046|NCT00866775|58678622|FG000|Overall Study|Adverse Event|5|||
30665047|NCT00866775|58678623|FG001|Overall Study|Adverse Event|19|||
30665048|NCT00866775|58678622|FG000|Overall Study|Death|1|||
30665049|NCT00866775|58678623|FG001|Overall Study|Death|0|||
30665050|NCT00866775|58678622|FG000|Overall Study|Lost to Follow-up|0|||
30665051|NCT00866775|58678623|FG001|Overall Study|Lost to Follow-up|4|||
30665052|NCT00866775|58678622|FG000|Overall Study|Physician Decision|0|||
30665053|NCT00866775|58678623|FG001|Overall Study|Physician Decision|3|||
30665054|NCT00866775|58678622|FG000|Overall Study|Protocol Violation|3|||
30665055|NCT00866775|58678623|FG001|Overall Study|Protocol Violation|4|||
30665056|NCT00866775|58678622|FG000|Overall Study|Withdrawal by Subject|4|||
30665057|NCT00866775|58678623|FG001|Overall Study|Withdrawal by Subject|4|||
30665058|NCT00866775|58678622|FG000|Overall Study|met exit criteria|23|||
30665059|NCT00866775|58678623|FG001|Overall Study|met exit criteria|17|||
30665060|NCT00866775|58678622|FG000|Overall Study|discontinued due to communication error|0|||
30665061|NCT00866775|58678623|FG001|Overall Study|discontinued due to communication error|1|||
30665062|NCT03265210|58678633|FG000|Overall Study|Withdrawal by Subject|7|||
30665063|NCT03265210|58678634|FG001|Overall Study|Withdrawal by Subject|9|||
30665064|NCT03265210|58678633|FG000|Overall Study|Lost to Follow-up|2|||
30665065|NCT03265210|58678634|FG001|Overall Study|Lost to Follow-up|0|||
30665066|NCT03265210|58678633|FG000|Overall Study|Physician Decision|2|||
30665067|NCT03265210|58678634|FG001|Overall Study|Physician Decision|0|||
30665068|NCT03265210|58678633|FG000|Overall Study|Adverse Event|1|||
30665069|NCT03265210|58678634|FG001|Overall Study|Adverse Event|0|||
30665070|NCT00543985|58678640|FG000|Overall Study|Withdrawal by Subject|4|||
30665071|NCT00582556|58678655|FG000|Overall Study|Withdrawal by Subject|0|||
30665072|NCT00582556|58678656|FG001|Overall Study|Withdrawal by Subject|1|||
30665073|NCT00582556|58678657|FG002|Overall Study|Withdrawal by Subject|1|||
30665074|NCT00582556|58678655|FG000|Overall Study|Physician Decision|0|||
30665075|NCT00582556|58678656|FG001|Overall Study|Physician Decision|0|||
30665076|NCT00582556|58678657|FG002|Overall Study|Physician Decision|1|||
30665077|NCT00542269|58678669|FG000|Overall Study|Adverse Event|10|||
30665078|NCT00542269|58678670|FG001|Overall Study|Adverse Event|4|||
30665079|NCT00542269|58678671|FG002|Overall Study|Adverse Event|5|||
30665080|NCT00542269|58678669|FG000|Overall Study|Protocol Violation|1|||
30665081|NCT00542269|58678670|FG001|Overall Study|Protocol Violation|1|||
30665082|NCT00542269|58678671|FG002|Overall Study|Protocol Violation|0|||
30665083|NCT00542269|58678669|FG000|Overall Study|Withdrawal by Subject|1|||
30665084|NCT00542269|58678670|FG001|Overall Study|Withdrawal by Subject|0|||
30665085|NCT00542269|58678671|FG002|Overall Study|Withdrawal by Subject|0|||
30665086|NCT00542269|58678669|FG000|Overall Study|Administrative problems|1|||
30665087|NCT00542269|58678670|FG001|Overall Study|Administrative problems|1|||
30665088|NCT00542269|58678671|FG002|Overall Study|Administrative problems|1|||
30665089|NCT00866697|58678683|FG000|Overall Study|Study closed/terminated|156|||
30665090|NCT00866697|58678684|FG001|Overall Study|Study closed/terminated|138|||
30665091|NCT00866697|58678683|FG000|Overall Study|Lost to Follow-up|22|||
30665092|NCT00866697|58678684|FG001|Overall Study|Lost to Follow-up|28|||
30665093|NCT00866697|58678683|FG000|Overall Study|Physician Decision|3|||
30665094|NCT00866697|58678684|FG001|Overall Study|Physician Decision|5|||
30665095|NCT00866697|58678683|FG000|Overall Study|Withdrawal by Subject|33|||
30665096|NCT00866697|58678684|FG001|Overall Study|Withdrawal by Subject|57|||
30665097|NCT00542191|58678690|FG000|Overall Study|Death|3|||
30665098|NCT00600938|58678696|FG000|Core Study|Abnormal test procedure result(s)|3|||
30855028|NCT01667900|58882466|FG009|Part B|Death|0|||
30665099|NCT00600938|58678697|FG001|Core Study|Abnormal test procedure result(s)|2|||
30665100|NCT00600938|58678698|FG002|Core Study|Abnormal test procedure result(s)|0|||
30665101|NCT00600938|58678699|FG003|Core Study|Abnormal test procedure result(s)|0|||
30665102|NCT00600938|58678696|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
30665103|NCT00600938|58678697|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
30665104|NCT00600938|58678698|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
30665105|NCT00600938|58678699|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
30665106|NCT00600938|58678696|FG000|Core Study|Patient withdrew consent|7|||
30665107|NCT00600938|58678697|FG001|Core Study|Patient withdrew consent|12|||
30665108|NCT00600938|58678698|FG002|Core Study|Patient withdrew consent|0|||
30665109|NCT00600938|58678699|FG003|Core Study|Patient withdrew consent|0|||
30665110|NCT00600938|58678696|FG000|Core Study|Lost to Follow-up|3|||
30665111|NCT00600938|58678697|FG001|Core Study|Lost to Follow-up|2|||
30665112|NCT00600938|58678698|FG002|Core Study|Lost to Follow-up|0|||
30665113|NCT00600938|58678699|FG003|Core Study|Lost to Follow-up|0|||
30665114|NCT00600938|58678696|FG000|Core Study|Death|1|||
30665115|NCT00600938|58678697|FG001|Core Study|Death|1|||
30665116|NCT00600938|58678698|FG002|Core Study|Death|0|||
30665117|NCT00600938|58678699|FG003|Core Study|Death|0|||
30665118|NCT00600938|58678696|FG000|Core Study|Protocol Violation|1|||
30665119|NCT00600938|58678697|FG001|Core Study|Protocol Violation|2|||
30665120|NCT00600938|58678698|FG002|Core Study|Protocol Violation|0|||
30665121|NCT00600938|58678699|FG003|Core Study|Protocol Violation|0|||
30665122|NCT00600938|58678696|FG000|Extension Study|Adverse Event|1|||
30665123|NCT00600938|58678697|FG001|Extension Study|Adverse Event|0|||
30665124|NCT00600938|58678698|FG002|Extension Study|Adverse Event|2|||
30665125|NCT00600938|58678699|FG003|Extension Study|Adverse Event|0|||
30665126|NCT00600938|58678696|FG000|Extension Study|Abnormal test procedure results|0|||
30665127|NCT00600938|58678697|FG001|Extension Study|Abnormal test procedure results|1|||
30665128|NCT00600938|58678698|FG002|Extension Study|Abnormal test procedure results|1|||
30665129|NCT00600938|58678699|FG003|Extension Study|Abnormal test procedure results|1|||
30665130|NCT00600938|58678696|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
30665131|NCT00600938|58678697|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
30665132|NCT00600938|58678698|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
30665133|NCT00600938|58678699|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
30665134|NCT00600938|58678696|FG000|Extension Study|Withdrawal by Subject|2|||
30665135|NCT00600938|58678697|FG001|Extension Study|Withdrawal by Subject|2|||
30665136|NCT00600938|58678698|FG002|Extension Study|Withdrawal by Subject|3|||
30665137|NCT00600938|58678699|FG003|Extension Study|Withdrawal by Subject|0|||
30665138|NCT00600938|58678696|FG000|Extension Study|Lost to Follow-up|1|||
30665139|NCT00600938|58678697|FG001|Extension Study|Lost to Follow-up|1|||
30665140|NCT00600938|58678698|FG002|Extension Study|Lost to Follow-up|2|||
30665141|NCT00600938|58678699|FG003|Extension Study|Lost to Follow-up|0|||
30665142|NCT00600938|58678696|FG000|Extension Study|Death|1|||
30665143|NCT00600938|58678697|FG001|Extension Study|Death|0|||
30665144|NCT00600938|58678698|FG002|Extension Study|Death|0|||
30958564|NCT01695239|59023633|FG003|Extension Long-Term Extension Periods|Death|0|||
30958565|NCT01695239|59023634|FG004|Extension Long-Term Extension Periods|Death|0|||
30665145|NCT00600938|58678699|FG003|Extension Study|Death|0|||
30665146|NCT00543439|58678740|FG000|Period 1|Adverse Event|0|||
30665147|NCT00543439|58678741|FG001|Period 1|Adverse Event|2|||
30665148|NCT00543439|58678742|FG002|Period 1|Adverse Event|1|||
30665149|NCT00543439|58678740|FG000|Period 1|Withdrawal by Subject|1|||
30665150|NCT00543439|58678741|FG001|Period 1|Withdrawal by Subject|1|||
30665151|NCT00543439|58678742|FG002|Period 1|Withdrawal by Subject|0|||
30665152|NCT00543439|58678740|FG000|Period 1|Physician Decision|0|||
30665153|NCT00543439|58678741|FG001|Period 1|Physician Decision|0|||
30958566|NCT01695239|59023635|FG005|Extension Long-Term Extension Periods|Death|0|||
30665154|NCT00543439|58678742|FG002|Period 1|Physician Decision|1|||
30665155|NCT00543439|58678740|FG000|Period 2|Protocol Violation|1|||
30665156|NCT00543439|58678741|FG001|Period 2|Protocol Violation|0|||
30665157|NCT00543439|58678742|FG002|Period 2|Protocol Violation|1|||
30665158|NCT00543439|58678740|FG000|Period 2|Adverse Event|0|||
30665159|NCT00543439|58678741|FG001|Period 2|Adverse Event|1|||
30665160|NCT00543439|58678742|FG002|Period 2|Adverse Event|1|||
30665161|NCT00582166|58678759|FG000|Overall Study|Death|1|||
30779946|NCT02996500|58791614|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30779947|NCT02996500|58791615|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30779948|NCT02996500|58791616|FG002|Overall Study|Non-Compliance With Study Drug|0|||
30855029|NCT01667900|58882467|FG010|Part B|Death|0|||
30855030|NCT01667900|58882468|FG011|Part B|Death|0|||
30855031|NCT01667900|58882469|FG012|Part B|Death|0|||
30855032|NCT01667900|58882470|FG013|Part B|Death|0|||
30855033|NCT01667900|58882471|FG014|Part B|Death|0|||
30855034|NCT01667900|58882472|FG015|Part B|Death|0|||
30855035|NCT01667900|58882473|FG016|Part B|Death|1|||
30855036|NCT01667900|58882474|FG017|Part B|Death|0|||
30855037|NCT01667900|58882475|FG018|Part B|Death|0|||
30855038|NCT01667900|58882476|FG019|Part B|Death|0|||
30855039|NCT02605928|58882505|FG000|Overall Study|Model tuning phase|28|||
30855040|NCT02605928|58882505|FG000|Overall Study|Lack of Efficacy|5|||
30855041|NCT02706717|58882511|FG000|Overall Study|Withdrawal by Subject|1|||
30958567|NCT01695239|59023636|FG006|Extension Long-Term Extension Periods|Death|0|||
30958568|NCT01695239|59023637|FG007|Extension Long-Term Extension Periods|Death|0|||
30958569|NCT01695239|59023638|FG008|Extension Long-Term Extension Periods|Death|1|||
30958570|NCT01695239|59023639|FG009|Extension Long-Term Extension Periods|Death|0|||
30958571|NCT01695239|59023640|FG010|Extension Long-Term Extension Periods|Death|0|||
30855042|NCT02706717|58882512|FG001|Overall Study|Withdrawal by Subject|8|||
30958572|NCT01695239|59023641|FG011|Extension Long-Term Extension Periods|Death|0|||
30855043|NCT02706717|58882511|FG000|Overall Study|Lost to Follow-up|0|||
30855044|NCT02706717|58882512|FG001|Overall Study|Lost to Follow-up|1|||
30665162|NCT00582166|58678759|FG000|Overall Study|Ineligible pathology|1|||
30665163|NCT00601172|58678765|FG000|Overall Study|Adverse Event|43|||
30665164|NCT00601172|58678766|FG001|Overall Study|Adverse Event|32|||
30665165|NCT00601172|58678765|FG000|Overall Study|Lack of Efficacy|11|||
30665166|NCT00601172|58678766|FG001|Overall Study|Lack of Efficacy|12|||
30665167|NCT00601172|58678765|FG000|Overall Study|Protocol Violation|2|||
30665168|NCT00601172|58678766|FG001|Overall Study|Protocol Violation|5|||
30665169|NCT00601172|58678765|FG000|Overall Study|Lost to Follow-up|4|||
30665170|NCT00601172|58678766|FG001|Overall Study|Lost to Follow-up|3|||
30665171|NCT00601172|58678765|FG000|Overall Study|Physician Decision|27|||
30665172|NCT00601172|58678766|FG001|Overall Study|Physician Decision|28|||
30665173|NCT00601172|58678765|FG000|Overall Study|Withdrawal by Subject|35|||
30665174|NCT00601172|58678766|FG001|Overall Study|Withdrawal by Subject|27|||
30665175|NCT00601172|58678765|FG000|Overall Study|Did not meet continuation criteria|19|||
30665176|NCT00601172|58678766|FG001|Overall Study|Did not meet continuation criteria|20|||
30665177|NCT00582010|58678775|FG000|Overall Study|Death|0|||
30665178|NCT00582010|58678776|FG001|Overall Study|Death|1|||
30665179|NCT03920215|58678790|FG000|Overall Study|Lost to Follow-up|1|||
30665180|NCT03920215|58678791|FG001|Overall Study|Lost to Follow-up|2|||
30665181|NCT03920215|58678792|FG002|Overall Study|Lost to Follow-up|0|||
30665182|NCT03920215|58678793|FG003|Overall Study|Lost to Follow-up|0|||
30665183|NCT03920215|58678790|FG000|Overall Study|Death|0|||
30665184|NCT03920215|58678791|FG001|Overall Study|Death|0|||
30665185|NCT03920215|58678792|FG002|Overall Study|Death|0|||
30665186|NCT03920215|58678793|FG003|Overall Study|Death|1|||
30665187|NCT00580840|58678803|FG000|Run-in|Adverse Event|17|||
30665188|NCT00580840|58678804|FG001|Run-in|Adverse Event|0|||
30665189|NCT00580840|58678805|FG002|Run-in|Adverse Event|0|||
30665190|NCT00580840|58678806|FG003|Run-in|Adverse Event|0|||
30665191|NCT00580840|58678803|FG000|Run-in|Lack of Efficacy|93|||
30665192|NCT00580840|58678804|FG001|Run-in|Lack of Efficacy|0|||
30855045|NCT02706717|58882511|FG000|Overall Study|Physician Decision|0|||
30665193|NCT00580840|58678805|FG002|Run-in|Lack of Efficacy|0|||
30665194|NCT00580840|58678806|FG003|Run-in|Lack of Efficacy|0|||
30665195|NCT00580840|58678803|FG000|Run-in|Loss of Efficacy|1|||
30665196|NCT00580840|58678804|FG001|Run-in|Loss of Efficacy|0|||
30665197|NCT00580840|58678805|FG002|Run-in|Loss of Efficacy|0|||
30665198|NCT00580840|58678806|FG003|Run-in|Loss of Efficacy|0|||
30665199|NCT00580840|58678803|FG000|Run-in|Lost to Follow-up|4|||
30665200|NCT00580840|58678804|FG001|Run-in|Lost to Follow-up|0|||
30855046|NCT02706717|58882512|FG001|Overall Study|Physician Decision|1|||
30665201|NCT00580840|58678805|FG002|Run-in|Lost to Follow-up|0|||
30665202|NCT00580840|58678806|FG003|Run-in|Lost to Follow-up|0|||
30665203|NCT00580840|58678803|FG000|Run-in|Withdrawal by Subject|5|||
30665204|NCT00580840|58678804|FG001|Run-in|Withdrawal by Subject|0|||
30665205|NCT00580840|58678805|FG002|Run-in|Withdrawal by Subject|0|||
30665206|NCT00580840|58678806|FG003|Run-in|Withdrawal by Subject|0|||
30665207|NCT00580840|58678803|FG000|Run-in|Other: Per Sponsor Request|2|||
30665208|NCT00580840|58678804|FG001|Run-in|Other: Per Sponsor Request|0|||
30665209|NCT00580840|58678805|FG002|Run-in|Other: Per Sponsor Request|0|||
30665210|NCT00580840|58678806|FG003|Run-in|Other: Per Sponsor Request|0|||
30665211|NCT00580840|58678803|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
30665212|NCT00580840|58678804|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
30665213|NCT00580840|58678805|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
30665214|NCT00580840|58678806|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
30665215|NCT00580840|58678803|FG000|Run-in|Other: Exclusionary Lab Value|1|||
30665216|NCT00580840|58678804|FG001|Run-in|Other: Exclusionary Lab Value|0|||
30665217|NCT00580840|58678805|FG002|Run-in|Other: Exclusionary Lab Value|0|||
30665218|NCT00580840|58678806|FG003|Run-in|Other: Exclusionary Lab Value|0|||
30665219|NCT00580840|58678803|FG000|Double-Blind|Adverse Event|0|||
30665220|NCT00580840|58678804|FG001|Double-Blind|Adverse Event|3|||
30665221|NCT00580840|58678805|FG002|Double-Blind|Adverse Event|4|||
30665222|NCT00580840|58678806|FG003|Double-Blind|Adverse Event|1|||
30665223|NCT00580840|58678803|FG000|Double-Blind|Loss of Efficacy|0|||
30665224|NCT00580840|58678804|FG001|Double-Blind|Loss of Efficacy|1|||
30665225|NCT00580840|58678805|FG002|Double-Blind|Loss of Efficacy|2|||
30665226|NCT00580840|58678806|FG003|Double-Blind|Loss of Efficacy|10|||
30665227|NCT00580840|58678803|FG000|Double-Blind|Lost to Follow-up|0|||
30665228|NCT00580840|58678804|FG001|Double-Blind|Lost to Follow-up|1|||
30665229|NCT00580840|58678805|FG002|Double-Blind|Lost to Follow-up|0|||
30665230|NCT00580840|58678806|FG003|Double-Blind|Lost to Follow-up|2|||
30779949|NCT02996500|58791617|FG003|Overall Study|Non-Compliance With Study Drug|0|||
30665231|NCT00580840|58678803|FG000|Double-Blind|Withdrawal by Subject|0|||
30665232|NCT00580840|58678804|FG001|Double-Blind|Withdrawal by Subject|1|||
30855047|NCT02706717|58882511|FG000|Overall Study|Death|0|||
30855048|NCT02706717|58882512|FG001|Overall Study|Death|1|||
30855049|NCT01331837|58882520|FG000|Overall Study|Death|30|||
30855050|NCT01331837|58882521|FG001|Overall Study|Death|34|||
30855051|NCT01331837|58882520|FG000|Overall Study|Lost to Follow-up|3|||
30855052|NCT01331837|58882521|FG001|Overall Study|Lost to Follow-up|1|||
30855053|NCT01331837|58882520|FG000|Overall Study|Info not recorded|10|||
30855054|NCT01331837|58882521|FG001|Overall Study|Info not recorded|16|||
30855055|NCT01331837|58882520|FG000|Overall Study|Withdrawal by Subject|13|||
30855056|NCT01331837|58882521|FG001|Overall Study|Withdrawal by Subject|16|||
30855057|NCT02706483|58882527|FG000|Overall Study|Adverse Event|97|||
30855058|NCT02706483|58882527|FG000|Overall Study|Death|1|||
30855059|NCT02706483|58882527|FG000|Overall Study|Lack of Efficacy|39|||
30855060|NCT02706483|58882527|FG000|Overall Study|Lost to Follow-up|101|||
30855061|NCT02706483|58882527|FG000|Overall Study|Non-compliance with study drug|15|||
30855062|NCT02706483|58882527|FG000|Overall Study|Physician Decision|6|||
30855063|NCT02706483|58882527|FG000|Overall Study|Pregnancy|6|||
30855064|NCT02706483|58882527|FG000|Overall Study|Protocol Violation|18|||
30855065|NCT02706483|58882527|FG000|Overall Study|Withdrawal by Subject|136|||
30855066|NCT02706483|58882527|FG000|Overall Study|Non-compliance with visits|6|||
30855067|NCT02706483|58882527|FG000|Overall Study|Site closure|4|||
30855068|NCT02706483|58882527|FG000|Overall Study|Subject moved|1|||
30665233|NCT00580840|58678805|FG002|Double-Blind|Withdrawal by Subject|2|||
30665234|NCT00580840|58678806|FG003|Double-Blind|Withdrawal by Subject|2|||
30665235|NCT00580840|58678803|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
30665236|NCT00580840|58678804|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
30665237|NCT00580840|58678805|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
30665238|NCT00580840|58678806|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
30665239|NCT00580840|58678803|FG000|Double-Blind|Other: Forbidden Medication|0|||
30855069|NCT01648348|58882534|FG000|Overall Study|Cancel|1|||
30855070|NCT01648348|58882535|FG001|Overall Study|Cancel|0|||
30855071|NCT01648348|58882536|FG002|Overall Study|Cancel|0|||
30855072|NCT01648348|58882537|FG003|Overall Study|Cancel|0|||
30855073|NCT01648348|58882538|FG004|Overall Study|Cancel|3|||
30855074|NCT01648348|58882539|FG005|Overall Study|Cancel|6|||
30855075|NCT01648348|58882534|FG000|Overall Study|Replaced for MTD analysis|1|||
30665240|NCT00580840|58678804|FG001|Double-Blind|Other: Forbidden Medication|0|||
30665241|NCT00580840|58678805|FG002|Double-Blind|Other: Forbidden Medication|1|||
30665242|NCT00580840|58678806|FG003|Double-Blind|Other: Forbidden Medication|0|||
30665243|NCT00879684|58678816|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
30665244|NCT00879684|58678817|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
30665245|NCT00879684|58678818|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
30665246|NCT00879684|58678819|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
30665247|NCT00879684|58678820|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
30665248|NCT00879684|58678821|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
30665249|NCT00879684|58678822|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
30665250|NCT00879684|58678816|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
30665251|NCT00879684|58678817|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
30958573|NCT01695239|59023642|FG012|Extension Long-Term Extension Periods|Death|0|||
30958574|NCT01695239|59023643|FG013|Extension Long-Term Extension Periods|Death|0|||
30855076|NCT01648348|58882535|FG001|Overall Study|Replaced for MTD analysis|0|||
30958575|NCT01695239|59023630|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30779950|NCT02996500|58791618|FG004|Overall Study|Non-Compliance With Study Drug|0|||
30779951|NCT02996500|58791619|FG005|Overall Study|Non-Compliance With Study Drug|1|||
30779952|NCT02996500|58791614|FG000|Overall Study|Progressive Disease|1|||
30779953|NCT02996500|58791615|FG001|Overall Study|Progressive Disease|0|||
30779954|NCT02996500|58791616|FG002|Overall Study|Progressive Disease|0|||
30779955|NCT02996500|58791617|FG003|Overall Study|Progressive Disease|0|||
30958576|NCT01695239|59023631|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30779956|NCT02996500|58791618|FG004|Overall Study|Progressive Disease|0|||
30958577|NCT01695239|59023632|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30958578|NCT01695239|59023633|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30779957|NCT02996500|58791619|FG005|Overall Study|Progressive Disease|0|||
30779958|NCT02996500|58791614|FG000|Overall Study|Other|2|||
30779959|NCT02996500|58791615|FG001|Overall Study|Other|0|||
30779960|NCT02996500|58791616|FG002|Overall Study|Other|2|||
30779961|NCT02996500|58791617|FG003|Overall Study|Other|0|||
30779962|NCT02996500|58791618|FG004|Overall Study|Other|0|||
30779963|NCT02996500|58791619|FG005|Overall Study|Other|0|||
30779964|NCT02996500|58791614|FG000|Overall Study|Protocol Violation|0|||
30665252|NCT00879684|58678818|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
30665253|NCT00879684|58678819|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
30665254|NCT00879684|58678820|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
30665255|NCT00879684|58678821|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
30665256|NCT00879684|58678822|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
30665257|NCT00879684|58678816|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
30665258|NCT00879684|58678817|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
30665259|NCT00879684|58678818|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
30665260|NCT00879684|58678819|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
30665261|NCT00879684|58678820|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
30665262|NCT00879684|58678821|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
30665263|NCT00879684|58678822|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
30665264|NCT00879684|58678816|FG000|Stage 1: Dose Escalation|Death|0|||
30665265|NCT00879684|58678817|FG001|Stage 1: Dose Escalation|Death|0|||
30665266|NCT00879684|58678818|FG002|Stage 1: Dose Escalation|Death|1|||
30665267|NCT00879684|58678819|FG003|Stage 1: Dose Escalation|Death|0|||
30665268|NCT00879684|58678820|FG004|Stage 1: Dose Escalation|Death|0|||
30665269|NCT00879684|58678821|FG005|Stage 1: Dose Escalation|Death|0|||
30665270|NCT00879684|58678822|FG006|Stage 1: Dose Escalation|Death|0|||
30665271|NCT00879684|58678816|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
30665272|NCT00879684|58678817|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
30665273|NCT00879684|58678818|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
30665274|NCT00879684|58678819|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
30665275|NCT00879684|58678820|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
30665276|NCT00879684|58678821|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
30665277|NCT00879684|58678822|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
30665278|NCT00879684|58678816|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
30665279|NCT00879684|58678817|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
30665280|NCT00879684|58678818|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
30665281|NCT00879684|58678819|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
30665282|NCT00879684|58678820|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
30665283|NCT00879684|58678821|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
30665284|NCT00879684|58678822|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
30665285|NCT00879684|58678816|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
30665286|NCT00879684|58678817|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
30665287|NCT00879684|58678818|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
30665288|NCT00879684|58678819|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
30665289|NCT00879684|58678820|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
30665290|NCT00879684|58678821|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
30665291|NCT00879684|58678822|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
30665292|NCT00581776|58678841|FG000|Overall Study|Disease progression or no response|3|||
30665293|NCT00883740|58678845|FG000|First Intervention|Lost to Follow-up|1|||
30665294|NCT00883740|58678846|FG001|First Intervention|Lost to Follow-up|0|||
30665295|NCT00883740|58678845|FG000|First Intervention|No longer willing to participate|2|||
30665296|NCT00883740|58678846|FG001|First Intervention|No longer willing to participate|0|||
30665297|NCT00883740|58678845|FG000|First Intervention|Protocol Violation|3|||
30665298|NCT00883740|58678846|FG001|First Intervention|Protocol Violation|6|||
30665299|NCT00883740|58678845|FG000|First Intervention|Adverse Event|1|||
30665300|NCT00883740|58678846|FG001|First Intervention|Adverse Event|2|||
30665301|NCT00883740|58678845|FG000|Second Intervention|Protocol Violation|1|||
30665302|NCT00883740|58678846|FG001|Second Intervention|Protocol Violation|0|||
30665303|NCT00883740|58678845|FG000|Second Intervention|No longer willing to participate|0|||
30665304|NCT00883740|58678846|FG001|Second Intervention|No longer willing to participate|1|||
30665305|NCT00597012|58678854|FG000|Overall Study|Death|1|||
30665306|NCT00597012|58678855|FG001|Overall Study|Death|1|||
30665307|NCT00597012|58678854|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
30665308|NCT00597012|58678855|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
30665309|NCT00597012|58678854|FG000|Overall Study|Withdrawal by Subject|7|||
30665310|NCT00597012|58678855|FG001|Overall Study|Withdrawal by Subject|4|||
30665311|NCT00597012|58678854|FG000|Overall Study|Ineligible|2|||
30665312|NCT00597012|58678855|FG001|Overall Study|Ineligible|0|||
30665313|NCT00597012|58678854|FG000|Overall Study|Lost to Follow-up|0|||
30665314|NCT00597012|58678855|FG001|Overall Study|Lost to Follow-up|2|||
30665315|NCT00542815|58678866|FG000|Overall Study|Adverse Event|19|||
30958579|NCT01695239|59023634|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30665316|NCT00542815|58678867|FG001|Overall Study|Adverse Event|6|||
30665317|NCT00542815|58678868|FG002|Overall Study|Adverse Event|9|||
30958580|NCT01695239|59023635|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30958581|NCT01695239|59023636|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30958582|NCT01695239|59023637|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30958583|NCT01695239|59023638|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30958584|NCT01695239|59023639|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30958585|NCT01695239|59023640|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
30665318|NCT00542815|58678866|FG000|Overall Study|Death|10|||
30855077|NCT01648348|58882536|FG002|Overall Study|Replaced for MTD analysis|1|||
30855078|NCT01648348|58882537|FG003|Overall Study|Replaced for MTD analysis|0|||
30665319|NCT00542815|58678867|FG001|Overall Study|Death|7|||
30665320|NCT00542815|58678868|FG002|Overall Study|Death|3|||
30665321|NCT00542815|58678866|FG000|Overall Study|Lack of Efficacy|9|||
30665322|NCT00542815|58678867|FG001|Overall Study|Lack of Efficacy|2|||
30665323|NCT00542815|58678868|FG002|Overall Study|Lack of Efficacy|0|||
30665324|NCT00542815|58678866|FG000|Overall Study|Physician Decision|2|||
30665325|NCT00542815|58678867|FG001|Overall Study|Physician Decision|1|||
30665326|NCT00542815|58678868|FG002|Overall Study|Physician Decision|0|||
30665327|NCT00542815|58678866|FG000|Overall Study|Protocol Violation|1|||
30665328|NCT00542815|58678867|FG001|Overall Study|Protocol Violation|1|||
30665329|NCT00542815|58678868|FG002|Overall Study|Protocol Violation|2|||
30665330|NCT00542815|58678866|FG000|Overall Study|Withdrawal by Subject|41|||
30665331|NCT00542815|58678867|FG001|Overall Study|Withdrawal by Subject|5|||
30665332|NCT00542815|58678868|FG002|Overall Study|Withdrawal by Subject|8|||
30665333|NCT00542815|58678866|FG000|Overall Study|Other reasons|24|||
30665334|NCT00542815|58678867|FG001|Overall Study|Other reasons|10|||
30665335|NCT00542815|58678868|FG002|Overall Study|Other reasons|10|||
30665336|NCT00542425|58678881|FG000|Initial 24 Weeks|Administrative reasons|0|||
30665337|NCT00542425|58678882|FG001|Initial 24 Weeks|Administrative reasons|0|||
30665338|NCT00542425|58678883|FG002|Initial 24 Weeks|Administrative reasons|1|||
30665339|NCT00542425|58678884|FG003|Initial 24 Weeks|Administrative reasons|1|||
30665340|NCT00542425|58678885|FG004|Initial 24 Weeks|Administrative reasons|0|||
30665341|NCT00542425|58678881|FG000|Initial 24 Weeks|Adverse Event|0|||
30665342|NCT00542425|58678882|FG001|Initial 24 Weeks|Adverse Event|1|||
30665343|NCT00542425|58678883|FG002|Initial 24 Weeks|Adverse Event|1|||
30665344|NCT00542425|58678884|FG003|Initial 24 Weeks|Adverse Event|3|||
30665345|NCT00542425|58678885|FG004|Initial 24 Weeks|Adverse Event|2|||
30665346|NCT00542425|58678881|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
30665347|NCT00542425|58678882|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
30665348|NCT00542425|58678883|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
30665349|NCT00542425|58678884|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
30665350|NCT00542425|58678885|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
30665351|NCT00542425|58678881|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
30665352|NCT00542425|58678882|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
30665353|NCT00542425|58678883|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
30665354|NCT00542425|58678884|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
30665355|NCT00542425|58678885|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
30665356|NCT00542425|58678881|FG000|Initial 24 Weeks|Non-compliance|0|||
30665357|NCT00542425|58678882|FG001|Initial 24 Weeks|Non-compliance|0|||
30665358|NCT00542425|58678883|FG002|Initial 24 Weeks|Non-compliance|0|||
30665359|NCT00542425|58678884|FG003|Initial 24 Weeks|Non-compliance|1|||
30665360|NCT00542425|58678885|FG004|Initial 24 Weeks|Non-compliance|1|||
30665361|NCT00542425|58678881|FG000|Initial 24 Weeks|Protocol Violation|0|||
30665362|NCT00542425|58678882|FG001|Initial 24 Weeks|Protocol Violation|0|||
30665363|NCT00542425|58678883|FG002|Initial 24 Weeks|Protocol Violation|0|||
30665364|NCT00542425|58678884|FG003|Initial 24 Weeks|Protocol Violation|1|||
30665365|NCT00542425|58678885|FG004|Initial 24 Weeks|Protocol Violation|0|||
30665366|NCT00542425|58678881|FG000|Initial 24 Weeks|Refusal of treatment|2|||
30665367|NCT00542425|58678882|FG001|Initial 24 Weeks|Refusal of treatment|2|||
30665368|NCT00542425|58678883|FG002|Initial 24 Weeks|Refusal of treatment|1|||
30665369|NCT00542425|58678884|FG003|Initial 24 Weeks|Refusal of treatment|4|||
30665370|NCT00542425|58678885|FG004|Initial 24 Weeks|Refusal of treatment|1|||
30665371|NCT00542425|58678881|FG000|Initial 24 Weeks|Other|0|||
30779965|NCT02996500|58791615|FG001|Overall Study|Protocol Violation|0|||
30779966|NCT02996500|58791616|FG002|Overall Study|Protocol Violation|0|||
30958586|NCT01695239|59023641|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
30958587|NCT01695239|59023642|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
30958588|NCT01695239|59023643|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
30958589|NCT01695239|59023630|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30958590|NCT01695239|59023631|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30958591|NCT01695239|59023632|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30665372|NCT00542425|58678882|FG001|Initial 24 Weeks|Other|2|||
30665373|NCT00542425|58678883|FG002|Initial 24 Weeks|Other|1|||
30665374|NCT00542425|58678884|FG003|Initial 24 Weeks|Other|0|||
30665375|NCT00542425|58678885|FG004|Initial 24 Weeks|Other|0|||
30665376|NCT00542425|58678881|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
30665377|NCT00542425|58678882|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
30665378|NCT00542425|58678883|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
30665379|NCT00542425|58678884|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
30665380|NCT00542425|58678885|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
30665381|NCT00542425|58678881|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
30665382|NCT00542425|58678882|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
30665383|NCT00542425|58678883|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
30665384|NCT00542425|58678884|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
30665385|NCT00542425|58678885|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
30665386|NCT00542425|58678881|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
30665387|NCT00542425|58678882|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
30665388|NCT00542425|58678883|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
30665389|NCT00542425|58678884|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
30665390|NCT00542425|58678885|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
30665391|NCT00542425|58678881|FG000|Extended 24 Weeks of Treatment|Other|1|||
30665392|NCT00542425|58678882|FG001|Extended 24 Weeks of Treatment|Other|1|||
30665393|NCT00542425|58678883|FG002|Extended 24 Weeks of Treatment|Other|0|||
30665394|NCT00542425|58678884|FG003|Extended 24 Weeks of Treatment|Other|0|||
30665395|NCT00542425|58678885|FG004|Extended 24 Weeks of Treatment|Other|1|||
30665396|NCT00541099|58678897|FG000|Overall Study|Ineligible|3|||
30665397|NCT00580606|58678903|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
30665398|NCT00580606|58678904|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
30665399|NCT00580606|58678903|FG000|Open Label (OL)|Withdrawal by Subject|4|||
30665400|NCT00580606|58678904|FG001|Open Label (OL)|Withdrawal by Subject|6|||
30665401|NCT00580606|58678903|FG000|Open Label (OL)|Dosing Symptoms|0|||
30665402|NCT00580606|58678904|FG001|Open Label (OL)|Dosing Symptoms|1|||
30665403|NCT00580606|58678903|FG000|Open Label (OL)|Lost to Follow-up|0|||
30665404|NCT00580606|58678904|FG001|Open Label (OL)|Lost to Follow-up|1|||
30665405|NCT00580606|58678903|FG000|Open Label (OL)|Pregnancy|0|||
30665406|NCT00580606|58678904|FG001|Open Label (OL)|Pregnancy|1|||
30665407|NCT00580606|58678903|FG000|Open Label (OL)|Non-compliance|2|||
30665408|NCT00580606|58678904|FG001|Open Label (OL)|Non-compliance|0|||
30665409|NCT00580606|58678903|FG000|Open Label (OL)|Physician Decision|1|||
30665410|NCT00580606|58678904|FG001|Open Label (OL)|Physician Decision|1|||
30665411|NCT00580606|58678903|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
30665412|NCT00580606|58678904|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
30665413|NCT00579982|58678918|FG000|Overall Study|Adverse Event|4|||
30665414|NCT00579982|58678918|FG000|Overall Study|Protocol Violation|4|||
30665415|NCT00596466|58678922|FG000|Overall Study|Lack of Efficacy|5|||
30665416|NCT00596466|58678922|FG000|Overall Study|Adverse Event|4|||
30665417|NCT00596466|58678922|FG000|Overall Study|Withdrawal by Subject|2|||
30665418|NCT00596466|58678922|FG000|Overall Study|Protocol Violation|2|||
30665419|NCT00596466|58678922|FG000|Overall Study|Unpecified|2|||
30665420|NCT00596466|58678922|FG000|Overall Study|Enrolled, not treated|2|||
30665421|NCT00596934|58678926|FG000|Overall Study|Protocol Violation|1|||
30665422|NCT00596934|58678926|FG000|Overall Study|Withdrawal by Subject|1|||
30665423|NCT03911401|58678935|FG000|Overall Study|Adverse Event|1|||
30665424|NCT03911401|58678936|FG001|Overall Study|Adverse Event|2|||
30665425|NCT03911401|58678937|FG002|Overall Study|Adverse Event|5|||
30665426|NCT03911401|58678935|FG000|Overall Study|Lack of Efficacy|1|||
30665427|NCT03911401|58678936|FG001|Overall Study|Lack of Efficacy|1|||
30665428|NCT03911401|58678937|FG002|Overall Study|Lack of Efficacy|8|||
30665429|NCT03911401|58678935|FG000|Overall Study|Physician Decision|0|||
30665430|NCT03911401|58678936|FG001|Overall Study|Physician Decision|0|||
30665431|NCT03911401|58678937|FG002|Overall Study|Physician Decision|1|||
30665432|NCT03911401|58678935|FG000|Overall Study|Withdrawal by Subject|1|||
30665433|NCT03911401|58678936|FG001|Overall Study|Withdrawal by Subject|2|||
30665434|NCT03911401|58678937|FG002|Overall Study|Withdrawal by Subject|0|||
30665435|NCT03911401|58678935|FG000|Overall Study|Withdrawal by parent/guardian|4|||
30665436|NCT03911401|58678936|FG001|Overall Study|Withdrawal by parent/guardian|4|||
30665437|NCT03911401|58678937|FG002|Overall Study|Withdrawal by parent/guardian|11|||
30665438|NCT00579670|58678950|FG000|Overall Study|Death|1|||
30665439|NCT00579670|58678951|FG001|Overall Study|Death|0|||
30665440|NCT00579670|58678952|FG002|Overall Study|Death|0|||
30665441|NCT00579670|58678953|FG003|Overall Study|Death|0|||
30665442|NCT00579670|58678954|FG004|Overall Study|Death|0|||
30665443|NCT00579670|58678950|FG000|Overall Study|Adverse Event|1|||
30665444|NCT00579670|58678951|FG001|Overall Study|Adverse Event|0|||
30665445|NCT00579670|58678952|FG002|Overall Study|Adverse Event|1|||
30665446|NCT00579670|58678953|FG003|Overall Study|Adverse Event|2|||
30665447|NCT00579670|58678954|FG004|Overall Study|Adverse Event|0|||
30665448|NCT00579670|58678950|FG000|Overall Study|Lack of Efficacy|0|||
30855079|NCT01648348|58882538|FG004|Overall Study|Replaced for MTD analysis|0|||
30855080|NCT01648348|58882539|FG005|Overall Study|Replaced for MTD analysis|0|||
30855081|NCT01648270|58882552|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
30855082|NCT02302846|58882562|FG000|Overall Study|Withdrawal by Subject|1|||
30855083|NCT02336230|58882566|FG000|Overall Study|Adverse Event|1|||
30855084|NCT02336230|58882566|FG000|Overall Study|Withdrawal of consent|1|||
30855085|NCT02336230|58882566|FG000|Overall Study|Death|9|||
30855086|NCT02336230|58882566|FG000|Overall Study|Dose not received due to shipping delay|1|||
30855087|NCT02336230|58882566|FG000|Overall Study|Discontinuation of MSC infusion|1|||
30855088|NCT02302222|58882572|FG000|Overall Study|Physician Decision|0|||
30855089|NCT02302222|58882573|FG001|Overall Study|Physician Decision|4|||
30855090|NCT02302222|58882572|FG000|Overall Study|Lost to Follow-up|1|||
30855091|NCT02302222|58882573|FG001|Overall Study|Lost to Follow-up|0|||
30855092|NCT02302222|58882572|FG000|Overall Study|Treatment discontinued before day 5|0|||
30855093|NCT02302222|58882573|FG001|Overall Study|Treatment discontinued before day 5|1|||
30855094|NCT02302222|58882572|FG000|Overall Study|Withdrawn prior to any treatment|0|||
30855095|NCT02302222|58882573|FG001|Overall Study|Withdrawn prior to any treatment|1|||
30855096|NCT02336074|58882581|FG000|Overall Study|Adverse Event|0|||
30855097|NCT02336074|58882582|FG001|Overall Study|Adverse Event|2|||
30855098|NCT02335450|58882593|FG000|Overall Study|Pregnancy|1|||
30855099|NCT04826900|58882605|FG000|Overall Study|Family factor|1|||
30855100|NCT04826900|58882606|FG001|Overall Study|Family factor|1|||
30855101|NCT02302066|58882616|FG000|Overall Study|Adverse Event|1|||
30855102|NCT02302066|58882617|FG001|Overall Study|Adverse Event|1|||
30855103|NCT02302066|58882618|FG002|Overall Study|Adverse Event|3|||
30855104|NCT02302066|58882619|FG003|Overall Study|Adverse Event|0|||
30855105|NCT02302066|58882616|FG000|Overall Study|Lost to Follow-up|4|||
30855106|NCT02302066|58882617|FG001|Overall Study|Lost to Follow-up|5|||
30855107|NCT02302066|58882618|FG002|Overall Study|Lost to Follow-up|24|||
30855108|NCT02302066|58882619|FG003|Overall Study|Lost to Follow-up|7|||
30855109|NCT02302066|58882616|FG000|Overall Study|Withdrawal by Subject|25|||
30855110|NCT02302066|58882617|FG001|Overall Study|Withdrawal by Subject|58|||
30855111|NCT02302066|58882618|FG002|Overall Study|Withdrawal by Subject|124|||
30665449|NCT00579670|58678951|FG001|Overall Study|Lack of Efficacy|0|||
30665450|NCT00579670|58678952|FG002|Overall Study|Lack of Efficacy|1|||
30665451|NCT00579670|58678953|FG003|Overall Study|Lack of Efficacy|14|||
30665452|NCT00579670|58678954|FG004|Overall Study|Lack of Efficacy|0|||
30665453|NCT00579670|58678950|FG000|Overall Study|Lost to Follow-up|0|||
30855112|NCT02302066|58882619|FG003|Overall Study|Withdrawal by Subject|33|||
30855113|NCT02302066|58882616|FG000|Overall Study|Pregnancy|2|||
30855114|NCT02302066|58882617|FG001|Overall Study|Pregnancy|10|||
30855115|NCT02302066|58882618|FG002|Overall Study|Pregnancy|12|||
30855116|NCT02302066|58882619|FG003|Overall Study|Pregnancy|0|||
30958592|NCT01695239|59023633|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30958593|NCT01695239|59023634|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30665454|NCT00579670|58678951|FG001|Overall Study|Lost to Follow-up|1|||
30855117|NCT02302066|58882616|FG000|Overall Study|Reason Not Specified|1|||
30855118|NCT02302066|58882617|FG001|Overall Study|Reason Not Specified|1|||
30855119|NCT02302066|58882618|FG002|Overall Study|Reason Not Specified|9|||
30665455|NCT00579670|58678952|FG002|Overall Study|Lost to Follow-up|0|||
30855120|NCT02302066|58882619|FG003|Overall Study|Reason Not Specified|1|||
30958594|NCT01695239|59023635|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30665456|NCT00579670|58678953|FG003|Overall Study|Lost to Follow-up|4|||
30665457|NCT00579670|58678954|FG004|Overall Study|Lost to Follow-up|0|||
30665458|NCT00579670|58678950|FG000|Overall Study|Other|0|||
30665459|NCT00579670|58678951|FG001|Overall Study|Other|0|||
30665460|NCT00579670|58678952|FG002|Overall Study|Other|1|||
30665461|NCT00579670|58678953|FG003|Overall Study|Other|2|||
30665462|NCT00579670|58678954|FG004|Overall Study|Other|0|||
30665463|NCT00579670|58678950|FG000|Overall Study|Withdrawal by Subject|0|||
30665464|NCT00579670|58678951|FG001|Overall Study|Withdrawal by Subject|0|||
30665465|NCT00579670|58678952|FG002|Overall Study|Withdrawal by Subject|1|||
30665466|NCT00579670|58678953|FG003|Overall Study|Withdrawal by Subject|0|||
30665467|NCT00579670|58678954|FG004|Overall Study|Withdrawal by Subject|0|||
30665468|NCT03909295|58678978|FG000|Overall Study|Adverse Event|2|||
30665469|NCT03909295|58678978|FG000|Overall Study|Study terminated by sponsor|50|||
30665470|NCT00599924|58678989|FG000|Overall Study|Lack of Efficacy|3|||
30665471|NCT00599924|58678990|FG001|Overall Study|Lack of Efficacy|5|||
30665472|NCT00599924|58678991|FG002|Overall Study|Lack of Efficacy|1|||
30665473|NCT00599924|58678992|FG003|Overall Study|Lack of Efficacy|2|||
30665474|NCT00599924|58678993|FG004|Overall Study|Lack of Efficacy|3|||
30665475|NCT00599924|58678994|FG005|Overall Study|Lack of Efficacy|2|||
30665476|NCT00599924|58678995|FG006|Overall Study|Lack of Efficacy|0|||
30665477|NCT00599924|58678989|FG000|Overall Study|Adverse Event|0|||
30665478|NCT00599924|58678990|FG001|Overall Study|Adverse Event|0|||
30665479|NCT00599924|58678991|FG002|Overall Study|Adverse Event|0|||
30665480|NCT00599924|58678992|FG003|Overall Study|Adverse Event|2|||
30665481|NCT00599924|58678993|FG004|Overall Study|Adverse Event|0|||
30665482|NCT00599924|58678994|FG005|Overall Study|Adverse Event|0|||
30665483|NCT00599924|58678995|FG006|Overall Study|Adverse Event|2|||
30665484|NCT00599924|58678989|FG000|Overall Study|Death|0|||
30665485|NCT00599924|58678990|FG001|Overall Study|Death|0|||
30779967|NCT02996500|58791617|FG003|Overall Study|Protocol Violation|1|||
30779968|NCT02996500|58791618|FG004|Overall Study|Protocol Violation|0|||
30665486|NCT00599924|58678991|FG002|Overall Study|Death|0|||
30665487|NCT00599924|58678992|FG003|Overall Study|Death|2|||
30665488|NCT00599924|58678993|FG004|Overall Study|Death|0|||
30665489|NCT00599924|58678994|FG005|Overall Study|Death|2|||
30665490|NCT00599924|58678995|FG006|Overall Study|Death|1|||
30665491|NCT00599924|58678989|FG000|Overall Study|Protocol Violation|0|||
30665492|NCT00599924|58678990|FG001|Overall Study|Protocol Violation|0|||
30665493|NCT00599924|58678991|FG002|Overall Study|Protocol Violation|0|||
30665494|NCT00599924|58678992|FG003|Overall Study|Protocol Violation|1|||
30665495|NCT00599924|58678993|FG004|Overall Study|Protocol Violation|0|||
30665496|NCT00599924|58678994|FG005|Overall Study|Protocol Violation|0|||
30665497|NCT00599924|58678995|FG006|Overall Study|Protocol Violation|0|||
30665498|NCT00599924|58678989|FG000|Overall Study|Withdrawal by Subject|0|||
30665499|NCT00599924|58678990|FG001|Overall Study|Withdrawal by Subject|0|||
30665500|NCT00599924|58678991|FG002|Overall Study|Withdrawal by Subject|1|||
30665501|NCT00599924|58678992|FG003|Overall Study|Withdrawal by Subject|0|||
30665502|NCT00599924|58678993|FG004|Overall Study|Withdrawal by Subject|1|||
30779969|NCT02996500|58791619|FG005|Overall Study|Protocol Violation|0|||
30779970|NCT02996500|58791614|FG000|Overall Study|Withdrawal by Subject|3|||
30779971|NCT02996500|58791615|FG001|Overall Study|Withdrawal by Subject|0|||
30665503|NCT00599924|58678994|FG005|Overall Study|Withdrawal by Subject|0|||
30665504|NCT00599924|58678995|FG006|Overall Study|Withdrawal by Subject|0|||
30665505|NCT00599924|58678989|FG000|Overall Study|Other|0|||
30665506|NCT00599924|58678990|FG001|Overall Study|Other|0|||
30665507|NCT00599924|58678991|FG002|Overall Study|Other|0|||
30665508|NCT00599924|58678992|FG003|Overall Study|Other|1|||
30665509|NCT00599924|58678993|FG004|Overall Study|Other|2|||
30665510|NCT00599924|58678994|FG005|Overall Study|Other|0|||
30665511|NCT00599924|58678995|FG006|Overall Study|Other|2|||
30665512|NCT00581542|58679018|FG000|Overall Study|they met an exclusion criteria|2|||
30665513|NCT00581542|58679019|FG001|Overall Study|they met an exclusion criteria|2|||
30665514|NCT00581542|58679018|FG000|Overall Study|Lost to Follow-up|9|||
30665515|NCT00581542|58679019|FG001|Overall Study|Lost to Follow-up|21|||
30665516|NCT03912337|58679029|FG000|Overall Study|Withdrawal of Consent From Study|1|||
30665517|NCT03912337|58679030|FG001|Overall Study|Withdrawal of Consent From Study|0|||
30665518|NCT03912337|58679029|FG000|Overall Study|Lost to Follow-up|1|||
30665519|NCT03912337|58679030|FG001|Overall Study|Lost to Follow-up|1|||
30665520|NCT03912259|58679038|FG000|Overall Study|Adverse Event (AE)|2|||
30665521|NCT03912259|58679039|FG001|Overall Study|Adverse Event (AE)|4|||
30665522|NCT03912259|58679038|FG000|Overall Study|Lack of Efficacy|4|||
30665523|NCT03912259|58679039|FG001|Overall Study|Lack of Efficacy|1|||
30665524|NCT03912259|58679038|FG000|Overall Study|Withdrawal by Subject|11|||
30665525|NCT03912259|58679039|FG001|Overall Study|Withdrawal by Subject|1|||
30665526|NCT02121652|58679048|FG000|Overall Study|Lost to Follow-up|2|||
30665527|NCT02121652|58679049|FG001|Overall Study|Lost to Follow-up|1|||
30665528|NCT02121652|58679048|FG000|Overall Study|Death|1|||
30665529|NCT02121652|58679049|FG001|Overall Study|Death|0|||
30665530|NCT02121652|58679048|FG000|Overall Study|Withdrawal by Subject|3|||
30665531|NCT02121652|58679049|FG001|Overall Study|Withdrawal by Subject|3|||
30665532|NCT00595920|58679068|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
30665533|NCT00595764|58679074|FG000|Overall Study|Protocol Violation|24|||
30665534|NCT00595764|58679075|FG001|Overall Study|Protocol Violation|19|||
30665535|NCT00595764|58679074|FG000|Overall Study|Missed Medication >1 week|10|||
30665536|NCT00595764|58679075|FG001|Overall Study|Missed Medication >1 week|17|||
30665537|NCT00595764|58679074|FG000|Overall Study|Missed 3 PM visits|1|||
30665538|NCT00595764|58679075|FG001|Overall Study|Missed 3 PM visits|7|||
30665539|NCT00595764|58679074|FG000|Overall Study|Withdrawal by Subject|4|||
30665540|NCT00595764|58679075|FG001|Overall Study|Withdrawal by Subject|0|||
30665541|NCT00581308|58679095|FG000|Pre Discharge|Lost to Follow-up|1|||
30665542|NCT00581308|58679095|FG000|Pre Discharge|Device Removed|1|||
30665543|NCT00581308|58679095|FG000|Month 1|Lost to Follow-up|3|||
30665544|NCT00581308|58679095|FG000|Month 1|Withdrawal by Subject|2|||
30665545|NCT00581308|58679095|FG000|Month 1|Device Removed|2|||
30665546|NCT00581308|58679095|FG000|Month 1|Uknown|1|||
30665547|NCT00581308|58679095|FG000|Month 6|Lost to Follow-up|1|||
30665548|NCT00581308|58679095|FG000|Month 6|Withdrawal by Subject|2|||
30665549|NCT00581308|58679095|FG000|Month 12|Death|1|||
30665550|NCT00581308|58679095|FG000|Month 12|Lost to Follow-up|14|||
30665551|NCT00581308|58679095|FG000|Month 12|Withdrawal by Subject|3|||
30779972|NCT02996500|58791616|FG002|Overall Study|Withdrawal by Subject|3|||
30855121|NCT02301988|58882641|FG000|Overall Study|Withdrawal by Subject|2|||
30855122|NCT02301988|58882642|FG001|Overall Study|Withdrawal by Subject|1|||
30855123|NCT02301988|58882641|FG000|Overall Study|Physician Decision|2|||
30855124|NCT02301988|58882642|FG001|Overall Study|Physician Decision|2|||
30665552|NCT00581308|58679095|FG000|Month 12|Device Removed|1|||
30665553|NCT00581308|58679095|FG000|Month 12|Other|1|||
30665554|NCT00877890|58679104|FG000|Overall Study|Adverse Event|6|||
30665555|NCT00877890|58679105|FG001|Overall Study|Adverse Event|6|||
30665556|NCT00877890|58679104|FG000|Overall Study|Lost to Follow-up|5|||
30665557|NCT00877890|58679105|FG001|Overall Study|Lost to Follow-up|5|||
30665558|NCT00877890|58679104|FG000|Overall Study|Protocol Violation|0|||
30665559|NCT00877890|58679105|FG001|Overall Study|Protocol Violation|1|||
30665560|NCT00877890|58679104|FG000|Overall Study|Withdrawal of Consent|6|||
30665561|NCT00877890|58679105|FG001|Overall Study|Withdrawal of Consent|12|||
30665562|NCT00877890|58679104|FG000|Overall Study|Investigator Decision|0|||
30665563|NCT00877890|58679105|FG001|Overall Study|Investigator Decision|2|||
30665564|NCT00877890|58679104|FG000|Overall Study|Loss of Glucose Control|3|||
30665565|NCT00877890|58679105|FG001|Overall Study|Loss of Glucose Control|4|||
30665566|NCT03474679|58679115|FG000|Overall Study|Death|7|||
30665567|NCT03474679|58679115|FG000|Overall Study|Withdrawal by Subject|1|||
30665568|NCT03472885|58679119|FG000|Overall Study|Adverse Event|1|||
30665569|NCT03905863|58679125|FG000|Overall Study|Adverse Event|2|||
30665570|NCT03905863|58679126|FG001|Overall Study|Adverse Event|4|||
30665571|NCT03905863|58679125|FG000|Overall Study|Withdrawal by Subject|2|||
30665572|NCT03905863|58679126|FG001|Overall Study|Withdrawal by Subject|2|||
30665573|NCT03905863|58679125|FG000|Overall Study|Physician Decision|0|||
30665574|NCT03905863|58679126|FG001|Overall Study|Physician Decision|3|||
30665575|NCT03905863|58679125|FG000|Overall Study|Lost to Follow-up|1|||
30665576|NCT03905863|58679126|FG001|Overall Study|Lost to Follow-up|0|||
30665577|NCT03905863|58679125|FG000|Overall Study|Protocol Violation|0|||
30665578|NCT03905863|58679126|FG001|Overall Study|Protocol Violation|2|||
30665579|NCT03905863|58679125|FG000|Overall Study|Death|0|||
30665580|NCT03905863|58679126|FG001|Overall Study|Death|1|||
30665581|NCT04067011|58679135|FG000|Overall Study|Not Treated|8|||
30665582|NCT04067011|58679136|FG001|Overall Study|Not Treated|7|||
30665583|NCT04067011|58679137|FG002|Overall Study|Not Treated|5|||
30665584|NCT04067011|58679135|FG000|Overall Study|Adverse Event|2|||
30665585|NCT04067011|58679136|FG001|Overall Study|Adverse Event|1|||
30665586|NCT04067011|58679137|FG002|Overall Study|Adverse Event|0|||
30665587|NCT04067011|58679135|FG000|Overall Study|Withdrawal by Subject|6|||
30665588|NCT04067011|58679136|FG001|Overall Study|Withdrawal by Subject|2|||
30665589|NCT04067011|58679137|FG002|Overall Study|Withdrawal by Subject|1|||
30665590|NCT04067011|58679135|FG000|Overall Study|Lost to Follow-up|0|||
30665591|NCT04067011|58679136|FG001|Overall Study|Lost to Follow-up|0|||
30665592|NCT04067011|58679137|FG002|Overall Study|Lost to Follow-up|1|||
30665593|NCT04067011|58679135|FG000|Overall Study|Physician Decision|1|||
30665594|NCT04067011|58679136|FG001|Overall Study|Physician Decision|1|||
30665595|NCT04067011|58679137|FG002|Overall Study|Physician Decision|0|||
30665596|NCT04067011|58679135|FG000|Overall Study|Other Reasons|2|||
30665597|NCT04067011|58679136|FG001|Overall Study|Other Reasons|0|||
30665598|NCT04067011|58679137|FG002|Overall Study|Other Reasons|1|||
30665599|NCT04067011|58679135|FG000|Overall Study|Missing|0|||
30665600|NCT04067011|58679136|FG001|Overall Study|Missing|2|||
30665601|NCT04067011|58679137|FG002|Overall Study|Missing|0|||
30665602|NCT00539305|58679181|FG000|Overall Study|Adverse Event|1|||
30855125|NCT02301988|58882641|FG000|Overall Study|Unknown Reason|1|||
30665603|NCT00539305|58679182|FG001|Overall Study|Adverse Event|0|||
30665604|NCT00539305|58679181|FG000|Overall Study|Substance Use|0|||
30665605|NCT00539305|58679182|FG001|Overall Study|Substance Use|1|||
30665606|NCT00539305|58679181|FG000|Overall Study|Withdrawal by Subject|0|||
30665607|NCT00539305|58679182|FG001|Overall Study|Withdrawal by Subject|1|||
30665608|NCT04469465|58679209|FG000|Overall Study|Adverse Event|2|||
30665609|NCT04469465|58679210|FG001|Overall Study|Adverse Event|1|||
30665610|NCT04469465|58679209|FG000|Overall Study|Ongoing treatment|7|||
30665611|NCT04469465|58679210|FG001|Overall Study|Ongoing treatment|4|||
30665612|NCT04469465|58679209|FG000|Overall Study|Withdrawal by Subject|0|||
30665613|NCT04469465|58679210|FG001|Overall Study|Withdrawal by Subject|1|||
30665614|NCT00877032|58679223|FG000|Overall Study|Did not meet entrance criteria|0|||
30665615|NCT00877032|58679224|FG001|Overall Study|Did not meet entrance criteria|0|||
30665616|NCT00877032|58679225|FG002|Overall Study|Did not meet entrance criteria|0|||
30665617|NCT00877032|58679226|FG003|Overall Study|Did not meet entrance criteria|1|||
30665618|NCT00877032|58679227|FG004|Overall Study|Did not meet entrance criteria|0|||
30665619|NCT00877032|58679228|FG005|Overall Study|Did not meet entrance criteria|0|||
30665620|NCT00877032|58679229|FG006|Overall Study|Did not meet entrance criteria|2|||
30665621|NCT00538681|58679268|FG000|Overall Study|Progressive Disease|7|||
30665622|NCT00538681|58679269|FG001|Overall Study|Progressive Disease|0|||
30665623|NCT00538681|58679270|FG002|Overall Study|Progressive Disease|1|||
30665624|NCT00538681|58679271|FG003|Overall Study|Progressive Disease|0|||
30665625|NCT00538681|58679268|FG000|Overall Study|Sponsor Decision|1|||
30665626|NCT00538681|58679269|FG001|Overall Study|Sponsor Decision|3|||
30665627|NCT00538681|58679270|FG002|Overall Study|Sponsor Decision|8|||
30665628|NCT00538681|58679271|FG003|Overall Study|Sponsor Decision|9|||
30665629|NCT00538681|58679268|FG000|Overall Study|Adverse Event|1|||
30665630|NCT00538681|58679269|FG001|Overall Study|Adverse Event|1|||
30665631|NCT00538681|58679270|FG002|Overall Study|Adverse Event|1|||
30665632|NCT00538681|58679271|FG003|Overall Study|Adverse Event|0|||
30665633|NCT00538681|58679268|FG000|Overall Study|Death|0|||
30665634|NCT00538681|58679269|FG001|Overall Study|Death|0|||
30665635|NCT00538681|58679270|FG002|Overall Study|Death|1|||
30665636|NCT00538681|58679271|FG003|Overall Study|Death|1|||
30665637|NCT00538681|58679268|FG000|Overall Study|Investigator Decision|0|||
30665638|NCT00538681|58679269|FG001|Overall Study|Investigator Decision|0|||
30665639|NCT00538681|58679270|FG002|Overall Study|Investigator Decision|0|||
30665640|NCT00538681|58679271|FG003|Overall Study|Investigator Decision|1|||
30665641|NCT00876018|58679285|FG000|Overall Study|Lost to Follow-up|0|||
30665642|NCT00876018|58679286|FG001|Overall Study|Lost to Follow-up|1|||
30665643|NCT00876018|58679287|FG002|Overall Study|Lost to Follow-up|1|||
30665644|NCT00876018|58679285|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
30665645|NCT00876018|58679286|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
30665646|NCT00876018|58679287|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
30665647|NCT03885934|58679312|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
30665648|NCT03885934|58679313|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
30665649|NCT03885934|58679314|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
30665650|NCT03885934|58679315|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
30665651|NCT03885934|58679316|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
30665652|NCT03885934|58679317|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
30665653|NCT00875706|58679334|FG000|Overall Study|Withdrawal by Subject|1|||
30665654|NCT00875706|58679335|FG001|Overall Study|Withdrawal by Subject|0|||
30665655|NCT00875706|58679336|FG002|Overall Study|Withdrawal by Subject|0|||
30665656|NCT04399889|58679347|FG000|Overall Study|Death|5|||
30665657|NCT04399889|58679348|FG001|Overall Study|Death|1|||
30665658|NCT04399889|58679349|FG002|Overall Study|Death|1|||
30665659|NCT00837265|58679364|FG000|Pilot Phase|Withdrawal by Subject|0|||
30665660|NCT00837265|58679365|FG001|Pilot Phase|Withdrawal by Subject|2|||
30665661|NCT00837265|58679366|FG002|Pilot Phase|Withdrawal by Subject|3|||
30665662|NCT00837265|58679367|FG003|Pilot Phase|Withdrawal by Subject|2|||
30665663|NCT00837265|58679368|FG004|Pilot Phase|Withdrawal by Subject|0|||
30665664|NCT00837265|58679369|FG005|Pilot Phase|Withdrawal by Subject|0|||
30665665|NCT00837265|58679370|FG006|Pilot Phase|Withdrawal by Subject|0|||
30665666|NCT00837265|58679364|FG000|Pilot Phase|Decision of the investigator|2|||
30665667|NCT00837265|58679365|FG001|Pilot Phase|Decision of the investigator|1|||
30665668|NCT00837265|58679366|FG002|Pilot Phase|Decision of the investigator|0|||
30779973|NCT02996500|58791617|FG003|Overall Study|Withdrawal by Subject|0|||
30779974|NCT02996500|58791618|FG004|Overall Study|Withdrawal by Subject|2|||
30779975|NCT02996500|58791619|FG005|Overall Study|Withdrawal by Subject|0|||
30665669|NCT00837265|58679367|FG003|Pilot Phase|Decision of the investigator|0|||
30665670|NCT00837265|58679368|FG004|Pilot Phase|Decision of the investigator|0|||
30665671|NCT00837265|58679369|FG005|Pilot Phase|Decision of the investigator|0|||
30665672|NCT00837265|58679370|FG006|Pilot Phase|Decision of the investigator|0|||
30665673|NCT00837265|58679364|FG000|Pilot Phase|Adverse Event|1|||
30665674|NCT00837265|58679365|FG001|Pilot Phase|Adverse Event|0|||
30665675|NCT00837265|58679366|FG002|Pilot Phase|Adverse Event|0|||
30665676|NCT00837265|58679367|FG003|Pilot Phase|Adverse Event|0|||
30665677|NCT00837265|58679368|FG004|Pilot Phase|Adverse Event|0|||
30665678|NCT00837265|58679369|FG005|Pilot Phase|Adverse Event|0|||
30665679|NCT00837265|58679370|FG006|Pilot Phase|Adverse Event|0|||
30665680|NCT00837265|58679364|FG000|Pilot Phase|Disease progression|0|||
30665681|NCT00837265|58679365|FG001|Pilot Phase|Disease progression|0|||
30665682|NCT00837265|58679366|FG002|Pilot Phase|Disease progression|0|||
30665683|NCT00837265|58679367|FG003|Pilot Phase|Disease progression|1|||
30665684|NCT00837265|58679368|FG004|Pilot Phase|Disease progression|0|||
30665685|NCT00837265|58679369|FG005|Pilot Phase|Disease progression|0|||
30665686|NCT00837265|58679370|FG006|Pilot Phase|Disease progression|0|||
30665687|NCT00837265|58679364|FG000|Pilot Phase|Participant left the city|0|||
30665688|NCT00837265|58679365|FG001|Pilot Phase|Participant left the city|0|||
30665689|NCT00837265|58679366|FG002|Pilot Phase|Participant left the city|0|||
30665690|NCT00837265|58679367|FG003|Pilot Phase|Participant left the city|1|||
30665691|NCT00837265|58679368|FG004|Pilot Phase|Participant left the city|0|||
30665692|NCT00837265|58679369|FG005|Pilot Phase|Participant left the city|0|||
30665693|NCT00837265|58679370|FG006|Pilot Phase|Participant left the city|0|||
30665694|NCT00837265|58679364|FG000|Main Phase|Withdrawal by Subject|0|||
30665695|NCT00837265|58679365|FG001|Main Phase|Withdrawal by Subject|0|||
30665696|NCT00837265|58679366|FG002|Main Phase|Withdrawal by Subject|0|||
30665697|NCT00837265|58679367|FG003|Main Phase|Withdrawal by Subject|0|||
30779976|NCT00006489|58791641|FG000|Overall Study|Adverse Event|3|||
30779977|NCT00006489|58791642|FG001|Overall Study|Adverse Event|2|||
30779978|NCT00006489|58791643|FG002|Overall Study|Adverse Event|4|||
30779979|NCT00006489|58791644|FG003|Overall Study|Adverse Event|3|||
30779980|NCT00006489|58791641|FG000|Overall Study|Withdrawal by Subject|10|||
30779981|NCT00006489|58791642|FG001|Overall Study|Withdrawal by Subject|9|||
30779982|NCT00006489|58791643|FG002|Overall Study|Withdrawal by Subject|9|||
30779983|NCT00006489|58791644|FG003|Overall Study|Withdrawal by Subject|6|||
30779984|NCT00006489|58791641|FG000|Overall Study|Scheduling Conflict|0|||
30779985|NCT00006489|58791642|FG001|Overall Study|Scheduling Conflict|3|||
30779986|NCT00006489|58791643|FG002|Overall Study|Scheduling Conflict|2|||
30779987|NCT00006489|58791644|FG003|Overall Study|Scheduling Conflict|1|||
30779988|NCT00006489|58791641|FG000|Overall Study|Death|0|||
30665698|NCT00837265|58679368|FG004|Main Phase|Withdrawal by Subject|4|||
30665699|NCT00837265|58679369|FG005|Main Phase|Withdrawal by Subject|2|||
30779989|NCT00006489|58791642|FG001|Overall Study|Death|0|||
30779990|NCT00006489|58791643|FG002|Overall Study|Death|0|||
30779991|NCT00006489|58791644|FG003|Overall Study|Death|1|||
30779992|NCT03535974|58791657|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
30958595|NCT01695239|59023636|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30779993|NCT03535974|58791658|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
30665700|NCT00837265|58679370|FG006|Main Phase|Withdrawal by Subject|1|||
30855126|NCT02301988|58882642|FG001|Overall Study|Unknown Reason|3|||
30665701|NCT00837265|58679364|FG000|Main Phase|Decision of the investigator|0|||
30665702|NCT00837265|58679365|FG001|Main Phase|Decision of the investigator|0|||
30665703|NCT00837265|58679366|FG002|Main Phase|Decision of the investigator|0|||
30665704|NCT00837265|58679367|FG003|Main Phase|Decision of the investigator|0|||
30665705|NCT00837265|58679368|FG004|Main Phase|Decision of the investigator|0|||
30665706|NCT00837265|58679369|FG005|Main Phase|Decision of the investigator|2|||
30665707|NCT00837265|58679370|FG006|Main Phase|Decision of the investigator|1|||
30665708|NCT00837265|58679364|FG000|Main Phase|Adverse Event|0|||
30665709|NCT00837265|58679365|FG001|Main Phase|Adverse Event|0|||
30665710|NCT00837265|58679366|FG002|Main Phase|Adverse Event|0|||
30665711|NCT00837265|58679367|FG003|Main Phase|Adverse Event|0|||
30665712|NCT00837265|58679368|FG004|Main Phase|Adverse Event|0|||
30665713|NCT00837265|58679369|FG005|Main Phase|Adverse Event|1|||
30665714|NCT00837265|58679370|FG006|Main Phase|Adverse Event|0|||
30665715|NCT00837265|58679364|FG000|Main Phase|Death|0|||
30665716|NCT00837265|58679365|FG001|Main Phase|Death|0|||
30665717|NCT00837265|58679366|FG002|Main Phase|Death|0|||
30665718|NCT00837265|58679367|FG003|Main Phase|Death|0|||
30665719|NCT00837265|58679368|FG004|Main Phase|Death|2|||
30665720|NCT00837265|58679369|FG005|Main Phase|Death|0|||
30665721|NCT00837265|58679370|FG006|Main Phase|Death|1|||
30665722|NCT00837265|58679364|FG000|Main Phase|Lost to Follow-up|0|||
30665723|NCT00837265|58679365|FG001|Main Phase|Lost to Follow-up|0|||
30855127|NCT02301988|58882641|FG000|Overall Study|Lack of Efficacy|3|||
30665724|NCT00837265|58679366|FG002|Main Phase|Lost to Follow-up|0|||
30779994|NCT03535974|58791659|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
30779995|NCT03535974|58791657|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
30779996|NCT03535974|58791658|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
30779997|NCT03535974|58791659|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
30779998|NCT00025233|58791667|FG000|Overall Study|Ineligible: wrong cell type|1|||
30779999|NCT00025233|58791667|FG000|Overall Study|Ineligible: wrong primary|1|||
30665725|NCT00837265|58679367|FG003|Main Phase|Lost to Follow-up|0|||
30665726|NCT00837265|58679368|FG004|Main Phase|Lost to Follow-up|1|||
30665727|NCT00837265|58679369|FG005|Main Phase|Lost to Follow-up|0|||
30665728|NCT00837265|58679370|FG006|Main Phase|Lost to Follow-up|0|||
30665729|NCT00837265|58679364|FG000|Main Phase|Principal investigator resignation|0|||
30665730|NCT00837265|58679365|FG001|Main Phase|Principal investigator resignation|0|||
30665731|NCT00837265|58679366|FG002|Main Phase|Principal investigator resignation|0|||
30665732|NCT00837265|58679367|FG003|Main Phase|Principal investigator resignation|0|||
30665733|NCT00837265|58679368|FG004|Main Phase|Principal investigator resignation|2|||
30665734|NCT00837265|58679369|FG005|Main Phase|Principal investigator resignation|0|||
30665735|NCT00837265|58679370|FG006|Main Phase|Principal investigator resignation|0|||
30665736|NCT00837265|58679364|FG000|Main Phase|Participant's personal reason|0|||
30665737|NCT00837265|58679365|FG001|Main Phase|Participant's personal reason|0|||
30665738|NCT00837265|58679366|FG002|Main Phase|Participant's personal reason|0|||
30665739|NCT00837265|58679367|FG003|Main Phase|Participant's personal reason|0|||
30665740|NCT00837265|58679368|FG004|Main Phase|Participant's personal reason|1|||
30665741|NCT00837265|58679369|FG005|Main Phase|Participant's personal reason|0|||
30665742|NCT00837265|58679370|FG006|Main Phase|Participant's personal reason|0|||
30665743|NCT00594516|58679383|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
30665744|NCT00594516|58679384|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
30665745|NCT00594516|58679385|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
30665746|NCT00594516|58679383|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
30665747|NCT00594516|58679384|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
30665748|NCT00594516|58679385|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
30665749|NCT00594516|58679383|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
30665750|NCT00594516|58679384|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
30665751|NCT00594516|58679385|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
30665752|NCT00594516|58679383|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
30665753|NCT00594516|58679384|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
30665754|NCT00594516|58679385|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
30665755|NCT00594516|58679383|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
30665756|NCT00594516|58679384|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
30665757|NCT00594516|58679385|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
30665758|NCT00594516|58679383|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
30665759|NCT00594516|58679384|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
30665760|NCT00594516|58679385|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
30665761|NCT00594516|58679383|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
30665762|NCT00594516|58679384|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
30665763|NCT00594516|58679385|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
30665764|NCT00594516|58679383|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
30665765|NCT00594516|58679384|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
30780000|NCT00025233|58791667|FG000|Overall Study|Ineligible: improper prior treatment|1|||
30780001|NCT00025233|58791667|FG000|Overall Study|Never treated|1|||
30780002|NCT00025155|58791677|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
30780003|NCT00025155|58791677|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
30780004|NCT02998996|58791692|FG000|Overall Study|Lost to Follow-up|0|||
30665766|NCT00594516|58679385|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
30665767|NCT00594516|58679383|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
30665768|NCT00594516|58679384|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
30665769|NCT00594516|58679385|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
30665770|NCT00538291|58679389|FG000|Overall Study|Adverse Event|2|||
30665771|NCT00538291|58679389|FG000|Overall Study|Withdrawal by Subject|1|||
30665772|NCT00594906|58679395|FG000|Overall Study|Physician Decision|1|||
30665773|NCT00594906|58679396|FG001|Overall Study|Physician Decision|0|||
30780005|NCT02998996|58791693|FG001|Overall Study|Lost to Follow-up|0|||
30855128|NCT02301988|58882642|FG001|Overall Study|Lack of Efficacy|2|||
30855129|NCT02301988|58882641|FG000|Overall Study|Death|1|||
30780006|NCT02998996|58791694|FG002|Overall Study|Lost to Follow-up|1|||
30780007|NCT02998996|58791695|FG003|Overall Study|Lost to Follow-up|0|||
30780008|NCT02998996|58791696|FG004|Overall Study|Lost to Follow-up|0|||
30780009|NCT02998996|58791697|FG005|Overall Study|Lost to Follow-up|0|||
30780010|NCT02998996|58791692|FG000|Overall Study|Pregnancy|0|||
30780011|NCT02998996|58791693|FG001|Overall Study|Pregnancy|1|||
30958596|NCT01695239|59023637|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30780012|NCT02998996|58791694|FG002|Overall Study|Pregnancy|0|||
30855130|NCT02301988|58882642|FG001|Overall Study|Death|0|||
30780013|NCT02998996|58791695|FG003|Overall Study|Pregnancy|0|||
30855131|NCT02301988|58882641|FG000|Overall Study|Adverse Event|1|||
30855132|NCT02301988|58882642|FG001|Overall Study|Adverse Event|1|||
30665774|NCT00594906|58679395|FG000|Overall Study|Physician Decision|0|||
30665775|NCT00594906|58679396|FG001|Overall Study|Physician Decision|1|||
30665776|NCT00594906|58679395|FG000|Overall Study|Death|0|||
30665777|NCT00594906|58679396|FG001|Overall Study|Death|1|||
30665778|NCT00537979|58679404|FG000|Overall Study|Adverse Event|2|||
30665779|NCT00537979|58679405|FG001|Overall Study|Adverse Event|2|||
30665780|NCT00537979|58679404|FG000|Overall Study|Withdrawal by Subject|1|||
30665781|NCT00537979|58679405|FG001|Overall Study|Withdrawal by Subject|4|||
30665782|NCT00537979|58679404|FG000|Overall Study|Lost to Follow-up|1|||
30665783|NCT00537979|58679405|FG001|Overall Study|Lost to Follow-up|4|||
30665784|NCT00537979|58679404|FG000|Overall Study|Lack of Efficacy|0|||
30665785|NCT00537979|58679405|FG001|Overall Study|Lack of Efficacy|1|||
30665786|NCT00537979|58679404|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
30665787|NCT00537979|58679405|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
30665788|NCT00537979|58679404|FG000|Overall Study|Death|0|||
30665789|NCT00537979|58679405|FG001|Overall Study|Death|3|||
30665790|NCT00537979|58679404|FG000|Overall Study|Kidney transplant|0|||
30665791|NCT00537979|58679405|FG001|Overall Study|Kidney transplant|3|||
30665792|NCT00537979|58679404|FG000|Overall Study|Heart failure|0|||
30665793|NCT00537979|58679405|FG001|Overall Study|Heart failure|1|||
30665794|NCT00537823|58679414|FG000|Overall Study|Adverse Event|2|||
30665795|NCT00537823|58679415|FG001|Overall Study|Adverse Event|0|||
30665796|NCT00537277|58679422|FG000|Overall Study|Adverse Event|1|||
30665797|NCT00537277|58679422|FG000|Overall Study|Lack of Efficacy|2|||
30665798|NCT00537277|58679422|FG000|Overall Study|Lost to Follow-up|12|||
30665799|NCT00537277|58679422|FG000|Overall Study|Protocol Violation|11|||
30665800|NCT00537277|58679422|FG000|Overall Study|Unclassified|4|||
30665801|NCT00537277|58679422|FG000|Overall Study|Inability to tolerate trial medication|4|||
30665802|NCT00537277|58679422|FG000|Overall Study|Non-compliance with trial procedures|15|||
30665803|NCT00537199|58679426|FG000|Overall Study|Study Terminated|1|||
30665804|NCT03898063|58679432|FG000|Overall Study|Withdrawal by Subject|10|||
30665805|NCT03898063|58679433|FG001|Overall Study|Withdrawal by Subject|8|||
30665806|NCT00873912|58679441|FG000|Overall Study|Withdrawal by Subject|1|||
30665807|NCT00873912|58679442|FG001|Overall Study|Withdrawal by Subject|0|||
30665808|NCT00873912|58679441|FG000|Overall Study|Lost to Follow-up|2|||
30665809|NCT00873912|58679442|FG001|Overall Study|Lost to Follow-up|0|||
30665810|NCT03823300|58679454|FG000|Overall Study|Withdrawal by Subject|16|||
30665811|NCT03823300|58679455|FG001|Overall Study|Withdrawal by Subject|22|||
30665812|NCT03823300|58679454|FG000|Overall Study|Death|10|||
30665813|NCT03823300|58679455|FG001|Overall Study|Death|14|||
30665814|NCT03823300|58679454|FG000|Overall Study|Adverse Event|3|||
30665815|NCT03823300|58679455|FG001|Overall Study|Adverse Event|5|||
30665816|NCT03823300|58679454|FG000|Overall Study|Physician Decision|1|||
30780014|NCT02998996|58791696|FG004|Overall Study|Pregnancy|0|||
30780015|NCT02998996|58791697|FG005|Overall Study|Pregnancy|0|||
30780016|NCT02998996|58791692|FG000|Overall Study|Family reasons|0|||
30780017|NCT02998996|58791693|FG001|Overall Study|Family reasons|0|||
30780018|NCT02998996|58791694|FG002|Overall Study|Family reasons|0|||
30665817|NCT03823300|58679455|FG001|Overall Study|Physician Decision|7|||
30665818|NCT03823300|58679454|FG000|Overall Study|Lost to Follow-up|1|||
30665819|NCT03823300|58679455|FG001|Overall Study|Lost to Follow-up|3|||
30665820|NCT03823300|58679454|FG000|Overall Study|Protocol Violation|1|||
30780019|NCT02998996|58791695|FG003|Overall Study|Family reasons|0|||
30780020|NCT02998996|58791696|FG004|Overall Study|Family reasons|1|||
30780021|NCT02998996|58791697|FG005|Overall Study|Family reasons|0|||
30780022|NCT02994940|58791713|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
30855133|NCT02334748|58882657|FG000|Overall Study|Adverse Event|1|||
30958597|NCT01695239|59023638|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30665821|NCT03823300|58679455|FG001|Overall Study|Protocol Violation|1|||
30665822|NCT03823300|58679454|FG000|Overall Study|Lack of Efficacy|1|||
30665823|NCT03823300|58679455|FG001|Overall Study|Lack of Efficacy|1|||
30665824|NCT03823300|58679454|FG000|Overall Study|Not Eligible|0|||
30665825|NCT03823300|58679455|FG001|Overall Study|Not Eligible|1|||
30665826|NCT03823300|58679454|FG000|Overall Study|Other|1|||
30665827|NCT03823300|58679455|FG001|Overall Study|Other|0|||
30665828|NCT00537745|58679461|FG000|Overall Study|Did not meet eligibility criteria|2|||
30665829|NCT00537745|58679461|FG000|Overall Study|Withdrawal by Subject|2|||
30665830|NCT00537745|58679461|FG000|Overall Study|Subject unable to provide Interlock info|1|||
30665831|NCT00874848|58679468|FG000|Overall Study|Adverse Event|13|||
30665832|NCT00874848|58679469|FG001|Overall Study|Adverse Event|2|||
30665833|NCT00874848|58679468|FG000|Overall Study|Progressive neoplastic disease|38|||
30665834|NCT00874848|58679469|FG001|Overall Study|Progressive neoplastic disease|18|||
30665835|NCT00874848|58679468|FG000|Overall Study|Withdrawal by Subject|7|||
30665836|NCT00874848|58679469|FG001|Overall Study|Withdrawal by Subject|4|||
30665837|NCT00874848|58679468|FG000|Overall Study|Noncompliance|1|||
30665838|NCT00874848|58679469|FG001|Overall Study|Noncompliance|1|||
30665839|NCT00874848|58679468|FG000|Overall Study|Failure to comply with protocol|0|||
30665840|NCT00874848|58679469|FG001|Overall Study|Failure to comply with protocol|1|||
30665841|NCT00874848|58679468|FG000|Overall Study|Physician Decision|0|||
30665842|NCT00874848|58679469|FG001|Overall Study|Physician Decision|2|||
30665843|NCT00578812|58679477|FG000|Overall Study|Not treated|6|||
30665844|NCT00578812|58679478|FG001|Overall Study|Not treated|7|||
30665845|NCT04043806|58679485|FG000|Overall Study|Commercial drug is available for participants|13|||
30665846|NCT04043806|58679485|FG000|Overall Study|Physician Decision|2|||
30665847|NCT04043806|58679485|FG000|Overall Study|Other|12|||
30665848|NCT04043806|58679485|FG000|Overall Study|Adverse Event|2|||
30665849|NCT04043806|58679485|FG000|Overall Study|Lost to Follow-up|6|||
30665850|NCT04043806|58679485|FG000|Overall Study|Other non-compliance|2|||
30665851|NCT04043806|58679485|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
30665852|NCT04043806|58679485|FG000|Overall Study|Never Dosed|1|||
30665853|NCT00536809|58679490|FG000|Phase II|Adverse Event|1|||
30665854|NCT00536809|58679490|FG000|Phase II|Referred for surgical resection|1|||
30665855|NCT00536731|58679501|FG000|Overall Study|Adverse Event|3|||
30665856|NCT00536731|58679502|FG001|Overall Study|Adverse Event|2|||
30665857|NCT00536731|58679503|FG002|Overall Study|Adverse Event|3|||
30665858|NCT00536731|58679501|FG000|Overall Study|Withdrawal by Subject|0|||
30665859|NCT00536731|58679502|FG001|Overall Study|Withdrawal by Subject|2|||
30665860|NCT00536731|58679503|FG002|Overall Study|Withdrawal by Subject|0|||
30665861|NCT00536731|58679501|FG000|Overall Study|Intake of prohibited conc. medication|0|||
30665862|NCT00536731|58679502|FG001|Overall Study|Intake of prohibited conc. medication|0|||
30665863|NCT00536731|58679503|FG002|Overall Study|Intake of prohibited conc. medication|1|||
30665864|NCT00536731|58679501|FG000|Overall Study|Safety reasons|0|||
30665865|NCT00536731|58679502|FG001|Overall Study|Safety reasons|0|||
30665866|NCT00536731|58679503|FG002|Overall Study|Safety reasons|1|||
30665867|NCT00536731|58679501|FG000|Overall Study|Other|1|||
30665868|NCT00536731|58679502|FG001|Overall Study|Other|1|||
30665869|NCT00536731|58679503|FG002|Overall Study|Other|0|||
30665870|NCT00536575|58679511|FG000|Overall Study|Withdrawal by Subject|1|||
30665871|NCT00536575|58679511|FG000|Overall Study|Death|1|||
30665872|NCT03214250|58679522|FG000|Overall Study|Death|5|||
30665873|NCT03214250|58679523|FG001|Overall Study|Death|5|||
30665874|NCT03214250|58679524|FG002|Overall Study|Death|7|||
30665875|NCT03214250|58679525|FG003|Overall Study|Death|4|||
30665876|NCT03214250|58679526|FG004|Overall Study|Death|23|||
30665877|NCT03214250|58679527|FG005|Overall Study|Death|23|||
30665878|NCT03214250|58679528|FG006|Overall Study|Death|24|||
30665879|NCT03214250|58679522|FG000|Overall Study|Lost to Follow-up|0|||
30855134|NCT02334748|58882657|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
30855135|NCT02334748|58882657|FG000|Overall Study|Patient no longer required study drug|2|||
30665880|NCT03214250|58679523|FG001|Overall Study|Lost to Follow-up|0|||
30665881|NCT03214250|58679524|FG002|Overall Study|Lost to Follow-up|0|||
30665882|NCT03214250|58679525|FG003|Overall Study|Lost to Follow-up|1|||
30665883|NCT03214250|58679526|FG004|Overall Study|Lost to Follow-up|1|||
30665884|NCT03214250|58679527|FG005|Overall Study|Lost to Follow-up|2|||
30665885|NCT03214250|58679528|FG006|Overall Study|Lost to Follow-up|0|||
30665886|NCT03214250|58679522|FG000|Overall Study|Other|0|||
30665887|NCT03214250|58679523|FG001|Overall Study|Other|0|||
30665888|NCT03214250|58679524|FG002|Overall Study|Other|0|||
30665889|NCT03214250|58679525|FG003|Overall Study|Other|0|||
30665890|NCT03214250|58679526|FG004|Overall Study|Other|1|||
30665891|NCT03214250|58679527|FG005|Overall Study|Other|1|||
30665892|NCT03214250|58679528|FG006|Overall Study|Other|2|||
30665893|NCT03214250|58679522|FG000|Overall Study|Remains on Study|2|||
30665894|NCT03214250|58679523|FG001|Overall Study|Remains on Study|2|||
30665895|NCT03214250|58679524|FG002|Overall Study|Remains on Study|0|||
30665896|NCT03214250|58679525|FG003|Overall Study|Remains on Study|1|||
30665897|NCT03214250|58679526|FG004|Overall Study|Remains on Study|7|||
30665898|NCT03214250|58679527|FG005|Overall Study|Remains on Study|5|||
30665899|NCT03214250|58679528|FG006|Overall Study|Remains on Study|3|||
30665900|NCT03214250|58679522|FG000|Overall Study|Withdrawal by Subject|0|||
30665901|NCT03214250|58679523|FG001|Overall Study|Withdrawal by Subject|0|||
30665902|NCT03214250|58679524|FG002|Overall Study|Withdrawal by Subject|1|||
30665903|NCT03214250|58679525|FG003|Overall Study|Withdrawal by Subject|2|||
30665904|NCT03214250|58679526|FG004|Overall Study|Withdrawal by Subject|5|||
30665905|NCT03214250|58679527|FG005|Overall Study|Withdrawal by Subject|0|||
30665906|NCT03214250|58679528|FG006|Overall Study|Withdrawal by Subject|2|||
30665907|NCT00874770|58679552|FG000|Overall Study|Lack of Efficacy|2|||
30665908|NCT00874770|58679553|FG001|Overall Study|Lack of Efficacy|0|||
30665909|NCT00874770|58679554|FG002|Overall Study|Lack of Efficacy|0|||
30665910|NCT00874770|58679555|FG003|Overall Study|Lack of Efficacy|2|||
30665911|NCT00874770|58679552|FG000|Overall Study|Adverse Event|1|||
30665912|NCT00874770|58679553|FG001|Overall Study|Adverse Event|1|||
30665913|NCT00874770|58679554|FG002|Overall Study|Adverse Event|4|||
30665914|NCT00874770|58679555|FG003|Overall Study|Adverse Event|2|||
30665915|NCT00874770|58679552|FG000|Overall Study|Lost to Follow-up|1|||
30665916|NCT00874770|58679553|FG001|Overall Study|Lost to Follow-up|0|||
30665917|NCT00874770|58679554|FG002|Overall Study|Lost to Follow-up|0|||
30665918|NCT00874770|58679555|FG003|Overall Study|Lost to Follow-up|1|||
30665919|NCT00874770|58679552|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
30665920|NCT00874770|58679553|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
30665921|NCT00874770|58679554|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
30665922|NCT00874770|58679555|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
30665923|NCT00536263|58679578|FG000|Overall Study|Adverse Event|5|||
30665924|NCT00536263|58679579|FG001|Overall Study|Adverse Event|5|||
30665925|NCT00536263|58679580|FG002|Overall Study|Adverse Event|7|||
30665926|NCT00536263|58679578|FG000|Overall Study|Lost to Follow-up|3|||
30665927|NCT00536263|58679579|FG001|Overall Study|Lost to Follow-up|4|||
30665928|NCT00536263|58679580|FG002|Overall Study|Lost to Follow-up|4|||
30665929|NCT00536263|58679578|FG000|Overall Study|Subject withdrew - not treatment related|2|||
30665930|NCT00536263|58679579|FG001|Overall Study|Subject withdrew - not treatment related|0|||
30665931|NCT00536263|58679580|FG002|Overall Study|Subject withdrew - not treatment related|5|||
30665932|NCT00536263|58679578|FG000|Overall Study|Subject withdrew - treatment related|0|||
30665933|NCT00536263|58679579|FG001|Overall Study|Subject withdrew - treatment related|3|||
30665934|NCT00536263|58679580|FG002|Overall Study|Subject withdrew - treatment related|2|||
30665935|NCT00536263|58679578|FG000|Overall Study|Noncompliance with protocol|0|||
30665936|NCT00536263|58679579|FG001|Overall Study|Noncompliance with protocol|0|||
30665937|NCT00536263|58679580|FG002|Overall Study|Noncompliance with protocol|1|||
30665938|NCT00536263|58679578|FG000|Overall Study|Did not meet protocol eligibility|1|||
30665939|NCT00536263|58679579|FG001|Overall Study|Did not meet protocol eligibility|2|||
30780023|NCT02994940|58791714|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
30665940|NCT00536263|58679580|FG002|Overall Study|Did not meet protocol eligibility|2|||
30665941|NCT00578344|58679588|FG000|Overall Study|Insurance problems|1|||
30665942|NCT00578344|58679588|FG000|Overall Study|Graft failure|1|||
30665943|NCT00873366|58679592|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
30665944|NCT00873366|58679592|FG000|Overall Study|Off tamoxifen due to side effects|2|||
30665945|NCT00873366|58679592|FG000|Overall Study|Refused to continue DM-BT testing|3|||
30665946|NCT00536107|58679598|FG000|Overall Study|Death|5|||
30564120|NCT04556838|58558016|FG000|Overall Study|Withdrawal by Subject|3|||
30564121|NCT04556838|58558017|FG001|Overall Study|Withdrawal by Subject|1|||
30564122|NCT04556838|58558018|FG002|Overall Study|Withdrawal by Subject|2|||
30564123|NCT04556838|58558016|FG000|Overall Study|Adverse Event|0|||
30564124|NCT04556838|58558017|FG001|Overall Study|Adverse Event|1|||
30564125|NCT04556838|58558018|FG002|Overall Study|Adverse Event|1|||
30564126|NCT04556838|58558016|FG000|Overall Study|Lost to Follow-up|0|||
30564127|NCT04556838|58558017|FG001|Overall Study|Lost to Follow-up|0|||
30564128|NCT04556838|58558018|FG002|Overall Study|Lost to Follow-up|2|||
30564129|NCT04556838|58558016|FG000|Overall Study|Subject travel|0|||
30564130|NCT04556838|58558017|FG001|Overall Study|Subject travel|1|||
30564131|NCT04556838|58558018|FG002|Overall Study|Subject travel|0|||
30564132|NCT04556838|58558016|FG000|Overall Study|Physician Decision|1|||
30564133|NCT04556838|58558017|FG001|Overall Study|Physician Decision|0|||
30564134|NCT04556838|58558018|FG002|Overall Study|Physician Decision|0|||
30564135|NCT03671148|58558041|FG000|Overall Study|Adverse Event|3|||
30564136|NCT03671148|58558042|FG001|Overall Study|Adverse Event|2|||
30564137|NCT03671148|58558041|FG000|Overall Study|Withdrawal by Subject|8|||
30564138|NCT03671148|58558042|FG001|Overall Study|Withdrawal by Subject|2|||
30564139|NCT03671148|58558041|FG000|Overall Study|Lost to Follow-up|1|||
30564140|NCT03671148|58558042|FG001|Overall Study|Lost to Follow-up|2|||
30665947|NCT00536107|58679599|FG001|Overall Study|Death|1|||
30665948|NCT00536107|58679598|FG000|Overall Study|Incorrect enrolment|1|||
30665949|NCT00536107|58679599|FG001|Overall Study|Incorrect enrolment|0|||
30665950|NCT00536107|58679598|FG000|Overall Study|Withdrawal by Subject|0|||
30665951|NCT00536107|58679599|FG001|Overall Study|Withdrawal by Subject|1|||
30665952|NCT00536107|58679598|FG000|Overall Study|Study Termination|2|||
30665953|NCT00536107|58679599|FG001|Overall Study|Study Termination|4|||
30665954|NCT00885482|58679619|FG000|Overall Study|Pregnancy|1|||
30665955|NCT00885482|58679619|FG000|Overall Study|Lack of Efficacy|1|||
30665956|NCT00885482|58679619|FG000|Overall Study|Death|1|||
30665957|NCT00885482|58679619|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
30665958|NCT00885170|58679643|FG000|Overall Study|Adverse Event|12|||
30665959|NCT00885170|58679644|FG001|Overall Study|Adverse Event|4|||
30665960|NCT00885170|58679643|FG000|Overall Study|Excessive bone loss|6|||
30665961|NCT00885170|58679644|FG001|Overall Study|Excessive bone loss|3|||
30665962|NCT00885170|58679643|FG000|Overall Study|Lost to Follow-up|2|||
30665963|NCT00885170|58679644|FG001|Overall Study|Lost to Follow-up|1|||
30665964|NCT00885170|58679643|FG000|Overall Study|Physician Decision|2|||
30665965|NCT00885170|58679644|FG001|Overall Study|Physician Decision|1|||
30665966|NCT00885170|58679643|FG000|Overall Study|Protocol Violation|3|||
30665967|NCT00885170|58679644|FG001|Overall Study|Protocol Violation|1|||
30665968|NCT00885170|58679643|FG000|Overall Study|Withdrawal by Subject|13|||
30665969|NCT00885170|58679644|FG001|Overall Study|Withdrawal by Subject|13|||
30665970|NCT00866619|58679671|FG000|Overall Study|Adverse Event|112|||
30665971|NCT00866619|58679672|FG001|Overall Study|Adverse Event|106|||
30665972|NCT00866619|58679673|FG002|Overall Study|Adverse Event|47|||
30665973|NCT00866619|58679674|FG003|Overall Study|Adverse Event|44|||
30665974|NCT00866619|58679671|FG000|Overall Study|Protocol Violation|2|||
30665975|NCT00866619|58679672|FG001|Overall Study|Protocol Violation|39|||
30564141|NCT03671148|58558041|FG000|Overall Study|Lack of Efficacy|7|||
30665976|NCT00866619|58679673|FG002|Overall Study|Protocol Violation|2|||
30665977|NCT00866619|58679674|FG003|Overall Study|Protocol Violation|17|||
30665978|NCT00866619|58679671|FG000|Overall Study|Withdrawal by Subject|587|||
30564142|NCT03671148|58558042|FG001|Overall Study|Lack of Efficacy|2|||
30564143|NCT03671148|58558041|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
30564144|NCT03671148|58558042|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
30564145|NCT03671148|58558041|FG000|Overall Study|Other|1|||
30665979|NCT00866619|58679672|FG001|Overall Study|Withdrawal by Subject|295|||
30564146|NCT03671148|58558042|FG001|Overall Study|Other|0|||
30564147|NCT03671148|58558041|FG000|Overall Study|Incomplete Randomization Visit|1|||
30564148|NCT03671148|58558042|FG001|Overall Study|Incomplete Randomization Visit|0|||
30564149|NCT02004522|58558050|FG000|Overall Study|Adverse Event|55|||
30564150|NCT02004522|58558051|FG001|Overall Study|Adverse Event|6|||
30564151|NCT02004522|58558050|FG000|Overall Study|Withdrawal by Subject|13|||
30564152|NCT02004522|58558051|FG001|Overall Study|Withdrawal by Subject|7|||
30564153|NCT02004522|58558050|FG000|Overall Study|Death|12|||
30564154|NCT02004522|58558051|FG001|Overall Study|Death|3|||
30564155|NCT02004522|58558050|FG000|Overall Study|Physician Decision|3|||
30564156|NCT02004522|58558051|FG001|Overall Study|Physician Decision|4|||
30564157|NCT02004522|58558050|FG000|Overall Study|Protocol Violation|1|||
30564158|NCT02004522|58558051|FG001|Overall Study|Protocol Violation|0|||
30564159|NCT02004522|58558050|FG000|Overall Study|Other is reason listed by PI|4|||
30564160|NCT02004522|58558051|FG001|Overall Study|Other is reason listed by PI|1|||
30564161|NCT02004522|58558050|FG000|Overall Study|Never Dosed|2|||
30564162|NCT02004522|58558051|FG001|Overall Study|Never Dosed|4|||
30564163|NCT02004522|58558050|FG000|Overall Study|Disease Progression|35|||
30564164|NCT02004522|58558051|FG001|Overall Study|Disease Progression|31|||
30564165|NCT02004522|58558050|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
30564166|NCT02004522|58558051|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
30564167|NCT01430442|58558069|FG000|Overall Study|Subject Withdrew Consent|3|||
30564168|NCT01430442|58558070|FG001|Overall Study|Subject Withdrew Consent|0|||
30564169|NCT01430442|58558071|FG002|Overall Study|Subject Withdrew Consent|1|||
30564170|NCT01430442|58558072|FG003|Overall Study|Subject Withdrew Consent|0|||
30564171|NCT01430442|58558073|FG004|Overall Study|Subject Withdrew Consent|2|||
30564172|NCT01430442|58558074|FG005|Overall Study|Subject Withdrew Consent|1|||
30564173|NCT01430442|58558075|FG006|Overall Study|Subject Withdrew Consent|5|||
30564174|NCT01430442|58558076|FG007|Overall Study|Subject Withdrew Consent|2|||
30564175|NCT01430442|58558069|FG000|Overall Study|Lost to Follow-up|2|||
30564176|NCT01430442|58558070|FG001|Overall Study|Lost to Follow-up|0|||
30564177|NCT01430442|58558071|FG002|Overall Study|Lost to Follow-up|1|||
30564178|NCT01430442|58558072|FG003|Overall Study|Lost to Follow-up|2|||
30564179|NCT01430442|58558073|FG004|Overall Study|Lost to Follow-up|2|||
30564180|NCT01430442|58558074|FG005|Overall Study|Lost to Follow-up|1|||
30564181|NCT01430442|58558075|FG006|Overall Study|Lost to Follow-up|5|||
30564182|NCT01430442|58558076|FG007|Overall Study|Lost to Follow-up|1|||
30564183|NCT01430442|58558069|FG000|Overall Study|Pregnancy|1|||
30564184|NCT01430442|58558070|FG001|Overall Study|Pregnancy|0|||
30564185|NCT01430442|58558071|FG002|Overall Study|Pregnancy|0|||
30564186|NCT01430442|58558072|FG003|Overall Study|Pregnancy|0|||
30564187|NCT01430442|58558073|FG004|Overall Study|Pregnancy|0|||
30564188|NCT01430442|58558074|FG005|Overall Study|Pregnancy|1|||
30564189|NCT01430442|58558075|FG006|Overall Study|Pregnancy|0|||
30564190|NCT01430442|58558076|FG007|Overall Study|Pregnancy|0|||
30564191|NCT01430442|58558069|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
30564192|NCT01430442|58558070|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
30564193|NCT01430442|58558071|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
30564194|NCT01430442|58558072|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
30564195|NCT01430442|58558073|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
30564196|NCT01430442|58558074|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
30564197|NCT01430442|58558075|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
30564198|NCT01430442|58558076|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
30564199|NCT01420926|58558096|FG000|Overall Study|Adverse Event|6|||
30564200|NCT01420926|58558097|FG001|Overall Study|Adverse Event|4|||
30564201|NCT01420926|58558096|FG000|Overall Study|Death|18|||
30564202|NCT01420926|58558097|FG001|Overall Study|Death|17|||
30564203|NCT01420926|58558096|FG000|Overall Study|Withdrawal by Subject|11|||
30564204|NCT01420926|58558097|FG001|Overall Study|Withdrawal by Subject|17|||
30564205|NCT01420926|58558096|FG000|Overall Study|Non-protocol treatment|17|||
30564206|NCT01420926|58558097|FG001|Overall Study|Non-protocol treatment|20|||
30564207|NCT01420926|58558096|FG000|Overall Study|Physician Decision|8|||
30665980|NCT00866619|58679673|FG002|Overall Study|Withdrawal by Subject|272|||
30564208|NCT01420926|58558097|FG001|Overall Study|Physician Decision|5|||
30564209|NCT04303572|58558653|FG000|Overall Study|Study closed due to poor enrollment|1|||
30958598|NCT01695239|59023639|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30958599|NCT01695239|59023640|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30958600|NCT01695239|59023641|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
30958601|NCT01695239|59023642|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
30665981|NCT00866619|58679674|FG003|Overall Study|Withdrawal by Subject|144|||
30958602|NCT01695239|59023643|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
30958603|NCT01695239|59023630|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
30665982|NCT00866619|58679671|FG000|Overall Study|Lost to Follow-up|1145|||
30564216|NCT03551730|58558697|FG000|Overall Study|Adverse Event|1|||
30564217|NCT03551730|58558698|FG001|Overall Study|Adverse Event|0|||
30564218|NCT03551730|58558699|FG002|Overall Study|Adverse Event|0|||
30665983|NCT00866619|58679672|FG001|Overall Study|Lost to Follow-up|830|||
30564219|NCT03551730|58558700|FG003|Overall Study|Adverse Event|0|||
30564220|NCT02656290|58558710|FG000|Overall Study|Subjects Remain On Study|26|||
30564221|NCT02534844|58558716|FG000|Part B|Withdrawal by Subject|0|||
30564222|NCT02534844|58558717|FG001|Part B|Withdrawal by Subject|0|||
30564223|NCT02534844|58558718|FG002|Part B|Withdrawal by Subject|0|||
30564224|NCT02534844|58558719|FG003|Part B|Withdrawal by Subject|0|||
30564225|NCT02534844|58558720|FG004|Part B|Withdrawal by Subject|2|||
30564226|NCT02534844|58558721|FG005|Part B|Withdrawal by Subject|1|||
30564227|NCT01818492|58558738|FG000|Overall Study|Adverse Event|2|||
30564228|NCT01818492|58558738|FG000|Overall Study|Death|3|||
30564229|NCT01818492|58558738|FG000|Overall Study|Withdrawal by Subject|1|||
30564230|NCT01818492|58558738|FG000|Overall Study|Additional therapy when not allowed PP|4|||
30564231|NCT01239030|58558748|FG000|Double Blind|Adverse Event|0|||
30564232|NCT01239030|58558749|FG001|Double Blind|Adverse Event|1|||
30564233|NCT01239030|58558750|FG002|Double Blind|Adverse Event|0|||
30564234|NCT01239030|58558751|FG003|Double Blind|Adverse Event|2|||
30564235|NCT01239030|58558752|FG004|Double Blind|Adverse Event|0|||
30564236|NCT01239030|58558748|FG000|Double Blind|Withdrawal by Subject|0|||
30564237|NCT01239030|58558749|FG001|Double Blind|Withdrawal by Subject|1|||
30564238|NCT01239030|58558750|FG002|Double Blind|Withdrawal by Subject|1|||
30564239|NCT01239030|58558751|FG003|Double Blind|Withdrawal by Subject|0|||
30564240|NCT01239030|58558752|FG004|Double Blind|Withdrawal by Subject|1|||
30564241|NCT01239030|58558748|FG000|Double Blind|Lost to Follow-up|1|||
30564242|NCT01239030|58558749|FG001|Double Blind|Lost to Follow-up|1|||
30564243|NCT01239030|58558750|FG002|Double Blind|Lost to Follow-up|0|||
30564244|NCT01239030|58558751|FG003|Double Blind|Lost to Follow-up|0|||
30564245|NCT01239030|58558752|FG004|Double Blind|Lost to Follow-up|0|||
30564246|NCT01239030|58558748|FG000|Double Blind|Physician Decision|0|||
30564247|NCT01239030|58558749|FG001|Double Blind|Physician Decision|1|||
30564248|NCT01239030|58558750|FG002|Double Blind|Physician Decision|0|||
30564249|NCT01239030|58558751|FG003|Double Blind|Physician Decision|0|||
30564250|NCT01239030|58558752|FG004|Double Blind|Physician Decision|0|||
30564251|NCT01239030|58558748|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
30564252|NCT01239030|58558749|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
30564253|NCT01239030|58558750|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
30564254|NCT01239030|58558751|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
30564255|NCT01239030|58558752|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
30564256|NCT01239030|58558748|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
30564257|NCT01239030|58558749|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
30564258|NCT01239030|58558750|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
30564259|NCT01239030|58558751|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
30564260|NCT01239030|58558752|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
30564261|NCT01239030|58558748|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
30564262|NCT01239030|58558749|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
30564263|NCT01239030|58558750|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
30564264|NCT01239030|58558751|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
30564265|NCT01239030|58558752|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
30564266|NCT01239030|58558748|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
30564267|NCT01239030|58558749|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
30564268|NCT01239030|58558750|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
30564269|NCT01239030|58558751|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
30564270|NCT01239030|58558752|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
30564271|NCT01086540|58558767|FG000|Overall Study|Death|3|||
30564272|NCT01086540|58558768|FG001|Overall Study|Death|1|||
30564273|NCT01086540|58558767|FG000|Overall Study|Physician Decision|2|||
30564274|NCT01086540|58558768|FG001|Overall Study|Physician Decision|1|||
30564275|NCT01086540|58558767|FG000|Overall Study|Addition of new therapy for PAH|1|||
30564276|NCT01086540|58558768|FG001|Overall Study|Addition of new therapy for PAH|0|||
30564277|NCT04567524|58562083|FG000|Overall Study|Adverse Event|1|||
30564278|NCT04567524|58562084|FG001|Overall Study|Adverse Event|1|||
30564279|NCT04567524|58562085|FG002|Overall Study|Adverse Event|0|||
30564280|NCT04567524|58562086|FG003|Overall Study|Adverse Event|0|||
30564281|NCT04567524|58562083|FG000|Overall Study|Withdrawal by Subject|2|||
30564282|NCT04567524|58562084|FG001|Overall Study|Withdrawal by Subject|0|||
30564283|NCT04567524|58562085|FG002|Overall Study|Withdrawal by Subject|0|||
30564284|NCT04567524|58562086|FG003|Overall Study|Withdrawal by Subject|1|||
30564285|NCT03370302|58562122|FG000|Dose Escalation Phase|Other|0|||
30564286|NCT03370302|58562123|FG001|Dose Escalation Phase|Other|1|||
30564287|NCT03370302|58562124|FG002|Dose Escalation Phase|Other|1|||
30564288|NCT03370302|58562125|FG003|Dose Escalation Phase|Other|0|||
30564289|NCT03370302|58562126|FG004|Dose Escalation Phase|Other|0|||
30564290|NCT03370302|58562127|FG005|Dose Escalation Phase|Other|0|||
30564291|NCT03370302|58562122|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
30564292|NCT03370302|58562123|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
30665984|NCT00866619|58679673|FG002|Overall Study|Lost to Follow-up|568|||
30564293|NCT03370302|58562124|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
30564294|NCT03370302|58562125|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
30564295|NCT03370302|58562126|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
30564296|NCT03370302|58562127|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
30564297|NCT03370302|58562122|FG000|Dose Escalation Phase|Adverse Event|1|||
30564298|NCT03370302|58562123|FG001|Dose Escalation Phase|Adverse Event|0|||
30564299|NCT03370302|58562124|FG002|Dose Escalation Phase|Adverse Event|2|||
30564300|NCT03370302|58562125|FG003|Dose Escalation Phase|Adverse Event|0|||
30564301|NCT03370302|58562126|FG004|Dose Escalation Phase|Adverse Event|0|||
30564302|NCT03370302|58562127|FG005|Dose Escalation Phase|Adverse Event|0|||
30564303|NCT03370302|58562122|FG000|Dose Escalation Phase|Progressive Disease|2|||
30564304|NCT03370302|58562123|FG001|Dose Escalation Phase|Progressive Disease|4|||
30564305|NCT03370302|58562124|FG002|Dose Escalation Phase|Progressive Disease|2|||
30564306|NCT03370302|58562125|FG003|Dose Escalation Phase|Progressive Disease|0|||
30564307|NCT03370302|58562126|FG004|Dose Escalation Phase|Progressive Disease|3|||
30564308|NCT03370302|58562127|FG005|Dose Escalation Phase|Progressive Disease|1|||
30564309|NCT03370302|58562122|FG000|Dose Expansion Phase|Progressive Disease|0|||
30564310|NCT03370302|58562123|FG001|Dose Expansion Phase|Progressive Disease|0|||
30564311|NCT03370302|58562124|FG002|Dose Expansion Phase|Progressive Disease|0|||
30564312|NCT03370302|58562125|FG003|Dose Expansion Phase|Progressive Disease|6|||
30564313|NCT03370302|58562126|FG004|Dose Expansion Phase|Progressive Disease|0|||
30564314|NCT03370302|58562127|FG005|Dose Expansion Phase|Progressive Disease|0|||
30564315|NCT03327324|58562151|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564316|NCT03327324|58562152|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
30564317|NCT03327324|58562153|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564318|NCT03327324|58562154|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
30564319|NCT03327324|58562155|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564320|NCT03327324|58562156|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
30564321|NCT03327324|58562151|FG000|Baseline (Month 0-Month 3)|Refused|0|||
30564322|NCT03327324|58562152|FG001|Baseline (Month 0-Month 3)|Refused|0|||
30564323|NCT03327324|58562153|FG002|Baseline (Month 0-Month 3)|Refused|0|||
30564324|NCT03327324|58562154|FG003|Baseline (Month 0-Month 3)|Refused|0|||
30564325|NCT03327324|58562155|FG004|Baseline (Month 0-Month 3)|Refused|1|||
30564326|NCT03327324|58562156|FG005|Baseline (Month 0-Month 3)|Refused|0|||
30564327|NCT03327324|58562151|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
30564328|NCT03327324|58562152|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
30564329|NCT03327324|58562153|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
30564330|NCT03327324|58562154|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
30564331|NCT03327324|58562155|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
30564332|NCT03327324|58562156|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
30564333|NCT03327324|58562151|FG000|Baseline (Month 0-Month 3)|Death|0|||
30564334|NCT03327324|58562152|FG001|Baseline (Month 0-Month 3)|Death|0|||
30564335|NCT03327324|58562153|FG002|Baseline (Month 0-Month 3)|Death|0|||
30564336|NCT03327324|58562154|FG003|Baseline (Month 0-Month 3)|Death|0|||
30564337|NCT03327324|58562155|FG004|Baseline (Month 0-Month 3)|Death|1|||
30564338|NCT03327324|58562156|FG005|Baseline (Month 0-Month 3)|Death|0|||
30564339|NCT03327324|58562151|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564340|NCT03327324|58562152|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564341|NCT03327324|58562153|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564342|NCT03327324|58562154|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564343|NCT03327324|58562155|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564344|NCT03327324|58562156|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
30564345|NCT03327324|58562151|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564346|NCT03327324|58562152|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564347|NCT03327324|58562153|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
30564348|NCT03327324|58562154|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564349|NCT03327324|58562155|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564350|NCT03327324|58562156|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564351|NCT03327324|58562151|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
30780024|NCT02994940|58791713|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
30780025|NCT02994940|58791714|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
30780026|NCT02994940|58791713|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
30564352|NCT03327324|58562152|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
30564353|NCT03327324|58562153|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
30564354|NCT03327324|58562154|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
30564355|NCT03327324|58562155|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
30564356|NCT03327324|58562156|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
30564357|NCT03327324|58562151|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
30564358|NCT03327324|58562152|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
30564359|NCT03327324|58562153|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
30564360|NCT03327324|58562154|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
30564361|NCT03327324|58562155|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
30564362|NCT03327324|58562156|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
30564363|NCT03327324|58562151|FG000|Intervention (Month 3-Month 6)|Death|1|||
30564364|NCT03327324|58562152|FG001|Intervention (Month 3-Month 6)|Death|0|||
30564365|NCT03327324|58562153|FG002|Intervention (Month 3-Month 6)|Death|1|||
30564366|NCT03327324|58562154|FG003|Intervention (Month 3-Month 6)|Death|1|||
30564367|NCT03327324|58562155|FG004|Intervention (Month 3-Month 6)|Death|1|||
30564368|NCT03327324|58562156|FG005|Intervention (Month 3-Month 6)|Death|0|||
30564369|NCT03327324|58562151|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564370|NCT03327324|58562152|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564371|NCT03327324|58562153|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564372|NCT03327324|58562154|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564373|NCT03327324|58562155|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564374|NCT03327324|58562156|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
30564375|NCT03327324|58562151|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
30564376|NCT03327324|58562152|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564377|NCT03327324|58562153|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564378|NCT03327324|58562154|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564379|NCT03327324|58562155|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564380|NCT03327324|58562156|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
30564381|NCT03327324|58562151|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
30564382|NCT03327324|58562152|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
30564383|NCT03327324|58562153|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
30564384|NCT03327324|58562154|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
30564385|NCT03327324|58562155|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
30564386|NCT03327324|58562156|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
30564387|NCT03327324|58562151|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
30564388|NCT03327324|58562152|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
30564389|NCT03327324|58562153|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
30564390|NCT03327324|58562154|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
30564391|NCT03327324|58562155|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
30564392|NCT03327324|58562156|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
30564393|NCT03327324|58562151|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564394|NCT03327324|58562152|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564395|NCT03327324|58562153|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564396|NCT03327324|58562154|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
30564397|NCT03327324|58562155|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
30564398|NCT03327324|58562156|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
30564399|NCT03327324|58562151|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
30564400|NCT03327324|58562152|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
30665985|NCT00866619|58679674|FG003|Overall Study|Lost to Follow-up|425|||
30665986|NCT00884390|58679721|FG000|Overall Study|Adverse Event|0|||
30665987|NCT00884390|58679722|FG001|Overall Study|Adverse Event|1|||
30665988|NCT00884390|58679721|FG000|Overall Study|Lost to Follow-up|0|||
30665989|NCT00884390|58679722|FG001|Overall Study|Lost to Follow-up|1|||
30780027|NCT02994940|58791714|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
30780028|NCT02994394|58791722|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
30780029|NCT02994394|58791723|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
30564401|NCT03327324|58562153|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
30564402|NCT03327324|58562154|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
30564403|NCT03327324|58562155|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
30564404|NCT03327324|58562156|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
30564405|NCT03327324|58562151|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
30564406|NCT03327324|58562152|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
30564407|NCT03327324|58562153|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
30564408|NCT03327324|58562154|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
30564409|NCT03327324|58562155|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
30564410|NCT03327324|58562156|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
30564411|NCT03252522|58562162|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
30564412|NCT03252522|58562163|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
30564413|NCT03252522|58562164|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
30564414|NCT03252522|58562162|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
30564415|NCT03252522|58562163|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
30564416|NCT03252522|58562164|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
30564417|NCT03252522|58562162|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
30564418|NCT03252522|58562163|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
30564419|NCT03252522|58562164|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
30564420|NCT03252522|58562162|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
30564421|NCT03252522|58562163|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
30564422|NCT03252522|58562164|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
30564423|NCT03252522|58562162|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
30564424|NCT03252522|58562163|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
30564425|NCT03252522|58562164|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
30564426|NCT03252522|58562162|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
30564427|NCT03252522|58562163|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
30564428|NCT03252522|58562164|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
30564429|NCT03252522|58562162|FG000|Phase 2: Open Label|Adverse Event|0|||
30564430|NCT03252522|58562163|FG001|Phase 2: Open Label|Adverse Event|0|||
30564431|NCT03252522|58562164|FG002|Phase 2: Open Label|Adverse Event|2|||
30564432|NCT03252522|58562162|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
30564433|NCT03252522|58562163|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
30564434|NCT03252522|58562164|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
30564435|NCT02756364|58562179|FG000|Overall Study|Site Terminated by Sponsor|24|||
30564436|NCT02756364|58562180|FG001|Overall Study|Site Terminated by Sponsor|30|||
30564437|NCT02756364|58562181|FG002|Overall Study|Site Terminated by Sponsor|21|||
30564438|NCT02756364|58562179|FG000|Overall Study|Death|20|||
30564439|NCT02756364|58562180|FG001|Overall Study|Death|15|||
30564440|NCT02756364|58562181|FG002|Overall Study|Death|18|||
30564441|NCT02756364|58562179|FG000|Overall Study|Withdrawal by Patient|2|||
30564442|NCT02756364|58562180|FG001|Overall Study|Withdrawal by Patient|1|||
30564443|NCT02756364|58562181|FG002|Overall Study|Withdrawal by Patient|8|||
30564444|NCT02756364|58562179|FG000|Overall Study|Lost to Follow-up|0|||
30564445|NCT02756364|58562180|FG001|Overall Study|Lost to Follow-up|1|||
30564446|NCT02756364|58562181|FG002|Overall Study|Lost to Follow-up|1|||
30564447|NCT02272842|58562191|FG000|Overall Study|Lost to Follow-up|8|||
30564448|NCT02272842|58562192|FG001|Overall Study|Lost to Follow-up|8|||
30564449|NCT02272842|58562191|FG000|Overall Study|Withdrawal by Subject|8|||
30564450|NCT02272842|58562192|FG001|Overall Study|Withdrawal by Subject|2|||
30564451|NCT01906476|58562201|FG000|Overall Study|Lost to Follow-up|17|||
30564452|NCT01906476|58562202|FG001|Overall Study|Lost to Follow-up|16|||
30564453|NCT05343624|58562208|FG000|Overall Study|Chart review not completed|1|||
30564454|NCT04208412|58562250|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
30564455|NCT04208412|58562251|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
30564456|NCT04208412|58562250|FG000|Overall Study|Withdrawal by Subject|1|||
30564457|NCT04208412|58562251|FG001|Overall Study|Withdrawal by Subject|0|||
30564458|NCT04208412|58562250|FG000|Overall Study|Lost to Follow-up|0|||
30564459|NCT04208412|58562251|FG001|Overall Study|Lost to Follow-up|1|||
30564460|NCT04095858|58562261|FG000|Overall Study|Death|1|||
30564461|NCT04095858|58562262|FG001|Overall Study|Death|0|||
30564462|NCT04095858|58562261|FG000|Overall Study|Study terminated by Sponsor|2|||
30564463|NCT04095858|58562262|FG001|Overall Study|Study terminated by Sponsor|4|||
30564464|NCT03937986|58562268|FG000|Overall Study|COVID-19 Pandemic|1|||
30564465|NCT03738150|58562283|FG000|Base Study|Withdrawal by Subject|1|||
30564466|NCT03738150|58562283|FG000|Extension Study|Withdrawal by Subject|1|||
30564467|NCT03567174|58562299|FG000|Overall Study|Death|24|||
30564468|NCT03567174|58562300|FG001|Overall Study|Death|31|||
30564469|NCT03567174|58562299|FG000|Overall Study|Lost to Follow-up|165|||
30564470|NCT03567174|58562300|FG001|Overall Study|Lost to Follow-up|174|||
30564471|NCT03529110|58562311|FG000|Overall Study|Progressive Disease|66|||
30564472|NCT03529110|58562312|FG001|Overall Study|Progressive Disease|158|||
30564473|NCT03529110|58562311|FG000|Overall Study|Clinical Progression|4|||
30564474|NCT03529110|58562312|FG001|Overall Study|Clinical Progression|12|||
30564475|NCT03529110|58562311|FG000|Overall Study|Adverse Event|35|||
30564476|NCT03529110|58562312|FG001|Overall Study|Adverse Event|17|||
30564477|NCT03529110|58562311|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
30564478|NCT03529110|58562312|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
30564479|NCT03529110|58562311|FG000|Overall Study|Lack of Efficacy|3|||
30564480|NCT03529110|58562312|FG001|Overall Study|Lack of Efficacy|3|||
30564481|NCT03529110|58562311|FG000|Overall Study|Physician Decision|2|||
30564482|NCT03529110|58562312|FG001|Overall Study|Physician Decision|8|||
30564483|NCT03529110|58562311|FG000|Overall Study|Miscellaneous|2|||
30564484|NCT03529110|58562312|FG001|Overall Study|Miscellaneous|5|||
30564485|NCT02663622|58562343|FG000|Overall Study|Death|3|||
30564486|NCT02663622|58562344|FG001|Overall Study|Death|1|||
30564487|NCT02663622|58562345|FG002|Overall Study|Death|1|||
30564488|NCT02663622|58562346|FG003|Overall Study|Death|8|||
30564489|NCT02663622|58562343|FG000|Overall Study|Protocol Violation|0|||
30564490|NCT02663622|58562344|FG001|Overall Study|Protocol Violation|0|||
30564491|NCT02663622|58562345|FG002|Overall Study|Protocol Violation|0|||
30564492|NCT02663622|58562346|FG003|Overall Study|Protocol Violation|1|||
30564493|NCT02545998|58562372|FG000|Overall Study|Lost to Follow-up|12|||
30564494|NCT02545998|58562373|FG001|Overall Study|Lost to Follow-up|3|||
30564495|NCT02545998|58562372|FG000|Overall Study|Withdrawal by Subject|3|||
30564496|NCT02545998|58562373|FG001|Overall Study|Withdrawal by Subject|2|||
30564497|NCT02257242|58562397|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
30564498|NCT02257242|58562398|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
30564499|NCT02257242|58562399|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
30564500|NCT02257242|58562400|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
30564501|NCT02257242|58562401|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
30564502|NCT02257242|58562402|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
30564503|NCT02257242|58562403|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
30564504|NCT02257242|58562404|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
30564505|NCT02257242|58562405|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
30564506|NCT01943916|58562435|FG000|Overall Study|Technically invalid images|10|||
30564507|NCT01943916|58562435|FG000|Overall Study|Enrollment Failure|23|||
30564508|NCT01943916|58562435|FG000|Overall Study|Pilot Phase exclusion|100|||
30564509|NCT01943916|58562435|FG000|Overall Study|Quality Assurance Reader Fail|130|||
30564510|NCT01943916|58562435|FG000|Overall Study|Technical Failure|39|||
30564511|NCT01943916|58562435|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
30564512|NCT01943916|58562435|FG000|Overall Study|No Truth Panel Review|38|||
30564513|NCT01943916|58562435|FG000|Overall Study|Protocol Deviation|1|||
30564514|NCT01564368|58562444|FG000|Overall Study|Ineligible|18|||
30564515|NCT01564368|58562444|FG000|Overall Study|Not Randomized in Parent study|116|||
30564516|NCT01564368|58562444|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
30564517|NCT01564368|58562444|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
30564518|NCT00281658|58562452|FG000|Randomized Phase|Adverse Event|0|||
30564519|NCT00281658|58562453|FG001|Randomized Phase|Adverse Event|2|||
30564520|NCT00281658|58562454|FG002|Randomized Phase|Adverse Event|0|||
30564521|NCT00281658|58562455|FG003|Randomized Phase|Adverse Event|0|||
30564522|NCT00281658|58562452|FG000|Randomized Phase|Lost to Follow-up|34|||
30564523|NCT00281658|58562453|FG001|Randomized Phase|Lost to Follow-up|27|||
30564524|NCT00281658|58562454|FG002|Randomized Phase|Lost to Follow-up|0|||
30564525|NCT00281658|58562455|FG003|Randomized Phase|Lost to Follow-up|0|||
30564526|NCT00281658|58562452|FG000|Randomized Phase|Withdrawal by Subject|8|||
30564527|NCT00281658|58562453|FG001|Randomized Phase|Withdrawal by Subject|7|||
30564528|NCT00281658|58562454|FG002|Randomized Phase|Withdrawal by Subject|0|||
30564529|NCT00281658|58562455|FG003|Randomized Phase|Withdrawal by Subject|0|||
30564530|NCT00281658|58562452|FG000|Randomized Phase|Study closed/terminated|1|||
30564531|NCT00281658|58562453|FG001|Randomized Phase|Study closed/terminated|1|||
30564532|NCT00281658|58562454|FG002|Randomized Phase|Study closed/terminated|0|||
30564533|NCT00281658|58562455|FG003|Randomized Phase|Study closed/terminated|0|||
30564534|NCT00281658|58562452|FG000|Randomized Phase|Disease progression|36|||
30564535|NCT00281658|58562453|FG001|Randomized Phase|Disease progression|27|||
30564536|NCT00281658|58562454|FG002|Randomized Phase|Disease progression|0|||
30564537|NCT00281658|58562455|FG003|Randomized Phase|Disease progression|0|||
30564538|NCT00281658|58562452|FG000|Randomized Phase|Physician Decision|1|||
30665990|NCT00884390|58679721|FG000|Overall Study|Physician Decision|2|||
30564539|NCT00281658|58562453|FG001|Randomized Phase|Physician Decision|1|||
30564540|NCT00281658|58562454|FG002|Randomized Phase|Physician Decision|0|||
30564541|NCT00281658|58562455|FG003|Randomized Phase|Physician Decision|0|||
30665991|NCT00884390|58679722|FG001|Overall Study|Physician Decision|1|||
30665992|NCT00884390|58679721|FG000|Overall Study|Protocol Violation|4|||
30564542|NCT00281658|58562452|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
30564543|NCT00281658|58562453|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
30564544|NCT00281658|58562454|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
30564545|NCT00281658|58562455|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
30564546|NCT00281658|58562452|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
30564547|NCT00281658|58562453|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
30564548|NCT00281658|58562454|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
30564549|NCT00281658|58562455|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
30564550|NCT00281658|58562452|FG000|Randomized Phase|Treatment ongoing|1|||
30564551|NCT00281658|58562453|FG001|Randomized Phase|Treatment ongoing|0|||
30564552|NCT00281658|58562454|FG002|Randomized Phase|Treatment ongoing|0|||
30564553|NCT00281658|58562455|FG003|Randomized Phase|Treatment ongoing|0|||
30665993|NCT00884390|58679722|FG001|Overall Study|Protocol Violation|1|||
30665994|NCT00884390|58679721|FG000|Overall Study|Withdrawal by Subject|4|||
30665995|NCT00884390|58679722|FG001|Overall Study|Withdrawal by Subject|1|||
30665996|NCT00884390|58679721|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
30665997|NCT00884390|58679722|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
30665998|NCT00884390|58679721|FG000|Overall Study|Other|11|||
30665999|NCT00884390|58679722|FG001|Overall Study|Other|1|||
30666000|NCT00872898|58679759|FG000|Part Two - Double Blind|Adverse Event|4|||
30564554|NCT00281658|58562452|FG000|Open Label Phase|Adverse Event|0|||
30564555|NCT00281658|58562453|FG001|Open Label Phase|Adverse Event|0|||
30564556|NCT00281658|58562454|FG002|Open Label Phase|Adverse Event|1|||
30564557|NCT00281658|58562455|FG003|Open Label Phase|Adverse Event|0|||
30564558|NCT00281658|58562452|FG000|Open Label Phase|Lost to Follow-up|0|||
30564559|NCT00281658|58562453|FG001|Open Label Phase|Lost to Follow-up|0|||
30564560|NCT00281658|58562454|FG002|Open Label Phase|Lost to Follow-up|16|||
30564561|NCT00281658|58562455|FG003|Open Label Phase|Lost to Follow-up|2|||
30564562|NCT00281658|58562452|FG000|Open Label Phase|Withdrawal by Subject|0|||
30564563|NCT00281658|58562453|FG001|Open Label Phase|Withdrawal by Subject|0|||
30564564|NCT00281658|58562454|FG002|Open Label Phase|Withdrawal by Subject|3|||
30564565|NCT00281658|58562455|FG003|Open Label Phase|Withdrawal by Subject|2|||
30564566|NCT00281658|58562452|FG000|Open Label Phase|Disease progression|0|||
30564567|NCT00281658|58562453|FG001|Open Label Phase|Disease progression|0|||
30564568|NCT00281658|58562454|FG002|Open Label Phase|Disease progression|18|||
30564569|NCT00281658|58562455|FG003|Open Label Phase|Disease progression|0|||
30564570|NCT00281658|58562452|FG000|Open Label Phase|Physician Decision|0|||
30564571|NCT00281658|58562453|FG001|Open Label Phase|Physician Decision|0|||
30564572|NCT00281658|58562454|FG002|Open Label Phase|Physician Decision|1|||
30564573|NCT00281658|58562455|FG003|Open Label Phase|Physician Decision|0|||
30564574|NCT00281658|58562452|FG000|Open Label Phase|Relocation of patient|0|||
30564575|NCT00281658|58562453|FG001|Open Label Phase|Relocation of patient|0|||
30564576|NCT00281658|58562454|FG002|Open Label Phase|Relocation of patient|1|||
30564577|NCT00281658|58562455|FG003|Open Label Phase|Relocation of patient|0|||
30564578|NCT00281658|58562452|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
30564579|NCT00281658|58562453|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
30564580|NCT00281658|58562454|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
30564581|NCT00281658|58562455|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
30564583|NCT02758626|58563852|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
30564584|NCT02758626|58563853|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
30564585|NCT02758626|58563852|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
30564586|NCT02758626|58563853|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
30564587|NCT02758626|58563852|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
30564588|NCT02758626|58563853|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
30564589|NCT02758626|58563852|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
30564590|NCT02758626|58563853|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
30564591|NCT02357784|58563859|FG000|Overall Study|Withdrawal by Subject|1|||
30564592|NCT01448616|58563866|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
30564593|NCT01448616|58563867|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
30564594|NCT01448616|58563868|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
30564595|NCT01448616|58563869|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
30564596|NCT01448616|58563866|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
30564597|NCT01448616|58563867|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
30564598|NCT01448616|58563868|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
30564599|NCT01448616|58563869|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
30564600|NCT01448616|58563866|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
30666001|NCT00872898|58679760|FG001|Part Two - Double Blind|Adverse Event|3|||
30666002|NCT00872898|58679759|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
30780030|NCT02994394|58791724|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
30780031|NCT02994394|58791725|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
30564601|NCT01448616|58563867|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
30564602|NCT01448616|58563868|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
30564603|NCT01448616|58563869|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
30564604|NCT01448616|58563866|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
30564605|NCT01448616|58563867|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
30564606|NCT01448616|58563868|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
30564607|NCT01448616|58563869|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
30564608|NCT01448616|58563866|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
30564609|NCT01448616|58563867|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
30564610|NCT01448616|58563868|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
30564611|NCT01448616|58563869|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
30564612|NCT00074412|58563906|FG000|Overall Study|Death|30|||
30564613|NCT00074412|58563907|FG001|Overall Study|Death|26|||
30564614|NCT00074412|58563906|FG000|Overall Study|Lost to Follow-up|52|||
30564615|NCT00074412|58563907|FG001|Overall Study|Lost to Follow-up|58|||
30564616|NCT04505592|58564913|FG000|Overall Study|Death|2|||
30564617|NCT04505592|58564914|FG001|Overall Study|Death|1|||
30564618|NCT04521114|58571287|FG000|Overall Study|Lost to Follow-up|1|||
30564619|NCT04521114|58571288|FG001|Overall Study|Lost to Follow-up|2|||
30564620|NCT04521114|58571289|FG002|Overall Study|Lost to Follow-up|0|||
30564621|NCT04521114|58571287|FG000|Overall Study|Withdrawal by Subject|1|||
30564622|NCT04521114|58571288|FG001|Overall Study|Withdrawal by Subject|2|||
30564623|NCT04521114|58571289|FG002|Overall Study|Withdrawal by Subject|2|||
30564624|NCT04521114|58571287|FG000|Overall Study|Adverse Event|1|||
30564625|NCT04521114|58571288|FG001|Overall Study|Adverse Event|0|||
30564626|NCT04521114|58571289|FG002|Overall Study|Adverse Event|0|||
30564627|NCT04521114|58571287|FG000|Overall Study|Sponsor Wish|1|||
30564628|NCT04521114|58571288|FG001|Overall Study|Sponsor Wish|0|||
30564629|NCT04521114|58571289|FG002|Overall Study|Sponsor Wish|0|||
30564630|NCT04521114|58571287|FG000|Overall Study|Withdrawal of Consent|2|||
30564631|NCT04521114|58571288|FG001|Overall Study|Withdrawal of Consent|2|||
30564632|NCT04521114|58571289|FG002|Overall Study|Withdrawal of Consent|0|||
30564633|NCT04360824|58571311|FG000|Overall Study|Withdrawal by Subject|2|||
30564634|NCT04360824|58571312|FG001|Overall Study|Withdrawal by Subject|1|||
30564635|NCT04360824|58571311|FG000|Overall Study|Did not receive assigned treatment|1|||
30564636|NCT04360824|58571312|FG001|Overall Study|Did not receive assigned treatment|3|||
30564637|NCT03711786|58571321|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
30564638|NCT03711786|58571322|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
30564639|NCT03711786|58571321|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
30564640|NCT03711786|58571322|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
30564641|NCT03711786|58571321|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
30564642|NCT03711786|58571322|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
30564643|NCT03711786|58571321|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
30564644|NCT03711786|58571322|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
30564645|NCT03711786|58571321|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
30564646|NCT03711786|58571322|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
30564647|NCT03711786|58571321|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
30564648|NCT03711786|58571322|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
30564649|NCT03691974|58571332|FG000|Overall Study|Physician Decision|1|||
30564650|NCT03691974|58571333|FG001|Overall Study|Physician Decision|0|||
30564651|NCT03691974|58571332|FG000|Overall Study|Adverse Event|1|||
30564652|NCT03691974|58571333|FG001|Overall Study|Adverse Event|0|||
30564653|NCT03691974|58571332|FG000|Overall Study|Withdrawal by Subject|11|||
30564654|NCT03691974|58571333|FG001|Overall Study|Withdrawal by Subject|9|||
30564655|NCT03691974|58571332|FG000|Overall Study|Protocol Violation|1|||
30564656|NCT03691974|58571333|FG001|Overall Study|Protocol Violation|0|||
30564657|NCT03691974|58571332|FG000|Overall Study|Lost to Follow-up|8|||
30564658|NCT03691974|58571333|FG001|Overall Study|Lost to Follow-up|7|||
30564659|NCT03525678|58571354|FG000|Overall Study|Ongoing at the time of interim analysis|60|||
30564660|NCT03525678|58571355|FG001|Overall Study|Ongoing at the time of interim analysis|65|||
30564661|NCT03525678|58571356|FG002|Overall Study|Ongoing at the time of interim analysis|21|||
30564662|NCT03525678|58571354|FG000|Overall Study|Withdrawal by Subject|3|||
30564663|NCT03525678|58571355|FG001|Overall Study|Withdrawal by Subject|1|||
30564664|NCT03525678|58571356|FG002|Overall Study|Withdrawal by Subject|0|||
30564665|NCT03525678|58571354|FG000|Overall Study|Physician Decision|1|||
30564666|NCT03525678|58571355|FG001|Overall Study|Physician Decision|2|||
30564667|NCT03525678|58571356|FG002|Overall Study|Physician Decision|0|||
30564668|NCT03525678|58571354|FG000|Overall Study|Lost to Follow-up|1|||
30564669|NCT03525678|58571355|FG001|Overall Study|Lost to Follow-up|0|||
30564670|NCT03525678|58571356|FG002|Overall Study|Lost to Follow-up|0|||
30564671|NCT03525678|58571354|FG000|Overall Study|Death|32|||
30564672|NCT03525678|58571355|FG001|Overall Study|Death|31|||
30564673|NCT03525678|58571356|FG002|Overall Study|Death|4|||
30780032|NCT02994394|58791726|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
30564674|NCT02829918|58571364|FG000|Overall Study|Death|2|||
30564675|NCT02829918|58571364|FG000|Overall Study|Withdrawal by Subject|4|||
30564676|NCT02829918|58571364|FG000|Overall Study|Adverse Event|1|||
30564677|NCT02829918|58571364|FG000|Overall Study|Progression|1|||
30564678|NCT02454972|58571377|FG000|Overall Study|Progressive disease|17|||
30564679|NCT02454972|58571378|FG001|Overall Study|Progressive disease|16|||
30564680|NCT02454972|58571379|FG002|Overall Study|Progressive disease|59|||
30564681|NCT02454972|58571380|FG003|Overall Study|Progressive disease|23|||
30564682|NCT02454972|58571381|FG004|Overall Study|Progressive disease|16|||
30564683|NCT02454972|58571382|FG005|Overall Study|Progressive disease|12|||
30564684|NCT02454972|58571383|FG006|Overall Study|Progressive disease|19|||
30564685|NCT02454972|58571384|FG007|Overall Study|Progressive disease|27|||
30564686|NCT02454972|58571385|FG008|Overall Study|Progressive disease|0|||
30564687|NCT02454972|58571377|FG000|Overall Study|Death|0|||
30564688|NCT02454972|58571378|FG001|Overall Study|Death|0|||
30564689|NCT02454972|58571379|FG002|Overall Study|Death|5|||
30564690|NCT02454972|58571380|FG003|Overall Study|Death|1|||
30564691|NCT02454972|58571381|FG004|Overall Study|Death|0|||
30564692|NCT02454972|58571382|FG005|Overall Study|Death|0|||
30564693|NCT02454972|58571383|FG006|Overall Study|Death|0|||
30564694|NCT02454972|58571384|FG007|Overall Study|Death|0|||
30564695|NCT02454972|58571385|FG008|Overall Study|Death|95|||
30564696|NCT02454972|58571377|FG000|Overall Study|Physician Decision|0|||
30564697|NCT02454972|58571378|FG001|Overall Study|Physician Decision|1|||
30564698|NCT02454972|58571379|FG002|Overall Study|Physician Decision|2|||
30564699|NCT02454972|58571380|FG003|Overall Study|Physician Decision|1|||
30564700|NCT02454972|58571381|FG004|Overall Study|Physician Decision|2|||
30564701|NCT02454972|58571382|FG005|Overall Study|Physician Decision|0|||
30564702|NCT02454972|58571383|FG006|Overall Study|Physician Decision|0|||
30564703|NCT02454972|58571384|FG007|Overall Study|Physician Decision|1|||
30564704|NCT02454972|58571385|FG008|Overall Study|Physician Decision|0|||
30564705|NCT02454972|58571377|FG000|Overall Study|Non treatment-related adverse event|2|||
30564706|NCT02454972|58571378|FG001|Overall Study|Non treatment-related adverse event|0|||
30564707|NCT02454972|58571379|FG002|Overall Study|Non treatment-related adverse event|1|||
30564708|NCT02454972|58571380|FG003|Overall Study|Non treatment-related adverse event|0|||
30564709|NCT02454972|58571381|FG004|Overall Study|Non treatment-related adverse event|0|||
30564710|NCT02454972|58571382|FG005|Overall Study|Non treatment-related adverse event|1|||
30564711|NCT02454972|58571383|FG006|Overall Study|Non treatment-related adverse event|0|||
30564712|NCT02454972|58571384|FG007|Overall Study|Non treatment-related adverse event|1|||
30564713|NCT02454972|58571385|FG008|Overall Study|Non treatment-related adverse event|0|||
30564714|NCT02454972|58571377|FG000|Overall Study|Treatment-related adverse events|0|||
30564715|NCT02454972|58571378|FG001|Overall Study|Treatment-related adverse events|1|||
30564716|NCT02454972|58571379|FG002|Overall Study|Treatment-related adverse events|1|||
30564717|NCT02454972|58571380|FG003|Overall Study|Treatment-related adverse events|0|||
30564718|NCT02454972|58571381|FG004|Overall Study|Treatment-related adverse events|2|||
30564719|NCT02454972|58571382|FG005|Overall Study|Treatment-related adverse events|0|||
30564720|NCT02454972|58571383|FG006|Overall Study|Treatment-related adverse events|0|||
30564721|NCT02454972|58571384|FG007|Overall Study|Treatment-related adverse events|2|||
30564722|NCT02454972|58571385|FG008|Overall Study|Treatment-related adverse events|0|||
30564723|NCT02454972|58571377|FG000|Overall Study|Patient moves to compassionate use|0|||
30564724|NCT02454972|58571378|FG001|Overall Study|Patient moves to compassionate use|0|||
30564725|NCT02454972|58571379|FG002|Overall Study|Patient moves to compassionate use|0|||
30564726|NCT02454972|58571380|FG003|Overall Study|Patient moves to compassionate use|0|||
30564727|NCT02454972|58571381|FG004|Overall Study|Patient moves to compassionate use|0|||
30564728|NCT02454972|58571382|FG005|Overall Study|Patient moves to compassionate use|0|||
30564729|NCT02454972|58571383|FG006|Overall Study|Patient moves to compassionate use|2|||
30564730|NCT02454972|58571384|FG007|Overall Study|Patient moves to compassionate use|0|||
30564731|NCT02454972|58571385|FG008|Overall Study|Patient moves to compassionate use|0|||
30564732|NCT02454972|58571377|FG000|Overall Study|Withdrawal by Subject|0|||
30855136|NCT02334748|58882657|FG000|Overall Study|Lack of Efficacy|4|||
30564733|NCT02454972|58571378|FG001|Overall Study|Withdrawal by Subject|1|||
30564734|NCT02454972|58571379|FG002|Overall Study|Withdrawal by Subject|5|||
30564735|NCT02454972|58571380|FG003|Overall Study|Withdrawal by Subject|2|||
30564736|NCT02454972|58571381|FG004|Overall Study|Withdrawal by Subject|3|||
30564737|NCT02454972|58571382|FG005|Overall Study|Withdrawal by Subject|2|||
30564738|NCT02454972|58571383|FG006|Overall Study|Withdrawal by Subject|0|||
30564739|NCT02454972|58571384|FG007|Overall Study|Withdrawal by Subject|1|||
30564740|NCT02454972|58571385|FG008|Overall Study|Withdrawal by Subject|2|||
30564741|NCT02454972|58571377|FG000|Overall Study|Multiple delay/holds on treatment|0|||
30564742|NCT02454972|58571378|FG001|Overall Study|Multiple delay/holds on treatment|0|||
30564743|NCT02454972|58571379|FG002|Overall Study|Multiple delay/holds on treatment|0|||
30564744|NCT02454972|58571380|FG003|Overall Study|Multiple delay/holds on treatment|1|||
30564745|NCT02454972|58571381|FG004|Overall Study|Multiple delay/holds on treatment|0|||
30564746|NCT02454972|58571382|FG005|Overall Study|Multiple delay/holds on treatment|0|||
30564747|NCT02454972|58571383|FG006|Overall Study|Multiple delay/holds on treatment|0|||
30855137|NCT02332876|58882663|FG000|Overall Study|Lost to Follow-up|1|||
30564748|NCT02454972|58571384|FG007|Overall Study|Multiple delay/holds on treatment|0|||
30564749|NCT02454972|58571385|FG008|Overall Study|Multiple delay/holds on treatment|0|||
30564750|NCT02454972|58571377|FG000|Overall Study|Never treated|0|||
30564751|NCT02454972|58571378|FG001|Overall Study|Never treated|0|||
30564752|NCT02454972|58571379|FG002|Overall Study|Never treated|3|||
30564753|NCT02454972|58571380|FG003|Overall Study|Never treated|1|||
30564754|NCT02454972|58571381|FG004|Overall Study|Never treated|1|||
30564755|NCT02454972|58571382|FG005|Overall Study|Never treated|0|||
30564756|NCT02454972|58571383|FG006|Overall Study|Never treated|0|||
30564757|NCT02454972|58571384|FG007|Overall Study|Never treated|0|||
30564758|NCT02454972|58571385|FG008|Overall Study|Never treated|5|||
30564759|NCT02454972|58571377|FG000|Overall Study|Lost to Follow-up|0|||
30564760|NCT02454972|58571378|FG001|Overall Study|Lost to Follow-up|0|||
30564761|NCT02454972|58571379|FG002|Overall Study|Lost to Follow-up|0|||
30564762|NCT02454972|58571380|FG003|Overall Study|Lost to Follow-up|0|||
30564763|NCT02454972|58571381|FG004|Overall Study|Lost to Follow-up|0|||
30564764|NCT02454972|58571382|FG005|Overall Study|Lost to Follow-up|0|||
30564765|NCT02454972|58571383|FG006|Overall Study|Lost to Follow-up|0|||
30564766|NCT02454972|58571384|FG007|Overall Study|Lost to Follow-up|0|||
30564767|NCT02454972|58571385|FG008|Overall Study|Lost to Follow-up|2|||
30564768|NCT02454972|58571377|FG000|Overall Study|Study termination|0|||
30564769|NCT02454972|58571378|FG001|Overall Study|Study termination|0|||
30564770|NCT02454972|58571379|FG002|Overall Study|Study termination|0|||
30564771|NCT02454972|58571380|FG003|Overall Study|Study termination|0|||
30564772|NCT02454972|58571381|FG004|Overall Study|Study termination|0|||
30564773|NCT02454972|58571382|FG005|Overall Study|Study termination|0|||
30564774|NCT02454972|58571383|FG006|Overall Study|Study termination|0|||
30564775|NCT02454972|58571384|FG007|Overall Study|Study termination|0|||
30564776|NCT02454972|58571385|FG008|Overall Study|Study termination|6|||
30564777|NCT01096368|58571402|FG000|Overall Study|Death|0|||
30564778|NCT01096368|58571403|FG001|Overall Study|Death|1|||
30564779|NCT01096368|58571404|FG002|Overall Study|Death|0|||
30564780|NCT01096368|58571405|FG003|Overall Study|Death|0|||
30564781|NCT01096368|58571406|FG004|Overall Study|Death|0|||
30564782|NCT01096368|58571402|FG000|Overall Study|Physician Decision|0|||
30564783|NCT01096368|58571403|FG001|Overall Study|Physician Decision|13|||
30564784|NCT01096368|58571404|FG002|Overall Study|Physician Decision|2|||
30564785|NCT01096368|58571405|FG003|Overall Study|Physician Decision|4|||
30564786|NCT01096368|58571406|FG004|Overall Study|Physician Decision|6|||
30564787|NCT01096368|58571402|FG000|Overall Study|Withdrawal by Subject|0|||
30564788|NCT01096368|58571403|FG001|Overall Study|Withdrawal by Subject|52|||
30564789|NCT01096368|58571404|FG002|Overall Study|Withdrawal by Subject|0|||
30564790|NCT01096368|58571405|FG003|Overall Study|Withdrawal by Subject|10|||
30564791|NCT01096368|58571406|FG004|Overall Study|Withdrawal by Subject|14|||
30564792|NCT01096368|58571402|FG000|Overall Study|Ineligible|0|||
30564793|NCT01096368|58571403|FG001|Overall Study|Ineligible|3|||
30564794|NCT01096368|58571404|FG002|Overall Study|Ineligible|2|||
30564795|NCT01096368|58571405|FG003|Overall Study|Ineligible|0|||
30564796|NCT01096368|58571406|FG004|Overall Study|Ineligible|25|||
30564797|NCT01096368|58571402|FG000|Overall Study|Did not start treatment|0|||
30564798|NCT01096368|58571403|FG001|Overall Study|Did not start treatment|4|||
30564799|NCT01096368|58571404|FG002|Overall Study|Did not start treatment|4|||
30564800|NCT01096368|58571405|FG003|Overall Study|Did not start treatment|0|||
30564801|NCT01096368|58571406|FG004|Overall Study|Did not start treatment|0|||
30564802|NCT01096368|58571402|FG000|Overall Study|Progressive disease|0|||
30564803|NCT01096368|58571403|FG001|Overall Study|Progressive disease|6|||
30564804|NCT01096368|58571404|FG002|Overall Study|Progressive disease|0|||
30564805|NCT01096368|58571405|FG003|Overall Study|Progressive disease|10|||
30564806|NCT01096368|58571406|FG004|Overall Study|Progressive disease|3|||
30564807|NCT01096368|58571402|FG000|Overall Study|Other|0|||
30564808|NCT01096368|58571403|FG001|Overall Study|Other|0|||
30564809|NCT01096368|58571404|FG002|Overall Study|Other|1|||
30564810|NCT01096368|58571405|FG003|Overall Study|Other|0|||
30564811|NCT01096368|58571406|FG004|Overall Study|Other|0|||
30564812|NCT01096368|58571402|FG000|Overall Study|Treated with institutional review|0|||
30564813|NCT01096368|58571403|FG001|Overall Study|Treated with institutional review|0|||
30564814|NCT01096368|58571404|FG002|Overall Study|Treated with institutional review|0|||
30780033|NCT02994394|58791727|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
30564815|NCT01096368|58571405|FG003|Overall Study|Treated with institutional review|0|||
30564816|NCT01096368|58571406|FG004|Overall Study|Treated with institutional review|1|||
30564817|NCT00063882|58571427|FG000|Overall Study|Protocol Violation|3|||
30564818|NCT00063882|58571428|FG001|Overall Study|Protocol Violation|3|||
30564819|NCT00063882|58571427|FG000|Overall Study|Withdrawal by Subject|2|||
30564820|NCT00063882|58571428|FG001|Overall Study|Withdrawal by Subject|1|||
30564821|NCT01279044|58571437|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
30564822|NCT01279044|58571438|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
30564823|NCT01279044|58571439|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
30564824|NCT01279044|58571437|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
30564825|NCT01279044|58571438|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
30564826|NCT01279044|58571439|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
30564827|NCT01279044|58571437|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
30564828|NCT01279044|58571438|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
30564829|NCT01279044|58571439|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
30564830|NCT01278342|58571448|FG000|Overall Study|Physician Decision|0|||
30564831|NCT01278342|58571449|FG001|Overall Study|Physician Decision|1|||
30564832|NCT01278342|58571450|FG002|Overall Study|Physician Decision|0|||
30564833|NCT01278342|58571448|FG000|Overall Study|Lost to Follow-up|1|||
30564834|NCT01278342|58571449|FG001|Overall Study|Lost to Follow-up|0|||
30564835|NCT01278342|58571450|FG002|Overall Study|Lost to Follow-up|0|||
30564836|NCT01278342|58571448|FG000|Overall Study|Administrative problems|2|||
30564837|NCT01278342|58571449|FG001|Overall Study|Administrative problems|0|||
30564838|NCT01278342|58571450|FG002|Overall Study|Administrative problems|0|||
30564839|NCT01278342|58571448|FG000|Overall Study|Other|1|||
30564840|NCT01278342|58571449|FG001|Overall Study|Other|0|||
30564841|NCT01278342|58571450|FG002|Overall Study|Other|0|||
30564842|NCT01278030|58571460|FG000|Overall Study|Withdrawal by Subject|8|||
30564843|NCT01278030|58571461|FG001|Overall Study|Withdrawal by Subject|4|||
30564844|NCT01277718|58571467|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
30564845|NCT01277718|58571468|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
30564846|NCT01277718|58571467|FG000|Period 2 - Second Intervention|Physician Decision|0|||
30564847|NCT01277718|58571468|FG001|Period 2 - Second Intervention|Physician Decision|2|||
30564848|NCT01276236|58571476|FG000|Overall Study|Lack of Efficacy|2|||
30564849|NCT01276236|58571476|FG000|Overall Study|Withdrawal by Subject|4|||
30564850|NCT01275222|58571486|FG000|Phase l by Treatment|Adverse Event|1|||
30564851|NCT01275222|58571487|FG001|Phase l by Treatment|Adverse Event|4|||
30564852|NCT01275222|58571488|FG002|Phase l by Treatment|Adverse Event|2|||
30564853|NCT01275222|58571489|FG003|Phase l by Treatment|Adverse Event|3|||
30564854|NCT01275222|58571490|FG004|Phase l by Treatment|Adverse Event|0|||
30564855|NCT01275222|58571491|FG005|Phase l by Treatment|Adverse Event|0|||
30564856|NCT01275222|58571486|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
30564857|NCT01275222|58571487|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
30564858|NCT01275222|58571488|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
30564859|NCT01275222|58571489|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
30564860|NCT01275222|58571490|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
30564861|NCT01275222|58571491|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
30564862|NCT01275222|58571486|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
30564863|NCT01275222|58571487|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
30564864|NCT01275222|58571488|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
30564865|NCT01275222|58571489|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
30564866|NCT01275222|58571490|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
30564867|NCT01275222|58571491|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
30564868|NCT01275222|58571486|FG000|Phase l by Treatment|Disease progression|12|||
30564869|NCT01275222|58571487|FG001|Phase l by Treatment|Disease progression|8|||
30564870|NCT01275222|58571488|FG002|Phase l by Treatment|Disease progression|2|||
30564871|NCT01275222|58571489|FG003|Phase l by Treatment|Disease progression|5|||
30564872|NCT01275222|58571490|FG004|Phase l by Treatment|Disease progression|0|||
30564873|NCT01275222|58571491|FG005|Phase l by Treatment|Disease progression|0|||
30564874|NCT01275222|58571486|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
30564875|NCT01275222|58571487|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
30564876|NCT01275222|58571488|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
30564877|NCT01275222|58571489|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
30564878|NCT01275222|58571490|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
30564879|NCT01275222|58571491|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
30564880|NCT01275222|58571486|FG000|Phase l by Treatment|Death|0|||
30564881|NCT01275222|58571487|FG001|Phase l by Treatment|Death|1|||
30564882|NCT01275222|58571488|FG002|Phase l by Treatment|Death|0|||
30564883|NCT01275222|58571489|FG003|Phase l by Treatment|Death|1|||
30564884|NCT01275222|58571490|FG004|Phase l by Treatment|Death|0|||
30564885|NCT01275222|58571491|FG005|Phase l by Treatment|Death|0|||
30564886|NCT01275222|58571486|FG000|Phase ll by Stratum|Adverse Event|0|||
30564887|NCT01275222|58571487|FG001|Phase ll by Stratum|Adverse Event|0|||
30564888|NCT01275222|58571488|FG002|Phase ll by Stratum|Adverse Event|0|||
30564889|NCT01275222|58571489|FG003|Phase ll by Stratum|Adverse Event|0|||
30564890|NCT01275222|58571490|FG004|Phase ll by Stratum|Adverse Event|2|||
30564891|NCT01275222|58571491|FG005|Phase ll by Stratum|Adverse Event|10|||
30564892|NCT01275222|58571486|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
30564893|NCT01275222|58571487|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
30564894|NCT01275222|58571488|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
30666003|NCT00872898|58679760|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
30564895|NCT01275222|58571489|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
30564896|NCT01275222|58571490|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
30564897|NCT01275222|58571491|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
30564898|NCT01275222|58571486|FG000|Phase ll by Stratum|Disease progression|0|||
30564899|NCT01275222|58571487|FG001|Phase ll by Stratum|Disease progression|0|||
30564900|NCT01275222|58571488|FG002|Phase ll by Stratum|Disease progression|0|||
30564901|NCT01275222|58571489|FG003|Phase ll by Stratum|Disease progression|0|||
30564902|NCT01275222|58571490|FG004|Phase ll by Stratum|Disease progression|23|||
30564903|NCT01275222|58571491|FG005|Phase ll by Stratum|Disease progression|31|||
30564904|NCT01275222|58571486|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
30564905|NCT01275222|58571487|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
30564906|NCT01275222|58571488|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
30564907|NCT01275222|58571489|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
30564908|NCT01275222|58571490|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
30564909|NCT01275222|58571491|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
30564910|NCT01275222|58571486|FG000|Phase ll by Stratum|Death|0|||
30564911|NCT01275222|58571487|FG001|Phase ll by Stratum|Death|0|||
30564912|NCT01275222|58571488|FG002|Phase ll by Stratum|Death|0|||
30564913|NCT01275222|58571489|FG003|Phase ll by Stratum|Death|0|||
30564914|NCT01275222|58571490|FG004|Phase ll by Stratum|Death|1|||
30564915|NCT01275222|58571491|FG005|Phase ll by Stratum|Death|1|||
30564916|NCT01275144|58571509|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
30564917|NCT01275144|58571510|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
30564918|NCT01275066|58571521|FG000|Overall Study|Withdrawal by Subject|0|||
30564919|NCT01275066|58571522|FG001|Overall Study|Withdrawal by Subject|0|||
30564920|NCT01275066|58571523|FG002|Overall Study|Withdrawal by Subject|1|||
30564921|NCT01275066|58571521|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
30564922|NCT01275066|58571522|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
30564923|NCT01275066|58571523|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
30564924|NCT01273038|58571533|FG000|Second Intervention (14 Days)|Adverse Event|0|||
30564925|NCT01273038|58571534|FG001|Second Intervention (14 Days)|Adverse Event|1|||
30564926|NCT01273038|58571533|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
30564927|NCT01273038|58571534|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
30564928|NCT01272180|58571544|FG000|Overall Study|Adverse Event|0|||
30564929|NCT01272180|58571545|FG001|Overall Study|Adverse Event|0|||
30564930|NCT01272180|58571546|FG002|Overall Study|Adverse Event|1|||
30564931|NCT01272180|58571547|FG003|Overall Study|Adverse Event|0|||
30564932|NCT01272180|58571544|FG000|Overall Study|Withdrawal by Subject|2|||
30564933|NCT01272180|58571545|FG001|Overall Study|Withdrawal by Subject|6|||
30564934|NCT01272180|58571546|FG002|Overall Study|Withdrawal by Subject|3|||
30564935|NCT01272180|58571547|FG003|Overall Study|Withdrawal by Subject|2|||
30564936|NCT01272180|58571544|FG000|Overall Study|Lost to Follow-up|15|||
30564937|NCT01272180|58571545|FG001|Overall Study|Lost to Follow-up|14|||
30564938|NCT01272180|58571546|FG002|Overall Study|Lost to Follow-up|8|||
30564939|NCT01272180|58571547|FG003|Overall Study|Lost to Follow-up|10|||
30564940|NCT01272180|58571544|FG000|Overall Study|Inappropriate enrollment|0|||
30564941|NCT01272180|58571545|FG001|Overall Study|Inappropriate enrollment|0|||
30564942|NCT01272180|58571546|FG002|Overall Study|Inappropriate enrollment|1|||
30564943|NCT01272180|58571547|FG003|Overall Study|Inappropriate enrollment|1|||
30564944|NCT01272180|58571544|FG000|Overall Study|Protocol Violation|0|||
30564945|NCT01272180|58571545|FG001|Overall Study|Protocol Violation|1|||
30564946|NCT01272180|58571546|FG002|Overall Study|Protocol Violation|0|||
30564947|NCT01272180|58571547|FG003|Overall Study|Protocol Violation|1|||
30564948|NCT01271712|58571563|FG000|Double Blind Treatment|Death|2|||
30564949|NCT01271712|58571564|FG001|Double Blind Treatment|Death|0|||
30564950|NCT01271712|58571563|FG000|Double Blind Treatment|Lack of Efficacy|1|||
30564951|NCT01271712|58571564|FG001|Double Blind Treatment|Lack of Efficacy|0|||
30564952|NCT01271712|58571563|FG000|Double Blind Treatment|Adverse Event|9|||
30666004|NCT00872898|58679759|FG000|Part Two - Double Blind|Protocol Violation|1|||
30666005|NCT00872898|58679760|FG001|Part Two - Double Blind|Protocol Violation|0|||
30666006|NCT00872898|58679759|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
30666007|NCT00872898|58679760|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
30666008|NCT00872898|58679759|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
30666009|NCT00872898|58679760|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
30666010|NCT00872898|58679759|FG000|Part Two - Double Blind|Other reasons|2|||
30666011|NCT00872898|58679760|FG001|Part Two - Double Blind|Other reasons|0|||
30666012|NCT00884312|58679771|FG000|Overall Study|Non-fatal Progressive Disease|0|||
30666013|NCT00884312|58679772|FG001|Overall Study|Non-fatal Progressive Disease|8|||
30666014|NCT00884312|58679771|FG000|Overall Study|Fatal Progressive Disease|0|||
30564953|NCT01271712|58571564|FG001|Double Blind Treatment|Adverse Event|4|||
30780034|NCT02994394|58791722|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
30780035|NCT02994394|58791723|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
30564954|NCT01271712|58571563|FG000|Double Blind Treatment|Progressive disease|23|||
30564955|NCT01271712|58571564|FG001|Double Blind Treatment|Progressive disease|3|||
30564956|NCT01271712|58571563|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
30564957|NCT01271712|58571564|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
30564958|NCT01271712|58571563|FG000|Double Blind Treatment|Non compliance with study drug|2|||
30666015|NCT00884312|58679772|FG001|Overall Study|Fatal Progressive Disease|1|||
30666016|NCT00884312|58679771|FG000|Overall Study|Non-fatal Adverse Event|1|||
30855138|NCT02332876|58882664|FG001|Overall Study|Lost to Follow-up|1|||
30564959|NCT01271712|58571564|FG001|Double Blind Treatment|Non compliance with study drug|0|||
30564960|NCT01271712|58571563|FG000|Double Blind Treatment|receive no study drug|1|||
30564961|NCT01271712|58571564|FG001|Double Blind Treatment|receive no study drug|0|||
30564962|NCT01271712|58571563|FG000|Open Label Treatment|Death|6|||
30564963|NCT01271712|58571564|FG001|Open Label Treatment|Death|5|||
30564964|NCT01271712|58571563|FG000|Open Label Treatment|Withdrawal by Subject|6|||
30564965|NCT01271712|58571564|FG001|Open Label Treatment|Withdrawal by Subject|11|||
30564966|NCT01271712|58571563|FG000|Open Label Treatment|Physician Decision|2|||
30564967|NCT01271712|58571564|FG001|Open Label Treatment|Physician Decision|0|||
30564968|NCT01271712|58571563|FG000|Open Label Treatment|Adverse Event|14|||
30564969|NCT01271712|58571564|FG001|Open Label Treatment|Adverse Event|8|||
30564970|NCT01271712|58571563|FG000|Open Label Treatment|Progressive disease|59|||
30564971|NCT01271712|58571564|FG001|Open Label Treatment|Progressive disease|32|||
30564972|NCT01271712|58571563|FG000|Open Label Treatment|transferred to rollover study|1|||
30564973|NCT01271712|58571564|FG001|Open Label Treatment|transferred to rollover study|0|||
30564974|NCT01271712|58571563|FG000|Open Label Treatment|Non-compliance with study drug|1|||
30564975|NCT01271712|58571564|FG001|Open Label Treatment|Non-compliance with study drug|0|||
30564976|NCT01271712|58571563|FG000|Open Label Treatment|Protocol Violation|0|||
30564977|NCT01271712|58571564|FG001|Open Label Treatment|Protocol Violation|1|||
30564978|NCT01271712|58571563|FG000|Open Label Treatment|Switching to other therapy|2|||
30564979|NCT01271712|58571564|FG001|Open Label Treatment|Switching to other therapy|1|||
30564980|NCT01271712|58571563|FG000|Safety Follow-up|Death|11|||
30564981|NCT01271712|58571564|FG001|Safety Follow-up|Death|7|||
30564982|NCT01271712|58571563|FG000|Safety Follow-up|Withdrawal by Subject|4|||
30564983|NCT01271712|58571564|FG001|Safety Follow-up|Withdrawal by Subject|2|||
30564984|NCT01271712|58571563|FG000|Safety Follow-up|Protocol Violation|1|||
30564985|NCT01271712|58571564|FG001|Safety Follow-up|Protocol Violation|1|||
30564986|NCT01271712|58571563|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
30564987|NCT01271712|58571564|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
30564988|NCT01271712|58571563|FG000|Safety Follow-up|No follow-up|1|||
30564989|NCT01271712|58571564|FG001|Safety Follow-up|No follow-up|1|||
30564990|NCT01271712|58571563|FG000|Safety Follow-up|Progressive disease|1|||
30564991|NCT01271712|58571564|FG001|Safety Follow-up|Progressive disease|0|||
30564992|NCT01271712|58571563|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
30564993|NCT01271712|58571564|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
30564994|NCT01271010|58571573|FG000|Overall Study|Reason not specified|11|||
30564995|NCT01271010|58571573|FG000|Overall Study|Start of new CLL therapy|1|||
30564996|NCT01271010|58571573|FG000|Overall Study|Protocol Violation|1|||
30564997|NCT01271010|58571573|FG000|Overall Study|Death|2|||
30564998|NCT01271010|58571573|FG000|Overall Study|Progression and relapse of disease|1|||
30564999|NCT01271010|58571573|FG000|Overall Study|Withdrawal by Subject|18|||
30565000|NCT01271010|58571573|FG000|Overall Study|Disease progression|27|||
30565001|NCT01270620|58571579|FG000|Overall Study|Withdrawal by Subject|1|||
30565002|NCT01270620|58571580|FG001|Overall Study|Withdrawal by Subject|3|||
30565003|NCT01270464|58571595|FG000|Overall Study|Protocol Violation|4|||
30565004|NCT01270464|58571596|FG001|Overall Study|Protocol Violation|3|||
30565005|NCT01270464|58571597|FG002|Overall Study|Protocol Violation|2|||
30565006|NCT01270464|58571595|FG000|Overall Study|Lack of Efficacy|2|||
30565007|NCT01270464|58571596|FG001|Overall Study|Lack of Efficacy|3|||
30565008|NCT01270464|58571597|FG002|Overall Study|Lack of Efficacy|1|||
30565009|NCT01270464|58571595|FG000|Overall Study|Adverse Event|9|||
30565010|NCT01270464|58571596|FG001|Overall Study|Adverse Event|1|||
30565011|NCT01270464|58571597|FG002|Overall Study|Adverse Event|7|||
30565012|NCT01270464|58571595|FG000|Overall Study|Withdrawal by Subject|2|||
30565013|NCT01270464|58571596|FG001|Overall Study|Withdrawal by Subject|1|||
30565014|NCT01270464|58571597|FG002|Overall Study|Withdrawal by Subject|4|||
30565015|NCT01270464|58571595|FG000|Overall Study|Lost to Follow-up|2|||
30565016|NCT01270464|58571596|FG001|Overall Study|Lost to Follow-up|3|||
30565017|NCT01270464|58571597|FG002|Overall Study|Lost to Follow-up|1|||
30565018|NCT01270464|58571595|FG000|Overall Study|Other|1|||
30565019|NCT01270464|58571596|FG001|Overall Study|Other|1|||
30565020|NCT01270464|58571597|FG002|Overall Study|Other|3|||
30565021|NCT00249834|58571613|FG000|Overall Study|Ovarian stimulation failed|1|||
30565022|NCT00249834|58571614|FG001|Overall Study|Ovarian stimulation failed|0|||
30565023|NCT00249834|58571615|FG002|Overall Study|Ovarian stimulation failed|0|||
30565024|NCT00249834|58571616|FG003|Overall Study|Ovarian stimulation failed|0|||
30565025|NCT00249834|58571617|FG004|Overall Study|Ovarian stimulation failed|0|||
30565026|NCT00249834|58571618|FG005|Overall Study|Ovarian stimulation failed|0|||
30565027|NCT00249834|58571619|FG006|Overall Study|Ovarian stimulation failed|0|||
30565028|NCT00249834|58571620|FG007|Overall Study|Ovarian stimulation failed|0|||
30565029|NCT00249834|58571613|FG000|Overall Study|Failure of down-regulation|0|||
30565030|NCT00249834|58571614|FG001|Overall Study|Failure of down-regulation|0|||
30565031|NCT00249834|58571615|FG002|Overall Study|Failure of down-regulation|0|||
30565032|NCT00249834|58571616|FG003|Overall Study|Failure of down-regulation|0|||
30565033|NCT00249834|58571617|FG004|Overall Study|Failure of down-regulation|0|||
30565034|NCT00249834|58571618|FG005|Overall Study|Failure of down-regulation|0|||
30565035|NCT00249834|58571619|FG006|Overall Study|Failure of down-regulation|1|||
30565036|NCT00249834|58571620|FG007|Overall Study|Failure of down-regulation|0|||
30565037|NCT00249834|58571613|FG000|Overall Study|Protocol Violation|0|||
30565038|NCT00249834|58571614|FG001|Overall Study|Protocol Violation|19|||
30565039|NCT00249834|58571615|FG002|Overall Study|Protocol Violation|14|||
30565040|NCT00249834|58571616|FG003|Overall Study|Protocol Violation|8|||
30565041|NCT00249834|58571617|FG004|Overall Study|Protocol Violation|5|||
30565042|NCT00249834|58571618|FG005|Overall Study|Protocol Violation|2|||
30565043|NCT00249834|58571619|FG006|Overall Study|Protocol Violation|0|||
30565044|NCT00249834|58571620|FG007|Overall Study|Protocol Violation|0|||
30565045|NCT00249444|58571634|FG000|Overall Study|Lost to Follow-up|2|||
30565046|NCT00249444|58571635|FG001|Overall Study|Lost to Follow-up|2|||
30565047|NCT00249444|58571634|FG000|Overall Study|non-compliant|9|||
30565048|NCT00249444|58571635|FG001|Overall Study|non-compliant|11|||
30565049|NCT00249444|58571634|FG000|Overall Study|Adverse Event|1|||
30565050|NCT00249444|58571635|FG001|Overall Study|Adverse Event|1|||
30565051|NCT00249444|58571634|FG000|Overall Study|life event|0|||
30565052|NCT00249444|58571635|FG001|Overall Study|life event|1|||
30565053|NCT00249288|58571643|FG000|Overall Study|Lost to Follow-up|3|||
30565054|NCT00249288|58571644|FG001|Overall Study|Lost to Follow-up|3|||
30565055|NCT00249288|58571643|FG000|Overall Study|Withdrawal by Subject|2|||
30565056|NCT00249288|58571644|FG001|Overall Study|Withdrawal by Subject|2|||
30565057|NCT00248040|58571661|FG000|Overall Study|transplantectomy|2|||
30565058|NCT00248040|58571662|FG001|Overall Study|transplantectomy|1|||
30565059|NCT00248040|58571663|FG002|Overall Study|transplantectomy|3|||
30565060|NCT00248040|58571661|FG000|Overall Study|transplant cancelled post treat start|1|||
30565061|NCT00248040|58571662|FG001|Overall Study|transplant cancelled post treat start|0|||
30565062|NCT00248040|58571663|FG002|Overall Study|transplant cancelled post treat start|0|||
30565063|NCT00248040|58571661|FG000|Overall Study|Death|0|||
30565064|NCT00248040|58571662|FG001|Overall Study|Death|0|||
30565065|NCT00248040|58571663|FG002|Overall Study|Death|1|||
30565066|NCT00247962|58571674|FG000|Overall Study|Adverse Event|15|||
30565067|NCT00247962|58571675|FG001|Overall Study|Adverse Event|12|||
30565068|NCT00247962|58571674|FG000|Overall Study|Lost to Follow-up|3|||
30565069|NCT00247962|58571675|FG001|Overall Study|Lost to Follow-up|1|||
30565070|NCT00247962|58571674|FG000|Overall Study|Physician Decision|0|||
30565071|NCT00247962|58571675|FG001|Overall Study|Physician Decision|1|||
30565072|NCT00247962|58571674|FG000|Overall Study|Protocol Violation|1|||
30565073|NCT00247962|58571675|FG001|Overall Study|Protocol Violation|1|||
30565074|NCT00247962|58571674|FG000|Overall Study|Withdrawal by Subject|3|||
30565075|NCT00247962|58571675|FG001|Overall Study|Withdrawal by Subject|2|||
30565076|NCT00247962|58571674|FG000|Overall Study|Lack of Efficacy|4|||
30565077|NCT00247962|58571675|FG001|Overall Study|Lack of Efficacy|2|||
30565078|NCT00247416|58571683|FG000|Overall Study|3 patients were found to be ineligible|1|||
30565079|NCT00247416|58571684|FG001|Overall Study|3 patients were found to be ineligible|2|||
30565080|NCT00246090|58571692|FG000|Overall Study|Adverse Event|25|||
30565081|NCT00246090|58571692|FG000|Overall Study|Withdrawal by Subject|7|||
30565082|NCT00246090|58571692|FG000|Overall Study|Progressive Disease|212|||
30565083|NCT00246090|58571692|FG000|Overall Study|Clinical Progression|30|||
30565084|NCT00246090|58571692|FG000|Overall Study|Physician Decision|11|||
30565085|NCT00246090|58571692|FG000|Overall Study|Not Otherwise Specified|10|||
30565086|NCT00246012|58571705|FG000|Overall Study|Adverse Event|0|||
30565087|NCT00246012|58571706|FG001|Overall Study|Adverse Event|0|||
30565088|NCT00246012|58571707|FG002|Overall Study|Adverse Event|0|||
30565089|NCT00246012|58571708|FG003|Overall Study|Adverse Event|0|||
30565090|NCT00246012|58571709|FG004|Overall Study|Adverse Event|0|||
30565091|NCT00246012|58571710|FG005|Overall Study|Adverse Event|1|||
30565092|NCT00246012|58571711|FG006|Overall Study|Adverse Event|0|||
30565093|NCT00246012|58571712|FG007|Overall Study|Adverse Event|0|||
30565094|NCT00246012|58571713|FG008|Overall Study|Adverse Event|2|||
30565095|NCT00246012|58571705|FG000|Overall Study|Withdrawal by Subject|0|||
30565096|NCT00246012|58571706|FG001|Overall Study|Withdrawal by Subject|0|||
30565097|NCT00246012|58571707|FG002|Overall Study|Withdrawal by Subject|0|||
30565098|NCT00246012|58571708|FG003|Overall Study|Withdrawal by Subject|0|||
30565099|NCT00246012|58571709|FG004|Overall Study|Withdrawal by Subject|0|||
30565100|NCT00246012|58571710|FG005|Overall Study|Withdrawal by Subject|1|||
30565101|NCT00246012|58571711|FG006|Overall Study|Withdrawal by Subject|0|||
30565102|NCT00246012|58571712|FG007|Overall Study|Withdrawal by Subject|0|||
30565103|NCT00246012|58571713|FG008|Overall Study|Withdrawal by Subject|0|||
30565104|NCT00246012|58571705|FG000|Overall Study|Disease progression|3|||
30565105|NCT00246012|58571706|FG001|Overall Study|Disease progression|1|||
30565106|NCT00246012|58571707|FG002|Overall Study|Disease progression|2|||
30565107|NCT00246012|58571708|FG003|Overall Study|Disease progression|3|||
30565108|NCT00246012|58571709|FG004|Overall Study|Disease progression|3|||
30565109|NCT00246012|58571710|FG005|Overall Study|Disease progression|25|||
30565110|NCT00246012|58571711|FG006|Overall Study|Disease progression|30|||
30565111|NCT00246012|58571712|FG007|Overall Study|Disease progression|27|||
30565112|NCT00246012|58571713|FG008|Overall Study|Disease progression|26|||
30565113|NCT00246012|58571705|FG000|Overall Study|Other|0|||
30565114|NCT00246012|58571706|FG001|Overall Study|Other|0|||
30565115|NCT00246012|58571707|FG002|Overall Study|Other|0|||
30565116|NCT00246012|58571708|FG003|Overall Study|Other|0|||
30565117|NCT00246012|58571709|FG004|Overall Study|Other|0|||
30565118|NCT00246012|58571710|FG005|Overall Study|Other|0|||
30565119|NCT00246012|58571711|FG006|Overall Study|Other|0|||
30565120|NCT00246012|58571712|FG007|Overall Study|Other|1|||
30565121|NCT00246012|58571713|FG008|Overall Study|Other|0|||
30565122|NCT00246012|58571705|FG000|Overall Study|Randomly assigned but not treated|0|||
30565123|NCT00246012|58571706|FG001|Overall Study|Randomly assigned but not treated|0|||
30565124|NCT00246012|58571707|FG002|Overall Study|Randomly assigned but not treated|0|||
30565125|NCT00246012|58571708|FG003|Overall Study|Randomly assigned but not treated|0|||
30565126|NCT00246012|58571709|FG004|Overall Study|Randomly assigned but not treated|0|||
30565127|NCT00246012|58571710|FG005|Overall Study|Randomly assigned but not treated|1|||
30565128|NCT00246012|58571711|FG006|Overall Study|Randomly assigned but not treated|1|||
30565129|NCT00246012|58571712|FG007|Overall Study|Randomly assigned but not treated|0|||
30565130|NCT00246012|58571713|FG008|Overall Study|Randomly assigned but not treated|0|||
30565131|NCT00245856|58571735|FG000|Period Two|Withdrawal by Subject|0|||
30565132|NCT00245856|58571736|FG001|Period Two|Withdrawal by Subject|1|||
30565133|NCT00245466|58571746|FG000|Overall Study|Adverse Event|2|||
30565134|NCT00245466|58571747|FG001|Overall Study|Adverse Event|8|||
30565135|NCT00245466|58571748|FG002|Overall Study|Adverse Event|4|||
30565136|NCT00245466|58571746|FG000|Overall Study|Low prostate specific antigen suppr|16|||
30565137|NCT00245466|58571747|FG001|Overall Study|Low prostate specific antigen suppr|14|||
30565138|NCT00245466|58571748|FG002|Overall Study|Low prostate specific antigen suppr|5|||
30565139|NCT00245466|58571746|FG000|Overall Study|Insufficient testosterone suppr|12|||
30565140|NCT00245466|58571747|FG001|Overall Study|Insufficient testosterone suppr|12|||
30565141|NCT00245466|58571748|FG002|Overall Study|Insufficient testosterone suppr|21|||
30565142|NCT00245466|58571746|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
30565143|NCT00245466|58571747|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
30565144|NCT00245466|58571748|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
30565145|NCT00245466|58571746|FG000|Overall Study|Withdrawal by Subject|2|||
30565146|NCT00245466|58571747|FG001|Overall Study|Withdrawal by Subject|2|||
30565147|NCT00245466|58571748|FG002|Overall Study|Withdrawal by Subject|1|||
30565148|NCT00245466|58571746|FG000|Overall Study|Lost to Follow-up|3|||
30565149|NCT00245466|58571747|FG001|Overall Study|Lost to Follow-up|0|||
30565150|NCT00245466|58571748|FG002|Overall Study|Lost to Follow-up|0|||
30565151|NCT00245466|58571746|FG000|Overall Study|Disease progression|0|||
30565152|NCT00245466|58571747|FG001|Overall Study|Disease progression|3|||
30565153|NCT00245466|58571748|FG002|Overall Study|Disease progression|1|||
30565154|NCT00245466|58571746|FG000|Overall Study|Protocol Violation|1|||
30565155|NCT00245466|58571747|FG001|Overall Study|Protocol Violation|2|||
30565156|NCT00245466|58571748|FG002|Overall Study|Protocol Violation|2|||
30565157|NCT00245466|58571746|FG000|Overall Study|Death|0|||
30565158|NCT00245466|58571747|FG001|Overall Study|Death|2|||
30565159|NCT00245466|58571748|FG002|Overall Study|Death|0|||
30565160|NCT00245466|58571746|FG000|Overall Study|Administrative reasons|0|||
30565161|NCT00245466|58571747|FG001|Overall Study|Administrative reasons|1|||
30565162|NCT00245466|58571748|FG002|Overall Study|Administrative reasons|0|||
30565163|NCT00244764|58571756|FG000|Overall Study|Adverse Event|37|||
30565164|NCT00244764|58571756|FG000|Overall Study|Lost to Follow-up|23|||
30565165|NCT00244764|58571756|FG000|Overall Study|Withdrawal by Subject|12|||
30565166|NCT00244764|58571756|FG000|Overall Study|Disease Progression|13|||
30565167|NCT00244764|58571756|FG000|Overall Study|Protocol Violation|2|||
30565168|NCT00244764|58571756|FG000|Overall Study|Death|1|||
30565169|NCT00244764|58571756|FG000|Overall Study|Off Study Medication for >21 Days|1|||
30565170|NCT00244764|58571756|FG000|Overall Study|Declining Performance Status|1|||
30565171|NCT00244764|58571756|FG000|Overall Study|Participant was Hospitalized until Death|1|||
30565172|NCT00244764|58571756|FG000|Overall Study|Primary Investigator Discretion|2|||
30565173|NCT00244764|58571756|FG000|Overall Study|Sponsor Terminated Study|2|||
30565174|NCT00244764|58571756|FG000|Overall Study|Developed Secondary Malignancy|1|||
30565175|NCT00244374|58571761|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
30565176|NCT00244374|58571762|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
30565177|NCT00244374|58571763|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
30565178|NCT00244374|58571764|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
30565179|NCT00244374|58571765|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
30565180|NCT00244374|58571761|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
30565181|NCT00244374|58571762|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
30565182|NCT00244374|58571763|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
30565183|NCT00244374|58571764|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
30565184|NCT00244374|58571765|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
30565185|NCT00244374|58571761|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
30565186|NCT00244374|58571762|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
30565187|NCT00244374|58571763|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
30565188|NCT00244374|58571764|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
30565189|NCT00244374|58571765|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
30565190|NCT00244374|58571761|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
30565191|NCT00244374|58571762|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
30565192|NCT00244374|58571763|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
30565193|NCT00244374|58571764|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
30565194|NCT00244374|58571765|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
30565195|NCT00244374|58571761|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
30565196|NCT00244374|58571762|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
30565197|NCT00244374|58571763|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
30565198|NCT00244374|58571764|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
30565199|NCT00244374|58571765|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
30565200|NCT00244374|58571761|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
30565201|NCT00244374|58571762|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
30565202|NCT00244374|58571763|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
30565203|NCT00244374|58571764|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
30565204|NCT00244374|58571765|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
30565205|NCT00244374|58571761|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
30565206|NCT00244374|58571762|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
30565207|NCT00244374|58571763|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
30565208|NCT00244374|58571764|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
30565209|NCT00244374|58571765|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
30565210|NCT00244374|58571761|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
30565211|NCT00244374|58571762|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
30565212|NCT00244374|58571763|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
30565213|NCT00244374|58571764|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
30565214|NCT00244374|58571765|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
30565215|NCT00244374|58571761|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
30565216|NCT00244374|58571762|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
30565217|NCT00244374|58571763|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
30565218|NCT00244374|58571764|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
30565219|NCT00244374|58571765|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
30565220|NCT00242658|58571783|FG000|Overall Study|Lost to Follow-up|22|||
30565221|NCT00242658|58571784|FG001|Overall Study|Lost to Follow-up|19|||
30565222|NCT00242580|58571793|FG000|Overall Study|Adverse Event|3|||
30565223|NCT00242580|58571794|FG001|Overall Study|Adverse Event|0|||
30565224|NCT00242580|58571795|FG002|Overall Study|Adverse Event|2|||
30565225|NCT00242580|58571793|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
30565226|NCT00242580|58571794|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
30565227|NCT00242580|58571795|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
30565228|NCT00242580|58571793|FG000|Overall Study|Protocol Violation|0|||
30565229|NCT00242580|58571794|FG001|Overall Study|Protocol Violation|0|||
30565230|NCT00242580|58571795|FG002|Overall Study|Protocol Violation|1|||
30565231|NCT00242580|58571793|FG000|Overall Study|Subject withdrew consent|2|||
30565232|NCT00242580|58571794|FG001|Overall Study|Subject withdrew consent|2|||
30565233|NCT00242580|58571795|FG002|Overall Study|Subject withdrew consent|5|||
30565234|NCT00242580|58571793|FG000|Overall Study|Lost to Follow-up|0|||
30565235|NCT00242580|58571794|FG001|Overall Study|Lost to Follow-up|3|||
30565236|NCT00242580|58571795|FG002|Overall Study|Lost to Follow-up|0|||
30565237|NCT00242580|58571793|FG000|Overall Study|Death|1|||
30565238|NCT00242580|58571794|FG001|Overall Study|Death|2|||
30565239|NCT00242580|58571795|FG002|Overall Study|Death|1|||
30565240|NCT00241644|58571807|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
30565241|NCT00241644|58571808|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
30565242|NCT00241644|58571809|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
30565243|NCT00241644|58571810|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
30565244|NCT00241644|58571807|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
30565245|NCT00241644|58571808|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
30565246|NCT00241644|58571809|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
30565247|NCT00241644|58571810|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
30565248|NCT00241644|58571807|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
30565249|NCT00241644|58571808|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
30565250|NCT00241644|58571809|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
30565251|NCT00241644|58571810|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
30565252|NCT00241644|58571807|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
30565253|NCT00241644|58571808|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
30565254|NCT00241644|58571809|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
30565255|NCT00241644|58571810|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
30565256|NCT00241644|58571807|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
30565257|NCT00241644|58571808|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
30565258|NCT00241644|58571809|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
30565259|NCT00241644|58571810|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
30565260|NCT00241644|58571807|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
30565261|NCT00241644|58571808|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
30565262|NCT00241644|58571809|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
30565263|NCT00241644|58571810|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
30565264|NCT00241644|58571807|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
30565265|NCT00241644|58571808|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
30565266|NCT00241644|58571809|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
30565267|NCT00241644|58571810|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
30565268|NCT00241644|58571807|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
30565269|NCT00241644|58571808|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
30565270|NCT00241644|58571809|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
30565271|NCT00241644|58571810|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
30565272|NCT00241644|58571807|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
30565273|NCT00241644|58571808|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
30565274|NCT00241644|58571809|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
30565275|NCT00241644|58571810|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
30565276|NCT00241644|58571807|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
30565277|NCT00241644|58571808|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
30565278|NCT00241644|58571809|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
30565279|NCT00241644|58571810|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
30565280|NCT00241644|58571807|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
30565281|NCT00241644|58571808|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
30565282|NCT00241644|58571809|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
30565283|NCT00241644|58571810|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
30565284|NCT00241644|58571807|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
30565285|NCT00241644|58571808|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
30565286|NCT00241644|58571809|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
30565287|NCT00241644|58571810|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
30565288|NCT00241644|58571807|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
30565289|NCT00241644|58571808|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
30565290|NCT00241644|58571809|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
30565291|NCT00241644|58571810|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
30565292|NCT03804684|58571831|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
30565293|NCT03804684|58571832|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
30565294|NCT04295772|58571847|FG000|Overall Study|Protocol Violation|1|||
30565295|NCT04295772|58571848|FG001|Overall Study|Protocol Violation|0|||
30565296|NCT04295772|58571847|FG000|Overall Study|Ongoing for safety monitoring|14|||
30565297|NCT04295772|58571848|FG001|Overall Study|Ongoing for safety monitoring|1|||
30565298|NCT04295772|58571847|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
30780036|NCT02994394|58791724|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
30780037|NCT02994394|58791725|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
30780038|NCT02994394|58791726|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
30780039|NCT02994394|58791727|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
30780040|NCT02998840|58791745|FG000|Overall Study|Lost to Follow-up|1|||
30780041|NCT02998840|58791746|FG001|Overall Study|Lost to Follow-up|1|||
30780042|NCT02998840|58791747|FG002|Overall Study|Lost to Follow-up|2|||
30780043|NCT02998840|58791748|FG003|Overall Study|Lost to Follow-up|3|||
30780044|NCT02998840|58791745|FG000|Overall Study|Withdrawal by Subject|1|||
30780045|NCT02998840|58791746|FG001|Overall Study|Withdrawal by Subject|1|||
30780046|NCT02998840|58791747|FG002|Overall Study|Withdrawal by Subject|0|||
30780047|NCT02998840|58791748|FG003|Overall Study|Withdrawal by Subject|1|||
30780048|NCT02998840|58791745|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
30780049|NCT02998840|58791746|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
30780050|NCT02998840|58791747|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
30780051|NCT02998840|58791748|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
30780052|NCT00023673|58791759|FG000|Overall Study|Ineligible / no protocol treatment|0|||
30780053|NCT00023673|58791760|FG001|Overall Study|Ineligible / no protocol treatment|0|||
30780054|NCT00023673|58791761|FG002|Overall Study|Ineligible / no protocol treatment|0|||
30780055|NCT00023673|58791762|FG003|Overall Study|Ineligible / no protocol treatment|1|||
30780056|NCT00023673|58791759|FG000|Overall Study|Patient withdrew consent|0|||
30780057|NCT00023673|58791760|FG001|Overall Study|Patient withdrew consent|0|||
30780058|NCT00023673|58791761|FG002|Overall Study|Patient withdrew consent|0|||
30780059|NCT00023673|58791762|FG003|Overall Study|Patient withdrew consent|1|||
30780060|NCT01069900|58791774|FG000|Overall Study|Technical problems|0|||
30780061|NCT01069900|58791775|FG001|Overall Study|Technical problems|1|||
30780062|NCT01069900|58791774|FG000|Overall Study|Lost to Follow-up|7|||
30780063|NCT01069900|58791775|FG001|Overall Study|Lost to Follow-up|1|||
30780064|NCT01069900|58791774|FG000|Overall Study|Withdrawal by Subject|6|||
30780065|NCT01069900|58791775|FG001|Overall Study|Withdrawal by Subject|1|||
30780066|NCT01069900|58791774|FG000|Overall Study|Protocol Violation|4|||
30780067|NCT01069900|58791775|FG001|Overall Study|Protocol Violation|1|||
30780068|NCT01069900|58791774|FG000|Overall Study|Insufficient Therapeutic effect|1|||
30780069|NCT01069900|58791775|FG001|Overall Study|Insufficient Therapeutic effect|0|||
30565299|NCT04295772|58571848|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
30565300|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #1|24|||
30565301|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #1|0|||
30565302|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
30565303|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
30565304|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
30565305|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
30565306|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
30565307|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
30565308|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
30565309|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
30565310|NCT03888066|58571857|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
30565311|NCT03888066|58571858|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
30565312|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
30565313|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
30565314|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
30565315|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
30565316|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
30565317|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
30565318|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
30565319|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
30565320|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #2|5|||
30565321|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #2|0|||
30565322|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
30565323|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
30565324|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
30565325|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
30565326|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
30565327|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
30565328|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #3|11|||
30565329|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #3|0|||
30565330|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
30565331|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
30565332|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
30565333|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
30565334|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
30565335|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
30565336|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #4|3|||
30565337|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #4|0|||
30565338|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
30565339|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
30565340|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
30565341|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
30565342|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
30666017|NCT00884312|58679772|FG001|Overall Study|Non-fatal Adverse Event|0|||
30780070|NCT01069120|58791783|FG000|Overall Study|Study prematurely terminated|27|||
30780071|NCT00006237|58791791|FG000|Overall Study|Adverse Event|39|||
30565343|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
30565344|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
30666018|NCT00884312|58679771|FG000|Overall Study|Fatal Adverse Event|1|||
30666019|NCT00884312|58679772|FG001|Overall Study|Fatal Adverse Event|4|||
30666020|NCT00884312|58679771|FG000|Overall Study|Withdrawal by Subject|0|||
30666021|NCT00884312|58679772|FG001|Overall Study|Withdrawal by Subject|6|||
30666022|NCT00884312|58679771|FG000|Overall Study|Physician Decision|0|||
30666023|NCT00884312|58679772|FG001|Overall Study|Physician Decision|1|||
30666024|NCT00884312|58679771|FG000|Overall Study|Other|0|||
30666025|NCT00884312|58679772|FG001|Overall Study|Other|4|||
30666026|NCT00884312|58679771|FG000|Overall Study|Did Not Receive Study Drug|0|||
30666027|NCT00884312|58679772|FG001|Overall Study|Did Not Receive Study Drug|1|||
30666028|NCT00534313|58679782|FG000|Short-term Period|Adverse Event|1|||
30666029|NCT00534313|58679783|FG001|Short-term Period|Adverse Event|2|||
30666030|NCT00534313|58679784|FG002|Short-term Period|Adverse Event|1|||
30666031|NCT00534313|58679785|FG003|Short-term Period|Adverse Event|3|||
30666032|NCT00534313|58679782|FG000|Short-term Period|Lack of Efficacy|3|||
30666033|NCT00534313|58679783|FG001|Short-term Period|Lack of Efficacy|4|||
30666034|NCT00534313|58679784|FG002|Short-term Period|Lack of Efficacy|0|||
30666035|NCT00534313|58679785|FG003|Short-term Period|Lack of Efficacy|3|||
30666036|NCT00534313|58679782|FG000|Short-term Period|Participant not meeting study criteria|0|||
30666037|NCT00534313|58679783|FG001|Short-term Period|Participant not meeting study criteria|0|||
30666038|NCT00534313|58679784|FG002|Short-term Period|Participant not meeting study criteria|0|||
30666039|NCT00534313|58679785|FG003|Short-term Period|Participant not meeting study criteria|1|||
30666040|NCT00534313|58679782|FG000|Short-term Period|Participant withdrew consent|2|||
30666041|NCT00534313|58679783|FG001|Short-term Period|Participant withdrew consent|0|||
30666042|NCT00534313|58679784|FG002|Short-term Period|Participant withdrew consent|0|||
30666043|NCT00534313|58679785|FG003|Short-term Period|Participant withdrew consent|2|||
30666044|NCT00534313|58679782|FG000|Short-term Period|Pregnancy|0|||
30666045|NCT00534313|58679783|FG001|Short-term Period|Pregnancy|0|||
30666046|NCT00534313|58679784|FG002|Short-term Period|Pregnancy|1|||
30666047|NCT00534313|58679785|FG003|Short-term Period|Pregnancy|0|||
30666048|NCT00534313|58679782|FG000|Long-term Period|Adverse Event|2|||
30666049|NCT00534313|58679783|FG001|Long-term Period|Adverse Event|1|||
30666050|NCT00534313|58679784|FG002|Long-term Period|Adverse Event|0|||
30666051|NCT00534313|58679785|FG003|Long-term Period|Adverse Event|1|||
30666052|NCT00534313|58679782|FG000|Long-term Period|Lack of Efficacy|14|||
30666053|NCT00534313|58679783|FG001|Long-term Period|Lack of Efficacy|10|||
30666054|NCT00534313|58679784|FG002|Long-term Period|Lack of Efficacy|14|||
30666055|NCT00534313|58679785|FG003|Long-term Period|Lack of Efficacy|12|||
30666056|NCT00534313|58679782|FG000|Long-term Period|Lost to Follow-up|1|||
30666057|NCT00534313|58679783|FG001|Long-term Period|Lost to Follow-up|2|||
30666058|NCT00534313|58679784|FG002|Long-term Period|Lost to Follow-up|0|||
30666059|NCT00534313|58679785|FG003|Long-term Period|Lost to Follow-up|0|||
30666060|NCT00534313|58679782|FG000|Long-term Period|Withdrawal by Subject|2|||
30666061|NCT00534313|58679783|FG001|Long-term Period|Withdrawal by Subject|2|||
30666062|NCT00534313|58679784|FG002|Long-term Period|Withdrawal by Subject|0|||
30666063|NCT00534313|58679785|FG003|Long-term Period|Withdrawal by Subject|0|||
30666064|NCT00534313|58679782|FG000|Long-term Period|No longer meets study criteria|0|||
30666065|NCT00534313|58679783|FG001|Long-term Period|No longer meets study criteria|1|||
30666066|NCT00534313|58679784|FG002|Long-term Period|No longer meets study criteria|0|||
30666067|NCT00534313|58679785|FG003|Long-term Period|No longer meets study criteria|0|||
30666068|NCT00534313|58679782|FG000|Long-term Period|Poor compliance/noncompliance|0|||
30666069|NCT00534313|58679783|FG001|Long-term Period|Poor compliance/noncompliance|1|||
30666070|NCT00534313|58679784|FG002|Long-term Period|Poor compliance/noncompliance|1|||
30666071|NCT00534313|58679785|FG003|Long-term Period|Poor compliance/noncompliance|0|||
30666072|NCT00534313|58679782|FG000|Long-term Period|Administrative reason by sponsor|17|||
30666073|NCT00534313|58679783|FG001|Long-term Period|Administrative reason by sponsor|15|||
30666074|NCT00534313|58679784|FG002|Long-term Period|Administrative reason by sponsor|26|||
30666075|NCT00534313|58679785|FG003|Long-term Period|Administrative reason by sponsor|18|||
30666076|NCT00534313|58679782|FG000|Long-term Period|Other|1|||
30666077|NCT00534313|58679783|FG001|Long-term Period|Other|2|||
30666078|NCT00534313|58679784|FG002|Long-term Period|Other|2|||
30666079|NCT00534313|58679785|FG003|Long-term Period|Other|2|||
30666080|NCT03888391|58679830|FG000|Overall Study|Lost to Follow-up|15|||
30666081|NCT00594204|58679836|FG000|Overall Study|Adverse Event|15|||
30666082|NCT00594204|58679837|FG001|Overall Study|Adverse Event|3|||
30666083|NCT00594204|58679836|FG000|Overall Study|Lost to Follow-up|9|||
30666084|NCT00594204|58679837|FG001|Overall Study|Lost to Follow-up|5|||
30666085|NCT00594204|58679836|FG000|Overall Study|Withdrawal by Subject|23|||
30666086|NCT00594204|58679837|FG001|Overall Study|Withdrawal by Subject|29|||
30666087|NCT00594204|58679836|FG000|Overall Study|Other|4|||
30666088|NCT00594204|58679837|FG001|Overall Study|Other|3|||
30666089|NCT00594204|58679836|FG000|Overall Study|Lack of Efficacy|3|||
30780072|NCT00006237|58791792|FG001|Overall Study|Adverse Event|29|||
30666090|NCT00594204|58679837|FG001|Overall Study|Lack of Efficacy|4|||
30565345|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
30565346|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
30565347|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
30565348|NCT03888066|58571857|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
30565349|NCT03888066|58571858|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
30565350|NCT03888066|58571857|FG000|Run-in Phase|AE (Adverse Event)|17|||
30565351|NCT03888066|58571858|FG001|Run-in Phase|AE (Adverse Event)|0|||
30565352|NCT03888066|58571857|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
30565353|NCT03888066|58571858|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
30565354|NCT03888066|58571857|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
30565355|NCT03888066|58571858|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
30565356|NCT03888066|58571857|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
30565357|NCT03888066|58571858|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
30565358|NCT03888066|58571857|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
30565359|NCT03888066|58571858|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
30565360|NCT03888066|58571857|FG000|Run-in Phase|Withdrawal by Subject|43|||
30565361|NCT03888066|58571858|FG001|Run-in Phase|Withdrawal by Subject|0|||
30565362|NCT03888066|58571857|FG000|Run-in Phase|AE; Physician Decision|1|||
30565363|NCT03888066|58571858|FG001|Run-in Phase|AE; Physician Decision|0|||
30565364|NCT03888066|58571857|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
30565365|NCT03888066|58571858|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
30565366|NCT03888066|58571857|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
30565367|NCT03888066|58571858|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
30565368|NCT03888066|58571857|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
30565369|NCT03888066|58571858|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
30565370|NCT03888066|58571857|FG000|Run-in Phase|Death|1|||
30565371|NCT03888066|58571858|FG001|Run-in Phase|Death|0|||
30565372|NCT03888066|58571857|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
30565373|NCT03888066|58571858|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
30565374|NCT03888066|58571857|FG000|Run-in Phase|Physician Decision|1|||
30565375|NCT03888066|58571858|FG001|Run-in Phase|Physician Decision|0|||
30565376|NCT03888066|58571857|FG000|Run-in Phase|Protocol Violation|13|||
30565377|NCT03888066|58571858|FG001|Run-in Phase|Protocol Violation|0|||
30565378|NCT03888066|58571857|FG000|Run-in Phase|Sponsor Request|34|||
30565379|NCT03888066|58571858|FG001|Run-in Phase|Sponsor Request|0|||
30565380|NCT03888066|58571857|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
30565381|NCT03888066|58571858|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
30565382|NCT03888066|58571857|FG000|Run-in Phase|Withdrawal Of Consent|1|||
30565383|NCT03888066|58571858|FG001|Run-in Phase|Withdrawal Of Consent|0|||
30565384|NCT03888066|58571857|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
30565385|NCT03888066|58571858|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
30565386|NCT03888066|58571857|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
30565387|NCT03888066|58571858|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
30565388|NCT03888066|58571857|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
30565389|NCT03888066|58571858|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
30666091|NCT00594204|58679836|FG000|Overall Study|Randomized but not treated|4|||
30666092|NCT00594204|58679837|FG001|Overall Study|Randomized but not treated|1|||
30666093|NCT03888235|58679855|FG000|Overall Study|Lost to Follow-up|1|||
30666094|NCT03888235|58679856|FG001|Overall Study|Lost to Follow-up|1|||
30666095|NCT03888235|58679857|FG002|Overall Study|Lost to Follow-up|0|||
30666096|NCT00866307|58679888|FG000|Induction|Adverse Event|5|||
30666097|NCT00866307|58679889|FG001|Induction|Adverse Event|0|||
30666098|NCT00866307|58679890|FG002|Induction|Adverse Event|0|||
30666099|NCT00866307|58679888|FG000|Induction|Death|2|||
30666100|NCT00866307|58679889|FG001|Induction|Death|0|||
30666101|NCT00866307|58679890|FG002|Induction|Death|0|||
30666102|NCT00866307|58679888|FG000|Induction|Physician Decision|5|||
30666103|NCT00866307|58679889|FG001|Induction|Physician Decision|0|||
30666104|NCT00866307|58679890|FG002|Induction|Physician Decision|0|||
30666105|NCT00866307|58679888|FG000|Induction|Progressive Disease|1|||
30666106|NCT00866307|58679889|FG001|Induction|Progressive Disease|0|||
30855139|NCT02332798|58882673|FG000|Overall Study|Unwilling to Participate in Study|0|||
30855140|NCT02332798|58882674|FG001|Overall Study|Unwilling to Participate in Study|1|||
30565390|NCT03888066|58571857|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
30565391|NCT03888066|58571858|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
30565392|NCT03888066|58571857|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
30666107|NCT00866307|58679890|FG002|Induction|Progressive Disease|0|||
30666108|NCT00866307|58679888|FG000|Induction|Identification of Patients with Day 29 M|3|||
30666109|NCT00866307|58679889|FG001|Induction|Identification of Patients with Day 29 M|0|||
30855141|NCT02332798|58882675|FG002|Overall Study|Unwilling to Participate in Study|1|||
30565393|NCT03888066|58571858|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
30565394|NCT03888066|58571857|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
30565395|NCT03888066|58571858|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
30565396|NCT03888066|58571857|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
30565397|NCT03888066|58571858|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
30565398|NCT03888066|58571857|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
30565399|NCT03888066|58571858|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
30565400|NCT03888066|58571857|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
30565401|NCT03888066|58571858|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
30565402|NCT03888066|58571857|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
30565403|NCT03888066|58571858|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
30565404|NCT03888066|58571857|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
30565405|NCT03888066|58571858|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
30565406|NCT03888066|58571857|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
30565407|NCT03888066|58571858|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
30565408|NCT02017704|58571867|FG000|Overall Study|Withdrawal by Subject|2|||
30565409|NCT02017704|58571868|FG001|Overall Study|Withdrawal by Subject|0|||
30565410|NCT01049334|58571878|FG000|Overall Study|Withdrawal by Subject|5|||
30565411|NCT01049334|58571879|FG001|Overall Study|Withdrawal by Subject|3|||
30565412|NCT01049334|58571878|FG000|Overall Study|Adverse Event|2|||
30565413|NCT01049334|58571879|FG001|Overall Study|Adverse Event|3|||
30565414|NCT01049334|58571878|FG000|Overall Study|Physician Decision|2|||
30565415|NCT01049334|58571879|FG001|Overall Study|Physician Decision|0|||
30565416|NCT01049334|58571878|FG000|Overall Study|Protocol Violation|0|||
30565417|NCT01049334|58571879|FG001|Overall Study|Protocol Violation|1|||
30565418|NCT01048944|58571889|FG000|Overall Study|Protocol Violation|8|||
30565419|NCT01048944|58571890|FG001|Overall Study|Protocol Violation|10|||
30666110|NCT00866307|58679890|FG002|Induction|Identification of Patients with Day 29 M|0|||
30666111|NCT00866307|58679888|FG000|Induction|Inadequate cytognetic samples th|1|||
30666112|NCT00866307|58679889|FG001|Induction|Inadequate cytognetic samples th|0|||
30666113|NCT00866307|58679890|FG002|Induction|Inadequate cytognetic samples th|0|||
30666114|NCT00866307|58679888|FG000|Induction|Improper post-induction consent|2|||
30666115|NCT00866307|58679889|FG001|Induction|Improper post-induction consent|0|||
30666116|NCT00866307|58679890|FG002|Induction|Improper post-induction consent|0|||
30666117|NCT00866307|58679888|FG000|Induction|Study was closed at the time|1|||
30666118|NCT00866307|58679889|FG001|Induction|Study was closed at the time|0|||
30666119|NCT00866307|58679890|FG002|Induction|Study was closed at the time|0|||
30666120|NCT00866307|58679888|FG000|Consolidation/Maintenance|Adverse Event|0|||
30666121|NCT00866307|58679889|FG001|Consolidation/Maintenance|Adverse Event|0|||
30666122|NCT00866307|58679890|FG002|Consolidation/Maintenance|Adverse Event|8|||
30666123|NCT00866307|58679888|FG000|Consolidation/Maintenance|Death|0|||
30666124|NCT00866307|58679889|FG001|Consolidation/Maintenance|Death|0|||
30666125|NCT00866307|58679890|FG002|Consolidation/Maintenance|Death|1|||
30666126|NCT00866307|58679888|FG000|Consolidation/Maintenance|Physician Decision|0|||
30666127|NCT00866307|58679889|FG001|Consolidation/Maintenance|Physician Decision|3|||
30666128|NCT00866307|58679890|FG002|Consolidation/Maintenance|Physician Decision|2|||
30666129|NCT00866307|58679888|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
30666130|NCT00866307|58679889|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
30666131|NCT00866307|58679890|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
30666132|NCT00866307|58679888|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
30666133|NCT00866307|58679889|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
30666134|NCT00866307|58679890|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
30666135|NCT00866307|58679888|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
30666136|NCT00866307|58679889|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
30666137|NCT00866307|58679890|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
30666138|NCT00866307|58679888|FG000|Consolidation/Maintenance|Therapy error|0|||
30666139|NCT00866307|58679889|FG001|Consolidation/Maintenance|Therapy error|1|||
30666140|NCT00866307|58679890|FG002|Consolidation/Maintenance|Therapy error|0|||
30666141|NCT00866307|58679888|FG000|Consolidation/Maintenance|Non-compliance|0|||
30666142|NCT00866307|58679889|FG001|Consolidation/Maintenance|Non-compliance|0|||
30666143|NCT00866307|58679890|FG002|Consolidation/Maintenance|Non-compliance|1|||
30666144|NCT00866307|58679888|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
30565420|NCT01048944|58571891|FG002|Overall Study|Protocol Violation|10|||
30565421|NCT01048944|58571892|FG003|Overall Study|Protocol Violation|2|||
30565422|NCT01048866|58571904|FG000|Overall Study|Adverse Event|1|||
30565423|NCT01048866|58571905|FG001|Overall Study|Adverse Event|0|||
30666145|NCT00866307|58679889|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
30666146|NCT00866307|58679890|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
30666147|NCT00531427|58679898|FG000|Overall Study|Withdrawal by Subject|7|||
30666148|NCT00531427|58679899|FG001|Overall Study|Withdrawal by Subject|13|||
30666149|NCT00531427|58679898|FG000|Overall Study|Adverse Event|44|||
30666150|NCT00531427|58679899|FG001|Overall Study|Adverse Event|30|||
30666151|NCT00531427|58679898|FG000|Overall Study|Lost to Follow-up|4|||
30666152|NCT00531427|58679899|FG001|Overall Study|Lost to Follow-up|3|||
30666153|NCT00531427|58679898|FG000|Overall Study|Lack of Efficacy|14|||
30666154|NCT00531427|58679899|FG001|Overall Study|Lack of Efficacy|39|||
30666155|NCT00531427|58679898|FG000|Overall Study|Administrative|4|||
30666156|NCT00531427|58679899|FG001|Overall Study|Administrative|9|||
30666157|NCT00871728|58679906|FG000|Overall Study|Adverse Event|1|||
30666158|NCT00871728|58679906|FG000|Overall Study|Protocol Violation|7|||
30666159|NCT00871728|58679906|FG000|Overall Study|Lost to Follow-up|2|||
30666160|NCT00871728|58679906|FG000|Overall Study|Failed to Visit Hospital|4|||
30666161|NCT00871728|58679906|FG000|Overall Study|Participant Non-compliance|1|||
30666162|NCT00871728|58679906|FG000|Overall Study|Withdrawal of Informed Consent|5|||
30666163|NCT00868998|58679910|FG000|Overall Study|Screen Failure|1|||
30666164|NCT00868998|58679910|FG000|Overall Study|Withdrawal by Subject|1|||
30666165|NCT00868998|58679910|FG000|Overall Study|Progression of disease|2|||
30666166|NCT00868998|58679910|FG000|Overall Study|Death|1|||
30666167|NCT00533845|58679925|FG000|Overall Study|Physician Decision|1|||
30666168|NCT00533845|58679926|FG001|Overall Study|Physician Decision|0|||
30780073|NCT00006237|58791791|FG000|Overall Study|Death|1|||
30780074|NCT00006237|58791792|FG001|Overall Study|Death|0|||
30780075|NCT00006237|58791791|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
30780076|NCT00006237|58791792|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
30780077|NCT00006237|58791791|FG000|Overall Study|Progression/relapse|54|||
30666169|NCT00857649|58679934|FG000|Overall Study|Adverse Event|15|||
30666170|NCT00857649|58679935|FG001|Overall Study|Adverse Event|10|||
30666171|NCT00857649|58679934|FG000|Overall Study|Non-compliance|1|||
30666172|NCT00857649|58679935|FG001|Overall Study|Non-compliance|1|||
30666173|NCT00857649|58679934|FG000|Overall Study|Protocol Violation|2|||
30666174|NCT00857649|58679935|FG001|Overall Study|Protocol Violation|2|||
30666175|NCT00857649|58679934|FG000|Overall Study|Withdrawal of Consent|10|||
30666176|NCT00857649|58679935|FG001|Overall Study|Withdrawal of Consent|7|||
30666177|NCT00857649|58679934|FG000|Overall Study|Nursing Home Placement|2|||
30666178|NCT00857649|58679935|FG001|Overall Study|Nursing Home Placement|9|||
30666179|NCT00857649|58679934|FG000|Overall Study|Other Reasons|1|||
30666180|NCT00857649|58679935|FG001|Overall Study|Other Reasons|3|||
30666181|NCT00857415|58679943|FG000|Overall Study|Image acquisition failure|2|||
30666182|NCT00857415|58679944|FG001|Overall Study|Image acquisition failure|0|||
30666183|NCT00857415|58679943|FG000|Overall Study|Invalid image or not imaged|3|||
30666184|NCT00857415|58679944|FG001|Overall Study|Invalid image or not imaged|0|||
30666185|NCT00857415|58679943|FG000|Overall Study|Subject still living at end of study|110|||
30666186|NCT00857415|58679944|FG001|Overall Study|Subject still living at end of study|0|||
30666187|NCT00857415|58679943|FG000|Overall Study|Deceased with no autopsy|2|||
30666188|NCT00857415|58679944|FG001|Overall Study|Deceased with no autopsy|0|||
30666189|NCT00532441|58679950|FG000|Overall Study|Death|1|||
30666190|NCT00532441|58679951|FG001|Overall Study|Death|0|||
30666191|NCT00857259|58679972|FG000|Overall Study|Protocol Violation|1|||
30666192|NCT00857259|58679973|FG001|Overall Study|Protocol Violation|0|||
30666193|NCT00857259|58679974|FG002|Overall Study|Protocol Violation|1|||
30666194|NCT00868608|58679987|FG000|Overall Study|Withdrawal by Subject|3|||
30666195|NCT00868608|58679988|FG001|Overall Study|Withdrawal by Subject|1|||
30666196|NCT00868608|58679989|FG002|Overall Study|Withdrawal by Subject|0|||
30666197|NCT00868608|58679987|FG000|Overall Study|Lost to Follow-up|3|||
30666198|NCT00868608|58679988|FG001|Overall Study|Lost to Follow-up|0|||
30666199|NCT00868608|58679989|FG002|Overall Study|Lost to Follow-up|1|||
30666200|NCT00868608|58679987|FG000|Overall Study|Death|16|||
30666201|NCT00868608|58679988|FG001|Overall Study|Death|2|||
30666202|NCT00868608|58679989|FG002|Overall Study|Death|4|||
30666203|NCT00868608|58679987|FG000|Overall Study|Other - Unspecified|1|||
30666204|NCT00868608|58679988|FG001|Overall Study|Other - Unspecified|0|||
30780078|NCT00006237|58791792|FG001|Overall Study|Progression/relapse|2|||
30780079|NCT00006237|58791791|FG000|Overall Study|Not eligible|9|||
30780080|NCT00006237|58791792|FG001|Overall Study|Not eligible|20|||
30780081|NCT00006237|58791791|FG000|Overall Study|Withdrawal by Subject|0|||
30780082|NCT00006237|58791792|FG001|Overall Study|Withdrawal by Subject|1|||
30565424|NCT01048866|58571904|FG000|Overall Study|Protocol Violation|1|||
30780083|NCT00006237|58791791|FG000|Overall Study|Not protocol specified|14|||
30780084|NCT00006237|58791792|FG001|Overall Study|Not protocol specified|5|||
30780085|NCT02993926|58791801|FG000|Enantone Treatment Phase|Adverse Event|1|||
30780086|NCT02993926|58791802|FG001|Enantone Treatment Phase|Adverse Event|0|||
30780087|NCT02993926|58791803|FG002|Enantone Treatment Phase|Adverse Event|0|||
30666205|NCT00868608|58679989|FG002|Overall Study|Other - Unspecified|0|||
30666206|NCT00856635|58679999|FG000|Overall Study|Lost to Follow-up|2|||
30666207|NCT00856635|58680000|FG001|Overall Study|Lost to Follow-up|5|||
30666208|NCT00856635|58679999|FG000|Overall Study|Pregnancy|1|||
30666209|NCT00856635|58680000|FG001|Overall Study|Pregnancy|0|||
30666210|NCT00856635|58679999|FG000|Overall Study|Withdrawal by Subject|3|||
30666211|NCT00856635|58680000|FG001|Overall Study|Withdrawal by Subject|1|||
30780088|NCT02993926|58791801|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
30780089|NCT02993926|58791802|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
30666212|NCT00856635|58679999|FG000|Overall Study|Serious Adverse Event|1|||
30666213|NCT00856635|58680000|FG001|Overall Study|Serious Adverse Event|0|||
30666214|NCT00856635|58679999|FG000|Overall Study|Other|1|||
30666215|NCT00856635|58680000|FG001|Overall Study|Other|0|||
30666216|NCT00856635|58679999|FG000|Overall Study|Discontinued at Randomization|2|||
30666217|NCT00856635|58680000|FG001|Overall Study|Discontinued at Randomization|2|||
30666218|NCT00856557|58680010|FG000|Overall Study|No patients with contextual flags|12|||
30666219|NCT00856557|58680011|FG001|Overall Study|No patients with contextual flags|16|||
30666220|NCT00856323|58680017|FG000|Overall Study|Withdrawal by Subject|2|||
30666221|NCT00856245|58680025|FG000|Overall Study|Was not transplanted|5|||
30666222|NCT00855933|58680031|FG000|Overall Study|Withdrawal by Subject|0|||
30666223|NCT00855933|58680032|FG001|Overall Study|Withdrawal by Subject|1|||
30666224|NCT00871572|58680042|FG000|Overall Study|Adverse Event|0|||
30666225|NCT00871572|58680043|FG001|Overall Study|Adverse Event|2|||
30666226|NCT00871572|58680044|FG002|Overall Study|Adverse Event|0|||
30666227|NCT00871572|58680045|FG003|Overall Study|Adverse Event|3|||
30780090|NCT02993926|58791803|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
30780091|NCT02993926|58791801|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
30780092|NCT02993926|58791802|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
30780093|NCT02993926|58791803|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
30780094|NCT02993926|58791801|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
30780095|NCT02993926|58791802|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
30780096|NCT02993926|58791803|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
30780097|NCT02993224|58791813|FG000|Core Phase - Period 1|Adverse Event|4|||
30780098|NCT02993224|58791813|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
30780099|NCT02993224|58791813|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
30780100|NCT02993224|58791813|FG000|Core Phase- Period 2|Adverse Event|1|||
30780101|NCT02993224|58791813|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
30780102|NCT02993224|58791813|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
30855142|NCT02332798|58882673|FG000|Overall Study|Positive Urine Drug Test|0|||
30855143|NCT02332798|58882674|FG001|Overall Study|Positive Urine Drug Test|1|||
30855144|NCT02332798|58882675|FG002|Overall Study|Positive Urine Drug Test|0|||
30855145|NCT02332798|58882673|FG000|Overall Study|Abnormal Laboratory Findings|1|||
30855146|NCT02332798|58882674|FG001|Overall Study|Abnormal Laboratory Findings|0|||
30855147|NCT02332798|58882675|FG002|Overall Study|Abnormal Laboratory Findings|0|||
30855148|NCT02790437|58882685|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
30855149|NCT02790437|58882686|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
30855150|NCT02790437|58882685|FG000|Overall Study|Adverse Event|1|||
30855151|NCT02790437|58882686|FG001|Overall Study|Adverse Event|0|||
30855152|NCT02790437|58882685|FG000|Overall Study|Withdrawal by Subject|1|||
30855153|NCT02790437|58882686|FG001|Overall Study|Withdrawal by Subject|0|||
30855154|NCT02604212|58882703|FG000|Overall Study|Study Terminated by Sponsor|2|||
30855155|NCT02604212|58882704|FG001|Overall Study|Study Terminated by Sponsor|1|||
30855156|NCT02604212|58882705|FG002|Overall Study|Study Terminated by Sponsor|3|||
30565425|NCT01048866|58571905|FG001|Overall Study|Protocol Violation|0|||
30565426|NCT01048866|58571904|FG000|Overall Study|Physician Decision|1|||
30565427|NCT01048866|58571905|FG001|Overall Study|Physician Decision|0|||
30565428|NCT01048866|58571904|FG000|Overall Study|Withdrawal by Subject|0|||
30565429|NCT01048866|58571905|FG001|Overall Study|Withdrawal by Subject|2|||
30565430|NCT01048866|58571904|FG000|Overall Study|Lost to Follow-up|0|||
30565431|NCT01048866|58571905|FG001|Overall Study|Lost to Follow-up|2|||
30565432|NCT01048866|58571904|FG000|Overall Study|Other|1|||
30565433|NCT01048866|58571905|FG001|Overall Study|Other|1|||
30565434|NCT01048788|58571914|FG000|Overall Study|Adverse Event|5|||
30565435|NCT01048788|58571915|FG001|Overall Study|Adverse Event|1|||
30565436|NCT01048788|58571916|FG002|Overall Study|Adverse Event|1|||
30565437|NCT01048788|58571914|FG000|Overall Study|Lack of Efficacy|0|||
30565438|NCT01048788|58571915|FG001|Overall Study|Lack of Efficacy|0|||
30565439|NCT01048788|58571916|FG002|Overall Study|Lack of Efficacy|1|||
30565440|NCT01048788|58571914|FG000|Overall Study|Withdrawal by Subject|0|||
30565441|NCT01048788|58571915|FG001|Overall Study|Withdrawal by Subject|1|||
30565442|NCT01048788|58571916|FG002|Overall Study|Withdrawal by Subject|0|||
30565443|NCT01048242|58571926|FG000|Overall Study|See study flow chart|4|||
30565444|NCT01048242|58571927|FG001|Overall Study|See study flow chart|2|||
30565445|NCT01047306|58571935|FG000|Overall Study|Withdrawal by Subject|2|||
30666228|NCT00871572|58680042|FG000|Overall Study|Investigator Decision|0|||
30565446|NCT01047306|58571936|FG001|Overall Study|Withdrawal by Subject|0|||
30565447|NCT01047306|58571935|FG000|Overall Study|Lost to Follow-up|1|||
30565448|NCT01047306|58571936|FG001|Overall Study|Lost to Follow-up|0|||
30666229|NCT00871572|58680043|FG001|Overall Study|Investigator Decision|1|||
30666230|NCT00871572|58680044|FG002|Overall Study|Investigator Decision|0|||
30565449|NCT01046682|58571946|FG000|Overall Study|Adverse Event|2|||
30666231|NCT00871572|58680045|FG003|Overall Study|Investigator Decision|1|||
30666232|NCT00871572|58680042|FG000|Overall Study|Lost to Follow-up|0|||
30666233|NCT00871572|58680043|FG001|Overall Study|Lost to Follow-up|1|||
30666234|NCT00871572|58680044|FG002|Overall Study|Lost to Follow-up|0|||
30666235|NCT00871572|58680045|FG003|Overall Study|Lost to Follow-up|1|||
30666236|NCT00871572|58680042|FG000|Overall Study|Protocol Violation|0|||
30666237|NCT00871572|58680043|FG001|Overall Study|Protocol Violation|0|||
30666238|NCT00871572|58680044|FG002|Overall Study|Protocol Violation|1|||
30666239|NCT00871572|58680045|FG003|Overall Study|Protocol Violation|1|||
30666240|NCT00871572|58680042|FG000|Overall Study|Sponsor Decision|1|||
30666241|NCT00871572|58680043|FG001|Overall Study|Sponsor Decision|0|||
30666242|NCT00871572|58680044|FG002|Overall Study|Sponsor Decision|0|||
30666243|NCT00871572|58680045|FG003|Overall Study|Sponsor Decision|0|||
30666244|NCT00871572|58680042|FG000|Overall Study|Withdrawal by Subject|1|||
30666245|NCT00871572|58680043|FG001|Overall Study|Withdrawal by Subject|2|||
30666246|NCT00871572|58680044|FG002|Overall Study|Withdrawal by Subject|3|||
30666247|NCT00871572|58680045|FG003|Overall Study|Withdrawal by Subject|1|||
30666248|NCT03885661|58680057|FG000|Overall Study|Withdrawal by Subject|0|||
30666249|NCT03885661|58680058|FG001|Overall Study|Withdrawal by Subject|1|||
30666250|NCT03885661|58680057|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
30666251|NCT03885661|58680058|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
30666252|NCT00868530|58680064|FG000|Overall Study|Adverse Event|3|||
30666253|NCT00868530|58680064|FG000|Overall Study|Lost to Follow-up|1|||
30666254|NCT00855465|58680070|FG000|Treatment Period|Adverse Event|4|||
30666255|NCT00855465|58680071|FG001|Treatment Period|Adverse Event|2|||
30666256|NCT00855465|58680070|FG000|Treatment Period|Death|2|||
30666257|NCT00855465|58680071|FG001|Treatment Period|Death|2|||
30666258|NCT00855465|58680070|FG000|Treatment Period|Lack of Efficacy|2|||
30666259|NCT00855465|58680071|FG001|Treatment Period|Lack of Efficacy|1|||
30666260|NCT00855465|58680070|FG000|Treatment Period|Non-compliance|1|||
30666261|NCT00855465|58680071|FG001|Treatment Period|Non-compliance|0|||
30666262|NCT00855465|58680070|FG000|Treatment Period|Protocol Violation|2|||
30666263|NCT00855465|58680071|FG001|Treatment Period|Protocol Violation|0|||
30666264|NCT00855465|58680070|FG000|Treatment Period|Withdrawal by Subject|2|||
30666265|NCT00855465|58680071|FG001|Treatment Period|Withdrawal by Subject|0|||
30666266|NCT00855465|58680070|FG000|Treatment Period|Not treated|1|||
30666267|NCT00855465|58680071|FG001|Treatment Period|Not treated|0|||
30666268|NCT00855465|58680070|FG000|Follow-up Period (FUP)|Adverse Event|0|||
30666269|NCT00855465|58680071|FG001|Follow-up Period (FUP)|Adverse Event|1|||
30666270|NCT00855465|58680070|FG000|Follow-up Period (FUP)|Death|0|||
30666271|NCT00855465|58680071|FG001|Follow-up Period (FUP)|Death|1|||
30666272|NCT00855465|58680070|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
30666273|NCT00855465|58680071|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
30666274|NCT00855465|58680070|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
30666275|NCT00855465|58680071|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
30666276|NCT00855465|58680070|FG000|Follow-up Period (FUP)|Missing|1|||
30666277|NCT00855465|58680071|FG001|Follow-up Period (FUP)|Missing|0|||
30666278|NCT00598442|58680080|FG000|Overall Study|Adverse Event|3|||
30666279|NCT00598442|58680081|FG001|Overall Study|Adverse Event|0|||
30666280|NCT00598442|58680082|FG002|Overall Study|Adverse Event|0|||
30666281|NCT00598442|58680080|FG000|Overall Study|Death|19|||
30666282|NCT00598442|58680081|FG001|Overall Study|Death|11|||
30666283|NCT00598442|58680082|FG002|Overall Study|Death|11|||
30666284|NCT00598442|58680080|FG000|Overall Study|Lost to Follow-up|4|||
30666285|NCT00598442|58680081|FG001|Overall Study|Lost to Follow-up|3|||
30666286|NCT00598442|58680082|FG002|Overall Study|Lost to Follow-up|3|||
30666287|NCT00598442|58680080|FG000|Overall Study|Physician Decision|2|||
30666288|NCT00598442|58680081|FG001|Overall Study|Physician Decision|1|||
30666289|NCT00598442|58680082|FG002|Overall Study|Physician Decision|1|||
30666290|NCT00598442|58680080|FG000|Overall Study|Withdrawal by Subject|8|||
30666291|NCT00598442|58680081|FG001|Overall Study|Withdrawal by Subject|16|||
30666292|NCT00598442|58680082|FG002|Overall Study|Withdrawal by Subject|6|||
30666293|NCT00598442|58680080|FG000|Overall Study|Noncompliance|0|||
30666294|NCT00598442|58680081|FG001|Overall Study|Noncompliance|2|||
30666295|NCT00598442|58680082|FG002|Overall Study|Noncompliance|1|||
30666296|NCT00598442|58680080|FG000|Overall Study|Relocation|1|||
30666297|NCT00598442|58680081|FG001|Overall Study|Relocation|4|||
30780103|NCT02993224|58791813|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
30666298|NCT00598442|58680082|FG002|Overall Study|Relocation|0|||
30666299|NCT00598442|58680080|FG000|Overall Study|Renal transplant|0|||
30666300|NCT00598442|58680081|FG001|Overall Study|Renal transplant|0|||
30666301|NCT00598442|58680082|FG002|Overall Study|Renal transplant|1|||
30780104|NCT02993224|58791813|FG000|Extension Phase|Adverse Event|3|||
30666302|NCT00598442|58680080|FG000|Overall Study|Site closed by sponsor|5|||
30666303|NCT00598442|58680081|FG001|Overall Study|Site closed by sponsor|2|||
30666304|NCT00598442|58680082|FG002|Overall Study|Site closed by sponsor|1|||
30666305|NCT00598442|58680080|FG000|Overall Study|Started dialysis|1|||
30666306|NCT00598442|58680081|FG001|Overall Study|Started dialysis|0|||
30666307|NCT00598442|58680082|FG002|Overall Study|Started dialysis|0|||
30666308|NCT00593814|58680092|FG000|Overall Study|Death|7|||
30666309|NCT00593814|58680093|FG001|Overall Study|Death|0|||
30666310|NCT00593814|58680092|FG000|Overall Study|Withdrawal by Subject|7|||
30780105|NCT02993224|58791813|FG000|Extension Phase|Withdrawal by Subject|3|||
30780106|NCT02993224|58791813|FG000|Extension Phase|Lost to Follow-up|2|||
30780107|NCT02993224|58791813|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
30780108|NCT03495908|58791821|FG000|Overall Study|Withdrawal by Subject|3|||
30780109|NCT03495908|58791822|FG001|Overall Study|Withdrawal by Subject|1|||
30780110|NCT03495908|58791821|FG000|Overall Study|Lost to Follow-up|1|||
30855157|NCT02604212|58882706|FG003|Overall Study|Study Terminated by Sponsor|3|||
30958604|NCT01695239|59023631|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958605|NCT01695239|59023632|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958606|NCT01695239|59023633|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958607|NCT01695239|59023634|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958608|NCT01695239|59023635|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958609|NCT01695239|59023636|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958610|NCT01695239|59023637|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958611|NCT01695239|59023638|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958612|NCT01695239|59023639|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958613|NCT01695239|59023640|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958614|NCT01695239|59023641|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958615|NCT01695239|59023642|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
30958616|NCT01695239|59023643|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
30958617|NCT01695239|59023630|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958618|NCT01695239|59023631|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958619|NCT01695239|59023632|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958620|NCT01695239|59023633|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958621|NCT01695239|59023634|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958622|NCT01695239|59023635|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958623|NCT01695239|59023636|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958624|NCT01695239|59023637|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958625|NCT01695239|59023638|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958626|NCT01695239|59023639|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30666311|NCT00593814|58680093|FG001|Overall Study|Withdrawal by Subject|0|||
30666312|NCT00593814|58680092|FG000|Overall Study|Lost to Follow-up|7|||
30666313|NCT00593814|58680093|FG001|Overall Study|Lost to Follow-up|0|||
30666314|NCT00593814|58680092|FG000|Overall Study|Physician Decision|3|||
30666315|NCT00593814|58680093|FG001|Overall Study|Physician Decision|0|||
30666316|NCT00855309|58680101|FG000|Overall Study|patient never recieved drug|1|||
30666317|NCT00855309|58680102|FG001|Overall Study|patient never recieved drug|0|||
30666318|NCT00532129|58680108|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
30958627|NCT01695239|59023640|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958628|NCT01695239|59023641|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958629|NCT01695239|59023642|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
30958630|NCT01695239|59023643|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
30958631|NCT02163694|59023667|FG000|Overall Study|Adverse event- related to progression|3|||
30565450|NCT01046682|58571947|FG001|Overall Study|Adverse Event|0|||
30565451|NCT01044732|58571955|FG000|Overall Study|Lost to Follow-up|2|||
30565452|NCT01044732|58571956|FG001|Overall Study|Lost to Follow-up|1|||
30565453|NCT01044732|58571955|FG000|Overall Study|Physician Decision|5|||
30565454|NCT01044732|58571956|FG001|Overall Study|Physician Decision|3|||
30565455|NCT01044732|58571955|FG000|Overall Study|Protocol Violation|11|||
30565456|NCT01044732|58571956|FG001|Overall Study|Protocol Violation|12|||
30565457|NCT01044732|58571955|FG000|Overall Study|Withdrawal by Subject|0|||
30565458|NCT01044732|58571956|FG001|Overall Study|Withdrawal by Subject|1|||
30565459|NCT01044732|58571955|FG000|Overall Study|Inadequate bowel preparation|11|||
30565460|NCT01044732|58571956|FG001|Overall Study|Inadequate bowel preparation|17|||
30565461|NCT01044732|58571955|FG000|Overall Study|Inability to reach cecum|5|||
30565462|NCT01044732|58571956|FG001|Overall Study|Inability to reach cecum|2|||
30666319|NCT00532129|58680108|FG000|Treatment Period|Physician Decision|15|||
30780111|NCT03495908|58791822|FG001|Overall Study|Lost to Follow-up|4|||
30855158|NCT02604212|58882703|FG000|Overall Study|Withdrawal by Subject|0|||
30958632|NCT02163694|59023668|FG001|Overall Study|Adverse event- related to progression|8|||
30958633|NCT02163694|59023667|FG000|Overall Study|Adverse event- not related to progression|7|||
30958634|NCT02163694|59023668|FG001|Overall Study|Adverse event- not related to progression|17|||
30958635|NCT02163694|59023667|FG000|Overall Study|Withdrew consent|8|||
30958636|NCT02163694|59023668|FG001|Overall Study|Withdrew consent|21|||
30565463|NCT01044732|58571955|FG000|Overall Study|Technical error or malfunction|15|||
30565464|NCT01044732|58571956|FG001|Overall Study|Technical error or malfunction|14|||
30565465|NCT01044498|58571966|FG000|Overall Study|Withdrew consent|1|||
30565466|NCT01044498|58571967|FG001|Overall Study|Withdrew consent|1|||
30780112|NCT03495908|58791821|FG000|Overall Study|Adverse Event|0|||
30780113|NCT03495908|58791822|FG001|Overall Study|Adverse Event|2|||
30780114|NCT03495908|58791821|FG000|Overall Study|Death|1|||
30780115|NCT03495908|58791822|FG001|Overall Study|Death|0|||
30666320|NCT00532129|58680108|FG000|Treatment Period|Disease progression|3|||
30666321|NCT00532129|58680108|FG000|Treatment Period|Protocol Violation|1|||
30666322|NCT00532129|58680108|FG000|Treatment Period|Other|5|||
30666323|NCT00532129|58680108|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
30666324|NCT00532129|58680108|FG000|Follow-up Period|Disease progression|57|||
30666325|NCT00532129|58680108|FG000|Follow-up Period|Lost to Follow-up|1|||
30666326|NCT00532129|58680108|FG000|Follow-up Period|Other|6|||
30666327|NCT00854607|58680112|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
30666328|NCT00854373|58680125|FG000|Overall Study|Withdrawal by Subject|1|||
30666329|NCT00854373|58680126|FG001|Overall Study|Withdrawal by Subject|3|||
30666330|NCT00854373|58680125|FG000|Overall Study|Forgot to take study drug|1|||
30666331|NCT00854373|58680126|FG001|Overall Study|Forgot to take study drug|1|||
30666332|NCT00853905|58680134|FG000|Overall Study|Lost to Follow-up|1|||
30666333|NCT00853905|58680135|FG001|Overall Study|Lost to Follow-up|3|||
30666334|NCT00853905|58680134|FG000|Overall Study|Withdrawal by Subject|0|||
30666335|NCT00853905|58680135|FG001|Overall Study|Withdrawal by Subject|1|||
30666336|NCT00853905|58680134|FG000|Overall Study|never had surgery|1|||
30666337|NCT00853905|58680135|FG001|Overall Study|never had surgery|0|||
30666338|NCT00868296|58680146|FG000|Overall Study|Adverse Event|0|||
30666339|NCT00868296|58680147|FG001|Overall Study|Adverse Event|2|||
30666340|NCT00868296|58680146|FG000|Overall Study|Withdrawal by Subject|0|||
30666341|NCT00868296|58680147|FG001|Overall Study|Withdrawal by Subject|1|||
30666342|NCT00867360|58680155|FG000|Overall Study|Withdrawal by Subject|1|||
30666343|NCT00867360|58680156|FG001|Overall Study|Withdrawal by Subject|0|||
30666344|NCT00867360|58680155|FG000|Overall Study|Physician Decision|0|||
30666345|NCT00867360|58680156|FG001|Overall Study|Physician Decision|1|||
30666346|NCT00593736|58680167|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
30666347|NCT00593736|58680168|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
30666348|NCT00593736|58680169|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
30666349|NCT00593736|58680170|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
30666350|NCT00593736|58680167|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
30666351|NCT00593736|58680168|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
30666352|NCT00593736|58680169|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
30666353|NCT00593736|58680170|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
30666354|NCT00593736|58680167|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
30666355|NCT00593736|58680168|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
30780116|NCT03495908|58791821|FG000|Overall Study|Physician Decision|5|||
30855159|NCT02604212|58882704|FG001|Overall Study|Withdrawal by Subject|0|||
30666356|NCT00593736|58680169|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
30666357|NCT00593736|58680170|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
30666358|NCT00593736|58680167|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
30666359|NCT00593736|58680168|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
30666360|NCT00593736|58680169|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
30666361|NCT00593736|58680170|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
30666362|NCT00593736|58680167|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
30666363|NCT00593736|58680168|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
30666364|NCT00593736|58680169|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
30666365|NCT00593736|58680170|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
30666366|NCT00593736|58680167|FG000|Screening Period and Placebo Run-in|Various|0|||
30666367|NCT00593736|58680168|FG001|Screening Period and Placebo Run-in|Various|0|||
30666368|NCT00593736|58680169|FG002|Screening Period and Placebo Run-in|Various|0|||
30666369|NCT00593736|58680170|FG003|Screening Period and Placebo Run-in|Various|25|||
30666370|NCT00593736|58680167|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
30666371|NCT00593736|58680168|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
30666372|NCT00593736|58680169|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
30666373|NCT00593736|58680170|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
30666374|NCT00593736|58680167|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
30666375|NCT00593736|58680168|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
30666376|NCT00593736|58680169|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
30666377|NCT00593736|58680170|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
30666378|NCT00593736|58680167|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
30780117|NCT03495908|58791822|FG001|Overall Study|Physician Decision|4|||
30780118|NCT03495908|58791821|FG000|Overall Study|No documented reason|0|||
30780119|NCT03495908|58791822|FG001|Overall Study|No documented reason|2|||
30780120|NCT02992288|58791834|FG000|Overall Study|Adverse Event|8|||
30780121|NCT02992288|58791835|FG001|Overall Study|Adverse Event|2|||
30780122|NCT02992288|58791836|FG002|Overall Study|Adverse Event|2|||
30780123|NCT02992288|58791837|FG003|Overall Study|Adverse Event|2|||
30666379|NCT00593736|58680168|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
30666380|NCT00593736|58680169|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
30666381|NCT00593736|58680170|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
30666382|NCT00593736|58680167|FG000|Treatment Period and Placebo Run-out|Various|1|||
30666383|NCT00593736|58680168|FG001|Treatment Period and Placebo Run-out|Various|1|||
30666384|NCT00593736|58680169|FG002|Treatment Period and Placebo Run-out|Various|1|||
30666385|NCT00593736|58680170|FG003|Treatment Period and Placebo Run-out|Various|0|||
30565467|NCT01044498|58571966|FG000|Overall Study|Adverse Event|1|||
30565468|NCT01044498|58571967|FG001|Overall Study|Adverse Event|1|||
30565469|NCT01044498|58571966|FG000|Overall Study|Other|1|||
30565470|NCT01044498|58571967|FG001|Overall Study|Other|0|||
30565471|NCT01043874|58571973|FG000|Overall Study|Adverse Event|3|||
30666386|NCT00883688|58680180|FG000|Overall Study|Ineligible|2|||
30666387|NCT03883477|58680186|FG000|Overall Study|Death|1|||
30666388|NCT03883477|58680187|FG001|Overall Study|Death|0|||
30666389|NCT03883477|58680186|FG000|Overall Study|Protocol Violation|0|||
30666390|NCT03883477|58680187|FG001|Overall Study|Protocol Violation|1|||
30666391|NCT00853827|58680195|FG000|Single Blind Period (1 Week)|Other|4|||
30666392|NCT00853827|58680196|FG001|Single Blind Period (1 Week)|Other|0|||
30666393|NCT00853827|58680195|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
30666394|NCT00853827|58680196|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
30666395|NCT00853827|58680195|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
30666396|NCT00853827|58680196|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
30666397|NCT00853827|58680195|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
30666398|NCT00853827|58680196|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
30666399|NCT00853827|58680195|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
30666400|NCT00853827|58680196|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
30666401|NCT00853827|58680195|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
30666402|NCT00853827|58680196|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
30666403|NCT00853827|58680195|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
30666404|NCT00853827|58680196|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
30666405|NCT00853827|58680195|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
30666406|NCT00853827|58680196|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
30666407|NCT00853827|58680195|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
30666408|NCT00853827|58680196|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
30666409|NCT00853827|58680195|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
30666410|NCT00853827|58680196|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
30666411|NCT00853827|58680195|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
30666412|NCT00853827|58680196|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
30666413|NCT00853827|58680195|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
30666414|NCT00853827|58680196|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
30666415|NCT00853827|58680195|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
30666416|NCT00853827|58680196|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
30666417|NCT00853827|58680195|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
30666418|NCT00853827|58680196|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
30666419|NCT00853827|58680195|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
30666420|NCT00853827|58680196|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
30666421|NCT00853827|58680195|FG000|Double Blind Period (103 Weeks)|Death|1|||
30666422|NCT00853827|58680196|FG001|Double Blind Period (103 Weeks)|Death|6|||
30666423|NCT00853749|58680204|FG000|Overall Study|Lost to Follow-up|0|||
30666424|NCT00853749|58680205|FG001|Overall Study|Lost to Follow-up|1|||
30666425|NCT00592839|58680214|FG000|Overall Study|Withdrawal by Subject|1|||
30666426|NCT00592839|58680215|FG001|Overall Study|Withdrawal by Subject|1|||
30666427|NCT00592839|58680216|FG002|Overall Study|Withdrawal by Subject|3|||
30666428|NCT00592839|58680214|FG000|Overall Study|Protocol Violation|1|||
30666429|NCT00592839|58680215|FG001|Overall Study|Protocol Violation|1|||
30666430|NCT00592839|58680216|FG002|Overall Study|Protocol Violation|2|||
30666431|NCT00592839|58680214|FG000|Overall Study|Adverse Event|0|||
30666432|NCT00592839|58680215|FG001|Overall Study|Adverse Event|1|||
30666433|NCT00592839|58680216|FG002|Overall Study|Adverse Event|0|||
30666434|NCT00592839|58680214|FG000|Overall Study|Lost to Follow-up|0|||
30666435|NCT00592839|58680215|FG001|Overall Study|Lost to Follow-up|1|||
30666436|NCT00592839|58680216|FG002|Overall Study|Lost to Follow-up|1|||
30666437|NCT00598832|58680226|FG000|Overall Study|Lack of Efficacy|3|||
30666438|NCT00598832|58680227|FG001|Overall Study|Lack of Efficacy|7|||
30666439|NCT00598832|58680226|FG000|Overall Study|Adverse Event|6|||
30666440|NCT00598832|58680227|FG001|Overall Study|Adverse Event|2|||
30666441|NCT00598832|58680226|FG000|Overall Study|Withdrawal by Subject|25|||
30666442|NCT00598832|58680227|FG001|Overall Study|Withdrawal by Subject|36|||
30666443|NCT00598832|58680226|FG000|Overall Study|Protocol Violation|0|||
30666444|NCT00598832|58680227|FG001|Overall Study|Protocol Violation|2|||
30565472|NCT01043874|58571973|FG000|Overall Study|Withdrawal by Subject|1|||
30565473|NCT01043874|58571973|FG000|Overall Study|Lack of Efficacy|1|||
30666445|NCT00598832|58680226|FG000|Overall Study|Lost to Follow-up|24|||
30666446|NCT00598832|58680227|FG001|Overall Study|Lost to Follow-up|29|||
30666447|NCT00598832|58680226|FG000|Overall Study|Pregnancy|2|||
30666448|NCT00598832|58680227|FG001|Overall Study|Pregnancy|2|||
30666449|NCT00598832|58680226|FG000|Overall Study|Physician Decision|1|||
30666450|NCT00598832|58680227|FG001|Overall Study|Physician Decision|4|||
30666451|NCT00598832|58680226|FG000|Overall Study|Non compliance|1|||
30666452|NCT00598832|58680227|FG001|Overall Study|Non compliance|0|||
30666453|NCT00853593|58680233|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
30666454|NCT00853593|58680233|FG000|Overall Study|Model 4396 lead not attempted|29|||
30666455|NCT00853593|58680233|FG000|Overall Study|Implant not attempted|4|||
30666456|NCT00853125|58680254|FG000|Overall Study|Study participant's donor was CMV +|1|||
30666457|NCT00530023|58680261|FG000|Overall Study|Withdrawal by Subject|0|||
30666458|NCT00530023|58680262|FG001|Overall Study|Withdrawal by Subject|1|||
30666459|NCT00529087|58680271|FG000|Overall Study|Adverse Event|10|||
30666460|NCT00529087|58680272|FG001|Overall Study|Adverse Event|13|||
30666461|NCT00529087|58680273|FG002|Overall Study|Adverse Event|4|||
30666462|NCT00529087|58680271|FG000|Overall Study|Lost to Follow-up|6|||
30666463|NCT00529087|58680272|FG001|Overall Study|Lost to Follow-up|4|||
30666464|NCT00529087|58680273|FG002|Overall Study|Lost to Follow-up|1|||
30666465|NCT00529087|58680271|FG000|Overall Study|Protocol Violation|8|||
30666466|NCT00529087|58680272|FG001|Overall Study|Protocol Violation|7|||
30666467|NCT00529087|58680273|FG002|Overall Study|Protocol Violation|6|||
30666468|NCT00529087|58680271|FG000|Overall Study|Withdrawal by Subject|3|||
30666469|NCT00529087|58680272|FG001|Overall Study|Withdrawal by Subject|3|||
30666470|NCT00529087|58680273|FG002|Overall Study|Withdrawal by Subject|3|||
30666471|NCT00529087|58680271|FG000|Overall Study|Protocol deviation|1|||
30666472|NCT00529087|58680272|FG001|Overall Study|Protocol deviation|1|||
30666473|NCT00529087|58680273|FG002|Overall Study|Protocol deviation|2|||
30666474|NCT00870870|58680308|FG000|Overall Study|Withdrawal by Subject|0|||
30666475|NCT00870870|58680309|FG001|Overall Study|Withdrawal by Subject|1|||
30666476|NCT00870870|58680310|FG002|Overall Study|Withdrawal by Subject|1|||
30666477|NCT00870870|58680311|FG003|Overall Study|Withdrawal by Subject|3|||
30666478|NCT00870870|58680308|FG000|Overall Study|Adverse Event|0|||
30666479|NCT00870870|58680309|FG001|Overall Study|Adverse Event|0|||
30666480|NCT00870870|58680310|FG002|Overall Study|Adverse Event|2|||
30666481|NCT00870870|58680311|FG003|Overall Study|Adverse Event|2|||
30666482|NCT03877237|58680328|FG000|Overall Study|Adverse Event|1|||
30666483|NCT03877237|58680329|FG001|Overall Study|Adverse Event|2|||
30666484|NCT03877237|58680328|FG000|Overall Study|Death|3|||
30666485|NCT03877237|58680329|FG001|Overall Study|Death|2|||
30666486|NCT03877237|58680328|FG000|Overall Study|Physician Decision|1|||
30666487|NCT03877237|58680329|FG001|Overall Study|Physician Decision|0|||
30666488|NCT03877237|58680328|FG000|Overall Study|Withdrawal by Subject|0|||
30666489|NCT03877237|58680329|FG001|Overall Study|Withdrawal by Subject|2|||
30666490|NCT00528931|58680335|FG000|Overall Study|Lost to Follow-up|1|||
30666491|NCT00866814|58680340|FG000|Overall Study|Lost to Follow-up|12|||
30666492|NCT00866814|58680340|FG000|Overall Study|Adverse Event|2|||
30666493|NCT00866814|58680340|FG000|Overall Study|Physician Decision|1|||
30666494|NCT00866814|58680340|FG000|Overall Study|Death|1|||
30666495|NCT00866814|58680340|FG000|Overall Study|No longer wished to participate|1|||
30666496|NCT00866814|58680340|FG000|Overall Study|Unable to meet follow-up requirements|2|||
30666497|NCT00866814|58680340|FG000|Overall Study|Moved to area without study site|1|||
30666498|NCT00871494|58680344|FG000|Overall Study|Protocol Violation|5|||
30666499|NCT00871494|58680344|FG000|Overall Study|Lack of Efficacy|4|||
30666500|NCT00871494|58680344|FG000|Overall Study|Adverse Event|4|||
30666501|NCT00871494|58680344|FG000|Overall Study|Lost to Follow-up|1|||
30666502|NCT00529789|58680348|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
30666503|NCT00529789|58680348|FG000|Study Period II/III|Adverse Event|3|||
30666504|NCT00529789|58680348|FG000|Study Period II/III|Lack of Efficacy|2|||
30666505|NCT00529789|58680348|FG000|Study Period II/III|Withdrawal by Subject|1|||
30666506|NCT00529789|58680348|FG000|Study Period II/III|Protocol Violation|3|||
30666507|NCT00529789|58680348|FG000|Study Period II/III|Physician Decision|3|||
30666508|NCT00529789|58680348|FG000|Study Period II/III|Lost to Follow-up|3|||
30666509|NCT00529789|58680348|FG000|Study Period IV|Parent/Caregiver Decision|1|||
30666510|NCT00529789|58680348|FG000|Study Period IV|Adverse Event|1|||
30666511|NCT00529789|58680348|FG000|Study Period IV|Lack of Efficacy|1|||
30666512|NCT00529789|58680348|FG000|Study Period IV|Lost to Follow-up|3|||
30666513|NCT00577642|58680358|FG000|Overall Study|Clinical Disease Progression|1|||
30666514|NCT00866658|58680364|FG000|Overall Study|Adverse Event|5|||
30666515|NCT00866658|58680365|FG001|Overall Study|Adverse Event|14|||
30666516|NCT00866658|58680364|FG000|Overall Study|Lack of Efficacy|2|||
30666517|NCT00866658|58680365|FG001|Overall Study|Lack of Efficacy|1|||
30666518|NCT00866658|58680364|FG000|Overall Study|Withdrawal by Subject|1|||
30666519|NCT00866658|58680365|FG001|Overall Study|Withdrawal by Subject|0|||
30666520|NCT00866658|58680364|FG000|Overall Study|Protocol Violation|1|||
30666521|NCT00866658|58680365|FG001|Overall Study|Protocol Violation|1|||
30666522|NCT00866658|58680364|FG000|Overall Study|Familial and Personal Reasons|4|||
30666523|NCT00866658|58680365|FG001|Overall Study|Familial and Personal Reasons|5|||
30666524|NCT03872453|58680375|FG000|Overall Study|Adverse Event|1|||
30666525|NCT03872453|58680376|FG001|Overall Study|Adverse Event|1|||
30666526|NCT03872453|58680377|FG002|Overall Study|Adverse Event|0|||
30666527|NCT03872453|58680378|FG003|Overall Study|Adverse Event|0|||
30666528|NCT03872453|58680375|FG000|Overall Study|Lost to Follow-up|8|||
30666529|NCT03872453|58680376|FG001|Overall Study|Lost to Follow-up|7|||
30666530|NCT03872453|58680377|FG002|Overall Study|Lost to Follow-up|4|||
30666531|NCT03872453|58680378|FG003|Overall Study|Lost to Follow-up|4|||
30666532|NCT03872453|58680375|FG000|Overall Study|Never Treated Migraine|19|||
30666533|NCT03872453|58680376|FG001|Overall Study|Never Treated Migraine|17|||
30666534|NCT03872453|58680377|FG002|Overall Study|Never Treated Migraine|13|||
30666535|NCT03872453|58680378|FG003|Overall Study|Never Treated Migraine|12|||
30666536|NCT03872453|58680375|FG000|Overall Study|Pregnancy|1|||
30666537|NCT03872453|58680376|FG001|Overall Study|Pregnancy|0|||
30666538|NCT03872453|58680377|FG002|Overall Study|Pregnancy|0|||
30666539|NCT03872453|58680378|FG003|Overall Study|Pregnancy|0|||
30666540|NCT03872453|58680375|FG000|Overall Study|Protocol Deviation|2|||
30666541|NCT03872453|58680376|FG001|Overall Study|Protocol Deviation|0|||
30666542|NCT03872453|58680377|FG002|Overall Study|Protocol Deviation|0|||
30666543|NCT03872453|58680378|FG003|Overall Study|Protocol Deviation|2|||
30666544|NCT03872453|58680375|FG000|Overall Study|Withdrawal by Subject|0|||
30666545|NCT03872453|58680376|FG001|Overall Study|Withdrawal by Subject|1|||
30666546|NCT03872453|58680377|FG002|Overall Study|Withdrawal by Subject|2|||
30666547|NCT03872453|58680378|FG003|Overall Study|Withdrawal by Subject|0|||
30666548|NCT03872453|58680375|FG000|Overall Study|Other Than Specified|1|||
30666549|NCT03872453|58680376|FG001|Overall Study|Other Than Specified|0|||
30666550|NCT03872453|58680377|FG002|Overall Study|Other Than Specified|0|||
30666551|NCT03872453|58680378|FG003|Overall Study|Other Than Specified|0|||
30666552|NCT00597584|58680390|FG000|Overall Study|Adverse Event|4|||
30666553|NCT00597584|58680391|FG001|Overall Study|Adverse Event|2|||
30666554|NCT00597584|58680390|FG000|Overall Study|Death|53|||
30666555|NCT00597584|58680391|FG001|Overall Study|Death|30|||
30666556|NCT00597584|58680390|FG000|Overall Study|Lack of Efficacy|1|||
30666557|NCT00597584|58680391|FG001|Overall Study|Lack of Efficacy|0|||
30666558|NCT00597584|58680390|FG000|Overall Study|Lost to Follow-up|2|||
30666559|NCT00597584|58680391|FG001|Overall Study|Lost to Follow-up|4|||
30666560|NCT00597584|58680390|FG000|Overall Study|Physician Decision|3|||
30666561|NCT00597584|58680391|FG001|Overall Study|Physician Decision|0|||
30666562|NCT00597584|58680390|FG000|Overall Study|Pregnancy|2|||
30666563|NCT00597584|58680391|FG001|Overall Study|Pregnancy|0|||
30666564|NCT00597584|58680390|FG000|Overall Study|Withdrawal by Subject|44|||
30666565|NCT00597584|58680391|FG001|Overall Study|Withdrawal by Subject|12|||
30666566|NCT00597584|58680390|FG000|Overall Study|Discontinued Dialysis|0|||
30666567|NCT00597584|58680391|FG001|Overall Study|Discontinued Dialysis|1|||
30666568|NCT00597584|58680390|FG000|Overall Study|Lost ability to consent|1|||
30666569|NCT00597584|58680391|FG001|Overall Study|Lost ability to consent|1|||
30666570|NCT00597584|58680390|FG000|Overall Study|Never dosed|1|||
30666571|NCT00597584|58680391|FG001|Overall Study|Never dosed|0|||
30666572|NCT00597584|58680390|FG000|Overall Study|Relocation|8|||
30666573|NCT00597584|58680391|FG001|Overall Study|Relocation|6|||
30666574|NCT00597584|58680390|FG000|Overall Study|Renal transplant|9|||
30666575|NCT00597584|58680391|FG001|Overall Study|Renal transplant|7|||
30666576|NCT00529633|58680399|FG000|Overall Study|Withdrawal by Subject|1|||
30565474|NCT01043874|58571973|FG000|Overall Study|Administrative Problems|1|||
30666577|NCT00529633|58680400|FG001|Overall Study|Withdrawal by Subject|1|||
30666578|NCT00530335|58680406|FG000|Overall Study|Adverse Event|3|||
30666579|NCT00530335|58680406|FG000|Overall Study|Protocol Violation|1|||
30666580|NCT00530335|58680406|FG000|Overall Study|Withdrawal by Subject|1|||
30565475|NCT01042938|58571979|FG000|Overall Study|Withdrawal by Subject|1|||
30565476|NCT01042938|58571980|FG001|Overall Study|Withdrawal by Subject|1|||
30565477|NCT01042938|58571979|FG000|Overall Study|Protocol Violation|1|||
30565478|NCT01042938|58571980|FG001|Overall Study|Protocol Violation|1|||
30565479|NCT01042938|58571979|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
30565480|NCT01042938|58571980|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
30565481|NCT01042158|58571988|FG000|Overall Study|Physician Decision|1|||
30565482|NCT03408444|58571996|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
30565483|NCT03408444|58571997|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
30565484|NCT03408444|58571998|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
30666581|NCT00530335|58680406|FG000|Overall Study|Physician Decision|1|||
30565485|NCT03408444|58571999|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
30855160|NCT02604212|58882705|FG002|Overall Study|Withdrawal by Subject|1|||
30666582|NCT00712270|58680413|FG000|Overall Study|Withdrawal by Subject|11|||
30666583|NCT00712270|58680413|FG000|Overall Study|Screen Failure|3|||
30565486|NCT03408444|58571996|FG000|Overall Study|Lens Discomfort|0|||
30666584|NCT00530257|58680439|FG000|Overall Study|Lost to Follow-up|1|||
30666585|NCT00869778|58680449|FG000|Overall Study|Adverse Event|2|||
30666586|NCT00869778|58680450|FG001|Overall Study|Adverse Event|0|||
30565487|NCT03408444|58571997|FG001|Overall Study|Lens Discomfort|1|||
30565488|NCT03408444|58571998|FG002|Overall Study|Lens Discomfort|0|||
30565489|NCT03408444|58571999|FG003|Overall Study|Lens Discomfort|0|||
30565490|NCT03408444|58571996|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
30565491|NCT03408444|58571997|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
30565492|NCT03408444|58571998|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
30565493|NCT03408444|58571999|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
30565494|NCT03408444|58571996|FG000|Overall Study|Withdrawal by Subject|0|||
30565495|NCT03408444|58571997|FG001|Overall Study|Withdrawal by Subject|2|||
30565496|NCT03408444|58571998|FG002|Overall Study|Withdrawal by Subject|3|||
30565497|NCT03408444|58571999|FG003|Overall Study|Withdrawal by Subject|0|||
30565498|NCT03408444|58571996|FG000|Overall Study|Lost to Follow-up|0|||
30565499|NCT03408444|58571997|FG001|Overall Study|Lost to Follow-up|0|||
30565500|NCT03408444|58571998|FG002|Overall Study|Lost to Follow-up|1|||
30565501|NCT03408444|58571999|FG003|Overall Study|Lost to Follow-up|0|||
30565502|NCT03408444|58571996|FG000|Overall Study|Adverse Event|0|||
30565503|NCT03408444|58571997|FG001|Overall Study|Adverse Event|0|||
30565504|NCT03408444|58571998|FG002|Overall Study|Adverse Event|0|||
30565505|NCT03408444|58571999|FG003|Overall Study|Adverse Event|1|||
30565506|NCT03408444|58571996|FG000|Overall Study|Lens Handling Difficulties|0|||
30565507|NCT03408444|58571997|FG001|Overall Study|Lens Handling Difficulties|0|||
30565508|NCT03408444|58571998|FG002|Overall Study|Lens Handling Difficulties|1|||
30565509|NCT03408444|58571999|FG003|Overall Study|Lens Handling Difficulties|0|||
30565510|NCT03408444|58571996|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
30565511|NCT03408444|58571997|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
30565512|NCT03408444|58571998|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
30565513|NCT03408444|58571999|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
30565514|NCT03400956|58572029|FG000|Treatment Period 1|Adverse Event|0|||
30565515|NCT03400956|58572030|FG001|Treatment Period 1|Adverse Event|1|||
30565516|NCT03400956|58572031|FG002|Treatment Period 1|Adverse Event|0|||
30565517|NCT03400956|58572029|FG000|Treatment Period 1|Lost to Follow-up|0|||
30565518|NCT03400956|58572030|FG001|Treatment Period 1|Lost to Follow-up|0|||
30565519|NCT03400956|58572031|FG002|Treatment Period 1|Lost to Follow-up|1|||
30565520|NCT03400956|58572029|FG000|Treatment Period 1|Protocol Violation|0|||
30565521|NCT03400956|58572030|FG001|Treatment Period 1|Protocol Violation|2|||
30565522|NCT03400956|58572031|FG002|Treatment Period 1|Protocol Violation|0|||
30565523|NCT03400956|58572029|FG000|Treatment Period 1|Study terminated by sponsor|3|||
30565524|NCT03400956|58572030|FG001|Treatment Period 1|Study terminated by sponsor|1|||
30565525|NCT03400956|58572031|FG002|Treatment Period 1|Study terminated by sponsor|1|||
30565526|NCT03400956|58572029|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30565527|NCT03400956|58572030|FG001|Treatment Period 1|Withdrawal by Subject|2|||
30565528|NCT03400956|58572031|FG002|Treatment Period 1|Withdrawal by Subject|4|||
30565529|NCT03400956|58572029|FG000|Treatment Period 1|Other|1|||
30565530|NCT03400956|58572030|FG001|Treatment Period 1|Other|2|||
30565531|NCT03400956|58572031|FG002|Treatment Period 1|Other|3|||
30565532|NCT03400956|58572029|FG000|Post-treatment Period 1|Adverse Event|0|||
30565533|NCT03400956|58572030|FG001|Post-treatment Period 1|Adverse Event|0|||
30565534|NCT03400956|58572031|FG002|Post-treatment Period 1|Adverse Event|1|||
30565535|NCT03400956|58572029|FG000|Post-treatment Period 1|Physician Decision|2|||
30565536|NCT03400956|58572030|FG001|Post-treatment Period 1|Physician Decision|3|||
30565537|NCT03400956|58572031|FG002|Post-treatment Period 1|Physician Decision|0|||
30565538|NCT03400956|58572029|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
30565539|NCT03400956|58572030|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
30565540|NCT03400956|58572031|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
30565541|NCT03400956|58572029|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
30565542|NCT03400956|58572030|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
30565543|NCT03400956|58572031|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
30565544|NCT03400956|58572029|FG000|Post-treatment Period 1|Other|4|||
30565545|NCT03400956|58572030|FG001|Post-treatment Period 1|Other|3|||
30565546|NCT03400956|58572031|FG002|Post-treatment Period 1|Other|4|||
30565547|NCT03400956|58572029|FG000|Treatment Period 2|Adverse Event|2|||
30565548|NCT03400956|58572030|FG001|Treatment Period 2|Adverse Event|1|||
30565549|NCT03400956|58572031|FG002|Treatment Period 2|Adverse Event|1|||
30565550|NCT03400956|58572029|FG000|Treatment Period 2|Lost to Follow-up|1|||
30565551|NCT03400956|58572030|FG001|Treatment Period 2|Lost to Follow-up|1|||
30565552|NCT03400956|58572031|FG002|Treatment Period 2|Lost to Follow-up|0|||
30565553|NCT03400956|58572029|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30565554|NCT03400956|58572030|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30565555|NCT03400956|58572031|FG002|Treatment Period 2|Withdrawal by Subject|3|||
30565556|NCT03400956|58572029|FG000|Treatment Period 2|Other|1|||
30565557|NCT03400956|58572030|FG001|Treatment Period 2|Other|1|||
30565558|NCT03400956|58572031|FG002|Treatment Period 2|Other|0|||
30780124|NCT02992288|58791838|FG004|Overall Study|Adverse Event|2|||
30780125|NCT02992288|58791839|FG005|Overall Study|Adverse Event|7|||
30565559|NCT03400956|58572029|FG000|Follow-up Period|Withdrawal by Subject|0|||
30565560|NCT03400956|58572030|FG001|Follow-up Period|Withdrawal by Subject|0|||
30565561|NCT03400956|58572031|FG002|Follow-up Period|Withdrawal by Subject|1|||
30565562|NCT03400956|58572029|FG000|Follow-up Period|Other|0|||
30565563|NCT03400956|58572030|FG001|Follow-up Period|Other|0|||
30565564|NCT03400956|58572031|FG002|Follow-up Period|Other|1|||
30565565|NCT00012012|58572044|FG000|Overall Study|Protocol Violation|1|||
30565566|NCT00012012|58572045|FG001|Overall Study|Protocol Violation|1|||
30565567|NCT00012012|58572044|FG000|Overall Study|Withdrawal by Subject|0|||
30565568|NCT00012012|58572045|FG001|Overall Study|Withdrawal by Subject|2|||
30565569|NCT00010374|58572051|FG000|Overall Study|False positive phrenic nerve test|1|||
30565570|NCT00559962|58572073|FG000|Overall Study|Adverse Event|1|||
30565571|NCT00559962|58572074|FG001|Overall Study|Adverse Event|7|||
30565572|NCT00559962|58572075|FG002|Overall Study|Adverse Event|8|||
30565573|NCT00559962|58572076|FG003|Overall Study|Adverse Event|5|||
30565574|NCT00559962|58572077|FG004|Overall Study|Adverse Event|11|||
30565575|NCT00559962|58572078|FG005|Overall Study|Adverse Event|4|||
30565576|NCT00559962|58572079|FG006|Overall Study|Adverse Event|4|||
30565577|NCT00559962|58572080|FG007|Overall Study|Adverse Event|2|||
30565578|NCT00559962|58572073|FG000|Overall Study|Lost to Follow-up|0|||
30565579|NCT00559962|58572074|FG001|Overall Study|Lost to Follow-up|1|||
30565580|NCT00559962|58572075|FG002|Overall Study|Lost to Follow-up|0|||
30565581|NCT00559962|58572076|FG003|Overall Study|Lost to Follow-up|0|||
30565582|NCT00559962|58572077|FG004|Overall Study|Lost to Follow-up|0|||
30565583|NCT00559962|58572078|FG005|Overall Study|Lost to Follow-up|0|||
30565584|NCT00559962|58572079|FG006|Overall Study|Lost to Follow-up|0|||
30565585|NCT00559962|58572080|FG007|Overall Study|Lost to Follow-up|0|||
30565586|NCT00559962|58572073|FG000|Overall Study|Withdrawal by Subject|1|||
30565587|NCT00559962|58572074|FG001|Overall Study|Withdrawal by Subject|1|||
30565588|NCT00559962|58572075|FG002|Overall Study|Withdrawal by Subject|2|||
30565589|NCT00559962|58572076|FG003|Overall Study|Withdrawal by Subject|0|||
30565590|NCT00559962|58572077|FG004|Overall Study|Withdrawal by Subject|3|||
30565591|NCT00559962|58572078|FG005|Overall Study|Withdrawal by Subject|1|||
30565592|NCT00559962|58572079|FG006|Overall Study|Withdrawal by Subject|0|||
30565593|NCT00559962|58572080|FG007|Overall Study|Withdrawal by Subject|2|||
30565594|NCT00559962|58572073|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
30565595|NCT00559962|58572074|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
30565596|NCT00559962|58572075|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
30565597|NCT00559962|58572076|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
30565598|NCT00559962|58572077|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
30565599|NCT00559962|58572078|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
30565600|NCT00559962|58572079|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
30565601|NCT00559962|58572080|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
30565602|NCT00559104|58572101|FG000|Overall Study|Lack of Efficacy|9|||
30565603|NCT00559104|58572102|FG001|Overall Study|Lack of Efficacy|0|||
30565604|NCT00558636|58572110|FG000|Treatment|Adverse Event|9|||
30565605|NCT00558636|58572111|FG001|Treatment|Adverse Event|2|||
30565606|NCT00558636|58572110|FG000|Treatment|Withdrawal by Subject|2|||
30565607|NCT00558636|58572111|FG001|Treatment|Withdrawal by Subject|0|||
30565608|NCT00558636|58572110|FG000|Treatment|Premature termination of the study|35|||
30565609|NCT00558636|58572111|FG001|Treatment|Premature termination of the study|37|||
30565610|NCT00558636|58572110|FG000|Treatment|Disease progression|1|||
30565611|NCT00558636|58572111|FG001|Treatment|Disease progression|5|||
30565612|NCT00558636|58572110|FG000|Follow-up|Premature termination of the study|12|||
30565613|NCT00558636|58572111|FG001|Follow-up|Premature termination of the study|7|||
30565614|NCT00558558|58572117|FG000|Overall Study|Unable to swallow|1|||
30565615|NCT00558558|58572117|FG000|Overall Study|Withdrawal by Subject|1|||
30565616|NCT00558558|58572117|FG000|Overall Study|Lack of Efficacy|4|||
30565617|NCT00557622|58572123|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
30565618|NCT00557622|58572124|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
30565619|NCT00557622|58572123|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
30565620|NCT00557622|58572124|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
30565621|NCT00557622|58572123|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
30565622|NCT00557622|58572124|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
30565623|NCT00557466|58572136|FG000|Overall Study|Adverse Event|3|||
30565624|NCT00557466|58572137|FG001|Overall Study|Adverse Event|1|||
30565625|NCT00557466|58572138|FG002|Overall Study|Adverse Event|4|||
30565626|NCT00557466|58572139|FG003|Overall Study|Adverse Event|1|||
30565627|NCT00557466|58572140|FG004|Overall Study|Adverse Event|2|||
30565628|NCT00557466|58572141|FG005|Overall Study|Adverse Event|4|||
30565629|NCT00557466|58572136|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30565630|NCT00557466|58572137|FG001|Overall Study|Abnormal laboratory value(s)|2|||
30565631|NCT00557466|58572138|FG002|Overall Study|Abnormal laboratory value(s)|0|||
30565632|NCT00557466|58572139|FG003|Overall Study|Abnormal laboratory value(s)|0|||
30565633|NCT00557466|58572140|FG004|Overall Study|Abnormal laboratory value(s)|0|||
30565634|NCT00557466|58572141|FG005|Overall Study|Abnormal laboratory value(s)|0|||
30565635|NCT00557466|58572136|FG000|Overall Study|Protocol deviation|0|||
30565636|NCT00557466|58572137|FG001|Overall Study|Protocol deviation|1|||
30565637|NCT00557466|58572138|FG002|Overall Study|Protocol deviation|0|||
30565638|NCT00557466|58572139|FG003|Overall Study|Protocol deviation|2|||
30565639|NCT00557466|58572140|FG004|Overall Study|Protocol deviation|0|||
30565640|NCT00557466|58572141|FG005|Overall Study|Protocol deviation|0|||
30565641|NCT00557466|58572136|FG000|Overall Study|Subject withdrew consent|0|||
30565642|NCT00557466|58572137|FG001|Overall Study|Subject withdrew consent|0|||
30565643|NCT00557466|58572138|FG002|Overall Study|Subject withdrew consent|0|||
30565644|NCT00557466|58572139|FG003|Overall Study|Subject withdrew consent|0|||
30565645|NCT00557466|58572140|FG004|Overall Study|Subject withdrew consent|1|||
30565646|NCT00557466|58572141|FG005|Overall Study|Subject withdrew consent|2|||
30565647|NCT00557466|58572136|FG000|Overall Study|Administrative problems|0|||
30565648|NCT00557466|58572137|FG001|Overall Study|Administrative problems|1|||
30565649|NCT00557466|58572138|FG002|Overall Study|Administrative problems|1|||
30565650|NCT00557466|58572139|FG003|Overall Study|Administrative problems|0|||
30565651|NCT00557466|58572140|FG004|Overall Study|Administrative problems|0|||
30565652|NCT00557466|58572141|FG005|Overall Study|Administrative problems|0|||
30565653|NCT00557466|58572136|FG000|Overall Study|Abnormal test procedure results|0|||
30565654|NCT00557466|58572137|FG001|Overall Study|Abnormal test procedure results|0|||
30565655|NCT00557466|58572138|FG002|Overall Study|Abnormal test procedure results|1|||
30565656|NCT00557466|58572139|FG003|Overall Study|Abnormal test procedure results|0|||
30565657|NCT00557466|58572140|FG004|Overall Study|Abnormal test procedure results|0|||
30565658|NCT00557466|58572141|FG005|Overall Study|Abnormal test procedure results|0|||
30565659|NCT00557466|58572136|FG000|Overall Study|Lost to Follow-up|0|||
30565660|NCT00557466|58572137|FG001|Overall Study|Lost to Follow-up|0|||
30565661|NCT00557466|58572138|FG002|Overall Study|Lost to Follow-up|0|||
30565662|NCT00557466|58572139|FG003|Overall Study|Lost to Follow-up|1|||
30565663|NCT00557466|58572140|FG004|Overall Study|Lost to Follow-up|0|||
30565664|NCT00557466|58572141|FG005|Overall Study|Lost to Follow-up|0|||
30565665|NCT00557310|58572155|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
30565666|NCT00557310|58572155|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
30565667|NCT00557310|58572155|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
30565668|NCT00557310|58572155|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
30565669|NCT00557310|58572155|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
30565670|NCT00557310|58572155|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
30565671|NCT00555438|58572159|FG000|10 Days Post-operative|Death|4|||
30565672|NCT00555438|58572159|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
30565673|NCT00553644|58572163|FG000|Overall Study|Adverse Event|17|||
30565674|NCT00553644|58572163|FG000|Overall Study|Withdrawal by Subject|4|||
30565675|NCT00553644|58572163|FG000|Overall Study|Physician Decision|1|||
30565676|NCT00553644|58572163|FG000|Overall Study|Alternative therapy|6|||
30565677|NCT00553332|58572167|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
30565678|NCT00552396|58572178|FG000|Overall Study|protocol withdrawal criteria|3|||
30565679|NCT00552396|58572179|FG001|Overall Study|protocol withdrawal criteria|3|||
30565680|NCT00552396|58572180|FG002|Overall Study|protocol withdrawal criteria|3|||
30565681|NCT00552396|58572181|FG003|Overall Study|protocol withdrawal criteria|6|||
30565682|NCT00552396|58572182|FG004|Overall Study|protocol withdrawal criteria|3|||
30565683|NCT00552396|58572183|FG005|Overall Study|protocol withdrawal criteria|3|||
30565684|NCT00552396|58572184|FG006|Overall Study|protocol withdrawal criteria|9|||
30565685|NCT00552240|58572220|FG000|Overall Study|Adverse Event|9|||
30565686|NCT00552240|58572221|FG001|Overall Study|Adverse Event|9|||
30565687|NCT00552240|58572220|FG000|Overall Study|Protocol Violation|1|||
30565688|NCT00552240|58572221|FG001|Overall Study|Protocol Violation|1|||
30565689|NCT00552240|58572220|FG000|Overall Study|Lost to Follow-up|5|||
30565690|NCT00552240|58572221|FG001|Overall Study|Lost to Follow-up|6|||
30565691|NCT00552240|58572220|FG000|Overall Study|Withdrawal by Subject|2|||
30565692|NCT00552240|58572221|FG001|Overall Study|Withdrawal by Subject|2|||
30565693|NCT00552240|58572220|FG000|Overall Study|Lack of Efficacy|6|||
30565694|NCT00552240|58572221|FG001|Overall Study|Lack of Efficacy|0|||
30565695|NCT00552240|58572220|FG000|Overall Study|Other|1|||
30565696|NCT00552240|58572221|FG001|Overall Study|Other|0|||
30565697|NCT00552084|58572229|FG000|Overall Study|Adverse Event|2|||
30565698|NCT00552084|58572230|FG001|Overall Study|Adverse Event|3|||
30565699|NCT00552084|58572229|FG000|Overall Study|Withdrawal by Subject|4|||
30565700|NCT00552084|58572230|FG001|Overall Study|Withdrawal by Subject|5|||
30565701|NCT00552084|58572229|FG000|Overall Study|Protocol Violation|1|||
30565702|NCT00552084|58572230|FG001|Overall Study|Protocol Violation|0|||
30565703|NCT00552084|58572229|FG000|Overall Study|change in anti-arrythmic drug|1|||
30565704|NCT00552084|58572230|FG001|Overall Study|change in anti-arrythmic drug|1|||
30565705|NCT00550836|58572238|FG000|Overall Study|Withdrawal by Subject|3|||
30565706|NCT00550836|58572239|FG001|Overall Study|Withdrawal by Subject|9|||
30565707|NCT00550680|58572245|FG000|Overall Study|Administrative Reasons|1|||
30565708|NCT00550680|58572245|FG000|Overall Study|Adverse Event|5|||
30565709|NCT00550680|58572245|FG000|Overall Study|Death|3|||
30565710|NCT00550680|58572245|FG000|Overall Study|Early Improvement|1|||
30855161|NCT02604212|58882706|FG003|Overall Study|Withdrawal by Subject|0|||
30565711|NCT00550680|58572245|FG000|Overall Study|Lost to Follow-up|3|||
30565712|NCT00550680|58572245|FG000|Overall Study|Lack of Efficacy|1|||
30565713|NCT00550680|58572245|FG000|Overall Study|Other|10|||
30565714|NCT00550680|58572245|FG000|Overall Study|Protocol Violation|7|||
30565715|NCT00550680|58572245|FG000|Overall Study|Refused Treatment|19|||
30565716|NCT00550680|58572245|FG000|Overall Study|Screen Failure|6|||
30565717|NCT00554190|58572249|FG000|Overall Study|Termination forms not completed|10|||
30565718|NCT00556374|58572255|FG000|Overall Study|Withdrawal by Subject|235|||
30565719|NCT00556374|58572256|FG001|Overall Study|Withdrawal by Subject|205|||
30565720|NCT00556374|58572255|FG000|Overall Study|Death|158|||
30565721|NCT00556374|58572256|FG001|Overall Study|Death|127|||
30565722|NCT00556374|58572255|FG000|Overall Study|Lost to Follow-up|24|||
30565723|NCT00556374|58572256|FG001|Overall Study|Lost to Follow-up|17|||
30565724|NCT00556374|58572255|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
30565725|NCT00556374|58572256|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
30565726|NCT04677959|58572287|FG000|Overall Study|Adverse Event|1|||
30565727|NCT04677959|58572288|FG001|Overall Study|Adverse Event|9|||
30565728|NCT04677959|58572287|FG000|Overall Study|Withdrawal by Subject|2|||
30565729|NCT04677959|58572288|FG001|Overall Study|Withdrawal by Subject|15|||
30565730|NCT04677959|58572287|FG000|Overall Study|Withdrawal by parent/guardian|0|||
30565731|NCT04677959|58572288|FG001|Overall Study|Withdrawal by parent/guardian|1|||
30565732|NCT04677959|58572287|FG000|Overall Study|Non-compliance with study drug|0|||
30565733|NCT04677959|58572288|FG001|Overall Study|Non-compliance with study drug|2|||
30565734|NCT04677959|58572287|FG000|Overall Study|Protocol deviation|0|||
30565735|NCT04677959|58572288|FG001|Overall Study|Protocol deviation|11|||
30565736|NCT04677959|58572287|FG000|Overall Study|Lost to Follow-up|9|||
30565737|NCT04677959|58572288|FG001|Overall Study|Lost to Follow-up|13|||
30565738|NCT04677959|58572287|FG000|Overall Study|Other than specified|0|||
30565739|NCT04677959|58572288|FG001|Overall Study|Other than specified|8|||
30565740|NCT04330638|58572315|FG000|Overall Study|Adverse Event|9|||
30565741|NCT04330638|58572316|FG001|Overall Study|Adverse Event|10|||
30565742|NCT04330638|58572317|FG002|Overall Study|Adverse Event|15|||
30565743|NCT04330638|58572318|FG003|Overall Study|Adverse Event|6|||
30565744|NCT04330638|58572319|FG004|Overall Study|Adverse Event|10|||
30565745|NCT04330638|58572320|FG005|Overall Study|Adverse Event|5|||
30565746|NCT04330638|58572315|FG000|Overall Study|Other|2|||
30565747|NCT04330638|58572316|FG001|Overall Study|Other|2|||
30565748|NCT04330638|58572317|FG002|Overall Study|Other|5|||
30565749|NCT04330638|58572318|FG003|Overall Study|Other|1|||
30565750|NCT04330638|58572319|FG004|Overall Study|Other|3|||
30565751|NCT04330638|58572320|FG005|Overall Study|Other|2|||
30565752|NCT04330638|58572315|FG000|Overall Study|Withdrawal by Subject|4|||
30565753|NCT04330638|58572316|FG001|Overall Study|Withdrawal by Subject|0|||
30565754|NCT04330638|58572317|FG002|Overall Study|Withdrawal by Subject|0|||
30565755|NCT04330638|58572318|FG003|Overall Study|Withdrawal by Subject|0|||
30565756|NCT04330638|58572319|FG004|Overall Study|Withdrawal by Subject|0|||
30565757|NCT04330638|58572320|FG005|Overall Study|Withdrawal by Subject|0|||
30565758|NCT04330638|58572315|FG000|Overall Study|Lost to Follow-up|3|||
30565759|NCT04330638|58572316|FG001|Overall Study|Lost to Follow-up|2|||
30565760|NCT04330638|58572317|FG002|Overall Study|Lost to Follow-up|3|||
30565761|NCT04330638|58572318|FG003|Overall Study|Lost to Follow-up|2|||
30565762|NCT04330638|58572319|FG004|Overall Study|Lost to Follow-up|3|||
30565763|NCT04330638|58572320|FG005|Overall Study|Lost to Follow-up|0|||
30565764|NCT04194541|58572341|FG000|Day 1 Through 13|Lost to Follow-up|3|||
30565765|NCT04194541|58572341|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
30565766|NCT04194541|58572341|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
30565767|NCT04006392|58572359|FG000|Overall Study|Lost to Follow-up|0|||
30565768|NCT04006392|58572360|FG001|Overall Study|Lost to Follow-up|1|||
30565769|NCT03959423|58572368|FG000|Overall Study|Withdrawal by Subject|2|||
30565770|NCT03959423|58572369|FG001|Overall Study|Withdrawal by Subject|3|||
30565771|NCT03959423|58572368|FG000|Overall Study|Physician Decision|0|||
30565772|NCT03959423|58572369|FG001|Overall Study|Physician Decision|1|||
30565773|NCT03959423|58572368|FG000|Overall Study|Lost to Follow-up|1|||
30565774|NCT03959423|58572369|FG001|Overall Study|Lost to Follow-up|0|||
30565775|NCT03959423|58572368|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
30565776|NCT03959423|58572369|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
30565777|NCT03786783|58572375|FG000|Overall Study|Death|1|||
30565778|NCT03786783|58572375|FG000|Overall Study|Physician Decision|6|||
30565779|NCT03786783|58572375|FG000|Overall Study|Withdrawal by Subject|2|||
30958637|NCT02163694|59023667|FG000|Overall Study|Lost to Follow-up|1|||
30565780|NCT03786783|58572375|FG000|Overall Study|Disease Progression|7|||
30565781|NCT03786783|58572375|FG000|Overall Study|Patient/Parent Refusal|4|||
30565782|NCT03432494|58572389|FG000|Overall Study|Death|1|||
30565783|NCT03432494|58572389|FG000|Overall Study|Noncompliance|1|||
30565784|NCT03312634|58572395|FG000|Overall Study|Adverse Event|6|||
30565785|NCT03312634|58572396|FG001|Overall Study|Adverse Event|0|||
30565786|NCT03312634|58572395|FG000|Overall Study|Sponsor request|2|||
30565787|NCT03312634|58572396|FG001|Overall Study|Sponsor request|0|||
30666587|NCT00869778|58680451|FG002|Overall Study|Adverse Event|0|||
30565788|NCT03312634|58572395|FG000|Overall Study|Withdrawal by Subject|11|||
30565789|NCT03312634|58572396|FG001|Overall Study|Withdrawal by Subject|9|||
30565790|NCT03312634|58572395|FG000|Overall Study|Ongoing in study at DCO|88|||
30565791|NCT03312634|58572396|FG001|Overall Study|Ongoing in study at DCO|0|||
30565792|NCT03312634|58572395|FG000|Overall Study|Enrolled in an interventional study|0|||
30565793|NCT03312634|58572396|FG001|Overall Study|Enrolled in an interventional study|52|||
30565794|NCT03312634|58572395|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
30565795|NCT03312634|58572396|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
30565796|NCT03312634|58572395|FG000|Overall Study|Death|0|||
30565797|NCT03312634|58572396|FG001|Overall Study|Death|1|||
30565798|NCT03312634|58572395|FG000|Overall Study|Non-compliance|0|||
30565799|NCT03312634|58572396|FG001|Overall Study|Non-compliance|2|||
30565800|NCT03312634|58572395|FG000|Overall Study|Lost to Follow-up|0|||
30565801|NCT03312634|58572396|FG001|Overall Study|Lost to Follow-up|1|||
30565802|NCT03312634|58572395|FG000|Overall Study|Enrolled into non-interventional study|0|||
30565803|NCT03312634|58572396|FG001|Overall Study|Enrolled into non-interventional study|5|||
30565804|NCT03312634|58572395|FG000|Overall Study|Worsening clinical condition|0|||
30565805|NCT03312634|58572396|FG001|Overall Study|Worsening clinical condition|1|||
30565806|NCT03312634|58572395|FG000|Overall Study|Participant did not want to travel|0|||
30565807|NCT03312634|58572396|FG001|Overall Study|Participant did not want to travel|1|||
30565808|NCT03287830|58572407|FG000|Overall Study|Withdrawal by Subject|1|||
30565809|NCT03287830|58572408|FG001|Overall Study|Withdrawal by Subject|1|||
30565810|NCT03287830|58572407|FG000|Overall Study|not meeting inclusion criteria|5|||
30565811|NCT03287830|58572408|FG001|Overall Study|not meeting inclusion criteria|12|||
30565812|NCT03181633|58572418|FG000|Overall Study|Withdrawal by Subject|1|||
30565813|NCT03181633|58572418|FG000|Overall Study|Missing follow-up visit|1|||
30565814|NCT03122223|58572435|FG000|Overall Study|Withdrawal by Subject|2|||
30565815|NCT03122223|58572436|FG001|Overall Study|Withdrawal by Subject|2|||
30565816|NCT03122223|58572437|FG002|Overall Study|Withdrawal by Subject|1|||
30565817|NCT03122223|58572438|FG003|Overall Study|Withdrawal by Subject|0|||
30565818|NCT03122223|58572435|FG000|Overall Study|Lost to Follow-up|0|||
30565819|NCT03122223|58572436|FG001|Overall Study|Lost to Follow-up|2|||
30565820|NCT03122223|58572437|FG002|Overall Study|Lost to Follow-up|2|||
30565821|NCT03122223|58572438|FG003|Overall Study|Lost to Follow-up|0|||
30565822|NCT03122223|58572435|FG000|Overall Study|Participant unable to adhere|1|||
30565823|NCT03122223|58572436|FG001|Overall Study|Participant unable to adhere|1|||
30565824|NCT03122223|58572437|FG002|Overall Study|Participant unable to adhere|1|||
30565825|NCT03122223|58572438|FG003|Overall Study|Participant unable to adhere|0|||
30565826|NCT03077087|58572448|FG000|Overall Study|Physician Decision|2|||
30565828|NCT02853604|58572458|FG000|Overall Study|Withdrawal by Subject|12|||
30565829|NCT02853604|58572459|FG001|Overall Study|Withdrawal by Subject|35|||
30565830|NCT02853604|58572458|FG000|Overall Study|Lost to Follow-up|4|||
30565831|NCT02853604|58572459|FG001|Overall Study|Lost to Follow-up|8|||
30565832|NCT02853604|58572458|FG000|Overall Study|Death|1|||
30565833|NCT02853604|58572459|FG001|Overall Study|Death|5|||
30565834|NCT02853604|58572458|FG000|Overall Study|Miscellaneous|11|||
30565835|NCT02853604|58572459|FG001|Overall Study|Miscellaneous|2|||
30565836|NCT02853604|58572458|FG000|Overall Study|Progressive Disease|0|||
30565837|NCT02853604|58572459|FG001|Overall Study|Progressive Disease|2|||
30565838|NCT02632552|58572485|FG000|Overall Study|Lost to Follow-up|14|||
30565839|NCT02632552|58572486|FG001|Overall Study|Lost to Follow-up|8|||
30565840|NCT02632552|58572485|FG000|Overall Study|Withdrawal by Subject|2|||
30565841|NCT02632552|58572486|FG001|Overall Study|Withdrawal by Subject|0|||
30565842|NCT02632552|58572485|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
30565843|NCT02632552|58572486|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
30565844|NCT02525562|58572533|FG000|Overall Study|Death|9|||
30565845|NCT02525562|58572534|FG001|Overall Study|Death|0|||
30565846|NCT02525562|58572535|FG002|Overall Study|Death|0|||
30565847|NCT02525562|58572533|FG000|Overall Study|Lost to Follow-up|19|||
30565848|NCT02525562|58572534|FG001|Overall Study|Lost to Follow-up|0|||
30565849|NCT02525562|58572535|FG002|Overall Study|Lost to Follow-up|0|||
30565850|NCT02525562|58572533|FG000|Overall Study|Withdrawal by Subject|37|||
30565851|NCT02525562|58572534|FG001|Overall Study|Withdrawal by Subject|0|||
30565852|NCT02525562|58572535|FG002|Overall Study|Withdrawal by Subject|0|||
30565853|NCT02525562|58572533|FG000|Overall Study|Revision/Removal of Study Device|4|||
30565854|NCT02525562|58572534|FG001|Overall Study|Revision/Removal of Study Device|0|||
30565855|NCT02525562|58572535|FG002|Overall Study|Revision/Removal of Study Device|0|||
30565856|NCT02525562|58572533|FG000|Overall Study|Study Closed by Sponsor|154|||
30565857|NCT02525562|58572534|FG001|Overall Study|Study Closed by Sponsor|0|||
30565858|NCT02525562|58572535|FG002|Overall Study|Study Closed by Sponsor|0|||
30565859|NCT01992653|58572548|FG000|Overall Study|Death|0|||
30565860|NCT01992653|58572549|FG001|Overall Study|Death|0|||
30565861|NCT01992653|58572550|FG002|Overall Study|Death|1|||
30565862|NCT01992653|58572551|FG003|Overall Study|Death|0|||
30565863|NCT01992653|58572552|FG004|Overall Study|Death|1|||
30565864|NCT01992653|58572553|FG005|Overall Study|Death|0|||
30565865|NCT01992653|58572554|FG006|Overall Study|Death|4|||
30565866|NCT01992653|58572555|FG007|Overall Study|Death|2|||
30565867|NCT01992653|58572548|FG000|Overall Study|Lost to Follow-up|0|||
30565868|NCT01992653|58572549|FG001|Overall Study|Lost to Follow-up|0|||
30565869|NCT01992653|58572550|FG002|Overall Study|Lost to Follow-up|0|||
30565870|NCT01992653|58572551|FG003|Overall Study|Lost to Follow-up|0|||
30565871|NCT01992653|58572552|FG004|Overall Study|Lost to Follow-up|0|||
30565872|NCT01992653|58572553|FG005|Overall Study|Lost to Follow-up|0|||
30565873|NCT01992653|58572554|FG006|Overall Study|Lost to Follow-up|0|||
30565874|NCT01992653|58572555|FG007|Overall Study|Lost to Follow-up|1|||
30565875|NCT01992653|58572548|FG000|Overall Study|Study Completed|0|||
30565876|NCT01992653|58572549|FG001|Overall Study|Study Completed|0|||
30565877|NCT01992653|58572550|FG002|Overall Study|Study Completed|0|||
30565878|NCT01992653|58572551|FG003|Overall Study|Study Completed|0|||
30565879|NCT01992653|58572552|FG004|Overall Study|Study Completed|0|||
30565880|NCT01992653|58572553|FG005|Overall Study|Study Completed|0|||
30565881|NCT01992653|58572554|FG006|Overall Study|Study Completed|0|||
30565882|NCT01992653|58572555|FG007|Overall Study|Study Completed|1|||
30565883|NCT01992653|58572548|FG000|Overall Study|Disease Progression|0|||
30565884|NCT01992653|58572549|FG001|Overall Study|Disease Progression|0|||
30565885|NCT01992653|58572550|FG002|Overall Study|Disease Progression|0|||
30565886|NCT01992653|58572551|FG003|Overall Study|Disease Progression|0|||
30565887|NCT01992653|58572552|FG004|Overall Study|Disease Progression|0|||
30565888|NCT01992653|58572553|FG005|Overall Study|Disease Progression|0|||
30565889|NCT01992653|58572554|FG006|Overall Study|Disease Progression|4|||
30565890|NCT01992653|58572555|FG007|Overall Study|Disease Progression|0|||
30565899|NCT01654276|58572599|FG000|Overall Study|Lack of Efficacy|1|||
30565900|NCT01654276|58572599|FG000|Overall Study|Lost to Follow-up|4|||
30565901|NCT01654276|58572599|FG000|Overall Study|Withdrawal by Subject|1|||
30565902|NCT01399658|58572603|FG000|Overall Study|Ineligible|1|||
30565903|NCT01399658|58572603|FG000|Overall Study|Machine Technical Issue|3|||
30565904|NCT01399658|58572603|FG000|Overall Study|Alternative therapy|1|||
30565905|NCT01399658|58572603|FG000|Overall Study|No reason given|1|||
30565906|NCT00590122|58572609|FG000|Overall Study|swallowed oral dissolving dose|1|||
30565907|NCT00590122|58572610|FG001|Overall Study|swallowed oral dissolving dose|0|||
30565908|NCT01386658|58572639|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
30565909|NCT01386658|58572640|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
30565910|NCT01386658|58572639|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
30565911|NCT01386658|58572640|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
30565912|NCT01386684|58572650|FG000|Overall Study|Lost to Follow-up|51|||
30565913|NCT01386684|58572650|FG000|Overall Study|Other|51|||
30565914|NCT01386684|58572650|FG000|Overall Study|Death|47|||
30565915|NCT01386684|58572650|FG000|Overall Study|Withdrawal of Consent|44|||
30565916|NCT01386684|58572650|FG000|Overall Study|Alternative Therapy Required|37|||
30565917|NCT01386684|58572650|FG000|Overall Study|Disease Progression|28|||
30565918|NCT01386684|58572650|FG000|Overall Study|Adverse Event|20|||
30565919|NCT01386684|58572650|FG000|Overall Study|Noncompliance|8|||
30565920|NCT01386684|58572650|FG000|Overall Study|Protocol Violation|4|||
30565921|NCT01386684|58572650|FG000|Overall Study|Missing|3|||
30565922|NCT04980014|58572667|FG000|Overall Study|Participants who are Duplicated|1|||
30565923|NCT04980014|58572667|FG000|Overall Study|Follow-up Failure|13|||
30565924|NCT04980014|58572667|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
30565925|NCT04980014|58572667|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
30565926|NCT04980014|58572667|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
30565927|NCT03735849|58572691|FG000|Overall Study|Lost to Follow-up|1|||
30565928|NCT03735849|58572692|FG001|Overall Study|Lost to Follow-up|0|||
30565929|NCT03735849|58572693|FG002|Overall Study|Lost to Follow-up|0|||
30565930|NCT03735849|58572691|FG000|Overall Study|Participant unable to adhere to visit|1|||
30565931|NCT03735849|58572692|FG001|Overall Study|Participant unable to adhere to visit|0|||
30565932|NCT03735849|58572693|FG002|Overall Study|Participant unable to adhere to visit|0|||
30565933|NCT03735849|58572691|FG000|Overall Study|Not Randomized|0|||
30565934|NCT03735849|58572692|FG001|Overall Study|Not Randomized|0|||
30565935|NCT03735849|58572693|FG002|Overall Study|Not Randomized|4|||
30565936|NCT03552393|58572700|FG000|Core Period|Kidney Transplant|1|||
30565937|NCT03552393|58572700|FG000|Core Period|Prohibited Medication|1|||
30565938|NCT03552393|58572700|FG000|Safety Extension Period|Kidney Transplant|4|||
30565939|NCT03333382|58572706|FG000|Overall Study|Lost to Follow-up|1|||
30565940|NCT03333382|58572707|FG001|Overall Study|Lost to Follow-up|0|||
30565941|NCT03107611|58572746|FG000|Overall Study|Adverse Event|1|||
30565942|NCT03107611|58572747|FG001|Overall Study|Adverse Event|0|||
30565943|NCT03107611|58572748|FG002|Overall Study|Adverse Event|2|||
30565944|NCT03107611|58572746|FG000|Overall Study|Lost to Follow-up|3|||
30565945|NCT03107611|58572747|FG001|Overall Study|Lost to Follow-up|3|||
30565946|NCT03107611|58572748|FG002|Overall Study|Lost to Follow-up|3|||
30565947|NCT03107611|58572746|FG000|Overall Study|Protocol Violation|0|||
30565948|NCT03107611|58572747|FG001|Overall Study|Protocol Violation|0|||
30565949|NCT03107611|58572748|FG002|Overall Study|Protocol Violation|1|||
30565950|NCT03107611|58572746|FG000|Overall Study|Withdrawal by Subject|1|||
30565951|NCT03107611|58572747|FG001|Overall Study|Withdrawal by Subject|0|||
30565952|NCT03107611|58572748|FG002|Overall Study|Withdrawal by Subject|1|||
30565953|NCT03107611|58572746|FG000|Overall Study|Worsening signs/symptoms|2|||
30565954|NCT03107611|58572747|FG001|Overall Study|Worsening signs/symptoms|1|||
30565955|NCT03107611|58572748|FG002|Overall Study|Worsening signs/symptoms|2|||
30565956|NCT02720016|58572759|FG000|Overall Study|Separation of couple|6|||
30565957|NCT02720016|58572760|FG001|Overall Study|Separation of couple|8|||
30565958|NCT02720016|58572761|FG002|Overall Study|Separation of couple|2|||
30565959|NCT02720016|58572759|FG000|Overall Study|Withdrawal by Subject|6|||
30565960|NCT02720016|58572760|FG001|Overall Study|Withdrawal by Subject|6|||
30565961|NCT02720016|58572761|FG002|Overall Study|Withdrawal by Subject|4|||
30565962|NCT02720016|58572759|FG000|Overall Study|Scheduling issues|2|||
30565963|NCT02720016|58572760|FG001|Overall Study|Scheduling issues|4|||
30565964|NCT02720016|58572761|FG002|Overall Study|Scheduling issues|7|||
30565965|NCT02720016|58572759|FG000|Overall Study|Childcare|2|||
30565966|NCT02720016|58572760|FG001|Overall Study|Childcare|0|||
30565967|NCT02720016|58572761|FG002|Overall Study|Childcare|2|||
30565968|NCT02720016|58572759|FG000|Overall Study|Withdrawal by PI|2|||
30565969|NCT02720016|58572760|FG001|Overall Study|Withdrawal by PI|2|||
30565970|NCT02720016|58572761|FG002|Overall Study|Withdrawal by PI|0|||
30565971|NCT02720016|58572759|FG000|Overall Study|Moved away|2|||
30565972|NCT02720016|58572760|FG001|Overall Study|Moved away|0|||
30565973|NCT02720016|58572761|FG002|Overall Study|Moved away|0|||
30565974|NCT02720016|58572759|FG000|Overall Study|Not Primary Health Concern|0|||
30565975|NCT02720016|58572760|FG001|Overall Study|Not Primary Health Concern|0|||
30565976|NCT02720016|58572761|FG002|Overall Study|Not Primary Health Concern|2|||
30565977|NCT02720016|58572759|FG000|Overall Study|Transportation issues|0|||
30565978|NCT02720016|58572760|FG001|Overall Study|Transportation issues|0|||
30565979|NCT02720016|58572761|FG002|Overall Study|Transportation issues|1|||
30565980|NCT02720016|58572759|FG000|Overall Study|Other|0|||
30666588|NCT00869778|58680449|FG000|Overall Study|Withdrawal by Subject|3|||
30666589|NCT00869778|58680450|FG001|Overall Study|Withdrawal by Subject|4|||
30666590|NCT00869778|58680451|FG002|Overall Study|Withdrawal by Subject|5|||
30666591|NCT00869778|58680449|FG000|Overall Study|Pregnancy|1|||
30666592|NCT00869778|58680450|FG001|Overall Study|Pregnancy|0|||
30666593|NCT00869778|58680451|FG002|Overall Study|Pregnancy|0|||
30666594|NCT00869778|58680449|FG000|Overall Study|Protocol Violation|5|||
30666595|NCT00869778|58680450|FG001|Overall Study|Protocol Violation|3|||
30666596|NCT00869778|58680451|FG002|Overall Study|Protocol Violation|5|||
30666597|NCT00869778|58680449|FG000|Overall Study|Unblinding|1|||
30666598|NCT00869778|58680450|FG001|Overall Study|Unblinding|0|||
30666599|NCT00869778|58680451|FG002|Overall Study|Unblinding|0|||
30666600|NCT00711958|58680482|FG000|Overall Study|Withdrawal by Subject|6|||
30666601|NCT00711958|58680483|FG001|Overall Study|Withdrawal by Subject|8|||
30666602|NCT00711958|58680482|FG000|Overall Study|Lack of Efficacy|3|||
30666603|NCT00711958|58680483|FG001|Overall Study|Lack of Efficacy|1|||
30666604|NCT00711958|58680482|FG000|Overall Study|Clinical deterioration|1|||
30666605|NCT00711958|58680483|FG001|Overall Study|Clinical deterioration|0|||
30666606|NCT00711958|58680482|FG000|Overall Study|Adverse Event|9|||
30666607|NCT00711958|58680483|FG001|Overall Study|Adverse Event|7|||
30666608|NCT00711958|58680482|FG000|Overall Study|Protocol Violation|1|||
30666609|NCT00711958|58680483|FG001|Overall Study|Protocol Violation|0|||
30565981|NCT02720016|58572760|FG001|Overall Study|Other|0|||
30565982|NCT02720016|58572761|FG002|Overall Study|Other|2|||
30565983|NCT02607956|58572772|FG000|Double-Blinded Phase|Withdrew Consent|17|||
30666610|NCT00711958|58680482|FG000|Overall Study|Lost to Follow-up|2|||
30666611|NCT00711958|58680483|FG001|Overall Study|Lost to Follow-up|2|||
30565984|NCT02607956|58572773|FG001|Double-Blinded Phase|Withdrew Consent|19|||
30565985|NCT02607956|58572774|FG002|Double-Blinded Phase|Withdrew Consent|0|||
30565986|NCT02607956|58572775|FG003|Double-Blinded Phase|Withdrew Consent|0|||
30666612|NCT00711958|58680482|FG000|Overall Study|Death|10|||
30666613|NCT00711958|58680483|FG001|Overall Study|Death|5|||
30666614|NCT00711958|58680482|FG000|Overall Study|Progression of disease|1|||
30565987|NCT02607956|58572772|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
30565988|NCT02607956|58572773|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
30565989|NCT02607956|58572774|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
30565990|NCT02607956|58572775|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
30565991|NCT02607956|58572772|FG000|Double-Blinded Phase|Randomized but never treated|7|||
30565992|NCT02607956|58572773|FG001|Double-Blinded Phase|Randomized but never treated|5|||
30666615|NCT00711958|58680483|FG001|Overall Study|Progression of disease|0|||
30565993|NCT02607956|58572774|FG002|Double-Blinded Phase|Randomized but never treated|0|||
30565994|NCT02607956|58572775|FG003|Double-Blinded Phase|Randomized but never treated|0|||
30565995|NCT02607956|58572772|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
30565996|NCT02607956|58572773|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
30565997|NCT02607956|58572774|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
30565998|NCT02607956|58572775|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
30565999|NCT02607956|58572772|FG000|Double-Blinded Phase|Death|4|||
30566000|NCT02607956|58572773|FG001|Double-Blinded Phase|Death|4|||
30566001|NCT02607956|58572774|FG002|Double-Blinded Phase|Death|0|||
30566002|NCT02607956|58572775|FG003|Double-Blinded Phase|Death|0|||
30566003|NCT02607956|58572772|FG000|Double-Blinded Phase|Adverse Event|4|||
30566004|NCT02607956|58572773|FG001|Double-Blinded Phase|Adverse Event|3|||
30566005|NCT02607956|58572774|FG002|Double-Blinded Phase|Adverse Event|0|||
30566006|NCT02607956|58572775|FG003|Double-Blinded Phase|Adverse Event|0|||
30566007|NCT02607956|58572772|FG000|Double-Blinded Phase|Protocol Violation|3|||
30566008|NCT02607956|58572773|FG001|Double-Blinded Phase|Protocol Violation|1|||
30566009|NCT02607956|58572774|FG002|Double-Blinded Phase|Protocol Violation|0|||
30566010|NCT02607956|58572775|FG003|Double-Blinded Phase|Protocol Violation|0|||
30566011|NCT02607956|58572772|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
30566012|NCT02607956|58572773|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
30566013|NCT02607956|58572774|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
30566014|NCT02607956|58572775|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
30566015|NCT02607956|58572772|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
30566016|NCT02607956|58572773|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
30566017|NCT02607956|58572774|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
30566018|NCT02607956|58572775|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
30566019|NCT02607956|58572772|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
30566020|NCT02607956|58572773|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
30566021|NCT02607956|58572774|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
30566022|NCT02607956|58572775|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
30566023|NCT02607956|58572772|FG000|Open-Label Extension Phase|Death|0|||
30566024|NCT02607956|58572773|FG001|Open-Label Extension Phase|Death|0|||
30566025|NCT02607956|58572774|FG002|Open-Label Extension Phase|Death|1|||
30566026|NCT02607956|58572775|FG003|Open-Label Extension Phase|Death|3|||
30566027|NCT02607956|58572772|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
30566028|NCT02607956|58572773|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
30566029|NCT02607956|58572774|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
30566030|NCT02607956|58572775|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
30566031|NCT02607956|58572772|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
30566032|NCT02607956|58572773|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
30566033|NCT02607956|58572774|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
30566034|NCT02607956|58572775|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
30566035|NCT02607956|58572772|FG000|Open-Label Extension Phase|Protocol Violation|0|||
30566036|NCT02607956|58572773|FG001|Open-Label Extension Phase|Protocol Violation|0|||
30566037|NCT02607956|58572774|FG002|Open-Label Extension Phase|Protocol Violation|0|||
30566038|NCT02607956|58572775|FG003|Open-Label Extension Phase|Protocol Violation|2|||
30566039|NCT02607956|58572772|FG000|Open-Label Extension Phase|Pregnancy|0|||
30566040|NCT02607956|58572773|FG001|Open-Label Extension Phase|Pregnancy|0|||
30566041|NCT02607956|58572774|FG002|Open-Label Extension Phase|Pregnancy|0|||
30566042|NCT02607956|58572775|FG003|Open-Label Extension Phase|Pregnancy|1|||
30566043|NCT02564523|58572805|FG000|Overall Study|Withdrawal by Subject|3|||
30566044|NCT02564523|58572806|FG001|Overall Study|Withdrawal by Subject|0|||
30566045|NCT02564523|58572807|FG002|Overall Study|Withdrawal by Subject|1|||
30566046|NCT02564523|58572808|FG003|Overall Study|Withdrawal by Subject|0|||
30566047|NCT02564523|58572809|FG004|Overall Study|Withdrawal by Subject|1|||
30566048|NCT02564523|58572810|FG005|Overall Study|Withdrawal by Subject|0|||
30566049|NCT02564523|58572811|FG006|Overall Study|Withdrawal by Subject|1|||
30566050|NCT02564523|58572812|FG007|Overall Study|Withdrawal by Subject|0|||
30566051|NCT02564523|58572813|FG008|Overall Study|Withdrawal by Subject|0|||
30566052|NCT02564523|58572814|FG009|Overall Study|Withdrawal by Subject|0|||
30566053|NCT02564523|58572815|FG010|Overall Study|Withdrawal by Subject|1|||
30566054|NCT02564523|58572816|FG011|Overall Study|Withdrawal by Subject|0|||
30566055|NCT02564523|58572817|FG012|Overall Study|Withdrawal by Subject|1|||
30566056|NCT02564523|58572818|FG013|Overall Study|Withdrawal by Subject|0|||
30566057|NCT02564523|58572819|FG014|Overall Study|Withdrawal by Subject|0|||
30566058|NCT02564523|58572820|FG015|Overall Study|Withdrawal by Subject|0|||
30566059|NCT02564523|58572821|FG016|Overall Study|Withdrawal by Subject|0|||
30566060|NCT02564523|58572822|FG017|Overall Study|Withdrawal by Subject|0|||
30566061|NCT02564523|58572805|FG000|Overall Study|Adverse Event|0|||
30566062|NCT02564523|58572806|FG001|Overall Study|Adverse Event|0|||
30566063|NCT02564523|58572807|FG002|Overall Study|Adverse Event|0|||
30566064|NCT02564523|58572808|FG003|Overall Study|Adverse Event|0|||
30566065|NCT02564523|58572809|FG004|Overall Study|Adverse Event|0|||
30566066|NCT02564523|58572810|FG005|Overall Study|Adverse Event|0|||
30566067|NCT02564523|58572811|FG006|Overall Study|Adverse Event|0|||
30566068|NCT02564523|58572812|FG007|Overall Study|Adverse Event|0|||
30566069|NCT02564523|58572813|FG008|Overall Study|Adverse Event|0|||
30566070|NCT02564523|58572814|FG009|Overall Study|Adverse Event|0|||
30566071|NCT02564523|58572815|FG010|Overall Study|Adverse Event|0|||
30566072|NCT02564523|58572816|FG011|Overall Study|Adverse Event|0|||
30566073|NCT02564523|58572817|FG012|Overall Study|Adverse Event|0|||
30566074|NCT02564523|58572818|FG013|Overall Study|Adverse Event|0|||
30566075|NCT02564523|58572819|FG014|Overall Study|Adverse Event|0|||
30566076|NCT02564523|58572820|FG015|Overall Study|Adverse Event|0|||
30566077|NCT02564523|58572821|FG016|Overall Study|Adverse Event|0|||
30566078|NCT02564523|58572822|FG017|Overall Study|Adverse Event|1|||
30566079|NCT02564523|58572805|FG000|Overall Study|Death|0|||
30566080|NCT02564523|58572806|FG001|Overall Study|Death|0|||
30566081|NCT02564523|58572807|FG002|Overall Study|Death|0|||
30566082|NCT02564523|58572808|FG003|Overall Study|Death|0|||
30566083|NCT02564523|58572809|FG004|Overall Study|Death|0|||
30566084|NCT02564523|58572810|FG005|Overall Study|Death|0|||
30566085|NCT02564523|58572811|FG006|Overall Study|Death|1|||
30566086|NCT02564523|58572812|FG007|Overall Study|Death|0|||
30566087|NCT02564523|58572813|FG008|Overall Study|Death|0|||
30566088|NCT02564523|58572814|FG009|Overall Study|Death|0|||
30566089|NCT02564523|58572815|FG010|Overall Study|Death|1|||
30566090|NCT02564523|58572816|FG011|Overall Study|Death|0|||
30566091|NCT02564523|58572817|FG012|Overall Study|Death|0|||
30566092|NCT02564523|58572818|FG013|Overall Study|Death|0|||
30566093|NCT02564523|58572819|FG014|Overall Study|Death|0|||
30566094|NCT02564523|58572820|FG015|Overall Study|Death|0|||
30566095|NCT02564523|58572821|FG016|Overall Study|Death|0|||
30566096|NCT02564523|58572822|FG017|Overall Study|Death|0|||
30566097|NCT02564523|58572805|FG000|Overall Study|Lost to Follow-up|2|||
30566098|NCT02564523|58572806|FG001|Overall Study|Lost to Follow-up|1|||
30566099|NCT02564523|58572807|FG002|Overall Study|Lost to Follow-up|4|||
30566100|NCT02564523|58572808|FG003|Overall Study|Lost to Follow-up|0|||
30566101|NCT02564523|58572809|FG004|Overall Study|Lost to Follow-up|1|||
30566102|NCT02564523|58572810|FG005|Overall Study|Lost to Follow-up|0|||
30566103|NCT02564523|58572811|FG006|Overall Study|Lost to Follow-up|1|||
30566104|NCT02564523|58572812|FG007|Overall Study|Lost to Follow-up|0|||
30566105|NCT02564523|58572813|FG008|Overall Study|Lost to Follow-up|0|||
30566106|NCT02564523|58572814|FG009|Overall Study|Lost to Follow-up|0|||
30566107|NCT02564523|58572815|FG010|Overall Study|Lost to Follow-up|0|||
30566108|NCT02564523|58572816|FG011|Overall Study|Lost to Follow-up|1|||
30566109|NCT02564523|58572817|FG012|Overall Study|Lost to Follow-up|1|||
30566110|NCT02564523|58572818|FG013|Overall Study|Lost to Follow-up|0|||
30566111|NCT02564523|58572819|FG014|Overall Study|Lost to Follow-up|0|||
30566112|NCT02564523|58572820|FG015|Overall Study|Lost to Follow-up|0|||
30566113|NCT02564523|58572821|FG016|Overall Study|Lost to Follow-up|0|||
30566114|NCT02564523|58572822|FG017|Overall Study|Lost to Follow-up|0|||
30566115|NCT02564523|58572805|FG000|Overall Study|Physician Decision|0|||
30566116|NCT02564523|58572806|FG001|Overall Study|Physician Decision|0|||
30566117|NCT02564523|58572807|FG002|Overall Study|Physician Decision|0|||
30566118|NCT02564523|58572808|FG003|Overall Study|Physician Decision|0|||
30566119|NCT02564523|58572809|FG004|Overall Study|Physician Decision|1|||
30566120|NCT02564523|58572810|FG005|Overall Study|Physician Decision|0|||
30566121|NCT02564523|58572811|FG006|Overall Study|Physician Decision|0|||
30566122|NCT02564523|58572812|FG007|Overall Study|Physician Decision|0|||
30566123|NCT02564523|58572813|FG008|Overall Study|Physician Decision|0|||
30566124|NCT02564523|58572814|FG009|Overall Study|Physician Decision|0|||
30566125|NCT02564523|58572815|FG010|Overall Study|Physician Decision|1|||
30566126|NCT02564523|58572816|FG011|Overall Study|Physician Decision|0|||
30666616|NCT00711880|58680491|FG000|Overall Study|Adverse Event|11|||
30566127|NCT02564523|58572817|FG012|Overall Study|Physician Decision|0|||
30566128|NCT02564523|58572818|FG013|Overall Study|Physician Decision|0|||
30566129|NCT02564523|58572819|FG014|Overall Study|Physician Decision|0|||
30566130|NCT02564523|58572820|FG015|Overall Study|Physician Decision|0|||
30566131|NCT02564523|58572821|FG016|Overall Study|Physician Decision|0|||
30566132|NCT02564523|58572822|FG017|Overall Study|Physician Decision|0|||
30566133|NCT02564523|58572805|FG000|Overall Study|Protocol Violation|2|||
30566134|NCT02564523|58572806|FG001|Overall Study|Protocol Violation|2|||
30566135|NCT02564523|58572807|FG002|Overall Study|Protocol Violation|5|||
30566136|NCT02564523|58572808|FG003|Overall Study|Protocol Violation|0|||
30566137|NCT02564523|58572809|FG004|Overall Study|Protocol Violation|1|||
30566138|NCT02564523|58572810|FG005|Overall Study|Protocol Violation|0|||
30566139|NCT02564523|58572811|FG006|Overall Study|Protocol Violation|0|||
30566140|NCT02564523|58572812|FG007|Overall Study|Protocol Violation|0|||
30566141|NCT02564523|58572813|FG008|Overall Study|Protocol Violation|0|||
30566142|NCT02564523|58572814|FG009|Overall Study|Protocol Violation|0|||
30566143|NCT02564523|58572815|FG010|Overall Study|Protocol Violation|0|||
30566144|NCT02564523|58572816|FG011|Overall Study|Protocol Violation|0|||
30566145|NCT02564523|58572817|FG012|Overall Study|Protocol Violation|0|||
30566146|NCT02564523|58572818|FG013|Overall Study|Protocol Violation|0|||
30566147|NCT02564523|58572819|FG014|Overall Study|Protocol Violation|0|||
30566148|NCT02564523|58572820|FG015|Overall Study|Protocol Violation|0|||
30566149|NCT02564523|58572821|FG016|Overall Study|Protocol Violation|0|||
30566150|NCT02564523|58572822|FG017|Overall Study|Protocol Violation|0|||
30566151|NCT02564523|58572805|FG000|Overall Study|Other|3|||
30566152|NCT02564523|58572806|FG001|Overall Study|Other|0|||
30566153|NCT02564523|58572807|FG002|Overall Study|Other|0|||
30566154|NCT02564523|58572808|FG003|Overall Study|Other|1|||
30566155|NCT02564523|58572809|FG004|Overall Study|Other|0|||
30566156|NCT02564523|58572810|FG005|Overall Study|Other|0|||
30566157|NCT02564523|58572811|FG006|Overall Study|Other|0|||
30566158|NCT02564523|58572812|FG007|Overall Study|Other|0|||
30566159|NCT02564523|58572813|FG008|Overall Study|Other|0|||
30566160|NCT02564523|58572814|FG009|Overall Study|Other|0|||
30566161|NCT02564523|58572815|FG010|Overall Study|Other|0|||
30566162|NCT02564523|58572816|FG011|Overall Study|Other|0|||
30566163|NCT02564523|58572817|FG012|Overall Study|Other|0|||
30566164|NCT02564523|58572818|FG013|Overall Study|Other|0|||
30566165|NCT02564523|58572819|FG014|Overall Study|Other|0|||
30566166|NCT02564523|58572820|FG015|Overall Study|Other|0|||
30566167|NCT02564523|58572821|FG016|Overall Study|Other|0|||
30566168|NCT02564523|58572822|FG017|Overall Study|Other|0|||
30566169|NCT01447628|58572929|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
30566170|NCT01447628|58572930|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
30566171|NCT01447628|58572931|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
30566172|NCT01447628|58572932|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
30566173|NCT00515853|58572954|FG000|Overall Study|Lost to Follow-up|9|||
30566174|NCT00515853|58572955|FG001|Overall Study|Lost to Follow-up|13|||
30566175|NCT00515853|58572954|FG000|Overall Study|Withdrawal by Subject|6|||
30566176|NCT00515853|58572955|FG001|Overall Study|Withdrawal by Subject|4|||
30566177|NCT00003458|58572961|FG000|Overall Study|Not evaluable|4|||
30566178|NCT05032872|58572968|FG000|Overall Study|Adverse Event|1|||
30566179|NCT05032872|58572969|FG001|Overall Study|Adverse Event|0|||
30566180|NCT05032872|58572968|FG000|Overall Study|Lost to Follow-up|2|||
30566181|NCT05032872|58572969|FG001|Overall Study|Lost to Follow-up|4|||
30566182|NCT05032872|58572968|FG000|Overall Study|Withdrawal by Subject|4|||
30566183|NCT05032872|58572969|FG001|Overall Study|Withdrawal by Subject|3|||
30566184|NCT04613739|58572995|FG000|Overall Study|Lost to Follow-up|6|||
30566185|NCT04613739|58572996|FG001|Overall Study|Lost to Follow-up|9|||
30566186|NCT04613739|58572995|FG000|Overall Study|potentially duplicative/fraudulent|1|||
30566187|NCT04613739|58572996|FG001|Overall Study|potentially duplicative/fraudulent|3|||
30566188|NCT04407806|58573023|FG000|Overall Study|Withdrawal by Subject|1|||
30566189|NCT04407806|58573024|FG001|Overall Study|Withdrawal by Subject|2|||
30566190|NCT04324021|58573033|FG000|Overall Study|Adverse Event|1|||
30566191|NCT04324021|58573034|FG001|Overall Study|Adverse Event|0|||
30566192|NCT04324021|58573035|FG002|Overall Study|Adverse Event|0|||
30566193|NCT04324021|58573033|FG000|Overall Study|Lack of Efficacy|0|||
30566194|NCT04324021|58573034|FG001|Overall Study|Lack of Efficacy|0|||
30566195|NCT04324021|58573035|FG002|Overall Study|Lack of Efficacy|1|||
30566196|NCT04324021|58573033|FG000|Overall Study|Death|1|||
30566197|NCT04324021|58573034|FG001|Overall Study|Death|1|||
30566198|NCT04324021|58573035|FG002|Overall Study|Death|0|||
30566199|NCT04209621|58573046|FG000|Overall Study|Death|1|||
30566200|NCT04209621|58573046|FG000|Overall Study|Study Terminated Early|2|||
30566201|NCT04186663|58573051|FG000|Overall Study|Lost to Follow-up|1|||
30566202|NCT04186663|58573051|FG000|Overall Study|Unable to complete blood draw|3|||
30566203|NCT04158219|58573055|FG000|Overall Study|Lost to Follow-up|1|||
30566204|NCT03954743|58573088|FG000|Overall Study|Adverse Event|1|||
30566205|NCT03954743|58573089|FG001|Overall Study|Adverse Event|0|||
30566206|NCT03954743|58573088|FG000|Overall Study|Lost to Follow-up|6|||
30566207|NCT03954743|58573089|FG001|Overall Study|Lost to Follow-up|4|||
30566208|NCT03954743|58573088|FG000|Overall Study|Protocol Violation|1|||
30566209|NCT03954743|58573089|FG001|Overall Study|Protocol Violation|0|||
30566210|NCT03954743|58573088|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
30666617|NCT00711880|58680492|FG001|Overall Study|Adverse Event|2|||
30566211|NCT03954743|58573089|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
30566212|NCT03954743|58573088|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
30566213|NCT03954743|58573089|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
30566214|NCT03880565|58573110|FG000|Overall Study|Withdrawal by Subject|1|||
30566215|NCT03880565|58573111|FG001|Overall Study|Withdrawal by Subject|0|||
30566216|NCT03782792|58573119|FG000|Overall Study|Patient left the country|0|||
30566217|NCT03782792|58573120|FG001|Overall Study|Patient left the country|1|||
30566218|NCT03782792|58573119|FG000|Overall Study|Withdrawal by Subject|1|||
30566219|NCT03782792|58573120|FG001|Overall Study|Withdrawal by Subject|2|||
30566220|NCT03733119|58573130|FG000|Overall Study|Physician Decision|2|||
30566221|NCT03733119|58573131|FG001|Overall Study|Physician Decision|1|||
30566222|NCT03733119|58573130|FG000|Overall Study|ineligible to treat per protocol|0|||
30566223|NCT03733119|58573131|FG001|Overall Study|ineligible to treat per protocol|1|||
30566224|NCT03661996|58573142|FG000|Overall Study|Adverse Event|0|||
30566225|NCT03661996|58573143|FG001|Overall Study|Adverse Event|0|||
30566226|NCT03661996|58573144|FG002|Overall Study|Adverse Event|1|||
30566227|NCT03661996|58573145|FG003|Overall Study|Adverse Event|1|||
30566228|NCT03661996|58573146|FG004|Overall Study|Adverse Event|0|||
30566229|NCT03661996|58573142|FG000|Overall Study|Lost to Follow-up|5|||
30566230|NCT03661996|58573143|FG001|Overall Study|Lost to Follow-up|1|||
30566231|NCT03661996|58573144|FG002|Overall Study|Lost to Follow-up|2|||
30566232|NCT03661996|58573145|FG003|Overall Study|Lost to Follow-up|2|||
30566233|NCT03661996|58573146|FG004|Overall Study|Lost to Follow-up|6|||
30566234|NCT03661996|58573142|FG000|Overall Study|Physician Decision|1|||
30566235|NCT03661996|58573143|FG001|Overall Study|Physician Decision|1|||
30566236|NCT03661996|58573144|FG002|Overall Study|Physician Decision|1|||
30566237|NCT03661996|58573145|FG003|Overall Study|Physician Decision|2|||
30566238|NCT03661996|58573146|FG004|Overall Study|Physician Decision|0|||
30566239|NCT03661996|58573142|FG000|Overall Study|Protocol Violation|0|||
30566240|NCT03661996|58573143|FG001|Overall Study|Protocol Violation|0|||
30566241|NCT03661996|58573144|FG002|Overall Study|Protocol Violation|0|||
30566242|NCT03661996|58573145|FG003|Overall Study|Protocol Violation|0|||
30566243|NCT03661996|58573146|FG004|Overall Study|Protocol Violation|1|||
30566244|NCT03661996|58573142|FG000|Overall Study|Withdrawal by Subject|3|||
30566245|NCT03661996|58573143|FG001|Overall Study|Withdrawal by Subject|5|||
30566246|NCT03661996|58573144|FG002|Overall Study|Withdrawal by Subject|1|||
30566247|NCT03661996|58573145|FG003|Overall Study|Withdrawal by Subject|7|||
30566248|NCT03661996|58573146|FG004|Overall Study|Withdrawal by Subject|7|||
30566249|NCT03661996|58573142|FG000|Overall Study|Sponsors Decision|2|||
30566250|NCT03661996|58573143|FG001|Overall Study|Sponsors Decision|0|||
30566251|NCT03661996|58573144|FG002|Overall Study|Sponsors Decision|0|||
30566252|NCT03661996|58573145|FG003|Overall Study|Sponsors Decision|0|||
30566253|NCT03661996|58573146|FG004|Overall Study|Sponsors Decision|0|||
30566254|NCT03661996|58573142|FG000|Overall Study|Other|1|||
30566255|NCT03661996|58573143|FG001|Overall Study|Other|1|||
30566256|NCT03661996|58573144|FG002|Overall Study|Other|1|||
30566257|NCT03661996|58573145|FG003|Overall Study|Other|1|||
30566258|NCT03661996|58573146|FG004|Overall Study|Other|0|||
30566259|NCT03633461|58573163|FG000|Overall Study|Lost to Follow-up|0|||
30566260|NCT03633461|58573164|FG001|Overall Study|Lost to Follow-up|1|||
30566261|NCT03499314|58573192|FG000|Overall Study|Time Commitment|1|||
30566262|NCT03499314|58573193|FG001|Overall Study|Time Commitment|2|||
30566263|NCT03499314|58573192|FG000|Overall Study|Medical issue unrelated to research study|1|||
30566264|NCT03499314|58573193|FG001|Overall Study|Medical issue unrelated to research study|1|||
30566265|NCT03369431|58573201|FG000|Overall Study|Lost to Follow-up|1|||
30566266|NCT03369431|58573202|FG001|Overall Study|Lost to Follow-up|3|||
30566267|NCT03369431|58573201|FG000|Overall Study|Withdrawal by Subject|2|||
30566268|NCT03369431|58573202|FG001|Overall Study|Withdrawal by Subject|3|||
30566269|NCT03369431|58573201|FG000|Overall Study|Protocol Violation|1|||
30566270|NCT03369431|58573202|FG001|Overall Study|Protocol Violation|1|||
30566271|NCT03336866|58573211|FG000|Overall Study|Lost to Follow-up|2|||
30566272|NCT03336866|58573212|FG001|Overall Study|Lost to Follow-up|0|||
30566273|NCT03336866|58573213|FG002|Overall Study|Lost to Follow-up|3|||
30566274|NCT03336866|58573211|FG000|Overall Study|Withdrawal by Subject|1|||
30566275|NCT03336866|58573212|FG001|Overall Study|Withdrawal by Subject|1|||
30566276|NCT03336866|58573213|FG002|Overall Study|Withdrawal by Subject|0|||
30566277|NCT03336866|58573211|FG000|Overall Study|Noncompliance with clinic house rules|0|||
30566278|NCT03336866|58573212|FG001|Overall Study|Noncompliance with clinic house rules|0|||
30566279|NCT03336866|58573213|FG002|Overall Study|Noncompliance with clinic house rules|1|||
30566280|NCT03332173|58573226|FG000|Overall Study|Death|7|||
30566281|NCT03332173|58573226|FG000|Overall Study|Withdrawal by Subject|6|||
30566282|NCT03332173|58573226|FG000|Overall Study|Lost to Follow-up|2|||
30566283|NCT03332173|58573226|FG000|Overall Study|Transferred to long-term extension study|29|||
30566284|NCT03322293|58573233|FG000|Overall Study|Lost to Follow-up|0|||
30566285|NCT03322293|58573234|FG001|Overall Study|Lost to Follow-up|0|||
30566286|NCT03322293|58573235|FG002|Overall Study|Lost to Follow-up|1|||
30566287|NCT03254394|58573257|FG000|Overall Study|Withdrawal by Subject|0|||
30566288|NCT03254394|58573258|FG001|Overall Study|Withdrawal by Subject|2|||
30566289|NCT03253809|58573264|FG000|Overall Study|Unable to obtain study related data|14|||
30566290|NCT02998476|58573343|FG000|Overall Study|Lost to Follow-up|1|||
30566291|NCT02998476|58573344|FG001|Overall Study|Lost to Follow-up|0|||
30566292|NCT02998476|58573343|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
30566293|NCT02998476|58573344|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
30566294|NCT02998476|58573343|FG000|Overall Study|Withdrawal by Subject|1|||
30566295|NCT02998476|58573344|FG001|Overall Study|Withdrawal by Subject|2|||
30566296|NCT02998476|58573343|FG000|Overall Study|Death|45|||
30566297|NCT02998476|58573344|FG001|Overall Study|Death|2|||
30566298|NCT02998476|58573343|FG000|Overall Study|Other|6|||
30566299|NCT02998476|58573344|FG001|Overall Study|Other|1|||
30566300|NCT02924064|58573362|FG000|Overall Study|Adverse Event|2|||
30566301|NCT02924064|58573363|FG001|Overall Study|Adverse Event|2|||
30566302|NCT02924064|58573362|FG000|Overall Study|Lost to Follow-up|0|||
30566303|NCT02924064|58573363|FG001|Overall Study|Lost to Follow-up|2|||
30566304|NCT02924064|58573362|FG000|Overall Study|Physician Decision|0|||
30566305|NCT02924064|58573363|FG001|Overall Study|Physician Decision|2|||
30566306|NCT02924064|58573362|FG000|Overall Study|Protocol Violation|1|||
30566307|NCT02924064|58573363|FG001|Overall Study|Protocol Violation|3|||
30566308|NCT02924064|58573362|FG000|Overall Study|Withdrawal by Subject|4|||
30566309|NCT02924064|58573363|FG001|Overall Study|Withdrawal by Subject|5|||
30566310|NCT02924064|58573362|FG000|Overall Study|Other|17|||
30566311|NCT02924064|58573363|FG001|Overall Study|Other|29|||
30566312|NCT02916706|58573371|FG000|Overall Study|Adverse Event|0|||
30566313|NCT02916706|58573372|FG001|Overall Study|Adverse Event|1|||
30566314|NCT02916706|58573371|FG000|Overall Study|Lost to Follow-up|0|||
30566315|NCT02916706|58573372|FG001|Overall Study|Lost to Follow-up|1|||
30566316|NCT02916706|58573371|FG000|Overall Study|Physician Decision|1|||
30566317|NCT02916706|58573372|FG001|Overall Study|Physician Decision|0|||
30566318|NCT02916706|58573371|FG000|Overall Study|Protocol Violation|3|||
30566319|NCT02916706|58573372|FG001|Overall Study|Protocol Violation|1|||
30566320|NCT02916706|58573371|FG000|Overall Study|Withdrawal by Subject|6|||
30566321|NCT02916706|58573372|FG001|Overall Study|Withdrawal by Subject|9|||
30566322|NCT02916706|58573371|FG000|Overall Study|Other|5|||
30566323|NCT02916706|58573372|FG001|Overall Study|Other|19|||
30566324|NCT02889900|58573378|FG000|Overall Study|Adverse Event|11|||
30566325|NCT02889900|58573378|FG000|Overall Study|Condition under investigation worsened|32|||
30566326|NCT02889900|58573378|FG000|Overall Study|Other|5|||
30566327|NCT02889900|58573378|FG000|Overall Study|Withdrawal by Subject|7|||
30566328|NCT02889900|58573378|FG000|Overall Study|Not treated|2|||
30566329|NCT02866695|58573382|FG000|Overall Study|Adverse Event|1|||
30566330|NCT02866695|58573382|FG000|Overall Study|Lost to Follow-up|1|||
30566331|NCT02834793|58573388|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
30566332|NCT02834793|58573389|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
30566333|NCT02834793|58573390|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
30566334|NCT02834793|58573391|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
30566335|NCT02834793|58573388|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
30566336|NCT02834793|58573389|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
30566337|NCT02834793|58573390|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
30566338|NCT02834793|58573391|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
30566339|NCT02834793|58573388|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
30566340|NCT02834793|58573389|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
30566341|NCT02834793|58573390|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
30566342|NCT02834793|58573391|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
30566343|NCT02834793|58573388|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
30566344|NCT02834793|58573389|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
30566345|NCT02834793|58573390|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
30566346|NCT02834793|58573391|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
30566347|NCT02834793|58573388|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
30566348|NCT02834793|58573389|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
30566349|NCT02834793|58573390|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
30566350|NCT02834793|58573391|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
30566351|NCT02834793|58573388|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
30566352|NCT02834793|58573389|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
30566353|NCT02834793|58573390|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
30566354|NCT02834793|58573391|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
30566355|NCT02834793|58573388|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
30566356|NCT02834793|58573389|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
30566357|NCT02834793|58573390|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
30566358|NCT02834793|58573391|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
30566359|NCT02834793|58573388|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
30566360|NCT02834793|58573389|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
30566361|NCT02834793|58573390|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
30566362|NCT02834793|58573391|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
30566363|NCT02834793|58573388|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
30566364|NCT02834793|58573389|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
30566365|NCT02834793|58573390|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
30566366|NCT02834793|58573391|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
30566367|NCT02834793|58573388|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
30566368|NCT02834793|58573389|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
30566369|NCT02834793|58573390|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
30566370|NCT02834793|58573391|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
30566371|NCT02834793|58573388|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
30566372|NCT02834793|58573389|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
30566373|NCT02834793|58573390|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
30566374|NCT02834793|58573391|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
30566375|NCT02834793|58573388|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
30958638|NCT02163694|59023668|FG001|Overall Study|Lost to Follow-up|2|||
30566376|NCT02834793|58573389|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
30566377|NCT02834793|58573390|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
30566378|NCT02834793|58573391|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
30566379|NCT02834793|58573388|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
30566380|NCT02834793|58573389|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
30566381|NCT02834793|58573390|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
30566382|NCT02834793|58573391|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
30566383|NCT02834793|58573388|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
30566384|NCT02834793|58573389|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
30566385|NCT02834793|58573390|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
30566386|NCT02834793|58573391|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
30566387|NCT02834793|58573388|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
30566388|NCT02834793|58573389|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
30566389|NCT02834793|58573390|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
30566390|NCT02834793|58573391|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
30566391|NCT02810457|58573401|FG000|Overall Study|Randomised but no treatment received|2|||
30566392|NCT02810457|58573402|FG001|Overall Study|Randomised but no treatment received|1|||
30566393|NCT02810457|58573401|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
30566394|NCT02810457|58573402|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
30566395|NCT02810457|58573401|FG000|Overall Study|Adverse Event|37|||
30566396|NCT02810457|58573402|FG001|Overall Study|Adverse Event|43|||
30566397|NCT02810457|58573401|FG000|Overall Study|Patient decision|31|||
30566398|NCT02810457|58573402|FG001|Overall Study|Patient decision|35|||
30566399|NCT02810457|58573401|FG000|Overall Study|Patient lost to follow-up|2|||
30566400|NCT02810457|58573402|FG001|Overall Study|Patient lost to follow-up|2|||
30566401|NCT02810457|58573401|FG000|Overall Study|Death|39|||
30566402|NCT02810457|58573402|FG001|Overall Study|Death|28|||
30566403|NCT02810457|58573401|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
30566404|NCT02810457|58573402|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
30566405|NCT02810457|58573401|FG000|Overall Study|Clinical progression|15|||
30566406|NCT02810457|58573402|FG001|Overall Study|Clinical progression|16|||
30566407|NCT02810457|58573401|FG000|Overall Study|Investigator decision|3|||
30566408|NCT02810457|58573402|FG001|Overall Study|Investigator decision|2|||
30566409|NCT02810457|58573401|FG000|Overall Study|Patient ineligibility|3|||
30566410|NCT02810457|58573402|FG001|Overall Study|Patient ineligibility|0|||
30566411|NCT02810457|58573401|FG000|Overall Study|Miscalculated PD|1|||
30566412|NCT02810457|58573402|FG001|Overall Study|Miscalculated PD|0|||
30566413|NCT02810457|58573401|FG000|Overall Study|Physician Decision|0|||
30566414|NCT02810457|58573402|FG001|Overall Study|Physician Decision|1|||
30566415|NCT02745535|58573408|FG000|Overall Study|Death|1|||
30566416|NCT02745535|58573408|FG000|Overall Study|Adverse Event|3|||
30566417|NCT02745535|58573408|FG000|Overall Study|Lost to Follow-up|2|||
30566418|NCT02625090|58573442|FG000|Overall Study|Participant wants to be pregnant|2|||
30566419|NCT02625090|58573442|FG000|Overall Study|For the Promoter|1|||
30566420|NCT02625090|58573442|FG000|Overall Study|Sponsor's Decision|9|||
30666618|NCT00711880|58680491|FG000|Overall Study|Patient non-compliance|1|||
30666619|NCT00711880|58680492|FG001|Overall Study|Patient non-compliance|0|||
30666620|NCT00711880|58680491|FG000|Overall Study|Lack of Efficacy|1|||
30666621|NCT00711880|58680492|FG001|Overall Study|Lack of Efficacy|5|||
30666622|NCT00528775|58680498|FG000|Overall Study|Other not specified|1|||
30666623|NCT00529399|58680505|FG000|Overall Study|Lost to Follow-up|1|||
30666624|NCT00529399|58680506|FG001|Overall Study|Lost to Follow-up|0|||
30666625|NCT00529399|58680507|FG002|Overall Study|Lost to Follow-up|1|||
30666626|NCT00529399|58680505|FG000|Overall Study|Withdrawal by Subject|1|||
30666627|NCT00529399|58680506|FG001|Overall Study|Withdrawal by Subject|0|||
30666628|NCT00529399|58680507|FG002|Overall Study|Withdrawal by Subject|1|||
30666629|NCT00529399|58680505|FG000|Overall Study|Non-compliant|0|||
30666630|NCT00529399|58680506|FG001|Overall Study|Non-compliant|1|||
30666631|NCT00529399|58680507|FG002|Overall Study|Non-compliant|0|||
30666632|NCT00852969|58680517|FG000|Overall Study|Adverse Event|0|||
30666633|NCT00852969|58680518|FG001|Overall Study|Adverse Event|1|||
30666634|NCT00852969|58680517|FG000|Overall Study|Lost to Follow-up|0|||
30666635|NCT00852969|58680518|FG001|Overall Study|Lost to Follow-up|1|||
30666636|NCT03870997|58680530|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
30666637|NCT03870997|58680531|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
30666638|NCT03870997|58680532|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
30666639|NCT03870997|58680533|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
30566421|NCT02625090|58573442|FG000|Overall Study|Somnolence|1|||
30566422|NCT02625090|58573442|FG000|Overall Study|Study terminated by Sponsor|7|||
30566423|NCT02625090|58573442|FG000|Overall Study|Negative Benefit/Risk|1|||
30666640|NCT03870997|58680534|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
30566424|NCT02625090|58573442|FG000|Overall Study|Protocol Deviation|2|||
30566425|NCT02625090|58573442|FG000|Overall Study|Lack of Efficacy|16|||
30566426|NCT02625090|58573442|FG000|Overall Study|Adverse Event|3|||
30566427|NCT02539225|58573449|FG000|Part A|Adverse Event|13|||
30566428|NCT02539225|58573450|FG001|Part A|Adverse Event|4|||
30566429|NCT02539225|58573449|FG000|Part A|Withdrawal by Subject|2|||
30566430|NCT02539225|58573450|FG001|Part A|Withdrawal by Subject|4|||
30566431|NCT02539225|58573449|FG000|Part A|Physician Decision|4|||
30566432|NCT02539225|58573450|FG001|Part A|Physician Decision|7|||
30566433|NCT02539225|58573449|FG000|Part A|Did Not Receive study Drug|1|||
30566434|NCT02539225|58573450|FG001|Part A|Did Not Receive study Drug|1|||
30566435|NCT02539225|58573449|FG000|Pre Treatment for Part B|Progressive disease|1|||
30566436|NCT02539225|58573450|FG001|Pre Treatment for Part B|Progressive disease|1|||
30566437|NCT02539225|58573449|FG000|Pre Treatment for Part B|Adverse Event|1|||
30566438|NCT02539225|58573450|FG001|Pre Treatment for Part B|Adverse Event|1|||
30566439|NCT02539225|58573449|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
30566440|NCT02539225|58573450|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
30566441|NCT02539225|58573449|FG000|Pre Treatment for Part B|Physician Decision|2|||
30566442|NCT02539225|58573450|FG001|Pre Treatment for Part B|Physician Decision|0|||
30566443|NCT02539225|58573449|FG000|Part B|Adverse Event|4|||
30566444|NCT02539225|58573450|FG001|Part B|Adverse Event|4|||
30566445|NCT02539225|58573449|FG000|Part B|Withdrawal by Subject|0|||
30566446|NCT02539225|58573450|FG001|Part B|Withdrawal by Subject|3|||
30566447|NCT02539225|58573449|FG000|Part B|Physician Decision|0|||
30566448|NCT02539225|58573450|FG001|Part B|Physician Decision|9|||
30566449|NCT02526017|58573470|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
30566450|NCT02526017|58573471|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
30566451|NCT02526017|58573472|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
30566452|NCT02526017|58573473|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
30566453|NCT02526017|58573474|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
30566454|NCT02526017|58573475|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
30566455|NCT02526017|58573476|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
30566456|NCT02526017|58573477|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
30566457|NCT02526017|58573478|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
30566458|NCT02369653|58573547|FG000|Overall Study|Lost to Follow-up|0|||
30566459|NCT02369653|58573548|FG001|Overall Study|Lost to Follow-up|1|||
30566460|NCT02369653|58573547|FG000|Overall Study|Administrative reason by sponsor|0|||
30566461|NCT02369653|58573548|FG001|Overall Study|Administrative reason by sponsor|1|||
30566462|NCT02369653|58573547|FG000|Overall Study|Death|1|||
30566463|NCT02369653|58573548|FG001|Overall Study|Death|2|||
30566464|NCT02369653|58573547|FG000|Overall Study|Participant withdrew consent|13|||
30566465|NCT02369653|58573548|FG001|Overall Study|Participant withdrew consent|3|||
30566466|NCT02284568|58573561|FG000|Overall Study|Adverse Event|2|||
30566467|NCT02284568|58573562|FG001|Overall Study|Adverse Event|9|||
30566468|NCT02284568|58573563|FG002|Overall Study|Adverse Event|4|||
30566469|NCT02284568|58573561|FG000|Overall Study|Withdrawal by Subject|22|||
30566470|NCT02284568|58573562|FG001|Overall Study|Withdrawal by Subject|21|||
30566471|NCT02284568|58573563|FG002|Overall Study|Withdrawal by Subject|1|||
30566472|NCT02284568|58573561|FG000|Overall Study|Noncompliance with study drug admin|1|||
30566473|NCT02284568|58573562|FG001|Overall Study|Noncompliance with study drug admin|2|||
30566474|NCT02284568|58573563|FG002|Overall Study|Noncompliance with study drug admin|0|||
30566475|NCT02284568|58573561|FG000|Overall Study|Noncompliance|1|||
30566476|NCT02284568|58573562|FG001|Overall Study|Noncompliance|0|||
30566477|NCT02284568|58573563|FG002|Overall Study|Noncompliance|0|||
30566478|NCT02284568|58573561|FG000|Overall Study|Protocol Violation|0|||
30566479|NCT02284568|58573562|FG001|Overall Study|Protocol Violation|1|||
30566480|NCT02284568|58573563|FG002|Overall Study|Protocol Violation|0|||
30566481|NCT02284568|58573561|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
30566482|NCT02284568|58573562|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
30566483|NCT02284568|58573563|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
30566484|NCT02284568|58573561|FG000|Overall Study|Lost to Follow-up|0|||
30566485|NCT02284568|58573562|FG001|Overall Study|Lost to Follow-up|3|||
30566486|NCT02284568|58573563|FG002|Overall Study|Lost to Follow-up|0|||
30566487|NCT02284568|58573561|FG000|Overall Study|Lack of Efficacy|4|||
30566488|NCT02284568|58573562|FG001|Overall Study|Lack of Efficacy|7|||
30566489|NCT02284568|58573563|FG002|Overall Study|Lack of Efficacy|0|||
30666641|NCT03870997|58680535|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
30666642|NCT00521365|58680544|FG000|Overall Study|Adverse Event|3|||
30666643|NCT00521365|58680544|FG000|Overall Study|Lost to Follow-up|6|||
30666644|NCT00521365|58680544|FG000|Overall Study|Protocol deviation|2|||
30566490|NCT02284568|58573561|FG000|Overall Study|Other|1|||
30566491|NCT02284568|58573562|FG001|Overall Study|Other|2|||
30566492|NCT02284568|58573563|FG002|Overall Study|Other|0|||
30566493|NCT02284568|58573561|FG000|Overall Study|Withdrew before taking study drug|0|||
30566494|NCT02284568|58573562|FG001|Overall Study|Withdrew before taking study drug|1|||
30566495|NCT02284568|58573563|FG002|Overall Study|Withdrew before taking study drug|0|||
30566496|NCT02195986|58573578|FG000|Overall Study|Adverse Event|3|||
30566497|NCT02195986|58573579|FG001|Overall Study|Adverse Event|0|||
30666645|NCT00521365|58680544|FG000|Overall Study|Drug compliance|3|||
30566498|NCT02195986|58573580|FG002|Overall Study|Adverse Event|0|||
30566499|NCT02195986|58573578|FG000|Overall Study|Withdrawal by Subject|0|||
30566500|NCT02195986|58573579|FG001|Overall Study|Withdrawal by Subject|3|||
30566501|NCT02195986|58573580|FG002|Overall Study|Withdrawal by Subject|0|||
30566502|NCT02195986|58573578|FG000|Overall Study|Family Emergency|0|||
30566503|NCT02195986|58573579|FG001|Overall Study|Family Emergency|0|||
30566504|NCT02195986|58573580|FG002|Overall Study|Family Emergency|1|||
30566505|NCT02195986|58573578|FG000|Overall Study|Protocol Violation|0|||
30566506|NCT02195986|58573579|FG001|Overall Study|Protocol Violation|1|||
30566507|NCT02195986|58573580|FG002|Overall Study|Protocol Violation|1|||
30566508|NCT02195986|58573578|FG000|Overall Study|Non-compliance|0|||
30566509|NCT02195986|58573579|FG001|Overall Study|Non-compliance|1|||
30566510|NCT02195986|58573580|FG002|Overall Study|Non-compliance|0|||
30566511|NCT01982630|58573596|FG000|Overall Study|Adverse Event|2|||
30566512|NCT01982630|58573597|FG001|Overall Study|Adverse Event|0|||
30566513|NCT01982630|58573598|FG002|Overall Study|Adverse Event|1|||
30566514|NCT01982630|58573599|FG003|Overall Study|Adverse Event|0|||
30566515|NCT01982630|58573600|FG004|Overall Study|Adverse Event|1|||
30566516|NCT01982630|58573601|FG005|Overall Study|Adverse Event|2|||
30566517|NCT01982630|58573602|FG006|Overall Study|Adverse Event|1|||
30566518|NCT01982630|58573603|FG007|Overall Study|Adverse Event|0|||
30566519|NCT01982630|58573596|FG000|Overall Study|Physician Decision|1|||
30566520|NCT01982630|58573597|FG001|Overall Study|Physician Decision|0|||
30566521|NCT01982630|58573598|FG002|Overall Study|Physician Decision|2|||
30566522|NCT01982630|58573599|FG003|Overall Study|Physician Decision|1|||
30566523|NCT01982630|58573600|FG004|Overall Study|Physician Decision|2|||
30566524|NCT01982630|58573601|FG005|Overall Study|Physician Decision|0|||
30566525|NCT01982630|58573602|FG006|Overall Study|Physician Decision|0|||
30566526|NCT01982630|58573603|FG007|Overall Study|Physician Decision|0|||
30566527|NCT01982630|58573596|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
30566528|NCT01982630|58573597|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
30566529|NCT01982630|58573598|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
30566530|NCT01982630|58573599|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
30566531|NCT01982630|58573600|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
30566532|NCT01982630|58573601|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
30566533|NCT01982630|58573602|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
30566534|NCT01982630|58573603|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
30566535|NCT01982630|58573596|FG000|Overall Study|Withdrawal by Subject|0|||
30566536|NCT01982630|58573597|FG001|Overall Study|Withdrawal by Subject|0|||
30566537|NCT01982630|58573598|FG002|Overall Study|Withdrawal by Subject|0|||
30566538|NCT01982630|58573599|FG003|Overall Study|Withdrawal by Subject|0|||
30566539|NCT01982630|58573600|FG004|Overall Study|Withdrawal by Subject|0|||
30566540|NCT01982630|58573601|FG005|Overall Study|Withdrawal by Subject|1|||
30566541|NCT01982630|58573602|FG006|Overall Study|Withdrawal by Subject|0|||
30566542|NCT01982630|58573603|FG007|Overall Study|Withdrawal by Subject|0|||
30566543|NCT01740297|58573668|FG000|Overall Study|Withdrawal by Subject|4|||
30566544|NCT01740297|58573669|FG001|Overall Study|Withdrawal by Subject|16|||
30566545|NCT01740297|58573670|FG002|Overall Study|Withdrawal by Subject|17|||
30566546|NCT01740297|58573668|FG000|Overall Study|Death|8|||
30566547|NCT01740297|58573669|FG001|Overall Study|Death|46|||
30566548|NCT01740297|58573670|FG002|Overall Study|Death|40|||
30566549|NCT01740297|58573668|FG000|Overall Study|Lost to Follow-up|1|||
30566550|NCT01740297|58573669|FG001|Overall Study|Lost to Follow-up|2|||
30566551|NCT01740297|58573670|FG002|Overall Study|Lost to Follow-up|4|||
30566552|NCT01729754|58573684|FG000|Part 1|Adverse Event|2|||
30566553|NCT01729754|58573685|FG001|Part 1|Adverse Event|0|||
30566554|NCT01729754|58573686|FG002|Part 1|Adverse Event|0|||
30566555|NCT01729754|58573687|FG003|Part 1|Adverse Event|1|||
30566556|NCT01729754|58573688|FG004|Part 1|Adverse Event|0|||
30566557|NCT01729754|58573689|FG005|Part 1|Adverse Event|0|||
30566558|NCT01729754|58573690|FG006|Part 1|Adverse Event|2|||
30566559|NCT01729754|58573691|FG007|Part 1|Adverse Event|0|||
30566560|NCT01729754|58573692|FG008|Part 1|Adverse Event|0|||
30566561|NCT01729754|58573693|FG009|Part 1|Adverse Event|5|||
30566562|NCT01729754|58573684|FG000|Part 1|Lack of Efficacy|1|||
30566563|NCT01729754|58573685|FG001|Part 1|Lack of Efficacy|0|||
30566564|NCT01729754|58573686|FG002|Part 1|Lack of Efficacy|0|||
30566565|NCT01729754|58573687|FG003|Part 1|Lack of Efficacy|0|||
30566566|NCT01729754|58573688|FG004|Part 1|Lack of Efficacy|0|||
30566567|NCT01729754|58573689|FG005|Part 1|Lack of Efficacy|0|||
30566568|NCT01729754|58573690|FG006|Part 1|Lack of Efficacy|2|||
30566569|NCT01729754|58573691|FG007|Part 1|Lack of Efficacy|0|||
30566570|NCT01729754|58573692|FG008|Part 1|Lack of Efficacy|0|||
30566571|NCT01729754|58573693|FG009|Part 1|Lack of Efficacy|0|||
30566572|NCT01729754|58573684|FG000|Part 1|Lost to Follow-up|1|||
30566573|NCT01729754|58573685|FG001|Part 1|Lost to Follow-up|0|||
30666646|NCT00521365|58680544|FG000|Overall Study|Usage of not allowed drugs|6|||
30566574|NCT01729754|58573686|FG002|Part 1|Lost to Follow-up|0|||
30566575|NCT01729754|58573687|FG003|Part 1|Lost to Follow-up|2|||
30566576|NCT01729754|58573688|FG004|Part 1|Lost to Follow-up|0|||
30566577|NCT01729754|58573689|FG005|Part 1|Lost to Follow-up|0|||
30566578|NCT01729754|58573690|FG006|Part 1|Lost to Follow-up|3|||
30566579|NCT01729754|58573691|FG007|Part 1|Lost to Follow-up|0|||
30566580|NCT01729754|58573692|FG008|Part 1|Lost to Follow-up|0|||
30566581|NCT01729754|58573693|FG009|Part 1|Lost to Follow-up|3|||
30566582|NCT01729754|58573684|FG000|Part 1|Non-compliance with Study Drug|1|||
30566583|NCT01729754|58573685|FG001|Part 1|Non-compliance with Study Drug|0|||
30566584|NCT01729754|58573686|FG002|Part 1|Non-compliance with Study Drug|0|||
30566585|NCT01729754|58573687|FG003|Part 1|Non-compliance with Study Drug|0|||
30566586|NCT01729754|58573688|FG004|Part 1|Non-compliance with Study Drug|0|||
30566587|NCT01729754|58573689|FG005|Part 1|Non-compliance with Study Drug|0|||
30566588|NCT01729754|58573690|FG006|Part 1|Non-compliance with Study Drug|0|||
30566589|NCT01729754|58573691|FG007|Part 1|Non-compliance with Study Drug|0|||
30566590|NCT01729754|58573692|FG008|Part 1|Non-compliance with Study Drug|0|||
30566591|NCT01729754|58573693|FG009|Part 1|Non-compliance with Study Drug|0|||
30566592|NCT01729754|58573684|FG000|Part 1|Physician Decision|0|||
30566593|NCT01729754|58573685|FG001|Part 1|Physician Decision|0|||
30566594|NCT01729754|58573686|FG002|Part 1|Physician Decision|0|||
30566595|NCT01729754|58573687|FG003|Part 1|Physician Decision|0|||
30566596|NCT01729754|58573688|FG004|Part 1|Physician Decision|0|||
30566597|NCT01729754|58573689|FG005|Part 1|Physician Decision|0|||
30566598|NCT01729754|58573690|FG006|Part 1|Physician Decision|0|||
30566599|NCT01729754|58573691|FG007|Part 1|Physician Decision|0|||
30566600|NCT01729754|58573692|FG008|Part 1|Physician Decision|0|||
30566601|NCT01729754|58573693|FG009|Part 1|Physician Decision|4|||
30566602|NCT01729754|58573684|FG000|Part 1|Pregnancy|0|||
30566603|NCT01729754|58573685|FG001|Part 1|Pregnancy|0|||
30566604|NCT01729754|58573686|FG002|Part 1|Pregnancy|0|||
30566605|NCT01729754|58573687|FG003|Part 1|Pregnancy|1|||
30566606|NCT01729754|58573688|FG004|Part 1|Pregnancy|0|||
30566607|NCT01729754|58573689|FG005|Part 1|Pregnancy|0|||
30566608|NCT01729754|58573690|FG006|Part 1|Pregnancy|0|||
30566609|NCT01729754|58573691|FG007|Part 1|Pregnancy|0|||
30566610|NCT01729754|58573692|FG008|Part 1|Pregnancy|0|||
30566611|NCT01729754|58573693|FG009|Part 1|Pregnancy|1|||
30566612|NCT01729754|58573684|FG000|Part 1|Progressive Disease|0|||
30566613|NCT01729754|58573685|FG001|Part 1|Progressive Disease|0|||
30566614|NCT01729754|58573686|FG002|Part 1|Progressive Disease|0|||
30566615|NCT01729754|58573687|FG003|Part 1|Progressive Disease|0|||
30566616|NCT01729754|58573688|FG004|Part 1|Progressive Disease|0|||
30566617|NCT01729754|58573689|FG005|Part 1|Progressive Disease|0|||
30566618|NCT01729754|58573690|FG006|Part 1|Progressive Disease|0|||
30566619|NCT01729754|58573691|FG007|Part 1|Progressive Disease|0|||
30566620|NCT01729754|58573692|FG008|Part 1|Progressive Disease|0|||
30566621|NCT01729754|58573693|FG009|Part 1|Progressive Disease|1|||
30566622|NCT01729754|58573684|FG000|Part 1|Protocol Violation|2|||
30566623|NCT01729754|58573685|FG001|Part 1|Protocol Violation|0|||
30566624|NCT01729754|58573686|FG002|Part 1|Protocol Violation|0|||
30566625|NCT01729754|58573687|FG003|Part 1|Protocol Violation|1|||
30566626|NCT01729754|58573688|FG004|Part 1|Protocol Violation|0|||
30566627|NCT01729754|58573689|FG005|Part 1|Protocol Violation|0|||
30566628|NCT01729754|58573690|FG006|Part 1|Protocol Violation|1|||
30566629|NCT01729754|58573691|FG007|Part 1|Protocol Violation|0|||
30566630|NCT01729754|58573692|FG008|Part 1|Protocol Violation|0|||
30566631|NCT01729754|58573693|FG009|Part 1|Protocol Violation|0|||
30566632|NCT01729754|58573684|FG000|Part 1|Withdrawal by Subject|5|||
30566633|NCT01729754|58573685|FG001|Part 1|Withdrawal by Subject|0|||
30566634|NCT01729754|58573686|FG002|Part 1|Withdrawal by Subject|0|||
30566635|NCT01729754|58573687|FG003|Part 1|Withdrawal by Subject|7|||
30566636|NCT01729754|58573688|FG004|Part 1|Withdrawal by Subject|0|||
30566637|NCT01729754|58573689|FG005|Part 1|Withdrawal by Subject|0|||
30566638|NCT01729754|58573690|FG006|Part 1|Withdrawal by Subject|5|||
30566639|NCT01729754|58573691|FG007|Part 1|Withdrawal by Subject|0|||
30566640|NCT01729754|58573692|FG008|Part 1|Withdrawal by Subject|0|||
30566641|NCT01729754|58573693|FG009|Part 1|Withdrawal by Subject|6|||
30566642|NCT01729754|58573684|FG000|Part 1|Other Protocol Specified Criteria|2|||
30566643|NCT01729754|58573685|FG001|Part 1|Other Protocol Specified Criteria|0|||
30566644|NCT01729754|58573686|FG002|Part 1|Other Protocol Specified Criteria|0|||
30566645|NCT01729754|58573687|FG003|Part 1|Other Protocol Specified Criteria|0|||
30566646|NCT01729754|58573688|FG004|Part 1|Other Protocol Specified Criteria|0|||
30566647|NCT01729754|58573689|FG005|Part 1|Other Protocol Specified Criteria|0|||
30566648|NCT01729754|58573690|FG006|Part 1|Other Protocol Specified Criteria|1|||
30566649|NCT01729754|58573691|FG007|Part 1|Other Protocol Specified Criteria|0|||
30566650|NCT01729754|58573692|FG008|Part 1|Other Protocol Specified Criteria|0|||
30566651|NCT01729754|58573693|FG009|Part 1|Other Protocol Specified Criteria|4|||
30566652|NCT01729754|58573684|FG000|Part 2|Adverse Event|2|||
30566653|NCT01729754|58573685|FG001|Part 2|Adverse Event|0|||
30566654|NCT01729754|58573686|FG002|Part 2|Adverse Event|0|||
30566655|NCT01729754|58573687|FG003|Part 2|Adverse Event|0|||
30566656|NCT01729754|58573688|FG004|Part 2|Adverse Event|0|||
30566657|NCT01729754|58573689|FG005|Part 2|Adverse Event|0|||
30566658|NCT01729754|58573690|FG006|Part 2|Adverse Event|0|||
30566659|NCT01729754|58573691|FG007|Part 2|Adverse Event|0|||
30566660|NCT01729754|58573692|FG008|Part 2|Adverse Event|1|||
30566661|NCT01729754|58573693|FG009|Part 2|Adverse Event|2|||
30566662|NCT01729754|58573684|FG000|Part 2|Lack of Efficacy|0|||
30566663|NCT01729754|58573685|FG001|Part 2|Lack of Efficacy|0|||
30566664|NCT01729754|58573686|FG002|Part 2|Lack of Efficacy|0|||
30566665|NCT01729754|58573687|FG003|Part 2|Lack of Efficacy|0|||
30566666|NCT01729754|58573688|FG004|Part 2|Lack of Efficacy|0|||
30566667|NCT01729754|58573689|FG005|Part 2|Lack of Efficacy|0|||
30566668|NCT01729754|58573690|FG006|Part 2|Lack of Efficacy|0|||
30566669|NCT01729754|58573691|FG007|Part 2|Lack of Efficacy|0|||
30566670|NCT01729754|58573692|FG008|Part 2|Lack of Efficacy|2|||
30566671|NCT01729754|58573693|FG009|Part 2|Lack of Efficacy|2|||
30566672|NCT01729754|58573684|FG000|Part 2|Lost to Follow-up|0|||
30566673|NCT01729754|58573685|FG001|Part 2|Lost to Follow-up|0|||
30566674|NCT01729754|58573686|FG002|Part 2|Lost to Follow-up|0|||
30566675|NCT01729754|58573687|FG003|Part 2|Lost to Follow-up|2|||
30566676|NCT01729754|58573688|FG004|Part 2|Lost to Follow-up|0|||
30566677|NCT01729754|58573689|FG005|Part 2|Lost to Follow-up|0|||
30566678|NCT01729754|58573690|FG006|Part 2|Lost to Follow-up|0|||
30566679|NCT01729754|58573691|FG007|Part 2|Lost to Follow-up|1|||
30566680|NCT01729754|58573692|FG008|Part 2|Lost to Follow-up|0|||
30566681|NCT01729754|58573693|FG009|Part 2|Lost to Follow-up|2|||
30566682|NCT01729754|58573684|FG000|Part 2|Non-Compliance with Study Drug|0|||
30566683|NCT01729754|58573685|FG001|Part 2|Non-Compliance with Study Drug|0|||
30566684|NCT01729754|58573686|FG002|Part 2|Non-Compliance with Study Drug|0|||
30566685|NCT01729754|58573687|FG003|Part 2|Non-Compliance with Study Drug|0|||
30566686|NCT01729754|58573688|FG004|Part 2|Non-Compliance with Study Drug|0|||
30566687|NCT01729754|58573689|FG005|Part 2|Non-Compliance with Study Drug|0|||
30566688|NCT01729754|58573690|FG006|Part 2|Non-Compliance with Study Drug|0|||
30566689|NCT01729754|58573691|FG007|Part 2|Non-Compliance with Study Drug|0|||
30566690|NCT01729754|58573692|FG008|Part 2|Non-Compliance with Study Drug|0|||
30566691|NCT01729754|58573693|FG009|Part 2|Non-Compliance with Study Drug|1|||
30566692|NCT01729754|58573684|FG000|Part 2|Pregnancy|0|||
30566693|NCT01729754|58573685|FG001|Part 2|Pregnancy|0|||
30566694|NCT01729754|58573686|FG002|Part 2|Pregnancy|0|||
30566695|NCT01729754|58573687|FG003|Part 2|Pregnancy|1|||
30566696|NCT01729754|58573688|FG004|Part 2|Pregnancy|0|||
30566697|NCT01729754|58573689|FG005|Part 2|Pregnancy|0|||
30566698|NCT01729754|58573690|FG006|Part 2|Pregnancy|0|||
30566699|NCT01729754|58573691|FG007|Part 2|Pregnancy|0|||
30566700|NCT01729754|58573692|FG008|Part 2|Pregnancy|0|||
30566701|NCT01729754|58573693|FG009|Part 2|Pregnancy|1|||
30566702|NCT01729754|58573684|FG000|Part 2|Withdrawal by Subject|3|||
30566703|NCT01729754|58573685|FG001|Part 2|Withdrawal by Subject|0|||
30566704|NCT01729754|58573686|FG002|Part 2|Withdrawal by Subject|0|||
30566705|NCT01729754|58573687|FG003|Part 2|Withdrawal by Subject|2|||
30566706|NCT01729754|58573688|FG004|Part 2|Withdrawal by Subject|0|||
30566707|NCT01729754|58573689|FG005|Part 2|Withdrawal by Subject|0|||
30566708|NCT01729754|58573690|FG006|Part 2|Withdrawal by Subject|0|||
30566709|NCT01729754|58573691|FG007|Part 2|Withdrawal by Subject|1|||
30566710|NCT01729754|58573692|FG008|Part 2|Withdrawal by Subject|1|||
30566711|NCT01729754|58573693|FG009|Part 2|Withdrawal by Subject|4|||
30566712|NCT01729754|58573684|FG000|Part 2|Other Protocol Specified Criteria|1|||
30566713|NCT01729754|58573685|FG001|Part 2|Other Protocol Specified Criteria|0|||
30566714|NCT01729754|58573686|FG002|Part 2|Other Protocol Specified Criteria|0|||
30566715|NCT01729754|58573687|FG003|Part 2|Other Protocol Specified Criteria|0|||
30566716|NCT01729754|58573688|FG004|Part 2|Other Protocol Specified Criteria|0|||
30566717|NCT01729754|58573689|FG005|Part 2|Other Protocol Specified Criteria|0|||
30566718|NCT01729754|58573690|FG006|Part 2|Other Protocol Specified Criteria|0|||
30566719|NCT01729754|58573691|FG007|Part 2|Other Protocol Specified Criteria|1|||
30566720|NCT01729754|58573692|FG008|Part 2|Other Protocol Specified Criteria|0|||
30566721|NCT01729754|58573693|FG009|Part 2|Other Protocol Specified Criteria|0|||
30566722|NCT01729754|58573684|FG000|Part 3|Adverse Event|0|||
30566723|NCT01729754|58573685|FG001|Part 3|Adverse Event|0|||
30666647|NCT00711802|58680556|FG000|Overall Study|Not treated (no further detail)|2|||
30566724|NCT01729754|58573686|FG002|Part 3|Adverse Event|1|||
30566725|NCT01729754|58573687|FG003|Part 3|Adverse Event|0|||
30566726|NCT01729754|58573688|FG004|Part 3|Adverse Event|0|||
30566727|NCT01729754|58573689|FG005|Part 3|Adverse Event|5|||
30566728|NCT01729754|58573690|FG006|Part 3|Adverse Event|0|||
30566729|NCT01729754|58573691|FG007|Part 3|Adverse Event|0|||
30566730|NCT01729754|58573692|FG008|Part 3|Adverse Event|0|||
30566731|NCT01729754|58573693|FG009|Part 3|Adverse Event|3|||
30566732|NCT01729754|58573684|FG000|Part 3|Death|0|||
30566733|NCT01729754|58573685|FG001|Part 3|Death|0|||
30566734|NCT01729754|58573686|FG002|Part 3|Death|0|||
30566735|NCT01729754|58573687|FG003|Part 3|Death|0|||
30566736|NCT01729754|58573688|FG004|Part 3|Death|0|||
30566737|NCT01729754|58573689|FG005|Part 3|Death|2|||
30566738|NCT01729754|58573690|FG006|Part 3|Death|0|||
30566739|NCT01729754|58573691|FG007|Part 3|Death|0|||
30566740|NCT01729754|58573692|FG008|Part 3|Death|0|||
30566741|NCT01729754|58573693|FG009|Part 3|Death|0|||
30566742|NCT01729754|58573684|FG000|Part 3|Lack of Efficacy|0|||
30566743|NCT01729754|58573685|FG001|Part 3|Lack of Efficacy|0|||
30566744|NCT01729754|58573686|FG002|Part 3|Lack of Efficacy|0|||
30566745|NCT01729754|58573687|FG003|Part 3|Lack of Efficacy|0|||
30566746|NCT01729754|58573688|FG004|Part 3|Lack of Efficacy|2|||
30566747|NCT01729754|58573689|FG005|Part 3|Lack of Efficacy|0|||
30566748|NCT01729754|58573690|FG006|Part 3|Lack of Efficacy|0|||
30566749|NCT01729754|58573691|FG007|Part 3|Lack of Efficacy|0|||
30566750|NCT01729754|58573692|FG008|Part 3|Lack of Efficacy|0|||
30566751|NCT01729754|58573693|FG009|Part 3|Lack of Efficacy|4|||
30566752|NCT01729754|58573684|FG000|Part 3|Lost to Follow-up|0|||
30566753|NCT01729754|58573685|FG001|Part 3|Lost to Follow-up|1|||
30566754|NCT01729754|58573686|FG002|Part 3|Lost to Follow-up|2|||
30566755|NCT01729754|58573687|FG003|Part 3|Lost to Follow-up|0|||
30566756|NCT01729754|58573688|FG004|Part 3|Lost to Follow-up|0|||
30566757|NCT01729754|58573689|FG005|Part 3|Lost to Follow-up|3|||
30566758|NCT01729754|58573690|FG006|Part 3|Lost to Follow-up|0|||
30566759|NCT01729754|58573691|FG007|Part 3|Lost to Follow-up|0|||
30566760|NCT01729754|58573692|FG008|Part 3|Lost to Follow-up|1|||
30566761|NCT01729754|58573693|FG009|Part 3|Lost to Follow-up|0|||
30566762|NCT01729754|58573684|FG000|Part 3|Physician Decision|0|||
30566763|NCT01729754|58573685|FG001|Part 3|Physician Decision|0|||
30566764|NCT01729754|58573686|FG002|Part 3|Physician Decision|1|||
30566765|NCT01729754|58573687|FG003|Part 3|Physician Decision|0|||
30566766|NCT01729754|58573688|FG004|Part 3|Physician Decision|0|||
30566767|NCT01729754|58573689|FG005|Part 3|Physician Decision|0|||
30566768|NCT01729754|58573690|FG006|Part 3|Physician Decision|0|||
30566769|NCT01729754|58573691|FG007|Part 3|Physician Decision|0|||
30566770|NCT01729754|58573692|FG008|Part 3|Physician Decision|0|||
30566771|NCT01729754|58573693|FG009|Part 3|Physician Decision|0|||
30566772|NCT01729754|58573684|FG000|Part 3|Withdrawal by Subject|0|||
30566773|NCT01729754|58573685|FG001|Part 3|Withdrawal by Subject|4|||
30566774|NCT01729754|58573686|FG002|Part 3|Withdrawal by Subject|1|||
30566775|NCT01729754|58573687|FG003|Part 3|Withdrawal by Subject|0|||
30566776|NCT01729754|58573688|FG004|Part 3|Withdrawal by Subject|2|||
30566777|NCT01729754|58573689|FG005|Part 3|Withdrawal by Subject|1|||
30566778|NCT01729754|58573690|FG006|Part 3|Withdrawal by Subject|0|||
30566779|NCT01729754|58573691|FG007|Part 3|Withdrawal by Subject|2|||
30566780|NCT01729754|58573692|FG008|Part 3|Withdrawal by Subject|0|||
30566781|NCT01729754|58573693|FG009|Part 3|Withdrawal by Subject|0|||
30566782|NCT01729754|58573684|FG000|Part 3|Other Protocol Specified Criteria|0|||
30566783|NCT01729754|58573685|FG001|Part 3|Other Protocol Specified Criteria|0|||
30566784|NCT01729754|58573686|FG002|Part 3|Other Protocol Specified Criteria|0|||
30566785|NCT01729754|58573687|FG003|Part 3|Other Protocol Specified Criteria|0|||
30566786|NCT01729754|58573688|FG004|Part 3|Other Protocol Specified Criteria|0|||
30566787|NCT01729754|58573689|FG005|Part 3|Other Protocol Specified Criteria|2|||
30566788|NCT01729754|58573690|FG006|Part 3|Other Protocol Specified Criteria|0|||
30566789|NCT01729754|58573691|FG007|Part 3|Other Protocol Specified Criteria|1|||
30566790|NCT01729754|58573692|FG008|Part 3|Other Protocol Specified Criteria|0|||
30566791|NCT01729754|58573693|FG009|Part 3|Other Protocol Specified Criteria|0|||
30566792|NCT01515306|58573738|FG000|Overall Study|Adverse Event|3|||
30566793|NCT01515306|58573739|FG001|Overall Study|Adverse Event|2|||
30566794|NCT01515306|58573738|FG000|Overall Study|Progressive Disease|19|||
30566795|NCT01515306|58573739|FG001|Overall Study|Progressive Disease|9|||
30566796|NCT01515306|58573738|FG000|Overall Study|Withdrawal by Subject|1|||
30566797|NCT01515306|58573739|FG001|Overall Study|Withdrawal by Subject|2|||
30566798|NCT01515306|58573738|FG000|Overall Study|Physician Decision|1|||
30566799|NCT01515306|58573739|FG001|Overall Study|Physician Decision|1|||
30566800|NCT01423851|58573760|FG000|Whole Study|Disease progression|2|||
30566801|NCT01423851|58573761|FG001|Whole Study|Disease progression|1|||
30566802|NCT01423851|58573762|FG002|Whole Study|Disease progression|1|||
30566803|NCT01423851|58573763|FG003|Whole Study|Disease progression|4|||
30566804|NCT01423851|58573764|FG004|Whole Study|Disease progression|1|||
30566805|NCT01423851|58573765|FG005|Whole Study|Disease progression|3|||
30566806|NCT01423851|58573766|FG006|Whole Study|Disease progression|1|||
30566807|NCT01423851|58573767|FG007|Whole Study|Disease progression|4|||
30566808|NCT01423851|58573768|FG008|Whole Study|Disease progression|0|||
30566809|NCT01423851|58573769|FG009|Whole Study|Disease progression|2|||
30566810|NCT01423851|58573770|FG010|Whole Study|Disease progression|10|||
30566811|NCT01423851|58573760|FG000|Whole Study|Physician Decision|0|||
30566812|NCT01423851|58573761|FG001|Whole Study|Physician Decision|1|||
30566813|NCT01423851|58573762|FG002|Whole Study|Physician Decision|2|||
30566814|NCT01423851|58573763|FG003|Whole Study|Physician Decision|0|||
30566815|NCT01423851|58573764|FG004|Whole Study|Physician Decision|2|||
30566816|NCT01423851|58573765|FG005|Whole Study|Physician Decision|0|||
30566817|NCT01423851|58573766|FG006|Whole Study|Physician Decision|2|||
30566818|NCT01423851|58573767|FG007|Whole Study|Physician Decision|1|||
30566819|NCT01423851|58573768|FG008|Whole Study|Physician Decision|3|||
30566820|NCT01423851|58573769|FG009|Whole Study|Physician Decision|4|||
30566821|NCT01423851|58573770|FG010|Whole Study|Physician Decision|12|||
30566822|NCT01423851|58573760|FG000|Whole Study|Withdrawal by Subject|1|||
30566823|NCT01423851|58573761|FG001|Whole Study|Withdrawal by Subject|1|||
30566824|NCT01423851|58573762|FG002|Whole Study|Withdrawal by Subject|0|||
30566825|NCT01423851|58573763|FG003|Whole Study|Withdrawal by Subject|0|||
30566826|NCT01423851|58573764|FG004|Whole Study|Withdrawal by Subject|0|||
30566827|NCT01423851|58573765|FG005|Whole Study|Withdrawal by Subject|0|||
30566828|NCT01423851|58573766|FG006|Whole Study|Withdrawal by Subject|0|||
30566829|NCT01423851|58573767|FG007|Whole Study|Withdrawal by Subject|0|||
30566830|NCT01423851|58573768|FG008|Whole Study|Withdrawal by Subject|2|||
30566831|NCT01423851|58573769|FG009|Whole Study|Withdrawal by Subject|0|||
30566832|NCT01423851|58573770|FG010|Whole Study|Withdrawal by Subject|4|||
30566833|NCT01423851|58573760|FG000|Whole Study|Adverse Event|0|||
30566834|NCT01423851|58573761|FG001|Whole Study|Adverse Event|0|||
30566835|NCT01423851|58573762|FG002|Whole Study|Adverse Event|0|||
30566836|NCT01423851|58573763|FG003|Whole Study|Adverse Event|2|||
30566837|NCT01423851|58573764|FG004|Whole Study|Adverse Event|0|||
30566838|NCT01423851|58573765|FG005|Whole Study|Adverse Event|0|||
30566839|NCT01423851|58573766|FG006|Whole Study|Adverse Event|0|||
30566840|NCT01423851|58573767|FG007|Whole Study|Adverse Event|3|||
30566841|NCT01423851|58573768|FG008|Whole Study|Adverse Event|3|||
30566842|NCT01423851|58573769|FG009|Whole Study|Adverse Event|2|||
30566843|NCT01423851|58573770|FG010|Whole Study|Adverse Event|3|||
30566844|NCT01334606|58573812|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
30566845|NCT01317875|58573828|FG000|Overall Study|Other|0|||
30566846|NCT01317875|58573829|FG001|Overall Study|Other|0|||
30566847|NCT01317875|58573830|FG002|Overall Study|Other|1|||
30566848|NCT01317875|58573831|FG003|Overall Study|Other|0|||
30566849|NCT01317875|58573832|FG004|Overall Study|Other|0|||
30566850|NCT01317875|58573833|FG005|Overall Study|Other|0|||
30566851|NCT01317875|58573834|FG006|Overall Study|Other|0|||
30566852|NCT01317875|58573835|FG007|Overall Study|Other|0|||
30566853|NCT01317875|58573836|FG008|Overall Study|Other|0|||
30566854|NCT01317875|58573837|FG009|Overall Study|Other|0|||
30566855|NCT01317875|58573828|FG000|Overall Study|Noncompliance with study drug|0|||
30566856|NCT01317875|58573829|FG001|Overall Study|Noncompliance with study drug|0|||
30566857|NCT01317875|58573830|FG002|Overall Study|Noncompliance with study drug|1|||
30566858|NCT01317875|58573831|FG003|Overall Study|Noncompliance with study drug|0|||
30566859|NCT01317875|58573832|FG004|Overall Study|Noncompliance with study drug|0|||
30566860|NCT01317875|58573833|FG005|Overall Study|Noncompliance with study drug|0|||
30566861|NCT01317875|58573834|FG006|Overall Study|Noncompliance with study drug|0|||
30566862|NCT01317875|58573835|FG007|Overall Study|Noncompliance with study drug|0|||
30566863|NCT01317875|58573836|FG008|Overall Study|Noncompliance with study drug|0|||
30566864|NCT01317875|58573837|FG009|Overall Study|Noncompliance with study drug|0|||
30566865|NCT01317875|58573828|FG000|Overall Study|Progressive Disease|1|||
30566866|NCT01317875|58573829|FG001|Overall Study|Progressive Disease|0|||
30566867|NCT01317875|58573830|FG002|Overall Study|Progressive Disease|2|||
30566868|NCT01317875|58573831|FG003|Overall Study|Progressive Disease|0|||
30566869|NCT01317875|58573832|FG004|Overall Study|Progressive Disease|1|||
30566870|NCT01317875|58573833|FG005|Overall Study|Progressive Disease|0|||
30566871|NCT01317875|58573834|FG006|Overall Study|Progressive Disease|0|||
30566872|NCT01317875|58573835|FG007|Overall Study|Progressive Disease|1|||
30566873|NCT01317875|58573836|FG008|Overall Study|Progressive Disease|0|||
30566874|NCT01317875|58573837|FG009|Overall Study|Progressive Disease|0|||
30566875|NCT01317875|58573828|FG000|Overall Study|Withdrawal by Subject|0|||
30566876|NCT01317875|58573829|FG001|Overall Study|Withdrawal by Subject|0|||
30566877|NCT01317875|58573830|FG002|Overall Study|Withdrawal by Subject|0|||
30566878|NCT01317875|58573831|FG003|Overall Study|Withdrawal by Subject|0|||
30566879|NCT01317875|58573832|FG004|Overall Study|Withdrawal by Subject|1|||
30566880|NCT01317875|58573833|FG005|Overall Study|Withdrawal by Subject|0|||
30566881|NCT01317875|58573834|FG006|Overall Study|Withdrawal by Subject|0|||
30566882|NCT01317875|58573835|FG007|Overall Study|Withdrawal by Subject|3|||
30566883|NCT01317875|58573836|FG008|Overall Study|Withdrawal by Subject|0|||
30566884|NCT01317875|58573837|FG009|Overall Study|Withdrawal by Subject|0|||
30566885|NCT01317875|58573828|FG000|Overall Study|Physician Decision|0|||
30566886|NCT01317875|58573829|FG001|Overall Study|Physician Decision|1|||
30566887|NCT01317875|58573830|FG002|Overall Study|Physician Decision|1|||
30566888|NCT01317875|58573831|FG003|Overall Study|Physician Decision|0|||
30566889|NCT01317875|58573832|FG004|Overall Study|Physician Decision|2|||
30566890|NCT01317875|58573833|FG005|Overall Study|Physician Decision|0|||
30566891|NCT01317875|58573834|FG006|Overall Study|Physician Decision|0|||
30566892|NCT01317875|58573835|FG007|Overall Study|Physician Decision|2|||
30566893|NCT01317875|58573836|FG008|Overall Study|Physician Decision|0|||
30566894|NCT01317875|58573837|FG009|Overall Study|Physician Decision|0|||
30566895|NCT01317875|58573828|FG000|Overall Study|Death|0|||
30566896|NCT01317875|58573829|FG001|Overall Study|Death|0|||
30566897|NCT01317875|58573830|FG002|Overall Study|Death|2|||
30566898|NCT01317875|58573831|FG003|Overall Study|Death|1|||
30566899|NCT01317875|58573832|FG004|Overall Study|Death|0|||
30566900|NCT01317875|58573833|FG005|Overall Study|Death|1|||
30566901|NCT01317875|58573834|FG006|Overall Study|Death|0|||
30566902|NCT01317875|58573835|FG007|Overall Study|Death|4|||
30566903|NCT01317875|58573836|FG008|Overall Study|Death|0|||
30566904|NCT01317875|58573837|FG009|Overall Study|Death|0|||
30566905|NCT01317875|58573828|FG000|Overall Study|Adverse Event|2|||
30566906|NCT01317875|58573829|FG001|Overall Study|Adverse Event|1|||
30566907|NCT01317875|58573830|FG002|Overall Study|Adverse Event|2|||
30566908|NCT01317875|58573831|FG003|Overall Study|Adverse Event|1|||
30566909|NCT01317875|58573832|FG004|Overall Study|Adverse Event|5|||
30566910|NCT01317875|58573833|FG005|Overall Study|Adverse Event|1|||
30566911|NCT01317875|58573834|FG006|Overall Study|Adverse Event|2|||
30566912|NCT01317875|58573835|FG007|Overall Study|Adverse Event|5|||
30566913|NCT01317875|58573836|FG008|Overall Study|Adverse Event|0|||
30566914|NCT01317875|58573837|FG009|Overall Study|Adverse Event|0|||
30566915|NCT00500071|58573913|FG000|Screening and Washout Phase|Protocol Violation|1|||
30566916|NCT00500071|58573913|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
30566917|NCT00500071|58573913|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
30566918|NCT00500071|58573913|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
30566919|NCT00500071|58573913|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
30566920|NCT00500071|58573913|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
30566921|NCT00500071|58573913|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
30566922|NCT00447122|58573921|FG000|Overall Study|worsening medical condition -came off|0|||
30566923|NCT00447122|58573922|FG001|Overall Study|worsening medical condition -came off|1|||
30566924|NCT00447122|58573923|FG002|Overall Study|worsening medical condition -came off|0|||
30566925|NCT00447122|58573924|FG003|Overall Study|worsening medical condition -came off|0|||
30566926|NCT00382252|58573934|FG000|Overall Study|Death|4|||
30566927|NCT00382252|58573934|FG000|Overall Study|Protocol Violation|8|||
30566928|NCT00382252|58573934|FG000|Overall Study|Not treated by RFA|1|||
30566929|NCT00290251|58573941|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
30566930|NCT00290251|58573942|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
30566931|NCT00290251|58573943|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
30566932|NCT00290251|58573944|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
30566933|NCT00290251|58573945|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
30566934|NCT00290251|58573946|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
30566935|NCT00290251|58573941|FG000|Treatment 1 (Months 2-4)|headache|0|||
30566936|NCT00290251|58573942|FG001|Treatment 1 (Months 2-4)|headache|0|||
30566937|NCT00290251|58573943|FG002|Treatment 1 (Months 2-4)|headache|0|||
30566938|NCT00290251|58573944|FG003|Treatment 1 (Months 2-4)|headache|0|||
30566939|NCT00290251|58573945|FG004|Treatment 1 (Months 2-4)|headache|1|||
30566940|NCT00290251|58573946|FG005|Treatment 1 (Months 2-4)|headache|0|||
30566941|NCT00290251|58573941|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
30566942|NCT00290251|58573942|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
30566943|NCT00290251|58573943|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
30566944|NCT00290251|58573944|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
30566945|NCT00290251|58573945|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
30566946|NCT00290251|58573946|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
30566947|NCT01403948|58573982|FG000|Overall Study|Progressive disease|0|||
30566948|NCT01403948|58573983|FG001|Overall Study|Progressive disease|2|||
30566949|NCT01403948|58573984|FG002|Overall Study|Progressive disease|2|||
30566950|NCT01403948|58573985|FG003|Overall Study|Progressive disease|4|||
30566951|NCT01403948|58573986|FG004|Overall Study|Progressive disease|2|||
30566952|NCT01403948|58573987|FG005|Overall Study|Progressive disease|6|||
30566953|NCT01403948|58573988|FG006|Overall Study|Progressive disease|2|||
30566954|NCT01403948|58573989|FG007|Overall Study|Progressive disease|4|||
30566955|NCT01403948|58573990|FG008|Overall Study|Progressive disease|5|||
30566956|NCT01403948|58573991|FG009|Overall Study|Progressive disease|5|||
30566957|NCT01403948|58573982|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
30566958|NCT01403948|58573983|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
30566959|NCT01403948|58573984|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
30566960|NCT01403948|58573985|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
30566961|NCT01403948|58573986|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
30566962|NCT01403948|58573987|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
30566963|NCT01403948|58573988|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
30566964|NCT01403948|58573989|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
30566965|NCT01403948|58573990|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
30566966|NCT01403948|58573991|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
30566967|NCT01403948|58573982|FG000|Overall Study|Lost to Follow-up|0|||
30566968|NCT01403948|58573983|FG001|Overall Study|Lost to Follow-up|0|||
30566969|NCT01403948|58573984|FG002|Overall Study|Lost to Follow-up|0|||
30566970|NCT01403948|58573985|FG003|Overall Study|Lost to Follow-up|0|||
30666648|NCT00711802|58680557|FG001|Overall Study|Not treated (no further detail)|1|||
30566971|NCT01403948|58573986|FG004|Overall Study|Lost to Follow-up|0|||
30566972|NCT01403948|58573987|FG005|Overall Study|Lost to Follow-up|0|||
30566973|NCT01403948|58573988|FG006|Overall Study|Lost to Follow-up|0|||
30566974|NCT01403948|58573989|FG007|Overall Study|Lost to Follow-up|0|||
30566975|NCT01403948|58573990|FG008|Overall Study|Lost to Follow-up|0|||
30566976|NCT01403948|58573991|FG009|Overall Study|Lost to Follow-up|1|||
30566977|NCT01403948|58573982|FG000|Overall Study|Refused cont. medication|0|||
30566978|NCT01403948|58573983|FG001|Overall Study|Refused cont. medication|0|||
30566979|NCT01403948|58573984|FG002|Overall Study|Refused cont. medication|0|||
30566980|NCT01403948|58573985|FG003|Overall Study|Refused cont. medication|0|||
30780126|NCT02992288|58791834|FG000|Overall Study|Non-compliance with study drug|0|||
30780127|NCT02992288|58791835|FG001|Overall Study|Non-compliance with study drug|1|||
30566981|NCT01403948|58573986|FG004|Overall Study|Refused cont. medication|1|||
30566982|NCT01403948|58573987|FG005|Overall Study|Refused cont. medication|0|||
30566983|NCT01403948|58573988|FG006|Overall Study|Refused cont. medication|0|||
30566984|NCT01403948|58573989|FG007|Overall Study|Refused cont. medication|0|||
30566985|NCT01403948|58573990|FG008|Overall Study|Refused cont. medication|0|||
30566986|NCT01403948|58573991|FG009|Overall Study|Refused cont. medication|1|||
30566987|NCT01403948|58573982|FG000|Overall Study|other than above|1|||
30566988|NCT01403948|58573983|FG001|Overall Study|other than above|2|||
30566989|NCT01403948|58573984|FG002|Overall Study|other than above|1|||
30566990|NCT01403948|58573985|FG003|Overall Study|other than above|0|||
30566991|NCT01403948|58573986|FG004|Overall Study|other than above|1|||
30566992|NCT01403948|58573987|FG005|Overall Study|other than above|1|||
30566993|NCT01403948|58573988|FG006|Overall Study|other than above|2|||
30566994|NCT01403948|58573989|FG007|Overall Study|other than above|0|||
30566995|NCT01403948|58573990|FG008|Overall Study|other than above|0|||
30566996|NCT01403948|58573991|FG009|Overall Study|other than above|0|||
30566997|NCT01404312|58574019|FG000|Overall Study|Death|21|||
30566998|NCT01404312|58574020|FG001|Overall Study|Death|27|||
30566999|NCT01404312|58574019|FG000|Overall Study|Withdrawal by Subject|15|||
30567000|NCT01404312|58574020|FG001|Overall Study|Withdrawal by Subject|18|||
30567001|NCT01404312|58574019|FG000|Overall Study|Participant Unable to get to clinic|93|||
30567002|NCT01404312|58574020|FG001|Overall Study|Participant Unable to get to clinic|103|||
30567003|NCT01404312|58574019|FG000|Overall Study|Lost to Follow-up|115|||
30567004|NCT01404312|58574020|FG001|Overall Study|Lost to Follow-up|111|||
30567005|NCT01404312|58574019|FG000|Overall Study|Site closed|22|||
30567006|NCT01404312|58574020|FG001|Overall Study|Site closed|21|||
30567007|NCT01404312|58574019|FG000|Overall Study|Participant not willing to adhere to req|31|||
30567008|NCT01404312|58574020|FG001|Overall Study|Participant not willing to adhere to req|29|||
30567009|NCT01404312|58574019|FG000|Overall Study|Severe debilitation, unable to continue|1|||
30567010|NCT01404312|58574020|FG001|Overall Study|Severe debilitation, unable to continue|2|||
30567011|NCT01414608|58574029|FG000|Overall Study|Ineligible|5|||
30567012|NCT01414608|58574030|FG001|Overall Study|Ineligible|2|||
30567013|NCT01425008|58574059|FG000|Dose Escalation Phase|Progressive Disease|2|||
30567014|NCT01425008|58574060|FG001|Dose Escalation Phase|Progressive Disease|3|||
30567015|NCT01425008|58574061|FG002|Dose Escalation Phase|Progressive Disease|2|||
30567016|NCT01425008|58574062|FG003|Dose Escalation Phase|Progressive Disease|3|||
30567017|NCT01425008|58574063|FG004|Dose Escalation Phase|Progressive Disease|5|||
30567018|NCT01425008|58574064|FG005|Dose Escalation Phase|Progressive Disease|4|||
30567019|NCT01425008|58574065|FG006|Dose Escalation Phase|Progressive Disease|0|||
30567020|NCT01425008|58574066|FG007|Dose Escalation Phase|Progressive Disease|2|||
30567021|NCT01425008|58574067|FG008|Dose Escalation Phase|Progressive Disease|6|||
30567022|NCT01425008|58574068|FG009|Dose Escalation Phase|Progressive Disease|2|||
30567023|NCT01425008|58574069|FG010|Dose Escalation Phase|Progressive Disease|0|||
30666649|NCT00711802|58680558|FG002|Overall Study|Not treated (no further detail)|2|||
30666650|NCT00711802|58680559|FG003|Overall Study|Not treated (no further detail)|0|||
30666651|NCT00711802|58680560|FG004|Overall Study|Not treated (no further detail)|2|||
30666652|NCT00711802|58680561|FG005|Overall Study|Not treated (no further detail)|0|||
30666653|NCT00711802|58680562|FG006|Overall Study|Not treated (no further detail)|0|||
30666654|NCT00711802|58680563|FG007|Overall Study|Not treated (no further detail)|0|||
30666655|NCT00711802|58680556|FG000|Overall Study|Adverse Event|0|||
30666656|NCT00711802|58680557|FG001|Overall Study|Adverse Event|0|||
30666657|NCT00711802|58680558|FG002|Overall Study|Adverse Event|0|||
30666658|NCT00711802|58680559|FG003|Overall Study|Adverse Event|0|||
30666659|NCT00711802|58680560|FG004|Overall Study|Adverse Event|1|||
30666660|NCT00711802|58680561|FG005|Overall Study|Adverse Event|1|||
30666661|NCT00711802|58680562|FG006|Overall Study|Adverse Event|0|||
30666662|NCT00711802|58680563|FG007|Overall Study|Adverse Event|0|||
30780128|NCT02992288|58791836|FG002|Overall Study|Non-compliance with study drug|1|||
30780129|NCT02992288|58791837|FG003|Overall Study|Non-compliance with study drug|0|||
30780130|NCT02992288|58791838|FG004|Overall Study|Non-compliance with study drug|1|||
30780131|NCT02992288|58791839|FG005|Overall Study|Non-compliance with study drug|0|||
30780132|NCT02992288|58791834|FG000|Overall Study|Physician Decision|3|||
30780133|NCT02992288|58791835|FG001|Overall Study|Physician Decision|0|||
30780134|NCT02992288|58791836|FG002|Overall Study|Physician Decision|1|||
30567024|NCT01425008|58574070|FG011|Dose Escalation Phase|Progressive Disease|0|||
30567025|NCT01425008|58574071|FG012|Dose Escalation Phase|Progressive Disease|0|||
30567026|NCT01425008|58574072|FG013|Dose Escalation Phase|Progressive Disease|0|||
30567027|NCT01425008|58574073|FG014|Dose Escalation Phase|Progressive Disease|0|||
30567028|NCT01425008|58574074|FG015|Dose Escalation Phase|Progressive Disease|0|||
30567029|NCT01425008|58574075|FG016|Dose Escalation Phase|Progressive Disease|0|||
30567030|NCT01425008|58574076|FG017|Dose Escalation Phase|Progressive Disease|0|||
30567031|NCT01425008|58574077|FG018|Dose Escalation Phase|Progressive Disease|0|||
30567032|NCT01425008|58574059|FG000|Dose Escalation Phase|Adverse Event|2|||
30567033|NCT01425008|58574060|FG001|Dose Escalation Phase|Adverse Event|0|||
30567034|NCT01425008|58574061|FG002|Dose Escalation Phase|Adverse Event|0|||
30567035|NCT01425008|58574062|FG003|Dose Escalation Phase|Adverse Event|0|||
30567036|NCT01425008|58574063|FG004|Dose Escalation Phase|Adverse Event|0|||
30567037|NCT01425008|58574064|FG005|Dose Escalation Phase|Adverse Event|2|||
30567038|NCT01425008|58574065|FG006|Dose Escalation Phase|Adverse Event|0|||
30567039|NCT01425008|58574066|FG007|Dose Escalation Phase|Adverse Event|0|||
30567040|NCT01425008|58574067|FG008|Dose Escalation Phase|Adverse Event|2|||
30567041|NCT01425008|58574068|FG009|Dose Escalation Phase|Adverse Event|0|||
30567042|NCT01425008|58574069|FG010|Dose Escalation Phase|Adverse Event|0|||
30567043|NCT01425008|58574070|FG011|Dose Escalation Phase|Adverse Event|0|||
30567044|NCT01425008|58574071|FG012|Dose Escalation Phase|Adverse Event|0|||
30567045|NCT01425008|58574072|FG013|Dose Escalation Phase|Adverse Event|0|||
30567046|NCT01425008|58574073|FG014|Dose Escalation Phase|Adverse Event|0|||
30567047|NCT01425008|58574074|FG015|Dose Escalation Phase|Adverse Event|0|||
30567048|NCT01425008|58574075|FG016|Dose Escalation Phase|Adverse Event|0|||
30567049|NCT01425008|58574076|FG017|Dose Escalation Phase|Adverse Event|0|||
30567050|NCT01425008|58574077|FG018|Dose Escalation Phase|Adverse Event|0|||
30567051|NCT01425008|58574059|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567052|NCT01425008|58574060|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567053|NCT01425008|58574061|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567054|NCT01425008|58574062|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567055|NCT01425008|58574063|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
30567056|NCT01425008|58574064|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567057|NCT01425008|58574065|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
30567058|NCT01425008|58574066|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
30567059|NCT01425008|58574067|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
30567060|NCT01425008|58574068|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567061|NCT01425008|58574069|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567062|NCT01425008|58574070|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567063|NCT01425008|58574071|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567064|NCT01425008|58574072|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567065|NCT01425008|58574073|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567066|NCT01425008|58574074|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567067|NCT01425008|58574075|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567068|NCT01425008|58574076|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567069|NCT01425008|58574077|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
30567070|NCT01425008|58574059|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
30567071|NCT01425008|58574060|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
30567072|NCT01425008|58574061|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
30567073|NCT01425008|58574062|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
30567074|NCT01425008|58574063|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
30567075|NCT01425008|58574064|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
30567076|NCT01425008|58574065|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
30567077|NCT01425008|58574066|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
30567078|NCT01425008|58574067|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
30567079|NCT01425008|58574068|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
30567080|NCT01425008|58574069|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
30567081|NCT01425008|58574070|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
30567082|NCT01425008|58574071|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
30567083|NCT01425008|58574072|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
30567084|NCT01425008|58574073|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
30567085|NCT01425008|58574074|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
30567086|NCT01425008|58574075|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
30567087|NCT01425008|58574076|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
30567088|NCT01425008|58574077|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
30567089|NCT01425008|58574059|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567090|NCT01425008|58574060|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567091|NCT01425008|58574061|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
30567092|NCT01425008|58574062|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567093|NCT01425008|58574063|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567094|NCT01425008|58574064|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567095|NCT01425008|58574065|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567096|NCT01425008|58574066|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567097|NCT01425008|58574067|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
30567098|NCT01425008|58574068|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
30567099|NCT01425008|58574069|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567100|NCT01425008|58574070|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567101|NCT01425008|58574071|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567102|NCT01425008|58574072|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567103|NCT01425008|58574073|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567104|NCT01425008|58574074|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567105|NCT01425008|58574075|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567106|NCT01425008|58574076|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567107|NCT01425008|58574077|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
30567108|NCT01425008|58574059|FG000|Dose Escalation Phase|Other|0|||
30567109|NCT01425008|58574060|FG001|Dose Escalation Phase|Other|0|||
30567110|NCT01425008|58574061|FG002|Dose Escalation Phase|Other|0|||
30567111|NCT01425008|58574062|FG003|Dose Escalation Phase|Other|0|||
30567112|NCT01425008|58574063|FG004|Dose Escalation Phase|Other|0|||
30567113|NCT01425008|58574064|FG005|Dose Escalation Phase|Other|0|||
30567114|NCT01425008|58574065|FG006|Dose Escalation Phase|Other|0|||
30567115|NCT01425008|58574066|FG007|Dose Escalation Phase|Other|0|||
30567116|NCT01425008|58574067|FG008|Dose Escalation Phase|Other|1|||
30567117|NCT01425008|58574068|FG009|Dose Escalation Phase|Other|0|||
30666663|NCT00711802|58680556|FG000|Overall Study|Microbiological failure|0|||
30666664|NCT00711802|58680557|FG001|Overall Study|Microbiological failure|1|||
30666665|NCT00711802|58680558|FG002|Overall Study|Microbiological failure|0|||
30666666|NCT00711802|58680559|FG003|Overall Study|Microbiological failure|0|||
30666667|NCT00711802|58680560|FG004|Overall Study|Microbiological failure|0|||
30666668|NCT00711802|58680561|FG005|Overall Study|Microbiological failure|1|||
30666669|NCT00711802|58680562|FG006|Overall Study|Microbiological failure|0|||
30666670|NCT00711802|58680563|FG007|Overall Study|Microbiological failure|0|||
30666671|NCT00711802|58680556|FG000|Overall Study|Protocol Violation|0|||
30666672|NCT00711802|58680557|FG001|Overall Study|Protocol Violation|0|||
30666673|NCT00711802|58680558|FG002|Overall Study|Protocol Violation|0|||
30666674|NCT00711802|58680559|FG003|Overall Study|Protocol Violation|1|||
30666675|NCT00711802|58680560|FG004|Overall Study|Protocol Violation|0|||
30567118|NCT01425008|58574069|FG010|Dose Escalation Phase|Other|0|||
30567119|NCT01425008|58574070|FG011|Dose Escalation Phase|Other|0|||
30666676|NCT00711802|58680561|FG005|Overall Study|Protocol Violation|0|||
30666677|NCT00711802|58680562|FG006|Overall Study|Protocol Violation|0|||
30666678|NCT00711802|58680563|FG007|Overall Study|Protocol Violation|0|||
30666679|NCT00711802|58680556|FG000|Overall Study|Physician Decision|0|||
30666680|NCT00711802|58680557|FG001|Overall Study|Physician Decision|2|||
30666681|NCT00711802|58680558|FG002|Overall Study|Physician Decision|0|||
30666682|NCT00711802|58680559|FG003|Overall Study|Physician Decision|0|||
30567120|NCT01425008|58574071|FG012|Dose Escalation Phase|Other|0|||
30666683|NCT00711802|58680560|FG004|Overall Study|Physician Decision|0|||
30666684|NCT00711802|58680561|FG005|Overall Study|Physician Decision|0|||
30666685|NCT00711802|58680562|FG006|Overall Study|Physician Decision|0|||
30666686|NCT00711802|58680563|FG007|Overall Study|Physician Decision|0|||
30666687|NCT00711802|58680556|FG000|Overall Study|Withdrawal by Subject|0|||
30666688|NCT00711802|58680557|FG001|Overall Study|Withdrawal by Subject|1|||
30666689|NCT00711802|58680558|FG002|Overall Study|Withdrawal by Subject|0|||
30666690|NCT00711802|58680559|FG003|Overall Study|Withdrawal by Subject|1|||
30666691|NCT00711802|58680560|FG004|Overall Study|Withdrawal by Subject|0|||
30666692|NCT00711802|58680561|FG005|Overall Study|Withdrawal by Subject|0|||
30666693|NCT00711802|58680562|FG006|Overall Study|Withdrawal by Subject|0|||
30666694|NCT00711802|58680563|FG007|Overall Study|Withdrawal by Subject|0|||
30666695|NCT00711802|58680556|FG000|Overall Study|Lost to Follow-up|0|||
30666696|NCT00711802|58680557|FG001|Overall Study|Lost to Follow-up|0|||
30666697|NCT00711802|58680558|FG002|Overall Study|Lost to Follow-up|3|||
30666698|NCT00711802|58680559|FG003|Overall Study|Lost to Follow-up|1|||
30666699|NCT00711802|58680560|FG004|Overall Study|Lost to Follow-up|10|||
30666700|NCT00711802|58680561|FG005|Overall Study|Lost to Follow-up|6|||
30666701|NCT00711802|58680562|FG006|Overall Study|Lost to Follow-up|4|||
30666702|NCT00711802|58680563|FG007|Overall Study|Lost to Follow-up|2|||
30666703|NCT00711802|58680556|FG000|Overall Study|Reason not reported|0|||
30666704|NCT00711802|58680557|FG001|Overall Study|Reason not reported|1|||
30666705|NCT00711802|58680558|FG002|Overall Study|Reason not reported|1|||
30666706|NCT00711802|58680559|FG003|Overall Study|Reason not reported|0|||
30567121|NCT01425008|58574072|FG013|Dose Escalation Phase|Other|0|||
30666707|NCT00711802|58680560|FG004|Overall Study|Reason not reported|1|||
30666708|NCT00711802|58680561|FG005|Overall Study|Reason not reported|0|||
30666709|NCT00711802|58680562|FG006|Overall Study|Reason not reported|1|||
30666710|NCT00711802|58680563|FG007|Overall Study|Reason not reported|0|||
30666711|NCT00851877|58680584|FG000|Phase I-1|Death|1|||
30666712|NCT00851877|58680585|FG001|Phase I-1|Death|0|||
30666713|NCT00851877|58680586|FG002|Phase I-1|Death|0|||
30666714|NCT00851877|58680584|FG000|Phase II|Withdrawal by Subject|0|||
30666715|NCT00851877|58680585|FG001|Phase II|Withdrawal by Subject|0|||
30666716|NCT00851877|58680586|FG002|Phase II|Withdrawal by Subject|3|||
30567122|NCT01425008|58574073|FG014|Dose Escalation Phase|Other|0|||
30567123|NCT01425008|58574074|FG015|Dose Escalation Phase|Other|0|||
30666717|NCT00882908|58680597|FG000|Overall Study|Adverse Event|0|||
30666718|NCT00882908|58680598|FG001|Overall Study|Adverse Event|0|||
30666719|NCT00882908|58680599|FG002|Overall Study|Adverse Event|1|||
30567124|NCT01425008|58574075|FG016|Dose Escalation Phase|Other|0|||
30666720|NCT00882908|58680600|FG003|Overall Study|Adverse Event|0|||
30666721|NCT00882908|58680601|FG004|Overall Study|Adverse Event|1|||
30567125|NCT01425008|58574076|FG017|Dose Escalation Phase|Other|0|||
30567126|NCT01425008|58574077|FG018|Dose Escalation Phase|Other|0|||
30567127|NCT01425008|58574059|FG000|Dose Expansion Phase|Progressive Disease|0|||
30567128|NCT01425008|58574060|FG001|Dose Expansion Phase|Progressive Disease|0|||
30567129|NCT01425008|58574061|FG002|Dose Expansion Phase|Progressive Disease|0|||
30567130|NCT01425008|58574062|FG003|Dose Expansion Phase|Progressive Disease|0|||
30567131|NCT01425008|58574063|FG004|Dose Expansion Phase|Progressive Disease|0|||
30567132|NCT01425008|58574064|FG005|Dose Expansion Phase|Progressive Disease|0|||
30567133|NCT01425008|58574065|FG006|Dose Expansion Phase|Progressive Disease|0|||
30567134|NCT01425008|58574066|FG007|Dose Expansion Phase|Progressive Disease|0|||
30567135|NCT01425008|58574067|FG008|Dose Expansion Phase|Progressive Disease|0|||
30567136|NCT01425008|58574068|FG009|Dose Expansion Phase|Progressive Disease|0|||
30567137|NCT01425008|58574069|FG010|Dose Expansion Phase|Progressive Disease|10|||
30567138|NCT01425008|58574070|FG011|Dose Expansion Phase|Progressive Disease|4|||
30567139|NCT01425008|58574071|FG012|Dose Expansion Phase|Progressive Disease|12|||
30567140|NCT01425008|58574072|FG013|Dose Expansion Phase|Progressive Disease|1|||
30567141|NCT01425008|58574073|FG014|Dose Expansion Phase|Progressive Disease|5|||
30567142|NCT01425008|58574074|FG015|Dose Expansion Phase|Progressive Disease|8|||
30567143|NCT01425008|58574075|FG016|Dose Expansion Phase|Progressive Disease|9|||
30567144|NCT01425008|58574076|FG017|Dose Expansion Phase|Progressive Disease|2|||
30567145|NCT01425008|58574077|FG018|Dose Expansion Phase|Progressive Disease|10|||
30567146|NCT01425008|58574059|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
30567147|NCT01425008|58574060|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
30567148|NCT01425008|58574061|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
30567149|NCT01425008|58574062|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
30567150|NCT01425008|58574063|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
30567151|NCT01425008|58574064|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
30567152|NCT01425008|58574065|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
30567153|NCT01425008|58574066|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
30567154|NCT01425008|58574067|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
30567155|NCT01425008|58574068|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
30567156|NCT01425008|58574069|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
30567157|NCT01425008|58574070|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
30567158|NCT01425008|58574071|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
30567159|NCT01425008|58574072|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
30567160|NCT01425008|58574073|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
30567161|NCT01425008|58574074|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
30567162|NCT01425008|58574075|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
30567163|NCT01425008|58574076|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
30567164|NCT01425008|58574077|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
30567165|NCT01425008|58574059|FG000|Dose Expansion Phase|Other|0|||
30567166|NCT01425008|58574060|FG001|Dose Expansion Phase|Other|0|||
30567167|NCT01425008|58574061|FG002|Dose Expansion Phase|Other|0|||
30567168|NCT01425008|58574062|FG003|Dose Expansion Phase|Other|0|||
30567169|NCT01425008|58574063|FG004|Dose Expansion Phase|Other|0|||
30567170|NCT01425008|58574064|FG005|Dose Expansion Phase|Other|0|||
30567171|NCT01425008|58574065|FG006|Dose Expansion Phase|Other|0|||
30567172|NCT01425008|58574066|FG007|Dose Expansion Phase|Other|0|||
30567173|NCT01425008|58574067|FG008|Dose Expansion Phase|Other|0|||
30567174|NCT01425008|58574068|FG009|Dose Expansion Phase|Other|0|||
30567175|NCT01425008|58574069|FG010|Dose Expansion Phase|Other|0|||
30567176|NCT01425008|58574070|FG011|Dose Expansion Phase|Other|0|||
30567177|NCT01425008|58574071|FG012|Dose Expansion Phase|Other|1|||
30567178|NCT01425008|58574072|FG013|Dose Expansion Phase|Other|0|||
30567179|NCT01425008|58574073|FG014|Dose Expansion Phase|Other|0|||
30567180|NCT01425008|58574074|FG015|Dose Expansion Phase|Other|0|||
30567181|NCT01425008|58574075|FG016|Dose Expansion Phase|Other|2|||
30567182|NCT01425008|58574076|FG017|Dose Expansion Phase|Other|0|||
30567183|NCT01425008|58574077|FG018|Dose Expansion Phase|Other|4|||
30567184|NCT01425008|58574059|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567185|NCT01425008|58574060|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567186|NCT01425008|58574061|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567187|NCT01425008|58574062|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567188|NCT01425008|58574063|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567189|NCT01425008|58574064|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567190|NCT01425008|58574065|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
30958639|NCT02163694|59023667|FG000|Overall Study|Progressive disease per protocol|122|||
30567191|NCT01425008|58574066|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567192|NCT01425008|58574067|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567193|NCT01425008|58574068|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567194|NCT01425008|58574069|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
30567195|NCT01425008|58574070|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
30567196|NCT01425008|58574071|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567197|NCT01425008|58574072|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567198|NCT01425008|58574073|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567199|NCT01425008|58574074|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
30567200|NCT01425008|58574075|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
30567201|NCT01425008|58574076|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
30567202|NCT01425008|58574077|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
30567203|NCT01425008|58574059|FG000|Dose Expansion Phase|Adverse Event|0|||
30567204|NCT01425008|58574060|FG001|Dose Expansion Phase|Adverse Event|0|||
30567205|NCT01425008|58574061|FG002|Dose Expansion Phase|Adverse Event|0|||
30567206|NCT01425008|58574062|FG003|Dose Expansion Phase|Adverse Event|0|||
30567207|NCT01425008|58574063|FG004|Dose Expansion Phase|Adverse Event|0|||
30567208|NCT01425008|58574064|FG005|Dose Expansion Phase|Adverse Event|0|||
30567209|NCT01425008|58574065|FG006|Dose Expansion Phase|Adverse Event|0|||
30567210|NCT01425008|58574066|FG007|Dose Expansion Phase|Adverse Event|0|||
30567211|NCT01425008|58574067|FG008|Dose Expansion Phase|Adverse Event|0|||
30567212|NCT01425008|58574068|FG009|Dose Expansion Phase|Adverse Event|0|||
30567213|NCT01425008|58574069|FG010|Dose Expansion Phase|Adverse Event|2|||
30567214|NCT01425008|58574070|FG011|Dose Expansion Phase|Adverse Event|3|||
30567215|NCT01425008|58574071|FG012|Dose Expansion Phase|Adverse Event|3|||
30567216|NCT01425008|58574072|FG013|Dose Expansion Phase|Adverse Event|0|||
30567217|NCT01425008|58574073|FG014|Dose Expansion Phase|Adverse Event|1|||
30567218|NCT01425008|58574074|FG015|Dose Expansion Phase|Adverse Event|1|||
30567219|NCT01425008|58574075|FG016|Dose Expansion Phase|Adverse Event|5|||
30567220|NCT01425008|58574076|FG017|Dose Expansion Phase|Adverse Event|0|||
30567221|NCT01425008|58574077|FG018|Dose Expansion Phase|Adverse Event|3|||
30567222|NCT01425008|58574059|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
30567223|NCT01425008|58574060|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
30567224|NCT01425008|58574061|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
30567225|NCT01425008|58574062|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
30567226|NCT01425008|58574063|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
30567227|NCT01425008|58574064|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
30567228|NCT01425008|58574065|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
30567229|NCT01425008|58574066|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
30567230|NCT01425008|58574067|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
30567231|NCT01425008|58574068|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
30567232|NCT01425008|58574069|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
30567233|NCT01425008|58574070|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
30567234|NCT01425008|58574071|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
30567235|NCT01425008|58574072|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
30567236|NCT01425008|58574073|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
30567237|NCT01425008|58574074|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
30567238|NCT01425008|58574075|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
30567239|NCT01425008|58574076|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
30567240|NCT01425008|58574077|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
30567241|NCT01425008|58574059|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567242|NCT01425008|58574060|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567243|NCT01425008|58574061|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567244|NCT01425008|58574062|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567245|NCT01425008|58574063|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567246|NCT01425008|58574064|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567247|NCT01425008|58574065|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567248|NCT01425008|58574066|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567249|NCT01425008|58574067|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567250|NCT01425008|58574068|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567251|NCT01425008|58574069|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567252|NCT01425008|58574070|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567253|NCT01425008|58574071|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567254|NCT01425008|58574072|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567255|NCT01425008|58574073|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567256|NCT01425008|58574074|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567257|NCT01425008|58574075|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30567258|NCT01425008|58574076|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
30666722|NCT00882908|58680597|FG000|Overall Study|Lost to Follow-up|3|||
30666723|NCT00882908|58680598|FG001|Overall Study|Lost to Follow-up|5|||
30666724|NCT00882908|58680599|FG002|Overall Study|Lost to Follow-up|3|||
30666725|NCT00882908|58680600|FG003|Overall Study|Lost to Follow-up|1|||
30666726|NCT00882908|58680601|FG004|Overall Study|Lost to Follow-up|2|||
30780135|NCT02992288|58791837|FG003|Overall Study|Physician Decision|0|||
30567259|NCT01425008|58574077|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
30567260|NCT04425902|58574130|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
30666727|NCT00882908|58680597|FG000|Overall Study|Protocol Violation|0|||
30666728|NCT00882908|58680598|FG001|Overall Study|Protocol Violation|1|||
30666729|NCT00882908|58680599|FG002|Overall Study|Protocol Violation|0|||
30666730|NCT00882908|58680600|FG003|Overall Study|Protocol Violation|0|||
30567261|NCT04072146|58574143|FG000|Overall Study|Adverse Event|0|||
30567262|NCT04072146|58574144|FG001|Overall Study|Adverse Event|1|||
30567263|NCT03861481|58574158|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
30567264|NCT03861481|58574159|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
30567265|NCT03861481|58574158|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
30567266|NCT03861481|58574159|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
30567267|NCT03861481|58574158|FG000|Overall Study|Relapse|1|||
30567268|NCT03861481|58574159|FG001|Overall Study|Relapse|0|||
30567269|NCT03861481|58574158|FG000|Overall Study|Withdrawal by Subject|0|||
30567270|NCT03861481|58574159|FG001|Overall Study|Withdrawal by Subject|1|||
30567271|NCT03861481|58574158|FG000|Overall Study|Lack of Efficacy|4|||
30567272|NCT03861481|58574159|FG001|Overall Study|Lack of Efficacy|5|||
30567273|NCT03648476|58574171|FG000|Overall Study|Withdrawal by Subject|2|||
30666731|NCT00882908|58680601|FG004|Overall Study|Protocol Violation|0|||
30666732|NCT00882908|58680597|FG000|Overall Study|Withdrawal by Subject|0|||
30666733|NCT00882908|58680598|FG001|Overall Study|Withdrawal by Subject|0|||
30666734|NCT00882908|58680599|FG002|Overall Study|Withdrawal by Subject|3|||
30666735|NCT00882908|58680600|FG003|Overall Study|Withdrawal by Subject|5|||
30567274|NCT03648476|58574172|FG001|Overall Study|Withdrawal by Subject|1|||
30567275|NCT04660799|58574190|FG000|Overall Study|Ongoing in Study|9|||
30567276|NCT04660799|58574191|FG001|Overall Study|Ongoing in Study|13|||
30567277|NCT04660799|58574190|FG000|Overall Study|Progressive Disease|1|||
30567278|NCT04660799|58574191|FG001|Overall Study|Progressive Disease|1|||
30567279|NCT04660799|58574190|FG000|Overall Study|Death|2|||
30567280|NCT04660799|58574191|FG001|Overall Study|Death|1|||
30567281|NCT04660799|58574190|FG000|Overall Study|Adverse Event|2|||
30567282|NCT04660799|58574191|FG001|Overall Study|Adverse Event|1|||
30567283|NCT04660799|58574190|FG000|Overall Study|Withdrawal by Subject|2|||
30567284|NCT04660799|58574191|FG001|Overall Study|Withdrawal by Subject|4|||
30567285|NCT04545060|58574199|FG000|Overall Study|Adverse Event|0|||
30567286|NCT04545060|58574200|FG001|Overall Study|Adverse Event|1|||
30567287|NCT04545060|58574199|FG000|Overall Study|Death|0|||
30567288|NCT04545060|58574200|FG001|Overall Study|Death|5|||
30567289|NCT04545060|58574199|FG000|Overall Study|Lost to Follow-up|10|||
30567290|NCT04545060|58574200|FG001|Overall Study|Lost to Follow-up|13|||
30567291|NCT04545060|58574199|FG000|Overall Study|Physician Decision|3|||
30567292|NCT04545060|58574200|FG001|Overall Study|Physician Decision|0|||
30567293|NCT04545060|58574199|FG000|Overall Study|Withdrawal by Subject|17|||
30567294|NCT04545060|58574200|FG001|Overall Study|Withdrawal by Subject|22|||
30567295|NCT03533660|58574256|FG000|Overall Study|Withdrawal by Subject|2|||
30567296|NCT03533660|58574257|FG001|Overall Study|Withdrawal by Subject|2|||
30567297|NCT03533660|58574256|FG000|Overall Study|Death|2|||
30567298|NCT03533660|58574257|FG001|Overall Study|Death|4|||
30567299|NCT03533660|58574256|FG000|Overall Study|Adverse Event|0|||
30567300|NCT03533660|58574257|FG001|Overall Study|Adverse Event|2|||
30567301|NCT03416127|58574271|FG000|Overall Study|Withdrawal by Subject|0|||
30567302|NCT03416127|58574272|FG001|Overall Study|Withdrawal by Subject|1|||
30567303|NCT03416127|58574273|FG002|Overall Study|Withdrawal by Subject|1|||
30567304|NCT02986334|58574307|FG000|Overall Study|Withdrawal by Subject|0|||
30567305|NCT02986334|58574308|FG001|Overall Study|Withdrawal by Subject|1|||
30567306|NCT02986334|58574309|FG002|Overall Study|Withdrawal by Subject|2|||
30567307|NCT02986334|58574307|FG000|Overall Study|Lost to Follow-up|1|||
30567308|NCT02986334|58574308|FG001|Overall Study|Lost to Follow-up|2|||
30567309|NCT02986334|58574309|FG002|Overall Study|Lost to Follow-up|1|||
30567310|NCT02986334|58574307|FG000|Overall Study|Adverse Event|0|||
30567311|NCT02986334|58574308|FG001|Overall Study|Adverse Event|2|||
30567312|NCT02986334|58574309|FG002|Overall Study|Adverse Event|1|||
30567313|NCT02986334|58574307|FG000|Overall Study|non compliance in phone ratings|2|||
30567314|NCT02986334|58574308|FG001|Overall Study|non compliance in phone ratings|1|||
30567315|NCT02986334|58574309|FG002|Overall Study|non compliance in phone ratings|2|||
30567316|NCT02986334|58574307|FG000|Overall Study|undisclosed comorbidities|0|||
30567317|NCT02986334|58574308|FG001|Overall Study|undisclosed comorbidities|1|||
30567318|NCT02986334|58574309|FG002|Overall Study|undisclosed comorbidities|1|||
30567319|NCT02210221|58574331|FG000|Overall Study|Lack of Efficacy|7|||
30666736|NCT00882908|58680601|FG004|Overall Study|Withdrawal by Subject|2|||
30666737|NCT00882908|58680597|FG000|Overall Study|Subject reached a virologic endpoint|0|||
30666738|NCT00882908|58680598|FG001|Overall Study|Subject reached a virologic endpoint|0|||
30666739|NCT00882908|58680599|FG002|Overall Study|Subject reached a virologic endpoint|0|||
30666740|NCT00882908|58680600|FG003|Overall Study|Subject reached a virologic endpoint|0|||
30567320|NCT02210221|58574331|FG000|Overall Study|Withdrawal by Subject|43|||
30567321|NCT02124902|58574344|FG000|Overall Study|Adverse Event|7|||
30567322|NCT02124902|58574345|FG001|Overall Study|Adverse Event|2|||
30567323|NCT02124902|58574344|FG000|Overall Study|Went to alternative treatment|4|||
30567324|NCT02124902|58574345|FG001|Overall Study|Went to alternative treatment|0|||
30567325|NCT02124902|58574344|FG000|Overall Study|Withdrawal by Subject|2|||
30567326|NCT02124902|58574345|FG001|Overall Study|Withdrawal by Subject|1|||
30567327|NCT02124902|58574344|FG000|Overall Study|Physician Decision|2|||
30567328|NCT02124902|58574345|FG001|Overall Study|Physician Decision|0|||
30567329|NCT02124902|58574344|FG000|Overall Study|Not eligible|1|||
30567330|NCT02124902|58574345|FG001|Overall Study|Not eligible|0|||
30567331|NCT02124902|58574344|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
30567332|NCT02124902|58574345|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
30567333|NCT01940341|58574353|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
30567334|NCT01940341|58574354|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
30567335|NCT01940341|58574353|FG000|Double-Blind Phase|Adverse Event|3|||
30567336|NCT01940341|58574354|FG001|Double-Blind Phase|Adverse Event|2|||
30567337|NCT01940341|58574353|FG000|Double-Blind Phase|Withdrew Consent|3|||
30567338|NCT01940341|58574354|FG001|Double-Blind Phase|Withdrew Consent|2|||
30567339|NCT01940341|58574353|FG000|Double-Blind Phase|Lost to Follow-up|4|||
30567340|NCT01940341|58574354|FG001|Double-Blind Phase|Lost to Follow-up|1|||
30567341|NCT01940341|58574353|FG000|Double-Blind Phase|Pregnancy|0|||
30567342|NCT01940341|58574354|FG001|Double-Blind Phase|Pregnancy|1|||
30567343|NCT01940341|58574353|FG000|Double-Blind Phase|Investigator's Discretion|1|||
30567344|NCT01940341|58574354|FG001|Double-Blind Phase|Investigator's Discretion|0|||
30567345|NCT01940341|58574353|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0|||
30567346|NCT01940341|58574354|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
30567347|NCT01940341|58574353|FG000|Double-Blind Phase|Protocol Specified Criteria|1|||
30567348|NCT01940341|58574354|FG001|Double-Blind Phase|Protocol Specified Criteria|0|||
30567349|NCT01940341|58574353|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269|||
30567350|NCT01940341|58574354|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132|||
30567351|NCT01940341|58574353|FG000|Open-label Extension Phase|Still on Study|4|||
30567352|NCT01940341|58574354|FG001|Open-label Extension Phase|Still on Study|1|||
30567353|NCT01877837|58574362|FG000|Overall Study|Lost to Follow-up|1|||
30567354|NCT01877837|58574362|FG000|Overall Study|Ineligible|4|||
30567355|NCT01624142|58574382|FG000|Overall Study|Withdrawal by Subject|14|||
30567356|NCT01624142|58574383|FG001|Overall Study|Withdrawal by Subject|4|||
30567357|NCT01624142|58574382|FG000|Overall Study|Death|3|||
30567358|NCT01624142|58574383|FG001|Overall Study|Death|6|||
30567359|NCT01624142|58574382|FG000|Overall Study|Study Closure|12|||
30567360|NCT01624142|58574383|FG001|Overall Study|Study Closure|6|||
30567361|NCT01624142|58574382|FG000|Overall Study|Lost to Follow-up|2|||
30567362|NCT01624142|58574383|FG001|Overall Study|Lost to Follow-up|0|||
30567363|NCT01624142|58574382|FG000|Overall Study|Other|1|||
30567364|NCT01624142|58574383|FG001|Overall Study|Other|0|||
30567365|NCT01535807|58574392|FG000|Overall Study|Withdrawal by Subject|1|||
30567366|NCT01535807|58574393|FG001|Overall Study|Withdrawal by Subject|1|||
30567367|NCT01535807|58574392|FG000|Overall Study|Data collection error|1|||
30567368|NCT01535807|58574393|FG001|Overall Study|Data collection error|1|||
30567369|NCT01375764|58574405|FG000|Overall Study|Lost to Follow-up|0|||
30567370|NCT01375764|58574406|FG001|Overall Study|Lost to Follow-up|1|||
30567371|NCT01375764|58574407|FG002|Overall Study|Lost to Follow-up|0|||
30567372|NCT01375764|58574408|FG003|Overall Study|Lost to Follow-up|0|||
30567373|NCT01375764|58574409|FG004|Overall Study|Lost to Follow-up|0|||
30567374|NCT01375764|58574405|FG000|Overall Study|Withdrawal by Subject|2|||
30567375|NCT01375764|58574406|FG001|Overall Study|Withdrawal by Subject|0|||
30567376|NCT01375764|58574407|FG002|Overall Study|Withdrawal by Subject|0|||
30567377|NCT01375764|58574408|FG003|Overall Study|Withdrawal by Subject|0|||
30567378|NCT01375764|58574409|FG004|Overall Study|Withdrawal by Subject|1|||
30567379|NCT01375764|58574405|FG000|Overall Study|Other|0|||
30567380|NCT01375764|58574406|FG001|Overall Study|Other|0|||
30567381|NCT01375764|58574407|FG002|Overall Study|Other|0|||
30567382|NCT01375764|58574408|FG003|Overall Study|Other|1|||
30567383|NCT01375764|58574409|FG004|Overall Study|Other|0|||
30567384|NCT00722046|58574428|FG000|Overall Study|Adverse Event|0|||
30567385|NCT00722046|58574429|FG001|Overall Study|Adverse Event|1|||
30567386|NCT00722046|58574430|FG002|Overall Study|Adverse Event|2|||
30567387|NCT00722046|58574431|FG003|Overall Study|Adverse Event|1|||
30567388|NCT00722046|58574432|FG004|Overall Study|Adverse Event|2|||
30567389|NCT00722046|58574433|FG005|Overall Study|Adverse Event|1|||
30567390|NCT00722046|58574434|FG006|Overall Study|Adverse Event|0|||
30567391|NCT00722046|58574428|FG000|Overall Study|Death|0|||
30567392|NCT00722046|58574429|FG001|Overall Study|Death|1|||
30567393|NCT00722046|58574430|FG002|Overall Study|Death|0|||
30567394|NCT00722046|58574431|FG003|Overall Study|Death|0|||
30567395|NCT00722046|58574432|FG004|Overall Study|Death|0|||
30958640|NCT02163694|59023668|FG001|Overall Study|Progressive disease per protocol|197|||
30958641|NCT02163694|59023667|FG000|Overall Study|Other, not specified|13|||
30958642|NCT02163694|59023668|FG001|Overall Study|Other, not specified|22|||
30567396|NCT00722046|58574433|FG005|Overall Study|Death|0|||
30567397|NCT00722046|58574434|FG006|Overall Study|Death|2|||
30567398|NCT00722046|58574428|FG000|Overall Study|Protocol Violation|1|||
30567399|NCT00722046|58574429|FG001|Overall Study|Protocol Violation|0|||
30567400|NCT00722046|58574430|FG002|Overall Study|Protocol Violation|0|||
30567401|NCT00722046|58574431|FG003|Overall Study|Protocol Violation|0|||
30567402|NCT00722046|58574432|FG004|Overall Study|Protocol Violation|0|||
30567403|NCT00722046|58574433|FG005|Overall Study|Protocol Violation|1|||
30567404|NCT00722046|58574434|FG006|Overall Study|Protocol Violation|0|||
30567405|NCT00722046|58574428|FG000|Overall Study|Withdrawal by Subject|3|||
30567406|NCT00722046|58574429|FG001|Overall Study|Withdrawal by Subject|3|||
30567407|NCT00722046|58574430|FG002|Overall Study|Withdrawal by Subject|4|||
30567408|NCT00722046|58574431|FG003|Overall Study|Withdrawal by Subject|4|||
30567409|NCT00722046|58574432|FG004|Overall Study|Withdrawal by Subject|4|||
30567410|NCT00722046|58574433|FG005|Overall Study|Withdrawal by Subject|7|||
30567411|NCT00722046|58574434|FG006|Overall Study|Withdrawal by Subject|3|||
30567412|NCT00722046|58574428|FG000|Overall Study|Randomized, but not treated|1|||
30567413|NCT00722046|58574429|FG001|Overall Study|Randomized, but not treated|1|||
30567414|NCT00722046|58574430|FG002|Overall Study|Randomized, but not treated|0|||
30567415|NCT00722046|58574431|FG003|Overall Study|Randomized, but not treated|2|||
30567416|NCT00722046|58574432|FG004|Overall Study|Randomized, but not treated|0|||
30567417|NCT00722046|58574433|FG005|Overall Study|Randomized, but not treated|0|||
30567418|NCT00722046|58574434|FG006|Overall Study|Randomized, but not treated|0|||
30567419|NCT00722046|58574428|FG000|Overall Study|Other|0|||
30567420|NCT00722046|58574429|FG001|Overall Study|Other|0|||
30567421|NCT00722046|58574430|FG002|Overall Study|Other|1|||
30567422|NCT00722046|58574431|FG003|Overall Study|Other|1|||
30567423|NCT00722046|58574432|FG004|Overall Study|Other|3|||
30567424|NCT00722046|58574433|FG005|Overall Study|Other|2|||
30567425|NCT00722046|58574434|FG006|Overall Study|Other|1|||
30567426|NCT00614523|58574454|FG000|Overall Study|Adverse Event|4|||
30567427|NCT00614523|58574455|FG001|Overall Study|Adverse Event|20|||
30567428|NCT00614523|58574454|FG000|Overall Study|Death|5|||
30567429|NCT00614523|58574455|FG001|Overall Study|Death|8|||
30567430|NCT00614523|58574454|FG000|Overall Study|Lack of Efficacy|9|||
30567431|NCT00614523|58574455|FG001|Overall Study|Lack of Efficacy|11|||
30567432|NCT00614523|58574454|FG000|Overall Study|Lost to Follow-up|0|||
30567433|NCT00614523|58574455|FG001|Overall Study|Lost to Follow-up|1|||
30567434|NCT00614523|58574454|FG000|Overall Study|Protocol Violation|3|||
30567435|NCT00614523|58574455|FG001|Overall Study|Protocol Violation|2|||
30567436|NCT00614523|58574454|FG000|Overall Study|Withdrawal by Subject|12|||
30567437|NCT00614523|58574455|FG001|Overall Study|Withdrawal by Subject|22|||
30567438|NCT00614523|58574454|FG000|Overall Study|Other|6|||
30567439|NCT00614523|58574455|FG001|Overall Study|Other|11|||
30567440|NCT00614523|58574454|FG000|Overall Study|Ineligibility Determined|1|||
30567441|NCT00614523|58574455|FG001|Overall Study|Ineligibility Determined|2|||
30567442|NCT00614523|58574454|FG000|Overall Study|Disease Progression|0|||
30567443|NCT00614523|58574455|FG001|Overall Study|Disease Progression|8|||
30567444|NCT00614523|58574454|FG000|Overall Study|Administrative Decision|23|||
30567445|NCT00614523|58574455|FG001|Overall Study|Administrative Decision|46|||
30567446|NCT00523341|58574463|FG000|Overall Study|Withdrawal by Subject|399|||
30567447|NCT00523341|58574464|FG001|Overall Study|Withdrawal by Subject|427|||
30567448|NCT00523341|58574463|FG000|Overall Study|Other|181|||
30567449|NCT00523341|58574464|FG001|Overall Study|Other|198|||
30567450|NCT00523341|58574463|FG000|Overall Study|Adverse Event|122|||
30567451|NCT00523341|58574464|FG001|Overall Study|Adverse Event|155|||
30567452|NCT00523341|58574463|FG000|Overall Study|Death|101|||
30567453|NCT00523341|58574464|FG001|Overall Study|Death|110|||
30567454|NCT00523341|58574463|FG000|Overall Study|Lost to Follow-up|73|||
30567455|NCT00523341|58574464|FG001|Overall Study|Lost to Follow-up|61|||
30567456|NCT00523341|58574463|FG000|Overall Study|Non-compliance|20|||
30567457|NCT00523341|58574464|FG001|Overall Study|Non-compliance|13|||
30567458|NCT00523341|58574463|FG000|Overall Study|Physician Decision|14|||
30567459|NCT00523341|58574464|FG001|Overall Study|Physician Decision|13|||
30567460|NCT00523341|58574463|FG000|Overall Study|Requirement for Alternative Therapy|4|||
30567461|NCT00523341|58574464|FG001|Overall Study|Requirement for Alternative Therapy|14|||
30567462|NCT00523341|58574463|FG000|Overall Study|Protocol Deviation|6|||
30567463|NCT00523341|58574464|FG001|Overall Study|Protocol Deviation|5|||
30567464|NCT00523341|58574463|FG000|Overall Study|Ineligibility Determined|3|||
30567465|NCT00523341|58574464|FG001|Overall Study|Ineligibility Determined|4|||
30567466|NCT00523341|58574463|FG000|Overall Study|Disease Progression|1|||
30567467|NCT00523341|58574464|FG001|Overall Study|Disease Progression|0|||
30567468|NCT00364013|58574472|FG000|Overall Study|Ineligibility determined|4|||
30567469|NCT00364013|58574473|FG001|Overall Study|Ineligibility determined|2|||
30567470|NCT00364013|58574472|FG000|Overall Study|Adverse Event|4|||
30567471|NCT00364013|58574473|FG001|Overall Study|Adverse Event|3|||
30567472|NCT00364013|58574472|FG000|Overall Study|Withdrawal by Subject|13|||
30567473|NCT00364013|58574473|FG001|Overall Study|Withdrawal by Subject|18|||
30567474|NCT00364013|58574472|FG000|Overall Study|Physician Decision|3|||
30567475|NCT00364013|58574473|FG001|Overall Study|Physician Decision|3|||
30567476|NCT00364013|58574472|FG000|Overall Study|Lost to Follow-up|10|||
30567477|NCT00364013|58574473|FG001|Overall Study|Lost to Follow-up|3|||
30567478|NCT00364013|58574472|FG000|Overall Study|Protocol-specified criteria|6|||
30567479|NCT00364013|58574473|FG001|Overall Study|Protocol-specified criteria|6|||
30567480|NCT00364013|58574472|FG000|Overall Study|Other|41|||
30567481|NCT00364013|58574473|FG001|Overall Study|Other|47|||
30567482|NCT00364013|58574472|FG000|Overall Study|Ongoing|20|||
30567483|NCT00364013|58574473|FG001|Overall Study|Ongoing|13|||
30567484|NCT00345839|58574485|FG000|Overall Study|Withdrawal by Subject|91|||
30567485|NCT00345839|58574486|FG001|Overall Study|Withdrawal by Subject|98|||
30567486|NCT00345839|58574485|FG000|Overall Study|Lost to Follow-up|58|||
30567487|NCT00345839|58574486|FG001|Overall Study|Lost to Follow-up|61|||
30567488|NCT00330759|58574494|FG000|Overall Study|Death|316|||
30567489|NCT00330759|58574495|FG001|Overall Study|Death|310|||
30567490|NCT00330759|58574494|FG000|Overall Study|Disease progression|104|||
30567491|NCT00330759|58574495|FG001|Overall Study|Disease progression|126|||
30567492|NCT00330759|58574494|FG000|Overall Study|Withdrawal by Subject|143|||
30567493|NCT00330759|58574495|FG001|Overall Study|Withdrawal by Subject|124|||
30567494|NCT00330759|58574494|FG000|Overall Study|Adverse Event|48|||
30567495|NCT00330759|58574495|FG001|Overall Study|Adverse Event|36|||
30567496|NCT00330759|58574494|FG000|Overall Study|Participant request|31|||
30567497|NCT00330759|58574495|FG001|Overall Study|Participant request|22|||
30567498|NCT00330759|58574494|FG000|Overall Study|Lost to Follow-up|16|||
30567499|NCT00330759|58574495|FG001|Overall Study|Lost to Follow-up|22|||
30567500|NCT00330759|58574494|FG000|Overall Study|Noncompliance|15|||
30567501|NCT00330759|58574495|FG001|Overall Study|Noncompliance|17|||
30567502|NCT00330759|58574494|FG000|Overall Study|Physician Decision|1|||
30567503|NCT00330759|58574495|FG001|Overall Study|Physician Decision|2|||
30567504|NCT00330759|58574494|FG000|Overall Study|Protocol deviation|0|||
30567505|NCT00330759|58574495|FG001|Overall Study|Protocol deviation|2|||
30567506|NCT00330759|58574494|FG000|Overall Study|Ineligibility determined|2|||
30567507|NCT00330759|58574495|FG001|Overall Study|Ineligibility determined|1|||
30567508|NCT00330759|58574494|FG000|Overall Study|Other|36|||
30567509|NCT00330759|58574495|FG001|Overall Study|Other|44|||
30567510|NCT00113763|58574503|FG000|Overall Study|Adverse Event|5|||
30567511|NCT00113763|58574504|FG001|Overall Study|Adverse Event|2|||
30567512|NCT00113763|58574503|FG000|Overall Study|Disease Progression|28|||
30567513|NCT00113763|58574504|FG001|Overall Study|Disease Progression|14|||
30567514|NCT00113763|58574503|FG000|Overall Study|Lost to Follow-up|10|||
30567515|NCT00113763|58574504|FG001|Overall Study|Lost to Follow-up|0|||
30567516|NCT00113763|58574503|FG000|Overall Study|Withdrawal by Subject|1|||
30567517|NCT00113763|58574504|FG001|Overall Study|Withdrawal by Subject|4|||
30567518|NCT00113763|58574503|FG000|Overall Study|Other|27|||
30567519|NCT00113763|58574504|FG001|Overall Study|Other|6|||
30567520|NCT00113763|58574503|FG000|Overall Study|Non-compliance|1|||
30567521|NCT00113763|58574504|FG001|Overall Study|Non-compliance|0|||
30567522|NCT00113763|58574503|FG000|Overall Study|Ongoing|1|||
30567523|NCT00113763|58574504|FG001|Overall Study|Ongoing|0|||
30567524|NCT05166902|58574518|FG000|First Intervention|Lost to Follow-up|0|||
30567525|NCT05166902|58574519|FG001|First Intervention|Lost to Follow-up|1|||
30567526|NCT05142566|58574525|FG000|Overall Study|Protocol Violation|1|||
30567527|NCT05083949|58574531|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
30567528|NCT05083949|58574532|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
30567529|NCT05083949|58574531|FG000|Period 1|Adverse Event|1|||
30567530|NCT05083949|58574532|FG001|Period 1|Adverse Event|1|||
30567531|NCT05083949|58574531|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
30567532|NCT05083949|58574532|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
30567533|NCT05083949|58574531|FG000|Period 2|Adverse Event|0|||
30567534|NCT05083949|58574532|FG001|Period 2|Adverse Event|2|||
30567535|NCT04982575|58574544|FG000|Overall Study|Withdrawal by Subject|2|||
30567536|NCT04982575|58574545|FG001|Overall Study|Withdrawal by Subject|0|||
30567537|NCT04982575|58574546|FG002|Overall Study|Withdrawal by Subject|2|||
30567538|NCT04554394|58574600|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
30567539|NCT04554394|58574601|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
30567540|NCT04554394|58574600|FG000|Overall Study|Withdrawal by Subject|2|||
30567541|NCT04554394|58574601|FG001|Overall Study|Withdrawal by Subject|2|||
30567542|NCT04554394|58574600|FG000|Overall Study|Lost to Follow-up|2|||
30567543|NCT04554394|58574601|FG001|Overall Study|Lost to Follow-up|2|||
30567544|NCT04554394|58574600|FG000|Overall Study|Physician Decision|1|||
30567545|NCT04554394|58574601|FG001|Overall Study|Physician Decision|1|||
30567546|NCT04518410|58574631|FG000|Overall Study|Lost to Follow-up|1|||
30567547|NCT04518410|58574632|FG001|Overall Study|Lost to Follow-up|1|||
30567548|NCT04518410|58574633|FG002|Overall Study|Lost to Follow-up|8|||
30567549|NCT04518410|58574634|FG003|Overall Study|Lost to Follow-up|5|||
30567550|NCT04518410|58574635|FG004|Overall Study|Lost to Follow-up|92|||
30567551|NCT04518410|58574636|FG005|Overall Study|Lost to Follow-up|27|||
30567552|NCT04518410|58574637|FG006|Overall Study|Lost to Follow-up|26|||
30567553|NCT04518410|58574638|FG007|Overall Study|Lost to Follow-up|3|||
30567554|NCT04518410|58574639|FG008|Overall Study|Lost to Follow-up|2|||
30567555|NCT04518410|58574640|FG009|Overall Study|Lost to Follow-up|15|||
30567556|NCT04518410|58574641|FG010|Overall Study|Lost to Follow-up|9|||
30567557|NCT04518410|58574642|FG011|Overall Study|Lost to Follow-up|13|||
30567558|NCT04518410|58574643|FG012|Overall Study|Lost to Follow-up|9|||
30567559|NCT04518410|58574644|FG013|Overall Study|Lost to Follow-up|14|||
30567560|NCT04518410|58574645|FG014|Overall Study|Lost to Follow-up|8|||
30567561|NCT04518410|58574646|FG015|Overall Study|Lost to Follow-up|10|||
30567562|NCT04518410|58574647|FG016|Overall Study|Lost to Follow-up|6|||
30567563|NCT04518410|58574648|FG017|Overall Study|Lost to Follow-up|8|||
30567564|NCT04518410|58574649|FG018|Overall Study|Lost to Follow-up|20|||
30567565|NCT04518410|58574650|FG019|Overall Study|Lost to Follow-up|6|||
30567566|NCT04518410|58574651|FG020|Overall Study|Lost to Follow-up|4|||
30567567|NCT04518410|58574652|FG021|Overall Study|Lost to Follow-up|22|||
30567568|NCT04518410|58574653|FG022|Overall Study|Lost to Follow-up|1|||
30567569|NCT04518410|58574654|FG023|Overall Study|Lost to Follow-up|7|||
30567570|NCT04518410|58574655|FG024|Overall Study|Lost to Follow-up|6|||
30567571|NCT04518410|58574631|FG000|Overall Study|Withdrawal by Subject|1|||
30567572|NCT04518410|58574632|FG001|Overall Study|Withdrawal by Subject|2|||
30567573|NCT04518410|58574633|FG002|Overall Study|Withdrawal by Subject|2|||
30567574|NCT04518410|58574634|FG003|Overall Study|Withdrawal by Subject|3|||
30567575|NCT04518410|58574635|FG004|Overall Study|Withdrawal by Subject|20|||
30567576|NCT04518410|58574636|FG005|Overall Study|Withdrawal by Subject|21|||
30567577|NCT04518410|58574637|FG006|Overall Study|Withdrawal by Subject|27|||
30567578|NCT04518410|58574638|FG007|Overall Study|Withdrawal by Subject|6|||
30567579|NCT04518410|58574639|FG008|Overall Study|Withdrawal by Subject|2|||
30567580|NCT04518410|58574640|FG009|Overall Study|Withdrawal by Subject|12|||
30567581|NCT04518410|58574641|FG010|Overall Study|Withdrawal by Subject|6|||
30567582|NCT04518410|58574642|FG011|Overall Study|Withdrawal by Subject|7|||
30567583|NCT04518410|58574643|FG012|Overall Study|Withdrawal by Subject|2|||
30567584|NCT04518410|58574644|FG013|Overall Study|Withdrawal by Subject|13|||
30567585|NCT04518410|58574645|FG014|Overall Study|Withdrawal by Subject|4|||
30567586|NCT04518410|58574646|FG015|Overall Study|Withdrawal by Subject|9|||
30567587|NCT04518410|58574647|FG016|Overall Study|Withdrawal by Subject|0|||
30567588|NCT04518410|58574648|FG017|Overall Study|Withdrawal by Subject|14|||
30567589|NCT04518410|58574649|FG018|Overall Study|Withdrawal by Subject|13|||
30567590|NCT04518410|58574650|FG019|Overall Study|Withdrawal by Subject|9|||
30567591|NCT04518410|58574651|FG020|Overall Study|Withdrawal by Subject|13|||
30567592|NCT04518410|58574652|FG021|Overall Study|Withdrawal by Subject|3|||
30567593|NCT04518410|58574653|FG022|Overall Study|Withdrawal by Subject|2|||
30567594|NCT04518410|58574654|FG023|Overall Study|Withdrawal by Subject|9|||
30567595|NCT04518410|58574655|FG024|Overall Study|Withdrawal by Subject|8|||
30567596|NCT04518410|58574631|FG000|Overall Study|Other|1|||
30567597|NCT04518410|58574632|FG001|Overall Study|Other|0|||
30567598|NCT04518410|58574633|FG002|Overall Study|Other|0|||
30567599|NCT04518410|58574634|FG003|Overall Study|Other|1|||
30567600|NCT04518410|58574635|FG004|Overall Study|Other|6|||
30567601|NCT04518410|58574636|FG005|Overall Study|Other|6|||
30567602|NCT04518410|58574637|FG006|Overall Study|Other|5|||
30567603|NCT04518410|58574638|FG007|Overall Study|Other|2|||
30567604|NCT04518410|58574639|FG008|Overall Study|Other|0|||
30567605|NCT04518410|58574640|FG009|Overall Study|Other|1|||
30567606|NCT04518410|58574641|FG010|Overall Study|Other|0|||
30567607|NCT04518410|58574642|FG011|Overall Study|Other|2|||
30567608|NCT04518410|58574643|FG012|Overall Study|Other|0|||
30567609|NCT04518410|58574644|FG013|Overall Study|Other|0|||
30567610|NCT04518410|58574645|FG014|Overall Study|Other|0|||
30567611|NCT04518410|58574646|FG015|Overall Study|Other|3|||
30567612|NCT04518410|58574647|FG016|Overall Study|Other|1|||
30567613|NCT04518410|58574648|FG017|Overall Study|Other|1|||
30567614|NCT04518410|58574649|FG018|Overall Study|Other|1|||
30567615|NCT04518410|58574650|FG019|Overall Study|Other|0|||
30567616|NCT04518410|58574651|FG020|Overall Study|Other|0|||
30567617|NCT04518410|58574652|FG021|Overall Study|Other|0|||
30567618|NCT04518410|58574653|FG022|Overall Study|Other|1|||
30567619|NCT04518410|58574654|FG023|Overall Study|Other|2|||
30567620|NCT04518410|58574655|FG024|Overall Study|Other|2|||
30567621|NCT04518410|58574631|FG000|Overall Study|Protocol Violation|0|||
30567622|NCT04518410|58574632|FG001|Overall Study|Protocol Violation|0|||
30567623|NCT04518410|58574633|FG002|Overall Study|Protocol Violation|0|||
30567624|NCT04518410|58574634|FG003|Overall Study|Protocol Violation|2|||
30567625|NCT04518410|58574635|FG004|Overall Study|Protocol Violation|17|||
30567626|NCT04518410|58574636|FG005|Overall Study|Protocol Violation|1|||
30567627|NCT04518410|58574637|FG006|Overall Study|Protocol Violation|2|||
30567628|NCT04518410|58574638|FG007|Overall Study|Protocol Violation|1|||
30567629|NCT04518410|58574639|FG008|Overall Study|Protocol Violation|0|||
30567630|NCT04518410|58574640|FG009|Overall Study|Protocol Violation|0|||
30567631|NCT04518410|58574641|FG010|Overall Study|Protocol Violation|0|||
30567632|NCT04518410|58574642|FG011|Overall Study|Protocol Violation|0|||
30567633|NCT04518410|58574643|FG012|Overall Study|Protocol Violation|0|||
30567634|NCT04518410|58574644|FG013|Overall Study|Protocol Violation|0|||
30567635|NCT04518410|58574645|FG014|Overall Study|Protocol Violation|0|||
30567636|NCT04518410|58574646|FG015|Overall Study|Protocol Violation|0|||
30567637|NCT04518410|58574647|FG016|Overall Study|Protocol Violation|1|||
30567638|NCT04518410|58574648|FG017|Overall Study|Protocol Violation|1|||
30567639|NCT04518410|58574649|FG018|Overall Study|Protocol Violation|0|||
30567640|NCT04518410|58574650|FG019|Overall Study|Protocol Violation|0|||
30567641|NCT04518410|58574651|FG020|Overall Study|Protocol Violation|1|||
30567642|NCT04518410|58574652|FG021|Overall Study|Protocol Violation|2|||
30567643|NCT04518410|58574653|FG022|Overall Study|Protocol Violation|0|||
30567644|NCT04518410|58574654|FG023|Overall Study|Protocol Violation|3|||
30567645|NCT04518410|58574655|FG024|Overall Study|Protocol Violation|0|||
30567646|NCT04518410|58574631|FG000|Overall Study|Death|0|||
30567647|NCT04518410|58574632|FG001|Overall Study|Death|0|||
30567648|NCT04518410|58574633|FG002|Overall Study|Death|0|||
30567649|NCT04518410|58574634|FG003|Overall Study|Death|0|||
30567650|NCT04518410|58574635|FG004|Overall Study|Death|12|||
30567651|NCT04518410|58574636|FG005|Overall Study|Death|2|||
30567652|NCT04518410|58574637|FG006|Overall Study|Death|11|||
30567653|NCT04518410|58574638|FG007|Overall Study|Death|0|||
30567654|NCT04518410|58574639|FG008|Overall Study|Death|1|||
30567655|NCT04518410|58574640|FG009|Overall Study|Death|0|||
30567656|NCT04518410|58574641|FG010|Overall Study|Death|0|||
30567657|NCT04518410|58574642|FG011|Overall Study|Death|0|||
30567658|NCT04518410|58574643|FG012|Overall Study|Death|0|||
30567659|NCT04518410|58574644|FG013|Overall Study|Death|1|||
30567660|NCT04518410|58574645|FG014|Overall Study|Death|1|||
30567661|NCT04518410|58574646|FG015|Overall Study|Death|0|||
30567662|NCT04518410|58574647|FG016|Overall Study|Death|0|||
30567663|NCT04518410|58574648|FG017|Overall Study|Death|1|||
30567664|NCT04518410|58574649|FG018|Overall Study|Death|3|||
30567665|NCT04518410|58574650|FG019|Overall Study|Death|4|||
30567666|NCT04518410|58574651|FG020|Overall Study|Death|1|||
30567667|NCT04518410|58574652|FG021|Overall Study|Death|0|||
30567668|NCT04518410|58574653|FG022|Overall Study|Death|0|||
30567669|NCT04518410|58574654|FG023|Overall Study|Death|0|||
30567670|NCT04518410|58574655|FG024|Overall Study|Death|0|||
30567671|NCT04518410|58574631|FG000|Overall Study|Requirement to start alternative therapy|0|||
30567672|NCT04518410|58574632|FG001|Overall Study|Requirement to start alternative therapy|0|||
30567673|NCT04518410|58574633|FG002|Overall Study|Requirement to start alternative therapy|1|||
30567674|NCT04518410|58574634|FG003|Overall Study|Requirement to start alternative therapy|0|||
30567675|NCT04518410|58574635|FG004|Overall Study|Requirement to start alternative therapy|0|||
30567676|NCT04518410|58574636|FG005|Overall Study|Requirement to start alternative therapy|0|||
30567677|NCT04518410|58574637|FG006|Overall Study|Requirement to start alternative therapy|0|||
30567678|NCT04518410|58574638|FG007|Overall Study|Requirement to start alternative therapy|0|||
30567679|NCT04518410|58574639|FG008|Overall Study|Requirement to start alternative therapy|0|||
30567680|NCT04518410|58574640|FG009|Overall Study|Requirement to start alternative therapy|0|||
30567681|NCT04518410|58574641|FG010|Overall Study|Requirement to start alternative therapy|0|||
30567682|NCT04518410|58574642|FG011|Overall Study|Requirement to start alternative therapy|0|||
30567683|NCT04518410|58574643|FG012|Overall Study|Requirement to start alternative therapy|0|||
30567684|NCT04518410|58574644|FG013|Overall Study|Requirement to start alternative therapy|0|||
30567685|NCT04518410|58574645|FG014|Overall Study|Requirement to start alternative therapy|0|||
30567686|NCT04518410|58574646|FG015|Overall Study|Requirement to start alternative therapy|0|||
30567687|NCT04518410|58574647|FG016|Overall Study|Requirement to start alternative therapy|0|||
30567688|NCT04518410|58574648|FG017|Overall Study|Requirement to start alternative therapy|0|||
30567689|NCT04518410|58574649|FG018|Overall Study|Requirement to start alternative therapy|0|||
30567690|NCT04518410|58574650|FG019|Overall Study|Requirement to start alternative therapy|0|||
30567691|NCT04518410|58574651|FG020|Overall Study|Requirement to start alternative therapy|0|||
30567692|NCT04518410|58574652|FG021|Overall Study|Requirement to start alternative therapy|0|||
30567693|NCT04518410|58574653|FG022|Overall Study|Requirement to start alternative therapy|1|||
30567694|NCT04518410|58574654|FG023|Overall Study|Requirement to start alternative therapy|0|||
30567695|NCT04518410|58574655|FG024|Overall Study|Requirement to start alternative therapy|0|||
30567696|NCT04518410|58574631|FG000|Overall Study|Ongoing in study|0|||
30567697|NCT04518410|58574632|FG001|Overall Study|Ongoing in study|0|||
30567698|NCT04518410|58574633|FG002|Overall Study|Ongoing in study|0|||
30567699|NCT04518410|58574634|FG003|Overall Study|Ongoing in study|0|||
30567700|NCT04518410|58574635|FG004|Overall Study|Ongoing in study|0|||
30567701|NCT04518410|58574636|FG005|Overall Study|Ongoing in study|0|||
30567702|NCT04518410|58574637|FG006|Overall Study|Ongoing in study|0|||
30567703|NCT04518410|58574638|FG007|Overall Study|Ongoing in study|0|||
30567704|NCT04518410|58574639|FG008|Overall Study|Ongoing in study|0|||
30567705|NCT04518410|58574640|FG009|Overall Study|Ongoing in study|0|||
30567706|NCT04518410|58574641|FG010|Overall Study|Ongoing in study|0|||
30567707|NCT04518410|58574642|FG011|Overall Study|Ongoing in study|0|||
30567708|NCT04518410|58574643|FG012|Overall Study|Ongoing in study|0|||
30666741|NCT00882908|58680601|FG004|Overall Study|Subject reached a virologic endpoint|1|||
30567709|NCT04518410|58574644|FG013|Overall Study|Ongoing in study|0|||
30567710|NCT04518410|58574645|FG014|Overall Study|Ongoing in study|0|||
30567711|NCT04518410|58574646|FG015|Overall Study|Ongoing in study|0|||
30567712|NCT04518410|58574647|FG016|Overall Study|Ongoing in study|0|||
30567713|NCT04518410|58574648|FG017|Overall Study|Ongoing in study|193|||
30567714|NCT04518410|58574649|FG018|Overall Study|Ongoing in study|173|||
30567715|NCT04518410|58574650|FG019|Overall Study|Ongoing in study|50|||
30567716|NCT04518410|58574651|FG020|Overall Study|Ongoing in study|65|||
30567717|NCT04518410|58574652|FG021|Overall Study|Ongoing in study|0|||
30567718|NCT04518410|58574653|FG022|Overall Study|Ongoing in study|0|||
30567719|NCT04518410|58574654|FG023|Overall Study|Ongoing in study|0|||
30567720|NCT04518410|58574655|FG024|Overall Study|Ongoing in study|0|||
30567721|NCT04518410|58574631|FG000|Overall Study|Randomized but not treated|0|||
30567722|NCT04518410|58574632|FG001|Overall Study|Randomized but not treated|0|||
30567723|NCT04518410|58574633|FG002|Overall Study|Randomized but not treated|0|||
30567724|NCT04518410|58574634|FG003|Overall Study|Randomized but not treated|2|||
30567725|NCT04518410|58574635|FG004|Overall Study|Randomized but not treated|6|||
30567726|NCT04518410|58574636|FG005|Overall Study|Randomized but not treated|6|||
30567727|NCT04518410|58574637|FG006|Overall Study|Randomized but not treated|3|||
30567728|NCT04518410|58574638|FG007|Overall Study|Randomized but not treated|3|||
30567729|NCT04518410|58574639|FG008|Overall Study|Randomized but not treated|0|||
30567730|NCT04518410|58574640|FG009|Overall Study|Randomized but not treated|4|||
30567731|NCT04518410|58574641|FG010|Overall Study|Randomized but not treated|0|||
30567732|NCT04518410|58574642|FG011|Overall Study|Randomized but not treated|0|||
30567733|NCT04518410|58574643|FG012|Overall Study|Randomized but not treated|1|||
30567734|NCT04518410|58574644|FG013|Overall Study|Randomized but not treated|4|||
30567735|NCT04518410|58574645|FG014|Overall Study|Randomized but not treated|3|||
30567736|NCT04518410|58574646|FG015|Overall Study|Randomized but not treated|3|||
30567737|NCT04518410|58574647|FG016|Overall Study|Randomized but not treated|4|||
30567738|NCT04518410|58574648|FG017|Overall Study|Randomized but not treated|6|||
30567739|NCT04518410|58574649|FG018|Overall Study|Randomized but not treated|4|||
30567740|NCT04518410|58574650|FG019|Overall Study|Randomized but not treated|0|||
30567741|NCT04518410|58574651|FG020|Overall Study|Randomized but not treated|0|||
30567742|NCT04518410|58574652|FG021|Overall Study|Randomized but not treated|5|||
30567743|NCT04518410|58574653|FG022|Overall Study|Randomized but not treated|0|||
30567744|NCT04518410|58574654|FG023|Overall Study|Randomized but not treated|3|||
30567745|NCT04518410|58574655|FG024|Overall Study|Randomized but not treated|1|||
30567746|NCT04518410|58574631|FG000|Overall Study|Screen Fail but Randomized|0|||
30567747|NCT04518410|58574632|FG001|Overall Study|Screen Fail but Randomized|0|||
30567748|NCT04518410|58574633|FG002|Overall Study|Screen Fail but Randomized|0|||
30567749|NCT04518410|58574634|FG003|Overall Study|Screen Fail but Randomized|0|||
30567750|NCT04518410|58574635|FG004|Overall Study|Screen Fail but Randomized|2|||
30567751|NCT04518410|58574636|FG005|Overall Study|Screen Fail but Randomized|0|||
30567752|NCT04518410|58574637|FG006|Overall Study|Screen Fail but Randomized|0|||
30567753|NCT04518410|58574638|FG007|Overall Study|Screen Fail but Randomized|0|||
30567754|NCT04518410|58574639|FG008|Overall Study|Screen Fail but Randomized|0|||
30567755|NCT04518410|58574640|FG009|Overall Study|Screen Fail but Randomized|0|||
30567756|NCT04518410|58574641|FG010|Overall Study|Screen Fail but Randomized|0|||
30567757|NCT04518410|58574642|FG011|Overall Study|Screen Fail but Randomized|0|||
30567758|NCT04518410|58574643|FG012|Overall Study|Screen Fail but Randomized|0|||
30567759|NCT04518410|58574644|FG013|Overall Study|Screen Fail but Randomized|0|||
30567760|NCT04518410|58574645|FG014|Overall Study|Screen Fail but Randomized|0|||
30567761|NCT04518410|58574646|FG015|Overall Study|Screen Fail but Randomized|0|||
30567762|NCT04518410|58574647|FG016|Overall Study|Screen Fail but Randomized|0|||
30567763|NCT04518410|58574648|FG017|Overall Study|Screen Fail but Randomized|0|||
30567764|NCT04518410|58574649|FG018|Overall Study|Screen Fail but Randomized|0|||
30567765|NCT04518410|58574650|FG019|Overall Study|Screen Fail but Randomized|0|||
30567766|NCT04518410|58574651|FG020|Overall Study|Screen Fail but Randomized|0|||
30567767|NCT04518410|58574652|FG021|Overall Study|Screen Fail but Randomized|0|||
30567768|NCT04518410|58574653|FG022|Overall Study|Screen Fail but Randomized|0|||
30567769|NCT04518410|58574654|FG023|Overall Study|Screen Fail but Randomized|0|||
30567770|NCT04518410|58574655|FG024|Overall Study|Screen Fail but Randomized|0|||
30567771|NCT04518410|58574631|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567772|NCT04518410|58574632|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567773|NCT04518410|58574633|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567774|NCT04518410|58574634|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567775|NCT04518410|58574635|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
30567776|NCT04518410|58574636|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
30567777|NCT04518410|58574637|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|9|||
30567778|NCT04518410|58574638|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567779|NCT04518410|58574639|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
30567780|NCT04518410|58574640|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567781|NCT04518410|58574641|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567782|NCT04518410|58574642|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30855162|NCT02789111|58882723|FG000|Overall Study|Withdrawal by Subject|1|||
30855163|NCT02789111|58882724|FG001|Overall Study|Withdrawal by Subject|4|||
30855164|NCT01359644|58882742|FG000|Treatment Period|Lack of Efficacy|0|||
30567783|NCT04518410|58574643|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567784|NCT04518410|58574644|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567785|NCT04518410|58574645|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567786|NCT04518410|58574646|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567787|NCT04518410|58574647|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567788|NCT04518410|58574648|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567789|NCT04518410|58574649|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567790|NCT04518410|58574650|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567791|NCT04518410|58574651|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567792|NCT04518410|58574652|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567793|NCT04518410|58574653|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
30567794|NCT04518410|58574654|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
30567795|NCT04518410|58574655|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
30567796|NCT04518410|58574631|FG000|Overall Study|Dual Enrolled Subject|0|||
30567797|NCT04518410|58574632|FG001|Overall Study|Dual Enrolled Subject|0|||
30567798|NCT04518410|58574633|FG002|Overall Study|Dual Enrolled Subject|0|||
30567799|NCT04518410|58574634|FG003|Overall Study|Dual Enrolled Subject|0|||
30567800|NCT04518410|58574635|FG004|Overall Study|Dual Enrolled Subject|0|||
30567801|NCT04518410|58574636|FG005|Overall Study|Dual Enrolled Subject|0|||
30567802|NCT04518410|58574637|FG006|Overall Study|Dual Enrolled Subject|0|||
30567803|NCT04518410|58574638|FG007|Overall Study|Dual Enrolled Subject|0|||
30567804|NCT04518410|58574639|FG008|Overall Study|Dual Enrolled Subject|0|||
30567805|NCT04518410|58574640|FG009|Overall Study|Dual Enrolled Subject|0|||
30567806|NCT04518410|58574641|FG010|Overall Study|Dual Enrolled Subject|0|||
30567807|NCT04518410|58574642|FG011|Overall Study|Dual Enrolled Subject|0|||
30567808|NCT04518410|58574643|FG012|Overall Study|Dual Enrolled Subject|0|||
30567809|NCT04518410|58574644|FG013|Overall Study|Dual Enrolled Subject|0|||
30567810|NCT04518410|58574645|FG014|Overall Study|Dual Enrolled Subject|0|||
30567811|NCT04518410|58574646|FG015|Overall Study|Dual Enrolled Subject|0|||
30567812|NCT04518410|58574647|FG016|Overall Study|Dual Enrolled Subject|0|||
30567813|NCT04518410|58574648|FG017|Overall Study|Dual Enrolled Subject|1|||
30567814|NCT04518410|58574649|FG018|Overall Study|Dual Enrolled Subject|0|||
30567815|NCT04518410|58574650|FG019|Overall Study|Dual Enrolled Subject|0|||
30567816|NCT04518410|58574651|FG020|Overall Study|Dual Enrolled Subject|0|||
30567817|NCT04518410|58574652|FG021|Overall Study|Dual Enrolled Subject|0|||
30567818|NCT04518410|58574653|FG022|Overall Study|Dual Enrolled Subject|0|||
30567819|NCT04518410|58574654|FG023|Overall Study|Dual Enrolled Subject|0|||
30567820|NCT04518410|58574655|FG024|Overall Study|Dual Enrolled Subject|0|||
30567821|NCT04517864|58574715|FG000|Placebo-Controlled Phase|Adverse Event|1|||
30567822|NCT04517864|58574716|FG001|Placebo-Controlled Phase|Adverse Event|0|||
30567823|NCT04517864|58574715|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
30567824|NCT04517864|58574716|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
30567825|NCT04517864|58574715|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
30567826|NCT04517864|58574716|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
30567827|NCT04517864|58574715|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
30567828|NCT04517864|58574716|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
30567829|NCT04517864|58574715|FG000|Active Therapy Extension Phase|Adverse Event|1|||
30567830|NCT04517864|58574716|FG001|Active Therapy Extension Phase|Adverse Event|0|||
30567831|NCT04507204|58574737|FG000|Overall Study|Adverse Event|8|||
30567832|NCT04507204|58574738|FG001|Overall Study|Adverse Event|13|||
30567833|NCT04507204|58574737|FG000|Overall Study|Death|0|||
30567834|NCT04507204|58574738|FG001|Overall Study|Death|1|||
30567835|NCT04507204|58574737|FG000|Overall Study|Lost to Follow-up|15|||
30567836|NCT04507204|58574738|FG001|Overall Study|Lost to Follow-up|14|||
30567837|NCT04507204|58574737|FG000|Overall Study|Poor Compliance with Protocol|2|||
30567838|NCT04507204|58574738|FG001|Overall Study|Poor Compliance with Protocol|4|||
30567839|NCT04507204|58574737|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
30567840|NCT04507204|58574738|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
30567841|NCT04507204|58574737|FG000|Overall Study|Withdrawal of Patient Consent|21|||
30567842|NCT04507204|58574738|FG001|Overall Study|Withdrawal of Patient Consent|13|||
30855165|NCT01359644|58882743|FG001|Treatment Period|Lack of Efficacy|1|||
30855166|NCT01359644|58882744|FG002|Treatment Period|Lack of Efficacy|0|||
30567845|NCT04158648|58574771|FG000|Overall Study|Ongoing in the Study|69|||
30567846|NCT04158648|58574771|FG000|Overall Study|Withdrawal by Subject|4|||
30567847|NCT04135937|58574778|FG000|Overall Study|Lost to Follow-up|2|||
30666742|NCT00882908|58680597|FG000|Overall Study|Study terminated in error|0|||
30567848|NCT04135937|58574778|FG000|Overall Study|Withdrawal by Subject|1|||
30567849|NCT04060147|58574782|FG000|Overall Study|Withdrew consent|1|||
30567850|NCT04045132|58574788|FG000|Overall Study|Lost to Follow-up|3|||
30567851|NCT04045132|58574789|FG001|Overall Study|Lost to Follow-up|6|||
30567852|NCT04019041|58574827|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
30567853|NCT04019041|58574828|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
30567854|NCT04019041|58574829|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
30567855|NCT04019041|58574830|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
30567856|NCT04019041|58574831|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
30567857|NCT04019041|58574832|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
30567858|NCT04019041|58574827|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
30567859|NCT04019041|58574828|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
30567860|NCT04019041|58574829|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
30567861|NCT04019041|58574830|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
30567862|NCT04019041|58574831|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
30567863|NCT04019041|58574832|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
30567864|NCT04019041|58574827|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
30567865|NCT04019041|58574828|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
30567866|NCT04019041|58574829|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
30567867|NCT04019041|58574830|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
30567868|NCT04019041|58574831|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
30567869|NCT04019041|58574832|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
30567870|NCT04019041|58574827|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
30567871|NCT04019041|58574828|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
30567872|NCT04019041|58574829|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
30567873|NCT04019041|58574830|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
30567874|NCT04019041|58574831|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
30567875|NCT04019041|58574832|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
30567876|NCT04019041|58574827|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
30567877|NCT04019041|58574828|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
30567878|NCT04019041|58574829|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
30567879|NCT04019041|58574830|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
30567880|NCT04019041|58574831|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
30567881|NCT04019041|58574832|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
30567882|NCT04019041|58574827|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
30567883|NCT04019041|58574828|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
30567884|NCT04019041|58574829|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
30567885|NCT04019041|58574830|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
30567886|NCT04019041|58574831|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
30567887|NCT04019041|58574832|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
30567888|NCT04019041|58574827|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
30567889|NCT04019041|58574828|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
30567890|NCT04019041|58574829|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
30567891|NCT04019041|58574830|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
30567892|NCT04019041|58574831|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
30567893|NCT04019041|58574832|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
30567894|NCT04019041|58574827|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
30567895|NCT04019041|58574828|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
30567896|NCT04019041|58574829|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
30567897|NCT04019041|58574830|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
30567898|NCT04019041|58574831|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
30567899|NCT04019041|58574832|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
30567900|NCT04019041|58574827|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
30567901|NCT04019041|58574828|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
30567902|NCT04019041|58574829|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
30567903|NCT04019041|58574830|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
30567904|NCT04019041|58574831|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
30567905|NCT04019041|58574832|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
30567906|NCT03919448|58574861|FG000|Overall Study|Withdrawal by Subject|1|||
30567907|NCT03919448|58574862|FG001|Overall Study|Withdrawal by Subject|0|||
30567908|NCT03919448|58574863|FG002|Overall Study|Withdrawal by Subject|0|||
30666743|NCT00882908|58680598|FG001|Overall Study|Study terminated in error|0|||
30666744|NCT00882908|58680599|FG002|Overall Study|Study terminated in error|0|||
30666745|NCT00882908|58680600|FG003|Overall Study|Study terminated in error|1|||
30567909|NCT03795922|58574890|FG000|Overall Study|Adverse Event|2|||
30666746|NCT00882908|58680601|FG004|Overall Study|Study terminated in error|0|||
30666747|NCT00851799|58680617|FG000|Overall Study|Death|1|||
30567910|NCT03795922|58574891|FG001|Overall Study|Adverse Event|1|||
30567911|NCT03795922|58574890|FG000|Overall Study|Withdrawal by Subject|5|||
30567912|NCT03795922|58574891|FG001|Overall Study|Withdrawal by Subject|13|||
30567913|NCT03795922|58574890|FG000|Overall Study|Lost to Follow-up|2|||
30567914|NCT03795922|58574891|FG001|Overall Study|Lost to Follow-up|3|||
30567915|NCT03795922|58574890|FG000|Overall Study|Pregnancy|0|||
30567916|NCT03795922|58574891|FG001|Overall Study|Pregnancy|1|||
30567917|NCT03795922|58574890|FG000|Overall Study|Physician Decision|1|||
30666748|NCT00851799|58680618|FG001|Overall Study|Death|0|||
30666749|NCT00851799|58680619|FG002|Overall Study|Death|1|||
30666750|NCT00851799|58680617|FG000|Overall Study|Lost to Follow-up|5|||
30666751|NCT00851799|58680618|FG001|Overall Study|Lost to Follow-up|3|||
30666752|NCT00851799|58680619|FG002|Overall Study|Lost to Follow-up|10|||
30666753|NCT00851799|58680617|FG000|Overall Study|Not able to get to clinic|8|||
30666754|NCT00851799|58680618|FG001|Overall Study|Not able to get to clinic|5|||
30666755|NCT00851799|58680619|FG002|Overall Study|Not able to get to clinic|9|||
30666756|NCT00851799|58680617|FG000|Overall Study|Not willing to adhere to requirements|1|||
30666757|NCT00851799|58680618|FG001|Overall Study|Not willing to adhere to requirements|2|||
30666758|NCT00851799|58680619|FG002|Overall Study|Not willing to adhere to requirements|2|||
30666759|NCT00851799|58680617|FG000|Overall Study|Withdrew consent prior study completion|1|||
30666760|NCT00851799|58680618|FG001|Overall Study|Withdrew consent prior study completion|2|||
30666761|NCT00851799|58680619|FG002|Overall Study|Withdrew consent prior study completion|1|||
30666762|NCT00851799|58680617|FG000|Overall Study|Severe Debilitation|0|||
30666763|NCT00851799|58680618|FG001|Overall Study|Severe Debilitation|1|||
30666764|NCT00851799|58680619|FG002|Overall Study|Severe Debilitation|0|||
30666765|NCT00851799|58680617|FG000|Overall Study|Completed protocol due to pregnancy|0|||
30666766|NCT00851799|58680618|FG001|Overall Study|Completed protocol due to pregnancy|0|||
30666767|NCT00851799|58680619|FG002|Overall Study|Completed protocol due to pregnancy|1|||
30666768|NCT00521053|58680627|FG000|Observation Phase|Disease Progression|55|||
30666769|NCT00521053|58680627|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
30666770|NCT00521053|58680627|FG000|Observation Phase|Death|2|||
30666771|NCT00521053|58680627|FG000|Observation Phase|Adverse Event|1|||
30666772|NCT00521053|58680627|FG000|Observation Phase|Other non-study melanoma treatment|1|||
30666773|NCT00521053|58680627|FG000|Observation Phase|Physician Decision|1|||
30666774|NCT00853047|58680639|FG000|Core Phase|Participant Request|0|||
30666775|NCT00853047|58680640|FG001|Core Phase|Participant Request|0|||
30666776|NCT00853047|58680641|FG002|Core Phase|Participant Request|0|||
30666777|NCT00853047|58680642|FG003|Core Phase|Participant Request|1|||
30666778|NCT00853047|58680643|FG004|Core Phase|Participant Request|0|||
30666779|NCT00853047|58680644|FG005|Core Phase|Participant Request|0|||
30666780|NCT00853047|58680639|FG000|Open-Label Extension Phase|Participant Request|0|||
30666781|NCT00853047|58680640|FG001|Open-Label Extension Phase|Participant Request|0|||
30666782|NCT00853047|58680641|FG002|Open-Label Extension Phase|Participant Request|0|||
30666783|NCT00853047|58680642|FG003|Open-Label Extension Phase|Participant Request|0|||
30666784|NCT00853047|58680643|FG004|Open-Label Extension Phase|Participant Request|0|||
30666785|NCT00853047|58680644|FG005|Open-Label Extension Phase|Participant Request|7|||
30666786|NCT00853047|58680639|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
30666787|NCT00853047|58680640|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
30666788|NCT00853047|58680641|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
30666789|NCT00853047|58680642|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
30666790|NCT00853047|58680643|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
30666791|NCT00853047|58680644|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
30666792|NCT00853047|58680639|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
30666793|NCT00853047|58680640|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
30666794|NCT00853047|58680641|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
30666795|NCT00853047|58680642|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
30666796|NCT00853047|58680643|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
30666797|NCT00853047|58680644|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
30666798|NCT00853047|58680639|FG000|Open-Label Extension Phase|Investigator Decision|0|||
30666799|NCT00853047|58680640|FG001|Open-Label Extension Phase|Investigator Decision|0|||
30666800|NCT00853047|58680641|FG002|Open-Label Extension Phase|Investigator Decision|0|||
30666801|NCT00853047|58680642|FG003|Open-Label Extension Phase|Investigator Decision|0|||
30666802|NCT00853047|58680643|FG004|Open-Label Extension Phase|Investigator Decision|0|||
30666803|NCT00853047|58680644|FG005|Open-Label Extension Phase|Investigator Decision|1|||
30666804|NCT00853047|58680639|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
30666805|NCT00853047|58680640|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
30567918|NCT03795922|58574891|FG001|Overall Study|Physician Decision|2|||
30666806|NCT00853047|58680641|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
30666807|NCT00853047|58680642|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
30666808|NCT00853047|58680643|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
30666809|NCT00853047|58680644|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
30666810|NCT00520975|58680661|FG000|Overall Study|Disease progression|31|||
30666811|NCT00520975|58680662|FG001|Overall Study|Disease progression|23|||
30567919|NCT03795922|58574890|FG000|Overall Study|Protocol Violation|0|||
30567920|NCT03795922|58574891|FG001|Overall Study|Protocol Violation|1|||
30567921|NCT03795922|58574890|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
30567922|NCT03795922|58574891|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
30567923|NCT03794089|58574901|FG000|Overall Study|Lost to Follow-up|4|||
30567924|NCT03794089|58574902|FG001|Overall Study|Lost to Follow-up|1|||
30567925|NCT03794089|58574901|FG000|Overall Study|Withdrawal by Subject|2|||
30567926|NCT03794089|58574902|FG001|Overall Study|Withdrawal by Subject|0|||
30567927|NCT03769025|58574910|FG000|Overall Study|Withdrawal by Subject|1|||
30567928|NCT03769025|58574911|FG001|Overall Study|Withdrawal by Subject|1|||
30567929|NCT03769025|58574910|FG000|Overall Study|Lost to Follow-up|4|||
30567930|NCT03769025|58574911|FG001|Overall Study|Lost to Follow-up|3|||
30567931|NCT03762473|58574919|FG000|Overall Study|Death|1|||
30567932|NCT03762473|58574920|FG001|Overall Study|Death|0|||
30567933|NCT03761056|58574926|FG000|Overall Study|Still on Study|34|||
30567934|NCT03761056|58574926|FG000|Overall Study|Death|6|||
30567935|NCT03761056|58574926|FG000|Overall Study|Investigator Decision|1|||
30567936|NCT03761056|58574926|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
30567937|NCT03759366|58574932|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
30567938|NCT03759366|58574932|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
30567939|NCT03745989|58574939|FG000|Overall Study|Death|3|||
30567940|NCT03745989|58574940|FG001|Overall Study|Death|7|||
30567941|NCT03745989|58574941|FG002|Overall Study|Death|4|||
30567942|NCT03745989|58574939|FG000|Overall Study|Lost to Follow-up|0|||
30567943|NCT03745989|58574940|FG001|Overall Study|Lost to Follow-up|2|||
30666812|NCT00520975|58680661|FG000|Overall Study|Adverse Event|7|||
30666813|NCT00520975|58680662|FG001|Overall Study|Adverse Event|10|||
30666814|NCT00520975|58680661|FG000|Overall Study|Death|0|||
30666815|NCT00520975|58680662|FG001|Overall Study|Death|2|||
30666816|NCT00520975|58680661|FG000|Overall Study|Withdrawal by Subject|3|||
30666817|NCT00520975|58680662|FG001|Overall Study|Withdrawal by Subject|5|||
30666818|NCT00520975|58680661|FG000|Overall Study|Other therapy|2|||
30666819|NCT00520975|58680662|FG001|Overall Study|Other therapy|4|||
30666820|NCT00520975|58680661|FG000|Overall Study|Other reasons|4|||
30666821|NCT00520975|58680662|FG001|Overall Study|Other reasons|2|||
30666822|NCT00520975|58680661|FG000|Overall Study|Not start protocol therapy|1|||
30666823|NCT00520975|58680662|FG001|Overall Study|Not start protocol therapy|2|||
30666824|NCT00851721|58680670|FG000|Overall Study|planned surgery|1|||
30666825|NCT00851721|58680671|FG001|Overall Study|planned surgery|0|||
30666826|NCT00851721|58680670|FG000|Overall Study|Death|1|||
30666827|NCT00851721|58680671|FG001|Overall Study|Death|0|||
30666828|NCT00851721|58680670|FG000|Overall Study|Adverse Event|0|||
30666829|NCT00851721|58680671|FG001|Overall Study|Adverse Event|1|||
30666830|NCT00520741|58680685|FG000|Overall Study|Adverse Event|16|||
30666831|NCT00520741|58680686|FG001|Overall Study|Adverse Event|56|||
30666832|NCT00520741|58680685|FG000|Overall Study|Lack of Efficacy|11|||
30666833|NCT00520741|58680686|FG001|Overall Study|Lack of Efficacy|30|||
30666834|NCT00520741|58680685|FG000|Overall Study|Withdrawal by Subject|0|||
30666835|NCT00520741|58680686|FG001|Overall Study|Withdrawal by Subject|11|||
30666836|NCT00520741|58680685|FG000|Overall Study|Protocol Violation|2|||
30666837|NCT00520741|58680686|FG001|Overall Study|Protocol Violation|15|||
30666838|NCT00520741|58680685|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
30666839|NCT00520741|58680686|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
30666840|NCT00520741|58680685|FG000|Overall Study|Lost to Follow-up|4|||
30666841|NCT00520741|58680686|FG001|Overall Study|Lost to Follow-up|4|||
30666842|NCT00520741|58680685|FG000|Overall Study|Other reasons for premature termination|0|||
30666843|NCT00520741|58680686|FG001|Overall Study|Other reasons for premature termination|6|||
30666844|NCT00882518|58680696|FG000|Overall Study|Adverse Event|9|||
30666845|NCT00882518|58680697|FG001|Overall Study|Adverse Event|18|||
30666846|NCT00882518|58680696|FG000|Overall Study|Withdrawal by Subject|9|||
30666847|NCT00882518|58680697|FG001|Overall Study|Withdrawal by Subject|13|||
30666848|NCT00882518|58680696|FG000|Overall Study|Lack of Efficacy|12|||
30666849|NCT00882518|58680697|FG001|Overall Study|Lack of Efficacy|9|||
30666850|NCT00882518|58680696|FG000|Overall Study|Severe non-compliance to protocol|3|||
30666851|NCT00882518|58680697|FG001|Overall Study|Severe non-compliance to protocol|1|||
30666852|NCT00882518|58680696|FG000|Overall Study|Incorrect enrolment|4|||
30666853|NCT00882518|58680697|FG001|Overall Study|Incorrect enrolment|2|||
30666854|NCT00882518|58680696|FG000|Overall Study|Central lab closure for National day|1|||
30666855|NCT00882518|58680697|FG001|Overall Study|Central lab closure for National day|0|||
30666856|NCT00882518|58680696|FG000|Overall Study|Allocating random number by mistake|0|||
30666857|NCT00882518|58680697|FG001|Overall Study|Allocating random number by mistake|1|||
30666858|NCT00882362|58680714|FG000|Overall Study|Adverse Event|13|||
30666859|NCT00882362|58680715|FG001|Overall Study|Adverse Event|10|||
30666860|NCT00882362|58680714|FG000|Overall Study|Withdrawal by Subject|13|||
30666861|NCT00882362|58680715|FG001|Overall Study|Withdrawal by Subject|10|||
30666862|NCT00882362|58680714|FG000|Overall Study|Lack of Efficacy|3|||
30666863|NCT00882362|58680715|FG001|Overall Study|Lack of Efficacy|0|||
30666864|NCT00882362|58680714|FG000|Overall Study|Protocol Violation|7|||
30567944|NCT03745989|58574941|FG002|Overall Study|Lost to Follow-up|0|||
30567945|NCT03745989|58574939|FG000|Overall Study|Sponsor Decision|0|||
30567946|NCT03745989|58574940|FG001|Overall Study|Sponsor Decision|2|||
30567947|NCT03745989|58574941|FG002|Overall Study|Sponsor Decision|8|||
30567948|NCT03745989|58574939|FG000|Overall Study|Withdrawal by Subject|0|||
30567949|NCT03745989|58574940|FG001|Overall Study|Withdrawal by Subject|1|||
30567950|NCT03745989|58574941|FG002|Overall Study|Withdrawal by Subject|3|||
30567951|NCT03646656|58574971|FG000|Overall Study|Lost to Follow-up|1|||
30567952|NCT03646656|58574972|FG001|Overall Study|Lost to Follow-up|0|||
30567953|NCT03646656|58574971|FG000|Overall Study|Withdrawal by Subject|2|||
30567954|NCT03646656|58574972|FG001|Overall Study|Withdrawal by Subject|0|||
30567955|NCT03555435|58574985|FG000|Overall Study|Lost to Follow-up|17|||
30567956|NCT03555435|58574986|FG001|Overall Study|Lost to Follow-up|19|||
30567957|NCT03555435|58574987|FG002|Overall Study|Lost to Follow-up|8|||
30567958|NCT03521115|58574997|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
30567959|NCT03521115|58574998|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
30567960|NCT03521115|58574997|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
30567961|NCT03521115|58574998|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
30567962|NCT03520413|58575012|FG000|Overall Study|Lost to Follow-up|1|||
30567963|NCT03520413|58575013|FG001|Overall Study|Lost to Follow-up|1|||
30567964|NCT03520413|58575012|FG000|Overall Study|Withdrawal by Subject|1|||
30567965|NCT03520413|58575013|FG001|Overall Study|Withdrawal by Subject|2|||
30567966|NCT03520413|58575012|FG000|Overall Study|Death|0|||
30567967|NCT03520413|58575013|FG001|Overall Study|Death|1|||
30567968|NCT03520413|58575012|FG000|Overall Study|Physician Decision|3|||
30567969|NCT03520413|58575013|FG001|Overall Study|Physician Decision|3|||
30567970|NCT03520413|58575012|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
30567971|NCT03520413|58575013|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
30567972|NCT03419897|58575020|FG000|Overall Study|Death|180|||
30567973|NCT03419897|58575020|FG000|Overall Study|Lost to Follow-up|1|||
30567974|NCT03419897|58575020|FG000|Overall Study|Withdrawal by Subject|6|||
30567975|NCT03419897|58575020|FG000|Overall Study|Sponsor Decision|61|||
30567976|NCT03419897|58575020|FG000|Overall Study|Physician Decision|1|||
30567977|NCT03418129|58575027|FG000|Overall Study|Lost to Follow-up|11|||
30567978|NCT03418129|58575028|FG001|Overall Study|Lost to Follow-up|20|||
30567979|NCT03418129|58575029|FG002|Overall Study|Lost to Follow-up|15|||
30567980|NCT03418129|58575027|FG000|Overall Study|Withdrawal by Subject|3|||
30567981|NCT03418129|58575028|FG001|Overall Study|Withdrawal by Subject|6|||
30567982|NCT03418129|58575029|FG002|Overall Study|Withdrawal by Subject|4|||
30567983|NCT03344796|58575047|FG000|Overall Study|Lost to Follow-up|0|||
30567984|NCT03344796|58575048|FG001|Overall Study|Lost to Follow-up|0|||
30567985|NCT03344796|58575049|FG002|Overall Study|Lost to Follow-up|0|||
30567986|NCT03344796|58575050|FG003|Overall Study|Lost to Follow-up|0|||
30567987|NCT03344796|58575051|FG004|Overall Study|Lost to Follow-up|0|||
30567988|NCT03344796|58575052|FG005|Overall Study|Lost to Follow-up|2|||
30567989|NCT03335488|58575075|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
30567990|NCT03335488|58575076|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
30567991|NCT03335488|58575075|FG000|Safety Extension Period|Adverse Event|1|||
30567992|NCT03335488|58575076|FG001|Safety Extension Period|Adverse Event|0|||
30567993|NCT03335488|58575075|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
30567994|NCT03335488|58575076|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
30567995|NCT03261700|58575104|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
30567996|NCT03261700|58575105|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
30567997|NCT03238417|58575116|FG000|Overall|non-response|955|||
30567998|NCT03238417|58575117|FG001|Overall|non-response|1920|||
30567999|NCT03238417|58575116|FG000|Overall|partial completion|48|||
30568000|NCT03238417|58575117|FG001|Overall|partial completion|68|||
30568001|NCT03238417|58575116|FG000|Baseline|Partial completion|17|||
30568002|NCT03238417|58575117|FG001|Baseline|Partial completion|48|||
30568003|NCT03238417|58575116|FG000|Baseline|non-response|372|||
30568004|NCT03238417|58575117|FG001|Baseline|non-response|669|||
30568005|NCT03238417|58575116|FG000|12-month|non-response|296|||
30568006|NCT03238417|58575117|FG001|12-month|non-response|669|||
30568007|NCT03238417|58575116|FG000|12-month|partial completion|23|||
30568008|NCT03238417|58575117|FG001|12-month|partial completion|37|||
30568009|NCT03238417|58575116|FG000|24-month|non-response|287|||
30568010|NCT03238417|58575117|FG001|24-month|non-response|594|||
30568011|NCT03238417|58575116|FG000|24-month|partial completion|8|||
30568012|NCT03238417|58575117|FG001|24-month|partial completion|31|||
30568013|NCT03215277|58575125|FG000|Overall Study|Adverse Event|2|||
30568014|NCT03215277|58575126|FG001|Overall Study|Adverse Event|3|||
30568015|NCT03215277|58575125|FG000|Overall Study|Death|1|||
30568016|NCT03215277|58575126|FG001|Overall Study|Death|0|||
30568017|NCT03215277|58575125|FG000|Overall Study|Lost to Follow-up|0|||
30568018|NCT03215277|58575126|FG001|Overall Study|Lost to Follow-up|1|||
30568019|NCT03215277|58575125|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
30568020|NCT03215277|58575126|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
30568021|NCT03185013|58575136|FG000|Overall Study|Withdrawal by Subject|5|||
30568022|NCT03185013|58575137|FG001|Overall Study|Withdrawal by Subject|3|||
30568023|NCT03185013|58575136|FG000|Overall Study|Adverse Event|1|||
30568024|NCT03185013|58575137|FG001|Overall Study|Adverse Event|0|||
30568025|NCT03185013|58575136|FG000|Overall Study|Progressive Disease|1|||
30568026|NCT03185013|58575137|FG001|Overall Study|Progressive Disease|0|||
30568027|NCT03185013|58575136|FG000|Overall Study|Lost to Follow-up|8|||
30568028|NCT03185013|58575137|FG001|Overall Study|Lost to Follow-up|2|||
30568029|NCT03185013|58575136|FG000|Overall Study|Physician Decision|1|||
30568030|NCT03185013|58575137|FG001|Overall Study|Physician Decision|0|||
30568031|NCT03185013|58575136|FG000|Overall Study|Protocol Deviation|2|||
30568032|NCT03185013|58575137|FG001|Overall Study|Protocol Deviation|0|||
30568033|NCT03185013|58575136|FG000|Overall Study|Reason not Specified|3|||
30568034|NCT03185013|58575137|FG001|Overall Study|Reason not Specified|2|||
30568035|NCT03185013|58575136|FG000|Overall Study|Death|1|||
30568036|NCT03185013|58575137|FG001|Overall Study|Death|0|||
30568037|NCT03182907|58575145|FG000|Overall Study|Death|3|||
30568038|NCT03182907|58575146|FG001|Overall Study|Death|0|||
30568039|NCT03182907|58575145|FG000|Overall Study|Protocol Violation|4|||
30568040|NCT03182907|58575146|FG001|Overall Study|Protocol Violation|0|||
30568041|NCT03182907|58575145|FG000|Overall Study|Lost to Follow-up|1|||
30568042|NCT03182907|58575146|FG001|Overall Study|Lost to Follow-up|0|||
30568043|NCT03182907|58575145|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30568044|NCT03182907|58575146|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
30568045|NCT03126019|58575157|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
30568046|NCT03126019|58575158|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
30568047|NCT03126019|58575157|FG000|Overall Study|Death|2|||
30568048|NCT03126019|58575158|FG001|Overall Study|Death|7|||
30568049|NCT03126019|58575157|FG000|Overall Study|Lost to Follow-up|2|||
30568050|NCT03126019|58575158|FG001|Overall Study|Lost to Follow-up|3|||
30568051|NCT03126019|58575157|FG000|Overall Study|Withdrawal by Participant|1|||
30568052|NCT03126019|58575158|FG001|Overall Study|Withdrawal by Participant|3|||
30568053|NCT03126019|58575157|FG000|Overall Study|Reason not Specified|1|||
30568054|NCT03126019|58575158|FG001|Overall Study|Reason not Specified|3|||
30568055|NCT03036813|58575168|FG000|Overall Study|Adverse Event|6|||
30568056|NCT03036813|58575169|FG001|Overall Study|Adverse Event|11|||
30568057|NCT03036813|58575170|FG002|Overall Study|Adverse Event|6|||
30568058|NCT03036813|58575168|FG000|Overall Study|Withdrawal by Subject|12|||
30568059|NCT03036813|58575169|FG001|Overall Study|Withdrawal by Subject|6|||
30568060|NCT03036813|58575170|FG002|Overall Study|Withdrawal by Subject|10|||
30568061|NCT03036813|58575168|FG000|Overall Study|Lost to Follow-up|1|||
30568062|NCT03036813|58575169|FG001|Overall Study|Lost to Follow-up|1|||
30568063|NCT03036813|58575170|FG002|Overall Study|Lost to Follow-up|0|||
30568064|NCT03036813|58575168|FG000|Overall Study|Physician Decision|2|||
30568065|NCT03036813|58575169|FG001|Overall Study|Physician Decision|1|||
30568066|NCT03036813|58575170|FG002|Overall Study|Physician Decision|1|||
30568067|NCT03036813|58575168|FG000|Overall Study|Non-Compliance|1|||
30568068|NCT03036813|58575169|FG001|Overall Study|Non-Compliance|5|||
30568069|NCT03036813|58575170|FG002|Overall Study|Non-Compliance|3|||
30568070|NCT03036813|58575168|FG000|Overall Study|Pregnancy|0|||
30568071|NCT03036813|58575169|FG001|Overall Study|Pregnancy|0|||
30568072|NCT03036813|58575170|FG002|Overall Study|Pregnancy|1|||
30568073|NCT03036813|58575168|FG000|Overall Study|Other|0|||
30568074|NCT03036813|58575169|FG001|Overall Study|Other|3|||
30568075|NCT03036813|58575170|FG002|Overall Study|Other|5|||
30568076|NCT03007953|58575183|FG000|Overall Study|Withdrawal by Subject|5|||
30568077|NCT03007953|58575184|FG001|Overall Study|Withdrawal by Subject|2|||
30568078|NCT03007953|58575183|FG000|Overall Study|Death|5|||
30568079|NCT03007953|58575184|FG001|Overall Study|Death|7|||
30568080|NCT03007953|58575183|FG000|Overall Study|Lost to Follow-up|3|||
30568081|NCT03007953|58575184|FG001|Overall Study|Lost to Follow-up|2|||
30666865|NCT00882362|58680715|FG001|Overall Study|Protocol Violation|2|||
30666866|NCT00882362|58680714|FG000|Overall Study|Pregnancy|1|||
30666867|NCT00882362|58680715|FG001|Overall Study|Pregnancy|0|||
30666868|NCT00882362|58680714|FG000|Overall Study|Physician Decision|5|||
30666869|NCT00882362|58680715|FG001|Overall Study|Physician Decision|1|||
30568082|NCT03007953|58575183|FG000|Overall Study|Enrolled in Hospice|3|||
30568083|NCT03007953|58575184|FG001|Overall Study|Enrolled in Hospice|2|||
30568084|NCT02919618|58575199|FG000|Overall Study|Death|1|||
30568085|NCT02911701|58575216|FG000|Overall Study|Withdrawal by Subject|2|||
30568086|NCT02911701|58575217|FG001|Overall Study|Withdrawal by Subject|4|||
30666870|NCT00882362|58680714|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
30568087|NCT02911701|58575216|FG000|Overall Study|Adverse Event|1|||
30568088|NCT02911701|58575217|FG001|Overall Study|Adverse Event|0|||
30568089|NCT02903368|58575225|FG000|Overall Study|Adverse Event|3|||
30568090|NCT02903368|58575226|FG001|Overall Study|Adverse Event|0|||
30568091|NCT02903368|58575225|FG000|Overall Study|Withdrawal by Subject|1|||
30568092|NCT02903368|58575226|FG001|Overall Study|Withdrawal by Subject|0|||
30568093|NCT02896257|58575236|FG000|Providers|Without eligible patients|21|||
30568094|NCT02896257|58575237|FG001|Providers|Without eligible patients|28|||
30568095|NCT02896257|58575236|FG000|Patients|PFT entry criteria not met|43|||
30568096|NCT02896257|58575237|FG001|Patients|PFT entry criteria not met|50|||
30568097|NCT02896257|58575236|FG000|Patients|No capacity to review|8|||
30568098|NCT02896257|58575237|FG001|Patients|No capacity to review|11|||
30568099|NCT02896257|58575236|FG000|Patients|Appointment rescheduled/cancelled|5|||
30568100|NCT02896257|58575237|FG001|Patients|Appointment rescheduled/cancelled|7|||
30568101|NCT02896257|58575236|FG000|Patients|PCP not assigned a clinic|4|||
30568102|NCT02896257|58575237|FG001|Patients|PCP not assigned a clinic|0|||
30568103|NCT02896257|58575236|FG000|Patients|No history of COPD|0|||
30568104|NCT02896257|58575237|FG001|Patients|No history of COPD|1|||
30568105|NCT02896257|58575236|FG000|Patients|Deceased between review and index date|0|||
30568106|NCT02896257|58575237|FG001|Patients|Deceased between review and index date|1|||
30568107|NCT02896257|58575236|FG000|Patients|No ICS Rx upon review|1|||
30568108|NCT02896257|58575237|FG001|Patients|No ICS Rx upon review|1|||
30568109|NCT02896257|58575236|FG000|Patients|Protocol Violation|2|||
30568110|NCT02896257|58575237|FG001|Patients|Protocol Violation|1|||
30568111|NCT02896257|58575236|FG000|Patients|Hospice care|0|||
30568112|NCT02896257|58575237|FG001|Patients|Hospice care|1|||
30568113|NCT02874742|58575247|FG000|Overall Study|Death|0|||
30568114|NCT02874742|58575248|FG001|Overall Study|Death|1|||
30568115|NCT02874742|58575249|FG002|Overall Study|Death|0|||
30568116|NCT02874742|58575247|FG000|Overall Study|Lost to Follow-up|5|||
30568117|NCT02874742|58575248|FG001|Overall Study|Lost to Follow-up|4|||
30568118|NCT02874742|58575249|FG002|Overall Study|Lost to Follow-up|1|||
30568119|NCT02874742|58575247|FG000|Overall Study|Withdrawal by Subject|17|||
30568120|NCT02874742|58575248|FG001|Overall Study|Withdrawal by Subject|8|||
30568121|NCT02874742|58575249|FG002|Overall Study|Withdrawal by Subject|0|||
30568122|NCT02874742|58575247|FG000|Overall Study|Other|4|||
30568123|NCT02874742|58575248|FG001|Overall Study|Other|1|||
30568124|NCT02874742|58575249|FG002|Overall Study|Other|0|||
30568125|NCT02874742|58575247|FG000|Overall Study|Progressive Disease|1|||
30568126|NCT02874742|58575248|FG001|Overall Study|Progressive Disease|0|||
30568127|NCT02874742|58575249|FG002|Overall Study|Progressive Disease|0|||
30568128|NCT02874742|58575247|FG000|Overall Study|Screen Failure|0|||
30568129|NCT02874742|58575248|FG001|Overall Study|Screen Failure|2|||
30568130|NCT02874742|58575249|FG002|Overall Study|Screen Failure|0|||
30568131|NCT02749292|58575259|FG000|Overall Study|Physician Decision|1|||
30568132|NCT02749292|58575260|FG001|Overall Study|Physician Decision|0|||
30568133|NCT02749292|58575259|FG000|Overall Study|Withdrawal by Subject|5|||
30568134|NCT02749292|58575260|FG001|Overall Study|Withdrawal by Subject|7|||
30568135|NCT02749292|58575259|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
30568136|NCT02749292|58575260|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
30568137|NCT02749292|58575259|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
30568138|NCT02749292|58575260|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
30568139|NCT02749292|58575259|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
30568140|NCT02749292|58575260|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
30568141|NCT02749292|58575259|FG000|Overall Study|Adverse Event|4|||
30568142|NCT02749292|58575260|FG001|Overall Study|Adverse Event|1|||
30568143|NCT02749292|58575259|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
30568144|NCT02749292|58575260|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
30568145|NCT02749292|58575259|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
30568146|NCT02749292|58575260|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
30568147|NCT02749292|58575259|FG000|Overall Study|Requiring glucocorticoids|0|||
30568148|NCT02749292|58575260|FG001|Overall Study|Requiring glucocorticoids|3|||
30568149|NCT02749292|58575259|FG000|Overall Study|Cancer|1|||
30568150|NCT02749292|58575260|FG001|Overall Study|Cancer|0|||
30568151|NCT02689076|58575279|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
30568152|NCT02689076|58575280|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
30568153|NCT02689076|58575281|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
30568154|NCT02689076|58575279|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
30568155|NCT02689076|58575280|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
30958643|NCT01694849|59023702|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
30568156|NCT02689076|58575281|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
30568157|NCT02689076|58575279|FG000|Overall Study|Did not have an HIE match|2|||
30568158|NCT02689076|58575280|FG001|Overall Study|Did not have an HIE match|0|||
30568159|NCT02689076|58575281|FG002|Overall Study|Did not have an HIE match|0|||
30568160|NCT02689076|58575279|FG000|Overall Study|Death during non-VA encounter|2|||
30568161|NCT02689076|58575280|FG001|Overall Study|Death during non-VA encounter|5|||
30568162|NCT02689076|58575281|FG002|Overall Study|Death during non-VA encounter|0|||
30568163|NCT02689076|58575279|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
30568164|NCT02689076|58575280|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
30568165|NCT02689076|58575281|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
30568166|NCT02689076|58575279|FG000|Overall Study|Participant no longer active in VA system|1|||
30568167|NCT02689076|58575280|FG001|Overall Study|Participant no longer active in VA system|0|||
30568168|NCT02689076|58575281|FG002|Overall Study|Participant no longer active in VA system|0|||
30568169|NCT02689076|58575279|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
30568170|NCT02689076|58575280|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
30568171|NCT02689076|58575281|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
30568172|NCT02670525|58575291|FG000|Overall Study|Death|94|||
30568173|NCT02670525|58575292|FG001|Overall Study|Death|14|||
30568174|NCT02670525|58575291|FG000|Overall Study|Lost to Follow-up|4|||
30568175|NCT02670525|58575292|FG001|Overall Study|Lost to Follow-up|1|||
30568176|NCT02670525|58575291|FG000|Overall Study|Subject withdrew consent|1|||
30568177|NCT02670525|58575292|FG001|Overall Study|Subject withdrew consent|0|||
30568178|NCT02670525|58575291|FG000|Overall Study|Unknown, data entry delayed|123|||
30568179|NCT02670525|58575292|FG001|Overall Study|Unknown, data entry delayed|78|||
30568180|NCT02576990|58575300|FG000|Overall Study|Death|29|||
30568181|NCT02576990|58575301|FG001|Overall Study|Death|18|||
30568182|NCT02576990|58575300|FG000|Overall Study|Physician Decision|1|||
30568183|NCT02576990|58575301|FG001|Overall Study|Physician Decision|0|||
30568184|NCT02576990|58575300|FG000|Overall Study|Screen failure|2|||
30568185|NCT02576990|58575301|FG001|Overall Study|Screen failure|0|||
30568186|NCT02576990|58575300|FG000|Overall Study|Sponsor's decision|24|||
30568187|NCT02576990|58575301|FG001|Overall Study|Sponsor's decision|4|||
30568188|NCT02576990|58575300|FG000|Overall Study|Withdrawal by Subject|0|||
30568189|NCT02576990|58575301|FG001|Overall Study|Withdrawal by Subject|2|||
30568190|NCT02550561|58575307|FG000|Overall Study|Lost to Follow-up|5|||
30568191|NCT02550561|58575307|FG000|Overall Study|Withdrawal by Subject|1|||
30568192|NCT02524171|58575317|FG000|6-month Follow-up|Lost to Follow-up|53|||
30568193|NCT02524171|58575318|FG001|6-month Follow-up|Lost to Follow-up|45|||
30568194|NCT02524171|58575317|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
30568195|NCT02524171|58575318|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
30568196|NCT02511106|58575326|FG000|Overall Study|Lost to Follow-up|1|||
30568197|NCT02511106|58575327|FG001|Overall Study|Lost to Follow-up|2|||
30568198|NCT02511106|58575326|FG000|Overall Study|Withdrawal by Subject|19|||
30568199|NCT02511106|58575327|FG001|Overall Study|Withdrawal by Subject|14|||
30568200|NCT02511106|58575326|FG000|Overall Study|Ongoing study at data cut-off|309|||
30568201|NCT02511106|58575327|FG001|Overall Study|Ongoing study at data cut-off|307|||
30568202|NCT02511106|58575326|FG000|Overall Study|Without specified reason|1|||
30568203|NCT02511106|58575327|FG001|Overall Study|Without specified reason|0|||
30568204|NCT02511106|58575326|FG000|Overall Study|Missing|1|||
30568205|NCT02511106|58575327|FG001|Overall Study|Missing|0|||
30568206|NCT02500589|58575337|FG000|Overall Study|Withdrawal by Subject|11|||
30568207|NCT02500589|58575338|FG001|Overall Study|Withdrawal by Subject|14|||
30568208|NCT02500589|58575337|FG000|Overall Study|Lost to Follow-up|10|||
30666871|NCT00882362|58680715|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
30666872|NCT00882362|58680714|FG000|Overall Study|change of residence or other commitments|5|||
30666873|NCT00882362|58680715|FG001|Overall Study|change of residence or other commitments|0|||
30666874|NCT00851643|58680727|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
30666875|NCT00851643|58680728|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
30666876|NCT00851643|58680729|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
30666877|NCT00851643|58680730|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
30666878|NCT00851643|58680731|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
30666879|NCT00851643|58680732|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
30666880|NCT00851643|58680727|FG000|Base Study (Up to 12 Months)|Other|0|||
30666881|NCT00851643|58680728|FG001|Base Study (Up to 12 Months)|Other|0|||
30666882|NCT00851643|58680729|FG002|Base Study (Up to 12 Months)|Other|0|||
30666883|NCT00851643|58680730|FG003|Base Study (Up to 12 Months)|Other|0|||
30666884|NCT00851643|58680731|FG004|Base Study (Up to 12 Months)|Other|0|||
30666885|NCT00851643|58680732|FG005|Base Study (Up to 12 Months)|Other|1|||
30666886|NCT00851643|58680727|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
30666887|NCT00851643|58680728|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
30666888|NCT00851643|58680729|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
30666889|NCT00851643|58680730|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
30666890|NCT00851643|58680731|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
30666891|NCT00851643|58680732|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
30666892|NCT00851643|58680727|FG000|Extension Study (Up to 36 Months)|Moved|0|||
30666893|NCT00851643|58680728|FG001|Extension Study (Up to 36 Months)|Moved|2|||
30666894|NCT00851643|58680729|FG002|Extension Study (Up to 36 Months)|Moved|1|||
30666895|NCT00851643|58680730|FG003|Extension Study (Up to 36 Months)|Moved|1|||
30666896|NCT00851643|58680731|FG004|Extension Study (Up to 36 Months)|Moved|0|||
30568209|NCT02500589|58575338|FG001|Overall Study|Lost to Follow-up|12|||
30780136|NCT02992288|58791838|FG004|Overall Study|Physician Decision|0|||
30568210|NCT02500589|58575337|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
30568211|NCT02500589|58575338|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
30568212|NCT02500589|58575337|FG000|Overall Study|Death|7|||
30568213|NCT02500589|58575338|FG001|Overall Study|Death|5|||
30568214|NCT02481830|58575350|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
30568215|NCT02481830|58575351|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
30568216|NCT02481830|58575350|FG000|Pre-treatment|Withdrawal by Subject|0|||
30568217|NCT02481830|58575351|FG001|Pre-treatment|Withdrawal by Subject|10|||
30568218|NCT02481830|58575350|FG000|Pre-treatment|Disease Progression|1|||
30568219|NCT02481830|58575351|FG001|Pre-treatment|Disease Progression|1|||
30568220|NCT02481830|58575350|FG000|Pre-treatment|Other reasons|0|||
30568221|NCT02481830|58575351|FG001|Pre-treatment|Other reasons|1|||
30568222|NCT02481830|58575350|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
30568223|NCT02481830|58575351|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
30568224|NCT02481830|58575350|FG000|Treatment|Disease Progression|233|||
30568225|NCT02481830|58575351|FG001|Treatment|Disease Progression|171|||
30568226|NCT02481830|58575350|FG000|Treatment|Study drug toxicity|18|||
30568227|NCT02481830|58575351|FG001|Treatment|Study drug toxicity|38|||
30568228|NCT02481830|58575350|FG000|Treatment|Death|1|||
30568229|NCT02481830|58575351|FG001|Treatment|Death|1|||
30568230|NCT02481830|58575350|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
30568231|NCT02481830|58575351|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
30568232|NCT02481830|58575350|FG000|Treatment|Participants request to discontinue Study treatment|6|||
30568233|NCT02481830|58575351|FG001|Treatment|Participants request to discontinue Study treatment|34|||
30568234|NCT02481830|58575350|FG000|Treatment|Withdrawal by Subject|2|||
30568235|NCT02481830|58575351|FG001|Treatment|Withdrawal by Subject|3|||
30568236|NCT02481830|58575350|FG000|Treatment|Lost to Follow-up|1|||
30568237|NCT02481830|58575351|FG001|Treatment|Lost to Follow-up|0|||
30568238|NCT02481830|58575350|FG000|Treatment|Maximum Clinical Benefit|0|||
30568239|NCT02481830|58575351|FG001|Treatment|Maximum Clinical Benefit|5|||
30568240|NCT02481830|58575350|FG000|Treatment|Administrative reason by sponsor|1|||
30568241|NCT02481830|58575351|FG001|Treatment|Administrative reason by sponsor|1|||
30568242|NCT02481830|58575350|FG000|Treatment|Other reasons|6|||
30568243|NCT02481830|58575351|FG001|Treatment|Other reasons|1|||
30568244|NCT02477111|58575357|FG000|Overall Study|Death|5|||
30568245|NCT02477111|58575357|FG000|Overall Study|Withdrawal by Subject|2|||
30568246|NCT02477111|58575357|FG000|Overall Study|missed visit|4|||
30568247|NCT02425943|58575365|FG000|Overall Study|Adverse Event|3|||
30568248|NCT02425943|58575366|FG001|Overall Study|Adverse Event|1|||
30568249|NCT02425943|58575365|FG000|Overall Study|Lost to Follow-up|59|||
30568250|NCT02425943|58575366|FG001|Overall Study|Lost to Follow-up|37|||
30568251|NCT02425943|58575365|FG000|Overall Study|Protocol Violation|4|||
30568252|NCT02425943|58575366|FG001|Overall Study|Protocol Violation|1|||
30568253|NCT02425943|58575365|FG000|Overall Study|Withdrawal by Subject|64|||
30568254|NCT02425943|58575366|FG001|Overall Study|Withdrawal by Subject|31|||
30568255|NCT02425943|58575365|FG000|Overall Study|Other|6|||
30568256|NCT02425943|58575366|FG001|Overall Study|Other|0|||
30568257|NCT02383173|58575376|FG000|Overall Study|Palliative Care Team withdrew|0|||
30568258|NCT02383173|58575377|FG001|Overall Study|Palliative Care Team withdrew|2|||
30568259|NCT02380690|58575385|FG000|Overall Study|Lost to Follow-up|14|||
30568260|NCT02380690|58575386|FG001|Overall Study|Lost to Follow-up|4|||
30568261|NCT02380690|58575385|FG000|Overall Study|Withdrawal by Subject|20|||
30568262|NCT02380690|58575386|FG001|Overall Study|Withdrawal by Subject|8|||
30568263|NCT02311673|58575428|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
30568264|NCT02311673|58575429|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
30568265|NCT02311673|58575430|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
30568266|NCT02311673|58575431|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
30568267|NCT02286089|58575467|FG000|Overall Study|Ongoing in Study|1|||
30568268|NCT02286089|58575468|FG001|Overall Study|Ongoing in Study|1|||
30568269|NCT02286089|58575469|FG002|Overall Study|Ongoing in Study|4|||
30568270|NCT02286089|58575470|FG003|Overall Study|Ongoing in Study|10|||
30568271|NCT02286089|58575467|FG000|Overall Study|Withdrawal by Subject|0|||
30568272|NCT02286089|58575468|FG001|Overall Study|Withdrawal by Subject|0|||
30666897|NCT00851643|58680732|FG005|Extension Study (Up to 36 Months)|Moved|1|||
30666898|NCT00529243|58680745|FG000|Overall Study|Adverse Event|1|||
30568273|NCT02286089|58575469|FG002|Overall Study|Withdrawal by Subject|2|||
30568274|NCT02286089|58575470|FG003|Overall Study|Withdrawal by Subject|2|||
30666899|NCT00529243|58680745|FG000|Overall Study|Death|1|||
30568275|NCT02284113|58575482|FG000|Overall Study|Adverse Event|1|||
30568276|NCT02284113|58575483|FG001|Overall Study|Adverse Event|0|||
30568277|NCT02284113|58575482|FG000|Overall Study|non-compliance|0|||
30666900|NCT00529243|58680745|FG000|Overall Study|Relocated|1|||
30568278|NCT02284113|58575483|FG001|Overall Study|non-compliance|1|||
30568279|NCT02284113|58575482|FG000|Overall Study|Withdrawal by Subject|0|||
30568280|NCT02284113|58575483|FG001|Overall Study|Withdrawal by Subject|1|||
30568281|NCT02284113|58575482|FG000|Overall Study|not provided|0|||
30568282|NCT02284113|58575483|FG001|Overall Study|not provided|1|||
30568283|NCT02284113|58575482|FG000|Overall Study|surgery cancelled|2|||
30568284|NCT02284113|58575483|FG001|Overall Study|surgery cancelled|0|||
30568285|NCT02233738|58575491|FG000|Overall Study|Lost to Follow-up|5|||
30568286|NCT02233738|58575492|FG001|Overall Study|Lost to Follow-up|12|||
30568287|NCT02233738|58575491|FG000|Overall Study|Death|0|||
30568288|NCT02233738|58575492|FG001|Overall Study|Death|1|||
30568289|NCT02233738|58575491|FG000|Overall Study|Withdrawal by Subject|0|||
30568290|NCT02233738|58575492|FG001|Overall Study|Withdrawal by Subject|1|||
30568291|NCT02233738|58575491|FG000|Overall Study|Did not return after Baseline|3|||
30568292|NCT02233738|58575492|FG001|Overall Study|Did not return after Baseline|2|||
30568293|NCT01959698|58575680|FG000|Overall Study|Adverse Event|0|||
30568294|NCT01959698|58575681|FG001|Overall Study|Adverse Event|0|||
30568295|NCT01959698|58575682|FG002|Overall Study|Adverse Event|0|||
30568296|NCT01959698|58575683|FG003|Overall Study|Adverse Event|0|||
30568297|NCT01959698|58575684|FG004|Overall Study|Adverse Event|0|||
30568298|NCT01959698|58575685|FG005|Overall Study|Adverse Event|0|||
30568299|NCT01959698|58575686|FG006|Overall Study|Adverse Event|1|||
30568300|NCT01959698|58575680|FG000|Overall Study|Physician Decision|1|||
30568301|NCT01959698|58575681|FG001|Overall Study|Physician Decision|0|||
30568302|NCT01959698|58575682|FG002|Overall Study|Physician Decision|1|||
30568303|NCT01959698|58575683|FG003|Overall Study|Physician Decision|2|||
30568304|NCT01959698|58575684|FG004|Overall Study|Physician Decision|0|||
30568305|NCT01959698|58575685|FG005|Overall Study|Physician Decision|3|||
30666901|NCT03728309|58680751|FG000|Overall Study|Randomized but not Treated|0|||
30666902|NCT03728309|58680752|FG001|Overall Study|Randomized but not Treated|1|||
30666903|NCT03728309|58680751|FG000|Overall Study|Adverse Event|0|||
30666904|NCT03728309|58680752|FG001|Overall Study|Adverse Event|1|||
30666905|NCT03728309|58680751|FG000|Overall Study|Withdrawal by Subject|2|||
30666906|NCT03728309|58680752|FG001|Overall Study|Withdrawal by Subject|8|||
30666907|NCT03728309|58680751|FG000|Overall Study|Lost to Follow-up|9|||
30666908|NCT03728309|58680752|FG001|Overall Study|Lost to Follow-up|10|||
30666909|NCT03728309|58680751|FG000|Overall Study|Protocol Deviation|0|||
30666910|NCT03728309|58680752|FG001|Overall Study|Protocol Deviation|1|||
30666911|NCT03728309|58680751|FG000|Overall Study|Due to COVID|1|||
30666912|NCT03728309|58680752|FG001|Overall Study|Due to COVID|3|||
30666913|NCT03683719|58680769|FG000|Overall Study|Lack of Efficacy|1|||
30666914|NCT03683719|58680770|FG001|Overall Study|Lack of Efficacy|3|||
30666915|NCT03683719|58680771|FG002|Overall Study|Lack of Efficacy|4|||
30666916|NCT03683719|58680772|FG003|Overall Study|Lack of Efficacy|0|||
30666917|NCT03683719|58680773|FG004|Overall Study|Lack of Efficacy|4|||
30666918|NCT03683719|58680769|FG000|Overall Study|Adverse Event|6|||
30666919|NCT03683719|58680770|FG001|Overall Study|Adverse Event|6|||
30666920|NCT03683719|58680771|FG002|Overall Study|Adverse Event|0|||
30666921|NCT03683719|58680772|FG003|Overall Study|Adverse Event|1|||
30666922|NCT03683719|58680773|FG004|Overall Study|Adverse Event|3|||
30666923|NCT03683719|58680769|FG000|Overall Study|Withdrawal by Subject|4|||
30666924|NCT03683719|58680770|FG001|Overall Study|Withdrawal by Subject|4|||
30666925|NCT03683719|58680771|FG002|Overall Study|Withdrawal by Subject|3|||
30666926|NCT03683719|58680772|FG003|Overall Study|Withdrawal by Subject|5|||
30666927|NCT03683719|58680773|FG004|Overall Study|Withdrawal by Subject|5|||
30666928|NCT03683719|58680769|FG000|Overall Study|Lost to Follow-up|1|||
30666929|NCT03683719|58680770|FG001|Overall Study|Lost to Follow-up|0|||
30666930|NCT03683719|58680771|FG002|Overall Study|Lost to Follow-up|0|||
30666931|NCT03683719|58680772|FG003|Overall Study|Lost to Follow-up|1|||
30666932|NCT03683719|58680773|FG004|Overall Study|Lost to Follow-up|1|||
30666933|NCT03683719|58680769|FG000|Overall Study|Other personal reasons|0|||
30666934|NCT03683719|58680770|FG001|Overall Study|Other personal reasons|0|||
30568306|NCT01959698|58575686|FG006|Overall Study|Physician Decision|3|||
30568307|NCT01910402|58575705|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
30568308|NCT01910402|58575706|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
30568309|NCT01910402|58575707|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
30568310|NCT01910402|58575705|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
30568311|NCT01910402|58575706|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
30568312|NCT01910402|58575707|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
30666935|NCT03683719|58680771|FG002|Overall Study|Other personal reasons|1|||
30666936|NCT03683719|58680772|FG003|Overall Study|Other personal reasons|0|||
30666937|NCT03683719|58680773|FG004|Overall Study|Other personal reasons|1|||
30666938|NCT00851253|58680787|FG000|Overall Study|Disease Progression|1|||
30666939|NCT00851253|58680788|FG001|Overall Study|Disease Progression|0|||
30568313|NCT01910402|58575705|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
30568314|NCT01910402|58575706|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
30568315|NCT01910402|58575707|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
30568316|NCT01910402|58575705|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
30666940|NCT00520351|58680796|FG000|First Intervention|Withdrawal by Subject|1|||
30666941|NCT00520351|58680797|FG001|First Intervention|Withdrawal by Subject|1|||
30666942|NCT00850395|58680807|FG000|Overall Study|Death|1|||
30666943|NCT00850395|58680807|FG000|Overall Study|Adverse Event|1|||
30568317|NCT01910402|58575706|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
30568318|NCT01910402|58575707|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
30568319|NCT01910402|58575705|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
30568320|NCT01910402|58575706|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
30568321|NCT01910402|58575707|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
30568322|NCT01910402|58575705|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
30568323|NCT01910402|58575706|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
30568324|NCT01910402|58575707|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
30568325|NCT01910402|58575705|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
30568326|NCT01910402|58575706|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
30568327|NCT01910402|58575707|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
30568328|NCT01910402|58575705|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
30568329|NCT01910402|58575706|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
30568330|NCT01910402|58575707|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
30568331|NCT01910402|58575705|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
30568332|NCT01910402|58575706|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
30568333|NCT01910402|58575707|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
30568334|NCT01910402|58575705|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
30568335|NCT01910402|58575706|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
30568336|NCT01910402|58575707|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
30568337|NCT01910402|58575705|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
30666944|NCT00850395|58680807|FG000|Overall Study|Insufficient clinical response|3|||
30666945|NCT00850395|58680807|FG000|Overall Study|Other|5|||
30666946|NCT00520039|58680813|FG000|Overall Study|Exclusion criteria met at first visit|7|||
30666947|NCT00520039|58680814|FG001|Overall Study|Exclusion criteria met at first visit|5|||
30666948|NCT00577720|58680826|FG000|Overall Study|Adverse Event|2|||
30666949|NCT00577720|58680827|FG001|Overall Study|Adverse Event|1|||
30666950|NCT00577720|58680828|FG002|Overall Study|Adverse Event|0|||
30666951|NCT00577720|58680829|FG003|Overall Study|Adverse Event|4|||
30666952|NCT00577720|58680826|FG000|Overall Study|Lost to Follow-up|0|||
30666953|NCT00577720|58680827|FG001|Overall Study|Lost to Follow-up|0|||
30666954|NCT00577720|58680828|FG002|Overall Study|Lost to Follow-up|1|||
30666955|NCT00577720|58680829|FG003|Overall Study|Lost to Follow-up|0|||
30666956|NCT00577720|58680826|FG000|Overall Study|Protocol Violation|0|||
30666957|NCT00577720|58680827|FG001|Overall Study|Protocol Violation|0|||
30568338|NCT01910402|58575706|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
30568339|NCT01910402|58575707|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
30568340|NCT01910402|58575705|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
30568341|NCT01910402|58575706|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
30568342|NCT01910402|58575707|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
30568343|NCT01910402|58575705|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
30568344|NCT01910402|58575706|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
30568345|NCT01910402|58575707|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
30666958|NCT00577720|58680828|FG002|Overall Study|Protocol Violation|0|||
30666959|NCT00577720|58680829|FG003|Overall Study|Protocol Violation|1|||
30666960|NCT00577720|58680826|FG000|Overall Study|Withdrawal by Subject|2|||
30666961|NCT00577720|58680827|FG001|Overall Study|Withdrawal by Subject|0|||
30666962|NCT00577720|58680828|FG002|Overall Study|Withdrawal by Subject|0|||
30780137|NCT02992288|58791839|FG005|Overall Study|Physician Decision|1|||
30780138|NCT02992288|58791834|FG000|Overall Study|Death|2|||
30780139|NCT02992288|58791835|FG001|Overall Study|Death|0|||
30780140|NCT02992288|58791836|FG002|Overall Study|Death|2|||
30780141|NCT02992288|58791837|FG003|Overall Study|Death|1|||
30855167|NCT01359644|58882745|FG003|Treatment Period|Lack of Efficacy|0|||
30855168|NCT01359644|58882746|FG004|Treatment Period|Lack of Efficacy|0|||
30855169|NCT01359644|58882747|FG005|Treatment Period|Lack of Efficacy|0|||
30855170|NCT01359644|58882748|FG006|Treatment Period|Lack of Efficacy|0|||
30855171|NCT01359644|58882749|FG007|Treatment Period|Lack of Efficacy|0|||
30855172|NCT01359644|58882750|FG008|Treatment Period|Lack of Efficacy|0|||
30855173|NCT01359644|58882751|FG009|Treatment Period|Lack of Efficacy|0|||
30855174|NCT01359644|58882742|FG000|Treatment Period|Adverse Event|0|||
30855175|NCT01359644|58882743|FG001|Treatment Period|Adverse Event|0|||
30780142|NCT02992288|58791838|FG004|Overall Study|Death|2|||
30780143|NCT02992288|58791839|FG005|Overall Study|Death|0|||
30780144|NCT02992288|58791834|FG000|Overall Study|Lost to Follow-up|0|||
30666963|NCT00577720|58680829|FG003|Overall Study|Withdrawal by Subject|2|||
30780145|NCT02992288|58791835|FG001|Overall Study|Lost to Follow-up|0|||
30780146|NCT02992288|58791836|FG002|Overall Study|Lost to Follow-up|0|||
30780147|NCT02992288|58791837|FG003|Overall Study|Lost to Follow-up|1|||
30855176|NCT01359644|58882744|FG002|Treatment Period|Adverse Event|1|||
30855177|NCT01359644|58882745|FG003|Treatment Period|Adverse Event|0|||
30855178|NCT01359644|58882746|FG004|Treatment Period|Adverse Event|0|||
30568346|NCT01757535|58575734|FG000|Overall Study|Disease Relapse|143|||
30568347|NCT01757535|58575735|FG001|Overall Study|Disease Relapse|180|||
30568348|NCT01757535|58575734|FG000|Overall Study|Adverse Event|29|||
30568349|NCT01757535|58575735|FG001|Overall Study|Adverse Event|11|||
30568350|NCT01757535|58575734|FG000|Overall Study|Withdrawal by Subject|9|||
30568351|NCT01757535|58575735|FG001|Overall Study|Withdrawal by Subject|13|||
30568352|NCT01757535|58575734|FG000|Overall Study|Miscellaneous|5|||
30568353|NCT01757535|58575735|FG001|Overall Study|Miscellaneous|2|||
30568354|NCT01757535|58575734|FG000|Overall Study|Physician Decision|6|||
30568355|NCT01757535|58575735|FG001|Overall Study|Physician Decision|0|||
30568356|NCT01757535|58575734|FG000|Overall Study|Death|1|||
30568357|NCT01757535|58575735|FG001|Overall Study|Death|2|||
30568358|NCT01614197|58575749|FG000|Overall Study|Withdrawal by Subject|0|||
30568359|NCT01614197|58575750|FG001|Overall Study|Withdrawal by Subject|1|||
30568360|NCT01614197|58575751|FG002|Overall Study|Withdrawal by Subject|0|||
30568361|NCT01614197|58575752|FG003|Overall Study|Withdrawal by Subject|0|||
30568362|NCT01236521|58575786|FG000|Overall Study|Withdrawal by Subject|12|||
30568363|NCT01236521|58575787|FG001|Overall Study|Withdrawal by Subject|17|||
30568364|NCT01236521|58575786|FG000|Overall Study|Death|2|||
30568365|NCT01236521|58575787|FG001|Overall Study|Death|1|||
30568366|NCT01236521|58575786|FG000|Overall Study|Lost to Follow-up|9|||
30568367|NCT01236521|58575787|FG001|Overall Study|Lost to Follow-up|7|||
30568368|NCT01226797|58575795|FG000|Overall Study|Adverse Event|1|||
30568369|NCT01226797|58575796|FG001|Overall Study|Adverse Event|0|||
30568370|NCT01226797|58575795|FG000|Overall Study|No longer willing to participate|1|||
30568371|NCT01226797|58575796|FG001|Overall Study|No longer willing to participate|0|||
30568372|NCT01226797|58575795|FG000|Overall Study|Protocol Violation|0|||
30568373|NCT01226797|58575796|FG001|Overall Study|Protocol Violation|1|||
30568374|NCT01142908|58575804|FG000|Overall Study|Lost to Follow-up|19|||
30568375|NCT01142908|58575805|FG001|Overall Study|Lost to Follow-up|13|||
30568376|NCT01142908|58575804|FG000|Overall Study|Death|1|||
30568377|NCT01142908|58575805|FG001|Overall Study|Death|4|||
30568378|NCT01142908|58575804|FG000|Overall Study|Excluded - did not meet criteria|9|||
30568379|NCT01142908|58575805|FG001|Overall Study|Excluded - did not meet criteria|5|||
30568380|NCT01142908|58575804|FG000|Overall Study|Withdrawal by Subject|3|||
30568381|NCT01142908|58575805|FG001|Overall Study|Withdrawal by Subject|0|||
30568382|NCT01470326|58575865|FG000|Overall Study|Protocol Violation|32|||
30568383|NCT01470326|58575865|FG000|Overall Study|No Drug Administration Information|2|||
30568384|NCT01470326|58575865|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
30568385|NCT01480180|58575880|FG000|Main Phase|Withdrawal criteria|12|||
30568386|NCT01480180|58575881|FG001|Main Phase|Withdrawal criteria|1|||
30568387|NCT01480180|58575882|FG002|Main Phase|Withdrawal criteria|0|||
30568388|NCT01480180|58575883|FG003|Main Phase|Withdrawal criteria|0|||
30568389|NCT01480180|58575884|FG004|Main Phase|Withdrawal criteria|0|||
30568390|NCT01480180|58575885|FG005|Main Phase|Withdrawal criteria|0|||
30568391|NCT01480180|58575880|FG000|Main Phase|Lack of Efficacy|1|||
30568392|NCT01480180|58575881|FG001|Main Phase|Lack of Efficacy|0|||
30568393|NCT01480180|58575882|FG002|Main Phase|Lack of Efficacy|0|||
30568394|NCT01480180|58575883|FG003|Main Phase|Lack of Efficacy|0|||
30568395|NCT01480180|58575884|FG004|Main Phase|Lack of Efficacy|0|||
30568396|NCT01480180|58575885|FG005|Main Phase|Lack of Efficacy|0|||
30568397|NCT01480180|58575880|FG000|Main Phase|Non-compliance|3|||
30568398|NCT01480180|58575881|FG001|Main Phase|Non-compliance|0|||
30568399|NCT01480180|58575882|FG002|Main Phase|Non-compliance|0|||
30568400|NCT01480180|58575883|FG003|Main Phase|Non-compliance|0|||
30666964|NCT00519649|58680839|FG000|Overall Study|Withdrawal by Subject|1|||
30666965|NCT00512707|58680857|FG000|Overall Study|Lost to Follow-up|5|||
30666966|NCT00512707|58680858|FG001|Overall Study|Lost to Follow-up|11|||
30780148|NCT02992288|58791838|FG004|Overall Study|Lost to Follow-up|0|||
30780149|NCT02992288|58791839|FG005|Overall Study|Lost to Follow-up|0|||
30780150|NCT02992288|58791834|FG000|Overall Study|Protocol Violation|0|||
30780151|NCT02992288|58791835|FG001|Overall Study|Protocol Violation|0|||
30780152|NCT02992288|58791836|FG002|Overall Study|Protocol Violation|0|||
30568401|NCT01480180|58575884|FG004|Main Phase|Non-compliance|0|||
30568402|NCT01480180|58575885|FG005|Main Phase|Non-compliance|0|||
30568403|NCT01480180|58575880|FG000|Main Phase|Unclassified|3|||
30568404|NCT01480180|58575881|FG001|Main Phase|Unclassified|0|||
30568405|NCT01480180|58575882|FG002|Main Phase|Unclassified|0|||
30568406|NCT01480180|58575883|FG003|Main Phase|Unclassified|0|||
30568407|NCT01480180|58575884|FG004|Main Phase|Unclassified|0|||
30568408|NCT01480180|58575885|FG005|Main Phase|Unclassified|0|||
30568409|NCT01480180|58575880|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
30666967|NCT00512707|58680857|FG000|Overall Study|Developed skin irritation|2|||
30568410|NCT01480180|58575881|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
30568411|NCT01480180|58575882|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
30568412|NCT01480180|58575883|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
30568413|NCT01480180|58575884|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
30568414|NCT01480180|58575885|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
30568415|NCT01480180|58575880|FG000|Extension Phase, Part 1|Unclassified|0|||
30568416|NCT01480180|58575881|FG001|Extension Phase, Part 1|Unclassified|0|||
30568417|NCT01480180|58575882|FG002|Extension Phase, Part 1|Unclassified|1|||
30568418|NCT01480180|58575883|FG003|Extension Phase, Part 1|Unclassified|0|||
30568419|NCT01480180|58575884|FG004|Extension Phase, Part 1|Unclassified|0|||
30568420|NCT01480180|58575885|FG005|Extension Phase, Part 1|Unclassified|0|||
30568421|NCT01480180|58575880|FG000|Extension Phase, Part 1|Adverse Event|0|||
30568422|NCT01480180|58575881|FG001|Extension Phase, Part 1|Adverse Event|0|||
30568423|NCT01480180|58575882|FG002|Extension Phase, Part 1|Adverse Event|4|||
30568424|NCT01480180|58575883|FG003|Extension Phase, Part 1|Adverse Event|1|||
30568425|NCT01480180|58575884|FG004|Extension Phase, Part 1|Adverse Event|0|||
30568426|NCT01480180|58575885|FG005|Extension Phase, Part 1|Adverse Event|0|||
30568427|NCT01480180|58575880|FG000|Extension Phase, Part 1|Change of treatment|0|||
30568428|NCT01480180|58575881|FG001|Extension Phase, Part 1|Change of treatment|0|||
30568429|NCT01480180|58575882|FG002|Extension Phase, Part 1|Change of treatment|0|||
30568430|NCT01480180|58575883|FG003|Extension Phase, Part 1|Change of treatment|9|||
30568431|NCT01480180|58575884|FG004|Extension Phase, Part 1|Change of treatment|0|||
30568432|NCT01480180|58575885|FG005|Extension Phase, Part 1|Change of treatment|0|||
30568433|NCT01480180|58575880|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
30568434|NCT01480180|58575881|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
30568435|NCT01480180|58575882|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
30568436|NCT01480180|58575883|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
30568437|NCT01480180|58575884|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
30568438|NCT01480180|58575885|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
30568439|NCT01480180|58575880|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
30568440|NCT01480180|58575881|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
30568441|NCT01480180|58575882|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
30568442|NCT01480180|58575883|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
30568443|NCT01480180|58575884|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
30568444|NCT01480180|58575885|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
30568445|NCT01480180|58575880|FG000|Extension Phase, Part 2|Unclassified|0|||
30568446|NCT01480180|58575881|FG001|Extension Phase, Part 2|Unclassified|0|||
30568447|NCT01480180|58575882|FG002|Extension Phase, Part 2|Unclassified|3|||
30568448|NCT01480180|58575883|FG003|Extension Phase, Part 2|Unclassified|1|||
30568449|NCT01480180|58575884|FG004|Extension Phase, Part 2|Unclassified|1|||
30568450|NCT01480180|58575885|FG005|Extension Phase, Part 2|Unclassified|0|||
30666968|NCT00512707|58680858|FG001|Overall Study|Developed skin irritation|1|||
30666969|NCT00512707|58680857|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
30666970|NCT00512707|58680858|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
30666971|NCT00512707|58680857|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
30666972|NCT00512707|58680858|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
30666973|NCT03471767|58680866|FG000|Overall Study|Withdrawal by Subject|3|||
30666974|NCT03471767|58680867|FG001|Overall Study|Withdrawal by Subject|1|||
30666975|NCT03471767|58680866|FG000|Overall Study|Adverse Event|1|||
30666976|NCT03471767|58680867|FG001|Overall Study|Adverse Event|0|||
30666977|NCT03471767|58680866|FG000|Overall Study|Lost to Follow-up|1|||
30666978|NCT03471767|58680867|FG001|Overall Study|Lost to Follow-up|0|||
30666979|NCT03471767|58680866|FG000|Overall Study|PI Withdrawal|1|||
30666980|NCT03471767|58680867|FG001|Overall Study|PI Withdrawal|3|||
30666981|NCT00849693|58680877|FG000|Acute Treatment Phase|Adverse Event|12|||
30666982|NCT00849693|58680878|FG001|Acute Treatment Phase|Adverse Event|7|||
30666983|NCT00849693|58680879|FG002|Acute Treatment Phase|Adverse Event|6|||
30666984|NCT00849693|58680880|FG003|Acute Treatment Phase|Adverse Event|4|||
30666985|NCT00849693|58680877|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
30666986|NCT00849693|58680878|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
30666987|NCT00849693|58680879|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
30666988|NCT00849693|58680880|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
30666989|NCT00849693|58680877|FG000|Acute Treatment Phase|Protocol Violation|1|||
30666990|NCT00849693|58680878|FG001|Acute Treatment Phase|Protocol Violation|5|||
30666991|NCT00849693|58680879|FG002|Acute Treatment Phase|Protocol Violation|2|||
30666992|NCT00849693|58680880|FG003|Acute Treatment Phase|Protocol Violation|6|||
30666993|NCT00849693|58680877|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
30666994|NCT00849693|58680878|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
30666995|NCT00849693|58680879|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
30666996|NCT00849693|58680880|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
30666997|NCT00849693|58680877|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
30666998|NCT00849693|58680878|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
30666999|NCT00849693|58680879|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
30667000|NCT00849693|58680880|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
30667001|NCT00849693|58680877|FG000|Acute Treatment Phase|Physician Decision|2|||
30667002|NCT00849693|58680878|FG001|Acute Treatment Phase|Physician Decision|1|||
30667003|NCT00849693|58680879|FG002|Acute Treatment Phase|Physician Decision|2|||
30667004|NCT00849693|58680880|FG003|Acute Treatment Phase|Physician Decision|1|||
30667005|NCT00849693|58680877|FG000|Acute Treatment Phase|Sponsor decision|0|||
30780153|NCT02992288|58791837|FG003|Overall Study|Protocol Violation|0|||
30568451|NCT01545050|58575921|FG000|Overall Study|Lack of Efficacy|0|||
30568452|NCT01545050|58575922|FG001|Overall Study|Lack of Efficacy|0|||
30568453|NCT01545050|58575923|FG002|Overall Study|Lack of Efficacy|0|||
30568454|NCT01545050|58575924|FG003|Overall Study|Lack of Efficacy|3|||
30568455|NCT01545050|58575925|FG004|Overall Study|Lack of Efficacy|2|||
30568456|NCT01545050|58575921|FG000|Overall Study|Adverse Event|1|||
30568457|NCT01545050|58575922|FG001|Overall Study|Adverse Event|1|||
30568458|NCT01545050|58575923|FG002|Overall Study|Adverse Event|2|||
30568459|NCT01545050|58575924|FG003|Overall Study|Adverse Event|2|||
30568460|NCT01545050|58575925|FG004|Overall Study|Adverse Event|0|||
30568461|NCT01545050|58575921|FG000|Overall Study|Discontinued study treatment|1|||
30568462|NCT01545050|58575922|FG001|Overall Study|Discontinued study treatment|0|||
30568463|NCT01545050|58575923|FG002|Overall Study|Discontinued study treatment|0|||
30568464|NCT01545050|58575924|FG003|Overall Study|Discontinued study treatment|0|||
30568465|NCT01545050|58575925|FG004|Overall Study|Discontinued study treatment|0|||
30568466|NCT01545050|58575921|FG000|Overall Study|Withdrawal by Subject|1|||
30568467|NCT01545050|58575922|FG001|Overall Study|Withdrawal by Subject|0|||
30568468|NCT01545050|58575923|FG002|Overall Study|Withdrawal by Subject|0|||
30568469|NCT01545050|58575924|FG003|Overall Study|Withdrawal by Subject|2|||
30568470|NCT01545050|58575925|FG004|Overall Study|Withdrawal by Subject|1|||
30568471|NCT01545050|58575921|FG000|Overall Study|Participant no longer meets study criteria|0|||
30568472|NCT01545050|58575922|FG001|Overall Study|Participant no longer meets study criteria|2|||
30568473|NCT01545050|58575923|FG002|Overall Study|Participant no longer meets study criteria|0|||
30568474|NCT01545050|58575924|FG003|Overall Study|Participant no longer meets study criteria|0|||
30568475|NCT01545050|58575925|FG004|Overall Study|Participant no longer meets study criteria|1|||
30568476|NCT01545050|58575921|FG000|Overall Study|Administrative reason by sponsor|4|||
30568477|NCT01545050|58575922|FG001|Overall Study|Administrative reason by sponsor|2|||
30568478|NCT01545050|58575923|FG002|Overall Study|Administrative reason by sponsor|3|||
30568479|NCT01545050|58575924|FG003|Overall Study|Administrative reason by sponsor|5|||
30568480|NCT01545050|58575925|FG004|Overall Study|Administrative reason by sponsor|5|||
30568481|NCT01555021|58575952|FG000|Overall Study|Lost to Follow-up|1|||
30568482|NCT01555021|58575953|FG001|Overall Study|Lost to Follow-up|2|||
30568483|NCT04721925|58575967|FG000|2-Month Assessment|Lost to Follow-up|5|||
30568484|NCT04721925|58575968|FG001|2-Month Assessment|Lost to Follow-up|3|||
30568485|NCT04721925|58575967|FG000|4-Month Assessment|Lost to Follow-up|3|||
30568486|NCT04721925|58575968|FG001|4-Month Assessment|Lost to Follow-up|6|||
30568487|NCT04710368|58575973|FG000|Overall Study|Withdrawal by Subject|9|||
30568488|NCT04710368|58575973|FG000|Overall Study|Lost to Follow-up|4|||
30568489|NCT04710368|58575973|FG000|Overall Study|Death|2|||
30568490|NCT04710368|58575973|FG000|Overall Study|Patient preference|11|||
30855179|NCT01359644|58882747|FG005|Treatment Period|Adverse Event|1|||
30855180|NCT01359644|58882748|FG006|Treatment Period|Adverse Event|0|||
30855181|NCT01359644|58882749|FG007|Treatment Period|Adverse Event|0|||
30855182|NCT01359644|58882750|FG008|Treatment Period|Adverse Event|0|||
30855183|NCT01359644|58882751|FG009|Treatment Period|Adverse Event|0|||
30568491|NCT04710368|58575973|FG000|Overall Study|Treatment discontinuation|1|||
30568492|NCT04677660|58575979|FG000|Overall Study|Lost to Follow-up|0|||
30568493|NCT04677660|58575980|FG001|Overall Study|Lost to Follow-up|2|||
30568494|NCT04677660|58575979|FG000|Overall Study|Withdrawal by Subject|0|||
30568495|NCT04677660|58575980|FG001|Overall Study|Withdrawal by Subject|1|||
30568496|NCT04677660|58575979|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
30568497|NCT04677660|58575980|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
30568498|NCT04518995|58575989|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
30568499|NCT04518995|58575990|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
30568500|NCT04518995|58575991|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
30568501|NCT04518995|58575989|FG000|Overall Study|Lack of Efficacy|2|||
30568502|NCT04518995|58575990|FG001|Overall Study|Lack of Efficacy|1|||
30568503|NCT04518995|58575991|FG002|Overall Study|Lack of Efficacy|0|||
30568504|NCT04518995|58575989|FG000|Overall Study|Non-compliance With Study Drug|0|||
30568505|NCT04518995|58575990|FG001|Overall Study|Non-compliance With Study Drug|3|||
30568506|NCT04518995|58575991|FG002|Overall Study|Non-compliance With Study Drug|2|||
30568507|NCT04518995|58575989|FG000|Overall Study|Pregnancy|0|||
30568508|NCT04518995|58575990|FG001|Overall Study|Pregnancy|0|||
30568509|NCT04518995|58575991|FG002|Overall Study|Pregnancy|1|||
30568510|NCT04518995|58575989|FG000|Overall Study|Protocol Violation|2|||
30568511|NCT04518995|58575990|FG001|Overall Study|Protocol Violation|0|||
30568512|NCT04518995|58575991|FG002|Overall Study|Protocol Violation|1|||
30780154|NCT02992288|58791838|FG004|Overall Study|Protocol Violation|0|||
30780155|NCT02992288|58791839|FG005|Overall Study|Protocol Violation|1|||
30780156|NCT02992288|58791834|FG000|Overall Study|Withdrawal by Subject|4|||
30780157|NCT02992288|58791835|FG001|Overall Study|Withdrawal by Subject|2|||
30780158|NCT02992288|58791836|FG002|Overall Study|Withdrawal by Subject|1|||
30780159|NCT02992288|58791837|FG003|Overall Study|Withdrawal by Subject|5|||
30780160|NCT02992288|58791838|FG004|Overall Study|Withdrawal by Subject|3|||
30780161|NCT02992288|58791839|FG005|Overall Study|Withdrawal by Subject|4|||
30568513|NCT04518995|58575989|FG000|Overall Study|Reason not Specified|4|||
30568514|NCT04518995|58575990|FG001|Overall Study|Reason not Specified|11|||
30568515|NCT04518995|58575991|FG002|Overall Study|Reason not Specified|2|||
30568516|NCT04518995|58575989|FG000|Overall Study|Lost to Follow-up|1|||
30568517|NCT04518995|58575990|FG001|Overall Study|Lost to Follow-up|10|||
30568518|NCT04518995|58575991|FG002|Overall Study|Lost to Follow-up|6|||
30568519|NCT04505722|58576001|FG000|Overall Study|Adverse Event|1|||
30568520|NCT04505722|58576002|FG001|Overall Study|Adverse Event|2|||
30568521|NCT04505722|58576001|FG000|Overall Study|Death|34|||
30568522|NCT04505722|58576002|FG001|Overall Study|Death|63|||
30568523|NCT04505722|58576001|FG000|Overall Study|Lost to Follow-up|271|||
30568524|NCT04505722|58576002|FG001|Overall Study|Lost to Follow-up|333|||
30568525|NCT04505722|58576001|FG000|Overall Study|Physician Decision|17|||
30568526|NCT04505722|58576002|FG001|Overall Study|Physician Decision|17|||
30568527|NCT04505722|58576001|FG000|Overall Study|Protocol Violation|0|||
30568528|NCT04505722|58576002|FG001|Overall Study|Protocol Violation|1|||
30568529|NCT04505722|58576001|FG000|Overall Study|Withdrawal by Subject|376|||
30568530|NCT04505722|58576002|FG001|Overall Study|Withdrawal by Subject|714|||
30568531|NCT04505722|58576001|FG000|Overall Study|Other|61|||
30568532|NCT04505722|58576002|FG001|Overall Study|Other|98|||
30568533|NCT04505722|58576001|FG000|Overall Study|Still ongoing|21138|||
30568534|NCT04505722|58576002|FG001|Overall Study|Still ongoing|20662|||
30568535|NCT04505722|58576001|FG000|Overall Study|Randomized not vaccinated|276|||
30568536|NCT04505722|58576002|FG001|Overall Study|Randomized not vaccinated|260|||
30568537|NCT04474691|58576008|FG000|Overall Study|Withdrawal by Subject|9|||
30568538|NCT04014075|58576040|FG000|Overall Study|Progressive Disease|48|||
30568539|NCT04014075|58576040|FG000|Overall Study|Adverse Event|11|||
30568540|NCT04014075|58576040|FG000|Overall Study|Clinical Progression|4|||
30568541|NCT04014075|58576040|FG000|Overall Study|Death|2|||
30568542|NCT04014075|58576040|FG000|Overall Study|Withdrawal by Subject|2|||
30568543|NCT04014075|58576040|FG000|Overall Study|Miscellaneous|1|||
30568544|NCT04014075|58576040|FG000|Overall Study|Physician Decision|1|||
30568545|NCT03840174|58576048|FG000|Overall Study|Withdrawal by Subject|1|||
30568546|NCT03840174|58576049|FG001|Overall Study|Withdrawal by Subject|0|||
30568547|NCT03840174|58576050|FG002|Overall Study|Withdrawal by Subject|0|||
30568548|NCT03840174|58576051|FG003|Overall Study|Withdrawal by Subject|0|||
30568549|NCT03786718|58576062|FG000|Overall Study|Lost to Follow-up|3|||
30568550|NCT03786718|58576062|FG000|Overall Study|Withdrawal by Subject|1|||
30568551|NCT03786718|58576062|FG000|Overall Study|Did not use the intervention|2|||
30568552|NCT03786718|58576062|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
30568553|NCT03400943|58576095|FG000|Treatment Period 1|Adverse Event|0|||
30568554|NCT03400943|58576096|FG001|Treatment Period 1|Adverse Event|0|||
30568555|NCT03400943|58576097|FG002|Treatment Period 1|Adverse Event|0|||
30568556|NCT03400943|58576098|FG003|Treatment Period 1|Adverse Event|1|||
30568557|NCT03400943|58576095|FG000|Treatment Period 1|Lost to Follow-up|1|||
30568558|NCT03400943|58576096|FG001|Treatment Period 1|Lost to Follow-up|0|||
30568559|NCT03400943|58576097|FG002|Treatment Period 1|Lost to Follow-up|0|||
30568560|NCT03400943|58576098|FG003|Treatment Period 1|Lost to Follow-up|0|||
30568561|NCT03400943|58576095|FG000|Treatment Period 1|Protocol Violation|0|||
30568562|NCT03400943|58576096|FG001|Treatment Period 1|Protocol Violation|1|||
30568563|NCT03400943|58576097|FG002|Treatment Period 1|Protocol Violation|1|||
30568564|NCT03400943|58576098|FG003|Treatment Period 1|Protocol Violation|0|||
30568565|NCT03400943|58576095|FG000|Treatment Period 1|Study terminated by sponsor|2|||
30568566|NCT03400943|58576096|FG001|Treatment Period 1|Study terminated by sponsor|0|||
30568567|NCT03400943|58576097|FG002|Treatment Period 1|Study terminated by sponsor|0|||
30568568|NCT03400943|58576098|FG003|Treatment Period 1|Study terminated by sponsor|1|||
30568569|NCT03400943|58576095|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30568570|NCT03400943|58576096|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30568571|NCT03400943|58576097|FG002|Treatment Period 1|Withdrawal by Subject|3|||
30568572|NCT03400943|58576098|FG003|Treatment Period 1|Withdrawal by Subject|1|||
30568573|NCT03400943|58576095|FG000|Treatment Period 1|Other|2|||
30568574|NCT03400943|58576096|FG001|Treatment Period 1|Other|1|||
30568575|NCT03400943|58576097|FG002|Treatment Period 1|Other|2|||
30568576|NCT03400943|58576098|FG003|Treatment Period 1|Other|2|||
30568577|NCT03400943|58576095|FG000|Post-treatment Period 1|Adverse Event|2|||
30568578|NCT03400943|58576096|FG001|Post-treatment Period 1|Adverse Event|0|||
30568579|NCT03400943|58576097|FG002|Post-treatment Period 1|Adverse Event|0|||
30568580|NCT03400943|58576098|FG003|Post-treatment Period 1|Adverse Event|0|||
30568581|NCT03400943|58576095|FG000|Post-treatment Period 1|Protocol Violation|1|||
30568582|NCT03400943|58576096|FG001|Post-treatment Period 1|Protocol Violation|0|||
30568583|NCT03400943|58576097|FG002|Post-treatment Period 1|Protocol Violation|0|||
30568584|NCT03400943|58576098|FG003|Post-treatment Period 1|Protocol Violation|0|||
30568585|NCT03400943|58576095|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
30568586|NCT03400943|58576096|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
30568587|NCT03400943|58576097|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
30568588|NCT03400943|58576098|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
30568589|NCT03400943|58576095|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
30568590|NCT03400943|58576096|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
30568591|NCT03400943|58576097|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
30568592|NCT03400943|58576098|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
30568593|NCT03400943|58576095|FG000|Post-treatment Period 1|Other|2|||
30568594|NCT03400943|58576096|FG001|Post-treatment Period 1|Other|0|||
30568595|NCT03400943|58576097|FG002|Post-treatment Period 1|Other|4|||
30568596|NCT03400943|58576098|FG003|Post-treatment Period 1|Other|5|||
30568597|NCT03400943|58576095|FG000|Treatment Period 2|Study terminated by sponsor|0|||
30568598|NCT03400943|58576096|FG001|Treatment Period 2|Study terminated by sponsor|1|||
30568599|NCT03400943|58576097|FG002|Treatment Period 2|Study terminated by sponsor|0|||
30568600|NCT03400943|58576098|FG003|Treatment Period 2|Study terminated by sponsor|0|||
30568601|NCT03400943|58576095|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30568602|NCT03400943|58576096|FG001|Treatment Period 2|Withdrawal by Subject|1|||
30568603|NCT03400943|58576097|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30568604|NCT03400943|58576098|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30568605|NCT03400943|58576095|FG000|Treatment Period 2|Other|1|||
30568606|NCT03400943|58576096|FG001|Treatment Period 2|Other|6|||
30568607|NCT03400943|58576097|FG002|Treatment Period 2|Other|0|||
30568608|NCT03400943|58576098|FG003|Treatment Period 2|Other|0|||
30568609|NCT03400943|58576095|FG000|Follow-up Period|Withdrawal by Subject|1|||
30568610|NCT03400943|58576096|FG001|Follow-up Period|Withdrawal by Subject|0|||
30568611|NCT03400943|58576097|FG002|Follow-up Period|Withdrawal by Subject|0|||
30568612|NCT03400943|58576098|FG003|Follow-up Period|Withdrawal by Subject|0|||
30568613|NCT03366103|58576113|FG000|Overall Study|Disease Progression|3|||
30568614|NCT03366103|58576114|FG001|Overall Study|Disease Progression|1|||
30568615|NCT03366103|58576115|FG002|Overall Study|Disease Progression|0|||
30568616|NCT03366103|58576113|FG000|Overall Study|Adverse Event|0|||
30568617|NCT03366103|58576114|FG001|Overall Study|Adverse Event|1|||
30568618|NCT03366103|58576115|FG002|Overall Study|Adverse Event|0|||
30568619|NCT03321526|58576128|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
30568620|NCT03321526|58576129|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
30568621|NCT03321526|58576128|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
30568622|NCT03321526|58576129|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
30568623|NCT03321526|58576128|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
30568624|NCT03321526|58576129|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
30568625|NCT03321526|58576128|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
30568626|NCT03321526|58576129|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
30568627|NCT03321526|58576128|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
30568628|NCT03321526|58576129|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
30568629|NCT03321526|58576128|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
30568630|NCT03321526|58576129|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
30568631|NCT03321526|58576128|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
30568632|NCT03321526|58576129|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
30568633|NCT03321526|58576128|FG000|Follow-up Phase (2 Weeks)|Other|24|||
30568634|NCT03321526|58576129|FG001|Follow-up Phase (2 Weeks)|Other|24|||
30568635|NCT03153111|58576143|FG000|Overall Study|Death|2|||
30568636|NCT03153111|58576144|FG001|Overall Study|Death|5|||
30568637|NCT03153111|58576143|FG000|Overall Study|Lost to Follow-up|1|||
30568638|NCT03153111|58576144|FG001|Overall Study|Lost to Follow-up|0|||
30568639|NCT03153111|58576143|FG000|Overall Study|Physician Decision|5|||
30568640|NCT03153111|58576144|FG001|Overall Study|Physician Decision|1|||
30568641|NCT03153111|58576143|FG000|Overall Study|Withdrawal by Subject|3|||
30568642|NCT03153111|58576144|FG001|Overall Study|Withdrawal by Subject|3|||
30568643|NCT03126435|58576152|FG000|Overall Study|Death|90|||
30568644|NCT03126435|58576153|FG001|Overall Study|Death|84|||
30568645|NCT03126435|58576152|FG000|Overall Study|Lost to Follow-up|4|||
30568646|NCT03126435|58576153|FG001|Overall Study|Lost to Follow-up|3|||
30568647|NCT03126435|58576152|FG000|Overall Study|Physician Decision|0|||
30568648|NCT03126435|58576153|FG001|Overall Study|Physician Decision|1|||
30568649|NCT03126435|58576152|FG000|Overall Study|Withdrawal by Subject|6|||
30568650|NCT03126435|58576153|FG001|Overall Study|Withdrawal by Subject|12|||
30568651|NCT03126435|58576152|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
30568652|NCT03126435|58576153|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
30568653|NCT02823574|58576174|FG000|Randomization|Disease Progression|0|||
30568654|NCT02823574|58576175|FG001|Randomization|Disease Progression|0|||
30568655|NCT02823574|58576176|FG002|Randomization|Disease Progression|1|||
30568656|NCT02823574|58576177|FG003|Randomization|Disease Progression|0|||
30568657|NCT02823574|58576174|FG000|Randomization|AE unrelated to Study Drug|1|||
30568658|NCT02823574|58576175|FG001|Randomization|AE unrelated to Study Drug|0|||
30568659|NCT02823574|58576176|FG002|Randomization|AE unrelated to Study Drug|0|||
30568660|NCT02823574|58576177|FG003|Randomization|AE unrelated to Study Drug|0|||
30568661|NCT02823574|58576174|FG000|Treatment Period|Poor/Non Compliance|1|||
30568662|NCT02823574|58576175|FG001|Treatment Period|Poor/Non Compliance|0|||
30568663|NCT02823574|58576176|FG002|Treatment Period|Poor/Non Compliance|0|||
30568664|NCT02823574|58576177|FG003|Treatment Period|Poor/Non Compliance|1|||
30568665|NCT02823574|58576174|FG000|Treatment Period|Maximum Clinical Benefit|8|||
30568666|NCT02823574|58576175|FG001|Treatment Period|Maximum Clinical Benefit|4|||
30568667|NCT02823574|58576176|FG002|Treatment Period|Maximum Clinical Benefit|7|||
30568668|NCT02823574|58576177|FG003|Treatment Period|Maximum Clinical Benefit|1|||
30568669|NCT02823574|58576174|FG000|Treatment Period|Lost to Follow-up|1|||
30568670|NCT02823574|58576175|FG001|Treatment Period|Lost to Follow-up|1|||
30568671|NCT02823574|58576176|FG002|Treatment Period|Lost to Follow-up|0|||
30568672|NCT02823574|58576177|FG003|Treatment Period|Lost to Follow-up|0|||
30568673|NCT02823574|58576174|FG000|Treatment Period|Participant withdrew consent|4|||
30568674|NCT02823574|58576175|FG001|Treatment Period|Participant withdrew consent|0|||
30568675|NCT02823574|58576176|FG002|Treatment Period|Participant withdrew consent|0|||
30568676|NCT02823574|58576177|FG003|Treatment Period|Participant withdrew consent|1|||
30568677|NCT02823574|58576174|FG000|Treatment Period|Participant request to discontinue|5|||
30568678|NCT02823574|58576175|FG001|Treatment Period|Participant request to discontinue|0|||
30568679|NCT02823574|58576176|FG002|Treatment Period|Participant request to discontinue|3|||
30568680|NCT02823574|58576177|FG003|Treatment Period|Participant request to discontinue|2|||
30568681|NCT02823574|58576174|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
30568682|NCT02823574|58576175|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
30568683|NCT02823574|58576176|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
30568684|NCT02823574|58576177|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
30568685|NCT02823574|58576174|FG000|Treatment Period|Study Drug Toxicity|11|||
30568686|NCT02823574|58576175|FG001|Treatment Period|Study Drug Toxicity|2|||
30568687|NCT02823574|58576176|FG002|Treatment Period|Study Drug Toxicity|14|||
30568688|NCT02823574|58576177|FG003|Treatment Period|Study Drug Toxicity|4|||
30568689|NCT02823574|58576174|FG000|Treatment Period|Disease Progression|113|||
30568690|NCT02823574|58576175|FG001|Treatment Period|Disease Progression|64|||
30568691|NCT02823574|58576176|FG002|Treatment Period|Disease Progression|82|||
30568692|NCT02823574|58576177|FG003|Treatment Period|Disease Progression|43|||
30667006|NCT00849693|58680878|FG001|Acute Treatment Phase|Sponsor decision|0|||
30667007|NCT00849693|58680879|FG002|Acute Treatment Phase|Sponsor decision|1|||
30667008|NCT00849693|58680880|FG003|Acute Treatment Phase|Sponsor decision|0|||
30667009|NCT00849693|58680877|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
30667010|NCT00849693|58680878|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
30667011|NCT00849693|58680879|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
30667012|NCT00849693|58680880|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
30667013|NCT00849693|58680877|FG000|Extension Phase|Adverse Event|4|||
30667014|NCT00849693|58680878|FG001|Extension Phase|Adverse Event|6|||
30667015|NCT00849693|58680879|FG002|Extension Phase|Adverse Event|3|||
30667016|NCT00849693|58680880|FG003|Extension Phase|Adverse Event|7|||
30667017|NCT00849693|58680877|FG000|Extension Phase|Lost to Follow-up|7|||
30667018|NCT00849693|58680878|FG001|Extension Phase|Lost to Follow-up|5|||
30667019|NCT00849693|58680879|FG002|Extension Phase|Lost to Follow-up|6|||
30667020|NCT00849693|58680880|FG003|Extension Phase|Lost to Follow-up|6|||
30667021|NCT00849693|58680877|FG000|Extension Phase|Protocol Violation|0|||
30667022|NCT00849693|58680878|FG001|Extension Phase|Protocol Violation|3|||
30667023|NCT00849693|58680879|FG002|Extension Phase|Protocol Violation|2|||
30667024|NCT00849693|58680880|FG003|Extension Phase|Protocol Violation|3|||
30667025|NCT00849693|58680877|FG000|Extension Phase|Withdrawal by Subject|6|||
30667026|NCT00849693|58680878|FG001|Extension Phase|Withdrawal by Subject|9|||
30667027|NCT00849693|58680879|FG002|Extension Phase|Withdrawal by Subject|10|||
30667028|NCT00849693|58680880|FG003|Extension Phase|Withdrawal by Subject|15|||
30667029|NCT00849693|58680877|FG000|Extension Phase|Parent or caregiver decision|9|||
30667030|NCT00849693|58680878|FG001|Extension Phase|Parent or caregiver decision|4|||
30667031|NCT00849693|58680879|FG002|Extension Phase|Parent or caregiver decision|10|||
30667032|NCT00849693|58680880|FG003|Extension Phase|Parent or caregiver decision|5|||
30667033|NCT00849693|58680877|FG000|Extension Phase|Physician Decision|1|||
30667034|NCT00849693|58680878|FG001|Extension Phase|Physician Decision|1|||
30667035|NCT00849693|58680879|FG002|Extension Phase|Physician Decision|2|||
30667036|NCT00849693|58680880|FG003|Extension Phase|Physician Decision|0|||
30667037|NCT00849693|58680877|FG000|Extension Phase|Sponsor decision|1|||
30667038|NCT00849693|58680878|FG001|Extension Phase|Sponsor decision|0|||
30568693|NCT02823574|58576174|FG000|Treatment Period|Other reasons|5|||
30568694|NCT02823574|58576175|FG001|Treatment Period|Other reasons|9|||
30568695|NCT02823574|58576176|FG002|Treatment Period|Other reasons|3|||
30568696|NCT02823574|58576177|FG003|Treatment Period|Other reasons|6|||
30568697|NCT02823574|58576174|FG000|Treatment Period|Participant no longer meets study criteria|0|||
30568698|NCT02823574|58576175|FG001|Treatment Period|Participant no longer meets study criteria|0|||
30568699|NCT02823574|58576176|FG002|Treatment Period|Participant no longer meets study criteria|1|||
30568700|NCT02823574|58576177|FG003|Treatment Period|Participant no longer meets study criteria|0|||
30568701|NCT02823574|58576174|FG000|Treatment Period|Death|0|||
30568702|NCT02823574|58576175|FG001|Treatment Period|Death|0|||
30667039|NCT00849693|58680879|FG002|Extension Phase|Sponsor decision|0|||
30667040|NCT00849693|58680880|FG003|Extension Phase|Sponsor decision|1|||
30667041|NCT00849693|58680877|FG000|Extension Phase|Lack of Efficacy|2|||
30667042|NCT00849693|58680878|FG001|Extension Phase|Lack of Efficacy|2|||
30667043|NCT00849693|58680879|FG002|Extension Phase|Lack of Efficacy|2|||
30667044|NCT00849693|58680880|FG003|Extension Phase|Lack of Efficacy|1|||
30667045|NCT00527605|58680904|FG000|Overall Study|Adverse Event|3|||
30667046|NCT00527605|58680905|FG001|Overall Study|Adverse Event|0|||
30667047|NCT00527605|58680904|FG000|Overall Study|Withdrawal by Subject|3|||
30568703|NCT02823574|58576176|FG002|Treatment Period|Death|3|||
30568704|NCT02823574|58576177|FG003|Treatment Period|Death|1|||
30568705|NCT02746809|58576190|FG000|Enrollment|Inclusion Exclusion not met|9|||
30568706|NCT02746809|58576190|FG000|Enrollment|Withdrawal by Subject|1|||
30568707|NCT02746809|58576190|FG000|Enrollment|Expected Enrollment Met|2|||
30568708|NCT02746809|58576190|FG000|Procedure|Death|1|||
30568709|NCT02746809|58576190|FG000|1-Month|Death|5|||
30568710|NCT02746809|58576190|FG000|6-Month|Death|2|||
30568711|NCT02746809|58576190|FG000|6-Month|Withdrawal by Subject|1|||
30568712|NCT02746809|58576190|FG000|12-Month|Death|3|||
30568713|NCT02746809|58576190|FG000|12-Month|Withdrawal by Subject|2|||
30568714|NCT02746809|58576190|FG000|24-Month|Death|1|||
30568715|NCT02746809|58576190|FG000|24-Month|Withdrawal by Subject|1|||
30568716|NCT02746809|58576190|FG000|36-Month|Death|8|||
30568717|NCT02746809|58576190|FG000|36-Month|Withdrawal by Subject|1|||
30568718|NCT02746809|58576190|FG000|48-Month|Death|7|||
30568719|NCT02746809|58576190|FG000|48-Month|Withdrawal by Subject|1|||
30568720|NCT02746809|58576190|FG000|60-Month|Death|1|||
30568721|NCT02746809|58576190|FG000|60-Month|Lost to Follow-up|2|||
30568722|NCT02525796|58576199|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
30568723|NCT02525796|58576200|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
30568724|NCT02525796|58576201|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
30568725|NCT02525796|58576199|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
30568726|NCT02525796|58576200|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
30568727|NCT02525796|58576201|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
30568728|NCT02525796|58576199|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
30568729|NCT02525796|58576200|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
30568730|NCT02525796|58576201|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
30568731|NCT02525796|58576199|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
30568732|NCT02525796|58576200|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
30568733|NCT02525796|58576201|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
30568734|NCT02525796|58576199|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
30568735|NCT02525796|58576200|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
30568736|NCT02525796|58576201|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
30568737|NCT02360280|58576217|FG000|Overall Study|Withdrawal by Subject|2|||
30568738|NCT02360280|58576218|FG001|Overall Study|Withdrawal by Subject|0|||
30568739|NCT02360280|58576217|FG000|Overall Study|Adverse Event|0|||
30568740|NCT02360280|58576218|FG001|Overall Study|Adverse Event|1|||
30568741|NCT02360280|58576217|FG000|Overall Study|Lost to Follow-up|1|||
30568742|NCT02360280|58576218|FG001|Overall Study|Lost to Follow-up|0|||
30568743|NCT02201251|58576226|FG000|Overall Study|Adverse Event|1|||
30568744|NCT02201251|58576227|FG001|Overall Study|Adverse Event|1|||
30568745|NCT02201251|58576226|FG000|Overall Study|Protocol Violation|1|||
30568746|NCT02201251|58576227|FG001|Overall Study|Protocol Violation|0|||
30568747|NCT02201251|58576226|FG000|Overall Study|Noncompliance with Study Drug|0|||
30568748|NCT02201251|58576227|FG001|Overall Study|Noncompliance with Study Drug|1|||
30568749|NCT02201251|58576226|FG000|Overall Study|Withdrawal by Subject|2|||
30568750|NCT02201251|58576227|FG001|Overall Study|Withdrawal by Subject|1|||
30568751|NCT02027545|58576235|FG000|Overall Study|Failed to sign HIPAA|0|||
30568752|NCT02027545|58576236|FG001|Overall Study|Failed to sign HIPAA|2|||
30568753|NCT02027545|58576235|FG000|Overall Study|Failed to attend study visit|2|||
30568754|NCT02027545|58576236|FG001|Overall Study|Failed to attend study visit|0|||
30568755|NCT02027545|58576235|FG000|Overall Study|Protocol Violation|1|||
30568756|NCT02027545|58576236|FG001|Overall Study|Protocol Violation|0|||
30568757|NCT01867242|58576266|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
30568758|NCT01867242|58576267|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
30568759|NCT01867242|58576268|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
30568760|NCT01858688|58576276|FG000|Overall Study|Withdrawal by Subject|8|||
30667048|NCT00527605|58680905|FG001|Overall Study|Withdrawal by Subject|7|||
30667049|NCT00527605|58680904|FG000|Overall Study|Lost to Follow-up|6|||
30568761|NCT01858688|58576276|FG000|Overall Study|Participant began another therapy|3|||
30568762|NCT01858688|58576276|FG000|Overall Study|Physician Decision|2|||
30568763|NCT01858688|58576276|FG000|Overall Study|Progressive Disease|2|||
30568764|NCT01858688|58576276|FG000|Overall Study|Reason not reproted|5|||
30568765|NCT01599234|58576295|FG000|Overall Study|Adverse Event|9|||
30568766|NCT01599234|58576296|FG001|Overall Study|Adverse Event|5|||
30568767|NCT01599234|58576295|FG000|Overall Study|Withdrawal by Subject|2|||
30568768|NCT01599234|58576296|FG001|Overall Study|Withdrawal by Subject|1|||
30568769|NCT01599234|58576295|FG000|Overall Study|Lost to Follow-up|1|||
30667050|NCT00527605|58680905|FG001|Overall Study|Lost to Follow-up|2|||
30568770|NCT01599234|58576296|FG001|Overall Study|Lost to Follow-up|2|||
30568771|NCT01599234|58576295|FG000|Overall Study|Lack of Efficacy|2|||
30568772|NCT01599234|58576296|FG001|Overall Study|Lack of Efficacy|4|||
30568773|NCT01599234|58576295|FG000|Overall Study|Unable to operate spray|1|||
30568774|NCT01599234|58576296|FG001|Overall Study|Unable to operate spray|0|||
30568775|NCT01599234|58576295|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
30568776|NCT01599234|58576296|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
30568777|NCT01599234|58576295|FG000|Overall Study|Death|1|||
30568778|NCT01599234|58576296|FG001|Overall Study|Death|0|||
30568779|NCT01599234|58576295|FG000|Overall Study|Patient would not stop driving|1|||
30568780|NCT01599234|58576296|FG001|Overall Study|Patient would not stop driving|0|||
30568781|NCT01599234|58576295|FG000|Overall Study|Contra-indication discovered|0|||
30568782|NCT01599234|58576296|FG001|Overall Study|Contra-indication discovered|1|||
30568783|NCT01599234|58576295|FG000|Overall Study|Pregnancy|0|||
30568784|NCT01599234|58576296|FG001|Overall Study|Pregnancy|1|||
30568785|NCT01586910|58576304|FG000|Overall Study|Death|4|||
30568786|NCT01586910|58576305|FG001|Overall Study|Death|4|||
30568787|NCT01586910|58576304|FG000|Overall Study|Withdrawal by Subject|6|||
30568788|NCT01586910|58576305|FG001|Overall Study|Withdrawal by Subject|43|||
30568789|NCT01586910|58576304|FG000|Overall Study|Physician withdrew Subject|5|||
30568790|NCT01586910|58576305|FG001|Overall Study|Physician withdrew Subject|24|||
30568791|NCT01393301|58576325|FG000|Overall Study|Lost to Follow-up|5|||
30568792|NCT01393301|58576326|FG001|Overall Study|Lost to Follow-up|3|||
30568793|NCT01393301|58576325|FG000|Overall Study|Withdrawal by Subject|2|||
30568794|NCT01393301|58576326|FG001|Overall Study|Withdrawal by Subject|0|||
30568795|NCT01393301|58576325|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
30568796|NCT01393301|58576326|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
30568797|NCT01251861|58576334|FG000|Overall Study|Disease progression|6|||
30568798|NCT01251861|58576335|FG001|Overall Study|Disease progression|6|||
30568799|NCT01251861|58576334|FG000|Overall Study|Adverse Event|2|||
30568800|NCT01251861|58576335|FG001|Overall Study|Adverse Event|17|||
30568801|NCT01251861|58576334|FG000|Overall Study|Withdrawal by Subject|2|||
30568802|NCT01251861|58576335|FG001|Overall Study|Withdrawal by Subject|2|||
30568803|NCT01251861|58576334|FG000|Overall Study|Alternative therapy|1|||
30568804|NCT01251861|58576335|FG001|Overall Study|Alternative therapy|0|||
30568805|NCT01251861|58576334|FG000|Overall Study|Other complicating disease|0|||
30568806|NCT01251861|58576335|FG001|Overall Study|Other complicating disease|1|||
30568807|NCT01251861|58576334|FG000|Overall Study|Physician Decision|1|||
30568808|NCT01251861|58576335|FG001|Overall Study|Physician Decision|0|||
30568809|NCT01251861|58576334|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
30568810|NCT01251861|58576335|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
30568811|NCT01251861|58576334|FG000|Overall Study|Other|1|||
30568812|NCT01251861|58576335|FG001|Overall Study|Other|0|||
30568813|NCT01251861|58576334|FG000|Overall Study|Never started therapy|4|||
30568814|NCT01251861|58576335|FG001|Overall Study|Never started therapy|1|||
30568815|NCT01251861|58576334|FG000|Overall Study|Potential interaction of drugs|0|||
30568816|NCT01251861|58576335|FG001|Overall Study|Potential interaction of drugs|1|||
30568853|NCT00843882|58576365|FG000|Step 1|Lack of Efficacy|14|||
30568854|NCT00843882|58576366|FG001|Step 1|Lack of Efficacy|10|||
30568855|NCT00843882|58576367|FG002|Step 1|Lack of Efficacy|21|||
30568856|NCT00843882|58576365|FG000|Step 1|Adverse Event|8|||
30568857|NCT00843882|58576366|FG001|Step 1|Adverse Event|17|||
30568858|NCT00843882|58576367|FG002|Step 1|Adverse Event|20|||
30568859|NCT00843882|58576365|FG000|Step 1|Death|1|||
30568860|NCT00843882|58576366|FG001|Step 1|Death|2|||
30568861|NCT00843882|58576367|FG002|Step 1|Death|4|||
30568862|NCT00843882|58576365|FG000|Step 1|Withdrawal by Subject|6|||
30568863|NCT00843882|58576366|FG001|Step 1|Withdrawal by Subject|12|||
30568864|NCT00843882|58576367|FG002|Step 1|Withdrawal by Subject|9|||
30568865|NCT00843882|58576365|FG000|Step 1|Physician Decision|0|||
30568866|NCT00843882|58576366|FG001|Step 1|Physician Decision|5|||
30568867|NCT00843882|58576367|FG002|Step 1|Physician Decision|1|||
30568868|NCT00843882|58576365|FG000|Step 1|Patient and physician's decision|0|||
30568869|NCT00843882|58576366|FG001|Step 1|Patient and physician's decision|0|||
30568870|NCT00843882|58576367|FG002|Step 1|Patient and physician's decision|1|||
30568871|NCT00843882|58576365|FG000|Step 1|Other complicating disease|1|||
30568872|NCT00843882|58576366|FG001|Step 1|Other complicating disease|3|||
30568873|NCT00843882|58576367|FG002|Step 1|Other complicating disease|4|||
30568874|NCT00843882|58576365|FG000|Step 1|Alternative therapy|0|||
30568875|NCT00843882|58576366|FG001|Step 1|Alternative therapy|1|||
30568876|NCT00843882|58576367|FG002|Step 1|Alternative therapy|1|||
30568877|NCT00843882|58576365|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
30568878|NCT00843882|58576366|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
30568879|NCT00843882|58576367|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
30568880|NCT00843882|58576365|FG000|Step 1|Off treatment reason unknown|0|||
30568881|NCT00843882|58576366|FG001|Step 1|Off treatment reason unknown|1|||
30568882|NCT00843882|58576367|FG002|Step 1|Off treatment reason unknown|4|||
30568883|NCT00843882|58576365|FG000|Step 1|Never started treatment|2|||
30568884|NCT00843882|58576366|FG001|Step 1|Never started treatment|0|||
30568885|NCT00843882|58576367|FG002|Step 1|Never started treatment|0|||
30568886|NCT00843882|58576365|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
30568887|NCT00843882|58576366|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
30568888|NCT00843882|58576367|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
30568889|NCT00843882|58576365|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
30568890|NCT00843882|58576366|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
30568891|NCT00843882|58576367|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
30568892|NCT00843882|58576365|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
30568893|NCT00843882|58576366|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
30568894|NCT00843882|58576367|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
30568895|NCT00843882|58576365|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
30568896|NCT00843882|58576366|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
30568897|NCT00843882|58576367|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
30568898|NCT00843882|58576365|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
30568899|NCT00843882|58576366|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
30568900|NCT00843882|58576367|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
30568901|NCT00843882|58576365|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
30568902|NCT00843882|58576366|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
30568903|NCT00843882|58576367|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
30568904|NCT00843882|58576365|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
30568905|NCT00843882|58576366|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
30568906|NCT00843882|58576367|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
30568907|NCT00716625|58576380|FG000|Overall Study|Safety was not Assessable|1|||
30568908|NCT00713323|58576407|FG000|Overall Study|Adverse Event|75|||
30855184|NCT01359644|58882742|FG000|Treatment Period|Lost to Follow-up|0|||
30568909|NCT00713323|58576407|FG000|Overall Study|Withdrawal by Subject|15|||
30568910|NCT00713323|58576407|FG000|Overall Study|Lost to Follow-up|11|||
30568911|NCT00713323|58576407|FG000|Overall Study|Lack of Efficacy|36|||
30568912|NCT00713323|58576407|FG000|Overall Study|Low creatine clearance at screening|1|||
30568913|NCT00713323|58576407|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
30568914|NCT00713323|58576407|FG000|Overall Study|Surgery cured allodynic pain|1|||
30568915|NCT00713323|58576407|FG000|Overall Study|Pain free|1|||
30568916|NCT00713323|58576407|FG000|Overall Study|Non-compliance|1|||
30568917|NCT00713323|58576407|FG000|Overall Study|Pain resolved|1|||
30568918|NCT00713323|58576407|FG000|Overall Study|Subject travelling to USA|1|||
30568919|NCT00713323|58576407|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
30568920|NCT00713323|58576407|FG000|Overall Study|Treatment that may interact with Sativex|1|||
30568921|NCT00710554|58576424|FG000|Overall Study|Adverse Event|24|||
30568922|NCT00710554|58576425|FG001|Overall Study|Adverse Event|7|||
30568923|NCT00710554|58576424|FG000|Overall Study|Withdrawal by Subject|7|||
30568924|NCT00710554|58576425|FG001|Overall Study|Withdrawal by Subject|3|||
30568925|NCT00710554|58576424|FG000|Overall Study|Lost to Follow-up|7|||
30568926|NCT00710554|58576425|FG001|Overall Study|Lost to Follow-up|1|||
30568927|NCT00710554|58576424|FG000|Overall Study|Lack of Efficacy|11|||
30568928|NCT00710554|58576425|FG001|Overall Study|Lack of Efficacy|12|||
30568929|NCT00710554|58576424|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
30568930|NCT00710554|58576425|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
30568931|NCT00710424|58576433|FG000|Overall Study|Adverse Event|30|||
30568932|NCT00710424|58576434|FG001|Overall Study|Adverse Event|12|||
30568933|NCT00710424|58576433|FG000|Overall Study|Lack of Efficacy|4|||
30568934|NCT00710424|58576434|FG001|Overall Study|Lack of Efficacy|5|||
30568935|NCT00710424|58576433|FG000|Overall Study|Withdrawal by Subject|5|||
30568936|NCT00710424|58576434|FG001|Overall Study|Withdrawal by Subject|3|||
30568937|NCT00710424|58576433|FG000|Overall Study|Lost to Follow-up|0|||
30568938|NCT00710424|58576434|FG001|Overall Study|Lost to Follow-up|1|||
30568939|NCT00710424|58576433|FG000|Overall Study|Refused medication, no side effects|1|||
30568940|NCT00710424|58576434|FG001|Overall Study|Refused medication, no side effects|0|||
30568941|NCT00710424|58576433|FG000|Overall Study|Non-compliance with stable analgesia|1|||
30568942|NCT00710424|58576434|FG001|Overall Study|Non-compliance with stable analgesia|0|||
30568943|NCT00710424|58576433|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
30568944|NCT00710424|58576434|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
30568945|NCT00710424|58576433|FG000|Overall Study|Subject thought medication changed|1|||
30568946|NCT00710424|58576434|FG001|Overall Study|Subject thought medication changed|0|||
30568947|NCT00710424|58576433|FG000|Overall Study|Ceased treatment due to travel|1|||
30568948|NCT00710424|58576434|FG001|Overall Study|Ceased treatment due to travel|0|||
30568949|NCT00710424|58576433|FG000|Overall Study|Subject preferred paracetamol|0|||
30568950|NCT00710424|58576434|FG001|Overall Study|Subject preferred paracetamol|1|||
30568951|NCT00710424|58576433|FG000|Overall Study|Felt good so stopped treatment|0|||
30568952|NCT00710424|58576434|FG001|Overall Study|Felt good so stopped treatment|1|||
30568953|NCT00118846|58576464|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
30568954|NCT00118846|58576465|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
30568955|NCT00118846|58576464|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
30568956|NCT00118846|58576465|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
30568957|NCT00118846|58576464|FG000|Overall Study|Physician Decision|1|||
30568958|NCT00118846|58576465|FG001|Overall Study|Physician Decision|0|||
30568959|NCT00118846|58576464|FG000|Overall Study|Medical condition|2|||
30568960|NCT00118846|58576465|FG001|Overall Study|Medical condition|2|||
30568961|NCT00118846|58576464|FG000|Overall Study|Lost to Follow-up|0|||
30568962|NCT00118846|58576465|FG001|Overall Study|Lost to Follow-up|2|||
30568963|NCT00118846|58576464|FG000|Overall Study|Personal reason|4|||
30568964|NCT00118846|58576465|FG001|Overall Study|Personal reason|5|||
30568965|NCT00026312|58576473|FG000|Overall Study|Adverse Event|0|||
30568966|NCT00026312|58576474|FG001|Overall Study|Adverse Event|32|||
30568967|NCT00026312|58576473|FG000|Overall Study|Death|1|||
30568968|NCT00026312|58576474|FG001|Overall Study|Death|7|||
30568969|NCT00026312|58576473|FG000|Overall Study|Lack of Efficacy|19|||
30568970|NCT00026312|58576474|FG001|Overall Study|Lack of Efficacy|114|||
30568971|NCT00026312|58576473|FG000|Overall Study|Lost to Follow-up|0|||
30568972|NCT00026312|58576474|FG001|Overall Study|Lost to Follow-up|5|||
30568973|NCT00026312|58576473|FG000|Overall Study|Physician Decision|1|||
30568974|NCT00026312|58576474|FG001|Overall Study|Physician Decision|37|||
30568975|NCT00026312|58576473|FG000|Overall Study|Protocol Violation|0|||
30568976|NCT00026312|58576474|FG001|Overall Study|Protocol Violation|3|||
30568977|NCT00026312|58576473|FG000|Overall Study|Withdrawal by Subject|1|||
30568978|NCT00026312|58576474|FG001|Overall Study|Withdrawal by Subject|6|||
30568979|NCT00026312|58576473|FG000|Overall Study|Ineligible|4|||
30568980|NCT00026312|58576474|FG001|Overall Study|Ineligible|5|||
30568981|NCT00026312|58576473|FG000|Overall Study|Entry onto another COG study|0|||
30568982|NCT00026312|58576474|FG001|Overall Study|Entry onto another COG study|1|||
30568983|NCT00026312|58576473|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
30568984|NCT00026312|58576474|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
30568985|NCT04705051|58576484|FG000|Overall Study|Enrolled but not treated|1|||
30568986|NCT04705051|58576484|FG000|Overall Study|Study terminated by sponsor|23|||
30568987|NCT04464421|58576491|FG000|Overall Study|Lost to Follow-up|2|||
30568988|NCT04464421|58576492|FG001|Overall Study|Lost to Follow-up|2|||
30855185|NCT01359644|58882743|FG001|Treatment Period|Lost to Follow-up|0|||
30855186|NCT01359644|58882744|FG002|Treatment Period|Lost to Follow-up|0|||
30855187|NCT01359644|58882745|FG003|Treatment Period|Lost to Follow-up|0|||
30568989|NCT04112784|58576510|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
30568990|NCT04112784|58576510|FG000|Overall Study|Screen Failures|4|||
30568991|NCT04049617|58576520|FG000|Overall Study|Adverse Event|0|||
30568992|NCT04049617|58576521|FG001|Overall Study|Adverse Event|0|||
30568993|NCT04049617|58576522|FG002|Overall Study|Adverse Event|0|||
30568994|NCT04049617|58576523|FG003|Overall Study|Adverse Event|1|||
30568995|NCT04049617|58576524|FG004|Overall Study|Adverse Event|0|||
30568996|NCT04049617|58576525|FG005|Overall Study|Adverse Event|0|||
30568997|NCT04049617|58576520|FG000|Overall Study|Death|0|||
30568998|NCT04049617|58576521|FG001|Overall Study|Death|0|||
30568999|NCT04049617|58576522|FG002|Overall Study|Death|0|||
30569000|NCT04049617|58576523|FG003|Overall Study|Death|0|||
30569001|NCT04049617|58576524|FG004|Overall Study|Death|0|||
30569002|NCT04049617|58576525|FG005|Overall Study|Death|1|||
30569003|NCT04049617|58576520|FG000|Overall Study|Lost to Follow-up|0|||
30569004|NCT04049617|58576521|FG001|Overall Study|Lost to Follow-up|0|||
30569005|NCT04049617|58576522|FG002|Overall Study|Lost to Follow-up|0|||
30569006|NCT04049617|58576523|FG003|Overall Study|Lost to Follow-up|1|||
30569007|NCT04049617|58576524|FG004|Overall Study|Lost to Follow-up|0|||
30569008|NCT04049617|58576525|FG005|Overall Study|Lost to Follow-up|0|||
30569009|NCT04049617|58576520|FG000|Overall Study|Withdrew consent|0|||
30569010|NCT04049617|58576521|FG001|Overall Study|Withdrew consent|0|||
30569011|NCT04049617|58576522|FG002|Overall Study|Withdrew consent|1|||
30569012|NCT04049617|58576523|FG003|Overall Study|Withdrew consent|0|||
30569013|NCT04049617|58576524|FG004|Overall Study|Withdrew consent|0|||
30569014|NCT04049617|58576525|FG005|Overall Study|Withdrew consent|0|||
30569015|NCT03911154|58576541|FG000|Overall Study|Withdrawal by Subject|1|||
30569016|NCT03781778|58576559|FG000|Overall Study|Withdrawal by Subject|2|||
30569017|NCT03781778|58576560|FG001|Overall Study|Withdrawal by Subject|2|||
30569018|NCT03710590|58576568|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
30569019|NCT03710590|58576569|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
30569020|NCT03470922|58576621|FG000|Overall Study|Death|107|||
30569021|NCT03470922|58576622|FG001|Overall Study|Death|118|||
30569022|NCT03470922|58576621|FG000|Overall Study|Lost to Follow-up|5|||
30569023|NCT03470922|58576622|FG001|Overall Study|Lost to Follow-up|5|||
30569024|NCT03470922|58576621|FG000|Overall Study|Participant Withdrew Consent|4|||
30569025|NCT03470922|58576622|FG001|Overall Study|Participant Withdrew Consent|9|||
30569026|NCT03470922|58576621|FG000|Overall Study|Other reasons|1|||
30569027|NCT03470922|58576622|FG001|Overall Study|Other reasons|0|||
30569028|NCT03470922|58576621|FG000|Overall Study|Not reported|1|||
30569029|NCT03470922|58576622|FG001|Overall Study|Not reported|0|||
30569030|NCT03465722|58576630|FG000|Overall Study|Withdrawal by Subject|21|||
30569031|NCT03465722|58576631|FG001|Overall Study|Withdrawal by Subject|14|||
30569032|NCT03465722|58576630|FG000|Overall Study|Death|89|||
30569033|NCT03465722|58576631|FG001|Overall Study|Death|87|||
30569034|NCT03465722|58576630|FG000|Overall Study|Lost to Follow-up|5|||
30569035|NCT03465722|58576631|FG001|Overall Study|Lost to Follow-up|3|||
30569036|NCT03465722|58576630|FG000|Overall Study|Administrative/Other|33|||
30569037|NCT03465722|58576631|FG001|Overall Study|Administrative/Other|32|||
30569038|NCT03465722|58576630|FG000|Overall Study|Not treated|1|||
30569039|NCT03465722|58576631|FG001|Overall Study|Not treated|2|||
30569040|NCT03465722|58576630|FG000|Overall Study|Sponsor decision|91|||
30569041|NCT03465722|58576631|FG001|Overall Study|Sponsor decision|98|||
30569042|NCT03205423|58576637|FG000|Overall Study|Personal|1|||
30569043|NCT03205423|58576638|FG001|Overall Study|Personal|1|||
30569044|NCT03205423|58576637|FG000|Overall Study|Physician Decision|0|||
30569045|NCT03205423|58576638|FG001|Overall Study|Physician Decision|2|||
30569046|NCT03104400|58576649|FG000|Overall Study|Adverse Event|5|||
30569047|NCT03104400|58576650|FG001|Overall Study|Adverse Event|7|||
30569048|NCT03104400|58576651|FG002|Overall Study|Adverse Event|11|||
30569049|NCT03104400|58576652|FG003|Overall Study|Adverse Event|9|||
30569050|NCT03104400|58576653|FG004|Overall Study|Adverse Event|21|||
30569051|NCT03104400|58576649|FG000|Overall Study|Withdrawal by Subject|17|||
30569052|NCT03104400|58576650|FG001|Overall Study|Withdrawal by Subject|19|||
30569053|NCT03104400|58576651|FG002|Overall Study|Withdrawal by Subject|29|||
30569054|NCT03104400|58576652|FG003|Overall Study|Withdrawal by Subject|25|||
30569055|NCT03104400|58576653|FG004|Overall Study|Withdrawal by Subject|24|||
30569056|NCT03104400|58576649|FG000|Overall Study|Lost to Follow-up|4|||
30569057|NCT03104400|58576650|FG001|Overall Study|Lost to Follow-up|1|||
30569058|NCT03104400|58576651|FG002|Overall Study|Lost to Follow-up|4|||
30569059|NCT03104400|58576652|FG003|Overall Study|Lost to Follow-up|8|||
30569060|NCT03104400|58576653|FG004|Overall Study|Lost to Follow-up|7|||
30569061|NCT03104400|58576649|FG000|Overall Study|Lack of Efficacy|6|||
30569062|NCT03104400|58576650|FG001|Overall Study|Lack of Efficacy|3|||
30569063|NCT03104400|58576651|FG002|Overall Study|Lack of Efficacy|8|||
30958644|NCT01694849|59023703|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
30569064|NCT03104400|58576652|FG003|Overall Study|Lack of Efficacy|2|||
30569065|NCT03104400|58576653|FG004|Overall Study|Lack of Efficacy|1|||
30569066|NCT03104400|58576649|FG000|Overall Study|COVID Logistical Restrictions|0|||
30569067|NCT03104400|58576650|FG001|Overall Study|COVID Logistical Restrictions|0|||
30569068|NCT03104400|58576651|FG002|Overall Study|COVID Logistical Restrictions|0|||
30569069|NCT03104400|58576652|FG003|Overall Study|COVID Logistical Restrictions|1|||
30569070|NCT03104400|58576653|FG004|Overall Study|COVID Logistical Restrictions|0|||
30569071|NCT03104400|58576649|FG000|Overall Study|Other|2|||
30569072|NCT03104400|58576650|FG001|Overall Study|Other|3|||
30569073|NCT03104400|58576651|FG002|Overall Study|Other|7|||
30569074|NCT03104400|58576652|FG003|Overall Study|Other|6|||
30569075|NCT03104400|58576653|FG004|Overall Study|Other|4|||
30569076|NCT03104400|58576649|FG000|Overall Study|Other|0|||
30569077|NCT03104400|58576650|FG001|Overall Study|Other|1|||
30569078|NCT03104400|58576651|FG002|Overall Study|Other|0|||
30569079|NCT03104400|58576652|FG003|Overall Study|Other|0|||
30569080|NCT03104400|58576653|FG004|Overall Study|Other|0|||
30569081|NCT03104374|58576670|FG000|Overall Study|Adverse Event|7|||
30569082|NCT03104374|58576671|FG001|Overall Study|Adverse Event|6|||
30569083|NCT03104374|58576672|FG002|Overall Study|Adverse Event|12|||
30569084|NCT03104374|58576673|FG003|Overall Study|Adverse Event|15|||
30569085|NCT03104374|58576670|FG000|Overall Study|Withdrawal by Subject|18|||
30569086|NCT03104374|58576671|FG001|Overall Study|Withdrawal by Subject|10|||
30569087|NCT03104374|58576672|FG002|Overall Study|Withdrawal by Subject|10|||
30569088|NCT03104374|58576673|FG003|Overall Study|Withdrawal by Subject|17|||
30569089|NCT03104374|58576670|FG000|Overall Study|Lost to Follow-up|4|||
30569090|NCT03104374|58576671|FG001|Overall Study|Lost to Follow-up|4|||
30569091|NCT03104374|58576672|FG002|Overall Study|Lost to Follow-up|6|||
30569092|NCT03104374|58576673|FG003|Overall Study|Lost to Follow-up|8|||
30569093|NCT03104374|58576670|FG000|Overall Study|Lack of Efficacy|6|||
30569094|NCT03104374|58576671|FG001|Overall Study|Lack of Efficacy|7|||
30569095|NCT03104374|58576672|FG002|Overall Study|Lack of Efficacy|12|||
30569096|NCT03104374|58576673|FG003|Overall Study|Lack of Efficacy|6|||
30569097|NCT03104374|58576670|FG000|Overall Study|Other|2|||
30569098|NCT03104374|58576671|FG001|Overall Study|Other|2|||
30569099|NCT03104374|58576672|FG002|Overall Study|Other|4|||
30569100|NCT03104374|58576673|FG003|Overall Study|Other|7|||
30569101|NCT03073603|58576685|FG000|Overall Study|Noncompliance|3|||
30569102|NCT03073603|58576686|FG001|Overall Study|Noncompliance|1|||
30569103|NCT03073603|58576685|FG000|Overall Study|Adverse Event|5|||
30569104|NCT03073603|58576686|FG001|Overall Study|Adverse Event|3|||
30569105|NCT03073603|58576685|FG000|Overall Study|Physician Decision|1|||
30569106|NCT03073603|58576686|FG001|Overall Study|Physician Decision|2|||
30569107|NCT03073603|58576685|FG000|Overall Study|Required treatment not allowed by protocol|1|||
30569108|NCT03073603|58576686|FG001|Overall Study|Required treatment not allowed by protocol|0|||
30569109|NCT03073603|58576685|FG000|Overall Study|Financial or insurance-related|8|||
30569110|NCT03073603|58576686|FG001|Overall Study|Financial or insurance-related|0|||
30569111|NCT03073603|58576685|FG000|Overall Study|Withdrawal by Subject|0|||
30569112|NCT03073603|58576686|FG001|Overall Study|Withdrawal by Subject|1|||
30569113|NCT03073603|58576685|FG000|Overall Study|Discontinued DMT|4|||
30569114|NCT03073603|58576686|FG001|Overall Study|Discontinued DMT|0|||
30569115|NCT03073603|58576685|FG000|Overall Study|Restarted DMT|0|||
30569116|NCT03073603|58576686|FG001|Overall Study|Restarted DMT|1|||
30569117|NCT03002155|58576698|FG000|Overall Study|Lost to Follow-up|1|||
30569118|NCT03002155|58576699|FG001|Overall Study|Lost to Follow-up|2|||
30569119|NCT03002155|58576698|FG000|Overall Study|Withdrawal by Subject|1|||
30569120|NCT03002155|58576699|FG001|Overall Study|Withdrawal by Subject|0|||
30569121|NCT03002155|58576698|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
30569122|NCT03002155|58576699|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
30569123|NCT02918006|58576709|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
30569124|NCT02918006|58576710|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
30569125|NCT02918006|58576711|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
30569126|NCT02918006|58576709|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
30569127|NCT02918006|58576710|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
30569128|NCT02918006|58576711|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
30569129|NCT02918006|58576709|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
30569130|NCT02918006|58576710|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
30569131|NCT02918006|58576711|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
30569132|NCT02918006|58576709|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
30569133|NCT02918006|58576710|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
30569134|NCT02918006|58576711|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
30569135|NCT02918006|58576709|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
30569136|NCT02918006|58576710|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
30569137|NCT02918006|58576711|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
30569138|NCT02918006|58576709|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
30569139|NCT02918006|58576710|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
30569140|NCT02918006|58576711|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
30569141|NCT02918006|58576709|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
30569142|NCT02918006|58576710|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
30569143|NCT02918006|58576711|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
30569144|NCT02918006|58576709|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
30569145|NCT02918006|58576710|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
30569146|NCT02918006|58576711|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
30569147|NCT02918006|58576709|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
30569148|NCT02918006|58576710|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
30569149|NCT02918006|58576711|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
30569150|NCT02658487|58576736|FG000|Overall Study|Death|2|||
30569151|NCT02658487|58576736|FG000|Overall Study|Disease progression|10|||
30569152|NCT02658487|58576736|FG000|Overall Study|Alternative therapy|1|||
30569153|NCT02658487|58576736|FG000|Overall Study|Adverse Event|1|||
30569154|NCT02658487|58576736|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
30569155|NCT02658487|58576736|FG000|Overall Study|Refractory AML|1|||
30569156|NCT02179749|58576765|FG000|Overall Study|Adverse Event|0|||
30569157|NCT02179749|58576766|FG001|Overall Study|Adverse Event|0|||
30569158|NCT02179749|58576767|FG002|Overall Study|Adverse Event|1|||
30569159|NCT02179749|58576765|FG000|Overall Study|Withdrawal by Subject|0|||
30569160|NCT02179749|58576766|FG001|Overall Study|Withdrawal by Subject|0|||
30569161|NCT02179749|58576767|FG002|Overall Study|Withdrawal by Subject|1|||
30569162|NCT02075593|58576778|FG000|Overall Study|Withdrawal by Subject|1|||
30569163|NCT00641186|58576811|FG000|Overall Study|Adverse Event|3|||
30569164|NCT01595009|58576817|FG000|Core|Patients completed per protocol|85|||
30569165|NCT01595009|58576818|FG001|Core|Patients completed per protocol|44|||
30569166|NCT01595009|58576819|FG002|Core|Patients completed per protocol|0|||
30569167|NCT01595009|58576820|FG003|Core|Patients completed per protocol|0|||
30569168|NCT01595009|58576817|FG000|Core|Adverse Event|19|||
30569169|NCT01595009|58576818|FG001|Core|Adverse Event|23|||
30569170|NCT01595009|58576819|FG002|Core|Adverse Event|0|||
30569171|NCT01595009|58576820|FG003|Core|Adverse Event|0|||
30569172|NCT01595009|58576817|FG000|Core|Disease progression|14|||
30569173|NCT01595009|58576818|FG001|Core|Disease progression|26|||
30569174|NCT01595009|58576819|FG002|Core|Disease progression|0|||
30569175|NCT01595009|58576820|FG003|Core|Disease progression|0|||
30569176|NCT01595009|58576817|FG000|Core|Withdrawal by Subject|4|||
30569177|NCT01595009|58576818|FG001|Core|Withdrawal by Subject|17|||
30569178|NCT01595009|58576819|FG002|Core|Withdrawal by Subject|0|||
30569179|NCT01595009|58576820|FG003|Core|Withdrawal by Subject|0|||
30569180|NCT01595009|58576817|FG000|Core|Death|3|||
30569181|NCT01595009|58576818|FG001|Core|Death|6|||
30569182|NCT01595009|58576819|FG002|Core|Death|0|||
30569183|NCT01595009|58576820|FG003|Core|Death|0|||
30569184|NCT01595009|58576817|FG000|Core|Lost to Follow-up|1|||
30569185|NCT01595009|58576818|FG001|Core|Lost to Follow-up|2|||
30569186|NCT01595009|58576819|FG002|Core|Lost to Follow-up|0|||
30569187|NCT01595009|58576820|FG003|Core|Lost to Follow-up|0|||
30569188|NCT01595009|58576817|FG000|Core|Protocol deviation|0|||
30569189|NCT01595009|58576818|FG001|Core|Protocol deviation|1|||
30569190|NCT01595009|58576819|FG002|Core|Protocol deviation|0|||
30569191|NCT01595009|58576820|FG003|Core|Protocol deviation|0|||
30569192|NCT01595009|58576817|FG000|Core|Administrative problems|0|||
30569193|NCT01595009|58576818|FG001|Core|Administrative problems|1|||
30569194|NCT01595009|58576819|FG002|Core|Administrative problems|0|||
30569195|NCT01595009|58576820|FG003|Core|Administrative problems|0|||
30569196|NCT01595009|58576817|FG000|Extension|Administrative problems|0|||
30569197|NCT01595009|58576818|FG001|Extension|Administrative problems|0|||
30569198|NCT01595009|58576819|FG002|Extension|Administrative problems|0|||
30569199|NCT01595009|58576820|FG003|Extension|Administrative problems|1|||
30569200|NCT01595009|58576817|FG000|Extension|Patients completed per protocol|0|||
30569201|NCT01595009|58576818|FG001|Extension|Patients completed per protocol|0|||
30569202|NCT01595009|58576819|FG002|Extension|Patients completed per protocol|0|||
30569203|NCT01595009|58576820|FG003|Extension|Patients completed per protocol|2|||
30569204|NCT01595009|58576817|FG000|Extension|Disease progression|0|||
30569205|NCT01595009|58576818|FG001|Extension|Disease progression|0|||
30569206|NCT01595009|58576819|FG002|Extension|Disease progression|4|||
30569207|NCT01595009|58576820|FG003|Extension|Disease progression|7|||
30569208|NCT01595009|58576817|FG000|Extension|Adverse Event|0|||
30569209|NCT01595009|58576818|FG001|Extension|Adverse Event|0|||
30569210|NCT01595009|58576819|FG002|Extension|Adverse Event|0|||
30569211|NCT01595009|58576820|FG003|Extension|Adverse Event|1|||
30569212|NCT05553808|58576837|FG000|Overall Study|Death|25|||
30569213|NCT05553808|58576838|FG001|Overall Study|Death|62|||
30569214|NCT05553808|58576837|FG000|Overall Study|Site Closed|6|||
30569215|NCT05553808|58576838|FG001|Overall Study|Site Closed|6|||
30569216|NCT05553808|58576837|FG000|Overall Study|Lost to Follow-up|1|||
30569217|NCT05553808|58576838|FG001|Overall Study|Lost to Follow-up|0|||
30569218|NCT05553808|58576837|FG000|Overall Study|Withdrawal by Subject|3|||
30569219|NCT05553808|58576838|FG001|Overall Study|Withdrawal by Subject|2|||
30569220|NCT04997161|58576854|FG000|Overall Study|Study terminated by sponsor|3|||
30569221|NCT04753216|58576858|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
30569222|NCT04753216|58576858|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
30569223|NCT04753216|58576858|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
30569224|NCT04530747|58576891|FG000|Overall Study|Withdrawal by Subject|1|||
30569225|NCT04530747|58576892|FG001|Overall Study|Withdrawal by Subject|0|||
30569226|NCT04493242|58576903|FG000|Overall Study|Death|10|||
30569227|NCT04493242|58576904|FG001|Overall Study|Death|14|||
30569228|NCT04493242|58576905|FG002|Overall Study|Death|16|||
30569229|NCT04493242|58576903|FG000|Overall Study|Lost to Follow-up|1|||
30569230|NCT04493242|58576904|FG001|Overall Study|Lost to Follow-up|1|||
30569231|NCT04493242|58576905|FG002|Overall Study|Lost to Follow-up|0|||
30569232|NCT04493242|58576903|FG000|Overall Study|Withdrawal by Subject|1|||
30569233|NCT04493242|58576904|FG001|Overall Study|Withdrawal by Subject|0|||
30569234|NCT04493242|58576905|FG002|Overall Study|Withdrawal by Subject|0|||
30569235|NCT04493242|58576903|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
30569236|NCT04493242|58576904|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
30569237|NCT04493242|58576905|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
30569238|NCT04493242|58576903|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
30569239|NCT04493242|58576904|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
30569240|NCT04493242|58576905|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
30569241|NCT04040751|58576926|FG000|Overall Study|Withdrawal by Subject|2|||
30569242|NCT04040751|58576927|FG001|Overall Study|Withdrawal by Subject|0|||
30569243|NCT04040751|58576928|FG002|Overall Study|Withdrawal by Subject|2|||
30569244|NCT04040751|58576929|FG003|Overall Study|Withdrawal by Subject|0|||
30569245|NCT03997916|58576939|FG000|Overall Study|Protocol Violation|35|||
30569246|NCT03596177|58576958|FG000|Single Blind Period|Withdrawal by Subject|1|||
30569247|NCT03596177|58576959|FG001|Single Blind Period|Withdrawal by Subject|1|||
30569248|NCT03596177|58576958|FG000|Single Blind Period|Other|1|||
30569249|NCT03596177|58576959|FG001|Single Blind Period|Other|0|||
30569250|NCT03596177|58576958|FG000|Double Blind Period|Withdrawal by Subject|0|||
30569251|NCT03596177|58576959|FG001|Double Blind Period|Withdrawal by Subject|1|||
30569252|NCT03596177|58576958|FG000|Double Blind Period|Other|0|||
30569253|NCT03596177|58576959|FG001|Double Blind Period|Other|4|||
30569254|NCT03596177|58576958|FG000|Double Blind Period|Death during safety follow-up|0|||
30569255|NCT03596177|58576959|FG001|Double Blind Period|Death during safety follow-up|1|||
30569256|NCT03579459|58576969|FG000|Overall Study|Adverse Event|7|||
30569257|NCT03579459|58576970|FG001|Overall Study|Adverse Event|6|||
30569258|NCT03579459|58576971|FG002|Overall Study|Adverse Event|2|||
30569259|NCT03579459|58576972|FG003|Overall Study|Adverse Event|6|||
30569260|NCT03579459|58576969|FG000|Overall Study|Death|1|||
30569261|NCT03579459|58576970|FG001|Overall Study|Death|0|||
30569262|NCT03579459|58576971|FG002|Overall Study|Death|1|||
30569263|NCT03579459|58576972|FG003|Overall Study|Death|2|||
30569264|NCT03579459|58576969|FG000|Overall Study|Lost to Follow-up|6|||
30569265|NCT03579459|58576970|FG001|Overall Study|Lost to Follow-up|2|||
30569266|NCT03579459|58576971|FG002|Overall Study|Lost to Follow-up|4|||
30569267|NCT03579459|58576972|FG003|Overall Study|Lost to Follow-up|1|||
30569268|NCT03579459|58576969|FG000|Overall Study|Physician Decision|0|||
30569269|NCT03579459|58576970|FG001|Overall Study|Physician Decision|1|||
30569270|NCT03579459|58576971|FG002|Overall Study|Physician Decision|0|||
30569271|NCT03579459|58576972|FG003|Overall Study|Physician Decision|1|||
30569272|NCT03579459|58576969|FG000|Overall Study|Protocol Violation|1|||
30569273|NCT03579459|58576970|FG001|Overall Study|Protocol Violation|2|||
30569274|NCT03579459|58576971|FG002|Overall Study|Protocol Violation|3|||
30569275|NCT03579459|58576972|FG003|Overall Study|Protocol Violation|5|||
30569276|NCT03579459|58576969|FG000|Overall Study|Withdrawal by Subject|12|||
30569277|NCT03579459|58576970|FG001|Overall Study|Withdrawal by Subject|8|||
30569278|NCT03579459|58576971|FG002|Overall Study|Withdrawal by Subject|11|||
30569279|NCT03579459|58576972|FG003|Overall Study|Withdrawal by Subject|8|||
30569280|NCT03579459|58576969|FG000|Overall Study|Medication error without associated adverse event|2|||
30569281|NCT03579459|58576970|FG001|Overall Study|Medication error without associated adverse event|1|||
30569282|NCT03579459|58576971|FG002|Overall Study|Medication error without associated adverse event|1|||
30569283|NCT03579459|58576972|FG003|Overall Study|Medication error without associated adverse event|0|||
30569284|NCT03579459|58576969|FG000|Overall Study|Other|0|||
30569285|NCT03579459|58576970|FG001|Overall Study|Other|1|||
30569286|NCT03579459|58576971|FG002|Overall Study|Other|1|||
30569287|NCT03579459|58576972|FG003|Overall Study|Other|0|||
30569288|NCT03579459|58576969|FG000|Overall Study|Randomized not vaccinated|0|||
30569289|NCT03579459|58576970|FG001|Overall Study|Randomized not vaccinated|2|||
30569290|NCT03579459|58576971|FG002|Overall Study|Randomized not vaccinated|0|||
30569291|NCT03579459|58576972|FG003|Overall Study|Randomized not vaccinated|1|||
30569292|NCT03340766|58576985|FG000|Overall Study|Death|6|||
30569293|NCT03340766|58576986|FG001|Overall Study|Death|6|||
30569294|NCT03340766|58576987|FG002|Overall Study|Death|2|||
30569295|NCT03340766|58576985|FG000|Overall Study|Withdrawal by Subject|2|||
30569296|NCT03340766|58576986|FG001|Overall Study|Withdrawal by Subject|1|||
30569297|NCT03340766|58576987|FG002|Overall Study|Withdrawal by Subject|2|||
30569298|NCT03340766|58576985|FG000|Overall Study|Continuing Study|3|||
30569299|NCT03340766|58576986|FG001|Overall Study|Continuing Study|3|||
30569300|NCT03340766|58576987|FG002|Overall Study|Continuing Study|5|||
30569301|NCT04449276|58577018|FG000|Overall Study|Adverse Event|1|||
30569302|NCT04449276|58577019|FG001|Overall Study|Adverse Event|2|||
30569303|NCT04449276|58577020|FG002|Overall Study|Adverse Event|0|||
30569304|NCT04449276|58577021|FG003|Overall Study|Adverse Event|0|||
30569305|NCT04449276|58577022|FG004|Overall Study|Adverse Event|2|||
30569306|NCT04449276|58577023|FG005|Overall Study|Adverse Event|0|||
30569307|NCT04449276|58577024|FG006|Overall Study|Adverse Event|0|||
30569308|NCT04449276|58577025|FG007|Overall Study|Adverse Event|1|||
30569309|NCT04449276|58577018|FG000|Overall Study|Withdrawal by Subject|2|||
30569310|NCT04449276|58577019|FG001|Overall Study|Withdrawal by Subject|0|||
30569311|NCT04449276|58577020|FG002|Overall Study|Withdrawal by Subject|0|||
30569312|NCT04449276|58577021|FG003|Overall Study|Withdrawal by Subject|1|||
30569313|NCT04449276|58577022|FG004|Overall Study|Withdrawal by Subject|0|||
30569314|NCT04449276|58577023|FG005|Overall Study|Withdrawal by Subject|0|||
30569315|NCT04449276|58577024|FG006|Overall Study|Withdrawal by Subject|0|||
30569316|NCT04449276|58577025|FG007|Overall Study|Withdrawal by Subject|0|||
30569317|NCT04449276|58577018|FG000|Overall Study|Other|0|||
30569318|NCT04449276|58577019|FG001|Overall Study|Other|2|||
30569319|NCT04449276|58577020|FG002|Overall Study|Other|3|||
30569320|NCT04449276|58577021|FG003|Overall Study|Other|2|||
30569321|NCT04449276|58577022|FG004|Overall Study|Other|0|||
30569322|NCT04449276|58577023|FG005|Overall Study|Other|0|||
30569323|NCT04449276|58577024|FG006|Overall Study|Other|0|||
30569324|NCT04449276|58577025|FG007|Overall Study|Other|1|||
30569325|NCT04391894|58577065|FG000|Overall Study|Adverse Event|1|||
30569326|NCT04391894|58577066|FG001|Overall Study|Adverse Event|1|||
30569327|NCT04391894|58577067|FG002|Overall Study|Adverse Event|1|||
30569328|NCT04391894|58577068|FG003|Overall Study|Adverse Event|1|||
30569329|NCT04391894|58577069|FG004|Overall Study|Adverse Event|1|||
30569330|NCT04391894|58577065|FG000|Overall Study|Lost to Follow-up|1|||
30569331|NCT04391894|58577066|FG001|Overall Study|Lost to Follow-up|0|||
30569332|NCT04391894|58577067|FG002|Overall Study|Lost to Follow-up|0|||
30569333|NCT04391894|58577068|FG003|Overall Study|Lost to Follow-up|0|||
30569334|NCT04391894|58577069|FG004|Overall Study|Lost to Follow-up|0|||
30569335|NCT04391894|58577065|FG000|Overall Study|Protocol Violation|0|||
30569336|NCT04391894|58577066|FG001|Overall Study|Protocol Violation|0|||
30569337|NCT04391894|58577067|FG002|Overall Study|Protocol Violation|0|||
30569338|NCT04391894|58577068|FG003|Overall Study|Protocol Violation|1|||
30569339|NCT04391894|58577069|FG004|Overall Study|Protocol Violation|0|||
30569340|NCT04391894|58577065|FG000|Overall Study|Withdrawal by Subject|2|||
30569341|NCT04391894|58577066|FG001|Overall Study|Withdrawal by Subject|0|||
30569342|NCT04391894|58577067|FG002|Overall Study|Withdrawal by Subject|3|||
30569343|NCT04391894|58577068|FG003|Overall Study|Withdrawal by Subject|0|||
30569344|NCT04391894|58577069|FG004|Overall Study|Withdrawal by Subject|1|||
30569345|NCT04391894|58577065|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
30569346|NCT04391894|58577066|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
30569347|NCT04391894|58577067|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
30569348|NCT04391894|58577068|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
30569349|NCT04391894|58577069|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
30569350|NCT04166435|58577085|FG000|Overall Study|2 patients ineligible for response|2|||
30569351|NCT03851705|58577091|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
30569352|NCT03851705|58577092|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
30569353|NCT03851705|58577093|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
30569354|NCT03851705|58577094|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
30569355|NCT03851705|58577091|FG000|Part 1: Double-Blind Period|Other reason|1|||
30569356|NCT03851705|58577092|FG001|Part 1: Double-Blind Period|Other reason|0|||
30569357|NCT03851705|58577093|FG002|Part 1: Double-Blind Period|Other reason|0|||
30569358|NCT03851705|58577094|FG003|Part 1: Double-Blind Period|Other reason|0|||
30569359|NCT03851705|58577091|FG000|Part 2: Open-Label Period|Other reason|0|||
30569360|NCT03851705|58577092|FG001|Part 2: Open-Label Period|Other reason|0|||
30569361|NCT03851705|58577093|FG002|Part 2: Open-Label Period|Other reason|0|||
30569362|NCT03851705|58577094|FG003|Part 2: Open-Label Period|Other reason|1|||
30569363|NCT03851705|58577091|FG000|Part 2: Open-Label Period|Death|0|||
30569364|NCT03851705|58577092|FG001|Part 2: Open-Label Period|Death|0|||
30855188|NCT01359644|58882746|FG004|Treatment Period|Lost to Follow-up|0|||
30855189|NCT01359644|58882747|FG005|Treatment Period|Lost to Follow-up|1|||
30855190|NCT01359644|58882748|FG006|Treatment Period|Lost to Follow-up|0|||
30569365|NCT03851705|58577093|FG002|Part 2: Open-Label Period|Death|3|||
30569366|NCT03851705|58577094|FG003|Part 2: Open-Label Period|Death|0|||
30569367|NCT03851705|58577091|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
30569368|NCT03851705|58577092|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
30569369|NCT03851705|58577093|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
30569370|NCT03851705|58577094|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
30569371|NCT03824366|58577107|FG000|Overall Study|Death|1|||
30569372|NCT03824366|58577107|FG000|Overall Study|Previously unidentified metal artifact|1|||
30569373|NCT03824366|58577107|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
30569374|NCT03824366|58577107|FG000|Overall Study|Withdrawal by Subject|1|||
30569375|NCT03810313|58577113|FG000|Overall Study|Study terminated by sponsor|164|||
30569376|NCT03810313|58577114|FG001|Overall Study|Study terminated by sponsor|159|||
30569377|NCT03810313|58577113|FG000|Overall Study|Subject decision|10|||
30569378|NCT03810313|58577114|FG001|Overall Study|Subject decision|11|||
30569379|NCT03810313|58577113|FG000|Overall Study|Lost to Follow-up|3|||
30569380|NCT03810313|58577114|FG001|Overall Study|Lost to Follow-up|3|||
30569381|NCT03810313|58577113|FG000|Overall Study|Adverse Event|2|||
30569382|NCT03810313|58577114|FG001|Overall Study|Adverse Event|1|||
30569383|NCT03810313|58577113|FG000|Overall Study|Death|2|||
30569384|NCT03810313|58577114|FG001|Overall Study|Death|1|||
30569385|NCT03810313|58577113|FG000|Overall Study|Physician Decision|0|||
30569386|NCT03810313|58577114|FG001|Overall Study|Physician Decision|1|||
30569387|NCT03802630|58577123|FG000|Overall Study|Study terminated by sponsor|130|||
30569388|NCT03802630|58577124|FG001|Overall Study|Study terminated by sponsor|134|||
30569389|NCT03802630|58577123|FG000|Overall Study|Subject decision|16|||
30569390|NCT03802630|58577124|FG001|Overall Study|Subject decision|9|||
30569391|NCT03802630|58577123|FG000|Overall Study|Adverse Event|3|||
30569392|NCT03802630|58577124|FG001|Overall Study|Adverse Event|1|||
30569393|NCT03802630|58577123|FG000|Overall Study|Lost to Follow-up|2|||
30569394|NCT03802630|58577124|FG001|Overall Study|Lost to Follow-up|2|||
30569395|NCT03802630|58577123|FG000|Overall Study|Physician Decision|2|||
30569396|NCT03802630|58577124|FG001|Overall Study|Physician Decision|0|||
30569397|NCT03802630|58577123|FG000|Overall Study|Death|0|||
30569398|NCT03802630|58577124|FG001|Overall Study|Death|2|||
30569399|NCT03775213|58577133|FG000|Overall Study|Withdrawal by Subject|51|||
30569400|NCT03775213|58577134|FG001|Overall Study|Withdrawal by Subject|53|||
30569401|NCT03775213|58577133|FG000|Overall Study|Incomplete Survey|7|||
30569402|NCT03775213|58577134|FG001|Overall Study|Incomplete Survey|7|||
30569403|NCT03710564|58577142|FG000|Overall Study|Study Terminated by Sponsor|104|||
30569404|NCT03710564|58577143|FG001|Overall Study|Study Terminated by Sponsor|55|||
30569405|NCT03710564|58577142|FG000|Overall Study|Withdrawal by Subject|57|||
30569406|NCT03710564|58577143|FG001|Overall Study|Withdrawal by Subject|25|||
30569407|NCT03710564|58577142|FG000|Overall Study|Death|10|||
30569408|NCT03710564|58577143|FG001|Overall Study|Death|4|||
30569409|NCT03710564|58577142|FG000|Overall Study|Lost to Follow-up|5|||
30569410|NCT03710564|58577143|FG001|Overall Study|Lost to Follow-up|4|||
30569411|NCT03710564|58577142|FG000|Overall Study|Protocol Violation|3|||
30569412|NCT03710564|58577143|FG001|Overall Study|Protocol Violation|2|||
30569413|NCT03710564|58577142|FG000|Overall Study|Adverse Event|3|||
30569414|NCT03710564|58577143|FG001|Overall Study|Adverse Event|0|||
30569415|NCT03710564|58577142|FG000|Overall Study|Physician Decision|2|||
30569416|NCT03710564|58577143|FG001|Overall Study|Physician Decision|3|||
30569417|NCT03624127|58577153|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
30569418|NCT03624127|58577154|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
30569419|NCT03624127|58577155|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
30569420|NCT03624127|58577153|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
30569421|NCT03624127|58577154|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
30569422|NCT03624127|58577155|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
30569423|NCT03624127|58577153|FG000|Treatment Week 0 - Week 16|Death|0|||
30569424|NCT03624127|58577154|FG001|Treatment Week 0 - Week 16|Death|1|||
30569425|NCT03624127|58577155|FG002|Treatment Week 0 - Week 16|Death|0|||
30569426|NCT03624127|58577153|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
30569427|NCT03624127|58577154|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
30569428|NCT03624127|58577155|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
30569429|NCT03624127|58577153|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
30569430|NCT03624127|58577154|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
30569431|NCT03624127|58577155|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
30569432|NCT03624127|58577153|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
30569433|NCT03624127|58577154|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
30569434|NCT03624127|58577155|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
30569435|NCT03624127|58577153|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
30569436|NCT03624127|58577154|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
30569437|NCT03624127|58577155|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
30569438|NCT03624127|58577153|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
30569439|NCT03624127|58577154|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
30667051|NCT00527605|58680904|FG000|Overall Study|Protocol Violation|1|||
30667052|NCT00527605|58680905|FG001|Overall Study|Protocol Violation|2|||
30569440|NCT03624127|58577155|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
30569441|NCT03624127|58577153|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
30569442|NCT03624127|58577154|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
30569443|NCT03624127|58577155|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
30569444|NCT03624127|58577153|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
30569445|NCT03624127|58577154|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
30569446|NCT03624127|58577155|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
30569447|NCT03624127|58577153|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
30569448|NCT03624127|58577154|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
30569449|NCT03624127|58577155|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
30569450|NCT03624127|58577153|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
30569451|NCT03624127|58577154|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
30569452|NCT03624127|58577155|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
30569453|NCT03624127|58577153|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
30569454|NCT03624127|58577154|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
30569455|NCT03624127|58577155|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
30569456|NCT03624127|58577153|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
30569457|NCT03624127|58577154|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
30569458|NCT03624127|58577155|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
30569459|NCT03624127|58577153|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
30667053|NCT00849381|58680911|FG000|Overall Study|Adverse Event|1|||
30667054|NCT00849381|58680911|FG000|Overall Study|Lost to Follow-up|129|||
30667055|NCT00849381|58680911|FG000|Overall Study|Protocol Violation|5|||
30667056|NCT00849381|58680911|FG000|Overall Study|Withdrawal by Subject|6|||
30667057|NCT00849381|58680911|FG000|Overall Study|Other|4|||
30667058|NCT00711412|58680915|FG000|Induction Treatment|Death|2|||
30667059|NCT00711412|58680915|FG000|Induction Treatment|Adverse Event|1|||
30667060|NCT00711412|58680915|FG000|Induction Treatment|Other|1|||
30667061|NCT00711412|58680915|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
30667062|NCT00711412|58680915|FG000|Evaluated for Combination Treatment|Death|1|||
30667063|NCT00711412|58680915|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
30667064|NCT00711412|58680915|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
30667065|NCT00711412|58680915|FG000|Combination Treatment|Progressive Disease|1|||
30667066|NCT00711412|58680915|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
30667067|NCT00711412|58680915|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
30667068|NCT00711412|58680915|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
30667069|NCT00711412|58680915|FG000|Evaluation for Response and Surgery|Death|1|||
30667070|NCT00711412|58680915|FG000|Survival Follow up Until Death|Other|12|||
30667071|NCT00577408|58680931|FG000|Overall Study|Stopped attending study visits|9|||
30667072|NCT00577408|58680932|FG001|Overall Study|Stopped attending study visits|11|||
30667073|NCT00577408|58680931|FG000|Overall Study|Continued opioid use|3|||
30667074|NCT00577408|58680932|FG001|Overall Study|Continued opioid use|2|||
30667075|NCT00577408|58680931|FG000|Overall Study|Non-compliance with study meds|0|||
30667076|NCT00577408|58680932|FG001|Overall Study|Non-compliance with study meds|3|||
30667077|NCT00577408|58680931|FG000|Overall Study|Refused Oral Naltrexone|0|||
30667078|NCT00577408|58680932|FG001|Overall Study|Refused Oral Naltrexone|1|||
30667079|NCT00577408|58680931|FG000|Overall Study|Moved out of state|0|||
30667080|NCT00577408|58680932|FG001|Overall Study|Moved out of state|1|||
30667081|NCT00577408|58680931|FG000|Overall Study|Scheduling Issues|0|||
30667082|NCT00577408|58680932|FG001|Overall Study|Scheduling Issues|3|||
30667083|NCT00577408|58680931|FG000|Overall Study|Death|0|||
30667084|NCT00577408|58680932|FG001|Overall Study|Death|1|||
30667085|NCT00577408|58680931|FG000|Overall Study|Psychiatric hospitalization|0|||
30667086|NCT00577408|58680932|FG001|Overall Study|Psychiatric hospitalization|1|||
30667087|NCT00713596|58680941|FG000|Overall Study|Study was terminated|2|||
30667088|NCT00713596|58680942|FG001|Overall Study|Study was terminated|3|||
30667089|NCT00713596|58680943|FG002|Overall Study|Study was terminated|2|||
30667090|NCT00880568|58680960|FG000|Overall Study|Disease progression|3|||
30667091|NCT00880568|58680961|FG001|Overall Study|Disease progression|3|||
30667092|NCT00880568|58680962|FG002|Overall Study|Disease progression|3|||
30667093|NCT00880568|58680963|FG003|Overall Study|Disease progression|1|||
30667094|NCT00880568|58680964|FG004|Overall Study|Disease progression|3|||
30667095|NCT00880568|58680965|FG005|Overall Study|Disease progression|3|||
30667096|NCT00880568|58680966|FG006|Overall Study|Disease progression|5|||
30569460|NCT03624127|58577154|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
30569461|NCT03624127|58577155|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
30569462|NCT03624127|58577153|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
30569463|NCT03624127|58577154|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
30569464|NCT03624127|58577155|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
30569465|NCT03624127|58577153|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
30569466|NCT03624127|58577154|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
30569467|NCT03624127|58577155|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
30569468|NCT03624127|58577153|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
30667097|NCT00880568|58680967|FG007|Overall Study|Disease progression|0|||
30667098|NCT00880568|58680968|FG008|Overall Study|Disease progression|3|||
30667099|NCT00880568|58680960|FG000|Overall Study|Adverse Event|0|||
30569469|NCT03624127|58577154|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
30569470|NCT03624127|58577155|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
30667100|NCT00880568|58680961|FG001|Overall Study|Adverse Event|0|||
30667101|NCT00880568|58680962|FG002|Overall Study|Adverse Event|0|||
30667102|NCT00880568|58680963|FG003|Overall Study|Adverse Event|0|||
30667103|NCT00880568|58680964|FG004|Overall Study|Adverse Event|0|||
30667104|NCT00880568|58680965|FG005|Overall Study|Adverse Event|0|||
30667105|NCT00880568|58680966|FG006|Overall Study|Adverse Event|1|||
30667106|NCT00880568|58680967|FG007|Overall Study|Adverse Event|1|||
30667107|NCT00880568|58680968|FG008|Overall Study|Adverse Event|0|||
30667108|NCT00880568|58680960|FG000|Overall Study|Withdrawal by Subject|0|||
30667109|NCT00880568|58680961|FG001|Overall Study|Withdrawal by Subject|0|||
30667110|NCT00880568|58680962|FG002|Overall Study|Withdrawal by Subject|0|||
30667111|NCT00880568|58680963|FG003|Overall Study|Withdrawal by Subject|0|||
30667112|NCT00880568|58680964|FG004|Overall Study|Withdrawal by Subject|0|||
30667113|NCT00880568|58680965|FG005|Overall Study|Withdrawal by Subject|0|||
30569471|NCT03624127|58577153|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
30569472|NCT03624127|58577154|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
30569473|NCT03624127|58577155|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
30569474|NCT03624127|58577153|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
30569475|NCT03624127|58577154|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
30569476|NCT03624127|58577155|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
30569477|NCT03624127|58577153|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
30569478|NCT03624127|58577154|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
30569479|NCT03624127|58577155|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
30569480|NCT03616912|58577173|FG000|Overall Study|Adverse Event|17|||
30569481|NCT03616912|58577174|FG001|Overall Study|Adverse Event|21|||
30569482|NCT03616912|58577175|FG002|Overall Study|Adverse Event|9|||
30569483|NCT03616912|58577176|FG003|Overall Study|Adverse Event|0|||
30667114|NCT00880568|58680966|FG006|Overall Study|Withdrawal by Subject|0|||
30667115|NCT00880568|58680967|FG007|Overall Study|Withdrawal by Subject|1|||
30667116|NCT00880568|58680968|FG008|Overall Study|Withdrawal by Subject|0|||
30667117|NCT00881894|58680995|FG000|Overall Study|Consent withdrawn|0|||
30667118|NCT00881894|58680996|FG001|Overall Study|Consent withdrawn|1|||
30667119|NCT00881894|58680995|FG000|Overall Study|Other reasons for premature termination|1|||
30667120|NCT00881894|58680996|FG001|Overall Study|Other reasons for premature termination|2|||
30667121|NCT00711100|58681002|FG000|Overall Study|Lack of Efficacy|5|||
30667122|NCT00711100|58681002|FG000|Overall Study|Withdrawal by Subject|8|||
30667123|NCT00827931|58681020|FG000|Overall Study|Death|3|||
30667124|NCT00827931|58681021|FG001|Overall Study|Death|5|||
30667125|NCT00827931|58681020|FG000|Overall Study|Adverse Event|1|||
30667126|NCT00827931|58681021|FG001|Overall Study|Adverse Event|0|||
30667127|NCT00827931|58681020|FG000|Overall Study|Lost to Follow-up|1|||
30569484|NCT03616912|58577177|FG004|Overall Study|Adverse Event|0|||
30569485|NCT03616912|58577178|FG005|Overall Study|Adverse Event|0|||
30569486|NCT03616912|58577173|FG000|Overall Study|Death|1|||
30569487|NCT03616912|58577174|FG001|Overall Study|Death|1|||
30569488|NCT03616912|58577175|FG002|Overall Study|Death|0|||
30569489|NCT03616912|58577176|FG003|Overall Study|Death|0|||
30667128|NCT00827931|58681021|FG001|Overall Study|Lost to Follow-up|0|||
30667129|NCT00827931|58681020|FG000|Overall Study|Withdrawal by Subject|0|||
30667130|NCT00827931|58681021|FG001|Overall Study|Withdrawal by Subject|1|||
30667131|NCT00827931|58681020|FG000|Overall Study|Other|1|||
30667132|NCT00827931|58681021|FG001|Overall Study|Other|0|||
30667133|NCT00526669|58681027|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
30667134|NCT00526669|58681028|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
30667135|NCT00526669|58681027|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
30667136|NCT00526669|58681028|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
30667137|NCT00526669|58681027|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
30667138|NCT00526669|58681028|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
30855191|NCT01359644|58882749|FG007|Treatment Period|Lost to Follow-up|0|||
30569490|NCT03616912|58577177|FG004|Overall Study|Death|0|||
30569491|NCT03616912|58577178|FG005|Overall Study|Death|0|||
30569492|NCT03616912|58577173|FG000|Overall Study|Lack of Efficacy|13|||
30569493|NCT03616912|58577174|FG001|Overall Study|Lack of Efficacy|6|||
30569494|NCT03616912|58577175|FG002|Overall Study|Lack of Efficacy|8|||
30569495|NCT03616912|58577176|FG003|Overall Study|Lack of Efficacy|4|||
30569496|NCT03616912|58577177|FG004|Overall Study|Lack of Efficacy|5|||
30569497|NCT03616912|58577178|FG005|Overall Study|Lack of Efficacy|1|||
30569498|NCT03616912|58577173|FG000|Overall Study|Lost to Follow-up|1|||
30569499|NCT03616912|58577174|FG001|Overall Study|Lost to Follow-up|2|||
30569500|NCT03616912|58577175|FG002|Overall Study|Lost to Follow-up|3|||
30569501|NCT03616912|58577176|FG003|Overall Study|Lost to Follow-up|0|||
30569502|NCT03616912|58577177|FG004|Overall Study|Lost to Follow-up|0|||
30569503|NCT03616912|58577178|FG005|Overall Study|Lost to Follow-up|0|||
30569504|NCT03616912|58577173|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
30667139|NCT00526669|58681027|FG000|Combined Treatment Phase|Death|0|||
30569505|NCT03616912|58577174|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
30569506|NCT03616912|58577175|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
30569507|NCT03616912|58577176|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
30569508|NCT03616912|58577177|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
30667140|NCT00526669|58681028|FG001|Combined Treatment Phase|Death|2|||
30667141|NCT00710866|58681040|FG000|Overall Study|Protocol Violation|5|||
30667142|NCT00710866|58681041|FG001|Overall Study|Protocol Violation|4|||
30667143|NCT00710866|58681040|FG000|Overall Study|Withdrawal by Subject|2|||
30667144|NCT00710866|58681041|FG001|Overall Study|Withdrawal by Subject|1|||
30569509|NCT03616912|58577178|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
30569510|NCT03616912|58577173|FG000|Overall Study|Withdrawal by Subject|12|||
30569511|NCT03616912|58577174|FG001|Overall Study|Withdrawal by Subject|12|||
30569512|NCT03616912|58577175|FG002|Overall Study|Withdrawal by Subject|15|||
30569513|NCT03616912|58577176|FG003|Overall Study|Withdrawal by Subject|2|||
30569514|NCT03616912|58577177|FG004|Overall Study|Withdrawal by Subject|0|||
30569515|NCT03616912|58577178|FG005|Overall Study|Withdrawal by Subject|2|||
30569516|NCT03616912|58577173|FG000|Overall Study|Study Terminated by Sponsor|0|||
30569517|NCT03616912|58577174|FG001|Overall Study|Study Terminated by Sponsor|0|||
30569518|NCT03616912|58577175|FG002|Overall Study|Study Terminated by Sponsor|0|||
30569519|NCT03616912|58577176|FG003|Overall Study|Study Terminated by Sponsor|10|||
30569520|NCT03616912|58577177|FG004|Overall Study|Study Terminated by Sponsor|9|||
30569521|NCT03616912|58577178|FG005|Overall Study|Study Terminated by Sponsor|11|||
30569522|NCT03616912|58577173|FG000|Overall Study|Protocol Deviation|1|||
30569523|NCT03616912|58577174|FG001|Overall Study|Protocol Deviation|1|||
30569524|NCT03616912|58577175|FG002|Overall Study|Protocol Deviation|0|||
30569525|NCT03616912|58577176|FG003|Overall Study|Protocol Deviation|0|||
30569526|NCT03616912|58577177|FG004|Overall Study|Protocol Deviation|0|||
30569527|NCT03616912|58577178|FG005|Overall Study|Protocol Deviation|0|||
30569528|NCT03616912|58577173|FG000|Overall Study|Pregnancy|1|||
30569529|NCT03616912|58577174|FG001|Overall Study|Pregnancy|0|||
30569530|NCT03616912|58577175|FG002|Overall Study|Pregnancy|4|||
30569531|NCT03616912|58577176|FG003|Overall Study|Pregnancy|0|||
30569532|NCT03616912|58577177|FG004|Overall Study|Pregnancy|0|||
30569533|NCT03616912|58577178|FG005|Overall Study|Pregnancy|0|||
30569534|NCT03616912|58577173|FG000|Overall Study|Protocol Violation|1|||
30667145|NCT00710866|58681040|FG000|Overall Study|Lost to Follow-up|1|||
30667146|NCT00710866|58681041|FG001|Overall Study|Lost to Follow-up|0|||
30667147|NCT00710866|58681040|FG000|Overall Study|Failed to meet eligibility|1|||
30667148|NCT00710866|58681041|FG001|Overall Study|Failed to meet eligibility|1|||
30569535|NCT03616912|58577174|FG001|Overall Study|Protocol Violation|0|||
30569536|NCT03616912|58577175|FG002|Overall Study|Protocol Violation|2|||
30569537|NCT03616912|58577176|FG003|Overall Study|Protocol Violation|0|||
30569538|NCT03616912|58577177|FG004|Overall Study|Protocol Violation|0|||
30569539|NCT03616912|58577178|FG005|Overall Study|Protocol Violation|0|||
30569540|NCT03616912|58577173|FG000|Overall Study|Physician Decision|2|||
30667149|NCT00827775|58681058|FG000|Overall Study|Withdrawal by Subject|0|||
30667150|NCT00827775|58681059|FG001|Overall Study|Withdrawal by Subject|5|||
30667151|NCT00827541|58681067|FG000|Overall Study|Exitus|1|||
30667152|NCT00827541|58681068|FG001|Overall Study|Exitus|8|||
30667153|NCT00827541|58681067|FG000|Overall Study|Other|1|||
30667154|NCT00827541|58681068|FG001|Overall Study|Other|3|||
30855192|NCT01359644|58882750|FG008|Treatment Period|Lost to Follow-up|0|||
30855193|NCT01359644|58882751|FG009|Treatment Period|Lost to Follow-up|0|||
30569541|NCT03616912|58577174|FG001|Overall Study|Physician Decision|0|||
30569542|NCT03616912|58577175|FG002|Overall Study|Physician Decision|0|||
30569543|NCT03616912|58577176|FG003|Overall Study|Physician Decision|0|||
30569544|NCT03616912|58577177|FG004|Overall Study|Physician Decision|1|||
30569545|NCT03616912|58577178|FG005|Overall Study|Physician Decision|0|||
30569546|NCT03616912|58577173|FG000|Overall Study|Randomized But Never Treated|0|||
30569547|NCT03616912|58577174|FG001|Overall Study|Randomized But Never Treated|2|||
30569548|NCT03616912|58577175|FG002|Overall Study|Randomized But Never Treated|0|||
30569549|NCT03616912|58577176|FG003|Overall Study|Randomized But Never Treated|0|||
30569550|NCT03616912|58577177|FG004|Overall Study|Randomized But Never Treated|0|||
30569551|NCT03616912|58577178|FG005|Overall Study|Randomized But Never Treated|0|||
30569552|NCT03499899|58577195|FG000|Overall Study|Adverse Event|2|||
30569553|NCT03499899|58577196|FG001|Overall Study|Adverse Event|3|||
30569554|NCT03499899|58577197|FG002|Overall Study|Adverse Event|3|||
30569555|NCT03499899|58577195|FG000|Overall Study|Death|0|||
30569556|NCT03499899|58577196|FG001|Overall Study|Death|0|||
30569557|NCT03499899|58577197|FG002|Overall Study|Death|1|||
30569558|NCT03499899|58577195|FG000|Overall Study|Physician Decision|3|||
30569559|NCT03499899|58577196|FG001|Overall Study|Physician Decision|6|||
30569560|NCT03499899|58577197|FG002|Overall Study|Physician Decision|6|||
30569561|NCT03499899|58577195|FG000|Overall Study|Progressive disease|15|||
30569562|NCT03499899|58577196|FG001|Overall Study|Progressive disease|23|||
30569563|NCT03499899|58577197|FG002|Overall Study|Progressive disease|23|||
30569564|NCT03499899|58577195|FG000|Overall Study|Patient decision|0|||
30569565|NCT03499899|58577196|FG001|Overall Study|Patient decision|1|||
30569566|NCT03499899|58577197|FG002|Overall Study|Patient decision|1|||
30569567|NCT03499899|58577195|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
30569568|NCT03499899|58577196|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
30569569|NCT03499899|58577197|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
30569570|NCT03481634|58577213|FG000|Overall Study|Withdrawal by Subject|16|||
30569571|NCT03481634|58577214|FG001|Overall Study|Withdrawal by Subject|19|||
30667155|NCT00827541|58681067|FG000|Overall Study|Pathogen not susceptible|1|||
30667156|NCT00827541|58681068|FG001|Overall Study|Pathogen not susceptible|0|||
30667157|NCT00827541|58681067|FG000|Overall Study|Lack of effectiveness|1|||
30667158|NCT00827541|58681068|FG001|Overall Study|Lack of effectiveness|0|||
30569572|NCT03481634|58577215|FG002|Overall Study|Withdrawal by Subject|14|||
30569573|NCT03481634|58577213|FG000|Overall Study|Protocol Violation|1|||
30569574|NCT03481634|58577214|FG001|Overall Study|Protocol Violation|0|||
30855194|NCT01359644|58882742|FG000|Follow-up Period|Withdrawal by Subject|0|||
30569575|NCT03481634|58577215|FG002|Overall Study|Protocol Violation|1|||
30569576|NCT03481634|58577213|FG000|Overall Study|Progressive disease|0|||
30569577|NCT03481634|58577214|FG001|Overall Study|Progressive disease|1|||
30569578|NCT03481634|58577215|FG002|Overall Study|Progressive disease|0|||
30569579|NCT03481634|58577213|FG000|Overall Study|Physician Decision|3|||
30569580|NCT03481634|58577214|FG001|Overall Study|Physician Decision|0|||
30569581|NCT03481634|58577215|FG002|Overall Study|Physician Decision|1|||
30569582|NCT03481634|58577213|FG000|Overall Study|Lost to Follow-up|3|||
30569583|NCT03481634|58577214|FG001|Overall Study|Lost to Follow-up|4|||
30569584|NCT03481634|58577215|FG002|Overall Study|Lost to Follow-up|4|||
30569585|NCT03481634|58577213|FG000|Overall Study|Death|4|||
30569586|NCT03481634|58577214|FG001|Overall Study|Death|8|||
30569587|NCT03481634|58577215|FG002|Overall Study|Death|7|||
30569588|NCT03481634|58577213|FG000|Overall Study|Adverse Event|6|||
30569589|NCT03481634|58577214|FG001|Overall Study|Adverse Event|3|||
30569590|NCT03481634|58577215|FG002|Overall Study|Adverse Event|7|||
30569591|NCT03373461|58577229|FG000|Part 2|Adverse Event|0|||
30569592|NCT03373461|58577230|FG001|Part 2|Adverse Event|1|||
30569593|NCT03373461|58577231|FG002|Part 2|Adverse Event|0|||
30569594|NCT03373461|58577232|FG003|Part 2|Adverse Event|0|||
30569595|NCT03373461|58577233|FG004|Part 2|Adverse Event|1|||
30569596|NCT03364751|58577284|FG000|Overall Study|Withdrawal by Subject|1|||
30569597|NCT03364751|58577285|FG001|Overall Study|Withdrawal by Subject|0|||
30569598|NCT03364751|58577286|FG002|Overall Study|Withdrawal by Subject|0|||
30569599|NCT03364751|58577287|FG003|Overall Study|Withdrawal by Subject|0|||
30569600|NCT03364751|58577284|FG000|Overall Study|Lost to Follow-up|0|||
30569601|NCT03364751|58577285|FG001|Overall Study|Lost to Follow-up|1|||
30569602|NCT03364751|58577286|FG002|Overall Study|Lost to Follow-up|0|||
30569603|NCT03364751|58577287|FG003|Overall Study|Lost to Follow-up|0|||
30569604|NCT03149003|58577308|FG000|Overall Study|Randomized but not treated|0|||
30569605|NCT03149003|58577309|FG001|Overall Study|Randomized but not treated|1|||
30569606|NCT03149003|58577310|FG002|Overall Study|Randomized but not treated|18|||
30569607|NCT02990806|58577320|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
30569608|NCT02990806|58577321|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
30569609|NCT02990806|58577322|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
30569610|NCT02990806|58577323|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
30569611|NCT02990806|58577320|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
30569612|NCT02990806|58577321|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
30569613|NCT02990806|58577322|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
30569614|NCT02990806|58577323|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
30569615|NCT02990806|58577320|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
30569616|NCT02990806|58577321|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
30569617|NCT02990806|58577322|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
30569618|NCT02990806|58577323|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
30569619|NCT02990806|58577320|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
30569620|NCT02990806|58577321|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
30569621|NCT02990806|58577322|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
30569622|NCT02990806|58577323|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
30569623|NCT02990806|58577320|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
30569624|NCT02990806|58577321|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
30569625|NCT02990806|58577322|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
30569626|NCT02990806|58577323|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
30569627|NCT02990806|58577320|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
30569628|NCT02990806|58577321|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
30569629|NCT02990806|58577322|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
30569630|NCT02990806|58577323|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
30569631|NCT02990806|58577320|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
30569632|NCT02990806|58577321|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
30569633|NCT02990806|58577322|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
30569634|NCT02990806|58577323|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
30569635|NCT02990806|58577320|FG000|Stage 1 (22 Weeks)|Death|0|||
30855195|NCT01359644|58882743|FG001|Follow-up Period|Withdrawal by Subject|0|||
30855196|NCT01359644|58882744|FG002|Follow-up Period|Withdrawal by Subject|0|||
30569636|NCT02990806|58577321|FG001|Stage 1 (22 Weeks)|Death|1|||
30569637|NCT02990806|58577322|FG002|Stage 1 (22 Weeks)|Death|0|||
30569638|NCT02990806|58577323|FG003|Stage 1 (22 Weeks)|Death|0|||
30569639|NCT02990806|58577320|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
30569640|NCT02990806|58577321|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
30569641|NCT02990806|58577322|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
30569642|NCT02990806|58577323|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
30569643|NCT02990806|58577320|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
30855197|NCT01359644|58882745|FG003|Follow-up Period|Withdrawal by Subject|0|||
30569644|NCT02990806|58577321|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
30569645|NCT02990806|58577322|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
30569646|NCT02990806|58577323|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
30569647|NCT02990806|58577320|FG000|Stage 1 (22 Weeks)|Other|1|||
30569648|NCT02990806|58577321|FG001|Stage 1 (22 Weeks)|Other|3|||
30569649|NCT02990806|58577322|FG002|Stage 1 (22 Weeks)|Other|0|||
30569650|NCT02990806|58577323|FG003|Stage 1 (22 Weeks)|Other|0|||
30569651|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
30569652|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
30569653|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
30569654|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
30569655|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Death|1|||
30569656|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Death|0|||
30569657|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Death|0|||
30569658|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Death|0|||
30569659|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
30569660|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
30569661|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
30569662|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
30569663|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
30569664|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
30569665|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
30569666|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
30569667|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
30569668|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
30569669|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
30569670|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
30569671|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
30569672|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
30569673|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
30569674|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
30569675|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
30569676|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
30569677|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
30569678|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
30569679|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
30569680|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
30569681|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
30569682|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
30569683|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
30569684|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
30855198|NCT01359644|58882746|FG004|Follow-up Period|Withdrawal by Subject|0|||
30667159|NCT00518323|58681078|FG000|Overall Study|Lack of Efficacy|14|||
30667160|NCT00518323|58681079|FG001|Overall Study|Lack of Efficacy|2|||
30667161|NCT00518323|58681080|FG002|Overall Study|Lack of Efficacy|4|||
30667162|NCT00518323|58681081|FG003|Overall Study|Lack of Efficacy|20|||
30667163|NCT00518323|58681078|FG000|Overall Study|Withdrawal by Subject|1|||
30667164|NCT00518323|58681079|FG001|Overall Study|Withdrawal by Subject|2|||
30667165|NCT00518323|58681080|FG002|Overall Study|Withdrawal by Subject|4|||
30667166|NCT00518323|58681081|FG003|Overall Study|Withdrawal by Subject|2|||
30667167|NCT00518323|58681078|FG000|Overall Study|Lost to Follow-up|0|||
30667168|NCT00518323|58681079|FG001|Overall Study|Lost to Follow-up|2|||
30667169|NCT00518323|58681080|FG002|Overall Study|Lost to Follow-up|1|||
30667170|NCT00518323|58681081|FG003|Overall Study|Lost to Follow-up|3|||
30855199|NCT01359644|58882747|FG005|Follow-up Period|Withdrawal by Subject|1|||
30855200|NCT01359644|58882748|FG006|Follow-up Period|Withdrawal by Subject|0|||
30855201|NCT01359644|58882749|FG007|Follow-up Period|Withdrawal by Subject|0|||
30855202|NCT01359644|58882750|FG008|Follow-up Period|Withdrawal by Subject|0|||
30569685|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
30569686|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
30569687|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
30569688|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
30569689|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
30667171|NCT00518323|58681078|FG000|Overall Study|Adverse Event|1|||
30958645|NCT01694849|59023704|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
30667172|NCT00518323|58681079|FG001|Overall Study|Adverse Event|1|||
30667173|NCT00518323|58681080|FG002|Overall Study|Adverse Event|1|||
30569690|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
30855203|NCT01359644|58882751|FG009|Follow-up Period|Withdrawal by Subject|0|||
30667174|NCT00518323|58681081|FG003|Overall Study|Adverse Event|0|||
30667175|NCT00518323|58681078|FG000|Overall Study|Prohibited medication and others|3|||
30569691|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
30569692|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
30569693|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
30667176|NCT00518323|58681079|FG001|Overall Study|Prohibited medication and others|1|||
30667177|NCT00518323|58681080|FG002|Overall Study|Prohibited medication and others|1|||
30667178|NCT00518323|58681081|FG003|Overall Study|Prohibited medication and others|0|||
30667179|NCT00826449|58681093|FG000|Overall Study|Disease Progression|4|||
30667180|NCT00826449|58681093|FG000|Overall Study|Withdrawal by Subject|1|||
30667181|NCT00825825|58681098|FG000|First Medication Period (14 Days)|Adverse Event|1|||
30667182|NCT00825825|58681099|FG001|First Medication Period (14 Days)|Adverse Event|0|||
30667183|NCT00825825|58681100|FG002|First Medication Period (14 Days)|Adverse Event|0|||
30667184|NCT00825825|58681101|FG003|First Medication Period (14 Days)|Adverse Event|0|||
30667185|NCT00825825|58681102|FG004|First Medication Period (14 Days)|Adverse Event|0|||
30667186|NCT00825825|58681103|FG005|First Medication Period (14 Days)|Adverse Event|1|||
30667187|NCT00825825|58681098|FG000|First Medication Period (14 Days)|Physician Decision|2|||
30667188|NCT00825825|58681099|FG001|First Medication Period (14 Days)|Physician Decision|0|||
30667189|NCT00825825|58681100|FG002|First Medication Period (14 Days)|Physician Decision|1|||
30667190|NCT00825825|58681101|FG003|First Medication Period (14 Days)|Physician Decision|0|||
30667191|NCT00825825|58681102|FG004|First Medication Period (14 Days)|Physician Decision|0|||
30667192|NCT00825825|58681103|FG005|First Medication Period (14 Days)|Physician Decision|1|||
30667193|NCT00825825|58681098|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
30667194|NCT00825825|58681099|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
30667195|NCT00825825|58681100|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
30667196|NCT00825825|58681101|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
30667197|NCT00825825|58681102|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
30667198|NCT00825825|58681103|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
30667199|NCT00825825|58681098|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
30667200|NCT00825825|58681099|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
30667201|NCT00825825|58681100|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
30667202|NCT00825825|58681101|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
30667203|NCT00825825|58681102|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
30667204|NCT00825825|58681103|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
30667205|NCT00825825|58681098|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
30667206|NCT00825825|58681099|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
30667207|NCT00825825|58681100|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
30667208|NCT00825825|58681101|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
30667209|NCT00825825|58681102|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
30667210|NCT00825825|58681103|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
30667211|NCT00825825|58681098|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
30667212|NCT00825825|58681099|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
30667213|NCT00825825|58681100|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
30667214|NCT00825825|58681101|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
30667215|NCT00825825|58681102|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
30667216|NCT00825825|58681103|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
30667217|NCT00825825|58681098|FG000|Third Medication Period (14 Days)|poor data quality|0|||
30667218|NCT00825825|58681099|FG001|Third Medication Period (14 Days)|poor data quality|1|||
30667219|NCT00825825|58681100|FG002|Third Medication Period (14 Days)|poor data quality|0|||
30667220|NCT00825825|58681101|FG003|Third Medication Period (14 Days)|poor data quality|0|||
30667221|NCT00825825|58681102|FG004|Third Medication Period (14 Days)|poor data quality|0|||
30667222|NCT00825825|58681103|FG005|Third Medication Period (14 Days)|poor data quality|0|||
30667223|NCT00710710|58681112|FG000|Overall Study|Consent withdrawn|2|||
30667224|NCT00710710|58681113|FG001|Overall Study|Consent withdrawn|2|||
30667225|NCT00710710|58681112|FG000|Overall Study|Protocol Violation|0|||
30667226|NCT00710710|58681113|FG001|Overall Study|Protocol Violation|1|||
30667227|NCT00710710|58681112|FG000|Overall Study|Adverse Event|3|||
30780162|NCT02992132|58791856|FG000|Overall Study|Adverse Event|4|||
30780163|NCT02992132|58791857|FG001|Overall Study|Adverse Event|1|||
30780164|NCT02992132|58791858|FG002|Overall Study|Adverse Event|3|||
30780165|NCT02992132|58791856|FG000|Overall Study|Lack of Efficacy|2|||
30780166|NCT02992132|58791857|FG001|Overall Study|Lack of Efficacy|0|||
30780167|NCT02992132|58791858|FG002|Overall Study|Lack of Efficacy|0|||
30780168|NCT02992132|58791856|FG000|Overall Study|Non-compliance with study drug|2|||
30958646|NCT01694849|59023702|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
30667228|NCT00710710|58681113|FG001|Overall Study|Adverse Event|3|||
30667229|NCT00710710|58681112|FG000|Overall Study|Progressive disease|40|||
30667230|NCT00710710|58681113|FG001|Overall Study|Progressive disease|38|||
30667231|NCT00880334|58681121|FG000|Randomized Phase|Physician Decision|1|||
30667232|NCT00880334|58681122|FG001|Randomized Phase|Physician Decision|0|||
30667233|NCT00880334|58681121|FG000|Randomized Phase|Withdrawal by Subject|2|||
30667234|NCT00880334|58681122|FG001|Randomized Phase|Withdrawal by Subject|1|||
30667235|NCT00880334|58681121|FG000|Randomized Phase|Inadequate Labs|1|||
30667236|NCT00880334|58681122|FG001|Randomized Phase|Inadequate Labs|1|||
30780169|NCT02992132|58791857|FG001|Overall Study|Non-compliance with study drug|0|||
30667237|NCT00880334|58681121|FG000|Randomized Phase|Brain Metastasis|0|||
30667238|NCT00880334|58681122|FG001|Randomized Phase|Brain Metastasis|1|||
30667239|NCT00880334|58681121|FG000|Randomized Phase|Crossover Participants|0|||
30667240|NCT00880334|58681122|FG001|Randomized Phase|Crossover Participants|37|||
30667241|NCT00865566|58681138|FG000|Overall Study|Death|1|||
30667242|NCT00865566|58681139|FG001|Overall Study|Death|11|||
30667243|NCT00865566|58681138|FG000|Overall Study|Lost to Follow-up|314|||
30667244|NCT00865566|58681139|FG001|Overall Study|Lost to Follow-up|315|||
30667245|NCT00865566|58681138|FG000|Overall Study|Withdrawal by Subject|45|||
30667246|NCT00865566|58681139|FG001|Overall Study|Withdrawal by Subject|65|||
30667247|NCT00865566|58681138|FG000|Overall Study|Physician Decision|0|||
30667248|NCT00865566|58681139|FG001|Overall Study|Physician Decision|1|||
30667249|NCT00865566|58681138|FG000|Overall Study|Participant relocated|78|||
30667250|NCT00865566|58681139|FG001|Overall Study|Participant relocated|107|||
30667251|NCT00865566|58681138|FG000|Overall Study|Participant unable to adhere|27|||
30667252|NCT00865566|58681139|FG001|Overall Study|Participant unable to adhere|42|||
30667253|NCT00865566|58681138|FG000|Overall Study|Other; N=245 due to early study closure|154|||
30667254|NCT00865566|58681139|FG001|Overall Study|Other; N=245 due to early study closure|139|||
30667255|NCT00865566|58681138|FG000|Overall Study|HIV infection|5|||
30667256|NCT00865566|58681139|FG001|Overall Study|HIV infection|7|||
30667257|NCT03866473|58681147|FG000|Phase 1|Death|1|||
30667258|NCT03866473|58681148|FG001|Phase 1|Death|0|||
30667259|NCT03866473|58681147|FG000|Phase 2|Death|0|||
30667260|NCT03866473|58681148|FG001|Phase 2|Death|2|||
30569694|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
30569695|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Other|3|||
30569696|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Other|0|||
30569697|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Other|4|||
30569698|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Other|1|||
30569699|NCT02990806|58577320|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
30569700|NCT02990806|58577321|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
30569701|NCT02990806|58577322|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
30569702|NCT02990806|58577323|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
30569703|NCT02990806|58577320|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
30569704|NCT02990806|58577321|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
30569705|NCT02990806|58577322|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
30569706|NCT02990806|58577323|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
30569707|NCT02990806|58577320|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
30569708|NCT02990806|58577321|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
30569709|NCT02990806|58577322|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
30569710|NCT02990806|58577323|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
30569711|NCT02990806|58577320|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
30569712|NCT02990806|58577321|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
30569713|NCT02990806|58577322|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
30569714|NCT02990806|58577323|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
30569715|NCT02990806|58577320|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
30569716|NCT02990806|58577321|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
30569717|NCT02990806|58577322|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
30569718|NCT02990806|58577323|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
30569719|NCT02990806|58577320|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
30569720|NCT02990806|58577321|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
30569721|NCT02990806|58577322|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
30569722|NCT02990806|58577323|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
30569723|NCT02990806|58577320|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
30569724|NCT02990806|58577321|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
30569725|NCT02990806|58577322|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
30569726|NCT02990806|58577323|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
30667261|NCT03866473|58681147|FG000|Phase 2|Dropped|1|||
30667262|NCT03866473|58681148|FG001|Phase 2|Dropped|1|||
30780170|NCT02992132|58791858|FG002|Overall Study|Non-compliance with study drug|0|||
30780171|NCT02992132|58791856|FG000|Overall Study|Progressive disease|1|||
30780172|NCT02992132|58791857|FG001|Overall Study|Progressive disease|0|||
30780173|NCT02992132|58791858|FG002|Overall Study|Progressive disease|0|||
30780174|NCT02992132|58791856|FG000|Overall Study|Protocol Violation|2|||
30667263|NCT03866473|58681147|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
30667264|NCT03866473|58681148|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
30667265|NCT00525499|58681162|FG000|Overall Study|Lost to Follow-up|2|||
30667266|NCT00525499|58681163|FG001|Overall Study|Lost to Follow-up|4|||
30667267|NCT00525499|58681164|FG002|Overall Study|Lost to Follow-up|1|||
30667268|NCT00525499|58681165|FG003|Overall Study|Lost to Follow-up|4|||
30780175|NCT02992132|58791857|FG001|Overall Study|Protocol Violation|2|||
30667269|NCT00525499|58681162|FG000|Overall Study|Adverse Event|0|||
30667270|NCT00525499|58681163|FG001|Overall Study|Adverse Event|1|||
30667271|NCT00525499|58681164|FG002|Overall Study|Adverse Event|0|||
30667272|NCT00525499|58681165|FG003|Overall Study|Adverse Event|1|||
30667273|NCT00525499|58681162|FG000|Overall Study|Withdrawal by Subject|5|||
30667274|NCT00525499|58681163|FG001|Overall Study|Withdrawal by Subject|1|||
30667275|NCT00525499|58681164|FG002|Overall Study|Withdrawal by Subject|5|||
30667276|NCT00525499|58681165|FG003|Overall Study|Withdrawal by Subject|2|||
30667277|NCT00525499|58681162|FG000|Overall Study|Protocol Violation|0|||
30667278|NCT00525499|58681163|FG001|Overall Study|Protocol Violation|1|||
30667279|NCT00525499|58681164|FG002|Overall Study|Protocol Violation|1|||
30667280|NCT00525499|58681165|FG003|Overall Study|Protocol Violation|0|||
30667281|NCT00824655|58681177|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
30667282|NCT00824655|58681178|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
30667283|NCT00824655|58681177|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
30667284|NCT00824655|58681178|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
30667285|NCT00525265|58681188|FG000|Overall Study|Protocol Violation|1|||
30667286|NCT00525265|58681189|FG001|Overall Study|Protocol Violation|0|||
30667287|NCT00880256|58681195|FG000|Overall Study|Lost to Follow-up|28|||
30667288|NCT03865381|58681204|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
30667289|NCT03865381|58681204|FG000|Overall Study|Withdrawal by Subject|2|||
30667290|NCT00865098|58681208|FG000|Overall Study|Progressive disease|1|||
30667291|NCT00880100|58681212|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
30667292|NCT00880100|58681212|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
30667293|NCT00880100|58681212|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
30667294|NCT00518011|58681218|FG000|Overall Study|Death|1|||
30667295|NCT00518011|58681219|FG001|Overall Study|Death|1|||
30667296|NCT00518011|58681218|FG000|Overall Study|Adverse Event|2|||
30667297|NCT00518011|58681219|FG001|Overall Study|Adverse Event|3|||
30667298|NCT00518011|58681218|FG000|Overall Study|Disease Progression|2|||
30667299|NCT00518011|58681219|FG001|Overall Study|Disease Progression|2|||
30667300|NCT00518011|58681218|FG000|Overall Study|Other Reasons|3|||
30667301|NCT00518011|58681219|FG001|Overall Study|Other Reasons|2|||
30667302|NCT00518011|58681218|FG000|Overall Study|Withdrawal by Subject|1|||
30667303|NCT00518011|58681219|FG001|Overall Study|Withdrawal by Subject|0|||
30569727|NCT02990806|58577320|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
30569728|NCT02990806|58577321|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
30569729|NCT02990806|58577322|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
30569730|NCT02990806|58577323|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
30569731|NCT02990806|58577320|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
30569732|NCT02990806|58577321|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
30569733|NCT02990806|58577322|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
30569734|NCT02990806|58577323|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
30569735|NCT02420821|58577394|FG000|Overall Study|Lost to Follow-up|6|||
30569736|NCT02420821|58577395|FG001|Overall Study|Lost to Follow-up|6|||
30569737|NCT02420821|58577394|FG000|Overall Study|Non-compliance|0|||
30569738|NCT02420821|58577395|FG001|Overall Study|Non-compliance|2|||
30569739|NCT02420821|58577394|FG000|Overall Study|Physician Decision|6|||
30569740|NCT02420821|58577395|FG001|Overall Study|Physician Decision|2|||
30569741|NCT02420821|58577394|FG000|Overall Study|Withdrawal by Subject|32|||
30569742|NCT02420821|58577395|FG001|Overall Study|Withdrawal by Subject|25|||
30569743|NCT02420821|58577394|FG000|Overall Study|Death|270|||
30569744|NCT02420821|58577395|FG001|Overall Study|Death|263|||
30569745|NCT02420821|58577394|FG000|Overall Study|Study Terminated By Sponsor|145|||
30569746|NCT02420821|58577395|FG001|Overall Study|Study Terminated By Sponsor|149|||
30569747|NCT02420821|58577394|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
30855204|NCT01359644|58882742|FG000|Follow-up Period|Lost to Follow-up|0|||
30569748|NCT02420821|58577395|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
30569749|NCT02420821|58577394|FG000|Overall Study|Adverse Event|0|||
30569750|NCT02420821|58577395|FG001|Overall Study|Adverse Event|1|||
30569751|NCT02420821|58577394|FG000|Overall Study|Protinuria|0|||
30569752|NCT02420821|58577395|FG001|Overall Study|Protinuria|1|||
30569753|NCT02420821|58577394|FG000|Overall Study|Progressive Disease|1|||
30569754|NCT02420821|58577395|FG001|Overall Study|Progressive Disease|1|||
30569755|NCT02420821|58577394|FG000|Overall Study|Disease Progression|0|||
30569756|NCT02420821|58577395|FG001|Overall Study|Disease Progression|1|||
30667304|NCT00865020|58681228|FG000|Overall Study|Withdrawal by Subject|22|||
30667305|NCT00865020|58681229|FG001|Overall Study|Withdrawal by Subject|16|||
30667306|NCT00865020|58681228|FG000|Overall Study|Adverse Event|9|||
30667307|NCT00865020|58681229|FG001|Overall Study|Adverse Event|14|||
30667308|NCT00865020|58681228|FG000|Overall Study|Abnormal test procedure result(s)|6|||
30667309|NCT00865020|58681229|FG001|Overall Study|Abnormal test procedure result(s)|8|||
30667310|NCT00865020|58681228|FG000|Overall Study|Lost to Follow-up|6|||
30667311|NCT00865020|58681229|FG001|Overall Study|Lost to Follow-up|4|||
30667312|NCT00865020|58681228|FG000|Overall Study|Protocol deviation|4|||
30569757|NCT02420821|58577394|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
30569758|NCT02420821|58577395|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
30569759|NCT02039063|58577426|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
30569760|NCT02039063|58577427|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
30569761|NCT02039063|58577428|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
30569762|NCT02039063|58577429|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
30569763|NCT02039063|58577426|FG000|Treatment Phase|Progression of disease|0|||
30569764|NCT02039063|58577427|FG001|Treatment Phase|Progression of disease|0|||
30569765|NCT02039063|58577428|FG002|Treatment Phase|Progression of disease|1|||
30569766|NCT02039063|58577429|FG003|Treatment Phase|Progression of disease|1|||
30569767|NCT02039063|58577426|FG000|Extension Phase|Inadequate therapeutic effect|0|||
30569768|NCT02039063|58577427|FG001|Extension Phase|Inadequate therapeutic effect|1|||
30569769|NCT02039063|58577428|FG002|Extension Phase|Inadequate therapeutic effect|2|||
30569770|NCT02039063|58577429|FG003|Extension Phase|Inadequate therapeutic effect|0|||
30569771|NCT02039063|58577426|FG000|Extension Phase|Progression of disease|0|||
30569772|NCT02039063|58577427|FG001|Extension Phase|Progression of disease|0|||
30569773|NCT02039063|58577428|FG002|Extension Phase|Progression of disease|0|||
30569774|NCT02039063|58577429|FG003|Extension Phase|Progression of disease|1|||
30569775|NCT02039063|58577426|FG000|Extension Phase|Adverse Event|0|||
30569776|NCT02039063|58577427|FG001|Extension Phase|Adverse Event|0|||
30569777|NCT02039063|58577428|FG002|Extension Phase|Adverse Event|1|||
30569778|NCT02039063|58577429|FG003|Extension Phase|Adverse Event|0|||
30569779|NCT01746173|58577450|FG000|Overall Study|Disease Progression|2|||
30569780|NCT02995733|58577490|FG000|Overall Study|Study site closed|9|||
30569781|NCT02995733|58577491|FG001|Overall Study|Study site closed|10|||
30569782|NCT02995733|58577490|FG000|Overall Study|Death|3|||
30569783|NCT02995733|58577491|FG001|Overall Study|Death|4|||
30569784|NCT02995733|58577490|FG000|Overall Study|Withdrawal by Subject|6|||
30569785|NCT02995733|58577491|FG001|Overall Study|Withdrawal by Subject|2|||
30569786|NCT02995733|58577490|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
30569787|NCT02995733|58577491|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
30569788|NCT02995733|58577490|FG000|Overall Study|Lost to Follow-up|48|||
30569789|NCT02995733|58577491|FG001|Overall Study|Lost to Follow-up|37|||
30569790|NCT02995733|58577490|FG000|Overall Study|Other|0|||
30569791|NCT02995733|58577491|FG001|Overall Study|Other|1|||
30569792|NCT02815566|58577508|FG000|Overall Study|Adverse Event|1|||
30569793|NCT02815566|58577509|FG001|Overall Study|Adverse Event|1|||
30569794|NCT02815566|58577508|FG000|Overall Study|Withdrawal by Subject|1|||
30569795|NCT02815566|58577509|FG001|Overall Study|Withdrawal by Subject|0|||
30569796|NCT02815566|58577508|FG000|Overall Study|Lost to Follow-up|0|||
30569797|NCT02815566|58577509|FG001|Overall Study|Lost to Follow-up|1|||
30569798|NCT02525783|58577516|FG000|Overall Study|Lost to Follow-up|10|||
30569799|NCT02466243|58577532|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
30569800|NCT02466243|58577533|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
30569801|NCT02466243|58577532|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
30569802|NCT02466243|58577533|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
30569803|NCT02466243|58577532|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
30569804|NCT02466243|58577533|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
30569805|NCT02466243|58577532|FG000|Part B Open-label Treatment Period|Missing|2|||
30569806|NCT02466243|58577533|FG001|Part B Open-label Treatment Period|Missing|2|||
30569807|NCT02321098|58577546|FG000|12 Weeks Treament|Lost to Follow-up|1|||
30569808|NCT02321098|58577547|FG001|12 Weeks Treament|Lost to Follow-up|1|||
30569809|NCT02321098|58577548|FG002|12 Weeks Treament|Lost to Follow-up|0|||
30569810|NCT02321098|58577546|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
30569811|NCT02321098|58577547|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
30569812|NCT02321098|58577548|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
30569813|NCT02321098|58577546|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
30569814|NCT02321098|58577547|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
30569815|NCT02321098|58577548|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
30569816|NCT02321098|58577546|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
30569817|NCT02321098|58577547|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
30569818|NCT02321098|58577548|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
30569819|NCT01966731|58577557|FG000|Overall Study|Death|2|||
30569820|NCT01966731|58577557|FG000|Overall Study|Lost to Follow-up|1|||
30569821|NCT01966731|58577557|FG000|Overall Study|Physician Decision|2|||
30569822|NCT01966731|58577557|FG000|Overall Study|Follow up is not complete|600|||
30569823|NCT01966731|58577557|FG000|Overall Study|Screening Failure|29|||
30569824|NCT01966731|58577557|FG000|Overall Study|Found to be ineligible|1|||
30569825|NCT01843374|58577563|FG000|Overall Study|Death|155|||
30958647|NCT01694849|59023703|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
30958648|NCT01694849|59023704|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
30569826|NCT01843374|58577564|FG001|Overall Study|Death|313|||
30569827|NCT01843374|58577563|FG000|Overall Study|Withdrawal by Subject|14|||
30569828|NCT01843374|58577564|FG001|Overall Study|Withdrawal by Subject|20|||
30569829|NCT01843374|58577563|FG000|Overall Study|Withdrawing due to Other reason|20|||
30569830|NCT01843374|58577564|FG001|Overall Study|Withdrawing due to Other reason|46|||
30569831|NCT01620944|58577586|FG000|Overall Study|Early termination of Study|2|||
30667313|NCT00865020|58681229|FG001|Overall Study|Protocol deviation|1|||
30667314|NCT00865020|58681228|FG000|Overall Study|Administrative problems|0|||
30667315|NCT00865020|58681229|FG001|Overall Study|Administrative problems|2|||
30667316|NCT00865020|58681228|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30667317|NCT00865020|58681229|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30667318|NCT00865020|58681228|FG000|Overall Study|Death|0|||
30569832|NCT01620944|58577587|FG001|Overall Study|Early termination of Study|1|||
30569833|NCT01627561|58577595|FG000|Overall Study|Lost to Follow-up|1|||
30569834|NCT01627561|58577596|FG001|Overall Study|Lost to Follow-up|0|||
30569835|NCT01627561|58577595|FG000|Overall Study|Withdrawal by Subject|0|||
30569836|NCT01627561|58577596|FG001|Overall Study|Withdrawal by Subject|1|||
30569837|NCT01627561|58577595|FG000|Overall Study|Migrated/moved from study area|0|||
30569838|NCT01627561|58577596|FG001|Overall Study|Migrated/moved from study area|2|||
30569839|NCT01652534|58577630|FG000|Overall Study|Lack of Efficacy|1|||
30569840|NCT01652534|58577631|FG001|Overall Study|Lack of Efficacy|0|||
30569841|NCT04709575|58577639|FG000|Overall Study|Withdrawal by Subject|6|||
30569842|NCT04709575|58577640|FG001|Overall Study|Withdrawal by Subject|2|||
30569843|NCT04709575|58577639|FG000|Overall Study|Lost to Follow-up|2|||
30667319|NCT00865020|58681229|FG001|Overall Study|Death|1|||
30667320|NCT00865020|58681228|FG000|Overall Study|Randomized but discontinued|2|||
30667321|NCT00865020|58681229|FG001|Overall Study|Randomized but discontinued|4|||
30667322|NCT00517933|58681237|FG000|Period 1|Death|2|||
30667323|NCT00517933|58681238|FG001|Period 1|Death|1|||
30667324|NCT00517933|58681237|FG000|Period 1|Adverse Event|4|||
30569844|NCT04709575|58577640|FG001|Overall Study|Lost to Follow-up|2|||
30569845|NCT04709575|58577639|FG000|Overall Study|Adverse Event|1|||
30569846|NCT04709575|58577640|FG001|Overall Study|Adverse Event|0|||
30569847|NCT04709575|58577639|FG000|Overall Study|Protocol Violation|1|||
30569848|NCT04709575|58577640|FG001|Overall Study|Protocol Violation|1|||
30569849|NCT04450407|58577649|FG000|Overall Study|Withdrawal by Subject|10|||
30569850|NCT04450407|58577650|FG001|Overall Study|Withdrawal by Subject|1|||
30569851|NCT04450407|58577651|FG002|Overall Study|Withdrawal by Subject|4|||
30569852|NCT04450407|58577649|FG000|Overall Study|Adverse Event|0|||
30569853|NCT04450407|58577650|FG001|Overall Study|Adverse Event|0|||
30569854|NCT04450407|58577651|FG002|Overall Study|Adverse Event|1|||
30569855|NCT04450407|58577649|FG000|Overall Study|Lost to Follow-up|1|||
30569856|NCT04450407|58577650|FG001|Overall Study|Lost to Follow-up|0|||
30569857|NCT04450407|58577651|FG002|Overall Study|Lost to Follow-up|0|||
30569858|NCT04450407|58577649|FG000|Overall Study|Physician Decision|0|||
30569859|NCT04450407|58577650|FG001|Overall Study|Physician Decision|0|||
30569860|NCT04450407|58577651|FG002|Overall Study|Physician Decision|1|||
30569861|NCT04450407|58577649|FG000|Overall Study|Pregnancy|1|||
30569862|NCT04450407|58577650|FG001|Overall Study|Pregnancy|0|||
30569863|NCT04450407|58577651|FG002|Overall Study|Pregnancy|0|||
30569864|NCT04450407|58577649|FG000|Overall Study|Protocol Violation|2|||
30569865|NCT04450407|58577650|FG001|Overall Study|Protocol Violation|0|||
30569866|NCT04450407|58577651|FG002|Overall Study|Protocol Violation|0|||
30569867|NCT04450407|58577649|FG000|Overall Study|Investigational site terminated by sponsor|3|||
30569868|NCT04450407|58577650|FG001|Overall Study|Investigational site terminated by sponsor|0|||
30569869|NCT04450407|58577651|FG002|Overall Study|Investigational site terminated by sponsor|2|||
30569870|NCT04418765|58577661|FG000|Overall Study|Adverse Event|1|||
30569871|NCT04418765|58577662|FG001|Overall Study|Adverse Event|1|||
30569872|NCT04418765|58577663|FG002|Overall Study|Adverse Event|6|||
30569873|NCT04418765|58577661|FG000|Overall Study|Lack of Efficacy|1|||
30569874|NCT04418765|58577662|FG001|Overall Study|Lack of Efficacy|3|||
30569875|NCT04418765|58577663|FG002|Overall Study|Lack of Efficacy|0|||
30569876|NCT04418765|58577661|FG000|Overall Study|Protocol Violation|0|||
30569877|NCT04418765|58577662|FG001|Overall Study|Protocol Violation|1|||
30569878|NCT04418765|58577663|FG002|Overall Study|Protocol Violation|1|||
30569879|NCT04418765|58577661|FG000|Overall Study|Withdrawal by Subject|1|||
30569880|NCT04418765|58577662|FG001|Overall Study|Withdrawal by Subject|5|||
30569881|NCT04418765|58577663|FG002|Overall Study|Withdrawal by Subject|2|||
30569882|NCT04418765|58577661|FG000|Overall Study|Lost to Follow-up|0|||
30667325|NCT00517933|58681238|FG001|Period 1|Adverse Event|4|||
30667326|NCT00517933|58681237|FG000|Period 1|Lost to Follow-up|2|||
30569883|NCT04418765|58577662|FG001|Overall Study|Lost to Follow-up|1|||
30569884|NCT04418765|58577663|FG002|Overall Study|Lost to Follow-up|0|||
30569885|NCT04418765|58577661|FG000|Overall Study|Other than specified|2|||
30569886|NCT04418765|58577662|FG001|Overall Study|Other than specified|0|||
30569887|NCT04418765|58577663|FG002|Overall Study|Other than specified|1|||
30569888|NCT04418765|58577661|FG000|Overall Study|Randomized but not treated|1|||
30667327|NCT00517933|58681238|FG001|Period 1|Lost to Follow-up|0|||
30667328|NCT00517933|58681237|FG000|Period 1|Underwent lung transplant|0|||
30667329|NCT00517933|58681238|FG001|Period 1|Underwent lung transplant|1|||
30667330|NCT00517933|58681237|FG000|Period 2|Death|2|||
30569889|NCT04418765|58577662|FG001|Overall Study|Randomized but not treated|0|||
30569890|NCT04418765|58577663|FG002|Overall Study|Randomized but not treated|0|||
30569891|NCT04388826|58577673|FG000|Overall Study|Lost to Follow-up|3|||
30569892|NCT04388826|58577674|FG001|Overall Study|Lost to Follow-up|2|||
30569893|NCT04388826|58577673|FG000|Overall Study|Adverse Event|1|||
30569894|NCT04388826|58577674|FG001|Overall Study|Adverse Event|0|||
30569895|NCT04218266|58577696|FG000|Overall Study|Death|1|||
30569896|NCT04218266|58577697|FG001|Overall Study|Death|2|||
30569897|NCT04218266|58577698|FG002|Overall Study|Death|3|||
30569898|NCT04218266|58577696|FG000|Overall Study|Adverse Event|13|||
30569899|NCT04218266|58577697|FG001|Overall Study|Adverse Event|14|||
30569900|NCT04218266|58577698|FG002|Overall Study|Adverse Event|11|||
30569901|NCT04218266|58577696|FG000|Overall Study|Other|7|||
30569902|NCT04218266|58577697|FG001|Overall Study|Other|5|||
30569903|NCT04218266|58577698|FG002|Overall Study|Other|14|||
30569904|NCT04218266|58577696|FG000|Overall Study|Physician Decision|1|||
30569905|NCT04218266|58577697|FG001|Overall Study|Physician Decision|3|||
30569906|NCT04218266|58577698|FG002|Overall Study|Physician Decision|2|||
30569907|NCT04218266|58577696|FG000|Overall Study|Non-compliance with study drug|0|||
30569908|NCT04218266|58577697|FG001|Overall Study|Non-compliance with study drug|0|||
30667331|NCT00517933|58681238|FG001|Period 2|Death|4|||
30667332|NCT00517933|58681237|FG000|Period 2|Adverse Event|2|||
30667333|NCT00517933|58681238|FG001|Period 2|Adverse Event|4|||
30667334|NCT00517933|58681237|FG000|Period 2|Physician Decision|1|||
30667335|NCT00517933|58681238|FG001|Period 2|Physician Decision|0|||
30667336|NCT00517933|58681237|FG000|Period 2|Withdrawal by Subject|1|||
30667337|NCT00517933|58681238|FG001|Period 2|Withdrawal by Subject|3|||
30667338|NCT00517933|58681237|FG000|Period 2|Underwent lung transplant|0|||
30667339|NCT00517933|58681238|FG001|Period 2|Underwent lung transplant|2|||
30667340|NCT00701038|58681249|FG000|Overall Study|study amended pilot group of patients|4|||
30667341|NCT00701038|58681250|FG001|Overall Study|study amended pilot group of patients|4|||
30667342|NCT00857766|58681258|FG000|Overall Study|Adverse Event|13|||
30667343|NCT00857766|58681259|FG001|Overall Study|Adverse Event|12|||
30667344|NCT00857766|58681258|FG000|Overall Study|Protocol Violation|11|||
30667345|NCT00857766|58681259|FG001|Overall Study|Protocol Violation|11|||
30667346|NCT00857766|58681258|FG000|Overall Study|Lost to Follow-up|1|||
30667347|NCT00857766|58681259|FG001|Overall Study|Lost to Follow-up|0|||
30667348|NCT00857766|58681258|FG000|Overall Study|Investigator Discretion|2|||
30667349|NCT00857766|58681259|FG001|Overall Study|Investigator Discretion|3|||
30667350|NCT00857766|58681258|FG000|Overall Study|Participant Withdrew Consent|4|||
30667351|NCT00857766|58681259|FG001|Overall Study|Participant Withdrew Consent|4|||
30667352|NCT00517699|58681265|FG000|Overall Study|Withdrawal by Subject|1|||
30667353|NCT00517699|58681265|FG000|Overall Study|Lack of Efficacy|1|||
30667354|NCT00517699|58681265|FG000|Overall Study|Administrative error|1|||
30667355|NCT00517699|58681265|FG000|Overall Study|Study terminated by Sponsor|2|||
30667356|NCT00857454|58681269|FG000|Overall Study|Withdrawal by Subject|2|||
30667357|NCT00857454|58681269|FG000|Overall Study|Lost to Follow-up|1|||
30667358|NCT00857454|58681269|FG000|Overall Study|Adverse Event|2|||
30667359|NCT00857454|58681269|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
30667360|NCT00857454|58681269|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
30667361|NCT00857454|58681269|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
30667362|NCT00525031|58681275|FG000|Overall Study|Disease Progression|1|||
30667363|NCT00525031|58681276|FG001|Overall Study|Disease Progression|1|||
30667364|NCT00524485|58681283|FG000|Overall Study|Withdrawal by Subject|5|||
30667365|NCT00857220|58681287|FG000|Overall Study|Adverse Event|35|||
30667366|NCT00857220|58681287|FG000|Overall Study|Death|1|||
30667367|NCT00857220|58681287|FG000|Overall Study|Lack of Efficacy|11|||
30667368|NCT00857220|58681287|FG000|Overall Study|Lost to Follow-up|30|||
30667369|NCT00857220|58681287|FG000|Overall Study|Physician Decision|4|||
30667370|NCT00857220|58681287|FG000|Overall Study|Protocol Violation|16|||
30667371|NCT00857220|58681287|FG000|Overall Study|Withdrawal by Subject|67|||
30667372|NCT00857220|58681287|FG000|Overall Study|Clinical Hold|6|||
30667373|NCT00857220|58681287|FG000|Overall Study|Site Closed|5|||
30667374|NCT00857220|58681287|FG000|Overall Study|Miscellaneous|8|||
30569909|NCT04218266|58577698|FG002|Overall Study|Non-compliance with study drug|1|||
30667375|NCT00524173|58681293|FG000|Overall Study|Lost to Follow-up|0|||
30667376|NCT00524173|58681294|FG001|Overall Study|Lost to Follow-up|1|||
30569910|NCT04218266|58577696|FG000|Overall Study|Withdrawal by Subject|1|||
30667377|NCT00524173|58681293|FG000|Overall Study|Death|1|||
30667378|NCT00524173|58681294|FG001|Overall Study|Death|0|||
30569911|NCT04218266|58577697|FG001|Overall Study|Withdrawal by Subject|3|||
30569912|NCT04218266|58577698|FG002|Overall Study|Withdrawal by Subject|1|||
30667379|NCT00524173|58681293|FG000|Overall Study|Had not reached endpoint at study close|4|||
30667380|NCT00524173|58681294|FG001|Overall Study|Had not reached endpoint at study close|1|||
30667381|NCT00879710|58681302|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
30667382|NCT00879710|58681303|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
30667383|NCT00879710|58681304|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
30667384|NCT00879710|58681305|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
30667385|NCT00879710|58681302|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
30667386|NCT00879710|58681303|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
30667387|NCT00879710|58681304|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
30667388|NCT00879710|58681305|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
30667389|NCT00597506|58681313|FG000|Overall Study|Subject is being followed for survival|1|||
30667390|NCT00708682|58681326|FG000|Infant Series|Adverse Event|1|||
30667391|NCT00708682|58681326|FG000|Infant Series|Lost to Follow-up|4|||
30667392|NCT00708682|58681326|FG000|Infant Series|Protocol Violation|1|||
30667393|NCT00708682|58681326|FG000|Infant Series|Parent/legal guardian request|6|||
30667394|NCT00708682|58681326|FG000|Infant Series|Failed to return|2|||
30667395|NCT00708682|58681326|FG000|Infant Series|Other|19|||
30667396|NCT00708682|58681326|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
30667397|NCT00708682|58681326|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
30667398|NCT00708682|58681326|FG000|Toddler Dose|Lost to Follow-up|3|||
30667399|NCT00708682|58681326|FG000|Toddler Dose|Failed to Return|4|||
30667400|NCT00712348|58681332|FG000|Overall Study|Withdrawal by Subject|1|||
30667401|NCT00881504|58681336|FG000|Overall Study|Withdrawal by Subject|1|||
30667402|NCT01936831|58681349|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
30667403|NCT01936831|58681350|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
30667404|NCT01936831|58681351|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
30667405|NCT01936831|58681352|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
30667406|NCT01936831|58681353|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
30667407|NCT01936831|58681354|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
30667408|NCT01936831|58681355|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
30569913|NCT04218266|58577696|FG000|Overall Study|Study drug never administered|2|||
30569914|NCT04218266|58577697|FG001|Overall Study|Study drug never administered|0|||
30569915|NCT04218266|58577698|FG002|Overall Study|Study drug never administered|0|||
30569916|NCT03894904|58577720|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
30569917|NCT03894904|58577721|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
30569918|NCT03894904|58577720|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
30569919|NCT03894904|58577721|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
30569920|NCT03518086|58577738|FG000|Overall Study|Adverse Event|23|||
30569921|NCT03518086|58577739|FG001|Overall Study|Adverse Event|15|||
30569922|NCT03518086|58577740|FG002|Overall Study|Adverse Event|0|||
30569923|NCT03518086|58577741|FG003|Overall Study|Adverse Event|0|||
30569924|NCT03518086|58577738|FG000|Overall Study|Withdrawal by Subject|8|||
30569925|NCT03518086|58577739|FG001|Overall Study|Withdrawal by Subject|5|||
30569926|NCT03518086|58577740|FG002|Overall Study|Withdrawal by Subject|0|||
30569927|NCT03518086|58577741|FG003|Overall Study|Withdrawal by Subject|0|||
30569928|NCT03518086|58577738|FG000|Overall Study|Lack of Efficacy|5|||
30569929|NCT03518086|58577739|FG001|Overall Study|Lack of Efficacy|5|||
30569930|NCT03518086|58577740|FG002|Overall Study|Lack of Efficacy|0|||
30569931|NCT03518086|58577741|FG003|Overall Study|Lack of Efficacy|0|||
30569932|NCT03518086|58577738|FG000|Overall Study|Protocol Violation|1|||
30569933|NCT03518086|58577739|FG001|Overall Study|Protocol Violation|5|||
30569934|NCT03518086|58577740|FG002|Overall Study|Protocol Violation|0|||
30569935|NCT03518086|58577741|FG003|Overall Study|Protocol Violation|0|||
30569936|NCT03518086|58577738|FG000|Overall Study|Lost to Follow-up|0|||
30569937|NCT03518086|58577739|FG001|Overall Study|Lost to Follow-up|3|||
30569938|NCT03518086|58577740|FG002|Overall Study|Lost to Follow-up|0|||
30569939|NCT03518086|58577741|FG003|Overall Study|Lost to Follow-up|0|||
30569940|NCT03518086|58577738|FG000|Overall Study|Insufficient Diary Data|0|||
30569941|NCT03518086|58577739|FG001|Overall Study|Insufficient Diary Data|2|||
30569942|NCT03518086|58577740|FG002|Overall Study|Insufficient Diary Data|0|||
30569943|NCT03518086|58577741|FG003|Overall Study|Insufficient Diary Data|0|||
30569944|NCT03518086|58577738|FG000|Overall Study|Non- compliance to Protocol|0|||
30569945|NCT03518086|58577739|FG001|Overall Study|Non- compliance to Protocol|1|||
30569946|NCT03518086|58577740|FG002|Overall Study|Non- compliance to Protocol|0|||
30569947|NCT03518086|58577741|FG003|Overall Study|Non- compliance to Protocol|0|||
30569948|NCT03518086|58577738|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
30569949|NCT03518086|58577739|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
30569950|NCT03518086|58577740|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
30569951|NCT03518086|58577741|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
30569952|NCT03518086|58577738|FG000|Overall Study|Site Terminated by Sponsor|0|||
30569953|NCT03518086|58577739|FG001|Overall Study|Site Terminated by Sponsor|1|||
30569954|NCT03518086|58577740|FG002|Overall Study|Site Terminated by Sponsor|0|||
30569955|NCT03518086|58577741|FG003|Overall Study|Site Terminated by Sponsor|0|||
30569956|NCT03225287|58577756|FG000|Overall Study|Adverse Event|0|||
30569957|NCT03225287|58577757|FG001|Overall Study|Adverse Event|0|||
30569958|NCT03225287|58577758|FG002|Overall Study|Adverse Event|1|||
30569959|NCT03225287|58577756|FG000|Overall Study|Protocol non-compliance|0|||
30667409|NCT01936831|58681356|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
30569960|NCT03225287|58577757|FG001|Overall Study|Protocol non-compliance|0|||
30569961|NCT03225287|58577758|FG002|Overall Study|Protocol non-compliance|1|||
30667410|NCT01936831|58681357|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
30569962|NCT03225287|58577756|FG000|Overall Study|Subject withdraws consent|3|||
30569963|NCT03225287|58577757|FG001|Overall Study|Subject withdraws consent|0|||
30569964|NCT03225287|58577758|FG002|Overall Study|Subject withdraws consent|0|||
30569965|NCT03225287|58577756|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
30569966|NCT03225287|58577757|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
30569967|NCT03225287|58577758|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
30569968|NCT03225287|58577756|FG000|Overall Study|Trial drug not effective|0|||
30569969|NCT03225287|58577757|FG001|Overall Study|Trial drug not effective|1|||
30569970|NCT03225287|58577758|FG002|Overall Study|Trial drug not effective|0|||
30569971|NCT03225287|58577756|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
30569972|NCT03225287|58577757|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
30569973|NCT03225287|58577758|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
30569974|NCT03225287|58577756|FG000|Overall Study|Stem cell transplantation|0|||
30569975|NCT03225287|58577757|FG001|Overall Study|Stem cell transplantation|1|||
30569976|NCT03225287|58577758|FG002|Overall Study|Stem cell transplantation|0|||
30569977|NCT03099265|58577766|FG000|Overall Study|Adverse Event|1|||
30569978|NCT02658656|58577784|FG000|Screening|Failed eligibility criteria|0|||
30667411|NCT03863353|58681374|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
30667412|NCT03863353|58681375|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
30667413|NCT00523705|58681383|FG000|Overall Study|No time for study.|0|||
30667414|NCT00523705|58681384|FG001|Overall Study|No time for study.|1|||
30667415|NCT00523549|58681397|FG000|Overall Study|Adverse Event|6|||
30667416|NCT00523549|58681398|FG001|Overall Study|Adverse Event|3|||
30667417|NCT00523549|58681397|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30667418|NCT00523549|58681398|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30667419|NCT00523549|58681397|FG000|Overall Study|Protocol Deviation|3|||
30667420|NCT00523549|58681398|FG001|Overall Study|Protocol Deviation|1|||
30667421|NCT00523549|58681397|FG000|Overall Study|Patient withdrew consent|7|||
30667422|NCT00523549|58681398|FG001|Overall Study|Patient withdrew consent|6|||
30667423|NCT00523549|58681397|FG000|Overall Study|Lost to Follow-up|3|||
30667424|NCT00523549|58681398|FG001|Overall Study|Lost to Follow-up|5|||
30667425|NCT03504085|58681406|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
30667426|NCT03504085|58681407|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
30667427|NCT03504085|58681406|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
30667428|NCT03504085|58681407|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
30667429|NCT00700102|58681415|FG000|Overall Study|Died|394|||
30667430|NCT00700102|58681416|FG001|Overall Study|Died|385|||
30667431|NCT00700102|58681415|FG000|Overall Study|Lost to Follow-up|8|||
30667432|NCT00700102|58681416|FG001|Overall Study|Lost to Follow-up|10|||
30667433|NCT00595478|58681424|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
30667434|NCT00595478|58681425|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
30667435|NCT00595478|58681424|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
30667436|NCT00595478|58681425|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
30667437|NCT00516295|58681434|FG000|Overall Study|Lack of Efficacy|2|||
30667438|NCT00516295|58681435|FG001|Overall Study|Lack of Efficacy|0|||
30667439|NCT00516295|58681436|FG002|Overall Study|Lack of Efficacy|0|||
30667440|NCT00516295|58681434|FG000|Overall Study|Ineligible|1|||
30569979|NCT02658656|58577785|FG001|Screening|Failed eligibility criteria|0|||
30569980|NCT02658656|58577786|FG002|Screening|Failed eligibility criteria|263|||
30569981|NCT02658656|58577784|FG000|Randomization|Withdrawal by Subject|8|||
30569982|NCT02658656|58577785|FG001|Randomization|Withdrawal by Subject|7|||
30569983|NCT02658656|58577786|FG002|Randomization|Withdrawal by Subject|0|||
30569984|NCT02658656|58577784|FG000|Randomization|Lost to Follow-up|1|||
30569985|NCT02658656|58577785|FG001|Randomization|Lost to Follow-up|3|||
30667441|NCT00516295|58681435|FG001|Overall Study|Ineligible|0|||
30667442|NCT00516295|58681436|FG002|Overall Study|Ineligible|0|||
30667443|NCT03861559|58681446|FG000|Overall Study|Adverse Event|0|||
30667444|NCT03861559|58681447|FG001|Overall Study|Adverse Event|2|||
30667445|NCT03861559|58681446|FG000|Overall Study|Treatment failure|0|||
30667446|NCT03861559|58681447|FG001|Overall Study|Treatment failure|2|||
30667447|NCT03861559|58681446|FG000|Overall Study|Noncompliance|1|||
30667448|NCT03861559|58681447|FG001|Overall Study|Noncompliance|1|||
30569986|NCT02658656|58577786|FG002|Randomization|Lost to Follow-up|0|||
30667449|NCT03861559|58681446|FG000|Overall Study|Did not meet eligibility requirements|1|||
30667450|NCT03861559|58681447|FG001|Overall Study|Did not meet eligibility requirements|0|||
30667451|NCT00516139|58681453|FG000|Overall Study|Adverse Event|27|||
30667452|NCT00516139|58681453|FG000|Overall Study|Lost to Follow-up|1|||
30667453|NCT00516139|58681453|FG000|Overall Study|Protocol Violation|1|||
30667454|NCT00516139|58681453|FG000|Overall Study|Withdrawal by Subject|8|||
30569987|NCT02658656|58577784|FG000|Randomization|Adverse Event|4|||
30569988|NCT02658656|58577785|FG001|Randomization|Adverse Event|0|||
30569989|NCT02658656|58577786|FG002|Randomization|Adverse Event|0|||
30667455|NCT00516139|58681453|FG000|Overall Study|Lack of Efficacy|1|||
30667456|NCT00515827|58681463|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
30667457|NCT00515827|58681464|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
30667458|NCT00515827|58681463|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
30667459|NCT00515827|58681464|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
30667460|NCT00522457|58681472|FG000|Overall Study|Due to disease progression|16|||
30667461|NCT00522457|58681472|FG000|Overall Study|Adverse Event|2|||
30667462|NCT00856986|58681481|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
30667463|NCT00856986|58681482|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
30667464|NCT00856986|58681483|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
30667465|NCT00856986|58681484|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
30569990|NCT02658656|58577784|FG000|Randomization|Administrative Termination|3|||
30569991|NCT02658656|58577785|FG001|Randomization|Administrative Termination|1|||
30569992|NCT02658656|58577786|FG002|Randomization|Administrative Termination|0|||
30569993|NCT02658656|58577784|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
30569994|NCT02658656|58577785|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
30569995|NCT02658656|58577786|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
30569996|NCT02658656|58577784|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
30569997|NCT02658656|58577785|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
30569998|NCT02658656|58577786|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
30569999|NCT02658656|58577784|FG000|Randomization|Not eligible for Randomization|1|||
30570000|NCT02658656|58577785|FG001|Randomization|Not eligible for Randomization|0|||
30570001|NCT02658656|58577786|FG002|Randomization|Not eligible for Randomization|0|||
30570002|NCT02658656|58577784|FG000|Randomization|Protocol Violation|1|||
30570003|NCT02658656|58577785|FG001|Randomization|Protocol Violation|0|||
30570004|NCT02658656|58577786|FG002|Randomization|Protocol Violation|0|||
30570005|NCT05141175|58577844|FG000|Overall Study|Withdrawal by Subject|1|||
30570006|NCT04869345|58577850|FG000|Overall Study|Lost to Follow-up|8|||
30570007|NCT04869345|58577851|FG001|Overall Study|Lost to Follow-up|3|||
30570008|NCT03610737|58577923|FG000|Overall Study|Withdrawal by Subject|1|||
30570009|NCT03610737|58577924|FG001|Overall Study|Withdrawal by Subject|5|||
30570010|NCT03610737|58577923|FG000|Overall Study|Death|1|||
30570011|NCT03610737|58577924|FG001|Overall Study|Death|0|||
30570012|NCT03610737|58577923|FG000|Overall Study|Not treated|5|||
30570013|NCT03610737|58577924|FG001|Overall Study|Not treated|2|||
30570014|NCT03610737|58577923|FG000|Overall Study|Missed Visit|1|||
30570015|NCT03610737|58577924|FG001|Overall Study|Missed Visit|2|||
30570016|NCT03321929|58577934|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
30570017|NCT03250624|58577941|FG000|Overall Study|Lack of Efficacy|1|||
30570018|NCT03250624|58577942|FG001|Overall Study|Lack of Efficacy|4|||
30570019|NCT03250624|58577941|FG000|Overall Study|Adverse Event|0|||
30570020|NCT03250624|58577942|FG001|Overall Study|Adverse Event|1|||
30570021|NCT03250624|58577941|FG000|Overall Study|Other|1|||
30570022|NCT03250624|58577942|FG001|Overall Study|Other|2|||
30570023|NCT02507297|58577950|FG000|Overall Study|Withdrawal by Subject|1|||
30570024|NCT02507297|58577951|FG001|Overall Study|Withdrawal by Subject|0|||
30570025|NCT02507297|58577950|FG000|Overall Study|Lost to Follow-up|0|||
30570026|NCT02507297|58577951|FG001|Overall Study|Lost to Follow-up|1|||
30570027|NCT01333514|58577959|FG000|Overall Study|Withdrawal by Subject|1|||
30570028|NCT01333514|58577960|FG001|Overall Study|Withdrawal by Subject|0|||
30570029|NCT02066636|58577969|FG000|Overall Study|Disease progression|51|||
30570030|NCT02066636|58577970|FG001|Overall Study|Disease progression|60|||
30570031|NCT02066636|58577971|FG002|Overall Study|Disease progression|700|||
30570032|NCT02066636|58577969|FG000|Overall Study|Study drug toxicity|13|||
30570033|NCT02066636|58577970|FG001|Overall Study|Study drug toxicity|2|||
30570034|NCT02066636|58577971|FG002|Overall Study|Study drug toxicity|58|||
30570035|NCT02066636|58577969|FG000|Overall Study|Death|4|||
30570036|NCT02066636|58577970|FG001|Overall Study|Death|2|||
30570037|NCT02066636|58577971|FG002|Overall Study|Death|158|||
30570038|NCT02066636|58577969|FG000|Overall Study|Adverse event unrelated to study drug|6|||
30570039|NCT02066636|58577970|FG001|Overall Study|Adverse event unrelated to study drug|4|||
30570040|NCT02066636|58577971|FG002|Overall Study|Adverse event unrelated to study drug|45|||
30570041|NCT02066636|58577969|FG000|Overall Study|Participant request to discontinue treatment|12|||
30570042|NCT02066636|58577970|FG001|Overall Study|Participant request to discontinue treatment|12|||
30570043|NCT02066636|58577971|FG002|Overall Study|Participant request to discontinue treatment|70|||
30570044|NCT02066636|58577969|FG000|Overall Study|Participant withdrew consent|10|||
30570045|NCT02066636|58577970|FG001|Overall Study|Participant withdrew consent|18|||
30570046|NCT02066636|58577971|FG002|Overall Study|Participant withdrew consent|61|||
30570047|NCT02066636|58577969|FG000|Overall Study|Lost to Follow-up|0|||
30570048|NCT02066636|58577970|FG001|Overall Study|Lost to Follow-up|2|||
30570049|NCT02066636|58577971|FG002|Overall Study|Lost to Follow-up|2|||
30570050|NCT02066636|58577969|FG000|Overall Study|Maximum clinical benefit|2|||
30570051|NCT02066636|58577970|FG001|Overall Study|Maximum clinical benefit|2|||
30570052|NCT02066636|58577971|FG002|Overall Study|Maximum clinical benefit|3|||
30570053|NCT02066636|58577969|FG000|Overall Study|Poor/non-compliance|2|||
30570054|NCT02066636|58577970|FG001|Overall Study|Poor/non-compliance|1|||
30570055|NCT02066636|58577971|FG002|Overall Study|Poor/non-compliance|1|||
30780176|NCT02992132|58791858|FG002|Overall Study|Protocol Violation|0|||
30570056|NCT02066636|58577969|FG000|Overall Study|Participant no loner meets study criteria|3|||
30570057|NCT02066636|58577970|FG001|Overall Study|Participant no loner meets study criteria|2|||
30570058|NCT02066636|58577971|FG002|Overall Study|Participant no loner meets study criteria|28|||
30570059|NCT02066636|58577969|FG000|Overall Study|Administrative reasons by sponsor|8|||
30570060|NCT02066636|58577970|FG001|Overall Study|Administrative reasons by sponsor|5|||
30570061|NCT02066636|58577971|FG002|Overall Study|Administrative reasons by sponsor|0|||
30570062|NCT02066636|58577969|FG000|Overall Study|Other reasons|16|||
30570063|NCT02066636|58577970|FG001|Overall Study|Other reasons|15|||
30570064|NCT02066636|58577971|FG002|Overall Study|Other reasons|50|||
30570065|NCT01486264|58577983|FG000|Overall Study|Death|1|||
30570066|NCT01486264|58577984|FG001|Overall Study|Death|1|||
30570067|NCT01486264|58577983|FG000|Overall Study|Adverse Event|3|||
30570068|NCT01486264|58577984|FG001|Overall Study|Adverse Event|3|||
30570069|NCT01486264|58577983|FG000|Overall Study|Lack of Efficacy|6|||
30570070|NCT01486264|58577984|FG001|Overall Study|Lack of Efficacy|10|||
30570071|NCT01486264|58577983|FG000|Overall Study|Withdrawal by Subject|7|||
30570072|NCT01486264|58577984|FG001|Overall Study|Withdrawal by Subject|18|||
30570073|NCT01486264|58577983|FG000|Overall Study|Physician Decision|1|||
30570074|NCT01486264|58577984|FG001|Overall Study|Physician Decision|1|||
30570075|NCT01486264|58577983|FG000|Overall Study|Protocol Violation|3|||
30570076|NCT01486264|58577984|FG001|Overall Study|Protocol Violation|0|||
30570077|NCT01486264|58577983|FG000|Overall Study|Lost to Follow-up|3|||
30570078|NCT01486264|58577984|FG001|Overall Study|Lost to Follow-up|2|||
30570079|NCT01486264|58577983|FG000|Overall Study|Other|5|||
30570080|NCT01486264|58577984|FG001|Overall Study|Other|11|||
30570081|NCT01486264|58577983|FG000|Overall Study|Not treated|0|||
30570082|NCT01486264|58577984|FG001|Overall Study|Not treated|1|||
30570083|NCT01323270|58577992|FG000|Overall Study|Withdrawal by Subject|19|||
30570084|NCT01323270|58577993|FG001|Overall Study|Withdrawal by Subject|10|||
30570085|NCT01323270|58577992|FG000|Overall Study|Protocol Violation|9|||
30570086|NCT01323270|58577993|FG001|Overall Study|Protocol Violation|7|||
30570087|NCT01323270|58577992|FG000|Overall Study|Lost to Follow-up|4|||
30570088|NCT01323270|58577993|FG001|Overall Study|Lost to Follow-up|6|||
30570089|NCT01323270|58577992|FG000|Overall Study|Adverse Event|8|||
30570090|NCT01323270|58577993|FG001|Overall Study|Adverse Event|0|||
30570091|NCT01323270|58577992|FG000|Overall Study|Other|0|||
30570092|NCT01323270|58577993|FG001|Overall Study|Other|3|||
30570093|NCT01323270|58577992|FG000|Overall Study|Physician Decision|0|||
30570094|NCT01323270|58577993|FG001|Overall Study|Physician Decision|2|||
30570095|NCT01323270|58577992|FG000|Overall Study|Not eligible|1|||
30570096|NCT01323270|58577993|FG001|Overall Study|Not eligible|1|||
30570097|NCT01323270|58577992|FG000|Overall Study|Death|1|||
30570098|NCT01323270|58577993|FG001|Overall Study|Death|0|||
30570099|NCT01323270|58577992|FG000|Overall Study|Randomized, but not vaccinated|1|||
30570100|NCT01323270|58577993|FG001|Overall Study|Randomized, but not vaccinated|0|||
30570101|NCT01300728|58578002|FG000|Overall Study|Withdrawal by Subject|1|||
30570102|NCT01300728|58578003|FG001|Overall Study|Withdrawal by Subject|1|||
30570103|NCT01300728|58578002|FG000|Overall Study|Physician Decision|1|||
30570104|NCT01300728|58578003|FG001|Overall Study|Physician Decision|0|||
30570105|NCT01299480|58578014|FG000|Overall Study|No longer willing to participate|19|||
30570106|NCT01299480|58578015|FG001|Overall Study|No longer willing to participate|17|||
30570107|NCT01299480|58578016|FG002|Overall Study|No longer willing to participate|14|||
30570108|NCT01299480|58578017|FG003|Overall Study|No longer willing to participate|13|||
30570109|NCT01299480|58578018|FG004|Overall Study|No longer willing to participate|10|||
30570110|NCT01299480|58578014|FG000|Overall Study|Protocol Violation|7|||
30570111|NCT01299480|58578015|FG001|Overall Study|Protocol Violation|5|||
30570112|NCT01299480|58578016|FG002|Overall Study|Protocol Violation|8|||
30570113|NCT01299480|58578017|FG003|Overall Study|Protocol Violation|1|||
30855205|NCT01359644|58882743|FG001|Follow-up Period|Lost to Follow-up|0|||
30855206|NCT01359644|58882744|FG002|Follow-up Period|Lost to Follow-up|0|||
30855207|NCT01359644|58882745|FG003|Follow-up Period|Lost to Follow-up|0|||
30855208|NCT01359644|58882746|FG004|Follow-up Period|Lost to Follow-up|0|||
30855209|NCT01359644|58882747|FG005|Follow-up Period|Lost to Follow-up|0|||
30958649|NCT01694849|59023702|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
30570114|NCT01299480|58578018|FG004|Overall Study|Protocol Violation|1|||
30570115|NCT01299480|58578014|FG000|Overall Study|Withdrawal by Subject|3|||
30570116|NCT01299480|58578015|FG001|Overall Study|Withdrawal by Subject|4|||
30570117|NCT01299480|58578016|FG002|Overall Study|Withdrawal by Subject|7|||
30570118|NCT01299480|58578017|FG003|Overall Study|Withdrawal by Subject|3|||
30855210|NCT01359644|58882748|FG006|Follow-up Period|Lost to Follow-up|1|||
30855211|NCT01359644|58882749|FG007|Follow-up Period|Lost to Follow-up|2|||
30570119|NCT01299480|58578018|FG004|Overall Study|Withdrawal by Subject|4|||
30570120|NCT01299480|58578014|FG000|Overall Study|Adverse Event|6|||
30570121|NCT01299480|58578015|FG001|Overall Study|Adverse Event|4|||
30570122|NCT01299480|58578016|FG002|Overall Study|Adverse Event|5|||
30570123|NCT01299480|58578017|FG003|Overall Study|Adverse Event|4|||
30667466|NCT00856986|58681485|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
30570124|NCT01299480|58578018|FG004|Overall Study|Adverse Event|0|||
30855212|NCT01359644|58882750|FG008|Follow-up Period|Lost to Follow-up|0|||
30855213|NCT01359644|58882751|FG009|Follow-up Period|Lost to Follow-up|0|||
30855214|NCT02603120|58882786|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
30855215|NCT02603120|58882787|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
30855216|NCT02603120|58882786|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
30855217|NCT02603120|58882787|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
30855218|NCT02603120|58882786|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
30855219|NCT02603120|58882787|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
30855220|NCT02603120|58882786|FG000|Double-Blind Treatment Phase|Death|2|||
30855221|NCT02603120|58882787|FG001|Double-Blind Treatment Phase|Death|0|||
30570125|NCT01299480|58578014|FG000|Overall Study|Withdrawal due to pregnancy|0|||
30570126|NCT01299480|58578015|FG001|Overall Study|Withdrawal due to pregnancy|1|||
30570127|NCT01299480|58578016|FG002|Overall Study|Withdrawal due to pregnancy|1|||
30570128|NCT01299480|58578017|FG003|Overall Study|Withdrawal due to pregnancy|0|||
30570129|NCT01299480|58578018|FG004|Overall Study|Withdrawal due to pregnancy|0|||
30570130|NCT01299480|58578014|FG000|Overall Study|Physician Decision|1|||
30570131|NCT01299480|58578015|FG001|Overall Study|Physician Decision|1|||
30570132|NCT01299480|58578016|FG002|Overall Study|Physician Decision|0|||
30570133|NCT01299480|58578017|FG003|Overall Study|Physician Decision|2|||
30570134|NCT01299480|58578018|FG004|Overall Study|Physician Decision|0|||
30570135|NCT01299480|58578014|FG000|Overall Study|Lost to Follow-up|3|||
30570136|NCT01299480|58578015|FG001|Overall Study|Lost to Follow-up|1|||
30570137|NCT01299480|58578016|FG002|Overall Study|Lost to Follow-up|2|||
30570138|NCT01299480|58578017|FG003|Overall Study|Lost to Follow-up|1|||
30570139|NCT01299480|58578018|FG004|Overall Study|Lost to Follow-up|2|||
30570140|NCT01299480|58578014|FG000|Overall Study|Other|3|||
30570141|NCT01299480|58578015|FG001|Overall Study|Other|2|||
30570142|NCT01299480|58578016|FG002|Overall Study|Other|3|||
30570143|NCT01299480|58578017|FG003|Overall Study|Other|0|||
30570144|NCT01299480|58578018|FG004|Overall Study|Other|3|||
30570145|NCT01299480|58578014|FG000|Overall Study|Started, but not vaccinated|0|||
30570146|NCT01299480|58578015|FG001|Overall Study|Started, but not vaccinated|0|||
30855222|NCT02603120|58882786|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
30855223|NCT02603120|58882787|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
30855224|NCT02603120|58882786|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
30855225|NCT02603120|58882787|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
30570147|NCT01299480|58578016|FG002|Overall Study|Started, but not vaccinated|1|||
30570148|NCT01299480|58578017|FG003|Overall Study|Started, but not vaccinated|1|||
30570149|NCT01299480|58578018|FG004|Overall Study|Started, but not vaccinated|0|||
30570150|NCT04799405|58578040|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
30570151|NCT04688671|58578050|FG000|Overall Study|Adverse Event|3|||
30570152|NCT04688671|58578051|FG001|Overall Study|Adverse Event|1|||
30570153|NCT04688671|58578050|FG000|Overall Study|Withdrawal by Subject|3|||
30570154|NCT04688671|58578051|FG001|Overall Study|Withdrawal by Subject|1|||
30570155|NCT04688671|58578050|FG000|Overall Study|Lack of Efficacy|1|||
30570156|NCT04688671|58578051|FG001|Overall Study|Lack of Efficacy|1|||
30570157|NCT04688671|58578050|FG000|Overall Study|Protocol Violation|1|||
30570158|NCT04688671|58578051|FG001|Overall Study|Protocol Violation|0|||
30570159|NCT04688671|58578050|FG000|Overall Study|Lost to Follow-up|0|||
30570160|NCT04688671|58578051|FG001|Overall Study|Lost to Follow-up|1|||
30570161|NCT04529499|58578059|FG000|Overall Study|Withdrawal by Subject|9|||
30570162|NCT04529499|58578060|FG001|Overall Study|Withdrawal by Subject|11|||
30570163|NCT04529499|58578059|FG000|Overall Study|Physician Decision|1|||
30570164|NCT04529499|58578060|FG001|Overall Study|Physician Decision|2|||
30570165|NCT04529499|58578059|FG000|Overall Study|Adverse Event|4|||
30570166|NCT04529499|58578060|FG001|Overall Study|Adverse Event|4|||
30570167|NCT04529499|58578059|FG000|Overall Study|Death|14|||
30570168|NCT04529499|58578060|FG001|Overall Study|Death|11|||
30570169|NCT04529499|58578059|FG000|Overall Study|Lost to Follow-up|1|||
30667467|NCT00856986|58681481|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
30667468|NCT00856986|58681482|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
30855226|NCT02603120|58882786|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
30667469|NCT00856986|58681483|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
30855227|NCT02603120|58882787|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
30958650|NCT01694849|59023703|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
30570170|NCT04529499|58578060|FG001|Overall Study|Lost to Follow-up|1|||
30570171|NCT04529499|58578059|FG000|Overall Study|Others|7|||
30570172|NCT04529499|58578060|FG001|Overall Study|Others|11|||
30570173|NCT04501094|58578068|FG000|Overall Study|Death (unrelated to research)|1|||
30570174|NCT04501094|58578069|FG001|Overall Study|Death (unrelated to research)|0|||
30570175|NCT04414618|58578077|FG000|Overall Study|Death|3|||
30667470|NCT00856986|58681484|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
30667471|NCT00856986|58681485|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
30570176|NCT04414618|58578078|FG001|Overall Study|Death|3|||
30570177|NCT04414618|58578077|FG000|Overall Study|Withdrawal by Subject|2|||
30570178|NCT04414618|58578078|FG001|Overall Study|Withdrawal by Subject|1|||
30667472|NCT00856986|58681481|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
30667473|NCT00856986|58681482|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
30667474|NCT00856986|58681483|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
30667475|NCT00856986|58681484|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
30667476|NCT00856986|58681485|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
30667477|NCT00856986|58681481|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
30667478|NCT00856986|58681482|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
30570179|NCT04414618|58578077|FG000|Overall Study|Lost to Follow-up|2|||
30570180|NCT04414618|58578078|FG001|Overall Study|Lost to Follow-up|3|||
30667479|NCT00856986|58681483|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
30667480|NCT00856986|58681484|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
30667481|NCT00856986|58681485|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
30667482|NCT00856986|58681481|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
30570181|NCT04414618|58578077|FG000|Overall Study|Physician Decision|1|||
30570182|NCT04414618|58578078|FG001|Overall Study|Physician Decision|0|||
30570183|NCT04412057|58578087|FG000|Overall Study|Death|3|||
30570184|NCT04412057|58578088|FG001|Overall Study|Death|7|||
30570185|NCT04412057|58578087|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
30570186|NCT04412057|58578088|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
30570187|NCT04402060|58578097|FG000|Overall Study|Death|1|||
30570188|NCT04402060|58578098|FG001|Overall Study|Death|12|||
30570189|NCT04402060|58578099|FG002|Overall Study|Death|7|||
30570190|NCT04402060|58578097|FG000|Overall Study|Adverse Event|0|||
30667483|NCT00856986|58681482|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
30667484|NCT00856986|58681483|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
30667485|NCT00856986|58681484|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
30667486|NCT00856986|58681485|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
30667487|NCT00856986|58681481|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
30667488|NCT00856986|58681482|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
30667489|NCT00856986|58681483|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
30667490|NCT00856986|58681484|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
30667491|NCT00856986|58681485|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
30667492|NCT00856986|58681481|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
30667493|NCT00856986|58681482|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
30667494|NCT00856986|58681483|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
30667495|NCT00856986|58681484|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
30667496|NCT00856986|58681485|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
30667497|NCT00856986|58681481|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
30667498|NCT00856986|58681482|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
30667499|NCT00856986|58681483|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
30667500|NCT00856986|58681484|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
30667501|NCT00856986|58681485|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
30667502|NCT00856986|58681481|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
30667503|NCT00856986|58681482|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
30667504|NCT00856986|58681483|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
30667505|NCT00856986|58681484|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
30667506|NCT00856986|58681485|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
30667507|NCT00856986|58681481|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
30667508|NCT00856986|58681482|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
30667509|NCT00856986|58681483|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
30667510|NCT00856986|58681484|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
30667511|NCT00856986|58681485|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
30780177|NCT02992132|58791856|FG000|Overall Study|Caregiver withdrew consent|2|||
30780178|NCT02992132|58791857|FG001|Overall Study|Caregiver withdrew consent|3|||
30780179|NCT02992132|58791858|FG002|Overall Study|Caregiver withdrew consent|2|||
30780180|NCT02992132|58791856|FG000|Overall Study|Withdrawal by Subject|0|||
30780181|NCT02992132|58791857|FG001|Overall Study|Withdrawal by Subject|2|||
30780182|NCT02992132|58791858|FG002|Overall Study|Withdrawal by Subject|1|||
30780183|NCT02992132|58791856|FG000|Overall Study|Physician Decision|0|||
30570191|NCT04402060|58578098|FG001|Overall Study|Adverse Event|0|||
30570192|NCT04402060|58578099|FG002|Overall Study|Adverse Event|1|||
30667512|NCT00856986|58681481|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
30667513|NCT00856986|58681482|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
30667514|NCT00856986|58681483|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
30667515|NCT00856986|58681484|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
30667516|NCT00856986|58681485|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
30667517|NCT00856986|58681481|FG000|Main Period, Weeks 0-26|Unclassified|7|||
30570193|NCT04402060|58578097|FG000|Overall Study|Withdrawal by Subject|0|||
30570194|NCT04402060|58578098|FG001|Overall Study|Withdrawal by Subject|1|||
30780184|NCT02992132|58791857|FG001|Overall Study|Physician Decision|0|||
30780185|NCT02992132|58791858|FG002|Overall Study|Physician Decision|1|||
30780186|NCT03444584|58791868|FG000|Overall Study|Withdrawal by Subject|0|||
30570195|NCT04402060|58578099|FG002|Overall Study|Withdrawal by Subject|2|||
30570196|NCT04402060|58578097|FG000|Overall Study|Sponsor Request|0|||
30667518|NCT00856986|58681482|FG001|Main Period, Weeks 0-26|Unclassified|6|||
30667519|NCT00856986|58681483|FG002|Main Period, Weeks 0-26|Unclassified|7|||
30667520|NCT00856986|58681484|FG003|Main Period, Weeks 0-26|Unclassified|0|||
30667521|NCT00856986|58681485|FG004|Main Period, Weeks 0-26|Unclassified|0|||
30667522|NCT00856986|58681481|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
30667523|NCT00856986|58681482|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
30667524|NCT00856986|58681483|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
30667525|NCT00856986|58681484|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
30667526|NCT00856986|58681485|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
30667527|NCT00856986|58681481|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
30667528|NCT00856986|58681482|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
30667529|NCT00856986|58681483|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
30667530|NCT00856986|58681484|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
30667531|NCT00856986|58681485|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
30667532|NCT00856986|58681481|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
30667533|NCT00856986|58681482|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
30667534|NCT00856986|58681483|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
30667535|NCT00856986|58681484|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
30667536|NCT00856986|58681485|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
30667537|NCT00856986|58681481|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
30667538|NCT00856986|58681482|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
30667539|NCT00856986|58681483|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
30667540|NCT00856986|58681484|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
30667541|NCT00856986|58681485|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
30667542|NCT00856986|58681481|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
30667543|NCT00856986|58681482|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
30667544|NCT00856986|58681483|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
30667545|NCT00856986|58681484|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
30667546|NCT00856986|58681485|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
30667547|NCT00856986|58681481|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
30667548|NCT00856986|58681482|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
30667549|NCT00856986|58681483|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
30667550|NCT00856986|58681484|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
30570197|NCT04402060|58578098|FG001|Overall Study|Sponsor Request|2|||
30570198|NCT04402060|58578099|FG002|Overall Study|Sponsor Request|0|||
30570199|NCT04402060|58578097|FG000|Overall Study|Physician Decision|0|||
30570200|NCT04402060|58578098|FG001|Overall Study|Physician Decision|0|||
30570201|NCT04402060|58578099|FG002|Overall Study|Physician Decision|1|||
30570202|NCT04402060|58578097|FG000|Overall Study|Other|0|||
30667551|NCT00856986|58681485|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
30667552|NCT00707746|58681499|FG000|Treatment Period|Adverse Event|2|||
30667553|NCT00707746|58681500|FG001|Treatment Period|Adverse Event|4|||
30667554|NCT00707746|58681499|FG000|Treatment Period|Ineligibility|0|||
30855228|NCT02603120|58882786|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
30570203|NCT04402060|58578098|FG001|Overall Study|Other|1|||
30570204|NCT04402060|58578099|FG002|Overall Study|Other|0|||
30570205|NCT04376684|58578134|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
30570206|NCT04376684|58578135|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
30570207|NCT04376684|58578136|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
30570208|NCT04376684|58578137|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
30570209|NCT04376684|58578134|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
30570210|NCT04376684|58578135|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
30570211|NCT04376684|58578136|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
30570212|NCT04376684|58578137|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
30570213|NCT04376684|58578134|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
30570214|NCT04376684|58578135|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
30570215|NCT04376684|58578136|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
30570216|NCT04376684|58578137|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
30570217|NCT04376684|58578134|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
30570218|NCT04376684|58578135|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
30667555|NCT00707746|58681500|FG001|Treatment Period|Ineligibility|1|||
30667556|NCT00856908|58681508|FG000|Overall Study|Lost to Follow-up|1|||
30667557|NCT00856908|58681509|FG001|Overall Study|Lost to Follow-up|0|||
30667558|NCT00522379|58681520|FG000|Overall Study|Adverse Event|12|||
30667559|NCT00522379|58681521|FG001|Overall Study|Adverse Event|15|||
30667560|NCT00522379|58681522|FG002|Overall Study|Adverse Event|12|||
30667561|NCT00522379|58681523|FG003|Overall Study|Adverse Event|5|||
30667562|NCT00522379|58681524|FG004|Overall Study|Adverse Event|17|||
30667563|NCT00522379|58681520|FG000|Overall Study|Lack of Efficacy|3|||
30667564|NCT00522379|58681521|FG001|Overall Study|Lack of Efficacy|0|||
30667565|NCT00522379|58681522|FG002|Overall Study|Lack of Efficacy|2|||
30570219|NCT04376684|58578136|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
30570220|NCT04376684|58578137|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
30570221|NCT04376684|58578134|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
30667566|NCT00522379|58681523|FG003|Overall Study|Lack of Efficacy|2|||
30667567|NCT00522379|58681524|FG004|Overall Study|Lack of Efficacy|7|||
30667568|NCT00522379|58681520|FG000|Overall Study|Withdrawal by Subject|2|||
30667569|NCT00522379|58681521|FG001|Overall Study|Withdrawal by Subject|3|||
30667570|NCT00522379|58681522|FG002|Overall Study|Withdrawal by Subject|1|||
30667571|NCT00522379|58681523|FG003|Overall Study|Withdrawal by Subject|2|||
30667572|NCT00522379|58681524|FG004|Overall Study|Withdrawal by Subject|0|||
30667573|NCT00522379|58681520|FG000|Overall Study|Protocol Violation|1|||
30667574|NCT00522379|58681521|FG001|Overall Study|Protocol Violation|1|||
30667575|NCT00522379|58681522|FG002|Overall Study|Protocol Violation|2|||
30667576|NCT00522379|58681523|FG003|Overall Study|Protocol Violation|0|||
30667577|NCT00522379|58681524|FG004|Overall Study|Protocol Violation|0|||
30667578|NCT00522379|58681520|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
30667579|NCT00522379|58681521|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
30667580|NCT00522379|58681522|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
30667581|NCT00522379|58681523|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
30667582|NCT00522379|58681524|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
30667583|NCT00522379|58681520|FG000|Overall Study|Lost to Follow-up|1|||
30667584|NCT00522379|58681521|FG001|Overall Study|Lost to Follow-up|0|||
30667585|NCT00522379|58681522|FG002|Overall Study|Lost to Follow-up|4|||
30667586|NCT00522379|58681523|FG003|Overall Study|Lost to Follow-up|2|||
30667587|NCT00522379|58681524|FG004|Overall Study|Lost to Follow-up|2|||
30667588|NCT00522379|58681520|FG000|Overall Study|Randomization error|0|||
30667589|NCT00522379|58681521|FG001|Overall Study|Randomization error|0|||
30667590|NCT00522379|58681522|FG002|Overall Study|Randomization error|0|||
30667591|NCT00522379|58681523|FG003|Overall Study|Randomization error|0|||
30667592|NCT00522379|58681524|FG004|Overall Study|Randomization error|1|||
30667593|NCT00522379|58681520|FG000|Overall Study|Dispensing error|1|||
30667594|NCT00522379|58681521|FG001|Overall Study|Dispensing error|0|||
30667595|NCT00522379|58681522|FG002|Overall Study|Dispensing error|0|||
30667596|NCT00522379|58681523|FG003|Overall Study|Dispensing error|1|||
30667597|NCT00522379|58681524|FG004|Overall Study|Dispensing error|0|||
30667598|NCT00522379|58681520|FG000|Overall Study|Subject Moved|1|||
30667599|NCT00522379|58681521|FG001|Overall Study|Subject Moved|1|||
30667600|NCT00522379|58681522|FG002|Overall Study|Subject Moved|0|||
30667601|NCT00522379|58681523|FG003|Overall Study|Subject Moved|0|||
30667602|NCT00522379|58681524|FG004|Overall Study|Subject Moved|0|||
30667603|NCT00522379|58681520|FG000|Overall Study|Sponsor Request|0|||
30667604|NCT00522379|58681521|FG001|Overall Study|Sponsor Request|1|||
30667605|NCT00522379|58681522|FG002|Overall Study|Sponsor Request|0|||
30667606|NCT00522379|58681523|FG003|Overall Study|Sponsor Request|0|||
30667607|NCT00522379|58681524|FG004|Overall Study|Sponsor Request|0|||
30667608|NCT00522379|58681520|FG000|Overall Study|Family Problem|0|||
30667609|NCT00522379|58681521|FG001|Overall Study|Family Problem|0|||
30667610|NCT00522379|58681522|FG002|Overall Study|Family Problem|1|||
30667611|NCT00522379|58681523|FG003|Overall Study|Family Problem|0|||
30667612|NCT00522379|58681524|FG004|Overall Study|Family Problem|0|||
30667613|NCT00522379|58681520|FG000|Overall Study|Site Closed|0|||
30667614|NCT00522379|58681521|FG001|Overall Study|Site Closed|0|||
30667615|NCT00522379|58681522|FG002|Overall Study|Site Closed|0|||
30667616|NCT00522379|58681523|FG003|Overall Study|Site Closed|1|||
30667617|NCT00522379|58681524|FG004|Overall Study|Site Closed|0|||
30667618|NCT00522379|58681520|FG000|Overall Study|Subject Withdrawal|0|||
30667619|NCT00522379|58681521|FG001|Overall Study|Subject Withdrawal|0|||
30667620|NCT00522379|58681522|FG002|Overall Study|Subject Withdrawal|0|||
30667621|NCT00522379|58681523|FG003|Overall Study|Subject Withdrawal|1|||
30667622|NCT00522379|58681524|FG004|Overall Study|Subject Withdrawal|0|||
30667623|NCT00856830|58681540|FG000|Irinotecan & Bendamustine|Death|0|||
30667624|NCT00856830|58681541|FG001|Irinotecan & Bendamustine|Death|0|||
30667625|NCT00856830|58681542|FG002|Irinotecan & Bendamustine|Death|0|||
30667626|NCT00856830|58681543|FG003|Irinotecan & Bendamustine|Death|2|||
30667627|NCT00856830|58681540|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
30667628|NCT00856830|58681541|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
30667629|NCT00856830|58681542|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
30570222|NCT04376684|58578135|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
30570223|NCT04376684|58578136|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
30667630|NCT00856830|58681543|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
30667631|NCT00522301|58681548|FG000|Overall Study|Withdrawal by Subject|1|||
30667632|NCT00522301|58681548|FG000|Overall Study|Adverse Event|5|||
30667633|NCT00863928|58681554|FG000|Overall Study|Protocol Violation|26|||
30667634|NCT00863928|58681555|FG001|Overall Study|Protocol Violation|0|||
30667635|NCT00863928|58681554|FG000|Overall Study|Withdrawal by Subject|3|||
30667636|NCT00863928|58681555|FG001|Overall Study|Withdrawal by Subject|0|||
30667637|NCT00863928|58681554|FG000|Overall Study|surgery cancellation|4|||
30667638|NCT00863928|58681555|FG001|Overall Study|surgery cancellation|0|||
30667639|NCT00863928|58681554|FG000|Overall Study|medication allergy|3|||
30667640|NCT00863928|58681555|FG001|Overall Study|medication allergy|0|||
30667641|NCT00856518|58681563|FG000|Overall Study|Lost to Follow-up|4|||
30667642|NCT00856518|58681564|FG001|Overall Study|Lost to Follow-up|2|||
30667643|NCT00506389|58681575|FG000|In-treatment Period|Other|3|||
30667644|NCT00506389|58681576|FG001|In-treatment Period|Other|3|||
30667645|NCT00506389|58681577|FG002|In-treatment Period|Other|4|||
30667646|NCT00506389|58681575|FG000|In-treatment Period|Lost to Follow-up|0|||
30667647|NCT00506389|58681576|FG001|In-treatment Period|Lost to Follow-up|0|||
30667648|NCT00506389|58681577|FG002|In-treatment Period|Lost to Follow-up|1|||
30667649|NCT00506389|58681575|FG000|In-treatment Period|Lack of compliance|1|||
30667650|NCT00506389|58681576|FG001|In-treatment Period|Lack of compliance|0|||
30667651|NCT00506389|58681577|FG002|In-treatment Period|Lack of compliance|0|||
30667652|NCT00506389|58681575|FG000|In-treatment Period|Reasons not related to trial|4|||
30667653|NCT00506389|58681576|FG001|In-treatment Period|Reasons not related to trial|1|||
30667654|NCT00506389|58681577|FG002|In-treatment Period|Reasons not related to trial|0|||
30667655|NCT00506389|58681575|FG000|In-treatment Period|Withdrawal by Subject|3|||
30570224|NCT04376684|58578137|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
30570225|NCT04376684|58578134|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
30570226|NCT04376684|58578135|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
30667656|NCT00506389|58681576|FG001|In-treatment Period|Withdrawal by Subject|3|||
30667657|NCT00506389|58681577|FG002|In-treatment Period|Withdrawal by Subject|4|||
30667658|NCT00506389|58681575|FG000|In-treatment Period|Lack of Efficacy|0|||
30667659|NCT00506389|58681576|FG001|In-treatment Period|Lack of Efficacy|2|||
30667660|NCT00506389|58681577|FG002|In-treatment Period|Lack of Efficacy|0|||
30667661|NCT00506389|58681575|FG000|In-treatment Period|Adverse Event|11|||
30667662|NCT00506389|58681576|FG001|In-treatment Period|Adverse Event|5|||
30667663|NCT00506389|58681577|FG002|In-treatment Period|Adverse Event|2|||
30667664|NCT00506389|58681575|FG000|In-treatment Period|Randomized but not treated|4|||
30667665|NCT00506389|58681576|FG001|In-treatment Period|Randomized but not treated|1|||
30667666|NCT00506389|58681577|FG002|In-treatment Period|Randomized but not treated|1|||
30667667|NCT00871338|58681590|FG000|Prior to Booster|Withdrawal by Subject|1|||
30667668|NCT00871338|58681591|FG001|Prior to Booster|Withdrawal by Subject|3|||
30667669|NCT00871338|58681590|FG000|Prior to Booster|Lost to Follow-up|1|||
30667670|NCT00871338|58681591|FG001|Prior to Booster|Lost to Follow-up|0|||
30667671|NCT00824421|58681600|FG000|Overall Study|Adverse Event|6|||
30667672|NCT00824421|58681601|FG001|Overall Study|Adverse Event|6|||
30667673|NCT00824421|58681602|FG002|Overall Study|Adverse Event|6|||
30667674|NCT00824421|58681600|FG000|Overall Study|Death|0|||
30780187|NCT03444584|58791869|FG001|Overall Study|Withdrawal by Subject|1|||
30780188|NCT03444584|58791868|FG000|Overall Study|Other|0|||
30780189|NCT03444584|58791869|FG001|Overall Study|Other|1|||
30780190|NCT02989168|58791878|FG000|Overall Study|Withdrawal by Subject|2|||
30780191|NCT02989168|58791879|FG001|Overall Study|Withdrawal by Subject|0|||
30780192|NCT02989168|58791878|FG000|Overall Study|Physician Decision|0|||
30780193|NCT02989168|58791879|FG001|Overall Study|Physician Decision|1|||
30780194|NCT02989168|58791878|FG000|Overall Study|Adverse Event|1|||
30855229|NCT02603120|58882787|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
30667675|NCT00824421|58681601|FG001|Overall Study|Death|1|||
30667676|NCT00824421|58681602|FG002|Overall Study|Death|0|||
30667677|NCT00824421|58681600|FG000|Overall Study|Lack of Efficacy|5|||
30667678|NCT00824421|58681601|FG001|Overall Study|Lack of Efficacy|7|||
30667679|NCT00824421|58681602|FG002|Overall Study|Lack of Efficacy|4|||
30667680|NCT00824421|58681600|FG000|Overall Study|Lost to Follow-up|2|||
30667681|NCT00824421|58681601|FG001|Overall Study|Lost to Follow-up|3|||
30667682|NCT00824421|58681602|FG002|Overall Study|Lost to Follow-up|0|||
30667683|NCT00824421|58681600|FG000|Overall Study|Pregnancy|1|||
30667684|NCT00824421|58681601|FG001|Overall Study|Pregnancy|0|||
30667685|NCT00824421|58681602|FG002|Overall Study|Pregnancy|1|||
30667686|NCT00824421|58681600|FG000|Overall Study|Withdrawal by Subject|2|||
30667687|NCT00824421|58681601|FG001|Overall Study|Withdrawal by Subject|3|||
30855230|NCT02603120|58882786|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
30855231|NCT02603120|58882787|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
30570227|NCT04376684|58578136|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
30667688|NCT00824421|58681602|FG002|Overall Study|Withdrawal by Subject|3|||
30667689|NCT00824421|58681600|FG000|Overall Study|Randomized but not Treated|1|||
30667690|NCT00824421|58681601|FG001|Overall Study|Randomized but not Treated|1|||
30667691|NCT00824421|58681602|FG002|Overall Study|Randomized but not Treated|0|||
30667692|NCT00824421|58681600|FG000|Overall Study|Other|0|||
30667693|NCT00824421|58681601|FG001|Overall Study|Other|1|||
30780195|NCT02989168|58791879|FG001|Overall Study|Adverse Event|2|||
30780196|NCT02989168|58791878|FG000|Overall Study|Sponsor stopped study.|1|||
30780197|NCT02989168|58791879|FG001|Overall Study|Sponsor stopped study.|0|||
30855232|NCT02603120|58882786|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
30667694|NCT00824421|58681602|FG002|Overall Study|Other|0|||
30667695|NCT00514813|58681616|FG000|Overall Study|Study terminated|14|||
30780198|NCT02988622|58791887|FG000|Overall Study|Lost to Follow-up|17|||
30780199|NCT03412604|58791893|FG000|Overall Study|Withdrawal by Subject|1|||
30780200|NCT02991430|58791900|FG000|Treatment Period 1|Adverse Event|1|||
30667696|NCT00514813|58681617|FG001|Overall Study|Study terminated|74|||
30667697|NCT00514813|58681618|FG002|Overall Study|Study terminated|40|||
30780201|NCT02991430|58791901|FG001|Treatment Period 1|Adverse Event|0|||
30570228|NCT04376684|58578137|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
30570229|NCT04376684|58578134|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
30570230|NCT04376684|58578135|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
30570231|NCT04376684|58578136|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
30570232|NCT04376684|58578137|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
30570233|NCT04353284|58578149|FG000|Overall Study|Adverse Event|1|||
30570234|NCT04353284|58578150|FG001|Overall Study|Adverse Event|1|||
30570235|NCT04353284|58578149|FG000|Overall Study|Lost to Follow-up|1|||
30570236|NCT04353284|58578150|FG001|Overall Study|Lost to Follow-up|0|||
30570237|NCT04294147|58578158|FG000|Overall Study|Protocol Violation|2|||
30570238|NCT04294147|58578159|FG001|Overall Study|Protocol Violation|0|||
30570239|NCT04231825|58578171|FG000|Overall Study|Protocol Violation|3|||
30570240|NCT04231825|58578172|FG001|Overall Study|Protocol Violation|3|||
30570241|NCT04231825|58578171|FG000|Overall Study|Lost to Follow-up|0|||
30570242|NCT04231825|58578172|FG001|Overall Study|Lost to Follow-up|1|||
30570243|NCT04178772|58578178|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
30570244|NCT04178772|58578178|FG000|Overall Study|study terminated early due to COVID-19|7|||
30570245|NCT04148651|58578182|FG000|Overall Study|Lost to Follow-up|2|||
30570246|NCT03924427|58578195|FG000|Overall Study|Adverse Event|4|||
30570247|NCT03924427|58578195|FG000|Overall Study|Lack of Efficacy|1|||
30570248|NCT03924427|58578195|FG000|Overall Study|Withdrawal by Subject|1|||
30570249|NCT03642132|58578233|FG000|Chemotherapy Period|Adverse Event|1|||
30570250|NCT03642132|58578234|FG001|Chemotherapy Period|Adverse Event|1|||
30570251|NCT03642132|58578235|FG002|Chemotherapy Period|Adverse Event|0|||
30570252|NCT03642132|58578233|FG000|Chemotherapy Period|Physician's decision|4|||
30570253|NCT03642132|58578234|FG001|Chemotherapy Period|Physician's decision|1|||
30570254|NCT03642132|58578235|FG002|Chemotherapy Period|Physician's decision|0|||
30570255|NCT03642132|58578233|FG000|Chemotherapy Period|Progressive disease|0|||
30570256|NCT03642132|58578234|FG001|Chemotherapy Period|Progressive disease|0|||
30570257|NCT03642132|58578235|FG002|Chemotherapy Period|Progressive disease|1|||
30570258|NCT03642132|58578233|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
30570259|NCT03642132|58578234|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
30570260|NCT03642132|58578235|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
30570261|NCT03642132|58578233|FG000|Chemotherapy Period|Other|1|||
30570262|NCT03642132|58578234|FG001|Chemotherapy Period|Other|0|||
30570263|NCT03642132|58578235|FG002|Chemotherapy Period|Other|2|||
30570264|NCT03642132|58578233|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
30570265|NCT03642132|58578234|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
30570266|NCT03642132|58578235|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
30570267|NCT03642132|58578233|FG000|Maintenance Period|Adverse Event|1|||
30570268|NCT03642132|58578234|FG001|Maintenance Period|Adverse Event|2|||
30570269|NCT03642132|58578235|FG002|Maintenance Period|Adverse Event|0|||
30570270|NCT03642132|58578233|FG000|Maintenance Period|Non-compliance with study drug|0|||
30570271|NCT03642132|58578234|FG001|Maintenance Period|Non-compliance with study drug|0|||
30570272|NCT03642132|58578235|FG002|Maintenance Period|Non-compliance with study drug|1|||
30570273|NCT03642132|58578233|FG000|Maintenance Period|Physician's decision|2|||
30570274|NCT03642132|58578234|FG001|Maintenance Period|Physician's decision|2|||
30570275|NCT03642132|58578235|FG002|Maintenance Period|Physician's decision|2|||
30570276|NCT03642132|58578233|FG000|Maintenance Period|Progressive disease|9|||
30570277|NCT03642132|58578234|FG001|Maintenance Period|Progressive disease|3|||
30570278|NCT03642132|58578235|FG002|Maintenance Period|Progressive disease|6|||
30570279|NCT03642132|58578233|FG000|Maintenance Period|Other|0|||
30570280|NCT03642132|58578234|FG001|Maintenance Period|Other|0|||
30570281|NCT03642132|58578235|FG002|Maintenance Period|Other|3|||
30570282|NCT03642132|58578233|FG000|Maintenance Period|Withdrawal by Subject|1|||
30570283|NCT03642132|58578234|FG001|Maintenance Period|Withdrawal by Subject|1|||
30570284|NCT03642132|58578235|FG002|Maintenance Period|Withdrawal by Subject|2|||
30570285|NCT03642132|58578233|FG000|Follow-up Period|Other|0|||
30570286|NCT03642132|58578234|FG001|Follow-up Period|Other|0|||
30570287|NCT03642132|58578235|FG002|Follow-up Period|Other|1|||
30570288|NCT03642132|58578233|FG000|Follow-up Period|Withdrawal by Subject|1|||
30570289|NCT03642132|58578234|FG001|Follow-up Period|Withdrawal by Subject|2|||
30570290|NCT03642132|58578235|FG002|Follow-up Period|Withdrawal by Subject|0|||
30570291|NCT03642132|58578233|FG000|Follow-up Period|Study terminated by sponsor|1|||
30570292|NCT03642132|58578234|FG001|Follow-up Period|Study terminated by sponsor|0|||
30570293|NCT03642132|58578235|FG002|Follow-up Period|Study terminated by sponsor|1|||
30570294|NCT03642132|58578233|FG000|Follow-up Period|Lack of Efficacy|1|||
30570295|NCT03642132|58578234|FG001|Follow-up Period|Lack of Efficacy|0|||
30570296|NCT03642132|58578235|FG002|Follow-up Period|Lack of Efficacy|0|||
30570297|NCT03642132|58578233|FG000|Follow-up Period|Death|1|||
30570298|NCT03642132|58578234|FG001|Follow-up Period|Death|0|||
30667698|NCT00514813|58681619|FG003|Overall Study|Study terminated|2|||
30570299|NCT03642132|58578235|FG002|Follow-up Period|Death|2|||
30667699|NCT00514813|58681616|FG000|Overall Study|Adverse Event|0|||
30570300|NCT03642132|58578233|FG000|Follow-up Period|Adverse Event|1|||
30570301|NCT03642132|58578234|FG001|Follow-up Period|Adverse Event|0|||
30570302|NCT03642132|58578235|FG002|Follow-up Period|Adverse Event|0|||
30667700|NCT00514813|58681617|FG001|Overall Study|Adverse Event|2|||
30570303|NCT03008122|58578250|FG000|Overall Study|Physician Decision|3|||
30570304|NCT03008122|58578251|FG001|Overall Study|Physician Decision|2|||
30570305|NCT03008122|58578252|FG002|Overall Study|Physician Decision|0|||
30570306|NCT03008122|58578250|FG000|Overall Study|Withdrawal by Subject|1|||
30570307|NCT03008122|58578251|FG001|Overall Study|Withdrawal by Subject|3|||
30570308|NCT03008122|58578252|FG002|Overall Study|Withdrawal by Subject|0|||
30570309|NCT03008122|58578250|FG000|Overall Study|Lost to Follow-up|4|||
30570310|NCT03008122|58578251|FG001|Overall Study|Lost to Follow-up|8|||
30570311|NCT03008122|58578252|FG002|Overall Study|Lost to Follow-up|3|||
30570312|NCT03008122|58578250|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
30570313|NCT03008122|58578251|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
30570314|NCT03008122|58578252|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
30570315|NCT03008122|58578250|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
30570316|NCT03008122|58578251|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
30570317|NCT03008122|58578252|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
30570318|NCT03008122|58578250|FG000|Overall Study|Death|0|||
30570319|NCT03008122|58578251|FG001|Overall Study|Death|0|||
30570320|NCT03008122|58578252|FG002|Overall Study|Death|1|||
30570321|NCT02003924|58578291|FG000|Double-blind Phase|Lost to Follow-up|2|||
30570322|NCT02003924|58578292|FG001|Double-blind Phase|Lost to Follow-up|1|||
30570323|NCT02003924|58578293|FG002|Double-blind Phase|Lost to Follow-up|0|||
30570324|NCT02003924|58578291|FG000|Double-blind Phase|Protocol Violation|1|||
30570325|NCT02003924|58578292|FG001|Double-blind Phase|Protocol Violation|2|||
30570326|NCT02003924|58578293|FG002|Double-blind Phase|Protocol Violation|0|||
30570327|NCT02003924|58578291|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
30570328|NCT02003924|58578292|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
30570329|NCT02003924|58578293|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
30570330|NCT02003924|58578291|FG000|Double-blind Phase|Disease Progression|229|||
30570331|NCT02003924|58578292|FG001|Double-blind Phase|Disease Progression|247|||
30570332|NCT02003924|58578293|FG002|Double-blind Phase|Disease Progression|0|||
30570333|NCT02003924|58578291|FG000|Double-blind Phase|Adverse Event|120|||
30570334|NCT02003924|58578292|FG001|Double-blind Phase|Adverse Event|31|||
30570335|NCT02003924|58578293|FG002|Double-blind Phase|Adverse Event|0|||
30570336|NCT02003924|58578291|FG000|Double-blind Phase|Randomized But not Treated|3|||
30570337|NCT02003924|58578292|FG001|Double-blind Phase|Randomized But not Treated|3|||
30570338|NCT02003924|58578293|FG002|Double-blind Phase|Randomized But not Treated|0|||
30570339|NCT02003924|58578291|FG000|Double-blind Phase|Other|29|||
30570340|NCT02003924|58578292|FG001|Double-blind Phase|Other|50|||
30570341|NCT02003924|58578293|FG002|Double-blind Phase|Other|0|||
30570342|NCT02003924|58578291|FG000|Open-label Phase|Lost to Follow-up|0|||
30570343|NCT02003924|58578292|FG001|Open-label Phase|Lost to Follow-up|0|||
30570344|NCT02003924|58578293|FG002|Open-label Phase|Lost to Follow-up|1|||
30570345|NCT02003924|58578291|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
30570346|NCT02003924|58578292|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
30570347|NCT02003924|58578293|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
30570348|NCT02003924|58578291|FG000|Open-label Phase|Disease Progression|59|||
30570349|NCT02003924|58578292|FG001|Open-label Phase|Disease Progression|0|||
30570350|NCT02003924|58578293|FG002|Open-label Phase|Disease Progression|5|||
30570351|NCT02003924|58578291|FG000|Open-label Phase|Adverse Event|25|||
30570352|NCT02003924|58578292|FG001|Open-label Phase|Adverse Event|0|||
30570353|NCT02003924|58578293|FG002|Open-label Phase|Adverse Event|10|||
30570354|NCT02003924|58578291|FG000|Open-label Phase|Other|7|||
30570355|NCT02003924|58578292|FG001|Open-label Phase|Other|0|||
30570356|NCT02003924|58578293|FG002|Open-label Phase|Other|0|||
30570357|NCT02003924|58578291|FG000|Long-term Follow-up Phase|Death|288|||
30570358|NCT02003924|58578292|FG001|Long-term Follow-up Phase|Death|174|||
30570359|NCT02003924|58578293|FG002|Long-term Follow-up Phase|Death|4|||
30570360|NCT02003924|58578291|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
30570361|NCT02003924|58578292|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
30570362|NCT02003924|58578293|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
30570363|NCT02003924|58578291|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
30570364|NCT02003924|58578292|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
30570365|NCT02003924|58578293|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
30570366|NCT02003924|58578291|FG000|Long-term Follow-up Phase|Other|5|||
30570367|NCT02003924|58578292|FG001|Long-term Follow-up Phase|Other|2|||
30570368|NCT02003924|58578293|FG002|Long-term Follow-up Phase|Other|1|||
30570369|NCT01817751|58578305|FG000|Overall Study|Physician Decision|1|||
30570370|NCT01349322|58578321|FG000|Overall Study|Protocol Violation|45|||
30570371|NCT01349322|58578322|FG001|Overall Study|Protocol Violation|47|||
30570372|NCT01182415|58578334|FG000|Overall Study|Lost to Follow-up|1|||
30570373|NCT01030523|58578340|FG000|Initial Study (5 Years)|Death|1|||
30570374|NCT01030523|58578341|FG001|Initial Study (5 Years)|Death|0|||
30570375|NCT01030523|58578340|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
30570376|NCT01030523|58578341|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
30570377|NCT01030523|58578340|FG000|Initial Study (5 Years)|Implant failure|1|||
30570378|NCT01030523|58578341|FG001|Initial Study (5 Years)|Implant failure|0|||
30570379|NCT01030523|58578340|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
30570380|NCT01030523|58578341|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
30570381|NCT01030523|58578340|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
30570382|NCT01030523|58578341|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
30570383|NCT01030523|58578340|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
30570384|NCT01030523|58578341|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
30570385|NCT03811574|58578380|FG000|Overall Study|Withdrawal by Subject|2|||
30570386|NCT03811574|58578381|FG001|Overall Study|Withdrawal by Subject|4|||
30570387|NCT03811574|58578382|FG002|Overall Study|Withdrawal by Subject|0|||
30570388|NCT03727750|58578405|FG000|Overall Study|Death|45|||
30570389|NCT03727750|58578405|FG000|Overall Study|Withdrawal by Subject|2|||
30570390|NCT03727750|58578405|FG000|Overall Study|Lost to Follow-up|1|||
30570391|NCT03727750|58578405|FG000|Overall Study|Other|1|||
30570392|NCT03715829|58578415|FG000|Dose Ranging Period|Adverse Event|2|||
30570393|NCT03715829|58578416|FG001|Dose Ranging Period|Adverse Event|4|||
30570394|NCT03715829|58578417|FG002|Dose Ranging Period|Adverse Event|5|||
30570395|NCT03715829|58578418|FG003|Dose Ranging Period|Adverse Event|2|||
30570396|NCT03715829|58578419|FG004|Dose Ranging Period|Adverse Event|3|||
30570397|NCT03715829|58578420|FG005|Dose Ranging Period|Adverse Event|3|||
30570398|NCT03715829|58578421|FG006|Dose Ranging Period|Adverse Event|0|||
30570399|NCT03715829|58578422|FG007|Dose Ranging Period|Adverse Event|0|||
30570400|NCT03715829|58578423|FG008|Dose Ranging Period|Adverse Event|0|||
30570401|NCT03715829|58578424|FG009|Dose Ranging Period|Adverse Event|0|||
30570402|NCT03715829|58578425|FG010|Dose Ranging Period|Adverse Event|0|||
30570403|NCT03715829|58578415|FG000|Dose Ranging Period|Lack of Efficacy|0|||
30570404|NCT03715829|58578416|FG001|Dose Ranging Period|Lack of Efficacy|1|||
30570405|NCT03715829|58578417|FG002|Dose Ranging Period|Lack of Efficacy|0|||
30570406|NCT03715829|58578418|FG003|Dose Ranging Period|Lack of Efficacy|1|||
30570407|NCT03715829|58578419|FG004|Dose Ranging Period|Lack of Efficacy|0|||
30570408|NCT03715829|58578420|FG005|Dose Ranging Period|Lack of Efficacy|0|||
30570409|NCT03715829|58578421|FG006|Dose Ranging Period|Lack of Efficacy|0|||
30570410|NCT03715829|58578422|FG007|Dose Ranging Period|Lack of Efficacy|0|||
30570411|NCT03715829|58578423|FG008|Dose Ranging Period|Lack of Efficacy|0|||
30570412|NCT03715829|58578424|FG009|Dose Ranging Period|Lack of Efficacy|0|||
30570413|NCT03715829|58578425|FG010|Dose Ranging Period|Lack of Efficacy|0|||
30570414|NCT03715829|58578415|FG000|Dose Ranging Period|Lost to Follow-up|2|||
30570415|NCT03715829|58578416|FG001|Dose Ranging Period|Lost to Follow-up|0|||
30570416|NCT03715829|58578417|FG002|Dose Ranging Period|Lost to Follow-up|1|||
30570417|NCT03715829|58578418|FG003|Dose Ranging Period|Lost to Follow-up|1|||
30570418|NCT03715829|58578419|FG004|Dose Ranging Period|Lost to Follow-up|1|||
30570419|NCT03715829|58578420|FG005|Dose Ranging Period|Lost to Follow-up|2|||
30570420|NCT03715829|58578421|FG006|Dose Ranging Period|Lost to Follow-up|0|||
30570421|NCT03715829|58578422|FG007|Dose Ranging Period|Lost to Follow-up|0|||
30570422|NCT03715829|58578423|FG008|Dose Ranging Period|Lost to Follow-up|0|||
30570423|NCT03715829|58578424|FG009|Dose Ranging Period|Lost to Follow-up|0|||
30570424|NCT03715829|58578425|FG010|Dose Ranging Period|Lost to Follow-up|0|||
30570425|NCT03715829|58578415|FG000|Dose Ranging Period|Protocol Violation|0|||
30570426|NCT03715829|58578416|FG001|Dose Ranging Period|Protocol Violation|0|||
30570427|NCT03715829|58578417|FG002|Dose Ranging Period|Protocol Violation|0|||
30570428|NCT03715829|58578418|FG003|Dose Ranging Period|Protocol Violation|1|||
30570429|NCT03715829|58578419|FG004|Dose Ranging Period|Protocol Violation|0|||
30570430|NCT03715829|58578420|FG005|Dose Ranging Period|Protocol Violation|0|||
30570431|NCT03715829|58578421|FG006|Dose Ranging Period|Protocol Violation|0|||
30570432|NCT03715829|58578422|FG007|Dose Ranging Period|Protocol Violation|0|||
30570433|NCT03715829|58578423|FG008|Dose Ranging Period|Protocol Violation|0|||
30570434|NCT03715829|58578424|FG009|Dose Ranging Period|Protocol Violation|0|||
30570435|NCT03715829|58578425|FG010|Dose Ranging Period|Protocol Violation|0|||
30570436|NCT03715829|58578415|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
30570437|NCT03715829|58578416|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
30570438|NCT03715829|58578417|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
30570439|NCT03715829|58578418|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
30570440|NCT03715829|58578419|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
30570441|NCT03715829|58578420|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
30570442|NCT03715829|58578421|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
30570443|NCT03715829|58578422|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
30570444|NCT03715829|58578423|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
30570445|NCT03715829|58578424|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
30570446|NCT03715829|58578425|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
30570447|NCT03715829|58578415|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
30570448|NCT03715829|58578416|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
30570449|NCT03715829|58578417|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
30570450|NCT03715829|58578418|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
30570451|NCT03715829|58578419|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
30570452|NCT03715829|58578420|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
30570453|NCT03715829|58578421|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
30570454|NCT03715829|58578422|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
30570455|NCT03715829|58578423|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
30570456|NCT03715829|58578424|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
30570457|NCT03715829|58578425|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
30570458|NCT03715829|58578415|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
30570459|NCT03715829|58578416|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
30570460|NCT03715829|58578417|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
30570461|NCT03715829|58578418|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
30570462|NCT03715829|58578419|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
30570463|NCT03715829|58578420|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
30570464|NCT03715829|58578421|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
30570465|NCT03715829|58578422|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
30570466|NCT03715829|58578423|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
30570467|NCT03715829|58578424|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
30570468|NCT03715829|58578425|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
30570469|NCT03715829|58578415|FG000|Dose Ranging Period|Other|0|||
30570470|NCT03715829|58578416|FG001|Dose Ranging Period|Other|0|||
30570471|NCT03715829|58578417|FG002|Dose Ranging Period|Other|2|||
30570472|NCT03715829|58578418|FG003|Dose Ranging Period|Other|0|||
30570473|NCT03715829|58578419|FG004|Dose Ranging Period|Other|0|||
30570474|NCT03715829|58578420|FG005|Dose Ranging Period|Other|3|||
30570475|NCT03715829|58578421|FG006|Dose Ranging Period|Other|0|||
30570476|NCT03715829|58578422|FG007|Dose Ranging Period|Other|0|||
30570477|NCT03715829|58578423|FG008|Dose Ranging Period|Other|0|||
30570478|NCT03715829|58578424|FG009|Dose Ranging Period|Other|0|||
30570479|NCT03715829|58578425|FG010|Dose Ranging Period|Other|0|||
30570480|NCT03715829|58578415|FG000|Extension Period|Adverse Event|0|||
30570481|NCT03715829|58578416|FG001|Extension Period|Adverse Event|0|||
30570482|NCT03715829|58578417|FG002|Extension Period|Adverse Event|0|||
30570483|NCT03715829|58578418|FG003|Extension Period|Adverse Event|0|||
30570484|NCT03715829|58578419|FG004|Extension Period|Adverse Event|0|||
30570485|NCT03715829|58578420|FG005|Extension Period|Adverse Event|0|||
30570486|NCT03715829|58578421|FG006|Extension Period|Adverse Event|3|||
30570487|NCT03715829|58578422|FG007|Extension Period|Adverse Event|1|||
30570488|NCT03715829|58578423|FG008|Extension Period|Adverse Event|6|||
30570489|NCT03715829|58578424|FG009|Extension Period|Adverse Event|0|||
30570490|NCT03715829|58578425|FG010|Extension Period|Adverse Event|0|||
30570491|NCT03715829|58578415|FG000|Extension Period|Lack of Efficacy|0|||
30570492|NCT03715829|58578416|FG001|Extension Period|Lack of Efficacy|0|||
30570493|NCT03715829|58578417|FG002|Extension Period|Lack of Efficacy|0|||
30570494|NCT03715829|58578418|FG003|Extension Period|Lack of Efficacy|0|||
30570495|NCT03715829|58578419|FG004|Extension Period|Lack of Efficacy|0|||
30570496|NCT03715829|58578420|FG005|Extension Period|Lack of Efficacy|0|||
30570497|NCT03715829|58578421|FG006|Extension Period|Lack of Efficacy|1|||
30570498|NCT03715829|58578422|FG007|Extension Period|Lack of Efficacy|9|||
30570499|NCT03715829|58578423|FG008|Extension Period|Lack of Efficacy|2|||
30570500|NCT03715829|58578424|FG009|Extension Period|Lack of Efficacy|0|||
30570501|NCT03715829|58578425|FG010|Extension Period|Lack of Efficacy|0|||
30570502|NCT03715829|58578415|FG000|Extension Period|Lost to Follow-up|0|||
30570503|NCT03715829|58578416|FG001|Extension Period|Lost to Follow-up|0|||
30570504|NCT03715829|58578417|FG002|Extension Period|Lost to Follow-up|0|||
30570505|NCT03715829|58578418|FG003|Extension Period|Lost to Follow-up|0|||
30570506|NCT03715829|58578419|FG004|Extension Period|Lost to Follow-up|0|||
30570507|NCT03715829|58578420|FG005|Extension Period|Lost to Follow-up|0|||
30570508|NCT03715829|58578421|FG006|Extension Period|Lost to Follow-up|0|||
30570509|NCT03715829|58578422|FG007|Extension Period|Lost to Follow-up|0|||
30570510|NCT03715829|58578423|FG008|Extension Period|Lost to Follow-up|2|||
30570511|NCT03715829|58578424|FG009|Extension Period|Lost to Follow-up|0|||
30570512|NCT03715829|58578425|FG010|Extension Period|Lost to Follow-up|0|||
30570513|NCT03715829|58578415|FG000|Extension Period|Protocol Violation|0|||
30570514|NCT03715829|58578416|FG001|Extension Period|Protocol Violation|0|||
30570515|NCT03715829|58578417|FG002|Extension Period|Protocol Violation|0|||
30570516|NCT03715829|58578418|FG003|Extension Period|Protocol Violation|0|||
30570517|NCT03715829|58578419|FG004|Extension Period|Protocol Violation|0|||
30570518|NCT03715829|58578420|FG005|Extension Period|Protocol Violation|0|||
30570519|NCT03715829|58578421|FG006|Extension Period|Protocol Violation|0|||
30570520|NCT03715829|58578422|FG007|Extension Period|Protocol Violation|0|||
30570521|NCT03715829|58578423|FG008|Extension Period|Protocol Violation|1|||
30570522|NCT03715829|58578424|FG009|Extension Period|Protocol Violation|0|||
30570523|NCT03715829|58578425|FG010|Extension Period|Protocol Violation|0|||
30570524|NCT03715829|58578415|FG000|Extension Period|Withdrawal by Subject|0|||
30570525|NCT03715829|58578416|FG001|Extension Period|Withdrawal by Subject|0|||
30570526|NCT03715829|58578417|FG002|Extension Period|Withdrawal by Subject|0|||
30570527|NCT03715829|58578418|FG003|Extension Period|Withdrawal by Subject|0|||
30570528|NCT03715829|58578419|FG004|Extension Period|Withdrawal by Subject|0|||
30570529|NCT03715829|58578420|FG005|Extension Period|Withdrawal by Subject|0|||
30570530|NCT03715829|58578421|FG006|Extension Period|Withdrawal by Subject|3|||
30570531|NCT03715829|58578422|FG007|Extension Period|Withdrawal by Subject|3|||
30570532|NCT03715829|58578423|FG008|Extension Period|Withdrawal by Subject|12|||
30570533|NCT03715829|58578424|FG009|Extension Period|Withdrawal by Subject|3|||
30570534|NCT03715829|58578425|FG010|Extension Period|Withdrawal by Subject|0|||
30570535|NCT03715829|58578415|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
30570536|NCT03715829|58578416|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
30570537|NCT03715829|58578417|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
30570538|NCT03715829|58578418|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
30570539|NCT03715829|58578419|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
30570540|NCT03715829|58578420|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
30570541|NCT03715829|58578421|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
30570542|NCT03715829|58578422|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
30570543|NCT03715829|58578423|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
30570544|NCT03715829|58578424|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
30570545|NCT03715829|58578425|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
30570546|NCT03715829|58578415|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
30570547|NCT03715829|58578416|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
30570548|NCT03715829|58578417|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
30570549|NCT03715829|58578418|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
30570550|NCT03715829|58578419|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
30570551|NCT03715829|58578420|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
30570552|NCT03715829|58578421|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
30570553|NCT03715829|58578422|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
30570554|NCT03715829|58578423|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
30570555|NCT03715829|58578424|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
30570556|NCT03715829|58578425|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
30570557|NCT03715829|58578415|FG000|Extension Period|Other|0|||
30570558|NCT03715829|58578416|FG001|Extension Period|Other|0|||
30570559|NCT03715829|58578417|FG002|Extension Period|Other|0|||
30570560|NCT03715829|58578418|FG003|Extension Period|Other|0|||
30570561|NCT03715829|58578419|FG004|Extension Period|Other|0|||
30570562|NCT03715829|58578420|FG005|Extension Period|Other|0|||
30570563|NCT03715829|58578421|FG006|Extension Period|Other|1|||
30570564|NCT03715829|58578422|FG007|Extension Period|Other|2|||
30570565|NCT03715829|58578423|FG008|Extension Period|Other|4|||
30570566|NCT03715829|58578424|FG009|Extension Period|Other|0|||
30570567|NCT03715829|58578425|FG010|Extension Period|Other|0|||
30570568|NCT03575104|58578487|FG000|Overall Study|Adverse Event|4|||
30570569|NCT03575104|58578488|FG001|Overall Study|Adverse Event|3|||
30570570|NCT03575104|58578489|FG002|Overall Study|Adverse Event|4|||
30570571|NCT03575104|58578487|FG000|Overall Study|Withdrawal by Subject|13|||
30570572|NCT03575104|58578488|FG001|Overall Study|Withdrawal by Subject|16|||
30570573|NCT03575104|58578489|FG002|Overall Study|Withdrawal by Subject|11|||
30570574|NCT03575104|58578487|FG000|Overall Study|Other reasons|6|||
30570575|NCT03575104|58578488|FG001|Overall Study|Other reasons|8|||
30570576|NCT03575104|58578489|FG002|Overall Study|Other reasons|6|||
30570577|NCT03575104|58578487|FG000|Overall Study|Lost to Follow-up|1|||
30570578|NCT03575104|58578488|FG001|Overall Study|Lost to Follow-up|2|||
30570579|NCT03575104|58578489|FG002|Overall Study|Lost to Follow-up|1|||
30570580|NCT03569475|58578500|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
30570581|NCT03569475|58578501|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
30570582|NCT03569475|58578502|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
30570583|NCT03569475|58578500|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
30570584|NCT03569475|58578501|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
30570585|NCT03569475|58578502|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
30570586|NCT03569475|58578500|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
30570587|NCT03569475|58578501|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
30570588|NCT03569475|58578502|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
30780202|NCT02991430|58791902|FG002|Treatment Period 1|Adverse Event|2|||
30570589|NCT03569475|58578500|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
30570590|NCT03569475|58578501|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
30570591|NCT03569475|58578502|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
30570592|NCT03569475|58578500|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
30780203|NCT02991430|58791900|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30780204|NCT02991430|58791901|FG001|Treatment Period 1|Withdrawal by Subject|4|||
30667701|NCT00514813|58681618|FG002|Overall Study|Adverse Event|2|||
30570593|NCT03569475|58578501|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
30570594|NCT03569475|58578502|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
30570595|NCT03569475|58578500|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
30570596|NCT03569475|58578501|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
30570597|NCT03569475|58578502|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
30570598|NCT03569475|58578500|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
30570599|NCT03569475|58578501|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
30570600|NCT03569475|58578502|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
30570601|NCT03569475|58578500|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
30570602|NCT03569475|58578501|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
30570603|NCT03569475|58578502|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
30570604|NCT03569475|58578500|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
30570605|NCT03569475|58578501|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
30570606|NCT03569475|58578502|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
30570607|NCT03545191|58578556|FG000|Overall Study|Death|1|||
30570608|NCT03545191|58578557|FG001|Overall Study|Death|0|||
30570609|NCT03545191|58578558|FG002|Overall Study|Death|0|||
30570610|NCT03545191|58578556|FG000|Overall Study|Adverse Event|4|||
30570611|NCT03545191|58578557|FG001|Overall Study|Adverse Event|2|||
30570612|NCT03545191|58578558|FG002|Overall Study|Adverse Event|7|||
30570613|NCT03545191|58578556|FG000|Overall Study|Other reasons|3|||
30570614|NCT03545191|58578557|FG001|Overall Study|Other reasons|11|||
30570615|NCT03545191|58578558|FG002|Overall Study|Other reasons|8|||
30570616|NCT03545191|58578556|FG000|Overall Study|Withdrawal by Subject|13|||
30570617|NCT03545191|58578557|FG001|Overall Study|Withdrawal by Subject|10|||
30570618|NCT03545191|58578558|FG002|Overall Study|Withdrawal by Subject|12|||
30570619|NCT03545191|58578556|FG000|Overall Study|Lost to Follow-up|1|||
30570620|NCT03545191|58578557|FG001|Overall Study|Lost to Follow-up|2|||
30570621|NCT03545191|58578558|FG002|Overall Study|Lost to Follow-up|3|||
30570622|NCT03500549|58578568|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
30570623|NCT03500549|58578569|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
30667702|NCT00514813|58681619|FG003|Overall Study|Adverse Event|0|||
30667703|NCT00514813|58681616|FG000|Overall Study|Protocol Violation|1|||
30667704|NCT00514813|58681617|FG001|Overall Study|Protocol Violation|0|||
30667705|NCT00514813|58681618|FG002|Overall Study|Protocol Violation|0|||
30667706|NCT00514813|58681619|FG003|Overall Study|Protocol Violation|0|||
30667707|NCT00514813|58681616|FG000|Overall Study|Withdrawal by Subject|0|||
30667708|NCT00514813|58681617|FG001|Overall Study|Withdrawal by Subject|1|||
30667709|NCT00514813|58681618|FG002|Overall Study|Withdrawal by Subject|0|||
30667710|NCT00514813|58681619|FG003|Overall Study|Withdrawal by Subject|0|||
30667711|NCT00514813|58681616|FG000|Overall Study|Lack of Efficacy|0|||
30667712|NCT00514813|58681617|FG001|Overall Study|Lack of Efficacy|1|||
30667713|NCT00514813|58681618|FG002|Overall Study|Lack of Efficacy|0|||
30667714|NCT00514813|58681619|FG003|Overall Study|Lack of Efficacy|0|||
30667715|NCT00514813|58681616|FG000|Overall Study|Kidney transplant|0|||
30667716|NCT00514813|58681617|FG001|Overall Study|Kidney transplant|6|||
30667717|NCT00514813|58681618|FG002|Overall Study|Kidney transplant|2|||
30667718|NCT00514813|58681619|FG003|Overall Study|Kidney transplant|0|||
30667719|NCT00514813|58681616|FG000|Overall Study|Death|0|||
30667720|NCT00514813|58681617|FG001|Overall Study|Death|2|||
30667721|NCT00514813|58681618|FG002|Overall Study|Death|3|||
30667722|NCT00514813|58681619|FG003|Overall Study|Death|2|||
30667723|NCT00597116|58681631|FG000|Overall Study|Adverse Event|2|||
30667724|NCT00597116|58681632|FG001|Overall Study|Adverse Event|1|||
30667725|NCT00597116|58681631|FG000|Overall Study|Withdrawal by Subject|0|||
30667726|NCT00597116|58681632|FG001|Overall Study|Withdrawal by Subject|2|||
30667727|NCT00597116|58681631|FG000|Overall Study|Physician Decision|0|||
30667728|NCT00597116|58681632|FG001|Overall Study|Physician Decision|1|||
30667729|NCT00597116|58681631|FG000|Overall Study|Death|0|||
30667730|NCT00597116|58681632|FG001|Overall Study|Death|1|||
30667731|NCT00597116|58681631|FG000|Overall Study|Lost to Follow-up|1|||
30667732|NCT00597116|58681632|FG001|Overall Study|Lost to Follow-up|0|||
30667733|NCT00597116|58681631|FG000|Overall Study|Progressive disease|11|||
30667734|NCT00597116|58681632|FG001|Overall Study|Progressive disease|6|||
30667735|NCT00514735|58681640|FG000|Overall Study|Withdrawal by Subject|13|||
30667736|NCT00514735|58681641|FG001|Overall Study|Withdrawal by Subject|5|||
30667737|NCT00514735|58681640|FG000|Overall Study|Death|1|||
30667738|NCT00514735|58681641|FG001|Overall Study|Death|0|||
30667739|NCT00514735|58681640|FG000|Overall Study|Lost to Follow-up|0|||
30667740|NCT00514735|58681641|FG001|Overall Study|Lost to Follow-up|1|||
30570624|NCT03500549|58578568|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
30667741|NCT03252587|58681653|FG000|Overall Study|Adverse Event|3|||
30667742|NCT03252587|58681654|FG001|Overall Study|Adverse Event|8|||
30667743|NCT03252587|58681655|FG002|Overall Study|Adverse Event|6|||
30667744|NCT03252587|58681656|FG003|Overall Study|Adverse Event|12|||
30667745|NCT03252587|58681653|FG000|Overall Study|Lack of Efficacy|7|||
30570625|NCT03500549|58578569|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
30570626|NCT03366792|58578589|FG000|Overall Study|Withdrawal by Subject|7|||
30570627|NCT03366792|58578589|FG000|Overall Study|Lost to Follow-up|2|||
30570628|NCT03366792|58578589|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
30570629|NCT03366792|58578589|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
30570630|NCT03366337|58578597|FG000|Overall Study|Lost to Follow-up|1|||
30570631|NCT03366337|58578598|FG001|Overall Study|Lost to Follow-up|0|||
30570632|NCT03366337|58578599|FG002|Overall Study|Lost to Follow-up|1|||
30570633|NCT03366337|58578600|FG003|Overall Study|Lost to Follow-up|0|||
30570634|NCT03366337|58578597|FG000|Overall Study|Withdrawal by Subject|2|||
30570635|NCT03366337|58578598|FG001|Overall Study|Withdrawal by Subject|0|||
30570636|NCT03366337|58578599|FG002|Overall Study|Withdrawal by Subject|1|||
30570637|NCT03366337|58578600|FG003|Overall Study|Withdrawal by Subject|1|||
30570638|NCT03342053|58578612|FG000|Overall Study|Adverse Event|2|||
30570639|NCT03342053|58578613|FG001|Overall Study|Adverse Event|0|||
30570640|NCT03342053|58578612|FG000|Overall Study|Withdrawal by Subject|0|||
30570641|NCT03342053|58578613|FG001|Overall Study|Withdrawal by Subject|1|||
30570642|NCT03325777|58578621|FG000|Overall Study|Lost to Follow-up|9|||
30570643|NCT03325777|58578622|FG001|Overall Study|Lost to Follow-up|12|||
30570644|NCT03283241|58578630|FG000|Overall Study|Adverse Event|4|||
30570645|NCT03283241|58578631|FG001|Overall Study|Adverse Event|1|||
30570646|NCT03283241|58578630|FG000|Overall Study|Withdrawal by Subject|0|||
30570647|NCT03283241|58578631|FG001|Overall Study|Withdrawal by Subject|1|||
30570648|NCT03283241|58578630|FG000|Overall Study|Subject relocated to Finland|0|||
30570649|NCT03283241|58578631|FG001|Overall Study|Subject relocated to Finland|1|||
30570650|NCT03242772|58578639|FG000|Overall Study|Lost to Follow-up|2|||
30570651|NCT03242772|58578640|FG001|Overall Study|Lost to Follow-up|0|||
30570652|NCT03242772|58578639|FG000|Overall Study|Physician Decision|0|||
30570653|NCT03242772|58578640|FG001|Overall Study|Physician Decision|1|||
30570654|NCT03242772|58578639|FG000|Overall Study|Withdrawal by Subject|1|||
30570655|NCT03242772|58578640|FG001|Overall Study|Withdrawal by Subject|0|||
30570656|NCT03236311|58578648|FG000|Overall Study|Study terminated by sponsor|0|||
30570657|NCT03236311|58578649|FG001|Overall Study|Study terminated by sponsor|2|||
30570658|NCT03236311|58578648|FG000|Overall Study|Adverse Event|0|||
30570659|NCT03236311|58578649|FG001|Overall Study|Adverse Event|1|||
30570660|NCT03192046|58578657|FG000|Overall Study|Withdrawal by Subject|1|||
30570661|NCT03192046|58578658|FG001|Overall Study|Withdrawal by Subject|1|||
30570662|NCT03190369|58578666|FG000|Overall Study|Poor compliance to protocol|0|||
30570663|NCT03190369|58578667|FG001|Overall Study|Poor compliance to protocol|1|||
30570664|NCT03190369|58578666|FG000|Overall Study|Withdraw before treatment|1|||
30570665|NCT03190369|58578667|FG001|Overall Study|Withdraw before treatment|5|||
30570666|NCT03190369|58578666|FG000|Overall Study|Randomized but not treated|0|||
30570667|NCT03190369|58578667|FG001|Overall Study|Randomized but not treated|2|||
30570668|NCT04657198|58578676|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
30570669|NCT04657198|58578677|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
30570670|NCT04657198|58578678|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
30570671|NCT04590586|58578692|FG000|Overall Study|Death|7|||
30570672|NCT04590586|58578693|FG001|Overall Study|Death|1|||
30570673|NCT04590586|58578694|FG002|Overall Study|Death|37|||
30570674|NCT04590586|58578695|FG003|Overall Study|Death|34|||
30570675|NCT04590586|58578696|FG004|Overall Study|Death|19|||
30570676|NCT04590586|58578697|FG005|Overall Study|Death|3|||
30570677|NCT04590586|58578692|FG000|Overall Study|Lost to Follow-up|3|||
30570678|NCT04590586|58578693|FG001|Overall Study|Lost to Follow-up|0|||
30570679|NCT04590586|58578694|FG002|Overall Study|Lost to Follow-up|11|||
30570680|NCT04590586|58578695|FG003|Overall Study|Lost to Follow-up|11|||
30570681|NCT04590586|58578696|FG004|Overall Study|Lost to Follow-up|6|||
30570682|NCT04590586|58578697|FG005|Overall Study|Lost to Follow-up|0|||
30570683|NCT04590586|58578692|FG000|Overall Study|Withdrawal by Subject|0|||
30667746|NCT03252587|58681654|FG001|Overall Study|Lack of Efficacy|2|||
30667747|NCT03252587|58681655|FG002|Overall Study|Lack of Efficacy|2|||
30667748|NCT03252587|58681656|FG003|Overall Study|Lack of Efficacy|4|||
30667749|NCT03252587|58681653|FG000|Overall Study|Lost to Follow-up|2|||
30667750|NCT03252587|58681654|FG001|Overall Study|Lost to Follow-up|0|||
30958651|NCT01694849|59023704|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
30958652|NCT01694849|59023702|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
30958653|NCT01694849|59023703|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
30570684|NCT04590586|58578693|FG001|Overall Study|Withdrawal by Subject|0|||
30570685|NCT04590586|58578694|FG002|Overall Study|Withdrawal by Subject|6|||
30570686|NCT04590586|58578695|FG003|Overall Study|Withdrawal by Subject|0|||
30570687|NCT04590586|58578696|FG004|Overall Study|Withdrawal by Subject|3|||
30570688|NCT04590586|58578697|FG005|Overall Study|Withdrawal by Subject|0|||
30570689|NCT04590586|58578692|FG000|Overall Study|Other|3|||
30570690|NCT04590586|58578693|FG001|Overall Study|Other|0|||
30570691|NCT04590586|58578694|FG002|Overall Study|Other|1|||
30570692|NCT04590586|58578695|FG003|Overall Study|Other|1|||
30667751|NCT03252587|58681655|FG002|Overall Study|Lost to Follow-up|0|||
30570693|NCT04590586|58578696|FG004|Overall Study|Other|2|||
30570694|NCT04590586|58578697|FG005|Overall Study|Other|1|||
30570695|NCT04312009|58578723|FG000|Overall Study|Withdrawal by Subject|2|||
30570696|NCT04312009|58578724|FG001|Overall Study|Withdrawal by Subject|1|||
30570697|NCT03937466|58578739|FG000|Overall Study|not eligbile after the 2-week diary|9|||
30570698|NCT03937466|58578739|FG000|Overall Study|never returned their diary|6|||
30570699|NCT03937466|58578739|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
30570700|NCT03937466|58578739|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
30570701|NCT03850483|58578752|FG000|Treatment for Stage 1|Adverse Event|1|||
30570702|NCT03850483|58578753|FG001|Treatment for Stage 1|Adverse Event|1|||
30570703|NCT03850483|58578754|FG002|Treatment for Stage 1|Adverse Event|3|||
30570704|NCT03850483|58578755|FG003|Treatment for Stage 1|Adverse Event|0|||
30570705|NCT03850483|58578756|FG004|Treatment for Stage 1|Adverse Event|2|||
30570706|NCT03850483|58578757|FG005|Treatment for Stage 1|Adverse Event|0|||
30570707|NCT03850483|58578758|FG006|Treatment for Stage 1|Adverse Event|2|||
30570708|NCT03850483|58578759|FG007|Treatment for Stage 1|Adverse Event|2|||
30570709|NCT03850483|58578760|FG008|Treatment for Stage 1|Adverse Event|0|||
30570710|NCT03850483|58578761|FG009|Treatment for Stage 1|Adverse Event|0|||
30570711|NCT03850483|58578752|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
30570712|NCT03850483|58578753|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
30570713|NCT03850483|58578754|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
30570714|NCT03850483|58578755|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
30570715|NCT03850483|58578756|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
30570716|NCT03850483|58578757|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
30570717|NCT03850483|58578758|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
30570718|NCT03850483|58578759|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
30570719|NCT03850483|58578760|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
30570720|NCT03850483|58578761|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
30570721|NCT03850483|58578752|FG000|Treatment for Stage 1|Protocol Violation|1|||
30570722|NCT03850483|58578753|FG001|Treatment for Stage 1|Protocol Violation|0|||
30570723|NCT03850483|58578754|FG002|Treatment for Stage 1|Protocol Violation|0|||
30570724|NCT03850483|58578755|FG003|Treatment for Stage 1|Protocol Violation|0|||
30570725|NCT03850483|58578756|FG004|Treatment for Stage 1|Protocol Violation|0|||
30570726|NCT03850483|58578757|FG005|Treatment for Stage 1|Protocol Violation|0|||
30570727|NCT03850483|58578758|FG006|Treatment for Stage 1|Protocol Violation|1|||
30570728|NCT03850483|58578759|FG007|Treatment for Stage 1|Protocol Violation|0|||
30570729|NCT03850483|58578760|FG008|Treatment for Stage 1|Protocol Violation|0|||
30570730|NCT03850483|58578761|FG009|Treatment for Stage 1|Protocol Violation|0|||
30570731|NCT03850483|58578752|FG000|Treatment for Stage 1|Physician Decision|0|||
30570732|NCT03850483|58578753|FG001|Treatment for Stage 1|Physician Decision|0|||
30570733|NCT03850483|58578754|FG002|Treatment for Stage 1|Physician Decision|0|||
30570734|NCT03850483|58578755|FG003|Treatment for Stage 1|Physician Decision|0|||
30570735|NCT03850483|58578756|FG004|Treatment for Stage 1|Physician Decision|0|||
30570736|NCT03850483|58578757|FG005|Treatment for Stage 1|Physician Decision|1|||
30570737|NCT03850483|58578758|FG006|Treatment for Stage 1|Physician Decision|0|||
30570738|NCT03850483|58578759|FG007|Treatment for Stage 1|Physician Decision|0|||
30570739|NCT03850483|58578760|FG008|Treatment for Stage 1|Physician Decision|0|||
30570740|NCT03850483|58578761|FG009|Treatment for Stage 1|Physician Decision|0|||
30570741|NCT03850483|58578752|FG000|Treatment for Stage 1|Other|0|||
30570742|NCT03850483|58578753|FG001|Treatment for Stage 1|Other|0|||
30570743|NCT03850483|58578754|FG002|Treatment for Stage 1|Other|0|||
30570744|NCT03850483|58578755|FG003|Treatment for Stage 1|Other|0|||
30570745|NCT03850483|58578756|FG004|Treatment for Stage 1|Other|2|||
30570746|NCT03850483|58578757|FG005|Treatment for Stage 1|Other|1|||
30570747|NCT03850483|58578758|FG006|Treatment for Stage 1|Other|0|||
30570748|NCT03850483|58578759|FG007|Treatment for Stage 1|Other|0|||
30570749|NCT03850483|58578760|FG008|Treatment for Stage 1|Other|0|||
30570750|NCT03850483|58578761|FG009|Treatment for Stage 1|Other|0|||
30570751|NCT03850483|58578752|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
30570752|NCT03850483|58578753|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
30570753|NCT03850483|58578754|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
30667752|NCT03252587|58681656|FG003|Overall Study|Lost to Follow-up|2|||
30667753|NCT03252587|58681653|FG000|Overall Study|Pregnancy|2|||
30570754|NCT03850483|58578755|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
30570755|NCT03850483|58578756|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
30570756|NCT03850483|58578757|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
30570757|NCT03850483|58578758|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
30570758|NCT03850483|58578759|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
30570759|NCT03850483|58578760|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
30570760|NCT03850483|58578761|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
30570761|NCT03850483|58578752|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
30667754|NCT03252587|58681654|FG001|Overall Study|Pregnancy|1|||
30667755|NCT03252587|58681655|FG002|Overall Study|Pregnancy|0|||
30667756|NCT03252587|58681656|FG003|Overall Study|Pregnancy|1|||
30570762|NCT03850483|58578753|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
30570763|NCT03850483|58578754|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
30570764|NCT03850483|58578755|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
30570765|NCT03850483|58578756|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
30570766|NCT03850483|58578757|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
30570767|NCT03850483|58578758|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
30570768|NCT03850483|58578759|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
30570769|NCT03850483|58578760|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
30570770|NCT03850483|58578761|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
30570771|NCT03850483|58578752|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
30570772|NCT03850483|58578753|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
30570773|NCT03850483|58578754|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
30570774|NCT03850483|58578755|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
30570775|NCT03850483|58578756|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
30570776|NCT03850483|58578757|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
30570777|NCT03850483|58578758|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
30570778|NCT03850483|58578759|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
30570779|NCT03850483|58578760|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
30570780|NCT03850483|58578761|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
30570781|NCT03850483|58578752|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
30570782|NCT03850483|58578753|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
30570783|NCT03850483|58578754|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
30570784|NCT03850483|58578755|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
30570785|NCT03850483|58578756|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
30570786|NCT03850483|58578757|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
30570787|NCT03850483|58578758|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
30570788|NCT03850483|58578759|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
30570789|NCT03850483|58578760|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
30570790|NCT03850483|58578761|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
30570791|NCT03850483|58578752|FG000|Treatment for Stage 1|Death|0|||
30570792|NCT03850483|58578753|FG001|Treatment for Stage 1|Death|0|||
30570793|NCT03850483|58578754|FG002|Treatment for Stage 1|Death|0|||
30570794|NCT03850483|58578755|FG003|Treatment for Stage 1|Death|0|||
30570795|NCT03850483|58578756|FG004|Treatment for Stage 1|Death|0|||
30570796|NCT03850483|58578757|FG005|Treatment for Stage 1|Death|1|||
30570797|NCT03850483|58578758|FG006|Treatment for Stage 1|Death|0|||
30570798|NCT03850483|58578759|FG007|Treatment for Stage 1|Death|0|||
30570799|NCT03850483|58578760|FG008|Treatment for Stage 1|Death|0|||
30570800|NCT03850483|58578761|FG009|Treatment for Stage 1|Death|0|||
30570801|NCT03850483|58578752|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
30570802|NCT03850483|58578753|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
30570803|NCT03850483|58578754|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
30570804|NCT03850483|58578755|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
30570805|NCT03850483|58578756|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
30570806|NCT03850483|58578757|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
30570807|NCT03850483|58578758|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
30570808|NCT03850483|58578759|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
30570809|NCT03850483|58578760|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
30570810|NCT03850483|58578761|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
30570811|NCT03850483|58578752|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
30570812|NCT03850483|58578753|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
30570813|NCT03850483|58578754|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
30570814|NCT03850483|58578755|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
30570815|NCT03850483|58578756|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
30570816|NCT03850483|58578757|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
30570817|NCT03850483|58578758|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
30570818|NCT03850483|58578759|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
30570819|NCT03850483|58578760|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
30570820|NCT03850483|58578761|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
30570821|NCT03850483|58578752|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
30570822|NCT03850483|58578753|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
30570823|NCT03850483|58578754|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
30570824|NCT03850483|58578755|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
30570825|NCT03850483|58578756|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
30570826|NCT03850483|58578757|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
30570827|NCT03850483|58578758|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
30570828|NCT03850483|58578759|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
30570829|NCT03850483|58578760|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
30570830|NCT03850483|58578761|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
30570831|NCT03850483|58578752|FG000|Follow-up for Stage 1|Physician Decision|0|||
30570832|NCT03850483|58578753|FG001|Follow-up for Stage 1|Physician Decision|0|||
30570833|NCT03850483|58578754|FG002|Follow-up for Stage 1|Physician Decision|0|||
30570834|NCT03850483|58578755|FG003|Follow-up for Stage 1|Physician Decision|0|||
30570835|NCT03850483|58578756|FG004|Follow-up for Stage 1|Physician Decision|1|||
30570836|NCT03850483|58578757|FG005|Follow-up for Stage 1|Physician Decision|0|||
30570837|NCT03850483|58578758|FG006|Follow-up for Stage 1|Physician Decision|1|||
30570838|NCT03850483|58578759|FG007|Follow-up for Stage 1|Physician Decision|0|||
30570839|NCT03850483|58578760|FG008|Follow-up for Stage 1|Physician Decision|0|||
30570840|NCT03850483|58578761|FG009|Follow-up for Stage 1|Physician Decision|0|||
30570841|NCT03850483|58578752|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
30570842|NCT03850483|58578753|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
30570843|NCT03850483|58578754|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
30570844|NCT03850483|58578755|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
30570845|NCT03850483|58578756|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
30570846|NCT03850483|58578757|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
30570847|NCT03850483|58578758|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
30570848|NCT03850483|58578759|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
30570849|NCT03850483|58578760|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
30570850|NCT03850483|58578761|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
30570851|NCT03850483|58578752|FG000|Follow-up for Stage 1|Adverse Event|0|||
30570852|NCT03850483|58578753|FG001|Follow-up for Stage 1|Adverse Event|0|||
30570853|NCT03850483|58578754|FG002|Follow-up for Stage 1|Adverse Event|1|||
30570854|NCT03850483|58578755|FG003|Follow-up for Stage 1|Adverse Event|0|||
30570855|NCT03850483|58578756|FG004|Follow-up for Stage 1|Adverse Event|0|||
30570856|NCT03850483|58578757|FG005|Follow-up for Stage 1|Adverse Event|1|||
30570857|NCT03850483|58578758|FG006|Follow-up for Stage 1|Adverse Event|0|||
30570858|NCT03850483|58578759|FG007|Follow-up for Stage 1|Adverse Event|0|||
30570859|NCT03850483|58578760|FG008|Follow-up for Stage 1|Adverse Event|0|||
30570860|NCT03850483|58578761|FG009|Follow-up for Stage 1|Adverse Event|0|||
30570861|NCT03850483|58578752|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
30570862|NCT03850483|58578753|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
30570863|NCT03850483|58578754|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
30570864|NCT03850483|58578755|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
30570865|NCT03850483|58578756|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
30570866|NCT03850483|58578757|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
30570867|NCT03850483|58578758|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
30570868|NCT03850483|58578759|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
30570869|NCT03850483|58578760|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
30570870|NCT03850483|58578761|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
30570871|NCT03850483|58578752|FG000|Follow-up for Stage 1|Other|0|||
30570872|NCT03850483|58578753|FG001|Follow-up for Stage 1|Other|2|||
30570873|NCT03850483|58578754|FG002|Follow-up for Stage 1|Other|0|||
30570874|NCT03850483|58578755|FG003|Follow-up for Stage 1|Other|2|||
30570875|NCT03850483|58578756|FG004|Follow-up for Stage 1|Other|0|||
30570876|NCT03850483|58578757|FG005|Follow-up for Stage 1|Other|1|||
30570877|NCT03850483|58578758|FG006|Follow-up for Stage 1|Other|0|||
30570878|NCT03850483|58578759|FG007|Follow-up for Stage 1|Other|0|||
30570879|NCT03850483|58578760|FG008|Follow-up for Stage 1|Other|0|||
30570880|NCT03850483|58578761|FG009|Follow-up for Stage 1|Other|0|||
30570881|NCT03850483|58578752|FG000|Treatment for Stage 2|Adverse Event|0|||
30570882|NCT03850483|58578753|FG001|Treatment for Stage 2|Adverse Event|0|||
30570883|NCT03850483|58578754|FG002|Treatment for Stage 2|Adverse Event|0|||
30570884|NCT03850483|58578755|FG003|Treatment for Stage 2|Adverse Event|0|||
30570885|NCT03850483|58578756|FG004|Treatment for Stage 2|Adverse Event|0|||
30570886|NCT03850483|58578757|FG005|Treatment for Stage 2|Adverse Event|0|||
30570887|NCT03850483|58578758|FG006|Treatment for Stage 2|Adverse Event|0|||
30570888|NCT03850483|58578759|FG007|Treatment for Stage 2|Adverse Event|0|||
30570889|NCT03850483|58578760|FG008|Treatment for Stage 2|Adverse Event|0|||
30570890|NCT03850483|58578761|FG009|Treatment for Stage 2|Adverse Event|1|||
30570891|NCT03850483|58578752|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
30570892|NCT03850483|58578753|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
30570893|NCT03850483|58578754|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
30570894|NCT03850483|58578755|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
30570895|NCT03850483|58578756|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
30570896|NCT03850483|58578757|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
30570897|NCT03850483|58578758|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
30570898|NCT03850483|58578759|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
30570899|NCT03850483|58578760|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
30570900|NCT03850483|58578761|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
30570901|NCT03850483|58578752|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
30570902|NCT03850483|58578753|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
30570903|NCT03850483|58578754|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
30570904|NCT03850483|58578755|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
30570905|NCT03850483|58578756|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
30570906|NCT03850483|58578757|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
30570907|NCT03850483|58578758|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
30570908|NCT03850483|58578759|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
30570909|NCT03850483|58578760|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
30570910|NCT03850483|58578761|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
30570911|NCT03850483|58578752|FG000|Treatment for Stage 2|Physician Decision|0|||
30570912|NCT03850483|58578753|FG001|Treatment for Stage 2|Physician Decision|0|||
30570913|NCT03850483|58578754|FG002|Treatment for Stage 2|Physician Decision|0|||
30570914|NCT03850483|58578755|FG003|Treatment for Stage 2|Physician Decision|0|||
30570915|NCT03850483|58578756|FG004|Treatment for Stage 2|Physician Decision|0|||
30570916|NCT03850483|58578757|FG005|Treatment for Stage 2|Physician Decision|0|||
30570917|NCT03850483|58578758|FG006|Treatment for Stage 2|Physician Decision|0|||
30570918|NCT03850483|58578759|FG007|Treatment for Stage 2|Physician Decision|0|||
30570919|NCT03850483|58578760|FG008|Treatment for Stage 2|Physician Decision|0|||
30570920|NCT03850483|58578761|FG009|Treatment for Stage 2|Physician Decision|1|||
30570921|NCT03850483|58578752|FG000|Treatment for Stage 2|Protocol Violation|0|||
30570922|NCT03850483|58578753|FG001|Treatment for Stage 2|Protocol Violation|0|||
30570923|NCT03850483|58578754|FG002|Treatment for Stage 2|Protocol Violation|0|||
30570924|NCT03850483|58578755|FG003|Treatment for Stage 2|Protocol Violation|0|||
30570925|NCT03850483|58578756|FG004|Treatment for Stage 2|Protocol Violation|0|||
30570926|NCT03850483|58578757|FG005|Treatment for Stage 2|Protocol Violation|0|||
30570927|NCT03850483|58578758|FG006|Treatment for Stage 2|Protocol Violation|0|||
30570928|NCT03850483|58578759|FG007|Treatment for Stage 2|Protocol Violation|0|||
30570929|NCT03850483|58578760|FG008|Treatment for Stage 2|Protocol Violation|1|||
30570930|NCT03850483|58578761|FG009|Treatment for Stage 2|Protocol Violation|0|||
30570931|NCT03850483|58578752|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
30570932|NCT03850483|58578753|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
30570933|NCT03850483|58578754|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
30570934|NCT03850483|58578755|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
30570935|NCT03850483|58578756|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
30570936|NCT03850483|58578757|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
30570937|NCT03850483|58578758|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
30570938|NCT03850483|58578759|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
30570939|NCT03850483|58578760|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
30570940|NCT03850483|58578761|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
30570941|NCT03850483|58578752|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
30570942|NCT03850483|58578753|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
30570943|NCT03850483|58578754|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
30570944|NCT03850483|58578755|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
30570945|NCT03850483|58578756|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
30570946|NCT03850483|58578757|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
30570947|NCT03850483|58578758|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
30570948|NCT03850483|58578759|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
30570949|NCT03850483|58578760|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
30570950|NCT03850483|58578761|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
30570951|NCT03850483|58578752|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
30570952|NCT03850483|58578753|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
30570953|NCT03850483|58578754|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
30570954|NCT03850483|58578755|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
30570955|NCT03850483|58578756|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
30570956|NCT03850483|58578757|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
30570957|NCT03850483|58578758|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
30570958|NCT03850483|58578759|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
30570959|NCT03850483|58578760|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
30570960|NCT03850483|58578761|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
30570961|NCT03850483|58578752|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
30570962|NCT03850483|58578753|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
30570963|NCT03850483|58578754|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
30570964|NCT03850483|58578755|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
30570965|NCT03850483|58578756|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
30570966|NCT03850483|58578757|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
30570967|NCT03850483|58578758|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
30570968|NCT03850483|58578759|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
30570969|NCT03850483|58578760|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
30570970|NCT03850483|58578761|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
30570971|NCT03850483|58578752|FG000|Follow-up For Stage 2|Other|0|||
30570972|NCT03850483|58578753|FG001|Follow-up For Stage 2|Other|0|||
30570973|NCT03850483|58578754|FG002|Follow-up For Stage 2|Other|0|||
30570974|NCT03850483|58578755|FG003|Follow-up For Stage 2|Other|0|||
30570975|NCT03850483|58578756|FG004|Follow-up For Stage 2|Other|0|||
30570976|NCT03850483|58578757|FG005|Follow-up For Stage 2|Other|0|||
30570977|NCT03850483|58578758|FG006|Follow-up For Stage 2|Other|0|||
30570978|NCT03850483|58578759|FG007|Follow-up For Stage 2|Other|0|||
30570979|NCT03850483|58578760|FG008|Follow-up For Stage 2|Other|0|||
30570980|NCT03850483|58578761|FG009|Follow-up For Stage 2|Other|1|||
30570981|NCT03473925|58578792|FG000|Overall Study|Death|48|||
30570982|NCT03473925|58578793|FG001|Overall Study|Death|44|||
30570983|NCT03473925|58578792|FG000|Overall Study|Sponsor Decision|2|||
30570984|NCT03473925|58578793|FG001|Overall Study|Sponsor Decision|7|||
30570985|NCT03473925|58578792|FG000|Overall Study|Withdrawal by Subject|1|||
30570986|NCT03473925|58578793|FG001|Overall Study|Withdrawal by Subject|3|||
30570987|NCT03473925|58578792|FG000|Overall Study|Not Treated|1|||
30570988|NCT03473925|58578793|FG001|Overall Study|Not Treated|1|||
30570989|NCT03230097|58578801|FG000|Overall Study|Adverse Event|2|||
30570990|NCT03230097|58578802|FG001|Overall Study|Adverse Event|1|||
30570991|NCT03230097|58578801|FG000|Overall Study|non-compliance|0|||
30570992|NCT03230097|58578802|FG001|Overall Study|non-compliance|1|||
30570993|NCT03230097|58578801|FG000|Overall Study|Lost to Follow-up|2|||
30570994|NCT03230097|58578802|FG001|Overall Study|Lost to Follow-up|4|||
30570995|NCT03230097|58578801|FG000|Overall Study|Withdrawal by Subject|7|||
30570996|NCT03230097|58578802|FG001|Overall Study|Withdrawal by Subject|3|||
30570997|NCT03230097|58578801|FG000|Overall Study|Trial termination|4|||
30570998|NCT03230097|58578802|FG001|Overall Study|Trial termination|5|||
30570999|NCT03230097|58578801|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
30571000|NCT03230097|58578802|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
30571001|NCT03230097|58578801|FG000|Overall Study|outcome event|0|||
30571002|NCT03230097|58578802|FG001|Overall Study|outcome event|1|||
30571003|NCT02803593|58578827|FG000|Overall Study|Lost to Follow-up|17|||
30571004|NCT02803593|58578828|FG001|Overall Study|Lost to Follow-up|35|||
30571005|NCT02663908|58578836|FG000|Overall Study|Withdrawal by Subject|8|||
30571006|NCT02663908|58578837|FG001|Overall Study|Withdrawal by Subject|5|||
30571007|NCT02663908|58578836|FG000|Overall Study|Lost to Follow-up|1|||
30571008|NCT02663908|58578837|FG001|Overall Study|Lost to Follow-up|5|||
30571009|NCT02663908|58578836|FG000|Overall Study|Adverse Event|13|||
30571010|NCT02663908|58578837|FG001|Overall Study|Adverse Event|11|||
30571011|NCT02663908|58578836|FG000|Overall Study|Protocol Violation|1|||
30571012|NCT02663908|58578837|FG001|Overall Study|Protocol Violation|2|||
30571013|NCT02663908|58578836|FG000|Overall Study|Lack of therapeutic response|2|||
30571014|NCT02663908|58578837|FG001|Overall Study|Lack of therapeutic response|0|||
30571015|NCT02663908|58578836|FG000|Overall Study|COVID-19|1|||
30571016|NCT02663908|58578837|FG001|Overall Study|COVID-19|0|||
30571017|NCT02663908|58578836|FG000|Overall Study|Site closed|1|||
30571018|NCT02663908|58578837|FG001|Overall Study|Site closed|0|||
30571019|NCT02663908|58578836|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
30571020|NCT02663908|58578837|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
30571021|NCT02663908|58578836|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
30571022|NCT02663908|58578837|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
30571023|NCT02663908|58578836|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
30571024|NCT02663908|58578837|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
30571025|NCT02663908|58578836|FG000|Overall Study|Death|1|||
30571026|NCT02663908|58578837|FG001|Overall Study|Death|0|||
30571027|NCT02663908|58578836|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
30571028|NCT02663908|58578837|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
30571029|NCT02663908|58578836|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
30571030|NCT02663908|58578837|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
30571031|NCT02650284|58578845|FG000|Overall Study|Lost to Follow-up|3|||
30571032|NCT02650284|58578846|FG001|Overall Study|Lost to Follow-up|3|||
30571033|NCT02650284|58578845|FG000|Overall Study|Consent incorrectly taken|0|||
30571034|NCT02650284|58578846|FG001|Overall Study|Consent incorrectly taken|1|||
30571035|NCT02175030|58578854|FG000|Overall Study|Failed screen after consent|7|||
30571036|NCT02175030|58578855|FG001|Overall Study|Failed screen after consent|6|||
30571037|NCT02175030|58578854|FG000|Overall Study|Failed IUD Insertion|20|||
30571038|NCT02175030|58578855|FG001|Overall Study|Failed IUD Insertion|21|||
30571039|NCT02175030|58578854|FG000|Overall Study|Physician Decision|1|||
30571040|NCT02175030|58578855|FG001|Overall Study|Physician Decision|1|||
30571041|NCT02175030|58578854|FG000|Overall Study|Lost to Follow-up|6|||
30571042|NCT02175030|58578855|FG001|Overall Study|Lost to Follow-up|6|||
30571043|NCT02175030|58578854|FG000|Overall Study|Withdrawal by Subject|1|||
30571044|NCT02175030|58578855|FG001|Overall Study|Withdrawal by Subject|4|||
30571045|NCT03096834|58578880|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
30571046|NCT03096834|58578881|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
30571047|NCT03096834|58578882|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
30571048|NCT03096834|58578883|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
30571049|NCT03096834|58578880|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
30571050|NCT03096834|58578881|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
30571051|NCT03096834|58578882|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
30571052|NCT03096834|58578883|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
30571053|NCT03096834|58578880|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
30571054|NCT03096834|58578881|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
30571055|NCT03096834|58578882|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
30571056|NCT03096834|58578883|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
30571057|NCT03096834|58578880|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
30571058|NCT03096834|58578881|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
30571059|NCT03096834|58578882|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
30571060|NCT03096834|58578883|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
30571061|NCT03096834|58578880|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
30571062|NCT03096834|58578881|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
30571063|NCT03096834|58578882|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
30571064|NCT03096834|58578883|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
30571065|NCT03096834|58578880|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
30571066|NCT03096834|58578881|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
30571067|NCT03096834|58578882|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
30571068|NCT03096834|58578883|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
30571069|NCT03096834|58578880|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
30571070|NCT03096834|58578881|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
30571071|NCT03096834|58578882|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
30571072|NCT03096834|58578883|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
30571073|NCT03096834|58578880|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
30571074|NCT03096834|58578881|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
30571075|NCT03096834|58578882|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
30571076|NCT03096834|58578883|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
30571077|NCT03096834|58578880|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
30571078|NCT03096834|58578881|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
30571079|NCT03096834|58578882|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
30571080|NCT03096834|58578883|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
30571081|NCT03096834|58578880|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
30571082|NCT03096834|58578881|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
30571083|NCT03096834|58578882|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
30571084|NCT03096834|58578883|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
30571085|NCT03096834|58578880|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
30571086|NCT03096834|58578881|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
30571087|NCT03096834|58578882|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
30571088|NCT03096834|58578883|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
30571089|NCT03096834|58578880|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
30571090|NCT03096834|58578881|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
30571091|NCT03096834|58578882|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
30571092|NCT03096834|58578883|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
30571093|NCT03012815|58578894|FG000|Overall Study|Lost to Follow-up|1|||
30571094|NCT03012815|58578895|FG001|Overall Study|Lost to Follow-up|0|||
30571095|NCT03012815|58578894|FG000|Overall Study|Physician Decision|3|||
30571096|NCT03012815|58578895|FG001|Overall Study|Physician Decision|2|||
30571097|NCT03012815|58578894|FG000|Overall Study|Adverse Event|1|||
30571098|NCT03012815|58578895|FG001|Overall Study|Adverse Event|0|||
30571099|NCT03001011|58578904|FG000|Overall Study|Adverse Event|9|||
30571100|NCT03001011|58578905|FG001|Overall Study|Adverse Event|3|||
30571101|NCT03001011|58578904|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
30571102|NCT03001011|58578905|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
30571103|NCT03001011|58578904|FG000|Overall Study|Other than specified above|3|||
30571104|NCT03001011|58578905|FG001|Overall Study|Other than specified above|8|||
30571105|NCT02993757|58578914|FG000|Overall Study|Non compliance with the protocol|155|||
30571106|NCT02993757|58578915|FG001|Overall Study|Non compliance with the protocol|170|||
30571107|NCT02993757|58578914|FG000|Overall Study|Lost to Follow-up|1|||
30571108|NCT02993757|58578915|FG001|Overall Study|Lost to Follow-up|0|||
30571109|NCT02993757|58578914|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
30571110|NCT02993757|58578915|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
30571111|NCT02979535|58578923|FG000|Overall Study|Non compliance with the protocol|78|||
30571112|NCT02979535|58578924|FG001|Overall Study|Non compliance with the protocol|82|||
30855233|NCT02603120|58882787|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
30571113|NCT02979535|58578923|FG000|Overall Study|Consent withdrawn by participant|11|||
30571114|NCT02979535|58578924|FG001|Overall Study|Consent withdrawn by participant|18|||
30571115|NCT02979535|58578923|FG000|Overall Study|Lost to Follow-up|6|||
30571116|NCT02979535|58578924|FG001|Overall Study|Lost to Follow-up|1|||
30571117|NCT02978716|58578933|FG000|Overall Study|Death|25|||
30571118|NCT02978716|58578934|FG001|Overall Study|Death|13|||
30571119|NCT02978716|58578935|FG002|Overall Study|Death|20|||
30571120|NCT02978716|58578933|FG000|Overall Study|Lost to Follow-up|0|||
30571121|NCT02978716|58578934|FG001|Overall Study|Lost to Follow-up|0|||
30571122|NCT02978716|58578935|FG002|Overall Study|Lost to Follow-up|1|||
30571123|NCT02978716|58578933|FG000|Overall Study|Withdrawal by Subject|6|||
30571124|NCT02978716|58578934|FG001|Overall Study|Withdrawal by Subject|4|||
30571125|NCT02978716|58578935|FG002|Overall Study|Withdrawal by Subject|5|||
30571126|NCT02978716|58578933|FG000|Overall Study|Sponsor terminated|2|||
30571127|NCT02978716|58578934|FG001|Overall Study|Sponsor terminated|13|||
30571128|NCT02978716|58578935|FG002|Overall Study|Sponsor terminated|9|||
30571129|NCT02978716|58578933|FG000|Overall Study|Other|1|||
30571130|NCT02978716|58578934|FG001|Overall Study|Other|3|||
30571131|NCT02978716|58578935|FG002|Overall Study|Other|0|||
30571132|NCT02973321|58578950|FG000|Overall Study|Other than specified|0|||
30571133|NCT02973321|58578951|FG001|Overall Study|Other than specified|5|||
30571134|NCT02973321|58578952|FG002|Overall Study|Other than specified|3|||
30571135|NCT02973321|58578953|FG003|Overall Study|Other than specified|3|||
30571136|NCT02973321|58578954|FG004|Overall Study|Other than specified|1|||
30571137|NCT02973321|58578950|FG000|Overall Study|Lack of Efficacy|0|||
30571138|NCT02973321|58578951|FG001|Overall Study|Lack of Efficacy|0|||
30571139|NCT02973321|58578952|FG002|Overall Study|Lack of Efficacy|0|||
30571140|NCT02973321|58578953|FG003|Overall Study|Lack of Efficacy|0|||
30571141|NCT02973321|58578954|FG004|Overall Study|Lack of Efficacy|1|||
30571142|NCT02973321|58578950|FG000|Overall Study|Adverse Event|1|||
30571143|NCT02973321|58578951|FG001|Overall Study|Adverse Event|10|||
30571144|NCT02973321|58578952|FG002|Overall Study|Adverse Event|11|||
30571145|NCT02973321|58578953|FG003|Overall Study|Adverse Event|13|||
30571146|NCT02973321|58578954|FG004|Overall Study|Adverse Event|3|||
30571147|NCT02943785|58578969|FG000|Overall Study|Adverse Event|112|||
30571148|NCT02943785|58578970|FG001|Overall Study|Adverse Event|97|||
30571149|NCT02943785|58578969|FG000|Overall Study|Withdrawal by Subject|63|||
30571150|NCT02943785|58578970|FG001|Overall Study|Withdrawal by Subject|126|||
30571151|NCT02943785|58578969|FG000|Overall Study|Physician Decision|23|||
30571152|NCT02943785|58578970|FG001|Overall Study|Physician Decision|47|||
30571153|NCT02943785|58578969|FG000|Overall Study|Death|46|||
30571154|NCT02943785|58578970|FG001|Overall Study|Death|46|||
30571155|NCT02943785|58578969|FG000|Overall Study|Lost to Follow-up|1|||
30571156|NCT02943785|58578970|FG001|Overall Study|Lost to Follow-up|0|||
30571157|NCT02943785|58578969|FG000|Overall Study|Other|16|||
30571158|NCT02943785|58578970|FG001|Overall Study|Other|19|||
30571159|NCT02943785|58578969|FG000|Overall Study|Did not receive any study medication|21|||
30571160|NCT02943785|58578970|FG001|Overall Study|Did not receive any study medication|28|||
30571161|NCT02923674|58578979|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
30571162|NCT02923674|58578980|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
30571163|NCT02923674|58578981|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
30571164|NCT02923674|58578979|FG000|Overall Study|Lost to Follow-up|7|||
30571165|NCT02923674|58578980|FG001|Overall Study|Lost to Follow-up|12|||
30571166|NCT02923674|58578981|FG002|Overall Study|Lost to Follow-up|7|||
30571167|NCT02923674|58578979|FG000|Overall Study|Problem with intervention|2|||
30571168|NCT02923674|58578980|FG001|Overall Study|Problem with intervention|2|||
30571169|NCT02923674|58578981|FG002|Overall Study|Problem with intervention|1|||
30571170|NCT02923674|58578979|FG000|Overall Study|Adverse Event|3|||
30571171|NCT02923674|58578980|FG001|Overall Study|Adverse Event|1|||
30571172|NCT02923674|58578981|FG002|Overall Study|Adverse Event|1|||
30571173|NCT02923674|58578979|FG000|Overall Study|Withdrawal by Subject|2|||
30571174|NCT02923674|58578980|FG001|Overall Study|Withdrawal by Subject|2|||
30571175|NCT02923674|58578981|FG002|Overall Study|Withdrawal by Subject|2|||
30571176|NCT02921971|58578991|FG000|Overall Study|Adverse Event|1|||
30571177|NCT02921971|58578992|FG001|Overall Study|Adverse Event|2|||
30571178|NCT02921971|58578991|FG000|Overall Study|Lack of Efficacy|3|||
30571179|NCT02921971|58578992|FG001|Overall Study|Lack of Efficacy|1|||
30958654|NCT01694849|59023704|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
30958655|NCT01694849|59023702|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
30958656|NCT01694849|59023703|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
30958657|NCT01694849|59023704|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
30958658|NCT01694849|59023702|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
30571180|NCT02921971|58578991|FG000|Overall Study|Other than specified above|2|||
30571181|NCT02921971|58578992|FG001|Overall Study|Other than specified above|1|||
30571182|NCT02886286|58579000|FG000|Overall Study|pump motor stall|0|||
30571183|NCT02886286|58579001|FG001|Overall Study|pump motor stall|1|||
30571184|NCT02865187|58579009|FG000|Overall Study|Lost to Follow-up|12|||
30571185|NCT02865187|58579010|FG001|Overall Study|Lost to Follow-up|7|||
30571186|NCT02865187|58579009|FG000|Overall Study|Adverse Event|1|||
30571187|NCT02865187|58579010|FG001|Overall Study|Adverse Event|0|||
30571188|NCT02824198|58579018|FG000|Overall Study|Non-compliance with the protocol|5|||
30571189|NCT02824198|58579019|FG001|Overall Study|Non-compliance with the protocol|1|||
30571190|NCT02824198|58579018|FG000|Overall Study|Lost to Follow-up|5|||
30571191|NCT02824198|58579019|FG001|Overall Study|Lost to Follow-up|2|||
30571192|NCT02824198|58579018|FG000|Overall Study|Withdrawal by Subject|5|||
30571193|NCT02824198|58579019|FG001|Overall Study|Withdrawal by Subject|0|||
30571194|NCT02787551|58579029|FG000|Core Period: 26 Weeks|Adverse Event|10|||
30571195|NCT02787551|58579030|FG001|Core Period: 26 Weeks|Adverse Event|0|||
30571196|NCT02787551|58579029|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
30571197|NCT02787551|58579030|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
30571198|NCT02787551|58579029|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
30571199|NCT02787551|58579030|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
30571200|NCT02787551|58579029|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
30571201|NCT02787551|58579030|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
30571202|NCT02787551|58579029|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
30571203|NCT02787551|58579030|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
30571204|NCT02787551|58579029|FG000|Core Period: 26 Weeks|Other than specified|3|||
30571205|NCT02787551|58579030|FG001|Core Period: 26 Weeks|Other than specified|1|||
30571206|NCT02787551|58579029|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
30571207|NCT02787551|58579030|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
30571208|NCT02787551|58579029|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
30571209|NCT02787551|58579030|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
30571210|NCT02787551|58579029|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
30571211|NCT02787551|58579030|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
30571212|NCT02735044|58579050|FG000|Overall Study|Adverse Event|3|||
30571213|NCT02735044|58579051|FG001|Overall Study|Adverse Event|3|||
30571214|NCT02735044|58579050|FG000|Overall Study|Lack of Efficacy|1|||
30571215|NCT02735044|58579051|FG001|Overall Study|Lack of Efficacy|0|||
30571216|NCT02735044|58579050|FG000|Overall Study|Poor compliance to protocol|7|||
30571217|NCT02735044|58579051|FG001|Overall Study|Poor compliance to protocol|7|||
30571218|NCT02735044|58579050|FG000|Overall Study|Randomized and not treated|0|||
30571219|NCT02735044|58579051|FG001|Overall Study|Randomized and not treated|2|||
30571220|NCT02735044|58579050|FG000|Overall Study|Other, not specified above|5|||
30571221|NCT02735044|58579051|FG001|Overall Study|Other, not specified above|11|||
30571222|NCT02720744|58579059|FG000|Overall Study|Protocol Violation|0|||
30571223|NCT02720744|58579060|FG001|Overall Study|Protocol Violation|2|||
30571224|NCT02720744|58579059|FG000|Overall Study|Pregnancy|2|||
30571225|NCT02720744|58579060|FG001|Overall Study|Pregnancy|0|||
30571226|NCT02720744|58579059|FG000|Overall Study|Lack of Efficacy|2|||
30571227|NCT02720744|58579060|FG001|Overall Study|Lack of Efficacy|8|||
30571228|NCT02720744|58579059|FG000|Overall Study|Adverse Event|21|||
30571229|NCT02720744|58579060|FG001|Overall Study|Adverse Event|3|||
30571230|NCT02720744|58579059|FG000|Overall Study|Withdrawal by Subject|11|||
30571231|NCT02720744|58579060|FG001|Overall Study|Withdrawal by Subject|11|||
30571232|NCT02720744|58579059|FG000|Overall Study|Lost to follow up|2|||
30571233|NCT02720744|58579060|FG001|Overall Study|Lost to follow up|0|||
30571234|NCT02720744|58579059|FG000|Overall Study|Non Compliance with Investigational Product|0|||
30571235|NCT02720744|58579060|FG001|Overall Study|Non Compliance with Investigational Product|1|||
30571236|NCT02720744|58579059|FG000|Overall Study|Excluded Concomitant Medication|0|||
30571237|NCT02720744|58579060|FG001|Overall Study|Excluded Concomitant Medication|1|||
30571238|NCT02694185|58579068|FG000|Overall Study|Withdrawal by Subject|45|||
30571239|NCT02694185|58579069|FG001|Overall Study|Withdrawal by Subject|0|||
30571240|NCT02692651|58579077|FG000|Study Treatment|Death|7|||
30571241|NCT02692651|58579078|FG001|Study Treatment|Death|3|||
30571242|NCT02692651|58579077|FG000|Study Treatment|comfort care|1|||
30571243|NCT02692651|58579078|FG001|Study Treatment|comfort care|1|||
30571244|NCT02692651|58579077|FG000|Study Treatment|Protocol violation per treating team preference|8|||
30571245|NCT02692651|58579078|FG001|Study Treatment|Protocol violation per treating team preference|6|||
30571246|NCT02692651|58579077|FG000|Post Study Treatment Follow-up|Death|4|||
30571247|NCT02692651|58579078|FG001|Post Study Treatment Follow-up|Death|4|||
30571248|NCT02686658|58579090|FG000|Overall Study|Adverse Event|0|||
30571249|NCT02686658|58579091|FG001|Overall Study|Adverse Event|0|||
30571250|NCT02686658|58579092|FG002|Overall Study|Adverse Event|1|||
30571251|NCT02686658|58579093|FG003|Overall Study|Adverse Event|1|||
30571252|NCT02686658|58579094|FG004|Overall Study|Adverse Event|2|||
30571253|NCT02686658|58579095|FG005|Overall Study|Adverse Event|1|||
30571254|NCT02686658|58579090|FG000|Overall Study|Investigator decision|0|||
30571255|NCT02686658|58579091|FG001|Overall Study|Investigator decision|0|||
30571256|NCT02686658|58579092|FG002|Overall Study|Investigator decision|0|||
30571257|NCT02686658|58579093|FG003|Overall Study|Investigator decision|1|||
30855234|NCT02603120|58882786|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
30855235|NCT02603120|58882787|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
30855236|NCT02603120|58882786|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
30855237|NCT02603120|58882787|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
30855238|NCT02603120|58882786|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
30855239|NCT02603120|58882787|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
30571258|NCT02686658|58579094|FG004|Overall Study|Investigator decision|2|||
30571259|NCT02686658|58579095|FG005|Overall Study|Investigator decision|1|||
30571260|NCT02686658|58579090|FG000|Overall Study|Sponsor decision|1|||
30571261|NCT02686658|58579091|FG001|Overall Study|Sponsor decision|2|||
30571262|NCT02686658|58579092|FG002|Overall Study|Sponsor decision|1|||
30571263|NCT02686658|58579093|FG003|Overall Study|Sponsor decision|5|||
30571264|NCT02686658|58579094|FG004|Overall Study|Sponsor decision|13|||
30571265|NCT02686658|58579095|FG005|Overall Study|Sponsor decision|2|||
30571266|NCT02686658|58579090|FG000|Overall Study|Lost to Follow-up|0|||
30571267|NCT02686658|58579091|FG001|Overall Study|Lost to Follow-up|0|||
30571268|NCT02686658|58579092|FG002|Overall Study|Lost to Follow-up|2|||
30571269|NCT02686658|58579093|FG003|Overall Study|Lost to Follow-up|0|||
30571270|NCT02686658|58579094|FG004|Overall Study|Lost to Follow-up|0|||
30571271|NCT02686658|58579095|FG005|Overall Study|Lost to Follow-up|1|||
30571272|NCT02686658|58579090|FG000|Overall Study|Death|1|||
30571273|NCT02686658|58579091|FG001|Overall Study|Death|0|||
30571274|NCT02686658|58579092|FG002|Overall Study|Death|0|||
30571275|NCT02686658|58579093|FG003|Overall Study|Death|1|||
30571276|NCT02686658|58579094|FG004|Overall Study|Death|1|||
30571277|NCT02686658|58579095|FG005|Overall Study|Death|1|||
30571278|NCT02686658|58579090|FG000|Overall Study|Withdrawal by Subject|2|||
30571279|NCT02686658|58579091|FG001|Overall Study|Withdrawal by Subject|5|||
30571280|NCT02686658|58579092|FG002|Overall Study|Withdrawal by Subject|4|||
30571281|NCT02686658|58579093|FG003|Overall Study|Withdrawal by Subject|4|||
30571282|NCT02686658|58579094|FG004|Overall Study|Withdrawal by Subject|17|||
30571283|NCT02686658|58579095|FG005|Overall Study|Withdrawal by Subject|8|||
30571284|NCT02686658|58579090|FG000|Overall Study|Placed in hospice care|0|||
30571285|NCT02686658|58579091|FG001|Overall Study|Placed in hospice care|0|||
30571286|NCT02686658|58579092|FG002|Overall Study|Placed in hospice care|1|||
30571287|NCT02686658|58579093|FG003|Overall Study|Placed in hospice care|0|||
30571288|NCT02686658|58579094|FG004|Overall Study|Placed in hospice care|0|||
30571289|NCT02686658|58579095|FG005|Overall Study|Placed in hospice care|0|||
30571290|NCT02686658|58579090|FG000|Overall Study|Participant non-compliance|0|||
30571291|NCT02686658|58579091|FG001|Overall Study|Participant non-compliance|0|||
30571292|NCT02686658|58579092|FG002|Overall Study|Participant non-compliance|0|||
30571293|NCT02686658|58579093|FG003|Overall Study|Participant non-compliance|0|||
30571294|NCT02686658|58579094|FG004|Overall Study|Participant non-compliance|0|||
30571295|NCT02686658|58579095|FG005|Overall Study|Participant non-compliance|1|||
30571296|NCT02686658|58579090|FG000|Overall Study|Concern over coronavirus disease care|0|||
30571297|NCT02686658|58579091|FG001|Overall Study|Concern over coronavirus disease care|0|||
30571298|NCT02686658|58579092|FG002|Overall Study|Concern over coronavirus disease care|0|||
30571299|NCT02686658|58579093|FG003|Overall Study|Concern over coronavirus disease care|0|||
30571300|NCT02686658|58579094|FG004|Overall Study|Concern over coronavirus disease care|2|||
30571301|NCT02686658|58579095|FG005|Overall Study|Concern over coronavirus disease care|1|||
30571302|NCT02674061|58579111|FG000|Overall Study|Death|229|||
30571303|NCT02674061|58579112|FG001|Overall Study|Death|77|||
30571304|NCT02674061|58579111|FG000|Overall Study|Lost to Follow-up|3|||
30571305|NCT02674061|58579112|FG001|Overall Study|Lost to Follow-up|3|||
30571306|NCT02674061|58579111|FG000|Overall Study|Withdrawal by Subject|9|||
30571307|NCT02674061|58579112|FG001|Overall Study|Withdrawal by Subject|1|||
30571308|NCT02674061|58579111|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
30571309|NCT02674061|58579112|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
30571310|NCT02628444|58579132|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
30571311|NCT02628444|58579133|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
30571312|NCT02628444|58579134|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
30571313|NCT02628444|58579135|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
30571314|NCT02628444|58579136|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
30571315|NCT02628444|58579137|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
30571316|NCT02628444|58579138|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
30571317|NCT02628444|58579139|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
30571318|NCT02628444|58579140|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
30571319|NCT02628444|58579132|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
30571320|NCT02628444|58579133|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
30571321|NCT02628444|58579134|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
30571322|NCT02628444|58579135|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
30571323|NCT02628444|58579136|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
30571324|NCT02628444|58579137|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
30571325|NCT02628444|58579138|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
30571326|NCT02628444|58579139|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
30571327|NCT02628444|58579140|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
30571328|NCT02628444|58579132|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
30571329|NCT02628444|58579133|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
30571330|NCT02628444|58579134|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
30571331|NCT02628444|58579135|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
30571332|NCT02628444|58579136|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
30571333|NCT02628444|58579137|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
30571334|NCT02628444|58579138|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
30571335|NCT02628444|58579139|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
30571336|NCT02628444|58579140|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
30571337|NCT02628444|58579132|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
30571338|NCT02628444|58579133|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
30571339|NCT02628444|58579134|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
30571340|NCT02628444|58579135|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
30571341|NCT02628444|58579136|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
30571342|NCT02628444|58579137|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
30571343|NCT02628444|58579138|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
30571344|NCT02628444|58579139|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
30571345|NCT02628444|58579140|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
30571346|NCT02628444|58579132|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
30571347|NCT02628444|58579133|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
30571348|NCT02628444|58579134|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
30571349|NCT02628444|58579135|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
30571350|NCT02628444|58579136|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
30571351|NCT02628444|58579137|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
30571352|NCT02628444|58579138|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
30571353|NCT02628444|58579139|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
30571354|NCT02628444|58579140|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
30571355|NCT02628444|58579132|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
30571356|NCT02628444|58579133|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
30571357|NCT02628444|58579134|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
30571358|NCT02628444|58579135|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
30571359|NCT02628444|58579136|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
30571360|NCT02628444|58579137|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
30571361|NCT02628444|58579138|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
30571362|NCT02628444|58579139|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
30571363|NCT02628444|58579140|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
30571364|NCT02628444|58579132|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
30571365|NCT02628444|58579133|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
30571366|NCT02628444|58579134|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
30571367|NCT02628444|58579135|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
30571368|NCT02628444|58579136|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
30571369|NCT02628444|58579137|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
30571370|NCT02628444|58579138|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
30571371|NCT02628444|58579139|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
30571372|NCT02628444|58579140|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
30571373|NCT02628444|58579132|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
30571374|NCT02628444|58579133|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
30571375|NCT02628444|58579134|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
30571376|NCT02628444|58579135|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
30571377|NCT02628444|58579136|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
30571378|NCT02628444|58579137|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
30571379|NCT02628444|58579138|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
30571380|NCT02628444|58579139|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
30571381|NCT02628444|58579140|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
30571382|NCT02628444|58579132|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
30571383|NCT02628444|58579133|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
30571384|NCT02628444|58579134|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
30571385|NCT02628444|58579135|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
30571386|NCT02628444|58579136|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
30571387|NCT02628444|58579137|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
30571388|NCT02628444|58579138|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
30571389|NCT02628444|58579139|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
30571390|NCT02628444|58579140|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
30667757|NCT03252587|58681653|FG000|Overall Study|Withdrawal by Subject|8|||
30667758|NCT03252587|58681654|FG001|Overall Study|Withdrawal by Subject|4|||
30667759|NCT03252587|58681655|FG002|Overall Study|Withdrawal by Subject|4|||
30667760|NCT03252587|58681656|FG003|Overall Study|Withdrawal by Subject|4|||
30571391|NCT02628444|58579132|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
30571392|NCT02628444|58579133|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
30571393|NCT02628444|58579134|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
30571394|NCT02628444|58579135|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
30571395|NCT02628444|58579136|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
30571396|NCT02628444|58579137|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
30571397|NCT02628444|58579138|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
30571398|NCT02628444|58579139|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
30571399|NCT02628444|58579140|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
30571400|NCT02623725|58579176|FG000|Overall Study|Non compliance with protocol|9|||
30571401|NCT02623725|58579177|FG001|Overall Study|Non compliance with protocol|3|||
30571402|NCT02623725|58579176|FG000|Overall Study|Serious adverse event|0|||
30571403|NCT02623725|58579177|FG001|Overall Study|Serious adverse event|2|||
30571404|NCT02623725|58579176|FG000|Overall Study|Withdrawal by Subject|7|||
30571405|NCT02623725|58579177|FG001|Overall Study|Withdrawal by Subject|1|||
30571406|NCT02608684|58579185|FG000|Overall Study|Physician Decision|2|||
30571407|NCT02608684|58579185|FG000|Overall Study|Withdrawal by Subject|1|||
30571408|NCT02587520|58579207|FG000|Overall Study|Protocol Violation|2|||
30571409|NCT02587520|58579208|FG001|Overall Study|Protocol Violation|0|||
30571410|NCT02587520|58579209|FG002|Overall Study|Protocol Violation|0|||
30571411|NCT02587520|58579210|FG003|Overall Study|Protocol Violation|2|||
30571412|NCT02587520|58579211|FG004|Overall Study|Protocol Violation|0|||
30571413|NCT02587520|58579212|FG005|Overall Study|Protocol Violation|1|||
30571414|NCT02587520|58579213|FG006|Overall Study|Protocol Violation|1|||
30571415|NCT02587520|58579214|FG007|Overall Study|Protocol Violation|1|||
30571416|NCT02587520|58579215|FG008|Overall Study|Protocol Violation|3|||
30571417|NCT02587520|58579216|FG009|Overall Study|Protocol Violation|3|||
30571418|NCT02587520|58579217|FG010|Overall Study|Protocol Violation|1|||
30571419|NCT02587520|58579218|FG011|Overall Study|Protocol Violation|2|||
30571420|NCT02587520|58579219|FG012|Overall Study|Protocol Violation|0|||
30571421|NCT02587520|58579220|FG013|Overall Study|Protocol Violation|0|||
30571422|NCT02587520|58579221|FG014|Overall Study|Protocol Violation|0|||
30571423|NCT02587520|58579222|FG015|Overall Study|Protocol Violation|0|||
30571424|NCT02587520|58579223|FG016|Overall Study|Protocol Violation|0|||
30571425|NCT02587520|58579224|FG017|Overall Study|Protocol Violation|0|||
30571426|NCT02587520|58579207|FG000|Overall Study|Adverse Event|0|||
30571427|NCT02587520|58579208|FG001|Overall Study|Adverse Event|0|||
30571428|NCT02587520|58579209|FG002|Overall Study|Adverse Event|0|||
30571429|NCT02587520|58579210|FG003|Overall Study|Adverse Event|0|||
30571430|NCT02587520|58579211|FG004|Overall Study|Adverse Event|0|||
30571431|NCT02587520|58579212|FG005|Overall Study|Adverse Event|0|||
30571432|NCT02587520|58579213|FG006|Overall Study|Adverse Event|0|||
30571433|NCT02587520|58579214|FG007|Overall Study|Adverse Event|0|||
30571434|NCT02587520|58579215|FG008|Overall Study|Adverse Event|0|||
30571435|NCT02587520|58579216|FG009|Overall Study|Adverse Event|0|||
30571436|NCT02587520|58579217|FG010|Overall Study|Adverse Event|0|||
30571437|NCT02587520|58579218|FG011|Overall Study|Adverse Event|1|||
30571438|NCT02587520|58579219|FG012|Overall Study|Adverse Event|0|||
30571439|NCT02587520|58579220|FG013|Overall Study|Adverse Event|0|||
30571440|NCT02587520|58579221|FG014|Overall Study|Adverse Event|0|||
30571441|NCT02587520|58579222|FG015|Overall Study|Adverse Event|0|||
30571442|NCT02587520|58579223|FG016|Overall Study|Adverse Event|0|||
30571443|NCT02587520|58579224|FG017|Overall Study|Adverse Event|0|||
30571444|NCT02587520|58579207|FG000|Overall Study|Withdrawal by Subject|0|||
30571445|NCT02587520|58579208|FG001|Overall Study|Withdrawal by Subject|0|||
30571446|NCT02587520|58579209|FG002|Overall Study|Withdrawal by Subject|1|||
30571447|NCT02587520|58579210|FG003|Overall Study|Withdrawal by Subject|1|||
30571448|NCT02587520|58579211|FG004|Overall Study|Withdrawal by Subject|0|||
30571449|NCT02587520|58579212|FG005|Overall Study|Withdrawal by Subject|1|||
30571450|NCT02587520|58579213|FG006|Overall Study|Withdrawal by Subject|1|||
30571451|NCT02587520|58579214|FG007|Overall Study|Withdrawal by Subject|0|||
30571452|NCT02587520|58579215|FG008|Overall Study|Withdrawal by Subject|0|||
30571453|NCT02587520|58579216|FG009|Overall Study|Withdrawal by Subject|0|||
30571454|NCT02587520|58579217|FG010|Overall Study|Withdrawal by Subject|0|||
30571455|NCT02587520|58579218|FG011|Overall Study|Withdrawal by Subject|0|||
30571456|NCT02587520|58579219|FG012|Overall Study|Withdrawal by Subject|0|||
30571457|NCT02587520|58579220|FG013|Overall Study|Withdrawal by Subject|1|||
30571458|NCT02587520|58579221|FG014|Overall Study|Withdrawal by Subject|0|||
30571459|NCT02587520|58579222|FG015|Overall Study|Withdrawal by Subject|0|||
30571460|NCT02587520|58579223|FG016|Overall Study|Withdrawal by Subject|0|||
30571461|NCT02587520|58579224|FG017|Overall Study|Withdrawal by Subject|0|||
30571462|NCT02587520|58579207|FG000|Overall Study|Lost to Follow-up|0|||
30571463|NCT02587520|58579208|FG001|Overall Study|Lost to Follow-up|2|||
30571464|NCT02587520|58579209|FG002|Overall Study|Lost to Follow-up|0|||
30571465|NCT02587520|58579210|FG003|Overall Study|Lost to Follow-up|2|||
30571466|NCT02587520|58579211|FG004|Overall Study|Lost to Follow-up|0|||
30571467|NCT02587520|58579212|FG005|Overall Study|Lost to Follow-up|1|||
30571468|NCT02587520|58579213|FG006|Overall Study|Lost to Follow-up|1|||
30571469|NCT02587520|58579214|FG007|Overall Study|Lost to Follow-up|1|||
30571470|NCT02587520|58579215|FG008|Overall Study|Lost to Follow-up|0|||
30571471|NCT02587520|58579216|FG009|Overall Study|Lost to Follow-up|2|||
30571472|NCT02587520|58579217|FG010|Overall Study|Lost to Follow-up|2|||
30571473|NCT02587520|58579218|FG011|Overall Study|Lost to Follow-up|1|||
30571474|NCT02587520|58579219|FG012|Overall Study|Lost to Follow-up|0|||
30571475|NCT02587520|58579220|FG013|Overall Study|Lost to Follow-up|0|||
30571476|NCT02587520|58579221|FG014|Overall Study|Lost to Follow-up|0|||
30571477|NCT02587520|58579222|FG015|Overall Study|Lost to Follow-up|0|||
30571478|NCT02587520|58579223|FG016|Overall Study|Lost to Follow-up|0|||
30571479|NCT02587520|58579224|FG017|Overall Study|Lost to Follow-up|0|||
30571480|NCT02584829|58579264|FG000|Overall Study|Physician Decision|1|||
30571481|NCT02584829|58579265|FG001|Overall Study|Physician Decision|0|||
30571482|NCT02584829|58579264|FG000|Overall Study|Withdrawal by Subject|0|||
30571483|NCT02584829|58579265|FG001|Overall Study|Withdrawal by Subject|1|||
30571484|NCT02584829|58579264|FG000|Overall Study|Progressive Disease|0|||
30571485|NCT02584829|58579265|FG001|Overall Study|Progressive Disease|3|||
30571486|NCT02570308|58579278|FG000|Overall Study|Death|1|||
30571487|NCT02570308|58579279|FG001|Overall Study|Death|5|||
30571488|NCT02570308|58579280|FG002|Overall Study|Death|4|||
30571489|NCT02570308|58579281|FG003|Overall Study|Death|4|||
30571490|NCT02570308|58579282|FG004|Overall Study|Death|69|||
30571491|NCT02570308|58579278|FG000|Overall Study|Lost to Follow-up|0|||
30571492|NCT02570308|58579279|FG001|Overall Study|Lost to Follow-up|0|||
30571493|NCT02570308|58579280|FG002|Overall Study|Lost to Follow-up|0|||
30571494|NCT02570308|58579281|FG003|Overall Study|Lost to Follow-up|0|||
30571495|NCT02570308|58579282|FG004|Overall Study|Lost to Follow-up|2|||
30571496|NCT02570308|58579278|FG000|Overall Study|Withdrawal by Subject|0|||
30571497|NCT02570308|58579279|FG001|Overall Study|Withdrawal by Subject|0|||
30571498|NCT02570308|58579280|FG002|Overall Study|Withdrawal by Subject|0|||
30571499|NCT02570308|58579281|FG003|Overall Study|Withdrawal by Subject|0|||
30571500|NCT02570308|58579282|FG004|Overall Study|Withdrawal by Subject|1|||
30571501|NCT02570308|58579278|FG000|Overall Study|Other|0|||
30571502|NCT02570308|58579279|FG001|Overall Study|Other|0|||
30571503|NCT02570308|58579280|FG002|Overall Study|Other|0|||
30571504|NCT02570308|58579281|FG003|Overall Study|Other|0|||
30571505|NCT02570308|58579282|FG004|Overall Study|Other|2|||
30571506|NCT02497612|58579304|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
30571507|NCT02497612|58579305|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
30571508|NCT02497612|58579306|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
30571509|NCT02497612|58579307|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
30571510|NCT02497612|58579304|FG000|Overall Study|Participant's request|2|||
30571511|NCT02497612|58579305|FG001|Overall Study|Participant's request|3|||
30571512|NCT02497612|58579306|FG002|Overall Study|Participant's request|4|||
30571513|NCT02497612|58579307|FG003|Overall Study|Participant's request|1|||
30571514|NCT02497612|58579304|FG000|Overall Study|Investigator's judgement|1|||
30571515|NCT02497612|58579305|FG001|Overall Study|Investigator's judgement|0|||
30571516|NCT02497612|58579306|FG002|Overall Study|Investigator's judgement|0|||
30571517|NCT02497612|58579307|FG003|Overall Study|Investigator's judgement|2|||
30571518|NCT02497612|58579304|FG000|Overall Study|Adverse Event|3|||
30571519|NCT02497612|58579305|FG001|Overall Study|Adverse Event|1|||
30571520|NCT02497612|58579306|FG002|Overall Study|Adverse Event|4|||
30571521|NCT02497612|58579307|FG003|Overall Study|Adverse Event|1|||
30571522|NCT02497612|58579304|FG000|Overall Study|Lost to Follow-up|1|||
30571523|NCT02497612|58579305|FG001|Overall Study|Lost to Follow-up|1|||
30571524|NCT02497612|58579306|FG002|Overall Study|Lost to Follow-up|0|||
30571525|NCT02497612|58579307|FG003|Overall Study|Lost to Follow-up|1|||
30571526|NCT02497612|58579304|FG000|Overall Study|Other unspecified|1|||
30571527|NCT02497612|58579305|FG001|Overall Study|Other unspecified|1|||
30571528|NCT02497612|58579306|FG002|Overall Study|Other unspecified|2|||
30571529|NCT02497612|58579307|FG003|Overall Study|Other unspecified|0|||
30571530|NCT02497612|58579304|FG000|Overall Study|Not eligible|1|||
30571531|NCT02497612|58579305|FG001|Overall Study|Not eligible|0|||
30571532|NCT02497612|58579306|FG002|Overall Study|Not eligible|0|||
30571533|NCT02497612|58579307|FG003|Overall Study|Not eligible|1|||
30571534|NCT02460458|58579317|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
30571535|NCT02460458|58579317|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
30571536|NCT02460458|58579317|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
30571537|NCT02460458|58579317|FG000|First Prospective Phase|Lost to Follow-up|16|||
30571538|NCT02460458|58579317|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
30571539|NCT02457559|58579332|FG000|Overall Study|Progressive Disease|1|||
30571540|NCT02457559|58579333|FG001|Overall Study|Progressive Disease|2|||
30571541|NCT02457559|58579334|FG002|Overall Study|Progressive Disease|3|||
30571542|NCT02457559|58579335|FG003|Overall Study|Progressive Disease|0|||
30571543|NCT02457559|58579336|FG004|Overall Study|Progressive Disease|0|||
30571544|NCT02457559|58579337|FG005|Overall Study|Progressive Disease|2|||
30571545|NCT02457559|58579338|FG006|Overall Study|Progressive Disease|1|||
30571546|NCT02457559|58579339|FG007|Overall Study|Progressive Disease|0|||
30571547|NCT02457559|58579340|FG008|Overall Study|Progressive Disease|1|||
30571548|NCT02457559|58579341|FG009|Overall Study|Progressive Disease|1|||
30571549|NCT02457559|58579342|FG010|Overall Study|Progressive Disease|1|||
30571550|NCT02457559|58579332|FG000|Overall Study|Investigator's Discretion|0|||
30571551|NCT02457559|58579333|FG001|Overall Study|Investigator's Discretion|0|||
30571552|NCT02457559|58579334|FG002|Overall Study|Investigator's Discretion|2|||
30571553|NCT02457559|58579335|FG003|Overall Study|Investigator's Discretion|0|||
30571554|NCT02457559|58579336|FG004|Overall Study|Investigator's Discretion|1|||
30571555|NCT02457559|58579337|FG005|Overall Study|Investigator's Discretion|0|||
30571556|NCT02457559|58579338|FG006|Overall Study|Investigator's Discretion|1|||
30571557|NCT02457559|58579339|FG007|Overall Study|Investigator's Discretion|0|||
30571558|NCT02457559|58579340|FG008|Overall Study|Investigator's Discretion|1|||
30571559|NCT02457559|58579341|FG009|Overall Study|Investigator's Discretion|0|||
30571560|NCT02457559|58579342|FG010|Overall Study|Investigator's Discretion|1|||
30571561|NCT02457559|58579332|FG000|Overall Study|Adverse Event|0|||
30571562|NCT02457559|58579333|FG001|Overall Study|Adverse Event|1|||
30571563|NCT02457559|58579334|FG002|Overall Study|Adverse Event|2|||
30571564|NCT02457559|58579335|FG003|Overall Study|Adverse Event|0|||
30571565|NCT02457559|58579336|FG004|Overall Study|Adverse Event|0|||
30571566|NCT02457559|58579337|FG005|Overall Study|Adverse Event|0|||
30571567|NCT02457559|58579338|FG006|Overall Study|Adverse Event|0|||
30571568|NCT02457559|58579339|FG007|Overall Study|Adverse Event|0|||
30571569|NCT02457559|58579340|FG008|Overall Study|Adverse Event|0|||
30571570|NCT02457559|58579341|FG009|Overall Study|Adverse Event|0|||
30571571|NCT02457559|58579342|FG010|Overall Study|Adverse Event|0|||
30571572|NCT02457559|58579332|FG000|Overall Study|Reason not Specified|1|||
30571573|NCT02457559|58579333|FG001|Overall Study|Reason not Specified|0|||
30571574|NCT02457559|58579334|FG002|Overall Study|Reason not Specified|0|||
30571575|NCT02457559|58579335|FG003|Overall Study|Reason not Specified|0|||
30571576|NCT02457559|58579336|FG004|Overall Study|Reason not Specified|0|||
30571577|NCT02457559|58579337|FG005|Overall Study|Reason not Specified|0|||
30571578|NCT02457559|58579338|FG006|Overall Study|Reason not Specified|0|||
30571579|NCT02457559|58579339|FG007|Overall Study|Reason not Specified|0|||
30571580|NCT02457559|58579340|FG008|Overall Study|Reason not Specified|0|||
30571581|NCT02457559|58579341|FG009|Overall Study|Reason not Specified|2|||
30571582|NCT02457559|58579342|FG010|Overall Study|Reason not Specified|0|||
30571583|NCT02457559|58579332|FG000|Overall Study|Death|0|||
30571584|NCT02457559|58579333|FG001|Overall Study|Death|0|||
30571585|NCT02457559|58579334|FG002|Overall Study|Death|0|||
30571586|NCT02457559|58579335|FG003|Overall Study|Death|0|||
30571587|NCT02457559|58579336|FG004|Overall Study|Death|0|||
30571588|NCT02457559|58579337|FG005|Overall Study|Death|0|||
30571589|NCT02457559|58579338|FG006|Overall Study|Death|0|||
30571590|NCT02457559|58579339|FG007|Overall Study|Death|0|||
30571591|NCT02457559|58579340|FG008|Overall Study|Death|1|||
30571592|NCT02457559|58579341|FG009|Overall Study|Death|1|||
30571593|NCT02457559|58579342|FG010|Overall Study|Death|0|||
30571594|NCT02381652|58579392|FG000|Overall Study|Withdrawal by Subject|0|||
30571595|NCT02381652|58579393|FG001|Overall Study|Withdrawal by Subject|0|||
30571596|NCT02381652|58579394|FG002|Overall Study|Withdrawal by Subject|1|||
30571597|NCT02367794|58579403|FG000|Overall Study|Death|252|||
30571598|NCT02367794|58579404|FG001|Overall Study|Death|245|||
30571599|NCT02367794|58579405|FG002|Overall Study|Death|243|||
30571600|NCT02367794|58579403|FG000|Overall Study|Lost to Follow-up|1|||
30571601|NCT02367794|58579404|FG001|Overall Study|Lost to Follow-up|2|||
30571602|NCT02367794|58579405|FG002|Overall Study|Lost to Follow-up|2|||
30571603|NCT02367794|58579403|FG000|Overall Study|Physician Decision|0|||
30571604|NCT02367794|58579404|FG001|Overall Study|Physician Decision|5|||
30571605|NCT02367794|58579405|FG002|Overall Study|Physician Decision|3|||
30571606|NCT02367794|58579403|FG000|Overall Study|Protocol Violation|1|||
30571607|NCT02367794|58579404|FG001|Overall Study|Protocol Violation|0|||
30571608|NCT02367794|58579405|FG002|Overall Study|Protocol Violation|1|||
30571609|NCT02367794|58579403|FG000|Overall Study|Withdrawal by Subject|25|||
30571610|NCT02367794|58579404|FG001|Overall Study|Withdrawal by Subject|12|||
30571611|NCT02367794|58579405|FG002|Overall Study|Withdrawal by Subject|20|||
30571612|NCT02367794|58579403|FG000|Overall Study|Brain metastasis|1|||
30571613|NCT02367794|58579404|FG001|Overall Study|Brain metastasis|0|||
30571614|NCT02367794|58579405|FG002|Overall Study|Brain metastasis|0|||
30571615|NCT02367794|58579403|FG000|Overall Study|Randomized in error|0|||
30571616|NCT02367794|58579404|FG001|Overall Study|Randomized in error|0|||
30571617|NCT02367794|58579405|FG002|Overall Study|Randomized in error|1|||
30571618|NCT02367794|58579403|FG000|Overall Study|Patient unable to receive carboplatin|0|||
30571619|NCT02367794|58579404|FG001|Overall Study|Patient unable to receive carboplatin|0|||
30571620|NCT02367794|58579405|FG002|Overall Study|Patient unable to receive carboplatin|1|||
30571621|NCT02367794|58579403|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
30571622|NCT02367794|58579404|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
30571623|NCT02367794|58579405|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
30571624|NCT02367794|58579403|FG000|Overall Study|Adverse Event|0|||
30571625|NCT02367794|58579404|FG001|Overall Study|Adverse Event|0|||
30571626|NCT02367794|58579405|FG002|Overall Study|Adverse Event|2|||
30571627|NCT02367794|58579403|FG000|Overall Study|Study Terminated By Sponsor|0|||
30571628|NCT02367794|58579404|FG001|Overall Study|Study Terminated By Sponsor|1|||
30571629|NCT02367794|58579405|FG002|Overall Study|Study Terminated By Sponsor|1|||
30571630|NCT02367794|58579403|FG000|Overall Study|Moved to Roll-Over Study|0|||
30571631|NCT02367794|58579404|FG001|Overall Study|Moved to Roll-Over Study|15|||
30571632|NCT02367794|58579405|FG002|Overall Study|Moved to Roll-Over Study|13|||
30571633|NCT02367794|58579403|FG000|Overall Study|Sponsor Request|60|||
30571634|NCT02367794|58579404|FG001|Overall Study|Sponsor Request|57|||
30571635|NCT02367794|58579405|FG002|Overall Study|Sponsor Request|45|||
30571636|NCT02367794|58579403|FG000|Overall Study|Moved into PTAP Study|0|||
30571637|NCT02367794|58579404|FG001|Overall Study|Moved into PTAP Study|2|||
30571638|NCT02367794|58579405|FG002|Overall Study|Moved into PTAP Study|3|||
30571639|NCT02367794|58579403|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
30571640|NCT02367794|58579404|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
30571641|NCT02367794|58579405|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
30571642|NCT02367794|58579403|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
30571643|NCT02367794|58579404|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
30571644|NCT02367794|58579405|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
30571645|NCT02367794|58579403|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
30571646|NCT02367794|58579404|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
30571647|NCT02367794|58579405|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
30571648|NCT02367794|58579403|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
30571649|NCT02367794|58579404|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
30571650|NCT02367794|58579405|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
30571651|NCT02353832|58579438|FG000|Overall Study|Ineligible after enrollment|1|||
30571652|NCT02353832|58579438|FG000|Overall Study|Lost to Follow-up|1|||
30571653|NCT02353728|58579442|FG000|Overall Study|Subject non-compliance|1|||
30571654|NCT02345070|58579449|FG000|Overall Study|Adverse Event|12|||
30571655|NCT02345070|58579450|FG001|Overall Study|Adverse Event|8|||
30571656|NCT02345070|58579451|FG002|Overall Study|Adverse Event|16|||
30571657|NCT02345070|58579449|FG000|Overall Study|Poor compliance to protocol|2|||
30571658|NCT02345070|58579450|FG001|Overall Study|Poor compliance to protocol|0|||
30571659|NCT02345070|58579451|FG002|Overall Study|Poor compliance to protocol|0|||
30571660|NCT02345070|58579449|FG000|Overall Study|Other than specified above|6|||
30571661|NCT02345070|58579450|FG001|Overall Study|Other than specified above|3|||
30571662|NCT02345070|58579451|FG002|Overall Study|Other than specified above|7|||
30571663|NCT02325466|58579459|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
30571664|NCT02325466|58579460|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
30571665|NCT02325466|58579461|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
30571666|NCT02325466|58579459|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
30571667|NCT02325466|58579460|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
30571668|NCT02325466|58579461|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
30571669|NCT02325466|58579459|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
30571670|NCT02325466|58579460|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
30571671|NCT02325466|58579461|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
30571672|NCT02325466|58579459|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
30571673|NCT02325466|58579460|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
30571674|NCT02325466|58579461|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
30571675|NCT02325466|58579459|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
30571676|NCT02325466|58579460|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
30571677|NCT02325466|58579461|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
30571678|NCT02325466|58579459|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
30571679|NCT02325466|58579460|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
30571680|NCT02325466|58579461|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
30571681|NCT02325466|58579459|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
30571682|NCT02325466|58579460|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
30571683|NCT02325466|58579461|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
30780205|NCT02991430|58791902|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30780206|NCT02991430|58791900|FG000|Treatment Period 2|Study Termination|6|||
30571684|NCT02325466|58579459|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
30571685|NCT02325466|58579460|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
30780207|NCT02991430|58791901|FG001|Treatment Period 2|Study Termination|3|||
30780208|NCT02991430|58791902|FG002|Treatment Period 2|Study Termination|3|||
30571686|NCT02325466|58579461|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
30571687|NCT02325466|58579459|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
30571688|NCT02325466|58579460|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
30571689|NCT02325466|58579461|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
30571690|NCT02322710|58579472|FG000|Overall Study|No efficacy assessment post-baseline|0|||
30571691|NCT02322710|58579473|FG001|Overall Study|No efficacy assessment post-baseline|1|||
30571692|NCT02322710|58579472|FG000|Overall Study|Protocol Violation|20|||
30571693|NCT02322710|58579473|FG001|Overall Study|Protocol Violation|25|||
30571694|NCT02234310|58579516|FG000|Overall Study|Physician Decision|1|||
30571695|NCT02234310|58579516|FG000|Overall Study|Adverse Event|1|||
30571696|NCT02234310|58579516|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
30571697|NCT02234310|58579516|FG000|Overall Study|Withdrawal by Subject|2|||
30571698|NCT02106195|58579549|FG000|Overall Study|Adverse Event|2|||
30571699|NCT02106195|58579549|FG000|Overall Study|Protocol Violation|1|||
30571700|NCT02104180|58579561|FG000|Overall Study|Protocol Violation|1|||
30571701|NCT02104180|58579562|FG001|Overall Study|Protocol Violation|0|||
30571702|NCT02040857|58579572|FG000|Overall Study|Adverse Event|14|||
30571703|NCT02040857|58579572|FG000|Overall Study|Physician Decision|5|||
30571704|NCT02040857|58579572|FG000|Overall Study|Withdrawal by Subject|31|||
30571705|NCT02040857|58579572|FG000|Overall Study|patient non-compliance|3|||
30571706|NCT02040857|58579572|FG000|Overall Study|Lost to Follow-up|2|||
30571707|NCT02040857|58579572|FG000|Overall Study|recurrence|4|||
30571708|NCT02040857|58579572|FG000|Overall Study|ineligible|1|||
30571709|NCT01943825|58579592|FG000|Overall Study|Lost to Follow-up|9|||
30571710|NCT01943825|58579593|FG001|Overall Study|Lost to Follow-up|3|||
30571711|NCT01943825|58579594|FG002|Overall Study|Lost to Follow-up|12|||
30571712|NCT01943825|58579595|FG003|Overall Study|Lost to Follow-up|8|||
30571713|NCT01943825|58579592|FG000|Overall Study|Withdrawal by Subject|1|||
30571714|NCT01943825|58579593|FG001|Overall Study|Withdrawal by Subject|0|||
30571715|NCT01943825|58579594|FG002|Overall Study|Withdrawal by Subject|3|||
30571716|NCT01943825|58579595|FG003|Overall Study|Withdrawal by Subject|2|||
30571717|NCT01943825|58579592|FG000|Overall Study|Other than specified above|0|||
30571718|NCT01943825|58579593|FG001|Overall Study|Other than specified above|1|||
30571719|NCT01943825|58579594|FG002|Overall Study|Other than specified above|0|||
30571720|NCT01943825|58579595|FG003|Overall Study|Other than specified above|1|||
30571721|NCT01722331|58579627|FG000|Part 1|Adverse Event|5|||
30571722|NCT01722331|58579628|FG001|Part 1|Adverse Event|0|||
30571723|NCT01722331|58579629|FG002|Part 1|Adverse Event|0|||
30571724|NCT01722331|58579630|FG003|Part 1|Adverse Event|0|||
30571725|NCT01722331|58579631|FG004|Part 1|Adverse Event|0|||
30571726|NCT01722331|58579632|FG005|Part 1|Adverse Event|0|||
30571727|NCT01722331|58579633|FG006|Part 1|Adverse Event|0|||
30571728|NCT01722331|58579627|FG000|Part 1|Lack of Efficacy|0|||
30571729|NCT01722331|58579628|FG001|Part 1|Lack of Efficacy|0|||
30571730|NCT01722331|58579629|FG002|Part 1|Lack of Efficacy|1|||
30571731|NCT01722331|58579630|FG003|Part 1|Lack of Efficacy|0|||
30571732|NCT01722331|58579631|FG004|Part 1|Lack of Efficacy|2|||
30571733|NCT01722331|58579632|FG005|Part 1|Lack of Efficacy|0|||
30571734|NCT01722331|58579633|FG006|Part 1|Lack of Efficacy|0|||
30571735|NCT01722331|58579627|FG000|Part 1|Lost to Follow-up|1|||
30571736|NCT01722331|58579628|FG001|Part 1|Lost to Follow-up|0|||
30571737|NCT01722331|58579629|FG002|Part 1|Lost to Follow-up|2|||
30571738|NCT01722331|58579630|FG003|Part 1|Lost to Follow-up|0|||
30571739|NCT01722331|58579631|FG004|Part 1|Lost to Follow-up|1|||
30571740|NCT01722331|58579632|FG005|Part 1|Lost to Follow-up|0|||
30571741|NCT01722331|58579633|FG006|Part 1|Lost to Follow-up|0|||
30571742|NCT01722331|58579627|FG000|Part 1|Physician Decision|0|||
30571743|NCT01722331|58579628|FG001|Part 1|Physician Decision|0|||
30571744|NCT01722331|58579629|FG002|Part 1|Physician Decision|3|||
30571745|NCT01722331|58579630|FG003|Part 1|Physician Decision|0|||
30571746|NCT01722331|58579631|FG004|Part 1|Physician Decision|1|||
30571747|NCT01722331|58579632|FG005|Part 1|Physician Decision|0|||
30571748|NCT01722331|58579633|FG006|Part 1|Physician Decision|0|||
30571749|NCT01722331|58579627|FG000|Part 1|Pregnancy|1|||
30571750|NCT01722331|58579628|FG001|Part 1|Pregnancy|0|||
30571751|NCT01722331|58579629|FG002|Part 1|Pregnancy|0|||
30571752|NCT01722331|58579630|FG003|Part 1|Pregnancy|0|||
30571753|NCT01722331|58579631|FG004|Part 1|Pregnancy|0|||
30571754|NCT01722331|58579632|FG005|Part 1|Pregnancy|0|||
30958659|NCT01694849|59023703|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
30571755|NCT01722331|58579633|FG006|Part 1|Pregnancy|0|||
30571756|NCT01722331|58579627|FG000|Part 1|Progressive Disease|0|||
30571757|NCT01722331|58579628|FG001|Part 1|Progressive Disease|0|||
30571758|NCT01722331|58579629|FG002|Part 1|Progressive Disease|0|||
30571759|NCT01722331|58579630|FG003|Part 1|Progressive Disease|0|||
30571760|NCT01722331|58579631|FG004|Part 1|Progressive Disease|1|||
30571761|NCT01722331|58579632|FG005|Part 1|Progressive Disease|0|||
30571762|NCT01722331|58579633|FG006|Part 1|Progressive Disease|0|||
30571763|NCT01722331|58579627|FG000|Part 1|Protocol Violation|1|||
30571764|NCT01722331|58579628|FG001|Part 1|Protocol Violation|0|||
30571765|NCT01722331|58579629|FG002|Part 1|Protocol Violation|0|||
30571766|NCT01722331|58579630|FG003|Part 1|Protocol Violation|0|||
30571767|NCT01722331|58579631|FG004|Part 1|Protocol Violation|1|||
30571768|NCT01722331|58579632|FG005|Part 1|Protocol Violation|0|||
30571769|NCT01722331|58579633|FG006|Part 1|Protocol Violation|0|||
30571770|NCT01722331|58579627|FG000|Part 1|Withdrawal by Subject|2|||
30571771|NCT01722331|58579628|FG001|Part 1|Withdrawal by Subject|0|||
30571772|NCT01722331|58579629|FG002|Part 1|Withdrawal by Subject|3|||
30571773|NCT01722331|58579630|FG003|Part 1|Withdrawal by Subject|0|||
30571774|NCT01722331|58579631|FG004|Part 1|Withdrawal by Subject|3|||
30571775|NCT01722331|58579632|FG005|Part 1|Withdrawal by Subject|0|||
30571776|NCT01722331|58579633|FG006|Part 1|Withdrawal by Subject|0|||
30571777|NCT01722331|58579627|FG000|Part 2|Adverse Event|3|||
30571778|NCT01722331|58579628|FG001|Part 2|Adverse Event|0|||
30571779|NCT01722331|58579629|FG002|Part 2|Adverse Event|0|||
30571780|NCT01722331|58579630|FG003|Part 2|Adverse Event|0|||
30571781|NCT01722331|58579631|FG004|Part 2|Adverse Event|0|||
30571782|NCT01722331|58579632|FG005|Part 2|Adverse Event|1|||
30571783|NCT01722331|58579633|FG006|Part 2|Adverse Event|0|||
30571784|NCT01722331|58579627|FG000|Part 2|Lack of Efficacy|3|||
30571785|NCT01722331|58579628|FG001|Part 2|Lack of Efficacy|0|||
30571786|NCT01722331|58579629|FG002|Part 2|Lack of Efficacy|11|||
30571787|NCT01722331|58579630|FG003|Part 2|Lack of Efficacy|0|||
30571788|NCT01722331|58579631|FG004|Part 2|Lack of Efficacy|0|||
30571789|NCT01722331|58579632|FG005|Part 2|Lack of Efficacy|3|||
30571790|NCT01722331|58579633|FG006|Part 2|Lack of Efficacy|3|||
30571791|NCT01722331|58579627|FG000|Part 2|Lost to Follow-up|0|||
30571792|NCT01722331|58579628|FG001|Part 2|Lost to Follow-up|0|||
30571793|NCT01722331|58579629|FG002|Part 2|Lost to Follow-up|3|||
30571794|NCT01722331|58579630|FG003|Part 2|Lost to Follow-up|0|||
30571795|NCT01722331|58579631|FG004|Part 2|Lost to Follow-up|0|||
30571796|NCT01722331|58579632|FG005|Part 2|Lost to Follow-up|1|||
30571797|NCT01722331|58579633|FG006|Part 2|Lost to Follow-up|1|||
30571798|NCT01722331|58579627|FG000|Part 2|Non-Compliance with Study Drug|1|||
30571799|NCT01722331|58579628|FG001|Part 2|Non-Compliance with Study Drug|0|||
30571800|NCT01722331|58579629|FG002|Part 2|Non-Compliance with Study Drug|1|||
30571801|NCT01722331|58579630|FG003|Part 2|Non-Compliance with Study Drug|0|||
30571802|NCT01722331|58579631|FG004|Part 2|Non-Compliance with Study Drug|0|||
30571803|NCT01722331|58579632|FG005|Part 2|Non-Compliance with Study Drug|0|||
30571804|NCT01722331|58579633|FG006|Part 2|Non-Compliance with Study Drug|0|||
30571805|NCT01722331|58579627|FG000|Part 2|Physician Decision|0|||
30571806|NCT01722331|58579628|FG001|Part 2|Physician Decision|0|||
30571807|NCT01722331|58579629|FG002|Part 2|Physician Decision|2|||
30571808|NCT01722331|58579630|FG003|Part 2|Physician Decision|0|||
30571809|NCT01722331|58579631|FG004|Part 2|Physician Decision|0|||
30571810|NCT01722331|58579632|FG005|Part 2|Physician Decision|0|||
30571811|NCT01722331|58579633|FG006|Part 2|Physician Decision|0|||
30571812|NCT01722331|58579627|FG000|Part 2|Pregnancy|0|||
30571813|NCT01722331|58579628|FG001|Part 2|Pregnancy|0|||
30571814|NCT01722331|58579629|FG002|Part 2|Pregnancy|0|||
30571815|NCT01722331|58579630|FG003|Part 2|Pregnancy|0|||
30571816|NCT01722331|58579631|FG004|Part 2|Pregnancy|0|||
30571817|NCT01722331|58579632|FG005|Part 2|Pregnancy|1|||
30571818|NCT01722331|58579633|FG006|Part 2|Pregnancy|0|||
30571819|NCT01722331|58579627|FG000|Part 2|Progressive Disease|0|||
30571820|NCT01722331|58579628|FG001|Part 2|Progressive Disease|0|||
30571821|NCT01722331|58579629|FG002|Part 2|Progressive Disease|1|||
30571822|NCT01722331|58579630|FG003|Part 2|Progressive Disease|0|||
30571823|NCT01722331|58579631|FG004|Part 2|Progressive Disease|0|||
30571824|NCT01722331|58579632|FG005|Part 2|Progressive Disease|0|||
30571825|NCT01722331|58579633|FG006|Part 2|Progressive Disease|0|||
30571826|NCT01722331|58579627|FG000|Part 2|Protocol Violation|1|||
30571827|NCT01722331|58579628|FG001|Part 2|Protocol Violation|0|||
30571828|NCT01722331|58579629|FG002|Part 2|Protocol Violation|0|||
30571829|NCT01722331|58579630|FG003|Part 2|Protocol Violation|0|||
30571830|NCT01722331|58579631|FG004|Part 2|Protocol Violation|0|||
30571831|NCT01722331|58579632|FG005|Part 2|Protocol Violation|0|||
30571832|NCT01722331|58579633|FG006|Part 2|Protocol Violation|0|||
30571833|NCT01722331|58579627|FG000|Part 2|Withdrawal by Subject|5|||
30571834|NCT01722331|58579628|FG001|Part 2|Withdrawal by Subject|0|||
30571835|NCT01722331|58579629|FG002|Part 2|Withdrawal by Subject|3|||
30571836|NCT01722331|58579630|FG003|Part 2|Withdrawal by Subject|0|||
30571837|NCT01722331|58579631|FG004|Part 2|Withdrawal by Subject|0|||
30571838|NCT01722331|58579632|FG005|Part 2|Withdrawal by Subject|2|||
30571839|NCT01722331|58579633|FG006|Part 2|Withdrawal by Subject|2|||
30571840|NCT01722331|58579627|FG000|Part 2|Other Protocol Specified Criteria|6|||
30571841|NCT01722331|58579628|FG001|Part 2|Other Protocol Specified Criteria|0|||
30571842|NCT01722331|58579629|FG002|Part 2|Other Protocol Specified Criteria|10|||
30571843|NCT01722331|58579630|FG003|Part 2|Other Protocol Specified Criteria|0|||
30571844|NCT01722331|58579631|FG004|Part 2|Other Protocol Specified Criteria|0|||
30571845|NCT01722331|58579632|FG005|Part 2|Other Protocol Specified Criteria|2|||
30571846|NCT01722331|58579633|FG006|Part 2|Other Protocol Specified Criteria|1|||
30571847|NCT01722331|58579627|FG000|Part 3|Adverse Event|2|||
30571848|NCT01722331|58579628|FG001|Part 3|Adverse Event|2|||
30571849|NCT01722331|58579629|FG002|Part 3|Adverse Event|0|||
30571850|NCT01722331|58579630|FG003|Part 3|Adverse Event|1|||
30571851|NCT01722331|58579631|FG004|Part 3|Adverse Event|0|||
30571852|NCT01722331|58579632|FG005|Part 3|Adverse Event|0|||
30571853|NCT01722331|58579633|FG006|Part 3|Adverse Event|0|||
30571854|NCT01722331|58579627|FG000|Part 3|Death|1|||
30571855|NCT01722331|58579628|FG001|Part 3|Death|0|||
30571856|NCT01722331|58579629|FG002|Part 3|Death|0|||
30571857|NCT01722331|58579630|FG003|Part 3|Death|0|||
30571858|NCT01722331|58579631|FG004|Part 3|Death|0|||
30571859|NCT01722331|58579632|FG005|Part 3|Death|0|||
30571860|NCT01722331|58579633|FG006|Part 3|Death|0|||
30571861|NCT01722331|58579627|FG000|Part 3|Lack of Efficacy|1|||
30571862|NCT01722331|58579628|FG001|Part 3|Lack of Efficacy|0|||
30571863|NCT01722331|58579629|FG002|Part 3|Lack of Efficacy|0|||
30571864|NCT01722331|58579630|FG003|Part 3|Lack of Efficacy|0|||
30571865|NCT01722331|58579631|FG004|Part 3|Lack of Efficacy|0|||
30571866|NCT01722331|58579632|FG005|Part 3|Lack of Efficacy|0|||
30667761|NCT03252587|58681653|FG000|Overall Study|Other Reasons|2|||
30667762|NCT03252587|58681654|FG001|Overall Study|Other Reasons|5|||
30667763|NCT03252587|58681655|FG002|Overall Study|Other Reasons|5|||
30667764|NCT03252587|58681656|FG003|Overall Study|Other Reasons|4|||
30667765|NCT00511147|58681669|FG000|Overall Study|Withdrawal by Subject|1|||
30667766|NCT00511147|58681669|FG000|Overall Study|Disease progression|5|||
30667767|NCT00511147|58681669|FG000|Overall Study|Required platelet transfusion|1|||
30667768|NCT00510835|58681676|FG000|Overall Study|Withdrawal by Subject|6|||
30780209|NCT02991430|58791900|FG000|Treatment Period 2|Lost to Follow-up|0|||
30780210|NCT02991430|58791901|FG001|Treatment Period 2|Lost to Follow-up|0|||
30780211|NCT02991430|58791902|FG002|Treatment Period 2|Lost to Follow-up|1|||
30780212|NCT02991430|58791900|FG000|Post-treatment Observation Period|Study Termination|3|||
30780213|NCT02991430|58791901|FG001|Post-treatment Observation Period|Study Termination|6|||
30780214|NCT02991430|58791902|FG002|Post-treatment Observation Period|Study Termination|5|||
30780215|NCT03411902|58791912|FG000|Overall Study|Lost to Follow-up|3|||
30780216|NCT03411902|58791913|FG001|Overall Study|Lost to Follow-up|0|||
30780217|NCT03494816|58791919|FG000|Overall Study|Protocol Violation|2|||
30855240|NCT02603120|58882786|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
30571867|NCT01722331|58579633|FG006|Part 3|Lack of Efficacy|0|||
30571868|NCT01722331|58579627|FG000|Part 3|Lost to Follow-up|3|||
30571869|NCT01722331|58579628|FG001|Part 3|Lost to Follow-up|4|||
30571870|NCT01722331|58579629|FG002|Part 3|Lost to Follow-up|0|||
30571871|NCT01722331|58579630|FG003|Part 3|Lost to Follow-up|0|||
30571872|NCT01722331|58579631|FG004|Part 3|Lost to Follow-up|0|||
30571873|NCT01722331|58579632|FG005|Part 3|Lost to Follow-up|1|||
30571874|NCT01722331|58579633|FG006|Part 3|Lost to Follow-up|0|||
30571875|NCT01722331|58579627|FG000|Part 3|Non-Compliance with Study Drug|0|||
30571876|NCT01722331|58579628|FG001|Part 3|Non-Compliance with Study Drug|1|||
30571877|NCT01722331|58579629|FG002|Part 3|Non-Compliance with Study Drug|0|||
30571878|NCT01722331|58579630|FG003|Part 3|Non-Compliance with Study Drug|0|||
30571879|NCT01722331|58579631|FG004|Part 3|Non-Compliance with Study Drug|0|||
30571880|NCT01722331|58579632|FG005|Part 3|Non-Compliance with Study Drug|0|||
30571881|NCT01722331|58579633|FG006|Part 3|Non-Compliance with Study Drug|0|||
30571882|NCT01722331|58579627|FG000|Part 3|Physician Decision|1|||
30571883|NCT01722331|58579628|FG001|Part 3|Physician Decision|1|||
30571884|NCT01722331|58579629|FG002|Part 3|Physician Decision|0|||
30571885|NCT01722331|58579630|FG003|Part 3|Physician Decision|0|||
30571886|NCT01722331|58579631|FG004|Part 3|Physician Decision|0|||
30571887|NCT01722331|58579632|FG005|Part 3|Physician Decision|0|||
30571888|NCT01722331|58579633|FG006|Part 3|Physician Decision|1|||
30571889|NCT01722331|58579627|FG000|Part 3|Protocol Violation|2|||
30571890|NCT01722331|58579628|FG001|Part 3|Protocol Violation|1|||
30571891|NCT01722331|58579629|FG002|Part 3|Protocol Violation|0|||
30571892|NCT01722331|58579630|FG003|Part 3|Protocol Violation|0|||
30571893|NCT01722331|58579631|FG004|Part 3|Protocol Violation|0|||
30571894|NCT01722331|58579632|FG005|Part 3|Protocol Violation|0|||
30571895|NCT01722331|58579633|FG006|Part 3|Protocol Violation|0|||
30571896|NCT01722331|58579627|FG000|Part 3|Withdrawal by Subject|4|||
30571897|NCT01722331|58579628|FG001|Part 3|Withdrawal by Subject|7|||
30571898|NCT01722331|58579629|FG002|Part 3|Withdrawal by Subject|0|||
30571899|NCT01722331|58579630|FG003|Part 3|Withdrawal by Subject|0|||
30571900|NCT01722331|58579631|FG004|Part 3|Withdrawal by Subject|0|||
30571901|NCT01722331|58579632|FG005|Part 3|Withdrawal by Subject|2|||
30571902|NCT01722331|58579633|FG006|Part 3|Withdrawal by Subject|1|||
30571903|NCT01722331|58579627|FG000|Part 3|Other Protocol Specified Criteria|1|||
30571904|NCT01722331|58579628|FG001|Part 3|Other Protocol Specified Criteria|1|||
30571905|NCT01722331|58579629|FG002|Part 3|Other Protocol Specified Criteria|0|||
30571906|NCT01722331|58579630|FG003|Part 3|Other Protocol Specified Criteria|0|||
30571907|NCT01722331|58579631|FG004|Part 3|Other Protocol Specified Criteria|0|||
30780218|NCT03494816|58791919|FG000|Overall Study|Physician Decision|2|||
30780219|NCT03494816|58791919|FG000|Overall Study|Did not start trial treatment|1|||
30571908|NCT01722331|58579632|FG005|Part 3|Other Protocol Specified Criteria|0|||
30571909|NCT01722331|58579633|FG006|Part 3|Other Protocol Specified Criteria|0|||
30571910|NCT01630590|58579645|FG000|Overall Study|Adverse Event|9|||
30571911|NCT01630590|58579645|FG000|Overall Study|Lack of Efficacy|37|||
30571912|NCT01630590|58579645|FG000|Overall Study|Withdrawal by Subject|4|||
30571913|NCT01630590|58579645|FG000|Overall Study|2nd primary tumor|2|||
30571914|NCT01630590|58579645|FG000|Overall Study|Automobile accident|1|||
30667769|NCT00510835|58681677|FG001|Overall Study|Withdrawal by Subject|2|||
30780220|NCT03494816|58791919|FG000|Overall Study|Adverse Event|1|||
30571915|NCT01630590|58579645|FG000|Overall Study|Maximum benefit|4|||
30571916|NCT01619085|58579649|FG000|Overall Study|Adverse Event|231|||
30571917|NCT01619085|58579649|FG000|Overall Study|Protocol Violation|4|||
30571918|NCT01619085|58579649|FG000|Overall Study|Lost to Follow-up|3|||
30571919|NCT01619085|58579649|FG000|Overall Study|Withdrawal by Subject|45|||
30571920|NCT01619085|58579649|FG000|Overall Study|Other than specified|96|||
30571921|NCT01619085|58579649|FG000|Overall Study|Not treated|1|||
30571922|NCT01619085|58579649|FG000|Overall Study|Death|145|||
30571923|NCT01499095|58579662|FG000|Overall Study|Randomized But Not Treated|1|||
30571924|NCT01499095|58579663|FG001|Overall Study|Randomized But Not Treated|1|||
30571925|NCT01499095|58579662|FG000|Overall Study|Adverse Event|12|||
30571926|NCT01499095|58579663|FG001|Overall Study|Adverse Event|7|||
30571927|NCT01499095|58579662|FG000|Overall Study|Lack of Efficacy|2|||
30571928|NCT01499095|58579663|FG001|Overall Study|Lack of Efficacy|1|||
30571929|NCT01499095|58579662|FG000|Overall Study|Protocol Violation|6|||
30571930|NCT01499095|58579663|FG001|Overall Study|Protocol Violation|7|||
30571931|NCT01499095|58579662|FG000|Overall Study|Received Rescue Therapy|32|||
30571932|NCT01499095|58579663|FG001|Overall Study|Received Rescue Therapy|40|||
30571933|NCT01499095|58579662|FG000|Overall Study|Diverse Reasons|22|||
30571934|NCT01499095|58579663|FG001|Overall Study|Diverse Reasons|25|||
30571935|NCT01499095|58579662|FG000|Overall Study|Lost to Follow-up|6|||
30571936|NCT01499095|58579663|FG001|Overall Study|Lost to Follow-up|4|||
30571937|NCT01499095|58579662|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
30571938|NCT01499095|58579663|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
30571939|NCT01499095|58579662|FG000|Overall Study|Hypoglycemia|3|||
30571940|NCT01499095|58579663|FG001|Overall Study|Hypoglycemia|1|||
30571941|NCT01499095|58579662|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
30571942|NCT01499095|58579663|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
30571943|NCT01499095|58579662|FG000|Overall Study|Change in Injection Schedule|2|||
30571944|NCT01499095|58579663|FG001|Overall Study|Change in Injection Schedule|0|||
30571945|NCT01499095|58579662|FG000|Overall Study|Perceived Lack of Efficacy|1|||
30571946|NCT01499095|58579663|FG001|Overall Study|Perceived Lack of Efficacy|1|||
30571947|NCT01499082|58579674|FG000|Overall Study|Randomized but not Treated|0|||
30571948|NCT01499082|58579675|FG001|Overall Study|Randomized but not Treated|1|||
30571949|NCT01499082|58579674|FG000|Overall Study|Adverse Event|12|||
30571950|NCT01499082|58579675|FG001|Overall Study|Adverse Event|16|||
30571951|NCT01499082|58579674|FG000|Overall Study|Lack of Efficacy|1|||
30571952|NCT01499082|58579675|FG001|Overall Study|Lack of Efficacy|1|||
30571953|NCT01499082|58579674|FG000|Overall Study|Protocol Violation|6|||
30571954|NCT01499082|58579675|FG001|Overall Study|Protocol Violation|8|||
30571955|NCT01499082|58579674|FG000|Overall Study|Diverse Reasons|18|||
30571956|NCT01499082|58579675|FG001|Overall Study|Diverse Reasons|14|||
30571957|NCT01499082|58579674|FG000|Overall Study|Site Closure for Noncompliance|5|||
30571958|NCT01499082|58579675|FG001|Overall Study|Site Closure for Noncompliance|2|||
30571959|NCT01499082|58579674|FG000|Overall Study|Hypoglycemia|2|||
30571960|NCT01499082|58579675|FG001|Overall Study|Hypoglycemia|3|||
30571961|NCT01499082|58579674|FG000|Overall Study|Lost to Follow-up|1|||
30571962|NCT01499082|58579675|FG001|Overall Study|Lost to Follow-up|3|||
30571963|NCT01488890|58579687|FG000|Overall Study|Serious adverse event|2|||
30571964|NCT01488890|58579688|FG001|Overall Study|Serious adverse event|0|||
30571965|NCT01488890|58579689|FG002|Overall Study|Serious adverse event|0|||
30571966|NCT01488890|58579690|FG003|Overall Study|Serious adverse event|0|||
30571967|NCT01488890|58579687|FG000|Overall Study|Protocol Violation|3|||
30571968|NCT01488890|58579688|FG001|Overall Study|Protocol Violation|0|||
30571969|NCT01488890|58579689|FG002|Overall Study|Protocol Violation|4|||
30571970|NCT01488890|58579690|FG003|Overall Study|Protocol Violation|0|||
30571971|NCT01488890|58579687|FG000|Overall Study|Lost to Follow-up|13|||
30571972|NCT01488890|58579688|FG001|Overall Study|Lost to Follow-up|10|||
30571973|NCT01488890|58579689|FG002|Overall Study|Lost to Follow-up|20|||
30667770|NCT00510835|58681678|FG002|Overall Study|Withdrawal by Subject|2|||
30667771|NCT00506077|58681688|FG000|Treatment Period 1|Adverse Event|2|||
30667772|NCT00506077|58681689|FG001|Treatment Period 1|Adverse Event|1|||
30571974|NCT01488890|58579690|FG003|Overall Study|Lost to Follow-up|3|||
30571975|NCT01488890|58579687|FG000|Overall Study|Withdrawal by Subject|14|||
30571976|NCT01488890|58579688|FG001|Overall Study|Withdrawal by Subject|10|||
30571977|NCT01488890|58579689|FG002|Overall Study|Withdrawal by Subject|11|||
30571978|NCT01488890|58579690|FG003|Overall Study|Withdrawal by Subject|2|||
30571979|NCT01436396|58579706|FG000|Overall Study|Protocol Violation|7|||
30571980|NCT01436396|58579707|FG001|Overall Study|Protocol Violation|5|||
30571981|NCT01436396|58579706|FG000|Overall Study|Adverse Event|1|||
30571982|NCT01436396|58579707|FG001|Overall Study|Adverse Event|2|||
30571983|NCT01436396|58579706|FG000|Overall Study|Withdrawal by Subject|19|||
30571984|NCT01436396|58579707|FG001|Overall Study|Withdrawal by Subject|29|||
30571985|NCT01436396|58579706|FG000|Overall Study|Serious adverse event|2|||
30571986|NCT01436396|58579707|FG001|Overall Study|Serious adverse event|3|||
30571987|NCT01436396|58579706|FG000|Overall Study|Lost to Follow-up|3|||
30571988|NCT01436396|58579707|FG001|Overall Study|Lost to Follow-up|3|||
30667773|NCT00506077|58681688|FG000|Treatment Period 1|Lost to Follow-up|0|||
30571989|NCT01411241|58579715|FG000|Overall Study|Protocol Violation|0|||
30571990|NCT01411241|58579716|FG001|Overall Study|Protocol Violation|5|||
30571991|NCT01411241|58579715|FG000|Overall Study|Withdrawal by Subject|9|||
30571992|NCT01411241|58579716|FG001|Overall Study|Withdrawal by Subject|10|||
30571993|NCT01411241|58579715|FG000|Overall Study|Serious Adverse Event|0|||
30571994|NCT01411241|58579716|FG001|Overall Study|Serious Adverse Event|3|||
30571995|NCT01411241|58579715|FG000|Overall Study|Lost to Follow-up|2|||
30571996|NCT01411241|58579716|FG001|Overall Study|Lost to Follow-up|4|||
30571997|NCT01374516|58579724|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
30571998|NCT01374516|58579725|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
30571999|NCT01374516|58579724|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
30572000|NCT01374516|58579725|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
30572001|NCT01374516|58579724|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
30572002|NCT01374516|58579725|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
30572003|NCT01374516|58579724|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
30572004|NCT01374516|58579725|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
30572005|NCT01374516|58579724|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
30572006|NCT01374516|58579725|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
30572007|NCT01374516|58579724|FG000|Surveillance Expansion Period|Protocol Violation|386|||
30572008|NCT01374516|58579725|FG001|Surveillance Expansion Period|Protocol Violation|217|||
30572009|NCT01374516|58579724|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
30572010|NCT01374516|58579725|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
30572011|NCT01374516|58579724|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
30572012|NCT01374516|58579725|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
30572013|NCT01374516|58579724|FG000|Surveillance Expansion Period|Serious adverse event|20|||
30572014|NCT01374516|58579725|FG001|Surveillance Expansion Period|Serious adverse event|5|||
30572015|NCT01373281|58579740|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
30572016|NCT01373281|58579741|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
30572017|NCT01373281|58579740|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
30572018|NCT01373281|58579741|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
30572019|NCT01373281|58579740|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
30572020|NCT01373281|58579741|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
30572021|NCT01373281|58579740|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
30572022|NCT01373281|58579741|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
30572023|NCT01373281|58579740|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
30572024|NCT01373281|58579741|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
30572025|NCT01373281|58579740|FG000|Surveillance Expansion Period|Protocol Violation|9|||
30572026|NCT01373281|58579741|FG001|Surveillance Expansion Period|Protocol Violation|1|||
30572027|NCT01373281|58579740|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
30572028|NCT01373281|58579741|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
30572029|NCT01373281|58579740|FG000|Surveillance Expansion Period|Serious adverse event|3|||
30572030|NCT01373281|58579741|FG001|Surveillance Expansion Period|Serious adverse event|4|||
30572031|NCT01287611|58579756|FG000|Overall Study|Lost to Follow-up|29|||
30572032|NCT01287611|58579757|FG001|Overall Study|Lost to Follow-up|16|||
30572033|NCT01287611|58579756|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
30572034|NCT01287611|58579757|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
30572035|NCT01254422|58579767|FG000|Overall Study|Protocol Violation|1|||
30572036|NCT01254422|58579768|FG001|Overall Study|Protocol Violation|0|||
30572037|NCT01254422|58579767|FG000|Overall Study|Adverse Event|1|||
30572038|NCT01254422|58579768|FG001|Overall Study|Adverse Event|0|||
30572039|NCT01254422|58579767|FG000|Overall Study|Serious adverse event|0|||
30572040|NCT01254422|58579768|FG001|Overall Study|Serious adverse event|1|||
30572041|NCT01254422|58579767|FG000|Overall Study|Lost to Follow-up|1|||
30572042|NCT01254422|58579768|FG001|Overall Study|Lost to Follow-up|0|||
30572043|NCT01187433|58579776|FG000|Overall Study|Protocol Violation|6|||
30572044|NCT01187433|58579777|FG001|Overall Study|Protocol Violation|2|||
30572045|NCT01187433|58579776|FG000|Overall Study|Withdrawal by Subject|5|||
30572046|NCT01187433|58579777|FG001|Overall Study|Withdrawal by Subject|2|||
30572047|NCT01150045|58579787|FG000|Overall Study|Protocol Violation|0|||
30572048|NCT01150045|58579788|FG001|Overall Study|Protocol Violation|1|||
30572049|NCT01150045|58579789|FG002|Overall Study|Protocol Violation|0|||
30572050|NCT01150045|58579790|FG003|Overall Study|Protocol Violation|1|||
30958660|NCT01694849|59023704|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
30572051|NCT01098032|58579800|FG000|Overall Study|Withdrawal by Subject|1|||
30572052|NCT01098032|58579801|FG001|Overall Study|Withdrawal by Subject|1|||
30572053|NCT01034306|58579809|FG000|Overall Study|Adverse Event|1|||
30572054|NCT01034306|58579810|FG001|Overall Study|Adverse Event|0|||
30572055|NCT01034306|58579809|FG000|Overall Study|Lost to Follow-up|0|||
30572056|NCT01034306|58579810|FG001|Overall Study|Lost to Follow-up|1|||
30572057|NCT01034306|58579809|FG000|Overall Study|Withdrawal by Subject|2|||
30572058|NCT01034306|58579810|FG001|Overall Study|Withdrawal by Subject|2|||
30572059|NCT01034306|58579809|FG000|Overall Study|hospitalized and decided to stop|1|||
30572060|NCT01034306|58579810|FG001|Overall Study|hospitalized and decided to stop|0|||
30572061|NCT01034306|58579809|FG000|Overall Study|Noncomplience|1|||
30572062|NCT01034306|58579810|FG001|Overall Study|Noncomplience|0|||
30572063|NCT00993447|58579818|FG000|Overall Study|Withdrawal by Subject|23|||
30572064|NCT00993447|58579819|FG001|Overall Study|Withdrawal by Subject|8|||
30572065|NCT00993447|58579818|FG000|Overall Study|Protocol Violation|12|||
30572066|NCT00993447|58579819|FG001|Overall Study|Protocol Violation|8|||
30572067|NCT00993447|58579818|FG000|Overall Study|Lost to Follow-up|1|||
30572068|NCT00993447|58579819|FG001|Overall Study|Lost to Follow-up|3|||
30572069|NCT00993447|58579818|FG000|Overall Study|Adverse Event|1|||
30572070|NCT00993447|58579819|FG001|Overall Study|Adverse Event|0|||
30572071|NCT00945009|58579828|FG000|Overall Study|Lack of Efficacy|10|||
30572072|NCT00945009|58579829|FG001|Overall Study|Lack of Efficacy|0|||
30572073|NCT00945009|58579830|FG002|Overall Study|Lack of Efficacy|0|||
30572074|NCT00945009|58579828|FG000|Overall Study|Physician Decision|21|||
30572075|NCT00945009|58579829|FG001|Overall Study|Physician Decision|4|||
30572076|NCT00945009|58579830|FG002|Overall Study|Physician Decision|3|||
30572077|NCT00945009|58579828|FG000|Overall Study|Protocol Violation|6|||
30572078|NCT00945009|58579829|FG001|Overall Study|Protocol Violation|1|||
30572079|NCT00945009|58579830|FG002|Overall Study|Protocol Violation|0|||
30572080|NCT00945009|58579828|FG000|Overall Study|Withdrawal by Subject|1|||
30572081|NCT00945009|58579829|FG001|Overall Study|Withdrawal by Subject|0|||
30572082|NCT00945009|58579830|FG002|Overall Study|Withdrawal by Subject|0|||
30572083|NCT00945009|58579828|FG000|Overall Study|Ineligible|6|||
30572084|NCT00945009|58579829|FG001|Overall Study|Ineligible|1|||
30572085|NCT00945009|58579830|FG002|Overall Study|Ineligible|0|||
30572086|NCT00945009|58579828|FG000|Overall Study|Inevaluable|0|||
30572087|NCT00945009|58579829|FG001|Overall Study|Inevaluable|1|||
30572088|NCT00945009|58579830|FG002|Overall Study|Inevaluable|0|||
30572089|NCT00945009|58579828|FG000|Overall Study|Refusal of further protocol|1|||
30572090|NCT00945009|58579829|FG001|Overall Study|Refusal of further protocol|0|||
30572091|NCT00945009|58579830|FG002|Overall Study|Refusal of further protocol|0|||
30572092|NCT00942877|58579840|FG000|Overall Study|Refused further treatment|1|||
30572093|NCT00942877|58579841|FG001|Overall Study|Refused further treatment|1|||
30572094|NCT00942877|58579840|FG000|Overall Study|Patient was not treated|1|||
30572095|NCT00942877|58579841|FG001|Overall Study|Patient was not treated|0|||
30572096|NCT00942877|58579840|FG000|Overall Study|Adverse Event|1|||
30572097|NCT00942877|58579841|FG001|Overall Study|Adverse Event|0|||
30572098|NCT00942877|58579840|FG000|Overall Study|Progressive disease|42|||
30572099|NCT00942877|58579841|FG001|Overall Study|Progressive disease|3|||
30572100|NCT00880893|58579856|FG000|Overall Study|Protocol Violation|13|||
30572101|NCT00880893|58579857|FG001|Overall Study|Protocol Violation|1|||
30572102|NCT00880893|58579856|FG000|Overall Study|Withdrawal by Subject|15|||
30572103|NCT00880893|58579857|FG001|Overall Study|Withdrawal by Subject|11|||
30572104|NCT00880893|58579856|FG000|Overall Study|Lost to Follow-up|76|||
30572105|NCT00880893|58579857|FG001|Overall Study|Lost to Follow-up|33|||
30572106|NCT00880893|58579856|FG000|Overall Study|Serious adverse event|3|||
30572107|NCT00880893|58579857|FG001|Overall Study|Serious adverse event|0|||
30572108|NCT00587301|58579863|FG000|Overall Study|Screen Failure|9|||
30572109|NCT00587301|58579863|FG000|Overall Study|Lost to Follow-up|22|||
30572110|NCT00587301|58579863|FG000|Overall Study|Withdrawal by Subject|7|||
30572111|NCT00587301|58579863|FG000|Overall Study|Protocol Violation|7|||
30572112|NCT00579527|58579867|FG000|Overall Study|Death|4|||
30667774|NCT00506077|58681689|FG001|Treatment Period 1|Lost to Follow-up|2|||
30667775|NCT00506077|58681688|FG000|Treatment Period 1|Withdrawal by Subject|2|||
30667776|NCT00506077|58681689|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30667777|NCT00506077|58681688|FG000|Treatment Period 2|Adverse Event|0|||
30667778|NCT00506077|58681689|FG001|Treatment Period 2|Adverse Event|1|||
30667779|NCT00506077|58681688|FG000|Treatment Period 2|Withdrawal by Subject|1|||
30667780|NCT00506077|58681689|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30667781|NCT00505921|58681695|FG000|Overall Study|Ineligible|1|||
30667782|NCT00505921|58681695|FG000|Overall Study|Failed to Mobilize|8|||
30667783|NCT00596960|58681701|FG000|Overall Study|Death|1|||
30667784|NCT00596960|58681702|FG001|Overall Study|Death|2|||
30667785|NCT00596960|58681701|FG000|Overall Study|Lost to Follow-up|6|||
30667786|NCT00596960|58681702|FG001|Overall Study|Lost to Follow-up|5|||
30667787|NCT00596960|58681701|FG000|Overall Study|Withdrawal by Subject|1|||
30667788|NCT00596960|58681702|FG001|Overall Study|Withdrawal by Subject|0|||
30667789|NCT00596960|58681701|FG000|Overall Study|Incarcerated|2|||
30667790|NCT00596960|58681702|FG001|Overall Study|Incarcerated|0|||
30667791|NCT00596960|58681701|FG000|Overall Study|Physician Decision|1|||
30667792|NCT00596960|58681702|FG001|Overall Study|Physician Decision|0|||
30667793|NCT00596960|58681701|FG000|Overall Study|Protocol Violation|0|||
30667794|NCT00596960|58681702|FG001|Overall Study|Protocol Violation|1|||
30667795|NCT00596960|58681701|FG000|Overall Study|No alcohol use data|0|||
30667796|NCT00596960|58681702|FG001|Overall Study|No alcohol use data|1|||
30667797|NCT00505765|58681711|FG000|Overall Study|Withdrawal by Subject|1|||
30667798|NCT00505765|58681712|FG001|Overall Study|Withdrawal by Subject|0|||
30667799|NCT00505765|58681713|FG002|Overall Study|Withdrawal by Subject|0|||
30667800|NCT00505765|58681711|FG000|Overall Study|Adverse Event|1|||
30572113|NCT00576836|58579872|FG000|Overall Study|Death|0|||
30572114|NCT00576836|58579873|FG001|Overall Study|Death|1|||
30572115|NCT00576836|58579872|FG000|Overall Study|Physician Decision|0|||
30572116|NCT00576836|58579873|FG001|Overall Study|Physician Decision|1|||
30572117|NCT00576407|58579877|FG000|Overall Study|Death|7|||
30572118|NCT00576407|58579877|FG000|Overall Study|Physician Decision|1|||
30572119|NCT00531232|58579885|FG000|Overall Study|Investigator decision|0|||
30572120|NCT00531232|58579886|FG001|Overall Study|Investigator decision|0|||
30572121|NCT00531232|58579887|FG002|Overall Study|Investigator decision|4|||
30572122|NCT00531232|58579885|FG000|Overall Study|Participants refused further treatment|0|||
30572123|NCT00531232|58579886|FG001|Overall Study|Participants refused further treatment|1|||
30572124|NCT00531232|58579887|FG002|Overall Study|Participants refused further treatment|2|||
30572125|NCT00531232|58579885|FG000|Overall Study|Adverse events (AEs)|1|||
30572126|NCT00531232|58579886|FG001|Overall Study|Adverse events (AEs)|2|||
30572127|NCT00531232|58579887|FG002|Overall Study|Adverse events (AEs)|2|||
30572128|NCT00531232|58579885|FG000|Overall Study|Treatment failure|1|||
30572129|NCT00531232|58579886|FG001|Overall Study|Treatment failure|3|||
30572130|NCT00531232|58579887|FG002|Overall Study|Treatment failure|7|||
30572131|NCT00531232|58579885|FG000|Overall Study|Disease recurrence|0|||
30572132|NCT00531232|58579886|FG001|Overall Study|Disease recurrence|0|||
30572133|NCT00531232|58579887|FG002|Overall Study|Disease recurrence|1|||
30572134|NCT00531232|58579885|FG000|Overall Study|Deceased|2|||
30572135|NCT00531232|58579886|FG001|Overall Study|Deceased|2|||
30572136|NCT00531232|58579887|FG002|Overall Study|Deceased|2|||
30572137|NCT00531232|58579885|FG000|Overall Study|Withdrawal by Subject|0|||
30572138|NCT00531232|58579886|FG001|Overall Study|Withdrawal by Subject|1|||
30572139|NCT00531232|58579887|FG002|Overall Study|Withdrawal by Subject|2|||
30572140|NCT00531232|58579885|FG000|Overall Study|Other|0|||
30572141|NCT00531232|58579886|FG001|Overall Study|Other|0|||
30572142|NCT00531232|58579887|FG002|Overall Study|Other|5|||
30572143|NCT01701583|58579900|FG000|Overall Study|Withdrawal by Subject|2|||
30572144|NCT01701583|58579901|FG001|Overall Study|Withdrawal by Subject|0|||
30572145|NCT01714817|58579910|FG000|Year 1 Period|Lack of Efficacy|11|||
30572146|NCT01714817|58579911|FG001|Year 1 Period|Lack of Efficacy|9|||
30572147|NCT01714817|58579910|FG000|Year 1 Period|Adverse Event|20|||
30572148|NCT01714817|58579911|FG001|Year 1 Period|Adverse Event|17|||
30572149|NCT01714817|58579910|FG000|Year 1 Period|Withdrawal by Subject|6|||
30572150|NCT01714817|58579911|FG001|Year 1 Period|Withdrawal by Subject|7|||
30572151|NCT01714817|58579910|FG000|Year 1 Period|Death|1|||
30572152|NCT01714817|58579911|FG001|Year 1 Period|Death|1|||
30572153|NCT01714817|58579910|FG000|Year 1 Period|Lost to Follow-up|0|||
30572154|NCT01714817|58579911|FG001|Year 1 Period|Lost to Follow-up|2|||
30572155|NCT01714817|58579910|FG000|Year 1 Period|Poor / non-compliance|0|||
30572156|NCT01714817|58579911|FG001|Year 1 Period|Poor / non-compliance|1|||
30572157|NCT01714817|58579910|FG000|Year 1 Period|Pregnancy|2|||
30572158|NCT01714817|58579911|FG001|Year 1 Period|Pregnancy|0|||
30572159|NCT01714817|58579910|FG000|Year 1 Period|Participant no longer meets criteria|6|||
30572160|NCT01714817|58579911|FG001|Year 1 Period|Participant no longer meets criteria|2|||
30572161|NCT01714817|58579910|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
30572162|NCT01714817|58579911|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
30572163|NCT01714817|58579910|FG000|Year 1 Period|Change in Concomitant Medication|0|||
30572164|NCT01714817|58579911|FG001|Year 1 Period|Change in Concomitant Medication|1|||
30572165|NCT01714817|58579910|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
30572166|NCT01714817|58579911|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
30572167|NCT01714817|58579910|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
30572168|NCT01714817|58579911|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
30572169|NCT01714817|58579910|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
30572170|NCT01714817|58579911|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
30572171|NCT01714817|58579910|FG000|Year 2 Period|Lack of Efficacy|4|||
30572172|NCT01714817|58579911|FG001|Year 2 Period|Lack of Efficacy|12|||
30572173|NCT01714817|58579910|FG000|Year 2 Period|Adverse Event|7|||
30572174|NCT01714817|58579911|FG001|Year 2 Period|Adverse Event|6|||
30572175|NCT01714817|58579910|FG000|Year 2 Period|Participant request to stop treatment|4|||
30572176|NCT01714817|58579911|FG001|Year 2 Period|Participant request to stop treatment|4|||
30572177|NCT01714817|58579910|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
30572178|NCT01714817|58579911|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
30572179|NCT01714817|58579910|FG000|Year 2 Period|Participant withdrew consent|1|||
30572180|NCT01714817|58579911|FG001|Year 2 Period|Participant withdrew consent|5|||
30572181|NCT01714817|58579910|FG000|Year 2 Period|Participant no longer meets criteria|1|||
30572182|NCT01714817|58579911|FG001|Year 2 Period|Participant no longer meets criteria|4|||
30572183|NCT01714817|58579910|FG000|Year 2 Period|Lost to Follow-up|2|||
30572184|NCT01714817|58579911|FG001|Year 2 Period|Lost to Follow-up|0|||
30572185|NCT01714817|58579910|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
30572186|NCT01714817|58579911|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
30572187|NCT01714817|58579910|FG000|Year 2 Period|Pregnancy|1|||
30572188|NCT01714817|58579911|FG001|Year 2 Period|Pregnancy|1|||
30572189|NCT01714817|58579910|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
30572190|NCT01714817|58579911|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
30572191|NCT01714817|58579910|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
30572192|NCT01714817|58579911|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
30572193|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
30572194|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
30572195|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
30572196|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
30572197|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
30572198|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
30572199|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
30572200|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
30572201|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
30572202|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
30572203|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
30572204|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
30572205|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
30572206|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
30572207|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
30572208|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
30572209|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
30572210|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
30572211|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
30572212|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
30572213|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
30572214|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
30572215|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
30572216|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
30572217|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
30572218|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
30572219|NCT01714817|58579910|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
30572220|NCT01714817|58579911|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
30572221|NCT01755689|58579935|FG000|Overall Study|Withdrawal by Subject|1|||
30572222|NCT01755689|58579936|FG001|Overall Study|Withdrawal by Subject|3|||
30572223|NCT01755689|58579937|FG002|Overall Study|Withdrawal by Subject|2|||
30572224|NCT01755689|58579938|FG003|Overall Study|Withdrawal by Subject|1|||
30572225|NCT01755689|58579939|FG004|Overall Study|Withdrawal by Subject|1|||
30572226|NCT01755689|58579935|FG000|Overall Study|Migrated/moved from study area|0|||
30572227|NCT01755689|58579936|FG001|Overall Study|Migrated/moved from study area|1|||
30572228|NCT01755689|58579937|FG002|Overall Study|Migrated/moved from study area|1|||
30572229|NCT01755689|58579938|FG003|Overall Study|Migrated/moved from study area|1|||
30572230|NCT01755689|58579939|FG004|Overall Study|Migrated/moved from study area|1|||
30572231|NCT01755689|58579935|FG000|Overall Study|Lost to Follow-up|1|||
30572232|NCT01755689|58579936|FG001|Overall Study|Lost to Follow-up|0|||
30572233|NCT01755689|58579937|FG002|Overall Study|Lost to Follow-up|1|||
30572234|NCT01755689|58579938|FG003|Overall Study|Lost to Follow-up|0|||
30572235|NCT01755689|58579939|FG004|Overall Study|Lost to Follow-up|2|||
30572236|NCT01755689|58579935|FG000|Overall Study|Pregnancy|1|||
30572237|NCT01755689|58579936|FG001|Overall Study|Pregnancy|1|||
30572238|NCT01755689|58579937|FG002|Overall Study|Pregnancy|2|||
30572239|NCT01755689|58579938|FG003|Overall Study|Pregnancy|4|||
30572240|NCT01755689|58579939|FG004|Overall Study|Pregnancy|2|||
30572241|NCT01762761|58579961|FG000|Overall Study|Adverse Event|15|||
30572242|NCT01762761|58579962|FG001|Overall Study|Adverse Event|17|||
30572243|NCT01762761|58579961|FG000|Overall Study|Lack of Efficacy|9|||
30572244|NCT01762761|58579962|FG001|Overall Study|Lack of Efficacy|25|||
30572245|NCT01762761|58579961|FG000|Overall Study|Protocol Violation|1|||
30572246|NCT01762761|58579962|FG001|Overall Study|Protocol Violation|1|||
30572247|NCT01762761|58579961|FG000|Overall Study|Study closed/terminated|0|||
30572248|NCT01762761|58579962|FG001|Overall Study|Study closed/terminated|2|||
30572249|NCT01762761|58579961|FG000|Overall Study|Lost to Follow-up|3|||
30667801|NCT00505765|58681712|FG001|Overall Study|Adverse Event|2|||
30572250|NCT01762761|58579962|FG001|Overall Study|Lost to Follow-up|6|||
30572251|NCT01762761|58579961|FG000|Overall Study|Physician Decision|4|||
30572252|NCT01762761|58579962|FG001|Overall Study|Physician Decision|6|||
30572253|NCT01762761|58579961|FG000|Overall Study|Withdrawal by Subject|7|||
30572254|NCT01762761|58579962|FG001|Overall Study|Withdrawal by Subject|8|||
30572255|NCT01763788|58579973|FG000|Overall Study|Lost to Follow-up|0|||
30572256|NCT01763788|58579974|FG001|Overall Study|Lost to Follow-up|0|||
30667802|NCT00505765|58681713|FG002|Overall Study|Adverse Event|0|||
30572257|NCT01763788|58579975|FG002|Overall Study|Lost to Follow-up|1|||
30572258|NCT01763788|58579976|FG003|Overall Study|Lost to Follow-up|0|||
30572259|NCT01774370|58579986|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
30572260|NCT01774370|58579986|FG000|Overall Study|Administered prior to the contract date|4|||
30572261|NCT01774370|58579986|FG000|Overall Study|Subjects of contraindications|34|||
30572262|NCT01774370|58579986|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
30572263|NCT01774370|58579986|FG000|Overall Study|Follow-up failure|34|||
30572264|NCT01777295|58579992|FG000|Overall Study|Withdrawal by Subject|2|||
30572265|NCT01777295|58579993|FG001|Overall Study|Withdrawal by Subject|2|||
30572266|NCT01777295|58579992|FG000|Overall Study|Pregnancy|0|||
30572267|NCT01777295|58579993|FG001|Overall Study|Pregnancy|1|||
30572268|NCT01777295|58579992|FG000|Overall Study|Personal problem|1|||
30572269|NCT01777295|58579993|FG001|Overall Study|Personal problem|0|||
30572270|NCT01777295|58579992|FG000|Overall Study|Investigator call for AEs check|1|||
30572271|NCT01777295|58579993|FG001|Overall Study|Investigator call for AEs check|0|||
30572272|NCT01787552|58580030|FG000|Overall Study|Withdrawal by Subject|2|||
30572273|NCT01787552|58580031|FG001|Overall Study|Withdrawal by Subject|0|||
30572274|NCT01787552|58580032|FG002|Overall Study|Withdrawal by Subject|0|||
30572275|NCT01787552|58580033|FG003|Overall Study|Withdrawal by Subject|4|||
30572276|NCT01787552|58580030|FG000|Overall Study|Physician Decision|2|||
30572277|NCT01787552|58580031|FG001|Overall Study|Physician Decision|2|||
30572278|NCT01787552|58580032|FG002|Overall Study|Physician Decision|1|||
30572279|NCT01787552|58580033|FG003|Overall Study|Physician Decision|2|||
30572280|NCT01787552|58580030|FG000|Overall Study|Death|0|||
30572281|NCT01787552|58580031|FG001|Overall Study|Death|0|||
30572282|NCT01787552|58580032|FG002|Overall Study|Death|0|||
30572283|NCT01787552|58580033|FG003|Overall Study|Death|1|||
30572284|NCT01787552|58580030|FG000|Overall Study|Adverse Event|2|||
30572285|NCT01787552|58580031|FG001|Overall Study|Adverse Event|5|||
30572286|NCT01787552|58580032|FG002|Overall Study|Adverse Event|2|||
30572287|NCT01787552|58580033|FG003|Overall Study|Adverse Event|16|||
30572288|NCT01787552|58580030|FG000|Overall Study|Study terminated by Sponsor|0|||
30572289|NCT01787552|58580031|FG001|Overall Study|Study terminated by Sponsor|0|||
30572290|NCT01787552|58580032|FG002|Overall Study|Study terminated by Sponsor|1|||
30572291|NCT01787552|58580033|FG003|Overall Study|Study terminated by Sponsor|3|||
30572292|NCT01787552|58580030|FG000|Overall Study|Progressive Disease|2|||
30572293|NCT01787552|58580031|FG001|Overall Study|Progressive Disease|2|||
30572294|NCT01787552|58580032|FG002|Overall Study|Progressive Disease|1|||
30572295|NCT01787552|58580033|FG003|Overall Study|Progressive Disease|1|||
30572296|NCT01808261|58580050|FG000|Overall Study|Physician Decision|0|||
30572297|NCT01808261|58580051|FG001|Overall Study|Physician Decision|2|||
30572298|NCT01808261|58580050|FG000|Overall Study|Study Closed/Terminated|25|||
30572299|NCT01808261|58580051|FG001|Overall Study|Study Closed/Terminated|23|||
30572300|NCT01808261|58580050|FG000|Overall Study|Adverse event, non-fatal|2|||
30572301|NCT01808261|58580051|FG001|Overall Study|Adverse event, non-fatal|0|||
30572302|NCT01808261|58580050|FG000|Overall Study|Consent withdrawn by subject|6|||
30572303|NCT01808261|58580051|FG001|Overall Study|Consent withdrawn by subject|7|||
30572304|NCT01808261|58580050|FG000|Overall Study|Lost to Follow-up|3|||
30572305|NCT01808261|58580051|FG001|Overall Study|Lost to Follow-up|1|||
30572306|NCT01814826|58580070|FG000|Overall Study|Other|3|||
30572307|NCT01814826|58580071|FG001|Overall Study|Other|5|||
30572308|NCT01814826|58580072|FG002|Overall Study|Other|0|||
30572309|NCT01814826|58580070|FG000|Overall Study|Death|29|||
30572310|NCT01814826|58580071|FG001|Overall Study|Death|24|||
30572311|NCT01814826|58580072|FG002|Overall Study|Death|3|||
30572312|NCT01819467|58580083|FG000|Overall Study|Physician Decision|20|||
30572313|NCT01819467|58580084|FG001|Overall Study|Physician Decision|9|||
30572314|NCT01829711|58580090|FG000|Overall Study|Lost to Follow-up|2|||
30572315|NCT01829711|58580090|FG000|Overall Study|Withdrawal by Subject|3|||
30572316|NCT01829711|58580090|FG000|Overall Study|Death|4|||
30572317|NCT01829711|58580090|FG000|Overall Study|Started new therapies|17|||
30572318|NCT01829711|58580090|FG000|Overall Study|Adverse Event|3|||
30572319|NCT01829711|58580090|FG000|Overall Study|Due to progression of disease|13|||
30667803|NCT00505765|58681711|FG000|Overall Study|Noncompliance|0|||
30572320|NCT01829711|58580090|FG000|Overall Study|Due to lack of response|1|||
30572321|NCT01846273|58580097|FG000|Overall Study|Adverse Event|9|||
30572322|NCT01846273|58580098|FG001|Overall Study|Adverse Event|7|||
30572323|NCT01846273|58580099|FG002|Overall Study|Adverse Event|0|||
30572324|NCT01846273|58580097|FG000|Overall Study|Subject withdrew consent|5|||
30572325|NCT01846273|58580098|FG001|Overall Study|Subject withdrew consent|8|||
30572326|NCT01846273|58580099|FG002|Overall Study|Subject withdrew consent|0|||
30572327|NCT01846273|58580097|FG000|Overall Study|Lost to Follow-up|2|||
30572328|NCT01846273|58580098|FG001|Overall Study|Lost to Follow-up|1|||
30572329|NCT01846273|58580099|FG002|Overall Study|Lost to Follow-up|0|||
30572330|NCT01846273|58580097|FG000|Overall Study|Administrative problems|1|||
30572331|NCT01846273|58580098|FG001|Overall Study|Administrative problems|0|||
30572332|NCT01846273|58580099|FG002|Overall Study|Administrative problems|0|||
30572333|NCT01846273|58580097|FG000|Overall Study|Death|2|||
30572334|NCT01846273|58580098|FG001|Overall Study|Death|1|||
30572335|NCT01846273|58580099|FG002|Overall Study|Death|0|||
30572336|NCT01846273|58580097|FG000|Overall Study|Disease Progression|0|||
30572337|NCT01846273|58580098|FG001|Overall Study|Disease Progression|4|||
30572338|NCT01846273|58580099|FG002|Overall Study|Disease Progression|0|||
30572339|NCT01846273|58580097|FG000|Overall Study|Protocol Deviation|2|||
30572340|NCT01846273|58580098|FG001|Overall Study|Protocol Deviation|3|||
30572341|NCT01846273|58580099|FG002|Overall Study|Protocol Deviation|0|||
30572342|NCT01846273|58580097|FG000|Overall Study|Physician Decision|1|||
30572343|NCT01846273|58580098|FG001|Overall Study|Physician Decision|2|||
30572344|NCT01846273|58580099|FG002|Overall Study|Physician Decision|0|||
30572345|NCT01871896|58580107|FG000|Overall Study|Lost to Follow-up|1|||
30572346|NCT04752475|58580114|FG000|Overall Study|Withdrawal by Subject|1|||
30572347|NCT04752475|58580115|FG001|Overall Study|Withdrawal by Subject|1|||
30572348|NCT03846947|58580161|FG000|Overall Study|technical issues with imaging sequence|2|||
30572349|NCT03675308|58580174|FG000|Overall Study|Adverse Event|3|||
30572350|NCT03675308|58580175|FG001|Overall Study|Adverse Event|2|||
30572351|NCT03675308|58580174|FG000|Overall Study|Withdrawal by Subject|6|||
30572352|NCT03675308|58580175|FG001|Overall Study|Withdrawal by Subject|4|||
30572353|NCT03675308|58580174|FG000|Overall Study|Lost to Follow-up|3|||
30572354|NCT03675308|58580175|FG001|Overall Study|Lost to Follow-up|0|||
30572355|NCT03675308|58580174|FG000|Overall Study|Lack of Efficacy|1|||
30572356|NCT03675308|58580175|FG001|Overall Study|Lack of Efficacy|1|||
30572357|NCT03675308|58580174|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
30572358|NCT03675308|58580175|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
30572359|NCT03675308|58580174|FG000|Overall Study|Other|0|||
30572360|NCT03675308|58580175|FG001|Overall Study|Other|1|||
30572361|NCT03334253|58580183|FG000|Overall Study|Withdrawal by Subject|1|||
30572362|NCT03334253|58580184|FG001|Overall Study|Withdrawal by Subject|0|||
30572363|NCT03334253|58580183|FG000|Overall Study|Lost to Follow-up|4|||
30572364|NCT03334253|58580184|FG001|Overall Study|Lost to Follow-up|3|||
30572365|NCT03334253|58580183|FG000|Overall Study|Moved residence|2|||
30572366|NCT03334253|58580184|FG001|Overall Study|Moved residence|2|||
30572367|NCT03131219|58580192|FG000|Initial Evaluation Period|Adverse Event|1|||
30572368|NCT03131219|58580193|FG001|Initial Evaluation Period|Adverse Event|0|||
30572369|NCT03131219|58580192|FG000|Initial Evaluation Period|Protocol Violation|1|||
30572370|NCT03131219|58580193|FG001|Initial Evaluation Period|Protocol Violation|0|||
30572371|NCT03131219|58580192|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2|||
30572372|NCT03131219|58580193|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0|||
30572373|NCT02914613|58580201|FG000|Overall Study|Withdrawal by Subject|1|||
30572374|NCT02914613|58580202|FG001|Overall Study|Withdrawal by Subject|2|||
30572375|NCT02914613|58580201|FG000|Overall Study|Adverse Event|1|||
30572376|NCT02914613|58580202|FG001|Overall Study|Adverse Event|0|||
30572377|NCT02586207|58580212|FG000|Overall Study|Physician Decision|1|||
30572378|NCT02586207|58580212|FG000|Overall Study|Withdrawal by Subject|1|||
30572379|NCT02573324|58580219|FG000|Overall Study|Withdrawal by Subject|26|||
30572380|NCT02573324|58580220|FG001|Overall Study|Withdrawal by Subject|23|||
30572381|NCT02573324|58580221|FG002|Overall Study|Withdrawal by Subject|3|||
30572382|NCT02573324|58580219|FG000|Overall Study|Lost to Follow-up|4|||
30572383|NCT02573324|58580220|FG001|Overall Study|Lost to Follow-up|5|||
30572384|NCT02573324|58580221|FG002|Overall Study|Lost to Follow-up|0|||
30572385|NCT02573324|58580219|FG000|Overall Study|Study Terminated by Sponsor|107|||
30572386|NCT02573324|58580220|FG001|Overall Study|Study Terminated by Sponsor|89|||
30572387|NCT02573324|58580221|FG002|Overall Study|Study Terminated by Sponsor|2|||
30572388|NCT02573324|58580219|FG000|Overall Study|Death|182|||
30572389|NCT02573324|58580220|FG001|Overall Study|Death|200|||
30572390|NCT02573324|58580221|FG002|Overall Study|Death|1|||
30572391|NCT02573324|58580219|FG000|Overall Study|Other, Not Specified|20|||
30572392|NCT02573324|58580220|FG001|Overall Study|Other, Not Specified|27|||
30572393|NCT02573324|58580221|FG002|Overall Study|Other, Not Specified|0|||
30572394|NCT02573324|58580219|FG000|Overall Study|Unknown Reason|2|||
30572395|NCT02573324|58580220|FG001|Overall Study|Unknown Reason|0|||
30572396|NCT02573324|58580221|FG002|Overall Study|Unknown Reason|0|||
30572397|NCT02296684|58580237|FG000|Overall Study|Withdrawal by Subject|0|||
30572398|NCT02296684|58580238|FG001|Overall Study|Withdrawal by Subject|1|||
30572399|NCT02296684|58580239|FG002|Overall Study|Withdrawal by Subject|1|||
30572400|NCT02296684|58580237|FG000|Overall Study|Death|2|||
30572401|NCT02296684|58580238|FG001|Overall Study|Death|0|||
30572402|NCT02296684|58580239|FG002|Overall Study|Death|0|||
30572403|NCT02107261|58580248|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
30572404|NCT02107261|58580249|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
30572405|NCT02107261|58580248|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
30572406|NCT02107261|58580249|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
30572407|NCT02014597|58580259|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
30572408|NCT02014597|58580260|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
30572409|NCT01342367|58580272|FG000|Overall Study|Death|1|||
30572410|NCT01342367|58580273|FG001|Overall Study|Death|0|||
30572411|NCT01342367|58580272|FG000|Overall Study|Withdrawal by Subject|1|||
30572412|NCT01342367|58580273|FG001|Overall Study|Withdrawal by Subject|2|||
30572413|NCT01185171|58580279|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
30572414|NCT01185171|58580279|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
30572415|NCT01185171|58580279|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
30572416|NCT01185171|58580279|FG000|Maintenance|Elevated liver transaminases|3|||
30572417|NCT01185171|58580279|FG000|Maintenance|Rush|2|||
30572418|NCT01185171|58580279|FG000|Maintenance|Diarrhea|1|||
30572419|NCT01185171|58580279|FG000|Maintenance|Xerostomia|1|||
30572420|NCT01185171|58580279|FG000|Maintenance|Nausea|1|||
30572421|NCT01185171|58580279|FG000|Maintenance|Comorbid Illness|2|||
30572422|NCT01185171|58580279|FG000|Maintenance|Withdrawal by Subject|1|||
30572423|NCT01185171|58580279|FG000|Maintenance|Disease Recurrence|1|||
30572424|NCT00896493|58580283|FG000|Overall Study|Early disease relapse|3|||
30572425|NCT00408005|58580289|FG000|Induction|Adverse Event|19|||
30572426|NCT00408005|58580290|FG001|Induction|Adverse Event|3|||
30572427|NCT00408005|58580291|FG002|Induction|Adverse Event|0|||
30572428|NCT00408005|58580292|FG003|Induction|Adverse Event|0|||
30572429|NCT00408005|58580293|FG004|Induction|Adverse Event|0|||
30572430|NCT00408005|58580294|FG005|Induction|Adverse Event|0|||
30572431|NCT00408005|58580295|FG006|Induction|Adverse Event|0|||
30572432|NCT00408005|58580296|FG007|Induction|Adverse Event|0|||
30572433|NCT00408005|58580289|FG000|Induction|Death|6|||
30572434|NCT00408005|58580290|FG001|Induction|Death|0|||
30572435|NCT00408005|58580291|FG002|Induction|Death|0|||
30572436|NCT00408005|58580292|FG003|Induction|Death|0|||
30572437|NCT00408005|58580293|FG004|Induction|Death|0|||
30572438|NCT00408005|58580294|FG005|Induction|Death|0|||
30572439|NCT00408005|58580295|FG006|Induction|Death|0|||
30572440|NCT00408005|58580296|FG007|Induction|Death|0|||
30572441|NCT00408005|58580289|FG000|Induction|Physician Decision|83|||
30572442|NCT00408005|58580290|FG001|Induction|Physician Decision|9|||
30572443|NCT00408005|58580291|FG002|Induction|Physician Decision|0|||
30572444|NCT00408005|58580292|FG003|Induction|Physician Decision|0|||
30572445|NCT00408005|58580293|FG004|Induction|Physician Decision|0|||
30572446|NCT00408005|58580294|FG005|Induction|Physician Decision|0|||
30572447|NCT00408005|58580295|FG006|Induction|Physician Decision|0|||
30572448|NCT00408005|58580296|FG007|Induction|Physician Decision|0|||
30572449|NCT00408005|58580289|FG000|Induction|Withdrawal by Subject|2|||
30572450|NCT00408005|58580290|FG001|Induction|Withdrawal by Subject|4|||
30572451|NCT00408005|58580291|FG002|Induction|Withdrawal by Subject|0|||
30572452|NCT00408005|58580292|FG003|Induction|Withdrawal by Subject|0|||
30572453|NCT00408005|58580293|FG004|Induction|Withdrawal by Subject|0|||
30572454|NCT00408005|58580294|FG005|Induction|Withdrawal by Subject|0|||
30572455|NCT00408005|58580295|FG006|Induction|Withdrawal by Subject|0|||
30572456|NCT00408005|58580296|FG007|Induction|Withdrawal by Subject|0|||
30572457|NCT00408005|58580289|FG000|Induction|Ineligible|33|||
30572458|NCT00408005|58580290|FG001|Induction|Ineligible|14|||
30572459|NCT00408005|58580291|FG002|Induction|Ineligible|0|||
30572460|NCT00408005|58580292|FG003|Induction|Ineligible|0|||
30572461|NCT00408005|58580293|FG004|Induction|Ineligible|0|||
30572462|NCT00408005|58580294|FG005|Induction|Ineligible|0|||
30572463|NCT00408005|58580295|FG006|Induction|Ineligible|0|||
30572464|NCT00408005|58580296|FG007|Induction|Ineligible|0|||
30572465|NCT00408005|58580289|FG000|Induction|Refusal of Further Protocol Therapy|225|||
30572466|NCT00408005|58580290|FG001|Induction|Refusal of Further Protocol Therapy|44|||
30572467|NCT00408005|58580291|FG002|Induction|Refusal of Further Protocol Therapy|0|||
30572468|NCT00408005|58580292|FG003|Induction|Refusal of Further Protocol Therapy|0|||
30572469|NCT00408005|58580293|FG004|Induction|Refusal of Further Protocol Therapy|0|||
30572470|NCT00408005|58580294|FG005|Induction|Refusal of Further Protocol Therapy|0|||
30572471|NCT00408005|58580295|FG006|Induction|Refusal of Further Protocol Therapy|0|||
30572472|NCT00408005|58580296|FG007|Induction|Refusal of Further Protocol Therapy|0|||
30572473|NCT00408005|58580289|FG000|Induction|Entered another COG therapeutic protocol|4|||
30572474|NCT00408005|58580290|FG001|Induction|Entered another COG therapeutic protocol|0|||
30572475|NCT00408005|58580291|FG002|Induction|Entered another COG therapeutic protocol|0|||
30572476|NCT00408005|58580292|FG003|Induction|Entered another COG therapeutic protocol|0|||
30572477|NCT00408005|58580293|FG004|Induction|Entered another COG therapeutic protocol|0|||
30572478|NCT00408005|58580294|FG005|Induction|Entered another COG therapeutic protocol|0|||
30572479|NCT00408005|58580295|FG006|Induction|Entered another COG therapeutic protocol|0|||
30572480|NCT00408005|58580296|FG007|Induction|Entered another COG therapeutic protocol|0|||
30572481|NCT00408005|58580289|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
30572482|NCT00408005|58580290|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
30572483|NCT00408005|58580291|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
30572484|NCT00408005|58580292|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
30572485|NCT00408005|58580293|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
30572486|NCT00408005|58580294|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
30572487|NCT00408005|58580295|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
30572488|NCT00408005|58580296|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
30572489|NCT00408005|58580289|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
30572490|NCT00408005|58580290|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
30572491|NCT00408005|58580291|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
30572492|NCT00408005|58580292|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
30572493|NCT00408005|58580293|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
30572494|NCT00408005|58580294|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
30572495|NCT00408005|58580295|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
30572496|NCT00408005|58580296|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
30572497|NCT00408005|58580289|FG000|Induction|Progressive Disease|0|||
30572498|NCT00408005|58580290|FG001|Induction|Progressive Disease|1|||
30572499|NCT00408005|58580291|FG002|Induction|Progressive Disease|0|||
30958661|NCT01694849|59023702|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
30958662|NCT01694849|59023703|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
30958663|NCT01694849|59023704|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
30958664|NCT01694849|59023702|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
30958665|NCT01694849|59023703|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
30958666|NCT01694849|59023704|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
30958667|NCT01694771|59023753|FG000|Overall Study|Adverse Event|18|||
30572500|NCT00408005|58580292|FG003|Induction|Progressive Disease|0|||
30572501|NCT00408005|58580293|FG004|Induction|Progressive Disease|0|||
30572502|NCT00408005|58580294|FG005|Induction|Progressive Disease|0|||
30572503|NCT00408005|58580295|FG006|Induction|Progressive Disease|0|||
30572504|NCT00408005|58580296|FG007|Induction|Progressive Disease|0|||
30572505|NCT00408005|58580289|FG000|Induction|Inevaluable|18|||
30572506|NCT00408005|58580290|FG001|Induction|Inevaluable|14|||
30572507|NCT00408005|58580291|FG002|Induction|Inevaluable|0|||
30572508|NCT00408005|58580292|FG003|Induction|Inevaluable|0|||
30572509|NCT00408005|58580293|FG004|Induction|Inevaluable|0|||
30572510|NCT00408005|58580294|FG005|Induction|Inevaluable|0|||
30572511|NCT00408005|58580295|FG006|Induction|Inevaluable|0|||
30572512|NCT00408005|58580296|FG007|Induction|Inevaluable|0|||
30572513|NCT00408005|58580289|FG000|Induction|Failed to Complete Randomization|3|||
30572514|NCT00408005|58580290|FG001|Induction|Failed to Complete Randomization|2|||
30572515|NCT00408005|58580291|FG002|Induction|Failed to Complete Randomization|0|||
30572516|NCT00408005|58580292|FG003|Induction|Failed to Complete Randomization|0|||
30572517|NCT00408005|58580293|FG004|Induction|Failed to Complete Randomization|0|||
30572518|NCT00408005|58580294|FG005|Induction|Failed to Complete Randomization|0|||
30572519|NCT00408005|58580295|FG006|Induction|Failed to Complete Randomization|0|||
30572520|NCT00408005|58580296|FG007|Induction|Failed to Complete Randomization|0|||
30572521|NCT00408005|58580289|FG000|Induction|Protocol Deviation|3|||
30572522|NCT00408005|58580290|FG001|Induction|Protocol Deviation|1|||
30572523|NCT00408005|58580291|FG002|Induction|Protocol Deviation|0|||
30572524|NCT00408005|58580292|FG003|Induction|Protocol Deviation|0|||
30572525|NCT00408005|58580293|FG004|Induction|Protocol Deviation|0|||
30572526|NCT00408005|58580294|FG005|Induction|Protocol Deviation|0|||
30572527|NCT00408005|58580295|FG006|Induction|Protocol Deviation|0|||
30572528|NCT00408005|58580296|FG007|Induction|Protocol Deviation|0|||
30572529|NCT00408005|58580289|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
30572530|NCT00408005|58580290|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
30572531|NCT00408005|58580291|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
30572532|NCT00408005|58580292|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
30572533|NCT00408005|58580293|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
30572534|NCT00408005|58580294|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
30572535|NCT00408005|58580295|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
30572536|NCT00408005|58580296|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
30572537|NCT00408005|58580289|FG000|Induction|Recurrent leukemia|1|||
30572538|NCT00408005|58580290|FG001|Induction|Recurrent leukemia|0|||
30572539|NCT00408005|58580291|FG002|Induction|Recurrent leukemia|0|||
30572540|NCT00408005|58580292|FG003|Induction|Recurrent leukemia|0|||
30572541|NCT00408005|58580293|FG004|Induction|Recurrent leukemia|0|||
30572542|NCT00408005|58580294|FG005|Induction|Recurrent leukemia|0|||
30572543|NCT00408005|58580295|FG006|Induction|Recurrent leukemia|0|||
30572544|NCT00408005|58580296|FG007|Induction|Recurrent leukemia|0|||
30572545|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
30572546|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
30572547|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
30572548|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
30572549|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
30572550|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
30958668|NCT01694771|59023754|FG001|Overall Study|Adverse Event|16|||
30958669|NCT01694771|59023753|FG000|Overall Study|Lack of Efficacy|1|||
30572551|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
30572552|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
30572553|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
30572554|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
30958670|NCT01694771|59023754|FG001|Overall Study|Lack of Efficacy|0|||
30572555|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
30572556|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
30572557|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
30572558|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
30572559|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
30572560|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
30572561|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
30572562|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
30572563|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
30572564|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
30572565|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
30572566|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
30572567|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
30572568|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
30572569|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
30572570|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
30572571|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
30572572|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
30572573|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
30572574|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
30572575|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
30572576|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
30572577|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
30572578|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
30572579|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
30572580|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
30572581|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
30572582|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
30572583|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
30572584|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
30572585|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
30572586|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
30572587|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
30572588|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
30572589|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
30572590|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
30572591|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
30572592|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
30572593|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
30572594|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
30572595|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
30572596|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
30572597|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
30572598|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
30572599|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
30572600|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
30572601|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
30572602|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
30572603|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
30572604|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
30572605|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
30572606|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
30572607|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
30572608|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
30572609|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
30572610|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
30572611|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
30958671|NCT01694771|59023753|FG000|Overall Study|Non compliance protocol|7|||
30958672|NCT01694771|59023754|FG001|Overall Study|Non compliance protocol|6|||
30958673|NCT01694771|59023753|FG000|Overall Study|Lost to Follow-up|2|||
30958674|NCT01694771|59023754|FG001|Overall Study|Lost to Follow-up|3|||
30572612|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
30572613|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
30572614|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
30572615|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
30572616|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
30572617|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
30572618|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
30572619|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
30572620|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
30572621|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
30572622|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
30572623|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
30572624|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
30572625|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
30572626|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
30572627|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
30572628|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
30572629|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
30572630|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
30572631|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
30572632|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
30572633|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
30572634|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
30572635|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
30572636|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
30572637|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
30572638|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
30572639|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
30572640|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
30572641|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
30572642|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
30572643|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
30572644|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
30572645|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
30572646|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
30572647|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
30572648|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
30572649|NCT00408005|58580289|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
30572650|NCT00408005|58580290|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
30572651|NCT00408005|58580291|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
30572652|NCT00408005|58580292|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
30572653|NCT00408005|58580293|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
30572654|NCT00408005|58580294|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
30572655|NCT00408005|58580295|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
30572656|NCT00408005|58580296|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
30572657|NCT01875185|58580327|FG000|Overall Study|study was terminated|52|||
30572658|NCT01875185|58580328|FG001|Overall Study|study was terminated|48|||
30572659|NCT01901432|58580357|FG000|Overall Study|Adverse Event|0|||
30572660|NCT01901432|58580358|FG001|Overall Study|Adverse Event|1|||
30572661|NCT01901432|58580359|FG002|Overall Study|Adverse Event|1|||
30572662|NCT01901432|58580360|FG003|Overall Study|Adverse Event|0|||
30572663|NCT01901432|58580361|FG004|Overall Study|Adverse Event|1|||
30572664|NCT01901432|58580357|FG000|Overall Study|Withdrawal by Subject|0|||
30572665|NCT01901432|58580358|FG001|Overall Study|Withdrawal by Subject|0|||
30572666|NCT01901432|58580359|FG002|Overall Study|Withdrawal by Subject|1|||
30572667|NCT01901432|58580360|FG003|Overall Study|Withdrawal by Subject|0|||
30572668|NCT01901432|58580361|FG004|Overall Study|Withdrawal by Subject|5|||
30572669|NCT01901432|58580357|FG000|Overall Study|Physician Decision|0|||
30572670|NCT01901432|58580358|FG001|Overall Study|Physician Decision|0|||
30572671|NCT01901432|58580359|FG002|Overall Study|Physician Decision|0|||
30572672|NCT01901432|58580360|FG003|Overall Study|Physician Decision|0|||
30667804|NCT00505765|58681712|FG001|Overall Study|Noncompliance|1|||
30667805|NCT00505765|58681713|FG002|Overall Study|Noncompliance|3|||
30667806|NCT00505687|58681721|FG000|Overall Study|Important protocol violation|2|||
30572673|NCT01901432|58580361|FG004|Overall Study|Physician Decision|2|||
30572674|NCT01901432|58580357|FG000|Overall Study|Patient decision to stop study drug|0|||
30572675|NCT01901432|58580358|FG001|Overall Study|Patient decision to stop study drug|0|||
30572676|NCT01901432|58580359|FG002|Overall Study|Patient decision to stop study drug|0|||
30572677|NCT01901432|58580360|FG003|Overall Study|Patient decision to stop study drug|0|||
30572678|NCT01901432|58580361|FG004|Overall Study|Patient decision to stop study drug|1|||
30572679|NCT01904279|58580382|FG000|Overall Study|Lack of Efficacy|2|||
30572680|NCT01904279|58580383|FG001|Overall Study|Lack of Efficacy|3|||
30572681|NCT01904279|58580382|FG000|Overall Study|Withdrawal by Subject|1|||
30572682|NCT01904279|58580383|FG001|Overall Study|Withdrawal by Subject|0|||
30572683|NCT01917318|58580392|FG000|First Treatment|Withdrawal by Subject|0|||
30572684|NCT01917318|58580393|FG001|First Treatment|Withdrawal by Subject|1|||
30572685|NCT01923168|58580402|FG000|Overall Study|Protocol Violation|1|||
30572686|NCT01923168|58580403|FG001|Overall Study|Protocol Violation|1|||
30572687|NCT01923168|58580404|FG002|Overall Study|Protocol Violation|0|||
30572688|NCT01923168|58580402|FG000|Overall Study|Subject/guardian decision|14|||
30572689|NCT01923168|58580403|FG001|Overall Study|Subject/guardian decision|14|||
30572690|NCT01923168|58580404|FG002|Overall Study|Subject/guardian decision|4|||
30572691|NCT01923168|58580402|FG000|Overall Study|Adverse Event|12|||
30572692|NCT01923168|58580403|FG001|Overall Study|Adverse Event|12|||
30572693|NCT01923168|58580404|FG002|Overall Study|Adverse Event|0|||
30572694|NCT01923168|58580402|FG000|Overall Study|Physician Decision|6|||
30572695|NCT01923168|58580403|FG001|Overall Study|Physician Decision|9|||
30572696|NCT01923168|58580404|FG002|Overall Study|Physician Decision|5|||
30572697|NCT01923168|58580402|FG000|Overall Study|Progressive disease|4|||
30572698|NCT01923168|58580403|FG001|Overall Study|Progressive disease|3|||
30572699|NCT01923168|58580404|FG002|Overall Study|Progressive disease|7|||
30572700|NCT01923168|58580402|FG000|Overall Study|Death|0|||
30572701|NCT01923168|58580403|FG001|Overall Study|Death|0|||
30572702|NCT01923168|58580404|FG002|Overall Study|Death|1|||
30572703|NCT01931098|58580414|FG000|Overall Study|Withdrawal by Subject|0|||
30572704|NCT01931098|58580415|FG001|Overall Study|Withdrawal by Subject|1|||
30572705|NCT01931098|58580414|FG000|Overall Study|Enrolled in different protocol|0|||
30572706|NCT01931098|58580415|FG001|Overall Study|Enrolled in different protocol|1|||
30572707|NCT01931098|58580414|FG000|Overall Study|Unable to begin trmt:active infection|0|||
30572708|NCT01931098|58580415|FG001|Overall Study|Unable to begin trmt:active infection|1|||
30572709|NCT01931098|58580414|FG000|Overall Study|Refused further treatment|0|||
30572710|NCT01931098|58580415|FG001|Overall Study|Refused further treatment|1|||
30572711|NCT01945021|58580423|FG000|Overall Study|Adverse Event|1|||
30572712|NCT01945021|58580423|FG000|Overall Study|Withdrawal of consent|12|||
30572713|NCT01945021|58580423|FG000|Overall Study|Lost to Follow-up|5|||
30572714|NCT01945021|58580423|FG000|Overall Study|Death|65|||
30572715|NCT01945060|58580429|FG000|Overall Study|Lost to follow up|1|||
30572716|NCT01945060|58580430|FG001|Overall Study|Lost to follow up|0|||
30572717|NCT01945060|58580429|FG000|Overall Study|Distress related to IV access|0|||
30572718|NCT01945060|58580430|FG001|Overall Study|Distress related to IV access|1|||
30572719|NCT03951077|58580473|FG000|Overall Study|Adverse Event|1|||
30572720|NCT03951077|58580474|FG001|Overall Study|Adverse Event|0|||
30572721|NCT03951077|58580475|FG002|Overall Study|Adverse Event|0|||
30572722|NCT03951077|58580476|FG003|Overall Study|Adverse Event|0|||
30572723|NCT03951077|58580477|FG004|Overall Study|Adverse Event|0|||
30572724|NCT03951077|58580478|FG005|Overall Study|Adverse Event|0|||
30572725|NCT03951077|58580473|FG000|Overall Study|Withdrawal by Subject|3|||
30572726|NCT03951077|58580474|FG001|Overall Study|Withdrawal by Subject|3|||
30572727|NCT03951077|58580475|FG002|Overall Study|Withdrawal by Subject|0|||
30572728|NCT03951077|58580476|FG003|Overall Study|Withdrawal by Subject|3|||
30572729|NCT03951077|58580477|FG004|Overall Study|Withdrawal by Subject|3|||
30572730|NCT03951077|58580478|FG005|Overall Study|Withdrawal by Subject|2|||
30572731|NCT03951077|58580473|FG000|Overall Study|Lost to Follow-up|1|||
30572732|NCT03951077|58580474|FG001|Overall Study|Lost to Follow-up|1|||
30572733|NCT03951077|58580475|FG002|Overall Study|Lost to Follow-up|2|||
30667807|NCT00505687|58681721|FG000|Overall Study|Lack of Efficacy|15|||
30667808|NCT00505687|58681721|FG000|Overall Study|Adverse Event|48|||
30572734|NCT03951077|58580476|FG003|Overall Study|Lost to Follow-up|3|||
30572735|NCT03951077|58580477|FG004|Overall Study|Lost to Follow-up|2|||
30572736|NCT03951077|58580478|FG005|Overall Study|Lost to Follow-up|3|||
30667809|NCT00505687|58681721|FG000|Overall Study|Subject withdrew consent|15|||
30572737|NCT03951077|58580473|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
30572738|NCT03951077|58580474|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
30667810|NCT00505687|58681721|FG000|Overall Study|Lost to Follow-up|1|||
30572739|NCT03951077|58580475|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
30572740|NCT03951077|58580476|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
30572741|NCT03951077|58580477|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
30572742|NCT03951077|58580478|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
30572743|NCT03951077|58580473|FG000|Overall Study|Other, Not Specified|12|||
30572744|NCT03951077|58580474|FG001|Overall Study|Other, Not Specified|10|||
30572745|NCT03951077|58580475|FG002|Overall Study|Other, Not Specified|10|||
30572746|NCT03951077|58580476|FG003|Overall Study|Other, Not Specified|5|||
30572747|NCT03951077|58580477|FG004|Overall Study|Other, Not Specified|9|||
30572748|NCT03951077|58580478|FG005|Overall Study|Other, Not Specified|6|||
30572749|NCT03951077|58580473|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
30572750|NCT03951077|58580474|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
30572751|NCT03951077|58580475|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
30572752|NCT03951077|58580476|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
30572753|NCT03951077|58580477|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
30572754|NCT03951077|58580478|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
30572755|NCT03873246|58580495|FG000|Overall Study|Adverse Event|1|||
30572756|NCT03873246|58580496|FG001|Overall Study|Adverse Event|3|||
30572757|NCT03873246|58580497|FG002|Overall Study|Adverse Event|3|||
30572758|NCT03873246|58580495|FG000|Overall Study|Lost to Follow-up|4|||
30572759|NCT03873246|58580496|FG001|Overall Study|Lost to Follow-up|4|||
30572760|NCT03873246|58580497|FG002|Overall Study|Lost to Follow-up|5|||
30572761|NCT03873246|58580495|FG000|Overall Study|Protocol Violation|0|||
30572762|NCT03873246|58580496|FG001|Overall Study|Protocol Violation|1|||
30572763|NCT03873246|58580497|FG002|Overall Study|Protocol Violation|0|||
30572764|NCT03873246|58580495|FG000|Overall Study|Withdrawal by Subject|0|||
30572765|NCT03873246|58580496|FG001|Overall Study|Withdrawal by Subject|4|||
30572766|NCT03873246|58580497|FG002|Overall Study|Withdrawal by Subject|1|||
30572767|NCT03769649|58580506|FG000|Overall Study|Lost to Follow-up|4|||
30572768|NCT02862548|58580532|FG000|Randomized Phase (Up to Week 48)|Death|0|||
30572769|NCT02862548|58580533|FG001|Randomized Phase (Up to Week 48)|Death|1|||
30572770|NCT02862548|58580532|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
30572771|NCT02862548|58580533|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
30572772|NCT02862548|58580532|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
30572773|NCT02862548|58580533|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
30572774|NCT02862548|58580532|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
30572775|NCT02862548|58580533|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
30572776|NCT02335099|58580552|FG000|Treatment|Withdrawal by Subject|1|||
30572777|NCT02335099|58580553|FG001|Treatment|Withdrawal by Subject|3|||
30572778|NCT02335099|58580552|FG000|Treatment|Lost to Follow-up|2|||
30572779|NCT02335099|58580553|FG001|Treatment|Lost to Follow-up|0|||
30572780|NCT02335099|58580552|FG000|Treatment|Death|1|||
30572781|NCT02335099|58580553|FG001|Treatment|Death|0|||
30572782|NCT02335099|58580552|FG000|Treatment|Adverse Event|1|||
30572783|NCT02335099|58580553|FG001|Treatment|Adverse Event|2|||
30572784|NCT02335099|58580552|FG000|Follow-up|Death|0|||
30572785|NCT02335099|58580553|FG001|Follow-up|Death|1|||
30572786|NCT02330562|58580570|FG000|Overall Study|Adverse Event|0|||
30572787|NCT02330562|58580571|FG001|Overall Study|Adverse Event|0|||
30572788|NCT02330562|58580572|FG002|Overall Study|Adverse Event|3|||
30572789|NCT02330562|58580573|FG003|Overall Study|Adverse Event|0|||
30572790|NCT02330562|58580574|FG004|Overall Study|Adverse Event|3|||
30572791|NCT02330562|58580575|FG005|Overall Study|Adverse Event|1|||
30572792|NCT02330562|58580576|FG006|Overall Study|Adverse Event|0|||
30572793|NCT02330562|58580577|FG007|Overall Study|Adverse Event|0|||
30572794|NCT02330562|58580578|FG008|Overall Study|Adverse Event|0|||
30572795|NCT02330562|58580579|FG009|Overall Study|Adverse Event|1|||
30572796|NCT02330562|58580580|FG010|Overall Study|Adverse Event|1|||
30572797|NCT02330562|58580570|FG000|Overall Study|Participant decision|1|||
30572798|NCT02330562|58580571|FG001|Overall Study|Participant decision|0|||
30572799|NCT02330562|58580572|FG002|Overall Study|Participant decision|4|||
30572800|NCT02330562|58580573|FG003|Overall Study|Participant decision|1|||
30572801|NCT02330562|58580574|FG004|Overall Study|Participant decision|5|||
30572802|NCT02330562|58580575|FG005|Overall Study|Participant decision|2|||
30572803|NCT02330562|58580576|FG006|Overall Study|Participant decision|0|||
30572804|NCT02330562|58580577|FG007|Overall Study|Participant decision|0|||
30572805|NCT02330562|58580578|FG008|Overall Study|Participant decision|0|||
30572806|NCT02330562|58580579|FG009|Overall Study|Participant decision|3|||
30572807|NCT02330562|58580580|FG010|Overall Study|Participant decision|0|||
30572808|NCT02330562|58580570|FG000|Overall Study|Disease progression|5|||
30572809|NCT02330562|58580571|FG001|Overall Study|Disease progression|3|||
30572810|NCT02330562|58580572|FG002|Overall Study|Disease progression|20|||
30780221|NCT03492554|58791929|FG000|Overall Study|Protocol Violation|0|||
30572811|NCT02330562|58580573|FG003|Overall Study|Disease progression|28|||
30572812|NCT02330562|58580574|FG004|Overall Study|Disease progression|23|||
30572813|NCT02330562|58580575|FG005|Overall Study|Disease progression|7|||
30572814|NCT02330562|58580576|FG006|Overall Study|Disease progression|1|||
30572815|NCT02330562|58580577|FG007|Overall Study|Disease progression|1|||
30572816|NCT02330562|58580578|FG008|Overall Study|Disease progression|1|||
30572817|NCT02330562|58580579|FG009|Overall Study|Disease progression|0|||
30572818|NCT02330562|58580580|FG010|Overall Study|Disease progression|5|||
30572819|NCT02330562|58580570|FG000|Overall Study|Other reasons|0|||
30572820|NCT02330562|58580571|FG001|Overall Study|Other reasons|0|||
30572821|NCT02330562|58580572|FG002|Overall Study|Other reasons|0|||
30780222|NCT03492554|58791930|FG001|Overall Study|Protocol Violation|14|||
30572822|NCT02330562|58580573|FG003|Overall Study|Other reasons|1|||
30572823|NCT02330562|58580574|FG004|Overall Study|Other reasons|0|||
30572824|NCT02330562|58580575|FG005|Overall Study|Other reasons|0|||
30572825|NCT02330562|58580576|FG006|Overall Study|Other reasons|0|||
30572826|NCT02330562|58580577|FG007|Overall Study|Other reasons|0|||
30572827|NCT02330562|58580578|FG008|Overall Study|Other reasons|0|||
30572828|NCT02330562|58580579|FG009|Overall Study|Other reasons|0|||
30572829|NCT02330562|58580580|FG010|Overall Study|Other reasons|0|||
30572830|NCT02330562|58580570|FG000|Overall Study|Withdrawal by Subject|0|||
30572831|NCT02330562|58580571|FG001|Overall Study|Withdrawal by Subject|0|||
30572832|NCT02330562|58580572|FG002|Overall Study|Withdrawal by Subject|0|||
30572833|NCT02330562|58580573|FG003|Overall Study|Withdrawal by Subject|0|||
30572834|NCT02330562|58580574|FG004|Overall Study|Withdrawal by Subject|0|||
30572835|NCT02330562|58580575|FG005|Overall Study|Withdrawal by Subject|0|||
30572836|NCT02330562|58580576|FG006|Overall Study|Withdrawal by Subject|0|||
30572837|NCT02330562|58580577|FG007|Overall Study|Withdrawal by Subject|0|||
30572838|NCT02330562|58580578|FG008|Overall Study|Withdrawal by Subject|0|||
30572839|NCT02330562|58580579|FG009|Overall Study|Withdrawal by Subject|1|||
30572840|NCT02330562|58580580|FG010|Overall Study|Withdrawal by Subject|0|||
30572841|NCT03703102|58580694|FG000|Overall Study|Adverse Event|4|||
30572842|NCT03703102|58580695|FG001|Overall Study|Adverse Event|3|||
30572843|NCT03703102|58580696|FG002|Overall Study|Adverse Event|7|||
30572844|NCT03703102|58580697|FG003|Overall Study|Adverse Event|3|||
30572845|NCT03703102|58580698|FG004|Overall Study|Adverse Event|13|||
30572846|NCT03703102|58580694|FG000|Overall Study|Lack of Efficacy|4|||
30572847|NCT03703102|58580695|FG001|Overall Study|Lack of Efficacy|0|||
30572848|NCT03703102|58580696|FG002|Overall Study|Lack of Efficacy|1|||
30572849|NCT03703102|58580697|FG003|Overall Study|Lack of Efficacy|4|||
30572850|NCT03703102|58580698|FG004|Overall Study|Lack of Efficacy|1|||
30572851|NCT03703102|58580694|FG000|Overall Study|Lost to Follow-up|0|||
30572852|NCT03703102|58580695|FG001|Overall Study|Lost to Follow-up|0|||
30572853|NCT03703102|58580696|FG002|Overall Study|Lost to Follow-up|1|||
30572854|NCT03703102|58580697|FG003|Overall Study|Lost to Follow-up|2|||
30572855|NCT03703102|58580698|FG004|Overall Study|Lost to Follow-up|2|||
30572856|NCT03703102|58580694|FG000|Overall Study|Physician Decision|2|||
30572857|NCT03703102|58580695|FG001|Overall Study|Physician Decision|2|||
30572858|NCT03703102|58580696|FG002|Overall Study|Physician Decision|2|||
30572859|NCT03703102|58580697|FG003|Overall Study|Physician Decision|2|||
30572860|NCT03703102|58580698|FG004|Overall Study|Physician Decision|4|||
30572861|NCT03703102|58580694|FG000|Overall Study|Withdrawal by Subject|7|||
30572862|NCT03703102|58580695|FG001|Overall Study|Withdrawal by Subject|5|||
30572863|NCT03703102|58580696|FG002|Overall Study|Withdrawal by Subject|5|||
30572864|NCT03703102|58580697|FG003|Overall Study|Withdrawal by Subject|5|||
30572865|NCT03703102|58580698|FG004|Overall Study|Withdrawal by Subject|9|||
30572866|NCT03703102|58580694|FG000|Overall Study|Ineligibility|0|||
30572867|NCT03703102|58580695|FG001|Overall Study|Ineligibility|0|||
30572868|NCT03703102|58580696|FG002|Overall Study|Ineligibility|1|||
30572869|NCT03703102|58580697|FG003|Overall Study|Ineligibility|0|||
30572870|NCT03703102|58580698|FG004|Overall Study|Ineligibility|0|||
30572871|NCT03703102|58580694|FG000|Overall Study|Protocol Deviation|4|||
30572872|NCT03703102|58580695|FG001|Overall Study|Protocol Deviation|4|||
30572873|NCT03703102|58580696|FG002|Overall Study|Protocol Deviation|3|||
30572874|NCT03703102|58580697|FG003|Overall Study|Protocol Deviation|0|||
30572875|NCT03703102|58580698|FG004|Overall Study|Protocol Deviation|0|||
30572876|NCT03703102|58580694|FG000|Overall Study|Non-Compliance with Study Drug|1|||
30572877|NCT03703102|58580695|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30572878|NCT03703102|58580696|FG002|Overall Study|Non-Compliance with Study Drug|2|||
30572879|NCT03703102|58580697|FG003|Overall Study|Non-Compliance with Study Drug|1|||
30572880|NCT03703102|58580698|FG004|Overall Study|Non-Compliance with Study Drug|4|||
30572881|NCT03395704|58580717|FG000|Overall Study|Adverse Event|2|||
30572882|NCT03395704|58580718|FG001|Overall Study|Adverse Event|1|||
30572883|NCT03395704|58580717|FG000|Overall Study|Withdrawal by Subject|2|||
30572884|NCT03395704|58580718|FG001|Overall Study|Withdrawal by Subject|1|||
30572885|NCT03395704|58580717|FG000|Overall Study|Physician Decision|0|||
30572886|NCT03395704|58580718|FG001|Overall Study|Physician Decision|1|||
30572887|NCT03335813|58580724|FG000|Overall Study|Withdrawal by Subject|1|||
30572888|NCT03246503|58580728|FG000|Overall Study|Lost to Follow-up|23|||
30572889|NCT03246503|58580728|FG000|Overall Study|Withdrawal by Subject|20|||
30572890|NCT03246503|58580728|FG000|Overall Study|Physician Decision|5|||
30572891|NCT03246503|58580728|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
30572892|NCT02514447|58580789|FG000|Overall Study|Withdrawal by Subject|3|||
30667811|NCT00505687|58681721|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
30667812|NCT00505687|58681721|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
30572893|NCT02514447|58580790|FG001|Overall Study|Withdrawal by Subject|1|||
30572894|NCT02514447|58580791|FG002|Overall Study|Withdrawal by Subject|1|||
30572895|NCT02514447|58580792|FG003|Overall Study|Withdrawal by Subject|0|||
30572896|NCT02514447|58580793|FG004|Overall Study|Withdrawal by Subject|0|||
30572897|NCT02514447|58580794|FG005|Overall Study|Withdrawal by Subject|0|||
30572898|NCT02514447|58580795|FG006|Overall Study|Withdrawal by Subject|0|||
30572899|NCT02514447|58580796|FG007|Overall Study|Withdrawal by Subject|1|||
30572900|NCT02514447|58580797|FG008|Overall Study|Withdrawal by Subject|1|||
30572901|NCT02514447|58580789|FG000|Overall Study|Death|24|||
30572902|NCT02514447|58580790|FG001|Overall Study|Death|28|||
30572903|NCT02514447|58580791|FG002|Overall Study|Death|29|||
30572904|NCT02514447|58580792|FG003|Overall Study|Death|0|||
30572905|NCT02514447|58580793|FG004|Overall Study|Death|3|||
30572906|NCT02514447|58580794|FG005|Overall Study|Death|4|||
30572907|NCT02514447|58580795|FG006|Overall Study|Death|8|||
30572908|NCT02514447|58580796|FG007|Overall Study|Death|6|||
30572909|NCT02514447|58580797|FG008|Overall Study|Death|5|||
30572910|NCT02514447|58580789|FG000|Overall Study|Lost to Follow-up|1|||
30572911|NCT02514447|58580790|FG001|Overall Study|Lost to Follow-up|0|||
30572912|NCT02514447|58580791|FG002|Overall Study|Lost to Follow-up|0|||
30572913|NCT02514447|58580792|FG003|Overall Study|Lost to Follow-up|0|||
30572914|NCT02514447|58580793|FG004|Overall Study|Lost to Follow-up|0|||
30572915|NCT02514447|58580794|FG005|Overall Study|Lost to Follow-up|0|||
30572916|NCT02514447|58580795|FG006|Overall Study|Lost to Follow-up|0|||
30572917|NCT02514447|58580796|FG007|Overall Study|Lost to Follow-up|0|||
30572918|NCT02514447|58580797|FG008|Overall Study|Lost to Follow-up|1|||
30572919|NCT02514447|58580789|FG000|Overall Study|Sponsor Termination of Study|0|||
30572920|NCT02514447|58580790|FG001|Overall Study|Sponsor Termination of Study|1|||
30572921|NCT02514447|58580791|FG002|Overall Study|Sponsor Termination of Study|1|||
30572922|NCT02514447|58580792|FG003|Overall Study|Sponsor Termination of Study|0|||
30572923|NCT02514447|58580793|FG004|Overall Study|Sponsor Termination of Study|0|||
30572924|NCT02514447|58580794|FG005|Overall Study|Sponsor Termination of Study|0|||
30572925|NCT02514447|58580795|FG006|Overall Study|Sponsor Termination of Study|0|||
30572926|NCT02514447|58580796|FG007|Overall Study|Sponsor Termination of Study|0|||
30572927|NCT02514447|58580797|FG008|Overall Study|Sponsor Termination of Study|0|||
30572928|NCT02514447|58580789|FG000|Overall Study|Study completion per Investigator|1|||
30572929|NCT02514447|58580790|FG001|Overall Study|Study completion per Investigator|0|||
30572930|NCT02514447|58580791|FG002|Overall Study|Study completion per Investigator|1|||
30572931|NCT02514447|58580792|FG003|Overall Study|Study completion per Investigator|2|||
30572932|NCT02514447|58580793|FG004|Overall Study|Study completion per Investigator|0|||
30572933|NCT02514447|58580794|FG005|Overall Study|Study completion per Investigator|0|||
30572934|NCT02514447|58580795|FG006|Overall Study|Study completion per Investigator|0|||
30572935|NCT02514447|58580796|FG007|Overall Study|Study completion per Investigator|0|||
30572936|NCT02514447|58580797|FG008|Overall Study|Study completion per Investigator|1|||
30572937|NCT01785563|58580841|FG000|Overall Study|Physician Decision|10|||
30572938|NCT01785563|58580841|FG000|Overall Study|Withdrawal by Subject|1|||
30572939|NCT01785563|58580841|FG000|Overall Study|Protocol Violation|2|||
30572940|NCT01434290|58580847|FG000|Overall Study|Protocol Violation|6|||
30572941|NCT01434290|58580848|FG001|Overall Study|Protocol Violation|3|||
30572942|NCT01434290|58580847|FG000|Overall Study|No protocol treatment|2|||
30572943|NCT01434290|58580848|FG001|Overall Study|No protocol treatment|4|||
30572944|NCT00750269|58580860|FG000|Overall Study|Protocol Violation|0|||
30572945|NCT00750269|58580861|FG001|Overall Study|Protocol Violation|1|||
30572946|NCT00750269|58580862|FG002|Overall Study|Protocol Violation|1|||
30572947|NCT00750269|58580863|FG003|Overall Study|Protocol Violation|2|||
30572948|NCT00750269|58580864|FG004|Overall Study|Protocol Violation|4|||
30572949|NCT00750269|58580860|FG000|Overall Study|Withdrawal by Subject|0|||
30572950|NCT00750269|58580861|FG001|Overall Study|Withdrawal by Subject|0|||
30572951|NCT00750269|58580862|FG002|Overall Study|Withdrawal by Subject|2|||
30572952|NCT00750269|58580863|FG003|Overall Study|Withdrawal by Subject|2|||
30572953|NCT00750269|58580864|FG004|Overall Study|Withdrawal by Subject|2|||
30572954|NCT00750269|58580860|FG000|Overall Study|Physician Decision|0|||
30572955|NCT00750269|58580861|FG001|Overall Study|Physician Decision|0|||
30572956|NCT00750269|58580862|FG002|Overall Study|Physician Decision|0|||
30572957|NCT00750269|58580863|FG003|Overall Study|Physician Decision|0|||
30572958|NCT00750269|58580864|FG004|Overall Study|Physician Decision|2|||
30572959|NCT00750269|58580860|FG000|Overall Study|Patient too large for positioning|0|||
30572960|NCT00750269|58580861|FG001|Overall Study|Patient too large for positioning|0|||
30572961|NCT00750269|58580862|FG002|Overall Study|Patient too large for positioning|1|||
30572962|NCT00750269|58580863|FG003|Overall Study|Patient too large for positioning|0|||
30572963|NCT00750269|58580864|FG004|Overall Study|Patient too large for positioning|0|||
30572964|NCT00750269|58580860|FG000|Overall Study|Site error|0|||
30572965|NCT00750269|58580861|FG001|Overall Study|Site error|0|||
30572966|NCT00750269|58580862|FG002|Overall Study|Site error|0|||
30572967|NCT00750269|58580863|FG003|Overall Study|Site error|1|||
30572968|NCT00750269|58580864|FG004|Overall Study|Site error|0|||
30572969|NCT00750269|58580860|FG000|Overall Study|SBRT plan could not be drawn|0|||
30572970|NCT00750269|58580861|FG001|Overall Study|SBRT plan could not be drawn|0|||
30572971|NCT00750269|58580862|FG002|Overall Study|SBRT plan could not be drawn|0|||
30572972|NCT00750269|58580863|FG003|Overall Study|SBRT plan could not be drawn|0|||
30572973|NCT00750269|58580864|FG004|Overall Study|SBRT plan could not be drawn|1|||
30572974|NCT00750269|58580860|FG000|Overall Study|Fiducials could not be placed|0|||
30572975|NCT00750269|58580861|FG001|Overall Study|Fiducials could not be placed|0|||
30572976|NCT00750269|58580862|FG002|Overall Study|Fiducials could not be placed|0|||
30572977|NCT00750269|58580863|FG003|Overall Study|Fiducials could not be placed|0|||
30572978|NCT00750269|58580864|FG004|Overall Study|Fiducials could not be placed|1|||
30572979|NCT00712322|58580886|FG000|Overall Study|Protocol deviation|0|||
30572980|NCT00712322|58580887|FG001|Overall Study|Protocol deviation|1|||
30572981|NCT00712322|58580888|FG002|Overall Study|Protocol deviation|0|||
30572982|NCT00323856|58580896|FG000|Overall Study|Withdrawal by Subject|1|||
30572983|NCT00323856|58580896|FG000|Overall Study|Was uncooperative and noncompliant|1|||
30572984|NCT00323856|58580896|FG000|Overall Study|Reason not specified|1|||
30855241|NCT02603120|58882787|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
30855242|NCT02599688|58882795|FG000|Overall Study|Lack of Efficacy|1|||
30572985|NCT00323856|58580896|FG000|Overall Study|Missing|2|||
30572986|NCT04594941|58580911|FG000|Overall Study|Other|0|||
30572987|NCT04594941|58580912|FG001|Overall Study|Other|3|||
30572988|NCT04594941|58580913|FG002|Overall Study|Other|1|||
30572989|NCT04594941|58580914|FG003|Overall Study|Other|0|||
30572990|NCT04524663|58580932|FG000|Overall Study|Withdrawal by Subject|0|||
30572991|NCT04524663|58580933|FG001|Overall Study|Withdrawal by Subject|2|||
30572992|NCT03738423|58580962|FG000|Overall Study|Withdrawal by Subject|9|||
30572993|NCT03738423|58580963|FG001|Overall Study|Withdrawal by Subject|12|||
30572994|NCT03738423|58580964|FG002|Overall Study|Withdrawal by Subject|9|||
30572995|NCT03738423|58580965|FG003|Overall Study|Withdrawal by Subject|12|||
30572996|NCT03738423|58580966|FG004|Overall Study|Withdrawal by Subject|10|||
30572997|NCT03738423|58580962|FG000|Overall Study|Lack of Efficacy|3|||
30572998|NCT03738423|58580963|FG001|Overall Study|Lack of Efficacy|1|||
30572999|NCT03738423|58580964|FG002|Overall Study|Lack of Efficacy|1|||
30573000|NCT03738423|58580965|FG003|Overall Study|Lack of Efficacy|1|||
30573001|NCT03738423|58580966|FG004|Overall Study|Lack of Efficacy|2|||
30573002|NCT03738423|58580962|FG000|Overall Study|Lost to Follow-up|1|||
30573003|NCT03738423|58580963|FG001|Overall Study|Lost to Follow-up|0|||
30573004|NCT03738423|58580964|FG002|Overall Study|Lost to Follow-up|1|||
30573005|NCT03738423|58580965|FG003|Overall Study|Lost to Follow-up|1|||
30573006|NCT03738423|58580966|FG004|Overall Study|Lost to Follow-up|0|||
30573007|NCT03738423|58580962|FG000|Overall Study|Protocol Violation|1|||
30573008|NCT03738423|58580963|FG001|Overall Study|Protocol Violation|0|||
30573009|NCT03738423|58580964|FG002|Overall Study|Protocol Violation|0|||
30573010|NCT03738423|58580965|FG003|Overall Study|Protocol Violation|0|||
30573011|NCT03738423|58580966|FG004|Overall Study|Protocol Violation|1|||
30573012|NCT03738423|58580962|FG000|Overall Study|Physician Decision|0|||
30573013|NCT03738423|58580963|FG001|Overall Study|Physician Decision|0|||
30573014|NCT03738423|58580964|FG002|Overall Study|Physician Decision|1|||
30573015|NCT03738423|58580965|FG003|Overall Study|Physician Decision|0|||
30573016|NCT03738423|58580966|FG004|Overall Study|Physician Decision|1|||
30573017|NCT03738423|58580962|FG000|Overall Study|Death|0|||
30573018|NCT03738423|58580963|FG001|Overall Study|Death|0|||
30573019|NCT03738423|58580964|FG002|Overall Study|Death|0|||
30573020|NCT03738423|58580965|FG003|Overall Study|Death|0|||
30573021|NCT03738423|58580966|FG004|Overall Study|Death|1|||
30573022|NCT03738423|58580962|FG000|Overall Study|Randomized but never treated|0|||
30573023|NCT03738423|58580963|FG001|Overall Study|Randomized but never treated|0|||
30573024|NCT03738423|58580964|FG002|Overall Study|Randomized but never treated|1|||
30780223|NCT04936334|58791975|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
30780224|NCT04822597|58791985|FG000|Overall Study|Withdrawal by Subject|0|||
30780225|NCT04822597|58791986|FG001|Overall Study|Withdrawal by Subject|1|||
30780226|NCT04822597|58791987|FG002|Overall Study|Withdrawal by Subject|1|||
30780227|NCT04822597|58791988|FG003|Overall Study|Withdrawal by Subject|0|||
30780228|NCT04822597|58791985|FG000|Overall Study|Physician Decision|0|||
30780229|NCT04822597|58791986|FG001|Overall Study|Physician Decision|0|||
30780230|NCT04822597|58791987|FG002|Overall Study|Physician Decision|1|||
30780231|NCT04822597|58791988|FG003|Overall Study|Physician Decision|1|||
30780232|NCT04822597|58791985|FG000|Overall Study|Subject withdrawn after enrollment|0|||
30573025|NCT03738423|58580965|FG003|Overall Study|Randomized but never treated|1|||
30573026|NCT03738423|58580966|FG004|Overall Study|Randomized but never treated|0|||
30573027|NCT03712228|58580984|FG000|Treatment Period 1|Lack of Efficacy|0|||
30573028|NCT03712228|58580985|FG001|Treatment Period 1|Lack of Efficacy|0|||
30573029|NCT03712228|58580986|FG002|Treatment Period 1|Lack of Efficacy|0|||
30573030|NCT03712228|58580987|FG003|Treatment Period 1|Lack of Efficacy|0|||
30573031|NCT03712228|58580988|FG004|Treatment Period 1|Lack of Efficacy|0|||
30855243|NCT02599688|58882795|FG000|Overall Study|Withdrawal by Subject|1|||
30573032|NCT03712228|58580989|FG005|Treatment Period 1|Lack of Efficacy|1|||
30573033|NCT03712228|58580984|FG000|Treatment Period 2|Pregnancy|0|||
30573034|NCT03712228|58580985|FG001|Treatment Period 2|Pregnancy|0|||
30573035|NCT03712228|58580986|FG002|Treatment Period 2|Pregnancy|0|||
30573036|NCT03712228|58580987|FG003|Treatment Period 2|Pregnancy|1|||
30573037|NCT03712228|58580988|FG004|Treatment Period 2|Pregnancy|0|||
30780233|NCT04822597|58791986|FG001|Overall Study|Subject withdrawn after enrollment|1|||
30573038|NCT03712228|58580989|FG005|Treatment Period 2|Pregnancy|0|||
30573039|NCT03712228|58580984|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30573040|NCT03712228|58580985|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30573041|NCT03712228|58580986|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30573042|NCT03712228|58580987|FG003|Treatment Period 2|Withdrawal by Subject|1|||
30573043|NCT03712228|58580988|FG004|Treatment Period 2|Withdrawal by Subject|0|||
30573044|NCT03712228|58580989|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30573045|NCT03600818|58581008|FG000|Overall Study|Adverse Event|4|||
30573046|NCT03600818|58581009|FG001|Overall Study|Adverse Event|7|||
30573047|NCT03600818|58581008|FG000|Overall Study|Lack of Efficacy|9|||
30573048|NCT03600818|58581009|FG001|Overall Study|Lack of Efficacy|4|||
30573049|NCT03600818|58581008|FG000|Overall Study|Withdrawal by Subject|4|||
30573050|NCT03600818|58581009|FG001|Overall Study|Withdrawal by Subject|3|||
30573051|NCT03600818|58581008|FG000|Overall Study|Other-unspecified|5|||
30573052|NCT03600818|58581009|FG001|Overall Study|Other-unspecified|3|||
30573053|NCT03600818|58581008|FG000|Overall Study|Randomized and not treated|0|||
30573054|NCT03600818|58581009|FG001|Overall Study|Randomized and not treated|1|||
30573055|NCT03578276|58581018|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
30573056|NCT03578276|58581019|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
30573057|NCT02034110|58581084|FG000|Overall Study|Physician Decision|0|||
30573058|NCT02034110|58581085|FG001|Overall Study|Physician Decision|0|||
30573059|NCT02034110|58581086|FG002|Overall Study|Physician Decision|0|||
30573060|NCT02034110|58581087|FG003|Overall Study|Physician Decision|0|||
30573061|NCT02034110|58581088|FG004|Overall Study|Physician Decision|2|||
30573062|NCT02034110|58581089|FG005|Overall Study|Physician Decision|0|||
30573063|NCT02034110|58581090|FG006|Overall Study|Physician Decision|1|||
30573064|NCT02034110|58581091|FG007|Overall Study|Physician Decision|0|||
30573065|NCT02034110|58581084|FG000|Overall Study|Lost to Follow-up|1|||
30573066|NCT02034110|58581085|FG001|Overall Study|Lost to Follow-up|0|||
30573067|NCT02034110|58581086|FG002|Overall Study|Lost to Follow-up|0|||
30573068|NCT02034110|58581087|FG003|Overall Study|Lost to Follow-up|0|||
30573069|NCT02034110|58581088|FG004|Overall Study|Lost to Follow-up|1|||
30573070|NCT02034110|58581089|FG005|Overall Study|Lost to Follow-up|0|||
30573071|NCT02034110|58581090|FG006|Overall Study|Lost to Follow-up|1|||
30573072|NCT02034110|58581091|FG007|Overall Study|Lost to Follow-up|0|||
30573073|NCT02034110|58581084|FG000|Overall Study|Withdrawal by Subject|5|||
30573074|NCT02034110|58581085|FG001|Overall Study|Withdrawal by Subject|7|||
30573075|NCT02034110|58581086|FG002|Overall Study|Withdrawal by Subject|0|||
30573076|NCT02034110|58581087|FG003|Overall Study|Withdrawal by Subject|3|||
30573077|NCT02034110|58581088|FG004|Overall Study|Withdrawal by Subject|7|||
30573078|NCT02034110|58581089|FG005|Overall Study|Withdrawal by Subject|0|||
30573079|NCT02034110|58581090|FG006|Overall Study|Withdrawal by Subject|3|||
30573080|NCT02034110|58581091|FG007|Overall Study|Withdrawal by Subject|1|||
30573081|NCT02034110|58581084|FG000|Overall Study|Study closed by sponsor|6|||
30573082|NCT02034110|58581085|FG001|Overall Study|Study closed by sponsor|2|||
30573083|NCT02034110|58581086|FG002|Overall Study|Study closed by sponsor|0|||
30573084|NCT02034110|58581087|FG003|Overall Study|Study closed by sponsor|6|||
30573085|NCT02034110|58581088|FG004|Overall Study|Study closed by sponsor|7|||
30573086|NCT02034110|58581089|FG005|Overall Study|Study closed by sponsor|0|||
30573087|NCT02034110|58581090|FG006|Overall Study|Study closed by sponsor|42|||
30573088|NCT02034110|58581091|FG007|Overall Study|Study closed by sponsor|0|||
30573089|NCT01627574|58581139|FG000|Overall Study|Withdrawal by Subject|8|||
30573090|NCT01627574|58581140|FG001|Overall Study|Withdrawal by Subject|5|||
30573091|NCT01627574|58581139|FG000|Overall Study|Lost to Follow-up|13|||
30573092|NCT01627574|58581140|FG001|Overall Study|Lost to Follow-up|13|||
30573093|NCT01498458|58581146|FG000|Overall Study|Adverse Event|4|||
30573094|NCT01498458|58581146|FG000|Overall Study|Physician Decision|3|||
30573095|NCT01427712|58581155|FG000|Overall Study|Transfer to a different hospital|2|||
30573096|NCT01427712|58581155|FG000|Overall Study|Lost to Follow-up|1|||
30573097|NCT01427712|58581155|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
30573098|NCT01427712|58581155|FG000|Overall Study|Failure to visit|1|||
30573099|NCT01369147|58581162|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
30573100|NCT01369147|58581163|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
30573101|NCT01369147|58581164|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
30573102|NCT04846231|58581180|FG000|Overall Study|Lost to Follow-up|1|||
30573103|NCT04846231|58581181|FG001|Overall Study|Lost to Follow-up|0|||
30573104|NCT04846231|58581182|FG002|Overall Study|Lost to Follow-up|0|||
30573105|NCT04846231|58581183|FG003|Overall Study|Lost to Follow-up|0|||
30573106|NCT04846231|58581184|FG004|Overall Study|Lost to Follow-up|0|||
30573107|NCT04846231|58581185|FG005|Overall Study|Lost to Follow-up|0|||
30573108|NCT04846231|58581186|FG006|Overall Study|Lost to Follow-up|0|||
30573109|NCT04846231|58581187|FG007|Overall Study|Lost to Follow-up|1|||
30573110|NCT04846231|58581180|FG000|Overall Study|Withdrawal by Subject|0|||
30573111|NCT04846231|58581181|FG001|Overall Study|Withdrawal by Subject|1|||
30573112|NCT04846231|58581182|FG002|Overall Study|Withdrawal by Subject|2|||
30573113|NCT04846231|58581183|FG003|Overall Study|Withdrawal by Subject|1|||
30958675|NCT01694771|59023753|FG000|Overall Study|Consent withdrawn|7|||
30573114|NCT04846231|58581184|FG004|Overall Study|Withdrawal by Subject|0|||
30573115|NCT04846231|58581185|FG005|Overall Study|Withdrawal by Subject|0|||
30573116|NCT04846231|58581186|FG006|Overall Study|Withdrawal by Subject|0|||
30573117|NCT04846231|58581187|FG007|Overall Study|Withdrawal by Subject|0|||
30573118|NCT04846231|58581180|FG000|Overall Study|Protocol Violation|0|||
30573119|NCT04846231|58581181|FG001|Overall Study|Protocol Violation|1|||
30573120|NCT04846231|58581182|FG002|Overall Study|Protocol Violation|0|||
30573121|NCT04846231|58581183|FG003|Overall Study|Protocol Violation|0|||
30573122|NCT04846231|58581184|FG004|Overall Study|Protocol Violation|0|||
30573123|NCT04846231|58581185|FG005|Overall Study|Protocol Violation|0|||
30573124|NCT04846231|58581186|FG006|Overall Study|Protocol Violation|0|||
30573125|NCT04846231|58581187|FG007|Overall Study|Protocol Violation|0|||
30573126|NCT04846231|58581180|FG000|Overall Study|Adverse Event|0|||
30573127|NCT04846231|58581181|FG001|Overall Study|Adverse Event|0|||
30573128|NCT04846231|58581182|FG002|Overall Study|Adverse Event|0|||
30573129|NCT04846231|58581183|FG003|Overall Study|Adverse Event|0|||
30573130|NCT04846231|58581184|FG004|Overall Study|Adverse Event|0|||
30573131|NCT04846231|58581185|FG005|Overall Study|Adverse Event|0|||
30573132|NCT04846231|58581186|FG006|Overall Study|Adverse Event|1|||
30573133|NCT04846231|58581187|FG007|Overall Study|Adverse Event|1|||
30573134|NCT04533594|58581213|FG000|Overall Study|Death|26|||
30573135|NCT04533438|58581219|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
30573136|NCT04533438|58581220|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
30573137|NCT04447846|58581228|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
30573138|NCT04405245|58581235|FG000|Overall Study|Adverse Event|0|||
30573139|NCT04405245|58581236|FG001|Overall Study|Adverse Event|1|||
30573140|NCT04405245|58581237|FG002|Overall Study|Adverse Event|0|||
30573141|NCT04277507|58581245|FG000|Overall Study|Lost to Follow-up|17|||
30573142|NCT04277507|58581245|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
30573143|NCT04277507|58581245|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
30573144|NCT04277507|58581245|FG000|Overall Study|Withdrawal by Subject|3|||
30573145|NCT04277507|58581245|FG000|Overall Study|Death due to COVID-19|1|||
30573146|NCT04277507|58581245|FG000|Overall Study|Data missing for full evaluation|5|||
30573147|NCT04198805|58581266|FG000|Overall Study|Death|0|||
30573148|NCT04198805|58581267|FG001|Overall Study|Death|0|||
30573149|NCT04198805|58581268|FG002|Overall Study|Death|0|||
30573150|NCT04198805|58581269|FG003|Overall Study|Death|1|||
30573151|NCT04198805|58581266|FG000|Overall Study|Early Termination|8|||
30573152|NCT04198805|58581267|FG001|Overall Study|Early Termination|4|||
30573153|NCT04198805|58581268|FG002|Overall Study|Early Termination|6|||
30573154|NCT04198805|58581269|FG003|Overall Study|Early Termination|9|||
30573155|NCT04179890|58581285|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
30573156|NCT04179890|58581286|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
30573157|NCT04179890|58581285|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
30573158|NCT04179890|58581286|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
30573159|NCT04179890|58581285|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
30573160|NCT04179890|58581286|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
30573161|NCT04179890|58581285|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
30573162|NCT04179890|58581286|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
30573163|NCT04179890|58581285|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
30573164|NCT04179890|58581286|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
30573165|NCT04179890|58581285|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
30573166|NCT04179890|58581286|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
30573167|NCT04179890|58581285|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
30573168|NCT04179890|58581286|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
30573169|NCT04179890|58581285|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
30573170|NCT04179890|58581286|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
30573171|NCT04179890|58581285|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
30573172|NCT04179890|58581286|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
30573173|NCT03721016|58581327|FG000|Overall Study|Adverse Event|0|||
30573174|NCT03721016|58581328|FG001|Overall Study|Adverse Event|1|||
30667813|NCT00505687|58681721|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
30667814|NCT00505687|58681721|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
30573175|NCT03721016|58581329|FG002|Overall Study|Adverse Event|1|||
30573176|NCT03721016|58581327|FG000|Overall Study|Withdrawal by Subject|8|||
30573177|NCT03721016|58581328|FG001|Overall Study|Withdrawal by Subject|16|||
30573178|NCT03721016|58581329|FG002|Overall Study|Withdrawal by Subject|13|||
30667815|NCT00505687|58681721|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
30573179|NCT03721016|58581327|FG000|Overall Study|Lost to Follow-up|4|||
30573180|NCT03721016|58581328|FG001|Overall Study|Lost to Follow-up|6|||
30573181|NCT03721016|58581329|FG002|Overall Study|Lost to Follow-up|5|||
30573182|NCT03721016|58581327|FG000|Overall Study|Physician Decision|0|||
30573183|NCT03721016|58581328|FG001|Overall Study|Physician Decision|1|||
30573184|NCT03721016|58581329|FG002|Overall Study|Physician Decision|2|||
30573185|NCT03721016|58581327|FG000|Overall Study|Protocol Violation|0|||
30573186|NCT03721016|58581328|FG001|Overall Study|Protocol Violation|1|||
30573187|NCT03721016|58581329|FG002|Overall Study|Protocol Violation|0|||
30573188|NCT03721016|58581327|FG000|Overall Study|Site terminated by sponsor|3|||
30573189|NCT03721016|58581328|FG001|Overall Study|Site terminated by sponsor|7|||
30573190|NCT03721016|58581329|FG002|Overall Study|Site terminated by sponsor|6|||
30573191|NCT03721016|58581327|FG000|Overall Study|Subject exited early due to COVID-19|1|||
30573192|NCT03721016|58581328|FG001|Overall Study|Subject exited early due to COVID-19|0|||
30573193|NCT03721016|58581329|FG002|Overall Study|Subject exited early due to COVID-19|0|||
30573194|NCT03563716|58581339|FG000|Overall Study|Death|20|||
30573195|NCT03563716|58581340|FG001|Overall Study|Death|14|||
30573196|NCT03563716|58581339|FG000|Overall Study|Withdrawal by Subject|3|||
30573197|NCT03563716|58581340|FG001|Overall Study|Withdrawal by Subject|3|||
30573198|NCT03563716|58581339|FG000|Overall Study|Still on Study|45|||
30573199|NCT03563716|58581340|FG001|Overall Study|Still on Study|50|||
30573200|NCT03117998|58581374|FG000|Overall Study|Adverse Event|1|||
30573201|NCT03117998|58581375|FG001|Overall Study|Adverse Event|0|||
30573202|NCT03117998|58581376|FG002|Overall Study|Adverse Event|0|||
30573203|NCT03117998|58581377|FG003|Overall Study|Adverse Event|0|||
30573204|NCT03117998|58581378|FG004|Overall Study|Adverse Event|0|||
30573205|NCT03117998|58581379|FG005|Overall Study|Adverse Event|0|||
30573206|NCT03117998|58581374|FG000|Overall Study|Withdrawal by Subject|0|||
30573207|NCT03117998|58581375|FG001|Overall Study|Withdrawal by Subject|0|||
30573208|NCT03117998|58581376|FG002|Overall Study|Withdrawal by Subject|2|||
30573209|NCT03117998|58581377|FG003|Overall Study|Withdrawal by Subject|3|||
30573210|NCT03117998|58581378|FG004|Overall Study|Withdrawal by Subject|3|||
30573211|NCT03117998|58581379|FG005|Overall Study|Withdrawal by Subject|0|||
30573212|NCT03117998|58581374|FG000|Overall Study|Physician Decision|0|||
30573213|NCT03117998|58581375|FG001|Overall Study|Physician Decision|1|||
30573214|NCT03117998|58581376|FG002|Overall Study|Physician Decision|1|||
30573215|NCT03117998|58581377|FG003|Overall Study|Physician Decision|0|||
30573216|NCT03117998|58581378|FG004|Overall Study|Physician Decision|0|||
30573217|NCT03117998|58581379|FG005|Overall Study|Physician Decision|0|||
30573218|NCT03117998|58581374|FG000|Overall Study|Lost to Follow-up|0|||
30573219|NCT03117998|58581375|FG001|Overall Study|Lost to Follow-up|0|||
30573220|NCT03117998|58581376|FG002|Overall Study|Lost to Follow-up|0|||
30573221|NCT03117998|58581377|FG003|Overall Study|Lost to Follow-up|1|||
30573222|NCT03117998|58581378|FG004|Overall Study|Lost to Follow-up|4|||
30573223|NCT03117998|58581379|FG005|Overall Study|Lost to Follow-up|0|||
30573224|NCT03117998|58581374|FG000|Overall Study|Subject noncompliance|0|||
30573225|NCT03117998|58581375|FG001|Overall Study|Subject noncompliance|0|||
30573226|NCT03117998|58581376|FG002|Overall Study|Subject noncompliance|1|||
30573227|NCT03117998|58581377|FG003|Overall Study|Subject noncompliance|0|||
30573228|NCT03117998|58581378|FG004|Overall Study|Subject noncompliance|0|||
30573229|NCT03117998|58581379|FG005|Overall Study|Subject noncompliance|2|||
30573230|NCT03117998|58581374|FG000|Overall Study|Protocol Violation|0|||
30573231|NCT03117998|58581375|FG001|Overall Study|Protocol Violation|0|||
30573232|NCT03117998|58581376|FG002|Overall Study|Protocol Violation|0|||
30573233|NCT03117998|58581377|FG003|Overall Study|Protocol Violation|0|||
30573234|NCT03117998|58581378|FG004|Overall Study|Protocol Violation|0|||
30573235|NCT03117998|58581379|FG005|Overall Study|Protocol Violation|1|||
30573236|NCT03100370|58581404|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
30958676|NCT01694771|59023754|FG001|Overall Study|Consent withdrawn|9|||
30573237|NCT03100370|58581405|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
30573238|NCT03100370|58581406|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
30573239|NCT03100370|58581407|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
30573240|NCT03100370|58581408|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
30573241|NCT03100370|58581409|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
30573242|NCT02920008|58581419|FG000|Overall Study|Death|117|||
30573243|NCT02920008|58581420|FG001|Overall Study|Death|127|||
30573244|NCT02920008|58581419|FG000|Overall Study|Withdrawal by Subject|3|||
30573245|NCT02920008|58581420|FG001|Overall Study|Withdrawal by Subject|6|||
30573246|NCT02920008|58581419|FG000|Overall Study|Lost to Follow-up|0|||
30573247|NCT02920008|58581420|FG001|Overall Study|Lost to Follow-up|1|||
30573248|NCT02766335|58581428|FG000|Initial Registration|Adverse Event|6|||
30573249|NCT02766335|58581429|FG001|Initial Registration|Adverse Event|3|||
30573250|NCT02766335|58581430|FG002|Initial Registration|Adverse Event|0|||
30573251|NCT02766335|58581428|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
30573252|NCT02766335|58581429|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
30573253|NCT02766335|58581430|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
30573254|NCT02766335|58581428|FG000|Initial Registration|Progression/relapse|49|||
30573255|NCT02766335|58581429|FG001|Initial Registration|Progression/relapse|15|||
30573256|NCT02766335|58581430|FG002|Initial Registration|Progression/relapse|0|||
30573257|NCT02766335|58581428|FG000|Initial Registration|Death|1|||
30573258|NCT02766335|58581429|FG001|Initial Registration|Death|3|||
30573259|NCT02766335|58581430|FG002|Initial Registration|Death|0|||
30573260|NCT02766335|58581428|FG000|Initial Registration|not protocol specified|1|||
30573261|NCT02766335|58581429|FG001|Initial Registration|not protocol specified|9|||
30573262|NCT02766335|58581430|FG002|Initial Registration|not protocol specified|0|||
30573263|NCT02766335|58581428|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
30573264|NCT02766335|58581429|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
30573265|NCT02766335|58581430|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
30573266|NCT02766335|58581428|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
30573267|NCT02766335|58581429|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
30573268|NCT02766335|58581430|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
30573269|NCT02577523|58581438|FG000|Overall Study|Adverse Event|1|||
30573270|NCT02577523|58581439|FG001|Overall Study|Adverse Event|1|||
30573271|NCT02577523|58581438|FG000|Overall Study|Lack of Efficacy|1|||
30573272|NCT02577523|58581439|FG001|Overall Study|Lack of Efficacy|1|||
30573273|NCT02577523|58581438|FG000|Overall Study|Withdrawal by Subject|1|||
30573274|NCT02577523|58581439|FG001|Overall Study|Withdrawal by Subject|0|||
30573275|NCT02516241|58581448|FG000|Overall Study|Death|255|||
30573276|NCT02516241|58581449|FG001|Overall Study|Death|262|||
30573277|NCT02516241|58581450|FG002|Overall Study|Death|270|||
30573278|NCT02516241|58581448|FG000|Overall Study|Lost to Follow-up|1|||
30573279|NCT02516241|58581449|FG001|Overall Study|Lost to Follow-up|1|||
30573280|NCT02516241|58581450|FG002|Overall Study|Lost to Follow-up|3|||
30573281|NCT02516241|58581448|FG000|Overall Study|Withdrawal by Subject|2|||
30573282|NCT02516241|58581449|FG001|Overall Study|Withdrawal by Subject|7|||
30573283|NCT02516241|58581450|FG002|Overall Study|Withdrawal by Subject|12|||
30573284|NCT02516241|58581448|FG000|Overall Study|participants ongoing at data cut-off|84|||
30573285|NCT02516241|58581449|FG001|Overall Study|participants ongoing at data cut-off|76|||
30573286|NCT02516241|58581450|FG002|Overall Study|participants ongoing at data cut-off|59|||
30573287|NCT02499328|58581482|FG000|Overall Study|Withdrawal by Subject|1|||
30573288|NCT02499328|58581483|FG001|Overall Study|Withdrawal by Subject|1|||
30573289|NCT02499328|58581484|FG002|Overall Study|Withdrawal by Subject|5|||
30573290|NCT02499328|58581485|FG003|Overall Study|Withdrawal by Subject|3|||
30573291|NCT02499328|58581486|FG004|Overall Study|Withdrawal by Subject|5|||
30573292|NCT02499328|58581487|FG005|Overall Study|Withdrawal by Subject|0|||
30573293|NCT02499328|58581488|FG006|Overall Study|Withdrawal by Subject|0|||
30573294|NCT02499328|58581489|FG007|Overall Study|Withdrawal by Subject|0|||
30573295|NCT02499328|58581490|FG008|Overall Study|Withdrawal by Subject|2|||
30573296|NCT02499328|58581491|FG009|Overall Study|Withdrawal by Subject|2|||
30573297|NCT02499328|58581492|FG010|Overall Study|Withdrawal by Subject|0|||
30573298|NCT02499328|58581493|FG011|Overall Study|Withdrawal by Subject|3|||
30573299|NCT02499328|58581494|FG012|Overall Study|Withdrawal by Subject|7|||
30667816|NCT00505687|58681721|FG000|Overall Study|Other: Disease Progression|1|||
30667817|NCT00505687|58681721|FG000|Overall Study|Other: As Per Sponsor|8|||
30667818|NCT00505375|58681727|FG000|Overall Study|Death|1|||
30667819|NCT00505375|58681728|FG001|Overall Study|Death|0|||
30667820|NCT00505375|58681727|FG000|Overall Study|Withdrawal by Subject|2|||
30667821|NCT00505375|58681728|FG001|Overall Study|Withdrawal by Subject|2|||
30667822|NCT00505375|58681727|FG000|Overall Study|Lost to Follow-up|0|||
30667823|NCT00505375|58681728|FG001|Overall Study|Lost to Follow-up|2|||
30667824|NCT00505375|58681727|FG000|Overall Study|Pregnancy|1|||
30667825|NCT00505375|58681728|FG001|Overall Study|Pregnancy|0|||
30780234|NCT04822597|58791987|FG002|Overall Study|Subject withdrawn after enrollment|0|||
30573300|NCT02499328|58581495|FG013|Overall Study|Withdrawal by Subject|3|||
30573301|NCT02499328|58581496|FG014|Overall Study|Withdrawal by Subject|1|||
30573302|NCT02499328|58581497|FG015|Overall Study|Withdrawal by Subject|0|||
30573303|NCT02499328|58581498|FG016|Overall Study|Withdrawal by Subject|0|||
30573304|NCT02499328|58581499|FG017|Overall Study|Withdrawal by Subject|3|||
30573305|NCT02499328|58581500|FG018|Overall Study|Withdrawal by Subject|0|||
30573306|NCT02499328|58581482|FG000|Overall Study|Lost to Follow-up|0|||
30780235|NCT04822597|58791988|FG003|Overall Study|Subject withdrawn after enrollment|1|||
30958677|NCT01694771|59023753|FG000|Overall Study|Other reasons|5|||
30573307|NCT02499328|58581483|FG001|Overall Study|Lost to Follow-up|1|||
30573308|NCT02499328|58581484|FG002|Overall Study|Lost to Follow-up|1|||
30573309|NCT02499328|58581485|FG003|Overall Study|Lost to Follow-up|2|||
30573310|NCT02499328|58581486|FG004|Overall Study|Lost to Follow-up|0|||
30573311|NCT02499328|58581487|FG005|Overall Study|Lost to Follow-up|0|||
30573312|NCT02499328|58581488|FG006|Overall Study|Lost to Follow-up|0|||
30573313|NCT02499328|58581489|FG007|Overall Study|Lost to Follow-up|2|||
30573314|NCT02499328|58581490|FG008|Overall Study|Lost to Follow-up|3|||
30573315|NCT02499328|58581491|FG009|Overall Study|Lost to Follow-up|0|||
30667826|NCT00505375|58681727|FG000|Overall Study|Travel issues|0|||
30667827|NCT00505375|58681728|FG001|Overall Study|Travel issues|1|||
30667828|NCT00594932|58681736|FG000|First 3 Months|Withdrawal by Subject|1|||
30573316|NCT02499328|58581492|FG010|Overall Study|Lost to Follow-up|0|||
30573317|NCT02499328|58581493|FG011|Overall Study|Lost to Follow-up|0|||
30573318|NCT02499328|58581494|FG012|Overall Study|Lost to Follow-up|0|||
30573319|NCT02499328|58581495|FG013|Overall Study|Lost to Follow-up|0|||
30573320|NCT02499328|58581496|FG014|Overall Study|Lost to Follow-up|0|||
30573321|NCT02499328|58581497|FG015|Overall Study|Lost to Follow-up|0|||
30573322|NCT02499328|58581498|FG016|Overall Study|Lost to Follow-up|0|||
30573323|NCT02499328|58581499|FG017|Overall Study|Lost to Follow-up|0|||
30573324|NCT02499328|58581500|FG018|Overall Study|Lost to Follow-up|1|||
30573325|NCT02499328|58581482|FG000|Overall Study|Death|0|||
30573326|NCT02499328|58581483|FG001|Overall Study|Death|3|||
30573327|NCT02499328|58581484|FG002|Overall Study|Death|3|||
30573328|NCT02499328|58581485|FG003|Overall Study|Death|2|||
30573329|NCT02499328|58581486|FG004|Overall Study|Death|4|||
30573330|NCT02499328|58581487|FG005|Overall Study|Death|7|||
30573331|NCT02499328|58581488|FG006|Overall Study|Death|3|||
30573332|NCT02499328|58581489|FG007|Overall Study|Death|0|||
30573333|NCT02499328|58581490|FG008|Overall Study|Death|2|||
30573334|NCT02499328|58581491|FG009|Overall Study|Death|6|||
30573335|NCT02499328|58581492|FG010|Overall Study|Death|6|||
30573336|NCT02499328|58581493|FG011|Overall Study|Death|20|||
30573337|NCT02499328|58581494|FG012|Overall Study|Death|9|||
30573338|NCT02499328|58581495|FG013|Overall Study|Death|7|||
30573339|NCT02499328|58581496|FG014|Overall Study|Death|3|||
30573340|NCT02499328|58581497|FG015|Overall Study|Death|1|||
30573341|NCT02499328|58581498|FG016|Overall Study|Death|1|||
30573342|NCT02499328|58581499|FG017|Overall Study|Death|16|||
30573343|NCT02499328|58581500|FG018|Overall Study|Death|5|||
30573344|NCT02499328|58581482|FG000|Overall Study|"Other"|2|||
30573345|NCT02499328|58581483|FG001|Overall Study|"Other"|2|||
30573346|NCT02499328|58581484|FG002|Overall Study|"Other"|1|||
30573347|NCT02499328|58581485|FG003|Overall Study|"Other"|3|||
30573348|NCT02499328|58581486|FG004|Overall Study|"Other"|6|||
30573349|NCT02499328|58581487|FG005|Overall Study|"Other"|2|||
30573350|NCT02499328|58581488|FG006|Overall Study|"Other"|3|||
30573351|NCT02499328|58581489|FG007|Overall Study|"Other"|4|||
30573352|NCT02499328|58581490|FG008|Overall Study|"Other"|6|||
30573353|NCT02499328|58581491|FG009|Overall Study|"Other"|16|||
30573354|NCT02499328|58581492|FG010|Overall Study|"Other"|13|||
30573355|NCT02499328|58581493|FG011|Overall Study|"Other"|31|||
30573356|NCT02499328|58581494|FG012|Overall Study|"Other"|8|||
30573357|NCT02499328|58581495|FG013|Overall Study|"Other"|7|||
30573358|NCT02499328|58581496|FG014|Overall Study|"Other"|6|||
30573359|NCT02499328|58581497|FG015|Overall Study|"Other"|0|||
30573360|NCT02499328|58581498|FG016|Overall Study|"Other"|0|||
30573361|NCT02499328|58581499|FG017|Overall Study|"Other"|34|||
30573362|NCT02499328|58581500|FG018|Overall Study|"Other"|43|||
30573363|NCT02499328|58581482|FG000|Overall Study|Disease Progression|0|||
30573364|NCT02499328|58581483|FG001|Overall Study|Disease Progression|0|||
30573365|NCT02499328|58581484|FG002|Overall Study|Disease Progression|0|||
30573366|NCT02499328|58581485|FG003|Overall Study|Disease Progression|0|||
30573367|NCT02499328|58581486|FG004|Overall Study|Disease Progression|0|||
30573368|NCT02499328|58581487|FG005|Overall Study|Disease Progression|0|||
30573369|NCT02499328|58581488|FG006|Overall Study|Disease Progression|1|||
30573370|NCT02499328|58581489|FG007|Overall Study|Disease Progression|0|||
30573371|NCT02499328|58581490|FG008|Overall Study|Disease Progression|1|||
30573372|NCT02499328|58581491|FG009|Overall Study|Disease Progression|0|||
30573373|NCT02499328|58581492|FG010|Overall Study|Disease Progression|1|||
30573374|NCT02499328|58581493|FG011|Overall Study|Disease Progression|0|||
30573375|NCT02499328|58581494|FG012|Overall Study|Disease Progression|0|||
30573376|NCT02499328|58581495|FG013|Overall Study|Disease Progression|0|||
30573377|NCT02499328|58581496|FG014|Overall Study|Disease Progression|0|||
30573378|NCT02499328|58581497|FG015|Overall Study|Disease Progression|0|||
30573379|NCT02499328|58581498|FG016|Overall Study|Disease Progression|0|||
30573380|NCT02499328|58581499|FG017|Overall Study|Disease Progression|2|||
30573381|NCT02499328|58581500|FG018|Overall Study|Disease Progression|0|||
30573382|NCT02499328|58581482|FG000|Overall Study|Adverse Event|1|||
30573383|NCT02499328|58581483|FG001|Overall Study|Adverse Event|0|||
30573384|NCT02499328|58581484|FG002|Overall Study|Adverse Event|0|||
30573385|NCT02499328|58581485|FG003|Overall Study|Adverse Event|1|||
30573386|NCT02499328|58581486|FG004|Overall Study|Adverse Event|0|||
30573387|NCT02499328|58581487|FG005|Overall Study|Adverse Event|0|||
30573388|NCT02499328|58581488|FG006|Overall Study|Adverse Event|0|||
30573389|NCT02499328|58581489|FG007|Overall Study|Adverse Event|0|||
30573390|NCT02499328|58581490|FG008|Overall Study|Adverse Event|0|||
30573391|NCT02499328|58581491|FG009|Overall Study|Adverse Event|0|||
30573392|NCT02499328|58581492|FG010|Overall Study|Adverse Event|0|||
30573393|NCT02499328|58581493|FG011|Overall Study|Adverse Event|0|||
30573394|NCT02499328|58581494|FG012|Overall Study|Adverse Event|1|||
30573395|NCT02499328|58581495|FG013|Overall Study|Adverse Event|0|||
30573396|NCT02499328|58581496|FG014|Overall Study|Adverse Event|0|||
30573397|NCT02499328|58581497|FG015|Overall Study|Adverse Event|0|||
30573398|NCT02499328|58581498|FG016|Overall Study|Adverse Event|0|||
30573399|NCT02499328|58581499|FG017|Overall Study|Adverse Event|0|||
30573400|NCT02499328|58581500|FG018|Overall Study|Adverse Event|0|||
30573401|NCT02388906|58581585|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
30573402|NCT02388906|58581586|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
30573403|NCT02388906|58581585|FG000|Treatment Period|Disease progression|121|||
30573404|NCT02388906|58581586|FG001|Treatment Period|Disease progression|101|||
30573405|NCT02388906|58581585|FG000|Treatment Period|Study drug toxicity|41|||
30573406|NCT02388906|58581586|FG001|Treatment Period|Study drug toxicity|208|||
30573407|NCT02388906|58581585|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
30573408|NCT02388906|58581586|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
30573409|NCT02388906|58581585|FG000|Treatment Period|Participant request to stop treatment|5|||
30573410|NCT02388906|58581586|FG001|Treatment Period|Participant request to stop treatment|9|||
30573411|NCT02388906|58581585|FG000|Treatment Period|Participant withdrew consent|2|||
30573412|NCT02388906|58581586|FG001|Treatment Period|Participant withdrew consent|3|||
30573413|NCT02388906|58581585|FG000|Treatment Period|Poor/non-compliance|0|||
30573414|NCT02388906|58581586|FG001|Treatment Period|Poor/non-compliance|1|||
30573415|NCT02388906|58581585|FG000|Treatment Period|Participant no longer meets study criteria|0|||
30573416|NCT02388906|58581586|FG001|Treatment Period|Participant no longer meets study criteria|1|||
30573417|NCT02388906|58581585|FG000|Treatment Period|Other reasons|3|||
30573418|NCT02388906|58581586|FG001|Treatment Period|Other reasons|3|||
30573419|NCT02177695|58581605|FG000|ITT Analysis|Ineligible|5|||
30573420|NCT02177695|58581606|FG001|ITT Analysis|Ineligible|5|||
30573421|NCT02177695|58581605|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
30573422|NCT02177695|58581606|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
30573423|NCT02177695|58581605|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
30573424|NCT02177695|58581606|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
30573425|NCT02177695|58581605|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
30573426|NCT02177695|58581606|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
30573427|NCT01719237|58581621|FG000|Overall Study|Physician Decision|0|||
30573428|NCT01719237|58581622|FG001|Overall Study|Physician Decision|1|||
30573429|NCT01956669|58581645|FG000|Overall Study|Disease Progression|12|||
30573430|NCT01956669|58581646|FG001|Overall Study|Disease Progression|7|||
30573431|NCT01956669|58581647|FG002|Overall Study|Disease Progression|7|||
30573432|NCT01956669|58581648|FG003|Overall Study|Disease Progression|8|||
30573433|NCT01956669|58581649|FG004|Overall Study|Disease Progression|4|||
30573434|NCT01956669|58581650|FG005|Overall Study|Disease Progression|3|||
30573435|NCT01956669|58581651|FG006|Overall Study|Disease Progression|5|||
30573436|NCT01956669|58581645|FG000|Overall Study|Adverse Event|0|||
30573437|NCT01956669|58581646|FG001|Overall Study|Adverse Event|2|||
30573438|NCT01956669|58581647|FG002|Overall Study|Adverse Event|2|||
30573439|NCT01956669|58581648|FG003|Overall Study|Adverse Event|1|||
30573440|NCT01956669|58581649|FG004|Overall Study|Adverse Event|0|||
30573441|NCT01956669|58581650|FG005|Overall Study|Adverse Event|0|||
30573442|NCT01956669|58581651|FG006|Overall Study|Adverse Event|0|||
30573443|NCT01956669|58581645|FG000|Overall Study|Physician Decision|0|||
30573444|NCT01956669|58581646|FG001|Overall Study|Physician Decision|2|||
30573445|NCT01956669|58581647|FG002|Overall Study|Physician Decision|0|||
30573446|NCT01956669|58581648|FG003|Overall Study|Physician Decision|0|||
30573447|NCT01956669|58581649|FG004|Overall Study|Physician Decision|0|||
30573448|NCT01956669|58581650|FG005|Overall Study|Physician Decision|1|||
30573449|NCT01956669|58581651|FG006|Overall Study|Physician Decision|0|||
30573450|NCT01956669|58581645|FG000|Overall Study|Withdrawal by Subject|0|||
30573451|NCT01956669|58581646|FG001|Overall Study|Withdrawal by Subject|0|||
30573452|NCT01956669|58581647|FG002|Overall Study|Withdrawal by Subject|1|||
30573453|NCT01956669|58581648|FG003|Overall Study|Withdrawal by Subject|1|||
30573454|NCT01956669|58581649|FG004|Overall Study|Withdrawal by Subject|0|||
30573455|NCT01956669|58581650|FG005|Overall Study|Withdrawal by Subject|0|||
30573456|NCT01956669|58581651|FG006|Overall Study|Withdrawal by Subject|1|||
30573457|NCT01967823|58581680|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
30573458|NCT01982760|58581690|FG000|Overall Study|Physician Decision|1|||
30573459|NCT01982760|58581691|FG001|Overall Study|Physician Decision|0|||
30780236|NCT04822597|58791985|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
30780237|NCT04822597|58791986|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
30780238|NCT04822597|58791987|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
30958678|NCT01694771|59023754|FG001|Overall Study|Other reasons|6|||
30573460|NCT01985022|58581699|FG000|Overall Study|Lost to Follow-up|0|||
30573461|NCT01985022|58581700|FG001|Overall Study|Lost to Follow-up|1|||
30573462|NCT01985022|58581699|FG000|Overall Study|Protocol Violation|0|||
30573463|NCT01985022|58581700|FG001|Overall Study|Protocol Violation|1|||
30573464|NCT01985022|58581699|FG000|Overall Study|Withdrawal by Subject|4|||
30573465|NCT01985022|58581700|FG001|Overall Study|Withdrawal by Subject|1|||
30573466|NCT01989676|58581708|FG000|Overall Study|Death|52|||
30573467|NCT01989676|58581709|FG001|Overall Study|Death|60|||
30573468|NCT01989676|58581708|FG000|Overall Study|Protocol Violation|2|||
30573469|NCT01989676|58581709|FG001|Overall Study|Protocol Violation|1|||
30573470|NCT01989676|58581708|FG000|Overall Study|Lost to Follow-up|8|||
30573471|NCT01989676|58581709|FG001|Overall Study|Lost to Follow-up|18|||
30573472|NCT01989676|58581708|FG000|Overall Study|No longer willing to participate in study|26|||
30573473|NCT01989676|58581709|FG001|Overall Study|No longer willing to participate in study|26|||
30573474|NCT01989676|58581708|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
30573475|NCT01989676|58581709|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
30573476|NCT01989676|58581708|FG000|Overall Study|Other|4|||
30573477|NCT01989676|58581709|FG001|Overall Study|Other|3|||
30573478|NCT02001974|58581719|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
30573479|NCT02001974|58581720|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
30573480|NCT02001974|58581721|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
30573481|NCT02001974|58581719|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
30573482|NCT02001974|58581720|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
30573483|NCT02001974|58581721|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
30573484|NCT02001974|58581719|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
30573485|NCT02001974|58581720|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
30573486|NCT02001974|58581721|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
30573487|NCT02001974|58581719|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
30573488|NCT02001974|58581720|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
30573489|NCT02001974|58581721|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
30573490|NCT05229406|58581759|FG000|Overall Study|Withdrawal by Subject|1|||
30573491|NCT05229406|58581760|FG001|Overall Study|Withdrawal by Subject|2|||
30573492|NCT04971187|58581784|FG000|Overall Study|Screen failures|2|||
30573493|NCT04756154|58581822|FG000|Overall Study|Did not meet treatment day baseline|30|||
30573494|NCT04756154|58581823|FG001|Overall Study|Did not meet treatment day baseline|28|||
30573495|NCT04756154|58581824|FG002|Overall Study|Did not meet treatment day baseline|7|||
30573496|NCT04756154|58581822|FG000|Overall Study|Did not return for final sample collection|1|||
30573497|NCT04756154|58581823|FG001|Overall Study|Did not return for final sample collection|1|||
30573498|NCT04756154|58581824|FG002|Overall Study|Did not return for final sample collection|0|||
30573499|NCT04677504|58581839|FG000|Overall Study|Death|31|||
30573500|NCT04677504|58581840|FG001|Overall Study|Death|24|||
30573501|NCT04677504|58581839|FG000|Overall Study|Progressive Disease|1|||
30573502|NCT04677504|58581840|FG001|Overall Study|Progressive Disease|0|||
30573503|NCT04677504|58581839|FG000|Overall Study|Symptomatic Deterioration|1|||
30573504|NCT04677504|58581840|FG001|Overall Study|Symptomatic Deterioration|0|||
30573505|NCT04677504|58581839|FG000|Overall Study|Withdrawal by Subject|2|||
30573506|NCT04677504|58581840|FG001|Overall Study|Withdrawal by Subject|5|||
30573507|NCT04677504|58581839|FG000|Overall Study|Ongoing in study|48|||
30573508|NCT04677504|58581840|FG001|Overall Study|Ongoing in study|50|||
30573509|NCT04629066|58581850|FG000|Overall Study|Lost to Follow-up|3|||
30573510|NCT04629066|58581851|FG001|Overall Study|Lost to Follow-up|2|||
30573511|NCT04614246|58581862|FG000|Overall Study|Adverse Event|0|||
30573512|NCT04614246|58581863|FG001|Overall Study|Adverse Event|1|||
30573513|NCT04614246|58581864|FG002|Overall Study|Adverse Event|1|||
30573514|NCT04614246|58581865|FG003|Overall Study|Adverse Event|2|||
30573515|NCT04614246|58581866|FG004|Overall Study|Adverse Event|1|||
30573516|NCT04614246|58581862|FG000|Overall Study|Lost to Follow-up|0|||
30573517|NCT04614246|58581863|FG001|Overall Study|Lost to Follow-up|1|||
30573518|NCT04614246|58581864|FG002|Overall Study|Lost to Follow-up|0|||
30573519|NCT04614246|58581865|FG003|Overall Study|Lost to Follow-up|1|||
30573520|NCT04614246|58581866|FG004|Overall Study|Lost to Follow-up|3|||
30573521|NCT04614246|58581862|FG000|Overall Study|Other reason|0|||
30573522|NCT04614246|58581863|FG001|Overall Study|Other reason|1|||
30573523|NCT04614246|58581864|FG002|Overall Study|Other reason|2|||
30573524|NCT04614246|58581865|FG003|Overall Study|Other reason|0|||
30573525|NCT04614246|58581866|FG004|Overall Study|Other reason|0|||
30573526|NCT04614246|58581862|FG000|Overall Study|Withdrawal by Subject|4|||
30573527|NCT04614246|58581863|FG001|Overall Study|Withdrawal by Subject|2|||
30573528|NCT04614246|58581864|FG002|Overall Study|Withdrawal by Subject|4|||
30573529|NCT04614246|58581865|FG003|Overall Study|Withdrawal by Subject|3|||
30573530|NCT04614246|58581866|FG004|Overall Study|Withdrawal by Subject|4|||
30573531|NCT04614246|58581862|FG000|Overall Study|Physician Decision|0|||
30573532|NCT04614246|58581863|FG001|Overall Study|Physician Decision|2|||
30573533|NCT04614246|58581864|FG002|Overall Study|Physician Decision|1|||
30573534|NCT04614246|58581865|FG003|Overall Study|Physician Decision|0|||
30573535|NCT04614246|58581866|FG004|Overall Study|Physician Decision|0|||
30573536|NCT04614246|58581862|FG000|Overall Study|Study terminated by sponsor|10|||
30573537|NCT04614246|58581863|FG001|Overall Study|Study terminated by sponsor|15|||
30573538|NCT04614246|58581864|FG002|Overall Study|Study terminated by sponsor|12|||
30573539|NCT04614246|58581865|FG003|Overall Study|Study terminated by sponsor|13|||
30573540|NCT04614246|58581866|FG004|Overall Study|Study terminated by sponsor|9|||
30573541|NCT04614246|58581862|FG000|Overall Study|Pregnancy|2|||
30573542|NCT04614246|58581863|FG001|Overall Study|Pregnancy|0|||
30667829|NCT00594932|58681737|FG001|First 3 Months|Withdrawal by Subject|3|||
30573543|NCT04614246|58581864|FG002|Overall Study|Pregnancy|1|||
30573544|NCT04614246|58581865|FG003|Overall Study|Pregnancy|0|||
30573545|NCT04614246|58581866|FG004|Overall Study|Pregnancy|0|||
30573546|NCT04593823|58581884|FG000|Overall Study|Withdrawal by Subject|1|||
30573547|NCT04593823|58581885|FG001|Overall Study|Withdrawal by Subject|1|||
30573548|NCT04593823|58581884|FG000|Overall Study|Lost to Follow-up|0|||
30573549|NCT04593823|58581885|FG001|Overall Study|Lost to Follow-up|1|||
30573550|NCT04556383|58581905|FG000|PCP|Lack of Efficacy|28|||
30573551|NCT04556383|58581906|FG001|PCP|Lack of Efficacy|23|||
30573552|NCT04556383|58581907|FG002|PCP|Lack of Efficacy|23|||
30573553|NCT04556383|58581908|FG003|PCP|Lack of Efficacy|0|||
30573554|NCT04556383|58581905|FG000|PCP|Study terminated by sponsor|15|||
30573555|NCT04556383|58581906|FG001|PCP|Study terminated by sponsor|13|||
30573556|NCT04556383|58581907|FG002|PCP|Study terminated by sponsor|16|||
30573557|NCT04556383|58581908|FG003|PCP|Study terminated by sponsor|0|||
30573558|NCT04556383|58581905|FG000|PCP|Withdrawal by Subject|8|||
30573559|NCT04556383|58581906|FG001|PCP|Withdrawal by Subject|6|||
30573560|NCT04556383|58581907|FG002|PCP|Withdrawal by Subject|6|||
30573561|NCT04556383|58581908|FG003|PCP|Withdrawal by Subject|0|||
30573562|NCT04556383|58581905|FG000|PCP|Adverse Event|1|||
30573563|NCT04556383|58581906|FG001|PCP|Adverse Event|7|||
30573564|NCT04556383|58581907|FG002|PCP|Adverse Event|7|||
30573565|NCT04556383|58581908|FG003|PCP|Adverse Event|0|||
30573566|NCT04556383|58581905|FG000|PCP|Other, Not Specified|1|||
30573567|NCT04556383|58581906|FG001|PCP|Other, Not Specified|2|||
30573568|NCT04556383|58581907|FG002|PCP|Other, Not Specified|1|||
30573569|NCT04556383|58581908|FG003|PCP|Other, Not Specified|0|||
30573570|NCT04556383|58581905|FG000|PCP|Protocol Violation|1|||
30573571|NCT04556383|58581906|FG001|PCP|Protocol Violation|0|||
30573572|NCT04556383|58581907|FG002|PCP|Protocol Violation|1|||
30573573|NCT04556383|58581908|FG003|PCP|Protocol Violation|0|||
30573574|NCT04556383|58581905|FG000|PCP|Lost to Follow-up|1|||
30573575|NCT04556383|58581906|FG001|PCP|Lost to Follow-up|0|||
30573576|NCT04556383|58581907|FG002|PCP|Lost to Follow-up|0|||
30573577|NCT04556383|58581908|FG003|PCP|Lost to Follow-up|0|||
30573578|NCT04556383|58581905|FG000|PCP|Physician Decision|0|||
30573579|NCT04556383|58581906|FG001|PCP|Physician Decision|1|||
30573580|NCT04556383|58581907|FG002|PCP|Physician Decision|0|||
30573581|NCT04556383|58581908|FG003|PCP|Physician Decision|0|||
30573582|NCT04556383|58581905|FG000|PCP|Site terminated by sponsor|0|||
30573583|NCT04556383|58581906|FG001|PCP|Site terminated by sponsor|1|||
30573584|NCT04556383|58581907|FG002|PCP|Site terminated by sponsor|0|||
30573585|NCT04556383|58581908|FG003|PCP|Site terminated by sponsor|0|||
30573586|NCT04556383|58581905|FG000|OLE|Study terminated by sponsor|0|||
30573587|NCT04556383|58581906|FG001|OLE|Study terminated by sponsor|0|||
30573588|NCT04556383|58581907|FG002|OLE|Study terminated by sponsor|0|||
30573589|NCT04556383|58581908|FG003|OLE|Study terminated by sponsor|68|||
30573590|NCT04556383|58581905|FG000|OLE|Withdrawal by Subject|0|||
30573591|NCT04556383|58581906|FG001|OLE|Withdrawal by Subject|0|||
30573592|NCT04556383|58581907|FG002|OLE|Withdrawal by Subject|0|||
30573593|NCT04556383|58581908|FG003|OLE|Withdrawal by Subject|10|||
30573594|NCT04556383|58581905|FG000|OLE|Lack of Efficacy|0|||
30573595|NCT04556383|58581906|FG001|OLE|Lack of Efficacy|0|||
30573596|NCT04556383|58581907|FG002|OLE|Lack of Efficacy|0|||
30573597|NCT04556383|58581908|FG003|OLE|Lack of Efficacy|7|||
30573598|NCT04556383|58581905|FG000|OLE|Adverse Event|0|||
30573599|NCT04556383|58581906|FG001|OLE|Adverse Event|0|||
30573600|NCT04556383|58581907|FG002|OLE|Adverse Event|0|||
30573601|NCT04556383|58581908|FG003|OLE|Adverse Event|2|||
30573602|NCT04556383|58581905|FG000|OLE|Other, Not Specified|0|||
30573603|NCT04556383|58581906|FG001|OLE|Other, Not Specified|0|||
30573604|NCT04556383|58581907|FG002|OLE|Other, Not Specified|0|||
30573605|NCT04556383|58581908|FG003|OLE|Other, Not Specified|2|||
30573606|NCT04556383|58581905|FG000|OLE|Death|0|||
30573607|NCT04556383|58581906|FG001|OLE|Death|0|||
30573608|NCT04556383|58581907|FG002|OLE|Death|0|||
30573609|NCT04556383|58581908|FG003|OLE|Death|1|||
30573610|NCT04556383|58581905|FG000|OLE|Lost to Follow-up|0|||
30573611|NCT04556383|58581906|FG001|OLE|Lost to Follow-up|0|||
30573612|NCT04556383|58581907|FG002|OLE|Lost to Follow-up|0|||
30573613|NCT04556383|58581908|FG003|OLE|Lost to Follow-up|1|||
30573614|NCT04444752|58581942|FG000|Overall Study|Adverse Event|1|||
30573615|NCT04444752|58581943|FG001|Overall Study|Adverse Event|0|||
30573616|NCT04444752|58581944|FG002|Overall Study|Adverse Event|0|||
30573617|NCT04444752|58581945|FG003|Overall Study|Adverse Event|2|||
30573618|NCT04444752|58581942|FG000|Overall Study|Lost to Follow-up|2|||
30573619|NCT04444752|58581943|FG001|Overall Study|Lost to Follow-up|6|||
30573620|NCT04444752|58581944|FG002|Overall Study|Lost to Follow-up|2|||
30573621|NCT04444752|58581945|FG003|Overall Study|Lost to Follow-up|5|||
30573622|NCT04444752|58581942|FG000|Overall Study|Physician Decision|0|||
30573623|NCT04444752|58581943|FG001|Overall Study|Physician Decision|0|||
30573624|NCT04444752|58581944|FG002|Overall Study|Physician Decision|0|||
30573625|NCT04444752|58581945|FG003|Overall Study|Physician Decision|2|||
30573626|NCT04444752|58581942|FG000|Overall Study|Pregnancy|0|||
30573627|NCT04444752|58581943|FG001|Overall Study|Pregnancy|0|||
30573628|NCT04444752|58581944|FG002|Overall Study|Pregnancy|0|||
30573629|NCT04444752|58581945|FG003|Overall Study|Pregnancy|1|||
30573630|NCT04444752|58581942|FG000|Overall Study|Withdrawal by Subject|6|||
30573631|NCT04444752|58581943|FG001|Overall Study|Withdrawal by Subject|5|||
30573632|NCT04444752|58581944|FG002|Overall Study|Withdrawal by Subject|3|||
30573633|NCT04444752|58581945|FG003|Overall Study|Withdrawal by Subject|4|||
30573634|NCT04444752|58581942|FG000|Overall Study|Protocol Violation|1|||
30573635|NCT04444752|58581943|FG001|Overall Study|Protocol Violation|1|||
30573636|NCT04444752|58581944|FG002|Overall Study|Protocol Violation|0|||
30573637|NCT04444752|58581945|FG003|Overall Study|Protocol Violation|0|||
30573638|NCT04444752|58581942|FG000|Overall Study|Patient moving out of town|1|||
30573639|NCT04444752|58581943|FG001|Overall Study|Patient moving out of town|0|||
30573640|NCT04444752|58581944|FG002|Overall Study|Patient moving out of town|0|||
30573641|NCT04444752|58581945|FG003|Overall Study|Patient moving out of town|1|||
30573642|NCT04444752|58581942|FG000|Overall Study|Lack of Efficacy|0|||
30573643|NCT04444752|58581943|FG001|Overall Study|Lack of Efficacy|0|||
30573644|NCT04444752|58581944|FG002|Overall Study|Lack of Efficacy|0|||
30573645|NCT04444752|58581945|FG003|Overall Study|Lack of Efficacy|1|||
30573646|NCT04444752|58581942|FG000|Overall Study|Death|0|||
30573647|NCT04444752|58581943|FG001|Overall Study|Death|0|||
30573648|NCT04444752|58581944|FG002|Overall Study|Death|1|||
30573649|NCT04444752|58581945|FG003|Overall Study|Death|0|||
30573650|NCT04429022|58581957|FG000|Overall Study|Protocol Violation|18|||
30573651|NCT04429022|58581958|FG001|Overall Study|Protocol Violation|1|||
30573652|NCT04351373|58581988|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
30573653|NCT04239924|58582001|FG000|Overall Study|Lost to Follow-up|2|||
30573654|NCT04154904|58582013|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
30573655|NCT04154904|58582014|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
30573656|NCT04154904|58582015|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
30573657|NCT04114656|58582027|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
30573658|NCT04114656|58582028|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
30573659|NCT04114656|58582027|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
30573660|NCT04114656|58582028|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
30573661|NCT04114656|58582027|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
30573662|NCT04114656|58582028|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
30573663|NCT04114656|58582027|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
30573664|NCT04114656|58582028|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
30573665|NCT04114656|58582027|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
30573666|NCT04114656|58582028|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
30573667|NCT04034238|58582046|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
30573668|NCT04034238|58582047|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
30573669|NCT04034238|58582048|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
30573670|NCT04034238|58582049|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
30573671|NCT04034238|58582046|FG000|Dose Escalation Phase|Screen failures|0|||
30573672|NCT04034238|58582047|FG001|Dose Escalation Phase|Screen failures|0|||
30573673|NCT04034238|58582048|FG002|Dose Escalation Phase|Screen failures|0|||
30573674|NCT04034238|58582049|FG003|Dose Escalation Phase|Screen failures|2|||
30573675|NCT04034238|58582046|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
30573676|NCT04034238|58582047|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
30573677|NCT04034238|58582048|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
30573678|NCT04034238|58582049|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
30573679|NCT04034238|58582046|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
30573680|NCT04034238|58582047|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
30573681|NCT04034238|58582048|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
30573682|NCT04034238|58582049|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
30573683|NCT03956056|58582060|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
30573684|NCT03956056|58582060|FG000|Overall Study|Lack of Efficacy|1|||
30573685|NCT03926195|58582066|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
30573686|NCT03926195|58582067|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
30573687|NCT03926195|58582066|FG000|EXT Phase (Through Week 26)|Ongoing in the study|29|||
30573688|NCT03926195|58582067|FG001|EXT Phase (Through Week 26)|Ongoing in the study|36|||
30573689|NCT03926195|58582066|FG000|EXT Phase (Through Week 26)|Adverse Event|5|||
30573690|NCT03926195|58582067|FG001|EXT Phase (Through Week 26)|Adverse Event|0|||
30573691|NCT03926195|58582066|FG000|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|12|||
30573692|NCT03926195|58582067|FG001|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|11|||
30573693|NCT03926195|58582066|FG000|EXT Phase (Through Week 26)|Withdrawal by Subject|0|||
30573694|NCT03926195|58582067|FG001|EXT Phase (Through Week 26)|Withdrawal by Subject|2|||
30573695|NCT03908476|58582082|FG000|Overall Study|Death|3|||
30780239|NCT04822597|58791988|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
30573696|NCT03908476|58582083|FG001|Overall Study|Death|0|||
30573697|NCT03908476|58582082|FG000|Overall Study|Lost to Follow-up|3|||
30780240|NCT04721158|58791998|FG000|Overall Study|Lost to Follow-up|4|||
30780241|NCT04721158|58791998|FG000|Overall Study|Device did not connect|1|||
30573698|NCT03908476|58582083|FG001|Overall Study|Lost to Follow-up|1|||
30573699|NCT03908476|58582082|FG000|Overall Study|Withdrawal by Subject|7|||
30573700|NCT03908476|58582083|FG001|Overall Study|Withdrawal by Subject|1|||
30573701|NCT03908476|58582082|FG000|Overall Study|Physician Decision|2|||
30573702|NCT03908476|58582083|FG001|Overall Study|Physician Decision|0|||
30573703|NCT03908476|58582082|FG000|Overall Study|System Explanted and not Replaced|4|||
30573704|NCT03908476|58582083|FG001|Overall Study|System Explanted and not Replaced|0|||
30573705|NCT03908476|58582082|FG000|Overall Study|Intrathecal Pump|1|||
30573706|NCT03908476|58582083|FG001|Overall Study|Intrathecal Pump|0|||
30573707|NCT03908476|58582082|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
30573708|NCT03908476|58582083|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
30573709|NCT03830866|58582091|FG000|Overall Study|Ongoing study at DCO|312|||
30573710|NCT03830866|58582092|FG001|Overall Study|Ongoing study at DCO|295|||
30573711|NCT03830866|58582091|FG000|Overall Study|Death|58|||
30573712|NCT03830866|58582092|FG001|Overall Study|Death|74|||
30573713|NCT03830866|58582091|FG000|Overall Study|Lost to Follow-up|0|||
30573714|NCT03830866|58582092|FG001|Overall Study|Lost to Follow-up|1|||
30573715|NCT03830866|58582091|FG000|Overall Study|Withdrawal by Subject|15|||
30573716|NCT03830866|58582092|FG001|Overall Study|Withdrawal by Subject|13|||
30573717|NCT03830866|58582091|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
30573718|NCT03830866|58582092|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
30573719|NCT03830866|58582091|FG000|Overall Study|Other|0|||
30573720|NCT03830866|58582092|FG001|Overall Study|Other|1|||
30573721|NCT03699007|58582109|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
30573722|NCT03699007|58582110|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
30573723|NCT03699007|58582109|FG000|6-month Follow Up|Lost to Follow-up|2|||
30573724|NCT03699007|58582110|FG001|6-month Follow Up|Lost to Follow-up|3|||
30573725|NCT03581188|58582120|FG000|Overall Study|Inclusion criteria not met|3|||
30573726|NCT03581188|58582121|FG001|Overall Study|Inclusion criteria not met|2|||
30573727|NCT03581188|58582120|FG000|Overall Study|Lost to Follow-up|5|||
30573728|NCT03581188|58582121|FG001|Overall Study|Lost to Follow-up|5|||
30573729|NCT03581188|58582120|FG000|Overall Study|Discontinued intervention|11|||
30573730|NCT03581188|58582121|FG001|Overall Study|Discontinued intervention|8|||
30573731|NCT03576131|58582138|FG000|Overall Study|Investigator decision|0|||
30573732|NCT03576131|58582139|FG001|Overall Study|Investigator decision|0|||
30573733|NCT03576131|58582140|FG002|Overall Study|Investigator decision|0|||
30573734|NCT03576131|58582141|FG003|Overall Study|Investigator decision|1|||
30573735|NCT03576131|58582142|FG004|Overall Study|Investigator decision|0|||
30573736|NCT03576131|58582143|FG005|Overall Study|Investigator decision|1|||
30573737|NCT03576131|58582144|FG006|Overall Study|Investigator decision|0|||
30573738|NCT03576131|58582145|FG007|Overall Study|Investigator decision|0|||
30573739|NCT03576131|58582138|FG000|Overall Study|Withdrawal by Subject|1|||
30573740|NCT03576131|58582139|FG001|Overall Study|Withdrawal by Subject|1|||
30573741|NCT03576131|58582140|FG002|Overall Study|Withdrawal by Subject|0|||
30573742|NCT03576131|58582141|FG003|Overall Study|Withdrawal by Subject|1|||
30573743|NCT03576131|58582142|FG004|Overall Study|Withdrawal by Subject|2|||
30573744|NCT03576131|58582143|FG005|Overall Study|Withdrawal by Subject|3|||
30667830|NCT00594932|58681736|FG000|Final 3 Months|Withdrawal by Subject|4|||
30667831|NCT00594932|58681737|FG001|Final 3 Months|Withdrawal by Subject|3|||
30667832|NCT00504829|58681746|FG000|Overall Study|Protocol Violation|6|||
30667833|NCT00504829|58681747|FG001|Overall Study|Protocol Violation|4|||
30855244|NCT02599688|58882795|FG000|Overall Study|Termination by Sponsor|2|||
30855245|NCT01331681|58882802|FG000|Overall Study|Adverse Event|10|||
30855246|NCT01331681|58882803|FG001|Overall Study|Adverse Event|13|||
30855247|NCT01331681|58882804|FG002|Overall Study|Adverse Event|10|||
30855248|NCT01331681|58882802|FG000|Overall Study|Death|6|||
30855249|NCT01331681|58882803|FG001|Overall Study|Death|6|||
30855250|NCT01331681|58882804|FG002|Overall Study|Death|2|||
30855251|NCT01331681|58882802|FG000|Overall Study|Lack of Efficacy|0|||
30855252|NCT01331681|58882803|FG001|Overall Study|Lack of Efficacy|1|||
30855253|NCT01331681|58882804|FG002|Overall Study|Lack of Efficacy|0|||
30855254|NCT01331681|58882802|FG000|Overall Study|Withdrawal by Subject|12|||
30855255|NCT01331681|58882803|FG001|Overall Study|Withdrawal by Subject|8|||
30855256|NCT01331681|58882804|FG002|Overall Study|Withdrawal by Subject|15|||
30855257|NCT01331681|58882802|FG000|Overall Study|Protocol Violation|1|||
30573745|NCT03576131|58582144|FG006|Overall Study|Withdrawal by Subject|1|||
30573746|NCT03576131|58582145|FG007|Overall Study|Withdrawal by Subject|0|||
30573747|NCT03576131|58582138|FG000|Overall Study|Death|3|||
30573748|NCT03576131|58582139|FG001|Overall Study|Death|3|||
30573749|NCT03576131|58582140|FG002|Overall Study|Death|1|||
30573750|NCT03576131|58582141|FG003|Overall Study|Death|5|||
30573751|NCT03576131|58582142|FG004|Overall Study|Death|4|||
30573752|NCT03576131|58582143|FG005|Overall Study|Death|1|||
30573753|NCT03576131|58582144|FG006|Overall Study|Death|0|||
30573754|NCT03576131|58582145|FG007|Overall Study|Death|1|||
30573755|NCT03576131|58582138|FG000|Overall Study|New anti-cancer treatment|5|||
30667834|NCT00504829|58681748|FG002|Overall Study|Protocol Violation|10|||
30573756|NCT03576131|58582139|FG001|Overall Study|New anti-cancer treatment|1|||
30573757|NCT03576131|58582140|FG002|Overall Study|New anti-cancer treatment|2|||
30573758|NCT03576131|58582141|FG003|Overall Study|New anti-cancer treatment|3|||
30573759|NCT03576131|58582142|FG004|Overall Study|New anti-cancer treatment|0|||
30573760|NCT03576131|58582143|FG005|Overall Study|New anti-cancer treatment|0|||
30573761|NCT03576131|58582144|FG006|Overall Study|New anti-cancer treatment|0|||
30573762|NCT03576131|58582145|FG007|Overall Study|New anti-cancer treatment|0|||
30573763|NCT03576131|58582138|FG000|Overall Study|Unspecified reason|0|||
30573764|NCT03576131|58582139|FG001|Overall Study|Unspecified reason|0|||
30573765|NCT03576131|58582140|FG002|Overall Study|Unspecified reason|1|||
30573766|NCT03576131|58582141|FG003|Overall Study|Unspecified reason|1|||
30573767|NCT03576131|58582142|FG004|Overall Study|Unspecified reason|1|||
30573768|NCT03576131|58582143|FG005|Overall Study|Unspecified reason|1|||
30573769|NCT03576131|58582144|FG006|Overall Study|Unspecified reason|0|||
30573770|NCT03576131|58582145|FG007|Overall Study|Unspecified reason|0|||
30573771|NCT03576131|58582138|FG000|Overall Study|Subject non-compliance|0|||
30573772|NCT03576131|58582139|FG001|Overall Study|Subject non-compliance|0|||
30573773|NCT03576131|58582140|FG002|Overall Study|Subject non-compliance|0|||
30573774|NCT03576131|58582141|FG003|Overall Study|Subject non-compliance|0|||
30573775|NCT03576131|58582142|FG004|Overall Study|Subject non-compliance|0|||
30573776|NCT03576131|58582143|FG005|Overall Study|Subject non-compliance|1|||
30573777|NCT03576131|58582144|FG006|Overall Study|Subject non-compliance|0|||
30573778|NCT03576131|58582145|FG007|Overall Study|Subject non-compliance|0|||
30573779|NCT03454529|58582182|FG000|Overall Study|Did not receive treatment|6|||
30573780|NCT03454529|58582182|FG000|Overall Study|Received < 80% doses|1|||
30573781|NCT03409731|58582186|FG000|Overall Study|Withdrawal by Subject|1|||
30573782|NCT03409731|58582186|FG000|Overall Study|Death|4|||
30573783|NCT03246061|58582201|FG000|Overall Study|Still in follow-up|15|||
30573784|NCT03246061|58582202|FG001|Overall Study|Still in follow-up|21|||
30573785|NCT03201458|58582212|FG000|Overall Study|No longer eligible|2|||
30573786|NCT03201458|58582213|FG001|Overall Study|No longer eligible|5|||
30573787|NCT03201458|58582212|FG000|Overall Study|Health event before starting|1|||
30573788|NCT03201458|58582213|FG001|Overall Study|Health event before starting|0|||
30573789|NCT03201458|58582212|FG000|Overall Study|Physician Decision|1|||
30573790|NCT03201458|58582213|FG001|Overall Study|Physician Decision|0|||
30573791|NCT02988817|58582248|FG000|Overall Study|Withdrawal by Subject|1|||
30573792|NCT02988817|58582249|FG001|Overall Study|Withdrawal by Subject|0|||
30573793|NCT02988817|58582250|FG002|Overall Study|Withdrawal by Subject|0|||
30573794|NCT02988817|58582251|FG003|Overall Study|Withdrawal by Subject|1|||
30573795|NCT02988817|58582252|FG004|Overall Study|Withdrawal by Subject|3|||
30573796|NCT02988817|58582253|FG005|Overall Study|Withdrawal by Subject|1|||
30573797|NCT02988817|58582254|FG006|Overall Study|Withdrawal by Subject|2|||
30573798|NCT02988817|58582255|FG007|Overall Study|Withdrawal by Subject|1|||
30573799|NCT02988817|58582256|FG008|Overall Study|Withdrawal by Subject|1|||
30573800|NCT02988817|58582257|FG009|Overall Study|Withdrawal by Subject|1|||
30573801|NCT02988817|58582258|FG010|Overall Study|Withdrawal by Subject|1|||
30573802|NCT02988817|58582259|FG011|Overall Study|Withdrawal by Subject|12|||
30573803|NCT02988817|58582260|FG012|Overall Study|Withdrawal by Subject|6|||
30573804|NCT02988817|58582261|FG013|Overall Study|Withdrawal by Subject|6|||
30573805|NCT02988817|58582262|FG014|Overall Study|Withdrawal by Subject|4|||
30573806|NCT02988817|58582263|FG015|Overall Study|Withdrawal by Subject|5|||
30573807|NCT02988817|58582264|FG016|Overall Study|Withdrawal by Subject|4|||
30573808|NCT02988817|58582265|FG017|Overall Study|Withdrawal by Subject|11|||
30573809|NCT02988817|58582266|FG018|Overall Study|Withdrawal by Subject|4|||
30573810|NCT02988817|58582267|FG019|Overall Study|Withdrawal by Subject|2|||
30573811|NCT02988817|58582248|FG000|Overall Study|Death|0|||
30573812|NCT02988817|58582249|FG001|Overall Study|Death|1|||
30573813|NCT02988817|58582250|FG002|Overall Study|Death|3|||
30573814|NCT02988817|58582251|FG003|Overall Study|Death|1|||
30573815|NCT02988817|58582252|FG004|Overall Study|Death|6|||
30573816|NCT02988817|58582253|FG005|Overall Study|Death|10|||
30573817|NCT02988817|58582254|FG006|Overall Study|Death|1|||
30573818|NCT02988817|58582255|FG007|Overall Study|Death|2|||
30573819|NCT02988817|58582256|FG008|Overall Study|Death|1|||
30780242|NCT04639245|58792003|FG000|Overall Study|Death|1|||
30573820|NCT02988817|58582257|FG009|Overall Study|Death|5|||
30573821|NCT02988817|58582258|FG010|Overall Study|Death|1|||
30573822|NCT02988817|58582259|FG011|Overall Study|Death|8|||
30573823|NCT02988817|58582260|FG012|Overall Study|Death|9|||
30573824|NCT02988817|58582261|FG013|Overall Study|Death|17|||
30573825|NCT02988817|58582262|FG014|Overall Study|Death|18|||
30573826|NCT02988817|58582263|FG015|Overall Study|Death|30|||
30573827|NCT02988817|58582264|FG016|Overall Study|Death|17|||
30573828|NCT02988817|58582265|FG017|Overall Study|Death|38|||
30573829|NCT02988817|58582266|FG018|Overall Study|Death|14|||
30573830|NCT02988817|58582267|FG019|Overall Study|Death|16|||
30573831|NCT02988817|58582248|FG000|Overall Study|Other|0|||
30573832|NCT02988817|58582249|FG001|Overall Study|Other|0|||
30573833|NCT02988817|58582250|FG002|Overall Study|Other|0|||
30573834|NCT02988817|58582251|FG003|Overall Study|Other|1|||
30573835|NCT02988817|58582252|FG004|Overall Study|Other|1|||
30573836|NCT02988817|58582253|FG005|Overall Study|Other|0|||
30573837|NCT02988817|58582254|FG006|Overall Study|Other|0|||
30573838|NCT02988817|58582255|FG007|Overall Study|Other|0|||
30573839|NCT02988817|58582256|FG008|Overall Study|Other|0|||
30573840|NCT02988817|58582257|FG009|Overall Study|Other|0|||
30573841|NCT02988817|58582258|FG010|Overall Study|Other|0|||
30573842|NCT02988817|58582259|FG011|Overall Study|Other|0|||
30573843|NCT02988817|58582260|FG012|Overall Study|Other|0|||
30573844|NCT02988817|58582261|FG013|Overall Study|Other|0|||
30573845|NCT02988817|58582262|FG014|Overall Study|Other|0|||
30573846|NCT02988817|58582263|FG015|Overall Study|Other|1|||
30573847|NCT02988817|58582264|FG016|Overall Study|Other|0|||
30573848|NCT02988817|58582265|FG017|Overall Study|Other|0|||
30573849|NCT02988817|58582266|FG018|Overall Study|Other|0|||
30573850|NCT02988817|58582267|FG019|Overall Study|Other|0|||
30573851|NCT02988817|58582248|FG000|Overall Study|Lost to Follow-up|0|||
30573852|NCT02988817|58582249|FG001|Overall Study|Lost to Follow-up|0|||
30573853|NCT02988817|58582250|FG002|Overall Study|Lost to Follow-up|0|||
30573854|NCT02988817|58582251|FG003|Overall Study|Lost to Follow-up|0|||
30573855|NCT02988817|58582252|FG004|Overall Study|Lost to Follow-up|0|||
30573856|NCT02988817|58582253|FG005|Overall Study|Lost to Follow-up|0|||
30573857|NCT02988817|58582254|FG006|Overall Study|Lost to Follow-up|0|||
30573858|NCT02988817|58582255|FG007|Overall Study|Lost to Follow-up|0|||
30573859|NCT02988817|58582256|FG008|Overall Study|Lost to Follow-up|1|||
30573860|NCT02988817|58582257|FG009|Overall Study|Lost to Follow-up|0|||
30573861|NCT02988817|58582258|FG010|Overall Study|Lost to Follow-up|1|||
30573862|NCT02988817|58582259|FG011|Overall Study|Lost to Follow-up|1|||
30573863|NCT02988817|58582260|FG012|Overall Study|Lost to Follow-up|0|||
30573864|NCT02988817|58582261|FG013|Overall Study|Lost to Follow-up|0|||
30573865|NCT02988817|58582262|FG014|Overall Study|Lost to Follow-up|1|||
30573866|NCT02988817|58582263|FG015|Overall Study|Lost to Follow-up|1|||
30573867|NCT02988817|58582264|FG016|Overall Study|Lost to Follow-up|2|||
30573868|NCT02988817|58582265|FG017|Overall Study|Lost to Follow-up|3|||
30573869|NCT02988817|58582266|FG018|Overall Study|Lost to Follow-up|0|||
30573870|NCT02988817|58582267|FG019|Overall Study|Lost to Follow-up|0|||
30573871|NCT02988817|58582248|FG000|Overall Study|Sponsor decision|0|||
30573872|NCT02988817|58582249|FG001|Overall Study|Sponsor decision|0|||
30573873|NCT02988817|58582250|FG002|Overall Study|Sponsor decision|0|||
30573874|NCT02988817|58582251|FG003|Overall Study|Sponsor decision|0|||
30573875|NCT02988817|58582252|FG004|Overall Study|Sponsor decision|0|||
30573876|NCT02988817|58582253|FG005|Overall Study|Sponsor decision|0|||
30573877|NCT02988817|58582254|FG006|Overall Study|Sponsor decision|0|||
30573878|NCT02988817|58582255|FG007|Overall Study|Sponsor decision|0|||
30573879|NCT02988817|58582256|FG008|Overall Study|Sponsor decision|0|||
30573880|NCT02988817|58582257|FG009|Overall Study|Sponsor decision|0|||
30573881|NCT02988817|58582258|FG010|Overall Study|Sponsor decision|0|||
30573882|NCT02988817|58582259|FG011|Overall Study|Sponsor decision|1|||
30573883|NCT02988817|58582260|FG012|Overall Study|Sponsor decision|1|||
30573884|NCT02988817|58582261|FG013|Overall Study|Sponsor decision|2|||
30573885|NCT02988817|58582262|FG014|Overall Study|Sponsor decision|2|||
30573886|NCT02988817|58582263|FG015|Overall Study|Sponsor decision|6|||
30573887|NCT02988817|58582264|FG016|Overall Study|Sponsor decision|2|||
30573888|NCT02988817|58582265|FG017|Overall Study|Sponsor decision|3|||
30573889|NCT02988817|58582266|FG018|Overall Study|Sponsor decision|2|||
30573890|NCT02988817|58582267|FG019|Overall Study|Sponsor decision|7|||
30573891|NCT02988817|58582248|FG000|Overall Study|Physician Decision|0|||
30573892|NCT02988817|58582249|FG001|Overall Study|Physician Decision|0|||
30573893|NCT02988817|58582250|FG002|Overall Study|Physician Decision|0|||
30573894|NCT02988817|58582251|FG003|Overall Study|Physician Decision|0|||
30573895|NCT02988817|58582252|FG004|Overall Study|Physician Decision|0|||
30573896|NCT02988817|58582253|FG005|Overall Study|Physician Decision|0|||
30573897|NCT02988817|58582254|FG006|Overall Study|Physician Decision|0|||
30573898|NCT02988817|58582255|FG007|Overall Study|Physician Decision|0|||
30573899|NCT02988817|58582256|FG008|Overall Study|Physician Decision|0|||
30573900|NCT02988817|58582257|FG009|Overall Study|Physician Decision|0|||
30573901|NCT02988817|58582258|FG010|Overall Study|Physician Decision|0|||
30958679|NCT01582061|59023783|FG000|Overall Study|Lack of Efficacy|3|||
30573902|NCT02988817|58582259|FG011|Overall Study|Physician Decision|0|||
30573903|NCT02988817|58582260|FG012|Overall Study|Physician Decision|0|||
30573904|NCT02988817|58582261|FG013|Overall Study|Physician Decision|0|||
30573905|NCT02988817|58582262|FG014|Overall Study|Physician Decision|0|||
30573906|NCT02988817|58582263|FG015|Overall Study|Physician Decision|1|||
30573907|NCT02988817|58582264|FG016|Overall Study|Physician Decision|0|||
30573908|NCT02988817|58582265|FG017|Overall Study|Physician Decision|0|||
30573909|NCT02988817|58582266|FG018|Overall Study|Physician Decision|1|||
30573910|NCT02988817|58582267|FG019|Overall Study|Physician Decision|1|||
30573911|NCT02960659|58582322|FG000|Overall Study|Withdrawal by Subject|1|||
30573912|NCT02960659|58582323|FG001|Overall Study|Withdrawal by Subject|0|||
30573913|NCT02960659|58582322|FG000|Overall Study|Poor compliance|0|||
30573914|NCT02960659|58582323|FG001|Overall Study|Poor compliance|1|||
30958680|NCT01582061|59023784|FG001|Overall Study|Lack of Efficacy|23|||
30573951|NCT02890355|58582351|FG000|Overall Study|Adverse Event|5|||
30573952|NCT02890355|58582352|FG001|Overall Study|Adverse Event|5|||
30573953|NCT02890355|58582351|FG000|Overall Study|Refusal unrelated to adverse event|5|||
30573954|NCT02890355|58582352|FG001|Overall Study|Refusal unrelated to adverse event|10|||
30573955|NCT02890355|58582351|FG000|Overall Study|Progression/relapse|46|||
30573956|NCT02890355|58582352|FG001|Overall Study|Progression/relapse|39|||
30573957|NCT02890355|58582351|FG000|Overall Study|Not protocol specified|3|||
30573958|NCT02890355|58582352|FG001|Overall Study|Not protocol specified|4|||
30573959|NCT02844933|58582362|FG000|Overall Study|Discontinued due to premature termination of study|3|||
30573960|NCT02844933|58582363|FG001|Overall Study|Discontinued due to premature termination of study|2|||
30573961|NCT02831764|58582371|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
30573962|NCT02831764|58582372|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
30573963|NCT02831764|58582373|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
30573964|NCT02831764|58582374|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
30573965|NCT02831764|58582375|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
30573966|NCT02831764|58582371|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
30573967|NCT02831764|58582372|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
30573968|NCT02831764|58582373|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
30573969|NCT02831764|58582374|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
30573970|NCT02831764|58582375|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
30573971|NCT02831764|58582371|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
30573972|NCT02831764|58582372|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
30573973|NCT02831764|58582373|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
30573974|NCT02831764|58582374|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
30573975|NCT02831764|58582375|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
30573976|NCT02831764|58582371|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
30573977|NCT02831764|58582372|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
30573978|NCT02831764|58582373|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
30573979|NCT02831764|58582374|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
30573980|NCT02831764|58582375|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
30573981|NCT02831764|58582371|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
30855258|NCT01331681|58882803|FG001|Overall Study|Protocol Violation|1|||
30573982|NCT02831764|58582372|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
30573983|NCT02831764|58582373|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
30573984|NCT02831764|58582374|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
30667835|NCT00504595|58681760|FG000|Overall Study|Lack of Efficacy|1|||
30855259|NCT01331681|58882804|FG002|Overall Study|Protocol Violation|0|||
30855260|NCT01331681|58882802|FG000|Overall Study|Lost to Follow-up|2|||
30855261|NCT01331681|58882803|FG001|Overall Study|Lost to Follow-up|4|||
30855262|NCT01331681|58882804|FG002|Overall Study|Lost to Follow-up|1|||
30855263|NCT01331681|58882802|FG000|Overall Study|Physician Decision|2|||
30855264|NCT01331681|58882803|FG001|Overall Study|Physician Decision|0|||
30855265|NCT01331681|58882804|FG002|Overall Study|Physician Decision|4|||
30855266|NCT01331681|58882802|FG000|Overall Study|Therapeutic procedure required|1|||
30855267|NCT01331681|58882803|FG001|Overall Study|Therapeutic procedure required|0|||
30855268|NCT01331681|58882804|FG002|Overall Study|Therapeutic procedure required|0|||
30855269|NCT01331681|58882802|FG000|Overall Study|Sponsor decision|1|||
30855270|NCT01331681|58882803|FG001|Overall Study|Sponsor decision|1|||
30855271|NCT01331681|58882804|FG002|Overall Study|Sponsor decision|0|||
30855272|NCT01331681|58882802|FG000|Overall Study|Switching to other therapy|0|||
30855273|NCT01331681|58882803|FG001|Overall Study|Switching to other therapy|0|||
30855274|NCT01331681|58882804|FG002|Overall Study|Switching to other therapy|1|||
30855275|NCT01331681|58882802|FG000|Overall Study|Not Received Study Treatment|0|||
30855276|NCT01331681|58882803|FG001|Overall Study|Not Received Study Treatment|0|||
30855277|NCT01331681|58882804|FG002|Overall Study|Not Received Study Treatment|2|||
30855278|NCT01331291|58882814|FG000|Overall Study|Lack of Efficacy|2|||
30855279|NCT01331291|58882815|FG001|Overall Study|Lack of Efficacy|8|||
30855280|NCT01331291|58882814|FG000|Overall Study|Death|0|||
30855281|NCT01331291|58882815|FG001|Overall Study|Death|1|||
30855282|NCT02601560|58882828|FG000|Overall Study|Other|0|||
30855283|NCT02601560|58882829|FG001|Overall Study|Other|0|||
30855284|NCT02601560|58882830|FG002|Overall Study|Other|0|||
30855285|NCT02601560|58882831|FG003|Overall Study|Other|0|||
30855286|NCT02601560|58882832|FG004|Overall Study|Other|0|||
30855287|NCT02601560|58882833|FG005|Overall Study|Other|0|||
30855288|NCT02601560|58882834|FG006|Overall Study|Other|1|||
30855289|NCT02601560|58882835|FG007|Overall Study|Other|0|||
30855290|NCT02595398|58882866|FG000|Overall Study|Non-compliance|1|||
30855291|NCT02595398|58882867|FG001|Overall Study|Non-compliance|0|||
30855292|NCT02595398|58882866|FG000|Overall Study|Withdrawal by Subject|2|||
30855293|NCT02595398|58882867|FG001|Overall Study|Withdrawal by Subject|1|||
30573985|NCT02831764|58582375|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
30573986|NCT02831764|58582371|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
30573987|NCT02831764|58582372|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
30573988|NCT02831764|58582373|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
30573989|NCT02831764|58582374|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
30573990|NCT02831764|58582375|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
30573991|NCT02831764|58582371|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
30573992|NCT02831764|58582372|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
30573993|NCT02831764|58582373|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
30573994|NCT02831764|58582374|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
30573995|NCT02831764|58582375|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
30573996|NCT02831764|58582371|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
30573997|NCT02831764|58582372|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
30573998|NCT02831764|58582373|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
30573999|NCT02831764|58582374|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
30574000|NCT02831764|58582375|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
30574001|NCT02831764|58582371|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
30574002|NCT02831764|58582372|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
30574003|NCT02831764|58582373|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
30574004|NCT02831764|58582374|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
30574005|NCT02831764|58582375|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
30574006|NCT02831764|58582371|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
30574007|NCT02831764|58582372|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
30574008|NCT02831764|58582373|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
30574009|NCT02831764|58582374|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
30574010|NCT02831764|58582375|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
30574011|NCT02831764|58582371|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
30574012|NCT02831764|58582372|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
30574013|NCT02831764|58582373|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
30574014|NCT02831764|58582374|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
30574015|NCT02831764|58582375|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
30574016|NCT02831764|58582371|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
30574017|NCT02831764|58582372|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
30574018|NCT02831764|58582373|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
30574019|NCT02831764|58582374|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
30574020|NCT02831764|58582375|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
30574021|NCT02831764|58582371|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
30574022|NCT02831764|58582372|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
30574023|NCT02831764|58582373|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
30574024|NCT02831764|58582374|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
30574025|NCT02831764|58582375|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
30574026|NCT02831764|58582371|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
30574027|NCT02831764|58582372|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
30574028|NCT02831764|58582373|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
30574029|NCT02831764|58582374|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
30574030|NCT02831764|58582375|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
30574031|NCT02831764|58582371|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
30574032|NCT02831764|58582372|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
30574033|NCT02831764|58582373|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
30574034|NCT02831764|58582374|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
30574035|NCT02831764|58582375|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
30574036|NCT02831764|58582371|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
30574037|NCT02831764|58582372|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
30574038|NCT02831764|58582373|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
30574039|NCT02831764|58582374|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
30574040|NCT02831764|58582375|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
30574041|NCT02831764|58582371|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
30574042|NCT02831764|58582372|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
30574043|NCT02831764|58582373|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
30667836|NCT00504595|58681761|FG001|Overall Study|Lack of Efficacy|0|||
30667837|NCT00504595|58681762|FG002|Overall Study|Lack of Efficacy|0|||
30667838|NCT00504595|58681763|FG003|Overall Study|Lack of Efficacy|0|||
30667839|NCT00504595|58681760|FG000|Overall Study|Other|0|||
30667840|NCT00504595|58681761|FG001|Overall Study|Other|0|||
30574044|NCT02831764|58582374|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
30574045|NCT02831764|58582375|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
30574046|NCT02831764|58582371|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
30574047|NCT02831764|58582372|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
30574048|NCT02831764|58582373|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
30574049|NCT02831764|58582374|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
30574050|NCT02831764|58582375|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
30574051|NCT02831764|58582371|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
30574052|NCT02831764|58582372|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
30574053|NCT02831764|58582373|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
30574054|NCT02831764|58582374|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
30574055|NCT02831764|58582375|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
30574056|NCT02642042|58582394|FG000|Overall Study|Adverse Event|22|||
30574057|NCT02642042|58582394|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
30574058|NCT02642042|58582394|FG000|Overall Study|Progression/Relapse|28|||
30574059|NCT02642042|58582394|FG000|Overall Study|Death|1|||
30574060|NCT02642042|58582394|FG000|Overall Study|Not Protocol Specified|2|||
30574061|NCT02499835|58582411|FG000|Overall Study|Withdrawal by Subject|1|||
30574062|NCT02499835|58582412|FG001|Overall Study|Withdrawal by Subject|0|||
30574063|NCT02499835|58582413|FG002|Overall Study|Withdrawal by Subject|0|||
30574064|NCT02499835|58582414|FG003|Overall Study|Withdrawal by Subject|1|||
30574065|NCT02499835|58582411|FG000|Overall Study|Physician Decision|0|||
30574066|NCT02499835|58582412|FG001|Overall Study|Physician Decision|3|||
30574067|NCT02499835|58582413|FG002|Overall Study|Physician Decision|18|||
30574068|NCT02499835|58582414|FG003|Overall Study|Physician Decision|7|||
30574069|NCT02499835|58582411|FG000|Overall Study|Adverse Event|0|||
30574070|NCT02499835|58582412|FG001|Overall Study|Adverse Event|0|||
30574071|NCT02499835|58582413|FG002|Overall Study|Adverse Event|0|||
30574072|NCT02499835|58582414|FG003|Overall Study|Adverse Event|1|||
30574073|NCT02499835|58582411|FG000|Overall Study|Disease progression|2|||
30574074|NCT02499835|58582412|FG001|Overall Study|Disease progression|1|||
30574075|NCT02499835|58582413|FG002|Overall Study|Disease progression|0|||
30574076|NCT02499835|58582414|FG003|Overall Study|Disease progression|7|||
30574077|NCT02460497|58582426|FG000|Overall Study|Participant Requested Withdrawal|4|||
30574078|NCT02460497|58582426|FG000|Overall Study|Non-Compliance|1|||
30574079|NCT02460497|58582426|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
30574080|NCT02460497|58582426|FG000|Overall Study|Lost to Follow-up|2|||
30574081|NCT02460497|58582426|FG000|Overall Study|Investigator Decision|1|||
30574082|NCT02460289|58582430|FG000|Overall Study|Adverse Event|1|||
30574083|NCT02460289|58582430|FG000|Overall Study|Withdrawal by Subject|8|||
30574084|NCT02460289|58582430|FG000|Overall Study|Lost to Follow-up|1|||
30574085|NCT02354651|58582454|FG000|Overall Study|Withdrawal by Subject|2|||
30574086|NCT02354651|58582454|FG000|Overall Study|Physician Decision|1|||
30574087|NCT02253316|58582470|FG000|Consolidation|Progression|4|||
30574088|NCT02253316|58582471|FG001|Consolidation|Progression|0|||
30574089|NCT02253316|58582472|FG002|Consolidation|Progression|0|||
30574090|NCT02253316|58582470|FG000|Consolidation|Non-Compliance|1|||
30574091|NCT02253316|58582471|FG001|Consolidation|Non-Compliance|0|||
30574092|NCT02253316|58582472|FG002|Consolidation|Non-Compliance|0|||
30574093|NCT02253316|58582470|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
30574094|NCT02253316|58582471|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
30574095|NCT02253316|58582472|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
30574096|NCT02253316|58582470|FG000|Consolidation|Secondary Malignancy|2|||
30574097|NCT02253316|58582471|FG001|Consolidation|Secondary Malignancy|0|||
30574098|NCT02253316|58582472|FG002|Consolidation|Secondary Malignancy|0|||
30574099|NCT02253316|58582470|FG000|Consolidation|Adverse Event|7|||
30574100|NCT02253316|58582471|FG001|Consolidation|Adverse Event|0|||
30574101|NCT02253316|58582472|FG002|Consolidation|Adverse Event|0|||
30574102|NCT02253316|58582470|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
30574103|NCT02253316|58582471|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
30574104|NCT02253316|58582472|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
30574105|NCT02253316|58582470|FG000|Maintenance|Physician Decision|0|||
30574106|NCT02253316|58582471|FG001|Maintenance|Physician Decision|5|||
30780243|NCT04599465|58792007|FG000|Overall Study|Physician Decision|1|||
30780244|NCT04599465|58792007|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
30780245|NCT04104646|58792054|FG000|Overall Study|Withdrawal by Subject|1|||
30780246|NCT04104646|58792055|FG001|Overall Study|Withdrawal by Subject|1|||
30574107|NCT02253316|58582472|FG002|Maintenance|Physician Decision|16|||
30574108|NCT02253316|58582470|FG000|Maintenance|Non-Compliance|0|||
30574109|NCT02253316|58582471|FG001|Maintenance|Non-Compliance|1|||
30574110|NCT02253316|58582472|FG002|Maintenance|Non-Compliance|1|||
30574111|NCT02253316|58582470|FG000|Maintenance|Secondary Malignancy|0|||
30574112|NCT02253316|58582471|FG001|Maintenance|Secondary Malignancy|2|||
30780247|NCT04104646|58792054|FG000|Overall Study|Lost to Follow-up|1|||
30574113|NCT02253316|58582472|FG002|Maintenance|Secondary Malignancy|5|||
30574114|NCT02253316|58582470|FG000|Maintenance|Adverse Event|0|||
30574115|NCT02253316|58582471|FG001|Maintenance|Adverse Event|8|||
30574116|NCT02253316|58582472|FG002|Maintenance|Adverse Event|12|||
30574117|NCT02253316|58582470|FG000|Maintenance|Still receiving active treatment|0|||
30574118|NCT02253316|58582471|FG001|Maintenance|Still receiving active treatment|8|||
30574119|NCT02253316|58582472|FG002|Maintenance|Still receiving active treatment|1|||
30574120|NCT02231749|58582482|FG000|Overall Study|Disease progression|229|||
30574121|NCT02231749|58582483|FG001|Overall Study|Disease progression|297|||
30574122|NCT02231749|58582482|FG000|Overall Study|Study Drug Toxicity|134|||
30574123|NCT02231749|58582483|FG001|Overall Study|Study Drug Toxicity|63|||
30574124|NCT02231749|58582482|FG000|Overall Study|Death|1|||
30574125|NCT02231749|58582483|FG001|Overall Study|Death|1|||
30574126|NCT02231749|58582482|FG000|Overall Study|AE unrelated to Study drug|32|||
30574127|NCT02231749|58582483|FG001|Overall Study|AE unrelated to Study drug|31|||
30574128|NCT02231749|58582482|FG000|Overall Study|Participant's request to discontinue|10|||
30574129|NCT02231749|58582483|FG001|Overall Study|Participant's request to discontinue|21|||
30574130|NCT02231749|58582482|FG000|Overall Study|Participant withdrew Consent|8|||
30574131|NCT02231749|58582483|FG001|Overall Study|Participant withdrew Consent|15|||
30574132|NCT02231749|58582482|FG000|Overall Study|Lost to Follow-up|1|||
30574133|NCT02231749|58582483|FG001|Overall Study|Lost to Follow-up|2|||
30574134|NCT02231749|58582482|FG000|Overall Study|Maximum Clinical Benefit|5|||
30574135|NCT02231749|58582483|FG001|Overall Study|Maximum Clinical Benefit|8|||
30574136|NCT02231749|58582482|FG000|Overall Study|Poor/Non-Compliance|0|||
30574137|NCT02231749|58582483|FG001|Overall Study|Poor/Non-Compliance|3|||
30574138|NCT02231749|58582482|FG000|Overall Study|Pregnancy|1|||
30574139|NCT02231749|58582483|FG001|Overall Study|Pregnancy|0|||
30574140|NCT02231749|58582482|FG000|Overall Study|other|0|||
30574141|NCT02231749|58582483|FG001|Overall Study|other|8|||
30574142|NCT02231749|58582482|FG000|Overall Study|No longer meets Study Criteria|1|||
30574143|NCT02231749|58582483|FG001|Overall Study|No longer meets Study Criteria|0|||
30574144|NCT02214160|58582492|FG000|Overall Study|Withdrawal by Subject|1|||
30574145|NCT02214160|58582493|FG001|Overall Study|Withdrawal by Subject|0|||
30574146|NCT02214160|58582494|FG002|Overall Study|Withdrawal by Subject|6|||
30574147|NCT02214160|58582492|FG000|Overall Study|Death|2|||
30574148|NCT02214160|58582493|FG001|Overall Study|Death|2|||
30574149|NCT02214160|58582494|FG002|Overall Study|Death|1|||
30574150|NCT02214160|58582492|FG000|Overall Study|Subject Non-Compliance|0|||
30574151|NCT02214160|58582493|FG001|Overall Study|Subject Non-Compliance|3|||
30574152|NCT02214160|58582494|FG002|Overall Study|Subject Non-Compliance|1|||
30574153|NCT02214160|58582492|FG000|Overall Study|Adverse Event|0|||
30574154|NCT02214160|58582493|FG001|Overall Study|Adverse Event|1|||
30574155|NCT02214160|58582494|FG002|Overall Study|Adverse Event|1|||
30574156|NCT02214160|58582492|FG000|Overall Study|Sponsor Decision|0|||
30574157|NCT02214160|58582493|FG001|Overall Study|Sponsor Decision|2|||
30574158|NCT02214160|58582494|FG002|Overall Study|Sponsor Decision|0|||
30574159|NCT02214160|58582492|FG000|Overall Study|Protocol Violation|1|||
30574160|NCT02214160|58582493|FG001|Overall Study|Protocol Violation|0|||
30574161|NCT02214160|58582494|FG002|Overall Study|Protocol Violation|0|||
30574162|NCT02214160|58582492|FG000|Overall Study|Physician Decision|0|||
30574163|NCT02214160|58582493|FG001|Overall Study|Physician Decision|0|||
30574164|NCT02214160|58582494|FG002|Overall Study|Physician Decision|1|||
30574165|NCT02059265|58582523|FG000|Overall Study|Ineligible|4|||
30574166|NCT01886872|58582530|FG000|Overall Study|Ineligible|7|||
30574167|NCT01886872|58582531|FG001|Overall Study|Ineligible|4|||
30574168|NCT01886872|58582532|FG002|Overall Study|Ineligible|12|||
30574169|NCT01856192|58582543|FG000|Overall Study|Adverse Event|12|||
30574170|NCT01856192|58582544|FG001|Overall Study|Adverse Event|4|||
30574171|NCT01856192|58582543|FG000|Overall Study|Alternative therapy|0|||
30574172|NCT01856192|58582544|FG001|Overall Study|Alternative therapy|3|||
30574173|NCT01856192|58582543|FG000|Overall Study|Death|3|||
30574174|NCT01856192|58582544|FG001|Overall Study|Death|5|||
30574175|NCT01856192|58582543|FG000|Overall Study|Lack of Efficacy|0|||
30574176|NCT01856192|58582544|FG001|Overall Study|Lack of Efficacy|5|||
30574177|NCT01856192|58582543|FG000|Overall Study|Withdrawal by Subject|1|||
30574178|NCT01856192|58582544|FG001|Overall Study|Withdrawal by Subject|1|||
30574179|NCT01856192|58582543|FG000|Overall Study|Other diseases|1|||
30574180|NCT01856192|58582544|FG001|Overall Study|Other diseases|0|||
30574181|NCT01856192|58582543|FG000|Overall Study|Never started treatment|7|||
30574182|NCT01856192|58582544|FG001|Overall Study|Never started treatment|5|||
30574183|NCT01856192|58582543|FG000|Overall Study|Path ineligible|20|||
30574184|NCT01856192|58582544|FG001|Overall Study|Path ineligible|34|||
30574185|NCT01856192|58582543|FG000|Overall Study|Non-path ineligible|2|||
30574186|NCT01856192|58582544|FG001|Overall Study|Non-path ineligible|2|||
30574187|NCT01856192|58582543|FG000|Overall Study|Physician Decision|1|||
30574188|NCT01856192|58582544|FG001|Overall Study|Physician Decision|1|||
30574189|NCT01856192|58582543|FG000|Overall Study|Suspicion of progressive disease|1|||
30574190|NCT01856192|58582544|FG001|Overall Study|Suspicion of progressive disease|0|||
30574191|NCT01856192|58582543|FG000|Overall Study|Non-compliance|1|||
30574192|NCT01856192|58582544|FG001|Overall Study|Non-compliance|0|||
30574193|NCT01708954|58582557|FG000|Step 1|Disease progression|26|||
30574194|NCT01708954|58582558|FG001|Step 1|Disease progression|17|||
30574195|NCT01708954|58582559|FG002|Step 1|Disease progression|14|||
30574196|NCT01708954|58582557|FG000|Step 1|Adverse Event|3|||
30574197|NCT01708954|58582558|FG001|Step 1|Adverse Event|11|||
30574198|NCT01708954|58582559|FG002|Step 1|Adverse Event|13|||
30574199|NCT01708954|58582557|FG000|Step 1|Death|3|||
30574200|NCT01708954|58582558|FG001|Step 1|Death|2|||
30574201|NCT01708954|58582559|FG002|Step 1|Death|3|||
30574202|NCT01708954|58582557|FG000|Step 1|Withdrawal by Subject|2|||
30574203|NCT01708954|58582558|FG001|Step 1|Withdrawal by Subject|5|||
30574204|NCT01708954|58582559|FG002|Step 1|Withdrawal by Subject|3|||
30574205|NCT01708954|58582557|FG000|Step 1|Other complicating disease|0|||
30574206|NCT01708954|58582558|FG001|Step 1|Other complicating disease|2|||
30574207|NCT01708954|58582559|FG002|Step 1|Other complicating disease|0|||
30574208|NCT01708954|58582557|FG000|Step 1|Crossed over to Step 2|2|||
30574209|NCT01708954|58582558|FG001|Step 1|Crossed over to Step 2|0|||
30574210|NCT01708954|58582559|FG002|Step 1|Crossed over to Step 2|0|||
30574211|NCT01708954|58582557|FG000|Step 1|Symptomatic deterioration|1|||
30574212|NCT01708954|58582558|FG001|Step 1|Symptomatic deterioration|0|||
30574213|NCT01708954|58582559|FG002|Step 1|Symptomatic deterioration|1|||
30574214|NCT01708954|58582557|FG000|Step 1|Off-treatment reason not submitted|1|||
30574215|NCT01708954|58582558|FG001|Step 1|Off-treatment reason not submitted|1|||
30574216|NCT01708954|58582559|FG002|Step 1|Off-treatment reason not submitted|1|||
30574217|NCT01708954|58582557|FG000|Step 1|Ineligible or never received treatment|4|||
30574218|NCT01708954|58582558|FG001|Step 1|Ineligible or never received treatment|2|||
30574219|NCT01708954|58582559|FG002|Step 1|Ineligible or never received treatment|8|||
30574220|NCT01708954|58582557|FG000|Step 2|Disease progression|9|||
30574221|NCT01708954|58582558|FG001|Step 2|Disease progression|4|||
30574222|NCT01708954|58582559|FG002|Step 2|Disease progression|0|||
30574223|NCT01708954|58582557|FG000|Step 2|Adverse Event|3|||
30574224|NCT01708954|58582558|FG001|Step 2|Adverse Event|2|||
30574225|NCT01708954|58582559|FG002|Step 2|Adverse Event|0|||
30574226|NCT01708954|58582557|FG000|Step 2|Withdrawal by Subject|1|||
30574227|NCT01708954|58582558|FG001|Step 2|Withdrawal by Subject|1|||
30574228|NCT01708954|58582559|FG002|Step 2|Withdrawal by Subject|0|||
30574229|NCT01708941|58582572|FG000|Overall Study|Adverse Event|4|||
30574230|NCT01708941|58582573|FG001|Overall Study|Adverse Event|6|||
30574231|NCT01708941|58582574|FG002|Overall Study|Adverse Event|1|||
30574232|NCT01708941|58582575|FG003|Overall Study|Adverse Event|0|||
30574233|NCT01708941|58582572|FG000|Overall Study|Death|1|||
30574234|NCT01708941|58582573|FG001|Overall Study|Death|1|||
30574235|NCT01708941|58582574|FG002|Overall Study|Death|2|||
30574236|NCT01708941|58582575|FG003|Overall Study|Death|14|||
30574237|NCT01708941|58582572|FG000|Overall Study|Withdrawal by Subject|1|||
30574238|NCT01708941|58582573|FG001|Overall Study|Withdrawal by Subject|0|||
30574239|NCT01708941|58582574|FG002|Overall Study|Withdrawal by Subject|3|||
30574240|NCT01708941|58582575|FG003|Overall Study|Withdrawal by Subject|4|||
30574241|NCT01708941|58582572|FG000|Overall Study|Disease progression|9|||
30574242|NCT01708941|58582573|FG001|Overall Study|Disease progression|10|||
30574243|NCT01708941|58582574|FG002|Overall Study|Disease progression|8|||
30574244|NCT01708941|58582575|FG003|Overall Study|Disease progression|0|||
30574245|NCT01708941|58582572|FG000|Overall Study|Alternative therapy|0|||
30574246|NCT01708941|58582573|FG001|Overall Study|Alternative therapy|0|||
30574247|NCT01708941|58582574|FG002|Overall Study|Alternative therapy|2|||
30574248|NCT01708941|58582575|FG003|Overall Study|Alternative therapy|0|||
30574249|NCT01708941|58582572|FG000|Overall Study|Ineligible and never started treatment|1|||
30574250|NCT01708941|58582573|FG001|Overall Study|Ineligible and never started treatment|0|||
30574251|NCT01708941|58582574|FG002|Overall Study|Ineligible and never started treatment|1|||
30574252|NCT01708941|58582575|FG003|Overall Study|Ineligible and never started treatment|0|||
30574253|NCT01708941|58582572|FG000|Overall Study|Never started treatment|2|||
30574254|NCT01708941|58582573|FG001|Overall Study|Never started treatment|1|||
30574255|NCT01708941|58582574|FG002|Overall Study|Never started treatment|0|||
30574256|NCT01708941|58582575|FG003|Overall Study|Never started treatment|0|||
30574257|NCT01708941|58582572|FG000|Overall Study|Ineligible|0|||
30574258|NCT01708941|58582573|FG001|Overall Study|Ineligible|0|||
30574259|NCT01708941|58582574|FG002|Overall Study|Ineligible|2|||
30574260|NCT01708941|58582575|FG003|Overall Study|Ineligible|0|||
30574261|NCT01592370|58582592|FG000|Overall Study|Disease Progression|62|||
30574262|NCT01592370|58582593|FG001|Overall Study|Disease Progression|16|||
30574263|NCT01592370|58582594|FG002|Overall Study|Disease Progression|52|||
30574264|NCT01592370|58582595|FG003|Overall Study|Disease Progression|3|||
30574265|NCT01592370|58582596|FG004|Overall Study|Disease Progression|3|||
30574266|NCT01592370|58582597|FG005|Overall Study|Disease Progression|31|||
30574267|NCT01592370|58582598|FG006|Overall Study|Disease Progression|14|||
30574268|NCT01592370|58582592|FG000|Overall Study|Study Drug Toxicity|14|||
30574269|NCT01592370|58582593|FG001|Overall Study|Study Drug Toxicity|3|||
30574270|NCT01592370|58582594|FG002|Overall Study|Study Drug Toxicity|0|||
30574271|NCT01592370|58582595|FG003|Overall Study|Study Drug Toxicity|0|||
30574272|NCT01592370|58582596|FG004|Overall Study|Study Drug Toxicity|0|||
30574273|NCT01592370|58582597|FG005|Overall Study|Study Drug Toxicity|0|||
30574274|NCT01592370|58582598|FG006|Overall Study|Study Drug Toxicity|1|||
30574275|NCT01592370|58582592|FG000|Overall Study|AE unrelated to study drug|4|||
30574276|NCT01592370|58582593|FG001|Overall Study|AE unrelated to study drug|3|||
30574277|NCT01592370|58582594|FG002|Overall Study|AE unrelated to study drug|0|||
30574278|NCT01592370|58582595|FG003|Overall Study|AE unrelated to study drug|0|||
30574279|NCT01592370|58582596|FG004|Overall Study|AE unrelated to study drug|0|||
30574280|NCT01592370|58582597|FG005|Overall Study|AE unrelated to study drug|0|||
30574281|NCT01592370|58582598|FG006|Overall Study|AE unrelated to study drug|1|||
30574282|NCT01592370|58582592|FG000|Overall Study|Request to discontinue study treatment|5|||
30574283|NCT01592370|58582593|FG001|Overall Study|Request to discontinue study treatment|0|||
30574284|NCT01592370|58582594|FG002|Overall Study|Request to discontinue study treatment|2|||
30574285|NCT01592370|58582595|FG003|Overall Study|Request to discontinue study treatment|0|||
30574286|NCT01592370|58582596|FG004|Overall Study|Request to discontinue study treatment|1|||
30574287|NCT01592370|58582597|FG005|Overall Study|Request to discontinue study treatment|2|||
30574288|NCT01592370|58582598|FG006|Overall Study|Request to discontinue study treatment|0|||
30574289|NCT01592370|58582592|FG000|Overall Study|Withdrew consent|1|||
30574290|NCT01592370|58582593|FG001|Overall Study|Withdrew consent|2|||
30574291|NCT01592370|58582594|FG002|Overall Study|Withdrew consent|1|||
30574292|NCT01592370|58582595|FG003|Overall Study|Withdrew consent|1|||
30574293|NCT01592370|58582596|FG004|Overall Study|Withdrew consent|0|||
30574294|NCT01592370|58582597|FG005|Overall Study|Withdrew consent|0|||
30574295|NCT01592370|58582598|FG006|Overall Study|Withdrew consent|0|||
30574296|NCT01592370|58582592|FG000|Overall Study|Maximum clinical benefit|11|||
30574297|NCT01592370|58582593|FG001|Overall Study|Maximum clinical benefit|1|||
30574298|NCT01592370|58582594|FG002|Overall Study|Maximum clinical benefit|7|||
30574299|NCT01592370|58582595|FG003|Overall Study|Maximum clinical benefit|1|||
30574300|NCT01592370|58582596|FG004|Overall Study|Maximum clinical benefit|0|||
30574301|NCT01592370|58582597|FG005|Overall Study|Maximum clinical benefit|0|||
30574302|NCT01592370|58582598|FG006|Overall Study|Maximum clinical benefit|0|||
30574303|NCT01592370|58582592|FG000|Overall Study|No longer meets study criteria|1|||
30574304|NCT01592370|58582593|FG001|Overall Study|No longer meets study criteria|0|||
30574305|NCT01592370|58582594|FG002|Overall Study|No longer meets study criteria|0|||
30574306|NCT01592370|58582595|FG003|Overall Study|No longer meets study criteria|0|||
30574307|NCT01592370|58582596|FG004|Overall Study|No longer meets study criteria|0|||
30574308|NCT01592370|58582597|FG005|Overall Study|No longer meets study criteria|0|||
30574309|NCT01592370|58582598|FG006|Overall Study|No longer meets study criteria|0|||
30574310|NCT01592370|58582592|FG000|Overall Study|Other Reasons|6|||
30574311|NCT01592370|58582593|FG001|Overall Study|Other Reasons|0|||
30574312|NCT01592370|58582594|FG002|Overall Study|Other Reasons|10|||
30574313|NCT01592370|58582595|FG003|Overall Study|Other Reasons|0|||
30574314|NCT01592370|58582596|FG004|Overall Study|Other Reasons|0|||
30574315|NCT01592370|58582597|FG005|Overall Study|Other Reasons|1|||
30574316|NCT01592370|58582598|FG006|Overall Study|Other Reasons|0|||
30574317|NCT01522976|58582621|FG000|Overall Study|Ineligible|4|||
30574318|NCT01522976|58582622|FG001|Overall Study|Ineligible|0|||
30574319|NCT01522976|58582623|FG002|Overall Study|Ineligible|1|||
30574320|NCT01522976|58582621|FG000|Overall Study|Death|7|||
30574321|NCT01522976|58582622|FG001|Overall Study|Death|6|||
30574322|NCT01522976|58582623|FG002|Overall Study|Death|2|||
30574323|NCT01522976|58582621|FG000|Overall Study|Still on treatment|9|||
30574324|NCT01522976|58582622|FG001|Overall Study|Still on treatment|9|||
30574325|NCT01522976|58582623|FG002|Overall Study|Still on treatment|6|||
30574326|NCT01522976|58582621|FG000|Overall Study|Disease progression|28|||
30574327|NCT01522976|58582622|FG001|Overall Study|Disease progression|30|||
30574328|NCT01522976|58582623|FG002|Overall Study|Disease progression|25|||
30574329|NCT01522976|58582621|FG000|Overall Study|Adverse Event|17|||
30574330|NCT01522976|58582622|FG001|Overall Study|Adverse Event|7|||
30574331|NCT01522976|58582623|FG002|Overall Study|Adverse Event|18|||
30574332|NCT01522976|58582621|FG000|Overall Study|Refusal unrelated to adverse event|10|||
30574333|NCT01522976|58582622|FG001|Overall Study|Refusal unrelated to adverse event|13|||
30574334|NCT01522976|58582623|FG002|Overall Study|Refusal unrelated to adverse event|14|||
30574335|NCT01522976|58582621|FG000|Overall Study|Not protocol specified|22|||
30574336|NCT01522976|58582622|FG001|Overall Study|Not protocol specified|27|||
30574337|NCT01522976|58582623|FG002|Overall Study|Not protocol specified|27|||
30574338|NCT01386385|58582639|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
30574339|NCT01386385|58582640|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
30574340|NCT01386385|58582641|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
30574341|NCT01386385|58582642|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
30574342|NCT01386385|58582643|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
30667841|NCT00504595|58681762|FG002|Overall Study|Other|2|||
30780248|NCT04104646|58792055|FG001|Overall Study|Lost to Follow-up|0|||
30574343|NCT01386385|58582644|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
30574344|NCT01386385|58582645|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
30574345|NCT01386385|58582646|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
30574346|NCT01386385|58582639|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
30667842|NCT00504595|58681763|FG003|Overall Study|Other|0|||
30574347|NCT01386385|58582640|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
30574348|NCT01386385|58582641|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
30574349|NCT01386385|58582642|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
30574350|NCT01386385|58582643|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
30574351|NCT01386385|58582644|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
30574352|NCT01386385|58582645|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
30574353|NCT01386385|58582646|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
30574354|NCT01386385|58582639|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
30574355|NCT01386385|58582640|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
30574356|NCT01386385|58582641|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
30574357|NCT01386385|58582642|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
30574358|NCT01386385|58582643|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
30574359|NCT01386385|58582644|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
30574360|NCT01386385|58582645|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
30574361|NCT01386385|58582646|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
30574362|NCT01386385|58582639|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
30574363|NCT01386385|58582640|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
30574364|NCT01386385|58582641|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
30574365|NCT01386385|58582642|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
30574366|NCT01386385|58582643|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
30574367|NCT01386385|58582644|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
30574368|NCT01386385|58582645|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
30574369|NCT01386385|58582646|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
30574370|NCT01386385|58582639|FG000|Phase II Concurrent CRT|Adverse Event|0|||
30574371|NCT01386385|58582640|FG001|Phase II Concurrent CRT|Adverse Event|0|||
30574372|NCT01386385|58582641|FG002|Phase II Concurrent CRT|Adverse Event|0|||
30574373|NCT01386385|58582642|FG003|Phase II Concurrent CRT|Adverse Event|0|||
30574374|NCT01386385|58582643|FG004|Phase II Concurrent CRT|Adverse Event|0|||
30574375|NCT01386385|58582644|FG005|Phase II Concurrent CRT|Adverse Event|0|||
30574376|NCT01386385|58582645|FG006|Phase II Concurrent CRT|Adverse Event|3|||
30574377|NCT01386385|58582646|FG007|Phase II Concurrent CRT|Adverse Event|3|||
30574378|NCT01386385|58582639|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
30574379|NCT01386385|58582640|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
30574380|NCT01386385|58582641|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
30574381|NCT01386385|58582642|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
30574382|NCT01386385|58582643|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
30574383|NCT01386385|58582644|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
30574384|NCT01386385|58582645|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
30574385|NCT01386385|58582646|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
30574386|NCT01386385|58582639|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
30574387|NCT01386385|58582640|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
30574388|NCT01386385|58582641|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
30574389|NCT01386385|58582642|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
30574390|NCT01386385|58582643|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
30574391|NCT01386385|58582644|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
30574392|NCT01386385|58582645|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
30574393|NCT01386385|58582646|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
30574394|NCT01386385|58582639|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
30574395|NCT01386385|58582640|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
30574396|NCT01386385|58582641|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
30574397|NCT01386385|58582642|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
30574398|NCT01386385|58582643|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
30574399|NCT01386385|58582644|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
30574400|NCT01386385|58582645|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
30574401|NCT01386385|58582646|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
30574402|NCT01386385|58582639|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
30574403|NCT01386385|58582640|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
30574404|NCT01386385|58582641|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
30574405|NCT01386385|58582642|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
30574406|NCT01386385|58582643|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
30574407|NCT01386385|58582644|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
30855294|NCT02595398|58882866|FG000|Overall Study|Lost to Follow-up|1|||
30574408|NCT01386385|58582645|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
30574409|NCT01386385|58582646|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
30574410|NCT01274338|58582673|FG000|Overall Study|Lack of Efficacy|72|||
30574411|NCT01274338|58582674|FG001|Overall Study|Lack of Efficacy|108|||
30574412|NCT01274338|58582675|FG002|Overall Study|Lack of Efficacy|116|||
30574413|NCT01274338|58582676|FG003|Overall Study|Lack of Efficacy|0|||
30574414|NCT01274338|58582677|FG004|Overall Study|Lack of Efficacy|0|||
30574415|NCT01274338|58582678|FG005|Overall Study|Lack of Efficacy|0|||
30574416|NCT01274338|58582673|FG000|Overall Study|Adverse Event|272|||
30574417|NCT01274338|58582674|FG001|Overall Study|Adverse Event|105|||
30574418|NCT01274338|58582675|FG002|Overall Study|Adverse Event|180|||
30574419|NCT01274338|58582676|FG003|Overall Study|Adverse Event|1|||
30574420|NCT01274338|58582677|FG004|Overall Study|Adverse Event|0|||
30574421|NCT01274338|58582678|FG005|Overall Study|Adverse Event|0|||
30574422|NCT01274338|58582673|FG000|Overall Study|Death|8|||
30574423|NCT01274338|58582674|FG001|Overall Study|Death|1|||
30574424|NCT01274338|58582675|FG002|Overall Study|Death|0|||
30574425|NCT01274338|58582676|FG003|Overall Study|Death|0|||
30574426|NCT01274338|58582677|FG004|Overall Study|Death|0|||
30574427|NCT01274338|58582678|FG005|Overall Study|Death|0|||
30574428|NCT01274338|58582673|FG000|Overall Study|Withdrawal by Subject|27|||
30574429|NCT01274338|58582674|FG001|Overall Study|Withdrawal by Subject|99|||
30574430|NCT01274338|58582675|FG002|Overall Study|Withdrawal by Subject|17|||
30574431|NCT01274338|58582676|FG003|Overall Study|Withdrawal by Subject|0|||
30574432|NCT01274338|58582677|FG004|Overall Study|Withdrawal by Subject|0|||
30574433|NCT01274338|58582678|FG005|Overall Study|Withdrawal by Subject|0|||
30574434|NCT01274338|58582673|FG000|Overall Study|Did not start treatment|8|||
30574435|NCT01274338|58582674|FG001|Overall Study|Did not start treatment|116|||
30574436|NCT01274338|58582675|FG002|Overall Study|Did not start treatment|7|||
30574437|NCT01274338|58582676|FG003|Overall Study|Did not start treatment|0|||
30574438|NCT01274338|58582677|FG004|Overall Study|Did not start treatment|0|||
30574439|NCT01274338|58582678|FG005|Overall Study|Did not start treatment|0|||
30574440|NCT01274338|58582673|FG000|Overall Study|Alternative therapy|0|||
30574441|NCT01274338|58582674|FG001|Overall Study|Alternative therapy|1|||
30574442|NCT01274338|58582675|FG002|Overall Study|Alternative therapy|0|||
30574443|NCT01274338|58582676|FG003|Overall Study|Alternative therapy|0|||
30574444|NCT01274338|58582677|FG004|Overall Study|Alternative therapy|0|||
30574445|NCT01274338|58582678|FG005|Overall Study|Alternative therapy|0|||
30574446|NCT01274338|58582673|FG000|Overall Study|Other complicating diseases|0|||
30574447|NCT01274338|58582674|FG001|Overall Study|Other complicating diseases|3|||
30574448|NCT01274338|58582675|FG002|Overall Study|Other complicating diseases|1|||
30574449|NCT01274338|58582676|FG003|Overall Study|Other complicating diseases|0|||
30574450|NCT01274338|58582677|FG004|Overall Study|Other complicating diseases|0|||
30574451|NCT01274338|58582678|FG005|Overall Study|Other complicating diseases|0|||
30574452|NCT01274338|58582673|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
30574453|NCT01274338|58582674|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
30574454|NCT01274338|58582675|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
30574455|NCT01274338|58582676|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
30574456|NCT01274338|58582677|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
30574457|NCT01274338|58582678|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
30574458|NCT01274338|58582673|FG000|Overall Study|Pregnancy|0|||
30574459|NCT01274338|58582674|FG001|Overall Study|Pregnancy|0|||
30574460|NCT01274338|58582675|FG002|Overall Study|Pregnancy|1|||
30574461|NCT01274338|58582676|FG003|Overall Study|Pregnancy|0|||
30667843|NCT00513409|58681775|FG000|Overall Study|Adverse Event|0|||
30667844|NCT00513409|58681776|FG001|Overall Study|Adverse Event|1|||
30667845|NCT00513409|58681775|FG000|Overall Study|Withdrawal by Subject|0|||
30667846|NCT00513409|58681776|FG001|Overall Study|Withdrawal by Subject|2|||
30667847|NCT00513409|58681775|FG000|Overall Study|Lost to Follow-up|0|||
30667848|NCT00513409|58681776|FG001|Overall Study|Lost to Follow-up|1|||
30667849|NCT00513409|58681775|FG000|Overall Study|Physician Decision|1|||
30667850|NCT00513409|58681776|FG001|Overall Study|Physician Decision|0|||
30667851|NCT00513409|58681775|FG000|Overall Study|Visit 3 not done|1|||
30667852|NCT00513409|58681776|FG001|Overall Study|Visit 3 not done|2|||
30667853|NCT03150095|58681784|FG000|Overall Study|Death|0|||
30667854|NCT03150095|58681785|FG001|Overall Study|Death|1|||
30667855|NCT03150095|58681784|FG000|Overall Study|Lost to Follow-up|1|||
30667856|NCT03150095|58681785|FG001|Overall Study|Lost to Follow-up|1|||
30667857|NCT03150095|58681784|FG000|Overall Study|Withdrawal by Subject|4|||
30667858|NCT03150095|58681785|FG001|Overall Study|Withdrawal by Subject|0|||
30667859|NCT03150095|58681784|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
30780249|NCT04104646|58792054|FG000|Overall Study|Physician Decision|2|||
30780250|NCT04104646|58792055|FG001|Overall Study|Physician Decision|0|||
30780251|NCT03919669|58792066|FG000|Overall Study|Withdrawal by Subject|1|||
30667860|NCT03150095|58681785|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
30574462|NCT01274338|58582677|FG004|Overall Study|Pregnancy|0|||
30574463|NCT01274338|58582678|FG005|Overall Study|Pregnancy|0|||
30574464|NCT01274338|58582673|FG000|Overall Study|Reason not reported|12|||
30574465|NCT01274338|58582674|FG001|Overall Study|Reason not reported|21|||
30574466|NCT01274338|58582675|FG002|Overall Study|Reason not reported|3|||
30780252|NCT03919669|58792067|FG001|Overall Study|Withdrawal by Subject|0|||
30574467|NCT01274338|58582676|FG003|Overall Study|Reason not reported|0|||
30667861|NCT00705016|58681794|FG000|Overall Study|Adverse Event|6|||
30667862|NCT00705016|58681795|FG001|Overall Study|Adverse Event|11|||
30667863|NCT00705016|58681796|FG002|Overall Study|Adverse Event|10|||
30574468|NCT01274338|58582677|FG004|Overall Study|Reason not reported|1|||
30574469|NCT01274338|58582678|FG005|Overall Study|Reason not reported|0|||
30574470|NCT01196390|58582693|FG000|Overall Study|Protocol Violation|4|||
30574471|NCT01196390|58582694|FG001|Overall Study|Protocol Violation|5|||
30574472|NCT01169337|58582705|FG000|Overall Study|Lack of Efficacy|5|||
30574473|NCT01169337|58582706|FG001|Overall Study|Lack of Efficacy|7|||
30574474|NCT01169337|58582707|FG002|Overall Study|Lack of Efficacy|0|||
30574475|NCT01169337|58582705|FG000|Overall Study|Adverse Event|12|||
30574476|NCT01169337|58582706|FG001|Overall Study|Adverse Event|18|||
30574477|NCT01169337|58582707|FG002|Overall Study|Adverse Event|0|||
30574478|NCT01169337|58582705|FG000|Overall Study|Death|2|||
30574479|NCT01169337|58582706|FG001|Overall Study|Death|0|||
30574480|NCT01169337|58582707|FG002|Overall Study|Death|0|||
30574481|NCT01169337|58582705|FG000|Overall Study|Withdrawal by Subject|11|||
30574482|NCT01169337|58582706|FG001|Overall Study|Withdrawal by Subject|11|||
30574483|NCT01169337|58582707|FG002|Overall Study|Withdrawal by Subject|6|||
30574484|NCT01169337|58582705|FG000|Overall Study|Noncompliance|2|||
30574485|NCT01169337|58582706|FG001|Overall Study|Noncompliance|0|||
30574486|NCT01169337|58582707|FG002|Overall Study|Noncompliance|0|||
30574487|NCT01169337|58582705|FG000|Overall Study|Other complicating disease|1|||
30574488|NCT01169337|58582706|FG001|Overall Study|Other complicating disease|1|||
30574489|NCT01169337|58582707|FG002|Overall Study|Other complicating disease|0|||
30574490|NCT01169337|58582705|FG000|Overall Study|Physician Decision|1|||
30574491|NCT01169337|58582706|FG001|Overall Study|Physician Decision|5|||
30574492|NCT01169337|58582707|FG002|Overall Study|Physician Decision|0|||
30574493|NCT01169337|58582705|FG000|Overall Study|Alternative therapy|0|||
30574494|NCT01169337|58582706|FG001|Overall Study|Alternative therapy|2|||
30574495|NCT01169337|58582707|FG002|Overall Study|Alternative therapy|0|||
30574496|NCT01169337|58582705|FG000|Overall Study|Changed hospital|0|||
30574497|NCT01169337|58582706|FG001|Overall Study|Changed hospital|1|||
30574498|NCT01169337|58582707|FG002|Overall Study|Changed hospital|0|||
30574499|NCT01169337|58582705|FG000|Overall Study|Never started treatment|0|||
30574500|NCT01169337|58582706|FG001|Overall Study|Never started treatment|2|||
30574501|NCT01169337|58582707|FG002|Overall Study|Never started treatment|0|||
30574502|NCT01169337|58582705|FG000|Overall Study|Reason not reported|1|||
30574503|NCT01169337|58582706|FG001|Overall Study|Reason not reported|0|||
30574504|NCT01169337|58582707|FG002|Overall Study|Reason not reported|0|||
30574505|NCT01169337|58582705|FG000|Overall Study|Continuing lenalidomide|9|||
30574506|NCT01169337|58582706|FG001|Overall Study|Continuing lenalidomide|43|||
30574507|NCT01169337|58582707|FG002|Overall Study|Continuing lenalidomide|0|||
30574508|NCT01142388|58582726|FG000|Overall Study|Lack of Efficacy|21|||
30574509|NCT01142388|58582727|FG001|Overall Study|Lack of Efficacy|31|||
30574510|NCT01142388|58582726|FG000|Overall Study|Adverse Event|9|||
30574511|NCT01142388|58582727|FG001|Overall Study|Adverse Event|5|||
30574512|NCT01142388|58582726|FG000|Overall Study|Death|3|||
30574513|NCT01142388|58582727|FG001|Overall Study|Death|2|||
30574514|NCT01142388|58582726|FG000|Overall Study|Withdrawal by Subject|5|||
30574515|NCT01142388|58582727|FG001|Overall Study|Withdrawal by Subject|3|||
30574516|NCT01142388|58582726|FG000|Overall Study|Alternative therapy|1|||
30574517|NCT01142388|58582727|FG001|Overall Study|Alternative therapy|0|||
30574518|NCT01142388|58582726|FG000|Overall Study|Other complications|0|||
30574519|NCT01142388|58582727|FG001|Overall Study|Other complications|2|||
30574520|NCT01142388|58582726|FG000|Overall Study|Other|1|||
30574521|NCT01142388|58582727|FG001|Overall Study|Other|1|||
30574522|NCT01142388|58582726|FG000|Overall Study|Never started therapy|7|||
30574523|NCT01142388|58582727|FG001|Overall Study|Never started therapy|3|||
30574524|NCT01134614|58582735|FG000|Overall Study|Still on treatment as of March 2013|21|||
30574525|NCT01134614|58582736|FG001|Overall Study|Still on treatment as of March 2013|13|||
30574526|NCT01134614|58582735|FG000|Overall Study|Progressive disease|60|||
30574527|NCT01134614|58582736|FG001|Overall Study|Progressive disease|54|||
30574528|NCT01134614|58582735|FG000|Overall Study|Adverse Event|26|||
30574529|NCT01134614|58582736|FG001|Overall Study|Adverse Event|39|||
30574530|NCT01134614|58582735|FG000|Overall Study|Death|5|||
30574531|NCT01134614|58582736|FG001|Overall Study|Death|8|||
30574532|NCT01134614|58582735|FG000|Overall Study|Withdrawal by Subject|3|||
30574533|NCT01134614|58582736|FG001|Overall Study|Withdrawal by Subject|2|||
30574534|NCT01134614|58582735|FG000|Overall Study|Alternative therapy|2|||
30574535|NCT01134614|58582736|FG001|Overall Study|Alternative therapy|0|||
30574536|NCT01134614|58582735|FG000|Overall Study|Complicating disease|2|||
30574537|NCT01134614|58582736|FG001|Overall Study|Complicating disease|1|||
30574538|NCT01134614|58582735|FG000|Overall Study|Physician's decision|0|||
30574539|NCT01134614|58582736|FG001|Overall Study|Physician's decision|1|||
30574540|NCT01134614|58582735|FG000|Overall Study|Never started treatment|4|||
30574541|NCT01134614|58582736|FG001|Overall Study|Never started treatment|1|||
30667864|NCT00705016|58681794|FG000|Overall Study|Death|5|||
30667865|NCT00705016|58681795|FG001|Overall Study|Death|7|||
30574542|NCT01134614|58582735|FG000|Overall Study|Pt received tx not allowed on study|0|||
30574543|NCT01134614|58582736|FG001|Overall Study|Pt received tx not allowed on study|1|||
30574544|NCT01134614|58582735|FG000|Overall Study|Symptomatic deterioration|0|||
30667866|NCT00705016|58681796|FG002|Overall Study|Death|5|||
30574545|NCT01134614|58582736|FG001|Overall Study|Symptomatic deterioration|1|||
30574546|NCT01134614|58582735|FG000|Overall Study|Patient in hospice care|0|||
30574547|NCT01134614|58582736|FG001|Overall Study|Patient in hospice care|1|||
30574548|NCT00977574|58582758|FG000|Overall Study|Never Treated|4|||
30574549|NCT00977574|58582759|FG001|Overall Study|Never Treated|2|||
30574550|NCT00977574|58582760|FG002|Overall Study|Never Treated|4|||
30574551|NCT00769379|58582770|FG000|Overall Study|No follow up data mapped to Other.|3|||
30574552|NCT00769379|58582771|FG001|Overall Study|No follow up data mapped to Other.|13|||
30574553|NCT00588770|58582783|FG000|Overall Study|Disease progression|85|||
30574554|NCT00588770|58582784|FG001|Overall Study|Disease progression|68|||
30574555|NCT00588770|58582783|FG000|Overall Study|Adverse Event|29|||
30574556|NCT00588770|58582784|FG001|Overall Study|Adverse Event|58|||
30574557|NCT00588770|58582783|FG000|Overall Study|Death|13|||
30574558|NCT00588770|58582784|FG001|Overall Study|Death|22|||
30574559|NCT00588770|58582783|FG000|Overall Study|Withdrawal by Subject|15|||
30574560|NCT00588770|58582784|FG001|Overall Study|Withdrawal by Subject|25|||
30574561|NCT00588770|58582783|FG000|Overall Study|Alternative therapy|2|||
30574562|NCT00588770|58582784|FG001|Overall Study|Alternative therapy|4|||
30574563|NCT00588770|58582783|FG000|Overall Study|Other complicating disease|3|||
30574564|NCT00588770|58582784|FG001|Overall Study|Other complicating disease|2|||
30574565|NCT00588770|58582783|FG000|Overall Study|Not start protocol therapy|0|||
30574566|NCT00588770|58582784|FG001|Overall Study|Not start protocol therapy|9|||
30574567|NCT00588770|58582783|FG000|Overall Study|Lack of Efficacy|8|||
30574568|NCT00588770|58582784|FG001|Overall Study|Lack of Efficacy|10|||
30574569|NCT00588770|58582783|FG000|Overall Study|Physician discretion|2|||
30574570|NCT00588770|58582784|FG001|Overall Study|Physician discretion|0|||
30574571|NCT00588770|58582783|FG000|Overall Study|Patient non-compliance|2|||
30574572|NCT00588770|58582784|FG001|Overall Study|Patient non-compliance|2|||
30574589|NCT00433511|58582802|FG000|Step 1|Adverse Event|50|||
30574590|NCT00433511|58582803|FG001|Step 1|Adverse Event|157|||
30574591|NCT00433511|58582804|FG002|Step 1|Adverse Event|153|||
30574592|NCT00433511|58582802|FG000|Step 1|Withdrawal by Subject|45|||
30574593|NCT00433511|58582803|FG001|Step 1|Withdrawal by Subject|143|||
30574594|NCT00433511|58582804|FG002|Step 1|Withdrawal by Subject|154|||
30574595|NCT00433511|58582802|FG000|Step 1|Death|3|||
30574596|NCT00433511|58582803|FG001|Step 1|Death|1|||
30574597|NCT00433511|58582804|FG002|Step 1|Death|1|||
30574598|NCT00433511|58582802|FG000|Step 1|Physician Decision|1|||
30574599|NCT00433511|58582803|FG001|Step 1|Physician Decision|4|||
30574600|NCT00433511|58582804|FG002|Step 1|Physician Decision|3|||
30574601|NCT00433511|58582802|FG000|Step 1|Never started protocol therapy|28|||
30574602|NCT00433511|58582803|FG001|Step 1|Never started protocol therapy|64|||
30574603|NCT00433511|58582804|FG002|Step 1|Never started protocol therapy|66|||
30574604|NCT00433511|58582802|FG000|Step 1|Alternative therapy|2|||
30574605|NCT00433511|58582803|FG001|Step 1|Alternative therapy|1|||
30574606|NCT00433511|58582804|FG002|Step 1|Alternative therapy|3|||
30574607|NCT00433511|58582802|FG000|Step 1|Disease progression, relapse|5|||
30574608|NCT00433511|58582803|FG001|Step 1|Disease progression, relapse|3|||
30855295|NCT02595398|58882867|FG001|Overall Study|Lost to Follow-up|0|||
30574609|NCT00433511|58582804|FG002|Step 1|Disease progression, relapse|3|||
30574610|NCT00433511|58582802|FG000|Step 1|Other complicating disease|2|||
30855296|NCT01368497|58882873|FG000|Overall Study|Lost to Follow-up|2|||
30574611|NCT00433511|58582803|FG001|Step 1|Other complicating disease|6|||
30574612|NCT00433511|58582804|FG002|Step 1|Other complicating disease|3|||
30855297|NCT02595008|58882879|FG000|Overall Study|Enrolled In Error|1|||
30574613|NCT00433511|58582802|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
30855298|NCT02595008|58882880|FG001|Overall Study|Enrolled In Error|0|||
30574614|NCT00433511|58582803|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
30574615|NCT00433511|58582804|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
30574616|NCT00433511|58582802|FG000|Step 1|Suspected recurrence|0|||
30574617|NCT00433511|58582803|FG001|Step 1|Suspected recurrence|1|||
30574618|NCT00433511|58582804|FG002|Step 1|Suspected recurrence|0|||
30574619|NCT00433511|58582802|FG000|Step 1|Insurance/drug distribution issues|0|||
30574620|NCT00433511|58582803|FG001|Step 1|Insurance/drug distribution issues|1|||
30574621|NCT00433511|58582804|FG002|Step 1|Insurance/drug distribution issues|2|||
30574622|NCT00433511|58582802|FG000|Step 1|Patient moved|0|||
30574623|NCT00433511|58582803|FG001|Step 1|Patient moved|0|||
30574624|NCT00433511|58582804|FG002|Step 1|Patient moved|1|||
30574625|NCT00433511|58582802|FG000|Step 2 (Arm D)|Adverse Event|0|||
30574626|NCT00433511|58582803|FG001|Step 2 (Arm D)|Adverse Event|0|||
30574627|NCT00433511|58582804|FG002|Step 2 (Arm D)|Adverse Event|135|||
30574628|NCT00433511|58582802|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
30574629|NCT00433511|58582803|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
30574630|NCT00433511|58582804|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
30574631|NCT00433511|58582802|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
30574632|NCT00433511|58582803|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
30574633|NCT00433511|58582804|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
30574634|NCT00433511|58582802|FG000|Step 2 (Arm D)|Physician Decision|0|||
30574635|NCT00433511|58582803|FG001|Step 2 (Arm D)|Physician Decision|0|||
30574636|NCT00433511|58582804|FG002|Step 2 (Arm D)|Physician Decision|9|||
30574637|NCT00433511|58582802|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
30574638|NCT00433511|58582803|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
30574639|NCT00433511|58582804|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
30574640|NCT00433511|58582802|FG000|Step 2 (Arm D)|Other complicating disease|0|||
30574641|NCT00433511|58582803|FG001|Step 2 (Arm D)|Other complicating disease|0|||
30574642|NCT00433511|58582804|FG002|Step 2 (Arm D)|Other complicating disease|3|||
30574643|NCT00433511|58582802|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
30574644|NCT00433511|58582803|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
30574645|NCT00433511|58582804|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
30574646|NCT00433511|58582802|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
30574647|NCT00433511|58582803|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
30574648|NCT00433511|58582804|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
30574649|NCT00433511|58582802|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
30574650|NCT00433511|58582803|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
30574651|NCT00433511|58582804|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
30574652|NCT00433511|58582802|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
30574653|NCT00433511|58582803|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
30574654|NCT00433511|58582804|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
30574655|NCT00324805|58582817|FG000|Overall Study|Adverse Event|62|||
30574656|NCT00324805|58582818|FG001|Overall Study|Adverse Event|203|||
30574657|NCT00324805|58582817|FG000|Overall Study|Progression|7|||
30574658|NCT00324805|58582818|FG001|Overall Study|Progression|35|||
30574659|NCT00324805|58582817|FG000|Overall Study|Withdrawal by Subject|51|||
30574660|NCT00324805|58582818|FG001|Overall Study|Withdrawal by Subject|174|||
30574661|NCT00324805|58582817|FG000|Overall Study|Death|6|||
30574662|NCT00324805|58582818|FG001|Overall Study|Death|9|||
30574663|NCT00324805|58582817|FG000|Overall Study|Alternative therapy|4|||
30574664|NCT00324805|58582818|FG001|Overall Study|Alternative therapy|8|||
30574665|NCT00324805|58582817|FG000|Overall Study|Other complicating disease|1|||
30574666|NCT00324805|58582818|FG001|Overall Study|Other complicating disease|9|||
30574667|NCT00324805|58582817|FG000|Overall Study|Other reasons|7|||
30574668|NCT00324805|58582818|FG001|Overall Study|Other reasons|26|||
30574669|NCT00324805|58582817|FG000|Overall Study|Other|0|||
30574670|NCT00324805|58582818|FG001|Overall Study|Other|2|||
30574671|NCT00324805|58582817|FG000|Overall Study|Did not start therapy|12|||
30574672|NCT00324805|58582818|FG001|Overall Study|Did not start therapy|17|||
30574673|NCT00098475|58582843|FG000|Step 1|Progressive disease|33|||
30574674|NCT00098475|58582844|FG001|Step 1|Progressive disease|35|||
30574675|NCT00098475|58582845|FG002|Step 1|Progressive disease|2|||
30574676|NCT00098475|58582846|FG003|Step 1|Progressive disease|1|||
30574677|NCT00098475|58582843|FG000|Step 1|Adverse Event|56|||
30574678|NCT00098475|58582844|FG001|Step 1|Adverse Event|37|||
30574679|NCT00098475|58582845|FG002|Step 1|Adverse Event|0|||
30574680|NCT00098475|58582846|FG003|Step 1|Adverse Event|1|||
30574681|NCT00098475|58582843|FG000|Step 1|Death|8|||
30574682|NCT00098475|58582844|FG001|Step 1|Death|5|||
30574683|NCT00098475|58582845|FG002|Step 1|Death|0|||
30574684|NCT00098475|58582846|FG003|Step 1|Death|1|||
30574685|NCT00098475|58582843|FG000|Step 1|Withdrawal by Subject|14|||
30574686|NCT00098475|58582844|FG001|Step 1|Withdrawal by Subject|11|||
30574687|NCT00098475|58582845|FG002|Step 1|Withdrawal by Subject|0|||
30574688|NCT00098475|58582846|FG003|Step 1|Withdrawal by Subject|0|||
30574689|NCT00098475|58582843|FG000|Step 1|Physician Decision|5|||
30574690|NCT00098475|58582844|FG001|Step 1|Physician Decision|2|||
30855299|NCT02598128|58882886|FG000|Period A: Days -7 to -1|Adverse Event|1|||
30574691|NCT00098475|58582845|FG002|Step 1|Physician Decision|0|||
30574692|NCT00098475|58582846|FG003|Step 1|Physician Decision|0|||
30574693|NCT00098475|58582843|FG000|Step 1|Alternative therapy|31|||
30574694|NCT00098475|58582844|FG001|Step 1|Alternative therapy|43|||
30574695|NCT00098475|58582845|FG002|Step 1|Alternative therapy|1|||
30574696|NCT00098475|58582846|FG003|Step 1|Alternative therapy|0|||
30574697|NCT00098475|58582843|FG000|Step 1|Other disease|2|||
30574698|NCT00098475|58582844|FG001|Step 1|Other disease|1|||
30574699|NCT00098475|58582845|FG002|Step 1|Other disease|1|||
30574700|NCT00098475|58582846|FG003|Step 1|Other disease|0|||
30574701|NCT00098475|58582843|FG000|Step 1|Never started treatment|0|||
30574702|NCT00098475|58582844|FG001|Step 1|Never started treatment|2|||
30574703|NCT00098475|58582845|FG002|Step 1|Never started treatment|0|||
30574704|NCT00098475|58582846|FG003|Step 1|Never started treatment|0|||
30574705|NCT00098475|58582843|FG000|Step 1|Still on treatment as of this analysis|14|||
30574706|NCT00098475|58582844|FG001|Step 1|Still on treatment as of this analysis|27|||
30574707|NCT00098475|58582845|FG002|Step 1|Still on treatment as of this analysis|0|||
30574708|NCT00098475|58582846|FG003|Step 1|Still on treatment as of this analysis|0|||
30574709|NCT00098475|58582843|FG000|Step 1|Knee surgery|1|||
30574710|NCT00098475|58582844|FG001|Step 1|Knee surgery|0|||
30574711|NCT00098475|58582845|FG002|Step 1|Knee surgery|0|||
30574712|NCT00098475|58582846|FG003|Step 1|Knee surgery|0|||
30574713|NCT00098475|58582843|FG000|Step 1|Complications|1|||
30574714|NCT00098475|58582844|FG001|Step 1|Complications|0|||
30574715|NCT00098475|58582845|FG002|Step 1|Complications|0|||
30574716|NCT00098475|58582846|FG003|Step 1|Complications|0|||
30574717|NCT00098475|58582843|FG000|Step 1|Cannot comply due to other tx|0|||
30574718|NCT00098475|58582844|FG001|Step 1|Cannot comply due to other tx|1|||
30574719|NCT00098475|58582845|FG002|Step 1|Cannot comply due to other tx|0|||
30574720|NCT00098475|58582846|FG003|Step 1|Cannot comply due to other tx|0|||
30574721|NCT00098475|58582843|FG000|Step 1|Both patient and physician's decision|2|||
30574722|NCT00098475|58582844|FG001|Step 1|Both patient and physician's decision|1|||
30574723|NCT00098475|58582845|FG002|Step 1|Both patient and physician's decision|0|||
30574724|NCT00098475|58582846|FG003|Step 1|Both patient and physician's decision|0|||
30574725|NCT00098475|58582843|FG000|Step 1|Incorrect disease assessment|2|||
30574726|NCT00098475|58582844|FG001|Step 1|Incorrect disease assessment|0|||
30574727|NCT00098475|58582845|FG002|Step 1|Incorrect disease assessment|0|||
30574728|NCT00098475|58582846|FG003|Step 1|Incorrect disease assessment|0|||
30574729|NCT00098475|58582843|FG000|Step 1|Off treatment for > specified timeframe|1|||
30574730|NCT00098475|58582844|FG001|Step 1|Off treatment for > specified timeframe|1|||
30574731|NCT00098475|58582845|FG002|Step 1|Off treatment for > specified timeframe|0|||
30574732|NCT00098475|58582846|FG003|Step 1|Off treatment for > specified timeframe|0|||
30574733|NCT00098475|58582843|FG000|Step 1|Declining performance status|0|||
30574734|NCT00098475|58582844|FG001|Step 1|Declining performance status|1|||
30574735|NCT00098475|58582845|FG002|Step 1|Declining performance status|0|||
30574736|NCT00098475|58582846|FG003|Step 1|Declining performance status|0|||
30574737|NCT00098475|58582843|FG000|Step 1|Insurance issue|0|||
30574738|NCT00098475|58582844|FG001|Step 1|Insurance issue|1|||
30574739|NCT00098475|58582845|FG002|Step 1|Insurance issue|0|||
30574740|NCT00098475|58582846|FG003|Step 1|Insurance issue|0|||
30574741|NCT00098475|58582843|FG000|Step 1|Rising paraprotein|0|||
30574742|NCT00098475|58582844|FG001|Step 1|Rising paraprotein|1|||
30574743|NCT00098475|58582845|FG002|Step 1|Rising paraprotein|0|||
30667867|NCT00705016|58681794|FG000|Overall Study|Protocol Violation|0|||
30667868|NCT00705016|58681795|FG001|Overall Study|Protocol Violation|1|||
30667869|NCT00705016|58681796|FG002|Overall Study|Protocol Violation|1|||
30667870|NCT00705016|58681794|FG000|Overall Study|Withdrawal by Subject|4|||
30667871|NCT00705016|58681795|FG001|Overall Study|Withdrawal by Subject|3|||
30667872|NCT00705016|58681796|FG002|Overall Study|Withdrawal by Subject|2|||
30667873|NCT00705016|58681794|FG000|Overall Study|Progressive Disease|33|||
30667874|NCT00705016|58681795|FG001|Overall Study|Progressive Disease|29|||
30667875|NCT00705016|58681796|FG002|Overall Study|Progressive Disease|33|||
30667876|NCT00705016|58681794|FG000|Overall Study|Symptomatic Deterioration|3|||
30667877|NCT00705016|58681795|FG001|Overall Study|Symptomatic Deterioration|1|||
30667878|NCT00705016|58681796|FG002|Overall Study|Symptomatic Deterioration|1|||
30667879|NCT00705016|58681794|FG000|Overall Study|Other|9|||
30667880|NCT00705016|58681795|FG001|Overall Study|Other|6|||
30667881|NCT00705016|58681796|FG002|Overall Study|Other|6|||
30667882|NCT00595868|58681806|FG000|Overall Study|Lost to Follow-up|45|||
30667883|NCT00595868|58681807|FG001|Overall Study|Lost to Follow-up|50|||
30667884|NCT00856284|58681837|FG000|Overall Study|Hyperglycemic rescue|231|||
30667885|NCT00856284|58681838|FG001|Overall Study|Hyperglycemic rescue|201|||
30667886|NCT00856284|58681839|FG002|Overall Study|Hyperglycemic rescue|235|||
30667887|NCT00856284|58681837|FG000|Overall Study|Adverse Event|60|||
30574744|NCT00098475|58582846|FG003|Step 1|Rising paraprotein|0|||
30574745|NCT00098475|58582843|FG000|Step 1|Referred to other physicians|0|||
30574746|NCT00098475|58582844|FG001|Step 1|Referred to other physicians|1|||
30574747|NCT00098475|58582845|FG002|Step 1|Referred to other physicians|0|||
30574748|NCT00098475|58582846|FG003|Step 1|Referred to other physicians|0|||
30574749|NCT00098475|58582843|FG000|Step 1|Criteria to continue treatment not met|0|||
30667888|NCT00856284|58681838|FG001|Overall Study|Adverse Event|74|||
30667889|NCT00856284|58681839|FG002|Overall Study|Adverse Event|82|||
30667890|NCT00856284|58681837|FG000|Overall Study|Major protocol deviation|24|||
30667891|NCT00856284|58681838|FG001|Overall Study|Major protocol deviation|16|||
30667892|NCT00856284|58681839|FG002|Overall Study|Major protocol deviation|15|||
30667893|NCT00856284|58681837|FG000|Overall Study|Lost to Follow-up|20|||
30667894|NCT00856284|58681838|FG001|Overall Study|Lost to Follow-up|22|||
30574750|NCT00098475|58582844|FG001|Step 1|Criteria to continue treatment not met|1|||
30574751|NCT00098475|58582845|FG002|Step 1|Criteria to continue treatment not met|0|||
30574752|NCT00098475|58582846|FG003|Step 1|Criteria to continue treatment not met|0|||
30574753|NCT00098475|58582843|FG000|Step 1|Misinterpretation of lab data|0|||
30574754|NCT00098475|58582844|FG001|Step 1|Misinterpretation of lab data|1|||
30574755|NCT00098475|58582845|FG002|Step 1|Misinterpretation of lab data|0|||
30574756|NCT00098475|58582846|FG003|Step 1|Misinterpretation of lab data|0|||
30574757|NCT00098475|58582843|FG000|Step 1|Patient fell with fracture|1|||
30574758|NCT00098475|58582844|FG001|Step 1|Patient fell with fracture|0|||
30574759|NCT00098475|58582845|FG002|Step 1|Patient fell with fracture|0|||
30574760|NCT00098475|58582846|FG003|Step 1|Patient fell with fracture|0|||
30574761|NCT00098475|58582843|FG000|Step 1|Not documented|0|||
30574762|NCT00098475|58582844|FG001|Step 1|Not documented|1|||
30574763|NCT00098475|58582845|FG002|Step 1|Not documented|0|||
30574764|NCT00098475|58582846|FG003|Step 1|Not documented|0|||
30574765|NCT00098475|58582843|FG000|Step 2|Disease progression|1|||
30574766|NCT00098475|58582844|FG001|Step 2|Disease progression|4|||
30574767|NCT00098475|58582845|FG002|Step 2|Disease progression|0|||
30574768|NCT00098475|58582846|FG003|Step 2|Disease progression|0|||
30574769|NCT00098475|58582843|FG000|Step 2|Adverse Event|2|||
30574770|NCT00098475|58582844|FG001|Step 2|Adverse Event|0|||
30574771|NCT00098475|58582845|FG002|Step 2|Adverse Event|0|||
30574772|NCT00098475|58582846|FG003|Step 2|Adverse Event|0|||
30574773|NCT00098475|58582843|FG000|Step 2|Withdrawal by Subject|0|||
30574774|NCT00098475|58582844|FG001|Step 2|Withdrawal by Subject|2|||
30574775|NCT00098475|58582845|FG002|Step 2|Withdrawal by Subject|0|||
30574776|NCT00098475|58582846|FG003|Step 2|Withdrawal by Subject|0|||
30574777|NCT00098475|58582843|FG000|Step 2|Physician Decision|0|||
30574778|NCT00098475|58582844|FG001|Step 2|Physician Decision|1|||
30574779|NCT00098475|58582845|FG002|Step 2|Physician Decision|0|||
30574780|NCT00098475|58582846|FG003|Step 2|Physician Decision|0|||
30574781|NCT00098475|58582843|FG000|Step 2|Alternative therapy|1|||
30574782|NCT00098475|58582844|FG001|Step 2|Alternative therapy|2|||
30574783|NCT00098475|58582845|FG002|Step 2|Alternative therapy|0|||
30574784|NCT00098475|58582846|FG003|Step 2|Alternative therapy|0|||
30574785|NCT00098475|58582843|FG000|Step 2|Never started treatment|1|||
30574786|NCT00098475|58582844|FG001|Step 2|Never started treatment|1|||
30574787|NCT00098475|58582845|FG002|Step 2|Never started treatment|0|||
30574788|NCT00098475|58582846|FG003|Step 2|Never started treatment|0|||
30574789|NCT04983589|58582858|FG000|Overall Study|Withdrawal by Subject|0|||
30574790|NCT04983589|58582859|FG001|Overall Study|Withdrawal by Subject|3|||
30574791|NCT04983589|58582858|FG000|Overall Study|COVID-19 Infection|1|||
30574792|NCT04983589|58582859|FG001|Overall Study|COVID-19 Infection|0|||
30574793|NCT04983589|58582858|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
30574794|NCT04983589|58582859|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
30574795|NCT04556591|58582879|FG000|Overall Study|Lost to Follow-up|1|||
30574796|NCT04556591|58582880|FG001|Overall Study|Lost to Follow-up|0|||
30574797|NCT04556591|58582879|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
30574798|NCT04556591|58582880|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
30574799|NCT04428034|58582889|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
30574800|NCT04364984|58582900|FG000|Overall Study|Death|2|||
30574801|NCT04364984|58582901|FG001|Overall Study|Death|2|||
30574802|NCT04364984|58582902|FG002|Overall Study|Death|0|||
30574803|NCT04294095|58582912|FG000|Overall Study|Adverse Event|1|||
30574804|NCT04294095|58582913|FG001|Overall Study|Adverse Event|0|||
30574805|NCT04266028|58582929|FG000|Overall Study|Adverse Event|0|||
30574806|NCT04266028|58582930|FG001|Overall Study|Adverse Event|0|||
30574807|NCT04266028|58582931|FG002|Overall Study|Adverse Event|1|||
30574808|NCT04266028|58582932|FG003|Overall Study|Adverse Event|0|||
30574809|NCT04266028|58582933|FG004|Overall Study|Adverse Event|1|||
30574810|NCT04266028|58582934|FG005|Overall Study|Adverse Event|0|||
30574811|NCT04266028|58582935|FG006|Overall Study|Adverse Event|2|||
30574812|NCT04266028|58582936|FG007|Overall Study|Adverse Event|0|||
30574813|NCT04266028|58582929|FG000|Overall Study|temporary halt of the study|0|||
30574814|NCT04266028|58582930|FG001|Overall Study|temporary halt of the study|0|||
30574815|NCT04266028|58582931|FG002|Overall Study|temporary halt of the study|0|||
30574816|NCT04266028|58582932|FG003|Overall Study|temporary halt of the study|0|||
30574817|NCT04266028|58582933|FG004|Overall Study|temporary halt of the study|0|||
30574818|NCT04266028|58582934|FG005|Overall Study|temporary halt of the study|0|||
30574819|NCT04266028|58582935|FG006|Overall Study|temporary halt of the study|2|||
30574820|NCT04266028|58582936|FG007|Overall Study|temporary halt of the study|1|||
30574821|NCT04266028|58582929|FG000|Overall Study|Onset of birch pollen season|0|||
30574822|NCT04266028|58582930|FG001|Overall Study|Onset of birch pollen season|0|||
30574823|NCT04266028|58582931|FG002|Overall Study|Onset of birch pollen season|0|||
30574824|NCT04266028|58582932|FG003|Overall Study|Onset of birch pollen season|0|||
30574825|NCT04266028|58582933|FG004|Overall Study|Onset of birch pollen season|1|||
30574826|NCT04266028|58582934|FG005|Overall Study|Onset of birch pollen season|0|||
30855300|NCT02598128|58882887|FG001|Period A: Days -7 to -1|Adverse Event|0|||
30574827|NCT04266028|58582935|FG006|Overall Study|Onset of birch pollen season|0|||
30574828|NCT04266028|58582936|FG007|Overall Study|Onset of birch pollen season|0|||
30574829|NCT03994731|58582986|FG000|Pegloticase + IMM Period|Death|2|||
30574830|NCT03994731|58582987|FG001|Pegloticase + IMM Period|Death|0|||
30574831|NCT03994731|58582986|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
30574832|NCT03994731|58582987|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
30574833|NCT03994731|58582986|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
30574834|NCT03994731|58582987|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
30855301|NCT02598128|58882888|FG002|Period A: Days -7 to -1|Adverse Event|0|||
30855302|NCT02598128|58882889|FG003|Period A: Days -7 to -1|Adverse Event|0|||
30855303|NCT02788175|58882901|FG000|Overall Study|Protocol Violation|3|||
30855304|NCT02788175|58882901|FG000|Overall Study|Withdrawal by Subject|4|||
30855305|NCT02788175|58882901|FG000|Overall Study|Ineligible prior to study agent|6|||
30855306|NCT02787083|58882907|FG000|Overall Study|Adverse Event|1|||
30855307|NCT02787083|58882908|FG001|Overall Study|Adverse Event|0|||
30855308|NCT02787083|58882907|FG000|Overall Study|Withdrawal by Subject|2|||
30574843|NCT03801915|58583008|FG000|Overall Study|Screen failure|0|||
30574844|NCT03801915|58583009|FG001|Overall Study|Screen failure|0|||
30574845|NCT03801915|58583010|FG002|Overall Study|Screen failure|1|||
30574846|NCT03801915|58583008|FG000|Overall Study|Ineligible|1|||
30574847|NCT03801915|58583009|FG001|Overall Study|Ineligible|0|||
30574848|NCT03801915|58583010|FG002|Overall Study|Ineligible|0|||
30574849|NCT03801915|58583008|FG000|Overall Study|Physician Decision|2|||
30574850|NCT03801915|58583009|FG001|Overall Study|Physician Decision|1|||
30574851|NCT03801915|58583010|FG002|Overall Study|Physician Decision|0|||
30574852|NCT03581305|58583024|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
30574853|NCT03581305|58583025|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
30574854|NCT03581305|58583024|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
30574855|NCT03581305|58583025|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
30574856|NCT03581305|58583024|FG000|Serotonergic Study|Withdrawal by Subject|5|||
30574857|NCT03581305|58583025|FG001|Serotonergic Study|Withdrawal by Subject|1|||
30574858|NCT03556202|58583036|FG000|Extension Treatment Period|Adverse Event|18|||
30574859|NCT03556202|58583037|FG001|Extension Treatment Period|Adverse Event|14|||
30574860|NCT03556202|58583038|FG002|Extension Treatment Period|Adverse Event|9|||
30574861|NCT03556202|58583036|FG000|Extension Treatment Period|Death|2|||
30574862|NCT03556202|58583037|FG001|Extension Treatment Period|Death|6|||
30574863|NCT03556202|58583038|FG002|Extension Treatment Period|Death|0|||
30574864|NCT03556202|58583036|FG000|Extension Treatment Period|Lack of Efficacy|5|||
30574865|NCT03556202|58583037|FG001|Extension Treatment Period|Lack of Efficacy|12|||
30574866|NCT03556202|58583038|FG002|Extension Treatment Period|Lack of Efficacy|18|||
30574867|NCT03556202|58583036|FG000|Extension Treatment Period|Lost to Follow-up|9|||
30574868|NCT03556202|58583037|FG001|Extension Treatment Period|Lost to Follow-up|20|||
30574869|NCT03556202|58583038|FG002|Extension Treatment Period|Lost to Follow-up|2|||
30574870|NCT03556202|58583036|FG000|Extension Treatment Period|Pregnancy|2|||
30574871|NCT03556202|58583037|FG001|Extension Treatment Period|Pregnancy|4|||
30574872|NCT03556202|58583038|FG002|Extension Treatment Period|Pregnancy|3|||
30574873|NCT03556202|58583036|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
30574874|NCT03556202|58583037|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
30574875|NCT03556202|58583038|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
30574876|NCT03556202|58583036|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
30574877|NCT03556202|58583037|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
30574878|NCT03556202|58583038|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
30574879|NCT03556202|58583036|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
30574880|NCT03556202|58583037|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
30574881|NCT03556202|58583038|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
30574882|NCT03556202|58583036|FG000|Extension Treatment Period|Physician Decision|0|||
30574883|NCT03556202|58583037|FG001|Extension Treatment Period|Physician Decision|8|||
30574884|NCT03556202|58583038|FG002|Extension Treatment Period|Physician Decision|2|||
30574885|NCT03556202|58583036|FG000|Extension Treatment Period|Protocol Violation|0|||
30574886|NCT03556202|58583037|FG001|Extension Treatment Period|Protocol Violation|1|||
30855309|NCT02787083|58882908|FG001|Overall Study|Withdrawal by Subject|2|||
30855310|NCT02787863|58882922|FG000|Overall Study|Death|1|||
30855311|NCT02787863|58882923|FG001|Overall Study|Death|0|||
30855312|NCT02787863|58882924|FG002|Overall Study|Death|1|||
30574887|NCT03556202|58583038|FG002|Extension Treatment Period|Protocol Violation|1|||
30574888|NCT03556202|58583036|FG000|Extension Treatment Period|Sponsor Decision|0|||
30574889|NCT03556202|58583037|FG001|Extension Treatment Period|Sponsor Decision|1|||
30574890|NCT03556202|58583038|FG002|Extension Treatment Period|Sponsor Decision|0|||
30574891|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
30574892|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
30574893|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
30574894|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Death|1|||
30855313|NCT02787863|58882925|FG003|Overall Study|Death|0|||
30855314|NCT02787863|58882926|FG004|Overall Study|Death|0|||
30574895|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Death|0|||
30574896|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Death|0|||
30574897|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
30574898|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
30574899|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
30574900|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
30574901|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
30574902|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
30574903|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
30574904|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
30574905|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
30574906|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
30574907|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
30574908|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
30574909|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
30574910|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
30574911|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
30574912|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
30574913|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
30574914|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
30574915|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
30574916|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
30574917|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
30574918|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
30574919|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
30574920|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
30574921|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
30574922|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
30574923|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
30574924|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
30574925|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
30574926|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
30574927|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
30574928|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
30574929|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
30574930|NCT03556202|58583036|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
30574931|NCT03556202|58583037|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
30574932|NCT03556202|58583038|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
30574933|NCT03541174|58583052|FG000|Part 1 Double-Blind|Adverse Event|6|||
30574934|NCT03541174|58583053|FG001|Part 1 Double-Blind|Adverse Event|5|||
30574935|NCT03541174|58583054|FG002|Part 1 Double-Blind|Adverse Event|2|||
30574936|NCT03541174|58583055|FG003|Part 1 Double-Blind|Adverse Event|0|||
30574937|NCT03541174|58583056|FG004|Part 1 Double-Blind|Adverse Event|0|||
30574938|NCT03541174|58583057|FG005|Part 1 Double-Blind|Adverse Event|0|||
30574939|NCT03541174|58583052|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
30574940|NCT03541174|58583053|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
30574941|NCT03541174|58583054|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
30574942|NCT03541174|58583055|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
30574943|NCT03541174|58583056|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
30574944|NCT03541174|58583057|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
30574945|NCT03541174|58583052|FG000|Part 1 Double-Blind|Other reasons|3|||
30574946|NCT03541174|58583053|FG001|Part 1 Double-Blind|Other reasons|2|||
30574947|NCT03541174|58583054|FG002|Part 1 Double-Blind|Other reasons|3|||
30574948|NCT03541174|58583055|FG003|Part 1 Double-Blind|Other reasons|0|||
30574949|NCT03541174|58583056|FG004|Part 1 Double-Blind|Other reasons|0|||
30574950|NCT03541174|58583057|FG005|Part 1 Double-Blind|Other reasons|0|||
30574951|NCT03541174|58583052|FG000|Part 2 Single-Blind|Adverse Event|0|||
30574952|NCT03541174|58583053|FG001|Part 2 Single-Blind|Adverse Event|0|||
30574953|NCT03541174|58583054|FG002|Part 2 Single-Blind|Adverse Event|0|||
30574954|NCT03541174|58583055|FG003|Part 2 Single-Blind|Adverse Event|25|||
30574955|NCT03541174|58583056|FG004|Part 2 Single-Blind|Adverse Event|0|||
30574956|NCT03541174|58583057|FG005|Part 2 Single-Blind|Adverse Event|0|||
30574957|NCT03541174|58583052|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
30574958|NCT03541174|58583053|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
30574959|NCT03541174|58583054|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
30574960|NCT03541174|58583055|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
30574961|NCT03541174|58583056|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
30574962|NCT03541174|58583057|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
30855315|NCT02787863|58882927|FG005|Overall Study|Death|0|||
30574963|NCT03541174|58583052|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
30855316|NCT02787863|58882928|FG006|Overall Study|Death|0|||
30574964|NCT03541174|58583053|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
30574965|NCT03541174|58583054|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
30574966|NCT03541174|58583055|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
30574967|NCT03541174|58583056|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
30574968|NCT03541174|58583057|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
30574969|NCT03541174|58583052|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
30574970|NCT03541174|58583053|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
30574971|NCT03541174|58583054|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
30574972|NCT03541174|58583055|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
30574973|NCT03541174|58583056|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
30574974|NCT03541174|58583057|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
30574975|NCT03541174|58583052|FG000|Part 2 Single-Blind|Death|0|||
30574976|NCT03541174|58583053|FG001|Part 2 Single-Blind|Death|0|||
30574977|NCT03541174|58583054|FG002|Part 2 Single-Blind|Death|0|||
30574978|NCT03541174|58583055|FG003|Part 2 Single-Blind|Death|5|||
30574979|NCT03541174|58583056|FG004|Part 2 Single-Blind|Death|0|||
30574980|NCT03541174|58583057|FG005|Part 2 Single-Blind|Death|0|||
30574981|NCT03541174|58583052|FG000|Part 2 Single-Blind|Pregnancy|0|||
30574982|NCT03541174|58583053|FG001|Part 2 Single-Blind|Pregnancy|0|||
30574983|NCT03541174|58583054|FG002|Part 2 Single-Blind|Pregnancy|0|||
30574984|NCT03541174|58583055|FG003|Part 2 Single-Blind|Pregnancy|1|||
30574985|NCT03541174|58583056|FG004|Part 2 Single-Blind|Pregnancy|0|||
30574986|NCT03541174|58583057|FG005|Part 2 Single-Blind|Pregnancy|0|||
30574987|NCT03541174|58583052|FG000|Part 2 Single-Blind|Other reasons|0|||
30574988|NCT03541174|58583053|FG001|Part 2 Single-Blind|Other reasons|0|||
30574989|NCT03541174|58583054|FG002|Part 2 Single-Blind|Other reasons|0|||
30574990|NCT03541174|58583055|FG003|Part 2 Single-Blind|Other reasons|32|||
30574991|NCT03541174|58583056|FG004|Part 2 Single-Blind|Other reasons|0|||
30574992|NCT03541174|58583057|FG005|Part 2 Single-Blind|Other reasons|0|||
30574993|NCT03541174|58583052|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
30574994|NCT03541174|58583053|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
30574995|NCT03541174|58583054|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
30574996|NCT03541174|58583055|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
30574997|NCT03541174|58583056|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
30574998|NCT03541174|58583057|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
30574999|NCT03541174|58583052|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
30575000|NCT03541174|58583053|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
30575001|NCT03541174|58583054|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
30575002|NCT03541174|58583055|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
30575003|NCT03541174|58583056|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
30575004|NCT03541174|58583057|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
30575005|NCT03541174|58583052|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
30575006|NCT03541174|58583053|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
30575007|NCT03541174|58583054|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
30575008|NCT03541174|58583055|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
30575009|NCT03541174|58583056|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
30575010|NCT03541174|58583057|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
30575011|NCT03541174|58583052|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
30575012|NCT03541174|58583053|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
30575013|NCT03541174|58583054|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
30575014|NCT03541174|58583055|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
30575015|NCT03541174|58583056|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
30575016|NCT03541174|58583057|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
30575017|NCT03541174|58583052|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
30575018|NCT03541174|58583053|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
30575019|NCT03541174|58583054|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
30575020|NCT03541174|58583055|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
30575021|NCT03541174|58583056|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
30575022|NCT03541174|58583057|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
30575023|NCT03289039|58583089|FG000|Overall Study|Withdrawal by Subject|0|||
30575024|NCT03289039|58583090|FG001|Overall Study|Withdrawal by Subject|1|||
30575025|NCT03289039|58583089|FG000|Overall Study|Became ineligible prior to treatment start|0|||
30575026|NCT03289039|58583090|FG001|Overall Study|Became ineligible prior to treatment start|1|||
30575027|NCT03289039|58583089|FG000|Overall Study|progressed before treatment start|1|||
30575028|NCT03289039|58583090|FG001|Overall Study|progressed before treatment start|0|||
30575029|NCT03281304|58583098|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
30575030|NCT03281304|58583099|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
30575031|NCT03281304|58583098|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
30575032|NCT03281304|58583099|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
30575033|NCT03281304|58583098|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
30575034|NCT03281304|58583099|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
30667895|NCT00856284|58681839|FG002|Overall Study|Lost to Follow-up|28|||
30575035|NCT03281304|58583098|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
30575036|NCT03281304|58583099|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
30575037|NCT03281304|58583098|FG000|Treatment Phase (up to 42 Months)|Death|0|||
30575038|NCT03281304|58583099|FG001|Treatment Phase (up to 42 Months)|Death|1|||
30575039|NCT03281304|58583098|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
30575040|NCT03281304|58583099|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
30575041|NCT03281304|58583098|FG000|Treatment Phase (up to 42 Months)|Other|0|||
30575042|NCT03281304|58583099|FG001|Treatment Phase (up to 42 Months)|Other|2|||
30575043|NCT03281304|58583098|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
30575044|NCT03281304|58583099|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
30575045|NCT03204305|58583108|FG000|Overall Study|Lost to Follow-up|6|||
30575046|NCT03204305|58583109|FG001|Overall Study|Lost to Follow-up|4|||
30575047|NCT03204305|58583110|FG002|Overall Study|Lost to Follow-up|0|||
30575048|NCT03204305|58583111|FG003|Overall Study|Lost to Follow-up|0|||
30575049|NCT03204305|58583108|FG000|Overall Study|Physician Decision|1|||
30575050|NCT03204305|58583109|FG001|Overall Study|Physician Decision|0|||
30575051|NCT03204305|58583110|FG002|Overall Study|Physician Decision|0|||
30575052|NCT03204305|58583111|FG003|Overall Study|Physician Decision|0|||
30575053|NCT03204305|58583108|FG000|Overall Study|failure to place arterial line|2|||
30575054|NCT03204305|58583109|FG001|Overall Study|failure to place arterial line|1|||
30575055|NCT03204305|58583110|FG002|Overall Study|failure to place arterial line|0|||
30575056|NCT03204305|58583111|FG003|Overall Study|failure to place arterial line|0|||
30575057|NCT03204305|58583108|FG000|Overall Study|Withdrawal by Subject|2|||
30575058|NCT03204305|58583109|FG001|Overall Study|Withdrawal by Subject|0|||
30575059|NCT03204305|58583110|FG002|Overall Study|Withdrawal by Subject|0|||
30575060|NCT03204305|58583111|FG003|Overall Study|Withdrawal by Subject|0|||
30575061|NCT03200717|58583123|FG000|Overall Study|Progressive disease|24|||
30575062|NCT03200717|58583124|FG001|Overall Study|Progressive disease|5|||
30575063|NCT03200717|58583123|FG000|Overall Study|Adverse Event|11|||
30575064|NCT03200717|58583124|FG001|Overall Study|Adverse Event|8|||
30575065|NCT03200717|58583123|FG000|Overall Study|Physician Decision|3|||
30575066|NCT03200717|58583124|FG001|Overall Study|Physician Decision|2|||
30575067|NCT03200717|58583123|FG000|Overall Study|Death|2|||
30575068|NCT03200717|58583124|FG001|Overall Study|Death|0|||
30575069|NCT03200717|58583123|FG000|Overall Study|Subject/Guardian Decision|1|||
30575070|NCT03200717|58583124|FG001|Overall Study|Subject/Guardian Decision|0|||
30575071|NCT03105700|58583133|FG000|Overall Study|screen fail|3|||
30575072|NCT03105700|58583133|FG000|Overall Study|Lost to Follow-up|4|||
30575073|NCT02738853|58583156|FG000|Enrollment|Inclusion/Exclusion not met|21|||
30575074|NCT02738853|58583156|FG000|Enrollment|Withdrawal by Subject|3|||
30780253|NCT03919669|58792068|FG002|Overall Study|Withdrawal by Subject|0|||
30575075|NCT02738853|58583156|FG000|Enrollment|Subject treated with commercially available device|6|||
30575076|NCT02738853|58583156|FG000|Enrollment|Study Enrollment Closed|3|||
30575077|NCT02738853|58583156|FG000|Procedure|Death|1|||
30575078|NCT02738853|58583156|FG000|1 Month|Death|2|||
30575079|NCT02738853|58583156|FG000|6 Month|Death|4|||
30575080|NCT02738853|58583156|FG000|6 Month|Withdrawal by Subject|2|||
30575081|NCT02738853|58583156|FG000|1 Year|Death|6|||
30575082|NCT02738853|58583156|FG000|1 Year|Withdrawal by Subject|1|||
30575083|NCT02738853|58583156|FG000|2 Year|Death|2|||
30575084|NCT02738853|58583156|FG000|2 Year|Lost to Follow-up|1|||
30575085|NCT02738853|58583156|FG000|3 Year|Death|2|||
30575086|NCT02738853|58583156|FG000|3 Year|Withdrawal by Subject|1|||
30575087|NCT02738853|58583156|FG000|4 Year|Death|9|||
30575088|NCT02738853|58583156|FG000|5 Year|Lost to Follow-up|4|||
30575089|NCT02358538|58583164|FG000|Through Week 26|Adverse Event|0|||
30575090|NCT02358538|58583165|FG001|Through Week 26|Adverse Event|1|||
30575091|NCT02358538|58583166|FG002|Through Week 26|Adverse Event|1|||
30780254|NCT03772665|58792079|FG000|Overall Study|Protocol Violation|1|||
30780255|NCT03772665|58792080|FG001|Overall Study|Protocol Violation|0|||
30575092|NCT02358538|58583167|FG003|Through Week 26|Adverse Event|2|||
30575093|NCT02358538|58583164|FG000|Through Week 26|Lack of Efficacy|1|||
30575094|NCT02358538|58583165|FG001|Through Week 26|Lack of Efficacy|1|||
30575095|NCT02358538|58583166|FG002|Through Week 26|Lack of Efficacy|3|||
30667896|NCT00856284|58681837|FG000|Overall Study|Voluntary withdrawal|48|||
30575096|NCT02358538|58583167|FG003|Through Week 26|Lack of Efficacy|3|||
30575097|NCT02358538|58583164|FG000|Through Week 26|Withdrawal by Subject|1|||
30575098|NCT02358538|58583165|FG001|Through Week 26|Withdrawal by Subject|0|||
30575099|NCT02358538|58583166|FG002|Through Week 26|Withdrawal by Subject|0|||
30575100|NCT02358538|58583167|FG003|Through Week 26|Withdrawal by Subject|0|||
30575101|NCT02358538|58583164|FG000|Through Week 26|Non-Compliance|0|||
30575102|NCT02358538|58583165|FG001|Through Week 26|Non-Compliance|0|||
30780256|NCT03594110|58792097|FG000|Overall Study|Participant concerned about study treatment|23|||
30575103|NCT02358538|58583166|FG002|Through Week 26|Non-Compliance|1|||
30575104|NCT02358538|58583167|FG003|Through Week 26|Non-Compliance|0|||
30575105|NCT02358538|58583164|FG000|Through Week 26|Family did not see benefit from IP|1|||
30575106|NCT02358538|58583165|FG001|Through Week 26|Family did not see benefit from IP|0|||
30667897|NCT00856284|58681838|FG001|Overall Study|Voluntary withdrawal|52|||
30575107|NCT02358538|58583166|FG002|Through Week 26|Family did not see benefit from IP|0|||
30575108|NCT02358538|58583167|FG003|Through Week 26|Family did not see benefit from IP|0|||
30575109|NCT02358538|58583164|FG000|52 Week Extension Period|Lack of Efficacy|0|||
30575110|NCT02358538|58583165|FG001|52 Week Extension Period|Lack of Efficacy|0|||
30575111|NCT02358538|58583166|FG002|52 Week Extension Period|Lack of Efficacy|2|||
30575112|NCT02358538|58583167|FG003|52 Week Extension Period|Lack of Efficacy|4|||
30575113|NCT02056119|58583202|FG000|Overall Study|Death|1|||
30575114|NCT02056119|58583203|FG001|Overall Study|Death|2|||
30575115|NCT02056119|58583202|FG000|Overall Study|Intubated for less than 24 hrs|2|||
30575116|NCT02056119|58583203|FG001|Overall Study|Intubated for less than 24 hrs|7|||
30575117|NCT02056119|58583202|FG000|Overall Study|No aerosol treatments were given.|3|||
30575118|NCT02056119|58583203|FG001|Overall Study|No aerosol treatments were given.|2|||
30575119|NCT02056119|58583202|FG000|Overall Study|Received Metaneb treatment|0|||
30575120|NCT02056119|58583203|FG001|Overall Study|Received Metaneb treatment|2|||
30575121|NCT02056119|58583202|FG000|Overall Study|Protocol Violation|4|||
30575122|NCT02056119|58583203|FG001|Overall Study|Protocol Violation|7|||
30575123|NCT02038452|58583211|FG000|Overall Study|Withdrawal by Subject|7|||
30575124|NCT02038452|58583212|FG001|Overall Study|Withdrawal by Subject|9|||
30575125|NCT02038452|58583211|FG000|Overall Study|Lost to Follow-up|31|||
30575126|NCT02038452|58583212|FG001|Overall Study|Lost to Follow-up|28|||
30575127|NCT01238172|58583251|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
30575128|NCT01238172|58583252|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
30575129|NCT01238172|58583251|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
30575130|NCT01238172|58583252|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
30575131|NCT00967005|58583260|FG000|Overall Study|Lost to Follow-up|7|||
30575132|NCT00967005|58583261|FG001|Overall Study|Lost to Follow-up|10|||
30575133|NCT00203996|58583319|FG000|Overall Study|Lost to Follow-up|0|||
30575134|NCT00203996|58583320|FG001|Overall Study|Lost to Follow-up|0|||
30575135|NCT00203996|58583321|FG002|Overall Study|Lost to Follow-up|0|||
30575136|NCT00203996|58583322|FG003|Overall Study|Lost to Follow-up|1|||
30575137|NCT00203996|58583323|FG004|Overall Study|Lost to Follow-up|0|||
30575138|NCT00203996|58583324|FG005|Overall Study|Lost to Follow-up|0|||
30575139|NCT00203996|58583325|FG006|Overall Study|Lost to Follow-up|0|||
30575140|NCT00203996|58583326|FG007|Overall Study|Lost to Follow-up|0|||
30575141|NCT00203996|58583327|FG008|Overall Study|Lost to Follow-up|0|||
30575142|NCT00203996|58583328|FG009|Overall Study|Lost to Follow-up|0|||
30575143|NCT00203996|58583319|FG000|Overall Study|Protocol Violation|0|||
30575144|NCT00203996|58583320|FG001|Overall Study|Protocol Violation|0|||
30575145|NCT00203996|58583321|FG002|Overall Study|Protocol Violation|0|||
30575146|NCT00203996|58583322|FG003|Overall Study|Protocol Violation|6|||
30575147|NCT00203996|58583323|FG004|Overall Study|Protocol Violation|1|||
30575148|NCT00203996|58583324|FG005|Overall Study|Protocol Violation|0|||
30575149|NCT00203996|58583325|FG006|Overall Study|Protocol Violation|0|||
30575150|NCT00203996|58583326|FG007|Overall Study|Protocol Violation|0|||
30575151|NCT00203996|58583327|FG008|Overall Study|Protocol Violation|0|||
30575152|NCT00203996|58583328|FG009|Overall Study|Protocol Violation|0|||
30575153|NCT00203996|58583319|FG000|Overall Study|Physician Decision|0|||
30575154|NCT00203996|58583320|FG001|Overall Study|Physician Decision|0|||
30575155|NCT00203996|58583321|FG002|Overall Study|Physician Decision|0|||
30575156|NCT00203996|58583322|FG003|Overall Study|Physician Decision|2|||
30575157|NCT00203996|58583323|FG004|Overall Study|Physician Decision|0|||
30575158|NCT00203996|58583324|FG005|Overall Study|Physician Decision|0|||
30575159|NCT00203996|58583325|FG006|Overall Study|Physician Decision|0|||
30575160|NCT00203996|58583326|FG007|Overall Study|Physician Decision|0|||
30575161|NCT00203996|58583327|FG008|Overall Study|Physician Decision|0|||
30575162|NCT00203996|58583328|FG009|Overall Study|Physician Decision|1|||
30575163|NCT00203996|58583319|FG000|Overall Study|CPAP machine malfunction|0|||
30575164|NCT00203996|58583320|FG001|Overall Study|CPAP machine malfunction|0|||
30575165|NCT00203996|58583321|FG002|Overall Study|CPAP machine malfunction|0|||
30575166|NCT00203996|58583322|FG003|Overall Study|CPAP machine malfunction|1|||
30575167|NCT00203996|58583323|FG004|Overall Study|CPAP machine malfunction|0|||
30575168|NCT00203996|58583324|FG005|Overall Study|CPAP machine malfunction|0|||
30575169|NCT00203996|58583325|FG006|Overall Study|CPAP machine malfunction|0|||
30575170|NCT00203996|58583326|FG007|Overall Study|CPAP machine malfunction|0|||
30575171|NCT00203996|58583327|FG008|Overall Study|CPAP machine malfunction|0|||
30575172|NCT00203996|58583328|FG009|Overall Study|CPAP machine malfunction|0|||
30575173|NCT00203996|58583319|FG000|Overall Study|Scheduling issue|0|||
30575174|NCT00203996|58583320|FG001|Overall Study|Scheduling issue|0|||
30575175|NCT00203996|58583321|FG002|Overall Study|Scheduling issue|0|||
30575176|NCT00203996|58583322|FG003|Overall Study|Scheduling issue|0|||
30575177|NCT00203996|58583323|FG004|Overall Study|Scheduling issue|0|||
30575178|NCT00203996|58583324|FG005|Overall Study|Scheduling issue|0|||
30575179|NCT00203996|58583325|FG006|Overall Study|Scheduling issue|0|||
30575180|NCT00203996|58583326|FG007|Overall Study|Scheduling issue|2|||
30575181|NCT00203996|58583327|FG008|Overall Study|Scheduling issue|0|||
30575182|NCT00203996|58583328|FG009|Overall Study|Scheduling issue|0|||
30575183|NCT02014558|58583357|FG000|Overall Study|Never Received Study Drug|0|||
30575184|NCT02014558|58583358|FG001|Overall Study|Never Received Study Drug|0|||
30575185|NCT02014558|58583359|FG002|Overall Study|Never Received Study Drug|0|||
30575186|NCT02014558|58583360|FG003|Overall Study|Never Received Study Drug|0|||
30575187|NCT02014558|58583361|FG004|Overall Study|Never Received Study Drug|1|||
30575188|NCT02014558|58583362|FG005|Overall Study|Never Received Study Drug|0|||
30575189|NCT02014558|58583363|FG006|Overall Study|Never Received Study Drug|1|||
30575190|NCT02014558|58583364|FG007|Overall Study|Never Received Study Drug|0|||
30575191|NCT02014558|58583365|FG008|Overall Study|Never Received Study Drug|2|||
30575192|NCT02014558|58583366|FG009|Overall Study|Never Received Study Drug|0|||
30575193|NCT02014558|58583367|FG010|Overall Study|Never Received Study Drug|2|||
30575194|NCT02014558|58583368|FG011|Overall Study|Never Received Study Drug|2|||
30575195|NCT02014558|58583369|FG012|Overall Study|Never Received Study Drug|0|||
30575196|NCT02014558|58583357|FG000|Overall Study|Adverse Event|0|||
30575197|NCT02014558|58583358|FG001|Overall Study|Adverse Event|0|||
30575198|NCT02014558|58583359|FG002|Overall Study|Adverse Event|0|||
30575199|NCT02014558|58583360|FG003|Overall Study|Adverse Event|0|||
30575200|NCT02014558|58583361|FG004|Overall Study|Adverse Event|1|||
30575201|NCT02014558|58583362|FG005|Overall Study|Adverse Event|0|||
30575202|NCT02014558|58583363|FG006|Overall Study|Adverse Event|0|||
30575203|NCT02014558|58583364|FG007|Overall Study|Adverse Event|0|||
30575204|NCT02014558|58583365|FG008|Overall Study|Adverse Event|2|||
30575205|NCT02014558|58583366|FG009|Overall Study|Adverse Event|2|||
30575206|NCT02014558|58583367|FG010|Overall Study|Adverse Event|5|||
30575207|NCT02014558|58583368|FG011|Overall Study|Adverse Event|21|||
30575208|NCT02014558|58583369|FG012|Overall Study|Adverse Event|3|||
30575209|NCT02014558|58583357|FG000|Overall Study|Death|1|||
30575210|NCT02014558|58583358|FG001|Overall Study|Death|0|||
30575211|NCT02014558|58583359|FG002|Overall Study|Death|0|||
30575212|NCT02014558|58583360|FG003|Overall Study|Death|0|||
30575213|NCT02014558|58583361|FG004|Overall Study|Death|0|||
30575214|NCT02014558|58583362|FG005|Overall Study|Death|0|||
30575215|NCT02014558|58583363|FG006|Overall Study|Death|1|||
30575216|NCT02014558|58583364|FG007|Overall Study|Death|1|||
30575217|NCT02014558|58583365|FG008|Overall Study|Death|2|||
30575218|NCT02014558|58583366|FG009|Overall Study|Death|5|||
30575219|NCT02014558|58583367|FG010|Overall Study|Death|5|||
30575220|NCT02014558|58583368|FG011|Overall Study|Death|19|||
30575221|NCT02014558|58583369|FG012|Overall Study|Death|2|||
30575222|NCT02014558|58583357|FG000|Overall Study|Lack of Efficacy|1|||
30575223|NCT02014558|58583358|FG001|Overall Study|Lack of Efficacy|2|||
30575224|NCT02014558|58583359|FG002|Overall Study|Lack of Efficacy|1|||
30575225|NCT02014558|58583360|FG003|Overall Study|Lack of Efficacy|1|||
30575226|NCT02014558|58583361|FG004|Overall Study|Lack of Efficacy|0|||
30575227|NCT02014558|58583362|FG005|Overall Study|Lack of Efficacy|0|||
30575228|NCT02014558|58583363|FG006|Overall Study|Lack of Efficacy|1|||
30575229|NCT02014558|58583364|FG007|Overall Study|Lack of Efficacy|3|||
30575230|NCT02014558|58583365|FG008|Overall Study|Lack of Efficacy|3|||
30575231|NCT02014558|58583366|FG009|Overall Study|Lack of Efficacy|3|||
30575232|NCT02014558|58583367|FG010|Overall Study|Lack of Efficacy|16|||
30575233|NCT02014558|58583368|FG011|Overall Study|Lack of Efficacy|8|||
30575234|NCT02014558|58583369|FG012|Overall Study|Lack of Efficacy|5|||
30575235|NCT02014558|58583357|FG000|Overall Study|Lost to Follow-up|0|||
30575236|NCT02014558|58583358|FG001|Overall Study|Lost to Follow-up|0|||
30575237|NCT02014558|58583359|FG002|Overall Study|Lost to Follow-up|0|||
30575238|NCT02014558|58583360|FG003|Overall Study|Lost to Follow-up|0|||
30575239|NCT02014558|58583361|FG004|Overall Study|Lost to Follow-up|0|||
30575240|NCT02014558|58583362|FG005|Overall Study|Lost to Follow-up|0|||
30575241|NCT02014558|58583363|FG006|Overall Study|Lost to Follow-up|0|||
30575242|NCT02014558|58583364|FG007|Overall Study|Lost to Follow-up|0|||
30575243|NCT02014558|58583365|FG008|Overall Study|Lost to Follow-up|0|||
30575244|NCT02014558|58583366|FG009|Overall Study|Lost to Follow-up|0|||
30855317|NCT02787863|58882929|FG007|Overall Study|Death|0|||
30855318|NCT02787863|58882922|FG000|Overall Study|Withdrawal by Subject|0|||
30855319|NCT02787863|58882923|FG001|Overall Study|Withdrawal by Subject|1|||
30855320|NCT02787863|58882924|FG002|Overall Study|Withdrawal by Subject|1|||
30575245|NCT02014558|58583367|FG010|Overall Study|Lost to Follow-up|1|||
30575246|NCT02014558|58583368|FG011|Overall Study|Lost to Follow-up|0|||
30575247|NCT02014558|58583369|FG012|Overall Study|Lost to Follow-up|0|||
30575248|NCT02014558|58583357|FG000|Overall Study|Progressive Disease|1|||
30575249|NCT02014558|58583358|FG001|Overall Study|Progressive Disease|0|||
30575250|NCT02014558|58583359|FG002|Overall Study|Progressive Disease|1|||
30575251|NCT02014558|58583360|FG003|Overall Study|Progressive Disease|1|||
30575252|NCT02014558|58583361|FG004|Overall Study|Progressive Disease|1|||
30575253|NCT02014558|58583362|FG005|Overall Study|Progressive Disease|2|||
30575254|NCT02014558|58583363|FG006|Overall Study|Progressive Disease|1|||
30575255|NCT02014558|58583364|FG007|Overall Study|Progressive Disease|6|||
30575256|NCT02014558|58583365|FG008|Overall Study|Progressive Disease|5|||
30575257|NCT02014558|58583366|FG009|Overall Study|Progressive Disease|6|||
30575258|NCT02014558|58583367|FG010|Overall Study|Progressive Disease|22|||
30575259|NCT02014558|58583368|FG011|Overall Study|Progressive Disease|31|||
30575260|NCT02014558|58583369|FG012|Overall Study|Progressive Disease|6|||
30575261|NCT02014558|58583357|FG000|Overall Study|Withdrawal by Subject|0|||
30575262|NCT02014558|58583358|FG001|Overall Study|Withdrawal by Subject|0|||
30575263|NCT02014558|58583359|FG002|Overall Study|Withdrawal by Subject|0|||
30575264|NCT02014558|58583360|FG003|Overall Study|Withdrawal by Subject|0|||
30575265|NCT02014558|58583361|FG004|Overall Study|Withdrawal by Subject|1|||
30575266|NCT02014558|58583362|FG005|Overall Study|Withdrawal by Subject|0|||
30575267|NCT02014558|58583363|FG006|Overall Study|Withdrawal by Subject|0|||
30575268|NCT02014558|58583364|FG007|Overall Study|Withdrawal by Subject|0|||
30575269|NCT02014558|58583365|FG008|Overall Study|Withdrawal by Subject|0|||
30575270|NCT02014558|58583366|FG009|Overall Study|Withdrawal by Subject|2|||
30575271|NCT02014558|58583367|FG010|Overall Study|Withdrawal by Subject|6|||
30575272|NCT02014558|58583368|FG011|Overall Study|Withdrawal by Subject|10|||
30575273|NCT02014558|58583369|FG012|Overall Study|Withdrawal by Subject|0|||
30575274|NCT02014558|58583357|FG000|Overall Study|Miscellaneous|2|||
30575275|NCT02014558|58583358|FG001|Overall Study|Miscellaneous|1|||
30575276|NCT02014558|58583359|FG002|Overall Study|Miscellaneous|1|||
30575277|NCT02014558|58583360|FG003|Overall Study|Miscellaneous|1|||
30575278|NCT02014558|58583361|FG004|Overall Study|Miscellaneous|0|||
30575279|NCT02014558|58583362|FG005|Overall Study|Miscellaneous|1|||
30575280|NCT02014558|58583363|FG006|Overall Study|Miscellaneous|0|||
30575281|NCT02014558|58583364|FG007|Overall Study|Miscellaneous|1|||
30575282|NCT02014558|58583365|FG008|Overall Study|Miscellaneous|1|||
30575283|NCT02014558|58583366|FG009|Overall Study|Miscellaneous|3|||
30575284|NCT02014558|58583367|FG010|Overall Study|Miscellaneous|12|||
30575285|NCT02014558|58583368|FG011|Overall Study|Miscellaneous|11|||
30575286|NCT02014558|58583369|FG012|Overall Study|Miscellaneous|1|||
30575287|NCT02024555|58583424|FG000|Overall Study|Lost to Follow-up|1|||
30575288|NCT02024555|58583425|FG001|Overall Study|Lost to Follow-up|1|||
30575289|NCT02024555|58583424|FG000|Overall Study|Withdrawal by Subject|5|||
30575290|NCT02024555|58583425|FG001|Overall Study|Withdrawal by Subject|1|||
30575291|NCT02040584|58583433|FG000|Overall Study|Adverse Event|13|||
30575292|NCT02040584|58583434|FG001|Overall Study|Adverse Event|6|||
30575293|NCT02040584|58583433|FG000|Overall Study|Protocol Violation|9|||
30575294|NCT02040584|58583434|FG001|Overall Study|Protocol Violation|11|||
30575295|NCT02040584|58583433|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30575296|NCT02040584|58583434|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30575297|NCT02040584|58583433|FG000|Overall Study|Death|6|||
30575298|NCT02040584|58583434|FG001|Overall Study|Death|3|||
30575299|NCT02040584|58583433|FG000|Overall Study|Transplant rejection/retransplant|0|||
30575300|NCT02040584|58583434|FG001|Overall Study|Transplant rejection/retransplant|1|||
30575301|NCT02040584|58583433|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
30575302|NCT02040584|58583434|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
30575303|NCT02045797|58583453|FG000|Overall Study|Adverse Event|3|||
30575304|NCT02045797|58583454|FG001|Overall Study|Adverse Event|1|||
30575305|NCT02045797|58583455|FG002|Overall Study|Adverse Event|0|||
30575306|NCT02045797|58583453|FG000|Overall Study|Lack of Efficacy|1|||
30575307|NCT02045797|58583454|FG001|Overall Study|Lack of Efficacy|0|||
30575308|NCT02045797|58583455|FG002|Overall Study|Lack of Efficacy|0|||
30575309|NCT02045797|58583453|FG000|Overall Study|Lost to Follow-up|2|||
30575310|NCT02045797|58583454|FG001|Overall Study|Lost to Follow-up|3|||
30575311|NCT02045797|58583455|FG002|Overall Study|Lost to Follow-up|1|||
30575312|NCT02045797|58583453|FG000|Overall Study|Physician Decision|0|||
30575313|NCT02045797|58583454|FG001|Overall Study|Physician Decision|1|||
30575314|NCT02045797|58583455|FG002|Overall Study|Physician Decision|0|||
30575315|NCT02045797|58583453|FG000|Overall Study|Withdrawal by Subject|1|||
30575316|NCT02045797|58583454|FG001|Overall Study|Withdrawal by Subject|2|||
30575317|NCT02045797|58583455|FG002|Overall Study|Withdrawal by Subject|0|||
30575318|NCT03385239|58583485|FG000|Overall Study|Voluntary Withdrawal|2|||
30575319|NCT03385239|58583486|FG001|Overall Study|Voluntary Withdrawal|3|||
30575320|NCT03385239|58583487|FG002|Overall Study|Voluntary Withdrawal|2|||
30575321|NCT03385239|58583488|FG003|Overall Study|Voluntary Withdrawal|3|||
30575322|NCT03385239|58583489|FG004|Overall Study|Voluntary Withdrawal|0|||
30575323|NCT03385239|58583485|FG000|Overall Study|Adverse Event|0|||
30575324|NCT03385239|58583486|FG001|Overall Study|Adverse Event|0|||
30575325|NCT03385239|58583487|FG002|Overall Study|Adverse Event|1|||
30575326|NCT03385239|58583488|FG003|Overall Study|Adverse Event|0|||
30575327|NCT03385239|58583489|FG004|Overall Study|Adverse Event|0|||
30575328|NCT03385239|58583485|FG000|Overall Study|Other|0|||
30575329|NCT03385239|58583486|FG001|Overall Study|Other|0|||
30575330|NCT03385239|58583487|FG002|Overall Study|Other|0|||
30575331|NCT03385239|58583488|FG003|Overall Study|Other|1|||
30575332|NCT03385239|58583489|FG004|Overall Study|Other|0|||
30575333|NCT03020160|58583507|FG000|Overall Study|Withdrawal by Subject|1|||
30575334|NCT03020160|58583508|FG001|Overall Study|Withdrawal by Subject|0|||
30575335|NCT02593110|58583519|FG000|Overall Study|Withdrawal by Subject|0|||
30575336|NCT02593110|58583520|FG001|Overall Study|Withdrawal by Subject|3|||
30575337|NCT02593110|58583521|FG002|Overall Study|Withdrawal by Subject|3|||
30575338|NCT02593110|58583522|FG003|Overall Study|Withdrawal by Subject|2|||
30575339|NCT02593110|58583519|FG000|Overall Study|Death|0|||
30575340|NCT02593110|58583520|FG001|Overall Study|Death|0|||
30575341|NCT02593110|58583521|FG002|Overall Study|Death|1|||
30575342|NCT02593110|58583522|FG003|Overall Study|Death|0|||
30575343|NCT02373813|58583535|FG000|Run-In Period|Other, Not Specified|5|||
30575344|NCT02373813|58583536|FG001|Run-In Period|Other, Not Specified|0|||
30575345|NCT02373813|58583537|FG002|Run-In Period|Other, Not Specified|0|||
30575346|NCT02373813|58583538|FG003|Run-In Period|Other, Not Specified|0|||
30575347|NCT02373813|58583535|FG000|Run-In Period|Withdrawal by Subject|16|||
30575348|NCT02373813|58583536|FG001|Run-In Period|Withdrawal by Subject|0|||
30575349|NCT02373813|58583537|FG002|Run-In Period|Withdrawal by Subject|0|||
30575350|NCT02373813|58583538|FG003|Run-In Period|Withdrawal by Subject|0|||
30575351|NCT02373813|58583535|FG000|Run-In Period|Decision by Sponsor|11|||
30575352|NCT02373813|58583536|FG001|Run-In Period|Decision by Sponsor|0|||
30575353|NCT02373813|58583537|FG002|Run-In Period|Decision by Sponsor|0|||
30575354|NCT02373813|58583538|FG003|Run-In Period|Decision by Sponsor|0|||
30575355|NCT02373813|58583535|FG000|Run-In Period|Protocol Violation|75|||
30575356|NCT02373813|58583536|FG001|Run-In Period|Protocol Violation|0|||
30575357|NCT02373813|58583537|FG002|Run-In Period|Protocol Violation|0|||
30575358|NCT02373813|58583538|FG003|Run-In Period|Protocol Violation|0|||
30575359|NCT02373813|58583535|FG000|Run-In Period|Lost to Follow-up|2|||
30575360|NCT02373813|58583536|FG001|Run-In Period|Lost to Follow-up|0|||
30575361|NCT02373813|58583537|FG002|Run-In Period|Lost to Follow-up|0|||
30575362|NCT02373813|58583538|FG003|Run-In Period|Lost to Follow-up|0|||
30575363|NCT02373813|58583535|FG000|Run-In Period|Adverse Event|3|||
30575364|NCT02373813|58583536|FG001|Run-In Period|Adverse Event|0|||
30575365|NCT02373813|58583537|FG002|Run-In Period|Adverse Event|0|||
30575366|NCT02373813|58583538|FG003|Run-In Period|Adverse Event|0|||
30575367|NCT02373813|58583535|FG000|Run-In Period|Noncompliance|1|||
30575368|NCT02373813|58583536|FG001|Run-In Period|Noncompliance|0|||
30575369|NCT02373813|58583537|FG002|Run-In Period|Noncompliance|0|||
30575370|NCT02373813|58583538|FG003|Run-In Period|Noncompliance|0|||
30575371|NCT02373813|58583535|FG000|Run-In Period|Ineligibility Determined|3|||
30575372|NCT02373813|58583536|FG001|Run-In Period|Ineligibility Determined|0|||
30575373|NCT02373813|58583537|FG002|Run-In Period|Ineligibility Determined|0|||
30575374|NCT02373813|58583538|FG003|Run-In Period|Ineligibility Determined|0|||
30575375|NCT02373813|58583535|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
30575376|NCT02373813|58583536|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
30575377|NCT02373813|58583537|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
30575378|NCT02373813|58583538|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
30575379|NCT02373813|58583535|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
30575380|NCT02373813|58583536|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
30575381|NCT02373813|58583537|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
30575382|NCT02373813|58583538|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
30575383|NCT02373813|58583535|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
30575384|NCT02373813|58583536|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
30575385|NCT02373813|58583537|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
30575386|NCT02373813|58583538|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
30575387|NCT02373813|58583535|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30575388|NCT02373813|58583536|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
30575389|NCT02373813|58583537|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
30575390|NCT02373813|58583538|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
30575391|NCT01853748|58583555|FG000|Allocation|Withdrawal by Subject|1|||
30575392|NCT01853748|58583556|FG001|Allocation|Withdrawal by Subject|13|||
30575393|NCT01853748|58583555|FG000|Allocation|not sufficient to receive intervention|0|||
30575394|NCT01853748|58583556|FG001|Allocation|not sufficient to receive intervention|1|||
30575395|NCT01853748|58583555|FG000|Follow-Up|Withdrawal by Subject|7|||
30575396|NCT01853748|58583556|FG001|Follow-Up|Withdrawal by Subject|6|||
30575397|NCT01853748|58583555|FG000|Follow-Up|Adverse Event|67|||
30575398|NCT01853748|58583556|FG001|Follow-Up|Adverse Event|7|||
30575399|NCT01853748|58583555|FG000|Follow-Up|not available for data collection|16|||
30575400|NCT01853748|58583556|FG001|Follow-Up|not available for data collection|4|||
30575401|NCT03863509|58583591|FG000|Overall Study|COVID-19 shutdown period|0|||
30575402|NCT03863509|58583592|FG001|Overall Study|COVID-19 shutdown period|4|||
30575403|NCT03863509|58583593|FG002|Overall Study|COVID-19 shutdown period|0|||
30575404|NCT03863509|58583591|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
30575405|NCT03863509|58583592|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
30575406|NCT03863509|58583593|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
30575407|NCT03863509|58583591|FG000|Overall Study|Lost to Follow-up|8|||
30575408|NCT03863509|58583592|FG001|Overall Study|Lost to Follow-up|0|||
30780257|NCT03594110|58792098|FG001|Overall Study|Participant concerned about study treatment|28|||
30780258|NCT03594110|58792097|FG000|Overall Study|Doctor advice|38|||
30575409|NCT03863509|58583593|FG002|Overall Study|Lost to Follow-up|2|||
30575410|NCT03863509|58583591|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
30575411|NCT03863509|58583592|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
30667898|NCT00856284|58681839|FG002|Overall Study|Voluntary withdrawal|62|||
30575412|NCT03863509|58583593|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
30575413|NCT03863509|58583591|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
30575414|NCT03863509|58583592|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
30575415|NCT03863509|58583593|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
30575416|NCT03116347|58583622|FG000|Overall Study|Withdrawal by Subject|1|||
30575417|NCT03116347|58583623|FG001|Overall Study|Withdrawal by Subject|2|||
30575418|NCT00001213|58583669|FG000|Overall Study|Death|18|||
30575419|NCT00000135|58583675|FG000|Overall Study|Death|27|||
30575420|NCT00000135|58583676|FG001|Overall Study|Death|14|||
30575421|NCT00001723|58583684|FG000|Overall Study|Lack of Efficacy|6|||
30575422|NCT00001723|58583685|FG001|Overall Study|Lack of Efficacy|7|||
30575423|NCT00001723|58583684|FG000|Overall Study|Lack of family interest|4|||
30575424|NCT00001723|58583685|FG001|Overall Study|Lack of family interest|5|||
30575425|NCT00001723|58583684|FG000|Overall Study|Lost to Follow-up|2|||
30575426|NCT00001723|58583685|FG001|Overall Study|Lost to Follow-up|2|||
30575427|NCT00001723|58583684|FG000|Overall Study|medication intolerance|1|||
30575428|NCT00001723|58583685|FG001|Overall Study|medication intolerance|2|||
30575429|NCT00000378|58583707|FG000|Overall Study|Lack of Efficacy|16|||
30575430|NCT00000378|58583708|FG001|Overall Study|Lack of Efficacy|14|||
30575431|NCT01350115|58583716|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
30575432|NCT01350115|58583717|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
30575433|NCT01350115|58583716|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
30575434|NCT01350115|58583717|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
30575435|NCT01350115|58583716|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
30575436|NCT01350115|58583717|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
30575437|NCT04142983|58583725|FG000|Overall Study|Lost to Follow-up|73|||
30575438|NCT04142983|58583725|FG000|Overall Study|Withdrawal by Subject|10|||
30575439|NCT04142983|58583725|FG000|Overall Study|Physician Decision|1|||
30575440|NCT04142983|58583725|FG000|Overall Study|Adverse Event|1|||
30575441|NCT04142983|58583725|FG000|Overall Study|No longer eligible|4|||
30575442|NCT04142983|58583725|FG000|Overall Study|Screen Failure|10|||
30575443|NCT03801031|58583732|FG000|Overall Study|Lost to Follow-up|1|||
30575444|NCT03801031|58583733|FG001|Overall Study|Lost to Follow-up|0|||
30575445|NCT03801031|58583732|FG000|Overall Study|Unable to comply|1|||
30575446|NCT03801031|58583733|FG001|Overall Study|Unable to comply|0|||
30575447|NCT03801031|58583732|FG000|Overall Study|Withdrawal by Subject|0|||
30575448|NCT03801031|58583733|FG001|Overall Study|Withdrawal by Subject|1|||
30575449|NCT03357952|58583741|FG000|Overall Study|Withdrawal by Subject|0|||
30575450|NCT03357952|58583742|FG001|Overall Study|Withdrawal by Subject|1|||
30575451|NCT03357952|58583741|FG000|Overall Study|Sponsor Decision|9|||
30575452|NCT03357952|58583742|FG001|Overall Study|Sponsor Decision|0|||
30575453|NCT03055858|58583748|FG000|Overall Study|Death|9|||
30575454|NCT03055858|58583748|FG000|Overall Study|Withdrawal by Subject|11|||
30575455|NCT03055858|58583748|FG000|Overall Study|Lost to Follow-up|6|||
30575456|NCT03055858|58583748|FG000|Overall Study|Missed Follow-Up Visits|18|||
30575457|NCT02393716|58583773|FG000|Overall Study|Death|29|||
30575458|NCT02393716|58583773|FG000|Overall Study|Withdrawal by Subject|8|||
30575459|NCT02393716|58583773|FG000|Overall Study|Device Explanted|8|||
30575460|NCT02393716|58583773|FG000|Overall Study|Missed visit|16|||
30575461|NCT01804816|58583778|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
30575462|NCT01804816|58583778|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
30575463|NCT00584233|58583785|FG000|Overall Study|Withdrawal by Subject|5|||
30575464|NCT00584233|58583785|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
30575465|NCT00001566|58583797|FG000|Overall Study|patients' choice to discontinue protocol|3|||
30575466|NCT00001566|58583797|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
30575467|NCT00001566|58583797|FG000|Overall Study|Death|13|||
30575468|NCT00001566|58583797|FG000|Overall Study|Lost to Follow-up|1|||
30575469|NCT00001566|58583797|FG000|Overall Study|unable to complete initial apheresis|1|||
30575470|NCT00001575|58583801|FG000|Overall Study|Screening failures-Ph I portion|22|||
30575471|NCT00001575|58583801|FG000|Overall Study|Withdrawn/deaths|23|||
30575472|NCT00001596|58583807|FG000|Overall Study|Death|1|||
30575473|NCT00001596|58583808|FG001|Overall Study|Death|0|||
30575474|NCT00001596|58583807|FG000|Overall Study|Withdrawal by Subject|3|||
30575475|NCT00001596|58583808|FG001|Overall Study|Withdrawal by Subject|1|||
30575476|NCT00001596|58583807|FG000|Overall Study|Study Termination|12|||
30575477|NCT00001596|58583808|FG001|Overall Study|Study Termination|9|||
30575478|NCT00001596|58583807|FG000|Overall Study|Adverse Event|1|||
30575479|NCT00001596|58583808|FG001|Overall Study|Adverse Event|0|||
30575480|NCT01349803|58583845|FG000|Overall Study|Adverse Event|0|||
30575481|NCT01349803|58583846|FG001|Overall Study|Adverse Event|0|||
30575482|NCT01349803|58583847|FG002|Overall Study|Adverse Event|0|||
30575483|NCT01349803|58583848|FG003|Overall Study|Adverse Event|2|||
30575484|NCT01349803|58583845|FG000|Overall Study|Withdrawal by Subject|1|||
30575485|NCT01349803|58583846|FG001|Overall Study|Withdrawal by Subject|0|||
30575486|NCT01349803|58583847|FG002|Overall Study|Withdrawal by Subject|0|||
30575487|NCT01349803|58583848|FG003|Overall Study|Withdrawal by Subject|0|||
30575488|NCT01349803|58583845|FG000|Overall Study|Protocol-specified criteria|0|||
30575489|NCT01349803|58583846|FG001|Overall Study|Protocol-specified criteria|1|||
30575490|NCT01349803|58583847|FG002|Overall Study|Protocol-specified criteria|3|||
30575491|NCT01349803|58583848|FG003|Overall Study|Protocol-specified criteria|0|||
30667899|NCT00856284|58681837|FG000|Overall Study|Pregnancy|1|||
30667900|NCT00856284|58681838|FG001|Overall Study|Pregnancy|2|||
30667901|NCT00856284|58681839|FG002|Overall Study|Pregnancy|0|||
30667902|NCT00856284|58681837|FG000|Overall Study|Investigator discretion|9|||
30667903|NCT00856284|58681838|FG001|Overall Study|Investigator discretion|8|||
30667904|NCT00856284|58681839|FG002|Overall Study|Investigator discretion|10|||
30667905|NCT00856284|58681837|FG000|Overall Study|Other|15|||
30667906|NCT00856284|58681838|FG001|Overall Study|Other|17|||
30667907|NCT00856284|58681839|FG002|Overall Study|Other|14|||
30667908|NCT00856284|58681837|FG000|Overall Study|Randomized in error|0|||
30667909|NCT00856284|58681838|FG001|Overall Study|Randomized in error|0|||
30667910|NCT00856284|58681839|FG002|Overall Study|Randomized in error|1|||
30780259|NCT03594110|58792098|FG001|Overall Study|Doctor advice|40|||
30780260|NCT03594110|58792097|FG000|Overall Study|Participants' wish|89|||
30780261|NCT03594110|58792098|FG001|Overall Study|Participants' wish|68|||
30780262|NCT03594110|58792097|FG000|Overall Study|Adverse Event|119|||
30780263|NCT03594110|58792098|FG001|Overall Study|Adverse Event|116|||
30855321|NCT02787863|58882925|FG003|Overall Study|Withdrawal by Subject|0|||
30575492|NCT04059146|58583990|FG000|Overall Study|Withdrawal by Subject|0|||
30575493|NCT04059146|58583991|FG001|Overall Study|Withdrawal by Subject|1|||
30575494|NCT03969641|58584012|FG000|Overall Study|Lost to Follow-up|5|||
30575495|NCT03969641|58584013|FG001|Overall Study|Lost to Follow-up|3|||
30575496|NCT03969641|58584012|FG000|Overall Study|Withdrawal by Subject|1|||
30575497|NCT03969641|58584013|FG001|Overall Study|Withdrawal by Subject|2|||
30575498|NCT03969641|58584012|FG000|Overall Study|Found to be ineligible|1|||
30575499|NCT03969641|58584013|FG001|Overall Study|Found to be ineligible|1|||
30575500|NCT03969641|58584012|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
30575501|NCT03969641|58584013|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
30575502|NCT03969641|58584012|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
30575503|NCT03969641|58584013|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
30575504|NCT03969641|58584012|FG000|Overall Study|Elective termination|0|||
30575505|NCT03969641|58584013|FG001|Overall Study|Elective termination|1|||
30575506|NCT03721172|58584063|FG000|Placebo-controlled Phase|Adverse Event|7|||
30575507|NCT03721172|58584064|FG001|Placebo-controlled Phase|Adverse Event|7|||
30575508|NCT03721172|58584065|FG002|Placebo-controlled Phase|Adverse Event|0|||
30575509|NCT03721172|58584063|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
30575510|NCT03721172|58584064|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
30575511|NCT03721172|58584065|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
30575512|NCT03721172|58584063|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
30575513|NCT03721172|58584064|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
30575514|NCT03721172|58584065|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
30575515|NCT03721172|58584063|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
30575516|NCT03721172|58584064|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
30575517|NCT03721172|58584065|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
30575518|NCT03721172|58584063|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
30575519|NCT03721172|58584064|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
30575520|NCT03721172|58584065|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
30575521|NCT03721172|58584063|FG000|Placebo-controlled Phase|Other|3|||
30575522|NCT03721172|58584064|FG001|Placebo-controlled Phase|Other|0|||
30575523|NCT03721172|58584065|FG002|Placebo-controlled Phase|Other|0|||
30575524|NCT03721172|58584063|FG000|Apremilast Extension Phase|Adverse Event|0|||
30575525|NCT03721172|58584064|FG001|Apremilast Extension Phase|Adverse Event|0|||
30575526|NCT03721172|58584065|FG002|Apremilast Extension Phase|Adverse Event|10|||
30575527|NCT03721172|58584063|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
30575528|NCT03721172|58584064|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
30575529|NCT03721172|58584065|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
30575530|NCT03721172|58584063|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
30575531|NCT03721172|58584064|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
30575532|NCT03721172|58584065|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
30575533|NCT03721172|58584063|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
30575534|NCT03721172|58584064|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
30667911|NCT00510289|58681847|FG000|Overall Study|Withdrawal by Subject|7|||
30667912|NCT00510289|58681847|FG000|Overall Study|Refused bone marrow biopsy|2|||
30667913|NCT00510289|58681847|FG000|Overall Study|Lost to Follow-up|1|||
30575535|NCT03721172|58584065|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
30667914|NCT00510289|58681847|FG000|Overall Study|Progressed prior to starting drug|2|||
30667915|NCT00492115|58681854|FG000|Overall Study|Withdrawal by Subject|3|||
30667916|NCT00492115|58681855|FG001|Overall Study|Withdrawal by Subject|4|||
30667917|NCT00856206|58681863|FG000|Overall Study|Protocol Violation|6|||
30780264|NCT03594110|58792097|FG000|Overall Study|Study drug stopped, reason missing|337|||
30575536|NCT03721172|58584063|FG000|Apremilast Extension Phase|Protocol Violation|0|||
30575537|NCT03721172|58584064|FG001|Apremilast Extension Phase|Protocol Violation|0|||
30575538|NCT03721172|58584065|FG002|Apremilast Extension Phase|Protocol Violation|1|||
30575539|NCT03721172|58584063|FG000|Apremilast Extension Phase|Physician Decision|0|||
30575540|NCT03721172|58584064|FG001|Apremilast Extension Phase|Physician Decision|0|||
30575541|NCT03721172|58584065|FG002|Apremilast Extension Phase|Physician Decision|1|||
30575542|NCT03721172|58584063|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
30575543|NCT03721172|58584064|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
30575544|NCT03721172|58584065|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
30575545|NCT03721172|58584063|FG000|Apremilast Extension Phase|Other|0|||
30575546|NCT03721172|58584064|FG001|Apremilast Extension Phase|Other|0|||
30575547|NCT03721172|58584065|FG002|Apremilast Extension Phase|Other|3|||
30575548|NCT03721172|58584063|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
30575549|NCT03721172|58584064|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
30575550|NCT03721172|58584065|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
30575551|NCT02337686|58584099|FG000|Overall Study|Adverse Event|1|||
30575552|NCT04540887|58584125|FG000|Overall Study|Withdrawal by Subject|2|||
30575553|NCT04294680|58584136|FG000|Overall Study|Withdrawal by Subject|2|||
30575554|NCT04294680|58584137|FG001|Overall Study|Withdrawal by Subject|1|||
30575555|NCT04294680|58584136|FG000|Overall Study|Follow-up visits completed outside of window|1|||
30575556|NCT04294680|58584137|FG001|Overall Study|Follow-up visits completed outside of window|0|||
30575557|NCT01350102|58584147|FG000|Overall Study|Adverse Event|0|||
30575558|NCT01350102|58584148|FG001|Overall Study|Adverse Event|0|||
30575559|NCT01350102|58584149|FG002|Overall Study|Adverse Event|1|||
30575560|NCT01350102|58584150|FG003|Overall Study|Adverse Event|0|||
30575561|NCT04059549|58584164|FG000|Overall Study|Withdrawal by Subject|2|||
30575562|NCT04059549|58584165|FG001|Overall Study|Withdrawal by Subject|0|||
30575563|NCT04041570|58584177|FG000|Overall Study|Moved from Area|0|||
30575564|NCT04041570|58584178|FG001|Overall Study|Moved from Area|2|||
30575565|NCT03879408|58584190|FG000|Overall Study|Lost to Follow-up|0|||
30575566|NCT03879408|58584191|FG001|Overall Study|Lost to Follow-up|3|||
30575567|NCT03879408|58584192|FG002|Overall Study|Lost to Follow-up|2|||
30575568|NCT03879408|58584193|FG003|Overall Study|Lost to Follow-up|1|||
30575569|NCT03879408|58584194|FG004|Overall Study|Lost to Follow-up|0|||
30575570|NCT03879408|58584190|FG000|Overall Study|Withdrawal by Subject|2|||
30575571|NCT03879408|58584191|FG001|Overall Study|Withdrawal by Subject|1|||
30575572|NCT03879408|58584192|FG002|Overall Study|Withdrawal by Subject|1|||
30575573|NCT03879408|58584193|FG003|Overall Study|Withdrawal by Subject|0|||
30575574|NCT03879408|58584194|FG004|Overall Study|Withdrawal by Subject|1|||
30575575|NCT00819780|58584218|FG000|Overall Study|Did not receive study drug|3|||
30575576|NCT00819780|58584219|FG001|Overall Study|Did not receive study drug|4|||
30575577|NCT00819780|58584218|FG000|Overall Study|Still in treatment|25|||
30575578|NCT00819780|58584219|FG001|Overall Study|Still in treatment|17|||
30575579|NCT00000620|58584358|FG000|Overall Study|Death|86|||
30575580|NCT00000620|58584359|FG001|Overall Study|Death|67|||
30575581|NCT00000620|58584360|FG002|Overall Study|Death|112|||
30575582|NCT00000620|58584361|FG003|Overall Study|Death|126|||
30575583|NCT00000620|58584362|FG004|Overall Study|Death|64|||
30575584|NCT00000620|58584363|FG005|Overall Study|Death|77|||
30575585|NCT00000620|58584364|FG006|Overall Study|Death|91|||
30575586|NCT00000620|58584365|FG007|Overall Study|Death|95|||
30575587|NCT00000620|58584358|FG000|Overall Study|Lost to Follow-up|14|||
30575588|NCT00000620|58584359|FG001|Overall Study|Lost to Follow-up|14|||
30575589|NCT00000620|58584360|FG002|Overall Study|Lost to Follow-up|14|||
30575590|NCT00000620|58584361|FG003|Overall Study|Lost to Follow-up|14|||
30575591|NCT00000620|58584362|FG004|Overall Study|Lost to Follow-up|15|||
30575592|NCT00000620|58584363|FG005|Overall Study|Lost to Follow-up|15|||
30575593|NCT00000620|58584364|FG006|Overall Study|Lost to Follow-up|13|||
30575594|NCT00000620|58584365|FG007|Overall Study|Lost to Follow-up|14|||
30575595|NCT00000620|58584358|FG000|Overall Study|Withdrawal by Subject|40|||
30575596|NCT00000620|58584359|FG001|Overall Study|Withdrawal by Subject|27|||
30575597|NCT00000620|58584360|FG002|Overall Study|Withdrawal by Subject|28|||
30575598|NCT00000620|58584361|FG003|Overall Study|Withdrawal by Subject|27|||
30575599|NCT00000620|58584362|FG004|Overall Study|Withdrawal by Subject|30|||
30575600|NCT00000620|58584363|FG005|Overall Study|Withdrawal by Subject|32|||
30575601|NCT00000620|58584364|FG006|Overall Study|Withdrawal by Subject|32|||
30575602|NCT00000620|58584365|FG007|Overall Study|Withdrawal by Subject|21|||
30575603|NCT00000620|58584358|FG000|Overall Study|missed closeout visit|22|||
30575604|NCT00000620|58584359|FG001|Overall Study|missed closeout visit|28|||
30575605|NCT00000620|58584360|FG002|Overall Study|missed closeout visit|16|||
30575606|NCT00000620|58584361|FG003|Overall Study|missed closeout visit|11|||
30575607|NCT00000620|58584362|FG004|Overall Study|missed closeout visit|26|||
30575608|NCT00000620|58584363|FG005|Overall Study|missed closeout visit|28|||
30575609|NCT00000620|58584364|FG006|Overall Study|missed closeout visit|13|||
30575610|NCT00000620|58584365|FG007|Overall Study|missed closeout visit|16|||
30575611|NCT00001262|58584428|FG000|Overall Study|Death|10|||
30575612|NCT00001262|58584429|FG001|Overall Study|Death|11|||
30575613|NCT00001262|58584430|FG002|Overall Study|Death|0|||
30575614|NCT00001262|58584428|FG000|Overall Study|Withdrawal by Subject|0|||
30575615|NCT00001262|58584429|FG001|Overall Study|Withdrawal by Subject|3|||
30575616|NCT00001262|58584430|FG002|Overall Study|Withdrawal by Subject|0|||
30575617|NCT00001277|58584447|FG000|Overall Study|Adverse Event|0|||
30575618|NCT00001277|58584448|FG001|Overall Study|Adverse Event|0|||
30575619|NCT00001277|58584449|FG002|Overall Study|Adverse Event|1|||
30667918|NCT00856206|58681864|FG001|Overall Study|Protocol Violation|18|||
30667919|NCT00856206|58681863|FG000|Overall Study|Adverse Event|10|||
30667920|NCT00856206|58681864|FG001|Overall Study|Adverse Event|46|||
30667921|NCT00856206|58681863|FG000|Overall Study|Lack of Efficacy|1|||
30667922|NCT00856206|58681864|FG001|Overall Study|Lack of Efficacy|2|||
30667923|NCT00856206|58681863|FG000|Overall Study|Withdrawal by Subject|15|||
30667924|NCT00856206|58681864|FG001|Overall Study|Withdrawal by Subject|36|||
30667925|NCT00856206|58681863|FG000|Overall Study|Lost to Follow-up|13|||
30667926|NCT00856206|58681864|FG001|Overall Study|Lost to Follow-up|39|||
30667927|NCT00856206|58681863|FG000|Overall Study|Death|2|||
30667928|NCT00856206|58681864|FG001|Overall Study|Death|2|||
30667929|NCT00856206|58681863|FG000|Overall Study|Decision by the Sponsor|4|||
30667930|NCT00856206|58681864|FG001|Overall Study|Decision by the Sponsor|8|||
30667931|NCT00856206|58681863|FG000|Overall Study|Other than specified above|3|||
30667932|NCT00856206|58681864|FG001|Overall Study|Other than specified above|10|||
30667933|NCT00593112|58681872|FG000|Overall Study|Scan Anxiety|3|||
30667934|NCT00593112|58681873|FG001|Overall Study|Scan Anxiety|0|||
30667935|NCT00593112|58681872|FG000|Overall Study|Abnormal Scan|1|||
30667936|NCT00593112|58681873|FG001|Overall Study|Abnormal Scan|0|||
30667937|NCT00593112|58681872|FG000|Overall Study|Unreadable Scan|1|||
30667938|NCT00593112|58681873|FG001|Overall Study|Unreadable Scan|0|||
30667939|NCT00593112|58681872|FG000|Overall Study|Withdrawal by Subject|5|||
30667940|NCT00593112|58681873|FG001|Overall Study|Withdrawal by Subject|0|||
30667941|NCT00491179|58681881|FG000|Overall Study|Adverse Event|5|||
30667942|NCT00491179|58681882|FG001|Overall Study|Adverse Event|1|||
30667943|NCT00491179|58681881|FG000|Overall Study|Withdrawal by Subject|2|||
30667944|NCT00491179|58681882|FG001|Overall Study|Withdrawal by Subject|1|||
30667945|NCT00503581|58681891|FG000|Overall Study|Study closed|3|||
30667946|NCT00503581|58681892|FG001|Overall Study|Study closed|4|||
30667947|NCT00503581|58681893|FG002|Overall Study|Study closed|2|||
30667948|NCT00703534|58681903|FG000|Overall Study|Adverse Event|14|||
30667949|NCT00703534|58681904|FG001|Overall Study|Adverse Event|3|||
30667950|NCT00703534|58681903|FG000|Overall Study|Withdrawal by Subject|8|||
30667951|NCT00703534|58681904|FG001|Overall Study|Withdrawal by Subject|7|||
30667952|NCT00703534|58681903|FG000|Overall Study|Incorrect Enrollment|6|||
30667953|NCT00703534|58681904|FG001|Overall Study|Incorrect Enrollment|6|||
30667954|NCT00703534|58681903|FG000|Overall Study|Lost to Follow-up|1|||
30667955|NCT00703534|58681904|FG001|Overall Study|Lost to Follow-up|4|||
30667956|NCT00703534|58681903|FG000|Overall Study|Severe Non Compliance|1|||
30667957|NCT00703534|58681904|FG001|Overall Study|Severe Non Compliance|5|||
30667958|NCT00503425|58681910|FG000|Overall Study|Participant files lost|6|||
30667959|NCT00503425|58681910|FG000|Overall Study|Adverse Event|5|||
30667960|NCT00503425|58681910|FG000|Overall Study|Lack of Efficacy|25|||
30667961|NCT00503425|58681910|FG000|Overall Study|Withdrawal by Subject|8|||
30667962|NCT00503425|58681910|FG000|Overall Study|Lost to Follow-up|3|||
30667963|NCT00503425|58681910|FG000|Overall Study|Death|3|||
30667964|NCT00503425|58681910|FG000|Overall Study|Missing Data/Unknown|4|||
30780265|NCT03594110|58792098|FG001|Overall Study|Study drug stopped, reason missing|295|||
30780266|NCT03594110|58792097|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
30780267|NCT03594110|58792098|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
30780268|NCT03594110|58792097|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
30575620|NCT00001277|58584447|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
30667965|NCT00863772|58681918|FG000|Overall Study|Adverse Event|1|||
30667966|NCT00863772|58681919|FG001|Overall Study|Adverse Event|4|||
30667967|NCT00863772|58681920|FG002|Overall Study|Adverse Event|0|||
30667968|NCT00863772|58681918|FG000|Overall Study|Lack of Efficacy|4|||
30667969|NCT00863772|58681919|FG001|Overall Study|Lack of Efficacy|2|||
30667970|NCT00863772|58681920|FG002|Overall Study|Lack of Efficacy|4|||
30667971|NCT00863772|58681918|FG000|Overall Study|Lost to Follow-up|5|||
30958681|NCT01582061|59023783|FG000|Overall Study|Adverse Event|12|||
30667972|NCT00863772|58681919|FG001|Overall Study|Lost to Follow-up|1|||
30667973|NCT00863772|58681920|FG002|Overall Study|Lost to Follow-up|1|||
30667974|NCT00863772|58681918|FG000|Overall Study|Protocol Violation|2|||
30667975|NCT00863772|58681919|FG001|Overall Study|Protocol Violation|0|||
30667976|NCT00863772|58681920|FG002|Overall Study|Protocol Violation|2|||
30667977|NCT00863772|58681918|FG000|Overall Study|Withdrawal by Subject|4|||
30667978|NCT00863772|58681919|FG001|Overall Study|Withdrawal by Subject|7|||
30667979|NCT00863772|58681920|FG002|Overall Study|Withdrawal by Subject|5|||
30667980|NCT00863772|58681918|FG000|Overall Study|Study terminated by sponsor|44|||
30667981|NCT00863772|58681919|FG001|Overall Study|Study terminated by sponsor|45|||
30667982|NCT00863772|58681920|FG002|Overall Study|Study terminated by sponsor|36|||
30575621|NCT00001277|58584448|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
30575622|NCT00001277|58584449|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
30575623|NCT00001703|58584491|FG000|Overall Study|progressed disease|2|||
30575624|NCT00001703|58584491|FG000|Overall Study|No evidence of disease|1|||
30575625|NCT00001703|58584491|FG000|Overall Study|recurrent disease|2|||
30575626|NCT01349907|58584515|FG000|Overall Study|Adverse Event|37|||
30575627|NCT01349907|58584516|FG001|Overall Study|Adverse Event|11|||
30575628|NCT01349907|58584515|FG000|Overall Study|Treatment failure|13|||
30575629|NCT01349907|58584516|FG001|Overall Study|Treatment failure|4|||
30575630|NCT01349907|58584515|FG000|Overall Study|Lost to Follow-up|25|||
30575631|NCT01349907|58584516|FG001|Overall Study|Lost to Follow-up|6|||
30575632|NCT01349907|58584515|FG000|Overall Study|Withdrawal by Subject|30|||
30575633|NCT01349907|58584516|FG001|Overall Study|Withdrawal by Subject|8|||
30575634|NCT01349907|58584515|FG000|Overall Study|Protocol Violation|33|||
30575635|NCT01349907|58584516|FG001|Overall Study|Protocol Violation|13|||
30575636|NCT01349907|58584515|FG000|Overall Study|Administrative|1|||
30575637|NCT01349907|58584516|FG001|Overall Study|Administrative|1|||
30575638|NCT04847141|58584525|FG000|Overall Study|Adverse Event|1|||
30575639|NCT04847141|58584526|FG001|Overall Study|Adverse Event|0|||
30575640|NCT04847141|58584527|FG002|Overall Study|Adverse Event|1|||
30575641|NCT04847141|58584525|FG000|Overall Study|Withdrawal by Subject|2|||
30575642|NCT04847141|58584526|FG001|Overall Study|Withdrawal by Subject|4|||
30575643|NCT04847141|58584527|FG002|Overall Study|Withdrawal by Subject|3|||
30575644|NCT04847141|58584525|FG000|Overall Study|Lost to Follow-up|7|||
30575645|NCT04847141|58584526|FG001|Overall Study|Lost to Follow-up|5|||
30575646|NCT04847141|58584527|FG002|Overall Study|Lost to Follow-up|7|||
30575647|NCT04847141|58584525|FG000|Overall Study|Reason not Specified|0|||
30575648|NCT04847141|58584526|FG001|Overall Study|Reason not Specified|1|||
30575649|NCT04847141|58584527|FG002|Overall Study|Reason not Specified|0|||
30575650|NCT01349829|58584537|FG000|Overall Study|Lost to Follow-up|4|||
30575651|NCT01349829|58584538|FG001|Overall Study|Lost to Follow-up|8|||
30575652|NCT01349829|58584537|FG000|Overall Study|Consent withdrawal|3|||
30575653|NCT01349829|58584538|FG001|Overall Study|Consent withdrawal|8|||
30575654|NCT01349829|58584537|FG000|Overall Study|Migrated/moved|2|||
30575655|NCT01349829|58584538|FG001|Overall Study|Migrated/moved|7|||
30575656|NCT01350128|58584546|FG000|Overall Study|Withdrawal by Subject|3|||
30575657|NCT01350128|58584546|FG000|Overall Study|Protocol discontinuation criteria|8|||
30575658|NCT01350128|58584546|FG000|Overall Study|Physician Decision|1|||
30575659|NCT01350128|58584546|FG000|Overall Study|Lost to Follow-up|2|||
30575660|NCT03893825|58584613|FG000|Overall Study|Death|2|||
30575661|NCT03893825|58584614|FG001|Overall Study|Death|1|||
30575662|NCT03893825|58584613|FG000|Overall Study|Adverse Event|0|||
30575663|NCT03893825|58584614|FG001|Overall Study|Adverse Event|2|||
30575664|NCT03893825|58584613|FG000|Overall Study|Withdrawal by Subject|19|||
30575665|NCT03893825|58584614|FG001|Overall Study|Withdrawal by Subject|21|||
30575666|NCT03893825|58584613|FG000|Overall Study|Protocol deviation|1|||
30575667|NCT03893825|58584614|FG001|Overall Study|Protocol deviation|0|||
30575668|NCT03893825|58584613|FG000|Overall Study|Lost to Follow-up|10|||
30575669|NCT03893825|58584614|FG001|Overall Study|Lost to Follow-up|10|||
30575670|NCT03893825|58584613|FG000|Overall Study|Other than specified|7|||
30667983|NCT00863772|58681918|FG000|Overall Study|Entered extension study|6|||
30667984|NCT00863772|58681919|FG001|Overall Study|Entered extension study|4|||
30667985|NCT00863772|58681920|FG002|Overall Study|Entered extension study|9|||
30667986|NCT00863772|58681918|FG000|Overall Study|Other|1|||
30667987|NCT00863772|58681919|FG001|Overall Study|Other|2|||
30667988|NCT00863772|58681920|FG002|Overall Study|Other|4|||
30667989|NCT00863772|58681918|FG000|Overall Study|Randomized but not Treated|1|||
30667990|NCT00863772|58681919|FG001|Overall Study|Randomized but not Treated|0|||
30667991|NCT00863772|58681920|FG002|Overall Study|Randomized but not Treated|0|||
30667992|NCT00502801|58681928|FG000|Treatment Period|Withdrawal by Subject|3|||
30667993|NCT00502801|58681928|FG000|Treatment Period|Adverse Event|7|||
30667994|NCT00502801|58681928|FG000|Treatment Period|Death|14|||
30667995|NCT00502801|58681928|FG000|Treatment Period|OTHER|30|||
30667996|NCT00502801|58681928|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
30958682|NCT01582061|59023784|FG001|Overall Study|Adverse Event|8|||
30575671|NCT03893825|58584614|FG001|Overall Study|Other than specified|6|||
30575672|NCT03890666|58584622|FG000|Overall Study|Withdrawal by Subject|0|||
30575673|NCT03890666|58584623|FG001|Overall Study|Withdrawal by Subject|1|||
30575674|NCT03890666|58584622|FG000|Overall Study|Protocol deviation|1|||
30575675|NCT03890666|58584623|FG001|Overall Study|Protocol deviation|4|||
30575676|NCT03890666|58584622|FG000|Overall Study|Lost to Follow-up|2|||
30575677|NCT03890666|58584623|FG001|Overall Study|Lost to Follow-up|5|||
30667997|NCT00502801|58681928|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
30667998|NCT00502801|58681928|FG000|End of Therapy to Test of Cure|Death|3|||
30667999|NCT00502801|58681928|FG000|End of Therapy to Test of Cure|OTHER|2|||
30575678|NCT03890666|58584622|FG000|Overall Study|Other than specified|1|||
30575679|NCT03890666|58584623|FG001|Overall Study|Other than specified|8|||
30668000|NCT00824265|58681934|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
30575680|NCT03276572|58584677|FG000|Overall Study|In follow-up|0|||
30575681|NCT03276572|58584678|FG001|Overall Study|In follow-up|0|||
30575682|NCT03276572|58584679|FG002|Overall Study|In follow-up|0|||
30575683|NCT03276572|58584680|FG003|Overall Study|In follow-up|0|||
30575684|NCT03276572|58584681|FG004|Overall Study|In follow-up|0|||
30575685|NCT03276572|58584682|FG005|Overall Study|In follow-up|1|||
30575686|NCT03276572|58584683|FG006|Overall Study|In follow-up|1|||
30575687|NCT03276572|58584677|FG000|Overall Study|Lost to Follow-up|0|||
30575688|NCT03276572|58584678|FG001|Overall Study|Lost to Follow-up|0|||
30575689|NCT03276572|58584679|FG002|Overall Study|Lost to Follow-up|0|||
30575690|NCT03276572|58584680|FG003|Overall Study|Lost to Follow-up|0|||
30575691|NCT03276572|58584681|FG004|Overall Study|Lost to Follow-up|0|||
30575692|NCT03276572|58584682|FG005|Overall Study|Lost to Follow-up|0|||
30575693|NCT03276572|58584683|FG006|Overall Study|Lost to Follow-up|1|||
30575694|NCT03090737|58584708|FG000|Overall Study|Other reasons|1|||
30575695|NCT03090737|58584708|FG000|Overall Study|Completed treatment as per protocol|17|||
30575696|NCT03090737|58584708|FG000|Overall Study|Maximum clinical benefit|2|||
30575697|NCT03090737|58584708|FG000|Overall Study|Adverse event unrelated to study drug|7|||
30575698|NCT03090737|58584708|FG000|Overall Study|Study drug toxicity|4|||
30575699|NCT03090737|58584708|FG000|Overall Study|Disease progression|98|||
30575700|NCT03004976|58584753|FG000|Overall Study|Lost to Follow-up|7|||
30575701|NCT03004976|58584754|FG001|Overall Study|Lost to Follow-up|5|||
30575702|NCT03004976|58584753|FG000|Overall Study|Physician Decision|1|||
30575703|NCT03004976|58584754|FG001|Overall Study|Physician Decision|0|||
30575704|NCT03004976|58584753|FG000|Overall Study|Withdrawal by Subject|1|||
30575705|NCT03004976|58584754|FG001|Overall Study|Withdrawal by Subject|0|||
30575706|NCT03004976|58584753|FG000|Overall Study|Death|4|||
30575707|NCT03004976|58584754|FG001|Overall Study|Death|1|||
30575708|NCT02985866|58584762|FG000|Overall Study|Poor CGM data|1|||
30575709|NCT02985866|58584763|FG001|Overall Study|Poor CGM data|1|||
30575710|NCT02762981|58584788|FG000|Overall Study|Adverse Event|2|||
30575711|NCT02762981|58584789|FG001|Overall Study|Adverse Event|3|||
30575712|NCT02762981|58584790|FG002|Overall Study|Adverse Event|1|||
30575713|NCT02762981|58584791|FG003|Overall Study|Adverse Event|1|||
30575714|NCT02762981|58584792|FG004|Overall Study|Adverse Event|3|||
30575715|NCT02762981|58584788|FG000|Overall Study|Physician Decision|0|||
30575716|NCT02762981|58584789|FG001|Overall Study|Physician Decision|1|||
30575717|NCT02762981|58584790|FG002|Overall Study|Physician Decision|0|||
30575718|NCT02762981|58584791|FG003|Overall Study|Physician Decision|0|||
30575719|NCT02762981|58584792|FG004|Overall Study|Physician Decision|1|||
30575720|NCT02762981|58584788|FG000|Overall Study|Disease progression|11|||
30575721|NCT02762981|58584789|FG001|Overall Study|Disease progression|23|||
30575722|NCT02762981|58584790|FG002|Overall Study|Disease progression|4|||
30575723|NCT02762981|58584791|FG003|Overall Study|Disease progression|10|||
30575724|NCT02762981|58584792|FG004|Overall Study|Disease progression|1|||
30575725|NCT02762981|58584788|FG000|Overall Study|Enrolled not treated|1|||
30575726|NCT02762981|58584789|FG001|Overall Study|Enrolled not treated|5|||
30575727|NCT02762981|58584790|FG002|Overall Study|Enrolled not treated|0|||
30575728|NCT02762981|58584791|FG003|Overall Study|Enrolled not treated|2|||
30575729|NCT02762981|58584792|FG004|Overall Study|Enrolled not treated|0|||
30575730|NCT02762981|58584788|FG000|Overall Study|Other|2|||
30575731|NCT02762981|58584789|FG001|Overall Study|Other|3|||
30575732|NCT02762981|58584790|FG002|Overall Study|Other|1|||
30575733|NCT02762981|58584791|FG003|Overall Study|Other|0|||
30575734|NCT02762981|58584792|FG004|Overall Study|Other|0|||
30575735|NCT02762981|58584788|FG000|Overall Study|Missing|1|||
30575736|NCT02762981|58584789|FG001|Overall Study|Missing|0|||
30575737|NCT02762981|58584790|FG002|Overall Study|Missing|0|||
30575738|NCT02762981|58584791|FG003|Overall Study|Missing|0|||
30575739|NCT02762981|58584792|FG004|Overall Study|Missing|0|||
30575740|NCT02762981|58584788|FG000|Overall Study|Withdrawal by Subject|0|||
30575741|NCT02762981|58584789|FG001|Overall Study|Withdrawal by Subject|5|||
30575742|NCT02762981|58584790|FG002|Overall Study|Withdrawal by Subject|1|||
30575743|NCT02762981|58584791|FG003|Overall Study|Withdrawal by Subject|3|||
30575744|NCT02762981|58584792|FG004|Overall Study|Withdrawal by Subject|0|||
30575745|NCT02255435|58584832|FG000|Overall Study|Patient's Limited Time Availability|0|||
30575746|NCT02255435|58584833|FG001|Overall Study|Patient's Limited Time Availability|0|||
30575747|NCT02255435|58584834|FG002|Overall Study|Patient's Limited Time Availability|0|||
30575748|NCT02255435|58584835|FG003|Overall Study|Patient's Limited Time Availability|0|||
30575749|NCT02255435|58584836|FG004|Overall Study|Patient's Limited Time Availability|0|||
30575750|NCT02255435|58584837|FG005|Overall Study|Patient's Limited Time Availability|0|||
30575751|NCT02255435|58584838|FG006|Overall Study|Patient's Limited Time Availability|0|||
30575752|NCT02255435|58584839|FG007|Overall Study|Patient's Limited Time Availability|1|||
30575753|NCT02255435|58584840|FG008|Overall Study|Patient's Limited Time Availability|0|||
30575754|NCT02255435|58584841|FG009|Overall Study|Patient's Limited Time Availability|0|||
30575755|NCT02255435|58584832|FG000|Overall Study|Withdrawal by Subject|0|||
30575756|NCT02255435|58584833|FG001|Overall Study|Withdrawal by Subject|0|||
30575757|NCT02255435|58584834|FG002|Overall Study|Withdrawal by Subject|0|||
30575758|NCT02255435|58584835|FG003|Overall Study|Withdrawal by Subject|0|||
30575759|NCT02255435|58584836|FG004|Overall Study|Withdrawal by Subject|0|||
30575760|NCT02255435|58584837|FG005|Overall Study|Withdrawal by Subject|0|||
30575761|NCT02255435|58584838|FG006|Overall Study|Withdrawal by Subject|0|||
30575762|NCT02255435|58584839|FG007|Overall Study|Withdrawal by Subject|0|||
30575763|NCT02255435|58584840|FG008|Overall Study|Withdrawal by Subject|1|||
30575764|NCT02255435|58584841|FG009|Overall Study|Withdrawal by Subject|4|||
30575765|NCT02255435|58584832|FG000|Overall Study|Administrative reasons|0|||
30575766|NCT02255435|58584833|FG001|Overall Study|Administrative reasons|0|||
30575767|NCT02255435|58584834|FG002|Overall Study|Administrative reasons|0|||
30575768|NCT02255435|58584835|FG003|Overall Study|Administrative reasons|0|||
30575769|NCT02255435|58584836|FG004|Overall Study|Administrative reasons|0|||
30575770|NCT02255435|58584837|FG005|Overall Study|Administrative reasons|0|||
30575771|NCT02255435|58584838|FG006|Overall Study|Administrative reasons|0|||
30575772|NCT02255435|58584839|FG007|Overall Study|Administrative reasons|0|||
30575773|NCT02255435|58584840|FG008|Overall Study|Administrative reasons|0|||
30575774|NCT02255435|58584841|FG009|Overall Study|Administrative reasons|2|||
30575775|NCT00001832|58584912|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
30575776|NCT00001832|58584913|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
30575777|NCT00001832|58584914|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
30575778|NCT00001832|58584915|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
30575779|NCT00001832|58584916|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
30575780|NCT00001832|58584917|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
30575781|NCT00001832|58584918|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
30575782|NCT00001832|58584919|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
30575783|NCT00001832|58584920|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
30575784|NCT00001832|58584921|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
30575785|NCT00001832|58584922|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
30575786|NCT00001832|58584923|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
30575787|NCT00001832|58584924|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
30575788|NCT00001832|58584925|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
30575789|NCT00001832|58584926|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
30575790|NCT00001832|58584912|FG000|Treatment Period|Death during treatment|0|||
30575791|NCT00001832|58584913|FG001|Treatment Period|Death during treatment|0|||
30575792|NCT00001832|58584914|FG002|Treatment Period|Death during treatment|0|||
30575793|NCT00001832|58584915|FG003|Treatment Period|Death during treatment|0|||
30575794|NCT00001832|58584916|FG004|Treatment Period|Death during treatment|0|||
30575795|NCT00001832|58584917|FG005|Treatment Period|Death during treatment|1|||
30575796|NCT00001832|58584918|FG006|Treatment Period|Death during treatment|0|||
30575797|NCT00001832|58584919|FG007|Treatment Period|Death during treatment|0|||
30575798|NCT00001832|58584920|FG008|Treatment Period|Death during treatment|0|||
30575799|NCT00001832|58584921|FG009|Treatment Period|Death during treatment|0|||
30575800|NCT00001832|58584922|FG010|Treatment Period|Death during treatment|0|||
30575801|NCT00001832|58584923|FG011|Treatment Period|Death during treatment|0|||
30575802|NCT00001832|58584924|FG012|Treatment Period|Death during treatment|0|||
30575803|NCT00001832|58584925|FG013|Treatment Period|Death during treatment|0|||
30575804|NCT00001832|58584926|FG014|Treatment Period|Death during treatment|0|||
30575805|NCT00001832|58584912|FG000|Treatment Period|Not treated|0|||
30575806|NCT00001832|58584913|FG001|Treatment Period|Not treated|0|||
30575807|NCT00001832|58584914|FG002|Treatment Period|Not treated|0|||
30575808|NCT00001832|58584915|FG003|Treatment Period|Not treated|0|||
30575809|NCT00001832|58584916|FG004|Treatment Period|Not treated|0|||
30575810|NCT00001832|58584917|FG005|Treatment Period|Not treated|0|||
30575811|NCT00001832|58584918|FG006|Treatment Period|Not treated|0|||
30575812|NCT00001832|58584919|FG007|Treatment Period|Not treated|1|||
30575813|NCT00001832|58584920|FG008|Treatment Period|Not treated|0|||
30668001|NCT00824265|58681935|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
30668002|NCT00824265|58681934|FG000|Treatment Phase|Protocol Violation|1|||
30668003|NCT00824265|58681935|FG001|Treatment Phase|Protocol Violation|0|||
30668004|NCT00824265|58681934|FG000|Treatment Phase|Lost to Follow-up|1|||
30668005|NCT00824265|58681935|FG001|Treatment Phase|Lost to Follow-up|1|||
30668006|NCT00824265|58681934|FG000|Treatment Phase|Physician Decision|6|||
30668007|NCT00824265|58681935|FG001|Treatment Phase|Physician Decision|12|||
30668008|NCT00824265|58681934|FG000|Treatment Phase|Withdrawal by Subject|6|||
30575814|NCT00001832|58584921|FG009|Treatment Period|Not treated|0|||
30575815|NCT00001832|58584922|FG010|Treatment Period|Not treated|0|||
30575816|NCT00001832|58584923|FG011|Treatment Period|Not treated|0|||
30575817|NCT00001832|58584924|FG012|Treatment Period|Not treated|0|||
30575818|NCT00001832|58584925|FG013|Treatment Period|Not treated|0|||
30575819|NCT00001832|58584926|FG014|Treatment Period|Not treated|0|||
30668009|NCT00824265|58681935|FG001|Treatment Phase|Withdrawal by Subject|15|||
30575820|NCT01349816|58585160|FG000|Overall Study|Withdrawal by Subject|4|||
30668010|NCT00824265|58681934|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
30668011|NCT00824265|58681935|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
30668012|NCT00824265|58681934|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
30575821|NCT01349816|58585160|FG000|Overall Study|Physician Decision|1|||
30575822|NCT01349816|58585160|FG000|Overall Study|Adverse Event|14|||
30575823|NCT01349816|58585160|FG000|Overall Study|Lost to Follow-up|2|||
30575824|NCT01349816|58585160|FG000|Overall Study|Protocol Violation|1|||
30575825|NCT01349816|58585160|FG000|Overall Study|Protocol-specified criteria|8|||
30575826|NCT05201807|58585339|FG000|Overall Study|Adverse Event|1|||
30575827|NCT05201807|58585339|FG000|Overall Study|COVID-19 Related|1|||
30575828|NCT04978337|58585345|FG000|Overall Study|Withdrawal by Subject|0|||
30575829|NCT04978337|58585346|FG001|Overall Study|Withdrawal by Subject|1|||
30575830|NCT04828707|58585355|FG000|Overall Study|Lost to Follow-up|3|||
30575831|NCT04828707|58585356|FG001|Overall Study|Lost to Follow-up|2|||
30575832|NCT04828707|58585355|FG000|Overall Study|Withdrawal by Subject|2|||
30575833|NCT04828707|58585356|FG001|Overall Study|Withdrawal by Subject|1|||
30575834|NCT04629534|58585364|FG000|Overall Study|Physician Decision|1|||
30575835|NCT04629534|58585365|FG001|Overall Study|Physician Decision|0|||
30575836|NCT04629534|58585364|FG000|Overall Study|Protocol Violation|0|||
30575837|NCT04629534|58585365|FG001|Overall Study|Protocol Violation|2|||
30575838|NCT04481191|58585377|FG000|Overall Study|Withdrawn by parent/guardian|15|||
30575839|NCT04481191|58585378|FG001|Overall Study|Withdrawn by parent/guardian|10|||
30575840|NCT03695185|58585401|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
30575841|NCT03695185|58585401|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
30575842|NCT03695185|58585401|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
30575843|NCT03695185|58585401|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
30575844|NCT03695185|58585401|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
30575845|NCT03695185|58585401|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
30575846|NCT03596164|58585408|FG000|Overall Study|Adverse Event|0|||
30575847|NCT03596164|58585409|FG001|Overall Study|Adverse Event|1|||
30575848|NCT03596164|58585408|FG000|Overall Study|Death|1|||
30575849|NCT03596164|58585409|FG001|Overall Study|Death|0|||
30575864|NCT03240874|58585430|FG000|Overall Study|Lost to Follow-up|0|||
30575865|NCT03240874|58585431|FG001|Overall Study|Lost to Follow-up|2|||
30575866|NCT03240874|58585432|FG002|Overall Study|Lost to Follow-up|4|||
30575867|NCT03240874|58585433|FG003|Overall Study|Lost to Follow-up|1|||
30575868|NCT03173560|58585443|FG000|Overall Study|Ongoing on Treatment|38|||
30575869|NCT03173560|58585444|FG001|Overall Study|Ongoing on Treatment|50|||
30575870|NCT03173560|58585443|FG000|Overall Study|Ongoing Survival Follow-up|56|||
30575871|NCT03173560|58585444|FG001|Overall Study|Ongoing Survival Follow-up|57|||
30575872|NCT03173560|58585443|FG000|Overall Study|Lost to Follow-up|1|||
30575873|NCT03173560|58585444|FG001|Overall Study|Lost to Follow-up|4|||
30575874|NCT03173560|58585443|FG000|Overall Study|Withdrawal by Subject|10|||
30575875|NCT03173560|58585444|FG001|Overall Study|Withdrawal by Subject|5|||
30575876|NCT03173560|58585443|FG000|Overall Study|Other|0|||
30575877|NCT03173560|58585444|FG001|Overall Study|Other|1|||
30575878|NCT02990468|58585453|FG000|Phase 2: MTD|Change in treatment|0|||
30575879|NCT02990468|58585454|FG001|Phase 2: MTD|Change in treatment|0|||
30575880|NCT02990468|58585455|FG002|Phase 2: MTD|Change in treatment|1|||
30575881|NCT02855944|58585465|FG000|Period 1: Treatment|Ongoing|14|||
30575882|NCT02855944|58585466|FG001|Period 1: Treatment|Ongoing|0|||
30575883|NCT02855944|58585465|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
30575884|NCT02855944|58585466|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
30575885|NCT02855944|58585465|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
30575886|NCT02855944|58585466|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
30575887|NCT02681055|58585477|FG000|Weeks 5-12|Adverse Event|1|||
30575888|NCT02577354|58585484|FG000|Overall Study|Lack of Efficacy|4|||
30575889|NCT02577354|58585485|FG001|Overall Study|Lack of Efficacy|4|||
30575890|NCT02577354|58585484|FG000|Overall Study|Lost to Follow-up|3|||
30575891|NCT02577354|58585485|FG001|Overall Study|Lost to Follow-up|1|||
30575892|NCT02577354|58585484|FG000|Overall Study|Missed Visit|4|||
30575893|NCT02577354|58585485|FG001|Overall Study|Missed Visit|3|||
30575894|NCT02577354|58585484|FG000|Overall Study|Adverse Event|4|||
30575895|NCT02577354|58585485|FG001|Overall Study|Adverse Event|5|||
30575896|NCT02451943|58585503|FG000|Overall Study|On Treatment|4|||
30575897|NCT02451943|58585504|FG001|Overall Study|On Treatment|4|||
30575898|NCT02451943|58585503|FG000|Overall Study|Withdrawal by Subject|13|||
30575899|NCT02451943|58585504|FG001|Overall Study|Withdrawal by Subject|16|||
30575900|NCT02451943|58585503|FG000|Overall Study|Lost to Follow-up|3|||
30575901|NCT02451943|58585504|FG001|Overall Study|Lost to Follow-up|4|||
30575902|NCT02409342|58585512|FG000|Overall Study|Death|211|||
30575903|NCT02409342|58585513|FG001|Overall Study|Death|201|||
30575904|NCT02409342|58585512|FG000|Overall Study|Withdrawal by Subject|24|||
30575905|NCT02409342|58585513|FG001|Overall Study|Withdrawal by Subject|17|||
30575906|NCT02409342|58585512|FG000|Overall Study|Study Terminated By Sponsor|48|||
30575907|NCT02409342|58585513|FG001|Overall Study|Study Terminated By Sponsor|59|||
30575908|NCT02409342|58585512|FG000|Overall Study|Lost to Follow-up|3|||
30575909|NCT02409342|58585513|FG001|Overall Study|Lost to Follow-up|5|||
30575910|NCT02409342|58585512|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
30575911|NCT02409342|58585513|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
30575912|NCT02409342|58585512|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
30575913|NCT02409342|58585513|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
30575914|NCT02409342|58585512|FG000|Overall Study|Sponsor Decision|1|||
30575915|NCT02409342|58585513|FG001|Overall Study|Sponsor Decision|0|||
30575916|NCT02336503|58585529|FG000|Overall Study|Lost to Follow-up|0|||
30575917|NCT02336503|58585530|FG001|Overall Study|Lost to Follow-up|3|||
30575918|NCT02336503|58585531|FG002|Overall Study|Lost to Follow-up|0|||
30575919|NCT02336503|58585532|FG003|Overall Study|Lost to Follow-up|2|||
30575920|NCT02336503|58585529|FG000|Overall Study|Withdrawal by Subject|2|||
30575921|NCT02336503|58585530|FG001|Overall Study|Withdrawal by Subject|0|||
30575922|NCT02336503|58585531|FG002|Overall Study|Withdrawal by Subject|0|||
30575923|NCT02336503|58585532|FG003|Overall Study|Withdrawal by Subject|4|||
30575924|NCT02336503|58585529|FG000|Overall Study|Adverse Event|0|||
30575925|NCT02336503|58585530|FG001|Overall Study|Adverse Event|0|||
30575926|NCT02336503|58585531|FG002|Overall Study|Adverse Event|1|||
30575927|NCT02336503|58585532|FG003|Overall Study|Adverse Event|0|||
30575928|NCT02255409|58585548|FG000|Overall Study|Administrative Reason|3|||
30575929|NCT02255409|58585549|FG001|Overall Study|Administrative Reason|7|||
30575930|NCT02255409|58585548|FG000|Overall Study|Withdrawal by Subject|1|||
30575931|NCT02255409|58585549|FG001|Overall Study|Withdrawal by Subject|5|||
30575932|NCT02255409|58585548|FG000|Overall Study|Lost to Follow-up|10|||
30575933|NCT02255409|58585549|FG001|Overall Study|Lost to Follow-up|19|||
30575934|NCT00630032|58585580|FG000|Overall Study|Death|55|||
30575935|NCT00630032|58585581|FG001|Overall Study|Death|49|||
30575936|NCT00630032|58585580|FG000|Overall Study|Withdrawal by Subject|3|||
30575937|NCT00630032|58585581|FG001|Overall Study|Withdrawal by Subject|2|||
30575938|NCT00630032|58585580|FG000|Overall Study|Lost to Follow-up|18|||
30575939|NCT00630032|58585581|FG001|Overall Study|Lost to Follow-up|31|||
30575940|NCT00630032|58585580|FG000|Overall Study|Protocol Violation|1|||
30575941|NCT00630032|58585581|FG001|Overall Study|Protocol Violation|0|||
30575942|NCT00630032|58585580|FG000|Overall Study|Patient has moved|1|||
30575943|NCT00630032|58585581|FG001|Overall Study|Patient has moved|1|||
30575944|NCT00630032|58585580|FG000|Overall Study|Disease progression|1|||
30575945|NCT00630032|58585581|FG001|Overall Study|Disease progression|1|||
30575946|NCT00630032|58585580|FG000|Overall Study|End of monitoring in US centers|11|||
30575947|NCT00630032|58585581|FG001|Overall Study|End of monitoring in US centers|11|||
30575948|NCT00465517|58585589|FG000|Overall Study|Adverse Event|7|||
30575949|NCT00465517|58585590|FG001|Overall Study|Adverse Event|3|||
30575950|NCT00465517|58585589|FG000|Overall Study|Lost to Follow-up|1|||
30575951|NCT00465517|58585590|FG001|Overall Study|Lost to Follow-up|0|||
30575952|NCT00465517|58585589|FG000|Overall Study|Withdrawal by Subject|4|||
30575953|NCT00465517|58585590|FG001|Overall Study|Withdrawal by Subject|1|||
30575954|NCT05050578|58585598|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
30575955|NCT05050578|58585599|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
30575956|NCT05050578|58585598|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
30575957|NCT05050578|58585599|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
30575958|NCT05050578|58585598|FG000|Period 2, 30 Days|Protocol Violation|0|||
30575959|NCT05050578|58585599|FG001|Period 2, 30 Days|Protocol Violation|1|||
30575960|NCT04490278|58585608|FG000|Overall Study|Lost to Follow-up|6|||
30575961|NCT04004221|58585612|FG000|Overall Study|Death|89|||
30575962|NCT04004221|58585612|FG000|Overall Study|Withdrawal by Subject|5|||
30575963|NCT04004221|58585612|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
30575964|NCT04004221|58585612|FG000|Overall Study|Sponsor Decision|9|||
30575965|NCT04004221|58585612|FG000|Overall Study|Participant refused to enter LTE|1|||
30575966|NCT03775512|58585622|FG000|Overall Study|Death|1|||
30780269|NCT03594110|58792098|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
30575967|NCT03775512|58585623|FG001|Overall Study|Death|1|||
30575968|NCT03775512|58585622|FG000|Overall Study|Withdrawal by Subject|7|||
30575969|NCT03775512|58585623|FG001|Overall Study|Withdrawal by Subject|4|||
30575970|NCT03775512|58585622|FG000|Overall Study|Lost to Follow-up|5|||
30575971|NCT03775512|58585623|FG001|Overall Study|Lost to Follow-up|5|||
30575972|NCT03775512|58585622|FG000|Overall Study|Excluded before Catheter insertion|14|||
30575973|NCT03775512|58585623|FG001|Overall Study|Excluded before Catheter insertion|5|||
30575974|NCT03775512|58585622|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
30575975|NCT03775512|58585623|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
30575976|NCT03775512|58585622|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
30575977|NCT03775512|58585623|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
30575978|NCT03620747|58585629|FG000|Overall Study|Participant decision|7|||
30575979|NCT03620747|58585629|FG000|Overall Study|Adverse Event|6|||
30575980|NCT03620747|58585629|FG000|Overall Study|Lack of Efficacy|1|||
30575981|NCT03620747|58585629|FG000|Overall Study|Poor compliance to protocol|2|||
30575982|NCT03620747|58585629|FG000|Overall Study|Other-unspecified|3|||
30575983|NCT03338790|58585654|FG000|Overall Study|Disease Progression|65|||
30575984|NCT03338790|58585655|FG001|Overall Study|Disease Progression|43|||
30575985|NCT03338790|58585656|FG002|Overall Study|Disease Progression|50|||
30575986|NCT03338790|58585657|FG003|Overall Study|Disease Progression|37|||
30575987|NCT03338790|58585654|FG000|Overall Study|Study Drug Toxicity|9|||
30575988|NCT03338790|58585655|FG001|Overall Study|Study Drug Toxicity|8|||
30575989|NCT03338790|58585656|FG002|Overall Study|Study Drug Toxicity|15|||
30575990|NCT03338790|58585657|FG003|Overall Study|Study Drug Toxicity|0|||
30575991|NCT03338790|58585654|FG000|Overall Study|Death|1|||
30575992|NCT03338790|58585655|FG001|Overall Study|Death|1|||
30575993|NCT03338790|58585656|FG002|Overall Study|Death|1|||
30575994|NCT03338790|58585657|FG003|Overall Study|Death|0|||
30575995|NCT03338790|58585654|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
30575996|NCT03338790|58585655|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
30575997|NCT03338790|58585656|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
30575998|NCT03338790|58585657|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
30575999|NCT03338790|58585654|FG000|Overall Study|Participant request to discontinue study treatment|3|||
30576000|NCT03338790|58585655|FG001|Overall Study|Participant request to discontinue study treatment|3|||
30576001|NCT03338790|58585656|FG002|Overall Study|Participant request to discontinue study treatment|2|||
30576002|NCT03338790|58585657|FG003|Overall Study|Participant request to discontinue study treatment|1|||
30576003|NCT03338790|58585654|FG000|Overall Study|Poor/non-compliance|0|||
30576004|NCT03338790|58585655|FG001|Overall Study|Poor/non-compliance|1|||
30576005|NCT03338790|58585656|FG002|Overall Study|Poor/non-compliance|0|||
30576006|NCT03338790|58585657|FG003|Overall Study|Poor/non-compliance|0|||
30576007|NCT03338790|58585654|FG000|Overall Study|Participant withdrew consent|1|||
30576008|NCT03338790|58585655|FG001|Overall Study|Participant withdrew consent|0|||
30576009|NCT03338790|58585656|FG002|Overall Study|Participant withdrew consent|1|||
30576010|NCT03338790|58585657|FG003|Overall Study|Participant withdrew consent|1|||
30576011|NCT03338790|58585654|FG000|Overall Study|Other reasons|0|||
30576012|NCT03338790|58585655|FG001|Overall Study|Other reasons|5|||
30576013|NCT03338790|58585656|FG002|Overall Study|Other reasons|0|||
30576014|NCT03338790|58585657|FG003|Overall Study|Other reasons|2|||
30576015|NCT03338790|58585654|FG000|Overall Study|Not reported|0|||
30576016|NCT03338790|58585655|FG001|Overall Study|Not reported|0|||
30576017|NCT03338790|58585656|FG002|Overall Study|Not reported|1|||
30576018|NCT03338790|58585657|FG003|Overall Study|Not reported|0|||
30576019|NCT03338790|58585654|FG000|Overall Study|Completed treatment period|1|||
30576020|NCT03338790|58585655|FG001|Overall Study|Completed treatment period|2|||
30576021|NCT03338790|58585656|FG002|Overall Study|Completed treatment period|0|||
30576022|NCT03338790|58585657|FG003|Overall Study|Completed treatment period|0|||
30576023|NCT02954536|58585684|FG000|Overall Study|Adverse Event|2|||
30576024|NCT02954536|58585684|FG000|Overall Study|Death|12|||
30576025|NCT02919670|58585690|FG000|Overall Study|Only 17 participants met compliance|43|||
30576026|NCT02919670|58585691|FG001|Overall Study|Only 17 participants met compliance|39|||
30576027|NCT02250326|58585790|FG000|Treatment Period|Death|1|||
30576028|NCT02250326|58585791|FG001|Treatment Period|Death|12|||
30576029|NCT02250326|58585792|FG002|Treatment Period|Death|2|||
30576030|NCT02250326|58585790|FG000|Treatment Period|Adverse Event|8|||
30576031|NCT02250326|58585791|FG001|Treatment Period|Adverse Event|4|||
30576032|NCT02250326|58585792|FG002|Treatment Period|Adverse Event|8|||
30576033|NCT02250326|58585790|FG000|Treatment Period|Progressive Disease|42|||
30576034|NCT02250326|58585791|FG001|Treatment Period|Progressive Disease|36|||
30576035|NCT02250326|58585792|FG002|Treatment Period|Progressive Disease|45|||
30576036|NCT02250326|58585790|FG000|Treatment Period|Symptomatic Deterioration|9|||
30576037|NCT02250326|58585791|FG001|Treatment Period|Symptomatic Deterioration|4|||
30576038|NCT02250326|58585792|FG002|Treatment Period|Symptomatic Deterioration|10|||
30576039|NCT02250326|58585790|FG000|Treatment Period|Withdrawal by Subject|11|||
30576040|NCT02250326|58585791|FG001|Treatment Period|Withdrawal by Subject|5|||
30576041|NCT02250326|58585792|FG002|Treatment Period|Withdrawal by Subject|4|||
30576042|NCT02250326|58585790|FG000|Treatment Period|Miscellaneous|8|||
30576043|NCT02250326|58585791|FG001|Treatment Period|Miscellaneous|2|||
30576044|NCT02250326|58585792|FG002|Treatment Period|Miscellaneous|7|||
30576045|NCT02250326|58585790|FG000|Treatment Period|Randomized or assigned; not treated|2|||
30576046|NCT02250326|58585791|FG001|Treatment Period|Randomized or assigned; not treated|1|||
30576047|NCT02250326|58585792|FG002|Treatment Period|Randomized or assigned; not treated|1|||
30576048|NCT02250326|58585790|FG000|Follow-Up Period|Death|46|||
30576049|NCT02250326|58585791|FG001|Follow-Up Period|Death|26|||
30576050|NCT02250326|58585792|FG002|Follow-Up Period|Death|32|||
30576051|NCT02250326|58585790|FG000|Follow-Up Period|Unknown or Missing|2|||
30576052|NCT02250326|58585791|FG001|Follow-Up Period|Unknown or Missing|3|||
30576053|NCT02250326|58585792|FG002|Follow-Up Period|Unknown or Missing|3|||
30576054|NCT02250326|58585790|FG000|Follow-Up Period|Lost to Follow-up|1|||
30576055|NCT02250326|58585791|FG001|Follow-Up Period|Lost to Follow-up|1|||
30576056|NCT02250326|58585792|FG002|Follow-Up Period|Lost to Follow-up|3|||
30576057|NCT01567722|58585804|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
30576058|NCT01567722|58585805|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
30576059|NCT01567722|58585806|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
30576060|NCT01567722|58585804|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
30576061|NCT01567722|58585805|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
30576062|NCT01567722|58585806|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
30576063|NCT01567722|58585804|FG000|Overall Study|Protocol closure by the OCG|2|||
30576064|NCT01567722|58585805|FG001|Overall Study|Protocol closure by the OCG|0|||
30576065|NCT01567722|58585806|FG002|Overall Study|Protocol closure by the OCG|0|||
30576066|NCT01567722|58585804|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
30576067|NCT01567722|58585805|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
30576068|NCT01567722|58585806|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
30576069|NCT01349790|58585831|FG000|Overall Study|Investigator Judgement|3|||
30576070|NCT01349790|58585831|FG000|Overall Study|Death|2|||
30576071|NCT01349790|58585831|FG000|Overall Study|Withdrawal by Patient|2|||
30576072|NCT01349790|58585831|FG000|Overall Study|Adverse Event|1|||
30576073|NCT01349790|58585831|FG000|Overall Study|Lost to Follow-up|1|||
30576074|NCT01349595|58585837|FG000|Overall Study|Lack of funding|2|||
30576075|NCT01349595|58585838|FG001|Overall Study|Lack of funding|2|||
30576076|NCT01349673|58585848|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
30576077|NCT01349673|58585848|FG000|Overall Study|No Longer Qualified For Study|1|||
30576078|NCT01349673|58585848|FG000|Overall Study|Site Closure|10|||
30576079|NCT01349673|58585848|FG000|Overall Study|Withdrawal by Subject|21|||
30576080|NCT01349673|58585848|FG000|Overall Study|Lost to Follow-up|6|||
30576081|NCT01349673|58585848|FG000|Overall Study|Adverse Event|17|||
30576082|NCT01349673|58585848|FG000|Overall Study|Study Terminated By Sponsor|50|||
30576083|NCT01349673|58585848|FG000|Overall Study|Lack of Efficacy|8|||
30576084|NCT01349660|58585957|FG000|Overall Study|Still Receiving Study Treatment|0|||
30576085|NCT01349660|58585958|FG001|Overall Study|Still Receiving Study Treatment|0|||
30576086|NCT01349660|58585959|FG002|Overall Study|Still Receiving Study Treatment|1|||
30576087|NCT01349660|58585957|FG000|Overall Study|Disease Progression|2|||
30576088|NCT01349660|58585958|FG001|Overall Study|Disease Progression|4|||
30576089|NCT01349660|58585959|FG002|Overall Study|Disease Progression|50|||
30576090|NCT01349660|58585957|FG000|Overall Study|Adverse Event|1|||
30576091|NCT01349660|58585958|FG001|Overall Study|Adverse Event|1|||
30576092|NCT01349660|58585959|FG002|Overall Study|Adverse Event|12|||
30576093|NCT01349660|58585957|FG000|Overall Study|Withdrawal by Subject|2|||
30576094|NCT01349660|58585958|FG001|Overall Study|Withdrawal by Subject|0|||
30576095|NCT01349660|58585959|FG002|Overall Study|Withdrawal by Subject|9|||
30576096|NCT01349660|58585957|FG000|Overall Study|Death|1|||
30576097|NCT01349660|58585958|FG001|Overall Study|Death|1|||
30576098|NCT01349660|58585959|FG002|Overall Study|Death|0|||
30576099|NCT01349660|58585957|FG000|Overall Study|Non-Permitted Interventions|0|||
30576100|NCT01349660|58585958|FG001|Overall Study|Non-Permitted Interventions|0|||
30576101|NCT01349660|58585959|FG002|Overall Study|Non-Permitted Interventions|2|||
30576102|NCT01349660|58585957|FG000|Overall Study|Study Compliance|0|||
30576103|NCT01349660|58585958|FG001|Overall Study|Study Compliance|0|||
30576104|NCT01349660|58585959|FG002|Overall Study|Study Compliance|1|||
30576105|NCT01349660|58585957|FG000|Overall Study|Declining Performance Status|0|||
30576106|NCT01349660|58585958|FG001|Overall Study|Declining Performance Status|0|||
30576107|NCT01349660|58585959|FG002|Overall Study|Declining Performance Status|1|||
30576108|NCT01349569|58585978|FG000|Overall Study|Lack of Efficacy|4|||
30576109|NCT05221749|58586029|FG000|Overall Study|Lost to Follow-up|2|||
30576110|NCT05221749|58586030|FG001|Overall Study|Lost to Follow-up|3|||
30576111|NCT04965389|58586084|FG000|Overall Study|Other reasons|1|||
30576112|NCT04965389|58586085|FG001|Overall Study|Other reasons|0|||
30576113|NCT04965389|58586086|FG002|Overall Study|Other reasons|0|||
30576114|NCT04965389|58586087|FG003|Overall Study|Other reasons|0|||
30576115|NCT04965389|58586084|FG000|Overall Study|Participant withdrew consent|0|||
30576116|NCT04965389|58586085|FG001|Overall Study|Participant withdrew consent|1|||
30576117|NCT04965389|58586086|FG002|Overall Study|Participant withdrew consent|0|||
30576118|NCT04965389|58586087|FG003|Overall Study|Participant withdrew consent|0|||
30576119|NCT04965389|58586084|FG000|Overall Study|Poor/Non-compliance|0|||
30576120|NCT04965389|58586085|FG001|Overall Study|Poor/Non-compliance|1|||
30576121|NCT04965389|58586086|FG002|Overall Study|Poor/Non-compliance|0|||
30576122|NCT04965389|58586087|FG003|Overall Study|Poor/Non-compliance|0|||
30576123|NCT04935931|58586104|FG000|Overall Study|Withdrawal by Subject|1|||
30576124|NCT04839393|58586116|FG000|Overall Study|Adverse Event|0|||
30576125|NCT04839393|58586117|FG001|Overall Study|Adverse Event|0|||
30576126|NCT04839393|58586118|FG002|Overall Study|Adverse Event|2|||
30576127|NCT04839393|58586116|FG000|Overall Study|Withdrawal by participant|0|||
30576128|NCT04839393|58586117|FG001|Overall Study|Withdrawal by participant|0|||
30576129|NCT04839393|58586118|FG002|Overall Study|Withdrawal by participant|1|||
30576130|NCT04696055|58586185|FG000|Overall Study|Adverse Event|10|||
30576131|NCT04696055|58586186|FG001|Overall Study|Adverse Event|0|||
30576132|NCT04696055|58586185|FG000|Overall Study|Death|2|||
30576133|NCT04696055|58586186|FG001|Overall Study|Death|1|||
30576134|NCT04696055|58586185|FG000|Overall Study|Other|4|||
30576135|NCT04696055|58586186|FG001|Overall Study|Other|0|||
30576136|NCT04696055|58586185|FG000|Overall Study|Physician Decision|1|||
30576137|NCT04696055|58586186|FG001|Overall Study|Physician Decision|0|||
30576138|NCT04696055|58586185|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
30576139|NCT04696055|58586186|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
30576140|NCT04696055|58586185|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
30576141|NCT04696055|58586186|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
30576142|NCT04696055|58586185|FG000|Overall Study|Subject Decision|1|||
30576143|NCT04696055|58586186|FG001|Overall Study|Subject Decision|2|||
30576144|NCT04696055|58586185|FG000|Overall Study|Ongoing with study treatment|13|||
30576145|NCT04696055|58586186|FG001|Overall Study|Ongoing with study treatment|10|||
30576146|NCT04677712|58586202|FG000|Overall Study|Lost to Follow-up|0|||
30576147|NCT04677712|58586203|FG001|Overall Study|Lost to Follow-up|1|||
30576148|NCT04677712|58586204|FG002|Overall Study|Lost to Follow-up|0|||
30576149|NCT04677712|58586205|FG003|Overall Study|Lost to Follow-up|0|||
30576150|NCT04677712|58586206|FG004|Overall Study|Lost to Follow-up|0|||
30576151|NCT04677712|58586207|FG005|Overall Study|Lost to Follow-up|0|||
30576152|NCT04630002|58586234|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
30576153|NCT04630002|58586235|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
30576154|NCT04630002|58586236|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
30576155|NCT04630002|58586234|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
30576156|NCT04630002|58586235|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
30576157|NCT04630002|58586236|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
30576158|NCT04630002|58586234|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
30576159|NCT04630002|58586235|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
30576160|NCT04630002|58586236|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
30576161|NCT04630002|58586234|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
30576162|NCT04630002|58586235|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
30576163|NCT04630002|58586236|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
30576164|NCT04630002|58586234|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
30576165|NCT04630002|58586235|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
30576166|NCT04630002|58586236|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
30576167|NCT04630002|58586234|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
30576168|NCT04630002|58586235|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
30576169|NCT04630002|58586236|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
30576170|NCT04630002|58586234|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
30576171|NCT04630002|58586235|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
30576172|NCT04630002|58586236|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
30576173|NCT04630002|58586234|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
30576174|NCT04630002|58586235|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
30576175|NCT04630002|58586236|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
30576176|NCT04626128|58586264|FG000|Overall Study|Withdrawal by Subject|0|||
30576177|NCT04626128|58586265|FG001|Overall Study|Withdrawal by Subject|1|||
30576178|NCT04626128|58586266|FG002|Overall Study|Withdrawal by Subject|0|||
30576179|NCT04626128|58586267|FG003|Overall Study|Withdrawal by Subject|0|||
30576180|NCT04576923|58586286|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
30576181|NCT04526197|58586300|FG000|Period 1|Adverse Event|0|||
30576182|NCT04526197|58586301|FG001|Period 1|Adverse Event|1|||
30576183|NCT04526197|58586300|FG000|Period 1|Withdrawal by Subject|1|||
30576184|NCT04526197|58586301|FG001|Period 1|Withdrawal by Subject|0|||
30576185|NCT04526197|58586300|FG000|Period 2|Adverse Event|0|||
30576186|NCT04526197|58586301|FG001|Period 2|Adverse Event|1|||
30576187|NCT04526197|58586300|FG000|Period 2|Withdrawal by Subject|0|||
30576188|NCT04526197|58586301|FG001|Period 2|Withdrawal by Subject|1|||
30576189|NCT04445688|58586308|FG000|Washout (One Week)|Adverse Event|2|||
30576190|NCT04445688|58586308|FG000|Washout (One Week)|Withdrawal by Subject|1|||
30576191|NCT04412668|58586319|FG000|Overall Study|Death - multiple comorbidities|2|||
30576192|NCT04412668|58586320|FG001|Overall Study|Death - multiple comorbidities|0|||
30576193|NCT04412668|58586321|FG002|Overall Study|Death - multiple comorbidities|0|||
30576194|NCT04412668|58586319|FG000|Overall Study|Withdrawal by Subject|3|||
30576195|NCT04412668|58586320|FG001|Overall Study|Withdrawal by Subject|0|||
30576196|NCT04412668|58586321|FG002|Overall Study|Withdrawal by Subject|0|||
30576197|NCT04412668|58586319|FG000|Overall Study|Other than Specified|2|||
30576198|NCT04412668|58586320|FG001|Overall Study|Other than Specified|0|||
30576199|NCT04412668|58586321|FG002|Overall Study|Other than Specified|0|||
30576200|NCT04360551|58586331|FG000|Overall Study|Withdrawal by Subject|1|||
30576201|NCT04360551|58586332|FG001|Overall Study|Withdrawal by Subject|0|||
30576202|NCT04299087|58586340|FG000|Overall Study|Lost to Follow-up|2|||
30576203|NCT04299087|58586341|FG001|Overall Study|Lost to Follow-up|1|||
30576204|NCT04288778|58586347|FG000|Overall Study|Withdrawal by Subject|2|||
30576205|NCT04288778|58586347|FG000|Overall Study|Adverse Event|5|||
30576206|NCT04288778|58586347|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30576207|NCT04288778|58586347|FG000|Overall Study|Other|1|||
30576208|NCT04288778|58586347|FG000|Overall Study|Started but not treated|2|||
30576209|NCT04233164|58586366|FG000|Overall Study|Unable to obtain specimen|0|||
30576210|NCT04233164|58586367|FG001|Overall Study|Unable to obtain specimen|1|||
30576211|NCT04152200|58586383|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
30576212|NCT04152200|58586384|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
30576213|NCT04147195|58586394|FG000|Overall Study|Adverse Event|0|||
30576214|NCT04147195|58586395|FG001|Overall Study|Adverse Event|3|||
30576215|NCT04147195|58586394|FG000|Overall Study|Study Terminated by Sponsor|4|||
30576216|NCT04147195|58586395|FG001|Overall Study|Study Terminated by Sponsor|2|||
30576217|NCT04147195|58586394|FG000|Overall Study|Withdrawal by Subject|0|||
30576218|NCT04147195|58586395|FG001|Overall Study|Withdrawal by Subject|1|||
30576219|NCT04124965|58586404|FG000|Overall Study|Adverse event, non-fatal|3|||
30576220|NCT04124965|58586405|FG001|Overall Study|Adverse event, non-fatal|1|||
30576221|NCT04124965|58586404|FG000|Overall Study|Withdrawal by Subject|1|||
30576222|NCT04124965|58586405|FG001|Overall Study|Withdrawal by Subject|1|||
30576223|NCT04124965|58586404|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
30576224|NCT04124965|58586405|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
30576225|NCT04124965|58586404|FG000|Overall Study|Pregnancy|1|||
30576226|NCT04124965|58586405|FG001|Overall Study|Pregnancy|0|||
30576227|NCT04124965|58586404|FG000|Overall Study|Sponsor and participant decision|0|||
30576228|NCT04124965|58586405|FG001|Overall Study|Sponsor and participant decision|1|||
30576229|NCT04124965|58586404|FG000|Overall Study|Personal surgery|0|||
30576230|NCT04124965|58586405|FG001|Overall Study|Personal surgery|1|||
30576231|NCT04124965|58586404|FG000|Overall Study|Physician Decision|0|||
30576232|NCT04124965|58586405|FG001|Overall Study|Physician Decision|1|||
30576233|NCT04092816|58586417|FG000|Overall Study|Lost to Follow-up|1|||
30576234|NCT04092816|58586418|FG001|Overall Study|Lost to Follow-up|2|||
30576235|NCT03985878|58586435|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
30576236|NCT03985878|58586435|FG000|Overall Study|Study Terminated by Sponsor|12|||
30576237|NCT03985878|58586435|FG000|Overall Study|Withdrawal by Subject|1|||
30576238|NCT03971422|58586501|FG000|Overall Study|Lost to Follow-up|0|||
30576239|NCT03971422|58586502|FG001|Overall Study|Lost to Follow-up|1|||
30576240|NCT03971422|58586503|FG002|Overall Study|Lost to Follow-up|0|||
30576241|NCT03971422|58586501|FG000|Overall Study|Lack of Efficacy|5|||
30576242|NCT03971422|58586502|FG001|Overall Study|Lack of Efficacy|1|||
30576243|NCT03971422|58586503|FG002|Overall Study|Lack of Efficacy|1|||
30576244|NCT03971422|58586501|FG000|Overall Study|Adverse event, not fatal|2|||
30576245|NCT03971422|58586502|FG001|Overall Study|Adverse event, not fatal|2|||
30576246|NCT03971422|58586503|FG002|Overall Study|Adverse event, not fatal|5|||
30576247|NCT03971422|58586501|FG000|Overall Study|Worsening of MG Symptoms|1|||
30576248|NCT03971422|58586502|FG001|Overall Study|Worsening of MG Symptoms|4|||
30576249|NCT03971422|58586503|FG002|Overall Study|Worsening of MG Symptoms|2|||
30576250|NCT03971422|58586501|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
30576251|NCT03971422|58586502|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
30576252|NCT03971422|58586503|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
30576253|NCT03971422|58586501|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
30576254|NCT03971422|58586502|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
30576255|NCT03971422|58586503|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
30576256|NCT03971422|58586501|FG000|Overall Study|Due to COVID-19 pandemic|0|||
30576257|NCT03971422|58586502|FG001|Overall Study|Due to COVID-19 pandemic|1|||
30576258|NCT03971422|58586503|FG002|Overall Study|Due to COVID-19 pandemic|1|||
30576259|NCT03946670|58586513|FG000|Overall Study|Progressive Disease|26|||
30576260|NCT03946670|58586514|FG001|Overall Study|Progressive Disease|23|||
30576261|NCT03946670|58586513|FG000|Overall Study|Adverse Event|7|||
30576262|NCT03946670|58586514|FG001|Overall Study|Adverse Event|9|||
30576263|NCT03946670|58586513|FG000|Overall Study|Death|5|||
30576264|NCT03946670|58586514|FG001|Overall Study|Death|6|||
30576265|NCT03946670|58586513|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
30576266|NCT03946670|58586514|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
30855322|NCT02787863|58882926|FG004|Overall Study|Withdrawal by Subject|0|||
30576267|NCT03946670|58586513|FG000|Overall Study|Subject Decision|4|||
30576268|NCT03946670|58586514|FG001|Overall Study|Subject Decision|4|||
30576269|NCT03946670|58586513|FG000|Overall Study|Physician Decision|3|||
30576270|NCT03946670|58586514|FG001|Overall Study|Physician Decision|3|||
30576271|NCT03946670|58586513|FG000|Overall Study|New Therapy for Study Indication|1|||
30576272|NCT03946670|58586514|FG001|Overall Study|New Therapy for Study Indication|0|||
30576273|NCT03946670|58586513|FG000|Overall Study|Not treated|1|||
30576274|NCT03946670|58586514|FG001|Overall Study|Not treated|1|||
30576275|NCT03905694|58586520|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
30576276|NCT03818035|58586541|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
30576277|NCT03818035|58586542|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
30576278|NCT03818035|58586543|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
30576279|NCT03818035|58586544|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
30576280|NCT03818035|58586541|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
30576281|NCT03818035|58586542|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
30576282|NCT03818035|58586543|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
30576283|NCT03818035|58586544|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
30576284|NCT03818035|58586541|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
30576285|NCT03818035|58586542|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
30576286|NCT03818035|58586543|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
30576287|NCT03818035|58586544|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
30576288|NCT03818035|58586541|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
30576289|NCT03818035|58586542|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
30576290|NCT03818035|58586543|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
30576291|NCT03818035|58586544|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
30576292|NCT03818035|58586541|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
30576293|NCT03818035|58586542|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
30576294|NCT03818035|58586543|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
30576295|NCT03818035|58586544|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
30576296|NCT03818035|58586541|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
30668013|NCT00824265|58681935|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
30668014|NCT00855894|58681945|FG000|Overall Study|Death|31|||
30668015|NCT00855894|58681945|FG000|Overall Study|Patient's decision|1|||
30668016|NCT00855894|58681945|FG000|Overall Study|Disease progression|1|||
30668017|NCT00855816|58681951|FG000|Overall Study|Withdrawal by Subject|22|||
30668018|NCT00855816|58681952|FG001|Overall Study|Withdrawal by Subject|15|||
30668019|NCT00855816|58681951|FG000|Overall Study|Lost to Follow-up|3|||
30668020|NCT00855816|58681952|FG001|Overall Study|Lost to Follow-up|5|||
30668021|NCT00855816|58681951|FG000|Overall Study|Death|1|||
30668022|NCT00855816|58681952|FG001|Overall Study|Death|0|||
30668023|NCT00855816|58681951|FG000|Overall Study|Became ineligible|0|||
30668024|NCT00855816|58681952|FG001|Overall Study|Became ineligible|1|||
30668025|NCT00855738|58681958|FG000|Overall Study|Lost to Follow-up|2|||
30668026|NCT00855738|58681958|FG000|Overall Study|Adverse Event|1|||
30668027|NCT00855738|58681958|FG000|Overall Study|Subject Defaulted|1|||
30668028|NCT00855738|58681958|FG000|Overall Study|Death|1|||
30668029|NCT00490945|58681969|FG000|Overall Study|Adverse Event|0|||
30668030|NCT00490945|58681970|FG001|Overall Study|Adverse Event|1|||
30668031|NCT00490945|58681971|FG002|Overall Study|Adverse Event|0|||
30668032|NCT00490945|58681972|FG003|Overall Study|Adverse Event|0|||
30668033|NCT00490945|58681973|FG004|Overall Study|Adverse Event|0|||
30668034|NCT00879398|58681991|FG000|Overall Study|Visit Stop|399|||
30668035|NCT00879398|58681991|FG000|Overall Study|Lack of Efficacy|64|||
30668036|NCT00879398|58681991|FG000|Overall Study|Adverse Event|41|||
30668037|NCT00879398|58681991|FG000|Overall Study|Other Reasons|171|||
30668038|NCT00696436|58682000|FG000|Overall Study|Adverse Event|7|||
30668039|NCT00696436|58682001|FG001|Overall Study|Adverse Event|9|||
30668040|NCT00696436|58682002|FG002|Overall Study|Adverse Event|8|||
30668041|NCT00696436|58682003|FG003|Overall Study|Adverse Event|6|||
30668042|NCT00696436|58682004|FG004|Overall Study|Adverse Event|4|||
30576297|NCT03818035|58586542|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
30576298|NCT03818035|58586543|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
30576299|NCT03818035|58586544|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
30668043|NCT00696436|58682000|FG000|Overall Study|Protocol Violation|3|||
30668044|NCT00696436|58682001|FG001|Overall Study|Protocol Violation|2|||
30668045|NCT00696436|58682002|FG002|Overall Study|Protocol Violation|2|||
30668046|NCT00696436|58682003|FG003|Overall Study|Protocol Violation|0|||
30668047|NCT00696436|58682004|FG004|Overall Study|Protocol Violation|1|||
30668048|NCT00696436|58682000|FG000|Overall Study|Lost to Follow-up|1|||
30668049|NCT00696436|58682001|FG001|Overall Study|Lost to Follow-up|6|||
30668050|NCT00696436|58682002|FG002|Overall Study|Lost to Follow-up|2|||
30668051|NCT00696436|58682003|FG003|Overall Study|Lost to Follow-up|4|||
30668052|NCT00696436|58682004|FG004|Overall Study|Lost to Follow-up|3|||
30668053|NCT00696436|58682000|FG000|Overall Study|Withdrawal by Subject|4|||
30855323|NCT02787863|58882927|FG005|Overall Study|Withdrawal by Subject|0|||
30668054|NCT00696436|58682001|FG001|Overall Study|Withdrawal by Subject|11|||
30576300|NCT03818035|58586541|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
30576301|NCT03818035|58586542|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
30576302|NCT03818035|58586543|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
30576303|NCT03818035|58586544|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
30576304|NCT03818035|58586541|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
30576305|NCT03818035|58586542|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
30576306|NCT03818035|58586543|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
30576307|NCT03818035|58586544|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
30576308|NCT03818035|58586541|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
30576309|NCT03818035|58586542|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
30576310|NCT03818035|58586543|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
30576311|NCT03818035|58586544|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
30576312|NCT03818035|58586541|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
30576313|NCT03818035|58586542|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
30576314|NCT03818035|58586543|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
30576315|NCT03818035|58586544|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
30576316|NCT03818035|58586541|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
30576317|NCT03818035|58586542|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
30576318|NCT03818035|58586543|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
30576319|NCT03818035|58586544|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
30576320|NCT03818035|58586541|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
30576321|NCT03818035|58586542|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
30576322|NCT03818035|58586543|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
30576323|NCT03818035|58586544|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
30576324|NCT03818035|58586541|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
30576325|NCT03818035|58586542|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
30576326|NCT03818035|58586543|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
30576327|NCT03818035|58586544|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
30576328|NCT03818035|58586541|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
30576329|NCT03818035|58586542|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
30576330|NCT03818035|58586543|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
30576331|NCT03818035|58586544|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
30576332|NCT03818035|58586541|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
30576333|NCT03818035|58586542|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
30576334|NCT03818035|58586543|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
30576335|NCT03818035|58586544|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
30576336|NCT03774394|58586555|FG000|Overall Study|Withdrawal by Subject|2|||
30576337|NCT03774394|58586556|FG001|Overall Study|Withdrawal by Subject|0|||
30576338|NCT03765788|58586564|FG000|Overall Study|Subject decision|2|||
30576339|NCT03765788|58586565|FG001|Overall Study|Subject decision|3|||
30576340|NCT03765788|58586564|FG000|Overall Study|Physician Decision|2|||
30576341|NCT03765788|58586565|FG001|Overall Study|Physician Decision|4|||
30576342|NCT03765788|58586564|FG000|Overall Study|Death|0|||
30576343|NCT03765788|58586565|FG001|Overall Study|Death|1|||
30576344|NCT03765788|58586564|FG000|Overall Study|Lost to Follow-up|1|||
30576345|NCT03765788|58586565|FG001|Overall Study|Lost to Follow-up|0|||
30576346|NCT03759379|58586575|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
30576347|NCT03759379|58586576|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
30576348|NCT03759379|58586575|FG000|Treatment Period|Death|2|||
30576349|NCT03759379|58586576|FG001|Treatment Period|Death|3|||
30576350|NCT03759379|58586575|FG000|Treatment Period|Lost to Follow-up|1|||
30576351|NCT03759379|58586576|FG001|Treatment Period|Lost to Follow-up|0|||
30576352|NCT03759379|58586575|FG000|Treatment Period|Physician Decision|0|||
30576353|NCT03759379|58586576|FG001|Treatment Period|Physician Decision|1|||
30576354|NCT03692403|58586586|FG000|Overall Study|Withdrawal by Subject|1|||
30576355|NCT03692403|58586587|FG001|Overall Study|Withdrawal by Subject|0|||
30576356|NCT03692403|58586588|FG002|Overall Study|Withdrawal by Subject|1|||
30576357|NCT03692403|58586589|FG003|Overall Study|Withdrawal by Subject|0|||
30576358|NCT03692403|58586586|FG000|Overall Study|Adverse Event|0|||
30576359|NCT03692403|58586587|FG001|Overall Study|Adverse Event|0|||
30576360|NCT03692403|58586588|FG002|Overall Study|Adverse Event|0|||
30576361|NCT03692403|58586589|FG003|Overall Study|Adverse Event|1|||
30576362|NCT03692403|58586586|FG000|Overall Study|Pregnancy|0|||
30576363|NCT03692403|58586587|FG001|Overall Study|Pregnancy|1|||
30576364|NCT03692403|58586588|FG002|Overall Study|Pregnancy|0|||
30576365|NCT03692403|58586589|FG003|Overall Study|Pregnancy|0|||
30780270|NCT03594110|58792097|FG000|Overall Study|Contraindicated drug started|32|||
30780271|NCT03594110|58792098|FG001|Overall Study|Contraindicated drug started|18|||
30855324|NCT02787863|58882928|FG006|Overall Study|Withdrawal by Subject|0|||
30576366|NCT03692403|58586586|FG000|Overall Study|Other|0|||
30576367|NCT03692403|58586587|FG001|Overall Study|Other|0|||
30576368|NCT03692403|58586588|FG002|Overall Study|Other|1|||
30576369|NCT03692403|58586589|FG003|Overall Study|Other|0|||
30576370|NCT03681184|58586604|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
30576371|NCT03681184|58586605|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
30576372|NCT03681184|58586604|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12|||
30576373|NCT03681184|58586605|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23|||
30576374|NCT03681184|58586604|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
30576375|NCT03681184|58586605|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
30576376|NCT03654651|58586613|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
30576377|NCT03654651|58586614|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
30576378|NCT03649230|58586621|FG000|Overall Study|Adverse Event|12|||
30576379|NCT03649230|58586621|FG000|Overall Study|Death|8|||
30576380|NCT03649230|58586621|FG000|Overall Study|Withdrawal by Subject|6|||
30576381|NCT03649230|58586621|FG000|Overall Study|Physician Decision|5|||
30576382|NCT03649230|58586621|FG000|Overall Study|Disease progression|5|||
30576383|NCT03649230|58586621|FG000|Overall Study|Switched to non-HEC|5|||
30576384|NCT03649230|58586621|FG000|Overall Study|Chemotherapy discontinued|4|||
30576385|NCT03649230|58586621|FG000|Overall Study|Received only 3 HEC cycles|4|||
30576386|NCT03649230|58586621|FG000|Overall Study|Screen Failure|3|||
30576387|NCT03649230|58586621|FG000|Overall Study|Patient stopped treatment|2|||
30576388|NCT03649230|58586621|FG000|Overall Study|Protocol Violation|1|||
30576389|NCT03649230|58586621|FG000|Overall Study|Non-compliance|1|||
30576390|NCT03649230|58586621|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
30576391|NCT03635983|58586631|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
30576392|NCT03635983|58586632|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
30576393|NCT03635983|58586631|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
30576394|NCT03635983|58586632|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
30576395|NCT03635983|58586631|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
30576396|NCT03635983|58586632|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30576397|NCT03635983|58586631|FG000|Pre-Treatment Period|Other reasons|1|||
30576398|NCT03635983|58586632|FG001|Pre-Treatment Period|Other reasons|2|||
30576399|NCT03635983|58586631|FG000|Pre-Treatment Period|Disease Progression|0|||
30576400|NCT03635983|58586632|FG001|Pre-Treatment Period|Disease Progression|1|||
30576401|NCT03635983|58586631|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
30576402|NCT03635983|58586632|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
30576403|NCT03635983|58586631|FG000|Treatment Period|Completed treatment period|13|||
30576404|NCT03635983|58586632|FG001|Treatment Period|Completed treatment period|20|||
30576405|NCT03635983|58586631|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
30576406|NCT03635983|58586632|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
30576407|NCT03635983|58586631|FG000|Treatment Period|Withdrawal by Subject|2|||
30576408|NCT03635983|58586632|FG001|Treatment Period|Withdrawal by Subject|4|||
30576409|NCT03635983|58586631|FG000|Treatment Period|Death|3|||
30576410|NCT03635983|58586632|FG001|Treatment Period|Death|4|||
30576411|NCT03635983|58586631|FG000|Treatment Period|Poor/Non-compliance|1|||
30576412|NCT03635983|58586632|FG001|Treatment Period|Poor/Non-compliance|0|||
30576413|NCT03635983|58586631|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
30576414|NCT03635983|58586632|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
30576415|NCT03635983|58586631|FG000|Treatment Period|Other reasons|5|||
30576416|NCT03635983|58586632|FG001|Treatment Period|Other reasons|2|||
30576417|NCT03635983|58586631|FG000|Treatment Period|Disease progression|184|||
30576418|NCT03635983|58586632|FG001|Treatment Period|Disease progression|168|||
30576419|NCT03635983|58586631|FG000|Treatment Period|Study drug toxicity|26|||
30576420|NCT03635983|58586632|FG001|Treatment Period|Study drug toxicity|29|||
30576421|NCT03635983|58586631|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
30576422|NCT03635983|58586632|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
30576423|NCT03635983|58586631|FG000|Treatment Period|Maximum clinical benefit|3|||
30576424|NCT03635983|58586632|FG001|Treatment Period|Maximum clinical benefit|2|||
30576425|NCT03626545|58586641|FG000|Overall Study|Progressive disease|3|||
30576426|NCT03626545|58586642|FG001|Overall Study|Progressive disease|82|||
30576427|NCT03626545|58586643|FG002|Overall Study|Progressive disease|85|||
30576428|NCT03626545|58586641|FG000|Overall Study|Adverse Event|3|||
30576429|NCT03626545|58586642|FG001|Overall Study|Adverse Event|13|||
30576430|NCT03626545|58586643|FG002|Overall Study|Adverse Event|10|||
30576431|NCT03626545|58586641|FG000|Overall Study|Physician Decision|1|||
30576432|NCT03626545|58586642|FG001|Overall Study|Physician Decision|18|||
30668055|NCT00696436|58682002|FG002|Overall Study|Withdrawal by Subject|5|||
30576433|NCT03626545|58586643|FG002|Overall Study|Physician Decision|14|||
30668056|NCT00696436|58682003|FG003|Overall Study|Withdrawal by Subject|7|||
30780272|NCT03594110|58792097|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
30576434|NCT03626545|58586641|FG000|Overall Study|Subject Decision|0|||
30576435|NCT03626545|58586642|FG001|Overall Study|Subject Decision|5|||
30576436|NCT03626545|58586643|FG002|Overall Study|Subject Decision|5|||
30576437|NCT03626545|58586641|FG000|Overall Study|Death|1|||
30576438|NCT03626545|58586642|FG001|Overall Study|Death|1|||
30576439|NCT03626545|58586643|FG002|Overall Study|Death|1|||
30576440|NCT03626545|58586641|FG000|Overall Study|Protocol Deviation|0|||
30576441|NCT03626545|58586642|FG001|Overall Study|Protocol Deviation|1|||
30576442|NCT03626545|58586643|FG002|Overall Study|Protocol Deviation|1|||
30576443|NCT03626545|58586641|FG000|Overall Study|Guardian Decision|0|||
30576444|NCT03626545|58586642|FG001|Overall Study|Guardian Decision|0|||
30576445|NCT03626545|58586643|FG002|Overall Study|Guardian Decision|1|||
30576446|NCT03575143|58586660|FG000|Overall Study|Lost to Follow-up|0|||
30576447|NCT03575143|58586661|FG001|Overall Study|Lost to Follow-up|0|||
30576448|NCT03575143|58586662|FG002|Overall Study|Lost to Follow-up|4|||
30576449|NCT03575143|58586660|FG000|Overall Study|Withdrawal by Subject|0|||
30576450|NCT03575143|58586661|FG001|Overall Study|Withdrawal by Subject|0|||
30576451|NCT03575143|58586662|FG002|Overall Study|Withdrawal by Subject|5|||
30576452|NCT03575143|58586660|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
30576453|NCT03575143|58586661|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
30576454|NCT03575143|58586662|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
30576455|NCT03548064|58586680|FG000|Overall Study|Withdrawal by Subject|0|||
30576456|NCT03548064|58586681|FG001|Overall Study|Withdrawal by Subject|0|||
30576457|NCT03548064|58586682|FG002|Overall Study|Withdrawal by Subject|0|||
30576458|NCT03548064|58586683|FG003|Overall Study|Withdrawal by Subject|1|||
30576459|NCT03548064|58586684|FG004|Overall Study|Withdrawal by Subject|0|||
30576460|NCT03548064|58586685|FG005|Overall Study|Withdrawal by Subject|0|||
30576461|NCT03548064|58586686|FG006|Overall Study|Withdrawal by Subject|0|||
30576462|NCT03548064|58586687|FG007|Overall Study|Withdrawal by Subject|0|||
30576463|NCT03548064|58586680|FG000|Overall Study|Lost to Follow-up|0|||
30576464|NCT03548064|58586681|FG001|Overall Study|Lost to Follow-up|0|||
30576465|NCT03548064|58586682|FG002|Overall Study|Lost to Follow-up|0|||
30576466|NCT03548064|58586683|FG003|Overall Study|Lost to Follow-up|0|||
30576467|NCT03548064|58586684|FG004|Overall Study|Lost to Follow-up|2|||
30576468|NCT03548064|58586685|FG005|Overall Study|Lost to Follow-up|0|||
30576469|NCT03548064|58586686|FG006|Overall Study|Lost to Follow-up|0|||
30576470|NCT03548064|58586687|FG007|Overall Study|Lost to Follow-up|0|||
30576471|NCT03548064|58586680|FG000|Overall Study|Covid-19 Pandemic|0|||
30576472|NCT03548064|58586681|FG001|Overall Study|Covid-19 Pandemic|0|||
30576473|NCT03548064|58586682|FG002|Overall Study|Covid-19 Pandemic|0|||
30576474|NCT03548064|58586683|FG003|Overall Study|Covid-19 Pandemic|0|||
30576475|NCT03548064|58586684|FG004|Overall Study|Covid-19 Pandemic|10|||
30576476|NCT03548064|58586685|FG005|Overall Study|Covid-19 Pandemic|3|||
30576477|NCT03548064|58586686|FG006|Overall Study|Covid-19 Pandemic|0|||
30576478|NCT03548064|58586687|FG007|Overall Study|Covid-19 Pandemic|0|||
30576479|NCT03512197|58586713|FG000|Overall Study|Guardian decision|1|||
30576480|NCT03512197|58586714|FG001|Overall Study|Guardian decision|1|||
30576481|NCT03512197|58586713|FG000|Overall Study|Lack of Efficacy|19|||
30576482|NCT03512197|58586714|FG001|Overall Study|Lack of Efficacy|11|||
30576483|NCT03512197|58586713|FG000|Overall Study|New Therapy for Study Indication|16|||
30576484|NCT03512197|58586714|FG001|Overall Study|New Therapy for Study Indication|16|||
30576485|NCT03512197|58586713|FG000|Overall Study|Physician Decision|60|||
30576486|NCT03512197|58586714|FG001|Overall Study|Physician Decision|60|||
30576487|NCT03512197|58586713|FG000|Overall Study|Protocol Violation|0|||
30576488|NCT03512197|58586714|FG001|Overall Study|Protocol Violation|2|||
30576489|NCT03512197|58586713|FG000|Overall Study|Terminated by Sponsored|46|||
30576490|NCT03512197|58586714|FG001|Overall Study|Terminated by Sponsored|50|||
30576491|NCT03512197|58586713|FG000|Overall Study|Subject Decision|15|||
30576492|NCT03512197|58586714|FG001|Overall Study|Subject Decision|12|||
30576493|NCT03512197|58586713|FG000|Overall Study|Withdrawal of informed consent|20|||
30576494|NCT03512197|58586714|FG001|Overall Study|Withdrawal of informed consent|14|||
30576495|NCT03512197|58586713|FG000|Overall Study|Adverse Event|30|||
30576496|NCT03512197|58586714|FG001|Overall Study|Adverse Event|34|||
30576497|NCT03512197|58586713|FG000|Overall Study|Death|14|||
30576498|NCT03512197|58586714|FG001|Overall Study|Death|9|||
30576499|NCT03512197|58586713|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
30576500|NCT03512197|58586714|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
30576501|NCT03512197|58586713|FG000|Overall Study|Missing|3|||
30576502|NCT03512197|58586714|FG001|Overall Study|Missing|13|||
30576503|NCT03502330|58586734|FG000|Overall Study|Adverse Event|2|||
30576504|NCT03502330|58586735|FG001|Overall Study|Adverse Event|1|||
30576505|NCT03502330|58586736|FG002|Overall Study|Adverse Event|0|||
30576506|NCT03502330|58586737|FG003|Overall Study|Adverse Event|0|||
30576507|NCT03502330|58586738|FG004|Overall Study|Adverse Event|1|||
30576508|NCT03502330|58586739|FG005|Overall Study|Adverse Event|0|||
30576509|NCT03502330|58586740|FG006|Overall Study|Adverse Event|1|||
30576510|NCT03502330|58586741|FG007|Overall Study|Adverse Event|1|||
30576511|NCT03502330|58586742|FG008|Overall Study|Adverse Event|0|||
30576512|NCT03502330|58586734|FG000|Overall Study|Lack of Efficacy|1|||
30576513|NCT03502330|58586735|FG001|Overall Study|Lack of Efficacy|5|||
30576514|NCT03502330|58586736|FG002|Overall Study|Lack of Efficacy|3|||
30576515|NCT03502330|58586737|FG003|Overall Study|Lack of Efficacy|5|||
30576516|NCT03502330|58586738|FG004|Overall Study|Lack of Efficacy|1|||
30576517|NCT03502330|58586739|FG005|Overall Study|Lack of Efficacy|5|||
30576518|NCT03502330|58586740|FG006|Overall Study|Lack of Efficacy|5|||
30576519|NCT03502330|58586741|FG007|Overall Study|Lack of Efficacy|6|||
30576520|NCT03502330|58586742|FG008|Overall Study|Lack of Efficacy|0|||
30576521|NCT03502330|58586734|FG000|Overall Study|Physician Decision|0|||
30576522|NCT03502330|58586735|FG001|Overall Study|Physician Decision|0|||
30576523|NCT03502330|58586736|FG002|Overall Study|Physician Decision|0|||
30576524|NCT03502330|58586737|FG003|Overall Study|Physician Decision|0|||
30576525|NCT03502330|58586738|FG004|Overall Study|Physician Decision|1|||
30576526|NCT03502330|58586739|FG005|Overall Study|Physician Decision|0|||
30576527|NCT03502330|58586740|FG006|Overall Study|Physician Decision|0|||
30576528|NCT03502330|58586741|FG007|Overall Study|Physician Decision|0|||
30576529|NCT03502330|58586742|FG008|Overall Study|Physician Decision|0|||
30576530|NCT03502330|58586734|FG000|Overall Study|Withdrawal by Subject|0|||
30576531|NCT03502330|58586735|FG001|Overall Study|Withdrawal by Subject|0|||
30576532|NCT03502330|58586736|FG002|Overall Study|Withdrawal by Subject|0|||
30576533|NCT03502330|58586737|FG003|Overall Study|Withdrawal by Subject|0|||
30576534|NCT03502330|58586738|FG004|Overall Study|Withdrawal by Subject|0|||
30576535|NCT03502330|58586739|FG005|Overall Study|Withdrawal by Subject|1|||
30576536|NCT03502330|58586740|FG006|Overall Study|Withdrawal by Subject|0|||
30576537|NCT03502330|58586741|FG007|Overall Study|Withdrawal by Subject|1|||
30576538|NCT03502330|58586742|FG008|Overall Study|Withdrawal by Subject|0|||
30576539|NCT03502330|58586734|FG000|Overall Study|Death|0|||
30576540|NCT03502330|58586735|FG001|Overall Study|Death|0|||
30576541|NCT03502330|58586736|FG002|Overall Study|Death|0|||
30576542|NCT03502330|58586737|FG003|Overall Study|Death|0|||
30576543|NCT03502330|58586738|FG004|Overall Study|Death|0|||
30576544|NCT03502330|58586739|FG005|Overall Study|Death|0|||
30576545|NCT03502330|58586740|FG006|Overall Study|Death|2|||
30576546|NCT03502330|58586741|FG007|Overall Study|Death|0|||
30576547|NCT03502330|58586742|FG008|Overall Study|Death|0|||
30576548|NCT03492177|58586763|FG000|Overall Study|Adverse Event|1|||
30576549|NCT03492177|58586764|FG001|Overall Study|Adverse Event|0|||
30576550|NCT03492177|58586765|FG002|Overall Study|Adverse Event|0|||
30576551|NCT03492177|58586763|FG000|Overall Study|Death|3|||
30576552|NCT03492177|58586764|FG001|Overall Study|Death|0|||
30576553|NCT03492177|58586765|FG002|Overall Study|Death|3|||
30576554|NCT03492177|58586763|FG000|Overall Study|Lack of Efficacy|1|||
30576555|NCT03492177|58586764|FG001|Overall Study|Lack of Efficacy|2|||
30576556|NCT03492177|58586765|FG002|Overall Study|Lack of Efficacy|0|||
30576557|NCT03492177|58586763|FG000|Overall Study|Other|1|||
30576558|NCT03492177|58586764|FG001|Overall Study|Other|0|||
30576559|NCT03492177|58586765|FG002|Overall Study|Other|0|||
30576560|NCT03492177|58586763|FG000|Overall Study|Ongoing|16|||
30576561|NCT03492177|58586764|FG001|Overall Study|Ongoing|19|||
30576562|NCT03492177|58586765|FG002|Overall Study|Ongoing|17|||
30576563|NCT03460756|58586777|FG000|Overall Study|Adverse Event|0|||
30576564|NCT03460756|58586778|FG001|Overall Study|Adverse Event|0|||
30576565|NCT03460756|58586779|FG002|Overall Study|Adverse Event|0|||
30576566|NCT03460756|58586780|FG003|Overall Study|Adverse Event|1|||
30576567|NCT03460756|58586777|FG000|Overall Study|Lack of Efficacy|0|||
30576568|NCT03460756|58586778|FG001|Overall Study|Lack of Efficacy|0|||
30576569|NCT03460756|58586779|FG002|Overall Study|Lack of Efficacy|0|||
30576570|NCT03460756|58586780|FG003|Overall Study|Lack of Efficacy|2|||
30576571|NCT03460756|58586777|FG000|Overall Study|Lost to Follow-up|0|||
30668057|NCT00696436|58682004|FG004|Overall Study|Withdrawal by Subject|1|||
30668058|NCT00696436|58682000|FG000|Overall Study|Lack of Efficacy|3|||
30576572|NCT03460756|58586778|FG001|Overall Study|Lost to Follow-up|1|||
30576573|NCT03460756|58586779|FG002|Overall Study|Lost to Follow-up|2|||
30576574|NCT03460756|58586780|FG003|Overall Study|Lost to Follow-up|1|||
30576575|NCT03460756|58586777|FG000|Overall Study|Pregnancy|0|||
30576576|NCT03460756|58586778|FG001|Overall Study|Pregnancy|0|||
30576577|NCT03460756|58586779|FG002|Overall Study|Pregnancy|0|||
30576578|NCT03460756|58586780|FG003|Overall Study|Pregnancy|1|||
30668059|NCT00696436|58682001|FG001|Overall Study|Lack of Efficacy|1|||
30668060|NCT00696436|58682002|FG002|Overall Study|Lack of Efficacy|5|||
30668061|NCT00696436|58682003|FG003|Overall Study|Lack of Efficacy|2|||
30668062|NCT00696436|58682004|FG004|Overall Study|Lack of Efficacy|4|||
30668063|NCT00696436|58682000|FG000|Overall Study|Participant Unavailability|2|||
30576579|NCT03460756|58586777|FG000|Overall Study|Protocol Violation|0|||
30576580|NCT03460756|58586778|FG001|Overall Study|Protocol Violation|0|||
30576581|NCT03460756|58586779|FG002|Overall Study|Protocol Violation|0|||
30576582|NCT03460756|58586780|FG003|Overall Study|Protocol Violation|1|||
30576583|NCT03460756|58586777|FG000|Overall Study|Withdrawal by Subject|0|||
30576584|NCT03460756|58586778|FG001|Overall Study|Withdrawal by Subject|4|||
30576585|NCT03460756|58586779|FG002|Overall Study|Withdrawal by Subject|7|||
30576586|NCT03460756|58586780|FG003|Overall Study|Withdrawal by Subject|3|||
30576587|NCT03459443|58586792|FG000|Overall Study|Lack of Efficacy|3|||
30576588|NCT03459443|58586792|FG000|Overall Study|Adverse Event|1|||
30576589|NCT03459443|58586792|FG000|Overall Study|Sponsor's decision to close the study|18|||
30576590|NCT03382834|58586798|FG000|Overall Study|Lost to Follow-up|1|||
30576591|NCT03382834|58586799|FG001|Overall Study|Lost to Follow-up|0|||
30576592|NCT03382834|58586798|FG000|Overall Study|Withdrawal by Subject|0|||
30576593|NCT03382834|58586799|FG001|Overall Study|Withdrawal by Subject|1|||
30576594|NCT03367156|58586807|FG000|Overall Study|Lack of interest|3|||
30576595|NCT03367156|58586808|FG001|Overall Study|Lack of interest|1|||
30576596|NCT03367156|58586807|FG000|Overall Study|Death|2|||
30576597|NCT03367156|58586808|FG001|Overall Study|Death|0|||
30576598|NCT03367156|58586807|FG000|Overall Study|Lost to Follow-up|2|||
30576599|NCT03367156|58586808|FG001|Overall Study|Lost to Follow-up|1|||
30668064|NCT00696436|58682001|FG001|Overall Study|Participant Unavailability|0|||
30668065|NCT00696436|58682002|FG002|Overall Study|Participant Unavailability|2|||
30668066|NCT00696436|58682003|FG003|Overall Study|Participant Unavailability|1|||
30668067|NCT00696436|58682004|FG004|Overall Study|Participant Unavailability|0|||
30668068|NCT00696436|58682000|FG000|Overall Study|Administrative Error|2|||
30668069|NCT00696436|58682001|FG001|Overall Study|Administrative Error|0|||
30668070|NCT00696436|58682002|FG002|Overall Study|Administrative Error|2|||
30668071|NCT00696436|58682003|FG003|Overall Study|Administrative Error|0|||
30668072|NCT00696436|58682004|FG004|Overall Study|Administrative Error|0|||
30668073|NCT00696436|58682000|FG000|Overall Study|Participant Non-compliance|0|||
30668074|NCT00696436|58682001|FG001|Overall Study|Participant Non-compliance|0|||
30668075|NCT00696436|58682002|FG002|Overall Study|Participant Non-compliance|1|||
30668076|NCT00696436|58682003|FG003|Overall Study|Participant Non-compliance|2|||
30668077|NCT00696436|58682004|FG004|Overall Study|Participant Non-compliance|0|||
30668078|NCT00696436|58682000|FG000|Overall Study|Administrative Decision|1|||
30668079|NCT00696436|58682001|FG001|Overall Study|Administrative Decision|0|||
30668080|NCT00696436|58682002|FG002|Overall Study|Administrative Decision|0|||
30668081|NCT00696436|58682003|FG003|Overall Study|Administrative Decision|0|||
30668082|NCT00696436|58682004|FG004|Overall Study|Administrative Decision|0|||
30668083|NCT00696436|58682000|FG000|Overall Study|Missing|0|||
30668084|NCT00696436|58682001|FG001|Overall Study|Missing|1|||
30668085|NCT00696436|58682002|FG002|Overall Study|Missing|1|||
30668086|NCT00696436|58682003|FG003|Overall Study|Missing|0|||
30668087|NCT00696436|58682004|FG004|Overall Study|Missing|0|||
30668088|NCT00878072|58682016|FG000|Overall Study|Withdrew consent|2|||
30668089|NCT00594854|58682044|FG000|Overall Study|Study terminated|7|||
30668090|NCT00594854|58682045|FG001|Overall Study|Study terminated|10|||
30668091|NCT00855582|58682054|FG000|Overall Study|Adverse Event|2|||
30668092|NCT00855582|58682055|FG001|Overall Study|Adverse Event|6|||
30668093|NCT00855582|58682056|FG002|Overall Study|Adverse Event|3|||
30668094|NCT00855582|58682054|FG000|Overall Study|Death|1|||
30668095|NCT00855582|58682055|FG001|Overall Study|Death|0|||
30668096|NCT00855582|58682056|FG002|Overall Study|Death|0|||
30668097|NCT00855582|58682054|FG000|Overall Study|Lack of Efficacy|1|||
30668098|NCT00855582|58682055|FG001|Overall Study|Lack of Efficacy|3|||
30668099|NCT00855582|58682056|FG002|Overall Study|Lack of Efficacy|8|||
30668100|NCT00855582|58682054|FG000|Overall Study|Lost to Follow-up|1|||
30668101|NCT00855582|58682055|FG001|Overall Study|Lost to Follow-up|3|||
30668102|NCT00855582|58682056|FG002|Overall Study|Lost to Follow-up|1|||
30668103|NCT00855582|58682054|FG000|Overall Study|Physician Decision|0|||
30668104|NCT00855582|58682055|FG001|Overall Study|Physician Decision|0|||
30668105|NCT00855582|58682056|FG002|Overall Study|Physician Decision|1|||
30668106|NCT00855582|58682054|FG000|Overall Study|Protocol Violation|6|||
30668107|NCT00855582|58682055|FG001|Overall Study|Protocol Violation|2|||
30668108|NCT00855582|58682056|FG002|Overall Study|Protocol Violation|6|||
30668109|NCT00855582|58682054|FG000|Overall Study|Entry Criteria Not Met|8|||
30668110|NCT00855582|58682055|FG001|Overall Study|Entry Criteria Not Met|6|||
30668111|NCT00855582|58682056|FG002|Overall Study|Entry Criteria Not Met|3|||
30668112|NCT00855582|58682054|FG000|Overall Study|Withdrawal by Subject|7|||
30780273|NCT03594110|58792098|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
30780274|NCT03594110|58792097|FG000|Overall Study|Death|129|||
30780275|NCT03594110|58792098|FG001|Overall Study|Death|120|||
30780276|NCT03057054|58792127|FG000|Overall Study|Death|4|||
30780277|NCT03057054|58792128|FG001|Overall Study|Death|4|||
30576600|NCT03367156|58586807|FG000|Overall Study|Became ineligible|1|||
30668113|NCT00855582|58682055|FG001|Overall Study|Withdrawal by Subject|4|||
30668114|NCT00855582|58682056|FG002|Overall Study|Withdrawal by Subject|8|||
30576601|NCT03367156|58586808|FG001|Overall Study|Became ineligible|2|||
30576602|NCT03367156|58586807|FG000|Overall Study|Hospitalization|1|||
30668115|NCT00854724|58682069|FG000|First Intervention|Withdrawal by Subject|1|||
30668116|NCT00854724|58682070|FG001|First Intervention|Withdrawal by Subject|1|||
30668117|NCT00854724|58682069|FG000|Washout|Protocol Violation|1|||
30668118|NCT00854724|58682070|FG001|Washout|Protocol Violation|0|||
30668119|NCT00854724|58682069|FG000|Washout|Withdrawal by Subject|0|||
30668120|NCT00854724|58682070|FG001|Washout|Withdrawal by Subject|1|||
30668121|NCT00854724|58682069|FG000|Second Intervention|Protocol Violation|1|||
30668122|NCT00854724|58682070|FG001|Second Intervention|Protocol Violation|0|||
30668123|NCT00854724|58682069|FG000|Second Intervention|Physician Decision|0|||
30668124|NCT00854724|58682070|FG001|Second Intervention|Physician Decision|1|||
30576603|NCT03367156|58586808|FG001|Overall Study|Hospitalization|0|||
30780278|NCT03057054|58792127|FG000|Overall Study|Withdrawal by Subject|6|||
30576604|NCT03367156|58586807|FG000|Overall Study|Concerned about Treatment|11|||
30576605|NCT03367156|58586808|FG001|Overall Study|Concerned about Treatment|3|||
30576606|NCT03367156|58586807|FG000|Overall Study|Started new treatment|4|||
30576607|NCT03367156|58586808|FG001|Overall Study|Started new treatment|1|||
30576608|NCT03316885|58586825|FG000|Overall Study|Adverse Event|1|||
30576609|NCT03316885|58586825|FG000|Overall Study|Death|10|||
30576610|NCT03316885|58586825|FG000|Overall Study|Lost to Follow-up|4|||
30576611|NCT03316885|58586825|FG000|Overall Study|Withdrawal by Subject|9|||
30576612|NCT03316885|58586825|FG000|Overall Study|COVID related|8|||
30576613|NCT03277105|58586865|FG000|Overall Study|Death|77|||
30576614|NCT03277105|58586866|FG001|Overall Study|Death|73|||
30576615|NCT03277105|58586865|FG000|Overall Study|Lost to Follow-up|0|||
30576616|NCT03277105|58586866|FG001|Overall Study|Lost to Follow-up|3|||
30576617|NCT03277105|58586865|FG000|Overall Study|Withdrawal by Subject|10|||
30576618|NCT03277105|58586866|FG001|Overall Study|Withdrawal by Subject|9|||
30576619|NCT03277105|58586865|FG000|Overall Study|Other|1|||
30576620|NCT03277105|58586866|FG001|Overall Study|Other|3|||
30576621|NCT03277105|58586865|FG000|Overall Study|Ongoing|171|||
30576622|NCT03277105|58586866|FG001|Overall Study|Ongoing|175|||
30576623|NCT03259074|58586875|FG000|Overall Study|Adverse Event|9|||
30576624|NCT03259074|58586876|FG001|Overall Study|Adverse Event|12|||
30576625|NCT03259074|58586877|FG002|Overall Study|Adverse Event|8|||
30576626|NCT03259074|58586875|FG000|Overall Study|Death|1|||
30576627|NCT03259074|58586876|FG001|Overall Study|Death|1|||
30576628|NCT03259074|58586877|FG002|Overall Study|Death|3|||
30576629|NCT03259074|58586875|FG000|Overall Study|Lost to Follow-up|2|||
30576630|NCT03259074|58586876|FG001|Overall Study|Lost to Follow-up|4|||
30576631|NCT03259074|58586877|FG002|Overall Study|Lost to Follow-up|3|||
30576632|NCT03259074|58586875|FG000|Overall Study|New Therapy For Study Indication|1|||
30576633|NCT03259074|58586876|FG001|Overall Study|New Therapy For Study Indication|2|||
30576634|NCT03259074|58586877|FG002|Overall Study|New Therapy For Study Indication|2|||
30576635|NCT03259074|58586875|FG000|Overall Study|Physician Decision|4|||
30576636|NCT03259074|58586876|FG001|Overall Study|Physician Decision|12|||
30576637|NCT03259074|58586877|FG002|Overall Study|Physician Decision|10|||
30576638|NCT03259074|58586875|FG000|Overall Study|Pregnancy|1|||
30576639|NCT03259074|58586876|FG001|Overall Study|Pregnancy|1|||
30576640|NCT03259074|58586877|FG002|Overall Study|Pregnancy|0|||
30576641|NCT03259074|58586875|FG000|Overall Study|Progressive Disease|1|||
30576642|NCT03259074|58586876|FG001|Overall Study|Progressive Disease|0|||
30576643|NCT03259074|58586877|FG002|Overall Study|Progressive Disease|0|||
30576644|NCT03259074|58586875|FG000|Overall Study|Protocol Deviation|1|||
30576645|NCT03259074|58586876|FG001|Overall Study|Protocol Deviation|1|||
30576646|NCT03259074|58586877|FG002|Overall Study|Protocol Deviation|3|||
30576647|NCT03259074|58586875|FG000|Overall Study|Subject/Guardian Decision|13|||
30576648|NCT03259074|58586876|FG001|Overall Study|Subject/Guardian Decision|16|||
30576649|NCT03259074|58586877|FG002|Overall Study|Subject/Guardian Decision|14|||
30576650|NCT03201965|58586888|FG000|Overall Study|Death|5|||
30576651|NCT03201965|58586889|FG001|Overall Study|Death|27|||
30576652|NCT03201965|58586890|FG002|Overall Study|Death|27|||
30576653|NCT03201965|58586888|FG000|Overall Study|Lost to Follow-up|0|||
30576654|NCT03201965|58586889|FG001|Overall Study|Lost to Follow-up|1|||
30576655|NCT03201965|58586890|FG002|Overall Study|Lost to Follow-up|0|||
30576656|NCT03201965|58586888|FG000|Overall Study|Withdrawal by Subject|3|||
30576657|NCT03201965|58586889|FG001|Overall Study|Withdrawal by Subject|13|||
30576658|NCT03201965|58586890|FG002|Overall Study|Withdrawal by Subject|4|||
30576659|NCT03201965|58586888|FG000|Overall Study|Ongoing|20|||
30576660|NCT03201965|58586889|FG001|Overall Study|Ongoing|152|||
30576661|NCT03201965|58586890|FG002|Overall Study|Ongoing|164|||
30576662|NCT03159104|58586899|FG000|Overall Study|Violation of inclusion criteria|1|||
30576663|NCT03159104|58586900|FG001|Overall Study|Violation of inclusion criteria|2|||
30576664|NCT03149237|58586908|FG000|Overall Study|Withdrawal by Subject|4|||
30576665|NCT03149237|58586909|FG001|Overall Study|Withdrawal by Subject|5|||
30576666|NCT03132467|58586915|FG000|Overall Study|Adverse Event|2|||
30576667|NCT03132467|58586915|FG000|Overall Study|Withdrawal by Subject|2|||
30576668|NCT03127852|58586922|FG000|Overall Study|Withdrawal by Subject|4|||
30576669|NCT03127852|58586923|FG001|Overall Study|Withdrawal by Subject|1|||
30576670|NCT03127852|58586922|FG000|Overall Study|Death|1|||
30576671|NCT03127852|58586923|FG001|Overall Study|Death|1|||
30576672|NCT03107793|58586929|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
30576673|NCT03107793|58586930|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
30576674|NCT03107793|58586931|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
30576675|NCT03107793|58586932|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
30576676|NCT03107793|58586933|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
30576677|NCT03107793|58586929|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
30576678|NCT03107793|58586930|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
30576679|NCT03107793|58586931|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
30576680|NCT03107793|58586932|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
30576681|NCT03107793|58586933|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
30576682|NCT03107793|58586929|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
30576683|NCT03107793|58586930|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
30576684|NCT03107793|58586931|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
30576685|NCT03107793|58586932|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
30576686|NCT03107793|58586933|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
30576687|NCT03107793|58586929|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
30576688|NCT03107793|58586930|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30576689|NCT03107793|58586931|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30576690|NCT03107793|58586932|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30576691|NCT03107793|58586933|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
30576692|NCT03107793|58586929|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
30576693|NCT03107793|58586930|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
30576694|NCT03107793|58586931|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
30576695|NCT03107793|58586932|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
30576696|NCT03107793|58586933|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
30576697|NCT03107793|58586929|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
30576698|NCT03107793|58586930|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
30576699|NCT03107793|58586931|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
30576700|NCT03107793|58586932|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
30576701|NCT03107793|58586933|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
30576702|NCT03107793|58586929|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
30576703|NCT03107793|58586930|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
30576704|NCT03107793|58586931|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
30576705|NCT03107793|58586932|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
30576706|NCT03107793|58586933|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
30576707|NCT03107793|58586929|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
30576708|NCT03107793|58586930|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
30576709|NCT03107793|58586931|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
30576710|NCT03107793|58586932|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
30576711|NCT03107793|58586933|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
30576712|NCT03107793|58586929|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
30576713|NCT03107793|58586930|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
30576714|NCT03107793|58586931|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
30576715|NCT03107793|58586932|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
30576716|NCT03107793|58586933|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
30576717|NCT03107793|58586929|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
30576718|NCT03107793|58586930|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
30576719|NCT03107793|58586931|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
30576720|NCT03107793|58586932|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
30576721|NCT03107793|58586933|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
30576722|NCT03107793|58586929|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
30576723|NCT03107793|58586930|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
30576724|NCT03107793|58586931|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
30576725|NCT03107793|58586932|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
30576726|NCT03107793|58586933|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
30576727|NCT03107793|58586929|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
30576728|NCT03107793|58586930|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
30576729|NCT03107793|58586931|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
30576730|NCT03107793|58586932|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
30576731|NCT03107793|58586933|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
30576732|NCT03107793|58586929|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
30576733|NCT03107793|58586930|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
30576734|NCT03107793|58586931|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
30576735|NCT03107793|58586932|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
30576736|NCT03107793|58586933|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
30576737|NCT03107793|58586929|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
30576738|NCT03107793|58586930|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
30576739|NCT03107793|58586931|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
30576740|NCT03107793|58586932|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
30576741|NCT03107793|58586933|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
30576742|NCT03107793|58586929|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
30576743|NCT03107793|58586930|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
30576744|NCT03107793|58586931|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
30576745|NCT03107793|58586932|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
30576746|NCT03107793|58586933|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
30576747|NCT03107793|58586929|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
30576748|NCT03107793|58586930|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
30576749|NCT03107793|58586931|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
30576750|NCT03107793|58586932|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
30576751|NCT03107793|58586933|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
30576752|NCT03107793|58586929|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
30576753|NCT03107793|58586930|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
30576754|NCT03107793|58586931|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
30576755|NCT03107793|58586932|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
30576756|NCT03107793|58586933|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
30576757|NCT03107793|58586929|FG000|Extension Period (Week 48- Week 104)|Death|0|||
30576758|NCT03107793|58586930|FG001|Extension Period (Week 48- Week 104)|Death|0|||
30576759|NCT03107793|58586931|FG002|Extension Period (Week 48- Week 104)|Death|0|||
30576760|NCT03107793|58586932|FG003|Extension Period (Week 48- Week 104)|Death|0|||
30576761|NCT03107793|58586933|FG004|Extension Period (Week 48- Week 104)|Death|1|||
30576762|NCT03107793|58586929|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
30576763|NCT03107793|58586930|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
30576764|NCT03107793|58586931|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
30576765|NCT03107793|58586932|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
30576766|NCT03107793|58586933|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
30576767|NCT03107793|58586929|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
30576768|NCT03107793|58586930|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
30576769|NCT03107793|58586931|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
30576770|NCT03107793|58586932|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
30576771|NCT03107793|58586933|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
30576772|NCT03107793|58586929|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
30576773|NCT03107793|58586930|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
30576774|NCT03107793|58586931|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
30576775|NCT03107793|58586932|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
30576776|NCT03107793|58586933|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
30576777|NCT03107793|58586929|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
30576778|NCT03107793|58586930|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
30576779|NCT03107793|58586931|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
30576780|NCT03107793|58586932|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
30576781|NCT03107793|58586933|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
30576782|NCT03107793|58586929|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
30576783|NCT03107793|58586930|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
30576784|NCT03107793|58586931|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
30576785|NCT03107793|58586932|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
30576786|NCT03107793|58586933|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
30576787|NCT03107793|58586929|FG000|Extension Period (Week 48- Week 104)|Other|0|||
30576788|NCT03107793|58586930|FG001|Extension Period (Week 48- Week 104)|Other|0|||
30576789|NCT03107793|58586931|FG002|Extension Period (Week 48- Week 104)|Other|0|||
30576790|NCT03107793|58586932|FG003|Extension Period (Week 48- Week 104)|Other|1|||
30576791|NCT03107793|58586933|FG004|Extension Period (Week 48- Week 104)|Other|3|||
30576792|NCT03107793|58586929|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
30576793|NCT03107793|58586930|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
30576794|NCT03107793|58586931|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
30576795|NCT03107793|58586932|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
30576796|NCT03107793|58586933|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
30576797|NCT03013543|58586952|FG000|Overall Study|Withdrawal by Subject|0|||
30576798|NCT03013543|58586953|FG001|Overall Study|Withdrawal by Subject|2|||
30576799|NCT03013543|58586954|FG002|Overall Study|Withdrawal by Subject|0|||
30576800|NCT03013543|58586955|FG003|Overall Study|Withdrawal by Subject|5|||
30576801|NCT03013543|58586956|FG004|Overall Study|Withdrawal by Subject|6|||
30576802|NCT03013543|58586957|FG005|Overall Study|Withdrawal by Subject|2|||
30576803|NCT03013543|58586958|FG006|Overall Study|Withdrawal by Subject|3|||
30576804|NCT03013543|58586959|FG007|Overall Study|Withdrawal by Subject|1|||
30576805|NCT03013543|58586960|FG008|Overall Study|Withdrawal by Subject|0|||
30576806|NCT03013543|58586961|FG009|Overall Study|Withdrawal by Subject|4|||
30576807|NCT03013543|58586952|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
30576808|NCT03013543|58586953|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
30576809|NCT03013543|58586954|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
30576810|NCT03013543|58586955|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
30576811|NCT03013543|58586956|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
30576812|NCT03013543|58586957|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
30668125|NCT00698932|58682108|FG000|Overall Study|Adverse Event|0|||
30576813|NCT03013543|58586958|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
30576814|NCT03013543|58586959|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
30576815|NCT03013543|58586960|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
30576816|NCT03013543|58586961|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
30576817|NCT03013543|58586952|FG000|Overall Study|Other|0|||
30576818|NCT03013543|58586953|FG001|Overall Study|Other|0|||
30576819|NCT03013543|58586954|FG002|Overall Study|Other|2|||
30576820|NCT03013543|58586955|FG003|Overall Study|Other|0|||
30576821|NCT03013543|58586956|FG004|Overall Study|Other|2|||
30576822|NCT03013543|58586957|FG005|Overall Study|Other|0|||
30576823|NCT03013543|58586958|FG006|Overall Study|Other|0|||
30576824|NCT03013543|58586959|FG007|Overall Study|Other|0|||
30576825|NCT03013543|58586960|FG008|Overall Study|Other|1|||
30576826|NCT03013543|58586961|FG009|Overall Study|Other|0|||
30576827|NCT03013543|58586952|FG000|Overall Study|Adverse Event|0|||
30576828|NCT03013543|58586953|FG001|Overall Study|Adverse Event|0|||
30576829|NCT03013543|58586954|FG002|Overall Study|Adverse Event|0|||
30576830|NCT03013543|58586955|FG003|Overall Study|Adverse Event|3|||
30576831|NCT03013543|58586956|FG004|Overall Study|Adverse Event|2|||
30576832|NCT03013543|58586957|FG005|Overall Study|Adverse Event|1|||
30576833|NCT03013543|58586958|FG006|Overall Study|Adverse Event|3|||
30576834|NCT03013543|58586959|FG007|Overall Study|Adverse Event|8|||
30576835|NCT03013543|58586960|FG008|Overall Study|Adverse Event|0|||
30576836|NCT03013543|58586961|FG009|Overall Study|Adverse Event|2|||
30576837|NCT03013543|58586952|FG000|Overall Study|Death|0|||
30576838|NCT03013543|58586953|FG001|Overall Study|Death|0|||
30576839|NCT03013543|58586954|FG002|Overall Study|Death|0|||
30576840|NCT03013543|58586955|FG003|Overall Study|Death|1|||
30576841|NCT03013543|58586956|FG004|Overall Study|Death|0|||
30576842|NCT03013543|58586957|FG005|Overall Study|Death|0|||
30576843|NCT03013543|58586958|FG006|Overall Study|Death|0|||
30576844|NCT03013543|58586959|FG007|Overall Study|Death|0|||
30576845|NCT03013543|58586960|FG008|Overall Study|Death|0|||
30576846|NCT03013543|58586961|FG009|Overall Study|Death|0|||
30576847|NCT03013543|58586952|FG000|Overall Study|Lack of Efficacy|0|||
30576848|NCT03013543|58586953|FG001|Overall Study|Lack of Efficacy|0|||
30576849|NCT03013543|58586954|FG002|Overall Study|Lack of Efficacy|0|||
30576850|NCT03013543|58586955|FG003|Overall Study|Lack of Efficacy|1|||
30576851|NCT03013543|58586956|FG004|Overall Study|Lack of Efficacy|0|||
30576852|NCT03013543|58586957|FG005|Overall Study|Lack of Efficacy|0|||
30576853|NCT03013543|58586958|FG006|Overall Study|Lack of Efficacy|0|||
30576854|NCT03013543|58586959|FG007|Overall Study|Lack of Efficacy|0|||
30576855|NCT03013543|58586960|FG008|Overall Study|Lack of Efficacy|0|||
30576856|NCT03013543|58586961|FG009|Overall Study|Lack of Efficacy|0|||
30576857|NCT03013543|58586952|FG000|Overall Study|Lost to Follow-up|0|||
30576858|NCT03013543|58586953|FG001|Overall Study|Lost to Follow-up|0|||
30576859|NCT03013543|58586954|FG002|Overall Study|Lost to Follow-up|0|||
30576860|NCT03013543|58586955|FG003|Overall Study|Lost to Follow-up|1|||
30576861|NCT03013543|58586956|FG004|Overall Study|Lost to Follow-up|0|||
30576862|NCT03013543|58586957|FG005|Overall Study|Lost to Follow-up|0|||
30576863|NCT03013543|58586958|FG006|Overall Study|Lost to Follow-up|1|||
30576864|NCT03013543|58586959|FG007|Overall Study|Lost to Follow-up|0|||
30576865|NCT03013543|58586960|FG008|Overall Study|Lost to Follow-up|0|||
30576866|NCT03013543|58586961|FG009|Overall Study|Lost to Follow-up|2|||
30576867|NCT03013543|58586952|FG000|Overall Study|Non-Compliance With Study Drug|0|||
30576868|NCT03013543|58586953|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30668126|NCT00698932|58682109|FG001|Overall Study|Adverse Event|2|||
30668127|NCT00698932|58682108|FG000|Overall Study|Incorrect enrollment|0|||
30576869|NCT03013543|58586954|FG002|Overall Study|Non-Compliance With Study Drug|0|||
30576870|NCT03013543|58586955|FG003|Overall Study|Non-Compliance With Study Drug|0|||
30576871|NCT03013543|58586956|FG004|Overall Study|Non-Compliance With Study Drug|0|||
30576872|NCT03013543|58586957|FG005|Overall Study|Non-Compliance With Study Drug|0|||
30576873|NCT03013543|58586958|FG006|Overall Study|Non-Compliance With Study Drug|0|||
30576874|NCT03013543|58586959|FG007|Overall Study|Non-Compliance With Study Drug|0|||
30576875|NCT03013543|58586960|FG008|Overall Study|Non-Compliance With Study Drug|1|||
30576876|NCT03013543|58586961|FG009|Overall Study|Non-Compliance With Study Drug|0|||
30576877|NCT03013543|58586952|FG000|Overall Study|Physician Decision|0|||
30576878|NCT03013543|58586953|FG001|Overall Study|Physician Decision|0|||
30576879|NCT03013543|58586954|FG002|Overall Study|Physician Decision|0|||
30576880|NCT03013543|58586955|FG003|Overall Study|Physician Decision|0|||
30576881|NCT03013543|58586956|FG004|Overall Study|Physician Decision|1|||
30576882|NCT03013543|58586957|FG005|Overall Study|Physician Decision|0|||
30576883|NCT03013543|58586958|FG006|Overall Study|Physician Decision|0|||
30576884|NCT03013543|58586959|FG007|Overall Study|Physician Decision|0|||
30576885|NCT03013543|58586960|FG008|Overall Study|Physician Decision|0|||
30576886|NCT03013543|58586961|FG009|Overall Study|Physician Decision|0|||
30576887|NCT03013543|58586952|FG000|Overall Study|Protocol Violation|0|||
30576888|NCT03013543|58586953|FG001|Overall Study|Protocol Violation|0|||
30576889|NCT03013543|58586954|FG002|Overall Study|Protocol Violation|0|||
30576890|NCT03013543|58586955|FG003|Overall Study|Protocol Violation|0|||
30576891|NCT03013543|58586956|FG004|Overall Study|Protocol Violation|0|||
30576892|NCT03013543|58586957|FG005|Overall Study|Protocol Violation|0|||
30576893|NCT03013543|58586958|FG006|Overall Study|Protocol Violation|0|||
30576894|NCT03013543|58586959|FG007|Overall Study|Protocol Violation|0|||
30576895|NCT03013543|58586960|FG008|Overall Study|Protocol Violation|0|||
30576896|NCT03013543|58586961|FG009|Overall Study|Protocol Violation|1|||
30576897|NCT02908685|58586999|FG000|Part 1 Exploratory|Withdrawal by Subject|0|||
30576898|NCT02908685|58587000|FG001|Part 1 Exploratory|Withdrawal by Subject|1|||
30576899|NCT02908685|58587001|FG002|Part 1 Exploratory|Withdrawal by Subject|0|||
30576900|NCT02908685|58587002|FG003|Part 1 Exploratory|Withdrawal by Subject|0|||
30576901|NCT02908685|58587003|FG004|Part 1 Exploratory|Withdrawal by Subject|0|||
30576902|NCT02908685|58587004|FG005|Part 1 Exploratory|Withdrawal by Subject|0|||
30576903|NCT02908685|58587005|FG006|Part 1 Exploratory|Withdrawal by Subject|0|||
30576904|NCT02908685|58587006|FG007|Part 1 Exploratory|Withdrawal by Subject|0|||
30576905|NCT02908685|58587007|FG008|Part 1 Exploratory|Withdrawal by Subject|0|||
30576906|NCT02908685|58587008|FG009|Part 1 Exploratory|Withdrawal by Subject|0|||
30576907|NCT02908685|58587009|FG010|Part 1 Exploratory|Withdrawal by Subject|0|||
30576908|NCT02908685|58587010|FG011|Part 1 Exploratory|Withdrawal by Subject|0|||
30576909|NCT02908685|58586999|FG000|Part 2 Confirmatory|Changed to Spinraza|0|||
30576910|NCT02908685|58587000|FG001|Part 2 Confirmatory|Changed to Spinraza|0|||
30576911|NCT02908685|58587001|FG002|Part 2 Confirmatory|Changed to Spinraza|0|||
30576912|NCT02908685|58587002|FG003|Part 2 Confirmatory|Changed to Spinraza|0|||
30576913|NCT02908685|58587003|FG004|Part 2 Confirmatory|Changed to Spinraza|0|||
30576914|NCT02908685|58587004|FG005|Part 2 Confirmatory|Changed to Spinraza|0|||
30576915|NCT02908685|58587005|FG006|Part 2 Confirmatory|Changed to Spinraza|0|||
30576916|NCT02908685|58587006|FG007|Part 2 Confirmatory|Changed to Spinraza|0|||
30576917|NCT02908685|58587007|FG008|Part 2 Confirmatory|Changed to Spinraza|0|||
30576918|NCT02908685|58587008|FG009|Part 2 Confirmatory|Changed to Spinraza|0|||
30576919|NCT02908685|58587009|FG010|Part 2 Confirmatory|Changed to Spinraza|2|||
30576920|NCT02908685|58587010|FG011|Part 2 Confirmatory|Changed to Spinraza|1|||
30576921|NCT02908685|58586999|FG000|Part 2 Confirmatory|Changed to other treatment|0|||
30576922|NCT02908685|58587000|FG001|Part 2 Confirmatory|Changed to other treatment|0|||
30576923|NCT02908685|58587001|FG002|Part 2 Confirmatory|Changed to other treatment|0|||
30576924|NCT02908685|58587002|FG003|Part 2 Confirmatory|Changed to other treatment|0|||
30576925|NCT02908685|58587003|FG004|Part 2 Confirmatory|Changed to other treatment|0|||
30576926|NCT02908685|58587004|FG005|Part 2 Confirmatory|Changed to other treatment|0|||
30576927|NCT02908685|58587005|FG006|Part 2 Confirmatory|Changed to other treatment|0|||
30576928|NCT02908685|58587006|FG007|Part 2 Confirmatory|Changed to other treatment|0|||
30576929|NCT02908685|58587007|FG008|Part 2 Confirmatory|Changed to other treatment|0|||
30576930|NCT02908685|58587008|FG009|Part 2 Confirmatory|Changed to other treatment|0|||
30576931|NCT02908685|58587009|FG010|Part 2 Confirmatory|Changed to other treatment|1|||
30576932|NCT02908685|58587010|FG011|Part 2 Confirmatory|Changed to other treatment|0|||
30576933|NCT02854436|58587027|FG000|Overall Study|Adverse Event|1|||
30576934|NCT02854436|58587027|FG000|Overall Study|Death|208|||
30576935|NCT02854436|58587027|FG000|Overall Study|Lost to Follow-up|5|||
30576936|NCT02854436|58587027|FG000|Overall Study|Withdrawal by Subject|12|||
30576937|NCT02854436|58587027|FG000|Overall Study|Other|45|||
30576938|NCT02854436|58587027|FG000|Overall Study|Ongoing|18|||
30576939|NCT02811549|58587031|FG000|Overall Study|Lost to Follow-up|1|||
30576940|NCT02811549|58587031|FG000|Overall Study|Withdrawal by Subject|3|||
30576941|NCT02811549|58587031|FG000|Overall Study|Subject screen failed|4|||
30576942|NCT02811549|58587031|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
30576943|NCT02773849|58587037|FG000|Overall Study|Adverse Event|3|||
30576944|NCT02773849|58587037|FG000|Overall Study|Lack of Efficacy|89|||
30576945|NCT02773849|58587037|FG000|Overall Study|Withdrawal by Subject|1|||
30576946|NCT02773849|58587037|FG000|Overall Study|Withdrawal of Consent|1|||
30576947|NCT02489318|58587076|FG000|Randomized|Withdrawal by Subject|0|||
30576948|NCT02489318|58587077|FG001|Randomized|Withdrawal by Subject|1|||
30576949|NCT02489318|58587076|FG000|Treated|Adverse Event|19|||
30576950|NCT02489318|58587077|FG001|Treated|Adverse Event|62|||
30576951|NCT02489318|58587076|FG000|Treated|Death|13|||
30576952|NCT02489318|58587077|FG001|Treated|Death|11|||
30576953|NCT02489318|58587076|FG000|Treated|Physician Decision|4|||
30576954|NCT02489318|58587077|FG001|Treated|Physician Decision|6|||
30576955|NCT02489318|58587076|FG000|Treated|Protocol Violation|1|||
30576956|NCT02489318|58587077|FG001|Treated|Protocol Violation|2|||
30576957|NCT02489318|58587076|FG000|Treated|Withdrawal by Subject|37|||
30576958|NCT02489318|58587077|FG001|Treated|Withdrawal by Subject|36|||
30576959|NCT02489318|58587076|FG000|Treated|Other: Progressive Disease|245|||
30855325|NCT02787863|58882929|FG007|Overall Study|Withdrawal by Subject|0|||
30576960|NCT02489318|58587077|FG001|Treated|Other: Progressive Disease|138|||
30576961|NCT02489318|58587076|FG000|Treated|Other|0|||
30576962|NCT02489318|58587077|FG001|Treated|Other|2|||
30576963|NCT02489318|58587076|FG000|Treated|Ongoing|0|||
30576964|NCT02489318|58587077|FG001|Treated|Ongoing|267|||
30576965|NCT02475681|58587087|FG000|Overall Study|Death|16|||
30576966|NCT02475681|58587088|FG001|Overall Study|Death|6|||
30576967|NCT02475681|58587089|FG002|Overall Study|Death|9|||
30576968|NCT02475681|58587087|FG000|Overall Study|Physician Decision|0|||
30576969|NCT02475681|58587088|FG001|Overall Study|Physician Decision|3|||
30576970|NCT02475681|58587089|FG002|Overall Study|Physician Decision|1|||
30576971|NCT02475681|58587087|FG000|Overall Study|Withdrawal by Subject|12|||
30576972|NCT02475681|58587088|FG001|Overall Study|Withdrawal by Subject|6|||
30576973|NCT02475681|58587089|FG002|Overall Study|Withdrawal by Subject|9|||
30576974|NCT02475681|58587087|FG000|Overall Study|Lost to Follow-up|2|||
30576975|NCT02475681|58587088|FG001|Overall Study|Lost to Follow-up|1|||
30576976|NCT02475681|58587089|FG002|Overall Study|Lost to Follow-up|3|||
30576977|NCT02475681|58587087|FG000|Overall Study|Ongoing in Study|0|||
30576978|NCT02475681|58587088|FG001|Overall Study|Ongoing in Study|163|||
30576979|NCT02475681|58587089|FG002|Overall Study|Ongoing in Study|157|||
30576980|NCT02475681|58587087|FG000|Overall Study|Reasons other than above listed|2|||
30576981|NCT02475681|58587088|FG001|Overall Study|Reasons other than above listed|0|||
30576982|NCT02475681|58587089|FG002|Overall Study|Reasons other than above listed|0|||
30576983|NCT02426125|58587110|FG000|Overall Study|Lost to Follow-up|14|||
30576984|NCT02426125|58587111|FG001|Overall Study|Lost to Follow-up|12|||
30576985|NCT02426125|58587110|FG000|Overall Study|Withdrawal by Subject|13|||
30576986|NCT02426125|58587111|FG001|Overall Study|Withdrawal by Subject|14|||
30576987|NCT02426125|58587110|FG000|Overall Study|Death|185|||
30576988|NCT02426125|58587111|FG001|Overall Study|Death|200|||
30576989|NCT02426125|58587110|FG000|Overall Study|Randomized, But Never Treated|5|||
30576990|NCT02426125|58587111|FG001|Overall Study|Randomized, But Never Treated|2|||
30576991|NCT02331277|58587139|FG000|Overall Study|Withdrawal by Subject|1|||
30576992|NCT02331277|58587140|FG001|Overall Study|Withdrawal by Subject|0|||
30576993|NCT02277444|58587147|FG000|Overall Study|Adverse Event|10|||
30576994|NCT02277444|58587147|FG000|Overall Study|Withdrawal by Subject|3|||
30576995|NCT02277444|58587147|FG000|Overall Study|Other|1|||
30576996|NCT02277444|58587147|FG000|Overall Study|Enrolled and not Treated|3|||
30576997|NCT02277444|58587147|FG000|Overall Study|Ongoing|113|||
30576998|NCT02257736|58587153|FG000|Overall Study|Progressive disease|365|||
30576999|NCT02257736|58587154|FG001|Overall Study|Progressive disease|327|||
30577000|NCT02257736|58587153|FG000|Overall Study|Adverse Event|45|||
30577001|NCT02257736|58587154|FG001|Overall Study|Adverse Event|56|||
30577002|NCT02257736|58587153|FG000|Overall Study|Withdrawal by Subject|21|||
30577003|NCT02257736|58587154|FG001|Overall Study|Withdrawal by Subject|38|||
30577004|NCT02257736|58587153|FG000|Overall Study|Death|11|||
30577005|NCT02257736|58587154|FG001|Overall Study|Death|6|||
30577006|NCT02257736|58587153|FG000|Overall Study|Physician Decision|5|||
30577007|NCT02257736|58587154|FG001|Overall Study|Physician Decision|9|||
30577008|NCT02257736|58587153|FG000|Overall Study|Non-Compliance with study drug|1|||
30577009|NCT02257736|58587154|FG001|Overall Study|Non-Compliance with study drug|2|||
30577010|NCT02257736|58587153|FG000|Overall Study|Protocol Violation|1|||
30577011|NCT02257736|58587154|FG001|Overall Study|Protocol Violation|0|||
30577012|NCT02257736|58587153|FG000|Overall Study|Other|1|||
30577013|NCT02257736|58587154|FG001|Overall Study|Other|7|||
30577014|NCT02257736|58587153|FG000|Overall Study|Randomized, not treated|1|||
30577015|NCT02257736|58587154|FG001|Overall Study|Randomized, not treated|2|||
30577016|NCT02136134|58587173|FG000|Overall Study|Death|35|||
30577017|NCT02136134|58587174|FG001|Overall Study|Death|29|||
30577018|NCT02136134|58587173|FG000|Overall Study|Withdrawal by Subject|14|||
30577019|NCT02136134|58587174|FG001|Overall Study|Withdrawal by Subject|4|||
30577020|NCT02136134|58587173|FG000|Overall Study|Other|3|||
30577021|NCT02136134|58587174|FG001|Overall Study|Other|3|||
30577022|NCT02136134|58587173|FG000|Overall Study|Ongoing|185|||
30577023|NCT02136134|58587174|FG001|Overall Study|Ongoing|207|||
30577024|NCT02136134|58587173|FG000|Overall Study|Subjects randomized but not treated|10|||
30577025|NCT02136134|58587174|FG001|Overall Study|Subjects randomized but not treated|8|||
30577026|NCT02120365|58587180|FG000|Overall Study|Withdrawal by Subject|0|||
30577027|NCT02120365|58587181|FG001|Overall Study|Withdrawal by Subject|0|||
30577028|NCT02120365|58587182|FG002|Overall Study|Withdrawal by Subject|2|||
30577029|NCT02120365|58587183|FG003|Overall Study|Withdrawal by Subject|4|||
30577030|NCT02120365|58587184|FG004|Overall Study|Withdrawal by Subject|0|||
30577031|NCT02120365|58587185|FG005|Overall Study|Withdrawal by Subject|2|||
30577032|NCT02043678|58587216|FG000|Overall Study|Never treated|11|||
30577033|NCT02043678|58587217|FG001|Overall Study|Never treated|9|||
30577034|NCT02043678|58587216|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
30577035|NCT02043678|58587217|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
30577036|NCT02043678|58587216|FG000|Overall Study|AE without clinical PD|51|||
30577037|NCT02043678|58587217|FG001|Overall Study|AE without clinical PD|34|||
30577038|NCT02043678|58587216|FG000|Overall Study|Lost to Follow-up|1|||
30577039|NCT02043678|58587217|FG001|Overall Study|Lost to Follow-up|1|||
30577040|NCT02043678|58587216|FG000|Overall Study|Other|19|||
30577041|NCT02043678|58587217|FG001|Overall Study|Other|16|||
30577042|NCT02043678|58587216|FG000|Overall Study|Clinical PD|108|||
30577043|NCT02043678|58587217|FG001|Overall Study|Clinical PD|138|||
30577044|NCT02043678|58587216|FG000|Overall Study|Radiological PD|91|||
30577045|NCT02043678|58587217|FG001|Overall Study|Radiological PD|80|||
30577046|NCT02043678|58587216|FG000|Overall Study|Protocol-driven decision point|56|||
30577047|NCT02043678|58587217|FG001|Overall Study|Protocol-driven decision point|56|||
30577048|NCT02043678|58587216|FG000|Overall Study|Withdrawal by Subject|12|||
30577049|NCT02043678|58587217|FG001|Overall Study|Withdrawal by Subject|15|||
30577050|NCT02043678|58587216|FG000|Overall Study|Ongoing with treatment|34|||
30577051|NCT02043678|58587217|FG001|Overall Study|Ongoing with treatment|38|||
30577052|NCT01946204|58587234|FG000|Overall Study|Death|38|||
30577053|NCT01946204|58587235|FG001|Overall Study|Death|59|||
30577054|NCT01946204|58587234|FG000|Overall Study|Withdrawal by Subject|37|||
30577055|NCT01946204|58587235|FG001|Overall Study|Withdrawal by Subject|50|||
30577056|NCT01946204|58587234|FG000|Overall Study|Lost to Follow-up|3|||
30577057|NCT01946204|58587235|FG001|Overall Study|Lost to Follow-up|7|||
30577058|NCT01946204|58587234|FG000|Overall Study|Ongoing|316|||
30577059|NCT01946204|58587235|FG001|Overall Study|Ongoing|687|||
30577060|NCT01946204|58587234|FG000|Overall Study|Other|7|||
30577061|NCT01946204|58587235|FG001|Overall Study|Other|3|||
30577062|NCT01854775|58587244|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
30577063|NCT01854775|58587245|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
30577064|NCT01854775|58587246|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
30577065|NCT01854775|58587244|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
30577066|NCT01854775|58587245|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
30577067|NCT01854775|58587246|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
30577068|NCT01854775|58587244|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
30577069|NCT01854775|58587245|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
30577070|NCT01854775|58587246|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
30577071|NCT01854775|58587244|FG000|Extension Phase|Pregnancy|3|||
30577072|NCT01854775|58587245|FG001|Extension Phase|Pregnancy|0|||
30577073|NCT01854775|58587246|FG002|Extension Phase|Pregnancy|0|||
30577074|NCT01854775|58587244|FG000|Extension Phase|Investigator's Discretion|1|||
30577075|NCT01854775|58587245|FG001|Extension Phase|Investigator's Discretion|0|||
30577076|NCT01854775|58587246|FG002|Extension Phase|Investigator's Discretion|0|||
30577077|NCT01854775|58587244|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
30577078|NCT01854775|58587245|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
30577079|NCT01854775|58587246|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
30577080|NCT01854775|58587244|FG000|Extension Phase|Lost to Follow-up|2|||
30577081|NCT01854775|58587245|FG001|Extension Phase|Lost to Follow-up|0|||
30577082|NCT01854775|58587246|FG002|Extension Phase|Lost to Follow-up|0|||
30577083|NCT01854775|58587244|FG000|Extension Phase|Still on Study|32|||
30577084|NCT01854775|58587245|FG001|Extension Phase|Still on Study|47|||
30577085|NCT01854775|58587246|FG002|Extension Phase|Still on Study|18|||
30577086|NCT01828099|58587256|FG000|Overall Study|Adverse Event|15|||
30577087|NCT01828099|58587257|FG001|Overall Study|Adverse Event|18|||
30577088|NCT01828099|58587256|FG000|Overall Study|Death|9|||
30577089|NCT01828099|58587257|FG001|Overall Study|Death|11|||
30577090|NCT01828099|58587256|FG000|Overall Study|Lost to Follow-up|2|||
30577091|NCT01828099|58587257|FG001|Overall Study|Lost to Follow-up|0|||
30577092|NCT01828099|58587256|FG000|Overall Study|Non-compliance with study treatment|2|||
30577093|NCT01828099|58587257|FG001|Overall Study|Non-compliance with study treatment|0|||
30577094|NCT01828099|58587256|FG000|Overall Study|Physician Decision|7|||
30577095|NCT01828099|58587257|FG001|Overall Study|Physician Decision|11|||
30577096|NCT01828099|58587256|FG000|Overall Study|Progressive disease|51|||
30577097|NCT01828099|58587257|FG001|Overall Study|Progressive disease|94|||
30577098|NCT01828099|58587256|FG000|Overall Study|Protocol Violation|1|||
30577099|NCT01828099|58587257|FG001|Overall Study|Protocol Violation|0|||
30577100|NCT01828099|58587256|FG000|Overall Study|Subject/guardian decision|7|||
30577101|NCT01828099|58587257|FG001|Overall Study|Subject/guardian decision|23|||
30577102|NCT01776840|58587265|FG000|Overall Study|Lost to Follow-up|4|||
30577103|NCT01776840|58587266|FG001|Overall Study|Lost to Follow-up|4|||
30577104|NCT01776840|58587265|FG000|Overall Study|Withdrawal by Subject|42|||
30577105|NCT01776840|58587266|FG001|Overall Study|Withdrawal by Subject|22|||
30577106|NCT01776840|58587265|FG000|Overall Study|Ongoing|112|||
30577107|NCT01776840|58587266|FG001|Overall Study|Ongoing|129|||
30855326|NCT02596958|58882970|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
30577108|NCT01615029|58587277|FG000|Overall Study|Adverse Event|0|||
30577109|NCT01615029|58587278|FG001|Overall Study|Adverse Event|0|||
30577110|NCT01615029|58587279|FG002|Overall Study|Adverse Event|0|||
30577111|NCT01615029|58587280|FG003|Overall Study|Adverse Event|0|||
30577112|NCT01615029|58587281|FG004|Overall Study|Adverse Event|1|||
30577113|NCT01615029|58587277|FG000|Overall Study|Death|0|||
30577114|NCT01615029|58587278|FG001|Overall Study|Death|0|||
30577115|NCT01615029|58587279|FG002|Overall Study|Death|0|||
30855327|NCT02596958|58882970|FG000|Overall Study|Cancer Progression|441|||
30855328|NCT02596958|58882970|FG000|Overall Study|Death From Cancer|112|||
30577116|NCT01615029|58587280|FG003|Overall Study|Death|0|||
30577117|NCT01615029|58587281|FG004|Overall Study|Death|1|||
30577118|NCT01615029|58587277|FG000|Overall Study|Lost to Follow-up|0|||
30577119|NCT01615029|58587278|FG001|Overall Study|Lost to Follow-up|0|||
30577120|NCT01615029|58587279|FG002|Overall Study|Lost to Follow-up|0|||
30577121|NCT01615029|58587280|FG003|Overall Study|Lost to Follow-up|0|||
30577122|NCT01615029|58587281|FG004|Overall Study|Lost to Follow-up|1|||
30577123|NCT01615029|58587277|FG000|Overall Study|Progressive disease|2|||
30577124|NCT01615029|58587278|FG001|Overall Study|Progressive disease|1|||
30577125|NCT01615029|58587279|FG002|Overall Study|Progressive disease|1|||
30577126|NCT01615029|58587280|FG003|Overall Study|Progressive disease|1|||
30577127|NCT01615029|58587281|FG004|Overall Study|Progressive disease|5|||
30577128|NCT01615029|58587277|FG000|Overall Study|Physician Decision|0|||
30577129|NCT01615029|58587278|FG001|Overall Study|Physician Decision|0|||
30577130|NCT01615029|58587279|FG002|Overall Study|Physician Decision|0|||
30577131|NCT01615029|58587280|FG003|Overall Study|Physician Decision|0|||
30577132|NCT01615029|58587281|FG004|Overall Study|Physician Decision|1|||
30577133|NCT01615029|58587277|FG000|Overall Study|Ongoing|1|||
30577134|NCT01615029|58587278|FG001|Overall Study|Ongoing|2|||
30577135|NCT01615029|58587279|FG002|Overall Study|Ongoing|3|||
30577136|NCT01615029|58587280|FG003|Overall Study|Ongoing|2|||
30577137|NCT01615029|58587281|FG004|Overall Study|Ongoing|23|||
30577138|NCT01314118|58587308|FG000|Overall Study|Adverse Event|9|||
30577139|NCT01314118|58587308|FG000|Overall Study|Progressive disease|27|||
30577140|NCT01314118|58587308|FG000|Overall Study|Physician Decision|11|||
30577141|NCT01314118|58587308|FG000|Overall Study|Death|4|||
30577142|NCT01314118|58587308|FG000|Overall Study|Protocol Violation|5|||
30577143|NCT01314118|58587308|FG000|Overall Study|Withdrawal by Subject|11|||
30577144|NCT01314118|58587308|FG000|Overall Study|Other|2|||
30577145|NCT01314118|58587308|FG000|Overall Study|Ongoing|62|||
30577146|NCT01199575|58587312|FG000|Overall Study|Withdrawal by Subject|5|||
30577147|NCT01171898|58587321|FG000|Overall Study|Death|0|||
30577148|NCT01171898|58587322|FG001|Overall Study|Death|0|||
30577149|NCT01171898|58587323|FG002|Overall Study|Death|2|||
30577150|NCT01171898|58587324|FG003|Overall Study|Death|0|||
30577151|NCT01171898|58587321|FG000|Overall Study|Lost to Follow-up|0|||
30577152|NCT01171898|58587322|FG001|Overall Study|Lost to Follow-up|1|||
30577153|NCT01171898|58587323|FG002|Overall Study|Lost to Follow-up|1|||
30577154|NCT01171898|58587324|FG003|Overall Study|Lost to Follow-up|1|||
30577155|NCT01171898|58587321|FG000|Overall Study|Withdrawal by Subject|1|||
30577156|NCT01171898|58587322|FG001|Overall Study|Withdrawal by Subject|4|||
30577157|NCT01171898|58587323|FG002|Overall Study|Withdrawal by Subject|6|||
30577158|NCT01171898|58587324|FG003|Overall Study|Withdrawal by Subject|3|||
30577159|NCT01171898|58587321|FG000|Overall Study|Terminated by Sponsor|1|||
30577160|NCT01171898|58587322|FG001|Overall Study|Terminated by Sponsor|0|||
30577161|NCT01171898|58587323|FG002|Overall Study|Terminated by Sponsor|0|||
30577162|NCT01171898|58587324|FG003|Overall Study|Terminated by Sponsor|0|||
30577163|NCT01171898|58587321|FG000|Overall Study|Ongoing|1|||
30577164|NCT01171898|58587322|FG001|Overall Study|Ongoing|9|||
30577165|NCT01171898|58587323|FG002|Overall Study|Ongoing|3|||
30577166|NCT01171898|58587324|FG003|Overall Study|Ongoing|0|||
30577167|NCT01171898|58587321|FG000|Overall Study|Other|1|||
30577168|NCT01171898|58587322|FG001|Overall Study|Other|5|||
30577169|NCT01171898|58587323|FG002|Overall Study|Other|0|||
30577170|NCT01171898|58587324|FG003|Overall Study|Other|2|||
30577171|NCT00980538|58587367|FG000|Overall Study|Lost to Follow-up|20|||
30577172|NCT00980538|58587367|FG000|Overall Study|Sponsor's Decision|4|||
30577173|NCT00980538|58587367|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
30577174|NCT00980538|58587367|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
30577175|NCT00980538|58587367|FG000|Overall Study|Switch to Commercially Available Medication|25|||
30577176|NCT00980538|58587367|FG000|Overall Study|Participant Non-Compliant|9|||
30577177|NCT00980538|58587367|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
30577178|NCT00980538|58587367|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
30577179|NCT00980538|58587367|FG000|Overall Study|Other|60|||
30577180|NCT00980538|58587367|FG000|Overall Study|Other|1|||
30577181|NCT00938340|58587371|FG000|Overall Study|Withdrawal by Subject|3|||
30577182|NCT00938340|58587371|FG000|Overall Study|Protocol Violation|1|||
30577183|NCT00938340|58587371|FG000|Overall Study|Adverse Event|1|||
30577184|NCT00539643|58587428|FG000|Overall Study|Adverse Event|1|||
30577185|NCT00539643|58587429|FG001|Overall Study|Adverse Event|0|||
30577186|NCT00539643|58587428|FG000|Overall Study|Death|2|||
30577187|NCT00539643|58587429|FG001|Overall Study|Death|1|||
30577188|NCT00539643|58587428|FG000|Overall Study|Physician Decision|3|||
30577189|NCT00539643|58587429|FG001|Overall Study|Physician Decision|1|||
30668128|NCT00698932|58682109|FG001|Overall Study|Incorrect enrollment|2|||
30577190|NCT00539643|58587428|FG000|Overall Study|Withdrawal by Subject|0|||
30577191|NCT00539643|58587429|FG001|Overall Study|Withdrawal by Subject|1|||
30577192|NCT00085202|58587437|FG000|Overall Study|Still on therapy|2|||
30577193|NCT00085202|58587438|FG001|Overall Study|Still on therapy|0|||
30577194|NCT00085202|58587437|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
30577195|NCT00085202|58587438|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
30577196|NCT00085202|58587437|FG000|Overall Study|Excessive toxicity|6|||
30577197|NCT00085202|58587438|FG001|Overall Study|Excessive toxicity|5|||
30577198|NCT00085202|58587437|FG000|Overall Study|Non-specified|3|||
30577199|NCT00085202|58587438|FG001|Overall Study|Non-specified|5|||
30577200|NCT00085202|58587437|FG000|Overall Study|Withdrawal by Subject|2|||
30577201|NCT00085202|58587438|FG001|Overall Study|Withdrawal by Subject|1|||
30577202|NCT00085202|58587437|FG000|Overall Study|Physician Decision|4|||
30577203|NCT00085202|58587438|FG001|Overall Study|Physician Decision|1|||
30577204|NCT00085202|58587437|FG000|Overall Study|Progressive disease|1|||
30577205|NCT00085202|58587438|FG001|Overall Study|Progressive disease|11|||
30577206|NCT00039130|58587471|FG000|Overall Study|Adverse Event|11|||
30577207|NCT00039130|58587471|FG000|Overall Study|Death|9|||
30577208|NCT00039130|58587471|FG000|Overall Study|Withdrawal by Subject|3|||
30577209|NCT00039130|58587471|FG000|Overall Study|Progression|2|||
30577210|NCT00039130|58587471|FG000|Overall Study|Subsequent treatment|2|||
30577211|NCT00039130|58587471|FG000|Overall Study|Physician Decision|3|||
30577212|NCT00005957|58587477|FG000|Overall Study|No treated|3|||
30577213|NCT00005957|58587478|FG001|Overall Study|No treated|9|||
30577214|NCT00005957|58587477|FG000|Overall Study|Crossover to the other arm|5|||
30577215|NCT00005957|58587478|FG001|Overall Study|Crossover to the other arm|19|||
30577216|NCT04642079|58587588|FG000|Overall Study|Lost to Follow-up|2|||
30577217|NCT04642079|58587589|FG001|Overall Study|Lost to Follow-up|5|||
30577218|NCT04642079|58587590|FG002|Overall Study|Lost to Follow-up|2|||
30577219|NCT04642079|58587591|FG003|Overall Study|Lost to Follow-up|0|||
30577220|NCT04642079|58587588|FG000|Overall Study|Withdrawal by Subject|0|||
30577221|NCT04642079|58587589|FG001|Overall Study|Withdrawal by Subject|4|||
30577222|NCT04642079|58587590|FG002|Overall Study|Withdrawal by Subject|1|||
30577223|NCT04642079|58587591|FG003|Overall Study|Withdrawal by Subject|2|||
30577224|NCT04642079|58587588|FG000|Overall Study|Other|0|||
30577225|NCT04642079|58587589|FG001|Overall Study|Other|0|||
30577226|NCT04642079|58587590|FG002|Overall Study|Other|0|||
30577227|NCT04642079|58587591|FG003|Overall Study|Other|1|||
30577228|NCT04642079|58587588|FG000|Overall Study|No longer met eligibility criteria|1|||
30577229|NCT04642079|58587589|FG001|Overall Study|No longer met eligibility criteria|0|||
30577230|NCT04642079|58587590|FG002|Overall Study|No longer met eligibility criteria|1|||
30577231|NCT04642079|58587591|FG003|Overall Study|No longer met eligibility criteria|1|||
30577232|NCT04419493|58587610|FG000|Wash-out After Period 1|Adverse Event|1|||
30577233|NCT04419493|58587611|FG001|Wash-out After Period 1|Adverse Event|2|||
30577234|NCT04419493|58587612|FG002|Wash-out After Period 1|Adverse Event|1|||
30577235|NCT04419493|58587613|FG003|Wash-out After Period 1|Adverse Event|0|||
30577236|NCT04359901|58587626|FG000|Overall Study|Withdrawal by Subject|0|||
30577237|NCT04359901|58587627|FG001|Overall Study|Withdrawal by Subject|1|||
30577238|NCT04359901|58587626|FG000|Overall Study|Death|6|||
30577239|NCT04359901|58587627|FG001|Overall Study|Death|2|||
30577240|NCT04147611|58587650|FG000|Overall Study|Physician Decision|0|||
30577241|NCT04147611|58587651|FG001|Overall Study|Physician Decision|1|||
30577242|NCT03635424|58587682|FG000|Overall Study|Adverse Event|1|||
30577243|NCT03635424|58587682|FG000|Overall Study|Death|1|||
30577244|NCT03635424|58587682|FG000|Overall Study|Device not implanted|1|||
30577245|NCT03603964|58587686|FG000|Overall Study|Death|9|||
30577246|NCT03603964|58587686|FG000|Overall Study|Withdrawal by participant|7|||
30577247|NCT03603964|58587686|FG000|Overall Study|Study terminated by Sponsor|19|||
30577248|NCT03191864|58587715|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
30577249|NCT03191864|58587716|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
30577250|NCT03191864|58587717|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
30577251|NCT03191864|58587718|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
30577252|NCT03191864|58587719|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
30577253|NCT03191864|58587720|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
30577254|NCT03191864|58587715|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
30577255|NCT03191864|58587716|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
30577256|NCT03191864|58587717|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
30577257|NCT03191864|58587718|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
30577258|NCT03191864|58587719|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
30577259|NCT03191864|58587720|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
30577260|NCT03191864|58587715|FG000|Baseline Symptom Assessment|Adverse Event|0|||
30577261|NCT03191864|58587716|FG001|Baseline Symptom Assessment|Adverse Event|0|||
30577262|NCT03191864|58587717|FG002|Baseline Symptom Assessment|Adverse Event|0|||
30577263|NCT03191864|58587718|FG003|Baseline Symptom Assessment|Adverse Event|0|||
30577264|NCT03191864|58587719|FG004|Baseline Symptom Assessment|Adverse Event|0|||
30577265|NCT03191864|58587720|FG005|Baseline Symptom Assessment|Adverse Event|2|||
30577266|NCT03191864|58587715|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
30577267|NCT03191864|58587716|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
30577268|NCT03191864|58587717|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
30577269|NCT03191864|58587718|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
30577270|NCT03191864|58587719|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
30577271|NCT03191864|58587720|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
30577272|NCT03191864|58587715|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
30577273|NCT03191864|58587716|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
30668129|NCT00698932|58682108|FG000|Overall Study|Study specific discontinuation criteria|3|||
30577274|NCT03191864|58587717|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
30577275|NCT03191864|58587718|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
30577276|NCT03191864|58587719|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
30577277|NCT03191864|58587720|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
30577278|NCT03191864|58587715|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
30577279|NCT03191864|58587716|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
30577280|NCT03191864|58587717|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
30577281|NCT03191864|58587718|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
30577282|NCT03191864|58587719|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
30577283|NCT03191864|58587720|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
30577284|NCT03191864|58587715|FG000|Part 1 - Induction|Adverse Event|0|||
30577285|NCT03191864|58587716|FG001|Part 1 - Induction|Adverse Event|2|||
30577286|NCT03191864|58587717|FG002|Part 1 - Induction|Adverse Event|0|||
30577287|NCT03191864|58587718|FG003|Part 1 - Induction|Adverse Event|1|||
30577288|NCT03191864|58587719|FG004|Part 1 - Induction|Adverse Event|0|||
30577289|NCT03191864|58587720|FG005|Part 1 - Induction|Adverse Event|2|||
30577290|NCT03191864|58587715|FG000|Part 1 - Induction|Randomized but never dosed|0|||
30577291|NCT03191864|58587716|FG001|Part 1 - Induction|Randomized but never dosed|0|||
30577292|NCT03191864|58587717|FG002|Part 1 - Induction|Randomized but never dosed|1|||
30577293|NCT03191864|58587718|FG003|Part 1 - Induction|Randomized but never dosed|0|||
30577294|NCT03191864|58587719|FG004|Part 1 - Induction|Randomized but never dosed|0|||
30577295|NCT03191864|58587720|FG005|Part 1 - Induction|Randomized but never dosed|0|||
30577296|NCT03191864|58587715|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
30577297|NCT03191864|58587716|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
30577298|NCT03191864|58587717|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
30577299|NCT03191864|58587718|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
30577300|NCT03191864|58587719|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
30577301|NCT03191864|58587720|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
30577302|NCT03191864|58587715|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
30577303|NCT03191864|58587716|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
30577304|NCT03191864|58587717|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
30577305|NCT03191864|58587718|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
30577306|NCT03191864|58587719|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
30577307|NCT03191864|58587720|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
30577308|NCT03191864|58587715|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
30577309|NCT03191864|58587716|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
30577310|NCT03191864|58587717|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
30577311|NCT03191864|58587718|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
30577312|NCT03191864|58587719|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
30577313|NCT03191864|58587720|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
30577314|NCT03191864|58587715|FG000|Part 2 - Maintenance|Physician Decision|1|||
30577315|NCT03191864|58587716|FG001|Part 2 - Maintenance|Physician Decision|0|||
30577316|NCT03191864|58587717|FG002|Part 2 - Maintenance|Physician Decision|0|||
30577317|NCT03191864|58587718|FG003|Part 2 - Maintenance|Physician Decision|0|||
30577318|NCT03191864|58587719|FG004|Part 2 - Maintenance|Physician Decision|0|||
30577319|NCT03191864|58587720|FG005|Part 2 - Maintenance|Physician Decision|0|||
30577320|NCT03191864|58587715|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
30577321|NCT03191864|58587716|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
30577322|NCT03191864|58587717|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
30577323|NCT03191864|58587718|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
30577324|NCT03191864|58587719|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
30577325|NCT03191864|58587720|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
30577326|NCT03191864|58587715|FG000|Part 2 - Maintenance|Adverse Event|0|||
30577327|NCT03191864|58587716|FG001|Part 2 - Maintenance|Adverse Event|0|||
30577328|NCT03191864|58587717|FG002|Part 2 - Maintenance|Adverse Event|0|||
30577329|NCT03191864|58587718|FG003|Part 2 - Maintenance|Adverse Event|0|||
30577330|NCT03191864|58587719|FG004|Part 2 - Maintenance|Adverse Event|1|||
30577331|NCT03191864|58587720|FG005|Part 2 - Maintenance|Adverse Event|0|||
30577332|NCT03191864|58587715|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
30577333|NCT03191864|58587716|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
30577334|NCT03191864|58587717|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
30577335|NCT03191864|58587718|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
30577336|NCT03191864|58587719|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
30577337|NCT03191864|58587720|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
30577338|NCT03191864|58587715|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
30577339|NCT03191864|58587716|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
30577340|NCT03191864|58587717|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
30577341|NCT03191864|58587718|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
30577342|NCT03191864|58587719|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
30577343|NCT03191864|58587720|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
30577344|NCT02975882|58587752|FG000|Overall Study|Adverse Event|1|||
30577345|NCT02975882|58587753|FG001|Overall Study|Adverse Event|2|||
30577346|NCT02975882|58587754|FG002|Overall Study|Adverse Event|1|||
30577347|NCT02975882|58587755|FG003|Overall Study|Adverse Event|1|||
30577348|NCT02975882|58587752|FG000|Overall Study|Death|0|||
30577349|NCT02975882|58587753|FG001|Overall Study|Death|1|||
30577350|NCT02975882|58587754|FG002|Overall Study|Death|0|||
30577351|NCT02975882|58587755|FG003|Overall Study|Death|0|||
30577352|NCT02975882|58587752|FG000|Overall Study|Lack of Efficacy|3|||
30577353|NCT02975882|58587753|FG001|Overall Study|Lack of Efficacy|7|||
30577354|NCT02975882|58587754|FG002|Overall Study|Lack of Efficacy|4|||
30577355|NCT02975882|58587755|FG003|Overall Study|Lack of Efficacy|3|||
30577356|NCT02975882|58587752|FG000|Overall Study|Physician Decision|0|||
30577357|NCT02975882|58587753|FG001|Overall Study|Physician Decision|2|||
30577358|NCT02975882|58587754|FG002|Overall Study|Physician Decision|4|||
30577359|NCT02975882|58587755|FG003|Overall Study|Physician Decision|2|||
30577360|NCT02975882|58587752|FG000|Overall Study|Ineligible|0|||
30577361|NCT02975882|58587753|FG001|Overall Study|Ineligible|1|||
30577362|NCT02975882|58587754|FG002|Overall Study|Ineligible|0|||
30577363|NCT02975882|58587755|FG003|Overall Study|Ineligible|0|||
30577364|NCT02636725|58587801|FG000|Baseline|Adverse Event|1|||
30577365|NCT02636725|58587801|FG000|Baseline|Lack of Efficacy|2|||
30577366|NCT02573493|58587809|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
30577367|NCT02573493|58587810|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
30577368|NCT02573493|58587811|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
30577369|NCT02573493|58587812|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
30577370|NCT02327078|58587845|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
30577371|NCT02327078|58587846|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
30577372|NCT02327078|58587847|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
30577373|NCT02327078|58587848|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
30577374|NCT02327078|58587849|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
30577375|NCT02327078|58587850|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
30577376|NCT02327078|58587851|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
30577377|NCT02327078|58587852|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
30577378|NCT02327078|58587853|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
30577379|NCT02327078|58587845|FG000|Overall Study|Death|2|||
30577380|NCT02327078|58587846|FG001|Overall Study|Death|4|||
30577381|NCT02327078|58587847|FG002|Overall Study|Death|10|||
30577382|NCT02327078|58587848|FG003|Overall Study|Death|6|||
30577383|NCT02327078|58587849|FG004|Overall Study|Death|4|||
30577384|NCT02327078|58587850|FG005|Overall Study|Death|3|||
30577385|NCT02327078|58587851|FG006|Overall Study|Death|2|||
30577386|NCT02327078|58587852|FG007|Overall Study|Death|51|||
30577387|NCT02327078|58587853|FG008|Overall Study|Death|97|||
30577388|NCT02327078|58587845|FG000|Overall Study|Lost to Follow-up|0|||
30577389|NCT02327078|58587846|FG001|Overall Study|Lost to Follow-up|1|||
30577390|NCT02327078|58587847|FG002|Overall Study|Lost to Follow-up|1|||
30577391|NCT02327078|58587848|FG003|Overall Study|Lost to Follow-up|0|||
30577392|NCT02327078|58587849|FG004|Overall Study|Lost to Follow-up|0|||
30577393|NCT02327078|58587850|FG005|Overall Study|Lost to Follow-up|0|||
30577394|NCT02327078|58587851|FG006|Overall Study|Lost to Follow-up|0|||
30577395|NCT02327078|58587852|FG007|Overall Study|Lost to Follow-up|2|||
30577396|NCT02327078|58587853|FG008|Overall Study|Lost to Follow-up|5|||
30577397|NCT02327078|58587845|FG000|Overall Study|Site Terminated by Sponsor|1|||
30577398|NCT02327078|58587846|FG001|Overall Study|Site Terminated by Sponsor|0|||
30577399|NCT02327078|58587847|FG002|Overall Study|Site Terminated by Sponsor|1|||
30577400|NCT02327078|58587848|FG003|Overall Study|Site Terminated by Sponsor|4|||
30577401|NCT02327078|58587849|FG004|Overall Study|Site Terminated by Sponsor|0|||
30855329|NCT02596958|58882970|FG000|Overall Study|Death From Other Cause|33|||
30577402|NCT02327078|58587850|FG005|Overall Study|Site Terminated by Sponsor|0|||
30577403|NCT02327078|58587851|FG006|Overall Study|Site Terminated by Sponsor|0|||
30577404|NCT02327078|58587852|FG007|Overall Study|Site Terminated by Sponsor|11|||
30577405|NCT02327078|58587853|FG008|Overall Study|Site Terminated by Sponsor|25|||
30577406|NCT02327078|58587845|FG000|Overall Study|Physician Decision|0|||
30577407|NCT02327078|58587846|FG001|Overall Study|Physician Decision|0|||
30577408|NCT02327078|58587847|FG002|Overall Study|Physician Decision|0|||
30577409|NCT02327078|58587848|FG003|Overall Study|Physician Decision|1|||
30577410|NCT02327078|58587849|FG004|Overall Study|Physician Decision|0|||
30577411|NCT02327078|58587850|FG005|Overall Study|Physician Decision|0|||
30577412|NCT02327078|58587851|FG006|Overall Study|Physician Decision|0|||
30577413|NCT02327078|58587852|FG007|Overall Study|Physician Decision|0|||
30577414|NCT02327078|58587853|FG008|Overall Study|Physician Decision|1|||
30577415|NCT02327078|58587845|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
30577416|NCT02327078|58587846|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
30577417|NCT02327078|58587847|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
30577418|NCT02327078|58587848|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
30577419|NCT02327078|58587849|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
30577420|NCT02327078|58587850|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
30577421|NCT02327078|58587851|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
30577422|NCT02327078|58587852|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
30577423|NCT02327078|58587853|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
30577424|NCT02327078|58587845|FG000|Overall Study|Reason not Specified|0|||
30577425|NCT02327078|58587846|FG001|Overall Study|Reason not Specified|0|||
30577426|NCT02327078|58587847|FG002|Overall Study|Reason not Specified|0|||
30577427|NCT02327078|58587848|FG003|Overall Study|Reason not Specified|0|||
30577428|NCT02327078|58587849|FG004|Overall Study|Reason not Specified|0|||
30577429|NCT02327078|58587850|FG005|Overall Study|Reason not Specified|0|||
30577430|NCT02327078|58587851|FG006|Overall Study|Reason not Specified|0|||
30577431|NCT02327078|58587852|FG007|Overall Study|Reason not Specified|5|||
30577432|NCT02327078|58587853|FG008|Overall Study|Reason not Specified|12|||
30855330|NCT02596958|58882970|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
30855331|NCT02596958|58882970|FG000|Overall Study|Administrative Reasons/Other|231|||
30855332|NCT02596958|58882970|FG000|Overall Study|Lost to Follow-up|33|||
30855333|NCT02596958|58882970|FG000|Overall Study|Missing|32|||
30855334|NCT02596958|58882970|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
30855335|NCT01367249|58882976|FG000|Overall Study|Withdrawal by Subject|6|||
30855336|NCT01367249|58882977|FG001|Overall Study|Withdrawal by Subject|6|||
30855337|NCT01367249|58882976|FG000|Overall Study|Other|3|||
30855338|NCT01367249|58882977|FG001|Overall Study|Other|10|||
30855339|NCT02786927|58882983|FG000|Overall Study|Adverse Event|1|||
30855340|NCT02786927|58882983|FG000|Overall Study|Protocol Violation|4|||
30855341|NCT02592434|58882988|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
30855342|NCT02592434|58882989|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
30855343|NCT02592434|58882990|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
30855344|NCT02592434|58882988|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
30855345|NCT02592434|58882989|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
30855346|NCT02592434|58882990|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
30855347|NCT02592434|58882988|FG000|Open-Label Phase (18 Weeks)|Other|3|||
30855348|NCT02592434|58882989|FG001|Open-Label Phase (18 Weeks)|Other|0|||
30855349|NCT02592434|58882990|FG002|Open-Label Phase (18 Weeks)|Other|0|||
30855350|NCT02592434|58882988|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
30577433|NCT02304458|58587896|FG000|Overall Study|Adverse Event|0|||
30577434|NCT02304458|58587897|FG001|Overall Study|Adverse Event|0|||
30577435|NCT02304458|58587898|FG002|Overall Study|Adverse Event|7|||
30577436|NCT02304458|58587899|FG003|Overall Study|Adverse Event|0|||
30577437|NCT02304458|58587900|FG004|Overall Study|Adverse Event|0|||
30577438|NCT02304458|58587901|FG005|Overall Study|Adverse Event|0|||
30577439|NCT02304458|58587902|FG006|Overall Study|Adverse Event|3|||
30577440|NCT02304458|58587903|FG007|Overall Study|Adverse Event|4|||
30577441|NCT02304458|58587896|FG000|Overall Study|Death|0|||
30577442|NCT02304458|58587897|FG001|Overall Study|Death|0|||
30577443|NCT02304458|58587898|FG002|Overall Study|Death|2|||
30577444|NCT02304458|58587899|FG003|Overall Study|Death|0|||
30577445|NCT02304458|58587900|FG004|Overall Study|Death|0|||
30577446|NCT02304458|58587901|FG005|Overall Study|Death|0|||
30577447|NCT02304458|58587902|FG006|Overall Study|Death|1|||
30577448|NCT02304458|58587903|FG007|Overall Study|Death|0|||
30577449|NCT02304458|58587896|FG000|Overall Study|Lack of Efficacy|4|||
30577450|NCT02304458|58587897|FG001|Overall Study|Lack of Efficacy|6|||
30577451|NCT02304458|58587898|FG002|Overall Study|Lack of Efficacy|38|||
30577452|NCT02304458|58587899|FG003|Overall Study|Lack of Efficacy|5|||
30577453|NCT02304458|58587900|FG004|Overall Study|Lack of Efficacy|6|||
30577454|NCT02304458|58587901|FG005|Overall Study|Lack of Efficacy|6|||
30577455|NCT02304458|58587902|FG006|Overall Study|Lack of Efficacy|21|||
30577456|NCT02304458|58587903|FG007|Overall Study|Lack of Efficacy|4|||
30577457|NCT02304458|58587896|FG000|Overall Study|Physician Decision|2|||
30577458|NCT02304458|58587897|FG001|Overall Study|Physician Decision|0|||
30855351|NCT02592434|58882989|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
30855352|NCT02592434|58882990|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
30577459|NCT02304458|58587898|FG002|Overall Study|Physician Decision|16|||
30577460|NCT02304458|58587899|FG003|Overall Study|Physician Decision|1|||
30577461|NCT02304458|58587900|FG004|Overall Study|Physician Decision|0|||
30577462|NCT02304458|58587901|FG005|Overall Study|Physician Decision|0|||
30577463|NCT02304458|58587902|FG006|Overall Study|Physician Decision|3|||
30577464|NCT02304458|58587903|FG007|Overall Study|Physician Decision|0|||
30577465|NCT02304458|58587896|FG000|Overall Study|Protocol Violation|0|||
30577466|NCT02304458|58587897|FG001|Overall Study|Protocol Violation|0|||
30577467|NCT02304458|58587898|FG002|Overall Study|Protocol Violation|1|||
30577468|NCT02304458|58587899|FG003|Overall Study|Protocol Violation|0|||
30577469|NCT02304458|58587900|FG004|Overall Study|Protocol Violation|0|||
30577470|NCT02304458|58587901|FG005|Overall Study|Protocol Violation|0|||
30577471|NCT02304458|58587902|FG006|Overall Study|Protocol Violation|0|||
30577472|NCT02304458|58587903|FG007|Overall Study|Protocol Violation|0|||
30577473|NCT02304458|58587896|FG000|Overall Study|Withdrawal by Subject|1|||
30577474|NCT02304458|58587897|FG001|Overall Study|Withdrawal by Subject|0|||
30577475|NCT02304458|58587898|FG002|Overall Study|Withdrawal by Subject|7|||
30577476|NCT02304458|58587899|FG003|Overall Study|Withdrawal by Subject|0|||
30577477|NCT02304458|58587900|FG004|Overall Study|Withdrawal by Subject|0|||
30577478|NCT02304458|58587901|FG005|Overall Study|Withdrawal by Subject|0|||
30577479|NCT02304458|58587902|FG006|Overall Study|Withdrawal by Subject|1|||
30577480|NCT02304458|58587903|FG007|Overall Study|Withdrawal by Subject|0|||
30577481|NCT02187224|58587939|FG000|Overall Study|Did not show up for test day|1|||
30577482|NCT02187224|58587940|FG001|Overall Study|Did not show up for test day|0|||
30577483|NCT02176226|58587950|FG000|Overall Study|Lost to Follow-up|3|||
30577484|NCT02176226|58587950|FG000|Overall Study|Withdrew prior to treatment|6|||
30577485|NCT02032823|58587956|FG000|Overall Study|Death|75|||
30577486|NCT02032823|58587957|FG001|Overall Study|Death|109|||
30577487|NCT02032823|58587956|FG000|Overall Study|Lost to Follow-up|18|||
30577488|NCT02032823|58587957|FG001|Overall Study|Lost to Follow-up|17|||
30577489|NCT02032823|58587956|FG000|Overall Study|Withdrawal by Subject|70|||
30577490|NCT02032823|58587957|FG001|Overall Study|Withdrawal by Subject|53|||
30577491|NCT02032823|58587956|FG000|Overall Study|Ongoing study at data cut-off|755|||
30577492|NCT02032823|58587957|FG001|Overall Study|Ongoing study at data cut-off|731|||
30577493|NCT02032823|58587956|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
30577494|NCT02032823|58587957|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
30577495|NCT01958021|58587965|FG000|Overall Study|Progressive disease|87|||
30577496|NCT01958021|58587966|FG001|Overall Study|Progressive disease|146|||
30577497|NCT01958021|58587965|FG000|Overall Study|Adverse Event|25|||
30577498|NCT01958021|58587966|FG001|Overall Study|Adverse Event|7|||
30577499|NCT01958021|58587965|FG000|Overall Study|Subject/guardian decision|12|||
30577500|NCT01958021|58587966|FG001|Overall Study|Subject/guardian decision|13|||
30577501|NCT01958021|58587965|FG000|Overall Study|Physician Decision|10|||
30577502|NCT01958021|58587966|FG001|Overall Study|Physician Decision|13|||
30577503|NCT01958021|58587965|FG000|Overall Study|Protocol Violation|3|||
30577504|NCT01958021|58587966|FG001|Overall Study|Protocol Violation|1|||
30577505|NCT01958021|58587965|FG000|Overall Study|Death|2|||
30577506|NCT01958021|58587966|FG001|Overall Study|Death|0|||
30577507|NCT05059600|58587972|FG000|Overall Study|Enrolled but not Treated|10|||
30577508|NCT04608448|58587985|FG000|Overall Study|Withdrawal by Subject|1|||
30577509|NCT04608448|58587985|FG000|Overall Study|Adverse Event|1|||
30577510|NCT04530344|58587995|FG000|Overall Study|Lost to Follow-up|3|||
30577511|NCT04530344|58587996|FG001|Overall Study|Lost to Follow-up|3|||
30577512|NCT04530344|58587997|FG002|Overall Study|Lost to Follow-up|3|||
30577513|NCT04530344|58587998|FG003|Overall Study|Lost to Follow-up|10|||
30577514|NCT04530344|58587995|FG000|Overall Study|Withdrawal by Subject|14|||
30577515|NCT04530344|58587996|FG001|Overall Study|Withdrawal by Subject|5|||
30577516|NCT04530344|58587997|FG002|Overall Study|Withdrawal by Subject|18|||
30577517|NCT04530344|58587998|FG003|Overall Study|Withdrawal by Subject|33|||
30577518|NCT04530344|58587995|FG000|Overall Study|Adverse Event|0|||
30577519|NCT04530344|58587996|FG001|Overall Study|Adverse Event|0|||
30577520|NCT04530344|58587997|FG002|Overall Study|Adverse Event|0|||
30577521|NCT04530344|58587998|FG003|Overall Study|Adverse Event|1|||
30577522|NCT04530344|58587995|FG000|Overall Study|Lack of Efficacy|0|||
30577523|NCT04530344|58587996|FG001|Overall Study|Lack of Efficacy|0|||
30577524|NCT04530344|58587997|FG002|Overall Study|Lack of Efficacy|0|||
30577525|NCT04530344|58587998|FG003|Overall Study|Lack of Efficacy|1|||
30577526|NCT04530344|58587995|FG000|Overall Study|Physician Decision|0|||
30577527|NCT04530344|58587996|FG001|Overall Study|Physician Decision|0|||
30577528|NCT04530344|58587997|FG002|Overall Study|Physician Decision|1|||
30577529|NCT04530344|58587998|FG003|Overall Study|Physician Decision|1|||
30577530|NCT04530344|58587995|FG000|Overall Study|Pregnancy|0|||
30577531|NCT04530344|58587996|FG001|Overall Study|Pregnancy|0|||
30577532|NCT04530344|58587997|FG002|Overall Study|Pregnancy|2|||
30577533|NCT04530344|58587998|FG003|Overall Study|Pregnancy|1|||
30577534|NCT04530344|58587995|FG000|Overall Study|Protocol Violation|0|||
30577535|NCT04530344|58587996|FG001|Overall Study|Protocol Violation|0|||
30577536|NCT04530344|58587997|FG002|Overall Study|Protocol Violation|0|||
30577537|NCT04530344|58587998|FG003|Overall Study|Protocol Violation|1|||
30577538|NCT04530344|58587995|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
30577539|NCT04530344|58587996|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
30577540|NCT04530344|58587997|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
30577541|NCT04530344|58587998|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
30577542|NCT04530344|58587995|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
30577543|NCT04530344|58587996|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
30577544|NCT04530344|58587997|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
30577545|NCT04530344|58587998|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
30577546|NCT04530344|58587995|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
30577547|NCT04530344|58587996|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
30577548|NCT04530344|58587997|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
30577549|NCT04530344|58587998|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
30577550|NCT04530344|58587995|FG000|Overall Study|Personal Reasons|0|||
30577551|NCT04530344|58587996|FG001|Overall Study|Personal Reasons|0|||
30577552|NCT04530344|58587997|FG002|Overall Study|Personal Reasons|0|||
30577553|NCT04530344|58587998|FG003|Overall Study|Personal Reasons|1|||
30577554|NCT04530344|58587995|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
30577555|NCT04530344|58587996|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
30577556|NCT04530344|58587997|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
30577557|NCT04530344|58587998|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
30577558|NCT04503096|58588014|FG000|Overall Study|Withdrawal by Subject|3|||
30577559|NCT04058886|58588036|FG000|Overall Study|Withdrawal by Subject|4|||
30577560|NCT04058886|58588036|FG000|Overall Study|Inadequate deafness interpreter service|1|||
30577561|NCT03704194|58588059|FG000|Overall Study|Withdrawal by Subject|0|||
30577562|NCT03704194|58588060|FG001|Overall Study|Withdrawal by Subject|1|||
30577563|NCT03451422|58588074|FG000|Overall Study|Lost to Follow-up|0|||
30577564|NCT03451422|58588075|FG001|Overall Study|Lost to Follow-up|0|||
30577565|NCT03451422|58588076|FG002|Overall Study|Lost to Follow-up|0|||
30577566|NCT03451422|58588077|FG003|Overall Study|Lost to Follow-up|0|||
30577567|NCT03451422|58588078|FG004|Overall Study|Lost to Follow-up|0|||
30577568|NCT03451422|58588079|FG005|Overall Study|Lost to Follow-up|1|||
30577569|NCT03451422|58588074|FG000|Overall Study|Decision by sponsor|1|||
30577570|NCT03451422|58588075|FG001|Overall Study|Decision by sponsor|0|||
30577571|NCT03451422|58588076|FG002|Overall Study|Decision by sponsor|1|||
30577572|NCT03451422|58588077|FG003|Overall Study|Decision by sponsor|0|||
30577573|NCT03451422|58588078|FG004|Overall Study|Decision by sponsor|0|||
30577574|NCT03451422|58588079|FG005|Overall Study|Decision by sponsor|0|||
30577575|NCT03451422|58588074|FG000|Overall Study|Withdrawal by Subject|0|||
30577576|NCT03451422|58588075|FG001|Overall Study|Withdrawal by Subject|0|||
30577577|NCT03451422|58588076|FG002|Overall Study|Withdrawal by Subject|2|||
30577578|NCT03451422|58588077|FG003|Overall Study|Withdrawal by Subject|3|||
30577579|NCT03451422|58588078|FG004|Overall Study|Withdrawal by Subject|2|||
30577580|NCT03451422|58588079|FG005|Overall Study|Withdrawal by Subject|1|||
30577581|NCT03446573|58588100|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
30577582|NCT03446573|58588101|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
30577583|NCT03446573|58588100|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
30577584|NCT03446573|58588101|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
30577585|NCT03446573|58588100|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
30577586|NCT03446573|58588101|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
30577587|NCT03446573|58588100|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
30577588|NCT03446573|58588101|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
30577589|NCT03446573|58588100|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
30577590|NCT03446573|58588101|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
30577591|NCT03446573|58588100|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
30577592|NCT03446573|58588101|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
30577593|NCT03446573|58588100|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
30577594|NCT03446573|58588101|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
30577595|NCT03446573|58588100|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
30577596|NCT03446573|58588101|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
30577597|NCT03446573|58588100|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
30577598|NCT03446573|58588101|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
30577599|NCT03446573|58588100|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
30577600|NCT03446573|58588101|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
30577601|NCT03446573|58588100|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
30577602|NCT03446573|58588101|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
30577603|NCT03446573|58588100|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
30577604|NCT03446573|58588101|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
30577605|NCT03446573|58588100|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
30577606|NCT03446573|58588101|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
30577607|NCT03422536|58588119|FG000|Randomized|Physician Decision|1|||
30577608|NCT03422536|58588120|FG001|Randomized|Physician Decision|1|||
30577609|NCT03422536|58588119|FG000|Allocation - Received Intervention|Disease progression|19|||
30577610|NCT03422536|58588120|FG001|Allocation - Received Intervention|Disease progression|25|||
30577611|NCT03422536|58588119|FG000|Allocation - Received Intervention|Death|1|||
30577612|NCT03422536|58588120|FG001|Allocation - Received Intervention|Death|3|||
30577613|NCT03422536|58588119|FG000|Allocation - Received Intervention|Adverse Event|1|||
30577614|NCT03422536|58588120|FG001|Allocation - Received Intervention|Adverse Event|0|||
30577615|NCT03422536|58588119|FG000|Allocation - Received Intervention|Physician Decision|1|||
30577616|NCT03422536|58588120|FG001|Allocation - Received Intervention|Physician Decision|1|||
30577617|NCT03422536|58588119|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
30577618|NCT03422536|58588120|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
30577619|NCT03422536|58588119|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
30577620|NCT03422536|58588120|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
30577621|NCT03228394|58588134|FG000|Overall Study|Lost to Follow-up|0|||
30577622|NCT03228394|58588135|FG001|Overall Study|Lost to Follow-up|0|||
30577623|NCT03228394|58588136|FG002|Overall Study|Lost to Follow-up|1|||
30577624|NCT03228394|58588137|FG003|Overall Study|Lost to Follow-up|1|||
30577625|NCT03228394|58588138|FG004|Overall Study|Lost to Follow-up|0|||
30577626|NCT03228394|58588139|FG005|Overall Study|Lost to Follow-up|0|||
30577627|NCT03228394|58588140|FG006|Overall Study|Lost to Follow-up|2|||
30577628|NCT03228394|58588141|FG007|Overall Study|Lost to Follow-up|0|||
30577629|NCT03228394|58588134|FG000|Overall Study|Withdrawal by Subject|0|||
30577630|NCT03228394|58588135|FG001|Overall Study|Withdrawal by Subject|0|||
30577631|NCT03228394|58588136|FG002|Overall Study|Withdrawal by Subject|1|||
30577632|NCT03228394|58588137|FG003|Overall Study|Withdrawal by Subject|0|||
30577633|NCT03228394|58588138|FG004|Overall Study|Withdrawal by Subject|0|||
30577634|NCT03228394|58588139|FG005|Overall Study|Withdrawal by Subject|0|||
30577635|NCT03228394|58588140|FG006|Overall Study|Withdrawal by Subject|1|||
30577636|NCT03228394|58588141|FG007|Overall Study|Withdrawal by Subject|3|||
30577637|NCT03228394|58588134|FG000|Overall Study|Protocol Violation|0|||
30577638|NCT03228394|58588135|FG001|Overall Study|Protocol Violation|0|||
30577639|NCT03228394|58588136|FG002|Overall Study|Protocol Violation|0|||
30577640|NCT03228394|58588137|FG003|Overall Study|Protocol Violation|1|||
30577641|NCT03228394|58588138|FG004|Overall Study|Protocol Violation|0|||
30577642|NCT03228394|58588139|FG005|Overall Study|Protocol Violation|0|||
30577643|NCT03228394|58588140|FG006|Overall Study|Protocol Violation|0|||
30577644|NCT03228394|58588141|FG007|Overall Study|Protocol Violation|0|||
30577645|NCT03228394|58588134|FG000|Overall Study|Physician Decision|0|||
30577646|NCT03228394|58588135|FG001|Overall Study|Physician Decision|0|||
30577647|NCT03228394|58588136|FG002|Overall Study|Physician Decision|0|||
30577648|NCT03228394|58588137|FG003|Overall Study|Physician Decision|0|||
30577649|NCT03228394|58588138|FG004|Overall Study|Physician Decision|0|||
30668130|NCT00698932|58682109|FG001|Overall Study|Study specific discontinuation criteria|4|||
30668131|NCT00698932|58682108|FG000|Overall Study|Withdrawal by Subject|11|||
30668132|NCT00698932|58682109|FG001|Overall Study|Withdrawal by Subject|23|||
30668133|NCT00698932|58682108|FG000|Overall Study|Lost to Follow-up|6|||
30668134|NCT00698932|58682109|FG001|Overall Study|Lost to Follow-up|1|||
30668135|NCT00698932|58682108|FG000|Overall Study|Severe non-compliance to protocol|1|||
30668136|NCT00698932|58682109|FG001|Overall Study|Severe non-compliance to protocol|2|||
30668137|NCT00698932|58682108|FG000|Overall Study|Safety reasons|0|||
30668138|NCT00698932|58682109|FG001|Overall Study|Safety reasons|2|||
30668139|NCT00698932|58682108|FG000|Overall Study|Death|1|||
30668140|NCT00698932|58682109|FG001|Overall Study|Death|0|||
30668141|NCT00823719|58682117|FG000|Overall Study|Adverse Event|1|||
30668142|NCT00823719|58682118|FG001|Overall Study|Adverse Event|2|||
30668143|NCT00823719|58682117|FG000|Overall Study|Physician Decision|1|||
30668144|NCT00823719|58682118|FG001|Overall Study|Physician Decision|4|||
30577650|NCT03228394|58588139|FG005|Overall Study|Physician Decision|0|||
30577651|NCT03228394|58588140|FG006|Overall Study|Physician Decision|1|||
30577652|NCT03228394|58588141|FG007|Overall Study|Physician Decision|0|||
30577653|NCT03228394|58588134|FG000|Overall Study|Noncompliance|0|||
30577654|NCT03228394|58588135|FG001|Overall Study|Noncompliance|0|||
30577655|NCT03228394|58588136|FG002|Overall Study|Noncompliance|0|||
30577656|NCT03228394|58588137|FG003|Overall Study|Noncompliance|0|||
30577657|NCT03228394|58588138|FG004|Overall Study|Noncompliance|0|||
30668145|NCT00823719|58682117|FG000|Overall Study|Withdrawal by Subject|0|||
30668146|NCT00823719|58682118|FG001|Overall Study|Withdrawal by Subject|1|||
30668147|NCT00823719|58682117|FG000|Overall Study|Disease Progression|4|||
30668148|NCT00823719|58682118|FG001|Overall Study|Disease Progression|4|||
30668149|NCT00875420|58682131|FG000|Overall Study|Adverse Event|0|||
30668150|NCT00875420|58682132|FG001|Overall Study|Adverse Event|1|||
30780279|NCT03057054|58792128|FG001|Overall Study|Withdrawal by Subject|3|||
30577658|NCT03228394|58588139|FG005|Overall Study|Noncompliance|0|||
30577659|NCT03228394|58588140|FG006|Overall Study|Noncompliance|1|||
30577660|NCT03228394|58588141|FG007|Overall Study|Noncompliance|0|||
30577661|NCT03043872|58588163|FG000|Overall Study|Withdrawal by Subject|6|||
30577662|NCT03043872|58588164|FG001|Overall Study|Withdrawal by Subject|6|||
30577663|NCT03043872|58588165|FG002|Overall Study|Withdrawal by Subject|15|||
30577664|NCT03043872|58588163|FG000|Overall Study|Lost to Follow-up|2|||
30577665|NCT03043872|58588164|FG001|Overall Study|Lost to Follow-up|1|||
30577666|NCT03043872|58588165|FG002|Overall Study|Lost to Follow-up|1|||
30577667|NCT03043872|58588163|FG000|Overall Study|Death|270|||
30668151|NCT00875420|58682133|FG002|Overall Study|Adverse Event|1|||
30668152|NCT00875420|58682134|FG003|Overall Study|Adverse Event|0|||
30668153|NCT00875420|58682135|FG004|Overall Study|Adverse Event|0|||
30577668|NCT03043872|58588164|FG001|Overall Study|Death|269|||
30780280|NCT03057054|58792127|FG000|Overall Study|Ineligible|1|||
30577669|NCT03043872|58588165|FG002|Overall Study|Death|296|||
30577670|NCT03008070|58588186|FG000|Overall Study|Adverse Event|3|||
30577671|NCT03008070|58588187|FG001|Overall Study|Adverse Event|3|||
30577672|NCT03008070|58588188|FG002|Overall Study|Adverse Event|3|||
30577673|NCT03008070|58588186|FG000|Overall Study|Lost to Follow-up|1|||
30577674|NCT03008070|58588187|FG001|Overall Study|Lost to Follow-up|1|||
30577675|NCT03008070|58588188|FG002|Overall Study|Lost to Follow-up|0|||
30577676|NCT03008070|58588186|FG000|Overall Study|Non compliance|0|||
30577677|NCT03008070|58588187|FG001|Overall Study|Non compliance|1|||
30577678|NCT03008070|58588188|FG002|Overall Study|Non compliance|1|||
30577679|NCT03008070|58588186|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
30577680|NCT03008070|58588187|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
30577681|NCT03008070|58588188|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
30577682|NCT03008070|58588186|FG000|Overall Study|Withdrawal by Subject|2|||
30577683|NCT03008070|58588187|FG001|Overall Study|Withdrawal by Subject|0|||
30577684|NCT03008070|58588188|FG002|Overall Study|Withdrawal by Subject|1|||
30577685|NCT03008070|58588186|FG000|Overall Study|Use of prohibited drug|0|||
30577686|NCT03008070|58588187|FG001|Overall Study|Use of prohibited drug|0|||
30577687|NCT03008070|58588188|FG002|Overall Study|Use of prohibited drug|2|||
30577688|NCT02979353|58588200|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
30577689|NCT02979353|58588201|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
30577690|NCT02979353|58588200|FG000|Overall Study|Withdrawal by Subject|16|||
30577691|NCT02979353|58588201|FG001|Overall Study|Withdrawal by Subject|12|||
30577692|NCT02979353|58588200|FG000|Overall Study|Death|10|||
30577693|NCT02979353|58588201|FG001|Overall Study|Death|11|||
30577694|NCT02979353|58588200|FG000|Overall Study|Transfer to Hospice Care|19|||
30577695|NCT02979353|58588201|FG001|Overall Study|Transfer to Hospice Care|14|||
30577696|NCT02979353|58588200|FG000|Overall Study|Lost to Follow-up|1|||
30577697|NCT02979353|58588201|FG001|Overall Study|Lost to Follow-up|5|||
30577698|NCT02633397|58588220|FG000|Overall Study|Adverse Event|8|||
30577699|NCT02633397|58588221|FG001|Overall Study|Adverse Event|8|||
30577700|NCT02633397|58588220|FG000|Overall Study|Study Burden|4|||
30577701|NCT02633397|58588221|FG001|Overall Study|Study Burden|1|||
30577702|NCT02633397|58588220|FG000|Overall Study|Treatment interruption|2|||
30577703|NCT02633397|58588221|FG001|Overall Study|Treatment interruption|5|||
30577704|NCT02633397|58588220|FG000|Overall Study|Death|2|||
30577705|NCT02633397|58588221|FG001|Overall Study|Death|2|||
30577706|NCT02633397|58588220|FG000|Overall Study|Physician Decision|0|||
30577707|NCT02633397|58588221|FG001|Overall Study|Physician Decision|1|||
30577708|NCT02592707|58588231|FG000|Overall Study|Consent Withdrawn|0|||
30577709|NCT02592707|58588232|FG001|Overall Study|Consent Withdrawn|1|||
30577710|NCT02592707|58588233|FG002|Overall Study|Consent Withdrawn|2|||
30577711|NCT02592707|58588234|FG003|Overall Study|Consent Withdrawn|0|||
30577712|NCT02592707|58588231|FG000|Overall Study|Death|1|||
30577713|NCT02592707|58588232|FG001|Overall Study|Death|0|||
30577714|NCT02592707|58588233|FG002|Overall Study|Death|0|||
30577715|NCT02592707|58588234|FG003|Overall Study|Death|0|||
30577716|NCT02592707|58588231|FG000|Overall Study|Progressive Disease|4|||
30577717|NCT02592707|58588232|FG001|Overall Study|Progressive Disease|4|||
30577718|NCT02592707|58588233|FG002|Overall Study|Progressive Disease|3|||
30577719|NCT02592707|58588234|FG003|Overall Study|Progressive Disease|3|||
30577720|NCT02592707|58588231|FG000|Overall Study|Other|0|||
30577721|NCT02592707|58588232|FG001|Overall Study|Other|0|||
30577722|NCT02592707|58588233|FG002|Overall Study|Other|1|||
30577723|NCT02592707|58588234|FG003|Overall Study|Other|2|||
30577724|NCT02592707|58588231|FG000|Overall Study|Never entered LTFU period|1|||
30577725|NCT02592707|58588232|FG001|Overall Study|Never entered LTFU period|0|||
30577726|NCT02592707|58588233|FG002|Overall Study|Never entered LTFU period|0|||
30577727|NCT02592707|58588234|FG003|Overall Study|Never entered LTFU period|2|||
30780281|NCT03057054|58792128|FG001|Overall Study|Ineligible|1|||
30577748|NCT02288247|58588269|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
30577749|NCT02288247|58588270|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
30577750|NCT02288247|58588269|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
30577751|NCT02288247|58588270|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
30577752|NCT02288247|58588269|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
30577753|NCT02288247|58588270|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
30577754|NCT02288247|58588269|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
30577755|NCT02288247|58588270|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
30577756|NCT02288247|58588269|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
30577757|NCT02288247|58588270|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
30577758|NCT02288247|58588269|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
30577759|NCT02288247|58588270|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
30577760|NCT02288247|58588269|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
30577761|NCT02288247|58588270|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
30577762|NCT02288247|58588269|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
30577763|NCT02288247|58588270|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
30577764|NCT02288247|58588269|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
30577765|NCT02288247|58588270|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
30577766|NCT02288247|58588269|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
30577767|NCT02288247|58588270|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
30577768|NCT02288247|58588269|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
30577769|NCT02288247|58588270|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
30577770|NCT02288247|58588269|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
30577771|NCT02288247|58588270|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
30577772|NCT02288247|58588269|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
30577773|NCT02288247|58588270|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
30577774|NCT02288247|58588269|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
30577775|NCT02288247|58588270|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
30577776|NCT02288247|58588269|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
30577777|NCT02288247|58588270|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
30577778|NCT02108964|58588286|FG000|Overall Study|Progressive disease|12|||
30577779|NCT02108964|58588287|FG001|Overall Study|Progressive disease|25|||
30577780|NCT02108964|58588288|FG002|Overall Study|Progressive disease|50|||
30577781|NCT02108964|58588289|FG003|Overall Study|Progressive disease|6|||
30577782|NCT02108964|58588290|FG004|Overall Study|Progressive disease|18|||
30577783|NCT02108964|58588291|FG005|Overall Study|Progressive disease|5|||
30577784|NCT02108964|58588292|FG006|Overall Study|Progressive disease|7|||
30577785|NCT02108964|58588293|FG007|Overall Study|Progressive disease|9|||
30577786|NCT02108964|58588286|FG000|Overall Study|Physician Decision|1|||
30577787|NCT02108964|58588287|FG001|Overall Study|Physician Decision|5|||
30577788|NCT02108964|58588288|FG002|Overall Study|Physician Decision|6|||
30577789|NCT02108964|58588289|FG003|Overall Study|Physician Decision|0|||
30577790|NCT02108964|58588290|FG004|Overall Study|Physician Decision|1|||
30577791|NCT02108964|58588291|FG005|Overall Study|Physician Decision|0|||
30577792|NCT02108964|58588292|FG006|Overall Study|Physician Decision|0|||
30577793|NCT02108964|58588293|FG007|Overall Study|Physician Decision|0|||
30577794|NCT02108964|58588286|FG000|Overall Study|Adverse Event|0|||
30577795|NCT02108964|58588287|FG001|Overall Study|Adverse Event|0|||
30577796|NCT02108964|58588288|FG002|Overall Study|Adverse Event|4|||
30577797|NCT02108964|58588289|FG003|Overall Study|Adverse Event|0|||
30577798|NCT02108964|58588290|FG004|Overall Study|Adverse Event|1|||
30577799|NCT02108964|58588291|FG005|Overall Study|Adverse Event|0|||
30577800|NCT02108964|58588292|FG006|Overall Study|Adverse Event|3|||
30577801|NCT02108964|58588293|FG007|Overall Study|Adverse Event|1|||
30577802|NCT02108964|58588286|FG000|Overall Study|Death|1|||
30577803|NCT02108964|58588287|FG001|Overall Study|Death|1|||
30577804|NCT02108964|58588288|FG002|Overall Study|Death|2|||
30855353|NCT02592434|58882988|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
30577805|NCT02108964|58588289|FG003|Overall Study|Death|0|||
30577806|NCT02108964|58588290|FG004|Overall Study|Death|3|||
30577807|NCT02108964|58588291|FG005|Overall Study|Death|0|||
30577808|NCT02108964|58588292|FG006|Overall Study|Death|0|||
30577809|NCT02108964|58588293|FG007|Overall Study|Death|1|||
30577810|NCT02108964|58588286|FG000|Overall Study|Subject/Guardian decision|0|||
30577811|NCT02108964|58588287|FG001|Overall Study|Subject/Guardian decision|1|||
30958683|NCT01582061|59023783|FG000|Overall Study|Withdrawal by Subject|10|||
30577812|NCT02108964|58588288|FG002|Overall Study|Subject/Guardian decision|3|||
30577813|NCT02108964|58588289|FG003|Overall Study|Subject/Guardian decision|0|||
30577814|NCT02108964|58588290|FG004|Overall Study|Subject/Guardian decision|2|||
30577815|NCT02108964|58588291|FG005|Overall Study|Subject/Guardian decision|0|||
30577816|NCT02108964|58588292|FG006|Overall Study|Subject/Guardian decision|1|||
30577817|NCT02108964|58588293|FG007|Overall Study|Subject/Guardian decision|1|||
30958684|NCT01582061|59023784|FG001|Overall Study|Withdrawal by Subject|4|||
30577818|NCT01423812|58588314|FG000|Overall Study|Lost to Follow-up|2|||
30577819|NCT01423812|58588315|FG001|Overall Study|Lost to Follow-up|2|||
30577820|NCT01423812|58588314|FG000|Overall Study|Withdrawal by Subject|1|||
30577821|NCT01423812|58588315|FG001|Overall Study|Withdrawal by Subject|2|||
30577822|NCT00965718|58588323|FG000|Overall Study|Withdrawal by Subject|4|||
30577823|NCT00792740|58588338|FG000|Overall Study|Disease Worsening|3|||
30577824|NCT00792740|58588339|FG001|Overall Study|Disease Worsening|2|||
30577825|NCT00792740|58588338|FG000|Overall Study|Personal Reason|1|||
30577826|NCT00792740|58588339|FG001|Overall Study|Personal Reason|0|||
30577827|NCT00792740|58588338|FG000|Overall Study|Adverse Event|1|||
30577828|NCT00792740|58588339|FG001|Overall Study|Adverse Event|3|||
30577829|NCT00792740|58588338|FG000|Overall Study|Patient's withdrawal of consent|0|||
30577830|NCT00792740|58588339|FG001|Overall Study|Patient's withdrawal of consent|1|||
30577831|NCT00792740|58588338|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
30577832|NCT00792740|58588339|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
30577833|NCT00792740|58588338|FG000|Overall Study|Other reasons|0|||
30577834|NCT00792740|58588339|FG001|Overall Study|Other reasons|1|||
30577835|NCT00567580|58588358|FG000|Overall Study|Protocol Violation|28|||
30577836|NCT00567580|58588359|FG001|Overall Study|Protocol Violation|24|||
30577837|NCT00567580|58588360|FG002|Overall Study|Protocol Violation|24|||
30577838|NCT01058863|58588371|FG000|Overall Study|Lost to Follow-up|1|||
30577839|NCT01058863|58588371|FG000|Overall Study|Withdrawal by Subject|1|||
30577840|NCT01058863|58588371|FG000|Overall Study|Sponsor requested withdrawal|1|||
30577841|NCT01058863|58588371|FG000|Overall Study|Randomized in error|1|||
30577842|NCT01058395|58588386|FG000|Overall Study|Death|2|||
30577843|NCT01058395|58588387|FG001|Overall Study|Death|1|||
30577844|NCT01058395|58588386|FG000|Overall Study|Lost to Follow-up|1|||
30577845|NCT01058395|58588387|FG001|Overall Study|Lost to Follow-up|0|||
30577846|NCT01058356|58588393|FG000|Overall Study|Adverse Event|5|||
30577847|NCT01058356|58588393|FG000|Overall Study|Administration of contraindicated drugs|12|||
30577848|NCT01058356|58588393|FG000|Overall Study|Withdrawal by Subject|21|||
30577849|NCT01058356|58588393|FG000|Overall Study|Lost to Follow-up|4|||
30577850|NCT01058005|58588400|FG000|Overall Study|Adverse Event|0|||
30577851|NCT01058005|58588401|FG001|Overall Study|Adverse Event|2|||
30577852|NCT01058005|58588402|FG002|Overall Study|Adverse Event|1|||
30577853|NCT01058005|58588400|FG000|Overall Study|Physician Decision|2|||
30577854|NCT01058005|58588401|FG001|Overall Study|Physician Decision|2|||
30577855|NCT01058005|58588402|FG002|Overall Study|Physician Decision|0|||
30780282|NCT03024996|58792136|FG000|Overall Study|Death|57|||
30780283|NCT03024996|58792137|FG001|Overall Study|Death|55|||
30780284|NCT03024996|58792136|FG000|Overall Study|Disease relapse|1|||
30780285|NCT03024996|58792137|FG001|Overall Study|Disease relapse|0|||
30780286|NCT03024996|58792136|FG000|Overall Study|Lost to Follow-up|5|||
30780287|NCT03024996|58792137|FG001|Overall Study|Lost to Follow-up|10|||
30780288|NCT03024996|58792136|FG000|Overall Study|Other|3|||
30780289|NCT03024996|58792137|FG001|Overall Study|Other|3|||
30780290|NCT03024996|58792136|FG000|Overall Study|Physician Decision|0|||
30780291|NCT03024996|58792137|FG001|Overall Study|Physician Decision|1|||
30780292|NCT03024996|58792136|FG000|Overall Study|Study terminated by sponsor|303|||
30780293|NCT03024996|58792137|FG001|Overall Study|Study terminated by sponsor|283|||
30780294|NCT03024996|58792136|FG000|Overall Study|Withdrawal by Subject|21|||
30780295|NCT03024996|58792137|FG001|Overall Study|Withdrawal by Subject|36|||
30780296|NCT02967692|58792147|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
30780297|NCT02967692|58792148|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
30780298|NCT02967692|58792149|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
30780299|NCT02967692|58792150|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
30780300|NCT02967692|58792147|FG000|Overall Study|Progressive disease|3|||
30780301|NCT02967692|58792148|FG001|Overall Study|Progressive disease|15|||
30780302|NCT02967692|58792149|FG002|Overall Study|Progressive disease|99|||
30780303|NCT02967692|58792150|FG003|Overall Study|Progressive disease|128|||
30780304|NCT02967692|58792147|FG000|Overall Study|Subject/guardian decision|1|||
30577856|NCT01058005|58588400|FG000|Overall Study|Withdrawal by Subject|4|||
30780305|NCT02967692|58792148|FG001|Overall Study|Subject/guardian decision|1|||
30780306|NCT02967692|58792149|FG002|Overall Study|Subject/guardian decision|6|||
30577857|NCT01058005|58588401|FG001|Overall Study|Withdrawal by Subject|5|||
30577858|NCT01058005|58588402|FG002|Overall Study|Withdrawal by Subject|11|||
30577859|NCT01058005|58588400|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
30577860|NCT01058005|58588401|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
30577861|NCT01058005|58588402|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
30780307|NCT02967692|58792150|FG003|Overall Study|Subject/guardian decision|13|||
30577862|NCT01058005|58588400|FG000|Overall Study|Reason Missing|5|||
30577863|NCT01058005|58588401|FG001|Overall Study|Reason Missing|3|||
30577864|NCT01058005|58588402|FG002|Overall Study|Reason Missing|1|||
30577865|NCT01056640|58588412|FG000|Overall Study|Withdrawal by Subject|11|||
30577866|NCT01056640|58588413|FG001|Overall Study|Withdrawal by Subject|8|||
30780308|NCT02967692|58792147|FG000|Overall Study|Death|0|||
30577867|NCT01056640|58588412|FG000|Overall Study|Death|15|||
30577868|NCT01056640|58588413|FG001|Overall Study|Death|4|||
30577869|NCT01056523|58588419|FG000|Overall Study|Death|1|||
30577870|NCT01056523|58588420|FG001|Overall Study|Death|0|||
30577871|NCT01056523|58588421|FG002|Overall Study|Death|2|||
30577872|NCT01056523|58588422|FG003|Overall Study|Death|3|||
30577873|NCT01056523|58588423|FG004|Overall Study|Death|0|||
30577874|NCT01056523|58588424|FG005|Overall Study|Death|0|||
30577875|NCT01056523|58588425|FG006|Overall Study|Death|1|||
30577876|NCT01056484|58588432|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
30577877|NCT01056484|58588433|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
30577878|NCT01056484|58588432|FG000|Randomized Controlled Trial|Physician Decision|1|||
30577879|NCT01056484|58588433|FG001|Randomized Controlled Trial|Physician Decision|0|||
30577880|NCT01056484|58588432|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
30577881|NCT01056484|58588433|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
30577882|NCT01055314|58588442|FG000|Overall Study|Adverse Event|7|||
30577883|NCT01055314|58588443|FG001|Overall Study|Adverse Event|4|||
30577884|NCT01055314|58588442|FG000|Overall Study|Death|2|||
30577885|NCT01055314|58588443|FG001|Overall Study|Death|1|||
30577886|NCT01055314|58588442|FG000|Overall Study|Lack of Efficacy|11|||
30577887|NCT01055314|58588443|FG001|Overall Study|Lack of Efficacy|19|||
30577888|NCT01055314|58588442|FG000|Overall Study|Physician Decision|10|||
30577889|NCT01055314|58588443|FG001|Overall Study|Physician Decision|5|||
30577890|NCT01055314|58588442|FG000|Overall Study|Withdrawal by Subject|1|||
30577891|NCT01055314|58588443|FG001|Overall Study|Withdrawal by Subject|0|||
30577892|NCT01055314|58588442|FG000|Overall Study|Ineligible|3|||
30577893|NCT01055314|58588443|FG001|Overall Study|Ineligible|5|||
30577894|NCT01055314|58588442|FG000|Overall Study|Refusal of further protocol therapy|10|||
30577895|NCT01055314|58588443|FG001|Overall Study|Refusal of further protocol therapy|4|||
30577896|NCT01055314|58588442|FG000|Overall Study|No treatment|1|||
30577897|NCT01055314|58588443|FG001|Overall Study|No treatment|0|||
30577898|NCT01055197|58588452|FG000|Overall Study|Protocol Violation|7|||
30577899|NCT01055197|58588453|FG001|Overall Study|Protocol Violation|2|||
30577900|NCT01055197|58588452|FG000|Overall Study|Withdrawal by Subject|2|||
30577901|NCT01055197|58588453|FG001|Overall Study|Withdrawal by Subject|0|||
30577902|NCT01054885|58588465|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
30577903|NCT01054885|58588466|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30577904|NCT01054885|58588467|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30577905|NCT01054885|58588468|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30577906|NCT01054885|58588469|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30577907|NCT01054885|58588470|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30577908|NCT01054885|58588471|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30577909|NCT01054885|58588465|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
30577910|NCT01054885|58588466|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
30577911|NCT01054885|58588467|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
30577912|NCT01054885|58588468|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
30577913|NCT01054885|58588469|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
30577914|NCT01054885|58588470|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
30577915|NCT01054885|58588471|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
30577916|NCT01054885|58588465|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
30577917|NCT01054885|58588466|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30577918|NCT01054885|58588467|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30577919|NCT01054885|58588468|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30577920|NCT01054885|58588469|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30577921|NCT01054885|58588470|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30577922|NCT01054885|58588471|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30577923|NCT01054885|58588465|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
30577924|NCT01054885|58588466|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30577925|NCT01054885|58588467|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30577926|NCT01054885|58588468|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30577927|NCT01054885|58588469|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30577928|NCT01054885|58588470|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30577929|NCT01054885|58588471|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30577930|NCT01054885|58588465|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
30577931|NCT01054885|58588466|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
30577932|NCT01054885|58588467|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
30577933|NCT01054885|58588468|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
30577934|NCT01054885|58588469|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
30577935|NCT01054885|58588470|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
30577936|NCT01054885|58588471|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
30577937|NCT01054885|58588465|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
30577938|NCT01054885|58588466|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
30577939|NCT01054885|58588467|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
30577940|NCT01054885|58588468|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
30577941|NCT01054885|58588469|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
30577942|NCT01054885|58588470|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
30577943|NCT01054885|58588471|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
30577944|NCT01054885|58588465|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
30577945|NCT01054885|58588466|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
30577946|NCT01054885|58588467|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
30577947|NCT01054885|58588468|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
30577948|NCT01054885|58588469|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
30577949|NCT01054885|58588470|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
30577950|NCT01054885|58588471|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
30577951|NCT01054885|58588465|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
30577952|NCT01054885|58588466|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
30577953|NCT01054885|58588467|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
30577954|NCT01054885|58588468|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
30577955|NCT01054885|58588469|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
30577956|NCT01054885|58588470|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
30577957|NCT01054885|58588471|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
30577958|NCT01054885|58588465|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
30577959|NCT01054885|58588466|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
30577960|NCT01054885|58588467|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
30577961|NCT01054885|58588468|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
30577962|NCT01054885|58588469|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
30577963|NCT01054885|58588470|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
30577964|NCT01054885|58588471|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
30577965|NCT01054885|58588465|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
30577966|NCT01054885|58588466|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
30577967|NCT01054885|58588467|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
30577968|NCT01054885|58588468|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
30577969|NCT01054885|58588469|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
30577970|NCT01054885|58588470|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
30577971|NCT01054885|58588471|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
30577972|NCT01054885|58588465|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
30577973|NCT01054885|58588466|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
30577974|NCT01054885|58588467|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
30577975|NCT01054885|58588468|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
30577976|NCT01054885|58588469|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
30577977|NCT01054885|58588470|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
30577978|NCT01054885|58588471|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
30577979|NCT01054885|58588465|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
30577980|NCT01054885|58588466|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
30577981|NCT01054885|58588467|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
30577982|NCT01054885|58588468|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
30577983|NCT01054885|58588469|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
30577984|NCT01054885|58588470|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
30577985|NCT01054885|58588471|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
30577986|NCT01054885|58588465|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30577987|NCT01054885|58588466|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
30577988|NCT01054885|58588467|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
30577989|NCT01054885|58588468|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30577990|NCT01054885|58588469|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30577991|NCT01054885|58588470|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
30577992|NCT01054885|58588471|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
30577993|NCT01054885|58588465|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
30577994|NCT01054885|58588466|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
30577995|NCT01054885|58588467|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
30577996|NCT01054885|58588468|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
30577997|NCT01054885|58588469|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
30577998|NCT01054885|58588470|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
30780309|NCT02967692|58792148|FG001|Overall Study|Death|1|||
30577999|NCT01054885|58588471|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
30578000|NCT01054885|58588465|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
30578001|NCT01054885|58588466|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
30578002|NCT01054885|58588467|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
30578003|NCT01054885|58588468|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
30578004|NCT01054885|58588469|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
30578005|NCT01054885|58588470|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
30578006|NCT01054885|58588471|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
30578007|NCT01054846|58588488|FG000|Overall Study|Lost to Follow-up|76|||
30578008|NCT01054846|58588489|FG001|Overall Study|Lost to Follow-up|17|||
30578009|NCT01054729|58588498|FG000|Overall Study|Randomized but Not Treated|0|||
30578010|NCT01054729|58588499|FG001|Overall Study|Randomized but Not Treated|1|||
30578011|NCT01054729|58588500|FG002|Overall Study|Randomized but Not Treated|0|||
30578012|NCT01054729|58588501|FG003|Overall Study|Randomized but Not Treated|0|||
30578013|NCT01054729|58588498|FG000|Overall Study|Adverse Event|1|||
30578014|NCT01054729|58588499|FG001|Overall Study|Adverse Event|1|||
30578015|NCT01054729|58588500|FG002|Overall Study|Adverse Event|2|||
30578016|NCT01054729|58588501|FG003|Overall Study|Adverse Event|1|||
30578017|NCT01054729|58588498|FG000|Overall Study|Withdrawal by Subject|1|||
30578018|NCT01054729|58588499|FG001|Overall Study|Withdrawal by Subject|0|||
30578019|NCT01054729|58588500|FG002|Overall Study|Withdrawal by Subject|1|||
30578020|NCT01054729|58588501|FG003|Overall Study|Withdrawal by Subject|0|||
30578021|NCT01054729|58588498|FG000|Overall Study|Lost to Follow-up|0|||
30578022|NCT01054729|58588499|FG001|Overall Study|Lost to Follow-up|1|||
30578023|NCT01054729|58588500|FG002|Overall Study|Lost to Follow-up|0|||
30578024|NCT01054729|58588501|FG003|Overall Study|Lost to Follow-up|0|||
30578025|NCT01054729|58588498|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
30578026|NCT01054729|58588499|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
30578027|NCT01054729|58588500|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
30578028|NCT01054729|58588501|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
30578029|NCT01054729|58588498|FG000|Overall Study|Non-responder|1|||
30578030|NCT01054729|58588499|FG001|Overall Study|Non-responder|0|||
30578031|NCT01054729|58588500|FG002|Overall Study|Non-responder|1|||
30578032|NCT01054729|58588501|FG003|Overall Study|Non-responder|1|||
30578033|NCT01054729|58588498|FG000|Overall Study|PEG/RBV Non-responder|1|||
30578034|NCT01054729|58588499|FG001|Overall Study|PEG/RBV Non-responder|0|||
30578035|NCT01054729|58588500|FG002|Overall Study|PEG/RBV Non-responder|1|||
30578036|NCT01054729|58588501|FG003|Overall Study|PEG/RBV Non-responder|0|||
30578037|NCT01054729|58588498|FG000|Overall Study|Personal/Obligations|0|||
30578038|NCT01054729|58588499|FG001|Overall Study|Personal/Obligations|1|||
30578039|NCT01054729|58588500|FG002|Overall Study|Personal/Obligations|0|||
30578040|NCT01054729|58588501|FG003|Overall Study|Personal/Obligations|0|||
30578041|NCT01054729|58588498|FG000|Overall Study|Subject moved|0|||
30578042|NCT01054729|58588499|FG001|Overall Study|Subject moved|0|||
30578043|NCT01054729|58588500|FG002|Overall Study|Subject moved|1|||
30578044|NCT01054729|58588501|FG003|Overall Study|Subject moved|0|||
30578045|NCT01054729|58588498|FG000|Overall Study|Lack of Efficacy|0|||
30578046|NCT01054729|58588499|FG001|Overall Study|Lack of Efficacy|0|||
30578047|NCT01054729|58588500|FG002|Overall Study|Lack of Efficacy|0|||
30578048|NCT01054729|58588501|FG003|Overall Study|Lack of Efficacy|1|||
30578049|NCT01054573|58588515|FG000|Overall Study|Adverse Event|1|||
30578050|NCT01054573|58588516|FG001|Overall Study|Adverse Event|0|||
30578051|NCT01054573|58588517|FG002|Overall Study|Adverse Event|1|||
30578052|NCT01054573|58588518|FG003|Overall Study|Adverse Event|1|||
30578053|NCT01054573|58588515|FG000|Overall Study|Lost to Follow-up|0|||
30578054|NCT01054573|58588516|FG001|Overall Study|Lost to Follow-up|2|||
30578055|NCT01054573|58588517|FG002|Overall Study|Lost to Follow-up|0|||
30578056|NCT01054573|58588518|FG003|Overall Study|Lost to Follow-up|0|||
30578057|NCT01054573|58588515|FG000|Overall Study|Withdrawal by Subject|0|||
30578058|NCT01054573|58588516|FG001|Overall Study|Withdrawal by Subject|2|||
30578059|NCT01054573|58588517|FG002|Overall Study|Withdrawal by Subject|2|||
30578060|NCT01054573|58588518|FG003|Overall Study|Withdrawal by Subject|1|||
30578061|NCT01054456|58588537|FG000|Overall Study|Other|1|||
30578062|NCT01054300|58588543|FG000|Period 1|Adverse Event|1|||
30578063|NCT01054300|58588544|FG001|Period 1|Adverse Event|0|||
30578064|NCT01054300|58588545|FG002|Period 1|Adverse Event|0|||
30578065|NCT01054300|58588546|FG003|Period 1|Adverse Event|0|||
30578066|NCT01054300|58588543|FG000|Period 2|Withdrawal by Subject|0|||
30578067|NCT01054300|58588544|FG001|Period 2|Withdrawal by Subject|0|||
30578068|NCT01054300|58588545|FG002|Period 2|Withdrawal by Subject|1|||
30578069|NCT01054300|58588546|FG003|Period 2|Withdrawal by Subject|0|||
30578070|NCT01053988|58588561|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
30578071|NCT01053988|58588562|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30578072|NCT01053988|58588563|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30578073|NCT01053988|58588564|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30578074|NCT01053988|58588565|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30578075|NCT01053988|58588566|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
30578076|NCT01053988|58588561|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
30578077|NCT01053988|58588562|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
30578078|NCT01053988|58588563|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
30578079|NCT01053988|58588564|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
30578080|NCT01053988|58588565|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
30578081|NCT01053988|58588566|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
30578082|NCT01053988|58588561|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
30578083|NCT01053988|58588562|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30578084|NCT01053988|58588563|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30578085|NCT01053988|58588564|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30578086|NCT01053988|58588565|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30578087|NCT01053988|58588566|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
30578088|NCT01053988|58588561|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
30578089|NCT01053988|58588562|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
30578090|NCT01053988|58588563|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
30578091|NCT01053988|58588564|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
30578092|NCT01053988|58588565|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
30578093|NCT01053988|58588566|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
30578094|NCT01053988|58588561|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
30578095|NCT01053988|58588562|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
30578096|NCT01053988|58588563|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
30578097|NCT01053988|58588564|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
30578098|NCT01053988|58588565|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
30578099|NCT01053988|58588566|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
30578100|NCT01053988|58588561|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
30578101|NCT01053988|58588562|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30578102|NCT01053988|58588563|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30578103|NCT01053988|58588564|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30578104|NCT01053988|58588565|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30578105|NCT01053988|58588566|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
30578106|NCT01053988|58588561|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
30578107|NCT01053988|58588562|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
30578108|NCT01053988|58588563|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
30578109|NCT01053988|58588564|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
30578110|NCT01053988|58588565|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
30578111|NCT01053988|58588566|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
30578112|NCT01053988|58588561|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
30578113|NCT01053988|58588562|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
30578114|NCT01053988|58588563|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
30578115|NCT01053988|58588564|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
30578116|NCT01053988|58588565|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
30578117|NCT01053988|58588566|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
30578118|NCT01053988|58588561|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
30578119|NCT01053988|58588562|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
30578120|NCT01053988|58588563|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
30578121|NCT01053988|58588564|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
30578122|NCT01053988|58588565|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
30578123|NCT01053988|58588566|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
30578124|NCT01053988|58588561|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
30578125|NCT01053988|58588562|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
30578126|NCT01053988|58588563|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
30578127|NCT01053988|58588564|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
30578128|NCT01053988|58588565|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
30578129|NCT01053988|58588566|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
30578130|NCT01053988|58588561|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
30578131|NCT01053988|58588562|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
30578132|NCT01053988|58588563|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
30578133|NCT01053988|58588564|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
30578134|NCT01053988|58588565|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
30578135|NCT01053988|58588566|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
30578136|NCT01053988|58588561|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30578137|NCT01053988|58588562|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
30578138|NCT01053988|58588563|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30578139|NCT01053988|58588564|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
30578140|NCT01053988|58588565|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
30578141|NCT01053988|58588566|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
30578142|NCT01053988|58588561|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
30578143|NCT01053988|58588562|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
30578144|NCT01053988|58588563|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
30578145|NCT01053988|58588564|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
30578146|NCT01053988|58588565|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
30578147|NCT01053988|58588566|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
30578148|NCT01053988|58588561|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
30578149|NCT01053988|58588562|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
30578150|NCT01053988|58588563|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
30578151|NCT01053988|58588564|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
30578152|NCT01053988|58588565|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
30578153|NCT01053988|58588566|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
30578154|NCT01053247|58588581|FG000|Overall Study|Withdrawal by Subject|9|||
30578155|NCT01053247|58588582|FG001|Overall Study|Withdrawal by Subject|4|||
30578156|NCT01053247|58588583|FG002|Overall Study|Withdrawal by Subject|15|||
30578157|NCT01053247|58588581|FG000|Overall Study|Lack of Efficacy|1|||
30578158|NCT01053247|58588582|FG001|Overall Study|Lack of Efficacy|0|||
30578159|NCT01053247|58588583|FG002|Overall Study|Lack of Efficacy|1|||
30578160|NCT01053247|58588581|FG000|Overall Study|Protocol Violation|2|||
30578161|NCT01053247|58588582|FG001|Overall Study|Protocol Violation|1|||
30578162|NCT01053247|58588583|FG002|Overall Study|Protocol Violation|2|||
30578163|NCT01053247|58588581|FG000|Overall Study|Lost to Follow-up|8|||
30578164|NCT01053247|58588582|FG001|Overall Study|Lost to Follow-up|5|||
30578165|NCT01053247|58588583|FG002|Overall Study|Lost to Follow-up|7|||
30578166|NCT01053247|58588581|FG000|Overall Study|Adverse Event|0|||
30578167|NCT01053247|58588582|FG001|Overall Study|Adverse Event|9|||
30578168|NCT01053247|58588583|FG002|Overall Study|Adverse Event|3|||
30578169|NCT01052662|58588594|FG000|Overall Study|Lost to Follow-up|15|||
30578170|NCT01052662|58588595|FG001|Overall Study|Lost to Follow-up|13|||
30578171|NCT01052662|58588596|FG002|Overall Study|Lost to Follow-up|18|||
30578172|NCT01052662|58588594|FG000|Overall Study|Withdrawal by Subject|3|||
30578173|NCT01052662|58588595|FG001|Overall Study|Withdrawal by Subject|2|||
30578174|NCT01052662|58588596|FG002|Overall Study|Withdrawal by Subject|1|||
30578175|NCT01052662|58588594|FG000|Overall Study|Pharmacy issue|1|||
30578176|NCT01052662|58588595|FG001|Overall Study|Pharmacy issue|3|||
30578177|NCT01052662|58588596|FG002|Overall Study|Pharmacy issue|3|||
30578178|NCT01052662|58588594|FG000|Overall Study|Adverse Event|1|||
30578179|NCT01052662|58588595|FG001|Overall Study|Adverse Event|1|||
30578180|NCT01052662|58588596|FG002|Overall Study|Adverse Event|0|||
30578181|NCT01052662|58588594|FG000|Overall Study|Legal Problem|2|||
30578182|NCT01052662|58588595|FG001|Overall Study|Legal Problem|0|||
30578183|NCT01052662|58588596|FG002|Overall Study|Legal Problem|0|||
30578184|NCT01052662|58588594|FG000|Overall Study|Administrative|0|||
30578185|NCT01052662|58588595|FG001|Overall Study|Administrative|3|||
30578186|NCT01052662|58588596|FG002|Overall Study|Administrative|0|||
30578187|NCT01052116|58588606|FG000|Overall Study|Lost to Follow-up|11|||
30578188|NCT01052116|58588607|FG001|Overall Study|Lost to Follow-up|17|||
30578189|NCT01052116|58588606|FG000|Overall Study|Withdrawal by Subject|3|||
30578190|NCT01052116|58588607|FG001|Overall Study|Withdrawal by Subject|6|||
30578191|NCT01052116|58588606|FG000|Overall Study|Spirometry not performed|0|||
30578192|NCT01052116|58588607|FG001|Overall Study|Spirometry not performed|4|||
30578193|NCT01052077|58588615|FG000|Phase A|Lost to Follow-up|22|||
30578194|NCT01052077|58588616|FG001|Phase A|Lost to Follow-up|0|||
30578195|NCT01052077|58588617|FG002|Phase A|Lost to Follow-up|0|||
30578196|NCT01052077|58588618|FG003|Phase A|Lost to Follow-up|0|||
30578197|NCT01052077|58588615|FG000|Phase A|Adverse Event|32|||
30578198|NCT01052077|58588616|FG001|Phase A|Adverse Event|0|||
30578199|NCT01052077|58588617|FG002|Phase A|Adverse Event|0|||
30578200|NCT01052077|58588618|FG003|Phase A|Adverse Event|0|||
30578201|NCT01052077|58588615|FG000|Phase A|Met Withdrawal Criteria|26|||
30578202|NCT01052077|58588616|FG001|Phase A|Met Withdrawal Criteria|0|||
30578203|NCT01052077|58588617|FG002|Phase A|Met Withdrawal Criteria|0|||
30578204|NCT01052077|58588618|FG003|Phase A|Met Withdrawal Criteria|0|||
30578205|NCT01052077|58588615|FG000|Phase A|Physician Decision|10|||
30578206|NCT01052077|58588616|FG001|Phase A|Physician Decision|0|||
30578207|NCT01052077|58588617|FG002|Phase A|Physician Decision|0|||
30578208|NCT01052077|58588618|FG003|Phase A|Physician Decision|0|||
30578209|NCT01052077|58588615|FG000|Phase A|Withdrawal by Subject|29|||
30578210|NCT01052077|58588616|FG001|Phase A|Withdrawal by Subject|0|||
30578211|NCT01052077|58588617|FG002|Phase A|Withdrawal by Subject|0|||
30578212|NCT01052077|58588618|FG003|Phase A|Withdrawal by Subject|0|||
30578213|NCT01052077|58588615|FG000|Phase A|Protocol Deviation|27|||
30578214|NCT01052077|58588616|FG001|Phase A|Protocol Deviation|0|||
30578215|NCT01052077|58588617|FG002|Phase A|Protocol Deviation|0|||
30578216|NCT01052077|58588618|FG003|Phase A|Protocol Deviation|0|||
30578217|NCT01052077|58588615|FG000|Phase B|Lost to Follow-up|0|||
30578218|NCT01052077|58588616|FG001|Phase B|Lost to Follow-up|2|||
30578219|NCT01052077|58588617|FG002|Phase B|Lost to Follow-up|3|||
30578220|NCT01052077|58588618|FG003|Phase B|Lost to Follow-up|0|||
30578221|NCT01052077|58588615|FG000|Phase B|Adverse Event|0|||
30578222|NCT01052077|58588616|FG001|Phase B|Adverse Event|9|||
30578223|NCT01052077|58588617|FG002|Phase B|Adverse Event|2|||
30578224|NCT01052077|58588618|FG003|Phase B|Adverse Event|0|||
30578225|NCT01052077|58588615|FG000|Phase B|Met Withdrawal Criteria|0|||
30578226|NCT01052077|58588616|FG001|Phase B|Met Withdrawal Criteria|2|||
30578227|NCT01052077|58588617|FG002|Phase B|Met Withdrawal Criteria|1|||
30578228|NCT01052077|58588618|FG003|Phase B|Met Withdrawal Criteria|0|||
30578229|NCT01052077|58588615|FG000|Phase B|Physician Decision|0|||
30578230|NCT01052077|58588616|FG001|Phase B|Physician Decision|1|||
30578231|NCT01052077|58588617|FG002|Phase B|Physician Decision|1|||
30578232|NCT01052077|58588618|FG003|Phase B|Physician Decision|0|||
30578233|NCT01052077|58588615|FG000|Phase B|Withdrawal by Subject|0|||
30578234|NCT01052077|58588616|FG001|Phase B|Withdrawal by Subject|0|||
30578235|NCT01052077|58588617|FG002|Phase B|Withdrawal by Subject|5|||
30578236|NCT01052077|58588618|FG003|Phase B|Withdrawal by Subject|0|||
30578237|NCT01052077|58588615|FG000|Phase B|Protocol Deviation|0|||
30578238|NCT01052077|58588616|FG001|Phase B|Protocol Deviation|3|||
30578239|NCT01052077|58588617|FG002|Phase B|Protocol Deviation|4|||
30578240|NCT01052077|58588618|FG003|Phase B|Protocol Deviation|0|||
30578241|NCT01052077|58588615|FG000|Phase B|Lack of Efficacy|0|||
30578242|NCT01052077|58588616|FG001|Phase B|Lack of Efficacy|1|||
30578243|NCT01052077|58588617|FG002|Phase B|Lack of Efficacy|0|||
30578244|NCT01052077|58588618|FG003|Phase B|Lack of Efficacy|0|||
30578245|NCT01052077|58588615|FG000|Phase A+|Lost to Follow-up|0|||
30578246|NCT01052077|58588616|FG001|Phase A+|Lost to Follow-up|0|||
30578247|NCT01052077|58588617|FG002|Phase A+|Lost to Follow-up|0|||
30578248|NCT01052077|58588618|FG003|Phase A+|Lost to Follow-up|8|||
30578249|NCT01052077|58588615|FG000|Phase A+|Adverse Event|0|||
30578250|NCT01052077|58588616|FG001|Phase A+|Adverse Event|0|||
30578251|NCT01052077|58588617|FG002|Phase A+|Adverse Event|0|||
30578252|NCT01052077|58588618|FG003|Phase A+|Adverse Event|4|||
30578253|NCT01052077|58588615|FG000|Phase A+|Met Withdrawal Criteria|0|||
30578254|NCT01052077|58588616|FG001|Phase A+|Met Withdrawal Criteria|0|||
30578255|NCT01052077|58588617|FG002|Phase A+|Met Withdrawal Criteria|0|||
30578256|NCT01052077|58588618|FG003|Phase A+|Met Withdrawal Criteria|2|||
30578257|NCT01052077|58588615|FG000|Phase A+|Withdrawal by Subject|0|||
30578258|NCT01052077|58588616|FG001|Phase A+|Withdrawal by Subject|0|||
30578259|NCT01052077|58588617|FG002|Phase A+|Withdrawal by Subject|0|||
30578260|NCT01052077|58588618|FG003|Phase A+|Withdrawal by Subject|7|||
30578261|NCT01052038|58588627|FG000|Overall Study|Lost to Follow-up|2|||
30578262|NCT01052038|58588628|FG001|Overall Study|Lost to Follow-up|3|||
30578263|NCT01052038|58588629|FG002|Overall Study|Lost to Follow-up|1|||
30578264|NCT01052038|58588627|FG000|Overall Study|Protocol Violation|2|||
30578265|NCT01052038|58588628|FG001|Overall Study|Protocol Violation|3|||
30578266|NCT01052038|58588629|FG002|Overall Study|Protocol Violation|3|||
30578267|NCT01051960|58588637|FG000|Overall Study|Adverse Event|1|||
30578268|NCT01051921|58588641|FG000|Overall Study|Physician Decision|9|||
30578269|NCT01051921|58588641|FG000|Overall Study|Adverse Event|8|||
30578270|NCT01051921|58588641|FG000|Overall Study|Withdrawal by Subject|7|||
30578271|NCT01051921|58588641|FG000|Overall Study|Lost to Follow-up|4|||
30578272|NCT01051921|58588641|FG000|Overall Study|virological failure|1|||
30578273|NCT01051921|58588641|FG000|Overall Study|patient moved|1|||
30578274|NCT01051063|58588647|FG000|Overall Study|Death|2|||
30578275|NCT01051063|58588648|FG001|Overall Study|Death|2|||
30578276|NCT01051063|58588647|FG000|Overall Study|Withdrawal by Subject|1|||
30578277|NCT01051063|58588648|FG001|Overall Study|Withdrawal by Subject|1|||
30578278|NCT01051063|58588647|FG000|Overall Study|Termination of the study|5|||
30578279|NCT01051063|58588648|FG001|Overall Study|Termination of the study|0|||
30578280|NCT01051063|58588647|FG000|Overall Study|Moved from the study site area|1|||
30578281|NCT01051063|58588648|FG001|Overall Study|Moved from the study site area|0|||
30578282|NCT01051063|58588647|FG000|Overall Study|Other|1|||
30578283|NCT01051063|58588648|FG001|Overall Study|Other|0|||
30578284|NCT01051063|58588647|FG000|Overall Study|Lost to Follow-up|0|||
30578285|NCT01051063|58588648|FG001|Overall Study|Lost to Follow-up|1|||
30578286|NCT01050790|58588655|FG000|Overall Study|Adverse Event|1|||
30578287|NCT01050673|58588662|FG000|Overall Study|Physician Decision|4|||
30578288|NCT01050673|58588663|FG001|Overall Study|Physician Decision|5|||
30578289|NCT01050205|58588671|FG000|Overall Study|Lost to Follow-up|7|||
30578290|NCT01050205|58588672|FG001|Overall Study|Lost to Follow-up|1|||
30578291|NCT01050205|58588671|FG000|Overall Study|Withdrawal by Subject|1|||
30578292|NCT01050205|58588672|FG001|Overall Study|Withdrawal by Subject|1|||
30578293|NCT01050205|58588671|FG000|Overall Study|Relocated from area|1|||
30578294|NCT01050205|58588672|FG001|Overall Study|Relocated from area|2|||
30578295|NCT01050205|58588671|FG000|Overall Study|Discontinued Intervention|2|||
30578296|NCT01050205|58588672|FG001|Overall Study|Discontinued Intervention|0|||
30578297|NCT01059448|58588682|FG000|Overall Study|Adverse Event|1|||
30578298|NCT01059448|58588683|FG001|Overall Study|Adverse Event|3|||
30578299|NCT01059448|58588684|FG002|Overall Study|Adverse Event|0|||
30578300|NCT01059448|58588685|FG003|Overall Study|Adverse Event|1|||
30578301|NCT01059448|58588682|FG000|Overall Study|Withdrawal by Subject|2|||
30578302|NCT01059448|58588683|FG001|Overall Study|Withdrawal by Subject|0|||
30578303|NCT01059448|58588684|FG002|Overall Study|Withdrawal by Subject|2|||
30578304|NCT01059448|58588685|FG003|Overall Study|Withdrawal by Subject|4|||
30578305|NCT01059448|58588682|FG000|Overall Study|Disease Progression|2|||
30578306|NCT01059448|58588683|FG001|Overall Study|Disease Progression|1|||
30578307|NCT01059448|58588684|FG002|Overall Study|Disease Progression|4|||
30578308|NCT01059448|58588685|FG003|Overall Study|Disease Progression|2|||
30578309|NCT01059448|58588682|FG000|Overall Study|Administrative Decision|43|||
30578310|NCT01059448|58588683|FG001|Overall Study|Administrative Decision|49|||
30578311|NCT01059448|58588684|FG002|Overall Study|Administrative Decision|45|||
30578312|NCT01059448|58588685|FG003|Overall Study|Administrative Decision|46|||
30578313|NCT01059448|58588682|FG000|Overall Study|Lost to Follow-up|0|||
30578314|NCT01059448|58588683|FG001|Overall Study|Lost to Follow-up|0|||
30578315|NCT01059448|58588684|FG002|Overall Study|Lost to Follow-up|2|||
30578316|NCT01059448|58588685|FG003|Overall Study|Lost to Follow-up|0|||
30578317|NCT01059448|58588682|FG000|Overall Study|Death|0|||
30578318|NCT01059448|58588683|FG001|Overall Study|Death|1|||
30578319|NCT01059448|58588684|FG002|Overall Study|Death|0|||
30578320|NCT01059448|58588685|FG003|Overall Study|Death|0|||
30578321|NCT01059448|58588682|FG000|Overall Study|Other|1|||
30578322|NCT01059448|58588683|FG001|Overall Study|Other|1|||
30578323|NCT01059448|58588684|FG002|Overall Study|Other|0|||
30578324|NCT01059448|58588685|FG003|Overall Study|Other|1|||
30578325|NCT01058707|58588702|FG000|Overall Study|Disease Progression|15|||
30578326|NCT01058707|58588703|FG001|Overall Study|Disease Progression|20|||
30578327|NCT01058707|58588704|FG002|Overall Study|Disease Progression|20|||
30578328|NCT01058707|58588705|FG003|Overall Study|Disease Progression|15|||
30578329|NCT01058707|58588706|FG004|Overall Study|Disease Progression|23|||
30578330|NCT01058707|58588707|FG005|Overall Study|Disease Progression|10|||
30578331|NCT01058707|58588708|FG006|Overall Study|Disease Progression|12|||
30578332|NCT01058707|58588702|FG000|Overall Study|Adverse Event|11|||
30578333|NCT01058707|58588703|FG001|Overall Study|Adverse Event|4|||
30578334|NCT01058707|58588704|FG002|Overall Study|Adverse Event|7|||
30578335|NCT01058707|58588705|FG003|Overall Study|Adverse Event|6|||
30578336|NCT01058707|58588706|FG004|Overall Study|Adverse Event|7|||
30578337|NCT01058707|58588707|FG005|Overall Study|Adverse Event|3|||
30578338|NCT01058707|58588708|FG006|Overall Study|Adverse Event|1|||
30578339|NCT01058707|58588702|FG000|Overall Study|Subject Decision|5|||
30578340|NCT01058707|58588703|FG001|Overall Study|Subject Decision|3|||
30578341|NCT01058707|58588704|FG002|Overall Study|Subject Decision|3|||
30578342|NCT01058707|58588705|FG003|Overall Study|Subject Decision|1|||
30578343|NCT01058707|58588706|FG004|Overall Study|Subject Decision|2|||
30578344|NCT01058707|58588707|FG005|Overall Study|Subject Decision|3|||
30578345|NCT01058707|58588708|FG006|Overall Study|Subject Decision|6|||
30578346|NCT01058707|58588702|FG000|Overall Study|Lost to Follow-up|0|||
30578347|NCT01058707|58588703|FG001|Overall Study|Lost to Follow-up|0|||
30578348|NCT01058707|58588704|FG002|Overall Study|Lost to Follow-up|1|||
30578349|NCT01058707|58588705|FG003|Overall Study|Lost to Follow-up|0|||
30578350|NCT01058707|58588706|FG004|Overall Study|Lost to Follow-up|0|||
30578351|NCT01058707|58588707|FG005|Overall Study|Lost to Follow-up|0|||
30578352|NCT01058707|58588708|FG006|Overall Study|Lost to Follow-up|0|||
30578353|NCT01058707|58588702|FG000|Overall Study|Reason Not Specified|0|||
30578354|NCT01058707|58588703|FG001|Overall Study|Reason Not Specified|3|||
30855354|NCT02592434|58882989|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
30578355|NCT01058707|58588704|FG002|Overall Study|Reason Not Specified|2|||
30578356|NCT01058707|58588705|FG003|Overall Study|Reason Not Specified|0|||
30578357|NCT01058707|58588706|FG004|Overall Study|Reason Not Specified|7|||
30578358|NCT01058707|58588707|FG005|Overall Study|Reason Not Specified|1|||
30578359|NCT01058707|58588708|FG006|Overall Study|Reason Not Specified|7|||
30578360|NCT01054144|58588746|FG000|Overall Study|Death|2|||
30578361|NCT00105586|58588755|FG000|Overall Study|Adverse Event|4|||
30855355|NCT02592434|58882990|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
30578362|NCT00105586|58588756|FG001|Overall Study|Adverse Event|3|||
30578363|NCT00105586|58588755|FG000|Overall Study|Physician Decision|13|||
30578364|NCT00105586|58588756|FG001|Overall Study|Physician Decision|13|||
30578365|NCT01059643|58588764|FG000|Overall Study|Adverse Event|3|||
30578366|NCT01059643|58588764|FG000|Overall Study|Withdrawal by Subject|2|||
30578367|NCT01059643|58588764|FG000|Overall Study|Physician Decision|1|||
30578368|NCT01059565|58588773|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
30578369|NCT01059565|58588774|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
30780310|NCT02967692|58792149|FG002|Overall Study|Death|10|||
30578370|NCT01059565|58588773|FG000|24-Week Randomized Phase|Adverse Event|5|||
30578371|NCT01059565|58588774|FG001|24-Week Randomized Phase|Adverse Event|0|||
30578372|NCT01059565|58588773|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
30578373|NCT01059565|58588774|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
30578374|NCT01059565|58588773|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
30578375|NCT01059565|58588774|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
30578376|NCT01059565|58588773|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
30578377|NCT01059565|58588774|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
30578378|NCT01059565|58588773|FG000|24-Week Open-Label Phase|Adverse Event|2|||
30578379|NCT01059565|58588774|FG001|24-Week Open-Label Phase|Adverse Event|0|||
30578380|NCT01059565|58588773|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
30578381|NCT01059565|58588774|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
30578382|NCT01059565|58588773|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
30578383|NCT01059565|58588774|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
30578384|NCT01059565|58588773|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
30578385|NCT01059565|58588774|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
30578386|NCT01059565|58588773|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
30578387|NCT01059565|58588774|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
30578388|NCT01059565|58588773|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
30578389|NCT01059565|58588774|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
30578390|NCT01059526|58588784|FG000|Overall Study|Patient enrolled but not treated|20|||
30578391|NCT01059526|58588785|FG001|Overall Study|Patient enrolled but not treated|17|||
30578392|NCT01059526|58588784|FG000|Overall Study|Adverse Event|2|||
30578393|NCT01059526|58588785|FG001|Overall Study|Adverse Event|2|||
30578394|NCT01059526|58588784|FG000|Overall Study|Protocol Violation|0|||
30578395|NCT01059526|58588785|FG001|Overall Study|Protocol Violation|1|||
30578396|NCT01059526|58588784|FG000|Overall Study|Withdrawal by Subject|3|||
30578397|NCT01059526|58588785|FG001|Overall Study|Withdrawal by Subject|1|||
30578398|NCT01059526|58588784|FG000|Overall Study|Lost to Follow-up|4|||
30578399|NCT01059526|58588785|FG001|Overall Study|Lost to Follow-up|1|||
30578400|NCT01059526|58588784|FG000|Overall Study|Patient found to be dermatographic|1|||
30578401|NCT01059526|58588785|FG001|Overall Study|Patient found to be dermatographic|0|||
30578402|NCT03277261|58588793|FG000|Overall Study|Adverse Event|17|||
30578403|NCT03277261|58588794|FG001|Overall Study|Adverse Event|1|||
30578404|NCT03277261|58588793|FG000|Overall Study|Participant Withdrawal of Consent|6|||
30578405|NCT03277261|58588794|FG001|Overall Study|Participant Withdrawal of Consent|15|||
30578406|NCT03277261|58588793|FG000|Overall Study|Investigator / Sponsor Decision|4|||
30578407|NCT03277261|58588794|FG001|Overall Study|Investigator / Sponsor Decision|2|||
30578408|NCT03277261|58588793|FG000|Overall Study|Pregnancy|2|||
30578409|NCT03277261|58588794|FG001|Overall Study|Pregnancy|0|||
30578410|NCT03277261|58588793|FG000|Overall Study|Lost to Follow-up|2|||
30578411|NCT03277261|58588794|FG001|Overall Study|Lost to Follow-up|2|||
30578412|NCT03277261|58588793|FG000|Overall Study|Lack of Efficacy|2|||
30578413|NCT03277261|58588794|FG001|Overall Study|Lack of Efficacy|2|||
30578414|NCT03277261|58588793|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
30578415|NCT03277261|58588794|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
30578416|NCT03277690|58588816|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
30578417|NCT03277690|58588817|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
30578418|NCT03277690|58588816|FG000|Dose Titration and Maintenance|Physician Decision|1|||
30578419|NCT03277690|58588817|FG001|Dose Titration and Maintenance|Physician Decision|0|||
30578420|NCT03277690|58588816|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
30578421|NCT03277690|58588817|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
30578422|NCT03277690|58588816|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
30578423|NCT03277690|58588817|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
30578424|NCT03277690|58588816|FG000|Dose Titration and Maintenance|Adverse Event|15|||
30578425|NCT03277690|58588817|FG001|Dose Titration and Maintenance|Adverse Event|0|||
30578426|NCT03277690|58588816|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
30578427|NCT03277690|58588817|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
30578428|NCT03277690|58588816|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
30578429|NCT03277690|58588817|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
30578430|NCT03271021|58588826|FG000|Overall Study|Adverse Event|3|||
30855356|NCT02592434|58882988|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
30578431|NCT03271021|58588827|FG001|Overall Study|Adverse Event|2|||
30578432|NCT03271021|58588826|FG000|Overall Study|Withdrawal by Subject|36|||
30578433|NCT03271021|58588827|FG001|Overall Study|Withdrawal by Subject|53|||
30578434|NCT03271021|58588826|FG000|Overall Study|Lost to Follow-up|34|||
30578435|NCT03271021|58588827|FG001|Overall Study|Lost to Follow-up|39|||
30578436|NCT03271021|58588826|FG000|Overall Study|Protocol Violation|6|||
30578437|NCT03271021|58588827|FG001|Overall Study|Protocol Violation|4|||
30578438|NCT03271021|58588826|FG000|Overall Study|Abnormal Lab Results|1|||
30578439|NCT03271021|58588827|FG001|Overall Study|Abnormal Lab Results|0|||
30578440|NCT03271021|58588826|FG000|Overall Study|Miscellaneous|9|||
30578441|NCT03271021|58588827|FG001|Overall Study|Miscellaneous|8|||
30578442|NCT01249651|58588848|FG000|Overall Study|Withdrawal by Subject|4|||
30578443|NCT01249651|58588848|FG000|Overall Study|Adverse Event|1|||
30578444|NCT01249651|58588848|FG000|Overall Study|Protocol Violation|1|||
30578445|NCT01249651|58588848|FG000|Overall Study|Sponsor Decision|1|||
30578446|NCT01249417|58588855|FG000|Randomised Population|Study treatment not received|0|||
30578447|NCT01249417|58588856|FG001|Randomised Population|Study treatment not received|0|||
30578448|NCT01249417|58588857|FG002|Randomised Population|Study treatment not received|2|||
30578449|NCT01249417|58588855|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
30578450|NCT01249417|58588856|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
30578451|NCT01249417|58588857|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
30578452|NCT01249417|58588855|FG000|Treatment Phase - ITT Population|Other|0|||
30578453|NCT01249417|58588856|FG001|Treatment Phase - ITT Population|Other|0|||
30578454|NCT01249417|58588857|FG002|Treatment Phase - ITT Population|Other|1|||
30578455|NCT01249417|58588855|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
30578456|NCT01249417|58588856|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
30578457|NCT01249417|58588857|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
30578458|NCT01249417|58588855|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
30578459|NCT01249417|58588856|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
30578460|NCT01249417|58588857|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
30578461|NCT01249417|58588855|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
30578462|NCT01249417|58588856|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
30578463|NCT01249417|58588857|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
30578464|NCT01249261|58588867|FG000|Overall Study|Withdrawal by Subject|1|||
30578465|NCT01249261|58588868|FG001|Overall Study|Withdrawal by Subject|0|||
30578466|NCT01248949|58588888|FG000|Overall Study|Lost to Follow-up|2|||
30578467|NCT01248949|58588889|FG001|Overall Study|Lost to Follow-up|2|||
30578468|NCT01248949|58588890|FG002|Overall Study|Lost to Follow-up|2|||
30578469|NCT01248949|58588891|FG003|Overall Study|Lost to Follow-up|1|||
30578470|NCT01248949|58588892|FG004|Overall Study|Lost to Follow-up|0|||
30578471|NCT01248949|58588888|FG000|Overall Study|Withdrawal by Subject|5|||
30578472|NCT01248949|58588889|FG001|Overall Study|Withdrawal by Subject|3|||
30578473|NCT01248949|58588890|FG002|Overall Study|Withdrawal by Subject|11|||
30578474|NCT01248949|58588891|FG003|Overall Study|Withdrawal by Subject|3|||
30578475|NCT01248949|58588892|FG004|Overall Study|Withdrawal by Subject|1|||
30578476|NCT01248949|58588888|FG000|Overall Study|Death|22|||
30578477|NCT01248949|58588889|FG001|Overall Study|Death|7|||
30578478|NCT01248949|58588890|FG002|Overall Study|Death|21|||
30578479|NCT01248949|58588891|FG003|Overall Study|Death|6|||
30578480|NCT01248949|58588892|FG004|Overall Study|Death|2|||
30578481|NCT01248949|58588888|FG000|Overall Study|Alternative Therapy|1|||
30578482|NCT01248949|58588889|FG001|Overall Study|Alternative Therapy|0|||
30578483|NCT01248949|58588890|FG002|Overall Study|Alternative Therapy|0|||
30578484|NCT01248949|58588891|FG003|Overall Study|Alternative Therapy|0|||
30578485|NCT01248949|58588892|FG004|Overall Study|Alternative Therapy|0|||
30578486|NCT01248949|58588888|FG000|Overall Study|Alternative Therapy.|1|||
30578487|NCT01248949|58588889|FG001|Overall Study|Alternative Therapy.|0|||
30578488|NCT01248949|58588890|FG002|Overall Study|Alternative Therapy.|0|||
30578489|NCT01248949|58588891|FG003|Overall Study|Alternative Therapy.|0|||
30578490|NCT01248949|58588892|FG004|Overall Study|Alternative Therapy.|0|||
30578491|NCT01248949|58588888|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
30578492|NCT01248949|58588889|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
30578493|NCT01248949|58588890|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
30578494|NCT01248949|58588891|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
30578495|NCT01248949|58588892|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
30578496|NCT01248949|58588888|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
30578497|NCT01248949|58588889|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
30578498|NCT01248949|58588890|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
30578499|NCT01248949|58588891|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
30578500|NCT01248949|58588892|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
30578501|NCT01248949|58588888|FG000|Overall Study|Participant Went To Hospice|0|||
30578502|NCT01248949|58588889|FG001|Overall Study|Participant Went To Hospice|0|||
30578503|NCT01248949|58588890|FG002|Overall Study|Participant Went To Hospice|1|||
30578504|NCT01248949|58588891|FG003|Overall Study|Participant Went To Hospice|0|||
30578505|NCT01248949|58588892|FG004|Overall Study|Participant Went To Hospice|0|||
30578506|NCT01248949|58588888|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
30578507|NCT01248949|58588889|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
30578508|NCT01248949|58588890|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
30578509|NCT01248949|58588891|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
30578510|NCT01248949|58588892|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
30780311|NCT02967692|58792150|FG003|Overall Study|Death|9|||
30578511|NCT01248949|58588888|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
30578512|NCT01248949|58588889|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
30578513|NCT01248949|58588890|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
30578514|NCT01248949|58588891|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
30578515|NCT01248949|58588892|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
30578516|NCT01248949|58588888|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
30578517|NCT01248949|58588889|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
30578518|NCT01248949|58588890|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
30578519|NCT01248949|58588891|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
30578520|NCT01248949|58588892|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
30578521|NCT01248949|58588888|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
30578522|NCT01248949|58588889|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
30578523|NCT01248949|58588890|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
30578524|NCT01248949|58588891|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
30578525|NCT01248949|58588892|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
30578526|NCT01248793|58588906|FG000|Overall Study|Lost to Follow-up|0|||
30578527|NCT01248793|58588907|FG001|Overall Study|Lost to Follow-up|1|||
30578528|NCT01248793|58588906|FG000|Overall Study|Adverse Event|1|||
30578529|NCT01248793|58588907|FG001|Overall Study|Adverse Event|1|||
30578530|NCT01248793|58588906|FG000|Overall Study|Protocol Violation|0|||
30578531|NCT01248793|58588907|FG001|Overall Study|Protocol Violation|1|||
30578532|NCT01248793|58588906|FG000|Overall Study|Withdrawal by Subject|3|||
30578533|NCT01248793|58588907|FG001|Overall Study|Withdrawal by Subject|3|||
30578534|NCT01248364|58588917|FG000|Overall Study|Adverse Event|0|||
30578535|NCT01248364|58588918|FG001|Overall Study|Adverse Event|1|||
30578536|NCT01248364|58588919|FG002|Overall Study|Adverse Event|0|||
30578537|NCT01248364|58588920|FG003|Overall Study|Adverse Event|0|||
30578538|NCT01248130|58588932|FG000|Overall Study|Protocol Violation|1|||
30578539|NCT01248130|58588933|FG001|Overall Study|Protocol Violation|0|||
30578540|NCT01248130|58588932|FG000|Overall Study|Ineligible|1|||
30578541|NCT01248130|58588933|FG001|Overall Study|Ineligible|0|||
30578542|NCT01248013|58588939|FG000|Overall Study|Withdrawal by Subject|14|||
30578543|NCT01247350|58588948|FG000|Overall Study|Adverse Event|0|||
30578544|NCT01247350|58588949|FG001|Overall Study|Adverse Event|0|||
30578545|NCT01247350|58588950|FG002|Overall Study|Adverse Event|1|||
30578546|NCT01247350|58588951|FG003|Overall Study|Adverse Event|0|||
30578547|NCT01247350|58588952|FG004|Overall Study|Adverse Event|0|||
30578548|NCT01247350|58588948|FG000|Overall Study|Withdrawal by Subject|0|||
30578549|NCT01247350|58588949|FG001|Overall Study|Withdrawal by Subject|0|||
30578550|NCT01247350|58588950|FG002|Overall Study|Withdrawal by Subject|0|||
30578551|NCT01247350|58588951|FG003|Overall Study|Withdrawal by Subject|1|||
30578552|NCT01247350|58588952|FG004|Overall Study|Withdrawal by Subject|0|||
30578553|NCT01247350|58588948|FG000|Overall Study|Entry criteria not met|0|||
30578554|NCT01247350|58588949|FG001|Overall Study|Entry criteria not met|0|||
30578555|NCT01247350|58588950|FG002|Overall Study|Entry criteria not met|0|||
30578556|NCT01247350|58588951|FG003|Overall Study|Entry criteria not met|0|||
30578557|NCT01247350|58588952|FG004|Overall Study|Entry criteria not met|1|||
30578558|NCT01246999|58588982|FG000|Overall Study|Lost to Follow-up|0|||
30578559|NCT01246999|58588983|FG001|Overall Study|Lost to Follow-up|1|||
30578560|NCT01246999|58588984|FG002|Overall Study|Lost to Follow-up|0|||
30578561|NCT01246999|58588985|FG003|Overall Study|Lost to Follow-up|0|||
30578562|NCT01246999|58588982|FG000|Overall Study|Withdrawal by Subject|0|||
30578563|NCT01246999|58588983|FG001|Overall Study|Withdrawal by Subject|0|||
30578564|NCT01246999|58588984|FG002|Overall Study|Withdrawal by Subject|0|||
30578565|NCT01246999|58588985|FG003|Overall Study|Withdrawal by Subject|2|||
30578566|NCT01245751|58589007|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
30578567|NCT01245751|58589008|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
30578568|NCT01245751|58589009|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
30578569|NCT01245751|58589010|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
30578570|NCT01245751|58589007|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
30578571|NCT01245751|58589008|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
30780312|NCT02967692|58792147|FG000|Overall Study|Protocol deviation|1|||
30780313|NCT02967692|58792148|FG001|Overall Study|Protocol deviation|0|||
30578572|NCT01245751|58589009|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
30578573|NCT01245751|58589010|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
30578574|NCT01245751|58589007|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
30578575|NCT01245751|58589008|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
30578576|NCT01245751|58589009|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
30578577|NCT01245751|58589010|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
30578578|NCT01245673|58589021|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
30578579|NCT01245283|58589028|FG000|Overall Study|Lost to Follow-up|14|||
30578580|NCT01245283|58589029|FG001|Overall Study|Lost to Follow-up|11|||
30578581|NCT01245283|58589030|FG002|Overall Study|Lost to Follow-up|11|||
30578582|NCT01245049|58589043|FG000|Overall Study|Migrated/moved from study area|0|||
30578583|NCT01245049|58589044|FG001|Overall Study|Migrated/moved from study area|1|||
30578584|NCT01245049|58589043|FG000|Overall Study|Withdrawal by Subject|0|||
30578585|NCT01245049|58589044|FG001|Overall Study|Withdrawal by Subject|1|||
30578586|NCT01245049|58589043|FG000|Overall Study|Lost to Follow-up|1|||
30578587|NCT01245049|58589044|FG001|Overall Study|Lost to Follow-up|2|||
30578588|NCT01244893|58589050|FG000|Baseline|Protocol Violation|0|||
30578589|NCT01244893|58589051|FG001|Baseline|Protocol Violation|1|||
30578590|NCT01244893|58589050|FG000|1-Week Follow Up|Lost to Follow-up|1|||
30578591|NCT01244893|58589051|FG001|1-Week Follow Up|Lost to Follow-up|0|||
30578592|NCT01244815|58589066|FG000|Overall Study|Not Treated|0|||
30578593|NCT01244815|58589067|FG001|Overall Study|Not Treated|1|||
30578594|NCT01244815|58589068|FG002|Overall Study|Not Treated|0|||
30578595|NCT01244815|58589069|FG003|Overall Study|Not Treated|0|||
30578596|NCT01244815|58589066|FG000|Overall Study|Adverse Event|4|||
30578597|NCT01244815|58589067|FG001|Overall Study|Adverse Event|7|||
30578598|NCT01244815|58589068|FG002|Overall Study|Adverse Event|5|||
30578599|NCT01244815|58589069|FG003|Overall Study|Adverse Event|5|||
30578600|NCT01244815|58589066|FG000|Overall Study|Treatment Failure|0|||
30578601|NCT01244815|58589067|FG001|Overall Study|Treatment Failure|0|||
30578602|NCT01244815|58589068|FG002|Overall Study|Treatment Failure|0|||
30578603|NCT01244815|58589069|FG003|Overall Study|Treatment Failure|1|||
30578604|NCT01244815|58589066|FG000|Overall Study|Lost to Follow-up|3|||
30578605|NCT01244815|58589067|FG001|Overall Study|Lost to Follow-up|2|||
30578606|NCT01244815|58589068|FG002|Overall Study|Lost to Follow-up|3|||
30578607|NCT01244815|58589069|FG003|Overall Study|Lost to Follow-up|2|||
30578608|NCT01244815|58589066|FG000|Overall Study|Withdrawal by Subject|0|||
30578609|NCT01244815|58589067|FG001|Overall Study|Withdrawal by Subject|2|||
30578610|NCT01244815|58589068|FG002|Overall Study|Withdrawal by Subject|0|||
30578611|NCT01244815|58589069|FG003|Overall Study|Withdrawal by Subject|3|||
30578612|NCT01244815|58589066|FG000|Overall Study|Protocol Violation|7|||
30578613|NCT01244815|58589067|FG001|Overall Study|Protocol Violation|4|||
30578614|NCT01244815|58589068|FG002|Overall Study|Protocol Violation|3|||
30578615|NCT01244815|58589069|FG003|Overall Study|Protocol Violation|1|||
30578616|NCT01244815|58589066|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
30578617|NCT01244815|58589067|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
30578618|NCT01244815|58589068|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
30578619|NCT01244815|58589069|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
30578620|NCT01244425|58589081|FG000|Overall Study|Withdrawal by Subject|2|||
30578621|NCT01244425|58589082|FG001|Overall Study|Withdrawal by Subject|2|||
30578622|NCT01244425|58589081|FG000|Overall Study|Adverse Event|1|||
30578623|NCT01244425|58589082|FG001|Overall Study|Adverse Event|1|||
30578624|NCT01244191|58589098|FG000|Overall Study|Progressive disease|295|||
30578625|NCT01244191|58589099|FG001|Overall Study|Progressive disease|350|||
30578626|NCT01244191|58589098|FG000|Overall Study|Clinical disease progression|54|||
30578627|NCT01244191|58589099|FG001|Overall Study|Clinical disease progression|36|||
30578628|NCT01244191|58589098|FG000|Overall Study|Adverse Event|65|||
30578629|NCT01244191|58589099|FG001|Overall Study|Adverse Event|48|||
30578630|NCT01244191|58589098|FG000|Overall Study|Death|22|||
30578631|NCT01244191|58589099|FG001|Overall Study|Death|29|||
30578632|NCT01244191|58589098|FG000|Overall Study|Lost to Follow-up|0|||
30578633|NCT01244191|58589099|FG001|Overall Study|Lost to Follow-up|2|||
30578634|NCT01244191|58589098|FG000|Overall Study|Protocol Violation|1|||
30578635|NCT01244191|58589099|FG001|Overall Study|Protocol Violation|2|||
30578636|NCT01244191|58589098|FG000|Overall Study|Withdrawal by Subject|31|||
30578637|NCT01244191|58589099|FG001|Overall Study|Withdrawal by Subject|23|||
30578638|NCT01244191|58589098|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
30578639|NCT01244191|58589099|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
30578640|NCT01244035|58589105|FG000|Part 1: Period 1|Adverse Event|0|||
30578641|NCT01244035|58589106|FG001|Part 1: Period 1|Adverse Event|0|||
30578642|NCT01244035|58589107|FG002|Part 1: Period 1|Adverse Event|0|||
30578643|NCT01244035|58589108|FG003|Part 1: Period 1|Adverse Event|0|||
30578644|NCT01244035|58589109|FG004|Part 1: Period 1|Adverse Event|0|||
30578645|NCT01244035|58589110|FG005|Part 1: Period 1|Adverse Event|1|||
30578646|NCT01244035|58589105|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
30578647|NCT01244035|58589106|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
30578648|NCT01244035|58589107|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
30578649|NCT01244035|58589108|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
30578650|NCT01244035|58589109|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
30578651|NCT01244035|58589110|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
30578652|NCT01244035|58589105|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
30578653|NCT01244035|58589106|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
30578654|NCT01244035|58589107|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
30578655|NCT01244035|58589108|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
30578656|NCT01244035|58589109|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
30578657|NCT01244035|58589110|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
30578658|NCT01244035|58589105|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
30578659|NCT01244035|58589106|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
30578660|NCT01244035|58589107|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
30578661|NCT01244035|58589108|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
30578662|NCT01244035|58589109|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
30578663|NCT01244035|58589110|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
30578664|NCT01244035|58589105|FG000|Part 1: Period 3|Adverse Event|0|||
30578665|NCT01244035|58589106|FG001|Part 1: Period 3|Adverse Event|0|||
30578666|NCT01244035|58589107|FG002|Part 1: Period 3|Adverse Event|0|||
30578667|NCT01244035|58589108|FG003|Part 1: Period 3|Adverse Event|0|||
30578668|NCT01244035|58589109|FG004|Part 1: Period 3|Adverse Event|0|||
30578669|NCT01244035|58589110|FG005|Part 1: Period 3|Adverse Event|1|||
30578670|NCT01244035|58589105|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
30578671|NCT01244035|58589106|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
30578672|NCT01244035|58589107|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
30578673|NCT01244035|58589108|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
30578674|NCT01244035|58589109|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
30578675|NCT01244035|58589110|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
30578676|NCT01244035|58589105|FG000|Part 1: Period 3|Protocol Deviation|0|||
30578677|NCT01244035|58589106|FG001|Part 1: Period 3|Protocol Deviation|1|||
30578678|NCT01244035|58589107|FG002|Part 1: Period 3|Protocol Deviation|0|||
30578679|NCT01244035|58589108|FG003|Part 1: Period 3|Protocol Deviation|0|||
30578680|NCT01244035|58589109|FG004|Part 1: Period 3|Protocol Deviation|0|||
30578681|NCT01244035|58589110|FG005|Part 1: Period 3|Protocol Deviation|0|||
30578682|NCT01243762|58589146|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
30578683|NCT01243762|58589147|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
30578684|NCT01243762|58589148|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
30578685|NCT01243762|58589149|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
30578686|NCT01243762|58589150|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
30578687|NCT01243762|58589151|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
30578688|NCT01243762|58589152|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
30578689|NCT01243762|58589146|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
30578690|NCT01243762|58589147|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
30578691|NCT01243762|58589148|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
30578692|NCT01243762|58589149|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
30578693|NCT01243762|58589150|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
30578694|NCT01243762|58589151|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
30578695|NCT01243762|58589152|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
30578696|NCT01243762|58589146|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
30578697|NCT01243762|58589147|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
30578698|NCT01243762|58589148|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
30578699|NCT01243762|58589149|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
30578700|NCT01243762|58589150|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
30578701|NCT01243762|58589151|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
30578702|NCT01243762|58589152|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
30578703|NCT01243762|58589146|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
30578704|NCT01243762|58589147|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
30578705|NCT01243762|58589148|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
30578706|NCT01243762|58589149|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
30578707|NCT01243762|58589150|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
30578708|NCT01243762|58589151|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
30578709|NCT01243762|58589152|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
30578710|NCT01243762|58589146|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
30578711|NCT01243762|58589147|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
30578712|NCT01243762|58589148|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
30578713|NCT01243762|58589149|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
30578714|NCT01243762|58589150|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
30578715|NCT01243762|58589151|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
30578716|NCT01243762|58589152|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
30578717|NCT01243762|58589146|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
30668154|NCT00875420|58682131|FG000|Overall Study|Inability to complete study procedures|1|||
30578718|NCT01243762|58589147|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
30578719|NCT01243762|58589148|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
30578720|NCT01243762|58589149|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
30578721|NCT01243762|58589150|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
30578722|NCT01243762|58589151|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
30578723|NCT01243762|58589152|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
30578724|NCT01243762|58589146|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
30578725|NCT01243762|58589147|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
30578726|NCT01243762|58589148|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
30780314|NCT02967692|58792149|FG002|Overall Study|Protocol deviation|1|||
30578727|NCT01243762|58589149|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
30780315|NCT02967692|58792150|FG003|Overall Study|Protocol deviation|1|||
30578728|NCT01243762|58589150|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
30578729|NCT01243762|58589151|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
30578730|NCT01243762|58589152|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
30578731|NCT01243762|58589146|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
30578732|NCT01243762|58589147|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
30578733|NCT01243762|58589148|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
30578734|NCT01243762|58589149|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
30578735|NCT01243762|58589150|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
30578736|NCT01243762|58589151|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
30578737|NCT01243762|58589152|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
30578738|NCT01243411|58589171|FG000|Overall Study|Withdrawal by Subject|18|||
30578739|NCT01243411|58589171|FG000|Overall Study|Lost to Follow-up|10|||
30578740|NCT01243411|58589171|FG000|Overall Study|Adverse Event|5|||
30578741|NCT01243411|58589171|FG000|Overall Study|Other|8|||
30578742|NCT01243177|58589177|FG000|Overall Study|Lack of Efficacy|47|||
30578743|NCT01243177|58589178|FG001|Overall Study|Lack of Efficacy|31|||
30578744|NCT01243177|58589177|FG000|Overall Study|Protocol Violation|11|||
30578745|NCT01243177|58589178|FG001|Overall Study|Protocol Violation|10|||
30578746|NCT01243177|58589177|FG000|Overall Study|Lost to Follow-up|15|||
30578747|NCT01243177|58589178|FG001|Overall Study|Lost to Follow-up|18|||
30578748|NCT01243177|58589177|FG000|Overall Study|Withdrawal by Subject|46|||
30578749|NCT01243177|58589178|FG001|Overall Study|Withdrawal by Subject|38|||
30578750|NCT01243177|58589177|FG000|Overall Study|AE, serious fatal|0|||
30578751|NCT01243177|58589178|FG001|Overall Study|AE, serious fatal|1|||
30578752|NCT01243177|58589177|FG000|Overall Study|SAE, non-fatal|7|||
30578753|NCT01243177|58589178|FG001|Overall Study|SAE, non-fatal|9|||
30578754|NCT01243177|58589177|FG000|Overall Study|AE, non-serious non-fatal|40|||
30578755|NCT01243177|58589178|FG001|Overall Study|AE, non-serious non-fatal|58|||
30578756|NCT01243177|58589177|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
30578757|NCT01243177|58589178|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
30578758|NCT01243177|58589177|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
30578759|NCT01243177|58589178|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
30578760|NCT01243177|58589177|FG000|Overall Study|Other Reason|11|||
30578761|NCT01243177|58589178|FG001|Overall Study|Other Reason|12|||
30578762|NCT01242748|58589186|FG000|Overall Study|Adverse Event|10|||
30578763|NCT01242748|58589187|FG001|Overall Study|Adverse Event|5|||
30578764|NCT01242748|58589186|FG000|Overall Study|Lost to Follow-up|6|||
30578765|NCT01242748|58589187|FG001|Overall Study|Lost to Follow-up|2|||
30578766|NCT01242748|58589186|FG000|Overall Study|Physician Decision|3|||
30578767|NCT01242748|58589187|FG001|Overall Study|Physician Decision|2|||
30578768|NCT01242748|58589186|FG000|Overall Study|Protocol Violation|1|||
30578769|NCT01242748|58589187|FG001|Overall Study|Protocol Violation|0|||
30578770|NCT01242748|58589186|FG000|Overall Study|Withdrawal by Subject|10|||
30578771|NCT01242748|58589187|FG001|Overall Study|Withdrawal by Subject|2|||
30578772|NCT01242748|58589186|FG000|Overall Study|Miscellaneous reasons|8|||
30578773|NCT01242748|58589187|FG001|Overall Study|Miscellaneous reasons|3|||
30578774|NCT01242514|58589196|FG000|Overall Study|e.g., project closure|1042|||
30578775|NCT01242514|58589197|FG001|Overall Study|e.g., project closure|305|||
30578776|NCT01242514|58589198|FG002|Overall Study|e.g., project closure|171|||
30578777|NCT01242514|58589196|FG000|Overall Study|Subject decision|33|||
30578778|NCT01242514|58589197|FG001|Overall Study|Subject decision|8|||
30578779|NCT01242514|58589198|FG002|Overall Study|Subject decision|2|||
30958685|NCT01582061|59023783|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30958686|NCT01582061|59023784|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30958687|NCT01582061|59023783|FG000|Overall Study|Death|0|||
30958688|NCT01582061|59023784|FG001|Overall Study|Death|1|||
30958689|NCT01582061|59023783|FG000|Overall Study|condition no longer requires study drug|1|||
30958690|NCT01582061|59023784|FG001|Overall Study|condition no longer requires study drug|0|||
30958691|NCT01582061|59023783|FG000|Overall Study|Lost to Follow-up|1|||
30958692|NCT01582061|59023784|FG001|Overall Study|Lost to Follow-up|0|||
30958693|NCT01693523|59023803|FG000|Overall Study|Adverse Event|2|||
30958694|NCT01693523|59023804|FG001|Overall Study|Adverse Event|1|||
30958695|NCT01693523|59023805|FG002|Overall Study|Adverse Event|0|||
30578780|NCT01242514|58589196|FG000|Overall Study|Severe non-compliance to protocol|5|||
30578781|NCT01242514|58589197|FG001|Overall Study|Severe non-compliance to protocol|2|||
30578782|NCT01242514|58589198|FG002|Overall Study|Severe non-compliance to protocol|1|||
30578783|NCT01242514|58589196|FG000|Overall Study|Lack of therapeutic response|99|||
30578784|NCT01242514|58589197|FG001|Overall Study|Lack of therapeutic response|16|||
30578785|NCT01242514|58589198|FG002|Overall Study|Lack of therapeutic response|10|||
30578786|NCT01242514|58589196|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
30578787|NCT01242514|58589197|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
30578788|NCT01242514|58589198|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
30578789|NCT01242514|58589196|FG000|Overall Study|Lost to Follow-up|14|||
30578790|NCT01242514|58589197|FG001|Overall Study|Lost to Follow-up|5|||
30958696|NCT01693523|59023803|FG000|Overall Study|Death|0|||
30578791|NCT01242514|58589198|FG002|Overall Study|Lost to Follow-up|4|||
30578792|NCT01242514|58589196|FG000|Overall Study|Adverse Event|129|||
30578793|NCT01242514|58589197|FG001|Overall Study|Adverse Event|18|||
30578794|NCT01242514|58589198|FG002|Overall Study|Adverse Event|19|||
30578795|NCT01242085|58589209|FG000|Overall Study|Withdrawal by Subject|4|||
30578796|NCT01242085|58589210|FG001|Overall Study|Withdrawal by Subject|2|||
30578797|NCT01242085|58589211|FG002|Overall Study|Withdrawal by Subject|0|||
30578798|NCT01242085|58589209|FG000|Overall Study|medically unable to have surgery|4|||
30578799|NCT01242085|58589210|FG001|Overall Study|medically unable to have surgery|5|||
30578800|NCT01242085|58589211|FG002|Overall Study|medically unable to have surgery|0|||
30578801|NCT01241461|58589219|FG000|Overall Study|Progressive Disease|3|||
30578802|NCT01241461|58589220|FG001|Overall Study|Progressive Disease|6|||
30578803|NCT01240135|58589232|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
30578804|NCT01240135|58589233|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
30578805|NCT01240135|58589232|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
30578806|NCT01240135|58589233|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
30578807|NCT01247701|58589239|FG000|Overall Study|Death|2|||
30578808|NCT01247701|58589239|FG000|Overall Study|Relapsed|8|||
30578809|NCT01248247|58589247|FG000|Overall Study|Adverse Event|2|||
30578810|NCT01248247|58589248|FG001|Overall Study|Adverse Event|4|||
30578811|NCT01248247|58589249|FG002|Overall Study|Adverse Event|4|||
30578812|NCT01248247|58589250|FG003|Overall Study|Adverse Event|2|||
30578813|NCT01248247|58589247|FG000|Overall Study|Death|0|||
30578814|NCT01248247|58589248|FG001|Overall Study|Death|1|||
30578815|NCT01248247|58589249|FG002|Overall Study|Death|4|||
30578816|NCT01248247|58589250|FG003|Overall Study|Death|7|||
30578817|NCT01248247|58589247|FG000|Overall Study|Lost to Follow-up|0|||
30578818|NCT01248247|58589248|FG001|Overall Study|Lost to Follow-up|1|||
30578819|NCT01248247|58589249|FG002|Overall Study|Lost to Follow-up|1|||
30578820|NCT01248247|58589250|FG003|Overall Study|Lost to Follow-up|0|||
30578821|NCT01248247|58589247|FG000|Overall Study|Alternative treatment|0|||
30578822|NCT01248247|58589248|FG001|Overall Study|Alternative treatment|1|||
30578823|NCT01248247|58589249|FG002|Overall Study|Alternative treatment|0|||
30578824|NCT01248247|58589250|FG003|Overall Study|Alternative treatment|0|||
30578825|NCT01248247|58589247|FG000|Overall Study|Other|2|||
30578826|NCT01248247|58589248|FG001|Overall Study|Other|8|||
30578827|NCT01248247|58589249|FG002|Overall Study|Other|8|||
30578828|NCT01248247|58589250|FG003|Overall Study|Other|5|||
30578829|NCT01248247|58589247|FG000|Overall Study|Progression|18|||
30578830|NCT01248247|58589248|FG001|Overall Study|Progression|27|||
30578831|NCT01248247|58589249|FG002|Overall Study|Progression|56|||
30578832|NCT01248247|58589250|FG003|Overall Study|Progression|44|||
30578833|NCT01248247|58589247|FG000|Overall Study|Refuse further treatment|0|||
30668155|NCT00875420|58682132|FG001|Overall Study|Inability to complete study procedures|0|||
30668156|NCT00875420|58682133|FG002|Overall Study|Inability to complete study procedures|1|||
30668157|NCT00875420|58682134|FG003|Overall Study|Inability to complete study procedures|1|||
30668158|NCT00875420|58682135|FG004|Overall Study|Inability to complete study procedures|1|||
30668159|NCT00875420|58682131|FG000|Overall Study|Lost to Follow-up|1|||
30668160|NCT00875420|58682132|FG001|Overall Study|Lost to Follow-up|0|||
30668161|NCT00875420|58682133|FG002|Overall Study|Lost to Follow-up|0|||
30668162|NCT00875420|58682134|FG003|Overall Study|Lost to Follow-up|0|||
30668163|NCT00875420|58682135|FG004|Overall Study|Lost to Follow-up|0|||
30668164|NCT00875420|58682131|FG000|Overall Study|Personal reason|0|||
30668165|NCT00875420|58682132|FG001|Overall Study|Personal reason|0|||
30668166|NCT00875420|58682133|FG002|Overall Study|Personal reason|0|||
30668167|NCT00875420|58682134|FG003|Overall Study|Personal reason|0|||
30668168|NCT00875420|58682135|FG004|Overall Study|Personal reason|1|||
30668169|NCT00875420|58682131|FG000|Overall Study|Prohibited medication|0|||
30668170|NCT00875420|58682132|FG001|Overall Study|Prohibited medication|0|||
30668171|NCT00875420|58682133|FG002|Overall Study|Prohibited medication|0|||
30668172|NCT00875420|58682134|FG003|Overall Study|Prohibited medication|1|||
30668173|NCT00875420|58682135|FG004|Overall Study|Prohibited medication|0|||
30855357|NCT02592434|58882989|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
30855358|NCT02592434|58882990|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
30578834|NCT01248247|58589248|FG001|Overall Study|Refuse further treatment|0|||
30578835|NCT01248247|58589249|FG002|Overall Study|Refuse further treatment|1|||
30578836|NCT01248247|58589250|FG003|Overall Study|Refuse further treatment|2|||
30578837|NCT01248247|58589247|FG000|Overall Study|Complicating disease|0|||
30578838|NCT01248247|58589248|FG001|Overall Study|Complicating disease|0|||
30578839|NCT01248247|58589249|FG002|Overall Study|Complicating disease|1|||
30578840|NCT01248247|58589250|FG003|Overall Study|Complicating disease|1|||
30668174|NCT00875420|58682131|FG000|Overall Study|Sponsor decision|0|||
30668175|NCT00875420|58682132|FG001|Overall Study|Sponsor decision|1|||
30668176|NCT00875420|58682133|FG002|Overall Study|Sponsor decision|0|||
30668177|NCT00875420|58682134|FG003|Overall Study|Sponsor decision|0|||
30668178|NCT00875420|58682135|FG004|Overall Study|Sponsor decision|0|||
30668179|NCT00875420|58682131|FG000|Overall Study|Withdrawal by Subject|0|||
30780316|NCT02967692|58792147|FG000|Overall Study|Lost to Follow-up|0|||
30578841|NCT02598583|58589262|FG000|Extension Period|Withdrawal by Subject|1|||
30578842|NCT02598583|58589263|FG001|Extension Period|Withdrawal by Subject|0|||
30578843|NCT04831736|58589280|FG000|Overall Study|Withdrawal by Subject|0|||
30578844|NCT04831736|58589281|FG001|Overall Study|Withdrawal by Subject|1|||
30578845|NCT04583956|58589296|FG000|Overall Study|Death|9|||
30578846|NCT04583956|58589297|FG001|Overall Study|Death|11|||
30578847|NCT04583956|58589296|FG000|Overall Study|Lost to Follow-up|7|||
30578848|NCT04583956|58589297|FG001|Overall Study|Lost to Follow-up|9|||
30578849|NCT04583956|58589296|FG000|Overall Study|Protocol Violation|2|||
30578850|NCT04583956|58589297|FG001|Overall Study|Protocol Violation|0|||
30578851|NCT04583956|58589296|FG000|Overall Study|Withdrawal by Subject|0|||
30578852|NCT04583956|58589297|FG001|Overall Study|Withdrawal by Subject|2|||
30578853|NCT04583956|58589296|FG000|Overall Study|Randomized but not dosed|2|||
30578854|NCT04583956|58589297|FG001|Overall Study|Randomized but not dosed|3|||
30578855|NCT04583956|58589296|FG000|Overall Study|Withdrawal of consent before product administration|1|||
30578856|NCT04583956|58589297|FG001|Overall Study|Withdrawal of consent before product administration|0|||
30578857|NCT04463680|58589313|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
30578858|NCT04463680|58589313|FG000|Overall Study|Not eligible due to implant duration of use|1|||
30578859|NCT04463680|58589313|FG000|Overall Study|Withdrawal by Subject|3|||
30578860|NCT04449029|58589325|FG000|Overall Study|Adverse Event|0|||
30578861|NCT04449029|58589326|FG001|Overall Study|Adverse Event|1|||
30578862|NCT04449029|58589327|FG002|Overall Study|Adverse Event|1|||
30578863|NCT04449029|58589328|FG003|Overall Study|Adverse Event|0|||
30578864|NCT04449029|58589329|FG004|Overall Study|Adverse Event|1|||
30578865|NCT04449029|58589330|FG005|Overall Study|Adverse Event|0|||
30578866|NCT04449029|58589331|FG006|Overall Study|Adverse Event|1|||
30578867|NCT04449029|58589332|FG007|Overall Study|Adverse Event|0|||
30578868|NCT04449029|58589325|FG000|Overall Study|Lost to Follow-up|0|||
30578869|NCT04449029|58589326|FG001|Overall Study|Lost to Follow-up|1|||
30578870|NCT04449029|58589327|FG002|Overall Study|Lost to Follow-up|0|||
30578871|NCT04449029|58589328|FG003|Overall Study|Lost to Follow-up|0|||
30578872|NCT04449029|58589329|FG004|Overall Study|Lost to Follow-up|0|||
30578873|NCT04449029|58589330|FG005|Overall Study|Lost to Follow-up|0|||
30578874|NCT04449029|58589331|FG006|Overall Study|Lost to Follow-up|0|||
30578875|NCT04449029|58589332|FG007|Overall Study|Lost to Follow-up|0|||
30578876|NCT04449029|58589325|FG000|Overall Study|Protocol Violation|0|||
30578877|NCT04449029|58589326|FG001|Overall Study|Protocol Violation|1|||
30578878|NCT04449029|58589327|FG002|Overall Study|Protocol Violation|0|||
30578879|NCT04449029|58589328|FG003|Overall Study|Protocol Violation|0|||
30578880|NCT04449029|58589329|FG004|Overall Study|Protocol Violation|0|||
30578881|NCT04449029|58589330|FG005|Overall Study|Protocol Violation|0|||
30578882|NCT04449029|58589331|FG006|Overall Study|Protocol Violation|0|||
30578883|NCT04449029|58589332|FG007|Overall Study|Protocol Violation|0|||
30578884|NCT04449029|58589325|FG000|Overall Study|Physician Decision|0|||
30578885|NCT04449029|58589326|FG001|Overall Study|Physician Decision|0|||
30578886|NCT04449029|58589327|FG002|Overall Study|Physician Decision|0|||
30578887|NCT04449029|58589328|FG003|Overall Study|Physician Decision|0|||
30578888|NCT04449029|58589329|FG004|Overall Study|Physician Decision|0|||
30578889|NCT04449029|58589330|FG005|Overall Study|Physician Decision|1|||
30578890|NCT04449029|58589331|FG006|Overall Study|Physician Decision|0|||
30578891|NCT04449029|58589332|FG007|Overall Study|Physician Decision|0|||
30578892|NCT04449029|58589325|FG000|Overall Study|Withdrawal by Subject|3|||
30578893|NCT04449029|58589326|FG001|Overall Study|Withdrawal by Subject|0|||
30578894|NCT04449029|58589327|FG002|Overall Study|Withdrawal by Subject|1|||
30578895|NCT04449029|58589328|FG003|Overall Study|Withdrawal by Subject|1|||
30578896|NCT04449029|58589329|FG004|Overall Study|Withdrawal by Subject|5|||
30578897|NCT04449029|58589330|FG005|Overall Study|Withdrawal by Subject|1|||
30578898|NCT04449029|58589331|FG006|Overall Study|Withdrawal by Subject|4|||
30578899|NCT04449029|58589332|FG007|Overall Study|Withdrawal by Subject|0|||
30578900|NCT04428333|58589362|FG000|Overall Study|Physician Decision|2|||
30578901|NCT04428333|58589363|FG001|Overall Study|Physician Decision|0|||
30578902|NCT04428333|58589362|FG000|Overall Study|Withdrawal by Subject|0|||
30578903|NCT04428333|58589363|FG001|Overall Study|Withdrawal by Subject|1|||
30578904|NCT04428333|58589362|FG000|Overall Study|In Follow-Up|5|||
30578905|NCT04428333|58589363|FG001|Overall Study|In Follow-Up|10|||
30578906|NCT04428333|58589362|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
30578907|NCT04428333|58589363|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
30578908|NCT04193202|58589371|FG000|Overall Study|Adverse Event|2|||
30668180|NCT00875420|58682132|FG001|Overall Study|Withdrawal by Subject|0|||
30780317|NCT02967692|58792148|FG001|Overall Study|Lost to Follow-up|0|||
30578909|NCT04193202|58589372|FG001|Overall Study|Adverse Event|1|||
30578910|NCT04193202|58589371|FG000|Overall Study|Death|0|||
30578911|NCT04193202|58589372|FG001|Overall Study|Death|1|||
30578912|NCT04193202|58589371|FG000|Overall Study|Physician Decision|1|||
30578913|NCT04193202|58589372|FG001|Overall Study|Physician Decision|1|||
30578914|NCT04193202|58589371|FG000|Overall Study|Protocol Violation|2|||
30578915|NCT04193202|58589372|FG001|Overall Study|Protocol Violation|2|||
30578916|NCT04193202|58589371|FG000|Overall Study|Withdrawal by Subject|11|||
30578917|NCT04193202|58589372|FG001|Overall Study|Withdrawal by Subject|5|||
30578918|NCT04159935|58589380|FG000|Overall Study|Study terminated due to COVID-19|1|||
30578919|NCT04159935|58589381|FG001|Overall Study|Study terminated due to COVID-19|3|||
30578920|NCT04128696|58589389|FG000|Overall Study|Lost to Follow-up|0|||
30578921|NCT04128696|58589390|FG001|Overall Study|Lost to Follow-up|1|||
30578922|NCT04128696|58589389|FG000|Overall Study|Withdrawal by Subject|8|||
30578923|NCT04128696|58589390|FG001|Overall Study|Withdrawal by Subject|5|||
30578924|NCT04128696|58589389|FG000|Overall Study|In Follow-up|47|||
30578925|NCT04128696|58589390|FG001|Overall Study|In Follow-up|51|||
30578926|NCT04128696|58589389|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52|||
30578927|NCT04128696|58589390|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62|||
30578928|NCT03871543|58589414|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
30578929|NCT03871543|58589414|FG000|Period 1|Investigator Error|1|||
30578930|NCT03871543|58589414|FG000|Period 1|Protocol Violation|2|||
30578931|NCT03871543|58589414|FG000|Period 1|COVID-19 Related|1|||
30578932|NCT03871543|58589414|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
30578933|NCT03871543|58589414|FG000|Period 1|Withdrawal by Subject|10|||
30578934|NCT03871543|58589414|FG000|Period 2|Adverse Event|1|||
30578935|NCT03871543|58589414|FG000|Period 2|Withdrawal by Subject|1|||
30578936|NCT03843125|58589426|FG000|Overall Study|Adverse Event|17|||
30578937|NCT03843125|58589427|FG001|Overall Study|Adverse Event|13|||
30578938|NCT03843125|58589428|FG002|Overall Study|Adverse Event|5|||
30578939|NCT03843125|58589429|FG003|Overall Study|Adverse Event|9|||
30578940|NCT03843125|58589426|FG000|Overall Study|Death|0|||
30578941|NCT03843125|58589427|FG001|Overall Study|Death|6|||
30578942|NCT03843125|58589428|FG002|Overall Study|Death|2|||
30578943|NCT03843125|58589429|FG003|Overall Study|Death|0|||
30578944|NCT03843125|58589426|FG000|Overall Study|Lack of Efficacy|14|||
30578945|NCT03843125|58589427|FG001|Overall Study|Lack of Efficacy|11|||
30578946|NCT03843125|58589428|FG002|Overall Study|Lack of Efficacy|9|||
30578947|NCT03843125|58589429|FG003|Overall Study|Lack of Efficacy|4|||
30578948|NCT03843125|58589426|FG000|Overall Study|Lost to Follow-up|3|||
30578949|NCT03843125|58589427|FG001|Overall Study|Lost to Follow-up|4|||
30578950|NCT03843125|58589428|FG002|Overall Study|Lost to Follow-up|0|||
30578951|NCT03843125|58589429|FG003|Overall Study|Lost to Follow-up|2|||
30578952|NCT03843125|58589426|FG000|Overall Study|Other|12|||
30578953|NCT03843125|58589427|FG001|Overall Study|Other|14|||
30578954|NCT03843125|58589428|FG002|Overall Study|Other|3|||
30578955|NCT03843125|58589429|FG003|Overall Study|Other|4|||
30578956|NCT03843125|58589426|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
30578957|NCT03843125|58589427|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
30578958|NCT03843125|58589428|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
30578959|NCT03843125|58589429|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
30578960|NCT03843125|58589426|FG000|Overall Study|Study Terminated by Sponsor|318|||
30578961|NCT03843125|58589427|FG001|Overall Study|Study Terminated by Sponsor|318|||
30578962|NCT03843125|58589428|FG002|Overall Study|Study Terminated by Sponsor|163|||
30578963|NCT03843125|58589429|FG003|Overall Study|Study Terminated by Sponsor|163|||
30578964|NCT03843125|58589426|FG000|Overall Study|Withdrawal by Subject|23|||
30578965|NCT03843125|58589427|FG001|Overall Study|Withdrawal by Subject|12|||
30578966|NCT03843125|58589428|FG002|Overall Study|Withdrawal by Subject|6|||
30578967|NCT03843125|58589429|FG003|Overall Study|Withdrawal by Subject|9|||
30578968|NCT03843125|58589426|FG000|Overall Study|Missing data|0|||
30578969|NCT03843125|58589427|FG001|Overall Study|Missing data|1|||
30578970|NCT03843125|58589428|FG002|Overall Study|Missing data|1|||
30578971|NCT03843125|58589429|FG003|Overall Study|Missing data|0|||
30578972|NCT03695237|58589442|FG000|Overall Study|Discontinued to Restart Puberty|1|||
30578973|NCT03695237|58589443|FG001|Overall Study|Discontinued to Restart Puberty|0|||
30578974|NCT03603509|58589452|FG000|Overall Study|Lost to Follow-up|3|||
30578975|NCT03603509|58589453|FG001|Overall Study|Lost to Follow-up|4|||
30578976|NCT03275285|58589470|FG000|Overall Study|Ongoing|61|||
30578977|NCT03275285|58589471|FG001|Overall Study|Ongoing|105|||
30578978|NCT03066258|58589490|FG000|Overall Study|Death|1|||
30578979|NCT03066258|58589491|FG001|Overall Study|Death|0|||
30578980|NCT03066258|58589492|FG002|Overall Study|Death|0|||
30578981|NCT03066258|58589493|FG003|Overall Study|Death|0|||
30578982|NCT03066258|58589494|FG004|Overall Study|Death|1|||
30578983|NCT03024255|58589510|FG000|Overall Study|Adverse Event|1|||
30578984|NCT03024255|58589511|FG001|Overall Study|Adverse Event|4|||
30578985|NCT03024255|58589512|FG002|Overall Study|Adverse Event|8|||
30578986|NCT03024255|58589513|FG003|Overall Study|Adverse Event|0|||
30578987|NCT03024255|58589510|FG000|Overall Study|Withdrawal by Subject|3|||
30578988|NCT03024255|58589511|FG001|Overall Study|Withdrawal by Subject|1|||
30578989|NCT03024255|58589512|FG002|Overall Study|Withdrawal by Subject|0|||
30578990|NCT03024255|58589513|FG003|Overall Study|Withdrawal by Subject|3|||
30578991|NCT03024255|58589510|FG000|Overall Study|Protocol Violation|0|||
30578992|NCT03024255|58589511|FG001|Overall Study|Protocol Violation|0|||
30578993|NCT03024255|58589512|FG002|Overall Study|Protocol Violation|2|||
30578994|NCT03024255|58589513|FG003|Overall Study|Protocol Violation|0|||
30578995|NCT03024255|58589510|FG000|Overall Study|Lost to Follow-up|1|||
30578996|NCT03024255|58589511|FG001|Overall Study|Lost to Follow-up|2|||
30578997|NCT03024255|58589512|FG002|Overall Study|Lost to Follow-up|1|||
30578998|NCT03024255|58589513|FG003|Overall Study|Lost to Follow-up|1|||
30578999|NCT03024255|58589510|FG000|Overall Study|Lack of Efficacy|1|||
30579000|NCT03024255|58589511|FG001|Overall Study|Lack of Efficacy|0|||
30579001|NCT03024255|58589512|FG002|Overall Study|Lack of Efficacy|0|||
30579002|NCT03024255|58589513|FG003|Overall Study|Lack of Efficacy|0|||
30579003|NCT03024255|58589510|FG000|Overall Study|Protocol Noncompliance|1|||
30579004|NCT03024255|58589511|FG001|Overall Study|Protocol Noncompliance|1|||
30579005|NCT03024255|58589512|FG002|Overall Study|Protocol Noncompliance|0|||
30579006|NCT03024255|58589513|FG003|Overall Study|Protocol Noncompliance|1|||
30579007|NCT02636582|58589532|FG000|Overall Study|Surgical Pathology|1|||
30579008|NCT02636582|58589533|FG001|Overall Study|Surgical Pathology|0|||
30579009|NCT02367040|58589541|FG000|Overall Study|Lost to Follow-up|1|||
30579010|NCT02367040|58589542|FG001|Overall Study|Lost to Follow-up|1|||
30579011|NCT02367040|58589541|FG000|Overall Study|Lack of Efficacy|1|||
30579012|NCT02367040|58589542|FG001|Overall Study|Lack of Efficacy|0|||
30579013|NCT02367040|58589541|FG000|Overall Study|Additional primary malignancy|0|||
30579014|NCT02367040|58589542|FG001|Overall Study|Additional primary malignancy|1|||
30579015|NCT02367040|58589541|FG000|Overall Study|AE not associated with clinical disease progression|104|||
30579016|NCT02367040|58589542|FG001|Overall Study|AE not associated with clinical disease progression|9|||
30579017|NCT02367040|58589541|FG000|Overall Study|AE associated with clinical disease progression|1|||
30579018|NCT02367040|58589542|FG001|Overall Study|AE associated with clinical disease progression|3|||
30579019|NCT02367040|58589541|FG000|Overall Study|Physician Decision|2|||
30579020|NCT02367040|58589542|FG001|Overall Study|Physician Decision|8|||
30579021|NCT02367040|58589541|FG000|Overall Study|Non-compliance with study drug|1|||
30579022|NCT02367040|58589542|FG001|Overall Study|Non-compliance with study drug|0|||
30579023|NCT02367040|58589541|FG000|Overall Study|Failure to meet continuation criteria|1|||
30579024|NCT02367040|58589542|FG001|Overall Study|Failure to meet continuation criteria|0|||
30579025|NCT02367040|58589541|FG000|Overall Study|Switching to other therapy|2|||
30579026|NCT02367040|58589542|FG001|Overall Study|Switching to other therapy|0|||
30579027|NCT02367040|58589541|FG000|Overall Study|Withdrawal by Subject|41|||
30579028|NCT02367040|58589542|FG001|Overall Study|Withdrawal by Subject|14|||
30579029|NCT02367040|58589541|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
30579030|NCT02367040|58589542|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
30579031|NCT02367040|58589541|FG000|Overall Study|Patient decision|35|||
30579032|NCT02367040|58589542|FG001|Overall Study|Patient decision|11|||
30579033|NCT02367040|58589541|FG000|Overall Study|Required procedure failed|1|||
30579034|NCT02367040|58589542|FG001|Overall Study|Required procedure failed|0|||
30579035|NCT02367040|58589541|FG000|Overall Study|Randomized by mistake with study treatment|1|||
30579036|NCT02367040|58589542|FG001|Overall Study|Randomized by mistake with study treatment|0|||
30579037|NCT02367040|58589541|FG000|Overall Study|Protocol Violation|1|||
30579038|NCT02367040|58589542|FG001|Overall Study|Protocol Violation|0|||
30579039|NCT02367040|58589541|FG000|Overall Study|Progressive disease - radiological progression|39|||
30579040|NCT02367040|58589542|FG001|Overall Study|Progressive disease - radiological progression|67|||
30579041|NCT02367040|58589541|FG000|Overall Study|Progressive disease - clinical progression|2|||
30579042|NCT02367040|58589542|FG001|Overall Study|Progressive disease - clinical progression|6|||
30579043|NCT02367040|58589541|FG000|Overall Study|Drug not administered|3|||
30579044|NCT02367040|58589542|FG001|Overall Study|Drug not administered|2|||
30579045|NCT01252953|58589554|FG000|Overall Study|Withdrawal by Subject|16|||
30579046|NCT01252953|58589555|FG001|Overall Study|Withdrawal by Subject|17|||
30579047|NCT01252953|58589554|FG000|Overall Study|Lost to Follow-up|22|||
30579048|NCT01252953|58589555|FG001|Overall Study|Lost to Follow-up|21|||
30579049|NCT01234480|58589562|FG000|Overall Study|Pregnancy|88|||
30579050|NCT01234480|58589562|FG000|Overall Study|>36/Normal History|50|||
30579051|NCT01234480|58589562|FG000|Overall Study|Age|3|||
30579052|NCT01234480|58589562|FG000|Overall Study|HPV Vaccine History|28|||
30579053|NCT01234480|58589562|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
30579054|NCT01234480|58589562|FG000|Overall Study|Hysterectomy|2|||
30579055|NCT01234480|58589562|FG000|Overall Study|Hysterectomy post enrollment|1|||
30579056|NCT01234480|58589562|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
30579057|NCT01234480|58589562|FG000|Overall Study|Informed Consent Form Violation|30|||
30579058|NCT01234480|58589562|FG000|Overall Study|Incorrect Visit|3|||
30579059|NCT01234480|58589562|FG000|Overall Study|No Florida Lab License|20|||
30579060|NCT01234480|58589562|FG000|Overall Study|Out of Window|42|||
30579061|NCT01234480|58589562|FG000|Overall Study|Sample Processing/Storage|92|||
30579062|NCT01234480|58589562|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
30579063|NCT01234480|58589562|FG000|Overall Study|Site/Subject non-compliance|44|||
30579064|NCT01234480|58589562|FG000|Overall Study|Missing Sample|9|||
30579065|NCT00877851|58589571|FG000|Overall Study|Lost to Follow-up|5|||
30579066|NCT00877851|58589572|FG001|Overall Study|Lost to Follow-up|5|||
30579067|NCT00877851|58589571|FG000|Overall Study|computer problem|3|||
30579068|NCT00877851|58589572|FG001|Overall Study|computer problem|0|||
30579069|NCT00877851|58589571|FG000|Overall Study|no longer interested in participating|1|||
30579070|NCT00877851|58589572|FG001|Overall Study|no longer interested in participating|0|||
30579071|NCT00846742|58589578|FG000|Overall Study|Withdrawal by Subject|1|||
30579072|NCT00837616|58589585|FG000|Overall Study|Withdrawal by Subject|0|||
30579073|NCT00837616|58589586|FG001|Overall Study|Withdrawal by Subject|1|||
30579074|NCT00176254|58589592|FG000|Overall Study|Lost to Follow-up|1|||
30579075|NCT04834726|58589623|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
30579076|NCT04834726|58589624|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
30579077|NCT04834726|58589625|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
30579078|NCT04834726|58589626|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
30579079|NCT04834726|58589627|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
30579080|NCT04834726|58589628|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
30579081|NCT04834726|58589629|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
30579082|NCT04834726|58589630|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
30579083|NCT04834726|58589631|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
30579084|NCT04732949|58589647|FG000|Overall Study|Withdrawal by Subject|23|||
30579085|NCT04732949|58589648|FG001|Overall Study|Withdrawal by Subject|27|||
30579086|NCT04732949|58589647|FG000|Overall Study|Protocol Violation|0|||
30579087|NCT04732949|58589648|FG001|Overall Study|Protocol Violation|1|||
30579088|NCT04732949|58589647|FG000|Overall Study|Non-compliance|0|||
30579089|NCT04732949|58589648|FG001|Overall Study|Non-compliance|2|||
30579090|NCT04732949|58589647|FG000|Overall Study|Physician Decision|2|||
30579091|NCT04732949|58589648|FG001|Overall Study|Physician Decision|1|||
30579092|NCT04732949|58589647|FG000|Overall Study|Serious adverse event (Fatal)|16|||
30579093|NCT04732949|58589648|FG001|Overall Study|Serious adverse event (Fatal)|18|||
30579094|NCT04732949|58589647|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
30579095|NCT04732949|58589648|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
30579096|NCT04732949|58589647|FG000|Overall Study|Non-serious adverse event|1|||
30579097|NCT04732949|58589648|FG001|Overall Study|Non-serious adverse event|3|||
30579098|NCT04732949|58589647|FG000|Overall Study|Lost to Follow-up|26|||
30579099|NCT04732949|58589648|FG001|Overall Study|Lost to Follow-up|27|||
30579100|NCT04732949|58589647|FG000|Overall Study|Other|6|||
30579101|NCT04732949|58589648|FG001|Overall Study|Other|3|||
30579102|NCT04235504|58589703|FG000|Study Phase|Withdrawal by Subject|5|||
30579103|NCT04235504|58589704|FG001|Study Phase|Withdrawal by Subject|2|||
30579104|NCT04235504|58589705|FG002|Study Phase|Withdrawal by Subject|0|||
30579105|NCT04235504|58589706|FG003|Study Phase|Withdrawal by Subject|0|||
30579106|NCT04235504|58589703|FG000|Continuation Phase|Withdrawal by Subject|0|||
30579107|NCT04235504|58589704|FG001|Continuation Phase|Withdrawal by Subject|4|||
30579108|NCT04235504|58589705|FG002|Continuation Phase|Withdrawal by Subject|0|||
30579109|NCT04235504|58589706|FG003|Continuation Phase|Withdrawal by Subject|0|||
30579110|NCT04235504|58589703|FG000|Continuation Phase|Adverse Event|0|||
30579111|NCT04235504|58589704|FG001|Continuation Phase|Adverse Event|1|||
30579112|NCT04235504|58589705|FG002|Continuation Phase|Adverse Event|0|||
30579113|NCT04235504|58589706|FG003|Continuation Phase|Adverse Event|0|||
30579114|NCT04235504|58589703|FG000|Continuation Phase|Physician Decision|1|||
30579115|NCT04235504|58589704|FG001|Continuation Phase|Physician Decision|2|||
30579116|NCT04235504|58589705|FG002|Continuation Phase|Physician Decision|1|||
30579117|NCT04235504|58589706|FG003|Continuation Phase|Physician Decision|0|||
30579118|NCT04172987|58589721|FG000|Lead In Period|Adverse Event|1|||
30579119|NCT04172987|58589721|FG000|Lead In Period|Protocol Violation|1|||
30579120|NCT04172987|58589721|FG000|Period 1|Physician Decision|1|||
30579121|NCT04172987|58589721|FG000|Period 2|Adverse Event|5|||
30579122|NCT04172987|58589721|FG000|Period 2|Dosing Termination by Sponsor|4|||
30579123|NCT03705832|58589730|FG000|Overall Study|Physician Decision|0|||
30579124|NCT03705832|58589731|FG001|Overall Study|Physician Decision|1|||
30579125|NCT03705832|58589730|FG000|Overall Study|Withdrawal by Subject|1|||
30579126|NCT03705832|58589731|FG001|Overall Study|Withdrawal by Subject|0|||
30579127|NCT03447743|58589737|FG000|Overall Study|Withdrawal by Subject|2|||
30579128|NCT03447743|58589737|FG000|Overall Study|Lost to Follow-up|3|||
30579129|NCT03447743|58589737|FG000|Overall Study|Adverse Event|1|||
30579130|NCT03447743|58589737|FG000|Overall Study|Did not meet criteria to continue|1|||
30579131|NCT03433755|58589745|FG000|Overall Study|Lost to Follow-up|1|||
30579132|NCT03433755|58589746|FG001|Overall Study|Lost to Follow-up|0|||
30579133|NCT03433755|58589747|FG002|Overall Study|Lost to Follow-up|0|||
30579134|NCT03433755|58589748|FG003|Overall Study|Lost to Follow-up|0|||
30579135|NCT03433755|58589745|FG000|Overall Study|Decision by Sponsor|1|||
30579136|NCT03433755|58589746|FG001|Overall Study|Decision by Sponsor|0|||
30579137|NCT03433755|58589747|FG002|Overall Study|Decision by Sponsor|0|||
30579138|NCT03433755|58589748|FG003|Overall Study|Decision by Sponsor|0|||
30579139|NCT03406507|58589771|FG000|Extension Period|Lack of Efficacy|0|||
30579140|NCT03406507|58589772|FG001|Extension Period|Lack of Efficacy|1|||
30579141|NCT03283150|58589781|FG000|Overall Study|Withdrawal by Subject|6|||
30579142|NCT03283150|58589782|FG001|Overall Study|Withdrawal by Subject|0|||
30579143|NCT03283150|58589783|FG002|Overall Study|Withdrawal by Subject|0|||
30579144|NCT03218917|58589794|FG000|Overall Study|Adverse Event|3|||
30579145|NCT03218917|58589795|FG001|Overall Study|Adverse Event|3|||
30579146|NCT03218917|58589796|FG002|Overall Study|Adverse Event|2|||
30579147|NCT03218917|58589794|FG000|Overall Study|Subject withdrew consent|2|||
30579148|NCT03218917|58589795|FG001|Overall Study|Subject withdrew consent|4|||
30579149|NCT03218917|58589796|FG002|Overall Study|Subject withdrew consent|10|||
30579150|NCT03218917|58589794|FG000|Overall Study|Physician Decision|0|||
30579151|NCT03218917|58589795|FG001|Overall Study|Physician Decision|1|||
30579152|NCT03218917|58589796|FG002|Overall Study|Physician Decision|1|||
30579153|NCT03218917|58589794|FG000|Overall Study|Lost to Follow-up|1|||
30579154|NCT03218917|58589795|FG001|Overall Study|Lost to Follow-up|0|||
30579155|NCT03218917|58589796|FG002|Overall Study|Lost to Follow-up|0|||
30579156|NCT03218917|58589794|FG000|Overall Study|Reason Missing|0|||
30579157|NCT03218917|58589795|FG001|Overall Study|Reason Missing|2|||
30579158|NCT03218917|58589796|FG002|Overall Study|Reason Missing|0|||
30579159|NCT03218917|58589794|FG000|Overall Study|Death|0|||
30579160|NCT03218917|58589795|FG001|Overall Study|Death|1|||
30579161|NCT03218917|58589796|FG002|Overall Study|Death|0|||
30579162|NCT03218917|58589794|FG000|Overall Study|Non-Compliance with Study Drug|0|||
30579163|NCT03218917|58589795|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30579164|NCT03218917|58589796|FG002|Overall Study|Non-Compliance with Study Drug|0|||
30579165|NCT03056040|58589807|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
30579166|NCT03056040|58589808|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
30579167|NCT03056040|58589807|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
30579168|NCT03056040|58589808|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
30579169|NCT03056040|58589807|FG000|Primary Evaluation Period|Pregnancy|0|||
30579170|NCT03056040|58589808|FG001|Primary Evaluation Period|Pregnancy|1|||
30579171|NCT03056040|58589807|FG000|Extension Period|Physician Decision|3|||
30579172|NCT03056040|58589808|FG001|Extension Period|Physician Decision|3|||
30579173|NCT03056040|58589807|FG000|Extension Period|Lost to Follow-up|0|||
30579174|NCT03056040|58589808|FG001|Extension Period|Lost to Follow-up|1|||
30579175|NCT03056040|58589807|FG000|Extension Period|Death|0|||
30579176|NCT03056040|58589808|FG001|Extension Period|Death|3|||
30579177|NCT03056040|58589807|FG000|Extension Period|Withdrawal by Subject|1|||
30579178|NCT03056040|58589808|FG001|Extension Period|Withdrawal by Subject|0|||
30579179|NCT03021499|58589819|FG000|Overall Study|Adverse Event|1|||
30579180|NCT03021499|58589820|FG001|Overall Study|Adverse Event|0|||
30579181|NCT03021499|58589819|FG000|Overall Study|Death|1|||
30579182|NCT03021499|58589820|FG001|Overall Study|Death|5|||
30579183|NCT03021499|58589819|FG000|Overall Study|Lack of Efficacy|0|||
30579184|NCT03021499|58589820|FG001|Overall Study|Lack of Efficacy|1|||
30579185|NCT03021499|58589819|FG000|Overall Study|Lost to Follow-up|1|||
30579186|NCT03021499|58589820|FG001|Overall Study|Lost to Follow-up|3|||
30579187|NCT03021499|58589819|FG000|Overall Study|Physician Decision|2|||
30579188|NCT03021499|58589820|FG001|Overall Study|Physician Decision|3|||
30958697|NCT01693523|59023804|FG001|Overall Study|Death|1|||
30958698|NCT01693523|59023805|FG002|Overall Study|Death|1|||
30958699|NCT01693523|59023803|FG000|Overall Study|Lost to Follow-up|0|||
30958700|NCT01693523|59023804|FG001|Overall Study|Lost to Follow-up|0|||
30958701|NCT01693523|59023805|FG002|Overall Study|Lost to Follow-up|4|||
30958702|NCT01693523|59023803|FG000|Overall Study|Physician Decision|0|||
30579189|NCT03021499|58589819|FG000|Overall Study|Pregnancy|1|||
30579190|NCT03021499|58589820|FG001|Overall Study|Pregnancy|0|||
30579191|NCT03021499|58589819|FG000|Overall Study|Withdrawal by Subject|7|||
30579192|NCT03021499|58589820|FG001|Overall Study|Withdrawal by Subject|14|||
30579193|NCT03021499|58589819|FG000|Overall Study|Prohibited medication required|1|||
30579194|NCT03021499|58589820|FG001|Overall Study|Prohibited medication required|0|||
30579195|NCT03021499|58589819|FG000|Overall Study|Protocol non-compliance|1|||
30958703|NCT01693523|59023804|FG001|Overall Study|Physician Decision|0|||
30958704|NCT01693523|59023805|FG002|Overall Study|Physician Decision|1|||
30958705|NCT01693523|59023803|FG000|Overall Study|Withdrawal by Subject|1|||
30958706|NCT01693523|59023804|FG001|Overall Study|Withdrawal by Subject|2|||
30958707|NCT01693523|59023805|FG002|Overall Study|Withdrawal by Subject|2|||
30958708|NCT01693523|59023803|FG000|Overall Study|Lack of compliance study medication|1|||
30958709|NCT01693523|59023804|FG001|Overall Study|Lack of compliance study medication|2|||
30958710|NCT01693523|59023805|FG002|Overall Study|Lack of compliance study medication|0|||
30958711|NCT01693523|59023803|FG000|Overall Study|Chemotherapy was held|1|||
30579196|NCT03021499|58589820|FG001|Overall Study|Protocol non-compliance|1|||
30579197|NCT03021499|58589819|FG000|Overall Study|None of the above|0|||
30579198|NCT03021499|58589820|FG001|Overall Study|None of the above|4|||
30579199|NCT03021499|58589819|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
30579200|NCT03021499|58589820|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
30579201|NCT02726581|58589849|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
30579202|NCT02726581|58589850|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
30579203|NCT02726581|58589851|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
30579204|NCT02726581|58589849|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
30579205|NCT02726581|58589850|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
30579206|NCT02726581|58589851|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
30579207|NCT02726581|58589849|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
30579208|NCT02726581|58589850|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30579209|NCT02726581|58589851|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30579210|NCT02726581|58589849|FG000|Treatment Period|Disease progression|47|||
30579211|NCT02726581|58589850|FG001|Treatment Period|Disease progression|50|||
30579212|NCT02726581|58589851|FG002|Treatment Period|Disease progression|16|||
30579213|NCT02726581|58589849|FG000|Treatment Period|Other reasons|9|||
30579214|NCT02726581|58589850|FG001|Treatment Period|Other reasons|8|||
30668181|NCT00875420|58682133|FG002|Overall Study|Withdrawal by Subject|1|||
30668182|NCT00875420|58682134|FG003|Overall Study|Withdrawal by Subject|0|||
30668183|NCT00875420|58682135|FG004|Overall Study|Withdrawal by Subject|0|||
30668184|NCT00822237|58682149|FG000|Dose 1 Vaccination|Not vaccinated|3|||
30668185|NCT00822237|58682150|FG001|Dose 1 Vaccination|Not vaccinated|0|||
30668186|NCT00822237|58682149|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
30668187|NCT00822237|58682150|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
30668188|NCT00822237|58682149|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
30668189|NCT00822237|58682150|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
30668190|NCT00822237|58682149|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
30668191|NCT00822237|58682150|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
30668192|NCT00822237|58682149|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
30668193|NCT00822237|58682150|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
30668194|NCT00577096|58682157|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
30668195|NCT00577096|58682158|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
30668196|NCT00577096|58682157|FG000|Short Term Participation|Withdrawal by Subject|3|||
30668197|NCT00577096|58682158|FG001|Short Term Participation|Withdrawal by Subject|5|||
30668198|NCT00577096|58682157|FG000|Short Term Participation|Death|1|||
30668199|NCT00577096|58682158|FG001|Short Term Participation|Death|1|||
30668200|NCT00863304|58682168|FG000|Overall Study|Adverse Event|10|||
30668201|NCT00863304|58682169|FG001|Overall Study|Adverse Event|4|||
30668202|NCT00863304|58682170|FG002|Overall Study|Adverse Event|14|||
30668203|NCT00863304|58682171|FG003|Overall Study|Adverse Event|16|||
30668204|NCT00863304|58682168|FG000|Overall Study|Lost to Follow-up|1|||
30668205|NCT00863304|58682169|FG001|Overall Study|Lost to Follow-up|5|||
30668206|NCT00863304|58682170|FG002|Overall Study|Lost to Follow-up|4|||
30668207|NCT00863304|58682171|FG003|Overall Study|Lost to Follow-up|2|||
30668208|NCT00863304|58682168|FG000|Overall Study|Lack of Efficacy|57|||
30668209|NCT00863304|58682169|FG001|Overall Study|Lack of Efficacy|26|||
30668210|NCT00863304|58682170|FG002|Overall Study|Lack of Efficacy|30|||
30668211|NCT00863304|58682171|FG003|Overall Study|Lack of Efficacy|28|||
30668212|NCT00863304|58682168|FG000|Overall Study|Withdrawal by Subject|19|||
30668213|NCT00863304|58682169|FG001|Overall Study|Withdrawal by Subject|14|||
30958712|NCT01693523|59023804|FG001|Overall Study|Chemotherapy was held|2|||
30958713|NCT01693523|59023805|FG002|Overall Study|Chemotherapy was held|0|||
30958714|NCT01581593|59023821|FG000|Overall Study|Withdrawal by Subject|1|||
30668214|NCT00863304|58682170|FG002|Overall Study|Withdrawal by Subject|20|||
30668215|NCT00863304|58682171|FG003|Overall Study|Withdrawal by Subject|18|||
30668216|NCT00863304|58682168|FG000|Overall Study|Other|1|||
30668217|NCT00863304|58682169|FG001|Overall Study|Other|0|||
30668218|NCT00863304|58682170|FG002|Overall Study|Other|0|||
30668219|NCT00863304|58682171|FG003|Overall Study|Other|1|||
30579215|NCT02726581|58589851|FG002|Treatment Period|Other reasons|2|||
30579216|NCT02726581|58589849|FG000|Treatment Period|Study drug toxicity|6|||
30579217|NCT02726581|58589850|FG001|Treatment Period|Study drug toxicity|3|||
30579218|NCT02726581|58589851|FG002|Treatment Period|Study drug toxicity|2|||
30579219|NCT02726581|58589849|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
30579220|NCT02726581|58589850|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
30579221|NCT02726581|58589851|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
30579222|NCT02726581|58589849|FG000|Treatment Period|Participant withdrew consent|3|||
30579223|NCT02726581|58589850|FG001|Treatment Period|Participant withdrew consent|1|||
30579224|NCT02726581|58589851|FG002|Treatment Period|Participant withdrew consent|1|||
30579225|NCT02726581|58589849|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
30579226|NCT02726581|58589850|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
30579227|NCT02726581|58589851|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
30579228|NCT02726581|58589849|FG000|Treatment Period|Maximum clinical benefit|0|||
30579229|NCT02726581|58589850|FG001|Treatment Period|Maximum clinical benefit|2|||
30579230|NCT02726581|58589851|FG002|Treatment Period|Maximum clinical benefit|0|||
30579231|NCT02726581|58589849|FG000|Treatment Period|Death|1|||
30579232|NCT02726581|58589850|FG001|Treatment Period|Death|0|||
30579233|NCT02726581|58589851|FG002|Treatment Period|Death|0|||
30855359|NCT02592434|58882988|FG000|Double Blind Phase (26 Weeks)|Other|0|||
30855360|NCT02592434|58882989|FG001|Double Blind Phase (26 Weeks)|Other|1|||
30855361|NCT02592434|58882990|FG002|Double Blind Phase (26 Weeks)|Other|0|||
30855362|NCT02592434|58882988|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
30855363|NCT02592434|58882989|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
30579234|NCT02726581|58589849|FG000|Treatment Period|Poor/non-compliance|1|||
30579235|NCT02726581|58589850|FG001|Treatment Period|Poor/non-compliance|0|||
30579236|NCT02726581|58589851|FG002|Treatment Period|Poor/non-compliance|0|||
30579237|NCT02726581|58589849|FG000|Treatment Period|Participant no longer meets study criteria|0|||
30579238|NCT02726581|58589850|FG001|Treatment Period|Participant no longer meets study criteria|1|||
30579239|NCT02726581|58589851|FG002|Treatment Period|Participant no longer meets study criteria|0|||
30579240|NCT02700048|58589861|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
30579241|NCT02700048|58589862|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
30579242|NCT02425904|58589879|FG000|Overall Study|Lost to Follow-up|1|||
30579243|NCT02425904|58589880|FG001|Overall Study|Lost to Follow-up|0|||
30579244|NCT02425904|58589879|FG000|Overall Study|Withdrawal by Subject|2|||
30579245|NCT02425904|58589880|FG001|Overall Study|Withdrawal by Subject|0|||
30579246|NCT02425904|58589879|FG000|Overall Study|Death|0|||
30579247|NCT02425904|58589880|FG001|Overall Study|Death|3|||
30579248|NCT02097420|58589900|FG000|Overall Study|Death|4|||
30579249|NCT02097420|58589900|FG000|Overall Study|Device explanted|3|||
30579250|NCT02097420|58589900|FG000|Overall Study|Not reached 12-month visit|7|||
30579251|NCT01964989|58589906|FG000|Overall Study|Protocol Violation|3|||
30579252|NCT01964989|58589907|FG001|Overall Study|Protocol Violation|4|||
30579253|NCT01964989|58589906|FG000|Overall Study|Administrative Reason|103|||
30579254|NCT01964989|58589907|FG001|Overall Study|Administrative Reason|95|||
30579255|NCT01964989|58589906|FG000|Overall Study|Adverse Event|0|||
30579256|NCT01964989|58589907|FG001|Overall Study|Adverse Event|1|||
30579257|NCT01964989|58589906|FG000|Overall Study|Death|1|||
30579258|NCT01964989|58589907|FG001|Overall Study|Death|3|||
30579259|NCT01964989|58589906|FG000|Overall Study|Withdrawal by Subject|156|||
30579260|NCT01964989|58589907|FG001|Overall Study|Withdrawal by Subject|160|||
30579261|NCT01964989|58589906|FG000|Overall Study|Lost to Follow-up|254|||
30579262|NCT01964989|58589907|FG001|Overall Study|Lost to Follow-up|232|||
30579263|NCT01964989|58589906|FG000|Overall Study|Other|267|||
30579264|NCT01964989|58589907|FG001|Overall Study|Other|252|||
30579265|NCT01575860|58589935|FG000|Overall Study|Withdrawal by Subject|1|||
30579266|NCT01575860|58589935|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
30579267|NCT01416831|58589942|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
30579268|NCT01416831|58589943|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
30579269|NCT01064648|58589952|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
30579270|NCT01064648|58589953|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
30579271|NCT01064648|58589954|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
30579272|NCT01064648|58589955|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
30579273|NCT01064648|58589952|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
30579274|NCT01064648|58589953|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
30579275|NCT01064648|58589954|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
30579276|NCT01064648|58589955|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
30579277|NCT01064648|58589952|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
30579278|NCT01064648|58589953|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
30579279|NCT01064648|58589954|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
30855364|NCT02592434|58882990|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
30579280|NCT01064648|58589955|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
30579281|NCT01064648|58589952|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
30579282|NCT01064648|58589953|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
30855365|NCT02592434|58882988|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
30579283|NCT01064648|58589954|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
30579284|NCT01064648|58589955|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
30579285|NCT01064648|58589952|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
30579286|NCT01064648|58589953|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
30579287|NCT01064648|58589954|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
30579288|NCT01064648|58589955|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
30579289|NCT01064648|58589952|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
30579290|NCT01064648|58589953|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
30579291|NCT01064648|58589954|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
30579292|NCT01064648|58589955|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
30579293|NCT01064648|58589952|FG000|Phase II|Adverse Event|0|||
30579294|NCT01064648|58589953|FG001|Phase II|Adverse Event|0|||
30579295|NCT01064648|58589954|FG002|Phase II|Adverse Event|15|||
30579296|NCT01064648|58589955|FG003|Phase II|Adverse Event|8|||
30579297|NCT01064648|58589952|FG000|Phase II|Death|0|||
30579298|NCT01064648|58589953|FG001|Phase II|Death|0|||
30579299|NCT01064648|58589954|FG002|Phase II|Death|4|||
30579300|NCT01064648|58589955|FG003|Phase II|Death|5|||
30579301|NCT01064648|58589952|FG000|Phase II|Withdrawal by Subject|0|||
30579302|NCT01064648|58589953|FG001|Phase II|Withdrawal by Subject|0|||
30579303|NCT01064648|58589954|FG002|Phase II|Withdrawal by Subject|2|||
30579304|NCT01064648|58589955|FG003|Phase II|Withdrawal by Subject|5|||
30579305|NCT01064648|58589952|FG000|Phase II|Progression|0|||
30579306|NCT01064648|58589953|FG001|Phase II|Progression|0|||
30579307|NCT01064648|58589954|FG002|Phase II|Progression|21|||
30579308|NCT01064648|58589955|FG003|Phase II|Progression|27|||
30579309|NCT01064648|58589952|FG000|Phase II|Non-protocol specified|0|||
30579310|NCT01064648|58589953|FG001|Phase II|Non-protocol specified|0|||
30579311|NCT01064648|58589954|FG002|Phase II|Non-protocol specified|5|||
30579312|NCT01064648|58589955|FG003|Phase II|Non-protocol specified|3|||
30579313|NCT01064648|58589952|FG000|Phase II|Under Review|0|||
30579314|NCT01064648|58589953|FG001|Phase II|Under Review|0|||
30579315|NCT01064648|58589954|FG002|Phase II|Under Review|2|||
30579316|NCT01064648|58589955|FG003|Phase II|Under Review|0|||
30579317|NCT00542451|58589981|FG000|Overall Study|Adverse Event|31|||
30579318|NCT00542451|58589981|FG000|Overall Study|Withdrawal by Subject|30|||
30579319|NCT00542451|58589981|FG000|Overall Study|Physician Decision|4|||
30579320|NCT00542451|58589981|FG000|Overall Study|Recurrent disease|1|||
30579321|NCT00542451|58589981|FG000|Overall Study|unknown reason|1|||
30579322|NCT00542451|58589981|FG000|Overall Study|Death|2|||
30579323|NCT00542451|58589981|FG000|Overall Study|Lost to Follow-up|10|||
30579324|NCT00382070|58589990|FG000|Overall Study|No follow up data mapped to Other|17|||
30579325|NCT00382070|58589991|FG001|Overall Study|No follow up data mapped to Other|19|||
30579326|NCT00382070|58589990|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
30579327|NCT00382070|58589991|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
30579328|NCT00382070|58589990|FG000|Overall Study|No clinical assessment|9|||
30579329|NCT00382070|58589991|FG001|Overall Study|No clinical assessment|11|||
30579330|NCT02921269|58590014|FG000|Overall Study|Did not complete DLT period|1|||
30579331|NCT04303559|58590053|FG000|Overall Study|Study closed due to poor enrollment.|1|||
30579332|NCT03784820|58590059|FG000|Overall Study|Lost to Follow-up|5|||
30579333|NCT03784820|58590060|FG001|Overall Study|Lost to Follow-up|5|||
30579334|NCT03784820|58590061|FG002|Overall Study|Lost to Follow-up|3|||
30579335|NCT03784820|58590062|FG003|Overall Study|Lost to Follow-up|3|||
30579336|NCT03769675|58590070|FG000|Overall Study|Lost to Follow-up|1|||
30579337|NCT03729245|58590076|FG000|Overall Study|Lost to Follow-up|5|||
30579338|NCT03729245|58590077|FG001|Overall Study|Lost to Follow-up|6|||
30579339|NCT03729245|58590076|FG000|Overall Study|Withdrawal by Subject|16|||
30579340|NCT03729245|58590077|FG001|Overall Study|Withdrawal by Subject|19|||
30579341|NCT03729245|58590076|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
30579342|NCT03729245|58590077|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
30579343|NCT03311711|58590097|FG000|Overall Study|Death|1|||
30579344|NCT03311711|58590098|FG001|Overall Study|Death|0|||
30579345|NCT03311711|58590099|FG002|Overall Study|Death|0|||
30579346|NCT03311711|58590100|FG003|Overall Study|Death|0|||
30579347|NCT03311711|58590101|FG004|Overall Study|Death|0|||
30579348|NCT03311711|58590102|FG005|Overall Study|Death|0|||
30579349|NCT03311711|58590103|FG006|Overall Study|Death|1|||
30579350|NCT03311711|58590104|FG007|Overall Study|Death|0|||
30579351|NCT03311711|58590105|FG008|Overall Study|Death|1|||
30579352|NCT03311711|58590106|FG009|Overall Study|Death|0|||
30579353|NCT03311711|58590097|FG000|Overall Study|Death of dyad partner|0|||
30579354|NCT03311711|58590098|FG001|Overall Study|Death of dyad partner|1|||
30579355|NCT03311711|58590099|FG002|Overall Study|Death of dyad partner|0|||
30579356|NCT03311711|58590100|FG003|Overall Study|Death of dyad partner|0|||
30579357|NCT03311711|58590101|FG004|Overall Study|Death of dyad partner|0|||
30579358|NCT03311711|58590102|FG005|Overall Study|Death of dyad partner|0|||
30579359|NCT03311711|58590103|FG006|Overall Study|Death of dyad partner|0|||
30579360|NCT03311711|58590104|FG007|Overall Study|Death of dyad partner|1|||
30579361|NCT03311711|58590105|FG008|Overall Study|Death of dyad partner|0|||
30579362|NCT03311711|58590106|FG009|Overall Study|Death of dyad partner|1|||
30579363|NCT03311711|58590097|FG000|Overall Study|Lost to Follow-up|2|||
30579364|NCT03311711|58590098|FG001|Overall Study|Lost to Follow-up|2|||
30579365|NCT03311711|58590099|FG002|Overall Study|Lost to Follow-up|0|||
30579366|NCT03311711|58590100|FG003|Overall Study|Lost to Follow-up|0|||
30579367|NCT03311711|58590101|FG004|Overall Study|Lost to Follow-up|0|||
30579368|NCT03311711|58590102|FG005|Overall Study|Lost to Follow-up|0|||
30579369|NCT03311711|58590103|FG006|Overall Study|Lost to Follow-up|1|||
30579370|NCT03311711|58590104|FG007|Overall Study|Lost to Follow-up|1|||
30579371|NCT03311711|58590105|FG008|Overall Study|Lost to Follow-up|0|||
30579372|NCT03311711|58590106|FG009|Overall Study|Lost to Follow-up|0|||
30579373|NCT03311711|58590097|FG000|Overall Study|Withdrawal by Subject|1|||
30579374|NCT03311711|58590098|FG001|Overall Study|Withdrawal by Subject|1|||
30579375|NCT03311711|58590099|FG002|Overall Study|Withdrawal by Subject|0|||
30579376|NCT03311711|58590100|FG003|Overall Study|Withdrawal by Subject|0|||
30579377|NCT03311711|58590101|FG004|Overall Study|Withdrawal by Subject|0|||
30579378|NCT03311711|58590102|FG005|Overall Study|Withdrawal by Subject|0|||
30579379|NCT03311711|58590103|FG006|Overall Study|Withdrawal by Subject|3|||
30579380|NCT03311711|58590104|FG007|Overall Study|Withdrawal by Subject|3|||
30579381|NCT03311711|58590105|FG008|Overall Study|Withdrawal by Subject|0|||
30579382|NCT03311711|58590106|FG009|Overall Study|Withdrawal by Subject|0|||
30579383|NCT03270891|58590136|FG000|Overall Study|Lost to Follow-up|3|||
30579384|NCT03270891|58590137|FG001|Overall Study|Lost to Follow-up|6|||
30579385|NCT03270891|58590138|FG002|Overall Study|Lost to Follow-up|0|||
30579386|NCT03270891|58590136|FG000|Overall Study|Withdrawal by Subject|1|||
30579387|NCT03270891|58590137|FG001|Overall Study|Withdrawal by Subject|0|||
30579388|NCT03270891|58590138|FG002|Overall Study|Withdrawal by Subject|0|||
30579389|NCT03270891|58590136|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
30579390|NCT03270891|58590137|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
30579391|NCT03270891|58590138|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
30579392|NCT02992743|58590150|FG000|Overall Study|Withdrawal by Subject|1|||
30579393|NCT02992743|58590151|FG001|Overall Study|Withdrawal by Subject|1|||
30780318|NCT02967692|58792149|FG002|Overall Study|Lost to Follow-up|1|||
30780319|NCT02967692|58792150|FG003|Overall Study|Lost to Follow-up|0|||
30780320|NCT02967692|58792147|FG000|Overall Study|Physician Decision|0|||
30780321|NCT02967692|58792148|FG001|Overall Study|Physician Decision|0|||
30780322|NCT02967692|58792149|FG002|Overall Study|Physician Decision|13|||
30780323|NCT02967692|58792150|FG003|Overall Study|Physician Decision|9|||
30780324|NCT02967692|58792147|FG000|Overall Study|Adverse Event|1|||
30780325|NCT02967692|58792148|FG001|Overall Study|Adverse Event|9|||
30579394|NCT02992743|58590150|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
30579395|NCT02992743|58590151|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
30780326|NCT02967692|58792149|FG002|Overall Study|Adverse Event|51|||
30780327|NCT02967692|58792150|FG003|Overall Study|Adverse Event|23|||
30579396|NCT02992743|58590150|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
30579397|NCT02992743|58590151|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
30579398|NCT02992743|58590150|FG000|Overall Study|No measurable disease|1|||
30579399|NCT02992743|58590151|FG001|Overall Study|No measurable disease|0|||
30780328|NCT02642965|58792186|FG000|Overall Study|Lack of Efficacy|4|||
30780329|NCT02642965|58792186|FG000|Overall Study|Physician Decision|9|||
30780330|NCT01920932|58792200|FG000|Overall Study|Death|1|||
30780331|NCT01920932|58792200|FG000|Overall Study|Withdrawal of consent|1|||
30780332|NCT01320085|58792224|FG000|Overall Study|Treatment Ongoing|0|||
30780333|NCT01320085|58792225|FG001|Overall Study|Treatment Ongoing|13|||
30780334|NCT01320085|58792226|FG002|Overall Study|Treatment Ongoing|2|||
30780335|NCT01320085|58792224|FG000|Overall Study|Disease Progression|26|||
30780336|NCT01320085|58792225|FG001|Overall Study|Disease Progression|86|||
30780337|NCT01320085|58792226|FG002|Overall Study|Disease Progression|16|||
30780338|NCT01320085|58792224|FG000|Overall Study|Adverse Event|12|||
30780339|NCT01320085|58792225|FG001|Overall Study|Adverse Event|14|||
30780340|NCT01320085|58792226|FG002|Overall Study|Adverse Event|5|||
30780341|NCT01320085|58792224|FG000|Overall Study|Withdrawal by Subject|2|||
30780342|NCT01320085|58792225|FG001|Overall Study|Withdrawal by Subject|4|||
30780343|NCT01320085|58792226|FG002|Overall Study|Withdrawal by Subject|1|||
30780344|NCT01320085|58792224|FG000|Overall Study|Protocol Deviation|1|||
30958715|NCT01581281|59023832|FG000|Overall Study|Early Study Closure|15|||
30579400|NCT02992743|58590150|FG000|Overall Study|Lost to Follow-up|0|||
30579401|NCT02992743|58590151|FG001|Overall Study|Lost to Follow-up|1|||
30579402|NCT02853344|58590159|FG000|Overall Study|Lost to Follow-up|1|||
30579403|NCT02853344|58590160|FG001|Overall Study|Lost to Follow-up|1|||
30579404|NCT02853344|58590159|FG000|Overall Study|Withdrawal by Subject|2|||
30579405|NCT02853344|58590160|FG001|Overall Study|Withdrawal by Subject|4|||
30579406|NCT02853344|58590159|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
30579407|NCT02853344|58590160|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
30579408|NCT02853344|58590159|FG000|Overall Study|Death|70|||
30780345|NCT01320085|58792225|FG001|Overall Study|Protocol Deviation|0|||
30780346|NCT01320085|58792226|FG002|Overall Study|Protocol Deviation|1|||
30579409|NCT02853344|58590160|FG001|Overall Study|Death|112|||
30579410|NCT02739620|58590171|FG000|Overall Study|Lost to Follow-up|3|||
30579411|NCT02739620|58590172|FG001|Overall Study|Lost to Follow-up|1|||
30579412|NCT02739620|58590171|FG000|Overall Study|Adverse Event|0|||
30579413|NCT02739620|58590172|FG001|Overall Study|Adverse Event|1|||
30579414|NCT02675426|58590181|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
30579415|NCT02675426|58590182|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
30579416|NCT02675426|58590183|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
30579417|NCT02675426|58590184|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
30579418|NCT02675426|58590181|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
30579419|NCT02675426|58590182|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
30579420|NCT02675426|58590183|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
30579421|NCT02675426|58590184|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
30579422|NCT02675426|58590181|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
30579423|NCT02675426|58590182|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
30579424|NCT02675426|58590183|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
30579425|NCT02675426|58590184|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
30579426|NCT02675426|58590181|FG000|Period 1: Week 1 to Week 12|Other|2|||
30780347|NCT01038778|58792249|FG000|Overall Study|Withdrawal by Subject|0|||
30780348|NCT01038778|58792250|FG001|Overall Study|Withdrawal by Subject|2|||
30780349|NCT01038778|58792251|FG002|Overall Study|Withdrawal by Subject|3|||
30780365|NCT03443414|58792295|FG000|Overall Study|Adverse Event|6|||
30780366|NCT03443414|58792296|FG001|Overall Study|Adverse Event|0|||
30780367|NCT03443414|58792297|FG002|Overall Study|Adverse Event|4|||
30780368|NCT03443414|58792298|FG003|Overall Study|Adverse Event|2|||
30780369|NCT03443414|58792299|FG004|Overall Study|Adverse Event|3|||
30780370|NCT03443414|58792295|FG000|Overall Study|Withdrawal by Subject|3|||
30780371|NCT03443414|58792296|FG001|Overall Study|Withdrawal by Subject|2|||
30780372|NCT03443414|58792297|FG002|Overall Study|Withdrawal by Subject|2|||
30780373|NCT03443414|58792298|FG003|Overall Study|Withdrawal by Subject|2|||
30780374|NCT03443414|58792299|FG004|Overall Study|Withdrawal by Subject|1|||
30780375|NCT03443414|58792295|FG000|Overall Study|Death|0|||
30780376|NCT03443414|58792296|FG001|Overall Study|Death|1|||
30780377|NCT03443414|58792297|FG002|Overall Study|Death|0|||
30780378|NCT03443414|58792298|FG003|Overall Study|Death|1|||
30780379|NCT03443414|58792299|FG004|Overall Study|Death|0|||
30780380|NCT03443414|58792295|FG000|Overall Study|Reason not specified|2|||
30780381|NCT03443414|58792296|FG001|Overall Study|Reason not specified|0|||
30780382|NCT03443414|58792297|FG002|Overall Study|Reason not specified|0|||
30780383|NCT03443414|58792298|FG003|Overall Study|Reason not specified|0|||
30780384|NCT03443414|58792299|FG004|Overall Study|Reason not specified|1|||
30780385|NCT02991118|58792313|FG000|Overall Study|Death|3|||
30780386|NCT02991118|58792314|FG001|Overall Study|Death|8|||
30780387|NCT02991118|58792313|FG000|Overall Study|Protocol Violation|0|||
30780388|NCT02991118|58792314|FG001|Overall Study|Protocol Violation|3|||
30780389|NCT02991118|58792313|FG000|Overall Study|Physician Decision|0|||
30780390|NCT02991118|58792314|FG001|Overall Study|Physician Decision|1|||
30780391|NCT02991118|58792313|FG000|Overall Study|Moved out of the country|0|||
30579427|NCT02675426|58590182|FG001|Period 1: Week 1 to Week 12|Other|1|||
30780392|NCT02991118|58792314|FG001|Overall Study|Moved out of the country|1|||
30780393|NCT02991118|58792313|FG000|Overall Study|Adverse Event|2|||
30780394|NCT02991118|58792314|FG001|Overall Study|Adverse Event|2|||
30780395|NCT02991118|58792313|FG000|Overall Study|Withdrawal by Subject|1|||
30780396|NCT02991118|58792314|FG001|Overall Study|Withdrawal by Subject|7|||
30780397|NCT02991118|58792313|FG000|Overall Study|Could not attend study visits|0|||
30579428|NCT02675426|58590183|FG002|Period 1: Week 1 to Week 12|Other|0|||
30579429|NCT02675426|58590184|FG003|Period 1: Week 1 to Week 12|Other|2|||
30579430|NCT02675426|58590181|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
30780398|NCT02991118|58792314|FG001|Overall Study|Could not attend study visits|1|||
30780399|NCT02991118|58792313|FG000|Overall Study|Lost to Follow-up|1|||
30780400|NCT02991118|58792314|FG001|Overall Study|Lost to Follow-up|9|||
30780401|NCT03491150|58792322|FG000|Overall Study|Adverse Event|1|||
30579431|NCT02675426|58590182|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
30579432|NCT02675426|58590183|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
30579433|NCT02675426|58590184|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
30579434|NCT02675426|58590181|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
30579435|NCT02675426|58590182|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
30579436|NCT02675426|58590183|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
30579437|NCT02675426|58590184|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
30579438|NCT02675426|58590181|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
30579439|NCT02675426|58590182|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
30579440|NCT02675426|58590183|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
30579441|NCT02675426|58590184|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
30579442|NCT02675426|58590181|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
30579443|NCT02675426|58590182|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
30579444|NCT02675426|58590183|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
30579445|NCT02675426|58590184|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
30579446|NCT02675426|58590181|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
30579447|NCT02675426|58590182|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
30579448|NCT02675426|58590183|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
30579449|NCT02675426|58590184|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
30579450|NCT02675426|58590181|FG000|Period 2: Week 12 to Week 260|Other|8|||
30579451|NCT02675426|58590182|FG001|Period 2: Week 12 to Week 260|Other|12|||
30780402|NCT03491150|58792323|FG001|Overall Study|Adverse Event|0|||
30780403|NCT03491150|58792322|FG000|Overall Study|Study Terminated by Sponsor|74|||
30780404|NCT03491150|58792323|FG001|Overall Study|Study Terminated by Sponsor|70|||
30780405|NCT03491150|58792322|FG000|Overall Study|Other|0|||
30780406|NCT03491150|58792323|FG001|Overall Study|Other|1|||
30780407|NCT03491150|58792322|FG000|Overall Study|Withdrawal by Subject|1|||
30780408|NCT03491150|58792323|FG001|Overall Study|Withdrawal by Subject|2|||
30780409|NCT02991040|58792329|FG000|Overall Study|Withdrawal by Subject|2|||
30780410|NCT02991040|58792329|FG000|Overall Study|Lost to Follow-up|2|||
30780411|NCT02910466|58792335|FG000|Overall Study|Adverse Event|1|||
30780412|NCT02910466|58792335|FG000|Overall Study|Withdrawal by Subject|3|||
30780413|NCT02910466|58792335|FG000|Overall Study|Lost to Follow-up|5|||
30780414|NCT02910466|58792335|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
30780415|NCT02910466|58792335|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
30780416|NCT03415178|58792341|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
30780417|NCT03415178|58792342|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
30780418|NCT03415178|58792341|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
30780419|NCT03415178|58792342|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
30780420|NCT01068730|58792352|FG000|Period 3|Personal reason|1|||
30780421|NCT01068730|58792353|FG001|Period 3|Personal reason|0|||
30780422|NCT01068730|58792354|FG002|Period 3|Personal reason|0|||
30780423|NCT01068730|58792355|FG003|Period 3|Personal reason|0|||
30780424|NCT01068730|58792352|FG000|Period 4|Family emergency|0|||
30780425|NCT01068730|58792353|FG001|Period 4|Family emergency|1|||
30780426|NCT01068730|58792354|FG002|Period 4|Family emergency|0|||
30780427|NCT01068730|58792355|FG003|Period 4|Family emergency|0|||
30780428|NCT01068652|58792374|FG000|Overall Study|Adverse Event|4|||
30780429|NCT01068652|58792375|FG001|Overall Study|Adverse Event|0|||
30780430|NCT01068652|58792374|FG000|Overall Study|Lack of Efficacy|0|||
30780431|NCT01068652|58792375|FG001|Overall Study|Lack of Efficacy|2|||
30855366|NCT02592434|58882989|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
30958716|NCT01581281|59023833|FG001|Overall Study|Early Study Closure|6|||
30958717|NCT01581281|59023834|FG002|Overall Study|Early Study Closure|12|||
30958718|NCT02692716|59023845|FG000|Overall Study|Lost to Follow-up|2|||
30958719|NCT02692716|59023846|FG001|Overall Study|Lost to Follow-up|5|||
30958720|NCT02692716|59023845|FG000|Overall Study|Withdrawal by Subject|3|||
30958721|NCT02692716|59023846|FG001|Overall Study|Withdrawal by Subject|1|||
30958722|NCT01580969|59023855|FG000|Overall Study|Physician Decision|3|||
30958723|NCT01580969|59023856|FG001|Overall Study|Physician Decision|0|||
30958724|NCT01580969|59023857|FG002|Overall Study|Physician Decision|0|||
30958725|NCT01693367|59023867|FG000|Overall Study|Withdrawal by Subject|1|||
30958726|NCT01693367|59023868|FG001|Overall Study|Withdrawal by Subject|1|||
30958727|NCT01693367|59023867|FG000|Overall Study|Physician Decision|0|||
30958728|NCT01693367|59023868|FG001|Overall Study|Physician Decision|1|||
30958729|NCT02696226|59023878|FG000|Overall Study|Study terminated - lack of enrollment|1|||
30958730|NCT02696226|59023879|FG001|Overall Study|Study terminated - lack of enrollment|0|||
30958731|NCT02696226|59023880|FG002|Overall Study|Study terminated - lack of enrollment|2|||
30958732|NCT02696226|59023881|FG003|Overall Study|Study terminated - lack of enrollment|0|||
30780432|NCT01068652|58792374|FG000|Overall Study|Lost to Follow-up|2|||
30958733|NCT01692275|59023897|FG000|Overall Study|Lost to Follow-up|57|||
30958734|NCT01692275|59023898|FG001|Overall Study|Lost to Follow-up|48|||
30958735|NCT01692275|59023897|FG000|Overall Study|Withdrawal by Subject|9|||
30780433|NCT01068652|58792375|FG001|Overall Study|Lost to Follow-up|1|||
30780434|NCT01068652|58792374|FG000|Overall Study|Protocol Violation|3|||
30780435|NCT01068652|58792375|FG001|Overall Study|Protocol Violation|6|||
30780436|NCT01068652|58792374|FG000|Overall Study|Withdrawal criteria|1|||
30780437|NCT01068652|58792375|FG001|Overall Study|Withdrawal criteria|2|||
30780438|NCT01068652|58792374|FG000|Overall Study|Patient was not eligible|1|||
30780439|NCT01068652|58792375|FG001|Overall Study|Patient was not eligible|0|||
30780440|NCT01068652|58792374|FG000|Overall Study|Unclassified|7|||
30780441|NCT01068652|58792375|FG001|Overall Study|Unclassified|4|||
30780442|NCT02921776|58792387|FG000|Overall Study|patient deterioration, fatigue|2|||
30780443|NCT02921776|58792388|FG001|Overall Study|patient deterioration, fatigue|6|||
30780444|NCT02921776|58792389|FG002|Overall Study|patient deterioration, fatigue|0|||
30780445|NCT02921776|58792390|FG003|Overall Study|patient deterioration, fatigue|0|||
30780446|NCT02921776|58792391|FG004|Overall Study|patient deterioration, fatigue|0|||
30780447|NCT02921776|58792392|FG005|Overall Study|patient deterioration, fatigue|0|||
30780448|NCT02921776|58792393|FG006|Overall Study|patient deterioration, fatigue|0|||
30780449|NCT02921776|58792394|FG007|Overall Study|patient deterioration, fatigue|0|||
30780450|NCT02921776|58792387|FG000|Overall Study|Withdrawal by Subject|0|||
30780451|NCT02921776|58792388|FG001|Overall Study|Withdrawal by Subject|2|||
30780452|NCT02921776|58792389|FG002|Overall Study|Withdrawal by Subject|0|||
30780453|NCT02921776|58792390|FG003|Overall Study|Withdrawal by Subject|1|||
30780454|NCT02921776|58792391|FG004|Overall Study|Withdrawal by Subject|1|||
30780455|NCT02921776|58792392|FG005|Overall Study|Withdrawal by Subject|0|||
30780456|NCT02921776|58792393|FG006|Overall Study|Withdrawal by Subject|8|||
30780457|NCT02921776|58792394|FG007|Overall Study|Withdrawal by Subject|1|||
30780458|NCT02921776|58792387|FG000|Overall Study|Death|0|||
30780459|NCT02921776|58792388|FG001|Overall Study|Death|0|||
30780460|NCT02921776|58792389|FG002|Overall Study|Death|0|||
30780461|NCT02921776|58792390|FG003|Overall Study|Death|2|||
30780462|NCT02921776|58792391|FG004|Overall Study|Death|0|||
30780463|NCT02921776|58792392|FG005|Overall Study|Death|0|||
30780464|NCT02921776|58792393|FG006|Overall Study|Death|0|||
30780465|NCT02921776|58792394|FG007|Overall Study|Death|0|||
30780466|NCT02921776|58792387|FG000|Overall Study|extubation or early discharge|0|||
30780467|NCT02921776|58792388|FG001|Overall Study|extubation or early discharge|0|||
30780468|NCT02921776|58792389|FG002|Overall Study|extubation or early discharge|0|||
30780469|NCT02921776|58792390|FG003|Overall Study|extubation or early discharge|5|||
30780470|NCT02921776|58792391|FG004|Overall Study|extubation or early discharge|5|||
30780471|NCT02921776|58792392|FG005|Overall Study|extubation or early discharge|0|||
30780472|NCT02921776|58792393|FG006|Overall Study|extubation or early discharge|0|||
30780473|NCT02921776|58792394|FG007|Overall Study|extubation or early discharge|0|||
30780474|NCT02921776|58792387|FG000|Overall Study|Lost to Follow-up|0|||
30780475|NCT02921776|58792388|FG001|Overall Study|Lost to Follow-up|0|||
30780476|NCT02921776|58792389|FG002|Overall Study|Lost to Follow-up|0|||
30780477|NCT02921776|58792390|FG003|Overall Study|Lost to Follow-up|0|||
30780478|NCT02921776|58792391|FG004|Overall Study|Lost to Follow-up|0|||
30780479|NCT02921776|58792392|FG005|Overall Study|Lost to Follow-up|2|||
30579452|NCT02675426|58590183|FG002|Period 2: Week 12 to Week 260|Other|23|||
30579453|NCT02675426|58590184|FG003|Period 2: Week 12 to Week 260|Other|15|||
30579454|NCT02060721|58590225|FG000|Overall Study|Lost to Follow-up|1|||
30579455|NCT02060721|58590225|FG000|Overall Study|Physician Decision|2|||
30579456|NCT02060721|58590225|FG000|Overall Study|Death|14|||
30579457|NCT02060721|58590225|FG000|Overall Study|Withdrawal by Subject|2|||
30579458|NCT02060721|58590225|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
30579459|NCT01527149|58590229|FG000|Overall Study|Death|2|||
30579460|NCT01359956|58590237|FG000|Overall Study|Death|58|||
30579461|NCT01359956|58590238|FG001|Overall Study|Death|60|||
30579462|NCT01359956|58590239|FG002|Overall Study|Death|66|||
30579463|NCT01359956|58590240|FG003|Overall Study|Death|57|||
30579464|NCT01359956|58590237|FG000|Overall Study|Lost to Follow-up|3|||
30579465|NCT01359956|58590238|FG001|Overall Study|Lost to Follow-up|4|||
30579466|NCT01359956|58590239|FG002|Overall Study|Lost to Follow-up|1|||
30780480|NCT02921776|58792393|FG006|Overall Study|Lost to Follow-up|3|||
30780481|NCT02921776|58792394|FG007|Overall Study|Lost to Follow-up|6|||
30780482|NCT02922634|58792418|FG000|Overall Study|Withdrawal by Subject|5|||
30780483|NCT02922634|58792418|FG000|Overall Study|Did not have their surgery|5|||
30780484|NCT00023595|58792434|FG000|5 Year Follow up|Lost to Follow-up|2|||
30780485|NCT00023595|58792435|FG001|5 Year Follow up|Lost to Follow-up|2|||
30780486|NCT00023595|58792436|FG002|5 Year Follow up|Lost to Follow-up|1|||
30579467|NCT01359956|58590240|FG003|Overall Study|Lost to Follow-up|1|||
30579468|NCT01306045|58590253|FG000|Met General Eligibility Criteria|Screen failures|193|||
30780487|NCT00023595|58792437|FG003|5 Year Follow up|Lost to Follow-up|7|||
30780488|NCT00023595|58792438|FG004|5 Year Follow up|Lost to Follow-up|3|||
30579469|NCT01306045|58590254|FG001|Met General Eligibility Criteria|Screen failures|11|||
30579470|NCT01306045|58590255|FG002|Met General Eligibility Criteria|Screen failures|8|||
30579471|NCT05121480|58590304|FG000|Overall Study|Lack of Efficacy|2|||
30579472|NCT05121480|58590305|FG001|Overall Study|Lack of Efficacy|2|||
30579473|NCT05121480|58590306|FG002|Overall Study|Lack of Efficacy|1|||
30579474|NCT05121480|58590307|FG003|Overall Study|Lack of Efficacy|4|||
30579475|NCT05121480|58590308|FG004|Overall Study|Lack of Efficacy|0|||
30579476|NCT05121480|58590309|FG005|Overall Study|Lack of Efficacy|1|||
30579477|NCT05121480|58590310|FG006|Overall Study|Lack of Efficacy|0|||
30579478|NCT05121480|58590311|FG007|Overall Study|Lack of Efficacy|2|||
30579479|NCT05121480|58590304|FG000|Overall Study|Treatment Failure|0|||
30579480|NCT05121480|58590305|FG001|Overall Study|Treatment Failure|2|||
30579481|NCT05121480|58590306|FG002|Overall Study|Treatment Failure|0|||
30579482|NCT05121480|58590307|FG003|Overall Study|Treatment Failure|1|||
30579483|NCT05121480|58590308|FG004|Overall Study|Treatment Failure|0|||
30780489|NCT00023595|58792434|FG000|10 Year Follow up|Lost to Follow-up|12|||
30780490|NCT00023595|58792435|FG001|10 Year Follow up|Lost to Follow-up|10|||
30780491|NCT00023595|58792436|FG002|10 Year Follow up|Lost to Follow-up|3|||
30780492|NCT00023595|58792437|FG003|10 Year Follow up|Lost to Follow-up|0|||
30780493|NCT00023595|58792438|FG004|10 Year Follow up|Lost to Follow-up|0|||
30780494|NCT02920528|58792464|FG000|Overall Study|Incomplete Data|1|||
30579484|NCT05121480|58590309|FG005|Overall Study|Treatment Failure|0|||
30579485|NCT05121480|58590310|FG006|Overall Study|Treatment Failure|0|||
30579486|NCT05121480|58590311|FG007|Overall Study|Treatment Failure|0|||
30579487|NCT05121480|58590304|FG000|Overall Study|Adverse Event|0|||
30579488|NCT05121480|58590305|FG001|Overall Study|Adverse Event|1|||
30579489|NCT05121480|58590306|FG002|Overall Study|Adverse Event|0|||
30579490|NCT05121480|58590307|FG003|Overall Study|Adverse Event|5|||
30579491|NCT05121480|58590308|FG004|Overall Study|Adverse Event|3|||
30579492|NCT05121480|58590309|FG005|Overall Study|Adverse Event|2|||
30579493|NCT05121480|58590310|FG006|Overall Study|Adverse Event|0|||
30579494|NCT05121480|58590311|FG007|Overall Study|Adverse Event|4|||
30780495|NCT02920528|58792465|FG001|Overall Study|Incomplete Data|1|||
30780496|NCT02920528|58792466|FG002|Overall Study|Incomplete Data|1|||
30855367|NCT02592434|58882990|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
30855368|NCT02592434|58882988|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
30855369|NCT02592434|58882989|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
30855370|NCT02592434|58882990|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
30855371|NCT02785913|58882998|FG000|Overall Study|Adverse Event|5|||
30855372|NCT02785913|58882998|FG000|Overall Study|Death|2|||
30855373|NCT02785913|58882998|FG000|Overall Study|Progression|18|||
30855374|NCT02785913|58882998|FG000|Overall Study|Not protocol specified|1|||
30855375|NCT02590562|58883007|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
30855376|NCT02783729|58883034|FG000|Overall Study|Lack of Efficacy|1|||
30855377|NCT02783729|58883035|FG001|Overall Study|Lack of Efficacy|0|||
30855378|NCT02783729|58883036|FG002|Overall Study|Lack of Efficacy|0|||
30855379|NCT02783729|58883037|FG003|Overall Study|Lack of Efficacy|0|||
30855380|NCT02783729|58883034|FG000|Overall Study|Adverse Event|2|||
30855381|NCT02783729|58883035|FG001|Overall Study|Adverse Event|6|||
30855382|NCT02783729|58883036|FG002|Overall Study|Adverse Event|2|||
30855383|NCT02783729|58883037|FG003|Overall Study|Adverse Event|3|||
30958736|NCT01692275|59023898|FG001|Overall Study|Withdrawal by Subject|11|||
30855384|NCT02783729|58883034|FG000|Overall Study|Other|1|||
30855385|NCT02783729|58883035|FG001|Overall Study|Other|6|||
30855386|NCT02783729|58883036|FG002|Overall Study|Other|2|||
30855387|NCT02783729|58883037|FG003|Overall Study|Other|3|||
30855388|NCT02783729|58883034|FG000|Overall Study|Withdrawal by Subject|2|||
30855389|NCT02783729|58883035|FG001|Overall Study|Withdrawal by Subject|3|||
30855390|NCT02783729|58883036|FG002|Overall Study|Withdrawal by Subject|1|||
30958737|NCT02692560|59023918|FG000|Overall Study|Withdrawal by Subject|0|||
30780497|NCT02920528|58792464|FG000|Overall Study|Adverse Event|0|||
30780498|NCT02920528|58792465|FG001|Overall Study|Adverse Event|0|||
30780499|NCT02920528|58792466|FG002|Overall Study|Adverse Event|3|||
30780500|NCT02920528|58792464|FG000|Overall Study|Did not meet inclusion criteria|2|||
30780501|NCT02920528|58792465|FG001|Overall Study|Did not meet inclusion criteria|0|||
30780502|NCT02920528|58792466|FG002|Overall Study|Did not meet inclusion criteria|1|||
30780503|NCT01068418|58792474|FG000|Overall Study|Physician Decision|12|||
30958738|NCT02692560|59023919|FG001|Overall Study|Withdrawal by Subject|6|||
30958739|NCT02688192|59023927|FG000|Overall Study|Lost to Follow-up|11|||
30780504|NCT01068262|58792482|FG000|Overall Study|Adverse Event|2|||
30855391|NCT02783729|58883037|FG003|Overall Study|Withdrawal by Subject|2|||
30855392|NCT02783729|58883034|FG000|Overall Study|Participant's choice|2|||
30855393|NCT02783729|58883035|FG001|Overall Study|Participant's choice|1|||
30855394|NCT02783729|58883036|FG002|Overall Study|Participant's choice|2|||
30958740|NCT02688192|59023928|FG001|Overall Study|Lost to Follow-up|5|||
30579495|NCT05121480|58590304|FG000|Overall Study|Withdrawal by Subject|4|||
30579496|NCT05121480|58590305|FG001|Overall Study|Withdrawal by Subject|9|||
30579497|NCT05121480|58590306|FG002|Overall Study|Withdrawal by Subject|1|||
30579498|NCT05121480|58590307|FG003|Overall Study|Withdrawal by Subject|8|||
30579499|NCT05121480|58590308|FG004|Overall Study|Withdrawal by Subject|0|||
30579500|NCT05121480|58590309|FG005|Overall Study|Withdrawal by Subject|9|||
30855395|NCT02783729|58883037|FG003|Overall Study|Participant's choice|1|||
30855396|NCT02783729|58883034|FG000|Overall Study|Lost to Follow-up|2|||
30855397|NCT02783729|58883035|FG001|Overall Study|Lost to Follow-up|1|||
30855398|NCT02783729|58883036|FG002|Overall Study|Lost to Follow-up|1|||
30855399|NCT02783729|58883037|FG003|Overall Study|Lost to Follow-up|0|||
30855400|NCT02784431|58883059|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
30855401|NCT02784431|58883059|FG000|Overall Study|Early Study Termination|19|||
30855402|NCT02590406|58883065|FG000|Overall Study|Adverse Event|1|||
30855403|NCT02590406|58883066|FG001|Overall Study|Adverse Event|0|||
30855404|NCT02590406|58883065|FG000|Overall Study|Saturometer malfunction|0|||
30855405|NCT02590406|58883066|FG001|Overall Study|Saturometer malfunction|1|||
30855406|NCT01359254|58883074|FG000|Overall Study|Death|1|||
30855407|NCT01359254|58883075|FG001|Overall Study|Death|0|||
30780505|NCT01068262|58792483|FG001|Overall Study|Adverse Event|0|||
30780506|NCT01068262|58792484|FG002|Overall Study|Adverse Event|1|||
30780507|NCT01068262|58792485|FG003|Overall Study|Adverse Event|0|||
30780508|NCT01068262|58792482|FG000|Overall Study|Protocol Violation|1|||
30855408|NCT01667432|58883081|FG000|Overall Study|Premature Study Termination|26|||
30855409|NCT01667432|58883081|FG000|Overall Study|Failure to Return|10|||
30855410|NCT01667432|58883081|FG000|Overall Study|Moved to Another Center|3|||
30855411|NCT01667432|58883081|FG000|Overall Study|Lost to Follow-up|3|||
30855412|NCT01667432|58883081|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
30855413|NCT01667432|58883081|FG000|Overall Study|Insufficient Therapeutic Response|4|||
30855414|NCT01667432|58883081|FG000|Overall Study|Adverse Event|1|||
30855415|NCT01667432|58883081|FG000|Overall Study|Protocol Deviation|2|||
30855416|NCT01667432|58883081|FG000|Overall Study|Principal Investigator Decision|1|||
30855417|NCT01667432|58883081|FG000|Overall Study|Reason Not Specified|2|||
30855418|NCT01667432|58883081|FG000|Overall Study|Missing Information|4|||
30855419|NCT01563107|58883089|FG000|Overall Study|Physician Decision|0|||
30780509|NCT01068262|58792483|FG001|Overall Study|Protocol Violation|0|||
30780510|NCT01068262|58792484|FG002|Overall Study|Protocol Violation|0|||
30855420|NCT01563107|58883090|FG001|Overall Study|Physician Decision|1|||
30855421|NCT01563107|58883091|FG002|Overall Study|Physician Decision|1|||
30855422|NCT01563107|58883092|FG003|Overall Study|Physician Decision|3|||
30855423|NCT01563107|58883089|FG000|Overall Study|Withdrawal by Subject|1|||
30855424|NCT01563107|58883090|FG001|Overall Study|Withdrawal by Subject|2|||
30855425|NCT01563107|58883091|FG002|Overall Study|Withdrawal by Subject|1|||
30579501|NCT05121480|58590310|FG006|Overall Study|Withdrawal by Subject|0|||
30579502|NCT05121480|58590311|FG007|Overall Study|Withdrawal by Subject|4|||
30579503|NCT05121480|58590304|FG000|Overall Study|Non-compliance with the protocol|0|||
30579504|NCT05121480|58590305|FG001|Overall Study|Non-compliance with the protocol|0|||
30579505|NCT05121480|58590306|FG002|Overall Study|Non-compliance with the protocol|0|||
30579506|NCT05121480|58590307|FG003|Overall Study|Non-compliance with the protocol|0|||
30579507|NCT05121480|58590308|FG004|Overall Study|Non-compliance with the protocol|1|||
30579508|NCT05121480|58590309|FG005|Overall Study|Non-compliance with the protocol|6|||
30579509|NCT05121480|58590310|FG006|Overall Study|Non-compliance with the protocol|0|||
30579510|NCT05121480|58590311|FG007|Overall Study|Non-compliance with the protocol|1|||
30579511|NCT05121480|58590304|FG000|Overall Study|Lost to Follow-up|0|||
30579512|NCT05121480|58590305|FG001|Overall Study|Lost to Follow-up|4|||
30579513|NCT05121480|58590306|FG002|Overall Study|Lost to Follow-up|1|||
30579514|NCT05121480|58590307|FG003|Overall Study|Lost to Follow-up|3|||
30579515|NCT05121480|58590308|FG004|Overall Study|Lost to Follow-up|1|||
30579516|NCT05121480|58590309|FG005|Overall Study|Lost to Follow-up|1|||
30579517|NCT05121480|58590310|FG006|Overall Study|Lost to Follow-up|1|||
30579518|NCT05121480|58590311|FG007|Overall Study|Lost to Follow-up|4|||
30668220|NCT00863304|58682168|FG000|Overall Study|Protocol Violation|2|||
30668221|NCT00863304|58682169|FG001|Overall Study|Protocol Violation|6|||
30668222|NCT00863304|58682170|FG002|Overall Study|Protocol Violation|2|||
30668223|NCT00863304|58682171|FG003|Overall Study|Protocol Violation|0|||
30668224|NCT00863304|58682168|FG000|Overall Study|Randomized, but not Treated|3|||
30668225|NCT00863304|58682169|FG001|Overall Study|Randomized, but not Treated|1|||
30668226|NCT00863304|58682170|FG002|Overall Study|Randomized, but not Treated|4|||
30668227|NCT00863304|58682171|FG003|Overall Study|Randomized, but not Treated|1|||
30780511|NCT01068262|58792485|FG003|Overall Study|Protocol Violation|0|||
30780512|NCT01068262|58792482|FG000|Overall Study|Withdrawal by Subject|0|||
30780513|NCT01068262|58792483|FG001|Overall Study|Withdrawal by Subject|1|||
30780514|NCT01068262|58792484|FG002|Overall Study|Withdrawal by Subject|0|||
30780515|NCT01068262|58792485|FG003|Overall Study|Withdrawal by Subject|0|||
30855426|NCT01563107|58883092|FG003|Overall Study|Withdrawal by Subject|2|||
30855427|NCT02589626|58883154|FG000|Overall Study|Other than the reason specified|1|||
30855428|NCT02589626|58883155|FG001|Overall Study|Other than the reason specified|0|||
30855429|NCT02589626|58883154|FG000|Overall Study|Withdrawal by Subject|1|||
30579519|NCT05121480|58590304|FG000|Overall Study|Physician Decision|0|||
30579520|NCT05121480|58590305|FG001|Overall Study|Physician Decision|0|||
30579521|NCT05121480|58590306|FG002|Overall Study|Physician Decision|0|||
30579522|NCT05121480|58590307|FG003|Overall Study|Physician Decision|0|||
30668228|NCT00863304|58682168|FG000|Overall Study|Entered extension study|101|||
30780516|NCT02920450|58792498|FG000|Overall Study|Death|1|||
30579523|NCT05121480|58590308|FG004|Overall Study|Physician Decision|0|||
30579524|NCT05121480|58590309|FG005|Overall Study|Physician Decision|1|||
30579525|NCT05121480|58590310|FG006|Overall Study|Physician Decision|0|||
30579526|NCT05121480|58590311|FG007|Overall Study|Physician Decision|1|||
30579527|NCT05121480|58590304|FG000|Overall Study|Other Reason|0|||
30579528|NCT05121480|58590305|FG001|Overall Study|Other Reason|0|||
30579529|NCT05121480|58590306|FG002|Overall Study|Other Reason|0|||
30579530|NCT05121480|58590307|FG003|Overall Study|Other Reason|0|||
30579531|NCT05121480|58590308|FG004|Overall Study|Other Reason|0|||
30579532|NCT05121480|58590309|FG005|Overall Study|Other Reason|1|||
30579533|NCT05121480|58590310|FG006|Overall Study|Other Reason|1|||
30579534|NCT05121480|58590311|FG007|Overall Study|Other Reason|1|||
30579535|NCT04772755|58590337|FG000|Overall Study|Withdrawal by Subject|1|||
30579536|NCT04772755|58590338|FG001|Overall Study|Withdrawal by Subject|0|||
30579537|NCT04772755|58590337|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
30579538|NCT04772755|58590338|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
30579539|NCT04590040|58590348|FG000|Treatment Period|Lost to Follow-up|2|||
30579540|NCT04590040|58590349|FG001|Treatment Period|Lost to Follow-up|5|||
30579541|NCT04590040|58590350|FG002|Treatment Period|Lost to Follow-up|0|||
30579542|NCT04590040|58590348|FG000|Treatment Period|Physician Decision|0|||
30579543|NCT04590040|58590349|FG001|Treatment Period|Physician Decision|0|||
30579544|NCT04590040|58590350|FG002|Treatment Period|Physician Decision|2|||
30579545|NCT04430335|58590368|FG000|Overall Study|Withdrawal by Subject|1|||
30579546|NCT03690427|58590381|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
30579547|NCT03690427|58590382|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
30579548|NCT03658668|58590391|FG000|Overall Study|Time Commitment|1|||
30579549|NCT03658668|58590392|FG001|Overall Study|Time Commitment|1|||
30579550|NCT03469934|58590400|FG000|Overall Study|Withdrawal by Subject|0|||
30579551|NCT03469934|58590401|FG001|Overall Study|Withdrawal by Subject|1|||
30579552|NCT03004404|58590418|FG000|Period 2|Adverse Event|0|||
30579553|NCT03004404|58590419|FG001|Period 2|Adverse Event|0|||
30579554|NCT03004404|58590420|FG002|Period 2|Adverse Event|0|||
30579555|NCT03004404|58590421|FG003|Period 2|Adverse Event|0|||
30579556|NCT03004404|58590422|FG004|Period 2|Adverse Event|0|||
30579557|NCT03004404|58590423|FG005|Period 2|Adverse Event|0|||
30579558|NCT03004404|58590424|FG006|Period 2|Adverse Event|0|||
30855430|NCT02589626|58883155|FG001|Overall Study|Withdrawal by Subject|1|||
30855431|NCT02589626|58883154|FG000|Overall Study|Adverse Event|1|||
30855432|NCT02589626|58883155|FG001|Overall Study|Adverse Event|1|||
30855433|NCT01666730|58883170|FG000|Overall Study|Adverse Event|16|||
30855434|NCT01666730|58883170|FG000|Overall Study|Death|2|||
30855435|NCT01666730|58883170|FG000|Overall Study|Physician Decision|5|||
30855436|NCT01666730|58883170|FG000|Overall Study|Withdrawal by Subject|9|||
30855437|NCT01666730|58883170|FG000|Overall Study|Disease progression/relapse|18|||
30855438|NCT00103285|58883183|FG000|Induction|Adverse Event|14|||
30855439|NCT00103285|58883184|FG001|Induction|Adverse Event|0|||
30855440|NCT00103285|58883185|FG002|Induction|Adverse Event|0|||
30855441|NCT00103285|58883186|FG003|Induction|Adverse Event|0|||
30855442|NCT00103285|58883187|FG004|Induction|Adverse Event|0|||
30855443|NCT00103285|58883188|FG005|Induction|Adverse Event|0|||
30855444|NCT00103285|58883189|FG006|Induction|Adverse Event|0|||
30855445|NCT00103285|58883190|FG007|Induction|Adverse Event|0|||
30855446|NCT00103285|58883183|FG000|Induction|Death|24|||
30855447|NCT00103285|58883184|FG001|Induction|Death|0|||
30855448|NCT00103285|58883185|FG002|Induction|Death|0|||
30855449|NCT00103285|58883186|FG003|Induction|Death|0|||
30855450|NCT00103285|58883187|FG004|Induction|Death|0|||
30855451|NCT00103285|58883188|FG005|Induction|Death|0|||
30855452|NCT00103285|58883189|FG006|Induction|Death|0|||
30855453|NCT00103285|58883190|FG007|Induction|Death|0|||
30855454|NCT00103285|58883183|FG000|Induction|Physician Decision|103|||
30855455|NCT00103285|58883184|FG001|Induction|Physician Decision|0|||
30855456|NCT00103285|58883185|FG002|Induction|Physician Decision|0|||
30855457|NCT00103285|58883186|FG003|Induction|Physician Decision|0|||
30855458|NCT00103285|58883187|FG004|Induction|Physician Decision|0|||
30855459|NCT00103285|58883188|FG005|Induction|Physician Decision|0|||
30855460|NCT00103285|58883189|FG006|Induction|Physician Decision|0|||
30855461|NCT00103285|58883190|FG007|Induction|Physician Decision|0|||
30579559|NCT03004404|58590425|FG007|Period 2|Adverse Event|0|||
30579560|NCT03004404|58590426|FG008|Period 2|Adverse Event|1|||
30579561|NCT03004404|58590427|FG009|Period 2|Adverse Event|0|||
30579562|NCT03004404|58590428|FG010|Period 2|Adverse Event|0|||
30579563|NCT03004404|58590429|FG011|Period 2|Adverse Event|0|||
30579564|NCT03004404|58590430|FG012|Period 2|Adverse Event|0|||
30579565|NCT03004404|58590431|FG013|Period 2|Adverse Event|0|||
30579566|NCT03004404|58590432|FG014|Period 2|Adverse Event|0|||
30579567|NCT03004404|58590433|FG015|Period 2|Adverse Event|1|||
30855462|NCT00103285|58883183|FG000|Induction|Withdrawal by Subject|1|||
30855463|NCT00103285|58883184|FG001|Induction|Withdrawal by Subject|0|||
30855464|NCT00103285|58883185|FG002|Induction|Withdrawal by Subject|0|||
30855465|NCT00103285|58883186|FG003|Induction|Withdrawal by Subject|0|||
30855466|NCT00103285|58883187|FG004|Induction|Withdrawal by Subject|0|||
30579568|NCT02985957|58590487|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30579569|NCT02985957|58590488|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30579570|NCT02985957|58590489|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30579571|NCT02985957|58590490|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30579572|NCT02985957|58590491|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
30579573|NCT02985957|58590492|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30579574|NCT02985957|58590493|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
30579575|NCT02985957|58590487|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
30579576|NCT02985957|58590488|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
30579577|NCT02985957|58590489|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
30579578|NCT02985957|58590490|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
30579579|NCT02985957|58590491|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
30668229|NCT00863304|58682169|FG001|Overall Study|Entered extension study|129|||
30780517|NCT02920450|58792499|FG001|Overall Study|Death|0|||
30780518|NCT02920450|58792500|FG002|Overall Study|Death|0|||
30780519|NCT02920450|58792501|FG003|Overall Study|Death|0|||
30780520|NCT02920450|58792498|FG000|Overall Study|Withdrawal by Subject|1|||
30780521|NCT02920450|58792499|FG001|Overall Study|Withdrawal by Subject|0|||
30780522|NCT02920450|58792500|FG002|Overall Study|Withdrawal by Subject|0|||
30780523|NCT02920450|58792501|FG003|Overall Study|Withdrawal by Subject|0|||
30780524|NCT01066936|58792512|FG000|Overall Study|Death|2|||
30579580|NCT02985957|58590492|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
30579581|NCT02985957|58590493|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
30579582|NCT02985957|58590487|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
30579583|NCT02985957|58590488|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
30579584|NCT02985957|58590489|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
30579585|NCT02985957|58590490|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
30579586|NCT02985957|58590491|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
30579587|NCT02985957|58590492|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
30579588|NCT02985957|58590493|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
30579589|NCT02985957|58590487|FG000|Treatment Period|Death|0|||
30579590|NCT02985957|58590488|FG001|Treatment Period|Death|0|||
30579591|NCT02985957|58590489|FG002|Treatment Period|Death|0|||
30579592|NCT02985957|58590490|FG003|Treatment Period|Death|0|||
30579593|NCT02985957|58590491|FG004|Treatment Period|Death|1|||
30579594|NCT02985957|58590492|FG005|Treatment Period|Death|0|||
30579595|NCT02985957|58590493|FG006|Treatment Period|Death|0|||
30579596|NCT02985957|58590487|FG000|Treatment Period|Participant withdrew consent|0|||
30579597|NCT02985957|58590488|FG001|Treatment Period|Participant withdrew consent|0|||
30579598|NCT02985957|58590489|FG002|Treatment Period|Participant withdrew consent|0|||
30579599|NCT02985957|58590490|FG003|Treatment Period|Participant withdrew consent|1|||
30579600|NCT02985957|58590491|FG004|Treatment Period|Participant withdrew consent|3|||
30579601|NCT02985957|58590492|FG005|Treatment Period|Participant withdrew consent|0|||
30579602|NCT02985957|58590493|FG006|Treatment Period|Participant withdrew consent|1|||
30780525|NCT01066936|58792512|FG000|Overall Study|Device revised/removed|1|||
30780526|NCT01066936|58792512|FG000|Overall Study|Lost to Follow-up|3|||
30780527|NCT01066936|58792512|FG000|Overall Study|Withdrawal by Subject|4|||
30780528|NCT02919436|58792520|FG000|Overall Study|Did not undergo surgery|16|||
30780529|NCT02919436|58792521|FG001|Overall Study|Did not undergo surgery|20|||
30780530|NCT02919436|58792520|FG000|Overall Study|Enrolled before trial registration|44|||
30780531|NCT02919436|58792521|FG001|Overall Study|Enrolled before trial registration|33|||
30780532|NCT03804879|58792531|FG000|Overall Study|Adverse Event|3|||
30780533|NCT03804879|58792532|FG001|Overall Study|Adverse Event|0|||
30780534|NCT03804879|58792531|FG000|Overall Study|Study Terminated By Sponsor|10|||
30780535|NCT03804879|58792532|FG001|Overall Study|Study Terminated By Sponsor|12|||
30780536|NCT03804879|58792531|FG000|Overall Study|Withdrawal by Subject|3|||
30780537|NCT03804879|58792532|FG001|Overall Study|Withdrawal by Subject|1|||
30780538|NCT03803475|58792539|FG000|Overall Study|Physician Decision|1|||
30780539|NCT00005937|58792543|FG000|Overall Study|Lack of Efficacy|5|||
30780540|NCT03443024|58792551|FG000|Overall Study|Adverse Event|2|||
30780541|NCT03443024|58792552|FG001|Overall Study|Adverse Event|4|||
30780542|NCT03443024|58792553|FG002|Overall Study|Adverse Event|3|||
30780543|NCT03443024|58792554|FG003|Overall Study|Adverse Event|1|||
30780544|NCT03443024|58792551|FG000|Overall Study|Lost to Follow-up|9|||
30780545|NCT03443024|58792552|FG001|Overall Study|Lost to Follow-up|9|||
30780546|NCT03443024|58792553|FG002|Overall Study|Lost to Follow-up|7|||
30780547|NCT03443024|58792554|FG003|Overall Study|Lost to Follow-up|5|||
30780548|NCT03443024|58792551|FG000|Overall Study|Withdrawal by Subject|8|||
30579603|NCT02985957|58590487|FG000|Treatment Period|Lost to Follow-up|0|||
30579604|NCT02985957|58590488|FG001|Treatment Period|Lost to Follow-up|0|||
30579605|NCT02985957|58590489|FG002|Treatment Period|Lost to Follow-up|0|||
30579606|NCT02985957|58590490|FG003|Treatment Period|Lost to Follow-up|0|||
30579607|NCT02985957|58590491|FG004|Treatment Period|Lost to Follow-up|1|||
30855467|NCT00103285|58883188|FG005|Induction|Withdrawal by Subject|0|||
30579608|NCT02985957|58590492|FG005|Treatment Period|Lost to Follow-up|0|||
30579609|NCT02985957|58590493|FG006|Treatment Period|Lost to Follow-up|0|||
30579610|NCT02985957|58590487|FG000|Treatment Period|Other reasons|0|||
30579611|NCT02985957|58590488|FG001|Treatment Period|Other reasons|0|||
30579612|NCT02985957|58590489|FG002|Treatment Period|Other reasons|1|||
30579613|NCT02985957|58590490|FG003|Treatment Period|Other reasons|3|||
30579614|NCT02985957|58590491|FG004|Treatment Period|Other reasons|6|||
30579615|NCT02985957|58590492|FG005|Treatment Period|Other reasons|0|||
30579616|NCT02985957|58590493|FG006|Treatment Period|Other reasons|1|||
30579617|NCT02985957|58590487|FG000|Treatment Period|Not reported|0|||
30579618|NCT02985957|58590488|FG001|Treatment Period|Not reported|1|||
30579619|NCT02985957|58590489|FG002|Treatment Period|Not reported|2|||
30579620|NCT02985957|58590490|FG003|Treatment Period|Not reported|5|||
30579621|NCT02985957|58590491|FG004|Treatment Period|Not reported|0|||
30579622|NCT02985957|58590492|FG005|Treatment Period|Not reported|0|||
30579623|NCT02985957|58590493|FG006|Treatment Period|Not reported|0|||
30579624|NCT02985957|58590487|FG000|Treatment Period|Maximum clinical benefit|0|||
30579625|NCT02985957|58590488|FG001|Treatment Period|Maximum clinical benefit|0|||
30579626|NCT02985957|58590489|FG002|Treatment Period|Maximum clinical benefit|1|||
30579627|NCT02985957|58590490|FG003|Treatment Period|Maximum clinical benefit|1|||
30579628|NCT02985957|58590491|FG004|Treatment Period|Maximum clinical benefit|0|||
30579629|NCT02985957|58590492|FG005|Treatment Period|Maximum clinical benefit|0|||
30579630|NCT02985957|58590493|FG006|Treatment Period|Maximum clinical benefit|2|||
30579631|NCT02985957|58590487|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
30579632|NCT02985957|58590488|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
30579633|NCT02985957|58590489|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
30579634|NCT02985957|58590490|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
30579635|NCT02985957|58590491|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
30579636|NCT02985957|58590492|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
30579637|NCT02985957|58590493|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
30579638|NCT02985957|58590487|FG000|Treatment Period|Study drug toxicity|1|||
30579639|NCT02985957|58590488|FG001|Treatment Period|Study drug toxicity|23|||
30579640|NCT02985957|58590489|FG002|Treatment Period|Study drug toxicity|20|||
30579641|NCT02985957|58590490|FG003|Treatment Period|Study drug toxicity|11|||
30780549|NCT03443024|58792552|FG001|Overall Study|Withdrawal by Subject|15|||
30780550|NCT03443024|58792553|FG002|Overall Study|Withdrawal by Subject|9|||
30780551|NCT03443024|58792554|FG003|Overall Study|Withdrawal by Subject|23|||
30780552|NCT03443024|58792551|FG000|Overall Study|Physician Decision|1|||
30780553|NCT03443024|58792552|FG001|Overall Study|Physician Decision|2|||
30780554|NCT03443024|58792553|FG002|Overall Study|Physician Decision|0|||
30780555|NCT03443024|58792554|FG003|Overall Study|Physician Decision|1|||
30780556|NCT03443024|58792551|FG000|Overall Study|Sponsor Decision|1|||
30780557|NCT03443024|58792552|FG001|Overall Study|Sponsor Decision|1|||
30780558|NCT03443024|58792553|FG002|Overall Study|Sponsor Decision|0|||
30780559|NCT03443024|58792554|FG003|Overall Study|Sponsor Decision|0|||
30855468|NCT00103285|58883189|FG006|Induction|Withdrawal by Subject|0|||
30855469|NCT00103285|58883190|FG007|Induction|Withdrawal by Subject|0|||
30855470|NCT00103285|58883183|FG000|Induction|Ineligible|43|||
30855471|NCT00103285|58883184|FG001|Induction|Ineligible|0|||
30855472|NCT00103285|58883185|FG002|Induction|Ineligible|0|||
30855473|NCT00103285|58883186|FG003|Induction|Ineligible|0|||
30855474|NCT00103285|58883187|FG004|Induction|Ineligible|0|||
30855475|NCT00103285|58883188|FG005|Induction|Ineligible|0|||
30855476|NCT00103285|58883189|FG006|Induction|Ineligible|0|||
30855477|NCT00103285|58883190|FG007|Induction|Ineligible|0|||
30855478|NCT00103285|58883183|FG000|Induction|Refusal|906|||
30855479|NCT00103285|58883184|FG001|Induction|Refusal|0|||
30855480|NCT00103285|58883185|FG002|Induction|Refusal|0|||
30855481|NCT00103285|58883186|FG003|Induction|Refusal|0|||
30855482|NCT00103285|58883187|FG004|Induction|Refusal|0|||
30855483|NCT00103285|58883188|FG005|Induction|Refusal|0|||
30855484|NCT00103285|58883189|FG006|Induction|Refusal|0|||
30855485|NCT00103285|58883190|FG007|Induction|Refusal|0|||
30855486|NCT00103285|58883183|FG000|Induction|Other|258|||
30780560|NCT03443024|58792551|FG000|Overall Study|Protocol Deviation|0|||
30780561|NCT03443024|58792552|FG001|Overall Study|Protocol Deviation|0|||
30780562|NCT03443024|58792553|FG002|Overall Study|Protocol Deviation|0|||
30855487|NCT00103285|58883184|FG001|Induction|Other|0|||
30855488|NCT00103285|58883185|FG002|Induction|Other|0|||
30855489|NCT00103285|58883186|FG003|Induction|Other|0|||
30855490|NCT00103285|58883187|FG004|Induction|Other|0|||
30855491|NCT00103285|58883188|FG005|Induction|Other|0|||
30855492|NCT00103285|58883189|FG006|Induction|Other|0|||
30579642|NCT02985957|58590491|FG004|Treatment Period|Study drug toxicity|19|||
30579643|NCT02985957|58590492|FG005|Treatment Period|Study drug toxicity|3|||
30780563|NCT03443024|58792554|FG003|Overall Study|Protocol Deviation|2|||
30855493|NCT00103285|58883190|FG007|Induction|Other|0|||
30855494|NCT00103285|58883183|FG000|Response Assignment|Adverse Event|0|||
30855495|NCT00103285|58883184|FG001|Response Assignment|Adverse Event|8|||
30855496|NCT00103285|58883185|FG002|Response Assignment|Adverse Event|3|||
30855497|NCT00103285|58883186|FG003|Response Assignment|Adverse Event|2|||
30780564|NCT02908516|58792566|FG000|Overall Study|Study Terminated|3|||
30780565|NCT02908516|58792567|FG001|Overall Study|Study Terminated|3|||
30780566|NCT02907892|58792575|FG000|Overall Study|Lost to Follow-up|27|||
30780567|NCT02907892|58792576|FG001|Overall Study|Lost to Follow-up|40|||
30780568|NCT02906644|58792584|FG000|First 2 Weeks|Withdrawal by Subject|0|||
30780569|NCT02906644|58792585|FG001|First 2 Weeks|Withdrawal by Subject|2|||
30780570|NCT02906644|58792584|FG000|First 2 Weeks|Physician Decision|1|||
30780571|NCT02906644|58792585|FG001|First 2 Weeks|Physician Decision|1|||
30780572|NCT02906644|58792584|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
30780573|NCT02906644|58792585|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
30780574|NCT02906644|58792584|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
30780575|NCT02906644|58792585|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
30780576|NCT03410108|58792592|FG000|Overall Study|Ongoing|41|||
30780577|NCT03410108|58792592|FG000|Overall Study|Adverse Event|4|||
30780578|NCT03410108|58792592|FG000|Overall Study|Progressive Disease|58|||
30780579|NCT03410108|58792592|FG000|Overall Study|Withdrawal by Subject|1|||
30780580|NCT02982772|58792601|FG000|Intervention|Lost to Follow-up|19|||
30780581|NCT02982772|58792602|FG001|Intervention|Lost to Follow-up|13|||
30780582|NCT02982772|58792601|FG000|1M Follow-Up|Lost to Follow-up|21|||
30780583|NCT02982772|58792602|FG001|1M Follow-Up|Lost to Follow-up|18|||
30780584|NCT02982772|58792601|FG000|3M Follow-Up|Lost to Follow-up|17|||
30780585|NCT02982772|58792602|FG001|3M Follow-Up|Lost to Follow-up|11|||
30780586|NCT02982772|58792601|FG000|6M Follow-Up|Lost to Follow-up|11|||
30780587|NCT02982772|58792602|FG001|6M Follow-Up|Lost to Follow-up|9|||
30780588|NCT02982772|58792601|FG000|12M Follow-Up|Lost to Follow-up|11|||
30780589|NCT02982772|58792602|FG001|12M Follow-Up|Lost to Follow-up|5|||
30780590|NCT03488108|58792612|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
30780591|NCT03488108|58792613|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
30780592|NCT03488108|58792612|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
30780593|NCT03488108|58792613|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
30780594|NCT03440918|58792623|FG000|Overall Study|Protocol Violation|0|||
30780595|NCT03440918|58792624|FG001|Overall Study|Protocol Violation|16|||
30780596|NCT03486392|58792635|FG000|Overall Study|Lost to Follow-up|0|||
30780597|NCT03486392|58792636|FG001|Overall Study|Lost to Follow-up|0|||
30780598|NCT03486392|58792637|FG002|Overall Study|Lost to Follow-up|8|||
30780599|NCT03486392|58792638|FG003|Overall Study|Lost to Follow-up|5|||
30780600|NCT03486392|58792639|FG004|Overall Study|Lost to Follow-up|2|||
30780601|NCT03486392|58792635|FG000|Overall Study|Withdrawal by Subject|3|||
30780602|NCT03486392|58792636|FG001|Overall Study|Withdrawal by Subject|0|||
30780603|NCT03486392|58792637|FG002|Overall Study|Withdrawal by Subject|6|||
30780604|NCT03486392|58792638|FG003|Overall Study|Withdrawal by Subject|4|||
30780605|NCT03486392|58792639|FG004|Overall Study|Withdrawal by Subject|1|||
30780606|NCT03486392|58792635|FG000|Overall Study|Death|0|||
30780607|NCT03486392|58792636|FG001|Overall Study|Death|0|||
30780608|NCT03486392|58792637|FG002|Overall Study|Death|0|||
30780609|NCT03486392|58792638|FG003|Overall Study|Death|0|||
30780610|NCT03486392|58792639|FG004|Overall Study|Death|1|||
30780611|NCT02981602|58792656|FG000|Overall Study|Adverse Event|0|||
30780612|NCT02981602|58792657|FG001|Overall Study|Adverse Event|0|||
30780613|NCT02981602|58792658|FG002|Overall Study|Adverse Event|0|||
30780614|NCT02981602|58792659|FG003|Overall Study|Adverse Event|1|||
30780615|NCT02981602|58792660|FG004|Overall Study|Adverse Event|0|||
30780616|NCT02981524|58792673|FG000|Overall Study|Progressive Disease|14|||
30780617|NCT02981524|58792673|FG000|Overall Study|Death (unrelated)|1|||
30668230|NCT00863304|58682170|FG002|Overall Study|Entered extension study|113|||
30668231|NCT00863304|58682171|FG003|Overall Study|Entered extension study|125|||
30668232|NCT00695110|58682183|FG000|Treatment Period 1|Adverse Event|1|||
30780618|NCT02981524|58792673|FG000|Overall Study|Treatment Related Toxicity|1|||
30780619|NCT02981524|58792673|FG000|Overall Study|Withdrawal by Subject|1|||
30780620|NCT03486314|58792677|FG000|Part A|Adverse Event|1|||
30780621|NCT03486314|58792678|FG001|Part A|Adverse Event|0|||
30579644|NCT02985957|58590493|FG006|Treatment Period|Study drug toxicity|5|||
30579645|NCT02985957|58590487|FG000|Treatment Period|Disease progression|0|||
30579646|NCT02985957|58590488|FG001|Treatment Period|Disease progression|16|||
30579647|NCT02985957|58590489|FG002|Treatment Period|Disease progression|20|||
30579648|NCT02985957|58590490|FG003|Treatment Period|Disease progression|39|||
30579649|NCT02985957|58590491|FG004|Treatment Period|Disease progression|29|||
30579650|NCT02985957|58590492|FG005|Treatment Period|Disease progression|11|||
30579651|NCT02985957|58590493|FG006|Treatment Period|Disease progression|28|||
30579652|NCT02985957|58590487|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
30579653|NCT02985957|58590488|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
30579654|NCT02985957|58590489|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
30668233|NCT00695110|58682183|FG000|Treatment Period 1|Withdrawal by Subject|2|||
30780622|NCT03486314|58792679|FG002|Part A|Adverse Event|0|||
30780623|NCT03486314|58792677|FG000|Part A|Symptomatic Deterioration|2|||
30780624|NCT03486314|58792678|FG001|Part A|Symptomatic Deterioration|0|||
30780625|NCT03486314|58792679|FG002|Part A|Symptomatic Deterioration|0|||
30780626|NCT02905006|58792693|FG000|Overall Study|Adverse Event|1|||
30780627|NCT02905006|58792694|FG001|Overall Study|Adverse Event|1|||
30780628|NCT02905006|58792695|FG002|Overall Study|Adverse Event|1|||
30780629|NCT02905006|58792696|FG003|Overall Study|Adverse Event|1|||
30780630|NCT02905006|58792697|FG004|Overall Study|Adverse Event|0|||
30780631|NCT02905006|58792698|FG005|Overall Study|Adverse Event|1|||
30780632|NCT02905006|58792693|FG000|Overall Study|Lack of Efficacy|1|||
30780633|NCT02905006|58792694|FG001|Overall Study|Lack of Efficacy|0|||
30780634|NCT02905006|58792695|FG002|Overall Study|Lack of Efficacy|0|||
30780635|NCT02905006|58792696|FG003|Overall Study|Lack of Efficacy|0|||
30780636|NCT02905006|58792697|FG004|Overall Study|Lack of Efficacy|0|||
30780637|NCT02905006|58792698|FG005|Overall Study|Lack of Efficacy|0|||
30780638|NCT02905006|58792693|FG000|Overall Study|Protocol Violation|2|||
30780639|NCT02905006|58792694|FG001|Overall Study|Protocol Violation|0|||
30780640|NCT02905006|58792695|FG002|Overall Study|Protocol Violation|0|||
30780641|NCT02905006|58792696|FG003|Overall Study|Protocol Violation|0|||
30780642|NCT02905006|58792697|FG004|Overall Study|Protocol Violation|0|||
30780643|NCT02905006|58792698|FG005|Overall Study|Protocol Violation|0|||
30780644|NCT02905006|58792693|FG000|Overall Study|Lost to Follow-up|0|||
30780645|NCT02905006|58792694|FG001|Overall Study|Lost to Follow-up|0|||
30780646|NCT02905006|58792695|FG002|Overall Study|Lost to Follow-up|0|||
30780647|NCT02905006|58792696|FG003|Overall Study|Lost to Follow-up|1|||
30780648|NCT02905006|58792697|FG004|Overall Study|Lost to Follow-up|1|||
30780649|NCT02905006|58792698|FG005|Overall Study|Lost to Follow-up|0|||
30780650|NCT02905006|58792693|FG000|Overall Study|Withdrawal by Subject|0|||
30780651|NCT02905006|58792694|FG001|Overall Study|Withdrawal by Subject|0|||
30780652|NCT02905006|58792695|FG002|Overall Study|Withdrawal by Subject|1|||
30780653|NCT02905006|58792696|FG003|Overall Study|Withdrawal by Subject|1|||
30780654|NCT02905006|58792697|FG004|Overall Study|Withdrawal by Subject|0|||
30780655|NCT02905006|58792698|FG005|Overall Study|Withdrawal by Subject|1|||
30780656|NCT02905006|58792693|FG000|Overall Study|Screening exclusion criteria met|1|||
30780657|NCT02905006|58792694|FG001|Overall Study|Screening exclusion criteria met|0|||
30780658|NCT02905006|58792695|FG002|Overall Study|Screening exclusion criteria met|0|||
30780659|NCT02905006|58792696|FG003|Overall Study|Screening exclusion criteria met|0|||
30780660|NCT02905006|58792697|FG004|Overall Study|Screening exclusion criteria met|0|||
30780661|NCT02905006|58792698|FG005|Overall Study|Screening exclusion criteria met|0|||
30780662|NCT02905006|58792693|FG000|Overall Study|Lab withdrawal criterion met|0|||
30780663|NCT02905006|58792694|FG001|Overall Study|Lab withdrawal criterion met|1|||
30780664|NCT02905006|58792695|FG002|Overall Study|Lab withdrawal criterion met|2|||
30780665|NCT02905006|58792696|FG003|Overall Study|Lab withdrawal criterion met|2|||
30780666|NCT02905006|58792697|FG004|Overall Study|Lab withdrawal criterion met|2|||
30780667|NCT02905006|58792698|FG005|Overall Study|Lab withdrawal criterion met|1|||
30780668|NCT02905006|58792693|FG000|Overall Study|Positive for Tuberculosis|0|||
30780669|NCT02905006|58792694|FG001|Overall Study|Positive for Tuberculosis|1|||
30780670|NCT02905006|58792695|FG002|Overall Study|Positive for Tuberculosis|0|||
30780671|NCT02905006|58792696|FG003|Overall Study|Positive for Tuberculosis|0|||
30780672|NCT02905006|58792697|FG004|Overall Study|Positive for Tuberculosis|0|||
30780673|NCT02905006|58792698|FG005|Overall Study|Positive for Tuberculosis|0|||
30780674|NCT02905006|58792693|FG000|Overall Study|Subject positive for Hep B|0|||
30780675|NCT02905006|58792694|FG001|Overall Study|Subject positive for Hep B|0|||
30780676|NCT02905006|58792695|FG002|Overall Study|Subject positive for Hep B|1|||
30780677|NCT02905006|58792696|FG003|Overall Study|Subject positive for Hep B|0|||
30780678|NCT02905006|58792697|FG004|Overall Study|Subject positive for Hep B|0|||
30780679|NCT02905006|58792698|FG005|Overall Study|Subject positive for Hep B|0|||
30780680|NCT02905006|58792693|FG000|Overall Study|Patient moved abroad|0|||
30780681|NCT02905006|58792694|FG001|Overall Study|Patient moved abroad|0|||
30780682|NCT02905006|58792695|FG002|Overall Study|Patient moved abroad|0|||
30780683|NCT02905006|58792696|FG003|Overall Study|Patient moved abroad|1|||
30780684|NCT02905006|58792697|FG004|Overall Study|Patient moved abroad|0|||
30780685|NCT02905006|58792698|FG005|Overall Study|Patient moved abroad|0|||
30780686|NCT02905006|58792693|FG000|Overall Study|Patient randomized by mistake|0|||
30780687|NCT02905006|58792694|FG001|Overall Study|Patient randomized by mistake|0|||
30780688|NCT02905006|58792695|FG002|Overall Study|Patient randomized by mistake|0|||
30780689|NCT02905006|58792696|FG003|Overall Study|Patient randomized by mistake|0|||
30780690|NCT02905006|58792697|FG004|Overall Study|Patient randomized by mistake|0|||
30780691|NCT02905006|58792698|FG005|Overall Study|Patient randomized by mistake|1|||
30780692|NCT01066780|58792736|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
30780693|NCT01066780|58792737|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
30780694|NCT02975206|58792744|FG000|Overall Study|Withdrawal by Subject|14|||
30579655|NCT02985957|58590490|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
30780695|NCT02975206|58792745|FG001|Overall Study|Withdrawal by Subject|11|||
30780696|NCT02975206|58792746|FG002|Overall Study|Withdrawal by Subject|11|||
30780697|NCT02975206|58792744|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
30780698|NCT02975206|58792745|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
30780699|NCT02975206|58792746|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
30780700|NCT01066156|58792754|FG000|Overall Study|ineligible|2|||
30780701|NCT01066156|58792754|FG000|Overall Study|Lost to Follow-up|7|||
30780702|NCT01066156|58792754|FG000|Overall Study|Withdrawal by Subject|1|||
30780703|NCT02980042|58792760|FG000|Overall Study|Lost to Follow-up|5|||
30780704|NCT02980042|58792761|FG001|Overall Study|Lost to Follow-up|0|||
30780705|NCT02980042|58792760|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
30780706|NCT02980042|58792761|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
30780707|NCT01066000|58792779|FG000|Overall Study|Protocol Violation|4|||
30780708|NCT01066000|58792779|FG000|Overall Study|Death|3|||
30780709|NCT01066000|58792779|FG000|Overall Study|Withdrawal by Subject|1|||
30780710|NCT01066000|58792779|FG000|Overall Study|Adverse Event|1|||
30780711|NCT01065844|58792783|FG000|Overall Study|Adverse Event|5|||
30780712|NCT00004635|58792789|FG000|Period One|refused|2|||
30780713|NCT00004635|58792790|FG001|Period One|refused|1|||
30780714|NCT00004635|58792789|FG000|Period One|Withdrawal by Subject|1|||
30780715|NCT00004635|58792790|FG001|Period One|Withdrawal by Subject|1|||
30780716|NCT00004635|58792789|FG000|Period One|Protocol Violation|1|||
30780717|NCT00004635|58792790|FG001|Period One|Protocol Violation|0|||
30780718|NCT00004635|58792789|FG000|Period One|PSA did not go <5 ng/mL|1|||
30780719|NCT00004635|58792790|FG001|Period One|PSA did not go <5 ng/mL|0|||
30780720|NCT00004635|58792789|FG000|Period One|second malignancy|1|||
30780721|NCT00004635|58792790|FG001|Period One|second malignancy|0|||
30780722|NCT00004635|58792789|FG000|Period One|progressed|0|||
30780723|NCT00004635|58792790|FG001|Period One|progressed|2|||
30780724|NCT00004635|58792789|FG000|Period One|health problem|0|||
30780725|NCT00004635|58792790|FG001|Period One|health problem|1|||
30780726|NCT00004635|58792789|FG000|Period One|discrepancy in data entry|0|||
30780727|NCT00004635|58792790|FG001|Period One|discrepancy in data entry|1|||
30780728|NCT00004635|58792789|FG000|Period Two|progression|2|||
30780729|NCT00004635|58792790|FG001|Period Two|progression|3|||
30780730|NCT00004635|58792789|FG000|Period Two|Adverse Event|1|||
30780731|NCT00004635|58792790|FG001|Period Two|Adverse Event|0|||
30780732|NCT00004635|58792789|FG000|Period Two|refused|0|||
30780733|NCT00004635|58792790|FG001|Period Two|refused|2|||
30780734|NCT00004635|58792789|FG000|Period Two|health problem|1|||
30780735|NCT00004635|58792790|FG001|Period Two|health problem|1|||
30780736|NCT00004635|58792789|FG000|Period Two|travel issues|0|||
30780737|NCT00004635|58792790|FG001|Period Two|travel issues|1|||
30780738|NCT00004635|58792789|FG000|Period Two|secondary malignancy|1|||
30780739|NCT00004635|58792790|FG001|Period Two|secondary malignancy|1|||
30780740|NCT00004635|58792789|FG000|Period Two|Lost to Follow-up|1|||
30780741|NCT00004635|58792790|FG001|Period Two|Lost to Follow-up|0|||
30780742|NCT00004635|58792789|FG000|Period Two|discrepancy in data entry|0|||
30780743|NCT00004635|58792790|FG001|Period Two|discrepancy in data entry|1|||
30780744|NCT00004563|58792801|FG000|Overall Study|Withdrawal by Subject|20|||
30780745|NCT00004563|58792802|FG001|Overall Study|Withdrawal by Subject|16|||
30780746|NCT00004563|58792801|FG000|Overall Study|Lack of Efficacy|3|||
30780747|NCT00004563|58792802|FG001|Overall Study|Lack of Efficacy|5|||
30780748|NCT00004563|58792801|FG000|Overall Study|Death|2|||
30780749|NCT00004563|58792802|FG001|Overall Study|Death|3|||
30780750|NCT00003645|58792810|FG000|Overall Study|Death|4|||
30780751|NCT00003645|58792811|FG001|Overall Study|Death|1|||
30780752|NCT00003645|58792810|FG000|Overall Study|Lost to Follow-up|7|||
30780753|NCT00003645|58792811|FG001|Overall Study|Lost to Follow-up|8|||
30780754|NCT00003645|58792810|FG000|Overall Study|Withdrawal by Subject|1|||
30780755|NCT00003645|58792811|FG001|Overall Study|Withdrawal by Subject|3|||
30780756|NCT00003537|58792819|FG000|Overall Study|Not evalauable|1|||
30780757|NCT00003531|58792823|FG000|Overall Study|Not evaluable|10|||
30780758|NCT02918968|58792829|FG000|1st Line AAT|Progressive disease|9|||
30780759|NCT02918968|58792830|FG001|1st Line AAT|Progressive disease|4|||
30780760|NCT02918968|58792829|FG000|1st Line AAT|Adverse Event|12|||
30780761|NCT02918968|58792830|FG001|1st Line AAT|Adverse Event|3|||
30780762|NCT02918968|58792829|FG000|1st Line AAT|Physician Decision|4|||
30780763|NCT02918968|58792830|FG001|1st Line AAT|Physician Decision|2|||
30780764|NCT02918968|58792829|FG000|1st Line AAT|Withdrawal by Subject|2|||
30780765|NCT02918968|58792830|FG001|1st Line AAT|Withdrawal by Subject|1|||
30780766|NCT02918968|58792829|FG000|1st Line AAT|Lost to Follow-up|0|||
30780767|NCT02918968|58792830|FG001|1st Line AAT|Lost to Follow-up|1|||
30780768|NCT02918968|58792829|FG000|1st Line AAT|Death|1|||
30780769|NCT02918968|58792830|FG001|1st Line AAT|Death|0|||
30780770|NCT02918968|58792829|FG000|1st Line AAT|Miscellaneous|1|||
30780771|NCT02918968|58792830|FG001|1st Line AAT|Miscellaneous|0|||
30780772|NCT02918968|58792829|FG000|2nd Line AAT|Progressive disease|21|||
30780773|NCT02918968|58792830|FG001|2nd Line AAT|Progressive disease|3|||
30780774|NCT02918968|58792829|FG000|2nd Line AAT|Adverse Event|2|||
30780775|NCT02918968|58792830|FG001|2nd Line AAT|Adverse Event|5|||
30780776|NCT02918968|58792829|FG000|2nd Line AAT|Physician Decision|0|||
30780777|NCT02918968|58792830|FG001|2nd Line AAT|Physician Decision|1|||
30780778|NCT02918968|58792829|FG000|2nd Line AAT|Withdrawal by Subject|2|||
30780779|NCT02918968|58792830|FG001|2nd Line AAT|Withdrawal by Subject|2|||
30780780|NCT02918968|58792829|FG000|2nd Line AAT|Death|0|||
30780781|NCT02918968|58792830|FG001|2nd Line AAT|Death|1|||
30780782|NCT01065766|58792838|FG000|Overall Study|Assessed before the contracted date|1|||
30780783|NCT01065766|58792838|FG000|Overall Study|Contraindication to administration|6|||
30780784|NCT01065766|58792838|FG000|Overall Study|Violated dosage/administration|25|||
30780785|NCT01063972|58792844|FG000|Overall Study|Death|12|||
30780786|NCT01063972|58792845|FG001|Overall Study|Death|11|||
30780787|NCT01063972|58792844|FG000|Overall Study|Incarcerated|2|||
30780788|NCT01063972|58792845|FG001|Overall Study|Incarcerated|1|||
30780789|NCT00003483|58792851|FG000|Overall Study|Not evaluable|1|||
30579656|NCT02985957|58590491|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
30579657|NCT02985957|58590492|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
30579658|NCT02985957|58590493|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
30579659|NCT02985957|58590487|FG000|Treatment Period|Poor/Non-Compliance|0|||
30579660|NCT02985957|58590488|FG001|Treatment Period|Poor/Non-Compliance|0|||
30579661|NCT02985957|58590489|FG002|Treatment Period|Poor/Non-Compliance|0|||
30579662|NCT02985957|58590490|FG003|Treatment Period|Poor/Non-Compliance|0|||
30579663|NCT02985957|58590491|FG004|Treatment Period|Poor/Non-Compliance|1|||
30579664|NCT02985957|58590492|FG005|Treatment Period|Poor/Non-Compliance|1|||
30579665|NCT02985957|58590493|FG006|Treatment Period|Poor/Non-Compliance|0|||
30579666|NCT02985957|58590487|FG000|Treatment Period|Continuing in Treatment Period|0|||
30579667|NCT02985957|58590488|FG001|Treatment Period|Continuing in Treatment Period|1|||
30579668|NCT02985957|58590489|FG002|Treatment Period|Continuing in Treatment Period|0|||
30579669|NCT02985957|58590490|FG003|Treatment Period|Continuing in Treatment Period|4|||
30579670|NCT02985957|58590491|FG004|Treatment Period|Continuing in Treatment Period|4|||
30579671|NCT02985957|58590492|FG005|Treatment Period|Continuing in Treatment Period|0|||
30579672|NCT02985957|58590493|FG006|Treatment Period|Continuing in Treatment Period|0|||
30579673|NCT02975934|58590526|FG000|Treatment Phase|Ongoing at data-analysis|33|||
30579674|NCT02975934|58590527|FG001|Treatment Phase|Ongoing at data-analysis|5|||
30579675|NCT02975934|58590526|FG000|Treatment Phase|Discontinued prior to study drug|0|||
30579676|NCT02975934|58590527|FG001|Treatment Phase|Discontinued prior to study drug|5|||
30579677|NCT02975934|58590526|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
30579678|NCT02975934|58590527|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
30579679|NCT02512965|58590544|FG000|Overall Study|Withdrawal by Subject|0|||
30579680|NCT02512965|58590545|FG001|Overall Study|Withdrawal by Subject|4|||
30579681|NCT02335268|58590553|FG000|Overall Study|Physician Decision|5|||
30579682|NCT02335268|58590554|FG001|Overall Study|Physician Decision|1|||
30579683|NCT02335268|58590553|FG000|Overall Study|Lack of Efficacy|2|||
30579684|NCT02335268|58590554|FG001|Overall Study|Lack of Efficacy|1|||
30579685|NCT02335268|58590553|FG000|Overall Study|Adverse Event|5|||
30579686|NCT02335268|58590554|FG001|Overall Study|Adverse Event|2|||
30579687|NCT02335268|58590553|FG000|Overall Study|increase blasts|2|||
30579688|NCT02335268|58590554|FG001|Overall Study|increase blasts|0|||
30579689|NCT02335268|58590553|FG000|Overall Study|Withdrawal by Subject|3|||
30579690|NCT02335268|58590554|FG001|Overall Study|Withdrawal by Subject|2|||
30579691|NCT01828112|58590576|FG000|Overall Study|Adverse Event|6|||
30579692|NCT01828112|58590577|FG001|Overall Study|Adverse Event|8|||
30579693|NCT01828112|58590576|FG000|Overall Study|Death|9|||
30579694|NCT01828112|58590577|FG001|Overall Study|Death|5|||
30579695|NCT01828112|58590576|FG000|Overall Study|Physician Decision|5|||
30579696|NCT01828112|58590577|FG001|Overall Study|Physician Decision|5|||
30579697|NCT01828112|58590576|FG000|Overall Study|Progressive disease|56|||
30579698|NCT01828112|58590577|FG001|Overall Study|Progressive disease|82|||
30579699|NCT01828112|58590576|FG000|Overall Study|Subject/guardian decision|6|||
30579700|NCT01828112|58590577|FG001|Overall Study|Subject/guardian decision|8|||
30579701|NCT01286272|58590585|FG000|Overall Study|Ineligible after beginning treatment|1|||
30579702|NCT01286272|58590586|FG001|Overall Study|Ineligible after beginning treatment|3|||
30579703|NCT01065454|58590596|FG000|Treatment|Adverse Event|7|||
30579704|NCT01065454|58590597|FG001|Treatment|Adverse Event|4|||
30579705|NCT01065454|58590598|FG002|Treatment|Adverse Event|3|||
30579706|NCT01065454|58590599|FG003|Treatment|Adverse Event|6|||
30579707|NCT01065454|58590596|FG000|Treatment|Death|1|||
30579708|NCT01065454|58590597|FG001|Treatment|Death|0|||
30579709|NCT01065454|58590598|FG002|Treatment|Death|0|||
30579710|NCT01065454|58590599|FG003|Treatment|Death|0|||
30579711|NCT01065454|58590596|FG000|Treatment|Non-compliance|1|||
30780790|NCT00003477|58792855|FG000|Overall Study|Not evalauable|4|||
30780791|NCT00003471|58792859|FG000|Overall Study|Not evaluable|4|||
30958741|NCT02688192|59023927|FG000|Overall Study|Physician Decision|1|||
30579712|NCT01065454|58590597|FG001|Treatment|Non-compliance|0|||
30579713|NCT01065454|58590598|FG002|Treatment|Non-compliance|0|||
30855498|NCT00103285|58883187|FG004|Response Assignment|Adverse Event|3|||
30958742|NCT02688192|59023928|FG001|Overall Study|Physician Decision|0|||
30579714|NCT01065454|58590599|FG003|Treatment|Non-compliance|1|||
30579715|NCT01065454|58590596|FG000|Treatment|Protocol Decision|0|||
30579716|NCT01065454|58590597|FG001|Treatment|Protocol Decision|0|||
30579717|NCT01065454|58590598|FG002|Treatment|Protocol Decision|3|||
30579718|NCT01065454|58590599|FG003|Treatment|Protocol Decision|2|||
30579719|NCT01065454|58590596|FG000|Treatment|Protocol Violation|1|||
30579720|NCT01065454|58590597|FG001|Treatment|Protocol Violation|0|||
30780792|NCT04185220|58792865|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
30780793|NCT04185220|58792866|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
30780794|NCT04185220|58792865|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
30780795|NCT04185220|58792866|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
30780796|NCT00002931|58792873|FG000|Overall Study|rapidly progressing disease during|2|||
30780797|NCT02918266|58792888|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
30780798|NCT02918266|58792889|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
30780799|NCT02918266|58792890|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
30780800|NCT02918266|58792891|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
30579721|NCT01065454|58590598|FG002|Treatment|Protocol Violation|1|||
30579722|NCT01065454|58590599|FG003|Treatment|Protocol Violation|0|||
30579723|NCT01065454|58590596|FG000|Treatment|Withdrawal by Subject|3|||
30579724|NCT01065454|58590597|FG001|Treatment|Withdrawal by Subject|1|||
30579725|NCT01065454|58590598|FG002|Treatment|Withdrawal by Subject|2|||
30579726|NCT01065454|58590599|FG003|Treatment|Withdrawal by Subject|3|||
30579727|NCT01065454|58590596|FG000|Follow up|Adverse Event|1|||
30579728|NCT01065454|58590597|FG001|Follow up|Adverse Event|0|||
30579729|NCT01065454|58590598|FG002|Follow up|Adverse Event|0|||
30579730|NCT01065454|58590599|FG003|Follow up|Adverse Event|1|||
30579731|NCT01065454|58590596|FG000|Follow up|Death|0|||
30579732|NCT01065454|58590597|FG001|Follow up|Death|1|||
30579733|NCT01065454|58590598|FG002|Follow up|Death|1|||
30579734|NCT01065454|58590599|FG003|Follow up|Death|0|||
30579735|NCT01065454|58590596|FG000|Follow up|Lost to Follow-up|0|||
30579736|NCT01065454|58590597|FG001|Follow up|Lost to Follow-up|0|||
30579737|NCT01065454|58590598|FG002|Follow up|Lost to Follow-up|0|||
30579738|NCT01065454|58590599|FG003|Follow up|Lost to Follow-up|1|||
30579739|NCT01065454|58590596|FG000|Follow up|Progressive disease|0|||
30579740|NCT01065454|58590597|FG001|Follow up|Progressive disease|0|||
30579741|NCT01065454|58590598|FG002|Follow up|Progressive disease|0|||
30579742|NCT01065454|58590599|FG003|Follow up|Progressive disease|1|||
30579743|NCT01065454|58590596|FG000|Follow up|Withdrawal by Subject|1|||
30579744|NCT01065454|58590597|FG001|Follow up|Withdrawal by Subject|1|||
30780801|NCT02918266|58792892|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
30780802|NCT02918266|58792893|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
30579745|NCT01065454|58590598|FG002|Follow up|Withdrawal by Subject|1|||
30579746|NCT01065454|58590599|FG003|Follow up|Withdrawal by Subject|0|||
30579747|NCT01065454|58590596|FG000|Follow up|study ongoing|37|||
30579748|NCT01065454|58590597|FG001|Follow up|study ongoing|22|||
30579749|NCT01065454|58590598|FG002|Follow up|study ongoing|15|||
30579750|NCT01065454|58590599|FG003|Follow up|study ongoing|41|||
30579751|NCT01029002|58590611|FG000|Overall Study|Lost to Follow-up|2|||
30579752|NCT01029002|58590612|FG001|Overall Study|Lost to Follow-up|4|||
30579753|NCT01011478|58590620|FG000|Overall Study|No follow up data|12|||
30579754|NCT01011478|58590621|FG001|Overall Study|No follow up data|7|||
30579755|NCT00980460|58590632|FG000|Overall Study|Death|0|||
30579756|NCT00980460|58590633|FG001|Overall Study|Death|0|||
30579757|NCT00980460|58590634|FG002|Overall Study|Death|1|||
30579758|NCT00980460|58590635|FG003|Overall Study|Death|2|||
30668234|NCT00695110|58682183|FG000|Treatment Period 3|Withdrawal by Subject|1|||
30668235|NCT00695110|58682183|FG000|Treatment Period 4|Adverse Event|1|||
30668236|NCT00594386|58682190|FG000|Overall Study|Major protocol violation|2|||
30668237|NCT00594386|58682190|FG000|Overall Study|Lack of Efficacy|12|||
30668238|NCT00594386|58682190|FG000|Overall Study|Adverse Event|68|||
30668239|NCT00594386|58682190|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
30668240|NCT00594386|58682190|FG000|Overall Study|Subject withdrew consent|35|||
30780803|NCT02918266|58792894|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
30780804|NCT02918266|58792895|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
30780805|NCT02918266|58792896|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
30780806|NCT02918266|58792897|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
30579759|NCT00980460|58590636|FG004|Overall Study|Death|1|||
30579760|NCT00980460|58590632|FG000|Overall Study|Lack of Efficacy|0|||
30579761|NCT00980460|58590633|FG001|Overall Study|Lack of Efficacy|0|||
30668241|NCT00594386|58682190|FG000|Overall Study|Study ended per sponsor|115|||
30579762|NCT00980460|58590634|FG002|Overall Study|Lack of Efficacy|10|||
30579763|NCT00980460|58590635|FG003|Overall Study|Lack of Efficacy|6|||
30579764|NCT00980460|58590636|FG004|Overall Study|Lack of Efficacy|8|||
30579765|NCT00980460|58590632|FG000|Overall Study|Lost to Follow-up|0|||
30579766|NCT00980460|58590633|FG001|Overall Study|Lost to Follow-up|0|||
30579767|NCT00980460|58590634|FG002|Overall Study|Lost to Follow-up|0|||
30579768|NCT00980460|58590635|FG003|Overall Study|Lost to Follow-up|1|||
30579769|NCT00980460|58590636|FG004|Overall Study|Lost to Follow-up|0|||
30579770|NCT00980460|58590632|FG000|Overall Study|Physician Decision|0|||
30579771|NCT00980460|58590633|FG001|Overall Study|Physician Decision|0|||
30579772|NCT00980460|58590634|FG002|Overall Study|Physician Decision|11|||
30579773|NCT00980460|58590635|FG003|Overall Study|Physician Decision|5|||
30579774|NCT00980460|58590636|FG004|Overall Study|Physician Decision|3|||
30579775|NCT00980460|58590632|FG000|Overall Study|Withdrawal by Subject|0|||
30579776|NCT00980460|58590633|FG001|Overall Study|Withdrawal by Subject|0|||
30579777|NCT00980460|58590634|FG002|Overall Study|Withdrawal by Subject|1|||
30579778|NCT00980460|58590635|FG003|Overall Study|Withdrawal by Subject|0|||
30579779|NCT00980460|58590636|FG004|Overall Study|Withdrawal by Subject|0|||
30579780|NCT00980460|58590632|FG000|Overall Study|Ineligible|0|||
30579781|NCT00980460|58590633|FG001|Overall Study|Ineligible|2|||
30579782|NCT00980460|58590634|FG002|Overall Study|Ineligible|3|||
30579783|NCT00980460|58590635|FG003|Overall Study|Ineligible|1|||
30579784|NCT00980460|58590636|FG004|Overall Study|Ineligible|4|||
30579785|NCT00980460|58590632|FG000|Overall Study|Refusal of further therapy|0|||
30579786|NCT00980460|58590633|FG001|Overall Study|Refusal of further therapy|2|||
30579787|NCT00980460|58590634|FG002|Overall Study|Refusal of further therapy|3|||
30579788|NCT00980460|58590635|FG003|Overall Study|Refusal of further therapy|2|||
30579789|NCT00980460|58590636|FG004|Overall Study|Refusal of further therapy|0|||
30579790|NCT00980460|58590632|FG000|Overall Study|No therapy within 42 days of resection|0|||
30579791|NCT00980460|58590633|FG001|Overall Study|No therapy within 42 days of resection|0|||
30579792|NCT00980460|58590634|FG002|Overall Study|No therapy within 42 days of resection|3|||
30579793|NCT00980460|58590635|FG003|Overall Study|No therapy within 42 days of resection|1|||
30579794|NCT00980460|58590636|FG004|Overall Study|No therapy within 42 days of resection|0|||
30579795|NCT00980460|58590632|FG000|Overall Study|No transplant by protocol timepoints|0|||
30579796|NCT00980460|58590633|FG001|Overall Study|No transplant by protocol timepoints|0|||
30579797|NCT00980460|58590634|FG002|Overall Study|No transplant by protocol timepoints|3|||
30579798|NCT00980460|58590635|FG003|Overall Study|No transplant by protocol timepoints|0|||
30579799|NCT00980460|58590636|FG004|Overall Study|No transplant by protocol timepoints|0|||
30579800|NCT00546260|58590657|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
30579801|NCT00546260|58590658|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
30579802|NCT01356940|58590675|FG000|First Intervention (28 Days)|Adverse Event|1|||
30579803|NCT01356940|58590676|FG001|First Intervention (28 Days)|Adverse Event|0|||
30579804|NCT01356940|58590675|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
30579805|NCT01356940|58590676|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
30579806|NCT01330030|58590695|FG000|Overall Study|Lost to Follow-up|16|||
30579807|NCT01330030|58590696|FG001|Overall Study|Lost to Follow-up|17|||
30579808|NCT00477295|58590825|FG000|Overall Study|Adverse Event|31|||
30579809|NCT00477295|58590826|FG001|Overall Study|Adverse Event|35|||
30579810|NCT00477295|58590825|FG000|Overall Study|Withdrawal by Subject|35|||
30579811|NCT00477295|58590826|FG001|Overall Study|Withdrawal by Subject|24|||
30579812|NCT00477295|58590825|FG000|Overall Study|Lack of Efficacy|23|||
30579813|NCT00477295|58590826|FG001|Overall Study|Lack of Efficacy|23|||
30579814|NCT00477295|58590825|FG000|Overall Study|Protocol Violation|3|||
30579815|NCT00477295|58590826|FG001|Overall Study|Protocol Violation|8|||
30579816|NCT00477295|58590825|FG000|Overall Study|Physician Decision|4|||
30579817|NCT00477295|58590826|FG001|Overall Study|Physician Decision|5|||
30579818|NCT00477295|58590825|FG000|Overall Study|Lost to Follow-up|21|||
30579819|NCT00477295|58590826|FG001|Overall Study|Lost to Follow-up|11|||
30579820|NCT00477295|58590825|FG000|Overall Study|Other|4|||
30579821|NCT00477295|58590826|FG001|Overall Study|Other|3|||
30579822|NCT00476593|58590838|FG000|Overall Study|Lost to Follow-up|10|||
30579823|NCT00476593|58590839|FG001|Overall Study|Lost to Follow-up|2|||
30579824|NCT00476593|58590840|FG002|Overall Study|Lost to Follow-up|8|||
30579825|NCT00476593|58590841|FG003|Overall Study|Lost to Follow-up|22|||
30579826|NCT00476476|58590853|FG000|Overall Study|Adverse Event|2|||
30579827|NCT00476476|58590854|FG001|Overall Study|Adverse Event|7|||
30579828|NCT00476476|58590853|FG000|Overall Study|Progressive Disease|0|||
30579829|NCT00476476|58590854|FG001|Overall Study|Progressive Disease|17|||
30579830|NCT00476086|58590859|FG000|Overall Study|Alternative therapy|1|||
30579831|NCT00476086|58590859|FG000|Overall Study|Progressive Disease|4|||
30579832|NCT00476047|58590865|FG000|Overall Study|Lost to Follow-up|1|||
30579833|NCT00476008|58590873|FG000|Overall Study|Adverse Event|4|||
30668242|NCT00594386|58682190|FG000|Overall Study|Lost to Follow-up|6|||
30579834|NCT00476008|58590874|FG001|Overall Study|Adverse Event|4|||
30579835|NCT00476008|58590873|FG000|Overall Study|Placebo concerns|2|||
30579836|NCT00476008|58590874|FG001|Overall Study|Placebo concerns|2|||
30579837|NCT00476008|58590873|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
30579838|NCT00476008|58590874|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
30579839|NCT00476008|58590873|FG000|Overall Study|Withdrawal by Subject|0|||
30579840|NCT00476008|58590874|FG001|Overall Study|Withdrawal by Subject|1|||
30579841|NCT00476008|58590873|FG000|Overall Study|Death|1|||
30855499|NCT00103285|58883188|FG005|Response Assignment|Adverse Event|1|||
30579842|NCT00476008|58590874|FG001|Overall Study|Death|0|||
30579843|NCT00475735|58590890|FG000|Treatment Period 1|Adverse Event|2|||
30579844|NCT00475735|58590891|FG001|Treatment Period 1|Adverse Event|0|||
30579845|NCT00475735|58590892|FG002|Treatment Period 1|Adverse Event|0|||
30579846|NCT00475735|58590893|FG003|Treatment Period 1|Adverse Event|0|||
30579847|NCT00475735|58590894|FG004|Treatment Period 1|Adverse Event|0|||
30579848|NCT00475735|58590895|FG005|Treatment Period 1|Adverse Event|0|||
30579849|NCT00475735|58590890|FG000|Treatment Period 1|Lack of Efficacy|1|||
30579850|NCT00475735|58590891|FG001|Treatment Period 1|Lack of Efficacy|0|||
30579851|NCT00475735|58590892|FG002|Treatment Period 1|Lack of Efficacy|0|||
30579852|NCT00475735|58590893|FG003|Treatment Period 1|Lack of Efficacy|0|||
30579853|NCT00475735|58590894|FG004|Treatment Period 1|Lack of Efficacy|0|||
30579854|NCT00475735|58590895|FG005|Treatment Period 1|Lack of Efficacy|0|||
30579855|NCT00475735|58590890|FG000|Treatment Period 1|Lost to Follow-up|0|||
30668243|NCT00594386|58682190|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
30668244|NCT00594386|58682190|FG000|Overall Study|Other: Subject moved to Seattle|1|||
30668245|NCT00594386|58682190|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
30780807|NCT02918266|58792898|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
30780808|NCT00041067|58792918|FG000|Overall Study|Adverse Event|20|||
30780809|NCT00041067|58792918|FG000|Overall Study|Progression|19|||
30780810|NCT00041067|58792918|FG000|Overall Study|Patient refusal|12|||
30780811|NCT00041067|58792918|FG000|Overall Study|Other reasons|23|||
30780812|NCT00041067|58792918|FG000|Overall Study|Ineligible|2|||
30780813|NCT01063036|58792923|FG000|Participants Treated With Study Drug|Adverse Event|1|||
30780814|NCT01063036|58792923|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
30780815|NCT01063036|58792923|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
30780816|NCT01063036|58792923|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
30780817|NCT01063036|58792923|FG000|Participants Treated With Study Drug|Pregnancy|1|||
30780818|NCT01063036|58792923|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
30780819|NCT01063036|58792923|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
30780820|NCT01063036|58792923|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
30668246|NCT00594386|58682190|FG000|Overall Study|Other: Study terminated per investigator|2|||
30668247|NCT00594386|58682190|FG000|Overall Study|Other: Sponsor closure of study|1|||
30668248|NCT00594386|58682190|FG000|Overall Study|Other: Site terminated participation|1|||
30668249|NCT00594386|58682190|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
30668250|NCT00594386|58682190|FG000|Overall Study|Other: Loss of drivers license|1|||
30668251|NCT00862992|58682197|FG000|Overall Study|Adverse Event|2|||
30668252|NCT00862992|58682198|FG001|Overall Study|Adverse Event|1|||
30668253|NCT00862992|58682199|FG002|Overall Study|Adverse Event|1|||
30668254|NCT00862992|58682197|FG000|Overall Study|Physician Decision|1|||
30668255|NCT00862992|58682198|FG001|Overall Study|Physician Decision|0|||
30668256|NCT00862992|58682199|FG002|Overall Study|Physician Decision|0|||
30668257|NCT00862992|58682197|FG000|Overall Study|Withdrawal by Subject|0|||
30668258|NCT00862992|58682198|FG001|Overall Study|Withdrawal by Subject|0|||
30668259|NCT00862992|58682199|FG002|Overall Study|Withdrawal by Subject|2|||
30668260|NCT00694096|58682207|FG000|Overall Study|Withdrawal by Subject|5|||
30668261|NCT00854100|58682214|FG000|Overall Study|Inability to complete the study visits|0|||
30668262|NCT00854100|58682215|FG001|Overall Study|Inability to complete the study visits|0|||
30668263|NCT00854100|58682216|FG002|Overall Study|Inability to complete the study visits|1|||
30668264|NCT00854100|58682214|FG000|Overall Study|Lost to Follow-up|2|||
30668265|NCT00854100|58682215|FG001|Overall Study|Lost to Follow-up|0|||
30668266|NCT00854100|58682216|FG002|Overall Study|Lost to Follow-up|3|||
30668267|NCT00854100|58682214|FG000|Overall Study|Withdrawal by Subject|3|||
30668268|NCT00854100|58682215|FG001|Overall Study|Withdrawal by Subject|1|||
30668269|NCT00854100|58682216|FG002|Overall Study|Withdrawal by Subject|2|||
30668270|NCT00854100|58682214|FG000|Overall Study|Protocol Violation|2|||
30668271|NCT00854100|58682215|FG001|Overall Study|Protocol Violation|4|||
30668272|NCT00854100|58682216|FG002|Overall Study|Protocol Violation|3|||
30668273|NCT00854100|58682214|FG000|Overall Study|Adverse Event|2|||
30668274|NCT00854100|58682215|FG001|Overall Study|Adverse Event|1|||
30668275|NCT00854100|58682216|FG002|Overall Study|Adverse Event|2|||
30668276|NCT00509899|58682233|FG000|Overall Study|Progressive disease|1|||
30668277|NCT00509899|58682234|FG001|Overall Study|Progressive disease|3|||
30668278|NCT00509899|58682235|FG002|Overall Study|Progressive disease|5|||
30668279|NCT00509899|58682236|FG003|Overall Study|Progressive disease|1|||
30668280|NCT00509899|58682237|FG004|Overall Study|Progressive disease|0|||
30668281|NCT00509899|58682238|FG005|Overall Study|Progressive disease|1|||
30668282|NCT00509899|58682239|FG006|Overall Study|Progressive disease|0|||
30668283|NCT00509899|58682240|FG007|Overall Study|Progressive disease|0|||
30780821|NCT00040365|58792927|FG000|Overall Study|Death|1|||
30780822|NCT00040365|58792927|FG000|Overall Study|Progressive disease|7|||
30668284|NCT00509899|58682233|FG000|Overall Study|Unacceptable Toxicity|1|||
30668285|NCT00509899|58682234|FG001|Overall Study|Unacceptable Toxicity|0|||
30668286|NCT00509899|58682235|FG002|Overall Study|Unacceptable Toxicity|0|||
30668287|NCT00509899|58682236|FG003|Overall Study|Unacceptable Toxicity|2|||
30668288|NCT00509899|58682237|FG004|Overall Study|Unacceptable Toxicity|0|||
30668289|NCT00509899|58682238|FG005|Overall Study|Unacceptable Toxicity|0|||
30668290|NCT00509899|58682239|FG006|Overall Study|Unacceptable Toxicity|0|||
30780823|NCT00040365|58792927|FG000|Overall Study|Lost to Follow-up|3|||
30780824|NCT02974114|58792934|FG000|Overall Study|Other (Not specified)|0|||
30780825|NCT02974114|58792935|FG001|Overall Study|Other (Not specified)|1|||
30579856|NCT00475735|58590891|FG001|Treatment Period 1|Lost to Follow-up|0|||
30579857|NCT00475735|58590892|FG002|Treatment Period 1|Lost to Follow-up|0|||
30579858|NCT00475735|58590893|FG003|Treatment Period 1|Lost to Follow-up|0|||
30579859|NCT00475735|58590894|FG004|Treatment Period 1|Lost to Follow-up|0|||
30579860|NCT00475735|58590895|FG005|Treatment Period 1|Lost to Follow-up|1|||
30579861|NCT00475735|58590890|FG000|Treatment Period 1|Protocol Violation|0|||
30579862|NCT00475735|58590891|FG001|Treatment Period 1|Protocol Violation|0|||
30579863|NCT00475735|58590892|FG002|Treatment Period 1|Protocol Violation|0|||
30579864|NCT00475735|58590893|FG003|Treatment Period 1|Protocol Violation|1|||
30579865|NCT00475735|58590894|FG004|Treatment Period 1|Protocol Violation|0|||
30579866|NCT00475735|58590895|FG005|Treatment Period 1|Protocol Violation|0|||
30579867|NCT00475735|58590890|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30579868|NCT00475735|58590891|FG001|Treatment Period 1|Withdrawal by Subject|1|||
30579869|NCT00475735|58590892|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30579870|NCT00475735|58590893|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30579871|NCT00475735|58590894|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30579872|NCT00475735|58590895|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30579873|NCT00475735|58590890|FG000|Treatment Period 1|DC due to AE but continuing|0|||
30579874|NCT00475735|58590891|FG001|Treatment Period 1|DC due to AE but continuing|0|||
30579875|NCT00475735|58590892|FG002|Treatment Period 1|DC due to AE but continuing|0|||
30579876|NCT00475735|58590893|FG003|Treatment Period 1|DC due to AE but continuing|1|||
30579877|NCT00475735|58590894|FG004|Treatment Period 1|DC due to AE but continuing|2|||
30579878|NCT00475735|58590895|FG005|Treatment Period 1|DC due to AE but continuing|2|||
30579879|NCT00475735|58590890|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
30579880|NCT00475735|58590891|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
30579881|NCT00475735|58590892|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
30579882|NCT00475735|58590893|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
30579883|NCT00475735|58590894|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
30579884|NCT00475735|58590895|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
30579885|NCT00475735|58590890|FG000|Treatment Washout|Lost to Follow-up|0|||
30579886|NCT00475735|58590891|FG001|Treatment Washout|Lost to Follow-up|1|||
30579887|NCT00475735|58590892|FG002|Treatment Washout|Lost to Follow-up|0|||
30579888|NCT00475735|58590893|FG003|Treatment Washout|Lost to Follow-up|0|||
30579889|NCT00475735|58590894|FG004|Treatment Washout|Lost to Follow-up|0|||
30579890|NCT00475735|58590895|FG005|Treatment Washout|Lost to Follow-up|0|||
30579891|NCT00475735|58590890|FG000|Treatment Washout|Protocol Violation|0|||
30579892|NCT00475735|58590891|FG001|Treatment Washout|Protocol Violation|1|||
30579893|NCT00475735|58590892|FG002|Treatment Washout|Protocol Violation|0|||
30579894|NCT00475735|58590893|FG003|Treatment Washout|Protocol Violation|0|||
30579895|NCT00475735|58590894|FG004|Treatment Washout|Protocol Violation|0|||
30579896|NCT00475735|58590895|FG005|Treatment Washout|Protocol Violation|0|||
30579897|NCT00475735|58590890|FG000|Treatment Period 2|Adverse Event|0|||
30579898|NCT00475735|58590891|FG001|Treatment Period 2|Adverse Event|1|||
30579899|NCT00475735|58590892|FG002|Treatment Period 2|Adverse Event|0|||
30579900|NCT00475735|58590893|FG003|Treatment Period 2|Adverse Event|2|||
30579901|NCT00475735|58590894|FG004|Treatment Period 2|Adverse Event|0|||
30579902|NCT00475735|58590895|FG005|Treatment Period 2|Adverse Event|0|||
30579903|NCT00475735|58590890|FG000|Treatment Period 2|Lack of Efficacy|0|||
30579904|NCT00475735|58590891|FG001|Treatment Period 2|Lack of Efficacy|0|||
30579905|NCT00475735|58590892|FG002|Treatment Period 2|Lack of Efficacy|0|||
30579906|NCT00475735|58590893|FG003|Treatment Period 2|Lack of Efficacy|0|||
30579907|NCT00475735|58590894|FG004|Treatment Period 2|Lack of Efficacy|0|||
30579908|NCT00475735|58590895|FG005|Treatment Period 2|Lack of Efficacy|1|||
30579909|NCT00475735|58590890|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30579910|NCT00475735|58590891|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30579911|NCT00475735|58590892|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30579912|NCT00475735|58590893|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30579913|NCT00475735|58590894|FG004|Treatment Period 2|Withdrawal by Subject|1|||
30579914|NCT00475735|58590895|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30579915|NCT00475657|58590903|FG000|Overall Study|Death|1|||
30579916|NCT00475657|58590903|FG000|Overall Study|Sponsor's Decision|3|||
30579917|NCT00475423|58590907|FG000|Overall Study|Protocol Violation|5|||
30579918|NCT00475423|58590907|FG000|Overall Study|Adverse Event|4|||
30579919|NCT00475423|58590907|FG000|Overall Study|Withdrawal by Subject|6|||
30579920|NCT00475423|58590907|FG000|Overall Study|Lack of Efficacy|8|||
30579921|NCT00475423|58590907|FG000|Overall Study|Death|1|||
30579922|NCT00475423|58590907|FG000|Overall Study|Reason not specified|1|||
30579923|NCT00475423|58590907|FG000|Overall Study|Lost to Follow-up|7|||
30579924|NCT00475306|58590915|FG000|Overall Study|Protocol Violation|1|||
30579925|NCT00475306|58590916|FG001|Overall Study|Protocol Violation|1|||
30579926|NCT00475306|58590917|FG002|Overall Study|Protocol Violation|0|||
30579927|NCT00475306|58590918|FG003|Overall Study|Protocol Violation|1|||
30579928|NCT00475228|58590930|FG000|Overall Study|Lost to Follow-up|17|||
30579929|NCT00475228|58590931|FG001|Overall Study|Lost to Follow-up|17|||
30579930|NCT00475033|58590943|FG000|Infant Series|Failed to return|3|||
30579931|NCT00475033|58590944|FG001|Infant Series|Failed to return|4|||
30855500|NCT00103285|58883189|FG006|Response Assignment|Adverse Event|1|||
30579932|NCT00475033|58590943|FG000|Infant Series|Parent or legal guardian request|1|||
30579933|NCT00475033|58590944|FG001|Infant Series|Parent or legal guardian request|5|||
30579934|NCT00475033|58590943|FG000|Infant Series|Protocol Violation|1|||
30579935|NCT00475033|58590944|FG001|Infant Series|Protocol Violation|2|||
30579936|NCT00475033|58590943|FG000|Infant Series|Lost to Follow-up|2|||
30579937|NCT00475033|58590944|FG001|Infant Series|Lost to Follow-up|0|||
30579938|NCT00475033|58590943|FG000|Infant Series|Adverse Event|0|||
30668291|NCT00509899|58682240|FG007|Overall Study|Unacceptable Toxicity|0|||
30668292|NCT00509899|58682233|FG000|Overall Study|Withdrawal by Subject|6|||
30668293|NCT00509899|58682234|FG001|Overall Study|Withdrawal by Subject|2|||
30668294|NCT00509899|58682235|FG002|Overall Study|Withdrawal by Subject|3|||
30668295|NCT00509899|58682236|FG003|Overall Study|Withdrawal by Subject|0|||
30668296|NCT00509899|58682237|FG004|Overall Study|Withdrawal by Subject|3|||
30668297|NCT00509899|58682238|FG005|Overall Study|Withdrawal by Subject|2|||
30668298|NCT00509899|58682239|FG006|Overall Study|Withdrawal by Subject|0|||
30668299|NCT00509899|58682240|FG007|Overall Study|Withdrawal by Subject|0|||
30668300|NCT00509899|58682233|FG000|Overall Study|Physician Decision|4|||
30668301|NCT00509899|58682234|FG001|Overall Study|Physician Decision|2|||
30668302|NCT00509899|58682235|FG002|Overall Study|Physician Decision|7|||
30668303|NCT00509899|58682236|FG003|Overall Study|Physician Decision|0|||
30668304|NCT00509899|58682237|FG004|Overall Study|Physician Decision|1|||
30668305|NCT00509899|58682238|FG005|Overall Study|Physician Decision|4|||
30668306|NCT00509899|58682239|FG006|Overall Study|Physician Decision|0|||
30668307|NCT00509899|58682240|FG007|Overall Study|Physician Decision|0|||
30668308|NCT00509899|58682233|FG000|Overall Study|Intercurrent Illness|1|||
30668309|NCT00509899|58682234|FG001|Overall Study|Intercurrent Illness|0|||
30668310|NCT00509899|58682235|FG002|Overall Study|Intercurrent Illness|0|||
30780826|NCT02974114|58792936|FG002|Overall Study|Other (Not specified)|2|||
30780827|NCT00001959|58792946|FG000|Overall Study|newly diagnosed colon cancer|1|||
30780828|NCT00001959|58792946|FG000|Overall Study|disabling sedation|1|||
30780829|NCT00001959|58792946|FG000|Overall Study|non-compliance|1|||
30780830|NCT00001941|58792950|FG000|Overall Study|not treated- rapidly progressing disease|0|||
30780831|NCT00001941|58792951|FG001|Overall Study|not treated- rapidly progressing disease|0|||
30780832|NCT00001941|58792952|FG002|Overall Study|not treated- rapidly progressing disease|0|||
30579939|NCT00475033|58590944|FG001|Infant Series|Adverse Event|2|||
30579940|NCT00475033|58590943|FG000|After the Infant Series|Adverse Event|0|||
30579941|NCT00475033|58590944|FG001|After the Infant Series|Adverse Event|4|||
30579942|NCT00475033|58590943|FG000|After the Infant Series|Parent or legal guardian request|2|||
30579943|NCT00475033|58590944|FG001|After the Infant Series|Parent or legal guardian request|2|||
30579944|NCT00475033|58590943|FG000|After the Infant Series|Failed to return|2|||
30579945|NCT00475033|58590944|FG001|After the Infant Series|Failed to return|1|||
30579946|NCT00475033|58590943|FG000|After the Infant Series|Protocol Violation|1|||
30579947|NCT00475033|58590944|FG001|After the Infant Series|Protocol Violation|0|||
30579948|NCT00475033|58590943|FG000|After the Infant Series|Lost to Follow-up|1|||
30579949|NCT00475033|58590944|FG001|After the Infant Series|Lost to Follow-up|0|||
30579950|NCT00475033|58590943|FG000|After the Infant Series|Other|0|||
30579951|NCT00475033|58590944|FG001|After the Infant Series|Other|1|||
30579952|NCT00475033|58590943|FG000|Toddler Dose|Parent or legal guardian request|2|||
30579953|NCT00475033|58590944|FG001|Toddler Dose|Parent or legal guardian request|0|||
30579954|NCT00475033|58590943|FG000|Toddler Dose|Failed to return|1|||
30579955|NCT00475033|58590944|FG001|Toddler Dose|Failed to return|0|||
30579956|NCT00475033|58590943|FG000|Toddler Dose|Lost to Follow-up|1|||
30579957|NCT00475033|58590944|FG001|Toddler Dose|Lost to Follow-up|0|||
30579958|NCT00474994|58590957|FG000|Overall Study|Patient Not treated|1|||
30579959|NCT00474994|58590957|FG000|Overall Study|Patient evaluable for toxicity only|3|||
30579960|NCT00474994|58590957|FG000|Overall Study|Patient found to be ineligible|1|||
30579961|NCT00474955|58590961|FG000|Overall Study|Adverse Event|2|||
30579962|NCT00474955|58590961|FG000|Overall Study|Drug unavailability|1|||
30579963|NCT00474955|58590961|FG000|Overall Study|Personal reasons|5|||
30579964|NCT00474487|58590969|FG000|Overall Study|Withdrawal by Subject|6|||
30579965|NCT00474487|58590970|FG001|Overall Study|Withdrawal by Subject|0|||
30780833|NCT00001941|58792953|FG003|Overall Study|not treated- rapidly progressing disease|0|||
30780834|NCT00001941|58792954|FG004|Overall Study|not treated- rapidly progressing disease|1|||
30780835|NCT02978326|58792962|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
30780836|NCT02978326|58792963|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
30780837|NCT02978326|58792964|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
30780838|NCT02978326|58792962|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
30855501|NCT00103285|58883190|FG007|Response Assignment|Adverse Event|2|||
30780839|NCT02978326|58792963|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
30579966|NCT00474487|58590971|FG002|Overall Study|Withdrawal by Subject|0|||
30579967|NCT00474487|58590972|FG003|Overall Study|Withdrawal by Subject|0|||
30579968|NCT00474487|58590969|FG000|Overall Study|Lost to Follow-up|20|||
30579969|NCT00474487|58590970|FG001|Overall Study|Lost to Follow-up|1|||
30579970|NCT00474487|58590971|FG002|Overall Study|Lost to Follow-up|7|||
30579971|NCT00474487|58590972|FG003|Overall Study|Lost to Follow-up|0|||
30579972|NCT00474487|58590969|FG000|Overall Study|Inappropriate enrollment|4|||
30579973|NCT00474487|58590970|FG001|Overall Study|Inappropriate enrollment|0|||
30579974|NCT00474487|58590971|FG002|Overall Study|Inappropriate enrollment|7|||
30579975|NCT00474487|58590972|FG003|Overall Study|Inappropriate enrollment|0|||
30579976|NCT00474487|58590969|FG000|Overall Study|Death|0|||
30579977|NCT00474487|58590970|FG001|Overall Study|Death|1|||
30579978|NCT00474487|58590971|FG002|Overall Study|Death|0|||
30579979|NCT00474487|58590972|FG003|Overall Study|Death|0|||
30579980|NCT00474253|58590984|FG000|Overall Study|Withdrew consent|2|||
30579981|NCT00474253|58590985|FG001|Overall Study|Withdrew consent|0|||
30579982|NCT00474253|58590984|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
30579983|NCT00474253|58590985|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
30579984|NCT00474253|58590984|FG000|Overall Study|Lost to Follow-up|1|||
30579985|NCT00474253|58590985|FG001|Overall Study|Lost to Follow-up|0|||
30579986|NCT00474253|58590984|FG000|Overall Study|Discharged prior to study completion|0|||
30579987|NCT00474253|58590985|FG001|Overall Study|Discharged prior to study completion|1|||
30579988|NCT00474058|58590993|FG000|Overall Study|Adverse Event|11|||
30579989|NCT00474058|58590994|FG001|Overall Study|Adverse Event|6|||
30579990|NCT00474058|58590993|FG000|Overall Study|Lack of Efficacy|0|||
30579991|NCT00474058|58590994|FG001|Overall Study|Lack of Efficacy|4|||
30579992|NCT00474058|58590993|FG000|Overall Study|Withdrawal by Subject|11|||
30579993|NCT00474058|58590994|FG001|Overall Study|Withdrawal by Subject|7|||
30579994|NCT00474058|58590993|FG000|Overall Study|Other|2|||
30579995|NCT00474058|58590994|FG001|Overall Study|Other|0|||
30579996|NCT00473824|58591002|FG000|Overall Study|Virologic Breakthrough|1|||
30579997|NCT00473824|58591003|FG001|Overall Study|Virologic Breakthrough|0|||
30579998|NCT00473824|58591002|FG000|Overall Study|Adverse Event|1|||
30579999|NCT00473824|58591003|FG001|Overall Study|Adverse Event|0|||
30580000|NCT00473824|58591002|FG000|Overall Study|Death|1|||
30580001|NCT00473824|58591003|FG001|Overall Study|Death|0|||
30580002|NCT00473824|58591002|FG000|Overall Study|Lost to Follow-up|1|||
30580003|NCT00473824|58591003|FG001|Overall Study|Lost to Follow-up|0|||
30580004|NCT00473824|58591002|FG000|Overall Study|Withdrawal by physician|1|||
30580005|NCT00473824|58591003|FG001|Overall Study|Withdrawal by physician|0|||
30580006|NCT00473746|58591014|FG000|Period 1 (Phase 1)|Adverse Event|1|||
30580007|NCT00473746|58591015|FG001|Period 1 (Phase 1)|Adverse Event|0|||
30580008|NCT00473746|58591016|FG002|Period 1 (Phase 1)|Adverse Event|0|||
30580009|NCT00473746|58591017|FG003|Period 1 (Phase 1)|Adverse Event|0|||
30580010|NCT00473746|58591018|FG004|Period 1 (Phase 1)|Adverse Event|0|||
30580011|NCT00473746|58591014|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
30580012|NCT00473746|58591015|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
30580013|NCT00473746|58591016|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
30580014|NCT00473746|58591017|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
30580015|NCT00473746|58591018|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
30580016|NCT00473746|58591014|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
30580017|NCT00473746|58591015|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
30580018|NCT00473746|58591016|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
30580019|NCT00473746|58591017|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
30580020|NCT00473746|58591018|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
30580021|NCT00473746|58591014|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
30580022|NCT00473746|58591015|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
30580023|NCT00473746|58591016|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
30580024|NCT00473746|58591017|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
30580025|NCT00473746|58591018|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
30580026|NCT00473746|58591014|FG000|Period 1 (Phase 1)|Reason not specified|0|||
30580027|NCT00473746|58591015|FG001|Period 1 (Phase 1)|Reason not specified|1|||
30580028|NCT00473746|58591016|FG002|Period 1 (Phase 1)|Reason not specified|0|||
30580029|NCT00473746|58591017|FG003|Period 1 (Phase 1)|Reason not specified|0|||
30580030|NCT00473746|58591018|FG004|Period 1 (Phase 1)|Reason not specified|0|||
30580031|NCT00473746|58591014|FG000|Period 2 (Phase 2)|Adverse Event|0|||
30580032|NCT00473746|58591015|FG001|Period 2 (Phase 2)|Adverse Event|0|||
30580033|NCT00473746|58591016|FG002|Period 2 (Phase 2)|Adverse Event|0|||
30580034|NCT00473746|58591017|FG003|Period 2 (Phase 2)|Adverse Event|0|||
30580035|NCT00473746|58591018|FG004|Period 2 (Phase 2)|Adverse Event|3|||
30668311|NCT00509899|58682236|FG003|Overall Study|Intercurrent Illness|1|||
30580036|NCT00473746|58591014|FG000|Period 2 (Phase 2)|Death|0|||
30580037|NCT00473746|58591015|FG001|Period 2 (Phase 2)|Death|0|||
30580038|NCT00473746|58591016|FG002|Period 2 (Phase 2)|Death|0|||
30855502|NCT00103285|58883183|FG000|Response Assignment|Death|0|||
30580039|NCT00473746|58591017|FG003|Period 2 (Phase 2)|Death|0|||
30580040|NCT00473746|58591018|FG004|Period 2 (Phase 2)|Death|1|||
30580041|NCT00473746|58591014|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
30668312|NCT00509899|58682237|FG004|Overall Study|Intercurrent Illness|0|||
30668313|NCT00509899|58682238|FG005|Overall Study|Intercurrent Illness|1|||
30855503|NCT00103285|58883184|FG001|Response Assignment|Death|5|||
30580042|NCT00473746|58591015|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
30580043|NCT00473746|58591016|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
30580044|NCT00473746|58591017|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
30580045|NCT00473746|58591018|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
30580046|NCT00473746|58591014|FG000|Period 2 (Phase 2)|Reason not specified|0|||
30580047|NCT00473746|58591015|FG001|Period 2 (Phase 2)|Reason not specified|0|||
30580048|NCT00473746|58591016|FG002|Period 2 (Phase 2)|Reason not specified|0|||
30580049|NCT00473746|58591017|FG003|Period 2 (Phase 2)|Reason not specified|0|||
30580050|NCT00473746|58591018|FG004|Period 2 (Phase 2)|Reason not specified|3|||
30580051|NCT00473668|58591035|FG000|Overall Study|Withdrawal by Subject|0|||
30580052|NCT00473668|58591036|FG001|Overall Study|Withdrawal by Subject|2|||
30580053|NCT00473668|58591037|FG002|Overall Study|Withdrawal by Subject|0|||
30580054|NCT00473668|58591035|FG000|Overall Study|Migrated/moved from study area|3|||
30580055|NCT00473668|58591036|FG001|Overall Study|Migrated/moved from study area|2|||
30580056|NCT00473668|58591037|FG002|Overall Study|Migrated/moved from study area|0|||
30580057|NCT00473668|58591035|FG000|Overall Study|Lost to Follow-up|0|||
30580058|NCT00473668|58591036|FG001|Overall Study|Lost to Follow-up|4|||
30580059|NCT00473668|58591037|FG002|Overall Study|Lost to Follow-up|6|||
30580060|NCT00473668|58591035|FG000|Overall Study|Other|2|||
30580061|NCT00473668|58591036|FG001|Overall Study|Other|3|||
30580062|NCT00473668|58591037|FG002|Overall Study|Other|4|||
30580063|NCT00473590|58591047|FG000|Overall Study|Adverse Event|3|||
30580064|NCT00473590|58591048|FG001|Overall Study|Adverse Event|3|||
30580065|NCT00473590|58591047|FG000|Overall Study|Death|4|||
30580066|NCT00473590|58591048|FG001|Overall Study|Death|2|||
30580067|NCT00473590|58591047|FG000|Overall Study|Progression not resulting in death|24|||
30580068|NCT00473590|58591048|FG001|Overall Study|Progression not resulting in death|20|||
30580069|NCT00473590|58591047|FG000|Overall Study|Non-protocol-specified therapy|7|||
30580070|NCT00473590|58591048|FG001|Overall Study|Non-protocol-specified therapy|5|||
30580071|NCT00473590|58591047|FG000|Overall Study|Physician Decision|2|||
30580072|NCT00473590|58591048|FG001|Overall Study|Physician Decision|4|||
30580073|NCT00473590|58591047|FG000|Overall Study|Withdrawal by Subject|5|||
30580074|NCT00473590|58591048|FG001|Overall Study|Withdrawal by Subject|3|||
30580075|NCT00473590|58591047|FG000|Overall Study|Other|0|||
30580076|NCT00473590|58591048|FG001|Overall Study|Other|1|||
30580077|NCT00473512|58591059|FG000|Period 1 (Phase 1)|Adverse Event|0|||
30580078|NCT00473512|58591060|FG001|Period 1 (Phase 1)|Adverse Event|0|||
30580079|NCT00473512|58591061|FG002|Period 1 (Phase 1)|Adverse Event|0|||
30580080|NCT00473512|58591062|FG003|Period 1 (Phase 1)|Adverse Event|5|||
30580081|NCT00473512|58591063|FG004|Period 1 (Phase 1)|Adverse Event|0|||
30580082|NCT00473512|58591059|FG000|Period 1 (Phase 1)|Death|0|||
30580083|NCT00473512|58591060|FG001|Period 1 (Phase 1)|Death|0|||
30580084|NCT00473512|58591061|FG002|Period 1 (Phase 1)|Death|0|||
30580085|NCT00473512|58591062|FG003|Period 1 (Phase 1)|Death|1|||
30580086|NCT00473512|58591063|FG004|Period 1 (Phase 1)|Death|0|||
30580087|NCT00473512|58591059|FG000|Period 1 (Phase 1)|Disease Progression|1|||
30580088|NCT00473512|58591060|FG001|Period 1 (Phase 1)|Disease Progression|1|||
30580089|NCT00473512|58591061|FG002|Period 1 (Phase 1)|Disease Progression|0|||
30580090|NCT00473512|58591062|FG003|Period 1 (Phase 1)|Disease Progression|10|||
30580091|NCT00473512|58591063|FG004|Period 1 (Phase 1)|Disease Progression|1|||
30580092|NCT00473512|58591059|FG000|Period 1 (Phase 1)|Other|0|||
30580093|NCT00473512|58591060|FG001|Period 1 (Phase 1)|Other|0|||
30580094|NCT00473512|58591061|FG002|Period 1 (Phase 1)|Other|0|||
30580095|NCT00473512|58591062|FG003|Period 1 (Phase 1)|Other|1|||
30580096|NCT00473512|58591063|FG004|Period 1 (Phase 1)|Other|0|||
30580097|NCT00473512|58591059|FG000|Period 2 (Phase 2)|Adverse Event|0|||
30580098|NCT00473512|58591060|FG001|Period 2 (Phase 2)|Adverse Event|0|||
30580099|NCT00473512|58591061|FG002|Period 2 (Phase 2)|Adverse Event|0|||
30580100|NCT00473512|58591062|FG003|Period 2 (Phase 2)|Adverse Event|1|||
30580101|NCT00473512|58591063|FG004|Period 2 (Phase 2)|Adverse Event|0|||
30580102|NCT00473512|58591059|FG000|Period 2 (Phase 2)|Death|0|||
30580103|NCT00473512|58591060|FG001|Period 2 (Phase 2)|Death|0|||
30580104|NCT00473512|58591061|FG002|Period 2 (Phase 2)|Death|0|||
30580105|NCT00473512|58591062|FG003|Period 2 (Phase 2)|Death|1|||
30580106|NCT00473512|58591063|FG004|Period 2 (Phase 2)|Death|1|||
30580107|NCT00473512|58591059|FG000|Period 2 (Phase 2)|Disease Progression|0|||
30580108|NCT00473512|58591060|FG001|Period 2 (Phase 2)|Disease Progression|2|||
30580109|NCT00473512|58591061|FG002|Period 2 (Phase 2)|Disease Progression|2|||
30580110|NCT00473512|58591062|FG003|Period 2 (Phase 2)|Disease Progression|17|||
30580111|NCT00473512|58591063|FG004|Period 2 (Phase 2)|Disease Progression|1|||
30580112|NCT00473512|58591059|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
30580113|NCT00473512|58591060|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
30580114|NCT00473512|58591061|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
30580115|NCT00473512|58591062|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
30580116|NCT00473512|58591063|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
30580117|NCT00473512|58591059|FG000|Period 2 (Phase 2)|Other|1|||
30580118|NCT00473512|58591060|FG001|Period 2 (Phase 2)|Other|0|||
30580119|NCT00473512|58591061|FG002|Period 2 (Phase 2)|Other|0|||
30580120|NCT00473512|58591062|FG003|Period 2 (Phase 2)|Other|3|||
30580121|NCT00473512|58591063|FG004|Period 2 (Phase 2)|Other|0|||
30580122|NCT00473434|58591083|FG000|Overall Study|Physician Decision|3|||
30580123|NCT00473434|58591083|FG000|Overall Study|Withdrawal by Subject|9|||
30580124|NCT00473434|58591083|FG000|Overall Study|Compliance|3|||
30580125|NCT00473434|58591083|FG000|Overall Study|Lack of Efficacy|3|||
30580126|NCT00473434|58591083|FG000|Overall Study|Adverse Event|3|||
30580127|NCT00473434|58591083|FG000|Overall Study|Patient was selling medication to others|1|||
30580128|NCT00473434|58591083|FG000|Overall Study|Safety evaluation|1|||
30580129|NCT00473434|58591083|FG000|Overall Study|Reason not specified|6|||
30580130|NCT00473434|58591083|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
30580131|NCT00473434|58591083|FG000|Overall Study|Switching to trial medication|1|||
30580132|NCT00473434|58591083|FG000|Overall Study|No longer required|1|||
30580133|NCT00473083|58591103|FG000|Overall Study|Adverse Event|1|||
30580134|NCT00473083|58591104|FG001|Overall Study|Adverse Event|0|||
30580135|NCT00473083|58591105|FG002|Overall Study|Adverse Event|0|||
30580136|NCT00472420|58591116|FG000|Induction Treatment Period|Physician Decision|9|||
30580137|NCT00472420|58591116|FG000|Induction Treatment Period|Adverse Event|3|||
30580138|NCT00472420|58591116|FG000|Induction Treatment Period|Non-compliance|1|||
30580139|NCT00472420|58591116|FG000|Induction Treatment Period|Death|3|||
30580140|NCT00472420|58591116|FG000|Follow-up Period|Death|5|||
30580141|NCT00472420|58591116|FG000|Follow-up Period|Physician Decision|9|||
30580142|NCT00472420|58591116|FG000|Follow-up Period|Lost to Follow-up|2|||
30580143|NCT00472420|58591116|FG000|Follow-up Period|Protocol Violation|1|||
30580144|NCT00472303|58591122|FG000|Titration Phase|Adverse Event|22|||
30580145|NCT00472303|58591123|FG001|Titration Phase|Adverse Event|12|||
30855504|NCT00103285|58883185|FG002|Response Assignment|Death|2|||
30855505|NCT00103285|58883186|FG003|Response Assignment|Death|2|||
30855506|NCT00103285|58883187|FG004|Response Assignment|Death|3|||
30855507|NCT00103285|58883188|FG005|Response Assignment|Death|1|||
30855508|NCT00103285|58883189|FG006|Response Assignment|Death|0|||
30855509|NCT00103285|58883190|FG007|Response Assignment|Death|8|||
30855510|NCT00103285|58883183|FG000|Response Assignment|Lost to Follow-up|0|||
30855511|NCT00103285|58883184|FG001|Response Assignment|Lost to Follow-up|9|||
30855512|NCT00103285|58883185|FG002|Response Assignment|Lost to Follow-up|5|||
30855513|NCT00103285|58883186|FG003|Response Assignment|Lost to Follow-up|5|||
30580146|NCT00472303|58591124|FG002|Titration Phase|Adverse Event|0|||
30580147|NCT00472303|58591122|FG000|Titration Phase|Death|4|||
30580148|NCT00472303|58591123|FG001|Titration Phase|Death|2|||
30580149|NCT00472303|58591124|FG002|Titration Phase|Death|0|||
30580150|NCT00472303|58591122|FG000|Titration Phase|Lack of Efficacy|10|||
30580151|NCT00472303|58591123|FG001|Titration Phase|Lack of Efficacy|0|||
30580152|NCT00472303|58591124|FG002|Titration Phase|Lack of Efficacy|0|||
30580153|NCT00472303|58591122|FG000|Titration Phase|Withdrawal by Subject|16|||
30580154|NCT00472303|58591123|FG001|Titration Phase|Withdrawal by Subject|13|||
30580155|NCT00472303|58591124|FG002|Titration Phase|Withdrawal by Subject|0|||
30580156|NCT00472303|58591122|FG000|Titration Phase|Trial Medication non-compliant|4|||
30580157|NCT00472303|58591123|FG001|Titration Phase|Trial Medication non-compliant|1|||
30580158|NCT00472303|58591124|FG002|Titration Phase|Trial Medication non-compliant|0|||
30580159|NCT00472303|58591122|FG000|Titration Phase|Other|3|||
30580160|NCT00472303|58591123|FG001|Titration Phase|Other|1|||
30580161|NCT00472303|58591124|FG002|Titration Phase|Other|0|||
30580162|NCT00472303|58591122|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
30580163|NCT00472303|58591123|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
30580164|NCT00472303|58591124|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
30580165|NCT00472303|58591122|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
30580166|NCT00472303|58591123|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
30580167|NCT00472303|58591124|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
30580168|NCT00472303|58591122|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
30580169|NCT00472303|58591123|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
30580170|NCT00472303|58591124|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
30580171|NCT00472303|58591122|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
30580172|NCT00472303|58591123|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
30580173|NCT00472303|58591124|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
30580174|NCT00472303|58591122|FG000|Discontinuations After Titration Phase|Other|5|||
30580175|NCT00472303|58591123|FG001|Discontinuations After Titration Phase|Other|0|||
30580176|NCT00472303|58591124|FG002|Discontinuations After Titration Phase|Other|0|||
30580177|NCT00472303|58591122|FG000|Maintenance Phase|Adverse Event|5|||
30580178|NCT00472303|58591123|FG001|Maintenance Phase|Adverse Event|6|||
30580179|NCT00472303|58591124|FG002|Maintenance Phase|Adverse Event|6|||
30855514|NCT00103285|58883187|FG004|Response Assignment|Lost to Follow-up|1|||
30855515|NCT00103285|58883188|FG005|Response Assignment|Lost to Follow-up|2|||
30580180|NCT00472303|58591122|FG000|Maintenance Phase|Death|3|||
30580181|NCT00472303|58591123|FG001|Maintenance Phase|Death|0|||
30580182|NCT00472303|58591124|FG002|Maintenance Phase|Death|2|||
30855516|NCT00103285|58883189|FG006|Response Assignment|Lost to Follow-up|2|||
30580183|NCT00472303|58591122|FG000|Maintenance Phase|Lack of Efficacy|2|||
30855517|NCT00103285|58883190|FG007|Response Assignment|Lost to Follow-up|5|||
30580184|NCT00472303|58591123|FG001|Maintenance Phase|Lack of Efficacy|2|||
30580185|NCT00472303|58591124|FG002|Maintenance Phase|Lack of Efficacy|4|||
30580186|NCT00472303|58591122|FG000|Maintenance Phase|Withdrawal by Subject|6|||
30958743|NCT01579565|59023937|FG000|Randomized|Adverse Event|1|||
30580187|NCT00472303|58591123|FG001|Maintenance Phase|Withdrawal by Subject|7|||
30580188|NCT00472303|58591124|FG002|Maintenance Phase|Withdrawal by Subject|3|||
30580189|NCT00472303|58591122|FG000|Maintenance Phase|Trial medication non-compliant|0|||
30580190|NCT00472303|58591123|FG001|Maintenance Phase|Trial medication non-compliant|0|||
30580191|NCT00472303|58591124|FG002|Maintenance Phase|Trial medication non-compliant|1|||
30580192|NCT00472303|58591122|FG000|Maintenance Phase|Resolution of pain|0|||
30580193|NCT00472303|58591123|FG001|Maintenance Phase|Resolution of pain|0|||
30580194|NCT00472303|58591124|FG002|Maintenance Phase|Resolution of pain|1|||
30580195|NCT00472303|58591122|FG000|Maintenance Phase|Other|1|||
30580196|NCT00472303|58591123|FG001|Maintenance Phase|Other|1|||
30580197|NCT00472303|58591124|FG002|Maintenance Phase|Other|0|||
30580198|NCT00471718|58591152|FG000|Overall Study|Adverse Event|3|||
30580199|NCT00471718|58591152|FG000|Overall Study|other complicating disease|1|||
30580200|NCT00471718|58591152|FG000|Overall Study|disease progression|22|||
30580201|NCT00471718|58591152|FG000|Overall Study|Withdrawal by Subject|1|||
30668314|NCT00509899|58682239|FG006|Overall Study|Intercurrent Illness|0|||
30668315|NCT00509899|58682240|FG007|Overall Study|Intercurrent Illness|0|||
30668316|NCT00509899|58682233|FG000|Overall Study|Death|2|||
30668317|NCT00509899|58682234|FG001|Overall Study|Death|2|||
30668318|NCT00509899|58682235|FG002|Overall Study|Death|3|||
30668319|NCT00509899|58682236|FG003|Overall Study|Death|0|||
30668320|NCT00509899|58682237|FG004|Overall Study|Death|1|||
30668321|NCT00509899|58682238|FG005|Overall Study|Death|1|||
30668322|NCT00509899|58682239|FG006|Overall Study|Death|1|||
30668323|NCT00509899|58682240|FG007|Overall Study|Death|1|||
30668324|NCT00509899|58682233|FG000|Overall Study|Lack of Efficacy|1|||
30668325|NCT00509899|58682234|FG001|Overall Study|Lack of Efficacy|0|||
30668326|NCT00509899|58682235|FG002|Overall Study|Lack of Efficacy|2|||
30668327|NCT00509899|58682236|FG003|Overall Study|Lack of Efficacy|0|||
30668328|NCT00509899|58682237|FG004|Overall Study|Lack of Efficacy|0|||
30668329|NCT00509899|58682238|FG005|Overall Study|Lack of Efficacy|1|||
30668330|NCT00509899|58682239|FG006|Overall Study|Lack of Efficacy|0|||
30668331|NCT00509899|58682240|FG007|Overall Study|Lack of Efficacy|0|||
30668332|NCT00862836|58682254|FG000|Overall Study|Withdrawal by Subject|1|||
30668333|NCT00820755|58682258|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
30668334|NCT00820755|58682259|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
30668335|NCT00820755|58682260|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
30668336|NCT00820755|58682258|FG000|Period 1: Combination Therapy Phase|Death|28|||
30668337|NCT00820755|58682259|FG001|Period 1: Combination Therapy Phase|Death|0|||
30668338|NCT00820755|58682260|FG002|Period 1: Combination Therapy Phase|Death|0|||
30668339|NCT00820755|58682258|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
30668340|NCT00820755|58682259|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
30668341|NCT00820755|58682260|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
30668342|NCT00820755|58682258|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
30668343|NCT00820755|58682259|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
30668344|NCT00820755|58682260|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
30668345|NCT00820755|58682258|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
30668346|NCT00820755|58682259|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
30668347|NCT00820755|58682260|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
30668348|NCT00820755|58682258|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
30668349|NCT00820755|58682259|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
30668350|NCT00820755|58682260|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
30668351|NCT00820755|58682258|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
30668352|NCT00820755|58682259|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
30668353|NCT00820755|58682260|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
30668354|NCT00820755|58682258|FG000|Period 1: Combination Therapy Phase|Other|11|||
30668355|NCT00820755|58682259|FG001|Period 1: Combination Therapy Phase|Other|0|||
30668356|NCT00820755|58682260|FG002|Period 1: Combination Therapy Phase|Other|0|||
30668357|NCT00820755|58682258|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
30668358|NCT00820755|58682259|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
30668359|NCT00820755|58682260|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
30668360|NCT00820599|58682268|FG000|Overall Study|Death|129|||
30668361|NCT00820599|58682268|FG000|Overall Study|Withdrawal by Subject|2|||
30855518|NCT00103285|58883183|FG000|Response Assignment|Physician Decision|0|||
30668362|NCT00819741|58682274|FG000|Overall Study|Adverse Event|5|||
30668363|NCT00819741|58682275|FG001|Overall Study|Adverse Event|2|||
30668364|NCT00819741|58682274|FG000|Overall Study|Lack of Efficacy|0|||
30668365|NCT00819741|58682275|FG001|Overall Study|Lack of Efficacy|2|||
30668366|NCT00819741|58682274|FG000|Overall Study|Lost to Follow-up|3|||
30668367|NCT00819741|58682275|FG001|Overall Study|Lost to Follow-up|1|||
30668368|NCT00819741|58682274|FG000|Overall Study|Protocol Violation|3|||
30580202|NCT00471445|58591162|FG000|Overall Study|Withdrawal by Subject|1|||
30580203|NCT00471445|58591163|FG001|Overall Study|Withdrawal by Subject|1|||
30580204|NCT00471445|58591162|FG000|Overall Study|Ineligible|1|||
30580205|NCT00471445|58591163|FG001|Overall Study|Ineligible|0|||
30580206|NCT00471445|58591162|FG000|Overall Study|Protocol Violation|0|||
30580207|NCT00471445|58591163|FG001|Overall Study|Protocol Violation|1|||
30580208|NCT00471328|58591171|FG000|Core Phase|Adverse Event|18|||
30580209|NCT00471328|58591172|FG001|Core Phase|Adverse Event|6|||
30580210|NCT00471328|58591171|FG000|Core Phase|Death|8|||
30580211|NCT00471328|58591172|FG001|Core Phase|Death|4|||
30580212|NCT00471328|58591171|FG000|Core Phase|Withdrawal by Subject|2|||
30580213|NCT00471328|58591172|FG001|Core Phase|Withdrawal by Subject|2|||
30580214|NCT00471328|58591171|FG000|Core Phase|Abnormal laboratory value|1|||
30580215|NCT00471328|58591172|FG001|Core Phase|Abnormal laboratory value|0|||
30580216|NCT00471328|58591171|FG000|Core Phase|Disease Progression|78|||
30580217|NCT00471328|58591172|FG001|Core Phase|Disease Progression|53|||
30580218|NCT00471328|58591171|FG000|Core Phase|Administrative Problem|0|||
30580219|NCT00471328|58591172|FG001|Core Phase|Administrative Problem|1|||
30580220|NCT00471328|58591171|FG000|Core Phase|Protocol Deviation|0|||
30580221|NCT00471328|58591172|FG001|Core Phase|Protocol Deviation|1|||
30580222|NCT00471328|58591171|FG000|Extension Phase|Adverse Event|3|||
30580223|NCT00471328|58591172|FG001|Extension Phase|Adverse Event|12|||
30580224|NCT00471328|58591171|FG000|Extension Phase|Withdrawal by Subject|0|||
30580225|NCT00471328|58591172|FG001|Extension Phase|Withdrawal by Subject|2|||
30855519|NCT00103285|58883184|FG001|Response Assignment|Physician Decision|13|||
30855520|NCT00103285|58883185|FG002|Response Assignment|Physician Decision|14|||
30855521|NCT00103285|58883186|FG003|Response Assignment|Physician Decision|9|||
30855522|NCT00103285|58883187|FG004|Response Assignment|Physician Decision|13|||
30580226|NCT00471328|58591171|FG000|Extension Phase|Death|1|||
30580227|NCT00471328|58591172|FG001|Extension Phase|Death|7|||
30580228|NCT00471328|58591171|FG000|Extension Phase|Protocol Deviation|3|||
30580229|NCT00471328|58591172|FG001|Extension Phase|Protocol Deviation|1|||
30580230|NCT00471328|58591171|FG000|Extension Phase|Treatment duration as per protocol|0|||
30580231|NCT00471328|58591172|FG001|Extension Phase|Treatment duration as per protocol|1|||
30580232|NCT00471328|58591171|FG000|Extension Phase|Disease Progression|32|||
30580233|NCT00471328|58591172|FG001|Extension Phase|Disease Progression|44|||
30580234|NCT00471328|58591171|FG000|Extension Phase|New cancer Therapy|1|||
30668369|NCT00819741|58682275|FG001|Overall Study|Protocol Violation|4|||
30668370|NCT00819741|58682274|FG000|Overall Study|Withdrawal by Subject|2|||
30668371|NCT00819741|58682275|FG001|Overall Study|Withdrawal by Subject|2|||
30668372|NCT00819741|58682274|FG000|Overall Study|Unclassified|6|||
30668373|NCT00819741|58682275|FG001|Overall Study|Unclassified|0|||
30668374|NCT00819741|58682274|FG000|Overall Study|Reasons unknown|3|||
30668375|NCT00819741|58682275|FG001|Overall Study|Reasons unknown|3|||
30668376|NCT00862134|58682283|FG000|Overall Study|Death|1|||
30668377|NCT00862134|58682284|FG001|Overall Study|Death|0|||
30668378|NCT00862134|58682283|FG000|Overall Study|Physician Decision|0|||
30668379|NCT00862134|58682284|FG001|Overall Study|Physician Decision|1|||
30668380|NCT00862134|58682283|FG000|Overall Study|Withdrawal by Subject|1|||
30668381|NCT00862134|58682284|FG001|Overall Study|Withdrawal by Subject|2|||
30668382|NCT00862134|58682283|FG000|Overall Study|Sponsor terminated study|5|||
30668383|NCT00862134|58682284|FG001|Overall Study|Sponsor terminated study|7|||
30668384|NCT00862134|58682283|FG000|Overall Study|Adverse Event|2|||
30668385|NCT00862134|58682284|FG001|Overall Study|Adverse Event|2|||
30668386|NCT00862134|58682283|FG000|Overall Study|Withdrew prior to dosing|2|||
30668387|NCT00862134|58682284|FG001|Overall Study|Withdrew prior to dosing|0|||
30668388|NCT00848484|58682292|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
30668389|NCT00848484|58682293|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
30668390|NCT00848484|58682292|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
30668391|NCT00848484|58682293|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
30668392|NCT00848484|58682292|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
30668393|NCT00848484|58682293|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
30855523|NCT00103285|58883188|FG005|Response Assignment|Physician Decision|7|||
30855524|NCT00103285|58883189|FG006|Response Assignment|Physician Decision|4|||
30855525|NCT00103285|58883190|FG007|Response Assignment|Physician Decision|35|||
30580235|NCT00471328|58591172|FG001|Extension Phase|New cancer Therapy|0|||
30580236|NCT00471328|58591171|FG000|Extension Phase|Administrative Problem|1|||
30580237|NCT00471328|58591172|FG001|Extension Phase|Administrative Problem|0|||
30668394|NCT00848484|58682292|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
30580238|NCT00470470|58591180|FG000|Overall Study|Adverse Event|2|||
30580239|NCT00470470|58591180|FG000|Overall Study|Death|2|||
30580240|NCT00470470|58591180|FG000|Overall Study|Not treated|1|||
30580241|NCT00470275|58591184|FG000|Overall Study|Death|1|||
30580242|NCT00470275|58591184|FG000|Overall Study|Lack of Efficacy|7|||
30580243|NCT00470275|58591184|FG000|Overall Study|Withdrawal by Subject|2|||
30580244|NCT00470158|58591193|FG000|Overall Study|Death|0|||
30580245|NCT00470158|58591194|FG001|Overall Study|Death|0|||
30580246|NCT00470158|58591195|FG002|Overall Study|Death|0|||
30668395|NCT00848484|58682293|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
30668396|NCT00848484|58682292|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
30580247|NCT00470158|58591196|FG003|Overall Study|Death|0|||
30580248|NCT00470158|58591197|FG004|Overall Study|Death|2|||
30580249|NCT00470158|58591193|FG000|Overall Study|Lost to Follow-up|7|||
30580250|NCT00470158|58591194|FG001|Overall Study|Lost to Follow-up|8|||
30580251|NCT00470158|58591195|FG002|Overall Study|Lost to Follow-up|8|||
30580252|NCT00470158|58591196|FG003|Overall Study|Lost to Follow-up|5|||
30580253|NCT00470158|58591197|FG004|Overall Study|Lost to Follow-up|4|||
30580254|NCT00470158|58591193|FG000|Overall Study|Protocol Violation|1|||
30580255|NCT00470158|58591194|FG001|Overall Study|Protocol Violation|0|||
30580256|NCT00470158|58591195|FG002|Overall Study|Protocol Violation|0|||
30580257|NCT00470158|58591196|FG003|Overall Study|Protocol Violation|0|||
30580258|NCT00470158|58591197|FG004|Overall Study|Protocol Violation|0|||
30580259|NCT00475540|58591211|FG000|36 Months|Lost to Follow-up|4|||
30580260|NCT00475540|58591212|FG001|36 Months|Lost to Follow-up|4|||
30580261|NCT00475540|58591211|FG000|36 Months|Death|1|||
30580262|NCT00475540|58591212|FG001|36 Months|Death|2|||
30580263|NCT00475540|58591211|FG000|36 Months|Censored due to reoperation|3|||
30580264|NCT00475540|58591212|FG001|36 Months|Censored due to reoperation|0|||
30580265|NCT00472186|58591220|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
30580266|NCT00472186|58591221|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
30580267|NCT00479713|58591231|FG000|Overall Study|Adverse Event|8|||
30580268|NCT00479713|58591232|FG001|Overall Study|Adverse Event|6|||
30580269|NCT00479713|58591231|FG000|Overall Study|Death|1|||
30580270|NCT00479713|58591232|FG001|Overall Study|Death|0|||
30580271|NCT00479713|58591231|FG000|Overall Study|Lost to Follow-up|0|||
30580272|NCT00479713|58591232|FG001|Overall Study|Lost to Follow-up|1|||
30580273|NCT00479713|58591231|FG000|Overall Study|Protocol Violation|0|||
30580274|NCT00479713|58591232|FG001|Overall Study|Protocol Violation|1|||
30580275|NCT00479713|58591231|FG000|Overall Study|Withdrawal by Subject|4|||
30580276|NCT00479713|58591232|FG001|Overall Study|Withdrawal by Subject|1|||
30580277|NCT00474526|58591264|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
30580278|NCT00474526|58591265|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
30580279|NCT00474526|58591266|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
30580280|NCT00474526|58591267|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
30580281|NCT00474526|58591268|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
30580282|NCT00474526|58591269|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
30580283|NCT00474526|58591270|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
30580284|NCT00474526|58591271|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
30580285|NCT00474526|58591272|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
30580286|NCT00474526|58591273|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
30580287|NCT00474526|58591274|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
30580288|NCT00474526|58591275|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
30580289|NCT00474526|58591276|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
30580290|NCT00474526|58591277|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
30580291|NCT00474526|58591278|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
30580292|NCT00474526|58591279|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
30580293|NCT00474526|58591280|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
30580294|NCT00474526|58591264|FG000|Overall Study|Adverse Event|2|||
30580295|NCT00474526|58591265|FG001|Overall Study|Adverse Event|0|||
30580296|NCT00474526|58591266|FG002|Overall Study|Adverse Event|2|||
30580297|NCT00474526|58591267|FG003|Overall Study|Adverse Event|4|||
30580298|NCT00474526|58591268|FG004|Overall Study|Adverse Event|2|||
30580299|NCT00474526|58591269|FG005|Overall Study|Adverse Event|1|||
30580300|NCT00474526|58591270|FG006|Overall Study|Adverse Event|1|||
30580301|NCT00474526|58591271|FG007|Overall Study|Adverse Event|0|||
30580302|NCT00474526|58591272|FG008|Overall Study|Adverse Event|0|||
30580303|NCT00474526|58591273|FG009|Overall Study|Adverse Event|0|||
30580304|NCT00474526|58591274|FG010|Overall Study|Adverse Event|0|||
30580305|NCT00474526|58591275|FG011|Overall Study|Adverse Event|0|||
30580306|NCT00474526|58591276|FG012|Overall Study|Adverse Event|0|||
30580307|NCT00474526|58591277|FG013|Overall Study|Adverse Event|0|||
30580308|NCT00474526|58591278|FG014|Overall Study|Adverse Event|1|||
30580309|NCT00474526|58591279|FG015|Overall Study|Adverse Event|1|||
30580310|NCT00474526|58591280|FG016|Overall Study|Adverse Event|0|||
30580311|NCT00474526|58591264|FG000|Overall Study|Death|0|||
30580312|NCT00474526|58591265|FG001|Overall Study|Death|0|||
30580313|NCT00474526|58591266|FG002|Overall Study|Death|0|||
30580314|NCT00474526|58591267|FG003|Overall Study|Death|0|||
30580315|NCT00474526|58591268|FG004|Overall Study|Death|0|||
30580316|NCT00474526|58591269|FG005|Overall Study|Death|0|||
30580317|NCT00474526|58591270|FG006|Overall Study|Death|0|||
30580318|NCT00474526|58591271|FG007|Overall Study|Death|0|||
30580319|NCT00474526|58591272|FG008|Overall Study|Death|0|||
30580320|NCT00474526|58591273|FG009|Overall Study|Death|0|||
30580321|NCT00474526|58591274|FG010|Overall Study|Death|0|||
30580322|NCT00474526|58591275|FG011|Overall Study|Death|0|||
30580323|NCT00474526|58591276|FG012|Overall Study|Death|0|||
30580324|NCT00474526|58591277|FG013|Overall Study|Death|3|||
30580325|NCT00474526|58591278|FG014|Overall Study|Death|0|||
30580326|NCT00474526|58591279|FG015|Overall Study|Death|0|||
30580327|NCT00474526|58591280|FG016|Overall Study|Death|0|||
30580328|NCT00474526|58591264|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580329|NCT00474526|58591265|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
30580330|NCT00474526|58591266|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580331|NCT00474526|58591267|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
30580332|NCT00474526|58591268|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
30580333|NCT00474526|58591269|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580334|NCT00474526|58591270|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580335|NCT00474526|58591271|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580336|NCT00474526|58591272|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580337|NCT00474526|58591273|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580338|NCT00474526|58591274|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580339|NCT00474526|58591275|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580340|NCT00474526|58591276|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580341|NCT00474526|58591277|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
30580342|NCT00474526|58591278|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
30580343|NCT00474526|58591279|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580344|NCT00474526|58591280|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
30580345|NCT00474526|58591264|FG000|Overall Study|Lost to Follow-up|8|||
30580346|NCT00474526|58591265|FG001|Overall Study|Lost to Follow-up|6|||
30580347|NCT00474526|58591266|FG002|Overall Study|Lost to Follow-up|13|||
30580348|NCT00474526|58591267|FG003|Overall Study|Lost to Follow-up|29|||
30580349|NCT00474526|58591268|FG004|Overall Study|Lost to Follow-up|11|||
30580350|NCT00474526|58591269|FG005|Overall Study|Lost to Follow-up|5|||
30580351|NCT00474526|58591270|FG006|Overall Study|Lost to Follow-up|8|||
30580352|NCT00474526|58591271|FG007|Overall Study|Lost to Follow-up|1|||
30580353|NCT00474526|58591272|FG008|Overall Study|Lost to Follow-up|0|||
30580354|NCT00474526|58591273|FG009|Overall Study|Lost to Follow-up|6|||
30580355|NCT00474526|58591274|FG010|Overall Study|Lost to Follow-up|2|||
30580356|NCT00474526|58591275|FG011|Overall Study|Lost to Follow-up|4|||
30580357|NCT00474526|58591276|FG012|Overall Study|Lost to Follow-up|6|||
30580358|NCT00474526|58591277|FG013|Overall Study|Lost to Follow-up|74|||
30580359|NCT00474526|58591278|FG014|Overall Study|Lost to Follow-up|29|||
30580360|NCT00474526|58591279|FG015|Overall Study|Lost to Follow-up|4|||
30580361|NCT00474526|58591280|FG016|Overall Study|Lost to Follow-up|5|||
30580362|NCT00474526|58591264|FG000|Overall Study|Protocol Violation|2|||
30580363|NCT00474526|58591265|FG001|Overall Study|Protocol Violation|6|||
30580364|NCT00474526|58591266|FG002|Overall Study|Protocol Violation|4|||
30580365|NCT00474526|58591267|FG003|Overall Study|Protocol Violation|12|||
30580366|NCT00474526|58591268|FG004|Overall Study|Protocol Violation|3|||
30580367|NCT00474526|58591269|FG005|Overall Study|Protocol Violation|1|||
30580368|NCT00474526|58591270|FG006|Overall Study|Protocol Violation|3|||
30580369|NCT00474526|58591271|FG007|Overall Study|Protocol Violation|0|||
30580370|NCT00474526|58591272|FG008|Overall Study|Protocol Violation|0|||
30580371|NCT00474526|58591273|FG009|Overall Study|Protocol Violation|4|||
30580372|NCT00474526|58591274|FG010|Overall Study|Protocol Violation|2|||
30580373|NCT00474526|58591275|FG011|Overall Study|Protocol Violation|2|||
30580374|NCT00474526|58591276|FG012|Overall Study|Protocol Violation|4|||
30580375|NCT00474526|58591277|FG013|Overall Study|Protocol Violation|19|||
30580376|NCT00474526|58591278|FG014|Overall Study|Protocol Violation|9|||
30580377|NCT00474526|58591279|FG015|Overall Study|Protocol Violation|6|||
30580378|NCT00474526|58591280|FG016|Overall Study|Protocol Violation|2|||
30580379|NCT00474526|58591264|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
30580380|NCT00474526|58591265|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
30580381|NCT00474526|58591266|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
30580382|NCT00474526|58591267|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
30580383|NCT00474526|58591268|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
30580384|NCT00474526|58591269|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
30580385|NCT00474526|58591270|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
30580386|NCT00474526|58591271|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
30580387|NCT00474526|58591272|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
30580388|NCT00474526|58591273|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
30580389|NCT00474526|58591274|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
30580390|NCT00474526|58591275|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
30580391|NCT00474526|58591276|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
30580392|NCT00474526|58591277|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
30580393|NCT00474526|58591278|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
30958744|NCT01579565|59023938|FG001|Randomized|Adverse Event|3|||
30580394|NCT00474526|58591279|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
30580395|NCT00474526|58591280|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
30580396|NCT00474526|58591264|FG000|Overall Study|Withdrawal by Subject|9|||
30580397|NCT00474526|58591265|FG001|Overall Study|Withdrawal by Subject|24|||
30580398|NCT00474526|58591266|FG002|Overall Study|Withdrawal by Subject|21|||
30580399|NCT00474526|58591267|FG003|Overall Study|Withdrawal by Subject|52|||
30580400|NCT00474526|58591268|FG004|Overall Study|Withdrawal by Subject|38|||
30580401|NCT00474526|58591269|FG005|Overall Study|Withdrawal by Subject|6|||
30580402|NCT00474526|58591270|FG006|Overall Study|Withdrawal by Subject|12|||
30580403|NCT00474526|58591271|FG007|Overall Study|Withdrawal by Subject|4|||
30580404|NCT00474526|58591272|FG008|Overall Study|Withdrawal by Subject|4|||
30580405|NCT00474526|58591273|FG009|Overall Study|Withdrawal by Subject|13|||
30580406|NCT00474526|58591274|FG010|Overall Study|Withdrawal by Subject|5|||
30580407|NCT00474526|58591275|FG011|Overall Study|Withdrawal by Subject|4|||
30580408|NCT00474526|58591276|FG012|Overall Study|Withdrawal by Subject|4|||
30580409|NCT00474526|58591277|FG013|Overall Study|Withdrawal by Subject|37|||
30580410|NCT00474526|58591278|FG014|Overall Study|Withdrawal by Subject|22|||
30580411|NCT00474526|58591279|FG015|Overall Study|Withdrawal by Subject|1|||
30580412|NCT00474526|58591280|FG016|Overall Study|Withdrawal by Subject|1|||
30580413|NCT00478426|58591366|FG000|Overall Study|Withdrawal by Subject|1|||
30580414|NCT00477412|58591374|FG000|Overall Study|Death|0|||
30580415|NCT00477412|58591375|FG001|Overall Study|Death|0|||
30580416|NCT00477412|58591376|FG002|Overall Study|Death|0|||
30580417|NCT00477412|58591377|FG003|Overall Study|Death|4|||
30580418|NCT00477412|58591374|FG000|Overall Study|Lost to Follow-up|0|||
30580419|NCT00477412|58591375|FG001|Overall Study|Lost to Follow-up|0|||
30580420|NCT00477412|58591376|FG002|Overall Study|Lost to Follow-up|0|||
30580421|NCT00477412|58591377|FG003|Overall Study|Lost to Follow-up|1|||
30580422|NCT00477412|58591374|FG000|Overall Study|Withdrawal by Subject|0|||
30580423|NCT00477412|58591375|FG001|Overall Study|Withdrawal by Subject|0|||
30580424|NCT00477412|58591376|FG002|Overall Study|Withdrawal by Subject|0|||
30580425|NCT00477412|58591377|FG003|Overall Study|Withdrawal by Subject|2|||
30580426|NCT00477412|58591374|FG000|Overall Study|Second Malignancy|0|||
30580427|NCT00477412|58591375|FG001|Overall Study|Second Malignancy|0|||
30580428|NCT00477412|58591376|FG002|Overall Study|Second Malignancy|0|||
30580429|NCT00477412|58591377|FG003|Overall Study|Second Malignancy|1|||
30580430|NCT00477412|58591374|FG000|Overall Study|Adverse Event|1|||
30580431|NCT00477412|58591375|FG001|Overall Study|Adverse Event|0|||
30580432|NCT00477412|58591376|FG002|Overall Study|Adverse Event|1|||
30580433|NCT00477412|58591377|FG003|Overall Study|Adverse Event|0|||
30580434|NCT01089556|58591387|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
30580435|NCT01089556|58591388|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
30580436|NCT01089556|58591389|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
30580437|NCT01089556|58591390|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
30580438|NCT01089556|58591391|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
30580439|NCT01089556|58591392|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
30580440|NCT01089556|58591387|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
30580441|NCT01089556|58591388|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
30580442|NCT01089556|58591389|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
30580443|NCT01089556|58591390|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
30580444|NCT01089556|58591391|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
30580445|NCT01089556|58591392|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
30580446|NCT01089556|58591387|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
30580447|NCT01089556|58591388|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
30580448|NCT01089556|58591389|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
30580449|NCT01089556|58591390|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
30580450|NCT01089556|58591391|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
30580451|NCT01089556|58591392|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
30580452|NCT01089556|58591387|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
30580453|NCT01089556|58591388|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
30580454|NCT01089556|58591389|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
30580455|NCT01089556|58591390|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
30580456|NCT01089556|58591391|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
30580457|NCT01089556|58591392|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
30580458|NCT01089556|58591387|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
30580459|NCT01089556|58591388|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
30580460|NCT01089556|58591389|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
30580461|NCT01089556|58591390|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
30580462|NCT01089556|58591391|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
30580463|NCT01089556|58591392|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
30580464|NCT01089556|58591387|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
30580465|NCT01089556|58591388|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
30580466|NCT01089556|58591389|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
30580467|NCT01089556|58591390|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
30580468|NCT01089556|58591391|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
30580469|NCT01089556|58591392|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
30580470|NCT01089556|58591387|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
30580471|NCT01089556|58591388|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
30580472|NCT01089556|58591389|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
30580473|NCT01089556|58591390|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
30580474|NCT01089556|58591391|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
30580475|NCT01089556|58591392|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
30580476|NCT01089556|58591387|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
30780840|NCT02978326|58792964|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
30580477|NCT01089556|58591388|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
30580478|NCT01089556|58591389|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
30580479|NCT01089556|58591390|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
30580480|NCT01089556|58591391|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
30580481|NCT01089556|58591392|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
30580482|NCT01089556|58591387|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
30580483|NCT01089556|58591388|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
30580484|NCT01089556|58591389|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
30580485|NCT01089556|58591390|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
30580486|NCT01089556|58591391|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
30580487|NCT01089556|58591392|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
30580488|NCT01089556|58591387|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
30580489|NCT01089556|58591388|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
30580490|NCT01089556|58591389|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
30580491|NCT01089556|58591390|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
30580492|NCT01089556|58591391|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
30580493|NCT01089556|58591392|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
30580494|NCT01089556|58591387|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
30580495|NCT01089556|58591388|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
30580496|NCT01089556|58591389|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
30580497|NCT01089556|58591390|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
30580498|NCT01089556|58591391|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
30580499|NCT01089556|58591392|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
30580500|NCT01089556|58591387|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
30580501|NCT01089556|58591388|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
30580502|NCT01089556|58591389|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
30580503|NCT01089556|58591390|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
30580504|NCT01089556|58591391|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
30580505|NCT01089556|58591392|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
30580506|NCT01089556|58591387|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
30580507|NCT01089556|58591388|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
30580508|NCT01089556|58591389|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
30580509|NCT01089556|58591390|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
30580510|NCT01089556|58591391|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
30580511|NCT01089556|58591392|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
30580512|NCT01089556|58591387|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
30580513|NCT01089556|58591388|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
30580514|NCT01089556|58591389|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
30580515|NCT01089556|58591390|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
30580516|NCT01089556|58591391|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
30580517|NCT01089556|58591392|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
30580518|NCT01089556|58591387|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
30580519|NCT01089556|58591388|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
30580520|NCT01089556|58591389|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
30580521|NCT01089556|58591390|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
30580522|NCT01089556|58591391|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
30580523|NCT01089556|58591392|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
30580524|NCT01089127|58591410|FG000|Overall Study|Adverse Event|5|||
30580525|NCT01089127|58591411|FG001|Overall Study|Adverse Event|1|||
30580526|NCT01089127|58591412|FG002|Overall Study|Adverse Event|1|||
30580527|NCT01089127|58591413|FG003|Overall Study|Adverse Event|0|||
30580528|NCT01089127|58591414|FG004|Overall Study|Adverse Event|0|||
30580529|NCT01089127|58591415|FG005|Overall Study|Adverse Event|1|||
30580530|NCT01089127|58591410|FG000|Overall Study|Subject withdrew consent|0|||
30580531|NCT01089127|58591411|FG001|Overall Study|Subject withdrew consent|1|||
30580532|NCT01089127|58591412|FG002|Overall Study|Subject withdrew consent|1|||
30580533|NCT01089127|58591413|FG003|Overall Study|Subject withdrew consent|1|||
30580534|NCT01089127|58591414|FG004|Overall Study|Subject withdrew consent|0|||
30580535|NCT01089127|58591415|FG005|Overall Study|Subject withdrew consent|2|||
30668397|NCT00848484|58682293|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
30580536|NCT01089127|58591410|FG000|Overall Study|Abnormal test procedure result(s)|2|||
30580537|NCT01089127|58591411|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30580538|NCT01089127|58591412|FG002|Overall Study|Abnormal test procedure result(s)|0|||
30580539|NCT01089127|58591413|FG003|Overall Study|Abnormal test procedure result(s)|0|||
30580540|NCT01089127|58591414|FG004|Overall Study|Abnormal test procedure result(s)|0|||
30580541|NCT01089127|58591415|FG005|Overall Study|Abnormal test procedure result(s)|0|||
30580542|NCT01089127|58591410|FG000|Overall Study|Lost to Follow-up|1|||
30580543|NCT01089127|58591411|FG001|Overall Study|Lost to Follow-up|1|||
30580544|NCT01089127|58591412|FG002|Overall Study|Lost to Follow-up|0|||
30668398|NCT00509821|58682301|FG000|Study Period 1 (Induction)|Death|0|||
30580545|NCT01089127|58591413|FG003|Overall Study|Lost to Follow-up|0|||
30580546|NCT01089127|58591414|FG004|Overall Study|Lost to Follow-up|1|||
30580547|NCT01089127|58591415|FG005|Overall Study|Lost to Follow-up|0|||
30580548|NCT01089127|58591410|FG000|Overall Study|Protocol deviation|0|||
30580549|NCT01089127|58591411|FG001|Overall Study|Protocol deviation|1|||
30580550|NCT01089127|58591412|FG002|Overall Study|Protocol deviation|0|||
30580551|NCT01089127|58591413|FG003|Overall Study|Protocol deviation|0|||
30580552|NCT01089127|58591414|FG004|Overall Study|Protocol deviation|1|||
30580553|NCT01089127|58591415|FG005|Overall Study|Protocol deviation|0|||
30580554|NCT01087957|58591431|FG000|Overall Study|Death|2|||
30580555|NCT01087957|58591432|FG001|Overall Study|Death|2|||
30580556|NCT01087957|58591431|FG000|Overall Study|Lost to Follow-up|3|||
30580557|NCT01087957|58591432|FG001|Overall Study|Lost to Follow-up|4|||
30580558|NCT01087957|58591431|FG000|Overall Study|Protocol Violation|13|||
30580559|NCT01087957|58591432|FG001|Overall Study|Protocol Violation|25|||
30580560|NCT01087957|58591431|FG000|Overall Study|Withdrawal by Subject|18|||
30580561|NCT01087957|58591432|FG001|Overall Study|Withdrawal by Subject|15|||
30580562|NCT01087957|58591431|FG000|Overall Study|Physician Decision|5|||
30580563|NCT01087957|58591432|FG001|Overall Study|Physician Decision|9|||
30580564|NCT01087723|58591440|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
30580565|NCT01087723|58591441|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
30580566|NCT01087723|58591440|FG000|Overall Study|Withdrawal by Subject|10|||
30580567|NCT01087723|58591441|FG001|Overall Study|Withdrawal by Subject|13|||
30580568|NCT01087723|58591440|FG000|Overall Study|Physician Decision|2|||
30580569|NCT01087723|58591441|FG001|Overall Study|Physician Decision|0|||
30580570|NCT01087723|58591440|FG000|Overall Study|Lost to Follow-up|1|||
30580571|NCT01087723|58591441|FG001|Overall Study|Lost to Follow-up|4|||
30580572|NCT01087723|58591440|FG000|Overall Study|Reason Not Specified|1|||
30580573|NCT01087723|58591441|FG001|Overall Study|Reason Not Specified|2|||
30580574|NCT01087528|58591447|FG000|Overall Study|Withdrawal by Subject|1|||
30580575|NCT01087528|58591447|FG000|Overall Study|Incomplete CE procedure|6|||
30580576|NCT01085812|58591453|FG000|Open-Label Period|Adverse Event|0|||
30580577|NCT01085812|58591454|FG001|Open-Label Period|Adverse Event|80|||
30580578|NCT01085812|58591453|FG000|Open-Label Period|Lack of Efficacy|0|||
30580579|NCT01085812|58591454|FG001|Open-Label Period|Lack of Efficacy|26|||
30580580|NCT01085812|58591453|FG000|Open-Label Period|Protocol Violation|0|||
30580581|NCT01085812|58591454|FG001|Open-Label Period|Protocol Violation|39|||
30580582|NCT01085812|58591453|FG000|Open-Label Period|Withdrawal by Subject|0|||
30580583|NCT01085812|58591454|FG001|Open-Label Period|Withdrawal by Subject|53|||
30580584|NCT01085812|58591453|FG000|Open-Label Period|Lost to Follow-up|0|||
30580585|NCT01085812|58591454|FG001|Open-Label Period|Lost to Follow-up|42|||
30580586|NCT01085812|58591453|FG000|Double-Blind Period|Adverse Event|3|||
30580587|NCT01085812|58591454|FG001|Double-Blind Period|Adverse Event|8|||
30580588|NCT01085812|58591453|FG000|Double-Blind Period|Protocol Violation|2|||
30580589|NCT01085812|58591454|FG001|Double-Blind Period|Protocol Violation|7|||
30580590|NCT01085812|58591453|FG000|Double-Blind Period|Withdrawal by Subject|11|||
30580591|NCT01085812|58591454|FG001|Double-Blind Period|Withdrawal by Subject|24|||
30580592|NCT01085812|58591453|FG000|Double-Blind Period|Lost to Follow-up|5|||
30580593|NCT01085812|58591454|FG001|Double-Blind Period|Lost to Follow-up|17|||
30580594|NCT01085812|58591453|FG000|Double-Blind Period|Other Reasons|0|||
30580595|NCT01085812|58591454|FG001|Double-Blind Period|Other Reasons|2|||
30580596|NCT01085812|58591453|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
30580597|NCT01085812|58591454|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
30580598|NCT01085812|58591453|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
30580599|NCT01085812|58591454|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
30580600|NCT01085812|58591453|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
30580601|NCT01085812|58591454|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
30580602|NCT01085812|58591453|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
30580603|NCT01085812|58591454|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
30580604|NCT01085812|58591453|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
30580605|NCT01085812|58591454|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
30580606|NCT01085734|58591463|FG000|Overall Study|Adverse Event|0|||
30580607|NCT01085734|58591464|FG001|Overall Study|Adverse Event|2|||
30580608|NCT01085734|58591463|FG000|Overall Study|Death|1|||
30580609|NCT01085734|58591464|FG001|Overall Study|Death|0|||
30580610|NCT01085734|58591463|FG000|Overall Study|Lost to Follow-up|0|||
30580611|NCT01085734|58591464|FG001|Overall Study|Lost to Follow-up|1|||
30580612|NCT01085734|58591463|FG000|Overall Study|Withdrawal by Subject|0|||
30580613|NCT01085734|58591464|FG001|Overall Study|Withdrawal by Subject|1|||
30580614|NCT01084603|58591471|FG000|Baseline|Withdrawal by Subject|2|||
30580615|NCT01084603|58591471|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
30580616|NCT01084603|58591471|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
30580617|NCT01084603|58591471|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
30580618|NCT01084603|58591471|FG000|Washout Period 4|Adverse Event|1|||
30580619|NCT01084174|58591486|FG000|Overall Study|gastrointestinal symptoms|1|||
30580620|NCT01084174|58591487|FG001|Overall Study|gastrointestinal symptoms|1|||
30580621|NCT01084174|58591486|FG000|Overall Study|Eosinophilic esophagitis|0|||
30580622|NCT01084174|58591487|FG001|Overall Study|Eosinophilic esophagitis|1|||
30580623|NCT01084174|58591486|FG000|Overall Study|Anaphylaxis|0|||
30580624|NCT01084174|58591487|FG001|Overall Study|Anaphylaxis|1|||
30580625|NCT01084174|58591486|FG000|Overall Study|Participant noncompliance|0|||
30580626|NCT01084174|58591487|FG001|Overall Study|Participant noncompliance|1|||
30580627|NCT01084135|58591497|FG000|20 Week|Physician Decision|0|||
30580628|NCT01084135|58591498|FG001|20 Week|Physician Decision|1|||
30580629|NCT01083316|58591506|FG000|Overall Study|Adverse Event|2|||
30580630|NCT01083316|58591506|FG000|Overall Study|Withdrawal by Subject|1|||
30580631|NCT01083160|58591511|FG000|Overall Study|Adverse Event|1|||
30580632|NCT01083121|58591515|FG000|Overall Study|Use of Humira outside the approved label|81|||
30580633|NCT01082614|58591525|FG000|Overall Study|Adverse Event|1|||
30580634|NCT01082614|58591526|FG001|Overall Study|Adverse Event|4|||
30580635|NCT01082614|58591525|FG000|Overall Study|Equipment Malfunction|0|||
30580636|NCT01082614|58591526|FG001|Overall Study|Equipment Malfunction|1|||
30580637|NCT01082614|58591525|FG000|Overall Study|Physician Decision|2|||
30580638|NCT01082614|58591526|FG001|Overall Study|Physician Decision|0|||
30580639|NCT01081873|58591532|FG000|Overall Study|Death|86|||
30580640|NCT01081873|58591532|FG000|Overall Study|Withdrawal by Subject|10|||
30580641|NCT01081873|58591532|FG000|Overall Study|Lost to Follow-up|142|||
30580642|NCT01081873|58591532|FG000|Overall Study|Progression of prostate cancer|13|||
30580643|NCT01081873|58591532|FG000|Overall Study|Other|47|||
30580644|NCT01081795|58591564|FG000|Overall Study|Adverse Event|18|||
30580645|NCT01081795|58591565|FG001|Overall Study|Adverse Event|23|||
30580646|NCT01081795|58591566|FG002|Overall Study|Adverse Event|6|||
30580647|NCT01081795|58591564|FG000|Overall Study|Lack of Efficacy|7|||
30580648|NCT01081795|58591565|FG001|Overall Study|Lack of Efficacy|5|||
30580649|NCT01081795|58591566|FG002|Overall Study|Lack of Efficacy|19|||
30580650|NCT01081795|58591564|FG000|Overall Study|Subject's schedule|1|||
30580651|NCT01081795|58591565|FG001|Overall Study|Subject's schedule|1|||
30580652|NCT01081795|58591566|FG002|Overall Study|Subject's schedule|2|||
30580653|NCT01081795|58591564|FG000|Overall Study|Revocation of informed consent|2|||
30580654|NCT01081795|58591565|FG001|Overall Study|Revocation of informed consent|0|||
30580655|NCT01081795|58591566|FG002|Overall Study|Revocation of informed consent|0|||
30580656|NCT01081795|58591564|FG000|Overall Study|Ineligible for participation|1|||
30580657|NCT01081795|58591565|FG001|Overall Study|Ineligible for participation|0|||
30580658|NCT01081795|58591566|FG002|Overall Study|Ineligible for participation|0|||
30580659|NCT01081795|58591564|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
30580660|NCT01081795|58591565|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
30580661|NCT01081795|58591566|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
30580662|NCT01081795|58591564|FG000|Overall Study|Using drug with restricted days of use|2|||
30580663|NCT01081795|58591565|FG001|Overall Study|Using drug with restricted days of use|3|||
30580664|NCT01081795|58591566|FG002|Overall Study|Using drug with restricted days of use|2|||
30580665|NCT01081795|58591564|FG000|Overall Study|Other|1|||
30580666|NCT01081795|58591565|FG001|Overall Study|Other|2|||
30580667|NCT01081795|58591566|FG002|Overall Study|Other|0|||
30580668|NCT01081678|58591578|FG000|Overall Study|Ineligibility Determined|0|||
30580669|NCT01081678|58591579|FG001|Overall Study|Ineligibility Determined|0|||
30580670|NCT01081678|58591580|FG002|Overall Study|Ineligibility Determined|1|||
30580671|NCT01081678|58591581|FG003|Overall Study|Ineligibility Determined|1|||
30580672|NCT01081678|58591578|FG000|Overall Study|Noncompliance|3|||
30580673|NCT01081678|58591579|FG001|Overall Study|Noncompliance|4|||
30580674|NCT01081678|58591580|FG002|Overall Study|Noncompliance|5|||
30580675|NCT01081678|58591581|FG003|Overall Study|Noncompliance|2|||
30580676|NCT01081678|58591578|FG000|Overall Study|Adverse Event|2|||
30580677|NCT01081678|58591579|FG001|Overall Study|Adverse Event|1|||
30580678|NCT01081678|58591580|FG002|Overall Study|Adverse Event|2|||
30580679|NCT01081678|58591581|FG003|Overall Study|Adverse Event|2|||
30580680|NCT01081678|58591578|FG000|Overall Study|Withdrawal by Subject|15|||
30580681|NCT01081678|58591579|FG001|Overall Study|Withdrawal by Subject|7|||
30580682|NCT01081678|58591580|FG002|Overall Study|Withdrawal by Subject|17|||
30580683|NCT01081678|58591581|FG003|Overall Study|Withdrawal by Subject|14|||
30580684|NCT01081678|58591578|FG000|Overall Study|Administrative Decision|1|||
30580685|NCT01081678|58591579|FG001|Overall Study|Administrative Decision|0|||
30580686|NCT01081678|58591580|FG002|Overall Study|Administrative Decision|0|||
30580687|NCT01081678|58591581|FG003|Overall Study|Administrative Decision|1|||
30580688|NCT01081678|58591578|FG000|Overall Study|Lost to Follow-up|4|||
30580689|NCT01081678|58591579|FG001|Overall Study|Lost to Follow-up|1|||
30580690|NCT01081678|58591580|FG002|Overall Study|Lost to Follow-up|4|||
30580691|NCT01081678|58591581|FG003|Overall Study|Lost to Follow-up|3|||
30580692|NCT01081678|58591578|FG000|Overall Study|Death|2|||
30580693|NCT01081678|58591579|FG001|Overall Study|Death|2|||
30580694|NCT01081678|58591580|FG002|Overall Study|Death|2|||
30580695|NCT01081678|58591581|FG003|Overall Study|Death|6|||
30580696|NCT01081678|58591578|FG000|Overall Study|Other|0|||
30580697|NCT01081678|58591579|FG001|Overall Study|Other|1|||
30580698|NCT01081678|58591580|FG002|Overall Study|Other|0|||
30580699|NCT01081678|58591581|FG003|Overall Study|Other|0|||
30580700|NCT01081249|58591591|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
30580701|NCT01081249|58591592|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
30580702|NCT01081132|58591600|FG000|Overall Study|Lack of Efficacy|25|||
30580703|NCT01081132|58591601|FG001|Overall Study|Lack of Efficacy|9|||
30580704|NCT01081132|58591600|FG000|Overall Study|Withdrawal by Subject|13|||
30580705|NCT01081132|58591601|FG001|Overall Study|Withdrawal by Subject|16|||
30580706|NCT01081132|58591600|FG000|Overall Study|Lost to Follow-up|4|||
30580707|NCT01081132|58591601|FG001|Overall Study|Lost to Follow-up|11|||
30580708|NCT01081132|58591600|FG000|Overall Study|Adverse Event|3|||
30580709|NCT01081132|58591601|FG001|Overall Study|Adverse Event|9|||
30580710|NCT01081132|58591600|FG000|Overall Study|Non Compliance|4|||
30580711|NCT01081132|58591601|FG001|Overall Study|Non Compliance|2|||
30580712|NCT01081132|58591600|FG000|Overall Study|Lack Of Compliance|0|||
30580713|NCT01081132|58591601|FG001|Overall Study|Lack Of Compliance|1|||
30580714|NCT01081132|58591600|FG000|Overall Study|Missed Visits|1|||
30580715|NCT01081132|58591601|FG001|Overall Study|Missed Visits|1|||
30580716|NCT01081132|58591600|FG000|Overall Study|Stopped Taking Meds|2|||
30580717|NCT01081132|58591601|FG001|Overall Study|Stopped Taking Meds|0|||
30580718|NCT01081132|58591600|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
30580719|NCT01081132|58591601|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
30580720|NCT01081132|58591600|FG000|Overall Study|Declined Taper Phase|0|||
30580721|NCT01081132|58591601|FG001|Overall Study|Declined Taper Phase|1|||
30580722|NCT01081132|58591600|FG000|Overall Study|Protocol Violation|3|||
30580723|NCT01081132|58591601|FG001|Overall Study|Protocol Violation|1|||
30580724|NCT01080625|58591610|FG000|Overall Study|Physician Decision|0|||
30580725|NCT01080625|58591611|FG001|Overall Study|Physician Decision|2|||
30580726|NCT01080625|58591612|FG002|Overall Study|Physician Decision|1|||
30580727|NCT01059903|58591622|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
30580728|NCT01059903|58591623|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
30580729|NCT00199888|58591679|FG000|Overall Study|Lost to Follow-up|1|||
30580730|NCT00199849|58591686|FG000|Overall Study|Unrelated illness or complication|0|||
30580731|NCT00199849|58591687|FG001|Overall Study|Unrelated illness or complication|1|||
30580732|NCT00199849|58591688|FG002|Overall Study|Unrelated illness or complication|0|||
30580733|NCT00199849|58591686|FG000|Overall Study|Progressive disease requiring intervention|0|||
30580734|NCT00199849|58591687|FG001|Overall Study|Progressive disease requiring intervention|0|||
30580735|NCT00199849|58591688|FG002|Overall Study|Progressive disease requiring intervention|1|||
30580736|NCT00199849|58591686|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
30580737|NCT00199849|58591687|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
30580738|NCT00199849|58591688|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
30580739|NCT00199381|58591696|FG000|Overall Study|Withdrawal by Subject|38|||
30580740|NCT00199381|58591696|FG000|Overall Study|Adverse Event|73|||
30580741|NCT00199381|58591696|FG000|Overall Study|Protocol Violation|6|||
30580742|NCT00199381|58591696|FG000|Overall Study|Lack of Efficacy|27|||
30580743|NCT00199381|58591696|FG000|Overall Study|Not including due to early termination|37|||
30580744|NCT00199381|58591696|FG000|Overall Study|Study termination by Sponsor|323|||
30580745|NCT00198133|58591702|FG000|Overall Study|Disease progression|2|||
30580746|NCT00198133|58591703|FG001|Overall Study|Disease progression|5|||
30580747|NCT00198133|58591702|FG000|Overall Study|Adverse Event|1|||
30580748|NCT00198133|58591703|FG001|Overall Study|Adverse Event|3|||
30580749|NCT00198133|58591702|FG000|Overall Study|Withdrawal by Subject|1|||
30580750|NCT00198133|58591703|FG001|Overall Study|Withdrawal by Subject|0|||
30580751|NCT00198133|58591702|FG000|Overall Study|Physician Decision|1|||
30580752|NCT00198133|58591703|FG001|Overall Study|Physician Decision|0|||
30580753|NCT00197236|58591712|FG000|Overall Study|Adverse Event|1|||
30580754|NCT00197236|58591713|FG001|Overall Study|Adverse Event|0|||
30580755|NCT00197236|58591714|FG002|Overall Study|Adverse Event|1|||
30580756|NCT00197236|58591712|FG000|Overall Study|Lost to Follow-up|5|||
30580757|NCT00197236|58591713|FG001|Overall Study|Lost to Follow-up|14|||
30580758|NCT00197236|58591714|FG002|Overall Study|Lost to Follow-up|6|||
30580759|NCT00197236|58591712|FG000|Overall Study|Protocol Violation|0|||
30580760|NCT00197236|58591713|FG001|Overall Study|Protocol Violation|0|||
30580761|NCT00197236|58591714|FG002|Overall Study|Protocol Violation|1|||
30580762|NCT00197236|58591712|FG000|Overall Study|Withdrawal by Subject|7|||
30580763|NCT00197236|58591713|FG001|Overall Study|Withdrawal by Subject|3|||
30580764|NCT00197236|58591714|FG002|Overall Study|Withdrawal by Subject|11|||
30580765|NCT00197236|58591712|FG000|Overall Study|Study drug/medication expiration|1|||
30580766|NCT00197236|58591713|FG001|Overall Study|Study drug/medication expiration|0|||
30580767|NCT00197236|58591714|FG002|Overall Study|Study drug/medication expiration|3|||
30580768|NCT00197236|58591712|FG000|Overall Study|Returned out of specified time window|0|||
30580769|NCT00197236|58591713|FG001|Overall Study|Returned out of specified time window|0|||
30580770|NCT00197236|58591714|FG002|Overall Study|Returned out of specified time window|1|||
30580771|NCT00197002|58591728|FG000|Overall Study|Adverse Event|0|||
30580772|NCT00197002|58591729|FG001|Overall Study|Adverse Event|1|||
30580773|NCT00197002|58591730|FG002|Overall Study|Adverse Event|0|||
30580774|NCT00197002|58591728|FG000|Overall Study|Protocol Violation|1|||
30580775|NCT00197002|58591729|FG001|Overall Study|Protocol Violation|0|||
30580776|NCT00197002|58591730|FG002|Overall Study|Protocol Violation|2|||
30580777|NCT00197002|58591728|FG000|Overall Study|Withdrawal by Subject|9|||
30580778|NCT00197002|58591729|FG001|Overall Study|Withdrawal by Subject|5|||
30580779|NCT00197002|58591730|FG002|Overall Study|Withdrawal by Subject|7|||
30580780|NCT00197002|58591728|FG000|Overall Study|Migrated/moved from study area|3|||
30580781|NCT00197002|58591729|FG001|Overall Study|Migrated/moved from study area|5|||
30580782|NCT00197002|58591730|FG002|Overall Study|Migrated/moved from study area|1|||
30580783|NCT00197002|58591728|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
30580784|NCT00197002|58591729|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
30580785|NCT00197002|58591730|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
30580786|NCT00197002|58591728|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
30580787|NCT00197002|58591729|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
30580788|NCT00197002|58591730|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
30580789|NCT00197002|58591728|FG000|Overall Study|Others|3|||
30580790|NCT00197002|58591729|FG001|Overall Study|Others|1|||
30580791|NCT00197002|58591730|FG002|Overall Study|Others|1|||
30580792|NCT00196105|58591744|FG000|Overall Study|Lost to Follow-up|4|||
30580793|NCT00196105|58591745|FG001|Overall Study|Lost to Follow-up|5|||
30580794|NCT00196105|58591746|FG002|Overall Study|Lost to Follow-up|7|||
30580795|NCT00195715|58591754|FG000|Overall Study|Adverse Event|122|||
30580796|NCT00195715|58591754|FG000|Overall Study|Withdrawal by Subject|58|||
30580797|NCT00195715|58591754|FG000|Overall Study|Lost to Follow-up|27|||
30580798|NCT00195715|58591754|FG000|Overall Study|Protocol Violation|13|||
30580799|NCT00195715|58591754|FG000|Overall Study|Lack of Efficacy|93|||
30580800|NCT00195715|58591754|FG000|Overall Study|Pregnancy|14|||
30580801|NCT00195715|58591754|FG000|Overall Study|Investigative site closure|8|||
30580802|NCT00195715|58591754|FG000|Overall Study|Subject moved/relocated|7|||
30580803|NCT00195715|58591754|FG000|Overall Study|Subject non-compliance|6|||
30580804|NCT00195715|58591754|FG000|Overall Study|Subject started commercial Humira|5|||
30580805|NCT00195715|58591754|FG000|Overall Study|Subject choice|3|||
30580806|NCT00195715|58591754|FG000|Overall Study|Loss of response/no improvement|3|||
30580807|NCT00195715|58591754|FG000|Overall Study|Sponsor stopped study|1|||
30580808|NCT00195715|58591754|FG000|Overall Study|Administrative reasons|2|||
30580809|NCT00195715|58591754|FG000|Overall Study|Investigator's decision|2|||
30580810|NCT00195715|58591754|FG000|Overall Study|Subject wants to get pregnant|4|||
30580811|NCT00195715|58591754|FG000|Overall Study|Use of prohibited medication|2|||
30580812|NCT00195715|58591754|FG000|Overall Study|Planned surgery|2|||
30580813|NCT00195715|58591754|FG000|Overall Study|Increased infection rate|1|||
30580814|NCT00195715|58591754|FG000|Overall Study|Ineligible|1|||
30580815|NCT00195715|58591754|FG000|Overall Study|Colonic stricture|1|||
30580816|NCT00195715|58591754|FG000|Overall Study|Sponsor discontinued trial|1|||
30580817|NCT00195715|58591754|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
30580818|NCT00195676|58591758|FG000|Period O - Open-label Treatment|Adverse Event|82|||
30580819|NCT00195676|58591758|FG000|Period O - Open-label Treatment|Death|6|||
30580820|NCT00195676|58591758|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
30580821|NCT00195676|58591758|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
30580822|NCT00195676|58591758|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
30580823|NCT00195676|58591758|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
30580824|NCT00195676|58591758|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
30580825|NCT00195676|58591758|FG000|Period O - Open-label Treatment|Other reasons|68|||
30580826|NCT00195676|58591758|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
30580827|NCT00195676|58591758|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
30580828|NCT00195676|58591758|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
30580829|NCT00195676|58591758|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
30580830|NCT00195676|58591758|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
30580831|NCT00195676|58591758|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
30580832|NCT00195676|58591758|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
30580833|NCT00195676|58591758|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
30580834|NCT00195676|58591758|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
30580835|NCT00195676|58591758|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
30580836|NCT00195676|58591758|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
30855526|NCT00103285|58883183|FG000|Response Assignment|Protocol Violation|0|||
30958745|NCT01579565|59023937|FG000|Randomized|Withdrawal by Subject|3|||
30580837|NCT00195676|58591758|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
30580838|NCT00195676|58591758|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
30580839|NCT00194077|58591768|FG000|Overall Study|Lack of Efficacy|22|||
30580840|NCT00194077|58591769|FG001|Overall Study|Lack of Efficacy|29|||
30580841|NCT00194077|58591768|FG000|Overall Study|Study nonadherence|1|||
30580842|NCT00194077|58591769|FG001|Overall Study|Study nonadherence|0|||
30580843|NCT00194077|58591768|FG000|Overall Study|Withdrawal by Subject|1|||
30580844|NCT00194077|58591769|FG001|Overall Study|Withdrawal by Subject|1|||
30580845|NCT00193609|58591775|FG000|Overall Study|Lack of Efficacy|2|||
30580846|NCT00193609|58591775|FG000|Overall Study|Adverse Event|2|||
30580847|NCT00193180|58591779|FG000|Overall Study|Lack of Efficacy|1|||
30580848|NCT00193180|58591779|FG000|Overall Study|Adverse Event|8|||
30580849|NCT00193180|58591779|FG000|Overall Study|Protocol Violation|1|||
30580850|NCT00193063|58591784|FG000|Overall Study|Lack of Efficacy|3|||
30580851|NCT00193063|58591784|FG000|Overall Study|Adverse Event|1|||
30580852|NCT00191854|58591791|FG000|Overall Study|Death|26|||
30580853|NCT00191854|58591792|FG001|Overall Study|Death|23|||
30580854|NCT00191854|58591793|FG002|Overall Study|Death|29|||
30580855|NCT00191854|58591791|FG000|Overall Study|Lost to Follow-up|7|||
30580856|NCT00191854|58591792|FG001|Overall Study|Lost to Follow-up|5|||
30580857|NCT00191854|58591793|FG002|Overall Study|Lost to Follow-up|5|||
30580858|NCT00191854|58591791|FG000|Overall Study|Withdrawal by Subject|4|||
30580859|NCT00191854|58591792|FG001|Overall Study|Withdrawal by Subject|2|||
30580860|NCT00191854|58591793|FG002|Overall Study|Withdrawal by Subject|3|||
30580861|NCT00191854|58591791|FG000|Overall Study|Sponsor Decision|0|||
30580862|NCT00191854|58591792|FG001|Overall Study|Sponsor Decision|0|||
30580863|NCT00191854|58591793|FG002|Overall Study|Sponsor Decision|1|||
30580864|NCT00191854|58591791|FG000|Overall Study|Screen Failure|0|||
30580865|NCT00191854|58591792|FG001|Overall Study|Screen Failure|0|||
30580866|NCT00191854|58591793|FG002|Overall Study|Screen Failure|1|||
30668399|NCT00509821|58682302|FG001|Study Period 1 (Induction)|Death|1|||
30668400|NCT00509821|58682301|FG000|Study Period 1 (Induction)|Adverse Event|0|||
30668401|NCT00509821|58682302|FG001|Study Period 1 (Induction)|Adverse Event|2|||
30668402|NCT00509821|58682301|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
30668403|NCT00509821|58682302|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
30668404|NCT00508651|58682315|FG000|Overall Study|Lost to Follow-up|3|||
30668405|NCT00508651|58682316|FG001|Overall Study|Lost to Follow-up|1|||
30668406|NCT00508651|58682315|FG000|Overall Study|Withdrawal by Subject|1|||
30668407|NCT00508651|58682316|FG001|Overall Study|Withdrawal by Subject|1|||
30668408|NCT00490555|58682326|FG000|Overall Study|noncompliant with drug administration|0|||
30668409|NCT00490555|58682327|FG001|Overall Study|noncompliant with drug administration|0|||
30668410|NCT00490555|58682328|FG002|Overall Study|noncompliant with drug administration|2|||
30668411|NCT00490555|58682329|FG003|Overall Study|noncompliant with drug administration|0|||
30668412|NCT00501085|58682339|FG000|Overall Study|Lost to Follow-up|195|||
30668413|NCT00501085|58682339|FG000|Overall Study|Withdrawal by Subject|34|||
30668414|NCT00501085|58682339|FG000|Overall Study|Subject Decision|1|||
30668415|NCT00501085|58682339|FG000|Overall Study|Revision Surgery|7|||
30668416|NCT00501085|58682339|FG000|Overall Study|Explantation Surgery|26|||
30668417|NCT00501085|58682339|FG000|Overall Study|Adverse Event|4|||
30668418|NCT00501085|58682339|FG000|Overall Study|Non-Compliance|24|||
30668419|NCT00501085|58682339|FG000|Overall Study|Study closed by sponsor|109|||
30668420|NCT00501085|58682339|FG000|Overall Study|Other loss to follow-up|32|||
30668421|NCT00501007|58682343|FG000|Overall Study|Inclusion criteria not met.|29|||
30668422|NCT00501007|58682344|FG001|Overall Study|Inclusion criteria not met.|25|||
30668423|NCT00873860|58682354|FG000|Overall Study|Lost to Follow-up|1|||
30668424|NCT00873860|58682355|FG001|Overall Study|Lost to Follow-up|0|||
30668425|NCT00873860|58682356|FG002|Overall Study|Lost to Follow-up|0|||
30668426|NCT00873860|58682357|FG003|Overall Study|Lost to Follow-up|1|||
30668427|NCT00873860|58682354|FG000|Overall Study|Withdrawal by Subject|1|||
30668428|NCT00873860|58682355|FG001|Overall Study|Withdrawal by Subject|0|||
30668429|NCT00873860|58682356|FG002|Overall Study|Withdrawal by Subject|2|||
30668430|NCT00873860|58682357|FG003|Overall Study|Withdrawal by Subject|0|||
30668431|NCT00873860|58682354|FG000|Overall Study|Death|1|||
30668432|NCT00873860|58682355|FG001|Overall Study|Death|0|||
30668433|NCT00873860|58682356|FG002|Overall Study|Death|0|||
30668434|NCT00873860|58682357|FG003|Overall Study|Death|0|||
30668435|NCT00873860|58682354|FG000|Overall Study|Other|1|||
30668436|NCT00873860|58682355|FG001|Overall Study|Other|0|||
30668437|NCT00873860|58682356|FG002|Overall Study|Other|1|||
30668438|NCT00873860|58682357|FG003|Overall Study|Other|0|||
30668439|NCT03853291|58682380|FG000|Overall Study|Lost to Follow-up|1|||
30668440|NCT03853291|58682381|FG001|Overall Study|Lost to Follow-up|2|||
30668441|NCT03853291|58682382|FG002|Overall Study|Lost to Follow-up|0|||
30580867|NCT00191815|58591801|FG000|Overall Study|Adverse Event|2|||
30580868|NCT00191815|58591801|FG000|Overall Study|Disease progression or relapse|24|||
30580869|NCT00191815|58591801|FG000|Overall Study|Death|2|||
30580870|NCT00191815|58591801|FG000|Overall Study|Protocol Violation|3|||
30580871|NCT00191815|58591801|FG000|Overall Study|Physician Decision|2|||
30580872|NCT00191815|58591801|FG000|Overall Study|Withdrawal by Subject|7|||
30580873|NCT00191386|58591805|FG000|Overall Study|Adverse Event|16|||
30668442|NCT03853291|58682383|FG003|Overall Study|Lost to Follow-up|0|||
30668443|NCT03853291|58682384|FG004|Overall Study|Lost to Follow-up|0|||
30668444|NCT03853291|58682385|FG005|Overall Study|Lost to Follow-up|0|||
30668445|NCT03853291|58682380|FG000|Overall Study|Determined to be ineligible|1|||
30668446|NCT03853291|58682381|FG001|Overall Study|Determined to be ineligible|1|||
30668447|NCT03853291|58682382|FG002|Overall Study|Determined to be ineligible|0|||
30668448|NCT03853291|58682383|FG003|Overall Study|Determined to be ineligible|0|||
30580874|NCT00191386|58591805|FG000|Overall Study|Lost to Follow-up|1|||
30580875|NCT00191386|58591805|FG000|Overall Study|Entry Criteria Exclusion|3|||
30580876|NCT00191386|58591805|FG000|Overall Study|Protocol Violation|18|||
30580877|NCT00191386|58591805|FG000|Overall Study|Withdrawal by Subject|96|||
30580878|NCT00191386|58591805|FG000|Overall Study|Physician Decision|11|||
30580879|NCT00191386|58591805|FG000|Overall Study|Lack of Efficacy|15|||
30580880|NCT00191308|58591809|FG000|Overall Study|Adverse Event|1|||
30580881|NCT00191269|58591815|FG000|Overall Study|Protocol Violation|0|||
30580882|NCT00191269|58591816|FG001|Overall Study|Protocol Violation|2|||
30580883|NCT00191269|58591815|FG000|Overall Study|Adverse Event|1|||
30580884|NCT00191269|58591816|FG001|Overall Study|Adverse Event|4|||
30580885|NCT00191269|58591815|FG000|Overall Study|Progression of Disease|4|||
30580886|NCT00191269|58591816|FG001|Overall Study|Progression of Disease|42|||
30580887|NCT00191269|58591815|FG000|Overall Study|Lack of Efficacy|1|||
30580888|NCT00191269|58591816|FG001|Overall Study|Lack of Efficacy|5|||
30580889|NCT00191269|58591815|FG000|Overall Study|Withdrawal by Subject|0|||
30580890|NCT00191269|58591816|FG001|Overall Study|Withdrawal by Subject|1|||
30580891|NCT00191269|58591815|FG000|Overall Study|Pathologic Aggrevation|0|||
30580892|NCT00191269|58591816|FG001|Overall Study|Pathologic Aggrevation|1|||
30580893|NCT00191269|58591815|FG000|Overall Study|Physician Decision|0|||
30580894|NCT00191269|58591816|FG001|Overall Study|Physician Decision|3|||
30580895|NCT00191191|58591825|FG000|Overall Study|Entry Criteria Exclusion|2|||
30580896|NCT00191191|58591826|FG001|Overall Study|Entry Criteria Exclusion|0|||
30580897|NCT00191191|58591825|FG000|Overall Study|Treated with Another Systemic Agent|1|||
30580898|NCT00191191|58591826|FG001|Overall Study|Treated with Another Systemic Agent|1|||
30580899|NCT00191191|58591825|FG000|Overall Study|Adverse Event|11|||
30580900|NCT00191191|58591826|FG001|Overall Study|Adverse Event|21|||
30580901|NCT00191191|58591825|FG000|Overall Study|Progressive Disease|84|||
30580902|NCT00191191|58591826|FG001|Overall Study|Progressive Disease|72|||
30580903|NCT00191191|58591825|FG000|Overall Study|Toxicity After Dose Reduction|7|||
30580904|NCT00191191|58591826|FG001|Overall Study|Toxicity After Dose Reduction|8|||
30580905|NCT00191191|58591825|FG000|Overall Study|Family/Caregiver Decision|5|||
30580906|NCT00191191|58591826|FG001|Overall Study|Family/Caregiver Decision|7|||
30580907|NCT00191191|58591825|FG000|Overall Study|Lost to Follow-up|1|||
30580908|NCT00191191|58591826|FG001|Overall Study|Lost to Follow-up|0|||
30580909|NCT00191191|58591825|FG000|Overall Study|Physician Decision|3|||
30580910|NCT00191191|58591826|FG001|Overall Study|Physician Decision|2|||
30580911|NCT00191191|58591825|FG000|Overall Study|Good Clinical Practice Violation|0|||
30580912|NCT00191191|58591826|FG001|Overall Study|Good Clinical Practice Violation|1|||
30580913|NCT00191152|58591834|FG000|Initial Treatment|Adverse Event|43|||
30580914|NCT00191152|58591835|FG001|Initial Treatment|Adverse Event|67|||
30580915|NCT00191152|58591834|FG000|Initial Treatment|Physician Decision|40|||
30580916|NCT00191152|58591835|FG001|Initial Treatment|Physician Decision|31|||
30580917|NCT00191152|58591834|FG000|Initial Treatment|Withdrawal by Subject|40|||
30580918|NCT00191152|58591835|FG001|Initial Treatment|Withdrawal by Subject|28|||
30580919|NCT00191152|58591834|FG000|Initial Treatment|Lost to Follow-up|0|||
30580920|NCT00191152|58591835|FG001|Initial Treatment|Lost to Follow-up|6|||
30580921|NCT00191152|58591834|FG000|Initial Treatment|Other|18|||
30580922|NCT00191152|58591835|FG001|Initial Treatment|Other|21|||
30580923|NCT00191152|58591834|FG000|Crossover Treatment|Adverse Event|8|||
30580924|NCT00191152|58591835|FG001|Crossover Treatment|Adverse Event|8|||
30580925|NCT00191152|58591834|FG000|Crossover Treatment|Physician Decision|7|||
30580926|NCT00191152|58591835|FG001|Crossover Treatment|Physician Decision|7|||
30668449|NCT03853291|58682384|FG004|Overall Study|Determined to be ineligible|0|||
30668450|NCT03853291|58682385|FG005|Overall Study|Determined to be ineligible|0|||
30780841|NCT02978326|58792962|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
30855527|NCT00103285|58883184|FG001|Response Assignment|Protocol Violation|2|||
30780842|NCT02978326|58792963|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
30780843|NCT02978326|58792964|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
30780844|NCT02978326|58792962|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
30855528|NCT00103285|58883185|FG002|Response Assignment|Protocol Violation|0|||
30780845|NCT02978326|58792963|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
30780846|NCT02978326|58792964|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
30780847|NCT01061866|58792974|FG000|Overall Study|Adverse Event|2|||
30855529|NCT00103285|58883186|FG003|Response Assignment|Protocol Violation|0|||
30780848|NCT01061008|58792980|FG000|Overall Study|Badiocephalic fistula failed|3|||
30855530|NCT00103285|58883187|FG004|Response Assignment|Protocol Violation|0|||
30580927|NCT00191152|58591834|FG000|Crossover Treatment|Withdrawal by Subject|6|||
30580928|NCT00191152|58591835|FG001|Crossover Treatment|Withdrawal by Subject|9|||
30580929|NCT00191152|58591834|FG000|Crossover Treatment|Lost to Follow-up|2|||
30580930|NCT00191152|58591835|FG001|Crossover Treatment|Lost to Follow-up|1|||
30580931|NCT00191152|58591834|FG000|Crossover Treatment|Other|4|||
30580932|NCT00191152|58591835|FG001|Crossover Treatment|Other|3|||
30580933|NCT00190684|58591853|FG000|Overall Study|Adverse Event|86|||
30580934|NCT00190684|58591853|FG000|Overall Study|Satisfactory response|80|||
30580935|NCT00190684|58591853|FG000|Overall Study|Lack of efficacy|204|||
30580936|NCT00190684|58591853|FG000|Overall Study|Lost to Follow-up|232|||
30580937|NCT00190684|58591853|FG000|Overall Study|Patient moved|60|||
30580938|NCT00190684|58591853|FG000|Overall Study|Patient Decision|432|||
30580939|NCT00190684|58591853|FG000|Overall Study|Clinical relapse|67|||
30580940|NCT00190684|58591853|FG000|Overall Study|Sponsor's decision|17|||
30580941|NCT00190684|58591853|FG000|Overall Study|Physician Decision|84|||
30580942|NCT00190684|58591853|FG000|Overall Study|Protocol Violation|123|||
30580943|NCT00190684|58591853|FG000|Overall Study|Study Period III Completed|103|||
30580944|NCT00190684|58591853|FG000|Overall Study|Study Period V Completed|1|||
30580945|NCT00179959|58591864|FG000|Overall Study|Lost to Follow-up|3|||
30580946|NCT00179959|58591865|FG001|Overall Study|Lost to Follow-up|1|||
30580947|NCT00179959|58591864|FG000|Overall Study|Withdrawal by Subject|3|||
30580948|NCT00179959|58591865|FG001|Overall Study|Withdrawal by Subject|2|||
30580949|NCT00179647|58591871|FG000|Overall Study|Adverse Event|294|||
30580950|NCT00179647|58591871|FG000|Overall Study|Lack of Efficacy|478|||
30580951|NCT00179647|58591871|FG000|Overall Study|Withdrawal by Subject|83|||
30580952|NCT00179647|58591871|FG000|Overall Study|Lost to Follow-up|4|||
30580953|NCT00179647|58591871|FG000|Overall Study|Death|94|||
30580954|NCT00179647|58591871|FG000|Overall Study|Other|960|||
30580955|NCT00179413|58591877|FG000|Overall Study|Adverse Event|38|||
30580956|NCT00179413|58591878|FG001|Overall Study|Adverse Event|20|||
30580957|NCT00179413|58591877|FG000|Overall Study|Withdrawal by Subject|87|||
30580958|NCT00179413|58591878|FG001|Overall Study|Withdrawal by Subject|95|||
30580959|NCT00178633|58591884|FG000|Overall Study|Lost to Follow-up|6|||
30580960|NCT00178399|58591889|FG000|Overall Study|Physician Decision|4|||
30580961|NCT00178399|58591889|FG000|Overall Study|Withdrawal by Subject|8|||
30580962|NCT00178399|58591889|FG000|Overall Study|Lost to Follow-up|1|||
30580963|NCT00178126|58591896|FG000|Overall Study|Lost to Follow-up|21|||
30580964|NCT00178126|58591897|FG001|Overall Study|Lost to Follow-up|21|||
30580965|NCT00178126|58591896|FG000|Overall Study|did not receive intervention|4|||
30580966|NCT00178126|58591897|FG001|Overall Study|did not receive intervention|6|||
30580967|NCT00177307|58591903|FG000|Overall Study|Withdrawal by Subject|1|||
30580968|NCT00176644|58591907|FG000|Overall Study|Withdrawal by Subject|1|||
30580969|NCT00176605|58591915|FG000|Overall Study|Withdrawal by Subject|2|||
30580970|NCT00176488|58591919|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
30580971|NCT00175825|58591927|FG000|Overall Study|Adverse Event|3|||
30580972|NCT00175825|58591928|FG001|Overall Study|Adverse Event|2|||
30580973|NCT00175825|58591929|FG002|Overall Study|Adverse Event|1|||
30580974|NCT00175825|58591930|FG003|Overall Study|Adverse Event|1|||
30580975|NCT00175825|58591927|FG000|Overall Study|Lost to Follow-up|1|||
30580976|NCT00175825|58591928|FG001|Overall Study|Lost to Follow-up|2|||
30580977|NCT00175825|58591929|FG002|Overall Study|Lost to Follow-up|0|||
30580978|NCT00175825|58591930|FG003|Overall Study|Lost to Follow-up|0|||
30580979|NCT00175825|58591927|FG000|Overall Study|Withdrawal by Subject|1|||
30580980|NCT00175825|58591928|FG001|Overall Study|Withdrawal by Subject|0|||
30668451|NCT03853213|58682398|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
30668452|NCT03853213|58682399|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
30668453|NCT03853213|58682398|FG000|Overall Study|Other (e.g., too busy)|0|||
30668454|NCT03853213|58682399|FG001|Overall Study|Other (e.g., too busy)|2|||
30668455|NCT02666105|58682425|FG000|Overall Study|Death|1|||
30668456|NCT00819585|58682444|FG000|Core Study|Adverse Event|2|||
30668457|NCT00819585|58682445|FG001|Core Study|Adverse Event|1|||
30668458|NCT00819585|58682446|FG002|Core Study|Adverse Event|1|||
30668459|NCT00819585|58682447|FG003|Core Study|Adverse Event|4|||
30668460|NCT00819585|58682448|FG004|Core Study|Adverse Event|1|||
30668461|NCT00819585|58682449|FG005|Core Study|Adverse Event|0|||
30668462|NCT00819585|58682450|FG006|Core Study|Adverse Event|2|||
30668463|NCT00819585|58682451|FG007|Core Study|Adverse Event|0|||
30668464|NCT00819585|58682452|FG008|Core Study|Adverse Event|0|||
30780849|NCT01061008|58792981|FG001|Overall Study|Badiocephalic fistula failed|2|||
30780850|NCT01061008|58792980|FG000|Overall Study|Death|1|||
30780851|NCT01061008|58792981|FG001|Overall Study|Death|0|||
30580981|NCT00175825|58591929|FG002|Overall Study|Withdrawal by Subject|0|||
30580982|NCT00175825|58591930|FG003|Overall Study|Withdrawal by Subject|0|||
30580983|NCT00174967|58591944|FG000|Overall Study|Adverse Event|1|||
30580984|NCT00174967|58591945|FG001|Overall Study|Adverse Event|2|||
30580985|NCT00174967|58591946|FG002|Overall Study|Adverse Event|2|||
30580986|NCT00174967|58591947|FG003|Overall Study|Adverse Event|1|||
30580987|NCT00174967|58591944|FG000|Overall Study|Gout Flare|0|||
30580988|NCT00174967|58591945|FG001|Overall Study|Gout Flare|0|||
30580989|NCT00174967|58591946|FG002|Overall Study|Gout Flare|0|||
30580990|NCT00174967|58591947|FG003|Overall Study|Gout Flare|1|||
30580991|NCT00174967|58591944|FG000|Overall Study|Other|0|||
30580992|NCT00174967|58591945|FG001|Overall Study|Other|1|||
30580993|NCT00174967|58591946|FG002|Overall Study|Other|0|||
30580994|NCT00174967|58591947|FG003|Overall Study|Other|0|||
30668465|NCT00819585|58682453|FG009|Core Study|Adverse Event|0|||
30668466|NCT00819585|58682454|FG010|Core Study|Adverse Event|0|||
30668467|NCT00819585|58682444|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
30668468|NCT00819585|58682445|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
30580995|NCT00174265|58591959|FG000|Overall Study|Adverse Event|7|||
30580996|NCT00174265|58591960|FG001|Overall Study|Adverse Event|4|||
30580997|NCT00174265|58591959|FG000|Overall Study|Lack of Efficacy|2|||
30580998|NCT00174265|58591960|FG001|Overall Study|Lack of Efficacy|2|||
30580999|NCT00174265|58591959|FG000|Overall Study|Withdrawal by Subject|3|||
30581000|NCT00174265|58591960|FG001|Overall Study|Withdrawal by Subject|5|||
30581001|NCT00174265|58591959|FG000|Overall Study|Lost to Follow-up|1|||
30581002|NCT00174265|58591960|FG001|Overall Study|Lost to Follow-up|0|||
30581003|NCT00174265|58591959|FG000|Overall Study|Other (Not specified)|16|||
30581004|NCT00174265|58591960|FG001|Overall Study|Other (Not specified)|10|||
30581005|NCT00172042|58591968|FG000|Overall Study|Adverse Event|27|||
30581006|NCT00172042|58591969|FG001|Overall Study|Adverse Event|13|||
30581007|NCT00172042|58591968|FG000|Overall Study|Abnormal laboratory value(s)|5|||
30581008|NCT00172042|58591969|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30581009|NCT00172042|58591968|FG000|Overall Study|Abnormal test procedure(s)|0|||
30581010|NCT00172042|58591969|FG001|Overall Study|Abnormal test procedure(s)|3|||
30581011|NCT00172042|58591968|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
30581012|NCT00172042|58591969|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
30581013|NCT00172042|58591968|FG000|Overall Study|Patient no longer requires study drug|10|||
30581014|NCT00172042|58591969|FG001|Overall Study|Patient no longer requires study drug|8|||
30581015|NCT00172042|58591968|FG000|Overall Study|Protocol Violation|8|||
30581016|NCT00172042|58591969|FG001|Overall Study|Protocol Violation|7|||
30581017|NCT00172042|58591968|FG000|Overall Study|Withdrawal by Subject|37|||
30581018|NCT00172042|58591969|FG001|Overall Study|Withdrawal by Subject|25|||
30581019|NCT00172042|58591968|FG000|Overall Study|Lost to Follow-up|3|||
30581020|NCT00172042|58591969|FG001|Overall Study|Lost to Follow-up|5|||
30581021|NCT00172042|58591968|FG000|Overall Study|Administrative problems|13|||
30581022|NCT00172042|58591969|FG001|Overall Study|Administrative problems|10|||
30581023|NCT00172042|58591968|FG000|Overall Study|Death|42|||
30581024|NCT00172042|58591969|FG001|Overall Study|Death|42|||
30581025|NCT00171925|58591977|FG000|Overall Study|Adverse Event|10|||
30581026|NCT00171925|58591978|FG001|Overall Study|Adverse Event|6|||
30581027|NCT00171925|58591977|FG000|Overall Study|Protocol Violation|1|||
30581028|NCT00171925|58591978|FG001|Overall Study|Protocol Violation|1|||
30581029|NCT00171925|58591977|FG000|Overall Study|Withdrawal by Subject|6|||
30581030|NCT00171925|58591978|FG001|Overall Study|Withdrawal by Subject|9|||
30581031|NCT00171925|58591977|FG000|Overall Study|Lost to Follow-up|2|||
30581032|NCT00171925|58591978|FG001|Overall Study|Lost to Follow-up|2|||
30581033|NCT00171925|58591977|FG000|Overall Study|Administrative problems|10|||
30581034|NCT00171925|58591978|FG001|Overall Study|Administrative problems|11|||
30581035|NCT00171925|58591977|FG000|Overall Study|Death|1|||
30581036|NCT00171925|58591978|FG001|Overall Study|Death|2|||
30581037|NCT00171340|58591986|FG000|Overall Study|Adverse Event|46|||
30581038|NCT00171340|58591987|FG001|Overall Study|Adverse Event|42|||
30581039|NCT00171340|58591986|FG000|Overall Study|Lack of Efficacy|29|||
30581040|NCT00171340|58591987|FG001|Overall Study|Lack of Efficacy|41|||
30581041|NCT00171340|58591986|FG000|Overall Study|Protocol Violation|7|||
30581042|NCT00171340|58591987|FG001|Overall Study|Protocol Violation|8|||
30581043|NCT00171340|58591986|FG000|Overall Study|Withdrawal by Subject|22|||
30581044|NCT00171340|58591987|FG001|Overall Study|Withdrawal by Subject|19|||
30581045|NCT00171340|58591986|FG000|Overall Study|Lost to Follow-up|0|||
30581046|NCT00171340|58591987|FG001|Overall Study|Lost to Follow-up|5|||
30581047|NCT00171340|58591986|FG000|Overall Study|Abnormal Laboratory Results|2|||
30581048|NCT00171340|58591987|FG001|Overall Study|Abnormal Laboratory Results|0|||
30581049|NCT00171340|58591986|FG000|Overall Study|Abnormal Test Procedure Results|6|||
30581050|NCT00171340|58591987|FG001|Overall Study|Abnormal Test Procedure Results|11|||
30581051|NCT00171340|58591986|FG000|Overall Study|No Longer Required Study Drug|1|||
30581052|NCT00171340|58591987|FG001|Overall Study|No Longer Required Study Drug|1|||
30581053|NCT00171340|58591986|FG000|Overall Study|Administrative Problems|5|||
30581054|NCT00171340|58591987|FG001|Overall Study|Administrative Problems|2|||
30581055|NCT00171340|58591986|FG000|Overall Study|Death|6|||
30581056|NCT00171340|58591987|FG001|Overall Study|Death|6|||
30581057|NCT00171301|58591997|FG000|Overall Study|Death|1|||
30581058|NCT00171301|58591998|FG001|Overall Study|Death|2|||
30581059|NCT00171301|58591997|FG000|Overall Study|Adverse Event|1|||
30581060|NCT00171301|58591998|FG001|Overall Study|Adverse Event|2|||
30581061|NCT00171301|58591997|FG000|Overall Study|Lost to Follow-up|6|||
30581062|NCT00171301|58591998|FG001|Overall Study|Lost to Follow-up|2|||
30581063|NCT00171301|58591997|FG000|Overall Study|Protocol Violation|0|||
30581064|NCT00171301|58591998|FG001|Overall Study|Protocol Violation|2|||
30581065|NCT00171301|58591997|FG000|Overall Study|Withdrawal by Subject|0|||
30581066|NCT00171301|58591998|FG001|Overall Study|Withdrawal by Subject|1|||
30581067|NCT00171223|58592008|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
30581068|NCT00171223|58592009|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
30581069|NCT00171223|58592010|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
30581070|NCT00171223|58592008|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
30581071|NCT00171223|58592009|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
30581072|NCT00171223|58592010|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
30581073|NCT00171223|58592008|FG000|Overall Study|Abnormal Procedure|1|||
30581074|NCT00171223|58592009|FG001|Overall Study|Abnormal Procedure|0|||
30581075|NCT00171223|58592010|FG002|Overall Study|Abnormal Procedure|0|||
30581076|NCT00171223|58592008|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
30581077|NCT00171223|58592009|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
30581078|NCT00171223|58592010|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
30581079|NCT00171223|58592008|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
30581080|NCT00171223|58592009|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
30581081|NCT00171223|58592010|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
30581082|NCT00171223|58592008|FG000|Overall Study|Protocol Violation|2|||
30581083|NCT00171223|58592009|FG001|Overall Study|Protocol Violation|2|||
30581084|NCT00171223|58592010|FG002|Overall Study|Protocol Violation|3|||
30581085|NCT00171223|58592008|FG000|Overall Study|Participant Withdrew Consent|12|||
30581086|NCT00171223|58592009|FG001|Overall Study|Participant Withdrew Consent|21|||
30581087|NCT00171223|58592010|FG002|Overall Study|Participant Withdrew Consent|15|||
30581088|NCT00171223|58592008|FG000|Overall Study|Lost to Follow-up|5|||
30581089|NCT00171223|58592009|FG001|Overall Study|Lost to Follow-up|2|||
30581090|NCT00171223|58592010|FG002|Overall Study|Lost to Follow-up|3|||
30581091|NCT00171223|58592008|FG000|Overall Study|Administrative Problems|4|||
30581092|NCT00171223|58592009|FG001|Overall Study|Administrative Problems|7|||
30581093|NCT00171223|58592010|FG002|Overall Study|Administrative Problems|6|||
30581094|NCT00171223|58592008|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
30581095|NCT00171223|58592009|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
30581096|NCT00171223|58592010|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
30581097|NCT00171223|58592008|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
30581098|NCT00171223|58592009|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
30581099|NCT00171223|58592010|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
30581100|NCT00479674|58592016|FG000|Overall Study|Adverse Event|18|||
30581101|NCT00479674|58592016|FG000|Overall Study|Withdrawal by Subject|6|||
30581102|NCT00479674|58592016|FG000|Overall Study|Physician Decision|14|||
30581103|NCT00479674|58592016|FG000|Overall Study|none provided|3|||
30581104|NCT00479401|58592023|FG000|Overall Study|Adverse Event|24|||
30581105|NCT00479401|58592024|FG001|Overall Study|Adverse Event|20|||
30581106|NCT00479401|58592025|FG002|Overall Study|Adverse Event|4|||
30581107|NCT00479401|58592023|FG000|Overall Study|Lack of Efficacy|2|||
30581108|NCT00479401|58592024|FG001|Overall Study|Lack of Efficacy|2|||
30581109|NCT00479401|58592025|FG002|Overall Study|Lack of Efficacy|4|||
30581110|NCT00479401|58592023|FG000|Overall Study|Protocol Violation|2|||
30581111|NCT00479401|58592024|FG001|Overall Study|Protocol Violation|1|||
30581112|NCT00479401|58592025|FG002|Overall Study|Protocol Violation|1|||
30581113|NCT00479401|58592023|FG000|Overall Study|Lost to Follow-up|1|||
30581114|NCT00479401|58592024|FG001|Overall Study|Lost to Follow-up|1|||
30581115|NCT00479401|58592025|FG002|Overall Study|Lost to Follow-up|1|||
30581116|NCT00479401|58592023|FG000|Overall Study|Withdrawal by Subject|16|||
30581117|NCT00479401|58592024|FG001|Overall Study|Withdrawal by Subject|10|||
30581118|NCT00479401|58592025|FG002|Overall Study|Withdrawal by Subject|2|||
30581119|NCT00479401|58592023|FG000|Overall Study|Exclusion criteria, relocation|4|||
30581120|NCT00479401|58592024|FG001|Overall Study|Exclusion criteria, relocation|3|||
30581121|NCT00479401|58592025|FG002|Overall Study|Exclusion criteria, relocation|0|||
30581122|NCT00478777|58592033|FG000|Overall Study|Adverse Event|29|||
30581123|NCT00478777|58592033|FG000|Overall Study|Lack of Efficacy|23|||
30581124|NCT00478777|58592033|FG000|Overall Study|Withdrawal by Subject|4|||
30581125|NCT00478777|58592033|FG000|Overall Study|Death|3|||
30581126|NCT00478777|58592033|FG000|Overall Study|Protocol Violation|3|||
30581127|NCT00478777|58592033|FG000|Overall Study|Lost to Follow-up|3|||
30581128|NCT00478777|58592033|FG000|Overall Study|Physician Decision|1|||
30581129|NCT00478777|58592033|FG000|Overall Study|Intolerance of therapy|1|||
30581130|NCT00478777|58592033|FG000|Overall Study|Lack of compliance|1|||
30581131|NCT00478777|58592033|FG000|Overall Study|Lymphocytes infusion|1|||
30581132|NCT00478777|58592033|FG000|Overall Study|End of therapy|2|||
30581133|NCT00478777|58592033|FG000|Overall Study|Not treated with lenalidomide|6|||
30581134|NCT00477607|58592039|FG000|Overall Study|Lost to Follow-up|7|||
30581135|NCT00477607|58592040|FG001|Overall Study|Lost to Follow-up|7|||
30581136|NCT00477490|58592051|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
30581137|NCT00477490|58592052|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
30581138|NCT00477490|58592053|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
30581139|NCT00477490|58592054|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
30581140|NCT00477490|58592055|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
30581141|NCT00477490|58592056|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
30581142|NCT00477490|58592057|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
30581143|NCT00477490|58592058|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
30581144|NCT00477490|58592059|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
30581145|NCT00477490|58592051|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
30581146|NCT00477490|58592052|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
30581147|NCT00477490|58592053|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
30581148|NCT00477490|58592054|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
30581149|NCT00477490|58592055|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
30581150|NCT00477490|58592056|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
30581151|NCT00477490|58592057|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
30581152|NCT00477490|58592058|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
30581153|NCT00477490|58592059|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
30581154|NCT00477490|58592051|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
30581155|NCT00477490|58592052|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
30581156|NCT00477490|58592053|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
30581157|NCT00477490|58592054|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
30581158|NCT00477490|58592055|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
30581159|NCT00477490|58592056|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
30581160|NCT00477490|58592057|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
30581161|NCT00477490|58592058|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
30581162|NCT00477490|58592059|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
30581163|NCT00477490|58592051|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
30581164|NCT00477490|58592052|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
30581165|NCT00477490|58592053|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
30581166|NCT00477490|58592054|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
30581167|NCT00477490|58592055|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
30581168|NCT00477490|58592056|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
30581169|NCT00477490|58592057|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
30581170|NCT00477490|58592058|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
30581171|NCT00477490|58592059|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
30581172|NCT00477490|58592051|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
30581173|NCT00477490|58592052|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
30581174|NCT00477490|58592053|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
30581175|NCT00477490|58592054|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
30581176|NCT00477490|58592055|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
30581177|NCT00477490|58592056|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
30581178|NCT00477490|58592057|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
30581179|NCT00477490|58592058|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
30581180|NCT00477490|58592059|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
30581181|NCT00477490|58592051|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
30581182|NCT00477490|58592052|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
30581183|NCT00477490|58592053|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
30581184|NCT00477490|58592054|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
30581185|NCT00477490|58592055|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
30581186|NCT00477490|58592056|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
30581187|NCT00477490|58592057|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
30581188|NCT00477490|58592058|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
30581189|NCT00477490|58592059|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
30581190|NCT00477490|58592051|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
30581191|NCT00477490|58592052|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
30581192|NCT00477490|58592053|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
30581193|NCT00477490|58592054|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
30581194|NCT00477490|58592055|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
30581195|NCT00477490|58592056|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
30581196|NCT00477490|58592057|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
30581197|NCT00477490|58592058|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
30581198|NCT00477490|58592059|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
30581199|NCT00477490|58592051|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
30581200|NCT00477490|58592052|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
30581201|NCT00477490|58592053|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
30581202|NCT00477490|58592054|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
30581203|NCT00477490|58592055|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
30581204|NCT00477490|58592056|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
30581205|NCT00477490|58592057|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
30581206|NCT00477490|58592058|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
30581207|NCT00477490|58592059|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
30581208|NCT00477490|58592051|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
30581209|NCT00477490|58592052|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
30581210|NCT00477490|58592053|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
30581211|NCT00477490|58592054|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
30581212|NCT00477490|58592055|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
30581213|NCT00477490|58592056|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
30581214|NCT00477490|58592057|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
30668469|NCT00819585|58682446|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
30668470|NCT00819585|58682447|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
30581215|NCT00477490|58592058|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
30668471|NCT00819585|58682448|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
30581216|NCT00477490|58592059|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
30581217|NCT00477490|58592051|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
30581218|NCT00477490|58592052|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
30581219|NCT00477490|58592053|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
30581220|NCT00477490|58592054|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
30581221|NCT00477490|58592055|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
30581222|NCT00477490|58592056|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
30581223|NCT00477490|58592057|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
30581224|NCT00477490|58592058|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
30581225|NCT00477490|58592059|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
30581226|NCT00477490|58592051|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
30581227|NCT00477490|58592052|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
30581228|NCT00477490|58592053|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
30581229|NCT00477490|58592054|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
30581230|NCT00477490|58592055|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
30581231|NCT00477490|58592056|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
30581232|NCT00477490|58592057|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
30581233|NCT00477490|58592058|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
30581234|NCT00477490|58592059|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
30581235|NCT00477490|58592051|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
30581236|NCT00477490|58592052|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
30581237|NCT00477490|58592053|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
30581238|NCT00477490|58592054|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
30581239|NCT00477490|58592055|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
30581240|NCT00477490|58592056|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
30581241|NCT00477490|58592057|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
30581242|NCT00477490|58592058|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
30581243|NCT00477490|58592059|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
30581244|NCT00477490|58592051|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
30581245|NCT00477490|58592052|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
30581246|NCT00477490|58592053|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
30581247|NCT00477490|58592054|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
30581248|NCT00477490|58592055|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
30581249|NCT00477490|58592056|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
30581250|NCT00477490|58592057|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
30581251|NCT00477490|58592058|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
30581252|NCT00477490|58592059|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
30581253|NCT00477490|58592051|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
30581254|NCT00477490|58592052|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
30581255|NCT00477490|58592053|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
30581256|NCT00477490|58592054|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
30581257|NCT00477490|58592055|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
30581258|NCT00477490|58592056|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
30581259|NCT00477490|58592057|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
30581260|NCT00477490|58592058|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
30581261|NCT00477490|58592059|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
30581262|NCT00477334|58592089|FG000|Overall Study|Discontinued prior to taking study drug|106|||
30581263|NCT00477334|58592090|FG001|Overall Study|Discontinued prior to taking study drug|53|||
30581264|NCT00477334|58592089|FG000|Overall Study|Adverse Event|1|||
30581265|NCT00477334|58592090|FG001|Overall Study|Adverse Event|2|||
30581266|NCT00477334|58592089|FG000|Overall Study|Withdrawal by Subject|2|||
30581267|NCT00477334|58592090|FG001|Overall Study|Withdrawal by Subject|1|||
30581268|NCT00477334|58592089|FG000|Overall Study|Lost to Follow-up|15|||
30581269|NCT00477334|58592090|FG001|Overall Study|Lost to Follow-up|4|||
30581270|NCT00477334|58592089|FG000|Overall Study|Administrative Problems|39|||
30581271|NCT00477334|58592090|FG001|Overall Study|Administrative Problems|15|||
30581272|NCT00477334|58592089|FG000|Overall Study|Protocol Violation|7|||
30581273|NCT00477334|58592090|FG001|Overall Study|Protocol Violation|1|||
30581274|NCT04971967|58592234|FG000|Overall Study|Lost to Follow-up|6|||
30581275|NCT04971967|58592235|FG001|Overall Study|Lost to Follow-up|7|||
30581276|NCT04716881|58592249|FG000|Overall Study|Adverse Event|1|||
30581277|NCT04716881|58592249|FG000|Overall Study|Lost to Follow-up|1|||
30581278|NCT04582266|58592266|FG000|Overall Study|Lost to Follow-up|7|||
30581279|NCT04582266|58592267|FG001|Overall Study|Lost to Follow-up|5|||
30668472|NCT00819585|58682449|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
30780852|NCT01061008|58792980|FG000|Overall Study|Withdrawal by Subject|1|||
30780853|NCT01061008|58792981|FG001|Overall Study|Withdrawal by Subject|3|||
30958746|NCT01579565|59023938|FG001|Randomized|Withdrawal by Subject|0|||
30581280|NCT04582266|58592266|FG000|Overall Study|Withdrawal by Subject|1|||
30581281|NCT04582266|58592267|FG001|Overall Study|Withdrawal by Subject|0|||
30581282|NCT04582266|58592266|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
30581283|NCT04582266|58592267|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
30581284|NCT04459338|58592277|FG000|Overall Study|Loss of IV during study|1|||
30581285|NCT04459338|58592278|FG001|Overall Study|Loss of IV during study|0|||
30581286|NCT04166383|58592284|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
30581287|NCT04166383|58592284|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
30581288|NCT04166383|58592284|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
30581289|NCT03740048|58592343|FG000|Overall Study|Withdrawal by Subject|1|||
30581290|NCT03740048|58592344|FG001|Overall Study|Withdrawal by Subject|1|||
30581291|NCT03740048|58592343|FG000|Overall Study|Death|1|||
30581292|NCT03740048|58592344|FG001|Overall Study|Death|6|||
30581293|NCT03740048|58592343|FG000|Overall Study|Switched to thrice-weekly HD|2|||
30581294|NCT03740048|58592344|FG001|Overall Study|Switched to thrice-weekly HD|0|||
30581295|NCT03740048|58592343|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
30581296|NCT03740048|58592344|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
30581297|NCT03740048|58592343|FG000|Overall Study|Lost to Follow-up|0|||
30581298|NCT03740048|58592344|FG001|Overall Study|Lost to Follow-up|1|||
30581299|NCT03740048|58592343|FG000|Overall Study|Non-compliance with HD|0|||
30581300|NCT03740048|58592344|FG001|Overall Study|Non-compliance with HD|1|||
30581301|NCT03436862|58592404|FG000|Overall Study|Adverse Event|4|||
30581302|NCT03436862|58592404|FG000|Overall Study|Progressive Disease|2|||
30581303|NCT03373760|58592425|FG000|Overall Study|Adverse Event|8|||
30581304|NCT03373760|58592425|FG000|Overall Study|Disease Progression|46|||
30581305|NCT03373760|58592425|FG000|Overall Study|Death|4|||
30581306|NCT03324880|58592434|FG000|Overall Study|Adverse Event|0|||
30581307|NCT03324880|58592435|FG001|Overall Study|Adverse Event|2|||
30581308|NCT03324880|58592434|FG000|Overall Study|Withdrawal by Subject|2|||
30581309|NCT03324880|58592435|FG001|Overall Study|Withdrawal by Subject|2|||
30581310|NCT03324880|58592434|FG000|Overall Study|Lost to Follow-up|0|||
30581311|NCT03324880|58592435|FG001|Overall Study|Lost to Follow-up|1|||
30581312|NCT03324880|58592434|FG000|Overall Study|Product Recall|0|||
30581313|NCT03324880|58592435|FG001|Overall Study|Product Recall|1|||
30581314|NCT03053440|58592445|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
30581315|NCT03053440|58592446|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
30581316|NCT03053440|58592445|FG000|Overall Study|Death|18|||
30581317|NCT03053440|58592446|FG001|Overall Study|Death|14|||
30581318|NCT03053440|58592445|FG000|Overall Study|Withdrawal by Subject|9|||
30581319|NCT03053440|58592446|FG001|Overall Study|Withdrawal by Subject|8|||
30581320|NCT03053440|58592445|FG000|Overall Study|Lost to Follow-up|1|||
30581321|NCT03053440|58592446|FG001|Overall Study|Lost to Follow-up|0|||
30581322|NCT03053440|58592445|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
30581323|NCT03053440|58592446|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
30581324|NCT03053440|58592445|FG000|Overall Study|Physician Decision|2|||
30581325|NCT03053440|58592446|FG001|Overall Study|Physician Decision|1|||
30581326|NCT03053440|58592445|FG000|Overall Study|Participant Randomized but died before dosing|1|||
30581327|NCT03053440|58592446|FG001|Overall Study|Participant Randomized but died before dosing|0|||
30581328|NCT02985684|58592453|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
30581329|NCT02985684|58592453|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
30581330|NCT02985684|58592453|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
30581331|NCT02949934|58592492|FG000|Natural Drinking Period|Adverse Event|1|||
30581332|NCT02949934|58592493|FG001|Natural Drinking Period|Adverse Event|0|||
30581333|NCT02949934|58592494|FG002|Natural Drinking Period|Adverse Event|0|||
30581334|NCT02949934|58592495|FG003|Natural Drinking Period|Adverse Event|1|||
30581335|NCT02949934|58592496|FG004|Natural Drinking Period|Adverse Event|0|||
30581336|NCT02949934|58592497|FG005|Natural Drinking Period|Adverse Event|0|||
30581337|NCT02949934|58592492|FG000|Natural Drinking Period|Lost to Follow-up|0|||
30581338|NCT02949934|58592493|FG001|Natural Drinking Period|Lost to Follow-up|0|||
30581339|NCT02949934|58592494|FG002|Natural Drinking Period|Lost to Follow-up|0|||
30668473|NCT00819585|58682450|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
30668474|NCT00819585|58682451|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
30668475|NCT00819585|58682452|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
30581340|NCT02949934|58592495|FG003|Natural Drinking Period|Lost to Follow-up|0|||
30668476|NCT00819585|58682453|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
30668477|NCT00819585|58682454|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
30668478|NCT00819585|58682444|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
30780854|NCT01061008|58792980|FG000|Overall Study|Unable to exercise following surgery|1|||
30581341|NCT02949934|58592496|FG004|Natural Drinking Period|Lost to Follow-up|1|||
30581342|NCT02949934|58592497|FG005|Natural Drinking Period|Lost to Follow-up|0|||
30581343|NCT02949934|58592492|FG000|Neuroimaging|Protocol Violation|2|||
30581344|NCT02949934|58592493|FG001|Neuroimaging|Protocol Violation|0|||
30668479|NCT00819585|58682445|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
30581345|NCT02949934|58592494|FG002|Neuroimaging|Protocol Violation|0|||
30581346|NCT02949934|58592495|FG003|Neuroimaging|Protocol Violation|0|||
30581347|NCT02949934|58592496|FG004|Neuroimaging|Protocol Violation|1|||
30581348|NCT02949934|58592497|FG005|Neuroimaging|Protocol Violation|0|||
30581349|NCT02949934|58592492|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
30581350|NCT02949934|58592493|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
30581351|NCT02949934|58592494|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
30581352|NCT02949934|58592495|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
30581353|NCT02949934|58592496|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
30581354|NCT02949934|58592497|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
30581355|NCT02949934|58592492|FG000|Neuroimaging|Not scanned|0|||
30581356|NCT02949934|58592493|FG001|Neuroimaging|Not scanned|0|||
30581357|NCT02949934|58592494|FG002|Neuroimaging|Not scanned|1|||
30668480|NCT00819585|58682446|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
30668481|NCT00819585|58682447|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
30668482|NCT00819585|58682448|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
30668483|NCT00819585|58682449|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
30668484|NCT00819585|58682450|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
30668485|NCT00819585|58682451|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
30668486|NCT00819585|58682452|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
30668487|NCT00819585|58682453|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
30668488|NCT00819585|58682454|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
30668489|NCT00819585|58682444|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
30668490|NCT00819585|58682445|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
30668491|NCT00819585|58682446|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
30668492|NCT00819585|58682447|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
30668493|NCT00819585|58682448|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
30668494|NCT00819585|58682449|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
30668495|NCT00819585|58682450|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
30668496|NCT00819585|58682451|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
30668497|NCT00819585|58682452|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
30780855|NCT01061008|58792981|FG001|Overall Study|Unable to exercise following surgery|0|||
30780856|NCT01061008|58792980|FG000|Overall Study|Adverse Event|0|||
30780857|NCT01061008|58792981|FG001|Overall Study|Adverse Event|1|||
30780858|NCT00039741|58792991|FG000|Overall Study|Death|0|||
30780859|NCT00039741|58792992|FG001|Overall Study|Death|1|||
30780860|NCT00039741|58792993|FG002|Overall Study|Death|0|||
30780861|NCT00039741|58792994|FG003|Overall Study|Death|0|||
30780862|NCT00039741|58792991|FG000|Overall Study|Lost to Follow-up|3|||
30581358|NCT02949934|58592495|FG003|Neuroimaging|Not scanned|0|||
30668498|NCT00819585|58682453|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
30668499|NCT00819585|58682454|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
30668500|NCT00819585|58682444|FG000|Core Study|Subject Withdrew Consent|0|||
30668501|NCT00819585|58682445|FG001|Core Study|Subject Withdrew Consent|3|||
30668502|NCT00819585|58682446|FG002|Core Study|Subject Withdrew Consent|2|||
30668503|NCT00819585|58682447|FG003|Core Study|Subject Withdrew Consent|1|||
30668504|NCT00819585|58682448|FG004|Core Study|Subject Withdrew Consent|0|||
30668505|NCT00819585|58682449|FG005|Core Study|Subject Withdrew Consent|0|||
30668506|NCT00819585|58682450|FG006|Core Study|Subject Withdrew Consent|3|||
30668507|NCT00819585|58682451|FG007|Core Study|Subject Withdrew Consent|0|||
30668508|NCT00819585|58682452|FG008|Core Study|Subject Withdrew Consent|0|||
30780863|NCT00039741|58792992|FG001|Overall Study|Lost to Follow-up|1|||
30780864|NCT00039741|58792993|FG002|Overall Study|Lost to Follow-up|5|||
30581359|NCT02949934|58592496|FG004|Neuroimaging|Not scanned|0|||
30581360|NCT02949934|58592497|FG005|Neuroimaging|Not scanned|2|||
30581361|NCT02949934|58592492|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
30581362|NCT02949934|58592493|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
30581363|NCT02949934|58592494|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
30780865|NCT00039741|58792994|FG003|Overall Study|Lost to Follow-up|2|||
30780866|NCT00039741|58792991|FG000|Overall Study|Confounding medical condition|1|||
30581364|NCT02949934|58592495|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
30581365|NCT02949934|58592496|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
30581366|NCT02949934|58592497|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
30581367|NCT02949934|58592492|FG000|Bar Laboratory|Adverse Event|1|||
30581368|NCT02949934|58592493|FG001|Bar Laboratory|Adverse Event|0|||
30581369|NCT02949934|58592494|FG002|Bar Laboratory|Adverse Event|2|||
30668509|NCT00819585|58682453|FG009|Core Study|Subject Withdrew Consent|0|||
30780867|NCT00039741|58792992|FG001|Overall Study|Confounding medical condition|0|||
30581370|NCT02949934|58592495|FG003|Bar Laboratory|Adverse Event|0|||
30668510|NCT00819585|58682454|FG010|Core Study|Subject Withdrew Consent|0|||
30668511|NCT00819585|58682444|FG000|Core Study|Lost to Follow-up|2|||
30668512|NCT00819585|58682445|FG001|Core Study|Lost to Follow-up|1|||
30780868|NCT00039741|58792993|FG002|Overall Study|Confounding medical condition|0|||
30855531|NCT00103285|58883188|FG005|Response Assignment|Protocol Violation|0|||
30581371|NCT02949934|58592496|FG004|Bar Laboratory|Adverse Event|1|||
30581372|NCT02949934|58592497|FG005|Bar Laboratory|Adverse Event|0|||
30581373|NCT02949934|58592492|FG000|Bar Laboratory|Protocol Violation|0|||
30581374|NCT02949934|58592493|FG001|Bar Laboratory|Protocol Violation|0|||
30581375|NCT02949934|58592494|FG002|Bar Laboratory|Protocol Violation|0|||
30581376|NCT02949934|58592495|FG003|Bar Laboratory|Protocol Violation|1|||
30581377|NCT02949934|58592496|FG004|Bar Laboratory|Protocol Violation|0|||
30581378|NCT02949934|58592497|FG005|Bar Laboratory|Protocol Violation|0|||
30581379|NCT02935634|58592529|FG000|Randomization|Participant withdrew consent|0|||
30581380|NCT02935634|58592530|FG001|Randomization|Participant withdrew consent|1|||
30581381|NCT02935634|58592531|FG002|Randomization|Participant withdrew consent|0|||
30581382|NCT02935634|58592532|FG003|Randomization|Participant withdrew consent|0|||
30581383|NCT02935634|58592533|FG004|Randomization|Participant withdrew consent|0|||
30581384|NCT02935634|58592534|FG005|Randomization|Participant withdrew consent|0|||
30581385|NCT02935634|58592529|FG000|Randomization|Death|2|||
30581386|NCT02935634|58592530|FG001|Randomization|Death|1|||
30581387|NCT02935634|58592531|FG002|Randomization|Death|1|||
30581388|NCT02935634|58592532|FG003|Randomization|Death|0|||
30581389|NCT02935634|58592533|FG004|Randomization|Death|0|||
30581390|NCT02935634|58592534|FG005|Randomization|Death|0|||
30581391|NCT02935634|58592529|FG000|Randomization|Other reasons|0|||
30581392|NCT02935634|58592530|FG001|Randomization|Other reasons|2|||
30581393|NCT02935634|58592531|FG002|Randomization|Other reasons|2|||
30581394|NCT02935634|58592532|FG003|Randomization|Other reasons|0|||
30581395|NCT02935634|58592533|FG004|Randomization|Other reasons|0|||
30581396|NCT02935634|58592534|FG005|Randomization|Other reasons|0|||
30581397|NCT02935634|58592529|FG000|Treatment: Track 1|Disease progression|15|||
30581398|NCT02935634|58592530|FG001|Treatment: Track 1|Disease progression|17|||
30581399|NCT02935634|58592531|FG002|Treatment: Track 1|Disease progression|28|||
30581400|NCT02935634|58592532|FG003|Treatment: Track 1|Disease progression|4|||
30581401|NCT02935634|58592533|FG004|Treatment: Track 1|Disease progression|6|||
30581402|NCT02935634|58592534|FG005|Treatment: Track 1|Disease progression|2|||
30581403|NCT02935634|58592529|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
30581404|NCT02935634|58592530|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
30581405|NCT02935634|58592531|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
30581406|NCT02935634|58592532|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
30581407|NCT02935634|58592533|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
30581408|NCT02935634|58592534|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
30581409|NCT02935634|58592529|FG000|Treatment: Track 1|Lost to Follow-up|1|||
30581410|NCT02935634|58592530|FG001|Treatment: Track 1|Lost to Follow-up|0|||
30581411|NCT02935634|58592531|FG002|Treatment: Track 1|Lost to Follow-up|0|||
30581412|NCT02935634|58592532|FG003|Treatment: Track 1|Lost to Follow-up|0|||
30581413|NCT02935634|58592533|FG004|Treatment: Track 1|Lost to Follow-up|0|||
30581414|NCT02935634|58592534|FG005|Treatment: Track 1|Lost to Follow-up|0|||
30581415|NCT02935634|58592529|FG000|Treatment: Track 1|Study drug toxicity|2|||
30581416|NCT02935634|58592530|FG001|Treatment: Track 1|Study drug toxicity|1|||
30581417|NCT02935634|58592531|FG002|Treatment: Track 1|Study drug toxicity|3|||
30581418|NCT02935634|58592532|FG003|Treatment: Track 1|Study drug toxicity|0|||
30581419|NCT02935634|58592533|FG004|Treatment: Track 1|Study drug toxicity|0|||
30581420|NCT02935634|58592534|FG005|Treatment: Track 1|Study drug toxicity|1|||
30581421|NCT02935634|58592529|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
30581422|NCT02935634|58592530|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
30581423|NCT02935634|58592531|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
30581424|NCT02935634|58592532|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
30581425|NCT02935634|58592533|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
30581426|NCT02935634|58592534|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
30581427|NCT02935634|58592529|FG000|Treatment: Track 1|Participant withdrew consent|2|||
30581428|NCT02935634|58592530|FG001|Treatment: Track 1|Participant withdrew consent|0|||
30581429|NCT02935634|58592531|FG002|Treatment: Track 1|Participant withdrew consent|1|||
30581430|NCT02935634|58592532|FG003|Treatment: Track 1|Participant withdrew consent|0|||
30581431|NCT02935634|58592533|FG004|Treatment: Track 1|Participant withdrew consent|1|||
30581432|NCT02935634|58592534|FG005|Treatment: Track 1|Participant withdrew consent|0|||
30581433|NCT02935634|58592529|FG000|Treatment: Track 1|Other reasons|0|||
30581434|NCT02935634|58592530|FG001|Treatment: Track 1|Other reasons|0|||
30581435|NCT02935634|58592531|FG002|Treatment: Track 1|Other reasons|2|||
30581436|NCT02935634|58592532|FG003|Treatment: Track 1|Other reasons|0|||
30581437|NCT02935634|58592533|FG004|Treatment: Track 1|Other reasons|0|||
30581438|NCT02935634|58592534|FG005|Treatment: Track 1|Other reasons|0|||
30668513|NCT00819585|58682446|FG002|Core Study|Lost to Follow-up|2|||
30668514|NCT00819585|58682447|FG003|Core Study|Lost to Follow-up|0|||
30855532|NCT00103285|58883189|FG006|Response Assignment|Protocol Violation|0|||
30581439|NCT02935634|58592529|FG000|Treatment: Track 2|Disease progression|13|||
30855533|NCT00103285|58883190|FG007|Response Assignment|Protocol Violation|0|||
30581440|NCT02935634|58592530|FG001|Treatment: Track 2|Disease progression|26|||
30668515|NCT00819585|58682448|FG004|Core Study|Lost to Follow-up|1|||
30581441|NCT02935634|58592531|FG002|Treatment: Track 2|Disease progression|20|||
30581442|NCT02935634|58592532|FG003|Treatment: Track 2|Disease progression|5|||
30581443|NCT02935634|58592533|FG004|Treatment: Track 2|Disease progression|1|||
30581444|NCT02935634|58592534|FG005|Treatment: Track 2|Disease progression|4|||
30581445|NCT02935634|58592529|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
30581446|NCT02935634|58592530|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
30581447|NCT02935634|58592531|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
30581448|NCT02935634|58592532|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
30581449|NCT02935634|58592533|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
30581450|NCT02935634|58592534|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
30581451|NCT02935634|58592529|FG000|Treatment: Track 2|Study drug toxicity|7|||
30581452|NCT02935634|58592530|FG001|Treatment: Track 2|Study drug toxicity|3|||
30581453|NCT02935634|58592531|FG002|Treatment: Track 2|Study drug toxicity|0|||
30581454|NCT02935634|58592532|FG003|Treatment: Track 2|Study drug toxicity|0|||
30581455|NCT02935634|58592533|FG004|Treatment: Track 2|Study drug toxicity|0|||
30581456|NCT02935634|58592534|FG005|Treatment: Track 2|Study drug toxicity|0|||
30581457|NCT02935634|58592529|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
30581458|NCT02935634|58592530|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
30581459|NCT02935634|58592531|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
30581460|NCT02935634|58592532|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
30581461|NCT02935634|58592533|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
30581462|NCT02935634|58592534|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
30581463|NCT02935634|58592529|FG000|Treatment: Track 2|Participant withdrew consent|0|||
30581464|NCT02935634|58592530|FG001|Treatment: Track 2|Participant withdrew consent|1|||
30581465|NCT02935634|58592531|FG002|Treatment: Track 2|Participant withdrew consent|1|||
30581466|NCT02935634|58592532|FG003|Treatment: Track 2|Participant withdrew consent|0|||
30581467|NCT02935634|58592533|FG004|Treatment: Track 2|Participant withdrew consent|1|||
30581468|NCT02935634|58592534|FG005|Treatment: Track 2|Participant withdrew consent|0|||
30581469|NCT02864992|58592563|FG000|Overall Study|still on treatment|15|||
30581470|NCT02864992|58592564|FG001|Overall Study|still on treatment|1|||
30581471|NCT02864992|58592565|FG002|Overall Study|still on treatment|33|||
30581472|NCT02684578|58592573|FG000|Overall Study|Withdrawal by Subject|10|||
30581473|NCT02684578|58592574|FG001|Overall Study|Withdrawal by Subject|7|||
30581474|NCT02684578|58592573|FG000|Overall Study|Lost to Follow-up|0|||
30581475|NCT02684578|58592574|FG001|Overall Study|Lost to Follow-up|3|||
30581476|NCT02684578|58592573|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
30581477|NCT02684578|58592574|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
30581478|NCT02684578|58592573|FG000|Overall Study|Missing follow-up data|0|||
30581479|NCT02684578|58592574|FG001|Overall Study|Missing follow-up data|1|||
30581480|NCT02612129|58592582|FG000|Single Dose Treatment Period|Screening Failure|1|||
30581481|NCT02612129|58592583|FG001|Single Dose Treatment Period|Screening Failure|0|||
30668516|NCT00819585|58682449|FG005|Core Study|Lost to Follow-up|1|||
30668517|NCT00819585|58682450|FG006|Core Study|Lost to Follow-up|1|||
30668518|NCT00819585|58682451|FG007|Core Study|Lost to Follow-up|0|||
30668519|NCT00819585|58682452|FG008|Core Study|Lost to Follow-up|0|||
30668520|NCT00819585|58682453|FG009|Core Study|Lost to Follow-up|0|||
30668521|NCT00819585|58682454|FG010|Core Study|Lost to Follow-up|0|||
30668522|NCT00819585|58682444|FG000|Core Study|Administrative Problems|0|||
30668523|NCT00819585|58682445|FG001|Core Study|Administrative Problems|0|||
30668524|NCT00819585|58682446|FG002|Core Study|Administrative Problems|0|||
30668525|NCT00819585|58682447|FG003|Core Study|Administrative Problems|0|||
30668526|NCT00819585|58682448|FG004|Core Study|Administrative Problems|0|||
30668527|NCT00819585|58682449|FG005|Core Study|Administrative Problems|0|||
30668528|NCT00819585|58682450|FG006|Core Study|Administrative Problems|2|||
30668529|NCT00819585|58682451|FG007|Core Study|Administrative Problems|0|||
30668530|NCT00819585|58682452|FG008|Core Study|Administrative Problems|0|||
30668531|NCT00819585|58682453|FG009|Core Study|Administrative Problems|0|||
30668532|NCT00819585|58682454|FG010|Core Study|Administrative Problems|0|||
30668533|NCT00819585|58682444|FG000|Core Study|Death|0|||
30668534|NCT00819585|58682445|FG001|Core Study|Death|0|||
30668535|NCT00819585|58682446|FG002|Core Study|Death|0|||
30668536|NCT00819585|58682447|FG003|Core Study|Death|0|||
30668537|NCT00819585|58682448|FG004|Core Study|Death|0|||
30668538|NCT00819585|58682449|FG005|Core Study|Death|0|||
30668539|NCT00819585|58682450|FG006|Core Study|Death|1|||
30668540|NCT00819585|58682451|FG007|Core Study|Death|0|||
30668541|NCT00819585|58682452|FG008|Core Study|Death|0|||
30581482|NCT02612129|58592584|FG002|Single Dose Treatment Period|Screening Failure|0|||
30581483|NCT02612129|58592582|FG000|Continuous Treatment Period|Early Escape|0|||
30581484|NCT02612129|58592583|FG001|Continuous Treatment Period|Early Escape|2|||
30581485|NCT02612129|58592584|FG002|Continuous Treatment Period|Early Escape|0|||
30668542|NCT00819585|58682453|FG009|Core Study|Death|0|||
30668543|NCT00819585|58682454|FG010|Core Study|Death|0|||
30668544|NCT00819585|58682444|FG000|Core Study|Protocol Violation|0|||
30668545|NCT00819585|58682445|FG001|Core Study|Protocol Violation|0|||
30581486|NCT02612129|58592582|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
30581487|NCT02612129|58592583|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
30581488|NCT02612129|58592584|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
30581489|NCT02612129|58592582|FG000|Continuous Treatment Period|Safety Reasons|0|||
30581490|NCT02612129|58592583|FG001|Continuous Treatment Period|Safety Reasons|3|||
30581491|NCT02612129|58592584|FG002|Continuous Treatment Period|Safety Reasons|0|||
30581492|NCT02612129|58592582|FG000|Continuous Treatment Period|Death|0|||
30581493|NCT02612129|58592583|FG001|Continuous Treatment Period|Death|1|||
30668546|NCT00819585|58682446|FG002|Core Study|Protocol Violation|1|||
30668547|NCT00819585|58682447|FG003|Core Study|Protocol Violation|0|||
30668548|NCT00819585|58682448|FG004|Core Study|Protocol Violation|0|||
30668549|NCT00819585|58682449|FG005|Core Study|Protocol Violation|1|||
30668550|NCT00819585|58682450|FG006|Core Study|Protocol Violation|3|||
30668551|NCT00819585|58682451|FG007|Core Study|Protocol Violation|0|||
30668552|NCT00819585|58682452|FG008|Core Study|Protocol Violation|0|||
30668553|NCT00819585|58682453|FG009|Core Study|Protocol Violation|0|||
30668554|NCT00819585|58682454|FG010|Core Study|Protocol Violation|0|||
30668555|NCT00819585|58682444|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
30668556|NCT00819585|58682445|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
30668557|NCT00819585|58682446|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
30668558|NCT00819585|58682447|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
30668559|NCT00819585|58682448|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
30668560|NCT00819585|58682449|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
30668561|NCT00819585|58682450|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
30668562|NCT00819585|58682451|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
30668563|NCT00819585|58682452|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
30668564|NCT00819585|58682453|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
30668565|NCT00819585|58682454|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
30668566|NCT00819585|58682444|FG000|Extension Study|Subject Withdrew Consent|0|||
30668567|NCT00819585|58682445|FG001|Extension Study|Subject Withdrew Consent|0|||
30668568|NCT00819585|58682446|FG002|Extension Study|Subject Withdrew Consent|0|||
30668569|NCT00819585|58682447|FG003|Extension Study|Subject Withdrew Consent|0|||
30668570|NCT00819585|58682448|FG004|Extension Study|Subject Withdrew Consent|0|||
30668571|NCT00819585|58682449|FG005|Extension Study|Subject Withdrew Consent|0|||
30668572|NCT00819585|58682450|FG006|Extension Study|Subject Withdrew Consent|0|||
30668573|NCT00819585|58682451|FG007|Extension Study|Subject Withdrew Consent|0|||
30668574|NCT00819585|58682452|FG008|Extension Study|Subject Withdrew Consent|3|||
30668575|NCT00819585|58682453|FG009|Extension Study|Subject Withdrew Consent|0|||
30668576|NCT00819585|58682454|FG010|Extension Study|Subject Withdrew Consent|1|||
30668577|NCT00819585|58682444|FG000|Extension Study|Lost to Follow-up|0|||
30668578|NCT00819585|58682445|FG001|Extension Study|Lost to Follow-up|0|||
30668579|NCT00819585|58682446|FG002|Extension Study|Lost to Follow-up|0|||
30668580|NCT00819585|58682447|FG003|Extension Study|Lost to Follow-up|0|||
30668581|NCT00819585|58682448|FG004|Extension Study|Lost to Follow-up|0|||
30668582|NCT00819585|58682449|FG005|Extension Study|Lost to Follow-up|0|||
30668583|NCT00819585|58682450|FG006|Extension Study|Lost to Follow-up|0|||
30668584|NCT00819585|58682451|FG007|Extension Study|Lost to Follow-up|0|||
30668585|NCT00819585|58682452|FG008|Extension Study|Lost to Follow-up|2|||
30668586|NCT00819585|58682453|FG009|Extension Study|Lost to Follow-up|1|||
30668587|NCT00819585|58682454|FG010|Extension Study|Lost to Follow-up|1|||
30668588|NCT00819585|58682444|FG000|Extension Study|Death|0|||
30668589|NCT00819585|58682445|FG001|Extension Study|Death|0|||
30668590|NCT00819585|58682446|FG002|Extension Study|Death|0|||
30668591|NCT00819585|58682447|FG003|Extension Study|Death|0|||
30668592|NCT00819585|58682448|FG004|Extension Study|Death|0|||
30668593|NCT00819585|58682449|FG005|Extension Study|Death|0|||
30668594|NCT00819585|58682450|FG006|Extension Study|Death|0|||
30668595|NCT00819585|58682451|FG007|Extension Study|Death|0|||
30668596|NCT00819585|58682452|FG008|Extension Study|Death|2|||
30668597|NCT00819585|58682453|FG009|Extension Study|Death|0|||
30668598|NCT00819585|58682454|FG010|Extension Study|Death|0|||
30668599|NCT00508261|58682486|FG000|Overall Study|Other|0|||
30668600|NCT00508261|58682487|FG001|Overall Study|Other|1|||
30668601|NCT00508261|58682488|FG002|Overall Study|Other|1|||
30668602|NCT00508261|58682489|FG003|Overall Study|Other|0|||
30668603|NCT00508261|58682486|FG000|Overall Study|Serious Adverse Event|0|||
30668604|NCT00508261|58682487|FG001|Overall Study|Serious Adverse Event|1|||
30668605|NCT00508261|58682488|FG002|Overall Study|Serious Adverse Event|0|||
30668606|NCT00508261|58682489|FG003|Overall Study|Serious Adverse Event|0|||
30668607|NCT00508261|58682486|FG000|Overall Study|Withdrawal by Subject|3|||
30668608|NCT00508261|58682487|FG001|Overall Study|Withdrawal by Subject|4|||
30668609|NCT00508261|58682488|FG002|Overall Study|Withdrawal by Subject|4|||
30581494|NCT02612129|58592584|FG002|Continuous Treatment Period|Death|0|||
30668610|NCT00508261|58682489|FG003|Overall Study|Withdrawal by Subject|0|||
30668611|NCT00508261|58682486|FG000|Overall Study|Migrated/ moved from study area|0|||
30668612|NCT00508261|58682487|FG001|Overall Study|Migrated/ moved from study area|1|||
30581495|NCT02612129|58592582|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
30581496|NCT02612129|58592583|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
30581497|NCT02612129|58592584|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
30581498|NCT02580305|58592594|FG000|Overall Study|Adverse Event|15|||
30581499|NCT02580305|58592595|FG001|Overall Study|Adverse Event|19|||
30581500|NCT02580305|58592596|FG002|Overall Study|Adverse Event|10|||
30581501|NCT02580305|58592594|FG000|Overall Study|Lack of Efficacy|5|||
30581502|NCT02580305|58592595|FG001|Overall Study|Lack of Efficacy|0|||
30581503|NCT02580305|58592596|FG002|Overall Study|Lack of Efficacy|2|||
30581504|NCT02580305|58592594|FG000|Overall Study|Protocol Violation|4|||
30581505|NCT02580305|58592595|FG001|Overall Study|Protocol Violation|9|||
30581506|NCT02580305|58592596|FG002|Overall Study|Protocol Violation|6|||
30581507|NCT02580305|58592594|FG000|Overall Study|Lost to Follow-up|4|||
30581508|NCT02580305|58592595|FG001|Overall Study|Lost to Follow-up|4|||
30581509|NCT02580305|58592596|FG002|Overall Study|Lost to Follow-up|2|||
30581510|NCT02580305|58592594|FG000|Overall Study|Withdrawal by Subject|11|||
30581511|NCT02580305|58592595|FG001|Overall Study|Withdrawal by Subject|9|||
30581512|NCT02580305|58592596|FG002|Overall Study|Withdrawal by Subject|7|||
30581513|NCT02580305|58592594|FG000|Overall Study|Randomized in error and never treated|4|||
30581514|NCT02580305|58592595|FG001|Overall Study|Randomized in error and never treated|8|||
30581515|NCT02580305|58592596|FG002|Overall Study|Randomized in error and never treated|5|||
30581516|NCT02054741|58592615|FG000|Overall Study|Protocol Violation|13|||
30581517|NCT02054741|58592616|FG001|Overall Study|Protocol Violation|2|||
30581518|NCT02054741|58592615|FG000|Overall Study|Withdrawal by Subject|10|||
30581519|NCT02054741|58592616|FG001|Overall Study|Withdrawal by Subject|5|||
30581520|NCT02054741|58592615|FG000|Overall Study|Death|94|||
30581521|NCT02054741|58592616|FG001|Overall Study|Death|90|||
30581522|NCT02054741|58592615|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
30581523|NCT02054741|58592616|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
30581524|NCT01555463|58592624|FG000|Treatment|Adverse Event|6|||
30581525|NCT01555463|58592625|FG001|Treatment|Adverse Event|12|||
30581526|NCT01555463|58592624|FG000|Treatment|Withdrawal by Subject|24|||
30581527|NCT01555463|58592625|FG001|Treatment|Withdrawal by Subject|36|||
30581528|NCT01555463|58592624|FG000|Treatment|Lost to Follow-up|28|||
30581529|NCT01555463|58592625|FG001|Treatment|Lost to Follow-up|23|||
30581530|NCT01555463|58592624|FG000|Treatment|Protocol Violation|4|||
30581531|NCT01555463|58592625|FG001|Treatment|Protocol Violation|5|||
30581532|NCT01555463|58592624|FG000|Treatment|Other reason|2|||
30581533|NCT01555463|58592625|FG001|Treatment|Other reason|3|||
30581534|NCT01555463|58592624|FG000|Follow up|Adverse Event|2|||
30581535|NCT01555463|58592625|FG001|Follow up|Adverse Event|5|||
30581536|NCT01555463|58592624|FG000|Follow up|Death|0|||
30581537|NCT01555463|58592625|FG001|Follow up|Death|1|||
30581538|NCT01555463|58592624|FG000|Follow up|Withdrawal by Subject|22|||
30581539|NCT01555463|58592625|FG001|Follow up|Withdrawal by Subject|22|||
30581540|NCT01555463|58592624|FG000|Follow up|Lost to Follow-up|9|||
30581541|NCT01555463|58592625|FG001|Follow up|Lost to Follow-up|10|||
30581542|NCT01555463|58592624|FG000|Follow up|Protocol Violation|2|||
30581543|NCT01555463|58592625|FG001|Follow up|Protocol Violation|4|||
30581544|NCT01555463|58592624|FG000|Follow up|Other reason|3|||
30581545|NCT01555463|58592625|FG001|Follow up|Other reason|3|||
30581546|NCT01081951|58592703|FG000|Overall Study|Death|54|||
30581547|NCT01081951|58592704|FG001|Overall Study|Death|47|||
30581548|NCT01081951|58592703|FG000|Overall Study|Withdrawal by Subject|2|||
30581549|NCT01081951|58592704|FG001|Overall Study|Withdrawal by Subject|6|||
30581550|NCT01081951|58592703|FG000|Overall Study|Allocated treatment but did not take it|0|||
30581551|NCT01081951|58592704|FG001|Overall Study|Allocated treatment but did not take it|1|||
30581552|NCT01081951|58592703|FG000|Overall Study|Lost to Follow-up|0|||
30668613|NCT00508261|58682488|FG002|Overall Study|Migrated/ moved from study area|0|||
30668614|NCT00508261|58682489|FG003|Overall Study|Migrated/ moved from study area|0|||
30668615|NCT00508261|58682486|FG000|Overall Study|Lost to Follow-up|0|||
30668616|NCT00508261|58682487|FG001|Overall Study|Lost to Follow-up|1|||
30581553|NCT01081951|58592704|FG001|Overall Study|Lost to Follow-up|1|||
30581554|NCT02277106|58592710|FG000|Stage 2|Adverse Event|0|||
30581555|NCT02277106|58592711|FG001|Stage 2|Adverse Event|0|||
30581556|NCT02277106|58592712|FG002|Stage 2|Adverse Event|1|||
30581557|NCT02215096|58592735|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
30581558|NCT02215096|58592736|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
30581559|NCT02215096|58592737|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
30668617|NCT00508261|58682488|FG002|Overall Study|Lost to Follow-up|1|||
30668618|NCT00508261|58682489|FG003|Overall Study|Lost to Follow-up|1|||
30581560|NCT02215096|58592738|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
30581561|NCT02215096|58592739|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
30581562|NCT02215096|58592735|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
30581563|NCT02215096|58592736|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
30581564|NCT02215096|58592737|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
30581565|NCT02215096|58592738|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
30581566|NCT02215096|58592739|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
30581567|NCT02215096|58592735|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
30581568|NCT02215096|58592736|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
30581569|NCT02215096|58592737|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
30581570|NCT02215096|58592738|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
30581571|NCT02215096|58592739|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
30581572|NCT02215096|58592735|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
30581573|NCT02215096|58592736|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
30581574|NCT02215096|58592737|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
30581575|NCT02215096|58592738|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
30581576|NCT02215096|58592739|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
30581577|NCT03189862|58592774|FG000|Overall Study|Withdrawal by Subject|1|||
30581578|NCT03189862|58592775|FG001|Overall Study|Withdrawal by Subject|0|||
30581579|NCT03189862|58592774|FG000|Overall Study|Lost to Follow-up|54|||
30581580|NCT03189862|58592775|FG001|Overall Study|Lost to Follow-up|62|||
30581581|NCT00107614|58592807|FG000|Overall Study|Physician Decision|10|||
30668619|NCT00819039|58682528|FG000|Overall Study|Physician Decision|1|||
30668620|NCT00819039|58682529|FG001|Overall Study|Physician Decision|0|||
30668621|NCT00819039|58682530|FG002|Overall Study|Physician Decision|1|||
30668622|NCT00819039|58682528|FG000|Overall Study|Protocol Violation|1|||
30668623|NCT00819039|58682529|FG001|Overall Study|Protocol Violation|0|||
30668624|NCT00819039|58682530|FG002|Overall Study|Protocol Violation|0|||
30668625|NCT00500539|58682540|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
30668626|NCT00500539|58682540|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
30668627|NCT00500539|58682540|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
30668628|NCT00500539|58682540|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
30668629|NCT00500539|58682540|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
30668630|NCT00500539|58682540|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
30668631|NCT00500539|58682540|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
30668632|NCT00500539|58682540|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
30668633|NCT00500539|58682540|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
30668634|NCT00500539|58682540|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
30668635|NCT00500539|58682540|FG000|Follow-up Period (16 Weeks)|Death|1|||
30668636|NCT00500539|58682540|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
30668637|NCT00500539|58682540|FG000|Follow-up Period (16 Weeks)|Missing|3|||
30668638|NCT00818883|58682549|FG000|Overall Study|Adverse Event|28|||
30668639|NCT00818883|58682550|FG001|Overall Study|Adverse Event|19|||
30668640|NCT00818883|58682549|FG000|Overall Study|Protocol Violation|2|||
30668641|NCT00818883|58682550|FG001|Overall Study|Protocol Violation|2|||
30668642|NCT00818883|58682549|FG000|Overall Study|Lost to Follow-up|3|||
30668643|NCT00818883|58682550|FG001|Overall Study|Lost to Follow-up|2|||
30668644|NCT00818883|58682549|FG000|Overall Study|Withdrawal by Subject|16|||
30668645|NCT00818883|58682550|FG001|Overall Study|Withdrawal by Subject|14|||
30668646|NCT00818883|58682549|FG000|Overall Study|Lack of Efficacy|0|||
30668647|NCT00818883|58682550|FG001|Overall Study|Lack of Efficacy|2|||
30668648|NCT00818883|58682549|FG000|Overall Study|Other|2|||
30668649|NCT00818883|58682550|FG001|Overall Study|Other|7|||
30668650|NCT00508027|58682556|FG000|Dose Level 1|Lost to Follow-up|4|||
30668651|NCT00508027|58682556|FG000|Dose Level 1|Withdrawal by Subject|2|||
30668652|NCT00508027|58682556|FG000|Dose Level 1|Physician Decision|2|||
30668653|NCT00508027|58682556|FG000|Dose Level 2|Lost to Follow-up|2|||
30668654|NCT00508027|58682556|FG000|Dose Level 2|Withdrawal by Subject|2|||
30668655|NCT00500149|58682585|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
30668656|NCT00500149|58682586|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
30668657|NCT00500149|58682585|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
30668658|NCT00500149|58682586|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
30668659|NCT00500149|58682585|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
30668660|NCT00500149|58682586|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
30668661|NCT00500149|58682585|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
30668662|NCT00500149|58682586|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
30668663|NCT00500149|58682585|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
30780869|NCT00039741|58792994|FG003|Overall Study|Confounding medical condition|0|||
30780870|NCT00039741|58792991|FG000|Overall Study|Not able to get to clinic|5|||
30780871|NCT00039741|58792992|FG001|Overall Study|Not able to get to clinic|2|||
30780872|NCT00039741|58792993|FG002|Overall Study|Not able to get to clinic|0|||
30581582|NCT00107614|58592807|FG000|Overall Study|Death|2|||
30668664|NCT00500149|58682586|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
30668665|NCT00500149|58682585|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
30668666|NCT00500149|58682586|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
30780873|NCT00039741|58792994|FG003|Overall Study|Not able to get to clinic|3|||
30581583|NCT00107380|58592811|FG000|Overall Study|Adverse Event|7|||
30581584|NCT00107380|58592811|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
30581585|NCT00107380|58592811|FG000|Overall Study|Progression/relapse|4|||
30581586|NCT00107380|58592811|FG000|Overall Study|Death|3|||
30581587|NCT00107380|58592811|FG000|Overall Study|Other - not protocol specified|7|||
30581588|NCT00107380|58592811|FG000|Overall Study|Ineligible|2|||
30581589|NCT01340014|58592818|FG000|Period 1, First 7 Days|Adverse Event|1|||
30581590|NCT01340014|58592819|FG001|Period 1, First 7 Days|Adverse Event|0|||
30581591|NCT01340014|58592818|FG000|Period 1, First 7 Days|Personal Reasons|1|||
30581592|NCT01340014|58592819|FG001|Period 1, First 7 Days|Personal Reasons|0|||
30581593|NCT01340014|58592818|FG000|Period 2, Second 7 Days|Adverse Event|0|||
30581594|NCT01340014|58592819|FG001|Period 2, Second 7 Days|Adverse Event|1|||
30581595|NCT01339897|58592829|FG000|Overall Study|Adverse Event|1|||
30581596|NCT01339897|58592830|FG001|Overall Study|Adverse Event|0|||
30581597|NCT01339897|58592831|FG002|Overall Study|Adverse Event|0|||
30581598|NCT01339897|58592832|FG003|Overall Study|Adverse Event|1|||
30581599|NCT01339429|58592844|FG000|Overall Study|Withdrawal by Subject|1|||
30581600|NCT01339429|58592844|FG000|Overall Study|Physician Decision|3|||
30581601|NCT01339390|58592850|FG000|Overall Study|Death|32|||
30581602|NCT01339390|58592851|FG001|Overall Study|Death|29|||
30581603|NCT01339390|58592850|FG000|Overall Study|Lost to Follow-up|125|||
30581604|NCT01339390|58592851|FG001|Overall Study|Lost to Follow-up|127|||
30581605|NCT01339273|58592859|FG000|Overall Study|Lost to Follow-up|8|||
30581606|NCT01339273|58592860|FG001|Overall Study|Lost to Follow-up|8|||
30581607|NCT01334866|58592866|FG000|Overall Study|Withdrawal by Subject|10|||
30581608|NCT01334866|58592866|FG000|Overall Study|Lost to Follow-up|3|||
30581609|NCT01334866|58592866|FG000|Overall Study|Physician Decision|3|||
30581610|NCT01334866|58592866|FG000|Overall Study|medically necessary prior to procedure|2|||
30581611|NCT01334866|58592866|FG000|Overall Study|medically necessary post-procedure|1|||
30581612|NCT01334710|58592872|FG000|Overall Study|Trial was terminated|3|||
30581613|NCT01334554|58592879|FG000|Overall Study|Adverse Event|4|||
30581614|NCT01334554|58592880|FG001|Overall Study|Adverse Event|2|||
30581615|NCT01332799|58592890|FG000|Overall Study|Insufficient funding|10|||
30581616|NCT01332799|58592891|FG001|Overall Study|Insufficient funding|10|||
30581617|NCT01332331|58592899|FG000|Overall Study|Lost to Follow-up|0|||
30581618|NCT01332331|58592900|FG001|Overall Study|Lost to Follow-up|1|||
30581619|NCT01332331|58592899|FG000|Overall Study|Adverse Event|1|||
30581620|NCT01332331|58592900|FG001|Overall Study|Adverse Event|1|||
30581621|NCT01332331|58592899|FG000|Overall Study|Physician Decision|1|||
30581622|NCT01332331|58592900|FG001|Overall Study|Physician Decision|0|||
30581623|NCT01332292|58592907|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
30581624|NCT01332292|58592908|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
30581625|NCT01332292|58592907|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
30581626|NCT01332292|58592908|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
30581627|NCT01332292|58592907|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
30581628|NCT01332292|58592908|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
30581629|NCT01332019|58592918|FG000|Overall Study|Was Not Dosed|1|||
30581630|NCT01332019|58592919|FG001|Overall Study|Was Not Dosed|0|||
30581631|NCT01332019|58592918|FG000|Overall Study|Other|16|||
30581632|NCT01332019|58592919|FG001|Overall Study|Other|18|||
30581633|NCT01332019|58592918|FG000|Overall Study|Death|2|||
30581634|NCT01332019|58592919|FG001|Overall Study|Death|1|||
30581635|NCT01332019|58592918|FG000|Overall Study|Physician Decision|4|||
30581636|NCT01332019|58592919|FG001|Overall Study|Physician Decision|3|||
30581637|NCT01332019|58592918|FG000|Overall Study|Withdrawal by Subject|73|||
30581638|NCT01332019|58592919|FG001|Overall Study|Withdrawal by Subject|71|||
30581639|NCT01332019|58592918|FG000|Overall Study|Lost to Follow-up|4|||
30581640|NCT01332019|58592919|FG001|Overall Study|Lost to Follow-up|7|||
30581641|NCT01332019|58592918|FG000|Overall Study|Adverse Event|13|||
30581642|NCT01332019|58592919|FG001|Overall Study|Adverse Event|22|||
30581643|NCT01331239|58592927|FG000|Part II: Core Study|Adverse Event|0|||
30581644|NCT01331239|58592928|FG001|Part II: Core Study|Adverse Event|3|||
30581645|NCT01331239|58592929|FG002|Part II: Core Study|Adverse Event|0|||
30581646|NCT01331239|58592927|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
30581647|NCT01331239|58592928|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
30581648|NCT01331239|58592929|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
30581649|NCT01331239|58592927|FG000|Part II: Core Study|Withdrawal by Subject|0|||
30581650|NCT01331239|58592928|FG001|Part II: Core Study|Withdrawal by Subject|2|||
30581651|NCT01331239|58592929|FG002|Part II: Core Study|Withdrawal by Subject|0|||
30581652|NCT01331239|58592927|FG000|Part II: Core Study|Administrative problems|0|||
30581653|NCT01331239|58592928|FG001|Part II: Core Study|Administrative problems|1|||
30581654|NCT01331239|58592929|FG002|Part II: Core Study|Administrative problems|0|||
30581655|NCT01331161|58592947|FG000|Overall Study|Physician Decision|1|||
30581656|NCT01331161|58592948|FG001|Overall Study|Physician Decision|0|||
30581657|NCT01331161|58592947|FG000|Overall Study|Lost to Follow-up|0|||
30581658|NCT01331161|58592948|FG001|Overall Study|Lost to Follow-up|1|||
30581659|NCT01331161|58592947|FG000|Overall Study|Pregnancy|0|||
30581660|NCT01331161|58592948|FG001|Overall Study|Pregnancy|1|||
30581661|NCT01331005|58592958|FG000|Overall Study|Lost to Follow-up|2|||
30581662|NCT01331005|58592959|FG001|Overall Study|Lost to Follow-up|1|||
30581663|NCT01331005|58592958|FG000|Overall Study|Withdrawal by Subject|2|||
30581664|NCT01331005|58592959|FG001|Overall Study|Withdrawal by Subject|3|||
30581665|NCT01330459|58592967|FG000|Overall Study|Physician Decision|0|||
30581666|NCT01330459|58592968|FG001|Overall Study|Physician Decision|2|||
30581667|NCT01330381|58592978|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
30581668|NCT01330381|58592979|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
30668667|NCT00500149|58682585|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
30855534|NCT00103285|58883183|FG000|Response Assignment|Withdrawal by Subject|0|||
30855535|NCT00103285|58883184|FG001|Response Assignment|Withdrawal by Subject|4|||
30855536|NCT00103285|58883185|FG002|Response Assignment|Withdrawal by Subject|1|||
30855537|NCT00103285|58883186|FG003|Response Assignment|Withdrawal by Subject|1|||
30855538|NCT00103285|58883187|FG004|Response Assignment|Withdrawal by Subject|2|||
30855539|NCT00103285|58883188|FG005|Response Assignment|Withdrawal by Subject|2|||
30855540|NCT00103285|58883189|FG006|Response Assignment|Withdrawal by Subject|0|||
30855541|NCT00103285|58883190|FG007|Response Assignment|Withdrawal by Subject|2|||
30855542|NCT00103285|58883183|FG000|Response Assignment|Ineligible|0|||
30855543|NCT00103285|58883184|FG001|Response Assignment|Ineligible|8|||
30855544|NCT00103285|58883185|FG002|Response Assignment|Ineligible|6|||
30855545|NCT00103285|58883186|FG003|Response Assignment|Ineligible|2|||
30855546|NCT00103285|58883187|FG004|Response Assignment|Ineligible|0|||
30855547|NCT00103285|58883188|FG005|Response Assignment|Ineligible|3|||
30855548|NCT00103285|58883189|FG006|Response Assignment|Ineligible|1|||
30855549|NCT00103285|58883190|FG007|Response Assignment|Ineligible|5|||
30668668|NCT00500149|58682586|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
30668669|NCT00489853|58682592|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
30668670|NCT00489853|58682593|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
30668671|NCT00489853|58682594|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
30668672|NCT00489853|58682592|FG000|Wash-out Period 1|Adverse Event|0|||
30668673|NCT00489853|58682593|FG001|Wash-out Period 1|Adverse Event|1|||
30668674|NCT00489853|58682594|FG002|Wash-out Period 1|Adverse Event|1|||
30668675|NCT00489853|58682592|FG000|Wash-out Period 1|Protocol Violation|0|||
30668676|NCT00489853|58682593|FG001|Wash-out Period 1|Protocol Violation|1|||
30668677|NCT00489853|58682594|FG002|Wash-out Period 1|Protocol Violation|1|||
30668678|NCT00489853|58682592|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
30668679|NCT00489853|58682593|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
30668680|NCT00489853|58682594|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
30668681|NCT00489853|58682592|FG000|Wash-out Period 2|Adverse Event|1|||
30668682|NCT00489853|58682593|FG001|Wash-out Period 2|Adverse Event|1|||
30668683|NCT00489853|58682594|FG002|Wash-out Period 2|Adverse Event|0|||
30668684|NCT00489853|58682592|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
30668685|NCT00489853|58682593|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
30668686|NCT00489853|58682594|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
30668687|NCT00489853|58682592|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
30668688|NCT00489853|58682593|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
30668689|NCT00489853|58682594|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
30668690|NCT03686423|58682602|FG000|Overall Study|Withdrawal by Subject|9|||
30668691|NCT03686423|58682602|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
30668692|NCT00499681|58682608|FG000|Overall Study|toxicity|0|||
30668693|NCT00499681|58682609|FG001|Overall Study|toxicity|1|||
30668694|NCT00499681|58682608|FG000|Overall Study|disease progression|0|||
30668695|NCT00499681|58682609|FG001|Overall Study|disease progression|1|||
30668696|NCT00875810|58682620|FG000|Overall Study|Withdrawal by Subject|1|||
30668697|NCT00875810|58682620|FG000|Overall Study|Physician Decision|3|||
30668698|NCT00875810|58682620|FG000|Overall Study|Lost to Follow-up|39|||
30668699|NCT00875810|58682620|FG000|Overall Study|Patient enroled but not implanted|2|||
30668700|NCT00875810|58682620|FG000|Overall Study|Device explanted|1|||
30668701|NCT00499603|58682626|FG000|Overall Study|Adverse Event|0|||
30668702|NCT00499603|58682627|FG001|Overall Study|Adverse Event|1|||
30668703|NCT00810069|58682646|FG000|Lead-in Period I|Adverse Event|43|||
30668704|NCT00810069|58682647|FG001|Lead-in Period I|Adverse Event|0|||
30668705|NCT00810069|58682648|FG002|Lead-in Period I|Adverse Event|0|||
30668706|NCT00810069|58682646|FG000|Lead-in Period I|Lack of Efficacy|1|||
30855550|NCT00103285|58883183|FG000|Response Assignment|Refusal|0|||
30855551|NCT00103285|58883184|FG001|Response Assignment|Refusal|53|||
30855552|NCT00103285|58883185|FG002|Response Assignment|Refusal|5|||
30855553|NCT00103285|58883186|FG003|Response Assignment|Refusal|3|||
30855554|NCT00103285|58883187|FG004|Response Assignment|Refusal|25|||
30855555|NCT00103285|58883188|FG005|Response Assignment|Refusal|15|||
30855556|NCT00103285|58883189|FG006|Response Assignment|Refusal|30|||
30855557|NCT00103285|58883190|FG007|Response Assignment|Refusal|10|||
30855558|NCT00103285|58883183|FG000|Response Assignment|Other|0|||
30668707|NCT00810069|58682647|FG001|Lead-in Period I|Lack of Efficacy|0|||
30668708|NCT00810069|58682648|FG002|Lead-in Period I|Lack of Efficacy|0|||
30668709|NCT00810069|58682646|FG000|Lead-in Period I|Lost to Follow-up|19|||
30855559|NCT00103285|58883184|FG001|Response Assignment|Other|30|||
30855560|NCT00103285|58883185|FG002|Response Assignment|Other|48|||
30855561|NCT00103285|58883186|FG003|Response Assignment|Other|38|||
30855562|NCT00103285|58883187|FG004|Response Assignment|Other|37|||
30855563|NCT00103285|58883188|FG005|Response Assignment|Other|17|||
30855564|NCT00103285|58883189|FG006|Response Assignment|Other|11|||
30855565|NCT00103285|58883190|FG007|Response Assignment|Other|53|||
30855566|NCT02783573|58883218|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
30855567|NCT02783573|58883219|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
30855568|NCT02783573|58883220|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
30855569|NCT02783573|58883218|FG000|Placebo-Controlled Treatment Period|Death|4|||
30855570|NCT02783573|58883219|FG001|Placebo-Controlled Treatment Period|Death|2|||
30855571|NCT02783573|58883220|FG002|Placebo-Controlled Treatment Period|Death|3|||
30855572|NCT02783573|58883218|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
30855573|NCT02783573|58883219|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
30855574|NCT02783573|58883220|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
30855575|NCT02783573|58883218|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
30855576|NCT02783573|58883219|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
30855577|NCT02783573|58883220|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
30581669|NCT01330381|58592980|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
30581670|NCT01330381|58592978|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
30581671|NCT01330381|58592979|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
30581672|NCT01330381|58592980|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
30581673|NCT01330381|58592978|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
30581674|NCT01330381|58592979|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
30581675|NCT01330381|58592980|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
30581676|NCT01330381|58592978|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
30581677|NCT01330381|58592979|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
30581678|NCT01330381|58592980|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
30581679|NCT01330381|58592978|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
30581680|NCT01330381|58592979|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
30581681|NCT01330381|58592980|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
30581682|NCT01330381|58592978|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
30581683|NCT01330381|58592979|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
30581684|NCT01330381|58592980|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
30581685|NCT01330381|58592978|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
30581686|NCT01330381|58592979|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
30581687|NCT01330381|58592980|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
30581688|NCT01330381|58592978|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
30581689|NCT01330381|58592979|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
30581690|NCT01330381|58592980|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
30581691|NCT01330381|58592978|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
30581692|NCT01330381|58592979|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
30581693|NCT01330381|58592980|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
30581694|NCT01330381|58592978|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
30581695|NCT01330381|58592979|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
30581696|NCT01330381|58592980|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
30581697|NCT01330303|58592989|FG000|Period 1|Adverse Event|1|||
30581698|NCT01330303|58592990|FG001|Period 1|Adverse Event|0|||
30581699|NCT01330303|58592989|FG000|Period 1|Protocol Violation|0|||
30581700|NCT01330303|58592990|FG001|Period 1|Protocol Violation|1|||
30581701|NCT01330303|58592989|FG000|Period 1|Withdrawal by Subject|0|||
30581702|NCT01330303|58592990|FG001|Period 1|Withdrawal by Subject|1|||
30581703|NCT01330108|58592997|FG000|Overall Study|Withdrawal by Subject|4|||
30581704|NCT01059825|58593007|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
30581705|NCT01059825|58593008|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
30581706|NCT01059825|58593009|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
30668710|NCT00810069|58682647|FG001|Lead-in Period I|Lost to Follow-up|0|||
30668711|NCT00810069|58682648|FG002|Lead-in Period I|Lost to Follow-up|0|||
30668712|NCT00810069|58682646|FG000|Lead-in Period I|Physician Decision|1|||
30668713|NCT00810069|58682647|FG001|Lead-in Period I|Physician Decision|0|||
30668714|NCT00810069|58682648|FG002|Lead-in Period I|Physician Decision|0|||
30581707|NCT01059825|58593010|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
30581708|NCT01059825|58593011|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
30581709|NCT01059825|58593012|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
30581710|NCT01059825|58593013|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
30581711|NCT01059825|58593007|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
30668715|NCT00810069|58682646|FG000|Lead-in Period I|Protocol Violation|1|||
30668716|NCT00810069|58682647|FG001|Lead-in Period I|Protocol Violation|0|||
30581712|NCT01059825|58593008|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
30581713|NCT01059825|58593009|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
30581714|NCT01059825|58593010|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
30581715|NCT01059825|58593011|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
30581716|NCT01059825|58593012|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
30581717|NCT01059825|58593013|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
30581718|NCT01059825|58593007|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
30581719|NCT01059825|58593008|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
30581720|NCT01059825|58593009|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
30581721|NCT01059825|58593010|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
30581722|NCT01059825|58593011|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
30581723|NCT01059825|58593012|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
30581724|NCT01059825|58593013|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
30581725|NCT01059825|58593007|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
30581726|NCT01059825|58593008|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
30581727|NCT01059825|58593009|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
30581728|NCT01059825|58593010|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
30581729|NCT01059825|58593011|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
30581730|NCT01059825|58593012|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
30581731|NCT01059825|58593013|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
30581732|NCT01059825|58593007|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
30581733|NCT01059825|58593008|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
30581734|NCT01059825|58593009|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
30581735|NCT01059825|58593010|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
30581736|NCT01059825|58593011|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
30581737|NCT01059825|58593012|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
30668717|NCT00810069|58682648|FG002|Lead-in Period I|Protocol Violation|0|||
30668718|NCT00810069|58682646|FG000|Lead-in Period I|Withdrawal by Subject|46|||
30668719|NCT00810069|58682647|FG001|Lead-in Period I|Withdrawal by Subject|0|||
30668720|NCT00810069|58682648|FG002|Lead-in Period I|Withdrawal by Subject|0|||
30668721|NCT00810069|58682646|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
30668722|NCT00810069|58682647|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
30668723|NCT00810069|58682648|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
30668724|NCT00810069|58682646|FG000|Lead-in Period I|Randomization criteria not met|158|||
30668725|NCT00810069|58682647|FG001|Lead-in Period I|Randomization criteria not met|0|||
30668726|NCT00810069|58682648|FG002|Lead-in Period I|Randomization criteria not met|0|||
30668727|NCT00810069|58682646|FG000|Double-Blind Period II|Adverse Event|0|||
30668728|NCT00810069|58682647|FG001|Double-Blind Period II|Adverse Event|9|||
30668729|NCT00810069|58682648|FG002|Double-Blind Period II|Adverse Event|8|||
30668730|NCT00810069|58682646|FG000|Double-Blind Period II|Lack of Efficacy|0|||
30668731|NCT00810069|58682647|FG001|Double-Blind Period II|Lack of Efficacy|7|||
30668732|NCT00810069|58682648|FG002|Double-Blind Period II|Lack of Efficacy|12|||
30668733|NCT00810069|58682646|FG000|Double-Blind Period II|Lost to Follow-up|0|||
30668734|NCT00810069|58682647|FG001|Double-Blind Period II|Lost to Follow-up|9|||
30668735|NCT00810069|58682648|FG002|Double-Blind Period II|Lost to Follow-up|9|||
30668736|NCT00810069|58682646|FG000|Double-Blind Period II|Physician Decision|0|||
30668737|NCT00810069|58682647|FG001|Double-Blind Period II|Physician Decision|0|||
30668738|NCT00810069|58682648|FG002|Double-Blind Period II|Physician Decision|1|||
30668739|NCT00810069|58682646|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
30668740|NCT00810069|58682647|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
30668741|NCT00810069|58682648|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
30668742|NCT00810069|58682646|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
30668743|NCT00810069|58682647|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
30668744|NCT00810069|58682648|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
30780874|NCT00039741|58792991|FG000|Overall Study|Moved|3|||
30780875|NCT00039741|58792992|FG001|Overall Study|Moved|2|||
30780876|NCT00039741|58792993|FG002|Overall Study|Moved|3|||
30780877|NCT00039741|58792994|FG003|Overall Study|Moved|6|||
30780878|NCT00039741|58792991|FG000|Overall Study|Non-compliance with protocol|1|||
30780879|NCT00039741|58792992|FG001|Overall Study|Non-compliance with protocol|0|||
30780880|NCT00039741|58792993|FG002|Overall Study|Non-compliance with protocol|1|||
30780881|NCT00039741|58792994|FG003|Overall Study|Non-compliance with protocol|0|||
30780882|NCT00039741|58792991|FG000|Overall Study|Withdrew consent|0|||
30780883|NCT00039741|58792992|FG001|Overall Study|Withdrew consent|5|||
30855578|NCT02783573|58883218|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
30581738|NCT01059825|58593013|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
30581739|NCT01059825|58593007|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
30581740|NCT01059825|58593008|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
30581741|NCT01059825|58593009|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
30780884|NCT00039741|58792993|FG002|Overall Study|Withdrew consent|0|||
30780885|NCT00039741|58792994|FG003|Overall Study|Withdrew consent|1|||
30780886|NCT00039741|58792991|FG000|Overall Study|Missed final visit|2|||
30581742|NCT01059825|58593010|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
30581743|NCT01059825|58593011|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
30581744|NCT01059825|58593012|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
30581745|NCT01059825|58593013|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
30581746|NCT01059825|58593007|FG000|Treatment Period|Lost to Follow-up|2|||
30581747|NCT01059825|58593008|FG001|Treatment Period|Lost to Follow-up|1|||
30581748|NCT01059825|58593009|FG002|Treatment Period|Lost to Follow-up|0|||
30581749|NCT01059825|58593010|FG003|Treatment Period|Lost to Follow-up|1|||
30581750|NCT01059825|58593011|FG004|Treatment Period|Lost to Follow-up|2|||
30581751|NCT01059825|58593012|FG005|Treatment Period|Lost to Follow-up|0|||
30581752|NCT01059825|58593013|FG006|Treatment Period|Lost to Follow-up|0|||
30581753|NCT01059825|58593007|FG000|Treatment Period|Withdrawal by Subject|3|||
30581754|NCT01059825|58593008|FG001|Treatment Period|Withdrawal by Subject|0|||
30581755|NCT01059825|58593009|FG002|Treatment Period|Withdrawal by Subject|1|||
30581756|NCT01059825|58593010|FG003|Treatment Period|Withdrawal by Subject|5|||
30581757|NCT01059825|58593011|FG004|Treatment Period|Withdrawal by Subject|4|||
30581758|NCT01059825|58593012|FG005|Treatment Period|Withdrawal by Subject|1|||
30581759|NCT01059825|58593013|FG006|Treatment Period|Withdrawal by Subject|0|||
30581760|NCT01059825|58593007|FG000|Treatment Period|Other reason not specified|1|||
30581761|NCT01059825|58593008|FG001|Treatment Period|Other reason not specified|2|||
30581762|NCT01059825|58593009|FG002|Treatment Period|Other reason not specified|1|||
30581763|NCT01059825|58593010|FG003|Treatment Period|Other reason not specified|2|||
30581764|NCT01059825|58593011|FG004|Treatment Period|Other reason not specified|0|||
30581765|NCT01059825|58593012|FG005|Treatment Period|Other reason not specified|0|||
30581766|NCT01059825|58593013|FG006|Treatment Period|Other reason not specified|0|||
30581767|NCT01059825|58593007|FG000|Treatment Period|Protocol Violation|0|||
30581768|NCT01059825|58593008|FG001|Treatment Period|Protocol Violation|0|||
30581769|NCT01059825|58593009|FG002|Treatment Period|Protocol Violation|1|||
30581770|NCT01059825|58593010|FG003|Treatment Period|Protocol Violation|1|||
30581771|NCT01059825|58593011|FG004|Treatment Period|Protocol Violation|1|||
30581772|NCT01059825|58593012|FG005|Treatment Period|Protocol Violation|1|||
30581773|NCT01059825|58593013|FG006|Treatment Period|Protocol Violation|0|||
30581774|NCT01059825|58593007|FG000|Treatment Period|Adverse event related to study drug|1|||
30581775|NCT01059825|58593008|FG001|Treatment Period|Adverse event related to study drug|0|||
30581776|NCT01059825|58593009|FG002|Treatment Period|Adverse event related to study drug|1|||
30581777|NCT01059825|58593010|FG003|Treatment Period|Adverse event related to study drug|1|||
30581778|NCT01059825|58593011|FG004|Treatment Period|Adverse event related to study drug|0|||
30581779|NCT01059825|58593012|FG005|Treatment Period|Adverse event related to study drug|0|||
30581780|NCT01059825|58593013|FG006|Treatment Period|Adverse event related to study drug|0|||
30581781|NCT01059825|58593007|FG000|Treatment Period|Insufficient clinical response|3|||
30581782|NCT01059825|58593008|FG001|Treatment Period|Insufficient clinical response|0|||
30581783|NCT01059825|58593009|FG002|Treatment Period|Insufficient clinical response|0|||
30581784|NCT01059825|58593010|FG003|Treatment Period|Insufficient clinical response|0|||
30581785|NCT01059825|58593011|FG004|Treatment Period|Insufficient clinical response|0|||
30581786|NCT01059825|58593012|FG005|Treatment Period|Insufficient clinical response|0|||
30581787|NCT01059825|58593013|FG006|Treatment Period|Insufficient clinical response|0|||
30581788|NCT01059825|58593007|FG000|Treatment Period|Adverse event not related to study drug|0|||
30581789|NCT01059825|58593008|FG001|Treatment Period|Adverse event not related to study drug|1|||
30581790|NCT01059825|58593009|FG002|Treatment Period|Adverse event not related to study drug|2|||
30581791|NCT01059825|58593010|FG003|Treatment Period|Adverse event not related to study drug|1|||
30581792|NCT01059825|58593011|FG004|Treatment Period|Adverse event not related to study drug|1|||
30581793|NCT01059825|58593012|FG005|Treatment Period|Adverse event not related to study drug|1|||
30581794|NCT01059825|58593013|FG006|Treatment Period|Adverse event not related to study drug|0|||
30581795|NCT01059773|58593072|FG000|Overall Study|Adverse Event|2|||
30581796|NCT01059773|58593073|FG001|Overall Study|Adverse Event|2|||
30581797|NCT01059773|58593072|FG000|Overall Study|Withdrawal by Subject|1|||
30581798|NCT01059773|58593073|FG001|Overall Study|Withdrawal by Subject|5|||
30581799|NCT01059773|58593072|FG000|Overall Study|Lost to Follow-up|1|||
30581800|NCT01059773|58593073|FG001|Overall Study|Lost to Follow-up|1|||
30581801|NCT01059773|58593072|FG000|Overall Study|Pregnancy|1|||
30581802|NCT01059773|58593073|FG001|Overall Study|Pregnancy|1|||
30581803|NCT01059773|58593072|FG000|Overall Study|Protocol Violation|6|||
30581804|NCT01059773|58593073|FG001|Overall Study|Protocol Violation|2|||
30581805|NCT01059773|58593072|FG000|Overall Study|Physician Decision|5|||
30581806|NCT01059773|58593073|FG001|Overall Study|Physician Decision|4|||
30581807|NCT01059773|58593072|FG000|Overall Study|Lack of Efficacy|3|||
30581808|NCT01059773|58593073|FG001|Overall Study|Lack of Efficacy|3|||
30581809|NCT01059773|58593072|FG000|Overall Study|Death|0|||
30581810|NCT01059773|58593073|FG001|Overall Study|Death|1|||
30581811|NCT01059773|58593072|FG000|Overall Study|Malignancy including squamous cell skin|0|||
30780887|NCT00039741|58792992|FG001|Overall Study|Missed final visit|1|||
30780888|NCT00039741|58792993|FG002|Overall Study|Missed final visit|2|||
30780889|NCT00039741|58792994|FG003|Overall Study|Missed final visit|2|||
30581812|NCT01059773|58593073|FG001|Overall Study|Malignancy including squamous cell skin|1|||
30581813|NCT01059773|58593072|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
30581814|NCT01059773|58593073|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
30581815|NCT01059773|58593072|FG000|Overall Study|Other|1|||
30581816|NCT01059773|58593073|FG001|Overall Study|Other|3|||
30581817|NCT01059318|58593084|FG000|Core Study (26 Week)|Adverse Event|3|||
30581818|NCT01059318|58593084|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
30581819|NCT01059318|58593084|FG000|Extension (36 Week)|Adverse Event|3|||
30581820|NCT01058655|58593095|FG000|Overall Study|Withdrawal by Subject|1|||
30581821|NCT01058655|58593096|FG001|Overall Study|Withdrawal by Subject|0|||
30581822|NCT01058655|58593097|FG002|Overall Study|Withdrawal by Subject|3|||
30581823|NCT01058655|58593098|FG003|Overall Study|Withdrawal by Subject|4|||
30581824|NCT01058655|58593095|FG000|Overall Study|Prolonged Treatment Delay|0|||
30581825|NCT01058655|58593096|FG001|Overall Study|Prolonged Treatment Delay|0|||
30581826|NCT01058655|58593097|FG002|Overall Study|Prolonged Treatment Delay|0|||
30581827|NCT01058655|58593098|FG003|Overall Study|Prolonged Treatment Delay|2|||
30581828|NCT01058655|58593095|FG000|Overall Study|Symptomatic Deterioration|0|||
30581829|NCT01058655|58593096|FG001|Overall Study|Symptomatic Deterioration|0|||
30581830|NCT01058655|58593097|FG002|Overall Study|Symptomatic Deterioration|0|||
30581831|NCT01058655|58593098|FG003|Overall Study|Symptomatic Deterioration|1|||
30581832|NCT01058655|58593095|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
30581833|NCT01058655|58593096|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
30581834|NCT01058655|58593097|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
30581835|NCT01058655|58593098|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
30581836|NCT01058655|58593095|FG000|Overall Study|Death|0|||
30581837|NCT01058655|58593096|FG001|Overall Study|Death|1|||
30581838|NCT01058655|58593097|FG002|Overall Study|Death|1|||
30581839|NCT01058655|58593098|FG003|Overall Study|Death|0|||
30581840|NCT01058655|58593095|FG000|Overall Study|Disease Progression|1|||
30581841|NCT01058655|58593096|FG001|Overall Study|Disease Progression|2|||
30581842|NCT01058655|58593097|FG002|Overall Study|Disease Progression|4|||
30581843|NCT01058655|58593098|FG003|Overall Study|Disease Progression|24|||
30668745|NCT00810069|58682646|FG000|Double-Blind Period II|Clinical relapse|0|||
30668746|NCT00810069|58682647|FG001|Double-Blind Period II|Clinical relapse|3|||
30668747|NCT00810069|58682648|FG002|Double-Blind Period II|Clinical relapse|0|||
30668748|NCT00810069|58682646|FG000|Double-Blind Period II|Protocol Violation|0|||
30668749|NCT00810069|58682647|FG001|Double-Blind Period II|Protocol Violation|7|||
30668750|NCT00810069|58682648|FG002|Double-Blind Period II|Protocol Violation|6|||
30668751|NCT00489541|58682659|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
30668752|NCT00489541|58682660|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
30668753|NCT00489541|58682659|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
30668754|NCT00489541|58682660|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
30668755|NCT00489541|58682659|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
30668756|NCT00489541|58682660|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
30668757|NCT00489541|58682659|FG000|12-Month Clinical Follow-up|Death|3|||
30668758|NCT00489541|58682660|FG001|12-Month Clinical Follow-up|Death|2|||
30668759|NCT00489541|58682659|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
30668760|NCT00489541|58682660|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
30668761|NCT00489541|58682659|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
30668762|NCT00489541|58682660|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
30668763|NCT00809835|58682670|FG000|Overall Study|Lost to Follow-up|7|||
30668764|NCT00809835|58682671|FG001|Overall Study|Lost to Follow-up|6|||
30668765|NCT00809835|58682672|FG002|Overall Study|Lost to Follow-up|10|||
30668766|NCT00809835|58682673|FG003|Overall Study|Lost to Follow-up|2|||
30668767|NCT00809835|58682670|FG000|Overall Study|Withdrawal by Subject|1|||
30668768|NCT00809835|58682671|FG001|Overall Study|Withdrawal by Subject|1|||
30668769|NCT00809835|58682672|FG002|Overall Study|Withdrawal by Subject|1|||
30668770|NCT00809835|58682673|FG003|Overall Study|Withdrawal by Subject|0|||
30668771|NCT00853242|58682690|FG000|Overall Study|Adverse Event|0|||
30668772|NCT00853242|58682691|FG001|Overall Study|Adverse Event|1|||
30668773|NCT00853242|58682692|FG002|Overall Study|Adverse Event|1|||
30668774|NCT00853242|58682693|FG003|Overall Study|Adverse Event|0|||
30581844|NCT01058655|58593095|FG000|Overall Study|Other|0|||
30581845|NCT01058655|58593096|FG001|Overall Study|Other|0|||
30581846|NCT01058655|58593097|FG002|Overall Study|Other|0|||
30581847|NCT01058655|58593098|FG003|Overall Study|Other|4|||
30581848|NCT01058421|58593111|FG000|1 Month Outcomes|Death|10|||
30668775|NCT00853242|58682694|FG004|Overall Study|Adverse Event|3|||
30668776|NCT00853242|58682695|FG005|Overall Study|Adverse Event|1|||
30581849|NCT01058421|58593112|FG001|1 Month Outcomes|Death|6|||
30581850|NCT01058421|58593111|FG000|1 Month Outcomes|Lost to Follow-up|8|||
30581851|NCT01058421|58593112|FG001|1 Month Outcomes|Lost to Follow-up|7|||
30581852|NCT01058421|58593111|FG000|1 Month Outcomes|Remained in Hospital|5|||
30581853|NCT01058421|58593112|FG001|1 Month Outcomes|Remained in Hospital|12|||
30581854|NCT01058421|58593111|FG000|1 Month Outcomes|Remained in Other Facility|16|||
30581855|NCT01058421|58593112|FG001|1 Month Outcomes|Remained in Other Facility|17|||
30581856|NCT01058421|58593111|FG000|3 Month Outcomes|Death|3|||
30581857|NCT01058421|58593112|FG001|3 Month Outcomes|Death|5|||
30581858|NCT01058421|58593111|FG000|3 Month Outcomes|Lost to Follow-up|12|||
30581859|NCT01058421|58593112|FG001|3 Month Outcomes|Lost to Follow-up|11|||
30581860|NCT01058421|58593111|FG000|3 Month Outcomes|Remained in Hospital|0|||
30581861|NCT01058421|58593112|FG001|3 Month Outcomes|Remained in Hospital|2|||
30581862|NCT01058421|58593111|FG000|3 Month Outcomes|Remained in Other Facility|5|||
30581863|NCT01058421|58593112|FG001|3 Month Outcomes|Remained in Other Facility|8|||
30581864|NCT01058421|58593111|FG000|6 Month Outcomes|Death|2|||
30581865|NCT01058421|58593112|FG001|6 Month Outcomes|Death|2|||
30581866|NCT01058421|58593111|FG000|6 Month Outcomes|Lost to Follow-up|16|||
30581867|NCT01058421|58593112|FG001|6 Month Outcomes|Lost to Follow-up|21|||
30581868|NCT01058421|58593111|FG000|6 Month Outcomes|Remained in Other Facility|1|||
30581869|NCT01058421|58593112|FG001|6 Month Outcomes|Remained in Other Facility|3|||
30581870|NCT01058304|58593120|FG000|Overall Study|Withdrawal by Subject|8|||
30581871|NCT01058304|58593121|FG001|Overall Study|Withdrawal by Subject|5|||
30581872|NCT01058304|58593120|FG000|Overall Study|Lost to Follow-up|13|||
30581873|NCT01058304|58593121|FG001|Overall Study|Lost to Follow-up|16|||
30581874|NCT01058304|58593120|FG000|Overall Study|Developed exclusion criterion|6|||
30581875|NCT01058304|58593121|FG001|Overall Study|Developed exclusion criterion|12|||
30581876|NCT01058265|58593129|FG000|Overall Study|Lost to Follow-up|11|||
30581877|NCT01058265|58593130|FG001|Overall Study|Lost to Follow-up|12|||
30581878|NCT01057251|58593138|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
30581879|NCT01057251|58593139|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
30581880|NCT01057251|58593138|FG000|Overall Study|Adverse Event|4|||
30581881|NCT01057251|58593139|FG001|Overall Study|Adverse Event|2|||
30581882|NCT01057251|58593138|FG000|Overall Study|Lack of Efficacy|2|||
30581883|NCT01057251|58593139|FG001|Overall Study|Lack of Efficacy|11|||
30581884|NCT01057251|58593138|FG000|Overall Study|Protocol Violation|6|||
30581885|NCT01057251|58593139|FG001|Overall Study|Protocol Violation|2|||
30581886|NCT01057251|58593138|FG000|Overall Study|Withdrawal by Subject|4|||
30581887|NCT01057251|58593139|FG001|Overall Study|Withdrawal by Subject|5|||
30581888|NCT01057251|58593138|FG000|Overall Study|Lost to Follow-up|7|||
30581889|NCT01057251|58593139|FG001|Overall Study|Lost to Follow-up|6|||
30581890|NCT01057251|58593138|FG000|Overall Study|Other Reason|1|||
30581891|NCT01057251|58593139|FG001|Overall Study|Other Reason|1|||
30581892|NCT01056822|58593147|FG000|Overall Study|Adverse Event|0|||
30581893|NCT01056822|58593148|FG001|Overall Study|Adverse Event|1|||
30581894|NCT01056822|58593147|FG000|Overall Study|Protocol Violation|6|||
30581895|NCT01056822|58593148|FG001|Overall Study|Protocol Violation|5|||
30581896|NCT01056822|58593147|FG000|Overall Study|Withdrawal by Subject|1|||
30581897|NCT01056822|58593148|FG001|Overall Study|Withdrawal by Subject|1|||
30581898|NCT01056822|58593147|FG000|Overall Study|Lost to Follow-up|1|||
30581899|NCT01056822|58593148|FG001|Overall Study|Lost to Follow-up|0|||
30581900|NCT01051791|58593155|FG000|Overall Study|Failed screening|3|||
30581901|NCT01051791|58593155|FG000|Overall Study|Withdrawal by Subject|1|||
30581902|NCT01056510|58593167|FG000|Overall Study|Dropout Before Start of Treatment|1|||
30581903|NCT01056510|58593168|FG001|Overall Study|Dropout Before Start of Treatment|1|||
30668777|NCT00853242|58682696|FG006|Overall Study|Adverse Event|1|||
30668778|NCT00853242|58682690|FG000|Overall Study|Noncompliant|0|||
30668779|NCT00853242|58682691|FG001|Overall Study|Noncompliant|0|||
30668780|NCT00853242|58682692|FG002|Overall Study|Noncompliant|0|||
30668781|NCT00853242|58682693|FG003|Overall Study|Noncompliant|0|||
30668782|NCT00853242|58682694|FG004|Overall Study|Noncompliant|1|||
30780890|NCT02973802|58793004|FG000|Overall Study|Lost to Follow-up|1|||
30780891|NCT02973802|58793004|FG000|Overall Study|Withdrawal by Subject|1|||
30780892|NCT02973100|58793013|FG000|Overall Study|Adverse Event|1|||
30780893|NCT02973100|58793014|FG001|Overall Study|Adverse Event|2|||
30780894|NCT02973100|58793015|FG002|Overall Study|Adverse Event|1|||
30581904|NCT01056510|58593167|FG000|Overall Study|Withdrawal by Subject|4|||
30581905|NCT01056510|58593168|FG001|Overall Study|Withdrawal by Subject|2|||
30581906|NCT01056510|58593167|FG000|Overall Study|Death|29|||
30581907|NCT01056510|58593168|FG001|Overall Study|Death|34|||
30581908|NCT01056510|58593167|FG000|Overall Study|Noncompliance|1|||
30581909|NCT01056510|58593168|FG001|Overall Study|Noncompliance|3|||
30581910|NCT01056510|58593167|FG000|Overall Study|Physician Decision|4|||
30668783|NCT00853242|58682695|FG005|Overall Study|Noncompliant|0|||
30780895|NCT02973100|58793016|FG003|Overall Study|Adverse Event|2|||
30958747|NCT01579565|59023937|FG000|Randomized|inadequate preoperative pupil dilation|0|||
30958748|NCT01579565|59023938|FG001|Randomized|inadequate preoperative pupil dilation|1|||
30958749|NCT01579565|59023937|FG000|Randomized|prohibited preoperative eating|1|||
30581911|NCT01056510|58593168|FG001|Overall Study|Physician Decision|5|||
30581912|NCT01056510|58593167|FG000|Overall Study|Lost to Follow-up|5|||
30581913|NCT01056510|58593168|FG001|Overall Study|Lost to Follow-up|6|||
30581914|NCT01056510|58593167|FG000|Overall Study|Other|10|||
30581915|NCT01056510|58593168|FG001|Overall Study|Other|12|||
30581916|NCT01056510|58593167|FG000|Overall Study|Missing|0|||
30581917|NCT01056510|58593168|FG001|Overall Study|Missing|1|||
30780896|NCT02973100|58793013|FG000|Overall Study|Lost to Follow-up|3|||
30581918|NCT01051323|58593176|FG000|Overall Study|Discontinuation of treatment|103|||
30581919|NCT01051323|58593176|FG000|Overall Study|Transplantation|28|||
30581920|NCT01051323|58593176|FG000|Overall Study|Dialysis dependency|22|||
30581921|NCT01051323|58593176|FG000|Overall Study|Withdrawal by Subject|13|||
30581922|NCT01051323|58593176|FG000|Overall Study|Lost to Follow-up|31|||
30581923|NCT01051323|58593176|FG000|Overall Study|Death|129|||
30581924|NCT01051323|58593176|FG000|Overall Study|Hospitalization|28|||
30581925|NCT01051323|58593176|FG000|Overall Study|Other|148|||
30581926|NCT01051323|58593176|FG000|Overall Study|Missing|37|||
30581927|NCT01056276|58593186|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
30668784|NCT00853242|58682696|FG006|Overall Study|Noncompliant|0|||
30668785|NCT00853242|58682690|FG000|Overall Study|Withdrawal by Subject|1|||
30668786|NCT00853242|58682691|FG001|Overall Study|Withdrawal by Subject|2|||
30668787|NCT00853242|58682692|FG002|Overall Study|Withdrawal by Subject|0|||
30668788|NCT00853242|58682693|FG003|Overall Study|Withdrawal by Subject|4|||
30668789|NCT00853242|58682694|FG004|Overall Study|Withdrawal by Subject|0|||
30668790|NCT00853242|58682695|FG005|Overall Study|Withdrawal by Subject|0|||
30668791|NCT00853242|58682696|FG006|Overall Study|Withdrawal by Subject|2|||
30668792|NCT00853242|58682690|FG000|Overall Study|Other|2|||
30668793|NCT00853242|58682691|FG001|Overall Study|Other|0|||
30668794|NCT00853242|58682692|FG002|Overall Study|Other|2|||
30668795|NCT00853242|58682693|FG003|Overall Study|Other|0|||
30668796|NCT00853242|58682694|FG004|Overall Study|Other|0|||
30668797|NCT00853242|58682695|FG005|Overall Study|Other|1|||
30668798|NCT00853242|58682696|FG006|Overall Study|Other|2|||
30668799|NCT00848250|58682720|FG000|Overall Study|surgery was completed without cardiopulm|0|||
30668800|NCT00848250|58682721|FG001|Overall Study|surgery was completed without cardiopulm|1|||
30668801|NCT00809757|58682731|FG000|Overall Study|Adverse Event|2|||
30668802|NCT00809757|58682732|FG001|Overall Study|Adverse Event|3|||
30668803|NCT00809757|58682733|FG002|Overall Study|Adverse Event|3|||
30668804|NCT00809757|58682731|FG000|Overall Study|Lost to Follow-up|0|||
30668805|NCT00809757|58682732|FG001|Overall Study|Lost to Follow-up|0|||
30668806|NCT00809757|58682733|FG002|Overall Study|Lost to Follow-up|1|||
30668807|NCT00809757|58682731|FG000|Overall Study|Protocol Violation|1|||
30668808|NCT00809757|58682732|FG001|Overall Study|Protocol Violation|1|||
30668809|NCT00809757|58682733|FG002|Overall Study|Protocol Violation|1|||
30668810|NCT00809757|58682731|FG000|Overall Study|Withdrawal by Subject|2|||
30668811|NCT00809757|58682732|FG001|Overall Study|Withdrawal by Subject|1|||
30668812|NCT00809757|58682733|FG002|Overall Study|Withdrawal by Subject|3|||
30668813|NCT00809757|58682731|FG000|Overall Study|Subject Uncooperative|1|||
30668814|NCT00809757|58682732|FG001|Overall Study|Subject Uncooperative|0|||
30668815|NCT00809757|58682733|FG002|Overall Study|Subject Uncooperative|2|||
30668816|NCT00809757|58682731|FG000|Overall Study|Noncompliance with Medication|0|||
30668817|NCT00809757|58682732|FG001|Overall Study|Noncompliance with Medication|0|||
30668818|NCT00809757|58682733|FG002|Overall Study|Noncompliance with Medication|1|||
30668819|NCT00594464|58682747|FG000|Overall Study|Withdrawal by Subject|1|||
30668820|NCT00594464|58682747|FG000|Overall Study|Delay in operation|2|||
30668821|NCT00809445|58682760|FG000|1 Month Follow-up|Lost contact|1|||
30668822|NCT00809445|58682761|FG001|1 Month Follow-up|Lost contact|2|||
30668823|NCT00809445|58682762|FG002|1 Month Follow-up|Lost contact|1|||
30668824|NCT00809445|58682760|FG000|1 Month Follow-up|Withdrew consent|1|||
30668825|NCT00809445|58682761|FG001|1 Month Follow-up|Withdrew consent|1|||
30581928|NCT01056276|58593187|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
30581929|NCT01056276|58593186|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
30581930|NCT01056276|58593187|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
30581931|NCT01056276|58593186|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
30668826|NCT00809445|58682762|FG002|1 Month Follow-up|Withdrew consent|1|||
30668827|NCT00809445|58682760|FG000|1 Month Follow-up|Death|0|||
30780897|NCT02973100|58793014|FG001|Overall Study|Lost to Follow-up|1|||
30780898|NCT02973100|58793015|FG002|Overall Study|Lost to Follow-up|1|||
30780899|NCT02973100|58793016|FG003|Overall Study|Lost to Follow-up|0|||
30780900|NCT02973100|58793013|FG000|Overall Study|Withdrawal by Subject|3|||
30780901|NCT02973100|58793014|FG001|Overall Study|Withdrawal by Subject|5|||
30780902|NCT02973100|58793015|FG002|Overall Study|Withdrawal by Subject|1|||
30855579|NCT02783573|58883219|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
30581932|NCT01056276|58593187|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
30668828|NCT00809445|58682761|FG001|1 Month Follow-up|Death|1|||
30668829|NCT00809445|58682762|FG002|1 Month Follow-up|Death|1|||
30668830|NCT00809445|58682760|FG000|1 Month Follow-up|Incarcerated|0|||
30668831|NCT00809445|58682761|FG001|1 Month Follow-up|Incarcerated|0|||
30668832|NCT00809445|58682762|FG002|1 Month Follow-up|Incarcerated|1|||
30668833|NCT00809445|58682760|FG000|6 Month Follow-up|Lost contact|16|||
30668834|NCT00809445|58682761|FG001|6 Month Follow-up|Lost contact|14|||
30668835|NCT00809445|58682762|FG002|6 Month Follow-up|Lost contact|14|||
30668836|NCT00809445|58682760|FG000|6 Month Follow-up|Death|2|||
30780903|NCT02973100|58793016|FG003|Overall Study|Withdrawal by Subject|4|||
30668837|NCT00809445|58682761|FG001|6 Month Follow-up|Death|1|||
30668838|NCT00809445|58682762|FG002|6 Month Follow-up|Death|1|||
30581933|NCT01056276|58593186|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
30581934|NCT01056276|58593187|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
30581935|NCT01056276|58593186|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
30581936|NCT01056276|58593187|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
30581937|NCT01056276|58593186|FG000|Treatment Period-Cycles 1-8|Death|3|||
30581938|NCT01056276|58593187|FG001|Treatment Period-Cycles 1-8|Death|1|||
30581939|NCT01056276|58593186|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
30581940|NCT01056276|58593187|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
30581941|NCT01056276|58593186|FG000|Maintenance Therapy|Toxicity|0|||
30581942|NCT01056276|58593187|FG001|Maintenance Therapy|Toxicity|2|||
30581943|NCT01056276|58593186|FG000|Maintenance Therapy|Progressive Disease|0|||
30581944|NCT01056276|58593187|FG001|Maintenance Therapy|Progressive Disease|9|||
30581945|NCT01056276|58593186|FG000|Maintenance Therapy|Physician Decision|0|||
30581946|NCT01056276|58593187|FG001|Maintenance Therapy|Physician Decision|1|||
30581947|NCT01056276|58593186|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
30581948|NCT01056276|58593187|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
30581949|NCT01056276|58593186|FG000|Maintenance Therapy|Intercurrent Illness|0|||
30581950|NCT01056276|58593187|FG001|Maintenance Therapy|Intercurrent Illness|1|||
30581951|NCT01056276|58593186|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
30581952|NCT01056276|58593187|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
30581953|NCT01055886|58593200|FG000|Overall Study|Withdrawal by Subject|4|||
30581954|NCT01055886|58593201|FG001|Overall Study|Withdrawal by Subject|9|||
30581955|NCT01055886|58593200|FG000|Overall Study|Lost to Follow-up|1|||
30581956|NCT01055886|58593201|FG001|Overall Study|Lost to Follow-up|1|||
30581957|NCT01055886|58593200|FG000|Overall Study|Withdrawal by PI|0|||
30581958|NCT01055886|58593201|FG001|Overall Study|Withdrawal by PI|1|||
30581959|NCT01055613|58593209|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
30581960|NCT01055613|58593210|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
30581961|NCT01055613|58593209|FG000|Overall Study|Unacceptable lens fit|1|||
30581962|NCT01055613|58593210|FG001|Overall Study|Unacceptable lens fit|0|||
30581963|NCT01055613|58593209|FG000|Overall Study|Discomfort|2|||
30581964|NCT01055613|58593210|FG001|Overall Study|Discomfort|1|||
30581965|NCT01055613|58593209|FG000|Overall Study|Lost to Follow-up|1|||
30581966|NCT01055613|58593210|FG001|Overall Study|Lost to Follow-up|1|||
30581967|NCT01055613|58593209|FG000|Overall Study|Protocol Violation|1|||
30581968|NCT01055613|58593210|FG001|Overall Study|Protocol Violation|1|||
30581969|NCT01055613|58593209|FG000|Overall Study|Subject Disinterest|1|||
30581970|NCT01055613|58593210|FG001|Overall Study|Subject Disinterest|1|||
30581971|NCT01055457|58593226|FG000|Overall Study|Lost to Follow-up|0|||
30581972|NCT01055457|58593227|FG001|Overall Study|Lost to Follow-up|1|||
30581973|NCT01055457|58593228|FG002|Overall Study|Lost to Follow-up|0|||
30581974|NCT01055457|58593229|FG003|Overall Study|Lost to Follow-up|0|||
30581975|NCT01055457|58593230|FG004|Overall Study|Lost to Follow-up|0|||
30581976|NCT01055457|58593231|FG005|Overall Study|Lost to Follow-up|1|||
30581977|NCT01055457|58593232|FG006|Overall Study|Lost to Follow-up|0|||
30581978|NCT01055457|58593233|FG007|Overall Study|Lost to Follow-up|0|||
30581979|NCT01055457|58593234|FG008|Overall Study|Lost to Follow-up|0|||
30581980|NCT01055457|58593235|FG009|Overall Study|Lost to Follow-up|0|||
30581981|NCT01055457|58593226|FG000|Overall Study|Protocol Violation|0|||
30581982|NCT01055457|58593227|FG001|Overall Study|Protocol Violation|0|||
30581983|NCT01055457|58593228|FG002|Overall Study|Protocol Violation|1|||
30581984|NCT01055457|58593229|FG003|Overall Study|Protocol Violation|1|||
30581985|NCT01055457|58593230|FG004|Overall Study|Protocol Violation|1|||
30581986|NCT01055457|58593231|FG005|Overall Study|Protocol Violation|2|||
30581987|NCT01055457|58593232|FG006|Overall Study|Protocol Violation|1|||
30581988|NCT01055457|58593233|FG007|Overall Study|Protocol Violation|0|||
30581989|NCT01055457|58593234|FG008|Overall Study|Protocol Violation|0|||
30581990|NCT01055457|58593235|FG009|Overall Study|Protocol Violation|1|||
30581991|NCT01055457|58593226|FG000|Overall Study|Subject Disinterest|0|||
30581992|NCT01055457|58593227|FG001|Overall Study|Subject Disinterest|0|||
30581993|NCT01055457|58593228|FG002|Overall Study|Subject Disinterest|0|||
30581994|NCT01055457|58593229|FG003|Overall Study|Subject Disinterest|0|||
30581995|NCT01055457|58593230|FG004|Overall Study|Subject Disinterest|0|||
30581996|NCT01055457|58593231|FG005|Overall Study|Subject Disinterest|0|||
30581997|NCT01055457|58593232|FG006|Overall Study|Subject Disinterest|0|||
30581998|NCT01055457|58593233|FG007|Overall Study|Subject Disinterest|1|||
30581999|NCT01055457|58593234|FG008|Overall Study|Subject Disinterest|0|||
30582000|NCT01055457|58593235|FG009|Overall Study|Subject Disinterest|0|||
30582001|NCT01055457|58593226|FG000|Overall Study|Subject Ineligible|1|||
30582002|NCT01055457|58593227|FG001|Overall Study|Subject Ineligible|0|||
30582003|NCT01055457|58593228|FG002|Overall Study|Subject Ineligible|1|||
30582004|NCT01055457|58593229|FG003|Overall Study|Subject Ineligible|0|||
30582005|NCT01055457|58593230|FG004|Overall Study|Subject Ineligible|1|||
30582006|NCT01055457|58593231|FG005|Overall Study|Subject Ineligible|0|||
30582007|NCT01055457|58593232|FG006|Overall Study|Subject Ineligible|0|||
30582008|NCT01055457|58593233|FG007|Overall Study|Subject Ineligible|0|||
30582009|NCT01055457|58593234|FG008|Overall Study|Subject Ineligible|0|||
30582010|NCT01055457|58593235|FG009|Overall Study|Subject Ineligible|0|||
30582011|NCT01055457|58593226|FG000|Overall Study|Discomfort|0|||
30582012|NCT01055457|58593227|FG001|Overall Study|Discomfort|0|||
30582013|NCT01055457|58593228|FG002|Overall Study|Discomfort|0|||
30582014|NCT01055457|58593229|FG003|Overall Study|Discomfort|0|||
30582015|NCT01055457|58593230|FG004|Overall Study|Discomfort|1|||
30582016|NCT01055457|58593231|FG005|Overall Study|Discomfort|0|||
30582017|NCT01055457|58593232|FG006|Overall Study|Discomfort|0|||
30582018|NCT01055457|58593233|FG007|Overall Study|Discomfort|0|||
30582019|NCT01055457|58593234|FG008|Overall Study|Discomfort|0|||
30582020|NCT01055457|58593235|FG009|Overall Study|Discomfort|0|||
30582021|NCT01055457|58593226|FG000|Overall Study|Pregnancy|0|||
30582022|NCT01055457|58593227|FG001|Overall Study|Pregnancy|0|||
30582023|NCT01055457|58593228|FG002|Overall Study|Pregnancy|0|||
30582024|NCT01055457|58593229|FG003|Overall Study|Pregnancy|1|||
30582025|NCT01055457|58593230|FG004|Overall Study|Pregnancy|0|||
30582026|NCT01055457|58593231|FG005|Overall Study|Pregnancy|0|||
30582027|NCT01055457|58593232|FG006|Overall Study|Pregnancy|0|||
30582028|NCT01055457|58593233|FG007|Overall Study|Pregnancy|0|||
30582029|NCT01055457|58593234|FG008|Overall Study|Pregnancy|0|||
30582030|NCT01055457|58593235|FG009|Overall Study|Pregnancy|0|||
30582031|NCT01055457|58593226|FG000|Overall Study|Adverse Event|0|||
30582032|NCT01055457|58593227|FG001|Overall Study|Adverse Event|0|||
30582033|NCT01055457|58593228|FG002|Overall Study|Adverse Event|0|||
30582034|NCT01055457|58593229|FG003|Overall Study|Adverse Event|1|||
30582035|NCT01055457|58593230|FG004|Overall Study|Adverse Event|0|||
30582036|NCT01055457|58593231|FG005|Overall Study|Adverse Event|0|||
30582037|NCT01055457|58593232|FG006|Overall Study|Adverse Event|0|||
30582038|NCT01055457|58593233|FG007|Overall Study|Adverse Event|0|||
30582039|NCT01055457|58593234|FG008|Overall Study|Adverse Event|0|||
30582040|NCT01055457|58593235|FG009|Overall Study|Adverse Event|0|||
30582041|NCT01055028|58593259|FG000|Screening|Screen Failure|1|||
30582042|NCT01055028|58593260|FG001|Screening|Screen Failure|1|||
30582043|NCT01055028|58593259|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
30582044|NCT01055028|58593260|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
30582045|NCT01055028|58593259|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
30582046|NCT01055028|58593260|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
30582047|NCT01055028|58593259|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
30582048|NCT01055028|58593260|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
30582049|NCT01050816|58593292|FG000|Overall Study|Lost to Follow-up|2|||
30582050|NCT01050816|58593292|FG000|Overall Study|patient's refusal|2|||
30582051|NCT01054560|58593298|FG000|Overall Study|Death|10|||
30582052|NCT01054560|58593299|FG001|Overall Study|Death|21|||
30582053|NCT01054560|58593298|FG000|Overall Study|Lost to Follow-up|2|||
30582054|NCT01054560|58593299|FG001|Overall Study|Lost to Follow-up|5|||
30582055|NCT01054560|58593298|FG000|Overall Study|Withdrawal by Subject|0|||
30582056|NCT01054560|58593299|FG001|Overall Study|Withdrawal by Subject|2|||
30582057|NCT01054560|58593298|FG000|Overall Study|Physician Decision|1|||
30582058|NCT01054560|58593299|FG001|Overall Study|Physician Decision|0|||
30582059|NCT01054443|58593311|FG000|Overall Study|Withdrawal by Subject|0|||
30582060|NCT01054443|58593312|FG001|Overall Study|Withdrawal by Subject|0|||
30582061|NCT01054443|58593313|FG002|Overall Study|Withdrawal by Subject|0|||
30582062|NCT01054443|58593314|FG003|Overall Study|Withdrawal by Subject|1|||
30582063|NCT01050543|58593329|FG000|Overall Study|Withdrawal by Subject|0|||
30582064|NCT01050543|58593330|FG001|Overall Study|Withdrawal by Subject|2|||
30582065|NCT01050543|58593329|FG000|Overall Study|Protocol Violation|0|||
30582066|NCT01050543|58593330|FG001|Overall Study|Protocol Violation|1|||
30582067|NCT01050543|58593329|FG000|Overall Study|Administrative|4|||
30582068|NCT01050543|58593330|FG001|Overall Study|Administrative|1|||
30582069|NCT01051557|58593343|FG000|Overall Study|Physician Decision|1|||
30582070|NCT01051557|58593344|FG001|Overall Study|Physician Decision|0|||
30668839|NCT00809445|58682760|FG000|6 Month Follow-up|Incarcerated|6|||
30668840|NCT00809445|58682761|FG001|6 Month Follow-up|Incarcerated|8|||
30582071|NCT01051557|58593345|FG002|Overall Study|Physician Decision|0|||
30582072|NCT01051557|58593346|FG003|Overall Study|Physician Decision|0|||
30582073|NCT01051557|58593347|FG004|Overall Study|Physician Decision|0|||
30582074|NCT01051557|58593348|FG005|Overall Study|Physician Decision|0|||
30582075|NCT01051557|58593349|FG006|Overall Study|Physician Decision|0|||
30582076|NCT01051557|58593343|FG000|Overall Study|disease progression|3|||
30582077|NCT01051557|58593344|FG001|Overall Study|disease progression|3|||
30582078|NCT01051557|58593345|FG002|Overall Study|disease progression|5|||
30582079|NCT01051557|58593346|FG003|Overall Study|disease progression|2|||
30582080|NCT01051557|58593347|FG004|Overall Study|disease progression|4|||
30582081|NCT01051557|58593348|FG005|Overall Study|disease progression|3|||
30582082|NCT01051557|58593349|FG006|Overall Study|disease progression|1|||
30582083|NCT01051557|58593343|FG000|Overall Study|Withdrawal by Subject|0|||
30582084|NCT01051557|58593344|FG001|Overall Study|Withdrawal by Subject|0|||
30582085|NCT01051557|58593345|FG002|Overall Study|Withdrawal by Subject|1|||
30582086|NCT01051557|58593346|FG003|Overall Study|Withdrawal by Subject|0|||
30582087|NCT01051557|58593347|FG004|Overall Study|Withdrawal by Subject|2|||
30582088|NCT01051557|58593348|FG005|Overall Study|Withdrawal by Subject|0|||
30582089|NCT01051557|58593349|FG006|Overall Study|Withdrawal by Subject|1|||
30582090|NCT01051557|58593343|FG000|Overall Study|Adverse Event|0|||
30582091|NCT01051557|58593344|FG001|Overall Study|Adverse Event|0|||
30582092|NCT01051557|58593345|FG002|Overall Study|Adverse Event|0|||
30582093|NCT01051557|58593346|FG003|Overall Study|Adverse Event|1|||
30582094|NCT01051557|58593347|FG004|Overall Study|Adverse Event|1|||
30582095|NCT01051557|58593348|FG005|Overall Study|Adverse Event|3|||
30582096|NCT01051557|58593349|FG006|Overall Study|Adverse Event|4|||
30582097|NCT01054170|58593368|FG000|Overall Study|Protocol Violation|1|||
30582098|NCT01054170|58593369|FG001|Overall Study|Protocol Violation|0|||
30582099|NCT01054170|58593368|FG000|Overall Study|Withdrawal by Subject|3|||
30582100|NCT01054170|58593369|FG001|Overall Study|Withdrawal by Subject|2|||
30582101|NCT01054170|58593368|FG000|Overall Study|Adverse Event|0|||
30582102|NCT01054170|58593369|FG001|Overall Study|Adverse Event|4|||
30582103|NCT01053741|58593377|FG000|2nd Study Intervention|Physician Decision|0|||
30582104|NCT01053741|58593378|FG001|2nd Study Intervention|Physician Decision|1|||
30582105|NCT01052493|58593384|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
30582106|NCT01052493|58593385|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
30582107|NCT01052493|58593386|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
30582108|NCT01052103|58593401|FG000|Overall Study|Adverse Event|10|||
30582109|NCT01052103|58593402|FG001|Overall Study|Adverse Event|6|||
30582110|NCT01052103|58593401|FG000|Overall Study|Entry Criteria Not Met|3|||
30582111|NCT01052103|58593402|FG001|Overall Study|Entry Criteria Not Met|1|||
30582112|NCT01052103|58593401|FG000|Overall Study|Lost to Follow-up|3|||
30582113|NCT01052103|58593402|FG001|Overall Study|Lost to Follow-up|5|||
30582114|NCT01052103|58593401|FG000|Overall Study|Protocol Violation|10|||
30582115|NCT01052103|58593402|FG001|Overall Study|Protocol Violation|4|||
30582116|NCT01052103|58593401|FG000|Overall Study|Scheduling conflict|2|||
30582117|NCT01052103|58593402|FG001|Overall Study|Scheduling conflict|1|||
30582118|NCT01052103|58593401|FG000|Overall Study|Sponsor Decision|2|||
30582119|NCT01052103|58593402|FG001|Overall Study|Sponsor Decision|0|||
30582120|NCT01052103|58593401|FG000|Overall Study|Withdrawal by Subject|3|||
30582121|NCT01052103|58593402|FG001|Overall Study|Withdrawal by Subject|6|||
30582122|NCT01052103|58593401|FG000|Overall Study|Perceived Lack of Efficacy|1|||
30582123|NCT01052103|58593402|FG001|Overall Study|Perceived Lack of Efficacy|0|||
30582124|NCT01051986|58593411|FG000|Overall Study|Death|1|||
30582125|NCT01051986|58593412|FG001|Overall Study|Death|0|||
30855580|NCT02783573|58883220|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
30855581|NCT02783573|58883218|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
30582126|NCT01051986|58593411|FG000|Overall Study|Withdrawal by Subject|2|||
30582127|NCT01051986|58593412|FG001|Overall Study|Withdrawal by Subject|1|||
30582128|NCT01051986|58593411|FG000|Overall Study|Protocol Violation|2|||
30582129|NCT01051986|58593412|FG001|Overall Study|Protocol Violation|3|||
30582130|NCT00105534|58593424|FG000|Overall Study|Adverse Event|2|||
30582131|NCT00105534|58593425|FG001|Overall Study|Adverse Event|5|||
30582132|NCT00105534|58593424|FG000|Overall Study|Protocol Violation|1|||
30582133|NCT00105534|58593425|FG001|Overall Study|Protocol Violation|4|||
30582134|NCT00105534|58593424|FG000|Overall Study|Withdrawal by Subject|6|||
30582135|NCT00105534|58593425|FG001|Overall Study|Withdrawal by Subject|6|||
30582136|NCT00105534|58593424|FG000|Overall Study|Lost to Follow-up|5|||
30582137|NCT00105534|58593425|FG001|Overall Study|Lost to Follow-up|1|||
30780904|NCT02973100|58793013|FG000|Overall Study|Notification of change in address|0|||
30780905|NCT02973100|58793014|FG001|Overall Study|Notification of change in address|0|||
30780906|NCT02973100|58793015|FG002|Overall Study|Notification of change in address|0|||
30780907|NCT02973100|58793016|FG003|Overall Study|Notification of change in address|1|||
30780908|NCT02973100|58793013|FG000|Overall Study|Failed to attend Safety followup period|0|||
30780909|NCT02973100|58793014|FG001|Overall Study|Failed to attend Safety followup period|0|||
30780910|NCT02973100|58793015|FG002|Overall Study|Failed to attend Safety followup period|1|||
30780911|NCT02973100|58793016|FG003|Overall Study|Failed to attend Safety followup period|0|||
30780912|NCT01060540|58793031|FG000|Overall Study|Withdrawal by Subject|10|||
30780913|NCT01060540|58793032|FG001|Overall Study|Withdrawal by Subject|20|||
30780914|NCT01060540|58793031|FG000|Overall Study|Lost to Follow-up|52|||
30582138|NCT00105534|58593424|FG000|Overall Study|Lack of Efficacy|7|||
30582139|NCT00105534|58593425|FG001|Overall Study|Lack of Efficacy|15|||
30582140|NCT00105534|58593424|FG000|Overall Study|Treatment unmasked|1|||
30582141|NCT00105534|58593425|FG001|Overall Study|Treatment unmasked|0|||
30582142|NCT00105534|58593424|FG000|Overall Study|Other Reason|0|||
30582143|NCT00105534|58593425|FG001|Overall Study|Other Reason|2|||
30582144|NCT00105183|58593434|FG000|Overall Study|Death|19|||
30582145|NCT00105183|58593435|FG001|Overall Study|Death|13|||
30582146|NCT00105183|58593436|FG002|Overall Study|Death|15|||
30582147|NCT00105183|58593434|FG000|Overall Study|Withdrawal by Subject|1|||
30582148|NCT00105183|58593435|FG001|Overall Study|Withdrawal by Subject|1|||
30582149|NCT00105183|58593436|FG002|Overall Study|Withdrawal by Subject|4|||
30668841|NCT00809445|58682762|FG002|6 Month Follow-up|Incarcerated|8|||
30780915|NCT01060540|58793032|FG001|Overall Study|Lost to Follow-up|43|||
30780916|NCT01060540|58793031|FG000|Overall Study|Death|2|||
30582150|NCT00105183|58593434|FG000|Overall Study|Physician Decision|1|||
30582151|NCT00105183|58593435|FG001|Overall Study|Physician Decision|2|||
30582152|NCT00105183|58593436|FG002|Overall Study|Physician Decision|3|||
30582153|NCT00105183|58593434|FG000|Overall Study|Lost to Follow-up|0|||
30582154|NCT00105183|58593435|FG001|Overall Study|Lost to Follow-up|1|||
30582155|NCT00105183|58593436|FG002|Overall Study|Lost to Follow-up|1|||
30582156|NCT00105183|58593434|FG000|Overall Study|Other reason|1|||
30582157|NCT00105183|58593435|FG001|Overall Study|Other reason|2|||
30582158|NCT00105183|58593436|FG002|Overall Study|Other reason|0|||
30582159|NCT01059617|58593448|FG000|Overall Study|Other|7|||
30582160|NCT01059617|58593449|FG001|Overall Study|Other|1|||
30582161|NCT01059617|58593450|FG002|Overall Study|Other|8|||
30582162|NCT01059617|58593451|FG003|Overall Study|Other|6|||
30582163|NCT01059344|58593471|FG000|Overall Study|Adverse Event|12|||
30582164|NCT01059344|58593472|FG001|Overall Study|Adverse Event|30|||
30582165|NCT01059344|58593471|FG000|Overall Study|Withdrawal by Subject|6|||
30582166|NCT01059344|58593472|FG001|Overall Study|Withdrawal by Subject|9|||
30582167|NCT01059344|58593471|FG000|Overall Study|Lost to Follow-up|1|||
30582168|NCT01059344|58593472|FG001|Overall Study|Lost to Follow-up|1|||
30582169|NCT01059344|58593471|FG000|Overall Study|Other|3|||
30582170|NCT01059344|58593472|FG001|Overall Study|Other|6|||
30582171|NCT01059071|58593480|FG000|Overall Study|Lack of Efficacy|1|||
30582172|NCT01059071|58593481|FG001|Overall Study|Lack of Efficacy|4|||
30582173|NCT01059071|58593482|FG002|Overall Study|Lack of Efficacy|2|||
30582174|NCT01059071|58593483|FG003|Overall Study|Lack of Efficacy|3|||
30582175|NCT01059071|58593480|FG000|Overall Study|Withdrawal by Subject|1|||
30582176|NCT01059071|58593481|FG001|Overall Study|Withdrawal by Subject|0|||
30582177|NCT01059071|58593482|FG002|Overall Study|Withdrawal by Subject|0|||
30582178|NCT01059071|58593483|FG003|Overall Study|Withdrawal by Subject|2|||
30582179|NCT01059071|58593480|FG000|Overall Study|Physician Decision|0|||
30582180|NCT01059071|58593481|FG001|Overall Study|Physician Decision|0|||
30582181|NCT01059071|58593482|FG002|Overall Study|Physician Decision|0|||
30582182|NCT01059071|58593483|FG003|Overall Study|Physician Decision|1|||
30582183|NCT01058369|58593491|FG000|Overall Study|Adverse Event|1|||
30582184|NCT01058369|58593491|FG000|Overall Study|Early termination study|1|||
30582185|NCT01057433|58593495|FG000|Overall Study|Adverse Event|1|||
30582186|NCT01057394|58593499|FG000|Overall Study|Not eligible|0|||
30582187|NCT01057394|58593500|FG001|Overall Study|Not eligible|2|||
30582188|NCT01058642|58593508|FG000|Treatment Period 1|Adverse Event|0|||
30582189|NCT01058642|58593509|FG001|Treatment Period 1|Adverse Event|1|||
30582190|NCT01058642|58593510|FG002|Treatment Period 1|Adverse Event|1|||
30582191|NCT01058642|58593511|FG003|Treatment Period 1|Adverse Event|0|||
30582192|NCT01058642|58593508|FG000|Treatment Period 1|Physician Decision|0|||
30582193|NCT01058642|58593509|FG001|Treatment Period 1|Physician Decision|0|||
30582194|NCT01058642|58593510|FG002|Treatment Period 1|Physician Decision|1|||
30582195|NCT01058642|58593511|FG003|Treatment Period 1|Physician Decision|0|||
30582196|NCT01058642|58593508|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30582197|NCT01058642|58593509|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30582198|NCT01058642|58593510|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30582199|NCT01058642|58593511|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30582200|NCT01058642|58593508|FG000|Treatment Period 1|Lack of Efficacy|0|||
30582201|NCT01058642|58593509|FG001|Treatment Period 1|Lack of Efficacy|0|||
30582202|NCT01058642|58593510|FG002|Treatment Period 1|Lack of Efficacy|0|||
30582203|NCT01058642|58593511|FG003|Treatment Period 1|Lack of Efficacy|1|||
30582204|NCT01058642|58593508|FG000|Treatment Period 1|Protocol Violation|0|||
30582205|NCT01058642|58593509|FG001|Treatment Period 1|Protocol Violation|0|||
30582206|NCT01058642|58593510|FG002|Treatment Period 1|Protocol Violation|0|||
30582207|NCT01058642|58593511|FG003|Treatment Period 1|Protocol Violation|1|||
30582208|NCT01058642|58593508|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
30582209|NCT01058642|58593509|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
30582210|NCT01058642|58593510|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
30582211|NCT01058642|58593511|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
30582212|NCT01056653|58593522|FG000|Overall Study|Lost to Follow-up|0|||
30582213|NCT01056653|58593523|FG001|Overall Study|Lost to Follow-up|0|||
30582214|NCT01056653|58593524|FG002|Overall Study|Lost to Follow-up|2|||
30582215|NCT01056536|58593536|FG000|Overall Study|Lost to Follow-up|202|||
30582216|NCT01056536|58593537|FG001|Overall Study|Lost to Follow-up|116|||
30582217|NCT01056536|58593538|FG002|Overall Study|Lost to Follow-up|248|||
30582218|NCT01056380|58593548|FG000|Overall Study|Lost to Follow-up|2|||
30582219|NCT01056380|58593549|FG001|Overall Study|Lost to Follow-up|3|||
30582220|NCT01055834|58593559|FG000|Treatment Period I|Adverse Event|1|||
30582221|NCT01055834|58593560|FG001|Treatment Period I|Adverse Event|0|||
30582222|NCT01055639|58593571|FG000|Overall Study|Adverse Event|0|||
30668842|NCT00809445|58682760|FG000|6 Month Follow-up|Withdrew consent|0|||
30582223|NCT01055639|58593572|FG001|Overall Study|Adverse Event|1|||
30582224|NCT01055639|58593571|FG000|Overall Study|Lack of Efficacy|0|||
30582225|NCT01055639|58593572|FG001|Overall Study|Lack of Efficacy|1|||
30582226|NCT01055639|58593571|FG000|Overall Study|Lost to Follow-up|8|||
30582227|NCT01055639|58593572|FG001|Overall Study|Lost to Follow-up|11|||
30582228|NCT01055639|58593571|FG000|Overall Study|Protocol Violation|5|||
30582229|NCT01055639|58593572|FG001|Overall Study|Protocol Violation|5|||
30582230|NCT01055639|58593571|FG000|Overall Study|Withdrawal by Subject|8|||
30582231|NCT01055639|58593572|FG001|Overall Study|Withdrawal by Subject|11|||
30582232|NCT01055132|58593587|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
30582233|NCT01055132|58593588|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
30582234|NCT01055132|58593587|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
30582235|NCT01055132|58593588|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
30582236|NCT01054976|58593598|FG000|Overall Study|Adverse Event|16|||
30582237|NCT01054976|58593598|FG000|Overall Study|Uncooperative participations to study|7|||
30582238|NCT01054976|58593598|FG000|Overall Study|Withdrawal by Subject|4|||
30582239|NCT01054976|58593598|FG000|Overall Study|Other|8|||
30582240|NCT01053962|58593607|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
30582241|NCT01053962|58593608|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
30582242|NCT01053962|58593609|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
30582243|NCT01053962|58593610|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
30582244|NCT01053962|58593611|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
30582245|NCT01053962|58593607|FG000|Pretreatment Period|Venipuncture Failure|0|||
30582246|NCT01053962|58593608|FG001|Pretreatment Period|Venipuncture Failure|0|||
30582247|NCT01053962|58593609|FG002|Pretreatment Period|Venipuncture Failure|1|||
30582248|NCT01053962|58593610|FG003|Pretreatment Period|Venipuncture Failure|0|||
30582249|NCT01053962|58593611|FG004|Pretreatment Period|Venipuncture Failure|0|||
30582250|NCT01053962|58593607|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
30582251|NCT01053962|58593608|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
30582252|NCT01053962|58593609|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
30582253|NCT01053962|58593610|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
30582254|NCT01053962|58593611|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
30582255|NCT01053962|58593607|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
30582256|NCT01053962|58593608|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
30582257|NCT01053962|58593609|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
30582258|NCT01053962|58593610|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
30582259|NCT01053962|58593611|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
30582260|NCT01053962|58593607|FG000|Treatment Period|Lack of Efficacy|0|||
30582261|NCT01053962|58593608|FG001|Treatment Period|Lack of Efficacy|0|||
30582262|NCT01053962|58593609|FG002|Treatment Period|Lack of Efficacy|0|||
30582263|NCT01053962|58593610|FG003|Treatment Period|Lack of Efficacy|0|||
30582264|NCT01053962|58593611|FG004|Treatment Period|Lack of Efficacy|1|||
30582265|NCT01053962|58593607|FG000|Treatment Period|Adverse Event|0|||
30582266|NCT01053962|58593608|FG001|Treatment Period|Adverse Event|0|||
30582267|NCT01053962|58593609|FG002|Treatment Period|Adverse Event|0|||
30582268|NCT01053962|58593610|FG003|Treatment Period|Adverse Event|0|||
30582269|NCT01053962|58593611|FG004|Treatment Period|Adverse Event|1|||
30582270|NCT01053962|58593607|FG000|Treatment Period|Withdrawal by Subject|0|||
30668843|NCT00809445|58682761|FG001|6 Month Follow-up|Withdrew consent|0|||
30668844|NCT00809445|58682762|FG002|6 Month Follow-up|Withdrew consent|1|||
30668845|NCT00593918|58682785|FG000|Overall Study|Withdrawal by Subject|5|||
30668846|NCT00593918|58682786|FG001|Overall Study|Withdrawal by Subject|24|||
30668847|NCT00499369|58682797|FG000|Overall Study|Adverse Event|2|||
30668848|NCT00499369|58682798|FG001|Overall Study|Adverse Event|2|||
30668849|NCT00499369|58682799|FG002|Overall Study|Adverse Event|3|||
30668850|NCT00499369|58682800|FG003|Overall Study|Adverse Event|1|||
30668851|NCT00499369|58682801|FG004|Overall Study|Adverse Event|2|||
30668852|NCT00499369|58682797|FG000|Overall Study|Withdrawal by Subject|0|||
30668853|NCT00499369|58682798|FG001|Overall Study|Withdrawal by Subject|1|||
30668854|NCT00499369|58682799|FG002|Overall Study|Withdrawal by Subject|1|||
30668855|NCT00499369|58682800|FG003|Overall Study|Withdrawal by Subject|0|||
30668856|NCT00499369|58682801|FG004|Overall Study|Withdrawal by Subject|0|||
30668857|NCT00499369|58682797|FG000|Overall Study|Progression|10|||
30668858|NCT00499369|58682798|FG001|Overall Study|Progression|12|||
30668859|NCT00499369|58682799|FG002|Overall Study|Progression|9|||
30668860|NCT00499369|58682800|FG003|Overall Study|Progression|6|||
30780917|NCT01060540|58793032|FG001|Overall Study|Death|1|||
30780918|NCT01060540|58793031|FG000|Overall Study|Physician Decision|0|||
30780919|NCT01060540|58793032|FG001|Overall Study|Physician Decision|1|||
30780920|NCT02972632|58793057|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
30780921|NCT02972632|58793057|FG000|Overall Study|Lost to Follow-up|4|||
30780922|NCT02972632|58793057|FG000|Overall Study|Voluntary Withdrawal|10|||
30582271|NCT01053962|58593608|FG001|Treatment Period|Withdrawal by Subject|0|||
30582272|NCT01053962|58593609|FG002|Treatment Period|Withdrawal by Subject|0|||
30668861|NCT00499369|58682801|FG004|Overall Study|Progression|10|||
30668862|NCT00499369|58682797|FG000|Overall Study|Death|0|||
30668863|NCT00499369|58682798|FG001|Overall Study|Death|1|||
30582273|NCT01053962|58593610|FG003|Treatment Period|Withdrawal by Subject|0|||
30582274|NCT01053962|58593611|FG004|Treatment Period|Withdrawal by Subject|1|||
30582275|NCT01053962|58593607|FG000|Treatment Period|Noncompliance with protocol|1|||
30668864|NCT00499369|58682799|FG002|Overall Study|Death|0|||
30582276|NCT01053962|58593608|FG001|Treatment Period|Noncompliance with protocol|0|||
30582277|NCT01053962|58593609|FG002|Treatment Period|Noncompliance with protocol|0|||
30582278|NCT01053962|58593610|FG003|Treatment Period|Noncompliance with protocol|0|||
30582279|NCT01053962|58593611|FG004|Treatment Period|Noncompliance with protocol|0|||
30582280|NCT01053221|58593630|FG000|Overall Study|The study was closed prematurely|5|||
30582281|NCT01053221|58593631|FG001|Overall Study|The study was closed prematurely|9|||
30582282|NCT01052012|58593643|FG000|Overall Study|Not treated|2|||
30582283|NCT01052012|58593644|FG001|Overall Study|Not treated|5|||
30582284|NCT01052012|58593645|FG002|Overall Study|Not treated|0|||
30582285|NCT01052012|58593646|FG003|Overall Study|Not treated|0|||
30582286|NCT01052012|58593647|FG004|Overall Study|Not treated|11|||
30582287|NCT01052012|58593648|FG005|Overall Study|Not treated|8|||
30582288|NCT01052012|58593643|FG000|Overall Study|Adverse Event|1|||
30582289|NCT01052012|58593644|FG001|Overall Study|Adverse Event|0|||
30582290|NCT01052012|58593645|FG002|Overall Study|Adverse Event|0|||
30582291|NCT01052012|58593646|FG003|Overall Study|Adverse Event|1|||
30582292|NCT01052012|58593647|FG004|Overall Study|Adverse Event|0|||
30582293|NCT01052012|58593648|FG005|Overall Study|Adverse Event|0|||
30582294|NCT01052012|58593643|FG000|Overall Study|Lost to Follow-up|0|||
30582295|NCT01052012|58593644|FG001|Overall Study|Lost to Follow-up|0|||
30582296|NCT01052012|58593645|FG002|Overall Study|Lost to Follow-up|0|||
30582297|NCT01052012|58593646|FG003|Overall Study|Lost to Follow-up|0|||
30582298|NCT01052012|58593647|FG004|Overall Study|Lost to Follow-up|1|||
30582299|NCT01052012|58593648|FG005|Overall Study|Lost to Follow-up|0|||
30582300|NCT01052012|58593643|FG000|Overall Study|Withdrawal by Subject|1|||
30582301|NCT01052012|58593644|FG001|Overall Study|Withdrawal by Subject|1|||
30582302|NCT01052012|58593645|FG002|Overall Study|Withdrawal by Subject|0|||
30582303|NCT01052012|58593646|FG003|Overall Study|Withdrawal by Subject|0|||
30582304|NCT01052012|58593647|FG004|Overall Study|Withdrawal by Subject|3|||
30582305|NCT01052012|58593648|FG005|Overall Study|Withdrawal by Subject|1|||
30582306|NCT01052012|58593643|FG000|Overall Study|Physician Decision|0|||
30582307|NCT01052012|58593644|FG001|Overall Study|Physician Decision|0|||
30582308|NCT01052012|58593645|FG002|Overall Study|Physician Decision|0|||
30582309|NCT01052012|58593646|FG003|Overall Study|Physician Decision|0|||
30582310|NCT01052012|58593647|FG004|Overall Study|Physician Decision|0|||
30582311|NCT01052012|58593648|FG005|Overall Study|Physician Decision|1|||
30582312|NCT01052012|58593643|FG000|Overall Study|Other|0|||
30582313|NCT01052012|58593644|FG001|Overall Study|Other|0|||
30582314|NCT01052012|58593645|FG002|Overall Study|Other|0|||
30582315|NCT01052012|58593646|FG003|Overall Study|Other|0|||
30582316|NCT01052012|58593647|FG004|Overall Study|Other|1|||
30582317|NCT01052012|58593648|FG005|Overall Study|Other|0|||
30582318|NCT01051817|58593664|FG000|Overall Study|Adverse Event|0|||
30582319|NCT01051817|58593665|FG001|Overall Study|Adverse Event|2|||
30582320|NCT01051817|58593664|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
30582321|NCT01051817|58593665|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
30582322|NCT01051817|58593664|FG000|Overall Study|Withdrawal by Subject|3|||
30582323|NCT01051817|58593665|FG001|Overall Study|Withdrawal by Subject|5|||
30582324|NCT01051817|58593664|FG000|Overall Study|Protocol Violation|0|||
30582325|NCT01051817|58593665|FG001|Overall Study|Protocol Violation|1|||
30582326|NCT01327846|58593675|FG000|Core Phase|Subject decision (vital status: missing)|1|||
30582327|NCT01327846|58593676|FG001|Core Phase|Subject decision (vital status: missing)|2|||
30582328|NCT01327846|58593677|FG002|Core Phase|Subject decision (vital status: missing)|2|||
30582329|NCT01327846|58593678|FG003|Core Phase|Subject decision (vital status: missing)|1|||
30582330|NCT01327846|58593675|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
30582331|NCT01327846|58593676|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
30582332|NCT01327846|58593677|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
30582333|NCT01327846|58593678|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
30582334|NCT01327846|58593675|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
30582335|NCT01327846|58593676|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
30582336|NCT01327846|58593677|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
30582337|NCT01327846|58593678|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
30582338|NCT01327846|58593675|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
30668865|NCT00499369|58682800|FG003|Overall Study|Death|0|||
30668866|NCT00499369|58682801|FG004|Overall Study|Death|0|||
30668867|NCT00499369|58682797|FG000|Overall Study|Not protocol specified|2|||
30668868|NCT00499369|58682798|FG001|Overall Study|Not protocol specified|0|||
30958750|NCT01579565|59023938|FG001|Randomized|prohibited preoperative eating|0|||
30582339|NCT01327846|58593676|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
30582340|NCT01327846|58593677|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
30582341|NCT01327846|58593678|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
30582342|NCT01327846|58593675|FG000|Core Phase|Lost to Follow-up|3|||
30582343|NCT01327846|58593676|FG001|Core Phase|Lost to Follow-up|3|||
30582344|NCT01327846|58593677|FG002|Core Phase|Lost to Follow-up|4|||
30582345|NCT01327846|58593678|FG003|Core Phase|Lost to Follow-up|5|||
30582346|NCT01327846|58593675|FG000|Extension Phase|Study terminated by sponsor|1073|||
30668869|NCT00499369|58682799|FG002|Overall Study|Not protocol specified|3|||
30582347|NCT01327846|58593676|FG001|Extension Phase|Study terminated by sponsor|1124|||
30582348|NCT01327846|58593677|FG002|Extension Phase|Study terminated by sponsor|1067|||
30582349|NCT01327846|58593678|FG003|Extension Phase|Study terminated by sponsor|1660|||
30582350|NCT01327846|58593675|FG000|Extension Phase|Withdrawal by Subject|20|||
30582351|NCT01327846|58593676|FG001|Extension Phase|Withdrawal by Subject|13|||
30582352|NCT01327846|58593677|FG002|Extension Phase|Withdrawal by Subject|19|||
30582353|NCT01327846|58593678|FG003|Extension Phase|Withdrawal by Subject|37|||
30582354|NCT01327846|58593675|FG000|Extension Phase|Lost to Follow-up|4|||
30582355|NCT01327846|58593676|FG001|Extension Phase|Lost to Follow-up|3|||
30582356|NCT01327846|58593677|FG002|Extension Phase|Lost to Follow-up|4|||
30582357|NCT01327846|58593678|FG003|Extension Phase|Lost to Follow-up|7|||
30582358|NCT01327846|58593675|FG000|Extension Phase|Technical Problems|2|||
30582359|NCT01327846|58593676|FG001|Extension Phase|Technical Problems|4|||
30582360|NCT01327846|58593677|FG002|Extension Phase|Technical Problems|2|||
30582361|NCT01327846|58593678|FG003|Extension Phase|Technical Problems|2|||
30582362|NCT01051739|58593691|FG000|Overall Study|Death|3|||
30582363|NCT01051739|58593692|FG001|Overall Study|Death|3|||
30582364|NCT01051739|58593691|FG000|Overall Study|Withdrawal by Subject|25|||
30582365|NCT01051739|58593692|FG001|Overall Study|Withdrawal by Subject|10|||
30582366|NCT01051661|58593704|FG000|Overall Study|Adverse Event|1|||
30582367|NCT01051661|58593705|FG001|Overall Study|Adverse Event|1|||
30582368|NCT01051661|58593706|FG002|Overall Study|Adverse Event|1|||
30582369|NCT01051661|58593707|FG003|Overall Study|Adverse Event|1|||
30582370|NCT01051661|58593708|FG004|Overall Study|Adverse Event|0|||
30582371|NCT01051661|58593709|FG005|Overall Study|Adverse Event|0|||
30582372|NCT01051661|58593704|FG000|Overall Study|Lost to Follow-up|13|||
30582373|NCT01051661|58593705|FG001|Overall Study|Lost to Follow-up|22|||
30582374|NCT01051661|58593706|FG002|Overall Study|Lost to Follow-up|15|||
30582375|NCT01051661|58593707|FG003|Overall Study|Lost to Follow-up|17|||
30582376|NCT01051661|58593708|FG004|Overall Study|Lost to Follow-up|10|||
30582377|NCT01051661|58593709|FG005|Overall Study|Lost to Follow-up|24|||
30582378|NCT01051661|58593704|FG000|Overall Study|Migrated/moved from study area|1|||
30582379|NCT01051661|58593705|FG001|Overall Study|Migrated/moved from study area|6|||
30582380|NCT01051661|58593706|FG002|Overall Study|Migrated/moved from study area|6|||
30582381|NCT01051661|58593707|FG003|Overall Study|Migrated/moved from study area|8|||
30582382|NCT01051661|58593708|FG004|Overall Study|Migrated/moved from study area|7|||
30582383|NCT01051661|58593709|FG005|Overall Study|Migrated/moved from study area|3|||
30582384|NCT01051661|58593704|FG000|Overall Study|Refused blood sampling|0|||
30582385|NCT01051661|58593705|FG001|Overall Study|Refused blood sampling|0|||
30582386|NCT01051661|58593706|FG002|Overall Study|Refused blood sampling|0|||
30582387|NCT01051661|58593707|FG003|Overall Study|Refused blood sampling|0|||
30582388|NCT01051661|58593708|FG004|Overall Study|Refused blood sampling|0|||
30582389|NCT01051661|58593709|FG005|Overall Study|Refused blood sampling|1|||
30582390|NCT01051661|58593704|FG000|Overall Study|Data not reliable|1|||
30582391|NCT01051661|58593705|FG001|Overall Study|Data not reliable|0|||
30582392|NCT01051661|58593706|FG002|Overall Study|Data not reliable|0|||
30582393|NCT01051661|58593707|FG003|Overall Study|Data not reliable|0|||
30582394|NCT01051661|58593708|FG004|Overall Study|Data not reliable|0|||
30582395|NCT01051661|58593709|FG005|Overall Study|Data not reliable|1|||
30582396|NCT01051661|58593704|FG000|Overall Study|Unable to attend visit(s)|2|||
30582397|NCT01051661|58593705|FG001|Overall Study|Unable to attend visit(s)|4|||
30582398|NCT01051661|58593706|FG002|Overall Study|Unable to attend visit(s)|2|||
30582399|NCT01051661|58593707|FG003|Overall Study|Unable to attend visit(s)|1|||
30582400|NCT01051661|58593708|FG004|Overall Study|Unable to attend visit(s)|3|||
30582401|NCT01051661|58593709|FG005|Overall Study|Unable to attend visit(s)|2|||
30582402|NCT01051661|58593704|FG000|Overall Study|Consent not received from both parents|0|||
30582403|NCT01051661|58593705|FG001|Overall Study|Consent not received from both parents|0|||
30582404|NCT01051661|58593706|FG002|Overall Study|Consent not received from both parents|0|||
30582405|NCT01051661|58593707|FG003|Overall Study|Consent not received from both parents|0|||
30582406|NCT01051661|58593708|FG004|Overall Study|Consent not received from both parents|0|||
30668870|NCT00499369|58682800|FG003|Overall Study|Not protocol specified|1|||
30668871|NCT00499369|58682801|FG004|Overall Study|Not protocol specified|0|||
30668872|NCT00499369|58682797|FG000|Overall Study|Ineligible|2|||
30668873|NCT00499369|58682798|FG001|Overall Study|Ineligible|2|||
30668874|NCT00499369|58682799|FG002|Overall Study|Ineligible|1|||
30582407|NCT01051661|58593709|FG005|Overall Study|Consent not received from both parents|1|||
30582408|NCT01051661|58593704|FG000|Overall Study|Failure to comply with protocol|0|||
30582409|NCT01051661|58593705|FG001|Overall Study|Failure to comply with protocol|0|||
30582410|NCT01051661|58593706|FG002|Overall Study|Failure to comply with protocol|2|||
30582411|NCT01051661|58593707|FG003|Overall Study|Failure to comply with protocol|0|||
30582412|NCT01051661|58593708|FG004|Overall Study|Failure to comply with protocol|0|||
30582413|NCT01051661|58593709|FG005|Overall Study|Failure to comply with protocol|0|||
30582414|NCT01051661|58593704|FG000|Overall Study|Subject lost legal representation|0|||
30668875|NCT00499369|58682800|FG003|Overall Study|Ineligible|1|||
30668876|NCT00499369|58682801|FG004|Overall Study|Ineligible|0|||
30582415|NCT01051661|58593705|FG001|Overall Study|Subject lost legal representation|0|||
30582416|NCT01051661|58593706|FG002|Overall Study|Subject lost legal representation|0|||
30582417|NCT01051661|58593707|FG003|Overall Study|Subject lost legal representation|0|||
30582418|NCT01051661|58593708|FG004|Overall Study|Subject lost legal representation|1|||
30582419|NCT01051661|58593709|FG005|Overall Study|Subject lost legal representation|0|||
30582420|NCT01051661|58593704|FG000|Overall Study|Protocol Violation|0|||
30582421|NCT01051661|58593705|FG001|Overall Study|Protocol Violation|0|||
30582422|NCT01051661|58593706|FG002|Overall Study|Protocol Violation|0|||
30582423|NCT01051661|58593707|FG003|Overall Study|Protocol Violation|1|||
30582424|NCT01051661|58593708|FG004|Overall Study|Protocol Violation|2|||
30582425|NCT01051661|58593709|FG005|Overall Study|Protocol Violation|1|||
30582426|NCT01051661|58593704|FG000|Overall Study|Withdrawal by Subject|16|||
30582427|NCT01051661|58593705|FG001|Overall Study|Withdrawal by Subject|30|||
30582428|NCT01051661|58593706|FG002|Overall Study|Withdrawal by Subject|13|||
30582429|NCT01051661|58593707|FG003|Overall Study|Withdrawal by Subject|28|||
30582430|NCT01051661|58593708|FG004|Overall Study|Withdrawal by Subject|12|||
30582431|NCT01051661|58593709|FG005|Overall Study|Withdrawal by Subject|34|||
30582432|NCT01051466|58593746|FG000|Overall Study|Adverse Event|1|||
30582433|NCT01051466|58593747|FG001|Overall Study|Adverse Event|0|||
30582434|NCT01051466|58593746|FG000|Overall Study|Lost to Follow-up|1|||
30582435|NCT01051466|58593747|FG001|Overall Study|Lost to Follow-up|1|||
30582436|NCT01051466|58593746|FG000|Overall Study|Withdrawal by Subject|5|||
30582437|NCT01051466|58593747|FG001|Overall Study|Withdrawal by Subject|1|||
30582438|NCT01051466|58593746|FG000|Overall Study|Entry Criteria Not Met|0|||
30582439|NCT01051466|58593747|FG001|Overall Study|Entry Criteria Not Met|3|||
30582440|NCT01051466|58593746|FG000|Overall Study|Physician Decision|1|||
30582441|NCT01051466|58593747|FG001|Overall Study|Physician Decision|0|||
30582442|NCT01051349|58593761|FG000|Overall Study|Adverse Event|88|||
30582443|NCT01051349|58593761|FG000|Overall Study|Consent Withdrawn|54|||
30582444|NCT01051349|58593761|FG000|Overall Study|Investigator Decision|6|||
30582445|NCT01051349|58593761|FG000|Overall Study|Lost to Follow-up|6|||
30582446|NCT01051349|58593761|FG000|Overall Study|Subject non-compliance|7|||
30582447|NCT01051349|58593761|FG000|Overall Study|Reason not Specified|12|||
30582448|NCT01050998|58593773|FG000|Overall Study|Adverse Event|1|||
30582449|NCT01050998|58593774|FG001|Overall Study|Adverse Event|0|||
30582450|NCT01050998|58593775|FG002|Overall Study|Adverse Event|1|||
30582451|NCT01050998|58593776|FG003|Overall Study|Adverse Event|0|||
30582452|NCT01050998|58593777|FG004|Overall Study|Adverse Event|2|||
30582453|NCT01050998|58593773|FG000|Overall Study|Withdrawal by Subject|0|||
30582454|NCT01050998|58593774|FG001|Overall Study|Withdrawal by Subject|0|||
30582455|NCT01050998|58593775|FG002|Overall Study|Withdrawal by Subject|0|||
30582456|NCT01050998|58593776|FG003|Overall Study|Withdrawal by Subject|1|||
30582457|NCT01050998|58593777|FG004|Overall Study|Withdrawal by Subject|3|||
30582458|NCT01050998|58593773|FG000|Overall Study|Other|3|||
30582459|NCT01050998|58593774|FG001|Overall Study|Other|2|||
30582460|NCT01050998|58593775|FG002|Overall Study|Other|1|||
30582461|NCT01050998|58593776|FG003|Overall Study|Other|1|||
30582462|NCT01050998|58593777|FG004|Overall Study|Other|5|||
30582463|NCT01050998|58593773|FG000|Overall Study|Data integrity issues|0|||
30582464|NCT01050998|58593774|FG001|Overall Study|Data integrity issues|0|||
30582465|NCT01050998|58593775|FG002|Overall Study|Data integrity issues|1|||
30582466|NCT01050998|58593776|FG003|Overall Study|Data integrity issues|1|||
30582467|NCT01050998|58593777|FG004|Overall Study|Data integrity issues|4|||
30582468|NCT00106028|58593795|FG000|Overall Study|Adverse Event|3|||
30582469|NCT00106028|58593796|FG001|Overall Study|Adverse Event|2|||
30582470|NCT00106028|58593795|FG000|Overall Study|Protocol Violation|1|||
30582471|NCT00106028|58593796|FG001|Overall Study|Protocol Violation|1|||
30582472|NCT00106028|58593795|FG000|Overall Study|Withdrawal by Subject|2|||
30582473|NCT00106028|58593796|FG001|Overall Study|Withdrawal by Subject|8|||
30582474|NCT00106028|58593795|FG000|Overall Study|Lost to Follow-up|0|||
30582475|NCT00106028|58593796|FG001|Overall Study|Lost to Follow-up|1|||
30582476|NCT01050764|58593804|FG000|Overall Study|Death, before HSCT|1|||
30582477|NCT01050764|58593804|FG000|Overall Study|Donor mobilization failure, death|1|||
30582478|NCT01050764|58593804|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
30582479|NCT01050569|58593811|FG000|Overall Study|Lost to Follow-up|20|||
30582480|NCT01050569|58593812|FG001|Overall Study|Lost to Follow-up|14|||
30582481|NCT01050569|58593813|FG002|Overall Study|Lost to Follow-up|16|||
30582482|NCT01050569|58593811|FG000|Overall Study|Withdrawal by Subject|9|||
30582483|NCT01050569|58593812|FG001|Overall Study|Withdrawal by Subject|3|||
30582484|NCT01050569|58593813|FG002|Overall Study|Withdrawal by Subject|11|||
30582485|NCT01050569|58593811|FG000|Overall Study|Lack of Efficacy|5|||
30582486|NCT01050569|58593812|FG001|Overall Study|Lack of Efficacy|4|||
30582487|NCT01050569|58593813|FG002|Overall Study|Lack of Efficacy|3|||
30582488|NCT01050569|58593811|FG000|Overall Study|Adverse Event|1|||
30582489|NCT01050569|58593812|FG001|Overall Study|Adverse Event|0|||
30582490|NCT01050569|58593813|FG002|Overall Study|Adverse Event|0|||
30582491|NCT01050569|58593811|FG000|Overall Study|Physician Decision|3|||
30582492|NCT01050569|58593812|FG001|Overall Study|Physician Decision|3|||
30582493|NCT01050569|58593813|FG002|Overall Study|Physician Decision|3|||
30582494|NCT01050530|58593827|FG000|Overall Study|Adverse Event|6|||
30582495|NCT01050530|58593828|FG001|Overall Study|Adverse Event|3|||
30582496|NCT01050530|58593827|FG000|Overall Study|Lack of Efficacy|1|||
30582497|NCT01050530|58593828|FG001|Overall Study|Lack of Efficacy|4|||
30582498|NCT01050530|58593827|FG000|Overall Study|Withdrawal by Subject|0|||
30668877|NCT00869258|58682813|FG000|Overall Study|Physician Decision|1|||
30668878|NCT00693784|58682817|FG000|Overall Study|Lost to Follow-up|2|||
30668879|NCT00693784|58682817|FG000|Overall Study|Withdrawal by Subject|2|||
30668880|NCT00693706|58682823|FG000|Overall Study|Protocol Violation|0|||
30668881|NCT00693706|58682824|FG001|Overall Study|Protocol Violation|1|||
30668882|NCT00488683|58682833|FG000|Overall Study|Withdrawal by Subject|1|||
30668883|NCT00488683|58682834|FG001|Overall Study|Withdrawal by Subject|2|||
30668884|NCT00488683|58682835|FG002|Overall Study|Withdrawal by Subject|2|||
30668885|NCT00488683|58682833|FG000|Overall Study|Lost to Follow-up|5|||
30668886|NCT00488683|58682834|FG001|Overall Study|Lost to Follow-up|3|||
30668887|NCT00488683|58682835|FG002|Overall Study|Lost to Follow-up|0|||
30668888|NCT00488683|58682833|FG000|Overall Study|Protocol Violation|5|||
30668889|NCT00488683|58682834|FG001|Overall Study|Protocol Violation|1|||
30668890|NCT00488683|58682835|FG002|Overall Study|Protocol Violation|0|||
30668891|NCT00488683|58682833|FG000|Overall Study|Unable to Classify|1|||
30668892|NCT00488683|58682834|FG001|Overall Study|Unable to Classify|0|||
30668893|NCT00488683|58682835|FG002|Overall Study|Unable to Classify|0|||
30668894|NCT00693472|58682869|FG000|Part 1|Adverse Event|1|||
30668895|NCT00693472|58682870|FG001|Part 1|Adverse Event|1|||
30668896|NCT00693472|58682871|FG002|Part 1|Adverse Event|0|||
30668897|NCT00693472|58682872|FG003|Part 1|Adverse Event|0|||
30668898|NCT00693472|58682869|FG000|Part 1|Lost to Follow-up|0|||
30668899|NCT00693472|58682870|FG001|Part 1|Lost to Follow-up|1|||
30668900|NCT00693472|58682871|FG002|Part 1|Lost to Follow-up|0|||
30668901|NCT00693472|58682872|FG003|Part 1|Lost to Follow-up|0|||
30668902|NCT00693472|58682869|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
30668903|NCT00693472|58682870|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
30668904|NCT00693472|58682871|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
30668905|NCT00693472|58682872|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
30668906|NCT00693472|58682869|FG000|Part 2|Adverse Event|0|||
30668907|NCT00693472|58682870|FG001|Part 2|Adverse Event|0|||
30668908|NCT00693472|58682871|FG002|Part 2|Adverse Event|1|||
30668909|NCT00693472|58682872|FG003|Part 2|Adverse Event|0|||
30668910|NCT00693472|58682869|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
30668911|NCT00693472|58682870|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
30668912|NCT00693472|58682871|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
30668913|NCT00693472|58682872|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
30668914|NCT00498433|58682885|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
30668915|NCT00498433|58682886|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
30668916|NCT00498433|58682887|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
30668917|NCT00498433|58682885|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
30668918|NCT00498433|58682886|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
30668919|NCT00498433|58682887|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
30668920|NCT00498433|58682885|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
30668921|NCT00498433|58682886|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
30668922|NCT00498433|58682887|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
30668923|NCT00498433|58682885|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
30668924|NCT00498433|58682886|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
30668925|NCT00498433|58682887|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
30668926|NCT00498355|58682904|FG000|Overall Study|Lost to Follow-up|1|||
30668927|NCT04327271|58682911|FG000|Overall Study|Death|1|||
30668928|NCT04327271|58682912|FG001|Overall Study|Death|0|||
30582499|NCT01050530|58593828|FG001|Overall Study|Withdrawal by Subject|3|||
30582500|NCT01050530|58593827|FG000|Overall Study|Protocol Violation|1|||
30582501|NCT01050530|58593828|FG001|Overall Study|Protocol Violation|0|||
30668929|NCT04327271|58682911|FG000|Overall Study|Withdrawal by Subject|1|||
30668930|NCT04327271|58682912|FG001|Overall Study|Withdrawal by Subject|0|||
30668931|NCT04327271|58682911|FG000|Overall Study|randomization error (data capture)|4|||
30668932|NCT04327271|58682912|FG001|Overall Study|randomization error (data capture)|3|||
30668933|NCT00688636|58682929|FG000|Overall Study|Adverse Event|2|||
30668934|NCT00688636|58682930|FG001|Overall Study|Adverse Event|1|||
30668935|NCT00870740|58682942|FG000|Overall Study|Adverse Event|2|||
30668936|NCT00870740|58682943|FG001|Overall Study|Adverse Event|1|||
30668937|NCT00870740|58682944|FG002|Overall Study|Adverse Event|3|||
30668938|NCT00870740|58682945|FG003|Overall Study|Adverse Event|2|||
30668939|NCT00870740|58682946|FG004|Overall Study|Adverse Event|1|||
30668940|NCT00870740|58682947|FG005|Overall Study|Adverse Event|6|||
30668941|NCT00870740|58682942|FG000|Overall Study|Consent Withdrawn|6|||
30668942|NCT00870740|58682943|FG001|Overall Study|Consent Withdrawn|3|||
30668943|NCT00870740|58682944|FG002|Overall Study|Consent Withdrawn|4|||
30668944|NCT00870740|58682945|FG003|Overall Study|Consent Withdrawn|6|||
30582502|NCT01050257|58593837|FG000|Overall Study|Adverse Event|4|||
30582503|NCT01050257|58593838|FG001|Overall Study|Adverse Event|4|||
30582504|NCT01050257|58593839|FG002|Overall Study|Adverse Event|2|||
30582505|NCT01050257|58593837|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
30582506|NCT01050257|58593838|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
30582507|NCT01050257|58593839|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
30582508|NCT01050257|58593837|FG000|Overall Study|Withdrawal by Subject|0|||
30582509|NCT01050257|58593838|FG001|Overall Study|Withdrawal by Subject|3|||
30582510|NCT01050257|58593839|FG002|Overall Study|Withdrawal by Subject|0|||
30582511|NCT01050257|58593837|FG000|Overall Study|No reason specified|0|||
30582512|NCT01050257|58593838|FG001|Overall Study|No reason specified|0|||
30582513|NCT01050257|58593839|FG002|Overall Study|No reason specified|2|||
30582514|NCT01050257|58593837|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
30582515|NCT01050257|58593838|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
30582516|NCT01050257|58593839|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
30582517|NCT01050257|58593837|FG000|Overall Study|Violation criteria|0|||
30582518|NCT01050257|58593838|FG001|Overall Study|Violation criteria|1|||
30582519|NCT01050257|58593839|FG002|Overall Study|Violation criteria|0|||
30582520|NCT01050257|58593837|FG000|Overall Study|Failure to return|0|||
30582521|NCT01050257|58593838|FG001|Overall Study|Failure to return|2|||
30582522|NCT01050257|58593839|FG002|Overall Study|Failure to return|0|||
30582523|NCT01050257|58593837|FG000|Overall Study|Death|0|||
30582524|NCT01050257|58593838|FG001|Overall Study|Death|0|||
30582525|NCT01050257|58593839|FG002|Overall Study|Death|1|||
30582526|NCT01050218|58593847|FG000|Overall Study|Adverse Event|37|||
30582527|NCT01050218|58593847|FG000|Overall Study|Lack of Efficacy|8|||
30582528|NCT01050218|58593847|FG000|Overall Study|Protocol Violation|3|||
30582529|NCT01050218|58593847|FG000|Overall Study|Withdrawal by Subject|18|||
30582530|NCT01050218|58593847|FG000|Overall Study|Discontinued by sponsor|18|||
30582531|NCT01050218|58593847|FG000|Overall Study|Compliance|2|||
30582532|NCT01050218|58593847|FG000|Overall Study|Failed to return|7|||
30582533|NCT01050218|58593847|FG000|Overall Study|Serious Adverse Event|1|||
30582534|NCT01050218|58593847|FG000|Overall Study|Family emergency|1|||
30582535|NCT01050062|58593853|FG000|Overall Study|Adverse Event|75|||
30582536|NCT01050062|58593854|FG001|Overall Study|Adverse Event|22|||
30582537|NCT01050062|58593853|FG000|Overall Study|Lost to Follow-up|83|||
30582538|NCT01050062|58593854|FG001|Overall Study|Lost to Follow-up|35|||
30582539|NCT01050062|58593853|FG000|Overall Study|Lack of Efficacy|22|||
30582540|NCT01050062|58593854|FG001|Overall Study|Lack of Efficacy|35|||
30582541|NCT01050062|58593853|FG000|Overall Study|Physician Decision|74|||
30582542|NCT01050062|58593854|FG001|Overall Study|Physician Decision|9|||
30582543|NCT01050062|58593853|FG000|Overall Study|Others|17|||
30582544|NCT01050062|58593854|FG001|Overall Study|Others|11|||
30582545|NCT00105989|58593872|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
30582546|NCT00105989|58593873|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
30582547|NCT00105989|58593872|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
30582548|NCT00105989|58593873|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
30582549|NCT00105989|58593872|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
30582550|NCT00105989|58593873|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
30582551|NCT00105989|58593872|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
30582552|NCT00105989|58593873|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
30582553|NCT00105989|58593872|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
30582554|NCT00105989|58593873|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
30582555|NCT00105989|58593872|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
30582556|NCT00105989|58593873|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
30582557|NCT00105989|58593872|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
30582558|NCT00105989|58593873|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
30582559|NCT00105989|58593872|FG000|Acute - Open Label: Week 0-10|Death|1|||
30582560|NCT00105989|58593873|FG001|Acute - Open Label: Week 0-10|Death|0|||
30582561|NCT00105989|58593872|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
30582562|NCT00105989|58593873|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
30582563|NCT00105989|58593872|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
30582564|NCT00105989|58593873|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
30582565|NCT00105989|58593872|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
30582566|NCT00105989|58593873|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
30582567|NCT00105989|58593872|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
30582568|NCT00105989|58593873|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
30582569|NCT00105989|58593872|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
30582570|NCT00105989|58593873|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
30582571|NCT00105989|58593872|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
30582572|NCT00105989|58593873|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
30582573|NCT00105989|58593872|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
30582574|NCT00105989|58593873|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
30582575|NCT00105989|58593872|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
30582576|NCT00105989|58593873|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
30582577|NCT00105989|58593872|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
30582578|NCT00105989|58593873|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
30582579|NCT00105989|58593872|FG000|Continuation - Open Label:Week 10-34|Death|0|||
30582580|NCT00105989|58593873|FG001|Continuation - Open Label:Week 10-34|Death|0|||
30582581|NCT00105989|58593872|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
30582582|NCT00105989|58593873|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
30582583|NCT00105989|58593872|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
30582584|NCT00105989|58593873|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
30582585|NCT00105989|58593872|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
30582586|NCT00105989|58593873|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
30582587|NCT00105989|58593872|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
30582588|NCT00105989|58593873|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
30582589|NCT00105989|58593872|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
30582590|NCT00105989|58593873|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
30582591|NCT00105989|58593872|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
30582592|NCT00105989|58593873|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
30582593|NCT00105989|58593872|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
30582594|NCT00105989|58593873|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
30582595|NCT00105989|58593872|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
30582596|NCT00105989|58593873|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
30582597|NCT00105989|58593872|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
30582598|NCT00105989|58593873|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
30582599|NCT00105989|58593872|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
30582600|NCT00105989|58593873|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
30582601|NCT00105989|58593872|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
30582602|NCT00105989|58593873|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
30582603|NCT00105989|58593872|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
30582604|NCT00105989|58593873|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
30582605|NCT03277248|58593891|FG000|Overall Study|Adverse Event|3|||
30582606|NCT03277248|58593892|FG001|Overall Study|Adverse Event|1|||
30582607|NCT03277248|58593891|FG000|Overall Study|Subject Withdrawal of Consent|6|||
30582608|NCT03277248|58593892|FG001|Overall Study|Subject Withdrawal of Consent|23|||
30582609|NCT03277248|58593891|FG000|Overall Study|Investigator/Sponsor Decision|2|||
30582610|NCT03277248|58593892|FG001|Overall Study|Investigator/Sponsor Decision|2|||
30582611|NCT03277248|58593891|FG000|Overall Study|Pregnancy|4|||
30582612|NCT03277248|58593892|FG001|Overall Study|Pregnancy|1|||
30582613|NCT03277248|58593891|FG000|Overall Study|Lost to Follow-up|0|||
30582614|NCT03277248|58593892|FG001|Overall Study|Lost to Follow-up|2|||
30582615|NCT03277248|58593891|FG000|Overall Study|Lack of Efficacy|0|||
30582616|NCT03277248|58593892|FG001|Overall Study|Lack of Efficacy|2|||
30582617|NCT03277248|58593891|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
30582618|NCT03277248|58593892|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
30582619|NCT03276780|58593900|FG000|Overall Study|Withdrawal by Subject|5|||
30582620|NCT03276780|58593901|FG001|Overall Study|Withdrawal by Subject|3|||
30582621|NCT03276780|58593900|FG000|Overall Study|Lost to Follow-up|3|||
30582622|NCT03276780|58593901|FG001|Overall Study|Lost to Follow-up|5|||
30582623|NCT03276780|58593900|FG000|Overall Study|Moved out of state|1|||
30582624|NCT03276780|58593901|FG001|Overall Study|Moved out of state|1|||
30582625|NCT03276780|58593900|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
30582626|NCT03276780|58593901|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
30582627|NCT03276780|58593900|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
30582628|NCT03276780|58593901|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
30582629|NCT03271047|58593917|FG000|Phase 1b: Dose Finding Period|Death|8|||
30582630|NCT03271047|58593918|FG001|Phase 1b: Dose Finding Period|Death|8|||
30582631|NCT03271047|58593919|FG002|Phase 1b: Dose Finding Period|Death|0|||
30582632|NCT03271047|58593920|FG003|Phase 1b: Dose Finding Period|Death|0|||
30582633|NCT03271047|58593917|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
30582634|NCT03271047|58593918|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
30582635|NCT03271047|58593919|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
30582636|NCT03271047|58593920|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
30582637|NCT03271047|58593917|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
30582638|NCT03271047|58593918|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
30582639|NCT03271047|58593919|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
30582640|NCT03271047|58593920|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
30582641|NCT03271047|58593917|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
30582642|NCT03271047|58593918|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
30582643|NCT03271047|58593919|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
30582644|NCT03271047|58593920|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
30582645|NCT03271047|58593917|FG000|Randomized Phase 2 Period|Other|0|||
30582646|NCT03271047|58593918|FG001|Randomized Phase 2 Period|Other|0|||
30582647|NCT03271047|58593919|FG002|Randomized Phase 2 Period|Other|0|||
30582648|NCT03271047|58593920|FG003|Randomized Phase 2 Period|Other|1|||
30582649|NCT03271047|58593917|FG000|Randomized Phase 2 Period|Death|0|||
30582650|NCT03271047|58593918|FG001|Randomized Phase 2 Period|Death|0|||
30582651|NCT03271047|58593919|FG002|Randomized Phase 2 Period|Death|20|||
30582652|NCT03271047|58593920|FG003|Randomized Phase 2 Period|Death|21|||
30582653|NCT03271047|58593917|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
30582654|NCT03271047|58593918|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
30582655|NCT03271047|58593919|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
30582656|NCT03271047|58593920|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
30582657|NCT03271047|58593917|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
30582658|NCT03271047|58593918|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
30582659|NCT03271047|58593919|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
30582660|NCT03271047|58593920|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
30582661|NCT03271047|58593917|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
30582662|NCT03271047|58593918|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
30582663|NCT03271047|58593919|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
30582664|NCT03271047|58593920|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
30582665|NCT03276936|58593934|FG000|Overall Study|Adverse Event|4|||
30582666|NCT03276936|58593935|FG001|Overall Study|Adverse Event|2|||
30582667|NCT03276936|58593934|FG000|Overall Study|Lost to Follow-up|16|||
30582668|NCT03276936|58593935|FG001|Overall Study|Lost to Follow-up|13|||
30582669|NCT03276936|58593934|FG000|Overall Study|Withdrawal by Subject|30|||
30582670|NCT03276936|58593935|FG001|Overall Study|Withdrawal by Subject|20|||
30582671|NCT03276936|58593934|FG000|Overall Study|Not mentioned|6|||
30582672|NCT03276936|58593935|FG001|Overall Study|Not mentioned|3|||
30582673|NCT00106002|58593941|FG000|Overall Study|Did not take any study drug|1|||
30582674|NCT00106002|58593941|FG000|Overall Study|Ineligible after Registration|1|||
30582675|NCT00105482|58593959|FG000|Overall Study|Adverse Event|1|||
30582676|NCT00105482|58593960|FG001|Overall Study|Adverse Event|1|||
30582677|NCT00105482|58593959|FG000|Overall Study|Lost to Follow-up|26|||
30582678|NCT00105482|58593960|FG001|Overall Study|Lost to Follow-up|17|||
30582679|NCT00105482|58593959|FG000|Overall Study|Withdrawal by Subject|0|||
30582680|NCT00105482|58593960|FG001|Overall Study|Withdrawal by Subject|1|||
30582681|NCT00105482|58593959|FG000|Overall Study|Lost Interest|29|||
30582682|NCT00105482|58593960|FG001|Overall Study|Lost Interest|32|||
30582683|NCT00105482|58593959|FG000|Overall Study|Scheduling Conflict|2|||
30582684|NCT00105482|58593960|FG001|Overall Study|Scheduling Conflict|3|||
30582685|NCT00105482|58593959|FG000|Overall Study|Withdrawn by PI|1|||
30582686|NCT00105482|58593960|FG001|Overall Study|Withdrawn by PI|1|||
30582687|NCT01327651|58593975|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
30582688|NCT01327651|58593976|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
30582689|NCT01327651|58593977|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
30582690|NCT01327651|58593978|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
30582691|NCT01327651|58593979|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
30582692|NCT01327651|58593980|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
30582693|NCT01327651|58593981|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
30582694|NCT01327651|58593982|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
30582695|NCT01327651|58593983|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
30582696|NCT01327651|58593975|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
30582697|NCT01327651|58593976|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
30582698|NCT01327651|58593977|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
30582699|NCT01327651|58593978|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
30582700|NCT01327651|58593979|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
30582701|NCT01327651|58593980|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
30582702|NCT01327651|58593981|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
30582703|NCT01327651|58593982|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
30582704|NCT01327651|58593983|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
30780923|NCT01060384|58793061|FG000|Overall Study|Withdrawal by Subject|0|||
30780924|NCT01060384|58793062|FG001|Overall Study|Withdrawal by Subject|1|||
30582705|NCT01327651|58593975|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
30582706|NCT01327651|58593976|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
30582707|NCT01327651|58593977|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
30582708|NCT01327651|58593978|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
30582709|NCT01327651|58593979|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
30780925|NCT01060384|58793063|FG002|Overall Study|Withdrawal by Subject|0|||
30582710|NCT01327651|58593980|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
30582711|NCT01327651|58593981|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
30582712|NCT01327651|58593982|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
30582713|NCT01327651|58593983|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
30582714|NCT01327651|58593975|FG000|Post Study Follow-up|Lost to Follow-up|0|||
30582715|NCT01327651|58593976|FG001|Post Study Follow-up|Lost to Follow-up|1|||
30582716|NCT01327651|58593977|FG002|Post Study Follow-up|Lost to Follow-up|1|||
30582717|NCT01327651|58593978|FG003|Post Study Follow-up|Lost to Follow-up|0|||
30582718|NCT01327651|58593979|FG004|Post Study Follow-up|Lost to Follow-up|0|||
30582719|NCT01327651|58593980|FG005|Post Study Follow-up|Lost to Follow-up|0|||
30582720|NCT01327651|58593981|FG006|Post Study Follow-up|Lost to Follow-up|4|||
30582721|NCT01327651|58593982|FG007|Post Study Follow-up|Lost to Follow-up|1|||
30582722|NCT01327651|58593983|FG008|Post Study Follow-up|Lost to Follow-up|2|||
30582723|NCT00105443|58594024|FG000|Double-Blind Treatment|Adverse Event|1|||
30582724|NCT00105443|58594025|FG001|Double-Blind Treatment|Adverse Event|0|||
30582725|NCT00105443|58594026|FG002|Double-Blind Treatment|Adverse Event|0|||
30582726|NCT00105443|58594027|FG003|Double-Blind Treatment|Adverse Event|0|||
30582727|NCT00105443|58594024|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
30582728|NCT00105443|58594025|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
30582729|NCT00105443|58594026|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
30582730|NCT00105443|58594027|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
30582731|NCT00105443|58594024|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
30582732|NCT00105443|58594025|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
30582733|NCT00105443|58594026|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
30582734|NCT00105443|58594027|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
30582735|NCT00105443|58594024|FG000|Double-Blind Treatment|Physician Decision|1|||
30582736|NCT00105443|58594025|FG001|Double-Blind Treatment|Physician Decision|0|||
30582737|NCT00105443|58594026|FG002|Double-Blind Treatment|Physician Decision|2|||
30582738|NCT00105443|58594027|FG003|Double-Blind Treatment|Physician Decision|0|||
30582739|NCT00105443|58594024|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
30668945|NCT00870740|58682946|FG004|Overall Study|Consent Withdrawn|6|||
30582740|NCT00105443|58594025|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
30582741|NCT00105443|58594026|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
30582742|NCT00105443|58594027|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
30582743|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
30582744|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
30582745|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
30582746|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
30582747|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
30582748|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
30582749|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
30582750|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
30582751|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
30582752|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
30582753|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
30582754|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
30668946|NCT00870740|58682947|FG005|Overall Study|Consent Withdrawn|5|||
30668947|NCT00870740|58682942|FG000|Overall Study|Investigator Decision|2|||
30668948|NCT00870740|58682943|FG001|Overall Study|Investigator Decision|0|||
30668949|NCT00870740|58682944|FG002|Overall Study|Investigator Decision|1|||
30668950|NCT00870740|58682945|FG003|Overall Study|Investigator Decision|0|||
30668951|NCT00870740|58682946|FG004|Overall Study|Investigator Decision|0|||
30668952|NCT00870740|58682947|FG005|Overall Study|Investigator Decision|0|||
30668953|NCT00870740|58682942|FG000|Overall Study|Subject Non-compliance|0|||
30668954|NCT00870740|58682943|FG001|Overall Study|Subject Non-compliance|0|||
30668955|NCT00870740|58682944|FG002|Overall Study|Subject Non-compliance|0|||
30668956|NCT00870740|58682945|FG003|Overall Study|Subject Non-compliance|0|||
30668957|NCT00870740|58682946|FG004|Overall Study|Subject Non-compliance|0|||
30668958|NCT00870740|58682947|FG005|Overall Study|Subject Non-compliance|1|||
30668959|NCT00870740|58682942|FG000|Overall Study|Death|0|||
30668960|NCT00870740|58682943|FG001|Overall Study|Death|0|||
30668961|NCT00870740|58682944|FG002|Overall Study|Death|0|||
30780926|NCT01060384|58793064|FG003|Overall Study|Withdrawal by Subject|0|||
30668962|NCT00870740|58682945|FG003|Overall Study|Death|0|||
30668963|NCT00870740|58682946|FG004|Overall Study|Death|1|||
30780927|NCT01060384|58793065|FG004|Overall Study|Withdrawal by Subject|0|||
30780928|NCT01060384|58793061|FG000|Overall Study|Death|0|||
30780929|NCT01060384|58793062|FG001|Overall Study|Death|0|||
30780930|NCT01060384|58793063|FG002|Overall Study|Death|0|||
30780931|NCT01060384|58793064|FG003|Overall Study|Death|0|||
30668964|NCT00870740|58682947|FG005|Overall Study|Death|0|||
30780932|NCT01060384|58793065|FG004|Overall Study|Death|1|||
30855582|NCT02783573|58883219|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
30668965|NCT00870740|58682942|FG000|Overall Study|Other|2|||
30582755|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
30582756|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
30582757|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
30582758|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
30582759|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
30582760|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
30582761|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
30582762|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
30582763|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
30877156|NCT01188096|58908801|FG000|Overall Study|progression of disease|4|||
30582764|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
30582765|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
30582766|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
30582767|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
30582768|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
30582769|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
30582770|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
30582771|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
30582772|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
30582773|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
30582774|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
30582775|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
30582776|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
30582777|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
30582778|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
30582779|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
30582780|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
30582781|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
30582782|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
30668966|NCT00870740|58682943|FG001|Overall Study|Other|5|||
30668967|NCT00870740|58682944|FG002|Overall Study|Other|2|||
30668968|NCT00870740|58682945|FG003|Overall Study|Other|4|||
30668969|NCT00870740|58682946|FG004|Overall Study|Other|3|||
30668970|NCT00870740|58682947|FG005|Overall Study|Other|5|||
30668971|NCT00869024|58682974|FG000|Overall Study|Death|2|||
30668972|NCT00869024|58682975|FG001|Overall Study|Death|3|||
30668973|NCT00869024|58682974|FG000|Overall Study|Lost to Follow-up|0|||
30668974|NCT00869024|58682975|FG001|Overall Study|Lost to Follow-up|1|||
30668975|NCT00869024|58682974|FG000|Overall Study|Protocol Violation|0|||
30668976|NCT00869024|58682975|FG001|Overall Study|Protocol Violation|1|||
30668977|NCT00506779|58682983|FG000|Overall Study|Withdrawal by Subject|1|||
30668978|NCT00506779|58682984|FG001|Overall Study|Withdrawal by Subject|0|||
30668979|NCT00506779|58682985|FG002|Overall Study|Withdrawal by Subject|1|||
30668980|NCT00506779|58682986|FG003|Overall Study|Withdrawal by Subject|0|||
30582783|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
30582784|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
30582785|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
30582786|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
30582787|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
30582788|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
30582789|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
30582790|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
30668981|NCT00506779|58682983|FG000|Overall Study|Adverse Event|0|||
30668982|NCT00506779|58682984|FG001|Overall Study|Adverse Event|1|||
30668983|NCT00506779|58682985|FG002|Overall Study|Adverse Event|1|||
30668984|NCT00506779|58682986|FG003|Overall Study|Adverse Event|1|||
30668985|NCT00488293|58682999|FG000|Overall Study|Lost to Follow-up|28|||
30668986|NCT00488293|58683000|FG001|Overall Study|Lost to Follow-up|25|||
30668987|NCT00488293|58682999|FG000|Overall Study|Withdrawal by Subject|5|||
30668988|NCT00488293|58683000|FG001|Overall Study|Withdrawal by Subject|3|||
30582791|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
30582792|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
30668989|NCT00488293|58682999|FG000|Overall Study|Death|2|||
30668990|NCT00488293|58683000|FG001|Overall Study|Death|1|||
30668991|NCT00488293|58682999|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
30668992|NCT00488293|58683000|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
30668993|NCT00868790|58683006|FG000|Period 1|Adverse Event|1|||
30780933|NCT01060384|58793061|FG000|Overall Study|Intercurrent illness|0|||
30668994|NCT00868790|58683007|FG001|Period 1|Adverse Event|0|||
30668995|NCT00868790|58683008|FG002|Period 1|Adverse Event|0|||
30668996|NCT00868790|58683009|FG003|Period 1|Adverse Event|0|||
30668997|NCT00868790|58683010|FG004|Period 1|Adverse Event|0|||
30668998|NCT00868790|58683011|FG005|Period 1|Adverse Event|0|||
30668999|NCT00868790|58683012|FG006|Period 1|Adverse Event|0|||
30669000|NCT00868790|58683013|FG007|Period 1|Adverse Event|3|||
30582793|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
30582794|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
30582795|NCT00105443|58594024|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
30582796|NCT00105443|58594025|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
30582797|NCT00105443|58594026|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
30582798|NCT00105443|58594027|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
30582799|NCT01327612|58594043|FG000|Overall Study|Withdrawal by Subject|0|||
30582800|NCT01327612|58594044|FG001|Overall Study|Withdrawal by Subject|0|||
30582801|NCT01327612|58594045|FG002|Overall Study|Withdrawal by Subject|0|||
30582802|NCT01327612|58594046|FG003|Overall Study|Withdrawal by Subject|0|||
30582803|NCT01327612|58594047|FG004|Overall Study|Withdrawal by Subject|0|||
30582804|NCT01327612|58594048|FG005|Overall Study|Withdrawal by Subject|1|||
30582805|NCT01327612|58594049|FG006|Overall Study|Withdrawal by Subject|0|||
30582806|NCT01327612|58594043|FG000|Overall Study|Disease Progression|1|||
30582807|NCT01327612|58594044|FG001|Overall Study|Disease Progression|1|||
30582808|NCT01327612|58594045|FG002|Overall Study|Disease Progression|1|||
30582809|NCT01327612|58594046|FG003|Overall Study|Disease Progression|0|||
30582810|NCT01327612|58594047|FG004|Overall Study|Disease Progression|1|||
30582811|NCT01327612|58594048|FG005|Overall Study|Disease Progression|2|||
30582812|NCT01327612|58594049|FG006|Overall Study|Disease Progression|2|||
30582813|NCT01327612|58594043|FG000|Overall Study|Administrative Decision|0|||
30669001|NCT00868790|58683014|FG008|Period 1|Adverse Event|1|||
30669002|NCT00868790|58683015|FG009|Period 1|Adverse Event|0|||
30669003|NCT00868790|58683016|FG010|Period 1|Adverse Event|0|||
30669004|NCT00868790|58683017|FG011|Period 1|Adverse Event|0|||
30582814|NCT01327612|58594044|FG001|Overall Study|Administrative Decision|0|||
30582815|NCT01327612|58594045|FG002|Overall Study|Administrative Decision|0|||
30582816|NCT01327612|58594046|FG003|Overall Study|Administrative Decision|1|||
30582817|NCT01327612|58594047|FG004|Overall Study|Administrative Decision|0|||
30582818|NCT01327612|58594048|FG005|Overall Study|Administrative Decision|0|||
30582819|NCT01327612|58594049|FG006|Overall Study|Administrative Decision|0|||
30582820|NCT01327612|58594043|FG000|Overall Study|Death|0|||
30582821|NCT01327612|58594044|FG001|Overall Study|Death|0|||
30582822|NCT01327612|58594045|FG002|Overall Study|Death|0|||
30582823|NCT01327612|58594046|FG003|Overall Study|Death|0|||
30582824|NCT01327612|58594047|FG004|Overall Study|Death|1|||
30582825|NCT01327612|58594048|FG005|Overall Study|Death|0|||
30582826|NCT01327612|58594049|FG006|Overall Study|Death|0|||
30582827|NCT01327573|58594068|FG000|Overall Study|Physician Decision|3|||
30582828|NCT01327573|58594069|FG001|Overall Study|Physician Decision|1|||
30582829|NCT01327495|58594082|FG000|Overall Study|Adverse Event|2|||
30582830|NCT01327495|58594083|FG001|Overall Study|Adverse Event|1|||
30582831|NCT01327495|58594084|FG002|Overall Study|Adverse Event|1|||
30582832|NCT01327495|58594085|FG003|Overall Study|Adverse Event|0|||
30582833|NCT01327495|58594086|FG004|Overall Study|Adverse Event|0|||
30582834|NCT01327495|58594087|FG005|Overall Study|Adverse Event|2|||
30582835|NCT01327495|58594082|FG000|Overall Study|Withdrawal by Subject|0|||
30582836|NCT01327495|58594083|FG001|Overall Study|Withdrawal by Subject|1|||
30582837|NCT01327495|58594084|FG002|Overall Study|Withdrawal by Subject|1|||
30582838|NCT01327495|58594085|FG003|Overall Study|Withdrawal by Subject|0|||
30582839|NCT01327495|58594086|FG004|Overall Study|Withdrawal by Subject|1|||
30582840|NCT01327495|58594087|FG005|Overall Study|Withdrawal by Subject|0|||
30582841|NCT01327495|58594082|FG000|Overall Study|Physician Decision|0|||
30582842|NCT01327495|58594083|FG001|Overall Study|Physician Decision|0|||
30582843|NCT01327495|58594084|FG002|Overall Study|Physician Decision|0|||
30582844|NCT01327495|58594085|FG003|Overall Study|Physician Decision|0|||
30582845|NCT01327495|58594086|FG004|Overall Study|Physician Decision|2|||
30582846|NCT01327495|58594087|FG005|Overall Study|Physician Decision|0|||
30669005|NCT00868790|58683018|FG012|Period 1|Adverse Event|0|||
30669006|NCT00868790|58683019|FG013|Period 1|Adverse Event|1|||
30780934|NCT01060384|58793062|FG001|Overall Study|Intercurrent illness|0|||
30582847|NCT01327339|58594107|FG000|Overall Study|Protocol Violation|8|||
30582848|NCT01327300|58594111|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
30582849|NCT01327300|58594112|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
30669007|NCT00868790|58683006|FG000|Period 1|Protocol Violation|1|||
30582850|NCT01379521|58594130|FG000|Overall Study -Treatment Period|Adverse Event|3|||
30582851|NCT01379521|58594131|FG001|Overall Study -Treatment Period|Adverse Event|0|||
30582852|NCT01379521|58594130|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
30669008|NCT00868790|58683007|FG001|Period 1|Protocol Violation|0|||
30669009|NCT00868790|58683008|FG002|Period 1|Protocol Violation|0|||
30669010|NCT00868790|58683009|FG003|Period 1|Protocol Violation|0|||
30582853|NCT01379521|58594131|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
30582854|NCT01379521|58594130|FG000|Overall Study -Treatment Period|Disease Progression|23|||
30582855|NCT01379521|58594131|FG001|Overall Study -Treatment Period|Disease Progression|22|||
30582856|NCT01379521|58594130|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
30582857|NCT01379521|58594131|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
30582858|NCT01379521|58594130|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
30582859|NCT01379521|58594131|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
30582860|NCT01379521|58594130|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
30582861|NCT01379521|58594131|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
30582862|NCT01379521|58594130|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
30582863|NCT01379521|58594131|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
30669011|NCT00868790|58683010|FG004|Period 1|Protocol Violation|0|||
30669012|NCT00868790|58683011|FG005|Period 1|Protocol Violation|0|||
30669013|NCT00868790|58683012|FG006|Period 1|Protocol Violation|0|||
30669014|NCT00868790|58683013|FG007|Period 1|Protocol Violation|0|||
30669015|NCT00868790|58683014|FG008|Period 1|Protocol Violation|0|||
30669016|NCT00868790|58683015|FG009|Period 1|Protocol Violation|0|||
30669017|NCT00868790|58683016|FG010|Period 1|Protocol Violation|0|||
30669018|NCT00868790|58683017|FG011|Period 1|Protocol Violation|0|||
30669019|NCT00868790|58683018|FG012|Period 1|Protocol Violation|0|||
30669020|NCT00868790|58683019|FG013|Period 1|Protocol Violation|0|||
30669021|NCT00868790|58683006|FG000|Period 1|Withdrawal by Subject|0|||
30669022|NCT00868790|58683007|FG001|Period 1|Withdrawal by Subject|1|||
30669023|NCT00868790|58683008|FG002|Period 1|Withdrawal by Subject|0|||
30669024|NCT00868790|58683009|FG003|Period 1|Withdrawal by Subject|0|||
30669025|NCT00868790|58683010|FG004|Period 1|Withdrawal by Subject|0|||
30669026|NCT00868790|58683011|FG005|Period 1|Withdrawal by Subject|0|||
30669027|NCT00868790|58683012|FG006|Period 1|Withdrawal by Subject|0|||
30669028|NCT00868790|58683013|FG007|Period 1|Withdrawal by Subject|0|||
30669029|NCT00868790|58683014|FG008|Period 1|Withdrawal by Subject|0|||
30669030|NCT00868790|58683015|FG009|Period 1|Withdrawal by Subject|0|||
30669031|NCT00868790|58683016|FG010|Period 1|Withdrawal by Subject|0|||
30669032|NCT00868790|58683017|FG011|Period 1|Withdrawal by Subject|0|||
30669033|NCT00868790|58683018|FG012|Period 1|Withdrawal by Subject|0|||
30669034|NCT00868790|58683019|FG013|Period 1|Withdrawal by Subject|1|||
30669035|NCT00868790|58683006|FG000|Period 1|Abnormal Triglycerides|0|||
30669036|NCT00868790|58683007|FG001|Period 1|Abnormal Triglycerides|0|||
30669037|NCT00868790|58683008|FG002|Period 1|Abnormal Triglycerides|0|||
30669038|NCT00868790|58683009|FG003|Period 1|Abnormal Triglycerides|0|||
30669039|NCT00868790|58683010|FG004|Period 1|Abnormal Triglycerides|1|||
30669040|NCT00868790|58683011|FG005|Period 1|Abnormal Triglycerides|0|||
30669041|NCT00868790|58683012|FG006|Period 1|Abnormal Triglycerides|0|||
30669042|NCT00868790|58683013|FG007|Period 1|Abnormal Triglycerides|0|||
30669043|NCT00868790|58683014|FG008|Period 1|Abnormal Triglycerides|0|||
30669044|NCT00868790|58683015|FG009|Period 1|Abnormal Triglycerides|0|||
30669045|NCT00868790|58683016|FG010|Period 1|Abnormal Triglycerides|0|||
30669046|NCT00868790|58683017|FG011|Period 1|Abnormal Triglycerides|0|||
30669047|NCT00868790|58683018|FG012|Period 1|Abnormal Triglycerides|0|||
30669048|NCT00868790|58683019|FG013|Period 1|Abnormal Triglycerides|0|||
30669049|NCT00868790|58683006|FG000|Period 1|Lost to Follow-up|0|||
30669050|NCT00868790|58683007|FG001|Period 1|Lost to Follow-up|0|||
30669051|NCT00868790|58683008|FG002|Period 1|Lost to Follow-up|0|||
30582864|NCT01379521|58594130|FG000|Overall Study -Treatment Period|Death|2|||
30582865|NCT01379521|58594131|FG001|Overall Study -Treatment Period|Death|1|||
30582866|NCT01379521|58594130|FG000|Post-Treatment Evaluations|Disease Progression|22|||
30582867|NCT01379521|58594131|FG001|Post-Treatment Evaluations|Disease Progression|20|||
30582868|NCT01379521|58594130|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
30582869|NCT01379521|58594131|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
30582870|NCT01379521|58594130|FG000|Post-Treatment Evaluations|Death|1|||
30582871|NCT01379521|58594131|FG001|Post-Treatment Evaluations|Death|0|||
30669052|NCT00868790|58683009|FG003|Period 1|Lost to Follow-up|0|||
30669053|NCT00868790|58683010|FG004|Period 1|Lost to Follow-up|0|||
30669054|NCT00868790|58683011|FG005|Period 1|Lost to Follow-up|1|||
30669055|NCT00868790|58683012|FG006|Period 1|Lost to Follow-up|0|||
30669056|NCT00868790|58683013|FG007|Period 1|Lost to Follow-up|0|||
30669057|NCT00868790|58683014|FG008|Period 1|Lost to Follow-up|0|||
30877157|NCT01188096|58908801|FG000|Overall Study|Withdrawal by Subject|2|||
30582872|NCT01371994|58594139|FG000|Overall Study|Adverse Event|3|||
30669058|NCT00868790|58683015|FG009|Period 1|Lost to Follow-up|0|||
30669059|NCT00868790|58683016|FG010|Period 1|Lost to Follow-up|0|||
30669060|NCT00868790|58683017|FG011|Period 1|Lost to Follow-up|0|||
30669061|NCT00868790|58683018|FG012|Period 1|Lost to Follow-up|0|||
30669062|NCT00868790|58683019|FG013|Period 1|Lost to Follow-up|0|||
30669063|NCT00868790|58683006|FG000|Period 2|Adverse Event|0|||
30669064|NCT00868790|58683007|FG001|Period 2|Adverse Event|0|||
30669065|NCT00868790|58683008|FG002|Period 2|Adverse Event|0|||
30669066|NCT00868790|58683009|FG003|Period 2|Adverse Event|0|||
30669067|NCT00868790|58683010|FG004|Period 2|Adverse Event|0|||
30582873|NCT01371994|58594140|FG001|Overall Study|Adverse Event|6|||
30582874|NCT01371994|58594139|FG000|Overall Study|Lack of Efficacy|3|||
30582875|NCT01371994|58594140|FG001|Overall Study|Lack of Efficacy|0|||
30582876|NCT01371994|58594139|FG000|Overall Study|Withdrawal by Subject|13|||
30582877|NCT01371994|58594140|FG001|Overall Study|Withdrawal by Subject|7|||
30582878|NCT01371994|58594139|FG000|Overall Study|Lost to Follow-up|1|||
30582879|NCT01371994|58594140|FG001|Overall Study|Lost to Follow-up|1|||
30582880|NCT01371994|58594139|FG000|Overall Study|Protocol Violation|24|||
30582881|NCT01371994|58594140|FG001|Overall Study|Protocol Violation|17|||
30582882|NCT01371994|58594139|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
30582883|NCT01371994|58594140|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
30582884|NCT01371994|58594139|FG000|Overall Study|Physician Decision|1|||
30582885|NCT01371994|58594140|FG001|Overall Study|Physician Decision|1|||
30582886|NCT01371994|58594139|FG000|Overall Study|Miscellaneous Reasons|6|||
30582887|NCT01371994|58594140|FG001|Overall Study|Miscellaneous Reasons|4|||
30582888|NCT01371877|58594148|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
30582889|NCT01371877|58594149|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
30582890|NCT01371838|58594157|FG000|Overall Study|Withdrawal by Subject|27|||
30582891|NCT01371838|58594158|FG001|Overall Study|Withdrawal by Subject|33|||
30582892|NCT01371838|58594157|FG000|Overall Study|Lost to Follow-up|10|||
30582893|NCT01371838|58594158|FG001|Overall Study|Lost to Follow-up|20|||
30582894|NCT01371838|58594157|FG000|Overall Study|Death|3|||
30582895|NCT01371838|58594158|FG001|Overall Study|Death|4|||
30582896|NCT01371838|58594157|FG000|Overall Study|Protocol Violation|3|||
30582897|NCT01371838|58594158|FG001|Overall Study|Protocol Violation|0|||
30582898|NCT01371838|58594157|FG000|Overall Study|Investigator Decision|3|||
30582899|NCT01371838|58594158|FG001|Overall Study|Investigator Decision|8|||
30582900|NCT01371838|58594157|FG000|Overall Study|Last follow-up visit not conducted|2|||
30582901|NCT01371838|58594158|FG001|Overall Study|Last follow-up visit not conducted|0|||
30582902|NCT01371838|58594157|FG000|Overall Study|Lack of therapeutic response|0|||
30582903|NCT01371838|58594158|FG001|Overall Study|Lack of therapeutic response|1|||
30582904|NCT01371838|58594157|FG000|Overall Study|Surgery|1|||
30582905|NCT01371838|58594158|FG001|Overall Study|Surgery|0|||
30582906|NCT01371721|58594167|FG000|Overall Study|Adverse Event|5|||
30669068|NCT00868790|58683011|FG005|Period 2|Adverse Event|0|||
30669069|NCT00868790|58683012|FG006|Period 2|Adverse Event|0|||
30669070|NCT00868790|58683013|FG007|Period 2|Adverse Event|0|||
30669071|NCT00868790|58683014|FG008|Period 2|Adverse Event|1|||
30669072|NCT00868790|58683015|FG009|Period 2|Adverse Event|0|||
30669073|NCT00868790|58683016|FG010|Period 2|Adverse Event|0|||
30669074|NCT00868790|58683017|FG011|Period 2|Adverse Event|0|||
30669075|NCT00868790|58683018|FG012|Period 2|Adverse Event|0|||
30669076|NCT00868790|58683019|FG013|Period 2|Adverse Event|0|||
30669077|NCT00868790|58683006|FG000|Period 2|Lost to Follow-up|0|||
30669078|NCT00868790|58683007|FG001|Period 2|Lost to Follow-up|1|||
30669079|NCT00868790|58683008|FG002|Period 2|Lost to Follow-up|0|||
30669080|NCT00868790|58683009|FG003|Period 2|Lost to Follow-up|0|||
30669081|NCT00868790|58683010|FG004|Period 2|Lost to Follow-up|0|||
30669082|NCT00868790|58683011|FG005|Period 2|Lost to Follow-up|1|||
30669083|NCT00868790|58683012|FG006|Period 2|Lost to Follow-up|0|||
30669084|NCT00868790|58683013|FG007|Period 2|Lost to Follow-up|0|||
30669085|NCT00868790|58683014|FG008|Period 2|Lost to Follow-up|0|||
30669086|NCT00868790|58683015|FG009|Period 2|Lost to Follow-up|0|||
30669087|NCT00868790|58683016|FG010|Period 2|Lost to Follow-up|0|||
30669088|NCT00868790|58683017|FG011|Period 2|Lost to Follow-up|0|||
30669089|NCT00868790|58683018|FG012|Period 2|Lost to Follow-up|0|||
30669090|NCT00868790|58683019|FG013|Period 2|Lost to Follow-up|0|||
30669091|NCT00868790|58683006|FG000|Period 2|Withdrawal by Subject|0|||
30669092|NCT00868790|58683007|FG001|Period 2|Withdrawal by Subject|0|||
30669093|NCT00868790|58683008|FG002|Period 2|Withdrawal by Subject|0|||
30669094|NCT00868790|58683009|FG003|Period 2|Withdrawal by Subject|0|||
30669095|NCT00868790|58683010|FG004|Period 2|Withdrawal by Subject|0|||
30855583|NCT02783573|58883220|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
30582907|NCT01371721|58594168|FG001|Overall Study|Adverse Event|4|||
30582908|NCT01371721|58594169|FG002|Overall Study|Adverse Event|5|||
30582909|NCT01371721|58594167|FG000|Overall Study|Protocol Violation|6|||
30582910|NCT01371721|58594168|FG001|Overall Study|Protocol Violation|4|||
30582911|NCT01371721|58594169|FG002|Overall Study|Protocol Violation|5|||
30669096|NCT00868790|58683011|FG005|Period 2|Withdrawal by Subject|0|||
30669097|NCT00868790|58683012|FG006|Period 2|Withdrawal by Subject|0|||
30669098|NCT00868790|58683013|FG007|Period 2|Withdrawal by Subject|0|||
30669099|NCT00868790|58683014|FG008|Period 2|Withdrawal by Subject|1|||
30669100|NCT00868790|58683015|FG009|Period 2|Withdrawal by Subject|0|||
30669101|NCT00868790|58683016|FG010|Period 2|Withdrawal by Subject|0|||
30669102|NCT00868790|58683017|FG011|Period 2|Withdrawal by Subject|0|||
30669103|NCT00868790|58683018|FG012|Period 2|Withdrawal by Subject|0|||
30669104|NCT00868790|58683019|FG013|Period 2|Withdrawal by Subject|1|||
30669105|NCT00868790|58683006|FG000|Period 3|Adverse Event|0|||
30669106|NCT00868790|58683007|FG001|Period 3|Adverse Event|0|||
30582912|NCT01371721|58594167|FG000|Overall Study|Lost to Follow-up|8|||
30582913|NCT01371721|58594168|FG001|Overall Study|Lost to Follow-up|2|||
30582914|NCT01371721|58594169|FG002|Overall Study|Lost to Follow-up|6|||
30582915|NCT01371721|58594167|FG000|Overall Study|Withdrawal by Subject|5|||
30582916|NCT01371721|58594168|FG001|Overall Study|Withdrawal by Subject|7|||
30582917|NCT01371721|58594169|FG002|Overall Study|Withdrawal by Subject|11|||
30582918|NCT01371721|58594167|FG000|Overall Study|Other|2|||
30582919|NCT01371721|58594168|FG001|Overall Study|Other|3|||
30582920|NCT01371721|58594169|FG002|Overall Study|Other|0|||
30582921|NCT01371721|58594167|FG000|Overall Study|Lack of Efficacy|2|||
30582922|NCT01371721|58594168|FG001|Overall Study|Lack of Efficacy|4|||
30582923|NCT01371721|58594169|FG002|Overall Study|Lack of Efficacy|3|||
30582924|NCT01371721|58594167|FG000|Overall Study|Randomized but not treated|1|||
30582925|NCT01371721|58594168|FG001|Overall Study|Randomized but not treated|0|||
30582926|NCT01371721|58594169|FG002|Overall Study|Randomized but not treated|0|||
30582927|NCT01366534|58594182|FG000|Overall Study|Lost to Follow-up|1|||
30669107|NCT00868790|58683008|FG002|Period 3|Adverse Event|0|||
30669108|NCT00868790|58683009|FG003|Period 3|Adverse Event|0|||
30669109|NCT00868790|58683010|FG004|Period 3|Adverse Event|0|||
30669110|NCT00868790|58683011|FG005|Period 3|Adverse Event|0|||
30669111|NCT00868790|58683012|FG006|Period 3|Adverse Event|0|||
30669112|NCT00868790|58683013|FG007|Period 3|Adverse Event|0|||
30582928|NCT01366534|58594183|FG001|Overall Study|Lost to Follow-up|0|||
30582929|NCT01366534|58594184|FG002|Overall Study|Lost to Follow-up|0|||
30582930|NCT01366534|58594182|FG000|Overall Study|Migrated|1|||
30582931|NCT01366534|58594183|FG001|Overall Study|Migrated|1|||
30582932|NCT01366534|58594184|FG002|Overall Study|Migrated|0|||
30582933|NCT01366534|58594182|FG000|Overall Study|Declined challenged|0|||
30582934|NCT01366534|58594183|FG001|Overall Study|Declined challenged|1|||
30582935|NCT01366534|58594184|FG002|Overall Study|Declined challenged|0|||
30669113|NCT00868790|58683014|FG008|Period 3|Adverse Event|0|||
30669114|NCT00868790|58683015|FG009|Period 3|Adverse Event|1|||
30669115|NCT00868790|58683016|FG010|Period 3|Adverse Event|0|||
30669116|NCT00868790|58683017|FG011|Period 3|Adverse Event|0|||
30855584|NCT02783573|58883218|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
30855585|NCT02783573|58883219|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
30855586|NCT02783573|58883220|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
30582936|NCT01365910|58594192|FG000|Overall Study|Withdrawal by Subject|7|||
30582937|NCT01365910|58594192|FG000|Overall Study|disease progression|18|||
30582938|NCT01365910|58594192|FG000|Overall Study|Adverse Event|3|||
30582939|NCT01365910|58594192|FG000|Overall Study|other complicating disease|1|||
30582940|NCT01365910|58594192|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
30582941|NCT01365481|58594200|FG000|Overall Study|Adverse Event|6|||
30582942|NCT01365481|58594201|FG001|Overall Study|Adverse Event|9|||
30582943|NCT01365481|58594202|FG002|Overall Study|Adverse Event|0|||
30582944|NCT01365481|58594203|FG003|Overall Study|Adverse Event|2|||
30582945|NCT01365481|58594200|FG000|Overall Study|Withdrawal by Subject|0|||
30582946|NCT01365481|58594201|FG001|Overall Study|Withdrawal by Subject|2|||
30582947|NCT01365481|58594202|FG002|Overall Study|Withdrawal by Subject|1|||
30582948|NCT01365481|58594203|FG003|Overall Study|Withdrawal by Subject|1|||
30582949|NCT01365481|58594200|FG000|Overall Study|Lost to Follow-up|1|||
30582950|NCT01365481|58594201|FG001|Overall Study|Lost to Follow-up|1|||
30582951|NCT01365481|58594202|FG002|Overall Study|Lost to Follow-up|2|||
30582952|NCT01365481|58594203|FG003|Overall Study|Lost to Follow-up|3|||
30582953|NCT01365481|58594200|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30582954|NCT01365481|58594201|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30582955|NCT01365481|58594202|FG002|Overall Study|Abnormal laboratory value(s)|0|||
30582956|NCT01365481|58594203|FG003|Overall Study|Abnormal laboratory value(s)|0|||
30582957|NCT01365481|58594200|FG000|Overall Study|Administrative problems|0|||
30582958|NCT01365481|58594201|FG001|Overall Study|Administrative problems|1|||
30582959|NCT01365481|58594202|FG002|Overall Study|Administrative problems|0|||
30582960|NCT01365481|58594203|FG003|Overall Study|Administrative problems|0|||
30582961|NCT01365481|58594200|FG000|Overall Study|Protocol deviation|0|||
30582962|NCT01365481|58594201|FG001|Overall Study|Protocol deviation|1|||
30582963|NCT01365481|58594202|FG002|Overall Study|Protocol deviation|0|||
30582964|NCT01365481|58594203|FG003|Overall Study|Protocol deviation|1|||
30582965|NCT01365481|58594200|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30582966|NCT01365481|58594201|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30582967|NCT01365481|58594202|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
30582968|NCT01365481|58594203|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
30582969|NCT01357915|58594215|FG000|Overall Study|Lost to Follow-up|3|||
30855587|NCT02783573|58883218|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
30582970|NCT01357915|58594216|FG001|Overall Study|Lost to Follow-up|0|||
30582971|NCT01350973|58594225|FG000|Overall Study|Adverse Event|4|||
30582972|NCT01350973|58594226|FG001|Overall Study|Adverse Event|7|||
30669117|NCT00868790|58683018|FG012|Period 3|Adverse Event|0|||
30669118|NCT00868790|58683019|FG013|Period 3|Adverse Event|0|||
30669119|NCT00868790|58683006|FG000|Period 3|Protocol Violation|0|||
30669120|NCT00868790|58683007|FG001|Period 3|Protocol Violation|0|||
30582973|NCT01350973|58594227|FG002|Overall Study|Adverse Event|7|||
30582974|NCT01350973|58594225|FG000|Overall Study|Voluntary Withdrawal|2|||
30582975|NCT01350973|58594226|FG001|Overall Study|Voluntary Withdrawal|1|||
30582976|NCT01350973|58594227|FG002|Overall Study|Voluntary Withdrawal|1|||
30582977|NCT01350544|58594237|FG000|Overall Study|Administrative Withdrawal|0|||
30582978|NCT01350544|58594238|FG001|Overall Study|Administrative Withdrawal|1|||
30582979|NCT01350544|58594237|FG000|Overall Study|Death|1|||
30582980|NCT01350544|58594238|FG001|Overall Study|Death|2|||
30582981|NCT01350544|58594237|FG000|Overall Study|Moved out of LA County|2|||
30582982|NCT01350544|58594238|FG001|Overall Study|Moved out of LA County|2|||
30582983|NCT01350544|58594237|FG000|Overall Study|Medical Issues|1|||
30582984|NCT01350544|58594238|FG001|Overall Study|Medical Issues|1|||
30582985|NCT01350544|58594237|FG000|Overall Study|Withdrawal by Subject|0|||
30582986|NCT01350544|58594238|FG001|Overall Study|Withdrawal by Subject|1|||
30582987|NCT01350544|58594237|FG000|Overall Study|Incarceration|1|||
30582988|NCT01350544|58594238|FG001|Overall Study|Incarceration|0|||
30582989|NCT01350544|58594237|FG000|Overall Study|Lost to Follow-up|18|||
30669121|NCT00868790|58683008|FG002|Period 3|Protocol Violation|0|||
30669122|NCT00868790|58683009|FG003|Period 3|Protocol Violation|0|||
30669123|NCT00868790|58683010|FG004|Period 3|Protocol Violation|0|||
30669124|NCT00868790|58683011|FG005|Period 3|Protocol Violation|0|||
30669125|NCT00868790|58683012|FG006|Period 3|Protocol Violation|0|||
30855588|NCT02783573|58883219|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
30855589|NCT02783573|58883220|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
30855590|NCT02783573|58883218|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
30855591|NCT02783573|58883219|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
30855592|NCT02783573|58883220|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
30855593|NCT02783573|58883218|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
30855594|NCT02783573|58883219|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
30855595|NCT02783573|58883220|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
30855596|NCT02783573|58883218|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
30855597|NCT02783573|58883219|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
30855598|NCT02783573|58883220|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
30855599|NCT02783573|58883218|FG000|Delayed-Start Period|Sponsor Decision|0|||
30855600|NCT02783573|58883219|FG001|Delayed-Start Period|Sponsor Decision|17|||
30855601|NCT02783573|58883220|FG002|Delayed-Start Period|Sponsor Decision|12|||
30855602|NCT01666652|58883236|FG000|Overall Study|Serious Adverse Event|0|||
30855603|NCT01666652|58883237|FG001|Overall Study|Serious Adverse Event|0|||
30855604|NCT01666652|58883238|FG002|Overall Study|Serious Adverse Event|0|||
30855605|NCT01666652|58883239|FG003|Overall Study|Serious Adverse Event|1|||
30855606|NCT01666652|58883240|FG004|Overall Study|Serious Adverse Event|0|||
30855607|NCT01666652|58883236|FG000|Overall Study|Withdrawal by Subject|0|||
30855608|NCT01666652|58883237|FG001|Overall Study|Withdrawal by Subject|0|||
30669126|NCT00868790|58683013|FG007|Period 3|Protocol Violation|0|||
30669127|NCT00868790|58683014|FG008|Period 3|Protocol Violation|0|||
30669128|NCT00868790|58683015|FG009|Period 3|Protocol Violation|0|||
30669129|NCT00868790|58683016|FG010|Period 3|Protocol Violation|1|||
30669130|NCT00868790|58683017|FG011|Period 3|Protocol Violation|0|||
30669131|NCT00868790|58683018|FG012|Period 3|Protocol Violation|0|||
30669132|NCT00868790|58683019|FG013|Period 3|Protocol Violation|0|||
30669133|NCT00868790|58683006|FG000|Period 3|Study Terminated by Sponsor|0|||
30669134|NCT00868790|58683007|FG001|Period 3|Study Terminated by Sponsor|0|||
30669135|NCT00868790|58683008|FG002|Period 3|Study Terminated by Sponsor|0|||
30669136|NCT00868790|58683009|FG003|Period 3|Study Terminated by Sponsor|1|||
30669137|NCT00868790|58683010|FG004|Period 3|Study Terminated by Sponsor|0|||
30669138|NCT00868790|58683011|FG005|Period 3|Study Terminated by Sponsor|0|||
30669139|NCT00868790|58683012|FG006|Period 3|Study Terminated by Sponsor|0|||
30669140|NCT00868790|58683013|FG007|Period 3|Study Terminated by Sponsor|0|||
30669141|NCT00868790|58683014|FG008|Period 3|Study Terminated by Sponsor|0|||
30669142|NCT00868790|58683015|FG009|Period 3|Study Terminated by Sponsor|0|||
30855609|NCT01666652|58883238|FG002|Overall Study|Withdrawal by Subject|0|||
30855610|NCT01666652|58883239|FG003|Overall Study|Withdrawal by Subject|0|||
30855611|NCT01666652|58883240|FG004|Overall Study|Withdrawal by Subject|1|||
30582990|NCT01350544|58594238|FG001|Overall Study|Lost to Follow-up|15|||
30582991|NCT01350505|58594244|FG000|Overall Study|Lost to Follow-up|4|||
30582992|NCT01350271|58594251|FG000|Overall Study|Lost to Follow-up|21|||
30582993|NCT01350271|58594252|FG001|Overall Study|Lost to Follow-up|17|||
30582994|NCT01350271|58594253|FG002|Overall Study|Lost to Follow-up|26|||
30582995|NCT01348828|58594264|FG000|Overall Study|Death|20|||
30582996|NCT01348828|58594264|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
30669143|NCT00868790|58683016|FG010|Period 3|Study Terminated by Sponsor|0|||
30669144|NCT00868790|58683017|FG011|Period 3|Study Terminated by Sponsor|0|||
30669145|NCT00868790|58683018|FG012|Period 3|Study Terminated by Sponsor|0|||
30669146|NCT00868790|58683019|FG013|Period 3|Study Terminated by Sponsor|0|||
30669147|NCT00868790|58683006|FG000|Period 4|Adverse Event|0|||
30669148|NCT00868790|58683007|FG001|Period 4|Adverse Event|0|||
30669149|NCT00868790|58683008|FG002|Period 4|Adverse Event|0|||
30669150|NCT00868790|58683009|FG003|Period 4|Adverse Event|0|||
30669151|NCT00868790|58683010|FG004|Period 4|Adverse Event|0|||
30669152|NCT00868790|58683011|FG005|Period 4|Adverse Event|0|||
30669153|NCT00868790|58683012|FG006|Period 4|Adverse Event|0|||
30669154|NCT00868790|58683013|FG007|Period 4|Adverse Event|1|||
30669155|NCT00868790|58683014|FG008|Period 4|Adverse Event|0|||
30669156|NCT00868790|58683015|FG009|Period 4|Adverse Event|0|||
30669157|NCT00868790|58683016|FG010|Period 4|Adverse Event|1|||
30669158|NCT00868790|58683017|FG011|Period 4|Adverse Event|0|||
30669159|NCT00868790|58683018|FG012|Period 4|Adverse Event|1|||
30669160|NCT00868790|58683019|FG013|Period 4|Adverse Event|0|||
30669161|NCT00868790|58683006|FG000|Period 4|Lost to Follow-up|0|||
30669162|NCT00868790|58683007|FG001|Period 4|Lost to Follow-up|0|||
30669163|NCT00868790|58683008|FG002|Period 4|Lost to Follow-up|0|||
30669164|NCT00868790|58683009|FG003|Period 4|Lost to Follow-up|0|||
30669165|NCT00868790|58683010|FG004|Period 4|Lost to Follow-up|0|||
30669166|NCT00868790|58683011|FG005|Period 4|Lost to Follow-up|0|||
30669167|NCT00868790|58683012|FG006|Period 4|Lost to Follow-up|0|||
30669168|NCT00868790|58683013|FG007|Period 4|Lost to Follow-up|1|||
30669169|NCT00868790|58683014|FG008|Period 4|Lost to Follow-up|0|||
30669170|NCT00868790|58683015|FG009|Period 4|Lost to Follow-up|0|||
30669171|NCT00868790|58683016|FG010|Period 4|Lost to Follow-up|0|||
30669172|NCT00868790|58683017|FG011|Period 4|Lost to Follow-up|0|||
30669173|NCT00868790|58683018|FG012|Period 4|Lost to Follow-up|0|||
30669174|NCT00868790|58683019|FG013|Period 4|Lost to Follow-up|0|||
30669175|NCT00868790|58683006|FG000|Period 4|Study Terminated by Sponsor|2|||
30669176|NCT00868790|58683007|FG001|Period 4|Study Terminated by Sponsor|0|||
30669177|NCT00868790|58683008|FG002|Period 4|Study Terminated by Sponsor|0|||
30669178|NCT00868790|58683009|FG003|Period 4|Study Terminated by Sponsor|0|||
30669179|NCT00868790|58683010|FG004|Period 4|Study Terminated by Sponsor|0|||
30669180|NCT00868790|58683011|FG005|Period 4|Study Terminated by Sponsor|0|||
30855612|NCT01666652|58883236|FG000|Overall Study|Moved from study area|1|||
30855613|NCT01666652|58883237|FG001|Overall Study|Moved from study area|0|||
30855614|NCT01666652|58883238|FG002|Overall Study|Moved from study area|0|||
30855615|NCT01666652|58883239|FG003|Overall Study|Moved from study area|2|||
30855616|NCT01666652|58883240|FG004|Overall Study|Moved from study area|0|||
30855617|NCT01666652|58883236|FG000|Overall Study|Lost to Follow-up|1|||
30855618|NCT01666652|58883237|FG001|Overall Study|Lost to Follow-up|1|||
30855619|NCT01666652|58883238|FG002|Overall Study|Lost to Follow-up|1|||
30855620|NCT01666652|58883239|FG003|Overall Study|Lost to Follow-up|1|||
30855621|NCT01666652|58883240|FG004|Overall Study|Lost to Follow-up|0|||
30855622|NCT00109733|58883254|FG000|Overall Study|Protocol Violation|0|||
30855623|NCT00109733|58883255|FG001|Overall Study|Protocol Violation|1|||
30855624|NCT00109733|58883254|FG000|Overall Study|Stopped taking study drug|1|||
30855625|NCT00109733|58883255|FG001|Overall Study|Stopped taking study drug|1|||
30855626|NCT00109733|58883254|FG000|Overall Study|Non-compliant|0|||
30855627|NCT00109733|58883255|FG001|Overall Study|Non-compliant|1|||
30855628|NCT00109733|58883254|FG000|Overall Study|Could not commit time for study|1|||
30855629|NCT00109733|58883255|FG001|Overall Study|Could not commit time for study|1|||
30855630|NCT02706405|58883269|FG000|Overall Study|Death|3|||
30855631|NCT02706405|58883270|FG001|Overall Study|Death|2|||
30855632|NCT02706405|58883271|FG002|Overall Study|Death|0|||
30855633|NCT02706405|58883272|FG003|Overall Study|Death|1|||
30855634|NCT02706405|58883273|FG004|Overall Study|Death|0|||
30855635|NCT02706405|58883274|FG005|Overall Study|Death|0|||
30855636|NCT02706405|58883275|FG006|Overall Study|Death|3|||
30855637|NCT02706405|58883276|FG007|Overall Study|Death|4|||
30855638|NCT02706405|58883269|FG000|Overall Study|Disease progression|0|||
30855639|NCT02706405|58883270|FG001|Overall Study|Disease progression|0|||
30855640|NCT02706405|58883271|FG002|Overall Study|Disease progression|0|||
30855641|NCT02706405|58883272|FG003|Overall Study|Disease progression|0|||
30855642|NCT02706405|58883273|FG004|Overall Study|Disease progression|0|||
30855643|NCT02706405|58883274|FG005|Overall Study|Disease progression|0|||
30855644|NCT02706405|58883275|FG006|Overall Study|Disease progression|0|||
30669181|NCT00868790|58683012|FG006|Period 4|Study Terminated by Sponsor|0|||
30855645|NCT02706405|58883276|FG007|Overall Study|Disease progression|1|||
30855646|NCT02706405|58883269|FG000|Overall Study|Pt moved to new therapy|0|||
30958751|NCT01579565|59023937|FG000|Randomized|prohibited preoperative medication|0|||
30669182|NCT00868790|58683013|FG007|Period 4|Study Terminated by Sponsor|1|||
30669183|NCT00868790|58683014|FG008|Period 4|Study Terminated by Sponsor|2|||
30669184|NCT00868790|58683015|FG009|Period 4|Study Terminated by Sponsor|0|||
30669185|NCT00868790|58683016|FG010|Period 4|Study Terminated by Sponsor|2|||
30958752|NCT01579565|59023938|FG001|Randomized|prohibited preoperative medication|1|||
30669186|NCT00868790|58683017|FG011|Period 4|Study Terminated by Sponsor|1|||
30669187|NCT00868790|58683018|FG012|Period 4|Study Terminated by Sponsor|0|||
30669188|NCT00868790|58683019|FG013|Period 4|Study Terminated by Sponsor|1|||
30669189|NCT00868790|58683006|FG000|Period 4|Abnormal ALT/AST|0|||
30669190|NCT00868790|58683007|FG001|Period 4|Abnormal ALT/AST|0|||
30855647|NCT02706405|58883270|FG001|Overall Study|Pt moved to new therapy|0|||
30855648|NCT02706405|58883271|FG002|Overall Study|Pt moved to new therapy|0|||
30855649|NCT02706405|58883272|FG003|Overall Study|Pt moved to new therapy|0|||
30855650|NCT02706405|58883273|FG004|Overall Study|Pt moved to new therapy|0|||
30855651|NCT02706405|58883274|FG005|Overall Study|Pt moved to new therapy|1|||
30855652|NCT02706405|58883275|FG006|Overall Study|Pt moved to new therapy|0|||
30855653|NCT02706405|58883276|FG007|Overall Study|Pt moved to new therapy|1|||
30855654|NCT02706405|58883269|FG000|Overall Study|Physician Decision|1|||
30855655|NCT02706405|58883270|FG001|Overall Study|Physician Decision|0|||
30855656|NCT02706405|58883271|FG002|Overall Study|Physician Decision|0|||
30855657|NCT02706405|58883272|FG003|Overall Study|Physician Decision|0|||
30855658|NCT02706405|58883273|FG004|Overall Study|Physician Decision|0|||
30855659|NCT02706405|58883274|FG005|Overall Study|Physician Decision|0|||
30855660|NCT02706405|58883275|FG006|Overall Study|Physician Decision|0|||
30855661|NCT02706405|58883276|FG007|Overall Study|Physician Decision|0|||
30855662|NCT02761993|58883305|FG000|Overall Study|Adverse Event|0|||
30855663|NCT02761993|58883306|FG001|Overall Study|Adverse Event|2|||
30855664|NCT02761993|58883307|FG002|Overall Study|Adverse Event|0|||
30855665|NCT02761993|58883305|FG000|Overall Study|Lost to Follow-up|1|||
30855666|NCT02761993|58883306|FG001|Overall Study|Lost to Follow-up|3|||
30855667|NCT02761993|58883307|FG002|Overall Study|Lost to Follow-up|2|||
30855668|NCT02761993|58883305|FG000|Overall Study|Withdrawal by Subject|1|||
30855669|NCT02761993|58883306|FG001|Overall Study|Withdrawal by Subject|1|||
30855670|NCT02761993|58883307|FG002|Overall Study|Withdrawal by Subject|2|||
30855671|NCT02766283|58883315|FG000|Overall Study|Lost to Follow-up|27|||
30582997|NCT01348828|58594264|FG000|Overall Study|Conversion|2|||
30582998|NCT01348828|58594264|FG000|Overall Study|missed visit|1|||
30582999|NCT01348789|58594268|FG000|Overall Study|Protocol Violation|2|||
30583000|NCT01348789|58594268|FG000|Overall Study|Withdrawal by Subject|2|||
30583001|NCT01342510|58594283|FG000|Overall Study|Protocol Violation|12|||
30583002|NCT01342510|58594284|FG001|Overall Study|Protocol Violation|6|||
30583003|NCT01342510|58594285|FG002|Overall Study|Protocol Violation|13|||
30583004|NCT01342510|58594286|FG003|Overall Study|Protocol Violation|11|||
30583005|NCT01340872|58594306|FG000|Double-blind Phase|Adverse Event|6|||
30583006|NCT01340872|58594307|FG001|Double-blind Phase|Adverse Event|4|||
30583007|NCT01340872|58594308|FG002|Double-blind Phase|Adverse Event|0|||
30583008|NCT01340872|58594309|FG003|Double-blind Phase|Adverse Event|0|||
30583009|NCT01340872|58594306|FG000|Double-blind Phase|Withdrawal by Subject|3|||
30583010|NCT01340872|58594307|FG001|Double-blind Phase|Withdrawal by Subject|5|||
30583011|NCT01340872|58594308|FG002|Double-blind Phase|Withdrawal by Subject|0|||
30583012|NCT01340872|58594309|FG003|Double-blind Phase|Withdrawal by Subject|0|||
30583013|NCT01340872|58594306|FG000|Double-blind Phase|Lost to Follow-up|0|||
30583014|NCT01340872|58594307|FG001|Double-blind Phase|Lost to Follow-up|1|||
30583015|NCT01340872|58594308|FG002|Double-blind Phase|Lost to Follow-up|0|||
30583016|NCT01340872|58594309|FG003|Double-blind Phase|Lost to Follow-up|0|||
30583017|NCT01340872|58594306|FG000|Double-blind Phase|Protocol Violation|0|||
30583018|NCT01340872|58594307|FG001|Double-blind Phase|Protocol Violation|1|||
30583019|NCT01340872|58594308|FG002|Double-blind Phase|Protocol Violation|0|||
30583020|NCT01340872|58594309|FG003|Double-blind Phase|Protocol Violation|0|||
30583021|NCT01340872|58594306|FG000|Open-label Phase|Physician Decision|0|||
30583022|NCT01340872|58594307|FG001|Open-label Phase|Physician Decision|0|||
30583023|NCT01340872|58594308|FG002|Open-label Phase|Physician Decision|2|||
30583024|NCT01340872|58594309|FG003|Open-label Phase|Physician Decision|1|||
30583025|NCT01340872|58594306|FG000|Open-label Phase|Pregnancy|0|||
30583026|NCT01340872|58594307|FG001|Open-label Phase|Pregnancy|0|||
30583027|NCT01340872|58594308|FG002|Open-label Phase|Pregnancy|1|||
30583028|NCT01340872|58594309|FG003|Open-label Phase|Pregnancy|0|||
30583029|NCT01340872|58594306|FG000|Open-label Phase|Adverse Event|0|||
30583030|NCT01340872|58594307|FG001|Open-label Phase|Adverse Event|0|||
30855672|NCT02761915|58883349|FG000|Overall Study|Death|3|||
30583031|NCT01340872|58594308|FG002|Open-label Phase|Adverse Event|8|||
30583032|NCT01340872|58594309|FG003|Open-label Phase|Adverse Event|4|||
30583033|NCT01340872|58594306|FG000|Open-label Phase|Withdrawal by Subject|0|||
30583034|NCT01340872|58594307|FG001|Open-label Phase|Withdrawal by Subject|0|||
30583035|NCT01340872|58594308|FG002|Open-label Phase|Withdrawal by Subject|1|||
30583036|NCT01340872|58594309|FG003|Open-label Phase|Withdrawal by Subject|6|||
30855673|NCT02761915|58883350|FG001|Overall Study|Death|1|||
30855674|NCT02761915|58883351|FG002|Overall Study|Death|1|||
30958753|NCT01579565|59023937|FG000|Treated|Physician Decision|0|||
30583037|NCT01340872|58594306|FG000|Open-label Phase|Worsening of IBD|0|||
30583038|NCT01340872|58594307|FG001|Open-label Phase|Worsening of IBD|0|||
30583039|NCT01340872|58594308|FG002|Open-label Phase|Worsening of IBD|1|||
30583040|NCT01340872|58594309|FG003|Open-label Phase|Worsening of IBD|0|||
30583041|NCT01340794|58594323|FG000|Overall Study|Withdrawal by Subject|0|||
30583042|NCT01340794|58594324|FG001|Overall Study|Withdrawal by Subject|1|||
30583043|NCT01340482|58594335|FG000|Overall Study|Adverse Event|2|||
30855675|NCT02761915|58883352|FG003|Overall Study|Death|1|||
30855676|NCT02761915|58883353|FG004|Overall Study|Death|0|||
30855677|NCT02761915|58883354|FG005|Overall Study|Death|1|||
30855678|NCT02761915|58883349|FG000|Overall Study|Withdrawal by Subject|1|||
30583044|NCT01340482|58594336|FG001|Overall Study|Adverse Event|0|||
30583045|NCT01340482|58594337|FG002|Overall Study|Adverse Event|0|||
30583046|NCT01340209|58594350|FG000|Overall Study|Adverse Event|1|||
30583047|NCT01340209|58594351|FG001|Overall Study|Adverse Event|1|||
30583048|NCT01340209|58594352|FG002|Overall Study|Adverse Event|2|||
30583049|NCT01340209|58594350|FG000|Overall Study|Protocol Violation|1|||
30583050|NCT01340209|58594351|FG001|Overall Study|Protocol Violation|2|||
30669191|NCT00868790|58683008|FG002|Period 4|Abnormal ALT/AST|1|||
30669192|NCT00868790|58683009|FG003|Period 4|Abnormal ALT/AST|0|||
30669193|NCT00868790|58683010|FG004|Period 4|Abnormal ALT/AST|0|||
30669194|NCT00868790|58683011|FG005|Period 4|Abnormal ALT/AST|0|||
30780935|NCT01060384|58793063|FG002|Overall Study|Intercurrent illness|0|||
30958754|NCT01579565|59023938|FG001|Treated|Physician Decision|1|||
30958755|NCT01579565|59023937|FG000|Treated|Lost to Follow-up|2|||
30958756|NCT01579565|59023938|FG001|Treated|Lost to Follow-up|1|||
30583051|NCT01340209|58594352|FG002|Overall Study|Protocol Violation|1|||
30583052|NCT01340209|58594350|FG000|Overall Study|Withdrawal by Subject|0|||
30583053|NCT01340209|58594351|FG001|Overall Study|Withdrawal by Subject|0|||
30583054|NCT01340209|58594352|FG002|Overall Study|Withdrawal by Subject|1|||
30958757|NCT01579565|59023937|FG000|Treated|declined to return for final visit|0|||
30958758|NCT01579565|59023938|FG001|Treated|declined to return for final visit|1|||
30958759|NCT01578785|59023948|FG000|Overall Study|Withdrawal by Subject|0|||
30958760|NCT01578785|59023949|FG001|Overall Study|Withdrawal by Subject|1|||
30583055|NCT01340209|58594350|FG000|Overall Study|Other reason not defined above|3|||
30583056|NCT01340209|58594351|FG001|Overall Study|Other reason not defined above|5|||
30583057|NCT01340209|58594352|FG002|Overall Study|Other reason not defined above|4|||
30583058|NCT01326910|58594362|FG000|Overall Study|Withdrawal by Subject|3|||
30583059|NCT01326910|58594363|FG001|Overall Study|Withdrawal by Subject|2|||
30583060|NCT01326910|58594362|FG000|Overall Study|Protocol Violation|1|||
30583061|NCT01326910|58594363|FG001|Overall Study|Protocol Violation|1|||
30583062|NCT01326481|58594369|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
30583063|NCT01325701|58594377|FG000|Overall Study|Adverse Event|12|||
30958761|NCT01578785|59023948|FG000|Overall Study|Study terminated by sponsor|59|||
30583064|NCT01325701|58594378|FG001|Overall Study|Adverse Event|0|||
30583065|NCT01325701|58594377|FG000|Overall Study|Protocol Violation|1|||
30583066|NCT01325701|58594378|FG001|Overall Study|Protocol Violation|0|||
30583067|NCT01325701|58594377|FG000|Overall Study|Physician Decision|2|||
30583068|NCT01325701|58594378|FG001|Overall Study|Physician Decision|2|||
30583069|NCT01325701|58594377|FG000|Overall Study|Withdrawal by Subject|2|||
30583070|NCT01325701|58594378|FG001|Overall Study|Withdrawal by Subject|1|||
30583071|NCT01325701|58594377|FG000|Overall Study|Rollerover Extension Study|4|||
30583072|NCT01325701|58594378|FG001|Overall Study|Rollerover Extension Study|0|||
30583073|NCT01325623|58594385|FG000|Overall Study|Withdrawal by Subject|3|||
30583074|NCT01325584|58594422|FG000|Overall Study|Death|1|||
30583075|NCT01325428|58594426|FG000|Part A|Progressive disease according to RECIST|9|||
30583076|NCT01325428|58594426|FG000|Part A|Clinical signs, symptoms of progression|2|||
30583077|NCT01325428|58594426|FG000|Part A|Other adverse event|1|||
30583078|NCT01325428|58594426|FG000|Part A|Refused continue taking trial medication|2|||
30583079|NCT01325428|58594426|FG000|Part A|Other reason not defined above|2|||
30583080|NCT01325428|58594426|FG000|Part B|Refused continue taking trial medication|2|||
30583081|NCT01325428|58594426|FG000|Part B|Other reason not defined above|1|||
30583082|NCT01325350|58594440|FG000|Overall Study|Adverse Event|3|||
30583083|NCT01325350|58594441|FG001|Overall Study|Adverse Event|3|||
30669195|NCT00868790|58683012|FG006|Period 4|Abnormal ALT/AST|0|||
30780936|NCT01060384|58793064|FG003|Overall Study|Intercurrent illness|0|||
30780937|NCT01060384|58793065|FG004|Overall Study|Intercurrent illness|1|||
30780938|NCT01060150|58793074|FG000|Overall Study|Adverse Event|6|||
30780939|NCT01060150|58793074|FG000|Overall Study|Lost to Follow-up|1|||
30780940|NCT01060150|58793074|FG000|Overall Study|Protocol Violation|6|||
30780941|NCT01060150|58793074|FG000|Overall Study|Withdrawal by Subject|8|||
30780942|NCT01060150|58793074|FG000|Overall Study|Enrolled, but not treated|2|||
30780943|NCT02972242|58793080|FG000|Overall Study|Withdrawal by Subject|1|||
30780944|NCT02972242|58793081|FG001|Overall Study|Withdrawal by Subject|0|||
30780945|NCT02970292|58793089|FG000|Overall Study|Physician Decision|1|||
30583084|NCT01325350|58594442|FG002|Overall Study|Adverse Event|3|||
30583085|NCT01325350|58594443|FG003|Overall Study|Adverse Event|1|||
30583086|NCT01325350|58594444|FG004|Overall Study|Adverse Event|2|||
30583087|NCT01325350|58594440|FG000|Overall Study|Pregnancy|0|||
30583088|NCT01325350|58594441|FG001|Overall Study|Pregnancy|0|||
30583089|NCT01325350|58594442|FG002|Overall Study|Pregnancy|1|||
30780946|NCT02970292|58793090|FG001|Overall Study|Physician Decision|1|||
30583090|NCT01325350|58594443|FG003|Overall Study|Pregnancy|0|||
30583091|NCT01325350|58594444|FG004|Overall Study|Pregnancy|1|||
30669196|NCT00868790|58683013|FG007|Period 4|Abnormal ALT/AST|0|||
30780947|NCT02970292|58793089|FG000|Overall Study|Withdrawal by Subject|11|||
30958762|NCT01578785|59023949|FG001|Overall Study|Study terminated by sponsor|118|||
30958763|NCT02692482|59023957|FG000|Overall Study|Death|2|||
30958764|NCT02692482|59023958|FG001|Overall Study|Death|2|||
30669197|NCT00868790|58683014|FG008|Period 4|Abnormal ALT/AST|0|||
30583092|NCT01325350|58594440|FG000|Overall Study|Lost to Follow-up|1|||
30583093|NCT01325350|58594441|FG001|Overall Study|Lost to Follow-up|0|||
30583094|NCT01325350|58594442|FG002|Overall Study|Lost to Follow-up|5|||
30583095|NCT01325350|58594443|FG003|Overall Study|Lost to Follow-up|1|||
30583096|NCT01325350|58594444|FG004|Overall Study|Lost to Follow-up|5|||
30583097|NCT01325350|58594440|FG000|Overall Study|Personal Reasons|2|||
30583098|NCT01325350|58594441|FG001|Overall Study|Personal Reasons|1|||
30583099|NCT01325350|58594442|FG002|Overall Study|Personal Reasons|6|||
30583100|NCT01325350|58594443|FG003|Overall Study|Personal Reasons|5|||
30583101|NCT01325350|58594444|FG004|Overall Study|Personal Reasons|3|||
30583102|NCT01325350|58594440|FG000|Overall Study|Protocol Violation|0|||
30583103|NCT01325350|58594441|FG001|Overall Study|Protocol Violation|0|||
30583104|NCT01325350|58594442|FG002|Overall Study|Protocol Violation|0|||
30583105|NCT01325350|58594443|FG003|Overall Study|Protocol Violation|1|||
30583106|NCT01325350|58594444|FG004|Overall Study|Protocol Violation|0|||
30583107|NCT01325350|58594440|FG000|Overall Study|Withdrawal by Subject|0|||
30583108|NCT01325350|58594441|FG001|Overall Study|Withdrawal by Subject|0|||
30583109|NCT01325350|58594442|FG002|Overall Study|Withdrawal by Subject|1|||
30583110|NCT01325350|58594443|FG003|Overall Study|Withdrawal by Subject|1|||
30583111|NCT01325350|58594444|FG004|Overall Study|Withdrawal by Subject|0|||
30583112|NCT01325350|58594440|FG000|Overall Study|Did Not Receive Treatment|0|||
30583113|NCT01325350|58594441|FG001|Overall Study|Did Not Receive Treatment|1|||
30583114|NCT01325350|58594442|FG002|Overall Study|Did Not Receive Treatment|1|||
30583115|NCT01325350|58594443|FG003|Overall Study|Did Not Receive Treatment|0|||
30583116|NCT01325350|58594444|FG004|Overall Study|Did Not Receive Treatment|1|||
30583117|NCT01324999|58594456|FG000|Overall Study|Adverse Event|3|||
30583118|NCT01324999|58594456|FG000|Overall Study|Withdrawal by Subject|2|||
30583119|NCT01324570|58594462|FG000|Overall Study|Adverse Event|4|||
30583120|NCT01324570|58594463|FG001|Overall Study|Adverse Event|7|||
30583121|NCT01324570|58594462|FG000|Overall Study|Withdrawal by Subject|0|||
30583122|NCT01324570|58594463|FG001|Overall Study|Withdrawal by Subject|3|||
30583123|NCT01324570|58594462|FG000|Overall Study|Lack of Efficacy|0|||
30583124|NCT01324570|58594463|FG001|Overall Study|Lack of Efficacy|1|||
30583125|NCT01324570|58594462|FG000|Overall Study|Confirmed or suspected diversion|0|||
30583126|NCT01324570|58594463|FG001|Overall Study|Confirmed or suspected diversion|1|||
30583127|NCT01324570|58594462|FG000|Overall Study|Administrative|0|||
30583128|NCT01324570|58594463|FG001|Overall Study|Administrative|2|||
30583129|NCT01324141|58594471|FG000|Overall Study|Declined to participate before treatment started|1|||
30583130|NCT01324141|58594471|FG000|Overall Study|Disease progression on study|1|||
30583131|NCT01324102|58594487|FG000|Overall Study|illness|1|||
30583132|NCT01324102|58594488|FG001|Overall Study|illness|6|||
30583133|NCT01324024|58594495|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
30583134|NCT01324024|58594496|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
30583135|NCT01323946|58594509|FG000|Overall Study|Lost to Follow-up|0|||
30583136|NCT01323946|58594510|FG001|Overall Study|Lost to Follow-up|1|||
30583137|NCT01323946|58594511|FG002|Overall Study|Lost to Follow-up|0|||
30583138|NCT01323946|58594509|FG000|Overall Study|Parents refused the last blood draw|1|||
30583139|NCT01323946|58594510|FG001|Overall Study|Parents refused the last blood draw|0|||
30583140|NCT01323946|58594511|FG002|Overall Study|Parents refused the last blood draw|0|||
30583141|NCT01323946|58594509|FG000|Overall Study|Withdrawal by Subject|2|||
30583142|NCT01323946|58594510|FG001|Overall Study|Withdrawal by Subject|2|||
30583143|NCT01323946|58594511|FG002|Overall Study|Withdrawal by Subject|0|||
30583144|NCT01323790|58594524|FG000|Overall Study|Other|3|||
30583145|NCT01323790|58594525|FG001|Overall Study|Other|2|||
30583146|NCT01323790|58594526|FG002|Overall Study|Other|1|||
30583147|NCT01323790|58594524|FG000|Overall Study|Lost to Follow-up|11|||
30583148|NCT01323790|58594525|FG001|Overall Study|Lost to Follow-up|9|||
30583149|NCT01323790|58594526|FG002|Overall Study|Lost to Follow-up|9|||
30583150|NCT01323790|58594524|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
30583151|NCT01323790|58594525|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
30583152|NCT01323790|58594526|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
30583153|NCT01323790|58594524|FG000|Overall Study|Lack of Efficacy|3|||
30583154|NCT01323790|58594525|FG001|Overall Study|Lack of Efficacy|0|||
30583155|NCT01323790|58594526|FG002|Overall Study|Lack of Efficacy|3|||
30583156|NCT01323790|58594524|FG000|Overall Study|Adverse Event|11|||
30583157|NCT01323790|58594525|FG001|Overall Study|Adverse Event|24|||
30583158|NCT01323790|58594526|FG002|Overall Study|Adverse Event|12|||
30583159|NCT01323790|58594524|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
30583160|NCT01323790|58594525|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
30583161|NCT01323790|58594526|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
30583162|NCT01323790|58594524|FG000|Overall Study|Withdrawal by Subject|23|||
30855679|NCT02761915|58883350|FG001|Overall Study|Withdrawal by Subject|0|||
30583163|NCT01323790|58594525|FG001|Overall Study|Withdrawal by Subject|20|||
30583164|NCT01323790|58594526|FG002|Overall Study|Withdrawal by Subject|13|||
30583165|NCT01323790|58594524|FG000|Overall Study|Did Not Receive Treatment|2|||
30583166|NCT01323790|58594525|FG001|Overall Study|Did Not Receive Treatment|0|||
30583167|NCT01323790|58594526|FG002|Overall Study|Did Not Receive Treatment|1|||
30669198|NCT00868790|58683015|FG009|Period 4|Abnormal ALT/AST|0|||
30669199|NCT00868790|58683016|FG010|Period 4|Abnormal ALT/AST|0|||
30669200|NCT00868790|58683017|FG011|Period 4|Abnormal ALT/AST|0|||
30669201|NCT00868790|58683018|FG012|Period 4|Abnormal ALT/AST|0|||
30669202|NCT00868790|58683019|FG013|Period 4|Abnormal ALT/AST|0|||
30669203|NCT00868790|58683006|FG000|Post-study|Withdrawal by Subject|0|||
30669204|NCT00868790|58683007|FG001|Post-study|Withdrawal by Subject|0|||
30669205|NCT00868790|58683008|FG002|Post-study|Withdrawal by Subject|0|||
30669206|NCT00868790|58683009|FG003|Post-study|Withdrawal by Subject|0|||
30669207|NCT00868790|58683010|FG004|Post-study|Withdrawal by Subject|1|||
30669208|NCT00868790|58683011|FG005|Post-study|Withdrawal by Subject|0|||
30669209|NCT00868790|58683012|FG006|Post-study|Withdrawal by Subject|0|||
30669210|NCT00868790|58683013|FG007|Post-study|Withdrawal by Subject|0|||
30669211|NCT00868790|58683014|FG008|Post-study|Withdrawal by Subject|0|||
30583168|NCT01323790|58594524|FG000|Overall Study|Severe non-compliance with protocol|2|||
30583169|NCT01323790|58594525|FG001|Overall Study|Severe non-compliance with protocol|2|||
30583170|NCT01323790|58594526|FG002|Overall Study|Severe non-compliance with protocol|2|||
30583171|NCT01323673|58594536|FG000|Overall Study|Adverse Event|0|||
30583172|NCT01323673|58594537|FG001|Overall Study|Adverse Event|1|||
30583173|NCT01323673|58594536|FG000|Overall Study|Lost to Follow-up|0|||
30583174|NCT01323673|58594537|FG001|Overall Study|Lost to Follow-up|1|||
30583175|NCT01323673|58594536|FG000|Overall Study|Protocol Violation|1|||
30583176|NCT01323673|58594537|FG001|Overall Study|Protocol Violation|0|||
30583177|NCT01323673|58594536|FG000|Overall Study|Withdrawal by Subject|2|||
30583178|NCT01323673|58594537|FG001|Overall Study|Withdrawal by Subject|3|||
30583179|NCT01323634|58594545|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
30583180|NCT01323634|58594546|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
30583181|NCT01323634|58594547|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
30583182|NCT01323634|58594545|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
30583183|NCT01323634|58594546|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
30583184|NCT01323634|58594547|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
30583185|NCT01323634|58594545|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
30583186|NCT01323634|58594546|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
30583187|NCT01323634|58594547|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
30583188|NCT01323634|58594545|FG000|2-week Run-in Period|Physician Decision|5|||
30583189|NCT01323634|58594546|FG001|2-week Run-in Period|Physician Decision|0|||
30583190|NCT01323634|58594547|FG002|2-week Run-in Period|Physician Decision|0|||
30583191|NCT01323634|58594545|FG000|2-week Run-in Period|Protocol Violation|1|||
30669212|NCT00868790|58683015|FG009|Post-study|Withdrawal by Subject|0|||
30669213|NCT00868790|58683016|FG010|Post-study|Withdrawal by Subject|0|||
30583192|NCT01323634|58594546|FG001|2-week Run-in Period|Protocol Violation|0|||
30583193|NCT01323634|58594547|FG002|2-week Run-in Period|Protocol Violation|0|||
30583194|NCT01323634|58594545|FG000|2-week Run-in Period|Adverse Event|1|||
30583195|NCT01323634|58594546|FG001|2-week Run-in Period|Adverse Event|0|||
30583196|NCT01323634|58594547|FG002|2-week Run-in Period|Adverse Event|0|||
30583197|NCT01323634|58594545|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
30583198|NCT01323634|58594546|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
30583199|NCT01323634|58594547|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
30583200|NCT01323634|58594545|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30583201|NCT01323634|58594546|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
30583202|NCT01323634|58594547|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
30583203|NCT01323634|58594545|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
30583204|NCT01323634|58594546|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
30583205|NCT01323634|58594547|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
30583206|NCT01323634|58594545|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
30583207|NCT01323634|58594546|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
30583208|NCT01323634|58594547|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
30583209|NCT01323634|58594545|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
30583210|NCT01323634|58594546|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
30583211|NCT01323634|58594547|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
30583212|NCT01323634|58594545|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
30583213|NCT01323634|58594546|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
30583214|NCT01323634|58594547|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
30583215|NCT01323634|58594545|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
30669214|NCT00868790|58683017|FG011|Post-study|Withdrawal by Subject|0|||
30958765|NCT02692482|59023957|FG000|Overall Study|Withdrawal by Subject|1|||
30958766|NCT02692482|59023958|FG001|Overall Study|Withdrawal by Subject|2|||
30669215|NCT00868790|58683018|FG012|Post-study|Withdrawal by Subject|0|||
30958767|NCT01578551|59023967|FG000|Overall Study|Adverse Event|1|||
30669216|NCT00868790|58683019|FG013|Post-study|Withdrawal by Subject|0|||
30669217|NCT00868790|58683006|FG000|Post-study|Excluded Medication|0|||
30669218|NCT00868790|58683007|FG001|Post-study|Excluded Medication|0|||
30669219|NCT00868790|58683008|FG002|Post-study|Excluded Medication|0|||
30669220|NCT00868790|58683009|FG003|Post-study|Excluded Medication|0|||
30583216|NCT01323634|58594546|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
30583217|NCT01323634|58594547|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
30583218|NCT01323478|58594553|FG000|Overall Study|Adverse Event|7|||
30583219|NCT01323478|58594553|FG000|Overall Study|Lack of Efficacy|4|||
30583220|NCT01323478|58594553|FG000|Overall Study|Non-compliance With Study Product|3|||
30583221|NCT01323478|58594553|FG000|Overall Study|Protocol Violation|1|||
30583222|NCT01323478|58594553|FG000|Overall Study|Withdrawal of Consent|1|||
30583223|NCT01323478|58594553|FG000|Overall Study|Administrative or Other Reasons|8|||
30583224|NCT01322386|58594559|FG000|Overall Study|Protocol Violation|0|||
30583225|NCT01322386|58594560|FG001|Overall Study|Protocol Violation|1|||
30583226|NCT01322386|58594559|FG000|Overall Study|Physician Decision|0|||
30583227|NCT01322386|58594560|FG001|Overall Study|Physician Decision|1|||
30583228|NCT01322347|58594570|FG000|Overall Study|Adverse Event|7|||
30583229|NCT01322347|58594571|FG001|Overall Study|Adverse Event|2|||
30583230|NCT01322347|58594570|FG000|Overall Study|Death|5|||
30583231|NCT01322347|58594571|FG001|Overall Study|Death|3|||
30583232|NCT01322347|58594570|FG000|Overall Study|Physician Decision|2|||
30583233|NCT01322347|58594571|FG001|Overall Study|Physician Decision|1|||
30583234|NCT01322347|58594570|FG000|Overall Study|Protocol Violation|5|||
30583235|NCT01322347|58594571|FG001|Overall Study|Protocol Violation|2|||
30583236|NCT01322347|58594570|FG000|Overall Study|Withdrawal by Subject|1|||
30583237|NCT01322347|58594571|FG001|Overall Study|Withdrawal by Subject|4|||
30583238|NCT01322347|58594570|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
30583239|NCT01322347|58594571|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
30583240|NCT01322347|58594570|FG000|Overall Study|blood transfusion|5|||
30583241|NCT01322347|58594571|FG001|Overall Study|blood transfusion|5|||
30583242|NCT01322347|58594570|FG000|Overall Study|sponsor decision|1|||
30583243|NCT01322347|58594571|FG001|Overall Study|sponsor decision|3|||
30583244|NCT01322347|58594570|FG000|Overall Study|ineligible|6|||
30583245|NCT01322347|58594571|FG001|Overall Study|ineligible|3|||
30583246|NCT01322347|58594570|FG000|Overall Study|kidney transplant|3|||
30583247|NCT01322347|58594571|FG001|Overall Study|kidney transplant|1|||
30583248|NCT01322347|58594570|FG000|Overall Study|study drug withheld > 12 wks|0|||
30583249|NCT01322347|58594571|FG001|Overall Study|study drug withheld > 12 wks|1|||
30583250|NCT01322347|58594570|FG000|Overall Study|moved/changed dialysis|2|||
30583251|NCT01322347|58594571|FG001|Overall Study|moved/changed dialysis|4|||
30583252|NCT01321879|58594578|FG000|Overall Study|Lack of Efficacy|5|||
30583253|NCT01321879|58594578|FG000|Overall Study|Adverse Event|5|||
30583254|NCT01321879|58594578|FG000|Overall Study|Death|3|||
30583255|NCT01321879|58594578|FG000|Overall Study|Withdrawal by Subject|1|||
30583256|NCT01321723|58594585|FG000|Overall Study|Adverse Event|3|||
30583257|NCT01321723|58594586|FG001|Overall Study|Adverse Event|5|||
30583258|NCT01321723|58594587|FG002|Overall Study|Adverse Event|2|||
30583259|NCT01321723|58594585|FG000|Overall Study|Withdrawal by Subject|2|||
30583260|NCT01321723|58594586|FG001|Overall Study|Withdrawal by Subject|0|||
30583261|NCT01321723|58594587|FG002|Overall Study|Withdrawal by Subject|2|||
30583262|NCT01321606|58594597|FG000|Overall Study|Lost to Follow-up|0|||
30583263|NCT01321606|58594598|FG001|Overall Study|Lost to Follow-up|0|||
30583264|NCT01321606|58594599|FG002|Overall Study|Lost to Follow-up|0|||
30583265|NCT01321606|58594600|FG003|Overall Study|Lost to Follow-up|1|||
30583266|NCT01320943|58594612|FG000|Overall Study|Lost to Follow-up|1|||
30583267|NCT01320943|58594613|FG001|Overall Study|Lost to Follow-up|0|||
30583268|NCT01320943|58594612|FG000|Overall Study|Physician Decision|0|||
30583269|NCT01320943|58594613|FG001|Overall Study|Physician Decision|1|||
30583270|NCT01320943|58594612|FG000|Overall Study|Randomized but not Treated|0|||
30583271|NCT01320943|58594613|FG001|Overall Study|Randomized but not Treated|1|||
30583272|NCT02482233|58594628|FG000|Overall Study|Lost to Follow-up|1|||
30583273|NCT02482233|58594629|FG001|Overall Study|Lost to Follow-up|1|||
30583274|NCT01320202|58594639|FG000|Overall Study|Adverse Event|5|||
30583275|NCT01320202|58594640|FG001|Overall Study|Adverse Event|5|||
30583276|NCT01320202|58594639|FG000|Overall Study|Death|5|||
30583277|NCT01320202|58594640|FG001|Overall Study|Death|3|||
30583278|NCT01320202|58594639|FG000|Overall Study|Lost to Follow-up|1|||
30583279|NCT01320202|58594640|FG001|Overall Study|Lost to Follow-up|0|||
30583280|NCT01320202|58594639|FG000|Overall Study|Physician Decision|3|||
30583281|NCT01320202|58594640|FG001|Overall Study|Physician Decision|1|||
30583282|NCT01320202|58594639|FG000|Overall Study|Protocol Violation|2|||
30669221|NCT00868790|58683010|FG004|Post-study|Excluded Medication|0|||
30669222|NCT00868790|58683011|FG005|Post-study|Excluded Medication|0|||
30583283|NCT01320202|58594640|FG001|Overall Study|Protocol Violation|1|||
30583284|NCT01320202|58594639|FG000|Overall Study|Withdrawal by Subject|10|||
30583285|NCT01320202|58594640|FG001|Overall Study|Withdrawal by Subject|3|||
30583286|NCT01320202|58594639|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
30583287|NCT01320202|58594640|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
30583288|NCT01320202|58594639|FG000|Overall Study|kidney transplant|1|||
30583289|NCT01320202|58594640|FG001|Overall Study|kidney transplant|2|||
30583290|NCT01320202|58594639|FG000|Overall Study|blood transfusion|1|||
30583291|NCT01320202|58594640|FG001|Overall Study|blood transfusion|7|||
30583292|NCT01320202|58594639|FG000|Overall Study|moved/changed dialysis|5|||
30583293|NCT01320202|58594640|FG001|Overall Study|moved/changed dialysis|2|||
30583294|NCT01320202|58594639|FG000|Overall Study|sponsor request|2|||
30583295|NCT01320202|58594640|FG001|Overall Study|sponsor request|0|||
30583296|NCT01320202|58594639|FG000|Overall Study|ineligible|3|||
30583297|NCT01320202|58594640|FG001|Overall Study|ineligible|0|||
30583298|NCT01320202|58594639|FG000|Overall Study|regained renal function|1|||
30583299|NCT01320202|58594640|FG001|Overall Study|regained renal function|0|||
30583300|NCT01319383|58594649|FG000|Overall Study|No ex vivo or in vivo response|4|||
30583301|NCT01319383|58594650|FG001|Overall Study|No ex vivo or in vivo response|0|||
30583302|NCT01319383|58594649|FG000|Overall Study|Physician Decision|3|||
30583303|NCT01319383|58594650|FG001|Overall Study|Physician Decision|0|||
30583304|NCT01319383|58594649|FG000|Overall Study|Lack of Efficacy|5|||
30583305|NCT01319383|58594650|FG001|Overall Study|Lack of Efficacy|9|||
30583306|NCT01319383|58594649|FG000|Overall Study|No in vivo response to interval doses|0|||
30583307|NCT01319383|58594650|FG001|Overall Study|No in vivo response to interval doses|1|||
30583308|NCT01316614|58594667|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
30583309|NCT01316614|58594667|FG000|Overall Study|Cytology slides not available for review|4|||
30583310|NCT01316614|58594667|FG000|Overall Study|Cystic lesion|5|||
30583311|NCT01316614|58594667|FG000|Overall Study|Inadequate number of passes|2|||
30583312|NCT01316614|58594667|FG000|Overall Study|Medically unstable|1|||
30583313|NCT01316575|58594674|FG000|Overall Study|Withdrawal by Subject|2|||
30583314|NCT01316575|58594675|FG001|Overall Study|Withdrawal by Subject|0|||
30583315|NCT01316575|58594674|FG000|Overall Study|Required alternate treatment|0|||
30583316|NCT01316575|58594675|FG001|Overall Study|Required alternate treatment|1|||
30583317|NCT01315678|58594683|FG000|Overall Study|Withdrawal by Subject|7|||
30583318|NCT01315678|58594684|FG001|Overall Study|Withdrawal by Subject|3|||
30583319|NCT01315678|58594683|FG000|Overall Study|Adverse Event|3|||
30583320|NCT01315678|58594684|FG001|Overall Study|Adverse Event|1|||
30583321|NCT01315678|58594683|FG000|Overall Study|Lost to Follow-up|1|||
30583322|NCT01315678|58594684|FG001|Overall Study|Lost to Follow-up|0|||
30583323|NCT01315678|58594683|FG000|Overall Study|similar reason to those listed above|3|||
30583324|NCT01315678|58594684|FG001|Overall Study|similar reason to those listed above|2|||
30583325|NCT01315249|58594694|FG000|Overall Study|Adverse Event|22|||
30583326|NCT01315249|58594695|FG001|Overall Study|Adverse Event|26|||
30583327|NCT01315249|58594694|FG000|Overall Study|Withdrawal by Subject|11|||
30583328|NCT01315249|58594695|FG001|Overall Study|Withdrawal by Subject|10|||
30583329|NCT01315249|58594694|FG000|Overall Study|Protocol Violation|8|||
30583330|NCT01315249|58594695|FG001|Overall Study|Protocol Violation|5|||
30583331|NCT01315249|58594694|FG000|Overall Study|Abnormal test results|1|||
30583332|NCT01315249|58594695|FG001|Overall Study|Abnormal test results|2|||
30583333|NCT01315249|58594694|FG000|Overall Study|Administrative problems|1|||
30583334|NCT01315249|58594695|FG001|Overall Study|Administrative problems|0|||
30583335|NCT01315249|58594694|FG000|Overall Study|inability to use device|1|||
30583336|NCT01315249|58594695|FG001|Overall Study|inability to use device|0|||
30583337|NCT01315249|58594694|FG000|Overall Study|Lack of Efficacy|0|||
30583338|NCT01315249|58594695|FG001|Overall Study|Lack of Efficacy|1|||
30583339|NCT01315249|58594694|FG000|Overall Study|Lost to Follow-up|0|||
30583340|NCT01315249|58594695|FG001|Overall Study|Lost to Follow-up|2|||
30583341|NCT01315249|58594694|FG000|Overall Study|Death|0|||
30583342|NCT01315249|58594695|FG001|Overall Study|Death|1|||
30583343|NCT01315132|58594701|FG000|Overall Study|not treated due to disease progression|1|||
30583344|NCT01313767|58594707|FG000|Overall Study|Adverse Event|1|||
30583345|NCT01313767|58594708|FG001|Overall Study|Adverse Event|0|||
30583346|NCT01313767|58594707|FG000|Overall Study|Lost to Follow-up|1|||
30583347|NCT01313767|58594708|FG001|Overall Study|Lost to Follow-up|0|||
30583348|NCT01313767|58594707|FG000|Overall Study|Withdrawal by Subject|2|||
30583349|NCT01313767|58594708|FG001|Overall Study|Withdrawal by Subject|1|||
30583350|NCT01313767|58594707|FG000|Overall Study|Protocol Violation|3|||
30583351|NCT01313767|58594708|FG001|Overall Study|Protocol Violation|1|||
30583352|NCT01313728|58594714|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
30583353|NCT01313650|58594723|FG000|Overall Study|Adverse Event|9|||
30583354|NCT01313650|58594724|FG001|Overall Study|Adverse Event|34|||
30583355|NCT01313650|58594725|FG002|Overall Study|Adverse Event|24|||
30583356|NCT01313650|58594726|FG003|Overall Study|Adverse Event|23|||
30583357|NCT01313650|58594723|FG000|Overall Study|Lack of Efficacy|37|||
30583358|NCT01313650|58594724|FG001|Overall Study|Lack of Efficacy|20|||
30583359|NCT01313650|58594725|FG002|Overall Study|Lack of Efficacy|32|||
30583360|NCT01313650|58594726|FG003|Overall Study|Lack of Efficacy|20|||
30583361|NCT01313650|58594723|FG000|Overall Study|Lost to Follow-up|1|||
30583362|NCT01313650|58594724|FG001|Overall Study|Lost to Follow-up|0|||
30583363|NCT01313650|58594725|FG002|Overall Study|Lost to Follow-up|3|||
30583364|NCT01313650|58594726|FG003|Overall Study|Lost to Follow-up|2|||
30583365|NCT01313650|58594723|FG000|Overall Study|Withdrawal by Subject|16|||
30583366|NCT01313650|58594724|FG001|Overall Study|Withdrawal by Subject|20|||
30583367|NCT01313650|58594725|FG002|Overall Study|Withdrawal by Subject|15|||
30583368|NCT01313650|58594726|FG003|Overall Study|Withdrawal by Subject|15|||
30583369|NCT01313650|58594723|FG000|Overall Study|Protocol Violation|4|||
30583370|NCT01313650|58594724|FG001|Overall Study|Protocol Violation|7|||
30583371|NCT01313650|58594725|FG002|Overall Study|Protocol Violation|5|||
30583372|NCT01313650|58594726|FG003|Overall Study|Protocol Violation|6|||
30583373|NCT01313650|58594723|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
30583374|NCT01313650|58594724|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
30583375|NCT01313650|58594725|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
30583376|NCT01313650|58594726|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
30583377|NCT01313299|58594739|FG000|Overall Study|Adverse Event|3|||
30583378|NCT01313299|58594740|FG001|Overall Study|Adverse Event|1|||
30583379|NCT01313299|58594741|FG002|Overall Study|Adverse Event|1|||
30583380|NCT01313299|58594739|FG000|Overall Study|Lost to Follow-up|1|||
30583381|NCT01313299|58594740|FG001|Overall Study|Lost to Follow-up|0|||
30583382|NCT01313299|58594741|FG002|Overall Study|Lost to Follow-up|0|||
30583383|NCT01313299|58594739|FG000|Overall Study|Protocol Violation|2|||
30583384|NCT01313299|58594740|FG001|Overall Study|Protocol Violation|0|||
30583385|NCT01313299|58594741|FG002|Overall Study|Protocol Violation|0|||
30583386|NCT01313299|58594739|FG000|Overall Study|Withdrawal by Subject|1|||
30583387|NCT01313299|58594740|FG001|Overall Study|Withdrawal by Subject|0|||
30583388|NCT01313299|58594741|FG002|Overall Study|Withdrawal by Subject|2|||
30583389|NCT01313299|58594739|FG000|Overall Study|Family reason and moved out of state|0|||
30583390|NCT01313299|58594740|FG001|Overall Study|Family reason and moved out of state|2|||
30583391|NCT01313299|58594741|FG002|Overall Study|Family reason and moved out of state|0|||
30583392|NCT01313299|58594739|FG000|Overall Study|Lack of subject compliance|0|||
30583393|NCT01313299|58594740|FG001|Overall Study|Lack of subject compliance|0|||
30583394|NCT01313299|58594741|FG002|Overall Study|Lack of subject compliance|1|||
30583395|NCT01313221|58594752|FG000|Overall Study|Protocol Violation|0|||
30583396|NCT01313221|58594753|FG001|Overall Study|Protocol Violation|1|||
30583397|NCT01313221|58594754|FG002|Overall Study|Protocol Violation|1|||
30583398|NCT01313221|58594752|FG000|Overall Study|Non-compliance|3|||
30583399|NCT01313221|58594753|FG001|Overall Study|Non-compliance|0|||
30583400|NCT01313221|58594754|FG002|Overall Study|Non-compliance|2|||
30583401|NCT01313221|58594752|FG000|Overall Study|Withdrawal by Subject|2|||
30583402|NCT01313221|58594753|FG001|Overall Study|Withdrawal by Subject|3|||
30583403|NCT01313221|58594754|FG002|Overall Study|Withdrawal by Subject|5|||
30583404|NCT01313221|58594752|FG000|Overall Study|Requirement for alternative therapy|0|||
30583405|NCT01313221|58594753|FG001|Overall Study|Requirement for alternative therapy|1|||
30583406|NCT01313221|58594754|FG002|Overall Study|Requirement for alternative therapy|1|||
30583407|NCT01313221|58594752|FG000|Overall Study|Lost to Follow-up|6|||
30583408|NCT01313221|58594753|FG001|Overall Study|Lost to Follow-up|3|||
30583409|NCT01313221|58594754|FG002|Overall Study|Lost to Follow-up|1|||
30583410|NCT01313221|58594752|FG000|Overall Study|Other|1|||
30583411|NCT01313221|58594753|FG001|Overall Study|Other|0|||
30583412|NCT01313221|58594754|FG002|Overall Study|Other|0|||
30583413|NCT01313221|58594752|FG000|Overall Study|Adverse Event|0|||
30583414|NCT01313221|58594753|FG001|Overall Study|Adverse Event|0|||
30669223|NCT00868790|58683012|FG006|Post-study|Excluded Medication|0|||
30669224|NCT00868790|58683013|FG007|Post-study|Excluded Medication|2|||
30669225|NCT00868790|58683014|FG008|Post-study|Excluded Medication|0|||
30669226|NCT00868790|58683015|FG009|Post-study|Excluded Medication|1|||
30669227|NCT00868790|58683016|FG010|Post-study|Excluded Medication|0|||
30669228|NCT00868790|58683017|FG011|Post-study|Excluded Medication|0|||
30669229|NCT00868790|58683018|FG012|Post-study|Excluded Medication|0|||
30669230|NCT00868790|58683019|FG013|Post-study|Excluded Medication|0|||
30669231|NCT00496483|58683035|FG000|Overall Study|Not dosed|9|||
30669232|NCT00496483|58683035|FG000|Overall Study|Adverse Event|2|||
30669233|NCT00496483|58683035|FG000|Overall Study|Lack of Efficacy|1|||
30669234|NCT03528551|58683045|FG000|Overall Study|Lost to Follow-up|0|||
30669235|NCT03528551|58683046|FG001|Overall Study|Lost to Follow-up|1|||
30669236|NCT03528551|58683047|FG002|Overall Study|Lost to Follow-up|0|||
30583415|NCT01313221|58594754|FG002|Overall Study|Adverse Event|7|||
30583416|NCT01313221|58594752|FG000|Overall Study|Disease progression|0|||
30583417|NCT01313221|58594753|FG001|Overall Study|Disease progression|0|||
30583418|NCT01313221|58594754|FG002|Overall Study|Disease progression|2|||
30669237|NCT03528551|58683045|FG000|Overall Study|Transferred to other arm/group|2|||
30669238|NCT03528551|58683046|FG001|Overall Study|Transferred to other arm/group|3|||
30958768|NCT01578551|59023968|FG001|Overall Study|Adverse Event|0|||
30583419|NCT01313221|58594752|FG000|Overall Study|Physician Decision|0|||
30583420|NCT01313221|58594753|FG001|Overall Study|Physician Decision|0|||
30583421|NCT01313221|58594754|FG002|Overall Study|Physician Decision|2|||
30583422|NCT01313221|58594752|FG000|Overall Study|Pregnancy|0|||
30583423|NCT01313221|58594753|FG001|Overall Study|Pregnancy|0|||
30583424|NCT01313221|58594754|FG002|Overall Study|Pregnancy|2|||
30583425|NCT01313182|58594764|FG000|Overall Study|Protocol Violation|66|||
30669239|NCT03528551|58683047|FG002|Overall Study|Transferred to other arm/group|0|||
30669240|NCT03528551|58683045|FG000|Overall Study|Withdrawal by parent/guardian|0|||
30669241|NCT03528551|58683046|FG001|Overall Study|Withdrawal by parent/guardian|5|||
30669242|NCT03528551|58683047|FG002|Overall Study|Withdrawal by parent/guardian|0|||
30583426|NCT01313182|58594765|FG001|Overall Study|Protocol Violation|92|||
30583427|NCT01312909|58594774|FG000|Overall Study|Randomized but not treated|1|||
30583428|NCT01312909|58594775|FG001|Overall Study|Randomized but not treated|3|||
30583429|NCT01312909|58594776|FG002|Overall Study|Randomized but not treated|1|||
30583430|NCT01312909|58594774|FG000|Overall Study|Adverse Event|1|||
30583431|NCT01312909|58594775|FG001|Overall Study|Adverse Event|0|||
30583432|NCT01312909|58594776|FG002|Overall Study|Adverse Event|3|||
30583433|NCT01312909|58594774|FG000|Overall Study|Protocol Violation|2|||
30583434|NCT01312909|58594775|FG001|Overall Study|Protocol Violation|0|||
30583435|NCT01312909|58594776|FG002|Overall Study|Protocol Violation|2|||
30583436|NCT01312909|58594774|FG000|Overall Study|Other|9|||
30583437|NCT01312909|58594775|FG001|Overall Study|Other|6|||
30583438|NCT01312909|58594776|FG002|Overall Study|Other|11|||
30583439|NCT01312909|58594774|FG000|Overall Study|Withdrawal by Subject|8|||
30583440|NCT01312909|58594775|FG001|Overall Study|Withdrawal by Subject|10|||
30583441|NCT01312909|58594776|FG002|Overall Study|Withdrawal by Subject|7|||
30583442|NCT01312909|58594774|FG000|Overall Study|Lost to Follow-up|21|||
30583443|NCT01312909|58594775|FG001|Overall Study|Lost to Follow-up|17|||
30583444|NCT01312909|58594776|FG002|Overall Study|Lost to Follow-up|20|||
30583445|NCT01312909|58594774|FG000|Overall Study|Insufficient clinical response|0|||
30583446|NCT01312909|58594775|FG001|Overall Study|Insufficient clinical response|0|||
30583447|NCT01312909|58594776|FG002|Overall Study|Insufficient clinical response|1|||
30583448|NCT01312909|58594774|FG000|Overall Study|Entrance criteria not met|0|||
30583449|NCT01312909|58594775|FG001|Overall Study|Entrance criteria not met|0|||
30583450|NCT01312909|58594776|FG002|Overall Study|Entrance criteria not met|2|||
30583451|NCT01312129|58594786|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
30583452|NCT01312129|58594787|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
30583453|NCT01311661|58594793|FG000|Overall Study|Adverse Event|2|||
30583454|NCT01311661|58594793|FG000|Overall Study|Protocol Violation|3|||
30583455|NCT01311661|58594793|FG000|Overall Study|Withdrawal by Subject|2|||
30583456|NCT01311505|58594805|FG000|First Intervention Period|Protocol Violation|0|||
30583457|NCT01311505|58594806|FG001|First Intervention Period|Protocol Violation|1|||
30583458|NCT01310803|58594817|FG000|Overall Study|Subject terminated by Sponsor|1|||
30583459|NCT01310803|58594818|FG001|Overall Study|Subject terminated by Sponsor|0|||
30583460|NCT01310413|58594830|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
30583461|NCT01310413|58594831|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
30583462|NCT01310413|58594832|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
30583463|NCT01310413|58594833|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
30583464|NCT01310413|58594834|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
30583465|NCT01310413|58594835|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
30583466|NCT01310413|58594836|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
30583467|NCT01310413|58594830|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
30583468|NCT01310413|58594831|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
30583469|NCT01310413|58594832|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
30583470|NCT01310413|58594833|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
30583471|NCT01310413|58594834|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
30583472|NCT01310413|58594835|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
30583473|NCT01310413|58594836|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
30583474|NCT01310413|58594830|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
30583475|NCT01310413|58594831|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
30583476|NCT01310413|58594832|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
30583477|NCT01310413|58594833|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
30583478|NCT01310413|58594834|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
30583479|NCT01310413|58594835|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
30583480|NCT01310413|58594836|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
30583481|NCT01310413|58594830|FG000|Day 0 to Day 385|Other|1|||
30583482|NCT01310413|58594831|FG001|Day 0 to Day 385|Other|0|||
30583483|NCT01310413|58594832|FG002|Day 0 to Day 385|Other|3|||
30583484|NCT01310413|58594833|FG003|Day 0 to Day 385|Other|0|||
30583485|NCT01310413|58594834|FG004|Day 0 to Day 385|Other|0|||
30669243|NCT03528551|58683045|FG000|Overall Study|Protocol Violation|0|||
30669244|NCT03528551|58683046|FG001|Overall Study|Protocol Violation|3|||
30958769|NCT01692197|59023975|FG000|Overall Study|Failed Screening|3|||
30669245|NCT03528551|58683047|FG002|Overall Study|Protocol Violation|0|||
30583486|NCT01310413|58594835|FG005|Day 0 to Day 385|Other|0|||
30583487|NCT01310413|58594836|FG006|Day 0 to Day 385|Other|0|||
30583488|NCT01310413|58594830|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
30583489|NCT01310413|58594831|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
30583490|NCT01310413|58594832|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
30583491|NCT01310413|58594833|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
30583492|NCT01310413|58594834|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
30583493|NCT01310413|58594835|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
30583494|NCT01310413|58594836|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
30583495|NCT01310413|58594830|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
30583496|NCT01310413|58594831|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
30669246|NCT03528551|58683045|FG000|Overall Study|Withdrawal by Subject|0|||
30583497|NCT01310413|58594832|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
30583498|NCT01310413|58594833|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
30583499|NCT01310413|58594834|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
30583500|NCT01310413|58594835|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
30583501|NCT01310413|58594836|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
30583502|NCT01309828|58594867|FG000|Overall Study|Adverse Event|10|||
30583503|NCT01309828|58594868|FG001|Overall Study|Adverse Event|11|||
30583504|NCT01309828|58594867|FG000|Overall Study|Voluntary Withdrawal|5|||
30583505|NCT01309828|58594868|FG001|Overall Study|Voluntary Withdrawal|4|||
30583506|NCT01309828|58594867|FG000|Overall Study|Major Protocol Deviation|0|||
30583507|NCT01309828|58594868|FG001|Overall Study|Major Protocol Deviation|1|||
30583508|NCT01309828|58594867|FG000|Overall Study|Other|1|||
30583509|NCT01309828|58594868|FG001|Overall Study|Other|0|||
30583510|NCT01309282|58594874|FG000|Overall Study|Lost to Follow-up|1|||
30583511|NCT01309243|58594880|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
30583512|NCT01309243|58594881|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
30583513|NCT01309243|58594880|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
30583514|NCT01309243|58594881|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
30583515|NCT01309243|58594880|FG000|Randomized Phase Through Week 96|Death|0|||
30583516|NCT01309243|58594881|FG001|Randomized Phase Through Week 96|Death|1|||
30583517|NCT01309243|58594880|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
30583518|NCT01309243|58594881|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
30583519|NCT01309243|58594880|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
30583520|NCT01309243|58594881|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
30583521|NCT01309243|58594880|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
30583522|NCT01309243|58594881|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
30583523|NCT01309243|58594880|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
30855680|NCT02761915|58883351|FG002|Overall Study|Withdrawal by Subject|0|||
30855681|NCT02761915|58883352|FG003|Overall Study|Withdrawal by Subject|0|||
30855682|NCT02761915|58883353|FG004|Overall Study|Withdrawal by Subject|1|||
30855683|NCT02761915|58883354|FG005|Overall Study|Withdrawal by Subject|2|||
30855684|NCT02761915|58883349|FG000|Overall Study|Disease Progression|0|||
30855685|NCT02761915|58883350|FG001|Overall Study|Disease Progression|0|||
30583524|NCT01309243|58594881|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
30583525|NCT01309243|58594880|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
30780948|NCT02970292|58793090|FG001|Overall Study|Withdrawal by Subject|5|||
30780949|NCT02970292|58793089|FG000|Overall Study|Noncompliance with study drug|2|||
30583526|NCT01309243|58594881|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
30583527|NCT01309243|58594880|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
30583528|NCT01309243|58594881|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
30583529|NCT01309243|58594880|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
30583530|NCT01309243|58594881|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
30583531|NCT01309243|58594880|FG000|Extension Phase|Lost to Follow-up|6|||
30583532|NCT01309243|58594881|FG001|Extension Phase|Lost to Follow-up|0|||
30583533|NCT01309204|58594889|FG000|Overall Study|Adverse Event|48|||
30583534|NCT01309204|58594890|FG001|Overall Study|Adverse Event|58|||
30583535|NCT01309204|58594889|FG000|Overall Study|Lost to Follow-up|2|||
30583536|NCT01309204|58594890|FG001|Overall Study|Lost to Follow-up|2|||
30583537|NCT01309204|58594889|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
30583538|NCT01309204|58594890|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
30780950|NCT02970292|58793090|FG001|Overall Study|Noncompliance with study drug|2|||
30780951|NCT02970292|58793089|FG000|Overall Study|Adverse Event|5|||
30780952|NCT02970292|58793090|FG001|Overall Study|Adverse Event|0|||
30780953|NCT02970292|58793089|FG000|Overall Study|Lack of Efficacy|1|||
30780954|NCT02970292|58793090|FG001|Overall Study|Lack of Efficacy|0|||
30780955|NCT02970292|58793089|FG000|Overall Study|Lost to Follow-up|1|||
30780956|NCT02970292|58793090|FG001|Overall Study|Lost to Follow-up|0|||
30780957|NCT02970292|58793089|FG000|Overall Study|Protocol Violation|2|||
30780958|NCT02970292|58793090|FG001|Overall Study|Protocol Violation|0|||
30780959|NCT02970292|58793089|FG000|Overall Study|Other|1|||
30780960|NCT02970292|58793090|FG001|Overall Study|Other|0|||
30780961|NCT02971228|58793096|FG000|Overall Study|Withdrawal by Subject|1|||
30780962|NCT02971228|58793097|FG001|Overall Study|Withdrawal by Subject|1|||
30780963|NCT02971228|58793098|FG002|Overall Study|Withdrawal by Subject|0|||
30958770|NCT01692119|59023982|FG000|Overall Study|Protocol Violation|3|||
30583539|NCT01309204|58594889|FG000|Overall Study|Inadequate control of IOP|4|||
30583540|NCT01309204|58594890|FG001|Overall Study|Inadequate control of IOP|4|||
30855686|NCT02761915|58883351|FG002|Overall Study|Disease Progression|0|||
30583541|NCT01309204|58594889|FG000|Overall Study|Other|4|||
30583542|NCT01309204|58594890|FG001|Overall Study|Other|1|||
30583543|NCT01309165|58594898|FG000|Overall Study|Lost to Follow-up|4|||
30583544|NCT01309165|58594899|FG001|Overall Study|Lost to Follow-up|3|||
30780964|NCT02971228|58793099|FG003|Overall Study|Withdrawal by Subject|0|||
30780965|NCT02971228|58793100|FG004|Overall Study|Withdrawal by Subject|0|||
30855687|NCT02761915|58883352|FG003|Overall Study|Disease Progression|2|||
30583545|NCT01309165|58594898|FG000|Overall Study|Return to work|1|||
30583546|NCT01309165|58594899|FG001|Overall Study|Return to work|2|||
30583547|NCT01309165|58594898|FG000|Overall Study|Left country|0|||
30583548|NCT01309165|58594899|FG001|Overall Study|Left country|1|||
30583549|NCT01309165|58594898|FG000|Overall Study|No transportation|0|||
30583550|NCT01309165|58594899|FG001|Overall Study|No transportation|1|||
30583551|NCT01309165|58594898|FG000|Overall Study|Admitted to hospital for second stroke|1|||
30583552|NCT01309165|58594899|FG001|Overall Study|Admitted to hospital for second stroke|0|||
30669247|NCT03528551|58683046|FG001|Overall Study|Withdrawal by Subject|7|||
30669248|NCT03528551|58683047|FG002|Overall Study|Withdrawal by Subject|0|||
30669249|NCT00487981|58683056|FG000|Overall Study|Hypothyroidism diagnosis|1|||
30669250|NCT00861744|58683064|FG000|Overall Study|Adverse Event|0|||
30669251|NCT00861744|58683065|FG001|Overall Study|Adverse Event|0|||
30669252|NCT00861744|58683066|FG002|Overall Study|Adverse Event|0|||
30669253|NCT00861744|58683067|FG003|Overall Study|Adverse Event|1|||
30669254|NCT00861744|58683064|FG000|Overall Study|Lost to Follow-up|7|||
30669255|NCT00861744|58683065|FG001|Overall Study|Lost to Follow-up|19|||
30669256|NCT00861744|58683066|FG002|Overall Study|Lost to Follow-up|17|||
30669257|NCT00861744|58683067|FG003|Overall Study|Lost to Follow-up|12|||
30669258|NCT00861744|58683064|FG000|Overall Study|Withdrawal by Subject|10|||
30669259|NCT00861744|58683065|FG001|Overall Study|Withdrawal by Subject|6|||
30669260|NCT00861744|58683066|FG002|Overall Study|Withdrawal by Subject|6|||
30669261|NCT00861744|58683067|FG003|Overall Study|Withdrawal by Subject|19|||
30669262|NCT00861744|58683064|FG000|Overall Study|Protocol Violation|0|||
30780966|NCT02971228|58793096|FG000|Overall Study|Logistical challenges|0|||
30583553|NCT01308853|58594906|FG000|Overall Study|Adverse Event|1|||
30583554|NCT01308853|58594906|FG000|Overall Study|Lost to Follow-up|2|||
30583555|NCT01308853|58594906|FG000|Overall Study|Insertion of permanent implants|1|||
30583556|NCT01308736|58594912|FG000|Overall Study|Did not attend a single session|6|||
30583557|NCT01308736|58594913|FG001|Overall Study|Did not attend a single session|5|||
30583558|NCT01308580|58594921|FG000|Overall Study|Lost to Follow-up|12|||
30583559|NCT01308580|58594922|FG001|Overall Study|Lost to Follow-up|7|||
30583560|NCT01308463|58594929|FG000|Overall Study|Study Discontinued|23|||
30583561|NCT01308463|58594929|FG000|Overall Study|Death|4|||
30583562|NCT01308463|58594929|FG000|Overall Study|Revision|2|||
30583563|NCT01308424|58594935|FG000|Baseline Eligibility|Screen Failures|71|||
30583564|NCT01308424|58594936|FG001|Baseline Eligibility|Screen Failures|0|||
30583565|NCT01308424|58594937|FG002|Baseline Eligibility|Screen Failures|0|||
30583566|NCT01308424|58594935|FG000|Randomization|Adverse Event|0|||
30583567|NCT01308424|58594936|FG001|Randomization|Adverse Event|1|||
30583568|NCT01308424|58594937|FG002|Randomization|Adverse Event|1|||
30583569|NCT01308424|58594935|FG000|Randomization|Lost to Follow-up|0|||
30583570|NCT01308424|58594936|FG001|Randomization|Lost to Follow-up|1|||
30583571|NCT01308424|58594937|FG002|Randomization|Lost to Follow-up|0|||
30583572|NCT01308424|58594935|FG000|Randomization|Physician Decision|0|||
30583573|NCT01308424|58594936|FG001|Randomization|Physician Decision|1|||
30583574|NCT01308424|58594937|FG002|Randomization|Physician Decision|1|||
30583575|NCT01307800|58594948|FG000|Overall Study|Adverse Event|9|||
30583576|NCT01307800|58594949|FG001|Overall Study|Adverse Event|8|||
30583577|NCT01307800|58594950|FG002|Overall Study|Adverse Event|10|||
30583578|NCT01307800|58594951|FG003|Overall Study|Adverse Event|14|||
30583579|NCT01307800|58594948|FG000|Overall Study|Entry Criteria Not Met|0|||
30583580|NCT01307800|58594949|FG001|Overall Study|Entry Criteria Not Met|0|||
30583581|NCT01307800|58594950|FG002|Overall Study|Entry Criteria Not Met|0|||
30583582|NCT01307800|58594951|FG003|Overall Study|Entry Criteria Not Met|2|||
30583583|NCT01307800|58594948|FG000|Overall Study|Lost to Follow-up|5|||
30583584|NCT01307800|58594949|FG001|Overall Study|Lost to Follow-up|6|||
30583585|NCT01307800|58594950|FG002|Overall Study|Lost to Follow-up|2|||
30583586|NCT01307800|58594951|FG003|Overall Study|Lost to Follow-up|8|||
30583587|NCT01307800|58594948|FG000|Overall Study|Perceived Lack of Efficacy|24|||
30583588|NCT01307800|58594949|FG001|Overall Study|Perceived Lack of Efficacy|23|||
30583589|NCT01307800|58594950|FG002|Overall Study|Perceived Lack of Efficacy|20|||
30780967|NCT02971228|58793097|FG001|Overall Study|Logistical challenges|1|||
30780968|NCT02971228|58793098|FG002|Overall Study|Logistical challenges|0|||
30583590|NCT01307800|58594951|FG003|Overall Study|Perceived Lack of Efficacy|33|||
30583591|NCT01307800|58594948|FG000|Overall Study|Protocol Violation|0|||
30583592|NCT01307800|58594949|FG001|Overall Study|Protocol Violation|3|||
30583593|NCT01307800|58594950|FG002|Overall Study|Protocol Violation|4|||
30669263|NCT00861744|58683065|FG001|Overall Study|Protocol Violation|1|||
30669264|NCT00861744|58683066|FG002|Overall Study|Protocol Violation|0|||
30669265|NCT00861744|58683067|FG003|Overall Study|Protocol Violation|0|||
30583594|NCT01307800|58594951|FG003|Overall Study|Protocol Violation|5|||
30583595|NCT01307800|58594948|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
30583596|NCT01307800|58594949|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
30669266|NCT00861744|58683064|FG000|Overall Study|Migration from study area|0|||
30669267|NCT00861744|58683065|FG001|Overall Study|Migration from study area|3|||
30669268|NCT00861744|58683066|FG002|Overall Study|Migration from study area|1|||
30780969|NCT02971228|58793099|FG003|Overall Study|Logistical challenges|0|||
30583597|NCT01307800|58594950|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
30583598|NCT01307800|58594951|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
30583599|NCT01307800|58594948|FG000|Overall Study|Sponsor Decision|6|||
30583600|NCT01307800|58594949|FG001|Overall Study|Sponsor Decision|9|||
30583601|NCT01307800|58594950|FG002|Overall Study|Sponsor Decision|12|||
30583602|NCT01307800|58594951|FG003|Overall Study|Sponsor Decision|28|||
30583603|NCT01307800|58594948|FG000|Overall Study|Withdrawal by Subject|10|||
30583604|NCT01307800|58594949|FG001|Overall Study|Withdrawal by Subject|11|||
30583605|NCT01307800|58594950|FG002|Overall Study|Withdrawal by Subject|8|||
30583606|NCT01307800|58594951|FG003|Overall Study|Withdrawal by Subject|15|||
30583607|NCT01307800|58594948|FG000|Overall Study|Participant Moved|0|||
30583608|NCT01307800|58594949|FG001|Overall Study|Participant Moved|2|||
30583609|NCT01307800|58594950|FG002|Overall Study|Participant Moved|1|||
30583610|NCT01307800|58594951|FG003|Overall Study|Participant Moved|3|||
30583611|NCT01307449|58594965|FG000|Overall Study|Adverse Event|1|||
30583612|NCT01307449|58594966|FG001|Overall Study|Adverse Event|0|||
30583613|NCT01307449|58594967|FG002|Overall Study|Adverse Event|0|||
30583614|NCT01307449|58594968|FG003|Overall Study|Adverse Event|0|||
30583615|NCT01307020|58594988|FG000|Overall Study|Lost to Follow-up|0|||
30583616|NCT01307020|58594989|FG001|Overall Study|Lost to Follow-up|0|||
30583617|NCT01307020|58594990|FG002|Overall Study|Lost to Follow-up|1|||
30583618|NCT01307020|58594991|FG003|Overall Study|Lost to Follow-up|1|||
30583619|NCT01307020|58594992|FG004|Overall Study|Lost to Follow-up|0|||
30583620|NCT01307020|58594993|FG005|Overall Study|Lost to Follow-up|0|||
30583621|NCT01307020|58594994|FG006|Overall Study|Lost to Follow-up|1|||
30583622|NCT01307020|58594995|FG007|Overall Study|Lost to Follow-up|0|||
30583623|NCT01307020|58594996|FG008|Overall Study|Lost to Follow-up|0|||
30583624|NCT01307020|58594997|FG009|Overall Study|Lost to Follow-up|0|||
30583625|NCT01307020|58594988|FG000|Overall Study|Electronic data capture failure|0|||
30583626|NCT01307020|58594989|FG001|Overall Study|Electronic data capture failure|1|||
30583627|NCT01307020|58594990|FG002|Overall Study|Electronic data capture failure|0|||
30583628|NCT01307020|58594991|FG003|Overall Study|Electronic data capture failure|0|||
30583629|NCT01307020|58594992|FG004|Overall Study|Electronic data capture failure|0|||
30583630|NCT01307020|58594993|FG005|Overall Study|Electronic data capture failure|0|||
30583631|NCT01307020|58594994|FG006|Overall Study|Electronic data capture failure|0|||
30583632|NCT01307020|58594995|FG007|Overall Study|Electronic data capture failure|0|||
30583633|NCT01307020|58594996|FG008|Overall Study|Electronic data capture failure|0|||
30669269|NCT00861744|58683067|FG003|Overall Study|Migration from study area|0|||
30669270|NCT00861744|58683064|FG000|Overall Study|Blood draws|0|||
30669271|NCT00861744|58683065|FG001|Overall Study|Blood draws|0|||
30669272|NCT00861744|58683066|FG002|Overall Study|Blood draws|0|||
30669273|NCT00861744|58683067|FG003|Overall Study|Blood draws|1|||
30669274|NCT00603239|58683079|FG000|Overall Study|Adverse Event|4|||
30669275|NCT00603239|58683080|FG001|Overall Study|Adverse Event|1|||
30669276|NCT00603239|58683079|FG000|Overall Study|Entry criteria not met|0|||
30669277|NCT00603239|58683080|FG001|Overall Study|Entry criteria not met|1|||
30669278|NCT00603239|58683079|FG000|Overall Study|Loss of glucose control|3|||
30669279|NCT00603239|58683080|FG001|Overall Study|Loss of glucose control|0|||
30669280|NCT00603239|58683079|FG000|Overall Study|Lost to Follow-up|2|||
30669281|NCT00603239|58683080|FG001|Overall Study|Lost to Follow-up|1|||
30669282|NCT00603239|58683079|FG000|Overall Study|Physician Decision|2|||
30669283|NCT00603239|58683080|FG001|Overall Study|Physician Decision|0|||
30669284|NCT00603239|58683079|FG000|Overall Study|Protocol Violation|2|||
30669285|NCT00603239|58683080|FG001|Overall Study|Protocol Violation|0|||
30669286|NCT00603239|58683079|FG000|Overall Study|Subject decision|2|||
30669287|NCT00603239|58683080|FG001|Overall Study|Subject decision|1|||
30669288|NCT00852930|58683089|FG000|Overall Study|Withdrawal by Subject|1|||
30669289|NCT00852930|58683090|FG001|Overall Study|Withdrawal by Subject|1|||
30669290|NCT00852930|58683091|FG002|Overall Study|Withdrawal by Subject|1|||
30669291|NCT00852930|58683089|FG000|Overall Study|Physician Decision|0|||
30669292|NCT00852930|58683090|FG001|Overall Study|Physician Decision|0|||
30583634|NCT01307020|58594997|FG009|Overall Study|Electronic data capture failure|0|||
30669293|NCT00852930|58683091|FG002|Overall Study|Physician Decision|1|||
30669294|NCT00852540|58683102|FG000|Overall Study|Adverse Event|10|||
30583635|NCT01306201|58595019|FG000|Overall Study|Arrhythmia|4|||
30583636|NCT01306201|58595019|FG000|Overall Study|Files could not be processed|3|||
30583637|NCT01306201|58595019|FG000|Overall Study|Files unreadable|3|||
30583638|NCT01306162|58595031|FG000|Period 1|Adverse Event|0|||
30583639|NCT01306162|58595032|FG001|Period 1|Adverse Event|0|||
30583640|NCT01306162|58595033|FG002|Period 1|Adverse Event|0|||
30669295|NCT00852540|58683103|FG001|Overall Study|Adverse Event|3|||
30669296|NCT00852540|58683102|FG000|Overall Study|Lack of Efficacy|15|||
30669297|NCT00852540|58683103|FG001|Overall Study|Lack of Efficacy|3|||
30669298|NCT00852540|58683102|FG000|Overall Study|Protocol Violation|1|||
30669299|NCT00852540|58683103|FG001|Overall Study|Protocol Violation|2|||
30669300|NCT00852540|58683102|FG000|Overall Study|Lost to Follow-up|2|||
30669301|NCT00852540|58683103|FG001|Overall Study|Lost to Follow-up|3|||
30669302|NCT00852540|58683102|FG000|Overall Study|Investigator Discretion|2|||
30855688|NCT02761915|58883353|FG004|Overall Study|Disease Progression|2|||
30669303|NCT00852540|58683103|FG001|Overall Study|Investigator Discretion|3|||
30583641|NCT01306162|58595034|FG003|Period 1|Adverse Event|1|||
30583642|NCT01306162|58595031|FG000|Washout 1|Non-compliance to protocol|0|||
30583643|NCT01306162|58595032|FG001|Washout 1|Non-compliance to protocol|1|||
30583644|NCT01306162|58595033|FG002|Washout 1|Non-compliance to protocol|0|||
30583645|NCT01306162|58595034|FG003|Washout 1|Non-compliance to protocol|0|||
30583646|NCT01305577|58595050|FG000|Overall Study|Adverse Event|2|||
30669304|NCT00852540|58683102|FG000|Overall Study|Withdrawal by Subject|3|||
30669305|NCT00852540|58683103|FG001|Overall Study|Withdrawal by Subject|1|||
30669306|NCT00852540|58683102|FG000|Overall Study|Did Not Receive Study Drug|3|||
30669307|NCT00852540|58683103|FG001|Overall Study|Did Not Receive Study Drug|3|||
30669308|NCT00861198|58683110|FG000|Overall Study|SpyGlass Failed|5|||
30669309|NCT00847704|58683114|FG000|Overall Study|Withdrawal by Subject|1|||
30669310|NCT00860574|58683118|FG000|Overall Study|Death|2|||
30669311|NCT00860574|58683118|FG000|Overall Study|Relapse|1|||
30669312|NCT00496015|58683127|FG000|Overall Study|Other|1|||
30669313|NCT00496015|58683128|FG001|Overall Study|Other|0|||
30669314|NCT00496015|58683129|FG002|Overall Study|Other|0|||
30669315|NCT00496015|58683130|FG003|Overall Study|Other|1|||
30669316|NCT00496015|58683131|FG004|Overall Study|Other|0|||
30669317|NCT00487825|58683153|FG000|Overall Study|Adverse Event|2|||
30669318|NCT00487825|58683154|FG001|Overall Study|Adverse Event|2|||
30669319|NCT00487825|58683153|FG000|Overall Study|Lack of Efficacy|1|||
30669320|NCT00487825|58683154|FG001|Overall Study|Lack of Efficacy|1|||
30669321|NCT00487825|58683153|FG000|Overall Study|Other|3|||
30669322|NCT00487825|58683154|FG001|Overall Study|Other|2|||
30669323|NCT00487747|58683160|FG000|Overall Study|Adverse Event|1|||
30669324|NCT00487747|58683160|FG000|Overall Study|Lost to Follow-up|9|||
30669325|NCT00487747|58683160|FG000|Overall Study|Lack of Efficacy|1|||
30669326|NCT00487435|58683164|FG000|Overall Study|Adverse Event|146|||
30669327|NCT00487435|58683164|FG000|Overall Study|Death|2|||
30669328|NCT00487435|58683164|FG000|Overall Study|Lack of Efficacy|33|||
30669329|NCT00487435|58683164|FG000|Overall Study|Lost to Follow-up|54|||
30669330|NCT00487435|58683164|FG000|Overall Study|Pregnancy|2|||
30669331|NCT00487435|58683164|FG000|Overall Study|Withdrawal by Subject|132|||
30669332|NCT00487435|58683164|FG000|Overall Study|Resolution Of Pain|1|||
30669333|NCT00487435|58683164|FG000|Overall Study|Study Medication Non-Compliant|32|||
30669334|NCT00487435|58683164|FG000|Overall Study|Other|83|||
30669335|NCT00487279|58683170|FG000|Overall Study|Death|1|||
30583647|NCT01305577|58595051|FG001|Overall Study|Adverse Event|2|||
30583648|NCT01305577|58595052|FG002|Overall Study|Adverse Event|1|||
30583649|NCT01305577|58595050|FG000|Overall Study|Withdrawal by Subject|7|||
30583650|NCT01305577|58595051|FG001|Overall Study|Withdrawal by Subject|5|||
30583651|NCT01305577|58595052|FG002|Overall Study|Withdrawal by Subject|6|||
30583652|NCT01305577|58595050|FG000|Overall Study|Lost to Follow-up|4|||
30583653|NCT01305577|58595051|FG001|Overall Study|Lost to Follow-up|3|||
30583654|NCT01305577|58595052|FG002|Overall Study|Lost to Follow-up|2|||
30583655|NCT01305577|58595050|FG000|Overall Study|Protocol Deviation|0|||
30583656|NCT01305577|58595051|FG001|Overall Study|Protocol Deviation|1|||
30583657|NCT01305577|58595052|FG002|Overall Study|Protocol Deviation|1|||
30583658|NCT01304329|58595060|FG000|Third Intervention (3 Days)|Adverse Event|0|||
30583659|NCT01304329|58595061|FG001|Third Intervention (3 Days)|Adverse Event|1|||
30583660|NCT01304329|58595062|FG002|Third Intervention (3 Days)|Adverse Event|0|||
30669336|NCT00487279|58683171|FG001|Overall Study|Death|0|||
30669337|NCT00487279|58683170|FG000|Overall Study|Withdrawal by Subject|0|||
30669338|NCT00487279|58683171|FG001|Overall Study|Withdrawal by Subject|2|||
30669339|NCT00495625|58683177|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
30669340|NCT00847626|58683192|FG000|Overall Study|Adverse Event|10|||
30669341|NCT00847626|58683193|FG001|Overall Study|Adverse Event|10|||
30669342|NCT00847626|58683194|FG002|Overall Study|Adverse Event|6|||
30958771|NCT01692119|59023983|FG001|Overall Study|Protocol Violation|1|||
30583661|NCT01304329|58595063|FG003|Third Intervention (3 Days)|Adverse Event|0|||
30583662|NCT01304329|58595064|FG004|Third Intervention (3 Days)|Adverse Event|0|||
30583663|NCT01304329|58595065|FG005|Third Intervention (3 Days)|Adverse Event|0|||
30583664|NCT01303861|58595078|FG000|Overall Study|Lost to Follow-up|34|||
30583665|NCT01303861|58595079|FG001|Overall Study|Lost to Follow-up|14|||
30583666|NCT01303861|58595080|FG002|Overall Study|Lost to Follow-up|27|||
30583667|NCT01303861|58595081|FG003|Overall Study|Lost to Follow-up|31|||
30583668|NCT01303861|58595078|FG000|Overall Study|Lack of Efficacy|3|||
30583669|NCT01303861|58595079|FG001|Overall Study|Lack of Efficacy|2|||
30583670|NCT01303861|58595080|FG002|Overall Study|Lack of Efficacy|1|||
30583671|NCT01303861|58595081|FG003|Overall Study|Lack of Efficacy|0|||
30669343|NCT00847626|58683195|FG003|Overall Study|Adverse Event|19|||
30669344|NCT00847626|58683196|FG004|Overall Study|Adverse Event|11|||
30669345|NCT00847626|58683197|FG005|Overall Study|Adverse Event|22|||
30669346|NCT00847626|58683198|FG006|Overall Study|Adverse Event|4|||
30669347|NCT00847626|58683199|FG007|Overall Study|Adverse Event|6|||
30669348|NCT00847626|58683200|FG008|Overall Study|Adverse Event|3|||
30669349|NCT00847626|58683201|FG009|Overall Study|Adverse Event|6|||
30669350|NCT00847626|58683202|FG010|Overall Study|Adverse Event|6|||
30669351|NCT00847626|58683192|FG000|Overall Study|Protocol Violation|2|||
30669352|NCT00847626|58683193|FG001|Overall Study|Protocol Violation|1|||
30669353|NCT00847626|58683194|FG002|Overall Study|Protocol Violation|2|||
30669354|NCT00847626|58683195|FG003|Overall Study|Protocol Violation|1|||
30669355|NCT00847626|58683196|FG004|Overall Study|Protocol Violation|1|||
30669356|NCT00847626|58683197|FG005|Overall Study|Protocol Violation|1|||
30669357|NCT00847626|58683198|FG006|Overall Study|Protocol Violation|1|||
30669358|NCT00847626|58683199|FG007|Overall Study|Protocol Violation|1|||
30669359|NCT00847626|58683200|FG008|Overall Study|Protocol Violation|0|||
30669360|NCT00847626|58683201|FG009|Overall Study|Protocol Violation|1|||
30669361|NCT00847626|58683202|FG010|Overall Study|Protocol Violation|1|||
30669362|NCT00847626|58683192|FG000|Overall Study|Lost to Follow-up|0|||
30669363|NCT00847626|58683193|FG001|Overall Study|Lost to Follow-up|1|||
30669364|NCT00847626|58683194|FG002|Overall Study|Lost to Follow-up|1|||
30583672|NCT01303861|58595078|FG000|Overall Study|Withdrawal by Subject|16|||
30669365|NCT00847626|58683195|FG003|Overall Study|Lost to Follow-up|1|||
30669366|NCT00847626|58683196|FG004|Overall Study|Lost to Follow-up|0|||
30669367|NCT00847626|58683197|FG005|Overall Study|Lost to Follow-up|3|||
30669368|NCT00847626|58683198|FG006|Overall Study|Lost to Follow-up|1|||
30669369|NCT00847626|58683199|FG007|Overall Study|Lost to Follow-up|3|||
30669370|NCT00847626|58683200|FG008|Overall Study|Lost to Follow-up|1|||
30669371|NCT00847626|58683201|FG009|Overall Study|Lost to Follow-up|0|||
30669372|NCT00847626|58683202|FG010|Overall Study|Lost to Follow-up|1|||
30669373|NCT00847626|58683192|FG000|Overall Study|Withdrawal by Subject|5|||
30669374|NCT00847626|58683193|FG001|Overall Study|Withdrawal by Subject|5|||
30669375|NCT00847626|58683194|FG002|Overall Study|Withdrawal by Subject|3|||
30669376|NCT00847626|58683195|FG003|Overall Study|Withdrawal by Subject|8|||
30669377|NCT00847626|58683196|FG004|Overall Study|Withdrawal by Subject|12|||
30669378|NCT00847626|58683197|FG005|Overall Study|Withdrawal by Subject|9|||
30669379|NCT00847626|58683198|FG006|Overall Study|Withdrawal by Subject|8|||
30669380|NCT00847626|58683199|FG007|Overall Study|Withdrawal by Subject|4|||
30669381|NCT00847626|58683200|FG008|Overall Study|Withdrawal by Subject|4|||
30669382|NCT00847626|58683201|FG009|Overall Study|Withdrawal by Subject|5|||
30583673|NCT01303861|58595079|FG001|Overall Study|Withdrawal by Subject|8|||
30583674|NCT01303861|58595080|FG002|Overall Study|Withdrawal by Subject|8|||
30583675|NCT01303861|58595081|FG003|Overall Study|Withdrawal by Subject|23|||
30583676|NCT01303861|58595078|FG000|Overall Study|Adverse Event|4|||
30583677|NCT01303861|58595079|FG001|Overall Study|Adverse Event|1|||
30583678|NCT01303861|58595080|FG002|Overall Study|Adverse Event|0|||
30583679|NCT01303861|58595081|FG003|Overall Study|Adverse Event|5|||
30583680|NCT01303861|58595078|FG000|Overall Study|Pregnancy|1|||
30583681|NCT01303861|58595079|FG001|Overall Study|Pregnancy|0|||
30583682|NCT01303861|58595080|FG002|Overall Study|Pregnancy|0|||
30583683|NCT01303861|58595081|FG003|Overall Study|Pregnancy|0|||
30583684|NCT01303627|58595094|FG000|Overall Study|the failure while performing URS|0|||
30583685|NCT01303627|58595095|FG001|Overall Study|the failure while performing URS|1|||
30583686|NCT01303510|58595103|FG000|Overall Study|Lost to Follow-up|1|||
30583687|NCT01303510|58595104|FG001|Overall Study|Lost to Follow-up|0|||
30583688|NCT01303159|58595110|FG000|Overall Study|Death|16|||
30583689|NCT01303159|58595110|FG000|Overall Study|Study Termination|7|||
30583690|NCT01302964|58595116|FG000|Overall Study|Adverse Event|1|||
30583691|NCT01302964|58595117|FG001|Overall Study|Adverse Event|0|||
30583692|NCT01302691|58595125|FG000|Overall Study|Adverse Event|2|||
30583693|NCT01302691|58595126|FG001|Overall Study|Adverse Event|0|||
30583694|NCT01302691|58595125|FG000|Overall Study|Death|0|||
30583695|NCT01302691|58595126|FG001|Overall Study|Death|1|||
30583696|NCT01302691|58595125|FG000|Overall Study|Lost to Follow-up|1|||
30583697|NCT01302691|58595126|FG001|Overall Study|Lost to Follow-up|0|||
30583698|NCT01302691|58595125|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
30583699|NCT01302691|58595126|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
30583700|NCT01302691|58595125|FG000|Overall Study|Physician Decision|0|||
30583701|NCT01302691|58595126|FG001|Overall Study|Physician Decision|1|||
30669383|NCT00847626|58683202|FG010|Overall Study|Withdrawal by Subject|2|||
30669384|NCT00847626|58683192|FG000|Overall Study|Lack of Efficacy|3|||
30583702|NCT01302691|58595125|FG000|Overall Study|Protocol Violation|1|||
30583703|NCT01302691|58595126|FG001|Overall Study|Protocol Violation|0|||
30583704|NCT01302418|58595132|FG000|Overall Study|Protocol Violation|9|||
30583705|NCT01302418|58595132|FG000|Overall Study|Non-evaluable|9|||
30669385|NCT00847626|58683193|FG001|Overall Study|Lack of Efficacy|1|||
30669386|NCT00847626|58683194|FG002|Overall Study|Lack of Efficacy|0|||
30669387|NCT00847626|58683195|FG003|Overall Study|Lack of Efficacy|1|||
30669388|NCT00847626|58683196|FG004|Overall Study|Lack of Efficacy|2|||
30669389|NCT00847626|58683197|FG005|Overall Study|Lack of Efficacy|0|||
30669390|NCT00847626|58683198|FG006|Overall Study|Lack of Efficacy|6|||
30669391|NCT00847626|58683199|FG007|Overall Study|Lack of Efficacy|2|||
30669392|NCT00847626|58683200|FG008|Overall Study|Lack of Efficacy|5|||
30583706|NCT01302067|58595139|FG000|Overall Study|Death|0|||
30583707|NCT01302067|58595140|FG001|Overall Study|Death|0|||
30583708|NCT01302067|58595141|FG002|Overall Study|Death|1|||
30583709|NCT01302067|58595139|FG000|Overall Study|Physician Decision|9|||
30583710|NCT01302067|58595140|FG001|Overall Study|Physician Decision|5|||
30583711|NCT01302067|58595141|FG002|Overall Study|Physician Decision|14|||
30583712|NCT01302067|58595139|FG000|Overall Study|Lack of Efficacy|8|||
30583713|NCT01302067|58595140|FG001|Overall Study|Lack of Efficacy|4|||
30583714|NCT01302067|58595141|FG002|Overall Study|Lack of Efficacy|2|||
30583715|NCT01302067|58595139|FG000|Overall Study|Lost to Follow-up|9|||
30583716|NCT01302067|58595140|FG001|Overall Study|Lost to Follow-up|4|||
30583717|NCT01302067|58595141|FG002|Overall Study|Lost to Follow-up|15|||
30583718|NCT01302067|58595139|FG000|Overall Study|Withdrawal by Subject|13|||
30583719|NCT01302067|58595140|FG001|Overall Study|Withdrawal by Subject|6|||
30583720|NCT01302067|58595141|FG002|Overall Study|Withdrawal by Subject|10|||
30583721|NCT01302067|58595139|FG000|Overall Study|Other|1|||
30583722|NCT01302067|58595140|FG001|Overall Study|Other|1|||
30583723|NCT01302067|58595141|FG002|Overall Study|Other|3|||
30583724|NCT01302067|58595139|FG000|Overall Study|Protocol Violation|11|||
30583725|NCT01302067|58595140|FG001|Overall Study|Protocol Violation|0|||
30583726|NCT01302067|58595141|FG002|Overall Study|Protocol Violation|8|||
30583727|NCT01302067|58595139|FG000|Overall Study|Adverse Event|27|||
30583728|NCT01302067|58595140|FG001|Overall Study|Adverse Event|14|||
30583729|NCT01302067|58595141|FG002|Overall Study|Adverse Event|45|||
30583730|NCT01301950|58595151|FG000|Overall Study|Surgery was cancelled by patient|0|||
30583731|NCT01301950|58595152|FG001|Overall Study|Surgery was cancelled by patient|1|||
30583732|NCT01301833|58595162|FG000|Overall Study|Adverse Event|7|||
30583733|NCT01301833|58595163|FG001|Overall Study|Adverse Event|5|||
30583734|NCT01301833|58595164|FG002|Overall Study|Adverse Event|5|||
30583735|NCT01301833|58595165|FG003|Overall Study|Adverse Event|5|||
30583736|NCT01301833|58595162|FG000|Overall Study|Lack of Efficacy|1|||
30669393|NCT00847626|58683201|FG009|Overall Study|Lack of Efficacy|1|||
30669394|NCT00847626|58683202|FG010|Overall Study|Lack of Efficacy|7|||
30669395|NCT00847626|58683192|FG000|Overall Study|Other|1|||
30669396|NCT00847626|58683193|FG001|Overall Study|Other|5|||
30669397|NCT00847626|58683194|FG002|Overall Study|Other|4|||
30669398|NCT00847626|58683195|FG003|Overall Study|Other|1|||
30669399|NCT00847626|58683196|FG004|Overall Study|Other|2|||
30669400|NCT00847626|58683197|FG005|Overall Study|Other|2|||
30669401|NCT00847626|58683198|FG006|Overall Study|Other|2|||
30669402|NCT00847626|58683199|FG007|Overall Study|Other|3|||
30669403|NCT00847626|58683200|FG008|Overall Study|Other|1|||
30669404|NCT00847626|58683201|FG009|Overall Study|Other|1|||
30669405|NCT00847626|58683202|FG010|Overall Study|Other|3|||
30669406|NCT00851682|58683231|FG000|Overall Study|screen failure|5|||
30669407|NCT00851682|58683232|FG001|Overall Study|screen failure|0|||
30669408|NCT00860262|58683241|FG000|Overall Study|Adverse Event|9|||
30669409|NCT00860262|58683242|FG001|Overall Study|Adverse Event|6|||
30669410|NCT00860262|58683243|FG002|Overall Study|Adverse Event|7|||
30669411|NCT00860262|58683241|FG000|Overall Study|Protocol Violation|0|||
30669412|NCT00860262|58683242|FG001|Overall Study|Protocol Violation|1|||
30669413|NCT00860262|58683243|FG002|Overall Study|Protocol Violation|0|||
30669414|NCT00860262|58683241|FG000|Overall Study|Lost to Follow-up|2|||
30669415|NCT00860262|58683242|FG001|Overall Study|Lost to Follow-up|0|||
30669416|NCT00860262|58683243|FG002|Overall Study|Lost to Follow-up|1|||
30669417|NCT00860262|58683241|FG000|Overall Study|Withdrawal by Subject|4|||
30669418|NCT00860262|58683242|FG001|Overall Study|Withdrawal by Subject|8|||
30669419|NCT00860262|58683243|FG002|Overall Study|Withdrawal by Subject|6|||
30669420|NCT00860262|58683241|FG000|Overall Study|Lack of Efficacy|0|||
30669421|NCT00860262|58683242|FG001|Overall Study|Lack of Efficacy|4|||
30669422|NCT00860262|58683243|FG002|Overall Study|Lack of Efficacy|3|||
30669423|NCT00860262|58683241|FG000|Overall Study|Other|5|||
30669424|NCT00860262|58683242|FG001|Overall Study|Other|3|||
30669425|NCT00860262|58683243|FG002|Overall Study|Other|1|||
30669426|NCT00860028|58683255|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
30583737|NCT01301833|58595163|FG001|Overall Study|Lack of Efficacy|1|||
30583738|NCT01301833|58595164|FG002|Overall Study|Lack of Efficacy|0|||
30583739|NCT01301833|58595165|FG003|Overall Study|Lack of Efficacy|0|||
30583740|NCT01301833|58595162|FG000|Overall Study|Physician Decision|3|||
30583741|NCT01301833|58595163|FG001|Overall Study|Physician Decision|1|||
30583742|NCT01301833|58595164|FG002|Overall Study|Physician Decision|1|||
30583743|NCT01301833|58595165|FG003|Overall Study|Physician Decision|0|||
30583744|NCT01301833|58595162|FG000|Overall Study|Withdrawal by Subject|3|||
30669427|NCT00860028|58683256|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
30669428|NCT00859638|58683266|FG000|Overall Study|Lost to Follow-up|6|||
30669429|NCT00859638|58683267|FG001|Overall Study|Lost to Follow-up|1|||
30669430|NCT00859638|58683266|FG000|Overall Study|Withdrawal by Subject|3|||
30669431|NCT00859638|58683267|FG001|Overall Study|Withdrawal by Subject|2|||
30669432|NCT00859638|58683266|FG000|Overall Study|Ill health|1|||
30669433|NCT00859638|58683267|FG001|Overall Study|Ill health|1|||
30669434|NCT00846846|58683273|FG000|Overall Study|Death|56|||
30669435|NCT00846846|58683273|FG000|Overall Study|Withdrawal by Subject|19|||
30669436|NCT00846768|58683277|FG000|Overall Study|Adverse Event|0|||
30669437|NCT00846768|58683278|FG001|Overall Study|Adverse Event|1|||
30583745|NCT01301833|58595163|FG001|Overall Study|Withdrawal by Subject|1|||
30583746|NCT01301833|58595164|FG002|Overall Study|Withdrawal by Subject|1|||
30583747|NCT01301833|58595165|FG003|Overall Study|Withdrawal by Subject|2|||
30583748|NCT01301833|58595162|FG000|Overall Study|Personal matter|1|||
30583749|NCT01301833|58595163|FG001|Overall Study|Personal matter|0|||
30583750|NCT01301833|58595164|FG002|Overall Study|Personal matter|0|||
30583751|NCT01301833|58595165|FG003|Overall Study|Personal matter|0|||
30583752|NCT01301092|58595178|FG000|Overall Study|Lost to Follow-up|0|||
30583753|NCT01301092|58595179|FG001|Overall Study|Lost to Follow-up|0|||
30583754|NCT01301092|58595180|FG002|Overall Study|Lost to Follow-up|1|||
30583755|NCT01300819|58595195|FG000|Overall Study|Adverse Event|9|||
30583756|NCT01300819|58595196|FG001|Overall Study|Adverse Event|27|||
30583757|NCT01300819|58595195|FG000|Overall Study|Lack of Efficacy|2|||
30583758|NCT01300819|58595196|FG001|Overall Study|Lack of Efficacy|1|||
30583759|NCT01300819|58595195|FG000|Overall Study|Withdrawal by Subject|10|||
30583760|NCT01300819|58595196|FG001|Overall Study|Withdrawal by Subject|12|||
30583761|NCT01300819|58595195|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
30583762|NCT01300819|58595196|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
30583763|NCT01300819|58595195|FG000|Overall Study|Refusal to down titrate study drug|0|||
30583764|NCT01300819|58595196|FG001|Overall Study|Refusal to down titrate study drug|1|||
30583765|NCT01300819|58595195|FG000|Overall Study|Administrative reason|0|||
30583766|NCT01300819|58595196|FG001|Overall Study|Administrative reason|1|||
30583767|NCT01300819|58595195|FG000|Overall Study|Safety follow up not done by mistake|0|||
30583768|NCT01300819|58595196|FG001|Overall Study|Safety follow up not done by mistake|1|||
30583769|NCT01300819|58595195|FG000|Overall Study|Follow up call was not done|1|||
30583770|NCT01300819|58595196|FG001|Overall Study|Follow up call was not done|0|||
30583771|NCT01300741|58595202|FG000|Overall Study|Lens deposits|1|||
30583772|NCT01300741|58595202|FG000|Overall Study|Lost to Follow-up|1|||
30583773|NCT01300741|58595202|FG000|Overall Study|Discomfort|1|||
30583774|NCT01300546|58595210|FG000|Overall Study|Withdrawal by Subject|1|||
30583775|NCT01300546|58595211|FG001|Overall Study|Withdrawal by Subject|0|||
30583776|NCT01300546|58595210|FG000|Overall Study|Lost to Follow-up|0|||
30583777|NCT01300546|58595211|FG001|Overall Study|Lost to Follow-up|2|||
30583778|NCT01300546|58595210|FG000|Overall Study|Lack of Efficacy|0|||
30583779|NCT01300546|58595211|FG001|Overall Study|Lack of Efficacy|3|||
30583780|NCT01300546|58595210|FG000|Overall Study|Adverse Event|0|||
30583781|NCT01300546|58595211|FG001|Overall Study|Adverse Event|1|||
30583782|NCT01300351|58595219|FG000|Overall Study|Did not receive treatment|2|||
30583783|NCT01300351|58595220|FG001|Overall Study|Did not receive treatment|0|||
30583784|NCT01300351|58595219|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
30583785|NCT01300351|58595220|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
30583786|NCT01300351|58595219|FG000|Overall Study|Lost to Follow-up|0|||
30583787|NCT01300351|58595220|FG001|Overall Study|Lost to Follow-up|1|||
30583788|NCT01300351|58595219|FG000|Overall Study|Adverse Event|0|||
30583789|NCT01300351|58595220|FG001|Overall Study|Adverse Event|4|||
30669438|NCT00846768|58683279|FG002|Overall Study|Adverse Event|0|||
30669439|NCT00846768|58683280|FG003|Overall Study|Adverse Event|0|||
30669440|NCT00863798|58683293|FG000|Overall Study|Adverse Event|5|||
30669441|NCT00863798|58683294|FG001|Overall Study|Adverse Event|2|||
30669442|NCT00863798|58683295|FG002|Overall Study|Adverse Event|4|||
30669443|NCT00863798|58683293|FG000|Overall Study|Participant failed to return|2|||
30669444|NCT00863798|58683294|FG001|Overall Study|Participant failed to return|1|||
30669445|NCT00863798|58683295|FG002|Overall Study|Participant failed to return|0|||
30669446|NCT00863798|58683293|FG000|Overall Study|Investigator request|1|||
30669447|NCT00863798|58683294|FG001|Overall Study|Investigator request|2|||
30669448|NCT00863798|58683295|FG002|Overall Study|Investigator request|1|||
30669449|NCT00863798|58683293|FG000|Overall Study|Lack of Efficacy|4|||
30669450|NCT00863798|58683294|FG001|Overall Study|Lack of Efficacy|3|||
30669451|NCT00863798|58683295|FG002|Overall Study|Lack of Efficacy|6|||
30669452|NCT00863798|58683293|FG000|Overall Study|Lost to Follow-up|6|||
30669453|NCT00863798|58683294|FG001|Overall Study|Lost to Follow-up|9|||
30583790|NCT01300351|58595219|FG000|Overall Study|Withdrawal by Subject|7|||
30583791|NCT01300351|58595220|FG001|Overall Study|Withdrawal by Subject|10|||
30583792|NCT01300234|58595228|FG000|Overall Study|Adverse Event|1|||
30583793|NCT01300234|58595229|FG001|Overall Study|Adverse Event|1|||
30583794|NCT01300234|58595228|FG000|Overall Study|Protocol Violation|2|||
30583795|NCT01300234|58595229|FG001|Overall Study|Protocol Violation|3|||
30583796|NCT01300234|58595228|FG000|Overall Study|Withdrawal by Subject|5|||
30583797|NCT01300234|58595229|FG001|Overall Study|Withdrawal by Subject|9|||
30583798|NCT01300234|58595228|FG000|Overall Study|Lost to Follow-up|14|||
30583799|NCT01300234|58595229|FG001|Overall Study|Lost to Follow-up|12|||
30583800|NCT01300234|58595228|FG000|Overall Study|Pregnancy|2|||
30669454|NCT00863798|58683295|FG002|Overall Study|Lost to Follow-up|5|||
30669455|NCT00863798|58683293|FG000|Overall Study|Other|2|||
30669456|NCT00863798|58683294|FG001|Overall Study|Other|3|||
30669457|NCT00863798|58683295|FG002|Overall Study|Other|1|||
30669458|NCT00863798|58683293|FG000|Overall Study|Protocol Violation|0|||
30583801|NCT01300234|58595229|FG001|Overall Study|Pregnancy|1|||
30583802|NCT01300234|58595228|FG000|Overall Study|Participant reached stopping critera|2|||
30583803|NCT01300234|58595229|FG001|Overall Study|Participant reached stopping critera|0|||
30583804|NCT01300234|58595228|FG000|Overall Study|Participant stopped medication|1|||
30583805|NCT01300234|58595229|FG001|Overall Study|Participant stopped medication|1|||
30583806|NCT01300234|58595228|FG000|Overall Study|Participant refused return to hospital|1|||
30669459|NCT00863798|58683294|FG001|Overall Study|Protocol Violation|1|||
30669460|NCT00863798|58683295|FG002|Overall Study|Protocol Violation|1|||
30669461|NCT00863798|58683293|FG000|Overall Study|Withdrawal by Subject|8|||
30669462|NCT00863798|58683294|FG001|Overall Study|Withdrawal by Subject|7|||
30669463|NCT00863798|58683295|FG002|Overall Study|Withdrawal by Subject|4|||
30669464|NCT00863798|58683293|FG000|Overall Study|Randomized not treated|4|||
30669465|NCT00863798|58683294|FG001|Overall Study|Randomized not treated|2|||
30669466|NCT00863798|58683295|FG002|Overall Study|Randomized not treated|3|||
30669467|NCT00859014|58683303|FG000|Overall Study|Death|4|||
30669468|NCT00859014|58683303|FG000|Overall Study|Lost to Follow-up|1|||
30669469|NCT00593606|58683307|FG000|Overall Study|Adverse Event|13|||
30669470|NCT00593606|58683307|FG000|Overall Study|Withdrawal by Subject|1|||
30669471|NCT00593606|58683307|FG000|Overall Study|Protocol Violation|3|||
30669472|NCT00593606|58683307|FG000|Overall Study|Lost to Follow-up|2|||
30669473|NCT00593606|58683307|FG000|Overall Study|Run-In Failure|5|||
30669474|NCT00593606|58683307|FG000|Overall Study|Screen Failure|3|||
30669475|NCT00870584|58683313|FG000|Overall Study|Adverse Event|3|||
30669476|NCT00870584|58683314|FG001|Overall Study|Adverse Event|3|||
30669477|NCT00870584|58683313|FG000|Overall Study|Withdrawal by Subject|6|||
30669478|NCT00870584|58683314|FG001|Overall Study|Withdrawal by Subject|7|||
30669479|NCT00870584|58683313|FG000|Overall Study|Lost to Follow-up|5|||
30669480|NCT00870584|58683314|FG001|Overall Study|Lost to Follow-up|1|||
30669481|NCT00870584|58683313|FG000|Overall Study|Protocol Deviation|2|||
30669482|NCT00870584|58683314|FG001|Overall Study|Protocol Deviation|2|||
30669483|NCT00870194|58683322|FG000|Overall Study|Adverse Event|10|||
30669484|NCT00870194|58683323|FG001|Overall Study|Adverse Event|5|||
30669485|NCT00870194|58683322|FG000|Overall Study|Lack of Efficacy|0|||
30669486|NCT00870194|58683323|FG001|Overall Study|Lack of Efficacy|1|||
30669487|NCT00870194|58683322|FG000|Overall Study|Lost to Follow-up|2|||
30669488|NCT00870194|58683323|FG001|Overall Study|Lost to Follow-up|0|||
30669489|NCT00870194|58683322|FG000|Overall Study|Physician Decision|3|||
30669490|NCT00870194|58683323|FG001|Overall Study|Physician Decision|1|||
30669491|NCT00870194|58683322|FG000|Overall Study|Protocol Violation|3|||
30669492|NCT00870194|58683323|FG001|Overall Study|Protocol Violation|3|||
30669493|NCT00870194|58683322|FG000|Overall Study|Entry Criteria Not Met|1|||
30669494|NCT00870194|58683323|FG001|Overall Study|Entry Criteria Not Met|2|||
30669495|NCT00870194|58683322|FG000|Overall Study|Subject Decision|7|||
30669496|NCT00870194|58683323|FG001|Overall Study|Subject Decision|2|||
30669497|NCT00690430|58683331|FG000|Core Phase|Abnormal Laboratory value|0|||
30669498|NCT00690430|58683332|FG001|Core Phase|Abnormal Laboratory value|1|||
30669499|NCT00690430|58683333|FG002|Core Phase|Abnormal Laboratory value|0|||
30669500|NCT00690430|58683331|FG000|Core Phase|Adverse Event|5|||
30669501|NCT00690430|58683332|FG001|Core Phase|Adverse Event|1|||
30669502|NCT00690430|58683333|FG002|Core Phase|Adverse Event|0|||
30669503|NCT00690430|58683331|FG000|Core Phase|Death|0|||
30669504|NCT00690430|58683332|FG001|Core Phase|Death|2|||
30669505|NCT00690430|58683333|FG002|Core Phase|Death|0|||
30669506|NCT00690430|58683331|FG000|Core Phase|Protocol Violation|1|||
30669507|NCT00690430|58683332|FG001|Core Phase|Protocol Violation|0|||
30669508|NCT00690430|58683333|FG002|Core Phase|Protocol Violation|0|||
30669509|NCT00690430|58683331|FG000|Core Phase|Withdrawal by Subject|3|||
30669510|NCT00690430|58683332|FG001|Core Phase|Withdrawal by Subject|3|||
30669511|NCT00690430|58683333|FG002|Core Phase|Withdrawal by Subject|0|||
30669512|NCT00690430|58683331|FG000|Core Phase|Subject no longer requires study drug|1|||
30669513|NCT00690430|58683332|FG001|Core Phase|Subject no longer requires study drug|0|||
30669514|NCT00690430|58683333|FG002|Core Phase|Subject no longer requires study drug|0|||
30669515|NCT00690430|58683331|FG000|Core Phase|Lack of Efficacy|8|||
30669516|NCT00690430|58683332|FG001|Core Phase|Lack of Efficacy|10|||
30669517|NCT00690430|58683333|FG002|Core Phase|Lack of Efficacy|0|||
30669518|NCT00690430|58683331|FG000|Core Phase|Administrative Problems|0|||
30669519|NCT00690430|58683332|FG001|Core Phase|Administrative Problems|1|||
30583807|NCT01300234|58595229|FG001|Overall Study|Participant refused return to hospital|0|||
30583808|NCT01299961|58595246|FG000|Overall Study|Adverse Event|3|||
30669520|NCT00690430|58683333|FG002|Core Phase|Administrative Problems|0|||
30583809|NCT01299961|58595246|FG000|Overall Study|Lack of Efficacy|2|||
30583810|NCT01299961|58595246|FG000|Overall Study|Lost to Follow-up|1|||
30669521|NCT00690430|58683331|FG000|Core Phase|Early Termination|0|||
30669522|NCT00690430|58683332|FG001|Core Phase|Early Termination|5|||
30669523|NCT00690430|58683333|FG002|Core Phase|Early Termination|0|||
30669524|NCT00690430|58683331|FG000|Extension Phase|Lack of Efficacy|3|||
30669525|NCT00690430|58683332|FG001|Extension Phase|Lack of Efficacy|1|||
30669526|NCT00690430|58683333|FG002|Extension Phase|Lack of Efficacy|4|||
30669527|NCT00690430|58683331|FG000|Extension Phase|Abnormal Lab Values|1|||
30669528|NCT00690430|58683332|FG001|Extension Phase|Abnormal Lab Values|0|||
30583811|NCT01299805|58595252|FG000|Overall Study|Adverse Event|2|||
30583812|NCT01299805|58595253|FG001|Overall Study|Adverse Event|0|||
30583813|NCT01299766|58595261|FG000|Overall Study|Death|5|||
30583814|NCT01299766|58595262|FG001|Overall Study|Death|4|||
30583815|NCT01299766|58595261|FG000|Overall Study|Withdrawal by Subject|29|||
30583816|NCT01299766|58595262|FG001|Overall Study|Withdrawal by Subject|19|||
30583817|NCT01299727|58595271|FG000|Overall Study|Withdrawal by Subject|1|||
30583818|NCT01299727|58595272|FG001|Overall Study|Withdrawal by Subject|0|||
30583819|NCT01299727|58595273|FG002|Overall Study|Withdrawal by Subject|0|||
30583820|NCT01299727|58595271|FG000|Overall Study|Adverse Event|0|||
30583821|NCT01299727|58595272|FG001|Overall Study|Adverse Event|0|||
30583822|NCT01299727|58595273|FG002|Overall Study|Adverse Event|1|||
30583823|NCT01299727|58595271|FG000|Overall Study|Completed the Treatment Period|3|||
30583824|NCT01299727|58595272|FG001|Overall Study|Completed the Treatment Period|4|||
30583825|NCT01299727|58595273|FG002|Overall Study|Completed the Treatment Period|3|||
30583826|NCT01299571|58595281|FG000|Overall Study|Protocol Violation|107|||
30669529|NCT00690430|58683333|FG002|Extension Phase|Abnormal Lab Values|0|||
30669530|NCT00690430|58683331|FG000|Extension Phase|Abnormal test procedure results|1|||
30669531|NCT00690430|58683332|FG001|Extension Phase|Abnormal test procedure results|0|||
30669532|NCT00690430|58683333|FG002|Extension Phase|Abnormal test procedure results|0|||
30669533|NCT00690430|58683331|FG000|Extension Phase|Administrative Problems|0|||
30669534|NCT00690430|58683332|FG001|Extension Phase|Administrative Problems|1|||
30669535|NCT00690430|58683333|FG002|Extension Phase|Administrative Problems|1|||
30669536|NCT00690430|58683331|FG000|Extension Phase|Adverse Event|2|||
30669537|NCT00690430|58683332|FG001|Extension Phase|Adverse Event|1|||
30669538|NCT00690430|58683333|FG002|Extension Phase|Adverse Event|2|||
30669539|NCT00690430|58683331|FG000|Extension Phase|Death|1|||
30669540|NCT00690430|58683332|FG001|Extension Phase|Death|1|||
30669541|NCT00690430|58683333|FG002|Extension Phase|Death|1|||
30669542|NCT00690430|58683331|FG000|Extension Phase|Withdrawal by Subject|0|||
30669543|NCT00690430|58683332|FG001|Extension Phase|Withdrawal by Subject|0|||
30583827|NCT01299376|58595288|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
30583828|NCT01299376|58595289|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
30583829|NCT01299376|58595288|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
30583830|NCT01299376|58595289|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
30583831|NCT01299376|58595288|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
30583832|NCT01299376|58595289|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
30583833|NCT01299376|58595288|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
30583834|NCT01299376|58595289|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
30583835|NCT01299376|58595288|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
30583836|NCT01299376|58595289|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
30583837|NCT01299376|58595288|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
30583838|NCT01299376|58595289|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
30583839|NCT01299376|58595288|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
30583840|NCT01299376|58595289|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
30583841|NCT01299376|58595288|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
30583842|NCT01299376|58595289|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
30583843|NCT01299376|58595288|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
30583844|NCT01299376|58595289|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
30583845|NCT01299376|58595288|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
30583846|NCT01299376|58595289|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
30583847|NCT01299376|58595288|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
30583848|NCT01299376|58595289|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
30583849|NCT01299025|58595301|FG000|Overall Study|Withdrawal by Subject|2|||
30583850|NCT01299025|58595302|FG001|Overall Study|Withdrawal by Subject|1|||
30583851|NCT01299025|58595301|FG000|Overall Study|Lost to Follow-up|1|||
30583852|NCT01299025|58595302|FG001|Overall Study|Lost to Follow-up|0|||
30583853|NCT01298596|58595310|FG000|Overall Study|Withdrawal by Subject|1|||
30583854|NCT01298596|58595311|FG001|Overall Study|Withdrawal by Subject|1|||
30583855|NCT01298596|58595310|FG000|Overall Study|Death|5|||
30583856|NCT01298596|58595311|FG001|Overall Study|Death|3|||
30669544|NCT00690430|58683333|FG002|Extension Phase|Withdrawal by Subject|2|||
30780970|NCT02971228|58793100|FG004|Overall Study|Logistical challenges|0|||
30583857|NCT01298596|58595310|FG000|Overall Study|Lost to Follow-up|6|||
30583858|NCT01298596|58595311|FG001|Overall Study|Lost to Follow-up|14|||
30583859|NCT01298596|58595310|FG000|Overall Study|Referred for further management|16|||
30583860|NCT01298596|58595311|FG001|Overall Study|Referred for further management|15|||
30583861|NCT01298518|58595320|FG000|Overall Study|Withdrawal by Subject|0|||
30583862|NCT01298518|58595321|FG001|Overall Study|Withdrawal by Subject|0|||
30583863|NCT01298518|58595322|FG002|Overall Study|Withdrawal by Subject|1|||
30583864|NCT01298362|58595332|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
30669545|NCT00690430|58683331|FG000|Extension Phase|Early Termination|10|||
30669546|NCT00690430|58683332|FG001|Extension Phase|Early Termination|1|||
30583865|NCT01298362|58595333|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
30583866|NCT01298323|58595343|FG000|Overall Study|Adverse Event|2|||
30583867|NCT01298323|58595344|FG001|Overall Study|Adverse Event|4|||
30583868|NCT01298323|58595343|FG000|Overall Study|Death|11|||
30583869|NCT01298323|58595344|FG001|Overall Study|Death|16|||
30583870|NCT01298323|58595343|FG000|Overall Study|Lost to Follow-up|1|||
30583871|NCT01298323|58595344|FG001|Overall Study|Lost to Follow-up|0|||
30583872|NCT01298323|58595343|FG000|Overall Study|Withdrawal by Subject|6|||
30583873|NCT01298323|58595344|FG001|Overall Study|Withdrawal by Subject|3|||
30583874|NCT01298323|58595343|FG000|Overall Study|Protocol Violation|1|||
30583875|NCT01298323|58595344|FG001|Overall Study|Protocol Violation|0|||
30583876|NCT01298323|58595343|FG000|Overall Study|Other|10|||
30583877|NCT01298323|58595344|FG001|Overall Study|Other|9|||
30583878|NCT01298323|58595343|FG000|Overall Study|Ongoing|55|||
30583879|NCT01298323|58595344|FG001|Overall Study|Ongoing|55|||
30583880|NCT01298323|58595343|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30583881|NCT01298323|58595344|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
30583882|NCT01297504|58595350|FG000|Overall Study|Invalid Consent|1|||
30583883|NCT01297504|58595350|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
30583884|NCT01297504|58595350|FG000|Overall Study|No Study Visits|4|||
30583885|NCT01297504|58595350|FG000|Overall Study|Death|3|||
30583886|NCT01297504|58595350|FG000|Overall Study|Lost to Follow-up|43|||
30583887|NCT01297504|58595350|FG000|Overall Study|Withdrawal by Subject|9|||
30583888|NCT01297504|58595350|FG000|Overall Study|Site Closure|3|||
30583889|NCT01297504|58595350|FG000|Overall Study|Protocol Violation|3|||
30583890|NCT01297465|58595360|FG000|Overall Study|Lack of Ovarian Response|1|||
30583891|NCT01297465|58595361|FG001|Overall Study|Lack of Ovarian Response|1|||
30583892|NCT01297465|58595360|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
30583893|NCT01297465|58595361|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
30583894|NCT01297465|58595360|FG000|Overall Study|No Oocytes Retrieved|1|||
30583895|NCT01297465|58595361|FG001|Overall Study|No Oocytes Retrieved|1|||
30583896|NCT01297465|58595360|FG000|Overall Study|Poor oocyte quality|0|||
30583897|NCT01297465|58595361|FG001|Overall Study|Poor oocyte quality|1|||
30583898|NCT01297465|58595360|FG000|Overall Study|No Fertilization|6|||
30583899|NCT01297465|58595361|FG001|Overall Study|No Fertilization|4|||
30583900|NCT01297465|58595360|FG000|Overall Study|All Embryos Discarded|0|||
30583901|NCT01297465|58595361|FG001|Overall Study|All Embryos Discarded|1|||
30583902|NCT01297465|58595360|FG000|Overall Study|Intention to Freeze all Embryos|0|||
30583903|NCT01297465|58595361|FG001|Overall Study|Intention to Freeze all Embryos|1|||
30583904|NCT01297309|58595367|FG000|Overall Study|Eligibility failure|2|||
30583905|NCT01297309|58595367|FG000|Overall Study|Screen failure|2|||
30583906|NCT01297309|58595367|FG000|Overall Study|Withdrawal by Subject|5|||
30583907|NCT01297309|58595367|FG000|Overall Study|Adverse Event|1|||
30583908|NCT01297309|58595367|FG000|Overall Study|Investigator Decision|2|||
30583909|NCT01297309|58595367|FG000|Overall Study|Death|1|||
30583910|NCT01297309|58595367|FG000|Overall Study|Participant not entering extensionperiod|1|||
30583911|NCT04518462|58595374|FG000|Overall Study|Withdrawal by Subject|0|||
30583912|NCT04518462|58595375|FG001|Overall Study|Withdrawal by Subject|0|||
30583913|NCT04518462|58595376|FG002|Overall Study|Withdrawal by Subject|1|||
30583914|NCT04518462|58595374|FG000|Overall Study|Physician Decision|1|||
30583915|NCT04518462|58595375|FG001|Overall Study|Physician Decision|1|||
30583916|NCT04518462|58595376|FG002|Overall Study|Physician Decision|0|||
30583917|NCT01297270|58595387|FG000|Overall Study|Adverse Event|19|||
30583918|NCT01297270|58595388|FG001|Overall Study|Adverse Event|32|||
30583919|NCT01297270|58595389|FG002|Overall Study|Adverse Event|5|||
30583920|NCT01297270|58595387|FG000|Overall Study|Lack of Efficacy|15|||
30583921|NCT01297270|58595388|FG001|Overall Study|Lack of Efficacy|17|||
30583922|NCT01297270|58595389|FG002|Overall Study|Lack of Efficacy|15|||
30583923|NCT01297270|58595387|FG000|Overall Study|Lost to Follow-up|1|||
30583924|NCT01297270|58595388|FG001|Overall Study|Lost to Follow-up|2|||
30583925|NCT01297270|58595389|FG002|Overall Study|Lost to Follow-up|1|||
30583926|NCT01297270|58595387|FG000|Overall Study|Protocol Violation|0|||
30583927|NCT01297270|58595388|FG001|Overall Study|Protocol Violation|2|||
30583928|NCT01297270|58595389|FG002|Overall Study|Protocol Violation|0|||
30583929|NCT01297270|58595387|FG000|Overall Study|Withdrawal by Subject|7|||
30583930|NCT01297270|58595388|FG001|Overall Study|Withdrawal by Subject|15|||
30583931|NCT01297270|58595389|FG002|Overall Study|Withdrawal by Subject|7|||
30583932|NCT01297270|58595387|FG000|Overall Study|Other reason not defined above|3|||
30583933|NCT01297270|58595388|FG001|Overall Study|Other reason not defined above|3|||
30583934|NCT01297270|58595389|FG002|Overall Study|Other reason not defined above|1|||
30583935|NCT01297270|58595387|FG000|Overall Study|Not treated|0|||
30583936|NCT01297270|58595388|FG001|Overall Study|Not treated|1|||
30583937|NCT01297270|58595389|FG002|Overall Study|Not treated|0|||
30583938|NCT01296568|58595397|FG000|Continued Access Phase|Lost to Follow-up|1|||
30583939|NCT01296568|58595397|FG000|Continued Access Phase|Withdrawal by Subject|1|||
30583940|NCT01296568|58595397|FG000|Continued Access Phase|Disease Progression|1|||
30583941|NCT01296412|58595405|FG000|Overall Study|Adverse Event|8|||
30583942|NCT01296412|58595406|FG001|Overall Study|Adverse Event|29|||
30583943|NCT01296412|58595405|FG000|Overall Study|Lack of Efficacy|1|||
30583944|NCT01296412|58595406|FG001|Overall Study|Lack of Efficacy|0|||
30583945|NCT01296412|58595405|FG000|Overall Study|Lost to Follow-up|10|||
30583946|NCT01296412|58595406|FG001|Overall Study|Lost to Follow-up|7|||
30583947|NCT01296412|58595405|FG000|Overall Study|Non-compliance with study drug|1|||
30583948|NCT01296412|58595406|FG001|Overall Study|Non-compliance with study drug|2|||
30583949|NCT01296412|58595405|FG000|Overall Study|Other reason not specified|20|||
30583950|NCT01296412|58595406|FG001|Overall Study|Other reason not specified|15|||
30583951|NCT01296412|58595405|FG000|Overall Study|Physician Decision|1|||
30583952|NCT01296412|58595406|FG001|Overall Study|Physician Decision|3|||
30583953|NCT01296412|58595405|FG000|Overall Study|Pregnancy|0|||
30583954|NCT01296412|58595406|FG001|Overall Study|Pregnancy|1|||
30583955|NCT01296412|58595405|FG000|Overall Study|Withdrawal by Subject|10|||
30583956|NCT01296412|58595406|FG001|Overall Study|Withdrawal by Subject|13|||
30583957|NCT01295905|58595414|FG000|Overall Study|Did not meet inclusion criteria|1|||
30583958|NCT01295905|58595415|FG001|Overall Study|Did not meet inclusion criteria|0|||
30583959|NCT01295905|58595414|FG000|Overall Study|Met exclusion criteria|1|||
30583960|NCT01295905|58595415|FG001|Overall Study|Met exclusion criteria|0|||
30583961|NCT02596035|58595424|FG000|Overall Study|Disease Progression|64|||
30583962|NCT02596035|58595425|FG001|Overall Study|Disease Progression|32|||
30583963|NCT02596035|58595426|FG002|Overall Study|Disease Progression|1|||
30583964|NCT02596035|58595424|FG000|Overall Study|study drug toxicity|12|||
30583965|NCT02596035|58595425|FG001|Overall Study|study drug toxicity|3|||
30583966|NCT02596035|58595426|FG002|Overall Study|study drug toxicity|0|||
30583967|NCT02596035|58595424|FG000|Overall Study|AE unrelated to study drug|5|||
30583968|NCT02596035|58595425|FG001|Overall Study|AE unrelated to study drug|2|||
30583969|NCT02596035|58595426|FG002|Overall Study|AE unrelated to study drug|0|||
30583970|NCT02596035|58595424|FG000|Overall Study|participant request to discontinue study treatment|2|||
30583971|NCT02596035|58595425|FG001|Overall Study|participant request to discontinue study treatment|0|||
30583972|NCT02596035|58595426|FG002|Overall Study|participant request to discontinue study treatment|0|||
30583973|NCT02596035|58595424|FG000|Overall Study|participant withdrew consent|2|||
30583974|NCT02596035|58595425|FG001|Overall Study|participant withdrew consent|2|||
30583975|NCT02596035|58595426|FG002|Overall Study|participant withdrew consent|0|||
30583976|NCT02596035|58595424|FG000|Overall Study|Poor/Non Comlpiance|0|||
30583977|NCT02596035|58595425|FG001|Overall Study|Poor/Non Comlpiance|1|||
30583978|NCT02596035|58595426|FG002|Overall Study|Poor/Non Comlpiance|0|||
30583979|NCT02596035|58595424|FG000|Overall Study|participant no longer meets study criteria|1|||
30583980|NCT02596035|58595425|FG001|Overall Study|participant no longer meets study criteria|0|||
30583981|NCT02596035|58595426|FG002|Overall Study|participant no longer meets study criteria|0|||
30583982|NCT02596035|58595424|FG000|Overall Study|other reasons|11|||
30583983|NCT02596035|58595425|FG001|Overall Study|other reasons|4|||
30583984|NCT02596035|58595426|FG002|Overall Study|other reasons|0|||
30583985|NCT02595372|58595435|FG000|Overall Study|Adverse Event|6|||
30583986|NCT02595372|58595435|FG000|Overall Study|Physician Decision|2|||
30669547|NCT00690430|58683333|FG002|Extension Phase|Early Termination|3|||
30669548|NCT00863330|58683342|FG000|Overall Study|study terminated early due to administra|6|||
30669549|NCT00688324|58683346|FG000|Overall Study|Withdrawal by Subject|2|||
30669550|NCT00688324|58683346|FG000|Overall Study|Physician Decision|5|||
30669551|NCT00688324|58683346|FG000|Overall Study|Lost to Follow-up|1|||
30669552|NCT00862940|58683353|FG000|Overall Study|Adverse Event|15|||
30669553|NCT00862940|58683354|FG001|Overall Study|Adverse Event|12|||
30669554|NCT00862940|58683353|FG000|Overall Study|Lack of Efficacy|1|||
30669555|NCT00862940|58683354|FG001|Overall Study|Lack of Efficacy|3|||
30669556|NCT00862940|58683353|FG000|Overall Study|Protocol Violation|2|||
30669557|NCT00862940|58683354|FG001|Overall Study|Protocol Violation|5|||
30669558|NCT00862940|58683353|FG000|Overall Study|Withdrawal by Subject|4|||
30669559|NCT00862940|58683354|FG001|Overall Study|Withdrawal by Subject|6|||
30669560|NCT00862940|58683353|FG000|Overall Study|Non-compliance|4|||
30669561|NCT00862940|58683354|FG001|Overall Study|Non-compliance|0|||
30669562|NCT00862940|58683353|FG000|Overall Study|Lost to Follow-up|0|||
30583987|NCT02595372|58595435|FG000|Overall Study|Disease Progression|1|||
30583988|NCT01248962|58595455|FG000|Overall Study|Withdrawal by Subject|1|||
30583989|NCT01248962|58595456|FG001|Overall Study|Withdrawal by Subject|1|||
30583990|NCT01248962|58595455|FG000|Overall Study|Adverse Event|2|||
30583991|NCT01248962|58595456|FG001|Overall Study|Adverse Event|1|||
30583992|NCT01248962|58595455|FG000|Overall Study|Complete Response after 4 Cycles|1|||
30583993|NCT01248962|58595456|FG001|Overall Study|Complete Response after 4 Cycles|0|||
30583994|NCT01248962|58595455|FG000|Overall Study|Complete Response after 3 Cycles|0|||
30583995|NCT01248962|58595456|FG001|Overall Study|Complete Response after 3 Cycles|1|||
30583996|NCT01248962|58595455|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
30583997|NCT01248962|58595456|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
30583998|NCT01248455|58595463|FG000|Overall Study|switched to alternate treatment|1|||
30583999|NCT01247090|58595470|FG000|Overall Study|Physician Decision|1|||
30669563|NCT00862940|58683354|FG001|Overall Study|Lost to Follow-up|1|||
30669564|NCT00862940|58683353|FG000|Overall Study|Administrative or other reason(s)|4|||
30669565|NCT00862940|58683354|FG001|Overall Study|Administrative or other reason(s)|3|||
30584000|NCT01247090|58595471|FG001|Overall Study|Physician Decision|0|||
30584001|NCT01247090|58595472|FG002|Overall Study|Physician Decision|0|||
30584002|NCT01247090|58595470|FG000|Overall Study|Withdrawal by Subject|0|||
30584003|NCT01247090|58595471|FG001|Overall Study|Withdrawal by Subject|1|||
30584004|NCT01247090|58595472|FG002|Overall Study|Withdrawal by Subject|0|||
30584005|NCT01249664|58595482|FG000|Overall Study|Withdrawal by Subject|5|||
30584006|NCT01249664|58595483|FG001|Overall Study|Withdrawal by Subject|0|||
30584007|NCT01249664|58595482|FG000|Overall Study|Adverse Event|1|||
30584008|NCT01249664|58595483|FG001|Overall Study|Adverse Event|0|||
30584009|NCT01249274|58595493|FG000|Overall Study|Lost to Follow-up|3|||
30584010|NCT01249274|58595494|FG001|Overall Study|Lost to Follow-up|4|||
30584011|NCT01249274|58595493|FG000|Overall Study|Received inpatient substance treatment|1|||
30584012|NCT01249274|58595494|FG001|Overall Study|Received inpatient substance treatment|2|||
30584013|NCT01249157|58595502|FG000|Overall Study|Withdrawal by Subject|1|||
30584014|NCT01249118|58595506|FG000|First Washout Period|Physician Decision|0|||
30584015|NCT01249118|58595507|FG001|First Washout Period|Physician Decision|1|||
30584016|NCT01249118|58595508|FG002|First Washout Period|Physician Decision|0|||
30584017|NCT01248884|58595518|FG000|Overall Study|Withdrawal by Subject|1|||
30584018|NCT01248884|58595519|FG001|Overall Study|Withdrawal by Subject|3|||
30584019|NCT01248884|58595520|FG002|Overall Study|Withdrawal by Subject|1|||
30584020|NCT01248884|58595518|FG000|Overall Study|Adverse Event|1|||
30584021|NCT01248884|58595519|FG001|Overall Study|Adverse Event|0|||
30584022|NCT01248884|58595520|FG002|Overall Study|Adverse Event|0|||
30584023|NCT01248728|58595532|FG000|Overall Study|Adverse Event|1|||
30584024|NCT01248728|58595533|FG001|Overall Study|Adverse Event|1|||
30584025|NCT01248728|58595532|FG000|Overall Study|Withdrawal by Subject|2|||
30584026|NCT01248728|58595533|FG001|Overall Study|Withdrawal by Subject|1|||
30584027|NCT01248728|58595532|FG000|Overall Study|Lack of Efficacy|1|||
30584028|NCT01248728|58595533|FG001|Overall Study|Lack of Efficacy|0|||
30584029|NCT01246973|58595543|FG000|Overall Study|Other|38|||
30584030|NCT01246973|58595544|FG001|Overall Study|Other|25|||
30584031|NCT01246973|58595543|FG000|Overall Study|Adverse Event|16|||
30584032|NCT01246973|58595544|FG001|Overall Study|Adverse Event|9|||
30584033|NCT01246973|58595543|FG000|Overall Study|Withdrawal by Subject|7|||
30584034|NCT01246973|58595544|FG001|Overall Study|Withdrawal by Subject|13|||
30584035|NCT01246466|58595550|FG000|Overall Study|Death|1|||
30584036|NCT01246466|58595550|FG000|Overall Study|Withdrawal by Subject|1|||
30584037|NCT01245764|58595559|FG000|Study Phase A|Other|3|||
30584038|NCT01245764|58595560|FG001|Study Phase A|Other|2|||
30584039|NCT01245764|58595561|FG002|Study Phase A|Other|3|||
30584040|NCT01245764|58595562|FG003|Study Phase A|Other|1|||
30584041|NCT01245764|58595559|FG000|Study Phase A|Protocol Violation|6|||
30584042|NCT01245764|58595560|FG001|Study Phase A|Protocol Violation|3|||
30584043|NCT01245764|58595561|FG002|Study Phase A|Protocol Violation|2|||
30584044|NCT01245764|58595562|FG003|Study Phase A|Protocol Violation|2|||
30584045|NCT01245764|58595559|FG000|Study Phase A|Lost to Follow-up|0|||
30584046|NCT01245764|58595560|FG001|Study Phase A|Lost to Follow-up|0|||
30584047|NCT01245764|58595561|FG002|Study Phase A|Lost to Follow-up|5|||
30584048|NCT01245764|58595562|FG003|Study Phase A|Lost to Follow-up|0|||
30584049|NCT01245140|58595582|FG000|Overall Study|Adverse Event|1|||
30584050|NCT01245140|58595583|FG001|Overall Study|Adverse Event|3|||
30584051|NCT01245140|58595582|FG000|Overall Study|Lack of Efficacy|2|||
30584052|NCT01245140|58595583|FG001|Overall Study|Lack of Efficacy|4|||
30584053|NCT01245140|58595582|FG000|Overall Study|Protocol Violation|0|||
30584054|NCT01245140|58595583|FG001|Overall Study|Protocol Violation|1|||
30584055|NCT01245140|58595582|FG000|Overall Study|Withdrawal by Subject|0|||
30584056|NCT01245140|58595583|FG001|Overall Study|Withdrawal by Subject|1|||
30584057|NCT01245140|58595582|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
30584058|NCT01245140|58595583|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
30584059|NCT01245101|58595591|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
30584060|NCT01245101|58595592|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
30584061|NCT01245101|58595591|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
30584062|NCT01245101|58595592|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
30584063|NCT01245101|58595591|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
30584064|NCT01245101|58595592|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
30584065|NCT01245062|58595600|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
30584066|NCT01245062|58595601|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
30584067|NCT01245062|58595602|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
30584068|NCT01245062|58595600|FG000|Randomization and Crossover Phase|Physician Decision|2|||
30855689|NCT02761915|58883354|FG005|Overall Study|Disease Progression|2|||
30584069|NCT01245062|58595601|FG001|Randomization and Crossover Phase|Physician Decision|4|||
30584070|NCT01245062|58595602|FG002|Randomization and Crossover Phase|Physician Decision|0|||
30584071|NCT01245062|58595600|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
30584072|NCT01245062|58595601|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
30584073|NCT01245062|58595602|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
30584074|NCT01245062|58595600|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
30584075|NCT01245062|58595601|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
30584076|NCT01245062|58595602|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
30584077|NCT01245062|58595600|FG000|Cross-over Phase|Lost to Follow-up|0|||
30584078|NCT01245062|58595601|FG001|Cross-over Phase|Lost to Follow-up|0|||
30584079|NCT01245062|58595602|FG002|Cross-over Phase|Lost to Follow-up|1|||
30584080|NCT01245062|58595600|FG000|Cross-over Phase|Physician Decision|0|||
30584081|NCT01245062|58595601|FG001|Cross-over Phase|Physician Decision|0|||
30584082|NCT01245062|58595602|FG002|Cross-over Phase|Physician Decision|1|||
30584083|NCT01245062|58595600|FG000|Cross-over Phase|Withdrew Consent|0|||
30584084|NCT01245062|58595601|FG001|Cross-over Phase|Withdrew Consent|0|||
30584085|NCT01245062|58595602|FG002|Cross-over Phase|Withdrew Consent|4|||
30584086|NCT01245062|58595600|FG000|Cross-over Phase|Study closed/ terminated|0|||
30584087|NCT01245062|58595601|FG001|Cross-over Phase|Study closed/ terminated|0|||
30584088|NCT01245062|58595602|FG002|Cross-over Phase|Study closed/ terminated|11|||
30584089|NCT01244984|58595613|FG000|Overall Study|Adverse Event|2|||
30584090|NCT01244984|58595614|FG001|Overall Study|Adverse Event|11|||
30584091|NCT01244984|58595615|FG002|Overall Study|Adverse Event|2|||
30584092|NCT01244984|58595613|FG000|Overall Study|Protocol Violation|1|||
30584093|NCT01244984|58595614|FG001|Overall Study|Protocol Violation|0|||
30584094|NCT01244984|58595615|FG002|Overall Study|Protocol Violation|0|||
30584095|NCT01244984|58595613|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
30584096|NCT01244984|58595614|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
30958772|NCT01692119|59023982|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
30958773|NCT01692119|59023983|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
30958774|NCT01691885|59023989|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
30958775|NCT01691885|59023990|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
30958776|NCT01691885|59023989|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
30958777|NCT01691885|59023990|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
30958778|NCT01587703|59024023|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
30958779|NCT01587703|59024024|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958780|NCT01587703|59024025|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30584097|NCT01244984|58595615|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
30584098|NCT01244984|58595613|FG000|Overall Study|Withdrawal by Subject|1|||
30584099|NCT01244984|58595614|FG001|Overall Study|Withdrawal by Subject|2|||
30584100|NCT01244984|58595615|FG002|Overall Study|Withdrawal by Subject|2|||
30584101|NCT01244516|58595627|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
30584102|NCT01244516|58595628|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
30584103|NCT01244516|58595629|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
30584104|NCT01244516|58595627|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
30584105|NCT01244516|58595628|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
30584106|NCT01244516|58595629|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
30584107|NCT01244516|58595627|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
30584108|NCT01244516|58595628|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
30584109|NCT01244516|58595629|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
30584110|NCT01244516|58595627|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
30584111|NCT01244516|58595628|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
30584112|NCT01244516|58595629|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
30584113|NCT01244516|58595627|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
30584114|NCT01244516|58595628|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
30584115|NCT01244516|58595629|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
30584116|NCT01244516|58595627|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
30584117|NCT01244516|58595628|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
30584118|NCT01244516|58595629|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
30584119|NCT01244516|58595627|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
30584120|NCT01244516|58595628|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
30584121|NCT01244516|58595629|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
30584122|NCT01244126|58595641|FG000|Overall Study|Protocol Violation|3|||
30584123|NCT01244126|58595642|FG001|Overall Study|Protocol Violation|3|||
30584124|NCT01244126|58595643|FG002|Overall Study|Protocol Violation|9|||
30584125|NCT01243892|58595653|FG000|Overall Study|Did not meet eligibility criteria|2|||
30584126|NCT01243892|58595654|FG001|Overall Study|Did not meet eligibility criteria|0|||
30584127|NCT01243775|58595660|FG000|Overall Study|Withdrawal by Subject|2|||
30584128|NCT01243268|58595664|FG000|Overall Study|Lost to Follow-up|4|||
30584129|NCT01243268|58595664|FG000|Overall Study|Protocol Violation|51|||
30584130|NCT01243268|58595664|FG000|Overall Study|Deviation with contract date|7|||
30584131|NCT01243268|58595664|FG000|Overall Study|Duplicate subject|2|||
30584132|NCT01242371|58595670|FG000|Overall Study|Withdrawal by Subject|2|||
30584133|NCT01242371|58595671|FG001|Overall Study|Withdrawal by Subject|2|||
30584134|NCT01242371|58595670|FG000|Overall Study|Protocol Violation|0|||
30584135|NCT01242371|58595671|FG001|Overall Study|Protocol Violation|3|||
30669566|NCT00868166|58683362|FG000|Overall Study|Death|58|||
30669567|NCT00868166|58683363|FG001|Overall Study|Death|65|||
30584136|NCT01242176|58595677|FG000|Washout Period of 7 Days|Adverse Event|0|||
30584137|NCT01242176|58595678|FG001|Washout Period of 7 Days|Adverse Event|2|||
30584138|NCT01242176|58595677|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
30584139|NCT01242176|58595678|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
30584140|NCT01242020|58595686|FG000|Overall Study|Withdrawal by Subject|2|||
30584141|NCT01242020|58595687|FG001|Overall Study|Withdrawal by Subject|0|||
30584142|NCT01242020|58595686|FG000|Overall Study|Failed screening|1|||
30584143|NCT01242020|58595687|FG001|Overall Study|Failed screening|0|||
30584144|NCT01241786|58595693|FG000|Overall Study|Lack of Efficacy|5|||
30584145|NCT01241318|58595700|FG000|Overall Study|Woman: false pregnancies|27|||
30584146|NCT01241318|58595701|FG001|Overall Study|Woman: false pregnancies|15|||
30584147|NCT01241318|58595700|FG000|Overall Study|Woman: miscarriage/abortion|46|||
30584148|NCT01241318|58595701|FG001|Overall Study|Woman: miscarriage/abortion|38|||
30855690|NCT02706327|58883375|FG000|Overall Study|Lost to Follow-up|1|||
30584149|NCT01241318|58595700|FG000|Overall Study|Withdrawal by Subject|175|||
30584150|NCT01241318|58595701|FG001|Overall Study|Withdrawal by Subject|46|||
30584151|NCT01241318|58595700|FG000|Overall Study|Lost to Follow-up|740|||
30584152|NCT01241318|58595701|FG001|Overall Study|Lost to Follow-up|455|||
30584153|NCT01241318|58595700|FG000|Overall Study|Death|2|||
30584154|NCT01241318|58595701|FG001|Overall Study|Death|4|||
30584155|NCT01241318|58595700|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
30584156|NCT01241318|58595701|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
30584157|NCT01241318|58595700|FG000|Overall Study|Woman: Stillborn infant|129|||
30584158|NCT01241318|58595701|FG001|Overall Study|Woman: Stillborn infant|146|||
30584159|NCT01241279|58595712|FG000|Overall Study|Lost to Follow-up|0|||
30584160|NCT01241279|58595713|FG001|Overall Study|Lost to Follow-up|1|||
30584161|NCT01241240|58595721|FG000|Overall Study|Adverse Event|5|||
30584162|NCT01241240|58595722|FG001|Overall Study|Adverse Event|4|||
30584163|NCT01241240|58595721|FG000|Overall Study|Lost to Follow-up|2|||
30584164|NCT01241240|58595722|FG001|Overall Study|Lost to Follow-up|4|||
30584165|NCT01241240|58595721|FG000|Overall Study|Personal Reasons|1|||
30584166|NCT01241240|58595722|FG001|Overall Study|Personal Reasons|1|||
30584167|NCT01240811|58595731|FG000|Overall Study|Physician Decision|0|||
30584168|NCT01240811|58595732|FG001|Overall Study|Physician Decision|1|||
30584169|NCT01240811|58595733|FG002|Overall Study|Physician Decision|0|||
30584170|NCT01240811|58595731|FG000|Overall Study|Withdrawal by Subject|0|||
30584171|NCT01240811|58595732|FG001|Overall Study|Withdrawal by Subject|0|||
30584172|NCT01240811|58595733|FG002|Overall Study|Withdrawal by Subject|1|||
30584173|NCT01240382|58595745|FG000|Overall Study|Adverse Event|2|||
30584174|NCT01240382|58595746|FG001|Overall Study|Adverse Event|1|||
30584175|NCT01240382|58595745|FG000|Overall Study|Lack of Efficacy|0|||
30584176|NCT01240382|58595746|FG001|Overall Study|Lack of Efficacy|2|||
30584177|NCT01240382|58595745|FG000|Overall Study|Fear of adverse events|0|||
30584178|NCT01240382|58595746|FG001|Overall Study|Fear of adverse events|1|||
30584179|NCT01244828|58595752|FG000|Overall Study|Adverse Event|37|||
30584180|NCT01244828|58595752|FG000|Overall Study|Withdrawal by Subject|31|||
30584181|NCT01244828|58595752|FG000|Overall Study|Lack of Efficacy|7|||
30584182|NCT01244828|58595752|FG000|Overall Study|Lost to Follow-up|2|||
30584183|NCT01244828|58595752|FG000|Overall Study|Other reason (not specified)|1|||
30584184|NCT01249833|58595758|FG000|Overall Study|Lost to Follow-up|0|||
30584185|NCT01249833|58595759|FG001|Overall Study|Lost to Follow-up|1|||
30584186|NCT01249404|58595768|FG000|Overall Study|Study treatment not received|0|||
30584187|NCT01249404|58595769|FG001|Overall Study|Study treatment not received|1|||
30584188|NCT01249404|58595770|FG002|Overall Study|Study treatment not received|2|||
30584189|NCT01249404|58595768|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
30669568|NCT00868166|58683362|FG000|Overall Study|Withdrawal by Subject|33|||
30669569|NCT00868166|58683363|FG001|Overall Study|Withdrawal by Subject|25|||
30669570|NCT00868166|58683362|FG000|Overall Study|Protocol Violation|1|||
30669571|NCT00868166|58683363|FG001|Overall Study|Protocol Violation|0|||
30669572|NCT00868166|58683362|FG000|Overall Study|Lost to Follow-up|1|||
30669573|NCT00868166|58683363|FG001|Overall Study|Lost to Follow-up|3|||
30669574|NCT00868166|58683362|FG000|Overall Study|Adverse Event|9|||
30669575|NCT00868166|58683363|FG001|Overall Study|Adverse Event|10|||
30584190|NCT01249404|58595769|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
30584191|NCT01249404|58595770|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
30584192|NCT01249404|58595768|FG000|Overall Study|Adverse Event|2|||
30584193|NCT01249404|58595769|FG001|Overall Study|Adverse Event|2|||
30669576|NCT00868166|58683362|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
30669577|NCT00868166|58683363|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
30584194|NCT01249404|58595770|FG002|Overall Study|Adverse Event|2|||
30584195|NCT01249404|58595768|FG000|Overall Study|Withdrawal by Subject|2|||
30584196|NCT01249404|58595769|FG001|Overall Study|Withdrawal by Subject|2|||
30584197|NCT01249404|58595770|FG002|Overall Study|Withdrawal by Subject|0|||
30584198|NCT01249404|58595768|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
30584199|NCT01249404|58595769|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
30669578|NCT00868166|58683362|FG000|Overall Study|Non-compliance with IMP|1|||
30584200|NCT01249404|58595770|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
30584201|NCT01249404|58595768|FG000|Overall Study|Non compliance to visit schedule|0|||
30584202|NCT01249404|58595769|FG001|Overall Study|Non compliance to visit schedule|1|||
30669579|NCT00868166|58683363|FG001|Overall Study|Non-compliance with IMP|1|||
30669580|NCT00858780|58683369|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
30669581|NCT00858780|58683370|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
30669582|NCT00858780|58683371|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
30669583|NCT00858780|58683372|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
30669584|NCT00858780|58683373|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
30669585|NCT00858780|58683369|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
30669586|NCT00858780|58683370|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
30669587|NCT00858780|58683371|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
30669588|NCT00858780|58683372|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
30669589|NCT00858780|58683373|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
30669590|NCT00858780|58683369|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
30669591|NCT00858780|58683370|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
30669592|NCT00858780|58683371|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
30669593|NCT00858780|58683372|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
30669594|NCT00858780|58683373|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
30584203|NCT01249404|58595770|FG002|Overall Study|Non compliance to visit schedule|0|||
30584204|NCT01249365|58595778|FG000|Overall Study|Lost to Follow-up|1|||
30584205|NCT01249131|58595782|FG000|Washout Period of 10 Days|Adverse Event|0|||
30584206|NCT01249131|58595783|FG001|Washout Period of 10 Days|Adverse Event|0|||
30584207|NCT01249131|58595784|FG002|Washout Period of 10 Days|Adverse Event|0|||
30584208|NCT01249131|58595785|FG003|Washout Period of 10 Days|Adverse Event|0|||
30584209|NCT01249131|58595786|FG004|Washout Period of 10 Days|Adverse Event|1|||
30584210|NCT01249131|58595787|FG005|Washout Period of 10 Days|Adverse Event|0|||
30584211|NCT01249092|58595795|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
30584212|NCT01249092|58595795|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
30584213|NCT01248936|58595801|FG000|Overall Study|Sponsor Decision|259|||
30584214|NCT01248936|58595801|FG000|Overall Study|Progression of Disease|50|||
30584215|NCT01248936|58595801|FG000|Overall Study|Death|26|||
30584216|NCT01248936|58595801|FG000|Overall Study|Withdrawal of Consent|20|||
30584217|NCT01248936|58595801|FG000|Overall Study|Adverse Event|8|||
30584218|NCT01248936|58595801|FG000|Overall Study|Lost to Follow-up|7|||
30584219|NCT01248936|58595801|FG000|Overall Study|Refused Treatment|1|||
30584220|NCT01248936|58595801|FG000|Overall Study|Other reason|3|||
30584221|NCT01248780|58595808|FG000|Overall Study|Lack of Efficacy|2|||
30584222|NCT01248780|58595809|FG001|Overall Study|Lack of Efficacy|0|||
30584223|NCT01248780|58595808|FG000|Overall Study|Lost to Follow-up|0|||
30584224|NCT01248780|58595809|FG001|Overall Study|Lost to Follow-up|1|||
30584225|NCT01248780|58595808|FG000|Overall Study|Death|0|||
30584226|NCT01248780|58595809|FG001|Overall Study|Death|1|||
30584227|NCT01248780|58595808|FG000|Overall Study|Adverse Event|2|||
30584228|NCT01248780|58595809|FG001|Overall Study|Adverse Event|7|||
30584229|NCT01248780|58595808|FG000|Overall Study|Protocol Violation|1|||
30584230|NCT01248780|58595809|FG001|Overall Study|Protocol Violation|1|||
30584231|NCT01248780|58595808|FG000|Overall Study|Withdrawal by Subject|4|||
30584232|NCT01248780|58595809|FG001|Overall Study|Withdrawal by Subject|4|||
30584233|NCT01248780|58595808|FG000|Overall Study|Not treated|0|||
30584234|NCT01248780|58595809|FG001|Overall Study|Not treated|1|||
30584235|NCT01248468|58595818|FG000|Overall Study|Administrative problem|1|||
30584236|NCT01248468|58595819|FG001|Overall Study|Administrative problem|0|||
30584237|NCT01248468|58595820|FG002|Overall Study|Administrative problem|0|||
30584238|NCT01248468|58595818|FG000|Overall Study|Lost to Follow-up|9|||
30584239|NCT01248468|58595819|FG001|Overall Study|Lost to Follow-up|12|||
30584240|NCT01248468|58595820|FG002|Overall Study|Lost to Follow-up|4|||
30584241|NCT01248468|58595818|FG000|Overall Study|Pregnancy|1|||
30584242|NCT01248468|58595819|FG001|Overall Study|Pregnancy|0|||
30584243|NCT01248468|58595820|FG002|Overall Study|Pregnancy|0|||
30584244|NCT01248468|58595818|FG000|Overall Study|Withdrawal by Subject|4|||
30584245|NCT01248468|58595819|FG001|Overall Study|Withdrawal by Subject|2|||
30584246|NCT01248468|58595820|FG002|Overall Study|Withdrawal by Subject|0|||
30584247|NCT01247922|58595828|FG000|Overall Study|Disease progression|4|||
30584248|NCT01246206|58595832|FG000|Overall Study|Patient did not receive study regiments.|1|||
30584249|NCT01246011|58595839|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
30584250|NCT01246011|58595840|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
30584251|NCT01246011|58595841|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
30584252|NCT01246011|58595839|FG000|Overall Study|Withdrawal by Subject|0|||
30584253|NCT01246011|58595840|FG001|Overall Study|Withdrawal by Subject|0|||
30584254|NCT01246011|58595841|FG002|Overall Study|Withdrawal by Subject|1|||
30584255|NCT01244490|58595853|FG000|Overall Study|Lack of Efficacy|14|||
30584256|NCT01244490|58595854|FG001|Overall Study|Lack of Efficacy|5|||
30584257|NCT01244490|58595855|FG002|Overall Study|Lack of Efficacy|5|||
30584258|NCT01244490|58595853|FG000|Overall Study|Withdrawal by Subject|4|||
30584259|NCT01244490|58595854|FG001|Overall Study|Withdrawal by Subject|4|||
30584260|NCT01244490|58595855|FG002|Overall Study|Withdrawal by Subject|9|||
30584261|NCT01244490|58595853|FG000|Overall Study|Adverse Event|1|||
30584262|NCT01244490|58595854|FG001|Overall Study|Adverse Event|9|||
30584263|NCT01244490|58595855|FG002|Overall Study|Adverse Event|5|||
30584264|NCT01244490|58595853|FG000|Overall Study|Lost to Follow-up|0|||
30584265|NCT01244490|58595854|FG001|Overall Study|Lost to Follow-up|6|||
30584266|NCT01244490|58595855|FG002|Overall Study|Lost to Follow-up|3|||
30584267|NCT01244490|58595853|FG000|Overall Study|Other|0|||
30584268|NCT01244490|58595854|FG001|Overall Study|Other|0|||
30584269|NCT01244490|58595855|FG002|Overall Study|Other|1|||
30584270|NCT01243944|58595865|FG000|Overall Study|Adverse Event|15|||
30584271|NCT01243944|58595866|FG001|Overall Study|Adverse Event|13|||
30584272|NCT01243944|58595865|FG000|Overall Study|Lost to Follow-up|2|||
30584273|NCT01243944|58595866|FG001|Overall Study|Lost to Follow-up|1|||
30584274|NCT01243944|58595865|FG000|Overall Study|Physician Decision|2|||
30584275|NCT01243944|58595866|FG001|Overall Study|Physician Decision|7|||
30584276|NCT01243944|58595865|FG000|Overall Study|Disease progression|12|||
30584277|NCT01243944|58595866|FG001|Overall Study|Disease progression|11|||
30584278|NCT01243944|58595865|FG000|Overall Study|Protocol deviation|1|||
30584279|NCT01243944|58595866|FG001|Overall Study|Protocol deviation|1|||
30584280|NCT01243944|58595865|FG000|Overall Study|Participant decision|10|||
30584281|NCT01243944|58595866|FG001|Overall Study|Participant decision|15|||
30584282|NCT01243944|58595865|FG000|Overall Study|Death|2|||
30584283|NCT01243944|58595866|FG001|Overall Study|Death|3|||
30584284|NCT01243944|58595865|FG000|Overall Study|Non-compliance with study treatment|1|||
30584285|NCT01243944|58595866|FG001|Overall Study|Non-compliance with study treatment|0|||
30584286|NCT01243242|58595875|FG000|Overall Study|Adverse Event|1|||
30584287|NCT01243242|58595876|FG001|Overall Study|Adverse Event|1|||
30584288|NCT01243242|58595875|FG000|Overall Study|Withdrawal by Subject|1|||
30584289|NCT01243242|58595876|FG001|Overall Study|Withdrawal by Subject|1|||
30584290|NCT01243242|58595875|FG000|Overall Study|Physician Decision|0|||
30584291|NCT01243242|58595876|FG001|Overall Study|Physician Decision|1|||
30584292|NCT01243242|58595875|FG000|Overall Study|sponsor decision|0|||
30584293|NCT01243242|58595876|FG001|Overall Study|sponsor decision|1|||
30584294|NCT01243242|58595875|FG000|Overall Study|non compliance|1|||
30669595|NCT00858780|58683369|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
30669596|NCT00858780|58683370|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
30669597|NCT00858780|58683371|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
30669598|NCT00858780|58683372|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
30669599|NCT00858780|58683373|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
30669600|NCT00858780|58683369|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
30669601|NCT00858780|58683370|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
30669602|NCT00858780|58683371|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
30669603|NCT00858780|58683372|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
30669604|NCT00858780|58683373|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
30669605|NCT00858780|58683369|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
30669606|NCT00858780|58683370|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
30669607|NCT00858780|58683371|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
30669608|NCT00858780|58683372|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
30669609|NCT00858780|58683373|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
30669610|NCT00850200|58683383|FG000|Overall Study|Physician Decision|2|||
30669611|NCT00850200|58683383|FG000|Overall Study|Did not recieve treatment|2|||
30669612|NCT00850200|58683383|FG000|Overall Study|Withdrawal by Subject|1|||
30669613|NCT00858234|58683390|FG000|Overall Study|Adverse Event|6|||
30669614|NCT00858234|58683390|FG000|Overall Study|Progressive disease|2|||
30669615|NCT00858234|58683390|FG000|Overall Study|Status unknown|1|||
30669616|NCT00862082|58683396|FG000|Overall Study|Sponsor decision to terminate the study|5|||
30669617|NCT00862082|58683397|FG001|Overall Study|Sponsor decision to terminate the study|0|||
30669618|NCT00862082|58683396|FG000|Overall Study|Withdrawal by Subject|0|||
30669619|NCT00862082|58683397|FG001|Overall Study|Withdrawal by Subject|1|||
30669620|NCT00849186|58683410|FG000|Overall Study|Adverse Event|2|||
30855691|NCT02706327|58883376|FG001|Overall Study|Lost to Follow-up|1|||
30584295|NCT01243242|58595876|FG001|Overall Study|non compliance|0|||
30669621|NCT00849186|58683410|FG000|Overall Study|Withdrawal by Subject|1|||
30584296|NCT01242813|58595882|FG000|Overall Study|Lost to Follow-up|2|||
30584297|NCT01242111|58595886|FG000|Overall Study|Adverse Event|1|||
30584298|NCT01242111|58595886|FG000|Overall Study|Withdrawal by Subject|1|||
30584299|NCT01242111|58595886|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
30584300|NCT01241604|58595890|FG000|Screening Period|Screen Failure|3|||
30584301|NCT01241604|58595891|FG001|Screening Period|Screen Failure|0|||
30584302|NCT01241604|58595892|FG002|Screening Period|Screen Failure|0|||
30584303|NCT01241292|58595901|FG000|Overall Study|Administrative Reason by Sponsor|1|||
30855692|NCT02706327|58883377|FG002|Overall Study|Lost to Follow-up|2|||
30584304|NCT01241292|58595902|FG001|Overall Study|Administrative Reason by Sponsor|0|||
30584305|NCT01241292|58595901|FG000|Overall Study|Disease Progression|2|||
30584306|NCT01241292|58595902|FG001|Overall Study|Disease Progression|0|||
30584307|NCT01241292|58595901|FG000|Overall Study|Study Drug Toxicity|0|||
30584308|NCT01241292|58595902|FG001|Overall Study|Study Drug Toxicity|1|||
30584309|NCT01241292|58595901|FG000|Overall Study|Participant Discontinued Treatment|0|||
30584310|NCT01241292|58595902|FG001|Overall Study|Participant Discontinued Treatment|2|||
30584311|NCT01240863|58595914|FG000|Open-label Titration Period|Adverse Event|47|||
30584312|NCT01240863|58595915|FG001|Open-label Titration Period|Adverse Event|0|||
30584313|NCT01240863|58595916|FG002|Open-label Titration Period|Adverse Event|0|||
30584314|NCT01240863|58595914|FG000|Open-label Titration Period|Lack of Efficacy|19|||
30584315|NCT01240863|58595915|FG001|Open-label Titration Period|Lack of Efficacy|0|||
30669622|NCT00849186|58683410|FG000|Overall Study|not treated|6|||
30669623|NCT00849186|58683410|FG000|Overall Study|Other|1|||
30669624|NCT00692770|58683417|FG000|Overall Study|Protocol Violation|2|||
30669625|NCT00692770|58683418|FG001|Overall Study|Protocol Violation|7|||
30669626|NCT00692770|58683417|FG000|Overall Study|Withdrawal by Subject|97|||
30669627|NCT00692770|58683418|FG001|Overall Study|Withdrawal by Subject|36|||
30669628|NCT00692770|58683417|FG000|Overall Study|Adverse Event|136|||
30669629|NCT00692770|58683418|FG001|Overall Study|Adverse Event|41|||
30669630|NCT00692770|58683417|FG000|Overall Study|Death|10|||
30584316|NCT01240863|58595916|FG002|Open-label Titration Period|Lack of Efficacy|0|||
30584317|NCT01240863|58595914|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
30584318|NCT01240863|58595915|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
30584319|NCT01240863|58595916|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
30584320|NCT01240863|58595914|FG000|Open-label Titration Period|Protocol Violation|7|||
30584321|NCT01240863|58595915|FG001|Open-label Titration Period|Protocol Violation|0|||
30584322|NCT01240863|58595916|FG002|Open-label Titration Period|Protocol Violation|0|||
30584323|NCT01240863|58595914|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
30584324|NCT01240863|58595915|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
30584325|NCT01240863|58595916|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
30584326|NCT01240863|58595914|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
30584327|NCT01240863|58595915|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
30584328|NCT01240863|58595916|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
30584329|NCT01240863|58595914|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
30584330|NCT01240863|58595915|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
30584331|NCT01240863|58595916|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
30584332|NCT01240863|58595914|FG000|Open-label Titration Period|Other|7|||
30584333|NCT01240863|58595915|FG001|Open-label Titration Period|Other|0|||
30584334|NCT01240863|58595916|FG002|Open-label Titration Period|Other|0|||
30584335|NCT01240863|58595914|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
30584336|NCT01240863|58595915|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
30669631|NCT00692770|58683418|FG001|Overall Study|Death|5|||
30669632|NCT00692770|58683417|FG000|Overall Study|Lost to Follow-up|7|||
30669633|NCT00692770|58683418|FG001|Overall Study|Lost to Follow-up|3|||
30669634|NCT00692770|58683417|FG000|Overall Study|Non-compliant with study medication|11|||
30669635|NCT00692770|58683418|FG001|Overall Study|Non-compliant with study medication|5|||
30669636|NCT00692770|58683417|FG000|Overall Study|Progression by clinical judgment|2|||
30669637|NCT00692770|58683418|FG001|Overall Study|Progression by clinical judgment|3|||
30669638|NCT00692770|58683417|FG000|Overall Study|Physician decision not protocol driven|10|||
30669639|NCT00692770|58683418|FG001|Overall Study|Physician decision not protocol driven|14|||
30669640|NCT00692770|58683417|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
30669641|NCT00692770|58683418|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
30669642|NCT00692770|58683417|FG000|Overall Study|Protocol driven decision point|3|||
30669643|NCT00692770|58683418|FG001|Overall Study|Protocol driven decision point|7|||
30669644|NCT00692770|58683417|FG000|Overall Study|Completed all planned assessments|79|||
30669645|NCT00692770|58683418|FG001|Overall Study|Completed all planned assessments|101|||
30669646|NCT00692770|58683417|FG000|Overall Study|Radiological and clinical progression|8|||
30584337|NCT01240863|58595916|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
30669647|NCT00692770|58683418|FG001|Overall Study|Radiological and clinical progression|8|||
30669648|NCT00692770|58683417|FG000|Overall Study|Clinical endpoint reached|16|||
30669649|NCT00692770|58683418|FG001|Overall Study|Clinical endpoint reached|43|||
30669650|NCT00692770|58683417|FG000|Overall Study|Study terminated by sponsor|2|||
30669651|NCT00692770|58683418|FG001|Overall Study|Study terminated by sponsor|2|||
30669652|NCT00692770|58683417|FG000|Overall Study|Randomized but not treated|3|||
30669653|NCT00692770|58683418|FG001|Overall Study|Randomized but not treated|4|||
30669654|NCT00849108|58683433|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
30669655|NCT00849108|58683434|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
30584338|NCT01240863|58595914|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
30584339|NCT01240863|58595915|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
30669656|NCT00849108|58683433|FG000|Cohort 2 Efficacy|Adverse Event|0|||
30669657|NCT00849108|58683434|FG001|Cohort 2 Efficacy|Adverse Event|1|||
30584340|NCT01240863|58595916|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
30584341|NCT01240863|58595914|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
30584342|NCT01240863|58595915|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
30584343|NCT01240863|58595916|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
30584344|NCT01240863|58595914|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
30584345|NCT01240863|58595915|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
30584346|NCT01240863|58595916|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
30584347|NCT01240863|58595914|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
30584348|NCT01240863|58595915|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
30584349|NCT01240863|58595916|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
30584350|NCT01240863|58595914|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
30584351|NCT01240863|58595915|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
30584352|NCT01240863|58595916|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
30584353|NCT01240863|58595914|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
30584354|NCT01240863|58595915|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
30584355|NCT01240863|58595916|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
30584356|NCT01240863|58595914|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
30584357|NCT01240863|58595915|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
30584358|NCT01240863|58595916|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
30584359|NCT01240746|58595931|FG000|Overall Study|Adverse Event|2|||
30584360|NCT01240746|58595932|FG001|Overall Study|Adverse Event|0|||
30584361|NCT01240746|58595933|FG002|Overall Study|Adverse Event|10|||
30584362|NCT01240746|58595931|FG000|Overall Study|Lost to Follow-up|23|||
30584363|NCT01240746|58595932|FG001|Overall Study|Lost to Follow-up|20|||
30584364|NCT01240746|58595933|FG002|Overall Study|Lost to Follow-up|102|||
30584365|NCT01240746|58595931|FG000|Overall Study|Protocol Violation|24|||
30584366|NCT01240746|58595932|FG001|Overall Study|Protocol Violation|15|||
30584367|NCT01240746|58595933|FG002|Overall Study|Protocol Violation|72|||
30584368|NCT01240746|58595931|FG000|Overall Study|Withdrawal by Subject|10|||
30584369|NCT01240746|58595932|FG001|Overall Study|Withdrawal by Subject|13|||
30584370|NCT01240746|58595933|FG002|Overall Study|Withdrawal by Subject|59|||
30584371|NCT01240590|58595946|FG000|Phase I|Refused further treatment|0|||
30584372|NCT01240590|58595947|FG001|Phase I|Refused further treatment|0|||
30584373|NCT01240590|58595948|FG002|Phase I|Refused further treatment|3|||
30584374|NCT01240590|58595949|FG003|Phase I|Refused further treatment|0|||
30584375|NCT01240590|58595950|FG004|Phase I|Refused further treatment|0|||
30669658|NCT00849108|58683433|FG000|Cohort 2 Efficacy|Other|0|||
30584376|NCT01240590|58595946|FG000|Phase II|Refused further treatment|0|||
30584377|NCT01240590|58595947|FG001|Phase II|Refused further treatment|0|||
30584378|NCT01240590|58595948|FG002|Phase II|Refused further treatment|0|||
30584379|NCT01240590|58595949|FG003|Phase II|Refused further treatment|2|||
30584380|NCT01240590|58595950|FG004|Phase II|Refused further treatment|1|||
30584381|NCT01240200|58595978|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
30584382|NCT01240200|58595979|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
30584383|NCT01356966|58595990|FG000|Overall Study|Withdrawal by Subject|1|||
30584384|NCT01356966|58595991|FG001|Overall Study|Withdrawal by Subject|2|||
30584385|NCT01356966|58595990|FG000|Overall Study|Physician Decision|1|||
30584386|NCT01356966|58595991|FG001|Overall Study|Physician Decision|0|||
30584387|NCT01295827|58596039|FG000|Overall Study|Adverse Event|1|||
30584388|NCT01295827|58596040|FG001|Overall Study|Adverse Event|2|||
30584389|NCT01295827|58596041|FG002|Overall Study|Adverse Event|2|||
30584390|NCT01295827|58596042|FG003|Overall Study|Adverse Event|1|||
30584391|NCT01295827|58596043|FG004|Overall Study|Adverse Event|1|||
30584392|NCT01295827|58596044|FG005|Overall Study|Adverse Event|4|||
30584393|NCT01295827|58596045|FG006|Overall Study|Adverse Event|15|||
30584394|NCT01295827|58596046|FG007|Overall Study|Adverse Event|49|||
30584395|NCT01295827|58596047|FG008|Overall Study|Adverse Event|22|||
30584396|NCT01295827|58596048|FG009|Overall Study|Adverse Event|7|||
30584397|NCT01295827|58596049|FG010|Overall Study|Adverse Event|50|||
30584398|NCT01295827|58596050|FG011|Overall Study|Adverse Event|21|||
30669659|NCT00849108|58683434|FG001|Cohort 2 Efficacy|Other|9|||
30669660|NCT00867308|58683444|FG000|Overall Study|Death|1|||
30584399|NCT01295827|58596051|FG012|Overall Study|Adverse Event|0|||
30584400|NCT01295827|58596052|FG013|Overall Study|Adverse Event|0|||
30584401|NCT01295827|58596053|FG014|Overall Study|Adverse Event|0|||
30584402|NCT01295827|58596039|FG000|Overall Study|Lost to Follow-up|0|||
30584403|NCT01295827|58596040|FG001|Overall Study|Lost to Follow-up|0|||
30584404|NCT01295827|58596041|FG002|Overall Study|Lost to Follow-up|3|||
30584405|NCT01295827|58596042|FG003|Overall Study|Lost to Follow-up|0|||
30584406|NCT01295827|58596043|FG004|Overall Study|Lost to Follow-up|1|||
30584407|NCT01295827|58596044|FG005|Overall Study|Lost to Follow-up|0|||
30584408|NCT01295827|58596045|FG006|Overall Study|Lost to Follow-up|4|||
30584409|NCT01295827|58596046|FG007|Overall Study|Lost to Follow-up|8|||
30584410|NCT01295827|58596047|FG008|Overall Study|Lost to Follow-up|7|||
30584411|NCT01295827|58596048|FG009|Overall Study|Lost to Follow-up|4|||
30584412|NCT01295827|58596049|FG010|Overall Study|Lost to Follow-up|7|||
30584413|NCT01295827|58596050|FG011|Overall Study|Lost to Follow-up|3|||
30584414|NCT01295827|58596051|FG012|Overall Study|Lost to Follow-up|0|||
30584415|NCT01295827|58596052|FG013|Overall Study|Lost to Follow-up|0|||
30584416|NCT01295827|58596053|FG014|Overall Study|Lost to Follow-up|0|||
30584417|NCT01295827|58596039|FG000|Overall Study|Not Reported|0|||
30584418|NCT01295827|58596040|FG001|Overall Study|Not Reported|0|||
30584419|NCT01295827|58596041|FG002|Overall Study|Not Reported|0|||
30584420|NCT01295827|58596042|FG003|Overall Study|Not Reported|1|||
30584421|NCT01295827|58596043|FG004|Overall Study|Not Reported|0|||
30584422|NCT01295827|58596044|FG005|Overall Study|Not Reported|0|||
30584423|NCT01295827|58596045|FG006|Overall Study|Not Reported|24|||
30584424|NCT01295827|58596046|FG007|Overall Study|Not Reported|58|||
30584425|NCT01295827|58596047|FG008|Overall Study|Not Reported|41|||
30584426|NCT01295827|58596048|FG009|Overall Study|Not Reported|2|||
30584427|NCT01295827|58596049|FG010|Overall Study|Not Reported|23|||
30584428|NCT01295827|58596050|FG011|Overall Study|Not Reported|13|||
30584429|NCT01295827|58596051|FG012|Overall Study|Not Reported|0|||
30584430|NCT01295827|58596052|FG013|Overall Study|Not Reported|0|||
30584431|NCT01295827|58596053|FG014|Overall Study|Not Reported|0|||
30584432|NCT01295827|58596039|FG000|Overall Study|Progressive Disease|2|||
30584433|NCT01295827|58596040|FG001|Overall Study|Progressive Disease|1|||
30584434|NCT01295827|58596041|FG002|Overall Study|Progressive Disease|5|||
30584435|NCT01295827|58596042|FG003|Overall Study|Progressive Disease|2|||
30584436|NCT01295827|58596043|FG004|Overall Study|Progressive Disease|0|||
30669661|NCT00867308|58683445|FG001|Overall Study|Death|0|||
30669662|NCT00867308|58683444|FG000|Overall Study|Adverse Event|1|||
30669663|NCT00867308|58683445|FG001|Overall Study|Adverse Event|4|||
30669664|NCT00867308|58683444|FG000|Overall Study|Lack of Efficacy|6|||
30584437|NCT01295827|58596044|FG005|Overall Study|Progressive Disease|1|||
30584438|NCT01295827|58596045|FG006|Overall Study|Progressive Disease|87|||
30584439|NCT01295827|58596046|FG007|Overall Study|Progressive Disease|144|||
30584440|NCT01295827|58596047|FG008|Overall Study|Progressive Disease|85|||
30584441|NCT01295827|58596048|FG009|Overall Study|Progressive Disease|40|||
30584442|NCT01295827|58596049|FG010|Overall Study|Progressive Disease|175|||
30584443|NCT01295827|58596050|FG011|Overall Study|Progressive Disease|136|||
30584444|NCT01295827|58596051|FG012|Overall Study|Progressive Disease|0|||
30584445|NCT01295827|58596052|FG013|Overall Study|Progressive Disease|0|||
30584446|NCT01295827|58596053|FG014|Overall Study|Progressive Disease|0|||
30584447|NCT01295827|58596039|FG000|Overall Study|Screen Failure|0|||
30584448|NCT01295827|58596040|FG001|Overall Study|Screen Failure|0|||
30584449|NCT01295827|58596041|FG002|Overall Study|Screen Failure|0|||
30584450|NCT01295827|58596042|FG003|Overall Study|Screen Failure|0|||
30584451|NCT01295827|58596043|FG004|Overall Study|Screen Failure|0|||
30584452|NCT01295827|58596044|FG005|Overall Study|Screen Failure|0|||
30584453|NCT01295827|58596045|FG006|Overall Study|Screen Failure|2|||
30584454|NCT01295827|58596046|FG007|Overall Study|Screen Failure|2|||
30584455|NCT01295827|58596047|FG008|Overall Study|Screen Failure|2|||
30584456|NCT01295827|58596048|FG009|Overall Study|Screen Failure|0|||
30584457|NCT01295827|58596049|FG010|Overall Study|Screen Failure|1|||
30584458|NCT01295827|58596050|FG011|Overall Study|Screen Failure|0|||
30584459|NCT01295827|58596051|FG012|Overall Study|Screen Failure|0|||
30584460|NCT01295827|58596052|FG013|Overall Study|Screen Failure|0|||
30584461|NCT01295827|58596053|FG014|Overall Study|Screen Failure|0|||
30584462|NCT01295827|58596039|FG000|Overall Study|Withdrawal by Subject|1|||
30584463|NCT01295827|58596040|FG001|Overall Study|Withdrawal by Subject|0|||
30584464|NCT01295827|58596041|FG002|Overall Study|Withdrawal by Subject|2|||
30584465|NCT01295827|58596042|FG003|Overall Study|Withdrawal by Subject|0|||
30584466|NCT01295827|58596043|FG004|Overall Study|Withdrawal by Subject|0|||
30584467|NCT01295827|58596044|FG005|Overall Study|Withdrawal by Subject|1|||
30584468|NCT01295827|58596045|FG006|Overall Study|Withdrawal by Subject|13|||
30584469|NCT01295827|58596046|FG007|Overall Study|Withdrawal by Subject|35|||
30584470|NCT01295827|58596047|FG008|Overall Study|Withdrawal by Subject|11|||
30669665|NCT00867308|58683445|FG001|Overall Study|Lack of Efficacy|12|||
30669666|NCT00867308|58683444|FG000|Overall Study|Withdrawal by Subject|1|||
30669667|NCT00867308|58683445|FG001|Overall Study|Withdrawal by Subject|2|||
30669668|NCT00866918|58683453|FG000|Overall Study|Death|1|||
30584471|NCT01295827|58596048|FG009|Overall Study|Withdrawal by Subject|2|||
30584472|NCT01295827|58596049|FG010|Overall Study|Withdrawal by Subject|18|||
30584473|NCT01295827|58596050|FG011|Overall Study|Withdrawal by Subject|13|||
30584474|NCT01295827|58596051|FG012|Overall Study|Withdrawal by Subject|0|||
30584475|NCT01295827|58596052|FG013|Overall Study|Withdrawal by Subject|0|||
30584476|NCT01295827|58596053|FG014|Overall Study|Withdrawal by Subject|0|||
30584477|NCT01295827|58596039|FG000|Overall Study|Other|0|||
30584478|NCT01295827|58596040|FG001|Overall Study|Other|0|||
30584479|NCT01295827|58596041|FG002|Overall Study|Other|0|||
30584480|NCT01295827|58596042|FG003|Overall Study|Other|0|||
30584481|NCT01295827|58596043|FG004|Overall Study|Other|0|||
30584482|NCT01295827|58596044|FG005|Overall Study|Other|0|||
30584483|NCT01295827|58596045|FG006|Overall Study|Other|1|||
30584484|NCT01295827|58596046|FG007|Overall Study|Other|1|||
30584485|NCT01295827|58596047|FG008|Overall Study|Other|1|||
30584486|NCT01295827|58596048|FG009|Overall Study|Other|0|||
30584487|NCT01295827|58596049|FG010|Overall Study|Other|2|||
30584488|NCT01295827|58596050|FG011|Overall Study|Other|0|||
30584489|NCT01295827|58596051|FG012|Overall Study|Other|0|||
30584490|NCT01295827|58596052|FG013|Overall Study|Other|0|||
30584491|NCT01295827|58596053|FG014|Overall Study|Other|0|||
30584492|NCT01295671|58596109|FG000|Overall Study|Lost to Follow-up|4|||
30584493|NCT01295671|58596110|FG001|Overall Study|Lost to Follow-up|6|||
30584494|NCT01295671|58596111|FG002|Overall Study|Lost to Follow-up|3|||
30584495|NCT01295671|58596109|FG000|Overall Study|Withdrawal by Subject|3|||
30584496|NCT01295671|58596110|FG001|Overall Study|Withdrawal by Subject|1|||
30584497|NCT01295671|58596111|FG002|Overall Study|Withdrawal by Subject|0|||
30584498|NCT01295320|58596119|FG000|Overall Study|Adverse Event|2|||
30584499|NCT01295320|58596119|FG000|Overall Study|Lost to Follow-up|4|||
30584500|NCT01295320|58596119|FG000|Overall Study|Withdrawal by Subject|2|||
30584501|NCT01295320|58596119|FG000|Overall Study|Subject was bedridden|1|||
30584502|NCT01295320|58596119|FG000|Overall Study|Unable to travel|1|||
30584503|NCT01295281|58596125|FG000|First Intervention (7 Days)|Death|0|||
30584504|NCT01295281|58596126|FG001|First Intervention (7 Days)|Death|1|||
30584505|NCT01294696|58596134|FG000|Overall Study|Screening failures|7|||
30584506|NCT01294696|58596134|FG000|Overall Study|Protocol Violation|8|||
30584507|NCT01294696|58596134|FG000|Overall Study|Missing BPI Response|7|||
30584508|NCT01294696|58596134|FG000|Overall Study|Site closure|52|||
30584509|NCT01294579|58596139|FG000|Overall Study|Disease progression|12|||
30584510|NCT01294579|58596139|FG000|Overall Study|Adverse Event|11|||
30584511|NCT01294579|58596139|FG000|Overall Study|Study closed/terminated|3|||
30584512|NCT01294579|58596139|FG000|Overall Study|Lost to Follow-up|1|||
30584513|NCT01294579|58596139|FG000|Overall Study|Physician Decision|3|||
30584514|NCT01294579|58596139|FG000|Overall Study|Withdrawal by Subject|5|||
30584515|NCT01294462|58596145|FG000|Overall Study|Lost to Follow-up|1|||
30584516|NCT01294462|58596146|FG001|Overall Study|Lost to Follow-up|0|||
30584517|NCT01294462|58596145|FG000|Overall Study|Withdrawal by Subject|65|||
30584518|NCT01294462|58596146|FG001|Overall Study|Withdrawal by Subject|63|||
30584519|NCT01294423|58596155|FG000|Overall Study|Adverse Event|1|||
30584520|NCT01294423|58596156|FG001|Overall Study|Adverse Event|2|||
30584521|NCT01294423|58596157|FG002|Overall Study|Adverse Event|3|||
30584522|NCT01294423|58596155|FG000|Overall Study|Withdrawal by Subject|1|||
30584523|NCT01294423|58596156|FG001|Overall Study|Withdrawal by Subject|2|||
30584524|NCT01294423|58596157|FG002|Overall Study|Withdrawal by Subject|2|||
30584525|NCT01294423|58596155|FG000|Overall Study|subject no longer meets study criteria|2|||
30584526|NCT01294423|58596156|FG001|Overall Study|subject no longer meets study criteria|5|||
30584527|NCT01294423|58596157|FG002|Overall Study|subject no longer meets study criteria|2|||
30584528|NCT01294423|58596155|FG000|Overall Study|poor/non-compliance|1|||
30584529|NCT01294423|58596156|FG001|Overall Study|poor/non-compliance|0|||
30584530|NCT01294423|58596157|FG002|Overall Study|poor/non-compliance|1|||
30584531|NCT01294150|58596167|FG000|Overall Study|Physician Decision|2|||
30584532|NCT01294150|58596168|FG001|Overall Study|Physician Decision|2|||
30584533|NCT01292473|58596180|FG000|Overall Study|Adverse Event|1|||
30584534|NCT01292473|58596181|FG001|Overall Study|Adverse Event|0|||
30584535|NCT01292473|58596182|FG002|Overall Study|Adverse Event|1|||
30584536|NCT01292473|58596183|FG003|Overall Study|Adverse Event|1|||
30584537|NCT01292473|58596180|FG000|Overall Study|Lost to Follow-up|1|||
30584538|NCT01292473|58596181|FG001|Overall Study|Lost to Follow-up|1|||
30584539|NCT01292473|58596182|FG002|Overall Study|Lost to Follow-up|2|||
30584540|NCT01292473|58596183|FG003|Overall Study|Lost to Follow-up|2|||
30584541|NCT01292473|58596180|FG000|Overall Study|Withdrawal by Subject|3|||
30584542|NCT01292473|58596181|FG001|Overall Study|Withdrawal by Subject|4|||
30584543|NCT01292473|58596182|FG002|Overall Study|Withdrawal by Subject|3|||
30584544|NCT01292473|58596183|FG003|Overall Study|Withdrawal by Subject|3|||
30584545|NCT01292473|58596180|FG000|Overall Study|Physician Decision|0|||
30584546|NCT01292473|58596181|FG001|Overall Study|Physician Decision|1|||
30584547|NCT01292473|58596182|FG002|Overall Study|Physician Decision|0|||
30584548|NCT01292473|58596183|FG003|Overall Study|Physician Decision|0|||
30584549|NCT01292473|58596180|FG000|Overall Study|Disease Progression|0|||
30958781|NCT01587703|59024026|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30584550|NCT01292473|58596181|FG001|Overall Study|Disease Progression|1|||
30584551|NCT01292473|58596182|FG002|Overall Study|Disease Progression|3|||
30584552|NCT01292473|58596183|FG003|Overall Study|Disease Progression|6|||
30584553|NCT01292239|58596199|FG000|Overall Study|Other|1|||
30584554|NCT01292239|58596200|FG001|Overall Study|Other|1|||
30584555|NCT01292239|58596199|FG000|Overall Study|Withdrawal by Subject|3|||
30584556|NCT01292239|58596200|FG001|Overall Study|Withdrawal by Subject|6|||
30584557|NCT01291225|58596208|FG000|Overall Study|Lost to Follow-up|85|||
30584558|NCT01291225|58596209|FG001|Overall Study|Lost to Follow-up|39|||
30584559|NCT01290796|58596219|FG000|Overall Study|Lost to Follow-up|21|||
30584560|NCT01290796|58596219|FG000|Overall Study|Withdrawal by Subject|4|||
30584561|NCT01290796|58596219|FG000|Overall Study|Physician Decision|2|||
30584562|NCT01290796|58596219|FG000|Overall Study|Secondary Surgical Intervention|2|||
30584563|NCT01290796|58596219|FG000|Overall Study|Withdrawal by Sponsor|1|||
30584564|NCT01290757|58596225|FG000|Overall Study|Adverse Event|1|||
30584565|NCT01290757|58596226|FG001|Overall Study|Adverse Event|0|||
30584566|NCT01290757|58596225|FG000|Overall Study|Protocol Violation|1|||
30584567|NCT01290757|58596226|FG001|Overall Study|Protocol Violation|1|||
30584568|NCT01290757|58596225|FG000|Overall Study|Other|0|||
30584569|NCT01290757|58596226|FG001|Overall Study|Other|1|||
30584570|NCT01290718|58596232|FG000|Overall Study|Early termination of the study|4|||
30584571|NCT01290679|58596238|FG000|Overall Study|Adverse Event|2|||
30584572|NCT01290679|58596239|FG001|Overall Study|Adverse Event|0|||
30584573|NCT01290679|58596238|FG000|Overall Study|Lost to Follow-up|8|||
30584574|NCT01290679|58596239|FG001|Overall Study|Lost to Follow-up|10|||
30584575|NCT01290679|58596238|FG000|Overall Study|Protocol Violation|0|||
30584576|NCT01290679|58596239|FG001|Overall Study|Protocol Violation|1|||
30584577|NCT01290679|58596238|FG000|Overall Study|Withdrawal by Subject|6|||
30584578|NCT01290679|58596239|FG001|Overall Study|Withdrawal by Subject|5|||
30584579|NCT01290679|58596238|FG000|Overall Study|Subject Entered Another Trial|0|||
30584580|NCT01290679|58596239|FG001|Overall Study|Subject Entered Another Trial|5|||
30584581|NCT01290601|58596247|FG000|Overall Study|Adverse Event|0|||
30584582|NCT01290601|58596248|FG001|Overall Study|Adverse Event|2|||
30584583|NCT01290601|58596249|FG002|Overall Study|Adverse Event|0|||
30584584|NCT01290601|58596250|FG003|Overall Study|Adverse Event|0|||
30584585|NCT01290601|58596247|FG000|Overall Study|Lack of Efficacy|2|||
30584586|NCT01290601|58596248|FG001|Overall Study|Lack of Efficacy|1|||
30584587|NCT01290601|58596249|FG002|Overall Study|Lack of Efficacy|0|||
30584588|NCT01290601|58596250|FG003|Overall Study|Lack of Efficacy|0|||
30584589|NCT01290601|58596247|FG000|Overall Study|Lost to Follow-up|7|||
30584590|NCT01290601|58596248|FG001|Overall Study|Lost to Follow-up|2|||
30584591|NCT01290601|58596249|FG002|Overall Study|Lost to Follow-up|0|||
30584592|NCT01290601|58596250|FG003|Overall Study|Lost to Follow-up|0|||
30584593|NCT01290601|58596247|FG000|Overall Study|Other|1|||
30584594|NCT01290601|58596248|FG001|Overall Study|Other|0|||
30584595|NCT01290601|58596249|FG002|Overall Study|Other|0|||
30584596|NCT01290601|58596250|FG003|Overall Study|Other|0|||
30584597|NCT01290601|58596247|FG000|Overall Study|Protocol Violation|1|||
30584598|NCT01290601|58596248|FG001|Overall Study|Protocol Violation|0|||
30584599|NCT01290601|58596249|FG002|Overall Study|Protocol Violation|0|||
30584600|NCT01290601|58596250|FG003|Overall Study|Protocol Violation|0|||
30584601|NCT01290523|58596256|FG000|Overall Study|Death|3|||
30584602|NCT01290094|58596260|FG000|Overall Study|Withdrawal by Subject|1|||
30584603|NCT01290094|58596260|FG000|Overall Study|Lost to Follow-up|5|||
30584604|NCT01289821|58596273|FG000|Treatment Period|Withdrawal by Subject|1|||
30584605|NCT01289821|58596273|FG000|Treatment Period|Physician Decision|3|||
30584606|NCT01289821|58596273|FG000|Treatment Period|Adverse Event|4|||
30584607|NCT01289821|58596273|FG000|Treatment Period|Radiological Progression|43|||
30584608|NCT01289821|58596273|FG000|Treatment Period|Clinical Progression|2|||
30584609|NCT01289821|58596273|FG000|Treatment Period|Therapeutic procedure required|1|||
30584610|NCT01289821|58596273|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
30584611|NCT01289821|58596273|FG000|Safety Follow-up Period|Protocol Violation|3|||
30584612|NCT01289821|58596273|FG000|Safety Follow-up Period|Unspecified reason|1|||
30584613|NCT01289821|58596273|FG000|Survival Follow-up Period|Protocol Violation|1|||
30584614|NCT01289821|58596273|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
30584615|NCT01289821|58596273|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
30584616|NCT01289782|58596279|FG000|Overall Study|Lost to Follow-up|14|||
30584617|NCT01289782|58596280|FG001|Overall Study|Lost to Follow-up|7|||
30584618|NCT01289782|58596279|FG000|Overall Study|Protocol Violation|1|||
30584619|NCT01289782|58596280|FG001|Overall Study|Protocol Violation|1|||
30584620|NCT01289782|58596279|FG000|Overall Study|Withdrawal by Subject|8|||
30584621|NCT01289782|58596280|FG001|Overall Study|Withdrawal by Subject|2|||
30584622|NCT01289782|58596279|FG000|Overall Study|Sponsor's Decision|1|||
30780971|NCT01060072|58793113|FG000|Overall Study|Adverse Event|1|||
30584623|NCT01289782|58596280|FG001|Overall Study|Sponsor's Decision|0|||
30584624|NCT01289782|58596279|FG000|Overall Study|Reason not specified|1|||
30584625|NCT01289782|58596280|FG001|Overall Study|Reason not specified|2|||
30780972|NCT01060072|58793114|FG001|Overall Study|Adverse Event|1|||
30780973|NCT01060072|58793113|FG000|Overall Study|Physician Decision|0|||
30780974|NCT01060072|58793114|FG001|Overall Study|Physician Decision|2|||
30780975|NCT01060072|58793113|FG000|Overall Study|Protocol Violation|0|||
30780976|NCT01060072|58793114|FG001|Overall Study|Protocol Violation|1|||
30584626|NCT01289353|58596286|FG000|Overall Study|Lost to Follow-up|2|||
30584627|NCT01289119|58596296|FG000|Overall Study|Adverse Event|2|||
30584628|NCT01289119|58596297|FG001|Overall Study|Adverse Event|1|||
30584629|NCT01289119|58596298|FG002|Overall Study|Adverse Event|0|||
30584630|NCT01289119|58596299|FG003|Overall Study|Adverse Event|2|||
30584631|NCT01289119|58596300|FG004|Overall Study|Adverse Event|1|||
30584632|NCT01289119|58596301|FG005|Overall Study|Adverse Event|0|||
30669669|NCT00866918|58683454|FG001|Overall Study|Death|5|||
30780977|NCT01060072|58793113|FG000|Overall Study|Acute cholecystitis|1|||
30958782|NCT01587703|59024027|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958783|NCT01587703|59024028|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958784|NCT01587703|59024029|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958785|NCT01587703|59024030|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958786|NCT01587703|59024031|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958787|NCT01587703|59024032|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958788|NCT01587703|59024033|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958789|NCT01587703|59024034|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958790|NCT01587703|59024035|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958791|NCT01587703|59024036|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958792|NCT01587703|59024037|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958793|NCT01587703|59024038|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958794|NCT01587703|59024039|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958795|NCT01587703|59024040|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958796|NCT01587703|59024041|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
30958797|NCT01587703|59024023|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958798|NCT01587703|59024024|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958799|NCT01587703|59024025|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958800|NCT01587703|59024026|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958801|NCT01587703|59024027|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958802|NCT01587703|59024028|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
30958803|NCT01587703|59024029|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958804|NCT01587703|59024030|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
30958805|NCT01587703|59024031|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958806|NCT01587703|59024032|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958807|NCT01587703|59024033|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958808|NCT01587703|59024034|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958809|NCT01587703|59024035|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958810|NCT01587703|59024036|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958811|NCT01587703|59024037|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958812|NCT01587703|59024038|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958813|NCT01587703|59024039|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958814|NCT01587703|59024040|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958815|NCT01587703|59024041|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
30958816|NCT01587703|59024023|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958817|NCT01587703|59024024|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958818|NCT01587703|59024025|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30584633|NCT01289119|58596296|FG000|Overall Study|Major Protocol Deviation|2|||
30584634|NCT01289119|58596297|FG001|Overall Study|Major Protocol Deviation|1|||
30584635|NCT01289119|58596298|FG002|Overall Study|Major Protocol Deviation|3|||
30584636|NCT01289119|58596299|FG003|Overall Study|Major Protocol Deviation|0|||
30584637|NCT01289119|58596300|FG004|Overall Study|Major Protocol Deviation|2|||
30584638|NCT01289119|58596301|FG005|Overall Study|Major Protocol Deviation|1|||
30584639|NCT01289119|58596296|FG000|Overall Study|Lost to Follow-up|0|||
30584640|NCT01289119|58596297|FG001|Overall Study|Lost to Follow-up|3|||
30584641|NCT01289119|58596298|FG002|Overall Study|Lost to Follow-up|0|||
30584642|NCT01289119|58596299|FG003|Overall Study|Lost to Follow-up|0|||
30584643|NCT01289119|58596300|FG004|Overall Study|Lost to Follow-up|0|||
30584644|NCT01289119|58596301|FG005|Overall Study|Lost to Follow-up|1|||
30584645|NCT01289119|58596296|FG000|Overall Study|Withdrawal by Subject|4|||
30584646|NCT01289119|58596297|FG001|Overall Study|Withdrawal by Subject|2|||
30584647|NCT01289119|58596298|FG002|Overall Study|Withdrawal by Subject|4|||
30584648|NCT01289119|58596299|FG003|Overall Study|Withdrawal by Subject|3|||
30584649|NCT01289119|58596300|FG004|Overall Study|Withdrawal by Subject|1|||
30584650|NCT01289119|58596301|FG005|Overall Study|Withdrawal by Subject|1|||
30584651|NCT01289119|58596296|FG000|Overall Study|Pregnancy|0|||
30584652|NCT01289119|58596297|FG001|Overall Study|Pregnancy|1|||
30584653|NCT01289119|58596298|FG002|Overall Study|Pregnancy|0|||
30584654|NCT01289119|58596299|FG003|Overall Study|Pregnancy|0|||
30584655|NCT01289119|58596300|FG004|Overall Study|Pregnancy|0|||
30584656|NCT01289119|58596301|FG005|Overall Study|Pregnancy|0|||
30584657|NCT01289119|58596296|FG000|Overall Study|Lack of Efficacy|0|||
30584658|NCT01289119|58596297|FG001|Overall Study|Lack of Efficacy|1|||
30669670|NCT00866918|58683453|FG000|Overall Study|Lack of Efficacy|1|||
30669671|NCT00866918|58683454|FG001|Overall Study|Lack of Efficacy|1|||
30669672|NCT00866918|58683453|FG000|Overall Study|Physician Decision|10|||
30584659|NCT01289119|58596298|FG002|Overall Study|Lack of Efficacy|1|||
30584660|NCT01289119|58596299|FG003|Overall Study|Lack of Efficacy|1|||
30584661|NCT01289119|58596300|FG004|Overall Study|Lack of Efficacy|1|||
30584662|NCT01289119|58596301|FG005|Overall Study|Lack of Efficacy|1|||
30584663|NCT01289119|58596296|FG000|Overall Study|Other|1|||
30584664|NCT01289119|58596297|FG001|Overall Study|Other|0|||
30584665|NCT01289119|58596298|FG002|Overall Study|Other|1|||
30584666|NCT01289119|58596299|FG003|Overall Study|Other|0|||
30584667|NCT01289119|58596300|FG004|Overall Study|Other|0|||
30584668|NCT01289119|58596301|FG005|Overall Study|Other|0|||
30584669|NCT01289041|58596315|FG000|Overall Study|Adverse Event|24|||
30584670|NCT01289041|58596315|FG000|Overall Study|Physician Decision|1|||
30855693|NCT02764333|58883385|FG000|Overall Study|Ineligible|1|||
30855694|NCT02705625|58883392|FG000|Overall Study|Protocol Violation|1|||
30855695|NCT02705625|58883393|FG001|Overall Study|Protocol Violation|0|||
30855696|NCT02705625|58883394|FG002|Overall Study|Protocol Violation|0|||
30855697|NCT02705625|58883392|FG000|Overall Study|Adverse Event|6|||
30855698|NCT02705625|58883393|FG001|Overall Study|Adverse Event|5|||
30855699|NCT02705625|58883394|FG002|Overall Study|Adverse Event|2|||
30855700|NCT02705625|58883392|FG000|Overall Study|Death|0|||
30855701|NCT02705625|58883393|FG001|Overall Study|Death|0|||
30958819|NCT01587703|59024026|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958820|NCT01587703|59024027|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958821|NCT01587703|59024028|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30584671|NCT01289041|58596315|FG000|Overall Study|Progressive Disease|41|||
30584672|NCT01289041|58596315|FG000|Overall Study|Withdrawal by Subject|3|||
30584673|NCT01289041|58596315|FG000|Overall Study|Death|1|||
30584674|NCT01288729|58596323|FG000|Overall Study|Withdrawal by Subject|1|||
30584675|NCT01288729|58596324|FG001|Overall Study|Withdrawal by Subject|0|||
30584676|NCT01288612|58596333|FG000|Overall Study|Unable to contact|11|||
30584677|NCT01288612|58596334|FG001|Overall Study|Unable to contact|16|||
30584678|NCT01288612|58596335|FG002|Overall Study|Unable to contact|20|||
30584679|NCT01288612|58596333|FG000|Overall Study|Declined|78|||
30584680|NCT01288612|58596334|FG001|Overall Study|Declined|63|||
30669673|NCT00866918|58683454|FG001|Overall Study|Physician Decision|2|||
30669674|NCT00866918|58683453|FG000|Overall Study|Ineligible|2|||
30669675|NCT00866918|58683454|FG001|Overall Study|Ineligible|4|||
30669676|NCT00866918|58683453|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
30669677|NCT00866918|58683454|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
30958822|NCT01587703|59024029|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
30958823|NCT01587703|59024030|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958824|NCT01587703|59024031|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958825|NCT01587703|59024032|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958826|NCT01587703|59024033|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958827|NCT01587703|59024034|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30584681|NCT01288612|58596335|FG002|Overall Study|Declined|62|||
30669678|NCT00866918|58683453|FG000|Overall Study|Secondary malignancy|1|||
30669679|NCT00866918|58683454|FG001|Overall Study|Secondary malignancy|0|||
30669680|NCT03158285|58683463|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
30669681|NCT03158285|58683464|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
30669682|NCT03158285|58683465|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
30669683|NCT03158285|58683463|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
30669684|NCT03158285|58683464|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
30669685|NCT03158285|58683465|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
30669686|NCT03158285|58683463|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
30669687|NCT03158285|58683464|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
30669688|NCT03158285|58683465|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
30669689|NCT03158285|58683463|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
30669690|NCT03158285|58683464|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
30669691|NCT03158285|58683465|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
30669692|NCT03158285|58683463|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
30669693|NCT03158285|58683464|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
30669694|NCT03158285|58683465|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
30669695|NCT03158285|58683463|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
30669696|NCT03158285|58683464|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
30669697|NCT03158285|58683465|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
30669698|NCT03158285|58683463|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
30669699|NCT03158285|58683464|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
30855702|NCT02705625|58883394|FG002|Overall Study|Death|1|||
30584682|NCT01288612|58596333|FG000|Overall Study|Unable to intubate|0|||
30584683|NCT01288612|58596334|FG001|Overall Study|Unable to intubate|3|||
30584684|NCT01288612|58596335|FG002|Overall Study|Unable to intubate|0|||
30584685|NCT01287832|58596345|FG000|Overall Study|Adverse Event|1|||
30584686|NCT01287832|58596346|FG001|Overall Study|Adverse Event|0|||
30584687|NCT01287832|58596345|FG000|Overall Study|Death|0|||
30855703|NCT02705625|58883392|FG000|Overall Study|Withdrawal by Subject|1|||
30855704|NCT02705625|58883393|FG001|Overall Study|Withdrawal by Subject|4|||
30855705|NCT02705625|58883394|FG002|Overall Study|Withdrawal by Subject|5|||
30958828|NCT01587703|59024035|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958829|NCT01587703|59024036|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958830|NCT01587703|59024037|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958831|NCT01587703|59024038|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958832|NCT01587703|59024039|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958833|NCT01587703|59024040|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958834|NCT01587703|59024041|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
30958835|NCT01587703|59024023|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
30958836|NCT01587703|59024024|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
30958837|NCT01587703|59024025|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
30958838|NCT01587703|59024026|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
30958839|NCT01587703|59024027|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
30958840|NCT01587703|59024028|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
30958841|NCT01587703|59024029|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
30958842|NCT01587703|59024030|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
30958843|NCT01587703|59024031|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
30958844|NCT01587703|59024032|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
30958845|NCT01587703|59024033|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
30958846|NCT01587703|59024034|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
30584688|NCT01287832|58596346|FG001|Overall Study|Death|1|||
30584689|NCT01287754|58596354|FG000|Overall Study|Death|2|||
30584690|NCT01287754|58596355|FG001|Overall Study|Death|12|||
30584691|NCT01287754|58596354|FG000|Overall Study|Lost to Follow-up|1|||
30584692|NCT01287754|58596355|FG001|Overall Study|Lost to Follow-up|6|||
30584693|NCT01287754|58596354|FG000|Overall Study|Protocol Violation|0|||
30584694|NCT01287754|58596355|FG001|Overall Study|Protocol Violation|3|||
30584695|NCT01287520|58596370|FG000|Overall Study|Adverse Event|2|||
30584696|NCT01287520|58596371|FG001|Overall Study|Adverse Event|2|||
30584697|NCT01287520|58596372|FG002|Overall Study|Adverse Event|2|||
30584698|NCT01287520|58596373|FG003|Overall Study|Adverse Event|1|||
30584699|NCT01287520|58596374|FG004|Overall Study|Adverse Event|1|||
30584700|NCT01287520|58596375|FG005|Overall Study|Adverse Event|2|||
30584701|NCT01287520|58596376|FG006|Overall Study|Adverse Event|0|||
30584702|NCT01287520|58596377|FG007|Overall Study|Adverse Event|2|||
30584703|NCT01287520|58596378|FG008|Overall Study|Adverse Event|0|||
30584704|NCT01287520|58596370|FG000|Overall Study|Physician Decision|1|||
30584705|NCT01287520|58596371|FG001|Overall Study|Physician Decision|1|||
30584706|NCT01287520|58596372|FG002|Overall Study|Physician Decision|2|||
30584707|NCT01287520|58596373|FG003|Overall Study|Physician Decision|0|||
30584708|NCT01287520|58596374|FG004|Overall Study|Physician Decision|1|||
30584709|NCT01287520|58596375|FG005|Overall Study|Physician Decision|1|||
30584710|NCT01287520|58596376|FG006|Overall Study|Physician Decision|0|||
30584711|NCT01287520|58596377|FG007|Overall Study|Physician Decision|1|||
30584712|NCT01287520|58596378|FG008|Overall Study|Physician Decision|0|||
30584713|NCT01287520|58596370|FG000|Overall Study|Progressive disease|0|||
30584714|NCT01287520|58596371|FG001|Overall Study|Progressive disease|4|||
30584715|NCT01287520|58596372|FG002|Overall Study|Progressive disease|1|||
30584716|NCT01287520|58596373|FG003|Overall Study|Progressive disease|6|||
30584717|NCT01287520|58596374|FG004|Overall Study|Progressive disease|1|||
30584718|NCT01287520|58596375|FG005|Overall Study|Progressive disease|0|||
30584719|NCT01287520|58596376|FG006|Overall Study|Progressive disease|2|||
30584720|NCT01287520|58596377|FG007|Overall Study|Progressive disease|2|||
30584721|NCT01287520|58596378|FG008|Overall Study|Progressive disease|4|||
30584722|NCT01287520|58596370|FG000|Overall Study|Withdrawal by Subject|0|||
30584723|NCT01287520|58596371|FG001|Overall Study|Withdrawal by Subject|0|||
30584724|NCT01287520|58596372|FG002|Overall Study|Withdrawal by Subject|0|||
30584725|NCT01287520|58596373|FG003|Overall Study|Withdrawal by Subject|0|||
30584726|NCT01287520|58596374|FG004|Overall Study|Withdrawal by Subject|0|||
30584727|NCT01287520|58596375|FG005|Overall Study|Withdrawal by Subject|1|||
30584728|NCT01287520|58596376|FG006|Overall Study|Withdrawal by Subject|0|||
30584729|NCT01287520|58596377|FG007|Overall Study|Withdrawal by Subject|0|||
30584730|NCT01287520|58596378|FG008|Overall Study|Withdrawal by Subject|1|||
30584731|NCT01287403|58596427|FG000|1st Intervention (1 Day)|Adverse Event|1|||
30584732|NCT01287364|58596443|FG000|Overall Study|Adverse Event|0|||
30855706|NCT02705625|58883392|FG000|Overall Study|Lost to Follow-up|0|||
30855707|NCT02705625|58883393|FG001|Overall Study|Lost to Follow-up|0|||
30855708|NCT02705625|58883394|FG002|Overall Study|Lost to Follow-up|1|||
30958847|NCT01587703|59024035|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
30958848|NCT01587703|59024036|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
30584733|NCT01287364|58596444|FG001|Overall Study|Adverse Event|3|||
30584734|NCT01287364|58596443|FG000|Overall Study|Protocol Violation|5|||
30584735|NCT01287364|58596444|FG001|Overall Study|Protocol Violation|5|||
30584736|NCT01287364|58596443|FG000|Overall Study|Other Reason|4|||
30584737|NCT01287364|58596444|FG001|Overall Study|Other Reason|2|||
30584738|NCT01287013|58596466|FG000|Overall Study|Non-evaluable|3|||
30584739|NCT01287013|58596467|FG001|Overall Study|Non-evaluable|5|||
30855709|NCT02705625|58883392|FG000|Overall Study|Non-compliance|0|||
30584740|NCT01287013|58596468|FG002|Overall Study|Non-evaluable|21|||
30584741|NCT01286779|58596476|FG000|Overall Study|Withdrawal by Subject|9|||
30584742|NCT01286779|58596476|FG000|Overall Study|Protocol Violation|5|||
30584743|NCT01286779|58596476|FG000|Overall Study|Physician Decision|2|||
30584744|NCT01286779|58596476|FG000|Overall Study|Participant had scheduled surgery|1|||
30584745|NCT01286779|58596476|FG000|Overall Study|Participant moved to another country|1|||
30584746|NCT01286779|58596476|FG000|Overall Study|Discontinued by sponsor|1|||
30584747|NCT01286740|58596490|FG000|Overall Study|Enrolled but not treated|1|||
30584748|NCT01286740|58596490|FG000|Overall Study|Protocol Violation|1|||
30584749|NCT01286311|58596496|FG000|Overall Study|Physician did not want outreach sent|14|||
30584750|NCT01286311|58596497|FG001|Overall Study|Physician did not want outreach sent|0|||
30584751|NCT01286077|58596505|FG000|Overall Study|Adverse Event|2|||
30584752|NCT01286077|58596506|FG001|Overall Study|Adverse Event|0|||
30584753|NCT01286077|58596505|FG000|Overall Study|Death|1|||
30584754|NCT01286077|58596506|FG001|Overall Study|Death|0|||
30584755|NCT01286077|58596505|FG000|Overall Study|Protocol Violation|1|||
30584756|NCT01286077|58596506|FG001|Overall Study|Protocol Violation|1|||
30584757|NCT01286077|58596505|FG000|Overall Study|Withdrawal by Subject|0|||
30584758|NCT01286077|58596506|FG001|Overall Study|Withdrawal by Subject|2|||
30584759|NCT01286077|58596505|FG000|Overall Study|Intercurrent illness|1|||
30584760|NCT01286077|58596506|FG001|Overall Study|Intercurrent illness|0|||
30584761|NCT01286077|58596505|FG000|Overall Study|Non-compliance|1|||
30584762|NCT01286077|58596506|FG001|Overall Study|Non-compliance|0|||
30584763|NCT01286077|58596505|FG000|Overall Study|The subject starts with alternative MMY|0|||
30584764|NCT01286077|58596506|FG001|Overall Study|The subject starts with alternative MMY|3|||
30584765|NCT01286077|58596505|FG000|Overall Study|Patient's decision to stop treatment|3|||
30669700|NCT03158285|58683465|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
30669701|NCT03158285|58683463|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
30669702|NCT03158285|58683464|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
30669703|NCT03158285|58683465|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
30669704|NCT03158285|58683463|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
30669705|NCT03158285|58683464|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
30669706|NCT03158285|58683465|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
30669707|NCT03158285|58683463|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
30669708|NCT03158285|58683464|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
30669709|NCT03158285|58683465|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
30669710|NCT03158285|58683463|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
30669711|NCT03158285|58683464|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
30669712|NCT03158285|58683465|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
30669713|NCT03158285|58683463|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
30669714|NCT03158285|58683464|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
30584766|NCT01286077|58596506|FG001|Overall Study|Patient's decision to stop treatment|0|||
30584767|NCT01286077|58596505|FG000|Overall Study|Progression of disease|0|||
30584768|NCT01286077|58596506|FG001|Overall Study|Progression of disease|1|||
30584769|NCT01286077|58596505|FG000|Overall Study|refill medication not received in time|1|||
30584770|NCT01286077|58596506|FG001|Overall Study|refill medication not received in time|0|||
30584771|NCT01285960|58596512|FG000|Overall Study|Withdrawal by Subject|2|||
30584772|NCT01285960|58596512|FG000|Overall Study|Lost to Follow-up|2|||
30584773|NCT01285960|58596512|FG000|Overall Study|2 subjects received less 10 sonications|2|||
30584774|NCT01285609|58596523|FG000|Randomized|Progressive Disease|41|||
30584775|NCT01285609|58596524|FG001|Randomized|Progressive Disease|61|||
30584776|NCT01285609|58596523|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
30584777|NCT01285609|58596524|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
30584778|NCT01285609|58596523|FG000|Randomized|Study Drug Toxicity|13|||
30584779|NCT01285609|58596524|FG001|Randomized|Study Drug Toxicity|14|||
30584780|NCT01285609|58596523|FG000|Randomized|Death|5|||
30584781|NCT01285609|58596524|FG001|Randomized|Death|7|||
30584782|NCT01285609|58596523|FG000|Randomized|Withdrawal by Subject|8|||
30584783|NCT01285609|58596524|FG001|Randomized|Withdrawal by Subject|11|||
30584784|NCT01285609|58596523|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
30584785|NCT01285609|58596524|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
30584786|NCT01285609|58596523|FG000|Randomized|Undisclosed Reasons|1|||
30669715|NCT03158285|58683465|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
30669716|NCT03158285|58683463|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
30669717|NCT03158285|58683464|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
30584787|NCT01285609|58596524|FG001|Randomized|Undisclosed Reasons|0|||
30584788|NCT01285609|58596523|FG000|Randomized|Randomized but not Treated|4|||
30780978|NCT01060072|58793114|FG001|Overall Study|Acute cholecystitis|0|||
30584789|NCT01285609|58596524|FG001|Randomized|Randomized but not Treated|4|||
30584790|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
30584791|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
30584792|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
30584793|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
30584794|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
30669718|NCT03158285|58683465|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
30584795|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
30584796|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
30584797|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
30669719|NCT03158285|58683463|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
30584798|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Death|11|||
30584799|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Death|3|||
30584800|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
30584801|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
30584802|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Not Reported|0|||
30584803|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Not Reported|2|||
30584804|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
30584805|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
30584806|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
30584807|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
30584808|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
30584809|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
30584810|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
30584811|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
30584812|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
30584813|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
30584814|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
30584815|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
30669720|NCT03158285|58683464|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
30669721|NCT03158285|58683465|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
30669722|NCT03158285|58683463|FG000|Active Treatment Period: Week 52-100|Death|1|||
30669723|NCT03158285|58683464|FG001|Active Treatment Period: Week 52-100|Death|0|||
30669724|NCT03158285|58683465|FG002|Active Treatment Period: Week 52-100|Death|0|||
30669725|NCT03158285|58683463|FG000|Active Treatment Period: Week 52-100|Other|4|||
30669726|NCT03158285|58683464|FG001|Active Treatment Period: Week 52-100|Other|1|||
30669727|NCT03158285|58683465|FG002|Active Treatment Period: Week 52-100|Other|0|||
30669728|NCT00861692|58683478|FG000|Overall Study|Death|6|||
30669729|NCT00602927|58683484|FG000|Period 1: 13 Days|Protocol Violation|2|||
30669730|NCT00602927|58683485|FG001|Period 1: 13 Days|Protocol Violation|4|||
30669731|NCT00602927|58683484|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
30669732|NCT00602927|58683485|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
30669733|NCT00602927|58683484|FG000|Period 1: 13 Days|Time|1|||
30669734|NCT00602927|58683485|FG001|Period 1: 13 Days|Time|0|||
30669735|NCT00602927|58683484|FG000|Period 1: 13 Days|Claustrophobia|0|||
30669736|NCT00602927|58683485|FG001|Period 1: 13 Days|Claustrophobia|1|||
30780979|NCT01060072|58793113|FG000|Overall Study|Excluded Medications|0|||
30780980|NCT01060072|58793114|FG001|Overall Study|Excluded Medications|1|||
30780981|NCT02969590|58793122|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
30780982|NCT02969590|58793123|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
30780983|NCT02969590|58793124|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
30780984|NCT03345849|58793136|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
30780985|NCT03345849|58793137|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
30780986|NCT03345849|58793138|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
30780987|NCT03345849|58793139|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
30780988|NCT03345849|58793136|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
30780989|NCT03345849|58793137|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
30780990|NCT03345849|58793138|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
30780991|NCT03345849|58793139|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
30780992|NCT03345849|58793136|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
30780993|NCT03345849|58793137|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
30780994|NCT03345849|58793138|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
30780995|NCT03345849|58793139|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
30780996|NCT03345849|58793136|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
30780997|NCT03345849|58793137|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
30958849|NCT01587703|59024037|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
30958850|NCT01587703|59024038|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
30584816|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
30584817|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
30669737|NCT00602927|58683484|FG000|Period 2: 14 Days|Protocol Violation|0|||
30669738|NCT00602927|58683485|FG001|Period 2: 14 Days|Protocol Violation|2|||
30669739|NCT00602927|58683484|FG000|Period 3: 13 Days|Protocol Violation|0|||
30669740|NCT00602927|58683485|FG001|Period 3: 13 Days|Protocol Violation|1|||
30584818|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
30584819|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
30584820|NCT01285609|58596523|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
30584821|NCT01285609|58596524|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
30669741|NCT00602927|58683484|FG000|Period 3: 13 Days|MRI data quality|2|||
30669742|NCT00602927|58683485|FG001|Period 3: 13 Days|MRI data quality|2|||
30669743|NCT00602537|58683493|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
30669744|NCT00602537|58683494|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
30669745|NCT00602537|58683493|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
30669746|NCT00602537|58683494|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
30669747|NCT00602537|58683493|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
30669748|NCT00602537|58683494|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
30669749|NCT00602537|58683493|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
30669750|NCT00602537|58683494|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
30669751|NCT00602537|58683493|FG000|Follow Up Study Comparison|Adverse Event|1|||
30584822|NCT01285609|58596523|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
30584823|NCT01285609|58596524|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
30584824|NCT01285492|58596534|FG000|Overall Study|Adverse Event|11|||
30669752|NCT00602537|58683494|FG001|Follow Up Study Comparison|Adverse Event|0|||
30584825|NCT01285492|58596535|FG001|Overall Study|Adverse Event|0|||
30584826|NCT01285492|58596534|FG000|Overall Study|Protocol Violation|3|||
30584827|NCT01285492|58596535|FG001|Overall Study|Protocol Violation|0|||
30584828|NCT01285492|58596534|FG000|Overall Study|Withdrawal by Subject|2|||
30584829|NCT01285492|58596535|FG001|Overall Study|Withdrawal by Subject|1|||
30584830|NCT01285492|58596534|FG000|Overall Study|Death|1|||
30584831|NCT01285492|58596535|FG001|Overall Study|Death|0|||
30584832|NCT01284634|58596545|FG000|Overall Study|Adverse Event|1|||
30584833|NCT01284634|58596546|FG001|Overall Study|Adverse Event|0|||
30584834|NCT01284634|58596547|FG002|Overall Study|Adverse Event|2|||
30584835|NCT01284634|58596548|FG003|Overall Study|Adverse Event|1|||
30584836|NCT01284361|58596558|FG000|Overall Study|Withdrawal by Subject|1|||
30584837|NCT01284361|58596558|FG000|Overall Study|Protocol Violation|5|||
30584838|NCT01284361|58596558|FG000|Overall Study|Adverse Event|1|||
30584839|NCT01284361|58596558|FG000|Overall Study|Lost to Follow-up|2|||
30584840|NCT01284127|58596565|FG000|Overall Study|Adverse Event|2|||
30584841|NCT01284127|58596565|FG000|Overall Study|Withdrawal by Subject|4|||
30584842|NCT01284127|58596565|FG000|Overall Study|Physician Decision|1|||
30584843|NCT01283971|58596571|FG000|Overall Study|Adverse Event|3|||
30584844|NCT01283971|58596572|FG001|Overall Study|Adverse Event|5|||
30584845|NCT01283971|58596571|FG000|Overall Study|Insufficient therapeutic responses|3|||
30584846|NCT01283971|58596572|FG001|Overall Study|Insufficient therapeutic responses|3|||
30584847|NCT01283971|58596571|FG000|Overall Study|Protocol Violation|5|||
30584848|NCT01283971|58596572|FG001|Overall Study|Protocol Violation|1|||
30584849|NCT01283971|58596571|FG000|Overall Study|Refused treatment|3|||
30584850|NCT01283971|58596572|FG001|Overall Study|Refused treatment|1|||
30584851|NCT01283971|58596571|FG000|Overall Study|Failure to return|0|||
30584852|NCT01283971|58596572|FG001|Overall Study|Failure to return|1|||
30584853|NCT01283971|58596571|FG000|Overall Study|Administrative reasons|1|||
30584854|NCT01283971|58596572|FG001|Overall Study|Administrative reasons|1|||
30584855|NCT01283581|58596581|FG000|Overall Study|Lost to Follow-up|8|||
30584856|NCT01283581|58596582|FG001|Overall Study|Lost to Follow-up|6|||
30584857|NCT01283581|58596583|FG002|Overall Study|Lost to Follow-up|8|||
30584858|NCT01283581|58596581|FG000|Overall Study|Withdrawal by Subject|2|||
30584859|NCT01283581|58596582|FG001|Overall Study|Withdrawal by Subject|5|||
30584860|NCT01283581|58596583|FG002|Overall Study|Withdrawal by Subject|2|||
30584861|NCT01283581|58596581|FG000|Overall Study|Adverse Event|1|||
30584862|NCT01283581|58596582|FG001|Overall Study|Adverse Event|1|||
30584863|NCT01283581|58596583|FG002|Overall Study|Adverse Event|4|||
30584864|NCT01283581|58596581|FG000|Overall Study|Physician Decision|0|||
30584865|NCT01283581|58596582|FG001|Overall Study|Physician Decision|1|||
30669753|NCT00602537|58683493|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
30669754|NCT00602537|58683494|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
30669755|NCT00602537|58683493|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
30669756|NCT00602537|58683494|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
30584866|NCT01283581|58596583|FG002|Overall Study|Physician Decision|2|||
30584867|NCT01283581|58596581|FG000|Overall Study|Protocol Violation|0|||
30584868|NCT01283581|58596582|FG001|Overall Study|Protocol Violation|1|||
30584869|NCT01283581|58596583|FG002|Overall Study|Protocol Violation|2|||
30584870|NCT01283581|58596581|FG000|Overall Study|Noncompliance|1|||
30584871|NCT01283581|58596582|FG001|Overall Study|Noncompliance|0|||
30584872|NCT01283581|58596583|FG002|Overall Study|Noncompliance|0|||
30584873|NCT01283581|58596581|FG000|Overall Study|Investigator unblinded|0|||
30584874|NCT01283581|58596582|FG001|Overall Study|Investigator unblinded|0|||
30584875|NCT01283581|58596583|FG002|Overall Study|Investigator unblinded|1|||
30584876|NCT01283581|58596581|FG000|Overall Study|"Early termination"|0|||
30584877|NCT01283581|58596582|FG001|Overall Study|"Early termination"|0|||
30584878|NCT01283581|58596583|FG002|Overall Study|"Early termination"|1|||
30584879|NCT01283542|58596594|FG000|Main Phase|Acute or progressive vision loss|1|||
30584880|NCT01283542|58596594|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
30584881|NCT01283542|58596594|FG000|Main Phase|abnormal laboratory values|5|||
30584882|NCT01283542|58596594|FG000|Extension Phase|Physician Decision|1|||
30584883|NCT01283542|58596594|FG000|Extension Phase|Adverse Event|1|||
30584884|NCT01283542|58596594|FG000|Extension Phase|Administrative problems|1|||
30584885|NCT01283386|58596618|FG000|Overall Study|Death|2|||
30584886|NCT01283386|58596619|FG001|Overall Study|Death|0|||
30584887|NCT01283386|58596618|FG000|Overall Study|Withdrawal by Subject|2|||
30584888|NCT01283386|58596619|FG001|Overall Study|Withdrawal by Subject|1|||
30584889|NCT01283386|58596618|FG000|Overall Study|Relapse of underlying disease|1|||
30669757|NCT00861614|58683502|FG000|Overall Study|Disease Progression|182|||
30669758|NCT00861614|58683503|FG001|Overall Study|Disease Progression|263|||
30584890|NCT01283386|58596619|FG001|Overall Study|Relapse of underlying disease|3|||
30584891|NCT01283386|58596618|FG000|Overall Study|Progression of underlying disease|2|||
30584892|NCT01283386|58596619|FG001|Overall Study|Progression of underlying disease|7|||
30584893|NCT01283386|58596618|FG000|Overall Study|Reason not specified|1|||
30584894|NCT01283386|58596619|FG001|Overall Study|Reason not specified|0|||
30584895|NCT01283386|58596618|FG000|Overall Study|Protocol Violation|0|||
30584896|NCT01283386|58596619|FG001|Overall Study|Protocol Violation|1|||
30584897|NCT01283152|58596627|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
30584898|NCT01283152|58596628|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
30584899|NCT01283152|58596627|FG000|Overall Study|Refused HESA|1|||
30584900|NCT01283152|58596628|FG001|Overall Study|Refused HESA|0|||
30584901|NCT01283035|58596634|FG000|Overall Study|Subject later found ineligible|1|||
30584902|NCT01283464|58596640|FG000|Overall Study|Lost to Follow-up|0|||
30584903|NCT01283464|58596641|FG001|Overall Study|Lost to Follow-up|1|||
30584904|NCT01283464|58596640|FG000|Overall Study|Withdrawal by Subject|1|||
30584905|NCT01283464|58596641|FG001|Overall Study|Withdrawal by Subject|0|||
30584906|NCT01283464|58596640|FG000|Overall Study|Physician Decision|1|||
30584907|NCT01283464|58596641|FG001|Overall Study|Physician Decision|0|||
30584908|NCT01282801|58596649|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
30584909|NCT01282801|58596650|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
30584910|NCT01282372|58596656|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
30584911|NCT01282372|58596656|FG000|Overall Study|Lost to Follow-up|23|||
30584912|NCT01282372|58596656|FG000|Overall Study|Withdrawal by Subject|11|||
30584913|NCT01282372|58596656|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
30584914|NCT01282372|58596656|FG000|Overall Study|Death|1|||
30584915|NCT01282372|58596656|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
30584916|NCT01282372|58596656|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
30584917|NCT01282372|58596656|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
30584918|NCT01282372|58596656|FG000|Overall Study|Adverse Event|12|||
30584919|NCT01282294|58596667|FG000|Overall Study|Lost to Follow-up|14|||
30584920|NCT01282294|58596667|FG000|Overall Study|Screening failure|1|||
30584921|NCT01282294|58596667|FG000|Overall Study|Adverse Event|1|||
30584922|NCT01282294|58596667|FG000|Overall Study|Patient non-compliance|2|||
30584923|NCT01282294|58596667|FG000|Overall Study|Physician Decision|1|||
30669759|NCT00861614|58683502|FG000|Overall Study|Study Drug Toxicity|79|||
30584924|NCT01282216|58596673|FG000|Overall Study|Graft failure|0|||
30584925|NCT01282216|58596674|FG001|Overall Study|Graft failure|0|||
30584926|NCT01282216|58596675|FG002|Overall Study|Graft failure|3|||
30584927|NCT01282216|58596676|FG003|Overall Study|Graft failure|2|||
30584928|NCT01282216|58596673|FG000|Overall Study|Physician Decision|0|||
30584929|NCT01282216|58596674|FG001|Overall Study|Physician Decision|0|||
30584930|NCT01282216|58596675|FG002|Overall Study|Physician Decision|11|||
30584931|NCT01282216|58596676|FG003|Overall Study|Physician Decision|0|||
30584932|NCT01282216|58596673|FG000|Overall Study|Relapse|0|||
30584933|NCT01282216|58596674|FG001|Overall Study|Relapse|0|||
30584934|NCT01282216|58596675|FG002|Overall Study|Relapse|17|||
30669760|NCT00861614|58683503|FG001|Overall Study|Study Drug Toxicity|6|||
30855710|NCT02705625|58883393|FG001|Overall Study|Non-compliance|1|||
30584935|NCT01282216|58596676|FG003|Overall Study|Relapse|6|||
30584936|NCT01282216|58596673|FG000|Overall Study|Death|0|||
30584937|NCT01282216|58596674|FG001|Overall Study|Death|0|||
30584938|NCT01282216|58596675|FG002|Overall Study|Death|2|||
30584939|NCT01282216|58596676|FG003|Overall Study|Death|0|||
30584940|NCT01281865|58596684|FG000|Overall Study|Adverse Event|1|||
30584941|NCT01281865|58596685|FG001|Overall Study|Adverse Event|1|||
30584942|NCT01281865|58596684|FG000|Overall Study|Withdrawal by Subject|1|||
30584943|NCT01281865|58596685|FG001|Overall Study|Withdrawal by Subject|0|||
30584944|NCT01281865|58596684|FG000|Overall Study|Lack of Efficacy|1|||
30584945|NCT01281865|58596685|FG001|Overall Study|Lack of Efficacy|0|||
30584946|NCT01281202|58596693|FG000|Overall Study|Adverse Event|2|||
30584947|NCT01281202|58596694|FG001|Overall Study|Adverse Event|0|||
30584948|NCT01281202|58596693|FG000|Overall Study|Withdrawal by Subject|2|||
30584949|NCT01281202|58596694|FG001|Overall Study|Withdrawal by Subject|2|||
30669761|NCT00861614|58683502|FG000|Overall Study|Death|32|||
30669762|NCT00861614|58683503|FG001|Overall Study|Death|19|||
30669763|NCT00861614|58683502|FG000|Overall Study|Adverse Event|27|||
30669764|NCT00861614|58683503|FG001|Overall Study|Adverse Event|23|||
30669765|NCT00861614|58683502|FG000|Overall Study|Withdrawal by Subject|34|||
30669766|NCT00861614|58683503|FG001|Overall Study|Withdrawal by Subject|35|||
30669767|NCT00861614|58683502|FG000|Overall Study|Other|17|||
30669768|NCT00861614|58683503|FG001|Overall Study|Other|22|||
30669769|NCT00485173|58683511|FG000|Overall Study|Death|4|||
30584950|NCT01281202|58596693|FG000|Overall Study|Protocol Violation|11|||
30584951|NCT01281202|58596694|FG001|Overall Study|Protocol Violation|10|||
30584952|NCT01281202|58596693|FG000|Overall Study|Administrative|2|||
30584953|NCT01281202|58596694|FG001|Overall Study|Administrative|8|||
30584954|NCT01281202|58596693|FG000|Overall Study|Lost to Follow-up|11|||
30584955|NCT01281202|58596694|FG001|Overall Study|Lost to Follow-up|13|||
30584956|NCT01281202|58596693|FG000|Overall Study|Incarceration|0|||
30584957|NCT01281202|58596694|FG001|Overall Study|Incarceration|3|||
30584958|NCT01281124|58596702|FG000|Overall Study|Death|1|||
30584959|NCT01280968|58596710|FG000|Overall Study|Lost to Follow-up|8|||
30584960|NCT01280968|58596711|FG001|Overall Study|Lost to Follow-up|2|||
30584961|NCT01280968|58596710|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
30584962|NCT01280968|58596711|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
30584963|NCT01280968|58596710|FG000|Overall Study|Commuting Problems|2|||
30584964|NCT01280968|58596711|FG001|Overall Study|Commuting Problems|0|||
30584965|NCT01280968|58596710|FG000|Overall Study|Anxiety|2|||
30584966|NCT01280968|58596711|FG001|Overall Study|Anxiety|0|||
30584967|NCT01280968|58596710|FG000|Overall Study|Adverse Event|1|||
30584968|NCT01280968|58596711|FG001|Overall Study|Adverse Event|0|||
30584969|NCT01280968|58596710|FG000|Overall Study|Scheduling Conflicts|1|||
30584970|NCT01280968|58596711|FG001|Overall Study|Scheduling Conflicts|1|||
30584971|NCT01280968|58596710|FG000|Overall Study|Pre-existing Neurological Condition|1|||
30584972|NCT01280968|58596711|FG001|Overall Study|Pre-existing Neurological Condition|0|||
30584973|NCT01280968|58596710|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
30584974|NCT01280968|58596711|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
30584975|NCT01280812|58596721|FG000|Overall Study|Withdrawal by Subject|2|||
30584976|NCT01280812|58596722|FG001|Overall Study|Withdrawal by Subject|1|||
30584977|NCT01280812|58596723|FG002|Overall Study|Withdrawal by Subject|0|||
30584978|NCT01280812|58596721|FG000|Overall Study|Lost to Follow-up|1|||
30584979|NCT01280812|58596722|FG001|Overall Study|Lost to Follow-up|1|||
30584980|NCT01280812|58596723|FG002|Overall Study|Lost to Follow-up|1|||
30584981|NCT01280656|58596735|FG000|Overall Study|Adverse Event|1|||
30584982|NCT01280656|58596736|FG001|Overall Study|Adverse Event|14|||
30584983|NCT01280656|58596737|FG002|Overall Study|Adverse Event|13|||
30584984|NCT01280656|58596735|FG000|Overall Study|Lack of Efficacy|1|||
30584985|NCT01280656|58596736|FG001|Overall Study|Lack of Efficacy|22|||
30584986|NCT01280656|58596737|FG002|Overall Study|Lack of Efficacy|38|||
30584987|NCT01280656|58596735|FG000|Overall Study|Treatment shortening (RGT)|0|||
30584988|NCT01280656|58596736|FG001|Overall Study|Treatment shortening (RGT)|4|||
30584989|NCT01280656|58596737|FG002|Overall Study|Treatment shortening (RGT)|5|||
30584990|NCT01280656|58596735|FG000|Overall Study|Other|1|||
30584991|NCT01280656|58596736|FG001|Overall Study|Other|7|||
30584992|NCT01280656|58596737|FG002|Overall Study|Other|7|||
30584993|NCT01280617|58596747|FG000|Overall Study|Adverse Event|0|||
30584994|NCT01280617|58596748|FG001|Overall Study|Adverse Event|1|||
30584995|NCT01280266|58596756|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
30584996|NCT01280266|58596757|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
30584997|NCT01280266|58596756|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
30584998|NCT01280266|58596757|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
30584999|NCT01279447|58596769|FG000|Overall Study|Lost to Follow-up|3|||
30669770|NCT00485173|58683512|FG001|Overall Study|Death|3|||
30669771|NCT00485173|58683511|FG000|Overall Study|Lost to Follow-up|32|||
30669772|NCT00485173|58683512|FG001|Overall Study|Lost to Follow-up|61|||
30669773|NCT00495469|58683525|FG000|Overall Study|Adverse Event|0|||
30669774|NCT00495469|58683526|FG001|Overall Study|Adverse Event|1|||
30669775|NCT00495469|58683527|FG002|Overall Study|Adverse Event|3|||
30669776|NCT00495469|58683528|FG003|Overall Study|Adverse Event|0|||
30585000|NCT01279447|58596770|FG001|Overall Study|Lost to Follow-up|1|||
30669777|NCT00495469|58683529|FG004|Overall Study|Adverse Event|1|||
30669778|NCT00495469|58683530|FG005|Overall Study|Adverse Event|1|||
30669779|NCT00495469|58683531|FG006|Overall Study|Adverse Event|1|||
30669780|NCT00495469|58683525|FG000|Overall Study|Lost to Follow-up|1|||
30669781|NCT00495469|58683526|FG001|Overall Study|Lost to Follow-up|1|||
30585001|NCT01276639|58596792|FG000|Week 0 to 16|Death|1|||
30585002|NCT01276639|58596793|FG001|Week 0 to 16|Death|0|||
30585003|NCT01276639|58596794|FG002|Week 0 to 16|Death|0|||
30585004|NCT01276639|58596795|FG003|Week 0 to 16|Death|0|||
30585005|NCT01276639|58596796|FG004|Week 0 to 16|Death|0|||
30585006|NCT01276639|58596792|FG000|Week 0 to 16|Adverse Event|11|||
30585007|NCT01276639|58596793|FG001|Week 0 to 16|Adverse Event|8|||
30585008|NCT01276639|58596794|FG002|Week 0 to 16|Adverse Event|11|||
30669782|NCT00495469|58683527|FG002|Overall Study|Lost to Follow-up|3|||
30669783|NCT00495469|58683528|FG003|Overall Study|Lost to Follow-up|1|||
30669784|NCT00495469|58683529|FG004|Overall Study|Lost to Follow-up|0|||
30669785|NCT00495469|58683530|FG005|Overall Study|Lost to Follow-up|0|||
30669786|NCT00495469|58683531|FG006|Overall Study|Lost to Follow-up|0|||
30669787|NCT00495469|58683525|FG000|Overall Study|Protocol Violation|0|||
30585009|NCT01276639|58596795|FG003|Week 0 to 16|Adverse Event|0|||
30585010|NCT01276639|58596796|FG004|Week 0 to 16|Adverse Event|0|||
30585011|NCT01276639|58596792|FG000|Week 0 to 16|Lack of Efficacy|20|||
30585012|NCT01276639|58596793|FG001|Week 0 to 16|Lack of Efficacy|15|||
30585013|NCT01276639|58596794|FG002|Week 0 to 16|Lack of Efficacy|25|||
30585014|NCT01276639|58596795|FG003|Week 0 to 16|Lack of Efficacy|0|||
30585015|NCT01276639|58596796|FG004|Week 0 to 16|Lack of Efficacy|0|||
30585016|NCT01276639|58596792|FG000|Week 0 to 16|Lost to Follow-up|3|||
30669788|NCT00495469|58683526|FG001|Overall Study|Protocol Violation|0|||
30669789|NCT00495469|58683527|FG002|Overall Study|Protocol Violation|0|||
30585017|NCT01276639|58596793|FG001|Week 0 to 16|Lost to Follow-up|5|||
30585018|NCT01276639|58596794|FG002|Week 0 to 16|Lost to Follow-up|3|||
30585019|NCT01276639|58596795|FG003|Week 0 to 16|Lost to Follow-up|0|||
30585020|NCT01276639|58596796|FG004|Week 0 to 16|Lost to Follow-up|0|||
30585021|NCT01276639|58596792|FG000|Week 0 to 16|Withdrawal by Subject|8|||
30669790|NCT00495469|58683528|FG003|Overall Study|Protocol Violation|0|||
30669791|NCT00495469|58683529|FG004|Overall Study|Protocol Violation|1|||
30669792|NCT00495469|58683530|FG005|Overall Study|Protocol Violation|2|||
30669793|NCT00495469|58683531|FG006|Overall Study|Protocol Violation|0|||
30669794|NCT00495469|58683525|FG000|Overall Study|Withdrawal by Subject|5|||
30669795|NCT00495469|58683526|FG001|Overall Study|Withdrawal by Subject|3|||
30669796|NCT00495469|58683527|FG002|Overall Study|Withdrawal by Subject|1|||
30669797|NCT00495469|58683528|FG003|Overall Study|Withdrawal by Subject|3|||
30669798|NCT00495469|58683529|FG004|Overall Study|Withdrawal by Subject|3|||
30669799|NCT00495469|58683530|FG005|Overall Study|Withdrawal by Subject|2|||
30669800|NCT00495469|58683531|FG006|Overall Study|Withdrawal by Subject|3|||
30669801|NCT00495469|58683525|FG000|Overall Study|Lack of Efficacy|0|||
30669802|NCT00495469|58683526|FG001|Overall Study|Lack of Efficacy|0|||
30585022|NCT01276639|58596793|FG001|Week 0 to 16|Withdrawal by Subject|5|||
30585023|NCT01276639|58596794|FG002|Week 0 to 16|Withdrawal by Subject|4|||
30585024|NCT01276639|58596795|FG003|Week 0 to 16|Withdrawal by Subject|0|||
30585025|NCT01276639|58596796|FG004|Week 0 to 16|Withdrawal by Subject|0|||
30585026|NCT01276639|58596792|FG000|Week 0 to 16|Other|7|||
30585027|NCT01276639|58596793|FG001|Week 0 to 16|Other|7|||
30585028|NCT01276639|58596794|FG002|Week 0 to 16|Other|2|||
30585029|NCT01276639|58596795|FG003|Week 0 to 16|Other|0|||
30585030|NCT01276639|58596796|FG004|Week 0 to 16|Other|0|||
30585031|NCT01276639|58596792|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
30585032|NCT01276639|58596793|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
30585033|NCT01276639|58596794|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
30585034|NCT01276639|58596795|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
30585035|NCT01276639|58596796|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
30585036|NCT01276639|58596792|FG000|Week 16 to 52|Death|1|||
30585037|NCT01276639|58596793|FG001|Week 16 to 52|Death|0|||
30780998|NCT03345849|58793138|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
30585038|NCT01276639|58596794|FG002|Week 16 to 52|Death|0|||
30585039|NCT01276639|58596795|FG003|Week 16 to 52|Death|0|||
30585040|NCT01276639|58596796|FG004|Week 16 to 52|Death|0|||
30585041|NCT01276639|58596792|FG000|Week 16 to 52|Adverse Event|10|||
30585042|NCT01276639|58596793|FG001|Week 16 to 52|Adverse Event|13|||
30585043|NCT01276639|58596794|FG002|Week 16 to 52|Adverse Event|0|||
30585044|NCT01276639|58596795|FG003|Week 16 to 52|Adverse Event|1|||
30780999|NCT03345849|58793139|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
30585045|NCT01276639|58596796|FG004|Week 16 to 52|Adverse Event|3|||
30585046|NCT01276639|58596792|FG000|Week 16 to 52|Lack of Efficacy|99|||
30585047|NCT01276639|58596793|FG001|Week 16 to 52|Lack of Efficacy|71|||
30585048|NCT01276639|58596794|FG002|Week 16 to 52|Lack of Efficacy|0|||
30669803|NCT00495469|58683527|FG002|Overall Study|Lack of Efficacy|0|||
30669804|NCT00495469|58683528|FG003|Overall Study|Lack of Efficacy|0|||
30669805|NCT00495469|58683529|FG004|Overall Study|Lack of Efficacy|0|||
30781000|NCT03345849|58793136|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
30669806|NCT00495469|58683530|FG005|Overall Study|Lack of Efficacy|0|||
30669807|NCT00495469|58683531|FG006|Overall Study|Lack of Efficacy|1|||
30669808|NCT00495469|58683525|FG000|Overall Study|Liver function test abnormality|0|||
30669809|NCT00495469|58683526|FG001|Overall Study|Liver function test abnormality|1|||
30669810|NCT00495469|58683527|FG002|Overall Study|Liver function test abnormality|0|||
30669811|NCT00495469|58683528|FG003|Overall Study|Liver function test abnormality|0|||
30585049|NCT01276639|58596795|FG003|Week 16 to 52|Lack of Efficacy|14|||
30585050|NCT01276639|58596796|FG004|Week 16 to 52|Lack of Efficacy|13|||
30585051|NCT01276639|58596792|FG000|Week 16 to 52|Lost to Follow-up|3|||
30585052|NCT01276639|58596793|FG001|Week 16 to 52|Lost to Follow-up|1|||
30585053|NCT01276639|58596794|FG002|Week 16 to 52|Lost to Follow-up|0|||
30585054|NCT01276639|58596795|FG003|Week 16 to 52|Lost to Follow-up|0|||
30585055|NCT01276639|58596796|FG004|Week 16 to 52|Lost to Follow-up|1|||
30585056|NCT01276639|58596792|FG000|Week 16 to 52|Withdrawal by Subject|4|||
30669812|NCT00495469|58683529|FG004|Overall Study|Liver function test abnormality|0|||
30669813|NCT00495469|58683530|FG005|Overall Study|Liver function test abnormality|0|||
30669814|NCT00495469|58683531|FG006|Overall Study|Liver function test abnormality|0|||
30669815|NCT00495469|58683525|FG000|Overall Study|ST depression at randomisation in ECG|0|||
30669816|NCT00495469|58683526|FG001|Overall Study|ST depression at randomisation in ECG|1|||
30669817|NCT00495469|58683527|FG002|Overall Study|ST depression at randomisation in ECG|0|||
30585057|NCT01276639|58596793|FG001|Week 16 to 52|Withdrawal by Subject|4|||
30669818|NCT00495469|58683528|FG003|Overall Study|ST depression at randomisation in ECG|0|||
30669819|NCT00495469|58683529|FG004|Overall Study|ST depression at randomisation in ECG|0|||
30781001|NCT03345849|58793137|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
30781002|NCT03345849|58793138|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
30781003|NCT03345849|58793139|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
30781004|NCT03345849|58793136|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
30781005|NCT03345849|58793137|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
30781006|NCT03345849|58793138|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
30781007|NCT03345849|58793139|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
30585058|NCT01276639|58596794|FG002|Week 16 to 52|Withdrawal by Subject|0|||
30585059|NCT01276639|58596795|FG003|Week 16 to 52|Withdrawal by Subject|0|||
30585060|NCT01276639|58596796|FG004|Week 16 to 52|Withdrawal by Subject|1|||
30585061|NCT01276639|58596792|FG000|Week 16 to 52|Other|10|||
30585062|NCT01276639|58596793|FG001|Week 16 to 52|Other|12|||
30585063|NCT01276639|58596794|FG002|Week 16 to 52|Other|0|||
30585064|NCT01276639|58596795|FG003|Week 16 to 52|Other|1|||
30585065|NCT01276639|58596796|FG004|Week 16 to 52|Other|3|||
30585066|NCT01275625|58596811|FG000|Overall Study|Death|1|||
30585067|NCT01275625|58596811|FG000|Overall Study|Lack of Efficacy|2|||
30585068|NCT01275625|58596811|FG000|Overall Study|Lost to Follow-up|1|||
30585069|NCT01275625|58596811|FG000|Overall Study|Withdrawal by Subject|3|||
30585070|NCT01275625|58596811|FG000|Overall Study|Protocol Violation|1|||
30585071|NCT01275625|58596811|FG000|Overall Study|Adverse Event|4|||
30585072|NCT01275625|58596811|FG000|Overall Study|Other|1|||
30585073|NCT01272193|58596817|FG000|Overall Study|Adverse Event|1|||
30585074|NCT01272193|58596818|FG001|Overall Study|Adverse Event|1|||
30585075|NCT01272193|58596817|FG000|Overall Study|Lack of Efficacy|0|||
30585076|NCT01272193|58596818|FG001|Overall Study|Lack of Efficacy|3|||
30585077|NCT01272193|58596817|FG000|Overall Study|Withdrawal Criteria|1|||
30585078|NCT01272193|58596818|FG001|Overall Study|Withdrawal Criteria|1|||
30585079|NCT01272193|58596817|FG000|Overall Study|Unclassified|8|||
30585080|NCT01272193|58596818|FG001|Overall Study|Unclassified|7|||
30585081|NCT01270828|58596830|FG000|Pregabalin CR SB|Reason Unspecified|0|||
30585082|NCT01270828|58596831|FG001|Pregabalin CR SB|Reason Unspecified|0|||
30585083|NCT01270828|58596832|FG002|Pregabalin CR SB|Reason Unspecified|8|||
30585084|NCT01270828|58596830|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
30585085|NCT01270828|58596831|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
30585086|NCT01270828|58596832|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
30585087|NCT01270828|58596830|FG000|Pregabalin CR SB|Related adverse event|0|||
30781008|NCT03345849|58793136|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
30781009|NCT03345849|58793137|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
30781010|NCT03345849|58793138|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
30781011|NCT03345849|58793139|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
30781012|NCT03345849|58793136|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
30781013|NCT03345849|58793137|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
30585088|NCT01270828|58596831|FG001|Pregabalin CR SB|Related adverse event|0|||
30585089|NCT01270828|58596832|FG002|Pregabalin CR SB|Related adverse event|46|||
30585090|NCT01270828|58596830|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
30585091|NCT01270828|58596831|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
30585092|NCT01270828|58596832|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
30585093|NCT01270828|58596830|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
30585094|NCT01270828|58596831|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
30585095|NCT01270828|58596832|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
30781014|NCT03345849|58793138|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
30855711|NCT02705625|58883394|FG002|Overall Study|Non-compliance|1|||
30855712|NCT02705625|58883392|FG000|Overall Study|Overdosing|0|||
30855713|NCT02705625|58883393|FG001|Overall Study|Overdosing|0|||
30585096|NCT01270828|58596830|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
30585097|NCT01270828|58596831|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
30585098|NCT01270828|58596832|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
30585099|NCT01270828|58596830|FG000|Pregabalin CR SB|Unrelated AE|0|||
30585100|NCT01270828|58596831|FG001|Pregabalin CR SB|Unrelated AE|0|||
30585101|NCT01270828|58596832|FG002|Pregabalin CR SB|Unrelated AE|8|||
30585102|NCT01270828|58596830|FG000|Pregabalin CR SB|Protocol Violation|0|||
30855714|NCT02705625|58883394|FG002|Overall Study|Overdosing|1|||
30855715|NCT02588612|58883402|FG000|Overall Study|Physician Decision|1|||
30585103|NCT01270828|58596831|FG001|Pregabalin CR SB|Protocol Violation|0|||
30585104|NCT01270828|58596832|FG002|Pregabalin CR SB|Protocol Violation|8|||
30585105|NCT01270828|58596830|FG000|Double Blind Phase|Death|0|||
30585106|NCT01270828|58596831|FG001|Double Blind Phase|Death|1|||
30585107|NCT01270828|58596832|FG002|Double Blind Phase|Death|0|||
30585108|NCT01270828|58596830|FG000|Double Blind Phase|Protocol Violation|0|||
30585109|NCT01270828|58596831|FG001|Double Blind Phase|Protocol Violation|1|||
30585110|NCT01270828|58596832|FG002|Double Blind Phase|Protocol Violation|0|||
30585111|NCT01270828|58596830|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
30585112|NCT01270828|58596831|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
30585113|NCT01270828|58596832|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
30585114|NCT01270828|58596830|FG000|Double Blind Phase|Reason Unspecified|7|||
30585115|NCT01270828|58596831|FG001|Double Blind Phase|Reason Unspecified|4|||
30585116|NCT01270828|58596832|FG002|Double Blind Phase|Reason Unspecified|0|||
30585117|NCT01270828|58596830|FG000|Double Blind Phase|Withdrawal by Subject|6|||
30585118|NCT01270828|58596831|FG001|Double Blind Phase|Withdrawal by Subject|15|||
30585119|NCT01270828|58596832|FG002|Double Blind Phase|Withdrawal by Subject|0|||
30585120|NCT01270828|58596830|FG000|Double Blind Phase|Lost to Follow-up|1|||
30585121|NCT01270828|58596831|FG001|Double Blind Phase|Lost to Follow-up|2|||
30585122|NCT01270828|58596832|FG002|Double Blind Phase|Lost to Follow-up|0|||
30585123|NCT01270828|58596830|FG000|Double Blind Phase|Lack of Efficacy|2|||
30585124|NCT01270828|58596831|FG001|Double Blind Phase|Lack of Efficacy|11|||
30585125|NCT01270828|58596832|FG002|Double Blind Phase|Lack of Efficacy|0|||
30585126|NCT01270828|58596830|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
30585127|NCT01270828|58596831|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
30585128|NCT01270828|58596832|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
30585129|NCT01270828|58596830|FG000|Double Blind Phase|Adverse event related to study drug|5|||
30585130|NCT01270828|58596831|FG001|Double Blind Phase|Adverse event related to study drug|7|||
30585131|NCT01270828|58596832|FG002|Double Blind Phase|Adverse event related to study drug|0|||
30585132|NCT01269385|58596840|FG000|Overall Study|Adverse Event|1|||
30585133|NCT01269385|58596841|FG001|Overall Study|Adverse Event|1|||
30585134|NCT01269385|58596842|FG002|Overall Study|Adverse Event|0|||
30585135|NCT01269385|58596843|FG003|Overall Study|Adverse Event|0|||
30585136|NCT01268683|58596853|FG000|Overall Study|Lost to Follow-up|1|||
30585137|NCT01268683|58596853|FG000|Overall Study|Death|1|||
30585138|NCT01268566|58596857|FG000|Overall Study|Lost to Follow-up|1|||
30585139|NCT01268566|58596857|FG000|Overall Study|Withdrawal by Subject|12|||
30585140|NCT01268566|58596857|FG000|Overall Study|Death|30|||
30585141|NCT01268488|58596861|FG000|Overall Study|Adverse Event|3|||
30585142|NCT01268488|58596861|FG000|Overall Study|Physician Decision|2|||
30585143|NCT01268098|58596868|FG000|Overall Study|Adverse Event|1|||
30585144|NCT01268098|58596869|FG001|Overall Study|Adverse Event|0|||
30585145|NCT01268059|58596879|FG000|Overall Study|Lost to Follow-up|0|||
30585146|NCT01268059|58596880|FG001|Overall Study|Lost to Follow-up|1|||
30585147|NCT01268059|58596881|FG002|Overall Study|Lost to Follow-up|0|||
30585148|NCT01268059|58596882|FG003|Overall Study|Lost to Follow-up|0|||
30585149|NCT01268059|58596879|FG000|Overall Study|Withdrawal by Subject|7|||
30585150|NCT01268059|58596880|FG001|Overall Study|Withdrawal by Subject|4|||
30585151|NCT01268059|58596881|FG002|Overall Study|Withdrawal by Subject|0|||
30585152|NCT01268059|58596882|FG003|Overall Study|Withdrawal by Subject|0|||
30585153|NCT01268059|58596879|FG000|Overall Study|Death|20|||
30585154|NCT01268059|58596880|FG001|Overall Study|Death|30|||
30585155|NCT01268059|58596881|FG002|Overall Study|Death|3|||
30585156|NCT01268059|58596882|FG003|Overall Study|Death|5|||
30585157|NCT01268059|58596879|FG000|Overall Study|Progression of disease|1|||
30585158|NCT01268059|58596880|FG001|Overall Study|Progression of disease|0|||
30585159|NCT01268059|58596881|FG002|Overall Study|Progression of disease|0|||
30585160|NCT01268059|58596882|FG003|Overall Study|Progression of disease|0|||
30585161|NCT01267825|58596897|FG000|Overall Study|study terminated. no data collected.|1|||
30585162|NCT01267825|58596898|FG001|Overall Study|study terminated. no data collected.|0|||
30669820|NCT00495469|58683530|FG005|Overall Study|ST depression at randomisation in ECG|0|||
30669821|NCT00495469|58683531|FG006|Overall Study|ST depression at randomisation in ECG|0|||
30585163|NCT01260181|58596904|FG000|Overall Study|Decision of Investigator|1|||
30585164|NCT01260142|58596914|FG000|Treatment Period 1|Study on hold|1|||
30585165|NCT01260142|58596915|FG001|Treatment Period 1|Study on hold|1|||
30585166|NCT01260142|58596916|FG002|Treatment Period 1|Study on hold|0|||
30585167|NCT01260142|58596917|FG003|Treatment Period 1|Study on hold|0|||
30585168|NCT01260142|58596918|FG004|Treatment Period 1|Study on hold|1|||
30585169|NCT01260142|58596919|FG005|Treatment Period 1|Study on hold|2|||
30585170|NCT01260142|58596914|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
30585171|NCT01260142|58596915|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
30585172|NCT01260142|58596916|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
30585173|NCT01260142|58596917|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
30585174|NCT01260142|58596918|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
30585175|NCT01260142|58596919|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
30585176|NCT01260142|58596914|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30585177|NCT01260142|58596915|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30585178|NCT01260142|58596916|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30585179|NCT01260142|58596917|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30585180|NCT01260142|58596918|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30585181|NCT01260142|58596919|FG005|Treatment Period 1|Withdrawal by Subject|1|||
30585182|NCT01259869|58596939|FG000|Overall Study|Duplicated registration|1|||
30585183|NCT01259713|58596945|FG000|Overall Study|Adverse Event|54|||
30585184|NCT01259713|58596946|FG001|Overall Study|Adverse Event|23|||
30585185|NCT01259713|58596945|FG000|Overall Study|Death Not Related to IFI|8|||
30585186|NCT01259713|58596946|FG001|Overall Study|Death Not Related to IFI|1|||
30585187|NCT01259713|58596945|FG000|Overall Study|Investigators Discretion|14|||
30585188|NCT01259713|58596946|FG001|Overall Study|Investigators Discretion|6|||
30585189|NCT01259713|58596945|FG000|Overall Study|Lack of Efficacy|2|||
30585190|NCT01259713|58596946|FG001|Overall Study|Lack of Efficacy|0|||
30585191|NCT01259713|58596945|FG000|Overall Study|Protocol Violation|5|||
30585192|NCT01259713|58596946|FG001|Overall Study|Protocol Violation|4|||
30585193|NCT01259713|58596945|FG000|Overall Study|Subject Withdrew Consent|12|||
30585194|NCT01259713|58596946|FG001|Overall Study|Subject Withdrew Consent|7|||
30585195|NCT01259401|58596954|FG000|4-month Follow-up|Death|0|||
30585196|NCT01259401|58596955|FG001|4-month Follow-up|Death|1|||
30585197|NCT01259401|58596954|FG000|4-month Follow-up|Lost to Follow-up|0|||
30585198|NCT01259401|58596955|FG001|4-month Follow-up|Lost to Follow-up|1|||
30585199|NCT01313923|58596970|FG000|Overall Study|Physician Decision|3|||
30585200|NCT01313884|58596974|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
30585201|NCT01135459|58596980|FG000|Overall Study|Adverse Event|8|||
30585202|NCT01135459|58596981|FG001|Overall Study|Adverse Event|10|||
30585203|NCT01135459|58596980|FG000|Overall Study|Lack of Efficacy|3|||
30585204|NCT01135459|58596981|FG001|Overall Study|Lack of Efficacy|1|||
30585205|NCT01135459|58596980|FG000|Overall Study|Withdrawal by Subject|2|||
30585206|NCT01135459|58596981|FG001|Overall Study|Withdrawal by Subject|3|||
30585207|NCT01135459|58596980|FG000|Overall Study|Protocol Violation|5|||
30585208|NCT01135459|58596981|FG001|Overall Study|Protocol Violation|3|||
30585209|NCT01135459|58596980|FG000|Overall Study|Lost to Follow-up|2|||
30585210|NCT01135459|58596981|FG001|Overall Study|Lost to Follow-up|1|||
30585211|NCT01135459|58596980|FG000|Overall Study|Non-compliance to study procedures|0|||
30585212|NCT01135459|58596981|FG001|Overall Study|Non-compliance to study procedures|1|||
30585213|NCT01135459|58596980|FG000|Overall Study|Other than specified|1|||
30585214|NCT01135459|58596981|FG001|Overall Study|Other than specified|1|||
30585215|NCT01259284|58596990|FG000|Overall Study|Study Termination|2|||
30585216|NCT01259284|58596991|FG001|Overall Study|Study Termination|0|||
30585217|NCT01259284|58596992|FG002|Overall Study|Study Termination|0|||
30585218|NCT01259245|58597002|FG000|Overall Study|Withdrawal by Subject|27|||
30585219|NCT01259245|58597003|FG001|Overall Study|Withdrawal by Subject|24|||
30585220|NCT01259245|58597002|FG000|Overall Study|Death|1|||
30585221|NCT01259245|58597003|FG001|Overall Study|Death|2|||
30585222|NCT01259089|58597011|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
30669822|NCT00861380|58683561|FG000|Overall Study|Withdrawal Information not recorded|8427|||
30669823|NCT00861380|58683562|FG001|Overall Study|Withdrawal Information not recorded|9112|||
30669824|NCT00861380|58683563|FG002|Overall Study|Withdrawal Information not recorded|8872|||
30669825|NCT00861380|58683564|FG003|Overall Study|Withdrawal Information not recorded|3689|||
30669826|NCT00861380|58683565|FG004|Overall Study|Withdrawal Information not recorded|1812|||
30669827|NCT00861380|58683566|FG005|Overall Study|Withdrawal Information not recorded|6249|||
30669828|NCT00861380|58683567|FG006|Overall Study|Withdrawal Information not recorded|3020|||
30669829|NCT00495391|58683602|FG000|Overall Study|Lack of Efficacy|34|||
30669830|NCT00495391|58683603|FG001|Overall Study|Lack of Efficacy|18|||
30669831|NCT00495391|58683602|FG000|Overall Study|Withdrawal by Subject|2|||
30669832|NCT00495391|58683603|FG001|Overall Study|Withdrawal by Subject|3|||
30669833|NCT00869960|58683609|FG000|Overall Study|Lost to Follow-up|2|||
30669834|NCT00494299|58683615|FG000|Overall Study|Adverse Event|93|||
30669835|NCT00494299|58683616|FG001|Overall Study|Adverse Event|13|||
30585223|NCT01259089|58597012|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
30585224|NCT01259089|58597013|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
30585225|NCT01259089|58597014|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
30585226|NCT01259089|58597015|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
30585227|NCT01259089|58597016|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
30585228|NCT01259089|58597011|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
30669836|NCT00494299|58683615|FG000|Overall Study|Lost to Follow-up|1|||
30669837|NCT00494299|58683616|FG001|Overall Study|Lost to Follow-up|0|||
30669838|NCT00494299|58683615|FG000|Overall Study|Physician Decision|0|||
30585229|NCT01259089|58597012|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
30585230|NCT01259089|58597013|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
30585231|NCT01259089|58597014|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
30585232|NCT01259089|58597015|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
30585233|NCT01259089|58597016|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
30669839|NCT00494299|58683616|FG001|Overall Study|Physician Decision|2|||
30669840|NCT00494299|58683615|FG000|Overall Study|Protocol Violation|1|||
30669841|NCT00494299|58683616|FG001|Overall Study|Protocol Violation|2|||
30669842|NCT00494299|58683615|FG000|Overall Study|Withdrawal by Subject|8|||
30669843|NCT00494299|58683616|FG001|Overall Study|Withdrawal by Subject|3|||
30669844|NCT00494299|58683615|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
30669845|NCT00494299|58683616|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
30669846|NCT00494299|58683615|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
30669847|NCT00494299|58683616|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
30669848|NCT00494299|58683615|FG000|Overall Study|Site Closed by Sponsor|6|||
30669849|NCT00494299|58683616|FG001|Overall Study|Site Closed by Sponsor|0|||
30669850|NCT00494299|58683615|FG000|Overall Study|Protocol Driven Decision Point|11|||
30585234|NCT01259089|58597011|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
30585235|NCT01259089|58597012|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
30585236|NCT01259089|58597013|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
30585237|NCT01259089|58597014|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
30585238|NCT01259089|58597015|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
30585239|NCT01259089|58597016|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
30585240|NCT01259089|58597011|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
30585241|NCT01259089|58597012|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
30585242|NCT01259089|58597013|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
30585243|NCT01259089|58597014|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
30585244|NCT01259089|58597015|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
30585245|NCT01259089|58597016|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
30585246|NCT01259089|58597011|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
30585247|NCT01259089|58597012|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
30585248|NCT01259089|58597013|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
30585249|NCT01259089|58597014|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
30585250|NCT01259089|58597015|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
30585251|NCT01259089|58597016|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
30585252|NCT01259089|58597011|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
30585253|NCT01259089|58597012|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
30585254|NCT01259089|58597013|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
30585255|NCT01259089|58597014|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
30585256|NCT01259089|58597015|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
30585257|NCT01259089|58597016|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
30585258|NCT01259089|58597011|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
30585259|NCT01259089|58597012|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
30585260|NCT01259089|58597013|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
30585261|NCT01259089|58597014|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
30585262|NCT01259089|58597015|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
30585263|NCT01259089|58597016|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
30585264|NCT01259089|58597011|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
30585265|NCT01259089|58597012|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
30585266|NCT01259089|58597013|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
30585267|NCT01259089|58597014|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
30585268|NCT01259089|58597015|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
30585269|NCT01259089|58597016|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
30585270|NCT01259089|58597011|FG000|Survival Follow up for Two Years|Death|3|||
30585271|NCT01259089|58597012|FG001|Survival Follow up for Two Years|Death|2|||
30585272|NCT01259089|58597013|FG002|Survival Follow up for Two Years|Death|2|||
30585273|NCT01259089|58597014|FG003|Survival Follow up for Two Years|Death|3|||
30585274|NCT01259089|58597015|FG004|Survival Follow up for Two Years|Death|6|||
30669851|NCT00494299|58683616|FG001|Overall Study|Protocol Driven Decision Point|22|||
30669852|NCT00593684|58683624|FG000|Overall Study|Death|2|||
30669853|NCT00593684|58683625|FG001|Overall Study|Death|1|||
30669854|NCT02963831|58683635|FG000|Overall Study|Progressive Disease|3|||
30669855|NCT02963831|58683636|FG001|Overall Study|Progressive Disease|3|||
30669856|NCT02963831|58683637|FG002|Overall Study|Progressive Disease|16|||
30669857|NCT02963831|58683638|FG003|Overall Study|Progressive Disease|27|||
30669858|NCT02963831|58683635|FG000|Overall Study|Withdrawal by Subject|1|||
30781015|NCT03345849|58793139|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
30781016|NCT03345849|58793136|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
30781017|NCT03345849|58793137|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
30585275|NCT01259089|58597016|FG005|Survival Follow up for Two Years|Death|13|||
30585276|NCT01259089|58597011|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
30585277|NCT01259089|58597012|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
30669859|NCT02963831|58683636|FG001|Overall Study|Withdrawal by Subject|0|||
30669860|NCT02963831|58683637|FG002|Overall Study|Withdrawal by Subject|2|||
30669861|NCT02963831|58683638|FG003|Overall Study|Withdrawal by Subject|4|||
30669862|NCT02963831|58683635|FG000|Overall Study|Adverse Event|0|||
30669863|NCT02963831|58683636|FG001|Overall Study|Adverse Event|1|||
30669864|NCT02963831|58683637|FG002|Overall Study|Adverse Event|1|||
30669865|NCT02963831|58683638|FG003|Overall Study|Adverse Event|2|||
30669866|NCT02963831|58683635|FG000|Overall Study|Death|0|||
30669867|NCT02963831|58683636|FG001|Overall Study|Death|0|||
30669868|NCT02963831|58683637|FG002|Overall Study|Death|0|||
30669869|NCT02963831|58683638|FG003|Overall Study|Death|2|||
30585278|NCT01259089|58597013|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
30585279|NCT01259089|58597014|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
30585280|NCT01259089|58597015|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
30585281|NCT01259089|58597016|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
30585282|NCT01259089|58597011|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
30585283|NCT01259089|58597012|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
30585284|NCT01259089|58597013|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
30585285|NCT01259089|58597014|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
30585286|NCT01259089|58597015|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
30669870|NCT00859898|58683653|FG000|Overall Study|Lack of Efficacy|0|||
30669871|NCT00859898|58683654|FG001|Overall Study|Lack of Efficacy|1|||
30669872|NCT00859898|58683655|FG002|Overall Study|Lack of Efficacy|1|||
30669873|NCT00859898|58683653|FG000|Overall Study|Adverse Event|4|||
30669874|NCT00859898|58683654|FG001|Overall Study|Adverse Event|9|||
30669875|NCT00859898|58683655|FG002|Overall Study|Adverse Event|8|||
30669876|NCT00859898|58683653|FG000|Overall Study|Withdrawal by Subject|11|||
30669877|NCT00859898|58683654|FG001|Overall Study|Withdrawal by Subject|8|||
30669878|NCT00859898|58683655|FG002|Overall Study|Withdrawal by Subject|11|||
30585287|NCT01259089|58597016|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
30585288|NCT01258738|58597032|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
30585289|NCT01258738|58597033|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
30585290|NCT01258738|58597032|FG000|Double-blind Period|Withdrawal by Subject|2|||
30585291|NCT01258738|58597033|FG001|Double-blind Period|Withdrawal by Subject|2|||
30585292|NCT01258738|58597032|FG000|Double-blind Period|Protocol Violation|1|||
30585293|NCT01258738|58597033|FG001|Double-blind Period|Protocol Violation|1|||
30585294|NCT01258738|58597032|FG000|Double-blind Period|Adverse Event|3|||
30585295|NCT01258738|58597033|FG001|Double-blind Period|Adverse Event|1|||
30585296|NCT01258738|58597032|FG000|Open-label Period|Did not meet inclusion criteria|0|||
30585297|NCT01258738|58597033|FG001|Open-label Period|Did not meet inclusion criteria|1|||
30585298|NCT01258738|58597032|FG000|Open-label Period|Insufficient clinical response|5|||
30585299|NCT01258738|58597033|FG001|Open-label Period|Insufficient clinical response|3|||
30585300|NCT01258738|58597032|FG000|Open-label Period|Lost to Follow-up|0|||
30585301|NCT01258738|58597033|FG001|Open-label Period|Lost to Follow-up|2|||
30585302|NCT01258738|58597032|FG000|Open-label Period|Withdrawal by Subject|5|||
30585303|NCT01258738|58597033|FG001|Open-label Period|Withdrawal by Subject|6|||
30585304|NCT01258738|58597032|FG000|Open-label Period|Protocol Violation|2|||
30585305|NCT01258738|58597033|FG001|Open-label Period|Protocol Violation|2|||
30585306|NCT01258738|58597032|FG000|Open-label Period|Adverse Event|4|||
30585307|NCT01258738|58597033|FG001|Open-label Period|Adverse Event|5|||
30585308|NCT01258738|58597032|FG000|Open-label Period|Other Reasons|0|||
30585309|NCT01258738|58597033|FG001|Open-label Period|Other Reasons|1|||
30585310|NCT01258738|58597032|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
30585311|NCT01258738|58597033|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
30585312|NCT01258660|58597041|FG000|Overall Study|Adverse Event|2|||
30585313|NCT01258660|58597042|FG001|Overall Study|Adverse Event|4|||
30585314|NCT01258660|58597041|FG000|Overall Study|Withdrawal by Subject|3|||
30585315|NCT01258660|58597042|FG001|Overall Study|Withdrawal by Subject|0|||
30585316|NCT01258660|58597041|FG000|Overall Study|due to relocation|2|||
30585317|NCT01258660|58597042|FG001|Overall Study|due to relocation|0|||
30585318|NCT01258660|58597041|FG000|Overall Study|Protocol Violation|0|||
30585319|NCT01258660|58597042|FG001|Overall Study|Protocol Violation|1|||
30585320|NCT01258660|58597041|FG000|Overall Study|Invalid for primary analysis data set|4|||
30585321|NCT01258660|58597042|FG001|Overall Study|Invalid for primary analysis data set|6|||
30585322|NCT01258348|58597049|FG000|Overall Study|Adverse Event|1|||
30585323|NCT01258348|58597050|FG001|Overall Study|Adverse Event|1|||
30585324|NCT01258348|58597051|FG002|Overall Study|Adverse Event|3|||
30669879|NCT00859898|58683653|FG000|Overall Study|Death|0|||
30585325|NCT01258348|58597052|FG003|Overall Study|Adverse Event|2|||
30585326|NCT01258348|58597053|FG004|Overall Study|Adverse Event|4|||
30669880|NCT00859898|58683654|FG001|Overall Study|Death|0|||
30781018|NCT03345849|58793138|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
30585327|NCT01258348|58597049|FG000|Overall Study|Progressive Disease|0|||
30585328|NCT01258348|58597050|FG001|Overall Study|Progressive Disease|3|||
30585329|NCT01258348|58597051|FG002|Overall Study|Progressive Disease|0|||
30669881|NCT00859898|58683655|FG002|Overall Study|Death|1|||
30669882|NCT00859898|58683653|FG000|Overall Study|Lost to Follow-up|10|||
30669883|NCT00859898|58683654|FG001|Overall Study|Lost to Follow-up|11|||
30585330|NCT01258348|58597052|FG003|Overall Study|Progressive Disease|2|||
30585331|NCT01258348|58597053|FG004|Overall Study|Progressive Disease|2|||
30585332|NCT01258348|58597049|FG000|Overall Study|Physician Decision|0|||
30585333|NCT01258348|58597050|FG001|Overall Study|Physician Decision|0|||
30669884|NCT00859898|58683655|FG002|Overall Study|Lost to Follow-up|5|||
30669885|NCT00859898|58683653|FG000|Overall Study|poor/non-compliance|2|||
30855716|NCT02588612|58883402|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
30855717|NCT02588612|58883402|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
30855718|NCT02588612|58883402|FG000|Overall Study|Death prior to T-cell infusion|1|||
30855719|NCT02704689|58883415|FG000|Overall Study|Physician Decision|1|||
30855720|NCT02704689|58883415|FG000|Overall Study|Study device not implanted|2|||
30855721|NCT02704143|58883419|FG000|Overall Study|disease progression|10|||
30855722|NCT02586506|58883423|FG000|Overall Study|Protocol Violation|6|||
30855723|NCT02586506|58883423|FG000|Overall Study|Lost to Follow-up|1|||
30855724|NCT02586506|58883423|FG000|Overall Study|Other Reason|2|||
30855725|NCT00109031|58883431|FG000|Overall Study|Adverse Event|0|||
30855726|NCT00109031|58883432|FG001|Overall Study|Adverse Event|0|||
30855727|NCT00109031|58883433|FG002|Overall Study|Adverse Event|1|||
30855728|NCT00109031|58883434|FG003|Overall Study|Adverse Event|0|||
30855729|NCT00109031|58883431|FG000|Overall Study|Withdrawal by Subject|0|||
30855730|NCT00109031|58883432|FG001|Overall Study|Withdrawal by Subject|1|||
30855731|NCT00109031|58883433|FG002|Overall Study|Withdrawal by Subject|0|||
30855732|NCT00109031|58883434|FG003|Overall Study|Withdrawal by Subject|0|||
30855733|NCT00109031|58883431|FG000|Overall Study|Physician Decision|0|||
30855734|NCT00109031|58883432|FG001|Overall Study|Physician Decision|1|||
30855735|NCT00109031|58883433|FG002|Overall Study|Physician Decision|0|||
30855736|NCT00109031|58883434|FG003|Overall Study|Physician Decision|0|||
30855737|NCT00109031|58883431|FG000|Overall Study|Protocol Violation|0|||
30855738|NCT00109031|58883432|FG001|Overall Study|Protocol Violation|0|||
30855739|NCT00109031|58883433|FG002|Overall Study|Protocol Violation|1|||
30855740|NCT00109031|58883434|FG003|Overall Study|Protocol Violation|0|||
30855741|NCT01664624|58883448|FG000|Overall Study|Adverse Event|0|||
30855742|NCT01664624|58883449|FG001|Overall Study|Adverse Event|1|||
30855743|NCT01664624|58883450|FG002|Overall Study|Adverse Event|0|||
30855744|NCT01664624|58883451|FG003|Overall Study|Adverse Event|0|||
30855745|NCT02702193|58883463|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
30855746|NCT02702193|58883464|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
30855747|NCT02702193|58883463|FG000|4 Month Follow up|Withdrawal by Subject|1|||
30855748|NCT02702193|58883464|FG001|4 Month Follow up|Withdrawal by Subject|0|||
30855749|NCT02702193|58883463|FG000|4 Month Follow up|Lost to Follow-up|17|||
30855750|NCT02702193|58883464|FG001|4 Month Follow up|Lost to Follow-up|18|||
30585334|NCT01258348|58597051|FG002|Overall Study|Physician Decision|0|||
30585335|NCT01258348|58597052|FG003|Overall Study|Physician Decision|2|||
30585336|NCT01258348|58597053|FG004|Overall Study|Physician Decision|0|||
30585337|NCT01258348|58597049|FG000|Overall Study|Withdrawal by Subject|0|||
30585338|NCT01258348|58597050|FG001|Overall Study|Withdrawal by Subject|1|||
30585339|NCT01258348|58597051|FG002|Overall Study|Withdrawal by Subject|0|||
30781019|NCT03345849|58793139|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
30781020|NCT03345849|58793136|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
30781021|NCT03345849|58793137|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
30781022|NCT03345849|58793138|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
30781023|NCT03345849|58793139|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
30781024|NCT03345849|58793136|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
30781025|NCT03345849|58793137|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
30781026|NCT03345849|58793138|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
30781027|NCT03345849|58793139|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
30781028|NCT03011307|58793149|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
30781029|NCT03011307|58793150|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
30781030|NCT03011307|58793149|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
30781031|NCT03011307|58793150|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
30781032|NCT03011307|58793149|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
30781033|NCT03011307|58793150|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
30781034|NCT03798717|58793162|FG000|Overall Study|Failed Screening|0|||
30781035|NCT03798717|58793163|FG001|Overall Study|Failed Screening|0|||
30781036|NCT03798717|58793164|FG002|Overall Study|Failed Screening|0|||
30781037|NCT03798717|58793165|FG003|Overall Study|Failed Screening|0|||
30781038|NCT03798717|58793166|FG004|Overall Study|Failed Screening|0|||
30781039|NCT03798717|58793167|FG005|Overall Study|Failed Screening|1|||
30781040|NCT03798717|58793162|FG000|Overall Study|Physician Decision|1|||
30781041|NCT03798717|58793163|FG001|Overall Study|Physician Decision|0|||
30855751|NCT02702193|58883463|FG000|8 Month Follow up|Withdrawal by Subject|1|||
30855752|NCT02702193|58883464|FG001|8 Month Follow up|Withdrawal by Subject|0|||
30958851|NCT01587703|59024039|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
30958852|NCT01587703|59024040|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
30958853|NCT01587703|59024041|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
30958854|NCT01587703|59024023|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30958855|NCT01587703|59024024|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30958856|NCT01587703|59024025|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30958857|NCT01587703|59024026|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30958858|NCT01587703|59024027|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30958859|NCT01587703|59024028|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30958860|NCT01587703|59024029|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30958861|NCT01587703|59024030|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30958862|NCT01587703|59024031|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
30669886|NCT00859898|58683654|FG001|Overall Study|poor/non-compliance|0|||
30669887|NCT00859898|58683655|FG002|Overall Study|poor/non-compliance|0|||
30669888|NCT00859898|58683653|FG000|Overall Study|No longer meets criteria|0|||
30669889|NCT00859898|58683654|FG001|Overall Study|No longer meets criteria|1|||
30669890|NCT00859898|58683655|FG002|Overall Study|No longer meets criteria|0|||
30669891|NCT00859898|58683653|FG000|Overall Study|non-specified|1|||
30669892|NCT00859898|58683654|FG001|Overall Study|non-specified|1|||
30669893|NCT00859898|58683655|FG002|Overall Study|non-specified|1|||
30958863|NCT01587703|59024032|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
30958864|NCT01587703|59024033|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
30958865|NCT01587703|59024034|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30958866|NCT01587703|59024035|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30958867|NCT01587703|59024036|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30585340|NCT01258348|58597052|FG003|Overall Study|Withdrawal by Subject|0|||
30585341|NCT01258348|58597053|FG004|Overall Study|Withdrawal by Subject|0|||
30585342|NCT01258075|58597069|FG000|Overall Study|Adverse Event|8|||
30585343|NCT01258075|58597070|FG001|Overall Study|Adverse Event|3|||
30585344|NCT01258075|58597069|FG000|Overall Study|Lost to Follow-up|11|||
30585345|NCT01258075|58597070|FG001|Overall Study|Lost to Follow-up|6|||
30585346|NCT01258075|58597069|FG000|Overall Study|Withdrawal by Subject|10|||
30585347|NCT01258075|58597070|FG001|Overall Study|Withdrawal by Subject|7|||
30585348|NCT01258075|58597069|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
30585349|NCT01258075|58597070|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
30585350|NCT01258075|58597069|FG000|Overall Study|Other|12|||
30585351|NCT01258075|58597070|FG001|Overall Study|Other|5|||
30585352|NCT01257568|58597076|FG000|Overall Study|Lost to Follow-up|2|||
30585353|NCT01257568|58597076|FG000|Overall Study|Withdrawal by Subject|6|||
30585354|NCT01257568|58597076|FG000|Overall Study|Terminated|1|||
30585355|NCT01257568|58597076|FG000|Overall Study|Component Revision|24|||
30585356|NCT01256788|58597085|FG000|Overall Study|Lost to Follow-up|5|||
30585357|NCT01256788|58597086|FG001|Overall Study|Lost to Follow-up|8|||
30585358|NCT01256788|58597087|FG002|Overall Study|Lost to Follow-up|3|||
30585359|NCT01256671|58597095|FG000|Overall Study|Adverse Event|29|||
30585360|NCT01256671|58597095|FG000|Overall Study|Lost to Follow-up|16|||
30585361|NCT01256671|58597095|FG000|Overall Study|Withdrawal by Subject|31|||
30585362|NCT01256671|58597095|FG000|Overall Study|Physician Decision|3|||
30585363|NCT01256671|58597095|FG000|Overall Study|Lack of Efficacy|4|||
30585364|NCT01256671|58597095|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
30585365|NCT01256593|58597099|FG000|Overall Study|Protocol Violation|26|||
30669894|NCT00859586|58683664|FG000|Overall Study|Donors|4|||
30669895|NCT00494221|58683671|FG000|Overall Study|Death|15|||
30781042|NCT03798717|58793164|FG002|Overall Study|Physician Decision|1|||
30781043|NCT03798717|58793165|FG003|Overall Study|Physician Decision|0|||
30781044|NCT03798717|58793166|FG004|Overall Study|Physician Decision|0|||
30781045|NCT03798717|58793167|FG005|Overall Study|Physician Decision|0|||
30781046|NCT03798717|58793162|FG000|Overall Study|Withdrawal by Subject|0|||
30781047|NCT03798717|58793163|FG001|Overall Study|Withdrawal by Subject|0|||
30781048|NCT03798717|58793164|FG002|Overall Study|Withdrawal by Subject|0|||
30781049|NCT03798717|58793165|FG003|Overall Study|Withdrawal by Subject|1|||
30781050|NCT03798717|58793166|FG004|Overall Study|Withdrawal by Subject|0|||
30781051|NCT03798717|58793167|FG005|Overall Study|Withdrawal by Subject|0|||
30781052|NCT03798717|58793162|FG000|Overall Study|Lost to Follow-up|1|||
30781053|NCT03798717|58793163|FG001|Overall Study|Lost to Follow-up|0|||
30781054|NCT03798717|58793164|FG002|Overall Study|Lost to Follow-up|0|||
30781055|NCT03798717|58793165|FG003|Overall Study|Lost to Follow-up|1|||
30958868|NCT01587703|59024037|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30781056|NCT03798717|58793166|FG004|Overall Study|Lost to Follow-up|0|||
30958869|NCT01587703|59024038|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30585366|NCT01256593|58597099|FG000|Overall Study|No Drug Administration Information|2|||
30585367|NCT01256593|58597099|FG000|Overall Study|No Visit After Treatment|186|||
30585368|NCT01256476|58597105|FG000|Overall Study|Adverse Event|2|||
30585369|NCT01256476|58597106|FG001|Overall Study|Adverse Event|1|||
30669896|NCT00494221|58683672|FG001|Overall Study|Death|9|||
30669897|NCT00494221|58683673|FG002|Overall Study|Death|14|||
30585370|NCT01256476|58597105|FG000|Overall Study|Withdrawal by Subject|2|||
30585371|NCT01256476|58597106|FG001|Overall Study|Withdrawal by Subject|1|||
30585372|NCT01256476|58597105|FG000|Overall Study|Lost to Follow-up|1|||
30585373|NCT01256476|58597106|FG001|Overall Study|Lost to Follow-up|2|||
30585374|NCT01256476|58597105|FG000|Overall Study|Persistent ALT or AST elevation|1|||
30585375|NCT01256476|58597106|FG001|Overall Study|Persistent ALT or AST elevation|0|||
30585376|NCT01256476|58597105|FG000|Overall Study|Physician Decision|0|||
30585377|NCT01256476|58597106|FG001|Overall Study|Physician Decision|1|||
30585378|NCT01256476|58597105|FG000|Overall Study|Subject non-compliance|0|||
30585379|NCT01256476|58597106|FG001|Overall Study|Subject non-compliance|1|||
30585380|NCT01256476|58597105|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
30585381|NCT01256476|58597106|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
30585382|NCT01256008|58597115|FG000|Overall Study|Lost to Follow-up|6|||
30585383|NCT01256008|58597116|FG001|Overall Study|Lost to Follow-up|4|||
30585384|NCT01256008|58597117|FG002|Overall Study|Lost to Follow-up|11|||
30585385|NCT01256008|58597115|FG000|Overall Study|Withdrawal by Subject|2|||
30585386|NCT01256008|58597116|FG001|Overall Study|Withdrawal by Subject|3|||
30585387|NCT01256008|58597117|FG002|Overall Study|Withdrawal by Subject|10|||
30585388|NCT01255423|58597129|FG000|Overall Study|Abnormal Laboratory value|3|||
30585389|NCT01255423|58597130|FG001|Overall Study|Abnormal Laboratory value|2|||
30585390|NCT01255423|58597129|FG000|Overall Study|Use of prohibited medications|0|||
30585391|NCT01255423|58597130|FG001|Overall Study|Use of prohibited medications|1|||
30585392|NCT01255306|58597138|FG000|Overall Study|Physician Decision|1|||
30585393|NCT01255306|58597139|FG001|Overall Study|Physician Decision|1|||
30585394|NCT01254721|58597150|FG000|Overall Study|Lost to Follow-up|0|||
30585395|NCT01254721|58597151|FG001|Overall Study|Lost to Follow-up|4|||
30585396|NCT01254721|58597150|FG000|Overall Study|Lack of Efficacy|4|||
30585397|NCT01254721|58597151|FG001|Overall Study|Lack of Efficacy|2|||
30585398|NCT01254721|58597150|FG000|Overall Study|Death|0|||
30585399|NCT01254721|58597151|FG001|Overall Study|Death|1|||
30585400|NCT01254721|58597150|FG000|Overall Study|technical problum|1|||
30585401|NCT01254721|58597151|FG001|Overall Study|technical problum|0|||
30585402|NCT01254721|58597150|FG000|Overall Study|Adverse Event|2|||
30585403|NCT01254721|58597151|FG001|Overall Study|Adverse Event|3|||
30585404|NCT01254721|58597150|FG000|Overall Study|Withdrawal by Subject|8|||
30585405|NCT01254721|58597151|FG001|Overall Study|Withdrawal by Subject|11|||
30585406|NCT01254721|58597150|FG000|Overall Study|Wrongly randomization|0|||
30585407|NCT01254721|58597151|FG001|Overall Study|Wrongly randomization|1|||
30585408|NCT01254643|58597157|FG000|Overall Study|Withdrawal by Subject|1|||
30585409|NCT01254604|58597163|FG000|Overall Study|Lost to Follow-up|1|||
30585410|NCT01254604|58597164|FG001|Overall Study|Lost to Follow-up|1|||
30669898|NCT00494221|58683671|FG000|Overall Study|Withdrawal by Subject|1|||
30669899|NCT00494221|58683672|FG001|Overall Study|Withdrawal by Subject|2|||
30669900|NCT00494221|58683673|FG002|Overall Study|Withdrawal by Subject|0|||
30669901|NCT00857948|58683685|FG000|Overall Study|Withdrawal by Subject|2|||
30669902|NCT00857948|58683686|FG001|Overall Study|Withdrawal by Subject|0|||
30669903|NCT00857948|58683687|FG002|Overall Study|Withdrawal by Subject|0|||
30669904|NCT00857948|58683688|FG003|Overall Study|Withdrawal by Subject|0|||
30669905|NCT00857948|58683685|FG000|Overall Study|Protocol Violation|1|||
30585411|NCT01254604|58597163|FG000|Overall Study|Protocol Violation|2|||
30669906|NCT00857948|58683686|FG001|Overall Study|Protocol Violation|0|||
30669907|NCT00857948|58683687|FG002|Overall Study|Protocol Violation|1|||
30585412|NCT01254604|58597164|FG001|Overall Study|Protocol Violation|2|||
30585413|NCT01254604|58597163|FG000|Overall Study|Withdrawal by Subject|2|||
30585414|NCT01254604|58597164|FG001|Overall Study|Withdrawal by Subject|4|||
30585415|NCT01254604|58597163|FG000|Overall Study|Adverse Event|3|||
30585416|NCT01254604|58597164|FG001|Overall Study|Adverse Event|2|||
30585417|NCT01254565|58597176|FG000|Overall Study|Non-compliance to Study Procedures|0|||
30585418|NCT01254565|58597177|FG001|Overall Study|Non-compliance to Study Procedures|0|||
30585419|NCT01254565|58597178|FG002|Overall Study|Non-compliance to Study Procedures|0|||
30585420|NCT01254565|58597179|FG003|Overall Study|Non-compliance to Study Procedures|0|||
30585421|NCT01254565|58597180|FG004|Overall Study|Non-compliance to Study Procedures|1|||
30669908|NCT00857948|58683688|FG003|Overall Study|Protocol Violation|0|||
30781057|NCT03798717|58793167|FG005|Overall Study|Lost to Follow-up|0|||
30585422|NCT01254565|58597181|FG005|Overall Study|Non-compliance to Study Procedures|0|||
30585423|NCT01254565|58597176|FG000|Overall Study|Did not Receive Treatment|1|||
30669909|NCT00866606|58683698|FG000|Overall Study|Lost to Follow-up|3|||
30781058|NCT03798717|58793162|FG000|Overall Study|Adverse Event|0|||
30781059|NCT03798717|58793163|FG001|Overall Study|Adverse Event|1|||
30781060|NCT03798717|58793164|FG002|Overall Study|Adverse Event|0|||
30585424|NCT01254565|58597177|FG001|Overall Study|Did not Receive Treatment|1|||
30585425|NCT01254565|58597178|FG002|Overall Study|Did not Receive Treatment|0|||
30585426|NCT01254565|58597179|FG003|Overall Study|Did not Receive Treatment|0|||
30585427|NCT01254565|58597180|FG004|Overall Study|Did not Receive Treatment|3|||
30585428|NCT01254565|58597181|FG005|Overall Study|Did not Receive Treatment|4|||
30669910|NCT00866606|58683698|FG000|Overall Study|Adverse Event|1|||
30669911|NCT00857792|58683702|FG000|Overall Study|inadequate image quality for analysis|12|||
30585429|NCT01254565|58597176|FG000|Overall Study|Other|0|||
30585430|NCT01254565|58597177|FG001|Overall Study|Other|0|||
30585431|NCT01254565|58597178|FG002|Overall Study|Other|0|||
30669912|NCT00601835|58683708|FG000|Overall Study|Withdrawal by Subject|9|||
30669913|NCT00601835|58683709|FG001|Overall Study|Withdrawal by Subject|6|||
30669914|NCT00601835|58683708|FG000|Overall Study|Physician Decision|1|||
30585432|NCT01254565|58597179|FG003|Overall Study|Other|1|||
30585433|NCT01254565|58597180|FG004|Overall Study|Other|0|||
30585434|NCT01254565|58597181|FG005|Overall Study|Other|0|||
30585435|NCT01254409|58597199|FG000|Overall Study|Adverse Event|0|||
30585436|NCT01254409|58597200|FG001|Overall Study|Adverse Event|1|||
30585437|NCT01254409|58597201|FG002|Overall Study|Adverse Event|0|||
30585438|NCT01254409|58597202|FG003|Overall Study|Adverse Event|0|||
30585439|NCT01254331|58597215|FG000|Initial Phase|Adverse Event|3|||
30585440|NCT01254331|58597215|FG000|Initial Phase|Withdrawal by Subject|1|||
30585441|NCT01254331|58597215|FG000|Initial Phase|Pregnancy|1|||
30585442|NCT01254331|58597215|FG000|Extension Phase|Lack of Efficacy|1|||
30585443|NCT01254331|58597215|FG000|Extension Phase|Lost to Follow-up|3|||
30669915|NCT00601835|58683709|FG001|Overall Study|Physician Decision|0|||
30669916|NCT00601835|58683708|FG000|Overall Study|Lost to Follow-up|37|||
30669917|NCT00601835|58683709|FG001|Overall Study|Lost to Follow-up|5|||
30669918|NCT00601835|58683708|FG000|Overall Study|Adverse Event|1|||
30669919|NCT00601835|58683709|FG001|Overall Study|Adverse Event|1|||
30669920|NCT00601835|58683708|FG000|Overall Study|Relocate|12|||
30669921|NCT00601835|58683709|FG001|Overall Study|Relocate|2|||
30669922|NCT00857246|58683715|FG000|Induction Regimen|Adverse Event|1|||
30669923|NCT00857246|58683715|FG000|Induction Regimen|disease-related complications|1|||
30669924|NCT00857246|58683715|FG000|Induction Regimen|Withdrawal by Subject|1|||
30669925|NCT00857246|58683715|FG000|Surgery (Curative)|disease progression|6|||
30669926|NCT00857246|58683715|FG000|ChemoRT|Withdrawal by Subject|1|||
30669927|NCT00857246|58683715|FG000|ChemoRT|Adverse Event|2|||
30669928|NCT00856856|58683722|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
30669929|NCT00856856|58683722|FG000|4-year Clinical Follow-up|Missed visit|1|||
30669930|NCT00493285|58683737|FG000|Overall Study|Lost to Follow-up|0|||
30669931|NCT00493285|58683738|FG001|Overall Study|Lost to Follow-up|0|||
30669932|NCT00493285|58683739|FG002|Overall Study|Lost to Follow-up|0|||
30669933|NCT00493285|58683740|FG003|Overall Study|Lost to Follow-up|0|||
30669934|NCT00493285|58683741|FG004|Overall Study|Lost to Follow-up|1|||
30669935|NCT00493285|58683742|FG005|Overall Study|Lost to Follow-up|0|||
30669936|NCT00856778|58683756|FG000|Overall Study|Adverse Event|7|||
30669937|NCT00856778|58683756|FG000|Overall Study|Withdrawal by Subject|10|||
30669938|NCT00856778|58683756|FG000|Overall Study|Study deviation|2|||
30669939|NCT00856778|58683756|FG000|Overall Study|Lost to Follow-up|5|||
30669940|NCT00603473|58683760|FG000|Overall Study|Adverse Event|4|||
30585444|NCT01254292|58597230|FG000|Comparative Phase|Adverse Event|25|||
30585445|NCT01254292|58597231|FG001|Comparative Phase|Adverse Event|25|||
30585446|NCT01254292|58597230|FG000|Comparative Phase|Lost to Follow-up|3|||
30585447|NCT01254292|58597231|FG001|Comparative Phase|Lost to Follow-up|21|||
30585448|NCT01254292|58597230|FG000|Comparative Phase|Pregnancy|2|||
30585449|NCT01254292|58597231|FG001|Comparative Phase|Pregnancy|6|||
30669941|NCT00603473|58683760|FG000|Overall Study|Lack of Efficacy|4|||
30585450|NCT01254292|58597230|FG000|Comparative Phase|Withdrawal by Subject|20|||
30585451|NCT01254292|58597231|FG001|Comparative Phase|Withdrawal by Subject|21|||
30585452|NCT01254292|58597230|FG000|Comparative Phase|Protocol Violation|1|||
30585453|NCT01254292|58597231|FG001|Comparative Phase|Protocol Violation|2|||
30585454|NCT01254292|58597230|FG000|Comparative Phase|Wish for pregnancy|4|||
30585455|NCT01254292|58597231|FG001|Comparative Phase|Wish for pregnancy|6|||
30585456|NCT01254292|58597230|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
30585457|NCT01254292|58597231|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
30585458|NCT01254292|58597230|FG000|LCS12 Extension Phase|Adverse Event|9|||
30585459|NCT01254292|58597231|FG001|LCS12 Extension Phase|Adverse Event|0|||
30585460|NCT01254292|58597230|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
30669942|NCT00603473|58683760|FG000|Overall Study|Protocol Violation|1|||
30669943|NCT00486889|58683764|FG000|Overall Study|Death|3|||
30669944|NCT00486889|58683764|FG000|Overall Study|Non-compliant|2|||
30669945|NCT00486889|58683764|FG000|Overall Study|Withdrawal by Subject|6|||
30669946|NCT00486811|58683771|FG000|Overall Study|Adverse Event|28|||
30669947|NCT00486811|58683772|FG001|Overall Study|Adverse Event|60|||
30669948|NCT00486811|58683773|FG002|Overall Study|Adverse Event|135|||
30585461|NCT01254292|58597231|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
30585462|NCT01254292|58597230|FG000|LCS12 Extension Phase|Other unknown|4|||
30585463|NCT01254292|58597231|FG001|LCS12 Extension Phase|Other unknown|0|||
30585464|NCT01254292|58597230|FG000|LCS12 Extension Phase|Pregnancy|2|||
30585465|NCT01254292|58597231|FG001|LCS12 Extension Phase|Pregnancy|0|||
30585466|NCT01254292|58597230|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
30585467|NCT01254292|58597231|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
30669949|NCT00486811|58683771|FG000|Overall Study|Lack of Efficacy|34|||
30669950|NCT00486811|58683772|FG001|Overall Study|Lack of Efficacy|14|||
30669951|NCT00486811|58683773|FG002|Overall Study|Lack of Efficacy|7|||
30669952|NCT00486811|58683771|FG000|Overall Study|Lost to Follow-up|4|||
30585468|NCT01254019|58597240|FG000|Overall Study|Adverse Event|0|||
30669953|NCT00486811|58683772|FG001|Overall Study|Lost to Follow-up|6|||
30669954|NCT00486811|58683773|FG002|Overall Study|Lost to Follow-up|4|||
30585469|NCT01254019|58597241|FG001|Overall Study|Adverse Event|2|||
30585470|NCT01254019|58597240|FG000|Overall Study|Protocol Violation|1|||
30585471|NCT01254019|58597241|FG001|Overall Study|Protocol Violation|0|||
30585472|NCT01254019|58597240|FG000|Overall Study|Withdrawal by Subject|0|||
30585473|NCT01254019|58597241|FG001|Overall Study|Withdrawal by Subject|2|||
30585474|NCT01253317|58597250|FG000|Overall Study|Adverse Event|2|||
30585475|NCT01253200|58597263|FG000|Overall Study|Death|1|||
30585476|NCT01253200|58597264|FG001|Overall Study|Death|0|||
30585477|NCT01253200|58597265|FG002|Overall Study|Death|0|||
30585478|NCT01253200|58597266|FG003|Overall Study|Death|0|||
30585479|NCT01253200|58597267|FG004|Overall Study|Death|0|||
30585480|NCT01253200|58597263|FG000|Overall Study|Lost to Follow-up|1|||
30585481|NCT01253200|58597264|FG001|Overall Study|Lost to Follow-up|1|||
30585482|NCT01253200|58597265|FG002|Overall Study|Lost to Follow-up|0|||
30585483|NCT01253200|58597266|FG003|Overall Study|Lost to Follow-up|0|||
30585484|NCT01253200|58597267|FG004|Overall Study|Lost to Follow-up|0|||
30585485|NCT01253200|58597263|FG000|Overall Study|Withdrawal by Subject|2|||
30585486|NCT01253200|58597264|FG001|Overall Study|Withdrawal by Subject|0|||
30585487|NCT01253200|58597265|FG002|Overall Study|Withdrawal by Subject|0|||
30585488|NCT01253200|58597266|FG003|Overall Study|Withdrawal by Subject|0|||
30585489|NCT01253200|58597267|FG004|Overall Study|Withdrawal by Subject|0|||
30585490|NCT01253200|58597263|FG000|Overall Study|Protocol Violation|1|||
30585491|NCT01253200|58597264|FG001|Overall Study|Protocol Violation|4|||
30585492|NCT01253200|58597265|FG002|Overall Study|Protocol Violation|0|||
30585493|NCT01253200|58597266|FG003|Overall Study|Protocol Violation|0|||
30585494|NCT01253200|58597267|FG004|Overall Study|Protocol Violation|5|||
30585495|NCT01253200|58597263|FG000|Overall Study|intents|10|||
30585496|NCT01253200|58597264|FG001|Overall Study|intents|10|||
30585497|NCT01253200|58597265|FG002|Overall Study|intents|1|||
30585498|NCT01253200|58597266|FG003|Overall Study|intents|3|||
30585499|NCT01253200|58597267|FG004|Overall Study|intents|0|||
30585500|NCT01253200|58597263|FG000|Overall Study|Attempts|6|||
30585501|NCT01253200|58597264|FG001|Overall Study|Attempts|4|||
30669955|NCT00486811|58683771|FG000|Overall Study|Withdrawal by Subject|33|||
30781061|NCT03798717|58793165|FG003|Overall Study|Adverse Event|0|||
30669956|NCT00486811|58683772|FG001|Overall Study|Withdrawal by Subject|44|||
30669957|NCT00486811|58683773|FG002|Overall Study|Withdrawal by Subject|58|||
30669958|NCT00486811|58683771|FG000|Overall Study|Study drug non-compliant|5|||
30669959|NCT00486811|58683772|FG001|Overall Study|Study drug non-compliant|6|||
30669960|NCT00486811|58683773|FG002|Overall Study|Study drug non-compliant|3|||
30669961|NCT00486811|58683771|FG000|Overall Study|All other|18|||
30669962|NCT00486811|58683772|FG001|Overall Study|All other|11|||
30669963|NCT00486811|58683773|FG002|Overall Study|All other|7|||
30669964|NCT00486265|58683781|FG000|Overall Study|Adverse Event|1|||
30669965|NCT00486265|58683781|FG000|Overall Study|Lack of Efficacy|8|||
30669966|NCT02151604|58683785|FG000|Overall Study|Lost to Follow-up|3|||
30669967|NCT02151604|58683785|FG000|Overall Study|Withdrawal by Subject|2|||
30669968|NCT02151604|58683785|FG000|Overall Study|Physician Decision|3|||
30669969|NCT02151604|58683785|FG000|Overall Study|Death|1|||
30669970|NCT00466921|58683790|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
30669971|NCT00466921|58683790|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
30669972|NCT00466921|58683790|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
30669973|NCT00466921|58683790|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
30669974|NCT00466921|58683790|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
30669975|NCT00466921|58683790|FG000|Follow up for a Minimum of 1 Year|Death|6|||
30669976|NCT00601523|58683796|FG000|Overall Study|Adverse Event|42|||
30669977|NCT00601523|58683797|FG001|Overall Study|Adverse Event|14|||
30669978|NCT00601523|58683796|FG000|Overall Study|Lack of Efficacy|3|||
30669979|NCT00601523|58683797|FG001|Overall Study|Lack of Efficacy|0|||
30669980|NCT00601523|58683796|FG000|Overall Study|Protocol Violation|5|||
30669981|NCT00601523|58683797|FG001|Overall Study|Protocol Violation|1|||
30669982|NCT00601523|58683796|FG000|Overall Study|Lost to Follow-up|0|||
30669983|NCT00601523|58683797|FG001|Overall Study|Lost to Follow-up|1|||
30669984|NCT00601523|58683796|FG000|Overall Study|Withdrawal by Subject|18|||
30781062|NCT03798717|58793166|FG004|Overall Study|Adverse Event|0|||
30585502|NCT01253200|58597265|FG002|Overall Study|Attempts|1|||
30585503|NCT01253200|58597266|FG003|Overall Study|Attempts|2|||
30585504|NCT01253200|58597267|FG004|Overall Study|Attempts|0|||
30585505|NCT01253044|58597278|FG000|Overall Study|Lost to Follow-up|38|||
30585506|NCT01253044|58597279|FG001|Overall Study|Lost to Follow-up|29|||
30585507|NCT01252966|58597287|FG000|Overall Study|Lost to Follow-up|16|||
30585508|NCT01252966|58597288|FG001|Overall Study|Lost to Follow-up|10|||
30585509|NCT01252966|58597287|FG000|Overall Study|Withdrawal by Subject|7|||
30585510|NCT01252966|58597288|FG001|Overall Study|Withdrawal by Subject|3|||
30585511|NCT01252810|58597298|FG000|Overall Study|Withdrawal by Subject|4|||
30585512|NCT01252810|58597299|FG001|Overall Study|Withdrawal by Subject|1|||
30669985|NCT00601523|58683797|FG001|Overall Study|Withdrawal by Subject|9|||
30585513|NCT01252810|58597298|FG000|Overall Study|Lost to Follow-up|0|||
30585514|NCT01252810|58597299|FG001|Overall Study|Lost to Follow-up|1|||
30585515|NCT01252810|58597298|FG000|Overall Study|Physician Decision|2|||
30585516|NCT01252810|58597299|FG001|Overall Study|Physician Decision|1|||
30585517|NCT01252810|58597298|FG000|Overall Study|Various reasons|8|||
30585518|NCT01252810|58597299|FG001|Overall Study|Various reasons|0|||
30585519|NCT01252186|58597308|FG000|Overall Study|Adverse Event|9|||
30585520|NCT01252186|58597309|FG001|Overall Study|Adverse Event|6|||
30585521|NCT01252186|58597310|FG002|Overall Study|Adverse Event|8|||
30585522|NCT01252186|58597308|FG000|Overall Study|Withdrawal by Subject|2|||
30585523|NCT01252186|58597309|FG001|Overall Study|Withdrawal by Subject|5|||
30585524|NCT01252186|58597310|FG002|Overall Study|Withdrawal by Subject|2|||
30585525|NCT01252186|58597308|FG000|Overall Study|Physician Decision|0|||
30585526|NCT01252186|58597309|FG001|Overall Study|Physician Decision|0|||
30585527|NCT01252186|58597310|FG002|Overall Study|Physician Decision|1|||
30585528|NCT01252186|58597308|FG000|Overall Study|Non-compliance|0|||
30585529|NCT01252186|58597309|FG001|Overall Study|Non-compliance|3|||
30585530|NCT01252186|58597310|FG002|Overall Study|Non-compliance|4|||
30585531|NCT01252186|58597308|FG000|Overall Study|Protocol Violation|0|||
30585532|NCT01252186|58597309|FG001|Overall Study|Protocol Violation|0|||
30585533|NCT01252186|58597310|FG002|Overall Study|Protocol Violation|1|||
30585534|NCT01252186|58597308|FG000|Overall Study|Pregnancy|2|||
30585535|NCT01252186|58597309|FG001|Overall Study|Pregnancy|2|||
30585536|NCT01252186|58597310|FG002|Overall Study|Pregnancy|0|||
30585537|NCT01252186|58597308|FG000|Overall Study|Sponsor Request|2|||
30585538|NCT01252186|58597309|FG001|Overall Study|Sponsor Request|1|||
30585539|NCT01252186|58597310|FG002|Overall Study|Sponsor Request|0|||
30585540|NCT01252186|58597308|FG000|Overall Study|Lost to Follow-up|10|||
30585541|NCT01252186|58597309|FG001|Overall Study|Lost to Follow-up|10|||
30585542|NCT01252186|58597310|FG002|Overall Study|Lost to Follow-up|11|||
30585543|NCT01252186|58597308|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
30585544|NCT01252186|58597309|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
30585545|NCT01252186|58597310|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
30585546|NCT01251952|58597345|FG000|Overall Study|Adverse Event|1|||
30585547|NCT01251367|58597349|FG000|Overall Study|Protocol Violation|1|||
30585548|NCT01251367|58597349|FG000|Overall Study|Lack of Efficacy|2|||
30585549|NCT01251367|58597349|FG000|Overall Study|Adverse Event|19|||
30585550|NCT01251367|58597349|FG000|Overall Study|Withdrawal by Subject|36|||
30669986|NCT00601523|58683796|FG000|Overall Study|Other|9|||
30669987|NCT00601523|58683797|FG001|Overall Study|Other|1|||
30669988|NCT00466687|58683803|FG000|Overall Study|Adverse Event|1|||
30669989|NCT00466687|58683803|FG000|Overall Study|Other complicating illness|3|||
30669990|NCT00466687|58683803|FG000|Overall Study|Withdrawal by Subject|1|||
30669991|NCT00466687|58683803|FG000|Overall Study|Disease progression|29|||
30669992|NCT00465985|58683825|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
30669993|NCT00465985|58683826|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
30669994|NCT00465985|58683825|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
30669995|NCT00465985|58683826|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
30669996|NCT00465985|58683825|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
30669997|NCT00465985|58683826|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
30669998|NCT00465985|58683825|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
30669999|NCT00465985|58683826|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
30670000|NCT00454051|58683837|FG000|Overall Study|Adverse Event|1|||
30670001|NCT00454051|58683838|FG001|Overall Study|Adverse Event|2|||
30670002|NCT00454051|58683837|FG000|Overall Study|Withdrawal by Subject|1|||
30670003|NCT00454051|58683838|FG001|Overall Study|Withdrawal by Subject|0|||
30670004|NCT00454051|58683837|FG000|Overall Study|Protocol Violation|1|||
30585551|NCT01251367|58597349|FG000|Overall Study|Lost to Follow-up|5|||
30670005|NCT00454051|58683838|FG001|Overall Study|Protocol Violation|1|||
30855753|NCT02702193|58883463|FG000|8 Month Follow up|Lost to Follow-up|14|||
30855754|NCT02702193|58883464|FG001|8 Month Follow up|Lost to Follow-up|18|||
30585552|NCT01251367|58597349|FG000|Overall Study|Subject Required Alternative Treatment|7|||
30585553|NCT01251367|58597349|FG000|Overall Study|No Study Drug Available|1|||
30585554|NCT01251367|58597349|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
30585555|NCT01251367|58597349|FG000|Overall Study|End of Study Visit Performed in Error|1|||
30585556|NCT01250509|58597355|FG000|Overall Study|Lost to Follow-up|5|||
30585557|NCT01250509|58597356|FG001|Overall Study|Lost to Follow-up|2|||
30585558|NCT01250119|58597364|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
30670006|NCT00484939|58683846|FG000|Overall Study|Death|9|||
30585559|NCT01250119|58597365|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
30585560|NCT01250119|58597364|FG000|Diagnostic Phase|Participants Not Tested|44|||
30585561|NCT01250119|58597365|FG001|Diagnostic Phase|Participants Not Tested|0|||
30585562|NCT01250119|58597364|FG000|Treatment Phase|Progressive Disease|0|||
30585563|NCT01250119|58597365|FG001|Treatment Phase|Progressive Disease|32|||
30585564|NCT01250119|58597364|FG000|Treatment Phase|Death|0|||
30585565|NCT01250119|58597365|FG001|Treatment Phase|Death|2|||
30585566|NCT01250119|58597364|FG000|Treatment Phase|Withdrawal by Subject|0|||
30585567|NCT01250119|58597365|FG001|Treatment Phase|Withdrawal by Subject|1|||
30585568|NCT01250119|58597364|FG000|Treatment Phase|Adverse Event|0|||
30585569|NCT01250119|58597365|FG001|Treatment Phase|Adverse Event|2|||
30585570|NCT01250119|58597364|FG000|Treatment Phase|Unknown reason|0|||
30585571|NCT01250119|58597365|FG001|Treatment Phase|Unknown reason|4|||
30585572|NCT01250002|58597374|FG000|Overall Study|Change to open surgical procedure|4|||
30585573|NCT01250002|58597375|FG001|Overall Study|Change to open surgical procedure|3|||
30585574|NCT01246960|58597383|FG000|Overall Study|Lost to Follow-up|3|||
30585575|NCT01246960|58597384|FG001|Overall Study|Lost to Follow-up|1|||
30585576|NCT01246960|58597383|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
30670007|NCT00484939|58683847|FG001|Overall Study|Death|13|||
30670008|NCT00484939|58683846|FG000|Overall Study|Adverse Event|22|||
30670009|NCT00484939|58683847|FG001|Overall Study|Adverse Event|12|||
30670010|NCT00484939|58683846|FG000|Overall Study|Patient Withdrew Consent|19|||
30585577|NCT01246960|58597384|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
30585578|NCT01244620|58597390|FG000|Overall Study|Study terminated|4|||
30585579|NCT01244620|58597391|FG001|Overall Study|Study terminated|4|||
30670011|NCT00484939|58683847|FG001|Overall Study|Patient Withdrew Consent|10|||
30670012|NCT00484939|58683846|FG000|Overall Study|Protocol Violation|3|||
30670013|NCT00484939|58683847|FG001|Overall Study|Protocol Violation|3|||
30670014|NCT00484939|58683846|FG000|Overall Study|Lost to Follow-up|0|||
30670015|NCT00484939|58683847|FG001|Overall Study|Lost to Follow-up|3|||
30670016|NCT00484939|58683846|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
30670017|NCT00484939|58683847|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
30585580|NCT01244620|58597392|FG002|Overall Study|Study terminated|4|||
30585581|NCT01244620|58597393|FG003|Overall Study|Study terminated|4|||
30585582|NCT01267201|58597403|FG000|First Intervention Period|Withdrawal by Subject|1|||
30585583|NCT01267201|58597404|FG001|First Intervention Period|Withdrawal by Subject|0|||
30585584|NCT01267201|58597405|FG002|First Intervention Period|Withdrawal by Subject|0|||
30585585|NCT01267201|58597406|FG003|First Intervention Period|Withdrawal by Subject|0|||
30585586|NCT01267201|58597407|FG004|First Intervention Period|Withdrawal by Subject|0|||
30585587|NCT01267201|58597408|FG005|First Intervention Period|Withdrawal by Subject|0|||
30585588|NCT01267201|58597403|FG000|Second Intervention Period|Withdrawal by Subject|0|||
30585589|NCT01267201|58597404|FG001|Second Intervention Period|Withdrawal by Subject|1|||
30585590|NCT01267201|58597405|FG002|Second Intervention Period|Withdrawal by Subject|0|||
30585591|NCT01267201|58597406|FG003|Second Intervention Period|Withdrawal by Subject|0|||
30585592|NCT01267201|58597407|FG004|Second Intervention Period|Withdrawal by Subject|0|||
30585593|NCT01267201|58597408|FG005|Second Intervention Period|Withdrawal by Subject|0|||
30585594|NCT01266967|58597418|FG000|Overall Study|Death|69|||
30585595|NCT01266967|58597419|FG001|Overall Study|Death|61|||
30585596|NCT01266967|58597418|FG000|Overall Study|Study Closed/Terminated|15|||
30585597|NCT01266967|58597419|FG001|Overall Study|Study Closed/Terminated|17|||
30585598|NCT01266967|58597418|FG000|Overall Study|Lost to Follow-up|2|||
30585599|NCT01266967|58597419|FG001|Overall Study|Lost to Follow-up|1|||
30585600|NCT01266967|58597418|FG000|Overall Study|Physician Decision|0|||
30585601|NCT01266967|58597419|FG001|Overall Study|Physician Decision|1|||
30585602|NCT01266967|58597418|FG000|Overall Study|Withdrawal by Subject|3|||
30585603|NCT01266967|58597419|FG001|Overall Study|Withdrawal by Subject|3|||
30585604|NCT01266850|58597433|FG000|Overall Study|Lost to Follow-up|19|||
30585605|NCT01266850|58597434|FG001|Overall Study|Lost to Follow-up|19|||
30585606|NCT01266850|58597435|FG002|Overall Study|Lost to Follow-up|13|||
30585607|NCT01266850|58597436|FG003|Overall Study|Lost to Follow-up|13|||
30585608|NCT01266850|58597437|FG004|Overall Study|Lost to Follow-up|12|||
30585609|NCT01266850|58597433|FG000|Overall Study|Withdrawal by Subject|8|||
30585610|NCT01266850|58597434|FG001|Overall Study|Withdrawal by Subject|9|||
30585611|NCT01266850|58597435|FG002|Overall Study|Withdrawal by Subject|6|||
30585612|NCT01266850|58597436|FG003|Overall Study|Withdrawal by Subject|9|||
30585613|NCT01266850|58597437|FG004|Overall Study|Withdrawal by Subject|12|||
30585614|NCT01266850|58597433|FG000|Overall Study|Physician Decision|3|||
30670018|NCT00484939|58683846|FG000|Overall Study|Disease progression|67|||
30958870|NCT01587703|59024039|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30958871|NCT01587703|59024040|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30585615|NCT01266850|58597434|FG001|Overall Study|Physician Decision|6|||
30670019|NCT00484939|58683847|FG001|Overall Study|Disease progression|88|||
30670020|NCT00484939|58683846|FG000|Overall Study|Screen Failure|2|||
30670021|NCT00484939|58683847|FG001|Overall Study|Screen Failure|2|||
30585616|NCT01266850|58597435|FG002|Overall Study|Physician Decision|4|||
30585617|NCT01266850|58597436|FG003|Overall Study|Physician Decision|4|||
30585618|NCT01266850|58597437|FG004|Overall Study|Physician Decision|3|||
30585619|NCT01266850|58597433|FG000|Overall Study|Protocol Violation|0|||
30585620|NCT01266850|58597434|FG001|Overall Study|Protocol Violation|1|||
30585621|NCT01266850|58597435|FG002|Overall Study|Protocol Violation|0|||
30585622|NCT01266850|58597436|FG003|Overall Study|Protocol Violation|1|||
30585623|NCT01266850|58597437|FG004|Overall Study|Protocol Violation|2|||
30585624|NCT01266850|58597433|FG000|Overall Study|Adverse Event|0|||
30585625|NCT01266850|58597434|FG001|Overall Study|Adverse Event|0|||
30585626|NCT01266850|58597435|FG002|Overall Study|Adverse Event|0|||
30585627|NCT01266850|58597436|FG003|Overall Study|Adverse Event|0|||
30585628|NCT01266850|58597437|FG004|Overall Study|Adverse Event|1|||
30585629|NCT01266850|58597433|FG000|Overall Study|Site Closure|0|||
30585630|NCT01266850|58597434|FG001|Overall Study|Site Closure|1|||
30585631|NCT01266850|58597435|FG002|Overall Study|Site Closure|1|||
30585632|NCT01266850|58597436|FG003|Overall Study|Site Closure|1|||
30585633|NCT01266850|58597437|FG004|Overall Study|Site Closure|0|||
30585634|NCT01266460|58597449|FG000|Overall Study|Adverse Event|3|||
30585635|NCT01266460|58597449|FG000|Overall Study|Withdrawal by Subject|5|||
30585636|NCT01266460|58597449|FG000|Overall Study|Disease Progression|18|||
30585637|NCT01266460|58597449|FG000|Overall Study|Not otherwise specified|8|||
30585638|NCT01266265|58597455|FG000|Overall Study|Death|95|||
30585639|NCT01266265|58597456|FG001|Overall Study|Death|73|||
30585640|NCT01266265|58597455|FG000|Overall Study|Lost to Follow-up|23|||
30585641|NCT01266265|58597456|FG001|Overall Study|Lost to Follow-up|28|||
30585642|NCT01266265|58597455|FG000|Overall Study|Withdrawal by Subject|13|||
30585643|NCT01266265|58597456|FG001|Overall Study|Withdrawal by Subject|11|||
30585644|NCT01266265|58597455|FG000|Overall Study|Respiratory-related adverse event|2|||
30585645|NCT01266265|58597456|FG001|Overall Study|Respiratory-related adverse event|1|||
30585646|NCT01266265|58597455|FG000|Overall Study|Transferred care to another provider|22|||
30585647|NCT01266265|58597456|FG001|Overall Study|Transferred care to another provider|28|||
30585648|NCT01266265|58597455|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
30585649|NCT01266265|58597456|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
30670022|NCT00484939|58683846|FG000|Overall Study|Reason Not Specified|11|||
30670023|NCT00484939|58683847|FG001|Overall Study|Reason Not Specified|6|||
30670024|NCT00453973|58683855|FG000|Overall Study|Adverse Event|4|||
30670025|NCT00453973|58683856|FG001|Overall Study|Adverse Event|9|||
30670026|NCT00453973|58683855|FG000|Overall Study|Withdrawal by Subject|7|||
30670027|NCT00453973|58683856|FG001|Overall Study|Withdrawal by Subject|6|||
30585650|NCT01266265|58597455|FG000|Overall Study|Enrolled in another clinical study|15|||
30585651|NCT01266265|58597456|FG001|Overall Study|Enrolled in another clinical study|26|||
30585652|NCT01266265|58597455|FG000|Overall Study|Non-compliance|8|||
30585653|NCT01266265|58597456|FG001|Overall Study|Non-compliance|5|||
30585654|NCT01266265|58597455|FG000|Overall Study|Lung transplant|6|||
30585655|NCT01266265|58597456|FG001|Overall Study|Lung transplant|5|||
30585656|NCT01266265|58597455|FG000|Overall Study|Site closed early|4|||
30585657|NCT01266265|58597456|FG001|Overall Study|Site closed early|3|||
30585658|NCT01266265|58597455|FG000|Overall Study|Clinical worsening|1|||
30585659|NCT01266265|58597456|FG001|Overall Study|Clinical worsening|1|||
30585660|NCT01266148|58597481|FG000|Overall Study|Adverse Event|2|||
30585661|NCT01266148|58597482|FG001|Overall Study|Adverse Event|0|||
30585662|NCT01266148|58597481|FG000|Overall Study|Ongoing rejection|1|||
30585663|NCT01266148|58597482|FG001|Overall Study|Ongoing rejection|0|||
30585664|NCT01266148|58597481|FG000|Overall Study|2 2R rejections|1|||
30585665|NCT01266148|58597482|FG001|Overall Study|2 2R rejections|0|||
30585666|NCT01266148|58597481|FG000|Overall Study|Death|2|||
30670028|NCT00453973|58683855|FG000|Overall Study|PI Decision|0|||
30670029|NCT00453973|58683856|FG001|Overall Study|PI Decision|2|||
30670030|NCT00453973|58683855|FG000|Overall Study|Relocation|1|||
30670031|NCT00453973|58683856|FG001|Overall Study|Relocation|0|||
30670032|NCT00453973|58683855|FG000|Overall Study|Renal transplant|1|||
30781063|NCT03798717|58793167|FG005|Overall Study|Adverse Event|0|||
30585667|NCT01266148|58597482|FG001|Overall Study|Death|3|||
30585668|NCT01266148|58597481|FG000|Overall Study|missing mGFR value + AE|1|||
30585669|NCT01266148|58597482|FG001|Overall Study|missing mGFR value + AE|0|||
30585670|NCT01266070|58597488|FG000|Overall Study|Adverse Event|3|||
30585671|NCT01266070|58597488|FG000|Overall Study|Protocol Violation|1|||
30585672|NCT01265992|58597492|FG000|Overall Study|Lost to Follow-up|1|||
30585673|NCT01265992|58597492|FG000|Overall Study|Withdrawal by Subject|1|||
30585674|NCT01265992|58597492|FG000|Overall Study|Adverse Event|1|||
30585675|NCT01265992|58597492|FG000|Overall Study|Administrative reasons|2|||
30585676|NCT01265992|58597492|FG000|Overall Study|Stopped treatment|3|||
30670033|NCT00453973|58683856|FG001|Overall Study|Renal transplant|1|||
30585677|NCT01265992|58597492|FG000|Overall Study|Did not receive treatment|1|||
30781064|NCT03798717|58793162|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
30585678|NCT01265953|58597498|FG000|Overall Study|Non compliance|5|||
30670034|NCT00453973|58683855|FG000|Overall Study|Site closed by sponsor|3|||
30670035|NCT00453973|58683856|FG001|Overall Study|Site closed by sponsor|0|||
30670036|NCT00453973|58683855|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
30670037|NCT00453973|58683856|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
30585679|NCT01265953|58597499|FG001|Overall Study|Non compliance|3|||
30585680|NCT01265875|58597505|FG000|Overall Study|Uncooperative/unreliable|1|||
30585681|NCT01265797|58597512|FG000|Run-in Month|Withdrawal by Subject|0|||
30585682|NCT01265797|58597513|FG001|Run-in Month|Withdrawal by Subject|4|||
30585683|NCT01265797|58597512|FG000|Run-in Month|1st seizure during run-in month|0|||
30585684|NCT01265797|58597513|FG001|Run-in Month|1st seizure during run-in month|1|||
30585685|NCT01265797|58597512|FG000|Blinded Month|Lack of Efficacy|5|||
30585686|NCT01265797|58597513|FG001|Blinded Month|Lack of Efficacy|0|||
30585687|NCT01265797|58597512|FG000|Blinded Month|Lost to Follow-up|1|||
30585688|NCT01265797|58597513|FG001|Blinded Month|Lost to Follow-up|0|||
30585689|NCT01265797|58597512|FG000|Blinded Month|Protocol Violation|2|||
30585690|NCT01265797|58597513|FG001|Blinded Month|Protocol Violation|1|||
30585691|NCT01265797|58597512|FG000|Blinded Month|Adverse Event|2|||
30585692|NCT01265797|58597513|FG001|Blinded Month|Adverse Event|0|||
30585693|NCT01265797|58597512|FG000|Blinded Month|Diary data incomplete|0|||
30585694|NCT01265797|58597513|FG001|Blinded Month|Diary data incomplete|1|||
30585695|NCT01265797|58597512|FG000|Open Label Month|Lost to Follow-up|0|||
30585696|NCT01265797|58597513|FG001|Open Label Month|Lost to Follow-up|1|||
30585697|NCT01265719|58597523|FG000|Overall Study|Does not meet entrance criteria|0|||
30585698|NCT01265719|58597524|FG001|Overall Study|Does not meet entrance criteria|3|||
30585699|NCT01265719|58597523|FG000|Overall Study|Other reasons|2|||
30585700|NCT01265719|58597524|FG001|Overall Study|Other reasons|0|||
30585701|NCT01265719|58597523|FG000|Overall Study|Withdrawal by Subject|8|||
30585702|NCT01265719|58597524|FG001|Overall Study|Withdrawal by Subject|3|||
30585703|NCT01265719|58597523|FG000|Overall Study|Lost to Follow-up|2|||
30585704|NCT01265719|58597524|FG001|Overall Study|Lost to Follow-up|7|||
30585705|NCT01265719|58597523|FG000|Overall Study|Adverse Event|2|||
30585706|NCT01265719|58597524|FG001|Overall Study|Adverse Event|0|||
30585707|NCT01265563|58597556|FG000|Overall Study|Withdrawal by Subject|0|||
30585708|NCT01265563|58597557|FG001|Overall Study|Withdrawal by Subject|1|||
30585709|NCT01265563|58597558|FG002|Overall Study|Withdrawal by Subject|1|||
30585710|NCT01265563|58597559|FG003|Overall Study|Withdrawal by Subject|0|||
30585711|NCT01265563|58597560|FG004|Overall Study|Withdrawal by Subject|2|||
30585712|NCT01265056|58597579|FG000|Initial Study Period|Withdrawal by Subject|1|||
30585713|NCT01265056|58597580|FG001|Initial Study Period|Withdrawal by Subject|1|||
30585714|NCT01265056|58597579|FG000|Initial Study Period|Withdrawal by Subject|1|||
30585715|NCT01265056|58597580|FG001|Initial Study Period|Withdrawal by Subject|1|||
30585716|NCT01265056|58597579|FG000|Follow up|Lost to Follow-up|7|||
30585717|NCT01265056|58597580|FG001|Follow up|Lost to Follow-up|3|||
30585718|NCT01264939|58597588|FG000|Overall Study|Adverse Event|1|||
30585719|NCT01264939|58597589|FG001|Overall Study|Adverse Event|3|||
30585720|NCT01264939|58597588|FG000|Overall Study|Lost to Follow-up|0|||
30585721|NCT01264939|58597589|FG001|Overall Study|Lost to Follow-up|3|||
30585722|NCT01264939|58597588|FG000|Overall Study|Physician Decision|1|||
30585723|NCT01264939|58597589|FG001|Overall Study|Physician Decision|1|||
30585724|NCT01264939|58597588|FG000|Overall Study|Patient/Guardian Decision|8|||
30585725|NCT01264939|58597589|FG001|Overall Study|Patient/Guardian Decision|10|||
30585726|NCT01264939|58597588|FG000|Overall Study|Disease Progression|8|||
30585727|NCT01264939|58597589|FG001|Overall Study|Disease Progression|11|||
30585728|NCT01264081|58597595|FG000|Participants Screened|Screening failures|30|||
30585729|NCT01264081|58597595|FG000|Started Treatment|Withdrawal by Subject|1|||
30585730|NCT01264081|58597595|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
30585731|NCT01263925|58597601|FG000|Overall Study|Protocol Violation|1|||
30585732|NCT01263925|58597602|FG001|Overall Study|Protocol Violation|0|||
30585733|NCT01263925|58597601|FG000|Overall Study|Lack of Efficacy|0|||
30585734|NCT01263925|58597602|FG001|Overall Study|Lack of Efficacy|1|||
30585735|NCT01263925|58597601|FG000|Overall Study|Adverse Event|23|||
30585736|NCT01263925|58597602|FG001|Overall Study|Adverse Event|22|||
30585737|NCT01263925|58597601|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
30585738|NCT01263925|58597602|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
30585739|NCT01263925|58597601|FG000|Overall Study|Withdrawal by Subject|6|||
30585740|NCT01263925|58597602|FG001|Overall Study|Withdrawal by Subject|8|||
30585741|NCT01263925|58597601|FG000|Overall Study|Other|4|||
30585742|NCT01263925|58597602|FG001|Overall Study|Other|4|||
30670038|NCT00465361|58683862|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
30670039|NCT00464815|58683868|FG000|Overall Study|Withdrawal by Subject|6|||
30670040|NCT00464815|58683869|FG001|Overall Study|Withdrawal by Subject|3|||
30585743|NCT01263925|58597601|FG000|Overall Study|Lost to Follow-up|3|||
30781065|NCT03798717|58793163|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
30585744|NCT01263925|58597602|FG001|Overall Study|Lost to Follow-up|1|||
30781066|NCT03798717|58793164|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
30585745|NCT01263925|58597601|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
30670041|NCT00464737|58683878|FG000|Overall Study|Adverse Event|12|||
30670042|NCT00464737|58683879|FG001|Overall Study|Adverse Event|17|||
30585746|NCT01263925|58597602|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
30585747|NCT01263925|58597601|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
30670043|NCT00464737|58683880|FG002|Overall Study|Adverse Event|33|||
30585748|NCT01263925|58597602|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
30585749|NCT01263925|58597601|FG000|Overall Study|AE/ Withdrawal|1|||
30585750|NCT01263925|58597602|FG001|Overall Study|AE/ Withdrawal|4|||
30585751|NCT01263925|58597601|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
30585752|NCT01263925|58597602|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
30670044|NCT00464737|58683878|FG000|Overall Study|Lack of Efficacy|7|||
30670045|NCT00464737|58683879|FG001|Overall Study|Lack of Efficacy|7|||
30670046|NCT00464737|58683880|FG002|Overall Study|Lack of Efficacy|4|||
30670047|NCT00464737|58683878|FG000|Overall Study|Withdrawal by Subject|5|||
30670048|NCT00464737|58683879|FG001|Overall Study|Withdrawal by Subject|3|||
30670049|NCT00464737|58683880|FG002|Overall Study|Withdrawal by Subject|5|||
30670050|NCT00464737|58683878|FG000|Overall Study|Protocol Violation|1|||
30670051|NCT00464737|58683879|FG001|Overall Study|Protocol Violation|1|||
30670052|NCT00464737|58683880|FG002|Overall Study|Protocol Violation|5|||
30670053|NCT00464737|58683878|FG000|Overall Study|Non-compliance|0|||
30670054|NCT00464737|58683879|FG001|Overall Study|Non-compliance|1|||
30670055|NCT00464737|58683880|FG002|Overall Study|Non-compliance|1|||
30670056|NCT00464737|58683878|FG000|Overall Study|Lost to Follow-up|5|||
30670057|NCT00464737|58683879|FG001|Overall Study|Lost to Follow-up|2|||
30670058|NCT00464737|58683880|FG002|Overall Study|Lost to Follow-up|5|||
30670059|NCT00464737|58683878|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
30670060|NCT00464737|58683879|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
30585753|NCT01263925|58597601|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
30585754|NCT01263925|58597602|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
30670061|NCT00464737|58683880|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
30670062|NCT00464737|58683878|FG000|Overall Study|Other: Subject left town; family illness|1|||
30585755|NCT01263925|58597601|FG000|Overall Study|Withdrawal/ Not specified|0|||
30585756|NCT01263925|58597602|FG001|Overall Study|Withdrawal/ Not specified|1|||
30585757|NCT01263769|58597608|FG000|Overall Study|Non-Compliant with treatment|1|||
30585758|NCT01263691|58597618|FG000|Overall Study|Lost to Follow-up|1|||
30585759|NCT01263691|58597619|FG001|Overall Study|Lost to Follow-up|0|||
30585760|NCT01263691|58597620|FG002|Overall Study|Lost to Follow-up|1|||
30585761|NCT01263691|58597621|FG003|Overall Study|Lost to Follow-up|1|||
30585762|NCT01263691|58597622|FG004|Overall Study|Lost to Follow-up|0|||
30585763|NCT01263691|58597623|FG005|Overall Study|Lost to Follow-up|0|||
30585764|NCT01263691|58597618|FG000|Overall Study|Withdrawal by Subject|1|||
30585765|NCT01263691|58597619|FG001|Overall Study|Withdrawal by Subject|0|||
30585766|NCT01263691|58597620|FG002|Overall Study|Withdrawal by Subject|0|||
30670063|NCT00464737|58683879|FG001|Overall Study|Other: Subject left town; family illness|0|||
30670064|NCT00464737|58683880|FG002|Overall Study|Other: Subject left town; family illness|0|||
30670065|NCT00464737|58683878|FG000|Overall Study|Other: Study demands too great|0|||
30670066|NCT00464737|58683879|FG001|Overall Study|Other: Study demands too great|1|||
30670067|NCT00464737|58683880|FG002|Overall Study|Other: Study demands too great|0|||
30670068|NCT00464737|58683878|FG000|Overall Study|Other: Personal family reasons|0|||
30670069|NCT00464737|58683879|FG001|Overall Study|Other: Personal family reasons|0|||
30670070|NCT00464737|58683880|FG002|Overall Study|Other: Personal family reasons|1|||
30670071|NCT00464737|58683878|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
30670072|NCT00464737|58683879|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
30670073|NCT00464737|58683880|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
30781067|NCT03798717|58793165|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
30781068|NCT03798717|58793166|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
30585767|NCT01263691|58597621|FG003|Overall Study|Withdrawal by Subject|0|||
30585768|NCT01263691|58597622|FG004|Overall Study|Withdrawal by Subject|0|||
30585769|NCT01263691|58597623|FG005|Overall Study|Withdrawal by Subject|0|||
30585770|NCT01263691|58597618|FG000|Overall Study|Adverse Event|1|||
30585771|NCT01263691|58597619|FG001|Overall Study|Adverse Event|0|||
30585772|NCT01263691|58597620|FG002|Overall Study|Adverse Event|0|||
30585773|NCT01263691|58597621|FG003|Overall Study|Adverse Event|0|||
30585774|NCT01263691|58597622|FG004|Overall Study|Adverse Event|0|||
30585775|NCT01263691|58597623|FG005|Overall Study|Adverse Event|0|||
30585776|NCT01263496|58597700|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
30781069|NCT03798717|58793167|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
30585777|NCT01263496|58597701|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
30585778|NCT01263496|58597702|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
30585779|NCT01263496|58597703|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
30585780|NCT01263496|58597704|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
30585781|NCT01263496|58597705|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
30585782|NCT01263496|58597706|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
30585783|NCT01263496|58597707|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
30585784|NCT01263496|58597708|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
30585785|NCT01263496|58597700|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30585786|NCT01263496|58597701|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30670074|NCT00453349|58683890|FG000|Randomized|Adverse Event|12|||
30670075|NCT00453349|58683891|FG001|Randomized|Adverse Event|11|||
30670076|NCT00453349|58683890|FG000|Randomized|Lack of Efficacy|2|||
30670077|NCT00453349|58683891|FG001|Randomized|Lack of Efficacy|1|||
30670078|NCT00453349|58683890|FG000|Randomized|Lost to Follow-up|7|||
30670079|NCT00453349|58683891|FG001|Randomized|Lost to Follow-up|5|||
30781070|NCT03798483|58793176|FG000|Overall Study|Lost to Follow-up|2|||
30670080|NCT00453349|58683890|FG000|Randomized|Protocol Violation|1|||
30670081|NCT00453349|58683891|FG001|Randomized|Protocol Violation|1|||
30670082|NCT00453349|58683890|FG000|Randomized|Withdrawal by Subject|3|||
30670083|NCT00453349|58683891|FG001|Randomized|Withdrawal by Subject|5|||
30670084|NCT00453349|58683890|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
30670085|NCT00453349|58683891|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
30670086|NCT00453349|58683890|FG000|Completed Study|Adverse Event|12|||
30670087|NCT00453349|58683891|FG001|Completed Study|Adverse Event|11|||
30670088|NCT00453349|58683890|FG000|Completed Study|Lack of Efficacy|2|||
30670089|NCT00453349|58683891|FG001|Completed Study|Lack of Efficacy|1|||
30585787|NCT01263496|58597702|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30855755|NCT02702193|58883463|FG000|12 Month Follow up|Withdrawal by Subject|1|||
30670090|NCT00453349|58683890|FG000|Completed Study|Lost to Follow-up|7|||
30670091|NCT00453349|58683891|FG001|Completed Study|Lost to Follow-up|5|||
30670092|NCT00453349|58683890|FG000|Completed Study|Protocol Violation|1|||
30670093|NCT00453349|58683891|FG001|Completed Study|Protocol Violation|1|||
30670094|NCT00453349|58683890|FG000|Completed Study|Withdrawal by Subject|3|||
30670095|NCT00453349|58683891|FG001|Completed Study|Withdrawal by Subject|5|||
30670096|NCT00453349|58683890|FG000|Completed Study|Lost to follow up after study treatment|2|||
30670097|NCT00453349|58683891|FG001|Completed Study|Lost to follow up after study treatment|11|||
30670098|NCT00464269|58683901|FG000|Overall Study|Lack of Efficacy|1|||
30670099|NCT00464269|58683902|FG001|Overall Study|Lack of Efficacy|0|||
30670100|NCT00464269|58683903|FG002|Overall Study|Lack of Efficacy|0|||
30670101|NCT00464269|58683904|FG003|Overall Study|Lack of Efficacy|0|||
30670102|NCT00464269|58683901|FG000|Overall Study|Lost to Follow-up|0|||
30670103|NCT00464269|58683902|FG001|Overall Study|Lost to Follow-up|4|||
30670104|NCT00464269|58683903|FG002|Overall Study|Lost to Follow-up|0|||
30670105|NCT00464269|58683904|FG003|Overall Study|Lost to Follow-up|1|||
30670106|NCT00464269|58683901|FG000|Overall Study|Withdrawal by Subject|0|||
30670107|NCT00464269|58683902|FG001|Overall Study|Withdrawal by Subject|2|||
30670108|NCT00464269|58683903|FG002|Overall Study|Withdrawal by Subject|1|||
30670109|NCT00464269|58683904|FG003|Overall Study|Withdrawal by Subject|1|||
30670110|NCT00464269|58683901|FG000|Overall Study|Other reason|3|||
30670111|NCT00464269|58683902|FG001|Overall Study|Other reason|3|||
30781071|NCT03792477|58793189|FG000|Overall Study|Adverse Event|0|||
30781072|NCT03792477|58793190|FG001|Overall Study|Adverse Event|0|||
30855756|NCT02702193|58883464|FG001|12 Month Follow up|Withdrawal by Subject|0|||
30855757|NCT02702193|58883463|FG000|12 Month Follow up|Lost to Follow-up|16|||
30855758|NCT02702193|58883464|FG001|12 Month Follow up|Lost to Follow-up|18|||
30855759|NCT02761057|58883474|FG000|Overall Study|Currently On Study Treatment|0|||
30855760|NCT02761057|58883475|FG001|Overall Study|Currently On Study Treatment|3|||
30855761|NCT02761057|58883476|FG002|Overall Study|Currently On Study Treatment|0|||
30855762|NCT02761057|58883477|FG003|Overall Study|Currently On Study Treatment|0|||
30855763|NCT02761057|58883474|FG000|Overall Study|Adverse Event|11|||
30855764|NCT02761057|58883475|FG001|Overall Study|Adverse Event|9|||
30855765|NCT02761057|58883476|FG002|Overall Study|Adverse Event|5|||
30855766|NCT02761057|58883477|FG003|Overall Study|Adverse Event|3|||
30585788|NCT01263496|58597703|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
30585789|NCT01263496|58597704|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
30585790|NCT01263496|58597705|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30585791|NCT01263496|58597706|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30585792|NCT01263496|58597707|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30585793|NCT01263496|58597708|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
30585794|NCT01263496|58597700|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
30670112|NCT00464269|58683903|FG002|Overall Study|Other reason|1|||
30670113|NCT00464269|58683904|FG003|Overall Study|Other reason|1|||
30670114|NCT00464269|58683901|FG000|Overall Study|AE, serious fatal|0|||
30781073|NCT03792477|58793191|FG002|Overall Study|Adverse Event|0|||
30781074|NCT03792477|58793192|FG003|Overall Study|Adverse Event|1|||
30781075|NCT03792477|58793193|FG004|Overall Study|Adverse Event|0|||
30781076|NCT03792477|58793189|FG000|Overall Study|Lost to Follow-up|0|||
30781077|NCT03792477|58793190|FG001|Overall Study|Lost to Follow-up|0|||
30781078|NCT03792477|58793191|FG002|Overall Study|Lost to Follow-up|2|||
30781079|NCT03792477|58793192|FG003|Overall Study|Lost to Follow-up|0|||
30781080|NCT03792477|58793193|FG004|Overall Study|Lost to Follow-up|0|||
30781081|NCT03792477|58793189|FG000|Overall Study|Other|0|||
30855767|NCT02761057|58883474|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
30855768|NCT02761057|58883475|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
30670115|NCT00464269|58683902|FG001|Overall Study|AE, serious fatal|0|||
30670116|NCT00464269|58683903|FG002|Overall Study|AE, serious fatal|1|||
30670117|NCT00464269|58683904|FG003|Overall Study|AE, serious fatal|1|||
30781082|NCT03792477|58793190|FG001|Overall Study|Other|0|||
30781083|NCT03792477|58793191|FG002|Overall Study|Other|0|||
30781084|NCT03792477|58793192|FG003|Overall Study|Other|0|||
30781085|NCT03792477|58793193|FG004|Overall Study|Other|1|||
30781086|NCT03790917|58793199|FG000|Overall Study|Death|1|||
30781087|NCT03788967|58793206|FG000|Overall Study|Lost to Follow-up|14|||
30855769|NCT02761057|58883476|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
30855770|NCT02761057|58883477|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
30585795|NCT01263496|58597701|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
30585796|NCT01263496|58597702|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
30585797|NCT01263496|58597703|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
30585798|NCT01263496|58597704|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
30585799|NCT01263496|58597705|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
30585800|NCT01263496|58597706|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
30585801|NCT01263496|58597707|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
30585802|NCT01263496|58597708|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
30585803|NCT01263496|58597700|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
30585804|NCT01263496|58597701|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
30585805|NCT01263496|58597702|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
30585806|NCT01263496|58597703|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
30585807|NCT01263496|58597704|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
30585808|NCT01263496|58597705|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
30585809|NCT01263496|58597706|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
30585810|NCT01263496|58597707|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
30585811|NCT01263496|58597708|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
30585812|NCT01263496|58597700|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
30585813|NCT01263496|58597701|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
30585814|NCT01263496|58597702|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
30585815|NCT01263496|58597703|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
30585816|NCT01263496|58597704|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
30585817|NCT01263496|58597705|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
30585818|NCT01263496|58597706|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
30585819|NCT01263496|58597707|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
30585820|NCT01263496|58597708|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
30585821|NCT01263496|58597700|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
30585822|NCT01263496|58597701|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
30585823|NCT01263496|58597702|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
30585824|NCT01263496|58597703|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
30585825|NCT01263496|58597704|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
30585826|NCT01263496|58597705|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
30585827|NCT01263496|58597706|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
30670118|NCT00464269|58683901|FG000|Overall Study|SAE, non-fatal|0|||
30670119|NCT00464269|58683902|FG001|Overall Study|SAE, non-fatal|0|||
30670120|NCT00464269|58683903|FG002|Overall Study|SAE, non-fatal|0|||
30670121|NCT00464269|58683904|FG003|Overall Study|SAE, non-fatal|1|||
30670122|NCT00464269|58683901|FG000|Overall Study|AE, non-serious non-fatal|2|||
30670123|NCT00464269|58683902|FG001|Overall Study|AE, non-serious non-fatal|8|||
30670124|NCT00464269|58683903|FG002|Overall Study|AE, non-serious non-fatal|3|||
30670125|NCT00464269|58683904|FG003|Overall Study|AE, non-serious non-fatal|4|||
30670126|NCT00464269|58683901|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
30670127|NCT00464269|58683902|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
30670128|NCT00464269|58683903|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
30670129|NCT00464269|58683904|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
30670130|NCT00484315|58683918|FG000|12-Month Clinical Follow-up|Death|6|||
30670131|NCT00484315|58683919|FG001|12-Month Clinical Follow-up|Death|2|||
30670132|NCT00484315|58683918|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
30670133|NCT00484315|58683919|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
30670134|NCT00484315|58683918|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
30670135|NCT00484315|58683919|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
30670136|NCT00484315|58683918|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
30670137|NCT00484315|58683919|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
30670138|NCT00484315|58683918|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
30670139|NCT00484315|58683919|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
30670140|NCT00484315|58683918|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
30670141|NCT00484315|58683919|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
30670142|NCT00484315|58683918|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
30670143|NCT00484315|58683919|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
30670144|NCT00463801|58683925|FG000|Overall Study|Protocol Violation|1|||
30670145|NCT00463801|58683925|FG000|Overall Study|Lack of Efficacy|2|||
30670146|NCT00463801|58683925|FG000|Overall Study|Adverse Event|4|||
30670147|NCT00463801|58683925|FG000|Overall Study|Lost to Follow-up|5|||
30670148|NCT00463801|58683925|FG000|Overall Study|No longer require therapy|1|||
30670149|NCT00463567|58683936|FG000|Overall Study|Adverse Event|29|||
30958872|NCT01587703|59024041|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
30670150|NCT00463567|58683937|FG001|Overall Study|Adverse Event|26|||
30585828|NCT01263496|58597707|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
30585829|NCT01263496|58597708|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
30585830|NCT01263496|58597700|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
30585831|NCT01263496|58597701|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
30670151|NCT00463567|58683938|FG002|Overall Study|Adverse Event|17|||
30670152|NCT00463567|58683939|FG003|Overall Study|Adverse Event|46|||
30670153|NCT00463567|58683940|FG004|Overall Study|Adverse Event|10|||
30670154|NCT00463567|58683941|FG005|Overall Study|Adverse Event|10|||
30670155|NCT00463567|58683942|FG006|Overall Study|Adverse Event|4|||
30670156|NCT00463567|58683936|FG000|Overall Study|Withdrawal by Subject|29|||
30585832|NCT01263496|58597702|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
30585833|NCT01263496|58597703|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
30585834|NCT01263496|58597704|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
30585835|NCT01263496|58597705|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
30585836|NCT01263496|58597706|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
30585837|NCT01263496|58597707|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
30585838|NCT01263496|58597708|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
30585839|NCT01263223|58597720|FG000|Period 2|Withdrawal by Subject|0|||
30585840|NCT01263223|58597721|FG001|Period 2|Withdrawal by Subject|1|||
30585841|NCT01263223|58597720|FG000|7-day Follow-up|Withdrawal by Subject|0|||
30585842|NCT01263223|58597721|FG001|7-day Follow-up|Withdrawal by Subject|1|||
30585843|NCT01263223|58597720|FG000|7-day Follow-up|Lost to Follow-up|1|||
30585844|NCT01263223|58597721|FG001|7-day Follow-up|Lost to Follow-up|0|||
30585845|NCT01263106|58597730|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
30585846|NCT01263106|58597731|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
30585847|NCT01263028|58597740|FG000|Overall Study|Withdrawal by Subject|1|||
30585848|NCT01263028|58597740|FG000|Overall Study|Adverse Event|1|||
30585849|NCT01263028|58597740|FG000|Overall Study|Study terminated due to low enrollment.|4|||
30585850|NCT01262989|58597744|FG000|Period 1|Lost to Follow-up|1|||
30585851|NCT01262989|58597745|FG001|Period 1|Lost to Follow-up|1|||
30585852|NCT01262989|58597744|FG000|Period 1|Intercurrent disease|0|||
30585853|NCT01262989|58597745|FG001|Period 1|Intercurrent disease|1|||
30585854|NCT01262989|58597744|FG000|Period 1|Positive answer for exclusion criteria|0|||
30585855|NCT01262989|58597745|FG001|Period 1|Positive answer for exclusion criteria|1|||
30585856|NCT01262989|58597744|FG000|Period 2|Intercurrent disease|0|||
30585857|NCT01262989|58597745|FG001|Period 2|Intercurrent disease|1|||
30585858|NCT01262872|58597759|FG000|Step 2|Death|0|||
30585859|NCT01262872|58597760|FG001|Step 2|Death|0|||
30585860|NCT01262872|58597761|FG002|Step 2|Death|0|||
30585861|NCT01262872|58597762|FG003|Step 2|Death|1|||
30585862|NCT01262872|58597763|FG004|Step 2|Death|0|||
30585863|NCT01262872|58597764|FG005|Step 2|Death|2|||
30585864|NCT01262872|58597765|FG006|Step 2|Death|2|||
30585865|NCT01262872|58597766|FG007|Step 2|Death|1|||
30585866|NCT01262872|58597759|FG000|Step 2|Protocol Violation|0|||
30585867|NCT01262872|58597760|FG001|Step 2|Protocol Violation|0|||
30585868|NCT01262872|58597761|FG002|Step 2|Protocol Violation|1|||
30585869|NCT01262872|58597762|FG003|Step 2|Protocol Violation|0|||
30585870|NCT01262872|58597763|FG004|Step 2|Protocol Violation|0|||
30585871|NCT01262872|58597764|FG005|Step 2|Protocol Violation|0|||
30585872|NCT01262872|58597765|FG006|Step 2|Protocol Violation|3|||
30585873|NCT01262872|58597766|FG007|Step 2|Protocol Violation|1|||
30585874|NCT01262872|58597759|FG000|Step 2|Withdrawal by Subject|0|||
30585875|NCT01262872|58597760|FG001|Step 2|Withdrawal by Subject|0|||
30585876|NCT01262872|58597761|FG002|Step 2|Withdrawal by Subject|4|||
30585877|NCT01262872|58597762|FG003|Step 2|Withdrawal by Subject|6|||
30585878|NCT01262872|58597763|FG004|Step 2|Withdrawal by Subject|3|||
30585879|NCT01262872|58597764|FG005|Step 2|Withdrawal by Subject|1|||
30670157|NCT00463567|58683937|FG001|Overall Study|Withdrawal by Subject|22|||
30670158|NCT00463567|58683938|FG002|Overall Study|Withdrawal by Subject|20|||
30781088|NCT03788967|58793207|FG001|Overall Study|Lost to Follow-up|10|||
30781089|NCT03788967|58793206|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
30781090|NCT03788967|58793207|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
30585880|NCT01262872|58597765|FG006|Step 2|Withdrawal by Subject|2|||
30585881|NCT01262872|58597766|FG007|Step 2|Withdrawal by Subject|1|||
30585882|NCT01262872|58597759|FG000|Step 2|Migrated/moved from study area|0|||
30585883|NCT01262872|58597760|FG001|Step 2|Migrated/moved from study area|0|||
30585884|NCT01262872|58597761|FG002|Step 2|Migrated/moved from study area|4|||
30585885|NCT01262872|58597762|FG003|Step 2|Migrated/moved from study area|3|||
30585886|NCT01262872|58597763|FG004|Step 2|Migrated/moved from study area|2|||
30585887|NCT01262872|58597764|FG005|Step 2|Migrated/moved from study area|6|||
30585888|NCT01262872|58597765|FG006|Step 2|Migrated/moved from study area|2|||
30585889|NCT01262872|58597766|FG007|Step 2|Migrated/moved from study area|3|||
30585890|NCT01262677|58597803|FG000|Overall Study|Does not meet entrance criteria|0|||
30585891|NCT01262677|58597804|FG001|Overall Study|Does not meet entrance criteria|2|||
30670159|NCT00463567|58683939|FG003|Overall Study|Withdrawal by Subject|37|||
30781091|NCT03788967|58793206|FG000|Overall Study|Participant Withdrawal of Consent|13|||
30670160|NCT00463567|58683940|FG004|Overall Study|Withdrawal by Subject|6|||
30670161|NCT00463567|58683941|FG005|Overall Study|Withdrawal by Subject|5|||
30670162|NCT00463567|58683942|FG006|Overall Study|Withdrawal by Subject|1|||
30670163|NCT00463567|58683936|FG000|Overall Study|Protocol Deviation|13|||
30670164|NCT00463567|58683937|FG001|Overall Study|Protocol Deviation|9|||
30670165|NCT00463567|58683938|FG002|Overall Study|Protocol Deviation|14|||
30670166|NCT00463567|58683939|FG003|Overall Study|Protocol Deviation|11|||
30670167|NCT00463567|58683940|FG004|Overall Study|Protocol Deviation|1|||
30670168|NCT00463567|58683941|FG005|Overall Study|Protocol Deviation|1|||
30670169|NCT00463567|58683942|FG006|Overall Study|Protocol Deviation|2|||
30670170|NCT00463567|58683936|FG000|Overall Study|Lost to Follow-up|12|||
30670171|NCT00463567|58683937|FG001|Overall Study|Lost to Follow-up|6|||
30670172|NCT00463567|58683938|FG002|Overall Study|Lost to Follow-up|13|||
30670173|NCT00463567|58683939|FG003|Overall Study|Lost to Follow-up|8|||
30670174|NCT00463567|58683940|FG004|Overall Study|Lost to Follow-up|1|||
30670175|NCT00463567|58683941|FG005|Overall Study|Lost to Follow-up|1|||
30670176|NCT00463567|58683942|FG006|Overall Study|Lost to Follow-up|1|||
30670177|NCT00463567|58683936|FG000|Overall Study|Administrative problems|5|||
30670178|NCT00463567|58683937|FG001|Overall Study|Administrative problems|3|||
30670179|NCT00463567|58683938|FG002|Overall Study|Administrative problems|6|||
30670180|NCT00463567|58683939|FG003|Overall Study|Administrative problems|9|||
30585892|NCT01262677|58597805|FG002|Overall Study|Does not meet entrance criteria|0|||
30585893|NCT01262677|58597803|FG000|Overall Study|Insufficient clinical response|0|||
30670181|NCT00463567|58683940|FG004|Overall Study|Administrative problems|3|||
30670182|NCT00463567|58683941|FG005|Overall Study|Administrative problems|2|||
30670183|NCT00463567|58683942|FG006|Overall Study|Administrative problems|2|||
30670184|NCT00463567|58683936|FG000|Overall Study|Lack of Efficacy|4|||
30670185|NCT00463567|58683937|FG001|Overall Study|Lack of Efficacy|9|||
30670186|NCT00463567|58683938|FG002|Overall Study|Lack of Efficacy|9|||
30670187|NCT00463567|58683939|FG003|Overall Study|Lack of Efficacy|17|||
30670188|NCT00463567|58683940|FG004|Overall Study|Lack of Efficacy|1|||
30670189|NCT00463567|58683941|FG005|Overall Study|Lack of Efficacy|0|||
30670190|NCT00463567|58683942|FG006|Overall Study|Lack of Efficacy|1|||
30670191|NCT00463567|58683936|FG000|Overall Study|Abnormal lab value(s)|1|||
30670192|NCT00463567|58683937|FG001|Overall Study|Abnormal lab value(s)|1|||
30670193|NCT00463567|58683938|FG002|Overall Study|Abnormal lab value(s)|2|||
30670194|NCT00463567|58683939|FG003|Overall Study|Abnormal lab value(s)|1|||
30670195|NCT00463567|58683940|FG004|Overall Study|Abnormal lab value(s)|1|||
30670196|NCT00463567|58683941|FG005|Overall Study|Abnormal lab value(s)|0|||
30670197|NCT00463567|58683942|FG006|Overall Study|Abnormal lab value(s)|0|||
30670198|NCT00463567|58683936|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30670199|NCT00463567|58683937|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30670200|NCT00463567|58683938|FG002|Overall Study|Abnormal test procedure result(s)|6|||
30670201|NCT00463567|58683939|FG003|Overall Study|Abnormal test procedure result(s)|2|||
30670202|NCT00463567|58683940|FG004|Overall Study|Abnormal test procedure result(s)|0|||
30670203|NCT00463567|58683941|FG005|Overall Study|Abnormal test procedure result(s)|2|||
30670204|NCT00463567|58683942|FG006|Overall Study|Abnormal test procedure result(s)|0|||
30670205|NCT00463567|58683936|FG000|Overall Study|Death|1|||
30670206|NCT00463567|58683937|FG001|Overall Study|Death|0|||
30585894|NCT01262677|58597804|FG001|Overall Study|Insufficient clinical response|0|||
30585895|NCT01262677|58597805|FG002|Overall Study|Insufficient clinical response|1|||
30585896|NCT01262677|58597803|FG000|Overall Study|Lost to Follow-up|1|||
30585897|NCT01262677|58597804|FG001|Overall Study|Lost to Follow-up|0|||
30585898|NCT01262677|58597805|FG002|Overall Study|Lost to Follow-up|2|||
30585899|NCT01262677|58597803|FG000|Overall Study|No longer willing to participate|3|||
30585900|NCT01262677|58597804|FG001|Overall Study|No longer willing to participate|3|||
30585901|NCT01262677|58597805|FG002|Overall Study|No longer willing to participate|2|||
30585902|NCT01262677|58597803|FG000|Overall Study|Reason not provided|2|||
30585903|NCT01262677|58597804|FG001|Overall Study|Reason not provided|1|||
30585904|NCT01262677|58597805|FG002|Overall Study|Reason not provided|3|||
30670207|NCT00463567|58683938|FG002|Overall Study|Death|2|||
30670208|NCT00463567|58683939|FG003|Overall Study|Death|0|||
30670209|NCT00463567|58683940|FG004|Overall Study|Death|0|||
30585905|NCT01262677|58597803|FG000|Overall Study|Protocol Violation|0|||
30585906|NCT01262677|58597804|FG001|Overall Study|Protocol Violation|1|||
30585907|NCT01262677|58597805|FG002|Overall Study|Protocol Violation|1|||
30585908|NCT01262677|58597803|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
30585909|NCT01262677|58597804|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
30585910|NCT01262677|58597805|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
30585911|NCT01262638|58597817|FG000|Overall Study|Adverse Event|3|||
30670210|NCT00463567|58683941|FG005|Overall Study|Death|0|||
30670211|NCT00463567|58683942|FG006|Overall Study|Death|0|||
30670212|NCT00484159|58683967|FG000|Overall Study|Lost to Follow-up|1|||
30670213|NCT00484159|58683968|FG001|Overall Study|Lost to Follow-up|1|||
30670214|NCT00484159|58683969|FG002|Overall Study|Lost to Follow-up|0|||
30670215|NCT00462865|58683977|FG000|Overall Study|Adverse Event|1|||
30670216|NCT03839641|58683983|FG000|Overall Study|Withdrawal by Subject|1|||
30670217|NCT03839641|58683984|FG001|Overall Study|Withdrawal by Subject|1|||
30670218|NCT00462709|58683992|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
30670219|NCT00462709|58683992|FG000|Overall Study|Lost to Follow-up|10|||
30670220|NCT00462709|58683992|FG000|Overall Study|Withdrawal by Subject|8|||
30670221|NCT00462709|58683992|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
30670222|NCT00462709|58683992|FG000|Overall Study|Death|2|||
30670223|NCT00462709|58683992|FG000|Overall Study|Logistical reasons|2|||
30670224|NCT00462709|58683992|FG000|Overall Study|Physician Decision|1|||
30670225|NCT00462709|58683992|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
30670226|NCT00461305|58683998|FG000|Treatment|Adverse Event|26|||
30670227|NCT00461305|58683999|FG001|Treatment|Adverse Event|3|||
30585912|NCT01262638|58597818|FG001|Overall Study|Adverse Event|4|||
30585913|NCT01262638|58597819|FG002|Overall Study|Adverse Event|3|||
30585914|NCT01262638|58597820|FG003|Overall Study|Adverse Event|4|||
30585915|NCT01262638|58597817|FG000|Overall Study|Protocol Violation|1|||
30585916|NCT01262638|58597818|FG001|Overall Study|Protocol Violation|0|||
30585917|NCT01262638|58597819|FG002|Overall Study|Protocol Violation|0|||
30585918|NCT01262638|58597820|FG003|Overall Study|Protocol Violation|1|||
30585919|NCT01262638|58597817|FG000|Overall Study|Withdrawal by Subject|2|||
30585920|NCT01262638|58597818|FG001|Overall Study|Withdrawal by Subject|1|||
30585921|NCT01262638|58597819|FG002|Overall Study|Withdrawal by Subject|0|||
30585922|NCT01262638|58597820|FG003|Overall Study|Withdrawal by Subject|1|||
30585923|NCT01262638|58597817|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
30585924|NCT01262638|58597818|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
30585925|NCT01262638|58597819|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
30585926|NCT01262638|58597820|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
30585927|NCT01262638|58597817|FG000|Overall Study|Lost to Follow-up|1|||
30585928|NCT01262638|58597818|FG001|Overall Study|Lost to Follow-up|1|||
30585929|NCT01262638|58597819|FG002|Overall Study|Lost to Follow-up|1|||
30585930|NCT01262638|58597820|FG003|Overall Study|Lost to Follow-up|1|||
30585931|NCT01262638|58597817|FG000|Overall Study|Participant Went Out of Town|0|||
30670228|NCT00461305|58683998|FG000|Treatment|Lost to Follow-up|4|||
30670229|NCT00461305|58683999|FG001|Treatment|Lost to Follow-up|2|||
30670230|NCT00461305|58683998|FG000|Treatment|Protocol Violation|13|||
30670231|NCT00461305|58683999|FG001|Treatment|Protocol Violation|2|||
30670232|NCT00461305|58683998|FG000|Treatment|Withdrawal by Subject|48|||
30670233|NCT00461305|58683999|FG001|Treatment|Withdrawal by Subject|2|||
30670234|NCT00461305|58683998|FG000|Treatment|Never dispensed|5|||
30670235|NCT00461305|58683999|FG001|Treatment|Never dispensed|0|||
30670236|NCT00461305|58683998|FG000|Treatment|Study drug not taken|1|||
30670237|NCT00461305|58683999|FG001|Treatment|Study drug not taken|0|||
30670238|NCT00461305|58683998|FG000|Treatment|Partially missing diary|2|||
30670239|NCT00461305|58683999|FG001|Treatment|Partially missing diary|0|||
30670240|NCT00461305|58683998|FG000|Treatment|Other (missing drug etc)|2|||
30585932|NCT01262638|58597818|FG001|Overall Study|Participant Went Out of Town|0|||
30585933|NCT01262638|58597819|FG002|Overall Study|Participant Went Out of Town|1|||
30585934|NCT01262638|58597820|FG003|Overall Study|Participant Went Out of Town|0|||
30585935|NCT01262560|58597836|FG000|Overall Study|Protocol Violation|0|||
30585936|NCT01262560|58597837|FG001|Overall Study|Protocol Violation|1|||
30585937|NCT01262560|58597838|FG002|Overall Study|Protocol Violation|2|||
30585938|NCT01262365|58597849|FG000|Overall Study|Lack of Efficacy|35|||
30585939|NCT01262365|58597850|FG001|Overall Study|Lack of Efficacy|30|||
30585940|NCT01262365|58597851|FG002|Overall Study|Lack of Efficacy|47|||
30585941|NCT01262365|58597849|FG000|Overall Study|Protocol Violation|3|||
30585942|NCT01262365|58597850|FG001|Overall Study|Protocol Violation|1|||
30585943|NCT01262365|58597851|FG002|Overall Study|Protocol Violation|1|||
30585944|NCT01262365|58597849|FG000|Overall Study|Lost to Follow-up|3|||
30585945|NCT01262365|58597850|FG001|Overall Study|Lost to Follow-up|7|||
30585946|NCT01262365|58597851|FG002|Overall Study|Lost to Follow-up|6|||
30585947|NCT01262365|58597849|FG000|Overall Study|Withdrawal by Subject|17|||
30585948|NCT01262365|58597850|FG001|Overall Study|Withdrawal by Subject|22|||
30585949|NCT01262365|58597851|FG002|Overall Study|Withdrawal by Subject|22|||
30585950|NCT01262365|58597849|FG000|Overall Study|Death|1|||
30585951|NCT01262365|58597850|FG001|Overall Study|Death|2|||
30585952|NCT01262365|58597851|FG002|Overall Study|Death|1|||
30585953|NCT01262365|58597849|FG000|Overall Study|Adverse Event|26|||
30585954|NCT01262365|58597850|FG001|Overall Study|Adverse Event|16|||
30585955|NCT01262365|58597851|FG002|Overall Study|Adverse Event|11|||
30585956|NCT01262365|58597849|FG000|Overall Study|sponsor decision|1|||
30670241|NCT00461305|58683999|FG001|Treatment|Other (missing drug etc)|0|||
30670242|NCT00461305|58683998|FG000|Continued Treatment|Adverse Event|26|||
30670243|NCT00461305|58683999|FG001|Continued Treatment|Adverse Event|0|||
30670244|NCT00461305|58683998|FG000|Continued Treatment|Lost to Follow-up|4|||
30670245|NCT00461305|58683999|FG001|Continued Treatment|Lost to Follow-up|0|||
30670246|NCT00461305|58683998|FG000|Continued Treatment|Protocol Violation|13|||
30670247|NCT00461305|58683999|FG001|Continued Treatment|Protocol Violation|0|||
30670248|NCT00461305|58683998|FG000|Continued Treatment|Withdrawal by Subject|48|||
30670249|NCT00461305|58683999|FG001|Continued Treatment|Withdrawal by Subject|0|||
30585957|NCT01262365|58597850|FG001|Overall Study|sponsor decision|1|||
30585958|NCT01262365|58597851|FG002|Overall Study|sponsor decision|0|||
30585959|NCT01262365|58597849|FG000|Overall Study|Randomization error|1|||
30585960|NCT01262365|58597850|FG001|Overall Study|Randomization error|0|||
30585961|NCT01262365|58597851|FG002|Overall Study|Randomization error|2|||
30585962|NCT01262365|58597849|FG000|Overall Study|Non-compliance|1|||
30585963|NCT01262365|58597850|FG001|Overall Study|Non-compliance|0|||
30585964|NCT01262365|58597851|FG002|Overall Study|Non-compliance|2|||
30585965|NCT01262365|58597849|FG000|Overall Study|Suspected pregnancy|1|||
30585966|NCT01262365|58597850|FG001|Overall Study|Suspected pregnancy|0|||
30585967|NCT01262365|58597851|FG002|Overall Study|Suspected pregnancy|0|||
30585968|NCT01262365|58597849|FG000|Overall Study|Patient pregnant|1|||
30585969|NCT01262365|58597850|FG001|Overall Study|Patient pregnant|0|||
30585970|NCT01262365|58597851|FG002|Overall Study|Patient pregnant|1|||
30585971|NCT01262365|58597849|FG000|Overall Study|Toxicity related to study drug|0|||
30585972|NCT01262365|58597850|FG001|Overall Study|Toxicity related to study drug|1|||
30585973|NCT01262365|58597851|FG002|Overall Study|Toxicity related to study drug|0|||
30585974|NCT01262365|58597849|FG000|Overall Study|Cannot tolerate the protocol|0|||
30585975|NCT01262365|58597850|FG001|Overall Study|Cannot tolerate the protocol|1|||
30585976|NCT01262365|58597851|FG002|Overall Study|Cannot tolerate the protocol|0|||
30585977|NCT01262365|58597849|FG000|Overall Study|Patient unavailable|0|||
30670250|NCT00461305|58683998|FG000|Continued Treatment|Partially missing diary|2|||
30670251|NCT00461305|58683999|FG001|Continued Treatment|Partially missing diary|0|||
30585978|NCT01262365|58597850|FG001|Overall Study|Patient unavailable|0|||
30585979|NCT01262365|58597851|FG002|Overall Study|Patient unavailable|1|||
30585980|NCT03932812|58597861|FG000|Overall Study|Lost to Follow-up|12|||
30585981|NCT03932812|58597862|FG001|Overall Study|Lost to Follow-up|14|||
30585982|NCT03932812|58597861|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
30585983|NCT03932812|58597862|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
30585984|NCT01262287|58597871|FG000|Overall Study|Lost to Follow-up|2|||
30585985|NCT01262287|58597872|FG001|Overall Study|Lost to Follow-up|1|||
30585986|NCT01262092|58597884|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
30585987|NCT01262092|58597885|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
30585988|NCT01262092|58597884|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
30585989|NCT01262092|58597885|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
30585990|NCT01262092|58597884|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
30585991|NCT01262092|58597885|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
30585992|NCT01262092|58597884|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
30585993|NCT01262092|58597885|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
30585994|NCT01261975|58597891|FG000|Overall Study|Surgical complication|1|||
30585995|NCT01261780|58597900|FG000|Overall Study|Withdrawal by Subject|1|||
30585996|NCT01261780|58597901|FG001|Overall Study|Withdrawal by Subject|0|||
30585997|NCT01261780|58597900|FG000|Overall Study|Event not related to subject|1|||
30585998|NCT01261780|58597901|FG001|Overall Study|Event not related to subject|2|||
30585999|NCT01261624|58597909|FG000|Week 0 to Week 12|Disease Progression|1|||
30586000|NCT01261624|58597910|FG001|Week 0 to Week 12|Disease Progression|1|||
30586001|NCT01261624|58597909|FG000|Week 0 to Week 12|Insufficient Response|0|||
30586002|NCT01261624|58597910|FG001|Week 0 to Week 12|Insufficient Response|2|||
30586003|NCT01261624|58597909|FG000|Week 13 to Week 24|Insufficient Response|0|||
30586004|NCT01261624|58597910|FG001|Week 13 to Week 24|Insufficient Response|1|||
30586005|NCT03694522|58597924|FG000|Overall Study|Withdrawal by Subject|8|||
30586006|NCT03694522|58597925|FG001|Overall Study|Withdrawal by Subject|10|||
30586007|NCT03694522|58597924|FG000|Overall Study|Physician Decision|53|||
30586008|NCT03694522|58597925|FG001|Overall Study|Physician Decision|54|||
30586009|NCT03694522|58597924|FG000|Overall Study|Other|1|||
30586010|NCT03694522|58597925|FG001|Overall Study|Other|1|||
30586011|NCT03694522|58597924|FG000|Overall Study|Lost to Follow-up|0|||
30586012|NCT03694522|58597925|FG001|Overall Study|Lost to Follow-up|1|||
30586013|NCT01261390|58597935|FG000|Overall Study|Significant Concurrent Illness|1|||
30586014|NCT01261390|58597936|FG001|Overall Study|Significant Concurrent Illness|0|||
30586015|NCT01261390|58597937|FG002|Overall Study|Significant Concurrent Illness|1|||
30586016|NCT01261390|58597938|FG003|Overall Study|Significant Concurrent Illness|0|||
30586017|NCT01261390|58597935|FG000|Overall Study|Dissatisfaction with Treatment|2|||
30670252|NCT00461305|58683998|FG000|Continued Treatment|Other (missing drug etc)|2|||
30781092|NCT03788967|58793207|FG001|Overall Study|Participant Withdrawal of Consent|5|||
30586018|NCT01261390|58597936|FG001|Overall Study|Dissatisfaction with Treatment|1|||
30586019|NCT01261390|58597937|FG002|Overall Study|Dissatisfaction with Treatment|1|||
30586020|NCT01261390|58597938|FG003|Overall Study|Dissatisfaction with Treatment|2|||
30586021|NCT01261390|58597935|FG000|Overall Study|Relocation|0|||
30586022|NCT01261390|58597936|FG001|Overall Study|Relocation|1|||
30586023|NCT01261390|58597937|FG002|Overall Study|Relocation|0|||
30586024|NCT01261390|58597938|FG003|Overall Study|Relocation|0|||
30586025|NCT01261390|58597935|FG000|Overall Study|Loss of Interest in the Study|3|||
30670253|NCT00461305|58683999|FG001|Continued Treatment|Other (missing drug etc)|0|||
30781093|NCT03788967|58793206|FG000|Overall Study|Adverse Event|1|||
30586026|NCT01261390|58597936|FG001|Overall Study|Loss of Interest in the Study|1|||
30586027|NCT01261390|58597937|FG002|Overall Study|Loss of Interest in the Study|0|||
30586028|NCT01261390|58597938|FG003|Overall Study|Loss of Interest in the Study|0|||
30586029|NCT01261390|58597935|FG000|Overall Study|Lost to Follow-up|1|||
30586030|NCT01261390|58597936|FG001|Overall Study|Lost to Follow-up|6|||
30586031|NCT01261390|58597937|FG002|Overall Study|Lost to Follow-up|5|||
30586032|NCT01261390|58597938|FG003|Overall Study|Lost to Follow-up|6|||
30586033|NCT03391882|58597959|FG000|Study Overall|Adverse Event|3|||
30586034|NCT03391882|58597960|FG001|Study Overall|Adverse Event|6|||
30586035|NCT03391882|58597961|FG002|Study Overall|Adverse Event|1|||
30586036|NCT03391882|58597962|FG003|Study Overall|Adverse Event|1|||
30586037|NCT03391882|58597963|FG004|Study Overall|Adverse Event|3|||
30586038|NCT03391882|58597964|FG005|Study Overall|Adverse Event|1|||
30586039|NCT03391882|58597959|FG000|Study Overall|Lack of Efficacy|13|||
30586040|NCT03391882|58597960|FG001|Study Overall|Lack of Efficacy|9|||
30586041|NCT03391882|58597961|FG002|Study Overall|Lack of Efficacy|0|||
30586042|NCT03391882|58597962|FG003|Study Overall|Lack of Efficacy|0|||
30586043|NCT03391882|58597963|FG004|Study Overall|Lack of Efficacy|0|||
30586044|NCT03391882|58597964|FG005|Study Overall|Lack of Efficacy|0|||
30586045|NCT03391882|58597959|FG000|Study Overall|Withdrawal by Subject|3|||
30586046|NCT03391882|58597960|FG001|Study Overall|Withdrawal by Subject|3|||
30586047|NCT03391882|58597961|FG002|Study Overall|Withdrawal by Subject|2|||
30586048|NCT03391882|58597962|FG003|Study Overall|Withdrawal by Subject|2|||
30586049|NCT03391882|58597963|FG004|Study Overall|Withdrawal by Subject|1|||
30586050|NCT03391882|58597964|FG005|Study Overall|Withdrawal by Subject|3|||
30586051|NCT03391882|58597959|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
30586052|NCT03391882|58597960|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
30586053|NCT03391882|58597961|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
30586054|NCT03391882|58597962|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
30586055|NCT03391882|58597963|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
30586056|NCT03391882|58597964|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
30586057|NCT03391882|58597959|FG000|Study Overall|Protocol Violation|1|||
30670254|NCT00856544|58684010|FG000|Overall Study|Randomized but not treated|3|||
30670255|NCT00856544|58684011|FG001|Overall Study|Randomized but not treated|0|||
30670256|NCT00856544|58684012|FG002|Overall Study|Randomized but not treated|0|||
30670257|NCT00856544|58684013|FG003|Overall Study|Randomized but not treated|0|||
30670258|NCT00856544|58684010|FG000|Overall Study|Death|0|||
30670259|NCT00856544|58684011|FG001|Overall Study|Death|2|||
30670260|NCT00856544|58684012|FG002|Overall Study|Death|0|||
30670261|NCT00856544|58684013|FG003|Overall Study|Death|0|||
30670262|NCT00856544|58684010|FG000|Overall Study|Adverse Event|20|||
30586058|NCT03391882|58597960|FG001|Study Overall|Protocol Violation|0|||
30586059|NCT03391882|58597961|FG002|Study Overall|Protocol Violation|0|||
30586060|NCT03391882|58597962|FG003|Study Overall|Protocol Violation|0|||
30586061|NCT03391882|58597963|FG004|Study Overall|Protocol Violation|0|||
30586062|NCT03391882|58597964|FG005|Study Overall|Protocol Violation|0|||
30670263|NCT00856544|58684011|FG001|Overall Study|Adverse Event|29|||
30670264|NCT00856544|58684012|FG002|Overall Study|Adverse Event|2|||
30670265|NCT00856544|58684013|FG003|Overall Study|Adverse Event|3|||
30670266|NCT00856544|58684010|FG000|Overall Study|Lack of Efficacy|16|||
30670267|NCT00856544|58684011|FG001|Overall Study|Lack of Efficacy|12|||
30670268|NCT00856544|58684012|FG002|Overall Study|Lack of Efficacy|3|||
30670269|NCT00856544|58684013|FG003|Overall Study|Lack of Efficacy|3|||
30670270|NCT00856544|58684010|FG000|Overall Study|Other|9|||
30670271|NCT00856544|58684011|FG001|Overall Study|Other|16|||
30670272|NCT00856544|58684012|FG002|Overall Study|Other|1|||
30670273|NCT00856544|58684013|FG003|Overall Study|Other|6|||
30781094|NCT03788967|58793207|FG001|Overall Study|Adverse Event|1|||
30586063|NCT03391882|58597959|FG000|Part A - Titration Phase|Adverse Event|3|||
30586064|NCT03391882|58597960|FG001|Part A - Titration Phase|Adverse Event|6|||
30586065|NCT03391882|58597961|FG002|Part A - Titration Phase|Adverse Event|0|||
30586066|NCT03391882|58597962|FG003|Part A - Titration Phase|Adverse Event|0|||
30586067|NCT03391882|58597963|FG004|Part A - Titration Phase|Adverse Event|0|||
30586068|NCT03391882|58597964|FG005|Part A - Titration Phase|Adverse Event|0|||
30670274|NCT00856544|58684010|FG000|Overall Study|Lost to Follow-up|1|||
30958873|NCT01587703|59024023|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30586069|NCT03391882|58597959|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
30586070|NCT03391882|58597960|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
30586071|NCT03391882|58597961|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
30586072|NCT03391882|58597962|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
30586073|NCT03391882|58597963|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
30586074|NCT03391882|58597964|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
30586075|NCT03391882|58597959|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
30670275|NCT00856544|58684011|FG001|Overall Study|Lost to Follow-up|2|||
30670276|NCT00856544|58684012|FG002|Overall Study|Lost to Follow-up|2|||
30670277|NCT00856544|58684013|FG003|Overall Study|Lost to Follow-up|0|||
30670278|NCT00856544|58684010|FG000|Overall Study|Withdrawal by Subject|8|||
30670279|NCT00856544|58684011|FG001|Overall Study|Withdrawal by Subject|5|||
30586076|NCT03391882|58597960|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
30586077|NCT03391882|58597961|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
30586078|NCT03391882|58597962|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
30670280|NCT00856544|58684012|FG002|Overall Study|Withdrawal by Subject|0|||
30670281|NCT00856544|58684013|FG003|Overall Study|Withdrawal by Subject|1|||
30670282|NCT00856388|58684035|FG000|Overall Study|Other|1|||
30670283|NCT00848354|58684042|FG000|Phase 1|Adverse Event|5|||
30670284|NCT00848354|58684043|FG001|Phase 1|Adverse Event|4|||
30670285|NCT00848354|58684042|FG000|Phase 1|Discontinuation of study by sponsor|2|||
30670286|NCT00848354|58684043|FG001|Phase 1|Discontinuation of study by sponsor|1|||
30670287|NCT00848354|58684042|FG000|Phase 1|Failed to return|0|||
30586079|NCT03391882|58597963|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
30586080|NCT03391882|58597964|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
30586081|NCT03391882|58597959|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
30670288|NCT00848354|58684043|FG001|Phase 1|Failed to return|1|||
30670289|NCT00848354|58684042|FG000|Phase 1|Lost to Follow-up|1|||
30670290|NCT00848354|58684043|FG001|Phase 1|Lost to Follow-up|1|||
30670291|NCT00848354|58684042|FG000|Phase 1|Unspecified Reason|1|||
30670292|NCT00848354|58684043|FG001|Phase 1|Unspecified Reason|1|||
30670293|NCT00848354|58684042|FG000|Phase 1|Protocol Violation|1|||
30670294|NCT00848354|58684043|FG001|Phase 1|Protocol Violation|1|||
30670295|NCT00848354|58684042|FG000|Phase 1|Withdrawal by Subject|2|||
30670296|NCT00848354|58684043|FG001|Phase 1|Withdrawal by Subject|4|||
30670297|NCT00848354|58684042|FG000|Phase 1|Lack of Efficacy|0|||
30670298|NCT00848354|58684043|FG001|Phase 1|Lack of Efficacy|1|||
30670299|NCT00848354|58684042|FG000|Phase 2 Year 1|Adverse Event|7|||
30670300|NCT00848354|58684043|FG001|Phase 2 Year 1|Adverse Event|2|||
30670301|NCT00848354|58684042|FG000|Phase 2 Year 1|Death|1|||
30670302|NCT00848354|58684043|FG001|Phase 2 Year 1|Death|0|||
30670303|NCT00848354|58684042|FG000|Phase 2 Year 1|Failed to Return|1|||
30670304|NCT00848354|58684043|FG001|Phase 2 Year 1|Failed to Return|1|||
30670305|NCT00848354|58684042|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
30670306|NCT00848354|58684043|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
30670307|NCT00848354|58684042|FG000|Phase 2 Year 1|Unspecified Reason|3|||
30670308|NCT00848354|58684043|FG001|Phase 2 Year 1|Unspecified Reason|0|||
30670309|NCT00848354|58684042|FG000|Phase 2 Year 1|Protocol Violation|4|||
30670310|NCT00848354|58684043|FG001|Phase 2 Year 1|Protocol Violation|1|||
30670311|NCT00848354|58684042|FG000|Phase 2 Year 1|Subject Request|1|||
30670312|NCT00848354|58684043|FG001|Phase 2 Year 1|Subject Request|2|||
30670313|NCT00848354|58684042|FG000|Phase 2 Year 2|Adverse Event|12|||
30670314|NCT00848354|58684043|FG001|Phase 2 Year 2|Adverse Event|2|||
30670315|NCT00848354|58684042|FG000|Phase 2 Year 2|Death|2|||
30586082|NCT03391882|58597960|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
30586083|NCT03391882|58597961|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
30586084|NCT03391882|58597962|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
30586085|NCT03391882|58597963|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
30586086|NCT03391882|58597964|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
30586087|NCT03391882|58597959|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
30586088|NCT03391882|58597960|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
30586089|NCT03391882|58597961|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
30586090|NCT03391882|58597962|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
30586091|NCT03391882|58597963|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
30586092|NCT03391882|58597964|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
30586093|NCT03391882|58597959|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
30586094|NCT03391882|58597960|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
30586095|NCT03391882|58597961|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
30586096|NCT03391882|58597962|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
30586097|NCT03391882|58597963|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
30586098|NCT03391882|58597964|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
30586099|NCT03391882|58597959|FG000|Part B - Treatment Phase|Adverse Event|0|||
30586100|NCT03391882|58597960|FG001|Part B - Treatment Phase|Adverse Event|0|||
30586101|NCT03391882|58597961|FG002|Part B - Treatment Phase|Adverse Event|1|||
30586102|NCT03391882|58597962|FG003|Part B - Treatment Phase|Adverse Event|1|||
30586103|NCT03391882|58597963|FG004|Part B - Treatment Phase|Adverse Event|3|||
30586104|NCT03391882|58597964|FG005|Part B - Treatment Phase|Adverse Event|1|||
30586105|NCT03391882|58597959|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
30670316|NCT00848354|58684043|FG001|Phase 2 Year 2|Death|0|||
30670317|NCT00848354|58684042|FG000|Phase 2 Year 2|Failed to return|3|||
30586106|NCT03391882|58597960|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
30586107|NCT03391882|58597961|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
30586108|NCT03391882|58597962|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
30586109|NCT03391882|58597963|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
30586110|NCT03391882|58597964|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
30670318|NCT00848354|58684043|FG001|Phase 2 Year 2|Failed to return|0|||
30670319|NCT00848354|58684042|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
30670320|NCT00848354|58684043|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
30670321|NCT00848354|58684042|FG000|Phase 2 Year 2|Unspecified Reason|1|||
30586111|NCT01261000|58597974|FG000|Overall Study|Screen failure|1|||
30586112|NCT01234402|58598007|FG000|Overall Study|Lost to Follow-up|0|||
30586113|NCT01234402|58598008|FG001|Overall Study|Lost to Follow-up|1|||
30586114|NCT01234402|58598009|FG002|Overall Study|Lost to Follow-up|3|||
30670322|NCT00848354|58684043|FG001|Phase 2 Year 2|Unspecified Reason|0|||
30670323|NCT00848354|58684042|FG000|Phase 2 Year 2|Protocol Violation|1|||
30670324|NCT00848354|58684043|FG001|Phase 2 Year 2|Protocol Violation|1|||
30670325|NCT00848354|58684042|FG000|Phase 2 Year 2|Subject Request|1|||
30670326|NCT00848354|58684043|FG001|Phase 2 Year 2|Subject Request|1|||
30670327|NCT00848354|58684042|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
30670328|NCT00848354|58684043|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
30670329|NCT00848198|58684053|FG000|Overall Study|Incomplete Case Report Forms|15|||
30670330|NCT00848120|58684061|FG000|Overall Study|Adverse Event|1|||
30670331|NCT00600821|58684067|FG000|Overall Study|Death|45|||
30670332|NCT00600821|58684068|FG001|Overall Study|Death|46|||
30670333|NCT00600821|58684067|FG000|Overall Study|Lost to Follow-up|2|||
30670334|NCT00600821|58684068|FG001|Overall Study|Lost to Follow-up|2|||
30670335|NCT00600821|58684067|FG000|Overall Study|Withdrawal by Subject|1|||
30670336|NCT00600821|58684068|FG001|Overall Study|Withdrawal by Subject|1|||
30670337|NCT00600821|58684067|FG000|Overall Study|Terminated by sponsor|8|||
30670338|NCT00600821|58684068|FG001|Overall Study|Terminated by sponsor|6|||
30670339|NCT00600821|58684067|FG000|Overall Study|Objective progression or relapse|0|||
30670340|NCT00600821|58684068|FG001|Overall Study|Objective progression or relapse|1|||
30670341|NCT00600821|58684067|FG000|Overall Study|Randomized but not treated|0|||
30670342|NCT00600821|58684068|FG001|Overall Study|Randomized but not treated|1|||
30670343|NCT00600821|58684067|FG000|Overall Study|Other|2|||
30670344|NCT00600821|58684068|FG001|Overall Study|Other|3|||
30670345|NCT00592904|58684080|FG000|Overall Study|Adverse Event|15|||
30670346|NCT00592904|58684081|FG001|Overall Study|Adverse Event|25|||
30670347|NCT00592904|58684082|FG002|Overall Study|Adverse Event|13|||
30670348|NCT00592904|58684083|FG003|Overall Study|Adverse Event|5|||
30670349|NCT00592904|58684080|FG000|Overall Study|Protocol Violation|1|||
30670350|NCT00592904|58684081|FG001|Overall Study|Protocol Violation|1|||
30670351|NCT00592904|58684082|FG002|Overall Study|Protocol Violation|0|||
30670352|NCT00592904|58684083|FG003|Overall Study|Protocol Violation|1|||
30670353|NCT00592904|58684080|FG000|Overall Study|Withdrawal by Subject|4|||
30586115|NCT01234402|58598007|FG000|Overall Study|Withdrawal by Subject|1|||
30586116|NCT01234402|58598008|FG001|Overall Study|Withdrawal by Subject|3|||
30586117|NCT01234402|58598009|FG002|Overall Study|Withdrawal by Subject|4|||
30586118|NCT01234402|58598007|FG000|Overall Study|Never treated: Death|0|||
30586119|NCT01234402|58598008|FG001|Overall Study|Never treated: Death|0|||
30586120|NCT01234402|58598009|FG002|Overall Study|Never treated: Death|1|||
30586121|NCT01234402|58598007|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
30586122|NCT01234402|58598008|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
30586123|NCT01234402|58598009|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
30586124|NCT01234402|58598007|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
30586125|NCT01234402|58598008|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
30586126|NCT01234402|58598009|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
30586127|NCT01260922|58598021|FG000|First Intervention|Withdrawal by Subject|0|||
30586128|NCT01260922|58598022|FG001|First Intervention|Withdrawal by Subject|1|||
30586129|NCT01260922|58598021|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
30586130|NCT01260922|58598022|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
30586131|NCT01260922|58598021|FG000|Second Intervention|Emesis|0|||
30586132|NCT01260922|58598022|FG001|Second Intervention|Emesis|2|||
30586133|NCT01233817|58598028|FG000|Overall Study|Lost to Follow-up|1|||
30586134|NCT01233817|58598028|FG000|Overall Study|Withdrawal by Subject|2|||
30586135|NCT01233232|58598035|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
30586136|NCT01233232|58598036|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
30586137|NCT01233232|58598037|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
30586138|NCT01233076|58598047|FG000|Period 2, One Week|Lost to Follow-up|1|||
30586139|NCT01233076|58598048|FG001|Period 2, One Week|Lost to Follow-up|0|||
30586140|NCT01212094|58598057|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
30586141|NCT01212094|58598058|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
30586142|NCT01212094|58598059|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
30586143|NCT01212094|58598057|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
30586144|NCT01212094|58598058|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
30586145|NCT01212094|58598059|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
30586146|NCT01212094|58598057|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
30670354|NCT00592904|58684081|FG001|Overall Study|Withdrawal by Subject|16|||
30670355|NCT00592904|58684082|FG002|Overall Study|Withdrawal by Subject|1|||
30670356|NCT00592904|58684083|FG003|Overall Study|Withdrawal by Subject|2|||
30670357|NCT00592904|58684080|FG000|Overall Study|Lack of Efficacy|2|||
30670358|NCT00592904|58684081|FG001|Overall Study|Lack of Efficacy|7|||
30670359|NCT00592904|58684082|FG002|Overall Study|Lack of Efficacy|2|||
30670360|NCT00592904|58684083|FG003|Overall Study|Lack of Efficacy|3|||
30670361|NCT00592904|58684080|FG000|Overall Study|Physician Decision|0|||
30586147|NCT01212094|58598058|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
30586148|NCT01212094|58598059|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
30586149|NCT01212094|58598057|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
30586150|NCT01212094|58598058|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
30586151|NCT01212094|58598059|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
30586152|NCT01212094|58598057|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
30670362|NCT00592904|58684081|FG001|Overall Study|Physician Decision|3|||
30670363|NCT00592904|58684082|FG002|Overall Study|Physician Decision|1|||
30670364|NCT00592904|58684083|FG003|Overall Study|Physician Decision|0|||
30670365|NCT00592904|58684080|FG000|Overall Study|Other|3|||
30670366|NCT00592904|58684081|FG001|Overall Study|Other|3|||
30670367|NCT00592904|58684082|FG002|Overall Study|Other|0|||
30670368|NCT00592904|58684083|FG003|Overall Study|Other|0|||
30670369|NCT00855920|58684096|FG000|Overall Study|Protocol Violation|0|||
30670370|NCT00855920|58684097|FG001|Overall Study|Protocol Violation|0|||
30670371|NCT00855920|58684098|FG002|Overall Study|Protocol Violation|2|||
30670372|NCT00855920|58684096|FG000|Overall Study|Adverse Event|2|||
30670373|NCT00855920|58684097|FG001|Overall Study|Adverse Event|1|||
30670374|NCT00855920|58684098|FG002|Overall Study|Adverse Event|1|||
30670375|NCT00855920|58684096|FG000|Overall Study|Lack of Efficacy|2|||
30670376|NCT00855920|58684097|FG001|Overall Study|Lack of Efficacy|2|||
30670377|NCT00855920|58684098|FG002|Overall Study|Lack of Efficacy|2|||
30670378|NCT00855920|58684096|FG000|Overall Study|Withdrawal by Subject|2|||
30670379|NCT00855920|58684097|FG001|Overall Study|Withdrawal by Subject|3|||
30670380|NCT00855920|58684098|FG002|Overall Study|Withdrawal by Subject|2|||
30670381|NCT00855920|58684096|FG000|Overall Study|Lost to Follow-up|1|||
30670382|NCT00855920|58684097|FG001|Overall Study|Lost to Follow-up|0|||
30670383|NCT00855920|58684098|FG002|Overall Study|Lost to Follow-up|2|||
30670384|NCT00855920|58684096|FG000|Overall Study|Death|0|||
30670385|NCT00855920|58684097|FG001|Overall Study|Death|1|||
30670386|NCT00855920|58684098|FG002|Overall Study|Death|0|||
30670387|NCT00855920|58684096|FG000|Overall Study|Decision by the sponsor|0|||
30670388|NCT00855920|58684097|FG001|Overall Study|Decision by the sponsor|1|||
30670389|NCT00855920|58684098|FG002|Overall Study|Decision by the sponsor|1|||
30670390|NCT00855920|58684096|FG000|Overall Study|Other than specified above|1|||
30670391|NCT00855920|58684097|FG001|Overall Study|Other than specified above|1|||
30670392|NCT00855920|58684098|FG002|Overall Study|Other than specified above|1|||
30670393|NCT00848042|58684109|FG000|Overall Study|Death|1|||
30670394|NCT00848042|58684110|FG001|Overall Study|Death|2|||
30670395|NCT00848042|58684111|FG002|Overall Study|Death|0|||
30670396|NCT00848042|58684109|FG000|Overall Study|Other Therapy|3|||
30670397|NCT00848042|58684110|FG001|Overall Study|Other Therapy|0|||
30670398|NCT00848042|58684111|FG002|Overall Study|Other Therapy|0|||
30670399|NCT00847886|58684121|FG000|Overall Study|Adverse Event|0|||
30670400|NCT00847886|58684122|FG001|Overall Study|Adverse Event|1|||
30670401|NCT00847808|58684128|FG000|Overall Study|Adverse Event|7|||
30670402|NCT00847808|58684128|FG000|Overall Study|Protocol Violation|1|||
30670403|NCT00847808|58684128|FG000|Overall Study|Lost to Follow-up|1|||
30670404|NCT00847808|58684128|FG000|Overall Study|Withdrawal by Subject|4|||
30781095|NCT03788967|58793206|FG000|Overall Study|COVID-19|1|||
30781096|NCT03788967|58793207|FG001|Overall Study|COVID-19|2|||
30781097|NCT03782571|58793215|FG000|Period 1|Withdrawal by Subject|1|||
30781098|NCT03782571|58793216|FG001|Period 1|Withdrawal by Subject|0|||
30781099|NCT03782571|58793217|FG002|Period 1|Withdrawal by Subject|0|||
30781100|NCT03782571|58793218|FG003|Period 1|Withdrawal by Subject|0|||
30586153|NCT01212094|58598058|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
30586154|NCT01212094|58598059|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
30670405|NCT00847808|58684128|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
30670406|NCT00847808|58684128|FG000|Overall Study|Participant Took Excluded Medication|1|||
30670407|NCT00600353|58684134|FG000|Overall Study|history of malignancy within 5 years|1|||
30670408|NCT00600353|58684135|FG001|Overall Study|history of malignancy within 5 years|0|||
30670409|NCT00600353|58684134|FG000|Overall Study|History of prepartive regimen|0|||
30670410|NCT00600353|58684135|FG001|Overall Study|History of prepartive regimen|1|||
30670411|NCT00691210|58684149|FG000|Overall Study|Progression of Disease|0|||
30670412|NCT00691210|58684150|FG001|Overall Study|Progression of Disease|0|||
30670413|NCT00691210|58684151|FG002|Overall Study|Progression of Disease|0|||
30670414|NCT00691210|58684152|FG003|Overall Study|Progression of Disease|2|||
30670415|NCT00691210|58684153|FG004|Overall Study|Progression of Disease|0|||
30670416|NCT00691210|58684154|FG005|Overall Study|Progression of Disease|0|||
30670417|NCT00691210|58684155|FG006|Overall Study|Progression of Disease|0|||
30958874|NCT01587703|59024024|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30586155|NCT01212094|58598057|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
30670418|NCT00691210|58684156|FG007|Overall Study|Progression of Disease|0|||
30670419|NCT00691210|58684149|FG000|Overall Study|Lack of Efficacy|0|||
30670420|NCT00691210|58684150|FG001|Overall Study|Lack of Efficacy|0|||
30670421|NCT00691210|58684151|FG002|Overall Study|Lack of Efficacy|0|||
30781101|NCT03782571|58793215|FG000|Period 3|Subject Unable to Attend V5|1|||
30586156|NCT01212094|58598058|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
30586157|NCT01212094|58598059|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
30586158|NCT01232569|58598068|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
30586159|NCT01232569|58598069|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
30586160|NCT01232569|58598070|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
30586161|NCT01232569|58598071|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
30586162|NCT01232569|58598068|FG000|Double-blind Treatment Period|Escape|2|||
30586163|NCT01232569|58598069|FG001|Double-blind Treatment Period|Escape|2|||
30586164|NCT01232569|58598070|FG002|Double-blind Treatment Period|Escape|0|||
30586165|NCT01232569|58598071|FG003|Double-blind Treatment Period|Escape|0|||
30586166|NCT01232569|58598068|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
30586167|NCT01232569|58598069|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
30586168|NCT01232569|58598070|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
30586169|NCT01232569|58598071|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
30586170|NCT01232569|58598068|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
30586171|NCT01232569|58598069|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
30586172|NCT01232569|58598070|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
30586173|NCT01232569|58598071|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
30586174|NCT01232569|58598068|FG000|Double-blind Treatment Period|Physician Decision|1|||
30586175|NCT01232569|58598069|FG001|Double-blind Treatment Period|Physician Decision|0|||
30586176|NCT01232569|58598070|FG002|Double-blind Treatment Period|Physician Decision|0|||
30586177|NCT01232569|58598071|FG003|Double-blind Treatment Period|Physician Decision|0|||
30586178|NCT01232569|58598068|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
30586179|NCT01232569|58598069|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
30586180|NCT01232569|58598070|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
30586181|NCT01232569|58598071|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
30586182|NCT01232569|58598068|FG000|Double-blind Treatment Period|Death|2|||
30586183|NCT01232569|58598069|FG001|Double-blind Treatment Period|Death|0|||
30586184|NCT01232569|58598070|FG002|Double-blind Treatment Period|Death|0|||
30586185|NCT01232569|58598071|FG003|Double-blind Treatment Period|Death|0|||
30586186|NCT01211665|58598082|FG000|Overall Study|Withdrawal by Subject|1|||
30670422|NCT00691210|58684152|FG003|Overall Study|Lack of Efficacy|1|||
30670423|NCT00691210|58684153|FG004|Overall Study|Lack of Efficacy|0|||
30670424|NCT00691210|58684154|FG005|Overall Study|Lack of Efficacy|1|||
30670425|NCT00691210|58684155|FG006|Overall Study|Lack of Efficacy|0|||
30670426|NCT00691210|58684156|FG007|Overall Study|Lack of Efficacy|0|||
30670427|NCT00691132|58684176|FG000|Overall Study|Adverse Event|2|||
30670428|NCT00691132|58684177|FG001|Overall Study|Adverse Event|3|||
30670429|NCT00691132|58684176|FG000|Overall Study|Withdrawal by Subject|10|||
30670430|NCT00691132|58684177|FG001|Overall Study|Withdrawal by Subject|10|||
30670431|NCT00855218|58684199|FG000|Overall Study|Adverse Event|43|||
30670432|NCT00855218|58684200|FG001|Overall Study|Adverse Event|27|||
30670433|NCT00855218|58684199|FG000|Overall Study|Withdrawal by Subject|10|||
30670434|NCT00855218|58684200|FG001|Overall Study|Withdrawal by Subject|6|||
30670435|NCT00855218|58684199|FG000|Overall Study|Physician Decision|18|||
30670436|NCT00855218|58684200|FG001|Overall Study|Physician Decision|11|||
30670437|NCT00855218|58684199|FG000|Overall Study|Lost to Follow-up|0|||
30670438|NCT00855218|58684200|FG001|Overall Study|Lost to Follow-up|1|||
30670439|NCT00855218|58684199|FG000|Overall Study|Protocol Violation|5|||
30670440|NCT00855218|58684200|FG001|Overall Study|Protocol Violation|9|||
30670441|NCT00855218|58684199|FG000|Overall Study|non-compliant with study drug|3|||
30670442|NCT00855218|58684200|FG001|Overall Study|non-compliant with study drug|1|||
30670443|NCT00855218|58684199|FG000|Overall Study|patient convenience|2|||
30670444|NCT00855218|58684200|FG001|Overall Study|patient convenience|0|||
30670445|NCT00855218|58684199|FG000|Overall Study|technical problems|2|||
30670446|NCT00855218|58684200|FG001|Overall Study|technical problems|1|||
30670447|NCT00855218|58684199|FG000|Overall Study|Still treated with study medication|0|||
30670448|NCT00855218|58684200|FG001|Overall Study|Still treated with study medication|1|||
30670449|NCT00855218|58684199|FG000|Overall Study|Untreatable disease progression|54|||
30670450|NCT00855218|58684200|FG001|Overall Study|Untreatable disease progression|67|||
30670451|NCT00855218|58684199|FG000|Overall Study|Second malignancy|0|||
30670452|NCT00855218|58684200|FG001|Overall Study|Second malignancy|1|||
30670453|NCT00855218|58684199|FG000|Overall Study|Progression measurement proven|7|||
30670454|NCT00855218|58684200|FG001|Overall Study|Progression measurement proven|15|||
30670455|NCT00855218|58684199|FG000|Overall Study|Clinical endpoint reached|10|||
30670456|NCT00855218|58684200|FG001|Overall Study|Clinical endpoint reached|13|||
30670457|NCT01063348|58684208|FG000|Overall Study|Lost to Follow-up|3|||
30670458|NCT01063348|58684209|FG001|Overall Study|Lost to Follow-up|10|||
30670459|NCT00855062|58684217|FG000|Step1|Early Study Closure|5|||
30781102|NCT03782571|58793216|FG001|Period 3|Subject Unable to Attend V5|0|||
30586187|NCT01211665|58598083|FG001|Overall Study|Withdrawal by Subject|0|||
30586188|NCT01211665|58598082|FG000|Overall Study|Death|1|||
30670460|NCT00855062|58684218|FG001|Step1|Early Study Closure|7|||
30670461|NCT00855062|58684217|FG000|Step1|Adverse Event|1|||
30670462|NCT00855062|58684218|FG001|Step1|Adverse Event|1|||
30670463|NCT00855062|58684217|FG000|Step1|Protocol Violation|1|||
30670464|NCT00855062|58684218|FG001|Step1|Protocol Violation|0|||
30670465|NCT00855062|58684217|FG000|Step1|Pregnancy|1|||
30586189|NCT01211665|58598083|FG001|Overall Study|Death|0|||
30586190|NCT01232491|58598091|FG000|Overall Study|Adverse Event|13|||
30586191|NCT01232491|58598092|FG001|Overall Study|Adverse Event|8|||
30586192|NCT01232491|58598091|FG000|Overall Study|Lack of Efficacy|1|||
30586193|NCT01232491|58598092|FG001|Overall Study|Lack of Efficacy|5|||
30586194|NCT01232491|58598091|FG000|Overall Study|Protocol Violation|13|||
30586195|NCT01232491|58598092|FG001|Overall Study|Protocol Violation|11|||
30586196|NCT01232491|58598091|FG000|Overall Study|Withdrawal Criteria|12|||
30586197|NCT01232491|58598092|FG001|Overall Study|Withdrawal Criteria|21|||
30586198|NCT01232491|58598091|FG000|Overall Study|Other|21|||
30670466|NCT00855062|58684218|FG001|Step1|Pregnancy|0|||
30670467|NCT00855062|58684217|FG000|Step1|Withdrawal by Subject|2|||
30670468|NCT00855062|58684218|FG001|Step1|Withdrawal by Subject|3|||
30670469|NCT00855062|58684217|FG000|Step2|Early Study Closure|6|||
30670470|NCT00855062|58684218|FG001|Step2|Early Study Closure|2|||
30670471|NCT00855062|58684217|FG000|Step2|Adverse Event|0|||
30670472|NCT00855062|58684218|FG001|Step2|Adverse Event|3|||
30670473|NCT00855062|58684217|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
30670474|NCT00855062|58684218|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
30670475|NCT00854906|58684224|FG000|Overall Study|One person had no ocular history|1|||
30670476|NCT00854828|58684235|FG000|Overall Study|Death|1|||
30670477|NCT00854828|58684236|FG001|Overall Study|Death|0|||
30781103|NCT03782571|58793217|FG002|Period 3|Subject Unable to Attend V5|0|||
30586199|NCT01232491|58598092|FG001|Overall Study|Other|18|||
30586200|NCT01232452|58598100|FG000|Overall Study|Adverse Event|17|||
30586201|NCT01232452|58598101|FG001|Overall Study|Adverse Event|15|||
30586202|NCT01232452|58598100|FG000|Overall Study|Withdrawal by Subject|11|||
30586203|NCT01232452|58598101|FG001|Overall Study|Withdrawal by Subject|8|||
30586204|NCT01232452|58598100|FG000|Overall Study|Physician Decision|8|||
30586205|NCT01232452|58598101|FG001|Overall Study|Physician Decision|12|||
30586206|NCT01232452|58598100|FG000|Overall Study|Protocol entry criterion not met|0|||
30586207|NCT01232452|58598101|FG001|Overall Study|Protocol entry criterion not met|2|||
30586208|NCT01232452|58598100|FG000|Overall Study|Sponsor Decision|3|||
30586209|NCT01232452|58598101|FG001|Overall Study|Sponsor Decision|1|||
30586210|NCT01232452|58598100|FG000|Overall Study|Protocol Violation|0|||
30586211|NCT01232452|58598101|FG001|Overall Study|Protocol Violation|1|||
30586212|NCT01211197|58598107|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30586213|NCT01211197|58598108|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30586214|NCT01211197|58598109|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
30586215|NCT01211197|58598110|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30586216|NCT01211197|58598111|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30586217|NCT01211197|58598112|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30586218|NCT01211197|58598107|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
30586219|NCT01211197|58598108|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
30586220|NCT01211197|58598109|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
30586221|NCT01211197|58598110|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
30586222|NCT01211197|58598111|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
30586223|NCT01211197|58598112|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
30670478|NCT00854828|58684237|FG002|Overall Study|Death|0|||
30670479|NCT00854828|58684238|FG003|Overall Study|Death|0|||
30670480|NCT00854828|58684235|FG000|Overall Study|Withdrawal by Subject|1|||
30670481|NCT00854828|58684236|FG001|Overall Study|Withdrawal by Subject|1|||
30670482|NCT00854828|58684237|FG002|Overall Study|Withdrawal by Subject|0|||
30586224|NCT01232296|58598122|FG000|Overall Study|Adverse Event|24|||
30586225|NCT01232296|58598123|FG001|Overall Study|Adverse Event|12|||
30586226|NCT01232296|58598122|FG000|Overall Study|Physician Decision|1|||
30586227|NCT01232296|58598123|FG001|Overall Study|Physician Decision|1|||
30586228|NCT01232296|58598122|FG000|Overall Study|Progressive disease|43|||
30586229|NCT01232296|58598123|FG001|Overall Study|Progressive disease|61|||
30586230|NCT01232296|58598122|FG000|Overall Study|Study terminated by sponsor|0|||
30670483|NCT00854828|58684238|FG003|Overall Study|Withdrawal by Subject|9|||
30586231|NCT01232296|58598123|FG001|Overall Study|Study terminated by sponsor|1|||
30586232|NCT01232296|58598122|FG000|Overall Study|Technical problems|3|||
30586233|NCT01232296|58598123|FG001|Overall Study|Technical problems|0|||
30586234|NCT01232296|58598122|FG000|Overall Study|Subject/guardian decision|10|||
30586235|NCT01232296|58598123|FG001|Overall Study|Subject/guardian decision|2|||
30586236|NCT01232296|58598122|FG000|Overall Study|Death|1|||
30586237|NCT01232296|58598123|FG001|Overall Study|Death|6|||
30586238|NCT01231984|58598131|FG000|Study Period 1|Withdrawal by Subject|0|||
30586239|NCT01231984|58598132|FG001|Study Period 1|Withdrawal by Subject|0|||
30586240|NCT01231984|58598133|FG002|Study Period 1|Withdrawal by Subject|0|||
30586241|NCT01231984|58598134|FG003|Study Period 1|Withdrawal by Subject|1|||
30586242|NCT01231984|58598131|FG000|Study Period 1|Lost to Follow-up|1|||
30586243|NCT01231984|58598132|FG001|Study Period 1|Lost to Follow-up|1|||
30586244|NCT01231984|58598133|FG002|Study Period 1|Lost to Follow-up|1|||
30586245|NCT01231984|58598134|FG003|Study Period 1|Lost to Follow-up|0|||
30586246|NCT01231984|58598131|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
30586247|NCT01231984|58598132|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
30586248|NCT01231984|58598133|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
30586249|NCT01231984|58598134|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
30586250|NCT01231984|58598131|FG000|Study Period 1|Screen Failure|0|||
30586251|NCT01231984|58598132|FG001|Study Period 1|Screen Failure|0|||
30586252|NCT01231984|58598133|FG002|Study Period 1|Screen Failure|0|||
30586253|NCT01231984|58598134|FG003|Study Period 1|Screen Failure|1|||
30586254|NCT01231984|58598131|FG000|Study Period 1|Non-compliance with study requirements|5|||
30586255|NCT01231984|58598132|FG001|Study Period 1|Non-compliance with study requirements|0|||
30586256|NCT01231984|58598133|FG002|Study Period 1|Non-compliance with study requirements|2|||
30586257|NCT01231984|58598134|FG003|Study Period 1|Non-compliance with study requirements|1|||
30586258|NCT01231984|58598131|FG000|Study Period 1|Protocol Violation|3|||
30586259|NCT01231984|58598132|FG001|Study Period 1|Protocol Violation|4|||
30586260|NCT01231984|58598133|FG002|Study Period 1|Protocol Violation|2|||
30586261|NCT01231984|58598134|FG003|Study Period 1|Protocol Violation|3|||
30670484|NCT00854828|58684235|FG000|Overall Study|Missed 24mo visit|1|||
30670485|NCT00854828|58684236|FG001|Overall Study|Missed 24mo visit|1|||
30670486|NCT00854828|58684237|FG002|Overall Study|Missed 24mo visit|8|||
30670487|NCT00854828|58684238|FG003|Overall Study|Missed 24mo visit|8|||
30670488|NCT00847730|58684248|FG000|Overall Study|Multiple interruptions in therapy|8|||
30670489|NCT00600119|58684258|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
30670490|NCT00600119|58684259|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
30670491|NCT00600119|58684260|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
30670492|NCT00600119|58684261|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
30670493|NCT00600119|58684262|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
30670494|NCT00600119|58684263|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
30670495|NCT00600119|58684258|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
30670496|NCT00600119|58684259|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
30670497|NCT00600119|58684260|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
30586262|NCT01231984|58598131|FG000|Study Period 1|Adverse Event|1|||
30586263|NCT01231984|58598132|FG001|Study Period 1|Adverse Event|0|||
30586264|NCT01231984|58598133|FG002|Study Period 1|Adverse Event|0|||
30586265|NCT01231984|58598134|FG003|Study Period 1|Adverse Event|0|||
30586266|NCT01231984|58598131|FG000|Study Period 1|Other|0|||
30586267|NCT01231984|58598132|FG001|Study Period 1|Other|0|||
30586268|NCT01231984|58598133|FG002|Study Period 1|Other|0|||
30586269|NCT01231984|58598134|FG003|Study Period 1|Other|1|||
30586270|NCT01231984|58598131|FG000|Study Period 2|Withdrawal by Subject|1|||
30586271|NCT01231984|58598132|FG001|Study Period 2|Withdrawal by Subject|1|||
30670498|NCT00600119|58684261|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
30670499|NCT00600119|58684262|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
30670500|NCT00600119|58684263|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
30670501|NCT00600119|58684258|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
30586272|NCT01231984|58598133|FG002|Study Period 2|Withdrawal by Subject|0|||
30586273|NCT01231984|58598134|FG003|Study Period 2|Withdrawal by Subject|0|||
30586274|NCT01231984|58598131|FG000|Study Period 2|Lost to Follow-up|1|||
30586275|NCT01231984|58598132|FG001|Study Period 2|Lost to Follow-up|0|||
30586276|NCT01231984|58598133|FG002|Study Period 2|Lost to Follow-up|0|||
30586277|NCT01231984|58598134|FG003|Study Period 2|Lost to Follow-up|3|||
30586278|NCT01231984|58598131|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
30586279|NCT01231984|58598132|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
30586280|NCT01231984|58598133|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
30586281|NCT01231984|58598134|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
30586282|NCT01210807|58598154|FG000|Overall Study|Lost to Follow-up|1|||
30586283|NCT01210807|58598155|FG001|Overall Study|Lost to Follow-up|2|||
30586284|NCT01210807|58598154|FG000|Overall Study|Not implanted bilaterally|2|||
30586285|NCT01210807|58598155|FG001|Overall Study|Not implanted bilaterally|1|||
30586286|NCT01231555|58598164|FG000|Overall Study|Study terminated|8|||
30586287|NCT01231555|58598165|FG001|Overall Study|Study terminated|5|||
30586288|NCT01231555|58598166|FG002|Overall Study|Study terminated|8|||
30586289|NCT01231555|58598164|FG000|Overall Study|Withdrawal by Subject|0|||
30670502|NCT00600119|58684259|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
30670503|NCT00600119|58684260|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
30670504|NCT00600119|58684261|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
30670505|NCT00600119|58684262|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
30670506|NCT00600119|58684263|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
30670507|NCT00600119|58684258|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
30670508|NCT00600119|58684259|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
30670509|NCT00600119|58684260|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
30670510|NCT00600119|58684261|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
30670511|NCT00600119|58684262|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
30670512|NCT00600119|58684263|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
30670513|NCT00600119|58684258|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
30670514|NCT00600119|58684259|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
30670515|NCT00600119|58684260|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
30670516|NCT00600119|58684261|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
30670517|NCT00600119|58684262|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
30670518|NCT00600119|58684263|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
30670519|NCT00600119|58684258|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
30670520|NCT00600119|58684259|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
30670521|NCT00600119|58684260|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
30670522|NCT00600119|58684261|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
30670523|NCT00600119|58684262|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
30670524|NCT00600119|58684263|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
30670525|NCT00600119|58684258|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
30670526|NCT00600119|58684259|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
30670527|NCT00600119|58684260|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
30670528|NCT00600119|58684261|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
30670529|NCT00600119|58684262|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
30670530|NCT00600119|58684263|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
30670531|NCT00600119|58684258|FG000|Double-blind Treatment Period|Other|0|||
30670532|NCT00600119|58684259|FG001|Double-blind Treatment Period|Other|0|||
30670533|NCT00600119|58684260|FG002|Double-blind Treatment Period|Other|0|||
30670534|NCT00600119|58684261|FG003|Double-blind Treatment Period|Other|0|||
30586290|NCT01231555|58598165|FG001|Overall Study|Withdrawal by Subject|2|||
30586291|NCT01231555|58598166|FG002|Overall Study|Withdrawal by Subject|0|||
30670535|NCT00600119|58684262|FG004|Double-blind Treatment Period|Other|2|||
30670536|NCT00600119|58684263|FG005|Double-blind Treatment Period|Other|1|||
30670537|NCT00600119|58684258|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
30670538|NCT00600119|58684259|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
30670539|NCT00600119|58684260|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
30670540|NCT00600119|58684261|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
30670541|NCT00600119|58684262|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
30670542|NCT00600119|58684263|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
30670543|NCT00600119|58684258|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
30670544|NCT00600119|58684259|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
30586292|NCT01210690|58598174|FG000|Overall Study|Adverse Event|7|||
30586293|NCT01210690|58598174|FG000|Overall Study|Lack of Efficacy|12|||
30586294|NCT01210690|58598174|FG000|Overall Study|Lost to Follow-up|3|||
30855771|NCT02761057|58883474|FG000|Overall Study|Progression/Relapse|29|||
30586295|NCT01210690|58598174|FG000|Overall Study|Disease Remission|1|||
30586296|NCT01210690|58598174|FG000|Overall Study|Withdrawal by Subject|1|||
30586297|NCT01210690|58598174|FG000|Overall Study|Patient refused to swallow|1|||
30586298|NCT01210690|58598174|FG000|Overall Study|Patient could not take glucose|1|||
30586299|NCT01210651|58598181|FG000|Overall Study|Lost to Follow-up|1|||
30586300|NCT01210651|58598182|FG001|Overall Study|Lost to Follow-up|1|||
30586301|NCT01210651|58598181|FG000|Overall Study|schedule conflicts|1|||
30586302|NCT01210651|58598182|FG001|Overall Study|schedule conflicts|5|||
30586303|NCT01210651|58598181|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
30670545|NCT00600119|58684260|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
30670546|NCT00600119|58684261|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
30670547|NCT00600119|58684262|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
30670548|NCT00600119|58684263|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
30670549|NCT00600119|58684258|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
30670550|NCT00600119|58684259|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
30670551|NCT00600119|58684260|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
30670552|NCT00600119|58684261|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
30586304|NCT01210651|58598182|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
30586305|NCT01210651|58598181|FG000|Overall Study|Withdrawal by Subject|1|||
30586306|NCT01210651|58598182|FG001|Overall Study|Withdrawal by Subject|1|||
30586307|NCT01210651|58598181|FG000|Overall Study|Injury outside study|2|||
30670553|NCT00600119|58684262|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
30670554|NCT00600119|58684263|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
30670555|NCT00600119|58684258|FG000|Double-blind Treatment Period|Physician Decision|2|||
30670556|NCT00600119|58684259|FG001|Double-blind Treatment Period|Physician Decision|0|||
30670557|NCT00600119|58684260|FG002|Double-blind Treatment Period|Physician Decision|0|||
30670558|NCT00600119|58684261|FG003|Double-blind Treatment Period|Physician Decision|0|||
30670559|NCT00600119|58684262|FG004|Double-blind Treatment Period|Physician Decision|0|||
30670560|NCT00600119|58684263|FG005|Double-blind Treatment Period|Physician Decision|0|||
30670561|NCT00600119|58684258|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
30670562|NCT00600119|58684259|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
30670563|NCT00600119|58684260|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
30670564|NCT00600119|58684261|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
30670565|NCT00600119|58684262|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
30670566|NCT00600119|58684263|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
30670567|NCT00600119|58684258|FG000|Double-blind Treatment Period|Adverse Event|1|||
30670568|NCT00600119|58684259|FG001|Double-blind Treatment Period|Adverse Event|1|||
30670569|NCT00600119|58684260|FG002|Double-blind Treatment Period|Adverse Event|0|||
30586308|NCT01210651|58598182|FG001|Overall Study|Injury outside study|0|||
30586309|NCT01210495|58598261|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
30586310|NCT01210495|58598262|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
30586311|NCT01210495|58598263|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
30586312|NCT01210495|58598264|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
30586313|NCT01210495|58598261|FG000|Overall Study|Death|14|||
30586314|NCT01210495|58598262|FG001|Overall Study|Death|7|||
30586315|NCT01210495|58598263|FG002|Overall Study|Death|112|||
30586316|NCT01210495|58598264|FG003|Overall Study|Death|54|||
30586317|NCT01210495|58598261|FG000|Overall Study|Study Terminated by Sponsor|0|||
30586318|NCT01210495|58598262|FG001|Overall Study|Study Terminated by Sponsor|0|||
30586319|NCT01210495|58598263|FG002|Overall Study|Study Terminated by Sponsor|4|||
30586320|NCT01210495|58598264|FG003|Overall Study|Study Terminated by Sponsor|11|||
30586321|NCT01210495|58598261|FG000|Overall Study|Lost to Follow-up|0|||
30586322|NCT01210495|58598262|FG001|Overall Study|Lost to Follow-up|0|||
30586323|NCT01210495|58598263|FG002|Overall Study|Lost to Follow-up|1|||
30586324|NCT01210495|58598264|FG003|Overall Study|Lost to Follow-up|1|||
30586325|NCT01210495|58598261|FG000|Overall Study|Other unspecified|0|||
30586326|NCT01210495|58598262|FG001|Overall Study|Other unspecified|0|||
30586327|NCT01210495|58598263|FG002|Overall Study|Other unspecified|6|||
30586328|NCT01210495|58598264|FG003|Overall Study|Other unspecified|0|||
30586329|NCT01231516|58598276|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
30586330|NCT01231516|58598277|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
30586331|NCT01231516|58598276|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
30586332|NCT01231516|58598277|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
30586333|NCT01231516|58598276|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
30586334|NCT01231516|58598277|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
30586335|NCT01231516|58598276|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
30586336|NCT01231516|58598277|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
30586337|NCT01231516|58598276|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
30586338|NCT01231516|58598277|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
30586339|NCT01231516|58598276|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
30586340|NCT01231516|58598277|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
30670570|NCT00600119|58684261|FG003|Double-blind Treatment Period|Adverse Event|1|||
30670571|NCT00600119|58684262|FG004|Double-blind Treatment Period|Adverse Event|2|||
30670572|NCT00600119|58684263|FG005|Double-blind Treatment Period|Adverse Event|10|||
30670573|NCT00600119|58684258|FG000|Follow-up Period|Adverse Event|0|||
30586341|NCT01231516|58598276|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
30586342|NCT01231516|58598277|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
30670574|NCT00600119|58684259|FG001|Follow-up Period|Adverse Event|0|||
30670575|NCT00600119|58684260|FG002|Follow-up Period|Adverse Event|0|||
30586343|NCT01231516|58598276|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
30586344|NCT01231516|58598277|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
30586345|NCT01231516|58598276|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
30586346|NCT01231516|58598277|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
30586347|NCT01231516|58598276|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
30586348|NCT01231516|58598277|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
30586349|NCT01231516|58598276|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
30586350|NCT01231516|58598277|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
30586351|NCT01231516|58598276|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
30586352|NCT01231516|58598277|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
30586353|NCT01231516|58598276|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
30586354|NCT01231516|58598277|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
30586355|NCT01231516|58598276|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
30670576|NCT00600119|58684261|FG003|Follow-up Period|Adverse Event|0|||
30670577|NCT00600119|58684262|FG004|Follow-up Period|Adverse Event|0|||
30670578|NCT00600119|58684263|FG005|Follow-up Period|Adverse Event|1|||
30586356|NCT01231516|58598277|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
30586357|NCT01231516|58598276|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
30586358|NCT01231516|58598277|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
30586359|NCT01231516|58598276|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
30586360|NCT01231516|58598277|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
30586361|NCT01231321|58598283|FG000|Overall Study|Adverse Event|3|||
30586362|NCT01231321|58598283|FG000|Overall Study|Lack of Efficacy|2|||
30586363|NCT01210222|58598293|FG000|Overall Study|Ineligible|2|||
30586364|NCT01210222|58598293|FG000|Overall Study|Never treated|1|||
30586365|NCT01210144|58598305|FG000|Overall Study|Lack of ovarian response|1|||
30586366|NCT01210144|58598306|FG001|Overall Study|Lack of ovarian response|0|||
30586367|NCT01210144|58598305|FG000|Overall Study|No fertilization|1|||
30586368|NCT01210144|58598306|FG001|Overall Study|No fertilization|0|||
30586369|NCT01210144|58598305|FG000|Overall Study|No transfer|1|||
30586370|NCT01210144|58598306|FG001|Overall Study|No transfer|0|||
30586371|NCT01209949|58598313|FG000|Overall Study|Lost to Follow-up|3|||
30586372|NCT01209832|58598317|FG000|Period 1|Sponsor Decision and was not dosed|1|||
30586373|NCT01209832|58598317|FG000|Period 2|Sponsor Decision|1|||
30586374|NCT01230892|58598330|FG000|Overall Study|Withdrawal by Subject|1|||
30586375|NCT01230892|58598331|FG001|Overall Study|Withdrawal by Subject|1|||
30586376|NCT01230892|58598330|FG000|Overall Study|Lost to Follow-up|2|||
30586377|NCT01230892|58598331|FG001|Overall Study|Lost to Follow-up|0|||
30586378|NCT01230814|58598339|FG000|Overall Study|Lost to Follow-up|11|||
30586379|NCT01230814|58598340|FG001|Overall Study|Lost to Follow-up|3|||
30586380|NCT01230814|58598339|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
30586381|NCT01230814|58598340|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
30586382|NCT01230307|58598348|FG000|Overall Study|LVAD Placement|0|||
30586383|NCT01230307|58598349|FG001|Overall Study|LVAD Placement|2|||
30586384|NCT01209598|58598357|FG000|Overall Study|Withdrawal by Subject|1|||
30586385|NCT01209598|58598358|FG001|Overall Study|Withdrawal by Subject|0|||
30586386|NCT01209520|58598365|FG000|Overall Study|Withdrawal by Subject|3|||
30586387|NCT01209325|58598369|FG000|Overall Study|Lost to Follow-up|24|||
30586388|NCT01209325|58598369|FG000|Overall Study|Adverse Event|1|||
30586389|NCT01209325|58598369|FG000|Overall Study|Relocated|3|||
30586390|NCT01209325|58598369|FG000|Overall Study|Refusal after starting therapy|8|||
30586391|NCT01209325|58598369|FG000|Overall Study|Protocol Violation|4|||
30586392|NCT01209325|58598369|FG000|Overall Study|Refusal prior to therapy|1|||
30586393|NCT01209325|58598369|FG000|Overall Study|Incarceration|2|||
30586394|NCT01209286|58598407|FG000|Overall Study|Adverse Event|4|||
30586395|NCT01209286|58598408|FG001|Overall Study|Adverse Event|3|||
30586396|NCT01209286|58598409|FG002|Overall Study|Adverse Event|1|||
30586397|NCT01209286|58598407|FG000|Overall Study|Hematological Relapse After Remission|0|||
30586398|NCT01209286|58598408|FG001|Overall Study|Hematological Relapse After Remission|1|||
30586399|NCT01209286|58598409|FG002|Overall Study|Hematological Relapse After Remission|1|||
30586400|NCT01209286|58598407|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
30586401|NCT01209286|58598408|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
30670579|NCT00600119|58684258|FG000|Follow-up Period|Other|1|||
30586402|NCT01209286|58598409|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
30586403|NCT01209286|58598407|FG000|Overall Study|Physician Decision|0|||
30586404|NCT01209286|58598408|FG001|Overall Study|Physician Decision|2|||
30586405|NCT01209286|58598409|FG002|Overall Study|Physician Decision|0|||
30586406|NCT01209286|58598407|FG000|Overall Study|Other|0|||
30586407|NCT01209286|58598408|FG001|Overall Study|Other|1|||
30586408|NCT01209286|58598409|FG002|Overall Study|Other|0|||
30586409|NCT01208233|58598432|FG000|Overall Study|Adverse Event|0|||
30670580|NCT00600119|58684259|FG001|Follow-up Period|Other|0|||
30670581|NCT00600119|58684260|FG002|Follow-up Period|Other|0|||
30670582|NCT00600119|58684261|FG003|Follow-up Period|Other|0|||
30586410|NCT01208233|58598433|FG001|Overall Study|Adverse Event|1|||
30586411|NCT01208233|58598434|FG002|Overall Study|Adverse Event|2|||
30586412|NCT01208233|58598435|FG003|Overall Study|Adverse Event|0|||
30586413|NCT01208233|58598436|FG004|Overall Study|Adverse Event|3|||
30586414|NCT01208233|58598437|FG005|Overall Study|Adverse Event|5|||
30586415|NCT01208233|58598432|FG000|Overall Study|Death|0|||
30670583|NCT00600119|58684262|FG004|Follow-up Period|Other|0|||
30670584|NCT00600119|58684263|FG005|Follow-up Period|Other|0|||
30670585|NCT00866294|58684280|FG000|Overall Study|Adverse Event|12|||
30670586|NCT00866294|58684281|FG001|Overall Study|Adverse Event|13|||
30670587|NCT00866294|58684282|FG002|Overall Study|Adverse Event|9|||
30670588|NCT00866294|58684280|FG000|Overall Study|Lack of Efficacy|7|||
30670589|NCT00866294|58684281|FG001|Overall Study|Lack of Efficacy|1|||
30670590|NCT00866294|58684282|FG002|Overall Study|Lack of Efficacy|0|||
30670591|NCT00866294|58684280|FG000|Overall Study|Protocol Violation|2|||
30670592|NCT00866294|58684281|FG001|Overall Study|Protocol Violation|0|||
30670593|NCT00866294|58684282|FG002|Overall Study|Protocol Violation|0|||
30670594|NCT00866294|58684280|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
30670595|NCT00866294|58684281|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
30670596|NCT00866294|58684282|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
30670597|NCT00866294|58684280|FG000|Overall Study|Lost to Follow-up|1|||
30670598|NCT00866294|58684281|FG001|Overall Study|Lost to Follow-up|3|||
30670599|NCT00866294|58684282|FG002|Overall Study|Lost to Follow-up|0|||
30670600|NCT00866294|58684280|FG000|Overall Study|Physician Decision|6|||
30670601|NCT00866294|58684281|FG001|Overall Study|Physician Decision|2|||
30670602|NCT00866294|58684282|FG002|Overall Study|Physician Decision|1|||
30670603|NCT00854360|58684302|FG000|Overall Study|Adverse Event|0|||
30670604|NCT00854360|58684303|FG001|Overall Study|Adverse Event|1|||
30670605|NCT00854360|58684304|FG002|Overall Study|Adverse Event|2|||
30670606|NCT00854360|58684305|FG003|Overall Study|Adverse Event|6|||
30670607|NCT00854360|58684302|FG000|Overall Study|Withdrawal by Subject|0|||
30670608|NCT00854360|58684303|FG001|Overall Study|Withdrawal by Subject|0|||
30670609|NCT00854360|58684304|FG002|Overall Study|Withdrawal by Subject|0|||
30670610|NCT00854360|58684305|FG003|Overall Study|Withdrawal by Subject|1|||
30670611|NCT00854360|58684302|FG000|Overall Study|Pregnancy|0|||
30670612|NCT00854360|58684303|FG001|Overall Study|Pregnancy|1|||
30670613|NCT00854360|58684304|FG002|Overall Study|Pregnancy|0|||
30670614|NCT00854360|58684305|FG003|Overall Study|Pregnancy|0|||
30670615|NCT00854360|58684302|FG000|Overall Study|Lack of Efficacy|2|||
30670616|NCT00854360|58684303|FG001|Overall Study|Lack of Efficacy|1|||
30670617|NCT00854360|58684304|FG002|Overall Study|Lack of Efficacy|0|||
30670618|NCT00854360|58684305|FG003|Overall Study|Lack of Efficacy|0|||
30670619|NCT00854360|58684302|FG000|Overall Study|Other|0|||
30670620|NCT00854360|58684303|FG001|Overall Study|Other|0|||
30670621|NCT00854360|58684304|FG002|Overall Study|Other|0|||
30670622|NCT00854360|58684305|FG003|Overall Study|Other|3|||
30670623|NCT00853970|58684317|FG000|Overall Study|Withdrawal by Subject|2|||
30586416|NCT01208233|58598433|FG001|Overall Study|Death|0|||
30586417|NCT01208233|58598434|FG002|Overall Study|Death|0|||
30586418|NCT01208233|58598435|FG003|Overall Study|Death|0|||
30586419|NCT01208233|58598436|FG004|Overall Study|Death|3|||
30586420|NCT01208233|58598437|FG005|Overall Study|Death|5|||
30586421|NCT01208233|58598432|FG000|Overall Study|Did not meet entrance criteria|2|||
30586422|NCT01208233|58598433|FG001|Overall Study|Did not meet entrance criteria|1|||
30586423|NCT01208233|58598434|FG002|Overall Study|Did not meet entrance criteria|1|||
30586424|NCT01208233|58598435|FG003|Overall Study|Did not meet entrance criteria|0|||
30586425|NCT01208233|58598436|FG004|Overall Study|Did not meet entrance criteria|1|||
30586426|NCT01208233|58598437|FG005|Overall Study|Did not meet entrance criteria|0|||
30586427|NCT01208233|58598432|FG000|Overall Study|Medication error without adverse event|0|||
30586428|NCT01208233|58598433|FG001|Overall Study|Medication error without adverse event|0|||
30586429|NCT01208233|58598434|FG002|Overall Study|Medication error without adverse event|0|||
30586430|NCT01208233|58598435|FG003|Overall Study|Medication error without adverse event|0|||
30586431|NCT01208233|58598436|FG004|Overall Study|Medication error without adverse event|0|||
30670624|NCT00853970|58684318|FG001|Overall Study|Withdrawal by Subject|1|||
30670625|NCT00853970|58684317|FG000|Overall Study|Cancelled surgery|4|||
30670626|NCT00853970|58684318|FG001|Overall Study|Cancelled surgery|2|||
30670627|NCT00865904|58684346|FG000|Overall Study|Randomized but not Treated|2|||
30670628|NCT00865904|58684347|FG001|Overall Study|Randomized but not Treated|0|||
30670629|NCT00865904|58684348|FG002|Overall Study|Randomized but not Treated|0|||
30958875|NCT01587703|59024025|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30958876|NCT01587703|59024026|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30586432|NCT01208233|58598437|FG005|Overall Study|Medication error without adverse event|1|||
30670630|NCT00865904|58684349|FG003|Overall Study|Randomized but not Treated|1|||
30670631|NCT00865904|58684350|FG004|Overall Study|Randomized but not Treated|1|||
30670632|NCT00599339|58684366|FG000|Overall Study|Adverse Event|79|||
30670633|NCT00599339|58684366|FG000|Overall Study|Withdrawal by Subject|137|||
30670634|NCT00599339|58684366|FG000|Overall Study|Other Reason|179|||
30670635|NCT00599339|58684366|FG000|Overall Study|Lost to Follow-up|221|||
30670636|NCT00599339|58684366|FG000|Overall Study|No valid data consent|36|||
30670637|NCT00599339|58684366|FG000|Overall Study|Study Termination Status Unknown|12|||
30670638|NCT00599027|58684390|FG000|Overall Study|Withdrawal by Subject|1|||
30670639|NCT00599027|58684391|FG001|Overall Study|Withdrawal by Subject|1|||
30670640|NCT00599027|58684390|FG000|Overall Study|Adverse Event|0|||
30670641|NCT00599027|58684391|FG001|Overall Study|Adverse Event|1|||
30586433|NCT01208233|58598432|FG000|Overall Study|Study terminated by sponsor|0|||
30586434|NCT01208233|58598433|FG001|Overall Study|Study terminated by sponsor|0|||
30586435|NCT01208233|58598434|FG002|Overall Study|Study terminated by sponsor|0|||
30586436|NCT01208233|58598435|FG003|Overall Study|Study terminated by sponsor|0|||
30586437|NCT01208233|58598436|FG004|Overall Study|Study terminated by sponsor|10|||
30586438|NCT01208233|58598437|FG005|Overall Study|Study terminated by sponsor|7|||
30586439|NCT01208233|58598432|FG000|Overall Study|Protocol Violation|0|||
30586440|NCT01208233|58598433|FG001|Overall Study|Protocol Violation|0|||
30670642|NCT00599027|58684390|FG000|Overall Study|Treatment Failure|0|||
30670643|NCT00599027|58684391|FG001|Overall Study|Treatment Failure|1|||
30670644|NCT02881151|58684406|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
30670645|NCT00689728|58684414|FG000|Double-Blind Treatment|Adverse Event|1|||
30670646|NCT00689728|58684415|FG001|Double-Blind Treatment|Adverse Event|0|||
30670647|NCT00689728|58684416|FG002|Double-Blind Treatment|Adverse Event|0|||
30670648|NCT00689728|58684414|FG000|Double-Blind Treatment|Protocol Violation|0|||
30670649|NCT00689728|58684415|FG001|Double-Blind Treatment|Protocol Violation|0|||
30670650|NCT00689728|58684416|FG002|Double-Blind Treatment|Protocol Violation|1|||
30670651|NCT00689728|58684414|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
30670652|NCT00689728|58684415|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
30670653|NCT00689728|58684416|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
30670654|NCT00689728|58684414|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
30670655|NCT00689728|58684415|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
30670656|NCT00689728|58684416|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
30670657|NCT00689728|58684414|FG000|Rescue|Adverse Event|0|||
30670658|NCT00689728|58684415|FG001|Rescue|Adverse Event|1|||
30670659|NCT00689728|58684416|FG002|Rescue|Adverse Event|0|||
30670660|NCT00689728|58684414|FG000|Rescue|Withdrawal by Subject|1|||
30670661|NCT00689728|58684415|FG001|Rescue|Withdrawal by Subject|1|||
30670662|NCT00689728|58684416|FG002|Rescue|Withdrawal by Subject|1|||
30670663|NCT00689728|58684414|FG000|Optional Follow-Up|Adverse Event|1|||
30670664|NCT00689728|58684415|FG001|Optional Follow-Up|Adverse Event|0|||
30670665|NCT00689728|58684416|FG002|Optional Follow-Up|Adverse Event|0|||
30670666|NCT00689728|58684414|FG000|Optional Follow-Up|Lack of Efficacy|0|||
30670667|NCT00689728|58684415|FG001|Optional Follow-Up|Lack of Efficacy|1|||
30670668|NCT00689728|58684416|FG002|Optional Follow-Up|Lack of Efficacy|1|||
30670669|NCT00689728|58684414|FG000|Optional Follow-Up|Lost to Follow-up|0|||
30670670|NCT00689728|58684415|FG001|Optional Follow-Up|Lost to Follow-up|1|||
30670671|NCT00689728|58684416|FG002|Optional Follow-Up|Lost to Follow-up|1|||
30670672|NCT00689728|58684414|FG000|Optional Follow-Up|Protocol Violation|0|||
30670673|NCT00689728|58684415|FG001|Optional Follow-Up|Protocol Violation|0|||
30670674|NCT00689728|58684416|FG002|Optional Follow-Up|Protocol Violation|1|||
30670675|NCT00689728|58684414|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
30670676|NCT00689728|58684415|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
30670677|NCT00689728|58684416|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
30670678|NCT00691054|58684445|FG000|Overall Study|Withdrawal by Subject|1|||
30670679|NCT00598871|58684453|FG000|Overall Study|Adverse Event|0|||
30670680|NCT00598871|58684454|FG001|Overall Study|Adverse Event|1|||
30670681|NCT00690820|58684462|FG000|Period 1|Withdrawal by Subject|0|||
30670682|NCT00690820|58684463|FG001|Period 1|Withdrawal by Subject|1|||
30670683|NCT00689338|58684469|FG000|Overall Study|Death|65|||
30670684|NCT00689338|58684469|FG000|Overall Study|Adverse Event|13|||
30670685|NCT00689338|58684469|FG000|Overall Study|Insufficient Clinical Response|1|||
30670686|NCT00689338|58684469|FG000|Overall Study|Lack of Efficacy|6|||
30670687|NCT00689338|58684469|FG000|Overall Study|Other|8|||
30670688|NCT00689338|58684469|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
30670689|NCT00689338|58684469|FG000|Overall Study|Lost to Follow-up|5|||
30670690|NCT00689338|58684469|FG000|Overall Study|Withdrawal by Subject|3|||
30781104|NCT03782571|58793218|FG003|Period 3|Subject Unable to Attend V5|0|||
30781105|NCT03782571|58793215|FG000|Period 3|Adverse Event|1|||
30781106|NCT03782571|58793216|FG001|Period 3|Adverse Event|0|||
30781107|NCT03782571|58793217|FG002|Period 3|Adverse Event|0|||
30781108|NCT03782571|58793218|FG003|Period 3|Adverse Event|0|||
30781109|NCT03783039|58793232|FG000|Overall Study|Death|2|||
30781110|NCT03783039|58793233|FG001|Overall Study|Death|1|||
30586441|NCT01208233|58598434|FG002|Overall Study|Protocol Violation|0|||
30670691|NCT00689338|58684469|FG000|Overall Study|Protocol Violation|15|||
30670692|NCT00686998|58684476|FG000|Overall Study|Adverse Event|3|||
30781111|NCT03776175|58793243|FG000|Treatment Period (42 Days)|Adverse Event|0|||
30586442|NCT01208233|58598435|FG003|Overall Study|Protocol Violation|0|||
30670693|NCT00686998|58684477|FG001|Overall Study|Adverse Event|2|||
30670694|NCT00686998|58684478|FG002|Overall Study|Adverse Event|1|||
30670695|NCT00686998|58684476|FG000|Overall Study|Withdrawal by Subject|2|||
30670696|NCT00686998|58684477|FG001|Overall Study|Withdrawal by Subject|1|||
30670697|NCT00686998|58684478|FG002|Overall Study|Withdrawal by Subject|2|||
30670698|NCT00686998|58684476|FG000|Overall Study|Lack of Efficacy|7|||
30670699|NCT00686998|58684477|FG001|Overall Study|Lack of Efficacy|5|||
30670700|NCT00686998|58684478|FG002|Overall Study|Lack of Efficacy|0|||
30670701|NCT00686998|58684476|FG000|Overall Study|Other|0|||
30670702|NCT00686998|58684477|FG001|Overall Study|Other|0|||
30670703|NCT00686998|58684478|FG002|Overall Study|Other|1|||
30670704|NCT00686998|58684476|FG000|Overall Study|Safety Reasons|1|||
30670705|NCT00686998|58684477|FG001|Overall Study|Safety Reasons|0|||
30670706|NCT00686998|58684478|FG002|Overall Study|Safety Reasons|0|||
30670707|NCT00848718|58684499|FG000|Overall Study|Adverse Event|2|||
30670708|NCT00848718|58684500|FG001|Overall Study|Adverse Event|2|||
30670709|NCT00848718|58684501|FG002|Overall Study|Adverse Event|1|||
30670710|NCT00848718|58684502|FG003|Overall Study|Adverse Event|1|||
30670711|NCT00848718|58684503|FG004|Overall Study|Adverse Event|1|||
30670712|NCT00848718|58684504|FG005|Overall Study|Adverse Event|0|||
30670713|NCT00848718|58684505|FG006|Overall Study|Adverse Event|0|||
30670714|NCT00848718|58684506|FG007|Overall Study|Adverse Event|1|||
30670715|NCT00848718|58684507|FG008|Overall Study|Adverse Event|1|||
30670716|NCT00848718|58684508|FG009|Overall Study|Adverse Event|0|||
30670717|NCT00848718|58684509|FG010|Overall Study|Adverse Event|0|||
30670718|NCT00848718|58684510|FG011|Overall Study|Adverse Event|0|||
30670719|NCT00848718|58684511|FG012|Overall Study|Adverse Event|2|||
30670720|NCT00848718|58684499|FG000|Overall Study|Lack of Efficacy|0|||
30670721|NCT00848718|58684500|FG001|Overall Study|Lack of Efficacy|0|||
30670722|NCT00848718|58684501|FG002|Overall Study|Lack of Efficacy|1|||
30670723|NCT00848718|58684502|FG003|Overall Study|Lack of Efficacy|0|||
30670724|NCT00848718|58684503|FG004|Overall Study|Lack of Efficacy|0|||
30670725|NCT00848718|58684504|FG005|Overall Study|Lack of Efficacy|0|||
30670726|NCT00848718|58684505|FG006|Overall Study|Lack of Efficacy|1|||
30670727|NCT00848718|58684506|FG007|Overall Study|Lack of Efficacy|0|||
30586443|NCT01208233|58598436|FG004|Overall Study|Protocol Violation|3|||
30586444|NCT01208233|58598437|FG005|Overall Study|Protocol Violation|0|||
30586445|NCT01208233|58598432|FG000|Overall Study|Other|2|||
30586446|NCT01208233|58598433|FG001|Overall Study|Other|1|||
30586447|NCT01208233|58598434|FG002|Overall Study|Other|0|||
30586448|NCT01208233|58598435|FG003|Overall Study|Other|0|||
30586449|NCT01208233|58598436|FG004|Overall Study|Other|0|||
30586450|NCT01208233|58598437|FG005|Overall Study|Other|1|||
30586451|NCT01208233|58598432|FG000|Overall Study|Withdrawal by Subject|1|||
30586452|NCT01208233|58598433|FG001|Overall Study|Withdrawal by Subject|0|||
30586453|NCT01208233|58598434|FG002|Overall Study|Withdrawal by Subject|1|||
30586454|NCT01208233|58598435|FG003|Overall Study|Withdrawal by Subject|1|||
30586455|NCT01208233|58598436|FG004|Overall Study|Withdrawal by Subject|4|||
30586456|NCT01208233|58598437|FG005|Overall Study|Withdrawal by Subject|2|||
30586457|NCT01208038|58598457|FG000|Overall Study|Withdrawal by Subject|1|||
30586458|NCT01207687|58598461|FG000|Overall Study|Adverse Event|1|||
30586459|NCT01207687|58598461|FG000|Overall Study|Withdrawal by Subject|1|||
30586460|NCT01207453|58598473|FG000|First Intervention|Adverse Event|2|||
30586461|NCT01207453|58598474|FG001|First Intervention|Adverse Event|1|||
30586462|NCT01207453|58598473|FG000|Washout|Adverse Event|1|||
30586463|NCT01207453|58598474|FG001|Washout|Adverse Event|0|||
30586464|NCT01207453|58598473|FG000|Washout|Lost to Follow-up|1|||
30586465|NCT01207453|58598474|FG001|Washout|Lost to Follow-up|0|||
30586466|NCT01207453|58598473|FG000|2nd Intervention|Adverse Event|1|||
30586467|NCT01207453|58598474|FG001|2nd Intervention|Adverse Event|2|||
30586468|NCT01207453|58598473|FG000|2nd Intervention|Lost to Follow-up|1|||
30586469|NCT01207453|58598474|FG001|2nd Intervention|Lost to Follow-up|0|||
30586470|NCT01207414|58598485|FG000|Overall Study|Adverse Event|25|||
30586471|NCT01207414|58598486|FG001|Overall Study|Adverse Event|39|||
30586472|NCT01207414|58598485|FG000|Overall Study|Abnormal test procedure results|0|||
30586473|NCT01207414|58598486|FG001|Overall Study|Abnormal test procedure results|1|||
30586474|NCT01207414|58598485|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
30670728|NCT00848718|58684507|FG008|Overall Study|Lack of Efficacy|0|||
30670729|NCT00848718|58684508|FG009|Overall Study|Lack of Efficacy|0|||
30670730|NCT00848718|58684509|FG010|Overall Study|Lack of Efficacy|0|||
30670731|NCT00848718|58684510|FG011|Overall Study|Lack of Efficacy|0|||
30670732|NCT00848718|58684511|FG012|Overall Study|Lack of Efficacy|0|||
30670733|NCT00848718|58684499|FG000|Overall Study|Physician Decision|0|||
30586475|NCT01207414|58598486|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
30586476|NCT01207414|58598485|FG000|Overall Study|Patient withdrew consent|14|||
30586477|NCT01207414|58598486|FG001|Overall Study|Patient withdrew consent|11|||
30670734|NCT00848718|58684500|FG001|Overall Study|Physician Decision|1|||
30670735|NCT00848718|58684501|FG002|Overall Study|Physician Decision|0|||
30670736|NCT00848718|58684502|FG003|Overall Study|Physician Decision|0|||
30586478|NCT01207414|58598485|FG000|Overall Study|Lost to Follow-up|15|||
30670737|NCT00848718|58684503|FG004|Overall Study|Physician Decision|1|||
30670738|NCT00848718|58684504|FG005|Overall Study|Physician Decision|1|||
30586479|NCT01207414|58598486|FG001|Overall Study|Lost to Follow-up|17|||
30586480|NCT01207414|58598485|FG000|Overall Study|Administrative problems|1|||
30586481|NCT01207414|58598486|FG001|Overall Study|Administrative problems|1|||
30586482|NCT01207414|58598485|FG000|Overall Study|Protocol deviation|12|||
30586483|NCT01207414|58598486|FG001|Overall Study|Protocol deviation|9|||
30586484|NCT01207414|58598485|FG000|Overall Study|Randomized in error|1|||
30586485|NCT01207414|58598486|FG001|Overall Study|Randomized in error|0|||
30586486|NCT01207219|58598495|FG000|Overall Study|changed diagnosis during study period|5|||
30586487|NCT01207219|58598496|FG001|Overall Study|changed diagnosis during study period|3|||
30586488|NCT01207219|58598497|FG002|Overall Study|changed diagnosis during study period|1|||
30586489|NCT01207219|58598495|FG000|Overall Study|Lost to Follow-up|6|||
30586490|NCT01207219|58598496|FG001|Overall Study|Lost to Follow-up|8|||
30586491|NCT01207219|58598497|FG002|Overall Study|Lost to Follow-up|6|||
30586492|NCT01206517|58598511|FG000|Overall Study|Withdrawal by Subject|0|||
30586493|NCT01206517|58598512|FG001|Overall Study|Withdrawal by Subject|0|||
30586494|NCT01206517|58598513|FG002|Overall Study|Withdrawal by Subject|2|||
30586495|NCT01206517|58598514|FG003|Overall Study|Withdrawal by Subject|0|||
30586496|NCT01206517|58598515|FG004|Overall Study|Withdrawal by Subject|1|||
30586497|NCT01206517|58598516|FG005|Overall Study|Withdrawal by Subject|0|||
30586498|NCT01206439|58598527|FG000|Overall Study|subject did not meet inclusion criteria|1|||
30586499|NCT01206322|58598533|FG000|Overall Study|Adverse Event|0|||
30586500|NCT01206322|58598534|FG001|Overall Study|Adverse Event|0|||
30586501|NCT01206322|58598535|FG002|Overall Study|Adverse Event|0|||
30586502|NCT01206322|58598536|FG003|Overall Study|Adverse Event|1|||
30586503|NCT01206166|58598548|FG000|Overall Study|No evaluable data|2|||
30586504|NCT01206166|58598549|FG001|Overall Study|No evaluable data|3|||
30586505|NCT01207102|58598558|FG000|Overall Study|Withdrawal by Subject|5|||
30586506|NCT01207102|58598558|FG000|Overall Study|Adverse Event|2|||
30586507|NCT01207102|58598558|FG000|Overall Study|progression|2|||
30586508|NCT01207102|58598558|FG000|Overall Study|Withdrawal by Treating Physician|1|||
30586509|NCT01205776|58598574|FG000|Overall Study|Lost to Follow-up|53|||
30586510|NCT01205776|58598575|FG001|Overall Study|Lost to Follow-up|61|||
30586511|NCT01205776|58598574|FG000|Overall Study|Withdrawal by Subject|11|||
30586512|NCT01205776|58598575|FG001|Overall Study|Withdrawal by Subject|34|||
30586513|NCT01205581|58598587|FG000|Overall Study|Withdrawal by Subject|1|||
30586514|NCT01205581|58598588|FG001|Overall Study|Withdrawal by Subject|0|||
30586515|NCT01205581|58598589|FG002|Overall Study|Withdrawal by Subject|0|||
30586516|NCT01205581|58598590|FG003|Overall Study|Withdrawal by Subject|0|||
30586517|NCT01205581|58598591|FG004|Overall Study|Withdrawal by Subject|0|||
30586518|NCT01205581|58598592|FG005|Overall Study|Withdrawal by Subject|0|||
30586519|NCT01205269|58598623|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
30586520|NCT01205269|58598624|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
30586521|NCT01205269|58598625|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
30586522|NCT01205269|58598626|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
30586523|NCT01205269|58598627|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
30586524|NCT01205269|58598628|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
30586525|NCT01240915|58598653|FG000|Overall Study|Adverse Event|0|||
30586526|NCT01240915|58598654|FG001|Overall Study|Adverse Event|0|||
30586527|NCT01240915|58598655|FG002|Overall Study|Adverse Event|0|||
30586528|NCT01240915|58598656|FG003|Overall Study|Adverse Event|1|||
30586529|NCT01240915|58598657|FG004|Overall Study|Adverse Event|0|||
30586530|NCT01240915|58598658|FG005|Overall Study|Adverse Event|2|||
30586531|NCT01240915|58598659|FG006|Overall Study|Adverse Event|0|||
30670739|NCT00848718|58684505|FG006|Overall Study|Physician Decision|0|||
30670740|NCT00848718|58684506|FG007|Overall Study|Physician Decision|0|||
30670741|NCT00848718|58684507|FG008|Overall Study|Physician Decision|1|||
30670742|NCT00848718|58684508|FG009|Overall Study|Physician Decision|2|||
30670743|NCT00848718|58684509|FG010|Overall Study|Physician Decision|0|||
30670744|NCT00848718|58684510|FG011|Overall Study|Physician Decision|0|||
30670745|NCT00848718|58684511|FG012|Overall Study|Physician Decision|1|||
30670746|NCT00848718|58684499|FG000|Overall Study|Progressive disease before treatment|1|||
30586532|NCT01240915|58598660|FG007|Overall Study|Adverse Event|0|||
30586533|NCT01240915|58598661|FG008|Overall Study|Adverse Event|1|||
30586534|NCT01240915|58598653|FG000|Overall Study|Lost to Follow-up|0|||
30586535|NCT01240915|58598654|FG001|Overall Study|Lost to Follow-up|0|||
30586536|NCT01240915|58598655|FG002|Overall Study|Lost to Follow-up|0|||
30586537|NCT01240915|58598656|FG003|Overall Study|Lost to Follow-up|0|||
30586538|NCT01240915|58598657|FG004|Overall Study|Lost to Follow-up|1|||
30586539|NCT01240915|58598658|FG005|Overall Study|Lost to Follow-up|1|||
30586540|NCT01240915|58598659|FG006|Overall Study|Lost to Follow-up|0|||
30586541|NCT01240915|58598660|FG007|Overall Study|Lost to Follow-up|1|||
30586542|NCT01240915|58598661|FG008|Overall Study|Lost to Follow-up|1|||
30586543|NCT01240915|58598653|FG000|Overall Study|Withdrawal by Subject|2|||
30586544|NCT01240915|58598654|FG001|Overall Study|Withdrawal by Subject|1|||
30586545|NCT01240915|58598655|FG002|Overall Study|Withdrawal by Subject|0|||
30670747|NCT00848718|58684500|FG001|Overall Study|Progressive disease before treatment|5|||
30855772|NCT02761057|58883475|FG001|Overall Study|Progression/Relapse|27|||
30670748|NCT00848718|58684501|FG002|Overall Study|Progressive disease before treatment|1|||
30670749|NCT00848718|58684502|FG003|Overall Study|Progressive disease before treatment|3|||
30670750|NCT00848718|58684503|FG004|Overall Study|Progressive disease before treatment|4|||
30670751|NCT00848718|58684504|FG005|Overall Study|Progressive disease before treatment|4|||
30670752|NCT00848718|58684505|FG006|Overall Study|Progressive disease before treatment|2|||
30670753|NCT00848718|58684506|FG007|Overall Study|Progressive disease before treatment|1|||
30670754|NCT00848718|58684507|FG008|Overall Study|Progressive disease before treatment|2|||
30670755|NCT00848718|58684508|FG009|Overall Study|Progressive disease before treatment|7|||
30670756|NCT00848718|58684509|FG010|Overall Study|Progressive disease before treatment|3|||
30670757|NCT00848718|58684510|FG011|Overall Study|Progressive disease before treatment|6|||
30670758|NCT00848718|58684511|FG012|Overall Study|Progressive disease before treatment|2|||
30670759|NCT00848718|58684499|FG000|Overall Study|Protocol Violation|0|||
30670760|NCT00848718|58684500|FG001|Overall Study|Protocol Violation|1|||
30670761|NCT00848718|58684501|FG002|Overall Study|Protocol Violation|0|||
30670762|NCT00848718|58684502|FG003|Overall Study|Protocol Violation|0|||
30670763|NCT00848718|58684503|FG004|Overall Study|Protocol Violation|0|||
30670764|NCT00848718|58684504|FG005|Overall Study|Protocol Violation|0|||
30670765|NCT00848718|58684505|FG006|Overall Study|Protocol Violation|0|||
30670766|NCT00848718|58684506|FG007|Overall Study|Protocol Violation|1|||
30670767|NCT00848718|58684507|FG008|Overall Study|Protocol Violation|0|||
30586546|NCT01240915|58598656|FG003|Overall Study|Withdrawal by Subject|2|||
30586547|NCT01240915|58598657|FG004|Overall Study|Withdrawal by Subject|0|||
30855773|NCT02761057|58883476|FG002|Overall Study|Progression/Relapse|20|||
30855774|NCT02761057|58883477|FG003|Overall Study|Progression/Relapse|23|||
30855775|NCT02761057|58883474|FG000|Overall Study|Death|2|||
30855776|NCT02761057|58883475|FG001|Overall Study|Death|2|||
30855777|NCT02761057|58883476|FG002|Overall Study|Death|1|||
30855778|NCT02761057|58883477|FG003|Overall Study|Death|1|||
30855779|NCT02761057|58883474|FG000|Overall Study|Other - Not Protocol Specified|2|||
30855780|NCT02761057|58883475|FG001|Overall Study|Other - Not Protocol Specified|1|||
30855781|NCT02761057|58883476|FG002|Overall Study|Other - Not Protocol Specified|2|||
30855782|NCT02761057|58883477|FG003|Overall Study|Other - Not Protocol Specified|0|||
30855783|NCT02701413|58883489|FG000|Overall Study|Withdrawal by Subject|7|||
30855784|NCT02701413|58883490|FG001|Overall Study|Withdrawal by Subject|11|||
30855785|NCT02582684|58883496|FG000|Overall Study|Unable to contact subject/parent|4|||
30855786|NCT02582684|58883496|FG000|Overall Study|Subject not able to get to clinic|10|||
30855787|NCT02582684|58883496|FG000|Overall Study|Subject withdrew consent|1|||
30855788|NCT02582684|58883496|FG000|Overall Study|Found to be ineligible after enrollment|2|||
30586548|NCT01240915|58598658|FG005|Overall Study|Withdrawal by Subject|4|||
30586549|NCT01240915|58598659|FG006|Overall Study|Withdrawal by Subject|2|||
30586550|NCT01240915|58598660|FG007|Overall Study|Withdrawal by Subject|3|||
30586551|NCT01240915|58598661|FG008|Overall Study|Withdrawal by Subject|3|||
30586552|NCT01240915|58598653|FG000|Overall Study|Other|0|||
30586553|NCT01240915|58598654|FG001|Overall Study|Other|0|||
30586554|NCT01240915|58598655|FG002|Overall Study|Other|0|||
30586555|NCT01240915|58598656|FG003|Overall Study|Other|0|||
30586556|NCT01240915|58598657|FG004|Overall Study|Other|2|||
30670768|NCT00848718|58684508|FG009|Overall Study|Protocol Violation|0|||
30670769|NCT00848718|58684509|FG010|Overall Study|Protocol Violation|0|||
30670770|NCT00848718|58684510|FG011|Overall Study|Protocol Violation|0|||
30670771|NCT00848718|58684511|FG012|Overall Study|Protocol Violation|1|||
30670772|NCT00848718|58684499|FG000|Overall Study|Withdrawal by Subject|1|||
30670773|NCT00848718|58684500|FG001|Overall Study|Withdrawal by Subject|0|||
30670774|NCT00848718|58684501|FG002|Overall Study|Withdrawal by Subject|0|||
30670775|NCT00848718|58684502|FG003|Overall Study|Withdrawal by Subject|1|||
30670776|NCT00848718|58684503|FG004|Overall Study|Withdrawal by Subject|0|||
30670777|NCT00848718|58684504|FG005|Overall Study|Withdrawal by Subject|0|||
30670778|NCT00848718|58684505|FG006|Overall Study|Withdrawal by Subject|0|||
30586557|NCT01240915|58598658|FG005|Overall Study|Other|0|||
30586558|NCT01240915|58598659|FG006|Overall Study|Other|0|||
30586559|NCT01240915|58598660|FG007|Overall Study|Other|0|||
30586560|NCT01240915|58598661|FG008|Overall Study|Other|0|||
30586561|NCT01240915|58598653|FG000|Overall Study|Insufficient Clinical Response|0|||
30586562|NCT01240915|58598654|FG001|Overall Study|Insufficient Clinical Response|0|||
30855789|NCT02585960|58883503|FG000|PK/Safety Assessment Period|Physician Decision|0|||
30586563|NCT01240915|58598655|FG002|Overall Study|Insufficient Clinical Response|0|||
30586564|NCT01240915|58598656|FG003|Overall Study|Insufficient Clinical Response|0|||
30586565|NCT01240915|58598657|FG004|Overall Study|Insufficient Clinical Response|1|||
30586566|NCT01240915|58598658|FG005|Overall Study|Insufficient Clinical Response|3|||
30670779|NCT00848718|58684506|FG007|Overall Study|Withdrawal by Subject|0|||
30670780|NCT00848718|58684507|FG008|Overall Study|Withdrawal by Subject|0|||
30670781|NCT00848718|58684508|FG009|Overall Study|Withdrawal by Subject|0|||
30670782|NCT00848718|58684509|FG010|Overall Study|Withdrawal by Subject|1|||
30670783|NCT00848718|58684510|FG011|Overall Study|Withdrawal by Subject|0|||
30855790|NCT02585960|58883504|FG001|PK/Safety Assessment Period|Physician Decision|1|||
30670784|NCT00848718|58684511|FG012|Overall Study|Withdrawal by Subject|0|||
30670785|NCT00848718|58684499|FG000|Overall Study|Progressive disease during treatment|3|||
30670786|NCT00848718|58684500|FG001|Overall Study|Progressive disease during treatment|0|||
30670787|NCT00848718|58684501|FG002|Overall Study|Progressive disease during treatment|3|||
30670788|NCT00848718|58684502|FG003|Overall Study|Progressive disease during treatment|0|||
30670789|NCT00848718|58684503|FG004|Overall Study|Progressive disease during treatment|0|||
30670790|NCT00848718|58684504|FG005|Overall Study|Progressive disease during treatment|0|||
30670791|NCT00848718|58684505|FG006|Overall Study|Progressive disease during treatment|0|||
30670792|NCT00848718|58684506|FG007|Overall Study|Progressive disease during treatment|2|||
30670793|NCT00848718|58684507|FG008|Overall Study|Progressive disease during treatment|0|||
30670794|NCT00848718|58684508|FG009|Overall Study|Progressive disease during treatment|0|||
30670795|NCT00848718|58684509|FG010|Overall Study|Progressive disease during treatment|0|||
30670796|NCT00848718|58684510|FG011|Overall Study|Progressive disease during treatment|0|||
30670797|NCT00848718|58684511|FG012|Overall Study|Progressive disease during treatment|2|||
30670798|NCT00883337|58684548|FG000|Core Treatment Period|Adverse Event|9|||
30670799|NCT00883337|58684549|FG001|Core Treatment Period|Adverse Event|12|||
30670800|NCT00883337|58684550|FG002|Core Treatment Period|Adverse Event|22|||
30670801|NCT00883337|58684548|FG000|Core Treatment Period|Lack of Efficacy|7|||
30670802|NCT00883337|58684549|FG001|Core Treatment Period|Lack of Efficacy|4|||
30670803|NCT00883337|58684550|FG002|Core Treatment Period|Lack of Efficacy|2|||
30670804|NCT00883337|58684548|FG000|Core Treatment Period|Lost to Follow-up|1|||
30670805|NCT00883337|58684549|FG001|Core Treatment Period|Lost to Follow-up|1|||
30670806|NCT00883337|58684550|FG002|Core Treatment Period|Lost to Follow-up|0|||
30670807|NCT00883337|58684548|FG000|Core Treatment Period|Withdrawal by Subject|2|||
30670808|NCT00883337|58684549|FG001|Core Treatment Period|Withdrawal by Subject|2|||
30670809|NCT00883337|58684550|FG002|Core Treatment Period|Withdrawal by Subject|6|||
30670810|NCT00883337|58684548|FG000|Core Treatment Period|Wish to be pregnant|1|||
30670811|NCT00883337|58684549|FG001|Core Treatment Period|Wish to be pregnant|2|||
30670812|NCT00883337|58684550|FG002|Core Treatment Period|Wish to be pregnant|1|||
30670813|NCT00883337|58684548|FG000|Core Treatment Period|Poor compliance to protocol|0|||
30670814|NCT00883337|58684549|FG001|Core Treatment Period|Poor compliance to protocol|0|||
30670815|NCT00883337|58684550|FG002|Core Treatment Period|Poor compliance to protocol|1|||
30670816|NCT00883337|58684548|FG000|Core Treatment Period|Other than above|0|||
30670817|NCT00883337|58684549|FG001|Core Treatment Period|Other than above|1|||
30670818|NCT00883337|58684550|FG002|Core Treatment Period|Other than above|1|||
30670819|NCT00883337|58684548|FG000|Extension Treatment Period|Adverse Event|8|||
30670820|NCT00883337|58684549|FG001|Extension Treatment Period|Adverse Event|5|||
30670821|NCT00883337|58684550|FG002|Extension Treatment Period|Adverse Event|5|||
30586567|NCT01240915|58598659|FG006|Overall Study|Insufficient Clinical Response|6|||
30586568|NCT01240915|58598660|FG007|Overall Study|Insufficient Clinical Response|0|||
30586569|NCT01240915|58598661|FG008|Overall Study|Insufficient Clinical Response|3|||
30586570|NCT01239745|58598683|FG000|Overall Study|Study terminated by sponsor|45|||
30586571|NCT01239745|58598683|FG000|Overall Study|Adverse Event|1|||
30586572|NCT01239472|58598689|FG000|Overall Study|Withdrawal by Subject|5|||
30586573|NCT01239472|58598690|FG001|Overall Study|Withdrawal by Subject|1|||
30586574|NCT01239472|58598689|FG000|Overall Study|Adverse Event|0|||
30586575|NCT01239472|58598690|FG001|Overall Study|Adverse Event|1|||
30586576|NCT01239472|58598689|FG000|Overall Study|Lack of Efficacy|0|||
30670822|NCT00883337|58684548|FG000|Extension Treatment Period|Lack of Efficacy|8|||
30670823|NCT00883337|58684549|FG001|Extension Treatment Period|Lack of Efficacy|8|||
30586577|NCT01239472|58598690|FG001|Overall Study|Lack of Efficacy|1|||
30586578|NCT01229449|58598703|FG000|Overall Study|Withdrawal by Subject|0|||
30586579|NCT01229449|58598704|FG001|Overall Study|Withdrawal by Subject|3|||
30670824|NCT00883337|58684550|FG002|Extension Treatment Period|Lack of Efficacy|8|||
30670825|NCT00883337|58684548|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
30670826|NCT00883337|58684549|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
30670827|NCT00883337|58684550|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
30670828|NCT00883337|58684548|FG000|Extension Treatment Period|Lost to Follow-up|1|||
30670829|NCT00883337|58684549|FG001|Extension Treatment Period|Lost to Follow-up|0|||
30670830|NCT00883337|58684550|FG002|Extension Treatment Period|Lost to Follow-up|0|||
30670831|NCT00883337|58684548|FG000|Extension Treatment Period|Other than above|10|||
30670832|NCT00883337|58684549|FG001|Extension Treatment Period|Other than above|9|||
30586580|NCT01229449|58598705|FG002|Overall Study|Withdrawal by Subject|0|||
30670833|NCT00883337|58684550|FG002|Extension Treatment Period|Other than above|5|||
30670834|NCT00838110|58684566|FG000|Overall Study|Death|0|||
30670835|NCT00838110|58684567|FG001|Overall Study|Death|0|||
30670836|NCT00838110|58684568|FG002|Overall Study|Death|1|||
30670837|NCT00838110|58684569|FG003|Overall Study|Death|2|||
30670838|NCT00838110|58684566|FG000|Overall Study|Adverse Event|11|||
30586581|NCT01229449|58598706|FG003|Overall Study|Withdrawal by Subject|1|||
30586582|NCT01229449|58598707|FG004|Overall Study|Withdrawal by Subject|1|||
30586583|NCT01229449|58598703|FG000|Overall Study|Lost to Follow-up|1|||
30670839|NCT00838110|58684567|FG001|Overall Study|Adverse Event|10|||
30670840|NCT00838110|58684568|FG002|Overall Study|Adverse Event|8|||
30670841|NCT00838110|58684569|FG003|Overall Study|Adverse Event|7|||
30586584|NCT01229449|58598704|FG001|Overall Study|Lost to Follow-up|1|||
30586585|NCT01229449|58598705|FG002|Overall Study|Lost to Follow-up|1|||
30586586|NCT01229449|58598706|FG003|Overall Study|Lost to Follow-up|0|||
30586587|NCT01229449|58598707|FG004|Overall Study|Lost to Follow-up|0|||
30586588|NCT01229449|58598703|FG000|Overall Study|Physician Decision|0|||
30586589|NCT01229449|58598704|FG001|Overall Study|Physician Decision|0|||
30586590|NCT01229449|58598705|FG002|Overall Study|Physician Decision|1|||
30586591|NCT01229449|58598706|FG003|Overall Study|Physician Decision|0|||
30586592|NCT01229449|58598707|FG004|Overall Study|Physician Decision|0|||
30586593|NCT01239316|58598719|FG000|Overall Study|Progression/Relapse|11|||
30586594|NCT01239316|58598719|FG000|Overall Study|Adverse Event|1|||
30586595|NCT01239160|58598725|FG000|Overall Study|Lost to Follow-up|3|||
30586596|NCT01239160|58598726|FG001|Overall Study|Lost to Follow-up|5|||
30586597|NCT01239160|58598727|FG002|Overall Study|Lost to Follow-up|0|||
30586598|NCT01239160|58598725|FG000|Overall Study|Withdrawal by Subject|17|||
30586599|NCT01239160|58598726|FG001|Overall Study|Withdrawal by Subject|6|||
30586600|NCT01239160|58598727|FG002|Overall Study|Withdrawal by Subject|2|||
30586601|NCT01239160|58598725|FG000|Overall Study|Physician Decision|5|||
30586602|NCT01239160|58598726|FG001|Overall Study|Physician Decision|7|||
30586603|NCT01239160|58598727|FG002|Overall Study|Physician Decision|2|||
30586604|NCT01239160|58598725|FG000|Overall Study|Early Termination Due to Study Closure|0|||
30586605|NCT01239160|58598726|FG001|Overall Study|Early Termination Due to Study Closure|1|||
30586606|NCT01239160|58598727|FG002|Overall Study|Early Termination Due to Study Closure|6|||
30586607|NCT01239121|58598736|FG000|Overall Study|Withdrawal by Subject|2|||
30586608|NCT01239121|58598737|FG001|Overall Study|Withdrawal by Subject|4|||
30586609|NCT01239121|58598738|FG002|Overall Study|Withdrawal by Subject|0|||
30586610|NCT01239043|58598748|FG000|Overall Study|Protocol Violation|2|||
30586611|NCT01239043|58598749|FG001|Overall Study|Protocol Violation|1|||
30586612|NCT01238848|58598757|FG000|Overall Study|Physician Decision|13|||
30586613|NCT01238848|58598758|FG001|Overall Study|Physician Decision|5|||
30586614|NCT01238575|58598766|FG000|Overall Study|Lack of Efficacy|2|||
30586615|NCT01238575|58598767|FG001|Overall Study|Lack of Efficacy|4|||
30586616|NCT01238575|58598766|FG000|Overall Study|Adverse Event|2|||
30586617|NCT01238575|58598767|FG001|Overall Study|Adverse Event|0|||
30586618|NCT01237951|58598773|FG000|Overall Study|Death|1|||
30586619|NCT01239394|58598777|FG000|Overall Study|Adverse Event|1|||
30586620|NCT01237678|58598784|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
30586621|NCT01237678|58598785|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
30586622|NCT01237678|58598786|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
30586623|NCT01237678|58598784|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
30586624|NCT01237678|58598785|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
30586625|NCT01237678|58598786|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
30586626|NCT01237678|58598784|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
30586627|NCT01237678|58598785|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
30586628|NCT01237678|58598786|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
30586629|NCT01237678|58598784|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
30586630|NCT01237678|58598785|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
30586631|NCT01237678|58598786|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
30586632|NCT01237678|58598784|FG000|Phase II|Adverse Event|0|||
30586633|NCT01237678|58598785|FG001|Phase II|Adverse Event|39|||
30586634|NCT01237678|58598786|FG002|Phase II|Adverse Event|9|||
30586635|NCT01237678|58598784|FG000|Phase II|Death|0|||
30586636|NCT01237678|58598785|FG001|Phase II|Death|0|||
30586637|NCT01237678|58598786|FG002|Phase II|Death|2|||
30586638|NCT01237678|58598784|FG000|Phase II|Lack of Efficacy|0|||
30586639|NCT01237678|58598785|FG001|Phase II|Lack of Efficacy|25|||
30586640|NCT01237678|58598786|FG002|Phase II|Lack of Efficacy|3|||
30670842|NCT00838110|58684566|FG000|Overall Study|Withdrawal by Subject|5|||
30670843|NCT00838110|58684567|FG001|Overall Study|Withdrawal by Subject|6|||
30670844|NCT00838110|58684568|FG002|Overall Study|Withdrawal by Subject|3|||
30670845|NCT00838110|58684569|FG003|Overall Study|Withdrawal by Subject|4|||
30670846|NCT00838110|58684566|FG000|Overall Study|Other|3|||
30586641|NCT01237678|58598784|FG000|Phase II|Withdrawal by Subject|0|||
30670847|NCT00838110|58684567|FG001|Overall Study|Other|3|||
30586642|NCT01237678|58598785|FG001|Phase II|Withdrawal by Subject|1|||
30586643|NCT01237678|58598786|FG002|Phase II|Withdrawal by Subject|5|||
30586644|NCT01237678|58598784|FG000|Phase II|Completed Cycles 4-6|0|||
30586645|NCT01237678|58598785|FG001|Phase II|Completed Cycles 4-6|11|||
30586646|NCT01237678|58598786|FG002|Phase II|Completed Cycles 4-6|21|||
30586647|NCT01237678|58598784|FG000|Phase II|Sponsor Decision/Study Closed|0|||
30586648|NCT01237678|58598785|FG001|Phase II|Sponsor Decision/Study Closed|18|||
30586649|NCT01237678|58598786|FG002|Phase II|Sponsor Decision/Study Closed|7|||
30586650|NCT01237678|58598784|FG000|Phase II|Randomized but were not treated|0|||
30670848|NCT00838110|58684568|FG002|Overall Study|Other|3|||
30670849|NCT00838110|58684569|FG003|Overall Study|Other|2|||
30670850|NCT00838110|58684566|FG000|Overall Study|Protocol Violation|0|||
30670851|NCT00838110|58684567|FG001|Overall Study|Protocol Violation|2|||
30670852|NCT00838110|58684568|FG002|Overall Study|Protocol Violation|1|||
30670853|NCT00838110|58684569|FG003|Overall Study|Protocol Violation|1|||
30670854|NCT00838110|58684566|FG000|Overall Study|Lost to Follow-up|3|||
30670855|NCT00838110|58684567|FG001|Overall Study|Lost to Follow-up|0|||
30670856|NCT00838110|58684568|FG002|Overall Study|Lost to Follow-up|0|||
30670857|NCT00838110|58684569|FG003|Overall Study|Lost to Follow-up|0|||
30670858|NCT00838110|58684566|FG000|Overall Study|Did not meet eligibility criteria|0|||
30670859|NCT00838110|58684567|FG001|Overall Study|Did not meet eligibility criteria|0|||
30670860|NCT00838110|58684568|FG002|Overall Study|Did not meet eligibility criteria|1|||
30670861|NCT00838110|58684569|FG003|Overall Study|Did not meet eligibility criteria|2|||
30670862|NCT00838110|58684566|FG000|Overall Study|Randomized but not treated|0|||
30670863|NCT00838110|58684567|FG001|Overall Study|Randomized but not treated|1|||
30670864|NCT00838110|58684568|FG002|Overall Study|Randomized but not treated|0|||
30670865|NCT00838110|58684569|FG003|Overall Study|Randomized but not treated|0|||
30670866|NCT00837876|58684579|FG000|Overall Study|Death|2|||
30670867|NCT00837876|58684579|FG000|Overall Study|Adverse Event|7|||
30670868|NCT00837876|58684579|FG000|Overall Study|Physician Decision|1|||
30670869|NCT00837876|58684579|FG000|Overall Study|Withdrawal by Subject|3|||
30670870|NCT00837876|58684579|FG000|Overall Study|disease progression|24|||
30670871|NCT02637713|58684583|FG000|Overall Study|Screen Failure|2|||
30670872|NCT00686920|58684589|FG000|Overall Study|Death|45|||
30670873|NCT00686920|58684590|FG001|Overall Study|Death|14|||
30670874|NCT00686920|58684589|FG000|Overall Study|Liver Transplant|23|||
30781112|NCT03776175|58793244|FG001|Treatment Period (42 Days)|Adverse Event|1|||
30781113|NCT03776175|58793245|FG002|Treatment Period (42 Days)|Adverse Event|1|||
30781114|NCT03776175|58793246|FG003|Treatment Period (42 Days)|Adverse Event|0|||
30781115|NCT03776175|58793243|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
30781116|NCT03776175|58793244|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
30781117|NCT03776175|58793245|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
30781118|NCT03776175|58793246|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
30781119|NCT03776175|58793243|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
30781120|NCT03776175|58793244|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
30781121|NCT03776175|58793245|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
30781122|NCT03776175|58793246|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
30781123|NCT03776175|58793243|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
30781124|NCT03776175|58793244|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
30781125|NCT03776175|58793245|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
30781126|NCT03776175|58793246|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
30781127|NCT03776175|58793243|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
30781128|NCT03776175|58793244|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
30781129|NCT03776175|58793245|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
30781130|NCT03776175|58793246|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
30781131|NCT03776175|58793243|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
30781132|NCT03776175|58793244|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
30781133|NCT03776175|58793245|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
30586651|NCT01237678|58598785|FG001|Phase II|Randomized but were not treated|4|||
30586652|NCT01237678|58598786|FG002|Phase II|Randomized but were not treated|3|||
30586653|NCT01229371|58598809|FG000|Overall Study|Withdrawal by Subject|0|||
30586654|NCT01229371|58598810|FG001|Overall Study|Withdrawal by Subject|1|||
30781134|NCT03776175|58793246|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
30781135|NCT02903914|58793264|FG000|Overall Study|Adverse Event|0|||
30781136|NCT02903914|58793265|FG001|Overall Study|Adverse Event|0|||
30781137|NCT02903914|58793266|FG002|Overall Study|Adverse Event|1|||
30855791|NCT02585960|58883505|FG002|PK/Safety Assessment Period|Physician Decision|0|||
30586655|NCT01229371|58598811|FG002|Overall Study|Withdrawal by Subject|0|||
30586656|NCT01229371|58598812|FG003|Overall Study|Withdrawal by Subject|0|||
30586657|NCT01237327|58598824|FG000|Overall Study|Protocol Violation: Core Study|1|||
30586658|NCT01237327|58598825|FG001|Overall Study|Protocol Violation: Core Study|0|||
30586659|NCT01237327|58598824|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
30586660|NCT01237327|58598825|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
30586661|NCT01237327|58598824|FG000|Overall Study|Progression of Disease: Core Study|18|||
30586662|NCT01237327|58598825|FG001|Overall Study|Progression of Disease: Core Study|22|||
30781138|NCT02903914|58793267|FG003|Overall Study|Adverse Event|0|||
30781139|NCT02903914|58793268|FG004|Overall Study|Adverse Event|0|||
30781140|NCT02903914|58793269|FG005|Overall Study|Adverse Event|1|||
30586663|NCT01237327|58598824|FG000|Overall Study|Progression of Disease: Extension Study|15|||
30670875|NCT00686920|58684590|FG001|Overall Study|Liver Transplant|8|||
30670876|NCT00686920|58684589|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
30670877|NCT00686920|58684590|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
30670878|NCT00686920|58684589|FG000|Overall Study|Withdrawal by Subject|23|||
30670879|NCT00686920|58684590|FG001|Overall Study|Withdrawal by Subject|5|||
30670880|NCT00686920|58684589|FG000|Overall Study|Protocol Violation|2|||
30670881|NCT00686920|58684590|FG001|Overall Study|Protocol Violation|1|||
30670882|NCT00686920|58684589|FG000|Overall Study|Adverse Event|10|||
30670883|NCT00686920|58684590|FG001|Overall Study|Adverse Event|2|||
30670884|NCT00686920|58684589|FG000|Overall Study|Personal Reason|0|||
30670885|NCT00686920|58684590|FG001|Overall Study|Personal Reason|1|||
30670886|NCT00686920|58684589|FG000|Overall Study|Lost to Follow-up|15|||
30670887|NCT00686920|58684590|FG001|Overall Study|Lost to Follow-up|3|||
30670888|NCT00686920|58684589|FG000|Overall Study|Moved to Another State|1|||
30670889|NCT00686920|58684590|FG001|Overall Study|Moved to Another State|0|||
30670890|NCT00686920|58684589|FG000|Overall Study|Transferred to Nursing Home|1|||
30670891|NCT00686920|58684590|FG001|Overall Study|Transferred to Nursing Home|0|||
30670892|NCT00686920|58684589|FG000|Overall Study|Noncompliance|9|||
30670893|NCT00686920|58684590|FG001|Overall Study|Noncompliance|0|||
30670894|NCT00686920|58684589|FG000|Overall Study|Principal Investigator Decision|2|||
30670895|NCT00686920|58684590|FG001|Overall Study|Principal Investigator Decision|0|||
30670896|NCT00845832|58684599|FG000|Treatment Period|Adverse Event|0|||
30670897|NCT00845832|58684600|FG001|Treatment Period|Adverse Event|2|||
30670898|NCT00845832|58684601|FG002|Treatment Period|Adverse Event|0|||
30670899|NCT00845832|58684599|FG000|Treatment Period|Protocol Violation|1|||
30670900|NCT00845832|58684600|FG001|Treatment Period|Protocol Violation|1|||
30670901|NCT00845832|58684601|FG002|Treatment Period|Protocol Violation|0|||
30670902|NCT00845832|58684599|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
30670903|NCT00845832|58684600|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
30670904|NCT00845832|58684601|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
30670905|NCT00845832|58684599|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
30670906|NCT00845832|58684600|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
30670907|NCT00845832|58684601|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
30670908|NCT00591864|58684609|FG000|Overall Study|Incomplete Imaging|5|||
30670909|NCT00885755|58684617|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
30586664|NCT01237327|58598825|FG001|Overall Study|Progression of Disease: Extension Study|13|||
30586665|NCT01237327|58598824|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
30586666|NCT01237327|58598825|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
30586667|NCT01237327|58598824|FG000|Overall Study|Withdrawal by Subject|1|||
30586668|NCT01237327|58598825|FG001|Overall Study|Withdrawal by Subject|3|||
30586669|NCT01237327|58598824|FG000|Overall Study|Lost to Follow-up|3|||
30586670|NCT01237327|58598825|FG001|Overall Study|Lost to Follow-up|0|||
30586671|NCT01237054|58598831|FG000|Overall Study|imaging 10C0096|1|||
30586672|NCT01236352|58598868|FG000|Overall Study|Death|0|||
30586673|NCT01236352|58598869|FG001|Overall Study|Death|0|||
30586674|NCT01236352|58598870|FG002|Overall Study|Death|0|||
30586675|NCT01236352|58598871|FG003|Overall Study|Death|0|||
30586676|NCT01236352|58598872|FG004|Overall Study|Death|0|||
30586677|NCT01236352|58598873|FG005|Overall Study|Death|0|||
30586678|NCT01236352|58598874|FG006|Overall Study|Death|0|||
30586679|NCT01236352|58598875|FG007|Overall Study|Death|1|||
30586680|NCT01236352|58598876|FG008|Overall Study|Death|0|||
30586681|NCT01236352|58598877|FG009|Overall Study|Death|0|||
30586682|NCT01236352|58598878|FG010|Overall Study|Death|0|||
30586683|NCT01236352|58598868|FG000|Overall Study|Withdrawal by Subject|0|||
30586684|NCT01236352|58598869|FG001|Overall Study|Withdrawal by Subject|0|||
30586685|NCT01236352|58598870|FG002|Overall Study|Withdrawal by Subject|0|||
30586686|NCT01236352|58598871|FG003|Overall Study|Withdrawal by Subject|0|||
30586687|NCT01236352|58598872|FG004|Overall Study|Withdrawal by Subject|0|||
30586688|NCT01236352|58598873|FG005|Overall Study|Withdrawal by Subject|0|||
30586689|NCT01236352|58598874|FG006|Overall Study|Withdrawal by Subject|0|||
30586690|NCT01236352|58598875|FG007|Overall Study|Withdrawal by Subject|0|||
30586691|NCT01236352|58598876|FG008|Overall Study|Withdrawal by Subject|0|||
30586692|NCT01236352|58598877|FG009|Overall Study|Withdrawal by Subject|2|||
30670910|NCT00885755|58684618|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
30586693|NCT01236352|58598878|FG010|Overall Study|Withdrawal by Subject|1|||
30670911|NCT00885755|58684619|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
30670912|NCT00885755|58684617|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
30670913|NCT00885755|58684618|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
30670914|NCT00885755|58684619|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
30670915|NCT00885755|58684617|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
30670916|NCT00885755|58684618|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
30586694|NCT01236352|58598868|FG000|Overall Study|Adverse Event|0|||
30586695|NCT01236352|58598869|FG001|Overall Study|Adverse Event|0|||
30586696|NCT01236352|58598870|FG002|Overall Study|Adverse Event|0|||
30586697|NCT01236352|58598871|FG003|Overall Study|Adverse Event|0|||
30586698|NCT01236352|58598872|FG004|Overall Study|Adverse Event|0|||
30586699|NCT01236352|58598873|FG005|Overall Study|Adverse Event|0|||
30670917|NCT00885755|58684619|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
30670918|NCT00885755|58684617|FG000|Part I: Trastuzumab+Taxane|Death|0|||
30586700|NCT01236352|58598874|FG006|Overall Study|Adverse Event|2|||
30586701|NCT01236352|58598875|FG007|Overall Study|Adverse Event|0|||
30586702|NCT01236352|58598876|FG008|Overall Study|Adverse Event|0|||
30586703|NCT01236352|58598877|FG009|Overall Study|Adverse Event|4|||
30586704|NCT01236352|58598878|FG010|Overall Study|Adverse Event|1|||
30586705|NCT01236352|58598868|FG000|Overall Study|Study drug toxicity|0|||
30586706|NCT01236352|58598869|FG001|Overall Study|Study drug toxicity|0|||
30586707|NCT01236352|58598870|FG002|Overall Study|Study drug toxicity|0|||
30586708|NCT01236352|58598871|FG003|Overall Study|Study drug toxicity|0|||
30586709|NCT01236352|58598872|FG004|Overall Study|Study drug toxicity|0|||
30586710|NCT01236352|58598873|FG005|Overall Study|Study drug toxicity|1|||
30670919|NCT00885755|58684618|FG001|Part I: Trastuzumab+Taxane|Death|0|||
30670920|NCT00885755|58684619|FG002|Part I: Trastuzumab+Taxane|Death|1|||
30670921|NCT00885755|58684617|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
30670922|NCT00885755|58684618|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
30670923|NCT00885755|58684619|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
30670924|NCT00837486|58684629|FG000|Blinded-treatment Phase|Physician Decision|1|||
30670925|NCT00837486|58684630|FG001|Blinded-treatment Phase|Physician Decision|0|||
30670926|NCT00837486|58684629|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
30670927|NCT00837486|58684630|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
30670928|NCT00837486|58684629|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
30670929|NCT00837486|58684630|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
30670930|NCT00837486|58684629|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
30670931|NCT00837486|58684630|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
30670932|NCT00845676|58684638|FG000|Overall Study|Virologic breakthrough at week 20|1|||
30670933|NCT00845676|58684638|FG000|Overall Study|Adverse Event|1|||
30670934|NCT00883181|58684643|FG000|Overall Study|Hematological Adverse Event|26|||
30670935|NCT00883181|58684643|FG000|Overall Study|Non-hematological Adverse Event|55|||
30670936|NCT00883181|58684643|FG000|Overall Study|Disease Progression|94|||
30670937|NCT00883181|58684643|FG000|Overall Study|Administrative Reason|24|||
30670938|NCT00883181|58684643|FG000|Overall Study|Withdrawal by Subject|4|||
30670939|NCT00883181|58684643|FG000|Overall Study|Death|31|||
30670940|NCT00883181|58684643|FG000|Overall Study|Other|38|||
30670941|NCT00883181|58684643|FG000|Overall Study|Protocol Deviation|3|||
30586711|NCT01236352|58598874|FG006|Overall Study|Study drug toxicity|1|||
30586712|NCT01236352|58598875|FG007|Overall Study|Study drug toxicity|0|||
30586713|NCT01236352|58598876|FG008|Overall Study|Study drug toxicity|0|||
30586714|NCT01236352|58598877|FG009|Overall Study|Study drug toxicity|2|||
30586715|NCT01236352|58598878|FG010|Overall Study|Study drug toxicity|2|||
30586716|NCT01236352|58598868|FG000|Overall Study|Disease progression|1|||
30586717|NCT01236352|58598869|FG001|Overall Study|Disease progression|2|||
30586718|NCT01236352|58598870|FG002|Overall Study|Disease progression|1|||
30586719|NCT01236352|58598871|FG003|Overall Study|Disease progression|2|||
30586720|NCT01236352|58598872|FG004|Overall Study|Disease progression|2|||
30586721|NCT01236352|58598873|FG005|Overall Study|Disease progression|2|||
30586722|NCT01236352|58598874|FG006|Overall Study|Disease progression|1|||
30586723|NCT01236352|58598875|FG007|Overall Study|Disease progression|3|||
30670942|NCT00883181|58684643|FG000|Overall Study|Noncompliance|3|||
30670943|NCT00845520|58684663|FG000|Overall Study|Death|1|||
30670944|NCT00845520|58684664|FG001|Overall Study|Death|2|||
30670945|NCT00845520|58684665|FG002|Overall Study|Death|0|||
30670946|NCT00845520|58684663|FG000|Overall Study|Lost to Follow-up|1|||
30670947|NCT00845520|58684664|FG001|Overall Study|Lost to Follow-up|0|||
30670948|NCT00845520|58684665|FG002|Overall Study|Lost to Follow-up|0|||
30670949|NCT00845520|58684663|FG000|Overall Study|Adverse Event|0|||
30670950|NCT00845520|58684664|FG001|Overall Study|Adverse Event|0|||
30670951|NCT00845520|58684665|FG002|Overall Study|Adverse Event|1|||
30670952|NCT00844896|58684681|FG000|Overall Study|Lost to Follow-up|12|||
30670953|NCT00844896|58684682|FG001|Overall Study|Lost to Follow-up|16|||
30586724|NCT01236352|58598876|FG008|Overall Study|Disease progression|2|||
30586725|NCT01236352|58598877|FG009|Overall Study|Disease progression|2|||
30670954|NCT00844896|58684681|FG000|Overall Study|Parents did not have time to complete|0|||
30586726|NCT01236352|58598878|FG010|Overall Study|Disease progression|2|||
30670955|NCT00844896|58684682|FG001|Overall Study|Parents did not have time to complete|1|||
30670956|NCT00827502|58684689|FG000|Overall Study|randomized but not treated|11|||
30670957|NCT00827502|58684689|FG000|Overall Study|Adverse Event|1|||
30670958|NCT00827502|58684689|FG000|Overall Study|Lost to Follow-up|4|||
30670959|NCT00827502|58684689|FG000|Overall Study|Withdrawal by Subject|5|||
30781141|NCT02903914|58793270|FG006|Overall Study|Adverse Event|2|||
30781142|NCT02903914|58793271|FG007|Overall Study|Adverse Event|1|||
30781143|NCT02903914|58793264|FG000|Overall Study|Withdrawal by Subject|3|||
30586727|NCT01236352|58598868|FG000|Overall Study|Poor/Non-compliance|1|||
30586728|NCT01236352|58598869|FG001|Overall Study|Poor/Non-compliance|0|||
30586729|NCT01236352|58598870|FG002|Overall Study|Poor/Non-compliance|0|||
30586730|NCT01236352|58598871|FG003|Overall Study|Poor/Non-compliance|0|||
30855792|NCT02585960|58883503|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
30586731|NCT01236352|58598872|FG004|Overall Study|Poor/Non-compliance|0|||
30586732|NCT01236352|58598873|FG005|Overall Study|Poor/Non-compliance|0|||
30670960|NCT00837330|58684695|FG000|Overall Study|Lost to Follow-up|1|||
30670961|NCT00837330|58684696|FG001|Overall Study|Lost to Follow-up|3|||
30670962|NCT00837096|58684704|FG000|Overall Study|Physician Decision|1|||
30670963|NCT00837096|58684705|FG001|Overall Study|Physician Decision|1|||
30670964|NCT00837096|58684704|FG000|Overall Study|Not reported|9|||
30670965|NCT00837096|58684705|FG001|Overall Study|Not reported|8|||
30670966|NCT00885677|58684713|FG000|Overall Study|Death|40|||
30670967|NCT00885677|58684714|FG001|Overall Study|Death|34|||
30670968|NCT00885677|58684713|FG000|Overall Study|Lost to Follow-up|15|||
30670969|NCT00885677|58684714|FG001|Overall Study|Lost to Follow-up|13|||
30670970|NCT00885677|58684713|FG000|Overall Study|Protocol Violation|54|||
30670971|NCT00885677|58684714|FG001|Overall Study|Protocol Violation|54|||
30586733|NCT01236352|58598874|FG006|Overall Study|Poor/Non-compliance|0|||
30586734|NCT01236352|58598875|FG007|Overall Study|Poor/Non-compliance|0|||
30586735|NCT01236352|58598876|FG008|Overall Study|Poor/Non-compliance|0|||
30586736|NCT01236352|58598877|FG009|Overall Study|Poor/Non-compliance|0|||
30670972|NCT00885677|58684713|FG000|Overall Study|premature study closure|41|||
30670973|NCT00885677|58684714|FG001|Overall Study|premature study closure|44|||
30670974|NCT00885677|58684713|FG000|Overall Study|device/lead revision or replacement|7|||
30670975|NCT00885677|58684714|FG001|Overall Study|device/lead revision or replacement|6|||
30670976|NCT00885677|58684713|FG000|Overall Study|Heart transplantation|1|||
30670977|NCT00885677|58684714|FG001|Overall Study|Heart transplantation|0|||
30670978|NCT00885677|58684713|FG000|Overall Study|Inclusion/exclusion not met|25|||
30670979|NCT00885677|58684714|FG001|Overall Study|Inclusion/exclusion not met|27|||
30670980|NCT00885365|58684722|FG000|4 Weeks ON Treatment|Adverse Event|2|||
30670981|NCT00885365|58684723|FG001|4 Weeks ON Treatment|Adverse Event|4|||
30670982|NCT00885365|58684722|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
30670983|NCT00885365|58684723|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
30670984|NCT00885365|58684722|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
30670985|NCT00885365|58684723|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
30586737|NCT01236352|58598878|FG010|Overall Study|Poor/Non-compliance|0|||
30586738|NCT01236352|58598868|FG000|Overall Study|Maximum clinical benefit|1|||
30586739|NCT01236352|58598869|FG001|Overall Study|Maximum clinical benefit|1|||
30586740|NCT01236352|58598870|FG002|Overall Study|Maximum clinical benefit|1|||
30586741|NCT01236352|58598871|FG003|Overall Study|Maximum clinical benefit|0|||
30586742|NCT01236352|58598872|FG004|Overall Study|Maximum clinical benefit|2|||
30586743|NCT01236352|58598873|FG005|Overall Study|Maximum clinical benefit|0|||
30586744|NCT01236352|58598874|FG006|Overall Study|Maximum clinical benefit|3|||
30586745|NCT01236352|58598875|FG007|Overall Study|Maximum clinical benefit|1|||
30586746|NCT01236352|58598876|FG008|Overall Study|Maximum clinical benefit|1|||
30586747|NCT01236352|58598877|FG009|Overall Study|Maximum clinical benefit|4|||
30586748|NCT01236352|58598878|FG010|Overall Study|Maximum clinical benefit|2|||
30586749|NCT01236352|58598868|FG000|Overall Study|Subject request to discontinue treatment|0|||
30586750|NCT01236352|58598869|FG001|Overall Study|Subject request to discontinue treatment|0|||
30586751|NCT01236352|58598870|FG002|Overall Study|Subject request to discontinue treatment|1|||
30586752|NCT01236352|58598871|FG003|Overall Study|Subject request to discontinue treatment|1|||
30586753|NCT01236352|58598872|FG004|Overall Study|Subject request to discontinue treatment|0|||
30586754|NCT01236352|58598873|FG005|Overall Study|Subject request to discontinue treatment|1|||
30586755|NCT01236352|58598874|FG006|Overall Study|Subject request to discontinue treatment|0|||
30586756|NCT01236352|58598875|FG007|Overall Study|Subject request to discontinue treatment|0|||
30586757|NCT01236352|58598876|FG008|Overall Study|Subject request to discontinue treatment|0|||
30586758|NCT01236352|58598877|FG009|Overall Study|Subject request to discontinue treatment|1|||
30586759|NCT01236352|58598878|FG010|Overall Study|Subject request to discontinue treatment|4|||
30586760|NCT01236352|58598868|FG000|Overall Study|Subject to receive drug via EAP|1|||
30586761|NCT01236352|58598869|FG001|Overall Study|Subject to receive drug via EAP|1|||
30586762|NCT01236352|58598870|FG002|Overall Study|Subject to receive drug via EAP|1|||
30586763|NCT01236352|58598871|FG003|Overall Study|Subject to receive drug via EAP|0|||
30586764|NCT01236352|58598872|FG004|Overall Study|Subject to receive drug via EAP|0|||
30586765|NCT01236352|58598873|FG005|Overall Study|Subject to receive drug via EAP|0|||
30586766|NCT01236352|58598874|FG006|Overall Study|Subject to receive drug via EAP|0|||
30586767|NCT01236352|58598875|FG007|Overall Study|Subject to receive drug via EAP|2|||
30586768|NCT01236352|58598876|FG008|Overall Study|Subject to receive drug via EAP|0|||
30586769|NCT01236352|58598877|FG009|Overall Study|Subject to receive drug via EAP|4|||
30586770|NCT01236352|58598878|FG010|Overall Study|Subject to receive drug via EAP|0|||
30586771|NCT01236352|58598868|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
30586772|NCT01236352|58598869|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
30586773|NCT01236352|58598870|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
30586774|NCT01236352|58598871|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
30670986|NCT00827112|58684731|FG000|Overall Study|Adverse Event|2|||
30670987|NCT00827112|58684732|FG001|Overall Study|Adverse Event|0|||
30670988|NCT00827112|58684731|FG000|Overall Study|Lack of Efficacy|2|||
30670989|NCT00827112|58684732|FG001|Overall Study|Lack of Efficacy|0|||
30670990|NCT00827112|58684731|FG000|Overall Study|Lost to Follow-up|3|||
30670991|NCT00827112|58684732|FG001|Overall Study|Lost to Follow-up|2|||
30670992|NCT00827112|58684731|FG000|Overall Study|Pregnancy|0|||
30670993|NCT00827112|58684732|FG001|Overall Study|Pregnancy|1|||
30586775|NCT01236352|58598872|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
30586776|NCT01236352|58598873|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
30586777|NCT01236352|58598874|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
30586778|NCT01236352|58598875|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
30586779|NCT01236352|58598876|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
30586780|NCT01236352|58598877|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
30586781|NCT01236352|58598878|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
30586782|NCT01236352|58598868|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
30586783|NCT01236352|58598869|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
30586784|NCT01236352|58598870|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
30586785|NCT01236352|58598871|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
30586786|NCT01236352|58598872|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
30586787|NCT01236352|58598873|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
30586788|NCT01236352|58598874|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
30586789|NCT01236352|58598875|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
30670994|NCT00827112|58684731|FG000|Overall Study|Protocol Violation|0|||
30670995|NCT00827112|58684732|FG001|Overall Study|Protocol Violation|2|||
30670996|NCT00827112|58684731|FG000|Overall Study|Withdrawal by Subject|2|||
30670997|NCT00827112|58684732|FG001|Overall Study|Withdrawal by Subject|1|||
30670998|NCT00827112|58684731|FG000|Overall Study|Randomized but not treated|5|||
30670999|NCT00827112|58684732|FG001|Overall Study|Randomized but not treated|3|||
30586790|NCT01236352|58598876|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
30586791|NCT01236352|58598877|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
30586792|NCT01236352|58598878|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
30586793|NCT01236352|58598868|FG000|Overall Study|Lack of response to drug|0|||
30586794|NCT01236352|58598869|FG001|Overall Study|Lack of response to drug|0|||
30586795|NCT01236352|58598870|FG002|Overall Study|Lack of response to drug|0|||
30586796|NCT01236352|58598871|FG003|Overall Study|Lack of response to drug|0|||
30586797|NCT01236352|58598872|FG004|Overall Study|Lack of response to drug|0|||
30586798|NCT01236352|58598873|FG005|Overall Study|Lack of response to drug|0|||
30586799|NCT01236352|58598874|FG006|Overall Study|Lack of response to drug|0|||
30586800|NCT01236352|58598875|FG007|Overall Study|Lack of response to drug|0|||
30586801|NCT01236352|58598876|FG008|Overall Study|Lack of response to drug|0|||
30586802|NCT01236352|58598877|FG009|Overall Study|Lack of response to drug|1|||
30586803|NCT01236352|58598878|FG010|Overall Study|Lack of response to drug|1|||
30586804|NCT01236352|58598868|FG000|Overall Study|Patient transferred to IST|0|||
30586805|NCT01236352|58598869|FG001|Overall Study|Patient transferred to IST|0|||
30586806|NCT01236352|58598870|FG002|Overall Study|Patient transferred to IST|0|||
30586807|NCT01236352|58598871|FG003|Overall Study|Patient transferred to IST|0|||
30671000|NCT00827112|58684731|FG000|Overall Study|Other|1|||
30671001|NCT00827112|58684732|FG001|Overall Study|Other|3|||
30671002|NCT00689104|58684742|FG000|Overall Study|Eligibility criterion not met|5|||
30671003|NCT00689104|58684743|FG001|Overall Study|Eligibility criterion not met|8|||
30671004|NCT00689104|58684744|FG002|Overall Study|Eligibility criterion not met|0|||
30671005|NCT00689104|58684745|FG003|Overall Study|Eligibility criterion not met|4|||
30671006|NCT00689104|58684742|FG000|Overall Study|Adverse Event|13|||
30671007|NCT00689104|58684743|FG001|Overall Study|Adverse Event|25|||
30671008|NCT00689104|58684744|FG002|Overall Study|Adverse Event|16|||
30671009|NCT00689104|58684745|FG003|Overall Study|Adverse Event|24|||
30671010|NCT00689104|58684742|FG000|Overall Study|Lack of Efficacy|5|||
30671011|NCT00689104|58684743|FG001|Overall Study|Lack of Efficacy|6|||
30671012|NCT00689104|58684744|FG002|Overall Study|Lack of Efficacy|2|||
30671013|NCT00689104|58684745|FG003|Overall Study|Lack of Efficacy|3|||
30671014|NCT00689104|58684742|FG000|Overall Study|Withdrawal by Subject|12|||
30671015|NCT00689104|58684743|FG001|Overall Study|Withdrawal by Subject|11|||
30671016|NCT00689104|58684744|FG002|Overall Study|Withdrawal by Subject|18|||
30671017|NCT00689104|58684745|FG003|Overall Study|Withdrawal by Subject|11|||
30671018|NCT00689104|58684742|FG000|Overall Study|Lost to Follow-up|4|||
30671019|NCT00689104|58684743|FG001|Overall Study|Lost to Follow-up|3|||
30671020|NCT00689104|58684744|FG002|Overall Study|Lost to Follow-up|2|||
30671021|NCT00689104|58684745|FG003|Overall Study|Lost to Follow-up|5|||
30671022|NCT00689104|58684742|FG000|Overall Study|Protocol Violation|2|||
30671023|NCT00689104|58684743|FG001|Overall Study|Protocol Violation|3|||
30671024|NCT00689104|58684744|FG002|Overall Study|Protocol Violation|5|||
30671025|NCT00689104|58684745|FG003|Overall Study|Protocol Violation|3|||
30671026|NCT00689104|58684742|FG000|Overall Study|Randomized but never received study drug|2|||
30671027|NCT00689104|58684743|FG001|Overall Study|Randomized but never received study drug|1|||
30671028|NCT00689104|58684744|FG002|Overall Study|Randomized but never received study drug|1|||
30671029|NCT00689104|58684745|FG003|Overall Study|Randomized but never received study drug|0|||
30671030|NCT00689104|58684742|FG000|Overall Study|Physician Decision|1|||
30671031|NCT00689104|58684743|FG001|Overall Study|Physician Decision|0|||
30671032|NCT00689104|58684744|FG002|Overall Study|Physician Decision|0|||
30671033|NCT00689104|58684745|FG003|Overall Study|Physician Decision|0|||
30671034|NCT00689104|58684742|FG000|Overall Study|Non-compliance with study procedures|0|||
30671035|NCT00689104|58684743|FG001|Overall Study|Non-compliance with study procedures|0|||
30671036|NCT00689104|58684744|FG002|Overall Study|Non-compliance with study procedures|1|||
30671037|NCT00689104|58684745|FG003|Overall Study|Non-compliance with study procedures|0|||
30671038|NCT00689026|58684757|FG000|Overall Study|Withdrawal by Subject|13|||
30671039|NCT00689026|58684758|FG001|Overall Study|Withdrawal by Subject|6|||
30671040|NCT00598559|58684767|FG000|Overall Study|Adverse Event|11|||
30671041|NCT00598559|58684768|FG001|Overall Study|Adverse Event|7|||
30671042|NCT00598559|58684769|FG002|Overall Study|Adverse Event|0|||
30671043|NCT00598559|58684767|FG000|Overall Study|Withdrawal by Subject|2|||
30671044|NCT00598559|58684768|FG001|Overall Study|Withdrawal by Subject|2|||
30671045|NCT00598559|58684769|FG002|Overall Study|Withdrawal by Subject|0|||
30671046|NCT00598559|58684767|FG000|Overall Study|Protocol Non-compliance|1|||
30586808|NCT01236352|58598872|FG004|Overall Study|Patient transferred to IST|0|||
30586809|NCT01236352|58598873|FG005|Overall Study|Patient transferred to IST|0|||
30586810|NCT01236352|58598874|FG006|Overall Study|Patient transferred to IST|0|||
30586811|NCT01236352|58598875|FG007|Overall Study|Patient transferred to IST|0|||
30586812|NCT01236352|58598876|FG008|Overall Study|Patient transferred to IST|0|||
30586813|NCT01236352|58598877|FG009|Overall Study|Patient transferred to IST|2|||
30586814|NCT01236352|58598878|FG010|Overall Study|Patient transferred to IST|6|||
30586815|NCT01236118|58598905|FG000|Overall Study|Adverse Event|2|||
30586816|NCT01236118|58598906|FG001|Overall Study|Adverse Event|0|||
30586817|NCT01236118|58598907|FG002|Overall Study|Adverse Event|2|||
30586818|NCT01236118|58598905|FG000|Overall Study|Physician Decision|0|||
30586819|NCT01236118|58598906|FG001|Overall Study|Physician Decision|1|||
30586820|NCT01236118|58598907|FG002|Overall Study|Physician Decision|0|||
30586821|NCT01236118|58598905|FG000|Overall Study|Withdrawal by Subject|0|||
30586822|NCT01236118|58598906|FG001|Overall Study|Withdrawal by Subject|0|||
30586823|NCT01236118|58598907|FG002|Overall Study|Withdrawal by Subject|1|||
30586824|NCT01236001|58598917|FG000|Overall Study|Adverse Event|5|||
30586825|NCT01236001|58598918|FG001|Overall Study|Adverse Event|14|||
30586826|NCT01236001|58598917|FG000|Overall Study|Lack of Efficacy|6|||
30586827|NCT01236001|58598918|FG001|Overall Study|Lack of Efficacy|6|||
30671047|NCT00598559|58684768|FG001|Overall Study|Protocol Non-compliance|0|||
30671048|NCT00598559|58684769|FG002|Overall Study|Protocol Non-compliance|0|||
30671049|NCT00598559|58684767|FG000|Overall Study|Early discharge from hospital|9|||
30671050|NCT00598559|58684768|FG001|Overall Study|Early discharge from hospital|12|||
30671051|NCT00598559|58684769|FG002|Overall Study|Early discharge from hospital|3|||
30671052|NCT00598559|58684767|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
30671053|NCT00598559|58684768|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
30671054|NCT00598559|58684769|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
30671055|NCT00686686|58684777|FG000|Overall Study|Non-compliance|1|||
30671056|NCT00686686|58684777|FG000|Overall Study|Adverse Event|2|||
30671057|NCT00686686|58684777|FG000|Overall Study|Lost to Follow-up|3|||
30671058|NCT04160195|58684783|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
30586828|NCT01236001|58598917|FG000|Overall Study|Lost to Follow-up|6|||
30586829|NCT01236001|58598918|FG001|Overall Study|Lost to Follow-up|1|||
30586830|NCT01236001|58598917|FG000|Overall Study|Incompliance|1|||
30586831|NCT01236001|58598918|FG001|Overall Study|Incompliance|0|||
30586832|NCT01236001|58598917|FG000|Overall Study|Planned Visit After End of Study|0|||
30586833|NCT01236001|58598918|FG001|Overall Study|Planned Visit After End of Study|1|||
30586834|NCT01229254|58598928|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
30586835|NCT01229254|58598929|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
30586836|NCT01229254|58598930|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
30586837|NCT01229254|58598928|FG000|Overall Study|Adverse Event|4|||
30586838|NCT01229254|58598929|FG001|Overall Study|Adverse Event|5|||
30586839|NCT01229254|58598930|FG002|Overall Study|Adverse Event|3|||
30586840|NCT01229254|58598928|FG000|Overall Study|Lost to Follow-up|3|||
30586841|NCT01229254|58598929|FG001|Overall Study|Lost to Follow-up|0|||
30586842|NCT01229254|58598930|FG002|Overall Study|Lost to Follow-up|1|||
30586843|NCT01229254|58598928|FG000|Overall Study|Physician Decision|0|||
30586844|NCT01229254|58598929|FG001|Overall Study|Physician Decision|3|||
30586845|NCT01229254|58598930|FG002|Overall Study|Physician Decision|0|||
30586846|NCT01229254|58598928|FG000|Overall Study|Protocol Violation|4|||
30586847|NCT01229254|58598929|FG001|Overall Study|Protocol Violation|6|||
30586848|NCT01229254|58598930|FG002|Overall Study|Protocol Violation|5|||
30671059|NCT04160195|58684784|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
30671060|NCT00686374|58684792|FG000|Overall Study|Lack of Efficacy|10|||
30671061|NCT00686374|58684792|FG000|Overall Study|Adverse Event|8|||
30781144|NCT02903914|58793265|FG001|Overall Study|Withdrawal by Subject|1|||
30781145|NCT02903914|58793266|FG002|Overall Study|Withdrawal by Subject|28|||
30781146|NCT02903914|58793267|FG003|Overall Study|Withdrawal by Subject|0|||
30855793|NCT02585960|58883504|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
30855794|NCT02585960|58883505|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
30781147|NCT02903914|58793268|FG004|Overall Study|Withdrawal by Subject|1|||
30781148|NCT02903914|58793269|FG005|Overall Study|Withdrawal by Subject|1|||
30781149|NCT02903914|58793270|FG006|Overall Study|Withdrawal by Subject|12|||
30781150|NCT02903914|58793271|FG007|Overall Study|Withdrawal by Subject|0|||
30781151|NCT02903914|58793264|FG000|Overall Study|Progressive Disease|1|||
30781152|NCT02903914|58793265|FG001|Overall Study|Progressive Disease|0|||
30781153|NCT02903914|58793266|FG002|Overall Study|Progressive Disease|4|||
30781154|NCT02903914|58793267|FG003|Overall Study|Progressive Disease|0|||
30781155|NCT02903914|58793268|FG004|Overall Study|Progressive Disease|0|||
30781156|NCT02903914|58793269|FG005|Overall Study|Progressive Disease|0|||
30781157|NCT02903914|58793270|FG006|Overall Study|Progressive Disease|2|||
30781158|NCT02903914|58793271|FG007|Overall Study|Progressive Disease|4|||
30781159|NCT02903914|58793264|FG000|Overall Study|Death|0|||
30781160|NCT02903914|58793265|FG001|Overall Study|Death|0|||
30781161|NCT02903914|58793266|FG002|Overall Study|Death|9|||
30781162|NCT02903914|58793267|FG003|Overall Study|Death|0|||
30781163|NCT02903914|58793268|FG004|Overall Study|Death|1|||
30781164|NCT02903914|58793269|FG005|Overall Study|Death|3|||
30781165|NCT02903914|58793270|FG006|Overall Study|Death|24|||
30781166|NCT02903914|58793271|FG007|Overall Study|Death|0|||
30781167|NCT02903914|58793264|FG000|Overall Study|Lost to Follow-up|0|||
30781168|NCT02903914|58793265|FG001|Overall Study|Lost to Follow-up|1|||
30781169|NCT02903914|58793266|FG002|Overall Study|Lost to Follow-up|0|||
30781170|NCT02903914|58793267|FG003|Overall Study|Lost to Follow-up|0|||
30781171|NCT02903914|58793268|FG004|Overall Study|Lost to Follow-up|2|||
30781172|NCT02903914|58793269|FG005|Overall Study|Lost to Follow-up|0|||
30781173|NCT02903914|58793270|FG006|Overall Study|Lost to Follow-up|1|||
30781174|NCT02903914|58793271|FG007|Overall Study|Lost to Follow-up|0|||
30781175|NCT02903914|58793264|FG000|Overall Study|Physician Decision|0|||
30781176|NCT02903914|58793265|FG001|Overall Study|Physician Decision|0|||
30781177|NCT02903914|58793266|FG002|Overall Study|Physician Decision|1|||
30586849|NCT01229254|58598928|FG000|Overall Study|Withdrawal by Subject|1|||
30586850|NCT01229254|58598929|FG001|Overall Study|Withdrawal by Subject|0|||
30586851|NCT01229254|58598930|FG002|Overall Study|Withdrawal by Subject|1|||
30586852|NCT01229254|58598928|FG000|Overall Study|Non-compliance with Study Drug|0|||
30586853|NCT01229254|58598929|FG001|Overall Study|Non-compliance with Study Drug|1|||
30586854|NCT01229254|58598930|FG002|Overall Study|Non-compliance with Study Drug|1|||
30586855|NCT01235728|58598939|FG000|Overall Study|Protocol Violation|0|||
30586856|NCT01235728|58598940|FG001|Overall Study|Protocol Violation|0|||
30586857|NCT01235728|58598941|FG002|Overall Study|Protocol Violation|0|||
30586858|NCT01235728|58598942|FG003|Overall Study|Protocol Violation|1|||
30586859|NCT01235728|58598943|FG004|Overall Study|Protocol Violation|0|||
30586860|NCT01235728|58598944|FG005|Overall Study|Protocol Violation|0|||
30586861|NCT01235728|58598945|FG006|Overall Study|Protocol Violation|0|||
30586862|NCT01235728|58598946|FG007|Overall Study|Protocol Violation|0|||
30586863|NCT01235689|58598956|FG000|Overall Study|Adverse Event|12|||
30586864|NCT01235689|58598957|FG001|Overall Study|Adverse Event|16|||
30586865|NCT01235689|58598956|FG000|Overall Study|Lack of Efficacy|12|||
30586866|NCT01235689|58598957|FG001|Overall Study|Lack of Efficacy|5|||
30586867|NCT01235689|58598956|FG000|Overall Study|Withdrawal by Subject|3|||
30586868|NCT01235689|58598957|FG001|Overall Study|Withdrawal by Subject|4|||
30586869|NCT01235689|58598956|FG000|Overall Study|Lost to Follow-up|1|||
30586870|NCT01235689|58598957|FG001|Overall Study|Lost to Follow-up|2|||
30586871|NCT01235689|58598956|FG000|Overall Study|Miscellaneous|1|||
30586872|NCT01235689|58598957|FG001|Overall Study|Miscellaneous|5|||
30586873|NCT01229176|58598971|FG000|Overall Study|Withdrawal by Subject|0|||
30586874|NCT01229176|58598972|FG001|Overall Study|Withdrawal by Subject|0|||
30586875|NCT01229176|58598973|FG002|Overall Study|Withdrawal by Subject|0|||
30781178|NCT02903914|58793267|FG003|Overall Study|Physician Decision|0|||
30781179|NCT02903914|58793268|FG004|Overall Study|Physician Decision|0|||
30781180|NCT02903914|58793269|FG005|Overall Study|Physician Decision|0|||
30781181|NCT02903914|58793270|FG006|Overall Study|Physician Decision|1|||
30781182|NCT02903914|58793271|FG007|Overall Study|Physician Decision|0|||
30781183|NCT02903914|58793264|FG000|Overall Study|Symptomatic Deterioration|0|||
30586876|NCT01229176|58598974|FG003|Overall Study|Withdrawal by Subject|1|||
30586877|NCT01229176|58598975|FG004|Overall Study|Withdrawal by Subject|1|||
30586878|NCT01229176|58598976|FG005|Overall Study|Withdrawal by Subject|1|||
30586879|NCT01229176|58598977|FG006|Overall Study|Withdrawal by Subject|0|||
30586880|NCT01229176|58598978|FG007|Overall Study|Withdrawal by Subject|1|||
30586881|NCT01229176|58598971|FG000|Overall Study|Lost to Follow-up|0|||
30586882|NCT01229176|58598972|FG001|Overall Study|Lost to Follow-up|3|||
30586883|NCT01229176|58598973|FG002|Overall Study|Lost to Follow-up|0|||
30586884|NCT01229176|58598974|FG003|Overall Study|Lost to Follow-up|0|||
30586885|NCT01229176|58598975|FG004|Overall Study|Lost to Follow-up|1|||
30586886|NCT01229176|58598976|FG005|Overall Study|Lost to Follow-up|1|||
30586887|NCT01229176|58598977|FG006|Overall Study|Lost to Follow-up|0|||
30781184|NCT02903914|58793265|FG001|Overall Study|Symptomatic Deterioration|0|||
30781185|NCT02903914|58793266|FG002|Overall Study|Symptomatic Deterioration|1|||
30781186|NCT02903914|58793267|FG003|Overall Study|Symptomatic Deterioration|0|||
30671062|NCT00686374|58684792|FG000|Overall Study|Withdrew consent|5|||
30671063|NCT00686374|58684792|FG000|Overall Study|Lost to Follow-up|1|||
30671064|NCT00686374|58684792|FG000|Overall Study|Missing reason|33|||
30671065|NCT00686374|58684792|FG000|Overall Study|Other, not specified|4|||
30671066|NCT00571948|58684798|FG000|Overall Study|Lost to Follow-up|2|||
30671067|NCT00571948|58684799|FG001|Overall Study|Lost to Follow-up|0|||
30671068|NCT00571948|58684798|FG000|Overall Study|Withdrawal by Subject|1|||
30671069|NCT00571948|58684799|FG001|Overall Study|Withdrawal by Subject|2|||
30671070|NCT00571948|58684798|FG000|Overall Study|Protocol Violation|3|||
30671071|NCT00571948|58684799|FG001|Overall Study|Protocol Violation|3|||
30671072|NCT00571948|58684798|FG000|Overall Study|infant refused study meal|3|||
30671073|NCT00571948|58684799|FG001|Overall Study|infant refused study meal|4|||
30671074|NCT00571948|58684798|FG000|Overall Study|Parent were afraid of blood colection|2|||
30671075|NCT00571948|58684799|FG001|Overall Study|Parent were afraid of blood colection|5|||
30671076|NCT00684424|58684805|FG000|Overall Study|Adverse Event|1|||
30671077|NCT00684424|58684805|FG000|Overall Study|Lost to Follow-up|2|||
30671078|NCT00684424|58684805|FG000|Overall Study|Other|2|||
30586888|NCT01229176|58598978|FG007|Overall Study|Lost to Follow-up|2|||
30586889|NCT01228747|58598998|FG000|Overall Study|Adverse Event|8|||
30586890|NCT01228747|58598999|FG001|Overall Study|Adverse Event|4|||
30586891|NCT01228747|58598998|FG000|Overall Study|Lack of Efficacy|40|||
30586892|NCT01228747|58598999|FG001|Overall Study|Lack of Efficacy|27|||
30586893|NCT01228747|58598998|FG000|Overall Study|Protocol Violation|6|||
30586894|NCT01228747|58598999|FG001|Overall Study|Protocol Violation|5|||
30586895|NCT01228747|58598998|FG000|Overall Study|Lost to Follow-up|4|||
30586896|NCT01228747|58598999|FG001|Overall Study|Lost to Follow-up|3|||
30586897|NCT01228747|58598998|FG000|Overall Study|Withdrawal by Subject|5|||
30671079|NCT00685750|58684817|FG000|Overall Study|Tumor sampling failure|0|||
30671080|NCT00685750|58684818|FG001|Overall Study|Tumor sampling failure|0|||
30671081|NCT00685750|58684819|FG002|Overall Study|Tumor sampling failure|1|||
30671082|NCT00685750|58684820|FG003|Overall Study|Tumor sampling failure|0|||
30671083|NCT00685750|58684821|FG004|Overall Study|Tumor sampling failure|0|||
30671084|NCT00685750|58684822|FG005|Overall Study|Tumor sampling failure|0|||
30671085|NCT00685750|58684823|FG006|Overall Study|Tumor sampling failure|0|||
30671086|NCT00685750|58684817|FG000|Overall Study|Patient didn't receive the treatment|0|||
30671087|NCT00685750|58684818|FG001|Overall Study|Patient didn't receive the treatment|0|||
30671088|NCT00685750|58684819|FG002|Overall Study|Patient didn't receive the treatment|0|||
30671089|NCT00685750|58684820|FG003|Overall Study|Patient didn't receive the treatment|0|||
30671090|NCT00685750|58684821|FG004|Overall Study|Patient didn't receive the treatment|0|||
30671091|NCT00685750|58684822|FG005|Overall Study|Patient didn't receive the treatment|0|||
30671092|NCT00685750|58684823|FG006|Overall Study|Patient didn't receive the treatment|1|||
30671093|NCT00685750|58684817|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30671094|NCT00685750|58684818|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30671095|NCT00685750|58684819|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
30671096|NCT00685750|58684820|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
30671097|NCT00685750|58684821|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
30671098|NCT00685750|58684822|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
30671099|NCT00685750|58684823|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
30671100|NCT00576628|58684843|FG000|Overall Study|Adverse Event|11|||
30671101|NCT00576628|58684843|FG000|Overall Study|Death|2|||
30671102|NCT00576628|58684843|FG000|Overall Study|Failure to return|1|||
30671103|NCT00576628|58684843|FG000|Overall Study|Refused Treatment|8|||
30671104|NCT00576628|58684843|FG000|Overall Study|Pregnancy|1|||
30671105|NCT00576628|58684843|FG000|Overall Study|RBC transfusion|1|||
30671106|NCT00576628|58684843|FG000|Overall Study|Progression of Kidney Disease|1|||
30671107|NCT00576628|58684843|FG000|Overall Study|Progression of Renal Failure|1|||
30671108|NCT00576628|58684843|FG000|Overall Study|The patient move into other town|1|||
30671109|NCT00576628|58684843|FG000|Overall Study|Transplantation|1|||
30671110|NCT00576628|58684843|FG000|Overall Study|Dialysis|15|||
30671111|NCT00683878|58684851|FG000|Overall Study|Lack of Efficacy|3|||
30586898|NCT01228747|58598999|FG001|Overall Study|Withdrawal by Subject|1|||
30586899|NCT01228747|58598998|FG000|Overall Study|Other Reason|2|||
30671112|NCT00683878|58684852|FG001|Overall Study|Lack of Efficacy|0|||
30671113|NCT00683878|58684853|FG002|Overall Study|Lack of Efficacy|1|||
30671114|NCT00683878|58684851|FG000|Overall Study|Adverse Event|4|||
30671115|NCT00683878|58684852|FG001|Overall Study|Adverse Event|3|||
30671116|NCT00683878|58684853|FG002|Overall Study|Adverse Event|3|||
30586900|NCT01228747|58598999|FG001|Overall Study|Other Reason|5|||
30586901|NCT01228591|58599005|FG000|Baseline|Lack of Efficacy|1|||
30586902|NCT01228591|58599006|FG001|Baseline|Lack of Efficacy|2|||
30586903|NCT01235338|58599018|FG000|Overall Study|Adverse Event|3|||
30781187|NCT02903914|58793268|FG004|Overall Study|Symptomatic Deterioration|0|||
30671117|NCT00683878|58684851|FG000|Overall Study|Withdrawal by Subject|9|||
30671118|NCT00683878|58684852|FG001|Overall Study|Withdrawal by Subject|8|||
30671119|NCT00683878|58684853|FG002|Overall Study|Withdrawal by Subject|6|||
30671120|NCT00683878|58684851|FG000|Overall Study|Death|0|||
30586904|NCT01235338|58599019|FG001|Overall Study|Adverse Event|2|||
30586905|NCT01235338|58599018|FG000|Overall Study|Protocol Violation|1|||
30586906|NCT01235338|58599019|FG001|Overall Study|Protocol Violation|1|||
30586907|NCT01235338|58599018|FG000|Overall Study|Withdrawal by Subject|5|||
30586908|NCT01235338|58599019|FG001|Overall Study|Withdrawal by Subject|0|||
30586909|NCT01235338|58599018|FG000|Overall Study|Exclusion criteria violations|1|||
30671121|NCT00683878|58684852|FG001|Overall Study|Death|1|||
30671122|NCT00683878|58684853|FG002|Overall Study|Death|0|||
30671123|NCT00683878|58684851|FG000|Overall Study|Lost to Follow-up|4|||
30671124|NCT00683878|58684852|FG001|Overall Study|Lost to Follow-up|2|||
30586910|NCT01235338|58599019|FG001|Overall Study|Exclusion criteria violations|1|||
30586911|NCT01235338|58599018|FG000|Overall Study|Positive drug screen|0|||
30586912|NCT01235338|58599019|FG001|Overall Study|Positive drug screen|1|||
30586913|NCT01235338|58599018|FG000|Overall Study|Prohibited meds|1|||
30586914|NCT01235338|58599019|FG001|Overall Study|Prohibited meds|0|||
30586915|NCT01234675|58599027|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
30586916|NCT01234675|58599028|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
30586917|NCT01234675|58599027|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
30586918|NCT01234675|58599028|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
30586919|NCT01228318|58599036|FG000|Overall Study|Clinic no show to receive intervention|1|||
30671125|NCT00683878|58684853|FG002|Overall Study|Lost to Follow-up|4|||
30671126|NCT00683878|58684851|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
30671127|NCT00683878|58684852|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
30671128|NCT00683878|58684853|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
30671129|NCT00884741|58684864|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
30671130|NCT00884741|58684865|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
30671131|NCT00884741|58684866|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
30671132|NCT00884741|58684867|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
30671133|NCT00884741|58684864|FG000|Step 1 Registration: Tissue Screening|Death|3|||
30671134|NCT00884741|58684865|FG001|Step 1 Registration: Tissue Screening|Death|0|||
30671135|NCT00884741|58684866|FG002|Step 1 Registration: Tissue Screening|Death|0|||
30671136|NCT00884741|58684867|FG003|Step 1 Registration: Tissue Screening|Death|0|||
30671137|NCT00884741|58684864|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
30671138|NCT00884741|58684865|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
30671139|NCT00884741|58684866|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
30671140|NCT00884741|58684867|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
30671141|NCT00884741|58684864|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
30671142|NCT00884741|58684865|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
30671143|NCT00884741|58684866|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
30671144|NCT00884741|58684867|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
30671145|NCT00884741|58684864|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
30671146|NCT00884741|58684865|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
30671147|NCT00884741|58684866|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
30671148|NCT00884741|58684867|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
30671149|NCT00884741|58684864|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
30671150|NCT00884741|58684865|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
30671151|NCT00884741|58684866|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
30671152|NCT00884741|58684867|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
30671153|NCT00884741|58684864|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
30671154|NCT00884741|58684865|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
30671155|NCT00884741|58684866|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
30671156|NCT00884741|58684867|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
30671157|NCT00884741|58684864|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
30671158|NCT00884741|58684865|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
30671159|NCT00884741|58684866|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
30671160|NCT00884741|58684867|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
30671161|NCT00884741|58684864|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
30671162|NCT00884741|58684865|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
30671163|NCT00884741|58684866|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
30671164|NCT00884741|58684867|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
30671165|NCT00884741|58684864|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
30671166|NCT00884741|58684865|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
30671167|NCT00884741|58684866|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
30586920|NCT01228318|58599037|FG001|Overall Study|Clinic no show to receive intervention|0|||
30586921|NCT01228318|58599036|FG000|Overall Study|Unable to contact|2|||
30586922|NCT01228318|58599037|FG001|Overall Study|Unable to contact|5|||
30586923|NCT01228318|58599036|FG000|Overall Study|Moved|0|||
30586924|NCT01228318|58599037|FG001|Overall Study|Moved|2|||
30671168|NCT00884741|58684867|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
30586925|NCT01228318|58599036|FG000|Overall Study|Incarcerated|1|||
30671169|NCT00884741|58684864|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
30671170|NCT00884741|58684865|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
30671171|NCT00884741|58684866|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
30671172|NCT00884741|58684867|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
30671173|NCT00884741|58684864|FG000|Randomization|Protocol Violation|0|||
30671174|NCT00884741|58684865|FG001|Randomization|Protocol Violation|0|||
30671175|NCT00884741|58684866|FG002|Randomization|Protocol Violation|8|||
30671176|NCT00884741|58684867|FG003|Randomization|Protocol Violation|8|||
30671177|NCT00598481|58684874|FG000|Treatment|Physician Decision|1|||
30671178|NCT00880763|58684885|FG000|Extension Period (Part 2)|Adverse Event|0|||
30671179|NCT00880763|58684886|FG001|Extension Period (Part 2)|Adverse Event|0|||
30671180|NCT00880763|58684887|FG002|Extension Period (Part 2)|Adverse Event|1|||
30671181|NCT00880763|58684888|FG003|Extension Period (Part 2)|Adverse Event|1|||
30671182|NCT00880763|58684885|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
30671183|NCT00880763|58684886|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
30671184|NCT00880763|58684887|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
30671185|NCT00880763|58684888|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
30671186|NCT00880763|58684885|FG000|Extension Period (Part 2)|Physician Decision|0|||
30671187|NCT00880763|58684886|FG001|Extension Period (Part 2)|Physician Decision|1|||
30671188|NCT00880763|58684887|FG002|Extension Period (Part 2)|Physician Decision|1|||
30671189|NCT00880763|58684888|FG003|Extension Period (Part 2)|Physician Decision|0|||
30671190|NCT00880763|58684885|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
30671191|NCT00880763|58684886|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
30671192|NCT00880763|58684887|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
30671193|NCT00880763|58684888|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
30671194|NCT00884273|58684900|FG000|Overall Study|Adverse Event|0|||
30671195|NCT00884273|58684901|FG001|Overall Study|Adverse Event|2|||
30671196|NCT00884273|58684900|FG000|Overall Study|Protocol Violation|1|||
30671197|NCT00884273|58684901|FG001|Overall Study|Protocol Violation|3|||
30671198|NCT00884273|58684900|FG000|Overall Study|Practical reasons|1|||
30671199|NCT00884273|58684901|FG001|Overall Study|Practical reasons|0|||
30671200|NCT00884117|58684907|FG000|Overall Study|Adverse Event|2|||
30671201|NCT00884117|58684907|FG000|Overall Study|Withdrawal by Subject|89|||
30671202|NCT00884117|58684907|FG000|Overall Study|Death|3|||
30671203|NCT00884117|58684907|FG000|Overall Study|Lost to Follow-up|143|||
30671204|NCT00884117|58684907|FG000|Overall Study|Other|12|||
30671205|NCT00884039|58684926|FG000|Overall Study|Withdrawal by Subject|0|||
30671206|NCT00884039|58684927|FG001|Overall Study|Withdrawal by Subject|1|||
30671207|NCT00884039|58684926|FG000|Overall Study|Lack of Efficacy|2|||
30671208|NCT00884039|58684927|FG001|Overall Study|Lack of Efficacy|0|||
30586926|NCT01228318|58599037|FG001|Overall Study|Incarcerated|0|||
30586927|NCT01227967|58599045|FG000|Overall Study|Protocol Violation|3|||
30586928|NCT01227967|58599046|FG001|Overall Study|Protocol Violation|1|||
30586929|NCT01227967|58599045|FG000|Overall Study|Death|0|||
30586930|NCT01227967|58599046|FG001|Overall Study|Death|1|||
30586931|NCT01227967|58599045|FG000|Overall Study|Lost to Follow-up|8|||
30586932|NCT01227967|58599046|FG001|Overall Study|Lost to Follow-up|3|||
30586933|NCT01227967|58599045|FG000|Overall Study|Withdrawal by Subject|4|||
30586934|NCT01227967|58599046|FG001|Overall Study|Withdrawal by Subject|3|||
30586935|NCT01227967|58599045|FG000|Overall Study|Physician Decision|0|||
30586936|NCT01227967|58599046|FG001|Overall Study|Physician Decision|1|||
30586937|NCT01227967|58599045|FG000|Overall Study|Never Started Treatment|0|||
30586938|NCT01227967|58599046|FG001|Overall Study|Never Started Treatment|4|||
30586939|NCT01227967|58599045|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
30586940|NCT01227967|58599046|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
30586941|NCT01227928|58599054|FG000|Overall Study|Lost to Follow-up|4|||
30586942|NCT01227928|58599055|FG001|Overall Study|Lost to Follow-up|2|||
30586943|NCT01227928|58599054|FG000|Overall Study|Withdrawal by Subject|4|||
30586944|NCT01227928|58599055|FG001|Overall Study|Withdrawal by Subject|3|||
30586945|NCT01227928|58599054|FG000|Overall Study|Death|14|||
30586946|NCT01227928|58599055|FG001|Overall Study|Death|12|||
30586947|NCT01227889|58599063|FG000|Randomized Phase (RP)|Adverse Event|13|||
30586948|NCT01227889|58599064|FG001|Randomized Phase (RP)|Adverse Event|0|||
30586949|NCT01227889|58599063|FG000|Randomized Phase (RP)|Physician Decision|13|||
30586950|NCT01227889|58599064|FG001|Randomized Phase (RP)|Physician Decision|5|||
30586951|NCT01227889|58599063|FG000|Randomized Phase (RP)|Progressive Disease|135|||
30586952|NCT01227889|58599064|FG001|Randomized Phase (RP)|Progressive Disease|52|||
30781188|NCT02903914|58793269|FG005|Overall Study|Symptomatic Deterioration|0|||
30781189|NCT02903914|58793270|FG006|Overall Study|Symptomatic Deterioration|0|||
30671209|NCT00835770|58684935|FG000|Overall Study|MS Relapse|17|||
30671210|NCT00835770|58684936|FG001|Overall Study|MS Relapse|23|||
30586953|NCT01227889|58599063|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
30586954|NCT01227889|58599064|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
30671211|NCT00835770|58684935|FG000|Overall Study|MS Progression|14|||
30781190|NCT02903914|58793271|FG007|Overall Study|Symptomatic Deterioration|0|||
30586955|NCT01227889|58599063|FG000|Randomized Phase (RP)|Missing|1|||
30586956|NCT01227889|58599064|FG001|Randomized Phase (RP)|Missing|3|||
30586957|NCT01227889|58599063|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
30586958|NCT01227889|58599064|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
30586959|NCT01227889|58599063|FG000|Crossover Phase|Adverse Event|0|||
30586960|NCT01227889|58599064|FG001|Crossover Phase|Adverse Event|1|||
30586961|NCT01227889|58599063|FG000|Crossover Phase|Physician Decision|0|||
30586962|NCT01227889|58599064|FG001|Crossover Phase|Physician Decision|3|||
30586963|NCT01227889|58599063|FG000|Crossover Phase|Progressive Disease|0|||
30586964|NCT01227889|58599064|FG001|Crossover Phase|Progressive Disease|31|||
30586965|NCT01227889|58599063|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
30586966|NCT01227889|58599064|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
30586967|NCT01227889|58599063|FG000|Crossover Phase|Withdrawal by Subject|0|||
30586968|NCT01227889|58599064|FG001|Crossover Phase|Withdrawal by Subject|1|||
30586969|NCT01227577|58599078|FG000|Overall Study|Protocol deviation|3|||
30586970|NCT01227577|58599078|FG000|Overall Study|Death|3|||
30586971|NCT01227577|58599078|FG000|Overall Study|Administrative problems|2|||
30586972|NCT01227577|58599078|FG000|Overall Study|Lost to Follow-up|1|||
30586973|NCT01227577|58599078|FG000|Overall Study|Withdrawal by Subject|4|||
30586974|NCT01227577|58599078|FG000|Overall Study|Lack of Efficacy|5|||
30586975|NCT01227577|58599078|FG000|Overall Study|Adverse Event|17|||
30586976|NCT01227421|58599098|FG000|Overall Study|Lost to Follow-up|6|||
30586977|NCT01227421|58599099|FG001|Overall Study|Lost to Follow-up|7|||
30586978|NCT01227421|58599100|FG002|Overall Study|Lost to Follow-up|5|||
30586979|NCT01227421|58599098|FG000|Overall Study|Adverse Event|2|||
30586980|NCT01227421|58599099|FG001|Overall Study|Adverse Event|7|||
30586981|NCT01227421|58599100|FG002|Overall Study|Adverse Event|2|||
30586982|NCT01227421|58599098|FG000|Overall Study|Withdrawal by Subject|1|||
30586983|NCT01227421|58599099|FG001|Overall Study|Withdrawal by Subject|2|||
30586984|NCT01227421|58599100|FG002|Overall Study|Withdrawal by Subject|1|||
30586985|NCT01227421|58599098|FG000|Overall Study|Protocol Violation|1|||
30586986|NCT01227421|58599099|FG001|Overall Study|Protocol Violation|1|||
30586987|NCT01227421|58599100|FG002|Overall Study|Protocol Violation|2|||
30586988|NCT01227421|58599098|FG000|Overall Study|Randomized in error|1|||
30586989|NCT01227421|58599099|FG001|Overall Study|Randomized in error|1|||
30586990|NCT01227421|58599100|FG002|Overall Study|Randomized in error|0|||
30586991|NCT01227265|58599111|FG000|Overall Study|Did Not Receive Treatment|1|||
30586992|NCT01227265|58599112|FG001|Overall Study|Did Not Receive Treatment|2|||
30671212|NCT00835770|58684936|FG001|Overall Study|MS Progression|9|||
30671213|NCT00835770|58684935|FG000|Overall Study|Adverse Event|113|||
30671214|NCT00835770|58684936|FG001|Overall Study|Adverse Event|124|||
30671215|NCT00835770|58684935|FG000|Overall Study|Lost to Follow-up|22|||
30671216|NCT00835770|58684936|FG001|Overall Study|Lost to Follow-up|19|||
30671217|NCT00835770|58684935|FG000|Overall Study|Consent Withdrawn|144|||
30671218|NCT00835770|58684936|FG001|Overall Study|Consent Withdrawn|156|||
30671219|NCT00835770|58684935|FG000|Overall Study|Investigator Decision|42|||
30671220|NCT00835770|58684936|FG001|Overall Study|Investigator Decision|42|||
30671221|NCT00835770|58684935|FG000|Overall Study|Participant Non-Compliance|11|||
30671222|NCT00835770|58684936|FG001|Overall Study|Participant Non-Compliance|9|||
30671223|NCT00835770|58684935|FG000|Overall Study|Death|4|||
30671224|NCT00835770|58684936|FG001|Overall Study|Death|6|||
30671225|NCT00835770|58684935|FG000|Overall Study|Other|115|||
30671226|NCT00835770|58684936|FG001|Overall Study|Other|104|||
30671227|NCT00835770|58684935|FG000|Overall Study|Other|2|||
30671228|NCT00835770|58684936|FG001|Overall Study|Other|1|||
30671229|NCT00880685|58684948|FG000|Memantine 10mg|Lost to Follow-up|2|||
30671230|NCT00880685|58684948|FG000|Memantine 20mg|Withdrawal by Subject|1|||
30671231|NCT00835380|58684955|FG000|Overall Study|Withdrawal by Subject|2|||
30671232|NCT00880607|58684961|FG000|Overall Study|Physician Decision|2|||
30671233|NCT00880607|58684962|FG001|Overall Study|Physician Decision|2|||
30671234|NCT00880607|58684961|FG000|Overall Study|Protocol Violation|2|||
30671235|NCT00880607|58684962|FG001|Overall Study|Protocol Violation|1|||
30671236|NCT00880607|58684961|FG000|Overall Study|surgery did not extend past L1 level|3|||
30671237|NCT00880607|58684962|FG001|Overall Study|surgery did not extend past L1 level|0|||
30671238|NCT00835068|58684972|FG000|Overall Study|Death|1|||
30671239|NCT00835068|58684973|FG001|Overall Study|Death|0|||
30671240|NCT00835068|58684972|FG000|Overall Study|Adverse Event|0|||
30671241|NCT00835068|58684973|FG001|Overall Study|Adverse Event|1|||
30671242|NCT00835068|58684972|FG000|Overall Study|Other|8|||
30671243|NCT00835068|58684973|FG001|Overall Study|Other|0|||
30671244|NCT00835068|58684972|FG000|Overall Study|Withdrawal by Subject|1|||
30586993|NCT01227265|58599113|FG002|Overall Study|Did Not Receive Treatment|0|||
30586994|NCT01227265|58599111|FG000|Overall Study|Administrative|1|||
30586995|NCT01227265|58599112|FG001|Overall Study|Administrative|0|||
30586996|NCT01227265|58599113|FG002|Overall Study|Administrative|2|||
30586997|NCT01227265|58599111|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
30586998|NCT01227265|58599112|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
30586999|NCT01227265|58599113|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
30671245|NCT00835068|58684973|FG001|Overall Study|Withdrawal by Subject|0|||
30671246|NCT00834912|58684985|FG000|Treatment Period 1|Adverse Event|0|||
30671247|NCT00834912|58684986|FG001|Treatment Period 1|Adverse Event|1|||
30671248|NCT00834912|58684987|FG002|Treatment Period 1|Adverse Event|0|||
30671249|NCT00834912|58684988|FG003|Treatment Period 1|Adverse Event|1|||
30587000|NCT01227265|58599111|FG000|Overall Study|Protocol Violation|2|||
30587001|NCT01227265|58599112|FG001|Overall Study|Protocol Violation|1|||
30587002|NCT01227265|58599113|FG002|Overall Study|Protocol Violation|0|||
30587003|NCT01227265|58599111|FG000|Overall Study|Withdrawal by Subject|7|||
30587004|NCT01227265|58599112|FG001|Overall Study|Withdrawal by Subject|7|||
30587005|NCT01227265|58599113|FG002|Overall Study|Withdrawal by Subject|3|||
30587006|NCT01227265|58599111|FG000|Overall Study|Lost to Follow-up|2|||
30587007|NCT01227265|58599112|FG001|Overall Study|Lost to Follow-up|0|||
30587008|NCT01227265|58599113|FG002|Overall Study|Lost to Follow-up|3|||
30587009|NCT01227265|58599111|FG000|Overall Study|Adverse Event|6|||
30587010|NCT01227265|58599112|FG001|Overall Study|Adverse Event|10|||
30587011|NCT01227265|58599113|FG002|Overall Study|Adverse Event|5|||
30587012|NCT01226095|58599121|FG000|Overall Study|Poor compliance|1|||
30587013|NCT01225822|58599137|FG000|Overall Study|Adverse Event|13|||
30671250|NCT00834912|58684989|FG004|Treatment Period 1|Adverse Event|0|||
30671251|NCT00834912|58684990|FG005|Treatment Period 1|Adverse Event|0|||
30587014|NCT01225822|58599138|FG001|Overall Study|Adverse Event|31|||
30671252|NCT00834912|58684985|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30671253|NCT00834912|58684986|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30671254|NCT00834912|58684987|FG002|Treatment Period 2|Withdrawal by Subject|1|||
30671255|NCT00834912|58684988|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30671256|NCT00834912|58684989|FG004|Treatment Period 2|Withdrawal by Subject|1|||
30671257|NCT00834912|58684990|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30671258|NCT00883493|58685000|FG000|Overall Study|Adverse Event|11|||
30587015|NCT01225822|58599139|FG002|Overall Study|Adverse Event|18|||
30587016|NCT01225822|58599140|FG003|Overall Study|Adverse Event|23|||
30671259|NCT00883493|58685001|FG001|Overall Study|Adverse Event|12|||
30671260|NCT00883493|58685000|FG000|Overall Study|Lack of Efficacy|4|||
30671261|NCT00883493|58685001|FG001|Overall Study|Lack of Efficacy|3|||
30671262|NCT00883493|58685000|FG000|Overall Study|Lost to Follow-up|7|||
30671263|NCT00883493|58685001|FG001|Overall Study|Lost to Follow-up|6|||
30671264|NCT00883493|58685000|FG000|Overall Study|Withdrawal by Subject|11|||
30671265|NCT00883493|58685001|FG001|Overall Study|Withdrawal by Subject|20|||
30671266|NCT00883493|58685000|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
30671267|NCT00883493|58685001|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
30671268|NCT00883493|58685000|FG000|Overall Study|Study specific disc. criteria|2|||
30671269|NCT00883493|58685001|FG001|Overall Study|Study specific disc. criteria|0|||
30671270|NCT00883493|58685000|FG000|Overall Study|Other|5|||
30671271|NCT00883493|58685001|FG001|Overall Study|Other|3|||
30671272|NCT04887922|58685016|FG000|1st Randomization|Decided not to have surgery|0|||
30671273|NCT04887922|58685017|FG001|1st Randomization|Decided not to have surgery|1|||
30671274|NCT04887922|58685018|FG002|1st Randomization|Decided not to have surgery|0|||
30671275|NCT04887922|58685019|FG003|1st Randomization|Decided not to have surgery|0|||
30671276|NCT04887922|58685020|FG004|1st Randomization|Decided not to have surgery|0|||
30671277|NCT04771403|58685043|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
30671278|NCT04771403|58685044|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
30671279|NCT04771403|58685043|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
30671280|NCT04771403|58685044|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
30671281|NCT04771403|58685043|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
30671282|NCT04771403|58685044|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
30587017|NCT01225822|58599141|FG004|Overall Study|Adverse Event|14|||
30587018|NCT01225822|58599137|FG000|Overall Study|Protocol Violation|6|||
30587019|NCT01225822|58599138|FG001|Overall Study|Protocol Violation|8|||
30587020|NCT01225822|58599139|FG002|Overall Study|Protocol Violation|6|||
30587021|NCT01225822|58599140|FG003|Overall Study|Protocol Violation|7|||
30587022|NCT01225822|58599141|FG004|Overall Study|Protocol Violation|4|||
30587023|NCT01225822|58599137|FG000|Overall Study|Lost to Follow-up|0|||
30587024|NCT01225822|58599138|FG001|Overall Study|Lost to Follow-up|0|||
30587025|NCT01225822|58599139|FG002|Overall Study|Lost to Follow-up|0|||
30587026|NCT01225822|58599140|FG003|Overall Study|Lost to Follow-up|1|||
30587027|NCT01225822|58599141|FG004|Overall Study|Lost to Follow-up|0|||
30587028|NCT01225822|58599137|FG000|Overall Study|Withdrawal by Subject|6|||
30671283|NCT04771403|58685043|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
30671284|NCT04771403|58685044|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
30671285|NCT04771403|58685043|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
30781191|NCT02903914|58793264|FG000|Overall Study|New Cancer Therapy|2|||
30587029|NCT01225822|58599138|FG001|Overall Study|Withdrawal by Subject|7|||
30587030|NCT01225822|58599139|FG002|Overall Study|Withdrawal by Subject|7|||
30587031|NCT01225822|58599140|FG003|Overall Study|Withdrawal by Subject|11|||
30587032|NCT01225822|58599141|FG004|Overall Study|Withdrawal by Subject|6|||
30671286|NCT04771403|58685044|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
30671287|NCT04771403|58685043|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
30587033|NCT01225822|58599137|FG000|Overall Study|Other|13|||
30671288|NCT04771403|58685044|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
30671289|NCT04771403|58685043|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
30587034|NCT01225822|58599138|FG001|Overall Study|Other|10|||
30587035|NCT01225822|58599139|FG002|Overall Study|Other|7|||
30587036|NCT01225822|58599140|FG003|Overall Study|Other|10|||
30671290|NCT04771403|58685044|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
30671291|NCT04771403|58685043|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
30671292|NCT04771403|58685044|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
30671293|NCT04698525|58685053|FG000|Overall Study|Lost to Follow-up|1|||
30671294|NCT04698525|58685054|FG001|Overall Study|Lost to Follow-up|2|||
30671295|NCT04698525|58685053|FG000|Overall Study|Three suffered of Covid-19|2|||
30671296|NCT04698525|58685054|FG001|Overall Study|Three suffered of Covid-19|1|||
30671297|NCT04510675|58685068|FG000|Overall Study|Withdrawal by Subject|5|||
30671298|NCT04228783|58685090|FG000|Overall Study|Adverse Event|1|||
30587037|NCT01225822|58599141|FG004|Overall Study|Other|7|||
30587038|NCT01225549|58599156|FG000|Period 4 - Washout|Disallowed medication|0|||
30587039|NCT01225549|58599157|FG001|Period 4 - Washout|Disallowed medication|1|||
30587040|NCT01225549|58599158|FG002|Period 4 - Washout|Disallowed medication|0|||
30587041|NCT01225549|58599159|FG003|Period 4 - Washout|Disallowed medication|0|||
30587042|NCT01225549|58599160|FG004|Period 4 - Washout|Disallowed medication|0|||
30587043|NCT01225549|58599161|FG005|Period 4 - Washout|Disallowed medication|0|||
30587044|NCT01225549|58599162|FG006|Period 4 - Washout|Disallowed medication|0|||
30587045|NCT01225549|58599163|FG007|Period 4 - Washout|Disallowed medication|0|||
30587046|NCT01225549|58599164|FG008|Period 4 - Washout|Disallowed medication|0|||
30671299|NCT04228783|58685091|FG001|Overall Study|Adverse Event|0|||
30671300|NCT04228783|58685092|FG002|Overall Study|Adverse Event|2|||
30671301|NCT04228783|58685093|FG003|Overall Study|Adverse Event|0|||
30671302|NCT04228783|58685094|FG004|Overall Study|Adverse Event|0|||
30671303|NCT04228783|58685095|FG005|Overall Study|Adverse Event|1|||
30671304|NCT04228783|58685090|FG000|Overall Study|Death|0|||
30671305|NCT04228783|58685091|FG001|Overall Study|Death|0|||
30671306|NCT04228783|58685092|FG002|Overall Study|Death|0|||
30671307|NCT04228783|58685093|FG003|Overall Study|Death|0|||
30671308|NCT04228783|58685094|FG004|Overall Study|Death|1|||
30671309|NCT04228783|58685095|FG005|Overall Study|Death|0|||
30671310|NCT04228783|58685090|FG000|Overall Study|Lost to Follow-up|36|||
30671311|NCT04228783|58685091|FG001|Overall Study|Lost to Follow-up|36|||
30671312|NCT04228783|58685092|FG002|Overall Study|Lost to Follow-up|28|||
30671313|NCT04228783|58685093|FG003|Overall Study|Lost to Follow-up|6|||
30587047|NCT01225549|58599165|FG009|Period 4 - Washout|Disallowed medication|0|||
30587048|NCT01225549|58599156|FG000|Period 6 - Washout|Disallowed medication|0|||
30587049|NCT01225549|58599157|FG001|Period 6 - Washout|Disallowed medication|0|||
30587050|NCT01225549|58599158|FG002|Period 6 - Washout|Disallowed medication|0|||
30587051|NCT01225549|58599159|FG003|Period 6 - Washout|Disallowed medication|1|||
30587052|NCT01225549|58599160|FG004|Period 6 - Washout|Disallowed medication|0|||
30587053|NCT01225549|58599161|FG005|Period 6 - Washout|Disallowed medication|0|||
30587054|NCT01225549|58599162|FG006|Period 6 - Washout|Disallowed medication|0|||
30587055|NCT01225549|58599163|FG007|Period 6 - Washout|Disallowed medication|0|||
30587056|NCT01225549|58599164|FG008|Period 6 - Washout|Disallowed medication|0|||
30587057|NCT01225549|58599165|FG009|Period 6 - Washout|Disallowed medication|0|||
30587058|NCT01225159|58599177|FG000|Overall Study|Change operation|1|||
30587059|NCT01225159|58599178|FG001|Overall Study|Change operation|0|||
30587060|NCT01224925|58599186|FG000|Overall Study|Lost to Follow-up|3|||
30587061|NCT01224925|58599187|FG001|Overall Study|Lost to Follow-up|2|||
30587062|NCT01223404|58599195|FG000|First Intervention (1 Day)|Adverse Event|0|||
30587063|NCT01223404|58599196|FG001|First Intervention (1 Day)|Adverse Event|0|||
30587064|NCT01223404|58599197|FG002|First Intervention (1 Day)|Adverse Event|0|||
30587065|NCT01223404|58599198|FG003|First Intervention (1 Day)|Adverse Event|1|||
30587066|NCT01223404|58599199|FG004|First Intervention (1 Day)|Adverse Event|0|||
30587067|NCT01223404|58599200|FG005|First Intervention (1 Day)|Adverse Event|0|||
30587068|NCT01223404|58599195|FG000|Second Intervention (1 Day)|Adverse Event|1|||
30587069|NCT01223404|58599196|FG001|Second Intervention (1 Day)|Adverse Event|0|||
30587070|NCT01223404|58599197|FG002|Second Intervention (1 Day)|Adverse Event|0|||
30587071|NCT01223404|58599198|FG003|Second Intervention (1 Day)|Adverse Event|0|||
30587072|NCT01223404|58599199|FG004|Second Intervention (1 Day)|Adverse Event|0|||
30587073|NCT01223404|58599200|FG005|Second Intervention (1 Day)|Adverse Event|0|||
30587074|NCT01223404|58599195|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
30587075|NCT01223404|58599196|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
30587076|NCT01223404|58599197|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
30587077|NCT01223404|58599198|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
30587078|NCT01223404|58599199|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
30587079|NCT01223404|58599200|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
30587080|NCT01223365|58599248|FG000|Open-label Titration Period|Enrolled but not treated|1|||
30587081|NCT01223365|58599248|FG000|Open-label Titration Period|Adverse Event|23|||
30587082|NCT01223365|58599248|FG000|Open-label Titration Period|Lack of Efficacy|3|||
30587083|NCT01223365|58599248|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
30587084|NCT01223365|58599248|FG000|Open-label Titration Period|Protocol Violation|1|||
30587085|NCT01223365|58599248|FG000|Open-label Titration Period|Lost to Follow-up|2|||
30587086|NCT01223365|58599248|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
30587087|NCT01223365|58599248|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
30587088|NCT01223365|58599248|FG000|Open-label Titration Period|Starting physical therapy|1|||
30587089|NCT01223365|58599248|FG000|Open-label Treatment Period|Adverse Event|39|||
30587090|NCT01223365|58599248|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
30587091|NCT01223365|58599248|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
30587092|NCT01223365|58599248|FG000|Open-label Treatment Period|Protocol Violation|15|||
30587093|NCT01223365|58599248|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
30587094|NCT01223365|58599248|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
30587095|NCT01223365|58599248|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
30587096|NCT01223365|58599248|FG000|Open-label Treatment Period|Moved out of area|2|||
30587097|NCT01223365|58599248|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
30587098|NCT01223365|58599248|FG000|Open-label Treatment Period|"Out of window"|1|||
30587099|NCT01223365|58599248|FG000|Open-label Treatment Period|Starting physical therapy|1|||
30587100|NCT01223365|58599248|FG000|Open-label Treatment Period|Physician Decision|2|||
30587101|NCT01222507|58599257|FG000|Overall Study|Physician Decision|1|||
30587102|NCT01222507|58599257|FG000|Overall Study|Withdrawal by Subject|1|||
30587103|NCT01222078|58599261|FG000|Overall Study|Early termination of the study|1|||
30587104|NCT01221727|58599268|FG000|Overall Study|Physician Decision|2|||
30587105|NCT01221727|58599269|FG001|Overall Study|Physician Decision|0|||
30587106|NCT01221727|58599268|FG000|Overall Study|Withdrawal by Subject|1|||
30587107|NCT01221727|58599269|FG001|Overall Study|Withdrawal by Subject|1|||
30587108|NCT01221181|58599281|FG000|Overall Study|Lost to Follow-up|1|||
30587109|NCT01220557|58599287|FG000|Overall Study|Lost to Follow-up|5|||
30587110|NCT01220557|58599288|FG001|Overall Study|Lost to Follow-up|3|||
30587111|NCT01220557|58599287|FG000|Overall Study|attended less than 6 lessons|1|||
30587112|NCT01220557|58599288|FG001|Overall Study|attended less than 6 lessons|2|||
30587113|NCT01220401|58599294|FG000|Overall Study|Withdrawal by Subject|2|||
30587114|NCT01220401|58599294|FG000|Overall Study|Protocol Violation|1|||
30587115|NCT01220167|58599301|FG000|Period 3|Urine positive for substance abuse|0|||
30587116|NCT01220167|58599302|FG001|Period 3|Urine positive for substance abuse|1|||
30587117|NCT01220167|58599303|FG002|Period 3|Urine positive for substance abuse|0|||
30587118|NCT01220128|58599316|FG000|Overall Study|Progressive disease|0|||
30587119|NCT01220128|58599317|FG001|Overall Study|Progressive disease|0|||
30587120|NCT01220128|58599318|FG002|Overall Study|Progressive disease|2|||
30587121|NCT01220128|58599319|FG003|Overall Study|Progressive disease|0|||
30587122|NCT01220128|58599320|FG004|Overall Study|Progressive disease|0|||
30587123|NCT01220128|58599321|FG005|Overall Study|Progressive disease|0|||
30587124|NCT01220128|58599322|FG006|Overall Study|Progressive disease|0|||
30587125|NCT01220128|58599316|FG000|Overall Study|Sponsor study termination|0|||
30587126|NCT01220128|58599317|FG001|Overall Study|Sponsor study termination|1|||
30587127|NCT01220128|58599318|FG002|Overall Study|Sponsor study termination|0|||
30587128|NCT01220128|58599319|FG003|Overall Study|Sponsor study termination|0|||
30587129|NCT01220128|58599320|FG004|Overall Study|Sponsor study termination|0|||
30587130|NCT01220128|58599321|FG005|Overall Study|Sponsor study termination|0|||
30587131|NCT01220128|58599322|FG006|Overall Study|Sponsor study termination|1|||
30587132|NCT01220128|58599316|FG000|Overall Study|Adverse event, serious fatal|2|||
30587133|NCT01220128|58599317|FG001|Overall Study|Adverse event, serious fatal|0|||
30587134|NCT01220128|58599318|FG002|Overall Study|Adverse event, serious fatal|0|||
30587135|NCT01220128|58599319|FG003|Overall Study|Adverse event, serious fatal|0|||
30587136|NCT01220128|58599320|FG004|Overall Study|Adverse event, serious fatal|0|||
30587137|NCT01220128|58599321|FG005|Overall Study|Adverse event, serious fatal|0|||
30587138|NCT01220128|58599322|FG006|Overall Study|Adverse event, serious fatal|1|||
30587139|NCT01220128|58599316|FG000|Overall Study|Adverse event, non-fatal|1|||
30587140|NCT01220128|58599317|FG001|Overall Study|Adverse event, non-fatal|0|||
30587141|NCT01220128|58599318|FG002|Overall Study|Adverse event, non-fatal|0|||
30587142|NCT01220128|58599319|FG003|Overall Study|Adverse event, non-fatal|0|||
30587143|NCT01220128|58599320|FG004|Overall Study|Adverse event, non-fatal|0|||
30587144|NCT01220128|58599321|FG005|Overall Study|Adverse event, non-fatal|0|||
30587145|NCT01220128|58599322|FG006|Overall Study|Adverse event, non-fatal|3|||
30587146|NCT01220128|58599316|FG000|Overall Study|Other|0|||
30587147|NCT01220128|58599317|FG001|Overall Study|Other|0|||
30587148|NCT01220128|58599318|FG002|Overall Study|Other|1|||
30587149|NCT01220128|58599319|FG003|Overall Study|Other|0|||
30587150|NCT01220128|58599320|FG004|Overall Study|Other|0|||
30587151|NCT01220128|58599321|FG005|Overall Study|Other|0|||
30587152|NCT01220128|58599322|FG006|Overall Study|Other|0|||
30587153|NCT01220128|58599316|FG000|Overall Study|Consent withdrawn by subject|1|||
30587154|NCT01220128|58599317|FG001|Overall Study|Consent withdrawn by subject|0|||
30587155|NCT01220128|58599318|FG002|Overall Study|Consent withdrawn by subject|0|||
30587156|NCT01220128|58599319|FG003|Overall Study|Consent withdrawn by subject|0|||
30587157|NCT01220128|58599320|FG004|Overall Study|Consent withdrawn by subject|0|||
30587158|NCT01220128|58599321|FG005|Overall Study|Consent withdrawn by subject|0|||
30587159|NCT01220128|58599322|FG006|Overall Study|Consent withdrawn by subject|0|||
30587160|NCT01219933|58599339|FG000|Overall Study|Adverse Event|8|||
30587161|NCT01219933|58599339|FG000|Overall Study|No LDA reached|5|||
30587162|NCT01219933|58599339|FG000|Overall Study|No LDA maintained|7|||
30587163|NCT01219933|58599339|FG000|Overall Study|Lost to Follow-up|3|||
30587164|NCT01219933|58599339|FG000|Overall Study|GC free|1|||
30587165|NCT01219933|58599339|FG000|Overall Study|Withdrawal by Subject|5|||
30671314|NCT04228783|58685094|FG004|Overall Study|Lost to Follow-up|14|||
30671315|NCT04228783|58685095|FG005|Overall Study|Lost to Follow-up|3|||
30671316|NCT04228783|58685090|FG000|Overall Study|Physician Decision|1|||
30671317|NCT04228783|58685091|FG001|Overall Study|Physician Decision|2|||
30671318|NCT04228783|58685092|FG002|Overall Study|Physician Decision|0|||
30671319|NCT04228783|58685093|FG003|Overall Study|Physician Decision|0|||
30671320|NCT04228783|58685094|FG004|Overall Study|Physician Decision|0|||
30671321|NCT04228783|58685095|FG005|Overall Study|Physician Decision|0|||
30671322|NCT04228783|58685090|FG000|Overall Study|Protocol Violation|0|||
30671323|NCT04228783|58685091|FG001|Overall Study|Protocol Violation|0|||
30671324|NCT04228783|58685092|FG002|Overall Study|Protocol Violation|0|||
30671325|NCT04228783|58685093|FG003|Overall Study|Protocol Violation|1|||
30671326|NCT04228783|58685094|FG004|Overall Study|Protocol Violation|0|||
30671327|NCT04228783|58685095|FG005|Overall Study|Protocol Violation|0|||
30671328|NCT04228783|58685090|FG000|Overall Study|Withdrawal by Subject|6|||
30671329|NCT04228783|58685091|FG001|Overall Study|Withdrawal by Subject|10|||
30671330|NCT04228783|58685092|FG002|Overall Study|Withdrawal by Subject|19|||
30671331|NCT04228783|58685093|FG003|Overall Study|Withdrawal by Subject|1|||
30671332|NCT04228783|58685094|FG004|Overall Study|Withdrawal by Subject|2|||
30671333|NCT04228783|58685095|FG005|Overall Study|Withdrawal by Subject|0|||
30671334|NCT04228783|58685090|FG000|Overall Study|Other|4|||
30671335|NCT04228783|58685091|FG001|Overall Study|Other|3|||
30671336|NCT04228783|58685092|FG002|Overall Study|Other|2|||
30671337|NCT04228783|58685093|FG003|Overall Study|Other|1|||
30671338|NCT04228783|58685094|FG004|Overall Study|Other|0|||
30671339|NCT04228783|58685095|FG005|Overall Study|Other|0|||
30671340|NCT03950674|58685111|FG000|Overall Study|Death|3|||
30671341|NCT03950674|58685112|FG001|Overall Study|Death|7|||
30671342|NCT03950674|58685111|FG000|Overall Study|Ongoing in Study|22|||
30671343|NCT03950674|58685112|FG001|Overall Study|Ongoing in Study|8|||
30671344|NCT03702621|58685121|FG000|Overall Study|Physician Decision|6|||
30671345|NCT03702621|58685122|FG001|Overall Study|Physician Decision|6|||
30671346|NCT03577990|58685130|FG000|Overall Study|Lost to Follow-up|4|||
30587166|NCT01219933|58599339|FG000|Overall Study|Protocol Violation|8|||
30587167|NCT01219933|58599339|FG000|Overall Study|Lack of Efficacy|1|||
30587168|NCT01218802|58599346|FG000|Overall Study|Lost to Follow-up|5|||
30587169|NCT01218802|58599347|FG001|Overall Study|Lost to Follow-up|6|||
30587170|NCT01218802|58599346|FG000|Overall Study|Withdrawal by Subject|3|||
30587171|NCT01218802|58599347|FG001|Overall Study|Withdrawal by Subject|10|||
30587172|NCT01218802|58599346|FG000|Overall Study|Adverse Event|0|||
30587173|NCT01218802|58599347|FG001|Overall Study|Adverse Event|2|||
30587174|NCT01218802|58599346|FG000|Overall Study|Incarcerated|2|||
30587175|NCT01218802|58599347|FG001|Overall Study|Incarcerated|0|||
30587176|NCT01218646|58599357|FG000|Overall Study|Adverse Event|0|||
30587177|NCT01218646|58599358|FG001|Overall Study|Adverse Event|0|||
30587178|NCT01218646|58599359|FG002|Overall Study|Adverse Event|1|||
30587179|NCT01218646|58599360|FG003|Overall Study|Adverse Event|0|||
30587180|NCT01218646|58599357|FG000|Overall Study|Lost to Follow-up|1|||
30671347|NCT03577990|58685131|FG001|Overall Study|Lost to Follow-up|6|||
30671348|NCT03577990|58685130|FG000|Overall Study|Withdrawal by Subject|4|||
30587181|NCT01218646|58599358|FG001|Overall Study|Lost to Follow-up|0|||
30587182|NCT01218646|58599359|FG002|Overall Study|Lost to Follow-up|0|||
30587183|NCT01218646|58599360|FG003|Overall Study|Lost to Follow-up|0|||
30587184|NCT01218646|58599357|FG000|Overall Study|Protocol Violation|0|||
30587185|NCT01218646|58599358|FG001|Overall Study|Protocol Violation|0|||
30587186|NCT01218646|58599359|FG002|Overall Study|Protocol Violation|1|||
30671349|NCT03577990|58685131|FG001|Overall Study|Withdrawal by Subject|7|||
30587187|NCT01218646|58599360|FG003|Overall Study|Protocol Violation|1|||
30587188|NCT01188772|58599374|FG000|Overall Study|Randomized but Not Treated|0|||
30671350|NCT03565497|58685141|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
30671351|NCT03565497|58685142|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
30671352|NCT03565497|58685143|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
30587189|NCT01188772|58599375|FG001|Overall Study|Randomized but Not Treated|1|||
30587190|NCT01188772|58599376|FG002|Overall Study|Randomized but Not Treated|0|||
30587191|NCT01188772|58599377|FG003|Overall Study|Randomized but Not Treated|0|||
30587192|NCT01188772|58599374|FG000|Overall Study|Adverse Event|0|||
30587193|NCT01188772|58599375|FG001|Overall Study|Adverse Event|1|||
30587194|NCT01188772|58599376|FG002|Overall Study|Adverse Event|2|||
30587195|NCT01188772|58599377|FG003|Overall Study|Adverse Event|0|||
30587196|NCT01188772|58599374|FG000|Overall Study|Lost to Follow-up|4|||
30587197|NCT01188772|58599375|FG001|Overall Study|Lost to Follow-up|1|||
30587198|NCT01188772|58599376|FG002|Overall Study|Lost to Follow-up|1|||
30587199|NCT01188772|58599377|FG003|Overall Study|Lost to Follow-up|1|||
30587200|NCT01188772|58599374|FG000|Overall Study|Non-responder|0|||
30587201|NCT01188772|58599375|FG001|Overall Study|Non-responder|0|||
30671353|NCT03565497|58685141|FG000|Overall Study|Lost to Follow-up|1|||
30671354|NCT03565497|58685142|FG001|Overall Study|Lost to Follow-up|1|||
30671355|NCT03565497|58685143|FG002|Overall Study|Lost to Follow-up|2|||
30671356|NCT03565497|58685141|FG000|Overall Study|Withdrawal by Subject|1|||
30671357|NCT03565497|58685142|FG001|Overall Study|Withdrawal by Subject|1|||
30671358|NCT03565497|58685143|FG002|Overall Study|Withdrawal by Subject|1|||
30671359|NCT03362931|58685151|FG000|Overall Study|Adverse Event|1|||
30587202|NCT01188772|58599376|FG002|Overall Study|Non-responder|3|||
30587203|NCT01188772|58599377|FG003|Overall Study|Non-responder|0|||
30587204|NCT01188772|58599374|FG000|Overall Study|Physician Decision|0|||
30587205|NCT01188772|58599375|FG001|Overall Study|Physician Decision|0|||
30587206|NCT01188772|58599376|FG002|Overall Study|Physician Decision|1|||
30587207|NCT01188772|58599377|FG003|Overall Study|Physician Decision|0|||
30587208|NCT01188772|58599374|FG000|Overall Study|Terminated by Sponsor|0|||
30587209|NCT01188772|58599375|FG001|Overall Study|Terminated by Sponsor|0|||
30587210|NCT01188772|58599376|FG002|Overall Study|Terminated by Sponsor|1|||
30587211|NCT01188772|58599377|FG003|Overall Study|Terminated by Sponsor|0|||
30587212|NCT01188772|58599374|FG000|Overall Study|Treatment Failure|0|||
30587213|NCT01188772|58599375|FG001|Overall Study|Treatment Failure|0|||
30587214|NCT01188772|58599376|FG002|Overall Study|Treatment Failure|1|||
30587215|NCT01188772|58599377|FG003|Overall Study|Treatment Failure|0|||
30587216|NCT01188772|58599374|FG000|Overall Study|Virologic Failure|1|||
30587217|NCT01188772|58599375|FG001|Overall Study|Virologic Failure|0|||
30587218|NCT01188772|58599376|FG002|Overall Study|Virologic Failure|0|||
30587219|NCT01188772|58599377|FG003|Overall Study|Virologic Failure|0|||
30587220|NCT01188772|58599374|FG000|Overall Study|Withdrawal by Subject|0|||
30587221|NCT01188772|58599375|FG001|Overall Study|Withdrawal by Subject|0|||
30587222|NCT01188772|58599376|FG002|Overall Study|Withdrawal by Subject|2|||
30587223|NCT01188772|58599377|FG003|Overall Study|Withdrawal by Subject|0|||
30587224|NCT01188655|58599390|FG000|Overall Study|Lack of Efficacy|1|||
30587225|NCT01188655|58599390|FG000|Overall Study|Lost to Follow-up|1|||
30587226|NCT01188655|58599390|FG000|Overall Study|Other|11|||
30587227|NCT01188538|58599396|FG000|Overall Study|Lost to Follow-up|0|||
30587228|NCT01188538|58599397|FG001|Overall Study|Lost to Follow-up|1|||
30587229|NCT01188343|58599408|FG000|Overall Study|Not vaccinated|0|||
30587230|NCT01188343|58599409|FG001|Overall Study|Not vaccinated|2|||
30587231|NCT01188343|58599410|FG002|Overall Study|Not vaccinated|1|||
30587232|NCT01188343|58599408|FG000|Overall Study|Withdrawal by Subject|1|||
30587233|NCT01188343|58599409|FG001|Overall Study|Withdrawal by Subject|24|||
30587234|NCT01188343|58599410|FG002|Overall Study|Withdrawal by Subject|0|||
30587235|NCT01188226|58599421|FG000|Overall Study|Withdrawal by Subject|4|||
30587236|NCT01218100|58599439|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
30587237|NCT01218100|58599440|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
30587238|NCT01218100|58599441|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
30587239|NCT01218100|58599442|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
30587240|NCT01218100|58599439|FG000|Overall Study|Adverse Event|4|||
30587241|NCT01218100|58599440|FG001|Overall Study|Adverse Event|6|||
30587242|NCT01218100|58599441|FG002|Overall Study|Adverse Event|6|||
30587243|NCT01218100|58599442|FG003|Overall Study|Adverse Event|7|||
30587244|NCT01218100|58599439|FG000|Overall Study|Lack of Efficacy|9|||
30587245|NCT01218100|58599440|FG001|Overall Study|Lack of Efficacy|6|||
30587246|NCT01218100|58599441|FG002|Overall Study|Lack of Efficacy|5|||
30587247|NCT01218100|58599442|FG003|Overall Study|Lack of Efficacy|12|||
30587248|NCT01218100|58599439|FG000|Overall Study|Protocol Violation|0|||
30587249|NCT01218100|58599440|FG001|Overall Study|Protocol Violation|0|||
30587250|NCT01218100|58599441|FG002|Overall Study|Protocol Violation|1|||
30587251|NCT01218100|58599442|FG003|Overall Study|Protocol Violation|1|||
30587252|NCT01218100|58599439|FG000|Overall Study|Withdrawal by Subject|5|||
30587253|NCT01218100|58599440|FG001|Overall Study|Withdrawal by Subject|2|||
30587254|NCT01218100|58599441|FG002|Overall Study|Withdrawal by Subject|6|||
30587255|NCT01218100|58599442|FG003|Overall Study|Withdrawal by Subject|7|||
30587256|NCT01218100|58599439|FG000|Overall Study|Lost to Follow-up|3|||
30671360|NCT03362931|58685151|FG000|Overall Study|Death|2|||
30587257|NCT01218100|58599440|FG001|Overall Study|Lost to Follow-up|8|||
30587258|NCT01218100|58599441|FG002|Overall Study|Lost to Follow-up|2|||
30587259|NCT01218100|58599442|FG003|Overall Study|Lost to Follow-up|1|||
30587260|NCT01218100|58599439|FG000|Overall Study|Other Reason|2|||
30587261|NCT01218100|58599440|FG001|Overall Study|Other Reason|2|||
30587262|NCT01218100|58599441|FG002|Overall Study|Other Reason|6|||
30587263|NCT01218100|58599442|FG003|Overall Study|Other Reason|4|||
30587264|NCT01187953|58599488|FG000|Overall Study|Death|11|||
30587265|NCT01187953|58599489|FG001|Overall Study|Death|13|||
30587266|NCT01187953|58599488|FG000|Overall Study|Adverse Event|1|||
30587267|NCT01187953|58599489|FG001|Overall Study|Adverse Event|2|||
30587268|NCT01187953|58599488|FG000|Overall Study|Lost to Follow-up|0|||
30587269|NCT01187953|58599489|FG001|Overall Study|Lost to Follow-up|3|||
30587270|NCT01187953|58599488|FG000|Overall Study|Withdrawal by Subject|3|||
30587271|NCT01187953|58599489|FG001|Overall Study|Withdrawal by Subject|3|||
30587272|NCT01217944|58599505|FG000|Overall Study|Protocol Violation|1|||
30587273|NCT01217944|58599506|FG001|Overall Study|Protocol Violation|1|||
30587274|NCT01217944|58599507|FG002|Overall Study|Protocol Violation|0|||
30587275|NCT01217944|58599505|FG000|Overall Study|Lost to Follow-up|3|||
30587276|NCT01217944|58599506|FG001|Overall Study|Lost to Follow-up|1|||
30587277|NCT01217944|58599507|FG002|Overall Study|Lost to Follow-up|0|||
30587278|NCT01217944|58599505|FG000|Overall Study|Withdrawal by Subject|1|||
30587279|NCT01217944|58599506|FG001|Overall Study|Withdrawal by Subject|2|||
30587280|NCT01217944|58599507|FG002|Overall Study|Withdrawal by Subject|0|||
30587281|NCT01217944|58599505|FG000|Overall Study|Lack of Efficacy|1|||
30587282|NCT01217944|58599506|FG001|Overall Study|Lack of Efficacy|0|||
30587283|NCT01217944|58599507|FG002|Overall Study|Lack of Efficacy|0|||
30587284|NCT01187446|58599519|FG000|Overall Study|Patient started non-protocol therapy|0|||
30587285|NCT01187446|58599520|FG001|Overall Study|Patient started non-protocol therapy|1|||
30587286|NCT01187407|58599530|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
30587287|NCT01187407|58599531|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
30587288|NCT01187407|58599532|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
30587289|NCT01187407|58599533|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
30587290|NCT01187407|58599534|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
30587291|NCT01187407|58599530|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
30587292|NCT01187407|58599531|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
30587293|NCT01187407|58599532|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
30587294|NCT01187407|58599533|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
30587295|NCT01187407|58599534|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
30587296|NCT01187407|58599530|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
30587297|NCT01187407|58599531|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
30587298|NCT01187407|58599532|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
30587299|NCT01187407|58599533|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
30587300|NCT01187407|58599534|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
30587301|NCT01187407|58599530|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
30587302|NCT01187407|58599531|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
30587303|NCT01187407|58599532|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
30671361|NCT03360019|58685158|FG000|Overall Study|Withdrawal by Subject|2|||
30671362|NCT03360019|58685159|FG001|Overall Study|Withdrawal by Subject|0|||
30671363|NCT03360019|58685160|FG002|Overall Study|Withdrawal by Subject|0|||
30671364|NCT03360019|58685158|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
30671365|NCT03360019|58685159|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
30671366|NCT03360019|58685160|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
30671367|NCT03260894|58685174|FG000|Overall Study|Death|6|||
30671368|NCT03260894|58685175|FG001|Overall Study|Death|8|||
30671369|NCT03260894|58685174|FG000|Overall Study|Withdrawal by Subject|4|||
30671370|NCT03260894|58685175|FG001|Overall Study|Withdrawal by Subject|11|||
30671371|NCT03260894|58685174|FG000|Overall Study|On-going at clinical cut off date|36|||
30671372|NCT03260894|58685175|FG001|Overall Study|On-going at clinical cut off date|31|||
30671373|NCT03245008|58685186|FG000|Overall Study|Adverse Event|15|||
30671374|NCT03245008|58685187|FG001|Overall Study|Adverse Event|18|||
30671375|NCT03245008|58685188|FG002|Overall Study|Adverse Event|15|||
30671376|NCT03245008|58685189|FG003|Overall Study|Adverse Event|0|||
30671377|NCT03245008|58685190|FG004|Overall Study|Adverse Event|1|||
30671378|NCT03245008|58685186|FG000|Overall Study|Lack of Efficacy|0|||
30671379|NCT03245008|58685187|FG001|Overall Study|Lack of Efficacy|1|||
30671380|NCT03245008|58685188|FG002|Overall Study|Lack of Efficacy|0|||
30671381|NCT03245008|58685189|FG003|Overall Study|Lack of Efficacy|0|||
30671382|NCT03245008|58685190|FG004|Overall Study|Lack of Efficacy|0|||
30671383|NCT03245008|58685186|FG000|Overall Study|Lost to Follow-up|4|||
30671384|NCT03245008|58685187|FG001|Overall Study|Lost to Follow-up|1|||
30671385|NCT03245008|58685188|FG002|Overall Study|Lost to Follow-up|0|||
30671386|NCT03245008|58685189|FG003|Overall Study|Lost to Follow-up|0|||
30671387|NCT03245008|58685190|FG004|Overall Study|Lost to Follow-up|1|||
30671388|NCT03245008|58685186|FG000|Overall Study|Physician Decision|1|||
30671389|NCT03245008|58685187|FG001|Overall Study|Physician Decision|3|||
30671390|NCT03245008|58685188|FG002|Overall Study|Physician Decision|4|||
30671391|NCT03245008|58685189|FG003|Overall Study|Physician Decision|0|||
30587304|NCT01187407|58599533|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
30587305|NCT01187407|58599534|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
30587306|NCT01187407|58599530|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
30587307|NCT01187407|58599531|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
30587308|NCT01187407|58599532|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
30671392|NCT03245008|58685190|FG004|Overall Study|Physician Decision|0|||
30671393|NCT03245008|58685186|FG000|Overall Study|Protocol Violation|0|||
30671394|NCT03245008|58685187|FG001|Overall Study|Protocol Violation|1|||
30671395|NCT03245008|58685188|FG002|Overall Study|Protocol Violation|0|||
30671396|NCT03245008|58685189|FG003|Overall Study|Protocol Violation|0|||
30671397|NCT03245008|58685190|FG004|Overall Study|Protocol Violation|0|||
30587309|NCT01187407|58599533|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
30587310|NCT01187407|58599534|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
30587311|NCT01187407|58599530|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
30587312|NCT01187407|58599531|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
30587313|NCT01187407|58599532|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
30587314|NCT01187407|58599533|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
30671398|NCT03245008|58685186|FG000|Overall Study|Withdrawal by Subject|20|||
30671399|NCT03245008|58685187|FG001|Overall Study|Withdrawal by Subject|19|||
30671400|NCT03245008|58685188|FG002|Overall Study|Withdrawal by Subject|11|||
30671401|NCT03245008|58685189|FG003|Overall Study|Withdrawal by Subject|0|||
30671402|NCT03245008|58685190|FG004|Overall Study|Withdrawal by Subject|0|||
30671403|NCT03245008|58685186|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
30671404|NCT03245008|58685187|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
30671405|NCT03245008|58685188|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
30671406|NCT03245008|58685189|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
30671407|NCT03245008|58685190|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
30671408|NCT03245008|58685186|FG000|Overall Study|Failure to meet randomization criteria|0|||
30671409|NCT03245008|58685187|FG001|Overall Study|Failure to meet randomization criteria|1|||
30671410|NCT03245008|58685188|FG002|Overall Study|Failure to meet randomization criteria|0|||
30671411|NCT03245008|58685189|FG003|Overall Study|Failure to meet randomization criteria|1|||
30671412|NCT03245008|58685190|FG004|Overall Study|Failure to meet randomization criteria|0|||
30671413|NCT03203473|58685212|FG000|Induction Phase|Never started primary treatment|2|||
30671414|NCT03203473|58685213|FG001|Induction Phase|Never started primary treatment|0|||
30671415|NCT03203473|58685214|FG002|Induction Phase|Never started primary treatment|0|||
30671416|NCT03203473|58685212|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
30671417|NCT03203473|58685213|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
30671418|NCT03203473|58685214|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
30671419|NCT03203473|58685212|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
30671420|NCT03203473|58685213|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
30671421|NCT03203473|58685214|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
30671422|NCT03203473|58685212|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
30671423|NCT03203473|58685213|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
30671424|NCT03203473|58685214|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
30671425|NCT03203473|58685212|FG000|Arm Allocation Phase|started salvage therapy|0|||
30671426|NCT03203473|58685213|FG001|Arm Allocation Phase|started salvage therapy|5|||
30671427|NCT03203473|58685214|FG002|Arm Allocation Phase|started salvage therapy|0|||
30671428|NCT03203473|58685212|FG000|Arm Allocation Phase|Disease progression|0|||
30671429|NCT03203473|58685213|FG001|Arm Allocation Phase|Disease progression|0|||
30671430|NCT03203473|58685214|FG002|Arm Allocation Phase|Disease progression|37|||
30671431|NCT03203473|58685212|FG000|Arm Allocation Phase|Adverse Event|0|||
30671432|NCT03203473|58685213|FG001|Arm Allocation Phase|Adverse Event|0|||
30671433|NCT03203473|58685214|FG002|Arm Allocation Phase|Adverse Event|11|||
30671434|NCT03203473|58685212|FG000|Arm Allocation Phase|Physician Decision|0|||
30587315|NCT01187407|58599534|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
30587316|NCT01187407|58599530|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
30587317|NCT01187407|58599531|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
30587318|NCT01187407|58599532|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
30587319|NCT01187407|58599533|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
30587320|NCT01187407|58599534|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
30587321|NCT01187407|58599530|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
30587322|NCT01187407|58599531|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
30587323|NCT01187407|58599532|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
30587324|NCT01187407|58599533|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
30587325|NCT01187407|58599534|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
30671435|NCT03203473|58685213|FG001|Arm Allocation Phase|Physician Decision|0|||
30671436|NCT03203473|58685214|FG002|Arm Allocation Phase|Physician Decision|3|||
30671437|NCT03203473|58685212|FG000|Arm Allocation Phase|Death|0|||
30671438|NCT03203473|58685213|FG001|Arm Allocation Phase|Death|0|||
30587326|NCT01187407|58599530|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
30587327|NCT01187407|58599531|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
30587328|NCT01187407|58599532|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
30587329|NCT01187407|58599533|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
30587330|NCT01187407|58599534|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
30587331|NCT01187407|58599530|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
30587332|NCT01187407|58599531|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
30587333|NCT01187407|58599532|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
30587334|NCT01187407|58599533|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
30587335|NCT01187407|58599534|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
30587336|NCT01187407|58599530|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
30587337|NCT01187407|58599531|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
30587338|NCT01187407|58599532|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
30587339|NCT01187407|58599533|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
30587340|NCT01187407|58599534|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
30587341|NCT01187407|58599530|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
30587342|NCT01187407|58599531|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
30587343|NCT01187407|58599532|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
30587344|NCT01187407|58599533|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
30587345|NCT01187407|58599534|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
30587346|NCT01187407|58599530|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
30587347|NCT01187407|58599531|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
30587348|NCT01187407|58599532|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
30587349|NCT01187407|58599533|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
30587350|NCT01187407|58599534|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
30587351|NCT01187407|58599530|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
30587352|NCT01187407|58599531|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
30587353|NCT01187407|58599532|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
30587354|NCT01187407|58599533|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
30587355|NCT01187407|58599534|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
30587356|NCT01186978|58599551|FG000|Overall Study|Withdrawal by Subject|1|||
30587357|NCT01186939|58599555|FG000|Overall Study|Death|7|||
30587358|NCT01186939|58599555|FG000|Overall Study|Withdrawal by Subject|2|||
30587359|NCT01186939|58599555|FG000|Overall Study|No longer receiving clinical benefit|17|||
30587360|NCT01186939|58599555|FG000|Overall Study|Program closed|5|||
30587361|NCT01186939|58599555|FG000|Overall Study|Sponsor decision|4|||
30587362|NCT01186939|58599555|FG000|Overall Study|Started additional treatment|1|||
30587363|NCT01186939|58599555|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
30587364|NCT01186939|58599555|FG000|Overall Study|Myocardial infarction|1|||
30587365|NCT01186939|58599555|FG000|Overall Study|Bone marrow transplant|1|||
30587366|NCT01186939|58599555|FG000|Overall Study|Transformation to AML|1|||
30587367|NCT04938648|58599580|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
30587368|NCT04938648|58599581|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
30587369|NCT04938648|58599580|FG000|Overall Study|Patient too ill|0|||
30587370|NCT04938648|58599581|FG001|Overall Study|Patient too ill|1|||
30587371|NCT04938648|58599580|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
30587372|NCT04938648|58599581|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
30587373|NCT04938648|58599580|FG000|Overall Study|Patient did not have memory problems|1|||
30587374|NCT04938648|58599581|FG001|Overall Study|Patient did not have memory problems|1|||
30587375|NCT04938648|58599580|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
30587376|NCT04938648|58599581|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
30587377|NCT04938648|58599580|FG000|Overall Study|Care partner could not be reached|0|||
30587378|NCT04938648|58599581|FG001|Overall Study|Care partner could not be reached|1|||
30587379|NCT04938648|58599580|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
30587380|NCT04938648|58599581|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
30587381|NCT04938648|58599580|FG000|Overall Study|Withdrawal by Subject|2|||
30587382|NCT04938648|58599581|FG001|Overall Study|Withdrawal by Subject|1|||
30671439|NCT03203473|58685214|FG002|Arm Allocation Phase|Death|1|||
30671440|NCT03203473|58685212|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
30671441|NCT03203473|58685213|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
30587383|NCT04564092|58599588|FG000|Overall Study|Withdrawal by Subject|1|||
30587384|NCT02128113|58599626|FG000|Overall Study|Withdrawal by Subject|3|||
30587385|NCT02128113|58599627|FG001|Overall Study|Withdrawal by Subject|1|||
30587386|NCT02128113|58599628|FG002|Overall Study|Withdrawal by Subject|0|||
30671442|NCT03203473|58685214|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
30671443|NCT03203473|58685212|FG000|Arm Allocation Phase|Intercurrent illness|0|||
30671444|NCT03203473|58685213|FG001|Arm Allocation Phase|Intercurrent illness|0|||
30587387|NCT02128113|58599626|FG000|Overall Study|Protocol Violation|0|||
30587388|NCT02128113|58599627|FG001|Overall Study|Protocol Violation|1|||
30587389|NCT02128113|58599628|FG002|Overall Study|Protocol Violation|0|||
30587390|NCT02128113|58599626|FG000|Overall Study|Surgery cancelled|0|||
30587391|NCT02128113|58599627|FG001|Overall Study|Surgery cancelled|1|||
30587392|NCT02128113|58599628|FG002|Overall Study|Surgery cancelled|0|||
30587393|NCT02128113|58599626|FG000|Overall Study|Adverse Event|0|||
30587394|NCT02128113|58599627|FG001|Overall Study|Adverse Event|0|||
30587395|NCT02128113|58599628|FG002|Overall Study|Adverse Event|1|||
30587396|NCT01658826|58599642|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
30587397|NCT01658826|58599643|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
30587398|NCT01658826|58599642|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
30587399|NCT01658826|58599643|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
30587400|NCT01658826|58599642|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
30587401|NCT01658826|58599643|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
30587402|NCT01658826|58599642|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
30587403|NCT01658826|58599643|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
30587404|NCT01658826|58599642|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
30587405|NCT01658826|58599643|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
30587406|NCT01658826|58599642|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
30587407|NCT01658826|58599643|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
30587408|NCT01658826|58599642|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
30587409|NCT01658826|58599643|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
30587410|NCT01658826|58599642|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
30587411|NCT01658826|58599643|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
30587412|NCT01658826|58599642|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
30587413|NCT01658826|58599643|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
30587414|NCT01186744|58599659|FG000|Overall Study|Lack of Efficacy|156|||
30587415|NCT01186744|58599660|FG001|Overall Study|Lack of Efficacy|99|||
30587416|NCT01186744|58599661|FG002|Overall Study|Lack of Efficacy|0|||
30587417|NCT01186744|58599662|FG003|Overall Study|Lack of Efficacy|2|||
30587418|NCT01186744|58599663|FG004|Overall Study|Lack of Efficacy|2|||
30671445|NCT03203473|58685214|FG002|Arm Allocation Phase|Intercurrent illness|1|||
30671446|NCT03203473|58685212|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
30671447|NCT03203473|58685213|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
30671448|NCT03203473|58685214|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
30671449|NCT03158051|58685227|FG000|Overall Study|Lost to Follow-up|41|||
30671450|NCT03158051|58685228|FG001|Overall Study|Lost to Follow-up|47|||
30671451|NCT03158051|58685227|FG000|Overall Study|Physician Decision|6|||
30671452|NCT03158051|58685228|FG001|Overall Study|Physician Decision|7|||
30671453|NCT03158051|58685227|FG000|Overall Study|Withdrawal by Subject|24|||
30671454|NCT03158051|58685228|FG001|Overall Study|Withdrawal by Subject|15|||
30671455|NCT03158051|58685227|FG000|Overall Study|Death|0|||
30671456|NCT03158051|58685228|FG001|Overall Study|Death|1|||
30671457|NCT03051659|58685245|FG000|Treatment Period|Withdrawal by Subject|0|||
30671458|NCT03051659|58685246|FG001|Treatment Period|Withdrawal by Subject|2|||
30671459|NCT03051659|58685245|FG000|Survival Follow-up|Lost to Follow-up|23|||
30671460|NCT03051659|58685246|FG001|Survival Follow-up|Lost to Follow-up|22|||
30671461|NCT02971761|58685252|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
30671462|NCT02724878|58685256|FG000|Overall Study|Still on Active Therapy|15|||
30671463|NCT02724878|58685256|FG000|Overall Study|Disease Progression|31|||
30671464|NCT02724878|58685256|FG000|Overall Study|Toxicity|5|||
30781192|NCT02903914|58793265|FG001|Overall Study|New Cancer Therapy|2|||
30587419|NCT01186744|58599664|FG005|Overall Study|Lack of Efficacy|5|||
30587420|NCT01186744|58599659|FG000|Overall Study|Protocol Violation|1|||
30587421|NCT01186744|58599660|FG001|Overall Study|Protocol Violation|2|||
30587422|NCT01186744|58599661|FG002|Overall Study|Protocol Violation|0|||
30587423|NCT01186744|58599662|FG003|Overall Study|Protocol Violation|1|||
30587424|NCT01186744|58599663|FG004|Overall Study|Protocol Violation|1|||
30587425|NCT01186744|58599664|FG005|Overall Study|Protocol Violation|2|||
30587426|NCT01186744|58599659|FG000|Overall Study|Lost to Follow-up|15|||
30958877|NCT01587703|59024027|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30587427|NCT01186744|58599660|FG001|Overall Study|Lost to Follow-up|16|||
30587428|NCT01186744|58599661|FG002|Overall Study|Lost to Follow-up|2|||
30587429|NCT01186744|58599662|FG003|Overall Study|Lost to Follow-up|1|||
30587430|NCT01186744|58599663|FG004|Overall Study|Lost to Follow-up|1|||
30671465|NCT02724878|58685256|FG000|Overall Study|Death|1|||
30671466|NCT02724878|58685256|FG000|Overall Study|Withdrawal by Subject|4|||
30671467|NCT02724878|58685256|FG000|Overall Study|Lost to Follow-up|2|||
30671468|NCT02724878|58685256|FG000|Overall Study|Protocol Violation|1|||
30671469|NCT02724878|58685256|FG000|Overall Study|Ineligible for Study Drug|5|||
30671470|NCT02724878|58685256|FG000|Overall Study|not started|1|||
30587431|NCT01186744|58599664|FG005|Overall Study|Lost to Follow-up|4|||
30587432|NCT01186744|58599659|FG000|Overall Study|Screen failure|1|||
30587433|NCT01186744|58599660|FG001|Overall Study|Screen failure|1|||
30587434|NCT01186744|58599661|FG002|Overall Study|Screen failure|0|||
30587435|NCT01186744|58599662|FG003|Overall Study|Screen failure|1|||
30587436|NCT01186744|58599663|FG004|Overall Study|Screen failure|0|||
30587437|NCT01186744|58599664|FG005|Overall Study|Screen failure|0|||
30587438|NCT01186744|58599659|FG000|Overall Study|Withdrawal by Subject|14|||
30587439|NCT01186744|58599660|FG001|Overall Study|Withdrawal by Subject|10|||
30587440|NCT01186744|58599661|FG002|Overall Study|Withdrawal by Subject|2|||
30587441|NCT01186744|58599662|FG003|Overall Study|Withdrawal by Subject|5|||
30587442|NCT01186744|58599663|FG004|Overall Study|Withdrawal by Subject|0|||
30587443|NCT01186744|58599664|FG005|Overall Study|Withdrawal by Subject|6|||
30587444|NCT01186744|58599659|FG000|Overall Study|Study terminated by Sponsor|1|||
30587445|NCT01186744|58599660|FG001|Overall Study|Study terminated by Sponsor|0|||
30587446|NCT01186744|58599661|FG002|Overall Study|Study terminated by Sponsor|0|||
30587447|NCT01186744|58599662|FG003|Overall Study|Study terminated by Sponsor|0|||
30587448|NCT01186744|58599663|FG004|Overall Study|Study terminated by Sponsor|0|||
30587449|NCT01186744|58599664|FG005|Overall Study|Study terminated by Sponsor|0|||
30587450|NCT01186744|58599659|FG000|Overall Study|Other|9|||
30587451|NCT01186744|58599660|FG001|Overall Study|Other|10|||
30587452|NCT01186744|58599661|FG002|Overall Study|Other|1|||
30587453|NCT01186744|58599662|FG003|Overall Study|Other|2|||
30587454|NCT01186744|58599663|FG004|Overall Study|Other|1|||
30587455|NCT01186744|58599664|FG005|Overall Study|Other|5|||
30587456|NCT01186744|58599659|FG000|Overall Study|Adverse Event|10|||
30587457|NCT01186744|58599660|FG001|Overall Study|Adverse Event|14|||
30587458|NCT01186744|58599661|FG002|Overall Study|Adverse Event|1|||
30587459|NCT01186744|58599662|FG003|Overall Study|Adverse Event|0|||
30587460|NCT01186744|58599663|FG004|Overall Study|Adverse Event|1|||
30587461|NCT01186744|58599664|FG005|Overall Study|Adverse Event|4|||
30587462|NCT01186744|58599659|FG000|Overall Study|Death|1|||
30587463|NCT01186744|58599660|FG001|Overall Study|Death|0|||
30587464|NCT01186744|58599661|FG002|Overall Study|Death|0|||
30587465|NCT01186744|58599662|FG003|Overall Study|Death|0|||
30587466|NCT01186744|58599663|FG004|Overall Study|Death|0|||
30587467|NCT01186744|58599664|FG005|Overall Study|Death|0|||
30587468|NCT01185964|58599702|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
30587469|NCT01185964|58599703|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
30587470|NCT01185964|58599704|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
30587471|NCT01185964|58599705|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
30587472|NCT01185964|58599702|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
30587473|NCT01185964|58599703|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
30587474|NCT01185964|58599704|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
30587475|NCT01185964|58599705|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
30587476|NCT01185964|58599702|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
30587477|NCT01185964|58599703|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
30587478|NCT01185964|58599704|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
30587479|NCT01185964|58599705|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
30587480|NCT01185964|58599702|FG000|Phase 1b and Phase 2|Adverse Event|1|||
30587481|NCT01185964|58599703|FG001|Phase 1b and Phase 2|Adverse Event|0|||
30587482|NCT01185964|58599704|FG002|Phase 1b and Phase 2|Adverse Event|2|||
30587483|NCT01185964|58599705|FG003|Phase 1b and Phase 2|Adverse Event|0|||
30587484|NCT01185964|58599702|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
30587485|NCT01185964|58599703|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
30587486|NCT01185964|58599704|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
30671471|NCT02600507|58685263|FG000|Overall Study|Adverse Event|3|||
30671472|NCT02600507|58685264|FG001|Overall Study|Adverse Event|15|||
30671473|NCT02600507|58685265|FG002|Overall Study|Adverse Event|5|||
30671474|NCT02600507|58685263|FG000|Overall Study|Lack of Efficacy|3|||
30671475|NCT02600507|58685264|FG001|Overall Study|Lack of Efficacy|8|||
30671476|NCT02600507|58685265|FG002|Overall Study|Lack of Efficacy|5|||
30671477|NCT02600507|58685263|FG000|Overall Study|Lost to Follow-up|3|||
30587487|NCT01185964|58599705|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
30587488|NCT01185964|58599702|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
30587489|NCT01185964|58599703|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
30671478|NCT02600507|58685264|FG001|Overall Study|Lost to Follow-up|5|||
30587490|NCT01185964|58599704|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
30587491|NCT01185964|58599705|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
30587492|NCT01185964|58599702|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
30587493|NCT01185964|58599703|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
30587494|NCT01185964|58599704|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
30671479|NCT02600507|58685265|FG002|Overall Study|Lost to Follow-up|2|||
30671480|NCT02600507|58685263|FG000|Overall Study|Protocol Violation|12|||
30671481|NCT02600507|58685264|FG001|Overall Study|Protocol Violation|4|||
30671482|NCT02600507|58685265|FG002|Overall Study|Protocol Violation|4|||
30587495|NCT01185964|58599705|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
30587496|NCT01185964|58599702|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
30587497|NCT01185964|58599703|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
30587498|NCT01185964|58599704|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
30587499|NCT01185964|58599705|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
30587500|NCT01217476|58599723|FG000|Overall Study|Adverse Event|6|||
30587501|NCT01217476|58599724|FG001|Overall Study|Adverse Event|1|||
30587502|NCT01217476|58599723|FG000|Overall Study|Physician Decision|0|||
30587503|NCT01217476|58599724|FG001|Overall Study|Physician Decision|1|||
30587504|NCT01217476|58599723|FG000|Overall Study|Withdrawal by Subject|3|||
30671483|NCT02600507|58685263|FG000|Overall Study|Physician Decision|1|||
30587505|NCT01217476|58599724|FG001|Overall Study|Withdrawal by Subject|3|||
30587506|NCT01217476|58599723|FG000|Overall Study|Surgery on the Target Limb|0|||
30587507|NCT01217476|58599724|FG001|Overall Study|Surgery on the Target Limb|2|||
30587508|NCT01217476|58599723|FG000|Overall Study|Protocol Deviation|1|||
30587509|NCT01217476|58599724|FG001|Overall Study|Protocol Deviation|0|||
30587510|NCT01217476|58599723|FG000|Overall Study|Other|2|||
30587511|NCT01217476|58599724|FG001|Overall Study|Other|0|||
30587512|NCT01217437|58599745|FG000|Overall Study|Adverse Event|0|||
30587513|NCT01217437|58599746|FG001|Overall Study|Adverse Event|8|||
30587514|NCT01217437|58599745|FG000|Overall Study|Death|5|||
30587515|NCT01217437|58599746|FG001|Overall Study|Death|0|||
30587516|NCT01217437|58599745|FG000|Overall Study|Lack of Efficacy|29|||
30587517|NCT01217437|58599746|FG001|Overall Study|Lack of Efficacy|25|||
30587518|NCT01217437|58599745|FG000|Overall Study|Physician Decision|8|||
30587519|NCT01217437|58599746|FG001|Overall Study|Physician Decision|5|||
30671484|NCT02600507|58685264|FG001|Overall Study|Physician Decision|0|||
30671485|NCT02600507|58685265|FG002|Overall Study|Physician Decision|1|||
30671486|NCT02600507|58685263|FG000|Overall Study|Withdrawal by Subject|7|||
30671487|NCT02600507|58685264|FG001|Overall Study|Withdrawal by Subject|11|||
30671488|NCT02600507|58685265|FG002|Overall Study|Withdrawal by Subject|7|||
30671489|NCT02600507|58685263|FG000|Overall Study|Other|0|||
30671490|NCT02600507|58685264|FG001|Overall Study|Other|1|||
30671491|NCT02600507|58685265|FG002|Overall Study|Other|1|||
30671492|NCT02578680|58685275|FG000|Overall Study|Death|124|||
30671493|NCT02578680|58685276|FG001|Overall Study|Death|104|||
30671494|NCT02578680|58685275|FG000|Overall Study|Protocol Violation|1|||
30671495|NCT02578680|58685276|FG001|Overall Study|Protocol Violation|1|||
30671496|NCT02578680|58685275|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
30671497|NCT02578680|58685276|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
30671498|NCT02578680|58685275|FG000|Overall Study|Withdrawal by Subject|8|||
30671499|NCT02578680|58685276|FG001|Overall Study|Withdrawal by Subject|5|||
30671500|NCT02578680|58685275|FG000|Overall Study|Ongoing in Study|276|||
30671501|NCT02578680|58685276|FG001|Overall Study|Ongoing in Study|96|||
30671502|NCT02385266|58685284|FG000|Overall Study|Withdrawal by Subject|1|||
30671503|NCT02385266|58685285|FG001|Overall Study|Withdrawal by Subject|3|||
30671504|NCT02379988|58685291|FG000|Overall Study|Not eligible|1|||
30671505|NCT02006069|58685306|FG000|Overall Study|MPP other programming|239|||
30671506|NCT02006069|58685307|FG001|Overall Study|MPP other programming|0|||
30671507|NCT02006069|58685306|FG000|Overall Study|RV only pacing|0|||
30671508|NCT02006069|58685307|FG001|Overall Study|RV only pacing|3|||
30671509|NCT01985867|58685315|FG000|Overall Study|Lost to Follow-up|3|||
30671510|NCT01985867|58685316|FG001|Overall Study|Lost to Follow-up|4|||
30671511|NCT01985867|58685315|FG000|Overall Study|Adverse Event|3|||
30671512|NCT01985867|58685316|FG001|Overall Study|Adverse Event|2|||
30671513|NCT01985867|58685315|FG000|Overall Study|Lack of Efficacy|1|||
30671514|NCT01985867|58685316|FG001|Overall Study|Lack of Efficacy|0|||
30671515|NCT01946139|58685322|FG000|Overall Study|Withdrawal by Subject|8|||
30671516|NCT01946139|58685322|FG000|Overall Study|ineligible|8|||
30671517|NCT01946139|58685322|FG000|Overall Study|Specimens not available|4|||
30587520|NCT01217437|58599745|FG000|Overall Study|Withdrawal by Subject|0|||
30587521|NCT01217437|58599746|FG001|Overall Study|Withdrawal by Subject|2|||
30587522|NCT01217437|58599745|FG000|Overall Study|Ineligible|1|||
30587523|NCT01217437|58599746|FG001|Overall Study|Ineligible|1|||
30587524|NCT01217047|58599756|FG000|Overall Study|Lost to Follow-up|0|||
30587525|NCT01217047|58599757|FG001|Overall Study|Lost to Follow-up|1|||
30587526|NCT01217047|58599758|FG002|Overall Study|Lost to Follow-up|0|||
30671518|NCT01367002|58685328|FG000|Overall Study|Withdrawal by Subject|1|||
30671519|NCT01367002|58685329|FG001|Overall Study|Withdrawal by Subject|0|||
30671520|NCT01367002|58685328|FG000|Overall Study|Physician Decision|0|||
30671521|NCT01367002|58685329|FG001|Overall Study|Physician Decision|2|||
30671522|NCT00858273|58685337|FG000|Overall Study|Protocol Violation|3|||
30671523|NCT00858273|58685338|FG001|Overall Study|Protocol Violation|5|||
30671524|NCT00844428|58685369|FG000|Screening Period|Screen Failure|3|||
30671525|NCT00844428|58685369|FG000|Extension Treatment Period|Death|1|||
30671526|NCT00844428|58685369|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
30587527|NCT01185340|58599770|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
30587528|NCT01185340|58599771|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
30587529|NCT01185340|58599772|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
30587530|NCT01185340|58599773|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
30587531|NCT01185340|58599770|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
30587532|NCT01185340|58599771|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
30587533|NCT01185340|58599772|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
30587534|NCT01185340|58599773|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
30587535|NCT01185340|58599770|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
30587536|NCT01185340|58599771|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
30587537|NCT01185340|58599772|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
30587538|NCT01185340|58599773|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
30587539|NCT01185340|58599770|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
30587540|NCT01185340|58599771|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
30587541|NCT01185340|58599772|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
30587542|NCT01185340|58599773|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
30587543|NCT01185340|58599770|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
30587544|NCT01185340|58599771|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
30587545|NCT01185340|58599772|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
30587546|NCT01185340|58599773|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
30587547|NCT01185340|58599770|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
30587548|NCT01185340|58599771|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
30587549|NCT01185340|58599772|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
30587550|NCT01185340|58599773|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
30587551|NCT01185340|58599770|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
30587552|NCT01185340|58599771|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
30587553|NCT01185340|58599772|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
30587554|NCT01185340|58599773|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
30587555|NCT01185340|58599770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
30587556|NCT01185340|58599771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
30587557|NCT01185340|58599772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
30587558|NCT01185340|58599773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
30587559|NCT01185340|58599770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
30587560|NCT01185340|58599771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
30587561|NCT01185340|58599772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
30587562|NCT01185340|58599773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
30671527|NCT00834834|58685375|FG000|Overall Study|Withdrawal by Subject|4|||
30671528|NCT00834834|58685376|FG001|Overall Study|Withdrawal by Subject|3|||
30671529|NCT00834366|58685384|FG000|Treatment Period 1|Adverse Event|1|||
30671530|NCT00834366|58685385|FG001|Treatment Period 1|Adverse Event|1|||
30671531|NCT00844194|58685393|FG000|Overall Study|Adverse Event|17|||
30671532|NCT00844194|58685394|FG001|Overall Study|Adverse Event|5|||
30671533|NCT00844194|58685393|FG000|Overall Study|Protocol Violation|1|||
30671534|NCT00844194|58685394|FG001|Overall Study|Protocol Violation|1|||
30671535|NCT00844194|58685393|FG000|Overall Study|Lost to Follow-up|1|||
30671536|NCT00844194|58685394|FG001|Overall Study|Lost to Follow-up|1|||
30671537|NCT00844194|58685393|FG000|Overall Study|Withdrawal by Subject|2|||
30671538|NCT00844194|58685394|FG001|Overall Study|Withdrawal by Subject|1|||
30671539|NCT00844194|58685393|FG000|Overall Study|Lack of Efficacy|3|||
30671540|NCT00844194|58685394|FG001|Overall Study|Lack of Efficacy|0|||
30671541|NCT00844194|58685393|FG000|Overall Study|Other reason (not specified)|1|||
30671542|NCT00844194|58685394|FG001|Overall Study|Other reason (not specified)|0|||
30781193|NCT02903914|58793266|FG002|Overall Study|New Cancer Therapy|21|||
30781194|NCT02903914|58793267|FG003|Overall Study|New Cancer Therapy|4|||
30781195|NCT02903914|58793268|FG004|Overall Study|New Cancer Therapy|3|||
30781196|NCT02903914|58793269|FG005|Overall Study|New Cancer Therapy|6|||
30671543|NCT00826176|58685406|FG000|Overall Study|Lost to Follow-up|1|||
30671544|NCT00826176|58685407|FG001|Overall Study|Lost to Follow-up|0|||
30671545|NCT00826176|58685406|FG000|Overall Study|Subject Withdrew Consent|3|||
30671546|NCT00826176|58685407|FG001|Overall Study|Subject Withdrew Consent|0|||
30671547|NCT00826176|58685406|FG000|Overall Study|Administrative|9|||
30671548|NCT00826176|58685407|FG001|Overall Study|Administrative|0|||
30781197|NCT02903914|58793270|FG006|Overall Study|New Cancer Therapy|55|||
30781198|NCT02903914|58793271|FG007|Overall Study|New Cancer Therapy|0|||
30781199|NCT02903914|58793264|FG000|Overall Study|Reasoning not specified|2|||
30781200|NCT02903914|58793265|FG001|Overall Study|Reasoning not specified|3|||
30781201|NCT02903914|58793266|FG002|Overall Study|Reasoning not specified|20|||
30671549|NCT00878969|58685416|FG000|Overall Study|Physician Decision|5|||
30671550|NCT00878969|58685417|FG001|Overall Study|Physician Decision|3|||
30671551|NCT00878969|58685418|FG002|Overall Study|Physician Decision|2|||
30671552|NCT00878969|58685416|FG000|Overall Study|Withdrawal by Subject|1|||
30671553|NCT00878969|58685417|FG001|Overall Study|Withdrawal by Subject|6|||
30781202|NCT02903914|58793267|FG003|Overall Study|Reasoning not specified|3|||
30781203|NCT02903914|58793268|FG004|Overall Study|Reasoning not specified|3|||
30671554|NCT00878969|58685418|FG002|Overall Study|Withdrawal by Subject|3|||
30671555|NCT00878969|58685416|FG000|Overall Study|kidney transplant|2|||
30671556|NCT00878969|58685417|FG001|Overall Study|kidney transplant|3|||
30671557|NCT00878969|58685418|FG002|Overall Study|kidney transplant|2|||
30671558|NCT00878969|58685416|FG000|Overall Study|Adverse Event|3|||
30671559|NCT00878969|58685417|FG001|Overall Study|Adverse Event|1|||
30671560|NCT00878969|58685418|FG002|Overall Study|Adverse Event|2|||
30671561|NCT00878969|58685416|FG000|Overall Study|Lost to Follow-up|2|||
30671562|NCT00878969|58685417|FG001|Overall Study|Lost to Follow-up|1|||
30671563|NCT00878969|58685418|FG002|Overall Study|Lost to Follow-up|0|||
30671564|NCT00878969|58685416|FG000|Overall Study|Protocol Violation|2|||
30671565|NCT00878969|58685417|FG001|Overall Study|Protocol Violation|0|||
30671566|NCT00878969|58685418|FG002|Overall Study|Protocol Violation|0|||
30671567|NCT00878969|58685416|FG000|Overall Study|Death|0|||
30671568|NCT00878969|58685417|FG001|Overall Study|Death|0|||
30671569|NCT00878969|58685418|FG002|Overall Study|Death|2|||
30671570|NCT00878969|58685416|FG000|Overall Study|Pregnancy|0|||
30671571|NCT00878969|58685417|FG001|Overall Study|Pregnancy|1|||
30671572|NCT00878969|58685418|FG002|Overall Study|Pregnancy|0|||
30671573|NCT00843726|58685432|FG000|Overall Study|Death|1|||
30671574|NCT00843726|58685433|FG001|Overall Study|Death|0|||
30671575|NCT00843726|58685432|FG000|Overall Study|Withdrawal by Subject|0|||
30671576|NCT00843726|58685433|FG001|Overall Study|Withdrawal by Subject|1|||
30671577|NCT00843492|58685442|FG000|Overall Study|Adverse Event|0|||
30587563|NCT01185340|58599770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
30587564|NCT01185340|58599771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
30587565|NCT01185340|58599772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
30587566|NCT01185340|58599773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
30587567|NCT01185340|58599770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
30587568|NCT01185340|58599771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
30671578|NCT00843492|58685443|FG001|Overall Study|Adverse Event|3|||
30587569|NCT01185340|58599772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
30587570|NCT01185340|58599773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
30671579|NCT00843492|58685442|FG000|Overall Study|Lost to Follow-up|4|||
30671580|NCT00843492|58685443|FG001|Overall Study|Lost to Follow-up|4|||
30671581|NCT00843492|58685442|FG000|Overall Study|Withdrawal by Subject|0|||
30671582|NCT00843492|58685443|FG001|Overall Study|Withdrawal by Subject|4|||
30587571|NCT01185340|58599770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
30587572|NCT01185340|58599771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
30671583|NCT00843492|58685442|FG000|Overall Study|Immobilization Stopped|1|||
30671584|NCT00843492|58685443|FG001|Overall Study|Immobilization Stopped|0|||
30671585|NCT00843492|58685442|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
30671586|NCT00843492|58685443|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
30671587|NCT00843492|58685442|FG000|Overall Study|Orthopedic Surgery|0|||
30671588|NCT00843492|58685443|FG001|Overall Study|Orthopedic Surgery|2|||
30671589|NCT00843492|58685442|FG000|Overall Study|Visit Not Performed|1|||
30671590|NCT00843492|58685443|FG001|Overall Study|Visit Not Performed|0|||
30671591|NCT00843492|58685442|FG000|Overall Study|Deep-vein Thrombosis|1|||
30671592|NCT00843492|58685443|FG001|Overall Study|Deep-vein Thrombosis|0|||
30587573|NCT01185340|58599772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
30587574|NCT01185340|58599773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
30587575|NCT01185340|58599770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
30587576|NCT01185340|58599771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
30671593|NCT00833976|58685449|FG000|Overall Study|Withdrawal by Subject|5|||
30671594|NCT00833976|58685449|FG000|Overall Study|Lost to Follow-up|4|||
30587577|NCT01185340|58599772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
30587578|NCT01185340|58599773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
30671595|NCT00833976|58685449|FG000|Overall Study|Did not meet eligibility criteria|41|||
30671596|NCT00833976|58685449|FG000|Overall Study|Physician Decision|1|||
30671597|NCT00833898|58685455|FG000|Overall Study|Withdrawal by Subject|33|||
30671598|NCT00833898|58685456|FG001|Overall Study|Withdrawal by Subject|27|||
30671599|NCT00833898|58685455|FG000|Overall Study|Lost to Follow-up|7|||
30671600|NCT00833898|58685456|FG001|Overall Study|Lost to Follow-up|7|||
30671601|NCT00833898|58685455|FG000|Overall Study|Patient did not receive transplant|0|||
30781204|NCT02903914|58793269|FG005|Overall Study|Reasoning not specified|3|||
30587579|NCT01185340|58599770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
30671602|NCT00833898|58685456|FG001|Overall Study|Patient did not receive transplant|2|||
30671603|NCT00825162|58685465|FG000|Overall Study|Withdrawal by Subject|11|||
30671604|NCT00825162|58685466|FG001|Overall Study|Withdrawal by Subject|13|||
30671605|NCT00825162|58685467|FG002|Overall Study|Withdrawal by Subject|3|||
30671606|NCT00825162|58685465|FG000|Overall Study|Lost to Follow-up|9|||
30671607|NCT00825162|58685466|FG001|Overall Study|Lost to Follow-up|6|||
30781205|NCT02903914|58793270|FG006|Overall Study|Reasoning not specified|20|||
30671608|NCT00825162|58685467|FG002|Overall Study|Lost to Follow-up|3|||
30671609|NCT00825162|58685465|FG000|Overall Study|Physician Decision|2|||
30671610|NCT00825162|58685466|FG001|Overall Study|Physician Decision|0|||
30671611|NCT00825162|58685467|FG002|Overall Study|Physician Decision|0|||
30587580|NCT01185340|58599771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
30671612|NCT00825162|58685465|FG000|Overall Study|Move away from the study area|1|||
30587581|NCT01185340|58599772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
30587582|NCT01185340|58599773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
30587583|NCT01216189|58599787|FG000|Overall Study|Lost to Follow-up|21|||
30587584|NCT01216189|58599788|FG001|Overall Study|Lost to Follow-up|3|||
30587585|NCT01216189|58599787|FG000|Overall Study|Death|4|||
30587586|NCT01216189|58599788|FG001|Overall Study|Death|2|||
30587587|NCT01185301|58599798|FG000|Overall Study|Adverse Event|3|||
30587588|NCT01185301|58599799|FG001|Overall Study|Adverse Event|0|||
30587589|NCT01185301|58599800|FG002|Overall Study|Adverse Event|2|||
30587590|NCT01185301|58599801|FG003|Overall Study|Adverse Event|3|||
30587591|NCT01185301|58599798|FG000|Overall Study|Withdrawal by Subject|7|||
30587592|NCT01185301|58599799|FG001|Overall Study|Withdrawal by Subject|5|||
30587593|NCT01185301|58599800|FG002|Overall Study|Withdrawal by Subject|2|||
30587594|NCT01185301|58599801|FG003|Overall Study|Withdrawal by Subject|3|||
30587595|NCT01185301|58599798|FG000|Overall Study|Lost to Follow-up|2|||
30587596|NCT01185301|58599799|FG001|Overall Study|Lost to Follow-up|0|||
30587597|NCT01185301|58599800|FG002|Overall Study|Lost to Follow-up|0|||
30587598|NCT01185301|58599801|FG003|Overall Study|Lost to Follow-up|1|||
30587599|NCT01185301|58599798|FG000|Overall Study|Other Reason|3|||
30587600|NCT01185301|58599799|FG001|Overall Study|Other Reason|2|||
30587601|NCT01185301|58599800|FG002|Overall Study|Other Reason|2|||
30587602|NCT01185301|58599801|FG003|Overall Study|Other Reason|2|||
30587603|NCT01216072|58599813|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
30587604|NCT01216072|58599814|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
30671613|NCT00825162|58685466|FG001|Overall Study|Move away from the study area|0|||
30671614|NCT00825162|58685467|FG002|Overall Study|Move away from the study area|0|||
30671615|NCT00825162|58685465|FG000|Overall Study|Unable to attend the study visit|5|||
30671616|NCT00825162|58685466|FG001|Overall Study|Unable to attend the study visit|2|||
30671617|NCT00825162|58685467|FG002|Overall Study|Unable to attend the study visit|0|||
30671618|NCT00824850|58685482|FG000|Overall Study|Withdrawal by Subject|0|||
30671619|NCT00824850|58685483|FG001|Overall Study|Withdrawal by Subject|1|||
30671620|NCT00596687|58685497|FG000|Overall Study|< 24 hours of insulin treatment|8|||
30671621|NCT00596687|58685498|FG001|Overall Study|< 24 hours of insulin treatment|6|||
30671622|NCT00596687|58685497|FG000|Overall Study|continuous insulin infusion during TPN|2|||
30671623|NCT00596687|58685498|FG001|Overall Study|continuous insulin infusion during TPN|1|||
30671624|NCT00596687|58685497|FG000|Overall Study|Withdrawal by Subject|3|||
30671625|NCT00596687|58685498|FG001|Overall Study|Withdrawal by Subject|1|||
30671626|NCT00596687|58685497|FG000|Overall Study|cancelled surgery|1|||
30671627|NCT00596687|58685498|FG001|Overall Study|cancelled surgery|1|||
30671628|NCT00824772|58685504|FG000|Overall Study|Withdrawal by Subject|8|||
30671629|NCT00824616|58685510|FG000|Overall Study|Adverse Event|2|||
30671630|NCT00824616|58685511|FG001|Overall Study|Adverse Event|1|||
30671631|NCT00824616|58685510|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
30671632|NCT00824616|58685511|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
30671633|NCT00824616|58685510|FG000|Overall Study|Hyperglycemia|1|||
30671634|NCT00824616|58685511|FG001|Overall Study|Hyperglycemia|1|||
30671635|NCT00824616|58685510|FG000|Overall Study|Lack of Efficacy|2|||
30671636|NCT00824616|58685511|FG001|Overall Study|Lack of Efficacy|1|||
30671637|NCT00824616|58685510|FG000|Overall Study|Lost to Follow-up|0|||
30671638|NCT00824616|58685511|FG001|Overall Study|Lost to Follow-up|1|||
30671639|NCT00824616|58685510|FG000|Overall Study|Withdrawal by Subject|1|||
30671640|NCT00824616|58685511|FG001|Overall Study|Withdrawal by Subject|1|||
30671641|NCT00824382|58685521|FG000|Overall Study|Adverse Event|4|||
30781206|NCT02903914|58793271|FG007|Overall Study|Reasoning not specified|0|||
30781207|NCT02969044|58793293|FG000|Overall Study|Withdrawal by Subject|2|||
30781208|NCT02969044|58793294|FG001|Overall Study|Withdrawal by Subject|6|||
30781209|NCT02969044|58793293|FG000|Overall Study|Adverse Event|3|||
30587605|NCT01216072|58599813|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
30587606|NCT01216072|58599814|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
30587607|NCT01216072|58599813|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
30587608|NCT01216072|58599814|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
30587609|NCT01216072|58599813|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
30671642|NCT00824382|58685522|FG001|Overall Study|Adverse Event|1|||
30671643|NCT00824382|58685523|FG002|Overall Study|Adverse Event|1|||
30671644|NCT00824382|58685524|FG003|Overall Study|Adverse Event|4|||
30587610|NCT01216072|58599814|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
30671645|NCT00824382|58685521|FG000|Overall Study|Protocol Violation|1|||
30671646|NCT00824382|58685522|FG001|Overall Study|Protocol Violation|0|||
30671647|NCT00824382|58685523|FG002|Overall Study|Protocol Violation|0|||
30781210|NCT02969044|58793294|FG001|Overall Study|Adverse Event|0|||
30671648|NCT00824382|58685524|FG003|Overall Study|Protocol Violation|1|||
30671649|NCT00824382|58685521|FG000|Overall Study|Investigator's decision|0|||
30671650|NCT00824382|58685522|FG001|Overall Study|Investigator's decision|1|||
30671651|NCT00824382|58685523|FG002|Overall Study|Investigator's decision|2|||
30671652|NCT00824382|58685524|FG003|Overall Study|Investigator's decision|0|||
30671653|NCT00833040|58685536|FG000|Overall Study|Adverse Event|0|||
30671654|NCT00833040|58685537|FG001|Overall Study|Adverse Event|0|||
30587611|NCT01216072|58599813|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
30587612|NCT01216072|58599814|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
30587613|NCT01216072|58599813|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
30587614|NCT01216072|58599814|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
30671655|NCT00833040|58685538|FG002|Overall Study|Adverse Event|0|||
30671656|NCT00833040|58685539|FG003|Overall Study|Adverse Event|0|||
30671657|NCT00833040|58685540|FG004|Overall Study|Adverse Event|0|||
30671658|NCT00833040|58685541|FG005|Overall Study|Adverse Event|1|||
30671659|NCT00843024|58685550|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
30587615|NCT01216072|58599813|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
30587616|NCT01216072|58599814|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
30587617|NCT01216072|58599813|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
30587618|NCT01216072|58599814|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
30587619|NCT01216072|58599813|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
30587620|NCT01216072|58599814|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
30671660|NCT00843024|58685551|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
30671661|NCT00843024|58685552|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
30671662|NCT00843024|58685553|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
30671663|NCT00843024|58685554|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
30671664|NCT00843024|58685555|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
30671665|NCT00843024|58685550|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
30671666|NCT00843024|58685551|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
30671667|NCT00843024|58685552|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
30671668|NCT00843024|58685553|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
30671669|NCT00843024|58685554|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
30671670|NCT00843024|58685555|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
30671671|NCT00843024|58685550|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
30671672|NCT00843024|58685551|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
30671673|NCT00843024|58685552|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
30671674|NCT00843024|58685553|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
30671675|NCT00843024|58685554|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
30671676|NCT00843024|58685555|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
30671677|NCT00843024|58685550|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
30671678|NCT00843024|58685551|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
30671679|NCT00843024|58685552|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
30671680|NCT00843024|58685553|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
30671681|NCT00843024|58685554|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
30671682|NCT00843024|58685555|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
30671683|NCT00843024|58685550|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
30671684|NCT00843024|58685551|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
30671685|NCT00843024|58685552|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
30671686|NCT00843024|58685553|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
30671687|NCT00843024|58685554|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
30671688|NCT00843024|58685555|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
30671689|NCT00843024|58685550|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
30671690|NCT00843024|58685551|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
30671691|NCT00843024|58685552|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
30671692|NCT00843024|58685553|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
30671693|NCT00843024|58685554|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
30671694|NCT00843024|58685555|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
30671695|NCT00843024|58685550|FG000|Single-blind Placebo Run-In Phase|Other|0|||
30671696|NCT00843024|58685551|FG001|Single-blind Placebo Run-In Phase|Other|1|||
30671697|NCT00843024|58685552|FG002|Single-blind Placebo Run-In Phase|Other|0|||
30671698|NCT00843024|58685553|FG003|Single-blind Placebo Run-In Phase|Other|0|||
30671699|NCT00843024|58685554|FG004|Single-blind Placebo Run-In Phase|Other|0|||
30671700|NCT00843024|58685555|FG005|Single-blind Placebo Run-In Phase|Other|0|||
30671701|NCT00843024|58685550|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
30587621|NCT01216072|58599813|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
30671702|NCT00843024|58685551|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
30587622|NCT01216072|58599814|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
30671703|NCT00843024|58685552|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
30671704|NCT00843024|58685553|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
30671705|NCT00843024|58685554|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
30671706|NCT00843024|58685555|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
30671707|NCT00843024|58685550|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
30671708|NCT00843024|58685551|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
30671709|NCT00843024|58685552|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
30671710|NCT00843024|58685553|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
30671711|NCT00843024|58685554|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
30671712|NCT00843024|58685555|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
30671713|NCT00843024|58685550|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
30671714|NCT00843024|58685551|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
30671715|NCT00843024|58685552|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
30671716|NCT00843024|58685553|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
30671717|NCT00843024|58685554|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
30671718|NCT00843024|58685555|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
30671719|NCT00843024|58685550|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
30671720|NCT00843024|58685551|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
30587623|NCT01184989|58599823|FG000|Overall Study|Adverse Event|11|||
30587624|NCT01184989|58599823|FG000|Overall Study|Withdrawal by Subject|1|||
30587625|NCT01215955|58599831|FG000|Overall Study|Adverse Event|1|||
30587626|NCT01215955|58599832|FG001|Overall Study|Adverse Event|4|||
30587627|NCT01215955|58599833|FG002|Overall Study|Adverse Event|2|||
30587628|NCT01215955|58599834|FG003|Overall Study|Adverse Event|3|||
30587629|NCT01215955|58599831|FG000|Overall Study|Death|2|||
30587630|NCT01215955|58599832|FG001|Overall Study|Death|0|||
30671721|NCT00843024|58685552|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
30671722|NCT00843024|58685553|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
30671723|NCT00843024|58685554|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
30671724|NCT00843024|58685555|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
30671725|NCT00843024|58685550|FG000|Double-blind Treatment Phase|Physician Decision|0|||
30671726|NCT00843024|58685551|FG001|Double-blind Treatment Phase|Physician Decision|0|||
30671727|NCT00843024|58685552|FG002|Double-blind Treatment Phase|Physician Decision|0|||
30671728|NCT00843024|58685553|FG003|Double-blind Treatment Phase|Physician Decision|3|||
30671729|NCT00843024|58685554|FG004|Double-blind Treatment Phase|Physician Decision|1|||
30587631|NCT01215955|58599833|FG002|Overall Study|Death|1|||
30587632|NCT01215955|58599834|FG003|Overall Study|Death|3|||
30587633|NCT01215955|58599831|FG000|Overall Study|Entry Criteria Not Met|1|||
30587634|NCT01215955|58599832|FG001|Overall Study|Entry Criteria Not Met|3|||
30587635|NCT01215955|58599833|FG002|Overall Study|Entry Criteria Not Met|4|||
30587636|NCT01215955|58599834|FG003|Overall Study|Entry Criteria Not Met|7|||
30587637|NCT01215955|58599831|FG000|Overall Study|Lack of Efficacy|1|||
30587638|NCT01215955|58599832|FG001|Overall Study|Lack of Efficacy|2|||
30587639|NCT01215955|58599833|FG002|Overall Study|Lack of Efficacy|1|||
30587640|NCT01215955|58599834|FG003|Overall Study|Lack of Efficacy|0|||
30671730|NCT00843024|58685555|FG005|Double-blind Treatment Phase|Physician Decision|1|||
30587641|NCT01215955|58599831|FG000|Overall Study|Lost to Follow-up|4|||
30587642|NCT01215955|58599832|FG001|Overall Study|Lost to Follow-up|4|||
30587643|NCT01215955|58599833|FG002|Overall Study|Lost to Follow-up|8|||
30587644|NCT01215955|58599834|FG003|Overall Study|Lost to Follow-up|9|||
30587645|NCT01215955|58599831|FG000|Overall Study|Physician Decision|4|||
30587646|NCT01215955|58599832|FG001|Overall Study|Physician Decision|10|||
30587647|NCT01215955|58599833|FG002|Overall Study|Physician Decision|8|||
30587648|NCT01215955|58599834|FG003|Overall Study|Physician Decision|11|||
30587649|NCT01215955|58599831|FG000|Overall Study|Protocol Violation|17|||
30587650|NCT01215955|58599832|FG001|Overall Study|Protocol Violation|13|||
30587651|NCT01215955|58599833|FG002|Overall Study|Protocol Violation|8|||
30587652|NCT01215955|58599834|FG003|Overall Study|Protocol Violation|8|||
30587653|NCT01215955|58599831|FG000|Overall Study|Sponsor Decision|1|||
30587654|NCT01215955|58599832|FG001|Overall Study|Sponsor Decision|2|||
30587655|NCT01215955|58599833|FG002|Overall Study|Sponsor Decision|0|||
30587656|NCT01215955|58599834|FG003|Overall Study|Sponsor Decision|1|||
30587657|NCT01215955|58599831|FG000|Overall Study|Withdrawal by Subject|14|||
30587658|NCT01215955|58599832|FG001|Overall Study|Withdrawal by Subject|15|||
30781211|NCT02967562|58793302|FG000|Overall Study|Consent not obtained|1|||
30958878|NCT01587703|59024028|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30958879|NCT01587703|59024029|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30587659|NCT01215955|58599833|FG002|Overall Study|Withdrawal by Subject|13|||
30587660|NCT01215955|58599834|FG003|Overall Study|Withdrawal by Subject|9|||
30587661|NCT01215955|58599831|FG000|Overall Study|Quality Issues|0|||
30587662|NCT01215955|58599832|FG001|Overall Study|Quality Issues|0|||
30587663|NCT01215955|58599833|FG002|Overall Study|Quality Issues|3|||
30587664|NCT01215955|58599834|FG003|Overall Study|Quality Issues|2|||
30587665|NCT01215916|58599869|FG000|Overall Study|Progressive Disease|0|||
30587666|NCT01215916|58599870|FG001|Overall Study|Progressive Disease|2|||
30587667|NCT01215916|58599871|FG002|Overall Study|Progressive Disease|1|||
30587668|NCT01215916|58599872|FG003|Overall Study|Progressive Disease|2|||
30587669|NCT01215916|58599873|FG004|Overall Study|Progressive Disease|5|||
30587670|NCT01215916|58599874|FG005|Overall Study|Progressive Disease|4|||
30587671|NCT01215916|58599875|FG006|Overall Study|Progressive Disease|5|||
30587672|NCT01215916|58599876|FG007|Overall Study|Progressive Disease|3|||
30587673|NCT01215916|58599877|FG008|Overall Study|Progressive Disease|1|||
30587674|NCT01215916|58599869|FG000|Overall Study|Adverse Event|1|||
30587675|NCT01215916|58599870|FG001|Overall Study|Adverse Event|1|||
30587676|NCT01215916|58599871|FG002|Overall Study|Adverse Event|0|||
30587677|NCT01215916|58599872|FG003|Overall Study|Adverse Event|1|||
30587678|NCT01215916|58599873|FG004|Overall Study|Adverse Event|0|||
30587679|NCT01215916|58599874|FG005|Overall Study|Adverse Event|0|||
30587680|NCT01215916|58599875|FG006|Overall Study|Adverse Event|3|||
30587681|NCT01215916|58599876|FG007|Overall Study|Adverse Event|0|||
30587682|NCT01215916|58599877|FG008|Overall Study|Adverse Event|0|||
30587683|NCT01215916|58599869|FG000|Overall Study|Withdrawal by Subject|0|||
30587684|NCT01215916|58599870|FG001|Overall Study|Withdrawal by Subject|1|||
30587685|NCT01215916|58599871|FG002|Overall Study|Withdrawal by Subject|1|||
30587686|NCT01215916|58599872|FG003|Overall Study|Withdrawal by Subject|2|||
30587687|NCT01215916|58599873|FG004|Overall Study|Withdrawal by Subject|0|||
30587688|NCT01215916|58599874|FG005|Overall Study|Withdrawal by Subject|0|||
30587689|NCT01215916|58599875|FG006|Overall Study|Withdrawal by Subject|1|||
30587690|NCT01215916|58599876|FG007|Overall Study|Withdrawal by Subject|0|||
30587691|NCT01215916|58599877|FG008|Overall Study|Withdrawal by Subject|0|||
30587692|NCT01215916|58599869|FG000|Overall Study|Death|0|||
30587693|NCT01215916|58599870|FG001|Overall Study|Death|1|||
30587694|NCT01215916|58599871|FG002|Overall Study|Death|0|||
30587695|NCT01215916|58599872|FG003|Overall Study|Death|0|||
30587696|NCT01215916|58599873|FG004|Overall Study|Death|1|||
30587697|NCT01215916|58599874|FG005|Overall Study|Death|0|||
30587698|NCT01215916|58599875|FG006|Overall Study|Death|0|||
30587699|NCT01215916|58599876|FG007|Overall Study|Death|0|||
30587700|NCT01215916|58599877|FG008|Overall Study|Death|1|||
30587701|NCT01215916|58599869|FG000|Overall Study|Physician Decision|0|||
30587702|NCT01215916|58599870|FG001|Overall Study|Physician Decision|0|||
30587703|NCT01215916|58599871|FG002|Overall Study|Physician Decision|1|||
30587704|NCT01215916|58599872|FG003|Overall Study|Physician Decision|1|||
30587705|NCT01215916|58599873|FG004|Overall Study|Physician Decision|0|||
30587706|NCT01215916|58599874|FG005|Overall Study|Physician Decision|0|||
30587707|NCT01215916|58599875|FG006|Overall Study|Physician Decision|0|||
30587708|NCT01215916|58599876|FG007|Overall Study|Physician Decision|0|||
30587709|NCT01215916|58599877|FG008|Overall Study|Physician Decision|0|||
30587710|NCT01184872|58599903|FG000|Overall Study|Adverse Event|3|||
30587711|NCT01184872|58599904|FG001|Overall Study|Adverse Event|4|||
30587712|NCT01184872|58599903|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
30587713|NCT01184872|58599904|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30587714|NCT01184872|58599903|FG000|Overall Study|Withdrawal by Subject|2|||
30587715|NCT01184872|58599904|FG001|Overall Study|Withdrawal by Subject|0|||
30587716|NCT01184872|58599903|FG000|Overall Study|Lost to Follow-up|0|||
30587717|NCT01184872|58599904|FG001|Overall Study|Lost to Follow-up|1|||
30587718|NCT01184872|58599903|FG000|Overall Study|Administrative problems|1|||
30587719|NCT01184872|58599904|FG001|Overall Study|Administrative problems|1|||
30587720|NCT01184872|58599903|FG000|Overall Study|Protocol deviation|1|||
30587721|NCT01184872|58599904|FG001|Overall Study|Protocol deviation|0|||
30587722|NCT01215721|58599910|FG000|Overall Study|Adverse Event|2|||
30587723|NCT01184326|58599917|FG000|Overall Study|Adverse Event|1|||
30587724|NCT01184326|58599918|FG001|Overall Study|Adverse Event|2|||
30587725|NCT01184326|58599919|FG002|Overall Study|Adverse Event|0|||
30587726|NCT01184326|58599917|FG000|Overall Study|Death|0|||
30587727|NCT01184326|58599918|FG001|Overall Study|Death|0|||
30587728|NCT01184326|58599919|FG002|Overall Study|Death|1|||
30587729|NCT01184326|58599917|FG000|Overall Study|Withdrawal by Subject|0|||
30587730|NCT01184326|58599918|FG001|Overall Study|Withdrawal by Subject|0|||
30587731|NCT01184326|58599919|FG002|Overall Study|Withdrawal by Subject|1|||
30587732|NCT01184326|58599917|FG000|Overall Study|Physician Decision|1|||
30855795|NCT02585960|58883503|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
30587733|NCT01184326|58599918|FG001|Overall Study|Physician Decision|1|||
30587734|NCT01184326|58599919|FG002|Overall Study|Physician Decision|0|||
30587735|NCT01184326|58599917|FG000|Overall Study|Disease Progression|1|||
30587736|NCT01184326|58599918|FG001|Overall Study|Disease Progression|3|||
30587737|NCT01184326|58599919|FG002|Overall Study|Disease Progression|12|||
30587738|NCT01215253|58599932|FG000|Overall Study|Withdrawal by Subject|57|||
30587739|NCT01215253|58599933|FG001|Overall Study|Withdrawal by Subject|35|||
30781212|NCT02967562|58793303|FG001|Overall Study|Consent not obtained|0|||
30587740|NCT01215253|58599932|FG000|Overall Study|Physician Decision|9|||
30587741|NCT01215253|58599933|FG001|Overall Study|Physician Decision|12|||
30587742|NCT01215253|58599932|FG000|Overall Study|Lost to Follow-up|6|||
30587743|NCT01215253|58599933|FG001|Overall Study|Lost to Follow-up|4|||
30587744|NCT01215253|58599932|FG000|Overall Study|Other|14|||
30587745|NCT01215253|58599933|FG001|Overall Study|Other|12|||
30671731|NCT00843024|58685550|FG000|Double-blind Treatment Phase|Adverse Event|0|||
30671732|NCT00843024|58685551|FG001|Double-blind Treatment Phase|Adverse Event|0|||
30671733|NCT00843024|58685552|FG002|Double-blind Treatment Phase|Adverse Event|0|||
30671734|NCT00843024|58685553|FG003|Double-blind Treatment Phase|Adverse Event|0|||
30671735|NCT00843024|58685554|FG004|Double-blind Treatment Phase|Adverse Event|1|||
30781213|NCT02967562|58793302|FG000|Overall Study|High leak precluding analysis|1|||
30781214|NCT02967562|58793303|FG001|Overall Study|High leak precluding analysis|1|||
30781215|NCT02968576|58793309|FG000|Overall Study|Pregnancy|0|||
30781216|NCT02968576|58793310|FG001|Overall Study|Pregnancy|1|||
30781217|NCT02966002|58793314|FG000|Overall Study|Withdrawal by Subject|2|||
30781218|NCT02966002|58793314|FG000|Overall Study|Adverse Event|1|||
30781219|NCT02966002|58793314|FG000|Overall Study|Lost to Follow-up|1|||
30781220|NCT02965846|58793321|FG000|Overall Study|Lost to Follow-up|1|||
30781221|NCT02965846|58793322|FG001|Overall Study|Lost to Follow-up|0|||
30781222|NCT02965846|58793323|FG002|Overall Study|Lost to Follow-up|0|||
30781223|NCT02965846|58793321|FG000|Overall Study|Withdrawal by Subject|0|||
30781224|NCT02965846|58793322|FG001|Overall Study|Withdrawal by Subject|1|||
30781225|NCT02965846|58793323|FG002|Overall Study|Withdrawal by Subject|0|||
30781226|NCT02965846|58793321|FG000|Overall Study|Study Terminated By Sponsor|4|||
30781227|NCT02965846|58793322|FG001|Overall Study|Study Terminated By Sponsor|4|||
30781228|NCT02965846|58793323|FG002|Overall Study|Study Terminated By Sponsor|0|||
30781229|NCT02965846|58793321|FG000|Overall Study|Participants not randomized|0|||
30781230|NCT02965846|58793322|FG001|Overall Study|Participants not randomized|0|||
30781231|NCT02965846|58793323|FG002|Overall Study|Participants not randomized|33|||
30781232|NCT02900170|58793329|FG000|Overall Study|Lost to Follow-up|8|||
30781233|NCT02900092|58793333|FG000|Overall Study|Adverse Event|1|||
30781234|NCT02902120|58793341|FG000|Overall Study|Lack of Efficacy|1|||
30781235|NCT02965456|58793347|FG000|Overall Study|Lost to Follow-up|40|||
30781236|NCT02965456|58793348|FG001|Overall Study|Lost to Follow-up|18|||
30781237|NCT02965456|58793347|FG000|Overall Study|Subject Request|22|||
30781238|NCT02965456|58793348|FG001|Overall Study|Subject Request|13|||
30781239|NCT02965456|58793347|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
30781240|NCT02965456|58793348|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
30781241|NCT02965456|58793347|FG000|Overall Study|Adverse Event|3|||
30781242|NCT02965456|58793348|FG001|Overall Study|Adverse Event|0|||
30781243|NCT02965456|58793347|FG000|Overall Study|Noncompliance with Study Drug|1|||
30781244|NCT02965456|58793348|FG001|Overall Study|Noncompliance with Study Drug|1|||
30781245|NCT02965456|58793347|FG000|Overall Study|Worsening Condition|0|||
30781246|NCT02965456|58793348|FG001|Overall Study|Worsening Condition|2|||
30781247|NCT02965456|58793347|FG000|Overall Study|Lack of Efficacy|1|||
30781248|NCT02965456|58793348|FG001|Overall Study|Lack of Efficacy|0|||
30781249|NCT02965456|58793347|FG000|Overall Study|Physician Decision|0|||
30781250|NCT02965456|58793348|FG001|Overall Study|Physician Decision|1|||
30781251|NCT02965456|58793347|FG000|Overall Study|Pregnancy|1|||
30781252|NCT02965456|58793348|FG001|Overall Study|Pregnancy|0|||
30781253|NCT02965456|58793347|FG000|Overall Study|Protocol Violation|0|||
30781254|NCT02965456|58793348|FG001|Overall Study|Protocol Violation|1|||
30781255|NCT02965456|58793347|FG000|Overall Study|Participant ran out of study drug|0|||
30781256|NCT02965456|58793348|FG001|Overall Study|Participant ran out of study drug|1|||
30781257|NCT02965378|58793356|FG000|Overall Study|Progression|16|||
30781258|NCT02965378|58793357|FG001|Overall Study|Progression|4|||
30781259|NCT02965378|58793356|FG000|Overall Study|Adverse Event|5|||
30781260|NCT02965378|58793357|FG001|Overall Study|Adverse Event|2|||
30781261|NCT02965378|58793356|FG000|Overall Study|Death|2|||
30781262|NCT02965378|58793357|FG001|Overall Study|Death|0|||
30781263|NCT02965378|58793356|FG000|Overall Study|Refusal|2|||
30781264|NCT02965378|58793357|FG001|Overall Study|Refusal|1|||
30781265|NCT02965378|58793356|FG000|Overall Study|Not protocol specified|0|||
30587746|NCT01184053|58599940|FG000|Overall Study|progression while on treatment|3|||
30587747|NCT01183975|58599945|FG000|Overall Study|Lost to Follow-up|73|||
30587748|NCT01183858|58599951|FG000|Overall Study|Death not related to Progressive Disease|5|||
30587749|NCT01183858|58599952|FG001|Overall Study|Death not related to Progressive Disease|6|||
30587750|NCT01183858|58599951|FG000|Overall Study|Adverse Event|14|||
30781266|NCT02965378|58793357|FG001|Overall Study|Not protocol specified|2|||
30781267|NCT03772041|58793365|FG000|Overall Study|Adverse Event|8|||
30781268|NCT03772041|58793366|FG001|Overall Study|Adverse Event|3|||
30781269|NCT03772041|58793365|FG000|Overall Study|Withdrawal by Subject|0|||
30781270|NCT03772041|58793366|FG001|Overall Study|Withdrawal by Subject|2|||
30781271|NCT03772041|58793365|FG000|Overall Study|Protocol Violation|4|||
30781272|NCT03772041|58793366|FG001|Overall Study|Protocol Violation|2|||
30855796|NCT02585960|58883504|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
30855797|NCT02585960|58883505|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
30587751|NCT01183858|58599952|FG001|Overall Study|Adverse Event|11|||
30781273|NCT03772041|58793365|FG000|Overall Study|Physician Decision|2|||
30781274|NCT03772041|58793366|FG001|Overall Study|Physician Decision|3|||
30781275|NCT02899156|58793374|FG000|Overall Study|Death|1|||
30587752|NCT01183858|58599951|FG000|Overall Study|Investigator's Decision|0|||
30587753|NCT01183858|58599952|FG001|Overall Study|Investigator's Decision|3|||
30587754|NCT01183858|58599951|FG000|Overall Study|Insufficient Therapeutic Response|2|||
30587755|NCT01183858|58599952|FG001|Overall Study|Insufficient Therapeutic Response|0|||
30587756|NCT01183858|58599951|FG000|Overall Study|Refused Treatment|1|||
30587757|NCT01183858|58599952|FG001|Overall Study|Refused Treatment|4|||
30587758|NCT01183858|58599951|FG000|Overall Study|Withdrew Consent|4|||
30587759|NCT01183858|58599952|FG001|Overall Study|Withdrew Consent|4|||
30587760|NCT01183858|58599951|FG000|Overall Study|Discontinued Smoking|3|||
30587761|NCT01183858|58599952|FG001|Overall Study|Discontinued Smoking|1|||
30587762|NCT01183858|58599951|FG000|Overall Study|Protocol Violation|1|||
30587763|NCT01183858|58599952|FG001|Overall Study|Protocol Violation|0|||
30587764|NCT01183858|58599951|FG000|Overall Study|Administrative/Other|6|||
30587765|NCT01183858|58599952|FG001|Overall Study|Administrative/Other|6|||
30587766|NCT01183858|58599951|FG000|Overall Study|Progressive Disease|112|||
30587767|NCT01183858|58599952|FG001|Overall Study|Progressive Disease|115|||
30587768|NCT01183858|58599951|FG000|Overall Study|Death related to Progressive Disease|4|||
30587769|NCT01183858|58599952|FG001|Overall Study|Death related to Progressive Disease|5|||
30671736|NCT00843024|58685555|FG005|Double-blind Treatment Phase|Adverse Event|1|||
30671737|NCT00843024|58685550|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
30671738|NCT00843024|58685551|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
30671739|NCT00843024|58685552|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
30671740|NCT00843024|58685553|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
30671741|NCT00843024|58685554|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
30587770|NCT01183858|58599951|FG000|Overall Study|Lost to Follow-up|1|||
30587771|NCT01183858|58599952|FG001|Overall Study|Lost to Follow-up|1|||
30587772|NCT01215175|58599963|FG000|Overall Study|Lost to Follow-up|0|||
30587773|NCT01215175|58599964|FG001|Overall Study|Lost to Follow-up|1|||
30587774|NCT01215175|58599965|FG002|Overall Study|Lost to Follow-up|0|||
30587775|NCT01215175|58599966|FG003|Overall Study|Lost to Follow-up|1|||
30587776|NCT01215175|58599967|FG004|Overall Study|Lost to Follow-up|0|||
30587777|NCT01215097|58599981|FG000|Overall Study|Adverse Event|1|||
30587778|NCT01215097|58599982|FG001|Overall Study|Adverse Event|3|||
30587779|NCT01215097|58599981|FG000|Overall Study|Protocol Violation|0|||
30587780|NCT01215097|58599982|FG001|Overall Study|Protocol Violation|2|||
30587781|NCT01215097|58599981|FG000|Overall Study|Lost to Follow-up|2|||
30587782|NCT01215097|58599982|FG001|Overall Study|Lost to Follow-up|0|||
30587783|NCT01215097|58599981|FG000|Overall Study|Withdrawal by Subject|6|||
30587784|NCT01215097|58599982|FG001|Overall Study|Withdrawal by Subject|3|||
30587785|NCT01215097|58599981|FG000|Overall Study|Lack of Efficacy|0|||
30587786|NCT01215097|58599982|FG001|Overall Study|Lack of Efficacy|3|||
30587787|NCT01215097|58599981|FG000|Overall Study|patient's refusal to come|2|||
30587788|NCT01215097|58599982|FG001|Overall Study|patient's refusal to come|2|||
30587789|NCT01215097|58599981|FG000|Overall Study|patient's private reason|1|||
30587790|NCT01215097|58599982|FG001|Overall Study|patient's private reason|1|||
30587791|NCT03303339|58600000|FG000|Overall Study|Death|2|||
30587792|NCT03303339|58600001|FG001|Overall Study|Death|2|||
30587793|NCT03303339|58600002|FG002|Overall Study|Death|2|||
30587794|NCT03303339|58600003|FG003|Overall Study|Death|1|||
30587795|NCT03303339|58600004|FG004|Overall Study|Death|4|||
30587796|NCT03303339|58600005|FG005|Overall Study|Death|2|||
30587797|NCT03303339|58600006|FG006|Overall Study|Death|2|||
30587798|NCT03303339|58600007|FG007|Overall Study|Death|2|||
30587799|NCT03303339|58600008|FG008|Overall Study|Death|3|||
30587800|NCT03303339|58600009|FG009|Overall Study|Death|3|||
30587801|NCT03303339|58600010|FG010|Overall Study|Death|4|||
30587802|NCT03303339|58600011|FG011|Overall Study|Death|24|||
30587803|NCT03303339|58600000|FG000|Overall Study|Study Terminated by Sponsor|0|||
30587804|NCT03303339|58600001|FG001|Overall Study|Study Terminated by Sponsor|0|||
30587805|NCT03303339|58600002|FG002|Overall Study|Study Terminated by Sponsor|0|||
30587806|NCT03303339|58600003|FG003|Overall Study|Study Terminated by Sponsor|0|||
30587807|NCT03303339|58600004|FG004|Overall Study|Study Terminated by Sponsor|0|||
30587808|NCT03303339|58600005|FG005|Overall Study|Study Terminated by Sponsor|0|||
30587809|NCT03303339|58600006|FG006|Overall Study|Study Terminated by Sponsor|0|||
30587810|NCT03303339|58600007|FG007|Overall Study|Study Terminated by Sponsor|0|||
30587811|NCT03303339|58600008|FG008|Overall Study|Study Terminated by Sponsor|1|||
30587812|NCT03303339|58600009|FG009|Overall Study|Study Terminated by Sponsor|0|||
30587813|NCT03303339|58600010|FG010|Overall Study|Study Terminated by Sponsor|1|||
30671742|NCT00843024|58685555|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
30587814|NCT03303339|58600011|FG011|Overall Study|Study Terminated by Sponsor|1|||
30587815|NCT03303339|58600000|FG000|Overall Study|Withdrawal by Subject|1|||
30587816|NCT03303339|58600001|FG001|Overall Study|Withdrawal by Subject|0|||
30855798|NCT02585960|58883503|FG000|PK/Safety Assessment Period|Other|4|||
30587817|NCT03303339|58600002|FG002|Overall Study|Withdrawal by Subject|0|||
30587818|NCT03303339|58600003|FG003|Overall Study|Withdrawal by Subject|0|||
30587819|NCT03303339|58600004|FG004|Overall Study|Withdrawal by Subject|0|||
30587820|NCT03303339|58600005|FG005|Overall Study|Withdrawal by Subject|1|||
30587821|NCT03303339|58600006|FG006|Overall Study|Withdrawal by Subject|1|||
30587822|NCT03303339|58600007|FG007|Overall Study|Withdrawal by Subject|0|||
30587823|NCT03303339|58600008|FG008|Overall Study|Withdrawal by Subject|0|||
30781276|NCT02899156|58793375|FG001|Overall Study|Death|0|||
30781277|NCT02899156|58793374|FG000|Overall Study|Physician Decision|0|||
30781278|NCT02899156|58793375|FG001|Overall Study|Physician Decision|1|||
30671743|NCT00832650|58685571|FG000|Overall Study|Randomized but not treated|0|||
30671744|NCT00832650|58685572|FG001|Overall Study|Randomized but not treated|0|||
30671745|NCT00832650|58685573|FG002|Overall Study|Randomized but not treated|1|||
30671746|NCT00595517|58685581|FG000|Overall Study|Adverse Event|6|||
30671747|NCT00595517|58685581|FG000|Overall Study|Withdrawal by Subject|4|||
30671748|NCT00595517|58685581|FG000|Overall Study|Protocol Violation|2|||
30671749|NCT00595517|58685581|FG000|Overall Study|Recurrence of ulcer|5|||
30671750|NCT00595517|58685581|FG000|Overall Study|usage of prohibited treatment|1|||
30671751|NCT00595517|58685581|FG000|Overall Study|No intention to attend regularly|1|||
30671752|NCT00823836|58685587|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
30671753|NCT00823836|58685588|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
30671754|NCT00823836|58685587|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
30671755|NCT00823836|58685588|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
30671756|NCT00823836|58685587|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
30671757|NCT00823836|58685588|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
30671758|NCT00823836|58685587|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
30671759|NCT00823836|58685588|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
30671760|NCT00823836|58685587|FG000|Long-term Phase|Adverse Event|3|||
30671761|NCT00823836|58685588|FG001|Long-term Phase|Adverse Event|2|||
30671762|NCT00823836|58685587|FG000|Long-term Phase|Physician Decision|1|||
30671763|NCT00823836|58685588|FG001|Long-term Phase|Physician Decision|2|||
30671764|NCT00823836|58685587|FG000|Long-term Phase|Withdrawal by Subject|1|||
30671765|NCT00823836|58685588|FG001|Long-term Phase|Withdrawal by Subject|1|||
30671766|NCT00879437|58685597|FG000|Overall Study|Protocol Violation|0|||
30671767|NCT00879437|58685598|FG001|Overall Study|Protocol Violation|1|||
30671768|NCT00879437|58685597|FG000|Overall Study|Death|1|||
30671769|NCT00879437|58685598|FG001|Overall Study|Death|0|||
30671770|NCT00877799|58685611|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
30671771|NCT00877799|58685612|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
30671772|NCT00877799|58685613|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
30671773|NCT00877799|58685614|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
30671774|NCT00877799|58685615|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
30671775|NCT00877799|58685611|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
30671776|NCT00877799|58685612|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
30671777|NCT00877799|58685613|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
30671778|NCT00877799|58685614|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
30671779|NCT00877799|58685615|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
30781279|NCT03773133|58793381|FG000|Overall Study|Screen Failure|8|||
30781280|NCT02969356|58793386|FG000|Overall Study|Adverse Event|7|||
30587824|NCT03303339|58600009|FG009|Overall Study|Withdrawal by Subject|0|||
30587825|NCT03303339|58600010|FG010|Overall Study|Withdrawal by Subject|0|||
30587826|NCT03303339|58600011|FG011|Overall Study|Withdrawal by Subject|2|||
30587827|NCT03303339|58600000|FG000|Overall Study|Physician Decision|0|||
30587828|NCT03303339|58600001|FG001|Overall Study|Physician Decision|0|||
30587829|NCT03303339|58600002|FG002|Overall Study|Physician Decision|0|||
30587830|NCT03303339|58600003|FG003|Overall Study|Physician Decision|0|||
30587831|NCT03303339|58600004|FG004|Overall Study|Physician Decision|1|||
30587832|NCT03303339|58600005|FG005|Overall Study|Physician Decision|0|||
30587833|NCT03303339|58600006|FG006|Overall Study|Physician Decision|0|||
30587834|NCT03303339|58600007|FG007|Overall Study|Physician Decision|0|||
30587835|NCT03303339|58600008|FG008|Overall Study|Physician Decision|0|||
30587836|NCT03303339|58600009|FG009|Overall Study|Physician Decision|0|||
30587837|NCT03303339|58600010|FG010|Overall Study|Physician Decision|0|||
30587838|NCT03303339|58600011|FG011|Overall Study|Physician Decision|0|||
30587839|NCT03303339|58600000|FG000|Overall Study|Safety/Non-compliance|0|||
30587840|NCT03303339|58600001|FG001|Overall Study|Safety/Non-compliance|0|||
30587841|NCT03303339|58600002|FG002|Overall Study|Safety/Non-compliance|0|||
30587842|NCT03303339|58600003|FG003|Overall Study|Safety/Non-compliance|0|||
30587843|NCT03303339|58600004|FG004|Overall Study|Safety/Non-compliance|0|||
30781281|NCT02969356|58793386|FG000|Overall Study|Consent withdrawn|2|||
30587844|NCT03303339|58600005|FG005|Overall Study|Safety/Non-compliance|0|||
30587845|NCT03303339|58600006|FG006|Overall Study|Safety/Non-compliance|0|||
30587846|NCT03303339|58600007|FG007|Overall Study|Safety/Non-compliance|0|||
30671780|NCT00877799|58685611|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
30671781|NCT00877799|58685612|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
30671782|NCT00877799|58685613|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
30781282|NCT02969356|58793386|FG000|Overall Study|Lost to Follow-up|3|||
30781283|NCT02969356|58793386|FG000|Overall Study|Did not need to be reinjected|6|||
30587847|NCT03303339|58600008|FG008|Overall Study|Safety/Non-compliance|0|||
30587848|NCT03303339|58600009|FG009|Overall Study|Safety/Non-compliance|0|||
30587849|NCT03303339|58600010|FG010|Overall Study|Safety/Non-compliance|0|||
30587850|NCT03303339|58600011|FG011|Overall Study|Safety/Non-compliance|1|||
30587851|NCT01183780|58600056|FG000|Overall Study|Withdrawal by Subject|25|||
30587852|NCT01183780|58600057|FG001|Overall Study|Withdrawal by Subject|14|||
30587853|NCT01183780|58600056|FG000|Overall Study|Lost to Follow-up|6|||
30587854|NCT01183780|58600057|FG001|Overall Study|Lost to Follow-up|11|||
30587855|NCT01183468|58600067|FG000|Overall Study|Lost to Follow-up|2|||
30587856|NCT01183468|58600068|FG001|Overall Study|Lost to Follow-up|1|||
30671783|NCT00877799|58685614|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
30671784|NCT00877799|58685615|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
30671785|NCT00877799|58685611|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
30671786|NCT00877799|58685612|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
30671787|NCT00877799|58685613|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
30671788|NCT00877799|58685614|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
30671789|NCT00877799|58685615|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
30671790|NCT00877799|58685611|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
30671791|NCT00877799|58685612|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
30671792|NCT00877799|58685613|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
30671793|NCT00877799|58685614|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
30671794|NCT00877799|58685615|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
30671795|NCT00595127|58685626|FG000|Overall Study|Death|6|||
30671796|NCT00595127|58685626|FG000|Overall Study|Relapsed|3|||
30671797|NCT00595127|58685626|FG000|Overall Study|joined another trial|1|||
30671798|NCT00877487|58685630|FG000|Open-label Treatment Phase|Adverse Event|1|||
30671799|NCT00877487|58685631|FG001|Open-label Treatment Phase|Adverse Event|0|||
30587857|NCT01183468|58600069|FG002|Overall Study|Lost to Follow-up|0|||
30587858|NCT01183468|58600070|FG003|Overall Study|Lost to Follow-up|0|||
30587859|NCT01183468|58600067|FG000|Overall Study|Physician Decision|1|||
30587860|NCT01183468|58600068|FG001|Overall Study|Physician Decision|0|||
30587861|NCT01183468|58600069|FG002|Overall Study|Physician Decision|0|||
30587862|NCT01183468|58600070|FG003|Overall Study|Physician Decision|0|||
30671800|NCT00877487|58685630|FG000|Open-label Treatment Phase|Protocol Violation|3|||
30671801|NCT00877487|58685631|FG001|Open-label Treatment Phase|Protocol Violation|0|||
30587863|NCT01183468|58600067|FG000|Overall Study|Withdrawal by Subject|0|||
30587864|NCT01183468|58600068|FG001|Overall Study|Withdrawal by Subject|1|||
30587865|NCT01183468|58600069|FG002|Overall Study|Withdrawal by Subject|0|||
30587866|NCT01183468|58600070|FG003|Overall Study|Withdrawal by Subject|0|||
30587867|NCT01183390|58600080|FG000|First Intervention|Adverse Event|0|||
30587868|NCT01183390|58600081|FG001|First Intervention|Adverse Event|1|||
30587869|NCT01214668|58600093|FG000|Overall Study|Adverse Event|0|||
30587870|NCT01214668|58600094|FG001|Overall Study|Adverse Event|1|||
30587871|NCT01214668|58600095|FG002|Overall Study|Adverse Event|0|||
30587872|NCT01214668|58600096|FG003|Overall Study|Adverse Event|2|||
30587873|NCT01214668|58600097|FG004|Overall Study|Adverse Event|1|||
30587874|NCT01214668|58600098|FG005|Overall Study|Adverse Event|1|||
30587875|NCT01214668|58600093|FG000|Overall Study|Death|0|||
30587876|NCT01214668|58600094|FG001|Overall Study|Death|0|||
30587877|NCT01214668|58600095|FG002|Overall Study|Death|1|||
30587878|NCT01214668|58600096|FG003|Overall Study|Death|0|||
30671802|NCT00877487|58685630|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
30671803|NCT00877487|58685631|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
30671804|NCT00877487|58685630|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
30671805|NCT00877487|58685631|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
30587879|NCT01214668|58600097|FG004|Overall Study|Death|0|||
30587880|NCT01214668|58600098|FG005|Overall Study|Death|0|||
30587881|NCT01214668|58600093|FG000|Overall Study|Progressive Disease|4|||
30671806|NCT00877487|58685630|FG000|Open-label Treatment Phase|Out of country for business|1|||
30587882|NCT01214668|58600094|FG001|Overall Study|Progressive Disease|2|||
30587883|NCT01214668|58600095|FG002|Overall Study|Progressive Disease|5|||
30587884|NCT01214668|58600096|FG003|Overall Study|Progressive Disease|4|||
30587885|NCT01214668|58600097|FG004|Overall Study|Progressive Disease|4|||
30671807|NCT00877487|58685631|FG001|Open-label Treatment Phase|Out of country for business|0|||
30671808|NCT00877487|58685630|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
30671809|NCT00877487|58685631|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
30671810|NCT00877487|58685630|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
30671811|NCT00877487|58685631|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
30671812|NCT00877487|58685630|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
30587886|NCT01214668|58600098|FG005|Overall Study|Progressive Disease|5|||
30671813|NCT00877487|58685631|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
30671814|NCT00877487|58685630|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
30587887|NCT01214668|58600093|FG000|Overall Study|Withdrawal by Subject|0|||
30587888|NCT01214668|58600094|FG001|Overall Study|Withdrawal by Subject|0|||
30587889|NCT01214668|58600095|FG002|Overall Study|Withdrawal by Subject|0|||
30587890|NCT01214668|58600096|FG003|Overall Study|Withdrawal by Subject|0|||
30587891|NCT01214668|58600097|FG004|Overall Study|Withdrawal by Subject|1|||
30587892|NCT01214668|58600098|FG005|Overall Study|Withdrawal by Subject|0|||
30587893|NCT01191268|58600116|FG000|Overall Study|Withdrawal by Subject|19|||
30587894|NCT01191268|58600117|FG001|Overall Study|Withdrawal by Subject|25|||
30587895|NCT01191268|58600118|FG002|Overall Study|Withdrawal by Subject|21|||
30587896|NCT01191268|58600116|FG000|Overall Study|Adverse Event|21|||
30587897|NCT01191268|58600117|FG001|Overall Study|Adverse Event|13|||
30587898|NCT01191268|58600118|FG002|Overall Study|Adverse Event|8|||
30587899|NCT01191268|58600116|FG000|Overall Study|Physician Decision|6|||
30587900|NCT01191268|58600117|FG001|Overall Study|Physician Decision|8|||
30587901|NCT01191268|58600118|FG002|Overall Study|Physician Decision|9|||
30671815|NCT00877487|58685631|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
30671816|NCT00878501|58685640|FG000|Overall Study|Adverse Event|11|||
30671817|NCT00878501|58685641|FG001|Overall Study|Adverse Event|3|||
30587902|NCT01191268|58600116|FG000|Overall Study|Lost to Follow-up|8|||
30587903|NCT01191268|58600117|FG001|Overall Study|Lost to Follow-up|5|||
30587904|NCT01191268|58600118|FG002|Overall Study|Lost to Follow-up|9|||
30671818|NCT00878501|58685642|FG002|Overall Study|Adverse Event|3|||
30671819|NCT00878501|58685640|FG000|Overall Study|Lack of Efficacy|2|||
30671820|NCT00878501|58685641|FG001|Overall Study|Lack of Efficacy|1|||
30671821|NCT00878501|58685642|FG002|Overall Study|Lack of Efficacy|0|||
30671822|NCT00878501|58685640|FG000|Overall Study|Withdrawal by Subject|2|||
30671823|NCT00878501|58685641|FG001|Overall Study|Withdrawal by Subject|1|||
30671824|NCT00878501|58685642|FG002|Overall Study|Withdrawal by Subject|2|||
30671825|NCT00878501|58685640|FG000|Overall Study|Protocol Violation|0|||
30671826|NCT00878501|58685641|FG001|Overall Study|Protocol Violation|0|||
30671827|NCT00878501|58685642|FG002|Overall Study|Protocol Violation|1|||
30671828|NCT00878501|58685640|FG000|Overall Study|Incorrect enrolment|1|||
30671829|NCT00878501|58685641|FG001|Overall Study|Incorrect enrolment|2|||
30671830|NCT00878501|58685642|FG002|Overall Study|Incorrect enrolment|0|||
30671831|NCT00878501|58685640|FG000|Overall Study|Intake of prohibited concom. medication|0|||
30671832|NCT00878501|58685641|FG001|Overall Study|Intake of prohibited concom. medication|0|||
30671833|NCT00878501|58685642|FG002|Overall Study|Intake of prohibited concom. medication|1|||
30671834|NCT00878501|58685640|FG000|Overall Study|Mis-randomisation of patient|1|||
30671835|NCT00878501|58685641|FG001|Overall Study|Mis-randomisation of patient|0|||
30671836|NCT00878501|58685642|FG002|Overall Study|Mis-randomisation of patient|0|||
30671837|NCT00878501|58685640|FG000|Overall Study|Administrative|0|||
30671838|NCT00878501|58685641|FG001|Overall Study|Administrative|0|||
30671839|NCT00878501|58685642|FG002|Overall Study|Administrative|1|||
30671840|NCT00882713|58685650|FG000|Overall Study|Adverse Event|2|||
30671841|NCT00882713|58685650|FG000|Overall Study|Death|3|||
30587905|NCT01191268|58600116|FG000|Overall Study|Entry Criteria Not Met|3|||
30587906|NCT01191268|58600117|FG001|Overall Study|Entry Criteria Not Met|1|||
30587907|NCT01191268|58600118|FG002|Overall Study|Entry Criteria Not Met|1|||
30781284|NCT02969356|58793386|FG000|Overall Study|Personal reasons|5|||
30587908|NCT01191268|58600116|FG000|Overall Study|Death|0|||
30587909|NCT01191268|58600117|FG001|Overall Study|Death|1|||
30587910|NCT01191268|58600118|FG002|Overall Study|Death|3|||
30587911|NCT01191268|58600116|FG000|Overall Study|Protocol Violation|1|||
30587912|NCT01191268|58600117|FG001|Overall Study|Protocol Violation|0|||
30587913|NCT01191268|58600118|FG002|Overall Study|Protocol Violation|1|||
30587914|NCT01191268|58600116|FG000|Overall Study|Sponsor Decision|0|||
30587915|NCT01191268|58600117|FG001|Overall Study|Sponsor Decision|2|||
30587916|NCT01191268|58600118|FG002|Overall Study|Sponsor Decision|0|||
30587917|NCT01191190|58600127|FG000|Overall Study|Withdrawal by Subject|1|||
30587918|NCT05751629|58600131|FG000|Overall Study|Withdrawal by Subject|6|||
30587919|NCT05751629|58600131|FG000|Overall Study|Death|25|||
30587920|NCT05751629|58600131|FG000|Overall Study|Study Site Closed|9|||
30587921|NCT05751629|58600131|FG000|Overall Study|Physician Decision|1|||
30587922|NCT05306977|58600135|FG000|Overall Study|Withdrawal by Subject|1|||
30587923|NCT05086276|58600141|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
30587924|NCT05086276|58600142|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
30587925|NCT04870710|58600148|FG000|Overall Study|Lost to Follow-up|3|||
30671842|NCT00882713|58685650|FG000|Overall Study|Administrative reasons|4|||
30781285|NCT02898454|58793393|FG000|Overall Study|Adverse Event|4|||
30587926|NCT04858802|58600154|FG000|Overall Study|Lost to Follow-up|1|||
30671843|NCT00882713|58685650|FG000|Overall Study|refused treatment/withdrew consent|4|||
30671844|NCT00882713|58685650|FG000|Overall Study|Blood transfusion|2|||
30671845|NCT00882713|58685650|FG000|Overall Study|Insufficient therapeutic response|3|||
30671846|NCT00882713|58685650|FG000|Overall Study|Failure to return|2|||
30587927|NCT04858802|58600155|FG001|Overall Study|Lost to Follow-up|1|||
30587928|NCT04858802|58600154|FG000|Overall Study|Withdrawal by Subject|1|||
30587929|NCT04858802|58600155|FG001|Overall Study|Withdrawal by Subject|1|||
30587930|NCT04562090|58600194|FG000|Overall Study|Withdrawal by Subject|3|||
30587931|NCT04562090|58600195|FG001|Overall Study|Withdrawal by Subject|4|||
30587932|NCT04562090|58600194|FG000|Overall Study|Protocol Violation|2|||
30781286|NCT02898454|58793394|FG001|Overall Study|Adverse Event|1|||
30587933|NCT04562090|58600195|FG001|Overall Study|Protocol Violation|0|||
30587934|NCT04562090|58600194|FG000|Overall Study|Lack of Efficacy|0|||
30587935|NCT04562090|58600195|FG001|Overall Study|Lack of Efficacy|1|||
30587936|NCT04562090|58600194|FG000|Overall Study|Adverse Event|1|||
30587937|NCT04562090|58600195|FG001|Overall Study|Adverse Event|4|||
30587938|NCT04562090|58600194|FG000|Overall Study|Miscellaneous|0|||
30781287|NCT02898454|58793395|FG002|Overall Study|Adverse Event|2|||
30781288|NCT02898454|58793393|FG000|Overall Study|Protocol Violation|1|||
30781289|NCT02898454|58793394|FG001|Overall Study|Protocol Violation|0|||
30781290|NCT02898454|58793395|FG002|Overall Study|Protocol Violation|1|||
30781291|NCT02898454|58793393|FG000|Overall Study|Lack of Efficacy|4|||
30781292|NCT02898454|58793394|FG001|Overall Study|Lack of Efficacy|1|||
30781293|NCT02898454|58793395|FG002|Overall Study|Lack of Efficacy|0|||
30781294|NCT02898454|58793393|FG000|Overall Study|Withdrawal by Subject|6|||
30781295|NCT02898454|58793394|FG001|Overall Study|Withdrawal by Subject|3|||
30781296|NCT02898454|58793395|FG002|Overall Study|Withdrawal by Subject|3|||
30781297|NCT02898454|58793393|FG000|Overall Study|Lost to Follow-up|1|||
30781298|NCT02898454|58793394|FG001|Overall Study|Lost to Follow-up|0|||
30781299|NCT02898454|58793395|FG002|Overall Study|Lost to Follow-up|0|||
30587939|NCT04562090|58600195|FG001|Overall Study|Miscellaneous|3|||
30587940|NCT04557189|58600206|FG000|Overall Study|Adverse Event|0|||
30587941|NCT04557189|58600207|FG001|Overall Study|Adverse Event|1|||
30587942|NCT04557189|58600206|FG000|Overall Study|Lost to Follow-up|1|||
30587943|NCT04557189|58600207|FG001|Overall Study|Lost to Follow-up|1|||
30587944|NCT04557189|58600206|FG000|Overall Study|Withdrawal by Subject|2|||
30587945|NCT04557189|58600207|FG001|Overall Study|Withdrawal by Subject|1|||
30587946|NCT04557189|58600206|FG000|Overall Study|Reason not Specified|3|||
30587947|NCT04557189|58600207|FG001|Overall Study|Reason not Specified|6|||
30587948|NCT04530838|58600220|FG000|Overall Study|Other|2|||
30587949|NCT04530838|58600221|FG001|Overall Study|Other|1|||
30587950|NCT04530838|58600222|FG002|Overall Study|Other|0|||
30587951|NCT04530838|58600220|FG000|Overall Study|Physician Decision|0|||
30587952|NCT04530838|58600221|FG001|Overall Study|Physician Decision|0|||
30587953|NCT04530838|58600222|FG002|Overall Study|Physician Decision|1|||
30587954|NCT04530838|58600220|FG000|Overall Study|Death|0|||
30587955|NCT04530838|58600221|FG001|Overall Study|Death|0|||
30587956|NCT04530838|58600222|FG002|Overall Study|Death|1|||
30587957|NCT04530838|58600220|FG000|Overall Study|Adverse Event|0|||
30587958|NCT04530838|58600221|FG001|Overall Study|Adverse Event|1|||
30587959|NCT04530838|58600222|FG002|Overall Study|Adverse Event|0|||
30587960|NCT04530838|58600220|FG000|Overall Study|No longer meets eligibility criteria|1|||
30587961|NCT04530838|58600221|FG001|Overall Study|No longer meets eligibility criteria|0|||
30587962|NCT04530838|58600222|FG002|Overall Study|No longer meets eligibility criteria|2|||
30587963|NCT04530838|58600220|FG000|Overall Study|Withdrawal by parent/guardian|5|||
30587964|NCT04530838|58600221|FG001|Overall Study|Withdrawal by parent/guardian|2|||
30587965|NCT04530838|58600222|FG002|Overall Study|Withdrawal by parent/guardian|2|||
30587966|NCT04424901|58600236|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
30587967|NCT04424901|58600237|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
30587968|NCT04410445|58600245|FG000|Overall Study|Lost to Follow-up|3|||
30587969|NCT04410445|58600246|FG001|Overall Study|Lost to Follow-up|9|||
30587970|NCT04410445|58600245|FG000|Overall Study|Withdrawal by Subject|27|||
30587971|NCT04410445|58600246|FG001|Overall Study|Withdrawal by Subject|15|||
30671847|NCT00882713|58685650|FG000|Overall Study|Other - Reasons|2|||
30671848|NCT00809133|58685669|FG000|Overall Study|Progressive disease|2|||
30671849|NCT00809133|58685670|FG001|Overall Study|Progressive disease|5|||
30671850|NCT00809133|58685671|FG002|Overall Study|Progressive disease|5|||
30671851|NCT00809133|58685672|FG003|Overall Study|Progressive disease|3|||
30671852|NCT00809133|58685673|FG004|Overall Study|Progressive disease|4|||
30671853|NCT00809133|58685674|FG005|Overall Study|Progressive disease|1|||
30671854|NCT00809133|58685675|FG006|Overall Study|Progressive disease|3|||
30671855|NCT00809133|58685676|FG007|Overall Study|Progressive disease|3|||
30671856|NCT00809133|58685677|FG008|Overall Study|Progressive disease|3|||
30671857|NCT00809133|58685678|FG009|Overall Study|Progressive disease|9|||
30671858|NCT00809133|58685679|FG010|Overall Study|Progressive disease|5|||
30671859|NCT00809133|58685680|FG011|Overall Study|Progressive disease|7|||
30671860|NCT00809133|58685681|FG012|Overall Study|Progressive disease|5|||
30671861|NCT00809133|58685682|FG013|Overall Study|Progressive disease|4|||
30781300|NCT02898454|58793393|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
30958880|NCT01587703|59024030|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30587972|NCT04062448|58600270|FG000|Overall Study|Lost to Follow-up|1|||
30587973|NCT04062448|58600270|FG000|Overall Study|Withdrawal by Subject|1|||
30587974|NCT04062448|58600270|FG000|Overall Study|Ongoing|14|||
30587975|NCT03970733|58600277|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
30587976|NCT03970733|58600278|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
30671862|NCT00809133|58685669|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30781301|NCT02898454|58793394|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
30781302|NCT02898454|58793395|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
30587977|NCT03970733|58600279|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
30587978|NCT03970733|58600280|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
30587979|NCT03970733|58600281|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
30587980|NCT03970733|58600277|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
30587981|NCT03970733|58600278|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
30587982|NCT03970733|58600279|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
30587983|NCT03970733|58600280|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
30587984|NCT03970733|58600281|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
30587985|NCT03970733|58600277|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
30587986|NCT03970733|58600278|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
30587987|NCT03970733|58600279|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
30587988|NCT03970733|58600280|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
30587989|NCT03970733|58600281|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
30587990|NCT03970733|58600277|FG000|Main Study Phase (18 Months)|Other|1|||
30587991|NCT03970733|58600278|FG001|Main Study Phase (18 Months)|Other|1|||
30587992|NCT03970733|58600279|FG002|Main Study Phase (18 Months)|Other|0|||
30587993|NCT03970733|58600280|FG003|Main Study Phase (18 Months)|Other|0|||
30587994|NCT03970733|58600281|FG004|Main Study Phase (18 Months)|Other|0|||
30587995|NCT03970733|58600277|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
30587996|NCT03970733|58600278|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
30587997|NCT03970733|58600279|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
30587998|NCT03970733|58600280|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
30587999|NCT03970733|58600281|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
30588000|NCT03921411|58600293|FG000|Overall Study|Withdrawal by Subject|1|||
30588001|NCT03921411|58600293|FG000|Overall Study|Protocol Deviation|2|||
30588002|NCT03921411|58600293|FG000|Overall Study|Enrolled, but never treated|2|||
30588003|NCT03728582|58600297|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
30588004|NCT03728582|58600298|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
30588005|NCT03728582|58600297|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
30588006|NCT03728582|58600298|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
30671863|NCT00809133|58685670|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30671864|NCT00809133|58685671|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30671865|NCT00809133|58685672|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30671866|NCT00809133|58685673|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30671867|NCT00809133|58685674|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
30671868|NCT00809133|58685675|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
30671869|NCT00809133|58685676|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
30671870|NCT00809133|58685677|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30671871|NCT00809133|58685678|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30671872|NCT00809133|58685679|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30671873|NCT00809133|58685680|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30671874|NCT00809133|58685681|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30671875|NCT00809133|58685682|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
30671876|NCT00809133|58685669|FG000|Overall Study|Other adverse event|1|||
30671877|NCT00809133|58685670|FG001|Overall Study|Other adverse event|1|||
30671878|NCT00809133|58685671|FG002|Overall Study|Other adverse event|1|||
30671879|NCT00809133|58685672|FG003|Overall Study|Other adverse event|0|||
30671880|NCT00809133|58685673|FG004|Overall Study|Other adverse event|0|||
30671881|NCT00809133|58685674|FG005|Overall Study|Other adverse event|3|||
30671882|NCT00809133|58685675|FG006|Overall Study|Other adverse event|2|||
30671883|NCT00809133|58685676|FG007|Overall Study|Other adverse event|4|||
30671884|NCT00809133|58685677|FG008|Overall Study|Other adverse event|0|||
30671885|NCT00809133|58685678|FG009|Overall Study|Other adverse event|0|||
30671886|NCT00809133|58685679|FG010|Overall Study|Other adverse event|1|||
30671887|NCT00809133|58685680|FG011|Overall Study|Other adverse event|1|||
30671888|NCT00809133|58685681|FG012|Overall Study|Other adverse event|0|||
30671889|NCT00809133|58685682|FG013|Overall Study|Other adverse event|1|||
30671890|NCT00809133|58685669|FG000|Overall Study|Lost to Follow-up|0|||
30671891|NCT00809133|58685670|FG001|Overall Study|Lost to Follow-up|0|||
30588007|NCT03416179|58600317|FG000|Overall Study|Death|90|||
30588008|NCT03416179|58600318|FG001|Overall Study|Death|87|||
30588009|NCT03416179|58600319|FG002|Overall Study|Death|117|||
30588010|NCT03416179|58600320|FG003|Overall Study|Death|113|||
30588011|NCT03416179|58600317|FG000|Overall Study|Withdrawal by Subject|15|||
30588012|NCT03416179|58600318|FG001|Overall Study|Withdrawal by Subject|20|||
30671892|NCT00809133|58685671|FG002|Overall Study|Lost to Follow-up|0|||
30588013|NCT03416179|58600319|FG002|Overall Study|Withdrawal by Subject|6|||
30588014|NCT03416179|58600320|FG003|Overall Study|Withdrawal by Subject|9|||
30588015|NCT03416179|58600317|FG000|Overall Study|Lost to Follow-up|1|||
30588016|NCT03416179|58600318|FG001|Overall Study|Lost to Follow-up|1|||
30671893|NCT00809133|58685672|FG003|Overall Study|Lost to Follow-up|0|||
30671894|NCT00809133|58685673|FG004|Overall Study|Lost to Follow-up|0|||
30671895|NCT00809133|58685674|FG005|Overall Study|Lost to Follow-up|1|||
30781303|NCT03772587|58793413|FG000|Overall Study|COVID-19|0|||
30588017|NCT03416179|58600319|FG002|Overall Study|Lost to Follow-up|0|||
30588018|NCT03416179|58600320|FG003|Overall Study|Lost to Follow-up|3|||
30588019|NCT03416179|58600317|FG000|Overall Study|Study participation terminated by Sponsor|93|||
30588020|NCT03416179|58600318|FG001|Overall Study|Study participation terminated by Sponsor|91|||
30588021|NCT03416179|58600319|FG002|Overall Study|Study participation terminated by Sponsor|26|||
30588022|NCT03416179|58600320|FG003|Overall Study|Study participation terminated by Sponsor|31|||
30588023|NCT03416179|58600317|FG000|Overall Study|Other|2|||
30588024|NCT03416179|58600318|FG001|Overall Study|Other|3|||
30588025|NCT03416179|58600319|FG002|Overall Study|Other|1|||
30588026|NCT03416179|58600320|FG003|Overall Study|Other|0|||
30588027|NCT03186638|58600332|FG000|Overall Study|Withdrawal by Subject|4|||
30588028|NCT03186638|58600333|FG001|Overall Study|Withdrawal by Subject|4|||
30588029|NCT03186638|58600332|FG000|Overall Study|Withdrawn due to medical problem|3|||
30588030|NCT03186638|58600333|FG001|Overall Study|Withdrawn due to medical problem|2|||
30588031|NCT03186638|58600332|FG000|Overall Study|Lost to Follow-up|1|||
30588032|NCT03186638|58600333|FG001|Overall Study|Lost to Follow-up|0|||
30588033|NCT02932332|58600356|FG000|Overall Study|Withdrawal by Subject|1|||
30588034|NCT02932332|58600357|FG001|Overall Study|Withdrawal by Subject|1|||
30588035|NCT02932332|58600358|FG002|Overall Study|Withdrawal by Subject|0|||
30588036|NCT02932332|58600359|FG003|Overall Study|Withdrawal by Subject|1|||
30588037|NCT02932332|58600356|FG000|Overall Study|Chest pain|0|||
30588038|NCT02932332|58600357|FG001|Overall Study|Chest pain|0|||
30588039|NCT02932332|58600358|FG002|Overall Study|Chest pain|0|||
30588040|NCT02932332|58600359|FG003|Overall Study|Chest pain|1|||
30588041|NCT02932332|58600356|FG000|Overall Study|Not Dyspneic cough|1|||
30588042|NCT02932332|58600357|FG001|Overall Study|Not Dyspneic cough|2|||
30588043|NCT02932332|58600358|FG002|Overall Study|Not Dyspneic cough|1|||
30588044|NCT02932332|58600359|FG003|Overall Study|Not Dyspneic cough|0|||
30588045|NCT02820623|58600393|FG000|Overall Study|Withdrawal by Subject|1|||
30671896|NCT00809133|58685675|FG006|Overall Study|Lost to Follow-up|0|||
30671897|NCT00809133|58685676|FG007|Overall Study|Lost to Follow-up|0|||
30671898|NCT00809133|58685677|FG008|Overall Study|Lost to Follow-up|0|||
30671899|NCT00809133|58685678|FG009|Overall Study|Lost to Follow-up|0|||
30671900|NCT00809133|58685679|FG010|Overall Study|Lost to Follow-up|0|||
30671901|NCT00809133|58685680|FG011|Overall Study|Lost to Follow-up|0|||
30671902|NCT00809133|58685681|FG012|Overall Study|Lost to Follow-up|0|||
30671903|NCT00809133|58685682|FG013|Overall Study|Lost to Follow-up|0|||
30671904|NCT00809133|58685669|FG000|Overall Study|Consent withdrawn|0|||
30671905|NCT00809133|58685670|FG001|Overall Study|Consent withdrawn|0|||
30671906|NCT00809133|58685671|FG002|Overall Study|Consent withdrawn|0|||
30671907|NCT00809133|58685672|FG003|Overall Study|Consent withdrawn|0|||
30671908|NCT00809133|58685673|FG004|Overall Study|Consent withdrawn|1|||
30671909|NCT00809133|58685674|FG005|Overall Study|Consent withdrawn|0|||
30671910|NCT00809133|58685675|FG006|Overall Study|Consent withdrawn|0|||
30671911|NCT00809133|58685676|FG007|Overall Study|Consent withdrawn|0|||
30671912|NCT00809133|58685677|FG008|Overall Study|Consent withdrawn|0|||
30671913|NCT00809133|58685678|FG009|Overall Study|Consent withdrawn|0|||
30671914|NCT00809133|58685679|FG010|Overall Study|Consent withdrawn|0|||
30671915|NCT00809133|58685680|FG011|Overall Study|Consent withdrawn|0|||
30671916|NCT00809133|58685681|FG012|Overall Study|Consent withdrawn|0|||
30671917|NCT00809133|58685682|FG013|Overall Study|Consent withdrawn|0|||
30671918|NCT00809133|58685669|FG000|Overall Study|Other not mentioned above|0|||
30671919|NCT00809133|58685670|FG001|Overall Study|Other not mentioned above|1|||
30671920|NCT00809133|58685671|FG002|Overall Study|Other not mentioned above|0|||
30671921|NCT00809133|58685672|FG003|Overall Study|Other not mentioned above|0|||
30671922|NCT00809133|58685673|FG004|Overall Study|Other not mentioned above|0|||
30671923|NCT00809133|58685674|FG005|Overall Study|Other not mentioned above|1|||
30671924|NCT00809133|58685675|FG006|Overall Study|Other not mentioned above|0|||
30671925|NCT00809133|58685676|FG007|Overall Study|Other not mentioned above|0|||
30671926|NCT00809133|58685677|FG008|Overall Study|Other not mentioned above|0|||
30671927|NCT00809133|58685678|FG009|Overall Study|Other not mentioned above|0|||
30671928|NCT00809133|58685679|FG010|Overall Study|Other not mentioned above|0|||
30671929|NCT00809133|58685680|FG011|Overall Study|Other not mentioned above|0|||
30588046|NCT02820623|58600394|FG001|Overall Study|Withdrawal by Subject|3|||
30671930|NCT00809133|58685681|FG012|Overall Study|Other not mentioned above|0|||
30671931|NCT00809133|58685682|FG013|Overall Study|Other not mentioned above|0|||
30671932|NCT00882557|58685727|FG000|Overall Study|Withdrawal by Subject|1|||
30588047|NCT02820623|58600395|FG002|Overall Study|Withdrawal by Subject|3|||
30671933|NCT00882557|58685728|FG001|Overall Study|Withdrawal by Subject|0|||
30588048|NCT02820623|58600393|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
30588049|NCT02820623|58600394|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
30588050|NCT02820623|58600395|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
30588051|NCT02820623|58600393|FG000|Overall Study|Therapist unable to enroll clients|1|||
30588052|NCT02820623|58600394|FG001|Overall Study|Therapist unable to enroll clients|1|||
30671934|NCT00882557|58685727|FG000|Overall Study|Trouble with Vein Access|1|||
30671935|NCT00882557|58685728|FG001|Overall Study|Trouble with Vein Access|0|||
30671936|NCT00882557|58685727|FG000|Overall Study|Randomized Not Treated|0|||
30671937|NCT00882557|58685728|FG001|Overall Study|Randomized Not Treated|1|||
30588053|NCT02820623|58600395|FG002|Overall Study|Therapist unable to enroll clients|3|||
30588054|NCT02820623|58600393|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
30588055|NCT02820623|58600394|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
30588056|NCT02820623|58600395|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
30588057|NCT02774005|58600403|FG000|Overall Study|Adverse Event|8|||
30588058|NCT02774005|58600403|FG000|Overall Study|Withdrawal by Subject|23|||
30588059|NCT02774005|58600403|FG000|Overall Study|Lost to Follow-up|7|||
30588060|NCT02774005|58600403|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
30588061|NCT02774005|58600403|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
30588062|NCT02774005|58600403|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
30588063|NCT02774005|58600403|FG000|Overall Study|Death|1|||
30588064|NCT02774005|58600403|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
30588065|NCT02774005|58600403|FG000|Overall Study|Lack of compliance with study medication|4|||
30588066|NCT02774005|58600403|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
30588067|NCT02774005|58600403|FG000|Overall Study|another study|1|||
30588068|NCT02774005|58600403|FG000|Overall Study|cardiologist imposed travel restriction|1|||
30588069|NCT01975428|58600437|FG000|Overall Study|Lost to Follow-up|17|||
30588070|NCT01975428|58600438|FG001|Overall Study|Lost to Follow-up|4|||
30588071|NCT01975428|58600437|FG000|Overall Study|Withdrawal by Subject|3|||
30588072|NCT01975428|58600438|FG001|Overall Study|Withdrawal by Subject|10|||
30588073|NCT01047540|58600479|FG000|Overall Study|Protocol Violation|1|||
30588074|NCT01047540|58600480|FG001|Overall Study|Protocol Violation|0|||
30588075|NCT01047540|58600481|FG002|Overall Study|Protocol Violation|0|||
30588076|NCT01047540|58600482|FG003|Overall Study|Protocol Violation|0|||
30588077|NCT01047540|58600483|FG004|Overall Study|Protocol Violation|0|||
30588078|NCT01047540|58600479|FG000|Overall Study|Lost to Follow-up|1|||
30588079|NCT01047540|58600480|FG001|Overall Study|Lost to Follow-up|0|||
30588080|NCT01047540|58600481|FG002|Overall Study|Lost to Follow-up|0|||
30588081|NCT01047540|58600482|FG003|Overall Study|Lost to Follow-up|0|||
30588082|NCT01047540|58600483|FG004|Overall Study|Lost to Follow-up|0|||
30588083|NCT01047540|58600479|FG000|Overall Study|Withdrawal by Subject|1|||
30588084|NCT01047540|58600480|FG001|Overall Study|Withdrawal by Subject|0|||
30588085|NCT01047540|58600481|FG002|Overall Study|Withdrawal by Subject|3|||
30588086|NCT01047540|58600482|FG003|Overall Study|Withdrawal by Subject|0|||
30588087|NCT01047540|58600483|FG004|Overall Study|Withdrawal by Subject|1|||
30588088|NCT01047540|58600479|FG000|Overall Study|Pregnancy|1|||
30588089|NCT01047540|58600480|FG001|Overall Study|Pregnancy|0|||
30588090|NCT01047540|58600481|FG002|Overall Study|Pregnancy|0|||
30588091|NCT01047540|58600482|FG003|Overall Study|Pregnancy|0|||
30588092|NCT01047540|58600483|FG004|Overall Study|Pregnancy|0|||
30588093|NCT01047540|58600479|FG000|Overall Study|Adverse Event|1|||
30588094|NCT01047540|58600480|FG001|Overall Study|Adverse Event|0|||
30588095|NCT01047540|58600481|FG002|Overall Study|Adverse Event|0|||
30671938|NCT00808899|58685734|FG000|Overall Study|Death|1|||
30671939|NCT00808899|58685734|FG000|Overall Study|Physician Decision|3|||
30671940|NCT00808665|58685740|FG000|Overall Study|Withdrawal by Subject|1|||
30671941|NCT00808665|58685741|FG001|Overall Study|Withdrawal by Subject|0|||
30588096|NCT01047540|58600482|FG003|Overall Study|Adverse Event|0|||
30588097|NCT01047540|58600483|FG004|Overall Study|Adverse Event|0|||
30588098|NCT00521222|58600499|FG000|Overall Study|Lost to Follow-up|0|||
30588099|NCT00521222|58600500|FG001|Overall Study|Lost to Follow-up|0|||
30588100|NCT00521222|58600501|FG002|Overall Study|Lost to Follow-up|1|||
30588101|NCT00521222|58600502|FG003|Overall Study|Lost to Follow-up|1|||
30588102|NCT00521222|58600499|FG000|Overall Study|Withdrawal by Subject|0|||
30588103|NCT00521222|58600500|FG001|Overall Study|Withdrawal by Subject|0|||
30588104|NCT00521222|58600501|FG002|Overall Study|Withdrawal by Subject|2|||
30588105|NCT00521222|58600502|FG003|Overall Study|Withdrawal by Subject|0|||
30588106|NCT00521222|58600499|FG000|Overall Study|Physician Decision|0|||
30588107|NCT00521222|58600500|FG001|Overall Study|Physician Decision|1|||
30588108|NCT00521222|58600501|FG002|Overall Study|Physician Decision|0|||
30588109|NCT00521222|58600502|FG003|Overall Study|Physician Decision|1|||
30671942|NCT00808665|58685740|FG000|Overall Study|only required minimally invasive surgery|1|||
30671943|NCT00808665|58685741|FG001|Overall Study|only required minimally invasive surgery|0|||
30588110|NCT01214629|58600536|FG000|Overall Study|Progressive Disease|1|||
30588111|NCT01214629|58600537|FG001|Overall Study|Progressive Disease|1|||
30588112|NCT01214629|58600538|FG002|Overall Study|Progressive Disease|0|||
30588113|NCT01214629|58600539|FG003|Overall Study|Progressive Disease|1|||
30588114|NCT01214629|58600540|FG004|Overall Study|Progressive Disease|2|||
30588115|NCT01214629|58600541|FG005|Overall Study|Progressive Disease|3|||
30588116|NCT01214629|58600542|FG006|Overall Study|Progressive Disease|1|||
30588117|NCT01214629|58600543|FG007|Overall Study|Progressive Disease|1|||
30588118|NCT01214629|58600544|FG008|Overall Study|Progressive Disease|1|||
30588119|NCT01214629|58600545|FG009|Overall Study|Progressive Disease|5|||
30588120|NCT01214629|58600546|FG010|Overall Study|Progressive Disease|1|||
30588121|NCT01214629|58600536|FG000|Overall Study|Adverse Event|0|||
30588122|NCT01214629|58600537|FG001|Overall Study|Adverse Event|0|||
30588123|NCT01214629|58600538|FG002|Overall Study|Adverse Event|0|||
30588124|NCT01214629|58600539|FG003|Overall Study|Adverse Event|1|||
30588125|NCT01214629|58600540|FG004|Overall Study|Adverse Event|0|||
30588126|NCT01214629|58600541|FG005|Overall Study|Adverse Event|1|||
30588127|NCT01214629|58600542|FG006|Overall Study|Adverse Event|0|||
30588128|NCT01214629|58600543|FG007|Overall Study|Adverse Event|0|||
30588129|NCT01214629|58600544|FG008|Overall Study|Adverse Event|0|||
30588130|NCT01214629|58600545|FG009|Overall Study|Adverse Event|1|||
30588131|NCT01214629|58600546|FG010|Overall Study|Adverse Event|0|||
30588132|NCT01214629|58600536|FG000|Overall Study|Physician Decision|0|||
30588133|NCT01214629|58600537|FG001|Overall Study|Physician Decision|0|||
30588134|NCT01214629|58600538|FG002|Overall Study|Physician Decision|0|||
30588135|NCT01214629|58600539|FG003|Overall Study|Physician Decision|0|||
30588136|NCT01214629|58600540|FG004|Overall Study|Physician Decision|0|||
30588137|NCT01214629|58600541|FG005|Overall Study|Physician Decision|0|||
30588138|NCT01214629|58600542|FG006|Overall Study|Physician Decision|0|||
30588139|NCT01214629|58600543|FG007|Overall Study|Physician Decision|0|||
30588140|NCT01214629|58600544|FG008|Overall Study|Physician Decision|0|||
30588141|NCT01214629|58600545|FG009|Overall Study|Physician Decision|0|||
30588142|NCT01214629|58600546|FG010|Overall Study|Physician Decision|1|||
30588143|NCT01214629|58600536|FG000|Overall Study|Withdrawal by Subject|0|||
30588144|NCT01214629|58600537|FG001|Overall Study|Withdrawal by Subject|0|||
30588145|NCT01214629|58600538|FG002|Overall Study|Withdrawal by Subject|0|||
30588146|NCT01214629|58600539|FG003|Overall Study|Withdrawal by Subject|0|||
30588147|NCT01214629|58600540|FG004|Overall Study|Withdrawal by Subject|0|||
30588148|NCT01214629|58600541|FG005|Overall Study|Withdrawal by Subject|0|||
30588149|NCT01214629|58600542|FG006|Overall Study|Withdrawal by Subject|0|||
30588150|NCT01214629|58600543|FG007|Overall Study|Withdrawal by Subject|0|||
30588151|NCT01214629|58600544|FG008|Overall Study|Withdrawal by Subject|0|||
30588152|NCT01214629|58600545|FG009|Overall Study|Withdrawal by Subject|1|||
30588153|NCT01214629|58600546|FG010|Overall Study|Withdrawal by Subject|0|||
30588154|NCT01214434|58600586|FG000|Overall Study|Withdrawal by Subject|1|||
30588155|NCT01214434|58600587|FG001|Overall Study|Withdrawal by Subject|0|||
30588156|NCT01214434|58600586|FG000|Overall Study|Lost to Follow-up|2|||
30588157|NCT01214434|58600587|FG001|Overall Study|Lost to Follow-up|2|||
30588158|NCT01214434|58600586|FG000|Overall Study|Site error|1|||
30588159|NCT01214434|58600587|FG001|Overall Study|Site error|0|||
30588160|NCT01214395|58600593|FG000|Overall Study|All patients had infection|5|||
30588161|NCT01214239|58600600|FG000|Overall Study|Adverse Event|3|||
30588162|NCT01214239|58600601|FG001|Overall Study|Adverse Event|4|||
30588163|NCT01214239|58600600|FG000|Overall Study|Protocol Violation|2|||
30588164|NCT01214239|58600601|FG001|Overall Study|Protocol Violation|1|||
30588165|NCT01214239|58600600|FG000|Overall Study|Lost to Follow-up|1|||
30588166|NCT01214239|58600601|FG001|Overall Study|Lost to Follow-up|1|||
30588167|NCT01214239|58600600|FG000|Overall Study|Withdrawal by Subject|4|||
30588168|NCT01214239|58600601|FG001|Overall Study|Withdrawal by Subject|9|||
30588169|NCT01214239|58600600|FG000|Overall Study|Lack of Efficacy|1|||
30588170|NCT01214239|58600601|FG001|Overall Study|Lack of Efficacy|2|||
30588171|NCT01214239|58600600|FG000|Overall Study|patient's private reason|1|||
30588172|NCT01214239|58600601|FG001|Overall Study|patient's private reason|1|||
30588173|NCT01214200|58600607|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
30588174|NCT01214200|58600607|FG000|Overall Study|Withdrawal by Subject|2|||
30588175|NCT01214044|58600613|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
30588176|NCT01214044|58600613|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
30588177|NCT01214044|58600613|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
30588178|NCT01214044|58600613|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
30588179|NCT01214044|58600613|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
30588180|NCT01214044|58600613|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
30588181|NCT01213966|58600625|FG000|Overall Study|Protocol Violation|1|||
30671944|NCT00808665|58685740|FG000|Overall Study|surgery cancelled|1|||
30671945|NCT00808665|58685741|FG001|Overall Study|surgery cancelled|0|||
30671946|NCT00808665|58685740|FG000|Overall Study|required an additional procedure|0|||
30671947|NCT00808665|58685741|FG001|Overall Study|required an additional procedure|1|||
30588182|NCT01213966|58600626|FG001|Overall Study|Protocol Violation|0|||
30588183|NCT01213966|58600627|FG002|Overall Study|Protocol Violation|3|||
30588184|NCT01213966|58600628|FG003|Overall Study|Protocol Violation|1|||
30588185|NCT01213264|58600641|FG000|Overall Study|Adverse Event|1|||
30588186|NCT01213264|58600642|FG001|Overall Study|Adverse Event|0|||
30588187|NCT01213264|58600643|FG002|Overall Study|Adverse Event|0|||
30588188|NCT01213264|58600641|FG000|Overall Study|Lost to Follow-up|1|||
30588189|NCT01213264|58600642|FG001|Overall Study|Lost to Follow-up|2|||
30588190|NCT01213264|58600643|FG002|Overall Study|Lost to Follow-up|6|||
30588191|NCT01212991|58600656|FG000|Double-blind|Lost to Follow-up|8|||
30588192|NCT01212991|58600657|FG001|Double-blind|Lost to Follow-up|4|||
30588193|NCT01212991|58600658|FG002|Double-blind|Lost to Follow-up|0|||
30671948|NCT00808665|58685740|FG000|Overall Study|Physician Decision|3|||
30588194|NCT01212991|58600656|FG000|Double-blind|Death|699|||
30588195|NCT01212991|58600657|FG001|Double-blind|Death|550|||
30588196|NCT01212991|58600658|FG002|Double-blind|Death|0|||
30588197|NCT01212991|58600656|FG000|Double-blind|Withdrawal by Subject|16|||
30588198|NCT01212991|58600657|FG001|Double-blind|Withdrawal by Subject|19|||
30588199|NCT01212991|58600658|FG002|Double-blind|Withdrawal by Subject|0|||
30588200|NCT01212991|58600656|FG000|Double-blind|Other|7|||
30588201|NCT01212991|58600657|FG001|Double-blind|Other|0|||
30588202|NCT01212991|58600658|FG002|Double-blind|Other|0|||
30588203|NCT01212991|58600656|FG000|Double-blind|Sponsor decision|142|||
30588204|NCT01212991|58600657|FG001|Double-blind|Sponsor decision|38|||
30588205|NCT01212991|58600658|FG002|Double-blind|Sponsor decision|0|||
30588206|NCT01212991|58600656|FG000|Open-label|Death|0|||
30588207|NCT01212991|58600657|FG001|Open-label|Death|0|||
30588208|NCT01212991|58600658|FG002|Open-label|Death|166|||
30588209|NCT01212991|58600656|FG000|Open-label|Lost to Follow-up|0|||
30588210|NCT01212991|58600657|FG001|Open-label|Lost to Follow-up|0|||
30588211|NCT01212991|58600658|FG002|Open-label|Lost to Follow-up|5|||
30588212|NCT01212991|58600656|FG000|Open-label|Withdrawal by Subject|0|||
30671949|NCT00808665|58685741|FG001|Overall Study|Physician Decision|1|||
30671950|NCT00808665|58685740|FG000|Overall Study|Medication stopped by resident|0|||
30671951|NCT00808665|58685741|FG001|Overall Study|Medication stopped by resident|1|||
30671952|NCT00808509|58685749|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
30671953|NCT00808509|58685750|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
30671954|NCT00808509|58685749|FG000|Randomized Phase|Reduced methotrexate dose|1|||
30671955|NCT00808509|58685750|FG001|Randomized Phase|Reduced methotrexate dose|2|||
30588213|NCT01212991|58600657|FG001|Open-label|Withdrawal by Subject|0|||
30588214|NCT01212991|58600658|FG002|Open-label|Withdrawal by Subject|7|||
30588215|NCT01212991|58600656|FG000|Open-label|Sponsor decision|0|||
30588216|NCT01212991|58600657|FG001|Open-label|Sponsor decision|0|||
30588217|NCT01212991|58600658|FG002|Open-label|Sponsor decision|53|||
30588218|NCT01212991|58600656|FG000|Open-label|Other|0|||
30588219|NCT01212991|58600657|FG001|Open-label|Other|0|||
30588220|NCT01212991|58600658|FG002|Open-label|Other|3|||
30588221|NCT01212757|58600669|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
30588222|NCT01212757|58600670|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
30588223|NCT01212757|58600671|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
30588224|NCT01212757|58600672|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30588225|NCT01212757|58600673|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30588226|NCT01212757|58600674|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30588227|NCT01212757|58600675|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30588228|NCT01212757|58600676|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30588229|NCT01212757|58600677|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
30588230|NCT01212757|58600669|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
30671956|NCT00808509|58685749|FG000|Randomized Phase|Patient refused rescue therapy|0|||
30671957|NCT00808509|58685750|FG001|Randomized Phase|Patient refused rescue therapy|3|||
30671958|NCT00807885|58685767|FG000|Overall Study|Lost to Follow-up|0|||
30671959|NCT00807885|58685768|FG001|Overall Study|Lost to Follow-up|0|||
30671960|NCT00807885|58685769|FG002|Overall Study|Lost to Follow-up|0|||
30671961|NCT00807885|58685770|FG003|Overall Study|Lost to Follow-up|0|||
30671962|NCT00807885|58685771|FG004|Overall Study|Lost to Follow-up|0|||
30588231|NCT01212757|58600670|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
30588232|NCT01212757|58600671|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
30588233|NCT01212757|58600672|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30588234|NCT01212757|58600673|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30588235|NCT01212757|58600674|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30588236|NCT01212757|58600675|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30588237|NCT01212757|58600676|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30588238|NCT01212757|58600677|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
30588239|NCT01212757|58600669|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
30588240|NCT01212757|58600670|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
30588241|NCT01212757|58600671|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
30588242|NCT01212757|58600672|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30588243|NCT01212757|58600673|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30588244|NCT01212757|58600674|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30588245|NCT01212757|58600675|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30671963|NCT00807885|58685772|FG005|Overall Study|Lost to Follow-up|1|||
30671964|NCT00807885|58685773|FG006|Overall Study|Lost to Follow-up|0|||
30588246|NCT01212757|58600676|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30671965|NCT00807885|58685774|FG007|Overall Study|Lost to Follow-up|0|||
30671966|NCT00807885|58685775|FG008|Overall Study|Lost to Follow-up|0|||
30671967|NCT00807573|58685795|FG000|Overall Study|Withdrawal by Subject|1|||
30671968|NCT00807573|58685795|FG000|Overall Study|Adverse Event|1|||
30671969|NCT00842712|58685806|FG000|Safety Run-in Part|Adverse Event|0|||
30671970|NCT00842712|58685807|FG001|Safety Run-in Part|Adverse Event|1|||
30671971|NCT00842712|58685808|FG002|Safety Run-in Part|Adverse Event|0|||
30671972|NCT00842712|58685809|FG003|Safety Run-in Part|Adverse Event|0|||
30671973|NCT00842712|58685810|FG004|Safety Run-in Part|Adverse Event|0|||
30671974|NCT00842712|58685811|FG005|Safety Run-in Part|Adverse Event|0|||
30671975|NCT00842712|58685812|FG006|Safety Run-in Part|Adverse Event|0|||
30671976|NCT00842712|58685806|FG000|Safety Run-in Part|Progressive disease|3|||
30671977|NCT00842712|58685807|FG001|Safety Run-in Part|Progressive disease|1|||
30671978|NCT00842712|58685808|FG002|Safety Run-in Part|Progressive disease|0|||
30671979|NCT00842712|58685809|FG003|Safety Run-in Part|Progressive disease|1|||
30671980|NCT00842712|58685810|FG004|Safety Run-in Part|Progressive disease|0|||
30671981|NCT00842712|58685811|FG005|Safety Run-in Part|Progressive disease|0|||
30671982|NCT00842712|58685812|FG006|Safety Run-in Part|Progressive disease|0|||
30671983|NCT00842712|58685806|FG000|Randomized Part|Randomized but not treated|0|||
30671984|NCT00842712|58685807|FG001|Randomized Part|Randomized but not treated|0|||
30671985|NCT00842712|58685808|FG002|Randomized Part|Randomized but not treated|0|||
30671986|NCT00842712|58685809|FG003|Randomized Part|Randomized but not treated|0|||
30671987|NCT00842712|58685810|FG004|Randomized Part|Randomized but not treated|0|||
30671988|NCT00842712|58685811|FG005|Randomized Part|Randomized but not treated|1|||
30671989|NCT00842712|58685812|FG006|Randomized Part|Randomized but not treated|4|||
30671990|NCT00842712|58685806|FG000|Randomized Part|Ongoing at cut-off date|0|||
30671991|NCT00842712|58685807|FG001|Randomized Part|Ongoing at cut-off date|0|||
30671992|NCT00842712|58685808|FG002|Randomized Part|Ongoing at cut-off date|0|||
30671993|NCT00842712|58685809|FG003|Randomized Part|Ongoing at cut-off date|0|||
30671994|NCT00842712|58685810|FG004|Randomized Part|Ongoing at cut-off date|0|||
30671995|NCT00842712|58685811|FG005|Randomized Part|Ongoing at cut-off date|0|||
30671996|NCT00842712|58685812|FG006|Randomized Part|Ongoing at cut-off date|2|||
30671997|NCT00842244|58685828|FG000|Overall Study|Death|3|||
30671998|NCT00842244|58685828|FG000|Overall Study|Withdrawal by Subject|1|||
30671999|NCT00842244|58685828|FG000|Overall Study|Other|17|||
30672000|NCT00832416|58685839|FG000|Overall Study|Lack of Efficacy|17|||
30588247|NCT01212757|58600677|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
30588248|NCT01212757|58600669|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
30588249|NCT01212757|58600670|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30672001|NCT00832416|58685840|FG001|Overall Study|Lack of Efficacy|15|||
30672002|NCT00832416|58685841|FG002|Overall Study|Lack of Efficacy|13|||
30672003|NCT00832416|58685842|FG003|Overall Study|Lack of Efficacy|52|||
30672004|NCT00832416|58685839|FG000|Overall Study|Withdrawal by Subject|5|||
30672005|NCT00832416|58685840|FG001|Overall Study|Withdrawal by Subject|7|||
30672006|NCT00832416|58685841|FG002|Overall Study|Withdrawal by Subject|2|||
30672007|NCT00832416|58685842|FG003|Overall Study|Withdrawal by Subject|10|||
30672008|NCT00832416|58685839|FG000|Overall Study|Physician Decision|2|||
30672009|NCT00832416|58685840|FG001|Overall Study|Physician Decision|12|||
30672010|NCT00832416|58685841|FG002|Overall Study|Physician Decision|5|||
30672011|NCT00832416|58685842|FG003|Overall Study|Physician Decision|10|||
30672012|NCT00832416|58685839|FG000|Overall Study|Administrative|0|||
30672013|NCT00832416|58685840|FG001|Overall Study|Administrative|0|||
30672014|NCT00832416|58685841|FG002|Overall Study|Administrative|0|||
30672015|NCT00832416|58685842|FG003|Overall Study|Administrative|1|||
30672016|NCT00832416|58685839|FG000|Overall Study|Adverse Event|21|||
30672017|NCT00832416|58685840|FG001|Overall Study|Adverse Event|19|||
30781304|NCT03772587|58793414|FG001|Overall Study|COVID-19|0|||
30781305|NCT03772587|58793415|FG002|Overall Study|COVID-19|1|||
30781306|NCT03772587|58793416|FG003|Overall Study|COVID-19|1|||
30781307|NCT03772587|58793417|FG004|Overall Study|COVID-19|0|||
30781308|NCT03772587|58793413|FG000|Overall Study|Withdrawal by Subject|1|||
30781309|NCT03772587|58793414|FG001|Overall Study|Withdrawal by Subject|0|||
30781310|NCT03772587|58793415|FG002|Overall Study|Withdrawal by Subject|0|||
30588250|NCT01212757|58600671|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
30588251|NCT01212757|58600672|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30588252|NCT01212757|58600673|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30588253|NCT01212757|58600674|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30588254|NCT01212757|58600675|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30588255|NCT01212757|58600676|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30672018|NCT00832416|58685841|FG002|Overall Study|Adverse Event|41|||
30672019|NCT00832416|58685842|FG003|Overall Study|Adverse Event|10|||
30672020|NCT00832416|58685839|FG000|Overall Study|Death|1|||
30781311|NCT03772587|58793416|FG003|Overall Study|Withdrawal by Subject|0|||
30781312|NCT03772587|58793417|FG004|Overall Study|Withdrawal by Subject|0|||
30781313|NCT02963506|58793444|FG000|Double-Blind Period|Adverse Event|0|||
30781314|NCT02963506|58793445|FG001|Double-Blind Period|Adverse Event|0|||
30672021|NCT00832416|58685840|FG001|Overall Study|Death|0|||
30672022|NCT00832416|58685841|FG002|Overall Study|Death|0|||
30672023|NCT00832416|58685842|FG003|Overall Study|Death|0|||
30672024|NCT00841776|58685854|FG000|Overall Study|Lack of Efficacy|0|||
30672025|NCT00841776|58685855|FG001|Overall Study|Lack of Efficacy|1|||
30588256|NCT01212757|58600677|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
30588257|NCT01212757|58600669|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
30588258|NCT01212757|58600670|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
30588259|NCT01212757|58600671|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
30588260|NCT01212757|58600672|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30588261|NCT01212757|58600673|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30588262|NCT01212757|58600674|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30588263|NCT01212757|58600675|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30588264|NCT01212757|58600676|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30588265|NCT01212757|58600677|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
30588266|NCT01212757|58600669|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30588267|NCT01212757|58600670|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
30588268|NCT01212757|58600671|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
30588269|NCT01212757|58600672|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30588270|NCT01212757|58600673|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30588271|NCT01212757|58600674|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30588272|NCT01212757|58600675|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30588273|NCT01212757|58600676|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30588274|NCT01212757|58600677|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
30588275|NCT01212757|58600669|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
30588276|NCT01212757|58600670|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
30588277|NCT01212757|58600671|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30588278|NCT01212757|58600672|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30588279|NCT01212757|58600673|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30588280|NCT01212757|58600674|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30588281|NCT01212757|58600675|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30855799|NCT02585960|58883504|FG001|PK/Safety Assessment Period|Other|4|||
30855800|NCT02585960|58883505|FG002|PK/Safety Assessment Period|Other|0|||
30855801|NCT02585960|58883503|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
30855802|NCT02585960|58883504|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
30855803|NCT02585960|58883505|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
30855804|NCT02585960|58883503|FG000|PK/Safety Assessment Period|Screen Failure|0|||
30855805|NCT02585960|58883504|FG001|PK/Safety Assessment Period|Screen Failure|0|||
30855806|NCT02585960|58883505|FG002|PK/Safety Assessment Period|Screen Failure|1|||
30855807|NCT02585960|58883503|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
30855808|NCT02585960|58883504|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
30855809|NCT02585960|58883505|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
30855810|NCT02585960|58883503|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
30855811|NCT02585960|58883504|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
30855812|NCT02585960|58883505|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
30855813|NCT02760433|58883521|FG000|Overall Study|Lost to Follow-up|1|||
30855814|NCT02760433|58883522|FG001|Overall Study|Lost to Follow-up|0|||
30855815|NCT02760433|58883523|FG002|Overall Study|Lost to Follow-up|1|||
30855816|NCT02760433|58883524|FG003|Overall Study|Lost to Follow-up|0|||
30588282|NCT01212757|58600676|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30588283|NCT01212757|58600677|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
30588284|NCT01212757|58600669|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
30672026|NCT00841776|58685854|FG000|Overall Study|Lost to Follow-up|2|||
30672027|NCT00841776|58685855|FG001|Overall Study|Lost to Follow-up|1|||
30672028|NCT00841776|58685854|FG000|Overall Study|Withdrawal by Subject|0|||
30672029|NCT00841776|58685855|FG001|Overall Study|Withdrawal by Subject|1|||
30672030|NCT00683800|58685863|FG000|Overall Study|Adverse Event|195|||
30672031|NCT00683800|58685864|FG001|Overall Study|Adverse Event|102|||
30672032|NCT00683800|58685863|FG000|Overall Study|Death|0|||
30672033|NCT00683800|58685864|FG001|Overall Study|Death|1|||
30672034|NCT00683800|58685863|FG000|Overall Study|Lost to Follow-up|57|||
30672035|NCT00683800|58685864|FG001|Overall Study|Lost to Follow-up|44|||
30672036|NCT00683800|58685863|FG000|Overall Study|Other|5|||
30672037|NCT00683800|58685864|FG001|Overall Study|Other|2|||
30672038|NCT00683800|58685863|FG000|Overall Study|Protocol Violation|13|||
30672039|NCT00683800|58685864|FG001|Overall Study|Protocol Violation|16|||
30672040|NCT00683800|58685863|FG000|Overall Study|Withdrawal by Subject|66|||
30672041|NCT00683800|58685864|FG001|Overall Study|Withdrawal by Subject|64|||
30672042|NCT00683800|58685863|FG000|Overall Study|Lack of Efficacy|61|||
30672043|NCT00683800|58685864|FG001|Overall Study|Lack of Efficacy|104|||
30672044|NCT00683800|58685863|FG000|Overall Study|Randomized, not treated|35|||
30672045|NCT00683800|58685864|FG001|Overall Study|Randomized, not treated|33|||
30672046|NCT00683644|58685872|FG000|Overall Study|Withdrawal by Subject|4|||
30672047|NCT00683644|58685873|FG001|Overall Study|Withdrawal by Subject|2|||
30855817|NCT02760433|58883525|FG004|Overall Study|Lost to Follow-up|0|||
30672048|NCT00683644|58685872|FG000|Overall Study|Lost to Follow-up|1|||
30855818|NCT02760433|58883521|FG000|Overall Study|Withdrawal by Subject|23|||
30588285|NCT01212757|58600670|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
30588286|NCT01212757|58600671|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
30588287|NCT01212757|58600672|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
30588288|NCT01212757|58600673|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
30672049|NCT00683644|58685873|FG001|Overall Study|Lost to Follow-up|4|||
30672050|NCT00683644|58685872|FG000|Overall Study|Adverse Event|1|||
30672051|NCT00683644|58685873|FG001|Overall Study|Adverse Event|2|||
30672052|NCT00683644|58685872|FG000|Overall Study|Low copper, other health problems,|7|||
30672053|NCT00683644|58685873|FG001|Overall Study|Low copper, other health problems,|6|||
30672054|NCT00685360|58685886|FG000|Overall Study|Lost to Follow-up|0|||
30672055|NCT00685360|58685887|FG001|Overall Study|Lost to Follow-up|1|||
30672056|NCT00685360|58685888|FG002|Overall Study|Lost to Follow-up|2|||
30672057|NCT00685360|58685886|FG000|Overall Study|Adverse Event|4|||
30672058|NCT00685360|58685887|FG001|Overall Study|Adverse Event|6|||
30672059|NCT00685360|58685888|FG002|Overall Study|Adverse Event|4|||
30672060|NCT00685360|58685886|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
30672061|NCT00685360|58685887|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
30672062|NCT00685360|58685888|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
30672063|NCT00685360|58685886|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
30672064|NCT00685360|58685887|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
30672065|NCT00685360|58685888|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
30672066|NCT00685360|58685886|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
30588289|NCT01212757|58600674|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
30672067|NCT00685360|58685887|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
30672068|NCT00685360|58685888|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
30672069|NCT00685360|58685886|FG000|Overall Study|Protocol Deviation|0|||
30672070|NCT00685360|58685887|FG001|Overall Study|Protocol Deviation|1|||
30672071|NCT00685360|58685888|FG002|Overall Study|Protocol Deviation|1|||
30672072|NCT00684814|58685896|FG000|Washout Period of 7 Days|Adverse Event|1|||
30672073|NCT00684814|58685897|FG001|Washout Period of 7 Days|Adverse Event|2|||
30672074|NCT00684814|58685896|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
30672075|NCT00684814|58685897|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
30672076|NCT00684814|58685896|FG000|Second Intervention|Adverse Event|1|||
30672077|NCT00684814|58685897|FG001|Second Intervention|Adverse Event|0|||
30672078|NCT00576472|58685918|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672079|NCT00576472|58685919|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672080|NCT00576472|58685920|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672081|NCT00576472|58685921|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
30672082|NCT00576472|58685922|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672083|NCT00576472|58685923|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672084|NCT00576472|58685924|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672085|NCT00576472|58685925|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
30781315|NCT02963506|58793446|FG002|Double-Blind Period|Adverse Event|1|||
30781316|NCT02963506|58793447|FG003|Double-Blind Period|Adverse Event|0|||
30588290|NCT01212757|58600675|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
30588291|NCT01212757|58600676|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
30588292|NCT01212757|58600677|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
30588293|NCT01212757|58600669|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
30588294|NCT01212757|58600670|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
30588295|NCT01212757|58600671|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
30588296|NCT01212757|58600672|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
30588297|NCT01212757|58600673|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
30588298|NCT01212757|58600674|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
30588299|NCT01212757|58600675|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
30588300|NCT01212757|58600676|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
30588301|NCT01212757|58600677|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
30588302|NCT01212757|58600669|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
30588303|NCT01212757|58600670|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
30588304|NCT01212757|58600671|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
30672086|NCT00576472|58685926|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672087|NCT00576472|58685927|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672088|NCT00576472|58685928|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672089|NCT00576472|58685929|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672090|NCT00576472|58685930|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672091|NCT00576472|58685931|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
30672092|NCT00576472|58685932|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
30958881|NCT01587703|59024031|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
30781317|NCT02963506|58793448|FG004|Double-Blind Period|Adverse Event|0|||
30672093|NCT00576472|58685918|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
30672094|NCT00576472|58685919|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
30672095|NCT00576472|58685920|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
30672096|NCT00576472|58685921|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
30672097|NCT00576472|58685922|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
30672098|NCT00576472|58685923|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
30672099|NCT00576472|58685924|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
30672100|NCT00576472|58685925|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
30672101|NCT00576472|58685926|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
30672102|NCT00576472|58685927|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
30672103|NCT00576472|58685928|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
30672104|NCT00576472|58685929|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
30672105|NCT00576472|58685930|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
30672106|NCT00576472|58685931|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
30672107|NCT00576472|58685932|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
30672108|NCT00576472|58685918|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30672109|NCT00576472|58685919|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30672110|NCT00576472|58685920|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30672111|NCT00576472|58685921|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
30672112|NCT00576472|58685922|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30781318|NCT02963506|58793449|FG005|Double-Blind Period|Adverse Event|0|||
30781319|NCT02963506|58793450|FG006|Double-Blind Period|Adverse Event|0|||
30781320|NCT02963506|58793451|FG007|Double-Blind Period|Adverse Event|0|||
30781321|NCT02963506|58793452|FG008|Double-Blind Period|Adverse Event|0|||
30588305|NCT01212757|58600672|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
30588306|NCT01212757|58600673|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
30588307|NCT01212757|58600674|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
30588308|NCT01212757|58600675|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
30588309|NCT01212757|58600676|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
30588310|NCT01212757|58600677|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
30588311|NCT01212757|58600669|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
30588312|NCT01212757|58600670|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
30588313|NCT01212757|58600671|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
30588314|NCT01212757|58600672|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
30588315|NCT01212757|58600673|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
30588316|NCT01212757|58600674|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
30588317|NCT01212757|58600675|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
30588318|NCT01212757|58600676|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
30588319|NCT01212757|58600677|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
30588320|NCT01212757|58600669|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
30588321|NCT01212757|58600670|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
30588322|NCT01212757|58600671|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
30588323|NCT01212757|58600672|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
30588324|NCT01212757|58600673|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
30588325|NCT01212757|58600674|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
30588326|NCT01212757|58600675|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
30588327|NCT01212757|58600676|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
30588328|NCT01212757|58600677|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
30588329|NCT01212757|58600669|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
30588330|NCT01212757|58600670|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
30588331|NCT01212757|58600671|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
30588332|NCT01212757|58600672|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
30588333|NCT01212757|58600673|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
30588334|NCT01212757|58600674|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
30588335|NCT01212757|58600675|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
30588336|NCT01212757|58600676|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
30588337|NCT01212757|58600677|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
30588338|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
30588339|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
30588340|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
30588341|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
30588342|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
30672113|NCT00576472|58685923|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30672114|NCT00576472|58685924|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30781322|NCT02963506|58793453|FG009|Double-Blind Period|Adverse Event|0|||
30781323|NCT02963506|58793454|FG010|Double-Blind Period|Adverse Event|0|||
30672115|NCT00576472|58685925|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30672116|NCT00576472|58685926|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30588343|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
30672117|NCT00576472|58685927|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30672118|NCT00576472|58685928|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30672119|NCT00576472|58685929|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30672120|NCT00576472|58685930|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30588344|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
30588345|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
30588346|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
30588347|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
30588348|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
30588349|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
30588350|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
30588351|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
30588352|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
30588353|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
30588354|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
30588355|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
30588356|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
30588357|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
30588358|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
30588359|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
30588360|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
30588361|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
30588362|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
30588363|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
30588364|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
30588365|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30588366|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
30672121|NCT00576472|58685931|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30672122|NCT00576472|58685932|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
30672123|NCT00576472|58685918|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
30672124|NCT00576472|58685919|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
30672125|NCT00576472|58685920|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
30672126|NCT00576472|58685921|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
30672127|NCT00576472|58685922|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
30672128|NCT00576472|58685923|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
30672129|NCT00576472|58685924|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
30672130|NCT00576472|58685925|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
30672131|NCT00576472|58685926|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
30672132|NCT00576472|58685927|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
30672133|NCT00576472|58685928|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
30672134|NCT00576472|58685929|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
30672135|NCT00576472|58685930|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
30672136|NCT00576472|58685931|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
30672137|NCT00576472|58685932|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
30672138|NCT00576472|58685918|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672139|NCT00576472|58685919|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672140|NCT00576472|58685920|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
30781324|NCT02963506|58793455|FG011|Double-Blind Period|Adverse Event|0|||
30588367|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
30588368|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30588369|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30588370|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30588371|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
30588372|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
30588373|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
30588374|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
30588375|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
30588376|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
30588377|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
30588378|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
30588379|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
30672141|NCT00576472|58685921|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
30672142|NCT00576472|58685922|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672143|NCT00576472|58685923|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672144|NCT00576472|58685924|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672145|NCT00576472|58685925|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672146|NCT00576472|58685926|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
30781325|NCT02963506|58793456|FG012|Double-Blind Period|Adverse Event|0|||
30781326|NCT02963506|58793444|FG000|Double-Blind Period|Death|0|||
30672147|NCT00576472|58685927|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672148|NCT00576472|58685928|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672149|NCT00576472|58685929|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672150|NCT00576472|58685930|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672151|NCT00576472|58685931|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672152|NCT00576472|58685932|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
30672153|NCT00576472|58685918|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
30588380|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
30588381|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
30588382|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
30588383|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
30588384|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
30588385|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
30588386|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
30588387|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
30672154|NCT00576472|58685919|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672155|NCT00576472|58685920|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672156|NCT00576472|58685921|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672157|NCT00576472|58685922|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672158|NCT00576472|58685923|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672159|NCT00576472|58685924|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
30588388|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
30588389|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
30588390|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
30588391|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
30588392|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
30588393|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
30588394|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
30588395|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
30588396|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
30588397|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
30588398|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
30588399|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
30588400|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
30588401|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
30588402|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
30588403|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
30588404|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
30672160|NCT00576472|58685925|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672161|NCT00576472|58685926|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672162|NCT00576472|58685927|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672163|NCT00576472|58685928|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672164|NCT00576472|58685929|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672165|NCT00576472|58685930|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672166|NCT00576472|58685931|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672167|NCT00576472|58685932|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
30672168|NCT00576472|58685918|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
30672169|NCT00576472|58685919|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
30672170|NCT00576472|58685920|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
30672171|NCT00576472|58685921|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
30672172|NCT00576472|58685922|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
30672173|NCT00576472|58685923|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
30672174|NCT00576472|58685924|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
30672175|NCT00576472|58685925|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
30672176|NCT00576472|58685926|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
30672177|NCT00576472|58685927|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
30672178|NCT00576472|58685928|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
30672179|NCT00576472|58685929|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
30672180|NCT00576472|58685930|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
30672181|NCT00576472|58685931|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
30672182|NCT00576472|58685932|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
30855819|NCT02760433|58883522|FG001|Overall Study|Withdrawal by Subject|9|||
30672183|NCT00576472|58685918|FG000|MPH Cross Over Phase|Physician Decision|0|||
30672184|NCT00576472|58685919|FG001|MPH Cross Over Phase|Physician Decision|0|||
30855820|NCT02760433|58883523|FG002|Overall Study|Withdrawal by Subject|0|||
30672185|NCT00576472|58685920|FG002|MPH Cross Over Phase|Physician Decision|0|||
30672186|NCT00576472|58685921|FG003|MPH Cross Over Phase|Physician Decision|0|||
30672187|NCT00576472|58685922|FG004|MPH Cross Over Phase|Physician Decision|0|||
30672188|NCT00576472|58685923|FG005|MPH Cross Over Phase|Physician Decision|0|||
30855821|NCT02760433|58883524|FG003|Overall Study|Withdrawal by Subject|2|||
30672189|NCT00576472|58685924|FG006|MPH Cross Over Phase|Physician Decision|4|||
30672190|NCT00576472|58685925|FG007|MPH Cross Over Phase|Physician Decision|0|||
30588405|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
30588406|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
30672191|NCT00576472|58685926|FG008|MPH Cross Over Phase|Physician Decision|0|||
30672192|NCT00576472|58685927|FG009|MPH Cross Over Phase|Physician Decision|0|||
30672193|NCT00576472|58685928|FG010|MPH Cross Over Phase|Physician Decision|0|||
30672194|NCT00576472|58685929|FG011|MPH Cross Over Phase|Physician Decision|0|||
30672195|NCT00576472|58685930|FG012|MPH Cross Over Phase|Physician Decision|0|||
30672196|NCT00576472|58685931|FG013|MPH Cross Over Phase|Physician Decision|0|||
30672197|NCT00576472|58685932|FG014|MPH Cross Over Phase|Physician Decision|0|||
30672198|NCT00576472|58685918|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672199|NCT00576472|58685919|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672200|NCT00576472|58685920|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672201|NCT00576472|58685921|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672202|NCT00576472|58685922|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672203|NCT00576472|58685923|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672204|NCT00576472|58685924|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672205|NCT00576472|58685925|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672206|NCT00576472|58685926|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
30672207|NCT00576472|58685927|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672208|NCT00576472|58685928|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
30672209|NCT00576472|58685929|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
30672210|NCT00576472|58685930|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672211|NCT00576472|58685931|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672212|NCT00576472|58685932|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
30672213|NCT00576472|58685918|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672214|NCT00576472|58685919|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30588407|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
30588408|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
30588409|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
30672215|NCT00576472|58685920|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672216|NCT00576472|58685921|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672217|NCT00576472|58685922|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672218|NCT00576472|58685923|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672219|NCT00576472|58685924|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672220|NCT00576472|58685925|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672221|NCT00576472|58685926|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672222|NCT00576472|58685927|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30588410|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30588411|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
30588412|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
30588413|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30588414|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30588415|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30588416|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
30588417|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
30588418|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
30588419|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
30588420|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
30588421|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
30588422|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
30588423|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
30588424|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
30588425|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
30588426|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
30588427|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
30588428|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
30588429|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
30588430|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
30588431|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
30588432|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
30672223|NCT00576472|58685928|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672224|NCT00576472|58685929|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672225|NCT00576472|58685930|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672226|NCT00576472|58685931|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
30855822|NCT02760433|58883525|FG004|Overall Study|Withdrawal by Subject|9|||
30588433|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
30588434|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
30588435|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
30588436|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
30588437|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
30588438|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
30588439|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
30588440|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
30588441|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
30588442|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
30588443|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
30588444|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
30588445|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
30588446|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
30588447|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
30588448|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
30588449|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
30588450|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
30588451|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
30588452|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
30588453|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
30588454|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
30588455|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
30588456|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
30588457|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
30588458|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
30588459|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
30588460|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
30588461|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
30588462|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
30588463|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
30958882|NCT01587703|59024032|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30958883|NCT01587703|59024033|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
30958884|NCT01587703|59024034|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30958885|NCT01587703|59024035|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30958886|NCT01587703|59024036|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30958887|NCT01587703|59024037|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30958888|NCT01587703|59024038|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30958889|NCT01587703|59024039|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30588464|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
30672227|NCT00576472|58685932|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
30672228|NCT00576472|58685918|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
30855823|NCT02760433|58883521|FG000|Overall Study|Lack of Response At Week 14|0|||
30958890|NCT01587703|59024040|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30958891|NCT01587703|59024041|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
30958892|NCT01587703|59024023|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958893|NCT01587703|59024024|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958894|NCT01587703|59024025|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958895|NCT01587703|59024026|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958896|NCT01587703|59024027|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958897|NCT01587703|59024028|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958898|NCT01587703|59024029|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958899|NCT01587703|59024030|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958900|NCT01587703|59024031|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958901|NCT01587703|59024032|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
30958902|NCT01587703|59024033|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
30958903|NCT01587703|59024034|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958904|NCT01587703|59024035|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958905|NCT01587703|59024036|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958906|NCT01587703|59024037|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958907|NCT01587703|59024038|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958908|NCT01587703|59024039|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958909|NCT01587703|59024040|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30958910|NCT01587703|59024041|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
30588465|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
30588466|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
30588467|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
30588468|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
30672229|NCT00576472|58685919|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
30672230|NCT00576472|58685920|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
30672231|NCT00576472|58685921|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
30672232|NCT00576472|58685922|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
30672233|NCT00576472|58685923|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
30672234|NCT00576472|58685924|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
30672235|NCT00576472|58685925|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
30672236|NCT00576472|58685926|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
30672237|NCT00576472|58685927|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
30672238|NCT00576472|58685928|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
30672239|NCT00576472|58685929|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
30672240|NCT00576472|58685930|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
30672241|NCT00576472|58685931|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
30672242|NCT00576472|58685932|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
30672243|NCT00576472|58685918|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
30672244|NCT00576472|58685919|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
30672245|NCT00576472|58685920|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
30672246|NCT00576472|58685921|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
30588469|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
30588470|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
30672247|NCT00576472|58685922|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
30672248|NCT00576472|58685923|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
30672249|NCT00576472|58685924|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
30672250|NCT00576472|58685925|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
30672251|NCT00576472|58685926|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
30672252|NCT00576472|58685927|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
30588471|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
30588472|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
30588473|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30588474|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
30588475|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
30588476|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30588477|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30588478|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30588479|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
30588480|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
30588481|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
30588482|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
30588483|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
30588484|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
30588485|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
30588486|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
30588487|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
30588488|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
30588489|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
30588490|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
30588491|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
30588492|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
30588493|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
30588494|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
30588495|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
30588496|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
30588497|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
30588498|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
30588499|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
30588500|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30588501|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
30588502|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
30588503|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30588504|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30588505|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30588506|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
30588507|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
30588508|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
30588509|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
30588510|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
30672253|NCT00576472|58685928|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
30672254|NCT00576472|58685929|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
30672255|NCT00576472|58685930|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
30672256|NCT00576472|58685931|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
30672257|NCT00576472|58685932|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
30672258|NCT00576472|58685918|FG000|MPH Home Maintenance Phase|Side effects|0|||
30672259|NCT00576472|58685919|FG001|MPH Home Maintenance Phase|Side effects|0|||
30672260|NCT00576472|58685920|FG002|MPH Home Maintenance Phase|Side effects|0|||
30672261|NCT00576472|58685921|FG003|MPH Home Maintenance Phase|Side effects|0|||
30672262|NCT00576472|58685922|FG004|MPH Home Maintenance Phase|Side effects|0|||
30672263|NCT00576472|58685923|FG005|MPH Home Maintenance Phase|Side effects|0|||
30672264|NCT00576472|58685924|FG006|MPH Home Maintenance Phase|Side effects|0|||
30672265|NCT00576472|58685925|FG007|MPH Home Maintenance Phase|Side effects|0|||
30672266|NCT00576472|58685926|FG008|MPH Home Maintenance Phase|Side effects|0|||
30672267|NCT00576472|58685927|FG009|MPH Home Maintenance Phase|Side effects|0|||
30672268|NCT00576472|58685928|FG010|MPH Home Maintenance Phase|Side effects|0|||
30672269|NCT00576472|58685929|FG011|MPH Home Maintenance Phase|Side effects|0|||
30672270|NCT00576472|58685930|FG012|MPH Home Maintenance Phase|Side effects|0|||
30672271|NCT00576472|58685931|FG013|MPH Home Maintenance Phase|Side effects|0|||
30588511|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
30588512|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
30588513|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
30588514|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
30588515|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
30588516|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
30588517|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
30588518|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
30588519|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
30588520|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
30588521|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
30588522|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
30588523|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
30588524|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
30588525|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
30588526|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
30588527|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
30588528|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
30588529|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
30588530|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
30588531|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
30588532|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
30588533|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
30588534|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
30672272|NCT00576472|58685932|FG014|MPH Home Maintenance Phase|Side effects|8|||
30672273|NCT00576472|58685918|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672274|NCT00576472|58685919|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672275|NCT00576472|58685920|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672276|NCT00576472|58685921|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672277|NCT00576472|58685922|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672278|NCT00576472|58685923|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672279|NCT00576472|58685924|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672280|NCT00576472|58685925|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672281|NCT00576472|58685926|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672282|NCT00576472|58685927|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672283|NCT00576472|58685928|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672284|NCT00576472|58685929|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672285|NCT00576472|58685930|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672286|NCT00576472|58685931|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
30672287|NCT00576472|58685932|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
30672288|NCT00576472|58685918|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
30672289|NCT00576472|58685919|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
30672290|NCT00576472|58685920|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
30672291|NCT00576472|58685921|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
30781327|NCT02963506|58793445|FG001|Double-Blind Period|Death|0|||
30781328|NCT02963506|58793446|FG002|Double-Blind Period|Death|0|||
30781329|NCT02963506|58793447|FG003|Double-Blind Period|Death|1|||
30588535|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
30588536|NCT01212757|58600669|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
30672292|NCT00576472|58685922|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
30781330|NCT02963506|58793448|FG004|Double-Blind Period|Death|0|||
30672293|NCT00576472|58685923|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
30781331|NCT02963506|58793449|FG005|Double-Blind Period|Death|0|||
30672294|NCT00576472|58685924|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
30672295|NCT00576472|58685925|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
30672296|NCT00576472|58685926|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
30672297|NCT00576472|58685927|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
30672298|NCT00576472|58685928|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
30672299|NCT00576472|58685929|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
30672300|NCT00576472|58685930|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
30672301|NCT00576472|58685931|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
30672302|NCT00576472|58685932|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
30672303|NCT00576472|58685918|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672304|NCT00576472|58685919|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672305|NCT00576472|58685920|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672306|NCT00576472|58685921|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672307|NCT00576472|58685922|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672308|NCT00576472|58685923|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672309|NCT00576472|58685924|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672310|NCT00576472|58685925|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672311|NCT00576472|58685926|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672312|NCT00576472|58685927|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672313|NCT00576472|58685928|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672314|NCT00576472|58685929|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672315|NCT00576472|58685930|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672316|NCT00576472|58685931|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
30672317|NCT00576472|58685932|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
30672318|NCT00823212|58685965|FG000|Overall Study|Death|8|||
30672319|NCT00823212|58685966|FG001|Overall Study|Death|10|||
30672320|NCT00823212|58685965|FG000|Overall Study|Withdrawal by Subject|6|||
30672321|NCT00823212|58685966|FG001|Overall Study|Withdrawal by Subject|1|||
30672322|NCT00823212|58685965|FG000|Overall Study|Incarcerated|0|||
30672323|NCT00823212|58685966|FG001|Overall Study|Incarcerated|1|||
30672324|NCT00823212|58685965|FG000|Overall Study|Missed 12-month visit|21|||
30672325|NCT00823212|58685966|FG001|Overall Study|Missed 12-month visit|21|||
30672326|NCT00807495|58685979|FG000|Overall Study|Adverse Event|6|||
30672327|NCT00807495|58685980|FG001|Overall Study|Adverse Event|3|||
30672328|NCT00807495|58685981|FG002|Overall Study|Adverse Event|1|||
30672329|NCT00807495|58685982|FG003|Overall Study|Adverse Event|1|||
30672330|NCT00807495|58685983|FG004|Overall Study|Adverse Event|2|||
30672331|NCT00807495|58685979|FG000|Overall Study|Withdrawal by Patient|2|||
30672332|NCT00807495|58685980|FG001|Overall Study|Withdrawal by Patient|0|||
30672333|NCT00807495|58685981|FG002|Overall Study|Withdrawal by Patient|1|||
30672334|NCT00807495|58685982|FG003|Overall Study|Withdrawal by Patient|0|||
30672335|NCT00807495|58685983|FG004|Overall Study|Withdrawal by Patient|0|||
30672336|NCT00807495|58685979|FG000|Overall Study|Reason Not Specified|0|||
30672337|NCT00807495|58685980|FG001|Overall Study|Reason Not Specified|3|||
30672338|NCT00807495|58685981|FG002|Overall Study|Reason Not Specified|2|||
30672339|NCT00807495|58685982|FG003|Overall Study|Reason Not Specified|0|||
30781332|NCT02963506|58793450|FG006|Double-Blind Period|Death|0|||
30781333|NCT02963506|58793451|FG007|Double-Blind Period|Death|0|||
30588537|NCT01212757|58600670|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
30588538|NCT01212757|58600671|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
30588539|NCT01212757|58600672|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
30588540|NCT01212757|58600673|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
30588541|NCT01212757|58600674|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
30588542|NCT01212757|58600675|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
30588543|NCT01212757|58600676|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
30588544|NCT01212757|58600677|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
30588545|NCT01190410|58600697|FG000|Overall Study|Adverse Event|0|||
30588546|NCT01190410|58600698|FG001|Overall Study|Adverse Event|3|||
30588547|NCT01190410|58600697|FG000|Overall Study|Lack of Efficacy|0|||
30588548|NCT01190410|58600698|FG001|Overall Study|Lack of Efficacy|2|||
30588549|NCT01190410|58600697|FG000|Overall Study|Withdrawal by Subject|0|||
30588550|NCT01190410|58600698|FG001|Overall Study|Withdrawal by Subject|2|||
30588551|NCT01190410|58600697|FG000|Overall Study|Administrative decision|1|||
30588552|NCT01190410|58600698|FG001|Overall Study|Administrative decision|0|||
30672340|NCT00807495|58685983|FG004|Overall Study|Reason Not Specified|3|||
30672341|NCT05074433|58685999|FG000|Overall Study|Adverse Event|0|||
30672342|NCT05074433|58686000|FG001|Overall Study|Adverse Event|2|||
30781334|NCT02963506|58793452|FG008|Double-Blind Period|Death|0|||
30588553|NCT01190410|58600697|FG000|Overall Study|PI discretion|0|||
30588554|NCT01190410|58600698|FG001|Overall Study|PI discretion|2|||
30672343|NCT05074433|58686001|FG002|Overall Study|Adverse Event|0|||
30672344|NCT05074433|58686002|FG003|Overall Study|Adverse Event|1|||
30672345|NCT05074433|58685999|FG000|Overall Study|Sponsor Request|0|||
30672346|NCT05074433|58686000|FG001|Overall Study|Sponsor Request|1|||
30672347|NCT05074433|58686001|FG002|Overall Study|Sponsor Request|1|||
30588555|NCT01190254|58600713|FG000|Overall Study|Adverse Event|3|||
30588556|NCT01190254|58600714|FG001|Overall Study|Adverse Event|6|||
30588557|NCT01190254|58600715|FG002|Overall Study|Adverse Event|8|||
30588558|NCT01190254|58600713|FG000|Overall Study|Lack of Efficacy|7|||
30588559|NCT01190254|58600714|FG001|Overall Study|Lack of Efficacy|4|||
30672348|NCT05074433|58686002|FG003|Overall Study|Sponsor Request|0|||
30672349|NCT05074433|58685999|FG000|Overall Study|Death|1|||
30672350|NCT05074433|58686000|FG001|Overall Study|Death|0|||
30672351|NCT05074433|58686001|FG002|Overall Study|Death|0|||
30672352|NCT05074433|58686002|FG003|Overall Study|Death|0|||
30672353|NCT05074433|58685999|FG000|Overall Study|Lost to Follow-up|0|||
30672354|NCT05074433|58686000|FG001|Overall Study|Lost to Follow-up|0|||
30672355|NCT05074433|58686001|FG002|Overall Study|Lost to Follow-up|2|||
30672356|NCT05074433|58686002|FG003|Overall Study|Lost to Follow-up|0|||
30672357|NCT05074433|58685999|FG000|Overall Study|Subject Decision|8|||
30672358|NCT05074433|58686000|FG001|Overall Study|Subject Decision|6|||
30672359|NCT05074433|58686001|FG002|Overall Study|Subject Decision|4|||
30672360|NCT05074433|58686002|FG003|Overall Study|Subject Decision|5|||
30672361|NCT04922021|58686026|FG000|Overall Study|Withdrawal by Subject|4|||
30672362|NCT04922021|58686027|FG001|Overall Study|Withdrawal by Subject|10|||
30672363|NCT04922021|58686026|FG000|Overall Study|Adverse Event|2|||
30672364|NCT04922021|58686027|FG001|Overall Study|Adverse Event|2|||
30672365|NCT04922021|58686026|FG000|Overall Study|Lack of Efficacy|0|||
30672366|NCT04922021|58686027|FG001|Overall Study|Lack of Efficacy|1|||
30672367|NCT04922021|58686026|FG000|Overall Study|Multiple reasons|1|||
30672368|NCT04922021|58686027|FG001|Overall Study|Multiple reasons|0|||
30672369|NCT04542057|58686043|FG000|Overall Study|Death|3|||
30672370|NCT04542057|58686044|FG001|Overall Study|Death|1|||
30672371|NCT04542057|58686043|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
30672372|NCT04542057|58686044|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
30672373|NCT04542057|58686043|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
30672374|NCT04542057|58686044|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
30672375|NCT04542057|58686043|FG000|Overall Study|Adverse Event|15|||
30672376|NCT04542057|58686044|FG001|Overall Study|Adverse Event|6|||
30672377|NCT04542057|58686043|FG000|Overall Study|COVID-19 adverse event|6|||
30672378|NCT04542057|58686044|FG001|Overall Study|COVID-19 adverse event|4|||
30672379|NCT04542057|58686043|FG000|Overall Study|Lack of Efficacy|2|||
30672380|NCT04542057|58686044|FG001|Overall Study|Lack of Efficacy|5|||
30672381|NCT04542057|58686043|FG000|Overall Study|Study terminated by sponsor|1|||
30588560|NCT01190254|58600715|FG002|Overall Study|Lack of Efficacy|5|||
30588561|NCT01190254|58600713|FG000|Overall Study|Lost to Follow-up|4|||
30588562|NCT01190254|58600714|FG001|Overall Study|Lost to Follow-up|2|||
30588563|NCT01190254|58600715|FG002|Overall Study|Lost to Follow-up|0|||
30588564|NCT01190254|58600713|FG000|Overall Study|Withdrawal by Subject|4|||
30588565|NCT01190254|58600714|FG001|Overall Study|Withdrawal by Subject|5|||
30588566|NCT01190254|58600715|FG002|Overall Study|Withdrawal by Subject|7|||
30588567|NCT01190254|58600713|FG000|Overall Study|Protocol Violation|2|||
30588568|NCT01190254|58600714|FG001|Overall Study|Protocol Violation|0|||
30588569|NCT01190254|58600715|FG002|Overall Study|Protocol Violation|2|||
30588570|NCT01190254|58600713|FG000|Overall Study|Did not meet protocol eligibility|1|||
30588571|NCT01190254|58600714|FG001|Overall Study|Did not meet protocol eligibility|0|||
30588572|NCT01190254|58600715|FG002|Overall Study|Did not meet protocol eligibility|0|||
30588573|NCT01190839|58600725|FG000|Overall Study|Adverse Event|32|||
30588574|NCT01190839|58600726|FG001|Overall Study|Adverse Event|41|||
30588575|NCT01190839|58600725|FG000|Overall Study|Protocol Violation|2|||
30588576|NCT01190839|58600726|FG001|Overall Study|Protocol Violation|2|||
30588577|NCT01190839|58600725|FG000|Overall Study|Lost to Follow-up|7|||
30588578|NCT01190839|58600726|FG001|Overall Study|Lost to Follow-up|1|||
30588579|NCT01190839|58600725|FG000|Overall Study|Death|1|||
30588580|NCT01190839|58600726|FG001|Overall Study|Death|0|||
30588581|NCT01190839|58600725|FG000|Overall Study|Trial stopped by Sponsor|71|||
30588582|NCT01190839|58600726|FG001|Overall Study|Trial stopped by Sponsor|68|||
30588583|NCT01190839|58600725|FG000|Overall Study|Undefined|35|||
30588584|NCT01190839|58600726|FG001|Overall Study|Undefined|31|||
30672382|NCT04542057|58686044|FG001|Overall Study|Study terminated by sponsor|0|||
30588585|NCT01190839|58600725|FG000|Overall Study|Randomized but not treated|2|||
30588586|NCT01190839|58600726|FG001|Overall Study|Randomized but not treated|4|||
30588587|NCT01190215|58600736|FG000|Up to Month 6|Lost to Follow-up|2|||
30588588|NCT01190215|58600737|FG001|Up to Month 6|Lost to Follow-up|0|||
30588589|NCT01190449|58600745|FG000|Overall Study|Ineligible|0|||
30588590|NCT01190449|58600746|FG001|Overall Study|Ineligible|4|||
30672383|NCT04542057|58686043|FG000|Overall Study|Investigator discretion|2|||
30672384|NCT04542057|58686044|FG001|Overall Study|Investigator discretion|1|||
30672385|NCT04542057|58686043|FG000|Overall Study|Withdrawal by Subject|52|||
30672386|NCT04542057|58686044|FG001|Overall Study|Withdrawal by Subject|30|||
30672387|NCT04542057|58686043|FG000|Overall Study|Lost to Follow-up|8|||
30672388|NCT04542057|58686044|FG001|Overall Study|Lost to Follow-up|11|||
30672389|NCT04542057|58686043|FG000|Overall Study|Other|2|||
30672390|NCT04542057|58686044|FG001|Overall Study|Other|2|||
30588591|NCT01190176|58600752|FG000|Overall Study|Withdrawal by Subject|1|||
30588592|NCT01190176|58600752|FG000|Overall Study|Lost to Follow-up|1|||
30588593|NCT01190098|58600758|FG000|Overall Study|Adverse Event|2|||
30588594|NCT01190098|58600759|FG001|Overall Study|Adverse Event|0|||
30588595|NCT01190098|58600758|FG000|Overall Study|Patient coomorbidity|0|||
30588596|NCT01190098|58600759|FG001|Overall Study|Patient coomorbidity|1|||
30588597|NCT01190098|58600758|FG000|Overall Study|Lack of transportation|1|||
30588598|NCT01190098|58600759|FG001|Overall Study|Lack of transportation|0|||
30588599|NCT01190098|58600758|FG000|Overall Study|Other|0|||
30588600|NCT01190098|58600759|FG001|Overall Study|Other|1|||
30672391|NCT04233580|58686087|FG000|Overall Study|Adverse Event|3|||
30672392|NCT04233580|58686088|FG001|Overall Study|Adverse Event|3|||
30588601|NCT01190020|58600767|FG000|Overall Study|Adverse Event|2|||
30588602|NCT01190020|58600768|FG001|Overall Study|Adverse Event|0|||
30672393|NCT04233580|58686087|FG000|Overall Study|Withdrawal by Subject|2|||
30672394|NCT04233580|58686088|FG001|Overall Study|Withdrawal by Subject|1|||
30672395|NCT04016805|58686108|FG000|Overall Study|Sponsor's Discretion|30|||
30672396|NCT04016805|58686109|FG001|Overall Study|Sponsor's Discretion|6|||
30672397|NCT04016805|58686110|FG002|Overall Study|Sponsor's Discretion|5|||
30672398|NCT03982199|58686120|FG000|Overall Study|Site terminated by sponsor|14|||
30672399|NCT03982199|58686121|FG001|Overall Study|Site terminated by sponsor|17|||
30672400|NCT03982199|58686120|FG000|Overall Study|Lost to Follow-up|137|||
30672401|NCT03982199|58686121|FG001|Overall Study|Lost to Follow-up|142|||
30672402|NCT03982199|58686120|FG000|Overall Study|Physician Decision|38|||
30672403|NCT03982199|58686121|FG001|Overall Study|Physician Decision|33|||
30672404|NCT03982199|58686120|FG000|Overall Study|Withdrawal by Subject|514|||
30672405|NCT03982199|58686121|FG001|Overall Study|Withdrawal by Subject|496|||
30672406|NCT03982199|58686120|FG000|Overall Study|Adverse Event|10|||
30672407|NCT03982199|58686121|FG001|Overall Study|Adverse Event|14|||
30672408|NCT03982199|58686120|FG000|Overall Study|Technical Problems|9|||
30672409|NCT03982199|58686121|FG001|Overall Study|Technical Problems|8|||
30672410|NCT03982199|58686120|FG000|Overall Study|Death|40|||
30672411|NCT03982199|58686121|FG001|Overall Study|Death|40|||
30672412|NCT03982199|58686120|FG000|Overall Study|Study terminated by sponsor|2|||
30672413|NCT03982199|58686121|FG001|Overall Study|Study terminated by sponsor|1|||
30672414|NCT03982199|58686120|FG000|Overall Study|Other|76|||
30672415|NCT03982199|58686121|FG001|Overall Study|Other|81|||
30672416|NCT03982199|58686120|FG000|Overall Study|Ongoing|743|||
30672417|NCT03982199|58686121|FG001|Overall Study|Ongoing|799|||
30672418|NCT03982199|58686120|FG000|Overall Study|Randomized but not vaccinated|18|||
30672419|NCT03982199|58686121|FG001|Overall Study|Randomized but not vaccinated|15|||
30672420|NCT03828448|58686127|FG000|Overall Study|Sponsor's Discretion|34|||
30672421|NCT03713593|58686137|FG000|Overall Study|Participants Ongoing|140|||
30672422|NCT03713593|58686138|FG001|Overall Study|Participants Ongoing|114|||
30588603|NCT01190020|58600767|FG000|Overall Study|Lost to Follow-up|2|||
30588604|NCT01190020|58600768|FG001|Overall Study|Lost to Follow-up|0|||
30588605|NCT01190020|58600767|FG000|Overall Study|Withdrawal by Subject|3|||
30588606|NCT01190020|58600768|FG001|Overall Study|Withdrawal by Subject|0|||
30588607|NCT01189435|58600774|FG000|Overall Study|Withdrawal by Subject|1|||
30588608|NCT01189435|58600774|FG000|Overall Study|Physician Decision|1|||
30588609|NCT01165996|58600778|FG000|Overall Study|Death|1|||
30588610|NCT01165996|58600778|FG000|Overall Study|Physician Decision|1|||
30588611|NCT01165684|58600785|FG000|Overall Study|Adverse Event|1|||
30588612|NCT01165684|58600786|FG001|Overall Study|Adverse Event|1|||
30588613|NCT01165684|58600785|FG000|Overall Study|Lack of Efficacy|2|||
30588614|NCT01165684|58600786|FG001|Overall Study|Lack of Efficacy|1|||
30588615|NCT01165684|58600785|FG000|Overall Study|Protocol Violation|7|||
30588616|NCT01165684|58600786|FG001|Overall Study|Protocol Violation|15|||
30588617|NCT01165684|58600785|FG000|Overall Study|Withdrawal Criteria|2|||
30672423|NCT03713593|58686137|FG000|Overall Study|Withdrawal by Subject|3|||
30672424|NCT03713593|58686138|FG001|Overall Study|Withdrawal by Subject|6|||
30672425|NCT03713593|58686137|FG000|Overall Study|Death|252|||
30672426|NCT03713593|58686138|FG001|Overall Study|Death|279|||
30588618|NCT01165684|58600786|FG001|Overall Study|Withdrawal Criteria|13|||
30588619|NCT01165684|58600785|FG000|Overall Study|Unclassified|16|||
30672427|NCT03580369|58686148|FG000|Overall Study|No treatment due to mis-randomization|1|||
30672428|NCT03580369|58686149|FG001|Overall Study|No treatment due to mis-randomization|0|||
30672429|NCT03580369|58686150|FG002|Overall Study|No treatment due to mis-randomization|0|||
30588620|NCT01165684|58600786|FG001|Overall Study|Unclassified|22|||
30588621|NCT01189201|58600792|FG000|Overall Study|Adverse Event|1|||
30588622|NCT01188967|58600809|FG000|Overall Study|Withdrawal by Subject|1|||
30588623|NCT01188967|58600810|FG001|Overall Study|Withdrawal by Subject|1|||
30588624|NCT01188967|58600809|FG000|Overall Study|Physician Decision|1|||
30672430|NCT03580369|58686151|FG003|Overall Study|No treatment due to mis-randomization|0|||
30672431|NCT03580369|58686152|FG004|Overall Study|No treatment due to mis-randomization|3|||
30672432|NCT03580369|58686153|FG005|Overall Study|No treatment due to mis-randomization|0|||
30672433|NCT03580369|58686154|FG006|Overall Study|No treatment due to mis-randomization|0|||
30672434|NCT03580369|58686155|FG007|Overall Study|No treatment due to mis-randomization|0|||
30672435|NCT03580369|58686148|FG000|Overall Study|Reason unknown|0|||
30672436|NCT03580369|58686149|FG001|Overall Study|Reason unknown|0|||
30672437|NCT03580369|58686150|FG002|Overall Study|Reason unknown|1|||
30672438|NCT03580369|58686151|FG003|Overall Study|Reason unknown|0|||
30672439|NCT03580369|58686152|FG004|Overall Study|Reason unknown|0|||
30672440|NCT03580369|58686153|FG005|Overall Study|Reason unknown|0|||
30672441|NCT03580369|58686154|FG006|Overall Study|Reason unknown|0|||
30672442|NCT03580369|58686155|FG007|Overall Study|Reason unknown|0|||
30672443|NCT03580369|58686148|FG000|Overall Study|Technical problems|0|||
30672444|NCT03580369|58686149|FG001|Overall Study|Technical problems|0|||
30672445|NCT03580369|58686150|FG002|Overall Study|Technical problems|0|||
30855824|NCT02760433|58883522|FG001|Overall Study|Lack of Response At Week 14|0|||
30855825|NCT02760433|58883523|FG002|Overall Study|Lack of Response At Week 14|0|||
30855826|NCT02760433|58883524|FG003|Overall Study|Lack of Response At Week 14|0|||
30855827|NCT02760433|58883525|FG004|Overall Study|Lack of Response At Week 14|1|||
30672446|NCT03580369|58686151|FG003|Overall Study|Technical problems|0|||
30672447|NCT03580369|58686152|FG004|Overall Study|Technical problems|1|||
30672448|NCT03580369|58686153|FG005|Overall Study|Technical problems|0|||
30672449|NCT03580369|58686154|FG006|Overall Study|Technical problems|2|||
30672450|NCT03580369|58686155|FG007|Overall Study|Technical problems|0|||
30672451|NCT03580369|58686148|FG000|Overall Study|Pregnancy|2|||
30672452|NCT03580369|58686149|FG001|Overall Study|Pregnancy|0|||
30672453|NCT03580369|58686150|FG002|Overall Study|Pregnancy|3|||
30672454|NCT03580369|58686151|FG003|Overall Study|Pregnancy|0|||
30672455|NCT03580369|58686152|FG004|Overall Study|Pregnancy|2|||
30672456|NCT03580369|58686153|FG005|Overall Study|Pregnancy|0|||
30672457|NCT03580369|58686154|FG006|Overall Study|Pregnancy|0|||
30672458|NCT03580369|58686155|FG007|Overall Study|Pregnancy|0|||
30672459|NCT03580369|58686148|FG000|Overall Study|Lost to Follow-up|2|||
30672460|NCT03580369|58686149|FG001|Overall Study|Lost to Follow-up|0|||
30672461|NCT03580369|58686150|FG002|Overall Study|Lost to Follow-up|2|||
30672462|NCT03580369|58686151|FG003|Overall Study|Lost to Follow-up|0|||
30672463|NCT03580369|58686152|FG004|Overall Study|Lost to Follow-up|3|||
30672464|NCT03580369|58686153|FG005|Overall Study|Lost to Follow-up|0|||
30672465|NCT03580369|58686154|FG006|Overall Study|Lost to Follow-up|1|||
30672466|NCT03580369|58686155|FG007|Overall Study|Lost to Follow-up|0|||
30672467|NCT03580369|58686148|FG000|Overall Study|Physician Decision|4|||
30672468|NCT03580369|58686149|FG001|Overall Study|Physician Decision|0|||
30672469|NCT03580369|58686150|FG002|Overall Study|Physician Decision|4|||
30672470|NCT03580369|58686151|FG003|Overall Study|Physician Decision|1|||
30672471|NCT03580369|58686152|FG004|Overall Study|Physician Decision|1|||
30672472|NCT03580369|58686153|FG005|Overall Study|Physician Decision|0|||
30672473|NCT03580369|58686154|FG006|Overall Study|Physician Decision|0|||
30588625|NCT01188967|58600810|FG001|Overall Study|Physician Decision|1|||
30588626|NCT01188967|58600809|FG000|Overall Study|Lost to Follow-up|3|||
30588627|NCT01188967|58600810|FG001|Overall Study|Lost to Follow-up|2|||
30588628|NCT01188811|58600820|FG000|Overall Study|Withdrawal by Subject|0|||
30588629|NCT01188811|58600821|FG001|Overall Study|Withdrawal by Subject|2|||
30588630|NCT01188811|58600820|FG000|Overall Study|Adverse Event|6|||
30588631|NCT01188811|58600821|FG001|Overall Study|Adverse Event|0|||
30588632|NCT01183234|58600829|FG000|First Intervention|Adverse Event|1|||
30588633|NCT01183234|58600830|FG001|First Intervention|Adverse Event|0|||
30588634|NCT01165216|58600838|FG000|Overall Study|Adverse Event|6|||
30672474|NCT03580369|58686155|FG007|Overall Study|Physician Decision|0|||
30672475|NCT03580369|58686148|FG000|Overall Study|Lack of Efficacy|3|||
30672476|NCT03580369|58686149|FG001|Overall Study|Lack of Efficacy|0|||
30672477|NCT03580369|58686150|FG002|Overall Study|Lack of Efficacy|7|||
30672478|NCT03580369|58686151|FG003|Overall Study|Lack of Efficacy|0|||
30672479|NCT03580369|58686152|FG004|Overall Study|Lack of Efficacy|2|||
30672480|NCT03580369|58686153|FG005|Overall Study|Lack of Efficacy|0|||
30672481|NCT03580369|58686154|FG006|Overall Study|Lack of Efficacy|3|||
30588635|NCT01165216|58600839|FG001|Overall Study|Adverse Event|3|||
30588636|NCT01165216|58600838|FG000|Overall Study|Withdrawal by Subject|1|||
30588637|NCT01165216|58600839|FG001|Overall Study|Withdrawal by Subject|1|||
30588638|NCT01165216|58600838|FG000|Overall Study|Disease progression|1|||
30588639|NCT01165216|58600839|FG001|Overall Study|Disease progression|3|||
30588640|NCT04675151|58600864|FG000|Overall Study|Protocol Violation|1|||
30588641|NCT04675151|58600865|FG001|Overall Study|Protocol Violation|0|||
30672482|NCT03580369|58686155|FG007|Overall Study|Lack of Efficacy|0|||
30672483|NCT03580369|58686148|FG000|Overall Study|Protocol Violation|6|||
30672484|NCT03580369|58686149|FG001|Overall Study|Protocol Violation|0|||
30672485|NCT03580369|58686150|FG002|Overall Study|Protocol Violation|6|||
30672486|NCT03580369|58686151|FG003|Overall Study|Protocol Violation|1|||
30672487|NCT03580369|58686152|FG004|Overall Study|Protocol Violation|8|||
30672488|NCT03580369|58686153|FG005|Overall Study|Protocol Violation|2|||
30672489|NCT03580369|58686154|FG006|Overall Study|Protocol Violation|1|||
30672490|NCT03580369|58686155|FG007|Overall Study|Protocol Violation|0|||
30672491|NCT03580369|58686148|FG000|Overall Study|Adverse Event|7|||
30672492|NCT03580369|58686149|FG001|Overall Study|Adverse Event|0|||
30672493|NCT03580369|58686150|FG002|Overall Study|Adverse Event|14|||
30672494|NCT03580369|58686151|FG003|Overall Study|Adverse Event|1|||
30672495|NCT03580369|58686152|FG004|Overall Study|Adverse Event|6|||
30672496|NCT03580369|58686153|FG005|Overall Study|Adverse Event|0|||
30672497|NCT03580369|58686154|FG006|Overall Study|Adverse Event|1|||
30672498|NCT03580369|58686155|FG007|Overall Study|Adverse Event|0|||
30672499|NCT03580369|58686148|FG000|Overall Study|Withdrawal by Subject|19|||
30672500|NCT03580369|58686149|FG001|Overall Study|Withdrawal by Subject|0|||
30672501|NCT03580369|58686150|FG002|Overall Study|Withdrawal by Subject|17|||
30672502|NCT03580369|58686151|FG003|Overall Study|Withdrawal by Subject|0|||
30672503|NCT03580369|58686152|FG004|Overall Study|Withdrawal by Subject|16|||
30672504|NCT03580369|58686153|FG005|Overall Study|Withdrawal by Subject|1|||
30672505|NCT03580369|58686154|FG006|Overall Study|Withdrawal by Subject|7|||
30672506|NCT03580369|58686155|FG007|Overall Study|Withdrawal by Subject|0|||
30958911|NCT01587703|59024023|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958912|NCT01587703|59024024|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958913|NCT01587703|59024025|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958914|NCT01587703|59024026|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958915|NCT01587703|59024027|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958916|NCT01587703|59024028|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958917|NCT01587703|59024029|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958918|NCT01587703|59024030|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958919|NCT01587703|59024031|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
30958920|NCT01587703|59024032|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958921|NCT01587703|59024033|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958922|NCT01587703|59024034|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958923|NCT01587703|59024035|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958924|NCT01587703|59024036|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30588642|NCT04675151|58600866|FG002|Overall Study|Protocol Violation|0|||
30588643|NCT04675151|58600867|FG003|Overall Study|Protocol Violation|1|||
30588644|NCT04545476|58600881|FG000|Overall Study|Lost to Follow-up|1|||
30588645|NCT04545476|58600882|FG001|Overall Study|Lost to Follow-up|1|||
30588646|NCT04545476|58600883|FG002|Overall Study|Lost to Follow-up|0|||
30588647|NCT04545476|58600884|FG003|Overall Study|Lost to Follow-up|0|||
30588648|NCT01969838|58600899|FG000|Double-blind Phase|Adverse Event|10|||
30588649|NCT01969838|58600900|FG001|Double-blind Phase|Adverse Event|4|||
30588650|NCT01969838|58600901|FG002|Double-blind Phase|Adverse Event|0|||
30588651|NCT01969838|58600902|FG003|Double-blind Phase|Adverse Event|0|||
30588652|NCT01969838|58600899|FG000|Double-blind Phase|Death|5|||
30588653|NCT01969838|58600900|FG001|Double-blind Phase|Death|2|||
30588654|NCT01969838|58600901|FG002|Double-blind Phase|Death|0|||
30588655|NCT01969838|58600902|FG003|Double-blind Phase|Death|0|||
30588656|NCT01969838|58600899|FG000|Double-blind Phase|Physician Decision|5|||
30588657|NCT01969838|58600900|FG001|Double-blind Phase|Physician Decision|1|||
30588658|NCT01969838|58600901|FG002|Double-blind Phase|Physician Decision|0|||
30588659|NCT01969838|58600902|FG003|Double-blind Phase|Physician Decision|0|||
30588660|NCT01969838|58600899|FG000|Double-blind Phase|Subject Decision|4|||
30588661|NCT01969838|58600900|FG001|Double-blind Phase|Subject Decision|2|||
30588662|NCT01969838|58600901|FG002|Double-blind Phase|Subject Decision|0|||
30588663|NCT01969838|58600902|FG003|Double-blind Phase|Subject Decision|0|||
30588664|NCT01969838|58600899|FG000|Double-blind Phase|Disease Progression|2|||
30588665|NCT01969838|58600900|FG001|Double-blind Phase|Disease Progression|0|||
30588666|NCT01969838|58600901|FG002|Double-blind Phase|Disease Progression|0|||
30588667|NCT01969838|58600902|FG003|Double-blind Phase|Disease Progression|0|||
30588668|NCT01969838|58600899|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
30588669|NCT01969838|58600900|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
30958925|NCT01587703|59024037|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30672527|NCT03215810|58686223|FG000|Overall Study|Still responding to nivolumab|1|||
30672528|NCT03215810|58686223|FG000|Overall Study|Insufficient TIL growth|1|||
30672529|NCT03215810|58686223|FG000|Overall Study|Decline in performance status|1|||
30672530|NCT03215810|58686223|FG000|Overall Study|Withdrawal by Subject|1|||
30672531|NCT02677922|58686262|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
30588670|NCT01969838|58600901|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
30588671|NCT01969838|58600902|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
30588672|NCT01969838|58600899|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
30588673|NCT01969838|58600900|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
30588674|NCT01969838|58600901|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
30588675|NCT01969838|58600902|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
30672532|NCT02677922|58686263|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
30672533|NCT02677922|58686264|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
30672534|NCT02677922|58686265|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
30588676|NCT01969838|58600899|FG000|Open-label Phase|Adverse Event|0|||
30588677|NCT01969838|58600900|FG001|Open-label Phase|Adverse Event|0|||
30672535|NCT02677922|58686266|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
30588678|NCT01969838|58600901|FG002|Open-label Phase|Adverse Event|37|||
30588679|NCT01969838|58600902|FG003|Open-label Phase|Adverse Event|49|||
30588680|NCT01969838|58600899|FG000|Open-label Phase|Disease Progression|0|||
30588681|NCT01969838|58600900|FG001|Open-label Phase|Disease Progression|0|||
30588682|NCT01969838|58600901|FG002|Open-label Phase|Disease Progression|26|||
30588683|NCT01969838|58600902|FG003|Open-label Phase|Disease Progression|27|||
30588684|NCT01969838|58600899|FG000|Open-label Phase|Lack of Efficacy|0|||
30588685|NCT01969838|58600900|FG001|Open-label Phase|Lack of Efficacy|0|||
30588686|NCT01969838|58600901|FG002|Open-label Phase|Lack of Efficacy|17|||
30588687|NCT01969838|58600902|FG003|Open-label Phase|Lack of Efficacy|19|||
30672536|NCT02677922|58686267|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
30672537|NCT02677922|58686262|FG000|Treatment Period|Adverse Event|0|||
30672538|NCT02677922|58686263|FG001|Treatment Period|Adverse Event|0|||
30672539|NCT02677922|58686264|FG002|Treatment Period|Adverse Event|1|||
30672540|NCT02677922|58686265|FG003|Treatment Period|Adverse Event|3|||
30672541|NCT02677922|58686266|FG004|Treatment Period|Adverse Event|5|||
30672542|NCT02677922|58686267|FG005|Treatment Period|Adverse Event|2|||
30672543|NCT02677922|58686262|FG000|Treatment Period|Progressive Disease|1|||
30672544|NCT02677922|58686263|FG001|Treatment Period|Progressive Disease|1|||
30672545|NCT02677922|58686264|FG002|Treatment Period|Progressive Disease|0|||
30672546|NCT02677922|58686265|FG003|Treatment Period|Progressive Disease|0|||
30588688|NCT01969838|58600899|FG000|Open-label Phase|Subject Decision|0|||
30588689|NCT01969838|58600900|FG001|Open-label Phase|Subject Decision|0|||
30588690|NCT01969838|58600901|FG002|Open-label Phase|Subject Decision|14|||
30588691|NCT01969838|58600902|FG003|Open-label Phase|Subject Decision|15|||
30588692|NCT01969838|58600899|FG000|Open-label Phase|Death|0|||
30588693|NCT01969838|58600900|FG001|Open-label Phase|Death|0|||
30588694|NCT01969838|58600901|FG002|Open-label Phase|Death|13|||
30588695|NCT01969838|58600902|FG003|Open-label Phase|Death|11|||
30588696|NCT01969838|58600899|FG000|Open-label Phase|Physician Decision|0|||
30588697|NCT01969838|58600900|FG001|Open-label Phase|Physician Decision|0|||
30588698|NCT01969838|58600901|FG002|Open-label Phase|Physician Decision|9|||
30588699|NCT01969838|58600902|FG003|Open-label Phase|Physician Decision|14|||
30588700|NCT01969838|58600899|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
30588701|NCT01969838|58600900|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
30588702|NCT01969838|58600901|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
30588703|NCT01969838|58600902|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
30588704|NCT01165177|58600913|FG000|Overall Study|Serious Adverse Event|227|||
30588705|NCT01165177|58600914|FG001|Overall Study|Serious Adverse Event|235|||
30588706|NCT01165177|58600913|FG000|Overall Study|Withdrawal by Subject|368|||
30588707|NCT01165177|58600914|FG001|Overall Study|Withdrawal by Subject|354|||
30588708|NCT01165177|58600913|FG000|Overall Study|Protocol Violation|19|||
30588709|NCT01165177|58600914|FG001|Overall Study|Protocol Violation|21|||
30588710|NCT01165177|58600913|FG000|Overall Study|Non-serious adverse event|30|||
30588711|NCT01165177|58600914|FG001|Overall Study|Non-serious adverse event|18|||
30588712|NCT01165177|58600913|FG000|Overall Study|Other unspecified reasons|47|||
30588713|NCT01165177|58600914|FG001|Overall Study|Other unspecified reasons|35|||
30588714|NCT01165177|58600913|FG000|Overall Study|Suspected HZ episode|0|||
30588715|NCT01165177|58600914|FG001|Overall Study|Suspected HZ episode|2|||
30588716|NCT01165177|58600913|FG000|Overall Study|Lost to Follow-up|183|||
30588717|NCT01165177|58600914|FG001|Overall Study|Lost to Follow-up|194|||
30588718|NCT01165177|58600913|FG000|Overall Study|Migrated/ moved from study area|48|||
30588719|NCT01165177|58600914|FG001|Overall Study|Migrated/ moved from study area|43|||
30588720|NCT01165138|58600931|FG000|Overall Study|Adverse Event|0|||
30588721|NCT01165138|58600932|FG001|Overall Study|Adverse Event|1|||
30588722|NCT01165138|58600933|FG002|Overall Study|Adverse Event|0|||
30588723|NCT01165138|58600934|FG003|Overall Study|Adverse Event|2|||
30588724|NCT01165138|58600931|FG000|Overall Study|Lack of Efficacy|0|||
30588725|NCT01165138|58600932|FG001|Overall Study|Lack of Efficacy|32|||
30588726|NCT01165138|58600933|FG002|Overall Study|Lack of Efficacy|6|||
30588727|NCT01165138|58600934|FG003|Overall Study|Lack of Efficacy|7|||
30588728|NCT01165138|58600931|FG000|Overall Study|Protocol Violation|0|||
30672547|NCT02677922|58686266|FG004|Treatment Period|Progressive Disease|8|||
30672548|NCT02677922|58686267|FG005|Treatment Period|Progressive Disease|7|||
30588729|NCT01165138|58600932|FG001|Overall Study|Protocol Violation|7|||
30672549|NCT02677922|58686262|FG000|Treatment Period|Lack of Efficacy|0|||
30781335|NCT02963506|58793453|FG009|Double-Blind Period|Death|0|||
30781336|NCT02963506|58793454|FG010|Double-Blind Period|Death|0|||
30588730|NCT01165138|58600933|FG002|Overall Study|Protocol Violation|0|||
30588731|NCT01165138|58600934|FG003|Overall Study|Protocol Violation|2|||
30588732|NCT01165138|58600931|FG000|Overall Study|Lost to Follow-up|0|||
30588733|NCT01165138|58600932|FG001|Overall Study|Lost to Follow-up|0|||
30588734|NCT01165138|58600933|FG002|Overall Study|Lost to Follow-up|1|||
30672550|NCT02677922|58686263|FG001|Treatment Period|Lack of Efficacy|0|||
30588735|NCT01165138|58600934|FG003|Overall Study|Lost to Follow-up|2|||
30588736|NCT01165138|58600931|FG000|Overall Study|Physician Decision|0|||
30672551|NCT02677922|58686264|FG002|Treatment Period|Lack of Efficacy|0|||
30588737|NCT01165138|58600932|FG001|Overall Study|Physician Decision|6|||
30781337|NCT02963506|58793455|FG011|Double-Blind Period|Death|0|||
30588738|NCT01165138|58600933|FG002|Overall Study|Physician Decision|7|||
30588739|NCT01165138|58600934|FG003|Overall Study|Physician Decision|6|||
30588740|NCT01165138|58600931|FG000|Overall Study|Withdrawal by Subject|0|||
30588741|NCT01165138|58600932|FG001|Overall Study|Withdrawal by Subject|6|||
30588742|NCT01165138|58600933|FG002|Overall Study|Withdrawal by Subject|6|||
30588743|NCT01165138|58600934|FG003|Overall Study|Withdrawal by Subject|3|||
30588744|NCT01165021|58600942|FG000|Overall Study|Death|1|||
30588745|NCT01182844|58600948|FG000|Overall Study|Withdrawal by Subject|0|||
30672552|NCT02677922|58686265|FG003|Treatment Period|Lack of Efficacy|1|||
30672553|NCT02677922|58686266|FG004|Treatment Period|Lack of Efficacy|1|||
30672554|NCT02677922|58686267|FG005|Treatment Period|Lack of Efficacy|6|||
30672555|NCT02677922|58686262|FG000|Treatment Period|Withdrawal by Subject|0|||
30672556|NCT02677922|58686263|FG001|Treatment Period|Withdrawal by Subject|0|||
30672557|NCT02677922|58686264|FG002|Treatment Period|Withdrawal by Subject|1|||
30672558|NCT02677922|58686265|FG003|Treatment Period|Withdrawal by Subject|3|||
30672559|NCT02677922|58686266|FG004|Treatment Period|Withdrawal by Subject|5|||
30672560|NCT02677922|58686267|FG005|Treatment Period|Withdrawal by Subject|5|||
30672561|NCT02677922|58686262|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
30672562|NCT02677922|58686263|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
30672563|NCT02677922|58686264|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
30672564|NCT02677922|58686265|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
30672565|NCT02677922|58686266|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
30672566|NCT02677922|58686267|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
30672567|NCT02677922|58686262|FG000|Treatment Period|Disease Relapse|0|||
30672568|NCT02677922|58686263|FG001|Treatment Period|Disease Relapse|0|||
30672569|NCT02677922|58686264|FG002|Treatment Period|Disease Relapse|0|||
30672570|NCT02677922|58686265|FG003|Treatment Period|Disease Relapse|3|||
30672571|NCT02677922|58686266|FG004|Treatment Period|Disease Relapse|6|||
30672572|NCT02677922|58686267|FG005|Treatment Period|Disease Relapse|1|||
30672573|NCT02677922|58686262|FG000|Treatment Period|Allogeneic HSCT|1|||
30672574|NCT02677922|58686263|FG001|Treatment Period|Allogeneic HSCT|0|||
30672575|NCT02677922|58686264|FG002|Treatment Period|Allogeneic HSCT|0|||
30672576|NCT02677922|58686265|FG003|Treatment Period|Allogeneic HSCT|1|||
30672577|NCT02677922|58686266|FG004|Treatment Period|Allogeneic HSCT|4|||
30672578|NCT02677922|58686267|FG005|Treatment Period|Allogeneic HSCT|1|||
30672579|NCT02677922|58686262|FG000|Treatment Period|Other Reasons|0|||
30672580|NCT02677922|58686263|FG001|Treatment Period|Other Reasons|0|||
30672581|NCT02677922|58686264|FG002|Treatment Period|Other Reasons|0|||
30672582|NCT02677922|58686265|FG003|Treatment Period|Other Reasons|1|||
30672583|NCT02677922|58686266|FG004|Treatment Period|Other Reasons|3|||
30672584|NCT02677922|58686267|FG005|Treatment Period|Other Reasons|5|||
30672585|NCT02677922|58686262|FG000|Treatment Period|Death|0|||
30672586|NCT02677922|58686263|FG001|Treatment Period|Death|0|||
30672587|NCT02677922|58686264|FG002|Treatment Period|Death|0|||
30672588|NCT02677922|58686265|FG003|Treatment Period|Death|0|||
30672589|NCT02677922|58686266|FG004|Treatment Period|Death|12|||
30672590|NCT02677922|58686267|FG005|Treatment Period|Death|1|||
30672591|NCT02677922|58686262|FG000|Treatment Period|Non-compliance with Study Drug|0|||
30672592|NCT02677922|58686263|FG001|Treatment Period|Non-compliance with Study Drug|0|||
30672593|NCT02677922|58686264|FG002|Treatment Period|Non-compliance with Study Drug|0|||
30672594|NCT02677922|58686265|FG003|Treatment Period|Non-compliance with Study Drug|0|||
30672595|NCT02677922|58686266|FG004|Treatment Period|Non-compliance with Study Drug|1|||
30672596|NCT02677922|58686267|FG005|Treatment Period|Non-compliance with Study Drug|0|||
30672597|NCT02677922|58686262|FG000|Treatment Period|Physician Decision|0|||
30672598|NCT02677922|58686263|FG001|Treatment Period|Physician Decision|0|||
30672599|NCT02677922|58686264|FG002|Treatment Period|Physician Decision|0|||
30672600|NCT02677922|58686265|FG003|Treatment Period|Physician Decision|0|||
30672601|NCT02677922|58686266|FG004|Treatment Period|Physician Decision|0|||
30672602|NCT02677922|58686267|FG005|Treatment Period|Physician Decision|1|||
30672603|NCT02677922|58686262|FG000|Treatment Period|Symptomatic Deterioration|0|||
30672604|NCT02677922|58686263|FG001|Treatment Period|Symptomatic Deterioration|0|||
30672605|NCT02677922|58686264|FG002|Treatment Period|Symptomatic Deterioration|0|||
30672606|NCT02677922|58686265|FG003|Treatment Period|Symptomatic Deterioration|0|||
30672607|NCT02677922|58686266|FG004|Treatment Period|Symptomatic Deterioration|1|||
30672608|NCT02677922|58686267|FG005|Treatment Period|Symptomatic Deterioration|0|||
30672609|NCT02634710|58686300|FG000|Overall Study|Death|4|||
30672610|NCT02540993|58686315|FG000|Overall Study|Lost to Follow-up|5|||
30588746|NCT01182844|58600949|FG001|Overall Study|Withdrawal by Subject|2|||
30588747|NCT01164865|58600957|FG000|Overall Study|Lost to Follow-up|2|||
30672611|NCT02540993|58686316|FG001|Overall Study|Lost to Follow-up|3|||
30672612|NCT02540993|58686315|FG000|Overall Study|Withdrawal by Subject|4|||
30672613|NCT02540993|58686316|FG001|Overall Study|Withdrawal by Subject|6|||
30781338|NCT02963506|58793456|FG012|Double-Blind Period|Death|0|||
30588748|NCT01164865|58600958|FG001|Overall Study|Lost to Follow-up|1|||
30672614|NCT02540993|58686315|FG000|Overall Study|GCP violations|33|||
30672615|NCT02540993|58686316|FG001|Overall Study|GCP violations|27|||
30588749|NCT01164475|58600966|FG000|Overall Study|Lack of Efficacy|1|||
30588750|NCT01164475|58600967|FG001|Overall Study|Lack of Efficacy|0|||
30588751|NCT01164475|58600966|FG000|Overall Study|Other|0|||
30588752|NCT01164475|58600967|FG001|Overall Study|Other|1|||
30588753|NCT01164475|58600966|FG000|Overall Study|Progressive disease|0|||
30588754|NCT01164475|58600967|FG001|Overall Study|Progressive disease|1|||
30588755|NCT01164475|58600966|FG000|Overall Study|Protocol Violation|1|||
30588756|NCT01164475|58600967|FG001|Overall Study|Protocol Violation|0|||
30588757|NCT01164007|58600973|FG000|Overall Study|Adverse Event|5|||
30588758|NCT01164007|58600973|FG000|Overall Study|Progression of Disease|30|||
30588759|NCT01164007|58600973|FG000|Overall Study|Protocol Violation|1|||
30588760|NCT01164007|58600973|FG000|Overall Study|Withdrawal by Subject|1|||
30588761|NCT01164007|58600973|FG000|Overall Study|Medical Decision|3|||
30588762|NCT01163851|58600979|FG000|Overall Study|Site Closure|0|||
30588763|NCT01163851|58600980|FG001|Overall Study|Site Closure|1|||
30588764|NCT01163851|58600979|FG000|Overall Study|Enrolled but not treated|1|||
30588765|NCT01163851|58600980|FG001|Overall Study|Enrolled but not treated|0|||
30588766|NCT01163617|58600986|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
30588767|NCT01163617|58600987|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
30588768|NCT01163617|58600988|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
30588769|NCT01163617|58600989|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
30588770|NCT01163617|58600990|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
30588771|NCT01163617|58600991|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
30588772|NCT01163617|58600992|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
30588773|NCT01163617|58600993|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
30588774|NCT01163617|58600986|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
30588775|NCT01163617|58600987|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
30588776|NCT01163617|58600988|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
30588777|NCT01163617|58600989|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
30588778|NCT01163617|58600990|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
30588779|NCT01163617|58600991|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
30588780|NCT01163617|58600992|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
30588781|NCT01163617|58600993|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
30588782|NCT01163617|58600986|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
30588783|NCT01163617|58600987|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
30588784|NCT01163617|58600988|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
30588785|NCT01163617|58600989|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
30588786|NCT01163617|58600990|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
30588787|NCT01163617|58600991|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
30588788|NCT01163617|58600992|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
30588789|NCT01163617|58600993|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
30588790|NCT01182337|58601015|FG000|Overall Study|Withdrawal by Subject|3|||
30588791|NCT01182337|58601016|FG001|Overall Study|Withdrawal by Subject|1|||
30588792|NCT01182337|58601015|FG000|Overall Study|Lost to Follow-up|0|||
30588793|NCT01182337|58601016|FG001|Overall Study|Lost to Follow-up|1|||
30588794|NCT01182298|58601023|FG000|Overall Study|Lack of Efficacy|4|||
30588795|NCT01182298|58601023|FG000|Overall Study|Withdrawal by Subject|2|||
30588796|NCT01163266|58601030|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
30588797|NCT01163266|58601031|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
30588798|NCT01163266|58601032|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
30588799|NCT01163266|58601030|FG000|Overall Study|Lack of Efficacy|1|||
30588800|NCT01163266|58601031|FG001|Overall Study|Lack of Efficacy|3|||
30588801|NCT01163266|58601032|FG002|Overall Study|Lack of Efficacy|1|||
30588802|NCT01163266|58601030|FG000|Overall Study|Noncompliance with Study Drug|0|||
30672616|NCT02449239|58686351|FG000|Induction Phase|Lack of Efficacy|64|||
30672617|NCT02449239|58686351|FG000|Induction Phase|Adverse Event|1|||
30672618|NCT02449239|58686351|FG000|Induction Phase|Lost to Follow-up|1|||
30672619|NCT02449239|58686351|FG000|Induction Phase|Protocol Violation|1|||
30672620|NCT02449239|58686351|FG000|Induction Phase|Physician Decision|1|||
30672621|NCT02449239|58686351|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
30672622|NCT02449239|58686351|FG000|Induction Phase|Withdrawal by Subject|1|||
30672623|NCT02449239|58686351|FG000|Maintenance Month 3|Lack of Efficacy|14|||
30672624|NCT02449239|58686351|FG000|Maintenance Month 6|Lack of Efficacy|10|||
30672625|NCT02449239|58686351|FG000|Maintenance Month 6|Adverse Event|2|||
30672626|NCT02449239|58686351|FG000|Maintenance Month 6|Physician Decision|1|||
30672627|NCT02449239|58686351|FG000|Maintenance Month 9|Lack of Efficacy|2|||
30588803|NCT01163266|58601031|FG001|Overall Study|Noncompliance with Study Drug|2|||
30672628|NCT02449239|58686351|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
30672629|NCT02449239|58686351|FG000|Maintenance Month 12|Lack of Efficacy|5|||
30588804|NCT01163266|58601032|FG002|Overall Study|Noncompliance with Study Drug|0|||
30588805|NCT01163266|58601030|FG000|Overall Study|Protocol Deviations|2|||
30588806|NCT01163266|58601031|FG001|Overall Study|Protocol Deviations|2|||
30588807|NCT01163266|58601032|FG002|Overall Study|Protocol Deviations|5|||
30588808|NCT01163266|58601030|FG000|Overall Study|Withdrawal of Consent|5|||
30588809|NCT01163266|58601031|FG001|Overall Study|Withdrawal of Consent|7|||
30588810|NCT01163266|58601032|FG002|Overall Study|Withdrawal of Consent|3|||
30588811|NCT01163266|58601030|FG000|Overall Study|Lost to Follow-up|7|||
30588812|NCT01163266|58601031|FG001|Overall Study|Lost to Follow-up|7|||
30588813|NCT01163266|58601032|FG002|Overall Study|Lost to Follow-up|10|||
30588814|NCT01163266|58601030|FG000|Overall Study|Other|1|||
30588815|NCT01163266|58601031|FG001|Overall Study|Other|1|||
30588816|NCT01163266|58601032|FG002|Overall Study|Other|2|||
30588817|NCT01163149|58601090|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
30588818|NCT01163149|58601091|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
30588819|NCT01163149|58601092|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
30588820|NCT01163149|58601090|FG000|Extension Treatment Period|Adverse Event|0|||
30672630|NCT02449239|58686351|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
30672631|NCT02449239|58686351|FG000|Maintenance Month 12|Subject moved from area|1|||
30672632|NCT02449239|58686351|FG000|Maintenance Month 15|Lack of Efficacy|1|||
30672633|NCT02449239|58686351|FG000|Maintenance Month 21|Lack of Efficacy|1|||
30672634|NCT02449239|58686351|FG000|Maintenance Month 21|Sponsor decision|1|||
30672635|NCT01292928|58686355|FG000|Overall Study|Death|8|||
30672636|NCT01292928|58686355|FG000|Overall Study|Withdrawal by Subject|8|||
30672637|NCT01292928|58686355|FG000|Overall Study|Lost to Follow-up|6|||
30672638|NCT01292928|58686355|FG000|Overall Study|Physician Decision|2|||
30672639|NCT01012817|58686401|FG000|Overall Study|Withdrawal by Subject|0|||
30672640|NCT01012817|58686402|FG001|Overall Study|Withdrawal by Subject|0|||
30672641|NCT01012817|58686403|FG002|Overall Study|Withdrawal by Subject|0|||
30672642|NCT01012817|58686404|FG003|Overall Study|Withdrawal by Subject|1|||
30672643|NCT01012817|58686405|FG004|Overall Study|Withdrawal by Subject|0|||
30672644|NCT01012817|58686406|FG005|Overall Study|Withdrawal by Subject|0|||
30672645|NCT01012817|58686407|FG006|Overall Study|Withdrawal by Subject|0|||
30672646|NCT01012817|58686408|FG007|Overall Study|Withdrawal by Subject|1|||
30672647|NCT01012817|58686409|FG008|Overall Study|Withdrawal by Subject|0|||
30672648|NCT01012817|58686410|FG009|Overall Study|Withdrawal by Subject|0|||
30672649|NCT01012817|58686411|FG010|Overall Study|Withdrawal by Subject|1|||
30672650|NCT01012817|58686412|FG011|Overall Study|Withdrawal by Subject|1|||
30672651|NCT01012817|58686413|FG012|Overall Study|Withdrawal by Subject|0|||
30672652|NCT01012817|58686414|FG013|Overall Study|Withdrawal by Subject|1|||
30672653|NCT01012817|58686401|FG000|Overall Study|Adverse Event|0|||
30672654|NCT01012817|58686402|FG001|Overall Study|Adverse Event|0|||
30672655|NCT01012817|58686403|FG002|Overall Study|Adverse Event|0|||
30672656|NCT01012817|58686404|FG003|Overall Study|Adverse Event|0|||
30672657|NCT01012817|58686405|FG004|Overall Study|Adverse Event|0|||
30672658|NCT01012817|58686406|FG005|Overall Study|Adverse Event|1|||
30672659|NCT01012817|58686407|FG006|Overall Study|Adverse Event|0|||
30672660|NCT01012817|58686408|FG007|Overall Study|Adverse Event|0|||
30672661|NCT01012817|58686409|FG008|Overall Study|Adverse Event|0|||
30672662|NCT01012817|58686410|FG009|Overall Study|Adverse Event|0|||
30672663|NCT01012817|58686411|FG010|Overall Study|Adverse Event|1|||
30672664|NCT01012817|58686412|FG011|Overall Study|Adverse Event|0|||
30672665|NCT01012817|58686413|FG012|Overall Study|Adverse Event|0|||
30672666|NCT01012817|58686414|FG013|Overall Study|Adverse Event|1|||
30672667|NCT00581828|58686444|FG000|Overall Study|Protocol Violation|1|||
30672668|NCT00220337|58686493|FG000|Overall Study|Adverse Event|70|||
30672669|NCT00220337|58686493|FG000|Overall Study|Lack of Efficacy|17|||
30672670|NCT00220337|58686493|FG000|Overall Study|Withdrawal by Subject|68|||
30588821|NCT01163149|58601091|FG001|Extension Treatment Period|Adverse Event|1|||
30588822|NCT01163149|58601092|FG002|Extension Treatment Period|Adverse Event|0|||
30588823|NCT01163149|58601090|FG000|Extension Treatment Period|Noncompliance|0|||
30672671|NCT00220337|58686493|FG000|Overall Study|Protocol Violation|2|||
30672672|NCT00220337|58686493|FG000|Overall Study|Lost to Follow-up|5|||
30672673|NCT00220337|58686493|FG000|Overall Study|Other|12|||
30588824|NCT01163149|58601091|FG001|Extension Treatment Period|Noncompliance|0|||
30588825|NCT01163149|58601092|FG002|Extension Treatment Period|Noncompliance|1|||
30588826|NCT01163032|58601117|FG000|Randomization Phase|Withdrawal by Subject|2|||
30588827|NCT01163032|58601118|FG001|Randomization Phase|Withdrawal by Subject|3|||
30588828|NCT01163032|58601119|FG002|Randomization Phase|Withdrawal by Subject|0|||
30588829|NCT01163032|58601117|FG000|Randomization Phase|Adverse Event|3|||
30588830|NCT01163032|58601118|FG001|Randomization Phase|Adverse Event|3|||
30672674|NCT00220337|58686493|FG000|Overall Study|Unsatisfactory compliance|5|||
30672675|NCT00576316|58686509|FG000|Overall Study|Adverse Event|9|||
30672676|NCT00576316|58686509|FG000|Overall Study|Withdrawal by Subject|2|||
30672677|NCT00576316|58686509|FG000|Overall Study|Protocol Violation|9|||
30672678|NCT00823134|58686513|FG000|Overall Study|Invalid measurement|1|||
30672679|NCT00831792|58686518|FG000|Overall Study|Not Eligible|3|||
30672680|NCT00831792|58686518|FG000|Overall Study|Adverse Event|1|||
30672681|NCT00831792|58686518|FG000|Overall Study|Death|1|||
30672682|NCT00831792|58686518|FG000|Overall Study|Lack of Efficacy|1|||
30672683|NCT00575380|58686524|FG000|Overall Study|Withdrawal by Subject|1|||
30672684|NCT00575380|58686525|FG001|Overall Study|Withdrawal by Subject|0|||
30672685|NCT00575380|58686524|FG000|Overall Study|Adverse Event|0|||
30781339|NCT02963506|58793444|FG000|Double-Blind Period|Lost to Follow-up|0|||
30781340|NCT02963506|58793445|FG001|Double-Blind Period|Lost to Follow-up|1|||
30781341|NCT02963506|58793446|FG002|Double-Blind Period|Lost to Follow-up|0|||
30781342|NCT02963506|58793447|FG003|Double-Blind Period|Lost to Follow-up|0|||
30588831|NCT01163032|58601119|FG002|Randomization Phase|Adverse Event|0|||
30588832|NCT01163032|58601117|FG000|Randomization Phase|Protocol Violation|0|||
30588833|NCT01163032|58601118|FG001|Randomization Phase|Protocol Violation|1|||
30588834|NCT01163032|58601119|FG002|Randomization Phase|Protocol Violation|0|||
30588835|NCT01163032|58601117|FG000|Randomization Phase|Various*|5|||
30588836|NCT01163032|58601118|FG001|Randomization Phase|Various*|4|||
30588837|NCT01163032|58601119|FG002|Randomization Phase|Various*|0|||
30588838|NCT01163032|58601117|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
30588839|NCT01163032|58601118|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
30588840|NCT01163032|58601119|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
30588841|NCT01163032|58601117|FG000|Open Label Extension Phase|Adverse Event|0|||
30588842|NCT01163032|58601118|FG001|Open Label Extension Phase|Adverse Event|0|||
30588843|NCT01163032|58601119|FG002|Open Label Extension Phase|Adverse Event|3|||
30588844|NCT01163032|58601117|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
30588845|NCT01163032|58601118|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
30588846|NCT01163032|58601119|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
30588847|NCT01163032|58601117|FG000|Open Label Extension Phase|Protocol Violation|0|||
30588848|NCT01163032|58601118|FG001|Open Label Extension Phase|Protocol Violation|0|||
30588849|NCT01163032|58601119|FG002|Open Label Extension Phase|Protocol Violation|1|||
30588850|NCT01163032|58601117|FG000|Open Label Extension Phase|Study Termination|0|||
30588851|NCT01163032|58601118|FG001|Open Label Extension Phase|Study Termination|0|||
30588852|NCT01163032|58601119|FG002|Open Label Extension Phase|Study Termination|7|||
30588853|NCT01163032|58601117|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
30588854|NCT01163032|58601118|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
30588855|NCT01163032|58601119|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
30588856|NCT01162486|58601132|FG000|Overall Study|low ANC|1|||
30588857|NCT01162486|58601133|FG001|Overall Study|low ANC|0|||
30588858|NCT01162486|58601134|FG002|Overall Study|low ANC|0|||
30588859|NCT01162486|58601135|FG003|Overall Study|low ANC|0|||
30588860|NCT01162486|58601136|FG004|Overall Study|low ANC|0|||
30588861|NCT01162486|58601132|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
30588862|NCT01162486|58601133|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
30588863|NCT01162486|58601134|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
30588864|NCT01162486|58601135|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
30588865|NCT01162486|58601136|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
30588866|NCT01162486|58601132|FG000|Overall Study|elevated LFTs|0|||
30588867|NCT01162486|58601133|FG001|Overall Study|elevated LFTs|0|||
30588868|NCT01162486|58601134|FG002|Overall Study|elevated LFTs|1|||
30588869|NCT01162486|58601135|FG003|Overall Study|elevated LFTs|0|||
30588870|NCT01162486|58601136|FG004|Overall Study|elevated LFTs|0|||
30588871|NCT01162486|58601132|FG000|Overall Study|Pregnancy|0|||
30588872|NCT01162486|58601133|FG001|Overall Study|Pregnancy|0|||
30588873|NCT01162486|58601134|FG002|Overall Study|Pregnancy|0|||
30588874|NCT01162486|58601135|FG003|Overall Study|Pregnancy|1|||
30588875|NCT01162486|58601136|FG004|Overall Study|Pregnancy|0|||
30588876|NCT01162135|58601152|FG000|Overall Study|Withdrawal by Subject|1|||
30588877|NCT01162135|58601152|FG000|Overall Study|Severe back pain|1|||
30588878|NCT01162135|58601152|FG000|Overall Study|Ineligible|1|||
30588879|NCT01161628|58601156|FG000|Overall Study|Death|6|||
30588880|NCT01161628|58601156|FG000|Overall Study|Lack of Efficacy|2|||
30588881|NCT01161472|58601160|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
30588882|NCT01161472|58601161|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
30588883|NCT01161472|58601162|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
30588884|NCT01161472|58601163|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
30588885|NCT01161043|58601173|FG000|Overall Study|Withdrawal by Subject|3|||
30588886|NCT01160770|58601177|FG000|Overall Study|Adverse Event|10|||
30588887|NCT01160770|58601177|FG000|Overall Study|Protocol Violation|2|||
30588888|NCT01160770|58601177|FG000|Overall Study|Subject/parent/caregiver request|33|||
30588889|NCT01160770|58601177|FG000|Overall Study|Physician Decision|1|||
30588890|NCT01160770|58601177|FG000|Overall Study|Lost to Follow-up|7|||
30588891|NCT01160770|58601177|FG000|Overall Study|Study termination or sponsor request|1|||
30588892|NCT01160770|58601177|FG000|Overall Study|Death|9|||
30588893|NCT01160770|58601177|FG000|Overall Study|Lack of Efficacy|15|||
30588894|NCT01160770|58601177|FG000|Overall Study|Other Reasons|1|||
30588895|NCT01160614|58601183|FG000|Overall Study|Withdrawal by Subject|0|||
30588896|NCT01160614|58601184|FG001|Overall Study|Withdrawal by Subject|2|||
30672686|NCT00575380|58686525|FG001|Overall Study|Adverse Event|1|||
30672687|NCT00575380|58686524|FG000|Overall Study|Various|0|||
30672688|NCT00575380|58686525|FG001|Overall Study|Various|2|||
30672689|NCT00840996|58686533|FG000|Overall Study|Withdrawal by Subject|1|||
30672690|NCT00840996|58686534|FG001|Overall Study|Withdrawal by Subject|0|||
30672691|NCT00680914|58686542|FG000|Overall Study|Consent withdrawal|6|||
30588897|NCT01159912|58601211|FG000|Overall Study|Adverse Event|2|||
30588898|NCT01159912|58601212|FG001|Overall Study|Adverse Event|2|||
30672692|NCT00680914|58686543|FG001|Overall Study|Consent withdrawal|3|||
30672693|NCT00680914|58686542|FG000|Overall Study|Lost to Follow-up|4|||
30588899|NCT01159912|58601213|FG002|Overall Study|Adverse Event|3|||
30588900|NCT01159912|58601211|FG000|Overall Study|Lack of Efficacy|23|||
30588901|NCT01159912|58601212|FG001|Overall Study|Lack of Efficacy|15|||
30588902|NCT01159912|58601213|FG002|Overall Study|Lack of Efficacy|14|||
30588903|NCT01159912|58601211|FG000|Overall Study|Protocol Violation|1|||
30588904|NCT01159912|58601212|FG001|Overall Study|Protocol Violation|2|||
30588905|NCT01159912|58601213|FG002|Overall Study|Protocol Violation|3|||
30588906|NCT01159912|58601211|FG000|Overall Study|Lost to Follow-up|4|||
30588907|NCT01159912|58601212|FG001|Overall Study|Lost to Follow-up|0|||
30588908|NCT01159912|58601213|FG002|Overall Study|Lost to Follow-up|0|||
30588909|NCT01159912|58601211|FG000|Overall Study|Physician Decision|0|||
30588910|NCT01159912|58601212|FG001|Overall Study|Physician Decision|0|||
30588911|NCT01159912|58601213|FG002|Overall Study|Physician Decision|3|||
30588912|NCT01159912|58601211|FG000|Overall Study|Withdrawal by Subject|10|||
30588913|NCT01159912|58601212|FG001|Overall Study|Withdrawal by Subject|3|||
30588914|NCT01159912|58601213|FG002|Overall Study|Withdrawal by Subject|3|||
30588915|NCT01159600|58601229|FG000|Overall Study|Not treated|0|||
30588916|NCT01159600|58601230|FG001|Overall Study|Not treated|0|||
30588917|NCT01159600|58601231|FG002|Overall Study|Not treated|1|||
30588918|NCT01159600|58601232|FG003|Overall Study|Not treated|0|||
30588919|NCT01159600|58601233|FG004|Overall Study|Not treated|0|||
30588920|NCT01159600|58601234|FG005|Overall Study|Not treated|1|||
30588921|NCT01159600|58601235|FG006|Overall Study|Not treated|2|||
30588922|NCT01159600|58601236|FG007|Overall Study|Not treated|2|||
30588923|NCT01159600|58601229|FG000|Overall Study|Adverse Event|7|||
30588924|NCT01159600|58601230|FG001|Overall Study|Adverse Event|2|||
30588925|NCT01159600|58601231|FG002|Overall Study|Adverse Event|5|||
30588926|NCT01159600|58601232|FG003|Overall Study|Adverse Event|1|||
30588927|NCT01159600|58601233|FG004|Overall Study|Adverse Event|8|||
30588928|NCT01159600|58601234|FG005|Overall Study|Adverse Event|6|||
30588929|NCT01159600|58601235|FG006|Overall Study|Adverse Event|7|||
30588930|NCT01159600|58601236|FG007|Overall Study|Adverse Event|5|||
30588931|NCT01159600|58601229|FG000|Overall Study|Lack of Efficacy|0|||
30672694|NCT00680914|58686543|FG001|Overall Study|Lost to Follow-up|0|||
30781343|NCT02963506|58793448|FG004|Double-Blind Period|Lost to Follow-up|0|||
30588932|NCT01159600|58601230|FG001|Overall Study|Lack of Efficacy|0|||
30588933|NCT01159600|58601231|FG002|Overall Study|Lack of Efficacy|0|||
30588934|NCT01159600|58601232|FG003|Overall Study|Lack of Efficacy|0|||
30588935|NCT01159600|58601233|FG004|Overall Study|Lack of Efficacy|2|||
30781344|NCT02963506|58793449|FG005|Double-Blind Period|Lost to Follow-up|0|||
30781345|NCT02963506|58793450|FG006|Double-Blind Period|Lost to Follow-up|0|||
30781346|NCT02963506|58793451|FG007|Double-Blind Period|Lost to Follow-up|0|||
30781347|NCT02963506|58793452|FG008|Double-Blind Period|Lost to Follow-up|0|||
30781348|NCT02963506|58793453|FG009|Double-Blind Period|Lost to Follow-up|0|||
30588936|NCT01159600|58601234|FG005|Overall Study|Lack of Efficacy|0|||
30588937|NCT01159600|58601235|FG006|Overall Study|Lack of Efficacy|0|||
30588938|NCT01159600|58601236|FG007|Overall Study|Lack of Efficacy|1|||
30588939|NCT01159600|58601229|FG000|Overall Study|Non compliant with protocol|2|||
30588940|NCT01159600|58601230|FG001|Overall Study|Non compliant with protocol|1|||
30588941|NCT01159600|58601231|FG002|Overall Study|Non compliant with protocol|0|||
30588942|NCT01159600|58601232|FG003|Overall Study|Non compliant with protocol|0|||
30588943|NCT01159600|58601233|FG004|Overall Study|Non compliant with protocol|2|||
30588944|NCT01159600|58601234|FG005|Overall Study|Non compliant with protocol|0|||
30588945|NCT01159600|58601235|FG006|Overall Study|Non compliant with protocol|2|||
30781349|NCT02963506|58793454|FG010|Double-Blind Period|Lost to Follow-up|0|||
30781350|NCT02963506|58793455|FG011|Double-Blind Period|Lost to Follow-up|0|||
30781351|NCT02963506|58793456|FG012|Double-Blind Period|Lost to Follow-up|0|||
30781352|NCT02963506|58793444|FG000|Double-Blind Period|Withdrawal by Subject|0|||
30588946|NCT01159600|58601236|FG007|Overall Study|Non compliant with protocol|0|||
30588947|NCT01159600|58601229|FG000|Overall Study|Lost to Follow-up|2|||
30588948|NCT01159600|58601230|FG001|Overall Study|Lost to Follow-up|3|||
30588949|NCT01159600|58601231|FG002|Overall Study|Lost to Follow-up|4|||
30588950|NCT01159600|58601232|FG003|Overall Study|Lost to Follow-up|3|||
30588951|NCT01159600|58601233|FG004|Overall Study|Lost to Follow-up|3|||
30588952|NCT01159600|58601234|FG005|Overall Study|Lost to Follow-up|0|||
30588953|NCT01159600|58601235|FG006|Overall Study|Lost to Follow-up|3|||
30588954|NCT01159600|58601236|FG007|Overall Study|Lost to Follow-up|2|||
30588955|NCT01159600|58601229|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
30588956|NCT01159600|58601230|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
30672695|NCT00680914|58686542|FG000|Overall Study|serious adverse event (SAE)|0|||
30588957|NCT01159600|58601231|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
30588958|NCT01159600|58601232|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
30588959|NCT01159600|58601233|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
30588960|NCT01159600|58601234|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
30588961|NCT01159600|58601235|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
30855828|NCT02760433|58883521|FG000|Overall Study|Subject refused to continue the study|1|||
30855829|NCT02760433|58883522|FG001|Overall Study|Subject refused to continue the study|0|||
30855830|NCT02760433|58883523|FG002|Overall Study|Subject refused to continue the study|0|||
30855831|NCT02760433|58883524|FG003|Overall Study|Subject refused to continue the study|0|||
30588962|NCT01159600|58601236|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
30672696|NCT00680914|58686543|FG001|Overall Study|serious adverse event (SAE)|1|||
30672697|NCT00680836|58686551|FG000|Overall Study|Withdrawal by Subject|3|||
30672698|NCT00680836|58686552|FG001|Overall Study|Withdrawal by Subject|0|||
30672699|NCT00680836|58686551|FG000|Overall Study|Lost to Follow-up|3|||
30672700|NCT00680836|58686552|FG001|Overall Study|Lost to Follow-up|1|||
30588963|NCT01159600|58601229|FG000|Overall Study|Other reason not defined above|3|||
30588964|NCT01159600|58601230|FG001|Overall Study|Other reason not defined above|0|||
30588965|NCT01159600|58601231|FG002|Overall Study|Other reason not defined above|4|||
30588966|NCT01159600|58601232|FG003|Overall Study|Other reason not defined above|2|||
30588967|NCT01159600|58601233|FG004|Overall Study|Other reason not defined above|5|||
30588968|NCT01159600|58601234|FG005|Overall Study|Other reason not defined above|7|||
30588969|NCT01159600|58601235|FG006|Overall Study|Other reason not defined above|3|||
30588970|NCT01159600|58601236|FG007|Overall Study|Other reason not defined above|3|||
30588971|NCT01159171|58601255|FG000|Overall Study|Adverse Event|11|||
30588972|NCT01159171|58601255|FG000|Overall Study|Progression of Disease|28|||
30588973|NCT01159171|58601255|FG000|Overall Study|Protocol Violation|1|||
30588974|NCT01159171|58601255|FG000|Overall Study|Need for Surgery|5|||
30588975|NCT01159171|58601255|FG000|Overall Study|Medical Decision|4|||
30588976|NCT01159171|58601255|FG000|Overall Study|Death|1|||
30588977|NCT01158118|58601262|FG000|Overall Study|Screen failure|1|||
30588978|NCT01158118|58601263|FG001|Overall Study|Screen failure|0|||
30588979|NCT01158118|58601262|FG000|Overall Study|Donor match was a screen failure|0|||
30588980|NCT01158118|58601263|FG001|Overall Study|Donor match was a screen failure|1|||
30588981|NCT01158118|58601262|FG000|Overall Study|Suffered stroke prior to transplant|0|||
30588982|NCT01158118|58601263|FG001|Overall Study|Suffered stroke prior to transplant|1|||
30588983|NCT01158118|58601262|FG000|Overall Study|Death|0|||
30588984|NCT01158118|58601263|FG001|Overall Study|Death|1|||
30588985|NCT01157845|58601269|FG000|Overall Study|Lost to Follow-up|5|||
30588986|NCT01157845|58601269|FG000|Overall Study|Withdrawal by Subject|12|||
30588987|NCT01157845|58601269|FG000|Overall Study|Physician Decision|3|||
30588988|NCT01157845|58601269|FG000|Overall Study|Protocol Violation|13|||
30588989|NCT01157845|58601269|FG000|Overall Study|Study was ended|1|||
30588990|NCT01157845|58601269|FG000|Overall Study|Device malfunction|1|||
30588991|NCT01157377|58601280|FG000|Overall Study|Lost to Follow-up|0|||
30588992|NCT01157377|58601281|FG001|Overall Study|Lost to Follow-up|0|||
30588993|NCT01157377|58601282|FG002|Overall Study|Lost to Follow-up|1|||
30588994|NCT01157377|58601283|FG003|Overall Study|Lost to Follow-up|0|||
30588995|NCT01157377|58601284|FG004|Overall Study|Lost to Follow-up|1|||
30588996|NCT01157377|58601285|FG005|Overall Study|Lost to Follow-up|1|||
30588997|NCT01157377|58601286|FG006|Overall Study|Lost to Follow-up|0|||
30588998|NCT01157377|58601280|FG000|Overall Study|Personal Reasons|2|||
30588999|NCT01157377|58601281|FG001|Overall Study|Personal Reasons|1|||
30589000|NCT01157377|58601282|FG002|Overall Study|Personal Reasons|0|||
30589001|NCT01157377|58601283|FG003|Overall Study|Personal Reasons|1|||
30589002|NCT01157377|58601284|FG004|Overall Study|Personal Reasons|0|||
30589003|NCT01157377|58601285|FG005|Overall Study|Personal Reasons|0|||
30672701|NCT00680836|58686551|FG000|Overall Study|Physician Decision|2|||
30672702|NCT00680836|58686552|FG001|Overall Study|Physician Decision|1|||
30672703|NCT00679432|58686563|FG000|Overall Study|Adverse Event|5|||
30672704|NCT00679432|58686564|FG001|Overall Study|Adverse Event|6|||
30589004|NCT01157377|58601286|FG006|Overall Study|Personal Reasons|0|||
30589005|NCT01157377|58601280|FG000|Overall Study|Protocol Violation|0|||
30589006|NCT01157377|58601281|FG001|Overall Study|Protocol Violation|0|||
30589007|NCT01157377|58601282|FG002|Overall Study|Protocol Violation|0|||
30589008|NCT01157377|58601283|FG003|Overall Study|Protocol Violation|0|||
30589009|NCT01157377|58601284|FG004|Overall Study|Protocol Violation|0|||
30589010|NCT01157377|58601285|FG005|Overall Study|Protocol Violation|1|||
30589011|NCT01157377|58601286|FG006|Overall Study|Protocol Violation|0|||
30589012|NCT01157377|58601280|FG000|Overall Study|Lack of Efficacy|0|||
30589013|NCT01157377|58601281|FG001|Overall Study|Lack of Efficacy|0|||
30672705|NCT00679432|58686565|FG002|Overall Study|Adverse Event|10|||
30589014|NCT01157377|58601282|FG002|Overall Study|Lack of Efficacy|0|||
30589015|NCT01157377|58601283|FG003|Overall Study|Lack of Efficacy|0|||
30589016|NCT01157377|58601284|FG004|Overall Study|Lack of Efficacy|0|||
30589017|NCT01157377|58601285|FG005|Overall Study|Lack of Efficacy|0|||
30589018|NCT01157377|58601286|FG006|Overall Study|Lack of Efficacy|1|||
30672706|NCT00679432|58686566|FG003|Overall Study|Adverse Event|7|||
30589019|NCT01157377|58601280|FG000|Overall Study|Other Miscellaneous Reasons|0|||
30589020|NCT01157377|58601281|FG001|Overall Study|Other Miscellaneous Reasons|2|||
30589021|NCT01157377|58601282|FG002|Overall Study|Other Miscellaneous Reasons|0|||
30589022|NCT01157377|58601283|FG003|Overall Study|Other Miscellaneous Reasons|0|||
30589023|NCT01157377|58601284|FG004|Overall Study|Other Miscellaneous Reasons|1|||
30589024|NCT01157377|58601285|FG005|Overall Study|Other Miscellaneous Reasons|1|||
30589025|NCT01157377|58601286|FG006|Overall Study|Other Miscellaneous Reasons|1|||
30589026|NCT01157182|58601304|FG000|Washout of 28 Days|Adverse Event|2|||
30589027|NCT01157182|58601305|FG001|Washout of 28 Days|Adverse Event|0|||
30589028|NCT01157065|58601313|FG000|Overall Study|Death|0|||
30589029|NCT01157065|58601314|FG001|Overall Study|Death|1|||
30589030|NCT01156792|58601320|FG000|Overall Study|Adverse Event|1|||
30589031|NCT01156792|58601320|FG000|Overall Study|Lack of Efficacy|36|||
30589032|NCT01156792|58601320|FG000|Overall Study|Protocol Violation|6|||
30589033|NCT01156792|58601320|FG000|Overall Study|Lost to Follow-up|3|||
30589034|NCT01156792|58601320|FG000|Overall Study|Physician Decision|3|||
30589035|NCT01156792|58601320|FG000|Overall Study|Withdrawal by Subject|9|||
30589036|NCT01156792|58601320|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
30589037|NCT01156714|58601338|FG000|Overall Study|Withdrawal by Subject|9|||
30589038|NCT01156714|58601339|FG001|Overall Study|Withdrawal by Subject|4|||
30589039|NCT01156714|58601340|FG002|Overall Study|Withdrawal by Subject|3|||
30589040|NCT01156675|58601354|FG000|Overall Study|Death|5|||
30589041|NCT01156675|58601355|FG001|Overall Study|Death|3|||
30589042|NCT01156675|58601356|FG002|Overall Study|Death|0|||
30589043|NCT01156675|58601354|FG000|Overall Study|No data|29|||
30589044|NCT01156675|58601355|FG001|Overall Study|No data|22|||
30589045|NCT01156675|58601356|FG002|Overall Study|No data|2|||
30589046|NCT01156480|58601367|FG000|Overall Study|change in diagnosis|0|||
30589047|NCT01156480|58601368|FG001|Overall Study|change in diagnosis|1|||
30589048|NCT01156363|58601376|FG000|Overall Study|Adverse Event|6|||
30589049|NCT01156363|58601376|FG000|Overall Study|Insufficient Therapeutic Response|5|||
30589050|NCT01156363|58601376|FG000|Overall Study|Failure to Return|1|||
30589051|NCT01156363|58601376|FG000|Overall Study|Refused Treatment|4|||
30589052|NCT01156363|58601376|FG000|Overall Study|Other|6|||
30589053|NCT01156051|58601389|FG000|Overall Study|Lost to Follow-up|1|||
30781353|NCT02963506|58793445|FG001|Double-Blind Period|Withdrawal by Subject|0|||
30781354|NCT02963506|58793446|FG002|Double-Blind Period|Withdrawal by Subject|1|||
30781355|NCT02963506|58793447|FG003|Double-Blind Period|Withdrawal by Subject|1|||
30781356|NCT02963506|58793448|FG004|Double-Blind Period|Withdrawal by Subject|0|||
30781357|NCT02963506|58793449|FG005|Double-Blind Period|Withdrawal by Subject|0|||
30781358|NCT02963506|58793450|FG006|Double-Blind Period|Withdrawal by Subject|0|||
30781359|NCT02963506|58793451|FG007|Double-Blind Period|Withdrawal by Subject|0|||
30781360|NCT02963506|58793452|FG008|Double-Blind Period|Withdrawal by Subject|0|||
30781361|NCT02963506|58793453|FG009|Double-Blind Period|Withdrawal by Subject|0|||
30781362|NCT02963506|58793454|FG010|Double-Blind Period|Withdrawal by Subject|0|||
30781363|NCT02963506|58793455|FG011|Double-Blind Period|Withdrawal by Subject|0|||
30781364|NCT02963506|58793456|FG012|Double-Blind Period|Withdrawal by Subject|0|||
30781365|NCT02963506|58793444|FG000|Double-Blind Period|No compliance|0|||
30781366|NCT02963506|58793445|FG001|Double-Blind Period|No compliance|1|||
30781367|NCT02963506|58793446|FG002|Double-Blind Period|No compliance|0|||
30781368|NCT02963506|58793447|FG003|Double-Blind Period|No compliance|0|||
30781369|NCT02963506|58793448|FG004|Double-Blind Period|No compliance|0|||
30781370|NCT02963506|58793449|FG005|Double-Blind Period|No compliance|0|||
30781371|NCT02963506|58793450|FG006|Double-Blind Period|No compliance|0|||
30781372|NCT02963506|58793451|FG007|Double-Blind Period|No compliance|0|||
30781373|NCT02963506|58793452|FG008|Double-Blind Period|No compliance|0|||
30781374|NCT02963506|58793453|FG009|Double-Blind Period|No compliance|0|||
30781375|NCT02963506|58793454|FG010|Double-Blind Period|No compliance|0|||
30781376|NCT02963506|58793455|FG011|Double-Blind Period|No compliance|0|||
30672707|NCT00679432|58686563|FG000|Overall Study|Protocol Violation|1|||
30672708|NCT00679432|58686564|FG001|Overall Study|Protocol Violation|1|||
30672709|NCT00679432|58686565|FG002|Overall Study|Protocol Violation|2|||
30672710|NCT00679432|58686566|FG003|Overall Study|Protocol Violation|1|||
30781377|NCT02963506|58793456|FG012|Double-Blind Period|No compliance|0|||
30781378|NCT02963506|58793444|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30781379|NCT02963506|58793445|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
30781380|NCT02963506|58793446|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30781381|NCT02963506|58793447|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30589054|NCT01156051|58601390|FG001|Overall Study|Lost to Follow-up|0|||
30589055|NCT01156051|58601389|FG000|Overall Study|patient not compliant with protocol|0|||
30589056|NCT01156051|58601390|FG001|Overall Study|patient not compliant with protocol|1|||
30589057|NCT01156012|58601398|FG000|Overall Study|Adverse Event|3|||
30589058|NCT01156012|58601399|FG001|Overall Study|Adverse Event|1|||
30781382|NCT02963506|58793448|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30589059|NCT01156012|58601398|FG000|Overall Study|Lost to Follow-up|1|||
30589060|NCT01156012|58601399|FG001|Overall Study|Lost to Follow-up|0|||
30589061|NCT01156012|58601398|FG000|Overall Study|Withdrawal by Subject|1|||
30781383|NCT02963506|58793449|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30672711|NCT00679432|58686563|FG000|Overall Study|Withdrawal by Subject|8|||
30672712|NCT00679432|58686564|FG001|Overall Study|Withdrawal by Subject|11|||
30672713|NCT00679432|58686565|FG002|Overall Study|Withdrawal by Subject|10|||
30672714|NCT00679432|58686566|FG003|Overall Study|Withdrawal by Subject|9|||
30672715|NCT00679432|58686563|FG000|Overall Study|Lost to Follow-up|1|||
30672716|NCT00679432|58686564|FG001|Overall Study|Lost to Follow-up|5|||
30672717|NCT00679432|58686565|FG002|Overall Study|Lost to Follow-up|4|||
30672718|NCT00679432|58686566|FG003|Overall Study|Lost to Follow-up|2|||
30672719|NCT00679432|58686563|FG000|Overall Study|Physician Decision|3|||
30672720|NCT00679432|58686564|FG001|Overall Study|Physician Decision|2|||
30672721|NCT00679432|58686565|FG002|Overall Study|Physician Decision|2|||
30672722|NCT00679432|58686566|FG003|Overall Study|Physician Decision|2|||
30672723|NCT00679432|58686563|FG000|Overall Study|Sponsor decision|1|||
30672724|NCT00679432|58686564|FG001|Overall Study|Sponsor decision|0|||
30672725|NCT00679432|58686565|FG002|Overall Study|Sponsor decision|0|||
30672726|NCT00679432|58686566|FG003|Overall Study|Sponsor decision|0|||
30672727|NCT00679432|58686563|FG000|Overall Study|Lack of Efficacy|13|||
30672728|NCT00679432|58686564|FG001|Overall Study|Lack of Efficacy|9|||
30672729|NCT00679432|58686565|FG002|Overall Study|Lack of Efficacy|14|||
30672730|NCT00679432|58686566|FG003|Overall Study|Lack of Efficacy|8|||
30672731|NCT00679432|58686563|FG000|Overall Study|Infectious colitis, normal histology|5|||
30672732|NCT00679432|58686564|FG001|Overall Study|Infectious colitis, normal histology|4|||
30672733|NCT00679432|58686565|FG002|Overall Study|Infectious colitis, normal histology|8|||
30672734|NCT00679432|58686566|FG003|Overall Study|Infectious colitis, normal histology|3|||
30672735|NCT00679432|58686563|FG000|Overall Study|Randomization error, return to prior Rx|0|||
30672736|NCT00679432|58686564|FG001|Overall Study|Randomization error, return to prior Rx|0|||
30672737|NCT00679432|58686565|FG002|Overall Study|Randomization error, return to prior Rx|3|||
30672738|NCT00679432|58686566|FG003|Overall Study|Randomization error, return to prior Rx|0|||
30672739|NCT00679354|58686576|FG000|Overall Study|Death|3|||
30672740|NCT00679354|58686576|FG000|Overall Study|Lack of Efficacy|22|||
30672741|NCT00679354|58686576|FG000|Overall Study|Physician Decision|4|||
30672742|NCT00679354|58686576|FG000|Overall Study|Ineligible|1|||
30672743|NCT00822900|58686583|FG000|Overall Study|Withdrawal by Subject|14|||
30672744|NCT00822900|58686584|FG001|Overall Study|Withdrawal by Subject|14|||
30672745|NCT00822900|58686583|FG000|Overall Study|Lost to Follow-up|9|||
30672746|NCT00822900|58686584|FG001|Overall Study|Lost to Follow-up|9|||
30589062|NCT01156012|58601399|FG001|Overall Study|Withdrawal by Subject|0|||
30589063|NCT01156012|58601398|FG000|Overall Study|use of commercial drug instead of study|0|||
30589064|NCT01156012|58601399|FG001|Overall Study|use of commercial drug instead of study|1|||
30589065|NCT01156012|58601398|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
30589066|NCT01156012|58601399|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
30589067|NCT01155661|58601405|FG000|Overall Study|Adverse Event|101|||
30589068|NCT01155661|58601405|FG000|Overall Study|Death|1|||
30589069|NCT01155661|58601405|FG000|Overall Study|Lack of Efficacy|32|||
30589070|NCT01155661|58601405|FG000|Overall Study|Lost to Follow-up|22|||
30589071|NCT01155661|58601405|FG000|Overall Study|Physician Decision|3|||
30589072|NCT01155661|58601405|FG000|Overall Study|Protocol Violation|35|||
30589073|NCT01155661|58601405|FG000|Overall Study|Withdrawal by Subject|73|||
30589074|NCT01155661|58601405|FG000|Overall Study|Sponsor Decision|13|||
30589075|NCT01155583|58601420|FG000|Phase I|Screen failure - did not start treatment|0|||
30589076|NCT01155583|58601421|FG001|Phase I|Screen failure - did not start treatment|0|||
30589077|NCT01155583|58601422|FG002|Phase I|Screen failure - did not start treatment|0|||
30589078|NCT01155583|58601423|FG003|Phase I|Screen failure - did not start treatment|0|||
30589079|NCT01155583|58601424|FG004|Phase I|Screen failure - did not start treatment|1|||
30589080|NCT01155583|58601425|FG005|Phase I|Screen failure - did not start treatment|0|||
30589081|NCT01155583|58601426|FG006|Phase I|Screen failure - did not start treatment|0|||
30589082|NCT01155583|58601427|FG007|Phase I|Screen failure - did not start treatment|2|||
30589083|NCT01155583|58601428|FG008|Phase I|Screen failure - did not start treatment|0|||
30589084|NCT01155583|58601420|FG000|Phase I|Withdrawal by Subject|0|||
30589085|NCT01155583|58601421|FG001|Phase I|Withdrawal by Subject|0|||
30589086|NCT01155583|58601422|FG002|Phase I|Withdrawal by Subject|0|||
30589087|NCT01155583|58601423|FG003|Phase I|Withdrawal by Subject|0|||
30589088|NCT01155583|58601424|FG004|Phase I|Withdrawal by Subject|0|||
30589089|NCT01155583|58601425|FG005|Phase I|Withdrawal by Subject|0|||
30589090|NCT01155583|58601426|FG006|Phase I|Withdrawal by Subject|0|||
30589091|NCT01155583|58601427|FG007|Phase I|Withdrawal by Subject|1|||
30589092|NCT01155583|58601428|FG008|Phase I|Withdrawal by Subject|0|||
30589093|NCT01155466|58601449|FG000|Overall Study|Adverse Event|13|||
30589094|NCT01155466|58601450|FG001|Overall Study|Adverse Event|15|||
30589095|NCT01155466|58601451|FG002|Overall Study|Adverse Event|6|||
30672747|NCT00822900|58686583|FG000|Overall Study|Death|83|||
30672748|NCT00822900|58686584|FG001|Overall Study|Death|69|||
30672749|NCT00822900|58686583|FG000|Overall Study|Became a ward of the state|2|||
30958926|NCT01587703|59024038|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30672750|NCT00822900|58686584|FG001|Overall Study|Became a ward of the state|1|||
30672751|NCT00682786|58686592|FG000|Overall Study|Withdrawal by Subject|2|||
30589096|NCT01155466|58601452|FG003|Overall Study|Adverse Event|17|||
30589097|NCT01155466|58601453|FG004|Overall Study|Adverse Event|18|||
30589098|NCT01155466|58601449|FG000|Overall Study|Lost to Follow-up|0|||
30589099|NCT01155466|58601450|FG001|Overall Study|Lost to Follow-up|0|||
30589100|NCT01155466|58601451|FG002|Overall Study|Lost to Follow-up|0|||
30589101|NCT01155466|58601452|FG003|Overall Study|Lost to Follow-up|0|||
30589102|NCT01155466|58601453|FG004|Overall Study|Lost to Follow-up|2|||
30589103|NCT01155466|58601449|FG000|Overall Study|Withdrawal by Subject|7|||
30589104|NCT01155466|58601450|FG001|Overall Study|Withdrawal by Subject|5|||
30589105|NCT01155466|58601451|FG002|Overall Study|Withdrawal by Subject|9|||
30589106|NCT01155466|58601452|FG003|Overall Study|Withdrawal by Subject|4|||
30672752|NCT00682786|58686593|FG001|Overall Study|Withdrawal by Subject|2|||
30672753|NCT00682786|58686592|FG000|Overall Study|Did not receive irinotecan|0|||
30672754|NCT00682786|58686593|FG001|Overall Study|Did not receive irinotecan|1|||
30672755|NCT00840450|58686605|FG000|Overall Study|Adverse Event|1|||
30672756|NCT00840450|58686605|FG000|Overall Study|Lack of Efficacy|2|||
30958927|NCT01587703|59024039|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958928|NCT01587703|59024040|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958929|NCT01587703|59024041|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
30958930|NCT01587703|59024023|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958931|NCT01587703|59024024|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958932|NCT01587703|59024025|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958933|NCT01587703|59024026|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958934|NCT01587703|59024027|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958935|NCT01587703|59024028|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958936|NCT01587703|59024029|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958937|NCT01587703|59024030|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958938|NCT01587703|59024031|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958939|NCT01587703|59024032|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958940|NCT01587703|59024033|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958941|NCT01587703|59024034|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958942|NCT01587703|59024035|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958943|NCT01587703|59024036|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958944|NCT01587703|59024037|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30672757|NCT00840294|58686611|FG000|Overall Study|Withdrawal by Subject|2|||
30672758|NCT00840294|58686612|FG001|Overall Study|Withdrawal by Subject|1|||
30672759|NCT00840294|58686611|FG000|Overall Study|Protocol Violation|1|||
30672760|NCT00840294|58686612|FG001|Overall Study|Protocol Violation|3|||
30672761|NCT00840294|58686611|FG000|Overall Study|Illness|0|||
30672762|NCT00840294|58686612|FG001|Overall Study|Illness|1|||
30672768|NCT00680368|58686622|FG000|Overall Study|not supervised, not eligible|15|||
30672769|NCT00680056|58686630|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
30672770|NCT00680056|58686631|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
30672771|NCT00680056|58686630|FG000|Second Intervention|Protocol Violation|3|||
30672772|NCT00680056|58686631|FG001|Second Intervention|Protocol Violation|1|||
30781384|NCT02963506|58793450|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30781385|NCT02963506|58793451|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30958945|NCT01587703|59024038|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958946|NCT01587703|59024039|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958947|NCT01587703|59024040|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
30958948|NCT01587703|59024041|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
30958949|NCT01587703|59024023|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30958950|NCT01587703|59024024|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30958951|NCT01587703|59024025|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30958952|NCT01587703|59024026|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30958953|NCT01587703|59024027|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30589107|NCT01155466|58601453|FG004|Overall Study|Withdrawal by Subject|4|||
30589108|NCT01155466|58601449|FG000|Overall Study|Protocol Violation|0|||
30589109|NCT01155466|58601450|FG001|Overall Study|Protocol Violation|0|||
30589110|NCT01155466|58601451|FG002|Overall Study|Protocol Violation|2|||
30672773|NCT00680992|58686641|FG000|Overall Study|Complete Resection (as per protocol)|25|||
30672774|NCT00680992|58686642|FG001|Overall Study|Complete Resection (as per protocol)|121|||
30672775|NCT00680992|58686643|FG002|Overall Study|Complete Resection (as per protocol)|0|||
30781386|NCT02963506|58793452|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30589111|NCT01155466|58601452|FG003|Overall Study|Protocol Violation|0|||
30958954|NCT01587703|59024028|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30958955|NCT01587703|59024029|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30958956|NCT01587703|59024030|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30958957|NCT01587703|59024031|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30958958|NCT01587703|59024032|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30958959|NCT01587703|59024033|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30958960|NCT01587703|59024034|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30589112|NCT01155466|58601453|FG004|Overall Study|Protocol Violation|1|||
30589113|NCT01155466|58601449|FG000|Overall Study|Administrative|0|||
30589114|NCT01155466|58601450|FG001|Overall Study|Administrative|3|||
30589115|NCT01155466|58601451|FG002|Overall Study|Administrative|0|||
30589116|NCT01155466|58601452|FG003|Overall Study|Administrative|0|||
30589117|NCT01155466|58601453|FG004|Overall Study|Administrative|0|||
30589118|NCT01155466|58601449|FG000|Overall Study|Randomized not treated|2|||
30589119|NCT01155466|58601450|FG001|Overall Study|Randomized not treated|2|||
30589120|NCT01155466|58601451|FG002|Overall Study|Randomized not treated|3|||
30589121|NCT01155466|58601452|FG003|Overall Study|Randomized not treated|0|||
30589122|NCT01155466|58601453|FG004|Overall Study|Randomized not treated|2|||
30589123|NCT01155388|58601467|FG000|Overall Study|Adverse Event|1|||
30589124|NCT01155388|58601468|FG001|Overall Study|Adverse Event|0|||
30589125|NCT01154452|58601479|FG000|Phase Ib|Not Treated|1|||
30589126|NCT01154452|58601480|FG001|Phase Ib|Not Treated|0|||
30589127|NCT01154452|58601481|FG002|Phase Ib|Not Treated|0|||
30589128|NCT01154452|58601482|FG003|Phase Ib|Not Treated|0|||
30589129|NCT01154452|58601479|FG000|Phase Ib|Adverse Event|2|||
30589130|NCT01154452|58601480|FG001|Phase Ib|Adverse Event|1|||
30589131|NCT01154452|58601481|FG002|Phase Ib|Adverse Event|0|||
30589132|NCT01154452|58601482|FG003|Phase Ib|Adverse Event|0|||
30589133|NCT01154452|58601479|FG000|Phase II|Withdrawal by Subject|0|||
30589134|NCT01154452|58601480|FG001|Phase II|Withdrawal by Subject|0|||
30589135|NCT01154452|58601481|FG002|Phase II|Withdrawal by Subject|1|||
30589136|NCT01154452|58601482|FG003|Phase II|Withdrawal by Subject|2|||
30589137|NCT01154452|58601479|FG000|Phase II|Adverse Event|0|||
30589138|NCT01154452|58601480|FG001|Phase II|Adverse Event|0|||
30589139|NCT01154452|58601481|FG002|Phase II|Adverse Event|4|||
30589140|NCT01154452|58601482|FG003|Phase II|Adverse Event|4|||
30589141|NCT01154296|58601497|FG000|Randomization and Intervention|Decided to decline|1|||
30589142|NCT01154296|58601498|FG001|Randomization and Intervention|Decided to decline|1|||
30589143|NCT01154296|58601497|FG000|Randomization and Intervention|Declined by staff|1|||
30589144|NCT01154296|58601498|FG001|Randomization and Intervention|Declined by staff|0|||
30589145|NCT01154296|58601497|FG000|Randomization and Intervention|Did not return|1|||
30589146|NCT01154296|58601498|FG001|Randomization and Intervention|Did not return|0|||
30589147|NCT01154296|58601497|FG000|Randomization and Intervention|Left before test|0|||
30589148|NCT01154296|58601498|FG001|Randomization and Intervention|Left before test|1|||
30589149|NCT01154296|58601497|FG000|Randomization and Intervention|Left clinic early|2|||
30589150|NCT01154296|58601498|FG001|Randomization and Intervention|Left clinic early|0|||
30589151|NCT01154296|58601497|FG000|6-month Follow-up|Lost contact|269|||
30589152|NCT01154296|58601498|FG001|6-month Follow-up|Lost contact|275|||
30672776|NCT00680992|58686641|FG000|Overall Study|Administrative Decision|83|||
30672777|NCT00680992|58686642|FG001|Overall Study|Administrative Decision|42|||
30672778|NCT00680992|58686643|FG002|Overall Study|Administrative Decision|5|||
30672779|NCT00680992|58686641|FG000|Overall Study|End of Trial|32|||
30672780|NCT00680992|58686642|FG001|Overall Study|End of Trial|12|||
30672781|NCT00680992|58686643|FG002|Overall Study|End of Trial|3|||
30672782|NCT00680992|58686641|FG000|Overall Study|Withdrawal by Subject|33|||
30672783|NCT00680992|58686642|FG001|Overall Study|Withdrawal by Subject|11|||
30589153|NCT01154296|58601497|FG000|6-month Follow-up|Incarcerated|37|||
30589154|NCT01154296|58601498|FG001|6-month Follow-up|Incarcerated|32|||
30589155|NCT01154296|58601497|FG000|6-month Follow-up|Withdrew consent|14|||
30589156|NCT01154296|58601498|FG001|6-month Follow-up|Withdrew consent|15|||
30589157|NCT01154296|58601497|FG000|6-month Follow-up|Death|3|||
30589158|NCT01154296|58601498|FG001|6-month Follow-up|Death|2|||
30672784|NCT00680992|58686643|FG002|Overall Study|Withdrawal by Subject|1|||
30672785|NCT00680992|58686641|FG000|Overall Study|Adverse Event|21|||
30672786|NCT00680992|58686642|FG001|Overall Study|Adverse Event|19|||
30958961|NCT01587703|59024035|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30672787|NCT00680992|58686643|FG002|Overall Study|Adverse Event|1|||
30672788|NCT00680992|58686641|FG000|Overall Study|Other|19|||
30781387|NCT02963506|58793453|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30589159|NCT01154296|58601497|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
30589160|NCT01154296|58601498|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
30589161|NCT01154218|58601504|FG000|Third Intervention Period|Adverse Event|0|||
30589162|NCT01154218|58601505|FG001|Third Intervention Period|Adverse Event|1|||
30589163|NCT01154218|58601506|FG002|Third Intervention Period|Adverse Event|0|||
30589164|NCT01154218|58601507|FG003|Third Intervention Period|Adverse Event|0|||
30589165|NCT01154218|58601504|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
30589166|NCT01154218|58601505|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
30589167|NCT01154218|58601506|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
30589168|NCT01154218|58601507|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
30589169|NCT01154218|58601504|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
30589170|NCT01154218|58601505|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
30589171|NCT01154218|58601506|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
30589172|NCT01154218|58601507|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
30589173|NCT01154140|58601532|FG000|Overall Study|Death|71|||
30589174|NCT01154140|58601533|FG001|Overall Study|Death|81|||
30589175|NCT01154140|58601532|FG000|Overall Study|Lost to Follow-up|4|||
30589176|NCT01154140|58601533|FG001|Overall Study|Lost to Follow-up|5|||
30589177|NCT01154140|58601532|FG000|Overall Study|Withdrawal by Subject|12|||
30589178|NCT01154140|58601533|FG001|Overall Study|Withdrawal by Subject|13|||
30589179|NCT01154140|58601532|FG000|Overall Study|Other|3|||
30589180|NCT01154140|58601533|FG001|Overall Study|Other|1|||
30589181|NCT01154140|58601532|FG000|Overall Study|Randomized but not treated|1|||
30589182|NCT01154140|58601533|FG001|Overall Study|Randomized but not treated|2|||
30589183|NCT01154101|58601544|FG000|Overall Study|Adverse Event|0|||
30589184|NCT01154101|58601545|FG001|Overall Study|Adverse Event|2|||
30589185|NCT01154101|58601546|FG002|Overall Study|Adverse Event|1|||
30589186|NCT01154101|58601547|FG003|Overall Study|Adverse Event|1|||
30589187|NCT01154101|58601548|FG004|Overall Study|Adverse Event|0|||
30589188|NCT01154101|58601544|FG000|Overall Study|Lost to Follow-up|0|||
30589189|NCT01154101|58601545|FG001|Overall Study|Lost to Follow-up|1|||
30589190|NCT01154101|58601546|FG002|Overall Study|Lost to Follow-up|0|||
30589191|NCT01154101|58601547|FG003|Overall Study|Lost to Follow-up|1|||
30589192|NCT01154101|58601548|FG004|Overall Study|Lost to Follow-up|0|||
30589193|NCT01154101|58601544|FG000|Overall Study|Withdrawal by Subject|0|||
30589194|NCT01154101|58601545|FG001|Overall Study|Withdrawal by Subject|1|||
30589195|NCT01154101|58601546|FG002|Overall Study|Withdrawal by Subject|2|||
30589196|NCT01154101|58601547|FG003|Overall Study|Withdrawal by Subject|0|||
30589197|NCT01154101|58601548|FG004|Overall Study|Withdrawal by Subject|1|||
30589198|NCT01153984|58601565|FG000|Overall Study|Withdrawal by Subject|1|||
30589199|NCT01153984|58601565|FG000|Overall Study|Adverse Event|1|||
30589200|NCT01153633|58601571|FG000|Overall Study|Protocol Violation|1|||
30589201|NCT01153633|58601572|FG001|Overall Study|Protocol Violation|1|||
30589202|NCT01153633|58601571|FG000|Overall Study|Therapeutic failure|3|||
30589203|NCT01153633|58601572|FG001|Overall Study|Therapeutic failure|3|||
30589204|NCT01153516|58601582|FG000|Overall Study|Both subjects refused surgery|2|||
30589205|NCT01153516|58601583|FG001|Overall Study|Both subjects refused surgery|0|||
30589206|NCT01153321|58601591|FG000|Overall Study|Development of study withdrawal criteria|0|||
30589207|NCT01153321|58601592|FG001|Overall Study|Development of study withdrawal criteria|1|||
30589208|NCT01153321|58601591|FG000|Overall Study|Withdrawal by Subject|0|||
30589209|NCT01153321|58601592|FG001|Overall Study|Withdrawal by Subject|1|||
30589210|NCT01153321|58601591|FG000|Overall Study|Adverse Event|1|||
30589211|NCT01153321|58601592|FG001|Overall Study|Adverse Event|1|||
30589212|NCT01153009|58601602|FG000|Overall Study|Adverse Event|4|||
30589213|NCT01153009|58601603|FG001|Overall Study|Adverse Event|14|||
30589214|NCT01153009|58601604|FG002|Overall Study|Adverse Event|14|||
30589215|NCT01153009|58601605|FG003|Overall Study|Adverse Event|10|||
30589216|NCT01153009|58601602|FG000|Overall Study|Lack of Efficacy|9|||
30589217|NCT01153009|58601603|FG001|Overall Study|Lack of Efficacy|0|||
30589218|NCT01153009|58601604|FG002|Overall Study|Lack of Efficacy|2|||
30589219|NCT01153009|58601605|FG003|Overall Study|Lack of Efficacy|1|||
30589220|NCT01153009|58601602|FG000|Overall Study|Noncompliance with Study Medication|1|||
30672789|NCT00680992|58686642|FG001|Overall Study|Other|14|||
30672790|NCT00680992|58686643|FG002|Overall Study|Other|1|||
30672791|NCT00680992|58686641|FG000|Overall Study|Disease Progression|21|||
30672792|NCT00680992|58686642|FG001|Overall Study|Disease Progression|9|||
30672793|NCT00680992|58686643|FG002|Overall Study|Disease Progression|0|||
30672794|NCT00680992|58686641|FG000|Overall Study|Lost to Follow-up|12|||
30672795|NCT00680992|58686642|FG001|Overall Study|Lost to Follow-up|14|||
30672796|NCT00680992|58686643|FG002|Overall Study|Lost to Follow-up|0|||
30672797|NCT00680992|58686641|FG000|Overall Study|Noncompliance|4|||
30589221|NCT01153009|58601603|FG001|Overall Study|Noncompliance with Study Medication|3|||
30672798|NCT00680992|58686642|FG001|Overall Study|Noncompliance|6|||
30589222|NCT01153009|58601604|FG002|Overall Study|Noncompliance with Study Medication|4|||
30589223|NCT01153009|58601605|FG003|Overall Study|Noncompliance with Study Medication|1|||
30589224|NCT01153009|58601602|FG000|Overall Study|Protocol Deviations|4|||
30589225|NCT01153009|58601603|FG001|Overall Study|Protocol Deviations|3|||
30589226|NCT01153009|58601604|FG002|Overall Study|Protocol Deviations|3|||
30589227|NCT01153009|58601605|FG003|Overall Study|Protocol Deviations|2|||
30672799|NCT00680992|58686643|FG002|Overall Study|Noncompliance|0|||
30589228|NCT01153009|58601602|FG000|Overall Study|Withdrawal of Consent|5|||
30589229|NCT01153009|58601603|FG001|Overall Study|Withdrawal of Consent|5|||
30589230|NCT01153009|58601604|FG002|Overall Study|Withdrawal of Consent|4|||
30589231|NCT01153009|58601605|FG003|Overall Study|Withdrawal of Consent|6|||
30589232|NCT01153009|58601602|FG000|Overall Study|Lost to Follow-up|8|||
30672800|NCT00680992|58686641|FG000|Overall Study|Requirement for Alternative Therapy|8|||
30672801|NCT00680992|58686642|FG001|Overall Study|Requirement for Alternative Therapy|2|||
30672802|NCT00680992|58686643|FG002|Overall Study|Requirement for Alternative Therapy|0|||
30672803|NCT00680992|58686641|FG000|Overall Study|Pregnancy|5|||
30672804|NCT00680992|58686642|FG001|Overall Study|Pregnancy|0|||
30672805|NCT00680992|58686643|FG002|Overall Study|Pregnancy|1|||
30672806|NCT00680992|58686641|FG000|Overall Study|Death|5|||
30672807|NCT00680992|58686642|FG001|Overall Study|Death|1|||
30672808|NCT00680992|58686643|FG002|Overall Study|Death|0|||
30672809|NCT00680992|58686641|FG000|Overall Study|Ineligibility Determined|0|||
30672810|NCT00680992|58686642|FG001|Overall Study|Ineligibility Determined|1|||
30672811|NCT00680992|58686643|FG002|Overall Study|Ineligibility Determined|0|||
30672812|NCT00805389|58686657|FG000|Overall Study|Adverse Event|0|||
30672813|NCT00805389|58686658|FG001|Overall Study|Adverse Event|0|||
30672814|NCT00805389|58686659|FG002|Overall Study|Adverse Event|1|||
30672815|NCT00805389|58686660|FG003|Overall Study|Adverse Event|2|||
30672816|NCT00805389|58686661|FG004|Overall Study|Adverse Event|0|||
30672817|NCT00805389|58686657|FG000|Overall Study|Lost to Follow-up|4|||
30672818|NCT00805389|58686658|FG001|Overall Study|Lost to Follow-up|3|||
30672819|NCT00805389|58686659|FG002|Overall Study|Lost to Follow-up|6|||
30589233|NCT01153009|58601603|FG001|Overall Study|Lost to Follow-up|8|||
30589234|NCT01153009|58601604|FG002|Overall Study|Lost to Follow-up|11|||
30589235|NCT01153009|58601605|FG003|Overall Study|Lost to Follow-up|15|||
30589236|NCT01153009|58601602|FG000|Overall Study|Other|1|||
30589237|NCT01153009|58601603|FG001|Overall Study|Other|1|||
30589238|NCT01153009|58601604|FG002|Overall Study|Other|3|||
30589239|NCT01153009|58601605|FG003|Overall Study|Other|2|||
30672820|NCT00805389|58686660|FG003|Overall Study|Lost to Follow-up|10|||
30672821|NCT00805389|58686661|FG004|Overall Study|Lost to Follow-up|9|||
30672822|NCT00805389|58686657|FG000|Overall Study|Protocol Violation|0|||
30672823|NCT00805389|58686658|FG001|Overall Study|Protocol Violation|0|||
30672824|NCT00805389|58686659|FG002|Overall Study|Protocol Violation|1|||
30589240|NCT01152814|58601615|FG000|Overall Study|Lost to Follow-up|2|||
30589241|NCT01152580|58601621|FG000|Overall Study|Withdrawal by Subject|0|||
30589242|NCT01152580|58601622|FG001|Overall Study|Withdrawal by Subject|1|||
30589243|NCT01152385|58601632|FG000|Overall Study|Withdrawal by Subject|3|||
30589244|NCT01152385|58601633|FG001|Overall Study|Withdrawal by Subject|1|||
30589245|NCT01152385|58601634|FG002|Overall Study|Withdrawal by Subject|1|||
30589246|NCT01152385|58601635|FG003|Overall Study|Withdrawal by Subject|1|||
30589247|NCT01152385|58601632|FG000|Overall Study|Protocol Violation|0|||
30589248|NCT01152385|58601633|FG001|Overall Study|Protocol Violation|0|||
30589249|NCT01152385|58601634|FG002|Overall Study|Protocol Violation|0|||
30672825|NCT00805389|58686660|FG003|Overall Study|Protocol Violation|0|||
30672826|NCT00805389|58686661|FG004|Overall Study|Protocol Violation|0|||
30672827|NCT00805389|58686657|FG000|Overall Study|Withdrawal by Subject|3|||
30672828|NCT00805389|58686658|FG001|Overall Study|Withdrawal by Subject|2|||
30672829|NCT00805389|58686659|FG002|Overall Study|Withdrawal by Subject|4|||
30672830|NCT00805389|58686660|FG003|Overall Study|Withdrawal by Subject|5|||
30672831|NCT00805389|58686661|FG004|Overall Study|Withdrawal by Subject|4|||
30672832|NCT00678886|58686685|FG000|Overall Study|Withdrawal by Subject|0|||
30672833|NCT00678886|58686686|FG001|Overall Study|Withdrawal by Subject|0|||
30672834|NCT00678886|58686687|FG002|Overall Study|Withdrawal by Subject|4|||
30672835|NCT00678886|58686688|FG003|Overall Study|Withdrawal by Subject|6|||
30672836|NCT00678886|58686685|FG000|Overall Study|Physician Decision|0|||
30672837|NCT00678886|58686686|FG001|Overall Study|Physician Decision|0|||
30672838|NCT00678886|58686687|FG002|Overall Study|Physician Decision|1|||
30672839|NCT00678886|58686688|FG003|Overall Study|Physician Decision|1|||
30672840|NCT00678886|58686685|FG000|Overall Study|Lost to Follow-up|0|||
30672841|NCT00678886|58686686|FG001|Overall Study|Lost to Follow-up|0|||
30672842|NCT00678886|58686687|FG002|Overall Study|Lost to Follow-up|3|||
30589250|NCT01152385|58601635|FG003|Overall Study|Protocol Violation|1|||
30589251|NCT01152385|58601632|FG000|Overall Study|Adverse Event|1|||
30589252|NCT01152385|58601633|FG001|Overall Study|Adverse Event|1|||
30589253|NCT01152385|58601634|FG002|Overall Study|Adverse Event|0|||
30589254|NCT01152385|58601635|FG003|Overall Study|Adverse Event|0|||
30672843|NCT00678886|58686688|FG003|Overall Study|Lost to Follow-up|2|||
30672844|NCT00678886|58686685|FG000|Overall Study|Other|0|||
30672845|NCT00678886|58686686|FG001|Overall Study|Other|0|||
30672846|NCT00678886|58686687|FG002|Overall Study|Other|1|||
30672847|NCT00678886|58686688|FG003|Overall Study|Other|0|||
30672848|NCT00804843|58686699|FG000|Overall Study|Protocol Violation|1|||
30672849|NCT00804843|58686700|FG001|Overall Study|Protocol Violation|0|||
30672850|NCT00804843|58686699|FG000|Overall Study|Adverse Event|8|||
30589255|NCT01152385|58601632|FG000|Overall Study|Study-specific withdrawal criteria|1|||
30589256|NCT01152385|58601633|FG001|Overall Study|Study-specific withdrawal criteria|1|||
30589257|NCT01152385|58601634|FG002|Overall Study|Study-specific withdrawal criteria|2|||
30672851|NCT00804843|58686700|FG001|Overall Study|Adverse Event|5|||
30672852|NCT00804843|58686699|FG000|Overall Study|Withdrawal by Subject|1|||
30672853|NCT00804843|58686700|FG001|Overall Study|Withdrawal by Subject|2|||
30672854|NCT00822120|58686709|FG000|Initial Registration|Adverse Event|1|||
30589258|NCT01152385|58601635|FG003|Overall Study|Study-specific withdrawal criteria|0|||
30589259|NCT01152385|58601632|FG000|Overall Study|Other|4|||
30781388|NCT02963506|58793454|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30781389|NCT02963506|58793455|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30781390|NCT02963506|58793456|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
30781391|NCT02963506|58793444|FG000|Dose-Blind Period|Adverse Event|0|||
30781392|NCT02963506|58793445|FG001|Dose-Blind Period|Adverse Event|0|||
30781393|NCT02963506|58793446|FG002|Dose-Blind Period|Adverse Event|0|||
30781394|NCT02963506|58793447|FG003|Dose-Blind Period|Adverse Event|0|||
30781395|NCT02963506|58793448|FG004|Dose-Blind Period|Adverse Event|0|||
30781396|NCT02963506|58793449|FG005|Dose-Blind Period|Adverse Event|1|||
30781397|NCT02963506|58793450|FG006|Dose-Blind Period|Adverse Event|3|||
30781398|NCT02963506|58793451|FG007|Dose-Blind Period|Adverse Event|2|||
30781399|NCT02963506|58793452|FG008|Dose-Blind Period|Adverse Event|2|||
30781400|NCT02963506|58793453|FG009|Dose-Blind Period|Adverse Event|2|||
30781401|NCT02963506|58793454|FG010|Dose-Blind Period|Adverse Event|1|||
30589260|NCT01152385|58601633|FG001|Overall Study|Other|3|||
30589261|NCT01152385|58601634|FG002|Overall Study|Other|2|||
30589262|NCT01152385|58601635|FG003|Overall Study|Other|3|||
30589263|NCT01152190|58601651|FG000|Overall Study|Adverse Event|2|||
30672855|NCT00822120|58686710|FG001|Initial Registration|Adverse Event|0|||
30672856|NCT00822120|58686711|FG002|Initial Registration|Adverse Event|0|||
30672857|NCT00822120|58686712|FG003|Initial Registration|Adverse Event|0|||
30672858|NCT00822120|58686713|FG004|Initial Registration|Adverse Event|0|||
30672859|NCT00822120|58686714|FG005|Initial Registration|Adverse Event|0|||
30672860|NCT00822120|58686709|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
30672861|NCT00822120|58686710|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
30672862|NCT00822120|58686711|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
30672863|NCT00822120|58686712|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
30672864|NCT00822120|58686713|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
30672865|NCT00822120|58686714|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
30672866|NCT00822120|58686709|FG000|Initial Registration|Reasons not Protocol Specified|2|||
30672867|NCT00822120|58686710|FG001|Initial Registration|Reasons not Protocol Specified|0|||
30672868|NCT00822120|58686711|FG002|Initial Registration|Reasons not Protocol Specified|0|||
30672869|NCT00822120|58686712|FG003|Initial Registration|Reasons not Protocol Specified|0|||
30672870|NCT00822120|58686713|FG004|Initial Registration|Reasons not Protocol Specified|0|||
30672871|NCT00822120|58686714|FG005|Initial Registration|Reasons not Protocol Specified|0|||
30672872|NCT00822120|58686709|FG000|Initial Registration|Ineligible|22|||
30672873|NCT00822120|58686710|FG001|Initial Registration|Ineligible|1|||
30672874|NCT00822120|58686711|FG002|Initial Registration|Ineligible|0|||
30672875|NCT00822120|58686712|FG003|Initial Registration|Ineligible|0|||
30672876|NCT00822120|58686713|FG004|Initial Registration|Ineligible|0|||
30672877|NCT00822120|58686714|FG005|Initial Registration|Ineligible|0|||
30672878|NCT00822120|58686709|FG000|PET-directed Therapy|Adverse Event|0|||
30672879|NCT00822120|58686710|FG001|PET-directed Therapy|Adverse Event|0|||
30672880|NCT00822120|58686711|FG002|PET-directed Therapy|Adverse Event|0|||
30672881|NCT00822120|58686712|FG003|PET-directed Therapy|Adverse Event|1|||
30672882|NCT00822120|58686713|FG004|PET-directed Therapy|Adverse Event|0|||
30672883|NCT00822120|58686714|FG005|PET-directed Therapy|Adverse Event|0|||
30672884|NCT00822120|58686709|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
30672885|NCT00822120|58686710|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
30781402|NCT02963506|58793455|FG011|Dose-Blind Period|Adverse Event|1|||
30781403|NCT02963506|58793456|FG012|Dose-Blind Period|Adverse Event|6|||
30781404|NCT02963506|58793444|FG000|Dose-Blind Period|Lack of Efficacy|0|||
30781405|NCT02963506|58793445|FG001|Dose-Blind Period|Lack of Efficacy|0|||
30781406|NCT02963506|58793446|FG002|Dose-Blind Period|Lack of Efficacy|0|||
30958962|NCT01587703|59024036|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30958963|NCT01587703|59024037|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30589264|NCT01152190|58601652|FG001|Overall Study|Adverse Event|4|||
30589265|NCT01152190|58601651|FG000|Overall Study|Death|1|||
30589266|NCT01152190|58601652|FG001|Overall Study|Death|0|||
30589267|NCT01152190|58601651|FG000|Overall Study|Protocol Violation|1|||
30589268|NCT01152190|58601652|FG001|Overall Study|Protocol Violation|1|||
30589269|NCT01152190|58601651|FG000|Overall Study|Withdrawal by Subject|1|||
30589270|NCT01152190|58601652|FG001|Overall Study|Withdrawal by Subject|3|||
30589271|NCT01151410|58601660|FG000|Overall Study|Withdrawal by Subject|3|||
30589272|NCT01151410|58601661|FG001|Overall Study|Withdrawal by Subject|5|||
30589273|NCT01151410|58601660|FG000|Overall Study|Lost to Follow-up|3|||
30589274|NCT01151410|58601661|FG001|Overall Study|Lost to Follow-up|4|||
30589275|NCT01151410|58601660|FG000|Overall Study|Adverse Event|1|||
30589276|NCT01151410|58601661|FG001|Overall Study|Adverse Event|2|||
30589277|NCT01151410|58601660|FG000|Overall Study|Protocol deviation|2|||
30589278|NCT01151410|58601661|FG001|Overall Study|Protocol deviation|1|||
30672886|NCT00822120|58686711|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
30672887|NCT00822120|58686712|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
30672888|NCT00822120|58686713|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
30672889|NCT00822120|58686714|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
30672890|NCT00822120|58686709|FG000|PET-directed Therapy|Death|0|||
30672891|NCT00822120|58686710|FG001|PET-directed Therapy|Death|0|||
30672892|NCT00822120|58686711|FG002|PET-directed Therapy|Death|0|||
30672893|NCT00822120|58686712|FG003|PET-directed Therapy|Death|2|||
30589279|NCT01151410|58601660|FG000|Overall Study|Administrative problems|1|||
30589280|NCT01151410|58601661|FG001|Overall Study|Administrative problems|1|||
30672894|NCT00822120|58686713|FG004|PET-directed Therapy|Death|0|||
30672895|NCT00822120|58686714|FG005|PET-directed Therapy|Death|0|||
30672896|NCT00822120|58686709|FG000|PET-directed Therapy|Protocol Violation|0|||
30672897|NCT00822120|58686710|FG001|PET-directed Therapy|Protocol Violation|0|||
30672898|NCT00822120|58686711|FG002|PET-directed Therapy|Protocol Violation|0|||
30672899|NCT00822120|58686712|FG003|PET-directed Therapy|Protocol Violation|6|||
30672900|NCT00822120|58686713|FG004|PET-directed Therapy|Protocol Violation|0|||
30672901|NCT00822120|58686714|FG005|PET-directed Therapy|Protocol Violation|0|||
30672902|NCT00804687|58686735|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
30672903|NCT00804687|58686736|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
30672904|NCT00804687|58686737|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
30672905|NCT00804687|58686738|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
30672906|NCT00804687|58686739|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
30672907|NCT00804687|58686740|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
30672908|NCT00804687|58686735|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
30672909|NCT00804687|58686736|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
30672910|NCT00804687|58686737|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
30672911|NCT00804687|58686738|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
30672912|NCT00804687|58686739|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
30672913|NCT00804687|58686740|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
30672914|NCT00804687|58686735|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
30672915|NCT00804687|58686736|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
30672916|NCT00804687|58686737|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
30672917|NCT00804687|58686738|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
30672918|NCT00804687|58686739|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
30672919|NCT00804687|58686740|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
30672920|NCT00804687|58686735|FG000|Period 5: Treatment Period|Positive drug test|1|||
30672921|NCT00804687|58686736|FG001|Period 5: Treatment Period|Positive drug test|0|||
30781407|NCT02963506|58793447|FG003|Dose-Blind Period|Lack of Efficacy|0|||
30958964|NCT01587703|59024038|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30589281|NCT01151410|58601660|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30589282|NCT01151410|58601661|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30589283|NCT01151410|58601660|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30589284|NCT01151410|58601661|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30589285|NCT01151215|58601670|FG000|Overall Study|Worsening of condition under study|1|||
30589286|NCT01151215|58601671|FG001|Overall Study|Worsening of condition under study|1|||
30589287|NCT01151215|58601672|FG002|Overall Study|Worsening of condition under study|1|||
30589288|NCT01151215|58601670|FG000|Overall Study|Death|16|||
30589289|NCT01151215|58601671|FG001|Overall Study|Death|20|||
30589290|NCT01151215|58601672|FG002|Overall Study|Death|11|||
30589291|NCT01151215|58601670|FG000|Overall Study|Lost to Follow-up|0|||
30589292|NCT01151215|58601671|FG001|Overall Study|Lost to Follow-up|0|||
30589293|NCT01151215|58601672|FG002|Overall Study|Lost to Follow-up|3|||
30589294|NCT01151215|58601670|FG000|Overall Study|Withdrawal by Subject|3|||
30589295|NCT01151215|58601671|FG001|Overall Study|Withdrawal by Subject|1|||
30589296|NCT01151215|58601672|FG002|Overall Study|Withdrawal by Subject|2|||
30589297|NCT01151215|58601670|FG000|Overall Study|Disease progression|0|||
30589298|NCT01151215|58601671|FG001|Overall Study|Disease progression|1|||
30589299|NCT01151215|58601672|FG002|Overall Study|Disease progression|1|||
30589300|NCT01151215|58601670|FG000|Overall Study|Safety as judged by the investigator|0|||
30589301|NCT01151215|58601671|FG001|Overall Study|Safety as judged by the investigator|0|||
30589302|NCT01151215|58601672|FG002|Overall Study|Safety as judged by the investigator|1|||
30589303|NCT01151137|58601682|FG000|Overall Study|Death|15|||
30589304|NCT01151137|58601683|FG001|Overall Study|Death|27|||
30589305|NCT01151137|58601682|FG000|Overall Study|Lost to Follow-up|1|||
30589306|NCT01151137|58601683|FG001|Overall Study|Lost to Follow-up|1|||
30672922|NCT00804687|58686737|FG002|Period 5: Treatment Period|Positive drug test|0|||
30672923|NCT00804687|58686738|FG003|Period 5: Treatment Period|Positive drug test|0|||
30672924|NCT00804687|58686739|FG004|Period 5: Treatment Period|Positive drug test|0|||
30672925|NCT00804687|58686740|FG005|Period 5: Treatment Period|Positive drug test|0|||
30672926|NCT00678652|58686752|FG000|Overall Study|Protocol Violation|2|||
30589307|NCT01151098|58601689|FG000|Overall Study|Adverse Event|82|||
30589308|NCT01151098|58601689|FG000|Overall Study|Lost to Follow-up|6|||
30589309|NCT01151098|58601689|FG000|Overall Study|Lack of Efficacy|15|||
30672927|NCT00678652|58686753|FG001|Overall Study|Protocol Violation|0|||
30672928|NCT00678652|58686754|FG002|Overall Study|Protocol Violation|0|||
30589310|NCT01151098|58601689|FG000|Overall Study|Protocol Violation|1|||
30589311|NCT01151098|58601689|FG000|Overall Study|Miscellaneous|13|||
30589312|NCT01151020|58601693|FG000|Overall Study|Death|25|||
30589313|NCT01151020|58601693|FG000|Overall Study|Conversion to open repair|1|||
30589314|NCT01151020|58601693|FG000|Overall Study|Lost to Follow-up|4|||
30589315|NCT01151020|58601693|FG000|Overall Study|Withdrawal by Subject|22|||
30589316|NCT01151020|58601693|FG000|Overall Study|Patients did not receive the device|2|||
30589317|NCT01150474|58601699|FG000|Overall Study|Withdrawal by Subject|5|||
30589318|NCT01150474|58601700|FG001|Overall Study|Withdrawal by Subject|2|||
30589319|NCT01150474|58601699|FG000|Overall Study|Cancer found|1|||
30589320|NCT01150474|58601700|FG001|Overall Study|Cancer found|0|||
30589321|NCT01150474|58601699|FG000|Overall Study|Multiple Studies|0|||
30589322|NCT01150474|58601700|FG001|Overall Study|Multiple Studies|1|||
30589323|NCT01150474|58601699|FG000|Overall Study|Rectotomy|1|||
30589324|NCT01150474|58601700|FG001|Overall Study|Rectotomy|0|||
30589325|NCT01150474|58601699|FG000|Overall Study|Drug did not arrive in time|1|||
30589326|NCT01150474|58601700|FG001|Overall Study|Drug did not arrive in time|0|||
30589327|NCT01150474|58601699|FG000|Overall Study|Drug not administered|1|||
30672929|NCT00678652|58686755|FG003|Overall Study|Protocol Violation|0|||
30672930|NCT00678652|58686752|FG000|Overall Study|Pregnancy|0|||
30672931|NCT00678652|58686753|FG001|Overall Study|Pregnancy|0|||
30672932|NCT00678652|58686754|FG002|Overall Study|Pregnancy|1|||
30672933|NCT00678652|58686755|FG003|Overall Study|Pregnancy|0|||
30672934|NCT00678652|58686752|FG000|Overall Study|Relocation|1|||
30672935|NCT00678652|58686753|FG001|Overall Study|Relocation|0|||
30672936|NCT00678652|58686754|FG002|Overall Study|Relocation|0|||
30672937|NCT00678652|58686755|FG003|Overall Study|Relocation|0|||
30672938|NCT00840060|58686776|FG000|Overall Study|Withdrawal by Subject|1|||
30672939|NCT00840060|58686777|FG001|Overall Study|Withdrawal by Subject|0|||
30672940|NCT00840060|58686776|FG000|Overall Study|Change in emotional/behavioral status|0|||
30672941|NCT00840060|58686777|FG001|Overall Study|Change in emotional/behavioral status|1|||
30672942|NCT00574912|58686783|FG000|Overall Study|Could not place IV lines.|3|||
30672943|NCT00574912|58686783|FG000|Overall Study|scheduling conflicts|3|||
30672944|NCT00574912|58686783|FG000|Overall Study|Physician Decision|2|||
30672945|NCT00674128|58686797|FG000|Overall Study|Withdrawal by Subject|25|||
30672946|NCT00674128|58686798|FG001|Overall Study|Withdrawal by Subject|23|||
30672947|NCT00804141|58686804|FG000|Overall Study|Adverse Event|157|||
30672948|NCT00804141|58686804|FG000|Overall Study|Death|4|||
30672949|NCT00804141|58686804|FG000|Overall Study|Failed to return|96|||
30672950|NCT00804141|58686804|FG000|Overall Study|Investigator request|8|||
30672951|NCT00804141|58686804|FG000|Overall Study|Protocol Violation|85|||
30672952|NCT00804141|58686804|FG000|Overall Study|Withdrawal by Subject|131|||
30672953|NCT00804141|58686804|FG000|Overall Study|Lack of Efficacy|46|||
30672954|NCT00804141|58686804|FG000|Overall Study|Other than specified|30|||
30672955|NCT00804141|58686804|FG000|Overall Study|Enrolled but not treated|6|||
30672956|NCT00677092|58686808|FG000|Overall Study|Adverse Event|1|||
30672957|NCT00677092|58686808|FG000|Overall Study|Lost to Follow-up|1|||
30672958|NCT00677092|58686808|FG000|Overall Study|Withdrawal by Subject|3|||
30672959|NCT00677092|58686808|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
30672960|NCT00677014|58686816|FG000|Overall Study|Lost to Follow-up|20|||
30672961|NCT00677014|58686817|FG001|Overall Study|Lost to Follow-up|12|||
30672962|NCT00677014|58686818|FG002|Overall Study|Lost to Follow-up|24|||
30672963|NCT00677014|58686816|FG000|Overall Study|Death|6|||
30672964|NCT00677014|58686817|FG001|Overall Study|Death|15|||
30672965|NCT00677014|58686818|FG002|Overall Study|Death|7|||
30672966|NCT00677014|58686816|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
30672967|NCT00677014|58686817|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
30672968|NCT00677014|58686818|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
30672969|NCT00839436|58686829|FG000|Overall Study|Developed exclusionary condition|1|||
30672970|NCT00839436|58686830|FG001|Overall Study|Developed exclusionary condition|0|||
30672971|NCT00839436|58686831|FG002|Overall Study|Developed exclusionary condition|0|||
30672972|NCT00839436|58686829|FG000|Overall Study|Withdrawal by Subject|0|||
30958965|NCT01587703|59024039|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
30589328|NCT01150474|58601700|FG001|Overall Study|Drug not administered|0|||
30672973|NCT00839436|58686830|FG001|Overall Study|Withdrawal by Subject|1|||
30672974|NCT00839436|58686831|FG002|Overall Study|Withdrawal by Subject|0|||
30672975|NCT00839436|58686829|FG000|Overall Study|Study drug no longer available|0|||
30672976|NCT00839436|58686830|FG001|Overall Study|Study drug no longer available|0|||
30958966|NCT01587703|59024040|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
30589329|NCT01150474|58601699|FG000|Overall Study|Surgery Changed|1|||
30589330|NCT01150474|58601700|FG001|Overall Study|Surgery Changed|0|||
30589331|NCT01150357|58601709|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
30672977|NCT00839436|58686831|FG002|Overall Study|Study drug no longer available|1|||
30672978|NCT00675766|58686843|FG000|Overall Study|Lost to Follow-up|6|||
30672979|NCT00675766|58686844|FG001|Overall Study|Lost to Follow-up|5|||
30672980|NCT00675766|58686845|FG002|Overall Study|Lost to Follow-up|21|||
30672981|NCT00675766|58686846|FG003|Overall Study|Lost to Follow-up|26|||
30672982|NCT00673894|58686858|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
30672983|NCT00673894|58686859|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
30672984|NCT00673894|58686858|FG000|First Intervention 4 Weeks|Adverse Event|1|||
30855832|NCT02760433|58883525|FG004|Overall Study|Subject refused to continue the study|0|||
30855833|NCT02760433|58883521|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
30855834|NCT02760433|58883522|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
30855835|NCT02760433|58883523|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
30855836|NCT02760433|58883524|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
30855837|NCT02760433|58883525|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
30589332|NCT01150357|58601710|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
30672985|NCT00673894|58686859|FG001|First Intervention 4 Weeks|Adverse Event|0|||
30672986|NCT00674986|58686867|FG000|Overall Study|Adverse Event|2|||
30589333|NCT01150357|58601711|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
30589334|NCT01150357|58601709|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
30589335|NCT01150357|58601710|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
30589336|NCT01150357|58601711|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
30589337|NCT01150357|58601709|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
30589338|NCT01150357|58601710|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
30589339|NCT01150357|58601711|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
30589340|NCT01150357|58601709|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
30589341|NCT01150357|58601710|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
30589342|NCT01150357|58601711|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
30589343|NCT01150357|58601709|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
30589344|NCT01150357|58601710|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
30589345|NCT01150357|58601711|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
30589346|NCT01150357|58601709|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
30589347|NCT01150357|58601710|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
30589348|NCT01150357|58601711|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
30589349|NCT01150357|58601709|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
30589350|NCT01150357|58601710|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
30589351|NCT01150357|58601711|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
30589352|NCT01150123|58601761|FG000|Overall Study|Withdrawal by Subject|1|||
30589353|NCT01150123|58601762|FG001|Overall Study|Withdrawal by Subject|1|||
30589354|NCT01150123|58601763|FG002|Overall Study|Withdrawal by Subject|2|||
30589355|NCT01150123|58601764|FG003|Overall Study|Withdrawal by Subject|1|||
30589356|NCT01150123|58601765|FG004|Overall Study|Withdrawal by Subject|1|||
30589357|NCT01150123|58601766|FG005|Overall Study|Withdrawal by Subject|1|||
30589358|NCT01150123|58601767|FG006|Overall Study|Withdrawal by Subject|0|||
30589359|NCT01150123|58601768|FG007|Overall Study|Withdrawal by Subject|3|||
30589360|NCT01150123|58601769|FG008|Overall Study|Withdrawal by Subject|2|||
30589361|NCT01150123|58601770|FG009|Overall Study|Withdrawal by Subject|0|||
30589362|NCT01150123|58601771|FG010|Overall Study|Withdrawal by Subject|1|||
30589363|NCT01150123|58601772|FG011|Overall Study|Withdrawal by Subject|0|||
30589364|NCT01150123|58601773|FG012|Overall Study|Withdrawal by Subject|1|||
30589365|NCT01150123|58601774|FG013|Overall Study|Withdrawal by Subject|0|||
30589366|NCT01150123|58601775|FG014|Overall Study|Withdrawal by Subject|0|||
30589367|NCT01150123|58601776|FG015|Overall Study|Withdrawal by Subject|1|||
30589368|NCT01150123|58601777|FG016|Overall Study|Withdrawal by Subject|0|||
30589369|NCT01150123|58601778|FG017|Overall Study|Withdrawal by Subject|1|||
30589370|NCT01150123|58601761|FG000|Overall Study|Lost to Follow-up|2|||
30589371|NCT01150123|58601762|FG001|Overall Study|Lost to Follow-up|1|||
30589372|NCT01150123|58601763|FG002|Overall Study|Lost to Follow-up|2|||
30589373|NCT01150123|58601764|FG003|Overall Study|Lost to Follow-up|2|||
30589374|NCT01150123|58601765|FG004|Overall Study|Lost to Follow-up|2|||
30589375|NCT01150123|58601766|FG005|Overall Study|Lost to Follow-up|5|||
30589376|NCT01150123|58601767|FG006|Overall Study|Lost to Follow-up|0|||
30589377|NCT01150123|58601768|FG007|Overall Study|Lost to Follow-up|0|||
30589378|NCT01150123|58601769|FG008|Overall Study|Lost to Follow-up|3|||
30672987|NCT00674986|58686868|FG001|Overall Study|Adverse Event|1|||
30672988|NCT00674986|58686867|FG000|Overall Study|Subject withdrew consent|12|||
30672989|NCT00674986|58686868|FG001|Overall Study|Subject withdrew consent|19|||
30672990|NCT00674986|58686867|FG000|Overall Study|Lost to Follow-up|25|||
30672991|NCT00674986|58686868|FG001|Overall Study|Lost to Follow-up|53|||
30672992|NCT00674986|58686867|FG000|Overall Study|Other reasons|4|||
30672993|NCT00674986|58686868|FG001|Overall Study|Other reasons|8|||
30589379|NCT01150123|58601770|FG009|Overall Study|Lost to Follow-up|1|||
30589380|NCT01150123|58601771|FG010|Overall Study|Lost to Follow-up|1|||
30672994|NCT00673816|58686875|FG000|Overall Study|Adverse Event|1|||
30589381|NCT01150123|58601772|FG011|Overall Study|Lost to Follow-up|1|||
30589382|NCT01150123|58601773|FG012|Overall Study|Lost to Follow-up|2|||
30589383|NCT01150123|58601774|FG013|Overall Study|Lost to Follow-up|0|||
30589384|NCT01150123|58601775|FG014|Overall Study|Lost to Follow-up|0|||
30672995|NCT00673816|58686875|FG000|Overall Study|Withdrawal by Subject|1|||
30672996|NCT00673660|58686880|FG000|Overall Study|Lost to Follow-up|107|||
30672997|NCT00672958|58686891|FG000|Overall Study|Adverse Event|11|||
30672998|NCT00672958|58686892|FG001|Overall Study|Adverse Event|9|||
30672999|NCT00672958|58686891|FG000|Overall Study|Lack of Efficacy|6|||
30673000|NCT00672958|58686892|FG001|Overall Study|Lack of Efficacy|11|||
30673001|NCT00672958|58686891|FG000|Overall Study|Non-compliance with study drug|2|||
30673002|NCT00672958|58686892|FG001|Overall Study|Non-compliance with study drug|3|||
30673003|NCT00672958|58686891|FG000|Overall Study|Protocol deviations|11|||
30673004|NCT00672958|58686892|FG001|Overall Study|Protocol deviations|5|||
30673005|NCT00672958|58686891|FG000|Overall Study|Voluntary withdrawal|12|||
30673006|NCT00672958|58686892|FG001|Overall Study|Voluntary withdrawal|8|||
30673007|NCT00672958|58686891|FG000|Overall Study|Lost to Follow-up|22|||
30673008|NCT00672958|58686892|FG001|Overall Study|Lost to Follow-up|17|||
30673009|NCT00672958|58686891|FG000|Overall Study|Reason not specified|0|||
30673010|NCT00672958|58686892|FG001|Overall Study|Reason not specified|3|||
30673011|NCT00672646|58686901|FG000|Overall Study|Lost to Follow-up|0|||
30673012|NCT00672646|58686902|FG001|Overall Study|Lost to Follow-up|1|||
30673013|NCT00672646|58686903|FG002|Overall Study|Lost to Follow-up|2|||
30673014|NCT00672646|58686901|FG000|Overall Study|Withdrawal by Subject|0|||
30673015|NCT00672646|58686902|FG001|Overall Study|Withdrawal by Subject|0|||
30673016|NCT00672646|58686903|FG002|Overall Study|Withdrawal by Subject|1|||
30673017|NCT00672490|58686913|FG000|Overall Study|Withdrawal by Subject|8|||
30673018|NCT00672490|58686914|FG001|Overall Study|Withdrawal by Subject|8|||
30673019|NCT00672490|58686913|FG000|Overall Study|Lack of Compliance|2|||
30673020|NCT00672490|58686914|FG001|Overall Study|Lack of Compliance|7|||
30673021|NCT00672490|58686913|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
30673022|NCT00672490|58686914|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
30673023|NCT00672490|58686913|FG000|Overall Study|Adverse Event|5|||
30673024|NCT00672490|58686914|FG001|Overall Study|Adverse Event|8|||
30673025|NCT00672490|58686913|FG000|Overall Study|Violation of Concomitant Medicine|1|||
30673026|NCT00672490|58686914|FG001|Overall Study|Violation of Concomitant Medicine|0|||
30673027|NCT00672490|58686913|FG000|Overall Study|Intolerance|0|||
30673028|NCT00672490|58686914|FG001|Overall Study|Intolerance|2|||
30673029|NCT00672490|58686913|FG000|Overall Study|Lost to Follow-up|1|||
30673030|NCT00672490|58686914|FG001|Overall Study|Lost to Follow-up|5|||
30673031|NCT00672490|58686913|FG000|Overall Study|No reason was provided|6|||
30673032|NCT00672490|58686914|FG001|Overall Study|No reason was provided|2|||
30673033|NCT00670930|58686922|FG000|Overall Study|Adminstrative Problem|0|||
30673034|NCT00670930|58686923|FG001|Overall Study|Adminstrative Problem|1|||
30673035|NCT00670930|58686922|FG000|Overall Study|Lost to Follow-up|1|||
30673036|NCT00670930|58686923|FG001|Overall Study|Lost to Follow-up|0|||
30673037|NCT00670540|58686929|FG000|Overall Study|ineligible|17|||
30673038|NCT00670540|58686929|FG000|Overall Study|not living in France|348|||
30673039|NCT00670540|58686929|FG000|Overall Study|refused to participate|189|||
30673040|NCT00670540|58686929|FG000|Overall Study|controls randomised for no follow up|2770|||
30673041|NCT00670540|58686929|FG000|Overall Study|missing information inclusion criteria|1|||
30673042|NCT00591786|58686943|FG000|Overall Study|Withdrawal of Informed Consent|0|||
30673043|NCT00591786|58686944|FG001|Overall Study|Withdrawal of Informed Consent|0|||
30673044|NCT00591786|58686945|FG002|Overall Study|Withdrawal of Informed Consent|1|||
30673045|NCT00591786|58686946|FG003|Overall Study|Withdrawal of Informed Consent|0|||
30673046|NCT00591786|58686947|FG004|Overall Study|Withdrawal of Informed Consent|0|||
30673047|NCT00591786|58686948|FG005|Overall Study|Withdrawal of Informed Consent|0|||
30589385|NCT01150123|58601776|FG015|Overall Study|Lost to Follow-up|0|||
30589386|NCT01150123|58601777|FG016|Overall Study|Lost to Follow-up|0|||
30589387|NCT01150123|58601778|FG017|Overall Study|Lost to Follow-up|0|||
30589388|NCT01149655|58601837|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
30589389|NCT01149655|58601838|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
30589390|NCT01149655|58601839|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
30589391|NCT01149655|58601840|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
30589392|NCT01149655|58601837|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
30589393|NCT01149655|58601838|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
30589394|NCT01149655|58601839|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
30673048|NCT00591786|58686949|FG006|Overall Study|Withdrawal of Informed Consent|0|||
30673049|NCT00591786|58686950|FG007|Overall Study|Withdrawal of Informed Consent|0|||
30958967|NCT01587703|59024041|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
30781408|NCT02963506|58793448|FG004|Dose-Blind Period|Lack of Efficacy|0|||
30673050|NCT00591786|58686951|FG008|Overall Study|Withdrawal of Informed Consent|0|||
30673051|NCT00591786|58686952|FG009|Overall Study|Withdrawal of Informed Consent|0|||
30673052|NCT00674362|58686976|FG000|Double Blind|Adverse Event|6|||
30673053|NCT00674362|58686977|FG001|Double Blind|Adverse Event|6|||
30673054|NCT00674362|58686976|FG000|Double Blind|Lack of Efficacy|2|||
30673055|NCT00674362|58686977|FG001|Double Blind|Lack of Efficacy|6|||
30958968|NCT01587703|59024023|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30589395|NCT01149655|58601840|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
30673056|NCT00674362|58686976|FG000|Double Blind|Loss of efficacy|0|||
30673057|NCT00674362|58686977|FG001|Double Blind|Loss of efficacy|1|||
30673058|NCT00674362|58686976|FG000|Double Blind|Withdrawal by Subject|4|||
30673059|NCT00674362|58686977|FG001|Double Blind|Withdrawal by Subject|3|||
30673060|NCT00674362|58686976|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
30673061|NCT00674362|58686977|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
30673062|NCT00674362|58686976|FG000|Double Blind|Other: Surgery|0|||
30673063|NCT00674362|58686977|FG001|Double Blind|Other: Surgery|1|||
30673064|NCT00674362|58686976|FG000|Open Label|Adverse Event|1|||
30673065|NCT00674362|58686977|FG001|Open Label|Adverse Event|0|||
30673066|NCT00674362|58686976|FG000|Open Label|Other: Subject moved to extension study|1|||
30673067|NCT00674362|58686977|FG001|Open Label|Other: Subject moved to extension study|0|||
30673068|NCT00820950|58686989|FG000|Overall Study|Scheduling Conflict|0|||
30673069|NCT00820950|58686990|FG001|Overall Study|Scheduling Conflict|0|||
30673070|NCT00820950|58686991|FG002|Overall Study|Scheduling Conflict|0|||
30673071|NCT00820950|58686992|FG003|Overall Study|Scheduling Conflict|0|||
30673072|NCT00820950|58686993|FG004|Overall Study|Scheduling Conflict|0|||
30589396|NCT01149655|58601837|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
30589397|NCT01149655|58601838|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
30589398|NCT01149655|58601839|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
30673073|NCT00820950|58686994|FG005|Overall Study|Scheduling Conflict|0|||
30673074|NCT00820950|58686995|FG006|Overall Study|Scheduling Conflict|1|||
30673075|NCT00820950|58686996|FG007|Overall Study|Scheduling Conflict|1|||
30673076|NCT00820950|58686997|FG008|Overall Study|Scheduling Conflict|0|||
30673077|NCT00820950|58686998|FG009|Overall Study|Scheduling Conflict|0|||
30673078|NCT00820950|58686989|FG000|Overall Study|Protocol Violation|1|||
30673079|NCT00820950|58686990|FG001|Overall Study|Protocol Violation|1|||
30673080|NCT00820950|58686991|FG002|Overall Study|Protocol Violation|0|||
30673081|NCT00820950|58686992|FG003|Overall Study|Protocol Violation|0|||
30673082|NCT00820950|58686993|FG004|Overall Study|Protocol Violation|0|||
30673083|NCT00820950|58686994|FG005|Overall Study|Protocol Violation|0|||
30673084|NCT00820950|58686995|FG006|Overall Study|Protocol Violation|0|||
30673085|NCT00820950|58686996|FG007|Overall Study|Protocol Violation|0|||
30673086|NCT00820950|58686997|FG008|Overall Study|Protocol Violation|0|||
30673087|NCT00820950|58686998|FG009|Overall Study|Protocol Violation|0|||
30781409|NCT02963506|58793449|FG005|Dose-Blind Period|Lack of Efficacy|0|||
30781410|NCT02963506|58793450|FG006|Dose-Blind Period|Lack of Efficacy|0|||
30781411|NCT02963506|58793451|FG007|Dose-Blind Period|Lack of Efficacy|1|||
30589399|NCT01149655|58601840|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
30589400|NCT01149655|58601837|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
30589401|NCT01149655|58601838|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
30589402|NCT01149655|58601839|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
30589403|NCT01149655|58601840|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
30589404|NCT01149655|58601837|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
30589405|NCT01149655|58601838|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
30589406|NCT01149655|58601839|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
30589407|NCT01149655|58601840|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
30589408|NCT01149655|58601837|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
30589409|NCT01149655|58601838|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
30589410|NCT01149655|58601839|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
30589411|NCT01149655|58601840|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
30589412|NCT01149655|58601837|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
30589413|NCT01149655|58601838|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
30589414|NCT01149655|58601839|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
30589415|NCT01149655|58601840|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
30589416|NCT01149655|58601837|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
30589417|NCT01149655|58601838|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
30589418|NCT01149655|58601839|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
30589419|NCT01149655|58601840|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
30589420|NCT01149655|58601837|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
30589421|NCT01149655|58601838|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
30589422|NCT01149655|58601839|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
30673088|NCT00670306|58687038|FG000|Overall Study|Adverse Event|8|||
30673089|NCT00670306|58687038|FG000|Overall Study|Lack of Efficacy|10|||
30673090|NCT00670306|58687038|FG000|Overall Study|Withdrawal by Subject|9|||
30673091|NCT00670306|58687038|FG000|Overall Study|Physician Decision|1|||
30673092|NCT00670306|58687038|FG000|Overall Study|Lost to Follow-up|8|||
30673093|NCT00670306|58687038|FG000|Overall Study|incl/excl criterias did not meet|19|||
30673094|NCT00672256|58687042|FG000|Overall Study|PI dropped, bad data|44|||
30673095|NCT00591630|58687050|FG000|Overall Study|Death|0|||
30589423|NCT01149655|58601840|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
30589424|NCT01149655|58601837|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
30589425|NCT01149655|58601838|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
30673096|NCT00591630|58687051|FG001|Overall Study|Death|0|||
30589426|NCT01149655|58601839|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
30589427|NCT01149655|58601840|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
30589428|NCT01149655|58601837|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
30589429|NCT01149655|58601838|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
30589430|NCT01149655|58601839|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
30589431|NCT01149655|58601840|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
30589432|NCT01149655|58601837|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
30589433|NCT01149655|58601838|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
30589434|NCT01149655|58601839|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
30589435|NCT01149655|58601840|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
30589436|NCT01149655|58601837|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
30589437|NCT01149655|58601838|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
30589438|NCT01149655|58601839|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
30589439|NCT01149655|58601840|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
30589440|NCT01149655|58601837|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
30589441|NCT01149655|58601838|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
30589442|NCT01149655|58601839|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
30589443|NCT01149655|58601840|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
30589444|NCT01149655|58601837|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
30589445|NCT01149655|58601838|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
30589446|NCT01149655|58601839|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
30589447|NCT01149655|58601840|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
30589448|NCT01149655|58601837|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
30589449|NCT01149655|58601838|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
30589450|NCT01149655|58601839|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
30589451|NCT01149655|58601840|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
30589452|NCT01149538|58601850|FG000|Overall Study|Lost to Follow-up|0|||
30589453|NCT01149538|58601851|FG001|Overall Study|Lost to Follow-up|1|||
30589454|NCT01149538|58601850|FG000|Overall Study|Withdrawal by Subject|5|||
30589455|NCT01149538|58601851|FG001|Overall Study|Withdrawal by Subject|3|||
30589456|NCT01149460|58601859|FG000|Overall Study|Withdrawal by Subject|0|||
30589457|NCT01149460|58601860|FG001|Overall Study|Withdrawal by Subject|2|||
30589458|NCT01149421|58601869|FG000|Overall Study|Adverse Event|22|||
30589459|NCT01149421|58601870|FG001|Overall Study|Adverse Event|6|||
30589460|NCT01149421|58601871|FG002|Overall Study|Adverse Event|11|||
30589461|NCT01149421|58601869|FG000|Overall Study|Withdrawal by Subject|20|||
30589462|NCT01149421|58601870|FG001|Overall Study|Withdrawal by Subject|12|||
30589463|NCT01149421|58601871|FG002|Overall Study|Withdrawal by Subject|13|||
30589464|NCT01149421|58601869|FG000|Overall Study|Sponsor Decision|0|||
30589465|NCT01149421|58601870|FG001|Overall Study|Sponsor Decision|1|||
30589466|NCT01149421|58601871|FG002|Overall Study|Sponsor Decision|1|||
30589467|NCT01149421|58601869|FG000|Overall Study|Lost to Follow-up|2|||
30589468|NCT01149421|58601870|FG001|Overall Study|Lost to Follow-up|4|||
30589469|NCT01149421|58601871|FG002|Overall Study|Lost to Follow-up|5|||
30589470|NCT01149421|58601869|FG000|Overall Study|Physician Decision|5|||
30589471|NCT01149421|58601870|FG001|Overall Study|Physician Decision|3|||
30589472|NCT01149421|58601871|FG002|Overall Study|Physician Decision|6|||
30589473|NCT01149421|58601869|FG000|Overall Study|Entry Criteria Not Met|1|||
30589474|NCT01149421|58601870|FG001|Overall Study|Entry Criteria Not Met|1|||
30589475|NCT01149421|58601871|FG002|Overall Study|Entry Criteria Not Met|2|||
30589476|NCT01149421|58601869|FG000|Overall Study|Protocol Violation|2|||
30589477|NCT01149421|58601870|FG001|Overall Study|Protocol Violation|2|||
30589478|NCT01149421|58601871|FG002|Overall Study|Protocol Violation|6|||
30589479|NCT01149343|58601889|FG000|Overall Study|Withdrawal by Subject|1|||
30589480|NCT01149343|58601890|FG001|Overall Study|Withdrawal by Subject|1|||
30589481|NCT01149343|58601891|FG002|Overall Study|Withdrawal by Subject|1|||
30589482|NCT01149343|58601892|FG003|Overall Study|Withdrawal by Subject|5|||
30589483|NCT01149343|58601889|FG000|Overall Study|Death|10|||
30589484|NCT01149343|58601890|FG001|Overall Study|Death|13|||
30589485|NCT01149343|58601891|FG002|Overall Study|Death|18|||
30589486|NCT01149343|58601892|FG003|Overall Study|Death|18|||
30589487|NCT01149343|58601889|FG000|Overall Study|Lost to Follow-up|1|||
30589488|NCT01149343|58601890|FG001|Overall Study|Lost to Follow-up|0|||
30589489|NCT01149343|58601891|FG002|Overall Study|Lost to Follow-up|0|||
30673097|NCT00591630|58687052|FG002|Overall Study|Death|1|||
30673098|NCT00591630|58687053|FG003|Overall Study|Death|0|||
30673099|NCT00670228|58687065|FG000|Overall Study|Adverse Event|1|||
30673100|NCT00670228|58687066|FG001|Overall Study|Adverse Event|0|||
30673101|NCT00670228|58687065|FG000|Overall Study|Death or MACE|0|||
30673102|NCT00670228|58687066|FG001|Overall Study|Death or MACE|1|||
30673103|NCT00670228|58687065|FG000|Overall Study|Not treated|2|||
30673104|NCT00670228|58687066|FG001|Overall Study|Not treated|2|||
30673105|NCT00670228|58687065|FG000|Overall Study|Not meeting the selection criteria|2|||
30673106|NCT00670228|58687066|FG001|Overall Study|Not meeting the selection criteria|0|||
30589490|NCT01149343|58601892|FG003|Overall Study|Lost to Follow-up|1|||
30589491|NCT01149343|58601889|FG000|Overall Study|Other|8|||
30589492|NCT01149343|58601890|FG001|Overall Study|Other|10|||
30589493|NCT01149343|58601891|FG002|Overall Study|Other|2|||
30589494|NCT01149343|58601892|FG003|Overall Study|Other|14|||
30589495|NCT01149343|58601889|FG000|Overall Study|Sponsor study termination|0|||
30589496|NCT01149343|58601890|FG001|Overall Study|Sponsor study termination|0|||
30589497|NCT01149343|58601891|FG002|Overall Study|Sponsor study termination|0|||
30589498|NCT01149343|58601892|FG003|Overall Study|Sponsor study termination|2|||
30589499|NCT01149343|58601889|FG000|Overall Study|Recurrence / Progressive disease|0|||
30589500|NCT01149343|58601890|FG001|Overall Study|Recurrence / Progressive disease|0|||
30589501|NCT01149343|58601891|FG002|Overall Study|Recurrence / Progressive disease|1|||
30589502|NCT01149343|58601892|FG003|Overall Study|Recurrence / Progressive disease|0|||
30589503|NCT01149148|58601908|FG000|Overall Study|Lost to Follow-up|1|||
30589504|NCT01149148|58601909|FG001|Overall Study|Lost to Follow-up|2|||
30589505|NCT01149148|58601908|FG000|Overall Study|Death|1|||
30589506|NCT01149148|58601909|FG001|Overall Study|Death|0|||
30589507|NCT01148017|58601920|FG000|Overall Study|Withdrawal by Subject|31|||
30589508|NCT01148017|58601921|FG001|Overall Study|Withdrawal by Subject|14|||
30589509|NCT01148017|58601922|FG002|Overall Study|Withdrawal by Subject|0|||
30589510|NCT01148017|58601923|FG003|Overall Study|Withdrawal by Subject|0|||
30589511|NCT01148017|58601920|FG000|Overall Study|Lost to Follow-up|23|||
30589512|NCT01148017|58601921|FG001|Overall Study|Lost to Follow-up|10|||
30589513|NCT01148017|58601922|FG002|Overall Study|Lost to Follow-up|0|||
30589514|NCT01148017|58601923|FG003|Overall Study|Lost to Follow-up|0|||
30589515|NCT01148017|58601920|FG000|Overall Study|Inappropriate enrollment|1|||
30589516|NCT01148017|58601921|FG001|Overall Study|Inappropriate enrollment|0|||
30589517|NCT01148017|58601922|FG002|Overall Study|Inappropriate enrollment|0|||
30589518|NCT01148017|58601923|FG003|Overall Study|Inappropriate enrollment|0|||
30589519|NCT01148017|58601920|FG000|Overall Study|Administrative reason|22|||
30589520|NCT01148017|58601921|FG001|Overall Study|Administrative reason|9|||
30589521|NCT01148017|58601922|FG002|Overall Study|Administrative reason|0|||
30589522|NCT01148017|58601923|FG003|Overall Study|Administrative reason|0|||
30589523|NCT01148017|58601920|FG000|Overall Study|Unable to classify|3|||
30589524|NCT01148017|58601921|FG001|Overall Study|Unable to classify|1|||
30589525|NCT01148017|58601922|FG002|Overall Study|Unable to classify|0|||
30589526|NCT01148017|58601923|FG003|Overall Study|Unable to classify|0|||
30589527|NCT01147900|58601937|FG000|At Year 10|Lost to Follow-up|0|||
30589528|NCT01147900|58601938|FG001|At Year 10|Lost to Follow-up|1|||
30589529|NCT01147900|58601939|FG002|At Year 10|Lost to Follow-up|0|||
30589530|NCT01147744|58601954|FG000|Overall Study|Protocol Violation|1|||
30589531|NCT01147744|58601955|FG001|Overall Study|Protocol Violation|0|||
30673107|NCT00570778|58687072|FG000|Overall Study|Protocol deviation|2|||
30673108|NCT00570778|58687073|FG001|Overall Study|Protocol deviation|1|||
30673109|NCT00570778|58687074|FG002|Overall Study|Protocol deviation|2|||
30673110|NCT00570778|58687075|FG003|Overall Study|Protocol deviation|2|||
30673111|NCT00570778|58687072|FG000|Overall Study|Adverse Event|0|||
30673112|NCT00570778|58687073|FG001|Overall Study|Adverse Event|1|||
30958969|NCT01587703|59024024|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30958970|NCT01587703|59024025|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30958971|NCT01587703|59024026|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30958972|NCT01587703|59024027|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30589532|NCT01147744|58601956|FG002|Overall Study|Protocol Violation|1|||
30589533|NCT01147744|58601957|FG003|Overall Study|Protocol Violation|0|||
30589534|NCT01147744|58601958|FG004|Overall Study|Protocol Violation|1|||
30589535|NCT01147744|58601959|FG005|Overall Study|Protocol Violation|3|||
30589536|NCT01147744|58601960|FG006|Overall Study|Protocol Violation|1|||
30589537|NCT01147744|58601954|FG000|Overall Study|Physician Decision|0|||
30589538|NCT01147744|58601955|FG001|Overall Study|Physician Decision|1|||
30589539|NCT01147744|58601956|FG002|Overall Study|Physician Decision|1|||
30589540|NCT01147744|58601957|FG003|Overall Study|Physician Decision|0|||
30589541|NCT01147744|58601958|FG004|Overall Study|Physician Decision|0|||
30589542|NCT01147744|58601959|FG005|Overall Study|Physician Decision|0|||
30589543|NCT01147744|58601960|FG006|Overall Study|Physician Decision|1|||
30589544|NCT01147744|58601954|FG000|Overall Study|Lack of Efficacy|11|||
30589545|NCT01147744|58601955|FG001|Overall Study|Lack of Efficacy|11|||
30589546|NCT01147744|58601956|FG002|Overall Study|Lack of Efficacy|9|||
30589547|NCT01147744|58601957|FG003|Overall Study|Lack of Efficacy|11|||
30589548|NCT01147744|58601958|FG004|Overall Study|Lack of Efficacy|13|||
30589549|NCT01147744|58601959|FG005|Overall Study|Lack of Efficacy|8|||
30589550|NCT01147744|58601960|FG006|Overall Study|Lack of Efficacy|7|||
30589551|NCT01147744|58601954|FG000|Overall Study|Adverse Event|1|||
30589552|NCT01147744|58601955|FG001|Overall Study|Adverse Event|2|||
30673113|NCT00570778|58687074|FG002|Overall Study|Adverse Event|4|||
30673114|NCT00570778|58687075|FG003|Overall Study|Adverse Event|1|||
30589553|NCT01147744|58601956|FG002|Overall Study|Adverse Event|3|||
30673115|NCT00570778|58687072|FG000|Overall Study|Subject withdrew consent|0|||
30589554|NCT01147744|58601957|FG003|Overall Study|Adverse Event|0|||
30589555|NCT01147744|58601958|FG004|Overall Study|Adverse Event|2|||
30589556|NCT01147744|58601959|FG005|Overall Study|Adverse Event|1|||
30589557|NCT01147744|58601960|FG006|Overall Study|Adverse Event|2|||
30589558|NCT01147744|58601954|FG000|Overall Study|Withdrawal by Subject|8|||
30589559|NCT01147744|58601955|FG001|Overall Study|Withdrawal by Subject|4|||
30589560|NCT01147744|58601956|FG002|Overall Study|Withdrawal by Subject|2|||
30589561|NCT01147744|58601957|FG003|Overall Study|Withdrawal by Subject|2|||
30589562|NCT01147744|58601958|FG004|Overall Study|Withdrawal by Subject|2|||
30589563|NCT01147744|58601959|FG005|Overall Study|Withdrawal by Subject|5|||
30589564|NCT01147744|58601960|FG006|Overall Study|Withdrawal by Subject|2|||
30589565|NCT01147744|58601954|FG000|Overall Study|Lost to Follow-up|0|||
30589566|NCT01147744|58601955|FG001|Overall Study|Lost to Follow-up|1|||
30589567|NCT01147744|58601956|FG002|Overall Study|Lost to Follow-up|0|||
30589568|NCT01147744|58601957|FG003|Overall Study|Lost to Follow-up|0|||
30589569|NCT01147744|58601958|FG004|Overall Study|Lost to Follow-up|0|||
30589570|NCT01147744|58601959|FG005|Overall Study|Lost to Follow-up|0|||
30673116|NCT00570778|58687073|FG001|Overall Study|Subject withdrew consent|1|||
30673117|NCT00570778|58687074|FG002|Overall Study|Subject withdrew consent|0|||
30673118|NCT00570778|58687075|FG003|Overall Study|Subject withdrew consent|1|||
30673119|NCT00570778|58687072|FG000|Overall Study|Abnormal test procedure|1|||
30673120|NCT00570778|58687073|FG001|Overall Study|Abnormal test procedure|0|||
30673121|NCT00570778|58687074|FG002|Overall Study|Abnormal test procedure|0|||
30673122|NCT00570778|58687075|FG003|Overall Study|Abnormal test procedure|0|||
30673123|NCT00570778|58687072|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30673124|NCT00570778|58687073|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30673125|NCT00570778|58687074|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
30673126|NCT00570778|58687075|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
30673127|NCT00570778|58687072|FG000|Overall Study|Lost to Follow-up|0|||
30673128|NCT00570778|58687073|FG001|Overall Study|Lost to Follow-up|0|||
30673129|NCT00570778|58687074|FG002|Overall Study|Lost to Follow-up|1|||
30589571|NCT01147744|58601960|FG006|Overall Study|Lost to Follow-up|0|||
30589572|NCT01147744|58601954|FG000|Overall Study|Sponsor decision to amend protocol|7|||
30589573|NCT01147744|58601955|FG001|Overall Study|Sponsor decision to amend protocol|4|||
30589574|NCT01147744|58601956|FG002|Overall Study|Sponsor decision to amend protocol|2|||
30589575|NCT01147744|58601957|FG003|Overall Study|Sponsor decision to amend protocol|5|||
30589576|NCT01147744|58601958|FG004|Overall Study|Sponsor decision to amend protocol|7|||
30589577|NCT01147744|58601959|FG005|Overall Study|Sponsor decision to amend protocol|2|||
30589578|NCT01147744|58601960|FG006|Overall Study|Sponsor decision to amend protocol|6|||
30589579|NCT01147744|58601954|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
30589580|NCT01147744|58601955|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
30589581|NCT01147744|58601956|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
30589582|NCT01147744|58601957|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
30589583|NCT01147744|58601958|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
30589584|NCT01147744|58601959|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
30589585|NCT01147744|58601960|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
30589586|NCT01147471|58601984|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
30589587|NCT01147471|58601985|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
30589588|NCT01147471|58601984|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
30589589|NCT01147471|58601985|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
30589590|NCT01147471|58601984|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
30589591|NCT01147471|58601985|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
30589592|NCT01147471|58601984|FG000|3 Month Follow Up|Lost to Follow-up|1|||
30589593|NCT01147471|58601985|FG001|3 Month Follow Up|Lost to Follow-up|1|||
30589594|NCT01147471|58601984|FG000|3 Month Follow Up|Physician Decision|0|||
30589595|NCT01147471|58601985|FG001|3 Month Follow Up|Physician Decision|1|||
30589596|NCT01147471|58601984|FG000|6 Month Follow Up|Lost to Follow-up|4|||
30589597|NCT01147471|58601985|FG001|6 Month Follow Up|Lost to Follow-up|2|||
30589598|NCT01147393|58601991|FG000|Dose Level 1|Dose limiting Toxicity|2|||
30589599|NCT01147393|58601991|FG000|Dose Level -1|Dose Limited Toxicity|1|||
30589600|NCT01146652|58601998|FG000|Overall Study|Adverse Event|506|||
30589601|NCT01146652|58601999|FG001|Overall Study|Adverse Event|15|||
30958973|NCT01587703|59024028|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30589602|NCT01146652|58601998|FG000|Overall Study|Lack of Efficacy|91|||
30589603|NCT01146652|58601999|FG001|Overall Study|Lack of Efficacy|7|||
30589604|NCT01146652|58601998|FG000|Overall Study|Poor compliance to protocol|38|||
30589605|NCT01146652|58601999|FG001|Overall Study|Poor compliance to protocol|1|||
30589606|NCT01146652|58601998|FG000|Overall Study|Other unspecified reasons|314|||
30589607|NCT01146652|58601999|FG001|Overall Study|Other unspecified reasons|22|||
30589608|NCT01146652|58601998|FG000|Overall Study|Enrolled but not treated|2|||
30673130|NCT00570778|58687075|FG003|Overall Study|Lost to Follow-up|0|||
30673131|NCT00570778|58687072|FG000|Overall Study|Subject no longer requires study drug|0|||
30673132|NCT00570778|58687073|FG001|Overall Study|Subject no longer requires study drug|1|||
30958974|NCT01587703|59024029|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30589609|NCT01146652|58601999|FG001|Overall Study|Enrolled but not treated|0|||
30589610|NCT01146613|58602014|FG000|Overall Study|Lost to Follow-up|3|||
30589611|NCT01146613|58602015|FG001|Overall Study|Lost to Follow-up|8|||
30589612|NCT01146613|58602014|FG000|Overall Study|Lack of Efficacy|0|||
30589613|NCT01146613|58602015|FG001|Overall Study|Lack of Efficacy|1|||
30589614|NCT01146613|58602014|FG000|Overall Study|Death|1|||
30589615|NCT01146613|58602015|FG001|Overall Study|Death|0|||
30589616|NCT01146613|58602014|FG000|Overall Study|Physician Decision|1|||
30589617|NCT01146613|58602015|FG001|Overall Study|Physician Decision|0|||
30589618|NCT01146613|58602014|FG000|Overall Study|Withdrawal by Subject|0|||
30589619|NCT01146613|58602015|FG001|Overall Study|Withdrawal by Subject|3|||
30589620|NCT01146613|58602014|FG000|Overall Study|schedule conflict|1|||
30589621|NCT01146613|58602015|FG001|Overall Study|schedule conflict|0|||
30589622|NCT01146613|58602014|FG000|Overall Study|Outpatient detox|1|||
30589623|NCT01146613|58602015|FG001|Overall Study|Outpatient detox|0|||
30589624|NCT01145755|58602024|FG000|Overall Study|Adverse Event|2|||
30589625|NCT01145755|58602025|FG001|Overall Study|Adverse Event|4|||
30589626|NCT01145755|58602026|FG002|Overall Study|Adverse Event|2|||
30589627|NCT01145755|58602024|FG000|Overall Study|Withdrawal by Subject|2|||
30673133|NCT00570778|58687074|FG002|Overall Study|Subject no longer requires study drug|0|||
30673134|NCT00570778|58687075|FG003|Overall Study|Subject no longer requires study drug|0|||
30673135|NCT00668746|58687087|FG000|Overall Study|Lost to Follow-up|2|||
30673136|NCT00668746|58687088|FG001|Overall Study|Lost to Follow-up|1|||
30673137|NCT00878189|58687106|FG000|Overall Study|Death|0|||
30673138|NCT00878189|58687107|FG001|Overall Study|Death|1|||
30589628|NCT01145755|58602025|FG001|Overall Study|Withdrawal by Subject|2|||
30673139|NCT00878189|58687108|FG002|Overall Study|Death|0|||
30673140|NCT00878189|58687109|FG003|Overall Study|Death|1|||
30673141|NCT00878189|58687110|FG004|Overall Study|Death|0|||
30673142|NCT00878189|58687111|FG005|Overall Study|Death|0|||
30673143|NCT00878189|58687112|FG006|Overall Study|Death|0|||
30673144|NCT00878189|58687113|FG007|Overall Study|Death|0|||
30673145|NCT00878189|58687114|FG008|Overall Study|Death|1|||
30673146|NCT00878189|58687106|FG000|Overall Study|Participant Refused to Follow-up|0|||
30673147|NCT00878189|58687107|FG001|Overall Study|Participant Refused to Follow-up|0|||
30673148|NCT00878189|58687108|FG002|Overall Study|Participant Refused to Follow-up|0|||
30673149|NCT00878189|58687109|FG003|Overall Study|Participant Refused to Follow-up|0|||
30781412|NCT02963506|58793452|FG008|Dose-Blind Period|Lack of Efficacy|0|||
30781413|NCT02963506|58793453|FG009|Dose-Blind Period|Lack of Efficacy|1|||
30958975|NCT01587703|59024030|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30589629|NCT01145755|58602026|FG002|Overall Study|Withdrawal by Subject|2|||
30589630|NCT01145755|58602024|FG000|Overall Study|Lost to Follow-up|2|||
30589631|NCT01145755|58602025|FG001|Overall Study|Lost to Follow-up|3|||
30589632|NCT01145755|58602026|FG002|Overall Study|Lost to Follow-up|1|||
30589633|NCT01145755|58602024|FG000|Overall Study|Protocol Violation|0|||
30589634|NCT01145755|58602025|FG001|Overall Study|Protocol Violation|3|||
30589635|NCT01145755|58602026|FG002|Overall Study|Protocol Violation|1|||
30589636|NCT01145755|58602024|FG000|Overall Study|Study Closure|14|||
30589637|NCT01145755|58602025|FG001|Overall Study|Study Closure|14|||
30589638|NCT01145755|58602026|FG002|Overall Study|Study Closure|17|||
30589639|NCT01145755|58602024|FG000|Overall Study|Lack of Efficacy|0|||
30589640|NCT01145755|58602025|FG001|Overall Study|Lack of Efficacy|1|||
30589641|NCT01145755|58602026|FG002|Overall Study|Lack of Efficacy|0|||
30589642|NCT01145755|58602024|FG000|Overall Study|Patient could not swollow medication|0|||
30589643|NCT01145755|58602025|FG001|Overall Study|Patient could not swollow medication|0|||
30589644|NCT01145755|58602026|FG002|Overall Study|Patient could not swollow medication|1|||
30589645|NCT01145755|58602024|FG000|Overall Study|Withdrawal by Subject|0|||
30589646|NCT01145755|58602025|FG001|Overall Study|Withdrawal by Subject|0|||
30589647|NCT01145755|58602026|FG002|Overall Study|Withdrawal by Subject|1|||
30589648|NCT01145755|58602024|FG000|Overall Study|Positive urine ethanol|0|||
30589649|NCT01145755|58602025|FG001|Overall Study|Positive urine ethanol|1|||
30589650|NCT01145755|58602026|FG002|Overall Study|Positive urine ethanol|0|||
30589651|NCT01145560|58602037|FG000|Overall Study|Withdrawal by Subject|2|||
30589652|NCT01145560|58602038|FG001|Overall Study|Withdrawal by Subject|1|||
30589653|NCT01145560|58602039|FG002|Overall Study|Withdrawal by Subject|0|||
30589654|NCT01145560|58602037|FG000|Overall Study|Lost to Follow-up|1|||
30673150|NCT00878189|58687110|FG004|Overall Study|Participant Refused to Follow-up|0|||
30673151|NCT00878189|58687111|FG005|Overall Study|Participant Refused to Follow-up|4|||
30673152|NCT00878189|58687112|FG006|Overall Study|Participant Refused to Follow-up|0|||
30781414|NCT02963506|58793454|FG010|Dose-Blind Period|Lack of Efficacy|0|||
30589655|NCT01145560|58602038|FG001|Overall Study|Lost to Follow-up|1|||
30589656|NCT01145560|58602039|FG002|Overall Study|Lost to Follow-up|1|||
30589657|NCT01145560|58602037|FG000|Overall Study|No study drug by 24h after organ failure|1|||
30589658|NCT01145560|58602038|FG001|Overall Study|No study drug by 24h after organ failure|0|||
30673153|NCT00878189|58687113|FG007|Overall Study|Participant Refused to Follow-up|0|||
30673154|NCT00878189|58687114|FG008|Overall Study|Participant Refused to Follow-up|0|||
30589659|NCT01145560|58602039|FG002|Overall Study|No study drug by 24h after organ failure|0|||
30673155|NCT00878189|58687106|FG000|Overall Study|Other|3|||
30589660|NCT01145560|58602037|FG000|Overall Study|Accidental unblinding of study treatment|0|||
30589661|NCT01145560|58602038|FG001|Overall Study|Accidental unblinding of study treatment|1|||
30589662|NCT01145560|58602039|FG002|Overall Study|Accidental unblinding of study treatment|0|||
30589663|NCT01145560|58602037|FG000|Overall Study|False insurance information|0|||
30589664|NCT01145560|58602038|FG001|Overall Study|False insurance information|1|||
30589665|NCT01145560|58602039|FG002|Overall Study|False insurance information|0|||
30589666|NCT01145560|58602037|FG000|Overall Study|Withdrawal of therapy|0|||
30589667|NCT01145560|58602038|FG001|Overall Study|Withdrawal of therapy|0|||
30589668|NCT01145560|58602039|FG002|Overall Study|Withdrawal of therapy|1|||
30589669|NCT01145482|58602049|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
30589670|NCT01145482|58602050|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
30589671|NCT01145053|58602056|FG000|Overall Study|Adverse Event|22|||
30589672|NCT01145053|58602056|FG000|Overall Study|Lost to Follow-up|28|||
30589673|NCT01145053|58602056|FG000|Overall Study|Withdrawal by Subject|25|||
30589674|NCT01145053|58602056|FG000|Overall Study|Other|18|||
30589675|NCT01144663|58602064|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
30589676|NCT01144663|58602065|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
30673156|NCT00878189|58687107|FG001|Overall Study|Other|2|||
30673157|NCT00878189|58687108|FG002|Overall Study|Other|4|||
30673158|NCT00878189|58687109|FG003|Overall Study|Other|7|||
30673159|NCT00878189|58687110|FG004|Overall Study|Other|4|||
30673160|NCT00878189|58687111|FG005|Overall Study|Other|18|||
30673161|NCT00878189|58687112|FG006|Overall Study|Other|15|||
30673162|NCT00878189|58687113|FG007|Overall Study|Other|3|||
30673163|NCT00878189|58687114|FG008|Overall Study|Other|4|||
30589677|NCT01144663|58602066|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
30589678|NCT01144663|58602067|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
30589679|NCT01144663|58602064|FG000|Primary Vaccination Phase|Adverse Event|1|||
30589680|NCT01144663|58602065|FG001|Primary Vaccination Phase|Adverse Event|0|||
30589681|NCT01144663|58602066|FG002|Primary Vaccination Phase|Adverse Event|0|||
30589682|NCT01144663|58602067|FG003|Primary Vaccination Phase|Adverse Event|1|||
30589683|NCT01144663|58602064|FG000|Primary Vaccination Phase|Protocol Violation|2|||
30589684|NCT01144663|58602065|FG001|Primary Vaccination Phase|Protocol Violation|0|||
30589685|NCT01144663|58602066|FG002|Primary Vaccination Phase|Protocol Violation|1|||
30589686|NCT01144663|58602067|FG003|Primary Vaccination Phase|Protocol Violation|0|||
30589687|NCT01144663|58602064|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
30589688|NCT01144663|58602065|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
30589689|NCT01144663|58602066|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
30589690|NCT01144663|58602067|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
30589691|NCT01144663|58602064|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
30589692|NCT01144663|58602065|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
30589693|NCT01144663|58602066|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
30589694|NCT01144663|58602067|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
30589695|NCT01144663|58602064|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
30589696|NCT01144663|58602065|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
30589697|NCT01144663|58602066|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
30589698|NCT01144663|58602067|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
30589699|NCT01144663|58602064|FG000|Primary Vaccination Phase|Other|0|||
30589700|NCT01144663|58602065|FG001|Primary Vaccination Phase|Other|1|||
30589701|NCT01144663|58602066|FG002|Primary Vaccination Phase|Other|0|||
30589702|NCT01144663|58602067|FG003|Primary Vaccination Phase|Other|2|||
30589703|NCT01144663|58602064|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
30589704|NCT01144663|58602065|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
30589705|NCT01144663|58602066|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
30589706|NCT01144663|58602067|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
30589707|NCT01144663|58602064|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
30589708|NCT01144663|58602065|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
30589709|NCT01144663|58602066|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
30589710|NCT01144663|58602067|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
30673164|NCT00878189|58687106|FG000|Overall Study|Lost to Follow-up|0|||
30673165|NCT00878189|58687107|FG001|Overall Study|Lost to Follow-up|0|||
30589711|NCT01144663|58602064|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
30589712|NCT01144663|58602065|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
30589713|NCT01144663|58602066|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
30589714|NCT01144663|58602067|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
30673166|NCT00878189|58687108|FG002|Overall Study|Lost to Follow-up|0|||
30673167|NCT00878189|58687109|FG003|Overall Study|Lost to Follow-up|0|||
30589715|NCT01144663|58602064|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
30673168|NCT00878189|58687110|FG004|Overall Study|Lost to Follow-up|0|||
30673169|NCT00878189|58687111|FG005|Overall Study|Lost to Follow-up|1|||
30673170|NCT00878189|58687112|FG006|Overall Study|Lost to Follow-up|1|||
30673171|NCT00878189|58687113|FG007|Overall Study|Lost to Follow-up|0|||
30673172|NCT00878189|58687114|FG008|Overall Study|Lost to Follow-up|0|||
30589716|NCT01144663|58602065|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
30589717|NCT01144663|58602066|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
30589718|NCT01144663|58602067|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
30589719|NCT01144663|58602064|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
30589720|NCT01144663|58602065|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
30673173|NCT00878189|58687106|FG000|Overall Study|Objection Progression or Relapse|0|||
30673174|NCT00878189|58687107|FG001|Overall Study|Objection Progression or Relapse|0|||
30589721|NCT01144663|58602066|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
30673175|NCT00878189|58687108|FG002|Overall Study|Objection Progression or Relapse|0|||
30673176|NCT00878189|58687109|FG003|Overall Study|Objection Progression or Relapse|0|||
30673177|NCT00878189|58687110|FG004|Overall Study|Objection Progression or Relapse|0|||
30673178|NCT00878189|58687111|FG005|Overall Study|Objection Progression or Relapse|0|||
30589722|NCT01144663|58602067|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
30589723|NCT01144663|58602064|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
30589724|NCT01144663|58602065|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
30589725|NCT01144663|58602066|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
30589726|NCT01144663|58602067|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
30589727|NCT01143337|58602079|FG000|Overall Study|Adverse Event|3|||
30673179|NCT00878189|58687112|FG006|Overall Study|Objection Progression or Relapse|0|||
30673180|NCT00878189|58687113|FG007|Overall Study|Objection Progression or Relapse|0|||
30673181|NCT00878189|58687114|FG008|Overall Study|Objection Progression or Relapse|3|||
30673182|NCT00668200|58687148|FG000|Overall Study|Withdrawal by Subject|2|||
30673183|NCT00668200|58687148|FG000|Overall Study|Lost to Follow-up|1|||
30673184|NCT00838578|58687152|FG000|Overall Study|Protocol Violation|2|||
30673185|NCT00829296|58687162|FG000|Overall Study|Adverse Event|5|||
30673186|NCT00829296|58687163|FG001|Overall Study|Adverse Event|4|||
30673187|NCT00881621|58687169|FG000|Overall Study|Physician Decision|34|||
30673188|NCT00818766|58687175|FG000|Overall Study|Could not be Contacted on Day 28|11|||
30673189|NCT00818766|58687176|FG001|Overall Study|Could not be Contacted on Day 28|10|||
30673190|NCT00818766|58687175|FG000|Overall Study|Death|1|||
30589728|NCT01143337|58602080|FG001|Overall Study|Adverse Event|9|||
30589729|NCT01143337|58602081|FG002|Overall Study|Adverse Event|5|||
30589730|NCT01143337|58602079|FG000|Overall Study|Lack of Efficacy|6|||
30589731|NCT01143337|58602080|FG001|Overall Study|Lack of Efficacy|2|||
30589732|NCT01143337|58602081|FG002|Overall Study|Lack of Efficacy|1|||
30589733|NCT01143337|58602079|FG000|Overall Study|Protocol Violation|1|||
30589734|NCT01143337|58602080|FG001|Overall Study|Protocol Violation|0|||
30589735|NCT01143337|58602081|FG002|Overall Study|Protocol Violation|0|||
30589736|NCT01143337|58602079|FG000|Overall Study|Withdrawal by Subject|0|||
30589737|NCT01143337|58602080|FG001|Overall Study|Withdrawal by Subject|0|||
30589738|NCT01143337|58602081|FG002|Overall Study|Withdrawal by Subject|1|||
30589739|NCT01143337|58602079|FG000|Overall Study|Other reason|0|||
30589740|NCT01143337|58602080|FG001|Overall Study|Other reason|0|||
30589741|NCT01143337|58602081|FG002|Overall Study|Other reason|5|||
30589742|NCT01143259|58602098|FG000|Overall Study|Withdrawal by Subject|3|||
30589743|NCT01143259|58602099|FG001|Overall Study|Withdrawal by Subject|2|||
30589744|NCT01143259|58602098|FG000|Overall Study|Protocol Violation|13|||
30589745|NCT01143259|58602099|FG001|Overall Study|Protocol Violation|9|||
30589746|NCT01143259|58602098|FG000|Overall Study|Screen Failure|7|||
30589747|NCT01143259|58602099|FG001|Overall Study|Screen Failure|9|||
30589748|NCT01142791|58602105|FG000|Overall Study|Alternative Treatment|1|||
30589749|NCT01142791|58602106|FG001|Overall Study|Alternative Treatment|0|||
30589750|NCT01142791|58602105|FG000|Overall Study|Lost to Follow-up|1|||
30589751|NCT01142791|58602106|FG001|Overall Study|Lost to Follow-up|0|||
30589752|NCT01142791|58602105|FG000|Overall Study|Withdrawal by Subject|5|||
30589753|NCT01142791|58602106|FG001|Overall Study|Withdrawal by Subject|0|||
30589754|NCT01142791|58602105|FG000|Overall Study|Received only 1 sonication|0|||
30589755|NCT01142791|58602106|FG001|Overall Study|Received only 1 sonication|6|||
30589756|NCT01142596|58602112|FG000|Overall Study|Withdrawal by Subject|9|||
30589757|NCT01142596|58602113|FG001|Overall Study|Withdrawal by Subject|35|||
30589758|NCT01142596|58602112|FG000|Overall Study|Adverse Event|8|||
30589759|NCT01142596|58602113|FG001|Overall Study|Adverse Event|35|||
30589760|NCT01142596|58602112|FG000|Overall Study|Lack of Efficacy|5|||
30589761|NCT01142596|58602113|FG001|Overall Study|Lack of Efficacy|9|||
30589762|NCT01142596|58602112|FG000|Overall Study|Lost to Follow-up|2|||
30673191|NCT00818766|58687176|FG001|Overall Study|Death|0|||
30673192|NCT00818766|58687175|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
30781415|NCT02963506|58793455|FG011|Dose-Blind Period|Lack of Efficacy|0|||
30781416|NCT02963506|58793456|FG012|Dose-Blind Period|Lack of Efficacy|0|||
30589763|NCT01142596|58602113|FG001|Overall Study|Lost to Follow-up|3|||
30589764|NCT01142596|58602112|FG000|Overall Study|Other reason (not specified)|5|||
30589765|NCT01142596|58602113|FG001|Overall Study|Other reason (not specified)|4|||
30589766|NCT01142128|58602123|FG000|Overall Study|Physician Decision|1|||
30589767|NCT01142128|58602123|FG000|Overall Study|Lost to Follow-up|1|||
30673193|NCT00818766|58687176|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
30589768|NCT01142128|58602123|FG000|Overall Study|Withdrawal by Subject|2|||
30589769|NCT01142089|58602135|FG000|Overall Study|Physician Decision|1|||
30589770|NCT01142089|58602136|FG001|Overall Study|Physician Decision|0|||
30589771|NCT01142089|58602135|FG000|Overall Study|Withdrawal by Subject|1|||
30589772|NCT01142089|58602136|FG001|Overall Study|Withdrawal by Subject|2|||
30589773|NCT01142089|58602135|FG000|Overall Study|Use of prohibited medications|0|||
30673194|NCT00667888|58687184|FG000|Overall Study|Death|1|||
30673195|NCT00667888|58687185|FG001|Overall Study|Death|1|||
30673196|NCT00667888|58687184|FG000|Overall Study|Withdrawal by Subject|6|||
30673197|NCT00667888|58687185|FG001|Overall Study|Withdrawal by Subject|3|||
30673198|NCT00667888|58687184|FG000|Overall Study|Proceed with other treatment|3|||
30673199|NCT00667888|58687185|FG001|Overall Study|Proceed with other treatment|3|||
30673200|NCT00667888|58687184|FG000|Overall Study|Ineligible after SIM|0|||
30673201|NCT00667888|58687185|FG001|Overall Study|Ineligible after SIM|2|||
30673202|NCT00594815|58687191|FG000|Overall Study|Never Treated|3|||
30673203|NCT00594815|58687191|FG000|Overall Study|Withdrawal by Subject|2|||
30673204|NCT00594815|58687191|FG000|Overall Study|Toxicity|4|||
30673205|NCT00820170|58687200|FG000|Overall Study|Adverse Event|0|||
30673206|NCT00820170|58687201|FG001|Overall Study|Adverse Event|0|||
30673207|NCT00820170|58687202|FG002|Overall Study|Adverse Event|0|||
30673208|NCT00820170|58687203|FG003|Overall Study|Adverse Event|0|||
30673209|NCT00820170|58687204|FG004|Overall Study|Adverse Event|2|||
30673210|NCT00820170|58687200|FG000|Overall Study|Progressive Disease|0|||
30673211|NCT00820170|58687201|FG001|Overall Study|Progressive Disease|0|||
30673212|NCT00820170|58687202|FG002|Overall Study|Progressive Disease|0|||
30673213|NCT00820170|58687203|FG003|Overall Study|Progressive Disease|0|||
30673214|NCT00820170|58687204|FG004|Overall Study|Progressive Disease|2|||
30673215|NCT00818454|58687221|FG000|Treatment Period 1|Adverse Event|0|||
30673216|NCT00818454|58687222|FG001|Treatment Period 1|Adverse Event|1|||
30673217|NCT00818454|58687223|FG002|Treatment Period 1|Adverse Event|0|||
30673218|NCT00818454|58687224|FG003|Treatment Period 1|Adverse Event|0|||
30673219|NCT00818454|58687221|FG000|Treatment Period 1|Other|3|||
30673220|NCT00818454|58687222|FG001|Treatment Period 1|Other|0|||
30673221|NCT00818454|58687223|FG002|Treatment Period 1|Other|0|||
30673222|NCT00818454|58687224|FG003|Treatment Period 1|Other|0|||
30673223|NCT00818454|58687221|FG000|Washout Period of 1 Week|Adverse Event|1|||
30673224|NCT00818454|58687222|FG001|Washout Period of 1 Week|Adverse Event|1|||
30781417|NCT02963506|58793444|FG000|Dose-Blind Period|Lost to Follow-up|0|||
30781418|NCT02963506|58793445|FG001|Dose-Blind Period|Lost to Follow-up|0|||
30781419|NCT02963506|58793446|FG002|Dose-Blind Period|Lost to Follow-up|0|||
30781420|NCT02963506|58793447|FG003|Dose-Blind Period|Lost to Follow-up|0|||
30781421|NCT02963506|58793448|FG004|Dose-Blind Period|Lost to Follow-up|0|||
30781422|NCT02963506|58793449|FG005|Dose-Blind Period|Lost to Follow-up|1|||
30781423|NCT02963506|58793450|FG006|Dose-Blind Period|Lost to Follow-up|0|||
30781424|NCT02963506|58793451|FG007|Dose-Blind Period|Lost to Follow-up|0|||
30781425|NCT02963506|58793452|FG008|Dose-Blind Period|Lost to Follow-up|1|||
30781426|NCT02963506|58793453|FG009|Dose-Blind Period|Lost to Follow-up|0|||
30781427|NCT02963506|58793454|FG010|Dose-Blind Period|Lost to Follow-up|0|||
30781428|NCT02963506|58793455|FG011|Dose-Blind Period|Lost to Follow-up|1|||
30877158|NCT00579826|58908821|FG000|Overall Study|Withdrawal by Subject|5|||
30877159|NCT00579826|58908822|FG001|Overall Study|Withdrawal by Subject|3|||
30958976|NCT01587703|59024031|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30958977|NCT01587703|59024032|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30958978|NCT01587703|59024033|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30589774|NCT01142089|58602136|FG001|Overall Study|Use of prohibited medications|1|||
30589775|NCT01142089|58602135|FG000|Overall Study|Noncompliance with study procedures|2|||
30589776|NCT01142089|58602136|FG001|Overall Study|Noncompliance with study procedures|1|||
30589777|NCT01142089|58602135|FG000|Overall Study|Patient required rescue medication|8|||
30589778|NCT01142089|58602136|FG001|Overall Study|Patient required rescue medication|17|||
30589779|NCT01141660|58602144|FG000|Overall Study|Physician Decision|0|||
30589780|NCT01141660|58602145|FG001|Overall Study|Physician Decision|12|||
30589781|NCT01140880|58602153|FG000|Overall Study|Death|0|||
30589782|NCT01140880|58602154|FG001|Overall Study|Death|1|||
30589783|NCT01140880|58602153|FG000|Overall Study|Withdrawal by Subject|6|||
30589784|NCT01140880|58602154|FG001|Overall Study|Withdrawal by Subject|3|||
30589785|NCT01140880|58602153|FG000|Overall Study|Lost to Follow-up|8|||
30589786|NCT01140880|58602154|FG001|Overall Study|Lost to Follow-up|10|||
30589787|NCT01140880|58602153|FG000|Overall Study|Protocol Violation|0|||
30589788|NCT01140880|58602154|FG001|Overall Study|Protocol Violation|30|||
30589789|NCT01140646|58602160|FG000|Overall Study|Adverse Event|4|||
30589790|NCT01140646|58602160|FG000|Overall Study|Refused Further Treatment|5|||
30589791|NCT01140568|58602164|FG000|Overall Study|disease progression|31|||
30589792|NCT01140568|58602164|FG000|Overall Study|Withdrawal by Subject|1|||
30589793|NCT01140568|58602164|FG000|Overall Study|Screen Fail|4|||
30589794|NCT01140451|58602170|FG000|Overall Study|Withdrawal by Subject|26|||
30589795|NCT01140451|58602171|FG001|Overall Study|Withdrawal by Subject|33|||
30589796|NCT01140451|58602170|FG000|Overall Study|Adverse Event|2|||
30673225|NCT00818454|58687223|FG002|Washout Period of 1 Week|Adverse Event|0|||
30673226|NCT00818454|58687224|FG003|Washout Period of 1 Week|Adverse Event|0|||
30673227|NCT00818454|58687221|FG000|Washout Period of 1 Week|Protocol Violation|2|||
30958979|NCT01587703|59024034|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30958980|NCT01587703|59024035|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30958981|NCT01587703|59024036|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30958982|NCT01587703|59024037|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30958983|NCT01587703|59024038|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
30673228|NCT00818454|58687222|FG001|Washout Period of 1 Week|Protocol Violation|0|||
30673229|NCT00818454|58687223|FG002|Washout Period of 1 Week|Protocol Violation|0|||
30673230|NCT00818454|58687224|FG003|Washout Period of 1 Week|Protocol Violation|0|||
30673231|NCT00818454|58687221|FG000|Washout Period of 1 Week|Other|1|||
30673232|NCT00818454|58687222|FG001|Washout Period of 1 Week|Other|2|||
30673233|NCT00818454|58687223|FG002|Washout Period of 1 Week|Other|0|||
30673234|NCT00818454|58687224|FG003|Washout Period of 1 Week|Other|0|||
30673235|NCT00818454|58687221|FG000|Treatment Period 2|Other|2|||
30781429|NCT02963506|58793456|FG012|Dose-Blind Period|Lost to Follow-up|0|||
30781430|NCT02963506|58793444|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
30781431|NCT02963506|58793445|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
30781432|NCT02963506|58793446|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
30781433|NCT02963506|58793447|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
30781434|NCT02963506|58793448|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
30781435|NCT02963506|58793449|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
30781436|NCT02963506|58793450|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
30781437|NCT02963506|58793451|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
30781438|NCT02963506|58793452|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
30781439|NCT02963506|58793453|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
30781440|NCT02963506|58793454|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
30781441|NCT02963506|58793455|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
30781442|NCT02963506|58793456|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
30781443|NCT02963506|58793444|FG000|Dose-Blind Period|Sponsor decision|0|||
30781444|NCT02963506|58793445|FG001|Dose-Blind Period|Sponsor decision|0|||
30781445|NCT02963506|58793446|FG002|Dose-Blind Period|Sponsor decision|0|||
30781446|NCT02963506|58793447|FG003|Dose-Blind Period|Sponsor decision|0|||
30781447|NCT02963506|58793448|FG004|Dose-Blind Period|Sponsor decision|0|||
30781448|NCT02963506|58793449|FG005|Dose-Blind Period|Sponsor decision|1|||
30781449|NCT02963506|58793450|FG006|Dose-Blind Period|Sponsor decision|0|||
30781450|NCT02963506|58793451|FG007|Dose-Blind Period|Sponsor decision|0|||
30781451|NCT02963506|58793452|FG008|Dose-Blind Period|Sponsor decision|0|||
30781452|NCT02963506|58793453|FG009|Dose-Blind Period|Sponsor decision|0|||
30781453|NCT02963506|58793454|FG010|Dose-Blind Period|Sponsor decision|0|||
30781454|NCT02963506|58793455|FG011|Dose-Blind Period|Sponsor decision|0|||
30781455|NCT02963506|58793456|FG012|Dose-Blind Period|Sponsor decision|0|||
30781456|NCT02963506|58793444|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781457|NCT02963506|58793445|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781458|NCT02963506|58793446|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781459|NCT02963506|58793447|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781460|NCT02963506|58793448|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781461|NCT02963506|58793449|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781462|NCT02963506|58793450|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781463|NCT02963506|58793451|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781464|NCT02963506|58793452|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781465|NCT02963506|58793453|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781466|NCT02963506|58793454|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781467|NCT02963506|58793455|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
30781468|NCT02963506|58793456|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
30589797|NCT01140451|58602171|FG001|Overall Study|Adverse Event|6|||
30589798|NCT01140451|58602170|FG000|Overall Study|Physician Decision|5|||
30589799|NCT01140451|58602171|FG001|Overall Study|Physician Decision|3|||
30589800|NCT01140451|58602170|FG000|Overall Study|Lost to Follow-up|2|||
30589801|NCT01140451|58602171|FG001|Overall Study|Lost to Follow-up|0|||
30589802|NCT01140451|58602170|FG000|Overall Study|Participants Planning Pregnancy|3|||
30589803|NCT01140451|58602171|FG001|Overall Study|Participants Planning Pregnancy|0|||
30589804|NCT01140061|58602188|FG000|Part I|Adverse Event|1|||
30589805|NCT01140061|58602189|FG001|Part I|Adverse Event|0|||
30589806|NCT01140061|58602190|FG002|Part I|Adverse Event|0|||
30589807|NCT01140061|58602191|FG003|Part I|Adverse Event|0|||
30673236|NCT00818454|58687222|FG001|Treatment Period 2|Other|1|||
30781469|NCT01345162|58793475|FG000|Overall Study|Protocol Violation|2|||
30781470|NCT01345162|58793476|FG001|Overall Study|Protocol Violation|4|||
30781471|NCT01345318|58793482|FG000|Overall Study|Adverse Event|16|||
30781472|NCT01345318|58793482|FG000|Overall Study|Lack of Efficacy|17|||
30781473|NCT01345318|58793482|FG000|Overall Study|Lost to Follow-up|2|||
30781474|NCT01345318|58793482|FG000|Overall Study|Protocol Violation|1|||
30589808|NCT01140061|58602192|FG004|Part I|Adverse Event|0|||
30855838|NCT02760433|58883521|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
30855839|NCT02760433|58883522|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
30877160|NCT00106691|58908830|FG000|Overall Study|Adverse Event|60|||
30673237|NCT00818454|58687223|FG002|Treatment Period 2|Other|0|||
30673238|NCT00818454|58687224|FG003|Treatment Period 2|Other|0|||
30673239|NCT00818454|58687221|FG000|Treatment Period 3|Adverse Event|0|||
30673240|NCT00818454|58687222|FG001|Treatment Period 3|Adverse Event|0|||
30673241|NCT00818454|58687223|FG002|Treatment Period 3|Adverse Event|0|||
30673242|NCT00818454|58687224|FG003|Treatment Period 3|Adverse Event|1|||
30673243|NCT00828984|58687237|FG000|Overall Study|Adverse Event|2|||
30673244|NCT00828984|58687238|FG001|Overall Study|Adverse Event|3|||
30673245|NCT00828984|58687239|FG002|Overall Study|Adverse Event|0|||
30673246|NCT00828984|58687237|FG000|Overall Study|Lost to Follow-up|5|||
30673247|NCT00828984|58687238|FG001|Overall Study|Lost to Follow-up|3|||
30673248|NCT00828984|58687239|FG002|Overall Study|Lost to Follow-up|1|||
30673249|NCT00828984|58687237|FG000|Overall Study|Withdrawal by Subject|4|||
30673250|NCT00828984|58687238|FG001|Overall Study|Withdrawal by Subject|4|||
30673251|NCT00828984|58687239|FG002|Overall Study|Withdrawal by Subject|4|||
30673252|NCT00828984|58687237|FG000|Overall Study|Ineligable|1|||
30673253|NCT00828984|58687238|FG001|Overall Study|Ineligable|2|||
30673254|NCT00828984|58687239|FG002|Overall Study|Ineligable|0|||
30673255|NCT00828984|58687237|FG000|Overall Study|Medical Contraindication|0|||
30673256|NCT00828984|58687238|FG001|Overall Study|Medical Contraindication|1|||
30673257|NCT00828984|58687239|FG002|Overall Study|Medical Contraindication|0|||
30673258|NCT00828984|58687237|FG000|Overall Study|Noncompliant|1|||
30673259|NCT00828984|58687238|FG001|Overall Study|Noncompliant|2|||
30673260|NCT00828984|58687239|FG002|Overall Study|Noncompliant|3|||
30673261|NCT00828984|58687237|FG000|Overall Study|ConMed|1|||
30673262|NCT00828984|58687238|FG001|Overall Study|ConMed|1|||
30673263|NCT00828984|58687239|FG002|Overall Study|ConMed|1|||
30673264|NCT00828750|58687247|FG000|Overall Study|Lack of Efficacy|3|||
30673265|NCT00828750|58687247|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
30673266|NCT00667810|58687256|FG000|Overall Study|Adverse Event|13|||
30673267|NCT00667810|58687257|FG001|Overall Study|Adverse Event|14|||
30673268|NCT00667810|58687258|FG002|Overall Study|Adverse Event|19|||
30673269|NCT00667810|58687259|FG003|Overall Study|Adverse Event|1|||
30673270|NCT00667810|58687256|FG000|Overall Study|Death|1|||
30673271|NCT00667810|58687257|FG001|Overall Study|Death|1|||
30673272|NCT00667810|58687258|FG002|Overall Study|Death|3|||
30673273|NCT00667810|58687259|FG003|Overall Study|Death|0|||
30673274|NCT00667810|58687256|FG000|Overall Study|Lack of Efficacy|1|||
30673275|NCT00667810|58687257|FG001|Overall Study|Lack of Efficacy|0|||
30673276|NCT00667810|58687258|FG002|Overall Study|Lack of Efficacy|2|||
30673277|NCT00667810|58687259|FG003|Overall Study|Lack of Efficacy|0|||
30673278|NCT00667810|58687256|FG000|Overall Study|Lost to Follow-up|1|||
30673279|NCT00667810|58687257|FG001|Overall Study|Lost to Follow-up|4|||
30673280|NCT00667810|58687258|FG002|Overall Study|Lost to Follow-up|2|||
30673281|NCT00667810|58687259|FG003|Overall Study|Lost to Follow-up|0|||
30781475|NCT01345318|58793482|FG000|Overall Study|Withdrawal by Subject|41|||
30781476|NCT01345318|58793482|FG000|Overall Study|Other|3|||
30781477|NCT02961244|58793489|FG000|Overall Study|Protocol Violation|0|||
30781478|NCT02961244|58793490|FG001|Overall Study|Protocol Violation|1|||
30781479|NCT02961244|58793489|FG000|Overall Study|Withdrawal by Subject|1|||
30781480|NCT02961244|58793490|FG001|Overall Study|Withdrawal by Subject|2|||
30781481|NCT02961244|58793489|FG000|Overall Study|Surgery plan change after study approval|0|||
30781482|NCT02961244|58793490|FG001|Overall Study|Surgery plan change after study approval|2|||
30589809|NCT01140061|58602193|FG005|Part I|Adverse Event|0|||
30589810|NCT01140061|58602194|FG006|Part I|Adverse Event|0|||
30589811|NCT01140061|58602195|FG007|Part I|Adverse Event|0|||
30589812|NCT01140061|58602196|FG008|Part I|Adverse Event|0|||
30589813|NCT01140061|58602197|FG009|Part I|Adverse Event|0|||
30589814|NCT01140061|58602188|FG000|Extension|Laboratory Adverse Event|0|||
30589815|NCT01140061|58602189|FG001|Extension|Laboratory Adverse Event|0|||
30589816|NCT01140061|58602190|FG002|Extension|Laboratory Adverse Event|0|||
30589817|NCT01140061|58602191|FG003|Extension|Laboratory Adverse Event|0|||
30589818|NCT01140061|58602192|FG004|Extension|Laboratory Adverse Event|0|||
30589819|NCT01140061|58602193|FG005|Extension|Laboratory Adverse Event|0|||
30673282|NCT00667810|58687256|FG000|Overall Study|Physician Decision|1|||
30673283|NCT00667810|58687257|FG001|Overall Study|Physician Decision|1|||
30673284|NCT00667810|58687258|FG002|Overall Study|Physician Decision|2|||
30673285|NCT00667810|58687259|FG003|Overall Study|Physician Decision|0|||
30673286|NCT00667810|58687256|FG000|Overall Study|Protocol Violation|0|||
30673287|NCT00667810|58687257|FG001|Overall Study|Protocol Violation|2|||
30673288|NCT00667810|58687258|FG002|Overall Study|Protocol Violation|0|||
30673289|NCT00667810|58687259|FG003|Overall Study|Protocol Violation|0|||
30589820|NCT01140061|58602194|FG006|Extension|Laboratory Adverse Event|0|||
30589821|NCT01140061|58602195|FG007|Extension|Laboratory Adverse Event|0|||
30673290|NCT00667810|58687256|FG000|Overall Study|Withdrawal by Subject|14|||
30673291|NCT00667810|58687257|FG001|Overall Study|Withdrawal by Subject|20|||
30673292|NCT00667810|58687258|FG002|Overall Study|Withdrawal by Subject|29|||
30673293|NCT00667810|58687259|FG003|Overall Study|Withdrawal by Subject|1|||
30673294|NCT00667810|58687256|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
30673295|NCT00667810|58687257|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
30673296|NCT00667810|58687258|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
30673297|NCT00667810|58687259|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
30673298|NCT00667810|58687256|FG000|Overall Study|Failed to Return|0|||
30673299|NCT00667810|58687257|FG001|Overall Study|Failed to Return|0|||
30673300|NCT00667810|58687258|FG002|Overall Study|Failed to Return|2|||
30673301|NCT00667810|58687259|FG003|Overall Study|Failed to Return|0|||
30781483|NCT02961244|58793489|FG000|Overall Study|Lost to Follow-up|0|||
30781484|NCT02961244|58793490|FG001|Overall Study|Lost to Follow-up|2|||
30781485|NCT02961244|58793489|FG000|Overall Study|İnadequate data|0|||
30781486|NCT02961244|58793490|FG001|Overall Study|İnadequate data|2|||
30855840|NCT02760433|58883523|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
30855841|NCT02760433|58883524|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
30855842|NCT02760433|58883525|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
30855843|NCT02699463|58883544|FG000|Overall Study|Lost to Follow-up|11|||
30855844|NCT02699463|58883545|FG001|Overall Study|Lost to Follow-up|8|||
30855845|NCT02699463|58883544|FG000|Overall Study|Withdrawal by Subject|4|||
30855846|NCT02699463|58883545|FG001|Overall Study|Withdrawal by Subject|1|||
30855847|NCT00100789|58883551|FG000|Overall Study|Adverse Event|10|||
30855848|NCT00100789|58883551|FG000|Overall Study|Withdrawal by Subject|1|||
30855849|NCT00100789|58883551|FG000|Overall Study|Progression/relapse|42|||
30855850|NCT00100789|58883551|FG000|Overall Study|Death|2|||
30855851|NCT00100789|58883551|FG000|Overall Study|Not protocol specified|5|||
30855852|NCT00100789|58883551|FG000|Overall Study|Ineligible|3|||
30781487|NCT03771963|58793496|FG000|Overall Study|Lost to Follow-up|22|||
30781488|NCT03771963|58793496|FG000|Overall Study|Withdrawal of Consent|10|||
30781489|NCT02962648|58793500|FG000|Overall Study|Withdrawal by Subject|3|||
30781490|NCT02962648|58793500|FG000|Overall Study|Lost to Follow-up|3|||
30781491|NCT02962648|58793500|FG000|Overall Study|Physician Decision|1|||
30781492|NCT02962648|58793500|FG000|Overall Study|Subject had problems with transportation|2|||
30781493|NCT02962882|58793504|FG000|Overall Study|Adverse Event|2|||
30781494|NCT02962882|58793504|FG000|Overall Study|Withdrawal by Subject|2|||
30781495|NCT02962882|58793504|FG000|Overall Study|Transfer from ICU|32|||
30781496|NCT02961790|58793513|FG000|Overall Study|Canceled|4|||
30781497|NCT02961790|58793514|FG001|Overall Study|Canceled|5|||
30781498|NCT02961790|58793515|FG002|Overall Study|Canceled|1|||
30781499|NCT02961790|58793516|FG003|Overall Study|Canceled|4|||
30781500|NCT02961790|58793513|FG000|Overall Study|without baseline data|4|||
30781501|NCT02961790|58793514|FG001|Overall Study|without baseline data|0|||
30781502|NCT02961790|58793515|FG002|Overall Study|without baseline data|1|||
30781503|NCT02961790|58793516|FG003|Overall Study|without baseline data|0|||
30781504|NCT02961790|58793513|FG000|Overall Study|without post baseline data|7|||
30781505|NCT02961790|58793514|FG001|Overall Study|without post baseline data|6|||
30781506|NCT02961790|58793515|FG002|Overall Study|without post baseline data|4|||
30781507|NCT02961790|58793516|FG003|Overall Study|without post baseline data|1|||
30781508|NCT02960854|58793538|FG000|Overall Study|Not Disclosed|2|||
30781509|NCT02960854|58793539|FG001|Overall Study|Not Disclosed|2|||
30781510|NCT02960854|58793538|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
30781511|NCT02960854|58793539|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
30781512|NCT02960854|58793538|FG000|Overall Study|Subject Withdrew Consent|0|||
30781513|NCT02960854|58793539|FG001|Overall Study|Subject Withdrew Consent|1|||
30855853|NCT00100789|58883551|FG000|Overall Study|Never received treatment|1|||
30855854|NCT00708123|58883556|FG000|Period 1|Protocol Violation|0|||
30855855|NCT00708123|58883557|FG001|Period 1|Protocol Violation|1|||
30855856|NCT00708123|58883558|FG002|Period 1|Protocol Violation|0|||
30855857|NCT00708123|58883559|FG003|Period 1|Protocol Violation|1|||
30855858|NCT00708123|58883560|FG004|Period 1|Protocol Violation|0|||
30855859|NCT00708123|58883556|FG000|Period 1|Adverse Event|0|||
30855860|NCT00708123|58883557|FG001|Period 1|Adverse Event|0|||
30855861|NCT00708123|58883558|FG002|Period 1|Adverse Event|1|||
30855862|NCT00708123|58883559|FG003|Period 1|Adverse Event|0|||
30855863|NCT00708123|58883560|FG004|Period 1|Adverse Event|0|||
30673302|NCT00667810|58687256|FG000|Overall Study|Loss of Caregiver|0|||
30673303|NCT00667810|58687257|FG001|Overall Study|Loss of Caregiver|1|||
30781514|NCT02960854|58793538|FG000|Overall Study|Death|4|||
30781515|NCT02960854|58793539|FG001|Overall Study|Death|6|||
30781516|NCT01344538|58793547|FG000|Overall Study|Adverse Event|1|||
30781517|NCT01344538|58793548|FG001|Overall Study|Adverse Event|1|||
30781518|NCT01344538|58793547|FG000|Overall Study|Lost to Follow-up|1|||
30781519|NCT01344538|58793548|FG001|Overall Study|Lost to Follow-up|0|||
30855864|NCT00708123|58883556|FG000|Period 2|Protocol Violation|0|||
30855865|NCT00708123|58883557|FG001|Period 2|Protocol Violation|0|||
30855866|NCT00708123|58883558|FG002|Period 2|Protocol Violation|0|||
30855867|NCT00708123|58883559|FG003|Period 2|Protocol Violation|1|||
30673304|NCT00667810|58687258|FG002|Overall Study|Loss of Caregiver|3|||
30673305|NCT00667810|58687259|FG003|Overall Study|Loss of Caregiver|0|||
30673306|NCT00667810|58687256|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
30673307|NCT00667810|58687257|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
30673308|NCT00667810|58687258|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
30673309|NCT00667810|58687259|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
30673310|NCT00667810|58687256|FG000|Overall Study|Other|6|||
30673311|NCT00667810|58687257|FG001|Overall Study|Other|6|||
30673312|NCT00667810|58687258|FG002|Overall Study|Other|5|||
30673313|NCT00667810|58687259|FG003|Overall Study|Other|0|||
30673314|NCT00819390|58687278|FG000|Overall Study|Lost to Follow-up|1|||
30673315|NCT00819390|58687279|FG001|Overall Study|Lost to Follow-up|1|||
30673316|NCT00819390|58687280|FG002|Overall Study|Lost to Follow-up|0|||
30673317|NCT00819390|58687281|FG003|Overall Study|Lost to Follow-up|0|||
30673318|NCT00819390|58687278|FG000|Overall Study|Withdrawal by Subject|2|||
30673319|NCT00819390|58687279|FG001|Overall Study|Withdrawal by Subject|0|||
30673320|NCT00819390|58687280|FG002|Overall Study|Withdrawal by Subject|0|||
30673321|NCT00819390|58687281|FG003|Overall Study|Withdrawal by Subject|0|||
30673322|NCT00819390|58687278|FG000|Overall Study|Adverse Event|0|||
30855868|NCT00708123|58883560|FG004|Period 2|Protocol Violation|0|||
30855869|NCT00708123|58883556|FG000|Period 2|Other Reason|1|||
30673323|NCT00819390|58687279|FG001|Overall Study|Adverse Event|0|||
30673324|NCT00819390|58687280|FG002|Overall Study|Adverse Event|1|||
30673325|NCT00819390|58687281|FG003|Overall Study|Adverse Event|0|||
30673326|NCT00876395|58687296|FG000|Overall Study|Untreated|8|||
30673327|NCT00876395|58687297|FG001|Overall Study|Untreated|1|||
30673328|NCT00876395|58687296|FG000|Overall Study|Adverse Event|63|||
30673329|NCT00876395|58687297|FG001|Overall Study|Adverse Event|11|||
30673330|NCT00876395|58687296|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30673331|NCT00876395|58687297|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30673332|NCT00876395|58687296|FG000|Overall Study|Disease progression|259|||
30673333|NCT00876395|58687297|FG001|Overall Study|Disease progression|162|||
30673334|NCT00876395|58687296|FG000|Overall Study|New cancer therapy|25|||
30673335|NCT00876395|58687297|FG001|Overall Study|New cancer therapy|7|||
30855870|NCT00708123|58883557|FG001|Period 2|Other Reason|0|||
30855871|NCT00708123|58883558|FG002|Period 2|Other Reason|0|||
30855872|NCT00708123|58883559|FG003|Period 2|Other Reason|0|||
30855873|NCT00708123|58883560|FG004|Period 2|Other Reason|0|||
30855874|NCT00708123|58883556|FG000|Period 3|Lost to Follow-up|0|||
30855875|NCT00708123|58883557|FG001|Period 3|Lost to Follow-up|0|||
30855876|NCT00708123|58883558|FG002|Period 3|Lost to Follow-up|1|||
30855877|NCT00708123|58883559|FG003|Period 3|Lost to Follow-up|1|||
30855878|NCT00708123|58883560|FG004|Period 3|Lost to Follow-up|0|||
30589822|NCT01140061|58602196|FG008|Extension|Laboratory Adverse Event|0|||
30589823|NCT01140061|58602197|FG009|Extension|Laboratory Adverse Event|1|||
30589824|NCT01139164|58602215|FG000|Overall Study|Withdrawn prior to study start|0|||
30589825|NCT01139164|58602216|FG001|Overall Study|Withdrawn prior to study start|2|||
30589826|NCT01139164|58602217|FG002|Overall Study|Withdrawn prior to study start|0|||
30589827|NCT01139125|58602225|FG000|Overall Study|Withdrawal by Subject|1|||
30589828|NCT01139047|58602229|FG000|Overall Study|Withdrawal by Subject|1|||
30589829|NCT01139008|58602236|FG000|Overall Study|Withdrawal by Subject|5|||
30589830|NCT01139008|58602236|FG000|Overall Study|Non-compliant, lost product|1|||
30589831|NCT01138657|58602245|FG000|Overall Study|Adverse Event|3|||
30589832|NCT01138657|58602246|FG001|Overall Study|Adverse Event|10|||
30589833|NCT01138657|58602245|FG000|Overall Study|Lack of Efficacy|2|||
30589834|NCT01138657|58602246|FG001|Overall Study|Lack of Efficacy|1|||
30589835|NCT01138657|58602245|FG000|Overall Study|Lost to Follow-up|0|||
30589836|NCT01138657|58602246|FG001|Overall Study|Lost to Follow-up|3|||
30589837|NCT01138657|58602245|FG000|Overall Study|Miscellaneous Reasons|3|||
30589838|NCT01138657|58602246|FG001|Overall Study|Miscellaneous Reasons|4|||
30589839|NCT01138501|58602254|FG000|Overall Study|Protocol Violation|2|||
30589840|NCT01138501|58602254|FG000|Overall Study|Withdrawal by Subject|3|||
30589841|NCT01138150|58602260|FG000|Overall Study|blood unable to be processed|0|||
30589842|NCT01138150|58602261|FG001|Overall Study|blood unable to be processed|1|||
30673336|NCT00876395|58687296|FG000|Overall Study|Protocol Violation|5|||
30673337|NCT00876395|58687297|FG001|Overall Study|Protocol Violation|2|||
30673338|NCT00876395|58687296|FG000|Overall Study|Withdrawal by Subject|66|||
30673339|NCT00876395|58687297|FG001|Overall Study|Withdrawal by Subject|33|||
30589843|NCT01138150|58602260|FG000|Overall Study|Physician Decision|1|||
30589844|NCT01138150|58602261|FG001|Overall Study|Physician Decision|0|||
30673340|NCT00876395|58687296|FG000|Overall Study|Lost to Follow-up|2|||
30673341|NCT00876395|58687297|FG001|Overall Study|Lost to Follow-up|0|||
30673342|NCT00876395|58687296|FG000|Overall Study|Administrative problems|39|||
30673343|NCT00876395|58687297|FG001|Overall Study|Administrative problems|23|||
30673344|NCT00876395|58687296|FG000|Overall Study|Death|12|||
30673345|NCT00876395|58687297|FG001|Overall Study|Death|0|||
30855879|NCT00708123|58883556|FG000|Period 4|Protocol Violation|0|||
30855880|NCT00708123|58883557|FG001|Period 4|Protocol Violation|1|||
30855881|NCT00708123|58883558|FG002|Period 4|Protocol Violation|0|||
30589845|NCT01138111|58602277|FG000|Overall Study|Withdrawal by Subject|5|||
30589846|NCT01138111|58602277|FG000|Overall Study|Adverse Event|1|||
30589847|NCT01138111|58602277|FG000|Overall Study|Death|1|||
30589848|NCT01138111|58602277|FG000|Overall Study|Lost to Follow-up|2|||
30589849|NCT01137955|58602308|FG000|Overall Study|Withdrawal by Subject|5|||
30589850|NCT01137955|58602309|FG001|Overall Study|Withdrawal by Subject|4|||
30589851|NCT01137682|58602319|FG000|Overall Study|Adverse Event-CORE|2|||
30589852|NCT01137682|58602320|FG001|Overall Study|Adverse Event-CORE|4|||
30673346|NCT00594659|58687311|FG000|Overall Study|Lost to Follow-up|13|||
30673347|NCT00594659|58687312|FG001|Overall Study|Lost to Follow-up|9|||
30673348|NCT00594659|58687313|FG002|Overall Study|Lost to Follow-up|7|||
30673349|NCT00667732|58687323|FG000|Run -In (8 Weeks)|Adverse Event|4|||
30673350|NCT00667732|58687324|FG001|Run -In (8 Weeks)|Adverse Event|0|||
30673351|NCT00667732|58687325|FG002|Run -In (8 Weeks)|Adverse Event|0|||
30673352|NCT00667732|58687323|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
30673353|NCT00667732|58687324|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
30673354|NCT00667732|58687325|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
30673355|NCT00667732|58687323|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
30673356|NCT00667732|58687324|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
30673357|NCT00667732|58687325|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
30673358|NCT00671788|58687335|FG000|Overall Study|Adverse Event|8|||
30673359|NCT00671788|58687335|FG000|Overall Study|Refused further treatment|3|||
30673360|NCT00671788|58687335|FG000|Overall Study|Ineligible|1|||
30673361|NCT00671788|58687335|FG000|Overall Study|MD Decision|1|||
30673362|NCT00671788|58687335|FG000|Overall Study|Other|1|||
30673363|NCT00875615|58687339|FG000|Overall Study|Withdrawal by Subject|1|||
30673364|NCT00597701|58687345|FG000|Overall Study|Withdrawal by Subject|5|||
30673365|NCT00597701|58687346|FG001|Overall Study|Withdrawal by Subject|5|||
30673366|NCT00597701|58687345|FG000|Overall Study|Death|0|||
30673367|NCT00597701|58687346|FG001|Overall Study|Death|1|||
30781520|NCT01344460|58793554|FG000|Overall Study|Withdrawal by Subject|1|||
30781521|NCT01344460|58793554|FG000|Overall Study|Lost to Follow-up|2|||
30781522|NCT03764631|58793564|FG000|Overall Study|Personal Reasons|3|||
30781523|NCT03764631|58793565|FG001|Overall Study|Personal Reasons|2|||
30781524|NCT03764631|58793564|FG000|Overall Study|Switching Therapy|3|||
30781525|NCT03764631|58793565|FG001|Overall Study|Switching Therapy|3|||
30781526|NCT03764631|58793564|FG000|Overall Study|Adverse Event|0|||
30781527|NCT03764631|58793565|FG001|Overall Study|Adverse Event|1|||
30781528|NCT03764631|58793564|FG000|Overall Study|Lost to Follow-up|33|||
30781529|NCT03764631|58793565|FG001|Overall Study|Lost to Follow-up|41|||
30781530|NCT03764631|58793564|FG000|Overall Study|No data as study site was closed|2|||
30781531|NCT03764631|58793565|FG001|Overall Study|No data as study site was closed|6|||
30781532|NCT02956486|58793584|FG000|Core Phase|Adverse Event|51|||
30781533|NCT02956486|58793585|FG001|Core Phase|Adverse Event|88|||
30781534|NCT02956486|58793586|FG002|Core Phase|Adverse Event|0|||
30781535|NCT02956486|58793584|FG000|Core Phase|Lost to Follow-up|8|||
30589853|NCT01137682|58602321|FG002|Overall Study|Adverse Event-CORE|0|||
30589854|NCT01137682|58602319|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
30589855|NCT01137682|58602320|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
30589856|NCT01137682|58602321|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
30589857|NCT01137682|58602319|FG000|Overall Study|Administrative problems-CORE|2|||
30589858|NCT01137682|58602320|FG001|Overall Study|Administrative problems-CORE|1|||
30589859|NCT01137682|58602321|FG002|Overall Study|Administrative problems-CORE|0|||
30589860|NCT01137682|58602319|FG000|Overall Study|Protocol Violation-CORE|0|||
30589861|NCT01137682|58602320|FG001|Overall Study|Protocol Violation-CORE|1|||
30589862|NCT01137682|58602321|FG002|Overall Study|Protocol Violation-CORE|1|||
30589863|NCT01137682|58602319|FG000|Overall Study|Adverse Event-Extension|4|||
30589864|NCT01137682|58602320|FG001|Overall Study|Adverse Event-Extension|8|||
30589865|NCT01137682|58602321|FG002|Overall Study|Adverse Event-Extension|7|||
30589866|NCT01137682|58602319|FG000|Overall Study|Lack of Efficacy-Extension|15|||
30589867|NCT01137682|58602320|FG001|Overall Study|Lack of Efficacy-Extension|9|||
30589868|NCT01137682|58602321|FG002|Overall Study|Lack of Efficacy-Extension|13|||
30589869|NCT01137682|58602319|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
30673368|NCT00597701|58687345|FG000|Overall Study|Physician Decision|2|||
30673369|NCT00597701|58687346|FG001|Overall Study|Physician Decision|0|||
30673370|NCT00597701|58687345|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
30781536|NCT02956486|58793585|FG001|Core Phase|Lost to Follow-up|6|||
30589870|NCT01137682|58602320|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
30589871|NCT01137682|58602321|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
30589872|NCT01137682|58602319|FG000|Overall Study|Lost to Follow Up-Extension|0|||
30673371|NCT00597701|58687346|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
30673372|NCT00671554|58687352|FG000|Overall Study|Disease progression|3|||
30673373|NCT00667576|58687362|FG000|Overall Study|Withdrawal by Subject|1|||
30673374|NCT00667576|58687363|FG001|Overall Study|Withdrawal by Subject|0|||
30781537|NCT02956486|58793586|FG002|Core Phase|Lost to Follow-up|0|||
30781538|NCT02956486|58793584|FG000|Core Phase|Inadequate therapeutic effect|4|||
30781539|NCT02956486|58793585|FG001|Core Phase|Inadequate therapeutic effect|5|||
30589873|NCT01137682|58602320|FG001|Overall Study|Lost to Follow Up-Extension|1|||
30589874|NCT01137682|58602321|FG002|Overall Study|Lost to Follow Up-Extension|0|||
30589875|NCT01137682|58602319|FG000|Overall Study|Administrative problems-Extension|0|||
30589876|NCT01137682|58602320|FG001|Overall Study|Administrative problems-Extension|2|||
30589877|NCT01137682|58602321|FG002|Overall Study|Administrative problems-Extension|0|||
30589878|NCT01137682|58602319|FG000|Overall Study|Death-Extension|2|||
30589879|NCT01137682|58602320|FG001|Overall Study|Death-Extension|0|||
30589880|NCT01137682|58602321|FG002|Overall Study|Death-Extension|0|||
30589881|NCT01137682|58602319|FG000|Overall Study|Protocol Violation-Extension|2|||
30589882|NCT01137682|58602320|FG001|Overall Study|Protocol Violation-Extension|1|||
30589883|NCT01137682|58602321|FG002|Overall Study|Protocol Violation-Extension|0|||
30589884|NCT01137682|58602319|FG000|Overall Study|Did not enter extension|2|||
30589885|NCT01137682|58602320|FG001|Overall Study|Did not enter extension|3|||
30589886|NCT01137682|58602321|FG002|Overall Study|Did not enter extension|2|||
30589887|NCT01137682|58602319|FG000|Overall Study|Did not receive treatment in extension|0|||
30589888|NCT01137682|58602320|FG001|Overall Study|Did not receive treatment in extension|0|||
30589889|NCT01137682|58602321|FG002|Overall Study|Did not receive treatment in extension|1|||
30589890|NCT03452397|58602337|FG000|Overall Study|Adverse Event|1|||
30589891|NCT03452397|58602338|FG001|Overall Study|Adverse Event|0|||
30589892|NCT03452397|58602339|FG002|Overall Study|Adverse Event|0|||
30589893|NCT03452397|58602340|FG003|Overall Study|Adverse Event|0|||
30589894|NCT03452397|58602337|FG000|Overall Study|Administrative reason|0|||
30589895|NCT03452397|58602338|FG001|Overall Study|Administrative reason|0|||
30589896|NCT03452397|58602339|FG002|Overall Study|Administrative reason|1|||
30589897|NCT03452397|58602340|FG003|Overall Study|Administrative reason|1|||
30589898|NCT03452397|58602337|FG000|Overall Study|Withdrawal by Subject|0|||
30589899|NCT03452397|58602338|FG001|Overall Study|Withdrawal by Subject|0|||
30589900|NCT03452397|58602339|FG002|Overall Study|Withdrawal by Subject|1|||
30589901|NCT03452397|58602340|FG003|Overall Study|Withdrawal by Subject|0|||
30589902|NCT00199875|58602374|FG000|Overall Study|Withdrawal by Subject|0|||
30589903|NCT00199875|58602375|FG001|Overall Study|Withdrawal by Subject|0|||
30589904|NCT00199875|58602376|FG002|Overall Study|Withdrawal by Subject|0|||
30589905|NCT00199875|58602377|FG003|Overall Study|Withdrawal by Subject|0|||
30589906|NCT00199875|58602378|FG004|Overall Study|Withdrawal by Subject|1|||
30589907|NCT00199836|58602390|FG000|Overall Study|Progressive Disease|5|||
30589908|NCT00199836|58602390|FG000|Overall Study|Death|1|||
30589909|NCT00199797|58602395|FG000|Overall Study|Progressive Disease|1|||
30673375|NCT00667576|58687364|FG002|Overall Study|Withdrawal by Subject|1|||
30673376|NCT00667576|58687365|FG003|Overall Study|Withdrawal by Subject|1|||
30673377|NCT00667576|58687366|FG004|Overall Study|Withdrawal by Subject|1|||
30673378|NCT00667576|58687362|FG000|Overall Study|Adverse Event|1|||
30673379|NCT00667576|58687363|FG001|Overall Study|Adverse Event|1|||
30673380|NCT00667576|58687364|FG002|Overall Study|Adverse Event|0|||
30673381|NCT00667576|58687365|FG003|Overall Study|Adverse Event|0|||
30673382|NCT00667576|58687366|FG004|Overall Study|Adverse Event|0|||
30673383|NCT00667576|58687362|FG000|Overall Study|Lost to Follow-up|0|||
30673384|NCT00667576|58687363|FG001|Overall Study|Lost to Follow-up|0|||
30673385|NCT00667576|58687364|FG002|Overall Study|Lost to Follow-up|1|||
30673386|NCT00667576|58687365|FG003|Overall Study|Lost to Follow-up|0|||
30673387|NCT00667576|58687366|FG004|Overall Study|Lost to Follow-up|0|||
30673388|NCT00667576|58687362|FG000|Overall Study|Protocol Violation|0|||
30673389|NCT00667576|58687363|FG001|Overall Study|Protocol Violation|0|||
30673390|NCT00667576|58687364|FG002|Overall Study|Protocol Violation|0|||
30673391|NCT00667576|58687365|FG003|Overall Study|Protocol Violation|1|||
30673392|NCT00667576|58687366|FG004|Overall Study|Protocol Violation|0|||
30673393|NCT00667576|58687362|FG000|Overall Study|Physician Decision|0|||
30673394|NCT00667576|58687363|FG001|Overall Study|Physician Decision|0|||
30673395|NCT00667576|58687364|FG002|Overall Study|Physician Decision|0|||
30673396|NCT00667576|58687365|FG003|Overall Study|Physician Decision|1|||
30673397|NCT00667576|58687366|FG004|Overall Study|Physician Decision|0|||
30673398|NCT00667576|58687362|FG000|Overall Study|Missed Visit|0|||
30589910|NCT00199797|58602395|FG000|Overall Study|Adverse Event|1|||
30673399|NCT00667576|58687363|FG001|Overall Study|Missed Visit|0|||
30673400|NCT00667576|58687364|FG002|Overall Study|Missed Visit|0|||
30673401|NCT00667576|58687365|FG003|Overall Study|Missed Visit|1|||
30673402|NCT00667576|58687366|FG004|Overall Study|Missed Visit|0|||
30673403|NCT00666718|58687380|FG000|Overall Study|Adverse Event|0|||
30589911|NCT00199797|58602395|FG000|Overall Study|Physician Decision|1|||
30589912|NCT01137604|58602404|FG000|Overall Study|Adverse Event|3|||
30589913|NCT01137604|58602405|FG001|Overall Study|Adverse Event|6|||
30673404|NCT00666718|58687381|FG001|Overall Study|Adverse Event|1|||
30673405|NCT00666718|58687380|FG000|Overall Study|Death|1|||
30589914|NCT01137604|58602406|FG002|Overall Study|Adverse Event|9|||
30589915|NCT01137604|58602407|FG003|Overall Study|Adverse Event|9|||
30589916|NCT01137604|58602404|FG000|Overall Study|Participant Choice|0|||
30589917|NCT01137604|58602405|FG001|Overall Study|Participant Choice|2|||
30673406|NCT00666718|58687381|FG001|Overall Study|Death|0|||
30673407|NCT00666718|58687380|FG000|Overall Study|Lost to Follow-up|1|||
30589918|NCT01137604|58602406|FG002|Overall Study|Participant Choice|2|||
30589919|NCT01137604|58602407|FG003|Overall Study|Participant Choice|0|||
30589920|NCT01137604|58602404|FG000|Overall Study|Withdrawal of consent|0|||
30589921|NCT01137604|58602405|FG001|Overall Study|Withdrawal of consent|0|||
30589922|NCT01137604|58602406|FG002|Overall Study|Withdrawal of consent|0|||
30589923|NCT01137604|58602407|FG003|Overall Study|Withdrawal of consent|2|||
30589924|NCT01137604|58602404|FG000|Overall Study|Clinical progression/deterioration|1|||
30589925|NCT01137604|58602405|FG001|Overall Study|Clinical progression/deterioration|2|||
30589926|NCT01137604|58602406|FG002|Overall Study|Clinical progression/deterioration|2|||
30589927|NCT01137604|58602407|FG003|Overall Study|Clinical progression/deterioration|0|||
30589928|NCT00198822|58602420|FG000|Overall Study|Lost to Follow-up|14|||
30589929|NCT00198822|58602421|FG001|Overall Study|Lost to Follow-up|20|||
30589930|NCT00198822|58602422|FG002|Overall Study|Lost to Follow-up|21|||
30589931|NCT01137292|58602430|FG000|Overall Study|Death|30|||
30589932|NCT01137292|58602430|FG000|Overall Study|Adverse Event|3|||
30589933|NCT01137292|58602430|FG000|Overall Study|Lack of Efficacy|13|||
30589934|NCT01137292|58602430|FG000|Overall Study|Lost to Follow-up|1|||
30589935|NCT01137292|58602430|FG000|Overall Study|Other|7|||
30589936|NCT00197496|58602436|FG000|Baseline to Discharge|not interested|1|||
30589937|NCT00197496|58602437|FG001|Baseline to Discharge|not interested|0|||
30589938|NCT00197496|58602436|FG000|Baseline to Discharge|MRSA|1|||
30589939|NCT00197496|58602437|FG001|Baseline to Discharge|MRSA|0|||
30589940|NCT00197496|58602436|FG000|Baseline to Discharge|Physician Decision|0|||
30589941|NCT00197496|58602437|FG001|Baseline to Discharge|Physician Decision|1|||
30589942|NCT00197496|58602436|FG000|Baseline to Discharge|Protocol Violation|0|||
30589943|NCT00197496|58602437|FG001|Baseline to Discharge|Protocol Violation|1|||
30589944|NCT00197496|58602436|FG000|Follow-up|Lost to Follow-up|2|||
30589945|NCT00197496|58602437|FG001|Follow-up|Lost to Follow-up|1|||
30589946|NCT00197145|58602445|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
30589947|NCT00197145|58602446|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
30589948|NCT00197145|58602445|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
30589949|NCT00197145|58602446|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
30589950|NCT00197145|58602445|FG000|Period 1: Randomized Treatment Phase|Other|2|||
30589951|NCT00197145|58602446|FG001|Period 1: Randomized Treatment Phase|Other|2|||
30589952|NCT00197145|58602445|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
30589953|NCT00197145|58602446|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
30589954|NCT00197145|58602445|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
30589955|NCT00197145|58602446|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
30673408|NCT00666718|58687381|FG001|Overall Study|Lost to Follow-up|0|||
30673409|NCT00666718|58687380|FG000|Overall Study|Entry Criteria Not Met|2|||
30673410|NCT00666718|58687381|FG001|Overall Study|Entry Criteria Not Met|0|||
30673411|NCT00666718|58687380|FG000|Overall Study|Protocol Violation|1|||
30673412|NCT00666718|58687381|FG001|Overall Study|Protocol Violation|3|||
30673413|NCT00666718|58687380|FG000|Overall Study|Withdrawal by Subject|7|||
30673414|NCT00666718|58687381|FG001|Overall Study|Withdrawal by Subject|12|||
30958984|NCT01587703|59024039|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30589956|NCT00197145|58602445|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
30589957|NCT00197145|58602446|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
30589958|NCT00197145|58602445|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
30589959|NCT00197145|58602446|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
30589960|NCT00197145|58602445|FG000|Period 2 : Open Label Phase|Other|1|||
30589961|NCT00197145|58602446|FG001|Period 2 : Open Label Phase|Other|0|||
30589962|NCT01136785|58602455|FG000|Overall Study|Protocol Violation|2|||
30589963|NCT01136785|58602456|FG001|Overall Study|Protocol Violation|1|||
30589964|NCT00197106|58602468|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
30589965|NCT00197106|58602469|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
30673415|NCT00666718|58687380|FG000|Overall Study|Physician Decision|0|||
30673416|NCT00666718|58687381|FG001|Overall Study|Physician Decision|2|||
30589966|NCT00197106|58602470|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
30589967|NCT00197106|58602468|FG000|Overall Treatment Period|Lack of Efficacy|0|||
30589968|NCT00197106|58602469|FG001|Overall Treatment Period|Lack of Efficacy|1|||
30589969|NCT00197106|58602470|FG002|Overall Treatment Period|Lack of Efficacy|0|||
30589970|NCT00197106|58602468|FG000|Overall Treatment Period|Lost to Follow-up|0|||
30589971|NCT00197106|58602469|FG001|Overall Treatment Period|Lost to Follow-up|0|||
30589972|NCT00197106|58602470|FG002|Overall Treatment Period|Lost to Follow-up|2|||
30589973|NCT00197106|58602468|FG000|Overall Treatment Period|Protocol Violation|0|||
30589974|NCT00197106|58602469|FG001|Overall Treatment Period|Protocol Violation|0|||
30589975|NCT00197106|58602470|FG002|Overall Treatment Period|Protocol Violation|2|||
30589976|NCT00197106|58602468|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
30589977|NCT00197106|58602469|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
30589978|NCT00197106|58602470|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
30673417|NCT00667420|58687387|FG000|Overall Study|Adverse Event|2|||
30673418|NCT00667420|58687387|FG000|Overall Study|Lack of Efficacy|5|||
30589979|NCT01136746|58602478|FG000|Overall Study|Lost to Follow-up|0|||
30589980|NCT01136746|58602479|FG001|Overall Study|Lost to Follow-up|2|||
30589981|NCT01136746|58602478|FG000|Overall Study|Protocol Violation|2|||
30589982|NCT01136746|58602479|FG001|Overall Study|Protocol Violation|1|||
30589983|NCT01136746|58602478|FG000|Overall Study|Death|1|||
30589984|NCT01136746|58602479|FG001|Overall Study|Death|0|||
30589985|NCT01136356|58602485|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
30589986|NCT01136356|58602486|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
30589987|NCT01136356|58602485|FG000|First 18-day Withdrawal|Physician Decision|1|||
30589988|NCT01136356|58602486|FG001|First 18-day Withdrawal|Physician Decision|0|||
30589989|NCT01136356|58602485|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
30589990|NCT01136356|58602486|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
30589991|NCT00196326|58602491|FG000|Overall Study|Did not meet protocol requirements|64|||
30589992|NCT00196326|58602491|FG000|Overall Study|Non-compliance with the protocol|81|||
30589993|NCT00196326|58602491|FG000|Overall Study|Physician Decision|3|||
30589994|NCT00196326|58602491|FG000|Overall Study|Withdrawal by Subject|225|||
30589995|NCT00196326|58602491|FG000|Overall Study|Adverse Event|253|||
30589996|NCT00196326|58602491|FG000|Overall Study|Pregnancy|34|||
30589997|NCT00196326|58602491|FG000|Overall Study|Lost to Follow-up|304|||
30589998|NCT00196326|58602491|FG000|Overall Study|Other|22|||
30589999|NCT00195663|58602498|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
30590000|NCT00195663|58602499|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
30590001|NCT00195663|58602500|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
30590002|NCT00195663|58602498|FG000|2-year Double-blind Treatment Period|Death|0|||
30590003|NCT00195663|58602499|FG001|2-year Double-blind Treatment Period|Death|2|||
30590004|NCT00195663|58602500|FG002|2-year Double-blind Treatment Period|Death|0|||
30590005|NCT00195663|58602498|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
30673419|NCT00667420|58687387|FG000|Overall Study|Physician Decision|1|||
30673420|NCT00667420|58687387|FG000|Overall Study|Withdrawal by Subject|2|||
30673421|NCT00853658|58687395|FG000|Overall Study|Death|713|||
30673422|NCT00853658|58687396|FG001|Overall Study|Death|768|||
30673423|NCT00853658|58687397|FG002|Overall Study|Death|753|||
30673424|NCT00853658|58687395|FG000|Overall Study|Lost to Follow-up|11|||
30673425|NCT00853658|58687396|FG001|Overall Study|Lost to Follow-up|6|||
30673426|NCT00853658|58687397|FG002|Overall Study|Lost to Follow-up|11|||
30673427|NCT00853658|58687395|FG000|Overall Study|H.A. Request|26|||
30673428|NCT00853658|58687396|FG001|Overall Study|H.A. Request|23|||
30673429|NCT00853658|58687397|FG002|Overall Study|H.A. Request|19|||
30673430|NCT00853658|58687395|FG000|Overall Study|IRB request|0|||
30673431|NCT00853658|58687396|FG001|Overall Study|IRB request|0|||
30673432|NCT00853658|58687397|FG002|Overall Study|IRB request|2|||
30673433|NCT00853658|58687395|FG000|Overall Study|Vital Status known (alive) at study end|2|||
30673434|NCT00853658|58687396|FG001|Overall Study|Vital Status known (alive) at study end|3|||
30673435|NCT00853658|58687397|FG002|Overall Study|Vital Status known (alive) at study end|3|||
30673436|NCT00853658|58687395|FG000|Overall Study|Vital Status unknown at study end|1|||
30673437|NCT00853658|58687396|FG001|Overall Study|Vital Status unknown at study end|1|||
30673438|NCT00853658|58687397|FG002|Overall Study|Vital Status unknown at study end|0|||
30673439|NCT00853658|58687395|FG000|Overall Study|Vital Status at study end N/A|8|||
30673440|NCT00853658|58687396|FG001|Overall Study|Vital Status at study end N/A|10|||
30673441|NCT00853658|58687397|FG002|Overall Study|Vital Status at study end N/A|10|||
30673442|NCT00853658|58687395|FG000|Overall Study|Patient's request|21|||
30673443|NCT00853658|58687396|FG001|Overall Study|Patient's request|17|||
30673444|NCT00853658|58687397|FG002|Overall Study|Patient's request|11|||
30673445|NCT00853658|58687395|FG000|Overall Study|Missing study completion information|5|||
30673446|NCT00853658|58687396|FG001|Overall Study|Missing study completion information|4|||
30673447|NCT00853658|58687397|FG002|Overall Study|Missing study completion information|6|||
30673448|NCT00666562|58687408|FG000|Overall Study|Withdrawal by Subject|0|||
30673449|NCT00666562|58687409|FG001|Overall Study|Withdrawal by Subject|1|||
30673450|NCT00666562|58687410|FG002|Overall Study|Withdrawal by Subject|0|||
30673451|NCT00666562|58687408|FG000|Overall Study|Concomitant Medication|0|||
30673452|NCT00666562|58687409|FG001|Overall Study|Concomitant Medication|1|||
30673453|NCT00666562|58687410|FG002|Overall Study|Concomitant Medication|0|||
30673454|NCT00666328|58687425|FG000|Overall Study|Death|2|||
30673455|NCT00666328|58687425|FG000|Overall Study|Lost to Follow-up|2|||
30673456|NCT00666328|58687425|FG000|Overall Study|No longer met eligibility criteria|1|||
30781540|NCT02956486|58793586|FG002|Core Phase|Inadequate therapeutic effect|0|||
30590006|NCT00195663|58602499|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
30673457|NCT00853580|58687433|FG000|Overall Study|Lost to Follow-up|3|||
30673458|NCT00853580|58687434|FG001|Overall Study|Lost to Follow-up|5|||
30673459|NCT00853580|58687433|FG000|Overall Study|Protocol Violation|2|||
30781541|NCT02956486|58793584|FG000|Core Phase|Withdrawal by Subject|101|||
30590007|NCT00195663|58602500|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
30590008|NCT00195663|58602498|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
30673460|NCT00853580|58687434|FG001|Overall Study|Protocol Violation|1|||
30673461|NCT00853580|58687433|FG000|Overall Study|Withdrawal by Subject|2|||
30855882|NCT00708123|58883559|FG003|Period 4|Protocol Violation|0|||
30855883|NCT00708123|58883560|FG004|Period 4|Protocol Violation|0|||
30855884|NCT02165215|58883579|FG000|Induction Phase|Adverse Event|1|||
30855885|NCT02165215|58883580|FG001|Induction Phase|Adverse Event|0|||
30855886|NCT02165215|58883581|FG002|Induction Phase|Adverse Event|0|||
30855887|NCT02165215|58883579|FG000|Induction Phase|Withdrawal by Subject|10|||
30855888|NCT02165215|58883580|FG001|Induction Phase|Withdrawal by Subject|0|||
30855889|NCT02165215|58883581|FG002|Induction Phase|Withdrawal by Subject|0|||
30855890|NCT02165215|58883579|FG000|Induction Phase|Protocol Violation|1|||
30855891|NCT02165215|58883580|FG001|Induction Phase|Protocol Violation|0|||
30855892|NCT02165215|58883581|FG002|Induction Phase|Protocol Violation|0|||
30855893|NCT02165215|58883579|FG000|Induction Phase|Physician Decision|1|||
30855894|NCT02165215|58883580|FG001|Induction Phase|Physician Decision|0|||
30855895|NCT02165215|58883581|FG002|Induction Phase|Physician Decision|0|||
30855896|NCT02165215|58883579|FG000|Induction Phase|Lack of Efficacy|2|||
30855897|NCT02165215|58883580|FG001|Induction Phase|Lack of Efficacy|0|||
30855898|NCT02165215|58883581|FG002|Induction Phase|Lack of Efficacy|0|||
30855899|NCT02165215|58883579|FG000|Induction Phase|Non-Compliance|2|||
30855900|NCT02165215|58883580|FG001|Induction Phase|Non-Compliance|0|||
30855901|NCT02165215|58883581|FG002|Induction Phase|Non-Compliance|0|||
30781542|NCT02956486|58793585|FG001|Core Phase|Withdrawal by Subject|104|||
30781543|NCT02956486|58793586|FG002|Core Phase|Withdrawal by Subject|0|||
30781544|NCT02956486|58793584|FG000|Core Phase|Study terminated by sponsor|888|||
30781545|NCT02956486|58793585|FG001|Core Phase|Study terminated by sponsor|848|||
30781546|NCT02956486|58793586|FG002|Core Phase|Study terminated by sponsor|0|||
30781547|NCT02956486|58793584|FG000|Core Phase|Other|27|||
30781548|NCT02956486|58793585|FG001|Core Phase|Other|18|||
30781549|NCT02956486|58793586|FG002|Core Phase|Other|0|||
30781550|NCT02956486|58793584|FG000|Core Phase|Not treated|0|||
30781551|NCT02956486|58793585|FG001|Core Phase|Not treated|3|||
30781552|NCT02956486|58793586|FG002|Core Phase|Not treated|0|||
30781553|NCT02956486|58793584|FG000|Extension Phase|Adverse Event|0|||
30781554|NCT02956486|58793585|FG001|Extension Phase|Adverse Event|0|||
30781555|NCT02956486|58793586|FG002|Extension Phase|Adverse Event|2|||
30781556|NCT02956486|58793584|FG000|Extension Phase|Study terminated by sponsor|0|||
30781557|NCT02956486|58793585|FG001|Extension Phase|Study terminated by sponsor|0|||
30781558|NCT02956486|58793586|FG002|Extension Phase|Study terminated by sponsor|16|||
30781559|NCT02956486|58793584|FG000|Extension Phase|Not Treated|0|||
30781560|NCT02956486|58793585|FG001|Extension Phase|Not Treated|0|||
30781561|NCT02956486|58793586|FG002|Extension Phase|Not Treated|1|||
30781562|NCT03445533|58793601|FG000|Overall Study|Progressive Disease|48|||
30781563|NCT03445533|58793602|FG001|Overall Study|Progressive Disease|81|||
30781564|NCT03445533|58793601|FG000|Overall Study|Adverse Event|60|||
30781565|NCT03445533|58793602|FG001|Overall Study|Adverse Event|64|||
30781566|NCT03445533|58793601|FG000|Overall Study|Death|9|||
30781567|NCT03445533|58793602|FG001|Overall Study|Death|19|||
30781568|NCT03445533|58793601|FG000|Overall Study|Miscellaneous|0|||
30781569|NCT03445533|58793602|FG001|Overall Study|Miscellaneous|16|||
30590009|NCT00195663|58602499|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
30590010|NCT00195663|58602500|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
30590011|NCT00195663|58602498|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
30590012|NCT00195663|58602499|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
30590013|NCT00195663|58602500|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
30590014|NCT00195663|58602498|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
30590015|NCT00195663|58602499|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
30590016|NCT00195663|58602500|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
30590017|NCT00195663|58602498|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
30590018|NCT00195663|58602499|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
30590019|NCT00195663|58602500|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
30590020|NCT00195663|58602498|FG000|2-year Double-blind Treatment Period|Recovery|1|||
30590021|NCT00195663|58602499|FG001|2-year Double-blind Treatment Period|Recovery|0|||
30590022|NCT00195663|58602500|FG002|2-year Double-blind Treatment Period|Recovery|1|||
30590023|NCT00195663|58602498|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
30781570|NCT03445533|58793601|FG000|Overall Study|Withdrawal by Subject|3|||
30781571|NCT03445533|58793602|FG001|Overall Study|Withdrawal by Subject|4|||
30781572|NCT03445533|58793601|FG000|Overall Study|Physician Decision|1|||
30781573|NCT03445533|58793602|FG001|Overall Study|Physician Decision|3|||
30781574|NCT03445533|58793601|FG000|Overall Study|Sponsor Decision|0|||
30781575|NCT03445533|58793602|FG001|Overall Study|Sponsor Decision|1|||
30781576|NCT03445533|58793601|FG000|Overall Study|Lost to Follow-up|0|||
30781577|NCT03445533|58793602|FG001|Overall Study|Lost to Follow-up|1|||
30781578|NCT03445533|58793601|FG000|Overall Study|Never Received any Study Treatment|7|||
30855902|NCT02165215|58883579|FG000|Induction Phase|Lost to Follow-up|6|||
30855903|NCT02165215|58883580|FG001|Induction Phase|Lost to Follow-up|0|||
30855904|NCT02165215|58883581|FG002|Induction Phase|Lost to Follow-up|0|||
30855905|NCT02165215|58883579|FG000|Maintenance Phase|Withdrawal by Subject|0|||
30590024|NCT00195663|58602499|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
30590025|NCT00195663|58602500|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
30590026|NCT00195663|58602498|FG000|Open-Label Extension Period|Adverse Event|21|||
30590027|NCT00195663|58602499|FG001|Open-Label Extension Period|Adverse Event|32|||
30590028|NCT00195663|58602500|FG002|Open-Label Extension Period|Adverse Event|36|||
30590029|NCT00195663|58602498|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
30590030|NCT00195663|58602499|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
30590031|NCT00195663|58602500|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
30590032|NCT00195663|58602498|FG000|Open-Label Extension Period|Recovery|0|||
30590033|NCT00195663|58602499|FG001|Open-Label Extension Period|Recovery|2|||
30590034|NCT00195663|58602500|FG002|Open-Label Extension Period|Recovery|2|||
30590035|NCT00195663|58602498|FG000|Open-Label Extension Period|Protocol Violation|3|||
30590036|NCT00195663|58602499|FG001|Open-Label Extension Period|Protocol Violation|4|||
30590037|NCT00195663|58602500|FG002|Open-Label Extension Period|Protocol Violation|4|||
30590038|NCT00195663|58602498|FG000|Open-Label Extension Period|Death|2|||
30590039|NCT00195663|58602499|FG001|Open-Label Extension Period|Death|2|||
30855906|NCT02165215|58883580|FG001|Maintenance Phase|Withdrawal by Subject|7|||
30855907|NCT02165215|58883581|FG002|Maintenance Phase|Withdrawal by Subject|3|||
30855908|NCT02165215|58883579|FG000|Maintenance Phase|Multiple reasons|0|||
30855909|NCT02165215|58883580|FG001|Maintenance Phase|Multiple reasons|2|||
30855910|NCT02165215|58883581|FG002|Maintenance Phase|Multiple reasons|1|||
30855911|NCT02165215|58883579|FG000|Maintenance Phase|Lost to Follow-up|0|||
30855912|NCT02165215|58883580|FG001|Maintenance Phase|Lost to Follow-up|2|||
30855913|NCT02165215|58883581|FG002|Maintenance Phase|Lost to Follow-up|0|||
30673462|NCT00853580|58687434|FG001|Overall Study|Withdrawal by Subject|8|||
30673463|NCT00853580|58687433|FG000|Overall Study|Commenced contraindicated therapy|0|||
30673464|NCT00853580|58687434|FG001|Overall Study|Commenced contraindicated therapy|2|||
30673465|NCT00865514|58687440|FG000|Overall Study|Infusion cost exceeded funding|2|||
30673466|NCT00865280|58687447|FG000|Overall Study|Withdrawal by Subject|4|||
30673467|NCT00865280|58687448|FG001|Overall Study|Withdrawal by Subject|1|||
30673468|NCT00865280|58687447|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
30673469|NCT00865280|58687448|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
30673470|NCT00865280|58687447|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
30673471|NCT00865280|58687448|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
30673472|NCT00865280|58687447|FG000|Overall Study|Exclusion Condition|1|||
30590040|NCT00195663|58602500|FG002|Open-Label Extension Period|Death|2|||
30590041|NCT00195663|58602498|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
30590042|NCT00195663|58602499|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
30673473|NCT00865280|58687448|FG001|Overall Study|Exclusion Condition|0|||
30673474|NCT00865280|58687447|FG000|Overall Study|Adverse Event|0|||
30673475|NCT00865280|58687448|FG001|Overall Study|Adverse Event|1|||
30673476|NCT00865124|58687457|FG000|Overall Study|Physician Decision|2|||
30673477|NCT00865124|58687458|FG001|Overall Study|Physician Decision|1|||
30673478|NCT00865124|58687459|FG002|Overall Study|Physician Decision|0|||
30673479|NCT00865124|58687457|FG000|Overall Study|Withdrawn consent|2|||
30673480|NCT00865124|58687458|FG001|Overall Study|Withdrawn consent|0|||
30673481|NCT00865124|58687459|FG002|Overall Study|Withdrawn consent|0|||
30673482|NCT00871715|58687470|FG000|Overall Study|Withdrawal by Subject|6|||
30673483|NCT00871715|58687471|FG001|Overall Study|Withdrawal by Subject|10|||
30673484|NCT00871715|58687472|FG002|Overall Study|Withdrawal by Subject|15|||
30673485|NCT00871715|58687470|FG000|Overall Study|Physician Decision|6|||
30673486|NCT00871715|58687471|FG001|Overall Study|Physician Decision|0|||
30673487|NCT00871715|58687472|FG002|Overall Study|Physician Decision|2|||
30673488|NCT00871715|58687470|FG000|Overall Study|Lost to Follow-up|3|||
30673489|NCT00871715|58687471|FG001|Overall Study|Lost to Follow-up|6|||
30673490|NCT00871715|58687472|FG002|Overall Study|Lost to Follow-up|9|||
30673491|NCT00819234|58687481|FG000|Overall Study|Withdrawal by Subject|8|||
30673492|NCT00819234|58687482|FG001|Overall Study|Withdrawal by Subject|13|||
30673493|NCT00819234|58687483|FG002|Overall Study|Withdrawal by Subject|6|||
30590043|NCT00195663|58602500|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
30590044|NCT00195663|58602498|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
30590045|NCT00195663|58602499|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
30673494|NCT00819234|58687484|FG003|Overall Study|Withdrawal by Subject|3|||
30673495|NCT00819234|58687485|FG004|Overall Study|Withdrawal by Subject|0|||
30673496|NCT00819234|58687486|FG005|Overall Study|Withdrawal by Subject|4|||
30673497|NCT00819234|58687487|FG006|Overall Study|Withdrawal by Subject|4|||
30673498|NCT00819234|58687488|FG007|Overall Study|Withdrawal by Subject|8|||
30590046|NCT00195663|58602500|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
30673499|NCT00819234|58687489|FG008|Overall Study|Withdrawal by Subject|5|||
30673500|NCT00819234|58687490|FG009|Overall Study|Withdrawal by Subject|3|||
30673501|NCT00819234|58687481|FG000|Overall Study|Adverse Event|0|||
30673502|NCT00819234|58687482|FG001|Overall Study|Adverse Event|0|||
30590047|NCT00195663|58602498|FG000|Open-Label Extension Period|Administrative reasons|11|||
30590048|NCT00195663|58602499|FG001|Open-Label Extension Period|Administrative reasons|11|||
30855914|NCT02165215|58883579|FG000|Maintenance Phase|Adverse Event|0|||
30673503|NCT00819234|58687483|FG002|Overall Study|Adverse Event|1|||
30673504|NCT00819234|58687484|FG003|Overall Study|Adverse Event|0|||
30673505|NCT00819234|58687485|FG004|Overall Study|Adverse Event|0|||
30673506|NCT00819234|58687486|FG005|Overall Study|Adverse Event|2|||
30673507|NCT00819234|58687487|FG006|Overall Study|Adverse Event|0|||
30673508|NCT00819234|58687488|FG007|Overall Study|Adverse Event|0|||
30673509|NCT00819234|58687489|FG008|Overall Study|Adverse Event|0|||
30673510|NCT00819234|58687490|FG009|Overall Study|Adverse Event|0|||
30673511|NCT00819234|58687481|FG000|Overall Study|Physician Decision|0|||
30673512|NCT00819234|58687482|FG001|Overall Study|Physician Decision|0|||
30673513|NCT00819234|58687483|FG002|Overall Study|Physician Decision|0|||
30673514|NCT00819234|58687484|FG003|Overall Study|Physician Decision|1|||
30673515|NCT00819234|58687485|FG004|Overall Study|Physician Decision|0|||
30673516|NCT00819234|58687486|FG005|Overall Study|Physician Decision|0|||
30673517|NCT00819234|58687487|FG006|Overall Study|Physician Decision|0|||
30673518|NCT00819234|58687488|FG007|Overall Study|Physician Decision|0|||
30673519|NCT00819234|58687489|FG008|Overall Study|Physician Decision|0|||
30590049|NCT00195663|58602500|FG002|Open-Label Extension Period|Administrative reasons|13|||
30590050|NCT01135498|58602518|FG000|Overall Study|Adverse Event|20|||
30673520|NCT00819234|58687490|FG009|Overall Study|Physician Decision|2|||
30673521|NCT00819234|58687481|FG000|Overall Study|Protocol Violation|0|||
30673522|NCT00819234|58687482|FG001|Overall Study|Protocol Violation|0|||
30673523|NCT00819234|58687483|FG002|Overall Study|Protocol Violation|1|||
30673524|NCT00819234|58687484|FG003|Overall Study|Protocol Violation|0|||
30673525|NCT00819234|58687485|FG004|Overall Study|Protocol Violation|0|||
30673526|NCT00819234|58687486|FG005|Overall Study|Protocol Violation|0|||
30673527|NCT00819234|58687487|FG006|Overall Study|Protocol Violation|0|||
30673528|NCT00819234|58687488|FG007|Overall Study|Protocol Violation|0|||
30673529|NCT00819234|58687489|FG008|Overall Study|Protocol Violation|0|||
30590051|NCT01135498|58602518|FG000|Overall Study|Progressive disease|38|||
30590052|NCT01135498|58602518|FG000|Overall Study|Investigator judgement|25|||
30590053|NCT01135498|58602518|FG000|Overall Study|Withdrawal by Subject|4|||
30590054|NCT01135498|58602518|FG000|Overall Study|Death|1|||
30590055|NCT01135498|58602518|FG000|Overall Study|Ongoing at time of analysis|2|||
30590056|NCT00195507|58602525|FG000|Overall Study|Adverse Event|24|||
30673530|NCT00819234|58687490|FG009|Overall Study|Protocol Violation|0|||
30673531|NCT00819234|58687481|FG000|Overall Study|Lost to Follow-up|2|||
30673532|NCT00819234|58687482|FG001|Overall Study|Lost to Follow-up|2|||
30673533|NCT00819234|58687483|FG002|Overall Study|Lost to Follow-up|0|||
30673534|NCT00819234|58687484|FG003|Overall Study|Lost to Follow-up|2|||
30673535|NCT00819234|58687485|FG004|Overall Study|Lost to Follow-up|1|||
30673536|NCT00819234|58687486|FG005|Overall Study|Lost to Follow-up|1|||
30673537|NCT00819234|58687487|FG006|Overall Study|Lost to Follow-up|1|||
30673538|NCT00819234|58687488|FG007|Overall Study|Lost to Follow-up|1|||
30673539|NCT00819234|58687489|FG008|Overall Study|Lost to Follow-up|1|||
30590057|NCT00195507|58602526|FG001|Overall Study|Adverse Event|13|||
30590058|NCT00195507|58602525|FG000|Overall Study|Death|0|||
30590059|NCT00195507|58602526|FG001|Overall Study|Death|1|||
30590060|NCT00195507|58602525|FG000|Overall Study|Failed to Return|4|||
30590061|NCT00195507|58602526|FG001|Overall Study|Failed to Return|3|||
30590062|NCT00195507|58602525|FG000|Overall Study|Physician Decision|1|||
30590063|NCT00195507|58602526|FG001|Overall Study|Physician Decision|2|||
30590064|NCT00195507|58602525|FG000|Overall Study|Lost to Follow-up|3|||
30590065|NCT00195507|58602526|FG001|Overall Study|Lost to Follow-up|2|||
30590066|NCT00195507|58602525|FG000|Overall Study|Protocol Violation|5|||
30590067|NCT00195507|58602526|FG001|Overall Study|Protocol Violation|4|||
30590068|NCT00195507|58602525|FG000|Overall Study|Lack of Efficacy|40|||
30590069|NCT00195507|58602526|FG001|Overall Study|Lack of Efficacy|67|||
30590070|NCT00195507|58602525|FG000|Overall Study|Withdrawal by Subject|16|||
30590071|NCT00195507|58602526|FG001|Overall Study|Withdrawal by Subject|23|||
30590072|NCT00195507|58602525|FG000|Overall Study|Protocol Deviation|6|||
30590073|NCT00195507|58602526|FG001|Overall Study|Protocol Deviation|3|||
30590074|NCT01134562|58602537|FG000|Overall Study|Adverse Event|0|||
30673540|NCT00819234|58687490|FG009|Overall Study|Lost to Follow-up|2|||
30673541|NCT00871403|58687548|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
30673542|NCT00871403|58687549|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
30673543|NCT00871403|58687550|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
30673544|NCT00871403|58687548|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
30673545|NCT00871403|58687549|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
30673546|NCT00871403|58687550|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
30673547|NCT00871403|58687548|FG000|Combination Treatment Phase|Adverse Event|0|||
30673548|NCT00871403|58687549|FG001|Combination Treatment Phase|Adverse Event|17|||
30673549|NCT00871403|58687550|FG002|Combination Treatment Phase|Adverse Event|2|||
30590075|NCT01134562|58602538|FG001|Overall Study|Adverse Event|1|||
30590076|NCT01134562|58602539|FG002|Overall Study|Adverse Event|0|||
30590077|NCT01134562|58602540|FG003|Overall Study|Adverse Event|0|||
30590078|NCT01134562|58602541|FG004|Overall Study|Adverse Event|0|||
30673550|NCT00871403|58687548|FG000|Combination Treatment Phase|Disease Progression|0|||
30673551|NCT00871403|58687549|FG001|Combination Treatment Phase|Disease Progression|8|||
30673552|NCT00871403|58687550|FG002|Combination Treatment Phase|Disease Progression|5|||
30673553|NCT00871403|58687548|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
30673554|NCT00871403|58687549|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
30673555|NCT00871403|58687550|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
30673556|NCT00871403|58687548|FG000|Combination Treatment Phase|Physician Decision|0|||
30673557|NCT00871403|58687549|FG001|Combination Treatment Phase|Physician Decision|1|||
30673558|NCT00871403|58687550|FG002|Combination Treatment Phase|Physician Decision|3|||
30673559|NCT00871403|58687548|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
30673560|NCT00871403|58687549|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
30673561|NCT00871403|58687550|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
30673562|NCT00871403|58687548|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
30673563|NCT00871403|58687549|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
30673564|NCT00871403|58687550|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
30673565|NCT00853112|58687564|FG000|Overall Study|Randomized but not treated|0|||
30673566|NCT00853112|58687565|FG001|Overall Study|Randomized but not treated|1|||
30673567|NCT00853112|58687566|FG002|Overall Study|Randomized but not treated|0|||
30673568|NCT00853112|58687567|FG003|Overall Study|Randomized but not treated|2|||
30673569|NCT00853112|58687568|FG004|Overall Study|Randomized but not treated|0|||
30673570|NCT00853112|58687569|FG005|Overall Study|Randomized but not treated|0|||
30673571|NCT00853112|58687570|FG006|Overall Study|Randomized but not treated|1|||
30673572|NCT00460603|58687598|FG000|Phase 1|Death|1|||
30673573|NCT00460603|58687599|FG001|Phase 1|Death|0|||
30673574|NCT00460603|58687600|FG002|Phase 1|Death|0|||
30673575|NCT00460603|58687601|FG003|Phase 1|Death|2|||
30673576|NCT00460603|58687602|FG004|Phase 1|Death|0|||
30673577|NCT00460603|58687603|FG005|Phase 1|Death|0|||
30673578|NCT00460603|58687604|FG006|Phase 1|Death|0|||
30673579|NCT00460603|58687605|FG007|Phase 1|Death|0|||
30673580|NCT00460603|58687606|FG008|Phase 1|Death|1|||
30673581|NCT00460603|58687607|FG009|Phase 1|Death|0|||
30673582|NCT00460603|58687608|FG010|Phase 1|Death|0|||
30673583|NCT00460603|58687609|FG011|Phase 1|Death|0|||
30673584|NCT00460603|58687598|FG000|Phase 1|Adverse Event|3|||
30673585|NCT00460603|58687599|FG001|Phase 1|Adverse Event|1|||
30673586|NCT00460603|58687600|FG002|Phase 1|Adverse Event|1|||
30673587|NCT00460603|58687601|FG003|Phase 1|Adverse Event|2|||
30673588|NCT00460603|58687602|FG004|Phase 1|Adverse Event|0|||
30673589|NCT00460603|58687603|FG005|Phase 1|Adverse Event|0|||
30673590|NCT00460603|58687604|FG006|Phase 1|Adverse Event|3|||
30673591|NCT00460603|58687605|FG007|Phase 1|Adverse Event|0|||
30673592|NCT00460603|58687606|FG008|Phase 1|Adverse Event|4|||
30673593|NCT00460603|58687607|FG009|Phase 1|Adverse Event|0|||
30673594|NCT00460603|58687608|FG010|Phase 1|Adverse Event|0|||
30673595|NCT00460603|58687609|FG011|Phase 1|Adverse Event|0|||
30673596|NCT00460603|58687598|FG000|Phase 1|Lack of Efficacy|1|||
30673597|NCT00460603|58687599|FG001|Phase 1|Lack of Efficacy|0|||
30673598|NCT00460603|58687600|FG002|Phase 1|Lack of Efficacy|1|||
30673599|NCT00460603|58687601|FG003|Phase 1|Lack of Efficacy|2|||
30673600|NCT00460603|58687602|FG004|Phase 1|Lack of Efficacy|2|||
30673601|NCT00460603|58687603|FG005|Phase 1|Lack of Efficacy|2|||
30673602|NCT00460603|58687604|FG006|Phase 1|Lack of Efficacy|2|||
30673603|NCT00460603|58687605|FG007|Phase 1|Lack of Efficacy|2|||
30673604|NCT00460603|58687606|FG008|Phase 1|Lack of Efficacy|11|||
30590079|NCT00195429|58602568|FG000|Overall Study|Adverse Event|2|||
30590080|NCT00195429|58602569|FG001|Overall Study|Adverse Event|4|||
30590081|NCT00195429|58602568|FG000|Overall Study|Lack of Efficacy|2|||
30590082|NCT00195429|58602569|FG001|Overall Study|Lack of Efficacy|1|||
30590083|NCT00195429|58602568|FG000|Overall Study|Lost to Follow-up|1|||
30590084|NCT00195429|58602569|FG001|Overall Study|Lost to Follow-up|0|||
30590085|NCT00195351|58602577|FG000|Overall Study|Lost to Follow-up|9|||
30590086|NCT00195351|58602578|FG001|Overall Study|Lost to Follow-up|9|||
30590087|NCT00195351|58602577|FG000|Overall Study|Withdrawal by Subject|6|||
30590088|NCT00195351|58602578|FG001|Overall Study|Withdrawal by Subject|3|||
30590089|NCT00195351|58602577|FG000|Overall Study|Protocol Deviation|3|||
30590090|NCT00195351|58602578|FG001|Overall Study|Protocol Deviation|2|||
30590091|NCT00195351|58602577|FG000|Overall Study|Death|3|||
30590092|NCT00195351|58602578|FG001|Overall Study|Death|1|||
30590093|NCT00195351|58602577|FG000|Overall Study|Lack of Efficacy|0|||
30673605|NCT00460603|58687607|FG009|Phase 1|Lack of Efficacy|0|||
30590094|NCT00195351|58602578|FG001|Overall Study|Lack of Efficacy|1|||
30673606|NCT00460603|58687608|FG010|Phase 1|Lack of Efficacy|0|||
30673607|NCT00460603|58687609|FG011|Phase 1|Lack of Efficacy|0|||
30673608|NCT00460603|58687598|FG000|Phase 1|Withdrawal by Subject|1|||
30673609|NCT00460603|58687599|FG001|Phase 1|Withdrawal by Subject|2|||
30590095|NCT00195273|58602586|FG000|Overall Study|Adverse Event|9|||
30590096|NCT00195273|58602587|FG001|Overall Study|Adverse Event|9|||
30673610|NCT00460603|58687600|FG002|Phase 1|Withdrawal by Subject|1|||
30673611|NCT00460603|58687601|FG003|Phase 1|Withdrawal by Subject|1|||
30673612|NCT00460603|58687602|FG004|Phase 1|Withdrawal by Subject|3|||
30673613|NCT00460603|58687603|FG005|Phase 1|Withdrawal by Subject|0|||
30673614|NCT00460603|58687604|FG006|Phase 1|Withdrawal by Subject|1|||
30673615|NCT00460603|58687605|FG007|Phase 1|Withdrawal by Subject|0|||
30673616|NCT00460603|58687606|FG008|Phase 1|Withdrawal by Subject|2|||
30590097|NCT00195273|58602586|FG000|Overall Study|Protocol deviation|0|||
30590098|NCT00195273|58602587|FG001|Overall Study|Protocol deviation|1|||
30590099|NCT00195273|58602586|FG000|Overall Study|Lack of Efficacy|3|||
30590100|NCT00195273|58602587|FG001|Overall Study|Lack of Efficacy|1|||
30673617|NCT00460603|58687607|FG009|Phase 1|Withdrawal by Subject|0|||
30673618|NCT00460603|58687608|FG010|Phase 1|Withdrawal by Subject|0|||
30673619|NCT00460603|58687609|FG011|Phase 1|Withdrawal by Subject|0|||
30673620|NCT00460603|58687598|FG000|Phase 1|Other|0|||
30590101|NCT00195273|58602586|FG000|Overall Study|Procedural complications|9|||
30590102|NCT00195273|58602587|FG001|Overall Study|Procedural complications|3|||
30590103|NCT00193479|58602593|FG000|Induction Chemotherapy|Adverse Event|2|||
30590104|NCT00193479|58602593|FG000|Induction Chemotherapy|Disease Progression|1|||
30590105|NCT00193479|58602593|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
30590106|NCT00193479|58602593|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
30590107|NCT00193206|58602597|FG000|Preoperative Therapy|Lack of Efficacy|2|||
30590108|NCT00193206|58602597|FG000|Preoperative Therapy|Adverse Event|2|||
30590109|NCT00193206|58602597|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
30590110|NCT00193206|58602597|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
30590111|NCT00193206|58602597|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
30590112|NCT00193206|58602597|FG000|Postoperative Therapy|Physician Decision|3|||
30590113|NCT00193206|58602597|FG000|Postoperative Therapy|Intercurrent Illness|2|||
30590114|NCT00193206|58602597|FG000|Postoperative Therapy|Lack of Efficacy|1|||
30590115|NCT00193206|58602597|FG000|Postoperative Therapy|Protocol Violation|1|||
30590116|NCT00193050|58602601|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
30673621|NCT00460603|58687599|FG001|Phase 1|Other|3|||
30673622|NCT00460603|58687600|FG002|Phase 1|Other|1|||
30673623|NCT00460603|58687601|FG003|Phase 1|Other|1|||
30673624|NCT00460603|58687602|FG004|Phase 1|Other|1|||
30673625|NCT00460603|58687603|FG005|Phase 1|Other|2|||
30673626|NCT00460603|58687604|FG006|Phase 1|Other|0|||
30673627|NCT00460603|58687605|FG007|Phase 1|Other|1|||
30673628|NCT00460603|58687606|FG008|Phase 1|Other|0|||
30673629|NCT00460603|58687607|FG009|Phase 1|Other|0|||
30673630|NCT00460603|58687608|FG010|Phase 1|Other|0|||
30673631|NCT00460603|58687609|FG011|Phase 1|Other|0|||
30673632|NCT00460603|58687598|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
30673633|NCT00460603|58687599|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
30673634|NCT00460603|58687600|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
30590117|NCT00193050|58602601|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
30590118|NCT00193050|58602601|FG000|Neoadjuvant Treatment|Physician Decision|2|||
30590119|NCT00193050|58602601|FG000|Neoadjuvant Treatment|Adverse Event|2|||
30590120|NCT00193050|58602601|FG000|Adjuvant|Physician Decision|5|||
30590121|NCT00193050|58602601|FG000|Adjuvant|Intercurrent Hospitalization|3|||
30590122|NCT00193050|58602601|FG000|Adjuvant|Lack of Efficacy|2|||
30590123|NCT00192504|58602610|FG000|Overall Study|Lost to Follow-up|1|||
30590124|NCT00192504|58602611|FG001|Overall Study|Lost to Follow-up|0|||
30590125|NCT00192504|58602612|FG002|Overall Study|Lost to Follow-up|0|||
30590126|NCT00192504|58602613|FG003|Overall Study|Lost to Follow-up|0|||
30590127|NCT00192504|58602610|FG000|Overall Study|Dosing window missed|0|||
30590128|NCT00192504|58602611|FG001|Overall Study|Dosing window missed|0|||
30590129|NCT00192504|58602612|FG002|Overall Study|Dosing window missed|1|||
30590130|NCT00192504|58602613|FG003|Overall Study|Dosing window missed|0|||
30590131|NCT00192114|58602623|FG000|Overall Study|Objective Tumor Progression|19|||
30590132|NCT00192114|58602623|FG000|Overall Study|Adverse Event|2|||
30590133|NCT00192114|58602623|FG000|Overall Study|Clinical Progression|2|||
30590134|NCT00192114|58602623|FG000|Overall Study|Death|1|||
30673635|NCT00460603|58687601|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
30673636|NCT00460603|58687602|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
30673637|NCT00460603|58687603|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
30673638|NCT00460603|58687604|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
30673639|NCT00460603|58687605|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
30673640|NCT00460603|58687606|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
30673641|NCT00460603|58687607|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
30673642|NCT00460603|58687608|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
30673643|NCT00460603|58687609|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
30673644|NCT00460603|58687598|FG000|Phase 2|Adverse Event|0|||
30673645|NCT00460603|58687599|FG001|Phase 2|Adverse Event|0|||
30673646|NCT00460603|58687600|FG002|Phase 2|Adverse Event|0|||
30673647|NCT00460603|58687601|FG003|Phase 2|Adverse Event|0|||
30673648|NCT00460603|58687602|FG004|Phase 2|Adverse Event|0|||
30673649|NCT00460603|58687603|FG005|Phase 2|Adverse Event|0|||
30673650|NCT00460603|58687604|FG006|Phase 2|Adverse Event|0|||
30673651|NCT00460603|58687605|FG007|Phase 2|Adverse Event|0|||
30673652|NCT00460603|58687606|FG008|Phase 2|Adverse Event|0|||
30590135|NCT00192075|58602629|FG000|Overall Study|Disease Progression|23|||
30673653|NCT00460603|58687607|FG009|Phase 2|Adverse Event|12|||
30673654|NCT00460603|58687608|FG010|Phase 2|Adverse Event|9|||
30673655|NCT00460603|58687609|FG011|Phase 2|Adverse Event|10|||
30673656|NCT00460603|58687598|FG000|Phase 2|Death|0|||
30673657|NCT00460603|58687599|FG001|Phase 2|Death|0|||
30590136|NCT00192075|58602630|FG001|Overall Study|Disease Progression|6|||
30590137|NCT00192075|58602629|FG000|Overall Study|Adverse Event|1|||
30590138|NCT00192075|58602630|FG001|Overall Study|Adverse Event|3|||
30590139|NCT00192075|58602629|FG000|Overall Study|Death|0|||
30590140|NCT00192075|58602630|FG001|Overall Study|Death|1|||
30590141|NCT00192075|58602629|FG000|Overall Study|Lack of Efficacy|0|||
30590142|NCT00192075|58602630|FG001|Overall Study|Lack of Efficacy|0|||
30590143|NCT00192075|58602629|FG000|Overall Study|Physician Decision|3|||
30590144|NCT00192075|58602630|FG001|Overall Study|Physician Decision|0|||
30673658|NCT00460603|58687600|FG002|Phase 2|Death|0|||
30673659|NCT00460603|58687601|FG003|Phase 2|Death|0|||
30673660|NCT00460603|58687602|FG004|Phase 2|Death|0|||
30673661|NCT00460603|58687603|FG005|Phase 2|Death|0|||
30673662|NCT00460603|58687604|FG006|Phase 2|Death|0|||
30673663|NCT00460603|58687605|FG007|Phase 2|Death|0|||
30673664|NCT00460603|58687606|FG008|Phase 2|Death|0|||
30673665|NCT00460603|58687607|FG009|Phase 2|Death|4|||
30673666|NCT00460603|58687608|FG010|Phase 2|Death|2|||
30673667|NCT00460603|58687609|FG011|Phase 2|Death|2|||
30673668|NCT00460603|58687598|FG000|Phase 2|Protocol Violation|0|||
30673669|NCT00460603|58687599|FG001|Phase 2|Protocol Violation|0|||
30673670|NCT00460603|58687600|FG002|Phase 2|Protocol Violation|0|||
30673671|NCT00460603|58687601|FG003|Phase 2|Protocol Violation|0|||
30673672|NCT00460603|58687602|FG004|Phase 2|Protocol Violation|0|||
30673673|NCT00460603|58687603|FG005|Phase 2|Protocol Violation|0|||
30673674|NCT00460603|58687604|FG006|Phase 2|Protocol Violation|0|||
30673675|NCT00460603|58687605|FG007|Phase 2|Protocol Violation|0|||
30673676|NCT00460603|58687606|FG008|Phase 2|Protocol Violation|0|||
30673677|NCT00460603|58687607|FG009|Phase 2|Protocol Violation|1|||
30673678|NCT00460603|58687608|FG010|Phase 2|Protocol Violation|1|||
30673679|NCT00460603|58687609|FG011|Phase 2|Protocol Violation|0|||
30673680|NCT00460603|58687598|FG000|Phase 2|Lost to Follow-up|0|||
30673681|NCT00460603|58687599|FG001|Phase 2|Lost to Follow-up|0|||
30673682|NCT00460603|58687600|FG002|Phase 2|Lost to Follow-up|0|||
30673683|NCT00460603|58687601|FG003|Phase 2|Lost to Follow-up|0|||
30673684|NCT00460603|58687602|FG004|Phase 2|Lost to Follow-up|0|||
30673685|NCT00460603|58687603|FG005|Phase 2|Lost to Follow-up|0|||
30673686|NCT00460603|58687604|FG006|Phase 2|Lost to Follow-up|0|||
30673687|NCT00460603|58687605|FG007|Phase 2|Lost to Follow-up|0|||
30673688|NCT00460603|58687606|FG008|Phase 2|Lost to Follow-up|0|||
30590145|NCT00192075|58602629|FG000|Overall Study|Withdrawal by Subject|5|||
30590146|NCT00192075|58602630|FG001|Overall Study|Withdrawal by Subject|5|||
30590147|NCT00192075|58602629|FG000|Overall Study|Patient Non-Compliance|0|||
30590148|NCT00192075|58602630|FG001|Overall Study|Patient Non-Compliance|1|||
30590149|NCT00192075|58602629|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
30590150|NCT00192075|58602630|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
30673689|NCT00460603|58687607|FG009|Phase 2|Lost to Follow-up|1|||
30673690|NCT00460603|58687608|FG010|Phase 2|Lost to Follow-up|0|||
30673691|NCT00460603|58687609|FG011|Phase 2|Lost to Follow-up|0|||
30673692|NCT00460603|58687598|FG000|Phase 2|Other|0|||
30673693|NCT00460603|58687599|FG001|Phase 2|Other|0|||
30673694|NCT00460603|58687600|FG002|Phase 2|Other|0|||
30673695|NCT00460603|58687601|FG003|Phase 2|Other|0|||
30673696|NCT00460603|58687602|FG004|Phase 2|Other|0|||
30673697|NCT00460603|58687603|FG005|Phase 2|Other|0|||
30673698|NCT00460603|58687604|FG006|Phase 2|Other|0|||
30673699|NCT00460603|58687605|FG007|Phase 2|Other|0|||
30673700|NCT00460603|58687606|FG008|Phase 2|Other|0|||
30673701|NCT00460603|58687607|FG009|Phase 2|Other|6|||
30673702|NCT00460603|58687608|FG010|Phase 2|Other|16|||
30673703|NCT00460603|58687609|FG011|Phase 2|Other|7|||
30673704|NCT00460603|58687598|FG000|Phase 2|Objective Progression or Relapse|0|||
30673705|NCT00460603|58687599|FG001|Phase 2|Objective Progression or Relapse|0|||
30673706|NCT00460603|58687600|FG002|Phase 2|Objective Progression or Relapse|0|||
30673707|NCT00460603|58687601|FG003|Phase 2|Objective Progression or Relapse|0|||
30673708|NCT00460603|58687602|FG004|Phase 2|Objective Progression or Relapse|0|||
30673709|NCT00460603|58687603|FG005|Phase 2|Objective Progression or Relapse|0|||
30673710|NCT00460603|58687604|FG006|Phase 2|Objective Progression or Relapse|0|||
30673711|NCT00460603|58687605|FG007|Phase 2|Objective Progression or Relapse|0|||
30673712|NCT00460603|58687606|FG008|Phase 2|Objective Progression or Relapse|0|||
30855915|NCT02165215|58883580|FG001|Maintenance Phase|Adverse Event|1|||
30855916|NCT02165215|58883581|FG002|Maintenance Phase|Adverse Event|1|||
30673713|NCT00460603|58687607|FG009|Phase 2|Objective Progression or Relapse|9|||
30673714|NCT00460603|58687608|FG010|Phase 2|Objective Progression or Relapse|10|||
30673715|NCT00460603|58687609|FG011|Phase 2|Objective Progression or Relapse|17|||
30673716|NCT00460603|58687598|FG000|Phase 2|Global Deterioration of Health Status|0|||
30673717|NCT00460603|58687599|FG001|Phase 2|Global Deterioration of Health Status|0|||
30673718|NCT00460603|58687600|FG002|Phase 2|Global Deterioration of Health Status|0|||
30673719|NCT00460603|58687601|FG003|Phase 2|Global Deterioration of Health Status|0|||
30673720|NCT00460603|58687602|FG004|Phase 2|Global Deterioration of Health Status|0|||
30673721|NCT00460603|58687603|FG005|Phase 2|Global Deterioration of Health Status|0|||
30673722|NCT00460603|58687604|FG006|Phase 2|Global Deterioration of Health Status|0|||
30855917|NCT02757625|58883596|FG000|Overall Study|Investigator's discretion|0|||
30590151|NCT00192075|58602629|FG000|Overall Study|Other|5|||
30590152|NCT00192075|58602630|FG001|Overall Study|Other|2|||
30590153|NCT00192036|58602641|FG000|Overall Study|Protocol Violation|3|||
30590154|NCT00192036|58602641|FG000|Overall Study|Adverse Event|6|||
30590155|NCT00192036|58602641|FG000|Overall Study|Patient/Physician Perception|1|||
30590156|NCT00192036|58602641|FG000|Overall Study|Objective Tumor Progression|4|||
30590157|NCT00192036|58602641|FG000|Overall Study|Clinical Disease Progression|1|||
30590158|NCT00192036|58602641|FG000|Overall Study|Death|1|||
30590159|NCT00192036|58602641|FG000|Overall Study|Unknown or Not Specified|5|||
30590160|NCT00191724|58602650|FG000|Overall Study|Adverse Event|0|||
30590161|NCT00191724|58602651|FG001|Overall Study|Adverse Event|0|||
30590162|NCT00191724|58602652|FG002|Overall Study|Adverse Event|1|||
30590163|NCT00191724|58602653|FG003|Overall Study|Adverse Event|0|||
30590164|NCT00191724|58602654|FG004|Overall Study|Adverse Event|0|||
30590165|NCT00191724|58602650|FG000|Overall Study|Lost to Follow-up|1|||
30590166|NCT00191724|58602651|FG001|Overall Study|Lost to Follow-up|1|||
30590167|NCT00191724|58602652|FG002|Overall Study|Lost to Follow-up|0|||
30590168|NCT00191724|58602653|FG003|Overall Study|Lost to Follow-up|2|||
30590169|NCT00191724|58602654|FG004|Overall Study|Lost to Follow-up|3|||
30590170|NCT00191724|58602650|FG000|Overall Study|Withdrawal by Subject|0|||
30590171|NCT00191724|58602651|FG001|Overall Study|Withdrawal by Subject|0|||
30590172|NCT00191724|58602652|FG002|Overall Study|Withdrawal by Subject|0|||
30590173|NCT00191724|58602653|FG003|Overall Study|Withdrawal by Subject|1|||
30590174|NCT00191724|58602654|FG004|Overall Study|Withdrawal by Subject|0|||
30590175|NCT00191646|58602668|FG000|Overall Study|Toxicity|26|||
30590176|NCT00191646|58602669|FG001|Overall Study|Toxicity|37|||
30590177|NCT00191646|58602668|FG000|Overall Study|Disease Progression|5|||
30590178|NCT00191646|58602669|FG001|Overall Study|Disease Progression|6|||
30590179|NCT00191646|58602668|FG000|Overall Study|Physician Decision|20|||
30673723|NCT00460603|58687605|FG007|Phase 2|Global Deterioration of Health Status|0|||
30673724|NCT00460603|58687606|FG008|Phase 2|Global Deterioration of Health Status|0|||
30673725|NCT00460603|58687607|FG009|Phase 2|Global Deterioration of Health Status|0|||
30673726|NCT00460603|58687608|FG010|Phase 2|Global Deterioration of Health Status|1|||
30673727|NCT00460603|58687609|FG011|Phase 2|Global Deterioration of Health Status|0|||
30673728|NCT00460603|58687598|FG000|Phase 2|Withdrawal by Subject|0|||
30673729|NCT00460603|58687599|FG001|Phase 2|Withdrawal by Subject|0|||
30855918|NCT02757625|58883597|FG001|Overall Study|Investigator's discretion|0|||
30855919|NCT02757625|58883598|FG002|Overall Study|Investigator's discretion|1|||
30855920|NCT02757625|58883599|FG003|Overall Study|Investigator's discretion|0|||
30855921|NCT02757625|58883596|FG000|Overall Study|Adverse Event|0|||
30855922|NCT02757625|58883597|FG001|Overall Study|Adverse Event|0|||
30855923|NCT02757625|58883598|FG002|Overall Study|Adverse Event|1|||
30855924|NCT02757625|58883599|FG003|Overall Study|Adverse Event|0|||
30855925|NCT02581202|58883611|FG000|Overall Study|Lack of Efficacy|2|||
30855926|NCT02581202|58883611|FG000|Overall Study|Withdrawal by Subject|4|||
30855927|NCT02581202|58883611|FG000|Overall Study|Lost to Follow-up|5|||
30855928|NCT02581202|58883611|FG000|Overall Study|Pregnancy|3|||
30855929|NCT02758171|58883618|FG000|Wash-out|Withdrawal by Subject|1|||
30855930|NCT02758171|58883619|FG001|Wash-out|Withdrawal by Subject|0|||
30590180|NCT00191646|58602669|FG001|Overall Study|Physician Decision|11|||
30590181|NCT00191646|58602668|FG000|Overall Study|Withdrawal by Subject|58|||
30590182|NCT00191646|58602669|FG001|Overall Study|Withdrawal by Subject|39|||
30590183|NCT00191646|58602668|FG000|Overall Study|Protocol Violation|5|||
30590184|NCT00191646|58602669|FG001|Overall Study|Protocol Violation|7|||
30590185|NCT00191646|58602668|FG000|Overall Study|Death|6|||
30590186|NCT00191646|58602669|FG001|Overall Study|Death|8|||
30590187|NCT00191646|58602668|FG000|Overall Study|Other|33|||
30590188|NCT00191646|58602669|FG001|Overall Study|Other|34|||
30673730|NCT00460603|58687600|FG002|Phase 2|Withdrawal by Subject|0|||
30673731|NCT00460603|58687601|FG003|Phase 2|Withdrawal by Subject|0|||
30781579|NCT03445533|58793602|FG001|Overall Study|Never Received any Study Treatment|4|||
30781580|NCT01337050|58793611|FG000|Overall Study|Death|0|||
30781581|NCT01337050|58793612|FG001|Overall Study|Death|0|||
30781582|NCT01337050|58793613|FG002|Overall Study|Death|4|||
30673732|NCT00460603|58687602|FG004|Phase 2|Withdrawal by Subject|0|||
30781583|NCT01337050|58793611|FG000|Overall Study|Other|4|||
30781584|NCT01337050|58793612|FG001|Overall Study|Other|6|||
30781585|NCT01337050|58793613|FG002|Overall Study|Other|8|||
30781586|NCT01337050|58793611|FG000|Overall Study|Participants refused further follow-up|0|||
30781587|NCT01337050|58793612|FG001|Overall Study|Participants refused further follow-up|7|||
30781588|NCT01337050|58793613|FG002|Overall Study|Participants refused further follow-up|7|||
30781589|NCT01336972|58793625|FG000|Overall Study|Adverse Event|1|||
30781590|NCT01336972|58793626|FG001|Overall Study|Adverse Event|1|||
30781591|NCT01336972|58793627|FG002|Overall Study|Adverse Event|0|||
30781592|NCT03762681|58793644|FG000|Part 1|Withdrawal by Subject|0|||
30781593|NCT03762681|58793645|FG001|Part 1|Withdrawal by Subject|0|||
30590189|NCT00191646|58602668|FG000|Overall Study|Missing Data|18|||
30855931|NCT02758171|58883618|FG000|Wash-out|Other reason|1|||
30855932|NCT02758171|58883619|FG001|Wash-out|Other reason|0|||
30673733|NCT00460603|58687603|FG005|Phase 2|Withdrawal by Subject|0|||
30673734|NCT00460603|58687604|FG006|Phase 2|Withdrawal by Subject|0|||
30673735|NCT00460603|58687605|FG007|Phase 2|Withdrawal by Subject|0|||
30673736|NCT00460603|58687606|FG008|Phase 2|Withdrawal by Subject|0|||
30673737|NCT00460603|58687607|FG009|Phase 2|Withdrawal by Subject|5|||
30673738|NCT00460603|58687608|FG010|Phase 2|Withdrawal by Subject|4|||
30855933|NCT01664078|58883648|FG000|Overall Study|Death|9|||
30590190|NCT00191646|58602669|FG001|Overall Study|Missing Data|11|||
30590191|NCT00191451|58602686|FG000|Overall Study|Withdrawal by Subject|2|||
30673739|NCT00460603|58687609|FG011|Phase 2|Withdrawal by Subject|5|||
30673740|NCT00460603|58687598|FG000|Phase 2|Randomized, but not treated|0|||
30673741|NCT00460603|58687599|FG001|Phase 2|Randomized, but not treated|0|||
30673742|NCT00460603|58687600|FG002|Phase 2|Randomized, but not treated|0|||
30673743|NCT00460603|58687601|FG003|Phase 2|Randomized, but not treated|0|||
30673744|NCT00460603|58687602|FG004|Phase 2|Randomized, but not treated|0|||
30673745|NCT00460603|58687603|FG005|Phase 2|Randomized, but not treated|0|||
30673746|NCT00460603|58687604|FG006|Phase 2|Randomized, but not treated|0|||
30673747|NCT00460603|58687605|FG007|Phase 2|Randomized, but not treated|0|||
30673748|NCT00460603|58687606|FG008|Phase 2|Randomized, but not treated|0|||
30673749|NCT00460603|58687607|FG009|Phase 2|Randomized, but not treated|3|||
30673750|NCT00460603|58687608|FG010|Phase 2|Randomized, but not treated|0|||
30673751|NCT00460603|58687609|FG011|Phase 2|Randomized, but not treated|0|||
30673752|NCT00662038|58687635|FG000|Overall Study|Reason not specified|3|||
30673753|NCT00662038|58687635|FG000|Overall Study|Withdrawn consent|22|||
30673754|NCT00662038|58687635|FG000|Overall Study|Withdrawal by Subject|83|||
30673755|NCT00662038|58687635|FG000|Overall Study|Sponsor decision|1|||
30673756|NCT00662038|58687635|FG000|Overall Study|Physician Decision|19|||
30673757|NCT00662038|58687635|FG000|Overall Study|Lung transplantation|44|||
30673758|NCT00662038|58687635|FG000|Overall Study|Lost to Follow-up|1|||
30673759|NCT00662038|58687635|FG000|Overall Study|Death|95|||
30673760|NCT00662038|58687635|FG000|Overall Study|Adverse Event|358|||
30673761|NCT00662038|58687635|FG000|Overall Study|Continued treatment|5|||
30673762|NCT00819156|58687645|FG000|Overall Study|Adverse Event|1|||
30673763|NCT00819156|58687646|FG001|Overall Study|Adverse Event|4|||
30673764|NCT00819156|58687647|FG002|Overall Study|Adverse Event|2|||
30673765|NCT00819156|58687648|FG003|Overall Study|Adverse Event|1|||
30673766|NCT00819156|58687649|FG004|Overall Study|Adverse Event|2|||
30673767|NCT00819156|58687650|FG005|Overall Study|Adverse Event|3|||
30673768|NCT00819156|58687645|FG000|Overall Study|Withdrawal by Subject|0|||
30781594|NCT03762681|58793646|FG002|Part 1|Withdrawal by Subject|0|||
30781595|NCT03762681|58793647|FG003|Part 1|Withdrawal by Subject|1|||
30781596|NCT03762681|58793648|FG004|Part 1|Withdrawal by Subject|0|||
30781597|NCT03762681|58793649|FG005|Part 1|Withdrawal by Subject|0|||
30781598|NCT03762681|58793650|FG006|Part 1|Withdrawal by Subject|0|||
30781599|NCT03762681|58793651|FG007|Part 1|Withdrawal by Subject|0|||
30781600|NCT03762681|58793644|FG000|Part 2a|Pandemic Travel Restrictions|0|||
30781601|NCT03762681|58793645|FG001|Part 2a|Pandemic Travel Restrictions|0|||
30781602|NCT03762681|58793646|FG002|Part 2a|Pandemic Travel Restrictions|0|||
30781603|NCT03762681|58793647|FG003|Part 2a|Pandemic Travel Restrictions|0|||
30781604|NCT03762681|58793648|FG004|Part 2a|Pandemic Travel Restrictions|0|||
30781605|NCT03762681|58793649|FG005|Part 2a|Pandemic Travel Restrictions|0|||
30781606|NCT03762681|58793650|FG006|Part 2a|Pandemic Travel Restrictions|0|||
30590192|NCT00191451|58602687|FG001|Overall Study|Withdrawal by Subject|3|||
30590193|NCT00191451|58602688|FG002|Overall Study|Withdrawal by Subject|5|||
30590194|NCT00191451|58602686|FG000|Overall Study|Physician Decision|2|||
30590195|NCT00191451|58602687|FG001|Overall Study|Physician Decision|9|||
30590196|NCT00191451|58602688|FG002|Overall Study|Physician Decision|6|||
30590197|NCT00191451|58602686|FG000|Overall Study|Sponsor Decision|1|||
30590198|NCT00191451|58602687|FG001|Overall Study|Sponsor Decision|0|||
30590199|NCT00191451|58602688|FG002|Overall Study|Sponsor Decision|0|||
30590200|NCT00191451|58602686|FG000|Overall Study|Ineligible|0|||
30590201|NCT00191451|58602687|FG001|Overall Study|Ineligible|1|||
30590202|NCT00191451|58602688|FG002|Overall Study|Ineligible|0|||
30590203|NCT00191451|58602686|FG000|Overall Study|Reason Not Specified|2|||
30590204|NCT00191451|58602687|FG001|Overall Study|Reason Not Specified|1|||
30590205|NCT00191451|58602688|FG002|Overall Study|Reason Not Specified|3|||
30590206|NCT00191334|58602696|FG000|Overall Study|Adverse Event|4|||
30590207|NCT00191334|58602696|FG000|Overall Study|Disease Progression or Relapse|8|||
30673769|NCT00819156|58687646|FG001|Overall Study|Withdrawal by Subject|3|||
30781607|NCT03762681|58793651|FG007|Part 2a|Pandemic Travel Restrictions|1|||
30590208|NCT00191334|58602696|FG000|Overall Study|Physician Decision|1|||
30590209|NCT00191334|58602696|FG000|Overall Study|Withdrawal by Subject|4|||
30590210|NCT00191139|58602702|FG000|Overall Study|Adverse Event|2|||
30590211|NCT00191139|58602703|FG001|Overall Study|Adverse Event|6|||
30673770|NCT00819156|58687647|FG002|Overall Study|Withdrawal by Subject|2|||
30673771|NCT00819156|58687648|FG003|Overall Study|Withdrawal by Subject|0|||
30673772|NCT00819156|58687649|FG004|Overall Study|Withdrawal by Subject|1|||
30781608|NCT03764475|58793680|FG000|Overall Study|Adverse Event|11|||
30855934|NCT01664078|58883648|FG000|Overall Study|Withdrawal by Subject|4|||
30855935|NCT01664078|58883648|FG000|Overall Study|Lost to Follow-up|2|||
30855936|NCT01664078|58883648|FG000|Overall Study|missed 5 year visit|1|||
30855937|NCT01664078|58883648|FG000|Overall Study|Other|53|||
30855938|NCT03367403|58883701|FG000|Overall Study|Adverse Event|20|||
30855939|NCT03367403|58883702|FG001|Overall Study|Adverse Event|6|||
30855940|NCT03367403|58883703|FG002|Overall Study|Adverse Event|2|||
30855941|NCT03367403|58883701|FG000|Overall Study|Withdrawal by Subject|12|||
30855942|NCT03367403|58883702|FG001|Overall Study|Withdrawal by Subject|13|||
30855943|NCT03367403|58883703|FG002|Overall Study|Withdrawal by Subject|1|||
30855944|NCT03367403|58883701|FG000|Overall Study|Death|1|||
30855945|NCT03367403|58883702|FG001|Overall Study|Death|2|||
30855946|NCT03367403|58883703|FG002|Overall Study|Death|0|||
30855947|NCT03367403|58883701|FG000|Overall Study|Physician Decision|0|||
30855948|NCT03367403|58883702|FG001|Overall Study|Physician Decision|1|||
30855949|NCT03367403|58883703|FG002|Overall Study|Physician Decision|0|||
30855950|NCT03367403|58883701|FG000|Overall Study|Protocol Violation|1|||
30855951|NCT03367403|58883702|FG001|Overall Study|Protocol Violation|1|||
30855952|NCT03367403|58883703|FG002|Overall Study|Protocol Violation|0|||
30855953|NCT03367403|58883701|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
30855954|NCT03367403|58883702|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
30855955|NCT03367403|58883703|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
30855956|NCT03367403|58883701|FG000|Overall Study|COVID-19|3|||
30855957|NCT03367403|58883702|FG001|Overall Study|COVID-19|6|||
30855958|NCT03367403|58883703|FG002|Overall Study|COVID-19|0|||
30855959|NCT03367403|58883701|FG000|Overall Study|Abuse of Alcohol Intake|0|||
30855960|NCT03367403|58883702|FG001|Overall Study|Abuse of Alcohol Intake|1|||
30855961|NCT03367403|58883703|FG002|Overall Study|Abuse of Alcohol Intake|0|||
30855962|NCT03367403|58883701|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
30673773|NCT00819156|58687650|FG005|Overall Study|Withdrawal by Subject|0|||
30673774|NCT00819156|58687645|FG000|Overall Study|Protocol Violation|1|||
30673775|NCT00819156|58687646|FG001|Overall Study|Protocol Violation|0|||
30673776|NCT00819156|58687647|FG002|Overall Study|Protocol Violation|1|||
30673777|NCT00819156|58687648|FG003|Overall Study|Protocol Violation|0|||
30673778|NCT00819156|58687649|FG004|Overall Study|Protocol Violation|0|||
30673779|NCT00819156|58687650|FG005|Overall Study|Protocol Violation|1|||
30673780|NCT00819156|58687645|FG000|Overall Study|Lost to Follow-up|0|||
30673781|NCT00819156|58687646|FG001|Overall Study|Lost to Follow-up|1|||
30673782|NCT00819156|58687647|FG002|Overall Study|Lost to Follow-up|0|||
30673783|NCT00819156|58687648|FG003|Overall Study|Lost to Follow-up|0|||
30673784|NCT00819156|58687649|FG004|Overall Study|Lost to Follow-up|0|||
30673785|NCT00819156|58687650|FG005|Overall Study|Lost to Follow-up|2|||
30673786|NCT00819156|58687645|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
30673787|NCT00819156|58687646|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
30673788|NCT00819156|58687647|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
30673789|NCT00819156|58687648|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
30673790|NCT00819156|58687649|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
30673791|NCT00819156|58687650|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
30673792|NCT00819156|58687645|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
30673793|NCT00819156|58687646|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
30673794|NCT00819156|58687647|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
30673795|NCT00819156|58687648|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
30781609|NCT03764475|58793681|FG001|Overall Study|Adverse Event|2|||
30781610|NCT03764475|58793680|FG000|Overall Study|Lost to Follow-up|24|||
30781611|NCT03764475|58793681|FG001|Overall Study|Lost to Follow-up|10|||
30781612|NCT03764475|58793680|FG000|Overall Study|Withdrawal by Subject|26|||
30781613|NCT03764475|58793681|FG001|Overall Study|Withdrawal by Subject|10|||
30781614|NCT03764475|58793680|FG000|Overall Study|Lack of Efficacy|3|||
30781615|NCT03764475|58793681|FG001|Overall Study|Lack of Efficacy|0|||
30781616|NCT03764475|58793680|FG000|Overall Study|COVID-19 Disruption|2|||
30781617|NCT03764475|58793681|FG001|Overall Study|COVID-19 Disruption|0|||
30781618|NCT02873338|58793694|FG000|Overall Study|Adverse Event|0|||
30781619|NCT02873338|58793695|FG001|Overall Study|Adverse Event|2|||
30781620|NCT02873338|58793696|FG002|Overall Study|Adverse Event|1|||
30781621|NCT02873338|58793694|FG000|Overall Study|Death|2|||
30781622|NCT02873338|58793695|FG001|Overall Study|Death|1|||
30781623|NCT02873338|58793696|FG002|Overall Study|Death|1|||
30781624|NCT02873338|58793694|FG000|Overall Study|Withdrawal by Subject|2|||
30855963|NCT03367403|58883702|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
30855964|NCT03367403|58883703|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
30855965|NCT02577146|58883711|FG000|Overall Study|Lost to Follow-up|8|||
30855966|NCT02577146|58883711|FG000|Overall Study|Physician Decision|3|||
30855967|NCT02577146|58883711|FG000|Overall Study|Screen Failure|17|||
30673796|NCT00819156|58687649|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
30673797|NCT00819156|58687650|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
30673798|NCT00819156|58687645|FG000|Overall Study|Prostate-specific antigen progression|0|||
30673799|NCT00819156|58687646|FG001|Overall Study|Prostate-specific antigen progression|0|||
30855968|NCT00109967|58883717|FG000|Overall Study|Cancel Prior to Treatment|2|||
30855969|NCT00109967|58883718|FG001|Overall Study|Cancel Prior to Treatment|0|||
30855970|NCT00109967|58883717|FG000|Overall Study|Adverse Event|12|||
30855971|NCT00109967|58883718|FG001|Overall Study|Adverse Event|1|||
30855972|NCT00109967|58883717|FG000|Overall Study|Withdrawal by Subject|5|||
30855973|NCT00109967|58883718|FG001|Overall Study|Withdrawal by Subject|0|||
30781625|NCT02873338|58793695|FG001|Overall Study|Withdrawal by Subject|1|||
30673800|NCT00819156|58687647|FG002|Overall Study|Prostate-specific antigen progression|0|||
30673801|NCT00819156|58687648|FG003|Overall Study|Prostate-specific antigen progression|0|||
30673802|NCT00819156|58687649|FG004|Overall Study|Prostate-specific antigen progression|1|||
30673803|NCT00819156|58687650|FG005|Overall Study|Prostate-specific antigen progression|0|||
30781626|NCT02873338|58793696|FG002|Overall Study|Withdrawal by Subject|3|||
30781627|NCT02873338|58793694|FG000|Overall Study|Lack of Efficacy|0|||
30781628|NCT02873338|58793695|FG001|Overall Study|Lack of Efficacy|2|||
30781629|NCT02873338|58793696|FG002|Overall Study|Lack of Efficacy|0|||
30781630|NCT02873338|58793694|FG000|Overall Study|Other or Missing|14|||
30781631|NCT02873338|58793695|FG001|Overall Study|Other or Missing|15|||
30781632|NCT02873338|58793696|FG002|Overall Study|Other or Missing|13|||
30781633|NCT02872012|58793709|FG000|Overall Study|Withdrawal by Subject|1|||
30855974|NCT00109967|58883717|FG000|Overall Study|Physician Decision|1|||
30855975|NCT00109967|58883718|FG001|Overall Study|Physician Decision|3|||
30855976|NCT00109967|58883717|FG000|Overall Study|Death|0|||
30855977|NCT00109967|58883718|FG001|Overall Study|Death|2|||
30855978|NCT02579096|58883726|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
30855979|NCT02579096|58883727|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
30855980|NCT02579096|58883726|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
30855981|NCT02579096|58883727|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
30673804|NCT00459979|58687672|FG000|Overall Study|Withdrawal by Subject|1|||
30673805|NCT00459979|58687672|FG000|Overall Study|Protocol Violation|1|||
30673806|NCT00851786|58687678|FG000|Overall Study|Withdrawal by Subject|0|||
30673807|NCT00851786|58687679|FG001|Overall Study|Withdrawal by Subject|1|||
30673808|NCT00851786|58687678|FG000|Overall Study|Protocol Violation|0|||
30673809|NCT00851786|58687679|FG001|Overall Study|Protocol Violation|1|||
30673810|NCT00851786|58687678|FG000|Overall Study|Lost to Follow-up|1|||
30673811|NCT00851786|58687679|FG001|Overall Study|Lost to Follow-up|0|||
30673812|NCT00851786|58687678|FG000|Overall Study|Incarceration|1|||
30855982|NCT02579096|58883726|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
30855983|NCT02579096|58883727|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
30855984|NCT02579096|58883726|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
30855985|NCT02579096|58883727|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
30855986|NCT02579096|58883726|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
30673813|NCT00851786|58687679|FG001|Overall Study|Incarceration|0|||
30673814|NCT00851786|58687678|FG000|Overall Study|Site Closure|1|||
30673815|NCT00851786|58687679|FG001|Overall Study|Site Closure|0|||
30673816|NCT00851786|58687678|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
30673817|NCT00851786|58687679|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
30673818|NCT00665626|58687687|FG000|Overall Study|Lack of Efficacy|8|||
30673819|NCT00665626|58687688|FG001|Overall Study|Lack of Efficacy|5|||
30673820|NCT00665626|58687687|FG000|Overall Study|Lost to Follow-up|0|||
30673821|NCT00665626|58687688|FG001|Overall Study|Lost to Follow-up|2|||
30673822|NCT00665626|58687687|FG000|Overall Study|Withdrawal by Subject|0|||
30673823|NCT00665626|58687688|FG001|Overall Study|Withdrawal by Subject|1|||
30673824|NCT00665626|58687687|FG000|Overall Study|Protocol Violation|0|||
30673825|NCT00665626|58687688|FG001|Overall Study|Protocol Violation|2|||
30673826|NCT00665626|58687687|FG000|Overall Study|Adverse Event|1|||
30673827|NCT00665626|58687688|FG001|Overall Study|Adverse Event|9|||
30673828|NCT00665626|58687687|FG000|Overall Study|Due to exclusion criteria|0|||
30673829|NCT00665626|58687688|FG001|Overall Study|Due to exclusion criteria|1|||
30673830|NCT00665626|58687687|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
30673831|NCT00665626|58687688|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
30673832|NCT00665626|58687687|FG000|Overall Study|Unably to comply with dosing regimen|0|||
30673833|NCT00665626|58687688|FG001|Overall Study|Unably to comply with dosing regimen|1|||
30673834|NCT00665626|58687687|FG000|Overall Study|Death|1|||
30673835|NCT00665626|58687688|FG001|Overall Study|Death|0|||
30673836|NCT00828672|58687696|FG000|Study Treatment|Lost to Follow-up|1|||
30673837|NCT00828672|58687697|FG001|Study Treatment|Lost to Follow-up|0|||
30781634|NCT02872012|58793710|FG001|Overall Study|Withdrawal by Subject|0|||
30855987|NCT02579096|58883727|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
30855988|NCT02579096|58883726|FG000|Phase 2, Weeks 25 - 48|Death|2|||
30855989|NCT02579096|58883727|FG001|Phase 2, Weeks 25 - 48|Death|4|||
30855990|NCT02579096|58883726|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
30855991|NCT02579096|58883727|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
30673838|NCT00828672|58687696|FG000|Study Treatment|Adverse Event|0|||
30673839|NCT00828672|58687697|FG001|Study Treatment|Adverse Event|1|||
30673840|NCT00828672|58687696|FG000|Study Treatment|Complete response, no surgery|1|||
30673841|NCT00828672|58687697|FG001|Study Treatment|Complete response, no surgery|1|||
30855992|NCT02579096|58883726|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
30855993|NCT02579096|58883727|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
30855994|NCT02579096|58883726|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
30855995|NCT02579096|58883727|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
30855996|NCT02579096|58883726|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
30855997|NCT02579096|58883727|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
30855998|NCT02579096|58883726|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
30855999|NCT02579096|58883727|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
30856000|NCT02579096|58883726|FG000|Phase 3, Weeks 49 - 72|Death|3|||
30856001|NCT02579096|58883727|FG001|Phase 3, Weeks 49 - 72|Death|2|||
30856002|NCT02579096|58883726|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
30856003|NCT02579096|58883727|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
30856004|NCT02579096|58883726|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
30856005|NCT02579096|58883727|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
30856006|NCT02579096|58883726|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
30856007|NCT02579096|58883727|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
30856008|NCT02579096|58883726|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
30856009|NCT02579096|58883727|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
30856010|NCT02579096|58883726|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
30856011|NCT02579096|58883727|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
30856012|NCT02579096|58883726|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
30673842|NCT00828672|58687696|FG000|Post-surgery (<30 Days)|No central review materials|0|||
30673843|NCT00828672|58687697|FG001|Post-surgery (<30 Days)|No central review materials|1|||
30673844|NCT00873119|58687705|FG000|Overall Study|Patient request|4|||
30673845|NCT00873119|58687706|FG001|Overall Study|Patient request|2|||
30673846|NCT00873119|58687705|FG000|Overall Study|Adverse Event|8|||
30673847|NCT00873119|58687706|FG001|Overall Study|Adverse Event|0|||
30673848|NCT00873119|58687705|FG000|Overall Study|Progressive disease|26|||
30673849|NCT00873119|58687706|FG001|Overall Study|Progressive disease|18|||
30673850|NCT00873119|58687705|FG000|Overall Study|Death|2|||
30673851|NCT00873119|58687706|FG001|Overall Study|Death|1|||
30673852|NCT00873119|58687705|FG000|Overall Study|Other|2|||
30673853|NCT00873119|58687706|FG001|Overall Study|Other|5|||
30673854|NCT00873119|58687705|FG000|Overall Study|Not treated|2|||
30673855|NCT00873119|58687706|FG001|Overall Study|Not treated|0|||
30673856|NCT00661726|58687712|FG000|Overall Study|Adverse Event|1|||
30673857|NCT00865046|58687719|FG000|Overall Study|Lost to Follow-up|1|||
30673858|NCT00865046|58687720|FG001|Overall Study|Lost to Follow-up|4|||
30673859|NCT00865046|58687721|FG002|Overall Study|Lost to Follow-up|0|||
30673860|NCT00865046|58687719|FG000|Overall Study|Death|0|||
30673861|NCT00865046|58687720|FG001|Overall Study|Death|1|||
30673862|NCT00865046|58687721|FG002|Overall Study|Death|1|||
30673863|NCT00865046|58687719|FG000|Overall Study|Withdrawal by Subject|5|||
30673864|NCT00865046|58687720|FG001|Overall Study|Withdrawal by Subject|0|||
30673865|NCT00865046|58687721|FG002|Overall Study|Withdrawal by Subject|0|||
30673866|NCT00828516|58687729|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
30673867|NCT00665392|58687733|FG000|Overall Study|not treated|1|||
30673868|NCT00851630|58687740|FG000|Overall Study|Death|2|||
30673869|NCT00851630|58687741|FG001|Overall Study|Death|1|||
30673870|NCT00851630|58687740|FG000|Overall Study|Clinical failure|0|||
30673871|NCT00851630|58687741|FG001|Overall Study|Clinical failure|1|||
30673872|NCT00459667|58687750|FG000|Overall Study|Adverse Event|9|||
30673873|NCT00459667|58687751|FG001|Overall Study|Adverse Event|12|||
30673874|NCT00459667|58687752|FG002|Overall Study|Adverse Event|8|||
30673875|NCT00459667|58687750|FG000|Overall Study|Lost to Follow-up|5|||
30673876|NCT00459667|58687751|FG001|Overall Study|Lost to Follow-up|9|||
30673877|NCT00459667|58687752|FG002|Overall Study|Lost to Follow-up|3|||
30673878|NCT00459667|58687750|FG000|Overall Study|Pregnancy|1|||
30673879|NCT00459667|58687751|FG001|Overall Study|Pregnancy|1|||
30673880|NCT00459667|58687752|FG002|Overall Study|Pregnancy|1|||
30673881|NCT00459667|58687750|FG000|Overall Study|Protocol Violation|1|||
30673882|NCT00459667|58687751|FG001|Overall Study|Protocol Violation|0|||
30673883|NCT00459667|58687752|FG002|Overall Study|Protocol Violation|0|||
30673884|NCT00459667|58687750|FG000|Overall Study|Withdrawal by Subject|3|||
30673885|NCT00459667|58687751|FG001|Overall Study|Withdrawal by Subject|5|||
30673886|NCT00459667|58687752|FG002|Overall Study|Withdrawal by Subject|5|||
30673887|NCT00459667|58687750|FG000|Overall Study|Other disease modifying treatment|1|||
30856013|NCT02579096|58883727|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
30856014|NCT02578940|58883733|FG000|Overall Study|Screening failure|5|||
30856015|NCT02578940|58883733|FG000|Overall Study|Lost to Follow-up|1|||
30673888|NCT00459667|58687751|FG001|Overall Study|Other disease modifying treatment|2|||
30673889|NCT00459667|58687752|FG002|Overall Study|Other disease modifying treatment|1|||
30673890|NCT00459667|58687750|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
30673891|NCT00459667|58687751|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
30673892|NCT00459667|58687752|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
30673893|NCT00459667|58687750|FG000|Overall Study|No treatment administered|6|||
30673894|NCT00459667|58687751|FG001|Overall Study|No treatment administered|3|||
30673895|NCT00459667|58687752|FG002|Overall Study|No treatment administered|1|||
30673896|NCT00828204|58687762|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
30673897|NCT00828204|58687763|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
30673898|NCT00828204|58687762|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
30673899|NCT00828204|58687763|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
30673900|NCT00828204|58687762|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
30673901|NCT00828204|58687763|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
30673902|NCT00828204|58687762|FG000|Main Study: After Study Restart|Adverse Event|0|||
30673903|NCT00828204|58687763|FG001|Main Study: After Study Restart|Adverse Event|2|||
30673904|NCT00828204|58687762|FG000|Main Study: After Study Restart|Noncompliance|0|||
30673905|NCT00828204|58687763|FG001|Main Study: After Study Restart|Noncompliance|1|||
30673906|NCT00828204|58687762|FG000|Extension Study|Lost to Follow-up|0|||
30673907|NCT00828204|58687763|FG001|Extension Study|Lost to Follow-up|1|||
30673908|NCT00828204|58687762|FG000|Extension Study|Physician Decision|0|||
30673909|NCT00828204|58687763|FG001|Extension Study|Physician Decision|2|||
30673910|NCT00851552|58687770|FG000|Overall Study|Death|2|||
30673911|NCT00851552|58687770|FG000|Overall Study|Adverse Event|1|||
30673912|NCT00851552|58687770|FG000|Overall Study|Disease Progression|4|||
30673913|NCT00459355|58687776|FG000|Overall Study|Subject no longer met inc criteria|20|||
30673914|NCT00459355|58687777|FG001|Overall Study|Subject no longer met inc criteria|18|||
30673915|NCT00459043|58687789|FG000|Overall Study|Withdrawal by Subject|1|||
30673916|NCT00459043|58687790|FG001|Overall Study|Withdrawal by Subject|0|||
30673917|NCT00817206|58687798|FG000|Overall Study|Adverse Event|10|||
30673918|NCT00817206|58687799|FG001|Overall Study|Adverse Event|3|||
30673919|NCT00817206|58687798|FG000|Overall Study|Protocol Violation|0|||
30673920|NCT00817206|58687799|FG001|Overall Study|Protocol Violation|2|||
30673921|NCT00817206|58687798|FG000|Overall Study|Lost to Follow-up|0|||
30673922|NCT00817206|58687799|FG001|Overall Study|Lost to Follow-up|1|||
30781635|NCT02872012|58793711|FG002|Overall Study|Withdrawal by Subject|0|||
30781636|NCT02872012|58793712|FG003|Overall Study|Withdrawal by Subject|0|||
30781637|NCT02872012|58793713|FG004|Overall Study|Withdrawal by Subject|0|||
30781638|NCT02959138|58793730|FG000|Overall Study|Enrolled but Never Treated|0|||
30781639|NCT02959138|58793731|FG001|Overall Study|Enrolled but Never Treated|1|||
30673923|NCT00817206|58687798|FG000|Overall Study|Death|2|||
30673924|NCT00817206|58687799|FG001|Overall Study|Death|0|||
30673925|NCT00817206|58687798|FG000|Overall Study|Withdrawal by Subject|7|||
30673926|NCT00817206|58687799|FG001|Overall Study|Withdrawal by Subject|3|||
30673927|NCT00817206|58687798|FG000|Overall Study|Physician Decision|2|||
30673928|NCT00817206|58687799|FG001|Overall Study|Physician Decision|0|||
30673929|NCT00665002|58687805|FG000|Overall Study|Progression/relapse during treatment|11|||
30673930|NCT00665002|58687805|FG000|Overall Study|Cytogenetic resistance|1|||
30673931|NCT03847987|58687811|FG000|Overall Study|Lost to Follow-up|1|||
30673932|NCT03847987|58687812|FG001|Overall Study|Lost to Follow-up|0|||
30673933|NCT03847987|58687811|FG000|Overall Study|Adverse Event|2|||
30673934|NCT03847987|58687812|FG001|Overall Study|Adverse Event|0|||
30673935|NCT00660010|58687829|FG000|Overall Study|Withdrawal by Subject|2|||
30673936|NCT00660010|58687829|FG000|Overall Study|Lost to Follow-up|3|||
30673937|NCT00660010|58687829|FG000|Overall Study|Adverse Event|1|||
30673938|NCT00660010|58687829|FG000|Overall Study|Noncompliance with visit schedule|3|||
30673939|NCT00873041|58687836|FG000|Core Study|Adverse Event|2|||
30673940|NCT00873041|58687837|FG001|Core Study|Adverse Event|3|||
30673941|NCT00873041|58687838|FG002|Core Study|Adverse Event|1|||
30673942|NCT00873041|58687836|FG000|Core Study|Withdrawal by Subject|1|||
30673943|NCT00873041|58687837|FG001|Core Study|Withdrawal by Subject|2|||
30673944|NCT00873041|58687838|FG002|Core Study|Withdrawal by Subject|2|||
30673945|NCT00873041|58687836|FG000|Core Study|Lost to Follow-up|3|||
30673946|NCT00873041|58687837|FG001|Core Study|Lost to Follow-up|1|||
30673947|NCT00873041|58687838|FG002|Core Study|Lost to Follow-up|0|||
30673948|NCT00873041|58687836|FG000|Core Study|Abnormal laboratory value|0|||
30673949|NCT00873041|58687837|FG001|Core Study|Abnormal laboratory value|0|||
30781640|NCT02959138|58793732|FG002|Overall Study|Enrolled but Never Treated|0|||
30781641|NCT01344226|58793744|FG000|Overall Study|Protocol Violation|2|||
30781642|NCT01344226|58793744|FG000|Overall Study|Withdrawal by Subject|3|||
30781643|NCT01344226|58793744|FG000|Overall Study|Lack of Efficacy|3|||
30781644|NCT02869438|58793750|FG000|Overall Study|Lost to Follow-up|1|||
30781645|NCT02869438|58793751|FG001|Overall Study|Lost to Follow-up|0|||
30781646|NCT02869438|58793750|FG000|Overall Study|Adverse Event|1|||
30673950|NCT00873041|58687838|FG002|Core Study|Abnormal laboratory value|1|||
30673951|NCT00873041|58687836|FG000|Core Study|Protocol deviation|1|||
30673952|NCT00873041|58687837|FG001|Core Study|Protocol deviation|0|||
30673953|NCT00873041|58687838|FG002|Core Study|Protocol deviation|1|||
30673954|NCT00873041|58687836|FG000|Extension Study|Adverse Event|1|||
30673955|NCT00873041|58687837|FG001|Extension Study|Adverse Event|0|||
30673956|NCT00873041|58687838|FG002|Extension Study|Adverse Event|1|||
30781647|NCT02869438|58793751|FG001|Overall Study|Adverse Event|0|||
30781648|NCT02869438|58793750|FG000|Overall Study|Withdrawal by Subject|1|||
30673957|NCT00873041|58687836|FG000|Extension Study|Administrative reasons|0|||
30673958|NCT00873041|58687837|FG001|Extension Study|Administrative reasons|0|||
30673959|NCT00873041|58687838|FG002|Extension Study|Administrative reasons|1|||
30673960|NCT00458341|58687855|FG000|Cycle 1|Adverse Event|1|||
30856016|NCT02578862|58883741|FG000|Overall Study|Withdrawal by Subject|0|||
30856017|NCT02578862|58883742|FG001|Overall Study|Withdrawal by Subject|1|||
30856018|NCT02578862|58883741|FG000|Overall Study|Unplanned unilateral procedure|0|||
30856019|NCT02578862|58883742|FG001|Overall Study|Unplanned unilateral procedure|1|||
30856020|NCT02578706|58883751|FG000|Overall Study|Withdrawal by Subject|1|||
30856021|NCT02578706|58883752|FG001|Overall Study|Withdrawal by Subject|0|||
30856022|NCT02578706|58883753|FG002|Overall Study|Withdrawal by Subject|0|||
30856023|NCT02578706|58883751|FG000|Overall Study|Lost to Follow-up|0|||
30958985|NCT01587703|59024040|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30673961|NCT00458341|58687856|FG001|Cycle 1|Adverse Event|0|||
30673962|NCT00816036|58687864|FG000|Overall Study|Death|47|||
30673963|NCT00816036|58687865|FG001|Overall Study|Death|28|||
30673964|NCT00816036|58687864|FG000|Overall Study|Lost to Follow-up|75|||
30673965|NCT00816036|58687865|FG001|Overall Study|Lost to Follow-up|57|||
30673966|NCT00816036|58687864|FG000|Overall Study|Withdrawal by Subject|54|||
30673967|NCT00816036|58687865|FG001|Overall Study|Withdrawal by Subject|23|||
30673968|NCT00664534|58687873|FG000|Overall Study|Adverse Event|2|||
30673969|NCT00664534|58687874|FG001|Overall Study|Adverse Event|3|||
30673970|NCT00664534|58687873|FG000|Overall Study|Lost to Follow-up|6|||
30673971|NCT00664534|58687874|FG001|Overall Study|Lost to Follow-up|10|||
30673972|NCT00664534|58687873|FG000|Overall Study|Protocol Violation|10|||
30673973|NCT00664534|58687874|FG001|Overall Study|Protocol Violation|8|||
30673974|NCT00664534|58687873|FG000|Overall Study|Withdrawal by Subject|7|||
30673975|NCT00664534|58687874|FG001|Overall Study|Withdrawal by Subject|6|||
30673976|NCT00664534|58687873|FG000|Overall Study|Physician Decision|8|||
30673977|NCT00664534|58687874|FG001|Overall Study|Physician Decision|0|||
30673978|NCT00664534|58687873|FG000|Overall Study|Sponsor decision|8|||
30673979|NCT00664534|58687874|FG001|Overall Study|Sponsor decision|6|||
30673980|NCT00594035|58687882|FG000|Overall Study|Lost to Follow-up|1|||
30673981|NCT00594035|58687883|FG001|Overall Study|Lost to Follow-up|1|||
30673982|NCT00594035|58687882|FG000|Overall Study|Withdrawal by Subject|1|||
30673983|NCT00594035|58687883|FG001|Overall Study|Withdrawal by Subject|0|||
30673984|NCT00594035|58687882|FG000|Overall Study|Subject transferred to nursing home|0|||
30673985|NCT00594035|58687883|FG001|Overall Study|Subject transferred to nursing home|1|||
30673986|NCT00594035|58687882|FG000|Overall Study|Subject couldn't return due to job|0|||
30673987|NCT00594035|58687883|FG001|Overall Study|Subject couldn't return due to job|1|||
30781649|NCT02869438|58793751|FG001|Overall Study|Withdrawal by Subject|2|||
30781650|NCT02868892|58793757|FG000|Overall Study|Investigator left site and no follow-up|6|||
30781651|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Death|1|||
30781652|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Death|1|||
30781653|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Death|0|||
30781654|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Death|0|||
30781655|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Death|1|||
30781656|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Death|0|||
30781657|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Death|0|||
30781658|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Death|0|||
30856024|NCT02578706|58883752|FG001|Overall Study|Lost to Follow-up|4|||
30856025|NCT02578706|58883753|FG002|Overall Study|Lost to Follow-up|0|||
30856026|NCT02578706|58883751|FG000|Overall Study|Physician Decision|0|||
30590212|NCT00191139|58602702|FG000|Overall Study|Death|2|||
30590213|NCT00191139|58602703|FG001|Overall Study|Death|0|||
30590214|NCT00191139|58602702|FG000|Overall Study|Withdrawal by Subject|0|||
30590215|NCT00191139|58602703|FG001|Overall Study|Withdrawal by Subject|3|||
30590216|NCT00191139|58602702|FG000|Overall Study|Disease Progression|0|||
30590217|NCT00191139|58602703|FG001|Overall Study|Disease Progression|1|||
30590218|NCT00191139|58602702|FG000|Overall Study|Other|1|||
30590219|NCT00191139|58602703|FG001|Overall Study|Other|2|||
30590220|NCT00190983|58602709|FG000|Overall Study|Inevaluable (never treated)|2|||
30590221|NCT00190749|58602715|FG000|Overall Study|Lost to Follow-up|8|||
30590222|NCT00190749|58602716|FG001|Overall Study|Lost to Follow-up|11|||
30590223|NCT00190749|58602715|FG000|Overall Study|Withdrawal by Subject|10|||
30590224|NCT00190749|58602716|FG001|Overall Study|Withdrawal by Subject|6|||
30590225|NCT00190749|58602715|FG000|Overall Study|Protocol Violation|5|||
30590226|NCT00190749|58602716|FG001|Overall Study|Protocol Violation|4|||
30590227|NCT00190749|58602715|FG000|Overall Study|Adverse Event|0|||
30590228|NCT00190749|58602716|FG001|Overall Study|Adverse Event|5|||
30590229|NCT00190749|58602715|FG000|Overall Study|Lack of Efficacy|2|||
30590230|NCT00190749|58602716|FG001|Overall Study|Lack of Efficacy|3|||
30590231|NCT00190749|58602715|FG000|Overall Study|Reason Not Specified|0|||
30673988|NCT00570310|58687891|FG000|Overall Study|Adverse Event|1|||
30673989|NCT00570310|58687892|FG001|Overall Study|Adverse Event|2|||
30673990|NCT00570310|58687891|FG000|Overall Study|Lack of Efficacy|1|||
30673991|NCT00570310|58687892|FG001|Overall Study|Lack of Efficacy|4|||
30673992|NCT00664066|58687898|FG000|Overall Study|Study terminated|3|||
30590232|NCT00190749|58602716|FG001|Overall Study|Reason Not Specified|2|||
30590233|NCT00190749|58602715|FG000|Overall Study|Sponsor Decision|1|||
30781659|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Death|0|||
30781660|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Death|0|||
30781661|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
30781662|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
30590234|NCT00190749|58602716|FG001|Overall Study|Sponsor Decision|0|||
30590235|NCT00190671|58602724|FG000|Overall Study|Satisfactory Response|4|||
30590236|NCT00190671|58602725|FG001|Overall Study|Satisfactory Response|7|||
30590237|NCT00190671|58602724|FG000|Overall Study|Lack of Efficacy|19|||
30590238|NCT00190671|58602725|FG001|Overall Study|Lack of Efficacy|24|||
30590239|NCT00190671|58602724|FG000|Overall Study|Death from Study Disease|1|||
30590240|NCT00190671|58602725|FG001|Overall Study|Death from Study Disease|1|||
30590241|NCT00190671|58602724|FG000|Overall Study|Adverse Event|3|||
30590242|NCT00190671|58602725|FG001|Overall Study|Adverse Event|2|||
30590243|NCT00190671|58602724|FG000|Overall Study|Clinical Relapse|0|||
30590244|NCT00190671|58602725|FG001|Overall Study|Clinical Relapse|1|||
30590245|NCT00190671|58602724|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
30590246|NCT00190671|58602725|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
30590247|NCT00190671|58602724|FG000|Overall Study|Death from Other Causes|0|||
30590248|NCT00190671|58602725|FG001|Overall Study|Death from Other Causes|2|||
30590249|NCT00190671|58602724|FG000|Overall Study|Protocol Violation|0|||
30590250|NCT00190671|58602725|FG001|Overall Study|Protocol Violation|1|||
30590251|NCT00190671|58602724|FG000|Overall Study|Withdrawal by Subject|0|||
30590252|NCT00190671|58602725|FG001|Overall Study|Withdrawal by Subject|2|||
30781663|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
30781664|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
30781665|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
30781666|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
30781667|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
30781668|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
30590253|NCT00477165|58602747|FG000|Overall Study|Adverse Event|7|||
30590254|NCT00477165|58602748|FG001|Overall Study|Adverse Event|2|||
30590255|NCT00476229|58602754|FG000|Overall Study|Progressive shortness of breath|1|||
30590256|NCT00476151|58602760|FG000|Overall Study|Adverse Event|0|||
30590257|NCT00476151|58602761|FG001|Overall Study|Adverse Event|2|||
30590258|NCT00476151|58602760|FG000|Overall Study|Protocol Violation|1|||
30590259|NCT00476151|58602761|FG001|Overall Study|Protocol Violation|3|||
30590260|NCT00476151|58602760|FG000|Overall Study|Withdrawal by Subject|2|||
30590261|NCT00476151|58602761|FG001|Overall Study|Withdrawal by Subject|0|||
30590262|NCT00476151|58602760|FG000|Overall Study|Physician Decision|0|||
30590263|NCT00476151|58602761|FG001|Overall Study|Physician Decision|2|||
30590264|NCT00475644|58602767|FG000|Overall Study|Protocol Violation|13|||
30590265|NCT00474903|58602774|FG000|Overall Study|Protocol Violation|1|||
30590266|NCT00474903|58602775|FG001|Overall Study|Protocol Violation|5|||
30590267|NCT00474903|58602776|FG002|Overall Study|Protocol Violation|2|||
30590268|NCT01134055|58602791|FG000|Overall Study|Adverse Event|5|||
30590269|NCT01134055|58602792|FG001|Overall Study|Adverse Event|2|||
30590270|NCT01134055|58602793|FG002|Overall Study|Adverse Event|2|||
30590271|NCT01134055|58602794|FG003|Overall Study|Adverse Event|2|||
30590272|NCT01134055|58602795|FG004|Overall Study|Adverse Event|5|||
30590273|NCT01134055|58602796|FG005|Overall Study|Adverse Event|7|||
30673993|NCT00814710|58687904|FG000|Overall Study|Adverse Event|1|||
30673994|NCT00814710|58687905|FG001|Overall Study|Adverse Event|0|||
30673995|NCT00814710|58687904|FG000|Overall Study|Lost to Follow-up|7|||
30673996|NCT00814710|58687905|FG001|Overall Study|Lost to Follow-up|3|||
30673997|NCT00871169|58687911|FG000|Overall Study|Protocol Violation|1|||
30673998|NCT00871169|58687911|FG000|Overall Study|Patient did not receive study treatment|2|||
30673999|NCT00814632|58687915|FG000|Overall Study|Lack of Efficacy|2|||
30781669|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
30781670|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
30781671|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
30781672|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
30781673|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
30958986|NCT01587703|59024041|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
30590274|NCT01134055|58602797|FG006|Overall Study|Adverse Event|2|||
30590275|NCT01134055|58602791|FG000|Overall Study|Lost to Follow-up|0|||
30590276|NCT01134055|58602792|FG001|Overall Study|Lost to Follow-up|1|||
30590277|NCT01134055|58602793|FG002|Overall Study|Lost to Follow-up|0|||
30590278|NCT01134055|58602794|FG003|Overall Study|Lost to Follow-up|1|||
30590279|NCT01134055|58602795|FG004|Overall Study|Lost to Follow-up|0|||
30590280|NCT01134055|58602796|FG005|Overall Study|Lost to Follow-up|0|||
30590281|NCT01134055|58602797|FG006|Overall Study|Lost to Follow-up|0|||
30590282|NCT01134055|58602791|FG000|Overall Study|Withdrawal by Subject|3|||
30590283|NCT01134055|58602792|FG001|Overall Study|Withdrawal by Subject|3|||
30590284|NCT01134055|58602793|FG002|Overall Study|Withdrawal by Subject|1|||
30590285|NCT01134055|58602794|FG003|Overall Study|Withdrawal by Subject|2|||
30674000|NCT00851318|58687923|FG000|Overall Study|Withdrawal by Subject|7|||
30590286|NCT01134055|58602795|FG004|Overall Study|Withdrawal by Subject|0|||
30590287|NCT01134055|58602796|FG005|Overall Study|Withdrawal by Subject|0|||
30590288|NCT01134055|58602797|FG006|Overall Study|Withdrawal by Subject|8|||
30590289|NCT01134055|58602791|FG000|Overall Study|Protocol Violation|0|||
30590290|NCT01134055|58602792|FG001|Overall Study|Protocol Violation|0|||
30590291|NCT01134055|58602793|FG002|Overall Study|Protocol Violation|0|||
30590292|NCT01134055|58602794|FG003|Overall Study|Protocol Violation|1|||
30590293|NCT01134055|58602795|FG004|Overall Study|Protocol Violation|1|||
30590294|NCT01134055|58602796|FG005|Overall Study|Protocol Violation|0|||
30590295|NCT01134055|58602797|FG006|Overall Study|Protocol Violation|0|||
30590296|NCT01134055|58602791|FG000|Overall Study|Physician Decision|0|||
30590297|NCT01134055|58602792|FG001|Overall Study|Physician Decision|0|||
30590298|NCT01134055|58602793|FG002|Overall Study|Physician Decision|0|||
30590299|NCT01134055|58602794|FG003|Overall Study|Physician Decision|0|||
30590300|NCT01134055|58602795|FG004|Overall Study|Physician Decision|0|||
30590301|NCT01134055|58602796|FG005|Overall Study|Physician Decision|0|||
30590302|NCT01134055|58602797|FG006|Overall Study|Physician Decision|1|||
30590303|NCT00474708|58602821|FG000|Overall Study|Lack of Efficacy|11|||
30590304|NCT00474708|58602822|FG001|Overall Study|Lack of Efficacy|5|||
30590305|NCT00474708|58602821|FG000|Overall Study|Suicide ideation/behavior|0|||
30590306|NCT00474708|58602822|FG001|Overall Study|Suicide ideation/behavior|1|||
30590307|NCT00474708|58602821|FG000|Overall Study|Withdrawal by Subject|7|||
30590308|NCT00474708|58602822|FG001|Overall Study|Withdrawal by Subject|0|||
30590309|NCT00474708|58602821|FG000|Overall Study|Lack of compliance|12|||
30590310|NCT00474708|58602822|FG001|Overall Study|Lack of compliance|4|||
30590311|NCT00474708|58602821|FG000|Overall Study|Lost to Follow-up|18|||
30590312|NCT00474708|58602822|FG001|Overall Study|Lost to Follow-up|9|||
30590313|NCT00474708|58602821|FG000|Overall Study|Physician Decision|9|||
30590314|NCT00474708|58602822|FG001|Overall Study|Physician Decision|6|||
30590315|NCT00474240|58602834|FG000|Overall Study|Withdrawal by Subject|1|||
30590316|NCT00474240|58602835|FG001|Overall Study|Withdrawal by Subject|1|||
30590317|NCT00474240|58602836|FG002|Overall Study|Withdrawal by Subject|0|||
30590318|NCT00474240|58602837|FG003|Overall Study|Withdrawal by Subject|2|||
30590319|NCT00474240|58602838|FG004|Overall Study|Withdrawal by Subject|3|||
30590320|NCT00474240|58602839|FG005|Overall Study|Withdrawal by Subject|1|||
30590321|NCT00474240|58602834|FG000|Overall Study|Adverse Event|0|||
30590322|NCT00474240|58602835|FG001|Overall Study|Adverse Event|0|||
30590323|NCT00474240|58602836|FG002|Overall Study|Adverse Event|9|||
30590324|NCT00474240|58602837|FG003|Overall Study|Adverse Event|14|||
30590325|NCT00474240|58602838|FG004|Overall Study|Adverse Event|5|||
30590326|NCT00474240|58602839|FG005|Overall Study|Adverse Event|16|||
30590327|NCT00474240|58602834|FG000|Overall Study|Removed due to lab value|0|||
30590328|NCT00474240|58602835|FG001|Overall Study|Removed due to lab value|0|||
30590329|NCT00474240|58602836|FG002|Overall Study|Removed due to lab value|0|||
30590330|NCT00474240|58602837|FG003|Overall Study|Removed due to lab value|0|||
30590331|NCT00474240|58602838|FG004|Overall Study|Removed due to lab value|0|||
30590332|NCT00474240|58602839|FG005|Overall Study|Removed due to lab value|1|||
30590333|NCT00473889|58602855|FG000|Overall Study|Did not receive study medication|1|||
30590334|NCT00473889|58602856|FG001|Overall Study|Did not receive study medication|4|||
30590335|NCT00473889|58602855|FG000|Overall Study|Adverse Event|30|||
30674001|NCT00851318|58687924|FG001|Overall Study|Withdrawal by Subject|1|||
30674002|NCT00851318|58687925|FG002|Overall Study|Withdrawal by Subject|5|||
30674003|NCT00851318|58687926|FG003|Overall Study|Withdrawal by Subject|3|||
30674004|NCT00851318|58687923|FG000|Overall Study|Adverse Event|13|||
30674005|NCT00851318|58687924|FG001|Overall Study|Adverse Event|2|||
30674006|NCT00851318|58687925|FG002|Overall Study|Adverse Event|9|||
30674007|NCT00851318|58687926|FG003|Overall Study|Adverse Event|12|||
30674008|NCT00851318|58687923|FG000|Overall Study|Pregnancy|0|||
30674009|NCT00851318|58687924|FG001|Overall Study|Pregnancy|0|||
30674010|NCT00851318|58687925|FG002|Overall Study|Pregnancy|1|||
30674011|NCT00851318|58687926|FG003|Overall Study|Pregnancy|1|||
30674012|NCT00851318|58687923|FG000|Overall Study|Lack of Efficacy|8|||
30674013|NCT00851318|58687924|FG001|Overall Study|Lack of Efficacy|2|||
30590336|NCT00473889|58602856|FG001|Overall Study|Adverse Event|17|||
30674014|NCT00851318|58687925|FG002|Overall Study|Lack of Efficacy|4|||
30590337|NCT00473889|58602855|FG000|Overall Study|Protocol Violation|4|||
30590338|NCT00473889|58602856|FG001|Overall Study|Protocol Violation|2|||
30590339|NCT00473889|58602855|FG000|Overall Study|Lack of Efficacy|28|||
30590340|NCT00473889|58602856|FG001|Overall Study|Lack of Efficacy|29|||
30590341|NCT00473889|58602855|FG000|Overall Study|Lost to Follow-up|2|||
30590342|NCT00473889|58602856|FG001|Overall Study|Lost to Follow-up|1|||
30590343|NCT00473889|58602855|FG000|Overall Study|Physician Decision|10|||
30590344|NCT00473889|58602856|FG001|Overall Study|Physician Decision|5|||
30590345|NCT00473889|58602855|FG000|Overall Study|Trial Terminated|3|||
30674015|NCT00851318|58687926|FG003|Overall Study|Lack of Efficacy|2|||
30674016|NCT00851318|58687923|FG000|Overall Study|Non-compliance with Study Procedures|2|||
30674017|NCT00851318|58687924|FG001|Overall Study|Non-compliance with Study Procedures|0|||
30674018|NCT00851318|58687925|FG002|Overall Study|Non-compliance with Study Procedures|1|||
30856027|NCT02578706|58883752|FG001|Overall Study|Physician Decision|1|||
30590346|NCT00473889|58602856|FG001|Overall Study|Trial Terminated|6|||
30590347|NCT00473889|58602855|FG000|Overall Study|Withdrawal by Subject|5|||
30590348|NCT00473889|58602856|FG001|Overall Study|Withdrawal by Subject|0|||
30590349|NCT00473694|58602866|FG000|Overall Study|Adverse Event|0|||
30590350|NCT00473694|58602867|FG001|Overall Study|Adverse Event|1|||
30590351|NCT00473694|58602868|FG002|Overall Study|Adverse Event|0|||
30590352|NCT00473694|58602869|FG003|Overall Study|Adverse Event|0|||
30590353|NCT00473694|58602866|FG000|Overall Study|Participants did not receive treatment|11|||
30590354|NCT00473694|58602867|FG001|Overall Study|Participants did not receive treatment|3|||
30590355|NCT00473694|58602868|FG002|Overall Study|Participants did not receive treatment|5|||
30590356|NCT00473694|58602869|FG003|Overall Study|Participants did not receive treatment|6|||
30590357|NCT00473694|58602866|FG000|Overall Study|Lost to Follow-up|0|||
30590358|NCT00473694|58602867|FG001|Overall Study|Lost to Follow-up|0|||
30590359|NCT00473694|58602868|FG002|Overall Study|Lost to Follow-up|0|||
30590360|NCT00473694|58602869|FG003|Overall Study|Lost to Follow-up|1|||
30590361|NCT00473655|58602885|FG000|Overall Study|Lost to Follow-up|9|||
30590362|NCT00473655|58602886|FG001|Overall Study|Lost to Follow-up|5|||
30590363|NCT00473655|58602887|FG002|Overall Study|Lost to Follow-up|8|||
30590364|NCT00473382|58602898|FG000|Core Study|Adverse Event|3|||
30590365|NCT00473382|58602899|FG001|Core Study|Adverse Event|1|||
30590366|NCT00473382|58602900|FG002|Core Study|Adverse Event|1|||
30590367|NCT00473382|58602898|FG000|Core Study|Death|3|||
30590368|NCT00473382|58602899|FG001|Core Study|Death|5|||
30590369|NCT00473382|58602900|FG002|Core Study|Death|10|||
30590370|NCT00473382|58602898|FG000|Core Study|Lost to Follow-up|3|||
30590371|NCT00473382|58602899|FG001|Core Study|Lost to Follow-up|3|||
30590372|NCT00473382|58602900|FG002|Core Study|Lost to Follow-up|3|||
30674019|NCT00851318|58687926|FG003|Overall Study|Non-compliance with Study Procedures|0|||
30674020|NCT00851318|58687923|FG000|Overall Study|Physician Decision|0|||
30674021|NCT00851318|58687924|FG001|Overall Study|Physician Decision|0|||
30674022|NCT00851318|58687925|FG002|Overall Study|Physician Decision|1|||
30674023|NCT00851318|58687926|FG003|Overall Study|Physician Decision|1|||
30674024|NCT00593957|58687939|FG000|Overall Study|Physician Decision|0|||
30674025|NCT00593957|58687940|FG001|Overall Study|Physician Decision|1|||
30674026|NCT00593957|58687941|FG002|Overall Study|Physician Decision|2|||
30674027|NCT00870233|58687963|FG000|Overall Study|Withdrawal by Subject|18|||
30674028|NCT00870233|58687963|FG000|Overall Study|Did not undergo laparotomy|3|||
30674029|NCT00870233|58687963|FG000|Overall Study|Incompatible internet browser|2|||
30674030|NCT00870233|58687963|FG000|Overall Study|Death|1|||
30674031|NCT00851084|58687970|FG000|Overall Study|Randomized but not treated|1|||
30674032|NCT00851084|58687971|FG001|Overall Study|Randomized but not treated|0|||
30674033|NCT00851084|58687970|FG000|Overall Study|Adverse Event|26|||
30674034|NCT00851084|58687971|FG001|Overall Study|Adverse Event|36|||
30674035|NCT00851084|58687970|FG000|Overall Study|Disease progression|52|||
30674036|NCT00851084|58687971|FG001|Overall Study|Disease progression|47|||
30674037|NCT00851084|58687970|FG000|Overall Study|Poor compliance to protocol|1|||
30674038|NCT00851084|58687971|FG001|Overall Study|Poor compliance to protocol|1|||
30674039|NCT00851084|58687970|FG000|Overall Study|Physician Decision|13|||
30674040|NCT00851084|58687971|FG001|Overall Study|Physician Decision|14|||
30674041|NCT00851084|58687970|FG000|Overall Study|Consent withdrawn|0|||
30674042|NCT00851084|58687971|FG001|Overall Study|Consent withdrawn|2|||
30674043|NCT00851084|58687970|FG000|Overall Study|Withdrawal by Subject|11|||
30674044|NCT00851084|58687971|FG001|Overall Study|Withdrawal by Subject|12|||
30674045|NCT00851084|58687970|FG000|Overall Study|Metastatic surgery|6|||
30590373|NCT00473382|58602898|FG000|Core Study|Physician Decision|1|||
30590374|NCT00473382|58602899|FG001|Core Study|Physician Decision|2|||
30590375|NCT00473382|58602900|FG002|Core Study|Physician Decision|2|||
30590376|NCT00473382|58602898|FG000|Core Study|Subject non-compliance|5|||
30590377|NCT00473382|58602899|FG001|Core Study|Subject non-compliance|2|||
30590378|NCT00473382|58602900|FG002|Core Study|Subject non-compliance|1|||
30590379|NCT00473382|58602898|FG000|Core Study|Subject needed other treatment|1|||
30590380|NCT00473382|58602899|FG001|Core Study|Subject needed other treatment|3|||
30590381|NCT00473382|58602900|FG002|Core Study|Subject needed other treatment|2|||
30590382|NCT00473382|58602898|FG000|Core Study|Subject's decision|12|||
30674046|NCT00851084|58687971|FG001|Overall Study|Metastatic surgery|6|||
30781674|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
30590383|NCT00473382|58602899|FG001|Core Study|Subject's decision|11|||
30590384|NCT00473382|58602900|FG002|Core Study|Subject's decision|10|||
30590385|NCT00473382|58602898|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
30590386|NCT00473382|58602899|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
30590387|NCT00473382|58602900|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
30590388|NCT00473382|58602898|FG000|Open-label Extension Through Month 48|Death|1|||
30590389|NCT00473382|58602899|FG001|Open-label Extension Through Month 48|Death|3|||
30674047|NCT00851084|58687970|FG000|Overall Study|Other|7|||
30674048|NCT00851084|58687971|FG001|Overall Study|Other|1|||
30674049|NCT00845858|58687982|FG000|Overall Study|Withdrawal by Subject|5|||
30674050|NCT00845858|58687983|FG001|Overall Study|Withdrawal by Subject|1|||
30674051|NCT00845858|58687984|FG002|Overall Study|Withdrawal by Subject|1|||
30590390|NCT00473382|58602900|FG002|Open-label Extension Through Month 48|Death|3|||
30590391|NCT00473382|58602898|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
30590392|NCT00473382|58602899|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
30590393|NCT00473382|58602900|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
30590394|NCT00473382|58602898|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
30590395|NCT00473382|58602899|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
30590396|NCT00473382|58602900|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
30590397|NCT00473382|58602898|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
30590398|NCT00473382|58602899|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
30590399|NCT00473382|58602900|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
30590400|NCT00473382|58602898|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
30590401|NCT00473382|58602899|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
30590402|NCT00473382|58602900|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
30590403|NCT00473382|58602898|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
30590404|NCT00473382|58602899|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
30674052|NCT00845858|58687982|FG000|Overall Study|Adverse Event|3|||
30674053|NCT00845858|58687983|FG001|Overall Study|Adverse Event|8|||
30674054|NCT00845858|58687984|FG002|Overall Study|Adverse Event|4|||
30674055|NCT00845858|58687982|FG000|Overall Study|Protocol Violation|0|||
30674056|NCT00845858|58687983|FG001|Overall Study|Protocol Violation|0|||
30674057|NCT00845858|58687984|FG002|Overall Study|Protocol Violation|1|||
30674058|NCT00845858|58687982|FG000|Overall Study|not eligible|0|||
30674059|NCT00845858|58687983|FG001|Overall Study|not eligible|3|||
30674060|NCT00845858|58687984|FG002|Overall Study|not eligible|2|||
30674061|NCT00850538|58687995|FG000|Overall Study|unable/unwilling to complete MRI|13|||
30674062|NCT00850538|58687995|FG000|Overall Study|specimen missed due to scheduling error|14|||
30674063|NCT00850538|58687995|FG000|Overall Study|specimen unusable|7|||
30674064|NCT00850538|58687995|FG000|Overall Study|Withdrawal by Subject|3|||
30674065|NCT00850538|58687995|FG000|Overall Study|radiology error|2|||
30781675|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
30781676|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
30781677|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
30781678|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
30674066|NCT00850538|58687995|FG000|Overall Study|Protocol Violation|2|||
30674067|NCT00850460|58688001|FG000|Overall Study|Lost to Follow-up|4|||
30674068|NCT00850460|58688002|FG001|Overall Study|Lost to Follow-up|4|||
30674069|NCT00661492|58688010|FG000|Overall Study|Adverse Event|16|||
30674070|NCT00661492|58688011|FG001|Overall Study|Adverse Event|13|||
30674071|NCT00661492|58688010|FG000|Overall Study|Disease Progression|44|||
30674072|NCT00661492|58688011|FG001|Overall Study|Disease Progression|14|||
30674073|NCT00661492|58688010|FG000|Overall Study|Patient Request|6|||
30674074|NCT00661492|58688011|FG001|Overall Study|Patient Request|1|||
30674075|NCT00661492|58688010|FG000|Overall Study|Investigator Request|1|||
30674076|NCT00661492|58688011|FG001|Overall Study|Investigator Request|0|||
30674077|NCT00661492|58688010|FG000|Overall Study|Lost to Follow-up|0|||
30674078|NCT00661492|58688011|FG001|Overall Study|Lost to Follow-up|1|||
30674079|NCT00661492|58688010|FG000|Overall Study|Other|1|||
30674080|NCT00661492|58688011|FG001|Overall Study|Other|0|||
30674081|NCT00850070|58688019|FG000|Overall Study|Lack of Efficacy|1|||
30674082|NCT00850070|58688020|FG001|Overall Study|Lack of Efficacy|1|||
30674083|NCT00850070|58688019|FG000|Overall Study|Adverse Event|2|||
30674084|NCT00850070|58688020|FG001|Overall Study|Adverse Event|0|||
30674085|NCT00592358|58688031|FG000|Overall Study|Withdrawal by Subject|2|||
30674086|NCT00592358|58688031|FG000|Overall Study|Adverse Event|1|||
30674087|NCT00592358|58688031|FG000|Overall Study|Lack of Efficacy|2|||
30674088|NCT00592358|58688031|FG000|Overall Study|Inability to swallow pills|1|||
30674089|NCT00814320|58688037|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
30674090|NCT00814320|58688038|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
30674091|NCT00814320|58688037|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
30674092|NCT00814320|58688038|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
30674093|NCT00814320|58688037|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
30781679|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
30674094|NCT00814320|58688038|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
30674095|NCT00814320|58688037|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
30674096|NCT00814320|58688038|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
30674097|NCT00814320|58688037|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
30674098|NCT00814320|58688038|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
30674099|NCT00814320|58688037|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
30674100|NCT00814320|58688038|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
30674101|NCT00814320|58688037|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
30674102|NCT00814320|58688038|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
30781680|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
30674103|NCT00814320|58688037|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
30674104|NCT00814320|58688038|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
30674105|NCT00814320|58688037|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
30674106|NCT00814320|58688038|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
30674107|NCT00814320|58688037|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
30674108|NCT00814320|58688038|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
30674109|NCT00869999|58688061|FG000|Overall Study|Withdrawal by Subject|1|||
30674110|NCT00869999|58688061|FG000|Overall Study|removed prior to starting therapy|1|||
30674111|NCT00570232|58688065|FG000|Overall Study|Adverse Event|10|||
30674112|NCT00570232|58688065|FG000|Overall Study|discontinued due to medical condition|3|||
30674113|NCT00570232|58688065|FG000|Overall Study|discontinued due to recurrence|8|||
30674114|NCT00570232|58688065|FG000|Overall Study|discontinued due to noncompliance|2|||
30674115|NCT00809328|58688069|FG000|Overall Study|Lack of Efficacy|18|||
30674116|NCT00809328|58688069|FG000|Overall Study|Adverse Event|6|||
30590405|NCT00473382|58602900|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
30590406|NCT00473382|58602898|FG000|Open-label Extension Through Month 60|Death|1|||
30590407|NCT00473382|58602899|FG001|Open-label Extension Through Month 60|Death|7|||
30590408|NCT00473382|58602900|FG002|Open-label Extension Through Month 60|Death|4|||
30674117|NCT00809328|58688069|FG000|Overall Study|Protocol Violation|3|||
30674118|NCT00809328|58688069|FG000|Overall Study|Withdrawal by Subject|2|||
30674119|NCT00868517|58688076|FG000|Overall Study|Withdrawal by Subject|3|||
30674120|NCT00868517|58688077|FG001|Overall Study|Withdrawal by Subject|3|||
30674121|NCT00868517|58688078|FG002|Overall Study|Withdrawal by Subject|2|||
30674122|NCT00868517|58688076|FG000|Overall Study|Protocol Violation|1|||
30674123|NCT00868517|58688077|FG001|Overall Study|Protocol Violation|1|||
30590409|NCT00473382|58602898|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
30590410|NCT00473382|58602899|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
30590411|NCT00473382|58602900|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
30590412|NCT00473382|58602898|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
30590413|NCT00473382|58602899|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
30590414|NCT00473382|58602900|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
30590415|NCT00473382|58602898|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
30590416|NCT00473382|58602899|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
30590417|NCT00473382|58602900|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
30590418|NCT00473382|58602898|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
30590419|NCT00473382|58602899|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
30590420|NCT00473382|58602900|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
30590421|NCT00473265|58602926|FG000|Overall Study|Unrelated adverse event|5|||
30590422|NCT00473265|58602926|FG000|Overall Study|Off treatment early|15|||
30590423|NCT00472641|58602930|FG000|Overall Study|Lack of Efficacy|3|||
30590424|NCT00472641|58602930|FG000|Overall Study|Adverse Event|3|||
30590425|NCT00472641|58602930|FG000|Overall Study|Lost to Follow-up|1|||
30674124|NCT00868517|58688078|FG002|Overall Study|Protocol Violation|0|||
30674125|NCT00868439|58688088|FG000|Overall Study|Adverse Event|4|||
30674126|NCT00868439|58688089|FG001|Overall Study|Adverse Event|3|||
30674127|NCT00868439|58688088|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
30674128|NCT00868439|58688089|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
30674129|NCT00868439|58688088|FG000|Overall Study|Death|0|||
30674130|NCT00868439|58688089|FG001|Overall Study|Death|1|||
30674131|NCT00868439|58688088|FG000|Overall Study|Protocol Violation|1|||
30674132|NCT00868439|58688089|FG001|Overall Study|Protocol Violation|1|||
30674133|NCT00868439|58688088|FG000|Overall Study|Physician Decision|1|||
30590426|NCT01133977|58602939|FG000|Overall Study|Adverse Event|0|||
30674134|NCT00868439|58688089|FG001|Overall Study|Physician Decision|0|||
30674135|NCT00868439|58688088|FG000|Overall Study|Withdrawal by Subject|0|||
30674136|NCT00868439|58688089|FG001|Overall Study|Withdrawal by Subject|1|||
30674137|NCT00814164|58688095|FG000|Overall Study|Progression|7|||
30674138|NCT00814164|58688095|FG000|Overall Study|not stated|7|||
30674139|NCT00814164|58688095|FG000|Overall Study|Death|5|||
30674140|NCT00659230|58688101|FG000|Overall Study|Lost to Follow-up|2|||
30674141|NCT00659230|58688102|FG001|Overall Study|Lost to Follow-up|5|||
30674142|NCT00659230|58688101|FG000|Overall Study|Lost source documentation|5|||
30674143|NCT00659230|58688102|FG001|Overall Study|Lost source documentation|4|||
30674144|NCT00659230|58688101|FG000|Overall Study|Did not return post-randomization|2|||
30781681|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
30781682|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
30590427|NCT01133977|58602940|FG001|Overall Study|Adverse Event|0|||
30781683|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
30674145|NCT00659230|58688102|FG001|Overall Study|Did not return post-randomization|3|||
30674146|NCT00809094|58688110|FG000|Overall Study|Lost to Follow-up|0|||
30856028|NCT02578706|58883753|FG002|Overall Study|Physician Decision|0|||
30674147|NCT00809094|58688111|FG001|Overall Study|Lost to Follow-up|1|||
30590428|NCT01133977|58602941|FG002|Overall Study|Adverse Event|1|||
30674148|NCT00658996|58688117|FG000|First Intervention|Positive slit lamp finding|1|||
30674149|NCT00658996|58688118|FG001|First Intervention|Positive slit lamp finding|0|||
30674150|NCT00658996|58688117|FG000|First Intervention|Lack of lenses|0|||
30674151|NCT00658996|58688118|FG001|First Intervention|Lack of lenses|1|||
30674152|NCT00658996|58688117|FG000|Crossover Period|Physician Decision|1|||
30674153|NCT00658996|58688118|FG001|Crossover Period|Physician Decision|0|||
30674154|NCT00658996|58688117|FG000|Crossover Period|Ineligible|1|||
30674155|NCT00658996|58688118|FG001|Crossover Period|Ineligible|1|||
30674156|NCT00658996|58688117|FG000|Second Intervention|Developed a stye on upper lid|1|||
30674157|NCT00658996|58688118|FG001|Second Intervention|Developed a stye on upper lid|0|||
30674158|NCT00658996|58688117|FG000|Second Intervention|Positive slit lamp finding|0|||
30590429|NCT01133977|58602942|FG003|Overall Study|Adverse Event|0|||
30590430|NCT01133977|58602943|FG004|Overall Study|Adverse Event|0|||
30590431|NCT01133977|58602939|FG000|Overall Study|Death|1|||
30590432|NCT01133977|58602940|FG001|Overall Study|Death|1|||
30590433|NCT01133977|58602941|FG002|Overall Study|Death|1|||
30590434|NCT01133977|58602942|FG003|Overall Study|Death|7|||
30590435|NCT01133977|58602943|FG004|Overall Study|Death|3|||
30590436|NCT01133977|58602939|FG000|Overall Study|Started a New Line of Therapy|2|||
30590437|NCT01133977|58602940|FG001|Overall Study|Started a New Line of Therapy|6|||
30590438|NCT01133977|58602941|FG002|Overall Study|Started a New Line of Therapy|4|||
30590439|NCT01133977|58602942|FG003|Overall Study|Started a New Line of Therapy|25|||
30590440|NCT01133977|58602943|FG004|Overall Study|Started a New Line of Therapy|33|||
30590441|NCT01133977|58602939|FG000|Overall Study|Lost to Follow-up|0|||
30590442|NCT01133977|58602940|FG001|Overall Study|Lost to Follow-up|0|||
30590443|NCT01133977|58602941|FG002|Overall Study|Lost to Follow-up|0|||
30590444|NCT01133977|58602942|FG003|Overall Study|Lost to Follow-up|2|||
30590445|NCT01133977|58602943|FG004|Overall Study|Lost to Follow-up|1|||
30590446|NCT01133977|58602939|FG000|Overall Study|Withdrawal by Subject|0|||
30590447|NCT01133977|58602940|FG001|Overall Study|Withdrawal by Subject|0|||
30590448|NCT01133977|58602941|FG002|Overall Study|Withdrawal by Subject|0|||
30590449|NCT01133977|58602942|FG003|Overall Study|Withdrawal by Subject|5|||
30590450|NCT01133977|58602943|FG004|Overall Study|Withdrawal by Subject|1|||
30590451|NCT01133821|58602960|FG000|Overall Study|Lost to Follow-up|8|||
30590452|NCT01133821|58602961|FG001|Overall Study|Lost to Follow-up|11|||
30590453|NCT01133821|58602960|FG000|Overall Study|Withdrawal by Subject|8|||
30590454|NCT01133821|58602961|FG001|Overall Study|Withdrawal by Subject|3|||
30590455|NCT01133821|58602960|FG000|Overall Study|preferred other treatment|1|||
30590456|NCT01133821|58602961|FG001|Overall Study|preferred other treatment|1|||
30590457|NCT01133821|58602960|FG000|Overall Study|Protocol Violation|0|||
30590458|NCT01133821|58602961|FG001|Overall Study|Protocol Violation|1|||
30590459|NCT01133821|58602960|FG000|Overall Study|Refused participation|1|||
30590460|NCT01133821|58602961|FG001|Overall Study|Refused participation|3|||
30590461|NCT00472446|58602971|FG000|Overall Study|Protocol Violation|0|||
30590462|NCT00472446|58602972|FG001|Overall Study|Protocol Violation|0|||
30590463|NCT00472446|58602973|FG002|Overall Study|Protocol Violation|0|||
30590464|NCT00472446|58602974|FG003|Overall Study|Protocol Violation|1|||
30590465|NCT00472446|58602971|FG000|Overall Study|Reintervention|0|||
30590466|NCT00472446|58602972|FG001|Overall Study|Reintervention|0|||
30590467|NCT00472446|58602973|FG002|Overall Study|Reintervention|1|||
30590468|NCT00472446|58602974|FG003|Overall Study|Reintervention|1|||
30590469|NCT00472446|58602971|FG000|Overall Study|Questionnaires not returned|5|||
30590470|NCT00472446|58602972|FG001|Overall Study|Questionnaires not returned|6|||
30590471|NCT00472446|58602973|FG002|Overall Study|Questionnaires not returned|6|||
30590472|NCT00472446|58602974|FG003|Overall Study|Questionnaires not returned|4|||
30590473|NCT00472290|58602984|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
30590474|NCT00472290|58602984|FG000|Overall Study|Protocol Specified Criteria|7|||
30590475|NCT00472290|58602984|FG000|Overall Study|Administrative Decision|37|||
30590476|NCT00472290|58602984|FG000|Overall Study|Death|3|||
30590477|NCT00472290|58602984|FG000|Overall Study|Lost to Follow-up|1|||
30590478|NCT00472290|58602984|FG000|Overall Study|Lack of Efficacy|1|||
30674159|NCT00658996|58688118|FG001|Second Intervention|Positive slit lamp finding|1|||
30674160|NCT00867815|58688124|FG000|Overall Study|Lost to Follow-up|1|||
30590479|NCT00472290|58602984|FG000|Overall Study|Disease Progression|4|||
30590480|NCT00472290|58602984|FG000|Overall Study|Withdrawal by Subject|5|||
30590481|NCT00472290|58602984|FG000|Overall Study|Adverse Event|6|||
30590482|NCT00472290|58602984|FG000|Overall Study|Requirement for alternative therapy|7|||
30590483|NCT01133704|58602990|FG000|Overall Study|Death|44|||
30590484|NCT01133704|58602991|FG001|Overall Study|Death|26|||
30590485|NCT01133704|58602990|FG000|Overall Study|Patient refused to continue|4|||
30590486|NCT01133704|58602991|FG001|Overall Study|Patient refused to continue|0|||
30590487|NCT01133704|58602990|FG000|Overall Study|Study Closure|1|||
30674161|NCT00452413|58688131|FG000|Overall Study|Progressive Disease|4|||
30674162|NCT00452413|58688132|FG001|Overall Study|Progressive Disease|11|||
30674163|NCT00452413|58688133|FG002|Overall Study|Progressive Disease|30|||
30590488|NCT01133704|58602991|FG001|Overall Study|Study Closure|0|||
30590489|NCT01133665|58602997|FG000|Overall Study|Physician Decision|2|||
30590490|NCT01133626|58603004|FG000|Overall Study|Adverse Event|0|||
30674164|NCT00452413|58688131|FG000|Overall Study|Withdrawal by Subject|0|||
30674165|NCT00452413|58688132|FG001|Overall Study|Withdrawal by Subject|1|||
30674166|NCT00452413|58688133|FG002|Overall Study|Withdrawal by Subject|4|||
30674167|NCT00452413|58688131|FG000|Overall Study|Adverse Event|0|||
30674168|NCT00452413|58688132|FG001|Overall Study|Adverse Event|0|||
30674169|NCT00452413|58688133|FG002|Overall Study|Adverse Event|5|||
30674170|NCT00452413|58688131|FG000|Overall Study|Physician Decision|0|||
30674171|NCT00452413|58688132|FG001|Overall Study|Physician Decision|0|||
30674172|NCT00452413|58688133|FG002|Overall Study|Physician Decision|4|||
30674173|NCT00452413|58688131|FG000|Overall Study|Death due to study disease|0|||
30674174|NCT00452413|58688132|FG001|Overall Study|Death due to study disease|0|||
30674175|NCT00452413|58688133|FG002|Overall Study|Death due to study disease|2|||
30674176|NCT00452413|58688131|FG000|Overall Study|Death due to adverse event (AE)|0|||
30674177|NCT00452413|58688132|FG001|Overall Study|Death due to adverse event (AE)|0|||
30674178|NCT00452413|58688133|FG002|Overall Study|Death due to adverse event (AE)|1|||
30674179|NCT00452413|58688131|FG000|Overall Study|On treatment|0|||
30674180|NCT00452413|58688132|FG001|Overall Study|On treatment|0|||
30674181|NCT00452413|58688133|FG002|Overall Study|On treatment|3|||
30674182|NCT00867503|58688142|FG000|Overall Study|Withdrawal by Subject|1|||
30674183|NCT00867113|58688148|FG000|Treatment Period|Adverse Event|15|||
30674184|NCT00867113|58688148|FG000|Treatment Period|Death|2|||
30674185|NCT00867113|58688148|FG000|Treatment Period|Withdrawal by Subject|19|||
30674186|NCT00867113|58688148|FG000|Treatment Period|Lost to Follow-up|3|||
30674187|NCT00867113|58688148|FG000|Treatment Period|Administrative problems|1|||
30674188|NCT00867113|58688148|FG000|Treatment Period|Disease progression/relapse|1|||
30674189|NCT00867113|58688148|FG000|Treatment Period|Protocol Violation|4|||
30674190|NCT00867113|58688148|FG000|Post Treatment After Survival Follow-up|Death|1|||
30674191|NCT00867113|58688148|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
30674192|NCT00867113|58688148|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
30674193|NCT00867113|58688148|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
30674194|NCT00451555|58688155|FG000|Overall Study|Protocol Violation|2|||
30674195|NCT00451555|58688156|FG001|Overall Study|Protocol Violation|2|||
30674196|NCT00451555|58688155|FG000|Overall Study|Adverse Event|3|||
30674197|NCT00451555|58688156|FG001|Overall Study|Adverse Event|1|||
30674198|NCT00451555|58688155|FG000|Overall Study|Withdrawal by Subject|6|||
30674199|NCT00451555|58688156|FG001|Overall Study|Withdrawal by Subject|0|||
30674200|NCT00451555|58688155|FG000|Overall Study|Physician Decision|2|||
30674201|NCT00451555|58688156|FG001|Overall Study|Physician Decision|1|||
30674202|NCT00808236|58688173|FG000|Overall Study|Was not resuscitated|50|||
30674203|NCT00808236|58688174|FG001|Overall Study|Was not resuscitated|56|||
30674204|NCT00808236|58688173|FG000|Overall Study|Pre-defined exclusion|13|||
30674205|NCT00808236|58688174|FG001|Overall Study|Pre-defined exclusion|3|||
30674206|NCT00808236|58688173|FG000|Overall Study|Lost to Follow-up|1|||
30674207|NCT00808236|58688174|FG001|Overall Study|Lost to Follow-up|1|||
30674208|NCT00808236|58688173|FG000|Overall Study|Physician Decision|0|||
30674209|NCT00808236|58688174|FG001|Overall Study|Physician Decision|1|||
30674210|NCT00808236|58688173|FG000|Overall Study|Death|18|||
30674211|NCT00808236|58688174|FG001|Overall Study|Death|30|||
30590491|NCT01133626|58603005|FG001|Overall Study|Adverse Event|1|||
30590492|NCT01133626|58603006|FG002|Overall Study|Adverse Event|0|||
30590493|NCT01133626|58603004|FG000|Overall Study|Withdrawal by Subject|1|||
30590494|NCT01133626|58603005|FG001|Overall Study|Withdrawal by Subject|2|||
30590495|NCT01133626|58603006|FG002|Overall Study|Withdrawal by Subject|2|||
30590496|NCT01133626|58603004|FG000|Overall Study|Other|0|||
30590497|NCT01133626|58603005|FG001|Overall Study|Other|2|||
30590498|NCT01133626|58603006|FG002|Overall Study|Other|0|||
30590499|NCT01133392|58603016|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
30590500|NCT01133392|58603017|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
30590501|NCT01133392|58603016|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
30590502|NCT01133392|58603017|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
30590503|NCT00471354|58603023|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
30590504|NCT00471354|58603023|FG000|Overall Study|Adverse Event|13|||
30590505|NCT00471354|58603023|FG000|Overall Study|Protocol Violation|12|||
30590506|NCT00471354|58603023|FG000|Overall Study|Withdrawal by Subject|1|||
30590507|NCT00471354|58603023|FG000|Overall Study|Physician Decision|4|||
30590508|NCT00471354|58603023|FG000|Overall Study|Sponsor Decision|1|||
30674212|NCT00867035|58688182|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
30674213|NCT00867035|58688183|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
30590509|NCT00471354|58603023|FG000|Overall Study|Lost to Follow-up|3|||
30590510|NCT00471354|58603023|FG000|Overall Study|Lack of Efficacy|5|||
30590511|NCT00471354|58603023|FG000|Overall Study|Patient/Caregiver Decision|12|||
30674214|NCT00867035|58688182|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
30590512|NCT00471315|58603027|FG000|Overall Study|Adverse Event|7|||
30674215|NCT00867035|58688183|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
30674216|NCT00663208|58688196|FG000|Treatment Period|Lost to Follow-up|0|||
30856029|NCT00108953|58883763|FG000|Follow-up|Death|18|||
30674217|NCT00663208|58688197|FG001|Treatment Period|Lost to Follow-up|1|||
30674218|NCT00663208|58688198|FG002|Treatment Period|Lost to Follow-up|0|||
30674219|NCT00663208|58688199|FG003|Treatment Period|Lost to Follow-up|0|||
30674220|NCT00663208|58688200|FG004|Treatment Period|Lost to Follow-up|0|||
30674221|NCT00663208|58688201|FG005|Treatment Period|Lost to Follow-up|0|||
30674222|NCT00663208|58688202|FG006|Treatment Period|Lost to Follow-up|0|||
30674223|NCT00663208|58688196|FG000|Follow-up Period|Lost to Follow-up|2|||
30674224|NCT00663208|58688197|FG001|Follow-up Period|Lost to Follow-up|0|||
30674225|NCT00663208|58688198|FG002|Follow-up Period|Lost to Follow-up|3|||
30674226|NCT00663208|58688199|FG003|Follow-up Period|Lost to Follow-up|2|||
30674227|NCT00663208|58688200|FG004|Follow-up Period|Lost to Follow-up|0|||
30674228|NCT00663208|58688201|FG005|Follow-up Period|Lost to Follow-up|0|||
30674229|NCT00663208|58688202|FG006|Follow-up Period|Lost to Follow-up|0|||
30674230|NCT00663208|58688196|FG000|Follow-up Period|Other reason|1|||
30674231|NCT00663208|58688197|FG001|Follow-up Period|Other reason|0|||
30674232|NCT00663208|58688198|FG002|Follow-up Period|Other reason|0|||
30674233|NCT00663208|58688199|FG003|Follow-up Period|Other reason|0|||
30674234|NCT00663208|58688200|FG004|Follow-up Period|Other reason|0|||
30674235|NCT00663208|58688201|FG005|Follow-up Period|Other reason|0|||
30674236|NCT00663208|58688202|FG006|Follow-up Period|Other reason|1|||
30674237|NCT00810810|58688224|FG000|Overall Study|Withdrawal by Subject|0|||
30674238|NCT00810810|58688225|FG001|Overall Study|Withdrawal by Subject|8|||
30674239|NCT00810810|58688226|FG002|Overall Study|Withdrawal by Subject|10|||
30674240|NCT00810810|58688227|FG003|Overall Study|Withdrawal by Subject|8|||
30674241|NCT00810810|58688224|FG000|Overall Study|Physician Decision|0|||
30674242|NCT00810810|58688225|FG001|Overall Study|Physician Decision|3|||
30674243|NCT00810810|58688226|FG002|Overall Study|Physician Decision|1|||
30674244|NCT00810810|58688227|FG003|Overall Study|Physician Decision|5|||
30674245|NCT00661258|58688239|FG000|Overall Study|Death|1|||
30674246|NCT00661258|58688240|FG001|Overall Study|Death|0|||
30674247|NCT00661258|58688239|FG000|Overall Study|caught by police and in detox center|2|||
30674248|NCT00661258|58688240|FG001|Overall Study|caught by police and in detox center|1|||
30674249|NCT00871871|58688248|FG000|Part I|Adverse Event|0|||
30674250|NCT00871871|58688249|FG001|Part I|Adverse Event|2|||
30674251|NCT00871871|58688250|FG002|Part I|Adverse Event|0|||
30674252|NCT00871871|58688251|FG003|Part I|Adverse Event|0|||
30674253|NCT00871871|58688248|FG000|Part I|Withdrawal by Subject|3|||
30674254|NCT00871871|58688249|FG001|Part I|Withdrawal by Subject|0|||
30674255|NCT00871871|58688250|FG002|Part I|Withdrawal by Subject|0|||
30674256|NCT00871871|58688251|FG003|Part I|Withdrawal by Subject|0|||
30674257|NCT00871871|58688248|FG000|Part I|Laboratory abnormality|0|||
30674258|NCT00871871|58688249|FG001|Part I|Laboratory abnormality|1|||
30674259|NCT00871871|58688250|FG002|Part I|Laboratory abnormality|0|||
30674260|NCT00871871|58688251|FG003|Part I|Laboratory abnormality|0|||
30674261|NCT00871871|58688248|FG000|Part II|Lack of Efficacy|0|||
30674262|NCT00871871|58688249|FG001|Part II|Lack of Efficacy|0|||
30674263|NCT00871871|58688250|FG002|Part II|Lack of Efficacy|1|||
30674264|NCT00871871|58688251|FG003|Part II|Lack of Efficacy|0|||
30674265|NCT00871871|58688248|FG000|Part II|Withdrawal by Subject|0|||
30674266|NCT00871871|58688249|FG001|Part II|Withdrawal by Subject|0|||
30590513|NCT00471315|58603027|FG000|Overall Study|Withdrawal by Subject|1|||
30590514|NCT00471237|58603038|FG000|Overall Study|Adverse Event|6|||
30590515|NCT00471237|58603039|FG001|Overall Study|Adverse Event|5|||
30590516|NCT00471237|58603040|FG002|Overall Study|Adverse Event|4|||
30590517|NCT00471237|58603041|FG003|Overall Study|Adverse Event|8|||
30590518|NCT00471237|58603042|FG004|Overall Study|Adverse Event|7|||
30590519|NCT00471237|58603043|FG005|Overall Study|Adverse Event|5|||
30674267|NCT00871871|58688250|FG002|Part II|Withdrawal by Subject|2|||
30674268|NCT00871871|58688251|FG003|Part II|Withdrawal by Subject|1|||
30674269|NCT00871871|58688248|FG000|Part II|Adverse Event|0|||
30674270|NCT00871871|58688249|FG001|Part II|Adverse Event|0|||
30674271|NCT00871871|58688250|FG002|Part II|Adverse Event|1|||
30674272|NCT00871871|58688251|FG003|Part II|Adverse Event|2|||
30674273|NCT00871871|58688248|FG000|Part II|Protocol Violation|0|||
30674274|NCT00871871|58688249|FG001|Part II|Protocol Violation|0|||
30590520|NCT00471237|58603044|FG006|Overall Study|Adverse Event|0|||
30590521|NCT00471237|58603038|FG000|Overall Study|Lost to Follow-up|1|||
30674275|NCT00871871|58688250|FG002|Part II|Protocol Violation|0|||
30674276|NCT00871871|58688251|FG003|Part II|Protocol Violation|1|||
30674277|NCT00849680|58688269|FG000|Overall Study|Adverse Event|0|||
30674278|NCT00849680|58688270|FG001|Overall Study|Adverse Event|0|||
30674279|NCT00849680|58688271|FG002|Overall Study|Adverse Event|0|||
30958987|NCT01587703|59024023|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30674280|NCT00849680|58688272|FG003|Overall Study|Adverse Event|0|||
30674281|NCT00849680|58688273|FG004|Overall Study|Adverse Event|0|||
30674282|NCT00849680|58688274|FG005|Overall Study|Adverse Event|0|||
30674283|NCT00849680|58688275|FG006|Overall Study|Adverse Event|2|||
30674284|NCT00849680|58688276|FG007|Overall Study|Adverse Event|0|||
30674285|NCT00849680|58688269|FG000|Overall Study|Lost to Follow-up|7|||
30674286|NCT00849680|58688270|FG001|Overall Study|Lost to Follow-up|3|||
30674287|NCT00849680|58688271|FG002|Overall Study|Lost to Follow-up|12|||
30674288|NCT00849680|58688272|FG003|Overall Study|Lost to Follow-up|11|||
30674289|NCT00849680|58688273|FG004|Overall Study|Lost to Follow-up|8|||
30674290|NCT00849680|58688274|FG005|Overall Study|Lost to Follow-up|11|||
30674291|NCT00849680|58688275|FG006|Overall Study|Lost to Follow-up|12|||
30674292|NCT00849680|58688276|FG007|Overall Study|Lost to Follow-up|5|||
30674293|NCT00849680|58688269|FG000|Overall Study|Subject moved|1|||
30674294|NCT00849680|58688270|FG001|Overall Study|Subject moved|0|||
30674295|NCT00849680|58688271|FG002|Overall Study|Subject moved|3|||
30674296|NCT00849680|58688272|FG003|Overall Study|Subject moved|1|||
30674297|NCT00849680|58688273|FG004|Overall Study|Subject moved|0|||
30674298|NCT00849680|58688274|FG005|Overall Study|Subject moved|2|||
30674299|NCT00849680|58688275|FG006|Overall Study|Subject moved|2|||
30674300|NCT00849680|58688276|FG007|Overall Study|Subject moved|2|||
30674301|NCT00849680|58688269|FG000|Overall Study|Withdrawal by Subject|2|||
30674302|NCT00849680|58688270|FG001|Overall Study|Withdrawal by Subject|0|||
30674303|NCT00849680|58688271|FG002|Overall Study|Withdrawal by Subject|0|||
30674304|NCT00849680|58688272|FG003|Overall Study|Withdrawal by Subject|2|||
30674305|NCT00849680|58688273|FG004|Overall Study|Withdrawal by Subject|2|||
30674306|NCT00849680|58688274|FG005|Overall Study|Withdrawal by Subject|2|||
30674307|NCT00849680|58688275|FG006|Overall Study|Withdrawal by Subject|1|||
30674308|NCT00849680|58688276|FG007|Overall Study|Withdrawal by Subject|1|||
30674309|NCT00849680|58688269|FG000|Overall Study|Subject unable to comply with protocol|1|||
30674310|NCT00849680|58688270|FG001|Overall Study|Subject unable to comply with protocol|0|||
30590522|NCT00471237|58603039|FG001|Overall Study|Lost to Follow-up|1|||
30590523|NCT00471237|58603040|FG002|Overall Study|Lost to Follow-up|0|||
30590524|NCT00471237|58603041|FG003|Overall Study|Lost to Follow-up|2|||
30590525|NCT00471237|58603042|FG004|Overall Study|Lost to Follow-up|3|||
30590526|NCT00471237|58603043|FG005|Overall Study|Lost to Follow-up|0|||
30590527|NCT00471237|58603044|FG006|Overall Study|Lost to Follow-up|0|||
30590528|NCT00471237|58603038|FG000|Overall Study|Protocol Violation|3|||
30590529|NCT00471237|58603039|FG001|Overall Study|Protocol Violation|6|||
30674311|NCT00849680|58688271|FG002|Overall Study|Subject unable to comply with protocol|0|||
30674312|NCT00849680|58688272|FG003|Overall Study|Subject unable to comply with protocol|0|||
30674313|NCT00849680|58688273|FG004|Overall Study|Subject unable to comply with protocol|0|||
30674314|NCT00849680|58688274|FG005|Overall Study|Subject unable to comply with protocol|0|||
30674315|NCT00849680|58688275|FG006|Overall Study|Subject unable to comply with protocol|0|||
30674316|NCT00849680|58688276|FG007|Overall Study|Subject unable to comply with protocol|0|||
30781684|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
30781685|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
30781686|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
30781687|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
30781688|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
30781689|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
30781690|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
30781691|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
30781692|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
30781693|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
30781694|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
30781695|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
30781696|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
30781697|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
30674317|NCT00810342|58688296|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
30674318|NCT00810342|58688297|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
30674319|NCT00810342|58688296|FG000|Month 1 Follow-up|Pregnancy|1|||
30674320|NCT00810342|58688297|FG001|Month 1 Follow-up|Pregnancy|0|||
30674321|NCT00810342|58688296|FG000|6-month Follow-up|Lost to Follow-up|18|||
30674322|NCT00810342|58688297|FG001|6-month Follow-up|Lost to Follow-up|6|||
30674323|NCT00810342|58688296|FG000|6-month Follow-up|Pregnancy|6|||
30674324|NCT00810342|58688297|FG001|6-month Follow-up|Pregnancy|2|||
30674325|NCT00810342|58688296|FG000|12-month Followup|Pregnancy|9|||
30674326|NCT00810342|58688297|FG001|12-month Followup|Pregnancy|10|||
30781698|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
30781699|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
30781700|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
30856030|NCT00108953|58883764|FG001|Follow-up|Death|26|||
30856031|NCT00108953|58883763|FG000|Follow-up|Lost to Follow-up|1|||
30590530|NCT00471237|58603040|FG002|Overall Study|Protocol Violation|3|||
30590531|NCT00471237|58603041|FG003|Overall Study|Protocol Violation|2|||
30590532|NCT00471237|58603042|FG004|Overall Study|Protocol Violation|2|||
30674327|NCT00810342|58688296|FG000|12-month Followup|Lost to Follow-up|3|||
30674328|NCT00810342|58688297|FG001|12-month Followup|Lost to Follow-up|1|||
30674329|NCT00849524|58688305|FG000|Overall Study|Lack of Efficacy|3|||
30674330|NCT00808080|58688309|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
30674331|NCT00866723|58688314|FG000|Overall Study|Withdrawal by Subject|1|||
30590533|NCT00471237|58603043|FG005|Overall Study|Protocol Violation|4|||
30590534|NCT00471237|58603044|FG006|Overall Study|Protocol Violation|1|||
30590535|NCT00471237|58603038|FG000|Overall Study|Withdrawal by Subject|8|||
30590536|NCT00471237|58603039|FG001|Overall Study|Withdrawal by Subject|6|||
30590537|NCT00471237|58603040|FG002|Overall Study|Withdrawal by Subject|5|||
30590538|NCT00471237|58603041|FG003|Overall Study|Withdrawal by Subject|8|||
30590539|NCT00471237|58603042|FG004|Overall Study|Withdrawal by Subject|7|||
30590540|NCT00471237|58603043|FG005|Overall Study|Withdrawal by Subject|4|||
30590541|NCT00471237|58603044|FG006|Overall Study|Withdrawal by Subject|2|||
30590542|NCT00471237|58603038|FG000|Overall Study|Sponsor terminated study|20|||
30590543|NCT00471237|58603039|FG001|Overall Study|Sponsor terminated study|23|||
30590544|NCT00471237|58603040|FG002|Overall Study|Sponsor terminated study|19|||
30590545|NCT00471237|58603041|FG003|Overall Study|Sponsor terminated study|22|||
30674332|NCT00866723|58688314|FG000|Overall Study|Disease Progression|4|||
30674333|NCT00849290|58688318|FG000|Overall Study|Adverse Event|3|||
30674334|NCT00849290|58688318|FG000|Overall Study|Death|14|||
30674335|NCT00849290|58688318|FG000|Overall Study|Withdrawal by Subject|11|||
30674336|NCT00849290|58688318|FG000|Overall Study|Lost to Follow-up|2|||
30674337|NCT00849290|58688318|FG000|Overall Study|Protocol Violation|5|||
30674338|NCT00849290|58688318|FG000|Overall Study|Disease Progression|20|||
30674339|NCT00849212|58688322|FG000|Overall Study|Lack of Efficacy|1|||
30674340|NCT00849212|58688322|FG000|Overall Study|Withdrawal by Subject|3|||
30674341|NCT00849212|58688322|FG000|Overall Study|Adverse Event|2|||
30674342|NCT00849212|58688322|FG000|Overall Study|Miscellaneous|1|||
30674343|NCT00810264|58688326|FG000|Overall Study|Lost to Follow-up|191|||
30674344|NCT00810264|58688326|FG000|Overall Study|Withdrawal by subject or physician|721|||
30674345|NCT00810264|58688326|FG000|Overall Study|Death|641|||
30674346|NCT00849056|58688336|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
30674347|NCT00849056|58688337|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
30674348|NCT00849056|58688336|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
30674349|NCT00849056|58688337|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
30674350|NCT00849056|58688336|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
30674351|NCT00849056|58688337|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
30674352|NCT00849056|58688336|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
30674353|NCT00849056|58688337|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
30674354|NCT00849056|58688336|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
30674355|NCT00849056|58688337|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
30674356|NCT00849056|58688336|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
30674357|NCT00849056|58688337|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
30674358|NCT00849056|58688336|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
30590546|NCT00471237|58603042|FG004|Overall Study|Sponsor terminated study|18|||
30590547|NCT00471237|58603043|FG005|Overall Study|Sponsor terminated study|24|||
30590548|NCT00471237|58603044|FG006|Overall Study|Sponsor terminated study|0|||
30590549|NCT00471237|58603038|FG000|Overall Study|Non-compliance|0|||
30590550|NCT00471237|58603039|FG001|Overall Study|Non-compliance|1|||
30590551|NCT00471237|58603040|FG002|Overall Study|Non-compliance|0|||
30674359|NCT00849056|58688337|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
30674360|NCT00849056|58688336|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
30674361|NCT00849056|58688337|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
30674362|NCT00849056|58688336|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
30674363|NCT00849056|58688337|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
30674364|NCT00849056|58688336|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
30674365|NCT00849056|58688337|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
30674366|NCT00849056|58688336|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
30674367|NCT00849056|58688337|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
30674368|NCT00849056|58688336|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
30674369|NCT00849056|58688337|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
30674370|NCT00849056|58688336|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
30674371|NCT00849056|58688337|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
30674372|NCT00849056|58688336|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
30674373|NCT00849056|58688337|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
30674374|NCT00849056|58688336|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
30674375|NCT00849056|58688337|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
30674376|NCT00849056|58688336|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
30674377|NCT00849056|58688337|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
30674378|NCT00837434|58688345|FG000|Overall Study|Physician Decision|3|||
30781701|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
30781702|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
30590552|NCT00471237|58603041|FG003|Overall Study|Non-compliance|1|||
30590553|NCT00471237|58603042|FG004|Overall Study|Non-compliance|0|||
30590554|NCT00471237|58603043|FG005|Overall Study|Non-compliance|0|||
30590555|NCT00471237|58603044|FG006|Overall Study|Non-compliance|0|||
30674379|NCT00837434|58688346|FG001|Overall Study|Physician Decision|0|||
30674380|NCT00837434|58688345|FG000|Overall Study|Lost to Follow-up|1|||
30590556|NCT00471237|58603038|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
30590557|NCT00471237|58603039|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
30590558|NCT00471237|58603040|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
30590559|NCT00471237|58603041|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
30590560|NCT00471237|58603042|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
30590561|NCT00471237|58603043|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
30590562|NCT00471237|58603044|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
30590563|NCT00471237|58603038|FG000|Overall Study|Early stopping due to non-efficacy|1|||
30590564|NCT00471237|58603039|FG001|Overall Study|Early stopping due to non-efficacy|0|||
30674381|NCT00837434|58688346|FG001|Overall Study|Lost to Follow-up|1|||
30674382|NCT00837434|58688345|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
30674383|NCT00837434|58688346|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
30674384|NCT00837434|58688345|FG000|Overall Study|Noncompliant|2|||
30674385|NCT00837434|58688346|FG001|Overall Study|Noncompliant|0|||
30674386|NCT00837434|58688345|FG000|Overall Study|Baseline assessments not done in time|1|||
30674387|NCT00837434|58688346|FG001|Overall Study|Baseline assessments not done in time|0|||
30674388|NCT00837434|58688345|FG000|Overall Study|Unable to obtain study drug|1|||
30674389|NCT00837434|58688346|FG001|Overall Study|Unable to obtain study drug|0|||
30674390|NCT00827918|58688355|FG000|Overall Study|Adverse Event|4|||
30674391|NCT00827918|58688356|FG001|Overall Study|Adverse Event|0|||
30674392|NCT00827918|58688357|FG002|Overall Study|Adverse Event|0|||
30674393|NCT00827918|58688355|FG000|Overall Study|Lack of Efficacy|16|||
30674394|NCT00827918|58688356|FG001|Overall Study|Lack of Efficacy|4|||
30674395|NCT00827918|58688357|FG002|Overall Study|Lack of Efficacy|15|||
30674396|NCT00827918|58688355|FG000|Overall Study|Physician Decision|1|||
30674397|NCT00827918|58688356|FG001|Overall Study|Physician Decision|0|||
30674398|NCT00827918|58688357|FG002|Overall Study|Physician Decision|0|||
30674399|NCT00827918|58688355|FG000|Overall Study|Pregnancy|0|||
30674400|NCT00827918|58688356|FG001|Overall Study|Pregnancy|1|||
30674401|NCT00827918|58688357|FG002|Overall Study|Pregnancy|0|||
30674402|NCT00827918|58688355|FG000|Overall Study|Progressive Disease|1|||
30674403|NCT00827918|58688356|FG001|Overall Study|Progressive Disease|1|||
30674404|NCT00827918|58688357|FG002|Overall Study|Progressive Disease|0|||
30674405|NCT00827918|58688355|FG000|Overall Study|Protocol Violation|0|||
30674406|NCT00827918|58688356|FG001|Overall Study|Protocol Violation|1|||
30674407|NCT00827918|58688357|FG002|Overall Study|Protocol Violation|0|||
30674408|NCT00827918|58688355|FG000|Overall Study|Withdrawal by Subject|6|||
30674409|NCT00827918|58688356|FG001|Overall Study|Withdrawal by Subject|2|||
30674410|NCT00827918|58688357|FG002|Overall Study|Withdrawal by Subject|6|||
30674411|NCT00813150|58688367|FG000|Treatment Period|Adverse Event|16|||
30674412|NCT00813150|58688368|FG001|Treatment Period|Adverse Event|15|||
30674413|NCT00813150|58688367|FG000|Treatment Period|Death|2|||
30674414|NCT00813150|58688368|FG001|Treatment Period|Death|0|||
30674415|NCT00813150|58688367|FG000|Treatment Period|Progressive disease|1|||
30674416|NCT00813150|58688368|FG001|Treatment Period|Progressive disease|0|||
30674417|NCT00813150|58688367|FG000|Treatment Period|Complete response|0|||
30674418|NCT00813150|58688368|FG001|Treatment Period|Complete response|1|||
30674419|NCT00813150|58688367|FG000|Treatment Period|Stable disease|1|||
30674420|NCT00813150|58688368|FG001|Treatment Period|Stable disease|2|||
30674421|NCT00813150|58688367|FG000|Treatment Period|Protocol Violation|3|||
30674422|NCT00813150|58688368|FG001|Treatment Period|Protocol Violation|4|||
30674423|NCT00813150|58688367|FG000|Treatment Period|Withdrawal by Subject|5|||
30674424|NCT00813150|58688368|FG001|Treatment Period|Withdrawal by Subject|3|||
30674425|NCT00813150|58688367|FG000|Treatment Period|Non compliance|0|||
30674426|NCT00813150|58688368|FG001|Treatment Period|Non compliance|1|||
30674427|NCT00813150|58688367|FG000|Treatment Period|Reason not specified|3|||
30674428|NCT00813150|58688368|FG001|Treatment Period|Reason not specified|4|||
30674429|NCT00813150|58688367|FG000|Treatment Period|Data not available|1|||
30674430|NCT00813150|58688368|FG001|Treatment Period|Data not available|2|||
30674431|NCT00813150|58688367|FG000|Long Term Follow-up|Death|0|||
30674432|NCT00813150|58688368|FG001|Long Term Follow-up|Death|4|||
30674433|NCT00813150|58688367|FG000|Long Term Follow-up|Other|0|||
30674434|NCT00813150|58688368|FG001|Long Term Follow-up|Other|3|||
30674435|NCT00813150|58688367|FG000|Long Term Follow-up|Lost to Follow-up|2|||
30674436|NCT00813150|58688368|FG001|Long Term Follow-up|Lost to Follow-up|0|||
30674437|NCT00813150|58688367|FG000|Long Term Follow-up|Progression/Relapse|22|||
30674438|NCT00813150|58688368|FG001|Long Term Follow-up|Progression/Relapse|24|||
30674439|NCT00807846|58688376|FG000|Overall Study|Adverse Event|5|||
30674440|NCT00807846|58688377|FG001|Overall Study|Adverse Event|0|||
30674441|NCT00807846|58688376|FG000|Overall Study|Lack of Efficacy|2|||
30674442|NCT00807846|58688377|FG001|Overall Study|Lack of Efficacy|0|||
30674443|NCT00807846|58688376|FG000|Overall Study|Protocol Violation|2|||
30674444|NCT00807846|58688377|FG001|Overall Study|Protocol Violation|1|||
30674445|NCT00807846|58688376|FG000|Overall Study|Withdrawal by Subject|2|||
30674446|NCT00807846|58688377|FG001|Overall Study|Withdrawal by Subject|1|||
30590565|NCT00471237|58603040|FG002|Overall Study|Early stopping due to non-efficacy|0|||
30674447|NCT00807846|58688376|FG000|Overall Study|Other|1|||
30674448|NCT00807846|58688377|FG001|Overall Study|Other|2|||
30674449|NCT00810108|58688385|FG000|Overall Study|Withdrawal by Subject|1|||
30674450|NCT00810108|58688386|FG001|Overall Study|Withdrawal by Subject|0|||
30674451|NCT00827606|58688393|FG000|Overall Study|Protocol Violation|4|||
30674452|NCT00827606|58688394|FG001|Overall Study|Protocol Violation|3|||
30674453|NCT00827606|58688393|FG000|Overall Study|Lost to Follow-up|3|||
30674454|NCT00827606|58688394|FG001|Overall Study|Lost to Follow-up|1|||
30674455|NCT00827606|58688393|FG000|Overall Study|Withdrawal by Subject|7|||
30674456|NCT00827606|58688394|FG001|Overall Study|Withdrawal by Subject|6|||
30674457|NCT00827606|58688393|FG000|Overall Study|Pregnancy|0|||
30674458|NCT00827606|58688394|FG001|Overall Study|Pregnancy|1|||
30674459|NCT00827606|58688393|FG000|Overall Study|Other|5|||
30674460|NCT00827606|58688394|FG001|Overall Study|Other|13|||
30674461|NCT00827606|58688393|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
30674462|NCT00827606|58688394|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
30674463|NCT00827606|58688393|FG000|Overall Study|Adverse Event|4|||
30674464|NCT00827606|58688394|FG001|Overall Study|Adverse Event|2|||
30674465|NCT00663052|58688408|FG000|Overall Study|Adverse Event|6|||
30674466|NCT00663052|58688409|FG001|Overall Study|Adverse Event|3|||
30674467|NCT00663052|58688408|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
30674468|NCT00663052|58688409|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
30674469|NCT00663052|58688408|FG000|Overall Study|Protocol Violation|1|||
30674470|NCT00663052|58688409|FG001|Overall Study|Protocol Violation|0|||
30781703|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
30781704|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
30781705|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
30781706|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
30781707|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
30781708|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
30781709|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
30781710|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
30590566|NCT00471237|58603041|FG003|Overall Study|Early stopping due to non-efficacy|0|||
30590567|NCT00471237|58603042|FG004|Overall Study|Early stopping due to non-efficacy|1|||
30590568|NCT00471237|58603043|FG005|Overall Study|Early stopping due to non-efficacy|0|||
30590569|NCT00471237|58603044|FG006|Overall Study|Early stopping due to non-efficacy|0|||
30590570|NCT00471237|58603038|FG000|Overall Study|Participant planned to travel to abraod|1|||
30590571|NCT00471237|58603039|FG001|Overall Study|Participant planned to travel to abraod|0|||
30590572|NCT00471237|58603040|FG002|Overall Study|Participant planned to travel to abraod|0|||
30590573|NCT00471237|58603041|FG003|Overall Study|Participant planned to travel to abraod|0|||
30590574|NCT00471237|58603042|FG004|Overall Study|Participant planned to travel to abraod|0|||
30590575|NCT00471237|58603043|FG005|Overall Study|Participant planned to travel to abraod|1|||
30590576|NCT00471237|58603044|FG006|Overall Study|Participant planned to travel to abraod|0|||
30590577|NCT00471237|58603038|FG000|Overall Study|High parathyroid hormone|0|||
30590578|NCT00471237|58603039|FG001|Overall Study|High parathyroid hormone|0|||
30590579|NCT00471237|58603040|FG002|Overall Study|High parathyroid hormone|1|||
30590580|NCT00471237|58603041|FG003|Overall Study|High parathyroid hormone|0|||
30590581|NCT00471237|58603042|FG004|Overall Study|High parathyroid hormone|0|||
30590582|NCT00471237|58603043|FG005|Overall Study|High parathyroid hormone|0|||
30590583|NCT00471237|58603044|FG006|Overall Study|High parathyroid hormone|0|||
30590584|NCT00471237|58603038|FG000|Overall Study|Participant lost medication|0|||
30590585|NCT00471237|58603039|FG001|Overall Study|Participant lost medication|0|||
30590586|NCT00471237|58603040|FG002|Overall Study|Participant lost medication|0|||
30590587|NCT00471237|58603041|FG003|Overall Study|Participant lost medication|0|||
30590588|NCT00471237|58603042|FG004|Overall Study|Participant lost medication|1|||
30590589|NCT00471237|58603043|FG005|Overall Study|Participant lost medication|0|||
30590590|NCT00471237|58603044|FG006|Overall Study|Participant lost medication|0|||
30590591|NCT00471237|58603038|FG000|Overall Study|Administration of prohibited medicine|0|||
30590592|NCT00471237|58603039|FG001|Overall Study|Administration of prohibited medicine|0|||
30590593|NCT00471237|58603040|FG002|Overall Study|Administration of prohibited medicine|0|||
30590594|NCT00471237|58603041|FG003|Overall Study|Administration of prohibited medicine|0|||
30590595|NCT00471237|58603042|FG004|Overall Study|Administration of prohibited medicine|1|||
30590596|NCT00471237|58603043|FG005|Overall Study|Administration of prohibited medicine|0|||
30590597|NCT00471237|58603044|FG006|Overall Study|Administration of prohibited medicine|0|||
30856032|NCT00108953|58883764|FG001|Follow-up|Lost to Follow-up|1|||
30590598|NCT00471237|58603038|FG000|Overall Study|Participant shifted residence|0|||
30590599|NCT00471237|58603039|FG001|Overall Study|Participant shifted residence|0|||
30590600|NCT00471237|58603040|FG002|Overall Study|Participant shifted residence|0|||
30674471|NCT00663052|58688408|FG000|Overall Study|Withdrawal by Subject|2|||
30674472|NCT00663052|58688409|FG001|Overall Study|Withdrawal by Subject|5|||
30674473|NCT00663052|58688408|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
30674474|NCT00663052|58688409|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
30674475|NCT00663052|58688408|FG000|Overall Study|Other|0|||
30674476|NCT00663052|58688409|FG001|Overall Study|Other|1|||
30674477|NCT00827372|58688415|FG000|Overall Study|Adverse Event|5|||
30674478|NCT00827372|58688415|FG000|Overall Study|Lack of Efficacy|3|||
30674479|NCT00826748|58688423|FG000|Overall Study|Withdrawal by Subject|0|||
30674480|NCT00826748|58688424|FG001|Overall Study|Withdrawal by Subject|0|||
30674481|NCT00826748|58688425|FG002|Overall Study|Withdrawal by Subject|2|||
30674482|NCT00826748|58688423|FG000|Overall Study|Physician Decision|0|||
30674483|NCT00826748|58688424|FG001|Overall Study|Physician Decision|0|||
30674484|NCT00826748|58688425|FG002|Overall Study|Physician Decision|1|||
30674485|NCT00826748|58688423|FG000|Overall Study|Samples Did Not pass QC|0|||
30674486|NCT00826748|58688424|FG001|Overall Study|Samples Did Not pass QC|0|||
30674487|NCT00826748|58688425|FG002|Overall Study|Samples Did Not pass QC|1|||
30674488|NCT00806988|58688435|FG000|Overall Study|Death|15|||
30674489|NCT00806988|58688436|FG001|Overall Study|Death|16|||
30674490|NCT00806988|58688435|FG000|Overall Study|Withdrawal by Subject|8|||
30674491|NCT00806988|58688436|FG001|Overall Study|Withdrawal by Subject|8|||
30674492|NCT00806988|58688435|FG000|Overall Study|Lost to Follow-up|4|||
30674493|NCT00806988|58688436|FG001|Overall Study|Lost to Follow-up|19|||
30674494|NCT00807144|58688444|FG000|Overall Study|Lost to Follow-up|0|||
30674495|NCT00807144|58688445|FG001|Overall Study|Lost to Follow-up|1|||
30674496|NCT00591006|58688451|FG000|Overall Study|Withdrawal by Subject|0|||
30674497|NCT00591006|58688452|FG001|Overall Study|Withdrawal by Subject|0|||
30674498|NCT00591006|58688453|FG002|Overall Study|Withdrawal by Subject|0|||
30674499|NCT00591006|58688454|FG003|Overall Study|Withdrawal by Subject|0|||
30674500|NCT00591006|58688455|FG004|Overall Study|Withdrawal by Subject|0|||
30674501|NCT00591006|58688456|FG005|Overall Study|Withdrawal by Subject|0|||
30674502|NCT00591006|58688457|FG006|Overall Study|Withdrawal by Subject|0|||
30674503|NCT00591006|58688458|FG007|Overall Study|Withdrawal by Subject|0|||
30674504|NCT00591006|58688459|FG008|Overall Study|Withdrawal by Subject|0|||
30674505|NCT00591006|58688460|FG009|Overall Study|Withdrawal by Subject|0|||
30674506|NCT00591006|58688461|FG010|Overall Study|Withdrawal by Subject|0|||
30674507|NCT00591006|58688462|FG011|Overall Study|Withdrawal by Subject|0|||
30674508|NCT00591006|58688463|FG012|Overall Study|Withdrawal by Subject|0|||
30674509|NCT00591006|58688464|FG013|Overall Study|Withdrawal by Subject|0|||
30674510|NCT00591006|58688465|FG014|Overall Study|Withdrawal by Subject|0|||
30674511|NCT00591006|58688466|FG015|Overall Study|Withdrawal by Subject|1|||
30674512|NCT00591006|58688467|FG016|Overall Study|Withdrawal by Subject|0|||
30674513|NCT00591006|58688468|FG017|Overall Study|Withdrawal by Subject|0|||
30674514|NCT00591006|58688469|FG018|Overall Study|Withdrawal by Subject|0|||
30674515|NCT00591006|58688470|FG019|Overall Study|Withdrawal by Subject|0|||
30674516|NCT00591006|58688471|FG020|Overall Study|Withdrawal by Subject|0|||
30674517|NCT00591006|58688472|FG021|Overall Study|Withdrawal by Subject|0|||
30674518|NCT00591006|58688473|FG022|Overall Study|Withdrawal by Subject|0|||
30674519|NCT00591006|58688474|FG023|Overall Study|Withdrawal by Subject|1|||
30674520|NCT00591006|58688451|FG000|Overall Study|Adverse Event|0|||
30674521|NCT00591006|58688452|FG001|Overall Study|Adverse Event|0|||
30674522|NCT00591006|58688453|FG002|Overall Study|Adverse Event|0|||
30674523|NCT00591006|58688454|FG003|Overall Study|Adverse Event|0|||
30674524|NCT00591006|58688455|FG004|Overall Study|Adverse Event|0|||
30674525|NCT00591006|58688456|FG005|Overall Study|Adverse Event|0|||
30674526|NCT00591006|58688457|FG006|Overall Study|Adverse Event|0|||
30674527|NCT00591006|58688458|FG007|Overall Study|Adverse Event|0|||
30674528|NCT00591006|58688459|FG008|Overall Study|Adverse Event|0|||
30674529|NCT00591006|58688460|FG009|Overall Study|Adverse Event|0|||
30674530|NCT00591006|58688461|FG010|Overall Study|Adverse Event|0|||
30674531|NCT00591006|58688462|FG011|Overall Study|Adverse Event|0|||
30674532|NCT00591006|58688463|FG012|Overall Study|Adverse Event|0|||
30674533|NCT00591006|58688464|FG013|Overall Study|Adverse Event|0|||
30674534|NCT00591006|58688465|FG014|Overall Study|Adverse Event|0|||
30674535|NCT00591006|58688466|FG015|Overall Study|Adverse Event|0|||
30674536|NCT00591006|58688467|FG016|Overall Study|Adverse Event|0|||
30674537|NCT00591006|58688468|FG017|Overall Study|Adverse Event|0|||
30674538|NCT00591006|58688469|FG018|Overall Study|Adverse Event|0|||
30674539|NCT00591006|58688470|FG019|Overall Study|Adverse Event|0|||
30674540|NCT00591006|58688471|FG020|Overall Study|Adverse Event|0|||
30674541|NCT00591006|58688472|FG021|Overall Study|Adverse Event|0|||
30674542|NCT00591006|58688473|FG022|Overall Study|Adverse Event|1|||
30674543|NCT00591006|58688474|FG023|Overall Study|Adverse Event|0|||
30674544|NCT00844844|58688491|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
30674545|NCT00844844|58688491|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
30674546|NCT00844844|58688491|FG000|Extension Treatment Period|Adverse Event|2|||
30674547|NCT00844844|58688491|FG000|Post Treatment Period|Withdrawal by Subject|1|||
30674548|NCT00660790|58688495|FG000|Baseline to 3 Months|Death|1|||
30674549|NCT00660790|58688495|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
30674550|NCT00660790|58688495|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
30674551|NCT00836810|58688501|FG000|Overall Study|New diagnosis|1|||
30674552|NCT00836810|58688502|FG001|Overall Study|New diagnosis|0|||
30674553|NCT00658684|58688511|FG000|Overall Study|Adverse Event|10|||
30674554|NCT00658684|58688512|FG001|Overall Study|Adverse Event|8|||
30674555|NCT00658684|58688513|FG002|Overall Study|Adverse Event|2|||
30674556|NCT00658684|58688514|FG003|Overall Study|Adverse Event|0|||
30674557|NCT00658684|58688511|FG000|Overall Study|Withdrawal by Subject|6|||
30674558|NCT00658684|58688512|FG001|Overall Study|Withdrawal by Subject|4|||
30674559|NCT00658684|58688513|FG002|Overall Study|Withdrawal by Subject|1|||
30674560|NCT00658684|58688514|FG003|Overall Study|Withdrawal by Subject|1|||
30674561|NCT00658684|58688511|FG000|Overall Study|Lack of Efficacy|1|||
30674562|NCT00658684|58688512|FG001|Overall Study|Lack of Efficacy|1|||
30674563|NCT00658684|58688513|FG002|Overall Study|Lack of Efficacy|0|||
30674564|NCT00658684|58688514|FG003|Overall Study|Lack of Efficacy|0|||
30674565|NCT00658684|58688511|FG000|Overall Study|Protocol Violation|1|||
30674566|NCT00658684|58688512|FG001|Overall Study|Protocol Violation|1|||
30590601|NCT00471237|58603041|FG003|Overall Study|Participant shifted residence|0|||
30590602|NCT00471237|58603042|FG004|Overall Study|Participant shifted residence|1|||
30590603|NCT00471237|58603043|FG005|Overall Study|Participant shifted residence|0|||
30674567|NCT00658684|58688513|FG002|Overall Study|Protocol Violation|0|||
30674568|NCT00658684|58688514|FG003|Overall Study|Protocol Violation|0|||
30674569|NCT00658684|58688511|FG000|Overall Study|Pregnancy|1|||
30674570|NCT00658684|58688512|FG001|Overall Study|Pregnancy|1|||
30674571|NCT00658684|58688513|FG002|Overall Study|Pregnancy|0|||
30674572|NCT00658684|58688514|FG003|Overall Study|Pregnancy|0|||
30674573|NCT00660400|58688524|FG000|Overall Study|Lack of insurance approval|1|||
30674574|NCT00660400|58688524|FG000|Overall Study|Suboptimal organ function|1|||
30674575|NCT00660400|58688524|FG000|Overall Study|Intracranial hemorrhage|1|||
30674576|NCT00660400|58688524|FG000|Overall Study|Withdrawal by Subject|1|||
30674577|NCT00826514|58688530|FG000|Overall Study|Adverse Event|1|||
30674578|NCT00826514|58688531|FG001|Overall Study|Adverse Event|1|||
30674579|NCT00826514|58688530|FG000|Overall Study|Lack of Efficacy|0|||
30674580|NCT00826514|58688531|FG001|Overall Study|Lack of Efficacy|1|||
30674581|NCT00826514|58688530|FG000|Overall Study|Withdrawal by Subject|2|||
30674582|NCT00826514|58688531|FG001|Overall Study|Withdrawal by Subject|3|||
30674583|NCT00826280|58688540|FG000|Overall Study|Randomized but drug not received|1|||
30674584|NCT00826280|58688541|FG001|Overall Study|Randomized but drug not received|0|||
30590604|NCT00471237|58603044|FG006|Overall Study|Participant shifted residence|0|||
30590605|NCT00471237|58603038|FG000|Overall Study|Participant's decision|0|||
30590606|NCT00471237|58603039|FG001|Overall Study|Participant's decision|0|||
30590607|NCT00471237|58603040|FG002|Overall Study|Participant's decision|0|||
30590608|NCT00471237|58603041|FG003|Overall Study|Participant's decision|0|||
30590609|NCT00471237|58603042|FG004|Overall Study|Participant's decision|0|||
30590610|NCT00471237|58603043|FG005|Overall Study|Participant's decision|1|||
30590611|NCT00471237|58603044|FG006|Overall Study|Participant's decision|0|||
30590612|NCT00471081|58603066|FG000|Active Phase|Protocol Violation|1|||
30590613|NCT00471081|58603067|FG001|Active Phase|Protocol Violation|1|||
30590614|NCT00471081|58603066|FG000|Active Phase|Withdrawal by Subject|0|||
30590615|NCT00471081|58603067|FG001|Active Phase|Withdrawal by Subject|3|||
30590616|NCT00471081|58603066|FG000|Active Phase|Lost to Follow-up|0|||
30590617|NCT00471081|58603067|FG001|Active Phase|Lost to Follow-up|1|||
30590618|NCT00471081|58603066|FG000|Active Phase|Lost health plan/insurance|1|||
30590619|NCT00471081|58603067|FG001|Active Phase|Lost health plan/insurance|8|||
30590620|NCT00471081|58603066|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
30590621|NCT00471081|58603067|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
30590622|NCT00471081|58603066|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
30590623|NCT00471081|58603067|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
30590624|NCT00471081|58603066|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
30674585|NCT00826280|58688542|FG002|Overall Study|Randomized but drug not received|1|||
30674586|NCT00826280|58688540|FG000|Overall Study|Adverse Event|1|||
30674587|NCT00826280|58688541|FG001|Overall Study|Adverse Event|3|||
30674588|NCT00826280|58688542|FG002|Overall Study|Adverse Event|0|||
30674589|NCT00826280|58688540|FG000|Overall Study|Lost to Follow-up|0|||
30674590|NCT00826280|58688541|FG001|Overall Study|Lost to Follow-up|1|||
30674591|NCT00826280|58688542|FG002|Overall Study|Lost to Follow-up|0|||
30674592|NCT00826280|58688540|FG000|Overall Study|Sponsor discontinued subject or study|1|||
30674593|NCT00826280|58688541|FG001|Overall Study|Sponsor discontinued subject or study|0|||
30674594|NCT00826280|58688542|FG002|Overall Study|Sponsor discontinued subject or study|0|||
30674595|NCT00826280|58688540|FG000|Overall Study|Reversible ischemic defect not present|43|||
30674596|NCT00826280|58688541|FG001|Overall Study|Reversible ischemic defect not present|40|||
30674597|NCT00826280|58688542|FG002|Overall Study|Reversible ischemic defect not present|44|||
30674598|NCT00826280|58688540|FG000|Overall Study|Interpretation Failure|1|||
30674599|NCT00826280|58688541|FG001|Overall Study|Interpretation Failure|0|||
30674600|NCT00826280|58688542|FG002|Overall Study|Interpretation Failure|0|||
30674601|NCT00826280|58688540|FG000|Overall Study|Machine Failure|1|||
30590625|NCT00471081|58603067|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
30590626|NCT00470847|58603074|FG000|Overall Study|Pt still receiving treatment|1|||
30590627|NCT00470535|58603080|FG000|Overall Study|Disease Progression|13|||
30674602|NCT00826280|58688541|FG001|Overall Study|Machine Failure|1|||
30674603|NCT00826280|58688542|FG002|Overall Study|Machine Failure|0|||
30674604|NCT00826280|58688540|FG000|Overall Study|One or more non-interpretable scan|0|||
30674605|NCT00826280|58688541|FG001|Overall Study|One or more non-interpretable scan|1|||
30674606|NCT00826280|58688542|FG002|Overall Study|One or more non-interpretable scan|1|||
30674607|NCT00864851|58688553|FG000|Overall Study|Withdrawal by Subject|0|||
30674608|NCT00864851|58688554|FG001|Overall Study|Withdrawal by Subject|1|||
30674609|NCT00864851|58688555|FG002|Overall Study|Withdrawal by Subject|0|||
30674610|NCT00864851|58688553|FG000|Overall Study|Physician Decision|1|||
30674611|NCT00864851|58688554|FG001|Overall Study|Physician Decision|0|||
30674612|NCT00864851|58688555|FG002|Overall Study|Physician Decision|0|||
30674613|NCT00864851|58688553|FG000|Overall Study|Death|1|||
30674614|NCT00864851|58688554|FG001|Overall Study|Death|0|||
30674615|NCT00864851|58688555|FG002|Overall Study|Death|0|||
30674616|NCT00864851|58688553|FG000|Overall Study|Patient uncooperative|1|||
30674617|NCT00864851|58688554|FG001|Overall Study|Patient uncooperative|0|||
30674618|NCT00864851|58688555|FG002|Overall Study|Patient uncooperative|0|||
30674619|NCT00857207|58688567|FG000|Overall Study|Withdrawal by Subject|13|||
30674620|NCT00857207|58688568|FG001|Overall Study|Withdrawal by Subject|0|||
30674621|NCT00857207|58688567|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
30674622|NCT00857207|58688568|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
30674623|NCT00857207|58688567|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
30674624|NCT00857207|58688568|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
30674625|NCT00836498|58688577|FG000|Overall Study|Adverse Event|1|||
30674626|NCT00836498|58688578|FG001|Overall Study|Adverse Event|0|||
30674627|NCT00836498|58688577|FG000|Overall Study|Lost to Follow-up|1|||
30674628|NCT00836498|58688578|FG001|Overall Study|Lost to Follow-up|0|||
30674629|NCT00836498|58688577|FG000|Overall Study|Withdrawal by Subject|2|||
30674630|NCT00836498|58688578|FG001|Overall Study|Withdrawal by Subject|1|||
30674631|NCT00856973|58688588|FG000|Overall Study|Adverse Event|5|||
30674632|NCT00856973|58688589|FG001|Overall Study|Adverse Event|5|||
30674633|NCT00856973|58688590|FG002|Overall Study|Adverse Event|3|||
30674634|NCT00856973|58688588|FG000|Overall Study|Lost to Follow-up|6|||
30674635|NCT00856973|58688589|FG001|Overall Study|Lost to Follow-up|3|||
30674636|NCT00856973|58688590|FG002|Overall Study|Lost to Follow-up|5|||
30674637|NCT00856973|58688588|FG000|Overall Study|Physician Decision|0|||
30674638|NCT00856973|58688589|FG001|Overall Study|Physician Decision|3|||
30674639|NCT00856973|58688590|FG002|Overall Study|Physician Decision|1|||
30674640|NCT00856973|58688588|FG000|Overall Study|Protocol Violation|1|||
30674641|NCT00856973|58688589|FG001|Overall Study|Protocol Violation|2|||
30674642|NCT00856973|58688590|FG002|Overall Study|Protocol Violation|1|||
30674643|NCT00856973|58688588|FG000|Overall Study|Withdrawal by Subject|13|||
30674644|NCT00856973|58688589|FG001|Overall Study|Withdrawal by Subject|16|||
30674645|NCT00856973|58688590|FG002|Overall Study|Withdrawal by Subject|15|||
30674646|NCT00856973|58688588|FG000|Overall Study|Other|11|||
30674647|NCT00856973|58688589|FG001|Overall Study|Other|12|||
30674648|NCT00856973|58688590|FG002|Overall Study|Other|13|||
30674649|NCT00844532|58688602|FG000|Overall Study|Death|16|||
30674650|NCT00844532|58688602|FG000|Overall Study|Withdrawal by Subject|16|||
30674651|NCT00844532|58688602|FG000|Overall Study|Lost to Follow-up|7|||
30674652|NCT00805194|58688608|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
30674653|NCT00805194|58688609|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
30674654|NCT00805194|58688608|FG000|Overall Study|Worsening or AE of underlying disease|64|||
30674655|NCT00805194|58688609|FG001|Overall Study|Worsening or AE of underlying disease|70|||
30674656|NCT00805194|58688608|FG000|Overall Study|Other AE|84|||
30674657|NCT00805194|58688609|FG001|Overall Study|Other AE|73|||
30674658|NCT00805194|58688608|FG000|Overall Study|Protocol Violation|9|||
30674659|NCT00805194|58688609|FG001|Overall Study|Protocol Violation|9|||
30674660|NCT00805194|58688608|FG000|Overall Study|Lost to Follow-up|5|||
30674661|NCT00805194|58688609|FG001|Overall Study|Lost to Follow-up|5|||
30674662|NCT00805194|58688608|FG000|Overall Study|Withdrawal by Subject|60|||
30674663|NCT00805194|58688609|FG001|Overall Study|Withdrawal by Subject|42|||
30674664|NCT00805194|58688608|FG000|Overall Study|Not treated|3|||
30674665|NCT00805194|58688609|FG001|Overall Study|Not treated|4|||
30674666|NCT00805194|58688608|FG000|Overall Study|Reasons other than stated above|20|||
30674667|NCT00805194|58688609|FG001|Overall Study|Reasons other than stated above|16|||
30674668|NCT00836186|58688620|FG000|Overall Study|Blood could not be drawn|1|||
30674669|NCT00657046|58688628|FG000|Overall Study|Adverse Event|1|||
30674670|NCT00657046|58688629|FG001|Overall Study|Adverse Event|1|||
30674671|NCT00657046|58688630|FG002|Overall Study|Adverse Event|0|||
30674672|NCT00657046|58688628|FG000|Overall Study|Protocol Violation|2|||
30674673|NCT00657046|58688629|FG001|Overall Study|Protocol Violation|2|||
30674674|NCT00657046|58688630|FG002|Overall Study|Protocol Violation|0|||
30674675|NCT00657046|58688628|FG000|Overall Study|Withdrawal by Subject|1|||
30674676|NCT00657046|58688629|FG001|Overall Study|Withdrawal by Subject|0|||
30674677|NCT00657046|58688630|FG002|Overall Study|Withdrawal by Subject|0|||
30674678|NCT00657046|58688628|FG000|Overall Study|Death|0|||
30674679|NCT00657046|58688629|FG001|Overall Study|Death|0|||
30674680|NCT00657046|58688630|FG002|Overall Study|Death|1|||
30674681|NCT00657046|58688628|FG000|Overall Study|Surgery|0|||
30674682|NCT00657046|58688629|FG001|Overall Study|Surgery|0|||
30674683|NCT00657046|58688630|FG002|Overall Study|Surgery|1|||
30674684|NCT00856661|58688640|FG000|Overall Study|Death|15|||
30674685|NCT00856661|58688641|FG001|Overall Study|Death|18|||
30674686|NCT00856661|58688640|FG000|Overall Study|Protocol Violation|2|||
30674687|NCT00856661|58688641|FG001|Overall Study|Protocol Violation|1|||
30674688|NCT00856661|58688640|FG000|Overall Study|Withdrawal by Subject|1|||
30674689|NCT00856661|58688641|FG001|Overall Study|Withdrawal by Subject|2|||
30674690|NCT00856661|58688640|FG000|Overall Study|Lost to Follow-up|1|||
30674691|NCT00856661|58688641|FG001|Overall Study|Lost to Follow-up|3|||
30674692|NCT00856661|58688640|FG000|Overall Study|Physician Judgement|8|||
30674693|NCT00856661|58688641|FG001|Overall Study|Physician Judgement|5|||
30674694|NCT00844376|58688647|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
30674695|NCT00844376|58688648|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
30674696|NCT00658606|58688656|FG000|Overall Study|Adverse Event|2|||
30674697|NCT00658606|58688657|FG001|Overall Study|Adverse Event|1|||
30674698|NCT00658606|58688656|FG000|Overall Study|Lack of Efficacy|6|||
30674699|NCT00658606|58688657|FG001|Overall Study|Lack of Efficacy|3|||
30674700|NCT00658606|58688656|FG000|Overall Study|Lost to Follow-up|1|||
30674701|NCT00658606|58688657|FG001|Overall Study|Lost to Follow-up|0|||
30674702|NCT00658606|58688656|FG000|Overall Study|Withdrawal by Subject|7|||
30674703|NCT00658606|58688657|FG001|Overall Study|Withdrawal by Subject|16|||
30674704|NCT00658606|58688656|FG000|Overall Study|Lack of Compliance|0|||
30674705|NCT00658606|58688657|FG001|Overall Study|Lack of Compliance|3|||
30674706|NCT00589290|58688663|FG000|Overall Study|Withdrawal by Subject|1|||
30674707|NCT00843518|58688671|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
30674708|NCT00843518|58688672|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
30674709|NCT00843518|58688671|FG000|Period 2 (Double-blind Treatment)|Death|0|||
30674710|NCT00843518|58688672|FG001|Period 2 (Double-blind Treatment)|Death|1|||
30674711|NCT00843518|58688671|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
30674712|NCT00843518|58688672|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
30674713|NCT00843518|58688671|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
30674714|NCT00843518|58688672|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
30674715|NCT00843518|58688671|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
30674716|NCT00843518|58688672|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
30590628|NCT00470535|58603080|FG000|Overall Study|Withdrawal by Subject|1|||
30590629|NCT00470535|58603080|FG000|Overall Study|Adverse Event|1|||
30590630|NCT00470535|58603080|FG000|Overall Study|Death|1|||
30590631|NCT00470535|58603080|FG000|Overall Study|Other|2|||
30590632|NCT00470418|58603086|FG000|Overall Study|Withdrawal by Subject|1|||
30590633|NCT00470418|58603087|FG001|Overall Study|Withdrawal by Subject|0|||
30590634|NCT01133275|58603093|FG000|Overall Study|Withdrawal by Subject|1|||
30590635|NCT01133275|58603093|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
30590636|NCT00470184|58603097|FG000|Overall Study|Not Treated(became ineligible)|4|||
30590637|NCT00470184|58603097|FG000|Overall Study|Not treated (other)|1|||
30590638|NCT00470184|58603097|FG000|Overall Study|disease Progression|4|||
30590639|NCT00470184|58603097|FG000|Overall Study|Adverse Event|3|||
30590640|NCT00470184|58603097|FG000|Overall Study|Withdrawal by Subject|4|||
30590641|NCT00470184|58603097|FG000|Overall Study|other|5|||
30590642|NCT00470184|58603097|FG000|Overall Study|recurrence|1|||
30590643|NCT00470067|58603102|FG000|Overall Study|Death|1|||
30674717|NCT00843518|58688671|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
30590644|NCT00470067|58603102|FG000|Overall Study|Disease Progression|6|||
30590645|NCT00475020|58603106|FG000|Overall Study|Physician Decision|3|||
30590646|NCT00475020|58603106|FG000|Overall Study|Insurance Denial|1|||
30590647|NCT00475020|58603106|FG000|Overall Study|Donor not able to donate the last minute|1|||
30590648|NCT02484456|58603112|FG000|Washout Period|Withdrawal by Subject|0|||
30590649|NCT02484456|58603113|FG001|Washout Period|Withdrawal by Subject|1|||
30590650|NCT02484456|58603112|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
30590651|NCT02484456|58603113|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
30590652|NCT02484456|58603112|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
30590653|NCT02484456|58603113|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
30590654|NCT02484456|58603112|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
30674718|NCT00843518|58688672|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
30674719|NCT00843518|58688671|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
30674720|NCT00843518|58688672|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
30674721|NCT00843284|58688682|FG000|Overall Study|Adverse Event|39|||
30590655|NCT02484456|58603113|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
30590656|NCT01132807|58603120|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
30590657|NCT01132807|58603121|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
30590658|NCT01132807|58603122|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
30674722|NCT00843284|58688682|FG000|Overall Study|Lack of Efficacy|5|||
30674723|NCT00843284|58688682|FG000|Overall Study|Lost to Follow-up|11|||
30674724|NCT00843284|58688682|FG000|Overall Study|Other|10|||
30674725|NCT00843284|58688682|FG000|Overall Study|Withdrawal by Subject|4|||
30674726|NCT00843284|58688682|FG000|Overall Study|Death|3|||
30590659|NCT01132807|58603120|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
30590660|NCT01132807|58603121|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
30590661|NCT01132807|58603122|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
30590662|NCT01132651|58603132|FG000|Overall Study|Lost to Follow-up|1|||
30590663|NCT01132651|58603133|FG001|Overall Study|Lost to Follow-up|1|||
30590664|NCT01089543|58603143|FG000|Overall Study|Withdrawal by Subject|2|||
30590665|NCT01089543|58603144|FG001|Overall Study|Withdrawal by Subject|3|||
30590666|NCT01089543|58603145|FG002|Overall Study|Withdrawal by Subject|3|||
30590667|NCT01089543|58603146|FG003|Overall Study|Withdrawal by Subject|1|||
30674727|NCT00652834|58688699|FG000|Overall Study|Withdrawal by Subject|3|||
30674728|NCT00652834|58688699|FG000|Overall Study|Lost to Follow-up|2|||
30674729|NCT00825812|58688707|FG000|Overall Study|Never entered follow up|0|||
30674730|NCT00825812|58688708|FG001|Overall Study|Never entered follow up|0|||
30674731|NCT00825812|58688709|FG002|Overall Study|Never entered follow up|0|||
30674732|NCT00825812|58688710|FG003|Overall Study|Never entered follow up|1|||
30674733|NCT00825812|58688707|FG000|Overall Study|Adverse Event|0|||
30674734|NCT00825812|58688708|FG001|Overall Study|Adverse Event|0|||
30674735|NCT00825812|58688709|FG002|Overall Study|Adverse Event|0|||
30674736|NCT00825812|58688710|FG003|Overall Study|Adverse Event|1|||
30590668|NCT01089543|58603143|FG000|Overall Study|Physician Decision|1|||
30590669|NCT01089543|58603144|FG001|Overall Study|Physician Decision|0|||
30590670|NCT01089543|58603145|FG002|Overall Study|Physician Decision|0|||
30590671|NCT01089543|58603146|FG003|Overall Study|Physician Decision|1|||
30590672|NCT01089543|58603143|FG000|Overall Study|Adverse Event|0|||
30590673|NCT01089543|58603144|FG001|Overall Study|Adverse Event|1|||
30590674|NCT01089543|58603145|FG002|Overall Study|Adverse Event|0|||
30590675|NCT01089543|58603146|FG003|Overall Study|Adverse Event|0|||
30590676|NCT01089504|58603158|FG000|Overall Study|Lost to Follow-up|1|||
30590677|NCT01089504|58603159|FG001|Overall Study|Lost to Follow-up|1|||
30590678|NCT01089504|58603158|FG000|Overall Study|Withdrawal by Subject|2|||
30590679|NCT01089504|58603159|FG001|Overall Study|Withdrawal by Subject|0|||
30590680|NCT01088997|58603167|FG000|Overall Study|Physician Decision|1|||
30590681|NCT01088997|58603168|FG001|Overall Study|Physician Decision|1|||
30674737|NCT00825812|58688707|FG000|Overall Study|Subject withdrew consent|0|||
30674738|NCT00825812|58688708|FG001|Overall Study|Subject withdrew consent|0|||
30674739|NCT00825812|58688709|FG002|Overall Study|Subject withdrew consent|3|||
30674740|NCT00825812|58688710|FG003|Overall Study|Subject withdrew consent|2|||
30674741|NCT00825812|58688707|FG000|Overall Study|Non-compliance with protocol|0|||
30674742|NCT00825812|58688708|FG001|Overall Study|Non-compliance with protocol|0|||
30674743|NCT00825812|58688709|FG002|Overall Study|Non-compliance with protocol|0|||
30674744|NCT00825812|58688710|FG003|Overall Study|Non-compliance with protocol|1|||
30674745|NCT00825812|58688707|FG000|Overall Study|Administrative|0|||
30674746|NCT00825812|58688708|FG001|Overall Study|Administrative|1|||
30674747|NCT00825812|58688709|FG002|Overall Study|Administrative|3|||
30674748|NCT00825812|58688710|FG003|Overall Study|Administrative|5|||
30674749|NCT00824720|58688723|FG000|Overall Study|failed plug insertion|3|||
30590682|NCT01088997|58603167|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
30590683|NCT01088997|58603168|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
30590684|NCT01088997|58603167|FG000|Overall Study|Excluded prior to receiving drug|1|||
30590685|NCT01088997|58603168|FG001|Overall Study|Excluded prior to receiving drug|1|||
30590686|NCT01088529|58603179|FG000|Overall Study|Did not receive study treatment|0|||
30590687|NCT01088529|58603180|FG001|Overall Study|Did not receive study treatment|1|||
30590688|NCT01087944|58603186|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
30590689|NCT01087944|58603187|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
30590690|NCT01087944|58603186|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
30590691|NCT01087944|58603187|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
30590692|NCT01132612|58603196|FG000|Overall Study|Death|0|||
30590693|NCT01132612|58603197|FG001|Overall Study|Death|0|||
30590694|NCT01132612|58603198|FG002|Overall Study|Death|1|||
30590695|NCT01132612|58603196|FG000|Overall Study|Protocol deviation|0|||
30590696|NCT01132612|58603197|FG001|Overall Study|Protocol deviation|0|||
30674750|NCT00824720|58688724|FG001|Overall Study|failed plug insertion|1|||
30674751|NCT00824720|58688725|FG002|Overall Study|failed plug insertion|0|||
30674752|NCT00824720|58688723|FG000|Overall Study|Protocol Violation|0|||
30674753|NCT00824720|58688724|FG001|Overall Study|Protocol Violation|0|||
30674754|NCT00824720|58688725|FG002|Overall Study|Protocol Violation|1|||
30590697|NCT01132612|58603198|FG002|Overall Study|Protocol deviation|3|||
30590698|NCT01132612|58603196|FG000|Overall Study|Lost to Follow-up|2|||
30590699|NCT01132612|58603197|FG001|Overall Study|Lost to Follow-up|2|||
30590700|NCT01132612|58603198|FG002|Overall Study|Lost to Follow-up|7|||
30590701|NCT01132612|58603196|FG000|Overall Study|Adverse Event|5|||
30590702|NCT01132612|58603197|FG001|Overall Study|Adverse Event|2|||
30590703|NCT01132612|58603198|FG002|Overall Study|Adverse Event|15|||
30674755|NCT03704064|58688735|FG000|Overall Study|Lost to Follow-up|8|||
30674756|NCT03704064|58688736|FG001|Overall Study|Lost to Follow-up|4|||
30674757|NCT03704064|58688735|FG000|Overall Study|Withdrawal by Subject|1|||
30674758|NCT03704064|58688736|FG001|Overall Study|Withdrawal by Subject|1|||
30674759|NCT03704064|58688735|FG000|Overall Study|No longer available for study visits|0|||
30674760|NCT03704064|58688736|FG001|Overall Study|No longer available for study visits|1|||
30674761|NCT03704064|58688735|FG000|Overall Study|Censoring event|1|||
30674762|NCT03704064|58688736|FG001|Overall Study|Censoring event|0|||
30674763|NCT00824564|58688744|FG000|Overall Study|Lost to Follow-up|5|||
30674764|NCT00824564|58688745|FG001|Overall Study|Lost to Follow-up|7|||
30674765|NCT00824564|58688744|FG000|Overall Study|Withdrawal by Subject|1|||
30674766|NCT00824564|58688745|FG001|Overall Study|Withdrawal by Subject|1|||
30674767|NCT00824564|58688744|FG000|Overall Study|Other|1|||
30674768|NCT00824564|58688745|FG001|Overall Study|Other|2|||
30674769|NCT00824564|58688744|FG000|Overall Study|Randomized, but not treated|1|||
30674770|NCT00824564|58688745|FG001|Overall Study|Randomized, but not treated|0|||
30674771|NCT00658528|58688753|FG000|Overall Study|Adverse Event|5|||
30674772|NCT00658528|58688754|FG001|Overall Study|Adverse Event|7|||
30674773|NCT00658528|58688753|FG000|Overall Study|Lost to Follow-up|14|||
30674774|NCT00658528|58688754|FG001|Overall Study|Lost to Follow-up|22|||
30674775|NCT00658528|58688753|FG000|Overall Study|Withdrawal by Subject|8|||
30674776|NCT00658528|58688754|FG001|Overall Study|Withdrawal by Subject|6|||
30674777|NCT00658528|58688753|FG000|Overall Study|Withdrawal of consent|5|||
30674778|NCT00658528|58688754|FG001|Overall Study|Withdrawal of consent|6|||
30674779|NCT00658528|58688753|FG000|Overall Study|Other|8|||
30674780|NCT00658528|58688754|FG001|Overall Study|Other|4|||
30674781|NCT00856583|58688762|FG000|Overall Study|Lack of Efficacy|389|||
30674782|NCT00856583|58688763|FG001|Overall Study|Lack of Efficacy|377|||
30674783|NCT00856583|58688762|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
30674784|NCT00856583|58688763|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
30674785|NCT00856583|58688762|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
30674786|NCT00856583|58688763|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
30674787|NCT00856583|58688762|FG000|Overall Study|Non-compliance|305|||
30674788|NCT00856583|58688763|FG001|Overall Study|Non-compliance|262|||
30674789|NCT00856583|58688762|FG000|Overall Study|Withdrawal by Subject|1092|||
30674790|NCT00856583|58688763|FG001|Overall Study|Withdrawal by Subject|919|||
30674791|NCT00856583|58688762|FG000|Overall Study|Physician Decision|59|||
30674792|NCT00856583|58688763|FG001|Overall Study|Physician Decision|82|||
30674793|NCT00856583|58688762|FG000|Overall Study|Pregnancy|14|||
30674794|NCT00856583|58688763|FG001|Overall Study|Pregnancy|5|||
30674795|NCT00856583|58688762|FG000|Overall Study|Other|92|||
30674796|NCT00856583|58688763|FG001|Overall Study|Other|104|||
30674797|NCT00856583|58688762|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
30674798|NCT00856583|58688763|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
30674799|NCT00856349|58688769|FG000|Overall Study|Death|418|||
30674800|NCT00856349|58688769|FG000|Overall Study|Withdrawal by Subject|116|||
30590704|NCT01132612|58603196|FG000|Overall Study|Withdrawal by Subject|5|||
30590705|NCT01132612|58603197|FG001|Overall Study|Withdrawal by Subject|8|||
30590706|NCT01132612|58603198|FG002|Overall Study|Withdrawal by Subject|19|||
30590707|NCT01132612|58603196|FG000|Overall Study|Administrative problems|5|||
30590708|NCT01132612|58603197|FG001|Overall Study|Administrative problems|1|||
30590709|NCT01132612|58603198|FG002|Overall Study|Administrative problems|52|||
30590710|NCT01132612|58603196|FG000|Overall Study|Lack of Efficacy|23|||
30674801|NCT00856349|58688769|FG000|Overall Study|Lost to Follow-up|91|||
30674802|NCT00856349|58688769|FG000|Overall Study|Protocol Violation|38|||
30674803|NCT00856349|58688769|FG000|Overall Study|Physician Decision|13|||
30674804|NCT00856349|58688769|FG000|Overall Study|Subject relocation|104|||
30590711|NCT01132612|58603197|FG001|Overall Study|Lack of Efficacy|22|||
30590712|NCT01132612|58603198|FG002|Overall Study|Lack of Efficacy|73|||
30590713|NCT01132495|58603210|FG000|Overall Study|Various reasons|40|||
30590714|NCT01132495|58603211|FG001|Overall Study|Various reasons|38|||
30590715|NCT01132495|58603212|FG002|Overall Study|Various reasons|20|||
30590716|NCT01132495|58603213|FG003|Overall Study|Various reasons|12|||
30674805|NCT00856349|58688769|FG000|Overall Study|Device explant|33|||
30674806|NCT00856349|58688769|FG000|Overall Study|Site closure|78|||
30674807|NCT00856349|58688769|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
30674808|NCT00803244|58688777|FG000|Overall Study|Adverse Event|1|||
30674809|NCT00803244|58688778|FG001|Overall Study|Adverse Event|2|||
30590717|NCT01087905|58603232|FG000|Overall Study|Lost to Follow-up|24|||
30590718|NCT01087905|58603233|FG001|Overall Study|Lost to Follow-up|28|||
30590719|NCT01087905|58603234|FG002|Overall Study|Lost to Follow-up|18|||
30590720|NCT01087905|58603235|FG003|Overall Study|Lost to Follow-up|31|||
30674810|NCT00803244|58688777|FG000|Overall Study|Withdrawal by Subject|2|||
30674811|NCT00803244|58688778|FG001|Overall Study|Withdrawal by Subject|3|||
30674812|NCT00803244|58688777|FG000|Overall Study|Any other reason not above-mentioned|4|||
30674813|NCT00803244|58688778|FG001|Overall Study|Any other reason not above-mentioned|10|||
30590721|NCT01087905|58603236|FG004|Overall Study|Lost to Follow-up|27|||
30674814|NCT04060212|58688784|FG000|Overall Study|Withdrawal by Subject|7|||
30674815|NCT00804570|58688790|FG000|Overall Study|Adverse Event|14|||
30674816|NCT00804570|58688791|FG001|Overall Study|Adverse Event|7|||
30674817|NCT00804570|58688790|FG000|Overall Study|Lack of Efficacy|0|||
30674818|NCT00804570|58688791|FG001|Overall Study|Lack of Efficacy|1|||
30674819|NCT00804570|58688790|FG000|Overall Study|Lost to Follow-up|18|||
30674820|NCT00804570|58688791|FG001|Overall Study|Lost to Follow-up|21|||
30674821|NCT00804570|58688790|FG000|Overall Study|Entry criteria not met|5|||
30674822|NCT00804570|58688791|FG001|Overall Study|Entry criteria not met|5|||
30674823|NCT00804570|58688790|FG000|Overall Study|Protocol Violation|12|||
30674824|NCT00804570|58688791|FG001|Overall Study|Protocol Violation|16|||
30674825|NCT00804570|58688790|FG000|Overall Study|Physician Decision|1|||
30674826|NCT00804570|58688791|FG001|Overall Study|Physician Decision|2|||
30674827|NCT00804570|58688790|FG000|Overall Study|Sponsor decision|1|||
30674828|NCT00804570|58688791|FG001|Overall Study|Sponsor decision|4|||
30674829|NCT00804570|58688790|FG000|Overall Study|Withdrawal by Subject|21|||
30674830|NCT00804570|58688791|FG001|Overall Study|Withdrawal by Subject|38|||
30674831|NCT00824408|58688803|FG000|Run-in Phase|Progressive disease|4|||
30590722|NCT01087905|58603237|FG005|Overall Study|Lost to Follow-up|25|||
30590723|NCT01087905|58603238|FG006|Overall Study|Lost to Follow-up|20|||
30590724|NCT01087905|58603239|FG007|Overall Study|Lost to Follow-up|24|||
30674832|NCT00824408|58688804|FG001|Run-in Phase|Progressive disease|4|||
30674833|NCT00824408|58688805|FG002|Run-in Phase|Progressive disease|0|||
30674834|NCT00824408|58688806|FG003|Run-in Phase|Progressive disease|0|||
30674835|NCT00824408|58688807|FG004|Run-in Phase|Progressive disease|0|||
30590725|NCT01087905|58603232|FG000|Overall Study|Withdrawal by Subject|5|||
30590726|NCT01087905|58603233|FG001|Overall Study|Withdrawal by Subject|4|||
30590727|NCT01087905|58603234|FG002|Overall Study|Withdrawal by Subject|4|||
30590728|NCT01087905|58603235|FG003|Overall Study|Withdrawal by Subject|5|||
30590729|NCT01087905|58603236|FG004|Overall Study|Withdrawal by Subject|4|||
30590730|NCT01087905|58603237|FG005|Overall Study|Withdrawal by Subject|3|||
30590731|NCT01087905|58603238|FG006|Overall Study|Withdrawal by Subject|3|||
30590732|NCT01087905|58603239|FG007|Overall Study|Withdrawal by Subject|5|||
30590733|NCT01087788|58603258|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
30590734|NCT01087788|58603259|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
30590735|NCT01087788|58603260|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
30590736|NCT01087788|58603258|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
30590737|NCT01087788|58603259|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
30590738|NCT01087788|58603260|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
30674836|NCT00824408|58688803|FG000|Run-in Phase|Adverse Event|1|||
30674837|NCT00824408|58688804|FG001|Run-in Phase|Adverse Event|1|||
30590739|NCT01087788|58603258|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
30590740|NCT01087788|58603259|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
30590741|NCT01087788|58603260|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
30590742|NCT01087788|58603258|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
30590743|NCT01087788|58603259|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
30590744|NCT01087788|58603260|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
30674838|NCT00824408|58688805|FG002|Run-in Phase|Adverse Event|0|||
30674839|NCT00824408|58688806|FG003|Run-in Phase|Adverse Event|0|||
30674840|NCT00824408|58688807|FG004|Run-in Phase|Adverse Event|0|||
30674841|NCT00824408|58688803|FG000|Run-in Phase|Refused to continue medication|1|||
30674842|NCT00824408|58688804|FG001|Run-in Phase|Refused to continue medication|0|||
30674843|NCT00824408|58688805|FG002|Run-in Phase|Refused to continue medication|0|||
30674844|NCT00824408|58688806|FG003|Run-in Phase|Refused to continue medication|0|||
30674845|NCT00824408|58688807|FG004|Run-in Phase|Refused to continue medication|0|||
30674846|NCT00824408|58688803|FG000|Run-in Phase|Other reason not defined above|0|||
30674847|NCT00824408|58688804|FG001|Run-in Phase|Other reason not defined above|1|||
30674848|NCT00824408|58688805|FG002|Run-in Phase|Other reason not defined above|0|||
30674849|NCT00824408|58688806|FG003|Run-in Phase|Other reason not defined above|0|||
30674850|NCT00824408|58688807|FG004|Run-in Phase|Other reason not defined above|0|||
30590745|NCT01087788|58603258|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
30590746|NCT01087788|58603259|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
30674851|NCT00824408|58688803|FG000|Randomized Phase|Not treated|0|||
30674852|NCT00824408|58688804|FG001|Randomized Phase|Not treated|0|||
30674853|NCT00824408|58688805|FG002|Randomized Phase|Not treated|1|||
30674854|NCT00824408|58688806|FG003|Randomized Phase|Not treated|1|||
30674855|NCT00824408|58688807|FG004|Randomized Phase|Not treated|1|||
30856033|NCT00108953|58883763|FG000|Follow-up|Study terminated by sponsor|10|||
30856034|NCT00108953|58883764|FG001|Follow-up|Study terminated by sponsor|6|||
30590747|NCT01087788|58603260|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
30590748|NCT01087788|58603258|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
30590749|NCT01087788|58603259|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
30674856|NCT00824408|58688803|FG000|Randomized Phase|Progressive disease|0|||
30674857|NCT00824408|58688804|FG001|Randomized Phase|Progressive disease|0|||
30674858|NCT00824408|58688805|FG002|Randomized Phase|Progressive disease|25|||
30674859|NCT00824408|58688806|FG003|Randomized Phase|Progressive disease|36|||
30856035|NCT02578316|58883772|FG000|Extension Phase|Progression of disease|6|||
30674860|NCT00824408|58688807|FG004|Randomized Phase|Progressive disease|34|||
30674861|NCT00824408|58688803|FG000|Randomized Phase|Adverse Event|0|||
30674862|NCT00824408|58688804|FG001|Randomized Phase|Adverse Event|0|||
30674863|NCT00824408|58688805|FG002|Randomized Phase|Adverse Event|4|||
30674864|NCT00824408|58688806|FG003|Randomized Phase|Adverse Event|5|||
30674865|NCT00824408|58688807|FG004|Randomized Phase|Adverse Event|5|||
30674866|NCT00824408|58688803|FG000|Randomized Phase|Refused to continue medication|0|||
30674867|NCT00824408|58688804|FG001|Randomized Phase|Refused to continue medication|0|||
30674868|NCT00824408|58688805|FG002|Randomized Phase|Refused to continue medication|2|||
30674869|NCT00824408|58688806|FG003|Randomized Phase|Refused to continue medication|2|||
30674870|NCT00824408|58688807|FG004|Randomized Phase|Refused to continue medication|2|||
30674871|NCT00824408|58688803|FG000|Randomized Phase|Other reason not defined above|0|||
30674872|NCT00824408|58688804|FG001|Randomized Phase|Other reason not defined above|0|||
30674873|NCT00824408|58688805|FG002|Randomized Phase|Other reason not defined above|4|||
30674874|NCT00824408|58688806|FG003|Randomized Phase|Other reason not defined above|2|||
30674875|NCT00824408|58688807|FG004|Randomized Phase|Other reason not defined above|4|||
30674876|NCT00866333|58688828|FG000|Overall Study|Withdrawal of consent|0|||
30674877|NCT00866333|58688829|FG001|Overall Study|Withdrawal of consent|1|||
30674878|NCT00866333|58688830|FG002|Overall Study|Withdrawal of consent|2|||
30674879|NCT00866333|58688828|FG000|Overall Study|Reason not Specified|3|||
30674880|NCT00866333|58688829|FG001|Overall Study|Reason not Specified|1|||
30674881|NCT00866333|58688830|FG002|Overall Study|Reason not Specified|1|||
30674882|NCT00866333|58688828|FG000|Overall Study|Study Terminated by Sponsor|2|||
30674883|NCT00866333|58688829|FG001|Overall Study|Study Terminated by Sponsor|5|||
30674884|NCT00866333|58688830|FG002|Overall Study|Study Terminated by Sponsor|9|||
30674885|NCT00834080|58688838|FG000|Overall Study|Adverse Event|7|||
30674886|NCT00834080|58688838|FG000|Overall Study|Lost to Follow-up|7|||
30674887|NCT00834080|58688838|FG000|Overall Study|Withdrawal by Subject|5|||
30674888|NCT00834080|58688838|FG000|Overall Study|Other - Pregnancy|1|||
30674889|NCT00834080|58688838|FG000|Overall Study|Other - False positive tests of the UDS|1|||
30674890|NCT00834080|58688838|FG000|Overall Study|Physician Decision|1|||
30674891|NCT00834080|58688838|FG000|Overall Study|Subject Relocated|1|||
30674892|NCT00823472|58688844|FG000|Overall Study|Physician Decision|24|||
30674893|NCT00823472|58688845|FG001|Overall Study|Physician Decision|28|||
30674894|NCT00856193|58688851|FG000|Period 2|Abnormal test procedure results|0|||
30674895|NCT00856193|58688852|FG001|Period 2|Abnormal test procedure results|1|||
30674896|NCT00856193|58688851|FG000|Period 2|Lost to Follow-up|0|||
30674897|NCT00856193|58688852|FG001|Period 2|Lost to Follow-up|1|||
30674898|NCT00652366|58688863|FG000|Overall Study|Adverse Event|8|||
30674899|NCT00652366|58688864|FG001|Overall Study|Adverse Event|4|||
30674900|NCT00652366|58688865|FG002|Overall Study|Adverse Event|7|||
30674901|NCT00652366|58688866|FG003|Overall Study|Adverse Event|17|||
30674902|NCT00652366|58688867|FG004|Overall Study|Adverse Event|13|||
30674903|NCT00652366|58688863|FG000|Overall Study|Death|5|||
30674904|NCT00652366|58688864|FG001|Overall Study|Death|4|||
30674905|NCT00652366|58688865|FG002|Overall Study|Death|1|||
30590750|NCT01087788|58603260|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
30781711|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
30590751|NCT01087788|58603258|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
30590752|NCT01087788|58603259|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
30590753|NCT01087788|58603260|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
30590754|NCT01087788|58603258|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
30590755|NCT01087788|58603259|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
30590756|NCT01087788|58603260|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
30590757|NCT01087788|58603258|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
30590758|NCT01087788|58603259|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
30590759|NCT01087788|58603260|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
30590760|NCT01087788|58603258|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
30590761|NCT01087788|58603259|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
30590762|NCT01087788|58603260|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
30674906|NCT00652366|58688866|FG003|Overall Study|Death|8|||
30674907|NCT00652366|58688867|FG004|Overall Study|Death|5|||
30674908|NCT00652366|58688863|FG000|Overall Study|Lack of Efficacy|84|||
30674909|NCT00652366|58688864|FG001|Overall Study|Lack of Efficacy|58|||
30674910|NCT00652366|58688865|FG002|Overall Study|Lack of Efficacy|53|||
30856036|NCT02576678|58883783|FG000|Overall Study|Adverse Event|0|||
30674911|NCT00652366|58688866|FG003|Overall Study|Lack of Efficacy|133|||
30674912|NCT00652366|58688867|FG004|Overall Study|Lack of Efficacy|13|||
30674913|NCT00652366|58688863|FG000|Overall Study|Violation of Selection Criteria|0|||
30674914|NCT00652366|58688864|FG001|Overall Study|Violation of Selection Criteria|0|||
30674915|NCT00652366|58688865|FG002|Overall Study|Violation of Selection Criteria|1|||
30674916|NCT00652366|58688866|FG003|Overall Study|Violation of Selection Criteria|0|||
30674917|NCT00652366|58688867|FG004|Overall Study|Violation of Selection Criteria|0|||
30674918|NCT00652366|58688863|FG000|Overall Study|Protocol Violation|1|||
30674919|NCT00652366|58688864|FG001|Overall Study|Protocol Violation|0|||
30674920|NCT00652366|58688865|FG002|Overall Study|Protocol Violation|0|||
30674921|NCT00652366|58688866|FG003|Overall Study|Protocol Violation|0|||
30674922|NCT00652366|58688867|FG004|Overall Study|Protocol Violation|0|||
30674923|NCT00652366|58688863|FG000|Overall Study|Refused treatment|3|||
30674924|NCT00652366|58688864|FG001|Overall Study|Refused treatment|7|||
30674925|NCT00652366|58688865|FG002|Overall Study|Refused treatment|6|||
30674926|NCT00652366|58688866|FG003|Overall Study|Refused treatment|17|||
30674927|NCT00652366|58688867|FG004|Overall Study|Refused treatment|5|||
30674928|NCT00652366|58688863|FG000|Overall Study|Other|5|||
30674929|NCT00652366|58688864|FG001|Overall Study|Other|2|||
30674930|NCT00652366|58688865|FG002|Overall Study|Other|3|||
30674931|NCT00652366|58688866|FG003|Overall Study|Other|4|||
30674932|NCT00652366|58688867|FG004|Overall Study|Other|0|||
30674933|NCT00841568|58688881|FG000|Overall Study|Adverse Event|1|||
30674934|NCT00841568|58688881|FG000|Overall Study|Death|1|||
30674935|NCT00841568|58688881|FG000|Overall Study|Withdrawal by Subject|2|||
30674936|NCT00841568|58688881|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
30674937|NCT00855959|58688889|FG000|Overall Study|Adverse Event|2|||
30674938|NCT00855959|58688889|FG000|Overall Study|Lost to Follow-up|2|||
30674939|NCT00855959|58688889|FG000|Overall Study|Withdrawal by Subject|3|||
30674940|NCT00855959|58688889|FG000|Overall Study|Pregnancy|1|||
30674941|NCT00855959|58688889|FG000|Overall Study|Incorrect enrolment|1|||
30674942|NCT00841100|58688893|FG000|Phase 1 (28 Days)|Adverse Event|1|||
30674943|NCT00841100|58688893|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
30674944|NCT00651820|58688897|FG000|Overall Study|Lost to Follow-up|2|||
30674945|NCT00866177|58688903|FG000|Overall Study|Withdrawal by Subject|1|||
30674946|NCT00866177|58688903|FG000|Overall Study|Not Treated|151|||
30674947|NCT00833924|58688907|FG000|Overall Study|Death|21|||
30674948|NCT00833924|58688907|FG000|Overall Study|Conversion|2|||
30674949|NCT00833924|58688907|FG000|Overall Study|Lost to Follow-up|2|||
30674950|NCT00833924|58688907|FG000|Overall Study|Withdrawal by Subject|13|||
30674951|NCT00833924|58688907|FG000|Overall Study|In study follow-up|71|||
30590763|NCT01087788|58603258|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
30674952|NCT00840086|58688911|FG000|Overall Study|Adverse Event|1|||
30674953|NCT00840086|58688911|FG000|Overall Study|Protocol Violation|2|||
30674954|NCT00840086|58688911|FG000|Overall Study|Lost to Follow-up|1|||
30674955|NCT00822926|58688920|FG000|Second Injection Visit|Lost to Follow-up|1|||
30674956|NCT00822926|58688921|FG001|Second Injection Visit|Lost to Follow-up|0|||
30674957|NCT00822926|58688920|FG000|Second Injection Visit|Withdrawal by Subject|0|||
30674958|NCT00822926|58688921|FG001|Second Injection Visit|Withdrawal by Subject|1|||
30674959|NCT00822770|58688932|FG000|Overall Study|Not treated|1|||
30781712|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
30781713|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
30781714|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
30856037|NCT02576678|58883784|FG001|Overall Study|Adverse Event|0|||
30590764|NCT01087788|58603259|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
30590765|NCT01087788|58603260|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
30590766|NCT01087788|58603258|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
30590767|NCT01087788|58603259|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
30590768|NCT01087788|58603260|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
30590769|NCT01087788|58603258|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
30590770|NCT01087788|58603259|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
30590771|NCT01087788|58603260|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
30590772|NCT01087788|58603258|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
30590773|NCT01087788|58603259|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
30590774|NCT01087788|58603260|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
30590775|NCT01087788|58603258|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
30590776|NCT01087788|58603259|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
30590777|NCT01087788|58603260|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
30590778|NCT01087788|58603258|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
30590779|NCT01087788|58603259|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
30590780|NCT01087788|58603260|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
30674960|NCT00822770|58688933|FG001|Overall Study|Not treated|0|||
30674961|NCT00822770|58688932|FG000|Overall Study|Complication/Incomplete treatment|1|||
30674962|NCT00822770|58688933|FG001|Overall Study|Complication/Incomplete treatment|0|||
30674963|NCT00822770|58688932|FG000|Overall Study|Death|1|||
30674964|NCT00822770|58688933|FG001|Overall Study|Death|1|||
30674965|NCT02842086|58688941|FG000|Overall Study|Randomized but Never Treated|6|||
30674966|NCT02842086|58688942|FG001|Overall Study|Randomized but Never Treated|6|||
30674967|NCT02842086|58688941|FG000|Overall Study|Still in Double-Blind Phase|7|||
30674968|NCT02842086|58688942|FG001|Overall Study|Still in Double-Blind Phase|3|||
30674969|NCT02842086|58688941|FG000|Overall Study|Adverse Event|18|||
30674970|NCT02842086|58688942|FG001|Overall Study|Adverse Event|20|||
30674971|NCT02842086|58688941|FG000|Overall Study|Death|3|||
30674972|NCT02842086|58688942|FG001|Overall Study|Death|3|||
30590781|NCT01087788|58603258|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
30590782|NCT01087788|58603259|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
30590783|NCT01087788|58603260|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
30590784|NCT01087788|58603258|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
30674973|NCT02842086|58688941|FG000|Overall Study|Investigator's Discretion|9|||
30674974|NCT02842086|58688942|FG001|Overall Study|Investigator's Discretion|13|||
30674975|NCT02842086|58688941|FG000|Overall Study|Non-Compliance with Study Drug|9|||
30674976|NCT02842086|58688942|FG001|Overall Study|Non-Compliance with Study Drug|8|||
30674977|NCT02842086|58688941|FG000|Overall Study|Protocol Violation|8|||
30674978|NCT02842086|58688942|FG001|Overall Study|Protocol Violation|4|||
30674979|NCT02842086|58688941|FG000|Overall Study|Withdrew Consent|205|||
30674980|NCT02842086|58688942|FG001|Overall Study|Withdrew Consent|194|||
30674981|NCT02842086|58688941|FG000|Overall Study|Lost to Follow-up|274|||
30674982|NCT02842086|58688942|FG001|Overall Study|Lost to Follow-up|236|||
30674983|NCT02842086|58688941|FG000|Overall Study|HIV-1 Infection|5|||
30674984|NCT02842086|58688942|FG001|Overall Study|HIV-1 Infection|6|||
30674985|NCT00822692|58688950|FG000|Overall Study|Lost to Follow-up|17|||
30674986|NCT00822692|58688951|FG001|Overall Study|Lost to Follow-up|25|||
30674987|NCT00806442|58688957|FG000|Overall Study|Lost to Follow-up|3|||
30674988|NCT00806442|58688958|FG001|Overall Study|Lost to Follow-up|2|||
30674989|NCT00806442|58688957|FG000|Overall Study|Withdrawal by Subject|1|||
30674990|NCT00806442|58688958|FG001|Overall Study|Withdrawal by Subject|5|||
30674991|NCT00821678|58688968|FG000|Overall Study|Withdrawal by Subject|8|||
30674992|NCT00821678|58688969|FG001|Overall Study|Withdrawal by Subject|0|||
30674993|NCT00821678|58688968|FG000|Overall Study|Lost to Follow-up|13|||
30674994|NCT00821678|58688969|FG001|Overall Study|Lost to Follow-up|12|||
30674995|NCT00821678|58688968|FG000|Overall Study|Death|0|||
30674996|NCT00821678|58688969|FG001|Overall Study|Death|2|||
30674997|NCT00839852|58688977|FG000|Overall Study|Adverse Event|10|||
30674998|NCT00839852|58688977|FG000|Overall Study|Insufficient Therapeutic Response|3|||
30674999|NCT00839852|58688977|FG000|Overall Study|Protocol Violation|9|||
30675000|NCT00839852|58688977|FG000|Overall Study|Withdrawal of Consent|16|||
30675001|NCT00839852|58688977|FG000|Overall Study|Lost to Follow-up|7|||
30675002|NCT00839852|58688977|FG000|Overall Study|Lack of Compliance While in Jail|1|||
30675003|NCT00839852|58688977|FG000|Overall Study|Pregnancy|1|||
30675004|NCT00833690|58688984|FG000|Overall Study|Withdrawal by Subject|1|||
30675005|NCT00833690|58688985|FG001|Overall Study|Withdrawal by Subject|0|||
30675006|NCT00833690|58688986|FG002|Overall Study|Withdrawal by Subject|0|||
30675007|NCT00833690|58688984|FG000|Overall Study|Discontinued study drug|3|||
30675008|NCT00833690|58688985|FG001|Overall Study|Discontinued study drug|2|||
30675009|NCT00833690|58688986|FG002|Overall Study|Discontinued study drug|0|||
30675010|NCT00820898|58688994|FG000|Overall Study|Inelgible - wrong primary site|1|||
30675011|NCT00865709|58689006|FG000|Treatment|Adverse Event|9|||
30675012|NCT00865709|58689007|FG001|Treatment|Adverse Event|6|||
30675013|NCT00865709|58689006|FG000|Treatment|Withdrawal by Subject|10|||
30675014|NCT00865709|58689007|FG001|Treatment|Withdrawal by Subject|7|||
30590785|NCT01087788|58603259|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
30590786|NCT01087788|58603260|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
30590787|NCT01087788|58603258|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
30590788|NCT01087788|58603259|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
30590789|NCT01087788|58603260|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
30590790|NCT01087788|58603258|FG000|24-weeks Dose-blind Period|Patient moved|0|||
30590791|NCT01087788|58603259|FG001|24-weeks Dose-blind Period|Patient moved|0|||
30590792|NCT01087788|58603260|FG002|24-weeks Dose-blind Period|Patient moved|1|||
30590793|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
30590794|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
30590795|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
30590796|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
30590797|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
30590798|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
30590799|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
30675015|NCT00865709|58689006|FG000|Treatment|Physician Decision|3|||
30675016|NCT00865709|58689007|FG001|Treatment|Physician Decision|2|||
30675017|NCT00865709|58689006|FG000|Treatment|Surgery|8|||
30675018|NCT00865709|58689007|FG001|Treatment|Surgery|3|||
30675019|NCT00839306|58689017|FG000|Overall Study|Adverse Event|3|||
30675020|NCT00839306|58689018|FG001|Overall Study|Adverse Event|5|||
30781715|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
30781716|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
30856038|NCT02576678|58883785|FG002|Overall Study|Adverse Event|2|||
30675021|NCT00839306|58689017|FG000|Overall Study|Lost to Follow-up|6|||
30675022|NCT00839306|58689018|FG001|Overall Study|Lost to Follow-up|9|||
30675023|NCT00839306|58689017|FG000|Overall Study|Withdrawal by Subject|5|||
30590800|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
30675024|NCT00839306|58689018|FG001|Overall Study|Withdrawal by Subject|7|||
30675025|NCT00839306|58689017|FG000|Overall Study|Lack of Efficacy|5|||
30675026|NCT00839306|58689018|FG001|Overall Study|Lack of Efficacy|4|||
30675027|NCT00839306|58689017|FG000|Overall Study|Other|6|||
30675028|NCT00839306|58689018|FG001|Overall Study|Other|18|||
30675029|NCT00839072|58689025|FG000|First Intervention Period|Withdrawal by Subject|1|||
30675030|NCT00839072|58689026|FG001|First Intervention Period|Withdrawal by Subject|0|||
30675031|NCT00839072|58689025|FG000|First Intervention Period|Adverse Event|1|||
30675032|NCT00839072|58689026|FG001|First Intervention Period|Adverse Event|1|||
30675033|NCT00839072|58689025|FG000|Second Intervention Period|Withdrawal by Subject|1|||
30675034|NCT00839072|58689026|FG001|Second Intervention Period|Withdrawal by Subject|0|||
30675035|NCT00855803|58689032|FG000|Overall Study|Death|2|||
30675036|NCT00855803|58689032|FG000|Overall Study|Lost to Follow-up|2|||
30675037|NCT00855803|58689032|FG000|Overall Study|Technical inability to undergo procedure|2|||
30675038|NCT00855803|58689032|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
30590801|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
30590802|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
30590803|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
30590804|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
30590805|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
30590806|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
30590807|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
30675039|NCT00855803|58689032|FG000|Overall Study|Withdrawal by Subject|3|||
30675040|NCT00855803|58689032|FG000|Overall Study|Physician Decision|3|||
30675041|NCT03553836|58689038|FG000|Overall Study|Ongoing in Study|460|||
30675042|NCT03553836|58689039|FG001|Overall Study|Ongoing in Study|459|||
30675043|NCT03553836|58689038|FG000|Overall Study|Withdrawal by Subject|9|||
30675044|NCT03553836|58689039|FG001|Overall Study|Withdrawal by Subject|10|||
30675045|NCT03553836|58689038|FG000|Overall Study|Lost to Follow-up|1|||
30675046|NCT03553836|58689039|FG001|Overall Study|Lost to Follow-up|3|||
30675047|NCT03553836|58689038|FG000|Overall Study|Death|17|||
30675048|NCT03553836|58689039|FG001|Overall Study|Death|17|||
30675049|NCT00838916|58689048|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
30675050|NCT00838916|58689049|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
30675051|NCT00838916|58689048|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
30675052|NCT00838916|58689049|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
30675053|NCT00838916|58689048|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
30675054|NCT00838916|58689049|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
30675055|NCT00838916|58689048|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
30675056|NCT00838916|58689049|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
30675057|NCT00838916|58689048|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
30675058|NCT00838916|58689049|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
30675059|NCT00838916|58689048|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
30675060|NCT00838916|58689049|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
30675061|NCT00838916|58689048|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
30675062|NCT00838916|58689049|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
30675063|NCT00838916|58689048|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
30781717|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
30781718|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
30781719|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
30781720|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
30781721|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
30781722|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
30781723|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
30590808|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
30675064|NCT00838916|58689049|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
30675065|NCT00838916|58689048|FG000|Treatment Period (156 Weeks)|Missing|3|||
30675066|NCT00838916|58689049|FG001|Treatment Period (156 Weeks)|Missing|1|||
30675067|NCT00838916|58689048|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
30675068|NCT00838916|58689049|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
30675069|NCT00838916|58689048|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
30675070|NCT00838916|58689049|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
30675071|NCT00838916|58689048|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
30675072|NCT00838916|58689049|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
30781724|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30675073|NCT00838916|58689048|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
30675074|NCT00838916|58689049|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
30675075|NCT00838916|58689048|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
30675076|NCT00838916|58689049|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
30675077|NCT00838916|58689048|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
30675078|NCT00838916|58689049|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
30675079|NCT00838916|58689048|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
30675080|NCT00838916|58689049|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
30675081|NCT00838916|58689048|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
30675082|NCT00838916|58689049|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
30675083|NCT00838916|58689048|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
30675084|NCT00838916|58689049|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
30675085|NCT00838916|58689048|FG000|Follow-up Period (8 Weeks)|Missing|3|||
30675086|NCT00838916|58689049|FG001|Follow-up Period (8 Weeks)|Missing|0|||
30675087|NCT00838682|58689057|FG000|Overall Study|Lost to Follow-up|21|||
30675088|NCT00838682|58689058|FG001|Overall Study|Lost to Follow-up|14|||
30675089|NCT00838682|58689057|FG000|Overall Study|detection of exclusion criteria|4|||
30675090|NCT00838682|58689058|FG001|Overall Study|detection of exclusion criteria|3|||
30675091|NCT00838682|58689057|FG000|Overall Study|Protocol Violation|0|||
30675092|NCT00838682|58689058|FG001|Overall Study|Protocol Violation|1|||
30675093|NCT00838682|58689057|FG000|Overall Study|Withdrawal by Subject|0|||
30675094|NCT00838682|58689058|FG001|Overall Study|Withdrawal by Subject|1|||
30675095|NCT00820040|58689064|FG000|Overall Study|Death|1|||
30675096|NCT00820040|58689064|FG000|Overall Study|Sponsor terminated study|1|||
30675097|NCT00820040|58689064|FG000|Overall Study|Screen failure|1|||
30675098|NCT00803712|58689070|FG000|Overall Study|Noncompliance|3|||
30675099|NCT00803712|58689071|FG001|Overall Study|Noncompliance|0|||
30675100|NCT00803712|58689070|FG000|Overall Study|Adverse Event|5|||
30675101|NCT00803712|58689071|FG001|Overall Study|Adverse Event|0|||
30675102|NCT00803712|58689070|FG000|Overall Study|Death|8|||
30675103|NCT00803712|58689071|FG001|Overall Study|Death|7|||
30675104|NCT00803712|58689070|FG000|Overall Study|Lost to Follow-up|3|||
30675105|NCT00803712|58689071|FG001|Overall Study|Lost to Follow-up|1|||
30675106|NCT00803712|58689070|FG000|Overall Study|Withdrawal by Subject|2|||
30675107|NCT00803712|58689071|FG001|Overall Study|Withdrawal by Subject|4|||
30675108|NCT00803712|58689070|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
30675109|NCT00803712|58689071|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
30675110|NCT00803712|58689070|FG000|Overall Study|Protocol criteria (other)|0|||
30675111|NCT00803712|58689071|FG001|Overall Study|Protocol criteria (other)|2|||
30675112|NCT00803712|58689070|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
30675113|NCT00803712|58689071|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
30675114|NCT00803712|58689070|FG000|Overall Study|Administrative decision|2|||
30675115|NCT00803712|58689071|FG001|Overall Study|Administrative decision|3|||
30675116|NCT00803712|58689070|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
30675117|NCT00803712|58689071|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
30675118|NCT00591344|58689079|FG000|Overall Study|Transportation issues|1|||
30675119|NCT00591344|58689080|FG001|Overall Study|Transportation issues|0|||
30675120|NCT00591344|58689079|FG000|Overall Study|Moved out of state|1|||
30675121|NCT00591344|58689080|FG001|Overall Study|Moved out of state|0|||
30958988|NCT01587703|59024024|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30590809|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
30590810|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
30590811|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
30590812|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
30590813|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
30590814|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
30590815|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
30958989|NCT01587703|59024025|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30958990|NCT01587703|59024026|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30590816|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
30590817|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
30590818|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
30590819|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
30590820|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
30590821|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
30590822|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
30590823|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
30590824|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
30590825|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
30590826|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
30675122|NCT00591344|58689079|FG000|Overall Study|Medical complications|1|||
30675123|NCT00591344|58689080|FG001|Overall Study|Medical complications|3|||
30675124|NCT00591344|58689079|FG000|Overall Study|Underwent DBS|2|||
30675125|NCT00591344|58689080|FG001|Overall Study|Underwent DBS|2|||
30675126|NCT00591344|58689079|FG000|Overall Study|Death|0|||
30675127|NCT00591344|58689080|FG001|Overall Study|Death|1|||
30675128|NCT00591344|58689079|FG000|Overall Study|Lost to Follow-up|0|||
30675129|NCT00591344|58689080|FG001|Overall Study|Lost to Follow-up|1|||
30675130|NCT00591344|58689079|FG000|Overall Study|Did not want to come off medication|0|||
30958991|NCT01587703|59024027|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30675131|NCT00591344|58689080|FG001|Overall Study|Did not want to come off medication|1|||
30675132|NCT00803634|58689092|FG000|Overall Study|Withdrew Consent|1|||
30675133|NCT00803634|58689093|FG001|Overall Study|Withdrew Consent|0|||
30675134|NCT00803634|58689092|FG000|Overall Study|Lost to Follow-up|2|||
30675135|NCT00803634|58689093|FG001|Overall Study|Lost to Follow-up|3|||
30675136|NCT00803634|58689092|FG000|Overall Study|Death|3|||
30675137|NCT00803634|58689093|FG001|Overall Study|Death|2|||
30675138|NCT00838526|58689102|FG000|Overall Study|Adverse Event|3|||
30675139|NCT00838526|58689103|FG001|Overall Study|Adverse Event|12|||
30675140|NCT00838526|58689102|FG000|Overall Study|Lost to Follow-up|4|||
30675141|NCT00838526|58689103|FG001|Overall Study|Lost to Follow-up|12|||
30675142|NCT00838526|58689102|FG000|Overall Study|Withdrawal by Subject|4|||
30675143|NCT00838526|58689103|FG001|Overall Study|Withdrawal by Subject|5|||
30675144|NCT00838526|58689102|FG000|Overall Study|Lack of Efficacy|2|||
30675145|NCT00838526|58689103|FG001|Overall Study|Lack of Efficacy|3|||
30675146|NCT00838526|58689102|FG000|Overall Study|Other|11|||
30675147|NCT00838526|58689103|FG001|Overall Study|Other|7|||
30675148|NCT00818246|58689122|FG000|Overall Study|Impossible to match pictures|5|||
30590827|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
30590828|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
30590829|NCT01087788|58603258|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
30590830|NCT01087788|58603259|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
30590831|NCT01087788|58603260|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
30590832|NCT01086969|58603272|FG000|Overall Study|Withdrawal by Subject|1|||
30590833|NCT01086969|58603273|FG001|Overall Study|Withdrawal by Subject|2|||
30590834|NCT01086969|58603274|FG002|Overall Study|Withdrawal by Subject|0|||
30590835|NCT01086423|58603285|FG000|Overall Study|Protocol Violation|0|||
30590836|NCT01086423|58603286|FG001|Overall Study|Protocol Violation|0|||
30590837|NCT01086423|58603287|FG002|Overall Study|Protocol Violation|1|||
30590838|NCT01086423|58603285|FG000|Overall Study|Migrated/moved from study area|2|||
30590839|NCT01086423|58603286|FG001|Overall Study|Migrated/moved from study area|0|||
30590840|NCT01086423|58603287|FG002|Overall Study|Migrated/moved from study area|4|||
30675149|NCT00818168|58689126|FG000|Overall Study|Lack of Efficacy|18|||
30675150|NCT00818168|58689126|FG000|Overall Study|Pregnancy|2|||
30675151|NCT00818168|58689126|FG000|Overall Study|Withdrawal by Subject|16|||
30675152|NCT00818168|58689126|FG000|Overall Study|Lost to Follow-up|7|||
30675153|NCT00818168|58689126|FG000|Overall Study|Adverse Event|19|||
30675154|NCT00818168|58689126|FG000|Overall Study|Reason for Non-completion Not reported|6|||
30675155|NCT00818168|58689126|FG000|Overall Study|Participant Moved|2|||
30675156|NCT00817778|58689132|FG000|Overall Study|Adverse Event|1|||
30675157|NCT00817778|58689133|FG001|Overall Study|Adverse Event|0|||
30675158|NCT00817778|58689132|FG000|Overall Study|Withdrawal by Subject|1|||
30675159|NCT00817778|58689133|FG001|Overall Study|Withdrawal by Subject|1|||
30590841|NCT01086423|58603285|FG000|Overall Study|Adverse event, fatal|1|||
30590842|NCT01086423|58603286|FG001|Overall Study|Adverse event, fatal|1|||
30590843|NCT01086423|58603287|FG002|Overall Study|Adverse event, fatal|0|||
30590844|NCT01086423|58603285|FG000|Overall Study|Adverse event, non-fatal|2|||
30590845|NCT01086423|58603286|FG001|Overall Study|Adverse event, non-fatal|1|||
30590846|NCT01086423|58603287|FG002|Overall Study|Adverse event, non-fatal|0|||
30590847|NCT01086423|58603285|FG000|Overall Study|Withdrawal by Subject|5|||
30590848|NCT01086423|58603286|FG001|Overall Study|Withdrawal by Subject|1|||
30590849|NCT01086423|58603287|FG002|Overall Study|Withdrawal by Subject|3|||
30590850|NCT01086423|58603285|FG000|Overall Study|Lost to Follow-up|0|||
30590851|NCT01086423|58603286|FG001|Overall Study|Lost to Follow-up|0|||
30590852|NCT01086423|58603287|FG002|Overall Study|Lost to Follow-up|1|||
30590853|NCT01086150|58603298|FG000|Overall Study|Withdrawal by Subject|0|||
30590854|NCT01086150|58603299|FG001|Overall Study|Withdrawal by Subject|4|||
30590855|NCT01086150|58603300|FG002|Overall Study|Withdrawal by Subject|1|||
30590856|NCT01086150|58603298|FG000|Overall Study|Lost to Follow-up|0|||
30590857|NCT01086150|58603299|FG001|Overall Study|Lost to Follow-up|1|||
30590858|NCT01086150|58603300|FG002|Overall Study|Lost to Follow-up|0|||
30590859|NCT01086150|58603298|FG000|Overall Study|Screen Failure|0|||
30590860|NCT01086150|58603299|FG001|Overall Study|Screen Failure|1|||
30590861|NCT01086150|58603300|FG002|Overall Study|Screen Failure|0|||
30590862|NCT01086033|58603308|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
30590863|NCT01086033|58603308|FG000|Overall Study|Lost to Follow-up|86|||
30675160|NCT00817778|58689132|FG000|Overall Study|Protocol Violation|0|||
30675161|NCT00817778|58689133|FG001|Overall Study|Protocol Violation|1|||
30675162|NCT00817778|58689132|FG000|Overall Study|Study-specific discontinuation criteria|0|||
30590864|NCT01086033|58603308|FG000|Overall Study|Adverse Event|42|||
30590865|NCT01086033|58603308|FG000|Overall Study|Withdrawal by Subject|41|||
30590866|NCT01086033|58603308|FG000|Overall Study|Other|14|||
30675163|NCT00817778|58689133|FG001|Overall Study|Study-specific discontinuation criteria|1|||
30675164|NCT00817778|58689132|FG000|Overall Study|Poor venous access|1|||
30675165|NCT00817778|58689133|FG001|Overall Study|Poor venous access|0|||
30675166|NCT00813098|58689142|FG000|Overall Study|Adverse Event|2|||
30590867|NCT01086033|58603308|FG000|Overall Study|Other|13|||
30675167|NCT00813098|58689143|FG001|Overall Study|Adverse Event|4|||
30675168|NCT00813098|58689144|FG002|Overall Study|Adverse Event|1|||
30675169|NCT00813098|58689142|FG000|Overall Study|Withdrawal by Subject|0|||
30675170|NCT00813098|58689143|FG001|Overall Study|Withdrawal by Subject|1|||
30675171|NCT00813098|58689144|FG002|Overall Study|Withdrawal by Subject|0|||
30675172|NCT00813098|58689142|FG000|Overall Study|Inability to complete study procedures|1|||
30675173|NCT00813098|58689143|FG001|Overall Study|Inability to complete study procedures|0|||
30675174|NCT00813098|58689144|FG002|Overall Study|Inability to complete study procedures|0|||
30675175|NCT00813098|58689142|FG000|Overall Study|Lost to Follow-up|0|||
30675176|NCT00813098|58689143|FG001|Overall Study|Lost to Follow-up|1|||
30675177|NCT00813098|58689144|FG002|Overall Study|Lost to Follow-up|0|||
30675178|NCT00813098|58689142|FG000|Overall Study|Protocol Violation|0|||
30675179|NCT00813098|58689143|FG001|Overall Study|Protocol Violation|0|||
30675180|NCT00813098|58689144|FG002|Overall Study|Protocol Violation|1|||
30675181|NCT00813098|58689142|FG000|Overall Study|Principal Investigator decision|0|||
30675182|NCT00813098|58689143|FG001|Overall Study|Principal Investigator decision|1|||
30675183|NCT00813098|58689144|FG002|Overall Study|Principal Investigator decision|0|||
30675184|NCT00813098|58689142|FG000|Overall Study|Withdrew Consent|0|||
30675185|NCT00813098|58689143|FG001|Overall Study|Withdrew Consent|1|||
30675186|NCT00813098|58689144|FG002|Overall Study|Withdrew Consent|0|||
30675187|NCT00796653|58689156|FG000|Overall Study|Adverse Event|19|||
30675188|NCT00796653|58689157|FG001|Overall Study|Adverse Event|16|||
30675189|NCT00796653|58689158|FG002|Overall Study|Adverse Event|16|||
30675190|NCT00796653|58689159|FG003|Overall Study|Adverse Event|16|||
30675191|NCT00796653|58689156|FG000|Overall Study|Lost to Follow-up|2|||
30675192|NCT00796653|58689157|FG001|Overall Study|Lost to Follow-up|1|||
30590868|NCT01086033|58603308|FG000|Overall Study|AE and Withdrew Consent|5|||
30590869|NCT01086033|58603308|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
30590870|NCT01086033|58603308|FG000|Overall Study|Withdrew consent and Other Reason|4|||
30590871|NCT01086033|58603308|FG000|Overall Study|AE and Lack of Efficacy|4|||
30675193|NCT00796653|58689158|FG002|Overall Study|Lost to Follow-up|2|||
30675194|NCT00796653|58689159|FG003|Overall Study|Lost to Follow-up|3|||
30675195|NCT00796653|58689156|FG000|Overall Study|Withdrawal by Subject|16|||
30675196|NCT00796653|58689157|FG001|Overall Study|Withdrawal by Subject|8|||
30675197|NCT00796653|58689158|FG002|Overall Study|Withdrawal by Subject|8|||
30675198|NCT00796653|58689159|FG003|Overall Study|Withdrawal by Subject|13|||
30590872|NCT01086033|58603308|FG000|Overall Study|Death|1|||
30590873|NCT01086033|58603308|FG000|Overall Study|AE and Lost to Follow-up|1|||
30590874|NCT01086033|58603308|FG000|Overall Study|AE and Other Reason|1|||
30590875|NCT01086033|58603308|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
30590876|NCT01085682|58603317|FG000|Overall Study|Withdrawal by Subject|25|||
30590877|NCT01085682|58603318|FG001|Overall Study|Withdrawal by Subject|25|||
30590878|NCT01085214|58603324|FG000|Overall Study|Alternate treatment required|1|||
30590879|NCT01085136|58603328|FG000|Part A|Other Adverse event|223|||
30590880|NCT01085136|58603329|FG001|Part A|Other Adverse event|0|||
30590881|NCT01085136|58603330|FG002|Part A|Other Adverse event|0|||
30590882|NCT01085136|58603328|FG000|Part A|Protocol Violation|3|||
30590883|NCT01085136|58603329|FG001|Part A|Protocol Violation|0|||
30590884|NCT01085136|58603330|FG002|Part A|Protocol Violation|0|||
30590885|NCT01085136|58603328|FG000|Part A|Lost to Follow-up|3|||
30590886|NCT01085136|58603329|FG001|Part A|Lost to Follow-up|0|||
30590887|NCT01085136|58603330|FG002|Part A|Lost to Follow-up|0|||
30590888|NCT01085136|58603328|FG000|Part A|Refusal to continue trial medication|64|||
30590889|NCT01085136|58603329|FG001|Part A|Refusal to continue trial medication|0|||
30590890|NCT01085136|58603330|FG002|Part A|Refusal to continue trial medication|0|||
30590891|NCT01085136|58603328|FG000|Part A|Other reason not defined above|30|||
30590892|NCT01085136|58603329|FG001|Part A|Other reason not defined above|0|||
30590893|NCT01085136|58603330|FG002|Part A|Other reason not defined above|0|||
30590894|NCT01085136|58603328|FG000|Part B|Other AE|0|||
30590895|NCT01085136|58603329|FG001|Part B|Other AE|29|||
30590896|NCT01085136|58603330|FG002|Part B|Other AE|8|||
30590897|NCT01085136|58603328|FG000|Part B|Refusal to continue trial medication|0|||
30590898|NCT01085136|58603329|FG001|Part B|Refusal to continue trial medication|12|||
30590899|NCT01085136|58603330|FG002|Part B|Refusal to continue trial medication|7|||
30675199|NCT00796653|58689156|FG000|Overall Study|Lack of Efficacy|8|||
30675200|NCT00796653|58689157|FG001|Overall Study|Lack of Efficacy|1|||
30675201|NCT00796653|58689158|FG002|Overall Study|Lack of Efficacy|3|||
30675202|NCT00796653|58689159|FG003|Overall Study|Lack of Efficacy|2|||
30675203|NCT00796653|58689156|FG000|Overall Study|Non compliance with protocol|2|||
30675204|NCT00796653|58689157|FG001|Overall Study|Non compliance with protocol|2|||
30590900|NCT01085136|58603328|FG000|Part B|Not treated|0|||
30590901|NCT01085136|58603329|FG001|Part B|Not treated|4|||
30590902|NCT01085136|58603330|FG002|Part B|Not treated|8|||
30590903|NCT01085136|58603328|FG000|Part B|Other reason not defined above|0|||
30590904|NCT01085136|58603329|FG001|Part B|Other reason not defined above|6|||
30675205|NCT00796653|58689158|FG002|Overall Study|Non compliance with protocol|0|||
30877161|NCT00106691|58908831|FG001|Overall Study|Adverse Event|64|||
30590905|NCT01085136|58603330|FG002|Part B|Other reason not defined above|3|||
30590906|NCT01084707|58603340|FG000|Overall Study|Withdrawal by Subject|6|||
30590907|NCT01084668|58603352|FG000|Overall Study|Lack of Efficacy|5|||
30590908|NCT01084668|58603352|FG000|Overall Study|Withdrawal by Subject|2|||
30590909|NCT01084668|58603352|FG000|Overall Study|Pregnancy|1|||
30590910|NCT01084668|58603352|FG000|Overall Study|Non-compliance|1|||
30590911|NCT01084551|58603361|FG000|Overall Study|Adverse Event|2|||
30590912|NCT01084551|58603362|FG001|Overall Study|Adverse Event|9|||
30590913|NCT01084551|58603363|FG002|Overall Study|Adverse Event|4|||
30590914|NCT01084551|58603361|FG000|Overall Study|Lack of Efficacy|2|||
30590915|NCT01084551|58603362|FG001|Overall Study|Lack of Efficacy|0|||
30590916|NCT01084551|58603363|FG002|Overall Study|Lack of Efficacy|1|||
30590917|NCT01084551|58603361|FG000|Overall Study|Withdrawal by Subject|2|||
30590918|NCT01084551|58603362|FG001|Overall Study|Withdrawal by Subject|1|||
30590919|NCT01084551|58603363|FG002|Overall Study|Withdrawal by Subject|0|||
30590920|NCT01084551|58603361|FG000|Overall Study|Protocol Violation|2|||
30590921|NCT01084551|58603362|FG001|Overall Study|Protocol Violation|4|||
30590922|NCT01084551|58603363|FG002|Overall Study|Protocol Violation|0|||
30590923|NCT01084551|58603361|FG000|Overall Study|Lost to Follow-up|0|||
30590924|NCT01084551|58603362|FG001|Overall Study|Lost to Follow-up|0|||
30590925|NCT01084551|58603363|FG002|Overall Study|Lost to Follow-up|3|||
30590926|NCT01084551|58603361|FG000|Overall Study|Physician Decision|1|||
30590927|NCT01084551|58603362|FG001|Overall Study|Physician Decision|0|||
30590928|NCT01084551|58603363|FG002|Overall Study|Physician Decision|0|||
30590929|NCT01084005|58603373|FG000|Overall Study|Adverse Event|1|||
30590930|NCT01084005|58603374|FG001|Overall Study|Adverse Event|8|||
30590931|NCT01084005|58603373|FG000|Overall Study|Protocol Violation|3|||
30590932|NCT01084005|58603374|FG001|Overall Study|Protocol Violation|7|||
30590933|NCT01084005|58603373|FG000|Overall Study|Withdrawal by Subject|1|||
30590934|NCT01084005|58603374|FG001|Overall Study|Withdrawal by Subject|1|||
30590935|NCT01083810|58603383|FG000|Overall Study|Lost to Follow-up|23|||
30590936|NCT01083810|58603384|FG001|Overall Study|Lost to Follow-up|11|||
30590937|NCT01083810|58603385|FG002|Overall Study|Lost to Follow-up|4|||
30590938|NCT01083810|58603383|FG000|Overall Study|Adverse Event|15|||
30590939|NCT01083810|58603384|FG001|Overall Study|Adverse Event|11|||
30590940|NCT01083810|58603385|FG002|Overall Study|Adverse Event|4|||
30590941|NCT01083810|58603383|FG000|Overall Study|Withdrawal by Subject|7|||
30590942|NCT01083810|58603384|FG001|Overall Study|Withdrawal by Subject|2|||
30590943|NCT01083810|58603385|FG002|Overall Study|Withdrawal by Subject|4|||
30590944|NCT01083810|58603383|FG000|Overall Study|Reason not reported|6|||
30590945|NCT01083810|58603384|FG001|Overall Study|Reason not reported|1|||
30590946|NCT01083810|58603385|FG002|Overall Study|Reason not reported|1|||
30590947|NCT01083810|58603383|FG000|Overall Study|Non-compliance|4|||
30590948|NCT01083810|58603384|FG001|Overall Study|Non-compliance|7|||
30590949|NCT01083810|58603385|FG002|Overall Study|Non-compliance|2|||
30590950|NCT01083810|58603383|FG000|Overall Study|Simplification|4|||
30590951|NCT01083810|58603384|FG001|Overall Study|Simplification|1|||
30590952|NCT01083810|58603385|FG002|Overall Study|Simplification|0|||
30590953|NCT01083810|58603383|FG000|Overall Study|Death|2|||
30590954|NCT01083810|58603384|FG001|Overall Study|Death|2|||
30590955|NCT01083810|58603385|FG002|Overall Study|Death|3|||
30590956|NCT01083810|58603383|FG000|Overall Study|Co-morbidities|1|||
30590957|NCT01083810|58603384|FG001|Overall Study|Co-morbidities|0|||
30590958|NCT01083810|58603385|FG002|Overall Study|Co-morbidities|0|||
30590959|NCT01083810|58603383|FG000|Overall Study|Participation in study|1|||
30590960|NCT01083810|58603384|FG001|Overall Study|Participation in study|0|||
30590961|NCT01083810|58603385|FG002|Overall Study|Participation in study|0|||
30590962|NCT01083810|58603383|FG000|Overall Study|Therapy break|1|||
30590963|NCT01083810|58603384|FG001|Overall Study|Therapy break|2|||
30675206|NCT00796653|58689159|FG003|Overall Study|Non compliance with protocol|2|||
30675207|NCT00796653|58689156|FG000|Overall Study|Other reason not described above|4|||
30675208|NCT00796653|58689157|FG001|Overall Study|Other reason not described above|9|||
30675209|NCT00796653|58689158|FG002|Overall Study|Other reason not described above|7|||
30781725|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
30781726|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30590964|NCT01083810|58603385|FG002|Overall Study|Therapy break|2|||
30590965|NCT01083810|58603383|FG000|Overall Study|Virologic failure|1|||
30590966|NCT01083810|58603384|FG001|Overall Study|Virologic failure|8|||
30590967|NCT01083810|58603385|FG002|Overall Study|Virologic failure|0|||
30590968|NCT01083771|58603391|FG000|Overall Study|non-compliant|2|||
30590969|NCT01083771|58603391|FG000|Overall Study|Withdrawal by Subject|3|||
30590970|NCT01083693|58603398|FG000|Overall Study|Adverse Event|1|||
30590971|NCT01083693|58603399|FG001|Overall Study|Adverse Event|1|||
30590972|NCT01083693|58603400|FG002|Overall Study|Adverse Event|0|||
30590973|NCT01083693|58603398|FG000|Overall Study|Lost to Follow-up|2|||
30590974|NCT01083693|58603399|FG001|Overall Study|Lost to Follow-up|0|||
30590975|NCT01083693|58603400|FG002|Overall Study|Lost to Follow-up|2|||
30590976|NCT01083693|58603398|FG000|Overall Study|Lack of effectiveness|13|||
30590977|NCT01083693|58603399|FG001|Overall Study|Lack of effectiveness|2|||
30675210|NCT00796653|58689159|FG003|Overall Study|Other reason not described above|4|||
30675211|NCT00806286|58689180|FG000|Overall Study|Adverse Event|5|||
30675212|NCT00806286|58689181|FG001|Overall Study|Adverse Event|2|||
30675213|NCT00806286|58689182|FG002|Overall Study|Adverse Event|0|||
30675214|NCT00806286|58689180|FG000|Overall Study|Disease progression|31|||
30675215|NCT00806286|58689181|FG001|Overall Study|Disease progression|38|||
30675216|NCT00806286|58689182|FG002|Overall Study|Disease progression|1|||
30675217|NCT00806286|58689180|FG000|Overall Study|Death|1|||
30675218|NCT00806286|58689181|FG001|Overall Study|Death|6|||
30675219|NCT00806286|58689182|FG002|Overall Study|Death|0|||
30675220|NCT00806286|58689180|FG000|Overall Study|Lost to Follow-up|0|||
30675221|NCT00806286|58689181|FG001|Overall Study|Lost to Follow-up|1|||
30675222|NCT00806286|58689182|FG002|Overall Study|Lost to Follow-up|0|||
30675223|NCT00806286|58689180|FG000|Overall Study|Withdrawal by Subject|8|||
30675224|NCT00806286|58689181|FG001|Overall Study|Withdrawal by Subject|3|||
30675225|NCT00806286|58689182|FG002|Overall Study|Withdrawal by Subject|1|||
30675226|NCT00806286|58689180|FG000|Overall Study|Physician Decision|2|||
30675227|NCT00806286|58689181|FG001|Overall Study|Physician Decision|2|||
30675228|NCT00806286|58689182|FG002|Overall Study|Physician Decision|0|||
30675229|NCT00806286|58689180|FG000|Overall Study|Due to a variety of reasons|7|||
30675230|NCT00806286|58689181|FG001|Overall Study|Due to a variety of reasons|2|||
30675231|NCT00806286|58689182|FG002|Overall Study|Due to a variety of reasons|1|||
30675232|NCT00590538|58689190|FG000|Overall Study|Study terminated before completed|2|||
30675233|NCT00796419|58689196|FG000|Overall Study|Death|0|||
30675234|NCT00796419|58689197|FG001|Overall Study|Death|1|||
30675235|NCT00796107|58689203|FG000|Overall Study|Lack of Efficacy|1|||
30675236|NCT00796107|58689203|FG000|Overall Study|Progressive Disease|5|||
30856039|NCT02576678|58883783|FG000|Overall Study|Withdrawal by Subject|3|||
30590978|NCT01083693|58603400|FG002|Overall Study|Lack of effectiveness|2|||
30590979|NCT01083693|58603398|FG000|Overall Study|Patient Moved|0|||
30590980|NCT01083693|58603399|FG001|Overall Study|Patient Moved|1|||
30590981|NCT01083693|58603400|FG002|Overall Study|Patient Moved|0|||
30590982|NCT01083693|58603398|FG000|Overall Study|Complete remission|0|||
30590983|NCT01083693|58603399|FG001|Overall Study|Complete remission|1|||
30590984|NCT01083693|58603400|FG002|Overall Study|Complete remission|0|||
30590985|NCT01083693|58603398|FG000|Overall Study|Other medical condition/surgery|1|||
30590986|NCT01083693|58603399|FG001|Overall Study|Other medical condition/surgery|1|||
30590987|NCT01083693|58603400|FG002|Overall Study|Other medical condition/surgery|0|||
30590988|NCT01083693|58603398|FG000|Overall Study|Withdrawal by Subject|3|||
30590989|NCT01083693|58603399|FG001|Overall Study|Withdrawal by Subject|0|||
30590990|NCT01083693|58603400|FG002|Overall Study|Withdrawal by Subject|2|||
30590991|NCT01083693|58603398|FG000|Overall Study|Reason unknown|0|||
30590992|NCT01083693|58603399|FG001|Overall Study|Reason unknown|0|||
30590993|NCT01083693|58603400|FG002|Overall Study|Reason unknown|1|||
30590994|NCT01083576|58603414|FG000|Overall Study|Treatment Failure|6|||
30590995|NCT01083576|58603415|FG001|Overall Study|Treatment Failure|1|||
30590996|NCT01083186|58603422|FG000|Overall Study|Lost to Follow-up|48|||
30590997|NCT01083186|58603422|FG000|Overall Study|Consent Withdrawal|7|||
30590998|NCT01083186|58603422|FG000|Overall Study|Death|3|||
30590999|NCT01083186|58603422|FG000|Overall Study|Adverse Event|3|||
30591000|NCT01083186|58603422|FG000|Overall Study|Lack of Efficacy|2|||
30591001|NCT01083186|58603422|FG000|Overall Study|Hemodialysis Initiation|28|||
30591002|NCT01083186|58603422|FG000|Overall Study|Administrative Reasons|2|||
30591003|NCT01083186|58603422|FG000|Overall Study|Non-compliance to Study Treatment|1|||
30591004|NCT01082640|58603449|FG000|Overall Study|Adverse Event|9|||
30591005|NCT01082640|58603450|FG001|Overall Study|Adverse Event|5|||
30591006|NCT01082640|58603451|FG002|Overall Study|Adverse Event|3|||
30591007|NCT01082640|58603449|FG000|Overall Study|Withdrawal by Subject|3|||
30591008|NCT01082640|58603450|FG001|Overall Study|Withdrawal by Subject|3|||
30591009|NCT01082640|58603451|FG002|Overall Study|Withdrawal by Subject|2|||
30591010|NCT01082640|58603449|FG000|Overall Study|Major protocol deviation|3|||
30591011|NCT01082640|58603450|FG001|Overall Study|Major protocol deviation|3|||
30591012|NCT01082640|58603451|FG002|Overall Study|Major protocol deviation|0|||
30591013|NCT01082640|58603449|FG000|Overall Study|Lost to Follow-up|0|||
30591014|NCT01082640|58603450|FG001|Overall Study|Lost to Follow-up|3|||
30591015|NCT01082640|58603451|FG002|Overall Study|Lost to Follow-up|0|||
30591016|NCT01082640|58603449|FG000|Overall Study|Other|2|||
30591017|NCT01082640|58603450|FG001|Overall Study|Other|1|||
30591018|NCT01082640|58603451|FG002|Overall Study|Other|3|||
30591019|NCT01082367|58603464|FG000|Double-blind Period|Administrative problems|0|||
30591020|NCT01082367|58603465|FG001|Double-blind Period|Administrative problems|1|||
30591021|NCT01082367|58603464|FG000|Double-blind Period|Lack of Efficacy|5|||
30591022|NCT01082367|58603465|FG001|Double-blind Period|Lack of Efficacy|11|||
30591023|NCT01082367|58603464|FG000|Double-blind Period|Adverse Event|0|||
30591024|NCT01082367|58603465|FG001|Double-blind Period|Adverse Event|1|||
30591025|NCT01082367|58603464|FG000|Follow-up (F-U) Period|Administrative problems|1|||
30675237|NCT00795951|58689207|FG000|Overall Study|Lost to Follow-up|1|||
30675238|NCT00795951|58689207|FG000|Overall Study|Withdrawal by Subject|1|||
30856040|NCT02576678|58883784|FG001|Overall Study|Withdrawal by Subject|1|||
30675239|NCT00795717|58689214|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
30675240|NCT00795717|58689215|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
30675241|NCT00795717|58689214|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
30675242|NCT00795717|58689215|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
30675243|NCT00795717|58689214|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
30675244|NCT00795717|58689215|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
30675245|NCT00795717|58689214|FG000|Phase II|too busy|0|||
30675246|NCT00795717|58689215|FG001|Phase II|too busy|1|||
30675247|NCT00805740|58689224|FG000|Overall Study|Death|7|||
30675248|NCT00805740|58689225|FG001|Overall Study|Death|4|||
30675249|NCT00805740|58689224|FG000|Overall Study|Withdrawal by Subject|1|||
30675250|NCT00805740|58689225|FG001|Overall Study|Withdrawal by Subject|0|||
30675251|NCT00805740|58689224|FG000|Overall Study|Lost to Follow-up|1|||
30675252|NCT00805740|58689225|FG001|Overall Study|Lost to Follow-up|0|||
30675253|NCT00805740|58689224|FG000|Overall Study|Randomized, but not treated|2|||
30675254|NCT00805740|58689225|FG001|Overall Study|Randomized, but not treated|0|||
30675255|NCT00795639|58689233|FG000|Overall Study|Death|1|||
30675256|NCT00795639|58689234|FG001|Overall Study|Death|6|||
30675257|NCT00795639|58689233|FG000|Overall Study|Withdrawal by Subject|1|||
30675258|NCT00795639|58689234|FG001|Overall Study|Withdrawal by Subject|3|||
30675259|NCT00795639|58689233|FG000|Overall Study|Pregnancy|1|||
30675260|NCT00795639|58689234|FG001|Overall Study|Pregnancy|0|||
30675261|NCT00795639|58689233|FG000|Overall Study|Adverse Event|5|||
30675262|NCT00795639|58689234|FG001|Overall Study|Adverse Event|2|||
30675263|NCT00795639|58689233|FG000|Overall Study|Other|0|||
30591026|NCT01082367|58603465|FG001|Follow-up (F-U) Period|Administrative problems|0|||
30591027|NCT01082367|58603464|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
30591028|NCT01082367|58603465|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
30591029|NCT01082367|58603464|FG000|Follow-up (F-U) Period|Adverse Event|0|||
30591030|NCT01082367|58603465|FG001|Follow-up (F-U) Period|Adverse Event|1|||
30591031|NCT01082211|58603475|FG000|Overall Study|Protocol Violation|4|||
30675264|NCT00795639|58689234|FG001|Overall Study|Other|2|||
30675265|NCT00795639|58689233|FG000|Overall Study|Terminated by sponsor|13|||
30675266|NCT00795639|58689234|FG001|Overall Study|Terminated by sponsor|12|||
30675267|NCT00795639|58689233|FG000|Overall Study|Randomized and not treated|0|||
30675268|NCT00795639|58689234|FG001|Overall Study|Randomized and not treated|1|||
30675269|NCT00589602|58689240|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
30781727|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30781728|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30781729|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30781730|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30877162|NCT00106691|58908830|FG000|Overall Study|Lost to Follow-up|23|||
30591032|NCT01082211|58603475|FG000|Overall Study|No protocol treatment received|3|||
30591033|NCT01081665|58603482|FG000|Overall Study|Death|41|||
30591034|NCT01081665|58603482|FG000|Overall Study|Lost to Follow-up|18|||
30591035|NCT01081665|58603482|FG000|Overall Study|Withdrawal by Subject|17|||
30591036|NCT01081665|58603482|FG000|Overall Study|Change of dialysis unit|10|||
30591037|NCT01081665|58603482|FG000|Overall Study|Regulation of iPTH|5|||
30591038|NCT01081665|58603482|FG000|Overall Study|Change in renal replacement therapy|2|||
30591039|NCT01081665|58603482|FG000|Overall Study|Adverse Event|1|||
30591040|NCT01081665|58603482|FG000|Overall Study|Lack of Efficacy|1|||
30591041|NCT01081626|58603488|FG000|Overall Study|Dosing error|1|||
30591042|NCT01081626|58603489|FG001|Overall Study|Dosing error|1|||
30591043|NCT01081626|58603488|FG000|Overall Study|Missing Estradiol|25|||
30591044|NCT01081626|58603489|FG001|Overall Study|Missing Estradiol|28|||
30591045|NCT01081626|58603488|FG000|Overall Study|Low antral follicle count|1|||
30591046|NCT01081626|58603489|FG001|Overall Study|Low antral follicle count|0|||
30591047|NCT01081626|58603488|FG000|Overall Study|Overstimulation|0|||
30591048|NCT01081626|58603489|FG001|Overall Study|Overstimulation|1|||
30591049|NCT01081626|58603488|FG000|Overall Study|Lost to Follow-up|0|||
30591050|NCT01081626|58603489|FG001|Overall Study|Lost to Follow-up|1|||
30591051|NCT01081626|58603488|FG000|Overall Study|Other|33|||
30591052|NCT01081626|58603489|FG001|Overall Study|Other|30|||
30591053|NCT01080768|58603497|FG000|Overall Study|Protocol Deviation|2|||
30591054|NCT01080768|58603498|FG001|Overall Study|Protocol Deviation|1|||
30591055|NCT01080300|58603506|FG000|Overall Study|Adverse Event|49|||
30591056|NCT01080300|58603507|FG001|Overall Study|Adverse Event|35|||
30675270|NCT00794157|58689249|FG000|Overall Study|Adverse Event|4|||
30675271|NCT00794157|58689250|FG001|Overall Study|Adverse Event|1|||
30675272|NCT00794157|58689251|FG002|Overall Study|Adverse Event|8|||
30675273|NCT00794157|58689249|FG000|Overall Study|Subject withdrew consent|2|||
30675274|NCT00794157|58689250|FG001|Overall Study|Subject withdrew consent|0|||
30675275|NCT00794157|58689251|FG002|Overall Study|Subject withdrew consent|3|||
30675276|NCT00794157|58689249|FG000|Overall Study|Lost to Follow-up|2|||
30675277|NCT00794157|58689250|FG001|Overall Study|Lost to Follow-up|0|||
30675278|NCT00794157|58689251|FG002|Overall Study|Lost to Follow-up|1|||
30591057|NCT01080300|58603506|FG000|Overall Study|Lack of Efficacy|12|||
30591058|NCT01080300|58603507|FG001|Overall Study|Lack of Efficacy|15|||
30591059|NCT01080300|58603506|FG000|Overall Study|Protocol Violation|7|||
30591060|NCT01080300|58603507|FG001|Overall Study|Protocol Violation|13|||
30591061|NCT01080300|58603506|FG000|Overall Study|Lost to Follow-up|10|||
30591062|NCT01080300|58603507|FG001|Overall Study|Lost to Follow-up|6|||
30591063|NCT01080300|58603506|FG000|Overall Study|Death|0|||
30591064|NCT01080300|58603507|FG001|Overall Study|Death|1|||
30591065|NCT01080300|58603506|FG000|Overall Study|Withdrawal by Subject|12|||
30591066|NCT01080300|58603507|FG001|Overall Study|Withdrawal by Subject|28|||
30591067|NCT01080300|58603506|FG000|Overall Study|Reasons not specified|4|||
30591068|NCT01080300|58603507|FG001|Overall Study|Reasons not specified|6|||
30591069|NCT01085097|58603518|FG000|Overall Study|Adverse Event|0|||
30591070|NCT01085097|58603519|FG001|Overall Study|Adverse Event|0|||
30591071|NCT01085097|58603520|FG002|Overall Study|Adverse Event|2|||
30591072|NCT01085097|58603518|FG000|Overall Study|Treatment failure|2|||
30591073|NCT01085097|58603519|FG001|Overall Study|Treatment failure|0|||
30591074|NCT01085097|58603520|FG002|Overall Study|Treatment failure|0|||
30591075|NCT03450629|58603534|FG000|Overall Study|Adverse Event|15|||
30591076|NCT03450629|58603535|FG001|Overall Study|Adverse Event|14|||
30591077|NCT03450629|58603534|FG000|Overall Study|Physician Decision|2|||
30591078|NCT03450629|58603535|FG001|Overall Study|Physician Decision|2|||
30591079|NCT03450629|58603534|FG000|Overall Study|Lack of Efficacy|2|||
30591080|NCT03450629|58603535|FG001|Overall Study|Lack of Efficacy|0|||
30591081|NCT03450629|58603534|FG000|Overall Study|Lost to Follow-up|4|||
30675279|NCT00794157|58689249|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30675280|NCT00794157|58689250|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30675281|NCT00794157|58689251|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
30675282|NCT00794157|58689249|FG000|Overall Study|Administrative problems|1|||
30675283|NCT00794157|58689250|FG001|Overall Study|Administrative problems|7|||
30675284|NCT00794157|58689251|FG002|Overall Study|Administrative problems|4|||
30675285|NCT00794157|58689249|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30675286|NCT00794157|58689250|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30675287|NCT00794157|58689251|FG002|Overall Study|Abnormal test procedure result(s)|0|||
30675288|NCT00794157|58689249|FG000|Overall Study|Protocol deviation|0|||
30781731|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
30781732|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
30781733|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
30781734|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
30781735|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
30781736|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
30781737|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
30781738|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
30781739|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
30781740|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
30781741|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
30781742|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
30781743|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781744|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
30781745|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
30781746|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781747|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781748|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781749|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781750|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30856041|NCT02576678|58883785|FG002|Overall Study|Withdrawal by Subject|2|||
30856042|NCT02576678|58883783|FG000|Overall Study|Lost to Follow-up|0|||
30856043|NCT02576678|58883784|FG001|Overall Study|Lost to Follow-up|0|||
30856044|NCT02576678|58883785|FG002|Overall Study|Lost to Follow-up|1|||
30856045|NCT02576678|58883783|FG000|Overall Study|Miscellaneous|2|||
30856046|NCT02576678|58883784|FG001|Overall Study|Miscellaneous|0|||
30591082|NCT03450629|58603535|FG001|Overall Study|Lost to Follow-up|2|||
30591083|NCT03450629|58603534|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
30591084|NCT03450629|58603535|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
30591085|NCT03450629|58603534|FG000|Overall Study|Non-Compliance With Study Drug|2|||
30675289|NCT00794157|58689250|FG001|Overall Study|Protocol deviation|1|||
30675290|NCT00794157|58689251|FG002|Overall Study|Protocol deviation|1|||
30675291|NCT00588237|58689259|FG000|Overall Study|Evaluable for toxicity only|3|||
30675292|NCT00588237|58689259|FG000|Overall Study|Patien not treated|1|||
30675293|NCT00790023|58689266|FG000|Overall Study|Adverse Event|2|||
30675294|NCT00790023|58689267|FG001|Overall Study|Adverse Event|1|||
30675295|NCT00790023|58689268|FG002|Overall Study|Adverse Event|4|||
30675296|NCT00790023|58689266|FG000|Overall Study|Protocol Violation|2|||
30675297|NCT00790023|58689267|FG001|Overall Study|Protocol Violation|4|||
30675298|NCT00790023|58689268|FG002|Overall Study|Protocol Violation|2|||
30675299|NCT00790023|58689266|FG000|Overall Study|Withdrawal by Subject|2|||
30675300|NCT00790023|58689267|FG001|Overall Study|Withdrawal by Subject|0|||
30675301|NCT00790023|58689268|FG002|Overall Study|Withdrawal by Subject|6|||
30675302|NCT00790023|58689266|FG000|Overall Study|Lost to Follow-up|0|||
30675303|NCT00790023|58689267|FG001|Overall Study|Lost to Follow-up|0|||
30675304|NCT00790023|58689268|FG002|Overall Study|Lost to Follow-up|1|||
30675305|NCT00790023|58689266|FG000|Overall Study|Other|5|||
30675306|NCT00790023|58689267|FG001|Overall Study|Other|5|||
30591086|NCT03450629|58603535|FG001|Overall Study|Non-Compliance With Study Drug|1|||
30591087|NCT03450629|58603534|FG000|Overall Study|Protocol Violation|11|||
30591088|NCT03450629|58603535|FG001|Overall Study|Protocol Violation|8|||
30591089|NCT03450629|58603534|FG000|Overall Study|Withdrawal by Subject|12|||
30675307|NCT00790023|58689268|FG002|Overall Study|Other|8|||
30675308|NCT00588822|58689277|FG000|Overall Study|progression of disease|8|||
30675309|NCT00589914|58689283|FG000|Overall Study|Adverse Event|19|||
30781751|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781752|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781753|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
30781754|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781755|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
30781756|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781757|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781758|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781759|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781760|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781761|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
30781762|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
30781763|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
30781764|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
30781765|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
30781766|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
30781767|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
30781768|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
30781769|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
30781770|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
30781771|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781772|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781773|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781774|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
30781775|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
30958992|NCT01587703|59024028|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30958993|NCT01587703|59024029|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30591090|NCT03450629|58603535|FG001|Overall Study|Withdrawal by Subject|6|||
30591091|NCT00198029|58603541|FG000|Overall Study|Withdrawal by Subject|4|||
30591092|NCT00197054|58603548|FG000|Overall Study|Withdrawal by Subject|9|||
30591093|NCT00197054|58603549|FG001|Overall Study|Withdrawal by Subject|3|||
30591094|NCT00197054|58603550|FG002|Overall Study|Withdrawal by Subject|3|||
30591095|NCT00197054|58603548|FG000|Overall Study|Moved from area|7|||
30591096|NCT00197054|58603549|FG001|Overall Study|Moved from area|14|||
30675310|NCT00589914|58689284|FG001|Overall Study|Adverse Event|10|||
30675311|NCT00589914|58689283|FG000|Overall Study|Death|2|||
30675312|NCT00589914|58689284|FG001|Overall Study|Death|0|||
30675313|NCT00589914|58689283|FG000|Overall Study|Lack of Efficacy|40|||
30675314|NCT00589914|58689284|FG001|Overall Study|Lack of Efficacy|43|||
30675315|NCT00589914|58689283|FG000|Overall Study|Lost to Follow-up|11|||
30675316|NCT00589914|58689284|FG001|Overall Study|Lost to Follow-up|18|||
30675317|NCT00589914|58689283|FG000|Overall Study|Pregnancy|1|||
30675318|NCT00589914|58689284|FG001|Overall Study|Pregnancy|0|||
30675319|NCT00589914|58689283|FG000|Overall Study|Withdrawal by Subject|55|||
30675320|NCT00589914|58689284|FG001|Overall Study|Withdrawal by Subject|49|||
30675321|NCT00589914|58689283|FG000|Overall Study|Other|22|||
30675322|NCT00589914|58689284|FG001|Overall Study|Other|17|||
30675323|NCT00789555|58689293|FG000|Overall Study|Protocol Amendment|78|||
30675324|NCT00789555|58689294|FG001|Overall Study|Protocol Amendment|76|||
30675325|NCT00789555|58689295|FG002|Overall Study|Protocol Amendment|80|||
30675326|NCT00789555|58689293|FG000|Overall Study|Adverse Event|17|||
30675327|NCT00789555|58689294|FG001|Overall Study|Adverse Event|7|||
30675328|NCT00789555|58689295|FG002|Overall Study|Adverse Event|10|||
30675329|NCT00789555|58689293|FG000|Overall Study|Lost to Follow-up|9|||
30675330|NCT00789555|58689294|FG001|Overall Study|Lost to Follow-up|10|||
30675331|NCT00789555|58689295|FG002|Overall Study|Lost to Follow-up|18|||
30675332|NCT00789555|58689293|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
30675333|NCT00789555|58689294|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
30675334|NCT00789555|58689295|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
30675335|NCT00789555|58689293|FG000|Overall Study|Treatment failure|11|||
30675336|NCT00789555|58689294|FG001|Overall Study|Treatment failure|8|||
30675337|NCT00789555|58689295|FG002|Overall Study|Treatment failure|12|||
30675338|NCT00789555|58689293|FG000|Overall Study|Protocol Violation|6|||
30675339|NCT00789555|58689294|FG001|Overall Study|Protocol Violation|9|||
30675340|NCT00789555|58689295|FG002|Overall Study|Protocol Violation|13|||
30675341|NCT00451321|58689311|FG000|Overall Study|Lost to Follow-up|3|||
30675342|NCT00451321|58689312|FG001|Overall Study|Lost to Follow-up|3|||
30675343|NCT00451321|58689313|FG002|Overall Study|Lost to Follow-up|1|||
30675344|NCT00451321|58689314|FG003|Overall Study|Lost to Follow-up|3|||
30675345|NCT00451321|58689315|FG004|Overall Study|Lost to Follow-up|0|||
30675346|NCT00451321|58689316|FG005|Overall Study|Lost to Follow-up|1|||
30675347|NCT00451321|58689317|FG006|Overall Study|Lost to Follow-up|0|||
30675348|NCT00451321|58689318|FG007|Overall Study|Lost to Follow-up|0|||
30675349|NCT00451321|58689311|FG000|Overall Study|Withdrawal by Subject|3|||
30675350|NCT00451321|58689312|FG001|Overall Study|Withdrawal by Subject|1|||
30675351|NCT00451321|58689313|FG002|Overall Study|Withdrawal by Subject|0|||
30675352|NCT00451321|58689314|FG003|Overall Study|Withdrawal by Subject|4|||
30675353|NCT00451321|58689315|FG004|Overall Study|Withdrawal by Subject|0|||
30675354|NCT00451321|58689316|FG005|Overall Study|Withdrawal by Subject|0|||
30675355|NCT00451321|58689317|FG006|Overall Study|Withdrawal by Subject|0|||
30675356|NCT00451321|58689318|FG007|Overall Study|Withdrawal by Subject|0|||
30675357|NCT00451321|58689311|FG000|Overall Study|Study closed/terminated|1|||
30675358|NCT00451321|58689312|FG001|Overall Study|Study closed/terminated|1|||
30675359|NCT00451321|58689313|FG002|Overall Study|Study closed/terminated|17|||
30675360|NCT00451321|58689314|FG003|Overall Study|Study closed/terminated|5|||
30675361|NCT00451321|58689315|FG004|Overall Study|Study closed/terminated|7|||
30675362|NCT00451321|58689316|FG005|Overall Study|Study closed/terminated|7|||
30675363|NCT00451321|58689317|FG006|Overall Study|Study closed/terminated|5|||
30675364|NCT00451321|58689318|FG007|Overall Study|Study closed/terminated|3|||
30675365|NCT00451321|58689311|FG000|Overall Study|Sponsor decision to amend protocol|0|||
30675366|NCT00451321|58689312|FG001|Overall Study|Sponsor decision to amend protocol|0|||
30675367|NCT00451321|58689313|FG002|Overall Study|Sponsor decision to amend protocol|0|||
30675368|NCT00451321|58689314|FG003|Overall Study|Sponsor decision to amend protocol|0|||
30675369|NCT00451321|58689315|FG004|Overall Study|Sponsor decision to amend protocol|0|||
30675370|NCT00451321|58689316|FG005|Overall Study|Sponsor decision to amend protocol|1|||
30591097|NCT00197054|58603550|FG002|Overall Study|Moved from area|9|||
30591098|NCT00197054|58603548|FG000|Overall Study|Lost to Follow-up|1|||
30591099|NCT00197054|58603549|FG001|Overall Study|Lost to Follow-up|4|||
30591100|NCT00197054|58603550|FG002|Overall Study|Lost to Follow-up|0|||
30591101|NCT00197015|58603571|FG000|Overall Study|Adverse Event|3|||
30591102|NCT00197015|58603572|FG001|Overall Study|Adverse Event|0|||
30591103|NCT00197015|58603573|FG002|Overall Study|Adverse Event|1|||
30591104|NCT00197015|58603571|FG000|Overall Study|Protocol Violation|0|||
30591105|NCT00197015|58603572|FG001|Overall Study|Protocol Violation|3|||
30675371|NCT00451321|58689317|FG006|Overall Study|Sponsor decision to amend protocol|1|||
30675372|NCT00451321|58689318|FG007|Overall Study|Sponsor decision to amend protocol|3|||
30675373|NCT00802464|58689344|FG000|Month 0 - Month 8|Adverse Event|0|||
30675374|NCT00802464|58689345|FG001|Month 0 - Month 8|Adverse Event|1|||
30591106|NCT00197015|58603573|FG002|Overall Study|Protocol Violation|3|||
30591107|NCT00197015|58603571|FG000|Overall Study|Withdrawal by Subject|17|||
30675375|NCT00802464|58689346|FG002|Month 0 - Month 8|Adverse Event|1|||
30675376|NCT00802464|58689347|FG003|Month 0 - Month 8|Adverse Event|2|||
30675377|NCT00802464|58689344|FG000|Month 0 - Month 8|Protocol Violation|0|||
30675378|NCT00802464|58689345|FG001|Month 0 - Month 8|Protocol Violation|0|||
30591108|NCT00197015|58603572|FG001|Overall Study|Withdrawal by Subject|37|||
30675379|NCT00802464|58689346|FG002|Month 0 - Month 8|Protocol Violation|1|||
30675380|NCT00802464|58689347|FG003|Month 0 - Month 8|Protocol Violation|0|||
30675381|NCT00802464|58689344|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
30675382|NCT00802464|58689345|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
30675383|NCT00802464|58689346|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
30675384|NCT00802464|58689347|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
30675385|NCT00802464|58689344|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
30675386|NCT00802464|58689345|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
30675387|NCT00802464|58689346|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
30675388|NCT00802464|58689347|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
30675389|NCT00802464|58689344|FG000|Month 0 - Month 8|Other|0|||
30675390|NCT00802464|58689345|FG001|Month 0 - Month 8|Other|0|||
30675391|NCT00802464|58689346|FG002|Month 0 - Month 8|Other|1|||
30675392|NCT00802464|58689347|FG003|Month 0 - Month 8|Other|0|||
30675393|NCT00802464|58689344|FG000|Month 8 - Month 14|Adverse Event|0|||
30675394|NCT00802464|58689345|FG001|Month 8 - Month 14|Adverse Event|1|||
30675395|NCT00802464|58689346|FG002|Month 8 - Month 14|Adverse Event|0|||
30675396|NCT00802464|58689347|FG003|Month 8 - Month 14|Adverse Event|0|||
30675397|NCT00802464|58689344|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
30781776|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781777|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781778|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30675398|NCT00802464|58689345|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
30675399|NCT00802464|58689346|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
30675400|NCT00802464|58689347|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
30675401|NCT00802464|58689344|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
30675402|NCT00802464|58689345|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
30675403|NCT00802464|58689346|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
30675404|NCT00802464|58689347|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
30675405|NCT00450619|58689361|FG000|Overall Study|refused treatment after randomization|2|||
30675406|NCT00450619|58689362|FG001|Overall Study|refused treatment after randomization|0|||
30675407|NCT00450619|58689361|FG000|Overall Study|did not progress; refused further trmt|1|||
30675408|NCT00450619|58689362|FG001|Overall Study|did not progress; refused further trmt|1|||
30675409|NCT00450619|58689361|FG000|Overall Study|Adverse Event|1|||
30675410|NCT00450619|58689362|FG001|Overall Study|Adverse Event|0|||
30675411|NCT00802074|58689375|FG000|Overall Study|Adverse Event|1|||
30675412|NCT00802074|58689376|FG001|Overall Study|Adverse Event|1|||
30675413|NCT00802074|58689377|FG002|Overall Study|Adverse Event|1|||
30675414|NCT00802074|58689378|FG003|Overall Study|Adverse Event|0|||
30675415|NCT00802074|58689379|FG004|Overall Study|Adverse Event|0|||
30675416|NCT00802074|58689380|FG005|Overall Study|Adverse Event|0|||
30675417|NCT00802074|58689375|FG000|Overall Study|Withdrawal by Subject|1|||
30675418|NCT00802074|58689376|FG001|Overall Study|Withdrawal by Subject|0|||
30675419|NCT00802074|58689377|FG002|Overall Study|Withdrawal by Subject|0|||
30675420|NCT00802074|58689378|FG003|Overall Study|Withdrawal by Subject|0|||
30675421|NCT00802074|58689379|FG004|Overall Study|Withdrawal by Subject|0|||
30675422|NCT00802074|58689380|FG005|Overall Study|Withdrawal by Subject|0|||
30675423|NCT00450385|58689397|FG000|Overall Study|Death|3|||
30675424|NCT00450385|58689397|FG000|Overall Study|Protocol Violation|1|||
30675425|NCT00450385|58689397|FG000|Overall Study|Withdrawal by Subject|2|||
30591109|NCT00197015|58603573|FG002|Overall Study|Withdrawal by Subject|34|||
30591110|NCT00197015|58603571|FG000|Overall Study|Lost to Follow-up|28|||
30591111|NCT00197015|58603572|FG001|Overall Study|Lost to Follow-up|46|||
30591112|NCT00197015|58603573|FG002|Overall Study|Lost to Follow-up|37|||
30591113|NCT00197015|58603571|FG000|Overall Study|Other|2|||
30591114|NCT00197015|58603572|FG001|Overall Study|Other|3|||
30591115|NCT00197015|58603573|FG002|Overall Study|Other|2|||
30591116|NCT00196976|58603595|FG000|Primary Study|Migrated from study area|0|||
30591117|NCT00196976|58603596|FG001|Primary Study|Migrated from study area|0|||
30591118|NCT00196976|58603597|FG002|Primary Study|Migrated from study area|0|||
30591119|NCT00196976|58603598|FG003|Primary Study|Migrated from study area|0|||
30591120|NCT00196976|58603599|FG004|Primary Study|Migrated from study area|0|||
30591121|NCT00196976|58603600|FG005|Primary Study|Migrated from study area|0|||
30591122|NCT00196976|58603601|FG006|Primary Study|Migrated from study area|0|||
30591123|NCT00196976|58603602|FG007|Primary Study|Migrated from study area|1|||
30591124|NCT00196976|58603603|FG008|Primary Study|Migrated from study area|0|||
30591125|NCT00196976|58603604|FG009|Primary Study|Migrated from study area|0|||
30591126|NCT00196976|58603605|FG010|Primary Study|Migrated from study area|0|||
30591127|NCT00196976|58603606|FG011|Primary Study|Migrated from study area|0|||
30591128|NCT00196976|58603607|FG012|Primary Study|Migrated from study area|0|||
30675426|NCT00450385|58689397|FG000|Overall Study|Lack of Efficacy|2|||
30675427|NCT00450385|58689397|FG000|Overall Study|Adverse Event|1|||
30675428|NCT00450385|58689397|FG000|Overall Study|Physician Decision|1|||
30675429|NCT00450385|58689397|FG000|Overall Study|Other|3|||
30675430|NCT00588354|58689404|FG000|Baseline to 2 Weeks|Adverse Event|1|||
30675431|NCT00588354|58689405|FG001|Baseline to 2 Weeks|Adverse Event|0|||
30675432|NCT00588354|58689404|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
30675433|NCT00588354|58689405|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
30675434|NCT00588354|58689404|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
30675435|NCT00588354|58689405|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
30856047|NCT02576678|58883785|FG002|Overall Study|Miscellaneous|0|||
30675436|NCT00449761|58689412|FG000|Overall Study|Disease progression|12|||
30675437|NCT00449761|58689412|FG000|Overall Study|Death|5|||
30675438|NCT00449761|58689412|FG000|Overall Study|New cancer therapy|1|||
30675439|NCT00800982|58689419|FG000|Overall Study|Lost to Follow-up|1|||
30675440|NCT00800982|58689420|FG001|Overall Study|Lost to Follow-up|2|||
30675441|NCT00800982|58689419|FG000|Overall Study|Withdrawal by Subject|0|||
30675442|NCT00800982|58689420|FG001|Overall Study|Withdrawal by Subject|1|||
30675443|NCT00800982|58689419|FG000|Overall Study|Patient moved out of state|1|||
30675444|NCT00800982|58689420|FG001|Overall Study|Patient moved out of state|0|||
30675445|NCT00830960|58689432|FG000|Overall Study|Death|5|||
30675446|NCT00830960|58689433|FG001|Overall Study|Death|4|||
30675447|NCT00830960|58689434|FG002|Overall Study|Death|3|||
30675448|NCT00830960|58689435|FG003|Overall Study|Death|2|||
30675449|NCT00830960|58689436|FG004|Overall Study|Death|6|||
30675450|NCT00830960|58689437|FG005|Overall Study|Death|1|||
30675451|NCT00830960|58689432|FG000|Overall Study|Lost to Follow-up|1|||
30675452|NCT00830960|58689433|FG001|Overall Study|Lost to Follow-up|1|||
30675453|NCT00830960|58689434|FG002|Overall Study|Lost to Follow-up|1|||
30675454|NCT00830960|58689435|FG003|Overall Study|Lost to Follow-up|0|||
30675455|NCT00830960|58689436|FG004|Overall Study|Lost to Follow-up|0|||
30675456|NCT00830960|58689437|FG005|Overall Study|Lost to Follow-up|1|||
30675457|NCT00830960|58689432|FG000|Overall Study|Withdrawal by Subject|19|||
30675458|NCT00830960|58689433|FG001|Overall Study|Withdrawal by Subject|19|||
30675459|NCT00830960|58689434|FG002|Overall Study|Withdrawal by Subject|18|||
30675460|NCT00830960|58689435|FG003|Overall Study|Withdrawal by Subject|23|||
30675461|NCT00830960|58689436|FG004|Overall Study|Withdrawal by Subject|16|||
30675462|NCT00830960|58689437|FG005|Overall Study|Withdrawal by Subject|21|||
30675463|NCT00830960|58689432|FG000|Overall Study|Sponsor Decision|1|||
30675464|NCT00830960|58689433|FG001|Overall Study|Sponsor Decision|2|||
30675465|NCT00830960|58689434|FG002|Overall Study|Sponsor Decision|3|||
30675466|NCT00830960|58689435|FG003|Overall Study|Sponsor Decision|4|||
30856048|NCT00108745|58883796|FG000|Overall Study|Withdrawal by Subject|19|||
30856049|NCT00108745|58883797|FG001|Overall Study|Withdrawal by Subject|12|||
30856050|NCT00108745|58883798|FG002|Overall Study|Withdrawal by Subject|12|||
30856051|NCT00108745|58883796|FG000|Overall Study|Never Treated|8|||
30856052|NCT00108745|58883797|FG001|Overall Study|Never Treated|10|||
30958994|NCT01587703|59024030|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30591129|NCT00196976|58603608|FG013|Primary Study|Migrated from study area|0|||
30591130|NCT00196976|58603595|FG000|Primary Study|Protocol Violation|0|||
30591131|NCT00196976|58603596|FG001|Primary Study|Protocol Violation|1|||
30591132|NCT00196976|58603597|FG002|Primary Study|Protocol Violation|1|||
30591133|NCT00196976|58603598|FG003|Primary Study|Protocol Violation|0|||
30591134|NCT00196976|58603599|FG004|Primary Study|Protocol Violation|0|||
30591135|NCT00196976|58603600|FG005|Primary Study|Protocol Violation|0|||
30591136|NCT00196976|58603601|FG006|Primary Study|Protocol Violation|0|||
30591137|NCT00196976|58603602|FG007|Primary Study|Protocol Violation|0|||
30591138|NCT00196976|58603603|FG008|Primary Study|Protocol Violation|0|||
30591139|NCT00196976|58603604|FG009|Primary Study|Protocol Violation|0|||
30591140|NCT00196976|58603605|FG010|Primary Study|Protocol Violation|0|||
30591141|NCT00196976|58603606|FG011|Primary Study|Protocol Violation|0|||
30591142|NCT00196976|58603607|FG012|Primary Study|Protocol Violation|0|||
30591143|NCT00196976|58603608|FG013|Primary Study|Protocol Violation|0|||
30591144|NCT00196976|58603595|FG000|Primary Study|Withdrawal by Subject|1|||
30591145|NCT00196976|58603596|FG001|Primary Study|Withdrawal by Subject|0|||
30591146|NCT00196976|58603597|FG002|Primary Study|Withdrawal by Subject|1|||
30591147|NCT00196976|58603598|FG003|Primary Study|Withdrawal by Subject|1|||
30591148|NCT00196976|58603599|FG004|Primary Study|Withdrawal by Subject|2|||
30591149|NCT00196976|58603600|FG005|Primary Study|Withdrawal by Subject|1|||
30591150|NCT00196976|58603601|FG006|Primary Study|Withdrawal by Subject|0|||
30675467|NCT00830960|58689436|FG004|Overall Study|Sponsor Decision|5|||
30675468|NCT00830960|58689437|FG005|Overall Study|Sponsor Decision|7|||
30675469|NCT00830960|58689432|FG000|Overall Study|No study drug received|7|||
30675470|NCT00830960|58689433|FG001|Overall Study|No study drug received|2|||
30675471|NCT00830960|58689434|FG002|Overall Study|No study drug received|4|||
30675472|NCT00830960|58689435|FG003|Overall Study|No study drug received|3|||
30675473|NCT00830960|58689436|FG004|Overall Study|No study drug received|5|||
30675474|NCT00830960|58689437|FG005|Overall Study|No study drug received|7|||
30675475|NCT00830804|58689474|FG000|Overall Study|Lost to Follow-up|4|||
30675476|NCT00830804|58689474|FG000|Overall Study|Death|1|||
30675477|NCT00830804|58689474|FG000|Overall Study|Unable to get to clinic|7|||
30675478|NCT00830804|58689474|FG000|Overall Study|Consent withdrawn|2|||
30675479|NCT00830804|58689474|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
30675480|NCT00789477|58689484|FG000|Overall Study|Withdrawal by Subject|2|||
30675481|NCT00789477|58689485|FG001|Overall Study|Withdrawal by Subject|1|||
30675482|NCT00789477|58689486|FG002|Overall Study|Withdrawal by Subject|3|||
30591151|NCT00196976|58603602|FG007|Primary Study|Withdrawal by Subject|0|||
30675483|NCT00789477|58689487|FG003|Overall Study|Withdrawal by Subject|2|||
30675484|NCT00789477|58689488|FG004|Overall Study|Withdrawal by Subject|3|||
30675485|NCT00789477|58689484|FG000|Overall Study|Protocol Violation|1|||
30675486|NCT00789477|58689485|FG001|Overall Study|Protocol Violation|0|||
30675487|NCT00789477|58689486|FG002|Overall Study|Protocol Violation|0|||
30675488|NCT00789477|58689487|FG003|Overall Study|Protocol Violation|1|||
30675489|NCT00789477|58689488|FG004|Overall Study|Protocol Violation|0|||
30675490|NCT00789477|58689484|FG000|Overall Study|Adverse Event|3|||
30675491|NCT00789477|58689485|FG001|Overall Study|Adverse Event|3|||
30675492|NCT00789477|58689486|FG002|Overall Study|Adverse Event|1|||
30675493|NCT00789477|58689487|FG003|Overall Study|Adverse Event|0|||
30675494|NCT00789477|58689488|FG004|Overall Study|Adverse Event|0|||
30675495|NCT00789477|58689484|FG000|Overall Study|Death|1|||
30675496|NCT00789477|58689485|FG001|Overall Study|Death|1|||
30675497|NCT00789477|58689486|FG002|Overall Study|Death|2|||
30675498|NCT00789477|58689487|FG003|Overall Study|Death|2|||
30675499|NCT00789477|58689488|FG004|Overall Study|Death|0|||
30675500|NCT00789477|58689484|FG000|Overall Study|Lost to Follow-up|0|||
30675501|NCT00789477|58689485|FG001|Overall Study|Lost to Follow-up|1|||
30675502|NCT00789477|58689486|FG002|Overall Study|Lost to Follow-up|4|||
30675503|NCT00789477|58689487|FG003|Overall Study|Lost to Follow-up|2|||
30675504|NCT00789477|58689488|FG004|Overall Study|Lost to Follow-up|4|||
30675505|NCT00789477|58689484|FG000|Overall Study|Lack of Efficacy|2|||
30675506|NCT00789477|58689485|FG001|Overall Study|Lack of Efficacy|0|||
30675507|NCT00789477|58689486|FG002|Overall Study|Lack of Efficacy|0|||
30675508|NCT00789477|58689487|FG003|Overall Study|Lack of Efficacy|0|||
30675509|NCT00789477|58689488|FG004|Overall Study|Lack of Efficacy|0|||
30675510|NCT00789477|58689484|FG000|Overall Study|Other|2|||
30675511|NCT00789477|58689485|FG001|Overall Study|Other|0|||
30675512|NCT00789477|58689486|FG002|Overall Study|Other|1|||
30675513|NCT00789477|58689487|FG003|Overall Study|Other|3|||
30675514|NCT00789477|58689488|FG004|Overall Study|Other|0|||
30675515|NCT00796614|58689506|FG000|Overall Study|Adverse Event|1|||
30675516|NCT00796614|58689507|FG001|Overall Study|Adverse Event|2|||
30675517|NCT00796614|58689508|FG002|Overall Study|Adverse Event|0|||
30675518|NCT00796614|58689509|FG003|Overall Study|Adverse Event|0|||
30675519|NCT00796614|58689506|FG000|Overall Study|Protocol Violation|0|||
30675520|NCT00796614|58689507|FG001|Overall Study|Protocol Violation|0|||
30675521|NCT00796614|58689508|FG002|Overall Study|Protocol Violation|2|||
30675522|NCT00796614|58689509|FG003|Overall Study|Protocol Violation|0|||
30675523|NCT00796614|58689506|FG000|Overall Study|Lost to Follow-up|2|||
30675524|NCT00796614|58689507|FG001|Overall Study|Lost to Follow-up|2|||
30675525|NCT00796614|58689508|FG002|Overall Study|Lost to Follow-up|1|||
30675526|NCT00796614|58689509|FG003|Overall Study|Lost to Follow-up|0|||
30675527|NCT00796614|58689506|FG000|Overall Study|Withdrawal by Subject|1|||
30675528|NCT00796614|58689507|FG001|Overall Study|Withdrawal by Subject|0|||
30675529|NCT00796614|58689508|FG002|Overall Study|Withdrawal by Subject|0|||
30675530|NCT00796614|58689509|FG003|Overall Study|Withdrawal by Subject|1|||
30675531|NCT00796614|58689506|FG000|Overall Study|Other than stated|1|||
30675532|NCT00796614|58689507|FG001|Overall Study|Other than stated|0|||
30675533|NCT00796614|58689508|FG002|Overall Study|Other than stated|0|||
30675534|NCT00796614|58689509|FG003|Overall Study|Other than stated|0|||
30675535|NCT00448747|58689521|FG000|Overall Study|collapsed veins|1|||
30675536|NCT00448747|58689522|FG001|Overall Study|collapsed veins|0|||
30675537|NCT00830180|58689538|FG000|Overall Study|Adverse Event|6|||
30675538|NCT00830180|58689538|FG000|Overall Study|Death|11|||
30675539|NCT00830180|58689538|FG000|Overall Study|Insufficient clinical response|1|||
30675540|NCT00830180|58689538|FG000|Overall Study|Withdrawal by Subject|5|||
30675541|NCT00830180|58689538|FG000|Overall Study|Progressive disease|2|||
30675542|NCT00830180|58689538|FG000|Overall Study|Other - Unspecified|1|||
30675543|NCT00863681|58689547|FG000|Overall Study|Other|2|||
30675544|NCT00863681|58689548|FG001|Overall Study|Other|0|||
30675545|NCT00863681|58689549|FG002|Overall Study|Other|0|||
30675546|NCT00863681|58689547|FG000|Overall Study|Missing|1|||
30675547|NCT00863681|58689548|FG001|Overall Study|Missing|0|||
30675548|NCT00863681|58689549|FG002|Overall Study|Missing|0|||
30675549|NCT00863681|58689547|FG000|Overall Study|Death|40|||
30856053|NCT00108745|58883798|FG002|Overall Study|Never Treated|12|||
30856054|NCT00108745|58883796|FG000|Overall Study|Ineligible|7|||
30675550|NCT00863681|58689548|FG001|Overall Study|Death|23|||
30675551|NCT00863681|58689549|FG002|Overall Study|Death|6|||
30675552|NCT00863681|58689547|FG000|Overall Study|Withdrawal by Subject|12|||
30675553|NCT00863681|58689548|FG001|Overall Study|Withdrawal by Subject|5|||
30675554|NCT00863681|58689549|FG002|Overall Study|Withdrawal by Subject|2|||
30675555|NCT00863681|58689547|FG000|Overall Study|Protocol Violation|2|||
30675556|NCT00863681|58689548|FG001|Overall Study|Protocol Violation|0|||
30675557|NCT00863681|58689549|FG002|Overall Study|Protocol Violation|0|||
30675558|NCT00863681|58689547|FG000|Overall Study|Lost to Follow-up|3|||
30675559|NCT00863681|58689548|FG001|Overall Study|Lost to Follow-up|0|||
30675560|NCT00863681|58689549|FG002|Overall Study|Lost to Follow-up|3|||
30958995|NCT01587703|59024031|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30675561|NCT00863681|58689547|FG000|Overall Study|Adverse Event|28|||
30675562|NCT00863681|58689548|FG001|Overall Study|Adverse Event|10|||
30675563|NCT00863681|58689549|FG002|Overall Study|Adverse Event|6|||
30675564|NCT00863681|58689547|FG000|Overall Study|Lack of Efficacy|2|||
30675565|NCT00863681|58689548|FG001|Overall Study|Lack of Efficacy|2|||
30675566|NCT00863681|58689549|FG002|Overall Study|Lack of Efficacy|1|||
30675567|NCT00863681|58689547|FG000|Overall Study|Non-compliance with study drug|1|||
30675568|NCT00863681|58689548|FG001|Overall Study|Non-compliance with study drug|3|||
30675569|NCT00863681|58689549|FG002|Overall Study|Non-compliance with study drug|0|||
30675570|NCT00789321|58689559|FG000|Overall Study|Adverse Event|0|||
30675571|NCT00789321|58689560|FG001|Overall Study|Adverse Event|1|||
30675572|NCT00811928|58689568|FG000|Overall Study|AEs and SAEs Including Death|7|||
30675573|NCT00811928|58689569|FG001|Overall Study|AEs and SAEs Including Death|11|||
30675574|NCT00811928|58689568|FG000|Overall Study|Withdrawal by Subject|18|||
30675575|NCT00811928|58689569|FG001|Overall Study|Withdrawal by Subject|12|||
30675576|NCT00811928|58689568|FG000|Overall Study|Did Not Take Study Drug|3|||
30675577|NCT00811928|58689569|FG001|Overall Study|Did Not Take Study Drug|0|||
30675578|NCT00811928|58689568|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
30675579|NCT00811928|58689569|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
30675580|NCT00811928|58689568|FG000|Overall Study|Investigator Decision|2|||
30675581|NCT00811928|58689569|FG001|Overall Study|Investigator Decision|1|||
30675582|NCT00811928|58689568|FG000|Overall Study|Poor Compliance|2|||
30675583|NCT00811928|58689569|FG001|Overall Study|Poor Compliance|5|||
30675584|NCT00788775|58689577|FG000|Overall Study|Progressive Disease|8|||
30675585|NCT00788775|58689578|FG001|Overall Study|Progressive Disease|6|||
30675586|NCT00788775|58689577|FG000|Overall Study|Withdrawal by Subject|0|||
30675587|NCT00788775|58689578|FG001|Overall Study|Withdrawal by Subject|2|||
30675588|NCT00788775|58689577|FG000|Overall Study|Patient Non-Compliance|1|||
30675589|NCT00788775|58689578|FG001|Overall Study|Patient Non-Compliance|0|||
30675590|NCT00788775|58689577|FG000|Overall Study|Patient's measurable disease resected.|1|||
30675591|NCT00788775|58689578|FG001|Overall Study|Patient's measurable disease resected.|0|||
30675592|NCT00448669|58689586|FG000|Overall Study|Lost to Follow-up|52|||
30675593|NCT00448669|58689587|FG001|Overall Study|Lost to Follow-up|63|||
30675594|NCT00448669|58689586|FG000|Overall Study|Withdrawal by Subject|90|||
30675595|NCT00448669|58689587|FG001|Overall Study|Withdrawal by Subject|74|||
30675596|NCT00448669|58689586|FG000|Overall Study|Relocated|49|||
30958996|NCT01587703|59024032|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30958997|NCT01587703|59024033|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30591152|NCT00196976|58603603|FG008|Primary Study|Withdrawal by Subject|0|||
30591153|NCT00196976|58603604|FG009|Primary Study|Withdrawal by Subject|1|||
30591154|NCT00196976|58603605|FG010|Primary Study|Withdrawal by Subject|0|||
30591155|NCT00196976|58603606|FG011|Primary Study|Withdrawal by Subject|0|||
30591156|NCT00196976|58603607|FG012|Primary Study|Withdrawal by Subject|0|||
30591157|NCT00196976|58603608|FG013|Primary Study|Withdrawal by Subject|0|||
30591158|NCT00196976|58603595|FG000|Primary Study|Lost to Follow-up|0|||
30591159|NCT00196976|58603596|FG001|Primary Study|Lost to Follow-up|0|||
30591160|NCT00196976|58603597|FG002|Primary Study|Lost to Follow-up|0|||
30591161|NCT00196976|58603598|FG003|Primary Study|Lost to Follow-up|0|||
30591162|NCT00196976|58603599|FG004|Primary Study|Lost to Follow-up|1|||
30591163|NCT00196976|58603600|FG005|Primary Study|Lost to Follow-up|1|||
30591164|NCT00196976|58603601|FG006|Primary Study|Lost to Follow-up|0|||
30591165|NCT00196976|58603602|FG007|Primary Study|Lost to Follow-up|2|||
30591166|NCT00196976|58603603|FG008|Primary Study|Lost to Follow-up|0|||
30591167|NCT00196976|58603604|FG009|Primary Study|Lost to Follow-up|0|||
30591168|NCT00196976|58603605|FG010|Primary Study|Lost to Follow-up|0|||
30591169|NCT00196976|58603606|FG011|Primary Study|Lost to Follow-up|0|||
30591170|NCT00196976|58603607|FG012|Primary Study|Lost to Follow-up|0|||
30591171|NCT00196976|58603608|FG013|Primary Study|Lost to Follow-up|0|||
30591172|NCT00196976|58603595|FG000|Primary Study|Other|0|||
30591173|NCT00196976|58603596|FG001|Primary Study|Other|0|||
30591174|NCT00196976|58603597|FG002|Primary Study|Other|2|||
30591175|NCT00196976|58603598|FG003|Primary Study|Other|0|||
30591176|NCT00196976|58603599|FG004|Primary Study|Other|0|||
30591177|NCT00196976|58603600|FG005|Primary Study|Other|0|||
30591178|NCT00196976|58603601|FG006|Primary Study|Other|0|||
30675597|NCT00448669|58689587|FG001|Overall Study|Relocated|36|||
30856055|NCT00108745|58883797|FG001|Overall Study|Ineligible|13|||
30958998|NCT01587703|59024034|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
30591179|NCT00196976|58603602|FG007|Primary Study|Other|0|||
30591180|NCT00196976|58603603|FG008|Primary Study|Other|0|||
30591181|NCT00196976|58603604|FG009|Primary Study|Other|0|||
30591182|NCT00196976|58603605|FG010|Primary Study|Other|0|||
30591183|NCT00196976|58603606|FG011|Primary Study|Other|0|||
30591184|NCT00196976|58603607|FG012|Primary Study|Other|0|||
30591185|NCT00196976|58603608|FG013|Primary Study|Other|0|||
30591186|NCT00196976|58603595|FG000|Booster Study|Withdrawal by Subject|0|||
30591187|NCT00196976|58603596|FG001|Booster Study|Withdrawal by Subject|0|||
30591188|NCT00196976|58603597|FG002|Booster Study|Withdrawal by Subject|0|||
30675598|NCT00448669|58689586|FG000|Overall Study|Were withdrawn by investigator|10|||
30675599|NCT00448669|58689587|FG001|Overall Study|Were withdrawn by investigator|6|||
30675600|NCT00448669|58689586|FG000|Overall Study|Death|2|||
30591189|NCT00196976|58603598|FG003|Booster Study|Withdrawal by Subject|0|||
30591190|NCT00196976|58603599|FG004|Booster Study|Withdrawal by Subject|0|||
30591191|NCT00196976|58603600|FG005|Booster Study|Withdrawal by Subject|0|||
30591192|NCT00196976|58603601|FG006|Booster Study|Withdrawal by Subject|0|||
30591193|NCT00196976|58603602|FG007|Booster Study|Withdrawal by Subject|0|||
30591194|NCT00196976|58603603|FG008|Booster Study|Withdrawal by Subject|0|||
30591195|NCT00196976|58603604|FG009|Booster Study|Withdrawal by Subject|0|||
30591196|NCT00196976|58603605|FG010|Booster Study|Withdrawal by Subject|1|||
30591197|NCT00196976|58603606|FG011|Booster Study|Withdrawal by Subject|0|||
30591198|NCT00196976|58603607|FG012|Booster Study|Withdrawal by Subject|0|||
30591199|NCT00196976|58603608|FG013|Booster Study|Withdrawal by Subject|0|||
30591200|NCT00196976|58603595|FG000|Booster Study|Lost to Follow-up|0|||
30591201|NCT00196976|58603596|FG001|Booster Study|Lost to Follow-up|0|||
30591202|NCT00196976|58603597|FG002|Booster Study|Lost to Follow-up|0|||
30591203|NCT00196976|58603598|FG003|Booster Study|Lost to Follow-up|0|||
30591204|NCT00196976|58603599|FG004|Booster Study|Lost to Follow-up|0|||
30591205|NCT00196976|58603600|FG005|Booster Study|Lost to Follow-up|0|||
30591206|NCT00196976|58603601|FG006|Booster Study|Lost to Follow-up|0|||
30591207|NCT00196976|58603602|FG007|Booster Study|Lost to Follow-up|0|||
30591208|NCT00196976|58603603|FG008|Booster Study|Lost to Follow-up|0|||
30591209|NCT00196976|58603604|FG009|Booster Study|Lost to Follow-up|0|||
30675601|NCT00448669|58689587|FG001|Overall Study|Death|4|||
30675602|NCT00448669|58689586|FG000|Overall Study|Had other reasons|5|||
30675603|NCT00448669|58689587|FG001|Overall Study|Had other reasons|6|||
30675604|NCT00448669|58689586|FG000|Overall Study|HIV-infected at enrollment|1|||
30675605|NCT00448669|58689587|FG001|Overall Study|HIV-infected at enrollment|2|||
30675606|NCT00448669|58689586|FG000|Overall Study|Never started drug|9|||
30675607|NCT00448669|58689587|FG001|Overall Study|Never started drug|7|||
30675608|NCT00591734|58689595|FG000|Overall Study|Lack of Efficacy|35|||
30675609|NCT00591734|58689595|FG000|Overall Study|Adverse Event|5|||
30675610|NCT00591734|58689595|FG000|Overall Study|Physician Decision|5|||
30675611|NCT00591734|58689595|FG000|Overall Study|Intercurrent Illness|8|||
30675612|NCT00788697|58689599|FG000|Overall Study|No study drug administered|12|||
30675613|NCT00788697|58689599|FG000|Overall Study|Training Patients|74|||
30675614|NCT00788697|58689599|FG000|Overall Study|no truth standard procedure available|5|||
30675615|NCT00788697|58689599|FG000|Overall Study|Technically inadequate truth standard|1|||
30675616|NCT00788697|58689599|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
30675617|NCT00848549|58689613|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
30675618|NCT00848549|58689614|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
30675619|NCT00848549|58689613|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
30675620|NCT00848549|58689614|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
30675621|NCT00848549|58689613|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
30675622|NCT00848549|58689614|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
30675623|NCT00848549|58689613|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
30675624|NCT00848549|58689614|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
30675625|NCT00848549|58689613|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
30675626|NCT00848549|58689614|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
30675627|NCT00848549|58689613|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
30675628|NCT00848549|58689614|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
30675629|NCT00848549|58689613|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
30675630|NCT00848549|58689614|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
30675631|NCT00848549|58689613|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
30675632|NCT00848549|58689614|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
30675633|NCT00848549|58689613|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
30675634|NCT00848549|58689614|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
30675635|NCT00848549|58689613|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
30675636|NCT00848549|58689614|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
30675637|NCT00848549|58689613|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
30675638|NCT00848549|58689614|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
30675639|NCT00848549|58689613|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
30675640|NCT00848549|58689614|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
30675641|NCT00848549|58689613|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
30675642|NCT00848549|58689614|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
30675643|NCT00848549|58689613|FG000|E2090-E044-314 (Extension Study)|Other|5|||
30675644|NCT00848549|58689614|FG001|E2090-E044-314 (Extension Study)|Other|6|||
30781779|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30591210|NCT00196976|58603605|FG010|Booster Study|Lost to Follow-up|1|||
30591211|NCT00196976|58603606|FG011|Booster Study|Lost to Follow-up|2|||
30591212|NCT00196976|58603607|FG012|Booster Study|Lost to Follow-up|0|||
30591213|NCT00196976|58603608|FG013|Booster Study|Lost to Follow-up|0|||
30591214|NCT00196313|58603650|FG000|Overall Study|Protocol Violation|2|||
30591215|NCT00196313|58603651|FG001|Overall Study|Protocol Violation|3|||
30675645|NCT00788151|58689624|FG000|Overall Study|Other adverse event|0|||
30675646|NCT00788151|58689625|FG001|Overall Study|Other adverse event|2|||
30675647|NCT00788151|58689624|FG000|Overall Study|Protocol Violation|0|||
30675648|NCT00788151|58689625|FG001|Overall Study|Protocol Violation|1|||
30591216|NCT00196313|58603650|FG000|Overall Study|Withdrawal by Subject|3|||
30591217|NCT00196313|58603651|FG001|Overall Study|Withdrawal by Subject|1|||
30591218|NCT00196313|58603650|FG000|Overall Study|Adverse Event|3|||
30591219|NCT00196313|58603651|FG001|Overall Study|Adverse Event|1|||
30591220|NCT00196313|58603650|FG000|Overall Study|Subject Pregnant|1|||
30591221|NCT00196313|58603651|FG001|Overall Study|Subject Pregnant|1|||
30591222|NCT00196313|58603650|FG000|Overall Study|Lost to Follow-up|2|||
30591223|NCT00196313|58603651|FG001|Overall Study|Lost to Follow-up|2|||
30591224|NCT00196196|58603658|FG000|Overall Study|Withdrawal by Subject|2|||
30591225|NCT00196196|58603658|FG000|Overall Study|Did not have required condition (hydroce|5|||
30591226|NCT00195650|58603662|FG000|Overall Study|Adverse Event|194|||
30591227|NCT00195650|58603662|FG000|Overall Study|Lack of Efficacy|99|||
30591228|NCT00195650|58603662|FG000|Overall Study|Withdrawal by Subject|67|||
30591229|NCT00195650|58603662|FG000|Overall Study|Lost to Follow-up|44|||
30591230|NCT00195650|58603662|FG000|Overall Study|Death|23|||
30591231|NCT00195650|58603662|FG000|Overall Study|Protocol Violation|15|||
30591232|NCT00195650|58603662|FG000|Overall Study|Administrative reasons|83|||
30591233|NCT00195494|58603668|FG000|Year 1|Adverse Event|0|||
30675649|NCT00788151|58689624|FG000|Overall Study|Withdrawal by Subject|13|||
30675650|NCT00788151|58689625|FG001|Overall Study|Withdrawal by Subject|6|||
30675651|NCT00788151|58689624|FG000|Overall Study|Enrolled but not treated|1|||
30675652|NCT00788151|58689625|FG001|Overall Study|Enrolled but not treated|1|||
30675653|NCT00788073|58689633|FG000|STX209 Then Placebo|Adverse Event|1|||
30675654|NCT00788073|58689634|FG001|STX209 Then Placebo|Adverse Event|0|||
30675655|NCT00788073|58689633|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
30675656|NCT00788073|58689634|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
30675657|NCT00788073|58689633|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
30675658|NCT00788073|58689634|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
30675659|NCT00788073|58689633|FG000|STX209 Then Placebo|unable to return due to travel|0|||
30675660|NCT00788073|58689634|FG001|STX209 Then Placebo|unable to return due to travel|1|||
30591234|NCT00195494|58603669|FG001|Year 1|Adverse Event|0|||
30591235|NCT00195494|58603670|FG002|Year 1|Adverse Event|0|||
30591236|NCT00195494|58603671|FG003|Year 1|Adverse Event|0|||
30591237|NCT00195494|58603672|FG004|Year 1|Adverse Event|34|||
30591238|NCT00195494|58603673|FG005|Year 1|Adverse Event|27|||
30591239|NCT00195494|58603668|FG000|Year 1|System Toxicity|0|||
30591240|NCT00195494|58603669|FG001|Year 1|System Toxicity|0|||
30591241|NCT00195494|58603670|FG002|Year 1|System Toxicity|0|||
30591242|NCT00195494|58603671|FG003|Year 1|System Toxicity|0|||
30591243|NCT00195494|58603672|FG004|Year 1|System Toxicity|0|||
30591244|NCT00195494|58603673|FG005|Year 1|System Toxicity|1|||
30591245|NCT00195494|58603668|FG000|Year 1|Lack of Efficacy|0|||
30591246|NCT00195494|58603669|FG001|Year 1|Lack of Efficacy|0|||
30591247|NCT00195494|58603670|FG002|Year 1|Lack of Efficacy|0|||
30591248|NCT00195494|58603671|FG003|Year 1|Lack of Efficacy|0|||
30591249|NCT00195494|58603672|FG004|Year 1|Lack of Efficacy|24|||
30591250|NCT00195494|58603673|FG005|Year 1|Lack of Efficacy|9|||
30675661|NCT00788073|58689633|FG000|Placebo Then STX209|Adverse Event|2|||
30675662|NCT00788073|58689634|FG001|Placebo Then STX209|Adverse Event|0|||
30675663|NCT00788073|58689633|FG000|Placebo Then STX209|Protocol Violation|0|||
30675664|NCT00788073|58689634|FG001|Placebo Then STX209|Protocol Violation|1|||
30675665|NCT00848393|58689643|FG000|Overall Study|Protocol Violation|0|||
30675666|NCT00848393|58689644|FG001|Overall Study|Protocol Violation|0|||
30675667|NCT00848393|58689645|FG002|Overall Study|Protocol Violation|1|||
30675668|NCT00848393|58689643|FG000|Overall Study|surgical complications unrelated to stud|0|||
30675669|NCT00848393|58689644|FG001|Overall Study|surgical complications unrelated to stud|0|||
30675670|NCT00848393|58689645|FG002|Overall Study|surgical complications unrelated to stud|2|||
30675671|NCT00815516|58689659|FG000|Overall Study|Death|3|||
30675672|NCT00815516|58689660|FG001|Overall Study|Death|1|||
30675673|NCT00815516|58689659|FG000|Overall Study|Physician Decision|1|||
30675674|NCT00815516|58689660|FG001|Overall Study|Physician Decision|0|||
30675675|NCT00787917|58689668|FG000|Blinded Treatment|Adverse Event|1|||
30675676|NCT00787917|58689669|FG001|Blinded Treatment|Adverse Event|0|||
30591251|NCT00195494|58603668|FG000|Year 1|Compliance|0|||
30591252|NCT00195494|58603669|FG001|Year 1|Compliance|0|||
30591253|NCT00195494|58603670|FG002|Year 1|Compliance|0|||
30591254|NCT00195494|58603671|FG003|Year 1|Compliance|0|||
30591255|NCT00195494|58603672|FG004|Year 1|Compliance|5|||
30591256|NCT00195494|58603673|FG005|Year 1|Compliance|1|||
30591257|NCT00195494|58603668|FG000|Year 1|Lost to Follow-up|0|||
30675677|NCT00787917|58689668|FG000|Blinded Treatment|Lack of Efficacy|1|||
30591258|NCT00195494|58603669|FG001|Year 1|Lost to Follow-up|0|||
30591259|NCT00195494|58603670|FG002|Year 1|Lost to Follow-up|0|||
30591260|NCT00195494|58603671|FG003|Year 1|Lost to Follow-up|0|||
30591261|NCT00195494|58603672|FG004|Year 1|Lost to Follow-up|1|||
30591262|NCT00195494|58603673|FG005|Year 1|Lost to Follow-up|0|||
30591263|NCT00195494|58603668|FG000|Year 1|Missed >4 consecutive doses|0|||
30675678|NCT00787917|58689669|FG001|Blinded Treatment|Lack of Efficacy|0|||
30675679|NCT00787917|58689668|FG000|Blinded Treatment|Administrative problems|3|||
30675680|NCT00787917|58689669|FG001|Blinded Treatment|Administrative problems|2|||
30675681|NCT00787917|58689668|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
30675682|NCT00787917|58689669|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
30675683|NCT00787917|58689668|FG000|Open Label|Administrative problems|3|||
30675684|NCT00787917|58689669|FG001|Open Label|Administrative problems|0|||
30675685|NCT00814892|58689677|FG000|Overall Study|Disease Progression|1|||
30675686|NCT00814892|58689677|FG000|Overall Study|Study Termination|1|||
30675687|NCT00787839|58689681|FG000|Overall Study|Failure to have the OGTT was most common|404|||
30675688|NCT00829244|58689704|FG000|Overall Study|Adverse Event|1|||
30675689|NCT00829244|58689705|FG001|Overall Study|Adverse Event|3|||
30675690|NCT00829244|58689704|FG000|Overall Study|Protocol Violation|1|||
30675691|NCT00829244|58689705|FG001|Overall Study|Protocol Violation|0|||
30675692|NCT00829244|58689704|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
30675693|NCT00829244|58689705|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
30675694|NCT00829244|58689704|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
30675695|NCT00829244|58689705|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
30675696|NCT00829244|58689704|FG000|Overall Study|No fertilization|2|||
30675697|NCT00829244|58689705|FG001|Overall Study|No fertilization|2|||
30675698|NCT00829244|58689704|FG000|Overall Study|All embryos discarded|0|||
30675699|NCT00829244|58689705|FG001|Overall Study|All embryos discarded|3|||
30675700|NCT00829244|58689704|FG000|Overall Study|No embryo cleavage|0|||
30675701|NCT00829244|58689705|FG001|Overall Study|No embryo cleavage|2|||
30675702|NCT00787605|58689713|FG000|Overall Study|Administrative Problems|3|||
30675703|NCT00787605|58689714|FG001|Overall Study|Administrative Problems|0|||
30675704|NCT00787605|58689713|FG000|Overall Study|Adverse Event|14|||
30675705|NCT00787605|58689714|FG001|Overall Study|Adverse Event|25|||
30675706|NCT00787605|58689713|FG000|Overall Study|Lost to Follow-up|3|||
30675707|NCT00787605|58689714|FG001|Overall Study|Lost to Follow-up|6|||
30675708|NCT00787605|58689713|FG000|Overall Study|Protocol Violation|7|||
30675709|NCT00787605|58689714|FG001|Overall Study|Protocol Violation|3|||
30675710|NCT00787605|58689713|FG000|Overall Study|Withdrawal by Subject|6|||
30675711|NCT00787605|58689714|FG001|Overall Study|Withdrawal by Subject|13|||
30591264|NCT00195494|58603669|FG001|Year 1|Missed >4 consecutive doses|0|||
30591265|NCT00195494|58603670|FG002|Year 1|Missed >4 consecutive doses|0|||
30591266|NCT00195494|58603671|FG003|Year 1|Missed >4 consecutive doses|0|||
30675712|NCT00787605|58689713|FG000|Overall Study|Lack of Efficacy|13|||
30675713|NCT00787605|58689714|FG001|Overall Study|Lack of Efficacy|9|||
30675714|NCT00448591|58689720|FG000|Overall Study|Withdrawal by Subject|178|||
30675715|NCT00448591|58689720|FG000|Overall Study|Progressive Disease|1382|||
30675716|NCT00448591|58689720|FG000|Overall Study|Adverse Event|382|||
30675717|NCT00448591|58689720|FG000|Overall Study|Protocol Violation|41|||
30675718|NCT00448591|58689720|FG000|Overall Study|Lost to Follow-up|19|||
30781780|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781781|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
30781782|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781783|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
30781784|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
30781785|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
30856056|NCT00108745|58883798|FG002|Overall Study|Ineligible|13|||
30591267|NCT00195494|58603672|FG004|Year 1|Missed >4 consecutive doses|3|||
30591268|NCT00195494|58603673|FG005|Year 1|Missed >4 consecutive doses|2|||
30591269|NCT00195494|58603668|FG000|Year 1|Protocol deviation|0|||
30591270|NCT00195494|58603669|FG001|Year 1|Protocol deviation|0|||
30591271|NCT00195494|58603670|FG002|Year 1|Protocol deviation|0|||
30591272|NCT00195494|58603671|FG003|Year 1|Protocol deviation|0|||
30591273|NCT00195494|58603672|FG004|Year 1|Protocol deviation|2|||
30591274|NCT00195494|58603673|FG005|Year 1|Protocol deviation|3|||
30591275|NCT00195494|58603668|FG000|Year 1|Physician Decision|0|||
30591276|NCT00195494|58603669|FG001|Year 1|Physician Decision|0|||
30591277|NCT00195494|58603670|FG002|Year 1|Physician Decision|0|||
30591278|NCT00195494|58603671|FG003|Year 1|Physician Decision|0|||
30675719|NCT00448591|58689720|FG000|Overall Study|Treatment Regimen Completed|70|||
30675720|NCT00448591|58689720|FG000|Overall Study|Other|154|||
30675721|NCT00448591|58689720|FG000|Overall Study|Termination of Study|70|||
30675722|NCT00651664|58689736|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
30675723|NCT00651664|58689737|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
30675724|NCT00651664|58689738|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
30675725|NCT00651664|58689739|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
30675726|NCT00651664|58689740|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
30591279|NCT00195494|58603672|FG004|Year 1|Physician Decision|1|||
30591280|NCT00195494|58603673|FG005|Year 1|Physician Decision|0|||
30591281|NCT00195494|58603668|FG000|Year 1|Withdrawal by Subject|0|||
30591282|NCT00195494|58603669|FG001|Year 1|Withdrawal by Subject|0|||
30675727|NCT00651664|58689741|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
30675728|NCT00651664|58689742|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
30675729|NCT00651664|58689743|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
30675730|NCT00651664|58689744|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
30675731|NCT00651664|58689745|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
30675732|NCT00651664|58689736|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
30675733|NCT00651664|58689737|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
30675734|NCT00651664|58689738|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
30675735|NCT00651664|58689739|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
30675736|NCT00651664|58689740|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
30675737|NCT00651664|58689741|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
30675738|NCT00651664|58689742|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
30675739|NCT00651664|58689743|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
30675740|NCT00651664|58689744|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
30675741|NCT00651664|58689745|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
30675742|NCT00651664|58689736|FG000|Overall Study|Progressive Disease|3|||
30675743|NCT00651664|58689737|FG001|Overall Study|Progressive Disease|3|||
30675744|NCT00651664|58689738|FG002|Overall Study|Progressive Disease|3|||
30675745|NCT00651664|58689739|FG003|Overall Study|Progressive Disease|12|||
30675746|NCT00651664|58689740|FG004|Overall Study|Progressive Disease|4|||
30675747|NCT00651664|58689741|FG005|Overall Study|Progressive Disease|1|||
30675748|NCT00651664|58689742|FG006|Overall Study|Progressive Disease|3|||
30675749|NCT00651664|58689743|FG007|Overall Study|Progressive Disease|6|||
30675750|NCT00651664|58689744|FG008|Overall Study|Progressive Disease|5|||
30675751|NCT00651664|58689745|FG009|Overall Study|Progressive Disease|5|||
30675752|NCT00651664|58689736|FG000|Overall Study|Patient Declined Further Treatment|0|||
30675753|NCT00651664|58689737|FG001|Overall Study|Patient Declined Further Treatment|0|||
30675754|NCT00651664|58689738|FG002|Overall Study|Patient Declined Further Treatment|0|||
30675755|NCT00651664|58689739|FG003|Overall Study|Patient Declined Further Treatment|1|||
30675756|NCT00651664|58689740|FG004|Overall Study|Patient Declined Further Treatment|1|||
30675757|NCT00651664|58689741|FG005|Overall Study|Patient Declined Further Treatment|1|||
30675758|NCT00651664|58689742|FG006|Overall Study|Patient Declined Further Treatment|0|||
30675759|NCT00651664|58689743|FG007|Overall Study|Patient Declined Further Treatment|0|||
30675760|NCT00651664|58689744|FG008|Overall Study|Patient Declined Further Treatment|0|||
30675761|NCT00651664|58689745|FG009|Overall Study|Patient Declined Further Treatment|1|||
30675762|NCT00651664|58689736|FG000|Overall Study|Symptomatic Deterioration|0|||
30781786|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781787|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781788|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781789|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781790|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781791|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
30781792|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781793|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781794|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781795|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
30781796|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781797|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781798|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781799|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781800|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
30781801|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781802|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781803|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781804|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781805|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
30781806|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781807|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30675763|NCT00651664|58689737|FG001|Overall Study|Symptomatic Deterioration|0|||
30675764|NCT00651664|58689738|FG002|Overall Study|Symptomatic Deterioration|0|||
30675765|NCT00651664|58689739|FG003|Overall Study|Symptomatic Deterioration|1|||
30675766|NCT00651664|58689740|FG004|Overall Study|Symptomatic Deterioration|0|||
30675767|NCT00651664|58689741|FG005|Overall Study|Symptomatic Deterioration|0|||
30675768|NCT00651664|58689742|FG006|Overall Study|Symptomatic Deterioration|1|||
30675769|NCT00651664|58689743|FG007|Overall Study|Symptomatic Deterioration|0|||
30675770|NCT00651664|58689744|FG008|Overall Study|Symptomatic Deterioration|1|||
30675771|NCT00651664|58689745|FG009|Overall Study|Symptomatic Deterioration|0|||
30675772|NCT00651664|58689736|FG000|Overall Study|Reason not Specified|0|||
30675773|NCT00651664|58689737|FG001|Overall Study|Reason not Specified|0|||
30675774|NCT00651664|58689738|FG002|Overall Study|Reason not Specified|0|||
30675775|NCT00651664|58689739|FG003|Overall Study|Reason not Specified|0|||
30675776|NCT00651664|58689740|FG004|Overall Study|Reason not Specified|0|||
30675777|NCT00651664|58689741|FG005|Overall Study|Reason not Specified|0|||
30675778|NCT00651664|58689742|FG006|Overall Study|Reason not Specified|1|||
30675779|NCT00651664|58689743|FG007|Overall Study|Reason not Specified|0|||
30675780|NCT00651664|58689744|FG008|Overall Study|Reason not Specified|0|||
30675781|NCT00651664|58689745|FG009|Overall Study|Reason not Specified|0|||
30675782|NCT00787527|58689771|FG000|Overall Study|Toxicity|3|||
30675783|NCT00787137|58689782|FG000|Overall Study|Study Termination|0|||
30675784|NCT00787137|58689783|FG001|Overall Study|Study Termination|0|||
30675785|NCT00787137|58689784|FG002|Overall Study|Study Termination|1|||
30675786|NCT00448435|58689792|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
30675787|NCT00448435|58689793|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
30675788|NCT00448279|58689804|FG000|Overall Study|Lost to Follow-up|2|||
30675789|NCT00448279|58689805|FG001|Overall Study|Lost to Follow-up|2|||
30675790|NCT00448279|58689804|FG000|Overall Study|Adverse Event|1|||
30675791|NCT00448279|58689805|FG001|Overall Study|Adverse Event|1|||
30675792|NCT00448279|58689804|FG000|Overall Study|Disease progression|16|||
30675793|NCT00448279|58689805|FG001|Overall Study|Disease progression|18|||
30675794|NCT00448279|58689804|FG000|Overall Study|Withdrawal by Subject|4|||
30675795|NCT00448279|58689805|FG001|Overall Study|Withdrawal by Subject|3|||
30675796|NCT00448279|58689804|FG000|Overall Study|Other|6|||
30675797|NCT00448279|58689805|FG001|Overall Study|Other|4|||
30675798|NCT00448279|58689804|FG000|Overall Study|Protocol Violation|0|||
30675799|NCT00448279|58689805|FG001|Overall Study|Protocol Violation|1|||
30675800|NCT00448123|58689813|FG000|Overall Study|Lost to Follow-up|9|||
30675801|NCT00448123|58689814|FG001|Overall Study|Lost to Follow-up|6|||
30675802|NCT00448123|58689813|FG000|Overall Study|Physician Decision|6|||
30675803|NCT00448123|58689814|FG001|Overall Study|Physician Decision|6|||
30675804|NCT00447499|58689823|FG000|Overall Study|Adverse Event|1|||
30675805|NCT00447499|58689823|FG000|Overall Study|Patient Decision|4|||
30675806|NCT00447499|58689823|FG000|Overall Study|Sponsor Decision|1|||
30675807|NCT00447499|58689823|FG000|Overall Study|Physician Decision|1|||
30675808|NCT00800436|58689836|FG000|Overall Study|Withdrawal by Subject|0|||
30675809|NCT00800436|58689837|FG001|Overall Study|Withdrawal by Subject|0|||
30675810|NCT00800436|58689838|FG002|Overall Study|Withdrawal by Subject|1|||
30591283|NCT00195494|58603670|FG002|Year 1|Withdrawal by Subject|0|||
30591284|NCT00195494|58603671|FG003|Year 1|Withdrawal by Subject|0|||
30591285|NCT00195494|58603672|FG004|Year 1|Withdrawal by Subject|8|||
30591286|NCT00195494|58603673|FG005|Year 1|Withdrawal by Subject|9|||
30591287|NCT00195494|58603668|FG000|Year 1|Protocol Violation|0|||
30591288|NCT00195494|58603669|FG001|Year 1|Protocol Violation|0|||
30591289|NCT00195494|58603670|FG002|Year 1|Protocol Violation|0|||
30591290|NCT00195494|58603671|FG003|Year 1|Protocol Violation|0|||
30591291|NCT00195494|58603672|FG004|Year 1|Protocol Violation|1|||
30591292|NCT00195494|58603673|FG005|Year 1|Protocol Violation|1|||
30591293|NCT00195494|58603668|FG000|Year 2|Adverse Event|3|||
30591294|NCT00195494|58603669|FG001|Year 2|Adverse Event|7|||
30591295|NCT00195494|58603670|FG002|Year 2|Adverse Event|5|||
30591296|NCT00195494|58603671|FG003|Year 2|Adverse Event|9|||
30591297|NCT00195494|58603672|FG004|Year 2|Adverse Event|0|||
30591298|NCT00195494|58603673|FG005|Year 2|Adverse Event|0|||
30591299|NCT00195494|58603668|FG000|Year 2|Lack of Efficacy|0|||
30591300|NCT00195494|58603669|FG001|Year 2|Lack of Efficacy|1|||
30591301|NCT00195494|58603670|FG002|Year 2|Lack of Efficacy|7|||
30675811|NCT00800436|58689839|FG003|Overall Study|Withdrawal by Subject|1|||
30675812|NCT00800436|58689840|FG004|Overall Study|Withdrawal by Subject|0|||
30675813|NCT00800436|58689841|FG005|Overall Study|Withdrawal by Subject|0|||
30675814|NCT00800436|58689842|FG006|Overall Study|Withdrawal by Subject|0|||
30675815|NCT00655564|58689858|FG000|Overall Study|Adverse Event|1|||
30675816|NCT00655564|58689858|FG000|Overall Study|Lost to Follow-up|1|||
30675817|NCT00655564|58689858|FG000|Overall Study|Desired Alternate Therapy|1|||
30958999|NCT01587703|59024035|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30591302|NCT00195494|58603671|FG003|Year 2|Lack of Efficacy|7|||
30591303|NCT00195494|58603672|FG004|Year 2|Lack of Efficacy|0|||
30675818|NCT00447421|58689863|FG000|Overall Study|Lack of Efficacy|1|||
30675819|NCT00447421|58689863|FG000|Overall Study|Adverse Event|3|||
30675820|NCT00447421|58689863|FG000|Overall Study|Sponsor Decision|2|||
30675821|NCT00651118|58689871|FG000|Overall Study|Adverse Event|4|||
30591304|NCT00195494|58603673|FG005|Year 2|Lack of Efficacy|0|||
30591305|NCT00195494|58603668|FG000|Year 2|Compliance|1|||
30591306|NCT00195494|58603669|FG001|Year 2|Compliance|0|||
30591307|NCT00195494|58603670|FG002|Year 2|Compliance|0|||
30591308|NCT00195494|58603671|FG003|Year 2|Compliance|2|||
30675822|NCT00651118|58689872|FG001|Overall Study|Adverse Event|0|||
30675823|NCT00651118|58689873|FG002|Overall Study|Adverse Event|1|||
30591309|NCT00195494|58603672|FG004|Year 2|Compliance|0|||
30591310|NCT00195494|58603673|FG005|Year 2|Compliance|0|||
30591311|NCT00195494|58603668|FG000|Year 2|Lost to Follow-up|0|||
30591312|NCT00195494|58603669|FG001|Year 2|Lost to Follow-up|0|||
30591313|NCT00195494|58603670|FG002|Year 2|Lost to Follow-up|1|||
30591314|NCT00195494|58603671|FG003|Year 2|Lost to Follow-up|1|||
30591315|NCT00195494|58603672|FG004|Year 2|Lost to Follow-up|0|||
30591316|NCT00195494|58603673|FG005|Year 2|Lost to Follow-up|0|||
30591317|NCT00195494|58603668|FG000|Year 2|Missed >4 consecutive doses|1|||
30591318|NCT00195494|58603669|FG001|Year 2|Missed >4 consecutive doses|1|||
30591319|NCT00195494|58603670|FG002|Year 2|Missed >4 consecutive doses|1|||
30591320|NCT00195494|58603671|FG003|Year 2|Missed >4 consecutive doses|0|||
30591321|NCT00195494|58603672|FG004|Year 2|Missed >4 consecutive doses|0|||
30591322|NCT00195494|58603673|FG005|Year 2|Missed >4 consecutive doses|0|||
30781808|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781809|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781810|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781811|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
30781812|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
30781813|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
30781814|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
30781815|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
30781816|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
30675824|NCT00651118|58689874|FG003|Overall Study|Adverse Event|1|||
30675825|NCT00651118|58689871|FG000|Overall Study|Protocol Violation|2|||
30675826|NCT00651118|58689872|FG001|Overall Study|Protocol Violation|2|||
30675827|NCT00651118|58689873|FG002|Overall Study|Protocol Violation|6|||
30675828|NCT00651118|58689874|FG003|Overall Study|Protocol Violation|2|||
30675829|NCT00651118|58689871|FG000|Overall Study|Lost to Follow-up|2|||
30675830|NCT00651118|58689872|FG001|Overall Study|Lost to Follow-up|0|||
30675831|NCT00651118|58689873|FG002|Overall Study|Lost to Follow-up|1|||
30675832|NCT00651118|58689874|FG003|Overall Study|Lost to Follow-up|2|||
30675833|NCT00651118|58689871|FG000|Overall Study|administrative|1|||
30675834|NCT00651118|58689872|FG001|Overall Study|administrative|4|||
30781817|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
30781818|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
30781819|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
30781820|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
30781821|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
30781822|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
30781823|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
30781824|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
30781825|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
30781826|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
30781827|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
30781828|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
30781829|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
30781830|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
30781831|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
30781832|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
30781833|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
30781834|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
30781835|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
30781836|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
30781837|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
30781838|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
30781839|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
30781840|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
30781841|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Other|5|||
30591323|NCT00195494|58603668|FG000|Year 2|Protocol deviation|0|||
30675835|NCT00651118|58689873|FG002|Overall Study|administrative|2|||
30675836|NCT00651118|58689874|FG003|Overall Study|administrative|1|||
30675837|NCT00651118|58689871|FG000|Overall Study|Withdrawal by Subject|0|||
30675838|NCT00651118|58689872|FG001|Overall Study|Withdrawal by Subject|1|||
30591324|NCT00195494|58603669|FG001|Year 2|Protocol deviation|1|||
30591325|NCT00195494|58603670|FG002|Year 2|Protocol deviation|0|||
30591326|NCT00195494|58603671|FG003|Year 2|Protocol deviation|0|||
30675839|NCT00651118|58689873|FG002|Overall Study|Withdrawal by Subject|1|||
30675840|NCT00651118|58689874|FG003|Overall Study|Withdrawal by Subject|1|||
30591327|NCT00195494|58603672|FG004|Year 2|Protocol deviation|0|||
30675841|NCT00447265|58689887|FG000|Overall Study|Physician Decision|1|||
30591328|NCT00195494|58603673|FG005|Year 2|Protocol deviation|0|||
30591329|NCT00195494|58603668|FG000|Year 2|Physician Decision|1|||
30591330|NCT00195494|58603669|FG001|Year 2|Physician Decision|1|||
30591331|NCT00195494|58603670|FG002|Year 2|Physician Decision|0|||
30591332|NCT00195494|58603671|FG003|Year 2|Physician Decision|0|||
30591333|NCT00195494|58603672|FG004|Year 2|Physician Decision|0|||
30591334|NCT00195494|58603673|FG005|Year 2|Physician Decision|0|||
30591335|NCT00195494|58603668|FG000|Year 2|Withdrawal by Subject|1|||
30591336|NCT00195494|58603669|FG001|Year 2|Withdrawal by Subject|5|||
30591337|NCT00195494|58603670|FG002|Year 2|Withdrawal by Subject|4|||
30591338|NCT00195494|58603671|FG003|Year 2|Withdrawal by Subject|3|||
30591339|NCT00195494|58603672|FG004|Year 2|Withdrawal by Subject|0|||
30591340|NCT00195494|58603673|FG005|Year 2|Withdrawal by Subject|0|||
30591341|NCT00195494|58603668|FG000|Year 2|System toxicity|0|||
30591342|NCT00195494|58603669|FG001|Year 2|System toxicity|0|||
30591343|NCT00195494|58603670|FG002|Year 2|System toxicity|0|||
30591344|NCT00195494|58603671|FG003|Year 2|System toxicity|1|||
30591345|NCT00195494|58603672|FG004|Year 2|System toxicity|0|||
30591346|NCT00195494|58603673|FG005|Year 2|System toxicity|0|||
30591347|NCT00194987|58603691|FG000|Overall Study|Withdrawal by Subject|0|||
30591348|NCT00194987|58603692|FG001|Overall Study|Withdrawal by Subject|3|||
30591349|NCT00194792|58603700|FG000|Overall Study|Withdrawal by Subject|1|||
30591350|NCT00194675|58603715|FG000|Overall Study|Lost to Follow-up|1|||
30591351|NCT00194675|58603716|FG001|Overall Study|Lost to Follow-up|1|||
30591352|NCT00194675|58603715|FG000|Overall Study|lack of interest|1|||
30591353|NCT00194675|58603716|FG001|Overall Study|lack of interest|1|||
30591354|NCT00194675|58603715|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
30591355|NCT00194675|58603716|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
30591356|NCT00194675|58603715|FG000|Overall Study|Protocol Violation|1|||
30591357|NCT00194675|58603716|FG001|Overall Study|Protocol Violation|0|||
30591358|NCT00194675|58603715|FG000|Overall Study|Death|1|||
30591359|NCT00194675|58603716|FG001|Overall Study|Death|0|||
30591360|NCT00194012|58603726|FG000|Randomized Phase|Lack of Efficacy|8|||
30591361|NCT00194012|58603727|FG001|Randomized Phase|Lack of Efficacy|18|||
30591362|NCT00194012|58603726|FG000|Randomized Phase|Study nonadherence|2|||
30675842|NCT00447265|58689888|FG001|Overall Study|Physician Decision|0|||
30675843|NCT00657358|58689892|FG000|Overall Study|Lack of Efficacy|6|||
30675844|NCT00457639|58689897|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
30675845|NCT00457639|58689898|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
30675846|NCT00457639|58689897|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
30675847|NCT00457639|58689898|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
30675848|NCT00457639|58689897|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
30675849|NCT00457639|58689898|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
30675850|NCT00800202|58689906|FG000|Overall Study|Adverse Event|7|||
30675851|NCT00800202|58689907|FG001|Overall Study|Adverse Event|6|||
30675852|NCT00800202|58689906|FG000|Overall Study|Death|1|||
30675853|NCT00800202|58689907|FG001|Overall Study|Death|0|||
30675854|NCT00800202|58689906|FG000|Overall Study|Other|5|||
30675855|NCT00800202|58689907|FG001|Overall Study|Other|0|||
30675856|NCT00800202|58689906|FG000|Overall Study|Disease Progression|54|||
30675857|NCT00800202|58689907|FG001|Overall Study|Disease Progression|18|||
30781842|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Other|1|||
30781843|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Other|0|||
30781844|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Other|3|||
30781845|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Other|0|||
30781846|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Other|0|||
30781847|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Other|0|||
30781848|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Other|0|||
30781849|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Other|0|||
30781850|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Other|0|||
30781851|NCT03352557|58793766|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
30781852|NCT03352557|58793767|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
30856057|NCT02716805|58883828|FG000|Overall Study|Progressive disease|2|||
30856058|NCT02716805|58883829|FG001|Overall Study|Progressive disease|0|||
30591363|NCT00194012|58603727|FG001|Randomized Phase|Study nonadherence|1|||
30591364|NCT00194012|58603726|FG000|Randomized Phase|Withdrawal by Subject|3|||
30591365|NCT00194012|58603727|FG001|Randomized Phase|Withdrawal by Subject|3|||
30591366|NCT00194012|58603726|FG000|Randomized Phase|Adverse Event|2|||
30781853|NCT03352557|58793768|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
30591367|NCT00194012|58603727|FG001|Randomized Phase|Adverse Event|1|||
30591368|NCT00194012|58603726|FG000|Randomized Phase|Participant reported having a rash|1|||
30591369|NCT00194012|58603727|FG001|Randomized Phase|Participant reported having a rash|0|||
30591370|NCT00194012|58603726|FG000|Randomized Phase|Emesis and enuresis|0|||
30675858|NCT00655486|58689913|FG000|Overall Study|Adverse Event|10|||
30675859|NCT00655486|58689913|FG000|Overall Study|Lack of Efficacy|8|||
30675860|NCT00655486|58689913|FG000|Overall Study|Withdrawal by Subject|4|||
30591371|NCT00194012|58603727|FG001|Randomized Phase|Emesis and enuresis|1|||
30781854|NCT03352557|58793769|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
30856059|NCT02716805|58883830|FG002|Overall Study|Progressive disease|0|||
30781855|NCT03352557|58793770|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
30781856|NCT03352557|58793771|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
30781857|NCT03352557|58793772|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
30781858|NCT03352557|58793773|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
30781859|NCT03352557|58793774|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
30781860|NCT03352557|58793775|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
30781861|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|Death|0|||
30781862|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|Death|0|||
30781863|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|Death|0|||
30781864|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|Death|0|||
30781865|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|Death|0|||
30781866|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|Death|1|||
30781867|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|Death|0|||
30781868|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|Death|1|||
30781869|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|Death|1|||
30781870|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|Death|1|||
30781871|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
30781872|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
30781873|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
30781874|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
30781875|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
30781876|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
30781877|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
30591372|NCT00194012|58603726|FG000|Randomized Phase|Oral/nasal twitching|0|||
30591373|NCT00194012|58603727|FG001|Randomized Phase|Oral/nasal twitching|1|||
30591374|NCT00194012|58603726|FG000|Open Label Extension (OLE)|Weight Gain|1|||
30591375|NCT00194012|58603727|FG001|Open Label Extension (OLE)|Weight Gain|0|||
30591376|NCT00194012|58603726|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
30591377|NCT00194012|58603727|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
30591378|NCT00194012|58603726|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
30591379|NCT00194012|58603727|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
30591380|NCT00194012|58603726|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
30591381|NCT00194012|58603727|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
30591382|NCT00192647|58603741|FG000|Overall Study|Death|1|||
30591383|NCT00192647|58603742|FG001|Overall Study|Death|1|||
30591384|NCT00192647|58603741|FG000|Overall Study|Adverse Event|35|||
30591385|NCT00192647|58603742|FG001|Overall Study|Adverse Event|29|||
30591386|NCT00192647|58603741|FG000|Overall Study|Laboratory Test Abnormality|4|||
30591387|NCT00192647|58603742|FG001|Overall Study|Laboratory Test Abnormality|2|||
30591388|NCT00192647|58603741|FG000|Overall Study|Insufficient Therapeutic Response|53|||
30591389|NCT00192647|58603742|FG001|Overall Study|Insufficient Therapeutic Response|83|||
30591390|NCT00192647|58603741|FG000|Overall Study|Entry Criteria Violation|6|||
30591391|NCT00192647|58603742|FG001|Overall Study|Entry Criteria Violation|6|||
30591392|NCT00192647|58603741|FG000|Overall Study|Protocol Violation|3|||
30591393|NCT00192647|58603742|FG001|Overall Study|Protocol Violation|1|||
30591394|NCT00192647|58603741|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
30591395|NCT00192647|58603742|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
30591396|NCT00192647|58603741|FG000|Overall Study|Failure to Return|11|||
30591397|NCT00192647|58603742|FG001|Overall Study|Failure to Return|13|||
30591398|NCT00192647|58603741|FG000|Overall Study|Other/Administrative|5|||
30591399|NCT00192647|58603742|FG001|Overall Study|Other/Administrative|3|||
30591400|NCT00192296|58603752|FG000|Overall Study|Withdrawal by Subject|0|||
30591401|NCT00192296|58603753|FG001|Overall Study|Withdrawal by Subject|1|||
30591402|NCT00192296|58603754|FG002|Overall Study|Withdrawal by Subject|0|||
30591403|NCT00192296|58603755|FG003|Overall Study|Withdrawal by Subject|0|||
30591404|NCT00192023|58603767|FG000|Period III - Double-Blind|Adverse Event|3|||
30591405|NCT00192023|58603768|FG001|Period III - Double-Blind|Adverse Event|0|||
30591406|NCT00192023|58603767|FG000|Period III - Double-Blind|Physician Decision|2|||
30591407|NCT00192023|58603768|FG001|Period III - Double-Blind|Physician Decision|0|||
30591408|NCT00192023|58603767|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
30591409|NCT00192023|58603768|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
30591410|NCT00192023|58603767|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
30591411|NCT00192023|58603768|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
30591412|NCT00192023|58603767|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
30591413|NCT00192023|58603768|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
30591414|NCT00192023|58603767|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
30591415|NCT00192023|58603768|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
30591416|NCT00192023|58603767|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
30591417|NCT00192023|58603768|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
30781878|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
30781879|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
30781880|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
30781881|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
30675861|NCT00655486|58689913|FG000|Overall Study|Protocol Violation|1|||
30675862|NCT00655486|58689913|FG000|Overall Study|Unsatisfactory compliance|2|||
30675863|NCT00655486|58689913|FG000|Overall Study|Other: Pregnancy|1|||
30675864|NCT00655486|58689913|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
30675865|NCT00655486|58689913|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
30675866|NCT00457249|58689919|FG000|Overall Study|Lost to Follow-up|3|||
30675867|NCT00457249|58689920|FG001|Overall Study|Lost to Follow-up|0|||
30675868|NCT00457249|58689919|FG000|Overall Study|Protocol Violation|4|||
30675869|NCT00457249|58689920|FG001|Overall Study|Protocol Violation|1|||
30675870|NCT00457249|58689919|FG000|Overall Study|Withdrawal by Subject|3|||
30675871|NCT00457249|58689920|FG001|Overall Study|Withdrawal by Subject|1|||
30675872|NCT00457249|58689919|FG000|Overall Study|Serious Adverse Events|2|||
30675873|NCT00457249|58689920|FG001|Overall Study|Serious Adverse Events|0|||
30675874|NCT00457015|58689930|FG000|Overall Study|Left study site against medical advice|0|||
30675875|NCT00457015|58689931|FG001|Overall Study|Left study site against medical advice|1|||
30675876|NCT00654940|58689939|FG000|Period 1|Adverse Event|0|||
30675877|NCT00654940|58689940|FG001|Period 1|Adverse Event|1|||
30675878|NCT00654940|58689939|FG000|Period 1|Intolerable Pain Level|1|||
30675879|NCT00654940|58689940|FG001|Period 1|Intolerable Pain Level|0|||
30675880|NCT00588666|58689952|FG000|Overall Study|Adverse Event|4|||
30675881|NCT00793182|58689967|FG000|Overall Study|Adverse Event|0|||
30675882|NCT00793182|58689968|FG001|Overall Study|Adverse Event|1|||
30675883|NCT00793104|58689974|FG000|Overall Study|Lost to Follow-up|1|||
30675884|NCT00446797|58689980|FG000|Overall Study|Lack of Efficacy|0|||
30675885|NCT00446797|58689981|FG001|Overall Study|Lack of Efficacy|2|||
30675886|NCT00446797|58689980|FG000|Overall Study|Lost to Follow-up|5|||
30675887|NCT00446797|58689981|FG001|Overall Study|Lost to Follow-up|3|||
30675888|NCT00446797|58689980|FG000|Overall Study|Withdrawal by Subject|2|||
30675889|NCT00446797|58689981|FG001|Overall Study|Withdrawal by Subject|2|||
30675890|NCT00446797|58689980|FG000|Overall Study|Protocol Violation|1|||
30675891|NCT00446797|58689981|FG001|Overall Study|Protocol Violation|3|||
30675892|NCT00446797|58689980|FG000|Overall Study|subject entered at another site|0|||
30675893|NCT00446797|58689981|FG001|Overall Study|subject entered at another site|1|||
30675894|NCT00446797|58689980|FG000|Overall Study|did not meet entrance criteria|0|||
30675895|NCT00446797|58689981|FG001|Overall Study|did not meet entrance criteria|1|||
30675896|NCT00855335|58689992|FG000|Overall Study|Lost to Follow-up|0|||
30675897|NCT00855335|58689993|FG001|Overall Study|Lost to Follow-up|0|||
30675898|NCT00855335|58689994|FG002|Overall Study|Lost to Follow-up|3|||
30675899|NCT00855335|58689995|FG003|Overall Study|Lost to Follow-up|1|||
30675900|NCT00855335|58689996|FG004|Overall Study|Lost to Follow-up|0|||
30675901|NCT00855335|58689992|FG000|Overall Study|Withdrawal by Subject|0|||
30675902|NCT00855335|58689993|FG001|Overall Study|Withdrawal by Subject|0|||
30675903|NCT00855335|58689994|FG002|Overall Study|Withdrawal by Subject|0|||
30675904|NCT00855335|58689995|FG003|Overall Study|Withdrawal by Subject|1|||
30675905|NCT00855335|58689996|FG004|Overall Study|Withdrawal by Subject|0|||
30675906|NCT00855335|58689992|FG000|Overall Study|Adverse Event|2|||
30675907|NCT00855335|58689993|FG001|Overall Study|Adverse Event|0|||
30675908|NCT00855335|58689994|FG002|Overall Study|Adverse Event|0|||
30675909|NCT00855335|58689995|FG003|Overall Study|Adverse Event|0|||
30675910|NCT00855335|58689996|FG004|Overall Study|Adverse Event|0|||
30675911|NCT00855335|58689992|FG000|Overall Study|Physician Decision|1|||
30591418|NCT00192023|58603767|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
30591419|NCT00192023|58603768|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
30591420|NCT00192023|58603767|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
30591421|NCT00192023|58603768|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
30591422|NCT00192023|58603767|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
30591423|NCT00192023|58603768|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
30591424|NCT00191984|58603774|FG000|Overall Study|Disease Progression|21|||
30591425|NCT00191984|58603774|FG000|Overall Study|Adverse Event|4|||
30591426|NCT00191984|58603774|FG000|Overall Study|Death|2|||
30591427|NCT00191984|58603774|FG000|Overall Study|Entry Criteria Exclusion|1|||
30591428|NCT00191984|58603774|FG000|Overall Study|Withdrawal by Subject|7|||
30591429|NCT00191984|58603774|FG000|Overall Study|Physician Decision|4|||
30591430|NCT00191906|58603782|FG000|Study Period II|Adverse Event|0|||
30591431|NCT00191906|58603783|FG001|Study Period II|Adverse Event|1|||
30591432|NCT00191906|58603784|FG002|Study Period II|Adverse Event|0|||
30591433|NCT00191906|58603785|FG003|Study Period II|Adverse Event|0|||
30591434|NCT00191906|58603782|FG000|Study Period II|Withdrawal by Subject|0|||
30675912|NCT00855335|58689993|FG001|Overall Study|Physician Decision|1|||
30675913|NCT00855335|58689994|FG002|Overall Study|Physician Decision|0|||
30591435|NCT00191906|58603783|FG001|Study Period II|Withdrawal by Subject|3|||
30675914|NCT00855335|58689995|FG003|Overall Study|Physician Decision|0|||
30675915|NCT00855335|58689996|FG004|Overall Study|Physician Decision|0|||
30675916|NCT00855335|58689992|FG000|Overall Study|Other|2|||
30675917|NCT00855335|58689993|FG001|Overall Study|Other|1|||
30675918|NCT00855335|58689994|FG002|Overall Study|Other|2|||
30675919|NCT00855335|58689995|FG003|Overall Study|Other|5|||
30675920|NCT00855335|58689996|FG004|Overall Study|Other|1|||
30675921|NCT00799422|58690021|FG000|First Week of Wear|Lost to Follow-up|0|||
30675922|NCT00799422|58690022|FG001|First Week of Wear|Lost to Follow-up|0|||
30675923|NCT00799422|58690023|FG002|First Week of Wear|Lost to Follow-up|1|||
30675924|NCT00799422|58690024|FG003|First Week of Wear|Lost to Follow-up|0|||
30675925|NCT00799422|58690025|FG004|First Week of Wear|Lost to Follow-up|0|||
30591436|NCT00191906|58603784|FG002|Study Period II|Withdrawal by Subject|0|||
30591437|NCT00191906|58603785|FG003|Study Period II|Withdrawal by Subject|0|||
30591438|NCT00191906|58603782|FG000|Study Period II|Parent/Caregiver Decision|0|||
30591439|NCT00191906|58603783|FG001|Study Period II|Parent/Caregiver Decision|1|||
30591440|NCT00191906|58603784|FG002|Study Period II|Parent/Caregiver Decision|0|||
30591441|NCT00191906|58603785|FG003|Study Period II|Parent/Caregiver Decision|0|||
30591442|NCT00191906|58603782|FG000|Study Period II|Entry Criteria Exclusion|0|||
30591443|NCT00191906|58603783|FG001|Study Period II|Entry Criteria Exclusion|0|||
30591444|NCT00191906|58603784|FG002|Study Period II|Entry Criteria Exclusion|1|||
30591445|NCT00191906|58603785|FG003|Study Period II|Entry Criteria Exclusion|0|||
30591446|NCT00191906|58603782|FG000|Study Period III|Adverse Event|1|||
30591447|NCT00191906|58603783|FG001|Study Period III|Adverse Event|0|||
30591448|NCT00191906|58603784|FG002|Study Period III|Adverse Event|0|||
30591449|NCT00191906|58603785|FG003|Study Period III|Adverse Event|0|||
30591450|NCT00191906|58603782|FG000|Study Period III|Lost to Follow-up|0|||
30591451|NCT00191906|58603783|FG001|Study Period III|Lost to Follow-up|1|||
30591452|NCT00191906|58603784|FG002|Study Period III|Lost to Follow-up|0|||
30591453|NCT00191906|58603785|FG003|Study Period III|Lost to Follow-up|0|||
30675926|NCT00799422|58690026|FG005|First Week of Wear|Lost to Follow-up|0|||
30675927|NCT00799422|58690021|FG000|First Week of Wear|Adverse Event|0|||
30675928|NCT00799422|58690022|FG001|First Week of Wear|Adverse Event|0|||
30675929|NCT00799422|58690023|FG002|First Week of Wear|Adverse Event|0|||
30675930|NCT00799422|58690024|FG003|First Week of Wear|Adverse Event|1|||
30675931|NCT00799422|58690025|FG004|First Week of Wear|Adverse Event|0|||
30675932|NCT00799422|58690026|FG005|First Week of Wear|Adverse Event|0|||
30675933|NCT00593489|58690036|FG000|Allocation|did not attend workshop; allocation not|2|||
30675934|NCT00593489|58690037|FG001|Allocation|did not attend workshop; allocation not|1|||
30675935|NCT00446641|58690047|FG000|Overall Study|Withdrawal by Subject|8|||
30675936|NCT00446641|58690048|FG001|Overall Study|Withdrawal by Subject|3|||
30675937|NCT00446641|58690047|FG000|Overall Study|poor compliance|8|||
30675938|NCT00446641|58690048|FG001|Overall Study|poor compliance|6|||
30675939|NCT00446641|58690047|FG000|Overall Study|Lost to Follow-up|1|||
30675940|NCT00446641|58690048|FG001|Overall Study|Lost to Follow-up|1|||
30675941|NCT00646282|58690056|FG000|Overall Study|Protocol terminated|4|||
30675942|NCT00646282|58690057|FG001|Overall Study|Protocol terminated|4|||
30675943|NCT00792636|58690066|FG000|Overall Study|Protocol Violation|17|||
30675944|NCT00792636|58690067|FG001|Overall Study|Protocol Violation|23|||
30675945|NCT00792636|58690068|FG002|Overall Study|Protocol Violation|20|||
30675946|NCT00792636|58690066|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
30675947|NCT00792636|58690067|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
30675948|NCT00792636|58690068|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
30675949|NCT00792636|58690066|FG000|Overall Study|Lost to Follow-up|13|||
30675950|NCT00792636|58690067|FG001|Overall Study|Lost to Follow-up|19|||
30675951|NCT00792636|58690068|FG002|Overall Study|Lost to Follow-up|14|||
30675952|NCT00792636|58690066|FG000|Overall Study|Withdrew Consent|10|||
30591454|NCT00191906|58603782|FG000|Study Period III|Parent/Caregiver Decision|1|||
30781882|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
30781883|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
30781884|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
30781885|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
30781886|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
30781887|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
30591455|NCT00191906|58603783|FG001|Study Period III|Parent/Caregiver Decision|0|||
30591456|NCT00191906|58603784|FG002|Study Period III|Parent/Caregiver Decision|0|||
30591457|NCT00191906|58603785|FG003|Study Period III|Parent/Caregiver Decision|0|||
30591458|NCT00191906|58603782|FG000|Study Period III|Lack of Efficacy|3|||
30591459|NCT00191906|58603783|FG001|Study Period III|Lack of Efficacy|3|||
30591460|NCT00191906|58603784|FG002|Study Period III|Lack of Efficacy|0|||
30675953|NCT00792636|58690067|FG001|Overall Study|Withdrew Consent|13|||
30675954|NCT00792636|58690068|FG002|Overall Study|Withdrew Consent|9|||
30591461|NCT00191906|58603785|FG003|Study Period III|Lack of Efficacy|0|||
30591462|NCT00191789|58603801|FG000|Overall Study|Adverse Event|5|||
30675955|NCT00792636|58690066|FG000|Overall Study|Lack of Efficacy|3|||
30675956|NCT00792636|58690067|FG001|Overall Study|Lack of Efficacy|4|||
30675957|NCT00792636|58690068|FG002|Overall Study|Lack of Efficacy|13|||
30675958|NCT00792636|58690066|FG000|Overall Study|Adverse Event|4|||
30675959|NCT00792636|58690067|FG001|Overall Study|Adverse Event|2|||
30591463|NCT00191789|58603801|FG000|Overall Study|Patient: Satisfactory Response|5|||
30675960|NCT00792636|58690068|FG002|Overall Study|Adverse Event|3|||
30675961|NCT00792636|58690066|FG000|Overall Study|Investigator Discretion|2|||
30675962|NCT00792636|58690067|FG001|Overall Study|Investigator Discretion|0|||
30675963|NCT00792636|58690068|FG002|Overall Study|Investigator Discretion|2|||
30675964|NCT00446563|58690080|FG000|Overall Study|Adverse Event|4|||
30675965|NCT00446563|58690081|FG001|Overall Study|Adverse Event|3|||
30675966|NCT00446563|58690080|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30675967|NCT00446563|58690081|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30675968|NCT00446563|58690080|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30675969|NCT00446563|58690081|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30675970|NCT00446563|58690080|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30675971|NCT00446563|58690081|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
30675972|NCT00446563|58690080|FG000|Overall Study|Withdrawal by Subject|2|||
30675973|NCT00446563|58690081|FG001|Overall Study|Withdrawal by Subject|1|||
30675974|NCT00446563|58690080|FG000|Overall Study|Administrative problems|0|||
30675975|NCT00446563|58690081|FG001|Overall Study|Administrative problems|1|||
30675976|NCT00650806|58690091|FG000|Overall Study|Adverse Event|0|||
30675977|NCT00650806|58690092|FG001|Overall Study|Adverse Event|5|||
30675978|NCT00650806|58690093|FG002|Overall Study|Adverse Event|3|||
30675979|NCT00650806|58690094|FG003|Overall Study|Adverse Event|4|||
30675980|NCT00650806|58690091|FG000|Overall Study|Lost to Follow-up|7|||
30675981|NCT00650806|58690092|FG001|Overall Study|Lost to Follow-up|6|||
30675982|NCT00650806|58690093|FG002|Overall Study|Lost to Follow-up|11|||
30675983|NCT00650806|58690094|FG003|Overall Study|Lost to Follow-up|10|||
30675984|NCT00650806|58690091|FG000|Overall Study|Protocol Violation|0|||
30675985|NCT00650806|58690092|FG001|Overall Study|Protocol Violation|0|||
30675986|NCT00650806|58690093|FG002|Overall Study|Protocol Violation|0|||
30675987|NCT00650806|58690094|FG003|Overall Study|Protocol Violation|1|||
30675988|NCT00650806|58690091|FG000|Overall Study|Pregnancy|0|||
30675989|NCT00650806|58690092|FG001|Overall Study|Pregnancy|0|||
30675990|NCT00650806|58690093|FG002|Overall Study|Pregnancy|0|||
30675991|NCT00650806|58690094|FG003|Overall Study|Pregnancy|1|||
30675992|NCT00650806|58690091|FG000|Overall Study|Withdrawal by Subject|7|||
30675993|NCT00650806|58690092|FG001|Overall Study|Withdrawal by Subject|5|||
30675994|NCT00650806|58690093|FG002|Overall Study|Withdrawal by Subject|8|||
30675995|NCT00650806|58690094|FG003|Overall Study|Withdrawal by Subject|6|||
30675996|NCT00650806|58690091|FG000|Overall Study|Noncompliance with study drug regimen|1|||
30675997|NCT00650806|58690092|FG001|Overall Study|Noncompliance with study drug regimen|1|||
30675998|NCT00650806|58690093|FG002|Overall Study|Noncompliance with study drug regimen|0|||
30675999|NCT00650806|58690094|FG003|Overall Study|Noncompliance with study drug regimen|0|||
30676000|NCT00650806|58690091|FG000|Overall Study|Study terminated by sponsor|2|||
30676001|NCT00650806|58690092|FG001|Overall Study|Study terminated by sponsor|3|||
30676002|NCT00650806|58690093|FG002|Overall Study|Study terminated by sponsor|5|||
30676003|NCT00650806|58690094|FG003|Overall Study|Study terminated by sponsor|4|||
30676004|NCT00650806|58690091|FG000|Overall Study|Other|1|||
30676005|NCT00650806|58690092|FG001|Overall Study|Other|1|||
30676006|NCT00650806|58690093|FG002|Overall Study|Other|2|||
30676007|NCT00650806|58690094|FG003|Overall Study|Other|0|||
30676008|NCT00863057|58690110|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
30676009|NCT00863057|58690111|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
30676010|NCT00863057|58690112|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
30676011|NCT00863057|58690113|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
30676012|NCT00863057|58690110|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
30676013|NCT00863057|58690111|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
30676014|NCT00863057|58690112|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
30591464|NCT00191789|58603801|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
30591465|NCT00191789|58603801|FG000|Overall Study|Withdrawal by Subject|4|||
30591466|NCT00191789|58603801|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
30591467|NCT00191789|58603801|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
30591468|NCT00191789|58603801|FG000|Overall Study|Death - Not Study-Drug Related|1|||
30591469|NCT00191282|58603807|FG000|Overall Study|Adverse Event|5|||
30591470|NCT00191282|58603808|FG001|Overall Study|Adverse Event|6|||
30591471|NCT00191282|58603807|FG000|Overall Study|Death|51|||
30591472|NCT00191282|58603808|FG001|Overall Study|Death|51|||
30591473|NCT00191282|58603807|FG000|Overall Study|Lack of Efficacy|11|||
30591474|NCT00191282|58603808|FG001|Overall Study|Lack of Efficacy|6|||
30591475|NCT00191282|58603807|FG000|Overall Study|Noncompliance|14|||
30676015|NCT00863057|58690113|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
30676016|NCT00863057|58690110|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
30676017|NCT00863057|58690111|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
30676018|NCT00863057|58690112|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
30676019|NCT00863057|58690113|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
30591476|NCT00191282|58603808|FG001|Overall Study|Noncompliance|17|||
30591477|NCT00191282|58603807|FG000|Overall Study|Patient moved|11|||
30676020|NCT00863057|58690110|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
30676021|NCT00863057|58690111|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
30676022|NCT00863057|58690112|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
30959000|NCT01587703|59024036|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30676023|NCT00863057|58690113|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
30676024|NCT00829166|58690131|FG000|Overall Study|Death|305|||
30676025|NCT00829166|58690132|FG001|Overall Study|Death|333|||
30676026|NCT00829166|58690131|FG000|Overall Study|Lost to Follow-up|5|||
30676027|NCT00829166|58690132|FG001|Overall Study|Lost to Follow-up|4|||
30676028|NCT00829166|58690131|FG000|Overall Study|Physician's Decision|4|||
30676029|NCT00829166|58690132|FG001|Overall Study|Physician's Decision|3|||
30676030|NCT00829166|58690131|FG000|Overall Study|Subject's Decision|41|||
30676031|NCT00829166|58690132|FG001|Overall Study|Subject's Decision|55|||
30676032|NCT00829166|58690131|FG000|Overall Study|Sponsor's Decision|137|||
30676033|NCT00829166|58690132|FG001|Overall Study|Sponsor's Decision|98|||
30676034|NCT00829166|58690131|FG000|Overall Study|Reason Not Specified|3|||
30676035|NCT00829166|58690132|FG001|Overall Study|Reason Not Specified|3|||
30676036|NCT00799266|58690141|FG000|Overall Study|Adverse Event|0|||
30676037|NCT00799266|58690142|FG001|Overall Study|Adverse Event|1|||
30676038|NCT00799266|58690141|FG000|Overall Study|Subject withdrew consent|3|||
30591478|NCT00191282|58603808|FG001|Overall Study|Patient moved|14|||
30591479|NCT00191282|58603807|FG000|Overall Study|Withdrawal by Subject|59|||
30591480|NCT00191282|58603808|FG001|Overall Study|Withdrawal by Subject|44|||
30591481|NCT00191282|58603807|FG000|Overall Study|Physician Decision|18|||
30591482|NCT00191282|58603808|FG001|Overall Study|Physician Decision|15|||
30676039|NCT00799266|58690142|FG001|Overall Study|Subject withdrew consent|0|||
30676040|NCT00650104|58690148|FG000|Overall Study|Adverse Event|17|||
30676041|NCT00650104|58690148|FG000|Overall Study|Death|2|||
30676042|NCT00650104|58690148|FG000|Overall Study|Withdrawal by Subject|11|||
30676043|NCT00650104|58690148|FG000|Overall Study|Physician Decision|7|||
30676044|NCT00650104|58690148|FG000|Overall Study|Lost to Follow-up|1|||
30676045|NCT00650104|58690148|FG000|Overall Study|Non-compliance|2|||
30676046|NCT00650104|58690148|FG000|Overall Study|Sponsor Terminated Dosing|1|||
30676047|NCT00654238|58690152|FG000|Overall Study|Screen Failures|4|||
30676048|NCT00862979|58690159|FG000|Overall Study|Adverse Event|6|||
30676049|NCT00862979|58690160|FG001|Overall Study|Adverse Event|3|||
30676050|NCT00862979|58690159|FG000|Overall Study|Protocol Violation|0|||
30676051|NCT00862979|58690160|FG001|Overall Study|Protocol Violation|1|||
30676052|NCT00862979|58690159|FG000|Overall Study|Patient withdrew consent|2|||
30676053|NCT00862979|58690160|FG001|Overall Study|Patient withdrew consent|1|||
30676054|NCT00862979|58690159|FG000|Overall Study|Administrative problems|0|||
30676055|NCT00862979|58690160|FG001|Overall Study|Administrative problems|1|||
30676056|NCT00862979|58690159|FG000|Overall Study|Death|0|||
30676057|NCT00862979|58690160|FG001|Overall Study|Death|1|||
30676058|NCT00483379|58690168|FG000|Treatment Period|Adverse Event|1|||
30676059|NCT00483379|58690169|FG001|Treatment Period|Adverse Event|0|||
30676060|NCT00483379|58690168|FG000|Treatment Period|Withdrawal by Subject|1|||
30591483|NCT00191282|58603807|FG000|Overall Study|Protocol entry criteria not met|14|||
30676061|NCT00483379|58690169|FG001|Treatment Period|Withdrawal by Subject|0|||
30676062|NCT00446251|58690177|FG000|Overall Study|On-study Transplants|2|||
30676063|NCT00446251|58690177|FG000|Overall Study|Rituximab Infusion Reaction|2|||
30676064|NCT00446251|58690177|FG000|Overall Study|Lost to Follow-up|1|||
30676065|NCT00796224|58690183|FG000|Overall Study|Adverse Event|1|||
30676066|NCT00796224|58690184|FG001|Overall Study|Adverse Event|0|||
30676067|NCT00796224|58690183|FG000|Overall Study|Protocol Violation|0|||
30591484|NCT00191282|58603808|FG001|Overall Study|Protocol entry criteria not met|9|||
30591485|NCT00191282|58603807|FG000|Overall Study|Protocol Violation|9|||
30591486|NCT00191282|58603808|FG001|Overall Study|Protocol Violation|12|||
30591487|NCT00191282|58603807|FG000|Overall Study|Severity of outcome|2|||
30591488|NCT00191282|58603808|FG001|Overall Study|Severity of outcome|5|||
30591489|NCT00191282|58603807|FG000|Overall Study|Sponsor's decision|2|||
30591490|NCT00191282|58603808|FG001|Overall Study|Sponsor's decision|2|||
30591491|NCT00191282|58603807|FG000|Overall Study|Lost to Follow-up|24|||
30591492|NCT00191282|58603808|FG001|Overall Study|Lost to Follow-up|31|||
30591493|NCT00191165|58603816|FG000|Overall Study|Adverse Event|2|||
30676068|NCT00796224|58690184|FG001|Overall Study|Protocol Violation|1|||
30676069|NCT00791934|58690192|FG000|Overall Study|Withdrawal by Subject|2|||
30676070|NCT00791934|58690192|FG000|Overall Study|Did not consent for extended follow-up|13|||
30676071|NCT00848081|58690198|FG000|Overall Study|Adverse Event|6|||
30591494|NCT00191165|58603817|FG001|Overall Study|Adverse Event|0|||
30591495|NCT00191165|58603816|FG000|Overall Study|Protocol Violation|0|||
30591496|NCT00191165|58603817|FG001|Overall Study|Protocol Violation|1|||
30591497|NCT00191165|58603816|FG000|Overall Study|Participant Moved Away|0|||
30676072|NCT00848081|58690199|FG001|Overall Study|Adverse Event|7|||
30676073|NCT00848081|58690198|FG000|Overall Study|Protocol Violation|8|||
30676074|NCT00848081|58690199|FG001|Overall Study|Protocol Violation|5|||
30676075|NCT00848081|58690198|FG000|Overall Study|Lost to Follow-up|1|||
30676076|NCT00848081|58690199|FG001|Overall Study|Lost to Follow-up|0|||
30676077|NCT00848081|58690198|FG000|Overall Study|Physician Decision|0|||
30676078|NCT00848081|58690199|FG001|Overall Study|Physician Decision|3|||
30676079|NCT00848081|58690198|FG000|Overall Study|Withdrawal by Subject|5|||
30676080|NCT00848081|58690199|FG001|Overall Study|Withdrawal by Subject|3|||
30676081|NCT00654004|58690207|FG000|Overall Study|Lost to Follow-up|1|||
30591498|NCT00191165|58603817|FG001|Overall Study|Participant Moved Away|1|||
30591499|NCT00190775|58603825|FG000|Overall Study|Adverse Event|57|||
30591500|NCT00190775|58603826|FG001|Overall Study|Adverse Event|22|||
30591501|NCT00190775|58603825|FG000|Overall Study|Satisfactory Response|1|||
30591502|NCT00190775|58603826|FG001|Overall Study|Satisfactory Response|0|||
30591503|NCT00190775|58603825|FG000|Overall Study|Lack of Efficacy|28|||
30591504|NCT00190775|58603826|FG001|Overall Study|Lack of Efficacy|32|||
30676082|NCT00654004|58690208|FG001|Overall Study|Lost to Follow-up|0|||
30676083|NCT00791778|58690216|FG000|Double-blind Treatment|Adverse Event|49|||
30676084|NCT00791778|58690217|FG001|Double-blind Treatment|Adverse Event|9|||
30676085|NCT00791778|58690216|FG000|Double-blind Treatment|Physician Decision|6|||
30676086|NCT00791778|58690217|FG001|Double-blind Treatment|Physician Decision|26|||
30676087|NCT00791778|58690216|FG000|Double-blind Treatment|Protocol Violation|0|||
30676088|NCT00791778|58690217|FG001|Double-blind Treatment|Protocol Violation|4|||
30591505|NCT00190775|58603825|FG000|Overall Study|Lost to Follow-up|31|||
30591506|NCT00190775|58603826|FG001|Overall Study|Lost to Follow-up|23|||
30591507|NCT00190775|58603825|FG000|Overall Study|Participant Moved|0|||
30591508|NCT00190775|58603826|FG001|Overall Study|Participant Moved|1|||
30591509|NCT00190775|58603825|FG000|Overall Study|Withdrawal by Subject|24|||
30591510|NCT00190775|58603826|FG001|Overall Study|Withdrawal by Subject|13|||
30591511|NCT00190775|58603825|FG000|Overall Study|Sponsor Decision|1|||
30591512|NCT00190775|58603826|FG001|Overall Study|Sponsor Decision|0|||
30591513|NCT00190775|58603825|FG000|Overall Study|Physician Decision|3|||
30676089|NCT00791778|58690216|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
30676090|NCT00791778|58690217|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
30676091|NCT00791778|58690216|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
30676092|NCT00791778|58690217|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
30676093|NCT00791778|58690216|FG000|Follow-up|Withdrawal by Subject|3|||
30676094|NCT00791778|58690217|FG001|Follow-up|Withdrawal by Subject|0|||
30676095|NCT00791778|58690216|FG000|Follow-up|Lost to Follow-up|2|||
30676096|NCT00791778|58690217|FG001|Follow-up|Lost to Follow-up|1|||
30676097|NCT00798174|58690223|FG000|Overall Study|inability to implant azygos coil|3|||
30676098|NCT00798174|58690224|FG001|Overall Study|inability to implant azygos coil|3|||
30676099|NCT00798174|58690223|FG000|Overall Study|Inability to sedate for DFT testing|1|||
30676100|NCT00798174|58690224|FG001|Overall Study|Inability to sedate for DFT testing|0|||
30676101|NCT00798096|58690228|FG000|Overall Study|Ongoing|2|||
30676102|NCT00795600|58690234|FG000|Overall Study|Adverse Event|1|||
30676103|NCT00795600|58690235|FG001|Overall Study|Adverse Event|1|||
30676104|NCT00795600|58690234|FG000|Overall Study|Protocol Violation|1|||
30676105|NCT00795600|58690235|FG001|Overall Study|Protocol Violation|2|||
30676106|NCT00795600|58690234|FG000|Overall Study|Withdrawal by Subject|1|||
30676107|NCT00795600|58690235|FG001|Overall Study|Withdrawal by Subject|0|||
30676108|NCT00795600|58690234|FG000|Overall Study|Unclassified|1|||
30676109|NCT00795600|58690235|FG001|Overall Study|Unclassified|1|||
30676110|NCT00795132|58690241|FG000|Overall Study|Death|1|||
30676111|NCT00795132|58690241|FG000|Overall Study|Relapse|2|||
30676112|NCT00647296|58690257|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
30676113|NCT00647296|58690258|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
30676114|NCT00647296|58690259|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
30676115|NCT00647296|58690260|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
30676116|NCT00647296|58690257|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
30676117|NCT00647296|58690258|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
30676118|NCT00647296|58690259|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
30676119|NCT00647296|58690260|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
30676120|NCT00647296|58690257|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
30676121|NCT00647296|58690258|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
30676122|NCT00647296|58690259|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
30676123|NCT00647296|58690260|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
30676124|NCT00647296|58690257|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
30676125|NCT00647296|58690258|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
30676126|NCT00647296|58690259|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
30676127|NCT00647296|58690260|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
30676128|NCT00647296|58690257|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
30676129|NCT00647296|58690258|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
30781888|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
30781889|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
30781890|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
30781891|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
30591514|NCT00190775|58603826|FG001|Overall Study|Physician Decision|0|||
30591515|NCT00190775|58603825|FG000|Overall Study|Noncompliance|3|||
30591516|NCT00190775|58603826|FG001|Overall Study|Noncompliance|5|||
30591517|NCT00190775|58603825|FG000|Overall Study|Protocol Violation|0|||
30591518|NCT00190775|58603826|FG001|Overall Study|Protocol Violation|1|||
30676130|NCT00647296|58690259|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
30676131|NCT00647296|58690260|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
30676132|NCT00647296|58690257|FG000|Part 2: 4-week Placebo Washout|Death|3|||
30676133|NCT00647296|58690258|FG001|Part 2: 4-week Placebo Washout|Death|0|||
30676134|NCT00647296|58690259|FG002|Part 2: 4-week Placebo Washout|Death|0|||
30676135|NCT00647296|58690260|FG003|Part 2: 4-week Placebo Washout|Death|0|||
30676136|NCT00647296|58690257|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
30676137|NCT00647296|58690258|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
30676138|NCT00647296|58690259|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
30676139|NCT00647296|58690260|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
30676140|NCT00647296|58690257|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
30676141|NCT00647296|58690258|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
30676142|NCT00647296|58690259|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
30676143|NCT00647296|58690260|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
30676144|NCT00647296|58690257|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
30591519|NCT00190775|58603825|FG000|Overall Study|Exclusion Criteria Met|1|||
30591520|NCT00190775|58603826|FG001|Overall Study|Exclusion Criteria Met|3|||
30591521|NCT00199901|58603841|FG000|Overall Study|Protocol Violation|2|||
30591522|NCT00199901|58603842|FG001|Overall Study|Protocol Violation|0|||
30591523|NCT00199901|58603841|FG000|Overall Study|Withdrawal by Subject|1|||
30591524|NCT00199901|58603842|FG001|Overall Study|Withdrawal by Subject|0|||
30591525|NCT00199901|58603841|FG000|Overall Study|Progressive Disease|24|||
30591526|NCT00199901|58603842|FG001|Overall Study|Progressive Disease|24|||
30591527|NCT00198107|58603852|FG000|Double-Blind Period|Adverse Event|1|||
30591528|NCT00198107|58603853|FG001|Double-Blind Period|Adverse Event|1|||
30591529|NCT00198107|58603854|FG002|Double-Blind Period|Adverse Event|0|||
30591530|NCT00198107|58603852|FG000|Double-Blind Period|Lack of Efficacy|2|||
30591531|NCT00198107|58603853|FG001|Double-Blind Period|Lack of Efficacy|0|||
30591532|NCT00198107|58603854|FG002|Double-Blind Period|Lack of Efficacy|0|||
30591533|NCT00198107|58603852|FG000|Double-Blind Period|Lost to Follow-up|2|||
30591534|NCT00198107|58603853|FG001|Double-Blind Period|Lost to Follow-up|1|||
30591535|NCT00198107|58603854|FG002|Double-Blind Period|Lost to Follow-up|0|||
30591536|NCT00198107|58603852|FG000|Double-Blind Period|Physician Decision|1|||
30591537|NCT00198107|58603853|FG001|Double-Blind Period|Physician Decision|0|||
30591538|NCT00198107|58603854|FG002|Double-Blind Period|Physician Decision|0|||
30591539|NCT00198107|58603852|FG000|Double-Blind Period|Withdrawal by Subject|0|||
30591540|NCT00198107|58603853|FG001|Double-Blind Period|Withdrawal by Subject|1|||
30591541|NCT00198107|58603854|FG002|Double-Blind Period|Withdrawal by Subject|0|||
30591542|NCT00198107|58603852|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
30591543|NCT00198107|58603853|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
30591544|NCT00198107|58603854|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
30591545|NCT00179660|58603862|FG000|Overall Study|Adverse Event|7|||
30591546|NCT00179660|58603862|FG000|Overall Study|Lack of therapeutic effect|28|||
30591547|NCT00179660|58603862|FG000|Overall Study|Withdrawal by Subject|2|||
30591548|NCT00179660|58603862|FG000|Overall Study|Lost to Follow-up|1|||
30591549|NCT00179660|58603862|FG000|Overall Study|Death|3|||
30591550|NCT00179660|58603862|FG000|Overall Study|Other - Unspecified|9|||
30591551|NCT00178256|58603866|FG000|Overall Study|Adverse Event|2|||
30591552|NCT00178256|58603867|FG001|Overall Study|Adverse Event|0|||
30591553|NCT00178256|58603868|FG002|Overall Study|Adverse Event|0|||
30591554|NCT00178256|58603869|FG003|Overall Study|Adverse Event|0|||
30591555|NCT00178256|58603866|FG000|Overall Study|Death|0|||
30591556|NCT00178256|58603867|FG001|Overall Study|Death|1|||
30591557|NCT00178256|58603868|FG002|Overall Study|Death|0|||
30591558|NCT00178256|58603869|FG003|Overall Study|Death|1|||
30591559|NCT00178256|58603866|FG000|Overall Study|Cancer progression|2|||
30591560|NCT00178256|58603867|FG001|Overall Study|Cancer progression|0|||
30676145|NCT00647296|58690258|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
30676146|NCT00647296|58690259|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
30676147|NCT00647296|58690260|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
30591561|NCT00178256|58603868|FG002|Overall Study|Cancer progression|0|||
30591562|NCT00178256|58603869|FG003|Overall Study|Cancer progression|1|||
30591563|NCT00177164|58603878|FG000|Overall Study|Protocol Violation|0|||
30591564|NCT00177164|58603879|FG001|Overall Study|Protocol Violation|7|||
30591565|NCT00177164|58603878|FG000|Overall Study|Lost to Follow-up|4|||
30591566|NCT00177164|58603879|FG001|Overall Study|Lost to Follow-up|5|||
30591567|NCT00177164|58603878|FG000|Overall Study|increase in alcohol and drug use|1|||
30591568|NCT00177164|58603879|FG001|Overall Study|increase in alcohol and drug use|2|||
30591569|NCT00177164|58603878|FG000|Overall Study|Adverse Event|1|||
30591570|NCT00177164|58603879|FG001|Overall Study|Adverse Event|0|||
30591571|NCT00177164|58603878|FG000|Overall Study|discharge from hospital|1|||
30591572|NCT00177164|58603879|FG001|Overall Study|discharge from hospital|0|||
30591573|NCT00177164|58603878|FG000|Overall Study|Lack of Efficacy|2|||
30591574|NCT00177164|58603879|FG001|Overall Study|Lack of Efficacy|1|||
30591575|NCT00177164|58603878|FG000|Overall Study|Pregnancy|0|||
30591576|NCT00177164|58603879|FG001|Overall Study|Pregnancy|1|||
30591577|NCT02489942|58603902|FG000|Overall Study|Request by patient|602|||
30676148|NCT00647296|58690257|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
30676149|NCT00647296|58690258|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
30676150|NCT00647296|58690259|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
30676151|NCT00647296|58690260|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
30676152|NCT00647296|58690257|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
30676153|NCT00647296|58690258|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
30676154|NCT00647296|58690259|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
30676155|NCT00647296|58690260|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
30676156|NCT00644878|58690282|FG000|Overall Study|Adverse Event|2|||
30676157|NCT00644878|58690282|FG000|Overall Study|Abnormal laboratory value|3|||
30676158|NCT00644878|58690282|FG000|Overall Study|Protocol deviation|2|||
30676159|NCT00644878|58690282|FG000|Overall Study|Treatment duration completed as per protocol|11|||
30676160|NCT00646906|58690290|FG000|Crossover Period 1|Withdrawal by Subject|1|||
30676161|NCT00646906|58690291|FG001|Crossover Period 1|Withdrawal by Subject|0|||
30676162|NCT00646906|58690292|FG002|Crossover Period 1|Withdrawal by Subject|0|||
30676163|NCT00646906|58690293|FG003|Crossover Period 1|Withdrawal by Subject|0|||
30676164|NCT00646906|58690294|FG004|Crossover Period 1|Withdrawal by Subject|0|||
30676165|NCT00646906|58690295|FG005|Crossover Period 1|Withdrawal by Subject|1|||
30676166|NCT00646906|58690296|FG006|Crossover Period 1|Withdrawal by Subject|0|||
30676167|NCT00646906|58690290|FG000|Crossover Period 2|Withdrawal by Subject|0|||
30676168|NCT00646906|58690291|FG001|Crossover Period 2|Withdrawal by Subject|1|||
30676169|NCT00646906|58690292|FG002|Crossover Period 2|Withdrawal by Subject|2|||
30959001|NCT01587703|59024037|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
30959002|NCT01587703|59024038|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30959003|NCT01587703|59024039|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30959004|NCT01587703|59024040|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30959005|NCT01587703|59024041|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
30959006|NCT01587703|59024023|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30959007|NCT01587703|59024024|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30959008|NCT01587703|59024025|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30591578|NCT02489942|58603902|FG000|Overall Study|Improvement/remission|157|||
30591579|NCT02489942|58603902|FG000|Overall Study|No change/Progressive disease|263|||
30591580|NCT02489942|58603902|FG000|Overall Study|Adverse Event|522|||
30591581|NCT02489942|58603902|FG000|Overall Study|Other personal reasons|1218|||
30676170|NCT00646906|58690293|FG003|Crossover Period 2|Withdrawal by Subject|1|||
30676171|NCT00646906|58690294|FG004|Crossover Period 2|Withdrawal by Subject|0|||
30676172|NCT00646906|58690295|FG005|Crossover Period 2|Withdrawal by Subject|0|||
30676173|NCT00646906|58690296|FG006|Crossover Period 2|Withdrawal by Subject|0|||
30676174|NCT00646906|58690290|FG000|Crossover Period 2|Physician Decision|0|||
30676175|NCT00646906|58690291|FG001|Crossover Period 2|Physician Decision|0|||
30676176|NCT00646906|58690292|FG002|Crossover Period 2|Physician Decision|0|||
30676177|NCT00646906|58690293|FG003|Crossover Period 2|Physician Decision|0|||
30676178|NCT00646906|58690294|FG004|Crossover Period 2|Physician Decision|0|||
30676179|NCT00646906|58690295|FG005|Crossover Period 2|Physician Decision|0|||
30676180|NCT00646906|58690296|FG006|Crossover Period 2|Physician Decision|1|||
30676181|NCT00642772|58690309|FG000|Overall Study|Lost to Follow-up|3|||
30676182|NCT00642772|58690309|FG000|Overall Study|Withdrawal by Subject|7|||
30676183|NCT00446095|58690318|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
30676184|NCT00446095|58690319|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
30676185|NCT00446095|58690320|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
30676186|NCT00446095|58690321|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
30676187|NCT00446095|58690322|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
30676188|NCT00446095|58690318|FG000|Phase II (8 Weeks)|Adverse Event|0|||
30676189|NCT00446095|58690319|FG001|Phase II (8 Weeks)|Adverse Event|1|||
30676190|NCT00446095|58690320|FG002|Phase II (8 Weeks)|Adverse Event|1|||
30676191|NCT00446095|58690321|FG003|Phase II (8 Weeks)|Adverse Event|0|||
30676192|NCT00446095|58690322|FG004|Phase II (8 Weeks)|Adverse Event|0|||
30591582|NCT02489942|58603902|FG000|Overall Study|Lost to Follow-up|456|||
30591583|NCT02489942|58603902|FG000|Overall Study|Not continuously investigated|7|||
30591584|NCT02489942|58603902|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
30591585|NCT02489942|58603902|FG000|Overall Study|Multiple registration|1|||
30676193|NCT00446095|58690318|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
30676194|NCT00446095|58690319|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
30959009|NCT01587703|59024026|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30591586|NCT02489942|58603902|FG000|Overall Study|No patient visit after entry|100|||
30676195|NCT00446095|58690320|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
30676196|NCT00446095|58690321|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
30676197|NCT00446095|58690322|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
30591587|NCT02489942|58603902|FG000|Overall Study|No treatment with Jardiance|2|||
30591588|NCT02489942|58603902|FG000|Overall Study|Patient received Jardiance before registration|1|||
30676198|NCT00446095|58690318|FG000|Phase II (8 Weeks)|Physician Decision|1|||
30676199|NCT00446095|58690319|FG001|Phase II (8 Weeks)|Physician Decision|0|||
30676200|NCT00446095|58690320|FG002|Phase II (8 Weeks)|Physician Decision|0|||
30676201|NCT00446095|58690321|FG003|Phase II (8 Weeks)|Physician Decision|0|||
30676202|NCT00446095|58690322|FG004|Phase II (8 Weeks)|Physician Decision|0|||
30676203|NCT00446095|58690318|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
30676204|NCT00446095|58690319|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
30676205|NCT00446095|58690320|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
30676206|NCT00446095|58690321|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
30676207|NCT00446095|58690322|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
30676208|NCT00446095|58690318|FG000|Phase II (8 Weeks)|Ongoing|0|||
30676209|NCT00446095|58690319|FG001|Phase II (8 Weeks)|Ongoing|0|||
30676210|NCT00446095|58690320|FG002|Phase II (8 Weeks)|Ongoing|1|||
30676211|NCT00446095|58690321|FG003|Phase II (8 Weeks)|Ongoing|0|||
30676212|NCT00446095|58690322|FG004|Phase II (8 Weeks)|Ongoing|0|||
30676213|NCT00446095|58690318|FG000|Phase I (28 Days)|Adverse Event|0|||
30676214|NCT00446095|58690319|FG001|Phase I (28 Days)|Adverse Event|0|||
30676215|NCT00446095|58690320|FG002|Phase I (28 Days)|Adverse Event|0|||
30676216|NCT00446095|58690321|FG003|Phase I (28 Days)|Adverse Event|1|||
30676217|NCT00446095|58690322|FG004|Phase I (28 Days)|Adverse Event|0|||
30676218|NCT00446095|58690318|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
30676219|NCT00446095|58690319|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
30676220|NCT00446095|58690320|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
30676221|NCT00446095|58690321|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
30676222|NCT00446095|58690322|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
30676223|NCT00829010|58690338|FG000|Overall Study|Adverse Event|1|||
30676224|NCT00829010|58690339|FG001|Overall Study|Adverse Event|0|||
30676225|NCT00829010|58690340|FG002|Overall Study|Adverse Event|0|||
30676226|NCT00829010|58690341|FG003|Overall Study|Adverse Event|0|||
30676227|NCT00829010|58690342|FG004|Overall Study|Adverse Event|0|||
30676228|NCT00829010|58690338|FG000|Overall Study|Withdrawal by Subject|0|||
30676229|NCT00829010|58690339|FG001|Overall Study|Withdrawal by Subject|1|||
30676230|NCT00829010|58690340|FG002|Overall Study|Withdrawal by Subject|1|||
30676231|NCT00829010|58690341|FG003|Overall Study|Withdrawal by Subject|0|||
30676232|NCT00829010|58690342|FG004|Overall Study|Withdrawal by Subject|2|||
30676233|NCT00829010|58690338|FG000|Overall Study|Lost to Follow-up|1|||
30676234|NCT00829010|58690339|FG001|Overall Study|Lost to Follow-up|0|||
30676235|NCT00829010|58690340|FG002|Overall Study|Lost to Follow-up|2|||
30676236|NCT00829010|58690341|FG003|Overall Study|Lost to Follow-up|0|||
30676237|NCT00829010|58690342|FG004|Overall Study|Lost to Follow-up|0|||
30676238|NCT00829010|58690338|FG000|Overall Study|Fatality|5|||
30676239|NCT00829010|58690339|FG001|Overall Study|Fatality|4|||
30676240|NCT00829010|58690340|FG002|Overall Study|Fatality|0|||
30676241|NCT00829010|58690341|FG003|Overall Study|Fatality|3|||
30676242|NCT00829010|58690342|FG004|Overall Study|Fatality|0|||
30676243|NCT00829010|58690338|FG000|Overall Study|Migrated/Moved from study area|3|||
30676244|NCT00829010|58690339|FG001|Overall Study|Migrated/Moved from study area|4|||
30676245|NCT00829010|58690340|FG002|Overall Study|Migrated/Moved from study area|0|||
30676246|NCT00829010|58690341|FG003|Overall Study|Migrated/Moved from study area|5|||
30676247|NCT00829010|58690342|FG004|Overall Study|Migrated/Moved from study area|0|||
30676248|NCT00644332|58690354|FG000|Overall Study|Adverse Event|11|||
30676249|NCT00644332|58690354|FG000|Overall Study|Withdrawal by Subject|6|||
30676250|NCT00644332|58690354|FG000|Overall Study|Completion Status Unknown|2|||
30591589|NCT02489942|58603902|FG000|Overall Study|No CRF collected|86|||
30591590|NCT00176462|58603908|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
30591591|NCT00176462|58603909|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
30591592|NCT00176462|58603908|FG000|Induction (4 Weeks)|Death|1|||
30591593|NCT00176462|58603909|FG001|Induction (4 Weeks)|Death|2|||
30591594|NCT00176462|58603908|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
30591595|NCT00176462|58603909|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
30591596|NCT00176462|58603908|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
30591597|NCT00176462|58603909|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
30591598|NCT00176462|58603908|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
30591599|NCT00176462|58603909|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
30676251|NCT00644332|58690354|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
30676252|NCT00644332|58690354|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
30676253|NCT00445939|58690361|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
30676254|NCT00445939|58690362|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
30676255|NCT00445939|58690363|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
30676256|NCT00445939|58690364|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
30676257|NCT00445939|58690361|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
30676258|NCT00445939|58690362|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
30676259|NCT00445939|58690363|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
30676260|NCT00445939|58690364|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
30676261|NCT00482053|58690384|FG000|Inter-treatment Period|Disease progression|1|||
30591600|NCT00176462|58603908|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
30591601|NCT00176462|58603909|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
30676262|NCT00455923|58690390|FG000|Overall Study|Pregnancy|0|||
30676263|NCT00455923|58690391|FG001|Overall Study|Pregnancy|2|||
30676264|NCT00455923|58690390|FG000|Overall Study|Other|3|||
30676265|NCT00455923|58690391|FG001|Overall Study|Other|1|||
30591602|NCT00176462|58603908|FG000|Consolidation (12 Weeks)|Not documented|0|||
30591603|NCT00176462|58603909|FG001|Consolidation (12 Weeks)|Not documented|1|||
30591604|NCT00176462|58603908|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
30591605|NCT00176462|58603909|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
30591606|NCT00176462|58603908|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
30591607|NCT00176462|58603909|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
30676266|NCT00642616|58690401|FG000|Overall Study|Adverse Event|2|||
30676267|NCT00642616|58690402|FG001|Overall Study|Adverse Event|0|||
30676268|NCT00642616|58690403|FG002|Overall Study|Adverse Event|1|||
30676269|NCT00642616|58690404|FG003|Overall Study|Adverse Event|0|||
30676270|NCT00642616|58690401|FG000|Overall Study|Study Terminated by Sponsor|7|||
30676271|NCT00642616|58690402|FG001|Overall Study|Study Terminated by Sponsor|6|||
30676272|NCT00642616|58690403|FG002|Overall Study|Study Terminated by Sponsor|4|||
30676273|NCT00642616|58690404|FG003|Overall Study|Study Terminated by Sponsor|5|||
30676274|NCT00642616|58690401|FG000|Overall Study|Withdrawal by Subject|0|||
30676275|NCT00642616|58690402|FG001|Overall Study|Withdrawal by Subject|1|||
30676276|NCT00642616|58690403|FG002|Overall Study|Withdrawal by Subject|1|||
30676277|NCT00642616|58690404|FG003|Overall Study|Withdrawal by Subject|1|||
30676278|NCT00642616|58690401|FG000|Overall Study|Protocol Violation|0|||
30676279|NCT00642616|58690402|FG001|Overall Study|Protocol Violation|0|||
30676280|NCT00642616|58690403|FG002|Overall Study|Protocol Violation|2|||
30676281|NCT00642616|58690404|FG003|Overall Study|Protocol Violation|0|||
30676282|NCT00642616|58690401|FG000|Overall Study|Physician Decision|0|||
30676283|NCT00642616|58690402|FG001|Overall Study|Physician Decision|0|||
30676284|NCT00642616|58690403|FG002|Overall Study|Physician Decision|1|||
30676285|NCT00642616|58690404|FG003|Overall Study|Physician Decision|1|||
30676286|NCT03844945|58690420|FG000|Overall Study|Adverse Event|1|||
30676287|NCT03844945|58690421|FG001|Overall Study|Adverse Event|1|||
30676288|NCT03844945|58690422|FG002|Overall Study|Adverse Event|4|||
30676289|NCT03844945|58690423|FG003|Overall Study|Adverse Event|0|||
30676290|NCT03844945|58690420|FG000|Overall Study|Withdrawal by Subject|0|||
30676291|NCT03844945|58690421|FG001|Overall Study|Withdrawal by Subject|0|||
30676292|NCT03844945|58690422|FG002|Overall Study|Withdrawal by Subject|1|||
30676293|NCT03844945|58690423|FG003|Overall Study|Withdrawal by Subject|0|||
30676294|NCT03844945|58690420|FG000|Overall Study|Lack of Efficacy|0|||
30676295|NCT03844945|58690421|FG001|Overall Study|Lack of Efficacy|0|||
30676296|NCT03844945|58690422|FG002|Overall Study|Lack of Efficacy|0|||
30676297|NCT03844945|58690423|FG003|Overall Study|Lack of Efficacy|1|||
30676298|NCT00445549|58690433|FG000|Overall Study|progressive disease|12|||
30676299|NCT00445003|58690440|FG000|Overall Study|Death|1|||
30676300|NCT00445003|58690441|FG001|Overall Study|Death|2|||
30676301|NCT00445003|58690442|FG002|Overall Study|Death|1|||
30676302|NCT00445003|58690440|FG000|Overall Study|Missed Visit|3|||
30676303|NCT00445003|58690441|FG001|Overall Study|Missed Visit|5|||
30676304|NCT00445003|58690442|FG002|Overall Study|Missed Visit|1|||
30676305|NCT00445003|58690440|FG000|Overall Study|Dropped|1|||
30676306|NCT00445003|58690441|FG001|Overall Study|Dropped|3|||
30676307|NCT00445003|58690442|FG002|Overall Study|Dropped|2|||
30676308|NCT00811070|58690456|FG000|Overall Study|Death|0|||
30676309|NCT00811070|58690457|FG001|Overall Study|Death|0|||
30676310|NCT00811070|58690458|FG002|Overall Study|Death|0|||
30676311|NCT00811070|58690459|FG003|Overall Study|Death|2|||
30676312|NCT00811070|58690460|FG004|Overall Study|Death|5|||
30676313|NCT00811070|58690461|FG005|Overall Study|Death|0|||
30591608|NCT00175019|58603919|FG000|Overall Study|Adverse Event|54|||
30676314|NCT00811070|58690456|FG000|Overall Study|Other|1|||
30676315|NCT00811070|58690457|FG001|Overall Study|Other|0|||
30676316|NCT00811070|58690458|FG002|Overall Study|Other|0|||
30676317|NCT00811070|58690459|FG003|Overall Study|Other|0|||
30676318|NCT00811070|58690460|FG004|Overall Study|Other|0|||
30676319|NCT00811070|58690461|FG005|Overall Study|Other|0|||
30676320|NCT00811070|58690456|FG000|Overall Study|Withdrawal by Subject|0|||
30676321|NCT00811070|58690457|FG001|Overall Study|Withdrawal by Subject|1|||
30676322|NCT00811070|58690458|FG002|Overall Study|Withdrawal by Subject|0|||
30676323|NCT00811070|58690459|FG003|Overall Study|Withdrawal by Subject|0|||
30676324|NCT00811070|58690460|FG004|Overall Study|Withdrawal by Subject|0|||
30676325|NCT00811070|58690461|FG005|Overall Study|Withdrawal by Subject|0|||
30676326|NCT00811070|58690456|FG000|Overall Study|Physician Decision|0|||
30676327|NCT00811070|58690457|FG001|Overall Study|Physician Decision|0|||
30676328|NCT00811070|58690458|FG002|Overall Study|Physician Decision|0|||
30676329|NCT00811070|58690459|FG003|Overall Study|Physician Decision|0|||
30676330|NCT00811070|58690460|FG004|Overall Study|Physician Decision|0|||
30676331|NCT00811070|58690461|FG005|Overall Study|Physician Decision|1|||
30676332|NCT00642460|58690479|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
30676333|NCT00642460|58690480|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
30591609|NCT00175019|58603920|FG001|Overall Study|Adverse Event|22|||
30676334|NCT00642460|58690481|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
30676335|NCT00642460|58690482|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
30591610|NCT00175019|58603921|FG002|Overall Study|Adverse Event|2|||
30591611|NCT00175019|58603919|FG000|Overall Study|Protocol Violation|6|||
30591612|NCT00175019|58603920|FG001|Overall Study|Protocol Violation|3|||
30591613|NCT00175019|58603921|FG002|Overall Study|Protocol Violation|3|||
30591614|NCT00175019|58603919|FG000|Overall Study|Lost to Follow-up|42|||
30591615|NCT00175019|58603920|FG001|Overall Study|Lost to Follow-up|39|||
30591616|NCT00175019|58603921|FG002|Overall Study|Lost to Follow-up|9|||
30591617|NCT00175019|58603919|FG000|Overall Study|Did not continue under Amendment 4|1|||
30591618|NCT00175019|58603920|FG001|Overall Study|Did not continue under Amendment 4|1|||
30591619|NCT00175019|58603921|FG002|Overall Study|Did not continue under Amendment 4|2|||
30676336|NCT00642460|58690483|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
30676337|NCT00642460|58690484|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
30676338|NCT00642460|58690479|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
30676339|NCT00642460|58690480|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
30676340|NCT00642460|58690481|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
30676341|NCT00642460|58690482|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
30676342|NCT00642460|58690483|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
30676343|NCT00642460|58690484|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
30676344|NCT00642460|58690479|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
30676345|NCT00642460|58690480|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
30676346|NCT00642460|58690481|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
30676347|NCT00642460|58690482|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
30676348|NCT00642460|58690483|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
30676349|NCT00642460|58690484|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
30676350|NCT00642460|58690479|FG000|Part II: Open-Label Up to Week 92|Death|0|||
30676351|NCT00642460|58690480|FG001|Part II: Open-Label Up to Week 92|Death|1|||
30676352|NCT00642460|58690481|FG002|Part II: Open-Label Up to Week 92|Death|0|||
30676353|NCT00642460|58690482|FG003|Part II: Open-Label Up to Week 92|Death|2|||
30676354|NCT00642460|58690483|FG004|Part II: Open-Label Up to Week 92|Death|0|||
30676355|NCT00642460|58690484|FG005|Part II: Open-Label Up to Week 92|Death|0|||
30676356|NCT00642460|58690479|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
30676357|NCT00642460|58690480|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
30676358|NCT00642460|58690481|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
30676359|NCT00642460|58690482|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
30676360|NCT00642460|58690483|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
30676361|NCT00642460|58690484|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
30591620|NCT00175019|58603919|FG000|Overall Study|Personal Reason(s)|39|||
30591621|NCT00175019|58603920|FG001|Overall Study|Personal Reason(s)|31|||
30591622|NCT00175019|58603921|FG002|Overall Study|Personal Reason(s)|8|||
30591623|NCT00175019|58603919|FG000|Overall Study|Therapeutic Failure|10|||
30591624|NCT00175019|58603920|FG001|Overall Study|Therapeutic Failure|38|||
30591625|NCT00175019|58603921|FG002|Overall Study|Therapeutic Failure|22|||
30591626|NCT00175019|58603919|FG000|Overall Study|Gout Flare|2|||
30591627|NCT00175019|58603920|FG001|Overall Study|Gout Flare|3|||
30591628|NCT00175019|58603921|FG002|Overall Study|Gout Flare|0|||
30591629|NCT00175019|58603919|FG000|Overall Study|Reason Not Specified|40|||
30591630|NCT00175019|58603920|FG001|Overall Study|Reason Not Specified|34|||
30591631|NCT00175019|58603921|FG002|Overall Study|Reason Not Specified|11|||
30591632|NCT00174941|58603932|FG000|Overall Study|Adverse Event|1|||
30591633|NCT00174941|58603933|FG001|Overall Study|Adverse Event|10|||
30591634|NCT00174941|58603934|FG002|Overall Study|Adverse Event|2|||
30591635|NCT00174941|58603935|FG003|Overall Study|Adverse Event|13|||
30591636|NCT00174941|58603932|FG000|Overall Study|Protocol Violation|0|||
30591637|NCT00174941|58603933|FG001|Overall Study|Protocol Violation|1|||
30591638|NCT00174941|58603934|FG002|Overall Study|Protocol Violation|0|||
30591639|NCT00174941|58603935|FG003|Overall Study|Protocol Violation|1|||
30591640|NCT00174941|58603932|FG000|Overall Study|Lost to Follow-up|0|||
30591641|NCT00174941|58603933|FG001|Overall Study|Lost to Follow-up|3|||
30591642|NCT00174941|58603934|FG002|Overall Study|Lost to Follow-up|2|||
30591643|NCT00174941|58603935|FG003|Overall Study|Lost to Follow-up|5|||
30591644|NCT00174941|58603932|FG000|Overall Study|Personal Reason(s)|0|||
30676362|NCT00642460|58690479|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
30676363|NCT00642460|58690480|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
30676364|NCT00642460|58690481|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
30856060|NCT02716805|58883831|FG003|Overall Study|Progressive disease|0|||
30591645|NCT00174941|58603933|FG001|Overall Study|Personal Reason(s)|14|||
30591646|NCT00174941|58603934|FG002|Overall Study|Personal Reason(s)|8|||
30591647|NCT00174941|58603935|FG003|Overall Study|Personal Reason(s)|22|||
30591648|NCT00174941|58603932|FG000|Overall Study|Gout Flare|0|||
30591649|NCT00174941|58603933|FG001|Overall Study|Gout Flare|4|||
30591650|NCT00174941|58603934|FG002|Overall Study|Gout Flare|4|||
30591651|NCT00174941|58603935|FG003|Overall Study|Gout Flare|8|||
30591652|NCT00174941|58603932|FG000|Overall Study|Reason Not Specified|1|||
30591653|NCT00174941|58603933|FG001|Overall Study|Reason Not Specified|6|||
30591654|NCT00174941|58603934|FG002|Overall Study|Reason Not Specified|2|||
30591655|NCT00174941|58603935|FG003|Overall Study|Reason Not Specified|9|||
30591656|NCT00171704|58603947|FG000|Overall Study|Adverse Event|24|||
30591657|NCT00171704|58603948|FG001|Overall Study|Adverse Event|33|||
30591658|NCT00171704|58603947|FG000|Overall Study|Disease Progression|14|||
30591659|NCT00171704|58603948|FG001|Overall Study|Disease Progression|9|||
30591660|NCT00171704|58603947|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
30591661|NCT00171704|58603948|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
30591662|NCT00171704|58603947|FG000|Overall Study|Administrative Problems|2|||
30591663|NCT00171704|58603948|FG001|Overall Study|Administrative Problems|1|||
30591664|NCT00171704|58603947|FG000|Overall Study|Death|2|||
30591665|NCT00171704|58603948|FG001|Overall Study|Death|2|||
30591666|NCT00171704|58603947|FG000|Overall Study|Withdrawal by Subject|1|||
30591667|NCT00171704|58603948|FG001|Overall Study|Withdrawal by Subject|3|||
30591668|NCT00171704|58603947|FG000|Overall Study|Protocol Violation|0|||
30676365|NCT00642460|58690482|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
30676366|NCT00642460|58690483|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
30676367|NCT00642460|58690484|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
30676368|NCT00642460|58690479|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
30676369|NCT00642460|58690480|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
30676370|NCT00642460|58690481|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
30676371|NCT00642460|58690482|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
30676372|NCT00642460|58690483|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
30676373|NCT00642460|58690484|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
30676374|NCT00642460|58690479|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
30676375|NCT00642460|58690480|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
30676376|NCT00642460|58690481|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
30676377|NCT00642460|58690482|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
30676378|NCT00642460|58690483|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
30676379|NCT00642460|58690484|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
30676380|NCT00642460|58690479|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
30676381|NCT00642460|58690480|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
30676382|NCT00642460|58690481|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
30676383|NCT00642460|58690482|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
30781892|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
30781893|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
30781894|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
30591669|NCT00171704|58603948|FG001|Overall Study|Protocol Violation|1|||
30591670|NCT00171314|58603956|FG000|Overall Study|Adverse Event|44|||
30591671|NCT00171314|58603957|FG001|Overall Study|Adverse Event|41|||
30591672|NCT00171314|58603956|FG000|Overall Study|Lack of Efficacy|19|||
30591673|NCT00171314|58603957|FG001|Overall Study|Lack of Efficacy|14|||
30676384|NCT00642460|58690483|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
30676385|NCT00642460|58690484|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
30676386|NCT00642460|58690479|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
30676387|NCT00642460|58690480|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
30676388|NCT00642460|58690481|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
30676389|NCT00642460|58690482|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
30676390|NCT00642460|58690483|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
30676391|NCT00642460|58690484|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
30676392|NCT00642460|58690479|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
30676393|NCT00642460|58690480|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
30676394|NCT00642460|58690481|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
30676395|NCT00642460|58690482|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
30676396|NCT00642460|58690483|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
30676397|NCT00642460|58690484|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
30676398|NCT00642460|58690479|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
30676399|NCT00642460|58690480|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
30676400|NCT00642460|58690481|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
30676401|NCT00642460|58690482|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
30676402|NCT00642460|58690483|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
30781895|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
30591674|NCT00171314|58603956|FG000|Overall Study|Withdrawal by Subject|9|||
30676403|NCT00642460|58690484|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
30676404|NCT00642460|58690479|FG000|Part III: Open-Label Up to Week 260|Other|0|||
30676405|NCT00642460|58690480|FG001|Part III: Open-Label Up to Week 260|Other|0|||
30856061|NCT02581982|58883835|FG000|Overall Study|Lack of Efficacy|12|||
30591675|NCT00171314|58603957|FG001|Overall Study|Withdrawal by Subject|6|||
30591676|NCT00171314|58603956|FG000|Overall Study|Abnormal Test Procedure Results|9|||
30591677|NCT00171314|58603957|FG001|Overall Study|Abnormal Test Procedure Results|3|||
30591678|NCT00171314|58603956|FG000|Overall Study|Protocol Violation|3|||
30959010|NCT01587703|59024027|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30959011|NCT01587703|59024028|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30959012|NCT01587703|59024029|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30959013|NCT01587703|59024030|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30591679|NCT00171314|58603957|FG001|Overall Study|Protocol Violation|7|||
30591680|NCT00171314|58603956|FG000|Overall Study|Administrative Problems|4|||
30591681|NCT00171314|58603957|FG001|Overall Study|Administrative Problems|3|||
30591682|NCT00171314|58603956|FG000|Overall Study|Lost to Follow-up|1|||
30591683|NCT00171314|58603957|FG001|Overall Study|Lost to Follow-up|3|||
30591684|NCT00171314|58603956|FG000|Overall Study|Death|2|||
30591685|NCT00171314|58603957|FG001|Overall Study|Death|1|||
30591686|NCT00171158|58603963|FG000|Core Study|Death|27|||
30591687|NCT00171158|58603963|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
30591688|NCT00171158|58603963|FG000|Core Study|Protocol Violation|4|||
30591689|NCT00171158|58603963|FG000|Core Study|Administrative problems|1|||
30591690|NCT00171158|58603963|FG000|Core Study|Adverse event, non-fatal|21|||
30591691|NCT00171158|58603963|FG000|Core Study|Consent withdrawn by subject|6|||
30591692|NCT00171158|58603963|FG000|Core Study|No longer required drug (BMT)|14|||
30591693|NCT00171158|58603963|FG000|Core Study|Abnormal Laboratory Values|2|||
30591694|NCT00171158|58603963|FG000|Core Study|Lost to Follow-up|1|||
30591695|NCT00171158|58603963|FG000|E2 Extension|Other|7|||
30591696|NCT00170846|58603970|FG000|Overall Study|Subject withdrew Informed Consent|5|||
30591697|NCT00170846|58603971|FG001|Overall Study|Subject withdrew Informed Consent|12|||
30591698|NCT00170846|58603972|FG002|Overall Study|Subject withdrew Informed Consent|8|||
30591699|NCT00170846|58603970|FG000|Overall Study|Lost to Follow-up|6|||
30591700|NCT00170846|58603971|FG001|Overall Study|Lost to Follow-up|3|||
30676406|NCT00642460|58690481|FG002|Part III: Open-Label Up to Week 260|Other|0|||
30676407|NCT00642460|58690482|FG003|Part III: Open-Label Up to Week 260|Other|0|||
30676408|NCT00642460|58690483|FG004|Part III: Open-Label Up to Week 260|Other|2|||
30676409|NCT00642460|58690484|FG005|Part III: Open-Label Up to Week 260|Other|2|||
30676410|NCT00642460|58690479|FG000|Part III: Open-Label Up to Week 260|Death|0|||
30676411|NCT00642460|58690480|FG001|Part III: Open-Label Up to Week 260|Death|0|||
30676412|NCT00642460|58690481|FG002|Part III: Open-Label Up to Week 260|Death|0|||
30676413|NCT00642460|58690482|FG003|Part III: Open-Label Up to Week 260|Death|0|||
30676414|NCT00642460|58690483|FG004|Part III: Open-Label Up to Week 260|Death|0|||
30676415|NCT00642460|58690484|FG005|Part III: Open-Label Up to Week 260|Death|3|||
30676416|NCT00642460|58690479|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
30676417|NCT00642460|58690480|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
30676418|NCT00642460|58690481|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
30676419|NCT00642460|58690482|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
30676420|NCT00642460|58690483|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
30676421|NCT00642460|58690484|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
30676422|NCT00642460|58690479|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
30676423|NCT00642460|58690480|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
30676424|NCT00642460|58690481|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
30676425|NCT00642460|58690482|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
30676426|NCT00642460|58690483|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
30676427|NCT00642460|58690484|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
30676428|NCT00814658|58690496|FG000|Overall Study|Lost to Follow-up|0|||
30676429|NCT00814658|58690497|FG001|Overall Study|Lost to Follow-up|1|||
30676430|NCT00814658|58690496|FG000|Overall Study|Physician Decision|1|||
30676431|NCT00814658|58690497|FG001|Overall Study|Physician Decision|0|||
30676432|NCT00814658|58690496|FG000|Overall Study|Adverse Event|3|||
30676433|NCT00814658|58690497|FG001|Overall Study|Adverse Event|3|||
30676434|NCT00642304|58690513|FG000|Overall Study|Adverse Event|1|||
30676435|NCT00642304|58690513|FG000|Overall Study|Death|1|||
30676436|NCT00642304|58690513|FG000|Overall Study|Blood transfusion|2|||
30676437|NCT00642304|58690513|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
30676438|NCT00642304|58690513|FG000|Overall Study|Transplantation|1|||
30676439|NCT00814580|58690519|FG000|Overall Study|Adverse Event|6|||
30676440|NCT00814580|58690520|FG001|Overall Study|Adverse Event|15|||
30676441|NCT00814580|58690519|FG000|Overall Study|Lack of Efficacy|18|||
30676442|NCT00814580|58690520|FG001|Overall Study|Lack of Efficacy|25|||
30676443|NCT00814580|58690519|FG000|Overall Study|Protocol Violation|2|||
30676444|NCT00814580|58690520|FG001|Overall Study|Protocol Violation|0|||
30676445|NCT00814580|58690519|FG000|Overall Study|Withdrawal by Subject|2|||
30676446|NCT00814580|58690520|FG001|Overall Study|Withdrawal by Subject|2|||
30591701|NCT00170846|58603972|FG002|Overall Study|Lost to Follow-up|2|||
30591702|NCT00170846|58603970|FG000|Overall Study|Death|0|||
30591703|NCT00170846|58603971|FG001|Overall Study|Death|3|||
30591704|NCT00170846|58603972|FG002|Overall Study|Death|3|||
30591705|NCT00170846|58603970|FG000|Overall Study|Reason Missing|0|||
30676447|NCT00814580|58690519|FG000|Overall Study|Other|1|||
30676448|NCT00814580|58690520|FG001|Overall Study|Other|3|||
30676449|NCT00814580|58690519|FG000|Overall Study|Did Not Take Drug|2|||
30676450|NCT00814580|58690520|FG001|Overall Study|Did Not Take Drug|2|||
30676451|NCT00643162|58690540|FG000|Overall Study|Withdrawal by Subject|1|||
30676452|NCT00643162|58690541|FG001|Overall Study|Withdrawal by Subject|1|||
30676453|NCT00643006|58690549|FG000|Overall Study|Lost to Follow-up|5|||
30676454|NCT00643006|58690550|FG001|Overall Study|Lost to Follow-up|4|||
30676455|NCT00814502|58690560|FG000|Overall Study|Adverse Event|1|||
30676456|NCT00814502|58690561|FG001|Overall Study|Adverse Event|0|||
30676457|NCT00814502|58690560|FG000|Overall Study|Withdrawal by Subject|0|||
30676458|NCT00814502|58690561|FG001|Overall Study|Withdrawal by Subject|2|||
30676459|NCT00653224|58690571|FG000|Overall Study|Adverse Event|2|||
30676460|NCT00653224|58690572|FG001|Overall Study|Adverse Event|1|||
30676461|NCT00653224|58690571|FG000|Overall Study|Lack of Efficacy|1|||
30676462|NCT00653224|58690572|FG001|Overall Study|Lack of Efficacy|2|||
30676463|NCT00653224|58690571|FG000|Overall Study|Loss of efficacy|1|||
30676464|NCT00653224|58690572|FG001|Overall Study|Loss of efficacy|0|||
30676465|NCT00653224|58690571|FG000|Overall Study|Lost to Follow-up|1|||
30676466|NCT00653224|58690572|FG001|Overall Study|Lost to Follow-up|0|||
30676467|NCT00653224|58690571|FG000|Overall Study|Other|2|||
30676468|NCT00653224|58690572|FG001|Overall Study|Other|4|||
30676469|NCT00444925|58690581|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
30676470|NCT00444925|58690582|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
30676471|NCT00444925|58690583|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
30676472|NCT00444925|58690581|FG000|Double-blind Treatment Period|Death|2|||
30676473|NCT00444925|58690582|FG001|Double-blind Treatment Period|Death|0|||
30676474|NCT00444925|58690583|FG002|Double-blind Treatment Period|Death|0|||
30676475|NCT00444925|58690581|FG000|Double-blind Treatment Period|Adverse Event|6|||
30676476|NCT00444925|58690582|FG001|Double-blind Treatment Period|Adverse Event|28|||
30676477|NCT00444925|58690583|FG002|Double-blind Treatment Period|Adverse Event|44|||
30676478|NCT00444925|58690581|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
30676479|NCT00444925|58690582|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
30676480|NCT00444925|58690583|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
30676481|NCT00444925|58690581|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
30676482|NCT00444925|58690582|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
30676483|NCT00444925|58690583|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
30676484|NCT00444925|58690581|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
30676485|NCT00444925|58690582|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
30676486|NCT00444925|58690583|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
30676487|NCT00444925|58690581|FG000|Double-blind Treatment Period|Other|7|||
30676488|NCT00444925|58690582|FG001|Double-blind Treatment Period|Other|7|||
30676489|NCT00444925|58690583|FG002|Double-blind Treatment Period|Other|12|||
30676490|NCT00641056|58690593|FG000|Overall Study|Adverse Event|12|||
30676491|NCT00641056|58690594|FG001|Overall Study|Adverse Event|2|||
30676492|NCT00641056|58690593|FG000|Overall Study|Lost to Follow-up|2|||
30676493|NCT00641056|58690594|FG001|Overall Study|Lost to Follow-up|1|||
30676494|NCT00641056|58690593|FG000|Overall Study|Physician Decision|3|||
30676495|NCT00641056|58690594|FG001|Overall Study|Physician Decision|1|||
30676496|NCT00641056|58690593|FG000|Overall Study|Protocol Violation|2|||
30591706|NCT00170846|58603971|FG001|Overall Study|Reason Missing|1|||
30591707|NCT00170846|58603972|FG002|Overall Study|Reason Missing|0|||
30591708|NCT00479882|58603984|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
30591709|NCT00479882|58603985|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
30591710|NCT00479882|58603986|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
30591711|NCT00479882|58603987|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
30591712|NCT00479882|58603984|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
30591713|NCT00479882|58603985|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
30591714|NCT00479882|58603986|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
30591715|NCT00479882|58603987|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
30591716|NCT00479882|58603984|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
30591717|NCT00479882|58603985|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
30591718|NCT00479882|58603986|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
30591719|NCT00479882|58603987|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
30676497|NCT00641056|58690594|FG001|Overall Study|Protocol Violation|0|||
30676498|NCT00641056|58690593|FG000|Overall Study|Entry Criteria Not Met|3|||
30676499|NCT00641056|58690594|FG001|Overall Study|Entry Criteria Not Met|0|||
30781896|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
30676500|NCT00641056|58690593|FG000|Overall Study|Subject Decision|6|||
30676501|NCT00641056|58690594|FG001|Overall Study|Subject Decision|19|||
30676502|NCT00641056|58690593|FG000|Overall Study|Sponsor Decision|1|||
30676503|NCT00641056|58690594|FG001|Overall Study|Sponsor Decision|2|||
30676504|NCT00814346|58690606|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
30676505|NCT00814346|58690607|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
30676506|NCT00814346|58690606|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
30676507|NCT00814346|58690607|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
30676508|NCT00814346|58690606|FG000|Open Phase (17 Months)|Adverse Event|5|||
30676509|NCT00814346|58690607|FG001|Open Phase (17 Months)|Adverse Event|0|||
30676510|NCT00814346|58690606|FG000|Open Phase (17 Months)|Consent|2|||
30676511|NCT00814346|58690607|FG001|Open Phase (17 Months)|Consent|0|||
30676512|NCT00814346|58690606|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
30676513|NCT00814346|58690607|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
30676514|NCT00814346|58690606|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
30676515|NCT00814346|58690607|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
30676516|NCT00569374|58690626|FG000|Overall Study|Withdrawal by Subject|4|||
30676517|NCT00828464|58690630|FG000|Overall Study|Withdrawal by Subject|1|||
30676518|NCT00810602|58690634|FG000|Overall Study|Withdrawal by Subject|8|||
30676519|NCT00810602|58690635|FG001|Overall Study|Withdrawal by Subject|3|||
30676520|NCT00791700|58690643|FG000|Overall Study|Insufficient clinical response|1|||
30676521|NCT00791700|58690644|FG001|Overall Study|Insufficient clinical response|4|||
30676522|NCT00791700|58690645|FG002|Overall Study|Insufficient clinical response|1|||
30676523|NCT00791700|58690646|FG003|Overall Study|Insufficient clinical response|8|||
30676524|NCT00791700|58690643|FG000|Overall Study|No longer willing to participate|1|||
30676525|NCT00791700|58690644|FG001|Overall Study|No longer willing to participate|1|||
30676526|NCT00791700|58690645|FG002|Overall Study|No longer willing to participate|0|||
30676527|NCT00791700|58690646|FG003|Overall Study|No longer willing to participate|8|||
30676528|NCT00791700|58690643|FG000|Overall Study|Non-compliance with study treatment|0|||
30676529|NCT00791700|58690644|FG001|Overall Study|Non-compliance with study treatment|2|||
30676530|NCT00791700|58690645|FG002|Overall Study|Non-compliance with study treatment|0|||
30676531|NCT00791700|58690646|FG003|Overall Study|Non-compliance with study treatment|4|||
30676532|NCT00791700|58690643|FG000|Overall Study|Withdrawn due to pregnancy|0|||
30676533|NCT00791700|58690644|FG001|Overall Study|Withdrawn due to pregnancy|0|||
30676534|NCT00791700|58690645|FG002|Overall Study|Withdrawn due to pregnancy|0|||
30676535|NCT00791700|58690646|FG003|Overall Study|Withdrawn due to pregnancy|1|||
30676536|NCT00791700|58690643|FG000|Overall Study|Other|0|||
30676537|NCT00791700|58690644|FG001|Overall Study|Other|1|||
30676538|NCT00791700|58690645|FG002|Overall Study|Other|0|||
30676539|NCT00791700|58690646|FG003|Overall Study|Other|1|||
30676540|NCT00791700|58690643|FG000|Overall Study|Death|0|||
30676541|NCT00791700|58690644|FG001|Overall Study|Death|0|||
30676542|NCT00791700|58690645|FG002|Overall Study|Death|0|||
30676543|NCT00791700|58690646|FG003|Overall Study|Death|1|||
30676544|NCT00791700|58690643|FG000|Overall Study|Lost to Follow-up|4|||
30676545|NCT00791700|58690644|FG001|Overall Study|Lost to Follow-up|3|||
30676546|NCT00791700|58690645|FG002|Overall Study|Lost to Follow-up|4|||
30676547|NCT00791700|58690646|FG003|Overall Study|Lost to Follow-up|6|||
30676548|NCT00791700|58690643|FG000|Overall Study|Adverse Event|0|||
30676549|NCT00791700|58690644|FG001|Overall Study|Adverse Event|0|||
30676550|NCT00791700|58690645|FG002|Overall Study|Adverse Event|1|||
30676551|NCT00791700|58690646|FG003|Overall Study|Adverse Event|1|||
30676552|NCT00810368|58690669|FG000|Overall Study|Lost to Follow-up|4|||
30676553|NCT00810368|58690670|FG001|Overall Study|Lost to Follow-up|2|||
30676554|NCT00810368|58690669|FG000|Overall Study|Lack of Efficacy|2|||
30676555|NCT00810368|58690670|FG001|Overall Study|Lack of Efficacy|0|||
30959014|NCT01587703|59024031|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30591720|NCT00479882|58603984|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
30591721|NCT00479882|58603985|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
30591722|NCT00479882|58603986|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
30591723|NCT00479882|58603987|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
30591724|NCT00479882|58603984|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
30591725|NCT00479882|58603985|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
30591726|NCT00479882|58603986|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
30591727|NCT00479882|58603987|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
30591728|NCT00479882|58603984|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
30676556|NCT00628108|58690680|FG000|Overall Study|Adverse Event|0|||
30676557|NCT00628108|58690681|FG001|Overall Study|Adverse Event|3|||
30676558|NCT00628108|58690680|FG000|Overall Study|Withdrawal by Subject|1|||
30676559|NCT00628108|58690681|FG001|Overall Study|Withdrawal by Subject|0|||
30676560|NCT00628030|58690689|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
30676561|NCT00628030|58690690|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
30676562|NCT00628030|58690689|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
30676563|NCT00628030|58690690|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
30676564|NCT00628030|58690689|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
30591729|NCT00479882|58603985|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
30676565|NCT00628030|58690690|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
30676566|NCT00591578|58690699|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
30856062|NCT02581982|58883835|FG000|Overall Study|Adverse Event|3|||
30591730|NCT00479882|58603986|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
30591731|NCT00479882|58603987|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
30591732|NCT00479882|58603984|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
30591733|NCT00479882|58603985|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
30591734|NCT00479882|58603986|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
30591735|NCT00479882|58603987|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
30591736|NCT00479882|58603984|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
30591737|NCT00479882|58603985|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
30591738|NCT00479882|58603986|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
30591739|NCT00479882|58603987|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
30591740|NCT00479882|58603984|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
30591741|NCT00479882|58603985|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
30591742|NCT00479882|58603986|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
30591743|NCT00479882|58603987|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
30591744|NCT00479882|58603984|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
30591745|NCT00479882|58603985|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
30591746|NCT00479882|58603986|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
30676567|NCT00591578|58690700|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
30676568|NCT00591578|58690701|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
30676569|NCT00591578|58690699|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
30676570|NCT00591578|58690700|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
30676571|NCT00591578|58690701|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
30676572|NCT00591578|58690699|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
30676573|NCT00591578|58690700|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
30676574|NCT00591578|58690701|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
30781897|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
30781898|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
30781899|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
30781900|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
30781901|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30781902|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30781903|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30781904|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30781905|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30781906|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
30781907|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
30781908|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
30781909|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
30591747|NCT00479882|58603987|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
30676575|NCT00591578|58690699|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
30676576|NCT00591578|58690700|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
30676577|NCT00591578|58690701|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
30676578|NCT00591578|58690699|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
30676579|NCT00591578|58690700|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
30676580|NCT00591578|58690701|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
30676581|NCT00591578|58690699|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
30676582|NCT00591578|58690700|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
30676583|NCT00591578|58690701|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
30676584|NCT00591578|58690699|FG000|Double-Blind Treatment Phase|Other|4|||
30676585|NCT00591578|58690700|FG001|Double-Blind Treatment Phase|Other|9|||
30676586|NCT00591578|58690701|FG002|Double-Blind Treatment Phase|Other|4|||
30676587|NCT00591578|58690699|FG000|Open-Label Extension Phase|Adverse Event|3|||
30676588|NCT00591578|58690700|FG001|Open-Label Extension Phase|Adverse Event|5|||
30676589|NCT00591578|58690701|FG002|Open-Label Extension Phase|Adverse Event|0|||
30676590|NCT00591578|58690699|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
30676591|NCT00591578|58690700|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
30676592|NCT00591578|58690701|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
30676593|NCT00591578|58690699|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
30676594|NCT00591578|58690700|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
30676595|NCT00591578|58690701|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
30676596|NCT00591578|58690699|FG000|Open-Label Extension Phase|Other|1|||
30676597|NCT00591578|58690700|FG001|Open-Label Extension Phase|Other|0|||
30676598|NCT00591578|58690701|FG002|Open-Label Extension Phase|Other|0|||
30676599|NCT00797862|58690713|FG000|Overall Study|Adverse Event|86|||
30591748|NCT00479882|58603984|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
30591749|NCT00479882|58603985|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
30591750|NCT00479882|58603986|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
30591751|NCT00479882|58603987|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
30591752|NCT00479882|58603984|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
30591753|NCT00479882|58603985|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
30591754|NCT00479882|58603986|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
30591755|NCT00479882|58603987|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
30591756|NCT00479882|58603984|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
30591757|NCT00479882|58603985|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
30591758|NCT00479882|58603986|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
30591759|NCT00479882|58603987|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
30591760|NCT00479882|58603984|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
30591761|NCT00479882|58603985|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
30591762|NCT00479882|58603986|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
30591763|NCT00479882|58603987|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
30591764|NCT00479765|58604013|FG000|Overall Study|study terminated|4|||
30591765|NCT00479687|58604019|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
30591766|NCT00479687|58604020|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
30591767|NCT00479687|58604021|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
30591768|NCT00479687|58604019|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
30591769|NCT00479687|58604020|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
30591770|NCT00479687|58604021|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
30591771|NCT00479687|58604019|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
30591772|NCT00479687|58604020|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
30591773|NCT00479687|58604021|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
30591774|NCT00479687|58604019|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
30591775|NCT00479687|58604020|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
30591776|NCT00479687|58604021|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
30591777|NCT00479687|58604019|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
30591778|NCT00479687|58604020|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
30591779|NCT00479687|58604021|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
30591780|NCT00479687|58604019|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
30591781|NCT00479687|58604020|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
30591782|NCT00479687|58604021|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
30591783|NCT00479687|58604019|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
30591784|NCT00479687|58604020|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
30591785|NCT00479687|58604021|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
30591786|NCT00479687|58604019|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
30591787|NCT00479687|58604020|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
30591788|NCT00479687|58604021|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
30591789|NCT00479687|58604019|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
30591790|NCT00479687|58604020|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
30591791|NCT00479687|58604021|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
30591792|NCT00479336|58604032|FG000|Overall Study|Adverse Event|1|||
30591793|NCT00479336|58604033|FG001|Overall Study|Adverse Event|1|||
30591794|NCT00479336|58604034|FG002|Overall Study|Adverse Event|1|||
30591795|NCT00479336|58604035|FG003|Overall Study|Adverse Event|3|||
30591796|NCT00479336|58604032|FG000|Overall Study|Lack of Efficacy|1|||
30591797|NCT00479336|58604033|FG001|Overall Study|Lack of Efficacy|0|||
30591798|NCT00479336|58604034|FG002|Overall Study|Lack of Efficacy|0|||
30591799|NCT00479336|58604035|FG003|Overall Study|Lack of Efficacy|0|||
30591800|NCT00479336|58604032|FG000|Overall Study|Protocol Violation|0|||
30591801|NCT00479336|58604033|FG001|Overall Study|Protocol Violation|1|||
30591802|NCT00479336|58604034|FG002|Overall Study|Protocol Violation|0|||
30676600|NCT00797862|58690714|FG001|Overall Study|Adverse Event|44|||
30676601|NCT00797862|58690715|FG002|Overall Study|Adverse Event|58|||
30676602|NCT00797862|58690713|FG000|Overall Study|Abnormal Test Procedure Result|0|||
30676603|NCT00797862|58690714|FG001|Overall Study|Abnormal Test Procedure Result|1|||
30676604|NCT00797862|58690715|FG002|Overall Study|Abnormal Test Procedure Result|1|||
30676605|NCT00797862|58690713|FG000|Overall Study|Lack of Efficacy|1|||
30676606|NCT00797862|58690714|FG001|Overall Study|Lack of Efficacy|7|||
30676607|NCT00797862|58690715|FG002|Overall Study|Lack of Efficacy|6|||
30676608|NCT00797862|58690713|FG000|Overall Study|No longer required study medication|1|||
30676609|NCT00797862|58690714|FG001|Overall Study|No longer required study medication|0|||
30676610|NCT00797862|58690715|FG002|Overall Study|No longer required study medication|0|||
30676611|NCT00797862|58690713|FG000|Overall Study|Withdrawal by Subject|14|||
30781910|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
30856063|NCT02581982|58883835|FG000|Overall Study|Physician Decision|1|||
30591803|NCT00479336|58604035|FG003|Overall Study|Protocol Violation|0|||
30676612|NCT00797862|58690714|FG001|Overall Study|Withdrawal by Subject|7|||
30676613|NCT00797862|58690715|FG002|Overall Study|Withdrawal by Subject|7|||
30676614|NCT00797862|58690713|FG000|Overall Study|Lost to Follow-up|11|||
30676615|NCT00797862|58690714|FG001|Overall Study|Lost to Follow-up|0|||
30676616|NCT00797862|58690715|FG002|Overall Study|Lost to Follow-up|5|||
30676617|NCT00797862|58690713|FG000|Overall Study|Administrative Problem|4|||
30676618|NCT00797862|58690714|FG001|Overall Study|Administrative Problem|0|||
30676619|NCT00797862|58690715|FG002|Overall Study|Administrative Problem|0|||
30676620|NCT00797862|58690713|FG000|Overall Study|Protocol Violation|4|||
30676621|NCT00797862|58690714|FG001|Overall Study|Protocol Violation|6|||
30676622|NCT00797862|58690715|FG002|Overall Study|Protocol Violation|8|||
30676623|NCT00797862|58690713|FG000|Overall Study|Mis-randomized|3|||
30676624|NCT00797862|58690714|FG001|Overall Study|Mis-randomized|3|||
30676625|NCT00797862|58690715|FG002|Overall Study|Mis-randomized|1|||
30676626|NCT00794820|58690723|FG000|Overall Study|Adverse Event|11|||
30676627|NCT00794820|58690723|FG000|Overall Study|Secondary Malignancies|2|||
30676628|NCT00794820|58690723|FG000|Overall Study|Resistant Disease|2|||
30676629|NCT00794820|58690723|FG000|Overall Study|Ineligible/Screen Failure|1|||
30676630|NCT00455533|58690729|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
30676631|NCT00455533|58690730|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
30676632|NCT00455533|58690731|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
30676633|NCT00455533|58690729|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
30676634|NCT00455533|58690730|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
30676635|NCT00455533|58690731|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
30676636|NCT00455533|58690729|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
30676637|NCT00455533|58690730|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
30676638|NCT00455533|58690731|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
30676639|NCT00455533|58690729|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
30676640|NCT00455533|58690730|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
30676641|NCT00455533|58690731|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
30676642|NCT00455533|58690729|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
30676643|NCT00455533|58690730|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
30676644|NCT00455533|58690731|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
30676645|NCT00455533|58690729|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
30676646|NCT00455533|58690730|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
30676647|NCT00455533|58690731|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
30676648|NCT00455533|58690729|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
30676649|NCT00455533|58690730|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
30676650|NCT00455533|58690731|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
30676651|NCT00455533|58690729|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
30676652|NCT00455533|58690730|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
30676653|NCT00455533|58690731|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
30676654|NCT00455533|58690729|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
30676655|NCT00455533|58690730|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
30676656|NCT00455533|58690731|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
30676657|NCT00455533|58690729|FG000|Period Two: Randomized Period|Death|0|||
30676658|NCT00455533|58690730|FG001|Period Two: Randomized Period|Death|0|||
30676659|NCT00455533|58690731|FG002|Period Two: Randomized Period|Death|3|||
30676660|NCT00455533|58690729|FG000|Period Two: Randomized Period|Disease Progression|0|||
30676661|NCT00455533|58690730|FG001|Period Two: Randomized Period|Disease Progression|1|||
30676662|NCT00455533|58690731|FG002|Period Two: Randomized Period|Disease Progression|1|||
30676663|NCT00455533|58690729|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
30676664|NCT00455533|58690730|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
30676665|NCT00455533|58690731|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
30676666|NCT00455533|58690729|FG000|Period Two: Randomized Period|Other - need reasons|0|||
30676667|NCT00455533|58690730|FG001|Period Two: Randomized Period|Other - need reasons|1|||
30676668|NCT00455533|58690731|FG002|Period Two: Randomized Period|Other - need reasons|0|||
30676669|NCT00455533|58690729|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
30676670|NCT00455533|58690730|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
30676671|NCT00455533|58690731|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
30676672|NCT00455533|58690729|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
30959015|NCT01587703|59024032|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30959016|NCT01587703|59024033|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30959017|NCT01587703|59024034|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
30676673|NCT00455533|58690730|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
30676674|NCT00455533|58690731|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
30676675|NCT00627094|58690741|FG000|Overall Study|Adverse Event|8|||
30676676|NCT00627094|58690742|FG001|Overall Study|Adverse Event|7|||
30959018|NCT01587703|59024035|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
30676677|NCT00627094|58690741|FG000|Overall Study|Lost to Follow-up|1|||
30676678|NCT00627094|58690742|FG001|Overall Study|Lost to Follow-up|0|||
30676679|NCT00627094|58690741|FG000|Overall Study|Withdrawal by Subject|1|||
30676680|NCT00627094|58690742|FG001|Overall Study|Withdrawal by Subject|1|||
30676681|NCT00627094|58690741|FG000|Overall Study|ulcer healed|1|||
30676682|NCT00627094|58690742|FG001|Overall Study|ulcer healed|7|||
30591804|NCT00479336|58604032|FG000|Overall Study|Withdrawal by Subject|1|||
30591805|NCT00479336|58604033|FG001|Overall Study|Withdrawal by Subject|2|||
30591806|NCT00479336|58604034|FG002|Overall Study|Withdrawal by Subject|0|||
30591807|NCT00479336|58604035|FG003|Overall Study|Withdrawal by Subject|0|||
30676683|NCT00627094|58690741|FG000|Overall Study|Other reason|1|||
30676684|NCT00627094|58690742|FG001|Overall Study|Other reason|0|||
30676685|NCT00642850|58690750|FG000|Overall Study|Death|7|||
30676686|NCT00642850|58690750|FG000|Overall Study|Adverse Event|2|||
30676687|NCT00642850|58690750|FG000|Overall Study|Lack of Efficacy|1|||
30676688|NCT00642850|58690750|FG000|Overall Study|Protocol Violation|2|||
30676689|NCT00642850|58690750|FG000|Overall Study|Kidney transplantation|8|||
30676690|NCT00642850|58690750|FG000|Overall Study|Blood transfusion|6|||
30676691|NCT00642850|58690750|FG000|Overall Study|Other reasons|7|||
30676692|NCT00455455|58690754|FG000|Washout|Withdrawal by Subject|0|||
30676693|NCT00455455|58690755|FG001|Washout|Withdrawal by Subject|1|||
30676694|NCT00455455|58690754|FG000|Washout|Withdrawal by Subject|1|||
30676695|NCT00455455|58690755|FG001|Washout|Withdrawal by Subject|0|||
30676696|NCT03840811|58690767|FG000|Overall Study|Lost to Follow-up|0|||
30676697|NCT03840811|58690768|FG001|Overall Study|Lost to Follow-up|0|||
30676698|NCT03840811|58690769|FG002|Overall Study|Lost to Follow-up|1|||
30676699|NCT00640510|58690779|FG000|Overall Study|Lack of Efficacy|0|||
30676700|NCT00640510|58690780|FG001|Overall Study|Lack of Efficacy|1|||
30676701|NCT00640510|58690779|FG000|Overall Study|Protocol Violation|1|||
30676702|NCT00640510|58690780|FG001|Overall Study|Protocol Violation|0|||
30676703|NCT00640510|58690779|FG000|Overall Study|Physician Decision|0|||
30676704|NCT00640510|58690780|FG001|Overall Study|Physician Decision|1|||
30676705|NCT00813800|58690786|FG000|Overall Study|Screen Failure after Consent|2|||
30676706|NCT00813800|58690786|FG000|Overall Study|Adverse Event|1|||
30676707|NCT00813800|58690786|FG000|Overall Study|Worsening of depression|2|||
30676708|NCT00813800|58690786|FG000|Overall Study|Physician Decision|1|||
30676709|NCT00627016|58690792|FG000|Overall Study|Adverse Event|1|||
30676710|NCT00627016|58690793|FG001|Overall Study|Adverse Event|1|||
30676711|NCT00627016|58690792|FG000|Overall Study|Protocol Violation|0|||
30676712|NCT00627016|58690793|FG001|Overall Study|Protocol Violation|2|||
30591808|NCT00479336|58604032|FG000|Overall Study|Physician Decision|0|||
30591809|NCT00479336|58604033|FG001|Overall Study|Physician Decision|1|||
30591810|NCT00479336|58604034|FG002|Overall Study|Physician Decision|0|||
30591811|NCT00479336|58604035|FG003|Overall Study|Physician Decision|2|||
30591812|NCT00479336|58604032|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
30591813|NCT00479336|58604033|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
30591814|NCT00479336|58604034|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
30591815|NCT00479336|58604035|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
30591816|NCT00478244|58604045|FG000|Overall Study|Did not receive transplant|1|||
30591817|NCT00478205|58604051|FG000|Overall Study|Adverse Event|182|||
30591818|NCT00478205|58604052|FG001|Overall Study|Adverse Event|39|||
30591819|NCT00478205|58604051|FG000|Overall Study|Medication Non-compliance|9|||
30591820|NCT00478205|58604052|FG001|Overall Study|Medication Non-compliance|4|||
30676713|NCT00627016|58690792|FG000|Overall Study|Lost to Follow-up|0|||
30676714|NCT00627016|58690793|FG001|Overall Study|Lost to Follow-up|1|||
30676715|NCT00627016|58690792|FG000|Overall Study|Withdrawal by Subject|2|||
30676716|NCT00627016|58690793|FG001|Overall Study|Withdrawal by Subject|1|||
30676717|NCT00627016|58690792|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
30676718|NCT00627016|58690793|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
30676719|NCT00627016|58690792|FG000|Overall Study|Lack of Efficacy|1|||
30591821|NCT00478205|58604051|FG000|Overall Study|Protocol Violation|15|||
30591822|NCT00478205|58604052|FG001|Overall Study|Protocol Violation|5|||
30676720|NCT00627016|58690793|FG001|Overall Study|Lack of Efficacy|0|||
30591823|NCT00478205|58604051|FG000|Overall Study|Request of Investigator or Sponsor|4|||
30591824|NCT00478205|58604052|FG001|Overall Study|Request of Investigator or Sponsor|5|||
30591825|NCT00478205|58604051|FG000|Overall Study|Withdrawal by Subject|61|||
30591826|NCT00478205|58604052|FG001|Overall Study|Withdrawal by Subject|22|||
30591827|NCT00478205|58604051|FG000|Overall Study|Lack of Efficacy|1|||
30676721|NCT00627016|58690792|FG000|Overall Study|Placed on Excluded Drugs|1|||
30676722|NCT00627016|58690793|FG001|Overall Study|Placed on Excluded Drugs|0|||
30676723|NCT00627016|58690792|FG000|Overall Study|Pregnancy|1|||
30676724|NCT00627016|58690793|FG001|Overall Study|Pregnancy|0|||
30676725|NCT00794664|58690801|FG000|Treatment Period|Withdrawal by Subject|0|||
30676726|NCT00794664|58690802|FG001|Treatment Period|Withdrawal by Subject|2|||
30676727|NCT00794664|58690801|FG000|Treatment Period|Protocol non-compliance|0|||
30676728|NCT00794664|58690802|FG001|Treatment Period|Protocol non-compliance|1|||
30676729|NCT00794664|58690801|FG000|Treatment Period|Other|0|||
30676730|NCT00794664|58690802|FG001|Treatment Period|Other|1|||
30591828|NCT00478205|58604052|FG001|Overall Study|Lack of Efficacy|0|||
30591829|NCT00478205|58604051|FG000|Overall Study|Other|24|||
30591830|NCT00478205|58604052|FG001|Overall Study|Other|12|||
30591831|NCT00477971|58604060|FG000|Overall Study|Disease progression|6|||
30591832|NCT00477971|58604061|FG001|Overall Study|Disease progression|0|||
30591833|NCT00477971|58604060|FG000|Overall Study|Withdrawal by Subject|3|||
30591834|NCT00477971|58604061|FG001|Overall Study|Withdrawal by Subject|1|||
30591835|NCT00477971|58604060|FG000|Overall Study|Adverse Event|3|||
30591836|NCT00477971|58604061|FG001|Overall Study|Adverse Event|0|||
30591837|NCT00477971|58604060|FG000|Overall Study|Death|2|||
30591838|NCT00477971|58604061|FG001|Overall Study|Death|4|||
30591839|NCT00477971|58604060|FG000|Overall Study|Alternative treatment|3|||
30676731|NCT00794664|58690801|FG000|Treatment Period|Adverse Event|1|||
30676732|NCT00794664|58690802|FG001|Treatment Period|Adverse Event|8|||
30676733|NCT00794664|58690801|FG000|Follow-up Period|Other|1|||
30676734|NCT00794664|58690802|FG001|Follow-up Period|Other|2|||
30676735|NCT00794664|58690801|FG000|Follow-up Period|Withdrawal by Subject|0|||
30676736|NCT00794664|58690802|FG001|Follow-up Period|Withdrawal by Subject|2|||
30676737|NCT00794664|58690801|FG000|Follow-up Period|Protocol non-compliance|0|||
30676738|NCT00794664|58690802|FG001|Follow-up Period|Protocol non-compliance|1|||
30676739|NCT00444535|58690808|FG000|Overall Study|Withdrawal by Subject|5|||
30676740|NCT00444535|58690808|FG000|Overall Study|Physician Decision|5|||
30676741|NCT00444535|58690808|FG000|Overall Study|progressive disease|1|||
30676742|NCT00444535|58690808|FG000|Overall Study|Adverse Event|2|||
30676743|NCT00847613|58690816|FG000|Overall Study|Ongoing at cut-off date|250|||
30676744|NCT00847613|58690817|FG001|Overall Study|Ongoing at cut-off date|265|||
30676745|NCT00847613|58690818|FG002|Overall Study|Ongoing at cut-off date|64|||
30676746|NCT00847613|58690819|FG003|Overall Study|Ongoing at cut-off date|64|||
30676747|NCT00847613|58690816|FG000|Overall Study|Death|1|||
30676748|NCT00847613|58690817|FG001|Overall Study|Death|1|||
30676749|NCT00847613|58690818|FG002|Overall Study|Death|0|||
30676750|NCT00847613|58690819|FG003|Overall Study|Death|0|||
30676751|NCT00847613|58690816|FG000|Overall Study|Adverse Event|36|||
30676752|NCT00847613|58690817|FG001|Overall Study|Adverse Event|26|||
30676753|NCT00847613|58690818|FG002|Overall Study|Adverse Event|5|||
30676754|NCT00847613|58690819|FG003|Overall Study|Adverse Event|6|||
30676755|NCT00847613|58690816|FG000|Overall Study|Lack of Efficacy|7|||
30676756|NCT00847613|58690817|FG001|Overall Study|Lack of Efficacy|3|||
30676757|NCT00847613|58690818|FG002|Overall Study|Lack of Efficacy|3|||
30676758|NCT00847613|58690819|FG003|Overall Study|Lack of Efficacy|1|||
30676759|NCT00847613|58690816|FG000|Overall Study|Study terminated by Sponsor|1|||
30676760|NCT00847613|58690817|FG001|Overall Study|Study terminated by Sponsor|0|||
30676761|NCT00847613|58690818|FG002|Overall Study|Study terminated by Sponsor|2|||
30676762|NCT00847613|58690819|FG003|Overall Study|Study terminated by Sponsor|1|||
30676763|NCT00847613|58690816|FG000|Overall Study|Lost to Follow-up|5|||
30676764|NCT00847613|58690817|FG001|Overall Study|Lost to Follow-up|0|||
30676765|NCT00847613|58690818|FG002|Overall Study|Lost to Follow-up|0|||
30676766|NCT00847613|58690819|FG003|Overall Study|Lost to Follow-up|3|||
30676767|NCT00847613|58690816|FG000|Overall Study|Protocol Violation|6|||
30676768|NCT00847613|58690817|FG001|Overall Study|Protocol Violation|6|||
30676769|NCT00847613|58690818|FG002|Overall Study|Protocol Violation|3|||
30676770|NCT00847613|58690819|FG003|Overall Study|Protocol Violation|1|||
30676771|NCT00847613|58690816|FG000|Overall Study|Pregnancy|1|||
30676772|NCT00847613|58690817|FG001|Overall Study|Pregnancy|1|||
30959019|NCT01587703|59024036|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
30959020|NCT01587703|59024037|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
30959021|NCT01587703|59024038|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
30959022|NCT01587703|59024039|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
30959023|NCT01587703|59024040|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30591840|NCT00477971|58604061|FG001|Overall Study|Alternative treatment|1|||
30591841|NCT00477464|58604067|FG000|Overall Study|Lost to Follow-up|1|||
30591842|NCT00477464|58604067|FG000|Overall Study|Death|36|||
30676773|NCT00847613|58690818|FG002|Overall Study|Pregnancy|0|||
30676774|NCT00847613|58690819|FG003|Overall Study|Pregnancy|0|||
30676775|NCT00847613|58690816|FG000|Overall Study|Site closure|1|||
30676776|NCT00847613|58690817|FG001|Overall Study|Site closure|0|||
30591843|NCT00477464|58604067|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
30591844|NCT00477386|58604075|FG000|Overall Study|Adverse Event|4|||
30591845|NCT00477386|58604076|FG001|Overall Study|Adverse Event|8|||
30591846|NCT00477386|58604075|FG000|Overall Study|Disease progression, relapse|3|||
30591847|NCT00477386|58604076|FG001|Overall Study|Disease progression, relapse|4|||
30676777|NCT00847613|58690818|FG002|Overall Study|Site closure|0|||
30676778|NCT00847613|58690819|FG003|Overall Study|Site closure|1|||
30676779|NCT00847613|58690816|FG000|Overall Study|Withdrawal by Subject|8|||
30676780|NCT00847613|58690817|FG001|Overall Study|Withdrawal by Subject|11|||
30676781|NCT00847613|58690818|FG002|Overall Study|Withdrawal by Subject|2|||
30676782|NCT00847613|58690819|FG003|Overall Study|Withdrawal by Subject|2|||
30591848|NCT00477386|58604075|FG000|Overall Study|Disease progression, refractory|1|||
30676783|NCT00847613|58690816|FG000|Overall Study|Participant moved|4|||
30676784|NCT00847613|58690817|FG001|Overall Study|Participant moved|1|||
30676785|NCT00847613|58690818|FG002|Overall Study|Participant moved|0|||
30676786|NCT00847613|58690819|FG003|Overall Study|Participant moved|0|||
30676787|NCT00847613|58690816|FG000|Overall Study|Sponsor request|0|||
30676788|NCT00847613|58690817|FG001|Overall Study|Sponsor request|1|||
30676789|NCT00847613|58690818|FG002|Overall Study|Sponsor request|0|||
30591849|NCT00477386|58604076|FG001|Overall Study|Disease progression, refractory|3|||
30591850|NCT00477386|58604075|FG000|Overall Study|Other|1|||
30591851|NCT00477386|58604076|FG001|Overall Study|Other|2|||
30591852|NCT00477386|58604075|FG000|Overall Study|Physician Decision|1|||
30591853|NCT00477386|58604076|FG001|Overall Study|Physician Decision|0|||
30591854|NCT00477386|58604075|FG000|Overall Study|Withdrawal by Subject|1|||
30591855|NCT00477386|58604076|FG001|Overall Study|Withdrawal by Subject|0|||
30591856|NCT00477269|58604084|FG000|Core Study|Adverse Event|6|||
30591857|NCT00477269|58604085|FG001|Core Study|Adverse Event|4|||
30591858|NCT00477269|58604086|FG002|Core Study|Adverse Event|0|||
30591859|NCT00477269|58604084|FG000|Core Study|Death|3|||
30591860|NCT00477269|58604085|FG001|Core Study|Death|3|||
30591861|NCT00477269|58604086|FG002|Core Study|Death|0|||
30591862|NCT00477269|58604084|FG000|Core Study|Withdrawn Consent|0|||
30591863|NCT00477269|58604085|FG001|Core Study|Withdrawn Consent|1|||
30591864|NCT00477269|58604086|FG002|Core Study|Withdrawn Consent|0|||
30591865|NCT00477269|58604084|FG000|Open Label Extension|Adverse Event|0|||
30591866|NCT00477269|58604085|FG001|Open Label Extension|Adverse Event|0|||
30591867|NCT00477269|58604086|FG002|Open Label Extension|Adverse Event|4|||
30591868|NCT00477269|58604084|FG000|Open Label Extension|Abnormal laboratory values|0|||
30591869|NCT00477269|58604085|FG001|Open Label Extension|Abnormal laboratory values|0|||
30676790|NCT00847613|58690819|FG003|Overall Study|Sponsor request|0|||
30676791|NCT00847613|58690816|FG000|Overall Study|Randomized, but not treated|0|||
30676792|NCT00847613|58690817|FG001|Overall Study|Randomized, but not treated|3|||
30676793|NCT00847613|58690818|FG002|Overall Study|Randomized, but not treated|0|||
30676794|NCT00847613|58690819|FG003|Overall Study|Randomized, but not treated|0|||
30676795|NCT00847613|58690816|FG000|Overall Study|Other|1|||
30676796|NCT00847613|58690817|FG001|Overall Study|Other|1|||
30676797|NCT00847613|58690818|FG002|Overall Study|Other|2|||
30676798|NCT00847613|58690819|FG003|Overall Study|Other|0|||
30676799|NCT00794196|58690838|FG000|Overall Study|Lost to Follow-up|5|||
30676800|NCT00794196|58690839|FG001|Overall Study|Lost to Follow-up|23|||
30676801|NCT00807092|58690847|FG000|Overall Study|Adverse Event|0|||
30676802|NCT00807092|58690848|FG001|Overall Study|Adverse Event|1|||
30676803|NCT00807092|58690847|FG000|Overall Study|Protocol Violation|0|||
30676804|NCT00807092|58690848|FG001|Overall Study|Protocol Violation|2|||
30676805|NCT00807092|58690847|FG000|Overall Study|Withdrawal by Subject|1|||
30676806|NCT00807092|58690848|FG001|Overall Study|Withdrawal by Subject|0|||
30676807|NCT00807092|58690847|FG000|Overall Study|CGMS data collection failed|0|||
30676808|NCT00807092|58690848|FG001|Overall Study|CGMS data collection failed|1|||
30676809|NCT00794118|58690854|FG000|Overall Study|Lost to Follow-up|16|||
30676810|NCT00794118|58690854|FG000|Overall Study|Withdrawal by Subject|9|||
30676811|NCT00794118|58690854|FG000|Overall Study|Changed hospital center|2|||
30676812|NCT00640042|58690858|FG000|Enrollment|Did not receive study drug|83|||
30676813|NCT00807014|58690864|FG000|Overall Study|Participant Considered Disease Cured|13|||
30676814|NCT00807014|58690865|FG001|Overall Study|Participant Considered Disease Cured|2|||
30676815|NCT00807014|58690864|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
30676816|NCT00807014|58690865|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
30676817|NCT00807014|58690864|FG000|Overall Study|Protocol Violation|2|||
30676818|NCT00807014|58690865|FG001|Overall Study|Protocol Violation|8|||
30676819|NCT00807014|58690864|FG000|Overall Study|Adverse Event|0|||
30676820|NCT00807014|58690865|FG001|Overall Study|Adverse Event|2|||
30676821|NCT00807014|58690864|FG000|Overall Study|Lost to Follow-up|9|||
30676822|NCT00807014|58690865|FG001|Overall Study|Lost to Follow-up|7|||
30676823|NCT00807014|58690864|FG000|Overall Study|Recovery|1|||
30591870|NCT00477269|58604086|FG002|Open Label Extension|Abnormal laboratory values|1|||
30676824|NCT00807014|58690865|FG001|Overall Study|Recovery|0|||
30676825|NCT00807014|58690864|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
30676826|NCT00807014|58690865|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
30676827|NCT00847535|58690871|FG000|Overall Study|Withdrawal by Subject|2|||
30676828|NCT00847535|58690872|FG001|Overall Study|Withdrawal by Subject|1|||
30676829|NCT00847535|58690873|FG002|Overall Study|Withdrawal by Subject|1|||
30676830|NCT00847535|58690871|FG000|Overall Study|Lost to Follow-up|0|||
30676831|NCT00847535|58690872|FG001|Overall Study|Lost to Follow-up|1|||
30676832|NCT00847535|58690873|FG002|Overall Study|Lost to Follow-up|0|||
30676833|NCT00592631|58690880|FG000|Overall Study|Lost to Follow-up|0|||
30676834|NCT00592631|58690881|FG001|Overall Study|Lost to Follow-up|2|||
30877163|NCT00106691|58908831|FG001|Overall Study|Lost to Follow-up|18|||
30591871|NCT00477269|58604084|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
30591872|NCT00477269|58604085|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
30676835|NCT00791388|58690892|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
30676836|NCT00791388|58690893|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
30591873|NCT00477269|58604086|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
30591874|NCT00477269|58604084|FG000|Open Label Extension|Adminiatrative problems|0|||
30676837|NCT00791388|58690894|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
30676838|NCT00791388|58690895|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
30676839|NCT00791388|58690896|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
30676840|NCT00791388|58690892|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
30676841|NCT00791388|58690893|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
30676842|NCT00791388|58690894|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
30676843|NCT00791388|58690895|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
30676844|NCT00791388|58690896|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
30676845|NCT00791388|58690892|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
30676846|NCT00791388|58690893|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
30781911|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781912|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781913|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781914|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781915|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781916|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
30781917|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781918|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
30781919|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
30781920|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
30781921|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
30781922|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
30781923|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
30781924|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
30781925|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
30781926|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
30781927|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
30781928|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
30591875|NCT00477269|58604085|FG001|Open Label Extension|Adminiatrative problems|0|||
30591876|NCT00477269|58604086|FG002|Open Label Extension|Adminiatrative problems|2|||
30591877|NCT00477269|58604084|FG000|Open Label Extension|Death|0|||
30591878|NCT00477269|58604085|FG001|Open Label Extension|Death|0|||
30781929|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
30781930|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
30781931|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781932|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781933|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781934|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781935|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781936|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30959024|NCT01587703|59024041|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
30959025|NCT01587703|59024023|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
30959026|NCT01587703|59024024|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
30591879|NCT00477269|58604086|FG002|Open Label Extension|Death|4|||
30591880|NCT00477152|58604094|FG000|Overall Study|Parent withdrew consent|2|||
30591881|NCT00477152|58604094|FG000|Overall Study|Adverse Event|1|||
30591882|NCT00476996|58604101|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
30591883|NCT00476996|58604102|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
30591884|NCT00476996|58604103|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
30591885|NCT00476996|58604104|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
30591886|NCT00476996|58604101|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
30591887|NCT00476996|58604102|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
30591888|NCT00476996|58604103|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
30591889|NCT00476996|58604104|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
30591890|NCT00476996|58604101|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
30591891|NCT00476996|58604102|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
30591892|NCT00476996|58604103|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
30591893|NCT00476996|58604104|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
30591894|NCT00476996|58604101|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
30591895|NCT00476996|58604102|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
30591896|NCT00476996|58604103|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
30591897|NCT00476996|58604104|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
30591898|NCT00476996|58604101|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
30591899|NCT00476996|58604102|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
30591900|NCT00476996|58604103|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
30591901|NCT00476996|58604104|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
30591902|NCT00476996|58604101|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
30676847|NCT00791388|58690894|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
30676848|NCT00791388|58690895|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
30676849|NCT00791388|58690896|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
30676850|NCT00794040|58690910|FG000|Overall Study|Withdrawal by Subject|3|||
30676851|NCT00794040|58690911|FG001|Overall Study|Withdrawal by Subject|4|||
30676852|NCT00794040|58690910|FG000|Overall Study|Physician Decision|0|||
30676853|NCT00794040|58690911|FG001|Overall Study|Physician Decision|1|||
30676854|NCT00813488|58690917|FG000|Titration Period 1|Adverse Event|6|||
30676855|NCT00813488|58690918|FG001|Titration Period 1|Adverse Event|1|||
30676856|NCT00813488|58690917|FG000|Titration Period 1|Lack of Efficacy|9|||
30676857|NCT00813488|58690918|FG001|Titration Period 1|Lack of Efficacy|7|||
30676858|NCT00813488|58690917|FG000|Titration Period 1|Withdrawal by Subject|2|||
30781937|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781938|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
30781939|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
30781940|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
30781941|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781942|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781943|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781944|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781945|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781946|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781947|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781948|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
30781949|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781950|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
30781951|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
30781952|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
30781953|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
30781954|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
30781955|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
30781956|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
30781957|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
30781958|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
30781959|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
30781960|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
30781961|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781962|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781963|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781964|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781965|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781966|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781967|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781968|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
30781969|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
30877164|NCT00106691|58908830|FG000|Overall Study|Physician Decision|18|||
30676859|NCT00813488|58690918|FG001|Titration Period 1|Withdrawal by Subject|2|||
30676860|NCT00813488|58690917|FG000|Titration Period 1|Protocol Violation|4|||
30676861|NCT00813488|58690918|FG001|Titration Period 1|Protocol Violation|3|||
30676862|NCT00813488|58690917|FG000|Titration Period 1|Non-compliance to study medication|4|||
30591903|NCT00476996|58604102|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
30591904|NCT00476996|58604103|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
30591905|NCT00476996|58604104|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
30591906|NCT00476996|58604101|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
30591907|NCT00476996|58604102|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
30676863|NCT00813488|58690918|FG001|Titration Period 1|Non-compliance to study medication|1|||
30676864|NCT00813488|58690917|FG000|Titration Period 1|Non-compliance to study procedures|2|||
30676865|NCT00813488|58690918|FG001|Titration Period 1|Non-compliance to study procedures|2|||
30676866|NCT00813488|58690917|FG000|Titration Period 1|Technical Difficulties|0|||
30676867|NCT00813488|58690918|FG001|Titration Period 1|Technical Difficulties|1|||
30676868|NCT00813488|58690917|FG000|Titration Period 2|Adverse Event|2|||
30676869|NCT00813488|58690918|FG001|Titration Period 2|Adverse Event|3|||
30676870|NCT00813488|58690917|FG000|Titration Period 2|Lack of Efficacy|8|||
30591908|NCT00476996|58604103|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
30591909|NCT00476996|58604104|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
30591910|NCT00476996|58604101|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
30591911|NCT00476996|58604102|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
30591912|NCT00476996|58604103|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
30591913|NCT00476996|58604104|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
30591914|NCT00476996|58604101|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
30591915|NCT00476996|58604102|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
30591916|NCT00476996|58604103|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
30591917|NCT00476996|58604104|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
30591918|NCT00476996|58604101|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
30591919|NCT00476996|58604102|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
30591920|NCT00476996|58604103|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
30591921|NCT00476996|58604104|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
30591922|NCT00476996|58604101|FG000|OLE Phase (From Week 48)|Death|0|||
30591923|NCT00476996|58604102|FG001|OLE Phase (From Week 48)|Death|0|||
30676871|NCT00813488|58690918|FG001|Titration Period 2|Lack of Efficacy|4|||
30676872|NCT00813488|58690917|FG000|Titration Period 2|Protocol Violation|3|||
30676873|NCT00813488|58690918|FG001|Titration Period 2|Protocol Violation|2|||
30676874|NCT00813488|58690917|FG000|Titration Period 2|Lost to Follow-up|1|||
30676875|NCT00813488|58690918|FG001|Titration Period 2|Lost to Follow-up|0|||
30676876|NCT00813488|58690917|FG000|Titration Period 2|Non-compliance with study procedures|2|||
30676877|NCT00813488|58690918|FG001|Titration Period 2|Non-compliance with study procedures|1|||
30676878|NCT00813488|58690917|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
30676879|NCT00813488|58690918|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
30676880|NCT00813488|58690917|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
30781970|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
30781971|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
30781972|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
30781973|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
30781974|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
30591924|NCT00476996|58604103|FG002|OLE Phase (From Week 48)|Death|0|||
30781975|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
30781976|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
30781977|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
30781978|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
30781979|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
30781980|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
30781981|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
30781982|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
30781983|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
30781984|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
30781985|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
30781986|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
30781987|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
30781988|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
30781989|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
30781990|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
30781991|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
30591925|NCT00476996|58604104|FG003|OLE Phase (From Week 48)|Death|7|||
30591926|NCT00476996|58604101|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
30591927|NCT00476996|58604102|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
30591928|NCT00476996|58604103|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
30676881|NCT00813488|58690918|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
30676882|NCT00813488|58690917|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
30781992|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
30877165|NCT00106691|58908831|FG001|Overall Study|Physician Decision|21|||
30591929|NCT00476996|58604104|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
30676883|NCT00813488|58690918|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
30676884|NCT00813488|58690917|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
30676885|NCT00813488|58690918|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
30676886|NCT00813488|58690917|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
30591930|NCT00476996|58604101|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
30591931|NCT00476996|58604102|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
30591932|NCT00476996|58604103|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
30591933|NCT00476996|58604104|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
30591934|NCT00476996|58604101|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
30591935|NCT00476996|58604102|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
30591936|NCT00476996|58604103|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
30676887|NCT00813488|58690918|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
30676888|NCT00813488|58690917|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
30676889|NCT00813488|58690918|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
30676890|NCT00813488|58690917|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
30676891|NCT00813488|58690918|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
30676892|NCT00813488|58690917|FG000|Double-blind Treatment Period 2|Other|1|||
30591937|NCT00476996|58604104|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
30591938|NCT00476996|58604101|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
30676893|NCT00813488|58690918|FG001|Double-blind Treatment Period 2|Other|0|||
30676894|NCT00813488|58690917|FG000|Open-label Extension|Adverse Event|1|||
30676895|NCT00813488|58690918|FG001|Open-label Extension|Adverse Event|2|||
30676896|NCT00813488|58690917|FG000|Open-label Extension|Lack of Efficacy|3|||
30676897|NCT00813488|58690918|FG001|Open-label Extension|Lack of Efficacy|0|||
30676898|NCT00813488|58690917|FG000|Open-label Extension|Withdrawal by Subject|0|||
30676899|NCT00813488|58690918|FG001|Open-label Extension|Withdrawal by Subject|2|||
30676900|NCT00813488|58690917|FG000|Open-label Extension|Protocol Violation|1|||
30676901|NCT00813488|58690918|FG001|Open-label Extension|Protocol Violation|2|||
30676902|NCT00813488|58690917|FG000|Open-label Extension|Non-compliance study medication|4|||
30676903|NCT00813488|58690918|FG001|Open-label Extension|Non-compliance study medication|0|||
30591939|NCT00476996|58604102|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
30591940|NCT00476996|58604103|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
30676904|NCT00813488|58690917|FG000|Open-label Extension|Non-compliance study procedures|2|||
30676905|NCT00813488|58690918|FG001|Open-label Extension|Non-compliance study procedures|1|||
30676906|NCT00813488|58690917|FG000|Open-label Extension|Other|1|||
30676907|NCT00813488|58690918|FG001|Open-label Extension|Other|0|||
30676908|NCT00797316|58690930|FG000|Overall Study|Administrative problems|1|||
30676909|NCT00797316|58690931|FG001|Overall Study|Administrative problems|0|||
30676910|NCT00797316|58690930|FG000|Overall Study|Adverse Event|5|||
30676911|NCT00797316|58690931|FG001|Overall Study|Adverse Event|3|||
30676912|NCT00797316|58690930|FG000|Overall Study|Lost to Follow-up|4|||
30676913|NCT00797316|58690931|FG001|Overall Study|Lost to Follow-up|8|||
30676914|NCT00797316|58690930|FG000|Overall Study|Protocol Deviation|1|||
30676915|NCT00797316|58690931|FG001|Overall Study|Protocol Deviation|2|||
30676916|NCT00797316|58690930|FG000|Overall Study|Patient withdrew consent|12|||
30676917|NCT00797316|58690931|FG001|Overall Study|Patient withdrew consent|6|||
30676918|NCT00797316|58690930|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30676919|NCT00797316|58690931|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
30676920|NCT00587964|58690937|FG000|Overall Study|Withdrawal by Subject|1|||
30676921|NCT00587964|58690937|FG000|Overall Study|Lost to Follow-up|1|||
30676922|NCT00587964|58690937|FG000|Overall Study|Patient found to be ineligible|1|||
30676923|NCT00587964|58690937|FG000|Overall Study|Patient did not receive intervention|5|||
30676924|NCT00587964|58690937|FG000|Overall Study|Progression of Disease|4|||
30676925|NCT00590954|58690941|FG000|Overall Study|Inevaluable|2|||
30676926|NCT00791076|58690947|FG000|Overall Study|Study was terminated,PI left institution|8|||
30676927|NCT00590720|58690955|FG000|Overall Study|Lost to Follow-up|1|||
30676928|NCT00590720|58690956|FG001|Overall Study|Lost to Follow-up|0|||
30676929|NCT00590720|58690955|FG000|Overall Study|Withdrawal by Subject|0|||
30676930|NCT00590720|58690956|FG001|Overall Study|Withdrawal by Subject|1|||
30676931|NCT00625378|58690964|FG000|Overall Study|Adverse Event|22|||
30676932|NCT00625378|58690965|FG001|Overall Study|Adverse Event|0|||
30676933|NCT00625378|58690964|FG000|Overall Study|Withdrawal by Subject|16|||
30676934|NCT00625378|58690965|FG001|Overall Study|Withdrawal by Subject|0|||
30591941|NCT00476996|58604104|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
30676935|NCT00625378|58690964|FG000|Overall Study|Death|38|||
30676936|NCT00625378|58690965|FG001|Overall Study|Death|0|||
30676937|NCT00625378|58690964|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
30959027|NCT01587703|59024025|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
30591942|NCT00476957|58604115|FG000|Overall Study|Lost to Follow-up|176|||
30676938|NCT00625378|58690965|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
30676939|NCT00625378|58690964|FG000|Overall Study|Lost to Follow-up|17|||
30591943|NCT00476957|58604116|FG001|Overall Study|Lost to Follow-up|193|||
30591944|NCT00475865|58604125|FG000|Overall Study|Adverse Event|0|||
30591945|NCT00475865|58604126|FG001|Overall Study|Adverse Event|3|||
30591946|NCT00475865|58604127|FG002|Overall Study|Adverse Event|4|||
30591947|NCT00475865|58604125|FG000|Overall Study|Lack of Efficacy|1|||
30591948|NCT00475865|58604126|FG001|Overall Study|Lack of Efficacy|0|||
30591949|NCT00475865|58604127|FG002|Overall Study|Lack of Efficacy|0|||
30591950|NCT00475865|58604125|FG000|Overall Study|Progressive disease|0|||
30591951|NCT00475865|58604126|FG001|Overall Study|Progressive disease|1|||
30591952|NCT00475865|58604127|FG002|Overall Study|Progressive disease|2|||
30591953|NCT00475865|58604125|FG000|Overall Study|Participant did not wish to continue|1|||
30591954|NCT00475865|58604126|FG001|Overall Study|Participant did not wish to continue|0|||
30591955|NCT00475865|58604127|FG002|Overall Study|Participant did not wish to continue|0|||
30591956|NCT00475865|58604125|FG000|Overall Study|Other than above|0|||
30591957|NCT00475865|58604126|FG001|Overall Study|Other than above|1|||
30591958|NCT00475865|58604127|FG002|Overall Study|Other than above|0|||
30591959|NCT00475709|58604137|FG000|Overall Study|Did not meet eligibility criteria|8|||
30591960|NCT00475709|58604137|FG000|Overall Study|Death|41|||
30591961|NCT00475709|58604137|FG000|Overall Study|Device Explant|6|||
30591962|NCT00475709|58604137|FG000|Overall Study|Lost to Follow-up|21|||
30591963|NCT00475670|58604143|FG000|Overall Study|Death|0|||
30591964|NCT00475670|58604144|FG001|Overall Study|Death|1|||
30591965|NCT00475670|58604143|FG000|Overall Study|Lack of Efficacy|3|||
30591966|NCT00475670|58604144|FG001|Overall Study|Lack of Efficacy|34|||
30591967|NCT00475670|58604143|FG000|Overall Study|Refused treatment|0|||
30591968|NCT00475670|58604144|FG001|Overall Study|Refused treatment|2|||
30591969|NCT00475670|58604143|FG000|Overall Study|Failure to Return|0|||
30591970|NCT00475670|58604144|FG001|Overall Study|Failure to Return|1|||
30591971|NCT00475670|58604143|FG000|Overall Study|Other|0|||
30591972|NCT00475670|58604144|FG001|Overall Study|Other|3|||
30591973|NCT00474968|58604152|FG000|Overall Study|Withdrawal by Subject|8|||
30591974|NCT00474968|58604153|FG001|Overall Study|Withdrawal by Subject|7|||
30591975|NCT00474968|58604152|FG000|Overall Study|Protocol Violation|9|||
30591976|NCT00474968|58604153|FG001|Overall Study|Protocol Violation|8|||
30591977|NCT00474968|58604152|FG000|Overall Study|Sample not collected|1|||
30591978|NCT00474968|58604153|FG001|Overall Study|Sample not collected|1|||
30591979|NCT00474929|58604164|FG000|Overall Study|Withdrawal by Subject|0|||
30591980|NCT00474929|58604165|FG001|Overall Study|Withdrawal by Subject|1|||
30591981|NCT00474929|58604166|FG002|Overall Study|Withdrawal by Subject|0|||
30591982|NCT00474929|58604167|FG003|Overall Study|Withdrawal by Subject|0|||
30591983|NCT00474929|58604168|FG004|Overall Study|Withdrawal by Subject|0|||
30591984|NCT00474929|58604164|FG000|Overall Study|Unrelated medical condition|0|||
30591985|NCT00474929|58604165|FG001|Overall Study|Unrelated medical condition|0|||
30591986|NCT00474929|58604166|FG002|Overall Study|Unrelated medical condition|1|||
30591987|NCT00474929|58604167|FG003|Overall Study|Unrelated medical condition|0|||
30591988|NCT00474929|58604168|FG004|Overall Study|Unrelated medical condition|0|||
30591989|NCT00474929|58604164|FG000|Overall Study|Physician Decision|0|||
30591990|NCT00474929|58604165|FG001|Overall Study|Physician Decision|0|||
30591991|NCT00474929|58604166|FG002|Overall Study|Physician Decision|1|||
30591992|NCT00474929|58604167|FG003|Overall Study|Physician Decision|2|||
30591993|NCT00474929|58604168|FG004|Overall Study|Physician Decision|0|||
30591994|NCT00474812|58604181|FG000|Overall Study|Withdrawal by Subject|5|||
30591995|NCT00474812|58604181|FG000|Overall Study|No Initiation of treatment|2|||
30591996|NCT00474383|58604185|FG000|Main Study|Adverse Event|11|||
30591997|NCT00474383|58604186|FG001|Main Study|Adverse Event|0|||
30591998|NCT00474383|58604185|FG000|Main Study|Symptomatic Deterioration|1|||
30591999|NCT00474383|58604186|FG001|Main Study|Symptomatic Deterioration|0|||
30592000|NCT00474383|58604185|FG000|Main Study|Progressive Disease|23|||
30592001|NCT00474383|58604186|FG001|Main Study|Progressive Disease|0|||
30592002|NCT00474383|58604185|FG000|Main Study|Other|1|||
30592003|NCT00474383|58604186|FG001|Main Study|Other|0|||
30592004|NCT00474383|58604185|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
30592005|NCT00474383|58604186|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
30592006|NCT00474383|58604185|FG000|Extension|Progressive Disease|0|||
30592007|NCT00474383|58604186|FG001|Extension|Progressive Disease|5|||
30592008|NCT00474266|58604194|FG000|Overall Study|Withdrawal by Subject|7|||
30592009|NCT00474266|58604195|FG001|Overall Study|Withdrawal by Subject|20|||
30592010|NCT00474266|58604196|FG002|Overall Study|Withdrawal by Subject|4|||
30592011|NCT00474266|58604197|FG003|Overall Study|Withdrawal by Subject|7|||
30592012|NCT00473564|58604210|FG000|Overall Study|robot surgery aborted in OR|23|||
30592013|NCT00472199|58604216|FG000|Overall Study|Adverse Event|19|||
30592014|NCT00472199|58604217|FG001|Overall Study|Adverse Event|23|||
30592015|NCT00472199|58604216|FG000|Overall Study|Lack of Efficacy|4|||
30592016|NCT00472199|58604217|FG001|Overall Study|Lack of Efficacy|25|||
30592017|NCT00472199|58604216|FG000|Overall Study|Lost to Follow-up|2|||
30592018|NCT00472199|58604217|FG001|Overall Study|Lost to Follow-up|4|||
30592019|NCT00472199|58604216|FG000|Overall Study|Protocol Violation|3|||
30592020|NCT00472199|58604217|FG001|Overall Study|Protocol Violation|2|||
30592021|NCT00472199|58604216|FG000|Overall Study|Withdrawal by Subject|6|||
30592022|NCT00472199|58604217|FG001|Overall Study|Withdrawal by Subject|5|||
30592023|NCT00472199|58604216|FG000|Overall Study|personal reason|0|||
30592024|NCT00472199|58604217|FG001|Overall Study|personal reason|1|||
30592025|NCT00472199|58604216|FG000|Overall Study|patient was asymptomatic|1|||
30592026|NCT00472199|58604217|FG001|Overall Study|patient was asymptomatic|0|||
30592027|NCT00472082|58604223|FG000|Overall Study|Study prematurely terminated|5|||
30592028|NCT00471887|58604227|FG000|Overall Study|Adverse Event|9|||
30592029|NCT00471536|58604231|FG000|Overall Study|Withdrawal by Subject|1|||
30592030|NCT00470834|58604237|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
30592031|NCT00470834|58604238|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
30592032|NCT00470834|58604237|FG000|Treatment Period (18 Months)|Adverse Event|7|||
30676940|NCT00625378|58690965|FG001|Overall Study|Lost to Follow-up|0|||
30676941|NCT00625378|58690964|FG000|Overall Study|Non-compliant with study medication|3|||
30676942|NCT00625378|58690965|FG001|Overall Study|Non-compliant with study medication|0|||
30676943|NCT00625378|58690964|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
30676944|NCT00625378|58690965|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
30676945|NCT00625378|58690964|FG000|Overall Study|Medical decision|1|||
30676946|NCT00625378|58690965|FG001|Overall Study|Medical decision|0|||
30676947|NCT00625378|58690964|FG000|Overall Study|Multiple toxicities|1|||
30676948|NCT00625378|58690965|FG001|Overall Study|Multiple toxicities|0|||
30676949|NCT00625378|58690964|FG000|Overall Study|New cancer|1|||
30676950|NCT00625378|58690965|FG001|Overall Study|New cancer|0|||
30676951|NCT00625378|58690964|FG000|Overall Study|PTA program|2|||
30676952|NCT00625378|58690965|FG001|Overall Study|PTA program|0|||
30676953|NCT00625378|58690964|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
30676954|NCT00625378|58690965|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
30676955|NCT00625378|58690964|FG000|Overall Study|Sponsor decision|1|||
30676956|NCT00625378|58690965|FG001|Overall Study|Sponsor decision|0|||
30676957|NCT00625378|58690964|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
30676958|NCT00625378|58690965|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
30676959|NCT00625378|58690964|FG000|Overall Study|Switch to commercial drug|6|||
30676960|NCT00625378|58690965|FG001|Overall Study|Switch to commercial drug|1|||
30676961|NCT00625378|58690964|FG000|Overall Study|Missing|2|||
30676962|NCT00625378|58690965|FG001|Overall Study|Missing|0|||
30676963|NCT00625378|58690964|FG000|Overall Study|End of treatment not available|2|||
30676964|NCT00625378|58690965|FG001|Overall Study|End of treatment not available|0|||
30676965|NCT00625378|58690964|FG000|Overall Study|Never treated|2|||
30676966|NCT00625378|58690965|FG001|Overall Study|Never treated|0|||
30676967|NCT00806624|58690974|FG000|Overall Study|Adverse Event|2|||
30676968|NCT00806624|58690975|FG001|Overall Study|Adverse Event|8|||
30676969|NCT00806624|58690976|FG002|Overall Study|Adverse Event|0|||
30676970|NCT00806624|58690974|FG000|Overall Study|Death|0|||
30676971|NCT00806624|58690975|FG001|Overall Study|Death|1|||
30676972|NCT00806624|58690976|FG002|Overall Study|Death|1|||
30676973|NCT00806624|58690974|FG000|Overall Study|Lost to Follow-up|1|||
30676974|NCT00806624|58690975|FG001|Overall Study|Lost to Follow-up|0|||
30676975|NCT00806624|58690976|FG002|Overall Study|Lost to Follow-up|1|||
30676976|NCT00806624|58690974|FG000|Overall Study|Withdrawal by Subject|6|||
30676977|NCT00806624|58690975|FG001|Overall Study|Withdrawal by Subject|3|||
30676978|NCT00806624|58690976|FG002|Overall Study|Withdrawal by Subject|3|||
30676979|NCT00806624|58690974|FG000|Overall Study|discontinued before start of treatment|0|||
30676980|NCT00806624|58690975|FG001|Overall Study|discontinued before start of treatment|0|||
30676981|NCT00806624|58690976|FG002|Overall Study|discontinued before start of treatment|1|||
30676982|NCT00806546|58690984|FG000|Overall Study|Enrolled, not treated|35|||
30676983|NCT00806546|58690984|FG000|Overall Study|Lost to Follow-up|32|||
30676984|NCT00806546|58690984|FG000|Overall Study|Adverse Event|74|||
30676985|NCT00806546|58690984|FG000|Overall Study|Withdrawal by Subject|75|||
30676986|NCT00806546|58690984|FG000|Overall Study|Protocol Violation|49|||
30676987|NCT00806546|58690984|FG000|Overall Study|Various|42|||
30592033|NCT00470834|58604238|FG001|Treatment Period (18 Months)|Adverse Event|6|||
30592034|NCT00470834|58604237|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
30592035|NCT00470834|58604238|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
30592036|NCT00470834|58604237|FG000|Treatment Period (18 Months)|Physician Decision|4|||
30592037|NCT00470834|58604238|FG001|Treatment Period (18 Months)|Physician Decision|4|||
30592038|NCT00470834|58604237|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
30592039|NCT00470834|58604238|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
30592040|NCT00470834|58604237|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
30676988|NCT00624832|58690992|FG000|Overall Study|Adverse Event|0|||
30676989|NCT00624832|58690993|FG001|Overall Study|Adverse Event|1|||
30676990|NCT00624832|58690994|FG002|Overall Study|Adverse Event|0|||
30676991|NCT00624832|58690995|FG003|Overall Study|Adverse Event|1|||
30676992|NCT00624832|58690992|FG000|Overall Study|Abnormal Laboratory Value|2|||
30676993|NCT00624832|58690993|FG001|Overall Study|Abnormal Laboratory Value|0|||
30592041|NCT00470834|58604238|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
30676994|NCT00624832|58690994|FG002|Overall Study|Abnormal Laboratory Value|0|||
30592042|NCT00470834|58604237|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
30592043|NCT00470834|58604238|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
30592044|NCT00470834|58604237|FG000|Treatment Period (18 Months)|Non-compliance|1|||
30592045|NCT00470834|58604238|FG001|Treatment Period (18 Months)|Non-compliance|0|||
30592046|NCT00470834|58604237|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
30592047|NCT00470834|58604238|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
30592048|NCT00470834|58604237|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
30592049|NCT00470834|58604238|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
30592050|NCT00470834|58604237|FG000|Extension Period (24 Months)|Adverse Event|3|||
30592051|NCT00470834|58604238|FG001|Extension Period (24 Months)|Adverse Event|4|||
30592052|NCT00470834|58604237|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
30592053|NCT00470834|58604238|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
30592054|NCT00470834|58604237|FG000|Extension Period (24 Months)|Physician Decision|4|||
30592055|NCT00470834|58604238|FG001|Extension Period (24 Months)|Physician Decision|3|||
30592056|NCT00470834|58604237|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
30592057|NCT00470834|58604238|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
30592058|NCT00470834|58604237|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
30592059|NCT00470834|58604238|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
30592060|NCT00470834|58604237|FG000|Extension Period (24 Months)|Non-compliance|0|||
30592061|NCT00470834|58604238|FG001|Extension Period (24 Months)|Non-compliance|1|||
30592062|NCT00470834|58604237|FG000|Extension Period (24 Months)|Disease Progression|0|||
30592063|NCT00470834|58604238|FG001|Extension Period (24 Months)|Disease Progression|1|||
30676995|NCT00624832|58690995|FG003|Overall Study|Abnormal Laboratory Value|0|||
30676996|NCT00633880|58691007|FG000|Open Label Titration|Lack of Efficacy|1|||
30676997|NCT00633880|58691008|FG001|Open Label Titration|Lack of Efficacy|0|||
30676998|NCT00633880|58691009|FG002|Open Label Titration|Lack of Efficacy|0|||
30676999|NCT00633880|58691007|FG000|Open Label Titration|Adverse Event|13|||
30677000|NCT00633880|58691008|FG001|Open Label Titration|Adverse Event|0|||
30677001|NCT00633880|58691009|FG002|Open Label Titration|Adverse Event|0|||
30677002|NCT00633880|58691007|FG000|Open Label Titration|Treatment Failure|55|||
30677003|NCT00633880|58691008|FG001|Open Label Titration|Treatment Failure|0|||
30677004|NCT00633880|58691009|FG002|Open Label Titration|Treatment Failure|0|||
30677005|NCT00633880|58691007|FG000|Open Label Titration|Protocol Violation|6|||
30677006|NCT00633880|58691008|FG001|Open Label Titration|Protocol Violation|0|||
30677007|NCT00633880|58691009|FG002|Open Label Titration|Protocol Violation|0|||
30677008|NCT00633880|58691007|FG000|Open Label Titration|Physician Decision|1|||
30677009|NCT00633880|58691008|FG001|Open Label Titration|Physician Decision|0|||
30677010|NCT00633880|58691009|FG002|Open Label Titration|Physician Decision|0|||
30677011|NCT00633880|58691007|FG000|Open Label Titration|Withdrawal by Subject|4|||
30677012|NCT00633880|58691008|FG001|Open Label Titration|Withdrawal by Subject|0|||
30677013|NCT00633880|58691009|FG002|Open Label Titration|Withdrawal by Subject|0|||
30677014|NCT00590564|58691016|FG000|Overall Study|Withdrawal by Subject|4|||
30677015|NCT00590564|58691016|FG000|Overall Study|Lost to Follow-up|6|||
30677016|NCT00590564|58691016|FG000|Overall Study|Protocol Violation|1|||
30677017|NCT00590564|58691016|FG000|Overall Study|Patient Found to be Ineligible|1|||
30677018|NCT00590564|58691016|FG000|Overall Study|Patient Non-compliance|6|||
30677019|NCT00631696|58691022|FG000|Overall Study|Entered, not randomized to treatment|1|||
30677020|NCT00631696|58691023|FG001|Overall Study|Entered, not randomized to treatment|1|||
30677021|NCT00631696|58691022|FG000|Overall Study|Discontinued after database release date|1|||
30677022|NCT00631696|58691023|FG001|Overall Study|Discontinued after database release date|0|||
30677023|NCT00631696|58691022|FG000|Overall Study|Follow up after database release date|1|||
30677024|NCT00631696|58691023|FG001|Overall Study|Follow up after database release date|0|||
30677025|NCT00631696|58691022|FG000|Overall Study|Lost to Follow-up|7|||
30677026|NCT00631696|58691023|FG001|Overall Study|Lost to Follow-up|10|||
30677027|NCT00631696|58691022|FG000|Overall Study|Withdrawal by Subject|2|||
30677028|NCT00631696|58691023|FG001|Overall Study|Withdrawal by Subject|9|||
30677029|NCT00631696|58691022|FG000|Overall Study|Other|8|||
30677030|NCT00631696|58691023|FG001|Overall Study|Other|8|||
30677031|NCT00631696|58691022|FG000|Overall Study|Protocol Violation|9|||
30677032|NCT00631696|58691023|FG001|Overall Study|Protocol Violation|9|||
30677033|NCT00631696|58691022|FG000|Overall Study|Study terminated by sponsor|3|||
30677034|NCT00631696|58691023|FG001|Overall Study|Study terminated by sponsor|3|||
30677035|NCT00631696|58691022|FG000|Overall Study|Adverse Event|5|||
30677036|NCT00631696|58691023|FG001|Overall Study|Adverse Event|0|||
30677037|NCT00631540|58691029|FG000|Overall Study|Withdrawal by Subject|5|||
30592064|NCT00470366|58604244|FG000|Overall Study|Adverse Event|3|||
30592065|NCT00470366|58604244|FG000|Overall Study|Poor compliance|1|||
30677038|NCT00631540|58691029|FG000|Overall Study|Death|4|||
30677039|NCT00631540|58691029|FG000|Overall Study|Lost to Follow-up|2|||
30677040|NCT00631540|58691029|FG000|Overall Study|Core Lab Data Unavailable|3|||
30677041|NCT00630916|58691033|FG000|Overall Study|Death|110|||
30677042|NCT00630916|58691033|FG000|Overall Study|Explant|8|||
30677043|NCT00630916|58691033|FG000|Overall Study|Lost to Follow-up|5|||
30677044|NCT00630916|58691033|FG000|Overall Study|Withdrawal by Subject|30|||
30677045|NCT00630916|58691033|FG000|Overall Study|Protocol Violation|7|||
30677046|NCT00630916|58691033|FG000|Overall Study|Physician Decision|47|||
30677047|NCT00630916|58691033|FG000|Overall Study|Lack of Efficacy|3|||
30677048|NCT00630292|58691037|FG000|Overall Study|Withdrawal by Subject|1|||
30677049|NCT00626548|58691043|FG000|Overall Study|Adverse Event|164|||
30677050|NCT00626548|58691044|FG001|Overall Study|Adverse Event|44|||
30677051|NCT00626548|58691043|FG000|Overall Study|Withdrawal by Subject|42|||
30677052|NCT00626548|58691044|FG001|Overall Study|Withdrawal by Subject|46|||
30677053|NCT00626548|58691043|FG000|Overall Study|Protocol Violation|4|||
30677054|NCT00626548|58691044|FG001|Overall Study|Protocol Violation|11|||
30677055|NCT00626548|58691043|FG000|Overall Study|Lost to Follow-up|2|||
30677056|NCT00626548|58691044|FG001|Overall Study|Lost to Follow-up|2|||
30677057|NCT00626548|58691043|FG000|Overall Study|Other termination reason|493|||
30677058|NCT00626548|58691044|FG001|Overall Study|Other termination reason|613|||
30781993|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
30781994|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
30781995|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
30781996|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
30781997|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
30592066|NCT00470093|58604248|FG000|Overall Study|Adverse Event|2|||
30592067|NCT00470054|58604252|FG000|Overall Study|Ineligible|1|||
30592068|NCT00474188|58604256|FG000|Overall Study|Withdrawal by Subject|1|||
30592069|NCT00474188|58604256|FG000|Overall Study|Study discontinued by sponsor|5|||
30592070|NCT00475982|58604261|FG000|Overall Study|surgery rescheduled|7|||
30592071|NCT00475982|58604262|FG001|Overall Study|surgery rescheduled|3|||
30592072|NCT01089647|58604270|FG000|Overall Study|Lost to Follow-up|2|||
30592073|NCT01089647|58604271|FG001|Overall Study|Lost to Follow-up|2|||
30592074|NCT01089647|58604270|FG000|Overall Study|Withdrawal by Subject|2|||
30592075|NCT01089647|58604271|FG001|Overall Study|Withdrawal by Subject|1|||
30592076|NCT01089647|58604270|FG000|Overall Study|Adverse Event|0|||
30592077|NCT01089647|58604271|FG001|Overall Study|Adverse Event|1|||
30592078|NCT01089608|58604279|FG000|Overall Study|Adverse Event|0|||
30592079|NCT01089608|58604280|FG001|Overall Study|Adverse Event|4|||
30592080|NCT01089608|58604279|FG000|Overall Study|Lost to Follow-up|0|||
30592081|NCT01089608|58604280|FG001|Overall Study|Lost to Follow-up|2|||
30592082|NCT01089413|58604289|FG000|Overall Study|Lost to Follow-up|1|||
30592083|NCT01089413|58604289|FG000|Overall Study|Progressive Disease|93|||
30592084|NCT01089413|58604289|FG000|Overall Study|Participant Withdrew Consent|1|||
30592085|NCT01089413|58604289|FG000|Overall Study|Unacceptable Toxicity|12|||
30592086|NCT01089413|58604289|FG000|Overall Study|Death|10|||
30592087|NCT01089413|58604289|FG000|Overall Study|Metastasectomy|13|||
30592088|NCT01089413|58604289|FG000|Overall Study|Other|71|||
30592089|NCT01089023|58604299|FG000|Overall Study|Lost to Follow-up|3|||
30592090|NCT01089023|58604299|FG000|Overall Study|Adverse Event|1|||
30592091|NCT01089023|58604299|FG000|Overall Study|Withdrawal by Subject|1|||
30592092|NCT01089023|58604299|FG000|Overall Study|Protocol Violation|1|||
30592093|NCT01089023|58604299|FG000|Overall Study|Lack of Efficacy|1|||
30592094|NCT01088984|58604305|FG000|Phase 1|Death|2|||
30592095|NCT01088984|58604306|FG001|Phase 1|Death|1|||
30592096|NCT01088984|58604305|FG000|Phase 1|Disease Progression|2|||
30592097|NCT01088984|58604306|FG001|Phase 1|Disease Progression|4|||
30781998|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
30781999|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
30782000|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
30782001|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
30782002|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
30782003|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
30782004|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
30782005|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
30592098|NCT01088984|58604305|FG000|Phase 1|Other|1|||
30592099|NCT01088984|58604306|FG001|Phase 1|Other|1|||
30592100|NCT01088984|58604305|FG000|Phase 2|Death|0|||
30592101|NCT01088984|58604306|FG001|Phase 2|Death|5|||
30592102|NCT01088984|58604305|FG000|Phase 2|Withdrawal by Subject|0|||
30592103|NCT01088984|58604306|FG001|Phase 2|Withdrawal by Subject|1|||
30592104|NCT01088984|58604305|FG000|Phase 2|DIsease Progression|0|||
30592105|NCT01088984|58604306|FG001|Phase 2|DIsease Progression|25|||
30592106|NCT01088984|58604305|FG000|Phase 2|Other|0|||
30592107|NCT01088984|58604306|FG001|Phase 2|Other|1|||
30592108|NCT01088438|58604317|FG000|Overall Study|Withdrawal by Subject|11|||
30592109|NCT01088438|58604318|FG001|Overall Study|Withdrawal by Subject|6|||
30592110|NCT01088438|58604317|FG000|Overall Study|Lost to Follow-up|18|||
30592111|NCT01088438|58604318|FG001|Overall Study|Lost to Follow-up|30|||
30592112|NCT01088243|58604326|FG000|Overall Study|Adverse Event|1|||
30592113|NCT01088243|58604327|FG001|Overall Study|Adverse Event|0|||
30677059|NCT00847379|58691053|FG000|Overall Study|Study terminated by Sponsor|59|||
30677060|NCT00847379|58691054|FG001|Overall Study|Study terminated by Sponsor|57|||
30677061|NCT00847379|58691055|FG002|Overall Study|Study terminated by Sponsor|57|||
30592114|NCT01088048|58604343|FG000|Overall Study|Adverse Event|7|||
30592115|NCT01088048|58604344|FG001|Overall Study|Adverse Event|9|||
30592116|NCT01088048|58604345|FG002|Overall Study|Adverse Event|7|||
30592117|NCT01088048|58604346|FG003|Overall Study|Adverse Event|5|||
30592118|NCT01088048|58604347|FG004|Overall Study|Adverse Event|6|||
30592119|NCT01088048|58604348|FG005|Overall Study|Adverse Event|3|||
30592120|NCT01088048|58604349|FG006|Overall Study|Adverse Event|3|||
30592121|NCT01088048|58604350|FG007|Overall Study|Adverse Event|0|||
30592122|NCT01088048|58604351|FG008|Overall Study|Adverse Event|2|||
30592123|NCT01088048|58604352|FG009|Overall Study|Adverse Event|2|||
30592124|NCT01088048|58604343|FG000|Overall Study|Withdrew Consent|1|||
30592125|NCT01088048|58604344|FG001|Overall Study|Withdrew Consent|1|||
30592126|NCT01088048|58604345|FG002|Overall Study|Withdrew Consent|1|||
30592127|NCT01088048|58604346|FG003|Overall Study|Withdrew Consent|1|||
30592128|NCT01088048|58604347|FG004|Overall Study|Withdrew Consent|2|||
30592129|NCT01088048|58604348|FG005|Overall Study|Withdrew Consent|1|||
30592130|NCT01088048|58604349|FG006|Overall Study|Withdrew Consent|0|||
30592131|NCT01088048|58604350|FG007|Overall Study|Withdrew Consent|2|||
30592132|NCT01088048|58604351|FG008|Overall Study|Withdrew Consent|2|||
30592133|NCT01088048|58604352|FG009|Overall Study|Withdrew Consent|1|||
30592134|NCT01088048|58604343|FG000|Overall Study|Concomitant Medication Prohibited|1|||
30592135|NCT01088048|58604344|FG001|Overall Study|Concomitant Medication Prohibited|0|||
30592136|NCT01088048|58604345|FG002|Overall Study|Concomitant Medication Prohibited|0|||
30592137|NCT01088048|58604346|FG003|Overall Study|Concomitant Medication Prohibited|0|||
30592138|NCT01088048|58604347|FG004|Overall Study|Concomitant Medication Prohibited|0|||
30592139|NCT01088048|58604348|FG005|Overall Study|Concomitant Medication Prohibited|0|||
30592140|NCT01088048|58604349|FG006|Overall Study|Concomitant Medication Prohibited|0|||
30592141|NCT01088048|58604350|FG007|Overall Study|Concomitant Medication Prohibited|0|||
30592142|NCT01088048|58604351|FG008|Overall Study|Concomitant Medication Prohibited|0|||
30592143|NCT01088048|58604352|FG009|Overall Study|Concomitant Medication Prohibited|0|||
30592144|NCT01088048|58604343|FG000|Overall Study|Investigator Request|2|||
30592145|NCT01088048|58604344|FG001|Overall Study|Investigator Request|2|||
30592146|NCT01088048|58604345|FG002|Overall Study|Investigator Request|0|||
30592147|NCT01088048|58604346|FG003|Overall Study|Investigator Request|0|||
30592148|NCT01088048|58604347|FG004|Overall Study|Investigator Request|3|||
30592149|NCT01088048|58604348|FG005|Overall Study|Investigator Request|1|||
30592150|NCT01088048|58604349|FG006|Overall Study|Investigator Request|1|||
30592151|NCT01088048|58604350|FG007|Overall Study|Investigator Request|0|||
30592152|NCT01088048|58604351|FG008|Overall Study|Investigator Request|0|||
30592153|NCT01088048|58604352|FG009|Overall Study|Investigator Request|0|||
30592154|NCT01088048|58604343|FG000|Overall Study|Patient Non-compliance|0|||
30592155|NCT01088048|58604344|FG001|Overall Study|Patient Non-compliance|1|||
30592156|NCT01088048|58604345|FG002|Overall Study|Patient Non-compliance|0|||
30592157|NCT01088048|58604346|FG003|Overall Study|Patient Non-compliance|0|||
30592158|NCT01088048|58604347|FG004|Overall Study|Patient Non-compliance|0|||
30592159|NCT01088048|58604348|FG005|Overall Study|Patient Non-compliance|0|||
30592160|NCT01088048|58604349|FG006|Overall Study|Patient Non-compliance|0|||
30592161|NCT01088048|58604350|FG007|Overall Study|Patient Non-compliance|0|||
30592162|NCT01088048|58604351|FG008|Overall Study|Patient Non-compliance|0|||
30592163|NCT01088048|58604352|FG009|Overall Study|Patient Non-compliance|0|||
30592164|NCT01088048|58604343|FG000|Overall Study|Disease Progression|7|||
30592165|NCT01088048|58604344|FG001|Overall Study|Disease Progression|4|||
30592166|NCT01088048|58604345|FG002|Overall Study|Disease Progression|3|||
30677062|NCT00847301|58691065|FG000|Overall Study|Adverse Event|35|||
30677063|NCT00847301|58691065|FG000|Overall Study|Switch to other anticoagulants|16|||
30677064|NCT00847301|58691065|FG000|Overall Study|Lost to Follow-up|1|||
30677065|NCT00847301|58691065|FG000|Overall Study|No prescription after hospital discharge|1|||
30677066|NCT00847301|58691065|FG000|Overall Study|Other reason not defined above|1|||
30677067|NCT00624520|58691071|FG000|Overall Study|Withdrawal by Subject|12|||
30677068|NCT00624520|58691072|FG001|Overall Study|Withdrawal by Subject|7|||
30677069|NCT00624520|58691071|FG000|Overall Study|Death|0|||
30677070|NCT00624520|58691072|FG001|Overall Study|Death|1|||
30677071|NCT00847145|58691086|FG000|Overall Study|AE or Death|0|||
30677072|NCT00847145|58691087|FG001|Overall Study|AE or Death|1|||
30677073|NCT00847145|58691088|FG002|Overall Study|AE or Death|1|||
30677074|NCT00847145|58691089|FG003|Overall Study|AE or Death|0|||
30959028|NCT01587703|59024026|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
30592167|NCT01088048|58604346|FG003|Overall Study|Disease Progression|5|||
30592168|NCT01088048|58604347|FG004|Overall Study|Disease Progression|3|||
30592169|NCT01088048|58604348|FG005|Overall Study|Disease Progression|3|||
30592170|NCT01088048|58604349|FG006|Overall Study|Disease Progression|2|||
30677075|NCT00847145|58691090|FG004|Overall Study|AE or Death|0|||
30592171|NCT01088048|58604350|FG007|Overall Study|Disease Progression|1|||
30592172|NCT01088048|58604351|FG008|Overall Study|Disease Progression|0|||
30592173|NCT01088048|58604352|FG009|Overall Study|Disease Progression|0|||
30592174|NCT01088048|58604343|FG000|Overall Study|Death|1|||
30677076|NCT00847145|58691091|FG005|Overall Study|AE or Death|0|||
30677077|NCT00847145|58691092|FG006|Overall Study|AE or Death|0|||
30677078|NCT00847145|58691093|FG007|Overall Study|AE or Death|0|||
30677079|NCT00847145|58691086|FG000|Overall Study|Withdrawal by Subject|3|||
30677080|NCT00847145|58691087|FG001|Overall Study|Withdrawal by Subject|4|||
30677081|NCT00847145|58691088|FG002|Overall Study|Withdrawal by Subject|6|||
30677082|NCT00847145|58691089|FG003|Overall Study|Withdrawal by Subject|1|||
30677083|NCT00847145|58691090|FG004|Overall Study|Withdrawal by Subject|0|||
30677084|NCT00847145|58691091|FG005|Overall Study|Withdrawal by Subject|0|||
30677085|NCT00847145|58691092|FG006|Overall Study|Withdrawal by Subject|1|||
30592175|NCT01088048|58604344|FG001|Overall Study|Death|5|||
30592176|NCT01088048|58604345|FG002|Overall Study|Death|3|||
30592177|NCT01088048|58604346|FG003|Overall Study|Death|3|||
30677086|NCT00847145|58691093|FG007|Overall Study|Withdrawal by Subject|1|||
30677087|NCT00847145|58691086|FG000|Overall Study|Lost to Follow-up|3|||
30677088|NCT00847145|58691087|FG001|Overall Study|Lost to Follow-up|1|||
30677089|NCT00847145|58691088|FG002|Overall Study|Lost to Follow-up|1|||
30677090|NCT00847145|58691089|FG003|Overall Study|Lost to Follow-up|0|||
30677091|NCT00847145|58691090|FG004|Overall Study|Lost to Follow-up|4|||
30677092|NCT00847145|58691091|FG005|Overall Study|Lost to Follow-up|4|||
30677093|NCT00847145|58691092|FG006|Overall Study|Lost to Follow-up|8|||
30677094|NCT00847145|58691093|FG007|Overall Study|Lost to Follow-up|2|||
30677095|NCT00847145|58691086|FG000|Overall Study|Inappropriate enrollment|0|||
30677096|NCT00847145|58691087|FG001|Overall Study|Inappropriate enrollment|0|||
30677097|NCT00847145|58691088|FG002|Overall Study|Inappropriate enrollment|0|||
30677098|NCT00847145|58691089|FG003|Overall Study|Inappropriate enrollment|0|||
30677099|NCT00847145|58691090|FG004|Overall Study|Inappropriate enrollment|1|||
30677100|NCT00847145|58691091|FG005|Overall Study|Inappropriate enrollment|0|||
30677101|NCT00847145|58691092|FG006|Overall Study|Inappropriate enrollment|0|||
30677102|NCT00847145|58691093|FG007|Overall Study|Inappropriate enrollment|0|||
30677103|NCT00847145|58691086|FG000|Overall Study|Protocol Violation|0|||
30782006|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
30782007|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
30782008|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
30782009|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
30782010|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
30782011|NCT03352557|58793766|FG000|LTE Period: Week 80 to Week 173|Other|0|||
30592178|NCT01088048|58604347|FG004|Overall Study|Death|1|||
30782012|NCT03352557|58793767|FG001|LTE Period: Week 80 to Week 173|Other|0|||
30782013|NCT03352557|58793768|FG002|LTE Period: Week 80 to Week 173|Other|0|||
30782014|NCT03352557|58793769|FG003|LTE Period: Week 80 to Week 173|Other|0|||
30782015|NCT03352557|58793770|FG004|LTE Period: Week 80 to Week 173|Other|0|||
30782016|NCT03352557|58793771|FG005|LTE Period: Week 80 to Week 173|Other|0|||
30782017|NCT03352557|58793772|FG006|LTE Period: Week 80 to Week 173|Other|0|||
30782018|NCT03352557|58793773|FG007|LTE Period: Week 80 to Week 173|Other|1|||
30782019|NCT03352557|58793774|FG008|LTE Period: Week 80 to Week 173|Other|0|||
30782020|NCT03352557|58793775|FG009|LTE Period: Week 80 to Week 173|Other|0|||
30782021|NCT02866942|58793800|FG000|Overall Study|Invalid consent|1|||
30782022|NCT02908672|58793854|FG000|Overall Study|Death|112|||
30782023|NCT02908672|58793855|FG001|Overall Study|Death|93|||
30782024|NCT02908672|58793854|FG000|Overall Study|Lost to Follow-up|3|||
30782025|NCT02908672|58793855|FG001|Overall Study|Lost to Follow-up|3|||
30782026|NCT02908672|58793854|FG000|Overall Study|Other|2|||
30592179|NCT01088048|58604348|FG005|Overall Study|Death|3|||
30592180|NCT01088048|58604349|FG006|Overall Study|Death|0|||
30592181|NCT01088048|58604350|FG007|Overall Study|Death|0|||
30592182|NCT01088048|58604351|FG008|Overall Study|Death|3|||
30592183|NCT01088048|58604352|FG009|Overall Study|Death|1|||
30592184|NCT01088048|58604343|FG000|Overall Study|Other|3|||
30592185|NCT01088048|58604344|FG001|Overall Study|Other|5|||
30592186|NCT01088048|58604345|FG002|Overall Study|Other|0|||
30592187|NCT01088048|58604346|FG003|Overall Study|Other|0|||
30592188|NCT01088048|58604347|FG004|Overall Study|Other|2|||
30592189|NCT01088048|58604348|FG005|Overall Study|Other|0|||
30677104|NCT00847145|58691087|FG001|Overall Study|Protocol Violation|0|||
30677105|NCT00847145|58691088|FG002|Overall Study|Protocol Violation|3|||
30677106|NCT00847145|58691089|FG003|Overall Study|Protocol Violation|0|||
30677107|NCT00847145|58691090|FG004|Overall Study|Protocol Violation|1|||
30782027|NCT02908672|58793855|FG001|Overall Study|Other|0|||
30677108|NCT00847145|58691091|FG005|Overall Study|Protocol Violation|0|||
30592190|NCT01088048|58604349|FG006|Overall Study|Other|0|||
30677109|NCT00847145|58691092|FG006|Overall Study|Protocol Violation|0|||
30677110|NCT00847145|58691093|FG007|Overall Study|Protocol Violation|1|||
30677111|NCT00846521|58691120|FG000|Overall Study|Withdrawal by Subject|5|||
30782028|NCT02908672|58793854|FG000|Overall Study|Protocol Violation|1|||
30677112|NCT00846521|58691120|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
30677113|NCT00846521|58691120|FG000|Overall Study|Protocol Violation|1|||
30782029|NCT02908672|58793855|FG001|Overall Study|Protocol Violation|1|||
30592191|NCT01088048|58604350|FG007|Overall Study|Other|2|||
30592192|NCT01088048|58604351|FG008|Overall Study|Other|0|||
30592193|NCT01088048|58604352|FG009|Overall Study|Other|0|||
30592194|NCT01087970|58604385|FG000|Overall Study|Protocol Violation|2|||
30592195|NCT01087814|58604392|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
30592196|NCT01087814|58604393|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
30592197|NCT01087814|58604392|FG000|Second Intervention (5 Days)|Physician Decision|1|||
30592198|NCT01087814|58604393|FG001|Second Intervention (5 Days)|Physician Decision|0|||
30592199|NCT01087775|58604399|FG000|Overall Study|failed inclusion criteria|2|||
30592200|NCT01087502|58604406|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
30592201|NCT01087502|58604407|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
30592202|NCT01087502|58604406|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
30592203|NCT01087502|58604407|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
30592204|NCT01087502|58604406|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
30592205|NCT01087502|58604407|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
30592206|NCT01087502|58604406|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
30592207|NCT01087502|58604407|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
30592208|NCT01087502|58604406|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
30592209|NCT01087502|58604407|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
30677114|NCT00862823|58691124|FG000|First Intervention|Withdrawal by Subject|1|||
30677115|NCT00862823|58691125|FG001|First Intervention|Withdrawal by Subject|1|||
30677116|NCT00790842|58691133|FG000|Dose Level 1|Adverse Event|1|||
30677117|NCT00790842|58691134|FG001|Dose Level 1|Adverse Event|0|||
30677118|NCT00790842|58691135|FG002|Dose Level 1|Adverse Event|0|||
30677119|NCT00790842|58691136|FG003|Dose Level 1|Adverse Event|2|||
30677120|NCT00790842|58691137|FG004|Dose Level 1|Adverse Event|0|||
30677121|NCT00790842|58691138|FG005|Dose Level 1|Adverse Event|0|||
30677122|NCT00790842|58691139|FG006|Dose Level 1|Adverse Event|0|||
30677123|NCT00790842|58691140|FG007|Dose Level 1|Adverse Event|1|||
30592210|NCT01087502|58604406|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
30677124|NCT00790842|58691141|FG008|Dose Level 1|Adverse Event|0|||
30677125|NCT00790842|58691142|FG009|Dose Level 1|Adverse Event|0|||
30677126|NCT00790842|58691143|FG010|Dose Level 1|Adverse Event|0|||
30677127|NCT00790842|58691133|FG000|Dose Level 1|Physician Decision|1|||
30677128|NCT00790842|58691134|FG001|Dose Level 1|Physician Decision|0|||
30677129|NCT00790842|58691135|FG002|Dose Level 1|Physician Decision|0|||
30677130|NCT00790842|58691136|FG003|Dose Level 1|Physician Decision|0|||
30677131|NCT00790842|58691137|FG004|Dose Level 1|Physician Decision|0|||
30677132|NCT00790842|58691138|FG005|Dose Level 1|Physician Decision|0|||
30677133|NCT00790842|58691139|FG006|Dose Level 1|Physician Decision|0|||
30677134|NCT00790842|58691140|FG007|Dose Level 1|Physician Decision|1|||
30677135|NCT00790842|58691141|FG008|Dose Level 1|Physician Decision|0|||
30677136|NCT00790842|58691142|FG009|Dose Level 1|Physician Decision|0|||
30677137|NCT00790842|58691143|FG010|Dose Level 1|Physician Decision|0|||
30677138|NCT00790842|58691133|FG000|Dose Level 1|Withdrawal by Subject|1|||
30677139|NCT00790842|58691134|FG001|Dose Level 1|Withdrawal by Subject|0|||
30677140|NCT00790842|58691135|FG002|Dose Level 1|Withdrawal by Subject|0|||
30677141|NCT00790842|58691136|FG003|Dose Level 1|Withdrawal by Subject|0|||
30677142|NCT00790842|58691137|FG004|Dose Level 1|Withdrawal by Subject|0|||
30677143|NCT00790842|58691138|FG005|Dose Level 1|Withdrawal by Subject|0|||
30677144|NCT00790842|58691139|FG006|Dose Level 1|Withdrawal by Subject|0|||
30677145|NCT00790842|58691140|FG007|Dose Level 1|Withdrawal by Subject|0|||
30677146|NCT00790842|58691141|FG008|Dose Level 1|Withdrawal by Subject|0|||
30782030|NCT02908672|58793854|FG000|Overall Study|Withdrawal by Subject|13|||
30782031|NCT02908672|58793855|FG001|Overall Study|Withdrawal by Subject|18|||
30782032|NCT02908672|58793854|FG000|Overall Study|Study is ongoing|124|||
30782033|NCT02908672|58793855|FG001|Overall Study|Study is ongoing|141|||
30782034|NCT02908672|58793854|FG000|Overall Study|Discontinued the study during run-in|3|||
30782035|NCT02908672|58793855|FG001|Overall Study|Discontinued the study during run-in|0|||
30782036|NCT01336894|58793863|FG000|Follow-up|Study terminated prematurely|2|||
30782037|NCT01336894|58793864|FG001|Follow-up|Study terminated prematurely|7|||
30677147|NCT00790842|58691142|FG009|Dose Level 1|Withdrawal by Subject|0|||
30782038|NCT02572167|58793873|FG000|Overall Study|Withdrawal by Subject|0|||
30677148|NCT00790842|58691143|FG010|Dose Level 1|Withdrawal by Subject|0|||
30677149|NCT00790842|58691133|FG000|Dose Level 2|Death|0|||
30677150|NCT00790842|58691134|FG001|Dose Level 2|Death|1|||
30677151|NCT00790842|58691135|FG002|Dose Level 2|Death|0|||
30677152|NCT00790842|58691136|FG003|Dose Level 2|Death|0|||
30782039|NCT02572167|58793874|FG001|Overall Study|Withdrawal by Subject|3|||
30782040|NCT02572167|58793875|FG002|Overall Study|Withdrawal by Subject|0|||
30782041|NCT02572167|58793873|FG000|Overall Study|Lost to Follow-up|2|||
30782042|NCT02572167|58793874|FG001|Overall Study|Lost to Follow-up|5|||
30782043|NCT02572167|58793875|FG002|Overall Study|Lost to Follow-up|3|||
30677153|NCT00790842|58691137|FG004|Dose Level 2|Death|1|||
30677154|NCT00790842|58691138|FG005|Dose Level 2|Death|0|||
30677155|NCT00790842|58691139|FG006|Dose Level 2|Death|0|||
30677156|NCT00790842|58691140|FG007|Dose Level 2|Death|0|||
30782044|NCT02572167|58793873|FG000|Overall Study|Death|0|||
30782045|NCT02572167|58793874|FG001|Overall Study|Death|8|||
30677157|NCT00790842|58691141|FG008|Dose Level 2|Death|0|||
30592211|NCT01087502|58604407|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
30592212|NCT01087502|58604406|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
30592213|NCT01087502|58604407|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
30592214|NCT01087502|58604406|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
30592215|NCT01087502|58604407|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
30592216|NCT01087502|58604406|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
30592217|NCT01087502|58604407|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
30592218|NCT01087502|58604406|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
30592219|NCT01087502|58604407|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
30592220|NCT01087502|58604406|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
30592221|NCT01087502|58604407|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
30592222|NCT01087502|58604406|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
30677158|NCT00790842|58691142|FG009|Dose Level 2|Death|0|||
30677159|NCT00790842|58691143|FG010|Dose Level 2|Death|0|||
30677160|NCT00790842|58691133|FG000|Dose Level 2|Physician Decision|0|||
30677161|NCT00790842|58691134|FG001|Dose Level 2|Physician Decision|1|||
30592223|NCT01087502|58604407|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
30592224|NCT01086410|58604419|FG000|Overall Study|Adverse Event|1|||
30592225|NCT01086410|58604420|FG001|Overall Study|Adverse Event|0|||
30677162|NCT00790842|58691135|FG002|Dose Level 2|Physician Decision|0|||
30677163|NCT00790842|58691136|FG003|Dose Level 2|Physician Decision|0|||
30592226|NCT01086410|58604421|FG002|Overall Study|Adverse Event|0|||
30592227|NCT01086410|58604422|FG003|Overall Study|Adverse Event|2|||
30592228|NCT01086410|58604419|FG000|Overall Study|Lack of Efficacy|1|||
30592229|NCT01086410|58604420|FG001|Overall Study|Lack of Efficacy|1|||
30592230|NCT01086410|58604421|FG002|Overall Study|Lack of Efficacy|0|||
30592231|NCT01086410|58604422|FG003|Overall Study|Lack of Efficacy|0|||
30592232|NCT01086410|58604419|FG000|Overall Study|Protocol Violation|1|||
30592233|NCT01086410|58604420|FG001|Overall Study|Protocol Violation|1|||
30592234|NCT01086410|58604421|FG002|Overall Study|Protocol Violation|0|||
30592235|NCT01086410|58604422|FG003|Overall Study|Protocol Violation|0|||
30592236|NCT01086410|58604419|FG000|Overall Study|Lost to Follow-up|0|||
30592237|NCT01086410|58604420|FG001|Overall Study|Lost to Follow-up|0|||
30677164|NCT00790842|58691137|FG004|Dose Level 2|Physician Decision|0|||
30677165|NCT00790842|58691138|FG005|Dose Level 2|Physician Decision|0|||
30677166|NCT00790842|58691139|FG006|Dose Level 2|Physician Decision|0|||
30677167|NCT00790842|58691140|FG007|Dose Level 2|Physician Decision|0|||
30677168|NCT00790842|58691141|FG008|Dose Level 2|Physician Decision|0|||
30677169|NCT00790842|58691142|FG009|Dose Level 2|Physician Decision|0|||
30677170|NCT00790842|58691143|FG010|Dose Level 2|Physician Decision|0|||
30677171|NCT00790842|58691133|FG000|Dose Level 2|Withdrawal by Subject|0|||
30677172|NCT00790842|58691134|FG001|Dose Level 2|Withdrawal by Subject|1|||
30677173|NCT00790842|58691135|FG002|Dose Level 2|Withdrawal by Subject|0|||
30677174|NCT00790842|58691136|FG003|Dose Level 2|Withdrawal by Subject|0|||
30677175|NCT00790842|58691137|FG004|Dose Level 2|Withdrawal by Subject|0|||
30677176|NCT00790842|58691138|FG005|Dose Level 2|Withdrawal by Subject|0|||
30677177|NCT00790842|58691139|FG006|Dose Level 2|Withdrawal by Subject|0|||
30677178|NCT00790842|58691140|FG007|Dose Level 2|Withdrawal by Subject|0|||
30677179|NCT00790842|58691141|FG008|Dose Level 2|Withdrawal by Subject|0|||
30677180|NCT00790842|58691142|FG009|Dose Level 2|Withdrawal by Subject|0|||
30677181|NCT00790842|58691143|FG010|Dose Level 2|Withdrawal by Subject|0|||
30677182|NCT00790842|58691133|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
30677183|NCT00790842|58691134|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
30677184|NCT00790842|58691135|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
30677185|NCT00790842|58691136|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
30677186|NCT00790842|58691137|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
30677187|NCT00790842|58691138|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
30677188|NCT00790842|58691139|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
30677189|NCT00790842|58691140|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
30677190|NCT00790842|58691141|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
30677191|NCT00790842|58691142|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
30782046|NCT02572167|58793875|FG002|Overall Study|Death|3|||
30782047|NCT02572167|58793873|FG000|Overall Study|Did not meet inclusion criteria|0|||
30782048|NCT02572167|58793874|FG001|Overall Study|Did not meet inclusion criteria|0|||
30592238|NCT01086410|58604421|FG002|Overall Study|Lost to Follow-up|1|||
30592239|NCT01086410|58604422|FG003|Overall Study|Lost to Follow-up|0|||
30782049|NCT02572167|58793875|FG002|Overall Study|Did not meet inclusion criteria|1|||
30592240|NCT04553679|58604434|FG000|Overall Study|Withdrawal by Subject|2|||
30592241|NCT04553679|58604435|FG001|Overall Study|Withdrawal by Subject|0|||
30592242|NCT04553679|58604434|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
30782050|NCT02572167|58793873|FG000|Overall Study|Study closure by Sponsor|4|||
30677192|NCT00790842|58691143|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
30677193|NCT00790842|58691133|FG000|Dose Level 3|Adverse Event|0|||
30677194|NCT00790842|58691134|FG001|Dose Level 3|Adverse Event|0|||
30677195|NCT00790842|58691135|FG002|Dose Level 3|Adverse Event|1|||
30677196|NCT00790842|58691136|FG003|Dose Level 3|Adverse Event|0|||
30677197|NCT00790842|58691137|FG004|Dose Level 3|Adverse Event|0|||
30677198|NCT00790842|58691138|FG005|Dose Level 3|Adverse Event|0|||
30677199|NCT00790842|58691139|FG006|Dose Level 3|Adverse Event|0|||
30677200|NCT00790842|58691140|FG007|Dose Level 3|Adverse Event|0|||
30677201|NCT00790842|58691141|FG008|Dose Level 3|Adverse Event|0|||
30677202|NCT00790842|58691142|FG009|Dose Level 3|Adverse Event|0|||
30677203|NCT00790842|58691143|FG010|Dose Level 3|Adverse Event|0|||
30677204|NCT00790842|58691133|FG000|Dose Level 3|Withdrawal by Subject|0|||
30592243|NCT04553679|58604435|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
30592244|NCT01086215|58604449|FG000|Overall Study|Death|14|||
30592245|NCT01086215|58604450|FG001|Overall Study|Death|8|||
30592246|NCT01086215|58604451|FG002|Overall Study|Death|8|||
30592247|NCT01086215|58604452|FG003|Overall Study|Death|1|||
30592248|NCT01086215|58604449|FG000|Overall Study|Lost to Follow-up|22|||
30592249|NCT01086215|58604450|FG001|Overall Study|Lost to Follow-up|39|||
30592250|NCT01086215|58604451|FG002|Overall Study|Lost to Follow-up|18|||
30592251|NCT01086215|58604452|FG003|Overall Study|Lost to Follow-up|2|||
30592252|NCT01085591|58604465|FG000|Overall Study|Adverse Event|0|||
30592253|NCT01085591|58604466|FG001|Overall Study|Adverse Event|1|||
30592254|NCT01085591|58604467|FG002|Overall Study|Adverse Event|3|||
30592255|NCT01085591|58604465|FG000|Overall Study|Physician Decision|1|||
30592256|NCT01085591|58604466|FG001|Overall Study|Physician Decision|0|||
30592257|NCT01085591|58604467|FG002|Overall Study|Physician Decision|1|||
30592258|NCT01085591|58604465|FG000|Overall Study|Withdrawal by Subject|0|||
30592259|NCT01085591|58604466|FG001|Overall Study|Withdrawal by Subject|2|||
30592260|NCT01085591|58604467|FG002|Overall Study|Withdrawal by Subject|1|||
30677205|NCT00790842|58691134|FG001|Dose Level 3|Withdrawal by Subject|0|||
30677206|NCT00790842|58691135|FG002|Dose Level 3|Withdrawal by Subject|3|||
30677207|NCT00790842|58691136|FG003|Dose Level 3|Withdrawal by Subject|0|||
30677208|NCT00790842|58691137|FG004|Dose Level 3|Withdrawal by Subject|0|||
30677209|NCT00790842|58691138|FG005|Dose Level 3|Withdrawal by Subject|0|||
30677210|NCT00790842|58691139|FG006|Dose Level 3|Withdrawal by Subject|0|||
30677211|NCT00790842|58691140|FG007|Dose Level 3|Withdrawal by Subject|0|||
30677212|NCT00790842|58691141|FG008|Dose Level 3|Withdrawal by Subject|0|||
30592261|NCT01085591|58604465|FG000|Overall Study|Lost to Follow-up|0|||
30592262|NCT01085591|58604466|FG001|Overall Study|Lost to Follow-up|1|||
30592263|NCT01085591|58604467|FG002|Overall Study|Lost to Follow-up|1|||
30592264|NCT01085591|58604465|FG000|Overall Study|Protocol Violation|1|||
30592265|NCT01085591|58604466|FG001|Overall Study|Protocol Violation|1|||
30592266|NCT01085591|58604467|FG002|Overall Study|Protocol Violation|1|||
30592267|NCT01085591|58604465|FG000|Overall Study|Other|0|||
30592268|NCT01085591|58604466|FG001|Overall Study|Other|1|||
30592269|NCT01085591|58604467|FG002|Overall Study|Other|0|||
30592270|NCT01085591|58604465|FG000|Overall Study|Not Properly Consented|1|||
30592271|NCT01085591|58604466|FG001|Overall Study|Not Properly Consented|0|||
30592272|NCT01085591|58604467|FG002|Overall Study|Not Properly Consented|0|||
30592273|NCT01085357|58604478|FG000|Overall Study|Adverse Event|1|||
30592274|NCT01085357|58604479|FG001|Overall Study|Adverse Event|1|||
30592275|NCT01085357|58604478|FG000|Overall Study|Subject Decision|4|||
30592276|NCT01085357|58604479|FG001|Overall Study|Subject Decision|3|||
30592277|NCT01085357|58604478|FG000|Overall Study|Investigator Decision|1|||
30592278|NCT01085357|58604479|FG001|Overall Study|Investigator Decision|1|||
30677213|NCT00790842|58691142|FG009|Dose Level 3|Withdrawal by Subject|2|||
30677214|NCT00790842|58691143|FG010|Dose Level 3|Withdrawal by Subject|0|||
30677215|NCT00790842|58691133|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
30677216|NCT00790842|58691134|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
30677217|NCT00790842|58691135|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
30677218|NCT00790842|58691136|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
30592279|NCT01085357|58604478|FG000|Overall Study|Death|11|||
30592280|NCT01085357|58604479|FG001|Overall Study|Death|1|||
30677219|NCT00790842|58691137|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
30677220|NCT00790842|58691138|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
30677221|NCT00790842|58691139|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
30677222|NCT00790842|58691140|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
30677223|NCT00790842|58691141|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
30677224|NCT00790842|58691142|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
30592281|NCT01085357|58604478|FG000|Overall Study|Lost to Follow-up|2|||
30592282|NCT01085357|58604479|FG001|Overall Study|Lost to Follow-up|0|||
30592283|NCT01085201|58604490|FG000|Overall Study|Scheduling conflict|1|||
30592284|NCT01085201|58604491|FG001|Overall Study|Scheduling conflict|0|||
30592285|NCT01085201|58604492|FG002|Overall Study|Scheduling conflict|1|||
30592286|NCT01085201|58604493|FG003|Overall Study|Scheduling conflict|0|||
30592287|NCT01085201|58604494|FG004|Overall Study|Scheduling conflict|0|||
30592288|NCT01085201|58604490|FG000|Overall Study|Unknown- no study drug|2|||
30592289|NCT01085201|58604491|FG001|Overall Study|Unknown- no study drug|0|||
30677225|NCT00790842|58691143|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
30677226|NCT00790842|58691133|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
30677227|NCT00790842|58691134|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
30677228|NCT00790842|58691135|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
30677229|NCT00790842|58691136|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
30677230|NCT00790842|58691137|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
30677231|NCT00790842|58691138|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
30677232|NCT00790842|58691139|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
30677233|NCT00790842|58691140|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
30677234|NCT00790842|58691141|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
30677235|NCT00790842|58691142|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
30677236|NCT00790842|58691143|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
30677237|NCT00790842|58691133|FG000|Dose Level 4|Adverse Event|0|||
30677238|NCT00790842|58691134|FG001|Dose Level 4|Adverse Event|0|||
30677239|NCT00790842|58691135|FG002|Dose Level 4|Adverse Event|0|||
30677240|NCT00790842|58691136|FG003|Dose Level 4|Adverse Event|0|||
30677241|NCT00790842|58691137|FG004|Dose Level 4|Adverse Event|0|||
30677242|NCT00790842|58691138|FG005|Dose Level 4|Adverse Event|0|||
30677243|NCT00790842|58691139|FG006|Dose Level 4|Adverse Event|1|||
30677244|NCT00790842|58691140|FG007|Dose Level 4|Adverse Event|0|||
30677245|NCT00790842|58691141|FG008|Dose Level 4|Adverse Event|0|||
30592290|NCT01085201|58604492|FG002|Overall Study|Unknown- no study drug|0|||
30592291|NCT01085201|58604493|FG003|Overall Study|Unknown- no study drug|0|||
30677246|NCT00790842|58691142|FG009|Dose Level 4|Adverse Event|0|||
30677247|NCT00790842|58691143|FG010|Dose Level 4|Adverse Event|0|||
30592292|NCT01085201|58604494|FG004|Overall Study|Unknown- no study drug|0|||
30592293|NCT01085201|58604490|FG000|Overall Study|Fond ineligible after consent|0|||
30592294|NCT01085201|58604491|FG001|Overall Study|Fond ineligible after consent|1|||
30592295|NCT01085201|58604492|FG002|Overall Study|Fond ineligible after consent|1|||
30592296|NCT01085201|58604493|FG003|Overall Study|Fond ineligible after consent|0|||
30592297|NCT01085201|58604494|FG004|Overall Study|Fond ineligible after consent|0|||
30592298|NCT01085084|58604514|FG000|Overall Study|Withdrawal by Subject|1|||
30592299|NCT01085084|58604515|FG001|Overall Study|Withdrawal by Subject|0|||
30592300|NCT01085084|58604516|FG002|Overall Study|Withdrawal by Subject|0|||
30592301|NCT01085084|58604514|FG000|Overall Study|Lost to Follow-up|2|||
30592302|NCT01085084|58604515|FG001|Overall Study|Lost to Follow-up|1|||
30592303|NCT01085084|58604516|FG002|Overall Study|Lost to Follow-up|1|||
30592304|NCT01085084|58604514|FG000|Overall Study|Adverse Event|4|||
30592305|NCT01085084|58604515|FG001|Overall Study|Adverse Event|3|||
30592306|NCT01085084|58604516|FG002|Overall Study|Adverse Event|6|||
30592307|NCT01085084|58604514|FG000|Overall Study|Treatment Failure|0|||
30592308|NCT01085084|58604515|FG001|Overall Study|Treatment Failure|1|||
30592309|NCT01085084|58604516|FG002|Overall Study|Treatment Failure|2|||
30592310|NCT01085045|58604524|FG000|Part A|Withdrawal by Subject|4|||
30592311|NCT01085045|58604524|FG000|Part A|Adverse Event|6|||
30592312|NCT01085045|58604524|FG000|Part A|Protocol Violation|1|||
30592313|NCT01085045|58604524|FG000|Part A|Protocol Specified Criteria|7|||
30592314|NCT01085045|58604524|FG000|Part B|Withdrawal by Subject|2|||
30592315|NCT01085045|58604524|FG000|Part B|Protocol Specified Criteria|6|||
30592316|NCT01085045|58604524|FG000|Part B|Lost to Follow-up|1|||
30592317|NCT01085045|58604524|FG000|Part B|Adverse Event|6|||
30592318|NCT01084772|58604546|FG000|Baseline|Withdrawal by Subject|7|||
30592319|NCT01084772|58604547|FG001|Baseline|Withdrawal by Subject|6|||
30592320|NCT01084772|58604546|FG000|3 Months|Death|1|||
30592321|NCT01084772|58604547|FG001|3 Months|Death|0|||
30592322|NCT01084772|58604546|FG000|3 Months|Study Termination|2|||
30592323|NCT01084772|58604547|FG001|3 Months|Study Termination|2|||
30592324|NCT01084772|58604546|FG000|1 Year|Withdrawal by Subject|0|||
30592325|NCT01084772|58604547|FG001|1 Year|Withdrawal by Subject|1|||
30592326|NCT01084772|58604546|FG000|1 Year|Lost to Follow-up|3|||
30592327|NCT01084772|58604547|FG001|1 Year|Lost to Follow-up|0|||
30677248|NCT00790842|58691133|FG000|Dose Level 4|Physician Decision|0|||
30677249|NCT00790842|58691134|FG001|Dose Level 4|Physician Decision|0|||
30677250|NCT00790842|58691135|FG002|Dose Level 4|Physician Decision|0|||
30592328|NCT01084772|58604546|FG000|1 Year|Study Termination|0|||
30677251|NCT00790842|58691136|FG003|Dose Level 4|Physician Decision|0|||
30592329|NCT01084772|58604547|FG001|1 Year|Study Termination|7|||
30592330|NCT01084772|58604546|FG000|2 Years|Withdrawal by Subject|1|||
30592331|NCT01084772|58604547|FG001|2 Years|Withdrawal by Subject|0|||
30592332|NCT01084772|58604546|FG000|2 Years|Lost to Follow-up|5|||
30592333|NCT01084772|58604547|FG001|2 Years|Lost to Follow-up|2|||
30677252|NCT00790842|58691137|FG004|Dose Level 4|Physician Decision|0|||
30677253|NCT00790842|58691138|FG005|Dose Level 4|Physician Decision|0|||
30592334|NCT01084772|58604546|FG000|2 Years|Study Termination|3|||
30592335|NCT01084772|58604547|FG001|2 Years|Study Termination|2|||
30592336|NCT00179673|58604553|FG000|Overall Study|Adverse Event|7|||
30592337|NCT00179673|58604553|FG000|Overall Study|Lack of Efficacy|15|||
30592338|NCT00179673|58604553|FG000|Overall Study|Withdrawal by Subject|3|||
30592339|NCT00179673|58604553|FG000|Overall Study|Death|4|||
30592340|NCT00179673|58604553|FG000|Overall Study|Other Observations and options|14|||
30592341|NCT01084655|58604560|FG000|Overall Study|Radiographic disease progression|3|||
30592342|NCT01084655|58604561|FG001|Overall Study|Radiographic disease progression|2|||
30592343|NCT01084655|58604562|FG002|Overall Study|Radiographic disease progression|8|||
30592344|NCT01084655|58604560|FG000|Overall Study|Withdrawal by Subject|1|||
30592345|NCT01084655|58604561|FG001|Overall Study|Withdrawal by Subject|0|||
30592346|NCT01084655|58604562|FG002|Overall Study|Withdrawal by Subject|4|||
30592347|NCT01084655|58604560|FG000|Overall Study|Adverse Event|2|||
30592348|NCT01084655|58604561|FG001|Overall Study|Adverse Event|1|||
30592349|NCT01084655|58604562|FG002|Overall Study|Adverse Event|2|||
30592350|NCT01084655|58604560|FG000|Overall Study|Other|0|||
30592351|NCT01084655|58604561|FG001|Overall Study|Other|3|||
30592352|NCT01084655|58604562|FG002|Overall Study|Other|2|||
30592353|NCT01084655|58604560|FG000|Overall Study|Symptomatic deterioration|0|||
30592354|NCT01084655|58604561|FG001|Overall Study|Symptomatic deterioration|0|||
30592355|NCT01084655|58604562|FG002|Overall Study|Symptomatic deterioration|2|||
30592356|NCT01084655|58604560|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
30592357|NCT01084655|58604561|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
30592358|NCT01084655|58604562|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
30592359|NCT01084538|58604574|FG000|Overall Study|Drug not available|30|||
30677254|NCT00790842|58691139|FG006|Dose Level 4|Physician Decision|1|||
30677255|NCT00790842|58691140|FG007|Dose Level 4|Physician Decision|0|||
30677256|NCT00790842|58691141|FG008|Dose Level 4|Physician Decision|0|||
30677257|NCT00790842|58691142|FG009|Dose Level 4|Physician Decision|0|||
30677258|NCT00790842|58691143|FG010|Dose Level 4|Physician Decision|1|||
30677259|NCT00790842|58691133|FG000|Dose Level 4|Withdrawal by Subject|0|||
30677260|NCT00790842|58691134|FG001|Dose Level 4|Withdrawal by Subject|0|||
30677261|NCT00790842|58691135|FG002|Dose Level 4|Withdrawal by Subject|0|||
30677262|NCT00790842|58691136|FG003|Dose Level 4|Withdrawal by Subject|0|||
30677263|NCT00790842|58691137|FG004|Dose Level 4|Withdrawal by Subject|0|||
30677264|NCT00790842|58691138|FG005|Dose Level 4|Withdrawal by Subject|0|||
30677265|NCT00790842|58691139|FG006|Dose Level 4|Withdrawal by Subject|0|||
30677266|NCT00790842|58691140|FG007|Dose Level 4|Withdrawal by Subject|0|||
30677267|NCT00790842|58691141|FG008|Dose Level 4|Withdrawal by Subject|0|||
30677268|NCT00790842|58691142|FG009|Dose Level 4|Withdrawal by Subject|0|||
30677269|NCT00790842|58691143|FG010|Dose Level 4|Withdrawal by Subject|1|||
30677270|NCT00790842|58691133|FG000|Expansion Cohort|Adverse Event|0|||
30677271|NCT00790842|58691134|FG001|Expansion Cohort|Adverse Event|0|||
30677272|NCT00790842|58691135|FG002|Expansion Cohort|Adverse Event|0|||
30677273|NCT00790842|58691136|FG003|Expansion Cohort|Adverse Event|0|||
30592360|NCT01084538|58604574|FG000|Overall Study|Adverse Event|9|||
30592361|NCT01084538|58604574|FG000|Overall Study|Kidney transplant|6|||
30592362|NCT01084538|58604574|FG000|Overall Study|Serious Adverse Event|3|||
30592363|NCT01084538|58604574|FG000|Overall Study|Lack of effectiveness|2|||
30592364|NCT01084538|58604574|FG000|Overall Study|Patient noncompliance|2|||
30677274|NCT00790842|58691137|FG004|Expansion Cohort|Adverse Event|0|||
30677275|NCT00790842|58691138|FG005|Expansion Cohort|Adverse Event|0|||
30677276|NCT00790842|58691139|FG006|Expansion Cohort|Adverse Event|1|||
30677277|NCT00790842|58691140|FG007|Expansion Cohort|Adverse Event|0|||
30677278|NCT00790842|58691141|FG008|Expansion Cohort|Adverse Event|0|||
30782051|NCT02572167|58793874|FG001|Overall Study|Study closure by Sponsor|40|||
30782052|NCT02572167|58793875|FG002|Overall Study|Study closure by Sponsor|24|||
30782053|NCT01336738|58793889|FG000|Overall Study|Adverse Event|0|||
30782054|NCT01336738|58793890|FG001|Overall Study|Adverse Event|3|||
30782055|NCT01336738|58793891|FG002|Overall Study|Adverse Event|2|||
30782056|NCT01336738|58793892|FG003|Overall Study|Adverse Event|1|||
30782057|NCT01336738|58793893|FG004|Overall Study|Adverse Event|3|||
30782058|NCT01336738|58793889|FG000|Overall Study|Lost to Follow-up|2|||
30782059|NCT01336738|58793890|FG001|Overall Study|Lost to Follow-up|1|||
30782060|NCT01336738|58793891|FG002|Overall Study|Lost to Follow-up|2|||
30782061|NCT01336738|58793892|FG003|Overall Study|Lost to Follow-up|2|||
30782062|NCT01336738|58793893|FG004|Overall Study|Lost to Follow-up|2|||
30782063|NCT01336738|58793889|FG000|Overall Study|Did not meet entrance criteria|0|||
30677279|NCT00790842|58691142|FG009|Expansion Cohort|Adverse Event|0|||
30677280|NCT00790842|58691143|FG010|Expansion Cohort|Adverse Event|0|||
30677281|NCT00790842|58691133|FG000|Expansion Cohort|Death|0|||
30677282|NCT00790842|58691134|FG001|Expansion Cohort|Death|0|||
30782064|NCT01336738|58793890|FG001|Overall Study|Did not meet entrance criteria|1|||
30782065|NCT01336738|58793891|FG002|Overall Study|Did not meet entrance criteria|0|||
30592365|NCT01084538|58604574|FG000|Overall Study|Hyperphosphatemia|2|||
30677283|NCT00790842|58691135|FG002|Expansion Cohort|Death|2|||
30677284|NCT00790842|58691136|FG003|Expansion Cohort|Death|0|||
30677285|NCT00790842|58691137|FG004|Expansion Cohort|Death|0|||
30677286|NCT00790842|58691138|FG005|Expansion Cohort|Death|0|||
30782066|NCT01336738|58793892|FG003|Overall Study|Did not meet entrance criteria|0|||
30592366|NCT01084538|58604574|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
30592367|NCT01084538|58604574|FG000|Overall Study|Change of residence|2|||
30677287|NCT00790842|58691139|FG006|Expansion Cohort|Death|0|||
30677288|NCT00790842|58691140|FG007|Expansion Cohort|Death|0|||
30677289|NCT00790842|58691141|FG008|Expansion Cohort|Death|0|||
30677290|NCT00790842|58691142|FG009|Expansion Cohort|Death|0|||
30677291|NCT00790842|58691143|FG010|Expansion Cohort|Death|0|||
30677292|NCT00790842|58691133|FG000|Expansion Cohort|Physician Decision|0|||
30677293|NCT00790842|58691134|FG001|Expansion Cohort|Physician Decision|0|||
30677294|NCT00790842|58691135|FG002|Expansion Cohort|Physician Decision|1|||
30782067|NCT01336738|58793893|FG004|Overall Study|Did not meet entrance criteria|0|||
30782068|NCT01336738|58793889|FG000|Overall Study|Protocol Violation|0|||
30782069|NCT01336738|58793890|FG001|Overall Study|Protocol Violation|1|||
30782070|NCT01336738|58793891|FG002|Overall Study|Protocol Violation|0|||
30782071|NCT01336738|58793892|FG003|Overall Study|Protocol Violation|0|||
30782072|NCT01336738|58793893|FG004|Overall Study|Protocol Violation|0|||
30782073|NCT01336738|58793889|FG000|Overall Study|Withdrawal by Subject|2|||
30782074|NCT01336738|58793890|FG001|Overall Study|Withdrawal by Subject|0|||
30782075|NCT01336738|58793891|FG002|Overall Study|Withdrawal by Subject|2|||
30782076|NCT01336738|58793892|FG003|Overall Study|Withdrawal by Subject|1|||
30782077|NCT01336738|58793893|FG004|Overall Study|Withdrawal by Subject|1|||
30782078|NCT01336738|58793889|FG000|Overall Study|Other|3|||
30782079|NCT01336738|58793890|FG001|Overall Study|Other|3|||
30782080|NCT01336738|58793891|FG002|Overall Study|Other|2|||
30782081|NCT01336738|58793892|FG003|Overall Study|Other|3|||
30782082|NCT01336738|58793893|FG004|Overall Study|Other|4|||
30592368|NCT01084538|58604574|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
30592369|NCT01084538|58604574|FG000|Overall Study|Reason unknown|8|||
30592370|NCT01083680|58604578|FG000|Overall Study|Lost to Follow-up|2758|||
30592371|NCT01083680|58604578|FG000|Overall Study|Withdrawal by Subject|1086|||
30592372|NCT00179517|58604584|FG000|Overall Study|Withdrawal by Subject|2|||
30592373|NCT00179517|58604585|FG001|Overall Study|Withdrawal by Subject|1|||
30592374|NCT01083641|58604591|FG000|Overall Study|Withdrawal by Subject|2|||
30592375|NCT00179010|58604597|FG000|Overall Study|Muscle probe defective|1|||
30592376|NCT00179010|58604598|FG001|Overall Study|Muscle probe defective|1|||
30592377|NCT00179010|58604597|FG000|Overall Study|Failure to place arterial line|0|||
30592378|NCT00179010|58604598|FG001|Overall Study|Failure to place arterial line|1|||
30592379|NCT01083602|58604605|FG000|Overall Study|Adverse Event|11|||
30592380|NCT01083602|58604605|FG000|Overall Study|New Cancer Therapy|2|||
30592381|NCT01083602|58604605|FG000|Overall Study|Death|1|||
30592382|NCT01083602|58604605|FG000|Overall Study|Withdrawal by Subject|5|||
30592383|NCT01083602|58604605|FG000|Overall Study|Lack of Efficacy|36|||
30592384|NCT00178464|58604609|FG000|Overall Study|Withdrawal by Subject|1|||
30592385|NCT00178464|58604609|FG000|Overall Study|Physician Decision|1|||
30592386|NCT01083485|58604615|FG000|Overall Study|Adverse Event|0|||
30592387|NCT01083485|58604616|FG001|Overall Study|Adverse Event|1|||
30592388|NCT01083485|58604615|FG000|Overall Study|Protocol Violation|1|||
30592389|NCT01083485|58604616|FG001|Overall Study|Protocol Violation|0|||
30592390|NCT01083485|58604615|FG000|Overall Study|Withdrawal by Subject|5|||
30592391|NCT01083485|58604616|FG001|Overall Study|Withdrawal by Subject|2|||
30592392|NCT01083485|58604615|FG000|Overall Study|Other|1|||
30592393|NCT01083485|58604616|FG001|Overall Study|Other|0|||
30592394|NCT01083173|58604624|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
30592395|NCT01083173|58604625|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
30592396|NCT01083173|58604624|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
30592397|NCT01083173|58604625|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
30592398|NCT01083173|58604624|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
30592399|NCT01083173|58604625|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
30592400|NCT01083173|58604624|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
30592401|NCT01083173|58604625|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
30592402|NCT01083173|58604624|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
30592403|NCT01083173|58604625|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
30592404|NCT01083173|58604624|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
30782083|NCT02865538|58793910|FG000|Overall Study|Withdrawal by Subject|0|||
30782084|NCT02865538|58793911|FG001|Overall Study|Withdrawal by Subject|0|||
30782085|NCT02865538|58793912|FG002|Overall Study|Withdrawal by Subject|1|||
30782086|NCT02865538|58793913|FG003|Overall Study|Withdrawal by Subject|0|||
30782087|NCT02865538|58793914|FG004|Overall Study|Withdrawal by Subject|0|||
30782088|NCT02865538|58793910|FG000|Overall Study|Lost to Follow-up|1|||
30592405|NCT01083173|58604625|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
30782089|NCT02865538|58793911|FG001|Overall Study|Lost to Follow-up|0|||
30592406|NCT01083173|58604624|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
30592407|NCT01083173|58604625|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
30677295|NCT00790842|58691136|FG003|Expansion Cohort|Physician Decision|0|||
30782090|NCT02865538|58793912|FG002|Overall Study|Lost to Follow-up|0|||
30782091|NCT02865538|58793913|FG003|Overall Study|Lost to Follow-up|0|||
30782092|NCT02865538|58793914|FG004|Overall Study|Lost to Follow-up|0|||
30782093|NCT02860546|58793926|FG000|Overall Study|Clinical Progression|6|||
30592408|NCT01083173|58604624|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
30592409|NCT01083173|58604625|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
30592410|NCT01083173|58604624|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
30592411|NCT01083173|58604625|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
30592412|NCT01083173|58604624|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
30592413|NCT01083173|58604625|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
30592414|NCT01083173|58604624|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
30592415|NCT01083173|58604625|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
30592416|NCT00177294|58604636|FG000|Overall Study|Withdrawal by Subject|7|||
30592417|NCT00177294|58604637|FG001|Overall Study|Withdrawal by Subject|5|||
30592418|NCT01082081|58604646|FG000|Overall Study|Lost to Follow-up|0|||
30592419|NCT01082081|58604647|FG001|Overall Study|Lost to Follow-up|0|||
30592420|NCT01082081|58604648|FG002|Overall Study|Lost to Follow-up|1|||
30592421|NCT01082081|58604646|FG000|Overall Study|Withdrawal by Subject|0|||
30592422|NCT01082081|58604647|FG001|Overall Study|Withdrawal by Subject|0|||
30592423|NCT01082081|58604648|FG002|Overall Study|Withdrawal by Subject|1|||
30592424|NCT01082081|58604646|FG000|Overall Study|Other Reason|0|||
30592425|NCT01082081|58604647|FG001|Overall Study|Other Reason|1|||
30592426|NCT01082081|58604648|FG002|Overall Study|Other Reason|0|||
30592427|NCT00177216|58604659|FG000|Overall Study|Withdrawal by Subject|6|||
30592428|NCT00177216|58604660|FG001|Overall Study|Withdrawal by Subject|3|||
30592429|NCT00177216|58604661|FG002|Overall Study|Withdrawal by Subject|1|||
30592430|NCT01081886|58604675|FG000|Overall Study|Study termination|11|||
30592431|NCT01081886|58604676|FG001|Overall Study|Study termination|13|||
30592432|NCT01081769|58604684|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
30592433|NCT01081769|58604685|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
30592434|NCT01081769|58604684|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
30592435|NCT01081769|58604685|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
30592436|NCT01081769|58604684|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
30592437|NCT01081769|58604685|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
30592438|NCT01081769|58604684|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
30592439|NCT01081769|58604685|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
30592440|NCT01081769|58604684|FG000|CORE Intent-To-Treat|Adverse Event|14|||
30592441|NCT01081769|58604685|FG001|CORE Intent-To-Treat|Adverse Event|11|||
30592442|NCT01081769|58604684|FG000|CORE Intent-To-Treat|Death|1|||
30592443|NCT01081769|58604685|FG001|CORE Intent-To-Treat|Death|1|||
30592444|NCT01081769|58604684|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
30592445|NCT01081769|58604685|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
30592446|NCT01081769|58604684|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
30592447|NCT01081769|58604685|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
30592448|NCT01081769|58604684|FG000|CORE Intent-To-Treat|Pregnancy|1|||
30592449|NCT01081769|58604685|FG001|CORE Intent-To-Treat|Pregnancy|0|||
30782094|NCT02860546|58793926|FG000|Overall Study|Radiological Progression|12|||
30782095|NCT01982955|58793935|FG000|Overall Study|Randomized but not treated|0|||
30782096|NCT01982955|58793936|FG001|Overall Study|Randomized but not treated|0|||
30782097|NCT01982955|58793937|FG002|Overall Study|Randomized but not treated|0|||
30677296|NCT00790842|58691137|FG004|Expansion Cohort|Physician Decision|0|||
30782098|NCT01982955|58793938|FG003|Overall Study|Randomized but not treated|1|||
30782099|NCT01982955|58793939|FG004|Overall Study|Randomized but not treated|0|||
30677297|NCT00790842|58691138|FG005|Expansion Cohort|Physician Decision|0|||
30677298|NCT00790842|58691139|FG006|Expansion Cohort|Physician Decision|0|||
30677299|NCT00790842|58691140|FG007|Expansion Cohort|Physician Decision|0|||
30677300|NCT00790842|58691141|FG008|Expansion Cohort|Physician Decision|0|||
30677301|NCT00790842|58691142|FG009|Expansion Cohort|Physician Decision|0|||
30677302|NCT00790842|58691143|FG010|Expansion Cohort|Physician Decision|0|||
30677303|NCT00790842|58691133|FG000|Expansion Cohort|Withdrawal by Subject|0|||
30677304|NCT00790842|58691134|FG001|Expansion Cohort|Withdrawal by Subject|0|||
30677305|NCT00790842|58691135|FG002|Expansion Cohort|Withdrawal by Subject|3|||
30677306|NCT00790842|58691136|FG003|Expansion Cohort|Withdrawal by Subject|0|||
30677307|NCT00790842|58691137|FG004|Expansion Cohort|Withdrawal by Subject|0|||
30677308|NCT00790842|58691138|FG005|Expansion Cohort|Withdrawal by Subject|0|||
30677309|NCT00790842|58691139|FG006|Expansion Cohort|Withdrawal by Subject|0|||
30677310|NCT00790842|58691140|FG007|Expansion Cohort|Withdrawal by Subject|0|||
30782100|NCT00396279|58793952|FG000|Overall Study|Ongoing in study|26|||
30782101|NCT00396279|58793952|FG000|Overall Study|Disease progression|2|||
30677311|NCT00790842|58691141|FG008|Expansion Cohort|Withdrawal by Subject|0|||
30677312|NCT00790842|58691142|FG009|Expansion Cohort|Withdrawal by Subject|0|||
30592450|NCT01081769|58604684|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
30677313|NCT00790842|58691143|FG010|Expansion Cohort|Withdrawal by Subject|0|||
30782102|NCT00396279|58793952|FG000|Overall Study|Withdrawal by Subject|1|||
30782103|NCT00396279|58793952|FG000|Overall Study|Physician Decision|1|||
30782104|NCT01347866|58793973|FG000|Overall Study|Death|0|||
30592451|NCT01081769|58604685|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
30592452|NCT01081769|58604684|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
30592453|NCT01081769|58604685|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
30592454|NCT01081769|58604684|FG000|CORE Intent-To-Treat|Other|0|||
30592455|NCT01081769|58604685|FG001|CORE Intent-To-Treat|Other|1|||
30592456|NCT01081769|58604684|FG000|CORE Intent-To-Treat|Ineligibility|3|||
30592457|NCT01081769|58604685|FG001|CORE Intent-To-Treat|Ineligibility|4|||
30592458|NCT01081769|58604684|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
30592459|NCT01081769|58604685|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
30592460|NCT01081769|58604684|FG000|CORE Intent-To-Treat|Patient Moved|2|||
30592461|NCT01081769|58604685|FG001|CORE Intent-To-Treat|Patient Moved|2|||
30592462|NCT01081301|58604691|FG000|Overall Study|Bereaved|3|||
30592463|NCT01081301|58604691|FG000|Overall Study|Too busy|5|||
30592464|NCT01081301|58604691|FG000|Overall Study|Patient too ill|2|||
30592465|NCT01081301|58604691|FG000|Overall Study|Lost to Follow-up|4|||
30592466|NCT00174954|58604712|FG000|Overall Study|Adverse Event|2|||
30592467|NCT00174954|58604712|FG000|Overall Study|No tophi found in MRI|1|||
30592468|NCT00174954|58604712|FG000|Overall Study|Physician Decision|1|||
30592469|NCT01081145|58604716|FG000|Open-Label Phase|Lack of Efficacy|56|||
30592470|NCT01081145|58604717|FG001|Open-Label Phase|Lack of Efficacy|0|||
30592471|NCT01081145|58604716|FG000|Open-Label Phase|Response criteria not met|46|||
30592472|NCT01081145|58604717|FG001|Open-Label Phase|Response criteria not met|0|||
30592473|NCT01081145|58604716|FG000|Open-Label Phase|Adverse Event|42|||
30592474|NCT01081145|58604717|FG001|Open-Label Phase|Adverse Event|0|||
30592475|NCT01081145|58604716|FG000|Open-Label Phase|Withdrawal by Subject|41|||
30592476|NCT01081145|58604717|FG001|Open-Label Phase|Withdrawal by Subject|0|||
30592477|NCT01081145|58604716|FG000|Open-Label Phase|Other|12|||
30592478|NCT01081145|58604717|FG001|Open-Label Phase|Other|0|||
30592479|NCT01081145|58604716|FG000|Open-Label Phase|Lost to Follow-up|11|||
30592480|NCT01081145|58604717|FG001|Open-Label Phase|Lost to Follow-up|0|||
30592481|NCT01081145|58604716|FG000|Open-Label Phase|Protocol Violation|4|||
30592482|NCT01081145|58604717|FG001|Open-Label Phase|Protocol Violation|0|||
30592483|NCT01081145|58604716|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
30592484|NCT01081145|58604717|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
30592485|NCT01081145|58604716|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
30592486|NCT01081145|58604717|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
30592487|NCT01081145|58604716|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
30592488|NCT01081145|58604717|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
30592489|NCT01081145|58604716|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
30592490|NCT01081145|58604717|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
30592491|NCT01081145|58604716|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
30592492|NCT01081145|58604717|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
30592493|NCT01081145|58604716|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
30592494|NCT01081145|58604717|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
30592495|NCT01081145|58604716|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
30592496|NCT01081145|58604717|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
30592497|NCT00174915|58604730|FG000|Overall Study|Lost to Follow-up|19|||
30592498|NCT00174915|58604731|FG001|Overall Study|Lost to Follow-up|17|||
30592499|NCT00174915|58604732|FG002|Overall Study|Lost to Follow-up|9|||
30592500|NCT00174915|58604733|FG003|Overall Study|Lost to Follow-up|17|||
30782105|NCT01347866|58793974|FG001|Overall Study|Death|0|||
30782106|NCT01347866|58793975|FG002|Overall Study|Death|0|||
30782107|NCT01347866|58793976|FG003|Overall Study|Death|1|||
30782108|NCT01347866|58793977|FG004|Overall Study|Death|2|||
30782109|NCT01347866|58793978|FG005|Overall Study|Death|2|||
30782110|NCT01347866|58793979|FG006|Overall Study|Death|1|||
30782111|NCT01347866|58793980|FG007|Overall Study|Death|0|||
30782112|NCT01347866|58793981|FG008|Overall Study|Death|4|||
30782113|NCT01347866|58793982|FG009|Overall Study|Death|1|||
30782114|NCT01347866|58793983|FG010|Overall Study|Death|3|||
30782115|NCT01347866|58793984|FG011|Overall Study|Death|1|||
30782116|NCT01347866|58793985|FG012|Overall Study|Death|2|||
30782117|NCT01347866|58793986|FG013|Overall Study|Death|0|||
30592501|NCT00174915|58604734|FG004|Overall Study|Lost to Follow-up|10|||
30592502|NCT00174915|58604730|FG000|Overall Study|Adverse Event|18|||
30592503|NCT00174915|58604731|FG001|Overall Study|Adverse Event|16|||
30592504|NCT00174915|58604732|FG002|Overall Study|Adverse Event|11|||
30592505|NCT00174915|58604733|FG003|Overall Study|Adverse Event|18|||
30592506|NCT00174915|58604734|FG004|Overall Study|Adverse Event|5|||
30677314|NCT00790842|58691133|FG000|Expansion Cohort|Study Closure|0|||
30592507|NCT00174915|58604730|FG000|Overall Study|Personal Reason(s)|16|||
30592508|NCT00174915|58604731|FG001|Overall Study|Personal Reason(s)|16|||
30677315|NCT00790842|58691134|FG001|Expansion Cohort|Study Closure|0|||
30782118|NCT01347866|58793987|FG014|Overall Study|Death|0|||
30782119|NCT01347866|58793988|FG015|Overall Study|Death|1|||
30782120|NCT01347866|58793989|FG016|Overall Study|Death|0|||
30782121|NCT01347866|58793973|FG000|Overall Study|Lost to Follow-up|0|||
30677316|NCT00790842|58691135|FG002|Expansion Cohort|Study Closure|1|||
30677317|NCT00790842|58691136|FG003|Expansion Cohort|Study Closure|0|||
30677318|NCT00790842|58691137|FG004|Expansion Cohort|Study Closure|0|||
30677319|NCT00790842|58691138|FG005|Expansion Cohort|Study Closure|0|||
30677320|NCT00790842|58691139|FG006|Expansion Cohort|Study Closure|0|||
30677321|NCT00790842|58691140|FG007|Expansion Cohort|Study Closure|0|||
30677322|NCT00790842|58691141|FG008|Expansion Cohort|Study Closure|0|||
30677323|NCT00790842|58691142|FG009|Expansion Cohort|Study Closure|0|||
30677324|NCT00790842|58691143|FG010|Expansion Cohort|Study Closure|0|||
30677325|NCT00574288|58691198|FG000|Overall Study|Adverse Event|2|||
30677326|NCT00574288|58691199|FG001|Overall Study|Adverse Event|0|||
30677327|NCT00574288|58691200|FG002|Overall Study|Adverse Event|0|||
30677328|NCT00574288|58691201|FG003|Overall Study|Adverse Event|0|||
30677329|NCT00574288|58691202|FG004|Overall Study|Adverse Event|1|||
30677330|NCT00574288|58691203|FG005|Overall Study|Adverse Event|0|||
30677331|NCT00574288|58691204|FG006|Overall Study|Adverse Event|0|||
30592509|NCT00174915|58604732|FG002|Overall Study|Personal Reason(s)|9|||
30592510|NCT00174915|58604733|FG003|Overall Study|Personal Reason(s)|9|||
30592511|NCT00174915|58604734|FG004|Overall Study|Personal Reason(s)|9|||
30592512|NCT00174915|58604730|FG000|Overall Study|Other|15|||
30592513|NCT00174915|58604731|FG001|Overall Study|Other|8|||
30592514|NCT00174915|58604732|FG002|Overall Study|Other|6|||
30592515|NCT00174915|58604733|FG003|Overall Study|Other|5|||
30592516|NCT00174915|58604734|FG004|Overall Study|Other|3|||
30592517|NCT00174915|58604730|FG000|Overall Study|Gout Flare|13|||
30677332|NCT00574288|58691198|FG000|Overall Study|Death|0|||
30677333|NCT00574288|58691199|FG001|Overall Study|Death|0|||
30677334|NCT00574288|58691200|FG002|Overall Study|Death|0|||
30677335|NCT00574288|58691201|FG003|Overall Study|Death|0|||
30677336|NCT00574288|58691202|FG004|Overall Study|Death|0|||
30677337|NCT00574288|58691203|FG005|Overall Study|Death|25|||
30677338|NCT00574288|58691204|FG006|Overall Study|Death|21|||
30677339|NCT00574288|58691198|FG000|Overall Study|Lost to Follow-up|0|||
30677340|NCT00574288|58691199|FG001|Overall Study|Lost to Follow-up|0|||
30677341|NCT00574288|58691200|FG002|Overall Study|Lost to Follow-up|0|||
30677342|NCT00574288|58691201|FG003|Overall Study|Lost to Follow-up|0|||
30677343|NCT00574288|58691202|FG004|Overall Study|Lost to Follow-up|0|||
30677344|NCT00574288|58691203|FG005|Overall Study|Lost to Follow-up|1|||
30677345|NCT00574288|58691204|FG006|Overall Study|Lost to Follow-up|2|||
30677346|NCT00574288|58691198|FG000|Overall Study|Study Terminated By Sponsor|0|||
30677347|NCT00574288|58691199|FG001|Overall Study|Study Terminated By Sponsor|0|||
30592518|NCT00174915|58604731|FG001|Overall Study|Gout Flare|6|||
30592519|NCT00174915|58604732|FG002|Overall Study|Gout Flare|8|||
30592520|NCT00174915|58604733|FG003|Overall Study|Gout Flare|1|||
30677348|NCT00574288|58691200|FG002|Overall Study|Study Terminated By Sponsor|0|||
30677349|NCT00574288|58691201|FG003|Overall Study|Study Terminated By Sponsor|0|||
30677350|NCT00574288|58691202|FG004|Overall Study|Study Terminated By Sponsor|0|||
30677351|NCT00574288|58691203|FG005|Overall Study|Study Terminated By Sponsor|0|||
30782122|NCT01347866|58793974|FG001|Overall Study|Lost to Follow-up|0|||
30782123|NCT01347866|58793975|FG002|Overall Study|Lost to Follow-up|0|||
30782124|NCT01347866|58793976|FG003|Overall Study|Lost to Follow-up|0|||
30782125|NCT01347866|58793977|FG004|Overall Study|Lost to Follow-up|0|||
30782126|NCT01347866|58793978|FG005|Overall Study|Lost to Follow-up|0|||
30782127|NCT01347866|58793979|FG006|Overall Study|Lost to Follow-up|0|||
30782128|NCT01347866|58793980|FG007|Overall Study|Lost to Follow-up|1|||
30782129|NCT01347866|58793981|FG008|Overall Study|Lost to Follow-up|1|||
30782130|NCT01347866|58793982|FG009|Overall Study|Lost to Follow-up|0|||
30782131|NCT01347866|58793983|FG010|Overall Study|Lost to Follow-up|0|||
30782132|NCT01347866|58793984|FG011|Overall Study|Lost to Follow-up|0|||
30782133|NCT01347866|58793985|FG012|Overall Study|Lost to Follow-up|0|||
30782134|NCT01347866|58793986|FG013|Overall Study|Lost to Follow-up|0|||
30592521|NCT00174915|58604734|FG004|Overall Study|Gout Flare|0|||
30677352|NCT00574288|58691204|FG006|Overall Study|Study Terminated By Sponsor|5|||
30677353|NCT00574288|58691198|FG000|Overall Study|Progressive Disease|17|||
30677354|NCT00574288|58691199|FG001|Overall Study|Progressive Disease|2|||
30592522|NCT00174915|58604730|FG000|Overall Study|Protocol Violation|6|||
30592523|NCT00174915|58604731|FG001|Overall Study|Protocol Violation|3|||
30677355|NCT00574288|58691200|FG002|Overall Study|Progressive Disease|3|||
30677356|NCT00574288|58691201|FG003|Overall Study|Progressive Disease|2|||
30677357|NCT00574288|58691202|FG004|Overall Study|Progressive Disease|1|||
30677358|NCT00574288|58691203|FG005|Overall Study|Progressive Disease|0|||
30677359|NCT00574288|58691204|FG006|Overall Study|Progressive Disease|0|||
30782135|NCT01347866|58793987|FG014|Overall Study|Lost to Follow-up|0|||
30592524|NCT00174915|58604732|FG002|Overall Study|Protocol Violation|3|||
30592525|NCT00174915|58604733|FG003|Overall Study|Protocol Violation|6|||
30677360|NCT00574288|58691198|FG000|Overall Study|Other|1|||
30677361|NCT00574288|58691199|FG001|Overall Study|Other|1|||
30677362|NCT00574288|58691200|FG002|Overall Study|Other|0|||
30677363|NCT00574288|58691201|FG003|Overall Study|Other|0|||
30677364|NCT00574288|58691202|FG004|Overall Study|Other|0|||
30677365|NCT00574288|58691203|FG005|Overall Study|Other|0|||
30782136|NCT01347866|58793988|FG015|Overall Study|Lost to Follow-up|0|||
30592526|NCT00174915|58604734|FG004|Overall Study|Protocol Violation|3|||
30592527|NCT00174915|58604730|FG000|Overall Study|Therapeutic Failure|6|||
30677366|NCT00574288|58691204|FG006|Overall Study|Other|0|||
30677367|NCT00790452|58691232|FG000|Overall Study|Drug supply issue|1|||
30677368|NCT00790452|58691233|FG001|Overall Study|Drug supply issue|0|||
30677369|NCT00626392|58691245|FG000|Run-in Period|Adverse Event|0|||
30677370|NCT00626392|58691246|FG001|Run-in Period|Adverse Event|0|||
30677371|NCT00626392|58691247|FG002|Run-in Period|Adverse Event|1|||
30677372|NCT00626392|58691248|FG003|Run-in Period|Adverse Event|0|||
30677373|NCT00626392|58691249|FG004|Run-in Period|Adverse Event|1|||
30677374|NCT00626392|58691250|FG005|Run-in Period|Adverse Event|0|||
30677375|NCT00626392|58691245|FG000|Run-in Period|Withdrawal by Subject|0|||
30677376|NCT00626392|58691246|FG001|Run-in Period|Withdrawal by Subject|1|||
30677377|NCT00626392|58691247|FG002|Run-in Period|Withdrawal by Subject|1|||
30677378|NCT00626392|58691248|FG003|Run-in Period|Withdrawal by Subject|1|||
30677379|NCT00626392|58691249|FG004|Run-in Period|Withdrawal by Subject|3|||
30677380|NCT00626392|58691250|FG005|Run-in Period|Withdrawal by Subject|1|||
30677381|NCT00626392|58691245|FG000|Run-in Period|Noncompliance|1|||
30677382|NCT00626392|58691246|FG001|Run-in Period|Noncompliance|0|||
30677383|NCT00626392|58691247|FG002|Run-in Period|Noncompliance|1|||
30592528|NCT00174915|58604731|FG001|Overall Study|Therapeutic Failure|3|||
30592529|NCT00174915|58604732|FG002|Overall Study|Therapeutic Failure|2|||
30592530|NCT00174915|58604733|FG003|Overall Study|Therapeutic Failure|1|||
30592531|NCT00174915|58604734|FG004|Overall Study|Therapeutic Failure|3|||
30592532|NCT01080716|58604750|FG000|Part 1|Physician Decision|1|||
30592533|NCT01080716|58604751|FG001|Part 1|Physician Decision|0|||
30592534|NCT01080716|58604752|FG002|Part 1|Physician Decision|0|||
30592535|NCT01080716|58604753|FG003|Part 1|Physician Decision|0|||
30677384|NCT00626392|58691248|FG003|Run-in Period|Noncompliance|0|||
30677385|NCT00626392|58691249|FG004|Run-in Period|Noncompliance|0|||
30677386|NCT00626392|58691250|FG005|Run-in Period|Noncompliance|0|||
30677387|NCT00626392|58691245|FG000|Coadministration Period|Adverse Event|3|||
30677388|NCT00626392|58691246|FG001|Coadministration Period|Adverse Event|1|||
30677389|NCT00626392|58691247|FG002|Coadministration Period|Adverse Event|7|||
30677390|NCT00626392|58691248|FG003|Coadministration Period|Adverse Event|4|||
30677391|NCT00626392|58691249|FG004|Coadministration Period|Adverse Event|3|||
30677392|NCT00626392|58691250|FG005|Coadministration Period|Adverse Event|4|||
30677393|NCT00626392|58691245|FG000|Coadministration Period|Withdrawal by Subject|1|||
30677394|NCT00626392|58691246|FG001|Coadministration Period|Withdrawal by Subject|1|||
30677395|NCT00626392|58691247|FG002|Coadministration Period|Withdrawal by Subject|0|||
30677396|NCT00626392|58691248|FG003|Coadministration Period|Withdrawal by Subject|1|||
30677397|NCT00626392|58691249|FG004|Coadministration Period|Withdrawal by Subject|0|||
30677398|NCT00626392|58691250|FG005|Coadministration Period|Withdrawal by Subject|1|||
30677399|NCT00626392|58691245|FG000|Coadministration Period|Protocol Violation|0|||
30677400|NCT00626392|58691246|FG001|Coadministration Period|Protocol Violation|1|||
30592536|NCT00172185|58604771|FG000|Overall Study|Adverse Event|0|||
30677401|NCT00626392|58691247|FG002|Coadministration Period|Protocol Violation|0|||
30592537|NCT00172185|58604772|FG001|Overall Study|Adverse Event|1|||
30592538|NCT00172185|58604773|FG002|Overall Study|Adverse Event|3|||
30592539|NCT00172185|58604774|FG003|Overall Study|Adverse Event|4|||
30592540|NCT00172185|58604771|FG000|Overall Study|Physician Decision|0|||
30592541|NCT00172185|58604772|FG001|Overall Study|Physician Decision|0|||
30592542|NCT00172185|58604773|FG002|Overall Study|Physician Decision|1|||
30592543|NCT00172185|58604774|FG003|Overall Study|Physician Decision|0|||
30592544|NCT00172185|58604771|FG000|Overall Study|SPONSOR Decision|0|||
30592545|NCT00172185|58604772|FG001|Overall Study|SPONSOR Decision|1|||
30592546|NCT00172185|58604773|FG002|Overall Study|SPONSOR Decision|0|||
30592547|NCT00172185|58604774|FG003|Overall Study|SPONSOR Decision|0|||
30592548|NCT00172185|58604771|FG000|Overall Study|Withdrawal by Subject|0|||
30592549|NCT00172185|58604772|FG001|Overall Study|Withdrawal by Subject|0|||
30592550|NCT00172185|58604773|FG002|Overall Study|Withdrawal by Subject|1|||
30592551|NCT00172185|58604774|FG003|Overall Study|Withdrawal by Subject|0|||
30592552|NCT01080326|58604788|FG000|Overall Study|Patient deterioration prior to procedure|3|||
30677402|NCT00626392|58691248|FG003|Coadministration Period|Protocol Violation|1|||
30677403|NCT00626392|58691249|FG004|Coadministration Period|Protocol Violation|1|||
30677404|NCT00626392|58691250|FG005|Coadministration Period|Protocol Violation|0|||
30677405|NCT00626392|58691245|FG000|Coadministration Period|Other|0|||
30677406|NCT00626392|58691246|FG001|Coadministration Period|Other|2|||
30677407|NCT00626392|58691247|FG002|Coadministration Period|Other|3|||
30782137|NCT01347866|58793989|FG016|Overall Study|Lost to Follow-up|0|||
30782138|NCT01347866|58793973|FG000|Overall Study|Other|3|||
30592553|NCT01080326|58604788|FG000|Overall Study|Surgeon decision|1|||
30592554|NCT00171951|58604792|FG000|Overall Study|Adverse Event|1|||
30592555|NCT00171951|58604792|FG000|Overall Study|Abnormal Laboratory Values|2|||
30677408|NCT00626392|58691248|FG003|Coadministration Period|Other|1|||
30677409|NCT00626392|58691249|FG004|Coadministration Period|Other|1|||
30677410|NCT00626392|58691250|FG005|Coadministration Period|Other|1|||
30677411|NCT00624286|58691258|FG000|Overall Study|Protocol Deviation|7|||
30677412|NCT00624286|58691259|FG001|Overall Study|Protocol Deviation|9|||
30677413|NCT00624286|58691258|FG000|Overall Study|Adverse Event|6|||
30677414|NCT00624286|58691259|FG001|Overall Study|Adverse Event|3|||
30677415|NCT00624286|58691258|FG000|Overall Study|Withdrawal by Subject|5|||
30677416|NCT00624286|58691259|FG001|Overall Study|Withdrawal by Subject|4|||
30677417|NCT00624286|58691258|FG000|Overall Study|Lost to Follow-up|3|||
30677418|NCT00624286|58691259|FG001|Overall Study|Lost to Follow-up|2|||
30677419|NCT00624286|58691258|FG000|Overall Study|Administrative problems|3|||
30677420|NCT00624286|58691259|FG001|Overall Study|Administrative problems|0|||
30677421|NCT00624286|58691258|FG000|Overall Study|Lack of Efficacy|1|||
30677422|NCT00624286|58691259|FG001|Overall Study|Lack of Efficacy|6|||
30677423|NCT00624286|58691258|FG000|Overall Study|Not stated|0|||
30677424|NCT00624286|58691259|FG001|Overall Study|Not stated|1|||
30677425|NCT00624286|58691258|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30677426|NCT00624286|58691259|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30782139|NCT01347866|58793974|FG001|Overall Study|Other|1|||
30782140|NCT01347866|58793975|FG002|Overall Study|Other|1|||
30782141|NCT01347866|58793976|FG003|Overall Study|Other|4|||
30782142|NCT01347866|58793977|FG004|Overall Study|Other|5|||
30782143|NCT01347866|58793978|FG005|Overall Study|Other|0|||
30782144|NCT01347866|58793979|FG006|Overall Study|Other|5|||
30782145|NCT01347866|58793980|FG007|Overall Study|Other|3|||
30782146|NCT01347866|58793981|FG008|Overall Study|Other|22|||
30782147|NCT01347866|58793982|FG009|Overall Study|Other|5|||
30782148|NCT01347866|58793983|FG010|Overall Study|Other|0|||
30856064|NCT04679675|58883888|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
30856065|NCT04679675|58883889|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
30856066|NCT04679675|58883890|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
30856067|NCT04679675|58883891|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
30856068|NCT04679675|58883888|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
30856069|NCT04679675|58883889|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
30856070|NCT04679675|58883890|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
30856071|NCT04679675|58883891|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
30856072|NCT04439201|58883901|FG000|Overall Study|Ineligible|2|||
30856073|NCT04439201|58883901|FG000|Overall Study|Never start protocol therapy|1|||
30856074|NCT04439201|58883901|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
30856075|NCT04439201|58883901|FG000|Overall Study|Mutation status not confirmed|4|||
30856076|NCT04439201|58883901|FG000|Overall Study|Adverse Event|1|||
30856077|NCT04439201|58883901|FG000|Overall Study|Death|7|||
30856078|NCT04439201|58883901|FG000|Overall Study|Withdrawal by Subject|2|||
30856079|NCT04439201|58883901|FG000|Overall Study|Disease progression|20|||
30856080|NCT04439201|58883901|FG000|Overall Study|Alternative therapy|1|||
30592556|NCT00171951|58604792|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
30592557|NCT00171951|58604792|FG000|Overall Study|Participants Withdrew Consent|3|||
30592558|NCT00171951|58604792|FG000|Overall Study|New Cancer Therapy|5|||
30592559|NCT00171951|58604792|FG000|Overall Study|Reason not Specified|2|||
30592560|NCT01080131|58604801|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
30592561|NCT01080131|58604802|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
30592562|NCT01080131|58604801|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
30592563|NCT01080131|58604802|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
30592564|NCT01080131|58604801|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
30592565|NCT01080131|58604802|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
30592566|NCT01080131|58604801|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
30592567|NCT01080131|58604802|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
30592568|NCT01080131|58604801|FG000|Core Study (0- 12 Weeks)|Death|1|||
30592569|NCT01080131|58604802|FG001|Core Study (0- 12 Weeks)|Death|0|||
30592570|NCT01080131|58604801|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
30592571|NCT01080131|58604802|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
30592572|NCT01080131|58604801|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
30592573|NCT01080131|58604802|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
30592574|NCT01080131|58604801|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
30592575|NCT01080131|58604802|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
30592576|NCT01080131|58604801|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
30592577|NCT01080131|58604802|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
30592578|NCT01080131|58604801|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
30677427|NCT00624286|58691258|FG000|Overall Study|Death|0|||
30677428|NCT00624286|58691259|FG001|Overall Study|Death|1|||
30782149|NCT01347866|58793984|FG011|Overall Study|Other|3|||
30677429|NCT00624052|58691269|FG000|Overall Study|Adverse Event|7|||
30677430|NCT00624052|58691270|FG001|Overall Study|Adverse Event|6|||
30677431|NCT00624052|58691271|FG002|Overall Study|Adverse Event|0|||
30782150|NCT01347866|58793985|FG012|Overall Study|Other|4|||
30782151|NCT01347866|58793986|FG013|Overall Study|Other|4|||
30677432|NCT00624052|58691272|FG003|Overall Study|Adverse Event|3|||
30677433|NCT00624052|58691269|FG000|Overall Study|Lack of Efficacy|1|||
30677434|NCT00624052|58691270|FG001|Overall Study|Lack of Efficacy|1|||
30677435|NCT00624052|58691271|FG002|Overall Study|Lack of Efficacy|0|||
30677436|NCT00624052|58691272|FG003|Overall Study|Lack of Efficacy|0|||
30592579|NCT01080131|58604802|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
30592580|NCT01080131|58604801|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
30592581|NCT01080131|58604802|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
30592582|NCT01080131|58604801|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
30592583|NCT01080131|58604802|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
30592584|NCT01080131|58604801|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
30592585|NCT01080131|58604802|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
30592586|NCT00171873|58604828|FG000|Overall Study|Withdrawal by Subject|4|||
30592587|NCT00171873|58604829|FG001|Overall Study|Withdrawal by Subject|2|||
30592588|NCT00171873|58604828|FG000|Overall Study|Adverse Event|5|||
30592589|NCT00171873|58604829|FG001|Overall Study|Adverse Event|0|||
30677437|NCT00624052|58691269|FG000|Overall Study|Lost to Follow-up|2|||
30677438|NCT00624052|58691270|FG001|Overall Study|Lost to Follow-up|3|||
30677439|NCT00624052|58691271|FG002|Overall Study|Lost to Follow-up|1|||
30677440|NCT00624052|58691272|FG003|Overall Study|Lost to Follow-up|0|||
30677441|NCT00624052|58691269|FG000|Overall Study|Non compliant with the protocol|2|||
30677442|NCT00624052|58691270|FG001|Overall Study|Non compliant with the protocol|1|||
30677443|NCT00624052|58691271|FG002|Overall Study|Non compliant with the protocol|1|||
30677444|NCT00624052|58691272|FG003|Overall Study|Non compliant with the protocol|1|||
30677445|NCT00624052|58691269|FG000|Overall Study|Consent withdrawn|3|||
30677446|NCT00624052|58691270|FG001|Overall Study|Consent withdrawn|1|||
30677447|NCT00624052|58691271|FG002|Overall Study|Consent withdrawn|1|||
30677448|NCT00624052|58691272|FG003|Overall Study|Consent withdrawn|0|||
30677449|NCT00624052|58691269|FG000|Overall Study|Changed job/ran out if meds|0|||
30677450|NCT00624052|58691270|FG001|Overall Study|Changed job/ran out if meds|2|||
30677451|NCT00624052|58691271|FG002|Overall Study|Changed job/ran out if meds|0|||
30677452|NCT00624052|58691272|FG003|Overall Study|Changed job/ran out if meds|0|||
30677453|NCT00785577|58691291|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
30677454|NCT00785577|58691292|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
30677455|NCT00785577|58691293|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
30677456|NCT00785577|58691294|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
30677457|NCT00785577|58691295|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
30677458|NCT00785577|58691291|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
30677459|NCT00785577|58691292|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
30677460|NCT00785577|58691293|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
30677461|NCT00785577|58691294|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
30677462|NCT00785577|58691295|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
30677463|NCT00785577|58691291|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
30677464|NCT00785577|58691292|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
30677465|NCT00785577|58691293|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
30677466|NCT00785577|58691294|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
30677467|NCT00785577|58691295|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
30677468|NCT00785577|58691291|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
30677469|NCT00785577|58691292|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
30677470|NCT00785577|58691293|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
30677471|NCT00785577|58691294|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
30677472|NCT00785577|58691295|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
30677473|NCT00785577|58691291|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
30677474|NCT00785577|58691292|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
30677475|NCT00785577|58691293|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
30677476|NCT00785577|58691294|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
30856081|NCT04439201|58883901|FG000|Overall Study|Physician Decision|1|||
30856082|NCT04318132|58883919|FG000|Overall Study|Protocol Violation|0|||
30592590|NCT00171873|58604828|FG000|Overall Study|Switched to Octreotide|0|||
30592591|NCT00171873|58604829|FG001|Overall Study|Switched to Octreotide|1|||
30677477|NCT00785577|58691295|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
30677478|NCT00785577|58691291|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
30677479|NCT00785577|58691292|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
30677480|NCT00785577|58691293|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
30677481|NCT00785577|58691294|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
30677482|NCT00785577|58691295|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
30677483|NCT00785577|58691291|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
30677484|NCT00785577|58691292|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
30677485|NCT00785577|58691293|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
30677486|NCT00785577|58691294|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
30782152|NCT01347866|58793987|FG014|Overall Study|Other|2|||
30856083|NCT04318132|58883920|FG001|Overall Study|Protocol Violation|0|||
30677487|NCT00785577|58691295|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
30677488|NCT00785577|58691291|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
30677489|NCT00785577|58691292|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
30677490|NCT00785577|58691293|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
30677491|NCT00785577|58691294|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
30677492|NCT00785577|58691295|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
30677493|NCT00785577|58691291|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
30677494|NCT00785577|58691292|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
30677495|NCT00785577|58691293|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
30677496|NCT00785577|58691294|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
30677497|NCT00785577|58691295|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
30677498|NCT00785577|58691291|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
30677499|NCT00785577|58691292|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
30677500|NCT00785577|58691293|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
30677501|NCT00785577|58691294|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
30677502|NCT00785577|58691295|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
30592592|NCT00171834|58604842|FG000|Overall Study|Adverse Event|2|||
30592593|NCT00171834|58604843|FG001|Overall Study|Adverse Event|1|||
30592594|NCT00171834|58604844|FG002|Overall Study|Adverse Event|3|||
30592595|NCT00171834|58604845|FG003|Overall Study|Adverse Event|2|||
30592596|NCT00171834|58604846|FG004|Overall Study|Adverse Event|2|||
30592597|NCT00171834|58604847|FG005|Overall Study|Adverse Event|15|||
30592598|NCT00171834|58604848|FG006|Overall Study|Adverse Event|1|||
30592599|NCT00171834|58604842|FG000|Overall Study|Withdrawal by Subject|0|||
30592600|NCT00171834|58604843|FG001|Overall Study|Withdrawal by Subject|2|||
30592601|NCT00171834|58604844|FG002|Overall Study|Withdrawal by Subject|0|||
30592602|NCT00171834|58604845|FG003|Overall Study|Withdrawal by Subject|1|||
30592603|NCT00171834|58604846|FG004|Overall Study|Withdrawal by Subject|1|||
30592604|NCT00171834|58604847|FG005|Overall Study|Withdrawal by Subject|1|||
30592605|NCT00171834|58604848|FG006|Overall Study|Withdrawal by Subject|0|||
30592606|NCT00171834|58604842|FG000|Overall Study|Death from study indication|0|||
30592607|NCT00171834|58604843|FG001|Overall Study|Death from study indication|1|||
30592608|NCT00171834|58604844|FG002|Overall Study|Death from study indication|0|||
30592609|NCT00171834|58604845|FG003|Overall Study|Death from study indication|0|||
30592610|NCT00171834|58604846|FG004|Overall Study|Death from study indication|1|||
30592611|NCT00171834|58604847|FG005|Overall Study|Death from study indication|0|||
30592612|NCT00171834|58604848|FG006|Overall Study|Death from study indication|0|||
30592613|NCT00171834|58604842|FG000|Overall Study|Disease Progression|4|||
30592614|NCT00171834|58604843|FG001|Overall Study|Disease Progression|8|||
30592615|NCT00171834|58604844|FG002|Overall Study|Disease Progression|8|||
30592616|NCT00171834|58604845|FG003|Overall Study|Disease Progression|9|||
30592617|NCT00171834|58604846|FG004|Overall Study|Disease Progression|2|||
30592618|NCT00171834|58604847|FG005|Overall Study|Disease Progression|18|||
30592619|NCT00171834|58604848|FG006|Overall Study|Disease Progression|3|||
30677503|NCT00789828|58691319|FG000|Core Period (48 Weeks)|Administrative problems|0|||
30677504|NCT00789828|58691320|FG001|Core Period (48 Weeks)|Administrative problems|1|||
30677505|NCT00789828|58691319|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
30677506|NCT00789828|58691320|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
30677507|NCT00789828|58691319|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
30677508|NCT00789828|58691320|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
30677509|NCT00789828|58691319|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
30677510|NCT00789828|58691320|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
30677511|NCT00789828|58691319|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
30677512|NCT00789828|58691320|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
30677513|NCT00789828|58691319|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
30677514|NCT00789828|58691320|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
30592620|NCT00171834|58604842|FG000|Overall Study|Treatment Duration Completed|0|||
30677515|NCT00789828|58691319|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
30677516|NCT00789828|58691320|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
30677517|NCT00789828|58691319|FG000|Open-label Extension Period (4 Years)|Death|1|||
30677518|NCT00789828|58691320|FG001|Open-label Extension Period (4 Years)|Death|0|||
30592621|NCT00171834|58604843|FG001|Overall Study|Treatment Duration Completed|0|||
30592622|NCT00171834|58604844|FG002|Overall Study|Treatment Duration Completed|1|||
30592623|NCT00171834|58604845|FG003|Overall Study|Treatment Duration Completed|0|||
30592624|NCT00171834|58604846|FG004|Overall Study|Treatment Duration Completed|2|||
30592625|NCT00171834|58604847|FG005|Overall Study|Treatment Duration Completed|1|||
30592626|NCT00171834|58604848|FG006|Overall Study|Treatment Duration Completed|0|||
30592627|NCT00171249|58604878|FG000|Overall Study|Withdrawal by Subject|2|||
30677519|NCT00789828|58691319|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
30592628|NCT00171249|58604879|FG001|Overall Study|Withdrawal by Subject|0|||
30592629|NCT00171249|58604880|FG002|Overall Study|Withdrawal by Subject|0|||
30592630|NCT00171249|58604881|FG003|Overall Study|Withdrawal by Subject|6|||
30592631|NCT00171249|58604882|FG004|Overall Study|Withdrawal by Subject|0|||
30677520|NCT00789828|58691320|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
30677521|NCT00789828|58691319|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
30677522|NCT00789828|58691320|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
30677523|NCT00790296|58691331|FG000|Overall Study|Did not meet study eligibility criteria|1|||
30677524|NCT00790296|58691332|FG001|Overall Study|Did not meet study eligibility criteria|1|||
30677525|NCT00790296|58691331|FG000|Overall Study|Adverse Event|0|||
30677526|NCT00790296|58691332|FG001|Overall Study|Adverse Event|1|||
30677527|NCT00623194|58691338|FG000|Overall Study|Lack of Efficacy|1|||
30592632|NCT00171249|58604883|FG005|Overall Study|Withdrawal by Subject|0|||
30592633|NCT00171249|58604884|FG006|Overall Study|Withdrawal by Subject|0|||
30592634|NCT00171249|58604878|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
30592635|NCT00171249|58604879|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
30592636|NCT00171249|58604880|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
30592637|NCT00171249|58604881|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
30592638|NCT00171249|58604882|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
30592639|NCT00171249|58604883|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
30592640|NCT00171249|58604884|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
30677528|NCT00623194|58691338|FG000|Overall Study|Protocol Violation|3|||
30677529|NCT00623194|58691338|FG000|Overall Study|Unclassified|1|||
30677530|NCT00784368|58691345|FG000|Overall Study|Physician Decision|0|||
30677531|NCT00784368|58691346|FG001|Overall Study|Physician Decision|0|||
30677532|NCT00784368|58691347|FG002|Overall Study|Physician Decision|6|||
30677533|NCT00784368|58691345|FG000|Overall Study|Lack of Efficacy|2|||
30677534|NCT00784368|58691346|FG001|Overall Study|Lack of Efficacy|0|||
30677535|NCT00784368|58691347|FG002|Overall Study|Lack of Efficacy|1|||
30677536|NCT00784368|58691345|FG000|Overall Study|Adverse Event|6|||
30677537|NCT00784368|58691346|FG001|Overall Study|Adverse Event|9|||
30677538|NCT00784368|58691347|FG002|Overall Study|Adverse Event|2|||
30677539|NCT00784368|58691345|FG000|Overall Study|Diagnosis of fever|0|||
30677540|NCT00784368|58691346|FG001|Overall Study|Diagnosis of fever|0|||
30677541|NCT00784368|58691347|FG002|Overall Study|Diagnosis of fever|1|||
30677542|NCT00784368|58691345|FG000|Overall Study|Worsening of complications|0|||
30677543|NCT00784368|58691346|FG001|Overall Study|Worsening of complications|0|||
30677544|NCT00784368|58691347|FG002|Overall Study|Worsening of complications|1|||
30677545|NCT00784368|58691345|FG000|Overall Study|Worsening of symptoms|0|||
30677546|NCT00784368|58691346|FG001|Overall Study|Worsening of symptoms|1|||
30677547|NCT00784368|58691347|FG002|Overall Study|Worsening of symptoms|0|||
30677548|NCT00784368|58691345|FG000|Overall Study|Withdrawal of informed consent|0|||
30677549|NCT00784368|58691346|FG001|Overall Study|Withdrawal of informed consent|1|||
30592641|NCT00171249|58604878|FG000|Overall Study|Death|7|||
30592642|NCT00171249|58604879|FG001|Overall Study|Death|1|||
30592643|NCT00171249|58604880|FG002|Overall Study|Death|0|||
30592644|NCT00171249|58604881|FG003|Overall Study|Death|4|||
30592645|NCT00171249|58604882|FG004|Overall Study|Death|0|||
30677550|NCT00784368|58691347|FG002|Overall Study|Withdrawal of informed consent|0|||
30677551|NCT00622726|58691360|FG000|March, 2008 to August, 2010|Death|5|||
30677552|NCT00622726|58691361|FG001|March, 2008 to August, 2010|Death|2|||
30782153|NCT01347866|58793988|FG015|Overall Study|Other|3|||
30782154|NCT01347866|58793989|FG016|Overall Study|Other|0|||
30782155|NCT01347866|58793973|FG000|Overall Study|Subject refused further follow-up|2|||
30782156|NCT01347866|58793974|FG001|Overall Study|Subject refused further follow-up|0|||
30782157|NCT01347866|58793975|FG002|Overall Study|Subject refused further follow-up|0|||
30782158|NCT01347866|58793976|FG003|Overall Study|Subject refused further follow-up|2|||
30782159|NCT01347866|58793977|FG004|Overall Study|Subject refused further follow-up|0|||
30782160|NCT01347866|58793978|FG005|Overall Study|Subject refused further follow-up|1|||
30782161|NCT01347866|58793979|FG006|Overall Study|Subject refused further follow-up|0|||
30782162|NCT01347866|58793980|FG007|Overall Study|Subject refused further follow-up|0|||
30782163|NCT01347866|58793981|FG008|Overall Study|Subject refused further follow-up|4|||
30782164|NCT01347866|58793982|FG009|Overall Study|Subject refused further follow-up|1|||
30782165|NCT01347866|58793983|FG010|Overall Study|Subject refused further follow-up|0|||
30782166|NCT01347866|58793984|FG011|Overall Study|Subject refused further follow-up|0|||
30592646|NCT00171249|58604883|FG005|Overall Study|Death|3|||
30677553|NCT00622726|58691360|FG000|August, 2010 to April, 2013|Death|1|||
30677554|NCT00622726|58691361|FG001|August, 2010 to April, 2013|Death|5|||
30677555|NCT00623428|58691373|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
30592647|NCT00171249|58604884|FG006|Overall Study|Death|1|||
30592648|NCT00171249|58604878|FG000|Overall Study|Other|10|||
30677556|NCT00623428|58691374|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
30677557|NCT00623428|58691373|FG000|Treatment Period|Death|0|||
30677558|NCT00623428|58691374|FG001|Treatment Period|Death|1|||
30677559|NCT00623428|58691373|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
30782167|NCT01347866|58793985|FG012|Overall Study|Subject refused further follow-up|1|||
30592649|NCT00171249|58604879|FG001|Overall Study|Other|0|||
30592650|NCT00171249|58604880|FG002|Overall Study|Other|0|||
30782168|NCT01347866|58793986|FG013|Overall Study|Subject refused further follow-up|3|||
30782169|NCT01347866|58793987|FG014|Overall Study|Subject refused further follow-up|1|||
30782170|NCT01347866|58793988|FG015|Overall Study|Subject refused further follow-up|0|||
30782171|NCT01347866|58793989|FG016|Overall Study|Subject refused further follow-up|2|||
30782172|NCT01347710|58794060|FG000|Overall Study|Withdrawal by Subject|2|||
30782173|NCT01347710|58794060|FG000|Overall Study|Adverse Event|4|||
30782174|NCT01347710|58794060|FG000|Overall Study|Angio or SPECT not completed|18|||
30782175|NCT01347710|58794060|FG000|Overall Study|issue with vitals prior to dosing|1|||
30782176|NCT01347710|58794060|FG000|Overall Study|Lost to Follow-up|1|||
30782177|NCT01347710|58794060|FG000|Overall Study|Physician Decision|2|||
30677560|NCT00623428|58691374|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
30677561|NCT00623428|58691373|FG000|Treatment Period|Insufficient therapeutic response|0|||
30677562|NCT00623428|58691374|FG001|Treatment Period|Insufficient therapeutic response|2|||
30677563|NCT00623428|58691373|FG000|Treatment Period|Other|0|||
30677564|NCT00623428|58691374|FG001|Treatment Period|Other|1|||
30677565|NCT00623428|58691373|FG000|Treatment Period|Withdrawal by Subject|0|||
30677566|NCT00623428|58691374|FG001|Treatment Period|Withdrawal by Subject|1|||
30677567|NCT00623428|58691373|FG000|Follow-up Period|Relapse post-treatment|11|||
30782178|NCT01347710|58794060|FG000|Overall Study|Other|3|||
30782179|NCT03485222|58794070|FG000|Overall Study|Death|0|||
30592651|NCT00171249|58604881|FG003|Overall Study|Other|43|||
30592652|NCT00171249|58604882|FG004|Overall Study|Other|0|||
30592653|NCT00171249|58604883|FG005|Overall Study|Other|2|||
30592654|NCT00171249|58604884|FG006|Overall Study|Other|0|||
30592655|NCT00171249|58604878|FG000|Overall Study|No Longer Requires Study Drug|4|||
30592656|NCT00171249|58604879|FG001|Overall Study|No Longer Requires Study Drug|0|||
30592657|NCT00171249|58604880|FG002|Overall Study|No Longer Requires Study Drug|0|||
30592658|NCT00171249|58604881|FG003|Overall Study|No Longer Requires Study Drug|3|||
30592659|NCT00171249|58604882|FG004|Overall Study|No Longer Requires Study Drug|0|||
30592660|NCT00171249|58604883|FG005|Overall Study|No Longer Requires Study Drug|5|||
30592661|NCT00171249|58604884|FG006|Overall Study|No Longer Requires Study Drug|0|||
30592662|NCT00171249|58604878|FG000|Overall Study|Administrative Problems|1|||
30592663|NCT00171249|58604879|FG001|Overall Study|Administrative Problems|0|||
30592664|NCT00171249|58604880|FG002|Overall Study|Administrative Problems|0|||
30592665|NCT00171249|58604881|FG003|Overall Study|Administrative Problems|2|||
30592666|NCT00171249|58604882|FG004|Overall Study|Administrative Problems|0|||
30592667|NCT00171249|58604883|FG005|Overall Study|Administrative Problems|0|||
30592668|NCT00171249|58604884|FG006|Overall Study|Administrative Problems|0|||
30592669|NCT00171249|58604878|FG000|Overall Study|Adverse Event|3|||
30592670|NCT00171249|58604879|FG001|Overall Study|Adverse Event|1|||
30592671|NCT00171249|58604880|FG002|Overall Study|Adverse Event|0|||
30592672|NCT00171249|58604881|FG003|Overall Study|Adverse Event|15|||
30592673|NCT00171249|58604882|FG004|Overall Study|Adverse Event|0|||
30592674|NCT00171249|58604883|FG005|Overall Study|Adverse Event|2|||
30592675|NCT00171249|58604884|FG006|Overall Study|Adverse Event|0|||
30592676|NCT00171249|58604878|FG000|Overall Study|Lost to Follow-up|5|||
30592677|NCT00171249|58604879|FG001|Overall Study|Lost to Follow-up|0|||
30592678|NCT00171249|58604880|FG002|Overall Study|Lost to Follow-up|0|||
30592679|NCT00171249|58604881|FG003|Overall Study|Lost to Follow-up|9|||
30677568|NCT00623428|58691374|FG001|Follow-up Period|Relapse post-treatment|3|||
30677569|NCT00623428|58691373|FG000|Follow-up Period|Failure to return|10|||
30677570|NCT00623428|58691374|FG001|Follow-up Period|Failure to return|2|||
30677571|NCT00623428|58691373|FG000|Follow-up Period|Patient withdrew consent|5|||
30677572|NCT00623428|58691374|FG001|Follow-up Period|Patient withdrew consent|4|||
30677573|NCT00623428|58691373|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
30677574|NCT00623428|58691374|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
30677575|NCT00623428|58691373|FG000|Follow-up Period|Did not cooperate|0|||
30677576|NCT00623428|58691374|FG001|Follow-up Period|Did not cooperate|3|||
30677577|NCT00623428|58691373|FG000|Follow-up Period|Reason not specified|1|||
30677578|NCT00623428|58691374|FG001|Follow-up Period|Reason not specified|1|||
30677579|NCT00623428|58691373|FG000|Follow-up Period|Death|0|||
30677580|NCT00623428|58691374|FG001|Follow-up Period|Death|1|||
30782180|NCT03485222|58794071|FG001|Overall Study|Death|1|||
30782181|NCT03485222|58794070|FG000|Overall Study|Lost to Follow-up|2|||
30782182|NCT03485222|58794071|FG001|Overall Study|Lost to Follow-up|1|||
30782183|NCT01347554|58794079|FG000|Overall Study|Lack of Efficacy|7|||
30959029|NCT01587703|59024027|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
30592680|NCT00171249|58604882|FG004|Overall Study|Lost to Follow-up|0|||
30592681|NCT00171249|58604883|FG005|Overall Study|Lost to Follow-up|0|||
30592682|NCT00171249|58604884|FG006|Overall Study|Lost to Follow-up|0|||
30592683|NCT01085630|58604895|FG000|Overall Study|Insufficient data|1|||
30592684|NCT01085630|58604896|FG001|Overall Study|Insufficient data|0|||
30782184|NCT01347554|58794080|FG001|Overall Study|Lack of Efficacy|11|||
30782185|NCT03482882|58794086|FG000|Overall Study|Adverse Event|3|||
30677581|NCT00784134|58691382|FG000|Overall Study|Lost to Follow-up|3|||
30677582|NCT00784134|58691383|FG001|Overall Study|Lost to Follow-up|6|||
30677583|NCT00776100|58691391|FG000|Overall Study|Disease Progression|1|||
30592685|NCT01085630|58604895|FG000|Overall Study|Ineligible|3|||
30592686|NCT01085630|58604896|FG001|Overall Study|Ineligible|0|||
30592687|NCT00171210|58604904|FG000|Overall Study|Adverse Event|16|||
30592688|NCT00171210|58604905|FG001|Overall Study|Adverse Event|27|||
30592689|NCT00171210|58604904|FG000|Overall Study|Abnormal laboratory value(s)|6|||
30592690|NCT00171210|58604905|FG001|Overall Study|Abnormal laboratory value(s)|3|||
30677584|NCT00776100|58691392|FG001|Overall Study|Disease Progression|0|||
30677585|NCT00783432|58691400|FG000|Overall Study|Adverse Event|22|||
30677586|NCT00783432|58691401|FG001|Overall Study|Adverse Event|17|||
30677587|NCT00783432|58691400|FG000|Overall Study|Lack of Efficacy|20|||
30782186|NCT03482882|58794086|FG000|Overall Study|Lost to Follow-up|1|||
30782187|NCT03482882|58794086|FG000|Overall Study|Protocol Violation|2|||
30592691|NCT00171210|58604904|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30592692|NCT00171210|58604905|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30592693|NCT00171210|58604904|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
30592694|NCT00171210|58604905|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
30592695|NCT00171210|58604904|FG000|Overall Study|Protocol Violation|0|||
30592696|NCT00171210|58604905|FG001|Overall Study|Protocol Violation|2|||
30592697|NCT00171210|58604904|FG000|Overall Study|Withdrawal by Subject|32|||
30592698|NCT00171210|58604905|FG001|Overall Study|Withdrawal by Subject|30|||
30592699|NCT00171210|58604904|FG000|Overall Study|Lost to Follow-up|1|||
30592700|NCT00171210|58604905|FG001|Overall Study|Lost to Follow-up|0|||
30592701|NCT00171210|58604904|FG000|Overall Study|Administrative problems|1|||
30592702|NCT00171210|58604905|FG001|Overall Study|Administrative problems|1|||
30592703|NCT00171210|58604904|FG000|Overall Study|Death|2|||
30592704|NCT00171210|58604905|FG001|Overall Study|Death|3|||
30592705|NCT00171210|58604904|FG000|Overall Study|Stopped at end of core|0|||
30592706|NCT00171210|58604905|FG001|Overall Study|Stopped at end of core|32|||
30592707|NCT00171210|58604904|FG000|Overall Study|Stopped at end of extension 1|0|||
30592708|NCT00171210|58604905|FG001|Overall Study|Stopped at end of extension 1|1|||
30592709|NCT00171054|58604913|FG000|Overall Study|Protocol Violation|1|||
30592710|NCT00171054|58604914|FG001|Overall Study|Protocol Violation|2|||
30592711|NCT00171054|58604913|FG000|Overall Study|Patient withdrew consent|1|||
30592712|NCT00171054|58604914|FG001|Overall Study|Patient withdrew consent|0|||
30592713|NCT00171054|58604913|FG000|Overall Study|Lost to Follow-up|0|||
30592714|NCT00171054|58604914|FG001|Overall Study|Lost to Follow-up|1|||
30592715|NCT00171054|58604913|FG000|Overall Study|Adverse Event|8|||
30592716|NCT00171054|58604914|FG001|Overall Study|Adverse Event|8|||
30592717|NCT00171054|58604913|FG000|Overall Study|Condition no longer required study drug|0|||
30592718|NCT00171054|58604914|FG001|Overall Study|Condition no longer required study drug|1|||
30592719|NCT01084694|58604922|FG000|Overall Study|Withdrawal by Subject|2|||
30592720|NCT01084694|58604923|FG001|Overall Study|Withdrawal by Subject|1|||
30592721|NCT01084694|58604922|FG000|Overall Study|Death|2|||
30592722|NCT01084694|58604923|FG001|Overall Study|Death|12|||
30592723|NCT01084694|58604922|FG000|Overall Study|eligibility not maintained|2|||
30592724|NCT01084694|58604923|FG001|Overall Study|eligibility not maintained|7|||
30592725|NCT00479856|58604937|FG000|Overall Study|Adverse Event|1|||
30592726|NCT00479856|58604937|FG000|Overall Study|Withdrawal by Subject|1|||
30592727|NCT00479856|58604937|FG000|Overall Study|Physician Decision|1|||
30592728|NCT00479466|58604947|FG000|Overall Study|Adverse Event|5|||
30592729|NCT00479466|58604948|FG001|Overall Study|Adverse Event|1|||
30592730|NCT00479466|58604949|FG002|Overall Study|Adverse Event|0|||
30592731|NCT00479466|58604950|FG003|Overall Study|Adverse Event|1|||
30592732|NCT00479466|58604951|FG004|Overall Study|Adverse Event|2|||
30592733|NCT00479466|58604952|FG005|Overall Study|Adverse Event|0|||
30592734|NCT00479466|58604947|FG000|Overall Study|Hyperglycemia|0|||
30592735|NCT00479466|58604948|FG001|Overall Study|Hyperglycemia|0|||
30592736|NCT00479466|58604949|FG002|Overall Study|Hyperglycemia|0|||
30592737|NCT00479466|58604950|FG003|Overall Study|Hyperglycemia|0|||
30592738|NCT00479466|58604951|FG004|Overall Study|Hyperglycemia|0|||
30592739|NCT00479466|58604952|FG005|Overall Study|Hyperglycemia|1|||
30592740|NCT00479466|58604947|FG000|Overall Study|Lack of Efficacy|2|||
30592741|NCT00479466|58604948|FG001|Overall Study|Lack of Efficacy|0|||
30782188|NCT03482882|58794086|FG000|Overall Study|Not further specified|1|||
30782189|NCT03480932|58794093|FG000|Overall Study|Death|1|||
30782190|NCT03480932|58794094|FG001|Overall Study|Death|1|||
30592742|NCT00479466|58604949|FG002|Overall Study|Lack of Efficacy|1|||
30592743|NCT00479466|58604950|FG003|Overall Study|Lack of Efficacy|0|||
30592744|NCT00479466|58604951|FG004|Overall Study|Lack of Efficacy|0|||
30592745|NCT00479466|58604952|FG005|Overall Study|Lack of Efficacy|0|||
30592746|NCT00479466|58604947|FG000|Overall Study|Lost to Follow-up|0|||
30592747|NCT00479466|58604948|FG001|Overall Study|Lost to Follow-up|1|||
30592748|NCT00479466|58604949|FG002|Overall Study|Lost to Follow-up|1|||
30592749|NCT00479466|58604950|FG003|Overall Study|Lost to Follow-up|0|||
30592750|NCT00479466|58604951|FG004|Overall Study|Lost to Follow-up|2|||
30592751|NCT00479466|58604952|FG005|Overall Study|Lost to Follow-up|2|||
30592752|NCT00479466|58604947|FG000|Overall Study|Physician Decision|2|||
30677588|NCT00783432|58691401|FG001|Overall Study|Lack of Efficacy|21|||
30677589|NCT00783432|58691400|FG000|Overall Study|Lost to Follow-up|11|||
30592753|NCT00479466|58604948|FG001|Overall Study|Physician Decision|1|||
30592754|NCT00479466|58604949|FG002|Overall Study|Physician Decision|1|||
30592755|NCT00479466|58604950|FG003|Overall Study|Physician Decision|0|||
30592756|NCT00479466|58604951|FG004|Overall Study|Physician Decision|0|||
30592757|NCT00479466|58604952|FG005|Overall Study|Physician Decision|0|||
30592758|NCT00479466|58604947|FG000|Overall Study|Pregnancy|0|||
30592759|NCT00479466|58604948|FG001|Overall Study|Pregnancy|0|||
30592760|NCT00479466|58604949|FG002|Overall Study|Pregnancy|0|||
30592761|NCT00479466|58604950|FG003|Overall Study|Pregnancy|0|||
30592762|NCT00479466|58604951|FG004|Overall Study|Pregnancy|1|||
30592763|NCT00479466|58604952|FG005|Overall Study|Pregnancy|0|||
30592764|NCT00479466|58604947|FG000|Overall Study|Protocol Violation|1|||
30592765|NCT00479466|58604948|FG001|Overall Study|Protocol Violation|0|||
30592766|NCT00479466|58604949|FG002|Overall Study|Protocol Violation|0|||
30592767|NCT00479466|58604950|FG003|Overall Study|Protocol Violation|0|||
30592768|NCT00479466|58604951|FG004|Overall Study|Protocol Violation|0|||
30677590|NCT00783432|58691401|FG001|Overall Study|Lost to Follow-up|6|||
30677591|NCT00783432|58691400|FG000|Overall Study|Withdrawal by Subject|23|||
30677592|NCT00783432|58691401|FG001|Overall Study|Withdrawal by Subject|20|||
30677593|NCT00783432|58691400|FG000|Overall Study|subject moved|3|||
30677594|NCT00783432|58691401|FG001|Overall Study|subject moved|5|||
30677595|NCT00783432|58691400|FG000|Overall Study|Protocol Violation|6|||
30677596|NCT00783432|58691401|FG001|Overall Study|Protocol Violation|9|||
30677597|NCT00783198|58691410|FG000|Overall Study|Adverse Event|15|||
30677598|NCT00783198|58691411|FG001|Overall Study|Adverse Event|19|||
30677599|NCT00783198|58691412|FG002|Overall Study|Adverse Event|3|||
30677600|NCT00783198|58691410|FG000|Overall Study|Lost to Follow-up|11|||
30677601|NCT00783198|58691411|FG001|Overall Study|Lost to Follow-up|1|||
30677602|NCT00783198|58691412|FG002|Overall Study|Lost to Follow-up|7|||
30677603|NCT00783198|58691410|FG000|Overall Study|Withdrawal by Subject|22|||
30677604|NCT00783198|58691411|FG001|Overall Study|Withdrawal by Subject|14|||
30677605|NCT00783198|58691412|FG002|Overall Study|Withdrawal by Subject|20|||
30677606|NCT00783198|58691410|FG000|Overall Study|Noncompliance with protocol|7|||
30677607|NCT00783198|58691411|FG001|Overall Study|Noncompliance with protocol|7|||
30677608|NCT00783198|58691412|FG002|Overall Study|Noncompliance with protocol|10|||
30592769|NCT00479466|58604952|FG005|Overall Study|Protocol Violation|0|||
30592770|NCT00479466|58604947|FG000|Overall Study|Withdrawal by Subject|3|||
30592771|NCT00479466|58604948|FG001|Overall Study|Withdrawal by Subject|5|||
30592772|NCT00479466|58604949|FG002|Overall Study|Withdrawal by Subject|0|||
30592773|NCT00479466|58604950|FG003|Overall Study|Withdrawal by Subject|2|||
30592774|NCT00479466|58604951|FG004|Overall Study|Withdrawal by Subject|3|||
30592775|NCT00479466|58604952|FG005|Overall Study|Withdrawal by Subject|1|||
30592776|NCT00479388|58604968|FG000|Overall Study|Adverse Event|90|||
30592777|NCT00479388|58604969|FG001|Overall Study|Adverse Event|45|||
30592778|NCT00479388|58604968|FG000|Overall Study|Lost to Follow-up|0|||
30592779|NCT00479388|58604969|FG001|Overall Study|Lost to Follow-up|2|||
30592780|NCT00479388|58604968|FG000|Overall Study|Protocol Violation|10|||
30592781|NCT00479388|58604969|FG001|Overall Study|Protocol Violation|9|||
30592782|NCT00479388|58604968|FG000|Overall Study|Withdrawal by Subject|32|||
30592783|NCT00479388|58604969|FG001|Overall Study|Withdrawal by Subject|17|||
30592784|NCT00479232|58604977|FG000|Overall Study|Adverse Event|0|||
30592785|NCT00479232|58604978|FG001|Overall Study|Adverse Event|0|||
30592786|NCT00479232|58604979|FG002|Overall Study|Adverse Event|5|||
30592787|NCT00479232|58604980|FG003|Overall Study|Adverse Event|0|||
30592788|NCT00479232|58604981|FG004|Overall Study|Adverse Event|0|||
30677609|NCT00783198|58691410|FG000|Overall Study|Did not meet protocol eligibility|0|||
30677610|NCT00783198|58691411|FG001|Overall Study|Did not meet protocol eligibility|1|||
30677611|NCT00783198|58691412|FG002|Overall Study|Did not meet protocol eligibility|0|||
30677612|NCT00783198|58691410|FG000|Overall Study|Administrative|2|||
30677613|NCT00783198|58691411|FG001|Overall Study|Administrative|1|||
30677614|NCT00783198|58691412|FG002|Overall Study|Administrative|2|||
30677615|NCT00789360|58691422|FG000|Overall Study|Protocol Violation|3|||
30677616|NCT00789360|58691423|FG001|Overall Study|Protocol Violation|1|||
30782191|NCT03480932|58794095|FG002|Overall Study|Death|0|||
30677617|NCT00782496|58691432|FG000|Overall Study|Lost to Follow-up|14|||
30677618|NCT00782496|58691433|FG001|Overall Study|Lost to Follow-up|15|||
30677619|NCT00782418|58691440|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
30677620|NCT00782418|58691441|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
30782192|NCT03480932|58794093|FG000|Overall Study|Lost to Follow-up|0|||
30782193|NCT03480932|58794094|FG001|Overall Study|Lost to Follow-up|2|||
30592789|NCT00479232|58604982|FG005|Overall Study|Adverse Event|10|||
30592790|NCT00479232|58604977|FG000|Overall Study|Deviation from Protocol|0|||
30592791|NCT00479232|58604978|FG001|Overall Study|Deviation from Protocol|0|||
30592792|NCT00479232|58604979|FG002|Overall Study|Deviation from Protocol|1|||
30592793|NCT00479232|58604980|FG003|Overall Study|Deviation from Protocol|0|||
30592794|NCT00479232|58604981|FG004|Overall Study|Deviation from Protocol|0|||
30677621|NCT00782418|58691442|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
30677622|NCT00782418|58691443|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
30782194|NCT03480932|58794095|FG002|Overall Study|Lost to Follow-up|3|||
30677623|NCT00782418|58691444|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
30677624|NCT00782418|58691445|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
30677625|NCT00782418|58691446|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
30677626|NCT00782418|58691440|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
30677627|NCT00782418|58691441|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
30677628|NCT00782418|58691442|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
30592795|NCT00479232|58604982|FG005|Overall Study|Deviation from Protocol|0|||
30592796|NCT00479232|58604977|FG000|Overall Study|Lack of Efficacy|0|||
30592797|NCT00479232|58604978|FG001|Overall Study|Lack of Efficacy|0|||
30592798|NCT00479232|58604979|FG002|Overall Study|Lack of Efficacy|2|||
30592799|NCT00479232|58604980|FG003|Overall Study|Lack of Efficacy|0|||
30592800|NCT00479232|58604981|FG004|Overall Study|Lack of Efficacy|0|||
30592801|NCT00479232|58604982|FG005|Overall Study|Lack of Efficacy|4|||
30592802|NCT00479232|58604977|FG000|Overall Study|Physician Decision|0|||
30592803|NCT00479232|58604978|FG001|Overall Study|Physician Decision|0|||
30592804|NCT00479232|58604979|FG002|Overall Study|Physician Decision|2|||
30592805|NCT00479232|58604980|FG003|Overall Study|Physician Decision|0|||
30592806|NCT00479232|58604981|FG004|Overall Study|Physician Decision|0|||
30592807|NCT00479232|58604982|FG005|Overall Study|Physician Decision|1|||
30592808|NCT00479232|58604977|FG000|Overall Study|Progressive Disease|3|||
30592809|NCT00479232|58604978|FG001|Overall Study|Progressive Disease|1|||
30592810|NCT00479232|58604979|FG002|Overall Study|Progressive Disease|12|||
30592811|NCT00479232|58604980|FG003|Overall Study|Progressive Disease|3|||
30592812|NCT00479232|58604981|FG004|Overall Study|Progressive Disease|3|||
30592813|NCT00479232|58604982|FG005|Overall Study|Progressive Disease|12|||
30592814|NCT00479232|58604977|FG000|Overall Study|Withdrew Consent|0|||
30592815|NCT00479232|58604978|FG001|Overall Study|Withdrew Consent|2|||
30592816|NCT00479232|58604979|FG002|Overall Study|Withdrew Consent|6|||
30592817|NCT00479232|58604980|FG003|Overall Study|Withdrew Consent|0|||
30592818|NCT00479232|58604981|FG004|Overall Study|Withdrew Consent|1|||
30592819|NCT00479232|58604982|FG005|Overall Study|Withdrew Consent|3|||
30592820|NCT00478881|58605002|FG000|Overall Study|Adverse Event|31|||
30592821|NCT00478881|58605003|FG001|Overall Study|Adverse Event|12|||
30592822|NCT00478881|58605002|FG000|Overall Study|Lack of Efficacy|0|||
30592823|NCT00478881|58605003|FG001|Overall Study|Lack of Efficacy|3|||
30592824|NCT00478881|58605002|FG000|Overall Study|Lost to Follow-up|0|||
30592825|NCT00478881|58605003|FG001|Overall Study|Lost to Follow-up|1|||
30592826|NCT00478881|58605002|FG000|Overall Study|Protocol Violation|2|||
30592827|NCT00478881|58605003|FG001|Overall Study|Protocol Violation|2|||
30592828|NCT00478881|58605002|FG000|Overall Study|Withdrawal by Subject|6|||
30592829|NCT00478881|58605003|FG001|Overall Study|Withdrawal by Subject|2|||
30592830|NCT00478881|58605002|FG000|Overall Study|Non-Compliance with Study Medication|0|||
30592831|NCT00478881|58605003|FG001|Overall Study|Non-Compliance with Study Medication|2|||
30592832|NCT00478647|58605009|FG000|Overall Study|Adverse Event|1|||
30592833|NCT00478647|58605009|FG000|Overall Study|Withdrawal by Subject|1|||
30592834|NCT00478608|58605013|FG000|Overall Study|Adverse Event|1|||
30592835|NCT00478608|58605013|FG000|Overall Study|Serious Adverse Event|14|||
30677629|NCT00782418|58691443|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
30677630|NCT00782418|58691444|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
30677631|NCT00782418|58691445|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
30677632|NCT00782418|58691446|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
30677633|NCT00782340|58691463|FG000|Open Label Titration|Adverse Event|12|||
30677634|NCT00782340|58691464|FG001|Open Label Titration|Adverse Event|0|||
30677635|NCT00782340|58691465|FG002|Open Label Titration|Adverse Event|0|||
30677636|NCT00782340|58691463|FG000|Open Label Titration|Treatment failure|50|||
30592836|NCT00478608|58605013|FG000|Overall Study|Withdrawal by Subject|2|||
30592837|NCT00478608|58605013|FG000|Overall Study|Protocol Violation|3|||
30677637|NCT00782340|58691464|FG001|Open Label Titration|Treatment failure|0|||
30677638|NCT00782340|58691465|FG002|Open Label Titration|Treatment failure|0|||
30677639|NCT00782340|58691463|FG000|Open Label Titration|Protocol Violation|5|||
30677640|NCT00782340|58691464|FG001|Open Label Titration|Protocol Violation|0|||
30677641|NCT00782340|58691465|FG002|Open Label Titration|Protocol Violation|0|||
30677642|NCT00782340|58691463|FG000|Open Label Titration|Withdrawal by Subject|5|||
30782195|NCT03480932|58794093|FG000|Overall Study|Incarcerated|2|||
30782196|NCT03480932|58794094|FG001|Overall Study|Incarcerated|2|||
30782197|NCT03480932|58794095|FG002|Overall Study|Incarcerated|2|||
30592838|NCT00478257|58605019|FG000|Overall Study|Withdrawal by Subject|8|||
30592839|NCT00478257|58605020|FG001|Overall Study|Withdrawal by Subject|3|||
30592840|NCT00478140|58605026|FG000|Overall Study|Clinical Disease Progression|1|||
30592841|NCT00478023|58605035|FG000|Overall Study|Adverse Event|11|||
30592842|NCT00478023|58605036|FG001|Overall Study|Adverse Event|7|||
30592843|NCT00478023|58605037|FG002|Overall Study|Adverse Event|8|||
30592844|NCT00478023|58605038|FG003|Overall Study|Adverse Event|14|||
30592845|NCT00478023|58605039|FG004|Overall Study|Adverse Event|6|||
30592846|NCT00478023|58605035|FG000|Overall Study|Death|1|||
30592847|NCT00478023|58605036|FG001|Overall Study|Death|0|||
30592848|NCT00478023|58605037|FG002|Overall Study|Death|0|||
30592849|NCT00478023|58605038|FG003|Overall Study|Death|0|||
30592850|NCT00478023|58605039|FG004|Overall Study|Death|0|||
30677643|NCT00782340|58691464|FG001|Open Label Titration|Withdrawal by Subject|0|||
30677644|NCT00782340|58691465|FG002|Open Label Titration|Withdrawal by Subject|0|||
30677645|NCT00782340|58691463|FG000|Open Label Titration|Enrollment capped|16|||
30677646|NCT00782340|58691464|FG001|Open Label Titration|Enrollment capped|0|||
30677647|NCT00782340|58691465|FG002|Open Label Titration|Enrollment capped|0|||
30677648|NCT00782340|58691463|FG000|Open Label Titration|Did not meet responder criteria|2|||
30592851|NCT00478023|58605035|FG000|Overall Study|Lack of Efficacy|11|||
30592852|NCT00478023|58605036|FG001|Overall Study|Lack of Efficacy|10|||
30592853|NCT00478023|58605037|FG002|Overall Study|Lack of Efficacy|4|||
30592854|NCT00478023|58605038|FG003|Overall Study|Lack of Efficacy|5|||
30592855|NCT00478023|58605039|FG004|Overall Study|Lack of Efficacy|41|||
30592856|NCT00478023|58605035|FG000|Overall Study|Lost to Follow-up|3|||
30592857|NCT00478023|58605036|FG001|Overall Study|Lost to Follow-up|1|||
30592858|NCT00478023|58605037|FG002|Overall Study|Lost to Follow-up|1|||
30592859|NCT00478023|58605038|FG003|Overall Study|Lost to Follow-up|1|||
30592860|NCT00478023|58605039|FG004|Overall Study|Lost to Follow-up|0|||
30592861|NCT00478023|58605035|FG000|Overall Study|Withdrawal by Subject|2|||
30592862|NCT00478023|58605036|FG001|Overall Study|Withdrawal by Subject|3|||
30592863|NCT00478023|58605037|FG002|Overall Study|Withdrawal by Subject|2|||
30592864|NCT00478023|58605038|FG003|Overall Study|Withdrawal by Subject|4|||
30592865|NCT00478023|58605039|FG004|Overall Study|Withdrawal by Subject|5|||
30592866|NCT00478023|58605035|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
30592867|NCT00478023|58605036|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
30592868|NCT00478023|58605037|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
30677649|NCT00782340|58691464|FG001|Open Label Titration|Did not meet responder criteria|0|||
30677650|NCT00782340|58691465|FG002|Open Label Titration|Did not meet responder criteria|0|||
30677651|NCT00782340|58691463|FG000|Open Label Titration|Lost to Follow-up|5|||
30677652|NCT00782340|58691464|FG001|Open Label Titration|Lost to Follow-up|0|||
30677653|NCT00782340|58691465|FG002|Open Label Titration|Lost to Follow-up|0|||
30677654|NCT00782340|58691463|FG000|Open Label Titration|Randomized in error|6|||
30677655|NCT00782340|58691464|FG001|Open Label Titration|Randomized in error|0|||
30677656|NCT00782340|58691465|FG002|Open Label Titration|Randomized in error|0|||
30677657|NCT00774852|58691474|FG000|Overall Study|Adverse Event|9|||
30677658|NCT00774852|58691475|FG001|Overall Study|Adverse Event|6|||
30677659|NCT00774852|58691474|FG000|Overall Study|Death|2|||
30677660|NCT00774852|58691475|FG001|Overall Study|Death|1|||
30677661|NCT00774852|58691474|FG000|Overall Study|Lack of Efficacy|3|||
30677662|NCT00774852|58691475|FG001|Overall Study|Lack of Efficacy|7|||
30677663|NCT00774852|58691474|FG000|Overall Study|Lost to Follow-up|9|||
30677664|NCT00774852|58691475|FG001|Overall Study|Lost to Follow-up|5|||
30677665|NCT00774852|58691474|FG000|Overall Study|Physician Decision|2|||
30677666|NCT00774852|58691475|FG001|Overall Study|Physician Decision|6|||
30677667|NCT00774852|58691474|FG000|Overall Study|Pregnancy|1|||
30677668|NCT00774852|58691475|FG001|Overall Study|Pregnancy|2|||
30677669|NCT00774852|58691474|FG000|Overall Study|Withdrawal by Subject|2|||
30677670|NCT00774852|58691475|FG001|Overall Study|Withdrawal by Subject|2|||
30677671|NCT00774852|58691474|FG000|Overall Study|Non-responder|15|||
30677672|NCT00774852|58691475|FG001|Overall Study|Non-responder|11|||
30677673|NCT00774852|58691474|FG000|Overall Study|Subject non-compliance|0|||
30677674|NCT00774852|58691475|FG001|Overall Study|Subject non-compliance|1|||
30677675|NCT00774852|58691474|FG000|Overall Study|Protocol Violation|1|||
30677676|NCT00774852|58691475|FG001|Overall Study|Protocol Violation|0|||
30677677|NCT00774852|58691474|FG000|Overall Study|Subject received prohibited medication|1|||
30677678|NCT00774852|58691475|FG001|Overall Study|Subject received prohibited medication|0|||
30677679|NCT00774306|58691495|FG000|Overall Study|Adverse Event|3|||
30677680|NCT00774306|58691496|FG001|Overall Study|Adverse Event|0|||
30677681|NCT00774306|58691497|FG002|Overall Study|Adverse Event|0|||
30856084|NCT04318132|58883921|FG002|Overall Study|Protocol Violation|3|||
30856085|NCT04318132|58883922|FG003|Overall Study|Protocol Violation|0|||
30592869|NCT00478023|58605038|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
30592870|NCT00478023|58605039|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
30592871|NCT00477750|58605051|FG000|Overall Study|Currently Receiving Treatment|11|||
30592872|NCT00477672|58605060|FG000|Overall Study|Adverse Event|3|||
30592873|NCT00477672|58605061|FG001|Overall Study|Adverse Event|5|||
30592874|NCT00477672|58605062|FG002|Overall Study|Adverse Event|6|||
30677682|NCT00774306|58691498|FG003|Overall Study|Adverse Event|0|||
30677683|NCT00774306|58691495|FG000|Overall Study|Protocol Violation|2|||
30677684|NCT00774306|58691496|FG001|Overall Study|Protocol Violation|0|||
30677685|NCT00774306|58691497|FG002|Overall Study|Protocol Violation|3|||
30677686|NCT00774306|58691498|FG003|Overall Study|Protocol Violation|0|||
30677687|NCT00774306|58691495|FG000|Overall Study|Withdrawal by Subject|6|||
30677688|NCT00774306|58691496|FG001|Overall Study|Withdrawal by Subject|1|||
30677689|NCT00774306|58691497|FG002|Overall Study|Withdrawal by Subject|1|||
30677690|NCT00774306|58691498|FG003|Overall Study|Withdrawal by Subject|0|||
30677691|NCT00774306|58691495|FG000|Overall Study|Lost to Follow-up|6|||
30677692|NCT00774306|58691496|FG001|Overall Study|Lost to Follow-up|0|||
30677693|NCT00774306|58691497|FG002|Overall Study|Lost to Follow-up|4|||
30677694|NCT00774306|58691498|FG003|Overall Study|Lost to Follow-up|5|||
30677695|NCT00774306|58691495|FG000|Overall Study|Death|1|||
30677696|NCT00774306|58691496|FG001|Overall Study|Death|1|||
30677697|NCT00774306|58691497|FG002|Overall Study|Death|0|||
30677698|NCT00774306|58691498|FG003|Overall Study|Death|0|||
30677699|NCT00781326|58691508|FG000|Phase I|Adverse Event|1|||
30677700|NCT00781326|58691508|FG000|Phase I|Withdrawal by Subject|1|||
30677701|NCT00781326|58691508|FG000|Phase I|Physician Decision|2|||
30677702|NCT00787800|58691514|FG000|Overall Study|Withdrawal by Subject|3|||
30677703|NCT00787800|58691515|FG001|Overall Study|Withdrawal by Subject|5|||
30677704|NCT00787800|58691514|FG000|Overall Study|Death|0|||
30677705|NCT00787800|58691515|FG001|Overall Study|Death|2|||
30677706|NCT00773838|58691522|FG000|Overall Study|Adverse Event|29|||
30677707|NCT00773838|58691522|FG000|Overall Study|Lost to Follow-up|1|||
30677708|NCT00773838|58691522|FG000|Overall Study|Physician Decision|8|||
30677709|NCT00773838|58691522|FG000|Overall Study|Progressive Disease|82|||
30677710|NCT00773838|58691522|FG000|Overall Study|Protocol Violation|2|||
30677711|NCT00773838|58691522|FG000|Overall Study|Withdrawal by Subject|21|||
30677712|NCT00787644|58691528|FG000|Overall Study|Lost to Follow-up|1|||
30677713|NCT00787644|58691529|FG001|Overall Study|Lost to Follow-up|1|||
30677714|NCT00787644|58691528|FG000|Overall Study|Withdrawal by Subject|1|||
30677715|NCT00787644|58691529|FG001|Overall Study|Withdrawal by Subject|1|||
30677716|NCT00787566|58691538|FG000|Overall Study|AE related to chemotherapy|0|||
30677717|NCT00787566|58691539|FG001|Overall Study|AE related to chemotherapy|1|||
30677718|NCT00787566|58691540|FG002|Overall Study|AE related to chemotherapy|0|||
30677719|NCT00787254|58691550|FG000|Overall Study|Adverse Event|24|||
30677720|NCT00787254|58691551|FG001|Overall Study|Adverse Event|23|||
30677721|NCT00787254|58691550|FG000|Overall Study|Protocol Violation|26|||
30677722|NCT00787254|58691551|FG001|Overall Study|Protocol Violation|23|||
30677723|NCT00787254|58691550|FG000|Overall Study|Withdrawal by Subject|16|||
30677724|NCT00787254|58691551|FG001|Overall Study|Withdrawal by Subject|11|||
30677725|NCT00787254|58691550|FG000|Overall Study|Lack of Efficacy|4|||
30677726|NCT00787254|58691551|FG001|Overall Study|Lack of Efficacy|15|||
30677727|NCT00787254|58691550|FG000|Overall Study|NSAIDs discontinuation|1|||
30677728|NCT00787254|58691551|FG001|Overall Study|NSAIDs discontinuation|2|||
30677729|NCT00787254|58691550|FG000|Overall Study|Institution closed|1|||
30677730|NCT00787254|58691551|FG001|Overall Study|Institution closed|0|||
30677731|NCT00787254|58691550|FG000|Overall Study|Physician Decision|4|||
30677732|NCT00787254|58691551|FG001|Overall Study|Physician Decision|8|||
30677733|NCT00625846|58691561|FG000|Overall Study|Withdrawal by Subject|2|||
30677734|NCT00625846|58691562|FG001|Overall Study|Withdrawal by Subject|0|||
30677735|NCT00625846|58691563|FG002|Overall Study|Withdrawal by Subject|1|||
30677736|NCT00625846|58691564|FG003|Overall Study|Withdrawal by Subject|2|||
30677737|NCT00773292|58691578|FG000|Treatment 48 Weeks|Adverse Event|1|||
30677738|NCT00773292|58691578|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
30677739|NCT00786864|58691584|FG000|Overall Study|Lost to Follow-up|0|||
30677740|NCT00786864|58691585|FG001|Overall Study|Lost to Follow-up|1|||
30677741|NCT00786864|58691584|FG000|Overall Study|Sustained serious back injury|1|||
30677742|NCT00786864|58691585|FG001|Overall Study|Sustained serious back injury|0|||
30677743|NCT00621322|58691597|FG000|Overall Study|Lost to Follow-up|0|||
30677744|NCT00621322|58691598|FG001|Overall Study|Lost to Follow-up|0|||
30677745|NCT00621322|58691599|FG002|Overall Study|Lost to Follow-up|0|||
30677746|NCT00621322|58691600|FG003|Overall Study|Lost to Follow-up|0|||
30677747|NCT00621322|58691601|FG004|Overall Study|Lost to Follow-up|1|||
30677748|NCT00621322|58691602|FG005|Overall Study|Lost to Follow-up|0|||
30677749|NCT00621322|58691597|FG000|Overall Study|Physician Decision|0|||
30677750|NCT00621322|58691598|FG001|Overall Study|Physician Decision|0|||
30782198|NCT03387020|58794106|FG000|Overall Study|Adverse Event|0|||
30782199|NCT03387020|58794107|FG001|Overall Study|Adverse Event|2|||
30677751|NCT00621322|58691599|FG002|Overall Study|Physician Decision|1|||
30677752|NCT00621322|58691600|FG003|Overall Study|Physician Decision|1|||
30677753|NCT00621322|58691601|FG004|Overall Study|Physician Decision|0|||
30677754|NCT00621322|58691602|FG005|Overall Study|Physician Decision|0|||
30677755|NCT00621322|58691597|FG000|Overall Study|Withdrawal by Subject|0|||
30782200|NCT03387020|58794108|FG002|Overall Study|Adverse Event|0|||
30782201|NCT03387020|58794106|FG000|Overall Study|Withdrawal by Subject|2|||
30782202|NCT03387020|58794107|FG001|Overall Study|Withdrawal by Subject|0|||
30677756|NCT00621322|58691598|FG001|Overall Study|Withdrawal by Subject|0|||
30677757|NCT00621322|58691599|FG002|Overall Study|Withdrawal by Subject|0|||
30677758|NCT00621322|58691600|FG003|Overall Study|Withdrawal by Subject|1|||
30677759|NCT00621322|58691601|FG004|Overall Study|Withdrawal by Subject|0|||
30677760|NCT00621322|58691602|FG005|Overall Study|Withdrawal by Subject|2|||
30677761|NCT00621322|58691597|FG000|Overall Study|Migrated/moved from study area|1|||
30782203|NCT03387020|58794108|FG002|Overall Study|Withdrawal by Subject|0|||
30677762|NCT00621322|58691598|FG001|Overall Study|Migrated/moved from study area|0|||
30677763|NCT00621322|58691599|FG002|Overall Study|Migrated/moved from study area|1|||
30677764|NCT00621322|58691600|FG003|Overall Study|Migrated/moved from study area|1|||
30677765|NCT00621322|58691601|FG004|Overall Study|Migrated/moved from study area|0|||
30677766|NCT00621322|58691602|FG005|Overall Study|Migrated/moved from study area|2|||
30677767|NCT00853385|58691621|FG000|Overall Study|Death|0|||
30677768|NCT00853385|58691622|FG001|Overall Study|Death|0|||
30677769|NCT00853385|58691623|FG002|Overall Study|Death|0|||
30592875|NCT00477672|58605060|FG000|Overall Study|Death|0|||
30592876|NCT00477672|58605061|FG001|Overall Study|Death|1|||
30592877|NCT00477672|58605062|FG002|Overall Study|Death|0|||
30592878|NCT00477672|58605060|FG000|Overall Study|Disease progression|0|||
30592879|NCT00477672|58605061|FG001|Overall Study|Disease progression|1|||
30677770|NCT00853385|58691624|FG003|Overall Study|Death|0|||
30677771|NCT00853385|58691625|FG004|Overall Study|Death|1|||
30677772|NCT00853385|58691621|FG000|Overall Study|Adverse Event|24|||
30677773|NCT00853385|58691622|FG001|Overall Study|Adverse Event|24|||
30677774|NCT00853385|58691623|FG002|Overall Study|Adverse Event|2|||
30677775|NCT00853385|58691624|FG003|Overall Study|Adverse Event|5|||
30592880|NCT00477672|58605062|FG002|Overall Study|Disease progression|0|||
30592881|NCT00477672|58605060|FG000|Overall Study|Physician Decision|1|||
30592882|NCT00477672|58605061|FG001|Overall Study|Physician Decision|0|||
30592883|NCT00477672|58605062|FG002|Overall Study|Physician Decision|0|||
30592884|NCT00477672|58605060|FG000|Overall Study|Protocol noncompliance|0|||
30592885|NCT00477672|58605061|FG001|Overall Study|Protocol noncompliance|2|||
30592886|NCT00477672|58605062|FG002|Overall Study|Protocol noncompliance|0|||
30592887|NCT00477672|58605060|FG000|Overall Study|Consent withdrawn|2|||
30677776|NCT00853385|58691625|FG004|Overall Study|Adverse Event|22|||
30677777|NCT00853385|58691621|FG000|Overall Study|Lack of Efficacy|6|||
30677778|NCT00853385|58691622|FG001|Overall Study|Lack of Efficacy|7|||
30677779|NCT00853385|58691623|FG002|Overall Study|Lack of Efficacy|3|||
30677780|NCT00853385|58691624|FG003|Overall Study|Lack of Efficacy|3|||
30677781|NCT00853385|58691625|FG004|Overall Study|Lack of Efficacy|6|||
30677782|NCT00853385|58691621|FG000|Overall Study|Lost to Follow-up|2|||
30677783|NCT00853385|58691622|FG001|Overall Study|Lost to Follow-up|1|||
30677784|NCT00853385|58691623|FG002|Overall Study|Lost to Follow-up|0|||
30677785|NCT00853385|58691624|FG003|Overall Study|Lost to Follow-up|0|||
30677786|NCT00853385|58691625|FG004|Overall Study|Lost to Follow-up|0|||
30677787|NCT00853385|58691621|FG000|Overall Study|Withdrawal by Subject|4|||
30677788|NCT00853385|58691622|FG001|Overall Study|Withdrawal by Subject|2|||
30677789|NCT00853385|58691623|FG002|Overall Study|Withdrawal by Subject|0|||
30677790|NCT00853385|58691624|FG003|Overall Study|Withdrawal by Subject|1|||
30677791|NCT00853385|58691625|FG004|Overall Study|Withdrawal by Subject|1|||
30677792|NCT00853385|58691621|FG000|Overall Study|Other|18|||
30677793|NCT00853385|58691622|FG001|Overall Study|Other|9|||
30677794|NCT00853385|58691623|FG002|Overall Study|Other|4|||
30677795|NCT00853385|58691624|FG003|Overall Study|Other|4|||
30677796|NCT00853385|58691625|FG004|Overall Study|Other|12|||
30677797|NCT00622336|58691647|FG000|Treatment Phase|Progression of Disease|181|||
30677798|NCT00622336|58691647|FG000|Treatment Phase|Adverse Event|46|||
30677799|NCT00622336|58691647|FG000|Treatment Phase|Other|40|||
30677800|NCT00622336|58691647|FG000|Treatment Phase|Death|14|||
30677801|NCT00622336|58691647|FG000|Treatment Phase|Lack of therapeutic effect|13|||
30677802|NCT00622336|58691647|FG000|Treatment Phase|Withdrawal by Subject|13|||
30677803|NCT00622336|58691647|FG000|Treatment Phase|Lost to Follow-up|2|||
30677804|NCT00622336|58691647|FG000|Extension Phase|Adverse Event|2|||
30677805|NCT00622336|58691647|FG000|Extension Phase|Progressive Disease|6|||
30959030|NCT01587703|59024028|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
30592888|NCT00477672|58605061|FG001|Overall Study|Consent withdrawn|5|||
30677806|NCT00622336|58691647|FG000|Extension Phase|Lack of therapeutic effect|2|||
30782204|NCT03386474|58794128|FG000|Overall Study|Death|1|||
30782205|NCT03386474|58794129|FG001|Overall Study|Death|0|||
30677807|NCT00622336|58691647|FG000|Extension Phase|Withdrawal by Subject|1|||
30677808|NCT00622336|58691647|FG000|Extension Phase|Lost to Follow-up|1|||
30677809|NCT00622336|58691647|FG000|Extension Phase|Other|9|||
30677810|NCT00779766|58691655|FG000|Month 24|Serious Adverse Event|2|||
30782206|NCT03386474|58794128|FG000|Overall Study|Adverse Event|0|||
30782207|NCT03386474|58794129|FG001|Overall Study|Adverse Event|1|||
30677811|NCT00779766|58691656|FG001|Month 24|Serious Adverse Event|3|||
30677812|NCT00779766|58691655|FG000|Month 24|Adverse Event|3|||
30677813|NCT00779766|58691656|FG001|Month 24|Adverse Event|3|||
30677814|NCT00779766|58691655|FG000|Month 24|Protocol Violation|3|||
30677815|NCT00779766|58691656|FG001|Month 24|Protocol Violation|1|||
30677816|NCT00779766|58691655|FG000|Month 24|Withdrawal by Subject|159|||
30677817|NCT00779766|58691656|FG001|Month 24|Withdrawal by Subject|127|||
30677818|NCT00779766|58691655|FG000|Month 24|Migrated/moved from study area|138|||
30782208|NCT03405818|58794140|FG000|Overall Study|Withdrawal by Subject|4|||
30959031|NCT01587703|59024029|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
30592889|NCT00477672|58605062|FG002|Overall Study|Consent withdrawn|10|||
30592890|NCT00477672|58605060|FG000|Overall Study|Discretion of Sponsor|1|||
30677819|NCT00779766|58691656|FG001|Month 24|Migrated/moved from study area|162|||
30677820|NCT00779766|58691655|FG000|Month 24|Lost to Follow-up|9|||
30592891|NCT00477672|58605061|FG001|Overall Study|Discretion of Sponsor|2|||
30592892|NCT00477672|58605062|FG002|Overall Study|Discretion of Sponsor|0|||
30592893|NCT00477633|58605070|FG000|Overall Study|Did not receive treatment|23|||
30592894|NCT00477633|58605070|FG000|Overall Study|Adverse Event|143|||
30677821|NCT00779766|58691656|FG001|Month 24|Lost to Follow-up|9|||
30677822|NCT00779766|58691655|FG000|Month 24|Other|18|||
30677823|NCT00779766|58691656|FG001|Month 24|Other|27|||
30677824|NCT00779766|58691655|FG000|Month 48|Withdrawal by Subject|68|||
30677825|NCT00779766|58691656|FG001|Month 48|Withdrawal by Subject|63|||
30677826|NCT00779766|58691655|FG000|Month 48|Migrated/moved from study area|76|||
30782209|NCT03405818|58794140|FG000|Overall Study|Lost to Follow-up|4|||
30782210|NCT03403634|58794144|FG000|Overall Study|Disease progression|3|||
30677827|NCT00779766|58691656|FG001|Month 48|Migrated/moved from study area|75|||
30677828|NCT00779766|58691655|FG000|Month 48|Lost to Follow-up|29|||
30677829|NCT00779766|58691656|FG001|Month 48|Lost to Follow-up|30|||
30677830|NCT00779766|58691655|FG000|Month 48|Other|1|||
30677831|NCT00779766|58691656|FG001|Month 48|Other|0|||
30677832|NCT00779766|58691655|FG000|Month 72|Withdrawal by Subject|55|||
30677833|NCT00779766|58691656|FG001|Month 72|Withdrawal by Subject|71|||
30677834|NCT00779766|58691655|FG000|Month 72|Migrated/moved from study area|124|||
30677835|NCT00779766|58691656|FG001|Month 72|Migrated/moved from study area|109|||
30677836|NCT00779766|58691655|FG000|Month 72|Lost to Follow-up|6|||
30677837|NCT00779766|58691656|FG001|Month 72|Lost to Follow-up|8|||
30677838|NCT00779766|58691655|FG000|Month 72|Other|0|||
30677839|NCT00779766|58691656|FG001|Month 72|Other|1|||
30677840|NCT00846365|58691666|FG000|Overall Study|Adverse Event|20|||
30677841|NCT00846365|58691667|FG001|Overall Study|Adverse Event|30|||
30677842|NCT00846365|58691668|FG002|Overall Study|Adverse Event|11|||
30677843|NCT00846365|58691666|FG000|Overall Study|Protocol Violation|5|||
30677844|NCT00846365|58691667|FG001|Overall Study|Protocol Violation|4|||
30677845|NCT00846365|58691668|FG002|Overall Study|Protocol Violation|0|||
30677846|NCT00846365|58691666|FG000|Overall Study|Lost to Follow-up|8|||
30677847|NCT00846365|58691667|FG001|Overall Study|Lost to Follow-up|2|||
30782211|NCT03403634|58794144|FG000|Overall Study|Did not meet eligibility criteria|4|||
30782212|NCT03403400|58794151|FG000|Overall Study|Lost to Follow-up|1|||
30782213|NCT03403400|58794152|FG001|Overall Study|Lost to Follow-up|0|||
30782214|NCT03403400|58794153|FG002|Overall Study|Lost to Follow-up|1|||
30782215|NCT03403400|58794151|FG000|Overall Study|Hospitalization|1|||
30782216|NCT03403400|58794152|FG001|Overall Study|Hospitalization|0|||
30782217|NCT03403400|58794153|FG002|Overall Study|Hospitalization|0|||
30782218|NCT03403400|58794151|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
30782219|NCT03403400|58794152|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
30782220|NCT03403400|58794153|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
30782221|NCT02863354|58794178|FG000|Year 1|Lost to Follow-up|1|||
30782222|NCT02863354|58794179|FG001|Year 1|Lost to Follow-up|1|||
30782223|NCT02863354|58794178|FG000|Year 1|Withdrawal by Subject|3|||
30782224|NCT02863354|58794179|FG001|Year 1|Withdrawal by Subject|0|||
30782225|NCT02863354|58794178|FG000|Year 1|Death|0|||
30592895|NCT00477633|58605070|FG000|Overall Study|Pregnancy|23|||
30592896|NCT00477633|58605070|FG000|Overall Study|Lost to Follow-up|271|||
30592897|NCT00477633|58605070|FG000|Overall Study|Withdrawal by Subject|149|||
30592898|NCT00477633|58605070|FG000|Overall Study|Protocol Violation|25|||
30592899|NCT00477633|58605070|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
30592900|NCT01131676|58605086|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
30592901|NCT01131676|58605087|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
30592902|NCT01131676|58605088|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
30592903|NCT01131676|58605086|FG000|Discontinuation From Treatment|Not treated|4|||
30592904|NCT01131676|58605087|FG001|Discontinuation From Treatment|Not treated|2|||
30592905|NCT01131676|58605088|FG002|Discontinuation From Treatment|Not treated|2|||
30592906|NCT01131676|58605086|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
30592907|NCT01131676|58605087|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
30592908|NCT01131676|58605088|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
30677848|NCT00846365|58691668|FG002|Overall Study|Lost to Follow-up|5|||
30677849|NCT00846365|58691666|FG000|Overall Study|Withdrawal by Subject|11|||
30677850|NCT00846365|58691667|FG001|Overall Study|Withdrawal by Subject|11|||
30677851|NCT00846365|58691668|FG002|Overall Study|Withdrawal by Subject|9|||
30677852|NCT00846365|58691666|FG000|Overall Study|Pregnancy|1|||
30677853|NCT00846365|58691667|FG001|Overall Study|Pregnancy|0|||
30677854|NCT00846365|58691668|FG002|Overall Study|Pregnancy|0|||
30677855|NCT00846365|58691666|FG000|Overall Study|Lack of Efficacy|1|||
30782226|NCT02863354|58794179|FG001|Year 1|Death|1|||
30782227|NCT02863354|58794178|FG000|Year 2|Lost to Follow-up|2|||
30782228|NCT02863354|58794179|FG001|Year 2|Lost to Follow-up|2|||
30782229|NCT03480152|58794187|FG000|Phase I|Signed consent. Died before treatment.|1|||
30782230|NCT03480152|58794188|FG001|Phase I|Signed consent. Died before treatment.|0|||
30877166|NCT00106691|58908830|FG000|Overall Study|Protocol Violation|13|||
30592909|NCT01131676|58605086|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
30677856|NCT00846365|58691667|FG001|Overall Study|Lack of Efficacy|1|||
30677857|NCT00846365|58691668|FG002|Overall Study|Lack of Efficacy|2|||
30677858|NCT00846365|58691666|FG000|Overall Study|Other|9|||
30677859|NCT00846365|58691667|FG001|Overall Study|Other|1|||
30677860|NCT00846365|58691668|FG002|Overall Study|Other|6|||
30677861|NCT00779142|58691676|FG000|Overall Study|Screen Failures|3|||
30677862|NCT00622180|58691681|FG000|Overall Study|Lost to Follow-up|1|||
30677863|NCT00622180|58691682|FG001|Overall Study|Lost to Follow-up|2|||
30677864|NCT00773136|58691688|FG000|Overall Study|Physician Decision|2|||
30677865|NCT00853307|58691695|FG000|Overall Study|Adverse Event|1|||
30677866|NCT00853307|58691696|FG001|Overall Study|Adverse Event|2|||
30677867|NCT00853307|58691695|FG000|Overall Study|Withdrawal by Subject|1|||
30677868|NCT00853307|58691696|FG001|Overall Study|Withdrawal by Subject|2|||
30677869|NCT00853307|58691695|FG000|Overall Study|Reason Not Specified|0|||
30677870|NCT00853307|58691696|FG001|Overall Study|Reason Not Specified|1|||
30677871|NCT00778830|58691704|FG000|Overall Study|Ongoing at data cut-off|0|||
30677872|NCT00778830|58691705|FG001|Overall Study|Ongoing at data cut-off|1|||
30677873|NCT00772668|58691711|FG000|Overall Study|Physician Decision|3|||
30677874|NCT00786474|58691718|FG000|Overall Study|Death|5|||
30677875|NCT00786474|58691719|FG001|Overall Study|Death|4|||
30677876|NCT00786474|58691718|FG000|Overall Study|Withdrawal by Subject|23|||
30677877|NCT00786474|58691719|FG001|Overall Study|Withdrawal by Subject|31|||
30677878|NCT00786474|58691718|FG000|Overall Study|Lost to Follow-up|3|||
30677879|NCT00786474|58691719|FG001|Overall Study|Lost to Follow-up|3|||
30677880|NCT00786474|58691718|FG000|Overall Study|Physician Decision|2|||
30677881|NCT00786474|58691719|FG001|Overall Study|Physician Decision|1|||
30677882|NCT00786474|58691718|FG000|Overall Study|Other|4|||
30677883|NCT00786474|58691719|FG001|Overall Study|Other|4|||
30677884|NCT00784875|58691729|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
30677885|NCT00784875|58691730|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
30677886|NCT00784875|58691731|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
30677887|NCT00784875|58691732|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
30677888|NCT00784875|58691729|FG000|Period A - Baseline|Adverse Event|0|||
30677889|NCT00784875|58691730|FG001|Period A - Baseline|Adverse Event|0|||
30677890|NCT00784875|58691731|FG002|Period A - Baseline|Adverse Event|0|||
30677891|NCT00784875|58691732|FG003|Period A - Baseline|Adverse Event|8|||
30677892|NCT00784875|58691729|FG000|Period A - Baseline|Protocol Violation|0|||
30677893|NCT00784875|58691730|FG001|Period A - Baseline|Protocol Violation|0|||
30677894|NCT00784875|58691731|FG002|Period A - Baseline|Protocol Violation|0|||
30677895|NCT00784875|58691732|FG003|Period A - Baseline|Protocol Violation|25|||
30677896|NCT00784875|58691729|FG000|Period A - Baseline|Withdrawal by Subject|0|||
30677897|NCT00784875|58691730|FG001|Period A - Baseline|Withdrawal by Subject|0|||
30677898|NCT00784875|58691731|FG002|Period A - Baseline|Withdrawal by Subject|0|||
30677899|NCT00784875|58691732|FG003|Period A - Baseline|Withdrawal by Subject|27|||
30677900|NCT00784875|58691729|FG000|Period A - Baseline|Physician Decision|0|||
30677901|NCT00784875|58691730|FG001|Period A - Baseline|Physician Decision|0|||
30677902|NCT00784875|58691731|FG002|Period A - Baseline|Physician Decision|0|||
30677903|NCT00784875|58691732|FG003|Period A - Baseline|Physician Decision|2|||
30677904|NCT00784875|58691729|FG000|Period A - Baseline|Sponsor Decision|0|||
30677905|NCT00784875|58691730|FG001|Period A - Baseline|Sponsor Decision|0|||
30677906|NCT00784875|58691731|FG002|Period A - Baseline|Sponsor Decision|0|||
30677907|NCT00784875|58691732|FG003|Period A - Baseline|Sponsor Decision|113|||
30677908|NCT00784875|58691729|FG000|Period A - Baseline|Lost to Follow-up|0|||
30677909|NCT00784875|58691730|FG001|Period A - Baseline|Lost to Follow-up|0|||
30677910|NCT00784875|58691731|FG002|Period A - Baseline|Lost to Follow-up|0|||
30677911|NCT00784875|58691732|FG003|Period A - Baseline|Lost to Follow-up|2|||
30677912|NCT00784875|58691729|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
30677913|NCT00784875|58691730|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
30677914|NCT00784875|58691731|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
30677915|NCT00784875|58691732|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
30677916|NCT00784875|58691729|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
30677917|NCT00784875|58691730|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
30677918|NCT00784875|58691731|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
30677919|NCT00784875|58691732|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
30677920|NCT00784875|58691729|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
30677921|NCT00784875|58691730|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
30677922|NCT00784875|58691731|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
30677923|NCT00784875|58691732|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
30677924|NCT00784875|58691729|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
30677925|NCT00784875|58691730|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
30677926|NCT00784875|58691731|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
30677927|NCT00784875|58691732|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
30677928|NCT00784875|58691729|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
30677929|NCT00784875|58691730|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
30677930|NCT00784875|58691731|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
30677931|NCT00784875|58691732|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
30677932|NCT00784875|58691729|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
30677933|NCT00784875|58691730|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
30592910|NCT01131676|58605087|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
30592911|NCT01131676|58605088|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
30592912|NCT01131676|58605086|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
30592913|NCT01131676|58605087|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
30592914|NCT01131676|58605088|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
30592915|NCT01131676|58605086|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
30592916|NCT01131676|58605087|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
30592917|NCT01131676|58605088|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
30592918|NCT01131676|58605086|FG000|Discontinuation From Treatment|Other than those specified|162|||
30592919|NCT01131676|58605087|FG001|Discontinuation From Treatment|Other than those specified|142|||
30592920|NCT01131676|58605088|FG002|Discontinuation From Treatment|Other than those specified|125|||
30677934|NCT00784875|58691731|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
30677935|NCT00784875|58691732|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
30677936|NCT00784875|58691729|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
30677937|NCT00784875|58691730|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
30677938|NCT00784875|58691731|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
30677939|NCT00784875|58691732|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
30677940|NCT00784875|58691729|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
30677941|NCT00784875|58691730|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
30677942|NCT00784875|58691731|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
30677943|NCT00784875|58691732|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
30677944|NCT00784875|58691729|FG000|Period C|Adverse Event|1|||
30677945|NCT00784875|58691730|FG001|Period C|Adverse Event|0|||
30677946|NCT00784875|58691731|FG002|Period C|Adverse Event|4|||
30677947|NCT00784875|58691732|FG003|Period C|Adverse Event|2|||
30677948|NCT00784875|58691729|FG000|Period C|Protocol Violation|0|||
30677949|NCT00784875|58691730|FG001|Period C|Protocol Violation|0|||
30677950|NCT00784875|58691731|FG002|Period C|Protocol Violation|1|||
30677951|NCT00784875|58691732|FG003|Period C|Protocol Violation|2|||
30677952|NCT00784875|58691729|FG000|Period C|Lack of Efficacy|0|||
30677953|NCT00784875|58691730|FG001|Period C|Lack of Efficacy|0|||
30677954|NCT00784875|58691731|FG002|Period C|Lack of Efficacy|1|||
30677955|NCT00784875|58691732|FG003|Period C|Lack of Efficacy|0|||
30677956|NCT00784875|58691729|FG000|Period C|Withdrawal by Subject|1|||
30677957|NCT00784875|58691730|FG001|Period C|Withdrawal by Subject|1|||
30677958|NCT00784875|58691731|FG002|Period C|Withdrawal by Subject|2|||
30677959|NCT00784875|58691732|FG003|Period C|Withdrawal by Subject|0|||
30677960|NCT00784875|58691729|FG000|Period C|Physician Decision|0|||
30677961|NCT00784875|58691730|FG001|Period C|Physician Decision|0|||
30677962|NCT00784875|58691731|FG002|Period C|Physician Decision|1|||
30677963|NCT00784875|58691732|FG003|Period C|Physician Decision|1|||
30677964|NCT00784875|58691729|FG000|Period C|Sponsor Decision|5|||
30677965|NCT00784875|58691730|FG001|Period C|Sponsor Decision|5|||
30677966|NCT00784875|58691731|FG002|Period C|Sponsor Decision|4|||
30677967|NCT00784875|58691732|FG003|Period C|Sponsor Decision|2|||
30677968|NCT00784875|58691729|FG000|Period D|Adverse Event|0|||
30677969|NCT00784875|58691730|FG001|Period D|Adverse Event|2|||
30677970|NCT00784875|58691731|FG002|Period D|Adverse Event|2|||
30677971|NCT00784875|58691732|FG003|Period D|Adverse Event|0|||
30677972|NCT00784875|58691729|FG000|Period D|Protocol Violation|1|||
30677973|NCT00784875|58691730|FG001|Period D|Protocol Violation|0|||
30677974|NCT00784875|58691731|FG002|Period D|Protocol Violation|0|||
30677975|NCT00784875|58691732|FG003|Period D|Protocol Violation|0|||
30677976|NCT00784875|58691729|FG000|Period D|Withdrawal by Subject|2|||
30782231|NCT03480152|58794189|FG002|Phase I|Signed consent. Died before treatment.|0|||
30782232|NCT02859454|58794197|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
30592921|NCT01131676|58605086|FG000|Discontinuation From Treatment|Adverse Event|303|||
30677977|NCT00784875|58691730|FG001|Period D|Withdrawal by Subject|0|||
30677978|NCT00784875|58691731|FG002|Period D|Withdrawal by Subject|2|||
30677979|NCT00784875|58691732|FG003|Period D|Withdrawal by Subject|0|||
30677980|NCT00784875|58691729|FG000|Period D|Physician Decision|0|||
30677981|NCT00784875|58691730|FG001|Period D|Physician Decision|1|||
30677982|NCT00784875|58691731|FG002|Period D|Physician Decision|0|||
30677983|NCT00784875|58691732|FG003|Period D|Physician Decision|0|||
30677984|NCT00784875|58691729|FG000|Period D|Sponsor Decision|1|||
30677985|NCT00784875|58691730|FG001|Period D|Sponsor Decision|1|||
30677986|NCT00784875|58691731|FG002|Period D|Sponsor Decision|1|||
30782233|NCT02862730|58794204|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
30782234|NCT02862730|58794205|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
30782235|NCT02862730|58794206|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
30677987|NCT00784875|58691732|FG003|Period D|Sponsor Decision|0|||
30677988|NCT00784875|58691729|FG000|Period D|Lost to Follow-up|1|||
30677989|NCT00784875|58691730|FG001|Period D|Lost to Follow-up|0|||
30677990|NCT00784875|58691731|FG002|Period D|Lost to Follow-up|1|||
30677991|NCT00784875|58691732|FG003|Period D|Lost to Follow-up|1|||
30677992|NCT00592553|58691758|FG000|Overall Study|Protocol Noncompliance|1|||
30677993|NCT00592553|58691759|FG001|Overall Study|Protocol Noncompliance|0|||
30677994|NCT00592553|58691760|FG002|Overall Study|Protocol Noncompliance|0|||
30677995|NCT00853229|58691770|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
30677996|NCT00853229|58691771|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
30677997|NCT00853151|58691783|FG000|Overall Study|Adverse Event|1|||
30677998|NCT00853151|58691784|FG001|Overall Study|Adverse Event|4|||
30677999|NCT00853151|58691785|FG002|Overall Study|Adverse Event|2|||
30678000|NCT00853151|58691786|FG003|Overall Study|Adverse Event|0|||
30678001|NCT00853151|58691783|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
30678002|NCT00853151|58691784|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30678003|NCT00853151|58691785|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30678004|NCT00853151|58691786|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
30678005|NCT00853151|58691783|FG000|Overall Study|Lost to Follow-up|2|||
30678006|NCT00853151|58691784|FG001|Overall Study|Lost to Follow-up|0|||
30678007|NCT00853151|58691785|FG002|Overall Study|Lost to Follow-up|3|||
30678008|NCT00853151|58691786|FG003|Overall Study|Lost to Follow-up|0|||
30678009|NCT00853151|58691783|FG000|Overall Study|Death|1|||
30678010|NCT00853151|58691784|FG001|Overall Study|Death|0|||
30782236|NCT02862730|58794207|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
30782237|NCT02862730|58794208|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
30782238|NCT02862730|58794209|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
30782239|NCT02862730|58794210|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
30782240|NCT02862730|58794204|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
30782241|NCT02862730|58794205|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
30678011|NCT00853151|58691785|FG002|Overall Study|Death|0|||
30678012|NCT00853151|58691786|FG003|Overall Study|Death|1|||
30678013|NCT00853151|58691783|FG000|Overall Study|Protocol Violation|0|||
30678014|NCT00853151|58691784|FG001|Overall Study|Protocol Violation|0|||
30678015|NCT00853151|58691785|FG002|Overall Study|Protocol Violation|0|||
30678016|NCT00853151|58691786|FG003|Overall Study|Protocol Violation|1|||
30678017|NCT00853151|58691783|FG000|Overall Study|Withdrawal by Subject|5|||
30678018|NCT00853151|58691784|FG001|Overall Study|Withdrawal by Subject|4|||
30678019|NCT00853151|58691785|FG002|Overall Study|Withdrawal by Subject|2|||
30678020|NCT00853151|58691786|FG003|Overall Study|Withdrawal by Subject|1|||
30678021|NCT00853151|58691783|FG000|Overall Study|Physician Decision|0|||
30678022|NCT00853151|58691784|FG001|Overall Study|Physician Decision|2|||
30678023|NCT00853151|58691785|FG002|Overall Study|Physician Decision|1|||
30678024|NCT00853151|58691786|FG003|Overall Study|Physician Decision|0|||
30678025|NCT00853151|58691783|FG000|Overall Study|Sponsor Decision|0|||
30678026|NCT00853151|58691784|FG001|Overall Study|Sponsor Decision|3|||
30678027|NCT00853151|58691785|FG002|Overall Study|Sponsor Decision|0|||
30678028|NCT00853151|58691786|FG003|Overall Study|Sponsor Decision|0|||
30782242|NCT02862730|58794206|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
30782243|NCT02862730|58794207|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
30782244|NCT02862730|58794208|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
30782245|NCT02862730|58794209|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
30782246|NCT02862730|58794210|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
30782247|NCT02862730|58794204|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
30782248|NCT02862730|58794205|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
30782249|NCT02862730|58794206|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
30782250|NCT02862730|58794207|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
30782251|NCT02862730|58794208|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
30782252|NCT02862730|58794209|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
30782253|NCT02862730|58794210|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
30856086|NCT04271254|58883938|FG000|Overall Study|Withdrawal by Subject|3|||
30959032|NCT01587703|59024030|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
30592922|NCT01131676|58605087|FG001|Discontinuation From Treatment|Adverse Event|267|||
30592923|NCT01131676|58605088|FG002|Discontinuation From Treatment|Adverse Event|273|||
30592924|NCT01131676|58605086|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
30592925|NCT01131676|58605087|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
30592926|NCT01131676|58605088|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
30592927|NCT01131676|58605086|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
30592928|NCT01131676|58605087|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
30592929|NCT01131676|58605088|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
30592930|NCT01131676|58605086|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
30678029|NCT00853073|58691801|FG000|Overall Study|Withdrawal by Subject|3|||
30678030|NCT00853073|58691802|FG001|Overall Study|Withdrawal by Subject|2|||
30678031|NCT00846053|58691810|FG000|Overall Study|Physician Decision|3|||
30678032|NCT00846053|58691811|FG001|Overall Study|Physician Decision|0|||
30678033|NCT00845897|58691822|FG000|Overall Study|Lost to Follow-up|1|||
30678034|NCT00845897|58691823|FG001|Overall Study|Lost to Follow-up|1|||
30678035|NCT00845897|58691824|FG002|Overall Study|Lost to Follow-up|0|||
30678036|NCT00845897|58691822|FG000|Overall Study|Withdrawal by Subject|0|||
30678037|NCT00845897|58691823|FG001|Overall Study|Withdrawal by Subject|3|||
30678038|NCT00845897|58691824|FG002|Overall Study|Withdrawal by Subject|2|||
30678039|NCT00845897|58691822|FG000|Overall Study|Ulcer did not heal|1|||
30678040|NCT00845897|58691823|FG001|Overall Study|Ulcer did not heal|0|||
30678041|NCT00845897|58691824|FG002|Overall Study|Ulcer did not heal|1|||
30678042|NCT00845897|58691822|FG000|Overall Study|Too ill to participate|0|||
30678043|NCT00845897|58691823|FG001|Overall Study|Too ill to participate|1|||
30678044|NCT00845897|58691824|FG002|Overall Study|Too ill to participate|0|||
30678045|NCT00862277|58691835|FG000|Overall Study|Protocol Violation|1|||
30678046|NCT00862277|58691836|FG001|Overall Study|Protocol Violation|2|||
30678047|NCT00862277|58691837|FG002|Overall Study|Protocol Violation|5|||
30678048|NCT00852995|58691850|FG000|Overall Study|Adverse Event|1|||
30678049|NCT00852995|58691851|FG001|Overall Study|Adverse Event|0|||
30678050|NCT00852995|58691852|FG002|Overall Study|Adverse Event|4|||
30678051|NCT00852995|58691853|FG003|Overall Study|Adverse Event|0|||
30678052|NCT00852995|58691854|FG004|Overall Study|Adverse Event|0|||
30678053|NCT00852995|58691850|FG000|Overall Study|Lost to Follow-up|0|||
30678054|NCT00852995|58691851|FG001|Overall Study|Lost to Follow-up|1|||
30678055|NCT00852995|58691852|FG002|Overall Study|Lost to Follow-up|1|||
30678056|NCT00852995|58691853|FG003|Overall Study|Lost to Follow-up|0|||
30678057|NCT00852995|58691854|FG004|Overall Study|Lost to Follow-up|0|||
30678058|NCT00852995|58691850|FG000|Overall Study|Withdrawal by Subject|4|||
30678059|NCT00852995|58691851|FG001|Overall Study|Withdrawal by Subject|0|||
30678060|NCT00852995|58691852|FG002|Overall Study|Withdrawal by Subject|0|||
30678061|NCT00852995|58691853|FG003|Overall Study|Withdrawal by Subject|1|||
30678062|NCT00852995|58691854|FG004|Overall Study|Withdrawal by Subject|2|||
30678063|NCT00852995|58691850|FG000|Overall Study|Non-Compliance|0|||
30678064|NCT00852995|58691851|FG001|Overall Study|Non-Compliance|0|||
30678065|NCT00852995|58691852|FG002|Overall Study|Non-Compliance|0|||
30678066|NCT00852995|58691853|FG003|Overall Study|Non-Compliance|2|||
30678067|NCT00852995|58691854|FG004|Overall Study|Non-Compliance|0|||
30678068|NCT00852995|58691850|FG000|Overall Study|Progressive Disease|1|||
30678069|NCT00852995|58691851|FG001|Overall Study|Progressive Disease|0|||
30678070|NCT00852995|58691852|FG002|Overall Study|Progressive Disease|0|||
30678071|NCT00852995|58691853|FG003|Overall Study|Progressive Disease|2|||
30678072|NCT00852995|58691854|FG004|Overall Study|Progressive Disease|1|||
30678073|NCT00852995|58691850|FG000|Overall Study|Physician Decision|1|||
30592931|NCT01131676|58605087|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
30592932|NCT01131676|58605088|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
30592933|NCT01131676|58605086|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
30592934|NCT01131676|58605087|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
30592935|NCT01131676|58605088|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
30592936|NCT01131676|58605086|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
30592937|NCT01131676|58605087|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
30592938|NCT01131676|58605088|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
30592939|NCT01131676|58605086|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
30592940|NCT01131676|58605087|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
30592941|NCT01131676|58605088|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
30592942|NCT01131520|58605110|FG000|Overall Study|Computer problem|1|||
30592943|NCT01131520|58605111|FG001|Overall Study|Computer problem|0|||
30592944|NCT01131520|58605110|FG000|Overall Study|Counselor not available|0|||
30592945|NCT01131520|58605111|FG001|Overall Study|Counselor not available|3|||
30592946|NCT01131520|58605110|FG000|Overall Study|Subject changed history after enrollment|0|||
30592947|NCT01131520|58605111|FG001|Overall Study|Subject changed history after enrollment|1|||
30592948|NCT01131325|58605117|FG000|Overall Study|Adverse Event|1|||
30592949|NCT01131325|58605117|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
30592950|NCT01131130|58605121|FG000|Period 1 - Baseline|Pregnancy|1|||
30678074|NCT00852995|58691851|FG001|Overall Study|Physician Decision|0|||
30678075|NCT00852995|58691852|FG002|Overall Study|Physician Decision|0|||
30678076|NCT00852995|58691853|FG003|Overall Study|Physician Decision|0|||
30678077|NCT00852995|58691854|FG004|Overall Study|Physician Decision|0|||
30678078|NCT00852995|58691850|FG000|Overall Study|Protocol Violation|0|||
30678079|NCT00852995|58691851|FG001|Overall Study|Protocol Violation|0|||
30678080|NCT00852995|58691852|FG002|Overall Study|Protocol Violation|0|||
30678081|NCT00852995|58691853|FG003|Overall Study|Protocol Violation|0|||
30678082|NCT00852995|58691854|FG004|Overall Study|Protocol Violation|1|||
30678083|NCT00852995|58691850|FG000|Overall Study|Moved Out of Area|1|||
30856087|NCT03938636|58883958|FG000|Overall Study|Protocol Violation|0|||
30678084|NCT00852995|58691851|FG001|Overall Study|Moved Out of Area|0|||
30678085|NCT00852995|58691852|FG002|Overall Study|Moved Out of Area|0|||
30678086|NCT00852995|58691853|FG003|Overall Study|Moved Out of Area|0|||
30678087|NCT00852995|58691854|FG004|Overall Study|Moved Out of Area|0|||
30678088|NCT00592319|58691873|FG000|Overall Study|Lost to Follow-up|0|||
30678089|NCT00592319|58691874|FG001|Overall Study|Lost to Follow-up|3|||
30678090|NCT00862121|58691884|FG000|Overall Study|Adverse Event|1|||
30678091|NCT00862121|58691885|FG001|Overall Study|Adverse Event|2|||
30678092|NCT00862121|58691884|FG000|Overall Study|Lack of Efficacy|0|||
30678093|NCT00862121|58691885|FG001|Overall Study|Lack of Efficacy|3|||
30678094|NCT00862121|58691884|FG000|Overall Study|Protocol Violation|0|||
30678095|NCT00862121|58691885|FG001|Overall Study|Protocol Violation|1|||
30678096|NCT00862121|58691884|FG000|Overall Study|Exclusion criterion violation|0|||
30678097|NCT00862121|58691885|FG001|Overall Study|Exclusion criterion violation|1|||
30678098|NCT00862121|58691884|FG000|Overall Study|Incorrect randomisation|0|||
30678099|NCT00862121|58691885|FG001|Overall Study|Incorrect randomisation|1|||
30678100|NCT00784719|58691898|FG000|Overall Study|Adverse Event|0|||
30678101|NCT00784719|58691899|FG001|Overall Study|Adverse Event|2|||
30678102|NCT00784719|58691900|FG002|Overall Study|Adverse Event|0|||
30592951|NCT01131130|58605121|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
30592952|NCT01130974|58605131|FG000|Overall Study|Protocol Violation|10|||
30592953|NCT01130974|58605132|FG001|Overall Study|Protocol Violation|10|||
30592954|NCT01130974|58605131|FG000|Overall Study|Withdrawal by Subject|0|||
30592955|NCT01130974|58605132|FG001|Overall Study|Withdrawal by Subject|1|||
30592956|NCT01130974|58605131|FG000|Overall Study|Ineligibility criteria|5|||
30592957|NCT01130974|58605132|FG001|Overall Study|Ineligibility criteria|2|||
30592958|NCT01130272|58605144|FG000|Overall Study|Adverse Event|2|||
30678103|NCT00784719|58691901|FG003|Overall Study|Adverse Event|0|||
30678104|NCT00784719|58691902|FG004|Overall Study|Adverse Event|1|||
30678105|NCT00784719|58691903|FG005|Overall Study|Adverse Event|1|||
30678106|NCT00784719|58691904|FG006|Overall Study|Adverse Event|1|||
30678107|NCT00784719|58691898|FG000|Overall Study|Lost to Follow-up|0|||
30678108|NCT00784719|58691899|FG001|Overall Study|Lost to Follow-up|0|||
30678109|NCT00784719|58691900|FG002|Overall Study|Lost to Follow-up|0|||
30678110|NCT00784719|58691901|FG003|Overall Study|Lost to Follow-up|0|||
30678111|NCT00784719|58691902|FG004|Overall Study|Lost to Follow-up|1|||
30678112|NCT00784719|58691903|FG005|Overall Study|Lost to Follow-up|1|||
30678113|NCT00784719|58691904|FG006|Overall Study|Lost to Follow-up|0|||
30678114|NCT00784719|58691898|FG000|Overall Study|Other|2|||
30678115|NCT00784719|58691899|FG001|Overall Study|Other|1|||
30678116|NCT00784719|58691900|FG002|Overall Study|Other|1|||
30678117|NCT00784719|58691901|FG003|Overall Study|Other|0|||
30678118|NCT00784719|58691902|FG004|Overall Study|Other|2|||
30678119|NCT00784719|58691903|FG005|Overall Study|Other|1|||
30678120|NCT00784719|58691904|FG006|Overall Study|Other|3|||
30678121|NCT00784719|58691898|FG000|Overall Study|Withdrawal by Subject|1|||
30678122|NCT00784719|58691899|FG001|Overall Study|Withdrawal by Subject|0|||
30678123|NCT00784719|58691900|FG002|Overall Study|Withdrawal by Subject|0|||
30678124|NCT00784719|58691901|FG003|Overall Study|Withdrawal by Subject|0|||
30678125|NCT00784719|58691902|FG004|Overall Study|Withdrawal by Subject|2|||
30678126|NCT00784719|58691903|FG005|Overall Study|Withdrawal by Subject|0|||
30678127|NCT00784719|58691904|FG006|Overall Study|Withdrawal by Subject|1|||
30678128|NCT00852917|58691924|FG000|Overall Study|Adverse Event|13|||
30678129|NCT00852917|58691925|FG001|Overall Study|Adverse Event|20|||
30678130|NCT00852917|58691926|FG002|Overall Study|Adverse Event|35|||
30678131|NCT00852917|58691927|FG003|Overall Study|Adverse Event|17|||
30678132|NCT00852917|58691924|FG000|Overall Study|Lack of Efficacy|21|||
30678133|NCT00852917|58691925|FG001|Overall Study|Lack of Efficacy|11|||
30678134|NCT00852917|58691926|FG002|Overall Study|Lack of Efficacy|11|||
30678135|NCT00852917|58691927|FG003|Overall Study|Lack of Efficacy|47|||
30678136|NCT00852917|58691924|FG000|Overall Study|Withdrawal by Subject|4|||
30678137|NCT00852917|58691925|FG001|Overall Study|Withdrawal by Subject|8|||
30678138|NCT00852917|58691926|FG002|Overall Study|Withdrawal by Subject|10|||
30678139|NCT00852917|58691927|FG003|Overall Study|Withdrawal by Subject|9|||
30678140|NCT00852917|58691924|FG000|Overall Study|Physician Decision|6|||
30678141|NCT00852917|58691925|FG001|Overall Study|Physician Decision|7|||
30678142|NCT00852917|58691926|FG002|Overall Study|Physician Decision|2|||
30678143|NCT00852917|58691927|FG003|Overall Study|Physician Decision|19|||
30678144|NCT00852917|58691924|FG000|Overall Study|Death|0|||
30678145|NCT00852917|58691925|FG001|Overall Study|Death|0|||
30678146|NCT00852917|58691926|FG002|Overall Study|Death|0|||
30678147|NCT00852917|58691927|FG003|Overall Study|Death|1|||
30678148|NCT00845429|58691940|FG000|Overall Study|Protocol Violation|5|||
30678149|NCT00845429|58691941|FG001|Overall Study|Protocol Violation|4|||
30678150|NCT00845429|58691942|FG002|Overall Study|Protocol Violation|7|||
30678151|NCT00845429|58691940|FG000|Overall Study|Lost to Follow-up|7|||
30678152|NCT00845429|58691941|FG001|Overall Study|Lost to Follow-up|9|||
30678153|NCT00845429|58691942|FG002|Overall Study|Lost to Follow-up|10|||
30678154|NCT00845429|58691940|FG000|Overall Study|Withdrawal by Subject|2|||
30678155|NCT00845429|58691941|FG001|Overall Study|Withdrawal by Subject|2|||
30782254|NCT02862730|58794204|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
30678156|NCT00845429|58691942|FG002|Overall Study|Withdrawal by Subject|2|||
30678157|NCT00845429|58691940|FG000|Overall Study|Serious adverse event|0|||
30678158|NCT00845429|58691941|FG001|Overall Study|Serious adverse event|0|||
30592959|NCT01130272|58605145|FG001|Overall Study|Adverse Event|5|||
30592960|NCT01130272|58605146|FG002|Overall Study|Adverse Event|6|||
30592961|NCT01130272|58605147|FG003|Overall Study|Adverse Event|22|||
30592962|NCT01130272|58605148|FG004|Overall Study|Adverse Event|7|||
30592963|NCT01130272|58605144|FG000|Overall Study|IVRS-confirmed constipation|0|||
30592964|NCT01130272|58605145|FG001|Overall Study|IVRS-confirmed constipation|1|||
30592965|NCT01130272|58605146|FG002|Overall Study|IVRS-confirmed constipation|1|||
30592966|NCT01130272|58605147|FG003|Overall Study|IVRS-confirmed constipation|2|||
30592967|NCT01130272|58605148|FG004|Overall Study|IVRS-confirmed constipation|0|||
30592968|NCT01130272|58605144|FG000|Overall Study|Rescue medications due to diarrhea|3|||
30592969|NCT01130272|58605145|FG001|Overall Study|Rescue medications due to diarrhea|5|||
30592970|NCT01130272|58605146|FG002|Overall Study|Rescue medications due to diarrhea|8|||
30592971|NCT01130272|58605147|FG003|Overall Study|Rescue medications due to diarrhea|8|||
30592972|NCT01130272|58605148|FG004|Overall Study|Rescue medications due to diarrhea|6|||
30592973|NCT01130272|58605144|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
30592974|NCT01130272|58605145|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
30592975|NCT01130272|58605146|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
30592976|NCT01130272|58605147|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
30592977|NCT01130272|58605148|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
30592978|NCT01130272|58605144|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
30592979|NCT01130272|58605145|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
30592980|NCT01130272|58605146|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
30592981|NCT01130272|58605147|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
30592982|NCT01130272|58605148|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
30592983|NCT01130272|58605144|FG000|Overall Study|Protocol Violation|0|||
30592984|NCT01130272|58605145|FG001|Overall Study|Protocol Violation|0|||
30592985|NCT01130272|58605146|FG002|Overall Study|Protocol Violation|3|||
30592986|NCT01130272|58605147|FG003|Overall Study|Protocol Violation|5|||
30592987|NCT01130272|58605148|FG004|Overall Study|Protocol Violation|5|||
30592988|NCT01130272|58605144|FG000|Overall Study|Lost to Follow-up|4|||
30592989|NCT01130272|58605145|FG001|Overall Study|Lost to Follow-up|3|||
30592990|NCT01130272|58605146|FG002|Overall Study|Lost to Follow-up|4|||
30592991|NCT01130272|58605147|FG003|Overall Study|Lost to Follow-up|7|||
30592992|NCT01130272|58605148|FG004|Overall Study|Lost to Follow-up|6|||
30592993|NCT01130272|58605144|FG000|Overall Study|Withdrawal by Subject|4|||
30592994|NCT01130272|58605145|FG001|Overall Study|Withdrawal by Subject|11|||
30592995|NCT01130272|58605146|FG002|Overall Study|Withdrawal by Subject|10|||
30592996|NCT01130272|58605147|FG003|Overall Study|Withdrawal by Subject|9|||
30592997|NCT01130272|58605148|FG004|Overall Study|Withdrawal by Subject|8|||
30592998|NCT01130272|58605144|FG000|Overall Study|Physician Decision|1|||
30592999|NCT01130272|58605145|FG001|Overall Study|Physician Decision|1|||
30593000|NCT01130272|58605146|FG002|Overall Study|Physician Decision|0|||
30593001|NCT01130272|58605147|FG003|Overall Study|Physician Decision|1|||
30593002|NCT01130272|58605148|FG004|Overall Study|Physician Decision|2|||
30593003|NCT01130272|58605144|FG000|Overall Study|Sponsor decision|6|||
30593004|NCT01130272|58605145|FG001|Overall Study|Sponsor decision|15|||
30593005|NCT01130272|58605146|FG002|Overall Study|Sponsor decision|16|||
30593006|NCT01130272|58605147|FG003|Overall Study|Sponsor decision|13|||
30593007|NCT01130272|58605148|FG004|Overall Study|Sponsor decision|16|||
30593008|NCT01130272|58605144|FG000|Overall Study|Study arm discontinued|38|||
30593009|NCT01130272|58605145|FG001|Overall Study|Study arm discontinued|0|||
30593010|NCT01130272|58605146|FG002|Overall Study|Study arm discontinued|0|||
30593011|NCT01130272|58605147|FG003|Overall Study|Study arm discontinued|0|||
30593012|NCT01130272|58605148|FG004|Overall Study|Study arm discontinued|0|||
30593013|NCT01129960|58605164|FG000|Overall Study|Withdrawal by Subject|3|||
30593014|NCT01129960|58605165|FG001|Overall Study|Withdrawal by Subject|0|||
30593015|NCT01129960|58605166|FG002|Overall Study|Withdrawal by Subject|3|||
30593016|NCT01129960|58605167|FG003|Overall Study|Withdrawal by Subject|2|||
30593017|NCT01129960|58605164|FG000|Overall Study|Lack of Efficacy|1|||
30593018|NCT01129960|58605165|FG001|Overall Study|Lack of Efficacy|1|||
30593019|NCT01129960|58605166|FG002|Overall Study|Lack of Efficacy|1|||
30593020|NCT01129960|58605167|FG003|Overall Study|Lack of Efficacy|1|||
30593021|NCT01129960|58605164|FG000|Overall Study|Adverse Event|23|||
30593022|NCT01129960|58605165|FG001|Overall Study|Adverse Event|16|||
30593023|NCT01129960|58605166|FG002|Overall Study|Adverse Event|16|||
30593024|NCT01129960|58605167|FG003|Overall Study|Adverse Event|7|||
30593025|NCT01129960|58605164|FG000|Overall Study|Protocol Violation|1|||
30593026|NCT01129960|58605165|FG001|Overall Study|Protocol Violation|2|||
30593027|NCT01129960|58605166|FG002|Overall Study|Protocol Violation|3|||
30593028|NCT01129960|58605167|FG003|Overall Study|Protocol Violation|0|||
30593029|NCT01129960|58605164|FG000|Overall Study|Lost to Follow-up|0|||
30593030|NCT01129960|58605165|FG001|Overall Study|Lost to Follow-up|2|||
30678159|NCT00845429|58691942|FG002|Overall Study|Serious adverse event|1|||
30593031|NCT01129960|58605166|FG002|Overall Study|Lost to Follow-up|3|||
30593032|NCT01129960|58605167|FG003|Overall Study|Lost to Follow-up|3|||
30593033|NCT01129960|58605164|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
30593034|NCT01129960|58605165|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
30593035|NCT01129960|58605166|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
30593036|NCT01129960|58605167|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
30593037|NCT01129960|58605164|FG000|Overall Study|Physician Decision|1|||
30593038|NCT01129960|58605165|FG001|Overall Study|Physician Decision|0|||
30593039|NCT01129960|58605166|FG002|Overall Study|Physician Decision|0|||
30593040|NCT01129960|58605167|FG003|Overall Study|Physician Decision|0|||
30593041|NCT01129960|58605164|FG000|Overall Study|Pregnancy|1|||
30593042|NCT01129960|58605165|FG001|Overall Study|Pregnancy|0|||
30593043|NCT01129960|58605166|FG002|Overall Study|Pregnancy|0|||
30593044|NCT01129960|58605167|FG003|Overall Study|Pregnancy|0|||
30593045|NCT01129921|58605179|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
30593046|NCT01129921|58605180|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
30593047|NCT01129921|58605179|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
30593048|NCT01129921|58605180|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
30593049|NCT01129921|58605179|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
30593050|NCT01129921|58605180|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
30593051|NCT01129921|58605179|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
30593052|NCT01129921|58605180|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
30593053|NCT01129882|58605199|FG000|Overall Study|Adverse Event|39|||
30593054|NCT01129882|58605199|FG000|Overall Study|Death|6|||
30593055|NCT01129882|58605199|FG000|Overall Study|Lack of Efficacy|5|||
30593056|NCT01129882|58605199|FG000|Overall Study|Lost to Follow-up|13|||
30593057|NCT01129882|58605199|FG000|Overall Study|Physician Decision|27|||
30593058|NCT01129882|58605199|FG000|Overall Study|Protocol Deviation|3|||
30593059|NCT01129882|58605199|FG000|Overall Study|Withdrawal Criteria Met|19|||
30593060|NCT01129882|58605199|FG000|Overall Study|Trial Termination by Sponsor|6|||
30593061|NCT01129882|58605199|FG000|Overall Study|Withdrawal by Subject|160|||
30593062|NCT01129102|58605206|FG000|Overall Study|No study drug treatment|2|||
30593063|NCT01129102|58605207|FG001|Overall Study|No study drug treatment|3|||
30593064|NCT01129102|58605208|FG002|Overall Study|No study drug treatment|1|||
30593065|NCT01129102|58605206|FG000|Overall Study|Withdrawal by Subject|2|||
30593066|NCT01129102|58605207|FG001|Overall Study|Withdrawal by Subject|0|||
30593067|NCT01129102|58605208|FG002|Overall Study|Withdrawal by Subject|3|||
30678160|NCT00593333|58691952|FG000|Overall Study|Lost to Follow-up|10|||
30678161|NCT00593333|58691953|FG001|Overall Study|Lost to Follow-up|11|||
30678162|NCT00844883|58691959|FG000|Overall Study|Bridged to liver transplant|3|||
30678163|NCT00844883|58691959|FG000|Overall Study|Bridged to resection|1|||
30678164|NCT00851903|58691963|FG000|Overall Study|Withdrawal by Subject|2|||
30678165|NCT00587457|58691970|FG000|Overall Study|Adverse Event|1|||
30678166|NCT00587457|58691971|FG001|Overall Study|Adverse Event|2|||
30678167|NCT00587457|58691972|FG002|Overall Study|Adverse Event|1|||
30678168|NCT00587457|58691970|FG000|Overall Study|Disease progression|2|||
30678169|NCT00587457|58691971|FG001|Overall Study|Disease progression|0|||
30678170|NCT00587457|58691972|FG002|Overall Study|Disease progression|2|||
30678171|NCT00587457|58691970|FG000|Overall Study|Initiation of alternative therapy|0|||
30678172|NCT00587457|58691971|FG001|Overall Study|Initiation of alternative therapy|1|||
30678173|NCT00587457|58691972|FG002|Overall Study|Initiation of alternative therapy|0|||
30678174|NCT00587457|58691970|FG000|Overall Study|Undefined|0|||
30678175|NCT00587457|58691971|FG001|Overall Study|Undefined|0|||
30593068|NCT01129102|58605206|FG000|Overall Study|Protocol Violation|0|||
30593069|NCT01129102|58605207|FG001|Overall Study|Protocol Violation|1|||
30593070|NCT01129102|58605208|FG002|Overall Study|Protocol Violation|1|||
30593071|NCT01129102|58605206|FG000|Overall Study|Pregnancy|0|||
30678176|NCT00587457|58691972|FG002|Overall Study|Undefined|1|||
30678177|NCT00587457|58691970|FG000|Overall Study|Development of neutralizing Abs|0|||
30678178|NCT00587457|58691971|FG001|Overall Study|Development of neutralizing Abs|0|||
30678179|NCT00587457|58691972|FG002|Overall Study|Development of neutralizing Abs|1|||
30678180|NCT00851747|58691983|FG000|Overall Study|Physician Decision|6|||
30678181|NCT00851747|58691984|FG001|Overall Study|Physician Decision|6|||
30678182|NCT00851747|58691985|FG002|Overall Study|Physician Decision|6|||
30678183|NCT00767325|58691992|FG000|Overall Study|Lack of Efficacy|2|||
30678184|NCT00767325|58691992|FG000|Overall Study|Adverse Event|7|||
30678185|NCT00767325|58691992|FG000|Overall Study|Lost to Follow-up|3|||
30678186|NCT00767325|58691992|FG000|Overall Study|No longer met study criteria|2|||
30678187|NCT00767325|58691992|FG000|Overall Study|Missed visit due to family reasons|1|||
30959033|NCT01587703|59024031|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
30593072|NCT01129102|58605207|FG001|Overall Study|Pregnancy|0|||
30593073|NCT01129102|58605208|FG002|Overall Study|Pregnancy|1|||
30593074|NCT01129102|58605206|FG000|Overall Study|Adverse Event|2|||
30593075|NCT01129102|58605207|FG001|Overall Study|Adverse Event|2|||
30593076|NCT01129102|58605208|FG002|Overall Study|Adverse Event|1|||
30678188|NCT00851591|58691998|FG000|Overall Study|Withdrawal by Subject|2|||
30678189|NCT00851591|58691999|FG001|Overall Study|Withdrawal by Subject|0|||
30678190|NCT00861341|58692005|FG000|Overall Study|Withdrawal by Subject|2|||
30593077|NCT01129102|58605206|FG000|Overall Study|Lost to Follow-up|2|||
30593078|NCT01129102|58605207|FG001|Overall Study|Lost to Follow-up|0|||
30593079|NCT01129102|58605208|FG002|Overall Study|Lost to Follow-up|0|||
30593080|NCT01129024|58605215|FG000|Overall Study|Physician Decision|5|||
30593081|NCT01129024|58605215|FG000|Overall Study|Study Terminated by Sponsor|8|||
30593082|NCT01129024|58605215|FG000|Overall Study|Withdrawal by Subject|2|||
30593083|NCT01129024|58605215|FG000|Overall Study|Lack of Efficacy|3|||
30593084|NCT01129024|58605215|FG000|Overall Study|Needed a Platelet Transfusion|1|||
30593085|NCT01128946|58605219|FG000|Period I|Protocol Violation|0|||
30593086|NCT01128946|58605220|FG001|Period I|Protocol Violation|1|||
30593087|NCT01128946|58605221|FG002|Period I|Protocol Violation|0|||
30593088|NCT01128946|58605222|FG003|Period I|Protocol Violation|0|||
30593089|NCT01128946|58605219|FG000|Period I|Withdrawal by Subject|0|||
30593090|NCT01128946|58605220|FG001|Period I|Withdrawal by Subject|0|||
30593091|NCT01128946|58605221|FG002|Period I|Withdrawal by Subject|1|||
30593092|NCT01128946|58605222|FG003|Period I|Withdrawal by Subject|1|||
30593093|NCT01128946|58605219|FG000|Period II|Protocol Violation|0|||
30593094|NCT01128946|58605220|FG001|Period II|Protocol Violation|1|||
30593095|NCT01128946|58605221|FG002|Period II|Protocol Violation|0|||
30593096|NCT01128946|58605222|FG003|Period II|Protocol Violation|0|||
30593097|NCT01128946|58605219|FG000|Period II|Withdrawal by Subject|0|||
30593098|NCT01128946|58605220|FG001|Period II|Withdrawal by Subject|0|||
30593099|NCT01128946|58605221|FG002|Period II|Withdrawal by Subject|0|||
30593100|NCT01128946|58605222|FG003|Period II|Withdrawal by Subject|1|||
30593101|NCT01128946|58605219|FG000|Period III|Protocol Violation|1|||
30593102|NCT01128946|58605220|FG001|Period III|Protocol Violation|0|||
30678191|NCT00766467|58692011|FG000|Overall Study|Withdrawal by Subject|7|||
30678192|NCT00766467|58692012|FG001|Overall Study|Withdrawal by Subject|2|||
30678193|NCT00766467|58692011|FG000|Overall Study|Adverse Event|1|||
30678194|NCT00766467|58692012|FG001|Overall Study|Adverse Event|1|||
30678195|NCT00766467|58692011|FG000|Overall Study|Protocol Violation|2|||
30678196|NCT00766467|58692012|FG001|Overall Study|Protocol Violation|4|||
30678197|NCT00766467|58692011|FG000|Overall Study|Tumor Progression on Study|0|||
30678198|NCT00766467|58692012|FG001|Overall Study|Tumor Progression on Study|1|||
30678199|NCT00766467|58692011|FG000|Overall Study|Physician Decision|1|||
30678200|NCT00766467|58692012|FG001|Overall Study|Physician Decision|0|||
30678201|NCT00850499|58692020|FG000|Overall Study|Adverse Event|3|||
30678202|NCT00850499|58692021|FG001|Overall Study|Adverse Event|1|||
30678203|NCT00850499|58692020|FG000|Overall Study|Lack of Efficacy|0|||
30678204|NCT00850499|58692021|FG001|Overall Study|Lack of Efficacy|1|||
30678205|NCT00860951|58692027|FG000|Overall Study|Withdrawal by Subject|2|||
30678206|NCT00860951|58692027|FG000|Overall Study|Lost to Follow-up|5|||
30678207|NCT00844805|58692045|FG000|Treatment Phase|Adverse Event|5|||
30678208|NCT00844805|58692046|FG001|Treatment Phase|Adverse Event|1|||
30678209|NCT00844805|58692047|FG002|Treatment Phase|Adverse Event|0|||
30678210|NCT00844805|58692048|FG003|Treatment Phase|Adverse Event|0|||
30678211|NCT00844805|58692045|FG000|Treatment Phase|Withdrawal by Subject|3|||
30856088|NCT03938636|58883959|FG001|Overall Study|Protocol Violation|1|||
30856089|NCT03938636|58883960|FG002|Overall Study|Protocol Violation|1|||
30678212|NCT00844805|58692046|FG001|Treatment Phase|Withdrawal by Subject|4|||
30678213|NCT00844805|58692047|FG002|Treatment Phase|Withdrawal by Subject|0|||
30678214|NCT00844805|58692048|FG003|Treatment Phase|Withdrawal by Subject|0|||
30678215|NCT00844805|58692045|FG000|Treatment Phase|Noncompliance With Protocol|1|||
30782255|NCT02862730|58794205|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
30782256|NCT02862730|58794206|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
30782257|NCT02862730|58794207|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
30782258|NCT02862730|58794208|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
30782259|NCT02862730|58794209|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
30782260|NCT02862730|58794210|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
30782261|NCT03402386|58794225|FG000|Overall Study|Adverse Event|3|||
30782262|NCT03402386|58794225|FG000|Overall Study|Physician Decision|1|||
30782263|NCT03402386|58794225|FG000|Overall Study|Difficult to control Hb|2|||
30782264|NCT03353792|58794231|FG000|Overall Study|Lost to Follow-up|1|||
30782265|NCT03353792|58794232|FG001|Overall Study|Lost to Follow-up|0|||
30782266|NCT03353792|58794231|FG000|Overall Study|Participant Unable to Manage Device|1|||
30856090|NCT03938636|58883958|FG000|Overall Study|Subject withdrew due to death in family|0|||
30959034|NCT01587703|59024032|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
30593103|NCT01128946|58605221|FG002|Period III|Protocol Violation|0|||
30678216|NCT00844805|58692046|FG001|Treatment Phase|Noncompliance With Protocol|0|||
30678217|NCT00844805|58692047|FG002|Treatment Phase|Noncompliance With Protocol|0|||
30678218|NCT00844805|58692048|FG003|Treatment Phase|Noncompliance With Protocol|0|||
30678219|NCT00844805|58692045|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
30782267|NCT03353792|58794232|FG001|Overall Study|Participant Unable to Manage Device|0|||
30593104|NCT01128946|58605222|FG003|Period III|Protocol Violation|0|||
30593105|NCT01128595|58605233|FG000|Treatment Period 3|Withdrawal by Subject|0|||
30593106|NCT01128595|58605234|FG001|Treatment Period 3|Withdrawal by Subject|1|||
30593107|NCT01128595|58605235|FG002|Treatment Period 3|Withdrawal by Subject|0|||
30593108|NCT01128595|58605236|FG003|Treatment Period 3|Withdrawal by Subject|0|||
30678220|NCT00844805|58692046|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
30678221|NCT00844805|58692047|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
30678222|NCT00844805|58692048|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
30678223|NCT00844805|58692045|FG000|Follow-Up Phase|Adverse Event|0|||
30678224|NCT00844805|58692046|FG001|Follow-Up Phase|Adverse Event|0|||
30678225|NCT00844805|58692047|FG002|Follow-Up Phase|Adverse Event|1|||
30678226|NCT00844805|58692048|FG003|Follow-Up Phase|Adverse Event|0|||
30678227|NCT00844805|58692045|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
30678228|NCT00844805|58692046|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
30678229|NCT00844805|58692047|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
30678230|NCT00844805|58692048|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
30678231|NCT00844805|58692045|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
30678232|NCT00844805|58692046|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
30678233|NCT00844805|58692047|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
30678234|NCT00844805|58692048|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
30678235|NCT00844805|58692045|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
30678236|NCT00844805|58692046|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
30678237|NCT00844805|58692047|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
30678238|NCT00844805|58692048|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
30678239|NCT00844805|58692045|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
30678240|NCT00844805|58692046|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
30678241|NCT00844805|58692047|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
30678242|NCT00844805|58692048|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
30678243|NCT00765999|58692059|FG000|Overall Study|Adverse Event|203|||
30678244|NCT00765999|58692059|FG000|Overall Study|Insufficient Therapeutic Response|100|||
30678245|NCT00765999|58692059|FG000|Overall Study|Protocol Violation|95|||
30678246|NCT00765999|58692059|FG000|Overall Study|Consent Withdrawn|202|||
30678247|NCT00765999|58692059|FG000|Overall Study|Lost to Follow-up|131|||
30678248|NCT00765999|58692059|FG000|Overall Study|Study Terminated by Sponsor|2|||
30678249|NCT00765999|58692059|FG000|Overall Study|Other Miscellaneous Reasons|51|||
30678250|NCT00765843|58692068|FG000|Overall Study|Lost to Follow-up|1|||
30678251|NCT00765843|58692069|FG001|Overall Study|Lost to Follow-up|3|||
30678252|NCT00765843|58692070|FG002|Overall Study|Lost to Follow-up|2|||
30678253|NCT00765843|58692068|FG000|Overall Study|did not return to receive intervention|0|||
30678254|NCT00765843|58692069|FG001|Overall Study|did not return to receive intervention|1|||
30678255|NCT00765843|58692070|FG002|Overall Study|did not return to receive intervention|0|||
30678256|NCT00765843|58692068|FG000|Overall Study|Adverse Event|0|||
30678257|NCT00765843|58692069|FG001|Overall Study|Adverse Event|0|||
30678258|NCT00765843|58692070|FG002|Overall Study|Adverse Event|1|||
30678259|NCT00765063|58692078|FG000|Overall Study|Lack of Efficacy|5|||
30678260|NCT00765063|58692078|FG000|Overall Study|Withdrawal by Subject|1|||
30678261|NCT00765063|58692078|FG000|Overall Study|Other|16|||
30678262|NCT00765063|58692078|FG000|Overall Study|Protocol Violation|6|||
30678263|NCT00765063|58692078|FG000|Overall Study|Adverse Event|4|||
30678264|NCT00764751|58692084|FG000|Overall Study|Adverse Event|1|||
30678265|NCT00764751|58692085|FG001|Overall Study|Adverse Event|1|||
30678266|NCT00764751|58692084|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
30678267|NCT00764751|58692085|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
30678268|NCT00764673|58692096|FG000|Overall Study|Death|1|||
30678269|NCT00764673|58692096|FG000|Overall Study|Lost to Follow-up|3|||
30678270|NCT00764673|58692096|FG000|Overall Study|Withdrawal by Subject|6|||
30678271|NCT00764673|58692096|FG000|Overall Study|Revision of Device|2|||
30678272|NCT00764517|58692102|FG000|Overall Study|Adverse Event|9|||
30678273|NCT00764517|58692103|FG001|Overall Study|Adverse Event|3|||
30678274|NCT00764517|58692102|FG000|Overall Study|Death|3|||
30678275|NCT00764517|58692103|FG001|Overall Study|Death|11|||
30678276|NCT00764517|58692102|FG000|Overall Study|Physician Decision|3|||
30678277|NCT00764517|58692103|FG001|Overall Study|Physician Decision|0|||
30678278|NCT00764361|58692111|FG000|Overall Study|Withdrawal by Subject|2|||
30678279|NCT00764361|58692112|FG001|Overall Study|Withdrawal by Subject|3|||
30678280|NCT00764361|58692111|FG000|Overall Study|Adverse Event|0|||
30678281|NCT00764361|58692112|FG001|Overall Study|Adverse Event|1|||
30678282|NCT00763971|58692121|FG000|Overall Study|Adverse Event|5|||
30678283|NCT00763971|58692122|FG001|Overall Study|Adverse Event|2|||
30678284|NCT00763971|58692123|FG002|Overall Study|Adverse Event|4|||
30678285|NCT00763971|58692121|FG000|Overall Study|Protocol Violation|3|||
30678286|NCT00763971|58692122|FG001|Overall Study|Protocol Violation|3|||
30678287|NCT00763971|58692123|FG002|Overall Study|Protocol Violation|2|||
30678288|NCT00763971|58692121|FG000|Overall Study|Withdrawal by Subject|4|||
30678289|NCT00763971|58692122|FG001|Overall Study|Withdrawal by Subject|5|||
30678290|NCT00763971|58692123|FG002|Overall Study|Withdrawal by Subject|5|||
30678291|NCT00763971|58692121|FG000|Overall Study|Lost to Follow-up|0|||
30678292|NCT00763971|58692122|FG001|Overall Study|Lost to Follow-up|1|||
30678293|NCT00763971|58692123|FG002|Overall Study|Lost to Follow-up|0|||
30678294|NCT00763971|58692121|FG000|Overall Study|Lack of Efficacy|11|||
30678295|NCT00763971|58692122|FG001|Overall Study|Lack of Efficacy|22|||
30678296|NCT00763971|58692123|FG002|Overall Study|Lack of Efficacy|54|||
30678297|NCT00763971|58692121|FG000|Overall Study|Unable to swallow capsule|2|||
30678298|NCT00763971|58692122|FG001|Overall Study|Unable to swallow capsule|1|||
30593109|NCT01129336|58605249|FG000|Overall Study|Protocol Violation|1|||
30593110|NCT01129336|58605250|FG001|Overall Study|Protocol Violation|0|||
30593111|NCT01129336|58605249|FG000|Overall Study|Disease Progression|1|||
30593112|NCT01129336|58605250|FG001|Overall Study|Disease Progression|4|||
30593113|NCT01129336|58605249|FG000|Overall Study|Lost to Follow-up|1|||
30593114|NCT01129336|58605250|FG001|Overall Study|Lost to Follow-up|0|||
30593115|NCT01129336|58605249|FG000|Overall Study|Withdrawal by Subject|7|||
30593116|NCT01129336|58605250|FG001|Overall Study|Withdrawal by Subject|4|||
30593117|NCT01129336|58605249|FG000|Overall Study|Adverse Event|0|||
30593118|NCT01129336|58605250|FG001|Overall Study|Adverse Event|1|||
30593119|NCT01129336|58605249|FG000|Overall Study|Missing Study Completion Status|2|||
30593120|NCT01129336|58605250|FG001|Overall Study|Missing Study Completion Status|3|||
30593121|NCT01129336|58605249|FG000|Overall Study|Death|0|||
30593122|NCT01129336|58605250|FG001|Overall Study|Death|4|||
30678299|NCT00763971|58692123|FG002|Overall Study|Unable to swallow capsule|1|||
30678300|NCT00763971|58692121|FG000|Overall Study|Personal reason|3|||
30678301|NCT00763971|58692122|FG001|Overall Study|Personal reason|0|||
30678302|NCT00763971|58692123|FG002|Overall Study|Personal reason|0|||
30678303|NCT00763971|58692121|FG000|Overall Study|Exclusion criteria met|1|||
30678304|NCT00763971|58692122|FG001|Overall Study|Exclusion criteria met|0|||
30678305|NCT00763971|58692123|FG002|Overall Study|Exclusion criteria met|0|||
30678306|NCT00763971|58692121|FG000|Overall Study|Sponsor decision|1|||
30678307|NCT00763971|58692122|FG001|Overall Study|Sponsor decision|0|||
30678308|NCT00763971|58692123|FG002|Overall Study|Sponsor decision|0|||
30678309|NCT00763971|58692121|FG000|Overall Study|Due to holiday season|2|||
30678310|NCT00763971|58692122|FG001|Overall Study|Due to holiday season|0|||
30678311|NCT00763971|58692123|FG002|Overall Study|Due to holiday season|1|||
30678312|NCT00763971|58692121|FG000|Overall Study|Randomization error|0|||
30678313|NCT00763971|58692122|FG001|Overall Study|Randomization error|0|||
30678314|NCT00763971|58692123|FG002|Overall Study|Randomization error|1|||
30678315|NCT00763971|58692121|FG000|Overall Study|Medical monitor decision|0|||
30678316|NCT00763971|58692122|FG001|Overall Study|Medical monitor decision|0|||
30678317|NCT00763971|58692123|FG002|Overall Study|Medical monitor decision|1|||
30678318|NCT00763971|58692121|FG000|Overall Study|Moved to another country|0|||
30678319|NCT00763971|58692122|FG001|Overall Study|Moved to another country|1|||
30678320|NCT00763971|58692123|FG002|Overall Study|Moved to another country|0|||
30678321|NCT00763971|58692121|FG000|Overall Study|Subject wanted dose reduction|0|||
30678322|NCT00763971|58692122|FG001|Overall Study|Subject wanted dose reduction|1|||
30782268|NCT02862574|58794241|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30782269|NCT02862574|58794242|FG001|Double-Blind Treatment Period|Adverse Event|1|||
30782270|NCT02862574|58794243|FG002|Double-Blind Treatment Period|Adverse Event|0|||
30782271|NCT02862574|58794241|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
30782272|NCT02862574|58794242|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
30782273|NCT02862574|58794243|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
30782274|NCT02862574|58794241|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
30782275|NCT02862574|58794242|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
30782276|NCT02862574|58794243|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
30782277|NCT02862106|58794258|FG000|Overall Study|Adverse Event|4|||
30782278|NCT02862106|58794259|FG001|Overall Study|Adverse Event|0|||
30782279|NCT02862106|58794258|FG000|Overall Study|Protocol Violation|16|||
30678323|NCT00763971|58692123|FG002|Overall Study|Subject wanted dose reduction|0|||
30678324|NCT00763971|58692121|FG000|Overall Study|Lack of availability|0|||
30678325|NCT00763971|58692122|FG001|Overall Study|Lack of availability|1|||
30782280|NCT02862106|58794259|FG001|Overall Study|Protocol Violation|1|||
30782281|NCT02862106|58794258|FG000|Overall Study|Lost to Follow-up|15|||
30782282|NCT02862106|58794259|FG001|Overall Study|Lost to Follow-up|5|||
30782283|NCT02862106|58794258|FG000|Overall Study|Withdrawal by Subject|2|||
30782284|NCT02862106|58794259|FG001|Overall Study|Withdrawal by Subject|0|||
30782285|NCT02862106|58794258|FG000|Overall Study|Subjects moved to other city|1|||
30856091|NCT03938636|58883959|FG001|Overall Study|Subject withdrew due to death in family|1|||
30593123|NCT01128400|58605259|FG000|Overall Study|Lost to Follow-up|1|||
30593124|NCT01128400|58605260|FG001|Overall Study|Lost to Follow-up|0|||
30593125|NCT01128400|58605261|FG002|Overall Study|Lost to Follow-up|1|||
30593126|NCT01128400|58605259|FG000|Overall Study|Screening failure|1|||
30678326|NCT00763971|58692123|FG002|Overall Study|Lack of availability|0|||
30678327|NCT00763971|58692121|FG000|Overall Study|Performed final visit on phone|0|||
30678328|NCT00763971|58692122|FG001|Overall Study|Performed final visit on phone|1|||
30678329|NCT00763971|58692123|FG002|Overall Study|Performed final visit on phone|0|||
30678330|NCT00763971|58692121|FG000|Overall Study|Participation in 489-326 required|1|||
30959035|NCT01587703|59024033|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
30782286|NCT02862106|58794259|FG001|Overall Study|Subjects moved to other city|0|||
30593127|NCT01128400|58605260|FG001|Overall Study|Screening failure|0|||
30593128|NCT01128400|58605261|FG002|Overall Study|Screening failure|0|||
30678331|NCT00763971|58692122|FG001|Overall Study|Participation in 489-326 required|0|||
30678332|NCT00763971|58692123|FG002|Overall Study|Participation in 489-326 required|0|||
30678333|NCT00763815|58692133|FG000|Overall Study|Adverse Event|14|||
30678334|NCT00763815|58692134|FG001|Overall Study|Adverse Event|29|||
30678335|NCT00763815|58692133|FG000|Overall Study|Lack of Efficacy|10|||
30678336|NCT00763815|58692134|FG001|Overall Study|Lack of Efficacy|11|||
30678337|NCT00763815|58692133|FG000|Overall Study|Poor Compliance to Protocol|6|||
30678338|NCT00763815|58692134|FG001|Overall Study|Poor Compliance to Protocol|6|||
30678339|NCT00763815|58692133|FG000|Overall Study|Lost to Follow-up|2|||
30678340|NCT00763815|58692134|FG001|Overall Study|Lost to Follow-up|4|||
30678341|NCT00763815|58692133|FG000|Overall Study|Early Termination|1|||
30593129|NCT01128400|58605259|FG000|Overall Study|were not invited to participate on taste|0|||
30593130|NCT01128400|58605260|FG001|Overall Study|were not invited to participate on taste|0|||
30593131|NCT01128400|58605261|FG002|Overall Study|were not invited to participate on taste|15|||
30593132|NCT01128400|58605259|FG000|Overall Study|Excluded due to sinus problems|0|||
30593133|NCT01128400|58605260|FG001|Overall Study|Excluded due to sinus problems|1|||
30593134|NCT01128400|58605261|FG002|Overall Study|Excluded due to sinus problems|0|||
30678342|NCT00763815|58692134|FG001|Overall Study|Early Termination|0|||
30678343|NCT00763815|58692133|FG000|Overall Study|Familial and Personal Reasons|9|||
30678344|NCT00763815|58692134|FG001|Overall Study|Familial and Personal Reasons|16|||
30678345|NCT00763815|58692133|FG000|Overall Study|Physician Decision|1|||
30678346|NCT00763815|58692134|FG001|Overall Study|Physician Decision|0|||
30593135|NCT01128361|58605271|FG000|Overall Study|Lost to Follow-up|0|||
30593136|NCT01128361|58605272|FG001|Overall Study|Lost to Follow-up|1|||
30678347|NCT00763815|58692133|FG000|Overall Study|Withdrawal by Subject|7|||
30678348|NCT00763815|58692134|FG001|Overall Study|Withdrawal by Subject|12|||
30678349|NCT00763815|58692133|FG000|Overall Study|Protocol Violation|2|||
30678350|NCT00763815|58692134|FG001|Overall Study|Protocol Violation|5|||
30678351|NCT00763815|58692133|FG000|Overall Study|Sponsor's Decision|0|||
30678352|NCT00763815|58692134|FG001|Overall Study|Sponsor's Decision|1|||
30678353|NCT00763269|58692142|FG000|Overall Study|Lost to Follow-up|12|||
30678354|NCT00763269|58692143|FG001|Overall Study|Lost to Follow-up|13|||
30678355|NCT00763035|58692149|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
30678356|NCT00763035|58692150|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
30678357|NCT00763035|58692149|FG000|First Intervention|Adverse Event|0|||
30678358|NCT00763035|58692150|FG001|First Intervention|Adverse Event|1|||
30678359|NCT00763035|58692149|FG000|Second Intervention|Adverse Event|1|||
30678360|NCT00763035|58692150|FG001|Second Intervention|Adverse Event|0|||
30678361|NCT00763035|58692149|FG000|Second Intervention|Physician Decision|2|||
30678362|NCT00763035|58692150|FG001|Second Intervention|Physician Decision|0|||
30678363|NCT00844649|58692158|FG000|Overall Study|Progressive Disease|196|||
30678364|NCT00844649|58692159|FG001|Overall Study|Progressive Disease|245|||
30593137|NCT01128361|58605271|FG000|Overall Study|Withdrawal by Subject|5|||
30593138|NCT01128361|58605272|FG001|Overall Study|Withdrawal by Subject|2|||
30593139|NCT01128244|58605278|FG000|Overall Study|Adverse Event|1|||
30593140|NCT01128244|58605278|FG000|Overall Study|Scheduling conflict|2|||
30593141|NCT01127893|58605286|FG000|Overall Study|Study Termination by the Sponsor|1|||
30593142|NCT01126879|58605292|FG000|Overall Study|Progressive Disease|3|||
30593143|NCT01126879|58605293|FG001|Overall Study|Progressive Disease|1|||
30593144|NCT01126879|58605292|FG000|Overall Study|Withdrawal by Subject|1|||
30593145|NCT01126879|58605293|FG001|Overall Study|Withdrawal by Subject|0|||
30593146|NCT01126879|58605292|FG000|Overall Study|Adverse Event|0|||
30678365|NCT00844649|58692158|FG000|Overall Study|Adverse Event|128|||
30678366|NCT00844649|58692159|FG001|Overall Study|Adverse Event|73|||
30678367|NCT00844649|58692158|FG000|Overall Study|Physician Decision|25|||
30678368|NCT00844649|58692159|FG001|Overall Study|Physician Decision|18|||
30678369|NCT00844649|58692158|FG000|Overall Study|Protocol Violation|10|||
30678370|NCT00844649|58692159|FG001|Overall Study|Protocol Violation|6|||
30678371|NCT00844649|58692158|FG000|Overall Study|Withdrawal by Subject|28|||
30959036|NCT01587703|59024034|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
30959037|NCT01587703|59024035|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
30593147|NCT01126879|58605293|FG001|Overall Study|Adverse Event|1|||
30593148|NCT01126879|58605292|FG000|Overall Study|Physician Decision|1|||
30593149|NCT01126879|58605293|FG001|Overall Study|Physician Decision|0|||
30593150|NCT01126060|58605301|FG000|Overall Study|Protocol Violation|0|||
30593151|NCT01126060|58605302|FG001|Overall Study|Protocol Violation|2|||
30593152|NCT01125748|58605310|FG000|Overall Study|Adverse Event|0|||
30593153|NCT01125748|58605311|FG001|Overall Study|Adverse Event|2|||
30593154|NCT01125748|58605310|FG000|Overall Study|Lost to Follow-up|0|||
30593155|NCT01125748|58605311|FG001|Overall Study|Lost to Follow-up|1|||
30782287|NCT04157296|58794274|FG000|Overall Study|Withdrawal by Subject|0|||
30678372|NCT00844649|58692159|FG001|Overall Study|Withdrawal by Subject|39|||
30593156|NCT01125748|58605310|FG000|Overall Study|Physician Decision|8|||
30678373|NCT00844649|58692158|FG000|Overall Study|Other|7|||
30678374|NCT00844649|58692159|FG001|Overall Study|Other|10|||
30678375|NCT00844649|58692158|FG000|Overall Study|Withdrew prior to starting treatment|11|||
30678376|NCT00844649|58692159|FG001|Overall Study|Withdrew prior to starting treatment|27|||
30678377|NCT00762723|58692170|FG000|Overall Study|Study Terminated slow enrollement|5|||
30678378|NCT00762723|58692171|FG001|Overall Study|Study Terminated slow enrollement|5|||
30678379|NCT00762723|58692172|FG002|Overall Study|Study Terminated slow enrollement|3|||
30678380|NCT00850343|58692184|FG000|Overall Study|Withdrawal by Subject|11|||
30678381|NCT00850343|58692185|FG001|Overall Study|Withdrawal by Subject|0|||
30678382|NCT00850343|58692186|FG002|Overall Study|Withdrawal by Subject|3|||
30678383|NCT00850343|58692187|FG003|Overall Study|Withdrawal by Subject|2|||
30678384|NCT00850343|58692184|FG000|Overall Study|Adverse Event|15|||
30678385|NCT00850343|58692185|FG001|Overall Study|Adverse Event|2|||
30678386|NCT00850343|58692186|FG002|Overall Study|Adverse Event|6|||
30678387|NCT00850343|58692187|FG003|Overall Study|Adverse Event|6|||
30678388|NCT00850343|58692184|FG000|Overall Study|Pregnancy|0|||
30678389|NCT00850343|58692185|FG001|Overall Study|Pregnancy|0|||
30678390|NCT00850343|58692186|FG002|Overall Study|Pregnancy|0|||
30678391|NCT00850343|58692187|FG003|Overall Study|Pregnancy|1|||
30678392|NCT00850343|58692184|FG000|Overall Study|Lack of Efficacy|17|||
30678393|NCT00850343|58692185|FG001|Overall Study|Lack of Efficacy|0|||
30678394|NCT00850343|58692186|FG002|Overall Study|Lack of Efficacy|3|||
30678395|NCT00850343|58692187|FG003|Overall Study|Lack of Efficacy|2|||
30593157|NCT01125748|58605311|FG001|Overall Study|Physician Decision|7|||
30593158|NCT01125748|58605310|FG000|Overall Study|Patient Decision to Withdraw|2|||
30593159|NCT01125748|58605311|FG001|Overall Study|Patient Decision to Withdraw|4|||
30678396|NCT00850343|58692184|FG000|Overall Study|Non-compliance with Study Procedures|1|||
30678397|NCT00850343|58692185|FG001|Overall Study|Non-compliance with Study Procedures|0|||
30678398|NCT00850343|58692186|FG002|Overall Study|Non-compliance with Study Procedures|1|||
30678399|NCT00850343|58692187|FG003|Overall Study|Non-compliance with Study Procedures|1|||
30678400|NCT00850343|58692184|FG000|Overall Study|Physician Decision|2|||
30678401|NCT00850343|58692185|FG001|Overall Study|Physician Decision|1|||
30678402|NCT00850343|58692186|FG002|Overall Study|Physician Decision|1|||
30782288|NCT04157296|58794275|FG001|Overall Study|Withdrawal by Subject|1|||
30782289|NCT04157296|58794274|FG000|Overall Study|Did not obtain second fMRI.|0|||
30593160|NCT01125514|58605317|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
30593161|NCT01125514|58605317|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
30593162|NCT01125514|58605317|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
30593163|NCT01125514|58605317|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
30593164|NCT01125514|58605317|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
30593165|NCT01125514|58605317|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
30593166|NCT01125358|58605335|FG000|Overall Study|Adverse Event|3|||
30593167|NCT01125358|58605336|FG001|Overall Study|Adverse Event|0|||
30593168|NCT01125358|58605337|FG002|Overall Study|Adverse Event|0|||
30593169|NCT01125358|58605338|FG003|Overall Study|Adverse Event|2|||
30593170|NCT01125358|58605335|FG000|Overall Study|Perceived Lack of Efficacy|6|||
30593171|NCT01125358|58605336|FG001|Overall Study|Perceived Lack of Efficacy|3|||
30593172|NCT01125358|58605337|FG002|Overall Study|Perceived Lack of Efficacy|7|||
30593173|NCT01125358|58605338|FG003|Overall Study|Perceived Lack of Efficacy|4|||
30593174|NCT01125358|58605335|FG000|Overall Study|Protocol Violation|1|||
30593175|NCT01125358|58605336|FG001|Overall Study|Protocol Violation|0|||
30593176|NCT01125358|58605337|FG002|Overall Study|Protocol Violation|0|||
30593177|NCT01125358|58605338|FG003|Overall Study|Protocol Violation|0|||
30593178|NCT01125358|58605335|FG000|Overall Study|Sponsor Decision|0|||
30593179|NCT01125358|58605336|FG001|Overall Study|Sponsor Decision|0|||
30593180|NCT01125358|58605337|FG002|Overall Study|Sponsor Decision|1|||
30593181|NCT01125358|58605338|FG003|Overall Study|Sponsor Decision|1|||
30593182|NCT01125358|58605335|FG000|Overall Study|Withdrawal by Subject|2|||
30593183|NCT01125358|58605336|FG001|Overall Study|Withdrawal by Subject|1|||
30593184|NCT01125358|58605337|FG002|Overall Study|Withdrawal by Subject|1|||
30593185|NCT01125358|58605338|FG003|Overall Study|Withdrawal by Subject|1|||
30593186|NCT01125046|58605348|FG000|First 6 Months of Treatment|Death|1|||
30593187|NCT01125046|58605348|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
30593188|NCT01125046|58605348|FG000|First 6 Months of Treatment|Non-compliance|1|||
30593189|NCT01125046|58605348|FG000|First 6 Months of Treatment|Surgery|1|||
30593190|NCT01125046|58605348|FG000|First 6 Months of Treatment|Progressive Disease|7|||
30593191|NCT01125046|58605348|FG000|First 6 Months of Treatment|Adverse Event|2|||
30593192|NCT01125046|58605348|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
30593193|NCT01125046|58605348|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
30593194|NCT01125046|58605348|FG000|Follow-up/Data Cut Off Point|Death|29|||
30593195|NCT01125046|58605348|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
30593196|NCT01124734|58605352|FG000|Overall Study|Disease progression|13|||
30593197|NCT01124734|58605352|FG000|Overall Study|Adverse Event|1|||
30593198|NCT01124734|58605352|FG000|Overall Study|Withdrawal by Subject|1|||
30593199|NCT01124734|58605352|FG000|Overall Study|Elected for alternative treatment|2|||
30593200|NCT01124617|58605363|FG000|Overall Study|Adverse Event|5|||
30593201|NCT01124617|58605364|FG001|Overall Study|Adverse Event|2|||
30593202|NCT01124617|58605363|FG000|Overall Study|Lack of Efficacy|2|||
30678403|NCT00850343|58692187|FG003|Overall Study|Physician Decision|1|||
30678404|NCT00849875|58692200|FG000|Overall Study|Death|28|||
30678405|NCT00849875|58692200|FG000|Overall Study|Ongoing (unknown completion status)|11|||
30678406|NCT00849875|58692200|FG000|Overall Study|Others|6|||
30678407|NCT00849875|58692200|FG000|Overall Study|Lost to Follow-up|2|||
30678408|NCT00844415|58692211|FG000|Overall Study|Withdrawal by Subject|1|||
30678409|NCT00843635|58692219|FG000|Overall Study|Adverse Event|2|||
30678410|NCT00843635|58692220|FG001|Overall Study|Adverse Event|2|||
30678411|NCT00843635|58692221|FG002|Overall Study|Adverse Event|0|||
30678412|NCT00843167|58692235|FG000|Treatment Period|Adverse Event|1|||
30678413|NCT00843167|58692236|FG001|Treatment Period|Adverse Event|5|||
30678414|NCT00843167|58692235|FG000|Treatment Period|Withdrawal by Subject|2|||
30678415|NCT00843167|58692236|FG001|Treatment Period|Withdrawal by Subject|3|||
30678416|NCT00849017|58692249|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
30678417|NCT00849017|58692250|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
30678418|NCT00849017|58692251|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
30678419|NCT00849017|58692249|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
30678420|NCT00849017|58692250|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
30678421|NCT00849017|58692251|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
30678422|NCT00849017|58692249|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
30678423|NCT00849017|58692250|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
30678424|NCT00849017|58692251|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
30678425|NCT00849017|58692249|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
30678426|NCT00849017|58692250|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
30678427|NCT00849017|58692251|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
30678428|NCT00849017|58692249|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
30782290|NCT04157296|58794275|FG001|Overall Study|Did not obtain second fMRI.|1|||
30782291|NCT04157296|58794274|FG000|Overall Study|MRI failed/no second fMRI|0|||
30782292|NCT04157296|58794275|FG001|Overall Study|MRI failed/no second fMRI|1|||
30782293|NCT02859142|58794283|FG000|Overall Study|Adverse Event|1|||
30782294|NCT02859142|58794284|FG001|Overall Study|Adverse Event|2|||
30782295|NCT02859142|58794283|FG000|Overall Study|Lost to Follow-up|1|||
30782296|NCT02859142|58794284|FG001|Overall Study|Lost to Follow-up|4|||
30782297|NCT02859142|58794283|FG000|Overall Study|Withdrawal by Subject|2|||
30782298|NCT02859142|58794284|FG001|Overall Study|Withdrawal by Subject|0|||
30782299|NCT02859142|58794283|FG000|Overall Study|Scheduling difficulties|0|||
30593203|NCT01124617|58605364|FG001|Overall Study|Lack of Efficacy|1|||
30593204|NCT01124617|58605363|FG000|Overall Study|Protocol Violation|1|||
30593205|NCT01124617|58605364|FG001|Overall Study|Protocol Violation|1|||
30593206|NCT01124617|58605363|FG000|Overall Study|Withdrawal by Subject|9|||
30593207|NCT01124617|58605364|FG001|Overall Study|Withdrawal by Subject|1|||
30593208|NCT01124617|58605363|FG000|Overall Study|Other|2|||
30593209|NCT01124617|58605364|FG001|Overall Study|Other|1|||
30593210|NCT01124422|58605372|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
30593211|NCT01124422|58605373|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
30593212|NCT01124422|58605374|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
30593213|NCT01124422|58605372|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
30593214|NCT01124422|58605373|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
30593215|NCT01124422|58605374|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
30593216|NCT01124422|58605372|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
30593217|NCT01124422|58605373|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
30593218|NCT01124422|58605374|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
30593219|NCT01124422|58605372|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
30593220|NCT01124422|58605373|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
30593221|NCT01124422|58605374|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
30593222|NCT01124422|58605372|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
30593223|NCT01124422|58605373|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
30593224|NCT01124422|58605374|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
30593225|NCT01124422|58605372|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
30593226|NCT01124422|58605373|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
30593227|NCT01124422|58605374|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
30593228|NCT01124422|58605372|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
30593229|NCT01124422|58605373|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
30593230|NCT01124422|58605374|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
30593231|NCT01124422|58605372|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
30593232|NCT01124422|58605373|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
30593233|NCT01124422|58605374|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
30593234|NCT01124422|58605372|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
30593235|NCT01124422|58605373|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
30678429|NCT00849017|58692250|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
30782300|NCT02859142|58794284|FG001|Overall Study|Scheduling difficulties|3|||
30856092|NCT03938636|58883960|FG002|Overall Study|Subject withdrew due to death in family|0|||
30678430|NCT00849017|58692251|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
30678431|NCT00849017|58692249|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
30678432|NCT00849017|58692250|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
30593236|NCT01124422|58605374|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
30593237|NCT01124422|58605372|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
30593238|NCT01124422|58605373|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
30593239|NCT01124422|58605374|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
30593240|NCT01124149|58605381|FG000|Acute Phase|Withdrawal by Subject|22|||
30593241|NCT01124149|58605381|FG000|Acute Phase|Adverse Event|21|||
30678433|NCT00849017|58692251|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
30678434|NCT00849017|58692249|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
30678435|NCT00849017|58692250|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
30678436|NCT00849017|58692251|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
30678437|NCT00849017|58692249|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
30678438|NCT00849017|58692250|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
30678439|NCT00849017|58692251|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
30678440|NCT00849017|58692249|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
30678441|NCT00849017|58692250|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
30678442|NCT00849017|58692251|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
30678443|NCT00849017|58692249|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
30678444|NCT00849017|58692250|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
30678445|NCT00849017|58692251|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
30678446|NCT00849017|58692249|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
30678447|NCT00849017|58692250|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
30678448|NCT00849017|58692251|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
30678449|NCT00849017|58692249|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
30678450|NCT00849017|58692250|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
30678451|NCT00849017|58692251|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
30678452|NCT00849017|58692249|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
30678453|NCT00849017|58692250|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
30678454|NCT00849017|58692251|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
30678455|NCT00849017|58692249|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
30678456|NCT00849017|58692250|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
30678457|NCT00849017|58692251|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
30678458|NCT00849017|58692249|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
30678459|NCT00849017|58692250|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
30678460|NCT00849017|58692251|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
30678461|NCT00849017|58692249|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
30678462|NCT00849017|58692250|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
30678463|NCT00849017|58692251|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
30678464|NCT00849017|58692249|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
30678465|NCT00849017|58692250|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
30678466|NCT00849017|58692251|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
30678467|NCT00849017|58692249|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
30782301|NCT03351608|58794295|FG000|Overall Study|Lost to Follow-up|0|||
30782302|NCT03351608|58794296|FG001|Overall Study|Lost to Follow-up|1|||
30593242|NCT01124149|58605381|FG000|Acute Phase|Lack of Efficacy|17|||
30593243|NCT01124149|58605381|FG000|Acute Phase|Protocol Violation|14|||
30593244|NCT01124149|58605381|FG000|Acute Phase|Lost to Follow-up|2|||
30593245|NCT01124149|58605381|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
30593246|NCT01124149|58605381|FG000|Acute Phase|Sponsor request|1|||
30593247|NCT01124149|58605381|FG000|Acute Phase|UC symptoms not ameliorated|1|||
30593248|NCT01124149|58605381|FG000|Acute Phase|Non-compliance|1|||
30593249|NCT01124149|58605381|FG000|Acute Phase|Low hemoglobin|1|||
30593250|NCT01124149|58605381|FG000|Acute Phase|Travelling to another country|1|||
30593251|NCT01124149|58605381|FG000|Acute Phase|Sponsor decision|1|||
30593252|NCT01124149|58605381|FG000|Maintenance Phase|Lack of Efficacy|40|||
30593253|NCT01124149|58605381|FG000|Maintenance Phase|Adverse Event|24|||
30593254|NCT01124149|58605381|FG000|Maintenance Phase|Lost to Follow-up|15|||
30593255|NCT01124149|58605381|FG000|Maintenance Phase|Withdrawal by Subject|10|||
30593256|NCT01124149|58605381|FG000|Maintenance Phase|Protocol Violation|5|||
30593257|NCT01124149|58605381|FG000|Maintenance Phase|Coordinator error|1|||
30593258|NCT01124149|58605381|FG000|Maintenance Phase|Non-compliance|1|||
30593259|NCT01123642|58605388|FG000|Overall Study|Lost to Follow-up|23|||
30593260|NCT01123642|58605388|FG000|Overall Study|Withdrawal by Subject|9|||
30593261|NCT01123642|58605388|FG000|Overall Study|ineligible at baseline assessment|36|||
30593262|NCT01122862|58605393|FG000|Period 1|Protocol Violation|0|||
30593263|NCT01122862|58605394|FG001|Period 1|Protocol Violation|1|||
30593264|NCT01122862|58605395|FG002|Period 1|Protocol Violation|0|||
30593265|NCT01122862|58605393|FG000|Period 2|Adverse Event|0|||
30593266|NCT01122862|58605394|FG001|Period 2|Adverse Event|0|||
30593267|NCT01122862|58605395|FG002|Period 2|Adverse Event|1|||
30593268|NCT01122394|58605406|FG000|Overall Study|Withdrawal by Subject|1|||
30593269|NCT01122394|58605407|FG001|Overall Study|Withdrawal by Subject|1|||
30593270|NCT01122394|58605406|FG000|Overall Study|Lost to Follow-up|2|||
30593271|NCT01122394|58605407|FG001|Overall Study|Lost to Follow-up|2|||
30593272|NCT01122394|58605406|FG000|Overall Study|Adverse Event|0|||
30593273|NCT01122394|58605407|FG001|Overall Study|Adverse Event|1|||
30593274|NCT01121926|58605415|FG000|First Intervention Period|Adverse Event|1|||
30593275|NCT01121926|58605416|FG001|First Intervention Period|Adverse Event|0|||
30593276|NCT01121926|58605415|FG000|Washout Period|Adverse Event|0|||
30593277|NCT01121926|58605416|FG001|Washout Period|Adverse Event|1|||
30593278|NCT01121926|58605415|FG000|Washout Period|Positive pregnancy test|0|||
30593279|NCT01121926|58605416|FG001|Washout Period|Positive pregnancy test|1|||
30593280|NCT01121575|58605428|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
30593281|NCT01121575|58605429|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
30593282|NCT01121575|58605430|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
30593283|NCT01121575|58605431|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
30593284|NCT01121575|58605432|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
30678468|NCT00849017|58692250|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
30678469|NCT00849017|58692251|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
30678470|NCT00849017|58692249|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
30678471|NCT00849017|58692250|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
30678472|NCT00849017|58692251|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
30678473|NCT00842543|58692267|FG000|Overall Study|Withdrawal by Subject|2|||
30678474|NCT00842543|58692268|FG001|Overall Study|Withdrawal by Subject|0|||
30678475|NCT00842543|58692269|FG002|Overall Study|Withdrawal by Subject|3|||
30678476|NCT00842543|58692270|FG003|Overall Study|Withdrawal by Subject|4|||
30678477|NCT00785928|58692289|FG000|Treatment Phase|Adverse Event|1|||
30678478|NCT00785928|58692290|FG001|Treatment Phase|Adverse Event|1|||
30678479|NCT00785928|58692291|FG002|Treatment Phase|Adverse Event|2|||
30678480|NCT00785928|58692292|FG003|Treatment Phase|Adverse Event|0|||
30678481|NCT00785928|58692293|FG004|Treatment Phase|Adverse Event|0|||
30678482|NCT00785928|58692294|FG005|Treatment Phase|Adverse Event|0|||
30678483|NCT00785928|58692295|FG006|Treatment Phase|Adverse Event|2|||
30678484|NCT00785928|58692289|FG000|Treatment Phase|Inadequate Response|0|||
30678485|NCT00785928|58692290|FG001|Treatment Phase|Inadequate Response|1|||
30593285|NCT01121575|58605433|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
30678486|NCT00785928|58692291|FG002|Treatment Phase|Inadequate Response|0|||
30678487|NCT00785928|58692292|FG003|Treatment Phase|Inadequate Response|0|||
30678488|NCT00785928|58692293|FG004|Treatment Phase|Inadequate Response|0|||
30678489|NCT00785928|58692294|FG005|Treatment Phase|Inadequate Response|0|||
30678490|NCT00785928|58692295|FG006|Treatment Phase|Inadequate Response|0|||
30678491|NCT00785928|58692289|FG000|Treatment Phase|Lack of Efficacy|0|||
30678492|NCT00785928|58692290|FG001|Treatment Phase|Lack of Efficacy|1|||
30678493|NCT00785928|58692291|FG002|Treatment Phase|Lack of Efficacy|1|||
30678494|NCT00785928|58692292|FG003|Treatment Phase|Lack of Efficacy|0|||
30678495|NCT00785928|58692293|FG004|Treatment Phase|Lack of Efficacy|0|||
30678496|NCT00785928|58692294|FG005|Treatment Phase|Lack of Efficacy|0|||
30678497|NCT00785928|58692295|FG006|Treatment Phase|Lack of Efficacy|0|||
30678498|NCT00785928|58692289|FG000|Treatment Phase|Physician Decision|0|||
30678499|NCT00785928|58692290|FG001|Treatment Phase|Physician Decision|0|||
30593286|NCT01121575|58605428|FG000|Overall Study|Unspecified Reasons|8|||
30593287|NCT01121575|58605429|FG001|Overall Study|Unspecified Reasons|6|||
30593288|NCT01121575|58605430|FG002|Overall Study|Unspecified Reasons|7|||
30593289|NCT01121575|58605431|FG003|Overall Study|Unspecified Reasons|5|||
30593290|NCT01121575|58605432|FG004|Overall Study|Unspecified Reasons|13|||
30593291|NCT01121575|58605433|FG005|Overall Study|Unspecified Reasons|10|||
30593292|NCT01121575|58605428|FG000|Overall Study|Death|6|||
30593293|NCT01121575|58605429|FG001|Overall Study|Death|0|||
30593294|NCT01121575|58605430|FG002|Overall Study|Death|0|||
30593295|NCT01121575|58605431|FG003|Overall Study|Death|1|||
30593296|NCT01121575|58605432|FG004|Overall Study|Death|7|||
30593297|NCT01121575|58605433|FG005|Overall Study|Death|1|||
30593298|NCT01121536|58605456|FG000|Overall Study|Adverse Event|63|||
30593299|NCT01121536|58605456|FG000|Overall Study|Lack of Efficacy|35|||
30593300|NCT01121536|58605456|FG000|Overall Study|Withdrawal by Subject|65|||
30593301|NCT01121536|58605456|FG000|Overall Study|Protocol Violation|20|||
30593302|NCT01121536|58605456|FG000|Overall Study|Noncompliance with study medication|12|||
30593303|NCT01121536|58605456|FG000|Overall Study|Noncompliance with study procedures|9|||
30678500|NCT00785928|58692291|FG002|Treatment Phase|Physician Decision|0|||
30678501|NCT00785928|58692292|FG003|Treatment Phase|Physician Decision|0|||
30678502|NCT00785928|58692293|FG004|Treatment Phase|Physician Decision|1|||
30678503|NCT00785928|58692294|FG005|Treatment Phase|Physician Decision|0|||
30856093|NCT03938636|58883958|FG000|Overall Study|Missed visit|0|||
30856094|NCT03938636|58883959|FG001|Overall Study|Missed visit|1|||
30678504|NCT00785928|58692295|FG006|Treatment Phase|Physician Decision|0|||
30678505|NCT00785928|58692289|FG000|Treatment Phase|Sponsor Decision|1|||
30678506|NCT00785928|58692290|FG001|Treatment Phase|Sponsor Decision|0|||
30678507|NCT00785928|58692291|FG002|Treatment Phase|Sponsor Decision|0|||
30593304|NCT01121536|58605456|FG000|Overall Study|Lost to Follow-up|39|||
30593305|NCT01121536|58605456|FG000|Overall Study|Other|118|||
30593306|NCT01121263|58605462|FG000|Overall Study|Death|3|||
30593307|NCT01121263|58605463|FG001|Overall Study|Death|2|||
30593308|NCT01121263|58605462|FG000|Overall Study|Lost to Follow-up|22|||
30593309|NCT01121263|58605463|FG001|Overall Study|Lost to Follow-up|12|||
30593310|NCT01121263|58605462|FG000|Overall Study|Withdrawal by Subject|0|||
30593311|NCT01121263|58605463|FG001|Overall Study|Withdrawal by Subject|1|||
30593312|NCT01121185|58605473|FG000|Overall Study|Not infused|0|||
30593313|NCT01121185|58605474|FG001|Overall Study|Not infused|1|||
30593314|NCT01121185|58605473|FG000|Overall Study|Not transplanted|1|||
30593315|NCT01121185|58605474|FG001|Overall Study|Not transplanted|0|||
30593316|NCT01121146|58605482|FG000|Overall Study|Death|17|||
30593317|NCT01121146|58605483|FG001|Overall Study|Death|15|||
30593318|NCT01121146|58605482|FG000|Overall Study|Adverse Event|2|||
30593319|NCT01121146|58605483|FG001|Overall Study|Adverse Event|11|||
30593320|NCT01121146|58605482|FG000|Overall Study|Lost to Follow-up|7|||
30593321|NCT01121146|58605483|FG001|Overall Study|Lost to Follow-up|16|||
30593322|NCT01120756|58605492|FG000|Overall Study|Withdrawal by Subject|1|||
30678508|NCT00785928|58692292|FG003|Treatment Phase|Sponsor Decision|0|||
30678509|NCT00785928|58692293|FG004|Treatment Phase|Sponsor Decision|0|||
30678510|NCT00785928|58692294|FG005|Treatment Phase|Sponsor Decision|0|||
30678511|NCT00785928|58692295|FG006|Treatment Phase|Sponsor Decision|1|||
30678512|NCT00785928|58692289|FG000|Treatment Phase|Withdrawal by Subject|1|||
30678513|NCT00785928|58692290|FG001|Treatment Phase|Withdrawal by Subject|2|||
30678514|NCT00785928|58692291|FG002|Treatment Phase|Withdrawal by Subject|0|||
30782303|NCT03351608|58794297|FG002|Overall Study|Lost to Follow-up|1|||
30782304|NCT03351608|58794298|FG003|Overall Study|Lost to Follow-up|1|||
30593323|NCT01120756|58605493|FG001|Overall Study|Withdrawal by Subject|1|||
30593324|NCT01120717|58605501|FG000|Overall Study|Withdrawal by Subject|11|||
30593325|NCT01120717|58605502|FG001|Overall Study|Withdrawal by Subject|6|||
30593326|NCT01120717|58605501|FG000|Overall Study|Adverse Event|10|||
30593327|NCT01120717|58605502|FG001|Overall Study|Adverse Event|6|||
30593328|NCT01120717|58605501|FG000|Overall Study|Protocol Deviation|2|||
30593329|NCT01120717|58605502|FG001|Overall Study|Protocol Deviation|5|||
30593330|NCT01120717|58605501|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
30593331|NCT01120717|58605502|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
30593332|NCT01120717|58605501|FG000|Overall Study|Lost to Follow-up|2|||
30593333|NCT01120717|58605502|FG001|Overall Study|Lost to Follow-up|3|||
30593334|NCT01120717|58605501|FG000|Overall Study|Death|3|||
30593335|NCT01120717|58605502|FG001|Overall Study|Death|1|||
30593336|NCT01120717|58605501|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
30593337|NCT01120717|58605502|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
30593338|NCT01120600|58605510|FG000|Overall Study|Adverse Event|7|||
30593339|NCT01120600|58605511|FG001|Overall Study|Adverse Event|7|||
30593340|NCT01120600|58605510|FG000|Overall Study|Excessive Bone Loss|0|||
30593341|NCT01120600|58605511|FG001|Overall Study|Excessive Bone Loss|4|||
30593342|NCT01120600|58605510|FG000|Overall Study|Lost to Follow-up|1|||
30593343|NCT01120600|58605511|FG001|Overall Study|Lost to Follow-up|3|||
30593344|NCT01120600|58605510|FG000|Overall Study|Physician Decision|1|||
30593345|NCT01120600|58605511|FG001|Overall Study|Physician Decision|3|||
30593346|NCT01120600|58605510|FG000|Overall Study|Protocol Violation|0|||
30593347|NCT01120600|58605511|FG001|Overall Study|Protocol Violation|4|||
30593348|NCT01120600|58605510|FG000|Overall Study|Withdrawal by Subject|10|||
30593349|NCT01120600|58605511|FG001|Overall Study|Withdrawal by Subject|11|||
30593350|NCT01120210|58605519|FG000|MAIN INFUSION|Adverse Event|1|||
30593351|NCT01120210|58605520|FG001|MAIN INFUSION|Adverse Event|0|||
30593352|NCT01120210|58605519|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
30593353|NCT01120210|58605520|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
30593354|NCT01120093|58605526|FG000|Treatment Period 1|Adverse Event|0|||
30782305|NCT03351608|58794299|FG004|Overall Study|Lost to Follow-up|1|||
30593355|NCT01120093|58605527|FG001|Treatment Period 1|Adverse Event|0|||
30593356|NCT01120093|58605528|FG002|Treatment Period 1|Adverse Event|1|||
30593357|NCT01120093|58605529|FG003|Treatment Period 1|Adverse Event|0|||
30593358|NCT01120093|58605530|FG004|Treatment Period 1|Adverse Event|1|||
30782306|NCT03351608|58794295|FG000|Overall Study|Physician Decision|1|||
30782307|NCT03351608|58794296|FG001|Overall Study|Physician Decision|0|||
30782308|NCT03351608|58794297|FG002|Overall Study|Physician Decision|0|||
30593359|NCT01120093|58605526|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30593360|NCT01120093|58605527|FG001|Treatment Period 1|Withdrawal by Subject|1|||
30593361|NCT01120093|58605528|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30593362|NCT01120093|58605529|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30593363|NCT01120093|58605530|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30593364|NCT01120093|58605526|FG000|Treatment Period 2|Adverse Event|0|||
30593365|NCT01120093|58605527|FG001|Treatment Period 2|Adverse Event|0|||
30593366|NCT01120093|58605528|FG002|Treatment Period 2|Adverse Event|0|||
30678515|NCT00785928|58692292|FG003|Treatment Phase|Withdrawal by Subject|0|||
30782309|NCT03351608|58794298|FG003|Overall Study|Physician Decision|2|||
30678516|NCT00785928|58692293|FG004|Treatment Phase|Withdrawal by Subject|1|||
30678517|NCT00785928|58692294|FG005|Treatment Phase|Withdrawal by Subject|0|||
30678518|NCT00785928|58692295|FG006|Treatment Phase|Withdrawal by Subject|0|||
30678519|NCT00842309|58692335|FG000|Overall Study|Withdrawal by Subject|3|||
30678520|NCT00842309|58692336|FG001|Overall Study|Withdrawal by Subject|1|||
30782310|NCT03351608|58794299|FG004|Overall Study|Physician Decision|1|||
30782311|NCT03351608|58794295|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
30782312|NCT03351608|58794296|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
30782313|NCT03351608|58794297|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
30782314|NCT03351608|58794298|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
30782315|NCT03351608|58794299|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
30782316|NCT03351608|58794295|FG000|Overall Study|Withdrawal by parent/guardian|0|||
30782317|NCT03351608|58794296|FG001|Overall Study|Withdrawal by parent/guardian|0|||
30782318|NCT03351608|58794297|FG002|Overall Study|Withdrawal by parent/guardian|1|||
30782319|NCT03351608|58794298|FG003|Overall Study|Withdrawal by parent/guardian|1|||
30782320|NCT03351608|58794299|FG004|Overall Study|Withdrawal by parent/guardian|0|||
30782321|NCT03351608|58794295|FG000|Overall Study|Other|0|||
30782322|NCT03351608|58794296|FG001|Overall Study|Other|1|||
30782323|NCT03351608|58794297|FG002|Overall Study|Other|1|||
30782324|NCT03351608|58794298|FG003|Overall Study|Other|3|||
30782325|NCT03351608|58794299|FG004|Overall Study|Other|0|||
30782326|NCT02857816|58794322|FG000|Overall Study|Screen Failure|33|||
30782327|NCT02857816|58794322|FG000|Overall Study|Withdrawal by Subject|4|||
30782328|NCT02857816|58794322|FG000|Overall Study|Lost to Follow-up|1|||
30782329|NCT02858440|58794327|FG000|Overall Study|Lost to Follow-up|3|||
30782330|NCT02858440|58794327|FG000|Overall Study|Protocol Violation|2|||
30782331|NCT02858440|58794327|FG000|Overall Study|Consent withdrawal|3|||
30782332|NCT02858440|58794327|FG000|Overall Study|Migrated/moved from study area|4|||
30782333|NCT03382418|58794334|FG000|Overall Study|Withdrawal by Subject|1|||
30782334|NCT03382418|58794335|FG001|Overall Study|Withdrawal by Subject|0|||
30782335|NCT03382418|58794336|FG002|Overall Study|Withdrawal by Subject|0|||
30782336|NCT03382418|58794334|FG000|Overall Study|Lost to Follow-up|2|||
30782337|NCT03382418|58794335|FG001|Overall Study|Lost to Follow-up|3|||
30782338|NCT03382418|58794336|FG002|Overall Study|Lost to Follow-up|0|||
30593367|NCT01120093|58605529|FG003|Treatment Period 2|Adverse Event|1|||
30593368|NCT01120093|58605530|FG004|Treatment Period 2|Adverse Event|0|||
30593369|NCT01120093|58605526|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30593370|NCT01120093|58605527|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30593371|NCT01120093|58605528|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30593372|NCT01120093|58605529|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30593373|NCT01120093|58605530|FG004|Treatment Period 2|Withdrawal by Subject|1|||
30593374|NCT01120093|58605526|FG000|Treatment Period 3|Lack of Efficacy|0|||
30593375|NCT01120093|58605527|FG001|Treatment Period 3|Lack of Efficacy|0|||
30593376|NCT01120093|58605528|FG002|Treatment Period 3|Lack of Efficacy|0|||
30782339|NCT02858362|58794348|FG000|Overall Study|Protocol Violation|0|||
30782340|NCT02858362|58794349|FG001|Overall Study|Protocol Violation|1|||
30782341|NCT02858362|58794350|FG002|Overall Study|Protocol Violation|0|||
30782342|NCT02858362|58794348|FG000|Overall Study|Withdrawal by Subject|1|||
30782343|NCT02858362|58794349|FG001|Overall Study|Withdrawal by Subject|0|||
30782344|NCT02858362|58794350|FG002|Overall Study|Withdrawal by Subject|0|||
30782345|NCT02858362|58794348|FG000|Overall Study|Early Study Termination|0|||
30782346|NCT02858362|58794349|FG001|Overall Study|Early Study Termination|0|||
30782347|NCT02858362|58794350|FG002|Overall Study|Early Study Termination|3|||
30782348|NCT02858362|58794348|FG000|Overall Study|Lost to Follow-up|1|||
30782349|NCT02858362|58794349|FG001|Overall Study|Lost to Follow-up|0|||
30782350|NCT02858362|58794350|FG002|Overall Study|Lost to Follow-up|0|||
30782351|NCT03382262|58794367|FG000|Overall Study|Physician Decision|0|||
30782352|NCT03382262|58794368|FG001|Overall Study|Physician Decision|0|||
30782353|NCT03382262|58794369|FG002|Overall Study|Physician Decision|1|||
30782354|NCT03382262|58794370|FG003|Overall Study|Physician Decision|0|||
30782355|NCT03382262|58794367|FG000|Overall Study|Withdrawal by Subject|0|||
30959038|NCT01587703|59024036|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
30593377|NCT01120093|58605529|FG003|Treatment Period 3|Lack of Efficacy|1|||
30593378|NCT01120093|58605530|FG004|Treatment Period 3|Lack of Efficacy|0|||
30782356|NCT03382262|58794368|FG001|Overall Study|Withdrawal by Subject|0|||
30782357|NCT03382262|58794369|FG002|Overall Study|Withdrawal by Subject|0|||
30782358|NCT03382262|58794370|FG003|Overall Study|Withdrawal by Subject|1|||
30782359|NCT03350750|58794382|FG000|Overall Study|Death|1|||
30782360|NCT03350750|58794383|FG001|Overall Study|Death|1|||
30782361|NCT03394508|58794393|FG000|Overall Study|Protocol Violation|0|||
30782362|NCT03394508|58794394|FG001|Overall Study|Protocol Violation|3|||
30782363|NCT03394508|58794393|FG000|Overall Study|Lost to Follow-up|1|||
30782364|NCT03394508|58794394|FG001|Overall Study|Lost to Follow-up|0|||
30593379|NCT01120093|58605526|FG000|Treatment Period 3|Adverse Event|0|||
30593380|NCT01120093|58605527|FG001|Treatment Period 3|Adverse Event|0|||
30593381|NCT01120093|58605528|FG002|Treatment Period 3|Adverse Event|0|||
30678521|NCT00842153|58692344|FG000|Overall Study|Adverse Event|0|||
30678522|NCT00842153|58692345|FG001|Overall Study|Adverse Event|1|||
30678523|NCT00842153|58692344|FG000|Overall Study|Lost to Follow-up|1|||
30678524|NCT00842153|58692345|FG001|Overall Study|Lost to Follow-up|2|||
30678525|NCT00762411|58692353|FG000|Initial Treatment|Death|7|||
30678526|NCT00762411|58692354|FG001|Initial Treatment|Death|6|||
30678527|NCT00762411|58692353|FG000|Initial Treatment|Adverse Event|132|||
30678528|NCT00762411|58692354|FG001|Initial Treatment|Adverse Event|40|||
30678529|NCT00762411|58692353|FG000|Initial Treatment|Protocol Violation|4|||
30678530|NCT00762411|58692354|FG001|Initial Treatment|Protocol Violation|1|||
30593382|NCT01120093|58605529|FG003|Treatment Period 3|Adverse Event|0|||
30593383|NCT01120093|58605530|FG004|Treatment Period 3|Adverse Event|1|||
30593384|NCT01120093|58605526|FG000|Treatment Period 3|Withdrawal by Subject|0|||
30593385|NCT01120093|58605527|FG001|Treatment Period 3|Withdrawal by Subject|0|||
30593386|NCT01120093|58605528|FG002|Treatment Period 3|Withdrawal by Subject|1|||
30593387|NCT01120093|58605529|FG003|Treatment Period 3|Withdrawal by Subject|0|||
30593388|NCT01120093|58605530|FG004|Treatment Period 3|Withdrawal by Subject|0|||
30593389|NCT01120093|58605526|FG000|Treatment Period 4|Adverse Event|1|||
30593390|NCT01120093|58605527|FG001|Treatment Period 4|Adverse Event|0|||
30782365|NCT02856880|58794404|FG000|Overall Study|Withdrawal of consent|1|||
30782366|NCT03393806|58794425|FG000|Overall Study|Physician Decision|1|||
30782367|NCT03393806|58794426|FG001|Overall Study|Physician Decision|0|||
30782368|NCT02856802|58794435|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
30782369|NCT02856802|58794436|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
30782370|NCT02856802|58794435|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
30782371|NCT02856802|58794436|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
30782372|NCT02856802|58794435|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
30782373|NCT02856802|58794436|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
30782374|NCT02856802|58794435|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
30782375|NCT02856802|58794436|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
30782376|NCT02856802|58794435|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
30782377|NCT02856802|58794436|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
30782378|NCT02856802|58794435|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
30782379|NCT02856802|58794436|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
30782380|NCT03381248|58794448|FG000|Overall Study|Withdrawal by Subject|5|||
30782381|NCT03381248|58794449|FG001|Overall Study|Withdrawal by Subject|3|||
30782382|NCT03381248|58794448|FG000|Overall Study|Lost to Follow-up|3|||
30782383|NCT03381248|58794449|FG001|Overall Study|Lost to Follow-up|2|||
30782384|NCT03381248|58794448|FG000|Overall Study|Lack of Efficacy|1|||
30782385|NCT03381248|58794449|FG001|Overall Study|Lack of Efficacy|0|||
30782386|NCT03381248|58794448|FG000|Overall Study|Adverse Event|2|||
30782387|NCT03381248|58794449|FG001|Overall Study|Adverse Event|0|||
30782388|NCT03381248|58794448|FG000|Overall Study|Protocol Violation|2|||
30782389|NCT03381248|58794449|FG001|Overall Study|Protocol Violation|1|||
30782390|NCT03380390|58794455|FG000|Overall Study|Adverse Event|3|||
30782391|NCT03350672|58794462|FG000|Overall Study|Withdrawal by Subject|7|||
30782392|NCT03350672|58794463|FG001|Overall Study|Withdrawal by Subject|0|||
30782393|NCT03350672|58794464|FG002|Overall Study|Withdrawal by Subject|0|||
30782394|NCT03392168|58794476|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
30782395|NCT03392168|58794477|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
30782396|NCT03392168|58794478|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
30782397|NCT03392168|58794479|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
30782398|NCT03392168|58794476|FG000|Period 2: Cohort 2|Other|0|||
30782399|NCT03392168|58794477|FG001|Period 2: Cohort 2|Other|1|||
30782400|NCT03392168|58794478|FG002|Period 2: Cohort 2|Other|0|||
30782401|NCT03392168|58794479|FG003|Period 2: Cohort 2|Other|0|||
30782402|NCT03391232|58794490|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
30782403|NCT03391232|58794491|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
30782404|NCT03391232|58794490|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
30782405|NCT03391232|58794491|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
30782406|NCT03379376|58794499|FG000|Overall Study|Lost to Follow-up|2|||
30782407|NCT03379376|58794499|FG000|Overall Study|Did not wish to complete follow up|1|||
30782408|NCT03379376|58794499|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
30856095|NCT03938636|58883960|FG002|Overall Study|Missed visit|0|||
30593391|NCT01120093|58605528|FG002|Treatment Period 4|Adverse Event|0|||
30593392|NCT01120093|58605529|FG003|Treatment Period 4|Adverse Event|0|||
30593393|NCT01120093|58605530|FG004|Treatment Period 4|Adverse Event|0|||
30678531|NCT00762411|58692353|FG000|Initial Treatment|Withdrawal by Subject|65|||
30782409|NCT03379376|58794499|FG000|Overall Study|Death|1|||
30782410|NCT03349034|58794505|FG000|Overall Study|catheters dislodged during transport|2|||
30782411|NCT03349034|58794506|FG001|Overall Study|catheters dislodged during transport|0|||
30856096|NCT03938636|58883958|FG000|Overall Study|Adverse Event|0|||
30593394|NCT01120093|58605526|FG000|Treatment Period 5|Adverse Event|0|||
30593395|NCT01120093|58605527|FG001|Treatment Period 5|Adverse Event|1|||
30678532|NCT00762411|58692354|FG001|Initial Treatment|Withdrawal by Subject|52|||
30678533|NCT00762411|58692353|FG000|Initial Treatment|Physician Decision|1|||
30593396|NCT01120093|58605528|FG002|Treatment Period 5|Adverse Event|0|||
30593397|NCT01120093|58605529|FG003|Treatment Period 5|Adverse Event|1|||
30593398|NCT01120093|58605530|FG004|Treatment Period 5|Adverse Event|0|||
30593399|NCT01119937|58605544|FG000|Overall Study|Adverse Event|11|||
30593400|NCT01119937|58605545|FG001|Overall Study|Adverse Event|5|||
30593401|NCT01119937|58605544|FG000|Overall Study|Protocol deviation|3|||
30593402|NCT01119937|58605545|FG001|Overall Study|Protocol deviation|1|||
30593403|NCT01119937|58605544|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
30593404|NCT01119937|58605545|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30593405|NCT01119937|58605544|FG000|Overall Study|Withdrawal by Subject|2|||
30593406|NCT01119937|58605545|FG001|Overall Study|Withdrawal by Subject|1|||
30593407|NCT01119898|58605553|FG000|Overall Study|Adverse Event|4|||
30593408|NCT01119898|58605554|FG001|Overall Study|Adverse Event|5|||
30593409|NCT01119898|58605553|FG000|Overall Study|Withdrawal by Subject|1|||
30593410|NCT01119898|58605554|FG001|Overall Study|Withdrawal by Subject|4|||
30593411|NCT01119898|58605553|FG000|Overall Study|Lack of Efficacy|0|||
30593412|NCT01119898|58605554|FG001|Overall Study|Lack of Efficacy|2|||
30593413|NCT01119898|58605553|FG000|Overall Study|Protocol Violation|1|||
30593414|NCT01119898|58605554|FG001|Overall Study|Protocol Violation|1|||
30593415|NCT01119898|58605553|FG000|Overall Study|Medical procedure|1|||
30593416|NCT01119898|58605554|FG001|Overall Study|Medical procedure|0|||
30593417|NCT01119898|58605553|FG000|Overall Study|Randomized in error did not participate|1|||
30593418|NCT01119898|58605554|FG001|Overall Study|Randomized in error did not participate|0|||
30593419|NCT01119859|58605562|FG000|Overall Study|Adverse Event|9|||
30593420|NCT01119859|58605563|FG001|Overall Study|Adverse Event|10|||
30593421|NCT01119859|58605562|FG000|Overall Study|Death|2|||
30593422|NCT01119859|58605563|FG001|Overall Study|Death|0|||
30593423|NCT01119859|58605562|FG000|Overall Study|Insufficient therapeutic response|7|||
30593424|NCT01119859|58605563|FG001|Overall Study|Insufficient therapeutic response|14|||
30782412|NCT03349034|58794505|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
30782413|NCT03349034|58794506|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
30782414|NCT03349034|58794505|FG000|Overall Study|soft tissue flap used|1|||
30782415|NCT03349034|58794506|FG001|Overall Study|soft tissue flap used|0|||
30782416|NCT03349034|58794505|FG000|Overall Study|Other|0|||
30782417|NCT03349034|58794506|FG001|Overall Study|Other|1|||
30782418|NCT00358215|58794516|FG000|Overall Study|Ineligibility determined|4|||
30782419|NCT00358215|58794517|FG001|Overall Study|Ineligibility determined|3|||
30782420|NCT00358215|58794516|FG000|Overall Study|Adverse Event|83|||
30782421|NCT00358215|58794517|FG001|Overall Study|Adverse Event|65|||
30782422|NCT00358215|58794516|FG000|Overall Study|Withdrawal by Subject|111|||
30782423|NCT00358215|58794517|FG001|Overall Study|Withdrawal by Subject|102|||
30782424|NCT00358215|58794516|FG000|Overall Study|Participant request|65|||
30782425|NCT00358215|58794517|FG001|Overall Study|Participant request|64|||
30782426|NCT00358215|58794516|FG000|Overall Study|Physician Decision|47|||
30782427|NCT00358215|58794517|FG001|Overall Study|Physician Decision|39|||
30856097|NCT03938636|58883959|FG001|Overall Study|Adverse Event|0|||
30678534|NCT00762411|58692354|FG001|Initial Treatment|Physician Decision|0|||
30678535|NCT00762411|58692353|FG000|Initial Treatment|Sponsor Decision|293|||
30678536|NCT00762411|58692354|FG001|Initial Treatment|Sponsor Decision|401|||
30678537|NCT00762411|58692353|FG000|Initial Treatment|Lost to Follow-up|5|||
30593425|NCT01119859|58605562|FG000|Overall Study|Refused treatment|3|||
30593426|NCT01119859|58605563|FG001|Overall Study|Refused treatment|6|||
30593427|NCT01119859|58605562|FG000|Overall Study|Failure to return|3|||
30593428|NCT01119859|58605563|FG001|Overall Study|Failure to return|0|||
30678538|NCT00762411|58692354|FG001|Initial Treatment|Lost to Follow-up|0|||
30678539|NCT00762411|58692353|FG000|Initial Treatment|Caregiver Decision|21|||
30678540|NCT00762411|58692354|FG001|Initial Treatment|Caregiver Decision|16|||
30678541|NCT00762411|58692353|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
30678542|NCT00762411|58692354|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
30678543|NCT00762411|58692353|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
30678544|NCT00762411|58692354|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
30678545|NCT00762411|58692353|FG000|Delayed Start|Adverse Event|0|||
30678546|NCT00762411|58692354|FG001|Delayed Start|Adverse Event|4|||
30678547|NCT00762411|58692353|FG000|Delayed Start|Protocol Violation|0|||
30678548|NCT00762411|58692354|FG001|Delayed Start|Protocol Violation|1|||
30678549|NCT00762411|58692353|FG000|Delayed Start|Sponsor Decision|16|||
30782428|NCT00358215|58794516|FG000|Overall Study|Lost to Follow-up|16|||
30782429|NCT00358215|58794517|FG001|Overall Study|Lost to Follow-up|22|||
30782430|NCT00358215|58794516|FG000|Overall Study|Death|265|||
30593429|NCT01119703|58605571|FG000|Overall Study|Adverse Event|0|||
30593430|NCT01119703|58605572|FG001|Overall Study|Adverse Event|1|||
30593431|NCT01119625|58605579|FG000|Overall Study|Lost to Follow-up|1|||
30593432|NCT01119625|58605580|FG001|Overall Study|Lost to Follow-up|2|||
30593433|NCT01119625|58605579|FG000|Overall Study|Withdrawal by Subject|2|||
30678550|NCT00762411|58692354|FG001|Delayed Start|Sponsor Decision|20|||
30678551|NCT00762411|58692353|FG000|Delayed Start|Caregiver Decision|1|||
30678552|NCT00762411|58692354|FG001|Delayed Start|Caregiver Decision|1|||
30678553|NCT00762411|58692353|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
30593434|NCT01119625|58605580|FG001|Overall Study|Withdrawal by Subject|1|||
30593435|NCT01119625|58605579|FG000|Overall Study|Other|0|||
30593436|NCT01119625|58605580|FG001|Overall Study|Other|1|||
30678554|NCT00762411|58692354|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
30678555|NCT00762411|58692353|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
30678556|NCT00762411|58692354|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
30678557|NCT00762411|58692353|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
30678558|NCT00762411|58692354|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
30678559|NCT00762411|58692353|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
30782431|NCT00358215|58794517|FG001|Overall Study|Death|281|||
30782432|NCT00358215|58794516|FG000|Overall Study|Protocol Violation|64|||
30782433|NCT00358215|58794517|FG001|Overall Study|Protocol Violation|59|||
30782434|NCT00358215|58794516|FG000|Overall Study|Pregnancy|1|||
30782435|NCT00358215|58794517|FG001|Overall Study|Pregnancy|0|||
30782436|NCT00358215|58794516|FG000|Overall Study|Other|21|||
30782437|NCT00358215|58794517|FG001|Overall Study|Other|14|||
30782438|NCT00358215|58794516|FG000|Overall Study|Did not receive investigational product|2|||
30782439|NCT00358215|58794517|FG001|Overall Study|Did not receive investigational product|3|||
30782440|NCT02855164|58794531|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
30782441|NCT02855164|58794532|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
30782442|NCT02855164|58794533|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
30782443|NCT02855164|58794534|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
30782444|NCT02855164|58794535|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
30782445|NCT02855164|58794536|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
30782446|NCT02855164|58794537|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
30782447|NCT02855164|58794538|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
30782448|NCT02855164|58794531|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
30782449|NCT02855164|58794532|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
30782450|NCT02855164|58794533|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
30782451|NCT02855164|58794534|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
30782452|NCT02855164|58794535|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
30782453|NCT02855164|58794536|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
30782454|NCT02855164|58794537|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
30782455|NCT02855164|58794538|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
30593437|NCT01119118|58605586|FG000|Overall Study|Adverse Event|1|||
30593438|NCT01119001|58605590|FG000|Overall Study|Withdrawal by Subject|2|||
30593439|NCT01118962|58605596|FG000|Overall Study|Adverse Event|2|||
30593440|NCT01118962|58605596|FG000|Overall Study|Lack of Efficacy|1|||
30593441|NCT01118962|58605596|FG000|Overall Study|Protocol Violation|1|||
30593442|NCT01118962|58605596|FG000|Overall Study|Withdrawal by Subject|4|||
30593443|NCT01118962|58605596|FG000|Overall Study|Pregnancy|1|||
30593444|NCT01118962|58605596|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
30593445|NCT01118728|58605600|FG000|Overall Study|Adverse Event|17|||
30593446|NCT01118728|58605600|FG000|Overall Study|Lack of Efficacy|27|||
30593447|NCT01118728|58605600|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
30593448|NCT01118728|58605600|FG000|Overall Study|Withdrawal by Subject|3|||
30593449|NCT01118728|58605600|FG000|Overall Study|Lost to Follow-up|4|||
30593450|NCT01118455|58605606|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
30593451|NCT01118455|58605607|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
30593452|NCT01118377|58605621|FG000|Overall Study|Did Not Receive Study Medication|1|||
30593453|NCT01118377|58605621|FG000|Overall Study|Death|38|||
30593454|NCT01118377|58605621|FG000|Overall Study|Failure to Return|3|||
30593455|NCT01118299|58605627|FG000|Overall Study|Death|7|||
30678560|NCT00762411|58692354|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
30678561|NCT00762411|58692353|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
30678562|NCT00762411|58692354|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
30678563|NCT00762411|58692353|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
30678564|NCT00762411|58692354|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
30678565|NCT00761865|58692366|FG000|Overall Study|Lost to Follow-up|8|||
30678566|NCT00761865|58692367|FG001|Overall Study|Lost to Follow-up|7|||
30678567|NCT00841763|58692375|FG000|Overall Study|Withdrawal by Subject|60|||
30678568|NCT00841763|58692376|FG001|Overall Study|Withdrawal by Subject|17|||
30678569|NCT00841763|58692377|FG002|Overall Study|Withdrawal by Subject|4|||
30678570|NCT00841763|58692378|FG003|Overall Study|Withdrawal by Subject|1|||
30782456|NCT02855164|58794531|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
30782457|NCT02855164|58794532|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
30593456|NCT01118299|58605628|FG001|Overall Study|Death|5|||
30593457|NCT01118299|58605627|FG000|Overall Study|Withdrawal by Subject|8|||
30593458|NCT01118299|58605628|FG001|Overall Study|Withdrawal by Subject|8|||
30593459|NCT01118299|58605627|FG000|Overall Study|Lost to Follow-up|2|||
30593460|NCT01118299|58605628|FG001|Overall Study|Lost to Follow-up|1|||
30593461|NCT01118299|58605627|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
30678571|NCT00841763|58692375|FG000|Overall Study|Adverse Event|9|||
30678572|NCT00841763|58692376|FG001|Overall Study|Adverse Event|10|||
30678573|NCT00841763|58692377|FG002|Overall Study|Adverse Event|3|||
30678574|NCT00841763|58692378|FG003|Overall Study|Adverse Event|2|||
30678575|NCT00841763|58692375|FG000|Overall Study|Lost to Follow-up|63|||
30678576|NCT00841763|58692376|FG001|Overall Study|Lost to Follow-up|25|||
30678577|NCT00841763|58692377|FG002|Overall Study|Lost to Follow-up|0|||
30678578|NCT00841763|58692378|FG003|Overall Study|Lost to Follow-up|0|||
30678579|NCT00841763|58692375|FG000|Overall Study|Protocol Violation|20|||
30678580|NCT00841763|58692376|FG001|Overall Study|Protocol Violation|3|||
30678581|NCT00841763|58692377|FG002|Overall Study|Protocol Violation|1|||
30678582|NCT00841763|58692378|FG003|Overall Study|Protocol Violation|0|||
30678583|NCT00841763|58692375|FG000|Overall Study|Administrative Reasons|3|||
30678584|NCT00841763|58692376|FG001|Overall Study|Administrative Reasons|1|||
30678585|NCT00841763|58692377|FG002|Overall Study|Administrative Reasons|0|||
30678586|NCT00841763|58692378|FG003|Overall Study|Administrative Reasons|0|||
30593462|NCT01118299|58605628|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
30593463|NCT01118143|58605635|FG000|Overall Study|Withdrawal by Subject|2|||
30593464|NCT01118143|58605636|FG001|Overall Study|Withdrawal by Subject|5|||
30593465|NCT01117987|58605646|FG000|Overall Study|Protocol deviation|0|||
30593466|NCT01117987|58605647|FG001|Overall Study|Protocol deviation|1|||
30593467|NCT01117987|58605646|FG000|Overall Study|Subject no longer requires study drug|1|||
30678587|NCT00841763|58692375|FG000|Overall Study|Unable to Classify|7|||
30678588|NCT00841763|58692376|FG001|Overall Study|Unable to Classify|1|||
30678589|NCT00841763|58692377|FG002|Overall Study|Unable to Classify|0|||
30678590|NCT00841763|58692378|FG003|Overall Study|Unable to Classify|0|||
30678591|NCT00838331|58692423|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
30678592|NCT00785538|58692431|FG000|Treatment Period|Adverse Event|1|||
30678593|NCT00785538|58692432|FG001|Treatment Period|Adverse Event|2|||
30678594|NCT00785538|58692433|FG002|Treatment Period|Adverse Event|2|||
30678595|NCT00785538|58692434|FG003|Treatment Period|Adverse Event|0|||
30678596|NCT00785538|58692431|FG000|Treatment Period|Withdrawal by Subject|0|||
30678597|NCT00785538|58692432|FG001|Treatment Period|Withdrawal by Subject|0|||
30678598|NCT00785538|58692433|FG002|Treatment Period|Withdrawal by Subject|0|||
30678599|NCT00785538|58692434|FG003|Treatment Period|Withdrawal by Subject|1|||
30593468|NCT01117987|58605647|FG001|Overall Study|Subject no longer requires study drug|0|||
30678600|NCT00860405|58692447|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
30678601|NCT00860405|58692448|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
30678602|NCT00838097|58692454|FG000|Overall Study|Ineligibility determined|6|||
30678603|NCT00838097|58692454|FG000|Overall Study|Adverse Event|2|||
30678604|NCT00838097|58692454|FG000|Overall Study|Withdrawal by Subject|3|||
30678605|NCT00838097|58692454|FG000|Overall Study|Requirement for alternative therapy|2|||
30678606|NCT00838097|58692454|FG000|Overall Study|Physician Decision|4|||
30678607|NCT00838097|58692454|FG000|Overall Study|Lost to Follow-up|11|||
30678608|NCT00838097|58692454|FG000|Overall Study|Death|6|||
30678609|NCT00838097|58692454|FG000|Overall Study|Protocol-specified criteria|142|||
30678610|NCT00840827|58692458|FG000|Overall Study|Adverse Event|1|||
30678611|NCT00840827|58692458|FG000|Overall Study|Lack of Efficacy|4|||
30678612|NCT00840827|58692458|FG000|Overall Study|Physician Decision|1|||
30678613|NCT00860249|58692465|FG000|Overall Study|trial was terminated prior to completion|21|||
30678614|NCT00860249|58692466|FG001|Overall Study|trial was terminated prior to completion|18|||
30678615|NCT00860249|58692467|FG002|Overall Study|trial was terminated prior to completion|21|||
30678616|NCT00840749|58692477|FG000|Overall Study|Death|1|||
30678617|NCT00840749|58692478|FG001|Overall Study|Death|2|||
30678618|NCT00840749|58692477|FG000|Overall Study|not treated on study arm|11|||
30678619|NCT00840749|58692478|FG001|Overall Study|not treated on study arm|11|||
30678620|NCT00840749|58692477|FG000|Overall Study|study closed|19|||
30678621|NCT00840749|58692478|FG001|Overall Study|study closed|14|||
30678622|NCT00859937|58692486|FG000|Overall Study|Protocol Violation|1|||
30678623|NCT00859937|58692487|FG001|Overall Study|Protocol Violation|0|||
30593469|NCT01117987|58605646|FG000|Overall Study|Lost to Follow-up|1|||
30593470|NCT01117987|58605647|FG001|Overall Study|Lost to Follow-up|1|||
30678624|NCT00592007|58692493|FG000|Overall Study|Withdrawal by Subject|1|||
30678625|NCT00592007|58692493|FG000|Overall Study|patient ineligible (out of lab range)|1|||
30678626|NCT00591851|58692497|FG000|Overall Study|Withdrawal by Subject|3|||
30678627|NCT00591851|58692497|FG000|Overall Study|Adverse Event|2|||
30856098|NCT03938636|58883960|FG002|Overall Study|Adverse Event|1|||
30593471|NCT01117987|58605646|FG000|Overall Study|Abnormal test procedure result|2|||
30593472|NCT01117987|58605647|FG001|Overall Study|Abnormal test procedure result|0|||
30593473|NCT01117987|58605646|FG000|Overall Study|Lack of Efficacy|3|||
30593474|NCT01117987|58605647|FG001|Overall Study|Lack of Efficacy|4|||
30678628|NCT00591851|58692497|FG000|Overall Study|Progressive Disease|1|||
30678629|NCT00837473|58692501|FG000|Overall Study|Lost to Follow-up|1|||
30678630|NCT00837473|58692501|FG000|Overall Study|Withdrawal by Subject|2|||
30678631|NCT00839423|58692509|FG000|Overall Study|Adverse Event|4|||
30678632|NCT00839423|58692510|FG001|Overall Study|Adverse Event|3|||
30678633|NCT00839423|58692511|FG002|Overall Study|Adverse Event|7|||
30678634|NCT00839423|58692512|FG003|Overall Study|Adverse Event|16|||
30678635|NCT00839423|58692509|FG000|Overall Study|Lack of Efficacy|6|||
30678636|NCT00839423|58692510|FG001|Overall Study|Lack of Efficacy|6|||
30678637|NCT00839423|58692511|FG002|Overall Study|Lack of Efficacy|3|||
30678638|NCT00839423|58692512|FG003|Overall Study|Lack of Efficacy|2|||
30678639|NCT00839423|58692509|FG000|Overall Study|Non-compliance|0|||
30678640|NCT00839423|58692510|FG001|Overall Study|Non-compliance|0|||
30678641|NCT00839423|58692511|FG002|Overall Study|Non-compliance|0|||
30678642|NCT00839423|58692512|FG003|Overall Study|Non-compliance|1|||
30678643|NCT00839423|58692509|FG000|Overall Study|Protocol Violation|0|||
30678644|NCT00839423|58692510|FG001|Overall Study|Protocol Violation|1|||
30678645|NCT00839423|58692511|FG002|Overall Study|Protocol Violation|2|||
30678646|NCT00839423|58692512|FG003|Overall Study|Protocol Violation|0|||
30678647|NCT00839423|58692509|FG000|Overall Study|Withdrawal of consent|4|||
30678648|NCT00839423|58692510|FG001|Overall Study|Withdrawal of consent|0|||
30678649|NCT00839423|58692511|FG002|Overall Study|Withdrawal of consent|4|||
30678650|NCT00839423|58692512|FG003|Overall Study|Withdrawal of consent|1|||
30678651|NCT00839423|58692509|FG000|Overall Study|Lost to Follow-up|1|||
30678652|NCT00839423|58692510|FG001|Overall Study|Lost to Follow-up|0|||
30678653|NCT00839423|58692511|FG002|Overall Study|Lost to Follow-up|1|||
30678654|NCT00839423|58692512|FG003|Overall Study|Lost to Follow-up|0|||
30678655|NCT00839423|58692509|FG000|Overall Study|Administrative or other reasons|3|||
30678656|NCT00839423|58692510|FG001|Overall Study|Administrative or other reasons|0|||
30678657|NCT00839423|58692511|FG002|Overall Study|Administrative or other reasons|1|||
30678658|NCT00839423|58692512|FG003|Overall Study|Administrative or other reasons|0|||
30678659|NCT00837161|58692522|FG000|Overall Study|refused hysterectomy|2|||
30678660|NCT00859547|58692526|FG000|Overall Study|Lost to Follow-up|1|||
30678661|NCT00859547|58692526|FG000|Overall Study|Parent withdrew consent|1|||
30678662|NCT00859469|58692530|FG000|Overall Study|Adverse Event|2|||
30678663|NCT00859469|58692530|FG000|Overall Study|Lack of Efficacy|9|||
30678664|NCT00859469|58692530|FG000|Overall Study|Withdrawal by Subject|1|||
30678665|NCT00859469|58692530|FG000|Overall Study|Death|16|||
30678666|NCT00859313|58692534|FG000|Overall Study|Lack of Efficacy|2|||
30678667|NCT00859313|58692534|FG000|Overall Study|Adverse Event|1|||
30678668|NCT00859313|58692534|FG000|Overall Study|staff error|1|||
30678669|NCT00771810|58692541|FG000|Overall Study|Adverse Event|3|||
30678670|NCT00771810|58692542|FG001|Overall Study|Adverse Event|0|||
30678671|NCT00771810|58692543|FG002|Overall Study|Adverse Event|2|||
30678672|NCT00771810|58692541|FG000|Overall Study|Lost to Follow-up|0|||
30678673|NCT00771810|58692542|FG001|Overall Study|Lost to Follow-up|0|||
30678674|NCT00771810|58692543|FG002|Overall Study|Lost to Follow-up|1|||
30678675|NCT00771810|58692541|FG000|Overall Study|Physician Decision|1|||
30678676|NCT00771810|58692542|FG001|Overall Study|Physician Decision|2|||
30678677|NCT00771810|58692543|FG002|Overall Study|Physician Decision|2|||
30678678|NCT00771810|58692541|FG000|Overall Study|Protocol Violation|0|||
30678679|NCT00771810|58692542|FG001|Overall Study|Protocol Violation|1|||
30678680|NCT00771810|58692543|FG002|Overall Study|Protocol Violation|1|||
30678681|NCT00771810|58692541|FG000|Overall Study|Withdrawal by Subject|1|||
30678682|NCT00771810|58692542|FG001|Overall Study|Withdrawal by Subject|2|||
30678683|NCT00771810|58692543|FG002|Overall Study|Withdrawal by Subject|0|||
30678684|NCT00771810|58692541|FG000|Overall Study|Other|0|||
30593475|NCT01117987|58605646|FG000|Overall Study|Death|5|||
30593476|NCT01117987|58605647|FG001|Overall Study|Death|10|||
30593477|NCT01117987|58605646|FG000|Overall Study|Withdrawal by Subject|5|||
30593478|NCT01117987|58605647|FG001|Overall Study|Withdrawal by Subject|10|||
30593479|NCT01117987|58605646|FG000|Overall Study|Adverse Event|19|||
30593480|NCT01117987|58605647|FG001|Overall Study|Adverse Event|26|||
30678685|NCT00771810|58692542|FG001|Overall Study|Other|0|||
30678686|NCT00771810|58692543|FG002|Overall Study|Other|1|||
30593481|NCT01117987|58605646|FG000|Overall Study|Administrative problems|25|||
30593482|NCT01117987|58605647|FG001|Overall Study|Administrative problems|22|||
30593483|NCT01117870|58605655|FG000|Overall Study|Inability to place needle|1|||
30593484|NCT01117870|58605656|FG001|Overall Study|Inability to place needle|0|||
30678687|NCT00836927|58692557|FG000|Overall Study|Progressive disease|2|||
30678688|NCT00836927|58692558|FG001|Overall Study|Progressive disease|0|||
30678689|NCT00836927|58692559|FG002|Overall Study|Progressive disease|0|||
30678690|NCT00836927|58692560|FG003|Overall Study|Progressive disease|1|||
30678691|NCT00836927|58692561|FG004|Overall Study|Progressive disease|1|||
30678692|NCT00836927|58692557|FG000|Overall Study|Withdrawal by Subject|1|||
30678693|NCT00836927|58692558|FG001|Overall Study|Withdrawal by Subject|0|||
30782458|NCT02855164|58794533|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
30593485|NCT01117792|58605666|FG000|Overall Study|Death|1|||
30593486|NCT01117792|58605666|FG000|Overall Study|Adverse Event|3|||
30593487|NCT02219490|58605670|FG000|Overall Study|Adverse Event|24|||
30593488|NCT02219490|58605670|FG000|Overall Study|Withdrew consent|96|||
30593489|NCT02219490|58605670|FG000|Overall Study|Lost to Follow-up|126|||
30678694|NCT00836927|58692559|FG002|Overall Study|Withdrawal by Subject|0|||
30593490|NCT02219490|58605670|FG000|Overall Study|COVID-19 infection|2|||
30678695|NCT00836927|58692560|FG003|Overall Study|Withdrawal by Subject|0|||
30678696|NCT00836927|58692561|FG004|Overall Study|Withdrawal by Subject|0|||
30678697|NCT00771030|58692582|FG000|Overall Study|Adverse Event|0|||
30593491|NCT02219490|58605670|FG000|Overall Study|COVID-19 logistical restrictions|33|||
30593492|NCT02219490|58605670|FG000|Overall Study|Other, not specified|57|||
30593493|NCT01117480|58605678|FG000|Overall Study|Protocol Violation|8|||
30593494|NCT01117480|58605678|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
30593495|NCT01117051|58605684|FG000|Overall Study|Withdrawal by Subject|5|||
30593496|NCT01117051|58605685|FG001|Overall Study|Withdrawal by Subject|3|||
30593497|NCT01117051|58605684|FG000|Overall Study|Adverse Event|4|||
30678698|NCT00771030|58692583|FG001|Overall Study|Adverse Event|1|||
30678699|NCT00771030|58692584|FG002|Overall Study|Adverse Event|0|||
30678700|NCT00771030|58692585|FG003|Overall Study|Adverse Event|0|||
30678701|NCT00771030|58692586|FG004|Overall Study|Adverse Event|0|||
30678702|NCT00771030|58692587|FG005|Overall Study|Adverse Event|0|||
30678703|NCT00771030|58692588|FG006|Overall Study|Adverse Event|0|||
30678704|NCT00768300|58692611|FG000|Overall Study|Randomized but not treated|1|||
30678705|NCT00768300|58692612|FG001|Overall Study|Randomized but not treated|1|||
30678706|NCT00768300|58692611|FG000|Overall Study|Adverse Event|10|||
30678707|NCT00768300|58692612|FG001|Overall Study|Adverse Event|2|||
30678708|NCT00768300|58692611|FG000|Overall Study|Protocol Violation|6|||
30678709|NCT00768300|58692612|FG001|Overall Study|Protocol Violation|1|||
30678710|NCT00768300|58692611|FG000|Overall Study|Withdrawal by Subject|13|||
30678711|NCT00768300|58692612|FG001|Overall Study|Withdrawal by Subject|7|||
30678712|NCT00768300|58692611|FG000|Overall Study|Physician Decision|2|||
30678713|NCT00768300|58692612|FG001|Overall Study|Physician Decision|3|||
30678714|NCT00768300|58692611|FG000|Overall Study|Study discontinued by Sponsor|271|||
30678715|NCT00768300|58692612|FG001|Overall Study|Study discontinued by Sponsor|140|||
30678716|NCT00768300|58692611|FG000|Overall Study|Death|21|||
30678717|NCT00768300|58692612|FG001|Overall Study|Death|5|||
30678718|NCT00768300|58692611|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
30678719|NCT00768300|58692612|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
30782459|NCT02855164|58794534|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
30782460|NCT02855164|58794535|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
30782461|NCT02855164|58794536|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
30782462|NCT02855164|58794537|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
30782463|NCT02855164|58794538|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
30782464|NCT02855164|58794531|FG000|Part C (Randomized Set)|Adverse Event|0|||
30782465|NCT02855164|58794532|FG001|Part C (Randomized Set)|Adverse Event|0|||
30782466|NCT02855164|58794533|FG002|Part C (Randomized Set)|Adverse Event|0|||
30782467|NCT02855164|58794534|FG003|Part C (Randomized Set)|Adverse Event|0|||
30782468|NCT02855164|58794535|FG004|Part C (Randomized Set)|Adverse Event|0|||
30782469|NCT02855164|58794536|FG005|Part C (Randomized Set)|Adverse Event|5|||
30782470|NCT02855164|58794537|FG006|Part C (Randomized Set)|Adverse Event|9|||
30782471|NCT02855164|58794538|FG007|Part C (Randomized Set)|Adverse Event|2|||
30782472|NCT02855164|58794531|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
30782473|NCT02855164|58794532|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
30782474|NCT02855164|58794533|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
30782475|NCT02855164|58794534|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
30782476|NCT02855164|58794535|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
30782477|NCT02855164|58794536|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
30782478|NCT02855164|58794537|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
30782479|NCT02855164|58794538|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
30782480|NCT02855164|58794531|FG000|Part C (Randomized Set)|Physician Decision|0|||
30782481|NCT02855164|58794532|FG001|Part C (Randomized Set)|Physician Decision|0|||
30782482|NCT02855164|58794533|FG002|Part C (Randomized Set)|Physician Decision|0|||
30782483|NCT02855164|58794534|FG003|Part C (Randomized Set)|Physician Decision|0|||
30782484|NCT02855164|58794535|FG004|Part C (Randomized Set)|Physician Decision|0|||
30782485|NCT02855164|58794536|FG005|Part C (Randomized Set)|Physician Decision|1|||
30782486|NCT02855164|58794537|FG006|Part C (Randomized Set)|Physician Decision|0|||
30782487|NCT02855164|58794538|FG007|Part C (Randomized Set)|Physician Decision|1|||
30782488|NCT02855164|58794531|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
30593498|NCT01117051|58605685|FG001|Overall Study|Adverse Event|3|||
30593499|NCT01117051|58605684|FG000|Overall Study|Lost to Follow-up|0|||
30593500|NCT01117051|58605685|FG001|Overall Study|Lost to Follow-up|1|||
30678720|NCT00768300|58692611|FG000|Overall Study|Screen failure following randomization|1|||
30678721|NCT00768300|58692612|FG001|Overall Study|Screen failure following randomization|0|||
30782489|NCT02855164|58794532|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
30782490|NCT02855164|58794533|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
30782491|NCT02855164|58794534|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
30782492|NCT02855164|58794535|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
30782493|NCT02855164|58794536|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
30593501|NCT01117051|58605684|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
30678722|NCT00768300|58692611|FG000|Overall Study|Received lung transplant|1|||
30678723|NCT00768300|58692612|FG001|Overall Study|Received lung transplant|1|||
30678724|NCT00768300|58692611|FG000|Overall Study|Lost to Follow-up|0|||
30678725|NCT00768300|58692612|FG001|Overall Study|Lost to Follow-up|1|||
30678726|NCT00768300|58692611|FG000|Overall Study|Began prohibited concomitant medication|0|||
30678727|NCT00768300|58692612|FG001|Overall Study|Began prohibited concomitant medication|1|||
30678728|NCT00768300|58692611|FG000|Overall Study|Treated but never dosed with Study drug|1|||
30678729|NCT00768300|58692612|FG001|Overall Study|Treated but never dosed with Study drug|0|||
30678730|NCT00768300|58692611|FG000|Overall Study|Missing data|1|||
30678731|NCT00768300|58692612|FG001|Overall Study|Missing data|0|||
30678732|NCT00768222|58692620|FG000|Overall Study|Lost to Follow-up|1|||
30678733|NCT00768222|58692621|FG001|Overall Study|Lost to Follow-up|1|||
30678734|NCT00768222|58692620|FG000|Overall Study|Withdrawal by Subject|3|||
30678735|NCT00768222|58692621|FG001|Overall Study|Withdrawal by Subject|1|||
30678736|NCT00768222|58692620|FG000|Overall Study|Protocol Violation|0|||
30678737|NCT00768222|58692621|FG001|Overall Study|Protocol Violation|2|||
30678738|NCT00768144|58692627|FG000|Overall Study|Adverse Event|13|||
30678739|NCT00768144|58692627|FG000|Overall Study|Progressive Disease|21|||
30678740|NCT00768144|58692627|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
30678741|NCT00768144|58692627|FG000|Overall Study|Pt Withdrew Consent|1|||
30678742|NCT00784836|58692631|FG000|Overall Study|Early Study Termination|3|||
30678743|NCT00784758|58692637|FG000|Overall Study|Withdrawal by Subject|3|||
30678744|NCT00784758|58692638|FG001|Overall Study|Withdrawal by Subject|0|||
30678745|NCT00784758|58692637|FG000|Overall Study|Adverse Event|1|||
30678746|NCT00784758|58692638|FG001|Overall Study|Adverse Event|0|||
30678747|NCT00768066|58692649|FG000|Overall Study|Did not receive study product injection.|3|||
30678748|NCT00768066|58692650|FG001|Overall Study|Did not receive study product injection.|3|||
30678749|NCT00768066|58692651|FG002|Overall Study|Did not receive study product injection.|0|||
30678750|NCT00767676|58692659|FG000|Overall Study|Investigator error|54|||
30678751|NCT00767520|58692665|FG000|Overall Study|Participants still on treatment|11|||
30678752|NCT00767520|58692666|FG001|Overall Study|Participants still on treatment|15|||
30678753|NCT00767520|58692665|FG000|Overall Study|Randomized in error and Never treated|0|||
30678754|NCT00767520|58692666|FG001|Overall Study|Randomized in error and Never treated|2|||
30678755|NCT00838565|58692678|FG000|Overall Study|Withdrawal by Subject|0|||
30678756|NCT00838565|58692679|FG001|Overall Study|Withdrawal by Subject|0|||
30678757|NCT00838565|58692680|FG002|Overall Study|Withdrawal by Subject|1|||
30678758|NCT00838565|58692681|FG003|Overall Study|Withdrawal by Subject|0|||
30678759|NCT00838565|58692682|FG004|Overall Study|Withdrawal by Subject|0|||
30678760|NCT00838565|58692683|FG005|Overall Study|Withdrawal by Subject|2|||
30678761|NCT00838565|58692678|FG000|Overall Study|Other|0|||
30678762|NCT00838565|58692679|FG001|Overall Study|Other|2|||
30678763|NCT00838565|58692680|FG002|Overall Study|Other|0|||
30678764|NCT00838565|58692681|FG003|Overall Study|Other|0|||
30678765|NCT00838565|58692682|FG004|Overall Study|Other|0|||
30678766|NCT00838565|58692683|FG005|Overall Study|Other|0|||
30678767|NCT00838565|58692678|FG000|Overall Study|Randomized but not Treated|0|||
30678768|NCT00838565|58692679|FG001|Overall Study|Randomized but not Treated|1|||
30678769|NCT00838565|58692680|FG002|Overall Study|Randomized but not Treated|0|||
30678770|NCT00838565|58692681|FG003|Overall Study|Randomized but not Treated|0|||
30678771|NCT00838565|58692682|FG004|Overall Study|Randomized but not Treated|0|||
30678772|NCT00838565|58692683|FG005|Overall Study|Randomized but not Treated|0|||
30678773|NCT00858845|58692704|FG000|Overall Study|Patient underwent heart transplant.|0|||
30678774|NCT00858845|58692705|FG001|Overall Study|Patient underwent heart transplant.|1|||
30678775|NCT00770562|58692713|FG000|Overall Study|Did not take treatment|1|||
30678776|NCT00770562|58692714|FG001|Overall Study|Did not take treatment|1|||
30678777|NCT00836693|58692723|FG000|Overall Study|Adverse Event|4|||
30678778|NCT00836693|58692724|FG001|Overall Study|Adverse Event|1|||
30678779|NCT00836693|58692723|FG000|Overall Study|Sponsor Decision|0|||
30678780|NCT00836693|58692724|FG001|Overall Study|Sponsor Decision|1|||
30678781|NCT00836693|58692723|FG000|Overall Study|Physician Decision|2|||
30678782|NCT00836693|58692724|FG001|Overall Study|Physician Decision|0|||
30678783|NCT00836693|58692723|FG000|Overall Study|Withdrawal by Subject|9|||
30678784|NCT00836693|58692724|FG001|Overall Study|Withdrawal by Subject|4|||
30678785|NCT00836693|58692723|FG000|Overall Study|Protocol Violation|1|||
30678786|NCT00836693|58692724|FG001|Overall Study|Protocol Violation|0|||
30678787|NCT00836693|58692723|FG000|Overall Study|Lost to Follow-up|1|||
30678788|NCT00836693|58692724|FG001|Overall Study|Lost to Follow-up|0|||
30678789|NCT00770484|58692732|FG000|Overall Study|Withdrawal by Subject|1|||
30856099|NCT03938636|58883958|FG000|Overall Study|Lost to Follow-up|0|||
30856100|NCT03938636|58883959|FG001|Overall Study|Lost to Follow-up|0|||
30678790|NCT00770484|58692733|FG001|Overall Study|Withdrawal by Subject|0|||
30678791|NCT00835679|58692743|FG000|Overall Study|Withdrawal by Subject|1|||
30678792|NCT00835679|58692744|FG001|Overall Study|Withdrawal by Subject|0|||
30678793|NCT00835679|58692745|FG002|Overall Study|Withdrawal by Subject|0|||
30678794|NCT00835679|58692746|FG003|Overall Study|Withdrawal by Subject|0|||
30678795|NCT00766506|58692762|FG000|Overall Study|Use rescue medication after 3 hours|3|||
30678796|NCT00766506|58692763|FG001|Overall Study|Use rescue medication after 3 hours|0|||
30678797|NCT00766506|58692762|FG000|Overall Study|Other|2|||
30678798|NCT00766506|58692763|FG001|Overall Study|Other|2|||
30678799|NCT00770328|58692771|FG000|Overall Study|Adverse Event|11|||
30678800|NCT00770328|58692772|FG001|Overall Study|Adverse Event|2|||
30678801|NCT00770328|58692771|FG000|Overall Study|Lost to Follow-up|2|||
30678802|NCT00770328|58692772|FG001|Overall Study|Lost to Follow-up|2|||
30678803|NCT00766038|58692780|FG000|Overall Study|Lost to Follow-up|15|||
30678804|NCT00766038|58692781|FG001|Overall Study|Lost to Follow-up|14|||
30678805|NCT00765882|58692792|FG000|Overall Study|Adverse Event|10|||
30678806|NCT00765882|58692793|FG001|Overall Study|Adverse Event|21|||
30678807|NCT00765882|58692794|FG002|Overall Study|Adverse Event|20|||
30678808|NCT00765882|58692792|FG000|Overall Study|Lack of Efficacy|4|||
30678809|NCT00765882|58692793|FG001|Overall Study|Lack of Efficacy|0|||
30678810|NCT00765882|58692794|FG002|Overall Study|Lack of Efficacy|1|||
30678811|NCT00765882|58692792|FG000|Overall Study|Protocol Violation|4|||
30678812|NCT00765882|58692793|FG001|Overall Study|Protocol Violation|3|||
30678813|NCT00765882|58692794|FG002|Overall Study|Protocol Violation|1|||
30678814|NCT00765882|58692792|FG000|Overall Study|Withdrawal by Subject|2|||
30678815|NCT00765882|58692793|FG001|Overall Study|Withdrawal by Subject|6|||
30678816|NCT00765882|58692794|FG002|Overall Study|Withdrawal by Subject|6|||
30678817|NCT00765882|58692792|FG000|Overall Study|Lost to Follow-up|1|||
30678818|NCT00765882|58692793|FG001|Overall Study|Lost to Follow-up|9|||
30678819|NCT00765882|58692794|FG002|Overall Study|Lost to Follow-up|6|||
30678820|NCT00765882|58692792|FG000|Overall Study|Other Reason|3|||
30678821|NCT00765882|58692793|FG001|Overall Study|Other Reason|1|||
30678822|NCT00765882|58692794|FG002|Overall Study|Other Reason|2|||
30678823|NCT00769860|58692804|FG000|Overall Study|Withdrawal by Subject|2|||
30678824|NCT00769860|58692805|FG001|Overall Study|Withdrawal by Subject|0|||
30678825|NCT00858143|58692811|FG000|Overall Study|Adverse Event|16|||
30678826|NCT00858143|58692811|FG000|Overall Study|Lack of Efficacy|4|||
30678827|NCT00858143|58692811|FG000|Overall Study|Death|7|||
30678828|NCT00858143|58692811|FG000|Overall Study|Other|23|||
30593502|NCT01117051|58605685|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
30593503|NCT01117051|58605684|FG000|Overall Study|Sponsor's decision|3|||
30593504|NCT01117051|58605685|FG001|Overall Study|Sponsor's decision|1|||
30593505|NCT01117051|58605684|FG000|Overall Study|Surgical procedure|0|||
30593506|NCT01117051|58605685|FG001|Overall Study|Surgical procedure|1|||
30593507|NCT01117051|58605684|FG000|Overall Study|Randomized by mistake|0|||
30593508|NCT01117051|58605685|FG001|Overall Study|Randomized by mistake|1|||
30593509|NCT01117051|58605684|FG000|Overall Study|Convenience issue|1|||
30593510|NCT01117051|58605685|FG001|Overall Study|Convenience issue|0|||
30593511|NCT02211417|58605694|FG000|Overall Study|Withdrawal by Subject|11|||
30593512|NCT02211417|58605695|FG001|Overall Study|Withdrawal by Subject|8|||
30593513|NCT02211417|58605694|FG000|Overall Study|Protocol Violation|1|||
30593514|NCT02211417|58605695|FG001|Overall Study|Protocol Violation|0|||
30593515|NCT02211417|58605694|FG000|Overall Study|Pregnancy|0|||
30593516|NCT02211417|58605695|FG001|Overall Study|Pregnancy|1|||
30593517|NCT02211417|58605694|FG000|Overall Study|Lost to Follow-up|2|||
30593518|NCT02211417|58605695|FG001|Overall Study|Lost to Follow-up|3|||
30593519|NCT02211417|58605694|FG000|Overall Study|Adverse Event|1|||
30593520|NCT02211417|58605695|FG001|Overall Study|Adverse Event|4|||
30593521|NCT01117012|58605708|FG000|Overall Study|Adverse Event|0|||
30593522|NCT01117012|58605709|FG001|Overall Study|Adverse Event|1|||
30593523|NCT01117012|58605708|FG000|Overall Study|Death|1|||
30593524|NCT01117012|58605709|FG001|Overall Study|Death|1|||
30593525|NCT01117012|58605708|FG000|Overall Study|Withdrawal by Subject|3|||
30593526|NCT01117012|58605709|FG001|Overall Study|Withdrawal by Subject|0|||
30593527|NCT01117012|58605708|FG000|Overall Study|Undefined|4|||
30678829|NCT00828113|58692817|FG000|Overall Study|Withdrawal by Subject|27|||
30678830|NCT00828113|58692818|FG001|Overall Study|Withdrawal by Subject|26|||
30678831|NCT00828113|58692817|FG000|Overall Study|Lost to Follow-up|3|||
30678832|NCT00828113|58692818|FG001|Overall Study|Lost to Follow-up|5|||
30678833|NCT00769704|58692826|FG000|Overall Study|Lost to Follow-up|3|||
30678834|NCT00769704|58692827|FG001|Overall Study|Lost to Follow-up|2|||
30593528|NCT01117012|58605709|FG001|Overall Study|Undefined|3|||
30678835|NCT00769704|58692826|FG000|Overall Study|Death|95|||
30678836|NCT00769704|58692827|FG001|Overall Study|Death|190|||
30678837|NCT00769704|58692826|FG000|Overall Study|Withdrawal by Subject|12|||
30678838|NCT00769704|58692827|FG001|Overall Study|Withdrawal by Subject|5|||
30678839|NCT00769704|58692826|FG000|Overall Study|Other|1|||
30678840|NCT00769704|58692827|FG001|Overall Study|Other|2|||
30856101|NCT03938636|58883960|FG002|Overall Study|Lost to Follow-up|1|||
30593529|NCT01116739|58605717|FG000|Overall Study|Child had 2 years of HS|110|||
30593530|NCT01116739|58605718|FG001|Overall Study|Child had 2 years of HS|128|||
30593531|NCT01116739|58605717|FG000|Overall Study|Withdrawal by Subject|6|||
30593532|NCT01116739|58605718|FG001|Overall Study|Withdrawal by Subject|0|||
30593533|NCT01116739|58605717|FG000|Overall Study|child too young|2|||
30593534|NCT01116739|58605718|FG001|Overall Study|child too young|6|||
30678841|NCT00818753|58692837|FG000|Overall Study|Protocol Violation|1|||
30678842|NCT00818753|58692838|FG001|Overall Study|Protocol Violation|0|||
30678843|NCT00818753|58692839|FG002|Overall Study|Protocol Violation|0|||
30678844|NCT00818753|58692837|FG000|Overall Study|Other reason (not specified)|0|||
30678845|NCT00818753|58692838|FG001|Overall Study|Other reason (not specified)|0|||
30593535|NCT01116739|58605717|FG000|Overall Study|child not enrolled in head start|10|||
30593536|NCT01116739|58605718|FG001|Overall Study|child not enrolled in head start|2|||
30593537|NCT01116739|58605717|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
30593538|NCT01116739|58605718|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
30593539|NCT01116544|58605726|FG000|Overall Study|Protocol Violation|1|||
30593540|NCT01116544|58605727|FG001|Overall Study|Protocol Violation|0|||
30593541|NCT01116544|58605726|FG000|Overall Study|Withdrawal by Subject|1|||
30593542|NCT01116544|58605727|FG001|Overall Study|Withdrawal by Subject|1|||
30678846|NCT00818753|58692839|FG002|Overall Study|Other reason (not specified)|1|||
30678847|NCT00818753|58692837|FG000|Overall Study|Randomised and not treated|2|||
30678848|NCT00818753|58692838|FG001|Overall Study|Randomised and not treated|0|||
30678849|NCT00818753|58692839|FG002|Overall Study|Randomised and not treated|0|||
30678850|NCT00765726|58692847|FG000|Overall Study|Withdrawal by Subject|1|||
30678851|NCT00765726|58692847|FG000|Overall Study|Discontinuation of study by sponsor|8|||
30678852|NCT00765336|58692853|FG000|Overall Study|Protocol Violation|4|||
30678853|NCT00765336|58692854|FG001|Overall Study|Protocol Violation|2|||
30678854|NCT00765336|58692853|FG000|Overall Study|Withdrawal by Subject|6|||
30678855|NCT00765336|58692854|FG001|Overall Study|Withdrawal by Subject|4|||
30678856|NCT00765336|58692853|FG000|Overall Study|Lost to Follow-up|7|||
30678857|NCT00765336|58692854|FG001|Overall Study|Lost to Follow-up|9|||
30678858|NCT00765336|58692853|FG000|Overall Study|Adverse Event|2|||
30678859|NCT00765336|58692854|FG001|Overall Study|Adverse Event|1|||
30678860|NCT00818519|58692862|FG000|Overall Study|Adverse Event|2|||
30678861|NCT00818519|58692863|FG001|Overall Study|Adverse Event|2|||
30678862|NCT00818519|58692862|FG000|Overall Study|Lost to Follow-up|4|||
30678863|NCT00818519|58692863|FG001|Overall Study|Lost to Follow-up|6|||
30678864|NCT00818519|58692862|FG000|Overall Study|Protocol Violation|2|||
30678865|NCT00818519|58692863|FG001|Overall Study|Protocol Violation|1|||
30678866|NCT00818519|58692862|FG000|Overall Study|Pregnancy|0|||
30678867|NCT00818519|58692863|FG001|Overall Study|Pregnancy|1|||
30678868|NCT00818519|58692862|FG000|Overall Study|Withdrawal by Subject|4|||
30678869|NCT00818519|58692863|FG001|Overall Study|Withdrawal by Subject|9|||
30678870|NCT00818519|58692862|FG000|Overall Study|participant recovered completely|1|||
30678871|NCT00818519|58692863|FG001|Overall Study|participant recovered completely|0|||
30678872|NCT00818519|58692862|FG000|Overall Study|participant will leave for long tme|1|||
30678873|NCT00818519|58692863|FG001|Overall Study|participant will leave for long tme|0|||
30678874|NCT00827567|58692869|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
30678875|NCT00765102|58692873|FG000|Overall Study|Progressive disease|18|||
30678876|NCT00765102|58692873|FG000|Overall Study|Adverse Event|6|||
30678877|NCT00765102|58692873|FG000|Overall Study|Physician Decision|4|||
30678878|NCT00765102|58692873|FG000|Overall Study|Withdrawal by Subject|2|||
30678879|NCT00765102|58692873|FG000|Overall Study|Protocol Violation|1|||
30678880|NCT00809354|58692889|FG000|Overall Study|Adverse Event|32|||
30678881|NCT00809354|58692890|FG001|Overall Study|Adverse Event|45|||
30678882|NCT00809354|58692891|FG002|Overall Study|Adverse Event|37|||
30678883|NCT00809354|58692892|FG003|Overall Study|Adverse Event|53|||
30678884|NCT00809354|58692893|FG004|Overall Study|Adverse Event|26|||
30678885|NCT00809354|58692894|FG005|Overall Study|Adverse Event|33|||
30678886|NCT00809354|58692895|FG006|Overall Study|Adverse Event|44|||
30678887|NCT00809354|58692896|FG007|Overall Study|Adverse Event|40|||
30593543|NCT01116427|58605735|FG000|Core Phase|Adverse Event|0|||
30593544|NCT01116427|58605736|FG001|Core Phase|Adverse Event|1|||
30593545|NCT01116427|58605735|FG000|Core Phase|Lost to Follow-up|1|||
30678888|NCT00809354|58692897|FG008|Overall Study|Adverse Event|46|||
30678889|NCT00809354|58692898|FG009|Overall Study|Adverse Event|26|||
30782494|NCT02855164|58794537|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
30782495|NCT02855164|58794538|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
30782496|NCT01002742|58794578|FG000|Overall Study|Determined to be ineligible|0|||
30782497|NCT01002742|58794579|FG001|Overall Study|Determined to be ineligible|1|||
30782498|NCT02853760|58794585|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
30782499|NCT02853760|58794586|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
30782500|NCT02853760|58794587|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
30782501|NCT02853760|58794588|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
30782502|NCT02853760|58794589|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
30782503|NCT02853760|58794590|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
30782504|NCT02852434|58794600|FG000|Overall Study|Withdrawal by Subject|0|||
30782505|NCT02852434|58794601|FG001|Overall Study|Withdrawal by Subject|1|||
30782506|NCT02852434|58794600|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
30782507|NCT02852434|58794601|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
30782508|NCT02850016|58794609|FG000|Overall Study|Withdrawal by Subject|1|||
30782509|NCT02850016|58794610|FG001|Overall Study|Withdrawal by Subject|2|||
30593546|NCT01116427|58605736|FG001|Core Phase|Lost to Follow-up|0|||
30678890|NCT00809354|58692889|FG000|Overall Study|Lack of Efficacy|23|||
30678891|NCT00809354|58692890|FG001|Overall Study|Lack of Efficacy|23|||
30678892|NCT00809354|58692891|FG002|Overall Study|Lack of Efficacy|22|||
30856102|NCT03836716|58883985|FG000|Overall Study|Adverse Event|3|||
30856103|NCT03836716|58883985|FG000|Overall Study|Death|22|||
30856104|NCT03836716|58883985|FG000|Overall Study|Withdrawal by Subject|8|||
30856105|NCT03836716|58883985|FG000|Overall Study|Study terminated by sponsor|87|||
30856106|NCT03686215|58883992|FG000|Overall Study|Adverse Event|0|||
30856107|NCT03686215|58883993|FG001|Overall Study|Adverse Event|0|||
30593547|NCT01116427|58605735|FG000|Core Phase|Withdrawal by Subject|3|||
30593548|NCT01116427|58605736|FG001|Core Phase|Withdrawal by Subject|0|||
30593549|NCT01116427|58605735|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
30593550|NCT01116427|58605736|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
30593551|NCT01116427|58605735|FG000|Extension Phase|Adverse Event|1|||
30593552|NCT01116427|58605736|FG001|Extension Phase|Adverse Event|1|||
30593553|NCT01116427|58605735|FG000|Extension Phase|Lost to Follow-up|2|||
30593554|NCT01116427|58605736|FG001|Extension Phase|Lost to Follow-up|0|||
30593555|NCT01116427|58605735|FG000|Extension Phase|Withdrawal by Subject|5|||
30593556|NCT01116427|58605736|FG001|Extension Phase|Withdrawal by Subject|1|||
30593557|NCT01116427|58605735|FG000|Extension Phase|Not using appropriate birth control|1|||
30593558|NCT01116427|58605736|FG001|Extension Phase|Not using appropriate birth control|0|||
30593559|NCT01116232|58605746|FG000|Overall Study|Progressive diease|4|||
30593560|NCT01115998|58605755|FG000|Overall Study|Lost to Follow-up|6|||
30593561|NCT01115998|58605756|FG001|Overall Study|Lost to Follow-up|6|||
30593562|NCT01205230|58605764|FG000|Overall Study|Adverse Event|4|||
30593563|NCT01205230|58605765|FG001|Overall Study|Adverse Event|0|||
30593564|NCT01205230|58605764|FG000|Overall Study|Physician Decision|1|||
30593565|NCT01205230|58605765|FG001|Overall Study|Physician Decision|0|||
30593566|NCT01205152|58605776|FG000|Overall Study|Death|1|||
30593567|NCT01205035|58605784|FG000|Overall Study|Withdrawal by Subject|1|||
30593568|NCT01205035|58605785|FG001|Overall Study|Withdrawal by Subject|0|||
30593569|NCT01205035|58605784|FG000|Overall Study|Physician Decision|1|||
30593570|NCT01205035|58605785|FG001|Overall Study|Physician Decision|0|||
30593571|NCT01204918|58605794|FG000|Overall Study|Withdrawal by Subject|4|||
30593572|NCT01204918|58605795|FG001|Overall Study|Withdrawal by Subject|10|||
30593573|NCT01204918|58605796|FG002|Overall Study|Withdrawal by Subject|5|||
30593574|NCT01204294|58605811|FG000|Overall Study|Adverse Event|2|||
30593575|NCT01204294|58605812|FG001|Overall Study|Adverse Event|6|||
30593576|NCT01204294|58605813|FG002|Overall Study|Adverse Event|0|||
30593577|NCT01204294|58605814|FG003|Overall Study|Adverse Event|7|||
30593578|NCT01204294|58605815|FG004|Overall Study|Adverse Event|1|||
30782510|NCT02849704|58794618|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
30782511|NCT02849704|58794619|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
30782512|NCT02849704|58794618|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
30782513|NCT02849704|58794619|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
30782514|NCT02849704|58794618|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
30782515|NCT02849704|58794619|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
30782516|NCT03347396|58794640|FG000|Part A (26 Weeks)|Adverse Event|1|||
30782517|NCT03347396|58794641|FG001|Part A (26 Weeks)|Adverse Event|0|||
30782518|NCT03347396|58794640|FG000|Part A (26 Weeks)|Death|0|||
30782519|NCT03347396|58794641|FG001|Part A (26 Weeks)|Death|1|||
30782520|NCT03347396|58794640|FG000|Part B (149 Weeks)|Adverse Event|1|||
30782521|NCT03347396|58794641|FG001|Part B (149 Weeks)|Adverse Event|1|||
30782522|NCT03347396|58794640|FG000|Part B (149 Weeks)|Death|1|||
30782523|NCT03347396|58794641|FG001|Part B (149 Weeks)|Death|0|||
30782524|NCT03335150|58794652|FG000|Overall Study|Withdrawal by Subject|10|||
30782525|NCT03335150|58794653|FG001|Overall Study|Withdrawal by Subject|4|||
30782526|NCT03335150|58794652|FG000|Overall Study|Adverse Event|0|||
30782527|NCT03335150|58794653|FG001|Overall Study|Adverse Event|1|||
30782528|NCT03334448|58794659|FG000|Washout|Personal Reason|0|||
30782529|NCT03334448|58794660|FG001|Washout|Personal Reason|1|||
30782530|NCT03334448|58794661|FG002|Washout|Personal Reason|0|||
30856108|NCT03686215|58883994|FG002|Overall Study|Adverse Event|7|||
30856109|NCT03686215|58883992|FG000|Overall Study|Physician Decision|0|||
30856110|NCT03686215|58883993|FG001|Overall Study|Physician Decision|0|||
30593579|NCT01204294|58605816|FG005|Overall Study|Adverse Event|4|||
30593580|NCT01204294|58605817|FG006|Overall Study|Adverse Event|0|||
30593581|NCT01204294|58605811|FG000|Overall Study|Protocol Violation|1|||
30593582|NCT01204294|58605812|FG001|Overall Study|Protocol Violation|0|||
30782531|NCT03334448|58794662|FG003|Washout|Personal Reason|0|||
30782532|NCT03334448|58794659|FG000|Washout|Protocol Violation|0|||
30782533|NCT03334448|58794660|FG001|Washout|Protocol Violation|0|||
30782534|NCT03334448|58794661|FG002|Washout|Protocol Violation|0|||
30593583|NCT01204294|58605813|FG002|Overall Study|Protocol Violation|2|||
30593584|NCT01204294|58605814|FG003|Overall Study|Protocol Violation|1|||
30593585|NCT01204294|58605815|FG004|Overall Study|Protocol Violation|0|||
30593586|NCT01204294|58605816|FG005|Overall Study|Protocol Violation|0|||
30593587|NCT01204294|58605817|FG006|Overall Study|Protocol Violation|0|||
30593588|NCT01204294|58605811|FG000|Overall Study|Withdrawal by Subject|0|||
30593589|NCT01204294|58605812|FG001|Overall Study|Withdrawal by Subject|2|||
30856111|NCT03686215|58883994|FG002|Overall Study|Physician Decision|1|||
30593590|NCT01204294|58605813|FG002|Overall Study|Withdrawal by Subject|2|||
30593591|NCT01204294|58605814|FG003|Overall Study|Withdrawal by Subject|1|||
30593592|NCT01204294|58605815|FG004|Overall Study|Withdrawal by Subject|1|||
30593593|NCT01204294|58605816|FG005|Overall Study|Withdrawal by Subject|1|||
30593594|NCT01204294|58605817|FG006|Overall Study|Withdrawal by Subject|2|||
30593595|NCT01204294|58605811|FG000|Overall Study|Lack of Efficacy|0|||
30593596|NCT01204294|58605812|FG001|Overall Study|Lack of Efficacy|0|||
30593597|NCT01204294|58605813|FG002|Overall Study|Lack of Efficacy|0|||
30593598|NCT01204294|58605814|FG003|Overall Study|Lack of Efficacy|2|||
30593599|NCT01204294|58605815|FG004|Overall Study|Lack of Efficacy|0|||
30593600|NCT01204294|58605816|FG005|Overall Study|Lack of Efficacy|0|||
30593601|NCT01204294|58605817|FG006|Overall Study|Lack of Efficacy|0|||
30593602|NCT01204294|58605811|FG000|Overall Study|Other (house moving)|0|||
30593603|NCT01204294|58605812|FG001|Overall Study|Other (house moving)|0|||
30593604|NCT01204294|58605813|FG002|Overall Study|Other (house moving)|1|||
30593605|NCT01204294|58605814|FG003|Overall Study|Other (house moving)|0|||
30593606|NCT01204294|58605815|FG004|Overall Study|Other (house moving)|0|||
30593607|NCT01204294|58605816|FG005|Overall Study|Other (house moving)|0|||
30593608|NCT01204294|58605817|FG006|Overall Study|Other (house moving)|0|||
30593609|NCT01182181|58605835|FG000|First Intervention|Adverse Event|1|||
30593610|NCT01182181|58605836|FG001|First Intervention|Adverse Event|0|||
30593611|NCT01182181|58605835|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
30593612|NCT01182181|58605836|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
30593613|NCT01181986|58605844|FG000|Phase 1|Lost to Follow-up|0|||
30593614|NCT01181986|58605845|FG001|Phase 1|Lost to Follow-up|1|||
30593615|NCT01181986|58605846|FG002|Phase 1|Lost to Follow-up|1|||
30593616|NCT01181986|58605844|FG000|Phase 1|Adverse Event|0|||
30593617|NCT01181986|58605845|FG001|Phase 1|Adverse Event|0|||
30593618|NCT01181986|58605846|FG002|Phase 1|Adverse Event|1|||
30593619|NCT01181986|58605844|FG000|Phase 1|Protocol Violation|1|||
30593620|NCT01181986|58605845|FG001|Phase 1|Protocol Violation|0|||
30593621|NCT01181986|58605846|FG002|Phase 1|Protocol Violation|0|||
30593622|NCT01181986|58605844|FG000|Phase 2|Adverse Event|0|||
30593623|NCT01181986|58605845|FG001|Phase 2|Adverse Event|3|||
30593624|NCT01181986|58605846|FG002|Phase 2|Adverse Event|0|||
30593625|NCT01181986|58605844|FG000|Phase 2|Medical condition|0|||
30593626|NCT01181986|58605845|FG001|Phase 2|Medical condition|1|||
30593627|NCT01181986|58605846|FG002|Phase 2|Medical condition|0|||
30593628|NCT01181167|58605862|FG000|Overall Study|Adverse Event|11|||
30593629|NCT01181167|58605863|FG001|Overall Study|Adverse Event|21|||
30593630|NCT01181167|58605862|FG000|Overall Study|Lost to Follow-up|1|||
30593631|NCT01181167|58605863|FG001|Overall Study|Lost to Follow-up|0|||
30593632|NCT01181167|58605862|FG000|Overall Study|Physician Decision|2|||
30593633|NCT01181167|58605863|FG001|Overall Study|Physician Decision|3|||
30593634|NCT01181167|58605862|FG000|Overall Study|Protocol Violation|3|||
30593635|NCT01181167|58605863|FG001|Overall Study|Protocol Violation|0|||
30593636|NCT01181167|58605862|FG000|Overall Study|Withdrawal by Subject|6|||
30593637|NCT01181167|58605863|FG001|Overall Study|Withdrawal by Subject|8|||
30593638|NCT01181128|58605872|FG000|Overall Study|Withdrawal by Subject|2|||
30593639|NCT01181128|58605873|FG001|Overall Study|Withdrawal by Subject|2|||
30593640|NCT01181128|58605874|FG002|Overall Study|Withdrawal by Subject|0|||
30593641|NCT01181128|58605872|FG000|Overall Study|Death|1|||
30593642|NCT01181128|58605873|FG001|Overall Study|Death|0|||
30593643|NCT01181128|58605874|FG002|Overall Study|Death|0|||
30593644|NCT01181128|58605872|FG000|Overall Study|Physician Decision|2|||
30593645|NCT01181128|58605873|FG001|Overall Study|Physician Decision|0|||
30593646|NCT01181128|58605874|FG002|Overall Study|Physician Decision|0|||
30593647|NCT01181128|58605872|FG000|Overall Study|Adverse Event|0|||
30593648|NCT01181128|58605873|FG001|Overall Study|Adverse Event|2|||
30593649|NCT01181128|58605874|FG002|Overall Study|Adverse Event|0|||
30593650|NCT01181128|58605872|FG000|Overall Study|Other|1|||
30593651|NCT01181128|58605873|FG001|Overall Study|Other|1|||
30593652|NCT01181128|58605874|FG002|Overall Study|Other|1|||
30593653|NCT01203787|58605896|FG000|Overall Study|Death|12|||
30593654|NCT01203787|58605897|FG001|Overall Study|Death|10|||
30593655|NCT01203787|58605896|FG000|Overall Study|Withdrawal by Subject|6|||
30593656|NCT01203787|58605897|FG001|Overall Study|Withdrawal by Subject|2|||
30593657|NCT01203787|58605896|FG000|Overall Study|Lost to Follow-up|2|||
30593658|NCT01203787|58605897|FG001|Overall Study|Lost to Follow-up|0|||
30593659|NCT01203787|58605896|FG000|Overall Study|Adverse Event|11|||
30593660|NCT01203787|58605897|FG001|Overall Study|Adverse Event|15|||
30593661|NCT01181011|58605905|FG000|Overall Study|Adverse Event|2|||
30593662|NCT01181011|58605905|FG000|Overall Study|Lost to Follow-up|1|||
30593663|NCT01180777|58605914|FG000|Overall Study|Protocol Violation|6|||
30593664|NCT01180777|58605914|FG000|Overall Study|Poor lens fit|4|||
30593665|NCT01180777|58605914|FG000|Overall Study|Lost to Follow-up|1|||
30593666|NCT01180777|58605914|FG000|Overall Study|Adverse Event|1|||
30593667|NCT01648023|58605922|FG000|Overall Study|Screen Fail Post Randomization|1|||
30593668|NCT01648023|58605923|FG001|Overall Study|Screen Fail Post Randomization|2|||
30593669|NCT02756208|58605937|FG000|Overall Study|Withdrawal by Subject|1|||
30593670|NCT02756208|58605938|FG001|Overall Study|Withdrawal by Subject|0|||
30593671|NCT02756208|58605939|FG002|Overall Study|Withdrawal by Subject|1|||
30593672|NCT02756208|58605940|FG003|Overall Study|Withdrawal by Subject|3|||
30593673|NCT02756208|58605937|FG000|Overall Study|Lost to Follow-up|3|||
30593674|NCT02756208|58605938|FG001|Overall Study|Lost to Follow-up|1|||
30593675|NCT02756208|58605939|FG002|Overall Study|Lost to Follow-up|1|||
30593676|NCT02756208|58605940|FG003|Overall Study|Lost to Follow-up|1|||
30593677|NCT02756208|58605937|FG000|Overall Study|Physician Decision|1|||
30593678|NCT02756208|58605938|FG001|Overall Study|Physician Decision|0|||
30593679|NCT02756208|58605939|FG002|Overall Study|Physician Decision|0|||
30593680|NCT02756208|58605940|FG003|Overall Study|Physician Decision|0|||
30593681|NCT02756208|58605937|FG000|Overall Study|Protocol Violation|0|||
30593682|NCT02756208|58605938|FG001|Overall Study|Protocol Violation|1|||
30593683|NCT02756208|58605939|FG002|Overall Study|Protocol Violation|0|||
30593684|NCT02756208|58605940|FG003|Overall Study|Protocol Violation|0|||
30593685|NCT02756013|58605950|FG000|Overall Study|Adverse Event|1|||
30593686|NCT02756013|58605950|FG000|Overall Study|Hypersensitivity|1|||
30593687|NCT01202773|58605957|FG000|Overall Study|Adverse Event|4|||
30593688|NCT01202773|58605958|FG001|Overall Study|Adverse Event|5|||
30593689|NCT01202773|58605959|FG002|Overall Study|Adverse Event|5|||
30593690|NCT01202773|58605957|FG000|Overall Study|Lack of Efficacy|5|||
30593691|NCT01202773|58605958|FG001|Overall Study|Lack of Efficacy|4|||
30593692|NCT01202773|58605959|FG002|Overall Study|Lack of Efficacy|9|||
30593693|NCT01202773|58605957|FG000|Overall Study|Entry Criteria Not Met|2|||
30593694|NCT01202773|58605958|FG001|Overall Study|Entry Criteria Not Met|0|||
30593695|NCT01202773|58605959|FG002|Overall Study|Entry Criteria Not Met|1|||
30593696|NCT01202773|58605957|FG000|Overall Study|Lost to Follow-up|1|||
30593697|NCT01202773|58605958|FG001|Overall Study|Lost to Follow-up|2|||
30593698|NCT01202773|58605959|FG002|Overall Study|Lost to Follow-up|2|||
30593699|NCT01202773|58605957|FG000|Overall Study|Withdrawal by Subject|13|||
30593700|NCT01202773|58605958|FG001|Overall Study|Withdrawal by Subject|6|||
30593701|NCT01202773|58605959|FG002|Overall Study|Withdrawal by Subject|5|||
30593702|NCT01202773|58605957|FG000|Overall Study|Physician Decision|2|||
30593703|NCT01202773|58605958|FG001|Overall Study|Physician Decision|0|||
30593704|NCT01202773|58605959|FG002|Overall Study|Physician Decision|0|||
30593705|NCT01202773|58605957|FG000|Overall Study|Protocol Violation|11|||
30593706|NCT01202773|58605958|FG001|Overall Study|Protocol Violation|6|||
30593707|NCT01202773|58605959|FG002|Overall Study|Protocol Violation|10|||
30593708|NCT01202773|58605957|FG000|Overall Study|Sponsor Decision|19|||
30593709|NCT01202773|58605958|FG001|Overall Study|Sponsor Decision|20|||
30593710|NCT01202773|58605959|FG002|Overall Study|Sponsor Decision|23|||
30593711|NCT01180660|58605979|FG000|Overall Study|Changed to open surgery|1|||
30593712|NCT01180660|58605980|FG001|Overall Study|Changed to open surgery|0|||
30593713|NCT01202227|58605986|FG000|Overall Study|Adverse Event|16|||
30593714|NCT01202227|58605986|FG000|Overall Study|Withdrawal by Subject|2|||
30593715|NCT01202227|58605986|FG000|Overall Study|Lack of Efficacy|1|||
30593716|NCT01202188|58605995|FG000|Overall Study|Protocol deviation|14|||
30593717|NCT01202188|58605996|FG001|Overall Study|Protocol deviation|8|||
30593718|NCT01202188|58605997|FG002|Overall Study|Protocol deviation|12|||
30593719|NCT01202188|58605998|FG003|Overall Study|Protocol deviation|10|||
30593720|NCT01202188|58605999|FG004|Overall Study|Protocol deviation|11|||
30593721|NCT01202188|58605995|FG000|Overall Study|Subject withdrew consent|12|||
30593722|NCT01202188|58605996|FG001|Overall Study|Subject withdrew consent|13|||
30593723|NCT01202188|58605997|FG002|Overall Study|Subject withdrew consent|22|||
30593724|NCT01202188|58605998|FG003|Overall Study|Subject withdrew consent|11|||
30593725|NCT01202188|58605999|FG004|Overall Study|Subject withdrew consent|13|||
30593726|NCT01202188|58605995|FG000|Overall Study|Adverse Event|5|||
30593727|NCT01202188|58605996|FG001|Overall Study|Adverse Event|23|||
30593728|NCT01202188|58605997|FG002|Overall Study|Adverse Event|13|||
30593729|NCT01202188|58605998|FG003|Overall Study|Adverse Event|10|||
30593730|NCT01202188|58605999|FG004|Overall Study|Adverse Event|10|||
30593731|NCT01202188|58605995|FG000|Overall Study|Administrative problems|3|||
30593732|NCT01202188|58605996|FG001|Overall Study|Administrative problems|2|||
30593733|NCT01202188|58605997|FG002|Overall Study|Administrative problems|1|||
30593734|NCT01202188|58605998|FG003|Overall Study|Administrative problems|1|||
30593735|NCT01202188|58605999|FG004|Overall Study|Administrative problems|2|||
30593736|NCT01202188|58605995|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30593737|NCT01202188|58605996|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
30593738|NCT01202188|58605997|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
30593739|NCT01202188|58605998|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
30593740|NCT01202188|58605999|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
30593741|NCT01202188|58605995|FG000|Overall Study|Lost to Follow-up|1|||
30593742|NCT01202188|58605996|FG001|Overall Study|Lost to Follow-up|1|||
30593743|NCT01202188|58605997|FG002|Overall Study|Lost to Follow-up|0|||
30593744|NCT01202188|58605998|FG003|Overall Study|Lost to Follow-up|4|||
30593745|NCT01202188|58605999|FG004|Overall Study|Lost to Follow-up|1|||
30593746|NCT01202188|58605995|FG000|Overall Study|Death|1|||
30593747|NCT01202188|58605996|FG001|Overall Study|Death|1|||
30593748|NCT01202188|58605997|FG002|Overall Study|Death|1|||
30593749|NCT01202188|58605998|FG003|Overall Study|Death|1|||
30593750|NCT01202188|58605999|FG004|Overall Study|Death|0|||
30593751|NCT01202188|58605995|FG000|Overall Study|Abnormal test procedure result (s)|0|||
30593752|NCT01202188|58605996|FG001|Overall Study|Abnormal test procedure result (s)|0|||
30593753|NCT01202188|58605997|FG002|Overall Study|Abnormal test procedure result (s)|2|||
30593754|NCT01202188|58605998|FG003|Overall Study|Abnormal test procedure result (s)|0|||
30593755|NCT01202188|58605999|FG004|Overall Study|Abnormal test procedure result (s)|0|||
30593756|NCT01201915|58606020|FG000|Overall Study|Adverse Event|2|||
30593757|NCT01201915|58606021|FG001|Overall Study|Adverse Event|1|||
30593758|NCT01201915|58606022|FG002|Overall Study|Adverse Event|1|||
30593759|NCT01201915|58606020|FG000|Overall Study|Lost to Follow-up|0|||
30593760|NCT01201915|58606021|FG001|Overall Study|Lost to Follow-up|4|||
30593761|NCT01201915|58606022|FG002|Overall Study|Lost to Follow-up|0|||
30593762|NCT01201915|58606020|FG000|Overall Study|Physician Decision|3|||
30593763|NCT01201915|58606021|FG001|Overall Study|Physician Decision|0|||
30593764|NCT01201915|58606022|FG002|Overall Study|Physician Decision|0|||
30593765|NCT01201915|58606020|FG000|Overall Study|Subject Decision|3|||
30593766|NCT01201915|58606021|FG001|Overall Study|Subject Decision|3|||
30593767|NCT01201915|58606022|FG002|Overall Study|Subject Decision|5|||
30593768|NCT01201915|58606020|FG000|Overall Study|Target Lesion Progression|0|||
30593769|NCT01201915|58606021|FG001|Overall Study|Target Lesion Progression|3|||
30593770|NCT01201915|58606022|FG002|Overall Study|Target Lesion Progression|0|||
30593771|NCT01179919|58606030|FG000|Overall Study|Protocol Violation|1|||
30593772|NCT01179919|58606030|FG000|Overall Study|Adverse Event|1|||
30593773|NCT01201798|58606036|FG000|Overall Study|Adverse Event|2|||
30593774|NCT01201798|58606037|FG001|Overall Study|Adverse Event|0|||
30593775|NCT01201798|58606036|FG000|Overall Study|Lost to Follow-up|3|||
30593776|NCT01201798|58606037|FG001|Overall Study|Lost to Follow-up|5|||
30593777|NCT01201798|58606036|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
30593778|NCT01201798|58606037|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
30593779|NCT01201798|58606036|FG000|Overall Study|Noncompliance|1|||
30593780|NCT01201798|58606037|FG001|Overall Study|Noncompliance|0|||
30593781|NCT01201798|58606036|FG000|Overall Study|Protocol Violation|1|||
30593782|NCT01201798|58606037|FG001|Overall Study|Protocol Violation|1|||
30593783|NCT01201798|58606036|FG000|Overall Study|Treatment Failure|1|||
30593784|NCT01201798|58606037|FG001|Overall Study|Treatment Failure|8|||
30593785|NCT01201759|58606045|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
30593786|NCT01201759|58606046|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
30593787|NCT01201759|58606045|FG000|Visit 3 - Washout|Adverse Event|0|||
30593788|NCT01201759|58606046|FG001|Visit 3 - Washout|Adverse Event|3|||
30593789|NCT01201759|58606045|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
30593790|NCT01201759|58606046|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
30593791|NCT01201759|58606045|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
30593792|NCT01201759|58606046|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
30593793|NCT01200589|58606056|FG000|Overall Study|Withdrawal by Subject|13|||
30593794|NCT01200589|58606057|FG001|Overall Study|Withdrawal by Subject|11|||
30593795|NCT01200589|58606056|FG000|Overall Study|Physician Decision|2|||
30593796|NCT01200589|58606057|FG001|Overall Study|Physician Decision|2|||
30593797|NCT01200589|58606056|FG000|Overall Study|Lost to Follow-up|5|||
30593798|NCT01200589|58606057|FG001|Overall Study|Lost to Follow-up|4|||
30593799|NCT01200589|58606056|FG000|Overall Study|Study terminated|170|||
30593800|NCT01200589|58606057|FG001|Overall Study|Study terminated|172|||
30593801|NCT01200511|58606063|FG000|Overall Study|Lost to Follow-up|3|||
30593802|NCT01200511|58606063|FG000|Overall Study|Withdrawal by Subject|1|||
30593803|NCT01200511|58606063|FG000|Overall Study|Adverse Event|1|||
30593804|NCT01179334|58606071|FG000|Treatment Period|Adverse Event|1|||
30593805|NCT01179334|58606072|FG001|Treatment Period|Adverse Event|0|||
30593806|NCT01179334|58606071|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
30593807|NCT01179334|58606072|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
30593808|NCT01179334|58606071|FG000|Long-term Extension (LTE) Period|Death|3|||
30593809|NCT01179334|58606072|FG001|Long-term Extension (LTE) Period|Death|0|||
30593810|NCT01179334|58606071|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
30593811|NCT01179334|58606072|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
30593812|NCT01178671|58606080|FG000|Overall Study|Adverse Event|4|||
30593813|NCT01178671|58606081|FG001|Overall Study|Adverse Event|6|||
30593814|NCT01178671|58606080|FG000|Overall Study|Protocol Violation|1|||
30593815|NCT01178671|58606081|FG001|Overall Study|Protocol Violation|1|||
30593816|NCT01178671|58606080|FG000|Overall Study|Lack of Efficacy|0|||
30593817|NCT01178671|58606081|FG001|Overall Study|Lack of Efficacy|1|||
30593818|NCT01178671|58606080|FG000|Overall Study|Lost to Follow-up|3|||
30593819|NCT01178671|58606081|FG001|Overall Study|Lost to Follow-up|1|||
30593820|NCT01178671|58606080|FG000|Overall Study|Physician Decision|4|||
30593821|NCT01178671|58606081|FG001|Overall Study|Physician Decision|6|||
30593822|NCT01178125|58606087|FG000|Overall Study|Lost to Follow-up|397|||
30593823|NCT01178125|58606087|FG000|Overall Study|Adverse Event|244|||
30593824|NCT01178125|58606087|FG000|Overall Study|Withdrawal by Subject|209|||
30593825|NCT01178125|58606087|FG000|Overall Study|Noncompliance|184|||
30593826|NCT01178125|58606087|FG000|Overall Study|Pregnancy|55|||
30593827|NCT01178125|58606087|FG000|Overall Study|Other Reason|39|||
30593828|NCT01178125|58606087|FG000|Overall Study|Sponsor Decision|28|||
30593829|NCT01178125|58606087|FG000|Overall Study|Protocol Violation|17|||
30593830|NCT01178125|58606087|FG000|Overall Study|Investigator Decision|5|||
30593831|NCT01178086|58606109|FG000|Overall Study|Participant refusal|7|||
30593832|NCT01178086|58606109|FG000|Overall Study|Physician Decision|44|||
30593833|NCT01178086|58606109|FG000|Overall Study|Switch to other CLL therapy|113|||
30593834|NCT01178086|58606109|FG000|Overall Study|Death|59|||
30593835|NCT01178086|58606109|FG000|Overall Study|Other unspecified|89|||
30593836|NCT01178086|58606109|FG000|Overall Study|Excluded from EAS|20|||
30593837|NCT01177969|58606117|FG000|Overall Study|Protocol Violation|2|||
30593838|NCT01177969|58606118|FG001|Overall Study|Protocol Violation|1|||
30593839|NCT01177969|58606117|FG000|Overall Study|Withdrawal by Subject|1|||
30593840|NCT01177969|58606118|FG001|Overall Study|Withdrawal by Subject|2|||
30593841|NCT01177813|58606129|FG000|Overall Study|Adverse Event|8|||
30593842|NCT01177813|58606130|FG001|Overall Study|Adverse Event|2|||
30593843|NCT01177813|58606131|FG002|Overall Study|Adverse Event|4|||
30593844|NCT01177813|58606132|FG003|Overall Study|Adverse Event|6|||
30593845|NCT01177813|58606133|FG004|Overall Study|Adverse Event|3|||
30593846|NCT01177813|58606129|FG000|Overall Study|Lack of Efficacy|1|||
30593847|NCT01177813|58606130|FG001|Overall Study|Lack of Efficacy|0|||
30593848|NCT01177813|58606131|FG002|Overall Study|Lack of Efficacy|0|||
30593849|NCT01177813|58606132|FG003|Overall Study|Lack of Efficacy|0|||
30593850|NCT01177813|58606133|FG004|Overall Study|Lack of Efficacy|0|||
30593851|NCT01177813|58606129|FG000|Overall Study|Protocol Violation|3|||
30593852|NCT01177813|58606130|FG001|Overall Study|Protocol Violation|2|||
30593853|NCT01177813|58606131|FG002|Overall Study|Protocol Violation|2|||
30593854|NCT01177813|58606132|FG003|Overall Study|Protocol Violation|0|||
30593855|NCT01177813|58606133|FG004|Overall Study|Protocol Violation|1|||
30593856|NCT01177813|58606129|FG000|Overall Study|Lost to Follow-up|12|||
30593857|NCT01177813|58606130|FG001|Overall Study|Lost to Follow-up|5|||
30593858|NCT01177813|58606131|FG002|Overall Study|Lost to Follow-up|6|||
30593859|NCT01177813|58606132|FG003|Overall Study|Lost to Follow-up|3|||
30593860|NCT01177813|58606133|FG004|Overall Study|Lost to Follow-up|0|||
30593861|NCT01177813|58606129|FG000|Overall Study|Withdrawal by Subject|12|||
30593862|NCT01177813|58606130|FG001|Overall Study|Withdrawal by Subject|7|||
30593863|NCT01177813|58606131|FG002|Overall Study|Withdrawal by Subject|6|||
30593864|NCT01177813|58606132|FG003|Overall Study|Withdrawal by Subject|5|||
30593865|NCT01177813|58606133|FG004|Overall Study|Withdrawal by Subject|3|||
30593866|NCT01177813|58606129|FG000|Overall Study|Other reason not defined above|5|||
30593867|NCT01177813|58606130|FG001|Overall Study|Other reason not defined above|2|||
30593868|NCT01177813|58606131|FG002|Overall Study|Other reason not defined above|2|||
30593869|NCT01177813|58606132|FG003|Overall Study|Other reason not defined above|3|||
30593870|NCT01177813|58606133|FG004|Overall Study|Other reason not defined above|2|||
30593871|NCT01200394|58606147|FG000|Overall Study|Adverse Event|0|||
30593872|NCT01200394|58606148|FG001|Overall Study|Adverse Event|14|||
30593873|NCT01200394|58606147|FG000|Overall Study|Death|1|||
30593874|NCT01200394|58606148|FG001|Overall Study|Death|0|||
30593875|NCT01200394|58606147|FG000|Overall Study|Lost to Follow-up|0|||
30593876|NCT01200394|58606148|FG001|Overall Study|Lost to Follow-up|1|||
30593877|NCT01200394|58606147|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
30593878|NCT01200394|58606148|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
30593879|NCT01200394|58606147|FG000|Overall Study|Protocol Violation|0|||
30593880|NCT01200394|58606148|FG001|Overall Study|Protocol Violation|3|||
30593881|NCT01200394|58606147|FG000|Overall Study|Withdrawal by Subject|0|||
30593882|NCT01200394|58606148|FG001|Overall Study|Withdrawal by Subject|5|||
30593883|NCT01200394|58606147|FG000|Overall Study|Other|0|||
30593884|NCT01200394|58606148|FG001|Overall Study|Other|1|||
30593885|NCT01200355|58606157|FG000|Overall Study|Death|7|||
30593886|NCT01200355|58606158|FG001|Overall Study|Death|2|||
30593887|NCT01200238|58606166|FG000|Overall Study|Adverse Event|2|||
30593888|NCT01200238|58606167|FG001|Overall Study|Adverse Event|1|||
30593889|NCT01200238|58606166|FG000|Overall Study|Progressive Disease|5|||
30593890|NCT01200238|58606167|FG001|Overall Study|Progressive Disease|8|||
30593891|NCT01200238|58606166|FG000|Overall Study|Withdrawal by Subject|0|||
30593892|NCT01200238|58606167|FG001|Overall Study|Withdrawal by Subject|1|||
30593893|NCT01199731|58606176|FG000|Overall Study|Adverse Event|0|||
30593894|NCT01199731|58606177|FG001|Overall Study|Adverse Event|1|||
30593895|NCT01199731|58606178|FG002|Overall Study|Adverse Event|0|||
30593896|NCT01199731|58606176|FG000|Overall Study|Study closed/terminated|7|||
30593897|NCT01199731|58606177|FG001|Overall Study|Study closed/terminated|9|||
30593898|NCT01199731|58606178|FG002|Overall Study|Study closed/terminated|7|||
30593899|NCT01199731|58606176|FG000|Overall Study|Lost to Follow-up|0|||
30593900|NCT01199731|58606177|FG001|Overall Study|Lost to Follow-up|0|||
30593901|NCT01199731|58606178|FG002|Overall Study|Lost to Follow-up|2|||
30593902|NCT01199731|58606176|FG000|Overall Study|Physician Decision|0|||
30593903|NCT01199731|58606177|FG001|Overall Study|Physician Decision|1|||
30593904|NCT01199731|58606178|FG002|Overall Study|Physician Decision|1|||
30593905|NCT01199731|58606176|FG000|Overall Study|Withdrawal by Subject|2|||
30678893|NCT00809354|58692892|FG003|Overall Study|Lack of Efficacy|15|||
30593906|NCT01199731|58606177|FG001|Overall Study|Withdrawal by Subject|0|||
30593907|NCT01199731|58606178|FG002|Overall Study|Withdrawal by Subject|0|||
30593908|NCT01199263|58606188|FG000|Overall Study|Ineligible|0|||
30593909|NCT01199263|58606189|FG001|Overall Study|Ineligible|2|||
30593910|NCT01199263|58606188|FG000|Overall Study|Never Treated|6|||
30593911|NCT01199263|58606189|FG001|Overall Study|Never Treated|0|||
30593912|NCT01199068|58606200|FG000|Overall Study|Unacceptable toxicity|0|||
30593913|NCT01199068|58606201|FG001|Overall Study|Unacceptable toxicity|0|||
30593914|NCT01199068|58606202|FG002|Overall Study|Unacceptable toxicity|2|||
30593915|NCT01199068|58606200|FG000|Overall Study|Progressive disease|3|||
30593916|NCT01199068|58606201|FG001|Overall Study|Progressive disease|3|||
30593917|NCT01199068|58606202|FG002|Overall Study|Progressive disease|6|||
30593918|NCT01199068|58606200|FG000|Overall Study|Withdrawal by Subject|0|||
30593919|NCT01199068|58606201|FG001|Overall Study|Withdrawal by Subject|0|||
30593920|NCT01199068|58606202|FG002|Overall Study|Withdrawal by Subject|1|||
30593921|NCT01198873|58606219|FG000|Overall Study|Adverse Event|4|||
30593922|NCT01198873|58606220|FG001|Overall Study|Adverse Event|7|||
30593923|NCT01198873|58606219|FG000|Overall Study|Study closure|29|||
30593924|NCT01198873|58606220|FG001|Overall Study|Study closure|23|||
30593925|NCT01198873|58606219|FG000|Overall Study|Other than above|4|||
30593926|NCT01198873|58606220|FG001|Overall Study|Other than above|2|||
30593927|NCT01198795|58606226|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
30593928|NCT01198795|58606226|FG000|Overall Study|Withdrawal by Subject|17|||
30593929|NCT01198795|58606226|FG000|Overall Study|Lost to Follow-up|15|||
30593930|NCT01198795|58606226|FG000|Overall Study|Adverse Event|9|||
30593931|NCT01198795|58606226|FG000|Overall Study|Lack of Efficacy|5|||
30593932|NCT01198795|58606226|FG000|Overall Study|Protocol Violation|2|||
30593933|NCT01198795|58606226|FG000|Overall Study|Other Reason|4|||
30593934|NCT01198756|58606234|FG000|Overall Study|Adverse Event|0|||
30593935|NCT01198756|58606235|FG001|Overall Study|Adverse Event|0|||
30593936|NCT01198756|58606236|FG002|Overall Study|Adverse Event|0|||
30593937|NCT01198756|58606237|FG003|Overall Study|Adverse Event|1|||
30593938|NCT01198756|58606234|FG000|Overall Study|Protocol Violation|0|||
30593939|NCT01198756|58606235|FG001|Overall Study|Protocol Violation|0|||
30593940|NCT01198756|58606236|FG002|Overall Study|Protocol Violation|0|||
30593941|NCT01198756|58606237|FG003|Overall Study|Protocol Violation|2|||
30593942|NCT01198756|58606234|FG000|Overall Study|Withdrawal by Subject|9|||
30593943|NCT01198756|58606235|FG001|Overall Study|Withdrawal by Subject|4|||
30593944|NCT01198756|58606236|FG002|Overall Study|Withdrawal by Subject|7|||
30593945|NCT01198756|58606237|FG003|Overall Study|Withdrawal by Subject|5|||
30593946|NCT01198756|58606234|FG000|Overall Study|Lost to Follow-up|29|||
30593947|NCT01198756|58606235|FG001|Overall Study|Lost to Follow-up|36|||
30593948|NCT01198756|58606236|FG002|Overall Study|Lost to Follow-up|23|||
30593949|NCT01198756|58606237|FG003|Overall Study|Lost to Follow-up|18|||
30593950|NCT01198600|58606254|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
30593951|NCT01198600|58606255|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
30593952|NCT01198600|58606256|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
30593953|NCT01198600|58606257|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
30593954|NCT01198600|58606254|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
30678894|NCT00809354|58692893|FG004|Overall Study|Lack of Efficacy|40|||
30678895|NCT00809354|58692894|FG005|Overall Study|Lack of Efficacy|19|||
30678896|NCT00809354|58692895|FG006|Overall Study|Lack of Efficacy|21|||
30678897|NCT00809354|58692896|FG007|Overall Study|Lack of Efficacy|15|||
30678898|NCT00809354|58692897|FG008|Overall Study|Lack of Efficacy|18|||
30678899|NCT00809354|58692898|FG009|Overall Study|Lack of Efficacy|38|||
30678900|NCT00809354|58692889|FG000|Overall Study|Lost to Follow-up|10|||
30678901|NCT00809354|58692890|FG001|Overall Study|Lost to Follow-up|11|||
30678902|NCT00809354|58692891|FG002|Overall Study|Lost to Follow-up|8|||
30678903|NCT00809354|58692892|FG003|Overall Study|Lost to Follow-up|13|||
30678904|NCT00809354|58692893|FG004|Overall Study|Lost to Follow-up|6|||
30678905|NCT00809354|58692894|FG005|Overall Study|Lost to Follow-up|2|||
30678906|NCT00809354|58692895|FG006|Overall Study|Lost to Follow-up|0|||
30678907|NCT00809354|58692896|FG007|Overall Study|Lost to Follow-up|5|||
30678908|NCT00809354|58692897|FG008|Overall Study|Lost to Follow-up|4|||
30593955|NCT01198600|58606255|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
30678909|NCT00809354|58692898|FG009|Overall Study|Lost to Follow-up|0|||
30593956|NCT01198600|58606256|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
30678910|NCT00809354|58692889|FG000|Overall Study|Protocol Violation|7|||
30678911|NCT00809354|58692890|FG001|Overall Study|Protocol Violation|14|||
30782535|NCT03334448|58794662|FG003|Washout|Protocol Violation|1|||
30782536|NCT02849080|58794670|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
30593957|NCT01198600|58606257|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
30593958|NCT01198600|58606254|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
30678912|NCT00809354|58692891|FG002|Overall Study|Protocol Violation|14|||
30678913|NCT00809354|58692892|FG003|Overall Study|Protocol Violation|12|||
30678914|NCT00809354|58692893|FG004|Overall Study|Protocol Violation|14|||
30678915|NCT00809354|58692894|FG005|Overall Study|Protocol Violation|6|||
30678916|NCT00809354|58692895|FG006|Overall Study|Protocol Violation|4|||
30678917|NCT00809354|58692896|FG007|Overall Study|Protocol Violation|6|||
30678918|NCT00809354|58692897|FG008|Overall Study|Protocol Violation|9|||
30678919|NCT00809354|58692898|FG009|Overall Study|Protocol Violation|3|||
30678920|NCT00809354|58692889|FG000|Overall Study|Withdrawal by Subject|32|||
30678921|NCT00809354|58692890|FG001|Overall Study|Withdrawal by Subject|27|||
30678922|NCT00809354|58692891|FG002|Overall Study|Withdrawal by Subject|31|||
30678923|NCT00809354|58692892|FG003|Overall Study|Withdrawal by Subject|33|||
30678924|NCT00809354|58692893|FG004|Overall Study|Withdrawal by Subject|34|||
30678925|NCT00809354|58692894|FG005|Overall Study|Withdrawal by Subject|29|||
30678926|NCT00809354|58692895|FG006|Overall Study|Withdrawal by Subject|27|||
30678927|NCT00809354|58692896|FG007|Overall Study|Withdrawal by Subject|19|||
30678928|NCT00809354|58692897|FG008|Overall Study|Withdrawal by Subject|18|||
30678929|NCT00809354|58692898|FG009|Overall Study|Withdrawal by Subject|20|||
30678930|NCT00809354|58692889|FG000|Overall Study|Other|10|||
30678931|NCT00809354|58692890|FG001|Overall Study|Other|2|||
30678932|NCT00809354|58692891|FG002|Overall Study|Other|7|||
30678933|NCT00809354|58692892|FG003|Overall Study|Other|10|||
30593959|NCT01198600|58606255|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
30593960|NCT01198600|58606256|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
30593961|NCT01198600|58606257|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
30593962|NCT01198600|58606254|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
30593963|NCT01198600|58606255|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
30593964|NCT01198600|58606256|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
30593965|NCT01198600|58606257|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
30593966|NCT01198600|58606254|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
30593967|NCT01198600|58606255|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
30593968|NCT01198600|58606256|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
30593969|NCT01198600|58606257|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
30593970|NCT01198600|58606254|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
30593971|NCT01198600|58606255|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
30593972|NCT01198600|58606256|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
30593973|NCT01198600|58606257|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
30593974|NCT01198600|58606254|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
30593975|NCT01198600|58606255|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
30593976|NCT01198600|58606256|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
30593977|NCT01198600|58606257|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
30593978|NCT01198132|58606267|FG000|Overall Study|Withdrawal by Subject|4|||
30593979|NCT01198132|58606268|FG001|Overall Study|Withdrawal by Subject|5|||
30593980|NCT01198132|58606267|FG000|Overall Study|Physician Decision|5|||
30593981|NCT01198132|58606268|FG001|Overall Study|Physician Decision|4|||
30593982|NCT01198132|58606267|FG000|Overall Study|Other Unspecified|3|||
30593983|NCT01198132|58606268|FG001|Overall Study|Other Unspecified|6|||
30593984|NCT01198132|58606267|FG000|Overall Study|Lack of Efficacy|2|||
30593985|NCT01198132|58606268|FG001|Overall Study|Lack of Efficacy|3|||
30593986|NCT01198132|58606267|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
30593987|NCT01198132|58606268|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
30593988|NCT01198132|58606267|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
30593989|NCT01198132|58606268|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
30593990|NCT01198132|58606267|FG000|Overall Study|Adverse Event|0|||
30593991|NCT01198132|58606268|FG001|Overall Study|Adverse Event|1|||
30593992|NCT01198132|58606267|FG000|Overall Study|Protocol Violation|1|||
30593993|NCT01198132|58606268|FG001|Overall Study|Protocol Violation|0|||
30593994|NCT01197508|58606280|FG000|Overall Study|Withdrawal by Subject|8|||
30593995|NCT01197508|58606281|FG001|Overall Study|Withdrawal by Subject|7|||
30593996|NCT01197508|58606282|FG002|Overall Study|Withdrawal by Subject|15|||
30593997|NCT01197508|58606283|FG003|Overall Study|Withdrawal by Subject|4|||
30593998|NCT01197508|58606280|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
30593999|NCT01197508|58606281|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
30594000|NCT01197508|58606282|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
30594001|NCT01197508|58606283|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
30594002|NCT01197508|58606280|FG000|Overall Study|Adverse Event|10|||
30594003|NCT01197508|58606281|FG001|Overall Study|Adverse Event|13|||
30678934|NCT00809354|58692893|FG004|Overall Study|Other|5|||
30678935|NCT00809354|58692894|FG005|Overall Study|Other|3|||
30678936|NCT00809354|58692895|FG006|Overall Study|Other|2|||
30678937|NCT00809354|58692896|FG007|Overall Study|Other|3|||
30678938|NCT00809354|58692897|FG008|Overall Study|Other|4|||
30678939|NCT00809354|58692898|FG009|Overall Study|Other|3|||
30959039|NCT01587703|59024037|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
30594004|NCT01197508|58606282|FG002|Overall Study|Adverse Event|23|||
30678940|NCT00809354|58692889|FG000|Overall Study|Study terminated by sponsor|138|||
30678941|NCT00809354|58692890|FG001|Overall Study|Study terminated by sponsor|134|||
30678942|NCT00809354|58692891|FG002|Overall Study|Study terminated by sponsor|129|||
30678943|NCT00809354|58692892|FG003|Overall Study|Study terminated by sponsor|120|||
30594005|NCT01197508|58606283|FG003|Overall Study|Adverse Event|3|||
30594006|NCT01197508|58606280|FG000|Overall Study|Severe non-compliance to protocol|0|||
30594007|NCT01197508|58606281|FG001|Overall Study|Severe non-compliance to protocol|3|||
30594008|NCT01197508|58606282|FG002|Overall Study|Severe non-compliance to protocol|1|||
30594009|NCT01197508|58606283|FG003|Overall Study|Severe non-compliance to protocol|3|||
30594010|NCT01197508|58606280|FG000|Overall Study|Condition under investigation worsened|1|||
30594011|NCT01197508|58606281|FG001|Overall Study|Condition under investigation worsened|1|||
30678944|NCT00809354|58692893|FG004|Overall Study|Study terminated by sponsor|126|||
30678945|NCT00809354|58692894|FG005|Overall Study|Study terminated by sponsor|133|||
30678946|NCT00809354|58692895|FG006|Overall Study|Study terminated by sponsor|124|||
30678947|NCT00809354|58692896|FG007|Overall Study|Study terminated by sponsor|148|||
30678948|NCT00809354|58692897|FG008|Overall Study|Study terminated by sponsor|127|||
30678949|NCT00809354|58692898|FG009|Overall Study|Study terminated by sponsor|135|||
30678950|NCT00809354|58692889|FG000|Overall Study|Withdrawn due to pregnancy|0|||
30678951|NCT00809354|58692890|FG001|Overall Study|Withdrawn due to pregnancy|1|||
30678952|NCT00809354|58692891|FG002|Overall Study|Withdrawn due to pregnancy|0|||
30678953|NCT00809354|58692892|FG003|Overall Study|Withdrawn due to pregnancy|0|||
30678954|NCT00809354|58692893|FG004|Overall Study|Withdrawn due to pregnancy|0|||
30678955|NCT00809354|58692894|FG005|Overall Study|Withdrawn due to pregnancy|0|||
30678956|NCT00809354|58692895|FG006|Overall Study|Withdrawn due to pregnancy|0|||
30678957|NCT00809354|58692896|FG007|Overall Study|Withdrawn due to pregnancy|0|||
30678958|NCT00809354|58692897|FG008|Overall Study|Withdrawn due to pregnancy|0|||
30678959|NCT00809354|58692898|FG009|Overall Study|Withdrawn due to pregnancy|0|||
30678960|NCT00809354|58692889|FG000|Overall Study|Randomized but not Treated|3|||
30678961|NCT00809354|58692890|FG001|Overall Study|Randomized but not Treated|1|||
30678962|NCT00809354|58692891|FG002|Overall Study|Randomized but not Treated|6|||
30678963|NCT00809354|58692892|FG003|Overall Study|Randomized but not Treated|0|||
30678964|NCT00809354|58692893|FG004|Overall Study|Randomized but not Treated|5|||
30678965|NCT00809354|58692894|FG005|Overall Study|Randomized but not Treated|0|||
30678966|NCT00809354|58692895|FG006|Overall Study|Randomized but not Treated|1|||
30678967|NCT00809354|58692896|FG007|Overall Study|Randomized but not Treated|1|||
30678968|NCT00809354|58692897|FG008|Overall Study|Randomized but not Treated|2|||
30678969|NCT00809354|58692898|FG009|Overall Study|Randomized but not Treated|1|||
30678970|NCT00809354|58692889|FG000|Overall Study|Death|0|||
30678971|NCT00809354|58692890|FG001|Overall Study|Death|0|||
30678972|NCT00809354|58692891|FG002|Overall Study|Death|0|||
30678973|NCT00809354|58692892|FG003|Overall Study|Death|0|||
30678974|NCT00809354|58692893|FG004|Overall Study|Death|0|||
30678975|NCT00809354|58692894|FG005|Overall Study|Death|0|||
30678976|NCT00809354|58692895|FG006|Overall Study|Death|0|||
30678977|NCT00809354|58692896|FG007|Overall Study|Death|1|||
30678978|NCT00809354|58692897|FG008|Overall Study|Death|0|||
30678979|NCT00809354|58692898|FG009|Overall Study|Death|0|||
30594012|NCT01197508|58606282|FG002|Overall Study|Condition under investigation worsened|1|||
30594013|NCT01197508|58606283|FG003|Overall Study|Condition under investigation worsened|1|||
30594014|NCT01197508|58606280|FG000|Overall Study|Lack of Efficacy|1|||
30594015|NCT01197508|58606281|FG001|Overall Study|Lack of Efficacy|2|||
30594016|NCT01197508|58606282|FG002|Overall Study|Lack of Efficacy|2|||
30594017|NCT01197508|58606283|FG003|Overall Study|Lack of Efficacy|1|||
30594018|NCT01197508|58606280|FG000|Overall Study|Study-specific withdrawal criteria|0|||
30594019|NCT01197508|58606281|FG001|Overall Study|Study-specific withdrawal criteria|0|||
30594020|NCT01197508|58606282|FG002|Overall Study|Study-specific withdrawal criteria|1|||
30594021|NCT01197508|58606283|FG003|Overall Study|Study-specific withdrawal criteria|2|||
30594022|NCT01197508|58606280|FG000|Overall Study|Lost to Follow-up|1|||
30594023|NCT01197508|58606281|FG001|Overall Study|Lost to Follow-up|1|||
30594024|NCT01197508|58606282|FG002|Overall Study|Lost to Follow-up|2|||
30594025|NCT01197508|58606283|FG003|Overall Study|Lost to Follow-up|0|||
30594026|NCT01197508|58606280|FG000|Overall Study|Other|2|||
30594027|NCT01197508|58606281|FG001|Overall Study|Other|3|||
30594028|NCT01197508|58606282|FG002|Overall Study|Other|2|||
30594029|NCT01197508|58606283|FG003|Overall Study|Other|2|||
30594030|NCT01196416|58606300|FG000|Overall Study|Withdrawal by Subject|2|||
30678980|NCT00834899|58692927|FG000|Overall Study|Withdrawal by Subject|1|||
30594031|NCT01196104|58606306|FG000|Overall Study|Lost to Follow-up|1|||
30594032|NCT01196104|58606307|FG001|Overall Study|Lost to Follow-up|0|||
30594033|NCT01196104|58606306|FG000|Overall Study|Physician Decision|0|||
30594034|NCT01196104|58606307|FG001|Overall Study|Physician Decision|1|||
30678981|NCT00834899|58692928|FG001|Overall Study|Withdrawal by Subject|1|||
30678982|NCT00764946|58692937|FG000|Overall Study|Lack of Efficacy|1|||
30678983|NCT00764946|58692938|FG001|Overall Study|Lack of Efficacy|0|||
30678984|NCT00764946|58692939|FG002|Overall Study|Lack of Efficacy|0|||
30678985|NCT00764946|58692937|FG000|Overall Study|Lost to Follow-up|3|||
30678986|NCT00764946|58692938|FG001|Overall Study|Lost to Follow-up|4|||
30678987|NCT00764946|58692939|FG002|Overall Study|Lost to Follow-up|0|||
30678988|NCT00764946|58692937|FG000|Overall Study|Physician Decision|2|||
30678989|NCT00764946|58692938|FG001|Overall Study|Physician Decision|4|||
30678990|NCT00764946|58692939|FG002|Overall Study|Physician Decision|0|||
30594035|NCT01196104|58606306|FG000|Overall Study|Withdrawal by Subject|3|||
30594036|NCT01196104|58606307|FG001|Overall Study|Withdrawal by Subject|3|||
30594037|NCT01196104|58606306|FG000|Overall Study|Various|0|||
30594038|NCT01196104|58606307|FG001|Overall Study|Various|1|||
30594039|NCT01196026|58606325|FG000|Overall Study|Withdrawal by Subject|1|||
30594040|NCT01196026|58606326|FG001|Overall Study|Withdrawal by Subject|4|||
30594041|NCT01196026|58606327|FG002|Overall Study|Withdrawal by Subject|0|||
30594042|NCT01196026|58606328|FG003|Overall Study|Withdrawal by Subject|0|||
30594043|NCT01196026|58606329|FG004|Overall Study|Withdrawal by Subject|0|||
30594044|NCT01196026|58606330|FG005|Overall Study|Withdrawal by Subject|0|||
30594045|NCT01196026|58606325|FG000|Overall Study|Lost to Follow-up|0|||
30594046|NCT01196026|58606326|FG001|Overall Study|Lost to Follow-up|3|||
30594047|NCT01196026|58606327|FG002|Overall Study|Lost to Follow-up|0|||
30594048|NCT01196026|58606328|FG003|Overall Study|Lost to Follow-up|0|||
30594049|NCT01196026|58606329|FG004|Overall Study|Lost to Follow-up|1|||
30594050|NCT01196026|58606330|FG005|Overall Study|Lost to Follow-up|0|||
30594051|NCT01196026|58606325|FG000|Overall Study|Other|0|||
30594052|NCT01196026|58606326|FG001|Overall Study|Other|1|||
30594053|NCT01196026|58606327|FG002|Overall Study|Other|0|||
30594054|NCT01196026|58606328|FG003|Overall Study|Other|0|||
30594055|NCT01196026|58606329|FG004|Overall Study|Other|0|||
30594056|NCT01196026|58606330|FG005|Overall Study|Other|0|||
30594057|NCT01195948|58606349|FG000|Overall Study|Lost to Follow-up|0|||
30594058|NCT01195948|58606350|FG001|Overall Study|Lost to Follow-up|1|||
30678991|NCT00764946|58692937|FG000|Overall Study|Adverse Event|3|||
30678992|NCT00764946|58692938|FG001|Overall Study|Adverse Event|2|||
30678993|NCT00764946|58692939|FG002|Overall Study|Adverse Event|1|||
30678994|NCT00764946|58692937|FG000|Overall Study|Withdrawal by Subject|3|||
30678995|NCT00764946|58692938|FG001|Overall Study|Withdrawal by Subject|6|||
30678996|NCT00764946|58692939|FG002|Overall Study|Withdrawal by Subject|2|||
30678997|NCT00764946|58692937|FG000|Overall Study|Never Treated|1|||
30678998|NCT00764946|58692938|FG001|Overall Study|Never Treated|1|||
30678999|NCT00764946|58692939|FG002|Overall Study|Never Treated|1|||
30679000|NCT00764868|58692953|FG000|Overall Study|Adverse Event|18|||
30679001|NCT00764868|58692953|FG000|Overall Study|Withdrawal by Subject|31|||
30679002|NCT00764868|58692953|FG000|Overall Study|Non-compliance|16|||
30679003|NCT00764868|58692953|FG000|Overall Study|Lost to Follow-up|25|||
30679004|NCT00764868|58692953|FG000|Overall Study|Lack of Efficacy|5|||
30679005|NCT00764868|58692953|FG000|Overall Study|Subject moved|7|||
30679006|NCT00764868|58692953|FG000|Overall Study|Pregnancy|3|||
30679007|NCT00764868|58692953|FG000|Overall Study|Prohibited medication|1|||
30679008|NCT00764868|58692953|FG000|Overall Study|Out of town|1|||
30679009|NCT00764868|58692953|FG000|Overall Study|Misuse and compliance of study drug|1|||
30679010|NCT00764868|58692953|FG000|Overall Study|Subject sent to boarding school|1|||
30679011|NCT00764868|58692953|FG000|Overall Study|Met an exclusion criteria|1|||
30679012|NCT00764868|58692953|FG000|Overall Study|Positive drug screen|2|||
30679013|NCT00764868|58692953|FG000|Overall Study|Sponsor requested withdrawal|1|||
30679014|NCT00764790|58692960|FG000|Overall Study|Protocol Violation|0|||
30679015|NCT00764790|58692961|FG001|Overall Study|Protocol Violation|0|||
30679016|NCT00764790|58692962|FG002|Overall Study|Protocol Violation|1|||
30679017|NCT00764790|58692960|FG000|Overall Study|Withdrawal by Subject|10|||
30679018|NCT00764790|58692961|FG001|Overall Study|Withdrawal by Subject|12|||
30679019|NCT00764790|58692962|FG002|Overall Study|Withdrawal by Subject|6|||
30679020|NCT00764790|58692960|FG000|Overall Study|Lost to Follow-up|28|||
30679021|NCT00764790|58692961|FG001|Overall Study|Lost to Follow-up|29|||
30679022|NCT00764790|58692962|FG002|Overall Study|Lost to Follow-up|23|||
30679023|NCT00756444|58692972|FG000|Overall Study|Adverse Event|1|||
30679024|NCT00756444|58692973|FG001|Overall Study|Adverse Event|1|||
30679025|NCT00756444|58692972|FG000|Overall Study|Withdrawal by Subject|6|||
30679026|NCT00756444|58692973|FG001|Overall Study|Withdrawal by Subject|8|||
30594059|NCT01195948|58606351|FG002|Overall Study|Lost to Follow-up|2|||
30594060|NCT01195831|58606364|FG000|Overall Study|Lost to Follow-up|2|||
30594061|NCT01195831|58606365|FG001|Overall Study|Lost to Follow-up|4|||
30594062|NCT01195831|58606364|FG000|Overall Study|Withdrawal by Subject|2|||
30594063|NCT01195831|58606365|FG001|Overall Study|Withdrawal by Subject|2|||
30679027|NCT00756444|58692972|FG000|Overall Study|Lost to Follow-up|0|||
30679028|NCT00756444|58692973|FG001|Overall Study|Lost to Follow-up|1|||
30679029|NCT00756444|58692972|FG000|Overall Study|Death|5|||
30679030|NCT00756444|58692973|FG001|Overall Study|Death|4|||
30679031|NCT00756444|58692972|FG000|Overall Study|Disease Progression|2|||
30679032|NCT00756444|58692973|FG001|Overall Study|Disease Progression|7|||
30679033|NCT00756444|58692972|FG000|Overall Study|Ineligibility Determined|1|||
30679034|NCT00756444|58692973|FG001|Overall Study|Ineligibility Determined|0|||
30679035|NCT00769002|58692984|FG000|Overall Study|Study was not completed, no data|9|||
30679036|NCT00769002|58692985|FG001|Overall Study|Study was not completed, no data|9|||
30594064|NCT01195831|58606364|FG000|Overall Study|Adverse Event|4|||
30594065|NCT01195831|58606365|FG001|Overall Study|Adverse Event|2|||
30594066|NCT01195831|58606364|FG000|Overall Study|Protocol Violation|0|||
30594067|NCT01195831|58606365|FG001|Overall Study|Protocol Violation|2|||
30594068|NCT01195675|58606371|FG000|Overall Study|Adverse Event|1|||
30594069|NCT01195675|58606371|FG000|Overall Study|Withdrawal by Subject|2|||
30594070|NCT01195636|58606388|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
30594071|NCT01195636|58606389|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
30594072|NCT01195636|58606388|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
30594073|NCT01195636|58606389|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
30594074|NCT01195636|58606388|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
30594075|NCT01195636|58606389|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
30594076|NCT01195636|58606388|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
30594077|NCT01195636|58606389|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
30594078|NCT01195636|58606388|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
30594079|NCT01195636|58606389|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
30594080|NCT01195636|58606388|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
30594081|NCT01195636|58606389|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
30594082|NCT01195636|58606388|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
30594083|NCT01195636|58606389|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
30594084|NCT01195636|58606388|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
30594085|NCT01195636|58606389|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
30594086|NCT01195363|58606397|FG000|Overall Study|Lost to Follow-up|7|||
30594087|NCT01195363|58606398|FG001|Overall Study|Lost to Follow-up|4|||
30594088|NCT01195363|58606397|FG000|Overall Study|Adverse Event|3|||
30594089|NCT01195363|58606398|FG001|Overall Study|Adverse Event|1|||
30594090|NCT01195363|58606397|FG000|Overall Study|Lack of Efficacy|0|||
30594091|NCT01195363|58606398|FG001|Overall Study|Lack of Efficacy|4|||
30594092|NCT01195363|58606397|FG000|Overall Study|incarceration|1|||
30594093|NCT01195363|58606398|FG001|Overall Study|incarceration|0|||
30594094|NCT01195090|58606406|FG000|Overall Study|Adverse Event|1|||
30594095|NCT01195090|58606407|FG001|Overall Study|Adverse Event|2|||
30679037|NCT00753012|58692992|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
30679038|NCT00753012|58692993|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
30679039|NCT00753012|58692992|FG000|Overall Study|Adverse Event|2|||
30679040|NCT00753012|58692993|FG001|Overall Study|Adverse Event|0|||
30679041|NCT00753012|58692992|FG000|Overall Study|Withdrawal by Subject|0|||
30679042|NCT00753012|58692993|FG001|Overall Study|Withdrawal by Subject|1|||
30679043|NCT00753012|58692992|FG000|Overall Study|Lost to Follow-up|4|||
30679044|NCT00753012|58692993|FG001|Overall Study|Lost to Follow-up|0|||
30679045|NCT00753012|58692992|FG000|Overall Study|Confounded endpoint data|1|||
30679046|NCT00753012|58692993|FG001|Overall Study|Confounded endpoint data|0|||
30679047|NCT00806156|58693002|FG000|Overall Study|Death|35|||
30679048|NCT00806156|58693003|FG001|Overall Study|Death|95|||
30679049|NCT00806156|58693002|FG000|Overall Study|Did not meet eligibility criteria|1|||
30679050|NCT00806156|58693003|FG001|Overall Study|Did not meet eligibility criteria|0|||
30679051|NCT00806156|58693002|FG000|Overall Study|Study terminated by Sponsor|2|||
30679052|NCT00806156|58693003|FG001|Overall Study|Study terminated by Sponsor|40|||
30679053|NCT00806156|58693002|FG000|Overall Study|Consent withdrawn by subject|1|||
30679054|NCT00806156|58693003|FG001|Overall Study|Consent withdrawn by subject|3|||
30679055|NCT00806156|58693002|FG000|Overall Study|Lost to Follow-up|0|||
30679056|NCT00806156|58693003|FG001|Overall Study|Lost to Follow-up|1|||
30679057|NCT00764478|58693024|FG000|Overall Study|Adverse Event|1|||
30679058|NCT00764478|58693025|FG001|Overall Study|Adverse Event|1|||
30679059|NCT00764478|58693026|FG002|Overall Study|Adverse Event|1|||
30679060|NCT00764478|58693024|FG000|Overall Study|Withdrawal by Subject|7|||
30679061|NCT00764478|58693025|FG001|Overall Study|Withdrawal by Subject|12|||
30679062|NCT00764478|58693026|FG002|Overall Study|Withdrawal by Subject|1|||
30679063|NCT00764478|58693024|FG000|Overall Study|Lost to Follow-up|7|||
30679064|NCT00764478|58693025|FG001|Overall Study|Lost to Follow-up|8|||
30679065|NCT00764478|58693026|FG002|Overall Study|Lost to Follow-up|5|||
30679066|NCT00764478|58693024|FG000|Overall Study|Protocol Violation|0|||
30679067|NCT00764478|58693025|FG001|Overall Study|Protocol Violation|1|||
30679068|NCT00764478|58693026|FG002|Overall Study|Protocol Violation|1|||
30679069|NCT00805766|58693034|FG000|Screening Period|Adverse Event|1|||
30679070|NCT00805766|58693034|FG000|Screening Period|Lack of Efficacy|2|||
30679071|NCT00805766|58693034|FG000|Screening Period|Pregnancy|1|||
30679072|NCT00805766|58693034|FG000|Screening Period|Responder|2|||
30679073|NCT00805766|58693034|FG000|Increased Dose Period|Adverse Event|4|||
30679074|NCT00805766|58693034|FG000|Increased Dose Period|Lack of Efficacy|7|||
30856112|NCT03686215|58883992|FG000|Overall Study|Protocol Violation|0|||
30594096|NCT01195090|58606406|FG000|Overall Study|Lost to Follow-up|2|||
30594097|NCT01195090|58606407|FG001|Overall Study|Lost to Follow-up|2|||
30679075|NCT00805766|58693034|FG000|Increased Dose Period|Pregnancy|1|||
30679076|NCT00805766|58693034|FG000|Increased Dose Period|Withdrawal by Subject|1|||
30679077|NCT00805532|58693044|FG000|Overall Study|invalid data|0|||
30679078|NCT00805532|58693045|FG001|Overall Study|invalid data|1|||
30679079|NCT00764322|58693055|FG000|Overall Study|Withdrawal by Subject|11|||
30594098|NCT01195090|58606406|FG000|Overall Study|Protocol Violation|3|||
30594099|NCT01195090|58606407|FG001|Overall Study|Protocol Violation|4|||
30594100|NCT01194973|58606413|FG000|Screening Period|Screen Failure|3|||
30594101|NCT01194973|58606413|FG000|26 Week Treatment Period|Adverse Event|1|||
30679080|NCT00764322|58693055|FG000|Overall Study|No CYP2D6 genotyping|9|||
30679081|NCT00752856|58693074|FG000|Overall Study|randomized but did not do viral kinetics|0|||
30679082|NCT00752856|58693075|FG001|Overall Study|randomized but did not do viral kinetics|1|||
30679083|NCT00755196|58693081|FG000|Overall Study|Lost to Follow-up|1|||
30679084|NCT00755196|58693081|FG000|Overall Study|Lack of Efficiency|1|||
30679085|NCT00805142|58693088|FG000|Titration Period|Adverse Event|3|||
30679086|NCT00805142|58693089|FG001|Titration Period|Adverse Event|3|||
30679087|NCT00805142|58693088|FG000|Titration Period|Lack of Efficacy|1|||
30679088|NCT00805142|58693089|FG001|Titration Period|Lack of Efficacy|1|||
30679089|NCT00805142|58693088|FG000|Titration Period|Lost to Follow-up|0|||
30679090|NCT00805142|58693089|FG001|Titration Period|Lost to Follow-up|1|||
30679091|NCT00805142|58693088|FG000|Titration Period|Disease Progression|2|||
30594102|NCT01194973|58606413|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
30594103|NCT01194973|58606413|FG000|26 Week Treatment Period|Pregnancy|1|||
30679092|NCT00805142|58693089|FG001|Titration Period|Disease Progression|1|||
30679093|NCT00805142|58693088|FG000|Titration Period|Withdrawal of consent|0|||
30679094|NCT00805142|58693089|FG001|Titration Period|Withdrawal of consent|1|||
30679095|NCT00805142|58693088|FG000|Titration Period|Other|0|||
30679096|NCT00805142|58693089|FG001|Titration Period|Other|3|||
30679097|NCT00805142|58693088|FG000|Maintenance Period|Adverse Event|0|||
30679098|NCT00805142|58693089|FG001|Maintenance Period|Adverse Event|1|||
30679099|NCT00805142|58693088|FG000|Maintenance Period|Other|0|||
30679100|NCT00805142|58693089|FG001|Maintenance Period|Other|1|||
30679101|NCT00761631|58693106|FG000|Overall Study|Parent/legal guardian request|8|||
30679102|NCT00761631|58693107|FG001|Overall Study|Parent/legal guardian request|3|||
30679103|NCT00761631|58693108|FG002|Overall Study|Parent/legal guardian request|8|||
30679104|NCT00761631|58693109|FG003|Overall Study|Parent/legal guardian request|0|||
30679105|NCT00761631|58693110|FG004|Overall Study|Parent/legal guardian request|5|||
30679106|NCT00761631|58693111|FG005|Overall Study|Parent/legal guardian request|0|||
30679107|NCT00761631|58693106|FG000|Overall Study|Lost to Follow-up|2|||
30782537|NCT02849080|58794671|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
30782538|NCT02849080|58794672|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
30782539|NCT02849080|58794673|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
30782540|NCT02849080|58794670|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
30782541|NCT02849080|58794671|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
30782542|NCT02849080|58794672|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
30782543|NCT02849080|58794673|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
30782544|NCT02849080|58794670|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
30782545|NCT02849080|58794671|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
30782546|NCT02849080|58794672|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
30782547|NCT02849080|58794673|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
30782548|NCT02849080|58794670|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
30782549|NCT02849080|58794671|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
30782550|NCT02849080|58794672|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
30782551|NCT02849080|58794673|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
30782552|NCT02849080|58794670|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
30782553|NCT02849080|58794671|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
30782554|NCT02849080|58794672|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
30782555|NCT02849080|58794673|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
30782556|NCT02849080|58794670|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
30782557|NCT02849080|58794671|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
30782558|NCT02849080|58794672|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
30782559|NCT02849080|58794673|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
30782560|NCT03346070|58794690|FG000|Overall Study|Death|0|||
30782561|NCT03346070|58794691|FG001|Overall Study|Death|0|||
30782562|NCT03346070|58794692|FG002|Overall Study|Death|0|||
30782563|NCT03346070|58794693|FG003|Overall Study|Death|0|||
30594104|NCT02218697|58606419|FG000|Overall Study|Adverse Event|0|||
30594105|NCT02218697|58606420|FG001|Overall Study|Adverse Event|2|||
30594106|NCT02218697|58606419|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
30594107|NCT02218697|58606420|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
30594108|NCT02218697|58606419|FG000|Overall Study|Withdrawal by Subject|2|||
30594109|NCT02218697|58606420|FG001|Overall Study|Withdrawal by Subject|3|||
30782564|NCT03346070|58794694|FG004|Overall Study|Death|1|||
30782565|NCT03346070|58794690|FG000|Overall Study|Lost to Follow-up|0|||
30782566|NCT03346070|58794691|FG001|Overall Study|Lost to Follow-up|1|||
30594110|NCT01177540|58606428|FG000|Overall Study|Adverse Event|1|||
30679108|NCT00761631|58693107|FG001|Overall Study|Lost to Follow-up|4|||
30679109|NCT00761631|58693108|FG002|Overall Study|Lost to Follow-up|7|||
30679110|NCT00761631|58693109|FG003|Overall Study|Lost to Follow-up|1|||
30679111|NCT00761631|58693110|FG004|Overall Study|Lost to Follow-up|6|||
30782567|NCT03346070|58794692|FG002|Overall Study|Lost to Follow-up|2|||
30782568|NCT03346070|58794693|FG003|Overall Study|Lost to Follow-up|0|||
30782569|NCT03346070|58794694|FG004|Overall Study|Lost to Follow-up|0|||
30782570|NCT03346070|58794690|FG000|Overall Study|Physician Decision|0|||
30782571|NCT03346070|58794691|FG001|Overall Study|Physician Decision|0|||
30679112|NCT00761631|58693111|FG005|Overall Study|Lost to Follow-up|1|||
30679113|NCT00761631|58693106|FG000|Overall Study|Protocol Violation|2|||
30679114|NCT00761631|58693107|FG001|Overall Study|Protocol Violation|0|||
30679115|NCT00761631|58693108|FG002|Overall Study|Protocol Violation|0|||
30679116|NCT00761631|58693109|FG003|Overall Study|Protocol Violation|1|||
30679117|NCT00761631|58693110|FG004|Overall Study|Protocol Violation|5|||
30679118|NCT00761631|58693111|FG005|Overall Study|Protocol Violation|1|||
30594111|NCT01177540|58606429|FG001|Overall Study|Adverse Event|0|||
30594112|NCT01177384|58606437|FG000|Overall Study|Adverse Event|6|||
30594113|NCT01177384|58606438|FG001|Overall Study|Adverse Event|4|||
30594114|NCT01177384|58606437|FG000|Overall Study|Lack of Efficacy|0|||
30594115|NCT01177384|58606438|FG001|Overall Study|Lack of Efficacy|1|||
30594116|NCT01177384|58606437|FG000|Overall Study|Lost to Follow-up|3|||
30594117|NCT01177384|58606438|FG001|Overall Study|Lost to Follow-up|4|||
30594118|NCT01177384|58606437|FG000|Overall Study|Physician Decision|0|||
30594119|NCT01177384|58606438|FG001|Overall Study|Physician Decision|3|||
30594120|NCT01177384|58606437|FG000|Overall Study|Protocol Violation|0|||
30594121|NCT01177384|58606438|FG001|Overall Study|Protocol Violation|2|||
30594122|NCT01177384|58606437|FG000|Overall Study|Withdrawal by Subject|5|||
30679119|NCT00761631|58693106|FG000|Overall Study|Randomized, not treated|1|||
30679120|NCT00761631|58693107|FG001|Overall Study|Randomized, not treated|0|||
30679121|NCT00761631|58693108|FG002|Overall Study|Randomized, not treated|0|||
30679122|NCT00761631|58693109|FG003|Overall Study|Randomized, not treated|0|||
30679123|NCT00761631|58693110|FG004|Overall Study|Randomized, not treated|0|||
30679124|NCT00761631|58693111|FG005|Overall Study|Randomized, not treated|0|||
30679125|NCT00761631|58693106|FG000|Overall Study|Failed to return|1|||
30679126|NCT00761631|58693107|FG001|Overall Study|Failed to return|0|||
30679127|NCT00761631|58693108|FG002|Overall Study|Failed to return|1|||
30679128|NCT00761631|58693109|FG003|Overall Study|Failed to return|1|||
30679129|NCT00761631|58693110|FG004|Overall Study|Failed to return|5|||
30679130|NCT00761631|58693111|FG005|Overall Study|Failed to return|2|||
30679131|NCT00761631|58693106|FG000|Overall Study|Physician Decision|1|||
30679132|NCT00761631|58693107|FG001|Overall Study|Physician Decision|0|||
30679133|NCT00761631|58693108|FG002|Overall Study|Physician Decision|0|||
30679134|NCT00761631|58693109|FG003|Overall Study|Physician Decision|0|||
30679135|NCT00761631|58693110|FG004|Overall Study|Physician Decision|0|||
30679136|NCT00761631|58693111|FG005|Overall Study|Physician Decision|0|||
30594123|NCT01177384|58606438|FG001|Overall Study|Withdrawal by Subject|12|||
30594124|NCT01194154|58606446|FG000|Overall Study|Adverse Event|12|||
30679137|NCT00761631|58693106|FG000|Overall Study|Other|0|||
30679138|NCT00761631|58693107|FG001|Overall Study|Other|0|||
30679139|NCT00761631|58693108|FG002|Overall Study|Other|0|||
30679140|NCT00761631|58693109|FG003|Overall Study|Other|0|||
30679141|NCT00761631|58693110|FG004|Overall Study|Other|1|||
30679142|NCT00761631|58693111|FG005|Overall Study|Other|1|||
30679143|NCT00763698|58693134|FG000|Overall Study|Unsuccessful Implant|5|||
30679144|NCT00763698|58693134|FG000|Overall Study|Death|4|||
30679145|NCT00763698|58693134|FG000|Overall Study|Withdrawal by Subject|1|||
30679146|NCT00763386|58693141|FG000|Overall Study|Adverse Event|43|||
30679147|NCT00763386|58693142|FG001|Overall Study|Adverse Event|33|||
30679148|NCT00763386|58693141|FG000|Overall Study|Death|1|||
30679149|NCT00763386|58693142|FG001|Overall Study|Death|2|||
30679150|NCT00763386|58693141|FG000|Overall Study|Lost to Follow-up|3|||
30679151|NCT00763386|58693142|FG001|Overall Study|Lost to Follow-up|3|||
30782572|NCT03346070|58794692|FG002|Overall Study|Physician Decision|0|||
30594125|NCT01194154|58606447|FG001|Overall Study|Adverse Event|7|||
30594126|NCT01194154|58606446|FG000|Overall Study|Lost to Follow-up|2|||
30594127|NCT01194154|58606447|FG001|Overall Study|Lost to Follow-up|3|||
30594128|NCT01194154|58606446|FG000|Overall Study|Protocol Violation|0|||
30594129|NCT01194154|58606447|FG001|Overall Study|Protocol Violation|1|||
30594130|NCT01194154|58606446|FG000|Overall Study|Withdrawal by Subject|5|||
30594131|NCT01194154|58606447|FG001|Overall Study|Withdrawal by Subject|6|||
30594132|NCT01194154|58606446|FG000|Overall Study|Blood pressure increase|5|||
30594133|NCT01194154|58606447|FG001|Overall Study|Blood pressure increase|3|||
30594134|NCT01194154|58606446|FG000|Overall Study|Hemoglobin decrease|0|||
30679152|NCT00763386|58693141|FG000|Overall Study|Withdrawal by Subject|0|||
30782573|NCT03346070|58794693|FG003|Overall Study|Physician Decision|1|||
30959040|NCT01587703|59024038|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
30679153|NCT00763386|58693142|FG001|Overall Study|Withdrawal by Subject|1|||
30679154|NCT00763386|58693141|FG000|Overall Study|CRF missing|0|||
30679155|NCT00763386|58693142|FG001|Overall Study|CRF missing|1|||
30679156|NCT00763386|58693141|FG000|Overall Study|Study Prosthesis Removed|1|||
30594135|NCT01194154|58606447|FG001|Overall Study|Hemoglobin decrease|1|||
30594136|NCT01194154|58606446|FG000|Overall Study|Hemoglobin increase|12|||
30679157|NCT00763386|58693142|FG001|Overall Study|Study Prosthesis Removed|0|||
30679158|NCT00761319|58693150|FG000|Overall Study|Protocol Violation|21|||
30679159|NCT00761319|58693151|FG001|Overall Study|Protocol Violation|14|||
30679160|NCT00761319|58693150|FG000|Overall Study|Adverse Event|11|||
30782574|NCT03346070|58794694|FG004|Overall Study|Physician Decision|1|||
30594137|NCT01194154|58606447|FG001|Overall Study|Hemoglobin increase|3|||
30594138|NCT01194154|58606446|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
30594139|NCT01194154|58606447|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
30594140|NCT01194154|58606446|FG000|Overall Study|Treatment with prohibited medication|4|||
30594141|NCT01194154|58606447|FG001|Overall Study|Treatment with prohibited medication|5|||
30679161|NCT00761319|58693151|FG001|Overall Study|Adverse Event|7|||
30679162|NCT00761319|58693150|FG000|Overall Study|Withdrawal by Subject|8|||
30679163|NCT00761319|58693151|FG001|Overall Study|Withdrawal by Subject|7|||
30679164|NCT00761319|58693150|FG000|Overall Study|Noncompliance|4|||
30679165|NCT00761319|58693151|FG001|Overall Study|Noncompliance|3|||
30679166|NCT00761319|58693150|FG000|Overall Study|Lost to Follow-up|1|||
30679167|NCT00761319|58693151|FG001|Overall Study|Lost to Follow-up|1|||
30679168|NCT00761319|58693150|FG000|Overall Study|Nonspecified|2|||
30679169|NCT00761319|58693151|FG001|Overall Study|Nonspecified|2|||
30679170|NCT00761319|58693150|FG000|Overall Study|Missing|1|||
30679171|NCT00761319|58693151|FG001|Overall Study|Missing|0|||
30679172|NCT00762996|58693157|FG000|Period One|Protocol Violation|0|||
30679173|NCT00762996|58693158|FG001|Period One|Protocol Violation|0|||
30679174|NCT00762996|58693159|FG002|Period One|Protocol Violation|1|||
30679175|NCT00762996|58693160|FG003|Period One|Protocol Violation|0|||
30679176|NCT00762996|58693157|FG000|Period One|ineligible|0|||
30679177|NCT00762996|58693158|FG001|Period One|ineligible|0|||
30594142|NCT01194154|58606446|FG000|Overall Study|Other|4|||
30594143|NCT01194154|58606447|FG001|Overall Study|Other|0|||
30594144|NCT01194154|58606446|FG000|Overall Study|Did not receive study medication|2|||
30594145|NCT01194154|58606447|FG001|Overall Study|Did not receive study medication|4|||
30679178|NCT00762996|58693159|FG002|Period One|ineligible|1|||
30679179|NCT00762996|58693160|FG003|Period One|ineligible|1|||
30679180|NCT00762996|58693157|FG000|Period One|Adverse Event|0|||
30679181|NCT00762996|58693158|FG001|Period One|Adverse Event|0|||
30679182|NCT00762996|58693159|FG002|Period One|Adverse Event|1|||
30679183|NCT00762996|58693160|FG003|Period One|Adverse Event|0|||
30679184|NCT00762996|58693157|FG000|Period One|Withdrawal by Subject|0|||
30679185|NCT00762996|58693158|FG001|Period One|Withdrawal by Subject|0|||
30679186|NCT00762996|58693159|FG002|Period One|Withdrawal by Subject|1|||
30679187|NCT00762996|58693160|FG003|Period One|Withdrawal by Subject|0|||
30679188|NCT00762606|58693170|FG000|Overall Study|Lost to Follow-up|18|||
30679189|NCT00762606|58693171|FG001|Overall Study|Lost to Follow-up|13|||
30679190|NCT00818441|58693179|FG000|Overall Study|Death|69|||
30679191|NCT00818441|58693180|FG001|Overall Study|Death|26|||
30679192|NCT00818441|58693179|FG000|Overall Study|Other|5|||
30679193|NCT00818441|58693180|FG001|Overall Study|Other|0|||
30679194|NCT00818441|58693179|FG000|Overall Study|Lost to Follow-up|2|||
30679195|NCT00818441|58693180|FG001|Overall Study|Lost to Follow-up|1|||
30679196|NCT00818441|58693179|FG000|Overall Study|Withdrawal by Subject|2|||
30679197|NCT00818441|58693180|FG001|Overall Study|Withdrawal by Subject|0|||
30594146|NCT01193920|58606474|FG000|Overall Study|Withdrawal by Subject|1|||
30594147|NCT01193920|58606475|FG001|Overall Study|Withdrawal by Subject|0|||
30594148|NCT01193920|58606476|FG002|Overall Study|Withdrawal by Subject|5|||
30594149|NCT01193920|58606477|FG003|Overall Study|Withdrawal by Subject|1|||
30594150|NCT01193920|58606478|FG004|Overall Study|Withdrawal by Subject|3|||
30594151|NCT01193920|58606479|FG005|Overall Study|Withdrawal by Subject|1|||
30594152|NCT01193920|58606480|FG006|Overall Study|Withdrawal by Subject|3|||
30594153|NCT01193920|58606481|FG007|Overall Study|Withdrawal by Subject|0|||
30594154|NCT01193920|58606482|FG008|Overall Study|Withdrawal by Subject|1|||
30594155|NCT01193920|58606483|FG009|Overall Study|Withdrawal by Subject|0|||
30594156|NCT01193920|58606474|FG000|Overall Study|Lost to Follow-up|1|||
30594157|NCT01193920|58606475|FG001|Overall Study|Lost to Follow-up|0|||
30594158|NCT01193920|58606476|FG002|Overall Study|Lost to Follow-up|1|||
30594159|NCT01193920|58606477|FG003|Overall Study|Lost to Follow-up|1|||
30594160|NCT01193920|58606478|FG004|Overall Study|Lost to Follow-up|3|||
30594161|NCT01193920|58606479|FG005|Overall Study|Lost to Follow-up|3|||
30594162|NCT01193920|58606480|FG006|Overall Study|Lost to Follow-up|1|||
30594163|NCT01193920|58606481|FG007|Overall Study|Lost to Follow-up|0|||
30594164|NCT01193920|58606482|FG008|Overall Study|Lost to Follow-up|2|||
30679198|NCT00818441|58693179|FG000|Overall Study|Adverse Event|0|||
30679199|NCT00818441|58693180|FG001|Overall Study|Adverse Event|1|||
30679200|NCT00818441|58693179|FG000|Overall Study|Study terminated by sponsor|11|||
30679201|NCT00818441|58693180|FG001|Overall Study|Study terminated by sponsor|2|||
30679202|NCT00826943|58693187|FG000|Overall Study|Withdrawal by Subject|0|||
30679203|NCT00826943|58693188|FG001|Overall Study|Withdrawal by Subject|0|||
30594165|NCT01193920|58606483|FG009|Overall Study|Lost to Follow-up|3|||
30594166|NCT01193920|58606474|FG000|Overall Study|Protocol Violation|1|||
30594167|NCT01193920|58606475|FG001|Overall Study|Protocol Violation|0|||
30679204|NCT00826943|58693189|FG002|Overall Study|Withdrawal by Subject|0|||
30679205|NCT00826943|58693190|FG003|Overall Study|Withdrawal by Subject|0|||
30679206|NCT00826943|58693191|FG004|Overall Study|Withdrawal by Subject|1|||
30679207|NCT00826943|58693192|FG005|Overall Study|Withdrawal by Subject|0|||
30679208|NCT00834041|58693202|FG000|Overall Study|Withdrawal by Subject|1|||
30679209|NCT00834041|58693203|FG001|Overall Study|Withdrawal by Subject|0|||
30594168|NCT01193920|58606476|FG002|Overall Study|Protocol Violation|0|||
30594169|NCT01193920|58606477|FG003|Overall Study|Protocol Violation|0|||
30594170|NCT01193920|58606478|FG004|Overall Study|Protocol Violation|0|||
30594171|NCT01193920|58606479|FG005|Overall Study|Protocol Violation|0|||
30594172|NCT01193920|58606480|FG006|Overall Study|Protocol Violation|0|||
30594173|NCT01193920|58606481|FG007|Overall Study|Protocol Violation|0|||
30594174|NCT01193920|58606482|FG008|Overall Study|Protocol Violation|0|||
30594175|NCT01193920|58606483|FG009|Overall Study|Protocol Violation|0|||
30594176|NCT01193920|58606474|FG000|Overall Study|Death|0|||
30594177|NCT01193920|58606475|FG001|Overall Study|Death|0|||
30594178|NCT01193920|58606476|FG002|Overall Study|Death|0|||
30594179|NCT01193920|58606477|FG003|Overall Study|Death|1|||
30594180|NCT01193920|58606478|FG004|Overall Study|Death|0|||
30594181|NCT01193920|58606479|FG005|Overall Study|Death|0|||
30594182|NCT01193920|58606480|FG006|Overall Study|Death|2|||
30594183|NCT01193920|58606481|FG007|Overall Study|Death|3|||
30594184|NCT01193920|58606482|FG008|Overall Study|Death|2|||
30679210|NCT00834041|58693202|FG000|Overall Study|Lost to Follow-up|0|||
30679211|NCT00834041|58693203|FG001|Overall Study|Lost to Follow-up|1|||
30679212|NCT00760929|58693213|FG000|Overall Study|Adverse Event|2|||
30679213|NCT00760929|58693214|FG001|Overall Study|Adverse Event|0|||
30679214|NCT00760929|58693215|FG002|Overall Study|Adverse Event|6|||
30679215|NCT00760929|58693216|FG003|Overall Study|Adverse Event|10|||
30594185|NCT01193920|58606483|FG009|Overall Study|Death|4|||
30594186|NCT01193920|58606474|FG000|Overall Study|Unable to classify|0|||
30679216|NCT00760929|58693213|FG000|Overall Study|Lack of Efficacy|0|||
30679217|NCT00760929|58693214|FG001|Overall Study|Lack of Efficacy|2|||
30679218|NCT00760929|58693215|FG002|Overall Study|Lack of Efficacy|1|||
30679219|NCT00760929|58693216|FG003|Overall Study|Lack of Efficacy|0|||
30679220|NCT00760929|58693213|FG000|Overall Study|Withdrawal by Subject|1|||
30679221|NCT00760929|58693214|FG001|Overall Study|Withdrawal by Subject|0|||
30679222|NCT00760929|58693215|FG002|Overall Study|Withdrawal by Subject|9|||
30679223|NCT00760929|58693216|FG003|Overall Study|Withdrawal by Subject|1|||
30679224|NCT00760929|58693213|FG000|Overall Study|Lost to Follow-up|0|||
30679225|NCT00760929|58693214|FG001|Overall Study|Lost to Follow-up|0|||
30679226|NCT00760929|58693215|FG002|Overall Study|Lost to Follow-up|1|||
30679227|NCT00760929|58693216|FG003|Overall Study|Lost to Follow-up|0|||
30679228|NCT00760929|58693213|FG000|Overall Study|Progression of Disease|21|||
30679229|NCT00760929|58693214|FG001|Overall Study|Progression of Disease|26|||
30594187|NCT01193920|58606475|FG001|Overall Study|Unable to classify|0|||
30594188|NCT01193920|58606476|FG002|Overall Study|Unable to classify|0|||
30594189|NCT01193920|58606477|FG003|Overall Study|Unable to classify|1|||
30594190|NCT01193920|58606478|FG004|Overall Study|Unable to classify|0|||
30594191|NCT01193920|58606479|FG005|Overall Study|Unable to classify|0|||
30594192|NCT01193920|58606480|FG006|Overall Study|Unable to classify|0|||
30594193|NCT01193920|58606481|FG007|Overall Study|Unable to classify|1|||
30594194|NCT01193920|58606482|FG008|Overall Study|Unable to classify|0|||
30594195|NCT01193920|58606483|FG009|Overall Study|Unable to classify|0|||
30594196|NCT01193686|58606508|FG000|Overall Study|Withdrawal by Subject|4|||
30594197|NCT01193686|58606509|FG001|Overall Study|Withdrawal by Subject|1|||
30594198|NCT01193686|58606508|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
30594199|NCT01193686|58606509|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
30594200|NCT01193608|58606522|FG000|Overall Study|Other|0|||
30594201|NCT01193608|58606523|FG001|Overall Study|Other|1|||
30594202|NCT01193608|58606524|FG002|Overall Study|Other|0|||
30594203|NCT01193608|58606525|FG003|Overall Study|Other|0|||
30594204|NCT01193608|58606526|FG004|Overall Study|Other|0|||
30594205|NCT01193608|58606527|FG005|Overall Study|Other|0|||
30594206|NCT01193608|58606522|FG000|Overall Study|Withdrawal by Subject|0|||
30594207|NCT01193608|58606523|FG001|Overall Study|Withdrawal by Subject|1|||
30594208|NCT01193608|58606524|FG002|Overall Study|Withdrawal by Subject|2|||
30594209|NCT01193608|58606525|FG003|Overall Study|Withdrawal by Subject|3|||
30594210|NCT01193608|58606526|FG004|Overall Study|Withdrawal by Subject|3|||
30594211|NCT01193608|58606527|FG005|Overall Study|Withdrawal by Subject|0|||
30594212|NCT01193608|58606522|FG000|Overall Study|Lost to Follow-up|0|||
30594213|NCT01193608|58606523|FG001|Overall Study|Lost to Follow-up|0|||
30594214|NCT01193608|58606524|FG002|Overall Study|Lost to Follow-up|0|||
30594215|NCT01193608|58606525|FG003|Overall Study|Lost to Follow-up|0|||
30594216|NCT01193608|58606526|FG004|Overall Study|Lost to Follow-up|1|||
30594217|NCT01193608|58606527|FG005|Overall Study|Lost to Follow-up|2|||
30594218|NCT01193608|58606522|FG000|Overall Study|Adverse Event|0|||
30594219|NCT01193608|58606523|FG001|Overall Study|Adverse Event|0|||
30594220|NCT01193608|58606524|FG002|Overall Study|Adverse Event|0|||
30594221|NCT01193608|58606525|FG003|Overall Study|Adverse Event|0|||
30594222|NCT01193608|58606526|FG004|Overall Study|Adverse Event|1|||
30594223|NCT01193608|58606527|FG005|Overall Study|Adverse Event|0|||
30594224|NCT01177228|58606550|FG000|Overall Study|Positive tuberculosis test|0|||
30679230|NCT00760929|58693215|FG002|Overall Study|Progression of Disease|38|||
30679231|NCT00760929|58693216|FG003|Overall Study|Progression of Disease|42|||
30679232|NCT00760929|58693213|FG000|Overall Study|Other|2|||
30679233|NCT00760929|58693214|FG001|Overall Study|Other|0|||
30679234|NCT00760929|58693215|FG002|Overall Study|Other|2|||
30679235|NCT00760929|58693216|FG003|Overall Study|Other|1|||
30679236|NCT00760929|58693213|FG000|Overall Study|Death|0|||
30679237|NCT00760929|58693214|FG001|Overall Study|Death|0|||
30679238|NCT00760929|58693215|FG002|Overall Study|Death|1|||
30679239|NCT00760929|58693216|FG003|Overall Study|Death|0|||
30594225|NCT01177228|58606551|FG001|Overall Study|Positive tuberculosis test|1|||
30594226|NCT01177228|58606552|FG002|Overall Study|Positive tuberculosis test|0|||
30679240|NCT00760929|58693213|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
30679241|NCT00760929|58693214|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
30679242|NCT00760929|58693215|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
30679243|NCT00760929|58693216|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
30679244|NCT00818207|58693227|FG000|Overall Study|Adverse Event|6|||
30679245|NCT00818207|58693228|FG001|Overall Study|Adverse Event|0|||
30594227|NCT01177228|58606553|FG003|Overall Study|Positive tuberculosis test|0|||
30594228|NCT01177228|58606550|FG000|Overall Study|Worsening disease activity|1|||
30594229|NCT01177228|58606551|FG001|Overall Study|Worsening disease activity|0|||
30594230|NCT01177228|58606552|FG002|Overall Study|Worsening disease activity|0|||
30594231|NCT01177228|58606553|FG003|Overall Study|Worsening disease activity|0|||
30594232|NCT01177228|58606550|FG000|Overall Study|Withdrawal by Subject|0|||
30594233|NCT01177228|58606551|FG001|Overall Study|Withdrawal by Subject|1|||
30594234|NCT01177228|58606552|FG002|Overall Study|Withdrawal by Subject|0|||
30594235|NCT01177228|58606553|FG003|Overall Study|Withdrawal by Subject|0|||
30594236|NCT01193530|58606570|FG000|Overall Study|Withdrawal by Subject|2|||
30594237|NCT01193530|58606571|FG001|Overall Study|Withdrawal by Subject|2|||
30594238|NCT01193530|58606570|FG000|Overall Study|Began Contraindicated Therapy|1|||
30594239|NCT01193530|58606571|FG001|Overall Study|Began Contraindicated Therapy|0|||
30594240|NCT01193530|58606570|FG000|Overall Study|Lost Light Box|0|||
30594241|NCT01193530|58606571|FG001|Overall Study|Lost Light Box|1|||
30594242|NCT01193530|58606570|FG000|Overall Study|Returned home - out of state|0|||
30594243|NCT01193530|58606571|FG001|Overall Study|Returned home - out of state|1|||
30594244|NCT01193530|58606570|FG000|Overall Study|Non-Compliance|0|||
30594245|NCT01193530|58606571|FG001|Overall Study|Non-Compliance|1|||
30594246|NCT00107172|58606579|FG000|Overall Study|Withdrawal by Subject|1|||
30594247|NCT00107172|58606580|FG001|Overall Study|Withdrawal by Subject|0|||
30594248|NCT00107172|58606579|FG000|Overall Study|Death|0|||
30594249|NCT00107172|58606580|FG001|Overall Study|Death|2|||
30594250|NCT00107172|58606579|FG000|Overall Study|Other Reason|4|||
30594251|NCT00107172|58606580|FG001|Overall Study|Other Reason|3|||
30594252|NCT01680965|58606594|FG000|Overall Study|Death|0|||
30594253|NCT01680965|58606595|FG001|Overall Study|Death|0|||
30594254|NCT01680965|58606596|FG002|Overall Study|Death|0|||
30594255|NCT01680965|58606597|FG003|Overall Study|Death|6|||
30594256|NCT01339923|58606612|FG000|Overall Study|Adverse Event|1|||
30594257|NCT01339923|58606613|FG001|Overall Study|Adverse Event|1|||
30594258|NCT01339923|58606614|FG002|Overall Study|Adverse Event|1|||
30594259|NCT01339923|58606615|FG003|Overall Study|Adverse Event|0|||
30679246|NCT00818207|58693227|FG000|Overall Study|Lost to Follow-up|160|||
30679247|NCT00818207|58693228|FG001|Overall Study|Lost to Follow-up|146|||
30679248|NCT00818207|58693227|FG000|Overall Study|Multiple reasons|11|||
30679249|NCT00818207|58693228|FG001|Overall Study|Multiple reasons|12|||
30679250|NCT00818207|58693227|FG000|Overall Study|Withdrawal by Subject|42|||
30679251|NCT00818207|58693228|FG001|Overall Study|Withdrawal by Subject|104|||
30679252|NCT00818207|58693227|FG000|Overall Study|Death|3|||
30679253|NCT00818207|58693228|FG001|Overall Study|Death|5|||
30679254|NCT00760617|58693237|FG000|Overall Study|Adverse Event|5|||
30679255|NCT00760617|58693238|FG001|Overall Study|Adverse Event|2|||
30679256|NCT00760617|58693239|FG002|Overall Study|Adverse Event|0|||
30679257|NCT00760617|58693237|FG000|Overall Study|Lost to Follow-up|0|||
30679258|NCT00760617|58693238|FG001|Overall Study|Lost to Follow-up|0|||
30679259|NCT00760617|58693239|FG002|Overall Study|Lost to Follow-up|5|||
30782575|NCT03346070|58794690|FG000|Overall Study|Withdrawal by Subject|1|||
30782576|NCT03346070|58794691|FG001|Overall Study|Withdrawal by Subject|0|||
30782577|NCT03346070|58794692|FG002|Overall Study|Withdrawal by Subject|0|||
30679260|NCT00760383|58693249|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
30679261|NCT00760383|58693250|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
30594260|NCT01339923|58606616|FG004|Overall Study|Adverse Event|0|||
30679262|NCT00759915|58693258|FG000|Overall Study|Withdrawal by Subject|1|||
30594261|NCT01339923|58606617|FG005|Overall Study|Adverse Event|0|||
30594262|NCT01339923|58606618|FG006|Overall Study|Adverse Event|1|||
30594263|NCT01339923|58606612|FG000|Overall Study|Inappropriate Enrollment|1|||
30594264|NCT01339923|58606613|FG001|Overall Study|Inappropriate Enrollment|0|||
30594265|NCT01339923|58606614|FG002|Overall Study|Inappropriate Enrollment|0|||
30782578|NCT03346070|58794693|FG003|Overall Study|Withdrawal by Subject|1|||
30594266|NCT01339923|58606615|FG003|Overall Study|Inappropriate Enrollment|0|||
30594267|NCT01339923|58606616|FG004|Overall Study|Inappropriate Enrollment|0|||
30679263|NCT00759915|58693259|FG001|Overall Study|Withdrawal by Subject|0|||
30594268|NCT01339923|58606617|FG005|Overall Study|Inappropriate Enrollment|1|||
30594269|NCT01339923|58606618|FG006|Overall Study|Inappropriate Enrollment|0|||
30594270|NCT01339923|58606612|FG000|Overall Study|Lost to Follow-up|4|||
30594271|NCT01339923|58606613|FG001|Overall Study|Lost to Follow-up|4|||
30594272|NCT01339923|58606614|FG002|Overall Study|Lost to Follow-up|0|||
30594273|NCT01339923|58606615|FG003|Overall Study|Lost to Follow-up|3|||
30679264|NCT00759915|58693258|FG000|Overall Study|Adverse Event|0|||
30679265|NCT00759915|58693259|FG001|Overall Study|Adverse Event|1|||
30679266|NCT00759759|58693267|FG000|Overall Study|didn't return for period 2|1|||
30679267|NCT00759759|58693268|FG001|Overall Study|didn't return for period 2|0|||
30594274|NCT01339923|58606616|FG004|Overall Study|Lost to Follow-up|1|||
30594275|NCT01339923|58606617|FG005|Overall Study|Lost to Follow-up|1|||
30594276|NCT01339923|58606618|FG006|Overall Study|Lost to Follow-up|5|||
30679268|NCT00759759|58693267|FG000|Overall Study|Didn't receive drug in period 2|1|||
30679269|NCT00759759|58693268|FG001|Overall Study|Didn't receive drug in period 2|0|||
30679270|NCT00759759|58693267|FG000|Overall Study|Withdrawal by Subject|2|||
30679271|NCT00759759|58693268|FG001|Overall Study|Withdrawal by Subject|1|||
30679272|NCT00759681|58693276|FG000|Overall Study|Death|2|||
30679273|NCT00759681|58693277|FG001|Overall Study|Death|5|||
30679274|NCT00759681|58693276|FG000|Overall Study|Lost to Follow-up|8|||
30679275|NCT00759681|58693277|FG001|Overall Study|Lost to Follow-up|5|||
30679276|NCT00826241|58693284|FG000|Overall Study|Withdrawal from Follow-up|1|||
30679277|NCT00826241|58693284|FG000|Overall Study|Withdrew consent|2|||
30679278|NCT00826241|58693284|FG000|Overall Study|Death|4|||
30679279|NCT00826241|58693284|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
30679280|NCT00826241|58693284|FG000|Overall Study|Non-compliance|1|||
30679281|NCT00826241|58693284|FG000|Overall Study|Progression of disease|1|||
30679282|NCT00826241|58693284|FG000|Overall Study|Patient refused follow-up|3|||
30679283|NCT00826241|58693284|FG000|Overall Study|Lost to Follow-up|9|||
30679284|NCT00826241|58693284|FG000|Overall Study|Could not obtain records|1|||
30679285|NCT00826241|58693284|FG000|Overall Study|Screen failure|2|||
30679286|NCT00826241|58693284|FG000|Overall Study|Pt unable to proceed to registration|1|||
30679287|NCT00826241|58693284|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
30679288|NCT00758589|58693292|FG000|Overall Study|Adverse Event|3|||
30679289|NCT00758589|58693293|FG001|Overall Study|Adverse Event|2|||
30679290|NCT00758589|58693294|FG002|Overall Study|Adverse Event|5|||
30679291|NCT00758589|58693295|FG003|Overall Study|Adverse Event|4|||
30679292|NCT00758589|58693292|FG000|Overall Study|Withdrawal by Subject|0|||
30679293|NCT00758589|58693293|FG001|Overall Study|Withdrawal by Subject|1|||
30679294|NCT00758589|58693294|FG002|Overall Study|Withdrawal by Subject|1|||
30679295|NCT00758589|58693295|FG003|Overall Study|Withdrawal by Subject|1|||
30679296|NCT00758589|58693292|FG000|Overall Study|Palm stopped to work|0|||
30679297|NCT00758589|58693293|FG001|Overall Study|Palm stopped to work|0|||
30679298|NCT00758589|58693294|FG002|Overall Study|Palm stopped to work|0|||
30679299|NCT00758589|58693295|FG003|Overall Study|Palm stopped to work|1|||
30679300|NCT00833417|58693307|FG000|Overall Study|Adverse Event|5|||
30679301|NCT00833417|58693308|FG001|Overall Study|Adverse Event|16|||
30679302|NCT00833417|58693307|FG000|Overall Study|Death|1|||
30679303|NCT00833417|58693308|FG001|Overall Study|Death|3|||
30679304|NCT00833417|58693307|FG000|Overall Study|Lost to Follow-up|1|||
30679305|NCT00833417|58693308|FG001|Overall Study|Lost to Follow-up|2|||
30679306|NCT00833417|58693307|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
30679307|NCT00833417|58693308|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
30679308|NCT00833417|58693307|FG000|Overall Study|Patient Decision to Withdraw|4|||
30679309|NCT00833417|58693308|FG001|Overall Study|Patient Decision to Withdraw|23|||
30679310|NCT00833417|58693307|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
30679311|NCT00833417|58693308|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
30679312|NCT00833417|58693307|FG000|Overall Study|Disease Progression|18|||
30679313|NCT00833417|58693308|FG001|Overall Study|Disease Progression|17|||
30679314|NCT00833417|58693307|FG000|Overall Study|Reason Not Specified|0|||
30679315|NCT00833417|58693308|FG001|Overall Study|Reason Not Specified|1|||
30679316|NCT00762372|58693318|FG000|Overall Study|Adverse Event|1|||
30679317|NCT00762372|58693319|FG001|Overall Study|Adverse Event|0|||
30679318|NCT00762372|58693320|FG002|Overall Study|Adverse Event|0|||
30679319|NCT00833261|58693334|FG000|Overall Study|Withdrawal by Subject|4|||
30679320|NCT00833105|58693338|FG000|Overall Study|Withdrawal by Subject|1|||
30679321|NCT00833105|58693338|FG000|Overall Study|Adverse Event|2|||
30594277|NCT01339923|58606612|FG000|Overall Study|Protocol Violation|0|||
30679322|NCT00833027|58693344|FG000|Overall Study|Adverse Event|33|||
30679323|NCT00833027|58693344|FG000|Overall Study|Death|1|||
30594278|NCT01339923|58606613|FG001|Overall Study|Protocol Violation|0|||
30594279|NCT01339923|58606614|FG002|Overall Study|Protocol Violation|0|||
30594280|NCT01339923|58606615|FG003|Overall Study|Protocol Violation|0|||
30594281|NCT01339923|58606616|FG004|Overall Study|Protocol Violation|0|||
30679324|NCT00833027|58693344|FG000|Overall Study|Lack of Efficacy|12|||
30679325|NCT00833027|58693344|FG000|Overall Study|Lost to Follow-up|24|||
30679326|NCT00833027|58693344|FG000|Overall Study|Protocol Violation|115|||
30679327|NCT00833027|58693344|FG000|Overall Study|Withdrawal by Subject|16|||
30594282|NCT01339923|58606617|FG005|Overall Study|Protocol Violation|3|||
30594283|NCT01339923|58606618|FG006|Overall Study|Protocol Violation|1|||
30679328|NCT00833027|58693344|FG000|Overall Study|Missing|10|||
30679329|NCT00752622|58693348|FG000|Induction Phase|Adverse Event|3|||
30679330|NCT00752622|58693348|FG000|Induction Phase|Other|3|||
30679331|NCT00752622|58693348|FG000|Induction Phase|Non-responder|14|||
30679332|NCT00752622|58693348|FG000|Induction Phase|Withdrawal by Subject|1|||
30679333|NCT00752622|58693348|FG000|Induction Phase|Premature study termination|14|||
30679334|NCT00752622|58693348|FG000|Observational Phase|Premature Study Termination|36|||
30679335|NCT00752622|58693348|FG000|Observational Phase|Non-responder|2|||
30679336|NCT00752622|58693348|FG000|Observational Phase|Withdrawal by Subject|2|||
30679337|NCT00752622|58693348|FG000|Observational Phase|Adverse Event|1|||
30679338|NCT00752622|58693348|FG000|Observational Phase|Other|2|||
30679339|NCT00752622|58693348|FG000|Interventional Phase|Non-responder|2|||
30679340|NCT00752622|58693348|FG000|Interventional Phase|Physician Decision|1|||
30679341|NCT00752622|58693348|FG000|Interventional Phase|Premature Study Termination|5|||
30679342|NCT00754650|58693353|FG000|Overall Study|Disease Progression|2|||
30679343|NCT00761748|58693357|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
30679344|NCT00761748|58693358|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
30679345|NCT00761748|58693357|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
30679346|NCT00761748|58693358|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
30679347|NCT00825305|58693366|FG000|Overall Study|Adverse Event|1|||
30679348|NCT00825305|58693367|FG001|Overall Study|Adverse Event|1|||
30679349|NCT00825305|58693366|FG000|Overall Study|Withdrawal by Subject|6|||
30679350|NCT00825305|58693367|FG001|Overall Study|Withdrawal by Subject|12|||
30679351|NCT00825305|58693366|FG000|Overall Study|Inappropriate inclusion|1|||
30679352|NCT00825305|58693367|FG001|Overall Study|Inappropriate inclusion|0|||
30679353|NCT00825305|58693366|FG000|Overall Study|Protocol Violation|9|||
30679354|NCT00825305|58693367|FG001|Overall Study|Protocol Violation|9|||
30679355|NCT00825305|58693366|FG000|Overall Study|Can not be classified|0|||
30679356|NCT00825305|58693367|FG001|Overall Study|Can not be classified|1|||
30679357|NCT00754572|58693373|FG000|Overall Study|Adverse Event|19|||
30679358|NCT00754572|58693373|FG000|Overall Study|Other|39|||
30679359|NCT00754572|58693373|FG000|Overall Study|Protocol Violation|3|||
30679360|NCT00754572|58693373|FG000|Overall Study|Withdrawal by Subject|3|||
30679361|NCT00754572|58693373|FG000|Overall Study|Lack of Efficacy|2|||
30679362|NCT00754572|58693373|FG000|Overall Study|Death|1|||
30679363|NCT00754572|58693373|FG000|Overall Study|Administrative Reason|3|||
30679364|NCT00754572|58693373|FG000|Overall Study|Lost to Follow-up|1|||
30679365|NCT00824993|58693379|FG000|Overall Study|Withdrawal by Subject|1|||
30679366|NCT00824993|58693380|FG001|Overall Study|Withdrawal by Subject|1|||
30679367|NCT00824993|58693379|FG000|Overall Study|Malignancy Relapse|9|||
30679368|NCT00824993|58693380|FG001|Overall Study|Malignancy Relapse|10|||
30679369|NCT00824993|58693379|FG000|Overall Study|Rapid Bone Loss|0|||
30782579|NCT03346070|58794694|FG004|Overall Study|Withdrawal by Subject|0|||
30782580|NCT03346070|58794690|FG000|Overall Study|Study medication not received as planned|2|||
30959041|NCT01587703|59024039|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
30594284|NCT01339923|58606612|FG000|Overall Study|Unable to Classify|1|||
30594285|NCT01339923|58606613|FG001|Overall Study|Unable to Classify|0|||
30594286|NCT01339923|58606614|FG002|Overall Study|Unable to Classify|1|||
30594287|NCT01339923|58606615|FG003|Overall Study|Unable to Classify|0|||
30594288|NCT01339923|58606616|FG004|Overall Study|Unable to Classify|0|||
30594289|NCT01339923|58606617|FG005|Overall Study|Unable to Classify|1|||
30594290|NCT01339923|58606618|FG006|Overall Study|Unable to Classify|5|||
30594291|NCT01339923|58606612|FG000|Overall Study|Withdrawal by Subject|7|||
30594292|NCT01339923|58606613|FG001|Overall Study|Withdrawal by Subject|11|||
30594293|NCT01339923|58606614|FG002|Overall Study|Withdrawal by Subject|6|||
30594294|NCT01339923|58606615|FG003|Overall Study|Withdrawal by Subject|1|||
30594295|NCT01339923|58606616|FG004|Overall Study|Withdrawal by Subject|4|||
30594296|NCT01339923|58606617|FG005|Overall Study|Withdrawal by Subject|3|||
30594297|NCT01339923|58606618|FG006|Overall Study|Withdrawal by Subject|2|||
30594298|NCT01380093|58606651|FG000|Naloxone Challenge Phase|Screen failures|21|||
30594299|NCT01380093|58606652|FG001|Naloxone Challenge Phase|Screen failures|0|||
30594300|NCT01380093|58606653|FG002|Naloxone Challenge Phase|Screen failures|0|||
30594301|NCT01380093|58606654|FG003|Naloxone Challenge Phase|Screen failures|0|||
30594302|NCT01380093|58606655|FG004|Naloxone Challenge Phase|Screen failures|0|||
30594303|NCT01380093|58606656|FG005|Naloxone Challenge Phase|Screen failures|0|||
30679370|NCT00824993|58693380|FG001|Overall Study|Rapid Bone Loss|1|||
30679371|NCT00824993|58693379|FG000|Overall Study|Non-Compliant|2|||
30679372|NCT00824993|58693380|FG001|Overall Study|Non-Compliant|1|||
30679373|NCT00824993|58693379|FG000|Overall Study|Insurance Issue|2|||
30679374|NCT00824993|58693380|FG001|Overall Study|Insurance Issue|1|||
30679375|NCT00824993|58693379|FG000|Overall Study|Death|0|||
30594304|NCT01380093|58606657|FG006|Naloxone Challenge Phase|Screen failures|0|||
30594305|NCT01380093|58606658|FG007|Naloxone Challenge Phase|Screen failures|0|||
30594306|NCT01380093|58606659|FG008|Naloxone Challenge Phase|Screen failures|0|||
30594307|NCT01380093|58606651|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
30679376|NCT00824993|58693380|FG001|Overall Study|Death|3|||
30679377|NCT00832091|58693388|FG000|Overall Study|Adverse Event|1|||
30679378|NCT00832091|58693389|FG001|Overall Study|Adverse Event|1|||
30679379|NCT00832091|58693388|FG000|Overall Study|Protocol Violation|1|||
30679380|NCT00832091|58693389|FG001|Overall Study|Protocol Violation|0|||
30679381|NCT00832091|58693388|FG000|Overall Study|Withdrawal by Subject|2|||
30679382|NCT00832091|58693389|FG001|Overall Study|Withdrawal by Subject|1|||
30679383|NCT00832091|58693388|FG000|Overall Study|Prohibited Medication|1|||
30679384|NCT00832091|58693389|FG001|Overall Study|Prohibited Medication|0|||
30679385|NCT00754338|58693399|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
30679386|NCT00754338|58693400|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
30679387|NCT00754338|58693401|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
30679388|NCT00754338|58693402|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
30679389|NCT00754338|58693399|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
30679390|NCT00754338|58693400|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
30679391|NCT00754338|58693401|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
30679392|NCT00754338|58693402|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
30679393|NCT00761514|58693414|FG000|Overall Study|Adverse Event|1|||
30679394|NCT00761514|58693414|FG000|Overall Study|Withdrawal by Subject|2|||
30679395|NCT00761514|58693414|FG000|Overall Study|Lost to Follow-up|1|||
30679396|NCT00761514|58693414|FG000|Overall Study|Health insurance didn't cover study drug|1|||
30679397|NCT00761514|58693414|FG000|Overall Study|Problem complying with study visit|1|||
30679398|NCT00761514|58693414|FG000|Overall Study|Unable to pay for medications|1|||
30679399|NCT00831779|58693420|FG000|Overall Study|Lost to Follow-up|1|||
30679400|NCT00831779|58693421|FG001|Overall Study|Lost to Follow-up|0|||
30594308|NCT01380093|58606652|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
30594309|NCT01380093|58606653|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
30594310|NCT01380093|58606654|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
30594311|NCT01380093|58606655|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
30594312|NCT01380093|58606656|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
30594313|NCT01380093|58606657|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
30594314|NCT01380093|58606658|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
30679401|NCT00831779|58693420|FG000|Overall Study|No longer met criteria|0|||
30679402|NCT00831779|58693421|FG001|Overall Study|No longer met criteria|1|||
30679403|NCT00758043|58693431|FG000|Overall Study|Adverse Event|1|||
30679404|NCT00758043|58693432|FG001|Overall Study|Adverse Event|20|||
30679405|NCT00758043|58693433|FG002|Overall Study|Adverse Event|12|||
30782581|NCT03346070|58794691|FG001|Overall Study|Study medication not received as planned|3|||
30782582|NCT03346070|58794692|FG002|Overall Study|Study medication not received as planned|2|||
30782583|NCT03346070|58794693|FG003|Overall Study|Study medication not received as planned|3|||
30782584|NCT03346070|58794694|FG004|Overall Study|Study medication not received as planned|2|||
30782585|NCT03346070|58794690|FG000|Overall Study|Screen Failure|0|||
30782586|NCT03346070|58794691|FG001|Overall Study|Screen Failure|0|||
30782587|NCT03346070|58794692|FG002|Overall Study|Screen Failure|0|||
30782588|NCT03346070|58794693|FG003|Overall Study|Screen Failure|1|||
30782589|NCT03346070|58794694|FG004|Overall Study|Screen Failure|1|||
30782590|NCT02951780|58794717|FG000|Period 1|Adverse Event|0|||
30782591|NCT02951780|58794718|FG001|Period 1|Adverse Event|0|||
30782592|NCT02951780|58794719|FG002|Period 1|Adverse Event|0|||
30782593|NCT02951780|58794720|FG003|Period 1|Adverse Event|1|||
30782594|NCT02951780|58794721|FG004|Period 1|Adverse Event|0|||
30782595|NCT02951780|58794722|FG005|Period 1|Adverse Event|0|||
30782596|NCT02951780|58794723|FG006|Period 1|Adverse Event|0|||
30782597|NCT02951780|58794724|FG007|Period 1|Adverse Event|0|||
30782598|NCT02951780|58794725|FG008|Period 1|Adverse Event|0|||
30782599|NCT02951780|58794717|FG000|Period 1|Scheduling Conflicts|0|||
30782600|NCT02951780|58794718|FG001|Period 1|Scheduling Conflicts|0|||
30782601|NCT02951780|58794719|FG002|Period 1|Scheduling Conflicts|0|||
30782602|NCT02951780|58794720|FG003|Period 1|Scheduling Conflicts|0|||
30782603|NCT02951780|58794721|FG004|Period 1|Scheduling Conflicts|0|||
30782604|NCT02951780|58794722|FG005|Period 1|Scheduling Conflicts|0|||
30782605|NCT02951780|58794723|FG006|Period 1|Scheduling Conflicts|0|||
30782606|NCT02951780|58794724|FG007|Period 1|Scheduling Conflicts|1|||
30782607|NCT02951780|58794725|FG008|Period 1|Scheduling Conflicts|0|||
30782608|NCT02951780|58794717|FG000|Period 2|Scheduling Conflicts|0|||
30594315|NCT01380093|58606659|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
30594316|NCT01380093|58606651|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
30782609|NCT02951780|58794718|FG001|Period 2|Scheduling Conflicts|0|||
30782610|NCT02951780|58794719|FG002|Period 2|Scheduling Conflicts|0|||
30782611|NCT02951780|58794720|FG003|Period 2|Scheduling Conflicts|0|||
30782612|NCT02951780|58794721|FG004|Period 2|Scheduling Conflicts|0|||
30782613|NCT02951780|58794722|FG005|Period 2|Scheduling Conflicts|0|||
30782614|NCT02951780|58794723|FG006|Period 2|Scheduling Conflicts|0|||
30782615|NCT02951780|58794724|FG007|Period 2|Scheduling Conflicts|1|||
30782616|NCT02951780|58794725|FG008|Period 2|Scheduling Conflicts|0|||
30679406|NCT00758043|58693434|FG003|Overall Study|Adverse Event|62|||
30679407|NCT00758043|58693431|FG000|Overall Study|Lack of Efficacy|0|||
30679408|NCT00758043|58693432|FG001|Overall Study|Lack of Efficacy|6|||
30679409|NCT00758043|58693433|FG002|Overall Study|Lack of Efficacy|18|||
30679410|NCT00758043|58693434|FG003|Overall Study|Lack of Efficacy|12|||
30679411|NCT00758043|58693431|FG000|Overall Study|Refused Further Treatment|0|||
30679412|NCT00758043|58693432|FG001|Overall Study|Refused Further Treatment|11|||
30679413|NCT00758043|58693433|FG002|Overall Study|Refused Further Treatment|5|||
30679414|NCT00758043|58693434|FG003|Overall Study|Refused Further Treatment|8|||
30679415|NCT00758043|58693431|FG000|Overall Study|Lost to Follow-up|0|||
30679416|NCT00758043|58693432|FG001|Overall Study|Lost to Follow-up|2|||
30594317|NCT01380093|58606652|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
30594318|NCT01380093|58606653|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
30594319|NCT01380093|58606654|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
30594320|NCT01380093|58606655|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
30594321|NCT01380093|58606656|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
30594322|NCT01380093|58606657|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
30594323|NCT01380093|58606658|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
30594324|NCT01380093|58606659|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
30594325|NCT01380093|58606651|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
30594326|NCT01380093|58606652|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
30679417|NCT00758043|58693433|FG002|Overall Study|Lost to Follow-up|2|||
30679418|NCT00758043|58693434|FG003|Overall Study|Lost to Follow-up|5|||
30679419|NCT00758043|58693431|FG000|Overall Study|Withdrawal by Subject|0|||
30594327|NCT01380093|58606653|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
30679420|NCT00758043|58693432|FG001|Overall Study|Withdrawal by Subject|1|||
30679421|NCT00758043|58693433|FG002|Overall Study|Withdrawal by Subject|1|||
30679422|NCT00758043|58693434|FG003|Overall Study|Withdrawal by Subject|4|||
30679423|NCT00758043|58693431|FG000|Overall Study|Required Prohibited Medication|0|||
30679424|NCT00758043|58693432|FG001|Overall Study|Required Prohibited Medication|0|||
30679425|NCT00758043|58693433|FG002|Overall Study|Required Prohibited Medication|1|||
30679426|NCT00758043|58693434|FG003|Overall Study|Required Prohibited Medication|3|||
30679427|NCT00758043|58693431|FG000|Overall Study|Non-Compliant With study Drug|0|||
30679428|NCT00758043|58693432|FG001|Overall Study|Non-Compliant With study Drug|0|||
30679429|NCT00758043|58693433|FG002|Overall Study|Non-Compliant With study Drug|0|||
30679430|NCT00758043|58693434|FG003|Overall Study|Non-Compliant With study Drug|1|||
30679431|NCT00758043|58693431|FG000|Overall Study|Other Reasons|0|||
30679432|NCT00758043|58693432|FG001|Overall Study|Other Reasons|1|||
30679433|NCT00758043|58693433|FG002|Overall Study|Other Reasons|0|||
30679434|NCT00758043|58693434|FG003|Overall Study|Other Reasons|5|||
30679435|NCT00831701|58693452|FG000|Overall Study|Withdrawal by Subject|2|||
30679436|NCT00831701|58693453|FG001|Overall Study|Withdrawal by Subject|0|||
30679437|NCT00831701|58693452|FG000|Overall Study|Stone expulsion before first medication|2|||
30679438|NCT00831701|58693453|FG001|Overall Study|Stone expulsion before first medication|2|||
30679439|NCT00831701|58693452|FG000|Overall Study|Lost to Follow-up|1|||
30679440|NCT00831701|58693453|FG001|Overall Study|Lost to Follow-up|3|||
30679441|NCT00752895|58693461|FG000|Overall Study|Withdrawal by Subject|8|||
30679442|NCT00752895|58693462|FG001|Overall Study|Withdrawal by Subject|3|||
30679443|NCT00831389|58693470|FG000|Overall Study|Withdrawal by Subject|0|||
30679444|NCT00831389|58693471|FG001|Overall Study|Withdrawal by Subject|1|||
30679445|NCT00831311|58693479|FG000|Overall Study|Definitive Contraindication|3|||
30679446|NCT00831311|58693480|FG001|Overall Study|Definitive Contraindication|3|||
30679447|NCT00831311|58693479|FG000|Overall Study|Lost to Follow-up|3|||
30679448|NCT00831311|58693480|FG001|Overall Study|Lost to Follow-up|0|||
30679449|NCT00831311|58693479|FG000|Overall Study|Physician Decision|0|||
30679450|NCT00831311|58693480|FG001|Overall Study|Physician Decision|1|||
30679451|NCT00831311|58693479|FG000|Overall Study|Withdrawal by Subject|6|||
30679452|NCT00831311|58693480|FG001|Overall Study|Withdrawal by Subject|4|||
30679453|NCT00831233|58693489|FG000|Overall Study|Adverse Event|0|||
30679454|NCT00831233|58693490|FG001|Overall Study|Adverse Event|1|||
30679455|NCT00831233|58693489|FG000|Overall Study|Protocol Violation|1|||
30679456|NCT00831233|58693490|FG001|Overall Study|Protocol Violation|0|||
30679457|NCT00831233|58693489|FG000|Overall Study|Selection Criteria Not Met|2|||
30679458|NCT00831233|58693490|FG001|Overall Study|Selection Criteria Not Met|0|||
30679459|NCT00761280|58693507|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
30679460|NCT00761280|58693508|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
30679461|NCT00761280|58693507|FG000|Randomization to First Dose|Sponsor decision|1|||
30594328|NCT01380093|58606654|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
30594329|NCT01380093|58606655|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
30594330|NCT01380093|58606656|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
30679462|NCT00761280|58693508|FG001|Randomization to First Dose|Sponsor decision|0|||
30679463|NCT00761280|58693507|FG000|Randomization to First Dose|Other|1|||
30679464|NCT00761280|58693508|FG001|Randomization to First Dose|Other|0|||
30679465|NCT00761280|58693507|FG000|First Dose to End of Study|End of trial|5|||
30679466|NCT00761280|58693508|FG001|First Dose to End of Study|End of trial|5|||
30679467|NCT00761280|58693507|FG000|First Dose to End of Study|Progressive disease|5|||
30679468|NCT00761280|58693508|FG001|First Dose to End of Study|Progressive disease|3|||
30679469|NCT00761280|58693507|FG000|First Dose to End of Study|Sponsor decision|1|||
30679470|NCT00761280|58693508|FG001|First Dose to End of Study|Sponsor decision|2|||
30679471|NCT00761280|58693507|FG000|First Dose to End of Study|Death|1|||
30679472|NCT00761280|58693508|FG001|First Dose to End of Study|Death|0|||
30679473|NCT00761280|58693507|FG000|First Dose to End of Study|Lost to Follow-up|0|||
30594331|NCT01380093|58606657|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
30594332|NCT01380093|58606658|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
30594333|NCT01380093|58606659|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
30594334|NCT01380093|58606651|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
30679474|NCT00761280|58693508|FG001|First Dose to End of Study|Lost to Follow-up|1|||
30594335|NCT01380093|58606652|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
30594336|NCT01380093|58606653|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
30594337|NCT01380093|58606654|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
30679475|NCT00824369|58693520|FG000|Overall Study|Nolonger willing to participate in study|1|||
30679476|NCT00824369|58693521|FG001|Overall Study|Nolonger willing to participate in study|0|||
30679477|NCT00824369|58693522|FG002|Overall Study|Nolonger willing to participate in study|1|||
30679478|NCT00824369|58693523|FG003|Overall Study|Nolonger willing to participate in study|2|||
30679479|NCT00824369|58693524|FG004|Overall Study|Nolonger willing to participate in study|0|||
30679480|NCT00824369|58693525|FG005|Overall Study|Nolonger willing to participate in study|1|||
30679481|NCT00824369|58693520|FG000|Overall Study|Lost to Follow-up|0|||
30679482|NCT00824369|58693521|FG001|Overall Study|Lost to Follow-up|0|||
30679483|NCT00824369|58693522|FG002|Overall Study|Lost to Follow-up|0|||
30679484|NCT00824369|58693523|FG003|Overall Study|Lost to Follow-up|0|||
30679485|NCT00824369|58693524|FG004|Overall Study|Lost to Follow-up|1|||
30679486|NCT00824369|58693525|FG005|Overall Study|Lost to Follow-up|0|||
30679487|NCT00824291|58693541|FG000|Overall Study|Adverse Event|15|||
30679488|NCT00824291|58693542|FG001|Overall Study|Adverse Event|6|||
30679489|NCT00824291|58693541|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
30679490|NCT00824291|58693542|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
30679491|NCT00824291|58693541|FG000|Overall Study|Lost to Follow-up|11|||
30679492|NCT00824291|58693542|FG001|Overall Study|Lost to Follow-up|9|||
30679493|NCT00824291|58693541|FG000|Overall Study|Non-compliance|1|||
30679494|NCT00824291|58693542|FG001|Overall Study|Non-compliance|1|||
30679495|NCT00824291|58693541|FG000|Overall Study|Protocol Violation|4|||
30679496|NCT00824291|58693542|FG001|Overall Study|Protocol Violation|1|||
30679497|NCT00824291|58693541|FG000|Overall Study|Withdrawal by Subject|14|||
30679498|NCT00824291|58693542|FG001|Overall Study|Withdrawal by Subject|8|||
30679499|NCT00824291|58693541|FG000|Overall Study|Lack of Efficacy|7|||
30679500|NCT00824291|58693542|FG001|Overall Study|Lack of Efficacy|8|||
30679501|NCT00824291|58693541|FG000|Overall Study|Participant on prohibited medication|1|||
30679502|NCT00824291|58693542|FG001|Overall Study|Participant on prohibited medication|0|||
30679503|NCT00804986|58693554|FG000|Overall Study|Adverse Event|0|||
30679504|NCT00804986|58693555|FG001|Overall Study|Adverse Event|1|||
30679505|NCT00804986|58693556|FG002|Overall Study|Adverse Event|2|||
30679506|NCT00804986|58693557|FG003|Overall Study|Adverse Event|1|||
30679507|NCT00804986|58693558|FG004|Overall Study|Adverse Event|3|||
30679508|NCT00804986|58693559|FG005|Overall Study|Adverse Event|0|||
30679509|NCT00804986|58693554|FG000|Overall Study|Lack of Efficacy|0|||
30679510|NCT00804986|58693555|FG001|Overall Study|Lack of Efficacy|0|||
30679511|NCT00804986|58693556|FG002|Overall Study|Lack of Efficacy|0|||
30679512|NCT00804986|58693557|FG003|Overall Study|Lack of Efficacy|1|||
30679513|NCT00804986|58693558|FG004|Overall Study|Lack of Efficacy|0|||
30679514|NCT00804986|58693559|FG005|Overall Study|Lack of Efficacy|3|||
30679515|NCT00804986|58693554|FG000|Overall Study|Lost to Follow-up|0|||
30679516|NCT00804986|58693555|FG001|Overall Study|Lost to Follow-up|0|||
30679517|NCT00804986|58693556|FG002|Overall Study|Lost to Follow-up|0|||
30679518|NCT00804986|58693557|FG003|Overall Study|Lost to Follow-up|1|||
30679519|NCT00804986|58693558|FG004|Overall Study|Lost to Follow-up|1|||
30594338|NCT01380093|58606655|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
30782617|NCT03334214|58794747|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
30594339|NCT01380093|58606656|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
30679520|NCT00804986|58693559|FG005|Overall Study|Lost to Follow-up|3|||
30679521|NCT00804986|58693554|FG000|Overall Study|Protocol Violation|0|||
30679522|NCT00804986|58693555|FG001|Overall Study|Protocol Violation|1|||
30679523|NCT00804986|58693556|FG002|Overall Study|Protocol Violation|0|||
30679524|NCT00804986|58693557|FG003|Overall Study|Protocol Violation|1|||
30679525|NCT00804986|58693558|FG004|Overall Study|Protocol Violation|0|||
30679526|NCT00804986|58693559|FG005|Overall Study|Protocol Violation|0|||
30679527|NCT00804986|58693554|FG000|Overall Study|Withdrawal by Subject|0|||
30679528|NCT00804986|58693555|FG001|Overall Study|Withdrawal by Subject|3|||
30679529|NCT00804986|58693556|FG002|Overall Study|Withdrawal by Subject|0|||
30679530|NCT00804986|58693557|FG003|Overall Study|Withdrawal by Subject|3|||
30594340|NCT01380093|58606657|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
30594341|NCT01380093|58606658|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
30594342|NCT01380093|58606659|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
30594343|NCT01380093|58606651|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
30594344|NCT01380093|58606652|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
30594345|NCT01380093|58606653|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
30594346|NCT01380093|58606654|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
30594347|NCT01380093|58606655|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
30594348|NCT01380093|58606656|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
30594349|NCT01380093|58606657|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
30594350|NCT01380093|58606658|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
30594351|NCT01380093|58606659|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
30594352|NCT01380093|58606651|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
30679531|NCT00804986|58693558|FG004|Overall Study|Withdrawal by Subject|5|||
30679532|NCT00804986|58693559|FG005|Overall Study|Withdrawal by Subject|3|||
30679533|NCT00804986|58693554|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
30679534|NCT00804986|58693555|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
30679535|NCT00804986|58693556|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
30679536|NCT00804986|58693557|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
30679537|NCT00804986|58693558|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
30679538|NCT00804986|58693559|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
30594353|NCT01380093|58606652|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
30594354|NCT01380093|58606653|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
30594355|NCT01380093|58606654|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
30594356|NCT01380093|58606655|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
30594357|NCT01380093|58606656|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
30594358|NCT01380093|58606657|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
30594359|NCT01380093|58606658|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
30594360|NCT01380093|58606659|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
30594361|NCT01380093|58606651|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
30594362|NCT01380093|58606652|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
30594363|NCT01380093|58606653|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
30594364|NCT01380093|58606654|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
30594365|NCT01380093|58606655|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
30594366|NCT01380093|58606656|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
30594367|NCT01380093|58606657|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
30594368|NCT01380093|58606658|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
30679539|NCT00804986|58693554|FG000|Overall Study|Sponsor Decision|0|||
30679540|NCT00804986|58693555|FG001|Overall Study|Sponsor Decision|1|||
30594369|NCT01380093|58606659|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
30594370|NCT01380093|58606651|FG000|Treatment Phase: Second Intervention|Other|0|||
30679541|NCT00804986|58693556|FG002|Overall Study|Sponsor Decision|0|||
30679542|NCT00804986|58693557|FG003|Overall Study|Sponsor Decision|0|||
30679543|NCT00804986|58693558|FG004|Overall Study|Sponsor Decision|0|||
30679544|NCT00804986|58693559|FG005|Overall Study|Sponsor Decision|0|||
30679545|NCT00804986|58693554|FG000|Overall Study|Physician Decision|1|||
30679546|NCT00804986|58693555|FG001|Overall Study|Physician Decision|0|||
30679547|NCT00804986|58693556|FG002|Overall Study|Physician Decision|0|||
30679548|NCT00804986|58693557|FG003|Overall Study|Physician Decision|0|||
30679549|NCT00804986|58693558|FG004|Overall Study|Physician Decision|0|||
30679550|NCT00804986|58693559|FG005|Overall Study|Physician Decision|0|||
30679551|NCT00752232|58693580|FG000|Overall Study|Protocol Violation|0|||
30679552|NCT00752232|58693581|FG001|Overall Study|Protocol Violation|0|||
30679553|NCT00752232|58693582|FG002|Overall Study|Protocol Violation|0|||
30679554|NCT00752232|58693583|FG003|Overall Study|Protocol Violation|0|||
30679555|NCT00752232|58693584|FG004|Overall Study|Protocol Violation|0|||
30679556|NCT00752232|58693585|FG005|Overall Study|Protocol Violation|1|||
30679557|NCT00752232|58693586|FG006|Overall Study|Protocol Violation|0|||
30679558|NCT00752232|58693580|FG000|Overall Study|Caregiver request|2|||
30679559|NCT00752232|58693581|FG001|Overall Study|Caregiver request|0|||
30679560|NCT00752232|58693582|FG002|Overall Study|Caregiver request|0|||
30679561|NCT00752232|58693583|FG003|Overall Study|Caregiver request|0|||
30782618|NCT03334214|58794748|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
30782619|NCT03334214|58794747|FG000|Overall Study|Withdrawal by Subject|0|||
30594371|NCT01380093|58606652|FG001|Treatment Phase: Second Intervention|Other|0|||
30679562|NCT00752232|58693584|FG004|Overall Study|Caregiver request|1|||
30679563|NCT00752232|58693585|FG005|Overall Study|Caregiver request|0|||
30679564|NCT00752232|58693586|FG006|Overall Study|Caregiver request|0|||
30679565|NCT00752232|58693580|FG000|Overall Study|Investigator request|0|||
30679566|NCT00752232|58693581|FG001|Overall Study|Investigator request|0|||
30679567|NCT00752232|58693582|FG002|Overall Study|Investigator request|0|||
30856113|NCT03686215|58883993|FG001|Overall Study|Protocol Violation|0|||
30679568|NCT00752232|58693583|FG003|Overall Study|Investigator request|0|||
30679569|NCT00752232|58693584|FG004|Overall Study|Investigator request|1|||
30679570|NCT00752232|58693585|FG005|Overall Study|Investigator request|0|||
30679571|NCT00752232|58693586|FG006|Overall Study|Investigator request|0|||
30679572|NCT00752232|58693580|FG000|Overall Study|Subject request|0|||
30679573|NCT00752232|58693581|FG001|Overall Study|Subject request|0|||
30679574|NCT00752232|58693582|FG002|Overall Study|Subject request|1|||
30679575|NCT00752232|58693583|FG003|Overall Study|Subject request|0|||
30679576|NCT00752232|58693584|FG004|Overall Study|Subject request|0|||
30679577|NCT00752232|58693585|FG005|Overall Study|Subject request|0|||
30679578|NCT00752232|58693586|FG006|Overall Study|Subject request|0|||
30679579|NCT00752232|58693580|FG000|Overall Study|Group home admission|0|||
30679580|NCT00752232|58693581|FG001|Overall Study|Group home admission|0|||
30679581|NCT00752232|58693582|FG002|Overall Study|Group home admission|0|||
30679582|NCT00752232|58693583|FG003|Overall Study|Group home admission|1|||
30679583|NCT00752232|58693584|FG004|Overall Study|Group home admission|0|||
30679584|NCT00752232|58693585|FG005|Overall Study|Group home admission|0|||
30679585|NCT00752232|58693586|FG006|Overall Study|Group home admission|0|||
30679586|NCT00752232|58693580|FG000|Overall Study|Caregiver could not attend the subject|0|||
30679587|NCT00752232|58693581|FG001|Overall Study|Caregiver could not attend the subject|0|||
30679588|NCT00752232|58693582|FG002|Overall Study|Caregiver could not attend the subject|0|||
30679589|NCT00752232|58693583|FG003|Overall Study|Caregiver could not attend the subject|0|||
30679590|NCT00752232|58693584|FG004|Overall Study|Caregiver could not attend the subject|1|||
30679591|NCT00752232|58693585|FG005|Overall Study|Caregiver could not attend the subject|0|||
30679592|NCT00752232|58693586|FG006|Overall Study|Caregiver could not attend the subject|0|||
30679593|NCT00760266|58693605|FG000|Overall Study|Adverse Event|13|||
30679594|NCT00760266|58693606|FG001|Overall Study|Adverse Event|7|||
30679595|NCT00760266|58693605|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30679596|NCT00760266|58693606|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30679597|NCT00760266|58693605|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30679598|NCT00760266|58693606|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30679599|NCT00760266|58693605|FG000|Overall Study|Lack of Efficacy|2|||
30679600|NCT00760266|58693606|FG001|Overall Study|Lack of Efficacy|2|||
30679601|NCT00760266|58693605|FG000|Overall Study|Protocol deviation|2|||
30679602|NCT00760266|58693606|FG001|Overall Study|Protocol deviation|4|||
30679603|NCT00760266|58693605|FG000|Overall Study|Patient withdrew consent|3|||
30679604|NCT00760266|58693606|FG001|Overall Study|Patient withdrew consent|3|||
30679605|NCT00760266|58693605|FG000|Overall Study|Lost to Follow-up|2|||
30679606|NCT00760266|58693606|FG001|Overall Study|Lost to Follow-up|1|||
30679607|NCT00760266|58693605|FG000|Overall Study|Administrative Problems|0|||
30679608|NCT00760266|58693606|FG001|Overall Study|Administrative Problems|1|||
30679609|NCT00753714|58693614|FG000|Overall Study|Lack of Efficacy|21|||
30679610|NCT00753714|58693615|FG001|Overall Study|Lack of Efficacy|34|||
30679611|NCT00753714|58693614|FG000|Overall Study|Adverse Event|26|||
30679612|NCT00753714|58693615|FG001|Overall Study|Adverse Event|18|||
30679613|NCT00753714|58693614|FG000|Overall Study|Protocol Violation|1|||
30679614|NCT00753714|58693615|FG001|Overall Study|Protocol Violation|0|||
30679615|NCT00753714|58693614|FG000|Overall Study|Lost to Follow-up|0|||
30679616|NCT00753714|58693615|FG001|Overall Study|Lost to Follow-up|1|||
30679617|NCT00753714|58693614|FG000|Overall Study|Withdrawal by Subject|2|||
30679618|NCT00753714|58693615|FG001|Overall Study|Withdrawal by Subject|1|||
30679619|NCT00753714|58693614|FG000|Overall Study|Death|3|||
30594372|NCT01380093|58606653|FG002|Treatment Phase: Second Intervention|Other|0|||
30594373|NCT01380093|58606654|FG003|Treatment Phase: Second Intervention|Other|1|||
30594374|NCT01380093|58606655|FG004|Treatment Phase: Second Intervention|Other|0|||
30594375|NCT01380093|58606656|FG005|Treatment Phase: Second Intervention|Other|0|||
30594376|NCT01380093|58606657|FG006|Treatment Phase: Second Intervention|Other|0|||
30594377|NCT01380093|58606658|FG007|Treatment Phase: Second Intervention|Other|0|||
30594378|NCT01380093|58606659|FG008|Treatment Phase: Second Intervention|Other|0|||
30594379|NCT01380093|58606651|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
30594380|NCT01380093|58606652|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
30594381|NCT01380093|58606653|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
30594382|NCT01380093|58606654|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
30594383|NCT01380093|58606655|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
30856114|NCT03686215|58883994|FG002|Overall Study|Protocol Violation|4|||
30594384|NCT01380093|58606656|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
30594385|NCT01380093|58606657|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
30679620|NCT00753714|58693615|FG001|Overall Study|Death|3|||
30679621|NCT00753714|58693614|FG000|Overall Study|Other|7|||
30679622|NCT00753714|58693615|FG001|Overall Study|Other|5|||
30679623|NCT00759954|58693626|FG000|Overall Study|Personal reason|1|||
30679624|NCT00759954|58693627|FG001|Overall Study|Personal reason|0|||
30679625|NCT00759954|58693626|FG000|Overall Study|Adverse Event|1|||
30679626|NCT00759954|58693627|FG001|Overall Study|Adverse Event|2|||
30679627|NCT00804908|58693636|FG000|Overall Study|Other|115|||
30594386|NCT01380093|58606658|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
30594387|NCT01380093|58606659|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
30594388|NCT01380093|58606651|FG000|Treatment Phase: Third Intervention|Other|0|||
30594389|NCT01380093|58606652|FG001|Treatment Phase: Third Intervention|Other|0|||
30594390|NCT01380093|58606653|FG002|Treatment Phase: Third Intervention|Other|0|||
30594391|NCT01380093|58606654|FG003|Treatment Phase: Third Intervention|Other|0|||
30594392|NCT01380093|58606655|FG004|Treatment Phase: Third Intervention|Other|0|||
30594393|NCT01380093|58606656|FG005|Treatment Phase: Third Intervention|Other|0|||
30594394|NCT01380093|58606657|FG006|Treatment Phase: Third Intervention|Other|0|||
30594395|NCT01380093|58606658|FG007|Treatment Phase: Third Intervention|Other|0|||
30594396|NCT01380093|58606659|FG008|Treatment Phase: Third Intervention|Other|1|||
30594397|NCT01379937|58606677|FG000|Overall Study|Protocol Violation|0|||
30594398|NCT01379937|58606678|FG001|Overall Study|Protocol Violation|0|||
30594399|NCT01379937|58606679|FG002|Overall Study|Protocol Violation|0|||
30594400|NCT01379937|58606680|FG003|Overall Study|Protocol Violation|1|||
30594401|NCT01379937|58606677|FG000|Overall Study|Consent withdrawal|0|||
30594402|NCT01379937|58606678|FG001|Overall Study|Consent withdrawal|1|||
30594403|NCT01379937|58606679|FG002|Overall Study|Consent withdrawal|0|||
30594404|NCT01379937|58606680|FG003|Overall Study|Consent withdrawal|0|||
30679628|NCT00804908|58693637|FG001|Overall Study|Other|116|||
30679629|NCT00804908|58693638|FG002|Overall Study|Other|114|||
30679630|NCT00808808|58693649|FG000|Overall Study|Vaccinated; survey not completed|131|||
30679631|NCT00808808|58693650|FG001|Overall Study|Vaccinated; survey not completed|169|||
30679632|NCT00808808|58693651|FG002|Overall Study|Vaccinated; survey not completed|302|||
30679633|NCT00808808|58693649|FG000|Overall Study|Employee was not vaccinated.|2686|||
30679634|NCT00808808|58693650|FG001|Overall Study|Employee was not vaccinated.|2268|||
30679635|NCT00808808|58693651|FG002|Overall Study|Employee was not vaccinated.|2255|||
30679636|NCT00589784|58693667|FG000|Overall Study|Withdrawal by Subject|0|||
30679637|NCT00589784|58693668|FG001|Overall Study|Withdrawal by Subject|6|||
30679638|NCT00589784|58693667|FG000|Overall Study|Patient inevaluable|1|||
30679639|NCT00589784|58693668|FG001|Overall Study|Patient inevaluable|0|||
30679640|NCT00589784|58693667|FG000|Overall Study|Adverse Event|0|||
30679641|NCT00589784|58693668|FG001|Overall Study|Adverse Event|4|||
30594405|NCT01379937|58606677|FG000|Overall Study|Lost to Follow-up|1|||
30594406|NCT01379937|58606678|FG001|Overall Study|Lost to Follow-up|2|||
30594407|NCT01379937|58606679|FG002|Overall Study|Lost to Follow-up|2|||
30594408|NCT01379937|58606680|FG003|Overall Study|Lost to Follow-up|0|||
30594409|NCT01379781|58606706|FG000|Overall Study|Lost to Follow-up|11|||
30594410|NCT01379781|58606707|FG001|Overall Study|Lost to Follow-up|8|||
30679642|NCT00759876|58693673|FG000|Overall Study|Sponsor terminated study early|36|||
30679643|NCT00823979|58693680|FG000|Overall Study|Lack of Efficacy|13|||
30679644|NCT00823979|58693681|FG001|Overall Study|Lack of Efficacy|16|||
30679645|NCT00823979|58693682|FG002|Overall Study|Lack of Efficacy|9|||
30679646|NCT00823979|58693680|FG000|Overall Study|Lost to Follow-up|2|||
30679647|NCT00823979|58693681|FG001|Overall Study|Lost to Follow-up|1|||
30679648|NCT00823979|58693682|FG002|Overall Study|Lost to Follow-up|0|||
30679649|NCT00823979|58693680|FG000|Overall Study|Withdrawal by Subject|2|||
30679650|NCT00823979|58693681|FG001|Overall Study|Withdrawal by Subject|3|||
30679651|NCT00823979|58693682|FG002|Overall Study|Withdrawal by Subject|2|||
30679652|NCT00823979|58693680|FG000|Overall Study|Protocol Violation|1|||
30679653|NCT00823979|58693681|FG001|Overall Study|Protocol Violation|1|||
30679654|NCT00823979|58693682|FG002|Overall Study|Protocol Violation|0|||
30679655|NCT00823979|58693680|FG000|Overall Study|Pregnancy|0|||
30679656|NCT00823979|58693681|FG001|Overall Study|Pregnancy|1|||
30679657|NCT00823979|58693682|FG002|Overall Study|Pregnancy|0|||
30679658|NCT00823979|58693680|FG000|Overall Study|Adverse Event|0|||
30679659|NCT00823979|58693681|FG001|Overall Study|Adverse Event|2|||
30679660|NCT00823979|58693682|FG002|Overall Study|Adverse Event|4|||
30679661|NCT00823979|58693680|FG000|Overall Study|Other|2|||
30594411|NCT01379703|58606713|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
30594412|NCT01379703|58606714|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
30594413|NCT01379703|58606715|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
30594414|NCT01379703|58606713|FG000|Study Start Through 9 Months|Adverse Event|0|||
30594415|NCT01379703|58606714|FG001|Study Start Through 9 Months|Adverse Event|14|||
30594416|NCT01379703|58606715|FG002|Study Start Through 9 Months|Adverse Event|10|||
30679662|NCT00823979|58693681|FG001|Overall Study|Other|0|||
30679663|NCT00823979|58693682|FG002|Overall Study|Other|1|||
30679664|NCT00823979|58693680|FG000|Overall Study|Randomized but not Treated|4|||
30856115|NCT03686215|58883992|FG000|Overall Study|Device issue|1|||
30594417|NCT01379703|58606713|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
30594418|NCT01379703|58606714|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
30594419|NCT01379703|58606715|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
30679665|NCT00823979|58693681|FG001|Overall Study|Randomized but not Treated|3|||
30679666|NCT00823979|58693682|FG002|Overall Study|Randomized but not Treated|1|||
30679667|NCT00823979|58693680|FG000|Overall Study|Study Terminated by Sponsor|5|||
30679668|NCT00823979|58693681|FG001|Overall Study|Study Terminated by Sponsor|5|||
30679669|NCT00823979|58693682|FG002|Overall Study|Study Terminated by Sponsor|7|||
30594420|NCT01379703|58606713|FG000|Study Start Through 9 Months|Treatment Failure|0|||
30594421|NCT01379703|58606714|FG001|Study Start Through 9 Months|Treatment Failure|2|||
30594422|NCT01379703|58606715|FG002|Study Start Through 9 Months|Treatment Failure|2|||
30594423|NCT01379703|58606713|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
30594424|NCT01379703|58606714|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
30594425|NCT01379703|58606715|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
30594426|NCT01379703|58606713|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
30594427|NCT01379703|58606714|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
30594428|NCT01379703|58606715|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
30679670|NCT00823901|58693692|FG000|Overall Study|Adverse Event|1|||
30679671|NCT00823901|58693693|FG001|Overall Study|Adverse Event|1|||
30679672|NCT00823901|58693692|FG000|Overall Study|Lack of Efficacy|1|||
30679673|NCT00823901|58693693|FG001|Overall Study|Lack of Efficacy|0|||
30679674|NCT00823901|58693692|FG000|Overall Study|Lost to Follow-up|2|||
30679675|NCT00823901|58693693|FG001|Overall Study|Lost to Follow-up|1|||
30679676|NCT00823823|58693701|FG000|Overall Study|Lost to Follow-up|3|||
30679677|NCT00823823|58693702|FG001|Overall Study|Lost to Follow-up|1|||
30679678|NCT00823823|58693701|FG000|Overall Study|Protocol Violation|5|||
30679679|NCT00823823|58693702|FG001|Overall Study|Protocol Violation|5|||
30679680|NCT00759564|58693722|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
30679681|NCT00759564|58693723|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
30679682|NCT00759564|58693724|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
30679683|NCT00759564|58693725|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
30679684|NCT00759564|58693726|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
30679685|NCT00816023|58693762|FG000|Overall Study|Lost to Follow-up|1|||
30679686|NCT00816023|58693763|FG001|Overall Study|Lost to Follow-up|1|||
30679687|NCT00816023|58693764|FG002|Overall Study|Lost to Follow-up|0|||
30679688|NCT00816023|58693765|FG003|Overall Study|Lost to Follow-up|0|||
30679689|NCT00816023|58693762|FG000|Overall Study|Withdrawal by Subject|1|||
30679690|NCT00816023|58693763|FG001|Overall Study|Withdrawal by Subject|0|||
30679691|NCT00816023|58693764|FG002|Overall Study|Withdrawal by Subject|0|||
30679692|NCT00816023|58693765|FG003|Overall Study|Withdrawal by Subject|0|||
30679693|NCT00816023|58693762|FG000|Overall Study|Physician Decision|0|||
30679694|NCT00816023|58693763|FG001|Overall Study|Physician Decision|0|||
30679695|NCT00816023|58693764|FG002|Overall Study|Physician Decision|1|||
30679696|NCT00816023|58693765|FG003|Overall Study|Physician Decision|0|||
30679697|NCT00816023|58693762|FG000|Overall Study|assessments complete prior to window|1|||
30679698|NCT00816023|58693763|FG001|Overall Study|assessments complete prior to window|1|||
30679699|NCT00816023|58693764|FG002|Overall Study|assessments complete prior to window|2|||
30679700|NCT00816023|58693765|FG003|Overall Study|assessments complete prior to window|1|||
30679701|NCT00816023|58693762|FG000|Overall Study|Randomized Not Treated|6|||
30679702|NCT00816023|58693763|FG001|Overall Study|Randomized Not Treated|4|||
30679703|NCT00816023|58693764|FG002|Overall Study|Randomized Not Treated|6|||
30679704|NCT00816023|58693765|FG003|Overall Study|Randomized Not Treated|11|||
30679705|NCT00759174|58693777|FG000|Overall Study|Other|0|||
30679706|NCT00759174|58693778|FG001|Overall Study|Other|2|||
30679707|NCT00815633|58693785|FG000|Overall Study|study terminated|1|||
30679708|NCT00830765|58693791|FG000|Overall Study|Protocol Violation|3|||
30679709|NCT00830765|58693792|FG001|Overall Study|Protocol Violation|2|||
30679710|NCT00830375|58693798|FG000|Overall Study|Lost to Follow-up|1|||
30679711|NCT00803270|58693804|FG000|Overall Study|Lost to Follow-up|1|||
30679712|NCT00803270|58693805|FG001|Overall Study|Lost to Follow-up|2|||
30679713|NCT00751998|58693811|FG000|Overall Study|Lost to Follow-up|7|||
30679714|NCT00751998|58693811|FG000|Overall Study|Death|11|||
30679715|NCT00751998|58693811|FG000|Overall Study|Withdrawal by Subject|2|||
30679716|NCT00803738|58693817|FG000|Overall Study|Adverse Event|3|||
30679717|NCT00803738|58693818|FG001|Overall Study|Adverse Event|5|||
30679718|NCT00803738|58693817|FG000|Overall Study|Lost to Follow-up|4|||
30679719|NCT00803738|58693818|FG001|Overall Study|Lost to Follow-up|4|||
30679720|NCT00803738|58693817|FG000|Overall Study|Protocol Violation|18|||
30679721|NCT00803738|58693818|FG001|Overall Study|Protocol Violation|10|||
30679722|NCT00803738|58693817|FG000|Overall Study|Withdrawal by Subject|1|||
30679723|NCT00803738|58693818|FG001|Overall Study|Withdrawal by Subject|4|||
30679724|NCT00803738|58693817|FG000|Overall Study|Lack of Efficacy|10|||
30679725|NCT00803738|58693818|FG001|Overall Study|Lack of Efficacy|16|||
30594429|NCT01379703|58606713|FG000|Study Start Through 9 Months|Medication not available|0|||
30594430|NCT01379703|58606714|FG001|Study Start Through 9 Months|Medication not available|2|||
30679726|NCT00803738|58693817|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
30679727|NCT00803738|58693818|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
30679728|NCT00803738|58693817|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
30679729|NCT00803738|58693818|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
30679730|NCT00758706|58693826|FG000|Overall Study|Adverse Event|4|||
30679731|NCT00758706|58693827|FG001|Overall Study|Adverse Event|4|||
30679732|NCT00591266|58693836|FG000|Overall Study|Adverse Event|2|||
30679733|NCT00591266|58693837|FG001|Overall Study|Adverse Event|2|||
30679734|NCT00591266|58693838|FG002|Overall Study|Adverse Event|3|||
30679735|NCT00591266|58693836|FG000|Overall Study|Lost to Follow-up|0|||
30679736|NCT00591266|58693837|FG001|Overall Study|Lost to Follow-up|1|||
30679737|NCT00591266|58693838|FG002|Overall Study|Lost to Follow-up|0|||
30679738|NCT00591266|58693836|FG000|Overall Study|Protocol Violation|0|||
30679739|NCT00591266|58693837|FG001|Overall Study|Protocol Violation|0|||
30679740|NCT00591266|58693838|FG002|Overall Study|Protocol Violation|1|||
30679741|NCT00591266|58693836|FG000|Overall Study|Withdrawal by Subject|6|||
30679742|NCT00591266|58693837|FG001|Overall Study|Withdrawal by Subject|2|||
30679743|NCT00591266|58693838|FG002|Overall Study|Withdrawal by Subject|5|||
30679744|NCT00591266|58693836|FG000|Overall Study|Lack of Efficacy|0|||
30679745|NCT00591266|58693837|FG001|Overall Study|Lack of Efficacy|2|||
30679746|NCT00591266|58693838|FG002|Overall Study|Lack of Efficacy|0|||
30679747|NCT00591266|58693836|FG000|Overall Study|Other|1|||
30679748|NCT00591266|58693837|FG001|Overall Study|Other|4|||
30679749|NCT00591266|58693838|FG002|Overall Study|Other|5|||
30679750|NCT00758394|58693850|FG000|2nd Intervention Order|Lost to Follow-up|0|||
30679751|NCT00758394|58693851|FG001|2nd Intervention Order|Lost to Follow-up|1|||
30679752|NCT00758394|58693852|FG002|2nd Intervention Order|Lost to Follow-up|0|||
30679753|NCT00758394|58693853|FG003|2nd Intervention Order|Lost to Follow-up|0|||
30679754|NCT00758394|58693850|FG000|3rd Intervention|Lost to Follow-up|1|||
30679755|NCT00758394|58693851|FG001|3rd Intervention|Lost to Follow-up|0|||
30679756|NCT00758394|58693852|FG002|3rd Intervention|Lost to Follow-up|0|||
30679757|NCT00758394|58693853|FG003|3rd Intervention|Lost to Follow-up|1|||
30679758|NCT04450394|58693866|FG000|Overall Study|Adverse Event|2|||
30679759|NCT04450394|58693867|FG001|Overall Study|Adverse Event|0|||
30679760|NCT04450394|58693868|FG002|Overall Study|Adverse Event|0|||
30679761|NCT04450394|58693866|FG000|Overall Study|Death|0|||
30679762|NCT04450394|58693867|FG001|Overall Study|Death|1|||
30594431|NCT01379703|58606715|FG002|Study Start Through 9 Months|Medication not available|1|||
30594432|NCT01379703|58606713|FG000|Study Start Through 9 Months|Poor general condition|0|||
30594433|NCT01379703|58606714|FG001|Study Start Through 9 Months|Poor general condition|1|||
30594434|NCT01379703|58606715|FG002|Study Start Through 9 Months|Poor general condition|0|||
30679763|NCT04450394|58693868|FG002|Overall Study|Death|0|||
30679764|NCT04450394|58693866|FG000|Overall Study|Lost to Follow-up|0|||
30679765|NCT04450394|58693867|FG001|Overall Study|Lost to Follow-up|3|||
30594435|NCT01379703|58606713|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
30594436|NCT01379703|58606714|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
30594437|NCT01379703|58606715|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
30594438|NCT01379703|58606713|FG000|Study Start Through 9 Months|Reason unknown|2|||
30594439|NCT01379703|58606714|FG001|Study Start Through 9 Months|Reason unknown|31|||
30594440|NCT01379703|58606715|FG002|Study Start Through 9 Months|Reason unknown|24|||
30594441|NCT01379703|58606713|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
30594442|NCT01379703|58606714|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
30594443|NCT01379703|58606715|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
30594444|NCT01379703|58606713|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
30594445|NCT01379703|58606714|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
30594446|NCT01379703|58606715|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
30594447|NCT01379703|58606713|FG000|9 Months Through 18 Months|Adverse Event|0|||
30594448|NCT01379703|58606714|FG001|9 Months Through 18 Months|Adverse Event|6|||
30594449|NCT01379703|58606715|FG002|9 Months Through 18 Months|Adverse Event|0|||
30594450|NCT01379703|58606713|FG000|9 Months Through 18 Months|Treatment failure|0|||
30594451|NCT01379703|58606714|FG001|9 Months Through 18 Months|Treatment failure|5|||
30594452|NCT01379703|58606715|FG002|9 Months Through 18 Months|Treatment failure|0|||
30594453|NCT01379703|58606713|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
30594454|NCT01379703|58606714|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
30594455|NCT01379703|58606715|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
30594456|NCT01379703|58606713|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
30594457|NCT01379703|58606714|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
30594458|NCT01379703|58606715|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
30594459|NCT01379703|58606713|FG000|9 Months Through 18 Months|Fatigue|0|||
30594460|NCT01379703|58606714|FG001|9 Months Through 18 Months|Fatigue|1|||
30679766|NCT04450394|58693868|FG002|Overall Study|Lost to Follow-up|0|||
30679767|NCT04450394|58693866|FG000|Overall Study|Physician Decision|0|||
30679768|NCT04450394|58693867|FG001|Overall Study|Physician Decision|1|||
30679769|NCT04450394|58693868|FG002|Overall Study|Physician Decision|0|||
30679770|NCT04450394|58693866|FG000|Overall Study|Protocol Violation|2|||
30679771|NCT04450394|58693867|FG001|Overall Study|Protocol Violation|0|||
30594461|NCT01379703|58606715|FG002|9 Months Through 18 Months|Fatigue|0|||
30594462|NCT01379703|58606713|FG000|9 Months Through 18 Months|Reason Unknown|0|||
30679772|NCT04450394|58693868|FG002|Overall Study|Protocol Violation|0|||
30679773|NCT04450394|58693866|FG000|Overall Study|Withdrawal by Subject|6|||
30679774|NCT04450394|58693867|FG001|Overall Study|Withdrawal by Subject|9|||
30679775|NCT04450394|58693868|FG002|Overall Study|Withdrawal by Subject|0|||
30679776|NCT00758160|58693875|FG000|Overall Study|No Longer Requires Study Medication|4|||
30679777|NCT00758160|58693875|FG000|Overall Study|Administration Problems|3|||
30679778|NCT00758160|58693875|FG000|Overall Study|Adverse Event|15|||
30679779|NCT00758160|58693875|FG000|Overall Study|Lack of Efficacy|10|||
30679780|NCT00758160|58693875|FG000|Overall Study|Lost to Follow-up|14|||
30679781|NCT00758160|58693875|FG000|Overall Study|Protocol Violation|12|||
30679782|NCT00758160|58693875|FG000|Overall Study|Withdrawal by Subject|8|||
30679783|NCT00757848|58693885|FG000|Overall Study|Voluntary discontinuation|1|||
30679784|NCT00757848|58693886|FG001|Overall Study|Voluntary discontinuation|0|||
30679785|NCT00757848|58693885|FG000|Overall Study|Adverse Event|1|||
30679786|NCT00757848|58693886|FG001|Overall Study|Adverse Event|2|||
30679787|NCT00757848|58693885|FG000|Overall Study|Incorrect enrolment|1|||
30679788|NCT00757848|58693886|FG001|Overall Study|Incorrect enrolment|0|||
30679789|NCT00751296|58693892|FG000|Overall Study|Adverse Event|2|||
30679790|NCT00751140|58693896|FG000|Overall Study|benign angioma excluded from analysis|1|||
30679791|NCT00751881|58693907|FG000|Core Treatment Period|Not treated|1|||
30679792|NCT00751881|58693908|FG001|Core Treatment Period|Not treated|1|||
30679793|NCT00751881|58693909|FG002|Core Treatment Period|Not treated|2|||
30679794|NCT00751881|58693907|FG000|Core Treatment Period|Adverse Event|26|||
30679795|NCT00751881|58693908|FG001|Core Treatment Period|Adverse Event|54|||
30679796|NCT00751881|58693909|FG002|Core Treatment Period|Adverse Event|58|||
30679797|NCT00751881|58693907|FG000|Core Treatment Period|Lack of Efficacy|37|||
30679798|NCT00751881|58693908|FG001|Core Treatment Period|Lack of Efficacy|30|||
30679799|NCT00751881|58693909|FG002|Core Treatment Period|Lack of Efficacy|20|||
30679800|NCT00751881|58693907|FG000|Core Treatment Period|Poor compliance to protocol|15|||
30679801|NCT00751881|58693908|FG001|Core Treatment Period|Poor compliance to protocol|3|||
30679802|NCT00751881|58693909|FG002|Core Treatment Period|Poor compliance to protocol|4|||
30679803|NCT00751881|58693907|FG000|Core Treatment Period|Lost to Follow-up|6|||
30679804|NCT00751881|58693908|FG001|Core Treatment Period|Lost to Follow-up|4|||
30679805|NCT00751881|58693909|FG002|Core Treatment Period|Lost to Follow-up|3|||
30679806|NCT00751881|58693907|FG000|Core Treatment Period|Other: protocol deviation|3|||
30679807|NCT00751881|58693908|FG001|Core Treatment Period|Other: protocol deviation|3|||
30679808|NCT00751881|58693909|FG002|Core Treatment Period|Other: protocol deviation|7|||
30782620|NCT03334214|58794748|FG001|Overall Study|Withdrawal by Subject|1|||
30782621|NCT03334214|58794747|FG000|Overall Study|Other|1|||
30782622|NCT03334214|58794748|FG001|Overall Study|Other|0|||
30782623|NCT02250664|58794758|FG000|Overall Study|Lost to Follow-up|18|||
30782624|NCT02250664|58794759|FG001|Overall Study|Lost to Follow-up|28|||
30782625|NCT02250664|58794760|FG002|Overall Study|Lost to Follow-up|33|||
30782626|NCT02250664|58794758|FG000|Overall Study|Personal Reasons|7|||
30782627|NCT02250664|58794759|FG001|Overall Study|Personal Reasons|8|||
30594463|NCT01379703|58606714|FG001|9 Months Through 18 Months|Reason Unknown|23|||
30594464|NCT01379703|58606715|FG002|9 Months Through 18 Months|Reason Unknown|0|||
30594465|NCT01335477|58606726|FG000|Overall Study|Adverse Event|30|||
30594466|NCT01335477|58606727|FG001|Overall Study|Adverse Event|42|||
30594467|NCT01335477|58606726|FG000|Overall Study|Non compliant with protocol|0|||
30594468|NCT01335477|58606727|FG001|Overall Study|Non compliant with protocol|2|||
30594469|NCT01335477|58606726|FG000|Overall Study|Lost to Follow-up|1|||
30594470|NCT01335477|58606727|FG001|Overall Study|Lost to Follow-up|2|||
30594471|NCT01335477|58606726|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
30594472|NCT01335477|58606727|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
30594473|NCT01335477|58606726|FG000|Overall Study|Not treated|1|||
30594474|NCT01335477|58606727|FG001|Overall Study|Not treated|2|||
30594475|NCT01335477|58606726|FG000|Overall Study|Reason other than those stated above|2|||
30594476|NCT01335477|58606727|FG001|Overall Study|Reason other than those stated above|2|||
30594477|NCT01371825|58606733|FG000|Overall Study|Death|4|||
30594478|NCT01371747|58606743|FG000|Overall Study|Adverse Event|4|||
30594479|NCT01371747|58606744|FG001|Overall Study|Adverse Event|2|||
30594480|NCT01371747|58606745|FG002|Overall Study|Adverse Event|7|||
30594481|NCT01371747|58606746|FG003|Overall Study|Adverse Event|2|||
30594482|NCT01371747|58606747|FG004|Overall Study|Adverse Event|2|||
30594483|NCT01371747|58606748|FG005|Overall Study|Adverse Event|2|||
30594484|NCT01371747|58606743|FG000|Overall Study|Death|1|||
30594485|NCT01371747|58606744|FG001|Overall Study|Death|0|||
30594486|NCT01371747|58606745|FG002|Overall Study|Death|4|||
30594487|NCT01371747|58606746|FG003|Overall Study|Death|1|||
30679809|NCT00751881|58693907|FG000|Core Treatment Period|Other: wish to parent|5|||
30679810|NCT00751881|58693908|FG001|Core Treatment Period|Other: wish to parent|7|||
30782628|NCT02250664|58794760|FG002|Overall Study|Personal Reasons|14|||
30594488|NCT01371747|58606747|FG004|Overall Study|Death|2|||
30594489|NCT01371747|58606748|FG005|Overall Study|Death|0|||
30594490|NCT01371747|58606743|FG000|Overall Study|Abnormal Renal Function|0|||
30594491|NCT01371747|58606744|FG001|Overall Study|Abnormal Renal Function|2|||
30594492|NCT01371747|58606745|FG002|Overall Study|Abnormal Renal Function|0|||
30679811|NCT00751881|58693909|FG002|Core Treatment Period|Other: wish to parent|4|||
30679812|NCT00751881|58693907|FG000|Core Treatment Period|Other: personal/family constraints|6|||
30679813|NCT00751881|58693908|FG001|Core Treatment Period|Other: personal/family constraints|7|||
30782629|NCT02250664|58794758|FG000|Overall Study|Adverse Event|6|||
30594493|NCT01371747|58606746|FG003|Overall Study|Abnormal Renal Function|1|||
30594494|NCT01371747|58606747|FG004|Overall Study|Abnormal Renal Function|0|||
30594495|NCT01371747|58606748|FG005|Overall Study|Abnormal Renal Function|1|||
30594496|NCT01371747|58606743|FG000|Overall Study|High Serum Potassium Results|1|||
30594497|NCT01371747|58606744|FG001|Overall Study|High Serum Potassium Results|1|||
30594498|NCT01371747|58606745|FG002|Overall Study|High Serum Potassium Results|1|||
30594499|NCT01371747|58606746|FG003|Overall Study|High Serum Potassium Results|2|||
30594500|NCT01371747|58606747|FG004|Overall Study|High Serum Potassium Results|0|||
30594501|NCT01371747|58606748|FG005|Overall Study|High Serum Potassium Results|2|||
30594502|NCT01371747|58606743|FG000|Overall Study|Low Serum Potassium Results|1|||
30594503|NCT01371747|58606744|FG001|Overall Study|Low Serum Potassium Results|1|||
30594504|NCT01371747|58606745|FG002|Overall Study|Low Serum Potassium Results|1|||
30594505|NCT01371747|58606746|FG003|Overall Study|Low Serum Potassium Results|1|||
30594506|NCT01371747|58606747|FG004|Overall Study|Low Serum Potassium Results|0|||
30594507|NCT01371747|58606748|FG005|Overall Study|Low Serum Potassium Results|3|||
30594508|NCT01371747|58606743|FG000|Overall Study|Protocol Violation|0|||
30594509|NCT01371747|58606744|FG001|Overall Study|Protocol Violation|0|||
30594510|NCT01371747|58606745|FG002|Overall Study|Protocol Violation|1|||
30594511|NCT01371747|58606746|FG003|Overall Study|Protocol Violation|0|||
30594512|NCT01371747|58606747|FG004|Overall Study|Protocol Violation|0|||
30594513|NCT01371747|58606748|FG005|Overall Study|Protocol Violation|0|||
30594514|NCT01371747|58606743|FG000|Overall Study|Non-Compliance|3|||
30594515|NCT01371747|58606744|FG001|Overall Study|Non-Compliance|4|||
30594516|NCT01371747|58606745|FG002|Overall Study|Non-Compliance|3|||
30594517|NCT01371747|58606746|FG003|Overall Study|Non-Compliance|0|||
30594518|NCT01371747|58606747|FG004|Overall Study|Non-Compliance|0|||
30594519|NCT01371747|58606748|FG005|Overall Study|Non-Compliance|1|||
30594520|NCT01371747|58606743|FG000|Overall Study|Physician Decision|0|||
30594521|NCT01371747|58606744|FG001|Overall Study|Physician Decision|0|||
30594522|NCT01371747|58606745|FG002|Overall Study|Physician Decision|0|||
30594523|NCT01371747|58606746|FG003|Overall Study|Physician Decision|0|||
30594524|NCT01371747|58606747|FG004|Overall Study|Physician Decision|1|||
30594525|NCT01371747|58606748|FG005|Overall Study|Physician Decision|0|||
30594526|NCT01371747|58606743|FG000|Overall Study|Withdrawal by Subject|6|||
30594527|NCT01371747|58606744|FG001|Overall Study|Withdrawal by Subject|12|||
30594528|NCT01371747|58606745|FG002|Overall Study|Withdrawal by Subject|5|||
30594529|NCT01371747|58606746|FG003|Overall Study|Withdrawal by Subject|2|||
30594530|NCT01371747|58606747|FG004|Overall Study|Withdrawal by Subject|2|||
30594531|NCT01371747|58606748|FG005|Overall Study|Withdrawal by Subject|4|||
30594532|NCT01371747|58606743|FG000|Overall Study|Other Reasons|2|||
30594533|NCT01371747|58606744|FG001|Overall Study|Other Reasons|1|||
30594534|NCT01371747|58606745|FG002|Overall Study|Other Reasons|2|||
30594535|NCT01371747|58606746|FG003|Overall Study|Other Reasons|0|||
30594536|NCT01371747|58606747|FG004|Overall Study|Other Reasons|0|||
30679814|NCT00751881|58693909|FG002|Core Treatment Period|Other: personal/family constraints|10|||
30679815|NCT00751881|58693907|FG000|Core Treatment Period|Other: MS treatment change|6|||
30679816|NCT00751881|58693908|FG001|Core Treatment Period|Other: MS treatment change|4|||
30679817|NCT00751881|58693909|FG002|Core Treatment Period|Other: MS treatment change|4|||
30679818|NCT00751881|58693907|FG000|Core Treatment Period|Other: tolerability complaints|2|||
30679819|NCT00751881|58693908|FG001|Core Treatment Period|Other: tolerability complaints|0|||
30679820|NCT00751881|58693909|FG002|Core Treatment Period|Other: tolerability complaints|0|||
30679821|NCT00751881|58693907|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
30679822|NCT00751881|58693908|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
30679823|NCT00751881|58693909|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
30679824|NCT00751881|58693907|FG000|Extension Study Period|Adverse Event|18|||
30679825|NCT00751881|58693908|FG001|Extension Study Period|Adverse Event|20|||
30856116|NCT03686215|58883993|FG001|Overall Study|Device issue|0|||
30856117|NCT03686215|58883994|FG002|Overall Study|Device issue|2|||
30856118|NCT03665077|58884002|FG000|Overall Study|Lost to Follow-up|2|||
30856119|NCT03665077|58884002|FG000|Overall Study|Physician Decision|2|||
30856120|NCT03606174|58884017|FG000|Overall Study|Death|37|||
30856121|NCT03606174|58884018|FG001|Overall Study|Death|15|||
30594537|NCT01371747|58606748|FG005|Overall Study|Other Reasons|1|||
30594538|NCT01371708|58606783|FG000|Overall Study|Insufficient clinical response|3|||
30594539|NCT01371708|58606784|FG001|Overall Study|Insufficient clinical response|2|||
30594540|NCT01371708|58606785|FG002|Overall Study|Insufficient clinical response|0|||
30594541|NCT01371708|58606783|FG000|Overall Study|Lost to Follow-up|5|||
30594542|NCT01371708|58606784|FG001|Overall Study|Lost to Follow-up|9|||
30594543|NCT01371708|58606785|FG002|Overall Study|Lost to Follow-up|7|||
30856122|NCT03606174|58884019|FG002|Overall Study|Death|15|||
30856123|NCT03606174|58884020|FG003|Overall Study|Death|7|||
30594544|NCT01371708|58606783|FG000|Overall Study|Protocol Violation|2|||
30594545|NCT01371708|58606784|FG001|Overall Study|Protocol Violation|1|||
30594546|NCT01371708|58606785|FG002|Overall Study|Protocol Violation|2|||
30594547|NCT01371708|58606783|FG000|Overall Study|No longer willing to participate|7|||
30679826|NCT00751881|58693909|FG002|Extension Study Period|Adverse Event|21|||
30594548|NCT01371708|58606784|FG001|Overall Study|No longer willing to participate|7|||
30594549|NCT01371708|58606785|FG002|Overall Study|No longer willing to participate|13|||
30679827|NCT00751881|58693907|FG000|Extension Study Period|Lack of Efficacy|14|||
30679828|NCT00751881|58693908|FG001|Extension Study Period|Lack of Efficacy|10|||
30679829|NCT00751881|58693909|FG002|Extension Study Period|Lack of Efficacy|20|||
30679830|NCT00751881|58693907|FG000|Extension Study Period|Lost to Follow-up|4|||
30679831|NCT00751881|58693908|FG001|Extension Study Period|Lost to Follow-up|9|||
30679832|NCT00751881|58693909|FG002|Extension Study Period|Lost to Follow-up|6|||
30679833|NCT00751881|58693907|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
30679834|NCT00751881|58693908|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
30679835|NCT00751881|58693909|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
30679836|NCT00751881|58693907|FG000|Extension Study Period|Other than specified above|26|||
30679837|NCT00751881|58693908|FG001|Extension Study Period|Other than specified above|30|||
30679838|NCT00751881|58693909|FG002|Extension Study Period|Other than specified above|18|||
30679839|NCT00747474|58693923|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
30679840|NCT00747474|58693924|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
30679841|NCT00747474|58693925|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
30679842|NCT00747474|58693926|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
30679843|NCT00747474|58693927|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
30679844|NCT00747474|58693928|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
30679845|NCT00747474|58693929|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
30679846|NCT00747474|58693930|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
30679847|NCT00747474|58693931|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
30679848|NCT00747474|58693932|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
30679849|NCT00747474|58693933|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
30679850|NCT00747474|58693934|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
30679851|NCT00830063|58693943|FG000|Overall Study|Adverse Event|7|||
30679852|NCT00830063|58693944|FG001|Overall Study|Adverse Event|13|||
30679853|NCT00830063|58693945|FG002|Overall Study|Adverse Event|16|||
30679854|NCT00830063|58693946|FG003|Overall Study|Adverse Event|13|||
30679855|NCT00830063|58693943|FG000|Overall Study|Death|1|||
30679856|NCT00830063|58693944|FG001|Overall Study|Death|0|||
30679857|NCT00830063|58693945|FG002|Overall Study|Death|0|||
30679858|NCT00830063|58693946|FG003|Overall Study|Death|0|||
30679859|NCT00830063|58693943|FG000|Overall Study|Lost to Follow-up|0|||
30679860|NCT00830063|58693944|FG001|Overall Study|Lost to Follow-up|0|||
30679861|NCT00830063|58693945|FG002|Overall Study|Lost to Follow-up|3|||
30679862|NCT00830063|58693946|FG003|Overall Study|Lost to Follow-up|1|||
30679863|NCT00830063|58693943|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
30679864|NCT00830063|58693944|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
30679865|NCT00830063|58693945|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
30679866|NCT00830063|58693946|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
30679867|NCT00830063|58693943|FG000|Overall Study|Lack of Efficacy|51|||
30679868|NCT00830063|58693944|FG001|Overall Study|Lack of Efficacy|23|||
30679869|NCT00830063|58693945|FG002|Overall Study|Lack of Efficacy|25|||
30679870|NCT00830063|58693946|FG003|Overall Study|Lack of Efficacy|32|||
30679871|NCT00830063|58693943|FG000|Overall Study|Other|5|||
30679872|NCT00830063|58693944|FG001|Overall Study|Other|5|||
30679873|NCT00830063|58693945|FG002|Overall Study|Other|8|||
30679874|NCT00830063|58693946|FG003|Overall Study|Other|6|||
30679875|NCT00830063|58693943|FG000|Overall Study|Withdrawal by Subject|16|||
30594550|NCT01371708|58606783|FG000|Overall Study|Medication error/not related to AE|0|||
30594551|NCT01371708|58606784|FG001|Overall Study|Medication error/not related to AE|1|||
30594552|NCT01371708|58606785|FG002|Overall Study|Medication error/not related to AE|0|||
30594553|NCT01371708|58606783|FG000|Overall Study|Other|3|||
30594554|NCT01371708|58606784|FG001|Overall Study|Other|2|||
30594555|NCT01371708|58606785|FG002|Overall Study|Other|4|||
30594556|NCT01371708|58606783|FG000|Overall Study|Adverse Event|5|||
30594557|NCT01371708|58606784|FG001|Overall Study|Adverse Event|8|||
30594558|NCT01371708|58606785|FG002|Overall Study|Adverse Event|12|||
30594559|NCT01371708|58606783|FG000|Overall Study|Started but did not receive treatment|1|||
30594560|NCT01371708|58606784|FG001|Overall Study|Started but did not receive treatment|0|||
30594561|NCT01371708|58606785|FG002|Overall Study|Started but did not receive treatment|1|||
30594562|NCT01335399|58606797|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
30594563|NCT01335399|58606798|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
30594564|NCT01335399|58606797|FG000|Pre-treatment Period|Participant request to discontinue|0|||
30679876|NCT00830063|58693944|FG001|Overall Study|Withdrawal by Subject|10|||
30679877|NCT00830063|58693945|FG002|Overall Study|Withdrawal by Subject|16|||
30679878|NCT00830063|58693946|FG003|Overall Study|Withdrawal by Subject|13|||
30679879|NCT00830063|58693943|FG000|Overall Study|Protocol Violation|1|||
30679880|NCT00830063|58693944|FG001|Overall Study|Protocol Violation|0|||
30679881|NCT00830063|58693945|FG002|Overall Study|Protocol Violation|3|||
30856124|NCT03606174|58884021|FG004|Overall Study|Death|35|||
30679882|NCT00830063|58693946|FG003|Overall Study|Protocol Violation|2|||
30679883|NCT00830063|58693943|FG000|Overall Study|Randomized But Not Treated|0|||
30679884|NCT00830063|58693944|FG001|Overall Study|Randomized But Not Treated|2|||
30679885|NCT00830063|58693945|FG002|Overall Study|Randomized But Not Treated|0|||
30679886|NCT00830063|58693946|FG003|Overall Study|Randomized But Not Treated|2|||
30679887|NCT00750438|58693960|FG000|Overall Study|Protocol Violation|4|||
30679888|NCT00750438|58693961|FG001|Overall Study|Protocol Violation|1|||
30679889|NCT00750438|58693960|FG000|Overall Study|Physician Decision|2|||
30679890|NCT00750438|58693961|FG001|Overall Study|Physician Decision|2|||
30679891|NCT00750438|58693960|FG000|Overall Study|Withdrawal by Subject|1|||
30679892|NCT00750438|58693961|FG001|Overall Study|Withdrawal by Subject|1|||
30679893|NCT00586326|58693967|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
30679894|NCT00586326|58693967|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
30679895|NCT00586326|58693967|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
30679896|NCT00586326|58693967|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
30679897|NCT00586326|58693967|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
30679898|NCT00586326|58693967|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
30679899|NCT00586326|58693967|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
30679900|NCT00586326|58693967|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
30679901|NCT00586326|58693967|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
30679902|NCT00586326|58693967|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
30679903|NCT00586326|58693967|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
30679904|NCT00586326|58693967|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
30679905|NCT00586326|58693967|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
30679906|NCT00586326|58693967|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
30679907|NCT00586326|58693967|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
30679908|NCT00586326|58693967|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
30679909|NCT00586326|58693967|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
30679910|NCT00751101|58693977|FG000|Overall Study|Withdrawal by Subject|1|||
30594565|NCT01335399|58606798|FG001|Pre-treatment Period|Participant request to discontinue|1|||
30594566|NCT01335399|58606797|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
30594567|NCT01335399|58606798|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
30594568|NCT01335399|58606797|FG000|Pre-treatment Period|Consent withdrawal|3|||
30594569|NCT01335399|58606798|FG001|Pre-treatment Period|Consent withdrawal|0|||
30594570|NCT01335399|58606797|FG000|Treatment Period|Disease progression|117|||
30594571|NCT01335399|58606798|FG001|Treatment Period|Disease progression|145|||
30594572|NCT01335399|58606797|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
30594573|NCT01335399|58606798|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
30594574|NCT01335399|58606797|FG000|Treatment Period|Study drug toxicity|52|||
30594575|NCT01335399|58606798|FG001|Treatment Period|Study drug toxicity|64|||
30594576|NCT01335399|58606797|FG000|Treatment Period|Participant request to discontinue|30|||
30594577|NCT01335399|58606798|FG001|Treatment Period|Participant request to discontinue|22|||
30594578|NCT01335399|58606797|FG000|Treatment Period|Other reasons|30|||
30594579|NCT01335399|58606798|FG001|Treatment Period|Other reasons|30|||
30594580|NCT01335399|58606797|FG000|Treatment Period|Consent withdrawal|10|||
30594581|NCT01335399|58606798|FG001|Treatment Period|Consent withdrawal|7|||
30594582|NCT01335399|58606797|FG000|Treatment Period|Death|7|||
30594583|NCT01335399|58606798|FG001|Treatment Period|Death|6|||
30594584|NCT01335399|58606797|FG000|Treatment Period|Poor/Non-compliance|3|||
30679911|NCT00751101|58693978|FG001|Overall Study|Withdrawal by Subject|0|||
30679912|NCT00751101|58693977|FG000|Overall Study|No HFS / Never Started Patch/|0|||
30679913|NCT00751101|58693978|FG001|Overall Study|No HFS / Never Started Patch/|4|||
30679914|NCT00751101|58693977|FG000|Overall Study|Never began capecitabine|1|||
30679915|NCT00751101|58693978|FG001|Overall Study|Never began capecitabine|0|||
30679916|NCT00751101|58693977|FG000|Overall Study|Physician Decision|0|||
30679917|NCT00751101|58693978|FG001|Overall Study|Physician Decision|1|||
30782630|NCT02250664|58794759|FG001|Overall Study|Adverse Event|3|||
30782631|NCT02250664|58794760|FG002|Overall Study|Adverse Event|8|||
30782632|NCT02250664|58794758|FG000|Overall Study|Incarcerated|2|||
30594585|NCT01335399|58606798|FG001|Treatment Period|Poor/Non-compliance|4|||
30594586|NCT01335399|58606797|FG000|Treatment Period|Lost to Follow-up|2|||
30679918|NCT00750204|58693990|FG000|Overall Study|study halted prematurely|1|||
30679919|NCT00750204|58693991|FG001|Overall Study|study halted prematurely|1|||
30679920|NCT00751023|58693999|FG000|Overall Study|Lost to Follow-up|11|||
30679921|NCT00751023|58694000|FG001|Overall Study|Lost to Follow-up|7|||
30782633|NCT02250664|58794759|FG001|Overall Study|Incarcerated|1|||
30856125|NCT03606174|58884022|FG005|Overall Study|Death|12|||
30594587|NCT01335399|58606798|FG001|Treatment Period|Lost to Follow-up|2|||
30594588|NCT01335399|58606797|FG000|Treatment Period|Maximum clinical benefit|1|||
30594589|NCT01335399|58606798|FG001|Treatment Period|Maximum clinical benefit|1|||
30594590|NCT01335399|58606797|FG000|Treatment Period|No longer meet study criteria|1|||
30679922|NCT00591773|58694009|FG000|Overall Study|Adverse Event|9|||
30679923|NCT00591773|58694010|FG001|Overall Study|Adverse Event|9|||
30594591|NCT01335399|58606798|FG001|Treatment Period|No longer meet study criteria|1|||
30594592|NCT01335399|58606797|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
30594593|NCT01335399|58606798|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
30594594|NCT01366521|58606808|FG000|Overall Study|Adverse Event|1|||
30594595|NCT01366521|58606809|FG001|Overall Study|Adverse Event|0|||
30594596|NCT01366521|58606810|FG002|Overall Study|Adverse Event|0|||
30594597|NCT01366521|58606811|FG003|Overall Study|Adverse Event|0|||
30594598|NCT01366521|58606808|FG000|Overall Study|Protocol Violation|0|||
30594599|NCT01366521|58606809|FG001|Overall Study|Protocol Violation|0|||
30594600|NCT01366521|58606810|FG002|Overall Study|Protocol Violation|1|||
30594601|NCT01366521|58606811|FG003|Overall Study|Protocol Violation|0|||
30594602|NCT01366521|58606808|FG000|Overall Study|Physician Decision|0|||
30679924|NCT00591773|58694011|FG002|Overall Study|Adverse Event|6|||
30679925|NCT00591773|58694009|FG000|Overall Study|Protocol Violation|2|||
30679926|NCT00591773|58694010|FG001|Overall Study|Protocol Violation|3|||
30679927|NCT00591773|58694011|FG002|Overall Study|Protocol Violation|0|||
30679928|NCT00591773|58694009|FG000|Overall Study|Lost to Follow-up|1|||
30679929|NCT00591773|58694010|FG001|Overall Study|Lost to Follow-up|4|||
30679930|NCT00591773|58694011|FG002|Overall Study|Lost to Follow-up|1|||
30679931|NCT00591773|58694009|FG000|Overall Study|Withdrawal by Subject|2|||
30679932|NCT00591773|58694010|FG001|Overall Study|Withdrawal by Subject|5|||
30679933|NCT00591773|58694011|FG002|Overall Study|Withdrawal by Subject|3|||
30679934|NCT00591773|58694009|FG000|Overall Study|Lack of Efficacy|1|||
30679935|NCT00591773|58694010|FG001|Overall Study|Lack of Efficacy|2|||
30679936|NCT00591773|58694011|FG002|Overall Study|Lack of Efficacy|2|||
30679937|NCT00591773|58694009|FG000|Overall Study|Other|1|||
30679938|NCT00591773|58694010|FG001|Overall Study|Other|1|||
30679939|NCT00591773|58694011|FG002|Overall Study|Other|4|||
30679940|NCT00750867|58694019|FG000|Overall Study|Adverse Event|2|||
30679941|NCT00744042|58694023|FG000|Overall Study|Withdrawal by Subject|1|||
30679942|NCT00829829|58694036|FG000|Overall Study|Protocol Violation|0|||
30679943|NCT00829829|58694037|FG001|Overall Study|Protocol Violation|3|||
30679944|NCT00829829|58694038|FG002|Overall Study|Protocol Violation|0|||
30679945|NCT00829829|58694036|FG000|Overall Study|Adverse Event|4|||
30679946|NCT00829829|58694037|FG001|Overall Study|Adverse Event|4|||
30679947|NCT00829829|58694038|FG002|Overall Study|Adverse Event|3|||
30679948|NCT00829829|58694036|FG000|Overall Study|Withdrawal by Subject|8|||
30679949|NCT00829829|58694037|FG001|Overall Study|Withdrawal by Subject|4|||
30679950|NCT00829829|58694038|FG002|Overall Study|Withdrawal by Subject|2|||
30679951|NCT00829829|58694036|FG000|Overall Study|Decision by the Sponsor|1|||
30679952|NCT00829829|58694037|FG001|Overall Study|Decision by the Sponsor|0|||
30679953|NCT00829829|58694038|FG002|Overall Study|Decision by the Sponsor|2|||
30679954|NCT00829829|58694036|FG000|Overall Study|Lost to Follow-up|7|||
30679955|NCT00829829|58694037|FG001|Overall Study|Lost to Follow-up|3|||
30679956|NCT00829829|58694038|FG002|Overall Study|Lost to Follow-up|3|||
30679957|NCT00829829|58694036|FG000|Overall Study|Other than specified above|2|||
30679958|NCT00829829|58694037|FG001|Overall Study|Other than specified above|2|||
30679959|NCT00829829|58694038|FG002|Overall Study|Other than specified above|1|||
30594603|NCT01366521|58606809|FG001|Overall Study|Physician Decision|0|||
30594604|NCT01366521|58606810|FG002|Overall Study|Physician Decision|1|||
30594605|NCT01366521|58606811|FG003|Overall Study|Physician Decision|0|||
30594606|NCT01366521|58606808|FG000|Overall Study|Withdrawal by Subject|0|||
30594607|NCT01366521|58606809|FG001|Overall Study|Withdrawal by Subject|1|||
30594608|NCT01366521|58606810|FG002|Overall Study|Withdrawal by Subject|0|||
30594609|NCT01366521|58606811|FG003|Overall Study|Withdrawal by Subject|0|||
30594610|NCT01335009|58606825|FG000|Overall Study|Too ill to travel to study sites|1|||
30679960|NCT00823199|58694047|FG000|Overall Study|Withdrawal by Subject|2|||
30679961|NCT00829439|58694052|FG000|Overall Study|Adverse Event|0|||
30679962|NCT00829439|58694053|FG001|Overall Study|Adverse Event|0|||
30679963|NCT00829439|58694054|FG002|Overall Study|Adverse Event|1|||
30679964|NCT00829439|58694055|FG003|Overall Study|Adverse Event|0|||
30679965|NCT00749775|58694059|FG000|Overall Study|Protocol Violation|24|||
30679966|NCT00749775|58694059|FG000|Overall Study|Lost to Follow-up|36|||
30679967|NCT00749775|58694059|FG000|Overall Study|No visit after first day of treatment|44|||
30679968|NCT00749775|58694059|FG000|Overall Study|No drug administration|3|||
30679969|NCT00829283|58694075|FG000|Overall Study|Lost to Follow-up|7|||
30679970|NCT00829283|58694076|FG001|Overall Study|Lost to Follow-up|25|||
30679971|NCT00821873|58694082|FG000|Overall Study|Lost to Follow-up|4|||
30679972|NCT00749463|58694089|FG000|Overall Study|Adverse Event|0|||
30594611|NCT01335009|58606826|FG001|Overall Study|Too ill to travel to study sites|0|||
30594612|NCT01335009|58606825|FG000|Overall Study|Death|28|||
30594613|NCT01335009|58606826|FG001|Overall Study|Death|32|||
30594614|NCT01335009|58606825|FG000|Overall Study|Withdrawal by Subject|1|||
30594615|NCT01335009|58606826|FG001|Overall Study|Withdrawal by Subject|1|||
30594616|NCT01335009|58606825|FG000|Overall Study|Lost to Follow-up|1|||
30594617|NCT01335009|58606826|FG001|Overall Study|Lost to Follow-up|0|||
30594618|NCT01366443|58606841|FG000|Overall Study|Lost to Follow-up|2|||
30679973|NCT00749463|58694090|FG001|Overall Study|Adverse Event|4|||
30679974|NCT00749463|58694091|FG002|Overall Study|Adverse Event|1|||
30594619|NCT01366443|58606841|FG000|Overall Study|Under 18 yo|1|||
30594620|NCT01332630|58606846|FG000|Overall Study|Withdrawal by Subject|3|||
30594621|NCT01366209|58606852|FG000|Overall Study|Adverse Event|6|||
30594622|NCT01366209|58606853|FG001|Overall Study|Adverse Event|7|||
30594623|NCT01366209|58606852|FG000|Overall Study|Withdrawal by Subject|4|||
30594624|NCT01366209|58606853|FG001|Overall Study|Withdrawal by Subject|4|||
30594625|NCT01366209|58606852|FG000|Overall Study|Death|12|||
30594626|NCT01366209|58606853|FG001|Overall Study|Death|19|||
30594627|NCT01366209|58606852|FG000|Overall Study|Lung transplantation|6|||
30594628|NCT01366209|58606853|FG001|Overall Study|Lung transplantation|1|||
30594629|NCT01366209|58606852|FG000|Overall Study|Lost to Follow-up|2|||
30594630|NCT01366209|58606853|FG001|Overall Study|Lost to Follow-up|1|||
30594631|NCT01366209|58606852|FG000|Overall Study|Physician Decision|1|||
30679975|NCT00749463|58694089|FG000|Overall Study|Withdrawal by Subject|1|||
30679976|NCT00749463|58694090|FG001|Overall Study|Withdrawal by Subject|0|||
30679977|NCT00749463|58694091|FG002|Overall Study|Withdrawal by Subject|0|||
30594632|NCT01366209|58606853|FG001|Overall Study|Physician Decision|0|||
30594633|NCT01366209|58606852|FG000|Overall Study|Sponsors decision|0|||
30679978|NCT00821327|58694099|FG000|Overall Study|Adverse Event|13|||
30679979|NCT00821327|58694099|FG000|Overall Study|Patient Request|1|||
30679980|NCT00821327|58694099|FG000|Overall Study|Investigator Request|2|||
30679981|NCT00821327|58694099|FG000|Overall Study|Sponsor Request|1|||
30679982|NCT00821327|58694099|FG000|Overall Study|Disease Progression|13|||
30782634|NCT02250664|58794760|FG002|Overall Study|Incarcerated|2|||
30782635|NCT02250664|58794758|FG000|Overall Study|Withdrawal by Subject|0|||
30856126|NCT03606174|58884023|FG006|Overall Study|Death|35|||
30856127|NCT03606174|58884024|FG007|Overall Study|Death|8|||
30856128|NCT03606174|58884025|FG008|Overall Study|Death|5|||
30959042|NCT01587703|59024040|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
30959043|NCT01587703|59024041|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
30959044|NCT01587703|59024023|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959045|NCT01587703|59024024|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30782636|NCT02250664|58794759|FG001|Overall Study|Withdrawal by Subject|1|||
30782637|NCT02250664|58794760|FG002|Overall Study|Withdrawal by Subject|2|||
30782638|NCT02250664|58794758|FG000|Overall Study|Death|0|||
30782639|NCT02250664|58794759|FG001|Overall Study|Death|1|||
30782640|NCT02250664|58794760|FG002|Overall Study|Death|1|||
30959046|NCT01587703|59024025|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959047|NCT01587703|59024026|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959048|NCT01587703|59024027|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959049|NCT01587703|59024028|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959050|NCT01587703|59024029|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959051|NCT01587703|59024030|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959052|NCT01587703|59024031|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959053|NCT01587703|59024032|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959054|NCT01587703|59024033|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959055|NCT01587703|59024034|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
30959056|NCT01587703|59024035|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959057|NCT01587703|59024036|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959058|NCT01587703|59024037|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959059|NCT01587703|59024038|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30782641|NCT02250664|58794758|FG000|Overall Study|Physician Decision|1|||
30782642|NCT02250664|58794759|FG001|Overall Study|Physician Decision|3|||
30782643|NCT02250664|58794760|FG002|Overall Study|Physician Decision|1|||
30782644|NCT02250664|58794758|FG000|Overall Study|Protocol Violation|1|||
30782645|NCT02250664|58794759|FG001|Overall Study|Protocol Violation|0|||
30782646|NCT02250664|58794760|FG002|Overall Study|Protocol Violation|1|||
30782647|NCT02250664|58794758|FG000|Overall Study|Reason unknown|1|||
30856129|NCT03606174|58884026|FG009|Overall Study|Death|3|||
30959060|NCT01587703|59024039|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959061|NCT01587703|59024040|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959062|NCT01587703|59024041|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
30959063|NCT01577381|59024104|FG000|Overall Study|Discontinued|2|||
30959064|NCT01577381|59024105|FG001|Overall Study|Discontinued|1|||
30594634|NCT01366209|58606853|FG001|Overall Study|Sponsors decision|1|||
30594635|NCT01366209|58606852|FG000|Overall Study|Withdrew consent|4|||
30594636|NCT01366209|58606853|FG001|Overall Study|Withdrew consent|3|||
30594637|NCT01365546|58606859|FG000|Overall Study|Withdrawal by Subject|1|||
30594638|NCT01365546|58606859|FG000|Overall Study|Screen failure|9|||
30594639|NCT01365546|58606859|FG000|Overall Study|Study termination|1|||
30594640|NCT01365507|58606869|FG000|Overall Study|Withdrawal Criteria|8|||
30782648|NCT02250664|58794759|FG001|Overall Study|Reason unknown|0|||
30782649|NCT02250664|58794760|FG002|Overall Study|Reason unknown|0|||
30594641|NCT01365507|58606870|FG001|Overall Study|Withdrawal Criteria|5|||
30782650|NCT02646982|58794770|FG000|Overall Study|Adverse Event|1|||
30782651|NCT02646982|58794771|FG001|Overall Study|Adverse Event|1|||
30594642|NCT01365507|58606869|FG000|Overall Study|Unclassified|1|||
30594643|NCT01365507|58606870|FG001|Overall Study|Unclassified|4|||
30594644|NCT01365468|58606894|FG000|Overall Study|Physician Decision|1|||
30594645|NCT01365468|58606895|FG001|Overall Study|Physician Decision|0|||
30594646|NCT01365468|58606894|FG000|Overall Study|Disease progression|1|||
30594647|NCT01365468|58606895|FG001|Overall Study|Disease progression|0|||
30594648|NCT01365468|58606894|FG000|Overall Study|Lost to Follow-up|2|||
30594649|NCT01365468|58606895|FG001|Overall Study|Lost to Follow-up|0|||
30594650|NCT01357980|58606906|FG000|Overall Study|Lack of Efficacy|0|||
30594651|NCT01357980|58606907|FG001|Overall Study|Lack of Efficacy|1|||
30594652|NCT01357980|58606908|FG002|Overall Study|Lack of Efficacy|0|||
30594653|NCT01357980|58606909|FG003|Overall Study|Lack of Efficacy|0|||
30594654|NCT01357980|58606906|FG000|Overall Study|Consent withdrawn|0|||
30594655|NCT01357980|58606907|FG001|Overall Study|Consent withdrawn|0|||
30594656|NCT01357980|58606908|FG002|Overall Study|Consent withdrawn|1|||
30594657|NCT01357980|58606909|FG003|Overall Study|Consent withdrawn|0|||
30594658|NCT01332318|58606923|FG000|Overall Study|Adverse Event|0|||
30594659|NCT01332318|58606924|FG001|Overall Study|Adverse Event|3|||
30594660|NCT01332318|58606925|FG002|Overall Study|Adverse Event|0|||
30594661|NCT01332318|58606926|FG003|Overall Study|Adverse Event|0|||
30594662|NCT01332318|58606923|FG000|Overall Study|Withdrawal by Subject|1|||
30594663|NCT01332318|58606924|FG001|Overall Study|Withdrawal by Subject|1|||
30594664|NCT01332318|58606925|FG002|Overall Study|Withdrawal by Subject|0|||
30594665|NCT01332318|58606926|FG003|Overall Study|Withdrawal by Subject|1|||
30594666|NCT01332318|58606923|FG000|Overall Study|Protocol Violation|1|||
30594667|NCT01332318|58606924|FG001|Overall Study|Protocol Violation|0|||
30594668|NCT01332318|58606925|FG002|Overall Study|Protocol Violation|1|||
30594669|NCT01332318|58606926|FG003|Overall Study|Protocol Violation|1|||
30594670|NCT01331109|58606941|FG000|Overall Study|Adverse Event|6|||
30594671|NCT01331109|58606941|FG000|Overall Study|Lack of Efficacy|2|||
30594672|NCT01331109|58606941|FG000|Overall Study|Protocol Violation|3|||
30594673|NCT01331109|58606941|FG000|Overall Study|Withdrawal by Subject|7|||
30594674|NCT01331109|58606941|FG000|Overall Study|Lost to Follow-up|1|||
30594675|NCT01331109|58606941|FG000|Overall Study|Study Terminated by Sponsor|38|||
30594676|NCT01357551|58606947|FG000|Overall Study|Withdrawal by Subject|6|||
30594677|NCT01357551|58606948|FG001|Overall Study|Withdrawal by Subject|4|||
30594678|NCT01357551|58606947|FG000|Overall Study|Death|0|||
30594679|NCT01357551|58606948|FG001|Overall Study|Death|1|||
30594680|NCT01357551|58606947|FG000|Overall Study|Lost to Follow-up|16|||
30594681|NCT01357551|58606948|FG001|Overall Study|Lost to Follow-up|6|||
30594682|NCT01357239|58606961|FG000|Stratum: All Patients|Adverse Event|0|||
30594683|NCT01357239|58606962|FG001|Stratum: All Patients|Adverse Event|0|||
30594684|NCT01357239|58606963|FG002|Stratum: All Patients|Adverse Event|1|||
30594685|NCT01357239|58606964|FG003|Stratum: All Patients|Adverse Event|1|||
30594686|NCT01357239|58606961|FG000|Stratum: All Patients|Subject withdrew consent|0|||
30594687|NCT01357239|58606962|FG001|Stratum: All Patients|Subject withdrew consent|0|||
30594688|NCT01357239|58606963|FG002|Stratum: All Patients|Subject withdrew consent|1|||
30594689|NCT01357239|58606964|FG003|Stratum: All Patients|Subject withdrew consent|1|||
30594690|NCT01357239|58606961|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
30594691|NCT01357239|58606962|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
30594692|NCT01357239|58606963|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
30782652|NCT02646982|58794770|FG000|Overall Study|Withdrawal by Subject|2|||
30856130|NCT03606174|58884027|FG010|Overall Study|Death|0|||
30959065|NCT01577381|59024106|FG002|Overall Study|Discontinued|2|||
30594693|NCT01357239|58606964|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
30594694|NCT01357239|58606961|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
30594695|NCT01357239|58606962|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
30594696|NCT01357239|58606963|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
30594697|NCT01357239|58606964|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
30594698|NCT01357239|58606961|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
30594699|NCT01357239|58606962|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
30594700|NCT01357239|58606963|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
30594701|NCT01357239|58606964|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
30594702|NCT01357161|58606980|FG000|Part 1 (Open Label Run-in)|Death|5|||
30594703|NCT01357161|58606981|FG001|Part 1 (Open Label Run-in)|Death|0|||
30594704|NCT01357161|58606982|FG002|Part 1 (Open Label Run-in)|Death|0|||
30594705|NCT01357161|58606980|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
30594706|NCT01357161|58606981|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
30594707|NCT01357161|58606982|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
30594708|NCT01357161|58606980|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
30594709|NCT01357161|58606981|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
30594710|NCT01357161|58606982|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
30594711|NCT01357161|58606980|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
30594712|NCT01357161|58606981|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
30594713|NCT01357161|58606982|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
30594714|NCT01357161|58606980|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
30594715|NCT01357161|58606981|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
30594716|NCT01357161|58606982|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
30594717|NCT01357161|58606980|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
30594718|NCT01357161|58606981|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
30594719|NCT01357161|58606982|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
30594720|NCT01357161|58606980|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
30594721|NCT01357161|58606981|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
30594722|NCT01357161|58606982|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
30594723|NCT01357161|58606980|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
30594724|NCT01357161|58606981|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
30594725|NCT01357161|58606982|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
30594726|NCT01357161|58606980|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
30679983|NCT00821327|58694099|FG000|Overall Study|Other/Unknown|5|||
30594727|NCT01357161|58606981|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
30594728|NCT01357161|58606982|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
30594729|NCT01357161|58606980|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
30594730|NCT01357161|58606981|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
30679984|NCT00821093|58694105|FG000|Overall Study|Adverse Event|20|||
30679985|NCT00821093|58694106|FG001|Overall Study|Adverse Event|12|||
30679986|NCT00821093|58694105|FG000|Overall Study|Withdrawal by Subject|9|||
30679987|NCT00821093|58694106|FG001|Overall Study|Withdrawal by Subject|13|||
30679988|NCT00821093|58694105|FG000|Overall Study|Lost to Follow-up|9|||
30679989|NCT00821093|58694106|FG001|Overall Study|Lost to Follow-up|3|||
30679990|NCT00821093|58694105|FG000|Overall Study|Protocol deviation|3|||
30679991|NCT00821093|58694106|FG001|Overall Study|Protocol deviation|6|||
30594731|NCT01357161|58606982|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
30594732|NCT01357161|58606980|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
30594733|NCT01357161|58606981|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
30594734|NCT01357161|58606982|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
30594735|NCT01351350|58606995|FG000|Overall Study|Disease Progression|5|||
30594736|NCT01351350|58606996|FG001|Overall Study|Disease Progression|13|||
30594737|NCT01351350|58606997|FG002|Overall Study|Disease Progression|6|||
30594738|NCT01351350|58606998|FG003|Overall Study|Disease Progression|8|||
30594739|NCT01351350|58606999|FG004|Overall Study|Disease Progression|5|||
30594740|NCT01351350|58606995|FG000|Overall Study|Adverse Event|1|||
30594741|NCT01351350|58606996|FG001|Overall Study|Adverse Event|10|||
30594742|NCT01351350|58606997|FG002|Overall Study|Adverse Event|1|||
30594743|NCT01351350|58606998|FG003|Overall Study|Adverse Event|2|||
30594744|NCT01351350|58606999|FG004|Overall Study|Adverse Event|0|||
30594745|NCT01351350|58606995|FG000|Overall Study|Participant Decision|2|||
30594746|NCT01351350|58606996|FG001|Overall Study|Participant Decision|6|||
30594747|NCT01351350|58606997|FG002|Overall Study|Participant Decision|3|||
30679992|NCT00821093|58694105|FG000|Overall Study|Abnormal laboratory value(s)|2|||
30679993|NCT00821093|58694106|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30679994|NCT00821093|58694105|FG000|Overall Study|Lack of Efficacy|2|||
30679995|NCT00821093|58694106|FG001|Overall Study|Lack of Efficacy|2|||
30679996|NCT00821093|58694105|FG000|Overall Study|Death|2|||
30679997|NCT00821093|58694106|FG001|Overall Study|Death|1|||
30679998|NCT00821093|58694105|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30679999|NCT00821093|58694106|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30594748|NCT01351350|58606998|FG003|Overall Study|Participant Decision|3|||
30594749|NCT01351350|58606999|FG004|Overall Study|Participant Decision|2|||
30594750|NCT01351350|58606995|FG000|Overall Study|Enrolled but not Treated|0|||
30594751|NCT01351350|58606996|FG001|Overall Study|Enrolled but not Treated|0|||
30594752|NCT01351350|58606997|FG002|Overall Study|Enrolled but not Treated|1|||
30594753|NCT01351350|58606998|FG003|Overall Study|Enrolled but not Treated|0|||
30594754|NCT01351350|58606999|FG004|Overall Study|Enrolled but not Treated|0|||
30594755|NCT01350999|58607027|FG000|Overall Study|Adverse Event|4|||
30594756|NCT01350999|58607028|FG001|Overall Study|Adverse Event|9|||
30594757|NCT01350999|58607029|FG002|Overall Study|Adverse Event|10|||
30594758|NCT01350999|58607027|FG000|Overall Study|Voluntary withdrawal|3|||
30594759|NCT01350999|58607028|FG001|Overall Study|Voluntary withdrawal|4|||
30594760|NCT01350999|58607029|FG002|Overall Study|Voluntary withdrawal|6|||
30594761|NCT01350999|58607027|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
30680000|NCT00821093|58694105|FG000|Overall Study|Administrative problems|1|||
30680001|NCT00821093|58694106|FG001|Overall Study|Administrative problems|2|||
30680002|NCT00821015|58694112|FG000|Overall Study|Lost to Follow-up|12|||
30594762|NCT01350999|58607028|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
30594763|NCT01350999|58607029|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
30594764|NCT01330914|58607048|FG000|Overall Study|Withdrawal by Subject|4|||
30594765|NCT01330914|58607048|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
30594766|NCT01350804|58607056|FG000|Core Study|Withdrawal by Subject|11|||
30594767|NCT01350804|58607057|FG001|Core Study|Withdrawal by Subject|17|||
30680003|NCT00814463|58694116|FG000|Overall Study|Lost to Follow-up|1|||
30594768|NCT01350804|58607058|FG002|Core Study|Withdrawal by Subject|16|||
30594769|NCT01350804|58607059|FG003|Core Study|Withdrawal by Subject|7|||
30594770|NCT01350804|58607056|FG000|Core Study|Study terminated by Sponsor|0|||
30594771|NCT01350804|58607057|FG001|Core Study|Study terminated by Sponsor|0|||
30594772|NCT01350804|58607058|FG002|Core Study|Study terminated by Sponsor|0|||
30594773|NCT01350804|58607059|FG003|Core Study|Study terminated by Sponsor|2|||
30594774|NCT01350804|58607056|FG000|Core Study|Protocol deviation|1|||
30594775|NCT01350804|58607057|FG001|Core Study|Protocol deviation|0|||
30594776|NCT01350804|58607058|FG002|Core Study|Protocol deviation|1|||
30594777|NCT01350804|58607059|FG003|Core Study|Protocol deviation|0|||
30594778|NCT01350804|58607056|FG000|Core Study|Physician Decision|1|||
30594779|NCT01350804|58607057|FG001|Core Study|Physician Decision|0|||
30594780|NCT01350804|58607058|FG002|Core Study|Physician Decision|1|||
30594781|NCT01350804|58607059|FG003|Core Study|Physician Decision|3|||
30594782|NCT01350804|58607056|FG000|Core Study|Lost to Follow-up|3|||
30594783|NCT01350804|58607057|FG001|Core Study|Lost to Follow-up|0|||
30594784|NCT01350804|58607058|FG002|Core Study|Lost to Follow-up|2|||
30594785|NCT01350804|58607059|FG003|Core Study|Lost to Follow-up|1|||
30594786|NCT01350804|58607056|FG000|Core Study|Lack of Efficacy|16|||
30594787|NCT01350804|58607057|FG001|Core Study|Lack of Efficacy|19|||
30594788|NCT01350804|58607058|FG002|Core Study|Lack of Efficacy|18|||
30594789|NCT01350804|58607059|FG003|Core Study|Lack of Efficacy|5|||
30594790|NCT01350804|58607056|FG000|Core Study|Death|1|||
30594791|NCT01350804|58607057|FG001|Core Study|Death|1|||
30594792|NCT01350804|58607058|FG002|Core Study|Death|1|||
30594793|NCT01350804|58607059|FG003|Core Study|Death|0|||
30594794|NCT01350804|58607056|FG000|Core Study|Adverse Event|8|||
30594795|NCT01350804|58607057|FG001|Core Study|Adverse Event|10|||
30594796|NCT01350804|58607058|FG002|Core Study|Adverse Event|8|||
30594797|NCT01350804|58607059|FG003|Core Study|Adverse Event|8|||
30594798|NCT01350804|58607056|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
30594799|NCT01350804|58607057|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
30594800|NCT01350804|58607058|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
30680004|NCT00743652|58694126|FG000|Overall Study|Parent/Legal Guardian Request|3|||
30680005|NCT00743652|58694127|FG001|Overall Study|Parent/Legal Guardian Request|2|||
30680006|NCT00743652|58694128|FG002|Overall Study|Parent/Legal Guardian Request|2|||
30680007|NCT00743652|58694129|FG003|Overall Study|Parent/Legal Guardian Request|2|||
30594801|NCT01350804|58607059|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
30594802|NCT01350804|58607056|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
30594803|NCT01350804|58607057|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
30680008|NCT00743652|58694130|FG004|Overall Study|Parent/Legal Guardian Request|0|||
30680009|NCT00743652|58694126|FG000|Overall Study|Adverse Event|3|||
30680010|NCT00743652|58694127|FG001|Overall Study|Adverse Event|0|||
30680011|NCT00743652|58694128|FG002|Overall Study|Adverse Event|0|||
30680012|NCT00743652|58694129|FG003|Overall Study|Adverse Event|0|||
30680013|NCT00743652|58694130|FG004|Overall Study|Adverse Event|0|||
30680014|NCT00743652|58694126|FG000|Overall Study|Death|2|||
30680015|NCT00743652|58694127|FG001|Overall Study|Death|0|||
30680016|NCT00743652|58694128|FG002|Overall Study|Death|0|||
30680017|NCT00743652|58694129|FG003|Overall Study|Death|0|||
30680018|NCT00743652|58694130|FG004|Overall Study|Death|0|||
30680019|NCT00743652|58694126|FG000|Overall Study|Investigator Request|0|||
30680020|NCT00743652|58694127|FG001|Overall Study|Investigator Request|0|||
30680021|NCT00743652|58694128|FG002|Overall Study|Investigator Request|0|||
30680022|NCT00743652|58694129|FG003|Overall Study|Investigator Request|2|||
30680023|NCT00743652|58694130|FG004|Overall Study|Investigator Request|0|||
30680024|NCT00743652|58694126|FG000|Overall Study|Other|1|||
30680025|NCT00743652|58694127|FG001|Overall Study|Other|1|||
30680026|NCT00743652|58694128|FG002|Overall Study|Other|0|||
30680027|NCT00743652|58694129|FG003|Overall Study|Other|0|||
30680028|NCT00743652|58694130|FG004|Overall Study|Other|0|||
30680029|NCT00743652|58694126|FG000|Overall Study|Lost to Follow-up|1|||
30680030|NCT00743652|58694127|FG001|Overall Study|Lost to Follow-up|0|||
30680031|NCT00743652|58694128|FG002|Overall Study|Lost to Follow-up|0|||
30594804|NCT01350804|58607058|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
30594805|NCT01350804|58607059|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
30680032|NCT00743652|58694129|FG003|Overall Study|Lost to Follow-up|0|||
30680033|NCT00743652|58694130|FG004|Overall Study|Lost to Follow-up|0|||
30594806|NCT01350804|58607056|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
30680034|NCT00748215|58694148|FG000|Overall Study|Withdrawal by Subject|7|||
30680035|NCT00748215|58694149|FG001|Overall Study|Withdrawal by Subject|7|||
30680036|NCT00748215|58694148|FG000|Overall Study|Treatment change|2|||
30594807|NCT01350804|58607057|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
30594808|NCT01350804|58607058|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
30594809|NCT01350804|58607059|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
30680037|NCT00748215|58694149|FG001|Overall Study|Treatment change|1|||
30680038|NCT00748215|58694148|FG000|Overall Study|Change in patient condition|0|||
30782653|NCT02646982|58794771|FG001|Overall Study|Withdrawal by Subject|1|||
30594810|NCT01350804|58607056|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
30680039|NCT00748215|58694149|FG001|Overall Study|Change in patient condition|3|||
30680040|NCT00748215|58694148|FG000|Overall Study|Non-compliant|0|||
30680041|NCT00748215|58694149|FG001|Overall Study|Non-compliant|2|||
30680042|NCT00748215|58694148|FG000|Overall Study|Adverse Event|0|||
30680043|NCT00748215|58694149|FG001|Overall Study|Adverse Event|5|||
30680044|NCT00749892|58694155|FG000|Overall Study|Withdrawal by Subject|3|||
30680045|NCT00749580|58694161|FG000|Overall Study|Lost to Follow-up|4|||
30680046|NCT00749580|58694162|FG001|Overall Study|Lost to Follow-up|8|||
30680047|NCT00749580|58694161|FG000|Overall Study|Adverse Event|0|||
30680048|NCT00749580|58694162|FG001|Overall Study|Adverse Event|1|||
30680049|NCT00747006|58694171|FG000|Overall Study|Adverse Event|1|||
30680050|NCT00747006|58694172|FG001|Overall Study|Adverse Event|0|||
30680051|NCT00747006|58694173|FG002|Overall Study|Adverse Event|0|||
30680052|NCT00747006|58694171|FG000|Overall Study|Lost to Follow-up|0|||
30680053|NCT00747006|58694172|FG001|Overall Study|Lost to Follow-up|1|||
30680054|NCT00747006|58694173|FG002|Overall Study|Lost to Follow-up|0|||
30680055|NCT00747006|58694171|FG000|Overall Study|Physician Decision|2|||
30680056|NCT00747006|58694172|FG001|Overall Study|Physician Decision|0|||
30680057|NCT00747006|58694173|FG002|Overall Study|Physician Decision|1|||
30680058|NCT00743340|58694184|FG000|Overall Study|Study medication non-compliance|1|||
30680059|NCT00743340|58694184|FG000|Overall Study|Lost to Follow-up|1|||
30680060|NCT00743340|58694184|FG000|Overall Study|Withdrawal from the Study|5|||
30680061|NCT00743340|58694184|FG000|Overall Study|Protocol Violation|1|||
30680062|NCT00743340|58694184|FG000|Overall Study|Virologic failure|8|||
30594811|NCT01350804|58607057|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
30594812|NCT01350804|58607058|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
30594813|NCT01350804|58607059|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
30594814|NCT01350804|58607056|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
30594815|NCT01350804|58607057|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
30594816|NCT01350804|58607058|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
30594817|NCT01350804|58607059|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
30594818|NCT01350804|58607056|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
30594819|NCT01350804|58607057|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
30594820|NCT01350804|58607058|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
30594821|NCT01350804|58607059|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
30680063|NCT00743340|58694184|FG000|Overall Study|Pregnancy|1|||
30680064|NCT00743340|58694184|FG000|Overall Study|Rolled over to other Gilead Study|23|||
30680065|NCT00743340|58694184|FG000|Overall Study|Participant Relocated|1|||
30680066|NCT00749190|58694195|FG000|Overall Study|Adverse Event|0|||
30680067|NCT00749190|58694196|FG001|Overall Study|Adverse Event|2|||
30680068|NCT00749190|58694197|FG002|Overall Study|Adverse Event|0|||
30680069|NCT00749190|58694198|FG003|Overall Study|Adverse Event|4|||
30680070|NCT00749190|58694199|FG004|Overall Study|Adverse Event|0|||
30680071|NCT00749190|58694200|FG005|Overall Study|Adverse Event|3|||
30680072|NCT00749190|58694201|FG006|Overall Study|Adverse Event|0|||
30680073|NCT00749190|58694195|FG000|Overall Study|Lack of Efficacy|3|||
30680074|NCT00749190|58694196|FG001|Overall Study|Lack of Efficacy|1|||
30680075|NCT00749190|58694197|FG002|Overall Study|Lack of Efficacy|1|||
30680076|NCT00749190|58694198|FG003|Overall Study|Lack of Efficacy|0|||
30680077|NCT00749190|58694199|FG004|Overall Study|Lack of Efficacy|0|||
30680078|NCT00749190|58694200|FG005|Overall Study|Lack of Efficacy|1|||
30680079|NCT00749190|58694201|FG006|Overall Study|Lack of Efficacy|0|||
30680080|NCT00749190|58694195|FG000|Overall Study|Withdrawal by Subject|2|||
30680081|NCT00749190|58694196|FG001|Overall Study|Withdrawal by Subject|1|||
30680082|NCT00749190|58694197|FG002|Overall Study|Withdrawal by Subject|0|||
30680083|NCT00749190|58694198|FG003|Overall Study|Withdrawal by Subject|0|||
30680084|NCT00749190|58694199|FG004|Overall Study|Withdrawal by Subject|0|||
30680085|NCT00749190|58694200|FG005|Overall Study|Withdrawal by Subject|1|||
30680086|NCT00749190|58694201|FG006|Overall Study|Withdrawal by Subject|0|||
30680087|NCT00749190|58694195|FG000|Overall Study|Protocol Violation|0|||
30680088|NCT00749190|58694196|FG001|Overall Study|Protocol Violation|1|||
30680089|NCT00749190|58694197|FG002|Overall Study|Protocol Violation|0|||
30680090|NCT00749190|58694198|FG003|Overall Study|Protocol Violation|0|||
30680091|NCT00749190|58694199|FG004|Overall Study|Protocol Violation|0|||
30680092|NCT00749190|58694200|FG005|Overall Study|Protocol Violation|0|||
30680093|NCT00749190|58694201|FG006|Overall Study|Protocol Violation|1|||
30680094|NCT00749190|58694195|FG000|Overall Study|Other reason not defined above|0|||
30680095|NCT00749190|58694196|FG001|Overall Study|Other reason not defined above|0|||
30680096|NCT00749190|58694197|FG002|Overall Study|Other reason not defined above|0|||
30782654|NCT02845336|58794779|FG000|Overall Study|Lost to Follow-up|3|||
30680097|NCT00749190|58694198|FG003|Overall Study|Other reason not defined above|1|||
30680098|NCT00749190|58694199|FG004|Overall Study|Other reason not defined above|0|||
30680099|NCT00749190|58694200|FG005|Overall Study|Other reason not defined above|0|||
30680100|NCT00749190|58694201|FG006|Overall Study|Other reason not defined above|0|||
30680101|NCT00748566|58694222|FG000|Overall Study|Adverse Event|49|||
30680102|NCT00748566|58694222|FG000|Overall Study|Death|1|||
30680103|NCT00748566|58694222|FG000|Overall Study|Lack of Efficacy|12|||
30680104|NCT00748566|58694222|FG000|Overall Study|Lost to Follow-up|1|||
30680105|NCT00748566|58694222|FG000|Overall Study|Protocol Violation|13|||
30680106|NCT00748566|58694222|FG000|Overall Study|Withdrawal by Subject|22|||
30680107|NCT00748566|58694222|FG000|Overall Study|Study terminated by sponsor|5|||
30680108|NCT00748566|58694222|FG000|Overall Study|Other|9|||
30594822|NCT01350492|58607081|FG000|Intervention|Lost to Follow-up|2|||
30594823|NCT01350492|58607082|FG001|Intervention|Lost to Follow-up|5|||
30594824|NCT01350492|58607081|FG000|Intervention|Withdrawal by Subject|3|||
30594825|NCT01350492|58607082|FG001|Intervention|Withdrawal by Subject|1|||
30594826|NCT01350492|58607081|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
30594827|NCT01350492|58607082|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
30594828|NCT01350492|58607081|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
30594829|NCT01350492|58607082|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
30594830|NCT02270957|58607090|FG000|Overall Study|Lack of Efficacy|2|||
30594831|NCT02270957|58607091|FG001|Overall Study|Lack of Efficacy|4|||
30594832|NCT02270957|58607090|FG000|Overall Study|Adverse Event|2|||
30594833|NCT02270957|58607091|FG001|Overall Study|Adverse Event|0|||
30594834|NCT01350414|58607098|FG000|Overall Study|Lost to Follow-up|13|||
30594835|NCT01350414|58607098|FG000|Overall Study|Withdrawal by Subject|4|||
30594836|NCT01350414|58607098|FG000|Overall Study|Physician Decision|2|||
30594837|NCT01350336|58607108|FG000|Overall Study|Lost to Follow-up|31|||
30594838|NCT01350336|58607108|FG000|Overall Study|Withdrawal by Subject|14|||
30594839|NCT01350336|58607108|FG000|Overall Study|Physician Decision|8|||
30594840|NCT01350336|58607108|FG000|Overall Study|Death|4|||
30594841|NCT01349049|58607166|FG000|Overall Study|Disease progression|3|||
30594842|NCT01349049|58607167|FG001|Overall Study|Disease progression|5|||
30594843|NCT01349049|58607168|FG002|Overall Study|Disease progression|3|||
30594844|NCT01349049|58607169|FG003|Overall Study|Disease progression|2|||
30594845|NCT01349049|58607170|FG004|Overall Study|Disease progression|2|||
30594846|NCT01349049|58607171|FG005|Overall Study|Disease progression|2|||
30680109|NCT00743106|58694228|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
30680110|NCT00743106|58694229|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
30680111|NCT00738699|58694237|FG000|Overall Study|Withdrawal by Subject|5|||
30782655|NCT02845336|58794780|FG001|Overall Study|Lost to Follow-up|1|||
30782656|NCT02845336|58794779|FG000|Overall Study|Inability to get medication|2|||
30782657|NCT02845336|58794780|FG001|Overall Study|Inability to get medication|0|||
30782658|NCT02844946|58794788|FG000|Overall Study|Lost to Follow-up|7|||
30782659|NCT02844946|58794789|FG001|Overall Study|Lost to Follow-up|0|||
30782660|NCT02951156|58794798|FG000|Overall Study|Death|3|||
30782661|NCT02951156|58794799|FG001|Overall Study|Death|8|||
30782662|NCT02951156|58794800|FG002|Overall Study|Death|5|||
30782663|NCT02951156|58794798|FG000|Overall Study|Progressive disease|1|||
30782664|NCT02951156|58794799|FG001|Overall Study|Progressive disease|0|||
30782665|NCT02951156|58794800|FG002|Overall Study|Progressive disease|1|||
30782666|NCT02951156|58794798|FG000|Overall Study|Withdrawal by Subject|0|||
30782667|NCT02951156|58794799|FG001|Overall Study|Withdrawal by Subject|0|||
30782668|NCT02951156|58794800|FG002|Overall Study|Withdrawal by Subject|1|||
30782669|NCT02951156|58794798|FG000|Overall Study|Study terminated by sponsor|0|||
30782670|NCT02951156|58794799|FG001|Overall Study|Study terminated by sponsor|0|||
30782671|NCT02951156|58794800|FG002|Overall Study|Study terminated by sponsor|1|||
30782672|NCT02951156|58794798|FG000|Overall Study|Other|5|||
30782673|NCT02951156|58794799|FG001|Overall Study|Other|1|||
30782674|NCT02951156|58794800|FG002|Overall Study|Other|2|||
30782675|NCT03345914|58794812|FG000|Overall Study|Transition to another study at week 16|80|||
30782676|NCT03345914|58794813|FG001|Overall Study|Transition to another study at week 16|86|||
30782677|NCT03345914|58794814|FG002|Overall Study|Transition to another study at week 16|78|||
30782678|NCT03345914|58794812|FG000|Overall Study|Transition to OLE during follow-up|37|||
30782679|NCT03345914|58794813|FG001|Overall Study|Transition to OLE during follow-up|33|||
30782680|NCT03345914|58794814|FG002|Overall Study|Transition to OLE during follow-up|39|||
30782681|NCT03345914|58794812|FG000|Overall Study|Physician Decision|0|||
30782682|NCT03345914|58794813|FG001|Overall Study|Physician Decision|1|||
30782683|NCT03345914|58794814|FG002|Overall Study|Physician Decision|1|||
30782684|NCT03345914|58794812|FG000|Overall Study|Withdrawal by Subject|5|||
30594847|NCT01349049|58607172|FG006|Overall Study|Disease progression|3|||
30594848|NCT01349049|58607173|FG007|Overall Study|Disease progression|2|||
30594849|NCT01349049|58607174|FG008|Overall Study|Disease progression|33|||
30594850|NCT01349049|58607166|FG000|Overall Study|Adverse Event|0|||
30594851|NCT01349049|58607167|FG001|Overall Study|Adverse Event|1|||
30782685|NCT03345914|58794813|FG001|Overall Study|Withdrawal by Subject|1|||
30594852|NCT01349049|58607168|FG002|Overall Study|Adverse Event|0|||
30594853|NCT01349049|58607169|FG003|Overall Study|Adverse Event|0|||
30782686|NCT03345914|58794814|FG002|Overall Study|Withdrawal by Subject|2|||
30959066|NCT01577381|59024107|FG003|Overall Study|Discontinued|2|||
30680112|NCT00738699|58694238|FG001|Overall Study|Withdrawal by Subject|0|||
30680113|NCT00738699|58694237|FG000|Overall Study|Lost to Follow-up|1|||
30680114|NCT00738699|58694238|FG001|Overall Study|Lost to Follow-up|0|||
30680115|NCT00738699|58694237|FG000|Overall Study|Death|144|||
30594854|NCT01349049|58607170|FG004|Overall Study|Adverse Event|0|||
30594855|NCT01349049|58607171|FG005|Overall Study|Adverse Event|3|||
30594856|NCT01349049|58607172|FG006|Overall Study|Adverse Event|1|||
30594857|NCT01349049|58607173|FG007|Overall Study|Adverse Event|0|||
30594858|NCT01349049|58607174|FG008|Overall Study|Adverse Event|4|||
30594859|NCT01349049|58607166|FG000|Overall Study|Physician Decision|0|||
30594860|NCT01349049|58607167|FG001|Overall Study|Physician Decision|1|||
30594861|NCT01349049|58607168|FG002|Overall Study|Physician Decision|0|||
30594862|NCT01349049|58607169|FG003|Overall Study|Physician Decision|0|||
30594863|NCT01349049|58607170|FG004|Overall Study|Physician Decision|0|||
30680116|NCT00738699|58694238|FG001|Overall Study|Death|68|||
30680117|NCT00738699|58694237|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
30680118|NCT00738699|58694238|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
30680119|NCT00738699|58694237|FG000|Overall Study|Other|2|||
30680120|NCT00738699|58694238|FG001|Overall Study|Other|0|||
30680121|NCT00814307|58694248|FG000|Overall Study|Randomized but not treated|1|||
30680122|NCT00814307|58694249|FG001|Overall Study|Randomized but not treated|0|||
30680123|NCT00814307|58694250|FG002|Overall Study|Randomized but not treated|0|||
30680124|NCT00814307|58694251|FG003|Overall Study|Randomized but not treated|0|||
30680125|NCT00814307|58694248|FG000|Overall Study|Adverse Event|3|||
30680126|NCT00814307|58694249|FG001|Overall Study|Adverse Event|9|||
30680127|NCT00814307|58694250|FG002|Overall Study|Adverse Event|3|||
30680128|NCT00814307|58694251|FG003|Overall Study|Adverse Event|2|||
30680129|NCT00814307|58694248|FG000|Overall Study|Lack of Efficacy|1|||
30680130|NCT00814307|58694249|FG001|Overall Study|Lack of Efficacy|1|||
30680131|NCT00814307|58694250|FG002|Overall Study|Lack of Efficacy|3|||
30680132|NCT00814307|58694251|FG003|Overall Study|Lack of Efficacy|4|||
30680133|NCT00814307|58694248|FG000|Overall Study|Other|1|||
30680134|NCT00814307|58694249|FG001|Overall Study|Other|2|||
30680135|NCT00814307|58694250|FG002|Overall Study|Other|0|||
30680136|NCT00814307|58694251|FG003|Overall Study|Other|1|||
30680137|NCT00814307|58694248|FG000|Overall Study|Protocol Violation|2|||
30680138|NCT00814307|58694249|FG001|Overall Study|Protocol Violation|8|||
30680139|NCT00814307|58694250|FG002|Overall Study|Protocol Violation|1|||
30680140|NCT00814307|58694251|FG003|Overall Study|Protocol Violation|1|||
30680141|NCT00814307|58694248|FG000|Overall Study|Withdrawal by Subject|4|||
30680142|NCT00814307|58694249|FG001|Overall Study|Withdrawal by Subject|6|||
30680143|NCT00814307|58694250|FG002|Overall Study|Withdrawal by Subject|0|||
30680144|NCT00814307|58694251|FG003|Overall Study|Withdrawal by Subject|2|||
30680145|NCT00814307|58694248|FG000|Overall Study|Death|0|||
30680146|NCT00814307|58694249|FG001|Overall Study|Death|1|||
30594864|NCT01349049|58607171|FG005|Overall Study|Physician Decision|0|||
30680147|NCT00814307|58694250|FG002|Overall Study|Death|0|||
30680148|NCT00814307|58694251|FG003|Overall Study|Death|0|||
30680149|NCT00748098|58694263|FG000|First Treatment Intervention Period|Adverse Event|1|||
30680150|NCT00748098|58694264|FG001|First Treatment Intervention Period|Adverse Event|1|||
30680151|NCT00748098|58694263|FG000|First Treatment Intervention Period|Protocol Violation|1|||
30680152|NCT00748098|58694264|FG001|First Treatment Intervention Period|Protocol Violation|0|||
30594865|NCT01349049|58607172|FG006|Overall Study|Physician Decision|0|||
30594866|NCT01349049|58607173|FG007|Overall Study|Physician Decision|0|||
30680153|NCT00748098|58694263|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
30680154|NCT00748098|58694264|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
30680155|NCT00748098|58694263|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
30680156|NCT00748098|58694264|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
30680157|NCT00748098|58694263|FG000|First Taper Period|Protocol Violation|1|||
30680158|NCT00748098|58694264|FG001|First Taper Period|Protocol Violation|0|||
30680159|NCT00748098|58694263|FG000|First Taper Period|Withdrawal by Subject|2|||
30680160|NCT00748098|58694264|FG001|First Taper Period|Withdrawal by Subject|0|||
30680161|NCT00748098|58694263|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
30680162|NCT00748098|58694264|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
30680163|NCT00748098|58694263|FG000|1-Week Washout Period|Adverse Event|0|||
30680164|NCT00748098|58694264|FG001|1-Week Washout Period|Adverse Event|1|||
30680165|NCT00748098|58694263|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
30680166|NCT00748098|58694264|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
30680167|NCT00748098|58694263|FG000|Second Treatment Intervention Period|Adverse Event|4|||
30856131|NCT03606174|58884017|FG000|Overall Study|Lost to Follow-up|0|||
30594867|NCT01349049|58607174|FG008|Overall Study|Physician Decision|2|||
30594868|NCT01349049|58607166|FG000|Overall Study|Protocol Violation|0|||
30594869|NCT01349049|58607167|FG001|Overall Study|Protocol Violation|0|||
30594870|NCT01349049|58607168|FG002|Overall Study|Protocol Violation|0|||
30594871|NCT01349049|58607169|FG003|Overall Study|Protocol Violation|0|||
30594872|NCT01349049|58607170|FG004|Overall Study|Protocol Violation|0|||
30959067|NCT01577381|59024104|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
30594873|NCT01349049|58607171|FG005|Overall Study|Protocol Violation|0|||
30680168|NCT00748098|58694264|FG001|Second Treatment Intervention Period|Adverse Event|1|||
30680169|NCT00748098|58694263|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
30594874|NCT01349049|58607172|FG006|Overall Study|Protocol Violation|0|||
30680170|NCT00748098|58694264|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
30680171|NCT00748098|58694263|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
30680172|NCT00748098|58694264|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
30680173|NCT00813995|58694273|FG000|Overall Study|Clinical adverse event|9|||
30680174|NCT00813995|58694274|FG001|Overall Study|Clinical adverse event|3|||
30680175|NCT00813995|58694273|FG000|Overall Study|Laboratory adverse event|0|||
30680176|NCT00813995|58694274|FG001|Overall Study|Laboratory adverse event|2|||
30680177|NCT00813995|58694273|FG000|Overall Study|Lack of Efficacy|1|||
30680178|NCT00813995|58694274|FG001|Overall Study|Lack of Efficacy|0|||
30680179|NCT00813995|58694273|FG000|Overall Study|Lost to Follow-up|4|||
30680180|NCT00813995|58694274|FG001|Overall Study|Lost to Follow-up|2|||
30680181|NCT00813995|58694273|FG000|Overall Study|Other reason|2|||
30680182|NCT00813995|58694274|FG001|Overall Study|Other reason|2|||
30680183|NCT00813995|58694273|FG000|Overall Study|Protocol Violation|3|||
30594875|NCT01349049|58607173|FG007|Overall Study|Protocol Violation|0|||
30594876|NCT01349049|58607174|FG008|Overall Study|Protocol Violation|1|||
30680184|NCT00813995|58694274|FG001|Overall Study|Protocol Violation|2|||
30680185|NCT00813995|58694273|FG000|Overall Study|Subject moved|4|||
30680186|NCT00813995|58694274|FG001|Overall Study|Subject moved|0|||
30680187|NCT00813995|58694273|FG000|Overall Study|Withdrawal by Subject|0|||
30680188|NCT00813995|58694274|FG001|Overall Study|Withdrawal by Subject|5|||
30680189|NCT00737529|58694284|FG000|Overall Study|Disease Progression|95|||
30594877|NCT01349049|58607166|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
30594878|NCT01349049|58607167|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
30594879|NCT01349049|58607168|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
30594880|NCT01349049|58607169|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
30594881|NCT01349049|58607170|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
30594882|NCT01349049|58607171|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
30594883|NCT01349049|58607172|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
30680190|NCT00737529|58694284|FG000|Overall Study|Adverse Event|24|||
30680191|NCT00737529|58694284|FG000|Overall Study|Withdrawal by Subject|5|||
30594884|NCT01349049|58607173|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
30594885|NCT01349049|58607174|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
30594886|NCT01349049|58607166|FG000|Overall Study|Other|0|||
30594887|NCT01349049|58607167|FG001|Overall Study|Other|0|||
30594888|NCT01349049|58607168|FG002|Overall Study|Other|0|||
30594889|NCT01349049|58607169|FG003|Overall Study|Other|0|||
30594890|NCT01349049|58607170|FG004|Overall Study|Other|0|||
30594891|NCT01349049|58607171|FG005|Overall Study|Other|1|||
30594892|NCT01349049|58607172|FG006|Overall Study|Other|0|||
30594893|NCT01349049|58607173|FG007|Overall Study|Other|0|||
30594894|NCT01349049|58607174|FG008|Overall Study|Other|4|||
30594895|NCT01349049|58607166|FG000|Overall Study|Death|0|||
30680192|NCT00737529|58694284|FG000|Overall Study|Death|4|||
30680193|NCT00737529|58694284|FG000|Overall Study|Protocol Violation|1|||
30680194|NCT00737529|58694284|FG000|Overall Study|Other|4|||
30680195|NCT00813917|58694290|FG000|Overall Study|Adverse Event|0|||
30680196|NCT00813917|58694291|FG001|Overall Study|Adverse Event|1|||
30680197|NCT00813917|58694290|FG000|Overall Study|Withdrawal by Subject|3|||
30680198|NCT00813917|58694291|FG001|Overall Study|Withdrawal by Subject|4|||
30680199|NCT00813917|58694290|FG000|Overall Study|Lost to Follow-up|3|||
30680200|NCT00813917|58694291|FG001|Overall Study|Lost to Follow-up|1|||
30680201|NCT00737061|58694297|FG000|Waiting Period|Lost to Follow-up|6|||
30680202|NCT00737061|58694297|FG000|Waiting Period|Withdrawal by Subject|1|||
30680203|NCT00737061|58694297|FG000|Waiting Period|Bilateral placement failure|34|||
30680204|NCT00737061|58694297|FG000|Waiting Period|Deemed patent following HSG|26|||
30680205|NCT00737061|58694297|FG000|Waiting Period|Alternative contraception failure|3|||
30680206|NCT00737061|58694297|FG000|Waiting Period|Elected surgical tubal ligation|5|||
30680207|NCT00737061|58694297|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
30680208|NCT00737061|58694297|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
30680209|NCT00737061|58694297|FG000|1 Year Wearing Period|Discontinued reilance|3|||
30680210|NCT00737061|58694297|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
30680211|NCT00585975|58694303|FG000|Overall Study|Withdrawal by Subject|3|||
30680212|NCT00585975|58694304|FG001|Overall Study|Withdrawal by Subject|3|||
30594896|NCT01349049|58607167|FG001|Overall Study|Death|0|||
30594897|NCT01349049|58607168|FG002|Overall Study|Death|0|||
30680213|NCT00585975|58694303|FG000|Overall Study|Lost to Follow-up|2|||
30680214|NCT00585975|58694304|FG001|Overall Study|Lost to Follow-up|1|||
30680215|NCT00585975|58694303|FG000|Overall Study|Enrollment met/over-enrolled|10|||
30680216|NCT00585975|58694304|FG001|Overall Study|Enrollment met/over-enrolled|9|||
30680217|NCT00585585|58694310|FG000|Overall Study|Adverse Event|1|||
30680218|NCT00734097|58694314|FG000|Screening|Protocol Violation|12|||
30680219|NCT00734097|58694314|FG000|Screening|Withdrawal by Subject|5|||
30594898|NCT01349049|58607169|FG003|Overall Study|Death|0|||
30594899|NCT01349049|58607170|FG004|Overall Study|Death|0|||
30594900|NCT01349049|58607171|FG005|Overall Study|Death|0|||
30594901|NCT01349049|58607172|FG006|Overall Study|Death|0|||
30680220|NCT00734097|58694314|FG000|Screening|Lost to Follow-up|2|||
30680221|NCT00734097|58694314|FG000|Screening|Unconfirmed pregnancy|1|||
30680222|NCT00734097|58694314|FG000|Open Label|Lost to Follow-up|7|||
30680223|NCT00734097|58694314|FG000|Open Label|Withdrawal by Subject|5|||
30680224|NCT00734097|58694314|FG000|Open Label|Protocol Violation|4|||
30680225|NCT00819767|58694320|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30680226|NCT00819767|58694321|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30680227|NCT00733005|58694329|FG000|Overall Study|Adverse Event|0|||
30680228|NCT00733005|58694330|FG001|Overall Study|Adverse Event|1|||
30680229|NCT00733005|58694329|FG000|Overall Study|Treatment Failure|0|||
30680230|NCT00733005|58694330|FG001|Overall Study|Treatment Failure|1|||
30680231|NCT00733005|58694329|FG000|Overall Study|Withdrawal by Subject|0|||
30680232|NCT00733005|58694330|FG001|Overall Study|Withdrawal by Subject|1|||
30680233|NCT00733005|58694329|FG000|Overall Study|Protocol Violation|2|||
30680234|NCT00733005|58694330|FG001|Overall Study|Protocol Violation|0|||
30680235|NCT00812981|58694338|FG000|Overall Study|Other|0|||
30680236|NCT00812981|58694339|FG001|Overall Study|Other|1|||
30680237|NCT00732615|58694347|FG000|Overall Study|Withdrawal by Subject|3|||
30680238|NCT00732615|58694348|FG001|Overall Study|Withdrawal by Subject|1|||
30680239|NCT00732615|58694347|FG000|Overall Study|Lost to Follow-up|0|||
30680240|NCT00732615|58694348|FG001|Overall Study|Lost to Follow-up|1|||
30680241|NCT00732615|58694347|FG000|Overall Study|Adverse Event|0|||
30680242|NCT00732615|58694348|FG001|Overall Study|Adverse Event|2|||
30680243|NCT00732615|58694347|FG000|Overall Study|Physician Decision|3|||
30782687|NCT03345914|58794812|FG000|Overall Study|Other|1|||
30782688|NCT03345914|58794813|FG001|Overall Study|Other|1|||
30782689|NCT03345914|58794814|FG002|Overall Study|Other|1|||
30782690|NCT03345914|58794812|FG000|Overall Study|Ongoing|0|||
30782691|NCT03345914|58794813|FG001|Overall Study|Ongoing|0|||
30782692|NCT03345914|58794814|FG002|Overall Study|Ongoing|1|||
30782693|NCT03369704|58794824|FG000|Treatment Epoch|technical problems|1|||
30782694|NCT03369704|58794825|FG001|Treatment Epoch|technical problems|0|||
30782695|NCT03369704|58794824|FG000|Treatment Epoch|Protocol Violation|1|||
30782696|NCT03369704|58794825|FG001|Treatment Epoch|Protocol Violation|0|||
30782697|NCT03369704|58794824|FG000|Treatment Epoch|Lost to Follow-up|0|||
30782698|NCT03369704|58794825|FG001|Treatment Epoch|Lost to Follow-up|1|||
30782699|NCT03369704|58794824|FG000|Treatment Epoch|Lack of Efficacy|0|||
30782700|NCT03369704|58794825|FG001|Treatment Epoch|Lack of Efficacy|2|||
30782701|NCT03369704|58794824|FG000|Treatment Epoch|Adverse Event|2|||
30782702|NCT03369704|58794825|FG001|Treatment Epoch|Adverse Event|0|||
30782703|NCT03369704|58794824|FG000|Follow-up Epoch|Lost to Follow-up|1|||
30782704|NCT03369704|58794825|FG001|Follow-up Epoch|Lost to Follow-up|0|||
30594902|NCT01349049|58607173|FG007|Overall Study|Death|1|||
30594903|NCT01349049|58607174|FG008|Overall Study|Death|5|||
30594904|NCT01349049|58607166|FG000|Overall Study|Non-compliance|0|||
30594905|NCT01349049|58607167|FG001|Overall Study|Non-compliance|0|||
30594906|NCT01349049|58607168|FG002|Overall Study|Non-compliance|0|||
30594907|NCT01349049|58607169|FG003|Overall Study|Non-compliance|1|||
30594908|NCT01349049|58607170|FG004|Overall Study|Non-compliance|0|||
30594909|NCT01349049|58607171|FG005|Overall Study|Non-compliance|0|||
30594910|NCT01349049|58607172|FG006|Overall Study|Non-compliance|0|||
30594911|NCT01349049|58607173|FG007|Overall Study|Non-compliance|0|||
30594912|NCT01349049|58607174|FG008|Overall Study|Non-compliance|0|||
30594913|NCT01349049|58607166|FG000|Overall Study|Withdrawal by Subject|0|||
30594914|NCT01349049|58607167|FG001|Overall Study|Withdrawal by Subject|0|||
30594915|NCT01349049|58607168|FG002|Overall Study|Withdrawal by Subject|0|||
30594916|NCT01349049|58607169|FG003|Overall Study|Withdrawal by Subject|0|||
30594917|NCT01349049|58607170|FG004|Overall Study|Withdrawal by Subject|0|||
30594918|NCT01349049|58607171|FG005|Overall Study|Withdrawal by Subject|0|||
30594919|NCT01349049|58607172|FG006|Overall Study|Withdrawal by Subject|0|||
30594920|NCT01349049|58607173|FG007|Overall Study|Withdrawal by Subject|0|||
30594921|NCT01349049|58607174|FG008|Overall Study|Withdrawal by Subject|6|||
30594922|NCT01348854|58607208|FG000|Overall Study|Lost to Follow-up|2|||
30594923|NCT01348854|58607209|FG001|Overall Study|Lost to Follow-up|1|||
30594924|NCT01348854|58607208|FG000|Overall Study|Withdrawal by Subject|1|||
30594925|NCT01348854|58607209|FG001|Overall Study|Withdrawal by Subject|0|||
30594926|NCT01348776|58607215|FG000|Overall Study|Lost to Follow-up|3|||
30680244|NCT00732615|58694348|FG001|Overall Study|Physician Decision|0|||
30680245|NCT00732615|58694347|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
30680246|NCT00732615|58694348|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
30680247|NCT00732381|58694357|FG000|Overall Study|Adverse Event|1|||
30680248|NCT00732381|58694358|FG001|Overall Study|Adverse Event|0|||
30680249|NCT00732381|58694357|FG000|Overall Study|Treatment Failure|1|||
30680250|NCT00732381|58694358|FG001|Overall Study|Treatment Failure|1|||
30680251|NCT00732303|58694364|FG000|Overall Study|Study Terminated|2|||
30680252|NCT00813761|58694370|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
30782705|NCT03366428|58794831|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
30782706|NCT03366428|58794831|FG000|Overall Study|Adverse Event|12|||
30782707|NCT03366428|58794831|FG000|Overall Study|Clinical progression|2|||
30594927|NCT01348698|58607228|FG000|Overall Study|Does not meet lesion size criteria|1|||
30680253|NCT00813761|58694371|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
30680254|NCT00813761|58694372|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
30680255|NCT00813761|58694373|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
30680256|NCT00813761|58694370|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
30680257|NCT00813761|58694371|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
30680258|NCT00813761|58694372|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
30680259|NCT00813761|58694373|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
30680260|NCT00813761|58694370|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
30680261|NCT00813761|58694371|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
30680262|NCT00813761|58694372|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
30680263|NCT00813761|58694373|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
30680264|NCT00813761|58694370|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
30680265|NCT00813761|58694371|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
30680266|NCT00813761|58694372|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
30680267|NCT00813761|58694373|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
30680268|NCT00813761|58694370|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
30680269|NCT00813761|58694371|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
30680270|NCT00813761|58694372|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
30680271|NCT00813761|58694373|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
30680272|NCT00813761|58694370|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
30680273|NCT00813761|58694371|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
30680274|NCT00813761|58694372|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
30680275|NCT00813761|58694373|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
30680276|NCT00813761|58694370|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
30680277|NCT00813761|58694371|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
30680278|NCT00813761|58694372|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
30680279|NCT00813761|58694373|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
30680280|NCT00813761|58694370|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
30680281|NCT00813761|58694371|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
30680282|NCT00813761|58694372|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
30680283|NCT00813761|58694373|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
30680284|NCT00813761|58694370|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
30680285|NCT00813761|58694371|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
30680286|NCT00813761|58694372|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
30680287|NCT00813761|58694373|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
30680288|NCT00813761|58694370|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
30680289|NCT00813761|58694371|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
30680290|NCT00813761|58694372|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
30680291|NCT00813761|58694373|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
30680292|NCT00813761|58694370|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
30680293|NCT00813761|58694371|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
30680294|NCT00813761|58694372|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
30594928|NCT01348698|58607228|FG000|Overall Study|Death|3|||
30594929|NCT01348698|58607228|FG000|Overall Study|PI decision to close study|68|||
30594930|NCT01348542|58607234|FG000|Overall Study|Withdrawal by Subject|3|||
30594931|NCT01348542|58607235|FG001|Overall Study|Withdrawal by Subject|0|||
30594932|NCT01346709|58607241|FG000|Overall Study|Protocol Violation|35|||
30594933|NCT01346709|58607241|FG000|Overall Study|Lost to Follow-up|31|||
30594934|NCT01346709|58607241|FG000|Overall Study|Missing data in candidate risk factor|285|||
30594935|NCT01346592|58607248|FG000|Overall Study|Lost to Follow-up|62|||
30594936|NCT01346592|58607249|FG001|Overall Study|Lost to Follow-up|29|||
30594937|NCT01346592|58607250|FG002|Overall Study|Lost to Follow-up|29|||
30680295|NCT00813761|58694373|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
30680296|NCT00813761|58694370|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
30680297|NCT00813761|58694371|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
30680298|NCT00813761|58694372|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
30680299|NCT00813761|58694373|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
30680300|NCT00732069|58694389|FG000|Washout After First Study Drug|Adverse Event|1|||
30782708|NCT03366428|58794831|FG000|Overall Study|Withdrawal by Subject|4|||
30782709|NCT02839876|58794839|FG000|Overall Study|Protocol Violation|10|||
30782710|NCT02839876|58794840|FG001|Overall Study|Protocol Violation|11|||
30782711|NCT03366194|58794846|FG000|Overall Study|Lost to Follow-up|2|||
30594938|NCT01346592|58607248|FG000|Overall Study|Protocol Violation|2|||
30594939|NCT01346592|58607249|FG001|Overall Study|Protocol Violation|1|||
30594940|NCT01346592|58607250|FG002|Overall Study|Protocol Violation|0|||
30594941|NCT01346592|58607248|FG000|Overall Study|Death|1|||
30782712|NCT02839798|58794851|FG000|Overall Study|Withdrawal by Subject|2|||
30782713|NCT03345836|58794858|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
30594942|NCT01346592|58607249|FG001|Overall Study|Death|3|||
30594943|NCT01346592|58607250|FG002|Overall Study|Death|4|||
30594944|NCT01346592|58607248|FG000|Overall Study|Adverse Event|0|||
30594945|NCT01346592|58607249|FG001|Overall Study|Adverse Event|1|||
30594946|NCT01346592|58607250|FG002|Overall Study|Adverse Event|0|||
30594947|NCT01346592|58607248|FG000|Overall Study|Withdrawal by Subject|77|||
30594948|NCT01346592|58607249|FG001|Overall Study|Withdrawal by Subject|51|||
30594949|NCT01346592|58607250|FG002|Overall Study|Withdrawal by Subject|38|||
30594950|NCT01346592|58607248|FG000|Overall Study|Inappropriate enrollment|3|||
30594951|NCT01346592|58607249|FG001|Overall Study|Inappropriate enrollment|1|||
30594952|NCT01346592|58607250|FG002|Overall Study|Inappropriate enrollment|1|||
30594953|NCT01346592|58607248|FG000|Overall Study|Administrative reason|1|||
30594954|NCT01346592|58607249|FG001|Overall Study|Administrative reason|0|||
30594955|NCT01346592|58607250|FG002|Overall Study|Administrative reason|0|||
30594956|NCT01346592|58607248|FG000|Overall Study|Unable to Classify|7|||
30594957|NCT01346592|58607249|FG001|Overall Study|Unable to Classify|3|||
30594958|NCT01346592|58607250|FG002|Overall Study|Unable to Classify|6|||
30594959|NCT01346514|58607277|FG000|Overall Study|Lost to Follow-up|19|||
30594960|NCT01346514|58607278|FG001|Overall Study|Lost to Follow-up|30|||
30594961|NCT01346514|58607277|FG000|Overall Study|Withdrawal by Subject|7|||
30594962|NCT01346514|58607278|FG001|Overall Study|Withdrawal by Subject|3|||
30594963|NCT01346514|58607277|FG000|Overall Study|Death|3|||
30594964|NCT01346514|58607278|FG001|Overall Study|Death|4|||
30594965|NCT01193335|58607288|FG000|After Infant Series|Lost to Follow-up|1|||
30594966|NCT01193335|58607289|FG001|After Infant Series|Lost to Follow-up|2|||
30594967|NCT01193335|58607288|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
30594968|NCT01193335|58607289|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
30594969|NCT01193335|58607288|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
30594970|NCT01193335|58607289|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
30594971|NCT01193335|58607288|FG000|1-Year Follow-up|Lost to Follow-up|4|||
30594972|NCT01193335|58607289|FG001|1-Year Follow-up|Lost to Follow-up|0|||
30594973|NCT01193335|58607288|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
30594974|NCT01193335|58607289|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
30594975|NCT01193335|58607288|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
30594976|NCT01193335|58607289|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
30594977|NCT01342887|58607311|FG000|Overall Study|Death|2|||
30594978|NCT01342341|58607317|FG000|Overall Study|Lost to Follow-up|4|||
30680301|NCT00732069|58694390|FG001|Washout After First Study Drug|Adverse Event|0|||
30680302|NCT00732069|58694391|FG002|Washout After First Study Drug|Adverse Event|0|||
30680303|NCT00732069|58694392|FG003|Washout After First Study Drug|Adverse Event|0|||
30680304|NCT00732069|58694393|FG004|Washout After First Study Drug|Adverse Event|0|||
30680305|NCT00732069|58694394|FG005|Washout After First Study Drug|Adverse Event|0|||
30680306|NCT00731679|58694404|FG000|Overall Study|Adverse Event|7|||
30680307|NCT00731679|58694405|FG001|Overall Study|Adverse Event|8|||
30680308|NCT00731679|58694404|FG000|Overall Study|Withdrawal by Subject|8|||
30680309|NCT00731679|58694405|FG001|Overall Study|Withdrawal by Subject|8|||
30680310|NCT00731679|58694404|FG000|Overall Study|Lost to Follow-up|7|||
30680311|NCT00731679|58694405|FG001|Overall Study|Lost to Follow-up|8|||
30680312|NCT00731679|58694404|FG000|Overall Study|Noncompliance|0|||
30680313|NCT00731679|58694405|FG001|Overall Study|Noncompliance|1|||
30782714|NCT03345836|58794859|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
30782715|NCT03345836|58794860|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
30782716|NCT03345836|58794861|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
30782717|NCT03345836|58794862|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
30782718|NCT03345836|58794863|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
30782719|NCT03345836|58794858|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
30782720|NCT03345836|58794859|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
30782721|NCT03345836|58794860|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
30782722|NCT03345836|58794861|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
30782723|NCT03345836|58794862|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
30782724|NCT03345836|58794863|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
30782725|NCT03345836|58794858|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
30782726|NCT03345836|58794859|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
30782727|NCT03345836|58794860|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
30782728|NCT03345836|58794861|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
30782729|NCT03345836|58794862|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
30594979|NCT01342341|58607318|FG001|Overall Study|Lost to Follow-up|4|||
30594980|NCT01340664|58607327|FG000|Overall Study|Adverse Event|0|||
30594981|NCT01340664|58607328|FG001|Overall Study|Adverse Event|1|||
30594982|NCT01340664|58607329|FG002|Overall Study|Adverse Event|7|||
30680314|NCT00731679|58694404|FG000|Overall Study|Pregnancy|0|||
30680315|NCT00731679|58694405|FG001|Overall Study|Pregnancy|1|||
30680316|NCT00731133|58694411|FG000|Overall Study|Withdrawal by Subject|10|||
30680317|NCT00730275|58694419|FG000|Overall Study|Withdrawal by Subject|0|||
30594983|NCT01340664|58607327|FG000|Overall Study|Lost to Follow-up|2|||
30594984|NCT01340664|58607328|FG001|Overall Study|Lost to Follow-up|0|||
30594985|NCT01340664|58607329|FG002|Overall Study|Lost to Follow-up|2|||
30594986|NCT01340664|58607327|FG000|Overall Study|Withdrawal by Subject|2|||
30594987|NCT01340664|58607328|FG001|Overall Study|Withdrawal by Subject|4|||
30594988|NCT01340664|58607329|FG002|Overall Study|Withdrawal by Subject|0|||
30594989|NCT01340664|58607327|FG000|Overall Study|Glycemic withdrawal criteria|2|||
30594990|NCT01340664|58607328|FG001|Overall Study|Glycemic withdrawal criteria|0|||
30782730|NCT03345836|58794863|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
30782731|NCT03345836|58794858|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
30782732|NCT03345836|58794859|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
30782733|NCT03345836|58794860|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
30782734|NCT03345836|58794861|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
30782735|NCT03345836|58794862|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
30782736|NCT03345836|58794863|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
30782737|NCT03345836|58794858|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
30782738|NCT03345836|58794859|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
30782739|NCT03345836|58794860|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
30782740|NCT03345836|58794861|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
30782741|NCT03345836|58794862|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
30782742|NCT03345836|58794863|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
30782743|NCT03345836|58794858|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
30782744|NCT03345836|58794859|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
30782745|NCT03345836|58794860|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
30782746|NCT03345836|58794861|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
30782747|NCT03345836|58794862|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
30782748|NCT03345836|58794863|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
30782749|NCT03345836|58794858|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
30782750|NCT03345836|58794859|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
30782751|NCT03345836|58794860|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
30782752|NCT03345836|58794861|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
30782753|NCT03345836|58794862|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
30782754|NCT03345836|58794863|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
30782755|NCT03345836|58794858|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
30782756|NCT03345836|58794859|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
30782757|NCT03345836|58794860|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
30782758|NCT03345836|58794861|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
30782759|NCT03345836|58794862|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
30782760|NCT03345836|58794863|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
30782761|NCT03345836|58794858|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
30782762|NCT03345836|58794859|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
30782763|NCT03345836|58794860|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
30782764|NCT03345836|58794861|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
30782765|NCT03345836|58794862|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
30782766|NCT03345836|58794863|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
30594991|NCT01340664|58607329|FG002|Overall Study|Glycemic withdrawal criteria|0|||
30594992|NCT01340664|58607327|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
30594993|NCT01340664|58607328|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
30594994|NCT01340664|58607329|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
30594995|NCT01340664|58607327|FG000|Overall Study|Other|1|||
30594996|NCT01340664|58607328|FG001|Overall Study|Other|2|||
30594997|NCT01340664|58607329|FG002|Overall Study|Other|2|||
30594998|NCT01340625|58607339|FG000|First Intervention|Adverse Event|1|||
30680318|NCT00730275|58694420|FG001|Overall Study|Withdrawal by Subject|0|||
30680319|NCT00730275|58694421|FG002|Overall Study|Withdrawal by Subject|0|||
30680320|NCT00730275|58694422|FG003|Overall Study|Withdrawal by Subject|1|||
30680321|NCT00730041|58694440|FG000|Overall Study|Lost to Follow-up|0|||
30680322|NCT00730041|58694441|FG001|Overall Study|Lost to Follow-up|2|||
30680323|NCT00729651|58694449|FG000|Overall Study|Withdrawal by Subject|5|||
30594999|NCT01340625|58607340|FG001|First Intervention|Adverse Event|0|||
30680324|NCT00729651|58694450|FG001|Overall Study|Withdrawal by Subject|6|||
30680325|NCT00729651|58694449|FG000|Overall Study|Lost to Follow-up|5|||
30680326|NCT00729651|58694450|FG001|Overall Study|Lost to Follow-up|4|||
30782767|NCT03345836|58794858|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
30782768|NCT03345836|58794859|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
30782769|NCT03345836|58794860|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
30856132|NCT03606174|58884018|FG001|Overall Study|Lost to Follow-up|0|||
30595000|NCT01340625|58607339|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
30595001|NCT01340625|58607340|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
30595002|NCT01340196|58607346|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
30680327|NCT00729651|58694449|FG000|Overall Study|Protocol Violation|0|||
30680328|NCT00729651|58694450|FG001|Overall Study|Protocol Violation|1|||
30680329|NCT00729651|58694449|FG000|Overall Study|Adverse Event|7|||
30680330|NCT00729651|58694450|FG001|Overall Study|Adverse Event|3|||
30680331|NCT00729651|58694449|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
30680332|NCT00729651|58694450|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
30680333|NCT00729651|58694449|FG000|Overall Study|Subject's private reason|2|||
30680334|NCT00729651|58694450|FG001|Overall Study|Subject's private reason|0|||
30680335|NCT00729183|58694458|FG000|Overall Study|Adverse Event|11|||
30680336|NCT00729183|58694459|FG001|Overall Study|Adverse Event|5|||
30680337|NCT00729183|58694458|FG000|Overall Study|Lack of Efficacy|0|||
30680338|NCT00729183|58694459|FG001|Overall Study|Lack of Efficacy|1|||
30680339|NCT00729183|58694458|FG000|Overall Study|Lost to Follow-up|3|||
30680340|NCT00729183|58694459|FG001|Overall Study|Lost to Follow-up|1|||
30680341|NCT00729183|58694458|FG000|Overall Study|Physician Decision|1|||
30680342|NCT00729183|58694459|FG001|Overall Study|Physician Decision|1|||
30680343|NCT00729183|58694458|FG000|Overall Study|Protocol Violation|1|||
30680344|NCT00729183|58694459|FG001|Overall Study|Protocol Violation|0|||
30680345|NCT00729183|58694458|FG000|Overall Study|Withdrawal by Subject|9|||
30680346|NCT00729183|58694459|FG001|Overall Study|Withdrawal by Subject|7|||
30680347|NCT00811733|58694467|FG000|Overall Study|Investigator Discretion|10|||
30680348|NCT00811733|58694468|FG001|Overall Study|Investigator Discretion|8|||
30680349|NCT00811733|58694467|FG000|Overall Study|Withdrawal by Subject|1|||
30680350|NCT00811733|58694468|FG001|Overall Study|Withdrawal by Subject|2|||
30680351|NCT00728949|58694476|FG000|Overall Study|Adverse Event|8|||
30680352|NCT00728949|58694477|FG001|Overall Study|Adverse Event|0|||
30680353|NCT00728949|58694476|FG000|Overall Study|Withdrawal by Subject|2|||
30680354|NCT00728949|58694477|FG001|Overall Study|Withdrawal by Subject|2|||
30680355|NCT00728949|58694476|FG000|Overall Study|Abnormal Lab Results|0|||
30680356|NCT00728949|58694477|FG001|Overall Study|Abnormal Lab Results|2|||
30680357|NCT00728949|58694476|FG000|Overall Study|On treatment at cutoff date|1|||
30680358|NCT00728949|58694477|FG001|Overall Study|On treatment at cutoff date|0|||
30680359|NCT00728481|58694485|FG000|Overall Study|Withdrawal by Subject|0|||
30680360|NCT00728481|58694486|FG001|Overall Study|Withdrawal by Subject|1|||
30680361|NCT00728481|58694485|FG000|Overall Study|Adverse Event|0|||
30595003|NCT01327599|58607355|FG000|Overall Study|Adverse Event|1|||
30595004|NCT01327599|58607355|FG000|Overall Study|Could Not Attend Visit|1|||
30595005|NCT01327599|58607355|FG000|Overall Study|Withdrawal of Consent|1|||
30595006|NCT01193257|58607361|FG000|Overall Study|Death|202|||
30680362|NCT00728481|58694486|FG001|Overall Study|Adverse Event|1|||
30680363|NCT00728481|58694485|FG000|Overall Study|Study medication non-compliance|0|||
30595007|NCT01193257|58607362|FG001|Overall Study|Death|391|||
30595008|NCT01193257|58607361|FG000|Overall Study|Study termination by sponsor|0|||
30595009|NCT01193257|58607362|FG001|Overall Study|Study termination by sponsor|3|||
30595010|NCT01193257|58607361|FG000|Overall Study|Withdrawal by Subject|26|||
30595011|NCT01193257|58607362|FG001|Overall Study|Withdrawal by Subject|86|||
30595012|NCT01193257|58607361|FG000|Overall Study|Lost to Follow-up|2|||
30595013|NCT01193257|58607362|FG001|Overall Study|Lost to Follow-up|3|||
30595014|NCT01193257|58607361|FG000|Overall Study|Unblinded due to futility|135|||
30595015|NCT01193257|58607362|FG001|Overall Study|Unblinded due to futility|251|||
30680364|NCT00728481|58694486|FG001|Overall Study|Study medication non-compliance|2|||
30680365|NCT00728481|58694485|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
30595016|NCT01193218|58607373|FG000|0-12 Weeks|Adverse Event|6|||
30595017|NCT01193218|58607374|FG001|0-12 Weeks|Adverse Event|0|||
30595018|NCT01193218|58607375|FG002|0-12 Weeks|Adverse Event|1|||
30680366|NCT00728481|58694486|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
30680367|NCT00811655|58694492|FG000|Overall Study|Physician Decision|1|||
30680368|NCT00727311|58694496|FG000|Overall Study|Did not receive drug|316|||
30680369|NCT00727311|58694496|FG000|Overall Study|Missing end of therapy data|205|||
30680370|NCT00727311|58694496|FG000|Overall Study|Adverse Event|58|||
30680371|NCT00727311|58694496|FG000|Overall Study|Lack of Efficacy|242|||
30680372|NCT00727311|58694496|FG000|Overall Study|Lost to Follow-up|73|||
30680373|NCT00727311|58694496|FG000|Overall Study|Withdrawal by Subject|77|||
30680374|NCT00727311|58694496|FG000|Overall Study|Other|97|||
30680375|NCT00727311|58694496|FG000|Overall Study|Multiple reasons|39|||
30680376|NCT00726999|58694502|FG000|Overall Study|Physician Decision|0|||
30680377|NCT00726999|58694503|FG001|Overall Study|Physician Decision|1|||
30595019|NCT01193218|58607376|FG003|0-12 Weeks|Adverse Event|0|||
30680378|NCT00726999|58694502|FG000|Overall Study|Withdrawal by Subject|2|||
30595020|NCT01193218|58607377|FG004|0-12 Weeks|Adverse Event|0|||
30595021|NCT01193218|58607378|FG005|0-12 Weeks|Adverse Event|2|||
30595022|NCT01193218|58607379|FG006|0-12 Weeks|Adverse Event|2|||
30595023|NCT01193218|58607380|FG007|0-12 Weeks|Adverse Event|0|||
30680379|NCT00726999|58694503|FG001|Overall Study|Withdrawal by Subject|0|||
30680380|NCT00726999|58694502|FG000|Overall Study|Protocol Violation|1|||
30680381|NCT00726999|58694503|FG001|Overall Study|Protocol Violation|0|||
30680382|NCT00585351|58694517|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
30680383|NCT00585351|58694518|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
30680384|NCT00585351|58694519|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
30595024|NCT01193218|58607373|FG000|0-12 Weeks|Protocol Violation|0|||
30595025|NCT01193218|58607374|FG001|0-12 Weeks|Protocol Violation|0|||
30595026|NCT01193218|58607375|FG002|0-12 Weeks|Protocol Violation|0|||
30595027|NCT01193218|58607376|FG003|0-12 Weeks|Protocol Violation|0|||
30595028|NCT01193218|58607377|FG004|0-12 Weeks|Protocol Violation|1|||
30595029|NCT01193218|58607378|FG005|0-12 Weeks|Protocol Violation|1|||
30595030|NCT01193218|58607379|FG006|0-12 Weeks|Protocol Violation|0|||
30595031|NCT01193218|58607380|FG007|0-12 Weeks|Protocol Violation|0|||
30595032|NCT01193218|58607373|FG000|0-12 Weeks|Withdrawal by Subject|3|||
30595033|NCT01193218|58607374|FG001|0-12 Weeks|Withdrawal by Subject|0|||
30595034|NCT01193218|58607375|FG002|0-12 Weeks|Withdrawal by Subject|2|||
30595035|NCT01193218|58607376|FG003|0-12 Weeks|Withdrawal by Subject|0|||
30680385|NCT00585351|58694520|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
30680386|NCT00585351|58694521|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
30680387|NCT00585351|58694522|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
30680388|NCT00585351|58694523|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
30680389|NCT00585351|58694524|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
30680390|NCT00585351|58694517|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
30680391|NCT00585351|58694518|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
30680392|NCT00585351|58694519|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
30680393|NCT00585351|58694520|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
30680394|NCT00585351|58694521|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
30680395|NCT00585351|58694522|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
30680396|NCT00585351|58694523|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
30680397|NCT00585351|58694524|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
30680398|NCT00585351|58694517|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
30595036|NCT01193218|58607377|FG004|0-12 Weeks|Withdrawal by Subject|0|||
30680399|NCT00585351|58694518|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
30595037|NCT01193218|58607378|FG005|0-12 Weeks|Withdrawal by Subject|0|||
30595038|NCT01193218|58607379|FG006|0-12 Weeks|Withdrawal by Subject|1|||
30680400|NCT00585351|58694519|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
30680401|NCT00585351|58694520|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
30680402|NCT00585351|58694521|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
30680403|NCT00585351|58694522|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
30680404|NCT00585351|58694523|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
30680405|NCT00585351|58694524|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
30680406|NCT00585351|58694517|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
30680407|NCT00585351|58694518|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
30680408|NCT00585351|58694519|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
30680409|NCT00585351|58694520|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
30680410|NCT00585351|58694521|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
30680411|NCT00585351|58694522|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
30680412|NCT00585351|58694523|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
30680413|NCT00585351|58694524|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
30680414|NCT00585351|58694517|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
30680415|NCT00585351|58694518|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
30680416|NCT00585351|58694519|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
30680417|NCT00585351|58694520|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
30680418|NCT00585351|58694521|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
30680419|NCT00585351|58694522|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
30680420|NCT00585351|58694523|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
30680421|NCT00585351|58694524|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
30680422|NCT00585351|58694517|FG000|Enrollment Period (Intervention)|Death|0|||
30680423|NCT00585351|58694518|FG001|Enrollment Period (Intervention)|Death|0|||
30680424|NCT00585351|58694519|FG002|Enrollment Period (Intervention)|Death|0|||
30680425|NCT00585351|58694520|FG003|Enrollment Period (Intervention)|Death|0|||
30680426|NCT00585351|58694521|FG004|Enrollment Period (Intervention)|Death|1|||
30680427|NCT00585351|58694522|FG005|Enrollment Period (Intervention)|Death|0|||
30680428|NCT00585351|58694523|FG006|Enrollment Period (Intervention)|Death|1|||
30680429|NCT00585351|58694524|FG007|Enrollment Period (Intervention)|Death|0|||
30680430|NCT00585351|58694517|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
30680431|NCT00585351|58694518|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
30680432|NCT00585351|58694519|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
30680433|NCT00585351|58694520|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
30595039|NCT01193218|58607380|FG007|0-12 Weeks|Withdrawal by Subject|0|||
30595040|NCT01193218|58607373|FG000|12-52 Weeks|Adverse Event|1|||
30595041|NCT01193218|58607374|FG001|12-52 Weeks|Adverse Event|0|||
30595042|NCT01193218|58607375|FG002|12-52 Weeks|Adverse Event|1|||
30680434|NCT00585351|58694521|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
30782770|NCT03345836|58794861|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
30782771|NCT03345836|58794862|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
30782772|NCT03345836|58794863|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
30782773|NCT03345836|58794858|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
30782774|NCT03345836|58794859|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
30782775|NCT03345836|58794860|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
30782776|NCT03345836|58794861|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
30782777|NCT03345836|58794862|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
30782778|NCT03345836|58794863|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
30782779|NCT02839330|58794883|FG000|Overall Study|Adverse Event|0|||
30782780|NCT02839330|58794884|FG001|Overall Study|Adverse Event|1|||
30782781|NCT02839330|58794885|FG002|Overall Study|Adverse Event|2|||
30782782|NCT02839330|58794886|FG003|Overall Study|Adverse Event|2|||
30782783|NCT02839330|58794883|FG000|Overall Study|Death|4|||
30782784|NCT02839330|58794884|FG001|Overall Study|Death|6|||
30782785|NCT02839330|58794885|FG002|Overall Study|Death|1|||
30782786|NCT02839330|58794886|FG003|Overall Study|Death|1|||
30782787|NCT02839330|58794883|FG000|Overall Study|Withdrawal by Subject|27|||
30782788|NCT02839330|58794884|FG001|Overall Study|Withdrawal by Subject|19|||
30782789|NCT02839330|58794885|FG002|Overall Study|Withdrawal by Subject|11|||
30782790|NCT02839330|58794886|FG003|Overall Study|Withdrawal by Subject|13|||
30782791|NCT02839330|58794883|FG000|Overall Study|Lost to Follow-up|22|||
30782792|NCT02839330|58794884|FG001|Overall Study|Lost to Follow-up|27|||
30782793|NCT02839330|58794885|FG002|Overall Study|Lost to Follow-up|29|||
30782794|NCT02839330|58794886|FG003|Overall Study|Lost to Follow-up|25|||
30782795|NCT02839330|58794883|FG000|Overall Study|Administrative Reason|0|||
30782796|NCT02839330|58794884|FG001|Overall Study|Administrative Reason|0|||
30782797|NCT02839330|58794885|FG002|Overall Study|Administrative Reason|0|||
30782798|NCT02839330|58794886|FG003|Overall Study|Administrative Reason|1|||
30782799|NCT02839330|58794883|FG000|Overall Study|Protocol Violation|1|||
30782800|NCT02839330|58794884|FG001|Overall Study|Protocol Violation|2|||
30782801|NCT02839330|58794885|FG002|Overall Study|Protocol Violation|2|||
30782802|NCT02839330|58794886|FG003|Overall Study|Protocol Violation|3|||
30782803|NCT02839330|58794883|FG000|Overall Study|Other reason, not specified|4|||
30782804|NCT02839330|58794884|FG001|Overall Study|Other reason, not specified|3|||
30782805|NCT02839330|58794885|FG002|Overall Study|Other reason, not specified|3|||
30782806|NCT02839330|58794886|FG003|Overall Study|Other reason, not specified|6|||
30782807|NCT03363776|58794900|FG000|Overall Study|Progressive disease|2|||
30782808|NCT03363776|58794901|FG001|Overall Study|Progressive disease|3|||
30782809|NCT03363776|58794902|FG002|Overall Study|Progressive disease|1|||
30782810|NCT03363776|58794900|FG000|Overall Study|Study drug toxicity|0|||
30782811|NCT03363776|58794901|FG001|Overall Study|Study drug toxicity|0|||
30782812|NCT03363776|58794902|FG002|Overall Study|Study drug toxicity|1|||
30782813|NCT03363776|58794900|FG000|Overall Study|Death|1|||
30782814|NCT03363776|58794901|FG001|Overall Study|Death|0|||
30782815|NCT03363776|58794902|FG002|Overall Study|Death|0|||
30782816|NCT03360344|58794913|FG000|Overall Study|Withdrawal by Subject|0|||
30782817|NCT03360344|58794914|FG001|Overall Study|Withdrawal by Subject|1|||
30782818|NCT03360344|58794915|FG002|Overall Study|Withdrawal by Subject|1|||
30595043|NCT01193218|58607376|FG003|12-52 Weeks|Adverse Event|2|||
30595044|NCT01193218|58607377|FG004|12-52 Weeks|Adverse Event|3|||
30595045|NCT01193218|58607378|FG005|12-52 Weeks|Adverse Event|3|||
30595046|NCT01193218|58607379|FG006|12-52 Weeks|Adverse Event|1|||
30595047|NCT01193218|58607380|FG007|12-52 Weeks|Adverse Event|2|||
30595048|NCT01193218|58607373|FG000|12-52 Weeks|Lack of Efficacy|0|||
30595049|NCT01193218|58607374|FG001|12-52 Weeks|Lack of Efficacy|0|||
30595050|NCT01193218|58607375|FG002|12-52 Weeks|Lack of Efficacy|0|||
30595051|NCT01193218|58607376|FG003|12-52 Weeks|Lack of Efficacy|0|||
30595052|NCT01193218|58607377|FG004|12-52 Weeks|Lack of Efficacy|0|||
30595053|NCT01193218|58607378|FG005|12-52 Weeks|Lack of Efficacy|0|||
30595054|NCT01193218|58607379|FG006|12-52 Weeks|Lack of Efficacy|1|||
30595055|NCT01193218|58607380|FG007|12-52 Weeks|Lack of Efficacy|0|||
30595056|NCT01193218|58607373|FG000|12-52 Weeks|Withdrawal by Subject|3|||
30782819|NCT02838628|58794925|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
30782820|NCT02838628|58794926|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
30782821|NCT02838628|58794925|FG000|Recurrence Follow-up Period|Adverse Event|1|||
30782822|NCT02838628|58794926|FG001|Recurrence Follow-up Period|Adverse Event|0|||
30782823|NCT02838628|58794925|FG000|Recurrence Follow-up Period|Non-compliance|0|||
30782824|NCT02838628|58794926|FG001|Recurrence Follow-up Period|Non-compliance|1|||
30782825|NCT02838628|58794925|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
30782826|NCT02838628|58794926|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
30959068|NCT01577381|59024105|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
30595057|NCT01193218|58607374|FG001|12-52 Weeks|Withdrawal by Subject|0|||
30595058|NCT01193218|58607375|FG002|12-52 Weeks|Withdrawal by Subject|3|||
30680435|NCT00585351|58694522|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
30680436|NCT00585351|58694523|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
30680437|NCT00585351|58694524|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
30680438|NCT00726609|58694538|FG000|Overall Study|Adverse Event|10|||
30680439|NCT00726609|58694538|FG000|Overall Study|Withdrawal by Subject|2|||
30680440|NCT00726609|58694538|FG000|Overall Study|Lack of Efficacy|25|||
30680441|NCT00726609|58694538|FG000|Overall Study|Other|16|||
30782827|NCT02838628|58794925|FG000|Recurrence Follow-up Period|Other un-specified|1|||
30782828|NCT02838628|58794926|FG001|Recurrence Follow-up Period|Other un-specified|1|||
30782829|NCT02835820|58794935|FG000|Overall Study|Baseline Screen Failure|0|||
30782830|NCT02835820|58794936|FG001|Overall Study|Baseline Screen Failure|3|||
30782831|NCT03359174|58794942|FG000|Overall Study|Adverse Event|1|||
30782832|NCT02832622|58794946|FG000|Overall Study|MPP not programmed|1259|||
30782833|NCT02832622|58794946|FG000|Overall Study|Withdrawal by Subject|123|||
30782834|NCT02832622|58794946|FG000|Overall Study|Death|119|||
30782835|NCT02832622|58794946|FG000|Overall Study|Unsuccessful CRT implant|93|||
30782836|NCT02832622|58794946|FG000|Overall Study|Lost to Follow-up|45|||
30782837|NCT02832622|58794946|FG000|Overall Study|Patient non-compliance|42|||
30782838|NCT02832622|58794946|FG000|Overall Study|Withdrawal by other reasons|25|||
30782839|NCT02832622|58794946|FG000|Overall Study|System explant|24|||
30782840|NCT02832622|58794946|FG000|Overall Study|Physician Decision|6|||
30856133|NCT03606174|58884019|FG002|Overall Study|Lost to Follow-up|0|||
30856134|NCT03606174|58884020|FG003|Overall Study|Lost to Follow-up|0|||
30856135|NCT03606174|58884021|FG004|Overall Study|Lost to Follow-up|1|||
30856136|NCT03606174|58884022|FG005|Overall Study|Lost to Follow-up|1|||
30856137|NCT03606174|58884023|FG006|Overall Study|Lost to Follow-up|0|||
30856138|NCT03606174|58884024|FG007|Overall Study|Lost to Follow-up|0|||
30856139|NCT03606174|58884025|FG008|Overall Study|Lost to Follow-up|0|||
30856140|NCT03606174|58884026|FG009|Overall Study|Lost to Follow-up|0|||
30856141|NCT03606174|58884027|FG010|Overall Study|Lost to Follow-up|0|||
30856142|NCT03606174|58884017|FG000|Overall Study|Withdrawal by Subject|6|||
30856143|NCT03606174|58884018|FG001|Overall Study|Withdrawal by Subject|0|||
30856144|NCT03606174|58884019|FG002|Overall Study|Withdrawal by Subject|0|||
30856145|NCT03606174|58884020|FG003|Overall Study|Withdrawal by Subject|1|||
30856146|NCT03606174|58884021|FG004|Overall Study|Withdrawal by Subject|2|||
30856147|NCT03606174|58884022|FG005|Overall Study|Withdrawal by Subject|1|||
30856148|NCT03606174|58884023|FG006|Overall Study|Withdrawal by Subject|4|||
30856149|NCT03606174|58884024|FG007|Overall Study|Withdrawal by Subject|0|||
30856150|NCT03606174|58884025|FG008|Overall Study|Withdrawal by Subject|0|||
30856151|NCT03606174|58884026|FG009|Overall Study|Withdrawal by Subject|0|||
30856152|NCT03606174|58884027|FG010|Overall Study|Withdrawal by Subject|1|||
30856153|NCT03606174|58884017|FG000|Overall Study|Study Terminated by Sponsor|5|||
30856154|NCT03606174|58884018|FG001|Overall Study|Study Terminated by Sponsor|7|||
30856155|NCT03606174|58884019|FG002|Overall Study|Study Terminated by Sponsor|3|||
30856156|NCT03606174|58884020|FG003|Overall Study|Study Terminated by Sponsor|0|||
30856157|NCT03606174|58884021|FG004|Overall Study|Study Terminated by Sponsor|11|||
30856158|NCT03606174|58884022|FG005|Overall Study|Study Terminated by Sponsor|6|||
30856159|NCT03606174|58884023|FG006|Overall Study|Study Terminated by Sponsor|12|||
30856160|NCT03606174|58884024|FG007|Overall Study|Study Terminated by Sponsor|1|||
30856161|NCT03606174|58884025|FG008|Overall Study|Study Terminated by Sponsor|3|||
30856162|NCT03606174|58884026|FG009|Overall Study|Study Terminated by Sponsor|1|||
30856163|NCT03606174|58884027|FG010|Overall Study|Study Terminated by Sponsor|2|||
30856164|NCT03606174|58884017|FG000|Overall Study|Miscellaneous|1|||
30856165|NCT03606174|58884018|FG001|Overall Study|Miscellaneous|1|||
30856166|NCT03606174|58884019|FG002|Overall Study|Miscellaneous|0|||
30856167|NCT03606174|58884020|FG003|Overall Study|Miscellaneous|1|||
30856168|NCT03606174|58884021|FG004|Overall Study|Miscellaneous|4|||
30856169|NCT03606174|58884022|FG005|Overall Study|Miscellaneous|7|||
30856170|NCT03606174|58884023|FG006|Overall Study|Miscellaneous|5|||
30856171|NCT03606174|58884024|FG007|Overall Study|Miscellaneous|0|||
30959069|NCT01577381|59024106|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
30959070|NCT01577381|59024107|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
30856172|NCT03606174|58884025|FG008|Overall Study|Miscellaneous|0|||
30856173|NCT03606174|58884026|FG009|Overall Study|Miscellaneous|0|||
30856174|NCT03606174|58884027|FG010|Overall Study|Miscellaneous|1|||
30959071|NCT02686164|59024117|FG000|Overall Study|Adverse Event|1|||
30959072|NCT02686164|59024117|FG000|Overall Study|Withdrawal of consent|1|||
30782841|NCT00093015|58794953|FG000|Overall Study|Withdrawal by Subject|194|||
30856175|NCT03450707|58884057|FG000|Overall Study|Outside enrollment window|4|||
30856176|NCT03450707|58884058|FG001|Overall Study|Outside enrollment window|1|||
30856177|NCT03450707|58884057|FG000|Overall Study|Death|1|||
30856178|NCT03450707|58884058|FG001|Overall Study|Death|0|||
30856179|NCT03450707|58884057|FG000|Overall Study|Indication for thiamine|1|||
30856180|NCT03450707|58884058|FG001|Overall Study|Indication for thiamine|1|||
30856181|NCT03450707|58884057|FG000|Overall Study|Evidence of traumatic brain injury|1|||
30782842|NCT00093015|58794954|FG001|Overall Study|Withdrawal by Subject|171|||
30782843|NCT00093015|58794953|FG000|Overall Study|Lost to Follow-up|96|||
30959073|NCT02686164|59024117|FG000|Overall Study|Clinical progression|1|||
30680442|NCT00726609|58694538|FG000|Overall Study|Missing|42|||
30680443|NCT00726609|58694538|FG000|Overall Study|Other|3|||
30680444|NCT00726453|58694544|FG000|Primary Enrollment Group|Death|18|||
30680445|NCT00726453|58694545|FG001|Primary Enrollment Group|Death|0|||
30680446|NCT00726453|58694544|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
30680447|NCT00726453|58694545|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
30680448|NCT00726453|58694544|FG000|38 mm Length Group|Death|0|||
30680449|NCT00726453|58694545|FG001|38 mm Length Group|Death|3|||
30680450|NCT00726063|58694552|FG000|Overall Study|Adverse Event|9|||
30680451|NCT00726063|58694553|FG001|Overall Study|Adverse Event|7|||
30680452|NCT00808028|58694563|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
30680453|NCT00808028|58694564|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
30680454|NCT00808028|58694565|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
30680455|NCT00808028|58694566|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
30680456|NCT00808028|58694563|FG000|Stage 1 (6 Months)|Other|1|||
30680457|NCT00808028|58694564|FG001|Stage 1 (6 Months)|Other|0|||
30680458|NCT00808028|58694565|FG002|Stage 1 (6 Months)|Other|2|||
30680459|NCT00808028|58694566|FG003|Stage 1 (6 Months)|Other|4|||
30680460|NCT00808028|58694563|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
30680461|NCT00808028|58694564|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
30680462|NCT00808028|58694565|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
30680463|NCT00808028|58694566|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
30680464|NCT00808028|58694563|FG000|Stage 1 (6 Months)|Adverse Event|0|||
30680465|NCT00808028|58694564|FG001|Stage 1 (6 Months)|Adverse Event|0|||
30680466|NCT00808028|58694565|FG002|Stage 1 (6 Months)|Adverse Event|1|||
30680467|NCT00808028|58694566|FG003|Stage 1 (6 Months)|Adverse Event|2|||
30680468|NCT00808028|58694563|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
30680469|NCT00808028|58694564|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
30680470|NCT00808028|58694565|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
30680471|NCT00808028|58694566|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
30680472|NCT00808028|58694563|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
30680473|NCT00808028|58694564|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
30680474|NCT00808028|58694565|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
30680475|NCT00808028|58694566|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
30680476|NCT00808028|58694563|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
30680477|NCT00808028|58694564|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
30680478|NCT00808028|58694565|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
30680479|NCT00808028|58694566|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
30680480|NCT00808028|58694563|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
30680481|NCT00808028|58694564|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
30680482|NCT00808028|58694565|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
30680483|NCT00808028|58694566|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
30680484|NCT00808028|58694563|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
30680485|NCT00808028|58694564|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
30680486|NCT00808028|58694565|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
30680487|NCT00808028|58694566|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
30680488|NCT00808028|58694563|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
30680489|NCT00808028|58694564|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
30680490|NCT00808028|58694565|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
30680491|NCT00808028|58694566|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
30680492|NCT00808028|58694563|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
30680493|NCT00808028|58694564|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
30680494|NCT00808028|58694565|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
30680495|NCT00808028|58694566|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
30680496|NCT00808028|58694563|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
30680497|NCT00808028|58694564|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
30680498|NCT00808028|58694565|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
30680499|NCT00808028|58694566|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
30680500|NCT00808028|58694563|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
30680501|NCT00808028|58694564|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
30680502|NCT00808028|58694565|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
30680503|NCT00808028|58694566|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
30680504|NCT00808028|58694563|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
30680505|NCT00808028|58694564|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
30680506|NCT00808028|58694565|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
30680507|NCT00808028|58694566|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
30680508|NCT00808028|58694563|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
30782844|NCT00093015|58794954|FG001|Overall Study|Lost to Follow-up|108|||
30680509|NCT00808028|58694564|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
30680510|NCT00808028|58694565|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
30680511|NCT00808028|58694566|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
30680512|NCT00809783|58694589|FG000|Overall Study|Death|1|||
30782845|NCT00093015|58794953|FG000|Overall Study|Death|375|||
30680513|NCT00809783|58694590|FG001|Overall Study|Death|0|||
30680514|NCT00809783|58694591|FG002|Overall Study|Death|0|||
30680515|NCT00809783|58694589|FG000|Overall Study|Adverse Event|34|||
30680516|NCT00809783|58694590|FG001|Overall Study|Adverse Event|52|||
30680517|NCT00809783|58694591|FG002|Overall Study|Adverse Event|71|||
30680518|NCT00809783|58694589|FG000|Overall Study|Lack of Efficacy|39|||
30680519|NCT00809783|58694590|FG001|Overall Study|Lack of Efficacy|52|||
30680520|NCT00809783|58694591|FG002|Overall Study|Lack of Efficacy|63|||
30680521|NCT00809783|58694589|FG000|Overall Study|Lost to Follow-up|0|||
30680522|NCT00809783|58694590|FG001|Overall Study|Lost to Follow-up|3|||
30680523|NCT00809783|58694591|FG002|Overall Study|Lost to Follow-up|4|||
30680524|NCT00809783|58694589|FG000|Overall Study|Withdrawal by Subject|47|||
30680525|NCT00809783|58694590|FG001|Overall Study|Withdrawal by Subject|72|||
30680526|NCT00809783|58694591|FG002|Overall Study|Withdrawal by Subject|64|||
30680527|NCT00809783|58694589|FG000|Overall Study|Protocol Violation|2|||
30680528|NCT00809783|58694590|FG001|Overall Study|Protocol Violation|6|||
30680529|NCT00809783|58694591|FG002|Overall Study|Protocol Violation|5|||
30680530|NCT00809783|58694589|FG000|Overall Study|Randomized, but not treated|3|||
30680531|NCT00809783|58694590|FG001|Overall Study|Randomized, but not treated|0|||
30680532|NCT00809783|58694591|FG002|Overall Study|Randomized, but not treated|2|||
30680533|NCT00809783|58694589|FG000|Overall Study|Study Terminated by Sponsor|378|||
30680534|NCT00809783|58694590|FG001|Overall Study|Study Terminated by Sponsor|626|||
30680535|NCT00809783|58694591|FG002|Overall Study|Study Terminated by Sponsor|565|||
30680536|NCT00809783|58694589|FG000|Overall Study|Other|21|||
30680537|NCT00809783|58694590|FG001|Overall Study|Other|21|||
30680538|NCT00809783|58694591|FG002|Overall Study|Other|16|||
30680539|NCT00809471|58694602|FG000|Overall Study|Protocol non-compliance|15|||
30782846|NCT00093015|58794954|FG001|Overall Study|Death|385|||
30782847|NCT03358238|58794962|FG000|Overall Study|Withdrawal by Subject|0|||
30782848|NCT03358238|58794963|FG001|Overall Study|Withdrawal by Subject|1|||
30782849|NCT03342638|58794975|FG000|Overall Study|Withdrawal by Subject|1|||
30782850|NCT03342638|58794976|FG001|Overall Study|Withdrawal by Subject|0|||
30782851|NCT03342638|58794975|FG000|Overall Study|Physician Decision|0|||
30782852|NCT03342638|58794976|FG001|Overall Study|Physician Decision|1|||
30782853|NCT03342560|58794982|FG000|Overall Study|Lost to Follow-up|2|||
30782854|NCT03355742|58794999|FG000|Overall Study|Lost to Follow-up|4|||
30782855|NCT03355742|58794999|FG000|Overall Study|Withdrawal by Subject|29|||
30782856|NCT03355742|58794999|FG000|Overall Study|Physician Decision|6|||
30782857|NCT03355742|58794999|FG000|Overall Study|Death|55|||
30782858|NCT03355742|58794999|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
30782859|NCT03341312|58795003|FG000|Period 1|Withdrawal by Subject|0|||
30782860|NCT03341312|58795004|FG001|Period 1|Withdrawal by Subject|1|||
30782861|NCT03341312|58795005|FG002|Period 1|Withdrawal by Subject|0|||
30782862|NCT03341312|58795006|FG003|Period 1|Withdrawal by Subject|0|||
30782863|NCT02949908|58795018|FG000|Overall Study|Study termination|2|||
30782864|NCT01358734|58795025|FG000|Overall Study|Adverse Event|4|||
30782865|NCT01358734|58795026|FG001|Overall Study|Adverse Event|7|||
30782866|NCT01358734|58795027|FG002|Overall Study|Adverse Event|3|||
30782867|NCT01358734|58795025|FG000|Overall Study|Lack of Efficacy|0|||
30782868|NCT01358734|58795026|FG001|Overall Study|Lack of Efficacy|1|||
30782869|NCT01358734|58795027|FG002|Overall Study|Lack of Efficacy|3|||
30782870|NCT01358734|58795025|FG000|Overall Study|Withdrawal by Subject|1|||
30782871|NCT01358734|58795026|FG001|Overall Study|Withdrawal by Subject|6|||
30782872|NCT01358734|58795027|FG002|Overall Study|Withdrawal by Subject|3|||
30782873|NCT01358734|58795025|FG000|Overall Study|Death|3|||
30782874|NCT01358734|58795026|FG001|Overall Study|Death|7|||
30782875|NCT01358734|58795027|FG002|Overall Study|Death|2|||
30782876|NCT01358734|58795025|FG000|Overall Study|Progressive Disease|5|||
30782877|NCT01358734|58795026|FG001|Overall Study|Progressive Disease|13|||
30782878|NCT01358734|58795027|FG002|Overall Study|Progressive Disease|16|||
30782879|NCT01358734|58795025|FG000|Overall Study|Non-compliance with study drug|0|||
30680540|NCT00809471|58694603|FG001|Overall Study|Protocol non-compliance|15|||
30782880|NCT01358734|58795026|FG001|Overall Study|Non-compliance with study drug|0|||
30680541|NCT00809471|58694604|FG002|Overall Study|Protocol non-compliance|6|||
30782881|NCT01358734|58795027|FG002|Overall Study|Non-compliance with study drug|1|||
30782882|NCT01358734|58795025|FG000|Overall Study|Other|2|||
30782883|NCT01358734|58795026|FG001|Overall Study|Other|5|||
30782884|NCT01358734|58795027|FG002|Overall Study|Other|4|||
30782885|NCT01358734|58795025|FG000|Overall Study|Protocol Violation|0|||
30782886|NCT01358734|58795026|FG001|Overall Study|Protocol Violation|0|||
30782887|NCT01358734|58795027|FG002|Overall Study|Protocol Violation|2|||
30782888|NCT01341652|58795037|FG000|Overall Study|Incorrect Random Assignment|0|||
30680542|NCT00809471|58694602|FG000|Overall Study|Lost to Follow-up|4|||
30680543|NCT00809471|58694603|FG001|Overall Study|Lost to Follow-up|2|||
30680544|NCT00809471|58694604|FG002|Overall Study|Lost to Follow-up|9|||
30680545|NCT00809471|58694602|FG000|Overall Study|Adverse Event|0|||
30680546|NCT00809471|58694603|FG001|Overall Study|Adverse Event|2|||
30680547|NCT00809471|58694604|FG002|Overall Study|Adverse Event|2|||
30782889|NCT01341652|58795038|FG001|Overall Study|Incorrect Random Assignment|1|||
30680548|NCT00809471|58694602|FG000|Overall Study|Requirement for restricted medication|1|||
30680549|NCT00809471|58694603|FG001|Overall Study|Requirement for restricted medication|1|||
30680550|NCT00809471|58694604|FG002|Overall Study|Requirement for restricted medication|0|||
30680551|NCT00807248|58694616|FG000|Overall Study|Adverse Event|1|||
30680552|NCT00807248|58694617|FG001|Overall Study|Adverse Event|2|||
30680553|NCT00807248|58694618|FG002|Overall Study|Adverse Event|2|||
30680554|NCT00807248|58694619|FG003|Overall Study|Adverse Event|6|||
30680555|NCT00807248|58694616|FG000|Overall Study|Lack of Efficacy|14|||
30680556|NCT00807248|58694617|FG001|Overall Study|Lack of Efficacy|4|||
30680557|NCT00807248|58694618|FG002|Overall Study|Lack of Efficacy|8|||
30680558|NCT00807248|58694619|FG003|Overall Study|Lack of Efficacy|3|||
30680559|NCT00807248|58694616|FG000|Overall Study|Protocol Violation|0|||
30680560|NCT00807248|58694617|FG001|Overall Study|Protocol Violation|1|||
30680561|NCT00807248|58694618|FG002|Overall Study|Protocol Violation|1|||
30680562|NCT00807248|58694619|FG003|Overall Study|Protocol Violation|0|||
30680563|NCT00807248|58694616|FG000|Overall Study|Withdrawal of Consent|5|||
30680564|NCT00807248|58694617|FG001|Overall Study|Withdrawal of Consent|5|||
30680565|NCT00807248|58694618|FG002|Overall Study|Withdrawal of Consent|5|||
30680566|NCT00807248|58694619|FG003|Overall Study|Withdrawal of Consent|5|||
30680567|NCT00807248|58694616|FG000|Overall Study|Lost to Follow-up|1|||
30680568|NCT00807248|58694617|FG001|Overall Study|Lost to Follow-up|0|||
30680569|NCT00807248|58694618|FG002|Overall Study|Lost to Follow-up|0|||
30680570|NCT00807248|58694619|FG003|Overall Study|Lost to Follow-up|0|||
30680571|NCT00807248|58694616|FG000|Overall Study|Other Reason|0|||
30680572|NCT00807248|58694617|FG001|Overall Study|Other Reason|0|||
30680573|NCT00807248|58694618|FG002|Overall Study|Other Reason|2|||
30680574|NCT00807248|58694619|FG003|Overall Study|Other Reason|0|||
30680575|NCT00589628|58694631|FG000|Overall Study|Lost to Follow-up|0|||
30782890|NCT01341652|58795037|FG000|Overall Study|ineligible; presence metastatic disease|0|||
30782891|NCT01341652|58795038|FG001|Overall Study|ineligible; presence metastatic disease|1|||
30595059|NCT01193218|58607376|FG003|12-52 Weeks|Withdrawal by Subject|0|||
30595060|NCT01193218|58607377|FG004|12-52 Weeks|Withdrawal by Subject|0|||
30595061|NCT01193218|58607378|FG005|12-52 Weeks|Withdrawal by Subject|2|||
30595062|NCT01193218|58607379|FG006|12-52 Weeks|Withdrawal by Subject|1|||
30595063|NCT01193218|58607380|FG007|12-52 Weeks|Withdrawal by Subject|2|||
30595064|NCT01193218|58607373|FG000|12-52 Weeks|Other reason than above|1|||
30595065|NCT01193218|58607374|FG001|12-52 Weeks|Other reason than above|0|||
30595066|NCT01193218|58607375|FG002|12-52 Weeks|Other reason than above|0|||
30782892|NCT02828644|58795046|FG000|Overall Study|Lost to Follow-up|23|||
30782893|NCT02828644|58795047|FG001|Overall Study|Lost to Follow-up|22|||
30782894|NCT02949362|58795056|FG000|Retrospective Period|Inform consent not signed by participant|4|||
30782895|NCT02949362|58795057|FG001|Retrospective Period|Inform consent not signed by participant|1|||
30782896|NCT02949362|58795058|FG002|Retrospective Period|Inform consent not signed by participant|0|||
30782897|NCT02949362|58795059|FG003|Retrospective Period|Inform consent not signed by participant|0|||
30782898|NCT02949362|58795056|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
30782899|NCT02949362|58795057|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
30782900|NCT02949362|58795058|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
30782901|NCT02949362|58795059|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
30782902|NCT02949362|58795056|FG000|Prospective Period|Other|0|||
30782903|NCT02949362|58795057|FG001|Prospective Period|Other|0|||
30782904|NCT02949362|58795058|FG002|Prospective Period|Other|0|||
30782905|NCT02949362|58795059|FG003|Prospective Period|Other|4|||
30782906|NCT02947022|58795071|FG000|Overall Study|Study Stopped|1|||
30782907|NCT03338972|58795082|FG000|Overall Study|Death|1|||
30782908|NCT03338972|58795083|FG001|Overall Study|Death|1|||
30782909|NCT03338972|58795084|FG002|Overall Study|Death|0|||
30782910|NCT03338972|58795085|FG003|Overall Study|Death|0|||
30782911|NCT03338972|58795082|FG000|Overall Study|Withdrawal by Subject|1|||
30782912|NCT03338972|58795083|FG001|Overall Study|Withdrawal by Subject|0|||
30782913|NCT03338972|58795084|FG002|Overall Study|Withdrawal by Subject|0|||
30782914|NCT03338972|58795085|FG003|Overall Study|Withdrawal by Subject|0|||
30782915|NCT03338894|58795095|FG000|Overall Study|not able able to attend 9 or more classes|10|||
30782916|NCT03338816|58795101|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
30782917|NCT03338816|58795102|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
30782918|NCT03338816|58795103|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
30782919|NCT03338816|58795104|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
30782920|NCT03338816|58795101|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
30595067|NCT01193218|58607376|FG003|12-52 Weeks|Other reason than above|1|||
30595068|NCT01193218|58607377|FG004|12-52 Weeks|Other reason than above|1|||
30680576|NCT00589628|58694632|FG001|Overall Study|Lost to Follow-up|1|||
30680577|NCT00588848|58694640|FG000|Overall Study|Physician Decision|0|||
30680578|NCT00588848|58694641|FG001|Overall Study|Physician Decision|3|||
30680579|NCT00797108|58694652|FG000|Overall Study|Adverse Event|1|||
30680580|NCT00797108|58694653|FG001|Overall Study|Adverse Event|0|||
30680581|NCT00797108|58694654|FG002|Overall Study|Adverse Event|3|||
30595069|NCT01193218|58607378|FG005|12-52 Weeks|Other reason than above|0|||
30595070|NCT01193218|58607379|FG006|12-52 Weeks|Other reason than above|0|||
30595071|NCT01193218|58607380|FG007|12-52 Weeks|Other reason than above|0|||
30680582|NCT00797108|58694652|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
30680583|NCT00797108|58694653|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
30680584|NCT00797108|58694654|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
30680585|NCT00797108|58694652|FG000|Overall Study|Global Deterioration of Health Status|0|||
30680586|NCT00797108|58694653|FG001|Overall Study|Global Deterioration of Health Status|1|||
30680587|NCT00797108|58694654|FG002|Overall Study|Global Deterioration of Health Status|0|||
30680588|NCT00797108|58694652|FG000|Overall Study|Lack of Efficacy|1|||
30680589|NCT00797108|58694653|FG001|Overall Study|Lack of Efficacy|0|||
30680590|NCT00797108|58694654|FG002|Overall Study|Lack of Efficacy|1|||
30680591|NCT00797108|58694652|FG000|Overall Study|Other|0|||
30595072|NCT01193101|58607400|FG000|Overall Study|Adverse Event|0|||
30595073|NCT01193101|58607401|FG001|Overall Study|Adverse Event|1|||
30595074|NCT01193101|58607402|FG002|Overall Study|Adverse Event|1|||
30595075|NCT01193101|58607403|FG003|Overall Study|Adverse Event|3|||
30595076|NCT01193101|58607400|FG000|Overall Study|Lack of Efficacy|3|||
30595077|NCT01193101|58607401|FG001|Overall Study|Lack of Efficacy|1|||
30595078|NCT01193101|58607402|FG002|Overall Study|Lack of Efficacy|0|||
30595079|NCT01193101|58607403|FG003|Overall Study|Lack of Efficacy|8|||
30595080|NCT01193101|58607400|FG000|Overall Study|Withdrawal by Subject|2|||
30595081|NCT01193101|58607401|FG001|Overall Study|Withdrawal by Subject|4|||
30680592|NCT00797108|58694653|FG001|Overall Study|Other|0|||
30680593|NCT00797108|58694654|FG002|Overall Study|Other|2|||
30680594|NCT00797108|58694652|FG000|Overall Study|Randomized but not Treated|2|||
30680595|NCT00797108|58694653|FG001|Overall Study|Randomized but not Treated|0|||
30680596|NCT00797108|58694654|FG002|Overall Study|Randomized but not Treated|0|||
30680597|NCT00742560|58694667|FG000|Overall Study|Adverse Event|0|||
30680598|NCT00742560|58694668|FG001|Overall Study|Adverse Event|0|||
30680599|NCT00742560|58694669|FG002|Overall Study|Adverse Event|1|||
30680600|NCT00742560|58694670|FG003|Overall Study|Adverse Event|1|||
30680601|NCT00742560|58694671|FG004|Overall Study|Adverse Event|1|||
30782921|NCT03338816|58795102|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
30782922|NCT03338816|58795103|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
30782923|NCT03338816|58795104|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
30595082|NCT01193101|58607402|FG002|Overall Study|Withdrawal by Subject|1|||
30595083|NCT01193101|58607403|FG003|Overall Study|Withdrawal by Subject|1|||
30595084|NCT01193101|58607400|FG000|Overall Study|Administrative problems|0|||
30595085|NCT01193101|58607401|FG001|Overall Study|Administrative problems|0|||
30680602|NCT00742560|58694667|FG000|Overall Study|Death|0|||
30782924|NCT03338816|58795101|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
30782925|NCT03338816|58795102|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
30782926|NCT03338816|58795103|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
30782927|NCT03338816|58795104|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
30782928|NCT03338816|58795101|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
30782929|NCT03338816|58795102|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
30782930|NCT03338816|58795103|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
30782931|NCT03338816|58795104|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
30782932|NCT03338816|58795101|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
30782933|NCT03338816|58795102|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
30782934|NCT03338816|58795103|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
30782935|NCT03338816|58795104|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
30782936|NCT03338816|58795101|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
30782937|NCT03338816|58795102|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
30782938|NCT03338816|58795103|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
30782939|NCT03338816|58795104|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
30782940|NCT03338816|58795101|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
30782941|NCT03338816|58795102|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
30782942|NCT03338816|58795103|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
30782943|NCT03338816|58795104|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
30782944|NCT03337490|58795116|FG000|Overall Study|Withdrawal by Subject|1|||
30782945|NCT03337490|58795117|FG001|Overall Study|Withdrawal by Subject|0|||
30782946|NCT03337490|58795118|FG002|Overall Study|Withdrawal by Subject|0|||
30782947|NCT03337490|58795116|FG000|Overall Study|Lack of Efficacy|10|||
30782948|NCT03337490|58795117|FG001|Overall Study|Lack of Efficacy|12|||
30595086|NCT01193101|58607402|FG002|Overall Study|Administrative problems|1|||
30595087|NCT01193101|58607403|FG003|Overall Study|Administrative problems|0|||
30680603|NCT00742560|58694668|FG001|Overall Study|Death|2|||
30680604|NCT00742560|58694669|FG002|Overall Study|Death|0|||
30680605|NCT00742560|58694670|FG003|Overall Study|Death|2|||
30680606|NCT00742560|58694671|FG004|Overall Study|Death|3|||
30595088|NCT01193101|58607400|FG000|Overall Study|Abnormal test procedure results|0|||
30595089|NCT01193101|58607401|FG001|Overall Study|Abnormal test procedure results|1|||
30595090|NCT01193101|58607402|FG002|Overall Study|Abnormal test procedure results|0|||
30595091|NCT01193101|58607403|FG003|Overall Study|Abnormal test procedure results|0|||
30595092|NCT01192516|58607416|FG000|Overall Study|Lost to Follow-up|7|||
30595093|NCT01192516|58607417|FG001|Overall Study|Lost to Follow-up|10|||
30595094|NCT01192516|58607418|FG002|Overall Study|Lost to Follow-up|7|||
30595095|NCT01192516|58607416|FG000|Overall Study|Withdrawal by Subject|4|||
30595096|NCT01192516|58607417|FG001|Overall Study|Withdrawal by Subject|4|||
30595097|NCT01192516|58607418|FG002|Overall Study|Withdrawal by Subject|1|||
30680607|NCT00742560|58694667|FG000|Overall Study|Subject's Decision|1|||
30680608|NCT00742560|58694668|FG001|Overall Study|Subject's Decision|0|||
30680609|NCT00742560|58694669|FG002|Overall Study|Subject's Decision|2|||
30680610|NCT00742560|58694670|FG003|Overall Study|Subject's Decision|3|||
30680611|NCT00742560|58694671|FG004|Overall Study|Subject's Decision|3|||
30680612|NCT00742560|58694667|FG000|Overall Study|Investigator's Decision|0|||
30680613|NCT00742560|58694668|FG001|Overall Study|Investigator's Decision|0|||
30680614|NCT00742560|58694669|FG002|Overall Study|Investigator's Decision|4|||
30680615|NCT00742560|58694670|FG003|Overall Study|Investigator's Decision|1|||
30680616|NCT00742560|58694671|FG004|Overall Study|Investigator's Decision|0|||
30680617|NCT00742560|58694667|FG000|Overall Study|Disease Progression|1|||
30680618|NCT00742560|58694668|FG001|Overall Study|Disease Progression|0|||
30680619|NCT00742560|58694669|FG002|Overall Study|Disease Progression|5|||
30680620|NCT00742560|58694670|FG003|Overall Study|Disease Progression|17|||
30680621|NCT00742560|58694671|FG004|Overall Study|Disease Progression|16|||
30680622|NCT00742560|58694667|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
30680623|NCT00742560|58694668|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
30680624|NCT00742560|58694669|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
30680625|NCT00742560|58694670|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
30680626|NCT00742560|58694671|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
30680627|NCT00742560|58694667|FG000|Overall Study|Other|0|||
30680628|NCT00742560|58694668|FG001|Overall Study|Other|1|||
30680629|NCT00742560|58694669|FG002|Overall Study|Other|8|||
30680630|NCT00742560|58694670|FG003|Overall Study|Other|9|||
30680631|NCT00742560|58694671|FG004|Overall Study|Other|9|||
30680632|NCT00742560|58694667|FG000|Overall Study|MIssing|0|||
30680633|NCT00742560|58694668|FG001|Overall Study|MIssing|0|||
30680634|NCT00742560|58694669|FG002|Overall Study|MIssing|0|||
30680635|NCT00742560|58694670|FG003|Overall Study|MIssing|0|||
30680636|NCT00742560|58694671|FG004|Overall Study|MIssing|1|||
30680637|NCT00740220|58694702|FG000|Overall Study|screen failures (non-COPD patients)|9|||
30680638|NCT00796718|58694706|FG000|Overall Study|Adverse Event|2|||
30680639|NCT00796718|58694706|FG000|Overall Study|Exclusion Criteria|1|||
30680640|NCT00796718|58694706|FG000|Overall Study|Lost to Follow-up|5|||
30680641|NCT00796718|58694706|FG000|Overall Study|Withdrawal by Informed Consent|1|||
30680642|NCT00809159|58694714|FG000|Part 1|Adverse Event|1|||
30680643|NCT00809159|58694715|FG001|Part 1|Adverse Event|1|||
30680644|NCT00809159|58694716|FG002|Part 1|Adverse Event|0|||
30680645|NCT00809159|58694717|FG003|Part 1|Adverse Event|0|||
30680646|NCT00809159|58694718|FG004|Part 1|Adverse Event|0|||
30595098|NCT01192516|58607416|FG000|Overall Study|started new treatment|5|||
30595099|NCT01192516|58607417|FG001|Overall Study|started new treatment|1|||
30595100|NCT01192516|58607418|FG002|Overall Study|started new treatment|0|||
30595101|NCT01192516|58607416|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
30595102|NCT01192516|58607417|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
30595103|NCT01192516|58607418|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
30595104|NCT01192399|58607430|FG000|Overall Study|Lack of Efficacy|2|||
30595105|NCT01176916|58607434|FG000|Overall Study|Adverse Event|61|||
30595106|NCT01176916|58607434|FG000|Overall Study|Death|1|||
30595107|NCT01176916|58607434|FG000|Overall Study|Lost to Follow-up|15|||
30595108|NCT01176916|58607434|FG000|Overall Study|Objective progression or relapse|17|||
30595109|NCT01176916|58607434|FG000|Overall Study|Protocol Violation|24|||
30595110|NCT01176916|58607434|FG000|Overall Study|Withdrawal by Subject|37|||
30595111|NCT01176916|58607434|FG000|Overall Study|Other|6|||
30595112|NCT01176916|58607434|FG000|Overall Study|Withdrawal prior to Treatment|6|||
30595113|NCT01192204|58607440|FG000|Overall Study|could not keep recall appointments|1|||
30680647|NCT00809159|58694719|FG005|Part 1|Adverse Event|0|||
30595114|NCT01192204|58607441|FG001|Overall Study|could not keep recall appointments|0|||
30680648|NCT00809159|58694714|FG000|Part 1|Lost to Follow-up|1|||
30680649|NCT00809159|58694715|FG001|Part 1|Lost to Follow-up|0|||
30680650|NCT00809159|58694716|FG002|Part 1|Lost to Follow-up|0|||
30595115|NCT01192126|58607448|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
30595116|NCT01192126|58607449|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
30595117|NCT01192126|58607448|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
30680651|NCT00809159|58694717|FG003|Part 1|Lost to Follow-up|0|||
30680652|NCT00809159|58694718|FG004|Part 1|Lost to Follow-up|0|||
30680653|NCT00809159|58694719|FG005|Part 1|Lost to Follow-up|0|||
30680654|NCT00809159|58694714|FG000|Part 1|Withdrawal by Subject|3|||
30680655|NCT00809159|58694715|FG001|Part 1|Withdrawal by Subject|1|||
30680656|NCT00809159|58694716|FG002|Part 1|Withdrawal by Subject|0|||
30680657|NCT00809159|58694717|FG003|Part 1|Withdrawal by Subject|0|||
30680658|NCT00809159|58694718|FG004|Part 1|Withdrawal by Subject|0|||
30680659|NCT00809159|58694719|FG005|Part 1|Withdrawal by Subject|0|||
30680660|NCT00809159|58694714|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
30680661|NCT00809159|58694715|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
30680662|NCT00809159|58694716|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
30680663|NCT00809159|58694717|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
30680664|NCT00809159|58694718|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
30595118|NCT01192126|58607449|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
30595119|NCT01327482|58607455|FG000|Overall Study|Adverse Event|1|||
30595120|NCT01176565|58607461|FG000|Overall Study|Lost to Follow-up|12|||
30595121|NCT01176565|58607462|FG001|Overall Study|Lost to Follow-up|16|||
30595122|NCT01176565|58607461|FG000|Overall Study|Withdrawal by Subject|7|||
30595123|NCT01176565|58607462|FG001|Overall Study|Withdrawal by Subject|1|||
30595124|NCT01176565|58607461|FG000|Overall Study|Not Analyzed (any other reason)|1|||
30595125|NCT01176565|58607462|FG001|Overall Study|Not Analyzed (any other reason)|2|||
30680665|NCT00809159|58694719|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
30680666|NCT00809159|58694714|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
30680667|NCT00809159|58694715|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
30680668|NCT00809159|58694716|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
30680669|NCT00809159|58694717|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
30680670|NCT00809159|58694718|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
30680671|NCT00809159|58694719|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
30680672|NCT00809159|58694714|FG000|Part 1 and 2|Administrative problems|0|||
30680673|NCT00809159|58694715|FG001|Part 1 and 2|Administrative problems|0|||
30680674|NCT00809159|58694716|FG002|Part 1 and 2|Administrative problems|0|||
30680675|NCT00809159|58694717|FG003|Part 1 and 2|Administrative problems|1|||
30680676|NCT00809159|58694718|FG004|Part 1 and 2|Administrative problems|0|||
30680677|NCT00809159|58694719|FG005|Part 1 and 2|Administrative problems|0|||
30680678|NCT00809159|58694714|FG000|Part 1 and 2|Adverse Event|0|||
30680679|NCT00809159|58694715|FG001|Part 1 and 2|Adverse Event|0|||
30680680|NCT00809159|58694716|FG002|Part 1 and 2|Adverse Event|1|||
30680681|NCT00809159|58694717|FG003|Part 1 and 2|Adverse Event|0|||
30680682|NCT00809159|58694718|FG004|Part 1 and 2|Adverse Event|1|||
30680683|NCT00809159|58694719|FG005|Part 1 and 2|Adverse Event|1|||
30680684|NCT00809159|58694714|FG000|Part 1 and 2|Lost to Follow-up|0|||
30680685|NCT00809159|58694715|FG001|Part 1 and 2|Lost to Follow-up|0|||
30680686|NCT00809159|58694716|FG002|Part 1 and 2|Lost to Follow-up|1|||
30680687|NCT00809159|58694717|FG003|Part 1 and 2|Lost to Follow-up|1|||
30680688|NCT00809159|58694718|FG004|Part 1 and 2|Lost to Follow-up|0|||
30680689|NCT00809159|58694719|FG005|Part 1 and 2|Lost to Follow-up|0|||
30680690|NCT00809159|58694714|FG000|Part 1 and 2|Withdrawal by Subject|0|||
30595126|NCT01176292|58607470|FG000|Overall Study|Lost to Follow-up|2|||
30595127|NCT01176292|58607471|FG001|Overall Study|Lost to Follow-up|4|||
30595128|NCT01176292|58607470|FG000|Overall Study|Adverse Event|1|||
30595129|NCT01176292|58607471|FG001|Overall Study|Adverse Event|1|||
30595130|NCT01176292|58607470|FG000|Overall Study|Physician Decision|0|||
30595131|NCT01176292|58607471|FG001|Overall Study|Physician Decision|2|||
30595132|NCT01176292|58607470|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
30595133|NCT01176292|58607471|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
30595134|NCT01113541|58607477|FG000|Overall Study|Withdrawal by Subject|1|||
30595135|NCT01113541|58607477|FG000|Overall Study|Protocol Violation|1|||
30595136|NCT01113541|58607477|FG000|Overall Study|Study Terminated by Sponsor|7|||
30595137|NCT01113541|58607477|FG000|Overall Study|Adverse Event|4|||
30595138|NCT01113502|58607490|FG000|Overall Study|Withdrawal by Subject|1|||
30595139|NCT01113502|58607491|FG001|Overall Study|Withdrawal by Subject|0|||
30595140|NCT01113502|58607492|FG002|Overall Study|Withdrawal by Subject|1|||
30595141|NCT01113502|58607493|FG003|Overall Study|Withdrawal by Subject|1|||
30595142|NCT01113502|58607494|FG004|Overall Study|Withdrawal by Subject|0|||
30595143|NCT01113502|58607490|FG000|Overall Study|Adverse Event|0|||
30595144|NCT01113502|58607491|FG001|Overall Study|Adverse Event|0|||
30595145|NCT01113502|58607492|FG002|Overall Study|Adverse Event|3|||
30595146|NCT01113502|58607493|FG003|Overall Study|Adverse Event|2|||
30595147|NCT01113502|58607494|FG004|Overall Study|Adverse Event|0|||
30595148|NCT01113463|58607507|FG000|Overall Study|Physician Decision|5|||
30680691|NCT00809159|58694715|FG001|Part 1 and 2|Withdrawal by Subject|0|||
30680692|NCT00809159|58694716|FG002|Part 1 and 2|Withdrawal by Subject|4|||
30680693|NCT00809159|58694717|FG003|Part 1 and 2|Withdrawal by Subject|0|||
30680694|NCT00809159|58694718|FG004|Part 1 and 2|Withdrawal by Subject|0|||
30595149|NCT01112917|58607511|FG000|Overall Study|Death|2|||
30680695|NCT00809159|58694719|FG005|Part 1 and 2|Withdrawal by Subject|1|||
30680696|NCT00745368|58694733|FG000|Overall Study|Unable to provide sample|3|||
30595150|NCT01112917|58607512|FG001|Overall Study|Death|11|||
30680697|NCT00589472|58694737|FG000|Overall Study|Adverse Event|1|||
30782949|NCT03337490|58795118|FG002|Overall Study|Lack of Efficacy|35|||
30680698|NCT00811577|58694743|FG000|Overall Study|Lost to Follow-up|7|||
30680699|NCT00811577|58694744|FG001|Overall Study|Lost to Follow-up|1|||
30680700|NCT00811577|58694743|FG000|Overall Study|Withdrawal by Subject|3|||
30680701|NCT00811577|58694744|FG001|Overall Study|Withdrawal by Subject|0|||
30680702|NCT00802178|58694793|FG000|Overall Study|Lack of Efficacy|36|||
30680703|NCT00802178|58694793|FG000|Overall Study|Insufficient tolerability (IT)|17|||
30680704|NCT00802178|58694793|FG000|Overall Study|Withdrawal by Subject|18|||
30680705|NCT00802178|58694793|FG000|Overall Study|Other|32|||
30680706|NCT00802178|58694793|FG000|Overall Study|Lack of efficacy and patient wish|1|||
30680707|NCT00802178|58694793|FG000|Overall Study|IT and patient wish|8|||
30680708|NCT00802178|58694793|FG000|Overall Study|Patients wish and other reason|1|||
30680709|NCT00744978|58694799|FG000|Period 1|Lost to Follow-up|1|||
30680710|NCT00744978|58694800|FG001|Period 1|Lost to Follow-up|0|||
30680711|NCT00744978|58694799|FG000|Period 1|Withdrawal by Subject|0|||
30680712|NCT00744978|58694800|FG001|Period 1|Withdrawal by Subject|2|||
30680713|NCT00744978|58694799|FG000|Period 1|Other|0|||
30782950|NCT03337490|58795116|FG000|Overall Study|Physician Decision|0|||
30782951|NCT03337490|58795117|FG001|Overall Study|Physician Decision|1|||
30959074|NCT01691105|59024138|FG000|1 Month Follow-up|Lost to Follow-up|41|||
30959075|NCT01691105|59024139|FG001|1 Month Follow-up|Lost to Follow-up|38|||
30959076|NCT01691105|59024138|FG000|1 Month Follow-up|Death|2|||
30959077|NCT01691105|59024139|FG001|1 Month Follow-up|Death|3|||
30959078|NCT01691105|59024138|FG000|6 Month Follow-up|Lost to Follow-up|39|||
30959079|NCT01691105|59024139|FG001|6 Month Follow-up|Lost to Follow-up|58|||
30595151|NCT01112917|58607511|FG000|Overall Study|Lost to Follow-up|1|||
30595152|NCT01112917|58607512|FG001|Overall Study|Lost to Follow-up|1|||
30595153|NCT01112917|58607511|FG000|Overall Study|Withdrawal by Subject|1|||
30595154|NCT01112917|58607512|FG001|Overall Study|Withdrawal by Subject|3|||
30595155|NCT01112917|58607511|FG000|Overall Study|Unable to Convert Filter|3|||
30595156|NCT01112917|58607512|FG001|Overall Study|Unable to Convert Filter|0|||
30595157|NCT01176058|58607518|FG000|Overall Study|Adverse Event|1|||
30595158|NCT01176058|58607519|FG001|Overall Study|Adverse Event|0|||
30595159|NCT01176058|58607518|FG000|Overall Study|Insufficient clinical response|2|||
30595160|NCT01176058|58607519|FG001|Overall Study|Insufficient clinical response|2|||
30595161|NCT01176058|58607518|FG000|Overall Study|Insufficient mycological response|0|||
30595162|NCT01176058|58607519|FG001|Overall Study|Insufficient mycological response|1|||
30595163|NCT01176058|58607518|FG000|Overall Study|Withdrawal by Subject|1|||
30595164|NCT01176058|58607519|FG001|Overall Study|Withdrawal by Subject|0|||
30595165|NCT01175824|58607527|FG000|Overall Study|Adverse Event|2|||
30595166|NCT01175824|58607528|FG001|Overall Study|Adverse Event|1|||
30595167|NCT01175824|58607527|FG000|Overall Study|Lack of Efficacy|2|||
30595168|NCT01175824|58607528|FG001|Overall Study|Lack of Efficacy|0|||
30595169|NCT01175824|58607527|FG000|Overall Study|Lost to Follow-up|0|||
30595170|NCT01175824|58607528|FG001|Overall Study|Lost to Follow-up|1|||
30595171|NCT01175824|58607527|FG000|Overall Study|Physician Decision|0|||
30595172|NCT01175824|58607528|FG001|Overall Study|Physician Decision|4|||
30595173|NCT01175824|58607527|FG000|Overall Study|Protocol Violation|2|||
30595174|NCT01175824|58607528|FG001|Overall Study|Protocol Violation|5|||
30595175|NCT01175824|58607527|FG000|Overall Study|Withdrawal by Subject|3|||
30595176|NCT01175824|58607528|FG001|Overall Study|Withdrawal by Subject|7|||
30595177|NCT01175824|58607527|FG000|Overall Study|Sponsor Decision|1|||
30595178|NCT01175824|58607528|FG001|Overall Study|Sponsor Decision|0|||
30595179|NCT01175824|58607527|FG000|Overall Study|Entry Criteria Not Met|6|||
30595180|NCT01175824|58607528|FG001|Overall Study|Entry Criteria Not Met|4|||
30595181|NCT01175707|58607536|FG000|Overall Study|Adverse Event|4|||
30595182|NCT01175707|58607537|FG001|Overall Study|Adverse Event|6|||
30595183|NCT01112059|58607546|FG000|Overall Study|Withdrawal by Subject|1|||
30595184|NCT01112059|58607547|FG001|Overall Study|Withdrawal by Subject|0|||
30595185|NCT01175668|58607558|FG000|Overall Study|Withdrawal by Subject|2|||
30595186|NCT01175668|58607559|FG001|Overall Study|Withdrawal by Subject|0|||
30680714|NCT00744978|58694800|FG001|Period 1|Other|2|||
30680715|NCT00744978|58694799|FG000|Period 1|Adverse Event|4|||
30782952|NCT03337490|58795118|FG002|Overall Study|Physician Decision|0|||
30782953|NCT03337490|58795116|FG000|Overall Study|Lost to Follow-up|0|||
30595187|NCT01111825|58607569|FG000|Overall Study|Withdrawal by Subject|0|||
30595188|NCT01111825|58607570|FG001|Overall Study|Withdrawal by Subject|0|||
30782954|NCT03337490|58795117|FG001|Overall Study|Lost to Follow-up|1|||
30595189|NCT01111825|58607571|FG002|Overall Study|Withdrawal by Subject|1|||
30595190|NCT01111825|58607572|FG003|Overall Study|Withdrawal by Subject|0|||
30595191|NCT01111825|58607569|FG000|Overall Study|Lost to Follow-up|0|||
30595192|NCT01111825|58607570|FG001|Overall Study|Lost to Follow-up|0|||
30595193|NCT01111825|58607571|FG002|Overall Study|Lost to Follow-up|3|||
30595194|NCT01111825|58607572|FG003|Overall Study|Lost to Follow-up|1|||
30595195|NCT01111825|58607569|FG000|Overall Study|Adverse Event|2|||
30595196|NCT01111825|58607570|FG001|Overall Study|Adverse Event|1|||
30680716|NCT00744978|58694800|FG001|Period 1|Adverse Event|0|||
30680717|NCT00744978|58694799|FG000|Period 1|Randomized but not Treated|1|||
30680718|NCT00744978|58694800|FG001|Period 1|Randomized but not Treated|1|||
30959080|NCT01691105|59024138|FG000|6 Month Follow-up|Death|13|||
30959081|NCT01691105|59024139|FG001|6 Month Follow-up|Death|13|||
30959082|NCT01691105|59024138|FG000|12 Month Follow-up|Lost to Follow-up|50|||
30959083|NCT01691105|59024139|FG001|12 Month Follow-up|Lost to Follow-up|71|||
30959084|NCT01691105|59024138|FG000|12 Month Follow-up|Death|22|||
30959085|NCT01691105|59024139|FG001|12 Month Follow-up|Death|30|||
30959086|NCT01691105|59024138|FG000|12 Month Biochemical Verification|Death|22|||
30959087|NCT01691105|59024139|FG001|12 Month Biochemical Verification|Death|30|||
30959088|NCT01691105|59024138|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
30959089|NCT01691105|59024139|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
30959090|NCT01691105|59024138|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
30959091|NCT01691105|59024139|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
30959092|NCT02685072|59024147|FG000|Treatment Period|Lost to Follow-up|12|||
30959093|NCT02685072|59024148|FG001|Treatment Period|Lost to Follow-up|6|||
30959094|NCT02685072|59024147|FG000|Treatment Period|Withdrawal by Subject|1|||
30595197|NCT01111825|58607571|FG002|Overall Study|Adverse Event|4|||
30595198|NCT01111825|58607572|FG003|Overall Study|Adverse Event|0|||
30595199|NCT01111825|58607569|FG000|Overall Study|Disease Progression|1|||
30595200|NCT01111825|58607570|FG001|Overall Study|Disease Progression|0|||
30595201|NCT01111825|58607571|FG002|Overall Study|Disease Progression|0|||
30595202|NCT01111825|58607572|FG003|Overall Study|Disease Progression|0|||
30959095|NCT02685072|59024148|FG001|Treatment Period|Withdrawal by Subject|3|||
30959096|NCT02685072|59024147|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
30959097|NCT02685072|59024148|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
30959098|NCT02695524|59024218|FG000|Overall Study|Lost to Follow-up|3|||
30959099|NCT02695524|59024219|FG001|Overall Study|Lost to Follow-up|2|||
30959100|NCT02695524|59024218|FG000|Overall Study|Death|0|||
30959101|NCT02695524|59024219|FG001|Overall Study|Death|1|||
30959102|NCT01576367|59024225|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30959103|NCT01576367|59024225|FG000|Overall Study|Moved to commercial use after 6 months|1|||
30595203|NCT01111825|58607569|FG000|Overall Study|Discontinuation by Sponsor|0|||
30595204|NCT01111825|58607570|FG001|Overall Study|Discontinuation by Sponsor|0|||
30595205|NCT01111825|58607571|FG002|Overall Study|Discontinuation by Sponsor|0|||
30680719|NCT00744978|58694799|FG000|Period 2|Adverse Event|0|||
30680720|NCT00744978|58694800|FG001|Period 2|Adverse Event|1|||
30680721|NCT00739908|58694808|FG000|Overall Study|Adverse Event|5|||
30680722|NCT00739908|58694809|FG001|Overall Study|Adverse Event|6|||
30680723|NCT00739908|58694808|FG000|Overall Study|Withdrawal by Subject|4|||
30680724|NCT00739908|58694809|FG001|Overall Study|Withdrawal by Subject|2|||
30680725|NCT00739908|58694808|FG000|Overall Study|Lost to Follow-up|14|||
30680726|NCT00739908|58694809|FG001|Overall Study|Lost to Follow-up|9|||
30680727|NCT00739908|58694808|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
30680728|NCT00739908|58694809|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
30680729|NCT00739908|58694808|FG000|Overall Study|Non-Compliance With Study Medication|0|||
30680730|NCT00739908|58694809|FG001|Overall Study|Non-Compliance With Study Medication|3|||
30680731|NCT00739908|58694808|FG000|Overall Study|Lack of Efficacy|0|||
30680732|NCT00739908|58694809|FG001|Overall Study|Lack of Efficacy|1|||
30680733|NCT00739908|58694808|FG000|Overall Study|Relocation|0|||
30680734|NCT00739908|58694809|FG001|Overall Study|Relocation|1|||
30680735|NCT00739596|58694819|FG000|Overall Study|Adverse Event|12|||
30680736|NCT00739596|58694820|FG001|Overall Study|Adverse Event|6|||
30680737|NCT00739596|58694819|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
30680738|NCT00739596|58694820|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
30680739|NCT00739596|58694819|FG000|Overall Study|Patient Withdrew Consent|8|||
30680740|NCT00739596|58694820|FG001|Overall Study|Patient Withdrew Consent|8|||
30680741|NCT00739596|58694819|FG000|Overall Study|Lost to Follow-up|0|||
30680742|NCT00739596|58694820|FG001|Overall Study|Lost to Follow-up|2|||
30680743|NCT00739596|58694819|FG000|Overall Study|Protocol Deviation|1|||
30680744|NCT00739596|58694820|FG001|Overall Study|Protocol Deviation|1|||
30680745|NCT00742326|58694828|FG000|Overall Study|Physician Decision|0|||
30959104|NCT01689857|59024236|FG000|Overall Study|Lost to Follow-up|5|||
30680746|NCT00742326|58694829|FG001|Overall Study|Physician Decision|1|||
30680747|NCT00741936|58694837|FG000|Overall Study|Lost to Follow-up|1|||
30680748|NCT00741936|58694838|FG001|Overall Study|Lost to Follow-up|1|||
30680749|NCT00741936|58694837|FG000|Overall Study|Adverse Event|3|||
30959105|NCT01689857|59024237|FG001|Overall Study|Lost to Follow-up|2|||
30595206|NCT01111825|58607572|FG003|Overall Study|Discontinuation by Sponsor|20|||
30959106|NCT01587079|59024252|FG000|Overall Study|Protocol-specified criteria|9|||
30959107|NCT01587079|59024252|FG000|Overall Study|Protocol Violation|5|||
30959108|NCT01587079|59024252|FG000|Overall Study|Lost to Follow-up|2|||
30959109|NCT01587079|59024252|FG000|Overall Study|Physician Decision|2|||
30595207|NCT01175590|58607584|FG000|Overall Study|Lost to Follow-up|1|||
30595208|NCT01175590|58607585|FG001|Overall Study|Lost to Follow-up|0|||
30680750|NCT00741936|58694838|FG001|Overall Study|Adverse Event|4|||
30680751|NCT00741936|58694837|FG000|Overall Study|Pregnancy|0|||
30680752|NCT00741936|58694838|FG001|Overall Study|Pregnancy|1|||
30680753|NCT00741936|58694837|FG000|Overall Study|Protocol Violation|2|||
30680754|NCT00741936|58694838|FG001|Overall Study|Protocol Violation|0|||
30680755|NCT00741936|58694837|FG000|Overall Study|Lack of Efficacy|0|||
30680756|NCT00741936|58694838|FG001|Overall Study|Lack of Efficacy|2|||
30680757|NCT00741936|58694837|FG000|Overall Study|Low compliance|3|||
30680758|NCT00741936|58694838|FG001|Overall Study|Low compliance|0|||
30680759|NCT00811187|58694846|FG000|Overall Study|Unable to place device / procedure abort|3|||
30680760|NCT00811187|58694847|FG001|Overall Study|Unable to place device / procedure abort|3|||
30680761|NCT00591149|58694853|FG000|Overall Study|Adverse Event|4|||
30680762|NCT00591149|58694853|FG000|Overall Study|Withdrawal by Subject|1|||
30680763|NCT00735072|58694859|FG000|Overall Study|interrupted study med during ARV change|1|||
30680764|NCT00735072|58694860|FG001|Overall Study|interrupted study med during ARV change|0|||
30680765|NCT00735072|58694859|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
30680766|NCT00735072|58694860|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
30680767|NCT00810641|58694871|FG000|Overall Study|Withdrawal by Subject|0|||
30680768|NCT00810641|58694872|FG001|Overall Study|Withdrawal by Subject|1|||
30680769|NCT00810641|58694873|FG002|Overall Study|Withdrawal by Subject|2|||
30680770|NCT00793598|58694886|FG000|Overall Study|Patient Request|0|||
30680771|NCT00793598|58694887|FG001|Overall Study|Patient Request|1|||
30680772|NCT00793598|58694888|FG002|Overall Study|Patient Request|0|||
30680773|NCT00793598|58694889|FG003|Overall Study|Patient Request|0|||
30959110|NCT01587079|59024252|FG000|Overall Study|Withdrawal by Subject|7|||
30959111|NCT01587079|59024252|FG000|Overall Study|Adverse Event|14|||
30959112|NCT01587001|59024305|FG000|Overall Study|Lost to Follow-up|2|||
30959113|NCT01587001|59024306|FG001|Overall Study|Lost to Follow-up|0|||
30959114|NCT01587001|59024305|FG000|Overall Study|Insufficient samples to complete testing|4|||
30959115|NCT01587001|59024306|FG001|Overall Study|Insufficient samples to complete testing|1|||
30959116|NCT01568047|59024336|FG000|Overall Study|Ineligibility|1|||
30959117|NCT01568047|59024337|FG001|Overall Study|Ineligibility|0|||
30959118|NCT01568047|59024338|FG002|Overall Study|Ineligibility|0|||
30959119|NCT01568047|59024339|FG003|Overall Study|Ineligibility|0|||
30959120|NCT01568047|59024336|FG000|Overall Study|Withdrawal by Subject|0|||
30595209|NCT01175590|58607584|FG000|Overall Study|Withdrawal by Subject|0|||
30595210|NCT01175590|58607585|FG001|Overall Study|Withdrawal by Subject|2|||
30595211|NCT01175590|58607584|FG000|Overall Study|Adverse Event|4|||
30595212|NCT01175590|58607585|FG001|Overall Study|Adverse Event|0|||
30595213|NCT01175590|58607584|FG000|Overall Study|Physician Decision|1|||
30595214|NCT01175590|58607585|FG001|Overall Study|Physician Decision|4|||
30595215|NCT01175590|58607584|FG000|Overall Study|Lack of Efficacy|1|||
30595216|NCT01175590|58607585|FG001|Overall Study|Lack of Efficacy|1|||
30595217|NCT01175590|58607584|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
30595218|NCT01175590|58607585|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
30595219|NCT01175590|58607584|FG000|Overall Study|Treated not as randomized|3|||
30595220|NCT01175590|58607585|FG001|Overall Study|Treated not as randomized|2|||
30595221|NCT01175590|58607584|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
30595222|NCT01175590|58607585|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
30595223|NCT01175590|58607584|FG000|Overall Study|Protocol Violation|0|||
30595224|NCT01175590|58607585|FG001|Overall Study|Protocol Violation|1|||
30595225|NCT01175473|58607594|FG000|Overall Study|Adverse Event|2|||
30595226|NCT01175473|58607595|FG001|Overall Study|Adverse Event|2|||
30595227|NCT01111552|58607601|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
30595228|NCT01111552|58607602|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
30595229|NCT01111552|58607603|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
30595230|NCT01111552|58607604|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
30595231|NCT01111552|58607605|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
30595232|NCT01111552|58607601|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
30595233|NCT01111552|58607602|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
30595234|NCT01111552|58607603|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
30595235|NCT01111552|58607604|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
30595236|NCT01111552|58607605|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
30595237|NCT01111552|58607601|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
30595238|NCT01111552|58607602|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
30595239|NCT01111552|58607603|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
30595240|NCT01111552|58607604|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
30595241|NCT01111552|58607605|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
30595242|NCT01111552|58607601|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
30680774|NCT00793598|58694890|FG004|Overall Study|Patient Request|0|||
30680775|NCT00793598|58694891|FG005|Overall Study|Patient Request|0|||
30595243|NCT01111552|58607602|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
30595244|NCT01111552|58607603|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
30595245|NCT01111552|58607604|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
30595246|NCT01111552|58607605|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
30680776|NCT00793598|58694892|FG006|Overall Study|Patient Request|0|||
30680777|NCT00793598|58694893|FG007|Overall Study|Patient Request|0|||
30680778|NCT00793598|58694886|FG000|Overall Study|Protocol Violation|0|||
30959121|NCT01568047|59024337|FG001|Overall Study|Withdrawal by Subject|1|||
30959122|NCT01568047|59024338|FG002|Overall Study|Withdrawal by Subject|0|||
30595247|NCT01111552|58607601|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
30595248|NCT01111552|58607602|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
30595249|NCT01111552|58607603|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
30595250|NCT01111552|58607604|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
30595251|NCT01111552|58607605|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
30595252|NCT01111552|58607601|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
30595253|NCT01111552|58607602|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
30595254|NCT01111552|58607603|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
30680779|NCT00793598|58694887|FG001|Overall Study|Protocol Violation|0|||
30680780|NCT00793598|58694888|FG002|Overall Study|Protocol Violation|0|||
30680781|NCT00793598|58694889|FG003|Overall Study|Protocol Violation|0|||
30680782|NCT00793598|58694890|FG004|Overall Study|Protocol Violation|0|||
30680783|NCT00793598|58694891|FG005|Overall Study|Protocol Violation|0|||
30680784|NCT00793598|58694892|FG006|Overall Study|Protocol Violation|0|||
30680785|NCT00793598|58694893|FG007|Overall Study|Protocol Violation|1|||
30680786|NCT00793598|58694886|FG000|Overall Study|Subject not dosed|0|||
30680787|NCT00793598|58694887|FG001|Overall Study|Subject not dosed|0|||
30680788|NCT00793598|58694888|FG002|Overall Study|Subject not dosed|0|||
30680789|NCT00793598|58694889|FG003|Overall Study|Subject not dosed|0|||
30680790|NCT00793598|58694890|FG004|Overall Study|Subject not dosed|0|||
30680791|NCT00793598|58694891|FG005|Overall Study|Subject not dosed|1|||
30595255|NCT01111552|58607604|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
30595256|NCT01111552|58607605|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
30595257|NCT01111552|58607601|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
30595258|NCT01111552|58607602|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
30680792|NCT00793598|58694892|FG006|Overall Study|Subject not dosed|0|||
30680793|NCT00793598|58694893|FG007|Overall Study|Subject not dosed|0|||
30680794|NCT00796562|58694915|FG000|Overall Study|Death|49|||
30680795|NCT00801632|58694919|FG000|Overall Study|Re-transplant|1|||
30680796|NCT00806819|58694925|FG000|Overall Study|progressive disease (modified RECIST )|217|||
30680797|NCT00806819|58694926|FG001|Overall Study|progressive disease (modified RECIST )|216|||
30680798|NCT00806819|58694925|FG000|Overall Study|Worsening or AE of underlying disease|18|||
30680799|NCT00806819|58694926|FG001|Overall Study|Worsening or AE of underlying disease|25|||
30680800|NCT00806819|58694925|FG000|Overall Study|Other AE|38|||
30680801|NCT00806819|58694926|FG001|Overall Study|Other AE|40|||
30680802|NCT00806819|58694925|FG000|Overall Study|Protocol Violation|9|||
30680803|NCT00806819|58694926|FG001|Overall Study|Protocol Violation|4|||
30680804|NCT00806819|58694925|FG000|Overall Study|Lost to Follow-up|1|||
30595259|NCT01111552|58607603|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
30595260|NCT01111552|58607604|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
30595261|NCT01111552|58607605|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
30595262|NCT01111552|58607601|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
30595263|NCT01111552|58607602|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
30595264|NCT01111552|58607603|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
30782955|NCT03337490|58795118|FG002|Overall Study|Lost to Follow-up|0|||
30782956|NCT02944448|58795128|FG000|Overall Study|Adverse Event|37|||
30782957|NCT02944448|58795129|FG001|Overall Study|Adverse Event|6|||
30595265|NCT01111552|58607604|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
30595266|NCT01111552|58607605|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
30595267|NCT01111552|58607601|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
30595268|NCT01111552|58607602|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
30595269|NCT01111552|58607603|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
30680805|NCT00806819|58694926|FG001|Overall Study|Lost to Follow-up|0|||
30680806|NCT00806819|58694925|FG000|Overall Study|Withdrawal by Subject|32|||
30680807|NCT00806819|58694926|FG001|Overall Study|Withdrawal by Subject|29|||
30680808|NCT00806819|58694925|FG000|Overall Study|Not treated|6|||
30680809|NCT00806819|58694926|FG001|Overall Study|Not treated|3|||
30782958|NCT02944448|58795128|FG000|Overall Study|Lack of Efficacy|8|||
30782959|NCT02944448|58795129|FG001|Overall Study|Lack of Efficacy|5|||
30680810|NCT00806819|58694925|FG000|Overall Study|Reasons other than stated above|25|||
30782960|NCT02944448|58795128|FG000|Overall Study|Lost to Follow-up|3|||
30782961|NCT02944448|58795129|FG001|Overall Study|Lost to Follow-up|1|||
30782962|NCT02944448|58795128|FG000|Overall Study|Protocol Violation|25|||
30782963|NCT02944448|58795129|FG001|Overall Study|Protocol Violation|7|||
30680811|NCT00806819|58694926|FG001|Overall Study|Reasons other than stated above|41|||
30680812|NCT00801242|58694933|FG000|Overall Study|Adverse Event|10|||
30680813|NCT00801242|58694933|FG000|Overall Study|Withdrawal by Subject|13|||
30680814|NCT00801242|58694933|FG000|Overall Study|Protocol Violation|5|||
30680815|NCT00801242|58694933|FG000|Overall Study|Physician Decision|3|||
30680816|NCT00801242|58694933|FG000|Overall Study|Lost to Follow-up|1|||
30680817|NCT00801242|58694933|FG000|Overall Study|Miscellaneous reasons|20|||
30680818|NCT00800540|58694946|FG000|Period One: 6 Weeks|Noncompliance|1|||
30680819|NCT00800540|58694947|FG001|Period One: 6 Weeks|Noncompliance|0|||
30782964|NCT02944448|58795128|FG000|Overall Study|Withdrawal by Subject|14|||
30595270|NCT01111552|58607604|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
30595271|NCT01111552|58607605|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
30595272|NCT01111552|58607601|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
30680820|NCT00800540|58694946|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
30680821|NCT00800540|58694947|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
30680822|NCT00800540|58694946|FG000|Period 2: 6 Weeks|Adverse Event|0|||
30680823|NCT00800540|58694947|FG001|Period 2: 6 Weeks|Adverse Event|1|||
30595273|NCT01111552|58607602|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
30595274|NCT01111552|58607603|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
30595275|NCT01111552|58607604|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
30595276|NCT01111552|58607605|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
30595277|NCT01111552|58607601|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
30595278|NCT01111552|58607602|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
30595279|NCT01111552|58607603|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
30595280|NCT01111552|58607604|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
30595281|NCT01111552|58607605|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
30595282|NCT01111552|58607601|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
30595283|NCT01111552|58607602|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
30595284|NCT01111552|58607603|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
30595285|NCT01111552|58607604|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
30680824|NCT00800384|58694955|FG000|Overall Study|Withdrawal by Subject|24|||
30680825|NCT00800384|58694956|FG001|Overall Study|Withdrawal by Subject|17|||
30680826|NCT00800384|58694955|FG000|Overall Study|Lost to Follow-up|17|||
30595286|NCT01111552|58607605|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
30595287|NCT01111552|58607601|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
30595288|NCT01111552|58607602|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
30595289|NCT01111552|58607603|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
30595290|NCT01111552|58607604|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
30595291|NCT01111552|58607605|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
30595292|NCT01111552|58607601|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
30595293|NCT01111552|58607602|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
30595294|NCT01111552|58607603|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
30595295|NCT01111552|58607604|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
30595296|NCT01111552|58607605|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
30595297|NCT01175083|58607621|FG000|Primary Epoch|Withdrawal by Subject|0|||
30680827|NCT00800384|58694956|FG001|Overall Study|Lost to Follow-up|26|||
30595298|NCT01175083|58607622|FG001|Primary Epoch|Withdrawal by Subject|0|||
30595299|NCT01175083|58607623|FG002|Primary Epoch|Withdrawal by Subject|0|||
30595300|NCT01175083|58607624|FG003|Primary Epoch|Withdrawal by Subject|0|||
30595301|NCT01175083|58607625|FG004|Primary Epoch|Withdrawal by Subject|0|||
30595302|NCT01175083|58607626|FG005|Primary Epoch|Withdrawal by Subject|2|||
30595303|NCT01175083|58607621|FG000|Primary Epoch|Lost to Follow-up|0|||
30595304|NCT01175083|58607622|FG001|Primary Epoch|Lost to Follow-up|0|||
30595305|NCT01175083|58607623|FG002|Primary Epoch|Lost to Follow-up|0|||
30680828|NCT00796328|58694963|FG000|Overall Study|experienced hypotension requiring tx|6|||
30782965|NCT02944448|58795129|FG001|Overall Study|Withdrawal by Subject|4|||
30782966|NCT02944448|58795128|FG000|Overall Study|Sponsor did not supply drug in time|0|||
30595306|NCT01175083|58607624|FG003|Primary Epoch|Lost to Follow-up|0|||
30595307|NCT01175083|58607625|FG004|Primary Epoch|Lost to Follow-up|0|||
30595308|NCT01175083|58607626|FG005|Primary Epoch|Lost to Follow-up|1|||
30595309|NCT01175083|58607621|FG000|Booster Epoch|Death|0|||
30595310|NCT01175083|58607622|FG001|Booster Epoch|Death|0|||
30595311|NCT01175083|58607623|FG002|Booster Epoch|Death|1|||
30595312|NCT01175083|58607624|FG003|Booster Epoch|Death|0|||
30595313|NCT01175083|58607625|FG004|Booster Epoch|Death|0|||
30595314|NCT01175083|58607626|FG005|Booster Epoch|Death|0|||
30595315|NCT01175083|58607621|FG000|Booster Epoch|Withdrawal by Subject|0|||
30595316|NCT01175083|58607622|FG001|Booster Epoch|Withdrawal by Subject|0|||
30595317|NCT01175083|58607623|FG002|Booster Epoch|Withdrawal by Subject|0|||
30595318|NCT01175083|58607624|FG003|Booster Epoch|Withdrawal by Subject|1|||
30680829|NCT00588692|58694969|FG000|Overall Study|Withdrawal by Subject|4|||
30595319|NCT01175083|58607625|FG004|Booster Epoch|Withdrawal by Subject|0|||
30595320|NCT01175083|58607626|FG005|Booster Epoch|Withdrawal by Subject|0|||
30595321|NCT01174459|58607644|FG000|Overall Study|case report form (CRF) not collected|5|||
30595322|NCT01174342|58607648|FG000|Overall Study|Conversion to cesarean section|4|||
30680830|NCT00588692|58694970|FG001|Overall Study|Withdrawal by Subject|2|||
30680831|NCT00588692|58694969|FG000|Overall Study|Hip Surgery|0|||
30782967|NCT02944448|58795129|FG001|Overall Study|Sponsor did not supply drug in time|1|||
30782968|NCT02944448|58795128|FG000|Overall Study|Noncompliant with dosing|1|||
30680832|NCT00588692|58694970|FG001|Overall Study|Hip Surgery|1|||
30680833|NCT00588692|58694969|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
30680834|NCT00588692|58694970|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
30680835|NCT00588692|58694969|FG000|Overall Study|Cancer|1|||
30680836|NCT00588692|58694970|FG001|Overall Study|Cancer|0|||
30680837|NCT00588692|58694969|FG000|Overall Study|Death|1|||
30680838|NCT00588692|58694970|FG001|Overall Study|Death|0|||
30680839|NCT00588146|58694978|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
30595323|NCT01111474|58607652|FG000|Overall Study|Lost to Follow-up|12|||
30595324|NCT01174264|58607661|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
30595325|NCT01174264|58607662|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
30595326|NCT01174264|58607663|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
30595327|NCT01174264|58607661|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
30595328|NCT01174264|58607662|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
30595329|NCT01174264|58607663|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
30595330|NCT01174264|58607661|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
30595331|NCT01174264|58607662|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
30595332|NCT01174264|58607663|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
30595333|NCT01174186|58607673|FG000|Overall Study|Lost to Follow-up|0|||
30595334|NCT01174186|58607674|FG001|Overall Study|Lost to Follow-up|1|||
30595335|NCT01174186|58607673|FG000|Overall Study|Withdrawal by Subject|0|||
30680840|NCT00588146|58694979|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
30680841|NCT00795704|58694987|FG000|Overall Study|Withdrawal by Subject|3|||
30680842|NCT00795704|58694988|FG001|Overall Study|Withdrawal by Subject|2|||
30680843|NCT00795704|58694987|FG000|Overall Study|Adverse Event|1|||
30680844|NCT00795704|58694988|FG001|Overall Study|Adverse Event|1|||
30680845|NCT00444457|58694998|FG000|Infant Series|Other|0|||
30680846|NCT00444457|58694999|FG001|Infant Series|Other|1|||
30680847|NCT00444457|58695000|FG002|Infant Series|Other|0|||
30680848|NCT00444457|58695001|FG003|Infant Series|Other|0|||
30680849|NCT00444457|58694998|FG000|Infant Series|Parent or legal guardian request|18|||
30680850|NCT00444457|58694999|FG001|Infant Series|Parent or legal guardian request|29|||
30680851|NCT00444457|58695000|FG002|Infant Series|Parent or legal guardian request|34|||
30680852|NCT00444457|58695001|FG003|Infant Series|Parent or legal guardian request|14|||
30680853|NCT00444457|58694998|FG000|Infant Series|Lost to Follow-up|10|||
30680854|NCT00444457|58694999|FG001|Infant Series|Lost to Follow-up|11|||
30680855|NCT00444457|58695000|FG002|Infant Series|Lost to Follow-up|7|||
30680856|NCT00444457|58695001|FG003|Infant Series|Lost to Follow-up|6|||
30680857|NCT00444457|58694998|FG000|Infant Series|Protocol Violation|16|||
30680858|NCT00444457|58694999|FG001|Infant Series|Protocol Violation|8|||
30680859|NCT00444457|58695000|FG002|Infant Series|Protocol Violation|6|||
30680860|NCT00444457|58695001|FG003|Infant Series|Protocol Violation|3|||
30680861|NCT00444457|58694998|FG000|Infant Series|Failed to return|5|||
30680862|NCT00444457|58694999|FG001|Infant Series|Failed to return|4|||
30680863|NCT00444457|58695000|FG002|Infant Series|Failed to return|4|||
30680864|NCT00444457|58695001|FG003|Infant Series|Failed to return|2|||
30680865|NCT00444457|58694998|FG000|Infant Series|Investigator request|4|||
30680866|NCT00444457|58694999|FG001|Infant Series|Investigator request|3|||
30680867|NCT00444457|58695000|FG002|Infant Series|Investigator request|3|||
30680868|NCT00444457|58695001|FG003|Infant Series|Investigator request|2|||
30680869|NCT00444457|58694998|FG000|Infant Series|Other|0|||
30680870|NCT00444457|58694999|FG001|Infant Series|Other|2|||
30680871|NCT00444457|58695000|FG002|Infant Series|Other|4|||
30680872|NCT00444457|58695001|FG003|Infant Series|Other|0|||
30680873|NCT00444457|58694998|FG000|Infant Series|Adverse Event|1|||
30680874|NCT00444457|58694999|FG001|Infant Series|Adverse Event|2|||
30680875|NCT00444457|58695000|FG002|Infant Series|Adverse Event|2|||
30680876|NCT00444457|58695001|FG003|Infant Series|Adverse Event|0|||
30680877|NCT00444457|58694998|FG000|Infant Series|Death|0|||
30680878|NCT00444457|58694999|FG001|Infant Series|Death|1|||
30680879|NCT00444457|58695000|FG002|Infant Series|Death|1|||
30680880|NCT00444457|58695001|FG003|Infant Series|Death|1|||
30680881|NCT00444457|58694998|FG000|After Infant Series|Other|0|||
30782969|NCT02944448|58795129|FG001|Overall Study|Noncompliant with dosing|0|||
30877167|NCT00106691|58908831|FG001|Overall Study|Protocol Violation|18|||
30680882|NCT00444457|58694999|FG001|After Infant Series|Other|1|||
30680883|NCT00444457|58695000|FG002|After Infant Series|Other|1|||
30680884|NCT00444457|58695001|FG003|After Infant Series|Other|1|||
30680885|NCT00444457|58694998|FG000|After Infant Series|Parent or legal guardian request|4|||
30680886|NCT00444457|58694999|FG001|After Infant Series|Parent or legal guardian request|11|||
30680887|NCT00444457|58695000|FG002|After Infant Series|Parent or legal guardian request|6|||
30680888|NCT00444457|58695001|FG003|After Infant Series|Parent or legal guardian request|3|||
30680889|NCT00444457|58694998|FG000|After Infant Series|Failed to return|7|||
30680890|NCT00444457|58694999|FG001|After Infant Series|Failed to return|6|||
30680891|NCT00444457|58695000|FG002|After Infant Series|Failed to return|5|||
30680892|NCT00444457|58695001|FG003|After Infant Series|Failed to return|1|||
30680893|NCT00444457|58694998|FG000|After Infant Series|Lost to Follow-up|5|||
30595336|NCT01174186|58607674|FG001|Overall Study|Withdrawal by Subject|2|||
30680894|NCT00444457|58694999|FG001|After Infant Series|Lost to Follow-up|5|||
30680895|NCT00444457|58695000|FG002|After Infant Series|Lost to Follow-up|5|||
30680896|NCT00444457|58695001|FG003|After Infant Series|Lost to Follow-up|2|||
30595337|NCT01173718|58607680|FG000|Overall Study|Death|17|||
30595338|NCT01173718|58607680|FG000|Overall Study|Abandonment of study graft|27|||
30680897|NCT00444457|58694998|FG000|After Infant Series|Protocol Violation|2|||
30595339|NCT01111240|58607684|FG000|Overall Study|Adverse Event|190|||
30595340|NCT01111240|58607684|FG000|Overall Study|Lack of Efficacy|545|||
30595341|NCT01111240|58607684|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
30595342|NCT01111240|58607684|FG000|Overall Study|Other|312|||
30595343|NCT01111123|58607690|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
30595344|NCT01111123|58607691|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
30595345|NCT01111123|58607690|FG000|Maintenance Phase|Lost to Follow-up|0|||
30680898|NCT00444457|58694999|FG001|After Infant Series|Protocol Violation|4|||
30782970|NCT02944448|58795128|FG000|Overall Study|Abnormal laboratory values|1|||
30595346|NCT01111123|58607691|FG001|Maintenance Phase|Lost to Follow-up|2|||
30595347|NCT01173679|58607699|FG000|Overall Study|Death|1|||
30595348|NCT01110382|58607706|FG000|Overall Study|Withdrawal by Subject|0|||
30595349|NCT01110382|58607707|FG001|Overall Study|Withdrawal by Subject|1|||
30595350|NCT01110382|58607706|FG000|Overall Study|Protocol Violation|0|||
30595351|NCT01110382|58607707|FG001|Overall Study|Protocol Violation|1|||
30595352|NCT01173601|58607717|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
30595353|NCT01173601|58607718|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
30595354|NCT01173601|58607719|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
30595355|NCT01173601|58607720|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
30595356|NCT01173601|58607721|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
30595357|NCT01173601|58607717|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
30595358|NCT01173601|58607718|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
30595359|NCT01173601|58607719|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
30680899|NCT00444457|58695000|FG002|After Infant Series|Protocol Violation|2|||
30680900|NCT00444457|58695001|FG003|After Infant Series|Protocol Violation|2|||
30782971|NCT02944448|58795129|FG001|Overall Study|Abnormal laboratory values|0|||
30782972|NCT02943668|58795136|FG000|Overall Study|Disease Progression|1|||
30782973|NCT02891408|58795171|FG000|Overall Study|Lost to Follow-up|0|||
30782974|NCT02891408|58795172|FG001|Overall Study|Lost to Follow-up|0|||
30782975|NCT02891408|58795173|FG002|Overall Study|Lost to Follow-up|1|||
30782976|NCT02891408|58795174|FG003|Overall Study|Lost to Follow-up|0|||
30782977|NCT02891408|58795175|FG004|Overall Study|Lost to Follow-up|0|||
30782978|NCT02891408|58795176|FG005|Overall Study|Lost to Follow-up|0|||
30782979|NCT02891408|58795177|FG006|Overall Study|Lost to Follow-up|0|||
30782980|NCT03283670|58795203|FG000|Placebo Gas|Withdrawal by Subject|2|||
30782981|NCT03283670|58795203|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
30782982|NCT03283670|58795203|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
30782983|NCT01358578|58795224|FG000|Induction Period|Adverse Event|2|||
30782984|NCT01358578|58795225|FG001|Induction Period|Adverse Event|4|||
30782985|NCT01358578|58795226|FG002|Induction Period|Adverse Event|2|||
30782986|NCT01358578|58795227|FG003|Induction Period|Adverse Event|6|||
30782987|NCT01358578|58795228|FG004|Induction Period|Adverse Event|0|||
30782988|NCT01358578|58795229|FG005|Induction Period|Adverse Event|0|||
30782989|NCT01358578|58795224|FG000|Induction Period|Lack of Efficacy|0|||
30782990|NCT01358578|58795225|FG001|Induction Period|Lack of Efficacy|0|||
30782991|NCT01358578|58795226|FG002|Induction Period|Lack of Efficacy|9|||
30782992|NCT01358578|58795227|FG003|Induction Period|Lack of Efficacy|1|||
30782993|NCT01358578|58795228|FG004|Induction Period|Lack of Efficacy|0|||
30782994|NCT01358578|58795229|FG005|Induction Period|Lack of Efficacy|0|||
30782995|NCT01358578|58795224|FG000|Induction Period|Lost to Follow-up|0|||
30782996|NCT01358578|58795225|FG001|Induction Period|Lost to Follow-up|0|||
30782997|NCT01358578|58795226|FG002|Induction Period|Lost to Follow-up|1|||
30782998|NCT01358578|58795227|FG003|Induction Period|Lost to Follow-up|4|||
30782999|NCT01358578|58795228|FG004|Induction Period|Lost to Follow-up|0|||
30783000|NCT01358578|58795229|FG005|Induction Period|Lost to Follow-up|0|||
30783001|NCT01358578|58795224|FG000|Induction Period|Physician Decision|2|||
30783002|NCT01358578|58795225|FG001|Induction Period|Physician Decision|1|||
30783003|NCT01358578|58795226|FG002|Induction Period|Physician Decision|2|||
30783004|NCT01358578|58795227|FG003|Induction Period|Physician Decision|0|||
30783005|NCT01358578|58795228|FG004|Induction Period|Physician Decision|0|||
30595360|NCT01173601|58607720|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
30680901|NCT00444457|58694998|FG000|After Infant Series|Adverse Event|2|||
30680902|NCT00444457|58694999|FG001|After Infant Series|Adverse Event|2|||
30595361|NCT01173601|58607721|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
30595362|NCT01173601|58607717|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
30595363|NCT01173601|58607718|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
30595364|NCT01173601|58607719|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
30680903|NCT00444457|58695000|FG002|After Infant Series|Adverse Event|0|||
30680904|NCT00444457|58695001|FG003|After Infant Series|Adverse Event|0|||
30680905|NCT00444457|58694998|FG000|After Infant Series|Investigator request|0|||
30680906|NCT00444457|58694999|FG001|After Infant Series|Investigator request|0|||
30680907|NCT00444457|58695000|FG002|After Infant Series|Investigator request|0|||
30680908|NCT00444457|58695001|FG003|After Infant Series|Investigator request|1|||
30680909|NCT00444457|58694998|FG000|After Infant Series|Other|0|||
30680910|NCT00444457|58694999|FG001|After Infant Series|Other|1|||
30680911|NCT00444457|58695000|FG002|After Infant Series|Other|0|||
30680912|NCT00444457|58695001|FG003|After Infant Series|Other|0|||
30680913|NCT00444457|58694998|FG000|Toddler Dose|Lost to Follow-up|4|||
30680914|NCT00444457|58694999|FG001|Toddler Dose|Lost to Follow-up|1|||
30680915|NCT00444457|58695000|FG002|Toddler Dose|Lost to Follow-up|1|||
30680916|NCT00444457|58695001|FG003|Toddler Dose|Lost to Follow-up|3|||
30680917|NCT00444457|58694998|FG000|Toddler Dose|Failed to return|2|||
30680918|NCT00444457|58694999|FG001|Toddler Dose|Failed to return|2|||
30680919|NCT00444457|58695000|FG002|Toddler Dose|Failed to return|1|||
30680920|NCT00444457|58695001|FG003|Toddler Dose|Failed to return|3|||
30680921|NCT00444457|58694998|FG000|Toddler Dose|Parent or legal guardian request|0|||
30680922|NCT00444457|58694999|FG001|Toddler Dose|Parent or legal guardian request|3|||
30680923|NCT00444457|58695000|FG002|Toddler Dose|Parent or legal guardian request|2|||
30680924|NCT00444457|58695001|FG003|Toddler Dose|Parent or legal guardian request|1|||
30680925|NCT00444457|58694998|FG000|Toddler Dose|Protocol Violation|1|||
30680926|NCT00444457|58694999|FG001|Toddler Dose|Protocol Violation|0|||
30680927|NCT00444457|58695000|FG002|Toddler Dose|Protocol Violation|0|||
30680928|NCT00444457|58695001|FG003|Toddler Dose|Protocol Violation|1|||
30680929|NCT00799058|58695025|FG000|Overall Study|Withdrawal by Subject|2|||
30680930|NCT00799058|58695026|FG001|Overall Study|Withdrawal by Subject|2|||
30680931|NCT00799058|58695027|FG002|Overall Study|Withdrawal by Subject|2|||
30680932|NCT00799058|58695025|FG000|Overall Study|Lost to Follow-up|1|||
30680933|NCT00799058|58695026|FG001|Overall Study|Lost to Follow-up|2|||
30680934|NCT00799058|58695027|FG002|Overall Study|Lost to Follow-up|1|||
30680935|NCT00799058|58695025|FG000|Overall Study|Adverse Event|0|||
30680936|NCT00799058|58695026|FG001|Overall Study|Adverse Event|2|||
30680937|NCT00799058|58695027|FG002|Overall Study|Adverse Event|0|||
30680938|NCT00799058|58695025|FG000|Overall Study|Pregnancy|1|||
30680939|NCT00799058|58695026|FG001|Overall Study|Pregnancy|0|||
30680940|NCT00799058|58695027|FG002|Overall Study|Pregnancy|0|||
30680941|NCT00799058|58695025|FG000|Overall Study|Not adherent|3|||
30680942|NCT00799058|58695026|FG001|Overall Study|Not adherent|2|||
30680943|NCT00799058|58695027|FG002|Overall Study|Not adherent|1|||
30680944|NCT00799058|58695025|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
30783006|NCT01358578|58795229|FG005|Induction Period|Physician Decision|0|||
30595365|NCT01173601|58607720|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
30595366|NCT01173601|58607721|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
30595367|NCT01173601|58607717|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
30595368|NCT01173601|58607718|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
30595369|NCT01173601|58607719|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
30595370|NCT01173601|58607720|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
30595371|NCT01173601|58607721|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
30595372|NCT01173601|58607717|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
30595373|NCT01173601|58607718|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
30595374|NCT01173601|58607719|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
30595375|NCT01173601|58607720|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
30595376|NCT01173601|58607721|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
30595377|NCT01173601|58607717|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
30595378|NCT01173601|58607718|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
30680945|NCT00799058|58695026|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
30680946|NCT00799058|58695027|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
30680947|NCT00799058|58695025|FG000|Overall Study|IP dispensing error|1|||
30680948|NCT00799058|58695026|FG001|Overall Study|IP dispensing error|0|||
30680949|NCT00799058|58695027|FG002|Overall Study|IP dispensing error|0|||
30680950|NCT00799058|58695025|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
30680951|NCT00799058|58695026|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
30680952|NCT00799058|58695027|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
30680953|NCT00799058|58695025|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
30680954|NCT00799058|58695026|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
30680955|NCT00799058|58695027|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
30595379|NCT01173601|58607719|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
30595380|NCT01173601|58607720|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
30595381|NCT01173601|58607721|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
30595382|NCT01173601|58607717|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
30595383|NCT01173601|58607718|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
30595384|NCT01173601|58607719|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
30595385|NCT01173601|58607720|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
30595386|NCT01173601|58607721|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
30595387|NCT01173601|58607717|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
30595388|NCT01173601|58607718|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
30680956|NCT00799058|58695025|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
30680957|NCT00799058|58695026|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
30680958|NCT00799058|58695027|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
30680959|NCT00799058|58695025|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
30680960|NCT00799058|58695026|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
30680961|NCT00799058|58695027|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
30680962|NCT00725985|58695040|FG000|ITP- Treatment Disposition|Adverse Event|20|||
30680963|NCT00725985|58695041|FG001|ITP- Treatment Disposition|Adverse Event|10|||
30680964|NCT00725985|58695042|FG002|ITP- Treatment Disposition|Adverse Event|5|||
30680965|NCT00725985|58695043|FG003|ITP- Treatment Disposition|Adverse Event|0|||
30680966|NCT00725985|58695044|FG004|ITP- Treatment Disposition|Adverse Event|0|||
30680967|NCT00725985|58695045|FG005|ITP- Treatment Disposition|Adverse Event|0|||
30680968|NCT00725985|58695046|FG006|ITP- Treatment Disposition|Adverse Event|0|||
30680969|NCT00725985|58695047|FG007|ITP- Treatment Disposition|Adverse Event|0|||
30680970|NCT00725985|58695048|FG008|ITP- Treatment Disposition|Adverse Event|0|||
30680971|NCT00725985|58695049|FG009|ITP- Treatment Disposition|Adverse Event|0|||
30680972|NCT00725985|58695050|FG010|ITP- Treatment Disposition|Adverse Event|0|||
30680973|NCT00725985|58695051|FG011|ITP- Treatment Disposition|Adverse Event|0|||
30680974|NCT00725985|58695040|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
30680975|NCT00725985|58695041|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
30680976|NCT00725985|58695042|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
30680977|NCT00725985|58695043|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
30680978|NCT00725985|58695044|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
30680979|NCT00725985|58695045|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
30680980|NCT00725985|58695046|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
30680981|NCT00725985|58695047|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
30680982|NCT00725985|58695048|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
30680983|NCT00725985|58695049|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
30680984|NCT00725985|58695050|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
30680985|NCT00725985|58695051|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
30680986|NCT00725985|58695040|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
30680987|NCT00725985|58695041|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
30680988|NCT00725985|58695042|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
30680989|NCT00725985|58695043|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
30680990|NCT00725985|58695044|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
30680991|NCT00725985|58695045|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
30680992|NCT00725985|58695046|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
30680993|NCT00725985|58695047|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
30680994|NCT00725985|58695048|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
30680995|NCT00725985|58695049|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
30680996|NCT00725985|58695050|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
30680997|NCT00725985|58695051|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
30680998|NCT00725985|58695040|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
30680999|NCT00725985|58695041|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
30681000|NCT00725985|58695042|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
30681001|NCT00725985|58695043|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
30681002|NCT00725985|58695044|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
30681003|NCT00725985|58695045|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
30681004|NCT00725985|58695046|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
30681005|NCT00725985|58695047|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
30681006|NCT00725985|58695048|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
30681007|NCT00725985|58695049|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
30681008|NCT00725985|58695050|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
30783007|NCT01358578|58795224|FG000|Induction Period|Protocol Deviation|3|||
30595389|NCT01173601|58607719|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
30595390|NCT01173601|58607720|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
30783008|NCT01358578|58795225|FG001|Induction Period|Protocol Deviation|5|||
30959123|NCT01568047|59024339|FG003|Overall Study|Withdrawal by Subject|0|||
30681009|NCT00725985|58695051|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
30681010|NCT00725985|58695040|FG000|ITP- Treatment Disposition|Other|50|||
30681011|NCT00725985|58695041|FG001|ITP- Treatment Disposition|Other|38|||
30681012|NCT00725985|58695042|FG002|ITP- Treatment Disposition|Other|24|||
30681013|NCT00725985|58695043|FG003|ITP- Treatment Disposition|Other|0|||
30681014|NCT00725985|58695044|FG004|ITP- Treatment Disposition|Other|0|||
30681015|NCT00725985|58695045|FG005|ITP- Treatment Disposition|Other|0|||
30681016|NCT00725985|58695046|FG006|ITP- Treatment Disposition|Other|0|||
30681017|NCT00725985|58695047|FG007|ITP- Treatment Disposition|Other|0|||
30681018|NCT00725985|58695048|FG008|ITP- Treatment Disposition|Other|0|||
30681019|NCT00725985|58695049|FG009|ITP- Treatment Disposition|Other|0|||
30681020|NCT00725985|58695050|FG010|ITP- Treatment Disposition|Other|0|||
30681021|NCT00725985|58695051|FG011|ITP- Treatment Disposition|Other|0|||
30681022|NCT00725985|58695040|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
30681023|NCT00725985|58695041|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
30681024|NCT00725985|58695042|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
30681025|NCT00725985|58695043|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
30681026|NCT00725985|58695044|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
30681027|NCT00725985|58695045|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
30681028|NCT00725985|58695046|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
30681029|NCT00725985|58695047|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
30681030|NCT00725985|58695048|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
30681031|NCT00725985|58695049|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
30681032|NCT00725985|58695050|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
30681033|NCT00725985|58695051|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
30681034|NCT00725985|58695040|FG000|OLMP (Up to 96 Weeks)|Death|0|||
30681035|NCT00725985|58695041|FG001|OLMP (Up to 96 Weeks)|Death|0|||
30681036|NCT00725985|58695042|FG002|OLMP (Up to 96 Weeks)|Death|0|||
30681037|NCT00725985|58695043|FG003|OLMP (Up to 96 Weeks)|Death|0|||
30681038|NCT00725985|58695044|FG004|OLMP (Up to 96 Weeks)|Death|1|||
30681039|NCT00725985|58695045|FG005|OLMP (Up to 96 Weeks)|Death|0|||
30681040|NCT00725985|58695046|FG006|OLMP (Up to 96 Weeks)|Death|0|||
30681041|NCT00725985|58695047|FG007|OLMP (Up to 96 Weeks)|Death|0|||
30681042|NCT00725985|58695048|FG008|OLMP (Up to 96 Weeks)|Death|0|||
30681043|NCT00725985|58695049|FG009|OLMP (Up to 96 Weeks)|Death|0|||
30681044|NCT00725985|58695050|FG010|OLMP (Up to 96 Weeks)|Death|0|||
30681045|NCT00725985|58695051|FG011|OLMP (Up to 96 Weeks)|Death|0|||
30681046|NCT00725985|58695040|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
30681047|NCT00725985|58695041|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
30681048|NCT00725985|58695042|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
30681049|NCT00725985|58695043|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
30681050|NCT00725985|58695044|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
30681051|NCT00725985|58695045|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
30681052|NCT00725985|58695046|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
30681053|NCT00725985|58695047|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
30681054|NCT00725985|58695048|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
30681055|NCT00725985|58695049|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
30681056|NCT00725985|58695050|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
30681057|NCT00725985|58695051|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
30681058|NCT00725985|58695040|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
30681059|NCT00725985|58695041|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
30681060|NCT00725985|58695042|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
30681061|NCT00725985|58695043|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
30681062|NCT00725985|58695044|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
30681063|NCT00725985|58695045|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
30681064|NCT00725985|58695046|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
30681065|NCT00725985|58695047|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
30681066|NCT00725985|58695048|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
30681067|NCT00725985|58695049|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
30681068|NCT00725985|58695050|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
30856182|NCT03450707|58884058|FG001|Overall Study|Evidence of traumatic brain injury|0|||
30681069|NCT00725985|58695051|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
30681070|NCT00725985|58695040|FG000|OLMP (Up to 96 Weeks)|Other|0|||
30681071|NCT00725985|58695041|FG001|OLMP (Up to 96 Weeks)|Other|0|||
30681072|NCT00725985|58695042|FG002|OLMP (Up to 96 Weeks)|Other|0|||
30681073|NCT00725985|58695043|FG003|OLMP (Up to 96 Weeks)|Other|15|||
30681074|NCT00725985|58695044|FG004|OLMP (Up to 96 Weeks)|Other|20|||
30681075|NCT00725985|58695045|FG005|OLMP (Up to 96 Weeks)|Other|44|||
30681076|NCT00725985|58695046|FG006|OLMP (Up to 96 Weeks)|Other|0|||
30681077|NCT00725985|58695047|FG007|OLMP (Up to 96 Weeks)|Other|0|||
30681078|NCT00725985|58695048|FG008|OLMP (Up to 96 Weeks)|Other|0|||
30681079|NCT00725985|58695049|FG009|OLMP (Up to 96 Weeks)|Other|0|||
30681080|NCT00725985|58695050|FG010|OLMP (Up to 96 Weeks)|Other|0|||
30681081|NCT00725985|58695051|FG011|OLMP (Up to 96 Weeks)|Other|0|||
30681082|NCT00725985|58695040|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
30681083|NCT00725985|58695041|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
30681084|NCT00725985|58695042|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
30681085|NCT00725985|58695043|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
30681086|NCT00725985|58695044|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
30681087|NCT00725985|58695045|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
30681088|NCT00725985|58695046|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
30681089|NCT00725985|58695047|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
30681090|NCT00725985|58695048|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
30681091|NCT00725985|58695049|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
30681092|NCT00725985|58695050|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
30681093|NCT00725985|58695051|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
30681094|NCT00725985|58695040|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
30681095|NCT00725985|58695041|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
30681096|NCT00725985|58695042|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
30681097|NCT00725985|58695043|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
30681098|NCT00725985|58695044|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
30681099|NCT00725985|58695045|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
30681100|NCT00725985|58695046|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
30595391|NCT01173601|58607721|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
30681101|NCT00725985|58695047|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
30681102|NCT00725985|58695048|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
30681103|NCT00725985|58695049|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
30681104|NCT00725985|58695050|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
30681105|NCT00725985|58695051|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
30681106|NCT00725985|58695040|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
30681107|NCT00725985|58695041|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
30595392|NCT01173601|58607717|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
30595393|NCT01173601|58607718|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
30595394|NCT01173601|58607719|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
30595395|NCT01173601|58607720|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
30595396|NCT01173601|58607721|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
30681108|NCT00725985|58695042|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
30681109|NCT00725985|58695043|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
30681110|NCT00725985|58695044|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
30681111|NCT00725985|58695045|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
30681112|NCT00725985|58695046|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
30681113|NCT00725985|58695047|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
30681114|NCT00725985|58695048|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
30681115|NCT00725985|58695049|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
30681116|NCT00725985|58695050|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
30681117|NCT00725985|58695051|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
30681118|NCT00725985|58695040|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
30681119|NCT00725985|58695041|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
30681120|NCT00725985|58695042|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
30681121|NCT00725985|58695043|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
30681122|NCT00725985|58695044|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
30681123|NCT00725985|58695045|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
30681124|NCT00725985|58695046|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
30681125|NCT00725985|58695047|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
30681126|NCT00725985|58695048|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
30681127|NCT00725985|58695049|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
30681128|NCT00725985|58695050|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
30681129|NCT00725985|58695051|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
30681130|NCT00793910|58695079|FG000|Overall Study|discarded study pills|0|||
30681131|NCT00793910|58695080|FG001|Overall Study|discarded study pills|1|||
30681132|NCT00793910|58695079|FG000|Overall Study|did not pick up medications|1|||
30681133|NCT00793910|58695080|FG001|Overall Study|did not pick up medications|1|||
30681134|NCT00793910|58695079|FG000|Overall Study|ineligible based on entry criteria|2|||
30681135|NCT00793910|58695080|FG001|Overall Study|ineligible based on entry criteria|3|||
30681136|NCT00793910|58695079|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
30783009|NCT01358578|58795226|FG002|Induction Period|Protocol Deviation|0|||
30681137|NCT00793910|58695080|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
30783010|NCT01358578|58795227|FG003|Induction Period|Protocol Deviation|3|||
30783011|NCT01358578|58795228|FG004|Induction Period|Protocol Deviation|0|||
30681138|NCT00793910|58695079|FG000|Overall Study|Withdrawal by Subject|0|||
30681139|NCT00793910|58695080|FG001|Overall Study|Withdrawal by Subject|1|||
30681140|NCT00444145|58695086|FG000|Overall Study|Withdrawal by Subject|2|||
30681141|NCT00444145|58695086|FG000|Overall Study|Lost to Follow-up|1|||
30681142|NCT00444145|58695086|FG000|Overall Study|non-compliant|11|||
30681143|NCT00444145|58695086|FG000|Overall Study|Screen Failures|5|||
30681144|NCT00725283|58695090|FG000|Overall Study|Missing Code|3|||
30783012|NCT01358578|58795229|FG005|Induction Period|Protocol Deviation|0|||
30595397|NCT01173601|58607717|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
30595398|NCT01173601|58607718|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
30595399|NCT01173601|58607719|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
30595400|NCT01173601|58607720|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
30595401|NCT01173601|58607721|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
30595402|NCT01173601|58607717|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
30595403|NCT01173601|58607718|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
30595404|NCT01173601|58607719|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
30681145|NCT00725283|58695090|FG000|Overall Study|Death|5|||
30681146|NCT00725283|58695090|FG000|Overall Study|Other|6|||
30681147|NCT00725283|58695090|FG000|Overall Study|Withdrawal by Subject|10|||
30681148|NCT00444067|58695096|FG000|Overall Study|Lost to Follow-up|0|||
30681149|NCT00444067|58695097|FG001|Overall Study|Lost to Follow-up|1|||
30681150|NCT00789854|58695106|FG000|Overall Study|Adverse Event|28|||
30681151|NCT00789854|58695107|FG001|Overall Study|Adverse Event|23|||
30681152|NCT00789854|58695108|FG002|Overall Study|Adverse Event|18|||
30681153|NCT00789854|58695106|FG000|Overall Study|Lost to Follow-up|1|||
30681154|NCT00789854|58695107|FG001|Overall Study|Lost to Follow-up|1|||
30681155|NCT00789854|58695108|FG002|Overall Study|Lost to Follow-up|4|||
30681156|NCT00789854|58695106|FG000|Overall Study|Withdrawal by Subject|9|||
30681157|NCT00789854|58695107|FG001|Overall Study|Withdrawal by Subject|6|||
30681158|NCT00789854|58695108|FG002|Overall Study|Withdrawal by Subject|17|||
30681159|NCT00789854|58695106|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
30681160|NCT00789854|58695107|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
30681161|NCT00789854|58695108|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
30681162|NCT00789854|58695106|FG000|Overall Study|Severe non-compliance to the protocol|3|||
30681163|NCT00789854|58695107|FG001|Overall Study|Severe non-compliance to the protocol|0|||
30681164|NCT00789854|58695108|FG002|Overall Study|Severe non-compliance to the protocol|0|||
30681165|NCT00789854|58695106|FG000|Overall Study|Safety reasons|0|||
30681166|NCT00789854|58695107|FG001|Overall Study|Safety reasons|0|||
30681167|NCT00789854|58695108|FG002|Overall Study|Safety reasons|2|||
30681168|NCT00789854|58695106|FG000|Overall Study|Other|6|||
30681169|NCT00789854|58695107|FG001|Overall Study|Other|0|||
30681170|NCT00789854|58695108|FG002|Overall Study|Other|5|||
30681171|NCT00725205|58695116|FG000|Overall Study|Adverse Event|22|||
30681172|NCT00725205|58695116|FG000|Overall Study|Investigator Discontinued|1|||
30681173|NCT00725205|58695116|FG000|Overall Study|Non-compliance With Protocol|14|||
30681174|NCT00725205|58695116|FG000|Overall Study|Other|8|||
30681175|NCT00725205|58695116|FG000|Overall Study|Protocol Defined Clinical Event|1|||
30681176|NCT00725205|58695116|FG000|Overall Study|Treatment Failure|41|||
30681177|NCT00443755|58695122|FG000|Overall Study|Withdrawal by Subject|2|||
30681178|NCT00443755|58695123|FG001|Overall Study|Withdrawal by Subject|1|||
30681179|NCT00724971|58695129|FG000|Overall Study|Adverse Event|5|||
30681180|NCT00724971|58695129|FG000|Overall Study|Withdrawal by Subject|1|||
30681181|NCT00443599|58695135|FG000|Overall Study|Physician Decision|2|||
30681182|NCT00443599|58695136|FG001|Overall Study|Physician Decision|1|||
30681183|NCT00443599|58695135|FG000|Overall Study|Death|1|||
30681184|NCT00443599|58695136|FG001|Overall Study|Death|1|||
30681185|NCT00443599|58695135|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
30681186|NCT00443599|58695136|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
30681187|NCT00455143|58695142|FG000|Overall Study|Physician Decision|1|||
30681188|NCT00455143|58695142|FG000|Overall Study|Withdrawal by Subject|1|||
30681189|NCT00455143|58695142|FG000|Overall Study|Staff was not avail to follow patient|2|||
30681190|NCT00455143|58695142|FG000|Overall Study|No longer met Inclusion Criteria|1|||
30681191|NCT00455143|58695142|FG000|Overall Study|Surgical time, staff not available|1|||
30681192|NCT00454987|58695150|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
30681193|NCT00454987|58695151|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
30681194|NCT00454987|58695152|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
30681195|NCT00454987|58695150|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
30681196|NCT00454987|58695151|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
30681197|NCT00454987|58695152|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
30681198|NCT00454987|58695150|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
30681199|NCT00454987|58695151|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
30783013|NCT01358578|58795224|FG000|Induction Period|technical problems|0|||
30783014|NCT01358578|58795225|FG001|Induction Period|technical problems|0|||
30681200|NCT00454987|58695152|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
30681201|NCT00724893|58695163|FG000|Overall Study|Adverse Event|76|||
30681202|NCT00724893|58695164|FG001|Overall Study|Adverse Event|142|||
30681203|NCT00724893|58695163|FG000|Overall Study|Withdrawal by Subject|0|||
30681204|NCT00724893|58695164|FG001|Overall Study|Withdrawal by Subject|1|||
30681205|NCT00724893|58695163|FG000|Overall Study|Lack of virologic response|94|||
30681206|NCT00724893|58695164|FG001|Overall Study|Lack of virologic response|202|||
30681207|NCT00724893|58695163|FG000|Overall Study|Reason not specified|193|||
30681208|NCT00724893|58695164|FG001|Overall Study|Reason not specified|7|||
30681209|NCT00724893|58695163|FG000|Overall Study|Patient choice|0|||
30681210|NCT00724893|58695164|FG001|Overall Study|Patient choice|26|||
30681211|NCT00724893|58695163|FG000|Overall Study|Geographic reasons|0|||
30681212|NCT00724893|58695164|FG001|Overall Study|Geographic reasons|11|||
30681213|NCT00724893|58695163|FG000|Overall Study|Incarceration|0|||
30681214|NCT00724893|58695164|FG001|Overall Study|Incarceration|9|||
30681215|NCT00724893|58695163|FG000|Overall Study|Substance abuse|0|||
30681216|NCT00724893|58695164|FG001|Overall Study|Substance abuse|3|||
30681217|NCT00724893|58695163|FG000|Overall Study|Financial reasons|0|||
30681218|NCT00724893|58695164|FG001|Overall Study|Financial reasons|2|||
30681219|NCT00724893|58695163|FG000|Overall Study|Assigned shorter treatment|0|||
30681220|NCT00724893|58695164|FG001|Overall Study|Assigned shorter treatment|2|||
30681221|NCT00724893|58695163|FG000|Overall Study|Lost to Follow-up|0|||
30681222|NCT00724893|58695164|FG001|Overall Study|Lost to Follow-up|52|||
30681223|NCT00724893|58695163|FG000|Overall Study|Unknown, missing data|1|||
30681224|NCT00724893|58695164|FG001|Overall Study|Unknown, missing data|1|||
30681225|NCT00789698|58695189|FG000|Overall Study|Lack of Efficacy|10|||
30681226|NCT00789698|58695190|FG001|Overall Study|Lack of Efficacy|4|||
30681227|NCT00789698|58695191|FG002|Overall Study|Lack of Efficacy|5|||
30681228|NCT00789698|58695192|FG003|Overall Study|Lack of Efficacy|18|||
30595405|NCT01173601|58607720|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
30595406|NCT01173601|58607721|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
30595407|NCT01173601|58607717|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
30595408|NCT01173601|58607718|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
30595409|NCT01173601|58607719|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
30595410|NCT01173601|58607720|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
30595411|NCT01173601|58607721|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
30681229|NCT00789698|58695189|FG000|Overall Study|Adverse Event|5|||
30681230|NCT00789698|58695190|FG001|Overall Study|Adverse Event|5|||
30681231|NCT00789698|58695191|FG002|Overall Study|Adverse Event|3|||
30681232|NCT00789698|58695192|FG003|Overall Study|Adverse Event|4|||
30681233|NCT00789698|58695189|FG000|Overall Study|Lost to Follow-up|5|||
30681234|NCT00789698|58695190|FG001|Overall Study|Lost to Follow-up|5|||
30681235|NCT00789698|58695191|FG002|Overall Study|Lost to Follow-up|2|||
30681236|NCT00789698|58695192|FG003|Overall Study|Lost to Follow-up|9|||
30681237|NCT00789698|58695189|FG000|Overall Study|Protocol Violation|6|||
30681238|NCT00789698|58695190|FG001|Overall Study|Protocol Violation|1|||
30681239|NCT00789698|58695191|FG002|Overall Study|Protocol Violation|2|||
30681240|NCT00789698|58695192|FG003|Overall Study|Protocol Violation|1|||
30681241|NCT00789698|58695189|FG000|Overall Study|Withdrawal by Subject|14|||
30681242|NCT00789698|58695190|FG001|Overall Study|Withdrawal by Subject|15|||
30681243|NCT00789698|58695191|FG002|Overall Study|Withdrawal by Subject|12|||
30681244|NCT00789698|58695192|FG003|Overall Study|Withdrawal by Subject|19|||
30681245|NCT00789698|58695189|FG000|Overall Study|Administrative|0|||
30681246|NCT00789698|58695190|FG001|Overall Study|Administrative|3|||
30681247|NCT00789698|58695191|FG002|Overall Study|Administrative|3|||
30681248|NCT00789698|58695192|FG003|Overall Study|Administrative|1|||
30681249|NCT00724815|58695203|FG000|Overall Study|Randomized, not treated|31|||
30959124|NCT01568047|59024336|FG000|Overall Study|Adverse Event|0|||
30681250|NCT00724815|58695204|FG001|Overall Study|Randomized, not treated|30|||
30681251|NCT00724815|58695203|FG000|Overall Study|Adverse Event|5|||
30681252|NCT00724815|58695204|FG001|Overall Study|Adverse Event|3|||
30681253|NCT00724815|58695203|FG000|Overall Study|Lost to Follow-up|4|||
30681254|NCT00724815|58695204|FG001|Overall Study|Lost to Follow-up|1|||
30681255|NCT00724815|58695203|FG000|Overall Study|Other Various|3|||
30681256|NCT00724815|58695204|FG001|Overall Study|Other Various|5|||
30681257|NCT00454909|58695213|FG000|Overall Study|Withdrawal by Subject|1|||
30783015|NCT01358578|58795226|FG002|Induction Period|technical problems|1|||
30783016|NCT01358578|58795227|FG003|Induction Period|technical problems|1|||
30783017|NCT01358578|58795228|FG004|Induction Period|technical problems|0|||
30783018|NCT01358578|58795229|FG005|Induction Period|technical problems|0|||
30783019|NCT01358578|58795224|FG000|Induction Period|Withdrawal by Subject|5|||
30783020|NCT01358578|58795225|FG001|Induction Period|Withdrawal by Subject|5|||
30783021|NCT01358578|58795226|FG002|Induction Period|Withdrawal by Subject|10|||
30595412|NCT01173601|58607717|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
30681258|NCT00454909|58695214|FG001|Overall Study|Withdrawal by Subject|0|||
30681259|NCT00454909|58695215|FG002|Overall Study|Withdrawal by Subject|0|||
30681260|NCT00454909|58695213|FG000|Overall Study|Migrated/moved from study area|0|||
30681261|NCT00454909|58695214|FG001|Overall Study|Migrated/moved from study area|0|||
30681262|NCT00454909|58695215|FG002|Overall Study|Migrated/moved from study area|1|||
30681263|NCT00454909|58695213|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
30681264|NCT00454909|58695214|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
30681265|NCT00454909|58695215|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
30959125|NCT01568047|59024337|FG001|Overall Study|Adverse Event|0|||
30681266|NCT00454909|58695213|FG000|Overall Study|Others|1|||
30681267|NCT00454909|58695214|FG001|Overall Study|Others|0|||
30681268|NCT00454909|58695215|FG002|Overall Study|Others|0|||
30681269|NCT00798590|58695226|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
30681270|NCT00798590|58695227|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
30681271|NCT00481195|58695235|FG000|Overall Study|Adverse Event|16|||
30681272|NCT00481195|58695236|FG001|Overall Study|Adverse Event|11|||
30681273|NCT00481195|58695235|FG000|Overall Study|Lack of Efficacy|1|||
30681274|NCT00481195|58695236|FG001|Overall Study|Lack of Efficacy|3|||
30681275|NCT00481195|58695235|FG000|Overall Study|Lost to Follow-up|4|||
30681276|NCT00481195|58695236|FG001|Overall Study|Lost to Follow-up|6|||
30681277|NCT00481195|58695235|FG000|Overall Study|Physician Decision|3|||
30681278|NCT00481195|58695236|FG001|Overall Study|Physician Decision|1|||
30681279|NCT00481195|58695235|FG000|Overall Study|Protocol Violation|10|||
30681280|NCT00481195|58695236|FG001|Overall Study|Protocol Violation|7|||
30681281|NCT00481195|58695235|FG000|Overall Study|Withdrawal by Subject|3|||
30681282|NCT00481195|58695236|FG001|Overall Study|Withdrawal by Subject|9|||
30681283|NCT00481195|58695235|FG000|Overall Study|Miscellaneous|2|||
30595413|NCT01173601|58607718|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
30595414|NCT01173601|58607719|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
30595415|NCT01173601|58607720|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
30595416|NCT01173601|58607721|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
30595417|NCT01173601|58607717|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
30595418|NCT01173601|58607718|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
30681284|NCT00481195|58695236|FG001|Overall Study|Miscellaneous|2|||
30681285|NCT00454363|58695253|FG000|Overall Study|Adverse Event|1|||
30681286|NCT00454363|58695254|FG001|Overall Study|Adverse Event|2|||
30681287|NCT00454363|58695253|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
30681288|NCT00454363|58695254|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
30681289|NCT00454207|58695261|FG000|Overall Study|Adverse Event|3|||
30681290|NCT00454207|58695262|FG001|Overall Study|Adverse Event|1|||
30681291|NCT00454207|58695261|FG000|Overall Study|Lack of Efficacy|1|||
30595419|NCT01173601|58607719|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
30595420|NCT01173601|58607720|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
30595421|NCT01173601|58607721|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
30595422|NCT01173523|58607741|FG000|Overall Study|Clinical Progression|1|||
30595423|NCT01173523|58607742|FG001|Overall Study|Clinical Progression|1|||
30595424|NCT01173523|58607741|FG000|Overall Study|Progressive Disease|10|||
30595425|NCT01173523|58607742|FG001|Overall Study|Progressive Disease|8|||
30595426|NCT01173523|58607741|FG000|Overall Study|Other|2|||
30595427|NCT01173523|58607742|FG001|Overall Study|Other|3|||
30595428|NCT01173055|58607750|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
30595429|NCT01173055|58607751|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
30595430|NCT01173055|58607750|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
30681292|NCT00454207|58695262|FG001|Overall Study|Lack of Efficacy|0|||
30681293|NCT00454207|58695261|FG000|Overall Study|Protocol Violation|0|||
30681294|NCT00454207|58695262|FG001|Overall Study|Protocol Violation|1|||
30681295|NCT00738894|58695282|FG000|Overall Study|Lost to Follow-up|23|||
30595431|NCT01173055|58607751|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
30595432|NCT01172938|58607760|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
30595433|NCT01172938|58607761|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
30595434|NCT01172938|58607762|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
30595435|NCT01172938|58607763|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30595436|NCT01172938|58607764|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30595437|NCT01172938|58607765|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30595438|NCT01172938|58607766|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30595439|NCT01172938|58607767|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30595440|NCT01172938|58607768|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
30595441|NCT01172938|58607760|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
30595442|NCT01172938|58607761|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
30681296|NCT00738894|58695283|FG001|Overall Study|Lost to Follow-up|13|||
30681297|NCT00738894|58695282|FG000|Overall Study|Withdrawal by Subject|10|||
30681298|NCT00738894|58695283|FG001|Overall Study|Withdrawal by Subject|15|||
30681299|NCT00738894|58695282|FG000|Overall Study|Physician Decision|4|||
30681300|NCT00738894|58695283|FG001|Overall Study|Physician Decision|5|||
30681301|NCT00738894|58695282|FG000|Overall Study|Death|2|||
30681302|NCT00738894|58695283|FG001|Overall Study|Death|0|||
30681303|NCT00480493|58695291|FG000|Overall Study|moved|2|||
30681304|NCT00480493|58695292|FG001|Overall Study|moved|7|||
30681305|NCT00734994|58695300|FG000|Overall Study|Withdrawal by Subject|1|||
30681306|NCT00798434|58695307|FG000|Double-Blind|Adverse Event|22|||
30681307|NCT00798434|58695308|FG001|Double-Blind|Adverse Event|46|||
30681308|NCT00798434|58695307|FG000|Double-Blind|Death|0|||
30681309|NCT00798434|58695308|FG001|Double-Blind|Death|1|||
30681310|NCT00798434|58695307|FG000|Double-Blind|Lost to Follow-up|1|||
30681311|NCT00798434|58695308|FG001|Double-Blind|Lost to Follow-up|0|||
30681312|NCT00798434|58695307|FG000|Double-Blind|Lack of Efficacy|8|||
30595443|NCT01172938|58607762|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
30595444|NCT01172938|58607763|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30595445|NCT01172938|58607764|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30595446|NCT01172938|58607765|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30595447|NCT01172938|58607766|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30595448|NCT01172938|58607767|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30595449|NCT01172938|58607768|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
30595450|NCT01172938|58607760|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30595451|NCT01172938|58607761|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
30595452|NCT01172938|58607762|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
30681313|NCT00798434|58695308|FG001|Double-Blind|Lack of Efficacy|12|||
30681314|NCT00798434|58695307|FG000|Double-Blind|Withdrawal by Subject|17|||
30681315|NCT00798434|58695308|FG001|Double-Blind|Withdrawal by Subject|14|||
30681316|NCT00798434|58695307|FG000|Double-Blind|Protocol Violation|1|||
30681317|NCT00798434|58695308|FG001|Double-Blind|Protocol Violation|4|||
30681318|NCT00798434|58695307|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
30681319|NCT00798434|58695308|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
30681320|NCT00798434|58695307|FG000|Double-Blind|Other|1|||
30681321|NCT00798434|58695308|FG001|Double-Blind|Other|0|||
30681322|NCT00798434|58695307|FG000|Double-Blind|Not Treated|3|||
30681323|NCT00798434|58695308|FG001|Double-Blind|Not Treated|6|||
30681324|NCT00798434|58695307|FG000|Open-Label|Adverse Event|33|||
30681325|NCT00798434|58695308|FG001|Open-Label|Adverse Event|11|||
30681326|NCT00798434|58695307|FG000|Open-Label|Lack of Efficacy|5|||
30681327|NCT00798434|58695308|FG001|Open-Label|Lack of Efficacy|11|||
30681328|NCT00798434|58695307|FG000|Open-Label|Withdrawal by Subject|2|||
30681329|NCT00798434|58695308|FG001|Open-Label|Withdrawal by Subject|7|||
30783022|NCT01358578|58795227|FG003|Induction Period|Withdrawal by Subject|6|||
30595453|NCT01172938|58607763|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30595454|NCT01172938|58607764|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30595455|NCT01172938|58607765|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30595456|NCT01172938|58607766|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30595457|NCT01172938|58607767|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30595458|NCT01172938|58607768|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
30595459|NCT01172938|58607760|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
30595460|NCT01172938|58607761|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
30595461|NCT01172938|58607762|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
30595462|NCT01172938|58607763|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30595463|NCT01172938|58607764|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30595464|NCT01172938|58607765|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30595465|NCT01172938|58607766|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30595466|NCT01172938|58607767|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30595467|NCT01172938|58607768|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
30595468|NCT01172938|58607760|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
30595469|NCT01172938|58607761|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
30595470|NCT01172938|58607762|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
30595471|NCT01172938|58607763|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
30595472|NCT01172938|58607764|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
30595473|NCT01172938|58607765|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
30595474|NCT01172938|58607766|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
30595475|NCT01172938|58607767|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
30595476|NCT01172938|58607768|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
30595477|NCT01172938|58607760|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
30595478|NCT01172938|58607761|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30595479|NCT01172938|58607762|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30595480|NCT01172938|58607763|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30595481|NCT01172938|58607764|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30595482|NCT01172938|58607765|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30595483|NCT01172938|58607766|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30595484|NCT01172938|58607767|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30595485|NCT01172938|58607768|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
30595486|NCT01172938|58607760|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
30783023|NCT01358578|58795228|FG004|Induction Period|Withdrawal by Subject|0|||
30856183|NCT03450707|58884057|FG000|Overall Study|Following commands|0|||
30681330|NCT00798434|58695307|FG000|Open-Label|Protocol Violation|1|||
30681331|NCT00798434|58695308|FG001|Open-Label|Protocol Violation|0|||
30681332|NCT00798434|58695307|FG000|Open-Label|Other|1|||
30681333|NCT00798434|58695308|FG001|Open-Label|Other|2|||
30681334|NCT00798434|58695307|FG000|Open-Label|Not Treated|0|||
30681335|NCT00798434|58695308|FG001|Open-Label|Not Treated|1|||
30595487|NCT01172938|58607761|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
30595488|NCT01172938|58607762|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
30595489|NCT01172938|58607763|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
30595490|NCT01172938|58607764|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
30595491|NCT01172938|58607765|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
30595492|NCT01172938|58607766|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
30595493|NCT01172938|58607767|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
30595494|NCT01172938|58607768|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
30595495|NCT01172938|58607760|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
30595496|NCT01172938|58607761|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
30595497|NCT01172938|58607762|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
30595498|NCT01172938|58607763|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
30595499|NCT01172938|58607764|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
30681336|NCT00724503|58695321|FG000|Overall Study|Lost to Follow-up|4|||
30681337|NCT00724503|58695322|FG001|Overall Study|Lost to Follow-up|8|||
30681338|NCT00724503|58695321|FG000|Overall Study|Withdrawal by Subject|11|||
30681339|NCT00724503|58695322|FG001|Overall Study|Withdrawal by Subject|23|||
30681340|NCT00724503|58695321|FG000|Overall Study|Death|190|||
30681341|NCT00724503|58695322|FG001|Overall Study|Death|182|||
30681342|NCT00724503|58695321|FG000|Overall Study|Adverse Event|1|||
30681343|NCT00724503|58695322|FG001|Overall Study|Adverse Event|0|||
30681344|NCT00724503|58695321|FG000|Overall Study|Not otherwise specified|4|||
30681345|NCT00724503|58695322|FG001|Overall Study|Not otherwise specified|7|||
30681346|NCT00791648|58695332|FG000|Overall Study|Physician Decision|0|||
30681347|NCT00791648|58695333|FG001|Overall Study|Physician Decision|1|||
30681348|NCT00791648|58695332|FG000|Overall Study|Withdrawal by Subject|0|||
30681349|NCT00791648|58695333|FG001|Overall Study|Withdrawal by Subject|1|||
30681350|NCT00791492|58695341|FG000|Overall Study|Withdrawal by Subject|1|||
30681351|NCT00791492|58695342|FG001|Overall Study|Withdrawal by Subject|2|||
30681352|NCT00791492|58695341|FG000|Overall Study|Liver transplantation|5|||
30681353|NCT00791492|58695342|FG001|Overall Study|Liver transplantation|1|||
30681354|NCT00723957|58695350|FG000|Overall Study|Adverse event unrelated to study drug|1|||
30681355|NCT00723957|58695351|FG001|Overall Study|Adverse event unrelated to study drug|4|||
30681356|NCT00723957|58695350|FG000|Overall Study|Death|3|||
30681357|NCT00723957|58695351|FG001|Overall Study|Death|4|||
30681358|NCT00723957|58695350|FG000|Overall Study|Disease progression|27|||
30681359|NCT00723957|58695351|FG001|Overall Study|Disease progression|25|||
30681360|NCT00723957|58695350|FG000|Overall Study|Maximum clinical benefit|4|||
30681361|NCT00723957|58695351|FG001|Overall Study|Maximum clinical benefit|5|||
30681362|NCT00723957|58695350|FG000|Overall Study|Investigator decision|1|||
30681363|NCT00723957|58695351|FG001|Overall Study|Investigator decision|1|||
30681364|NCT00723957|58695350|FG000|Overall Study|Study drug toxicity|4|||
30681365|NCT00723957|58695351|FG001|Overall Study|Study drug toxicity|6|||
30681366|NCT00723957|58695350|FG000|Overall Study|Withdrawal by Subject|7|||
30681367|NCT00723957|58695351|FG001|Overall Study|Withdrawal by Subject|5|||
30681368|NCT00723957|58695350|FG000|Overall Study|Reason not analyzed|1|||
30681369|NCT00723957|58695351|FG001|Overall Study|Reason not analyzed|0|||
30681370|NCT00723957|58695350|FG000|Overall Study|Never received treatment|3|||
30681371|NCT00723957|58695351|FG001|Overall Study|Never received treatment|3|||
30681372|NCT00723801|58695359|FG000|Overall Study|Lost to Follow-up|1|||
30681373|NCT00723801|58695360|FG001|Overall Study|Lost to Follow-up|2|||
30681374|NCT00723801|58695359|FG000|Overall Study|Protocol Violation|2|||
30681375|NCT00723801|58695360|FG001|Overall Study|Protocol Violation|1|||
30681376|NCT00797966|58695370|FG000|Phase A|Lost to Follow-up|0|||
30681377|NCT00797966|58695371|FG001|Phase A|Lost to Follow-up|0|||
30681378|NCT00797966|58695372|FG002|Phase A|Lost to Follow-up|0|||
30681379|NCT00797966|58695373|FG003|Phase A|Lost to Follow-up|0|||
30681380|NCT00797966|58695374|FG004|Phase A|Lost to Follow-up|33|||
30681381|NCT00797966|58695375|FG005|Phase A|Lost to Follow-up|0|||
30681382|NCT00797966|58695370|FG000|Phase A|Adverse Event|0|||
30681383|NCT00797966|58695371|FG001|Phase A|Adverse Event|0|||
30681384|NCT00797966|58695372|FG002|Phase A|Adverse Event|0|||
30681385|NCT00797966|58695373|FG003|Phase A|Adverse Event|0|||
30959126|NCT01568047|59024338|FG002|Overall Study|Adverse Event|1|||
30959127|NCT01568047|59024339|FG003|Overall Study|Adverse Event|1|||
30595500|NCT01172938|58607765|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
30595501|NCT01172938|58607766|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
30595502|NCT01172938|58607767|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
30595503|NCT01172938|58607768|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
30681386|NCT00797966|58695374|FG004|Phase A|Adverse Event|46|||
30681387|NCT00797966|58695375|FG005|Phase A|Adverse Event|0|||
30681388|NCT00797966|58695370|FG000|Phase A|Met withdrawal criteria|0|||
30681389|NCT00797966|58695371|FG001|Phase A|Met withdrawal criteria|0|||
30681390|NCT00797966|58695372|FG002|Phase A|Met withdrawal criteria|0|||
30681391|NCT00797966|58695373|FG003|Phase A|Met withdrawal criteria|0|||
30681392|NCT00797966|58695374|FG004|Phase A|Met withdrawal criteria|4|||
30681393|NCT00797966|58695375|FG005|Phase A|Met withdrawal criteria|0|||
30681394|NCT00797966|58695370|FG000|Phase A|Physician Decision|0|||
30595504|NCT01172938|58607760|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
30595505|NCT01172938|58607761|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
30595506|NCT01172938|58607762|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
30595507|NCT01172938|58607763|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
30595508|NCT01172938|58607764|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
30595509|NCT01172938|58607765|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
30595510|NCT01172938|58607766|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
30595511|NCT01172938|58607767|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
30595512|NCT01172938|58607768|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
30595513|NCT01172938|58607760|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
30681395|NCT00797966|58695371|FG001|Phase A|Physician Decision|0|||
30681396|NCT00797966|58695372|FG002|Phase A|Physician Decision|0|||
30681397|NCT00797966|58695373|FG003|Phase A|Physician Decision|0|||
30681398|NCT00797966|58695374|FG004|Phase A|Physician Decision|13|||
30681399|NCT00797966|58695375|FG005|Phase A|Physician Decision|0|||
30681400|NCT00797966|58695370|FG000|Phase A|Withdrawal by Subject|0|||
30681401|NCT00797966|58695371|FG001|Phase A|Withdrawal by Subject|0|||
30681402|NCT00797966|58695372|FG002|Phase A|Withdrawal by Subject|0|||
30681403|NCT00797966|58695373|FG003|Phase A|Withdrawal by Subject|0|||
30681404|NCT00797966|58695374|FG004|Phase A|Withdrawal by Subject|33|||
30681405|NCT00797966|58695375|FG005|Phase A|Withdrawal by Subject|0|||
30681406|NCT00797966|58695370|FG000|Phase A|Protocol deviation|0|||
30681407|NCT00797966|58695371|FG001|Phase A|Protocol deviation|0|||
30681408|NCT00797966|58695372|FG002|Phase A|Protocol deviation|0|||
30681409|NCT00797966|58695373|FG003|Phase A|Protocol deviation|0|||
30681410|NCT00797966|58695374|FG004|Phase A|Protocol deviation|56|||
30681411|NCT00797966|58695375|FG005|Phase A|Protocol deviation|0|||
30681412|NCT00797966|58695370|FG000|Phase B|Lost to Follow-up|0|||
30681413|NCT00797966|58695371|FG001|Phase B|Lost to Follow-up|1|||
30681414|NCT00797966|58695372|FG002|Phase B|Lost to Follow-up|3|||
30681415|NCT00797966|58695373|FG003|Phase B|Lost to Follow-up|0|||
30681416|NCT00797966|58695374|FG004|Phase B|Lost to Follow-up|0|||
30681417|NCT00797966|58695375|FG005|Phase B|Lost to Follow-up|0|||
30681418|NCT00797966|58695370|FG000|Phase B|Adverse Event|2|||
30681419|NCT00797966|58695371|FG001|Phase B|Adverse Event|1|||
30681420|NCT00797966|58695372|FG002|Phase B|Adverse Event|3|||
30681421|NCT00797966|58695373|FG003|Phase B|Adverse Event|1|||
30681422|NCT00797966|58695374|FG004|Phase B|Adverse Event|0|||
30681423|NCT00797966|58695375|FG005|Phase B|Adverse Event|0|||
30681424|NCT00797966|58695370|FG000|Phase B|Met Withdrawal Criteria|3|||
30595514|NCT01172938|58607761|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
30595515|NCT01172938|58607762|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
30595516|NCT01172938|58607763|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
30595517|NCT01172938|58607764|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
30595518|NCT01172938|58607765|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
30595519|NCT01172938|58607766|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
30595520|NCT01172938|58607767|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
30595521|NCT01172938|58607768|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
30595522|NCT01172938|58607760|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
30595523|NCT01172938|58607761|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
30595524|NCT01172938|58607762|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
30595525|NCT01172938|58607763|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
30595526|NCT01172938|58607764|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
30595527|NCT01172938|58607765|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
30595528|NCT01172938|58607766|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
30595529|NCT01172938|58607767|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
30595530|NCT01172938|58607768|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
30595531|NCT01172938|58607760|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
30595532|NCT01172938|58607761|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
30681425|NCT00797966|58695371|FG001|Phase B|Met Withdrawal Criteria|3|||
30681426|NCT00797966|58695372|FG002|Phase B|Met Withdrawal Criteria|6|||
30681427|NCT00797966|58695373|FG003|Phase B|Met Withdrawal Criteria|1|||
30681428|NCT00797966|58695374|FG004|Phase B|Met Withdrawal Criteria|0|||
30681429|NCT00797966|58695375|FG005|Phase B|Met Withdrawal Criteria|0|||
30681430|NCT00797966|58695370|FG000|Phase B|Physician Decision|1|||
30681431|NCT00797966|58695371|FG001|Phase B|Physician Decision|0|||
30681432|NCT00797966|58695372|FG002|Phase B|Physician Decision|3|||
30681433|NCT00797966|58695373|FG003|Phase B|Physician Decision|1|||
30681434|NCT00797966|58695374|FG004|Phase B|Physician Decision|0|||
30595533|NCT01172938|58607762|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
30681435|NCT00797966|58695375|FG005|Phase B|Physician Decision|0|||
30681436|NCT00797966|58695370|FG000|Phase B|Withdrawal by Subject|1|||
30595534|NCT01172938|58607763|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
30595535|NCT01172938|58607764|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
30595536|NCT01172938|58607765|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
30595537|NCT01172938|58607766|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
30595538|NCT01172938|58607767|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
30595539|NCT01172938|58607768|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
30595540|NCT01172938|58607760|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
30595541|NCT01172938|58607761|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
30595542|NCT01172938|58607762|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
30595543|NCT01172938|58607763|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
30595544|NCT01172938|58607764|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
30595545|NCT01172938|58607765|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
30595546|NCT01172938|58607766|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
30595547|NCT01172938|58607767|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
30595548|NCT01172938|58607768|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
30595549|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
30595550|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
30595551|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
30595552|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
30595553|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
30595554|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
30595555|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
30595556|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
30595557|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
30595558|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
30595559|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
30595560|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
30595561|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
30595562|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
30595563|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
30595564|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
30595565|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
30595566|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
30595567|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
30595568|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
30595569|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
30595570|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
30595571|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
30595572|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
30595573|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
30595574|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
30595575|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
30595576|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
30595577|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
30595578|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
30595579|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
30595580|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
30595581|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
30595582|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
30595583|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
30595584|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
30595585|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
30595586|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
30595587|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
30595588|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
30595589|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
30595590|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
30595591|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
30595592|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
30595593|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
30595594|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
30595595|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
30595596|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
30595597|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
30595598|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
30595599|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
30595600|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
30681437|NCT00797966|58695371|FG001|Phase B|Withdrawal by Subject|4|||
30681438|NCT00797966|58695372|FG002|Phase B|Withdrawal by Subject|3|||
30681439|NCT00797966|58695373|FG003|Phase B|Withdrawal by Subject|3|||
30681440|NCT00797966|58695374|FG004|Phase B|Withdrawal by Subject|0|||
30681441|NCT00797966|58695375|FG005|Phase B|Withdrawal by Subject|0|||
30681442|NCT00797966|58695370|FG000|Phase B|Protocol Deviation|4|||
30681443|NCT00797966|58695371|FG001|Phase B|Protocol Deviation|8|||
30681444|NCT00797966|58695372|FG002|Phase B|Protocol Deviation|2|||
30681445|NCT00797966|58695373|FG003|Phase B|Protocol Deviation|6|||
30681446|NCT00797966|58695374|FG004|Phase B|Protocol Deviation|0|||
30681447|NCT00797966|58695375|FG005|Phase B|Protocol Deviation|0|||
30681448|NCT00797966|58695370|FG000|Phase B|Lack of Efficacy|0|||
30681449|NCT00797966|58695371|FG001|Phase B|Lack of Efficacy|1|||
30681450|NCT00797966|58695372|FG002|Phase B|Lack of Efficacy|1|||
30681451|NCT00797966|58695373|FG003|Phase B|Lack of Efficacy|4|||
30681452|NCT00797966|58695374|FG004|Phase B|Lack of Efficacy|0|||
30681453|NCT00797966|58695375|FG005|Phase B|Lack of Efficacy|0|||
30681454|NCT00797966|58695370|FG000|Phase A+|Lost to Follow-up|0|||
30681455|NCT00797966|58695371|FG001|Phase A+|Lost to Follow-up|0|||
30681456|NCT00797966|58695372|FG002|Phase A+|Lost to Follow-up|0|||
30681457|NCT00797966|58695373|FG003|Phase A+|Lost to Follow-up|0|||
30681458|NCT00797966|58695374|FG004|Phase A+|Lost to Follow-up|0|||
30681459|NCT00797966|58695375|FG005|Phase A+|Lost to Follow-up|9|||
30681460|NCT00797966|58695370|FG000|Phase A+|Met withdrawal criteria|0|||
30681461|NCT00797966|58695371|FG001|Phase A+|Met withdrawal criteria|0|||
30681462|NCT00797966|58695372|FG002|Phase A+|Met withdrawal criteria|0|||
30681463|NCT00797966|58695373|FG003|Phase A+|Met withdrawal criteria|0|||
30681464|NCT00797966|58695374|FG004|Phase A+|Met withdrawal criteria|0|||
30681465|NCT00797966|58695375|FG005|Phase A+|Met withdrawal criteria|5|||
30681466|NCT00797966|58695370|FG000|Phase A+|Withdrawal by Subject|0|||
30681467|NCT00797966|58695371|FG001|Phase A+|Withdrawal by Subject|0|||
30681468|NCT00797966|58695372|FG002|Phase A+|Withdrawal by Subject|0|||
30681469|NCT00797966|58695373|FG003|Phase A+|Withdrawal by Subject|0|||
30681470|NCT00797966|58695374|FG004|Phase A+|Withdrawal by Subject|0|||
30681471|NCT00797966|58695375|FG005|Phase A+|Withdrawal by Subject|6|||
30681472|NCT00797966|58695370|FG000|Phase A+|Adverse Event|0|||
30681473|NCT00797966|58695371|FG001|Phase A+|Adverse Event|0|||
30681474|NCT00797966|58695372|FG002|Phase A+|Adverse Event|0|||
30681475|NCT00797966|58695373|FG003|Phase A+|Adverse Event|0|||
30681476|NCT00797966|58695374|FG004|Phase A+|Adverse Event|0|||
30681477|NCT00797966|58695375|FG005|Phase A+|Adverse Event|4|||
30681478|NCT00797966|58695370|FG000|Phase A+|Protocol deviation|0|||
30681479|NCT00797966|58695371|FG001|Phase A+|Protocol deviation|0|||
30681480|NCT00797966|58695372|FG002|Phase A+|Protocol deviation|0|||
30681481|NCT00797966|58695373|FG003|Phase A+|Protocol deviation|0|||
30681482|NCT00797966|58695374|FG004|Phase A+|Protocol deviation|0|||
30681483|NCT00797966|58695375|FG005|Phase A+|Protocol deviation|4|||
30681484|NCT00723489|58695391|FG000|Overall Study|Physician Decision|0|||
30681485|NCT00723489|58695392|FG001|Overall Study|Physician Decision|1|||
30681486|NCT00723489|58695393|FG002|Overall Study|Physician Decision|0|||
30681487|NCT00723489|58695394|FG003|Overall Study|Physician Decision|0|||
30681488|NCT00723489|58695391|FG000|Overall Study|Pregnancy|0|||
30783024|NCT01358578|58795229|FG005|Induction Period|Withdrawal by Subject|0|||
30595601|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
30595602|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
30595603|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
30595604|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
30595605|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
30595606|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
30595607|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
30681489|NCT00723489|58695392|FG001|Overall Study|Pregnancy|0|||
30681490|NCT00723489|58695393|FG002|Overall Study|Pregnancy|0|||
30681491|NCT00723489|58695394|FG003|Overall Study|Pregnancy|1|||
30681492|NCT00723489|58695391|FG000|Overall Study|Withdrawal by Subject|0|||
30681493|NCT00723489|58695392|FG001|Overall Study|Withdrawal by Subject|0|||
30783025|NCT01358578|58795224|FG000|Maintenance Period|Adverse Event|2|||
30681494|NCT00723489|58695393|FG002|Overall Study|Withdrawal by Subject|0|||
30681495|NCT00723489|58695394|FG003|Overall Study|Withdrawal by Subject|1|||
30681496|NCT00723489|58695391|FG000|Overall Study|Seropositive at baseline|1|||
30681497|NCT00723489|58695392|FG001|Overall Study|Seropositive at baseline|0|||
30681498|NCT00723489|58695393|FG002|Overall Study|Seropositive at baseline|0|||
30681499|NCT00723489|58695394|FG003|Overall Study|Seropositive at baseline|0|||
30681500|NCT00723489|58695391|FG000|Overall Study|Prohibited Medication|0|||
30681501|NCT00723489|58695392|FG001|Overall Study|Prohibited Medication|0|||
30681502|NCT00723489|58695393|FG002|Overall Study|Prohibited Medication|0|||
30681503|NCT00723489|58695394|FG003|Overall Study|Prohibited Medication|1|||
30681504|NCT00723489|58695391|FG000|Overall Study|Samples Collected Out of Window|0|||
30595608|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
30595609|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
30595610|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
30595611|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
30595612|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
30595613|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
30595614|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
30595615|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
30595616|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
30595617|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
30595618|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
30595619|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
30595620|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
30595621|NCT01172938|58607760|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
30595622|NCT01172938|58607761|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
30595623|NCT01172938|58607762|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
30595624|NCT01172938|58607763|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
30595625|NCT01172938|58607764|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
30595626|NCT01172938|58607765|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
30595627|NCT01172938|58607766|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
30595628|NCT01172938|58607767|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
30595629|NCT01172938|58607768|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
30595630|NCT01172938|58607760|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
30595631|NCT01172938|58607761|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
30595632|NCT01172938|58607762|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
30595633|NCT01172938|58607763|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
30595634|NCT01172938|58607764|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
30595635|NCT01172938|58607765|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
30595636|NCT01172938|58607766|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
30595637|NCT01172938|58607767|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
30595638|NCT01172938|58607768|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
30595639|NCT01172938|58607760|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
30595640|NCT01172938|58607761|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
30595641|NCT01172938|58607762|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
30595642|NCT01172938|58607763|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
30595643|NCT01172938|58607764|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
30595644|NCT01172938|58607765|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
30595645|NCT01172938|58607766|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
30595646|NCT01172938|58607767|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
30595647|NCT01172938|58607768|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
30595648|NCT01172938|58607760|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
30595649|NCT01172938|58607761|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
30595650|NCT01172938|58607762|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
30595651|NCT01172938|58607763|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
30595652|NCT01172938|58607764|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
30595653|NCT01172938|58607765|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
30595654|NCT01172938|58607766|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
30595655|NCT01172938|58607767|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
30595656|NCT01172938|58607768|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
30595657|NCT01172938|58607760|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
30595658|NCT01172938|58607761|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
30595659|NCT01172938|58607762|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
30595660|NCT01172938|58607763|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
30595661|NCT01172938|58607764|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
30595662|NCT01172938|58607765|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
30595663|NCT01172938|58607766|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
30595664|NCT01172938|58607767|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
30595665|NCT01172938|58607768|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
30595666|NCT01172938|58607760|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
30595667|NCT01172938|58607761|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
30595668|NCT01172938|58607762|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
30595669|NCT01172938|58607763|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
30595670|NCT01172938|58607764|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
30595671|NCT01172938|58607765|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
30595672|NCT01172938|58607766|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
30783026|NCT01358578|58795225|FG001|Maintenance Period|Adverse Event|7|||
30595673|NCT01172938|58607767|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
30681505|NCT00723489|58695392|FG001|Overall Study|Samples Collected Out of Window|3|||
30681506|NCT00723489|58695393|FG002|Overall Study|Samples Collected Out of Window|0|||
30681507|NCT00723489|58695394|FG003|Overall Study|Samples Collected Out of Window|0|||
30681508|NCT00587990|58695407|FG000|Overall Study|Death|0|||
30681509|NCT00587990|58695408|FG001|Overall Study|Death|0|||
30681510|NCT00587990|58695409|FG002|Overall Study|Death|1|||
30681511|NCT00723255|58695417|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
30595674|NCT01172938|58607768|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
30595675|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
30595676|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
30595677|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
30595678|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
30595679|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
30595680|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
30681512|NCT00723255|58695417|FG000|Overall Study|Ineligible: Second primary|1|||
30681513|NCT00723255|58695417|FG000|Overall Study|Ineligible: Wrong Primary|2|||
30595681|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
30595682|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
30681514|NCT00791258|58695433|FG000|Overall Study|Adverse Event|87|||
30681515|NCT00791258|58695433|FG000|Overall Study|Lost to Follow-up|18|||
30681516|NCT00791258|58695433|FG000|Overall Study|Protocol Violation|109|||
30681517|NCT00791258|58695433|FG000|Overall Study|Withdrawal by Subject|40|||
30681518|NCT00791258|58695433|FG000|Overall Study|Did not take medication for >3 days|1|||
30681519|NCT00791258|58695433|FG000|Overall Study|subject left area|2|||
30681520|NCT00791258|58695433|FG000|Overall Study|non-compliance|3|||
30681521|NCT00791258|58695433|FG000|Overall Study|Subject incarcerated|1|||
30681522|NCT00791258|58695433|FG000|Overall Study|Subject required restricted medication|1|||
30681523|NCT00791258|58695433|FG000|Overall Study|Lack of Efficacy|1|||
30681524|NCT00808067|58695439|FG000|Overall Study|Major/minor bleed|30|||
30681525|NCT00808067|58695440|FG001|Overall Study|Major/minor bleed|44|||
30681526|NCT00808067|58695439|FG000|Overall Study|Outcome event - other|33|||
30681527|NCT00808067|58695440|FG001|Overall Study|Outcome event - other|25|||
30681528|NCT00808067|58695439|FG000|Overall Study|Adverse Event|111|||
30681529|NCT00808067|58695440|FG001|Overall Study|Adverse Event|121|||
30681530|NCT00808067|58695439|FG000|Overall Study|Hospitalization (not including surgery)|18|||
30681531|NCT00808067|58695440|FG001|Overall Study|Hospitalization (not including surgery)|17|||
30681532|NCT00808067|58695439|FG000|Overall Study|Hospitalization due to surgery|37|||
30681533|NCT00808067|58695440|FG001|Overall Study|Hospitalization due to surgery|40|||
30681534|NCT00808067|58695439|FG000|Overall Study|Reduced creatinine clearance|53|||
30681535|NCT00808067|58695440|FG001|Overall Study|Reduced creatinine clearance|55|||
30681536|NCT00808067|58695439|FG000|Overall Study|Elevated LFT results|7|||
30681537|NCT00808067|58695440|FG001|Overall Study|Elevated LFT results|3|||
30681538|NCT00808067|58695439|FG000|Overall Study|Patient refused to take study medication|65|||
30783027|NCT01358578|58795226|FG002|Maintenance Period|Adverse Event|0|||
30783028|NCT01358578|58795227|FG003|Maintenance Period|Adverse Event|6|||
30783029|NCT01358578|58795228|FG004|Maintenance Period|Adverse Event|4|||
30783030|NCT01358578|58795229|FG005|Maintenance Period|Adverse Event|3|||
30783031|NCT01358578|58795224|FG000|Maintenance Period|Lack of Efficacy|10|||
30783032|NCT01358578|58795225|FG001|Maintenance Period|Lack of Efficacy|2|||
30783033|NCT01358578|58795226|FG002|Maintenance Period|Lack of Efficacy|0|||
30783034|NCT01358578|58795227|FG003|Maintenance Period|Lack of Efficacy|11|||
30783035|NCT01358578|58795228|FG004|Maintenance Period|Lack of Efficacy|3|||
30783036|NCT01358578|58795229|FG005|Maintenance Period|Lack of Efficacy|0|||
30783037|NCT01358578|58795224|FG000|Maintenance Period|Lost to Follow-up|4|||
30595683|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
30595684|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
30595685|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
30595686|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
30595687|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
30595688|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
30681539|NCT00808067|58695440|FG001|Overall Study|Patient refused to take study medication|76|||
30681540|NCT00808067|58695439|FG000|Overall Study|Missing|1|||
30681541|NCT00808067|58695440|FG001|Overall Study|Missing|0|||
30681542|NCT00808067|58695439|FG000|Overall Study|Death|1|||
30681543|NCT00808067|58695440|FG001|Overall Study|Death|1|||
30681544|NCT00808067|58695439|FG000|Overall Study|Procedure|6|||
30681545|NCT00808067|58695440|FG001|Overall Study|Procedure|7|||
30681546|NCT00808067|58695439|FG000|Overall Study|Withdrawal by Subject|21|||
30681547|NCT00808067|58695440|FG001|Overall Study|Withdrawal by Subject|25|||
30783038|NCT01358578|58795225|FG001|Maintenance Period|Lost to Follow-up|0|||
30595689|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
30595690|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
30595691|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
30595692|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
30595693|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
30595694|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
30595695|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
30595696|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
30595697|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
30595698|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
30595699|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
30595700|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
30595701|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
30595702|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
30595703|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
30595704|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
30595705|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
30595706|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
30595707|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
30595708|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
30595709|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
30595710|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
30595711|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
30595712|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
30595713|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
30595714|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
30595715|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
30595716|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
30595717|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
30595718|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
30595719|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
30595720|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
30595721|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
30595722|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
30595723|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
30595724|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
30595725|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
30595726|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
30595727|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
30595728|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
30595729|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
30595730|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
30595731|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
30595732|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
30595733|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
30595734|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
30681548|NCT00808067|58695439|FG000|Overall Study|Site closed|4|||
30681549|NCT00808067|58695440|FG001|Overall Study|Site closed|3|||
30681550|NCT00808067|58695439|FG000|Overall Study|Physician Decision|47|||
30681551|NCT00808067|58695440|FG001|Overall Study|Physician Decision|38|||
30681552|NCT00808067|58695439|FG000|Overall Study|Protocol Violation|3|||
30681553|NCT00808067|58695440|FG001|Overall Study|Protocol Violation|11|||
30783039|NCT01358578|58795226|FG002|Maintenance Period|Lost to Follow-up|0|||
30783040|NCT01358578|58795227|FG003|Maintenance Period|Lost to Follow-up|5|||
30783041|NCT01358578|58795228|FG004|Maintenance Period|Lost to Follow-up|1|||
30783042|NCT01358578|58795229|FG005|Maintenance Period|Lost to Follow-up|1|||
30783043|NCT01358578|58795224|FG000|Maintenance Period|Non-compliance with study treatment|3|||
30783044|NCT01358578|58795225|FG001|Maintenance Period|Non-compliance with study treatment|1|||
30783045|NCT01358578|58795226|FG002|Maintenance Period|Non-compliance with study treatment|0|||
30783046|NCT01358578|58795227|FG003|Maintenance Period|Non-compliance with study treatment|2|||
30783047|NCT01358578|58795228|FG004|Maintenance Period|Non-compliance with study treatment|1|||
30783048|NCT01358578|58795229|FG005|Maintenance Period|Non-compliance with study treatment|2|||
30783049|NCT01358578|58795224|FG000|Maintenance Period|Physician Decision|0|||
30783050|NCT01358578|58795225|FG001|Maintenance Period|Physician Decision|1|||
30595735|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
30681554|NCT00808067|58695439|FG000|Overall Study|Patient elected|7|||
30681555|NCT00808067|58695440|FG001|Overall Study|Patient elected|9|||
30681556|NCT00808067|58695439|FG000|Overall Study|Site closed for cause|19|||
30681557|NCT00808067|58695440|FG001|Overall Study|Site closed for cause|19|||
30681558|NCT00808067|58695439|FG000|Overall Study|Other reason not defined above|5|||
30681559|NCT00808067|58695440|FG001|Overall Study|Other reason not defined above|5|||
30681560|NCT00808067|58695439|FG000|Overall Study|Excluded from analysis|13|||
30681561|NCT00808067|58695440|FG001|Overall Study|Excluded from analysis|19|||
30681562|NCT00723021|58695446|FG000|Intervention Period 4|Adverse Event|0|||
30681563|NCT00723021|58695447|FG001|Intervention Period 4|Adverse Event|0|||
30681564|NCT00723021|58695448|FG002|Intervention Period 4|Adverse Event|0|||
30681565|NCT00723021|58695449|FG003|Intervention Period 4|Adverse Event|0|||
30681566|NCT00723021|58695450|FG004|Intervention Period 4|Adverse Event|1|||
30681567|NCT00721227|58695471|FG000|Overall Study|Lost to Follow-up|3|||
30681568|NCT00721227|58695472|FG001|Overall Study|Lost to Follow-up|0|||
30681569|NCT00721227|58695471|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
30681570|NCT00721227|58695472|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
30681571|NCT00807599|58695480|FG000|Overall Study|Not treated on protocol study|0|||
30681572|NCT00807599|58695481|FG001|Overall Study|Not treated on protocol study|0|||
30681573|NCT00807599|58695482|FG002|Overall Study|Not treated on protocol study|2|||
30681574|NCT00807599|58695480|FG000|Overall Study|Adverse Event|0|||
30681575|NCT00807599|58695481|FG001|Overall Study|Adverse Event|0|||
30681576|NCT00807599|58695482|FG002|Overall Study|Adverse Event|5|||
30681577|NCT00807599|58695480|FG000|Overall Study|Inadequate response to induction|0|||
30681578|NCT00807599|58695481|FG001|Overall Study|Inadequate response to induction|0|||
30681579|NCT00807599|58695482|FG002|Overall Study|Inadequate response to induction|9|||
30681580|NCT00807599|58695480|FG000|Overall Study|Withdrawal by Subject|0|||
30681581|NCT00807599|58695481|FG001|Overall Study|Withdrawal by Subject|0|||
30681582|NCT00807599|58695482|FG002|Overall Study|Withdrawal by Subject|1|||
30681583|NCT00721149|58695488|FG000|Overall Study|Physician Decision|1|||
30681584|NCT00788372|58695492|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
30681585|NCT00788372|58695492|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
30681586|NCT00788372|58695492|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
30681587|NCT00788372|58695492|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
30681588|NCT00788372|58695492|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
30681589|NCT00788372|58695492|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
30681590|NCT00788372|58695492|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
30681591|NCT00738582|58695496|FG000|Combination Therapy|Completed Combination Therapy|1|||
30595736|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
30595737|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
30595738|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
30595739|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
30681592|NCT00738582|58695497|FG001|Combination Therapy|Completed Combination Therapy|0|||
30681593|NCT00738582|58695496|FG000|Combination Therapy|Physician Decision|1|||
30681594|NCT00738582|58695497|FG001|Combination Therapy|Physician Decision|0|||
30681595|NCT00738582|58695496|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
30783051|NCT01358578|58795226|FG002|Maintenance Period|Physician Decision|0|||
30783052|NCT01358578|58795227|FG003|Maintenance Period|Physician Decision|1|||
30783053|NCT01358578|58795228|FG004|Maintenance Period|Physician Decision|0|||
30783054|NCT01358578|58795229|FG005|Maintenance Period|Physician Decision|0|||
30783055|NCT01358578|58795224|FG000|Maintenance Period|Pregnancy|1|||
30783056|NCT01358578|58795225|FG001|Maintenance Period|Pregnancy|0|||
30783057|NCT01358578|58795226|FG002|Maintenance Period|Pregnancy|0|||
30783058|NCT01358578|58795227|FG003|Maintenance Period|Pregnancy|0|||
30783059|NCT01358578|58795228|FG004|Maintenance Period|Pregnancy|0|||
30783060|NCT01358578|58795229|FG005|Maintenance Period|Pregnancy|0|||
30783061|NCT01358578|58795224|FG000|Maintenance Period|Protocol deviation|7|||
30783062|NCT01358578|58795225|FG001|Maintenance Period|Protocol deviation|4|||
30595740|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
30595741|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
30595742|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
30595743|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
30595744|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
30595745|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
30595746|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
30681596|NCT00738582|58695497|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
30681597|NCT00738582|58695496|FG000|Combination Therapy|Other|5|||
30681598|NCT00738582|58695497|FG001|Combination Therapy|Other|0|||
30681599|NCT00738582|58695496|FG000|Combination Therapy|Adverse Event|16|||
30681600|NCT00738582|58695497|FG001|Combination Therapy|Adverse Event|0|||
30681601|NCT00738582|58695496|FG000|Combination Therapy|Progressive Disease|9|||
30783063|NCT01358578|58795226|FG002|Maintenance Period|Protocol deviation|0|||
30783064|NCT01358578|58795227|FG003|Maintenance Period|Protocol deviation|2|||
30783065|NCT01358578|58795228|FG004|Maintenance Period|Protocol deviation|2|||
30783066|NCT01358578|58795229|FG005|Maintenance Period|Protocol deviation|2|||
30783067|NCT01358578|58795224|FG000|Maintenance Period|Withdrawal by Subject|12|||
30783068|NCT01358578|58795225|FG001|Maintenance Period|Withdrawal by Subject|7|||
30681602|NCT00738582|58695497|FG001|Combination Therapy|Progressive Disease|0|||
30595747|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
30595748|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
30595749|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
30595750|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
30595751|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
30595752|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
30595753|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
30595754|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
30595755|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
30595756|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
30681603|NCT00738582|58695496|FG000|Maintenance Therapy|Other|0|||
30681604|NCT00738582|58695497|FG001|Maintenance Therapy|Other|2|||
30681605|NCT00738582|58695496|FG000|Maintenance Therapy|Adverse Event|0|||
30681606|NCT00738582|58695497|FG001|Maintenance Therapy|Adverse Event|6|||
30681607|NCT00738582|58695496|FG000|Maintenance Therapy|Progressive Disease|0|||
30681608|NCT00738582|58695497|FG001|Maintenance Therapy|Progressive Disease|47|||
30681609|NCT00738582|58695496|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
30681610|NCT00738582|58695497|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
30681611|NCT00720759|58695508|FG000|Overall Study|Lost to Follow-up|0|||
30681612|NCT00720759|58695509|FG001|Overall Study|Lost to Follow-up|1|||
30681613|NCT00720759|58695510|FG002|Overall Study|Lost to Follow-up|1|||
30681614|NCT00720759|58695511|FG003|Overall Study|Lost to Follow-up|0|||
30681615|NCT00720213|58695521|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
30681616|NCT00720213|58695522|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
30681617|NCT00720213|58695523|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
30681618|NCT00810407|58695531|FG000|Overall Study|Protocol Violation|3|||
30681619|NCT00810407|58695531|FG000|Overall Study|No Visit After First Day of Treatment|3|||
30681620|NCT00720057|58695537|FG000|Overall Study|Lost to Follow-up|0|||
30681621|NCT00720057|58695538|FG001|Overall Study|Lost to Follow-up|2|||
30681622|NCT00720057|58695537|FG000|Overall Study|Protocol Violation|1|||
30681623|NCT00720057|58695538|FG001|Overall Study|Protocol Violation|0|||
30681624|NCT00720057|58695537|FG000|Overall Study|Withdrawal by Subject|0|||
30681625|NCT00720057|58695538|FG001|Overall Study|Withdrawal by Subject|1|||
30681626|NCT00790868|58695546|FG000|Overall Study|Withdrawal by Subject|4|||
30681627|NCT00790868|58695547|FG001|Overall Study|Withdrawal by Subject|5|||
30681628|NCT00790868|58695546|FG000|Overall Study|Lost to Follow-up|2|||
30681629|NCT00790868|58695547|FG001|Overall Study|Lost to Follow-up|12|||
30681630|NCT00719901|58695555|FG000|Overall Study|Adverse Event|5|||
30681631|NCT00719901|58695555|FG000|Overall Study|Withdrawal by Subject|1|||
30681632|NCT00719901|58695555|FG000|Overall Study|Alternate Treatment|1|||
30681633|NCT00719901|58695555|FG000|Overall Study|Disease Progression|3|||
30681634|NCT00719901|58695555|FG000|Overall Study|Availability of Study Drug|1|||
30681635|NCT00807365|58695559|FG000|Overall Study|Study Terminated|5|||
30681636|NCT00719355|58695565|FG000|Overall Study|Death|0|||
30681637|NCT00719355|58695566|FG001|Overall Study|Death|1|||
30681638|NCT00719355|58695565|FG000|Overall Study|Medical|14|||
30595757|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
30681639|NCT00719355|58695566|FG001|Overall Study|Medical|5|||
30681640|NCT00719355|58695565|FG000|Overall Study|Compliance|4|||
30681641|NCT00719355|58695566|FG001|Overall Study|Compliance|6|||
30681642|NCT00719355|58695565|FG000|Overall Study|Moved|0|||
30681643|NCT00719355|58695566|FG001|Overall Study|Moved|1|||
30681644|NCT00590759|58695572|FG000|Overall Study|Death|52|||
30681645|NCT00590759|58695572|FG000|Overall Study|Lost to Follow-up|28|||
30681646|NCT00734604|58695582|FG000|Overall Study|Adverse Event|0|||
30681647|NCT00734604|58695583|FG001|Overall Study|Adverse Event|2|||
30681648|NCT00734604|58695584|FG002|Overall Study|Adverse Event|0|||
30595758|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
30595759|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
30595760|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
30681649|NCT00734604|58695585|FG003|Overall Study|Adverse Event|2|||
30681650|NCT00734604|58695586|FG004|Overall Study|Adverse Event|1|||
30681651|NCT00734604|58695587|FG005|Overall Study|Adverse Event|1|||
30681652|NCT00734604|58695582|FG000|Overall Study|Serious Adverse Event|1|||
30681653|NCT00734604|58695583|FG001|Overall Study|Serious Adverse Event|0|||
30595761|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
30681654|NCT00734604|58695584|FG002|Overall Study|Serious Adverse Event|1|||
30681655|NCT00734604|58695585|FG003|Overall Study|Serious Adverse Event|2|||
30681656|NCT00734604|58695586|FG004|Overall Study|Serious Adverse Event|0|||
30681657|NCT00734604|58695587|FG005|Overall Study|Serious Adverse Event|1|||
30681658|NCT00734604|58695582|FG000|Overall Study|Lost to Follow-up|1|||
30681659|NCT00734604|58695583|FG001|Overall Study|Lost to Follow-up|2|||
30681660|NCT00734604|58695584|FG002|Overall Study|Lost to Follow-up|2|||
30681661|NCT00734604|58695585|FG003|Overall Study|Lost to Follow-up|4|||
30959128|NCT01688999|59024352|FG000|Overall Study|Withdrawal by Subject|5|||
30595762|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
30681662|NCT00734604|58695586|FG004|Overall Study|Lost to Follow-up|2|||
30681663|NCT00734604|58695587|FG005|Overall Study|Lost to Follow-up|3|||
30681664|NCT00734604|58695582|FG000|Overall Study|Physician Decision|0|||
30681665|NCT00734604|58695583|FG001|Overall Study|Physician Decision|1|||
30681666|NCT00734604|58695584|FG002|Overall Study|Physician Decision|1|||
30681667|NCT00734604|58695585|FG003|Overall Study|Physician Decision|0|||
30595763|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
30595764|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
30595765|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
30595766|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
30595767|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
30595768|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
30595769|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
30595770|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
30595771|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
30595772|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
30681668|NCT00734604|58695586|FG004|Overall Study|Physician Decision|0|||
30681669|NCT00734604|58695587|FG005|Overall Study|Physician Decision|0|||
30681670|NCT00734604|58695582|FG000|Overall Study|Protocol Violation|0|||
30681671|NCT00734604|58695583|FG001|Overall Study|Protocol Violation|2|||
30681672|NCT00734604|58695584|FG002|Overall Study|Protocol Violation|0|||
30681673|NCT00734604|58695585|FG003|Overall Study|Protocol Violation|0|||
30681674|NCT00734604|58695586|FG004|Overall Study|Protocol Violation|1|||
30681675|NCT00734604|58695587|FG005|Overall Study|Protocol Violation|0|||
30681676|NCT00734604|58695582|FG000|Overall Study|Sponsor Decision|1|||
30681677|NCT00734604|58695583|FG001|Overall Study|Sponsor Decision|2|||
30681678|NCT00734604|58695584|FG002|Overall Study|Sponsor Decision|1|||
30681679|NCT00734604|58695585|FG003|Overall Study|Sponsor Decision|0|||
30681680|NCT00734604|58695586|FG004|Overall Study|Sponsor Decision|2|||
30595773|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
30595774|NCT01172938|58607760|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
30595775|NCT01172938|58607761|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
30595776|NCT01172938|58607762|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
30595777|NCT01172938|58607763|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
30595778|NCT01172938|58607764|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
30595779|NCT01172938|58607765|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
30595780|NCT01172938|58607766|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
30595781|NCT01172938|58607767|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
30595782|NCT01172938|58607768|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
30595783|NCT01109992|58607788|FG000|Overall Study|Withdrawal by Subject|0|||
30595784|NCT01109992|58607789|FG001|Overall Study|Withdrawal by Subject|1|||
30595785|NCT01109992|58607788|FG000|Overall Study|Movement during rest scan.|0|||
30595786|NCT01109992|58607789|FG001|Overall Study|Movement during rest scan.|1|||
30681681|NCT00734604|58695587|FG005|Overall Study|Sponsor Decision|0|||
30681682|NCT00734604|58695582|FG000|Overall Study|Withdrawal by Subject|0|||
30681683|NCT00734604|58695583|FG001|Overall Study|Withdrawal by Subject|2|||
30681684|NCT00734604|58695584|FG002|Overall Study|Withdrawal by Subject|0|||
30681685|NCT00734604|58695585|FG003|Overall Study|Withdrawal by Subject|1|||
30681686|NCT00734604|58695586|FG004|Overall Study|Withdrawal by Subject|2|||
30681687|NCT00734604|58695587|FG005|Overall Study|Withdrawal by Subject|1|||
30595787|NCT01109524|58607798|FG000|Overall Study|Disease Progression|29|||
30681688|NCT00734604|58695582|FG000|Overall Study|Lack of Efficacy|0|||
30681689|NCT00734604|58695583|FG001|Overall Study|Lack of Efficacy|1|||
30681690|NCT00734604|58695584|FG002|Overall Study|Lack of Efficacy|1|||
30681691|NCT00734604|58695585|FG003|Overall Study|Lack of Efficacy|0|||
30681692|NCT00734604|58695586|FG004|Overall Study|Lack of Efficacy|0|||
30681693|NCT00734604|58695587|FG005|Overall Study|Lack of Efficacy|0|||
30681694|NCT00590681|58695598|FG000|Overall Study|Withdrawal by Subject|7|||
30681695|NCT00590681|58695598|FG000|Overall Study|Adverse Event|8|||
30681696|NCT00590681|58695598|FG000|Overall Study|Death|3|||
30681697|NCT00590681|58695598|FG000|Overall Study|Lost to Follow-up|1|||
30681698|NCT00590681|58695598|FG000|Overall Study|disease progression|1|||
30681699|NCT00727272|58695602|FG000|Washout Period A|Adverse Event|0|||
30681700|NCT00727272|58695603|FG001|Washout Period A|Adverse Event|0|||
30595788|NCT01109524|58607798|FG000|Overall Study|Study Drug toxicity|6|||
30595789|NCT01109524|58607798|FG000|Overall Study|Adverse Event|4|||
30681701|NCT00727272|58695604|FG002|Washout Period A|Adverse Event|1|||
30681702|NCT00727272|58695602|FG000|Washout Period B|Withdrawal by Subject|0|||
30681703|NCT00727272|58695603|FG001|Washout Period B|Withdrawal by Subject|0|||
30595790|NCT01109524|58607798|FG000|Overall Study|Withdrawal by Subject|2|||
30595791|NCT01109524|58607798|FG000|Overall Study|Maximum clinical benefit|3|||
30595792|NCT01109524|58607798|FG000|Overall Study|Death|2|||
30681704|NCT00727272|58695604|FG002|Washout Period B|Withdrawal by Subject|1|||
30681705|NCT00805025|58695614|FG000|Overall Study|Screened but not enrolled/treated|42|||
30681706|NCT00805025|58695614|FG000|Overall Study|Adverse Event|4|||
30681707|NCT00805025|58695614|FG000|Overall Study|Withdrawal by Subject|2|||
30681708|NCT00805025|58695614|FG000|Overall Study|Physician Decision|1|||
30681709|NCT00734214|58695620|FG000|Overall Study|Withdrawal by Subject|3|||
30681710|NCT00734214|58695621|FG001|Overall Study|Withdrawal by Subject|4|||
30681711|NCT00734214|58695620|FG000|Overall Study|MD withdrawal|1|||
30681712|NCT00734214|58695621|FG001|Overall Study|MD withdrawal|0|||
30681713|NCT00787202|58695632|FG000|Overall Study|Adverse Event|3|||
30681714|NCT00787202|58695633|FG001|Overall Study|Adverse Event|2|||
30681715|NCT00787202|58695634|FG002|Overall Study|Adverse Event|0|||
30681716|NCT00787202|58695635|FG003|Overall Study|Adverse Event|0|||
30681717|NCT00787202|58695636|FG004|Overall Study|Adverse Event|2|||
30681718|NCT00787202|58695632|FG000|Overall Study|Lack of Efficacy|5|||
30681719|NCT00787202|58695633|FG001|Overall Study|Lack of Efficacy|6|||
30681720|NCT00787202|58695634|FG002|Overall Study|Lack of Efficacy|5|||
30681721|NCT00787202|58695635|FG003|Overall Study|Lack of Efficacy|2|||
30681722|NCT00787202|58695636|FG004|Overall Study|Lack of Efficacy|1|||
30681723|NCT00787202|58695632|FG000|Overall Study|Lost to Follow-up|1|||
30681724|NCT00787202|58695633|FG001|Overall Study|Lost to Follow-up|0|||
30681725|NCT00787202|58695634|FG002|Overall Study|Lost to Follow-up|0|||
30681726|NCT00787202|58695635|FG003|Overall Study|Lost to Follow-up|0|||
30681727|NCT00787202|58695636|FG004|Overall Study|Lost to Follow-up|0|||
30681728|NCT00787202|58695632|FG000|Overall Study|Withdrawal by Subject|2|||
30681729|NCT00787202|58695633|FG001|Overall Study|Withdrawal by Subject|2|||
30681730|NCT00787202|58695634|FG002|Overall Study|Withdrawal by Subject|2|||
30681731|NCT00787202|58695635|FG003|Overall Study|Withdrawal by Subject|0|||
30681732|NCT00787202|58695636|FG004|Overall Study|Withdrawal by Subject|0|||
30681733|NCT00787202|58695632|FG000|Overall Study|Protocol Violation|2|||
30681734|NCT00787202|58695633|FG001|Overall Study|Protocol Violation|1|||
30681735|NCT00787202|58695634|FG002|Overall Study|Protocol Violation|0|||
30681736|NCT00787202|58695635|FG003|Overall Study|Protocol Violation|0|||
30681737|NCT00787202|58695636|FG004|Overall Study|Protocol Violation|1|||
30681738|NCT00787202|58695632|FG000|Overall Study|Randomized, not treated|1|||
30681739|NCT00787202|58695633|FG001|Overall Study|Randomized, not treated|0|||
30681740|NCT00787202|58695634|FG002|Overall Study|Randomized, not treated|0|||
30681741|NCT00787202|58695635|FG003|Overall Study|Randomized, not treated|0|||
30681742|NCT00787202|58695636|FG004|Overall Study|Randomized, not treated|0|||
30681743|NCT04033367|58695654|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
30595793|NCT01109524|58607798|FG000|Overall Study|No longer meets criteria|2|||
30595794|NCT01109524|58607798|FG000|Overall Study|Participant requested to end treatment|4|||
30595795|NCT01109524|58607798|FG000|Overall Study|Other|5|||
30595796|NCT01109173|58607813|FG000|Overall Study|Adverse Event|15|||
30595797|NCT01109173|58607814|FG001|Overall Study|Adverse Event|17|||
30595798|NCT01109173|58607815|FG002|Overall Study|Adverse Event|9|||
30595799|NCT01109173|58607816|FG003|Overall Study|Adverse Event|6|||
30681744|NCT04033367|58695655|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
30681745|NCT04033367|58695654|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
30681746|NCT04033367|58695655|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
30681747|NCT04033367|58695654|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
30681748|NCT04033367|58695655|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
30681749|NCT04033367|58695654|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
30681750|NCT04033367|58695655|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
30681751|NCT00733980|58695667|FG000|Overall Study|Adverse Event|5|||
30681752|NCT00733980|58695668|FG001|Overall Study|Adverse Event|2|||
30681753|NCT00733980|58695667|FG000|Overall Study|Lack of Efficacy|0|||
30681754|NCT00733980|58695668|FG001|Overall Study|Lack of Efficacy|1|||
30681755|NCT00733980|58695667|FG000|Overall Study|Protocol Violation|2|||
30681756|NCT00733980|58695668|FG001|Overall Study|Protocol Violation|1|||
30681757|NCT00733980|58695667|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
30681758|NCT00733980|58695668|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
30681759|NCT00733980|58695667|FG000|Overall Study|Lost to Follow-up|6|||
30681760|NCT00733980|58695668|FG001|Overall Study|Lost to Follow-up|11|||
30681761|NCT00733980|58695667|FG000|Overall Study|Physician Decision|2|||
30595800|NCT01109173|58607813|FG000|Overall Study|Lost to Follow-up|0|||
30595801|NCT01109173|58607814|FG001|Overall Study|Lost to Follow-up|1|||
30595802|NCT01109173|58607815|FG002|Overall Study|Lost to Follow-up|0|||
30595803|NCT01109173|58607816|FG003|Overall Study|Lost to Follow-up|0|||
30595804|NCT01109173|58607813|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
30595805|NCT01109173|58607814|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
30681762|NCT00733980|58695668|FG001|Overall Study|Physician Decision|3|||
30681763|NCT00733980|58695667|FG000|Overall Study|Withdrawal by Subject|6|||
30681764|NCT00733980|58695668|FG001|Overall Study|Withdrawal by Subject|2|||
30681765|NCT00806585|58695680|FG000|Overall Study|Study terminated by Sponsor|0|||
30681766|NCT00806585|58695681|FG001|Overall Study|Study terminated by Sponsor|0|||
30681767|NCT00806585|58695682|FG002|Overall Study|Study terminated by Sponsor|1|||
30681768|NCT00806585|58695683|FG003|Overall Study|Study terminated by Sponsor|2|||
30681769|NCT00806585|58695684|FG004|Overall Study|Study terminated by Sponsor|0|||
30681770|NCT00806585|58695680|FG000|Overall Study|Protocol Violation|3|||
30681771|NCT00806585|58695681|FG001|Overall Study|Protocol Violation|1|||
30595806|NCT01109173|58607815|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
30595807|NCT01109173|58607816|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
30595808|NCT01109173|58607813|FG000|Overall Study|Noncompliance|0|||
30595809|NCT01109173|58607814|FG001|Overall Study|Noncompliance|1|||
30595810|NCT01109173|58607815|FG002|Overall Study|Noncompliance|0|||
30595811|NCT01109173|58607816|FG003|Overall Study|Noncompliance|0|||
30595812|NCT01109173|58607813|FG000|Overall Study|Treatment Failure|25|||
30595813|NCT01109173|58607814|FG001|Overall Study|Treatment Failure|32|||
30595814|NCT01109173|58607815|FG002|Overall Study|Treatment Failure|69|||
30595815|NCT01109173|58607816|FG003|Overall Study|Treatment Failure|64|||
30681772|NCT00806585|58695682|FG002|Overall Study|Protocol Violation|2|||
30681773|NCT00806585|58695683|FG003|Overall Study|Protocol Violation|0|||
30783069|NCT01358578|58795226|FG002|Maintenance Period|Withdrawal by Subject|2|||
30783070|NCT01358578|58795227|FG003|Maintenance Period|Withdrawal by Subject|15|||
30783071|NCT01358578|58795228|FG004|Maintenance Period|Withdrawal by Subject|6|||
30783072|NCT01358578|58795229|FG005|Maintenance Period|Withdrawal by Subject|3|||
30783073|NCT01358578|58795224|FG000|Follow-up Period|Adverse Event|1|||
30783074|NCT01358578|58795225|FG001|Follow-up Period|Adverse Event|1|||
30783075|NCT01358578|58795226|FG002|Follow-up Period|Adverse Event|0|||
30783076|NCT01358578|58795227|FG003|Follow-up Period|Adverse Event|0|||
30783077|NCT01358578|58795228|FG004|Follow-up Period|Adverse Event|0|||
30783078|NCT01358578|58795229|FG005|Follow-up Period|Adverse Event|0|||
30783079|NCT01358578|58795224|FG000|Follow-up Period|Lack of Efficacy|3|||
30783080|NCT01358578|58795225|FG001|Follow-up Period|Lack of Efficacy|0|||
30783081|NCT01358578|58795226|FG002|Follow-up Period|Lack of Efficacy|4|||
30783082|NCT01358578|58795227|FG003|Follow-up Period|Lack of Efficacy|1|||
30783083|NCT01358578|58795228|FG004|Follow-up Period|Lack of Efficacy|0|||
30783084|NCT01358578|58795229|FG005|Follow-up Period|Lack of Efficacy|0|||
30783085|NCT01358578|58795224|FG000|Follow-up Period|Lost to Follow-up|0|||
30783086|NCT01358578|58795225|FG001|Follow-up Period|Lost to Follow-up|1|||
30783087|NCT01358578|58795226|FG002|Follow-up Period|Lost to Follow-up|0|||
30783088|NCT01358578|58795227|FG003|Follow-up Period|Lost to Follow-up|4|||
30783089|NCT01358578|58795228|FG004|Follow-up Period|Lost to Follow-up|0|||
30783090|NCT01358578|58795229|FG005|Follow-up Period|Lost to Follow-up|0|||
30783091|NCT01358578|58795224|FG000|Follow-up Period|non- compliance with study treatment|1|||
30783092|NCT01358578|58795225|FG001|Follow-up Period|non- compliance with study treatment|0|||
30783093|NCT01358578|58795226|FG002|Follow-up Period|non- compliance with study treatment|0|||
30783094|NCT01358578|58795227|FG003|Follow-up Period|non- compliance with study treatment|0|||
30783095|NCT01358578|58795228|FG004|Follow-up Period|non- compliance with study treatment|0|||
30783096|NCT01358578|58795229|FG005|Follow-up Period|non- compliance with study treatment|0|||
30783097|NCT01358578|58795224|FG000|Follow-up Period|Pregnancy|1|||
30783098|NCT01358578|58795225|FG001|Follow-up Period|Pregnancy|0|||
30783099|NCT01358578|58795226|FG002|Follow-up Period|Pregnancy|0|||
30783100|NCT01358578|58795227|FG003|Follow-up Period|Pregnancy|0|||
30783101|NCT01358578|58795228|FG004|Follow-up Period|Pregnancy|0|||
30783102|NCT01358578|58795229|FG005|Follow-up Period|Pregnancy|0|||
30783103|NCT01358578|58795224|FG000|Follow-up Period|Withdrawal by Subject|3|||
30783104|NCT01358578|58795225|FG001|Follow-up Period|Withdrawal by Subject|3|||
30783105|NCT01358578|58795226|FG002|Follow-up Period|Withdrawal by Subject|1|||
30783106|NCT01358578|58795227|FG003|Follow-up Period|Withdrawal by Subject|12|||
30783107|NCT01358578|58795228|FG004|Follow-up Period|Withdrawal by Subject|0|||
30783108|NCT01358578|58795229|FG005|Follow-up Period|Withdrawal by Subject|0|||
30783109|NCT01358578|58795224|FG000|Follow-up Period|Physician Decision|1|||
30783110|NCT01358578|58795225|FG001|Follow-up Period|Physician Decision|1|||
30681774|NCT00806585|58695684|FG004|Overall Study|Protocol Violation|0|||
30681775|NCT00806585|58695680|FG000|Overall Study|Physician Decision|0|||
30681776|NCT00806585|58695681|FG001|Overall Study|Physician Decision|2|||
30681777|NCT00806585|58695682|FG002|Overall Study|Physician Decision|3|||
30681778|NCT00806585|58695683|FG003|Overall Study|Physician Decision|0|||
30681779|NCT00806585|58695684|FG004|Overall Study|Physician Decision|1|||
30681780|NCT00806585|58695680|FG000|Overall Study|Lost to Follow-up|2|||
30681781|NCT00806585|58695681|FG001|Overall Study|Lost to Follow-up|1|||
30783111|NCT01358578|58795226|FG002|Follow-up Period|Physician Decision|0|||
30783112|NCT01358578|58795227|FG003|Follow-up Period|Physician Decision|2|||
30783113|NCT01358578|58795228|FG004|Follow-up Period|Physician Decision|0|||
30783114|NCT01358578|58795229|FG005|Follow-up Period|Physician Decision|0|||
30595816|NCT01109173|58607813|FG000|Overall Study|Protocol Violation|4|||
30595817|NCT01109173|58607814|FG001|Overall Study|Protocol Violation|5|||
30595818|NCT01109173|58607815|FG002|Overall Study|Protocol Violation|1|||
30681782|NCT00806585|58695682|FG002|Overall Study|Lost to Follow-up|2|||
30681783|NCT00806585|58695683|FG003|Overall Study|Lost to Follow-up|2|||
30783115|NCT02833948|58795259|FG000|Overall Study|Death|2|||
30783116|NCT02833948|58795260|FG001|Overall Study|Death|3|||
30783117|NCT02833948|58795259|FG000|Overall Study|were not scanned|8|||
30783118|NCT02833948|58795260|FG001|Overall Study|were not scanned|13|||
30783119|NCT02833948|58795259|FG000|Overall Study|scans could not be evaluated|5|||
30595819|NCT01109173|58607816|FG003|Overall Study|Protocol Violation|2|||
30681784|NCT00806585|58695684|FG004|Overall Study|Lost to Follow-up|5|||
30681785|NCT00806585|58695680|FG000|Overall Study|Lack of Efficacy|1|||
30681786|NCT00806585|58695681|FG001|Overall Study|Lack of Efficacy|0|||
30681787|NCT00806585|58695682|FG002|Overall Study|Lack of Efficacy|0|||
30681788|NCT00806585|58695683|FG003|Overall Study|Lack of Efficacy|0|||
30681789|NCT00806585|58695684|FG004|Overall Study|Lack of Efficacy|0|||
30681790|NCT00806585|58695680|FG000|Overall Study|Adverse Event|1|||
30681791|NCT00806585|58695681|FG001|Overall Study|Adverse Event|5|||
30681792|NCT00806585|58695682|FG002|Overall Study|Adverse Event|3|||
30681793|NCT00806585|58695683|FG003|Overall Study|Adverse Event|4|||
30681794|NCT00806585|58695684|FG004|Overall Study|Adverse Event|2|||
30681795|NCT00806585|58695680|FG000|Overall Study|Withdrawal by Subject|10|||
30681796|NCT00806585|58695681|FG001|Overall Study|Withdrawal by Subject|8|||
30681797|NCT00806585|58695682|FG002|Overall Study|Withdrawal by Subject|9|||
30681798|NCT00806585|58695683|FG003|Overall Study|Withdrawal by Subject|3|||
30595820|NCT01109173|58607813|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
30595821|NCT01109173|58607814|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
30595822|NCT01109173|58607815|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
30595823|NCT01109173|58607816|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
30595824|NCT01109173|58607813|FG000|Overall Study|Not Specifiied|5|||
30595825|NCT01109173|58607814|FG001|Overall Study|Not Specifiied|4|||
30595826|NCT01109173|58607815|FG002|Overall Study|Not Specifiied|9|||
30595827|NCT01109173|58607816|FG003|Overall Study|Not Specifiied|14|||
30595828|NCT01172821|58607830|FG000|Overall Study|Adverse Event|5|||
30595829|NCT01172821|58607831|FG001|Overall Study|Adverse Event|2|||
30595830|NCT01172821|58607832|FG002|Overall Study|Adverse Event|2|||
30595831|NCT01172821|58607833|FG003|Overall Study|Adverse Event|7|||
30681799|NCT00806585|58695684|FG004|Overall Study|Withdrawal by Subject|11|||
30681800|NCT00806585|58695680|FG000|Overall Study|Completion status unknown|15|||
30681801|NCT00806585|58695681|FG001|Overall Study|Completion status unknown|14|||
30681802|NCT00806585|58695682|FG002|Overall Study|Completion status unknown|12|||
30681803|NCT00806585|58695683|FG003|Overall Study|Completion status unknown|4|||
30681804|NCT00806585|58695684|FG004|Overall Study|Completion status unknown|12|||
30681805|NCT00480025|58695698|FG000|Overall Study|Protocol Violation|12|||
30681806|NCT00480025|58695699|FG001|Overall Study|Protocol Violation|7|||
30681807|NCT00480025|58695698|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
30681808|NCT00480025|58695699|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
30681809|NCT00480025|58695698|FG000|Overall Study|Disease Progression / Recurrence|449|||
30681810|NCT00480025|58695699|FG001|Overall Study|Disease Progression / Recurrence|224|||
30681811|NCT00480025|58695698|FG000|Overall Study|Adverse Event|44|||
30681812|NCT00480025|58695699|FG001|Overall Study|Adverse Event|12|||
30681813|NCT00480025|58695698|FG000|Overall Study|Other|70|||
30681814|NCT00480025|58695699|FG001|Overall Study|Other|29|||
30681815|NCT00480025|58695698|FG000|Overall Study|SAE including intercurrent illness|76|||
30681816|NCT00480025|58695699|FG001|Overall Study|SAE including intercurrent illness|42|||
30681817|NCT00806351|58695713|FG000|Overall Study|Death|5|||
30595832|NCT01172821|58607830|FG000|Overall Study|Protocol Violation|0|||
30595833|NCT01172821|58607831|FG001|Overall Study|Protocol Violation|2|||
30595834|NCT01172821|58607832|FG002|Overall Study|Protocol Violation|1|||
30595835|NCT01172821|58607833|FG003|Overall Study|Protocol Violation|2|||
30595836|NCT01172821|58607830|FG000|Overall Study|Lost to Follow-up|4|||
30595837|NCT01172821|58607831|FG001|Overall Study|Lost to Follow-up|1|||
30595838|NCT01172821|58607832|FG002|Overall Study|Lost to Follow-up|2|||
30595839|NCT01172821|58607833|FG003|Overall Study|Lost to Follow-up|2|||
30595840|NCT01172821|58607830|FG000|Overall Study|Withdrawal by Subject|2|||
30681818|NCT00806351|58695714|FG001|Overall Study|Death|4|||
30681819|NCT00733902|58695724|FG000|Overall Study|Death|0|||
30681820|NCT00733902|58695725|FG001|Overall Study|Death|0|||
30681821|NCT00733902|58695726|FG002|Overall Study|Death|0|||
30681822|NCT00733902|58695727|FG003|Overall Study|Death|1|||
30681823|NCT00733902|58695724|FG000|Overall Study|Adverse Event|3|||
30595841|NCT01172821|58607831|FG001|Overall Study|Withdrawal by Subject|3|||
30595842|NCT01172821|58607832|FG002|Overall Study|Withdrawal by Subject|3|||
30681824|NCT00733902|58695725|FG001|Overall Study|Adverse Event|4|||
30681825|NCT00733902|58695726|FG002|Overall Study|Adverse Event|7|||
30681826|NCT00733902|58695727|FG003|Overall Study|Adverse Event|11|||
30783120|NCT02833948|58795260|FG001|Overall Study|scans could not be evaluated|2|||
30595843|NCT01172821|58607833|FG003|Overall Study|Withdrawal by Subject|3|||
30595844|NCT01172821|58607830|FG000|Overall Study|Other|3|||
30595845|NCT01172821|58607831|FG001|Overall Study|Other|4|||
30595846|NCT01172821|58607832|FG002|Overall Study|Other|5|||
30595847|NCT01172821|58607833|FG003|Overall Study|Other|3|||
30681827|NCT00733902|58695724|FG000|Overall Study|Lack of Efficacy|56|||
30681828|NCT00733902|58695725|FG001|Overall Study|Lack of Efficacy|21|||
30681829|NCT00733902|58695726|FG002|Overall Study|Lack of Efficacy|34|||
30681830|NCT00733902|58695727|FG003|Overall Study|Lack of Efficacy|23|||
30681831|NCT00733902|58695724|FG000|Overall Study|Protocol Violation|4|||
30681832|NCT00733902|58695725|FG001|Overall Study|Protocol Violation|6|||
30595848|NCT01172275|58607845|FG000|Overall Study|Lost to Follow-up|1|||
30595849|NCT01172275|58607846|FG001|Overall Study|Lost to Follow-up|0|||
30783121|NCT02828020|58795273|FG000|Treatment Period|Adverse Event|3|||
30783122|NCT02828020|58795274|FG001|Treatment Period|Adverse Event|1|||
30783123|NCT02828020|58795275|FG002|Treatment Period|Adverse Event|1|||
30681833|NCT00733902|58695726|FG002|Overall Study|Protocol Violation|3|||
30681834|NCT00733902|58695727|FG003|Overall Study|Protocol Violation|3|||
30681835|NCT00733902|58695724|FG000|Overall Study|Withdrawal by Subject|10|||
30681836|NCT00733902|58695725|FG001|Overall Study|Withdrawal by Subject|5|||
30681837|NCT00733902|58695726|FG002|Overall Study|Withdrawal by Subject|4|||
30681838|NCT00733902|58695727|FG003|Overall Study|Withdrawal by Subject|16|||
30681839|NCT00733902|58695724|FG000|Overall Study|Entered extension study|89|||
30681840|NCT00733902|58695725|FG001|Overall Study|Entered extension study|124|||
30681841|NCT00733902|58695726|FG002|Overall Study|Entered extension study|111|||
30681842|NCT00733902|58695727|FG003|Overall Study|Entered extension study|109|||
30681843|NCT00733902|58695724|FG000|Overall Study|Randomized but not treated|2|||
30783124|NCT02828020|58795273|FG000|Treatment Period|Withdrawal of Consent|10|||
30783125|NCT02828020|58795274|FG001|Treatment Period|Withdrawal of Consent|14|||
30783126|NCT02828020|58795275|FG002|Treatment Period|Withdrawal of Consent|9|||
30783127|NCT02828020|58795273|FG000|Treatment Period|Lost to Follow-up|21|||
30783128|NCT02828020|58795274|FG001|Treatment Period|Lost to Follow-up|24|||
30783129|NCT02828020|58795275|FG002|Treatment Period|Lost to Follow-up|18|||
30783130|NCT02828020|58795273|FG000|Treatment Period|Lack of Qualifying Event|44|||
30783131|NCT02828020|58795274|FG001|Treatment Period|Lack of Qualifying Event|53|||
30783132|NCT02828020|58795275|FG002|Treatment Period|Lack of Qualifying Event|43|||
30783133|NCT02828020|58795273|FG000|Treatment Period|Pregnancy|0|||
30783134|NCT02828020|58795274|FG001|Treatment Period|Pregnancy|2|||
30783135|NCT02828020|58795275|FG002|Treatment Period|Pregnancy|0|||
30595850|NCT01172275|58607845|FG000|Overall Study|Protocol Violation|1|||
30595851|NCT01172275|58607846|FG001|Overall Study|Protocol Violation|0|||
30595852|NCT01108510|58607854|FG000|Overall Study|Randomized but Not Treated|5|||
30595853|NCT01108510|58607855|FG001|Overall Study|Randomized but Not Treated|1|||
30595854|NCT01108510|58607854|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
30595855|NCT01108510|58607855|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
30595856|NCT01108510|58607854|FG000|Overall Study|Adverse Event|26|||
30595857|NCT01108510|58607855|FG001|Overall Study|Adverse Event|19|||
30595858|NCT01108510|58607854|FG000|Overall Study|Lost to Follow-up|20|||
30595859|NCT01108510|58607855|FG001|Overall Study|Lost to Follow-up|17|||
30595860|NCT01108510|58607854|FG000|Overall Study|Withdrew Consent|21|||
30595861|NCT01108510|58607855|FG001|Overall Study|Withdrew Consent|15|||
30595862|NCT01108510|58607854|FG000|Overall Study|Investigator's Discretion|12|||
30595863|NCT01108510|58607855|FG001|Overall Study|Investigator's Discretion|10|||
30595864|NCT01108510|58607854|FG000|Overall Study|Participant Noncompliance|5|||
30595865|NCT01108510|58607855|FG001|Overall Study|Participant Noncompliance|7|||
30595866|NCT01108510|58607854|FG000|Overall Study|Lack of Efficacy|3|||
30595867|NCT01108510|58607855|FG001|Overall Study|Lack of Efficacy|0|||
30595868|NCT01108510|58607854|FG000|Overall Study|Pregnancy|0|||
30595869|NCT01108510|58607855|FG001|Overall Study|Pregnancy|3|||
30595870|NCT01108510|58607854|FG000|Overall Study|Death|1|||
30595871|NCT01108510|58607855|FG001|Overall Study|Death|1|||
30595872|NCT01108237|58607863|FG000|Overall Study|No alignment data|2|||
30595873|NCT01108237|58607864|FG001|Overall Study|No alignment data|17|||
30595874|NCT01108237|58607863|FG000|Overall Study|Did not meet criteria for analysis|7|||
30595875|NCT01108237|58607864|FG001|Overall Study|Did not meet criteria for analysis|0|||
30595876|NCT01340027|58607882|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
30595877|NCT01340027|58607883|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
30595878|NCT01340027|58607884|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
30595879|NCT01340027|58607885|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
30595880|NCT01340027|58607886|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
30595881|NCT01340027|58607887|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
30595882|NCT01340027|58607888|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
30595883|NCT01340027|58607889|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
30595884|NCT01340027|58607890|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
30783136|NCT02828020|58795273|FG000|Treatment Period|Protocol Violation|2|||
30783137|NCT02828020|58795274|FG001|Treatment Period|Protocol Violation|4|||
30595885|NCT01340027|58607891|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
30595886|NCT01340027|58607892|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
30595887|NCT01340027|58607893|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
30595888|NCT01340027|58607882|FG000|Overall Study|Adverse Event|0|||
30595889|NCT01340027|58607883|FG001|Overall Study|Adverse Event|1|||
30595890|NCT01340027|58607884|FG002|Overall Study|Adverse Event|2|||
30681844|NCT00733902|58695725|FG001|Overall Study|Randomized but not treated|2|||
30681845|NCT00733902|58695726|FG002|Overall Study|Randomized but not treated|2|||
30681846|NCT00733902|58695727|FG003|Overall Study|Randomized but not treated|1|||
30595891|NCT01340027|58607885|FG003|Overall Study|Adverse Event|0|||
30681847|NCT00790790|58695740|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
30681848|NCT00790790|58695741|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
30681849|NCT00790790|58695742|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
30681850|NCT00790790|58695740|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
30681851|NCT00790790|58695741|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
30681852|NCT00790790|58695742|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
30681853|NCT00790790|58695740|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
30681854|NCT00790790|58695741|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
30681855|NCT00790790|58695742|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
30681856|NCT00790790|58695740|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
30681857|NCT00790790|58695741|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
30681858|NCT00790790|58695742|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
30681859|NCT00790790|58695740|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
30681860|NCT00790790|58695741|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
30595892|NCT01340027|58607886|FG004|Overall Study|Adverse Event|1|||
30595893|NCT01340027|58607887|FG005|Overall Study|Adverse Event|2|||
30595894|NCT01340027|58607888|FG006|Overall Study|Adverse Event|2|||
30595895|NCT01340027|58607889|FG007|Overall Study|Adverse Event|1|||
30595896|NCT01340027|58607890|FG008|Overall Study|Adverse Event|4|||
30595897|NCT01340027|58607891|FG009|Overall Study|Adverse Event|1|||
30681861|NCT00790790|58695742|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
30681862|NCT00719043|58695762|FG000|Overall Study|Adverse Event|5|||
30681863|NCT00719043|58695763|FG001|Overall Study|Adverse Event|1|||
30681864|NCT00719043|58695764|FG002|Overall Study|Adverse Event|2|||
30681865|NCT00719043|58695765|FG003|Overall Study|Adverse Event|2|||
30681866|NCT00719043|58695766|FG004|Overall Study|Adverse Event|1|||
30681867|NCT00719043|58695767|FG005|Overall Study|Adverse Event|4|||
30681868|NCT00719043|58695768|FG006|Overall Study|Adverse Event|4|||
30681869|NCT00719043|58695762|FG000|Overall Study|Lost to Follow-up|14|||
30681870|NCT00719043|58695763|FG001|Overall Study|Lost to Follow-up|10|||
30681871|NCT00719043|58695764|FG002|Overall Study|Lost to Follow-up|8|||
30681872|NCT00719043|58695765|FG003|Overall Study|Lost to Follow-up|9|||
30681873|NCT00719043|58695766|FG004|Overall Study|Lost to Follow-up|10|||
30681874|NCT00719043|58695767|FG005|Overall Study|Lost to Follow-up|9|||
30595898|NCT01340027|58607892|FG010|Overall Study|Adverse Event|1|||
30595899|NCT01340027|58607893|FG011|Overall Study|Adverse Event|3|||
30595900|NCT01340027|58607882|FG000|Overall Study|Lack of Efficacy|0|||
30595901|NCT01340027|58607883|FG001|Overall Study|Lack of Efficacy|0|||
30595902|NCT01340027|58607884|FG002|Overall Study|Lack of Efficacy|0|||
30595903|NCT01340027|58607885|FG003|Overall Study|Lack of Efficacy|0|||
30595904|NCT01340027|58607886|FG004|Overall Study|Lack of Efficacy|0|||
30595905|NCT01340027|58607887|FG005|Overall Study|Lack of Efficacy|0|||
30595906|NCT01340027|58607888|FG006|Overall Study|Lack of Efficacy|1|||
30595907|NCT01340027|58607889|FG007|Overall Study|Lack of Efficacy|1|||
30595908|NCT01340027|58607890|FG008|Overall Study|Lack of Efficacy|1|||
30595909|NCT01340027|58607891|FG009|Overall Study|Lack of Efficacy|0|||
30595910|NCT01340027|58607892|FG010|Overall Study|Lack of Efficacy|0|||
30595911|NCT01340027|58607893|FG011|Overall Study|Lack of Efficacy|0|||
30595912|NCT01340027|58607882|FG000|Overall Study|Lost to Follow-up|0|||
30595913|NCT01340027|58607883|FG001|Overall Study|Lost to Follow-up|1|||
30595914|NCT01340027|58607884|FG002|Overall Study|Lost to Follow-up|0|||
30595915|NCT01340027|58607885|FG003|Overall Study|Lost to Follow-up|0|||
30595916|NCT01340027|58607886|FG004|Overall Study|Lost to Follow-up|0|||
30595917|NCT01340027|58607887|FG005|Overall Study|Lost to Follow-up|0|||
30595918|NCT01340027|58607888|FG006|Overall Study|Lost to Follow-up|1|||
30595919|NCT01340027|58607889|FG007|Overall Study|Lost to Follow-up|0|||
30595920|NCT01340027|58607890|FG008|Overall Study|Lost to Follow-up|0|||
30595921|NCT01340027|58607891|FG009|Overall Study|Lost to Follow-up|1|||
30595922|NCT01340027|58607892|FG010|Overall Study|Lost to Follow-up|0|||
30595923|NCT01340027|58607893|FG011|Overall Study|Lost to Follow-up|0|||
30595924|NCT01340027|58607882|FG000|Overall Study|Protocol Violation|1|||
30595925|NCT01340027|58607883|FG001|Overall Study|Protocol Violation|2|||
30595926|NCT01340027|58607884|FG002|Overall Study|Protocol Violation|0|||
30595927|NCT01340027|58607885|FG003|Overall Study|Protocol Violation|0|||
30681875|NCT00719043|58695768|FG006|Overall Study|Lost to Follow-up|9|||
30681876|NCT00719043|58695762|FG000|Overall Study|Protocol Violation|0|||
30681877|NCT00719043|58695763|FG001|Overall Study|Protocol Violation|0|||
30595928|NCT01340027|58607886|FG004|Overall Study|Protocol Violation|6|||
30595929|NCT01340027|58607887|FG005|Overall Study|Protocol Violation|0|||
30595930|NCT01340027|58607888|FG006|Overall Study|Protocol Violation|0|||
30595931|NCT01340027|58607889|FG007|Overall Study|Protocol Violation|1|||
30595932|NCT01340027|58607890|FG008|Overall Study|Protocol Violation|2|||
30595933|NCT01340027|58607891|FG009|Overall Study|Protocol Violation|2|||
30595934|NCT01340027|58607892|FG010|Overall Study|Protocol Violation|0|||
30595935|NCT01340027|58607893|FG011|Overall Study|Protocol Violation|0|||
30595936|NCT01340027|58607882|FG000|Overall Study|Withdrawal by Subject|4|||
30595937|NCT01340027|58607883|FG001|Overall Study|Withdrawal by Subject|3|||
30595938|NCT01340027|58607884|FG002|Overall Study|Withdrawal by Subject|1|||
30595939|NCT01340027|58607885|FG003|Overall Study|Withdrawal by Subject|3|||
30595940|NCT01340027|58607886|FG004|Overall Study|Withdrawal by Subject|3|||
30595941|NCT01340027|58607887|FG005|Overall Study|Withdrawal by Subject|2|||
30595942|NCT01340027|58607888|FG006|Overall Study|Withdrawal by Subject|3|||
30595943|NCT01340027|58607889|FG007|Overall Study|Withdrawal by Subject|4|||
30595944|NCT01340027|58607890|FG008|Overall Study|Withdrawal by Subject|1|||
30595945|NCT01340027|58607891|FG009|Overall Study|Withdrawal by Subject|2|||
30595946|NCT01340027|58607892|FG010|Overall Study|Withdrawal by Subject|0|||
30595947|NCT01340027|58607893|FG011|Overall Study|Withdrawal by Subject|1|||
30595948|NCT01340027|58607882|FG000|Overall Study|Miscellaneous|0|||
30595949|NCT01340027|58607883|FG001|Overall Study|Miscellaneous|0|||
30595950|NCT01340027|58607884|FG002|Overall Study|Miscellaneous|0|||
30595951|NCT01340027|58607885|FG003|Overall Study|Miscellaneous|1|||
30595952|NCT01340027|58607886|FG004|Overall Study|Miscellaneous|0|||
30595953|NCT01340027|58607887|FG005|Overall Study|Miscellaneous|0|||
30595954|NCT01340027|58607888|FG006|Overall Study|Miscellaneous|0|||
30595955|NCT01340027|58607889|FG007|Overall Study|Miscellaneous|0|||
30595956|NCT01340027|58607890|FG008|Overall Study|Miscellaneous|0|||
30595957|NCT01340027|58607891|FG009|Overall Study|Miscellaneous|0|||
30595958|NCT01340027|58607892|FG010|Overall Study|Miscellaneous|1|||
30595959|NCT01340027|58607893|FG011|Overall Study|Miscellaneous|0|||
30595960|NCT01327053|58607921|FG000|Overall Study|Adverse Event|23|||
30595961|NCT01327053|58607922|FG001|Overall Study|Adverse Event|57|||
30595962|NCT01327053|58607921|FG000|Overall Study|Patient/guardian decision|11|||
30595963|NCT01327053|58607922|FG001|Overall Study|Patient/guardian decision|35|||
30595964|NCT01327053|58607921|FG000|Overall Study|Physician Decision|10|||
30595965|NCT01327053|58607922|FG001|Overall Study|Physician Decision|14|||
30595966|NCT01327053|58607921|FG000|Overall Study|Death|1|||
30595967|NCT01327053|58607922|FG001|Overall Study|Death|5|||
30595968|NCT01327053|58607921|FG000|Overall Study|Lost to Follow-up|2|||
30595969|NCT01327053|58607922|FG001|Overall Study|Lost to Follow-up|4|||
30595970|NCT01327053|58607921|FG000|Overall Study|Non-compliance with study treatment|0|||
30595971|NCT01327053|58607922|FG001|Overall Study|Non-compliance with study treatment|5|||
30595972|NCT01327053|58607921|FG000|Overall Study|Study terminated by Sponsor|1|||
30595973|NCT01327053|58607922|FG001|Overall Study|Study terminated by Sponsor|3|||
30595974|NCT01327053|58607921|FG000|Overall Study|Progressive disease|31|||
30595975|NCT01327053|58607922|FG001|Overall Study|Progressive disease|26|||
30595976|NCT01327053|58607921|FG000|Overall Study|Protocol Violation|0|||
30595977|NCT01327053|58607922|FG001|Overall Study|Protocol Violation|1|||
30595978|NCT01327053|58607921|FG000|Overall Study|Untreated|0|||
30595979|NCT01327053|58607922|FG001|Overall Study|Untreated|1|||
30595980|NCT01107925|58607936|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
30595981|NCT01107925|58607937|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
30595982|NCT01107925|58607938|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
30595983|NCT01107925|58607939|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
30595984|NCT01107925|58607940|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
30595985|NCT01107925|58607941|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
30595986|NCT01107925|58607936|FG000|Period 2|Withdrawal by Subject|0|||
30595987|NCT01107925|58607937|FG001|Period 2|Withdrawal by Subject|1|||
30595988|NCT01107925|58607938|FG002|Period 2|Withdrawal by Subject|0|||
30595989|NCT01107925|58607939|FG003|Period 2|Withdrawal by Subject|0|||
30595990|NCT01107925|58607940|FG004|Period 2|Withdrawal by Subject|0|||
30595991|NCT01107925|58607941|FG005|Period 2|Withdrawal by Subject|1|||
30595992|NCT01339832|58607969|FG000|Overall Study|Lost to Follow-up|3|||
30595993|NCT01339832|58607969|FG000|Overall Study|Death|11|||
30595994|NCT01339559|58607973|FG000|Overall Study|Adverse Event|92|||
30595995|NCT01339559|58607973|FG000|Overall Study|Death|5|||
30595996|NCT01339559|58607973|FG000|Overall Study|Lack of Efficacy|164|||
30595997|NCT01339559|58607973|FG000|Overall Study|Lost to Follow-up|22|||
30595998|NCT01339559|58607973|FG000|Overall Study|Subject choice|89|||
30595999|NCT01339559|58607973|FG000|Overall Study|Protocol Violation|15|||
30596000|NCT01339559|58607973|FG000|Overall Study|Study closure at site|1|||
30681878|NCT00719043|58695764|FG002|Overall Study|Protocol Violation|0|||
30681879|NCT00719043|58695765|FG003|Overall Study|Protocol Violation|0|||
30681880|NCT00719043|58695766|FG004|Overall Study|Protocol Violation|0|||
30681881|NCT00719043|58695767|FG005|Overall Study|Protocol Violation|1|||
30681882|NCT00719043|58695768|FG006|Overall Study|Protocol Violation|0|||
30596001|NCT01339559|58607973|FG000|Overall Study|Incarcerated|2|||
30596002|NCT01339559|58607973|FG000|Overall Study|Epilepsy surgery|1|||
30596003|NCT01339559|58607973|FG000|Overall Study|Pregnancy planned|2|||
30596004|NCT01339559|58607973|FG000|Overall Study|Left the country|1|||
30596005|NCT01339559|58607973|FG000|Overall Study|Investigator decision|2|||
30596006|NCT01339559|58607973|FG000|Overall Study|Patient didn't wish to continue|1|||
30596007|NCT01339559|58607973|FG000|Overall Study|PI decision|1|||
30596008|NCT00107900|58607984|FG000|Overall Study|Adverse Event|3|||
30596009|NCT00107900|58607985|FG001|Overall Study|Adverse Event|2|||
30596010|NCT00107900|58607986|FG002|Overall Study|Adverse Event|10|||
30596011|NCT00107900|58607987|FG003|Overall Study|Adverse Event|3|||
30596012|NCT00107900|58607988|FG004|Overall Study|Adverse Event|5|||
30596013|NCT00107900|58607989|FG005|Overall Study|Adverse Event|3|||
30596014|NCT00107900|58607984|FG000|Overall Study|Death|0|||
30681883|NCT00719043|58695762|FG000|Overall Study|Other|1|||
30681884|NCT00719043|58695763|FG001|Overall Study|Other|0|||
30681885|NCT00719043|58695764|FG002|Overall Study|Other|1|||
30681886|NCT00719043|58695765|FG003|Overall Study|Other|2|||
30681887|NCT00719043|58695766|FG004|Overall Study|Other|0|||
30681888|NCT00719043|58695767|FG005|Overall Study|Other|2|||
30681889|NCT00719043|58695768|FG006|Overall Study|Other|1|||
30681890|NCT00719043|58695762|FG000|Overall Study|Withdrawal by Subject|12|||
30681891|NCT00719043|58695763|FG001|Overall Study|Withdrawal by Subject|14|||
30681892|NCT00719043|58695764|FG002|Overall Study|Withdrawal by Subject|9|||
30681893|NCT00719043|58695765|FG003|Overall Study|Withdrawal by Subject|10|||
30681894|NCT00719043|58695766|FG004|Overall Study|Withdrawal by Subject|16|||
30681895|NCT00719043|58695767|FG005|Overall Study|Withdrawal by Subject|18|||
30681896|NCT00719043|58695768|FG006|Overall Study|Withdrawal by Subject|14|||
30681897|NCT00786422|58695796|FG000|Rivaroxaban Treatment|Death|2|||
30681898|NCT00786422|58695796|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
30681899|NCT00786422|58695796|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
30681900|NCT00786422|58695796|FG000|Rivaroxaban Treatment|Physician Decision|1|||
30681901|NCT00786422|58695796|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
30681902|NCT00786422|58695796|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
30681903|NCT00786422|58695796|FG000|Rivaroxaban Treatment|Adverse Event|2|||
30681904|NCT00786422|58695796|FG000|Follow-up Period|Death|1|||
30681905|NCT00786422|58695796|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
30681906|NCT00718887|58695804|FG000|Overall Study|Withdrawal by Subject|3|||
30681907|NCT00718887|58695805|FG001|Overall Study|Withdrawal by Subject|2|||
30681908|NCT00718887|58695804|FG000|Overall Study|Not identified|2|||
30681909|NCT00718887|58695805|FG001|Overall Study|Not identified|7|||
30681910|NCT00786188|58695819|FG000|Overall Study|Adverse Event|3|||
30681911|NCT00786188|58695820|FG001|Overall Study|Adverse Event|1|||
30681912|NCT00786188|58695819|FG000|Overall Study|Withdrawal by Subject|2|||
30681913|NCT00786188|58695820|FG001|Overall Study|Withdrawal by Subject|0|||
30681914|NCT00790556|58695828|FG000|Treatment Period 1|Physician Decision|1|||
30681915|NCT00790556|58695829|FG001|Treatment Period 1|Physician Decision|0|||
30681916|NCT00790556|58695828|FG000|Treatment Period 1|Withdrawal by Subject|1|||
30681917|NCT00790556|58695829|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30681918|NCT00733824|58695840|FG000|Phase I|Withdrawal by Subject|1|||
30681919|NCT00733824|58695841|FG001|Phase I|Withdrawal by Subject|0|||
30681920|NCT00733824|58695842|FG002|Phase I|Withdrawal by Subject|0|||
30681921|NCT00733824|58695843|FG003|Phase I|Withdrawal by Subject|0|||
30681922|NCT00733824|58695844|FG004|Phase I|Withdrawal by Subject|0|||
30681923|NCT00718809|58695860|FG000|Overall Study|Disease progression|9|||
30681924|NCT00718809|58695861|FG001|Overall Study|Disease progression|7|||
30681925|NCT00718809|58695860|FG000|Overall Study|Adverse Event|1|||
30681926|NCT00718809|58695861|FG001|Overall Study|Adverse Event|1|||
30681927|NCT00718809|58695860|FG000|Overall Study|Withdrawal by Subject|0|||
30681928|NCT00718809|58695861|FG001|Overall Study|Withdrawal by Subject|1|||
30681929|NCT00718809|58695860|FG000|Overall Study|Lost to Follow-up|1|||
30681930|NCT00718809|58695861|FG001|Overall Study|Lost to Follow-up|0|||
30681931|NCT00718809|58695860|FG000|Overall Study|Noncompliance|1|||
30681932|NCT00718809|58695861|FG001|Overall Study|Noncompliance|0|||
30681933|NCT00585039|58695869|FG000|Overall Study|medication spilled|2|||
30681934|NCT00585039|58695870|FG001|Overall Study|medication spilled|0|||
30783138|NCT02828020|58795275|FG002|Treatment Period|Protocol Violation|7|||
30596015|NCT00107900|58607985|FG001|Overall Study|Death|0|||
30596016|NCT00107900|58607986|FG002|Overall Study|Death|0|||
30596017|NCT00107900|58607987|FG003|Overall Study|Death|0|||
30596018|NCT00107900|58607988|FG004|Overall Study|Death|1|||
30596019|NCT00107900|58607989|FG005|Overall Study|Death|0|||
30596020|NCT00107900|58607984|FG000|Overall Study|Lost to Follow-up|4|||
30596021|NCT00107900|58607985|FG001|Overall Study|Lost to Follow-up|1|||
30596022|NCT00107900|58607986|FG002|Overall Study|Lost to Follow-up|3|||
30596023|NCT00107900|58607987|FG003|Overall Study|Lost to Follow-up|2|||
30681935|NCT00806195|58695882|FG000|Overall Study|Death|6|||
30681936|NCT00806195|58695883|FG001|Overall Study|Death|0|||
30681937|NCT00806195|58695884|FG002|Overall Study|Death|1|||
30681938|NCT00806195|58695885|FG003|Overall Study|Death|0|||
30681939|NCT00806195|58695882|FG000|Overall Study|Adverse Event|25|||
30681940|NCT00806195|58695883|FG001|Overall Study|Adverse Event|5|||
30856184|NCT03450707|58884058|FG001|Overall Study|Following commands|3|||
30596024|NCT00107900|58607988|FG004|Overall Study|Lost to Follow-up|5|||
30596025|NCT00107900|58607989|FG005|Overall Study|Lost to Follow-up|5|||
30681941|NCT00806195|58695884|FG002|Overall Study|Adverse Event|11|||
30681942|NCT00806195|58695885|FG003|Overall Study|Adverse Event|2|||
30681943|NCT00806195|58695882|FG000|Overall Study|Withdrawal by Subject|119|||
30681944|NCT00806195|58695883|FG001|Overall Study|Withdrawal by Subject|31|||
30681945|NCT00806195|58695884|FG002|Overall Study|Withdrawal by Subject|76|||
30681946|NCT00806195|58695885|FG003|Overall Study|Withdrawal by Subject|35|||
30681947|NCT00806195|58695882|FG000|Overall Study|Lost to Follow-up|217|||
30681948|NCT00806195|58695883|FG001|Overall Study|Lost to Follow-up|66|||
30681949|NCT00806195|58695884|FG002|Overall Study|Lost to Follow-up|90|||
30681950|NCT00806195|58695885|FG003|Overall Study|Lost to Follow-up|34|||
30681951|NCT00806195|58695882|FG000|Overall Study|Inappropriate Enrollment|0|||
30596026|NCT00107900|58607984|FG000|Overall Study|Protocol Violation|1|||
30596027|NCT00107900|58607985|FG001|Overall Study|Protocol Violation|0|||
30596028|NCT00107900|58607986|FG002|Overall Study|Protocol Violation|5|||
30596029|NCT00107900|58607987|FG003|Overall Study|Protocol Violation|5|||
30596030|NCT00107900|58607988|FG004|Overall Study|Protocol Violation|7|||
30596031|NCT00107900|58607989|FG005|Overall Study|Protocol Violation|0|||
30596032|NCT00107900|58607984|FG000|Overall Study|Withdrawal by Subject|1|||
30596033|NCT00107900|58607985|FG001|Overall Study|Withdrawal by Subject|0|||
30596034|NCT00107900|58607986|FG002|Overall Study|Withdrawal by Subject|5|||
30596035|NCT00107900|58607987|FG003|Overall Study|Withdrawal by Subject|0|||
30596036|NCT00107900|58607988|FG004|Overall Study|Withdrawal by Subject|1|||
30596037|NCT00107900|58607989|FG005|Overall Study|Withdrawal by Subject|1|||
30596038|NCT00107900|58607984|FG000|Overall Study|Administrative Reasons|1|||
30596039|NCT00107900|58607985|FG001|Overall Study|Administrative Reasons|0|||
30596040|NCT00107900|58607986|FG002|Overall Study|Administrative Reasons|2|||
30596041|NCT00107900|58607987|FG003|Overall Study|Administrative Reasons|2|||
30596042|NCT00107900|58607988|FG004|Overall Study|Administrative Reasons|2|||
30596043|NCT00107900|58607989|FG005|Overall Study|Administrative Reasons|0|||
30596044|NCT01339052|58608005|FG000|Overall Study|Disease progression|13|||
30596045|NCT01339052|58608006|FG001|Overall Study|Disease progression|46|||
30596046|NCT01339052|58608005|FG000|Overall Study|Adverse Event|1|||
30596047|NCT01339052|58608006|FG001|Overall Study|Adverse Event|1|||
30596048|NCT01339052|58608005|FG000|Overall Study|Withdrawal by Subject|0|||
30596049|NCT01339052|58608006|FG001|Overall Study|Withdrawal by Subject|3|||
30596050|NCT01339052|58608005|FG000|Overall Study|Physician Decision|1|||
30596051|NCT01339052|58608006|FG001|Overall Study|Physician Decision|0|||
30783139|NCT02828020|58795273|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
30783140|NCT02828020|58795274|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
30596052|NCT00107315|58608015|FG000|Overall Study|Disease Progression|9|||
30596053|NCT00107315|58608015|FG000|Overall Study|Adverse Event|4|||
30596054|NCT00107315|58608015|FG000|Overall Study|Withdrawal by Subject|2|||
30596055|NCT01335971|58608022|FG000|Overall Study|Withdrawal by Subject|1|||
30596056|NCT01335971|58608023|FG001|Overall Study|Withdrawal by Subject|0|||
30596057|NCT01335971|58608024|FG002|Overall Study|Withdrawal by Subject|0|||
30596058|NCT01335971|58608022|FG000|Overall Study|Did not complete bronchoscopy|1|||
30596059|NCT01335971|58608023|FG001|Overall Study|Did not complete bronchoscopy|1|||
30596060|NCT01335971|58608024|FG002|Overall Study|Did not complete bronchoscopy|1|||
30596061|NCT00107276|58608032|FG000|Overall Study|Progression|46|||
30596062|NCT00107276|58608032|FG000|Overall Study|Adverse Event|6|||
30596063|NCT00107276|58608032|FG000|Overall Study|M.D. decision|2|||
30596064|NCT00107276|58608032|FG000|Overall Study|Patient refusal|1|||
30681952|NCT00806195|58695883|FG001|Overall Study|Inappropriate Enrollment|1|||
30681953|NCT00806195|58695884|FG002|Overall Study|Inappropriate Enrollment|0|||
30681954|NCT00806195|58695885|FG003|Overall Study|Inappropriate Enrollment|0|||
30681955|NCT00806195|58695882|FG000|Overall Study|Administrative Reason|113|||
30681956|NCT00806195|58695883|FG001|Overall Study|Administrative Reason|35|||
30681957|NCT00806195|58695884|FG002|Overall Study|Administrative Reason|66|||
30681958|NCT00806195|58695885|FG003|Overall Study|Administrative Reason|26|||
30681959|NCT00806195|58695882|FG000|Overall Study|Protocol Violation|34|||
30681960|NCT00806195|58695883|FG001|Overall Study|Protocol Violation|24|||
30681961|NCT00806195|58695884|FG002|Overall Study|Protocol Violation|26|||
30681962|NCT00806195|58695885|FG003|Overall Study|Protocol Violation|9|||
30681963|NCT00733746|58695897|FG000|Overall Study|Ineligible|5|||
30681964|NCT00718419|58695903|FG000|Overall Study|Adverse Event|2|||
30681965|NCT00718419|58695904|FG001|Overall Study|Adverse Event|1|||
30681966|NCT00718419|58695903|FG000|Overall Study|Physician Decision|1|||
30681967|NCT00718419|58695904|FG001|Overall Study|Physician Decision|6|||
30681968|NCT00718419|58695903|FG000|Overall Study|Sponsor decision|0|||
30681969|NCT00718419|58695904|FG001|Overall Study|Sponsor decision|1|||
30681970|NCT00718419|58695903|FG000|Overall Study|Withdrawal by Subject|0|||
30783141|NCT02828020|58795275|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
30596065|NCT00107276|58608032|FG000|Overall Study|Death|1|||
30681971|NCT00718419|58695904|FG001|Overall Study|Withdrawal by Subject|5|||
30681972|NCT00718419|58695903|FG000|Overall Study|Progressive Disease|7|||
30681973|NCT00718419|58695904|FG001|Overall Study|Progressive Disease|25|||
30681974|NCT00718419|58695903|FG000|Overall Study|Death Due to Progressive Disease|2|||
30856185|NCT03450707|58884057|FG000|Overall Study|Lactate < 3.5|0|||
30596066|NCT00107276|58608032|FG000|Overall Study|Ineligible|16|||
30596067|NCT01335698|58608042|FG000|Treatment Stage 1|Lack of Efficacy|3|||
30596068|NCT01335698|58608043|FG001|Treatment Stage 1|Lack of Efficacy|1|||
30596069|NCT01335698|58608044|FG002|Treatment Stage 1|Lack of Efficacy|3|||
30681975|NCT00718419|58695904|FG001|Overall Study|Death Due to Progressive Disease|0|||
30681976|NCT00718419|58695903|FG000|Overall Study|Death Due to Study Drug Related|0|||
30681977|NCT00718419|58695904|FG001|Overall Study|Death Due to Study Drug Related|1|||
30681978|NCT00718419|58695903|FG000|Overall Study|Death Due to Adverse Events|1|||
30681979|NCT00718419|58695904|FG001|Overall Study|Death Due to Adverse Events|0|||
30681980|NCT00717249|58695912|FG000|Overall Study|Lens Discomfort|4|||
30681981|NCT00717249|58695913|FG001|Overall Study|Lens Discomfort|1|||
30681982|NCT00717249|58695912|FG000|Overall Study|Unsatisfactory visual Response|0|||
30681983|NCT00717249|58695913|FG001|Overall Study|Unsatisfactory visual Response|2|||
30681984|NCT00717249|58695912|FG000|Overall Study|Adverse Event|4|||
30681985|NCT00717249|58695913|FG001|Overall Study|Adverse Event|2|||
30681986|NCT00717249|58695912|FG000|Overall Study|Lost to Follow-up|2|||
30681987|NCT00717249|58695913|FG001|Overall Study|Lost to Follow-up|0|||
30681988|NCT00717249|58695912|FG000|Overall Study|Withdrawal by Subject|1|||
30681989|NCT00717249|58695913|FG001|Overall Study|Withdrawal by Subject|2|||
30681990|NCT00717249|58695912|FG000|Overall Study|Pregnancy|6|||
30681991|NCT00717249|58695913|FG001|Overall Study|Pregnancy|3|||
30681992|NCT00717249|58695912|FG000|Overall Study|Protocol Violation|0|||
30681993|NCT00717249|58695913|FG001|Overall Study|Protocol Violation|2|||
30681994|NCT00717249|58695912|FG000|Overall Study|Subject became Ineligible|1|||
30681995|NCT00717249|58695913|FG001|Overall Study|Subject became Ineligible|1|||
30681996|NCT00717249|58695912|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
30681997|NCT00717249|58695913|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
30681998|NCT00717249|58695912|FG000|Overall Study|Gastric Surgery|0|||
30681999|NCT00717249|58695913|FG001|Overall Study|Gastric Surgery|1|||
30682000|NCT00717249|58695912|FG000|Overall Study|Diagnosed with Diabetes|1|||
30682001|NCT00717249|58695913|FG001|Overall Study|Diagnosed with Diabetes|0|||
30682002|NCT00717249|58695912|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
30682003|NCT00717249|58695913|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
30682004|NCT00717249|58695912|FG000|Overall Study|Subject relocated|1|||
30682005|NCT00717249|58695913|FG001|Overall Study|Subject relocated|0|||
30682006|NCT00717249|58695912|FG000|Overall Study|Headaches|1|||
30682007|NCT00717249|58695913|FG001|Overall Study|Headaches|0|||
30682008|NCT00727194|58695919|FG000|Screening Period|Low QMG scores|0|||
30682009|NCT00727194|58695920|FG001|Screening Period|Low QMG scores|0|||
30682010|NCT00727194|58695921|FG002|Screening Period|Low QMG scores|6|||
30682011|NCT00727194|58695919|FG000|Screening Period|Lacked AChR antibodies|0|||
30682012|NCT00727194|58695920|FG001|Screening Period|Lacked AChR antibodies|0|||
30682013|NCT00727194|58695921|FG002|Screening Period|Lacked AChR antibodies|5|||
30682014|NCT00727194|58695919|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
30682015|NCT00727194|58695920|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
30682016|NCT00727194|58695921|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
30682017|NCT00727194|58695919|FG000|Screening Period|Severe infections|0|||
30682018|NCT00727194|58695920|FG001|Screening Period|Severe infections|0|||
30682019|NCT00727194|58695921|FG002|Screening Period|Severe infections|2|||
30682020|NCT00727194|58695919|FG000|Screening Period|History of thymoma|0|||
30596070|NCT01335698|58608045|FG003|Treatment Stage 1|Lack of Efficacy|3|||
30596071|NCT01335698|58608046|FG004|Treatment Stage 1|Lack of Efficacy|1|||
30596072|NCT01335698|58608042|FG000|Treatment Stage 1|Adverse Event|1|||
30596073|NCT01335698|58608043|FG001|Treatment Stage 1|Adverse Event|2|||
30596074|NCT01335698|58608044|FG002|Treatment Stage 1|Adverse Event|2|||
30596075|NCT01335698|58608045|FG003|Treatment Stage 1|Adverse Event|1|||
30596076|NCT01335698|58608046|FG004|Treatment Stage 1|Adverse Event|1|||
30596077|NCT01335698|58608042|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
30596078|NCT01335698|58608043|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
30596079|NCT01335698|58608044|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
30596080|NCT01335698|58608045|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
30596081|NCT01335698|58608046|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
30596082|NCT01335698|58608042|FG000|Treatment Stage 1|Lost to Follow-up|1|||
30596083|NCT01335698|58608043|FG001|Treatment Stage 1|Lost to Follow-up|1|||
30596084|NCT01335698|58608044|FG002|Treatment Stage 1|Lost to Follow-up|0|||
30596085|NCT01335698|58608045|FG003|Treatment Stage 1|Lost to Follow-up|0|||
30596086|NCT01335698|58608046|FG004|Treatment Stage 1|Lost to Follow-up|0|||
30596087|NCT01335698|58608042|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
30596088|NCT01335698|58608043|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
30596089|NCT01335698|58608044|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
30596090|NCT01335698|58608045|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
30682021|NCT00727194|58695920|FG001|Screening Period|History of thymoma|0|||
30682022|NCT00727194|58695921|FG002|Screening Period|History of thymoma|1|||
30682023|NCT00727194|58695919|FG000|Treatment Period 2|Lack of Efficacy|0|||
30682024|NCT00727194|58695920|FG001|Treatment Period 2|Lack of Efficacy|1|||
30682025|NCT00727194|58695921|FG002|Treatment Period 2|Lack of Efficacy|0|||
30682026|NCT00717093|58695937|FG000|Overall Study|Adverse Event|19|||
30682027|NCT00717093|58695938|FG001|Overall Study|Adverse Event|9|||
30596091|NCT01335698|58608046|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
30596092|NCT01335698|58608042|FG000|Treatment Stage 1|No longer meets study criteria|1|||
30596093|NCT01335698|58608043|FG001|Treatment Stage 1|No longer meets study criteria|1|||
30682028|NCT00717093|58695937|FG000|Overall Study|Lack of Efficacy|3|||
30596094|NCT01335698|58608044|FG002|Treatment Stage 1|No longer meets study criteria|0|||
30596095|NCT01335698|58608045|FG003|Treatment Stage 1|No longer meets study criteria|1|||
30596096|NCT01335698|58608046|FG004|Treatment Stage 1|No longer meets study criteria|0|||
30596097|NCT01335698|58608042|FG000|Treatment Stage 1|Other|1|||
30596098|NCT01335698|58608043|FG001|Treatment Stage 1|Other|0|||
30596099|NCT01335698|58608044|FG002|Treatment Stage 1|Other|0|||
30596100|NCT01335698|58608045|FG003|Treatment Stage 1|Other|1|||
30596101|NCT01335698|58608046|FG004|Treatment Stage 1|Other|0|||
30596102|NCT01335698|58608042|FG000|Treatment Stage 2|Lack of Efficacy|2|||
30596103|NCT01335698|58608043|FG001|Treatment Stage 2|Lack of Efficacy|1|||
30596104|NCT01335698|58608044|FG002|Treatment Stage 2|Lack of Efficacy|3|||
30596105|NCT01335698|58608045|FG003|Treatment Stage 2|Lack of Efficacy|1|||
30596106|NCT01335698|58608046|FG004|Treatment Stage 2|Lack of Efficacy|0|||
30596107|NCT01335698|58608042|FG000|Treatment Stage 2|Adverse Event|2|||
30596108|NCT01335698|58608043|FG001|Treatment Stage 2|Adverse Event|0|||
30596109|NCT01335698|58608044|FG002|Treatment Stage 2|Adverse Event|0|||
30596110|NCT01335698|58608045|FG003|Treatment Stage 2|Adverse Event|3|||
30596111|NCT01335698|58608046|FG004|Treatment Stage 2|Adverse Event|0|||
30596112|NCT01335698|58608042|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
30596113|NCT01335698|58608043|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
30682029|NCT00717093|58695938|FG001|Overall Study|Lack of Efficacy|13|||
30682030|NCT00717093|58695937|FG000|Overall Study|Lost to Follow-up|9|||
30682031|NCT00717093|58695938|FG001|Overall Study|Lost to Follow-up|6|||
30682032|NCT00717093|58695937|FG000|Overall Study|Withdrawal by Subject|12|||
30682033|NCT00717093|58695938|FG001|Overall Study|Withdrawal by Subject|19|||
30682034|NCT00717093|58695937|FG000|Overall Study|Other|0|||
30682035|NCT00717093|58695938|FG001|Overall Study|Other|1|||
30682036|NCT00717093|58695937|FG000|Overall Study|Randomized but not treated|1|||
30682037|NCT00717093|58695938|FG001|Overall Study|Randomized but not treated|0|||
30682038|NCT00716859|58695946|FG000|Overall Study|Adverse Event|4|||
30682039|NCT00716859|58695947|FG001|Overall Study|Adverse Event|1|||
30682040|NCT00716859|58695946|FG000|Overall Study|Lack of Efficacy|3|||
30682041|NCT00716859|58695947|FG001|Overall Study|Lack of Efficacy|0|||
30682042|NCT00716859|58695946|FG000|Overall Study|Withdrawal by Subject|1|||
30682043|NCT00716859|58695947|FG001|Overall Study|Withdrawal by Subject|3|||
30682044|NCT00716859|58695946|FG000|Overall Study|Not treated|1|||
30682045|NCT00716859|58695947|FG001|Overall Study|Not treated|1|||
30682046|NCT00589121|58695955|FG000|Overall Study|Protocol Violation|2|||
30682047|NCT00589121|58695956|FG001|Overall Study|Protocol Violation|6|||
30682048|NCT00589121|58695955|FG000|Overall Study|No protocol treatment received|0|||
30682049|NCT00589121|58695956|FG001|Overall Study|No protocol treatment received|1|||
30682050|NCT00590135|58695965|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
30682051|NCT00589667|58695970|FG000|Overall Study|Adverse Event|2|||
30682052|NCT00589667|58695970|FG000|Overall Study|Withdrawal by Subject|1|||
30682053|NCT00737568|58695976|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
30682054|NCT00737568|58695977|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
30682055|NCT00737568|58695976|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
30596114|NCT01335698|58608044|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
30596115|NCT01335698|58608045|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
30596116|NCT01335698|58608046|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
30596117|NCT01335698|58608042|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
30682056|NCT00737568|58695977|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
30682057|NCT00737568|58695976|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
30682058|NCT00737568|58695977|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
30682059|NCT00737568|58695976|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
30682060|NCT00737568|58695977|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
30682061|NCT00737568|58695976|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
30682062|NCT00737568|58695977|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
30596118|NCT01335698|58608043|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
30596119|NCT01335698|58608044|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
30596120|NCT01335698|58608045|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
30596121|NCT01335698|58608046|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
30596122|NCT01335698|58608042|FG000|Treatment Stage 2|Lost to Follow-up|1|||
30682063|NCT00737568|58695976|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
30682064|NCT00737568|58695977|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
30682065|NCT00737568|58695976|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
30682066|NCT00737568|58695977|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
30596123|NCT01335698|58608043|FG001|Treatment Stage 2|Lost to Follow-up|0|||
30682067|NCT00737568|58695976|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
30682068|NCT00737568|58695977|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
30682069|NCT00737568|58695976|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
30596124|NCT01335698|58608044|FG002|Treatment Stage 2|Lost to Follow-up|0|||
30856186|NCT03450707|58884058|FG001|Overall Study|Lactate < 3.5|2|||
30682070|NCT00737568|58695977|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
30682071|NCT00737100|58695986|FG000|Overall Study|Adverse Event|6|||
30682072|NCT00737100|58695987|FG001|Overall Study|Adverse Event|5|||
30682073|NCT00737100|58695988|FG002|Overall Study|Adverse Event|3|||
30682074|NCT00737100|58695986|FG000|Overall Study|Lost to Follow-up|0|||
30596125|NCT01335698|58608045|FG003|Treatment Stage 2|Lost to Follow-up|0|||
30596126|NCT01335698|58608046|FG004|Treatment Stage 2|Lost to Follow-up|0|||
30596127|NCT01335698|58608042|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
30596128|NCT01335698|58608043|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
30596129|NCT01335698|58608044|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
30682075|NCT00737100|58695987|FG001|Overall Study|Lost to Follow-up|1|||
30682076|NCT00737100|58695988|FG002|Overall Study|Lost to Follow-up|0|||
30682077|NCT00737100|58695986|FG000|Overall Study|Withdrawal by Subject|0|||
30682078|NCT00737100|58695987|FG001|Overall Study|Withdrawal by Subject|0|||
30682079|NCT00737100|58695988|FG002|Overall Study|Withdrawal by Subject|3|||
30682080|NCT00737100|58695986|FG000|Overall Study|Reason discontinued not explained above|1|||
30682081|NCT00737100|58695987|FG001|Overall Study|Reason discontinued not explained above|1|||
30682082|NCT00737100|58695988|FG002|Overall Study|Reason discontinued not explained above|1|||
30682083|NCT00732498|58695998|FG000|Overall Study|Ineligible|1|||
30682084|NCT00732498|58695998|FG000|Overall Study|Adverse Event|2|||
30682085|NCT00732498|58695998|FG000|Overall Study|Physician Decision|3|||
30682086|NCT00726882|58696002|FG000|Overall Study|Withdrawal by Subject|5|||
30682087|NCT00726882|58696002|FG000|Overall Study|Lost to Follow-up|7|||
30682088|NCT00726882|58696002|FG000|Overall Study|Other|10|||
30682089|NCT00790400|58696010|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
30682090|NCT00790400|58696011|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
30682091|NCT00790400|58696010|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
30682092|NCT00790400|58696011|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
30682093|NCT00790400|58696010|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
30682094|NCT00790400|58696011|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
30682095|NCT00790400|58696010|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
30682096|NCT00790400|58696011|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
30682097|NCT00790400|58696010|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
30682098|NCT00790400|58696011|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
30682099|NCT00790400|58696010|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
30682100|NCT00790400|58696011|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
30682101|NCT00790400|58696010|FG000|Double-blind Period (Core Phase)|Death|1|||
30682102|NCT00790400|58696011|FG001|Double-blind Period (Core Phase)|Death|0|||
30682103|NCT00790400|58696010|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
30682104|NCT00790400|58696011|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
30682105|NCT00790400|58696010|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
30682106|NCT00790400|58696011|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
30682107|NCT00790400|58696010|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
30682108|NCT00790400|58696011|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
30682109|NCT00790400|58696010|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
30682110|NCT00790400|58696011|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
30682111|NCT00790400|58696010|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
30682112|NCT00790400|58696011|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
30682113|NCT00790400|58696010|FG000|Everolimus Period (Core or Extension)|Death|1|||
30682114|NCT00790400|58696011|FG001|Everolimus Period (Core or Extension)|Death|0|||
30682115|NCT00790400|58696010|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
30596130|NCT01335698|58608045|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
30596131|NCT01335698|58608046|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
30682116|NCT00790400|58696011|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
30682117|NCT00790400|58696010|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
30682118|NCT00790400|58696011|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
30682119|NCT00790400|58696010|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
30682120|NCT00790400|58696011|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
30682121|NCT00786032|58696020|FG000|Overall Study|Death|4|||
30682122|NCT00786032|58696020|FG000|Overall Study|Withdrawal by Subject|14|||
30682123|NCT00786032|58696020|FG000|Overall Study|Did not complete in the timeframe|6|||
30682124|NCT00785486|58696026|FG000|Midazolam Alone|Withdrawal by Subject|1|||
30682125|NCT00589979|58696049|FG000|Run-In Period|Adverse Event|5|||
30682126|NCT00589979|58696050|FG001|Run-In Period|Adverse Event|0|||
30682127|NCT00589979|58696051|FG002|Run-In Period|Adverse Event|0|||
30856187|NCT03450707|58884057|FG000|Overall Study|Rearrest with ECMO|0|||
30682128|NCT00589979|58696049|FG000|Run-In Period|Protocol Violation|3|||
30856188|NCT03450707|58884058|FG001|Overall Study|Rearrest with ECMO|1|||
30682129|NCT00589979|58696050|FG001|Run-In Period|Protocol Violation|0|||
30682130|NCT00589979|58696051|FG002|Run-In Period|Protocol Violation|0|||
30682131|NCT00589979|58696049|FG000|Run-In Period|Did not qualify for randomization|54|||
30682132|NCT00589979|58696050|FG001|Run-In Period|Did not qualify for randomization|0|||
30682133|NCT00589979|58696051|FG002|Run-In Period|Did not qualify for randomization|0|||
30682134|NCT00589979|58696049|FG000|Run-In Period|Withdrawal by Subject|10|||
30682135|NCT00589979|58696050|FG001|Run-In Period|Withdrawal by Subject|0|||
30682136|NCT00589979|58696051|FG002|Run-In Period|Withdrawal by Subject|0|||
30682137|NCT00589979|58696049|FG000|Run-In Period|Informed Consent Withdrawn|4|||
30682138|NCT00589979|58696050|FG001|Run-In Period|Informed Consent Withdrawn|0|||
30682139|NCT00589979|58696051|FG002|Run-In Period|Informed Consent Withdrawn|0|||
30682140|NCT00589979|58696049|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
30682141|NCT00589979|58696050|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
30596132|NCT01335698|58608042|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
30596133|NCT01335698|58608043|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
30596134|NCT01335698|58608044|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
30596135|NCT01335698|58608045|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
30596136|NCT01335698|58608046|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
30596137|NCT01335698|58608042|FG000|Treatment Stage 2|Switched to another formulation|1|||
30596138|NCT01335698|58608043|FG001|Treatment Stage 2|Switched to another formulation|1|||
30682142|NCT00589979|58696051|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
30682143|NCT00589979|58696049|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
30682144|NCT00589979|58696050|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
30682145|NCT00589979|58696051|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
30682146|NCT00589979|58696049|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
30682147|NCT00589979|58696050|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
30783142|NCT02828020|58795273|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
30783143|NCT02828020|58795274|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
30783144|NCT02828020|58795275|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
30783145|NCT02828020|58795273|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
30783146|NCT02828020|58795274|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
30783147|NCT02828020|58795275|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
30783148|NCT02828020|58795273|FG000|Safety Follow-up Period|Protocol Violation|0|||
30783149|NCT02828020|58795274|FG001|Safety Follow-up Period|Protocol Violation|2|||
30783150|NCT02828020|58795275|FG002|Safety Follow-up Period|Protocol Violation|1|||
30783151|NCT02828020|58795273|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
30783152|NCT02828020|58795274|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
30783153|NCT02828020|58795275|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
30783154|NCT02827708|58795294|FG000|Overall Study|Lost to Follow-up|3|||
30783155|NCT02827708|58795295|FG001|Overall Study|Lost to Follow-up|1|||
30783156|NCT02827708|58795294|FG000|Overall Study|Withdrawal by Subject|1|||
30783157|NCT02827708|58795295|FG001|Overall Study|Withdrawal by Subject|2|||
30783158|NCT02827708|58795294|FG000|Overall Study|Death|1|||
30783159|NCT02827708|58795295|FG001|Overall Study|Death|2|||
30783160|NCT03760185|58795301|FG000|Overall Study|Lost to Follow-up|1|||
30783161|NCT03760185|58795302|FG001|Overall Study|Lost to Follow-up|1|||
30783162|NCT02891174|58795312|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
30783163|NCT02891174|58795313|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
30783164|NCT02891174|58795312|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
30783165|NCT02891174|58795313|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
30783166|NCT02891174|58795312|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
30783167|NCT02891174|58795313|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
30783168|NCT02891174|58795312|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
30783169|NCT02891174|58795313|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
30783170|NCT02891174|58795312|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
30783171|NCT02891174|58795313|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
30783172|NCT02891174|58795312|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
30783173|NCT02891174|58795313|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
30783174|NCT02891174|58795312|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
30783175|NCT02891174|58795313|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
30783176|NCT01751984|58795334|FG000|Overall Study|Adverse Event|5|||
30783177|NCT01751984|58795335|FG001|Overall Study|Adverse Event|3|||
30783178|NCT01751984|58795334|FG000|Overall Study|Withdrawal by Subject|0|||
30596139|NCT01335698|58608044|FG002|Treatment Stage 2|Switched to another formulation|0|||
30596140|NCT01335698|58608045|FG003|Treatment Stage 2|Switched to another formulation|0|||
30596141|NCT01335698|58608046|FG004|Treatment Stage 2|Switched to another formulation|0|||
30596142|NCT00107198|58608060|FG000|Overall Study|Lack of Efficacy|28|||
30596143|NCT00107198|58608060|FG000|Overall Study|Lost to Follow-up|12|||
30682148|NCT00589979|58696051|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
30682149|NCT00589979|58696049|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
30783179|NCT01751984|58795335|FG001|Overall Study|Withdrawal by Subject|1|||
30682150|NCT00589979|58696050|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
30596144|NCT00107198|58608060|FG000|Overall Study|Protocol Violation|1|||
30596145|NCT00107198|58608060|FG000|Overall Study|Withdrawal by Subject|6|||
30682151|NCT00589979|58696051|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
30682152|NCT00589979|58696049|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
30682153|NCT00589979|58696050|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
30682154|NCT00589979|58696051|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
30682155|NCT00589979|58696049|FG000|Double-Blind Treatment Period 2|Other|0|||
30682156|NCT00589979|58696050|FG001|Double-Blind Treatment Period 2|Other|0|||
30682157|NCT00589979|58696051|FG002|Double-Blind Treatment Period 2|Other|1|||
30682158|NCT00589979|58696049|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
30783180|NCT01751984|58795334|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
30783181|NCT01751984|58795335|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
30783182|NCT03330236|58795343|FG000|Overall Study|Death|2|||
30783183|NCT03330236|58795344|FG001|Overall Study|Death|1|||
30783184|NCT03330236|58795343|FG000|Overall Study|Withdrawal by Subject|2|||
30783185|NCT03330236|58795344|FG001|Overall Study|Withdrawal by Subject|4|||
30783186|NCT03330236|58795343|FG000|Overall Study|Lost to Follow-up|0|||
30783187|NCT03330236|58795344|FG001|Overall Study|Lost to Follow-up|2|||
30783188|NCT03330236|58795343|FG000|Overall Study|Physician Decision|2|||
30783189|NCT03330236|58795344|FG001|Overall Study|Physician Decision|0|||
30783190|NCT03330236|58795343|FG000|Overall Study|Protocol Violation|4|||
30783191|NCT03330236|58795344|FG001|Overall Study|Protocol Violation|3|||
30783192|NCT03330236|58795343|FG000|Overall Study|SedLine malfunction/blinding|19|||
30783193|NCT03330236|58795344|FG001|Overall Study|SedLine malfunction/blinding|14|||
30783194|NCT03330236|58795343|FG000|Overall Study|Volatile anesthetics used|11|||
30783195|NCT03330236|58795344|FG001|Overall Study|Volatile anesthetics used|8|||
30783196|NCT03330236|58795343|FG000|Overall Study|Surgery aborted/converted to open|60|||
30783197|NCT03330236|58795344|FG001|Overall Study|Surgery aborted/converted to open|52|||
30783198|NCT03330002|58795350|FG000|Overall Study|Lost to Follow-up|15|||
30783199|NCT03330002|58795350|FG000|Overall Study|Death|7|||
30783200|NCT02948582|58795354|FG000|Washout Period 1|Adverse Event|0|||
30783201|NCT02948582|58795355|FG001|Washout Period 1|Adverse Event|2|||
30783202|NCT02948582|58795356|FG002|Washout Period 1|Adverse Event|0|||
30783203|NCT02948582|58795357|FG003|Washout Period 1|Adverse Event|0|||
30783204|NCT02948582|58795358|FG004|Washout Period 1|Adverse Event|0|||
30783205|NCT02948582|58795359|FG005|Washout Period 1|Adverse Event|0|||
30783206|NCT02948582|58795354|FG000|Washout Period 1|Protocol Violation|0|||
30783207|NCT02948582|58795355|FG001|Washout Period 1|Protocol Violation|0|||
30783208|NCT02948582|58795356|FG002|Washout Period 1|Protocol Violation|0|||
30783209|NCT02948582|58795357|FG003|Washout Period 1|Protocol Violation|0|||
30783210|NCT02948582|58795358|FG004|Washout Period 1|Protocol Violation|0|||
30783211|NCT02948582|58795359|FG005|Washout Period 1|Protocol Violation|1|||
30783212|NCT02948582|58795354|FG000|Washout Period 2|Adverse Event|0|||
30783213|NCT02948582|58795355|FG001|Washout Period 2|Adverse Event|1|||
30783214|NCT02948582|58795356|FG002|Washout Period 2|Adverse Event|0|||
30783215|NCT02948582|58795357|FG003|Washout Period 2|Adverse Event|0|||
30783216|NCT02948582|58795358|FG004|Washout Period 2|Adverse Event|0|||
30682159|NCT00589979|58696050|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
30682160|NCT00589979|58696051|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
30783217|NCT02948582|58795359|FG005|Washout Period 2|Adverse Event|0|||
30783218|NCT02948582|58795354|FG000|Washout Period 2|personal reasons|0|||
30783219|NCT02948582|58795355|FG001|Washout Period 2|personal reasons|0|||
30783220|NCT02948582|58795356|FG002|Washout Period 2|personal reasons|0|||
30783221|NCT02948582|58795357|FG003|Washout Period 2|personal reasons|1|||
30856189|NCT03450707|58884057|FG000|Overall Study|Indication for thiamine + head CT results|0|||
30856190|NCT03450707|58884058|FG001|Overall Study|Indication for thiamine + head CT results|1|||
30596146|NCT00107198|58608060|FG000|Overall Study|Ineligible|5|||
30596147|NCT00107120|58608066|FG000|Overall Study|Adverse Event|4|||
30596148|NCT00107120|58608067|FG001|Overall Study|Adverse Event|1|||
30596149|NCT00107120|58608066|FG000|Overall Study|Lack of Efficacy|5|||
30596150|NCT00107120|58608067|FG001|Overall Study|Lack of Efficacy|5|||
30596151|NCT00107120|58608066|FG000|Overall Study|Protocol Violation|3|||
30596152|NCT00107120|58608067|FG001|Overall Study|Protocol Violation|0|||
30682161|NCT00589979|58696049|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
30682162|NCT00589979|58696050|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
30682163|NCT00589979|58696051|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
30682164|NCT00797732|58696065|FG000|Overall Study|Withdrawal by Subject|3|||
30783222|NCT02948582|58795358|FG004|Washout Period 2|personal reasons|0|||
30783223|NCT02948582|58795359|FG005|Washout Period 2|personal reasons|0|||
30783224|NCT02948582|58795354|FG000|Washout Period 4|Adverse Event|1|||
30783225|NCT02948582|58795355|FG001|Washout Period 4|Adverse Event|0|||
30783226|NCT02948582|58795356|FG002|Washout Period 4|Adverse Event|1|||
30783227|NCT02948582|58795357|FG003|Washout Period 4|Adverse Event|0|||
30783228|NCT02948582|58795358|FG004|Washout Period 4|Adverse Event|0|||
30596153|NCT00107120|58608066|FG000|Overall Study|Withdrawal by Subject|8|||
30596154|NCT00107120|58608067|FG001|Overall Study|Withdrawal by Subject|9|||
30682165|NCT00797732|58696066|FG001|Overall Study|Withdrawal by Subject|3|||
30682166|NCT00797732|58696067|FG002|Overall Study|Withdrawal by Subject|0|||
30682167|NCT00797732|58696065|FG000|Overall Study|Lost to Follow-up|1|||
30682168|NCT00797732|58696066|FG001|Overall Study|Lost to Follow-up|0|||
30682169|NCT00797732|58696067|FG002|Overall Study|Lost to Follow-up|0|||
30682170|NCT00797732|58696065|FG000|Overall Study|Death|1|||
30682171|NCT00797732|58696066|FG001|Overall Study|Death|0|||
30682172|NCT00797732|58696067|FG002|Overall Study|Death|0|||
30682173|NCT00797732|58696065|FG000|Overall Study|Not meet inclusion criteria|0|||
30682174|NCT00797732|58696066|FG001|Overall Study|Not meet inclusion criteria|0|||
30682175|NCT00797732|58696067|FG002|Overall Study|Not meet inclusion criteria|7|||
30596155|NCT00107120|58608066|FG000|Overall Study|Lost to Follow-up|8|||
30596156|NCT00107120|58608067|FG001|Overall Study|Lost to Follow-up|6|||
30596157|NCT00107120|58608066|FG000|Overall Study|Pregnancy|0|||
30596158|NCT00107120|58608067|FG001|Overall Study|Pregnancy|1|||
30596159|NCT00107120|58608066|FG000|Overall Study|moving away from site|1|||
30596160|NCT00107120|58608067|FG001|Overall Study|moving away from site|1|||
30596161|NCT00107120|58608066|FG000|Overall Study|death of parent|0|||
30596162|NCT00107120|58608067|FG001|Overall Study|death of parent|1|||
30596163|NCT01335464|58608075|FG000|Overall Study|Adverse Event|15|||
30596164|NCT01335464|58608076|FG001|Overall Study|Adverse Event|25|||
30596165|NCT01335464|58608075|FG000|Overall Study|Non compliant with protocol|2|||
30596166|NCT01335464|58608076|FG001|Overall Study|Non compliant with protocol|0|||
30596167|NCT01335464|58608075|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
30596168|NCT01335464|58608076|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
30682176|NCT00797732|58696065|FG000|Overall Study|Excluded due to time constraints|0|||
30682177|NCT00797732|58696066|FG001|Overall Study|Excluded due to time constraints|0|||
30682178|NCT00797732|58696067|FG002|Overall Study|Excluded due to time constraints|24|||
30682179|NCT00797732|58696065|FG000|Overall Study|Refused to Participate|0|||
30682180|NCT00797732|58696066|FG001|Overall Study|Refused to Participate|0|||
30682181|NCT00797732|58696067|FG002|Overall Study|Refused to Participate|123|||
30682182|NCT00790088|58696073|FG000|Overall Study|Protocol Violation|11|||
30682183|NCT00790088|58696073|FG000|Overall Study|Withdrawal by Subject|17|||
30682184|NCT00790088|58696073|FG000|Overall Study|Lost to Follow-up|7|||
30682185|NCT00790088|58696073|FG000|Overall Study|Physician Decision|4|||
30682186|NCT00736944|58696079|FG000|Induction|Death|1|||
30682187|NCT00736944|58696079|FG000|Definitive Treatment|Physician Decision|1|||
30682188|NCT00736476|58696088|FG000|Overall Study|Adverse Event|1|||
30682189|NCT00736476|58696089|FG001|Overall Study|Adverse Event|0|||
30682190|NCT00715299|58696101|FG000|Overall Study|Withdrawal by Subject|1|||
30682191|NCT00715299|58696101|FG000|Overall Study|Adverse Event|3|||
30682192|NCT00715299|58696101|FG000|Overall Study|failed the pre-screen exercise test|2|||
30682193|NCT00730236|58696105|FG000|Overall Study|Adverse Event|4|||
30682194|NCT00730236|58696105|FG000|Overall Study|Withdrawal by Subject|1|||
30682195|NCT00730236|58696105|FG000|Overall Study|Non-compliance|1|||
30682196|NCT00714285|58696113|FG000|Overall Study|Lost to Follow-up|0|||
30682197|NCT00714285|58696114|FG001|Overall Study|Lost to Follow-up|2|||
30682198|NCT00714285|58696115|FG002|Overall Study|Lost to Follow-up|0|||
30682199|NCT00714285|58696116|FG003|Overall Study|Lost to Follow-up|1|||
30682200|NCT00714285|58696113|FG000|Overall Study|Migrated/moved from study area|0|||
30682201|NCT00714285|58696114|FG001|Overall Study|Migrated/moved from study area|1|||
30959129|NCT01688999|59024353|FG001|Overall Study|Withdrawal by Subject|1|||
30596169|NCT01335464|58608075|FG000|Overall Study|Not treated|2|||
30596170|NCT01335464|58608076|FG001|Overall Study|Not treated|0|||
30596171|NCT01335464|58608075|FG000|Overall Study|Reason other than those stated above|1|||
30596172|NCT01335464|58608076|FG001|Overall Study|Reason other than those stated above|1|||
30596173|NCT00107042|58608084|FG000|Overall Study|Lost to Follow-up|9|||
30596174|NCT00107042|58608085|FG001|Overall Study|Lost to Follow-up|7|||
30596175|NCT00107042|58608084|FG000|Overall Study|Withdrawal by Subject|6|||
30682202|NCT00714285|58696115|FG002|Overall Study|Migrated/moved from study area|0|||
30682203|NCT00714285|58696116|FG003|Overall Study|Migrated/moved from study area|0|||
30682204|NCT00776984|58696130|FG000|Overall Study|Adverse Event|8|||
30682205|NCT00776984|58696131|FG001|Overall Study|Adverse Event|2|||
30682206|NCT00776984|58696130|FG000|Overall Study|Protocol Violation|4|||
30682207|NCT00776984|58696131|FG001|Overall Study|Protocol Violation|2|||
30682208|NCT00776984|58696130|FG000|Overall Study|Lost to Follow-up|2|||
30682209|NCT00776984|58696131|FG001|Overall Study|Lost to Follow-up|0|||
30682210|NCT00776984|58696130|FG000|Overall Study|Withdrawal by Subject|12|||
30682211|NCT00776984|58696131|FG001|Overall Study|Withdrawal by Subject|7|||
30596176|NCT00107042|58608085|FG001|Overall Study|Withdrawal by Subject|1|||
30596177|NCT00107042|58608084|FG000|Overall Study|Moved out of area|5|||
30596178|NCT00107042|58608085|FG001|Overall Study|Moved out of area|3|||
30596179|NCT00107042|58608084|FG000|Overall Study|Pregnancy|1|||
30596180|NCT00107042|58608085|FG001|Overall Study|Pregnancy|1|||
30596181|NCT00107042|58608084|FG000|Overall Study|Inadvertent enrollment|0|||
30682212|NCT00776984|58696130|FG000|Overall Study|Lack of Efficacy|0|||
30682213|NCT00776984|58696131|FG001|Overall Study|Lack of Efficacy|1|||
30682214|NCT00776984|58696130|FG000|Overall Study|Other|5|||
30596182|NCT00107042|58608085|FG001|Overall Study|Inadvertent enrollment|1|||
30596183|NCT00107042|58608084|FG000|Overall Study|vaccinated outside window|1|||
30596184|NCT00107042|58608085|FG001|Overall Study|vaccinated outside window|1|||
30682215|NCT00776984|58696131|FG001|Overall Study|Other|9|||
30682216|NCT00714051|58696139|FG000|Overall Study|Withdrawal by Subject|1|||
30682217|NCT00714051|58696140|FG001|Overall Study|Withdrawal by Subject|0|||
30682218|NCT00714051|58696139|FG000|Overall Study|Death|0|||
30682219|NCT00714051|58696140|FG001|Overall Study|Death|1|||
30682220|NCT00784784|58696148|FG000|Overall Study|Withdrawal by Subject|2|||
30682221|NCT00784784|58696149|FG001|Overall Study|Withdrawal by Subject|2|||
30682222|NCT00801983|58696157|FG000|Period 1|Lost to Follow-up|2|||
30682223|NCT00801983|58696158|FG001|Period 1|Lost to Follow-up|0|||
30682224|NCT00801983|58696157|FG000|Period 1|Withdrawal by Subject|2|||
30682225|NCT00801983|58696158|FG001|Period 1|Withdrawal by Subject|8|||
30682226|NCT00801983|58696157|FG000|Period 2|Withdrawal by Subject|2|||
30682227|NCT00801983|58696158|FG001|Period 2|Withdrawal by Subject|1|||
30682228|NCT00587288|58696166|FG000|Overall Study|Adverse Event|0|||
30682229|NCT00587288|58696167|FG001|Overall Study|Adverse Event|1|||
30682230|NCT00587288|58696166|FG000|Overall Study|Lack of Efficacy|2|||
30682231|NCT00587288|58696167|FG001|Overall Study|Lack of Efficacy|8|||
30682232|NCT00587288|58696166|FG000|Overall Study|Protocol Violation|1|||
30682233|NCT00587288|58696167|FG001|Overall Study|Protocol Violation|0|||
30682234|NCT00800735|58696175|FG000|Overall Study|Administrative/Other|2|||
30682235|NCT00800735|58696175|FG000|Overall Study|Insufficient Therapeutic Response|2|||
30682236|NCT00800735|58696175|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
30682237|NCT00800735|58696175|FG000|Overall Study|Withdrew Consent|3|||
30682238|NCT00730158|58696181|FG000|Overall Study|Withdrawal by Subject|1|||
30682239|NCT00730158|58696182|FG001|Overall Study|Withdrawal by Subject|1|||
30682240|NCT00784550|58696194|FG000|Overall Study|Adverse Event|12|||
30596185|NCT00107042|58608084|FG000|Overall Study|Disallowed medications|0|||
30596186|NCT00107042|58608085|FG001|Overall Study|Disallowed medications|2|||
30596187|NCT00106964|58608136|FG000|Overall Study|Lost to Follow-up|8|||
30596188|NCT00106964|58608137|FG001|Overall Study|Lost to Follow-up|6|||
30596189|NCT00106964|58608138|FG002|Overall Study|Lost to Follow-up|2|||
30596190|NCT00106964|58608136|FG000|Overall Study|Pregnancy|2|||
30596191|NCT00106964|58608137|FG001|Overall Study|Pregnancy|3|||
30596192|NCT00106964|58608138|FG002|Overall Study|Pregnancy|2|||
30596193|NCT00106964|58608136|FG000|Overall Study|Death|1|||
30596194|NCT00106964|58608137|FG001|Overall Study|Death|1|||
30596195|NCT00106964|58608138|FG002|Overall Study|Death|0|||
30596196|NCT00106964|58608136|FG000|Overall Study|Incarceration|0|||
30596197|NCT00106964|58608137|FG001|Overall Study|Incarceration|1|||
30596198|NCT00106964|58608138|FG002|Overall Study|Incarceration|0|||
30596199|NCT00106964|58608136|FG000|Overall Study|Site Funding Terminated|0|||
30596200|NCT00106964|58608137|FG001|Overall Study|Site Funding Terminated|1|||
30682241|NCT00784550|58696195|FG001|Overall Study|Adverse Event|10|||
30682242|NCT00784550|58696194|FG000|Overall Study|Lack of Efficacy|0|||
30682243|NCT00784550|58696195|FG001|Overall Study|Lack of Efficacy|1|||
30682244|NCT00784550|58696194|FG000|Overall Study|Protocol Violation|10|||
30682245|NCT00784550|58696195|FG001|Overall Study|Protocol Violation|10|||
30682246|NCT00784550|58696194|FG000|Overall Study|Lost to Follow-up|8|||
30682247|NCT00784550|58696195|FG001|Overall Study|Lost to Follow-up|5|||
30682248|NCT00784550|58696194|FG000|Overall Study|Physician Decision|2|||
30682249|NCT00784550|58696195|FG001|Overall Study|Physician Decision|3|||
30596201|NCT00106964|58608138|FG002|Overall Study|Site Funding Terminated|1|||
30596202|NCT00106964|58608136|FG000|Overall Study|Failure to adhere|2|||
30596203|NCT00106964|58608137|FG001|Overall Study|Failure to adhere|0|||
30596204|NCT00106964|58608138|FG002|Overall Study|Failure to adhere|0|||
30596205|NCT00106964|58608136|FG000|Overall Study|Did not meet eligibility criteria|0|||
30596206|NCT00106964|58608137|FG001|Overall Study|Did not meet eligibility criteria|2|||
30596207|NCT00106964|58608138|FG002|Overall Study|Did not meet eligibility criteria|2|||
30596208|NCT00106964|58608136|FG000|Overall Study|Required disallowed medication|0|||
30596209|NCT00106964|58608137|FG001|Overall Study|Required disallowed medication|1|||
30682250|NCT00784550|58696194|FG000|Overall Study|Withdrawal by Subject|4|||
30682251|NCT00784550|58696195|FG001|Overall Study|Withdrawal by Subject|13|||
30682252|NCT00729690|58696204|FG000|Overall Study|IT Catheter Malfunction|0|||
30682253|NCT00729690|58696205|FG001|Overall Study|IT Catheter Malfunction|2|||
30682254|NCT00729690|58696206|FG002|Overall Study|IT Catheter Malfunction|2|||
30682255|NCT00784238|58696214|FG000|Overall Study|Adverse Event|14|||
30682256|NCT00784238|58696214|FG000|Overall Study|Death|2|||
30682257|NCT00784238|58696214|FG000|Overall Study|Lack of Efficacy|33|||
30682258|NCT00784238|58696214|FG000|Overall Study|Lost to Follow-up|29|||
30596210|NCT00106964|58608138|FG002|Overall Study|Required disallowed medication|0|||
30596211|NCT00106184|58608157|FG000|Overall Study|Withdrawal by Subject|3|||
30596212|NCT00106184|58608158|FG001|Overall Study|Withdrawal by Subject|2|||
30596213|NCT01334918|58608168|FG000|Overall Study|Did not receive study drug|6|||
30596214|NCT01334918|58608169|FG001|Overall Study|Did not receive study drug|0|||
30596215|NCT01334918|58608168|FG000|Overall Study|Adverse Event|2|||
30682259|NCT00784238|58696214|FG000|Overall Study|Pregnancy|1|||
30682260|NCT00784238|58696214|FG000|Overall Study|Withdrawal by Subject|26|||
30682261|NCT00784238|58696214|FG000|Overall Study|Other|14|||
30682262|NCT00729612|58696221|FG000|Overall Study|Non evaluable for response|10|||
30682263|NCT00585546|58696225|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
30682264|NCT00585546|58696225|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
30682265|NCT00768248|58696231|FG000|Overall Study|Research coordinator didn't collect data|1|||
30682266|NCT00768248|58696232|FG001|Overall Study|Research coordinator didn't collect data|1|||
30682267|NCT00775268|58696240|FG000|Baseline|Drug not synthesize dose|1|||
30682268|NCT00775268|58696241|FG001|Baseline|Drug not synthesize dose|0|||
30682269|NCT00775268|58696240|FG000|Baseline|Not treated-ineligible per CT|0|||
30682270|NCT00775268|58696241|FG001|Baseline|Not treated-ineligible per CT|1|||
30682271|NCT00775268|58696240|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
30682272|NCT00775268|58696241|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
30682273|NCT00775268|58696240|FG000|After Completion|Participant missed scan appointment|1|||
30682274|NCT00775268|58696241|FG001|After Completion|Participant missed scan appointment|0|||
30682275|NCT00775190|58696260|FG000|Overall Study|Lost to Follow-up|2|||
30682276|NCT00775190|58696261|FG001|Overall Study|Lost to Follow-up|3|||
30682277|NCT00775190|58696260|FG000|Overall Study|Withdrawal by Subject|1|||
30682278|NCT00775190|58696261|FG001|Overall Study|Withdrawal by Subject|2|||
30682279|NCT00775190|58696260|FG000|Overall Study|Protocol Violation|1|||
30682280|NCT00775190|58696261|FG001|Overall Study|Protocol Violation|0|||
30682281|NCT00479557|58696274|FG000|Overall Study|Death|0|||
30682282|NCT00479557|58696275|FG001|Overall Study|Death|0|||
30682283|NCT00479557|58696276|FG002|Overall Study|Death|0|||
30682284|NCT00479557|58696277|FG003|Overall Study|Death|0|||
30682285|NCT00479557|58696278|FG004|Overall Study|Death|0|||
30682286|NCT00479557|58696279|FG005|Overall Study|Death|1|||
30682287|NCT00479557|58696280|FG006|Overall Study|Death|0|||
30682288|NCT00479557|58696274|FG000|Overall Study|Lack of Efficacy|1|||
30682289|NCT00479557|58696275|FG001|Overall Study|Lack of Efficacy|0|||
30682290|NCT00479557|58696276|FG002|Overall Study|Lack of Efficacy|0|||
30682291|NCT00479557|58696277|FG003|Overall Study|Lack of Efficacy|0|||
30682292|NCT00479557|58696278|FG004|Overall Study|Lack of Efficacy|0|||
30682293|NCT00479557|58696279|FG005|Overall Study|Lack of Efficacy|0|||
30682294|NCT00479557|58696280|FG006|Overall Study|Lack of Efficacy|0|||
30682295|NCT00479557|58696274|FG000|Overall Study|Lost to Follow-up|0|||
30682296|NCT00479557|58696275|FG001|Overall Study|Lost to Follow-up|2|||
30682297|NCT00479557|58696276|FG002|Overall Study|Lost to Follow-up|0|||
30682298|NCT00479557|58696277|FG003|Overall Study|Lost to Follow-up|2|||
30682299|NCT00479557|58696278|FG004|Overall Study|Lost to Follow-up|0|||
30682300|NCT00479557|58696279|FG005|Overall Study|Lost to Follow-up|0|||
30682301|NCT00479557|58696280|FG006|Overall Study|Lost to Follow-up|0|||
30682302|NCT00479557|58696274|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
30682303|NCT00479557|58696275|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
30682304|NCT00479557|58696276|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
30682305|NCT00479557|58696277|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
30682306|NCT00479557|58696278|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
30682307|NCT00479557|58696279|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
30682308|NCT00479557|58696280|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
30682309|NCT00479557|58696274|FG000|Overall Study|AE not related to Study Drug|1|||
30682310|NCT00479557|58696275|FG001|Overall Study|AE not related to Study Drug|3|||
30682311|NCT00479557|58696276|FG002|Overall Study|AE not related to Study Drug|0|||
30682312|NCT00479557|58696277|FG003|Overall Study|AE not related to Study Drug|0|||
30682313|NCT00479557|58696278|FG004|Overall Study|AE not related to Study Drug|2|||
30682314|NCT00479557|58696279|FG005|Overall Study|AE not related to Study Drug|2|||
30682315|NCT00479557|58696280|FG006|Overall Study|AE not related to Study Drug|1|||
30682316|NCT00479557|58696274|FG000|Overall Study|Caregiver Request|2|||
30682317|NCT00479557|58696275|FG001|Overall Study|Caregiver Request|2|||
30682318|NCT00479557|58696276|FG002|Overall Study|Caregiver Request|2|||
30682319|NCT00479557|58696277|FG003|Overall Study|Caregiver Request|0|||
30682320|NCT00479557|58696278|FG004|Overall Study|Caregiver Request|1|||
30682321|NCT00479557|58696279|FG005|Overall Study|Caregiver Request|2|||
30682322|NCT00479557|58696280|FG006|Overall Study|Caregiver Request|0|||
30682323|NCT00479557|58696274|FG000|Overall Study|Investigator Request|0|||
30682324|NCT00479557|58696275|FG001|Overall Study|Investigator Request|0|||
30682325|NCT00479557|58696276|FG002|Overall Study|Investigator Request|1|||
30682326|NCT00479557|58696277|FG003|Overall Study|Investigator Request|0|||
30682327|NCT00479557|58696278|FG004|Overall Study|Investigator Request|0|||
30783229|NCT02948582|58795359|FG005|Washout Period 4|Adverse Event|0|||
30783230|NCT03756285|58795375|FG000|Overall Study|Lost to Follow-up|0|||
30783231|NCT03756285|58795376|FG001|Overall Study|Lost to Follow-up|1|||
30783232|NCT03756285|58795375|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
30783233|NCT03756285|58795376|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
30783234|NCT03756285|58795375|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
30682328|NCT00479557|58696279|FG005|Overall Study|Investigator Request|0|||
30682329|NCT00479557|58696280|FG006|Overall Study|Investigator Request|0|||
30682330|NCT00479557|58696274|FG000|Overall Study|Subject Request|3|||
30682331|NCT00479557|58696275|FG001|Overall Study|Subject Request|0|||
30682332|NCT00479557|58696276|FG002|Overall Study|Subject Request|1|||
30682333|NCT00479557|58696277|FG003|Overall Study|Subject Request|1|||
30682334|NCT00479557|58696278|FG004|Overall Study|Subject Request|1|||
30682335|NCT00479557|58696279|FG005|Overall Study|Subject Request|4|||
30682336|NCT00479557|58696280|FG006|Overall Study|Subject Request|1|||
30682337|NCT00479557|58696274|FG000|Overall Study|Other|2|||
30682338|NCT00479557|58696275|FG001|Overall Study|Other|3|||
30682339|NCT00479557|58696276|FG002|Overall Study|Other|1|||
30682340|NCT00479557|58696277|FG003|Overall Study|Other|0|||
30682341|NCT00479557|58696278|FG004|Overall Study|Other|0|||
30682342|NCT00479557|58696279|FG005|Overall Study|Other|3|||
30682343|NCT00479557|58696280|FG006|Overall Study|Other|0|||
30682344|NCT00774800|58696302|FG000|Intervention 4|Withdrawal by Subject|1|||
30682345|NCT00439309|58696314|FG000|Follow-Up|Death|1|||
30682346|NCT00439309|58696315|FG001|Follow-Up|Death|0|||
30682347|NCT00439309|58696314|FG000|Follow-Up|Lost to Follow-up|2|||
30682348|NCT00439309|58696315|FG001|Follow-Up|Lost to Follow-up|0|||
30682349|NCT00439309|58696314|FG000|Follow-Up|Withdrawal by Subject|0|||
30682350|NCT00439309|58696315|FG001|Follow-Up|Withdrawal by Subject|1|||
30682351|NCT00439309|58696314|FG000|Follow-Up|Late response by subject|0|||
30682352|NCT00439309|58696315|FG001|Follow-Up|Late response by subject|1|||
30682353|NCT00479167|58696321|FG000|Overall Study|Withdrawal by Subject|1|||
30682354|NCT00725712|58696328|FG000|Overall Study|Withdrawal by Subject|2|||
30682355|NCT00725712|58696329|FG001|Overall Study|Withdrawal by Subject|1|||
30682356|NCT00725712|58696328|FG000|Overall Study|Protocol Violation|1|||
30682357|NCT00725712|58696329|FG001|Overall Study|Protocol Violation|0|||
30682358|NCT00725712|58696328|FG000|Overall Study|Progressive disease|37|||
30682359|NCT00725712|58696329|FG001|Overall Study|Progressive disease|16|||
30682360|NCT00725712|58696328|FG000|Overall Study|Clinical progression not based on RECIST|0|||
30682361|NCT00725712|58696329|FG001|Overall Study|Clinical progression not based on RECIST|3|||
30682362|NCT00725712|58696328|FG000|Overall Study|Adverse Event|5|||
30682363|NCT00725712|58696329|FG001|Overall Study|Adverse Event|5|||
30682364|NCT00725712|58696328|FG000|Overall Study|Death|2|||
30682365|NCT00725712|58696329|FG001|Overall Study|Death|0|||
30682366|NCT00725712|58696328|FG000|Overall Study|Other: Death|1|||
30682367|NCT00725712|58696329|FG001|Overall Study|Other: Death|0|||
30682368|NCT00725712|58696328|FG000|Overall Study|Hospitalized, unable to continue|0|||
30682369|NCT00725712|58696329|FG001|Overall Study|Hospitalized, unable to continue|1|||
30682370|NCT00729378|58696341|FG000|Baseline|Did not complete study measurements|72|||
30682371|NCT00729378|58696342|FG001|Baseline|Did not complete study measurements|33|||
30682372|NCT00729378|58696341|FG000|Baseline|Withdrawal by Subject|66|||
30682373|NCT00729378|58696342|FG001|Baseline|Withdrawal by Subject|59|||
30682374|NCT00729378|58696341|FG000|12-months|Lost to Follow-up|100|||
30682375|NCT00729378|58696342|FG001|12-months|Lost to Follow-up|65|||
30682376|NCT00729378|58696341|FG000|24-months|Lost to Follow-up|72|||
30682377|NCT00729378|58696342|FG001|24-months|Lost to Follow-up|51|||
30682378|NCT00729378|58696341|FG000|36-months|Lost to Follow-up|15|||
30682379|NCT00729378|58696342|FG001|36-months|Lost to Follow-up|6|||
30682380|NCT00478933|58696351|FG000|Overall Study|Protocol Violation|22|||
30682381|NCT00478933|58696351|FG000|Overall Study|Informed consent not verified|3|||
30682382|NCT00478933|58696351|FG000|Overall Study|Inadequate data available|53|||
30682383|NCT00725322|58696377|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
30682384|NCT00725322|58696378|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
30682385|NCT00725322|58696377|FG000|Washout (28 Days)|Protocol Violation|0|||
30682386|NCT00725322|58696378|FG001|Washout (28 Days)|Protocol Violation|1|||
30682387|NCT00725010|58696384|FG000|Overall Study|Toxicity|9|||
30596216|NCT01334918|58608169|FG001|Overall Study|Adverse Event|0|||
30596217|NCT01334918|58608168|FG000|Overall Study|Withdrawal by Subject|0|||
30596218|NCT01334918|58608169|FG001|Overall Study|Withdrawal by Subject|1|||
30596219|NCT01332968|58608188|FG000|Induction Period|Adverse Event|23|||
30596220|NCT01332968|58608189|FG001|Induction Period|Adverse Event|26|||
30596221|NCT01332968|58608190|FG002|Induction Period|Adverse Event|0|||
30596222|NCT01332968|58608191|FG003|Induction Period|Adverse Event|0|||
30682388|NCT00725010|58696384|FG000|Overall Study|Tumor Progression|7|||
30856191|NCT03450707|58884057|FG000|Overall Study|Family/patient goals of care|0|||
30682389|NCT00725010|58696384|FG000|Overall Study|Withdrawal by Subject|2|||
30682390|NCT00725010|58696384|FG000|Overall Study|Death|1|||
30682391|NCT00725010|58696384|FG000|Overall Study|Lost to Follow-up|1|||
30682392|NCT00725010|58696384|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
30682393|NCT00725010|58696384|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
30682394|NCT00725010|58696384|FG000|Overall Study|No further documentation|1|||
30682395|NCT00725010|58696384|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
30959130|NCT01688999|59024354|FG002|Overall Study|Withdrawal by Subject|1|||
30596223|NCT01332968|58608192|FG004|Induction Period|Adverse Event|0|||
30682396|NCT00767000|58696395|FG000|54-week Study|Adverse Event|4|||
30682397|NCT00767000|58696396|FG001|54-week Study|Adverse Event|6|||
30682398|NCT00767000|58696397|FG002|54-week Study|Adverse Event|6|||
30682399|NCT00767000|58696398|FG003|54-week Study|Adverse Event|8|||
30682400|NCT00767000|58696399|FG004|54-week Study|Adverse Event|4|||
30682401|NCT00767000|58696395|FG000|54-week Study|Creaninine/creatinine clearance|2|||
30682402|NCT00767000|58696396|FG001|54-week Study|Creaninine/creatinine clearance|1|||
30682403|NCT00767000|58696397|FG002|54-week Study|Creaninine/creatinine clearance|2|||
30682404|NCT00767000|58696398|FG003|54-week Study|Creaninine/creatinine clearance|2|||
30682405|NCT00767000|58696399|FG004|54-week Study|Creaninine/creatinine clearance|4|||
30682406|NCT00767000|58696395|FG000|54-week Study|Hyperglycemia|0|||
30682407|NCT00767000|58696396|FG001|54-week Study|Hyperglycemia|0|||
30682408|NCT00767000|58696397|FG002|54-week Study|Hyperglycemia|1|||
30682409|NCT00767000|58696398|FG003|54-week Study|Hyperglycemia|0|||
30682410|NCT00767000|58696399|FG004|54-week Study|Hyperglycemia|1|||
30682411|NCT00767000|58696395|FG000|54-week Study|Hypoglycemia|0|||
30682412|NCT00767000|58696396|FG001|54-week Study|Hypoglycemia|1|||
30682413|NCT00767000|58696397|FG002|54-week Study|Hypoglycemia|0|||
30682414|NCT00767000|58696398|FG003|54-week Study|Hypoglycemia|0|||
30682415|NCT00767000|58696399|FG004|54-week Study|Hypoglycemia|0|||
30682416|NCT00767000|58696395|FG000|54-week Study|Interruption of study medication|0|||
30682417|NCT00767000|58696396|FG001|54-week Study|Interruption of study medication|0|||
30682418|NCT00767000|58696397|FG002|54-week Study|Interruption of study medication|1|||
30682419|NCT00767000|58696398|FG003|54-week Study|Interruption of study medication|0|||
30682420|NCT00767000|58696399|FG004|54-week Study|Interruption of study medication|0|||
30682421|NCT00767000|58696395|FG000|54-week Study|Lack of Efficacy|2|||
30682422|NCT00767000|58696396|FG001|54-week Study|Lack of Efficacy|0|||
30682423|NCT00767000|58696397|FG002|54-week Study|Lack of Efficacy|1|||
30682424|NCT00767000|58696398|FG003|54-week Study|Lack of Efficacy|0|||
30682425|NCT00767000|58696399|FG004|54-week Study|Lack of Efficacy|5|||
30682426|NCT00767000|58696395|FG000|54-week Study|Lost to Follow-up|4|||
30682427|NCT00767000|58696396|FG001|54-week Study|Lost to Follow-up|0|||
30682428|NCT00767000|58696397|FG002|54-week Study|Lost to Follow-up|1|||
30682429|NCT00767000|58696398|FG003|54-week Study|Lost to Follow-up|4|||
30682430|NCT00767000|58696399|FG004|54-week Study|Lost to Follow-up|2|||
30682431|NCT00767000|58696395|FG000|54-week Study|Physician Decision|4|||
30682432|NCT00767000|58696396|FG001|54-week Study|Physician Decision|0|||
30682433|NCT00767000|58696397|FG002|54-week Study|Physician Decision|1|||
30682434|NCT00767000|58696398|FG003|54-week Study|Physician Decision|1|||
30682435|NCT00767000|58696399|FG004|54-week Study|Physician Decision|1|||
30682436|NCT00767000|58696395|FG000|54-week Study|Progressive disease|0|||
30682437|NCT00767000|58696396|FG001|54-week Study|Progressive disease|0|||
30682438|NCT00767000|58696397|FG002|54-week Study|Progressive disease|1|||
30682439|NCT00767000|58696398|FG003|54-week Study|Progressive disease|0|||
30682440|NCT00767000|58696399|FG004|54-week Study|Progressive disease|0|||
30682441|NCT00767000|58696395|FG000|54-week Study|Protocol Violation|0|||
30682442|NCT00767000|58696396|FG001|54-week Study|Protocol Violation|0|||
30682443|NCT00767000|58696397|FG002|54-week Study|Protocol Violation|1|||
30682444|NCT00767000|58696398|FG003|54-week Study|Protocol Violation|2|||
30682445|NCT00767000|58696399|FG004|54-week Study|Protocol Violation|0|||
30682446|NCT00767000|58696395|FG000|54-week Study|Withdrawal by Subject|2|||
30682447|NCT00767000|58696396|FG001|54-week Study|Withdrawal by Subject|3|||
30682448|NCT00767000|58696397|FG002|54-week Study|Withdrawal by Subject|5|||
30682449|NCT00767000|58696398|FG003|54-week Study|Withdrawal by Subject|11|||
30682450|NCT00767000|58696399|FG004|54-week Study|Withdrawal by Subject|13|||
30682451|NCT00767000|58696395|FG000|54-week Study|Study terminated by sponsor|90|||
30682452|NCT00767000|58696396|FG001|54-week Study|Study terminated by sponsor|102|||
30682453|NCT00767000|58696397|FG002|54-week Study|Study terminated by sponsor|89|||
30682454|NCT00767000|58696398|FG003|54-week Study|Study terminated by sponsor|196|||
30682455|NCT00767000|58696399|FG004|54-week Study|Study terminated by sponsor|194|||
30682456|NCT00767000|58696395|FG000|54-week Study|Reason not reported|0|||
30682457|NCT00767000|58696396|FG001|54-week Study|Reason not reported|0|||
30682458|NCT00767000|58696397|FG002|54-week Study|Reason not reported|0|||
30682459|NCT00767000|58696398|FG003|54-week Study|Reason not reported|1|||
30682460|NCT00767000|58696399|FG004|54-week Study|Reason not reported|0|||
30682461|NCT00767000|58696395|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
30682462|NCT00767000|58696396|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
30682463|NCT00767000|58696397|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
30682464|NCT00767000|58696398|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
30682465|NCT00767000|58696399|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
30682466|NCT00724932|58696413|FG000|Overall Study|Lost to Follow-up|1|||
30783235|NCT03756285|58795376|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
30783236|NCT02825992|58795402|FG000|Overall Study|Withdrawal by Subject|4|||
30783237|NCT02825992|58795402|FG000|Overall Study|Lost to Follow-up|2|||
30682467|NCT00724932|58696414|FG001|Overall Study|Lost to Follow-up|0|||
30682468|NCT00724932|58696413|FG000|Overall Study|Not treated|4|||
30682469|NCT00724932|58696414|FG001|Overall Study|Not treated|3|||
30682470|NCT00766532|58696422|FG000|Overall Study|Protocol Violation|2|||
30682471|NCT00774566|58696428|FG000|Overall Study|Protocol Violation|18|||
30682472|NCT00774566|58696429|FG001|Overall Study|Protocol Violation|15|||
30682473|NCT00766376|58696435|FG000|Overall Study|Withdrawal by Subject|27|||
30682474|NCT00587054|58696439|FG000|Overall Study|Patient not treated|9|||
30682475|NCT00766142|58696443|FG000|Overall Study|Protocol Violation|4|||
30682476|NCT00724854|58696449|FG000|Overall Study|Lack of Efficacy|187|||
30682477|NCT00724854|58696450|FG001|Overall Study|Lack of Efficacy|13|||
30682478|NCT00724854|58696449|FG000|Overall Study|Lost to Follow-up|87|||
30682479|NCT00724854|58696450|FG001|Overall Study|Lost to Follow-up|10|||
30682480|NCT00724854|58696449|FG000|Overall Study|Adverse Event|62|||
30682481|NCT00724854|58696450|FG001|Overall Study|Adverse Event|4|||
30682482|NCT00724854|58696449|FG000|Overall Study|Other|42|||
30682483|NCT00724854|58696450|FG001|Overall Study|Other|3|||
30682484|NCT00724854|58696449|FG000|Overall Study|Death|11|||
30783238|NCT02825992|58795402|FG000|Overall Study|Procedure terminated|2|||
30783239|NCT01339000|58795414|FG000|Overall Study|study closed due to lack of drug supply|1|||
30783240|NCT01339000|58795415|FG001|Overall Study|study closed due to lack of drug supply|0|||
30783241|NCT03755661|58795426|FG000|Overall Study|Lost to Follow-up|1|||
30783242|NCT03755661|58795427|FG001|Overall Study|Lost to Follow-up|0|||
30783243|NCT03752151|58795433|FG000|Overall Study|Withdrawal by Subject|1|||
30783244|NCT03752151|58795433|FG000|Overall Study|Protocol Violation|1|||
30783245|NCT01336634|58795441|FG000|Overall Study|Study closed/terminated|5|||
30783246|NCT01336634|58795442|FG001|Overall Study|Study closed/terminated|6|||
30783247|NCT01336634|58795443|FG002|Overall Study|Study closed/terminated|6|||
30783248|NCT01336634|58795441|FG000|Overall Study|Lost to Follow-up|2|||
30783249|NCT01336634|58795442|FG001|Overall Study|Lost to Follow-up|1|||
30783250|NCT01336634|58795443|FG002|Overall Study|Lost to Follow-up|1|||
30783251|NCT01336634|58795441|FG000|Overall Study|Physician Decision|1|||
30783252|NCT01336634|58795442|FG001|Overall Study|Physician Decision|1|||
30783253|NCT01336634|58795443|FG002|Overall Study|Physician Decision|0|||
30783254|NCT01336634|58795441|FG000|Overall Study|Withdrawal by Subject|6|||
30783255|NCT01336634|58795442|FG001|Overall Study|Withdrawal by Subject|0|||
30783256|NCT01336634|58795443|FG002|Overall Study|Withdrawal by Subject|2|||
30783257|NCT02947100|58795458|FG000|Overall Study|study terminated early|3|||
30783258|NCT02947100|58795458|FG000|Overall Study|did not meet inclusion criteria|1|||
30783259|NCT03329846|58795464|FG000|Overall Study|Disease progression|4|||
30783260|NCT03329846|58795465|FG001|Overall Study|Disease progression|6|||
30783261|NCT03329846|58795464|FG000|Overall Study|Study drug toxicity|1|||
30783262|NCT03329846|58795465|FG001|Overall Study|Study drug toxicity|0|||
30783263|NCT03329846|58795464|FG000|Overall Study|Participant request to discontinue treatment|0|||
30783264|NCT03329846|58795465|FG001|Overall Study|Participant request to discontinue treatment|1|||
30783265|NCT03329846|58795464|FG000|Overall Study|Participant withdrew consent|1|||
30783266|NCT03329846|58795465|FG001|Overall Study|Participant withdrew consent|0|||
30783267|NCT03329846|58795464|FG000|Overall Study|Other reasons|2|||
30596224|NCT01332968|58608193|FG005|Induction Period|Adverse Event|0|||
30596225|NCT01332968|58608194|FG006|Induction Period|Adverse Event|0|||
30596226|NCT01332968|58608195|FG007|Induction Period|Adverse Event|0|||
30596227|NCT01332968|58608188|FG000|Induction Period|Death|1|||
30596228|NCT01332968|58608189|FG001|Induction Period|Death|4|||
30596229|NCT01332968|58608190|FG002|Induction Period|Death|0|||
30596230|NCT01332968|58608191|FG003|Induction Period|Death|0|||
30596231|NCT01332968|58608192|FG004|Induction Period|Death|0|||
30596232|NCT01332968|58608193|FG005|Induction Period|Death|0|||
30596233|NCT01332968|58608194|FG006|Induction Period|Death|0|||
30596234|NCT01332968|58608195|FG007|Induction Period|Death|0|||
30596235|NCT01332968|58608188|FG000|Induction Period|Non-compliance|1|||
30596236|NCT01332968|58608189|FG001|Induction Period|Non-compliance|0|||
30596237|NCT01332968|58608190|FG002|Induction Period|Non-compliance|0|||
30596238|NCT01332968|58608191|FG003|Induction Period|Non-compliance|0|||
30682485|NCT00724854|58696450|FG001|Overall Study|Death|0|||
30682486|NCT00724854|58696449|FG000|Overall Study|Change of treatment|7|||
30682487|NCT00724854|58696450|FG001|Overall Study|Change of treatment|0|||
30783268|NCT03329846|58795465|FG001|Overall Study|Other reasons|2|||
30783269|NCT03325010|58795473|FG000|Overall Study|Adverse Event|3|||
30783270|NCT03325010|58795474|FG001|Overall Study|Adverse Event|8|||
30783271|NCT03325010|58795473|FG000|Overall Study|Protocol Violation|1|||
30783272|NCT03325010|58795474|FG001|Overall Study|Protocol Violation|8|||
30783273|NCT03325010|58795473|FG000|Overall Study|Withdrawal by Subject|1|||
30783274|NCT03325010|58795474|FG001|Overall Study|Withdrawal by Subject|3|||
30783275|NCT03325010|58795473|FG000|Overall Study|Lost to Follow-up|1|||
30783276|NCT03325010|58795474|FG001|Overall Study|Lost to Follow-up|0|||
30596239|NCT01332968|58608192|FG004|Induction Period|Non-compliance|0|||
30596240|NCT01332968|58608193|FG005|Induction Period|Non-compliance|0|||
30682488|NCT00724854|58696449|FG000|Overall Study|Withdrawal by Subject|5|||
30682489|NCT00724854|58696450|FG001|Overall Study|Withdrawal by Subject|0|||
30682490|NCT00724854|58696449|FG000|Overall Study|Adverse event + lack of efficacy|2|||
30596241|NCT01332968|58608194|FG006|Induction Period|Non-compliance|0|||
30596242|NCT01332968|58608195|FG007|Induction Period|Non-compliance|0|||
30682491|NCT00724854|58696450|FG001|Overall Study|Adverse event + lack of efficacy|1|||
30682492|NCT00728988|58696459|FG000|Overall Study|Not Treated|2|||
30596243|NCT01332968|58608188|FG000|Induction Period|Other|2|||
30596244|NCT01332968|58608189|FG001|Induction Period|Other|2|||
30682493|NCT00728988|58696460|FG001|Overall Study|Not Treated|2|||
30596245|NCT01332968|58608190|FG002|Induction Period|Other|0|||
30596246|NCT01332968|58608191|FG003|Induction Period|Other|0|||
30596247|NCT01332968|58608192|FG004|Induction Period|Other|0|||
30596248|NCT01332968|58608193|FG005|Induction Period|Other|0|||
30596249|NCT01332968|58608194|FG006|Induction Period|Other|0|||
30596250|NCT01332968|58608195|FG007|Induction Period|Other|0|||
30596251|NCT01332968|58608188|FG000|Induction Period|Physician Decision|6|||
30682494|NCT00728988|58696459|FG000|Overall Study|Death|1|||
30682495|NCT00728988|58696460|FG001|Overall Study|Death|1|||
30682496|NCT00728988|58696459|FG000|Overall Study|Adverse Event|3|||
30682497|NCT00728988|58696460|FG001|Overall Study|Adverse Event|2|||
30682498|NCT00728988|58696459|FG000|Overall Study|Other|85|||
30682499|NCT00728988|58696460|FG001|Overall Study|Other|77|||
30682500|NCT00728988|58696459|FG000|Overall Study|Withdrawal by Subject|2|||
30682501|NCT00728988|58696460|FG001|Overall Study|Withdrawal by Subject|6|||
30682502|NCT00728754|58696469|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
30682503|NCT00728754|58696470|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
30682504|NCT00728754|58696469|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
30682505|NCT00728754|58696470|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
30682506|NCT00728754|58696469|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
30682507|NCT00728754|58696470|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
30682508|NCT00728130|58696476|FG000|Overall Study|Withdrawal by Subject|1|||
30682509|NCT00728130|58696476|FG000|Overall Study|Paperwork not completed in time|1|||
30682510|NCT00728130|58696476|FG000|Overall Study|Physician Decision|1|||
30682511|NCT00735696|58696480|FG000|Overall Study|Withdrawal by Subject|1|||
30682512|NCT00735696|58696480|FG000|Overall Study|Enrolled but never Treated|1|||
30682513|NCT00478231|58696489|FG000|Overall Study|Death|7|||
30682514|NCT00478231|58696489|FG000|Overall Study|Lack of Efficacy|47|||
30682515|NCT00478231|58696489|FG000|Overall Study|Lost to Follow-up|7|||
30682516|NCT00478231|58696489|FG000|Overall Study|Withdrawal by Subject|6|||
30596252|NCT01332968|58608189|FG001|Induction Period|Physician Decision|1|||
30596253|NCT01332968|58608190|FG002|Induction Period|Physician Decision|0|||
30596254|NCT01332968|58608191|FG003|Induction Period|Physician Decision|0|||
30596255|NCT01332968|58608192|FG004|Induction Period|Physician Decision|0|||
30596256|NCT01332968|58608193|FG005|Induction Period|Physician Decision|0|||
30596257|NCT01332968|58608194|FG006|Induction Period|Physician Decision|0|||
30596258|NCT01332968|58608195|FG007|Induction Period|Physician Decision|0|||
30596259|NCT01332968|58608188|FG000|Induction Period|Progressive Disease|15|||
30596260|NCT01332968|58608189|FG001|Induction Period|Progressive Disease|7|||
30596261|NCT01332968|58608190|FG002|Induction Period|Progressive Disease|0|||
30596262|NCT01332968|58608191|FG003|Induction Period|Progressive Disease|0|||
30596263|NCT01332968|58608192|FG004|Induction Period|Progressive Disease|0|||
30596264|NCT01332968|58608193|FG005|Induction Period|Progressive Disease|0|||
30596265|NCT01332968|58608194|FG006|Induction Period|Progressive Disease|0|||
30596266|NCT01332968|58608195|FG007|Induction Period|Progressive Disease|0|||
30596267|NCT01332968|58608188|FG000|Induction Period|Protocol Violation|3|||
30596268|NCT01332968|58608189|FG001|Induction Period|Protocol Violation|4|||
30596269|NCT01332968|58608190|FG002|Induction Period|Protocol Violation|0|||
30596270|NCT01332968|58608191|FG003|Induction Period|Protocol Violation|0|||
30596271|NCT01332968|58608192|FG004|Induction Period|Protocol Violation|0|||
30596272|NCT01332968|58608193|FG005|Induction Period|Protocol Violation|0|||
30596273|NCT01332968|58608194|FG006|Induction Period|Protocol Violation|0|||
30596274|NCT01332968|58608195|FG007|Induction Period|Protocol Violation|0|||
30596275|NCT01332968|58608188|FG000|Induction Period|Withdrawal by Subject|3|||
30596276|NCT01332968|58608189|FG001|Induction Period|Withdrawal by Subject|5|||
30596277|NCT01332968|58608190|FG002|Induction Period|Withdrawal by Subject|0|||
30596278|NCT01332968|58608191|FG003|Induction Period|Withdrawal by Subject|0|||
30596279|NCT01332968|58608192|FG004|Induction Period|Withdrawal by Subject|0|||
30596280|NCT01332968|58608193|FG005|Induction Period|Withdrawal by Subject|0|||
30596281|NCT01332968|58608194|FG006|Induction Period|Withdrawal by Subject|0|||
30596282|NCT01332968|58608195|FG007|Induction Period|Withdrawal by Subject|0|||
30596283|NCT01332968|58608188|FG000|Induction Period|Randomised but not treated|4|||
30596284|NCT01332968|58608189|FG001|Induction Period|Randomised but not treated|7|||
30682517|NCT00478231|58696489|FG000|Overall Study|Other|9|||
30682518|NCT00478231|58696489|FG000|Overall Study|Adverse Event|5|||
30682519|NCT00478231|58696489|FG000|Overall Study|Randomized, not treated|3|||
30682520|NCT00474175|58696496|FG000|Overall Study|Lack of Efficacy|0|||
30682521|NCT00474175|58696497|FG001|Overall Study|Lack of Efficacy|0|||
30682522|NCT00474175|58696498|FG002|Overall Study|Lack of Efficacy|1|||
30682523|NCT00474175|58696496|FG000|Overall Study|Withdrawal by Subject|0|||
30596285|NCT01332968|58608190|FG002|Induction Period|Randomised but not treated|0|||
30596286|NCT01332968|58608191|FG003|Induction Period|Randomised but not treated|0|||
30682524|NCT00474175|58696497|FG001|Overall Study|Withdrawal by Subject|1|||
30596287|NCT01332968|58608192|FG004|Induction Period|Randomised but not treated|0|||
30596288|NCT01332968|58608193|FG005|Induction Period|Randomised but not treated|0|||
30596289|NCT01332968|58608194|FG006|Induction Period|Randomised but not treated|0|||
30596290|NCT01332968|58608195|FG007|Induction Period|Randomised but not treated|0|||
30596291|NCT01332968|58608188|FG000|Maintenance/Observation Period|Adverse Event|0|||
30596292|NCT01332968|58608189|FG001|Maintenance/Observation Period|Adverse Event|0|||
30596293|NCT01332968|58608190|FG002|Maintenance/Observation Period|Adverse Event|53|||
30596294|NCT01332968|58608191|FG003|Maintenance/Observation Period|Adverse Event|66|||
30596295|NCT01332968|58608192|FG004|Maintenance/Observation Period|Adverse Event|0|||
30596296|NCT01332968|58608193|FG005|Maintenance/Observation Period|Adverse Event|0|||
30596297|NCT01332968|58608194|FG006|Maintenance/Observation Period|Adverse Event|0|||
30596298|NCT01332968|58608195|FG007|Maintenance/Observation Period|Adverse Event|0|||
30596299|NCT01332968|58608188|FG000|Maintenance/Observation Period|Death|0|||
30596300|NCT01332968|58608189|FG001|Maintenance/Observation Period|Death|0|||
30596301|NCT01332968|58608190|FG002|Maintenance/Observation Period|Death|5|||
30596302|NCT01332968|58608191|FG003|Maintenance/Observation Period|Death|6|||
30596303|NCT01332968|58608192|FG004|Maintenance/Observation Period|Death|0|||
30596304|NCT01332968|58608193|FG005|Maintenance/Observation Period|Death|0|||
30596305|NCT01332968|58608194|FG006|Maintenance/Observation Period|Death|0|||
30596306|NCT01332968|58608195|FG007|Maintenance/Observation Period|Death|0|||
30596307|NCT01332968|58608188|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
30596308|NCT01332968|58608189|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
30596309|NCT01332968|58608190|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
30596310|NCT01332968|58608191|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
30596311|NCT01332968|58608192|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
30596312|NCT01332968|58608193|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
30596313|NCT01332968|58608194|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
30596314|NCT01332968|58608195|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
30596315|NCT01332968|58608188|FG000|Maintenance/Observation Period|Non-compliance|0|||
30596316|NCT01332968|58608189|FG001|Maintenance/Observation Period|Non-compliance|0|||
30596317|NCT01332968|58608190|FG002|Maintenance/Observation Period|Non-compliance|4|||
30596318|NCT01332968|58608191|FG003|Maintenance/Observation Period|Non-compliance|3|||
30596319|NCT01332968|58608192|FG004|Maintenance/Observation Period|Non-compliance|0|||
30596320|NCT01332968|58608193|FG005|Maintenance/Observation Period|Non-compliance|0|||
30596321|NCT01332968|58608194|FG006|Maintenance/Observation Period|Non-compliance|0|||
30596322|NCT01332968|58608195|FG007|Maintenance/Observation Period|Non-compliance|0|||
30596323|NCT01332968|58608188|FG000|Maintenance/Observation Period|Other|0|||
30596324|NCT01332968|58608189|FG001|Maintenance/Observation Period|Other|0|||
30596325|NCT01332968|58608190|FG002|Maintenance/Observation Period|Other|4|||
30596326|NCT01332968|58608191|FG003|Maintenance/Observation Period|Other|7|||
30596327|NCT01332968|58608192|FG004|Maintenance/Observation Period|Other|0|||
30596328|NCT01332968|58608193|FG005|Maintenance/Observation Period|Other|0|||
30596329|NCT01332968|58608194|FG006|Maintenance/Observation Period|Other|0|||
30596330|NCT01332968|58608195|FG007|Maintenance/Observation Period|Other|0|||
30596331|NCT01332968|58608188|FG000|Maintenance/Observation Period|Physician Decision|0|||
30596332|NCT01332968|58608189|FG001|Maintenance/Observation Period|Physician Decision|0|||
30596333|NCT01332968|58608190|FG002|Maintenance/Observation Period|Physician Decision|14|||
30596334|NCT01332968|58608191|FG003|Maintenance/Observation Period|Physician Decision|19|||
30596335|NCT01332968|58608192|FG004|Maintenance/Observation Period|Physician Decision|0|||
30596336|NCT01332968|58608193|FG005|Maintenance/Observation Period|Physician Decision|1|||
30682525|NCT00474175|58696498|FG002|Overall Study|Withdrawal by Subject|1|||
30682526|NCT00474175|58696496|FG000|Overall Study|Ineligible|1|||
30682527|NCT00474175|58696497|FG001|Overall Study|Ineligible|3|||
30682528|NCT00474175|58696498|FG002|Overall Study|Ineligible|1|||
30682529|NCT00474175|58696496|FG000|Overall Study|Protocol Violation|0|||
30682530|NCT00474175|58696497|FG001|Overall Study|Protocol Violation|2|||
30682531|NCT00474175|58696498|FG002|Overall Study|Protocol Violation|1|||
30682532|NCT00474175|58696496|FG000|Overall Study|Administrative|0|||
30682533|NCT00474175|58696497|FG001|Overall Study|Administrative|1|||
30682534|NCT00474175|58696498|FG002|Overall Study|Administrative|0|||
30682535|NCT00443209|58696529|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
30682536|NCT00443209|58696530|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
30682537|NCT00443209|58696529|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
30682538|NCT00443209|58696530|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
30682539|NCT00443209|58696529|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
30682540|NCT00443209|58696530|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
30682541|NCT00443209|58696529|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
30682542|NCT00443209|58696530|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
30682543|NCT00443209|58696529|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
30682544|NCT00443209|58696530|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
30682545|NCT00443209|58696529|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
30682546|NCT00443209|58696530|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
30682547|NCT00443209|58696529|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
30682548|NCT00443209|58696530|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
30682549|NCT00443209|58696529|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
30682550|NCT00443209|58696530|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
30682551|NCT00443209|58696529|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
30682552|NCT00443209|58696530|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
30682553|NCT00443209|58696529|FG000|Months 1 to 12 Treatment Period|Missing|2|||
30682554|NCT00443209|58696530|FG001|Months 1 to 12 Treatment Period|Missing|1|||
30682555|NCT00443209|58696529|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
30682556|NCT00443209|58696530|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
30682557|NCT00443209|58696529|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
30682558|NCT00443209|58696530|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
30596337|NCT01332968|58608194|FG006|Maintenance/Observation Period|Physician Decision|0|||
30682559|NCT00443209|58696529|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
30682560|NCT00443209|58696530|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
30682561|NCT00443209|58696529|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
30682562|NCT00443209|58696530|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
30682563|NCT00443209|58696529|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
30682564|NCT00443209|58696530|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
30682565|NCT00443209|58696529|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
30682566|NCT00443209|58696530|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
30682567|NCT00443209|58696529|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
30682568|NCT00443209|58696530|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
30783277|NCT03325010|58795473|FG000|Overall Study|Physician Decision|1|||
30783278|NCT03325010|58795474|FG001|Overall Study|Physician Decision|1|||
30783279|NCT03325010|58795473|FG000|Overall Study|Lack of Efficacy|2|||
30783280|NCT03325010|58795474|FG001|Overall Study|Lack of Efficacy|0|||
30783281|NCT02824432|58795482|FG000|Overall Study|Major Protocol Deviation|1|||
30783282|NCT02824432|58795483|FG001|Overall Study|Major Protocol Deviation|0|||
30783283|NCT02823964|58795489|FG000|Overall Study|Adverse Event|2|||
30783284|NCT02823964|58795489|FG000|Overall Study|Physician Decision|1|||
30783285|NCT02823964|58795489|FG000|Overall Study|Lack of Efficacy|1|||
30783286|NCT02823964|58795489|FG000|Overall Study|Withdrawal by Subject|1|||
30783287|NCT01338610|58795496|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
30783288|NCT01338610|58795497|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
30783289|NCT01338610|58795498|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
30783290|NCT01338610|58795496|FG000|Overall Study|Protocol Violation|1|||
30783291|NCT01338610|58795497|FG001|Overall Study|Protocol Violation|0|||
30783292|NCT01338610|58795498|FG002|Overall Study|Protocol Violation|1|||
30783293|NCT01338610|58795496|FG000|Overall Study|Adverse Event|3|||
30783294|NCT01338610|58795497|FG001|Overall Study|Adverse Event|0|||
30783295|NCT01338610|58795498|FG002|Overall Study|Adverse Event|0|||
30783296|NCT01355302|58795505|FG000|Phase 1b|Death|4|||
30783297|NCT01355302|58795506|FG001|Phase 1b|Death|0|||
30783298|NCT01355302|58795507|FG002|Phase 1b|Death|0|||
30783299|NCT01355302|58795505|FG000|Phase 1b|Study terminated by sponsor|2|||
30783300|NCT01355302|58795506|FG001|Phase 1b|Study terminated by sponsor|0|||
30783301|NCT01355302|58795507|FG002|Phase 1b|Study terminated by sponsor|0|||
30783302|NCT01355068|58795515|FG000|First Intervention Period|Adverse Event|0|||
30783303|NCT01355068|58795516|FG001|First Intervention Period|Adverse Event|1|||
30783304|NCT01355068|58795515|FG000|First Intervention Period|Withdrawal by Subject|0|||
30783305|NCT01355068|58795516|FG001|First Intervention Period|Withdrawal by Subject|1|||
30596338|NCT01332968|58608195|FG007|Maintenance/Observation Period|Physician Decision|0|||
30596339|NCT01332968|58608188|FG000|Maintenance/Observation Period|Progressive Disease|0|||
30596340|NCT01332968|58608189|FG001|Maintenance/Observation Period|Progressive Disease|0|||
30596341|NCT01332968|58608190|FG002|Maintenance/Observation Period|Progressive Disease|72|||
30596342|NCT01332968|58608191|FG003|Maintenance/Observation Period|Progressive Disease|40|||
30596343|NCT01332968|58608192|FG004|Maintenance/Observation Period|Progressive Disease|0|||
30596344|NCT01332968|58608193|FG005|Maintenance/Observation Period|Progressive Disease|0|||
30596345|NCT01332968|58608194|FG006|Maintenance/Observation Period|Progressive Disease|0|||
30596346|NCT01332968|58608195|FG007|Maintenance/Observation Period|Progressive Disease|0|||
30596347|NCT01332968|58608188|FG000|Maintenance/Observation Period|Protocol Violation|0|||
30682569|NCT00439231|58696536|FG000|Overall Study|Lack of Efficacy|28|||
30783306|NCT03756129|58795528|FG000|Overall Study|Adverse Event|1|||
30783307|NCT03756129|58795529|FG001|Overall Study|Adverse Event|1|||
30682570|NCT00437983|58696542|FG000|Overall Study|Adverse Event|6|||
30682571|NCT00437983|58696543|FG001|Overall Study|Adverse Event|6|||
30682572|NCT00437983|58696542|FG000|Overall Study|Protocol Violation|2|||
30783308|NCT03756129|58795530|FG002|Overall Study|Adverse Event|0|||
30783309|NCT03756129|58795531|FG003|Overall Study|Adverse Event|2|||
30783310|NCT03756129|58795532|FG004|Overall Study|Adverse Event|0|||
30783311|NCT03756129|58795533|FG005|Overall Study|Adverse Event|0|||
30783312|NCT03756129|58795528|FG000|Overall Study|Withdrawal by Subject|2|||
30783313|NCT03756129|58795529|FG001|Overall Study|Withdrawal by Subject|1|||
30596348|NCT01332968|58608189|FG001|Maintenance/Observation Period|Protocol Violation|0|||
30596349|NCT01332968|58608190|FG002|Maintenance/Observation Period|Protocol Violation|1|||
30596350|NCT01332968|58608191|FG003|Maintenance/Observation Period|Protocol Violation|1|||
30596351|NCT01332968|58608192|FG004|Maintenance/Observation Period|Protocol Violation|0|||
30596352|NCT01332968|58608193|FG005|Maintenance/Observation Period|Protocol Violation|0|||
30596353|NCT01332968|58608194|FG006|Maintenance/Observation Period|Protocol Violation|0|||
30596354|NCT01332968|58608195|FG007|Maintenance/Observation Period|Protocol Violation|0|||
30596355|NCT01332968|58608188|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
30596356|NCT01332968|58608189|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
30596357|NCT01332968|58608190|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
30596358|NCT01332968|58608191|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
30596359|NCT01332968|58608192|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
30596360|NCT01332968|58608193|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
30596361|NCT01332968|58608194|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
30596362|NCT01332968|58608195|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
30596363|NCT01332968|58608188|FG000|Follow-Up Period|Adverse Event|0|||
30596364|NCT01332968|58608189|FG001|Follow-Up Period|Adverse Event|0|||
30596365|NCT01332968|58608190|FG002|Follow-Up Period|Adverse Event|0|||
30596366|NCT01332968|58608191|FG003|Follow-Up Period|Adverse Event|0|||
30596367|NCT01332968|58608192|FG004|Follow-Up Period|Adverse Event|0|||
30596368|NCT01332968|58608193|FG005|Follow-Up Period|Adverse Event|0|||
30596369|NCT01332968|58608194|FG006|Follow-Up Period|Adverse Event|0|||
30596370|NCT01332968|58608195|FG007|Follow-Up Period|Adverse Event|4|||
30596371|NCT01332968|58608188|FG000|Follow-Up Period|Death|0|||
30596372|NCT01332968|58608189|FG001|Follow-Up Period|Death|0|||
30596373|NCT01332968|58608190|FG002|Follow-Up Period|Death|0|||
30596374|NCT01332968|58608191|FG003|Follow-Up Period|Death|0|||
30596375|NCT01332968|58608192|FG004|Follow-Up Period|Death|0|||
30596376|NCT01332968|58608193|FG005|Follow-Up Period|Death|0|||
30596377|NCT01332968|58608194|FG006|Follow-Up Period|Death|27|||
30596378|NCT01332968|58608195|FG007|Follow-Up Period|Death|30|||
30682573|NCT00437983|58696543|FG001|Overall Study|Protocol Violation|1|||
30682574|NCT00437983|58696542|FG000|Overall Study|Withdrawal by Subject|5|||
30682575|NCT00437983|58696543|FG001|Overall Study|Withdrawal by Subject|6|||
30682576|NCT00783692|58696552|FG000|Induction Phase|Adverse Event|7|||
30682577|NCT00783692|58696553|FG001|Induction Phase|Adverse Event|9|||
30682578|NCT00783692|58696554|FG002|Induction Phase|Adverse Event|24|||
30682579|NCT00783692|58696555|FG003|Induction Phase|Adverse Event|0|||
30596379|NCT01332968|58608188|FG000|Follow-Up Period|Lost to Follow-up|0|||
30596380|NCT01332968|58608189|FG001|Follow-Up Period|Lost to Follow-up|0|||
30596381|NCT01332968|58608190|FG002|Follow-Up Period|Lost to Follow-up|0|||
30596382|NCT01332968|58608191|FG003|Follow-Up Period|Lost to Follow-up|0|||
30596383|NCT01332968|58608192|FG004|Follow-Up Period|Lost to Follow-up|0|||
30596384|NCT01332968|58608193|FG005|Follow-Up Period|Lost to Follow-up|0|||
30596385|NCT01332968|58608194|FG006|Follow-Up Period|Lost to Follow-up|11|||
30682580|NCT00783692|58696556|FG004|Induction Phase|Adverse Event|0|||
30682581|NCT00783692|58696557|FG005|Induction Phase|Adverse Event|0|||
30682582|NCT00783692|58696558|FG006|Induction Phase|Adverse Event|0|||
30682583|NCT00783692|58696552|FG000|Induction Phase|Protocol Violation|0|||
30682584|NCT00783692|58696553|FG001|Induction Phase|Protocol Violation|0|||
30682585|NCT00783692|58696554|FG002|Induction Phase|Protocol Violation|1|||
30682586|NCT00783692|58696555|FG003|Induction Phase|Protocol Violation|0|||
30682587|NCT00783692|58696556|FG004|Induction Phase|Protocol Violation|0|||
30682588|NCT00783692|58696557|FG005|Induction Phase|Protocol Violation|0|||
30682589|NCT00783692|58696558|FG006|Induction Phase|Protocol Violation|0|||
30682590|NCT00783692|58696552|FG000|Induction Phase|Lack of Efficacy|1|||
30596386|NCT01332968|58608195|FG007|Follow-Up Period|Lost to Follow-up|15|||
30596387|NCT01332968|58608188|FG000|Follow-Up Period|Non-compliance|0|||
30596388|NCT01332968|58608189|FG001|Follow-Up Period|Non-compliance|0|||
30596389|NCT01332968|58608190|FG002|Follow-Up Period|Non-compliance|0|||
30596390|NCT01332968|58608191|FG003|Follow-Up Period|Non-compliance|0|||
30596391|NCT01332968|58608192|FG004|Follow-Up Period|Non-compliance|0|||
30596392|NCT01332968|58608193|FG005|Follow-Up Period|Non-compliance|0|||
30596393|NCT01332968|58608194|FG006|Follow-Up Period|Non-compliance|4|||
30682591|NCT00783692|58696553|FG001|Induction Phase|Lack of Efficacy|3|||
30856192|NCT03450707|58884058|FG001|Overall Study|Family/patient goals of care|1|||
30596394|NCT01332968|58608195|FG007|Follow-Up Period|Non-compliance|9|||
30596395|NCT01332968|58608188|FG000|Follow-Up Period|Other|0|||
30682592|NCT00783692|58696554|FG002|Induction Phase|Lack of Efficacy|28|||
30682593|NCT00783692|58696555|FG003|Induction Phase|Lack of Efficacy|0|||
30682594|NCT00783692|58696556|FG004|Induction Phase|Lack of Efficacy|0|||
30682595|NCT00783692|58696557|FG005|Induction Phase|Lack of Efficacy|0|||
30682596|NCT00783692|58696558|FG006|Induction Phase|Lack of Efficacy|0|||
30596396|NCT01332968|58608189|FG001|Follow-Up Period|Other|0|||
30682597|NCT00783692|58696552|FG000|Induction Phase|Withdrawal by Subject|3|||
30596397|NCT01332968|58608190|FG002|Follow-Up Period|Other|0|||
30596398|NCT01332968|58608191|FG003|Follow-Up Period|Other|0|||
30856193|NCT03296527|58884066|FG000|Overall Study|Adverse Event|15|||
30682598|NCT00783692|58696553|FG001|Induction Phase|Withdrawal by Subject|9|||
30682599|NCT00783692|58696554|FG002|Induction Phase|Withdrawal by Subject|16|||
30682600|NCT00783692|58696555|FG003|Induction Phase|Withdrawal by Subject|0|||
30682601|NCT00783692|58696556|FG004|Induction Phase|Withdrawal by Subject|0|||
30682602|NCT00783692|58696557|FG005|Induction Phase|Withdrawal by Subject|0|||
30783314|NCT03756129|58795530|FG002|Overall Study|Withdrawal by Subject|3|||
30783315|NCT03756129|58795531|FG003|Overall Study|Withdrawal by Subject|1|||
30783316|NCT03756129|58795532|FG004|Overall Study|Withdrawal by Subject|1|||
30783317|NCT03756129|58795533|FG005|Overall Study|Withdrawal by Subject|3|||
30783318|NCT03756129|58795528|FG000|Overall Study|Lost to Follow-up|0|||
30783319|NCT03756129|58795529|FG001|Overall Study|Lost to Follow-up|0|||
30783320|NCT03756129|58795530|FG002|Overall Study|Lost to Follow-up|0|||
30783321|NCT03756129|58795531|FG003|Overall Study|Lost to Follow-up|0|||
30783322|NCT03756129|58795532|FG004|Overall Study|Lost to Follow-up|0|||
30783323|NCT03756129|58795533|FG005|Overall Study|Lost to Follow-up|1|||
30783324|NCT03756129|58795528|FG000|Overall Study|Physician Decision|0|||
30783325|NCT03756129|58795529|FG001|Overall Study|Physician Decision|0|||
30783326|NCT03756129|58795530|FG002|Overall Study|Physician Decision|0|||
30596399|NCT01332968|58608192|FG004|Follow-Up Period|Other|0|||
30596400|NCT01332968|58608193|FG005|Follow-Up Period|Other|0|||
30596401|NCT01332968|58608194|FG006|Follow-Up Period|Other|18|||
30596402|NCT01332968|58608195|FG007|Follow-Up Period|Other|21|||
30596403|NCT01332968|58608188|FG000|Follow-Up Period|Physician Decision|0|||
30596404|NCT01332968|58608189|FG001|Follow-Up Period|Physician Decision|0|||
30783327|NCT03756129|58795531|FG003|Overall Study|Physician Decision|0|||
30783328|NCT03756129|58795532|FG004|Overall Study|Physician Decision|0|||
30783329|NCT03756129|58795533|FG005|Overall Study|Physician Decision|1|||
30783330|NCT02822794|58795559|FG000|Overall Study|Withdrew Consent|1|||
30783331|NCT02822794|58795560|FG001|Overall Study|Withdrew Consent|0|||
30783332|NCT01338298|58795575|FG000|Overall Study|Withdrawal by Subject|1|||
30783333|NCT01338298|58795576|FG001|Overall Study|Withdrawal by Subject|1|||
30783334|NCT01338298|58795575|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
30783335|NCT01338298|58795576|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
30783336|NCT01338298|58795575|FG000|Overall Study|Administrative error|0|||
30783337|NCT01338298|58795576|FG001|Overall Study|Administrative error|1|||
30783338|NCT01338298|58795575|FG000|Overall Study|Positive symptom worsening|1|||
30783339|NCT01338298|58795576|FG001|Overall Study|Positive symptom worsening|0|||
30783340|NCT01338298|58795575|FG000|Overall Study|Depressive symptoms and nausea|1|||
30783341|NCT01338298|58795576|FG001|Overall Study|Depressive symptoms and nausea|0|||
30783342|NCT01338298|58795575|FG000|Overall Study|Non-adherence|1|||
30783343|NCT01338298|58795576|FG001|Overall Study|Non-adherence|0|||
30783344|NCT01354132|58795584|FG000|Randomization|Physician Decision|1|||
30783345|NCT01354132|58795585|FG001|Randomization|Physician Decision|0|||
30783346|NCT01354132|58795584|FG000|Randomization|Withdrawal by Subject|0|||
30596405|NCT01332968|58608190|FG002|Follow-Up Period|Physician Decision|0|||
30596406|NCT01332968|58608191|FG003|Follow-Up Period|Physician Decision|0|||
30596407|NCT01332968|58608192|FG004|Follow-Up Period|Physician Decision|0|||
30596408|NCT01332968|58608193|FG005|Follow-Up Period|Physician Decision|0|||
30596409|NCT01332968|58608194|FG006|Follow-Up Period|Physician Decision|12|||
30596410|NCT01332968|58608195|FG007|Follow-Up Period|Physician Decision|15|||
30596411|NCT01332968|58608188|FG000|Follow-Up Period|Progressive Disease|0|||
30596412|NCT01332968|58608189|FG001|Follow-Up Period|Progressive Disease|0|||
30682603|NCT00783692|58696558|FG006|Induction Phase|Withdrawal by Subject|0|||
30682604|NCT00783692|58696552|FG000|Induction Phase|Lost to Follow-up|0|||
30682605|NCT00783692|58696553|FG001|Induction Phase|Lost to Follow-up|0|||
30783347|NCT01354132|58795585|FG001|Randomization|Withdrawal by Subject|1|||
30783348|NCT01354132|58795584|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
30783349|NCT01354132|58795585|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
30783350|NCT01354132|58795584|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
30783351|NCT01354132|58795585|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
30783352|NCT01354132|58795584|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
30783353|NCT01354132|58795585|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
30783354|NCT01353898|58795600|FG000|Overall Study|Study site terminated|0|||
30783355|NCT01353898|58795601|FG001|Overall Study|Study site terminated|0|||
30959131|NCT01688999|59024352|FG000|Overall Study|Adverse Event|2|||
30682606|NCT00783692|58696554|FG002|Induction Phase|Lost to Follow-up|3|||
30783356|NCT01353898|58795602|FG002|Overall Study|Study site terminated|0|||
30783357|NCT01353898|58795603|FG003|Overall Study|Study site terminated|0|||
30783358|NCT01353898|58795604|FG004|Overall Study|Study site terminated|0|||
30783359|NCT01353898|58795605|FG005|Overall Study|Study site terminated|1|||
30783360|NCT01372150|58795622|FG000|Overall Study|Lack of Efficacy|3|||
30596413|NCT01332968|58608190|FG002|Follow-Up Period|Progressive Disease|0|||
30596414|NCT01332968|58608191|FG003|Follow-Up Period|Progressive Disease|0|||
30596415|NCT01332968|58608192|FG004|Follow-Up Period|Progressive Disease|0|||
30596416|NCT01332968|58608193|FG005|Follow-Up Period|Progressive Disease|0|||
30682607|NCT00783692|58696555|FG003|Induction Phase|Lost to Follow-up|0|||
30783361|NCT01372150|58795623|FG001|Overall Study|Lack of Efficacy|0|||
30682608|NCT00783692|58696556|FG004|Induction Phase|Lost to Follow-up|0|||
30682609|NCT00783692|58696557|FG005|Induction Phase|Lost to Follow-up|0|||
30682610|NCT00783692|58696558|FG006|Induction Phase|Lost to Follow-up|0|||
30682611|NCT00783692|58696552|FG000|Induction Phase|Other|0|||
30682612|NCT00783692|58696553|FG001|Induction Phase|Other|0|||
30682613|NCT00783692|58696554|FG002|Induction Phase|Other|2|||
30682614|NCT00783692|58696555|FG003|Induction Phase|Other|0|||
30682615|NCT00783692|58696556|FG004|Induction Phase|Other|0|||
30682616|NCT00783692|58696557|FG005|Induction Phase|Other|0|||
30682617|NCT00783692|58696558|FG006|Induction Phase|Other|0|||
30682618|NCT00783692|58696552|FG000|Maintenance Phase|Adverse Event|7|||
30596417|NCT01332968|58608194|FG006|Follow-Up Period|Progressive Disease|126|||
30596418|NCT01332968|58608195|FG007|Follow-Up Period|Progressive Disease|106|||
30682619|NCT00783692|58696553|FG001|Maintenance Phase|Adverse Event|0|||
30682620|NCT00783692|58696554|FG002|Maintenance Phase|Adverse Event|0|||
30682621|NCT00783692|58696555|FG003|Maintenance Phase|Adverse Event|15|||
30682622|NCT00783692|58696556|FG004|Maintenance Phase|Adverse Event|12|||
30682623|NCT00783692|58696557|FG005|Maintenance Phase|Adverse Event|9|||
30682624|NCT00783692|58696558|FG006|Maintenance Phase|Adverse Event|38|||
30596419|NCT01332968|58608188|FG000|Follow-Up Period|Protocol Violation|0|||
30596420|NCT01332968|58608189|FG001|Follow-Up Period|Protocol Violation|0|||
30596421|NCT01332968|58608190|FG002|Follow-Up Period|Protocol Violation|0|||
30596422|NCT01332968|58608191|FG003|Follow-Up Period|Protocol Violation|0|||
30596423|NCT01332968|58608192|FG004|Follow-Up Period|Protocol Violation|0|||
30596424|NCT01332968|58608193|FG005|Follow-Up Period|Protocol Violation|0|||
30596425|NCT01332968|58608194|FG006|Follow-Up Period|Protocol Violation|1|||
30596426|NCT01332968|58608195|FG007|Follow-Up Period|Protocol Violation|0|||
30596427|NCT01332968|58608188|FG000|Follow-Up Period|Withdrawal by Subject|0|||
30596428|NCT01332968|58608189|FG001|Follow-Up Period|Withdrawal by Subject|0|||
30596429|NCT01332968|58608190|FG002|Follow-Up Period|Withdrawal by Subject|0|||
30596430|NCT01332968|58608191|FG003|Follow-Up Period|Withdrawal by Subject|0|||
30596431|NCT01332968|58608192|FG004|Follow-Up Period|Withdrawal by Subject|0|||
30596432|NCT01332968|58608193|FG005|Follow-Up Period|Withdrawal by Subject|0|||
30596433|NCT01332968|58608194|FG006|Follow-Up Period|Withdrawal by Subject|29|||
30596434|NCT01332968|58608195|FG007|Follow-Up Period|Withdrawal by Subject|32|||
30596435|NCT01332968|58608188|FG000|Follow-Up Period|No reason provided|0|||
30596436|NCT01332968|58608189|FG001|Follow-Up Period|No reason provided|0|||
30596437|NCT01332968|58608190|FG002|Follow-Up Period|No reason provided|0|||
30596438|NCT01332968|58608191|FG003|Follow-Up Period|No reason provided|0|||
30596439|NCT01332968|58608192|FG004|Follow-Up Period|No reason provided|0|||
30596440|NCT01332968|58608193|FG005|Follow-Up Period|No reason provided|0|||
30596441|NCT01332968|58608194|FG006|Follow-Up Period|No reason provided|2|||
30596442|NCT01332968|58608195|FG007|Follow-Up Period|No reason provided|3|||
30682625|NCT00783692|58696552|FG000|Maintenance Phase|Protocol Violation|0|||
30682626|NCT00783692|58696553|FG001|Maintenance Phase|Protocol Violation|0|||
30682627|NCT00783692|58696554|FG002|Maintenance Phase|Protocol Violation|0|||
30682628|NCT00783692|58696555|FG003|Maintenance Phase|Protocol Violation|1|||
30682629|NCT00783692|58696556|FG004|Maintenance Phase|Protocol Violation|2|||
30682630|NCT00783692|58696557|FG005|Maintenance Phase|Protocol Violation|3|||
30682631|NCT00783692|58696558|FG006|Maintenance Phase|Protocol Violation|4|||
30682632|NCT00783692|58696552|FG000|Maintenance Phase|Lack of Efficacy|79|||
30682633|NCT00783692|58696553|FG001|Maintenance Phase|Lack of Efficacy|0|||
30682634|NCT00783692|58696554|FG002|Maintenance Phase|Lack of Efficacy|0|||
30682635|NCT00783692|58696555|FG003|Maintenance Phase|Lack of Efficacy|64|||
30682636|NCT00783692|58696556|FG004|Maintenance Phase|Lack of Efficacy|58|||
30682637|NCT00783692|58696557|FG005|Maintenance Phase|Lack of Efficacy|48|||
30682638|NCT00783692|58696558|FG006|Maintenance Phase|Lack of Efficacy|177|||
30682639|NCT00783692|58696552|FG000|Maintenance Phase|Withdrawal by Subject|7|||
30682640|NCT00783692|58696553|FG001|Maintenance Phase|Withdrawal by Subject|0|||
30682641|NCT00783692|58696554|FG002|Maintenance Phase|Withdrawal by Subject|0|||
30682642|NCT00783692|58696555|FG003|Maintenance Phase|Withdrawal by Subject|7|||
30682643|NCT00783692|58696556|FG004|Maintenance Phase|Withdrawal by Subject|6|||
30959132|NCT01688999|59024353|FG001|Overall Study|Adverse Event|0|||
30682644|NCT00783692|58696557|FG005|Maintenance Phase|Withdrawal by Subject|9|||
30682645|NCT00783692|58696558|FG006|Maintenance Phase|Withdrawal by Subject|24|||
30682646|NCT00783692|58696552|FG000|Maintenance Phase|Lost to Follow-up|2|||
30682647|NCT00783692|58696553|FG001|Maintenance Phase|Lost to Follow-up|0|||
30682648|NCT00783692|58696554|FG002|Maintenance Phase|Lost to Follow-up|0|||
30682649|NCT00783692|58696555|FG003|Maintenance Phase|Lost to Follow-up|1|||
30682650|NCT00783692|58696556|FG004|Maintenance Phase|Lost to Follow-up|3|||
30682651|NCT00783692|58696557|FG005|Maintenance Phase|Lost to Follow-up|2|||
30682652|NCT00783692|58696558|FG006|Maintenance Phase|Lost to Follow-up|5|||
30682653|NCT00783692|58696552|FG000|Maintenance Phase|Other|0|||
30596443|NCT01332851|58608205|FG000|Overall Study|Withdrawal by Subject|4|||
30596444|NCT01332851|58608206|FG001|Overall Study|Withdrawal by Subject|2|||
30596445|NCT01332851|58608205|FG000|Overall Study|Lost to Follow-up|7|||
30596446|NCT01332851|58608206|FG001|Overall Study|Lost to Follow-up|11|||
30682654|NCT00783692|58696553|FG001|Maintenance Phase|Other|0|||
30682655|NCT00783692|58696554|FG002|Maintenance Phase|Other|0|||
30682656|NCT00783692|58696555|FG003|Maintenance Phase|Other|1|||
30682657|NCT00783692|58696556|FG004|Maintenance Phase|Other|0|||
30682658|NCT00783692|58696557|FG005|Maintenance Phase|Other|1|||
30682659|NCT00783692|58696558|FG006|Maintenance Phase|Other|1|||
30682660|NCT04992273|58696573|FG000|Overall Study|Lost to Follow-up|0|||
30682661|NCT04992273|58696574|FG001|Overall Study|Lost to Follow-up|1|||
30682662|NCT00783302|58696581|FG000|Overall Study|Lost to Follow-up|17|||
30682663|NCT00783302|58696581|FG000|Overall Study|Technical Problems|11|||
30682664|NCT00783302|58696581|FG000|Overall Study|Protocol Violation|3|||
30682665|NCT00783302|58696581|FG000|Overall Study|Physician Decision|1|||
30682666|NCT00783302|58696581|FG000|Overall Study|Withdrawal by Subject|3|||
30682667|NCT00783224|58696603|FG000|Overall Study|Adverse Event|0|||
30682668|NCT00783224|58696604|FG001|Overall Study|Adverse Event|0|||
30682669|NCT00783224|58696605|FG002|Overall Study|Adverse Event|1|||
30682670|NCT00783224|58696606|FG003|Overall Study|Adverse Event|0|||
30682671|NCT00783224|58696603|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
30682672|NCT00783224|58696604|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
30682673|NCT00783224|58696605|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
30596447|NCT01332305|58608221|FG000|Overall Study|Adverse Event|1|||
30596448|NCT01332305|58608222|FG001|Overall Study|Adverse Event|4|||
30596449|NCT01332305|58608223|FG002|Overall Study|Adverse Event|6|||
30596450|NCT01332305|58608224|FG003|Overall Study|Adverse Event|3|||
30596451|NCT01332305|58608225|FG004|Overall Study|Adverse Event|5|||
30596452|NCT01332305|58608221|FG000|Overall Study|Withdrawal by Subject|6|||
30596453|NCT01332305|58608222|FG001|Overall Study|Withdrawal by Subject|5|||
30596454|NCT01332305|58608223|FG002|Overall Study|Withdrawal by Subject|4|||
30596455|NCT01332305|58608224|FG003|Overall Study|Withdrawal by Subject|1|||
30596456|NCT01332305|58608225|FG004|Overall Study|Withdrawal by Subject|0|||
30596457|NCT01332305|58608221|FG000|Overall Study|Lost to Follow-up|0|||
30596458|NCT01332305|58608222|FG001|Overall Study|Lost to Follow-up|2|||
30596459|NCT01332305|58608223|FG002|Overall Study|Lost to Follow-up|3|||
30682674|NCT00783224|58696606|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
30682675|NCT00783224|58696603|FG000|Overall Study|Inappropriate as a study subject|0|||
30682676|NCT00783224|58696604|FG001|Overall Study|Inappropriate as a study subject|0|||
30682677|NCT00783224|58696605|FG002|Overall Study|Inappropriate as a study subject|0|||
30682678|NCT00783224|58696606|FG003|Overall Study|Inappropriate as a study subject|1|||
30682679|NCT00782834|58696615|FG000|Treatment Phase|fibrous tumor not GIST|1|||
30682680|NCT00584805|58696619|FG000|Overall Study|No longer at risk of exposure|39|||
30682681|NCT00584805|58696619|FG000|Overall Study|Relocation|36|||
30682682|NCT00584805|58696619|FG000|Overall Study|Withdrawal by Subject|18|||
30682683|NCT00584805|58696619|FG000|Overall Study|Non-compliance|1|||
30682684|NCT00584805|58696619|FG000|Overall Study|Lost to follow up|3|||
30682685|NCT00584805|58696619|FG000|Overall Study|Screen failures|2|||
30682686|NCT00765674|58696629|FG000|Overall Study|Adverse Event|7|||
30682687|NCT00765674|58696630|FG001|Overall Study|Adverse Event|2|||
30682688|NCT00765674|58696631|FG002|Overall Study|Adverse Event|8|||
30682689|NCT00765674|58696632|FG003|Overall Study|Adverse Event|11|||
30682690|NCT00765674|58696629|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
30682691|NCT00765674|58696630|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
30682692|NCT00765674|58696631|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
30682693|NCT00765674|58696632|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
30682694|NCT00765674|58696629|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
30682695|NCT00765674|58696630|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
30682696|NCT00765674|58696631|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
30682697|NCT00765674|58696632|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
30682698|NCT00765674|58696629|FG000|Overall Study|Lack of Efficacy|2|||
30682699|NCT00765674|58696630|FG001|Overall Study|Lack of Efficacy|3|||
30682700|NCT00765674|58696631|FG002|Overall Study|Lack of Efficacy|1|||
30682701|NCT00765674|58696632|FG003|Overall Study|Lack of Efficacy|2|||
30682702|NCT00765674|58696629|FG000|Overall Study|Protocol Violation|2|||
30783362|NCT01372150|58795624|FG002|Overall Study|Lack of Efficacy|1|||
30596460|NCT01332305|58608224|FG003|Overall Study|Lost to Follow-up|2|||
30682703|NCT00765674|58696630|FG001|Overall Study|Protocol Violation|0|||
30682704|NCT00765674|58696631|FG002|Overall Study|Protocol Violation|1|||
30682705|NCT00765674|58696632|FG003|Overall Study|Protocol Violation|0|||
30682706|NCT00765674|58696629|FG000|Overall Study|Withdrawal by Subject|5|||
30682707|NCT00765674|58696630|FG001|Overall Study|Withdrawal by Subject|7|||
30682708|NCT00765674|58696631|FG002|Overall Study|Withdrawal by Subject|3|||
30682709|NCT00765674|58696632|FG003|Overall Study|Withdrawal by Subject|8|||
30682710|NCT00765674|58696629|FG000|Overall Study|Lost to Follow-up|4|||
30682711|NCT00765674|58696630|FG001|Overall Study|Lost to Follow-up|6|||
30783363|NCT01372150|58795622|FG000|Overall Study|Lost to Follow-up|4|||
30596461|NCT01332305|58608225|FG004|Overall Study|Lost to Follow-up|3|||
30596462|NCT01332305|58608221|FG000|Overall Study|Protocol Violation|1|||
30596463|NCT01332305|58608222|FG001|Overall Study|Protocol Violation|2|||
30596464|NCT01332305|58608223|FG002|Overall Study|Protocol Violation|1|||
30682712|NCT00765674|58696631|FG002|Overall Study|Lost to Follow-up|2|||
30682713|NCT00765674|58696632|FG003|Overall Study|Lost to Follow-up|1|||
30682714|NCT00765674|58696629|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
30596465|NCT01332305|58608224|FG003|Overall Study|Protocol Violation|0|||
30596466|NCT01332305|58608225|FG004|Overall Study|Protocol Violation|3|||
30596467|NCT01332305|58608221|FG000|Overall Study|Withdrawal by Sponsor|1|||
30682715|NCT00765674|58696630|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
30682716|NCT00765674|58696631|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
30682717|NCT00765674|58696632|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
30682718|NCT00765362|58696642|FG000|Overall Study|Death|9|||
30682719|NCT00765362|58696642|FG000|Overall Study|Adverse Event|2|||
30682720|NCT00765362|58696642|FG000|Overall Study|Protocol Violation|18|||
30682721|NCT00765362|58696642|FG000|Overall Study|Withdrawal by Subject|13|||
30682722|NCT00765362|58696642|FG000|Overall Study|Lost to Follow-up|95|||
30682723|NCT00586898|58696646|FG000|Overall Study|Adverse Event|1|||
30682724|NCT00586898|58696646|FG000|Overall Study|Patiemt Non-compliance|1|||
30682725|NCT00586898|58696646|FG000|Overall Study|Evaluable for Toxicity Only|5|||
30682726|NCT04912245|58696650|FG000|Overall Study|Withdrawal by Subject|21|||
30682727|NCT04912245|58696651|FG001|Overall Study|Withdrawal by Subject|4|||
30682728|NCT04912245|58696650|FG000|Overall Study|Lost to Follow-up|5|||
30682729|NCT04912245|58696651|FG001|Overall Study|Lost to Follow-up|11|||
30682730|NCT00796991|58696658|FG000|Overall Study|Adverse Event|0|||
30682731|NCT00796991|58696659|FG001|Overall Study|Adverse Event|0|||
30682732|NCT00796991|58696660|FG002|Overall Study|Adverse Event|1|||
30682733|NCT00796991|58696658|FG000|Overall Study|Death|2|||
30682734|NCT00796991|58696659|FG001|Overall Study|Death|0|||
30682735|NCT00796991|58696660|FG002|Overall Study|Death|0|||
30682736|NCT00796991|58696658|FG000|Overall Study|Disease Progression|10|||
30682737|NCT00796991|58696659|FG001|Overall Study|Disease Progression|9|||
30682738|NCT00796991|58696660|FG002|Overall Study|Disease Progression|7|||
30682739|NCT00796991|58696658|FG000|Overall Study|Study Drug Toxicity|3|||
30682740|NCT00796991|58696659|FG001|Overall Study|Study Drug Toxicity|3|||
30682741|NCT00796991|58696660|FG002|Overall Study|Study Drug Toxicity|5|||
30682742|NCT00796991|58696658|FG000|Overall Study|Withdrawal by Subject|0|||
30682743|NCT00796991|58696659|FG001|Overall Study|Withdrawal by Subject|0|||
30682744|NCT00796991|58696660|FG002|Overall Study|Withdrawal by Subject|1|||
30682745|NCT00799487|58696671|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
30682746|NCT00799487|58696672|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
30682747|NCT00799487|58696673|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
30682748|NCT00799487|58696671|FG000|Dose Adjustment Period|Adverse Event|2|||
30783364|NCT01372150|58795623|FG001|Overall Study|Lost to Follow-up|5|||
30783365|NCT01372150|58795624|FG002|Overall Study|Lost to Follow-up|6|||
30783366|NCT01372150|58795622|FG000|Overall Study|Protocol Violation|1|||
30783367|NCT01372150|58795623|FG001|Overall Study|Protocol Violation|0|||
30783368|NCT01372150|58795624|FG002|Overall Study|Protocol Violation|3|||
30596468|NCT01332305|58608222|FG001|Overall Study|Withdrawal by Sponsor|0|||
30596469|NCT01332305|58608223|FG002|Overall Study|Withdrawal by Sponsor|0|||
30783369|NCT01372150|58795622|FG000|Overall Study|Withdrawal by Subject|2|||
30783370|NCT01372150|58795623|FG001|Overall Study|Withdrawal by Subject|7|||
30783371|NCT01372150|58795624|FG002|Overall Study|Withdrawal by Subject|2|||
30783372|NCT01372150|58795622|FG000|Overall Study|Other|1|||
30783373|NCT01372150|58795623|FG001|Overall Study|Other|0|||
30783374|NCT01372150|58795624|FG002|Overall Study|Other|2|||
30783375|NCT01372150|58795622|FG000|Overall Study|Adverse Event|2|||
30783376|NCT01372150|58795623|FG001|Overall Study|Adverse Event|1|||
30783377|NCT01372150|58795624|FG002|Overall Study|Adverse Event|2|||
30783378|NCT01372150|58795622|FG000|Overall Study|Randomized but not treated|0|||
30783379|NCT01372150|58795623|FG001|Overall Study|Randomized but not treated|1|||
30783380|NCT01372150|58795624|FG002|Overall Study|Randomized but not treated|0|||
30783381|NCT03329690|58795637|FG000|Overall Study|Progressive disease per RECIST|85|||
30783382|NCT03329690|58795638|FG001|Overall Study|Progressive disease per RECIST|44|||
30596470|NCT01332305|58608224|FG003|Overall Study|Withdrawal by Sponsor|1|||
30596471|NCT01332305|58608225|FG004|Overall Study|Withdrawal by Sponsor|1|||
30596472|NCT01332305|58608221|FG000|Overall Study|Treatment Failure|1|||
30682749|NCT00799487|58696672|FG001|Dose Adjustment Period|Adverse Event|0|||
30682750|NCT00799487|58696673|FG002|Dose Adjustment Period|Adverse Event|0|||
30682751|NCT00799487|58696671|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
30783383|NCT03329690|58795639|FG002|Overall Study|Progressive disease per RECIST|6|||
30783384|NCT03329690|58795640|FG003|Overall Study|Progressive disease per RECIST|16|||
30783385|NCT03329690|58795641|FG004|Overall Study|Progressive disease per RECIST|20|||
30783386|NCT03329690|58795637|FG000|Overall Study|Clinical progression|7|||
30783387|NCT03329690|58795638|FG001|Overall Study|Clinical progression|4|||
30596473|NCT01332305|58608222|FG001|Overall Study|Treatment Failure|1|||
30682752|NCT00799487|58696672|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
30682753|NCT00799487|58696673|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
30682754|NCT00799487|58696671|FG000|Dose Adjustment Period|Investigator Discretion|2|||
30682755|NCT00799487|58696672|FG001|Dose Adjustment Period|Investigator Discretion|0|||
30682756|NCT00799487|58696673|FG002|Dose Adjustment Period|Investigator Discretion|0|||
30682757|NCT00799487|58696671|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
30682758|NCT00799487|58696672|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
30682759|NCT00799487|58696673|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
30682760|NCT00799487|58696671|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
30682761|NCT00799487|58696672|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
30682762|NCT00799487|58696673|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
30682763|NCT00799487|58696671|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
30682764|NCT00799487|58696672|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
30682765|NCT00799487|58696673|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
30682766|NCT00799487|58696671|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
30682767|NCT00799487|58696672|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
30682768|NCT00799487|58696673|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
30682769|NCT00799487|58696671|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
30783388|NCT03329690|58795639|FG002|Overall Study|Clinical progression|1|||
30783389|NCT03329690|58795640|FG003|Overall Study|Clinical progression|1|||
30783390|NCT03329690|58795641|FG004|Overall Study|Clinical progression|1|||
30783391|NCT03329690|58795637|FG000|Overall Study|Adverse Event|22|||
30783392|NCT03329690|58795638|FG001|Overall Study|Adverse Event|4|||
30783393|NCT03329690|58795639|FG002|Overall Study|Adverse Event|0|||
30783394|NCT03329690|58795640|FG003|Overall Study|Adverse Event|1|||
30783395|NCT03329690|58795641|FG004|Overall Study|Adverse Event|2|||
30783396|NCT03329690|58795637|FG000|Overall Study|Death|2|||
30783397|NCT03329690|58795638|FG001|Overall Study|Death|0|||
30783398|NCT03329690|58795639|FG002|Overall Study|Death|0|||
30783399|NCT03329690|58795640|FG003|Overall Study|Death|1|||
30783400|NCT03329690|58795641|FG004|Overall Study|Death|0|||
30783401|NCT03329690|58795637|FG000|Overall Study|Withdrawal by Subject|2|||
30783402|NCT03329690|58795638|FG001|Overall Study|Withdrawal by Subject|3|||
30783403|NCT03329690|58795639|FG002|Overall Study|Withdrawal by Subject|0|||
30783404|NCT03329690|58795640|FG003|Overall Study|Withdrawal by Subject|1|||
30783405|NCT03329690|58795641|FG004|Overall Study|Withdrawal by Subject|0|||
30783406|NCT03329690|58795637|FG000|Overall Study|Physician Decision|1|||
30783407|NCT03329690|58795638|FG001|Overall Study|Physician Decision|0|||
30783408|NCT03329690|58795639|FG002|Overall Study|Physician Decision|0|||
30783409|NCT03329690|58795640|FG003|Overall Study|Physician Decision|0|||
30783410|NCT03329690|58795641|FG004|Overall Study|Physician Decision|1|||
30783411|NCT03329690|58795637|FG000|Overall Study|Miscellaneous|6|||
30783412|NCT03329690|58795638|FG001|Overall Study|Miscellaneous|0|||
30783413|NCT03329690|58795639|FG002|Overall Study|Miscellaneous|0|||
30783414|NCT03329690|58795640|FG003|Overall Study|Miscellaneous|0|||
30783415|NCT03329690|58795641|FG004|Overall Study|Miscellaneous|0|||
30783416|NCT03329690|58795637|FG000|Overall Study|Did not receive treatment|1|||
30783417|NCT03329690|58795638|FG001|Overall Study|Did not receive treatment|0|||
30783418|NCT03329690|58795639|FG002|Overall Study|Did not receive treatment|0|||
30783419|NCT03329690|58795640|FG003|Overall Study|Did not receive treatment|1|||
30783420|NCT03329690|58795641|FG004|Overall Study|Did not receive treatment|0|||
30783421|NCT03328832|58795661|FG000|Overall Study|Lost to Follow-up|0|||
30783422|NCT03328832|58795662|FG001|Overall Study|Lost to Follow-up|1|||
30783423|NCT02820844|58795670|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
30783424|NCT02820844|58795671|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
30783425|NCT02820844|58795672|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
30783426|NCT02820844|58795673|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
30783427|NCT02820844|58795674|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
30959133|NCT01688999|59024354|FG002|Overall Study|Adverse Event|2|||
30596474|NCT01332305|58608223|FG002|Overall Study|Treatment Failure|0|||
30596475|NCT01332305|58608224|FG003|Overall Study|Treatment Failure|0|||
30596476|NCT01332305|58608225|FG004|Overall Study|Treatment Failure|0|||
30596477|NCT01332305|58608221|FG000|Overall Study|Physician Decision|0|||
30596478|NCT01332305|58608222|FG001|Overall Study|Physician Decision|0|||
30596479|NCT01332305|58608223|FG002|Overall Study|Physician Decision|0|||
30596480|NCT01332305|58608224|FG003|Overall Study|Physician Decision|1|||
30682770|NCT00799487|58696672|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
30682771|NCT00799487|58696673|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
30783428|NCT02820844|58795675|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
30783429|NCT02820844|58795670|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
30783430|NCT02820844|58795671|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
30783431|NCT02820844|58795672|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
30783432|NCT02820844|58795673|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
30783433|NCT02820844|58795674|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
30783434|NCT02820844|58795675|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
30596481|NCT01332305|58608225|FG004|Overall Study|Physician Decision|0|||
30596482|NCT01332227|58608239|FG000|Overall Study|Adverse Event|4|||
30682772|NCT00799487|58696671|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
30682773|NCT00799487|58696672|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
30682774|NCT00799487|58696673|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
30682775|NCT00799487|58696671|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
30682776|NCT00799487|58696672|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
30682777|NCT00799487|58696673|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
30682778|NCT00799487|58696671|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
30682779|NCT00799487|58696672|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
30682780|NCT00799487|58696673|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
30682781|NCT00584727|58696684|FG000|First Intervention|Discontinuation|0|||
30682782|NCT00584727|58696685|FG001|First Intervention|Discontinuation|0|||
30682783|NCT00584727|58696686|FG002|First Intervention|Discontinuation|1|||
30682784|NCT00584727|58696687|FG003|First Intervention|Discontinuation|0|||
30682785|NCT00584727|58696688|FG004|First Intervention|Discontinuation|0|||
30682786|NCT00584727|58696689|FG005|First Intervention|Discontinuation|0|||
30682787|NCT00584727|58696684|FG000|Third Intervention|Protocol Violation|0|||
30682788|NCT00584727|58696685|FG001|Third Intervention|Protocol Violation|0|||
30682789|NCT00584727|58696686|FG002|Third Intervention|Protocol Violation|1|||
30682790|NCT00584727|58696687|FG003|Third Intervention|Protocol Violation|0|||
30682791|NCT00584727|58696688|FG004|Third Intervention|Protocol Violation|4|||
30682792|NCT00584727|58696689|FG005|Third Intervention|Protocol Violation|2|||
30682793|NCT00799409|58696703|FG000|Overall Study|Withdrawal by Subject|1|||
30682794|NCT00799409|58696704|FG001|Overall Study|Withdrawal by Subject|0|||
30682795|NCT00799409|58696705|FG002|Overall Study|Withdrawal by Subject|0|||
30682796|NCT00799409|58696703|FG000|Overall Study|Lost to Follow-up|1|||
30682797|NCT00799409|58696704|FG001|Overall Study|Lost to Follow-up|0|||
30682798|NCT00799409|58696705|FG002|Overall Study|Lost to Follow-up|0|||
30682799|NCT00799409|58696703|FG000|Overall Study|Optimal Dose Not Achieved|2|||
30682800|NCT00799409|58696704|FG001|Overall Study|Optimal Dose Not Achieved|0|||
30682801|NCT00799409|58696705|FG002|Overall Study|Optimal Dose Not Achieved|0|||
30682802|NCT00799409|58696703|FG000|Overall Study|Failure to follow study protocol)|1|||
30682803|NCT00799409|58696704|FG001|Overall Study|Failure to follow study protocol)|0|||
30682804|NCT00799409|58696705|FG002|Overall Study|Failure to follow study protocol)|0|||
30682805|NCT00799409|58696703|FG000|Overall Study|Did not attend lab school day 1|1|||
30682806|NCT00799409|58696704|FG001|Overall Study|Did not attend lab school day 1|0|||
30682807|NCT00799409|58696705|FG002|Overall Study|Did not attend lab school day 1|0|||
30682808|NCT00799409|58696703|FG000|Overall Study|medication compliance|1|||
30682809|NCT00799409|58696704|FG001|Overall Study|medication compliance|0|||
30682810|NCT00799409|58696705|FG002|Overall Study|medication compliance|0|||
30682811|NCT00782210|58696716|FG000|Overall Study|Adverse Event|21|||
30682812|NCT00782210|58696717|FG001|Overall Study|Adverse Event|17|||
30682813|NCT00782210|58696718|FG002|Overall Study|Adverse Event|16|||
30783435|NCT02820844|58795670|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
30783436|NCT02820844|58795671|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
30783437|NCT02820844|58795672|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
30783438|NCT02820844|58795673|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
30783439|NCT02820844|58795674|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
30783440|NCT02820844|58795675|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
30783441|NCT02820844|58795670|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
30783442|NCT02820844|58795671|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
30783443|NCT02820844|58795672|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
30783444|NCT02820844|58795673|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
30783445|NCT02820844|58795674|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
30856194|NCT03296527|58884067|FG001|Overall Study|Adverse Event|33|||
30959134|NCT01688999|59024352|FG000|Overall Study|Ineligible/Not treated|1|||
30596483|NCT01332227|58608240|FG001|Overall Study|Adverse Event|1|||
30596484|NCT01332227|58608239|FG000|Overall Study|Withdrawal by Subject|5|||
30596485|NCT01332227|58608240|FG001|Overall Study|Withdrawal by Subject|1|||
30596486|NCT01332227|58608239|FG000|Overall Study|Lost to Follow-up|2|||
30596487|NCT01332227|58608240|FG001|Overall Study|Lost to Follow-up|0|||
30596488|NCT01332227|58608239|FG000|Overall Study|Lack of Efficacy|3|||
30596489|NCT01332227|58608240|FG001|Overall Study|Lack of Efficacy|1|||
30682814|NCT00782210|58696716|FG000|Overall Study|Lost to Follow-up|2|||
30682815|NCT00782210|58696717|FG001|Overall Study|Lost to Follow-up|1|||
30682816|NCT00782210|58696718|FG002|Overall Study|Lost to Follow-up|2|||
30596490|NCT01332227|58608239|FG000|Overall Study|Poor compliance/noncompliance|1|||
30682817|NCT00782210|58696716|FG000|Overall Study|Withdrawal by Subject|11|||
30682818|NCT00782210|58696717|FG001|Overall Study|Withdrawal by Subject|8|||
30682819|NCT00782210|58696718|FG002|Overall Study|Withdrawal by Subject|11|||
30682820|NCT00782210|58696716|FG000|Overall Study|Non compliance with protocol|0|||
30682821|NCT00782210|58696717|FG001|Overall Study|Non compliance with protocol|3|||
30682822|NCT00782210|58696718|FG002|Overall Study|Non compliance with protocol|2|||
30682823|NCT00782210|58696716|FG000|Overall Study|Lack of Efficacy|13|||
30783446|NCT02820844|58795675|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
30596491|NCT01332227|58608240|FG001|Overall Study|Poor compliance/noncompliance|1|||
30596492|NCT01332227|58608239|FG000|Overall Study|Patient moved from area|1|||
30682824|NCT00782210|58696717|FG001|Overall Study|Lack of Efficacy|4|||
30682825|NCT00782210|58696718|FG002|Overall Study|Lack of Efficacy|1|||
30682826|NCT00782210|58696716|FG000|Overall Study|Other reason not described above|3|||
30596493|NCT01332227|58608240|FG001|Overall Study|Patient moved from area|0|||
30596494|NCT01332227|58608239|FG000|Overall Study|Patient began prohibited medication|0|||
30596495|NCT01332227|58608240|FG001|Overall Study|Patient began prohibited medication|1|||
30596496|NCT01332149|58608248|FG000|Overall Study|Adverse Event|11|||
30596497|NCT01332149|58608249|FG001|Overall Study|Adverse Event|9|||
30596498|NCT01332149|58608248|FG000|Overall Study|Other unspecified|5|||
30596499|NCT01332149|58608249|FG001|Overall Study|Other unspecified|7|||
30596500|NCT01332149|58608248|FG000|Overall Study|Protocol Violation|1|||
30596501|NCT01332149|58608249|FG001|Overall Study|Protocol Violation|3|||
30596502|NCT01332149|58608248|FG000|Overall Study|Withdrawal by Subject|4|||
30596503|NCT01332149|58608249|FG001|Overall Study|Withdrawal by Subject|5|||
30596504|NCT01332149|58608248|FG000|Overall Study|Lost to Follow-up|1|||
30596505|NCT01332149|58608249|FG001|Overall Study|Lost to Follow-up|1|||
30596506|NCT01332149|58608248|FG000|Overall Study|Insufficient clinical response|4|||
30596507|NCT01332149|58608249|FG001|Overall Study|Insufficient clinical response|7|||
30596508|NCT01332149|58608248|FG000|Overall Study|Did not meet entrance criteria|3|||
30596509|NCT01332149|58608249|FG001|Overall Study|Did not meet entrance criteria|4|||
30596510|NCT01332149|58608248|FG000|Overall Study|Randomized but not treated|1|||
30596511|NCT01332149|58608249|FG001|Overall Study|Randomized but not treated|2|||
30596512|NCT01330628|58608257|FG000|Overall Study|Death|2|||
30596513|NCT01330628|58608258|FG001|Overall Study|Death|3|||
30596514|NCT01330628|58608257|FG000|Overall Study|Lost to Follow-up|5|||
30596515|NCT01330628|58608258|FG001|Overall Study|Lost to Follow-up|6|||
30596516|NCT01330628|58608257|FG000|Overall Study|Adverse Event|44|||
30682827|NCT00782210|58696717|FG001|Overall Study|Other reason not described above|2|||
30682828|NCT00782210|58696718|FG002|Overall Study|Other reason not described above|3|||
30682829|NCT01558115|58696735|FG000|Overall Study|Withdrawal by Subject|3|||
30682830|NCT01558115|58696735|FG000|Overall Study|Study closed due to poor enrollment|4|||
30596517|NCT01330628|58608258|FG001|Overall Study|Adverse Event|25|||
30596518|NCT01330628|58608257|FG000|Overall Study|Withdrawn|18|||
30596519|NCT01330628|58608258|FG001|Overall Study|Withdrawn|6|||
30596520|NCT01330628|58608257|FG000|Overall Study|Didn't receive study treatment|1|||
30682831|NCT00764660|58696758|FG000|Overall Study|Adverse Event|6|||
30682832|NCT00764660|58696759|FG001|Overall Study|Adverse Event|3|||
30682833|NCT00764660|58696758|FG000|Overall Study|Lost to Follow-up|3|||
30682834|NCT00764660|58696759|FG001|Overall Study|Lost to Follow-up|4|||
30682835|NCT00764660|58696758|FG000|Overall Study|Withdrawal by Subject|7|||
30682836|NCT00764660|58696759|FG001|Overall Study|Withdrawal by Subject|3|||
30682837|NCT00764660|58696758|FG000|Overall Study|Noncompliance With Protocol|5|||
30682838|NCT00764660|58696759|FG001|Overall Study|Noncompliance With Protocol|1|||
30682839|NCT00764660|58696758|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
30682840|NCT00764660|58696759|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
30682841|NCT00584415|58696765|FG000|Overall Study|Adverse Event|7|||
30682842|NCT00764504|58696773|FG000|Overall Study|Death|12|||
30682843|NCT00764504|58696774|FG001|Overall Study|Death|6|||
30682844|NCT00764504|58696775|FG002|Overall Study|Death|13|||
30682845|NCT00764504|58696773|FG000|Overall Study|Revision of Device|12|||
30783447|NCT02820844|58795670|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
30783448|NCT02820844|58795671|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
30783449|NCT02820844|58795672|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
30596521|NCT01330628|58608258|FG001|Overall Study|Didn't receive study treatment|0|||
30682846|NCT00764504|58696774|FG001|Overall Study|Revision of Device|23|||
30783450|NCT02820844|58795673|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
30783451|NCT02820844|58795674|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
30783452|NCT02820844|58795675|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
30783453|NCT02820844|58795670|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
30783454|NCT02820844|58795671|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
30783455|NCT02820844|58795672|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
30783456|NCT02820844|58795673|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
30596522|NCT01330433|58608266|FG000|Overall Study|Death|1|||
30596523|NCT01330433|58608267|FG001|Overall Study|Death|3|||
30596524|NCT01330433|58608266|FG000|Overall Study|Lost to Follow-up|1|||
30596525|NCT01330433|58608267|FG001|Overall Study|Lost to Follow-up|0|||
30596526|NCT01330316|58608275|FG000|Overall Study|Adverse Event|2|||
30596527|NCT01330316|58608276|FG001|Overall Study|Adverse Event|2|||
30682847|NCT00764504|58696775|FG002|Overall Study|Revision of Device|14|||
30596528|NCT01330316|58608275|FG000|Overall Study|Lack of Efficacy|0|||
30682848|NCT00764504|58696773|FG000|Overall Study|Physician Decision|1|||
30682849|NCT00764504|58696774|FG001|Overall Study|Physician Decision|0|||
30682850|NCT00764504|58696775|FG002|Overall Study|Physician Decision|0|||
30682851|NCT00764504|58696773|FG000|Overall Study|Withdrawal by Subject|1|||
30596529|NCT01330316|58608276|FG001|Overall Study|Lack of Efficacy|10|||
30596530|NCT01330316|58608275|FG000|Overall Study|Lost to Follow-up|0|||
30596531|NCT01330316|58608276|FG001|Overall Study|Lost to Follow-up|1|||
30596532|NCT01330316|58608275|FG000|Overall Study|Withdrawal by Subject|0|||
30596533|NCT01330316|58608276|FG001|Overall Study|Withdrawal by Subject|1|||
30596534|NCT01330316|58608275|FG000|Overall Study|other than above|0|||
30596535|NCT01330316|58608276|FG001|Overall Study|other than above|1|||
30596536|NCT01326702|58608289|FG000|Overall Study|Other|1|||
30596537|NCT01326702|58608290|FG001|Overall Study|Other|0|||
30596538|NCT01326702|58608291|FG002|Overall Study|Other|0|||
30596539|NCT01326702|58608292|FG003|Overall Study|Other|0|||
30596540|NCT01326702|58608293|FG004|Overall Study|Other|0|||
30596541|NCT01326702|58608294|FG005|Overall Study|Other|1|||
30596542|NCT01326702|58608295|FG006|Overall Study|Other|0|||
30596543|NCT01326702|58608289|FG000|Overall Study|progressive disease|1|||
30596544|NCT01326702|58608290|FG001|Overall Study|progressive disease|1|||
30596545|NCT01326702|58608291|FG002|Overall Study|progressive disease|3|||
30596546|NCT01326702|58608292|FG003|Overall Study|progressive disease|1|||
30596547|NCT01326702|58608293|FG004|Overall Study|progressive disease|3|||
30596548|NCT01326702|58608294|FG005|Overall Study|progressive disease|2|||
30596549|NCT01326702|58608295|FG006|Overall Study|progressive disease|3|||
30596550|NCT01326702|58608289|FG000|Overall Study|Death|0|||
30596551|NCT01326702|58608290|FG001|Overall Study|Death|1|||
30596552|NCT01326702|58608291|FG002|Overall Study|Death|0|||
30596553|NCT01326702|58608292|FG003|Overall Study|Death|0|||
30596554|NCT01326702|58608293|FG004|Overall Study|Death|0|||
30596555|NCT01326702|58608294|FG005|Overall Study|Death|0|||
30596556|NCT01326702|58608295|FG006|Overall Study|Death|0|||
30596557|NCT01326702|58608289|FG000|Overall Study|Adverse Event|0|||
30596558|NCT01326702|58608290|FG001|Overall Study|Adverse Event|0|||
30596559|NCT01326702|58608291|FG002|Overall Study|Adverse Event|1|||
30596560|NCT01326702|58608292|FG003|Overall Study|Adverse Event|1|||
30596561|NCT01326702|58608293|FG004|Overall Study|Adverse Event|0|||
30596562|NCT01326702|58608294|FG005|Overall Study|Adverse Event|3|||
30596563|NCT01326702|58608295|FG006|Overall Study|Adverse Event|1|||
30596564|NCT01326702|58608289|FG000|Overall Study|Withdrawal by Subject|0|||
30596565|NCT01326702|58608290|FG001|Overall Study|Withdrawal by Subject|0|||
30596566|NCT01326702|58608291|FG002|Overall Study|Withdrawal by Subject|1|||
30596567|NCT01326702|58608292|FG003|Overall Study|Withdrawal by Subject|0|||
30596568|NCT01326702|58608293|FG004|Overall Study|Withdrawal by Subject|1|||
30596569|NCT01326702|58608294|FG005|Overall Study|Withdrawal by Subject|1|||
30596570|NCT01326702|58608295|FG006|Overall Study|Withdrawal by Subject|3|||
30596571|NCT01326702|58608289|FG000|Overall Study|Not Treated|0|||
30596572|NCT01326702|58608290|FG001|Overall Study|Not Treated|0|||
30596573|NCT01326702|58608291|FG002|Overall Study|Not Treated|0|||
30596574|NCT01326702|58608292|FG003|Overall Study|Not Treated|1|||
30596575|NCT01326702|58608293|FG004|Overall Study|Not Treated|0|||
30596576|NCT01326702|58608294|FG005|Overall Study|Not Treated|1|||
30596577|NCT01326702|58608295|FG006|Overall Study|Not Treated|0|||
30596578|NCT01327703|58608314|FG000|Second Treatment Period|Adverse Event|1|||
30596579|NCT01327703|58608315|FG001|Second Treatment Period|Adverse Event|1|||
30596580|NCT01327703|58608314|FG000|Second Treatment Period|Protocol Violation|0|||
30596581|NCT01327703|58608315|FG001|Second Treatment Period|Protocol Violation|1|||
30596582|NCT01380080|58608326|FG000|Overall Study|Death|36|||
30596583|NCT01380080|58608327|FG001|Overall Study|Death|44|||
30596584|NCT01380080|58608326|FG000|Overall Study|Site is closing|28|||
30596585|NCT01380080|58608327|FG001|Overall Study|Site is closing|31|||
30596586|NCT01380080|58608326|FG000|Overall Study|Not able to get to clinic|7|||
30783457|NCT02820844|58795674|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
30783458|NCT02820844|58795675|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
30596587|NCT01380080|58608327|FG001|Overall Study|Not able to get to clinic|1|||
30596588|NCT01380080|58608326|FG000|Overall Study|Not willing to adhere to requirements|6|||
30596589|NCT01380080|58608327|FG001|Overall Study|Not willing to adhere to requirements|2|||
30596590|NCT01380080|58608326|FG000|Overall Study|Withdrawal by Subject|5|||
30596591|NCT01380080|58608327|FG001|Overall Study|Withdrawal by Subject|2|||
30596592|NCT01380080|58608326|FG000|Overall Study|Lost to Follow-up|3|||
30596593|NCT01380080|58608327|FG001|Overall Study|Lost to Follow-up|3|||
30596594|NCT01379768|58608336|FG000|Overall Study|Adverse Event|1|||
30596595|NCT01379768|58608337|FG001|Overall Study|Adverse Event|1|||
30596596|NCT01379768|58608338|FG002|Overall Study|Adverse Event|0|||
30596597|NCT01379768|58608336|FG000|Overall Study|Lost to Follow-up|2|||
30596598|NCT01379768|58608337|FG001|Overall Study|Lost to Follow-up|0|||
30596599|NCT01379768|58608338|FG002|Overall Study|Lost to Follow-up|0|||
30783459|NCT02820844|58795670|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
30596600|NCT01379573|58608346|FG000|Overall Study|Lost to Follow-up|1|||
30596601|NCT01379573|58608346|FG000|Overall Study|Screen Failure|10|||
30596602|NCT01379534|58608352|FG000|Treatment Phase|Withdrawal by Subject|2|||
30596603|NCT01379534|58608353|FG001|Treatment Phase|Withdrawal by Subject|2|||
30596604|NCT01379534|58608352|FG000|Treatment Phase|Progressive disease|13|||
30596605|NCT01379534|58608353|FG001|Treatment Phase|Progressive disease|22|||
30596606|NCT01379534|58608352|FG000|Treatment Phase|Adverse Event|7|||
30596607|NCT01379534|58608353|FG001|Treatment Phase|Adverse Event|7|||
30596608|NCT01379534|58608352|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
30596609|NCT01379534|58608353|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
30596610|NCT01379534|58608352|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
30596611|NCT01379534|58608353|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
30596612|NCT01379534|58608352|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
30596613|NCT01379534|58608353|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
30596614|NCT01379534|58608352|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
30596615|NCT01379534|58608353|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
30596616|NCT01371851|58608361|FG000|Overall Study|Lost to Follow-up|5|||
30596617|NCT01371851|58608362|FG001|Overall Study|Lost to Follow-up|8|||
30596618|NCT01371851|58608361|FG000|Overall Study|was arrested and put in jail|0|||
30596619|NCT01371851|58608362|FG001|Overall Study|was arrested and put in jail|1|||
30596620|NCT01371851|58608361|FG000|Overall Study|non study related adverse event|1|||
30596621|NCT01371851|58608362|FG001|Overall Study|non study related adverse event|0|||
30596622|NCT01371851|58608361|FG000|Overall Study|Blood Pressure outside study parameters|2|||
30596623|NCT01371851|58608362|FG001|Overall Study|Blood Pressure outside study parameters|0|||
30596624|NCT01371734|58608371|FG000|Overall Study|Other|2|||
30596625|NCT01371734|58608372|FG001|Overall Study|Other|1|||
30596626|NCT01371734|58608373|FG002|Overall Study|Other|2|||
30596627|NCT01371734|58608371|FG000|Overall Study|Withdrawal by Subject|3|||
30596628|NCT01371734|58608372|FG001|Overall Study|Withdrawal by Subject|4|||
30682852|NCT00764504|58696774|FG001|Overall Study|Withdrawal by Subject|7|||
30682853|NCT00764504|58696775|FG002|Overall Study|Withdrawal by Subject|4|||
30682854|NCT00764504|58696773|FG000|Overall Study|Lost to Follow-up|40|||
30682855|NCT00764504|58696774|FG001|Overall Study|Lost to Follow-up|34|||
30682856|NCT00764504|58696775|FG002|Overall Study|Lost to Follow-up|72|||
30682857|NCT00763958|58696785|FG000|Overall Study|did not meet final criteria|4|||
30682858|NCT00763958|58696786|FG001|Overall Study|did not meet final criteria|4|||
30682859|NCT00763958|58696785|FG000|Overall Study|Lost to Follow-up|10|||
30682860|NCT00763958|58696786|FG001|Overall Study|Lost to Follow-up|2|||
30682861|NCT00763958|58696785|FG000|Overall Study|Believed they were receiving placebo|0|||
30596629|NCT01371734|58608373|FG002|Overall Study|Withdrawal by Subject|9|||
30596630|NCT01371734|58608371|FG000|Overall Study|Lost to Follow-up|5|||
30596631|NCT01371734|58608372|FG001|Overall Study|Lost to Follow-up|3|||
30596632|NCT01371734|58608373|FG002|Overall Study|Lost to Follow-up|1|||
30596633|NCT01371734|58608371|FG000|Overall Study|Protocol Violation|3|||
30596634|NCT01371734|58608372|FG001|Overall Study|Protocol Violation|1|||
30596635|NCT01371734|58608373|FG002|Overall Study|Protocol Violation|2|||
30596636|NCT01371734|58608371|FG000|Overall Study|Adverse Event|8|||
30596637|NCT01371734|58608372|FG001|Overall Study|Adverse Event|8|||
30596638|NCT01371734|58608373|FG002|Overall Study|Adverse Event|3|||
30596639|NCT01371734|58608371|FG000|Overall Study|Lack of Efficacy|2|||
30596640|NCT01371734|58608372|FG001|Overall Study|Lack of Efficacy|2|||
30682862|NCT00763958|58696786|FG001|Overall Study|Believed they were receiving placebo|5|||
30682863|NCT00763256|58696795|FG000|Overall Study|Didn't return for appointments|7|||
30682864|NCT00763256|58696796|FG001|Overall Study|Didn't return for appointments|10|||
30682865|NCT00762788|58696808|FG000|Overall Study|Lost to Follow-up|26|||
30682866|NCT00762788|58696809|FG001|Overall Study|Lost to Follow-up|37|||
30682867|NCT00762788|58696810|FG002|Overall Study|Lost to Follow-up|21|||
30682868|NCT00762788|58696811|FG003|Overall Study|Lost to Follow-up|26|||
30682869|NCT00762788|58696812|FG004|Overall Study|Lost to Follow-up|13|||
30682870|NCT00762788|58696813|FG005|Overall Study|Lost to Follow-up|21|||
30682871|NCT00583947|58696829|FG000|Cross-over Period|Adverse Event|2|||
30682872|NCT00583947|58696830|FG001|Cross-over Period|Adverse Event|0|||
30682873|NCT00583947|58696829|FG000|Cross-over Period|Withdrawal by Subject|2|||
30682874|NCT00583947|58696830|FG001|Cross-over Period|Withdrawal by Subject|0|||
30682875|NCT00583947|58696829|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
30682876|NCT00583947|58696830|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
30682877|NCT00583947|58696829|FG000|Cross-over Period|Other|1|||
30682878|NCT00583947|58696830|FG001|Cross-over Period|Other|1|||
30682879|NCT00772928|58696840|FG000|Overall Study|Lost to Follow-up|9|||
30682880|NCT00772928|58696841|FG001|Overall Study|Lost to Follow-up|6|||
30596641|NCT01371734|58608373|FG002|Overall Study|Lack of Efficacy|0|||
30596642|NCT01365494|58608383|FG000|Overall Study|Adverse Event|1|||
30682881|NCT00772928|58696840|FG000|Overall Study|Protocol Violation|10|||
30596643|NCT01365494|58608384|FG001|Overall Study|Adverse Event|0|||
30596644|NCT01365494|58608383|FG000|Overall Study|Withdrawal by Subject|0|||
30682882|NCT00772928|58696841|FG001|Overall Study|Protocol Violation|12|||
30682883|NCT00772928|58696840|FG000|Overall Study|Withdrawal by Subject|25|||
30682884|NCT00772928|58696841|FG001|Overall Study|Withdrawal by Subject|22|||
30596645|NCT01365494|58608384|FG001|Overall Study|Withdrawal by Subject|1|||
30596646|NCT01365494|58608383|FG000|Overall Study|Lost to Follow-up|1|||
30682885|NCT00772928|58696840|FG000|Overall Study|Did not receive vaccine|0|||
30682886|NCT00772928|58696841|FG001|Overall Study|Did not receive vaccine|1|||
30682887|NCT00762476|58696849|FG000|Overall Study|Adverse Event|7|||
30682888|NCT00762476|58696850|FG001|Overall Study|Adverse Event|1|||
30682889|NCT00762476|58696849|FG000|Overall Study|Lost to Follow-up|2|||
30682890|NCT00762476|58696850|FG001|Overall Study|Lost to Follow-up|0|||
30682891|NCT00762476|58696849|FG000|Overall Study|Protocol Violation|5|||
30682892|NCT00762476|58696850|FG001|Overall Study|Protocol Violation|6|||
30682893|NCT00762476|58696849|FG000|Overall Study|Physician Decision|2|||
30682894|NCT00762476|58696850|FG001|Overall Study|Physician Decision|14|||
30682895|NCT00762476|58696849|FG000|Overall Study|Withdrawal by Subject|6|||
30682896|NCT00762476|58696850|FG001|Overall Study|Withdrawal by Subject|12|||
30682897|NCT00762476|58696849|FG000|Overall Study|antibiotic use|0|||
30682898|NCT00762476|58696850|FG001|Overall Study|antibiotic use|1|||
30682899|NCT00762476|58696849|FG000|Overall Study|non-compliance with study visits|0|||
30682900|NCT00762476|58696850|FG001|Overall Study|non-compliance with study visits|2|||
30682901|NCT00762476|58696849|FG000|Overall Study|Seasonal allergies|1|||
30682902|NCT00762476|58696850|FG001|Overall Study|Seasonal allergies|0|||
30682903|NCT00762164|58696859|FG000|Overall Study|Lost to Follow-up|1|||
30682904|NCT00762164|58696860|FG001|Overall Study|Lost to Follow-up|1|||
30682905|NCT00762164|58696859|FG000|Overall Study|Discontinued medication|2|||
30682906|NCT00762164|58696860|FG001|Overall Study|Discontinued medication|0|||
30682907|NCT00762164|58696859|FG000|Overall Study|Withdrawal by Subject|0|||
30682908|NCT00762164|58696860|FG001|Overall Study|Withdrawal by Subject|1|||
30682909|NCT00762086|58696868|FG000|Overall Study|Adverse Event|2|||
30682910|NCT00762086|58696869|FG001|Overall Study|Adverse Event|0|||
30682911|NCT00762086|58696868|FG000|Overall Study|Lost to Follow-up|0|||
30682912|NCT00762086|58696869|FG001|Overall Study|Lost to Follow-up|2|||
30682913|NCT00762086|58696868|FG000|Overall Study|Non compliance|1|||
30682914|NCT00762086|58696869|FG001|Overall Study|Non compliance|0|||
30682915|NCT00762086|58696868|FG000|Overall Study|Withdrawal by Subject|2|||
30682916|NCT00762086|58696869|FG001|Overall Study|Withdrawal by Subject|2|||
30682917|NCT00762086|58696868|FG000|Overall Study|Ineligible to participate in the study|1|||
30682918|NCT00762086|58696869|FG001|Overall Study|Ineligible to participate in the study|0|||
30682919|NCT00761774|58696875|FG000|Overall Study|Adverse Event|17|||
30682920|NCT00761774|58696875|FG000|Overall Study|Lack of Efficacy|37|||
30682921|NCT00761774|58696875|FG000|Overall Study|Lost to Follow-up|2|||
30682922|NCT00761774|58696875|FG000|Overall Study|Withdrawal by Subject|9|||
30682923|NCT00761774|58696875|FG000|Overall Study|Non-compliance|4|||
30682924|NCT00761774|58696875|FG000|Overall Study|End of study|2|||
30682925|NCT00761774|58696875|FG000|Overall Study|Reclassification of seizures|1|||
30682926|NCT00761774|58696875|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
30682927|NCT00761774|58696875|FG000|Overall Study|Sponsor decision|1|||
30682928|NCT00761774|58696875|FG000|Overall Study|Investigator clinical judgement|1|||
30682929|NCT00761774|58696875|FG000|Overall Study|Patient moved out of study area|1|||
30682930|NCT00761774|58696875|FG000|Overall Study|Coordinator leaving site|1|||
30682931|NCT00761774|58696875|FG000|Overall Study|Subject IP non-compliance|1|||
30682932|NCT00761774|58696875|FG000|Overall Study|IP stopped by hospital physician|1|||
30682933|NCT00583791|58696881|FG000|Overall Study|Other|67|||
30682934|NCT00583791|58696881|FG000|Overall Study|Death|6|||
30682935|NCT00781274|58696885|FG000|Overall Study|Withdrawal by Subject|2|||
30682936|NCT00780416|58696891|FG000|Overall Study|Physician Decision|3|||
30682937|NCT00780416|58696892|FG001|Overall Study|Physician Decision|3|||
30682938|NCT00780416|58696891|FG000|Overall Study|Protocol Violation|1|||
30682939|NCT00780416|58696892|FG001|Overall Study|Protocol Violation|0|||
30682940|NCT00780416|58696891|FG000|Overall Study|Withdrawal by Subject|8|||
30682941|NCT00780416|58696892|FG001|Overall Study|Withdrawal by Subject|6|||
30682942|NCT00761462|58696900|FG000|Treatment|Subjects never received study medication|23|||
30682943|NCT00761462|58696901|FG001|Treatment|Subjects never received study medication|12|||
30682944|NCT00761462|58696900|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
30682945|NCT00761462|58696901|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
30682946|NCT00761462|58696900|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
30682947|NCT00761462|58696901|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
30682948|NCT00761462|58696900|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
30682949|NCT00761462|58696901|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
30682950|NCT00761306|58696907|FG000|Overall Study|Adverse Event|5|||
30682951|NCT00761306|58696907|FG000|Overall Study|Lack of Efficacy|4|||
30682952|NCT00761306|58696907|FG000|Overall Study|Protocol Violation|2|||
30682953|NCT00761306|58696907|FG000|Overall Study|Withdrawal of Consent|3|||
30682954|NCT00761306|58696907|FG000|Overall Study|Lost to Follow-up|1|||
30682955|NCT00761306|58696907|FG000|Overall Study|Administrative or Other Reasons|5|||
30682956|NCT00772538|58696913|FG000|Overall Study|Adverse Event|6|||
30682957|NCT00772538|58696914|FG001|Overall Study|Adverse Event|6|||
30682958|NCT00772538|58696913|FG000|Overall Study|Protocol Violation|3|||
30682959|NCT00772538|58696914|FG001|Overall Study|Protocol Violation|3|||
30682960|NCT00772538|58696913|FG000|Overall Study|Lost to Follow-up|1|||
30682961|NCT00772538|58696914|FG001|Overall Study|Lost to Follow-up|1|||
30682962|NCT00772538|58696913|FG000|Overall Study|Withdrawal by Subject|3|||
30682963|NCT00772538|58696914|FG001|Overall Study|Withdrawal by Subject|8|||
30682964|NCT00772538|58696913|FG000|Overall Study|Lack of Efficacy|0|||
30682965|NCT00772538|58696914|FG001|Overall Study|Lack of Efficacy|1|||
30682966|NCT00772538|58696913|FG000|Overall Study|Other|7|||
30682967|NCT00772538|58696914|FG001|Overall Study|Other|7|||
30682968|NCT00761150|58696923|FG000|Open-label Period|Adverse Event|36|||
30682969|NCT00761150|58696924|FG001|Open-label Period|Adverse Event|0|||
30682970|NCT00761150|58696925|FG002|Open-label Period|Adverse Event|0|||
30682971|NCT00761150|58696923|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
30682972|NCT00761150|58696924|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
30682973|NCT00761150|58696925|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
30682974|NCT00761150|58696923|FG000|Open-label Period|Lost to Follow-up|7|||
30682975|NCT00761150|58696924|FG001|Open-label Period|Lost to Follow-up|0|||
30682976|NCT00761150|58696925|FG002|Open-label Period|Lost to Follow-up|0|||
30682977|NCT00761150|58696923|FG000|Open-label Period|Lack of Efficacy|4|||
30682978|NCT00761150|58696924|FG001|Open-label Period|Lack of Efficacy|0|||
30682979|NCT00761150|58696925|FG002|Open-label Period|Lack of Efficacy|0|||
30682980|NCT00761150|58696923|FG000|Open-label Period|Withdrawal by Subject|5|||
30682981|NCT00761150|58696924|FG001|Open-label Period|Withdrawal by Subject|0|||
30682982|NCT00761150|58696925|FG002|Open-label Period|Withdrawal by Subject|0|||
30682983|NCT00761150|58696923|FG000|Open-label Period|Noncompliance|2|||
30682984|NCT00761150|58696924|FG001|Open-label Period|Noncompliance|0|||
30682985|NCT00761150|58696925|FG002|Open-label Period|Noncompliance|0|||
30682986|NCT00761150|58696923|FG000|Open-label Period|Other|5|||
30682987|NCT00761150|58696924|FG001|Open-label Period|Other|0|||
30682988|NCT00761150|58696925|FG002|Open-label Period|Other|0|||
30682989|NCT00761150|58696923|FG000|Double-blind Period|Lack of Efficacy|0|||
30682990|NCT00761150|58696924|FG001|Double-blind Period|Lack of Efficacy|2|||
30682991|NCT00761150|58696925|FG002|Double-blind Period|Lack of Efficacy|19|||
30682992|NCT00761150|58696923|FG000|Double-blind Period|Adverse Event|0|||
30682993|NCT00761150|58696924|FG001|Double-blind Period|Adverse Event|3|||
30682994|NCT00761150|58696925|FG002|Double-blind Period|Adverse Event|3|||
30682995|NCT00761150|58696923|FG000|Double-blind Period|Withdrawal by Subject|0|||
30682996|NCT00761150|58696924|FG001|Double-blind Period|Withdrawal by Subject|3|||
30682997|NCT00761150|58696925|FG002|Double-blind Period|Withdrawal by Subject|2|||
30682998|NCT00761150|58696923|FG000|Double-blind Period|Lost to Follow-up|0|||
30682999|NCT00761150|58696924|FG001|Double-blind Period|Lost to Follow-up|2|||
30683000|NCT00761150|58696925|FG002|Double-blind Period|Lost to Follow-up|1|||
30683001|NCT00761150|58696923|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
30683002|NCT00761150|58696924|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
30683003|NCT00761150|58696925|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
30683004|NCT00761150|58696923|FG000|Double-blind Period|Noncompliance|0|||
30683005|NCT00761150|58696924|FG001|Double-blind Period|Noncompliance|1|||
30683006|NCT00761150|58696925|FG002|Double-blind Period|Noncompliance|0|||
30683007|NCT00761150|58696923|FG000|Double-blind Period|Other|0|||
30683008|NCT00761150|58696924|FG001|Double-blind Period|Other|3|||
30683009|NCT00761150|58696925|FG002|Double-blind Period|Other|3|||
30683010|NCT00760994|58696935|FG000|Overall Study|Lost to Follow-up|4|||
30683011|NCT00760994|58696936|FG001|Overall Study|Lost to Follow-up|4|||
30596647|NCT01365494|58608384|FG001|Overall Study|Lost to Follow-up|2|||
30596648|NCT01357889|58608393|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
30596649|NCT01357889|58608394|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
30596650|NCT01357889|58608393|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
30596651|NCT01357889|58608394|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
30596652|NCT01357889|58608393|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
30596653|NCT01357889|58608394|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
30596654|NCT01357889|58608393|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
30596655|NCT01357889|58608394|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
30596656|NCT01357889|58608393|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
30596657|NCT01357889|58608394|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
30596658|NCT01357889|58608393|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
30596659|NCT01357889|58608394|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
30596660|NCT01357889|58608393|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
30596661|NCT01357889|58608394|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
30596662|NCT01357889|58608393|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
30596663|NCT01357889|58608394|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
30683012|NCT00760994|58696937|FG002|Overall Study|Lost to Follow-up|3|||
30596664|NCT01357889|58608393|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
30683013|NCT00583557|58696947|FG000|Overall Study|Withdrawal by Subject|18|||
30683014|NCT00583557|58696947|FG000|Overall Study|Adverse Event|9|||
30683015|NCT00583557|58696947|FG000|Overall Study|Lack of Efficacy|31|||
30683016|NCT00583557|58696947|FG000|Overall Study|Lack of Compliance|5|||
30683017|NCT00583557|58696947|FG000|Overall Study|Other|5|||
30683018|NCT00583557|58696947|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
30683019|NCT00586820|58696953|FG000|Overall Study|Unsuccessful PCI|1|||
30683020|NCT00586820|58696954|FG001|Overall Study|Unsuccessful PCI|0|||
30683021|NCT00760838|58696962|FG000|Overall Study|Adverse Event|1|||
30683022|NCT00760838|58696963|FG001|Overall Study|Adverse Event|1|||
30683023|NCT00760838|58696962|FG000|Overall Study|Lack of Efficacy|1|||
30683024|NCT00760838|58696963|FG001|Overall Study|Lack of Efficacy|0|||
30683025|NCT00760838|58696962|FG000|Overall Study|Lost to Follow-up|2|||
30596665|NCT01357889|58608394|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
30596666|NCT01357889|58608393|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
30596667|NCT01357889|58608394|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
30596668|NCT01357889|58608393|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
30596669|NCT01357889|58608394|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
30683026|NCT00760838|58696963|FG001|Overall Study|Lost to Follow-up|0|||
30683027|NCT00760838|58696962|FG000|Overall Study|Withdrawal by Subject|1|||
30683028|NCT00760838|58696963|FG001|Overall Study|Withdrawal by Subject|1|||
30683029|NCT00586664|58696972|FG000|Overall Study|Withdrawal by Subject|3|||
30683030|NCT00586664|58696973|FG001|Overall Study|Withdrawal by Subject|7|||
30683031|NCT00586664|58696974|FG002|Overall Study|Withdrawal by Subject|1|||
30683032|NCT00586664|58696972|FG000|Overall Study|Exclusion criteria met|2|||
30683033|NCT00586664|58696973|FG001|Overall Study|Exclusion criteria met|0|||
30683034|NCT00586664|58696974|FG002|Overall Study|Exclusion criteria met|0|||
30683035|NCT00437281|58697002|FG000|Overall Study|Adverse Event|0|||
30683036|NCT00437281|58697003|FG001|Overall Study|Adverse Event|0|||
30683037|NCT00437281|58697004|FG002|Overall Study|Adverse Event|0|||
30683038|NCT00437281|58697005|FG003|Overall Study|Adverse Event|1|||
30683039|NCT00437281|58697006|FG004|Overall Study|Adverse Event|0|||
30596670|NCT01357889|58608393|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
30596671|NCT01357889|58608394|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
30596672|NCT01357889|58608393|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
30683040|NCT00437281|58697007|FG005|Overall Study|Adverse Event|1|||
30683041|NCT00437281|58697008|FG006|Overall Study|Adverse Event|0|||
30683042|NCT00437281|58697009|FG007|Overall Study|Adverse Event|0|||
30683043|NCT00437281|58697010|FG008|Overall Study|Adverse Event|0|||
30683044|NCT00437281|58697011|FG009|Overall Study|Adverse Event|1|||
30683045|NCT00437281|58697012|FG010|Overall Study|Adverse Event|0|||
30683046|NCT00437281|58697013|FG011|Overall Study|Adverse Event|0|||
30683047|NCT00437281|58697014|FG012|Overall Study|Adverse Event|0|||
30683048|NCT00437281|58697015|FG013|Overall Study|Adverse Event|1|||
30683049|NCT00437281|58697016|FG014|Overall Study|Adverse Event|1|||
30683050|NCT00437281|58697017|FG015|Overall Study|Adverse Event|0|||
30683051|NCT00437281|58697018|FG016|Overall Study|Adverse Event|0|||
30683052|NCT00437281|58697019|FG017|Overall Study|Adverse Event|0|||
30683053|NCT00437281|58697020|FG018|Overall Study|Adverse Event|1|||
30683054|NCT00437281|58697021|FG019|Overall Study|Adverse Event|0|||
30683055|NCT00437281|58697002|FG000|Overall Study|Lost to Follow-up|0|||
30683056|NCT00437281|58697003|FG001|Overall Study|Lost to Follow-up|0|||
30683057|NCT00437281|58697004|FG002|Overall Study|Lost to Follow-up|0|||
30683058|NCT00437281|58697005|FG003|Overall Study|Lost to Follow-up|0|||
30683059|NCT00437281|58697006|FG004|Overall Study|Lost to Follow-up|0|||
30683060|NCT00437281|58697007|FG005|Overall Study|Lost to Follow-up|0|||
30683061|NCT00437281|58697008|FG006|Overall Study|Lost to Follow-up|0|||
30683062|NCT00437281|58697009|FG007|Overall Study|Lost to Follow-up|0|||
30683063|NCT00437281|58697010|FG008|Overall Study|Lost to Follow-up|0|||
30683064|NCT00437281|58697011|FG009|Overall Study|Lost to Follow-up|0|||
30683065|NCT00437281|58697012|FG010|Overall Study|Lost to Follow-up|0|||
30683066|NCT00437281|58697013|FG011|Overall Study|Lost to Follow-up|0|||
30683067|NCT00437281|58697014|FG012|Overall Study|Lost to Follow-up|0|||
30683068|NCT00437281|58697015|FG013|Overall Study|Lost to Follow-up|0|||
30783460|NCT02820844|58795671|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
30783461|NCT02820844|58795672|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
30783462|NCT02820844|58795673|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
30783463|NCT02820844|58795674|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
30783464|NCT02820844|58795675|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
30783465|NCT02820844|58795670|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
30856195|NCT03296527|58884066|FG000|Overall Study|Protocol Deviation|4|||
30596673|NCT01357889|58608394|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
30596674|NCT01357850|58608406|FG000|Overall Study|Lost to Follow-up|1|||
30596675|NCT01357850|58608407|FG001|Overall Study|Lost to Follow-up|0|||
30683069|NCT00437281|58697016|FG014|Overall Study|Lost to Follow-up|0|||
30683070|NCT00437281|58697017|FG015|Overall Study|Lost to Follow-up|0|||
30683071|NCT00437281|58697018|FG016|Overall Study|Lost to Follow-up|0|||
30683072|NCT00437281|58697019|FG017|Overall Study|Lost to Follow-up|0|||
30683073|NCT00437281|58697020|FG018|Overall Study|Lost to Follow-up|0|||
30683074|NCT00437281|58697021|FG019|Overall Study|Lost to Follow-up|1|||
30683075|NCT00741039|58697095|FG000|Overall Study|Patient non-compliance|2|||
30683076|NCT00741039|58697096|FG001|Overall Study|Patient non-compliance|0|||
30683077|NCT00772382|58697102|FG000|Overall Study|Adverse Event|19|||
30683078|NCT00772382|58697102|FG000|Overall Study|Death|6|||
30683079|NCT00772382|58697102|FG000|Overall Study|Lack of Efficacy|4|||
30683080|NCT00772382|58697102|FG000|Overall Study|Physician Decision|5|||
30683081|NCT00772382|58697102|FG000|Overall Study|Protocol Violation|1|||
30683082|NCT00772382|58697102|FG000|Overall Study|Withdrawal by Subject|10|||
30683083|NCT00772382|58697102|FG000|Overall Study|Other Reasons|10|||
30683084|NCT00798707|58697109|FG000|Overall Study|Adverse Event|6|||
30683085|NCT00798707|58697110|FG001|Overall Study|Adverse Event|8|||
30683086|NCT00798707|58697111|FG002|Overall Study|Adverse Event|8|||
30683087|NCT00798707|58697109|FG000|Overall Study|Failed to return|2|||
30683088|NCT00798707|58697110|FG001|Overall Study|Failed to return|2|||
30683089|NCT00798707|58697111|FG002|Overall Study|Failed to return|0|||
30683090|NCT00798707|58697109|FG000|Overall Study|Investigator|0|||
30683091|NCT00798707|58697110|FG001|Overall Study|Investigator|1|||
30683092|NCT00798707|58697111|FG002|Overall Study|Investigator|2|||
30683093|NCT00798707|58697109|FG000|Overall Study|Lack of Efficacy|2|||
30683094|NCT00798707|58697110|FG001|Overall Study|Lack of Efficacy|2|||
30683095|NCT00798707|58697111|FG002|Overall Study|Lack of Efficacy|1|||
30683096|NCT00798707|58697109|FG000|Overall Study|Lost to Follow-up|5|||
30683097|NCT00798707|58697110|FG001|Overall Study|Lost to Follow-up|6|||
30683098|NCT00798707|58697111|FG002|Overall Study|Lost to Follow-up|6|||
30683099|NCT00798707|58697109|FG000|Overall Study|Other|0|||
30683100|NCT00798707|58697110|FG001|Overall Study|Other|1|||
30683101|NCT00798707|58697111|FG002|Overall Study|Other|0|||
30683102|NCT00798707|58697109|FG000|Overall Study|Protocol Violation|4|||
30683103|NCT00798707|58697110|FG001|Overall Study|Protocol Violation|0|||
30683104|NCT00798707|58697111|FG002|Overall Study|Protocol Violation|2|||
30683105|NCT00798707|58697109|FG000|Overall Study|Withdrawal by Subject|3|||
30683106|NCT00798707|58697110|FG001|Overall Study|Withdrawal by Subject|8|||
30683107|NCT00798707|58697111|FG002|Overall Study|Withdrawal by Subject|2|||
30683108|NCT00798707|58697109|FG000|Overall Study|Randomized not treated|4|||
30683109|NCT00798707|58697110|FG001|Overall Study|Randomized not treated|5|||
30683110|NCT00798707|58697111|FG002|Overall Study|Randomized not treated|1|||
30683111|NCT00760214|58697122|FG000|Overall Study|Adverse Event|8|||
30683112|NCT00760214|58697123|FG001|Overall Study|Adverse Event|9|||
30683113|NCT00760214|58697124|FG002|Overall Study|Adverse Event|12|||
30683114|NCT00760214|58697122|FG000|Overall Study|Protocol Violation|3|||
30683115|NCT00760214|58697123|FG001|Overall Study|Protocol Violation|0|||
30683116|NCT00760214|58697124|FG002|Overall Study|Protocol Violation|3|||
30683117|NCT00760214|58697122|FG000|Overall Study|Lost to Follow-up|0|||
30683118|NCT00760214|58697123|FG001|Overall Study|Lost to Follow-up|0|||
30683119|NCT00760214|58697124|FG002|Overall Study|Lost to Follow-up|1|||
30683120|NCT00760214|58697122|FG000|Overall Study|Withdrawal by Subject|12|||
30683121|NCT00760214|58697123|FG001|Overall Study|Withdrawal by Subject|14|||
30683122|NCT00760214|58697124|FG002|Overall Study|Withdrawal by Subject|13|||
30683123|NCT00760214|58697122|FG000|Overall Study|Lack of Efficacy|3|||
30683124|NCT00760214|58697123|FG001|Overall Study|Lack of Efficacy|2|||
30683125|NCT00760214|58697124|FG002|Overall Study|Lack of Efficacy|4|||
30783466|NCT02820844|58795671|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
30596676|NCT01357850|58608408|FG002|Overall Study|Lost to Follow-up|0|||
30596677|NCT01357850|58608409|FG003|Overall Study|Lost to Follow-up|0|||
30596678|NCT01357655|58608422|FG000|Overall Study|Administrative Reason by Sponsor|45|||
30596679|NCT01357655|58608423|FG001|Overall Study|Administrative Reason by Sponsor|0|||
30596680|NCT01357655|58608422|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
30596681|NCT01357655|58608423|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
30596682|NCT01357655|58608422|FG000|Overall Study|Disease Progression|1|||
30596683|NCT01357655|58608423|FG001|Overall Study|Disease Progression|0|||
30596684|NCT01357655|58608422|FG000|Overall Study|Lost to Follow-up|2|||
30596685|NCT01357655|58608423|FG001|Overall Study|Lost to Follow-up|0|||
30596686|NCT01357655|58608422|FG000|Overall Study|Maximum Clinical Benefit|2|||
30596687|NCT01357655|58608423|FG001|Overall Study|Maximum Clinical Benefit|0|||
30596688|NCT01357655|58608422|FG000|Overall Study|Reason Unspecified|1|||
30596689|NCT01357655|58608423|FG001|Overall Study|Reason Unspecified|0|||
30596690|NCT01357655|58608422|FG000|Overall Study|Study Drug Toxicity|11|||
30596691|NCT01357655|58608423|FG001|Overall Study|Study Drug Toxicity|0|||
30596692|NCT01357655|58608422|FG000|Overall Study|Subject Withdrew Consent|1|||
30596693|NCT01357655|58608423|FG001|Overall Study|Subject Withdrew Consent|0|||
30596694|NCT01357616|58608430|FG000|Overall Study|Adverse Event|1|||
30596695|NCT01357616|58608431|FG001|Overall Study|Adverse Event|1|||
30683126|NCT00760214|58697122|FG000|Overall Study|Pregnancy|0|||
30683127|NCT00760214|58697123|FG001|Overall Study|Pregnancy|0|||
30683128|NCT00760214|58697124|FG002|Overall Study|Pregnancy|1|||
30683129|NCT00760214|58697122|FG000|Overall Study|Physician Decision|1|||
30683130|NCT00760214|58697123|FG001|Overall Study|Physician Decision|1|||
30683131|NCT00760214|58697124|FG002|Overall Study|Physician Decision|1|||
30683132|NCT00760214|58697122|FG000|Overall Study|Other|3|||
30683133|NCT00760214|58697123|FG001|Overall Study|Other|4|||
30683134|NCT00760214|58697124|FG002|Overall Study|Other|6|||
30683135|NCT00802841|58697134|FG000|Overall Study|Administrative problems|1|||
30683136|NCT00802841|58697135|FG001|Overall Study|Administrative problems|0|||
30683137|NCT00802841|58697134|FG000|Overall Study|Lost to Follow-up|2|||
30683138|NCT00802841|58697135|FG001|Overall Study|Lost to Follow-up|1|||
30683139|NCT00802841|58697134|FG000|Overall Study|Death|1|||
30683140|NCT00802841|58697135|FG001|Overall Study|Death|2|||
30683141|NCT00802841|58697134|FG000|Overall Study|Adverse Event|8|||
30783467|NCT02820844|58795672|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
30783468|NCT02820844|58795673|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
30783469|NCT02820844|58795674|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
30783470|NCT02820844|58795675|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
30783471|NCT02820844|58795670|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
30783472|NCT02820844|58795671|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
30783473|NCT02820844|58795672|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
30783474|NCT02820844|58795673|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
30783475|NCT02820844|58795674|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
30783476|NCT02820844|58795675|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
30783477|NCT02820844|58795670|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
30783478|NCT02820844|58795671|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
30783479|NCT02820844|58795672|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
30783480|NCT02820844|58795673|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
30596696|NCT01357616|58608430|FG000|Overall Study|Lost to Follow-up|4|||
30596697|NCT01357616|58608431|FG001|Overall Study|Lost to Follow-up|3|||
30596698|NCT01357616|58608430|FG000|Overall Study|Protocol Violation|0|||
30783481|NCT02820844|58795674|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
30783482|NCT02820844|58795675|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
30783483|NCT02942576|58795694|FG000|Overall Study|Adverse Event|28|||
30783484|NCT02942576|58795695|FG001|Overall Study|Adverse Event|6|||
30783485|NCT02942576|58795694|FG000|Overall Study|Withdrawal by Subject|7|||
30783486|NCT02942576|58795695|FG001|Overall Study|Withdrawal by Subject|5|||
30783487|NCT02942576|58795694|FG000|Overall Study|Physician Decision|1|||
30783488|NCT02942576|58795695|FG001|Overall Study|Physician Decision|4|||
30783489|NCT02942576|58795694|FG000|Overall Study|Other|10|||
30783490|NCT02942576|58795695|FG001|Overall Study|Other|8|||
30783491|NCT02820298|58795703|FG000|Overall Study|Withdrawal by Subject|0|||
30783492|NCT02820298|58795704|FG001|Overall Study|Withdrawal by Subject|1|||
30783493|NCT02820298|58795703|FG000|Overall Study|Physician Decision|1|||
30783494|NCT02820298|58795704|FG001|Overall Study|Physician Decision|0|||
30783495|NCT02820298|58795703|FG000|Overall Study|Protocol Violation|0|||
30783496|NCT02820298|58795704|FG001|Overall Study|Protocol Violation|1|||
30783497|NCT02819440|58795718|FG000|Overall Study|Adverse Event|3|||
30783498|NCT02819440|58795719|FG001|Overall Study|Adverse Event|1|||
30783499|NCT02819440|58795718|FG000|Overall Study|Lost to Follow-up|1|||
30783500|NCT02819440|58795719|FG001|Overall Study|Lost to Follow-up|3|||
30596699|NCT01357616|58608431|FG001|Overall Study|Protocol Violation|2|||
30596700|NCT01357616|58608430|FG000|Overall Study|Inadequate Control of IOP|1|||
30596701|NCT01357616|58608431|FG001|Overall Study|Inadequate Control of IOP|2|||
30596702|NCT01357616|58608430|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
30596703|NCT01357616|58608431|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
30596704|NCT01357616|58608430|FG000|Overall Study|Withdrawal by Subject|1|||
30596705|NCT01357616|58608431|FG001|Overall Study|Withdrawal by Subject|0|||
30596706|NCT01357577|58608439|FG000|Overall Study|Lost to Follow-up|20|||
30596707|NCT01357577|58608440|FG001|Overall Study|Lost to Follow-up|16|||
30596708|NCT01357577|58608439|FG000|Overall Study|Withdrawal by Subject|16|||
30596709|NCT01357577|58608440|FG001|Overall Study|Withdrawal by Subject|8|||
30596710|NCT01357577|58608439|FG000|Overall Study|look at data in database?|1|||
30596711|NCT01357577|58608440|FG001|Overall Study|look at data in database?|2|||
30596712|NCT01351025|58608449|FG000|Week 0 - 20|Lost to Follow-up|2|||
30596713|NCT01351025|58608450|FG001|Week 0 - 20|Lost to Follow-up|1|||
30596714|NCT01351025|58608449|FG000|Week 0 - 20|Withdrawal by Subject|1|||
30596715|NCT01351025|58608450|FG001|Week 0 - 20|Withdrawal by Subject|0|||
30596716|NCT01351025|58608449|FG000|Week 24 - 44|Lost to Follow-up|0|||
30683142|NCT00802841|58697135|FG001|Overall Study|Adverse Event|2|||
30683143|NCT00802841|58697134|FG000|Overall Study|Disease progression|7|||
30683144|NCT00802841|58697135|FG001|Overall Study|Disease progression|3|||
30683145|NCT00802841|58697134|FG000|Overall Study|Withdrawal by Subject|9|||
30683146|NCT00802841|58697135|FG001|Overall Study|Withdrawal by Subject|5|||
30596717|NCT01351025|58608450|FG001|Week 24 - 44|Lost to Follow-up|2|||
30596718|NCT01351025|58608449|FG000|Week 24 - 44|Site closed|0|||
30596719|NCT01351025|58608450|FG001|Week 24 - 44|Site closed|1|||
30683147|NCT00802841|58697134|FG000|Overall Study|Protocol deviation|2|||
30783501|NCT02819440|58795718|FG000|Overall Study|Withdrawal by Subject|9|||
30783502|NCT02819440|58795719|FG001|Overall Study|Withdrawal by Subject|8|||
30596720|NCT01351025|58608449|FG000|Week 24 - 44|unable to get to clinic|1|||
30596721|NCT01351025|58608450|FG001|Week 24 - 44|unable to get to clinic|1|||
30683148|NCT00802841|58697135|FG001|Overall Study|Protocol deviation|6|||
30683149|NCT00802841|58697134|FG000|Overall Study|Treatment duration completed|66|||
30683150|NCT00802841|58697135|FG001|Overall Study|Treatment duration completed|76|||
30683151|NCT00772148|58697145|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
30683152|NCT00772148|58697146|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
30683153|NCT00772148|58697145|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
30683154|NCT00772148|58697146|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
30683155|NCT00772148|58697145|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
30683156|NCT00772148|58697146|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
30683157|NCT00772148|58697145|FG000|Maintenance Phase (Week 52)|Death|2|||
30683158|NCT00772148|58697146|FG001|Maintenance Phase (Week 52)|Death|2|||
30683159|NCT00772148|58697145|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
30683160|NCT00772148|58697146|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
30683161|NCT00772148|58697145|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
30683162|NCT00772148|58697146|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
30683163|NCT00772148|58697145|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
30683164|NCT00772148|58697146|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
30683165|NCT00759902|58697154|FG000|Overall Study|Adverse Event|0|||
30683166|NCT00759902|58697155|FG001|Overall Study|Adverse Event|1|||
30683167|NCT00772070|58697163|FG000|Overall Study|Lost to Follow-up|0|||
30683168|NCT00772070|58697164|FG001|Overall Study|Lost to Follow-up|8|||
30683169|NCT00772070|58697163|FG000|Overall Study|Withdrawal by Subject|0|||
30683170|NCT00772070|58697164|FG001|Overall Study|Withdrawal by Subject|2|||
30683171|NCT00772070|58697163|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
30683172|NCT00772070|58697164|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
30683173|NCT00796757|58697170|FG000|Overall Study|Withdrawal by Subject|14|||
30683174|NCT00796757|58697170|FG000|Overall Study|Death|61|||
30683175|NCT00796757|58697170|FG000|Overall Study|Protocol Violation|1|||
30683176|NCT00796757|58697170|FG000|Overall Study|Participant noncompliance|1|||
30683177|NCT00796757|58697170|FG000|Overall Study|Investigator's decision|2|||
30683178|NCT00796757|58697170|FG000|Overall Study|Other|7|||
30683179|NCT00759356|58697176|FG000|Overall Study|Adverse Event|0|||
30683180|NCT00759356|58697177|FG001|Overall Study|Adverse Event|1|||
30683181|NCT00759356|58697176|FG000|Overall Study|Withdrawal by Subject|0|||
30683182|NCT00759356|58697177|FG001|Overall Study|Withdrawal by Subject|2|||
30683183|NCT00759356|58697176|FG000|Overall Study|Subject was unable to return|1|||
30683184|NCT00759356|58697177|FG001|Overall Study|Subject was unable to return|0|||
30683185|NCT00721734|58697188|FG000|Overall Study|Progressive Disease|3|||
30596722|NCT01349036|58608464|FG000|Overall Study|Disease progression|13|||
30596723|NCT01349036|58608465|FG001|Overall Study|Disease progression|22|||
30596724|NCT01349036|58608464|FG000|Overall Study|Other|1|||
30596725|NCT01349036|58608465|FG001|Overall Study|Other|0|||
30596726|NCT01349036|58608464|FG000|Overall Study|Withdrawal by Subject|0|||
30596727|NCT01349036|58608465|FG001|Overall Study|Withdrawal by Subject|2|||
30596728|NCT01348763|58608475|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
30596729|NCT01348763|58608475|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
30596730|NCT01346969|58608483|FG000|Overall Study|Withdrawal by Subject|0|||
30596731|NCT01346969|58608484|FG001|Overall Study|Withdrawal by Subject|0|||
30596732|NCT01346969|58608485|FG002|Overall Study|Withdrawal by Subject|1|||
30596733|NCT01346969|58608486|FG003|Overall Study|Withdrawal by Subject|0|||
30596734|NCT01346969|58608483|FG000|Overall Study|Lost to Follow-up|1|||
30596735|NCT01346969|58608484|FG001|Overall Study|Lost to Follow-up|0|||
30596736|NCT01346969|58608485|FG002|Overall Study|Lost to Follow-up|2|||
30596737|NCT01346969|58608486|FG003|Overall Study|Lost to Follow-up|0|||
30683186|NCT00721734|58697189|FG001|Overall Study|Progressive Disease|10|||
30683187|NCT00721734|58697190|FG002|Overall Study|Progressive Disease|4|||
30683188|NCT00721734|58697191|FG003|Overall Study|Progressive Disease|5|||
30683189|NCT00721734|58697192|FG004|Overall Study|Progressive Disease|2|||
30683190|NCT00721734|58697188|FG000|Overall Study|Adverse Event|3|||
30683191|NCT00721734|58697189|FG001|Overall Study|Adverse Event|1|||
30683192|NCT00721734|58697190|FG002|Overall Study|Adverse Event|4|||
30683193|NCT00721734|58697191|FG003|Overall Study|Adverse Event|0|||
30683194|NCT00721734|58697192|FG004|Overall Study|Adverse Event|3|||
30683195|NCT00721734|58697188|FG000|Overall Study|Withdrawal by Subject|2|||
30683196|NCT00721734|58697189|FG001|Overall Study|Withdrawal by Subject|1|||
30683197|NCT00721734|58697190|FG002|Overall Study|Withdrawal by Subject|0|||
30683198|NCT00721734|58697191|FG003|Overall Study|Withdrawal by Subject|0|||
30683199|NCT00721734|58697192|FG004|Overall Study|Withdrawal by Subject|1|||
30683200|NCT00721734|58697188|FG000|Overall Study|Other|0|||
30683201|NCT00721734|58697189|FG001|Overall Study|Other|0|||
30683202|NCT00721734|58697190|FG002|Overall Study|Other|0|||
30683203|NCT00721734|58697191|FG003|Overall Study|Other|1|||
30683204|NCT00721734|58697192|FG004|Overall Study|Other|0|||
30596738|NCT01346969|58608483|FG000|Overall Study|Physician Decision|0|||
30596739|NCT01346969|58608484|FG001|Overall Study|Physician Decision|0|||
30596740|NCT01346969|58608485|FG002|Overall Study|Physician Decision|0|||
30683205|NCT00798317|58697206|FG000|Overall Study|Physician Decision|0|||
30596741|NCT01346969|58608486|FG003|Overall Study|Physician Decision|1|||
30683206|NCT00798317|58697207|FG001|Overall Study|Physician Decision|1|||
30683207|NCT00798317|58697206|FG000|Overall Study|Withdrawal by Subject|5|||
30683208|NCT00798317|58697207|FG001|Overall Study|Withdrawal by Subject|4|||
30683209|NCT00798317|58697206|FG000|Overall Study|Lost to Follow-up|2|||
30683210|NCT00798317|58697207|FG001|Overall Study|Lost to Follow-up|2|||
30683211|NCT00798317|58697206|FG000|Overall Study|Adverse Event|2|||
30683212|NCT00798317|58697207|FG001|Overall Study|Adverse Event|0|||
30683213|NCT00798317|58697206|FG000|Overall Study|Death|1|||
30683214|NCT00798317|58697207|FG001|Overall Study|Death|0|||
30683215|NCT00779402|58697215|FG000|Treatment Phase 1|Disease Progression|1|||
30683216|NCT00779402|58697216|FG001|Treatment Phase 1|Disease Progression|0|||
30683217|NCT00779402|58697215|FG000|Treatment Phase 1|Adverse Event|2|||
30683218|NCT00779402|58697216|FG001|Treatment Phase 1|Adverse Event|0|||
30683219|NCT00779402|58697215|FG000|Treatment Phase 1|Protocol Violation|1|||
30683220|NCT00779402|58697216|FG001|Treatment Phase 1|Protocol Violation|0|||
30683221|NCT00779402|58697215|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
30683222|NCT00779402|58697216|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
30683223|NCT00779402|58697215|FG000|Treatment Phase 1|Lost to Follow-up|0|||
30683224|NCT00779402|58697216|FG001|Treatment Phase 1|Lost to Follow-up|1|||
30683225|NCT00779402|58697215|FG000|Treatment Phase 1|Death|0|||
30683226|NCT00779402|58697216|FG001|Treatment Phase 1|Death|1|||
30683227|NCT00779402|58697215|FG000|Treatment Phase 1|Intercurrent Illness|1|||
30683228|NCT00779402|58697216|FG001|Treatment Phase 1|Intercurrent Illness|1|||
30683229|NCT00779402|58697215|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
30683230|NCT00779402|58697216|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
30683231|NCT00779402|58697215|FG000|Treatment Phase 1|Other|4|||
30683232|NCT00779402|58697216|FG001|Treatment Phase 1|Other|2|||
30683233|NCT00779402|58697215|FG000|Treatment Phase 1|Closure of Study|3|||
30683234|NCT00779402|58697216|FG001|Treatment Phase 1|Closure of Study|2|||
30683235|NCT00779402|58697215|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
30683236|NCT00779402|58697216|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
30683237|NCT00779402|58697215|FG000|Surveillance Phase|Protocol Violation|0|||
30683238|NCT00779402|58697216|FG001|Surveillance Phase|Protocol Violation|1|||
30683239|NCT00779402|58697215|FG000|Surveillance Phase|Patient refused to continue|22|||
30596742|NCT01346969|58608483|FG000|Overall Study|Randomized but not treated|1|||
30596743|NCT01346969|58608484|FG001|Overall Study|Randomized but not treated|0|||
30596744|NCT01346969|58608485|FG002|Overall Study|Randomized but not treated|0|||
30596745|NCT01346969|58608486|FG003|Overall Study|Randomized but not treated|0|||
30596746|NCT01346774|58608498|FG000|Overall Study|Did not take a single dose|6|||
30596747|NCT01346774|58608499|FG001|Overall Study|Did not take a single dose|4|||
30596748|NCT01346774|58608498|FG000|Overall Study|Lost to Follow-up|3|||
30596749|NCT01346774|58608499|FG001|Overall Study|Lost to Follow-up|4|||
30596750|NCT01346774|58608498|FG000|Overall Study|Withdrawal by Subject|1|||
30596751|NCT01346774|58608499|FG001|Overall Study|Withdrawal by Subject|4|||
30596752|NCT01346774|58608498|FG000|Overall Study|Protocol Violation|2|||
30683240|NCT00779402|58697216|FG001|Surveillance Phase|Patient refused to continue|14|||
30683241|NCT00779402|58697215|FG000|Surveillance Phase|Lost to Follow-up|2|||
30683242|NCT00779402|58697216|FG001|Surveillance Phase|Lost to Follow-up|1|||
30683243|NCT00779402|58697215|FG000|Surveillance Phase|Death|0|||
30683244|NCT00779402|58697216|FG001|Surveillance Phase|Death|1|||
30683245|NCT00779402|58697215|FG000|Surveillance Phase|Intercurrent Illness|2|||
30783503|NCT03814720|58795730|FG000|Overall Study|Lost to Follow-up|0|||
30783504|NCT03814720|58795731|FG001|Overall Study|Lost to Follow-up|1|||
30783505|NCT03814720|58795732|FG002|Overall Study|Lost to Follow-up|0|||
30596753|NCT01346774|58608499|FG001|Overall Study|Protocol Violation|3|||
30596754|NCT01346774|58608498|FG000|Overall Study|Adverse Event|1|||
30596755|NCT01346774|58608499|FG001|Overall Study|Adverse Event|2|||
30596756|NCT01346696|58608505|FG000|Overall Study|Death|1|||
30596757|NCT01346540|58608511|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
30596758|NCT01346540|58608512|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
30596759|NCT01346540|58608511|FG000|Overall Study|Adverse Event|0|||
30596760|NCT01346540|58608512|FG001|Overall Study|Adverse Event|4|||
30596761|NCT01342913|58608521|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
30596762|NCT01342913|58608522|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
30596763|NCT01342913|58608523|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
30783506|NCT03814720|58795733|FG003|Overall Study|Lost to Follow-up|0|||
30783507|NCT03814720|58795734|FG004|Overall Study|Lost to Follow-up|0|||
30783508|NCT02818036|58795750|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
30783509|NCT02818036|58795751|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
30596764|NCT01342913|58608521|FG000|2-week Run-in Period|Physician Decision|6|||
30596765|NCT01342913|58608522|FG001|2-week Run-in Period|Physician Decision|0|||
30596766|NCT01342913|58608523|FG002|2-week Run-in Period|Physician Decision|0|||
30683246|NCT00779402|58697216|FG001|Surveillance Phase|Intercurrent Illness|0|||
30683247|NCT00779402|58697215|FG000|Surveillance Phase|Other|5|||
30683248|NCT00779402|58697216|FG001|Surveillance Phase|Other|5|||
30683249|NCT00779402|58697215|FG000|Surveillance Phase|Withdrawal by Subject|4|||
30683250|NCT00779402|58697216|FG001|Surveillance Phase|Withdrawal by Subject|1|||
30596767|NCT01342913|58608521|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
30596768|NCT01342913|58608522|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
30596769|NCT01342913|58608523|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
30596770|NCT01342913|58608521|FG000|2-week Run-in Period|Adverse Event|2|||
30596771|NCT01342913|58608522|FG001|2-week Run-in Period|Adverse Event|0|||
30596772|NCT01342913|58608523|FG002|2-week Run-in Period|Adverse Event|0|||
30596773|NCT01342913|58608521|FG000|2-week Run-in Period|Protocol Violation|5|||
30596774|NCT01342913|58608522|FG001|2-week Run-in Period|Protocol Violation|0|||
30596775|NCT01342913|58608523|FG002|2-week Run-in Period|Protocol Violation|0|||
30596776|NCT01342913|58608521|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
30596777|NCT01342913|58608522|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
30596778|NCT01342913|58608523|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
30596779|NCT01342913|58608521|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30596780|NCT01342913|58608522|FG001|Double-Blind Treatment Period|Adverse Event|3|||
30596781|NCT01342913|58608523|FG002|Double-Blind Treatment Period|Adverse Event|6|||
30596782|NCT01342913|58608521|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
30596783|NCT01342913|58608522|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
30596784|NCT01342913|58608523|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
30683251|NCT00779402|58697215|FG000|Surveillance Phase|Closure of study|5|||
30683252|NCT00779402|58697216|FG001|Surveillance Phase|Closure of study|6|||
30683253|NCT00779402|58697215|FG000|Surveillance Phase|Completed Protocol Visits|3|||
30683254|NCT00779402|58697216|FG001|Surveillance Phase|Completed Protocol Visits|2|||
30683255|NCT00779402|58697215|FG000|Long-term Follow-up|Patient refused to continue|2|||
30683256|NCT00779402|58697216|FG001|Long-term Follow-up|Patient refused to continue|0|||
30683257|NCT00779402|58697215|FG000|Long-term Follow-up|Other|5|||
30683258|NCT00779402|58697216|FG001|Long-term Follow-up|Other|0|||
30596785|NCT01342913|58608521|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
30683259|NCT00779402|58697215|FG000|Long-term Follow-up|Closure of Study|8|||
30683260|NCT00779402|58697216|FG001|Long-term Follow-up|Closure of Study|4|||
30683261|NCT00779402|58697215|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
30683262|NCT00779402|58697216|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
30683263|NCT00771914|58697226|FG000|Overall Study|Physician Decision|0|||
30683264|NCT00771914|58697227|FG001|Overall Study|Physician Decision|0|||
30683265|NCT00771914|58697228|FG002|Overall Study|Physician Decision|0|||
30683266|NCT00771914|58697229|FG003|Overall Study|Physician Decision|1|||
30683267|NCT00771914|58697226|FG000|Overall Study|Lost to Follow-up|0|||
30683268|NCT00771914|58697227|FG001|Overall Study|Lost to Follow-up|0|||
30683269|NCT00771914|58697228|FG002|Overall Study|Lost to Follow-up|0|||
30683270|NCT00771914|58697229|FG003|Overall Study|Lost to Follow-up|1|||
30596786|NCT01342913|58608522|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
30596787|NCT01342913|58608523|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
30596788|NCT01342913|58608521|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
30596789|NCT01342913|58608522|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
30596790|NCT01342913|58608523|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
30596791|NCT01342913|58608521|FG000|Double-Blind Treatment Period|Physician Decision|0|||
30596792|NCT01342913|58608522|FG001|Double-Blind Treatment Period|Physician Decision|2|||
30683271|NCT00779324|58697241|FG000|Overall Study|Lost to Follow-up|2|||
30683272|NCT00779324|58697242|FG001|Overall Study|Lost to Follow-up|1|||
30683273|NCT00779324|58697241|FG000|Overall Study|Withdrawal by Subject|4|||
30683274|NCT00779324|58697242|FG001|Overall Study|Withdrawal by Subject|2|||
30683275|NCT00779324|58697241|FG000|Overall Study|Missed visit|1|||
30683276|NCT00779324|58697242|FG001|Overall Study|Missed visit|1|||
30683277|NCT00779246|58697250|FG000|Overall Study|Missing sufficient data for analysis|33|||
30683278|NCT00779246|58697251|FG001|Overall Study|Missing sufficient data for analysis|53|||
30683279|NCT00771758|58697260|FG000|Overall Study|Adverse Event|2|||
30683280|NCT00771758|58697261|FG001|Overall Study|Adverse Event|8|||
30683281|NCT00771758|58697262|FG002|Overall Study|Adverse Event|1|||
30683282|NCT00771758|58697260|FG000|Overall Study|Lack of Efficacy|0|||
30683283|NCT00771758|58697261|FG001|Overall Study|Lack of Efficacy|2|||
30683284|NCT00771758|58697262|FG002|Overall Study|Lack of Efficacy|1|||
30683285|NCT00771758|58697260|FG000|Overall Study|Lost to Follow-up|1|||
30683286|NCT00771758|58697261|FG001|Overall Study|Lost to Follow-up|0|||
30783510|NCT02818036|58795750|FG000|Overall Study|Withdrawal by Subject|1|||
30596793|NCT01342913|58608523|FG002|Double-Blind Treatment Period|Physician Decision|0|||
30683287|NCT00771758|58697262|FG002|Overall Study|Lost to Follow-up|0|||
30683288|NCT00771758|58697260|FG000|Overall Study|Protocol Violation|1|||
30783511|NCT02818036|58795751|FG001|Overall Study|Withdrawal by Subject|0|||
30596794|NCT01342913|58608521|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
30596795|NCT01342913|58608522|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
30596796|NCT01342913|58608523|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
30683289|NCT00771758|58697261|FG001|Overall Study|Protocol Violation|0|||
30683290|NCT00771758|58697262|FG002|Overall Study|Protocol Violation|0|||
30683291|NCT00771758|58697260|FG000|Overall Study|Withdrawal by Subject|1|||
30683292|NCT00771758|58697261|FG001|Overall Study|Withdrawal by Subject|0|||
30683293|NCT00771758|58697262|FG002|Overall Study|Withdrawal by Subject|0|||
30683294|NCT00771758|58697260|FG000|Overall Study|Other|3|||
30683295|NCT00771758|58697261|FG001|Overall Study|Other|2|||
30683296|NCT00771758|58697262|FG002|Overall Study|Other|0|||
30683297|NCT00758498|58697290|FG000|Overall Study|Adverse Event|2|||
30683298|NCT00758498|58697291|FG001|Overall Study|Adverse Event|2|||
30683299|NCT00758498|58697292|FG002|Overall Study|Adverse Event|3|||
30683300|NCT00758498|58697290|FG000|Overall Study|Subject legally detained out of state|1|||
30683301|NCT00758498|58697291|FG001|Overall Study|Subject legally detained out of state|0|||
30683302|NCT00758498|58697292|FG002|Overall Study|Subject legally detained out of state|0|||
30683303|NCT00758498|58697290|FG000|Overall Study|Withdrawal by Subject|0|||
30683304|NCT00758498|58697291|FG001|Overall Study|Withdrawal by Subject|0|||
30683305|NCT00758498|58697292|FG002|Overall Study|Withdrawal by Subject|1|||
30683306|NCT00758498|58697290|FG000|Overall Study|Noncompliance to study procedures|0|||
30683307|NCT00758498|58697291|FG001|Overall Study|Noncompliance to study procedures|0|||
30683308|NCT00758498|58697292|FG002|Overall Study|Noncompliance to study procedures|1|||
30683309|NCT00798161|58697307|FG000|Overall Study|Adverse Event|3|||
30683310|NCT00798161|58697308|FG001|Overall Study|Adverse Event|4|||
30683311|NCT00798161|58697309|FG002|Overall Study|Adverse Event|6|||
30683312|NCT00798161|58697310|FG003|Overall Study|Adverse Event|6|||
30683313|NCT00798161|58697311|FG004|Overall Study|Adverse Event|5|||
30683314|NCT00798161|58697312|FG005|Overall Study|Adverse Event|2|||
30683315|NCT00798161|58697313|FG006|Overall Study|Adverse Event|4|||
30683316|NCT00798161|58697307|FG000|Overall Study|Protocol Violation|2|||
30683317|NCT00798161|58697308|FG001|Overall Study|Protocol Violation|1|||
30783512|NCT01287741|58795759|FG000|Overall Study|Withdrawal by Subject|35|||
30783513|NCT01287741|58795760|FG001|Overall Study|Withdrawal by Subject|38|||
30783514|NCT01287741|58795759|FG000|Overall Study|Protocol Violation|2|||
30783515|NCT01287741|58795760|FG001|Overall Study|Protocol Violation|0|||
30783516|NCT01287741|58795759|FG000|Overall Study|Physician Decision|15|||
30783517|NCT01287741|58795760|FG001|Overall Study|Physician Decision|23|||
30783518|NCT01287741|58795759|FG000|Overall Study|Non-compliance|8|||
30783519|NCT01287741|58795760|FG001|Overall Study|Non-compliance|6|||
30783520|NCT01287741|58795759|FG000|Overall Study|Lost to Follow-up|10|||
30783521|NCT01287741|58795760|FG001|Overall Study|Lost to Follow-up|8|||
30783522|NCT01287741|58795759|FG000|Overall Study|Death|32|||
30783523|NCT01287741|58795760|FG001|Overall Study|Death|44|||
30783524|NCT01287741|58795759|FG000|Overall Study|Adverse Event|4|||
30783525|NCT01287741|58795760|FG001|Overall Study|Adverse Event|6|||
30783526|NCT01287741|58795759|FG000|Overall Study|Study terminated by Sponsor|307|||
30783527|NCT01287741|58795760|FG001|Overall Study|Study terminated by Sponsor|315|||
30783528|NCT01287741|58795759|FG000|Overall Study|Progressive disease|190|||
30783529|NCT01287741|58795760|FG001|Overall Study|Progressive disease|166|||
30783530|NCT01287741|58795759|FG000|Overall Study|Reason not specified|23|||
30783531|NCT01287741|58795760|FG001|Overall Study|Reason not specified|9|||
30783532|NCT05372315|58795773|FG000|Overall Study|Withdrawal by Subject|1|||
30783533|NCT05372315|58795774|FG001|Overall Study|Withdrawal by Subject|0|||
30783534|NCT04913675|58795794|FG000|Main Study (Up to Week 36)|Death|0|||
30783535|NCT04913675|58795795|FG001|Main Study (Up to Week 36)|Death|2|||
30783536|NCT04913675|58795796|FG002|Main Study (Up to Week 36)|Death|2|||
30783537|NCT04913675|58795797|FG003|Main Study (Up to Week 36)|Death|0|||
30783538|NCT04913675|58795794|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
30783539|NCT04913675|58795795|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
30783540|NCT04913675|58795796|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
30783541|NCT04913675|58795797|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
30596797|NCT01342796|58608531|FG000|Overall Study|Withdrawal by Subject|2|||
30596798|NCT01342796|58608532|FG001|Overall Study|Withdrawal by Subject|0|||
30596799|NCT01342796|58608531|FG000|Overall Study|Lost to Follow-up|0|||
30596800|NCT01342796|58608532|FG001|Overall Study|Lost to Follow-up|3|||
30596801|NCT01342796|58608531|FG000|Overall Study|Inappropriate enrollment|1|||
30596802|NCT01342796|58608532|FG001|Overall Study|Inappropriate enrollment|0|||
30596803|NCT01342640|58608538|FG000|Overall Study|Adverse Event|3|||
30596804|NCT01342640|58608538|FG000|Overall Study|Protocol Violation|16|||
30596805|NCT01342640|58608538|FG000|Overall Study|Lost to Follow-up|21|||
30596806|NCT01342640|58608538|FG000|Overall Study|Other|1|||
30596807|NCT01342484|58608545|FG000|Overall Study|Other Reasons|1|||
30596808|NCT01342484|58608546|FG001|Overall Study|Other Reasons|0|||
30683318|NCT00798161|58697309|FG002|Overall Study|Protocol Violation|3|||
30683319|NCT00798161|58697310|FG003|Overall Study|Protocol Violation|3|||
30783542|NCT04913675|58795794|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
30783543|NCT04913675|58795795|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
30783544|NCT04913675|58795796|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
30783545|NCT04913675|58795797|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
30783546|NCT04913675|58795794|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
30596809|NCT01342484|58608547|FG002|Overall Study|Other Reasons|0|||
30783547|NCT04913675|58795795|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
30856196|NCT03296527|58884067|FG001|Overall Study|Protocol Deviation|0|||
30683320|NCT00798161|58697311|FG004|Overall Study|Protocol Violation|3|||
30683321|NCT00798161|58697312|FG005|Overall Study|Protocol Violation|2|||
30683322|NCT00798161|58697313|FG006|Overall Study|Protocol Violation|0|||
30683323|NCT00798161|58697307|FG000|Overall Study|Lost to Follow-up|1|||
30683324|NCT00798161|58697308|FG001|Overall Study|Lost to Follow-up|3|||
30683325|NCT00798161|58697309|FG002|Overall Study|Lost to Follow-up|4|||
30683326|NCT00798161|58697310|FG003|Overall Study|Lost to Follow-up|3|||
30683327|NCT00798161|58697311|FG004|Overall Study|Lost to Follow-up|4|||
30683328|NCT00798161|58697312|FG005|Overall Study|Lost to Follow-up|0|||
30596810|NCT01342484|58608545|FG000|Overall Study|Protocol Violation|0|||
30596811|NCT01342484|58608546|FG001|Overall Study|Protocol Violation|0|||
30596812|NCT01342484|58608547|FG002|Overall Study|Protocol Violation|1|||
30596813|NCT01342484|58608545|FG000|Overall Study|Withdrawal by Subject|1|||
30596814|NCT01342484|58608546|FG001|Overall Study|Withdrawal by Subject|0|||
30596815|NCT01342484|58608547|FG002|Overall Study|Withdrawal by Subject|0|||
30596816|NCT01342445|58608557|FG000|Overall Study|Experienced side effects|0|||
30596817|NCT01342445|58608558|FG001|Overall Study|Experienced side effects|2|||
30596818|NCT01342211|58608573|FG000|Overall Study|Lost to Follow-up|0|||
30596819|NCT01342211|58608574|FG001|Overall Study|Lost to Follow-up|0|||
30596820|NCT01342211|58608575|FG002|Overall Study|Lost to Follow-up|0|||
30596821|NCT01342211|58608576|FG003|Overall Study|Lost to Follow-up|1|||
30596822|NCT01342211|58608577|FG004|Overall Study|Lost to Follow-up|0|||
30596823|NCT01342211|58608573|FG000|Overall Study|Adverse Event|0|||
30596824|NCT01342211|58608574|FG001|Overall Study|Adverse Event|0|||
30596825|NCT01342211|58608575|FG002|Overall Study|Adverse Event|0|||
30596826|NCT01342211|58608576|FG003|Overall Study|Adverse Event|0|||
30596827|NCT01342211|58608577|FG004|Overall Study|Adverse Event|1|||
30596828|NCT01342211|58608573|FG000|Overall Study|Withdrawal by Subject|0|||
30596829|NCT01342211|58608574|FG001|Overall Study|Withdrawal by Subject|0|||
30596830|NCT01342211|58608575|FG002|Overall Study|Withdrawal by Subject|0|||
30596831|NCT01342211|58608576|FG003|Overall Study|Withdrawal by Subject|1|||
30596832|NCT01342211|58608577|FG004|Overall Study|Withdrawal by Subject|0|||
30596833|NCT01342211|58608573|FG000|Overall Study|Randomized, but not Treated|0|||
30596834|NCT01342211|58608574|FG001|Overall Study|Randomized, but not Treated|2|||
30596835|NCT01342211|58608575|FG002|Overall Study|Randomized, but not Treated|0|||
30596836|NCT01342211|58608576|FG003|Overall Study|Randomized, but not Treated|0|||
30596837|NCT01342211|58608577|FG004|Overall Study|Randomized, but not Treated|1|||
30596838|NCT01342094|58608595|FG000|Overall Study|Adverse Event|5|||
30596839|NCT01342094|58608596|FG001|Overall Study|Adverse Event|0|||
30596840|NCT01342094|58608595|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
30596841|NCT01342094|58608596|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
30596842|NCT01342094|58608595|FG000|Overall Study|Withdrawal by Subject|0|||
30596843|NCT01342094|58608596|FG001|Overall Study|Withdrawal by Subject|2|||
30596844|NCT01340768|58608604|FG000|Overall Study|Lost to Follow-up|10|||
30596845|NCT01340768|58608605|FG001|Overall Study|Lost to Follow-up|4|||
30596846|NCT01340768|58608604|FG000|Overall Study|Withdrawal by Subject|5|||
30596847|NCT01340768|58608605|FG001|Overall Study|Withdrawal by Subject|1|||
30596848|NCT01340768|58608604|FG000|Overall Study|Other|2|||
30596849|NCT01340768|58608605|FG001|Overall Study|Other|0|||
30596850|NCT01340651|58608611|FG000|Overall Study|Adverse Event|3|||
30596851|NCT01340651|58608611|FG000|Overall Study|Consent Withdrawn|2|||
30596852|NCT01340651|58608611|FG000|Overall Study|Commercial Supply per Sponsor|12|||
30596853|NCT01340495|58608617|FG000|Overall Study|Withdrawal by Subject|1|||
30596854|NCT01340300|58608625|FG000|Overall Study|Lost to Follow-up|3|||
30596855|NCT01340300|58608626|FG001|Overall Study|Lost to Follow-up|0|||
30683329|NCT00798161|58697313|FG006|Overall Study|Lost to Follow-up|0|||
30683330|NCT00798161|58697307|FG000|Overall Study|Withdrawal by Subject|5|||
30683331|NCT00798161|58697308|FG001|Overall Study|Withdrawal by Subject|4|||
30683332|NCT00798161|58697309|FG002|Overall Study|Withdrawal by Subject|5|||
30683333|NCT00798161|58697310|FG003|Overall Study|Withdrawal by Subject|4|||
30683334|NCT00798161|58697311|FG004|Overall Study|Withdrawal by Subject|2|||
30683335|NCT00798161|58697312|FG005|Overall Study|Withdrawal by Subject|3|||
30596856|NCT01340300|58608627|FG002|Overall Study|Lost to Follow-up|5|||
30596857|NCT01340300|58608628|FG003|Overall Study|Lost to Follow-up|10|||
30596858|NCT01340300|58608625|FG000|Overall Study|Withdrawal by Subject|5|||
30683336|NCT00798161|58697313|FG006|Overall Study|Withdrawal by Subject|1|||
30683337|NCT00798161|58697307|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
30683338|NCT00798161|58697308|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
30596859|NCT01340300|58608626|FG001|Overall Study|Withdrawal by Subject|6|||
30596860|NCT01340300|58608627|FG002|Overall Study|Withdrawal by Subject|6|||
30596861|NCT01340300|58608628|FG003|Overall Study|Withdrawal by Subject|3|||
30596862|NCT01340300|58608625|FG000|Overall Study|Adverse Event|1|||
30596863|NCT01340300|58608626|FG001|Overall Study|Adverse Event|0|||
30596864|NCT01340300|58608627|FG002|Overall Study|Adverse Event|4|||
30683339|NCT00798161|58697309|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
30683340|NCT00798161|58697310|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
30596865|NCT01340300|58608628|FG003|Overall Study|Adverse Event|0|||
30596866|NCT01340300|58608625|FG000|Overall Study|Physician Decision|0|||
30596867|NCT01340300|58608626|FG001|Overall Study|Physician Decision|1|||
30596868|NCT01340300|58608627|FG002|Overall Study|Physician Decision|0|||
30596869|NCT01340300|58608628|FG003|Overall Study|Physician Decision|0|||
30596870|NCT01340300|58608625|FG000|Overall Study|Unrelated sickness|0|||
30596871|NCT01340300|58608626|FG001|Overall Study|Unrelated sickness|2|||
30596872|NCT01340300|58608627|FG002|Overall Study|Unrelated sickness|0|||
30596873|NCT01340300|58608628|FG003|Overall Study|Unrelated sickness|1|||
30596874|NCT01340066|58608640|FG000|Placebo Run in Period|Screen Failures|27|||
30596875|NCT01340066|58608641|FG001|Placebo Run in Period|Screen Failures|0|||
30683341|NCT00798161|58697311|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
30683342|NCT00798161|58697312|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
30683343|NCT00798161|58697313|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
30683344|NCT00588341|58697329|FG000|Overall Study|Withdrawal by Subject|3|||
30683345|NCT00588341|58697329|FG000|Overall Study|Not treated due to metastatic disease|1|||
30683346|NCT00588341|58697329|FG000|Overall Study|Patient ineligible|1|||
30683347|NCT00802529|58697335|FG000|Overall Study|Lost to Follow-up|0|||
30783548|NCT04913675|58795796|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
30783549|NCT04913675|58795797|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
30783550|NCT04913675|58795794|FG000|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
30783551|NCT04913675|58795795|FG001|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
30783552|NCT04913675|58795796|FG002|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
30783553|NCT04913675|58795797|FG003|Safety Sub-study (Up to Day 29)|Ongoing in this study|80|||
30783554|NCT04913675|58795794|FG000|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
30783555|NCT04913675|58795795|FG001|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
30783556|NCT04913675|58795796|FG002|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
30783557|NCT04913675|58795797|FG003|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|1|||
30783558|NCT04760314|58795814|FG000|Induction Period|Withdrawal by Subject|0|||
30783559|NCT04760314|58795815|FG001|Induction Period|Withdrawal by Subject|1|||
30783560|NCT04760314|58795816|FG002|Induction Period|Withdrawal by Subject|1|||
30783561|NCT04760314|58795817|FG003|Induction Period|Withdrawal by Subject|0|||
30783562|NCT04760314|58795818|FG004|Induction Period|Withdrawal by Subject|0|||
30783563|NCT04760314|58795819|FG005|Induction Period|Withdrawal by Subject|0|||
30783564|NCT04760314|58795820|FG006|Induction Period|Withdrawal by Subject|0|||
30783565|NCT04760314|58795821|FG007|Induction Period|Withdrawal by Subject|0|||
30783566|NCT04760314|58795822|FG008|Induction Period|Withdrawal by Subject|0|||
30783567|NCT04760314|58795823|FG009|Induction Period|Withdrawal by Subject|0|||
30783568|NCT04760314|58795824|FG010|Induction Period|Withdrawal by Subject|0|||
30783569|NCT04760314|58795814|FG000|Induction Period|Adverse Event|0|||
30783570|NCT04760314|58795815|FG001|Induction Period|Adverse Event|0|||
30783571|NCT04760314|58795816|FG002|Induction Period|Adverse Event|2|||
30783572|NCT04760314|58795817|FG003|Induction Period|Adverse Event|0|||
30783573|NCT04760314|58795818|FG004|Induction Period|Adverse Event|0|||
30783574|NCT04760314|58795819|FG005|Induction Period|Adverse Event|0|||
30783575|NCT04760314|58795820|FG006|Induction Period|Adverse Event|0|||
30783576|NCT04760314|58795821|FG007|Induction Period|Adverse Event|0|||
30783577|NCT04760314|58795822|FG008|Induction Period|Adverse Event|0|||
30783578|NCT04760314|58795823|FG009|Induction Period|Adverse Event|0|||
30596876|NCT01340066|58608642|FG002|Placebo Run in Period|Screen Failures|0|||
30596877|NCT01340066|58608640|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
30596878|NCT01340066|58608641|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
30596879|NCT01340066|58608642|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
30596880|NCT01340066|58608640|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
30596881|NCT01340066|58608641|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
30596882|NCT01340066|58608642|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
30596883|NCT01340066|58608640|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
30596884|NCT01340066|58608641|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
30596885|NCT01340066|58608642|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
30596886|NCT01107535|58608649|FG000|Overall Study|Death|5|||
30596887|NCT01326546|58608655|FG000|Overall Study|Lost to Follow-up|8|||
30596888|NCT01326546|58608656|FG001|Overall Study|Lost to Follow-up|7|||
30596889|NCT01326546|58608655|FG000|Overall Study|Protocol Violation|3|||
30596890|NCT01326546|58608656|FG001|Overall Study|Protocol Violation|4|||
30596891|NCT01326546|58608655|FG000|Overall Study|Pregnancy|0|||
30596892|NCT01326546|58608656|FG001|Overall Study|Pregnancy|1|||
30596893|NCT01326546|58608655|FG000|Overall Study|Adverse Event|1|||
30596894|NCT01326546|58608656|FG001|Overall Study|Adverse Event|0|||
30683348|NCT00802529|58697336|FG001|Overall Study|Lost to Follow-up|1|||
30683349|NCT00758264|58697345|FG000|Active Phase|Withdrawal by Subject|0|||
30683350|NCT00758264|58697346|FG001|Active Phase|Withdrawal by Subject|0|||
30783579|NCT04760314|58795824|FG010|Induction Period|Adverse Event|0|||
30783580|NCT04760314|58795814|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
30783581|NCT04760314|58795815|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
30783582|NCT04760314|58795816|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
30683351|NCT00758264|58697347|FG002|Active Phase|Withdrawal by Subject|1|||
30596895|NCT01326546|58608655|FG000|Overall Study|Withdrawal by Subject|5|||
30596896|NCT01326546|58608656|FG001|Overall Study|Withdrawal by Subject|1|||
30596897|NCT01325532|58608664|FG000|Overall Study|Withdrawal by Subject|2|||
30596898|NCT01325532|58608665|FG001|Overall Study|Withdrawal by Subject|0|||
30596899|NCT01171963|58608673|FG000|Overall Study|Adverse Event|10|||
30596900|NCT01171963|58608674|FG001|Overall Study|Adverse Event|15|||
30596901|NCT01171963|58608673|FG000|Overall Study|Lost to Follow-up|23|||
30596902|NCT01171963|58608674|FG001|Overall Study|Lost to Follow-up|24|||
30596903|NCT01171963|58608673|FG000|Overall Study|Other - diarrhoea|1|||
30596904|NCT01171963|58608674|FG001|Overall Study|Other - diarrhoea|0|||
30596905|NCT01171963|58608673|FG000|Overall Study|Withdrawal by Subject|114|||
30596906|NCT01171963|58608674|FG001|Overall Study|Withdrawal by Subject|129|||
30596907|NCT01171183|58608685|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
30596908|NCT01171183|58608686|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
30596909|NCT01171183|58608685|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
30596910|NCT01171183|58608686|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
30596911|NCT01171183|58608685|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
30683352|NCT00758264|58697345|FG000|Active Phase|Lost to Follow-up|1|||
30683353|NCT00758264|58697346|FG001|Active Phase|Lost to Follow-up|0|||
30683354|NCT00758264|58697347|FG002|Active Phase|Lost to Follow-up|0|||
30683355|NCT00758264|58697345|FG000|Active Phase|Other|0|||
30683356|NCT00758264|58697346|FG001|Active Phase|Other|0|||
30683357|NCT00758264|58697347|FG002|Active Phase|Other|4|||
30596912|NCT01171183|58608686|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
30596913|NCT01171183|58608685|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
30596914|NCT01171183|58608686|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
30596915|NCT01171183|58608685|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
30596916|NCT01171183|58608686|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
30596917|NCT01171183|58608685|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
30596918|NCT01171183|58608686|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
30596919|NCT01170091|58608692|FG000|Overall Study|Missing efficacy evaluation|3|||
30596920|NCT01170091|58608692|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
30596921|NCT01169779|58608698|FG000|Overall Study|Adverse Event|3|||
30596922|NCT01169779|58608699|FG001|Overall Study|Adverse Event|11|||
30596923|NCT01169779|58608698|FG000|Overall Study|Lack of Efficacy|1|||
30596924|NCT01169779|58608699|FG001|Overall Study|Lack of Efficacy|0|||
30683358|NCT00588731|58697357|FG000|Overall Study|Withdrawal by Subject|3|||
30683359|NCT00588731|58697358|FG001|Overall Study|Withdrawal by Subject|2|||
30683360|NCT00757172|58697364|FG000|Overall Study|Withdrawal by Subject|4|||
30683361|NCT00757172|58697364|FG000|Overall Study|Physician Decision|3|||
30683362|NCT00757172|58697364|FG000|Overall Study|Progression|4|||
30683363|NCT00797225|58697372|FG000|Weeks 1 to 12|Adverse Event|0|||
30683364|NCT00797225|58697373|FG001|Weeks 1 to 12|Adverse Event|0|||
30683365|NCT00797225|58697374|FG002|Weeks 1 to 12|Adverse Event|1|||
30683366|NCT00797225|58697375|FG003|Weeks 1 to 12|Adverse Event|0|||
30783583|NCT04760314|58795817|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
30783584|NCT04760314|58795818|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
30783585|NCT04760314|58795819|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
30683367|NCT00797225|58697376|FG004|Weeks 1 to 12|Adverse Event|0|||
30683368|NCT00797225|58697377|FG005|Weeks 1 to 12|Adverse Event|0|||
30683369|NCT00797225|58697378|FG006|Weeks 1 to 12|Adverse Event|0|||
30683370|NCT00797225|58697379|FG007|Weeks 1 to 12|Adverse Event|0|||
30683371|NCT00797225|58697372|FG000|Weeks 1 to 12|Non-compliance|0|||
30683372|NCT00797225|58697373|FG001|Weeks 1 to 12|Non-compliance|1|||
30683373|NCT00797225|58697374|FG002|Weeks 1 to 12|Non-compliance|0|||
30683374|NCT00797225|58697375|FG003|Weeks 1 to 12|Non-compliance|0|||
30683375|NCT00797225|58697376|FG004|Weeks 1 to 12|Non-compliance|0|||
30683376|NCT00797225|58697377|FG005|Weeks 1 to 12|Non-compliance|0|||
30783586|NCT04760314|58795820|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
30783587|NCT04760314|58795821|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
30783588|NCT04760314|58795822|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
30783589|NCT04760314|58795823|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
30783590|NCT04760314|58795824|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
30783591|NCT04760314|58795814|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
30783592|NCT04760314|58795815|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
30596925|NCT01169779|58608698|FG000|Overall Study|Protocol Violation|1|||
30596926|NCT01169779|58608699|FG001|Overall Study|Protocol Violation|1|||
30596927|NCT01169779|58608698|FG000|Overall Study|Withdrawal by Subject|3|||
30596928|NCT01169779|58608699|FG001|Overall Study|Withdrawal by Subject|2|||
30596929|NCT01169779|58608698|FG000|Overall Study|Familial and personal reasons|3|||
30683377|NCT00797225|58697378|FG006|Weeks 1 to 12|Non-compliance|0|||
30683378|NCT00797225|58697379|FG007|Weeks 1 to 12|Non-compliance|0|||
30683379|NCT00797225|58697372|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
30683380|NCT00797225|58697373|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
30959135|NCT01688999|59024353|FG001|Overall Study|Ineligible/Not treated|0|||
30596930|NCT01169779|58608699|FG001|Overall Study|Familial and personal reasons|3|||
30596931|NCT01169701|58608707|FG000|Overall Study|Lost to Follow-up|1|||
30596932|NCT01169701|58608708|FG001|Overall Study|Lost to Follow-up|1|||
30596933|NCT01169701|58608707|FG000|Overall Study|Withdrawal by Subject|1|||
30596934|NCT01169701|58608708|FG001|Overall Study|Withdrawal by Subject|3|||
30596935|NCT01169701|58608707|FG000|Overall Study|Adverse Event|1|||
30596936|NCT01169701|58608708|FG001|Overall Study|Adverse Event|2|||
30783593|NCT04760314|58795816|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
30783594|NCT04760314|58795817|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
30783595|NCT04760314|58795818|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
30783596|NCT04760314|58795819|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
30783597|NCT04760314|58795820|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
30783598|NCT04760314|58795821|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
30783599|NCT04760314|58795822|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
30783600|NCT04760314|58795823|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
30783601|NCT04760314|58795824|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
30783602|NCT04760314|58795814|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
30783603|NCT04760314|58795815|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
30783604|NCT04760314|58795816|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
30783605|NCT04760314|58795817|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
30783606|NCT04760314|58795818|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
30783607|NCT04760314|58795819|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
30783608|NCT04760314|58795820|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
30683381|NCT00797225|58697374|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
30683382|NCT00797225|58697375|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
30683383|NCT00797225|58697376|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
30683384|NCT00797225|58697377|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
30683385|NCT00797225|58697378|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
30683386|NCT00797225|58697379|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
30683387|NCT00797225|58697372|FG000|Weeks 1 to 12|Sponsor Decision|1|||
30683388|NCT00797225|58697373|FG001|Weeks 1 to 12|Sponsor Decision|0|||
30683389|NCT00797225|58697374|FG002|Weeks 1 to 12|Sponsor Decision|0|||
30683390|NCT00797225|58697375|FG003|Weeks 1 to 12|Sponsor Decision|0|||
30683391|NCT00797225|58697376|FG004|Weeks 1 to 12|Sponsor Decision|0|||
30683392|NCT00797225|58697377|FG005|Weeks 1 to 12|Sponsor Decision|0|||
30683393|NCT00797225|58697378|FG006|Weeks 1 to 12|Sponsor Decision|0|||
30683394|NCT00797225|58697379|FG007|Weeks 1 to 12|Sponsor Decision|0|||
30683395|NCT00797225|58697372|FG000|Weeks 13 to 24|Non-compliance|0|||
30683396|NCT00797225|58697373|FG001|Weeks 13 to 24|Non-compliance|2|||
30683397|NCT00797225|58697374|FG002|Weeks 13 to 24|Non-compliance|0|||
30683398|NCT00797225|58697375|FG003|Weeks 13 to 24|Non-compliance|0|||
30683399|NCT00797225|58697376|FG004|Weeks 13 to 24|Non-compliance|0|||
30683400|NCT00797225|58697377|FG005|Weeks 13 to 24|Non-compliance|0|||
30683401|NCT00797225|58697378|FG006|Weeks 13 to 24|Non-compliance|0|||
30683402|NCT00797225|58697379|FG007|Weeks 13 to 24|Non-compliance|0|||
30683403|NCT00797225|58697372|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
30683404|NCT00797225|58697373|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
30683405|NCT00797225|58697374|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
30683406|NCT00797225|58697375|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
30683407|NCT00797225|58697376|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
30683408|NCT00797225|58697377|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
30683409|NCT00797225|58697378|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
30683410|NCT00797225|58697379|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
30683411|NCT00797225|58697372|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
30683412|NCT00797225|58697373|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
30683413|NCT00797225|58697374|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
30683414|NCT00797225|58697375|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
30683415|NCT00797225|58697376|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
30683416|NCT00797225|58697377|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
30683417|NCT00797225|58697378|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
30683418|NCT00797225|58697379|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
30683419|NCT00797225|58697372|FG000|Weeks 13 to 24|Adverse Event|0|||
30683420|NCT00797225|58697373|FG001|Weeks 13 to 24|Adverse Event|1|||
30783609|NCT04760314|58795821|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
30596937|NCT01169701|58608707|FG000|Overall Study|Exclusion criteria|2|||
30683421|NCT00797225|58697374|FG002|Weeks 13 to 24|Adverse Event|0|||
30683422|NCT00797225|58697375|FG003|Weeks 13 to 24|Adverse Event|0|||
30683423|NCT00797225|58697376|FG004|Weeks 13 to 24|Adverse Event|0|||
30596938|NCT01169701|58608708|FG001|Overall Study|Exclusion criteria|0|||
30683424|NCT00797225|58697377|FG005|Weeks 13 to 24|Adverse Event|0|||
30683425|NCT00797225|58697378|FG006|Weeks 13 to 24|Adverse Event|1|||
30683426|NCT00797225|58697379|FG007|Weeks 13 to 24|Adverse Event|0|||
30683427|NCT00797225|58697372|FG000|Weeks 13 to 24|Sponsor Decision|0|||
30683428|NCT00797225|58697373|FG001|Weeks 13 to 24|Sponsor Decision|0|||
30683429|NCT00797225|58697374|FG002|Weeks 13 to 24|Sponsor Decision|0|||
30783610|NCT04760314|58795822|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
30596939|NCT01169701|58608707|FG000|Overall Study|Death|0|||
30596940|NCT01169701|58608708|FG001|Overall Study|Death|1|||
30596941|NCT01169701|58608707|FG000|Overall Study|Administrative problems|0|||
30596942|NCT01169701|58608708|FG001|Overall Study|Administrative problems|1|||
30596943|NCT01169701|58608707|FG000|Overall Study|Serious adverse event|0|||
30596944|NCT01169701|58608708|FG001|Overall Study|Serious adverse event|1|||
30596945|NCT01169701|58608707|FG000|Overall Study|Sponsor decision|0|||
30596946|NCT01169701|58608708|FG001|Overall Study|Sponsor decision|1|||
30596947|NCT01168999|58608718|FG000|Overall Study|Lost to Follow-up|2|||
30683430|NCT00797225|58697375|FG003|Weeks 13 to 24|Sponsor Decision|0|||
30683431|NCT00797225|58697376|FG004|Weeks 13 to 24|Sponsor Decision|0|||
30683432|NCT00797225|58697377|FG005|Weeks 13 to 24|Sponsor Decision|0|||
30683433|NCT00797225|58697378|FG006|Weeks 13 to 24|Sponsor Decision|1|||
30683434|NCT00797225|58697379|FG007|Weeks 13 to 24|Sponsor Decision|0|||
30683435|NCT00778700|58697399|FG000|Overall Study|Adverse Event|6|||
30683436|NCT00778700|58697400|FG001|Overall Study|Adverse Event|1|||
30683437|NCT00778700|58697401|FG002|Overall Study|Adverse Event|3|||
30683438|NCT00778700|58697402|FG003|Overall Study|Adverse Event|5|||
30683439|NCT00778700|58697399|FG000|Overall Study|Protocol Violation|1|||
30683440|NCT00778700|58697400|FG001|Overall Study|Protocol Violation|1|||
30683441|NCT00778700|58697401|FG002|Overall Study|Protocol Violation|0|||
30683442|NCT00778700|58697402|FG003|Overall Study|Protocol Violation|0|||
30683443|NCT00778700|58697399|FG000|Overall Study|Subject Withdrew Consent|6|||
30683444|NCT00778700|58697400|FG001|Overall Study|Subject Withdrew Consent|4|||
30683445|NCT00778700|58697401|FG002|Overall Study|Subject Withdrew Consent|1|||
30683446|NCT00778700|58697402|FG003|Overall Study|Subject Withdrew Consent|4|||
30683447|NCT00778700|58697399|FG000|Overall Study|Lost to Follow-up|3|||
30683448|NCT00778700|58697400|FG001|Overall Study|Lost to Follow-up|1|||
30683449|NCT00778700|58697401|FG002|Overall Study|Lost to Follow-up|0|||
30683450|NCT00778700|58697402|FG003|Overall Study|Lost to Follow-up|1|||
30683451|NCT00778700|58697399|FG000|Overall Study|Reason not Specified|2|||
30683452|NCT00778700|58697400|FG001|Overall Study|Reason not Specified|0|||
30683453|NCT00778700|58697401|FG002|Overall Study|Reason not Specified|1|||
30683454|NCT00778700|58697402|FG003|Overall Study|Reason not Specified|3|||
30683455|NCT00778700|58697399|FG000|Overall Study|Other|0|||
30683456|NCT00778700|58697400|FG001|Overall Study|Other|0|||
30683457|NCT00778700|58697401|FG002|Overall Study|Other|1|||
30683458|NCT00778700|58697402|FG003|Overall Study|Other|0|||
30683459|NCT00793403|58697416|FG000|Overall Study|Other|73|||
30683460|NCT00793325|58697420|FG000|Overall Study|Protocol Violation|18|||
30683461|NCT00793325|58697420|FG000|Overall Study|Lost to Follow-up|1|||
30683462|NCT00778622|58697446|FG000|Overall Study|Adverse Event|5|||
30683463|NCT00778622|58697447|FG001|Overall Study|Adverse Event|4|||
30683464|NCT00778622|58697448|FG002|Overall Study|Adverse Event|7|||
30683465|NCT00778622|58697446|FG000|Overall Study|Withdrawal by Subject|4|||
30683466|NCT00778622|58697447|FG001|Overall Study|Withdrawal by Subject|5|||
30683467|NCT00778622|58697448|FG002|Overall Study|Withdrawal by Subject|5|||
30683468|NCT00778622|58697446|FG000|Overall Study|Lost to Follow-up|3|||
30683469|NCT00778622|58697447|FG001|Overall Study|Lost to Follow-up|3|||
30683470|NCT00778622|58697448|FG002|Overall Study|Lost to Follow-up|2|||
30683471|NCT00778622|58697446|FG000|Overall Study|Protocol Violation|0|||
30683472|NCT00778622|58697447|FG001|Overall Study|Protocol Violation|3|||
30683473|NCT00778622|58697448|FG002|Overall Study|Protocol Violation|0|||
30683474|NCT00778622|58697446|FG000|Overall Study|Lack of Efficacy|2|||
30683475|NCT00778622|58697447|FG001|Overall Study|Lack of Efficacy|0|||
30683476|NCT00778622|58697448|FG002|Overall Study|Lack of Efficacy|0|||
30683477|NCT00778622|58697446|FG000|Overall Study|immigration|1|||
30683478|NCT00778622|58697447|FG001|Overall Study|immigration|0|||
30683479|NCT00778622|58697448|FG002|Overall Study|immigration|0|||
30683480|NCT00778622|58697446|FG000|Overall Study|Other|1|||
30683481|NCT00778622|58697447|FG001|Overall Study|Other|0|||
30683482|NCT00778622|58697448|FG002|Overall Study|Other|1|||
30783611|NCT04760314|58795823|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
30959136|NCT01688999|59024354|FG002|Overall Study|Ineligible/Not treated|0|||
30596948|NCT01168999|58608719|FG001|Overall Study|Lost to Follow-up|1|||
30596949|NCT01168999|58608720|FG002|Overall Study|Lost to Follow-up|0|||
30683483|NCT00777920|58697460|FG000|Overall Study|Adverse Event|39|||
30683484|NCT00777920|58697460|FG000|Overall Study|Withdrawal of Consent|4|||
30683485|NCT00777920|58697460|FG000|Overall Study|Lost to Follow-up|1|||
30683486|NCT00777920|58697460|FG000|Overall Study|Investigator's discretion|1|||
30683487|NCT00777920|58697460|FG000|Overall Study|Clinical status did not improve|1|||
30683488|NCT00777920|58697460|FG000|Overall Study|Other, not specified|4|||
30683489|NCT04236141|58697466|FG000|Overall Study|Death|18|||
30683490|NCT04236141|58697467|FG001|Overall Study|Death|10|||
30683491|NCT04236141|58697466|FG000|Overall Study|Withdrawal by Participant|1|||
30683492|NCT04236141|58697467|FG001|Overall Study|Withdrawal by Participant|0|||
30683493|NCT04236141|58697466|FG000|Overall Study|Reason not Specified|1|||
30683494|NCT04236141|58697467|FG001|Overall Study|Reason not Specified|0|||
30683495|NCT04236141|58697466|FG000|Overall Study|Study terminated by Sponsor|8|||
30683496|NCT04236141|58697467|FG001|Overall Study|Study terminated by Sponsor|4|||
30596950|NCT01168999|58608721|FG003|Overall Study|Lost to Follow-up|0|||
30596951|NCT01167907|58608733|FG000|Overall Study|Protocol Violation|1|||
30596952|NCT01167907|58608734|FG001|Overall Study|Protocol Violation|0|||
30596953|NCT01167907|58608733|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
30596954|NCT01167907|58608734|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
30596955|NCT01166659|58608740|FG000|Overall Study|Subject Decision|8|||
30596956|NCT01166659|58608740|FG000|Overall Study|Investigator Decision|2|||
30596957|NCT01166659|58608740|FG000|Overall Study|Death|1|||
30596958|NCT01166659|58608740|FG000|Overall Study|Lost to Follow-up|1|||
30596959|NCT01166659|58608740|FG000|Overall Study|Study Closed at Site|1|||
30596960|NCT01115491|58608745|FG000|Overall Study|Death|22|||
30596961|NCT01115491|58608745|FG000|Overall Study|Adverse Event|3|||
30596962|NCT01115491|58608745|FG000|Overall Study|Lost to Follow-up|3|||
30596963|NCT01115491|58608745|FG000|Overall Study|Withdrawal by Subject|1|||
30596964|NCT01115491|58608745|FG000|Overall Study|Physician Decision|1|||
30683497|NCT00796445|58697475|FG000|Overall Study|Protocol Violation|5|||
30683498|NCT00796445|58697476|FG001|Overall Study|Protocol Violation|3|||
30683499|NCT00796445|58697475|FG000|Overall Study|Adverse event, serious fatal|10|||
30683500|NCT00796445|58697476|FG001|Overall Study|Adverse event, serious fatal|5|||
30683501|NCT00796445|58697475|FG000|Overall Study|Adverse event, non-fatal|4|||
30683502|NCT00796445|58697476|FG001|Overall Study|Adverse event, non-fatal|0|||
30683503|NCT00796445|58697475|FG000|Overall Study|Disease progression/recurrence|537|||
30683504|NCT00796445|58697476|FG001|Overall Study|Disease progression/recurrence|268|||
30683505|NCT00796445|58697475|FG000|Overall Study|Other|10|||
30683506|NCT00796445|58697476|FG001|Overall Study|Other|7|||
30683507|NCT00796445|58697475|FG000|Overall Study|Withdrawal by Subject|18|||
30683508|NCT00796445|58697476|FG001|Overall Study|Withdrawal by Subject|9|||
30683509|NCT00796445|58697475|FG000|Overall Study|Invalid Informed Consent Form|1|||
30683510|NCT00796445|58697476|FG001|Overall Study|Invalid Informed Consent Form|0|||
30683511|NCT03939819|58697492|FG000|Overall Study|Death|2|||
30683512|NCT03939819|58697493|FG001|Overall Study|Death|0|||
30683513|NCT00756938|58697502|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
30683514|NCT00756938|58697503|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
30683515|NCT00756938|58697504|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
30683516|NCT00756938|58697505|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
30683517|NCT00756938|58697502|FG000|12-week Base Study|Protocol Violation|0|||
30683518|NCT00756938|58697503|FG001|12-week Base Study|Protocol Violation|0|||
30683519|NCT00756938|58697504|FG002|12-week Base Study|Protocol Violation|1|||
30683520|NCT00756938|58697505|FG003|12-week Base Study|Protocol Violation|0|||
30683521|NCT00756938|58697502|FG000|12-week Base Study|Lost to Follow-up|1|||
30683522|NCT00756938|58697503|FG001|12-week Base Study|Lost to Follow-up|0|||
30683523|NCT00756938|58697504|FG002|12-week Base Study|Lost to Follow-up|0|||
30683524|NCT00756938|58697505|FG003|12-week Base Study|Lost to Follow-up|0|||
30683525|NCT00756938|58697502|FG000|Optional Extension|Lack of Efficacy|0|||
30683526|NCT00756938|58697503|FG001|Optional Extension|Lack of Efficacy|0|||
30683527|NCT00756938|58697504|FG002|Optional Extension|Lack of Efficacy|0|||
30683528|NCT00756938|58697505|FG003|Optional Extension|Lack of Efficacy|1|||
30683529|NCT00756938|58697502|FG000|Optional Extension|End of Study|0|||
30683530|NCT00756938|58697503|FG001|Optional Extension|End of Study|0|||
30683531|NCT00756938|58697504|FG002|Optional Extension|End of Study|0|||
30683532|NCT00756938|58697505|FG003|Optional Extension|End of Study|11|||
30683533|NCT00756938|58697502|FG000|Optional Extension|Protocol-specific criteria met|0|||
30683534|NCT00756938|58697503|FG001|Optional Extension|Protocol-specific criteria met|0|||
30683535|NCT00756938|58697504|FG002|Optional Extension|Protocol-specific criteria met|0|||
30683536|NCT00756938|58697505|FG003|Optional Extension|Protocol-specific criteria met|9|||
30683537|NCT00756938|58697502|FG000|Optional Extension|Physician Decision|0|||
30683538|NCT00756938|58697503|FG001|Optional Extension|Physician Decision|0|||
30683539|NCT00756938|58697504|FG002|Optional Extension|Physician Decision|0|||
30683540|NCT00756938|58697505|FG003|Optional Extension|Physician Decision|3|||
30683541|NCT00756938|58697502|FG000|Optional Extension|Lost to Follow-up|0|||
30683542|NCT00756938|58697503|FG001|Optional Extension|Lost to Follow-up|0|||
30683543|NCT00756938|58697504|FG002|Optional Extension|Lost to Follow-up|0|||
30683544|NCT00756938|58697505|FG003|Optional Extension|Lost to Follow-up|1|||
30683545|NCT00756938|58697502|FG000|Optional Extension|Protocol Violation|0|||
30596965|NCT01113931|58608751|FG000|Overall Study|Adverse Event|2|||
30683546|NCT00756938|58697503|FG001|Optional Extension|Protocol Violation|0|||
30596966|NCT01113931|58608752|FG001|Overall Study|Adverse Event|2|||
30683547|NCT00756938|58697504|FG002|Optional Extension|Protocol Violation|0|||
30683548|NCT00756938|58697505|FG003|Optional Extension|Protocol Violation|1|||
30683549|NCT00756938|58697502|FG000|Optional Extension|Withdrawal by Subject|0|||
30683550|NCT00756938|58697503|FG001|Optional Extension|Withdrawal by Subject|0|||
30596967|NCT01113931|58608751|FG000|Overall Study|Physician Decision|0|||
30683551|NCT00756938|58697504|FG002|Optional Extension|Withdrawal by Subject|0|||
30683552|NCT00756938|58697505|FG003|Optional Extension|Withdrawal by Subject|10|||
30683553|NCT00756938|58697502|FG000|Optional Extension|Adverse Event|0|||
30683554|NCT00756938|58697503|FG001|Optional Extension|Adverse Event|0|||
30683555|NCT00756938|58697504|FG002|Optional Extension|Adverse Event|0|||
30683556|NCT00756938|58697505|FG003|Optional Extension|Adverse Event|1|||
30596968|NCT01113931|58608752|FG001|Overall Study|Physician Decision|2|||
30596969|NCT01113931|58608751|FG000|Overall Study|Lost to Follow-up|12|||
30596970|NCT01113931|58608752|FG001|Overall Study|Lost to Follow-up|9|||
30596971|NCT01113931|58608751|FG000|Overall Study|Various|2|||
30596972|NCT01113931|58608752|FG001|Overall Study|Various|4|||
30596973|NCT01113931|58608751|FG000|Overall Study|Withdrawal by Subject|3|||
30596974|NCT01113931|58608752|FG001|Overall Study|Withdrawal by Subject|0|||
30596975|NCT01107379|58608758|FG000|Overall Study|Withdrawal by Subject|18|||
30596976|NCT01107379|58608758|FG000|Overall Study|Lost to Follow-up|3|||
30683557|NCT00796367|58697526|FG000|Overall Study|Adverse Event|6|||
30683558|NCT00796367|58697527|FG001|Overall Study|Adverse Event|4|||
30683559|NCT00796367|58697528|FG002|Overall Study|Adverse Event|7|||
30683560|NCT00796367|58697526|FG000|Overall Study|Lost to Follow-up|5|||
30683561|NCT00796367|58697527|FG001|Overall Study|Lost to Follow-up|4|||
30683562|NCT00796367|58697528|FG002|Overall Study|Lost to Follow-up|21|||
30683563|NCT00796367|58697526|FG000|Overall Study|Withdrawal by Subject|9|||
30683564|NCT00796367|58697527|FG001|Overall Study|Withdrawal by Subject|11|||
30683565|NCT00796367|58697528|FG002|Overall Study|Withdrawal by Subject|12|||
30683566|NCT00796367|58697526|FG000|Overall Study|Lack of Efficacy|2|||
30683567|NCT00796367|58697527|FG001|Overall Study|Lack of Efficacy|1|||
30683568|NCT00796367|58697528|FG002|Overall Study|Lack of Efficacy|0|||
30683569|NCT00796367|58697526|FG000|Overall Study|non compliance|3|||
30683570|NCT00796367|58697527|FG001|Overall Study|non compliance|1|||
30683571|NCT00796367|58697528|FG002|Overall Study|non compliance|1|||
30683572|NCT00796367|58697526|FG000|Overall Study|Pregnancy|1|||
30683573|NCT00796367|58697527|FG001|Overall Study|Pregnancy|0|||
30683574|NCT00796367|58697528|FG002|Overall Study|Pregnancy|1|||
30683575|NCT00796367|58697526|FG000|Overall Study|Requirement for restricted medication|2|||
30683576|NCT00796367|58697527|FG001|Overall Study|Requirement for restricted medication|0|||
30683577|NCT00796367|58697528|FG002|Overall Study|Requirement for restricted medication|2|||
30683578|NCT00796367|58697526|FG000|Overall Study|other|2|||
30683579|NCT00796367|58697527|FG001|Overall Study|other|4|||
30683580|NCT00796367|58697528|FG002|Overall Study|other|3|||
30683581|NCT00770588|58697538|FG000|Overall Study|Adverse Event|9|||
30683582|NCT00770588|58697539|FG001|Overall Study|Adverse Event|2|||
30683583|NCT00770588|58697538|FG000|Overall Study|Death caused by progression of disease|70|||
30783612|NCT04760314|58795824|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
30783613|NCT04760314|58795814|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
30596977|NCT01106911|58608762|FG000|Overall Study|Physician Decision|2|||
30596978|NCT01106911|58608762|FG000|Overall Study|deemed ineligible after screening|3|||
30596979|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
30596980|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
30596981|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
30596982|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
30596983|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Death|0|||
30596984|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Death|0|||
30596985|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Death|1|||
30596986|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Death|0|||
30596987|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
30596988|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
30596989|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
30596990|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
30596991|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
30596992|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
30596993|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
30596994|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
30596995|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
30596996|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
30596997|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
30596998|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
30596999|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
30597000|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
30597001|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
30597002|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
30683584|NCT00770588|58697539|FG001|Overall Study|Death caused by progression of disease|91|||
30683585|NCT00770588|58697538|FG000|Overall Study|Lost to Follow-up|1|||
30683586|NCT00770588|58697539|FG001|Overall Study|Lost to Follow-up|1|||
30683587|NCT00770588|58697538|FG000|Overall Study|Withdrawal by Subject|1|||
30683588|NCT00770588|58697539|FG001|Overall Study|Withdrawal by Subject|1|||
30683589|NCT00777608|58697548|FG000|Overall Study|Lost to Follow-up|1|||
30683590|NCT00777608|58697549|FG001|Overall Study|Lost to Follow-up|1|||
30683591|NCT00777608|58697548|FG000|Overall Study|Withdrawal by Subject|1|||
30683592|NCT00777608|58697549|FG001|Overall Study|Withdrawal by Subject|3|||
30683593|NCT00777608|58697548|FG000|Overall Study|Protocol Violation|1|||
30683594|NCT00777608|58697549|FG001|Overall Study|Protocol Violation|0|||
30683595|NCT00777608|58697548|FG000|Overall Study|Investigator Decision|1|||
30683596|NCT00777608|58697549|FG001|Overall Study|Investigator Decision|2|||
30683597|NCT00792935|58697557|FG000|Overall Study|Adverse Event|2|||
30683598|NCT00792935|58697558|FG001|Overall Study|Adverse Event|1|||
30783614|NCT04760314|58795815|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
30783615|NCT04760314|58795816|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
30783616|NCT04760314|58795817|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
30783617|NCT04760314|58795818|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
30783618|NCT04760314|58795819|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
30783619|NCT04760314|58795820|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
30783620|NCT04760314|58795821|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
30783621|NCT04760314|58795822|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
30783622|NCT04760314|58795823|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
30783623|NCT04760314|58795824|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
30783624|NCT04760314|58795814|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30783625|NCT04760314|58795815|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30783626|NCT04760314|58795816|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30783627|NCT04760314|58795817|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30783628|NCT04760314|58795818|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30783629|NCT04760314|58795819|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30783630|NCT04760314|58795820|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30783631|NCT04760314|58795821|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
30783632|NCT04760314|58795822|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
30783633|NCT04760314|58795823|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
30783634|NCT04760314|58795824|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
30783635|NCT04760314|58795814|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30783636|NCT04760314|58795815|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30783637|NCT04760314|58795816|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30783638|NCT04760314|58795817|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30783639|NCT04760314|58795818|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30783640|NCT04760314|58795819|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30783641|NCT04760314|58795820|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30783642|NCT04760314|58795821|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
30783643|NCT04760314|58795822|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
30783644|NCT04760314|58795823|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
30783645|NCT04760314|58795824|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
30783646|NCT04760314|58795814|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30783647|NCT04760314|58795815|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30783648|NCT04760314|58795816|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30783649|NCT04760314|58795817|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30783650|NCT04760314|58795818|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30783651|NCT04760314|58795819|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30783652|NCT04760314|58795820|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30783653|NCT04760314|58795821|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
30783654|NCT04760314|58795822|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30783655|NCT04760314|58795823|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30783656|NCT04760314|58795824|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
30783657|NCT04760314|58795814|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
30783658|NCT04760314|58795815|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
30783659|NCT04760314|58795816|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
30783660|NCT04760314|58795817|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
30783661|NCT04760314|58795818|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
30597003|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
30597004|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
30597005|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
30597006|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
30597007|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
30597008|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
30597009|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
30597010|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
30597011|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
30597012|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
30683599|NCT00792935|58697557|FG000|Overall Study|Lost to Follow-up|0|||
30783662|NCT04760314|58795819|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
30783663|NCT04760314|58795820|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
30683600|NCT00792935|58697558|FG001|Overall Study|Lost to Follow-up|1|||
30683601|NCT00792935|58697557|FG000|Overall Study|Protocol Violation|2|||
30683602|NCT00792935|58697558|FG001|Overall Study|Protocol Violation|0|||
30683603|NCT00792935|58697557|FG000|Overall Study|Withdrawal by Subject|0|||
30683604|NCT00792935|58697558|FG001|Overall Study|Withdrawal by Subject|1|||
30683605|NCT00770510|58697564|FG000|Overall Study|Lost to Follow-up|2|||
30683606|NCT00770510|58697564|FG000|Overall Study|Pregnancy|1|||
30683607|NCT00770510|58697564|FG000|Overall Study|Withdrawal by Subject|2|||
30683608|NCT00770432|58697578|FG000|Overall Study|Other|4|||
30683609|NCT00770432|58697579|FG001|Overall Study|Other|6|||
30683610|NCT00770432|58697578|FG000|Overall Study|Non-compliance|0|||
30683611|NCT00770432|58697579|FG001|Overall Study|Non-compliance|1|||
30683612|NCT00792701|58697587|FG000|Overall Study|Adverse Event|0|||
30683613|NCT00792701|58697588|FG001|Overall Study|Adverse Event|22|||
30683614|NCT00792701|58697587|FG000|Overall Study|Ineligible|1|||
30683615|NCT00792701|58697588|FG001|Overall Study|Ineligible|3|||
30683616|NCT00792701|58697587|FG000|Overall Study|Withdrawal by Subject|1|||
30683617|NCT00792701|58697588|FG001|Overall Study|Withdrawal by Subject|19|||
30683618|NCT00792701|58697587|FG000|Overall Study|Not protocol specified|17|||
30683619|NCT00792701|58697588|FG001|Overall Study|Not protocol specified|0|||
30683620|NCT00777296|58697600|FG000|Overall Study|Adverse Event|0|||
30683621|NCT00777296|58697601|FG001|Overall Study|Adverse Event|1|||
30683622|NCT00777296|58697602|FG002|Overall Study|Adverse Event|0|||
30683623|NCT00777296|58697603|FG003|Overall Study|Adverse Event|1|||
30683624|NCT00777296|58697600|FG000|Overall Study|Withdrawal by Subject|1|||
30683625|NCT00777296|58697601|FG001|Overall Study|Withdrawal by Subject|0|||
30683626|NCT00777296|58697602|FG002|Overall Study|Withdrawal by Subject|0|||
30683627|NCT00777296|58697603|FG003|Overall Study|Withdrawal by Subject|0|||
30683628|NCT00777296|58697600|FG000|Overall Study|CRF form not completed|0|||
30683629|NCT00777296|58697601|FG001|Overall Study|CRF form not completed|0|||
30683630|NCT00777296|58697602|FG002|Overall Study|CRF form not completed|2|||
30683631|NCT00777296|58697603|FG003|Overall Study|CRF form not completed|0|||
30683632|NCT00756470|58697625|FG000|Overall Study|Withdrawal by Subject|1|||
30683633|NCT00756470|58697625|FG000|Overall Study|Adverse Event|4|||
30683634|NCT00792623|58697629|FG000|Overall Study|Adverse Event|2|||
30683635|NCT00792623|58697629|FG000|Overall Study|Withdrawal by Subject|5|||
30683636|NCT00756314|58697636|FG000|Overall Study|Lost to Follow-up|2|||
30683637|NCT00756314|58697637|FG001|Overall Study|Lost to Follow-up|59|||
30597013|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
30597014|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
30597015|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
30683638|NCT00727506|58697649|FG000|Overall Study|Adverse Event|0|||
30683639|NCT00727506|58697650|FG001|Overall Study|Adverse Event|0|||
30683640|NCT00727506|58697651|FG002|Overall Study|Adverse Event|4|||
30683641|NCT00727506|58697652|FG003|Overall Study|Adverse Event|4|||
30683642|NCT00727506|58697653|FG004|Overall Study|Adverse Event|1|||
30683643|NCT00727506|58697654|FG005|Overall Study|Adverse Event|8|||
30683644|NCT00727506|58697649|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
30683645|NCT00727506|58697650|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30683646|NCT00727506|58697651|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
30683647|NCT00727506|58697652|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30783664|NCT04760314|58795821|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
30783665|NCT04760314|58795822|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
30783666|NCT04760314|58795823|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
30783667|NCT04760314|58795824|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
30783668|NCT04576455|58795852|FG000|Overall Study|Ongoing in the Study|122|||
30783669|NCT04576455|58795853|FG001|Overall Study|Ongoing in the Study|135|||
30783670|NCT04576455|58795852|FG000|Overall Study|Death|18|||
30783671|NCT04576455|58795853|FG001|Overall Study|Death|12|||
30783672|NCT04576455|58795852|FG000|Overall Study|Lost to Follow-up|1|||
30597016|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
30597017|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
30597018|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
30597019|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
30597020|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
30783673|NCT04576455|58795853|FG001|Overall Study|Lost to Follow-up|0|||
30783674|NCT04576455|58795852|FG000|Overall Study|Withdrawal by Subject|10|||
30783675|NCT04576455|58795853|FG001|Overall Study|Withdrawal by Subject|5|||
30783676|NCT04493684|58795877|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
30783677|NCT04493684|58795878|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30783678|NCT04493684|58795879|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
30783679|NCT04493684|58795880|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30783680|NCT04493684|58795881|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30783681|NCT04493684|58795882|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
30597021|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
30597022|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
30597023|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Other|8|||
30597024|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Other|14|||
30597025|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Other|8|||
30597026|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Other|23|||
30597027|NCT01106677|58608770|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
30597028|NCT01106677|58608771|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
30597029|NCT01106677|58608772|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
30597030|NCT01106677|58608773|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
30597031|NCT01106677|58608770|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
30597032|NCT01106677|58608771|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
30597033|NCT01106677|58608772|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
30597034|NCT01106677|58608773|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
30597035|NCT01106677|58608770|FG000|Extension Period: Week 26 to Week 52|Death|0|||
30597036|NCT01106677|58608771|FG001|Extension Period: Week 26 to Week 52|Death|0|||
30597037|NCT01106677|58608772|FG002|Extension Period: Week 26 to Week 52|Death|0|||
30597038|NCT01106677|58608773|FG003|Extension Period: Week 26 to Week 52|Death|1|||
30597039|NCT01106677|58608770|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
30597040|NCT01106677|58608771|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
30597041|NCT01106677|58608772|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
30597042|NCT01106677|58608773|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
30597043|NCT01106677|58608770|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
30597044|NCT01106677|58608771|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
30597045|NCT01106677|58608772|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
30597046|NCT01106677|58608773|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
30597047|NCT01106677|58608770|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
30597048|NCT01106677|58608771|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
30597049|NCT01106677|58608772|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
30597050|NCT01106677|58608773|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
30597051|NCT01106677|58608770|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
30597052|NCT01106677|58608771|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
30597053|NCT01106677|58608772|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
30597054|NCT01106677|58608773|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
30597055|NCT01106677|58608770|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
30597056|NCT01106677|58608771|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
30597057|NCT01106677|58608772|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
30597058|NCT01106677|58608773|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
30597059|NCT01106677|58608770|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
30597060|NCT01106677|58608771|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
30597061|NCT01106677|58608772|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
30597062|NCT01106677|58608773|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
30597063|NCT01106677|58608770|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
30597064|NCT01106677|58608771|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
30597065|NCT01106677|58608772|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
30597066|NCT01106677|58608773|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
30597067|NCT01106677|58608770|FG000|Extension Period: Week 26 to Week 52|Other|6|||
30597068|NCT01106677|58608771|FG001|Extension Period: Week 26 to Week 52|Other|5|||
30597069|NCT01106677|58608772|FG002|Extension Period: Week 26 to Week 52|Other|8|||
30597070|NCT01106677|58608773|FG003|Extension Period: Week 26 to Week 52|Other|5|||
30597071|NCT01106287|58608794|FG000|Overall Study|Adverse Event|1|||
30597072|NCT01106287|58608795|FG001|Overall Study|Adverse Event|0|||
30597073|NCT01106287|58608796|FG002|Overall Study|Adverse Event|0|||
30597074|NCT01106287|58608797|FG003|Overall Study|Adverse Event|0|||
30597075|NCT01104493|58608813|FG000|Overall Study|Lost to Follow-up|0|||
30597076|NCT01104493|58608814|FG001|Overall Study|Lost to Follow-up|2|||
30597077|NCT01104415|58608820|FG000|Core Phase|Consent withdrawn by subjects|1|||
30597078|NCT01104415|58608821|FG001|Core Phase|Consent withdrawn by subjects|0|||
30597079|NCT01104415|58608820|FG000|Extension Period|Progressive disease|0|||
30597080|NCT01104415|58608821|FG001|Extension Period|Progressive disease|4|||
30597081|NCT01104415|58608820|FG000|Extension Period|Death|0|||
30597082|NCT01104415|58608821|FG001|Extension Period|Death|1|||
30597083|NCT01104415|58608820|FG000|Extension Period|Physician Decision|0|||
30597084|NCT01104415|58608821|FG001|Extension Period|Physician Decision|1|||
30597085|NCT01104415|58608820|FG000|Extension Period|Transition to Study LX1606.302|0|||
30597086|NCT01104415|58608821|FG001|Extension Period|Transition to Study LX1606.302|4|||
30597087|NCT01104415|58608820|FG000|Extension Period|Heart surgery/feeling miserable|0|||
30597088|NCT01104415|58608821|FG001|Extension Period|Heart surgery/feeling miserable|1|||
30597089|NCT01099579|58608831|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
30597090|NCT01099579|58608832|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
30597091|NCT01099579|58608833|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
30597092|NCT01099579|58608831|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
30597093|NCT01099579|58608832|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
30597094|NCT01099579|58608833|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
30597095|NCT01099579|58608831|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
30597096|NCT01099579|58608832|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
30597097|NCT01099579|58608833|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
30597098|NCT01099579|58608831|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
30597099|NCT01099579|58608832|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
30597100|NCT01099579|58608833|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
30597101|NCT01099579|58608831|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
30597102|NCT01099579|58608832|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
30597103|NCT01099579|58608833|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
30597104|NCT01099579|58608831|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
30683648|NCT00727506|58697653|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30683649|NCT00727506|58697654|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
30683650|NCT00727506|58697649|FG000|Overall Study|Progressive disease|4|||
30683651|NCT00727506|58697650|FG001|Overall Study|Progressive disease|7|||
30683652|NCT00727506|58697651|FG002|Overall Study|Progressive disease|9|||
30683653|NCT00727506|58697652|FG003|Overall Study|Progressive disease|28|||
30683654|NCT00727506|58697653|FG004|Overall Study|Progressive disease|38|||
30683655|NCT00727506|58697654|FG005|Overall Study|Progressive disease|28|||
30683656|NCT00727506|58697649|FG000|Overall Study|Refused to continue medication|0|||
30683657|NCT00727506|58697650|FG001|Overall Study|Refused to continue medication|1|||
30683658|NCT00727506|58697651|FG002|Overall Study|Refused to continue medication|2|||
30683659|NCT00727506|58697652|FG003|Overall Study|Refused to continue medication|3|||
30597105|NCT01099579|58608832|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
30597106|NCT01099579|58608833|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
30597107|NCT01099579|58608831|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
30597108|NCT01099579|58608832|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
30683660|NCT00727506|58697653|FG004|Overall Study|Refused to continue medication|1|||
30683661|NCT00727506|58697654|FG005|Overall Study|Refused to continue medication|2|||
30683662|NCT00727506|58697649|FG000|Overall Study|Other reason not described above|0|||
30683663|NCT00727506|58697650|FG001|Overall Study|Other reason not described above|0|||
30683664|NCT00727506|58697651|FG002|Overall Study|Other reason not described above|1|||
30683665|NCT00727506|58697652|FG003|Overall Study|Other reason not described above|4|||
30683666|NCT00727506|58697653|FG004|Overall Study|Other reason not described above|1|||
30683667|NCT00727506|58697654|FG005|Overall Study|Other reason not described above|1|||
30683668|NCT00789815|58697676|FG000|Overall Study|Protocol Violation|6|||
30683669|NCT00789815|58697677|FG001|Overall Study|Protocol Violation|1|||
30683670|NCT00789815|58697676|FG000|Overall Study|Intubation due to massive bleeding|1|||
30683671|NCT00789815|58697677|FG001|Overall Study|Intubation due to massive bleeding|0|||
30683672|NCT00721578|58697683|FG000|Overall Study|Death|1|||
30683673|NCT00721578|58697684|FG001|Overall Study|Death|1|||
30683674|NCT00721578|58697683|FG000|Overall Study|Withdrawal by Subject|1|||
30597109|NCT01099579|58608833|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
30597110|NCT01099579|58608831|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
30597111|NCT01099579|58608832|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
30597112|NCT01099579|58608833|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
30597113|NCT01099579|58608831|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
30597114|NCT01099579|58608832|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
30597115|NCT01099579|58608833|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
30683675|NCT00721578|58697684|FG001|Overall Study|Withdrawal by Subject|1|||
30683676|NCT00789737|58697692|FG000|Overall Study|Withdrawal by Subject|13|||
30683677|NCT00789737|58697693|FG001|Overall Study|Withdrawal by Subject|22|||
30683678|NCT00789737|58697692|FG000|Overall Study|Lost to Follow-up|10|||
30683679|NCT00789737|58697693|FG001|Overall Study|Lost to Follow-up|14|||
30683680|NCT00789737|58697692|FG000|Overall Study|Adverse Event|8|||
30683681|NCT00789737|58697693|FG001|Overall Study|Adverse Event|8|||
30683682|NCT00789737|58697692|FG000|Overall Study|Protocol Violation|3|||
30683683|NCT00789737|58697693|FG001|Overall Study|Protocol Violation|0|||
30683684|NCT00789737|58697692|FG000|Overall Study|Lack of Efficacy|3|||
30683685|NCT00789737|58697693|FG001|Overall Study|Lack of Efficacy|0|||
30683686|NCT00789737|58697692|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
30683687|NCT00789737|58697693|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
30597116|NCT01099579|58608831|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
30683688|NCT00789737|58697692|FG000|Overall Study|Other|11|||
30597117|NCT01099579|58608832|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
30683689|NCT00789737|58697693|FG001|Overall Study|Other|7|||
30683690|NCT00792467|58697699|FG000|Overall Study|progression of disease|17|||
30597118|NCT01099579|58608833|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
30683691|NCT00792467|58697699|FG000|Overall Study|Adverse Event|1|||
30683692|NCT00792467|58697699|FG000|Overall Study|patient request|1|||
30683693|NCT00792467|58697699|FG000|Overall Study|Lost to Follow-up|1|||
30683694|NCT00792467|58697699|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
30683695|NCT00792467|58697699|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
30683696|NCT00585468|58697704|FG000|First Intervention|Withdrawal by Subject|1|||
30683697|NCT00585468|58697705|FG001|First Intervention|Withdrawal by Subject|1|||
30683698|NCT00724152|58697718|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
30683699|NCT00724152|58697719|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
30683700|NCT00724152|58697720|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
30683701|NCT00724152|58697718|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
30683702|NCT00724152|58697719|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
30683703|NCT00724152|58697720|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
30683704|NCT00721110|58697734|FG000|Overall Study|Ultram use|1|||
30683705|NCT00721110|58697735|FG001|Overall Study|Ultram use|0|||
30683706|NCT00721110|58697736|FG002|Overall Study|Ultram use|0|||
30683707|NCT00721110|58697737|FG003|Overall Study|Ultram use|0|||
30683708|NCT00721110|58697734|FG000|Overall Study|vertical incision|0|||
30683709|NCT00721110|58697735|FG001|Overall Study|vertical incision|0|||
30683710|NCT00721110|58697736|FG002|Overall Study|vertical incision|1|||
30683711|NCT00721110|58697737|FG003|Overall Study|vertical incision|0|||
30683712|NCT00791999|58697751|FG000|Overall Study|Protocol planed withdrawal|14|||
30683713|NCT00791999|58697752|FG001|Overall Study|Protocol planed withdrawal|11|||
30683714|NCT00791999|58697753|FG002|Overall Study|Protocol planed withdrawal|11|||
30683715|NCT00791999|58697754|FG003|Overall Study|Protocol planed withdrawal|45|||
30683716|NCT00791999|58697751|FG000|Overall Study|Withdrawal by Subject|0|||
30683717|NCT00791999|58697752|FG001|Overall Study|Withdrawal by Subject|1|||
30683718|NCT00791999|58697753|FG002|Overall Study|Withdrawal by Subject|0|||
30683719|NCT00791999|58697754|FG003|Overall Study|Withdrawal by Subject|2|||
30683720|NCT00791999|58697751|FG000|Overall Study|Protocol Violation|3|||
30683721|NCT00791999|58697752|FG001|Overall Study|Protocol Violation|0|||
30683722|NCT00791999|58697753|FG002|Overall Study|Protocol Violation|1|||
30683723|NCT00791999|58697754|FG003|Overall Study|Protocol Violation|0|||
30683724|NCT00791999|58697751|FG000|Overall Study|Adverse Event|3|||
30683725|NCT00791999|58697752|FG001|Overall Study|Adverse Event|3|||
30683726|NCT00791999|58697753|FG002|Overall Study|Adverse Event|7|||
30783682|NCT04493684|58795883|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30597119|NCT01103713|58608843|FG000|Overall Study|Lost to Follow-up|2|||
30597120|NCT01103713|58608843|FG000|Overall Study|Withdrawal by Subject|8|||
30597121|NCT01103713|58608843|FG000|Overall Study|Study terminated by sponsor|2|||
30597122|NCT01103713|58608843|FG000|Overall Study|Other|1|||
30597123|NCT01103479|58608853|FG000|Overall Study|Up to date with CRC screening|1|||
30597124|NCT01103479|58608854|FG001|Overall Study|Up to date with CRC screening|9|||
30597125|NCT01103479|58608855|FG002|Overall Study|Up to date with CRC screening|12|||
30597126|NCT01103479|58608853|FG000|Overall Study|Family history of CRC|1|||
30597127|NCT01103479|58608854|FG001|Overall Study|Family history of CRC|0|||
30597128|NCT01103479|58608855|FG002|Overall Study|Family history of CRC|2|||
30597129|NCT01103479|58608853|FG000|Overall Study|Active cancer|1|||
30597130|NCT01103479|58608854|FG001|Overall Study|Active cancer|0|||
30597131|NCT01103479|58608855|FG002|Overall Study|Active cancer|0|||
30597132|NCT01103479|58608853|FG000|Overall Study|Saw non-study physician|2|||
30597133|NCT01103479|58608854|FG001|Overall Study|Saw non-study physician|0|||
30597134|NCT01103479|58608855|FG002|Overall Study|Saw non-study physician|0|||
30597135|NCT01103323|58608866|FG000|Without/Before Drug Switch|Adverse Event|50|||
30597136|NCT01103323|58608867|FG001|Without/Before Drug Switch|Adverse Event|7|||
30597137|NCT01103323|58608866|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
30597138|NCT01103323|58608867|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
30597139|NCT01103323|58608866|FG000|Without/Before Drug Switch|Protocol Violation|2|||
30597140|NCT01103323|58608867|FG001|Without/Before Drug Switch|Protocol Violation|0|||
30597141|NCT01103323|58608866|FG000|Without/Before Drug Switch|Physician Decision|2|||
30597142|NCT01103323|58608867|FG001|Without/Before Drug Switch|Physician Decision|0|||
30597143|NCT01103323|58608866|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
30597144|NCT01103323|58608867|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
30683727|NCT00791999|58697754|FG003|Overall Study|Adverse Event|3|||
30683728|NCT00791999|58697751|FG000|Overall Study|Lack of Efficacy|0|||
30783683|NCT04493684|58795884|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30597145|NCT01103323|58608866|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
30597146|NCT01103323|58608867|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
30597147|NCT01103323|58608866|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
30597148|NCT01103323|58608867|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
30597149|NCT01103245|58608878|FG000|Overall Study|Withdrawal by Subject|1|||
30683729|NCT00791999|58697752|FG001|Overall Study|Lack of Efficacy|1|||
30683730|NCT00791999|58697753|FG002|Overall Study|Lack of Efficacy|0|||
30683731|NCT00791999|58697754|FG003|Overall Study|Lack of Efficacy|2|||
30683732|NCT00791999|58697751|FG000|Overall Study|Reason other than those above|1|||
30683733|NCT00791999|58697752|FG001|Overall Study|Reason other than those above|0|||
30683734|NCT00791999|58697753|FG002|Overall Study|Reason other than those above|1|||
30683735|NCT00791999|58697754|FG003|Overall Study|Reason other than those above|0|||
30683736|NCT00585078|58697768|FG000|Overall Study|Withdrawal by Subject|4|||
30683737|NCT00585078|58697768|FG000|Overall Study|Poor performance status|1|||
30683738|NCT00585078|58697768|FG000|Overall Study|Disease Progression|24|||
30683739|NCT00585078|58697768|FG000|Overall Study|Adverse Event|10|||
30683740|NCT00585078|58697768|FG000|Overall Study|Death|1|||
30683741|NCT00720876|58697772|FG000|Overall Study|found to be ineligible after starting tx|2|||
30683742|NCT00723840|58697776|FG000|Overall Study|Lost to Follow-up|2|||
30683743|NCT00723840|58697776|FG000|Overall Study|Failure to return|18|||
30683744|NCT00723840|58697776|FG000|Overall Study|Withdrawal by Subject|55|||
30683745|NCT00723840|58697776|FG000|Overall Study|Serious Adverse Events|3|||
30683746|NCT00723840|58697776|FG000|Overall Study|Other Medical Event|2|||
30683747|NCT00723840|58697776|FG000|Overall Study|Unspecified reason|2|||
30683748|NCT00789581|58697789|FG000|AC Therapy|Adverse Event|2|||
30683749|NCT00789581|58697790|FG001|AC Therapy|Adverse Event|3|||
30683750|NCT00789581|58697789|FG000|AC Therapy|Withdrawal by Subject|4|||
30683751|NCT00789581|58697790|FG001|AC Therapy|Withdrawal by Subject|7|||
30683752|NCT00789581|58697789|FG000|AC Therapy|Disease recurrence|3|||
30597150|NCT01103245|58608879|FG001|Overall Study|Withdrawal by Subject|0|||
30597151|NCT01103245|58608880|FG002|Overall Study|Withdrawal by Subject|3|||
30597152|NCT01103245|58608881|FG003|Overall Study|Withdrawal by Subject|0|||
30597153|NCT01103245|58608878|FG000|Overall Study|Inadequate IV access|1|||
30597154|NCT01103245|58608879|FG001|Overall Study|Inadequate IV access|0|||
30597155|NCT01103245|58608880|FG002|Overall Study|Inadequate IV access|0|||
30597156|NCT01103245|58608881|FG003|Overall Study|Inadequate IV access|0|||
30597157|NCT01103245|58608878|FG000|Overall Study|Adverse Event|0|||
30683753|NCT00789581|58697790|FG001|AC Therapy|Disease recurrence|1|||
30683754|NCT00789581|58697789|FG000|AC Therapy|Intercurrent Illness|1|||
30683755|NCT00789581|58697790|FG001|AC Therapy|Intercurrent Illness|0|||
30683756|NCT00789581|58697789|FG000|AC Therapy|Never Treated|1|||
30683757|NCT00789581|58697790|FG001|AC Therapy|Never Treated|4|||
30683758|NCT00789581|58697789|FG000|AC Therapy|Other|0|||
30683759|NCT00789581|58697790|FG001|AC Therapy|Other|2|||
30683760|NCT00789581|58697789|FG000|Adjuvant Therapy|Never treated|2|||
30683761|NCT00789581|58697790|FG001|Adjuvant Therapy|Never treated|2|||
30683762|NCT00789581|58697789|FG000|Adjuvant Therapy|Adverse Event|20|||
30597158|NCT01103245|58608879|FG001|Overall Study|Adverse Event|2|||
30597159|NCT01103245|58608880|FG002|Overall Study|Adverse Event|1|||
30597160|NCT01103245|58608881|FG003|Overall Study|Adverse Event|0|||
30597161|NCT01103245|58608878|FG000|Overall Study|Physician Decision|1|||
30597162|NCT01103245|58608879|FG001|Overall Study|Physician Decision|0|||
30597163|NCT01103245|58608880|FG002|Overall Study|Physician Decision|0|||
30597164|NCT01103245|58608881|FG003|Overall Study|Physician Decision|0|||
30683763|NCT00789581|58697790|FG001|Adjuvant Therapy|Adverse Event|44|||
30683764|NCT00789581|58697789|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
30683765|NCT00789581|58697790|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
30683766|NCT00789581|58697789|FG000|Adjuvant Therapy|Disease recurrence|2|||
30683767|NCT00789581|58697790|FG001|Adjuvant Therapy|Disease recurrence|1|||
30683768|NCT00789581|58697789|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
30683769|NCT00789581|58697790|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
30683770|NCT00789581|58697789|FG000|Adjuvant Therapy|Protocol Violation|1|||
30683771|NCT00789581|58697790|FG001|Adjuvant Therapy|Protocol Violation|1|||
30683772|NCT00789581|58697789|FG000|Adjuvant Therapy|Other|0|||
30683773|NCT00789581|58697790|FG001|Adjuvant Therapy|Other|1|||
30959137|NCT01541917|59024378|FG000|Overall Study|Lost to Follow-up|2|||
30683774|NCT00717756|58697797|FG000|Overall Study|Withdrawal by Subject|1|||
30683775|NCT00717522|58697801|FG000|Overall Study|Disease Progression|5|||
30683776|NCT00717522|58697801|FG000|Overall Study|Adverse Event|1|||
30683777|NCT00717522|58697801|FG000|Overall Study|Death|1|||
30683778|NCT00791921|58697807|FG000|Overall Study|Protocol planed|24|||
30683779|NCT00791921|58697808|FG001|Overall Study|Protocol planed|88|||
30683780|NCT00791921|58697807|FG000|Overall Study|Withdrawal by Subject|1|||
30683781|NCT00791921|58697808|FG001|Overall Study|Withdrawal by Subject|2|||
30597165|NCT01099267|58608891|FG000|MDS-003 Study|Adverse Event|37|||
30597166|NCT01099267|58608891|FG000|MDS-003 Study|Lack of Efficacy|52|||
30597167|NCT01099267|58608891|FG000|MDS-003 Study|Withdrawal by Subject|8|||
30597168|NCT01099267|58608891|FG000|MDS-003 Study|Lost to Follow-up|1|||
30597169|NCT01099267|58608891|FG000|MDS-003 Study|Death|11|||
30683782|NCT00791921|58697807|FG000|Overall Study|Adverse Event|8|||
30683783|NCT00791921|58697808|FG001|Overall Study|Adverse Event|2|||
30683784|NCT00791921|58697807|FG000|Overall Study|Lack of Efficacy|0|||
30683785|NCT00791921|58697808|FG001|Overall Study|Lack of Efficacy|2|||
30683786|NCT00791921|58697807|FG000|Overall Study|Lack of study drug administration|1|||
30683787|NCT00791921|58697808|FG001|Overall Study|Lack of study drug administration|1|||
30683788|NCT00791921|58697807|FG000|Overall Study|Reason other than those above|0|||
30683789|NCT00791921|58697808|FG001|Overall Study|Reason other than those above|1|||
30597170|NCT01099267|58608891|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
30597171|NCT01099267|58608891|FG000|MDS-003 Study|Disease Progression|7|||
30597172|NCT01099267|58608891|FG000|MDS-003 Study|Investigator Decision|2|||
30597173|NCT01099267|58608891|FG000|MDS-003 Study|Non-Compliance|2|||
30597174|NCT01099267|58608891|FG000|MDS-003 Study|Loss of Response|1|||
30597175|NCT01099267|58608891|FG000|MDS-003 Study|Secondary Malign Disease|1|||
30597176|NCT01098487|58608895|FG000|Overall Study|Adverse Event|22|||
30597177|NCT01098487|58608895|FG000|Overall Study|Lack of Efficacy|11|||
30597178|NCT01098487|58608895|FG000|Overall Study|Withdrawal by Subject|7|||
30597179|NCT01098487|58608895|FG000|Overall Study|Lost to Follow-up|3|||
30597180|NCT01098487|58608895|FG000|Overall Study|Physician Decision|1|||
30597181|NCT01098097|58608899|FG000|Overall Study|Adverse Event|17|||
30597182|NCT01098097|58608899|FG000|Overall Study|Lost to Follow-up|18|||
30597183|NCT01098097|58608899|FG000|Overall Study|Status unknown|16|||
30597184|NCT01098097|58608899|FG000|Overall Study|No reason reported|31|||
30597185|NCT01097863|58608906|FG000|Overall Study|Discomfort|1|||
30597186|NCT01097863|58608907|FG001|Overall Study|Discomfort|0|||
30597187|NCT01097863|58608908|FG002|Overall Study|Discomfort|1|||
30597188|NCT01097863|58608906|FG000|Overall Study|Did not return for final visit|0|||
30683790|NCT00582933|58697814|FG000|Overall Study|Physician Decision|3|||
30683791|NCT00791765|58697820|FG000|Weeks 1 to 12|Adverse Event|0|||
30683792|NCT00791765|58697821|FG001|Weeks 1 to 12|Adverse Event|1|||
30683793|NCT00791765|58697820|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
30683794|NCT00791765|58697821|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
30683795|NCT00791765|58697820|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
30683796|NCT00791765|58697821|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
30683797|NCT00791765|58697820|FG000|Weeks 1 to 12|Physician Decision|1|||
30683798|NCT00791765|58697821|FG001|Weeks 1 to 12|Physician Decision|0|||
30683799|NCT00791765|58697820|FG000|Weeks 1 to 12|Disease progression|3|||
30683800|NCT00791765|58697821|FG001|Weeks 1 to 12|Disease progression|0|||
30683801|NCT00791765|58697820|FG000|Weeks 1 to 12|Ineligibility determined|0|||
30683802|NCT00791765|58697821|FG001|Weeks 1 to 12|Ineligibility determined|3|||
30683803|NCT00791765|58697820|FG000|Weeks 13 to 24|Protocol deviation|2|||
30683804|NCT00791765|58697821|FG001|Weeks 13 to 24|Protocol deviation|0|||
30683805|NCT00791765|58697820|FG000|Weeks 13 to 24|Adverse Event|0|||
30683806|NCT00791765|58697821|FG001|Weeks 13 to 24|Adverse Event|3|||
30683807|NCT00791765|58697820|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
30683808|NCT00791765|58697821|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
30683809|NCT00791765|58697820|FG000|Weeks 13 to 24|Disease progression|0|||
30683810|NCT00791765|58697821|FG001|Weeks 13 to 24|Disease progression|1|||
30683811|NCT00791765|58697820|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
30683812|NCT00791765|58697821|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
30683813|NCT00791765|58697820|FG000|Weeks 13 to 24|Other|0|||
30683814|NCT00791765|58697821|FG001|Weeks 13 to 24|Other|1|||
30683815|NCT00789191|58697829|FG000|Overall Study|Adverse Event|2|||
30683816|NCT00789191|58697830|FG001|Overall Study|Adverse Event|4|||
30683817|NCT00789191|58697829|FG000|Overall Study|Lack of Efficacy|0|||
30683818|NCT00789191|58697830|FG001|Overall Study|Lack of Efficacy|5|||
30683819|NCT00789191|58697829|FG000|Overall Study|Protocol Violation|5|||
30683820|NCT00789191|58697830|FG001|Overall Study|Protocol Violation|3|||
30683821|NCT00789191|58697829|FG000|Overall Study|Withdrawal Criteria|2|||
30683822|NCT00789191|58697830|FG001|Overall Study|Withdrawal Criteria|4|||
30683823|NCT00789191|58697829|FG000|Overall Study|Unclassified|5|||
30683824|NCT00789191|58697830|FG001|Overall Study|Unclassified|3|||
30683825|NCT00789035|58697841|FG000|Overall Study|Adverse Event|0|||
30683826|NCT00789035|58697842|FG001|Overall Study|Adverse Event|2|||
30683827|NCT00789035|58697843|FG002|Overall Study|Adverse Event|0|||
30683828|NCT00789035|58697844|FG003|Overall Study|Adverse Event|1|||
30683829|NCT00789035|58697845|FG004|Overall Study|Adverse Event|3|||
30683830|NCT00789035|58697841|FG000|Overall Study|Lack of Efficacy|3|||
30683831|NCT00789035|58697842|FG001|Overall Study|Lack of Efficacy|0|||
30683832|NCT00789035|58697843|FG002|Overall Study|Lack of Efficacy|0|||
30683833|NCT00789035|58697844|FG003|Overall Study|Lack of Efficacy|0|||
30683834|NCT00789035|58697845|FG004|Overall Study|Lack of Efficacy|2|||
30683835|NCT00789035|58697841|FG000|Overall Study|Protocol Violation|1|||
30683836|NCT00789035|58697842|FG001|Overall Study|Protocol Violation|0|||
30683837|NCT00789035|58697843|FG002|Overall Study|Protocol Violation|0|||
30683838|NCT00789035|58697844|FG003|Overall Study|Protocol Violation|0|||
30597189|NCT01097863|58608907|FG001|Overall Study|Did not return for final visit|0|||
30597190|NCT01097863|58608908|FG002|Overall Study|Did not return for final visit|1|||
30597191|NCT01326962|58608916|FG000|Overall Study|Adverse Event|1|||
30683839|NCT00789035|58697845|FG004|Overall Study|Protocol Violation|0|||
30683840|NCT00789035|58697841|FG000|Overall Study|Withdrawal by Subject|0|||
30683841|NCT00789035|58697842|FG001|Overall Study|Withdrawal by Subject|2|||
30683842|NCT00789035|58697843|FG002|Overall Study|Withdrawal by Subject|0|||
30683843|NCT00789035|58697844|FG003|Overall Study|Withdrawal by Subject|0|||
30683844|NCT00789035|58697845|FG004|Overall Study|Withdrawal by Subject|0|||
30683845|NCT00789035|58697841|FG000|Overall Study|Other reason not defined above|2|||
30683846|NCT00789035|58697842|FG001|Overall Study|Other reason not defined above|3|||
30683847|NCT00789035|58697843|FG002|Overall Study|Other reason not defined above|1|||
30683848|NCT00789035|58697844|FG003|Overall Study|Other reason not defined above|0|||
30683849|NCT00789035|58697845|FG004|Overall Study|Other reason not defined above|1|||
30683850|NCT03326193|58697869|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
30683851|NCT03326193|58697869|FG000|Overall Study|Death|19|||
30683852|NCT03326193|58697869|FG000|Overall Study|Withdrawal by Subject|8|||
30683853|NCT00437203|58697892|FG000|Overall Study|Death|0|||
30683854|NCT00437203|58697893|FG001|Overall Study|Death|0|||
30683855|NCT00437203|58697894|FG002|Overall Study|Death|1|||
30683856|NCT00437203|58697895|FG003|Overall Study|Death|0|||
30597192|NCT01326962|58608916|FG000|Overall Study|Withdrawal by Subject|1|||
30597193|NCT01326962|58608916|FG000|Overall Study|Lost to Follow-up|3|||
30683857|NCT00437203|58697896|FG004|Overall Study|Death|0|||
30683858|NCT00437203|58697897|FG005|Overall Study|Death|0|||
30683859|NCT00437203|58697898|FG006|Overall Study|Death|0|||
30683860|NCT00437203|58697899|FG007|Overall Study|Death|1|||
30683861|NCT00437203|58697900|FG008|Overall Study|Death|0|||
30683862|NCT00437203|58697901|FG009|Overall Study|Death|1|||
30683863|NCT00437203|58697892|FG000|Overall Study|Adverse Event|1|||
30683864|NCT00437203|58697893|FG001|Overall Study|Adverse Event|1|||
30683865|NCT00437203|58697894|FG002|Overall Study|Adverse Event|0|||
30683866|NCT00437203|58697895|FG003|Overall Study|Adverse Event|0|||
30683867|NCT00437203|58697896|FG004|Overall Study|Adverse Event|0|||
30683868|NCT00437203|58697897|FG005|Overall Study|Adverse Event|0|||
30683869|NCT00437203|58697898|FG006|Overall Study|Adverse Event|0|||
30683870|NCT00437203|58697899|FG007|Overall Study|Adverse Event|1|||
30597194|NCT01326962|58608916|FG000|Overall Study|Other|2|||
30597195|NCT01326728|58608922|FG000|Overall Study|Death|13|||
30597196|NCT01326728|58608923|FG001|Overall Study|Death|0|||
30597197|NCT01326728|58608922|FG000|Overall Study|Early closure of study|34|||
30597198|NCT01326728|58608923|FG001|Overall Study|Early closure of study|9|||
30597199|NCT01097707|58608933|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
30597200|NCT01097707|58608934|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
30597201|NCT01097707|58608935|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
30597202|NCT01097707|58608936|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
30597203|NCT01097707|58608937|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
30597204|NCT01097707|58608933|FG000|Overall Study|Adverse Event|4|||
30597205|NCT01097707|58608934|FG001|Overall Study|Adverse Event|2|||
30597206|NCT01097707|58608935|FG002|Overall Study|Adverse Event|3|||
30597207|NCT01097707|58608936|FG003|Overall Study|Adverse Event|1|||
30597208|NCT01097707|58608937|FG004|Overall Study|Adverse Event|3|||
30597209|NCT01097707|58608933|FG000|Overall Study|Entry Criteria Not Met|2|||
30597210|NCT01097707|58608934|FG001|Overall Study|Entry Criteria Not Met|1|||
30597211|NCT01097707|58608935|FG002|Overall Study|Entry Criteria Not Met|1|||
30597212|NCT01097707|58608936|FG003|Overall Study|Entry Criteria Not Met|0|||
30597213|NCT01097707|58608937|FG004|Overall Study|Entry Criteria Not Met|1|||
30597214|NCT01097707|58608933|FG000|Overall Study|Lack of Efficacy|1|||
30597215|NCT01097707|58608934|FG001|Overall Study|Lack of Efficacy|0|||
30597216|NCT01097707|58608935|FG002|Overall Study|Lack of Efficacy|0|||
30597217|NCT01097707|58608936|FG003|Overall Study|Lack of Efficacy|1|||
30597218|NCT01097707|58608937|FG004|Overall Study|Lack of Efficacy|0|||
30597219|NCT01097707|58608933|FG000|Overall Study|Lost to Follow-up|1|||
30597220|NCT01097707|58608934|FG001|Overall Study|Lost to Follow-up|1|||
30597221|NCT01097707|58608935|FG002|Overall Study|Lost to Follow-up|2|||
30597222|NCT01097707|58608936|FG003|Overall Study|Lost to Follow-up|0|||
30597223|NCT01097707|58608937|FG004|Overall Study|Lost to Follow-up|3|||
30597224|NCT01097707|58608933|FG000|Overall Study|Protocol Violation|2|||
30597225|NCT01097707|58608934|FG001|Overall Study|Protocol Violation|2|||
30597226|NCT01097707|58608935|FG002|Overall Study|Protocol Violation|3|||
30597227|NCT01097707|58608936|FG003|Overall Study|Protocol Violation|2|||
30683871|NCT00437203|58697900|FG008|Overall Study|Adverse Event|0|||
30683872|NCT00437203|58697901|FG009|Overall Study|Adverse Event|1|||
30683873|NCT00437203|58697892|FG000|Overall Study|Study terminated by sponsor|0|||
30683874|NCT00437203|58697893|FG001|Overall Study|Study terminated by sponsor|0|||
30597228|NCT01097707|58608937|FG004|Overall Study|Protocol Violation|2|||
30597229|NCT01097707|58608933|FG000|Overall Study|Sponsor Decision|31|||
30597230|NCT01097707|58608934|FG001|Overall Study|Sponsor Decision|31|||
30683875|NCT00437203|58697894|FG002|Overall Study|Study terminated by sponsor|0|||
30683876|NCT00437203|58697895|FG003|Overall Study|Study terminated by sponsor|0|||
30683877|NCT00437203|58697896|FG004|Overall Study|Study terminated by sponsor|0|||
30597231|NCT01097707|58608935|FG002|Overall Study|Sponsor Decision|34|||
30597232|NCT01097707|58608936|FG003|Overall Study|Sponsor Decision|35|||
30597233|NCT01097707|58608937|FG004|Overall Study|Sponsor Decision|36|||
30597234|NCT01097707|58608933|FG000|Overall Study|Withdrawal by Subject|3|||
30597235|NCT01097707|58608934|FG001|Overall Study|Withdrawal by Subject|6|||
30683878|NCT00437203|58697897|FG005|Overall Study|Study terminated by sponsor|0|||
30683879|NCT00437203|58697898|FG006|Overall Study|Study terminated by sponsor|0|||
30683880|NCT00437203|58697899|FG007|Overall Study|Study terminated by sponsor|0|||
30683881|NCT00437203|58697900|FG008|Overall Study|Study terminated by sponsor|1|||
30683882|NCT00437203|58697901|FG009|Overall Study|Study terminated by sponsor|0|||
30683883|NCT00437203|58697892|FG000|Overall Study|Objective progression or relapse|5|||
30683884|NCT00437203|58697893|FG001|Overall Study|Objective progression or relapse|6|||
30683885|NCT00437203|58697894|FG002|Overall Study|Objective progression or relapse|2|||
30683886|NCT00437203|58697895|FG003|Overall Study|Objective progression or relapse|3|||
30683887|NCT00437203|58697896|FG004|Overall Study|Objective progression or relapse|3|||
30683888|NCT00437203|58697897|FG005|Overall Study|Objective progression or relapse|3|||
30683889|NCT00437203|58697898|FG006|Overall Study|Objective progression or relapse|6|||
30683890|NCT00437203|58697899|FG007|Overall Study|Objective progression or relapse|1|||
30683891|NCT00437203|58697900|FG008|Overall Study|Objective progression or relapse|2|||
30683892|NCT00437203|58697901|FG009|Overall Study|Objective progression or relapse|2|||
30683893|NCT00437203|58697892|FG000|Overall Study|Other|0|||
30683894|NCT00437203|58697893|FG001|Overall Study|Other|1|||
30683895|NCT00437203|58697894|FG002|Overall Study|Other|0|||
30683896|NCT00437203|58697895|FG003|Overall Study|Other|0|||
30683897|NCT00437203|58697896|FG004|Overall Study|Other|0|||
30597236|NCT01097707|58608935|FG002|Overall Study|Withdrawal by Subject|1|||
30597237|NCT01097707|58608936|FG003|Overall Study|Withdrawal by Subject|4|||
30597238|NCT01097707|58608937|FG004|Overall Study|Withdrawal by Subject|3|||
30597239|NCT01097707|58608933|FG000|Overall Study|Reason unknown|0|||
30683898|NCT00437203|58697897|FG005|Overall Study|Other|0|||
30683899|NCT00437203|58697898|FG006|Overall Study|Other|1|||
30683900|NCT00437203|58697899|FG007|Overall Study|Other|0|||
30683901|NCT00437203|58697900|FG008|Overall Study|Other|0|||
30683902|NCT00437203|58697901|FG009|Overall Study|Other|0|||
30683903|NCT00753272|58697934|FG000|Overall Study|Adverse Event|878|||
30683904|NCT00753272|58697935|FG001|Overall Study|Adverse Event|869|||
30683905|NCT00753272|58697934|FG000|Overall Study|Protocol Violation|28|||
30683906|NCT00753272|58697935|FG001|Overall Study|Protocol Violation|46|||
30683907|NCT00753272|58697934|FG000|Overall Study|Withdrawal by Subject|2481|||
30683908|NCT00753272|58697935|FG001|Overall Study|Withdrawal by Subject|2407|||
30683909|NCT00753272|58697934|FG000|Overall Study|Lost to Follow-up|491|||
30683910|NCT00753272|58697935|FG001|Overall Study|Lost to Follow-up|497|||
30683911|NCT00753272|58697934|FG000|Overall Study|Other|1104|||
30683912|NCT00753272|58697935|FG001|Overall Study|Other|1088|||
30783684|NCT04493684|58795885|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30959138|NCT01541917|59024379|FG001|Overall Study|Lost to Follow-up|2|||
30959139|NCT01541917|59024378|FG000|Overall Study|Withdrawal by Subject|13|||
30959140|NCT01541917|59024379|FG001|Overall Study|Withdrawal by Subject|7|||
30959141|NCT01688921|59024399|FG000|Overall Study|Lost to Follow-up|7|||
30959142|NCT01688921|59024400|FG001|Overall Study|Lost to Follow-up|13|||
30959143|NCT01688921|59024399|FG000|Overall Study|Physician Decision|6|||
30959144|NCT01688921|59024400|FG001|Overall Study|Physician Decision|1|||
30959145|NCT01688921|59024399|FG000|Overall Study|Protocol Violation|0|||
30959146|NCT01688921|59024400|FG001|Overall Study|Protocol Violation|1|||
30959147|NCT01688921|59024399|FG000|Overall Study|informed consent|3|||
30959148|NCT01688921|59024400|FG001|Overall Study|informed consent|0|||
30959149|NCT01541371|59024422|FG000|Overall Study|Withdrawal by Subject|14|||
30959150|NCT01541371|59024422|FG000|Overall Study|Lost to Follow-up|21|||
30959151|NCT01541371|59024422|FG000|Overall Study|Adverse Event|15|||
30959152|NCT01541371|59024422|FG000|Overall Study|Lack of Efficacy|12|||
30959153|NCT01541371|59024422|FG000|Overall Study|Protocol Violation|6|||
30959154|NCT01541371|59024422|FG000|Overall Study|Study medication non-compliance|3|||
30959155|NCT01541371|59024422|FG000|Overall Study|Other|6|||
30959156|NCT01687673|59024455|FG000|Overall Study|Physician Decision|1|||
30959157|NCT01687595|59024535|FG000|Overall Study|Withdrawal by Subject|8|||
30959158|NCT01687595|59024536|FG001|Overall Study|Withdrawal by Subject|0|||
30597240|NCT01097707|58608934|FG001|Overall Study|Reason unknown|0|||
30597241|NCT01097707|58608935|FG002|Overall Study|Reason unknown|0|||
30597242|NCT01097707|58608936|FG003|Overall Study|Reason unknown|0|||
30597243|NCT01097707|58608937|FG004|Overall Study|Reason unknown|1|||
30597244|NCT01326104|58608951|FG000|Overall Study|progressed prior to vaccine|0|||
30597245|NCT01326104|58608952|FG001|Overall Study|progressed prior to vaccine|2|||
30597246|NCT01326104|58608951|FG000|Overall Study|unable to make vaccine|0|||
30597247|NCT01326104|58608952|FG001|Overall Study|unable to make vaccine|2|||
30597248|NCT01326026|58608960|FG000|Overall Study|Adverse Event|4|||
30597249|NCT01326026|58608961|FG001|Overall Study|Adverse Event|3|||
30597250|NCT01326026|58608960|FG000|Overall Study|Withdrawal Criteria|5|||
30683913|NCT00437125|58697944|FG000|Overall Study|Adverse Event|12|||
30683914|NCT00437125|58697944|FG000|Overall Study|Death|1|||
30683915|NCT00437125|58697944|FG000|Overall Study|Clinical Relapse|1|||
30683916|NCT00437125|58697944|FG000|Overall Study|Lack of Efficacy|1|||
30683917|NCT00437125|58697944|FG000|Overall Study|Lost to Follow-up|1|||
30683918|NCT00437125|58697944|FG000|Overall Study|Withdrawal by Subject|13|||
30683919|NCT00437125|58697944|FG000|Overall Study|Withdrawal by Caregiver|2|||
30959159|NCT01687595|59024535|FG000|Overall Study|Lost to Follow-up|3|||
30959160|NCT01687595|59024536|FG001|Overall Study|Lost to Follow-up|1|||
30959161|NCT01687595|59024535|FG000|Overall Study|Investigator's decision|1|||
30959162|NCT01687595|59024536|FG001|Overall Study|Investigator's decision|0|||
30597251|NCT01326026|58608961|FG001|Overall Study|Withdrawal Criteria|7|||
30597252|NCT01326026|58608960|FG000|Overall Study|Other|3|||
30597253|NCT01326026|58608961|FG001|Overall Study|Other|3|||
30597254|NCT01097629|58608970|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
30597255|NCT01097629|58608971|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
30597256|NCT01097629|58608972|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
30597257|NCT01097629|58608973|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
30597258|NCT01097629|58608974|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
30597259|NCT01097629|58608975|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
30597260|NCT01097629|58608976|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
30597261|NCT01097629|58608977|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
30597262|NCT01097629|58608970|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
30597263|NCT01097629|58608971|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
30597264|NCT01097629|58608972|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
30597265|NCT01097629|58608973|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
30683920|NCT00437125|58697944|FG000|Overall Study|Physician Decision|1|||
30683921|NCT00582309|58697960|FG000|Overall Study|Protocol Violation|0|||
30683922|NCT00582309|58697961|FG001|Overall Study|Protocol Violation|0|||
30683923|NCT00582309|58697962|FG002|Overall Study|Protocol Violation|2|||
30683924|NCT00443053|58697972|FG000|Overall Study|Adverse Event|2|||
30683925|NCT00443053|58697973|FG001|Overall Study|Adverse Event|1|||
30783685|NCT04493684|58795886|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30783686|NCT04493684|58795887|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30783687|NCT04493684|58795888|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30783688|NCT04493684|58795889|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30783689|NCT04493684|58795890|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30783690|NCT04493684|58795891|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30783691|NCT04493684|58795892|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30783692|NCT04493684|58795893|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
30783693|NCT04493684|58795877|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
30783694|NCT04493684|58795878|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30683926|NCT00443053|58697972|FG000|Overall Study|Withdrawal by Subject|9|||
30683927|NCT00443053|58697973|FG001|Overall Study|Withdrawal by Subject|18|||
30683928|NCT00443053|58697972|FG000|Overall Study|Lost to Follow-up|4|||
30683929|NCT00443053|58697973|FG001|Overall Study|Lost to Follow-up|5|||
30683930|NCT00443053|58697972|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
30683931|NCT00443053|58697973|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
30683932|NCT00443053|58697972|FG000|Overall Study|Noncompliance|2|||
30683933|NCT00443053|58697973|FG001|Overall Study|Noncompliance|1|||
30683934|NCT00443053|58697972|FG000|Overall Study|Other|3|||
30683935|NCT00443053|58697973|FG001|Overall Study|Other|4|||
30783695|NCT04493684|58795879|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783696|NCT04493684|58795880|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783697|NCT04493684|58795881|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783698|NCT04493684|58795882|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783699|NCT04493684|58795883|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783700|NCT04493684|58795884|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783701|NCT04493684|58795885|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783702|NCT04493684|58795886|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783703|NCT04493684|58795887|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783704|NCT04493684|58795888|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783705|NCT04493684|58795889|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783706|NCT04493684|58795890|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783707|NCT04493684|58795891|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783708|NCT04493684|58795892|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783709|NCT04493684|58795893|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
30783710|NCT04493684|58795877|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783711|NCT04493684|58795878|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30959163|NCT01687595|59024535|FG000|Overall Study|Sponsor's decision|1|||
30959164|NCT01687595|59024536|FG001|Overall Study|Sponsor's decision|0|||
30959165|NCT01687595|59024535|FG000|Overall Study|Noncompliance|1|||
30597266|NCT01097629|58608974|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
30597267|NCT01097629|58608975|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
30683936|NCT00443053|58697972|FG000|Overall Study|Physician Decision|0|||
30683937|NCT00443053|58697973|FG001|Overall Study|Physician Decision|4|||
30683938|NCT00720798|58697979|FG000|Overall Study|Adverse Event|304|||
30683939|NCT00720798|58697979|FG000|Overall Study|Death|39|||
30683940|NCT00720798|58697979|FG000|Overall Study|Insufficient Therapeutic Response|129|||
30683941|NCT00720798|58697979|FG000|Overall Study|Protocol Violation|4|||
30683942|NCT00720798|58697979|FG000|Overall Study|Refused Treatment|151|||
30683943|NCT00720798|58697979|FG000|Overall Study|Failure to Return|46|||
30683944|NCT00720798|58697979|FG000|Overall Study|Reason not Specified|83|||
30683945|NCT00756002|58697989|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
30683946|NCT00756002|58697990|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
30683947|NCT00756002|58697989|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
30683948|NCT00756002|58697990|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
30683949|NCT00756002|58697989|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
30683950|NCT00756002|58697990|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
30683951|NCT00756002|58697989|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
30683952|NCT00756002|58697990|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
30783712|NCT04493684|58795879|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783713|NCT04493684|58795880|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783714|NCT04493684|58795881|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30959166|NCT01687595|59024536|FG001|Overall Study|Noncompliance|2|||
30959167|NCT01687595|59024535|FG000|Overall Study|Other than specified|56|||
30959168|NCT01687595|59024536|FG001|Overall Study|Other than specified|7|||
30959169|NCT01687283|59024544|FG000|Overall Study|Adverse Event|11|||
30959170|NCT01687283|59024545|FG001|Overall Study|Adverse Event|4|||
30959171|NCT01687283|59024544|FG000|Overall Study|Lack of Efficacy|3|||
30959172|NCT01687283|59024545|FG001|Overall Study|Lack of Efficacy|1|||
30959173|NCT01687283|59024544|FG000|Overall Study|Protocol Violation|1|||
30959174|NCT01687283|59024545|FG001|Overall Study|Protocol Violation|3|||
30959175|NCT01687283|59024544|FG000|Overall Study|protocol defined stopping criteria|8|||
30959176|NCT01687283|59024545|FG001|Overall Study|protocol defined stopping criteria|10|||
30959177|NCT01687283|59024544|FG000|Overall Study|Lost to Follow-up|1|||
30959178|NCT01687283|59024545|FG001|Overall Study|Lost to Follow-up|1|||
30959179|NCT01687283|59024544|FG000|Overall Study|Investigator discretion|2|||
30959180|NCT01687283|59024545|FG001|Overall Study|Investigator discretion|0|||
30959181|NCT01687283|59024544|FG000|Overall Study|Withdrawal by Subject|9|||
30959182|NCT01687283|59024545|FG001|Overall Study|Withdrawal by Subject|8|||
30959183|NCT02684370|59024554|FG000|Part A|Adverse Event|2|||
30597268|NCT01097629|58608976|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
30597269|NCT01097629|58608977|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
30597270|NCT01097629|58608970|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
30783715|NCT04493684|58795882|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783716|NCT04493684|58795883|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
30783717|NCT04493684|58795884|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783718|NCT04493684|58795885|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783719|NCT04493684|58795886|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783720|NCT04493684|58795887|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783721|NCT04493684|58795888|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30959184|NCT02684370|59024555|FG001|Part A|Adverse Event|0|||
30597271|NCT01097629|58608971|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
30597272|NCT01097629|58608972|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
30597273|NCT01097629|58608973|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
30597274|NCT01097629|58608974|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
30597275|NCT01097629|58608975|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
30597276|NCT01097629|58608976|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
30597277|NCT01097629|58608977|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
30597278|NCT01097629|58608970|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
30597279|NCT01097629|58608971|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
30597280|NCT01097629|58608972|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
30597281|NCT01097629|58608973|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
30597282|NCT01097629|58608974|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
30597283|NCT01097629|58608975|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
30597284|NCT01097629|58608976|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
30597285|NCT01097629|58608977|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
30597286|NCT01097629|58608970|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
30597287|NCT01097629|58608971|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
30597288|NCT01097629|58608972|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
30683953|NCT00756002|58697989|FG000|Double-Blind Treatment Period|Other|2|||
30683954|NCT00756002|58697990|FG001|Double-Blind Treatment Period|Other|2|||
30959185|NCT02684370|59024556|FG002|Part A|Adverse Event|1|||
30959186|NCT02684370|59024557|FG003|Part A|Adverse Event|0|||
30959187|NCT02684370|59024558|FG004|Part A|Adverse Event|0|||
30959188|NCT02684370|59024559|FG005|Part A|Adverse Event|0|||
30959189|NCT02684370|59024554|FG000|Part A|Lost to Follow-up|1|||
30959190|NCT02684370|59024555|FG001|Part A|Lost to Follow-up|1|||
30959191|NCT02684370|59024556|FG002|Part A|Lost to Follow-up|0|||
30959192|NCT02684370|59024557|FG003|Part A|Lost to Follow-up|0|||
30959193|NCT02684370|59024558|FG004|Part A|Lost to Follow-up|0|||
30959194|NCT02684370|59024559|FG005|Part A|Lost to Follow-up|0|||
30959195|NCT02684370|59024554|FG000|Part A|Subject Withdrawal|1|||
30959196|NCT02684370|59024555|FG001|Part A|Subject Withdrawal|0|||
30959197|NCT02684370|59024556|FG002|Part A|Subject Withdrawal|3|||
30959198|NCT02684370|59024557|FG003|Part A|Subject Withdrawal|0|||
30597289|NCT01097629|58608973|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
30683955|NCT00717366|58697998|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
30683956|NCT00717366|58697999|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
30683957|NCT00717366|58697998|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
30683958|NCT00717366|58697999|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
30683959|NCT00717366|58697998|FG000|Core Study Period (20 Weeks)|Death|0|||
30683960|NCT00717366|58697999|FG001|Core Study Period (20 Weeks)|Death|1|||
30683961|NCT00717366|58697998|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
30683962|NCT00717366|58697999|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
30683963|NCT00717366|58697998|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
30683964|NCT00717366|58697999|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
30597290|NCT01097629|58608974|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
30597291|NCT01097629|58608975|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
30597292|NCT01097629|58608976|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
30597293|NCT01097629|58608977|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
30597294|NCT01097629|58608970|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
30597295|NCT01097629|58608971|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
30683965|NCT00717366|58697998|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
30683966|NCT00717366|58697999|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
30683967|NCT00717366|58697998|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
30683968|NCT00717366|58697999|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
30683969|NCT00723606|58698018|FG000|Overall Study|Adverse Event|2|||
30597296|NCT01097629|58608972|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30597297|NCT01097629|58608973|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30597298|NCT01097629|58608974|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30597299|NCT01097629|58608975|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30597300|NCT01097629|58608976|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30597301|NCT01097629|58608977|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
30597302|NCT01097629|58608970|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
30597303|NCT01097629|58608971|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
30597304|NCT01097629|58608972|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
30597305|NCT01097629|58608973|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30597306|NCT01097629|58608974|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30597307|NCT01097629|58608975|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30597308|NCT01097629|58608976|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30683970|NCT00723606|58698019|FG001|Overall Study|Adverse Event|5|||
30683971|NCT00723606|58698018|FG000|Overall Study|Other|2|||
30683972|NCT00723606|58698019|FG001|Overall Study|Other|0|||
30683973|NCT00723606|58698018|FG000|Overall Study|Withdrawal by Subject|0|||
30683974|NCT00723606|58698019|FG001|Overall Study|Withdrawal by Subject|2|||
30683975|NCT00442351|58698027|FG000|Overall Study|Administrative|6|||
30683976|NCT00442351|58698028|FG001|Overall Study|Administrative|5|||
30683977|NCT00442351|58698027|FG000|Overall Study|Did not meet protocol eligibility|1|||
30683978|NCT00442351|58698028|FG001|Overall Study|Did not meet protocol eligibility|0|||
30683979|NCT00442351|58698027|FG000|Overall Study|Other|0|||
30683980|NCT00442351|58698028|FG001|Overall Study|Other|1|||
30683981|NCT00436501|58698036|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
30683982|NCT00436501|58698037|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
30683983|NCT00436501|58698036|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
30683984|NCT00436501|58698037|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
30683985|NCT00755846|58698050|FG000|Overall Study|Adverse Event|0|||
30683986|NCT00755846|58698051|FG001|Overall Study|Adverse Event|0|||
30683987|NCT00755846|58698052|FG002|Overall Study|Adverse Event|0|||
30683988|NCT00755846|58698053|FG003|Overall Study|Adverse Event|1|||
30683989|NCT00755846|58698054|FG004|Overall Study|Adverse Event|3|||
30683990|NCT00755846|58698055|FG005|Overall Study|Adverse Event|2|||
30683991|NCT00755846|58698050|FG000|Overall Study|Protocol Violation|1|||
30783722|NCT04493684|58795889|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783723|NCT04493684|58795890|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30959199|NCT02684370|59024558|FG004|Part A|Subject Withdrawal|0|||
30959200|NCT02684370|59024559|FG005|Part A|Subject Withdrawal|0|||
30959201|NCT02684370|59024554|FG000|Part A|Other|0|||
30959202|NCT02684370|59024555|FG001|Part A|Other|0|||
30959203|NCT02684370|59024556|FG002|Part A|Other|1|||
30959204|NCT02684370|59024557|FG003|Part A|Other|0|||
30683992|NCT00755846|58698051|FG001|Overall Study|Protocol Violation|1|||
30683993|NCT00755846|58698052|FG002|Overall Study|Protocol Violation|1|||
30683994|NCT00755846|58698053|FG003|Overall Study|Protocol Violation|1|||
30683995|NCT00755846|58698054|FG004|Overall Study|Protocol Violation|1|||
30683996|NCT00755846|58698055|FG005|Overall Study|Protocol Violation|1|||
30683997|NCT00755846|58698050|FG000|Overall Study|Lost to Follow-up|0|||
30683998|NCT00755846|58698051|FG001|Overall Study|Lost to Follow-up|2|||
30683999|NCT00755846|58698052|FG002|Overall Study|Lost to Follow-up|1|||
30684000|NCT00755846|58698053|FG003|Overall Study|Lost to Follow-up|0|||
30684001|NCT00755846|58698054|FG004|Overall Study|Lost to Follow-up|4|||
30684002|NCT00755846|58698055|FG005|Overall Study|Lost to Follow-up|2|||
30684003|NCT00755846|58698050|FG000|Overall Study|Withdrawal by Subject|2|||
30684004|NCT00755846|58698051|FG001|Overall Study|Withdrawal by Subject|3|||
30684005|NCT00755846|58698052|FG002|Overall Study|Withdrawal by Subject|5|||
30684006|NCT00755846|58698053|FG003|Overall Study|Withdrawal by Subject|2|||
30684007|NCT00755846|58698054|FG004|Overall Study|Withdrawal by Subject|0|||
30684008|NCT00755846|58698055|FG005|Overall Study|Withdrawal by Subject|1|||
30684009|NCT00755846|58698050|FG000|Overall Study|Hyperglycemic Rescue|21|||
30684010|NCT00755846|58698051|FG001|Overall Study|Hyperglycemic Rescue|7|||
30684011|NCT00755846|58698052|FG002|Overall Study|Hyperglycemic Rescue|5|||
30684012|NCT00755846|58698053|FG003|Overall Study|Hyperglycemic Rescue|8|||
30684013|NCT00755846|58698054|FG004|Overall Study|Hyperglycemic Rescue|8|||
30684014|NCT00755846|58698055|FG005|Overall Study|Hyperglycemic Rescue|7|||
30684015|NCT00755846|58698050|FG000|Overall Study|Physician Decision|1|||
30684016|NCT00755846|58698051|FG001|Overall Study|Physician Decision|3|||
30684017|NCT00755846|58698052|FG002|Overall Study|Physician Decision|0|||
30684018|NCT00755846|58698053|FG003|Overall Study|Physician Decision|1|||
30684019|NCT00755846|58698054|FG004|Overall Study|Physician Decision|0|||
30783724|NCT04493684|58795891|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783725|NCT04493684|58795892|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783726|NCT04493684|58795893|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
30783727|NCT04493684|58795877|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
30783728|NCT04493684|58795878|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783729|NCT04493684|58795879|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783730|NCT04493684|58795880|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783731|NCT04493684|58795881|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783732|NCT04493684|58795882|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783733|NCT04493684|58795883|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783734|NCT04493684|58795884|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783735|NCT04493684|58795885|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783736|NCT04493684|58795886|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783737|NCT04493684|58795887|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783738|NCT04493684|58795888|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783739|NCT04493684|58795889|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783740|NCT04493684|58795890|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783741|NCT04493684|58795891|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783742|NCT04493684|58795892|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30783743|NCT04493684|58795893|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
30684020|NCT00755846|58698055|FG005|Overall Study|Physician Decision|1|||
30783744|NCT04493684|58795877|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783745|NCT04493684|58795878|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783746|NCT04493684|58795879|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783747|NCT04493684|58795880|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783748|NCT04493684|58795881|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783749|NCT04493684|58795882|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
30783750|NCT04493684|58795883|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783751|NCT04493684|58795884|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783752|NCT04493684|58795885|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783753|NCT04493684|58795886|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783754|NCT04493684|58795887|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783755|NCT04493684|58795888|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783756|NCT04493684|58795889|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783757|NCT04493684|58795890|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783758|NCT04493684|58795891|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783759|NCT04493684|58795892|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30684021|NCT00755846|58698050|FG000|Overall Study|Administrative Error|0|||
30684022|NCT00755846|58698051|FG001|Overall Study|Administrative Error|1|||
30684023|NCT00755846|58698052|FG002|Overall Study|Administrative Error|0|||
30684024|NCT00755846|58698053|FG003|Overall Study|Administrative Error|0|||
30684025|NCT00755846|58698054|FG004|Overall Study|Administrative Error|0|||
30684026|NCT00755846|58698055|FG005|Overall Study|Administrative Error|0|||
30684027|NCT00755846|58698050|FG000|Overall Study|Participant Non-compliance|0|||
30684028|NCT00755846|58698051|FG001|Overall Study|Participant Non-compliance|0|||
30684029|NCT00755846|58698052|FG002|Overall Study|Participant Non-compliance|0|||
30684030|NCT00755846|58698053|FG003|Overall Study|Participant Non-compliance|0|||
30684031|NCT00755846|58698054|FG004|Overall Study|Participant Non-compliance|1|||
30684032|NCT00755846|58698055|FG005|Overall Study|Participant Non-compliance|0|||
30684033|NCT03850093|58698072|FG000|Overall Study|Withdrawal by Subject|1|||
30684034|NCT03850093|58698073|FG001|Overall Study|Withdrawal by Subject|0|||
30684035|NCT03850093|58698074|FG002|Overall Study|Withdrawal by Subject|2|||
30783760|NCT04493684|58795893|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
30783761|NCT04493684|58795877|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783762|NCT04493684|58795878|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783763|NCT04493684|58795879|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783764|NCT04493684|58795880|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783765|NCT04493684|58795881|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783766|NCT04493684|58795882|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783767|NCT04493684|58795883|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783768|NCT04493684|58795884|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783769|NCT04493684|58795885|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783770|NCT04493684|58795886|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783771|NCT04493684|58795887|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783772|NCT04493684|58795888|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
30783773|NCT04493684|58795889|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783774|NCT04493684|58795890|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783775|NCT04493684|58795891|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783776|NCT04493684|58795892|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783777|NCT04493684|58795893|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
30783778|NCT04493684|58795877|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783779|NCT04493684|58795878|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783780|NCT04493684|58795879|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783781|NCT04493684|58795880|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783782|NCT04493684|58795881|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783783|NCT04493684|58795882|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783784|NCT04493684|58795883|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783785|NCT04493684|58795884|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783786|NCT04493684|58795885|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783787|NCT04493684|58795886|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783788|NCT04493684|58795887|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783789|NCT04493684|58795888|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783790|NCT04493684|58795889|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783791|NCT04493684|58795890|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783792|NCT04493684|58795891|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783793|NCT04493684|58795892|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
30783794|NCT04493684|58795893|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
30783795|NCT04493684|58795877|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783796|NCT04493684|58795878|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783797|NCT04493684|58795879|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783798|NCT04493684|58795880|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783799|NCT04493684|58795881|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783800|NCT04493684|58795882|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30959205|NCT02684370|59024558|FG004|Part A|Other|0|||
30684036|NCT00442117|58698084|FG000|Overall Study|Adverse Event|3|||
30684037|NCT00442117|58698085|FG001|Overall Study|Adverse Event|2|||
30684038|NCT00442117|58698084|FG000|Overall Study|Lack of Efficacy|2|||
30684039|NCT00442117|58698085|FG001|Overall Study|Lack of Efficacy|6|||
30684040|NCT00442117|58698084|FG000|Overall Study|Lost to Follow-up|1|||
30684041|NCT00442117|58698085|FG001|Overall Study|Lost to Follow-up|2|||
30684042|NCT00442117|58698084|FG000|Overall Study|Withdrawal by Subject|2|||
30684043|NCT00442117|58698085|FG001|Overall Study|Withdrawal by Subject|2|||
30684044|NCT00442117|58698084|FG000|Overall Study|Major Deviation|25|||
30684045|NCT00442117|58698085|FG001|Overall Study|Major Deviation|20|||
30684046|NCT00442117|58698084|FG000|Overall Study|Non compliance with protocol|3|||
30684047|NCT00442117|58698085|FG001|Overall Study|Non compliance with protocol|5|||
30783801|NCT04493684|58795883|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30959206|NCT02684370|59024559|FG005|Part A|Other|0|||
30684048|NCT00442117|58698084|FG000|Overall Study|Met Withdrawal Criteria|2|||
30684049|NCT00442117|58698085|FG001|Overall Study|Met Withdrawal Criteria|1|||
30684050|NCT00752726|58698093|FG000|Overall Study|Lost to Follow-up|2|||
30684051|NCT00752726|58698094|FG001|Overall Study|Lost to Follow-up|1|||
30684052|NCT00752726|58698093|FG000|Overall Study|Adverse Event|3|||
30684053|NCT00752726|58698094|FG001|Overall Study|Adverse Event|0|||
30684054|NCT00752726|58698093|FG000|Overall Study|Withdrawal by Subject|5|||
30684055|NCT00752726|58698094|FG001|Overall Study|Withdrawal by Subject|10|||
30684056|NCT00752726|58698093|FG000|Overall Study|Other Reason|1|||
30684057|NCT00752726|58698094|FG001|Overall Study|Other Reason|2|||
30684058|NCT00755222|58698102|FG000|Overall Study|Withdrawal by Subject|4|||
30684059|NCT00755222|58698103|FG001|Overall Study|Withdrawal by Subject|2|||
30684060|NCT00755222|58698102|FG000|Overall Study|Adverse Event|2|||
30684061|NCT00755222|58698103|FG001|Overall Study|Adverse Event|0|||
30684062|NCT00755222|58698102|FG000|Overall Study|Protocol Violation|2|||
30684063|NCT00755222|58698103|FG001|Overall Study|Protocol Violation|0|||
30684064|NCT00441727|58698112|FG000|Overall Study|Protocol Violation|19|||
30684065|NCT00441727|58698113|FG001|Overall Study|Protocol Violation|28|||
30684066|NCT00441727|58698114|FG002|Overall Study|Protocol Violation|32|||
30684067|NCT00441727|58698112|FG000|Overall Study|Adverse Event|26|||
30684068|NCT00441727|58698113|FG001|Overall Study|Adverse Event|33|||
30684069|NCT00441727|58698114|FG002|Overall Study|Adverse Event|28|||
30684070|NCT00441727|58698112|FG000|Overall Study|Lack of Efficacy|7|||
30684071|NCT00441727|58698113|FG001|Overall Study|Lack of Efficacy|8|||
30684072|NCT00441727|58698114|FG002|Overall Study|Lack of Efficacy|48|||
30684073|NCT00441727|58698112|FG000|Overall Study|Withdrawal by Subject|40|||
30684074|NCT00441727|58698113|FG001|Overall Study|Withdrawal by Subject|34|||
30684075|NCT00441727|58698114|FG002|Overall Study|Withdrawal by Subject|47|||
30684076|NCT00441727|58698112|FG000|Overall Study|Lost to Follow-up|5|||
30684077|NCT00441727|58698113|FG001|Overall Study|Lost to Follow-up|6|||
30684078|NCT00441727|58698114|FG002|Overall Study|Lost to Follow-up|5|||
30684079|NCT00441727|58698112|FG000|Overall Study|Safety Reasons|3|||
30684080|NCT00441727|58698113|FG001|Overall Study|Safety Reasons|1|||
30684081|NCT00441727|58698114|FG002|Overall Study|Safety Reasons|3|||
30684082|NCT00441727|58698112|FG000|Overall Study|Various reason specified|6|||
30684083|NCT00441727|58698113|FG001|Overall Study|Various reason specified|8|||
30684084|NCT00441727|58698114|FG002|Overall Study|Various reason specified|5|||
30684085|NCT00770120|58698136|FG000|Overall Study|Progression|31|||
30684086|NCT00770120|58698136|FG000|Overall Study|Adverse Event|11|||
30684087|NCT00770120|58698136|FG000|Overall Study|Not Protocol Specified|11|||
30684088|NCT00770120|58698136|FG000|Overall Study|Death|3|||
30684089|NCT00770120|58698136|FG000|Overall Study|Withdrawal by Subject|2|||
30684090|NCT00770120|58698136|FG000|Overall Study|Ineligible|1|||
30684091|NCT00770120|58698136|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
30684092|NCT00770120|58698136|FG000|Overall Study|Reason under Review|1|||
30684093|NCT00436345|58698143|FG000|Overall Study|ICU resident beyond follow-up period|3|||
30684094|NCT00436345|58698144|FG001|Overall Study|ICU resident beyond follow-up period|0|||
30684095|NCT00769184|58698151|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
30684096|NCT00769184|58698152|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
30684097|NCT00769184|58698151|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
30684098|NCT00769184|58698152|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
30684099|NCT00769184|58698151|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
30684100|NCT00769184|58698152|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
30684101|NCT00768560|58698166|FG000|Intervention Set 1|Adverse Event|0|||
30684102|NCT00768560|58698167|FG001|Intervention Set 1|Adverse Event|1|||
30684103|NCT00768560|58698168|FG002|Intervention Set 1|Adverse Event|0|||
30684104|NCT00768560|58698169|FG003|Intervention Set 1|Adverse Event|0|||
30597309|NCT01097629|58608977|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
30597310|NCT01097629|58608970|FG000|DB RO Phase|Withdrawal by Subject|0|||
30597311|NCT01097629|58608971|FG001|DB RO Phase|Withdrawal by Subject|0|||
30597312|NCT01097629|58608972|FG002|DB RO Phase|Withdrawal by Subject|0|||
30597313|NCT01097629|58608973|FG003|DB RO Phase|Withdrawal by Subject|0|||
30597314|NCT01097629|58608974|FG004|DB RO Phase|Withdrawal by Subject|0|||
30597315|NCT01097629|58608975|FG005|DB RO Phase|Withdrawal by Subject|0|||
30597316|NCT01097629|58608976|FG006|DB RO Phase|Withdrawal by Subject|0|||
30684105|NCT00768560|58698170|FG004|Intervention Set 1|Adverse Event|0|||
30684106|NCT00768560|58698171|FG005|Intervention Set 1|Adverse Event|0|||
30684107|NCT00468559|58698181|FG000|Open-label Treatment Phase|Adverse Event|5|||
30684108|NCT00468559|58698182|FG001|Open-label Treatment Phase|Adverse Event|0|||
30684109|NCT00468559|58698183|FG002|Open-label Treatment Phase|Adverse Event|0|||
30684110|NCT00468559|58698181|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
30684111|NCT00468559|58698182|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
30684112|NCT00468559|58698183|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
30597317|NCT01097629|58608977|FG007|DB RO Phase|Withdrawal by Subject|1|||
30597318|NCT01097629|58608970|FG000|DB RO Phase|Protocol Violation|0|||
30684113|NCT00468559|58698181|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
30684114|NCT00468559|58698182|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
30597319|NCT01097629|58608971|FG001|DB RO Phase|Protocol Violation|0|||
30597320|NCT01097629|58608972|FG002|DB RO Phase|Protocol Violation|0|||
30597321|NCT01097629|58608973|FG003|DB RO Phase|Protocol Violation|1|||
30597322|NCT01097629|58608974|FG004|DB RO Phase|Protocol Violation|0|||
30597323|NCT01097629|58608975|FG005|DB RO Phase|Protocol Violation|1|||
30597324|NCT01097629|58608976|FG006|DB RO Phase|Protocol Violation|1|||
30597325|NCT01097629|58608977|FG007|DB RO Phase|Protocol Violation|0|||
30597326|NCT01097629|58608970|FG000|DB RO Phase|Lost to Follow-up|0|||
30597327|NCT01097629|58608971|FG001|DB RO Phase|Lost to Follow-up|0|||
30597328|NCT01097629|58608972|FG002|DB RO Phase|Lost to Follow-up|0|||
30597329|NCT01097629|58608973|FG003|DB RO Phase|Lost to Follow-up|0|||
30597330|NCT01097629|58608974|FG004|DB RO Phase|Lost to Follow-up|0|||
30597331|NCT01097629|58608975|FG005|DB RO Phase|Lost to Follow-up|0|||
30684115|NCT00468559|58698183|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
30684116|NCT00468559|58698181|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
30684117|NCT00468559|58698182|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
30684118|NCT00468559|58698183|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
30684119|NCT00468559|58698181|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
30684120|NCT00468559|58698182|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
30684121|NCT00468559|58698183|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
30684122|NCT00754442|58698193|FG000|Overall Study|Withdrawal by Subject|5|||
30684123|NCT00754442|58698194|FG001|Overall Study|Withdrawal by Subject|3|||
30684124|NCT00754052|58698203|FG000|Overall Study|Study terminated by Sponsor|5|||
30684125|NCT00754052|58698204|FG001|Overall Study|Study terminated by Sponsor|3|||
30684126|NCT00747812|58698212|FG000|Overall Study|Research Site Staff Relocation|5|||
30684127|NCT00747812|58698213|FG001|Overall Study|Research Site Staff Relocation|3|||
30684128|NCT02927067|58698221|FG000|Overall Study|Withdrawn Consent|20|||
30684129|NCT02927067|58698222|FG001|Overall Study|Withdrawn Consent|12|||
30684130|NCT02927067|58698221|FG000|Overall Study|Death|18|||
30684131|NCT02927067|58698222|FG001|Overall Study|Death|31|||
30684132|NCT02927067|58698221|FG000|Overall Study|Adverse Event|13|||
30684133|NCT02927067|58698222|FG001|Overall Study|Adverse Event|10|||
30684134|NCT02927067|58698221|FG000|Overall Study|Noncompliance|5|||
30684135|NCT02927067|58698222|FG001|Overall Study|Noncompliance|2|||
30684136|NCT02927067|58698221|FG000|Overall Study|Reason not Specified|4|||
30684137|NCT02927067|58698222|FG001|Overall Study|Reason not Specified|6|||
30684138|NCT01751685|58698232|FG000|6-mo Followup|Missed study visit|1|||
30684139|NCT01751685|58698233|FG001|6-mo Followup|Missed study visit|0|||
30684140|NCT01751685|58698232|FG000|6-mo Followup|Withdrawal by Subject|2|||
30684141|NCT01751685|58698233|FG001|6-mo Followup|Withdrawal by Subject|2|||
30684142|NCT01751685|58698232|FG000|6-mo Followup|Lost to Follow-up|0|||
30684143|NCT01751685|58698233|FG001|6-mo Followup|Lost to Follow-up|1|||
30684144|NCT01751685|58698232|FG000|12-mo Followup|Lost to Follow-up|5|||
30684145|NCT01751685|58698233|FG001|12-mo Followup|Lost to Follow-up|0|||
30684146|NCT00586508|58698241|FG000|Overall Study|Progressive disease|52|||
30684147|NCT00586508|58698242|FG001|Overall Study|Progressive disease|8|||
30597332|NCT01097629|58608976|FG006|DB RO Phase|Lost to Follow-up|2|||
30597333|NCT01097629|58608977|FG007|DB RO Phase|Lost to Follow-up|0|||
30684148|NCT00586508|58698241|FG000|Overall Study|Death|0|||
30684149|NCT00586508|58698242|FG001|Overall Study|Death|1|||
30684150|NCT00586508|58698241|FG000|Overall Study|Adverse Event|12|||
30684151|NCT00586508|58698242|FG001|Overall Study|Adverse Event|4|||
30684152|NCT00586508|58698241|FG000|Overall Study|Withdrawal by Subject|4|||
30684153|NCT00586508|58698242|FG001|Overall Study|Withdrawal by Subject|0|||
30684154|NCT00581919|58698248|FG000|Overall Study|Adverse Event|8|||
30684155|NCT00581919|58698248|FG000|Overall Study|Death|1|||
30783802|NCT04493684|58795884|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783803|NCT04493684|58795885|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783804|NCT04493684|58795886|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30597334|NCT01324622|58609002|FG000|Overall Study|Lost to Follow-up|7|||
30597335|NCT01324622|58609003|FG001|Overall Study|Lost to Follow-up|7|||
30597336|NCT01324622|58609002|FG000|Overall Study|Death|1|||
30597337|NCT01324622|58609003|FG001|Overall Study|Death|0|||
30597338|NCT01324622|58609002|FG000|Overall Study|Lack of Efficacy|1|||
30597339|NCT01324622|58609003|FG001|Overall Study|Lack of Efficacy|0|||
30597340|NCT01097005|58609010|FG000|Overall Study|Case Report Form not collected|18|||
30597341|NCT01097005|58609010|FG000|Overall Study|Subjects cannot visit the hospital|1|||
30597342|NCT01097005|58609010|FG000|Overall Study|Poor medication compliance|1|||
30597343|NCT01097005|58609010|FG000|Overall Study|No examination data available|244|||
30684156|NCT00581919|58698248|FG000|Overall Study|Disease Progression|10|||
30684157|NCT00581919|58698248|FG000|Overall Study|Physician Decision|1|||
30684158|NCT00581919|58698248|FG000|Overall Study|Other Complicating Disease|1|||
30684159|NCT00581919|58698248|FG000|Overall Study|Started Non-Protocol Therapy|2|||
30684160|NCT00581919|58698248|FG000|Overall Study|Withdrawal by Subject|1|||
30684161|NCT00723528|58698256|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
30684162|NCT00723528|58698257|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
30684163|NCT00723528|58698258|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
30684164|NCT00723528|58698259|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
30684165|NCT00723528|58698260|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
30684166|NCT00723528|58698261|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
30684167|NCT00723528|58698262|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
30684168|NCT00723528|58698256|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
30684169|NCT00723528|58698257|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
30684170|NCT00723528|58698258|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
30684171|NCT00723528|58698259|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
30684172|NCT00723528|58698260|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
30684173|NCT00723528|58698261|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
30684174|NCT00723528|58698262|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
30684175|NCT00723528|58698256|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
30684176|NCT00723528|58698257|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
30684177|NCT00723528|58698258|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
30684178|NCT00723528|58698259|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
30597344|NCT01097005|58609010|FG000|Overall Study|Deviation from exclusion criteria|37|||
30597345|NCT01097005|58609010|FG000|Overall Study|Adverse Event|14|||
30597346|NCT01097005|58609010|FG000|Overall Study|Discontinuance by complication|50|||
30597347|NCT01096849|58609019|FG000|Overall Study|Consent Withdrawn|1|||
30597348|NCT01096849|58609020|FG001|Overall Study|Consent Withdrawn|4|||
30597349|NCT01096849|58609021|FG002|Overall Study|Consent Withdrawn|2|||
30597350|NCT01096849|58609019|FG000|Overall Study|Lack of Efficacy|0|||
30597351|NCT01096849|58609020|FG001|Overall Study|Lack of Efficacy|2|||
30597352|NCT01096849|58609021|FG002|Overall Study|Lack of Efficacy|0|||
30597353|NCT01096849|58609019|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
30597354|NCT01096849|58609020|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
30597355|NCT01096849|58609021|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
30684179|NCT00723528|58698260|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
30684180|NCT00723528|58698261|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
30684181|NCT00723528|58698262|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
30684182|NCT00723528|58698256|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
30684183|NCT00723528|58698257|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
30684184|NCT00723528|58698258|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
30684185|NCT00723528|58698259|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
30684186|NCT00723528|58698260|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
30684187|NCT00723528|58698261|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
30684188|NCT00723528|58698262|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
30684189|NCT00723528|58698256|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
30684190|NCT00723528|58698257|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
30684191|NCT00723528|58698258|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
30684192|NCT00723528|58698259|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
30684193|NCT00723528|58698260|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
30684194|NCT00723528|58698261|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
30684195|NCT00723528|58698262|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
30684196|NCT00723528|58698256|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
30597356|NCT01096849|58609019|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
30597357|NCT01096849|58609020|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
30597358|NCT01096849|58609021|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
30597359|NCT01096849|58609019|FG000|Overall Study|Administrative Reasons|0|||
30597360|NCT01096849|58609020|FG001|Overall Study|Administrative Reasons|1|||
30597361|NCT01096849|58609021|FG002|Overall Study|Administrative Reasons|2|||
30597362|NCT01096849|58609019|FG000|Overall Study|Lost to Follow-up|1|||
30597363|NCT01096849|58609020|FG001|Overall Study|Lost to Follow-up|3|||
30597364|NCT01096849|58609021|FG002|Overall Study|Lost to Follow-up|1|||
30597365|NCT01324388|58609032|FG000|Part 1 of Study|Adverse Event|2|||
30684197|NCT00723528|58698257|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
30684198|NCT00723528|58698258|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
30684199|NCT00723528|58698259|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
30684200|NCT00723528|58698260|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
30684201|NCT00723528|58698261|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
30684202|NCT00723528|58698262|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
30684203|NCT00723528|58698256|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
30684204|NCT00723528|58698257|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
30597366|NCT01324388|58609033|FG001|Part 1 of Study|Adverse Event|0|||
30597367|NCT01324388|58609034|FG002|Part 1 of Study|Adverse Event|0|||
30597368|NCT01324388|58609035|FG003|Part 1 of Study|Adverse Event|0|||
30597369|NCT01324388|58609032|FG000|Part 1 of Study|Protocol Violation|1|||
30597370|NCT01324388|58609033|FG001|Part 1 of Study|Protocol Violation|2|||
30684205|NCT00723528|58698258|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
30684206|NCT00723528|58698259|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
30684207|NCT00723528|58698260|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
30684208|NCT00723528|58698261|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
30684209|NCT00723528|58698262|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
30684210|NCT00723528|58698256|FG000|Period 2: After Controlled Period|Other|0|||
30684211|NCT00723528|58698257|FG001|Period 2: After Controlled Period|Other|0|||
30684212|NCT00723528|58698258|FG002|Period 2: After Controlled Period|Other|0|||
30684213|NCT00723528|58698259|FG003|Period 2: After Controlled Period|Other|0|||
30684214|NCT00723528|58698260|FG004|Period 2: After Controlled Period|Other|1|||
30684215|NCT00723528|58698261|FG005|Period 2: After Controlled Period|Other|4|||
30684216|NCT00723528|58698262|FG006|Period 2: After Controlled Period|Other|0|||
30684217|NCT00723528|58698256|FG000|Period 2: After Controlled Period|Adverse Event|0|||
30684218|NCT00723528|58698257|FG001|Period 2: After Controlled Period|Adverse Event|0|||
30684219|NCT00723528|58698258|FG002|Period 2: After Controlled Period|Adverse Event|0|||
30684220|NCT00723528|58698259|FG003|Period 2: After Controlled Period|Adverse Event|0|||
30684221|NCT00723528|58698260|FG004|Period 2: After Controlled Period|Adverse Event|1|||
30684222|NCT00723528|58698261|FG005|Period 2: After Controlled Period|Adverse Event|0|||
30684223|NCT00723528|58698262|FG006|Period 2: After Controlled Period|Adverse Event|1|||
30684224|NCT00723528|58698256|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
30684225|NCT00723528|58698257|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
30684226|NCT00723528|58698258|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
30684227|NCT00723528|58698259|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
30684228|NCT00723528|58698260|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
30684229|NCT00723528|58698261|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
30684230|NCT00723528|58698262|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
30684231|NCT00723528|58698256|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
30684232|NCT00723528|58698257|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
30684233|NCT00723528|58698258|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
30684234|NCT00723528|58698259|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
30684235|NCT00723528|58698260|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
30684236|NCT00723528|58698261|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
30684237|NCT00723528|58698262|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
30684238|NCT00751790|58698278|FG000|Overall Study|Lost to Follow-up|1|||
30684239|NCT00751790|58698278|FG000|Overall Study|Death|3|||
30684240|NCT00751790|58698278|FG000|Overall Study|Withdrawal by Subject|1|||
30684241|NCT00723450|58698284|FG000|Open-Label Phase|Adverse Event|26|||
30684242|NCT00723450|58698285|FG001|Open-Label Phase|Adverse Event|0|||
30684243|NCT00723450|58698286|FG002|Open-Label Phase|Adverse Event|0|||
30684244|NCT00723450|58698284|FG000|Open-Label Phase|Lack of Efficacy|18|||
30684245|NCT00723450|58698285|FG001|Open-Label Phase|Lack of Efficacy|0|||
30684246|NCT00723450|58698286|FG002|Open-Label Phase|Lack of Efficacy|0|||
30684247|NCT00723450|58698284|FG000|Open-Label Phase|Protocol Violation|35|||
30684248|NCT00723450|58698285|FG001|Open-Label Phase|Protocol Violation|0|||
30684249|NCT00723450|58698286|FG002|Open-Label Phase|Protocol Violation|0|||
30684250|NCT00723450|58698284|FG000|Open-Label Phase|Lost to Follow-up|7|||
30684251|NCT00723450|58698285|FG001|Open-Label Phase|Lost to Follow-up|0|||
30684252|NCT00723450|58698286|FG002|Open-Label Phase|Lost to Follow-up|0|||
30684253|NCT00723450|58698284|FG000|Open-Label Phase|Physician Decision|2|||
30684254|NCT00723450|58698285|FG001|Open-Label Phase|Physician Decision|0|||
30684255|NCT00723450|58698286|FG002|Open-Label Phase|Physician Decision|0|||
30684256|NCT00723450|58698284|FG000|Open-Label Phase|Withdrawal by Subject|37|||
30684257|NCT00723450|58698285|FG001|Open-Label Phase|Withdrawal by Subject|0|||
30684258|NCT00723450|58698286|FG002|Open-Label Phase|Withdrawal by Subject|0|||
30684259|NCT00723450|58698284|FG000|Randomized Phase|Adverse Event|0|||
30684260|NCT00723450|58698285|FG001|Randomized Phase|Adverse Event|26|||
30684261|NCT00723450|58698286|FG002|Randomized Phase|Adverse Event|17|||
30684262|NCT00723450|58698284|FG000|Randomized Phase|Lack of Efficacy|0|||
30684263|NCT00723450|58698285|FG001|Randomized Phase|Lack of Efficacy|11|||
30597371|NCT01324388|58609034|FG002|Part 1 of Study|Protocol Violation|0|||
30597372|NCT01324388|58609035|FG003|Part 1 of Study|Protocol Violation|0|||
30597373|NCT01324388|58609032|FG000|Part 1 of Study|Physician Decision|1|||
30597374|NCT01324388|58609033|FG001|Part 1 of Study|Physician Decision|0|||
30597375|NCT01324388|58609034|FG002|Part 1 of Study|Physician Decision|0|||
30597376|NCT01324388|58609035|FG003|Part 1 of Study|Physician Decision|0|||
30597377|NCT01324388|58609032|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
30856197|NCT03296527|58884066|FG000|Overall Study|Participant withdrew consent|3|||
30597378|NCT01324388|58609033|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
30684264|NCT00723450|58698286|FG002|Randomized Phase|Lack of Efficacy|11|||
30856198|NCT03296527|58884067|FG001|Overall Study|Participant withdrew consent|1|||
30597379|NCT01324388|58609034|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
30597380|NCT01324388|58609035|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
30597381|NCT01324388|58609032|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
30597382|NCT01324388|58609033|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
30597383|NCT01324388|58609034|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
30597384|NCT01324388|58609035|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
30597385|NCT01102777|58609049|FG000|Overall Study|Death|2|||
30597386|NCT01102777|58609050|FG001|Overall Study|Death|6|||
30684265|NCT00723450|58698284|FG000|Randomized Phase|Protocol Violation|0|||
30684266|NCT00723450|58698285|FG001|Randomized Phase|Protocol Violation|9|||
30684267|NCT00723450|58698286|FG002|Randomized Phase|Protocol Violation|13|||
30684268|NCT00723450|58698284|FG000|Randomized Phase|Lost to Follow-up|0|||
30684269|NCT00723450|58698285|FG001|Randomized Phase|Lost to Follow-up|2|||
30684270|NCT00723450|58698286|FG002|Randomized Phase|Lost to Follow-up|3|||
30684271|NCT00723450|58698284|FG000|Randomized Phase|Physician Decision|0|||
30684272|NCT00723450|58698285|FG001|Randomized Phase|Physician Decision|3|||
30684273|NCT00723450|58698286|FG002|Randomized Phase|Physician Decision|1|||
30684274|NCT00723450|58698284|FG000|Randomized Phase|Withdrawal by Subject|0|||
30684275|NCT00723450|58698285|FG001|Randomized Phase|Withdrawal by Subject|14|||
30684276|NCT00723450|58698286|FG002|Randomized Phase|Withdrawal by Subject|22|||
30684277|NCT00751400|58698295|FG000|Overall Study|Lost to Follow-up|10|||
30684278|NCT00585312|58698301|FG000|Overall Study|Adverse Event|3|||
30684279|NCT00585312|58698302|FG001|Overall Study|Adverse Event|0|||
30684280|NCT00585312|58698301|FG000|Overall Study|Lack of Efficacy|6|||
30684281|NCT00585312|58698302|FG001|Overall Study|Lack of Efficacy|11|||
30684282|NCT00585312|58698301|FG000|Overall Study|Lost to Follow-up|1|||
30684283|NCT00585312|58698302|FG001|Overall Study|Lost to Follow-up|1|||
30684284|NCT00585312|58698301|FG000|Overall Study|Reason not specified|2|||
30684285|NCT00585312|58698302|FG001|Overall Study|Reason not specified|0|||
30684286|NCT00585312|58698301|FG000|Overall Study|Withdrawal by Subject|5|||
30684287|NCT00585312|58698302|FG001|Overall Study|Withdrawal by Subject|1|||
30684288|NCT00585312|58698301|FG000|Overall Study|Study terminated by the sponsor|34|||
30684289|NCT00585312|58698302|FG001|Overall Study|Study terminated by the sponsor|31|||
30684290|NCT00753506|58698310|FG000|Overall Study|Withdrawal by Subject|4|||
30684291|NCT00753506|58698311|FG001|Overall Study|Withdrawal by Subject|1|||
30684292|NCT00753506|58698310|FG000|Overall Study|Lost to Follow-up|2|||
30684293|NCT00753506|58698311|FG001|Overall Study|Lost to Follow-up|0|||
30684294|NCT00753506|58698310|FG000|Overall Study|Other reason|1|||
30684295|NCT00753506|58698311|FG001|Overall Study|Other reason|1|||
30684296|NCT00720096|58698319|FG000|Overall Study|Withdrawal by Subject|0|||
30684297|NCT00720096|58698320|FG001|Overall Study|Withdrawal by Subject|2|||
30684298|NCT00723294|58698326|FG000|Overall Study|Lobular histology|2|||
30684299|NCT00723294|58698326|FG000|Overall Study|>25% intraductal component|1|||
30684300|NCT00723294|58698326|FG000|Overall Study|No MRI tumor enhancement|1|||
30597387|NCT01102777|58609049|FG000|Overall Study|Lost to Follow-up|7|||
30597388|NCT01102777|58609050|FG001|Overall Study|Lost to Follow-up|10|||
30597389|NCT01324310|58609057|FG000|Overall Study|Adverse Event|1|||
30597390|NCT01324310|58609057|FG000|Overall Study|Disease Progression|1|||
30597391|NCT01102231|58609063|FG000|Overall Study|Protocol Violation|3|||
30597392|NCT01102231|58609063|FG000|Overall Study|Lack of Efficacy|2|||
30597393|NCT01102231|58609063|FG000|Overall Study|Death|2|||
30597394|NCT01102231|58609063|FG000|Overall Study|Adverse Event|3|||
30597395|NCT01102231|58609063|FG000|Overall Study|Withdrawal by Subject|1|||
30597396|NCT01102231|58609063|FG000|Overall Study|Did not received the treatment|4|||
30597397|NCT01094743|58609068|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
30597398|NCT01095835|58609076|FG000|Overall Study|Adverse Event|8|||
30597399|NCT01095835|58609077|FG001|Overall Study|Adverse Event|6|||
30597400|NCT01095835|58609078|FG002|Overall Study|Adverse Event|6|||
30684301|NCT00723294|58698326|FG000|Overall Study|1.0-Tesla MRI|1|||
30684302|NCT00723294|58698326|FG000|Overall Study|No cryoabalation|2|||
30684303|NCT00723294|58698326|FG000|Overall Study|Did not undergo surgery|1|||
30684304|NCT00723294|58698326|FG000|Overall Study|Treated prior to registration|1|||
30597401|NCT01095835|58609076|FG000|Overall Study|Lack of Efficacy|0|||
30597402|NCT01095835|58609077|FG001|Overall Study|Lack of Efficacy|1|||
30597403|NCT01095835|58609078|FG002|Overall Study|Lack of Efficacy|0|||
30597404|NCT01095835|58609076|FG000|Overall Study|Physician Decision|0|||
30597405|NCT01095835|58609077|FG001|Overall Study|Physician Decision|0|||
30684305|NCT00723294|58698326|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
30684306|NCT00723294|58698326|FG000|Overall Study|Benign lesion|1|||
30684307|NCT00723294|58698326|FG000|Overall Study|Withdrawal by Subject|1|||
30684308|NCT00723294|58698326|FG000|Overall Study|No treatment due to probe failure|1|||
30684309|NCT00747344|58698332|FG000|Controlled Period|Adverse Event|3|||
30684310|NCT00747344|58698333|FG001|Controlled Period|Adverse Event|0|||
30684311|NCT00747344|58698334|FG002|Controlled Period|Adverse Event|0|||
30684312|NCT00747344|58698335|FG003|Controlled Period|Adverse Event|0|||
30684313|NCT00747344|58698332|FG000|Controlled Period|Lack of Efficacy|2|||
30684314|NCT00747344|58698333|FG001|Controlled Period|Lack of Efficacy|1|||
30684315|NCT00747344|58698334|FG002|Controlled Period|Lack of Efficacy|0|||
30684316|NCT00747344|58698335|FG003|Controlled Period|Lack of Efficacy|0|||
30684317|NCT00747344|58698332|FG000|Controlled Period|Other|0|||
30684318|NCT00747344|58698333|FG001|Controlled Period|Other|3|||
30684319|NCT00747344|58698334|FG002|Controlled Period|Other|0|||
30684320|NCT00747344|58698335|FG003|Controlled Period|Other|0|||
30684321|NCT00747344|58698332|FG000|After Controlled Period|Adverse Event|0|||
30684322|NCT00747344|58698333|FG001|After Controlled Period|Adverse Event|0|||
30684323|NCT00747344|58698334|FG002|After Controlled Period|Adverse Event|0|||
30684324|NCT00747344|58698335|FG003|After Controlled Period|Adverse Event|1|||
30684325|NCT00580983|58698343|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
30684326|NCT00753896|58698347|FG000|Overall Study|Adverse Event|4|||
30684327|NCT00753896|58698347|FG000|Overall Study|Death|1|||
30684328|NCT00753896|58698347|FG000|Overall Study|Lost to Follow-up|2|||
30684329|NCT00753896|58698347|FG000|Overall Study|Protocol Violation|1|||
30684330|NCT00753896|58698347|FG000|Overall Study|Withdrawal by Subject|4|||
30684331|NCT00753896|58698347|FG000|Overall Study|Entry Criteria Not Met|4|||
30684332|NCT00716976|58698353|FG000|Overall Study|Adverse Event|2|||
30684333|NCT00716976|58698354|FG001|Overall Study|Adverse Event|0|||
30684334|NCT00716976|58698353|FG000|Overall Study|Death|1|||
30684335|NCT00716976|58698354|FG001|Overall Study|Death|0|||
30684336|NCT00716976|58698353|FG000|Overall Study|Physician Decision|2|||
30684337|NCT00716976|58698354|FG001|Overall Study|Physician Decision|2|||
30684338|NCT00716976|58698353|FG000|Overall Study|Withdrawal by Subject|5|||
30684339|NCT00716976|58698354|FG001|Overall Study|Withdrawal by Subject|1|||
30684340|NCT00716976|58698353|FG000|Overall Study|Premature discontinuation cisplatin|5|||
30684341|NCT00716976|58698354|FG001|Overall Study|Premature discontinuation cisplatin|4|||
30684342|NCT00716976|58698353|FG000|Overall Study|Radiation during protocol|1|||
30684343|NCT00716976|58698354|FG001|Overall Study|Radiation during protocol|0|||
30684344|NCT00716976|58698353|FG000|Overall Study|Ineligibles|4|||
30684345|NCT00716976|58698354|FG001|Overall Study|Ineligibles|2|||
30597406|NCT01095835|58609078|FG002|Overall Study|Physician Decision|1|||
30597407|NCT01095835|58609076|FG000|Overall Study|Withdrawal by Subject|1|||
30597408|NCT01095835|58609077|FG001|Overall Study|Withdrawal by Subject|3|||
30684346|NCT00743444|58698362|FG000|First Intervention|Catheter placement problems|0|||
30684347|NCT00743444|58698363|FG001|First Intervention|Catheter placement problems|1|||
30684348|NCT00743444|58698362|FG000|Washout Period|Adverse Event|0|||
30684349|NCT00743444|58698363|FG001|Washout Period|Adverse Event|1|||
30684350|NCT00743366|58698369|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
30684351|NCT00743366|58698370|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
30684352|NCT00721968|58698378|FG000|Overall Study|Lost to Follow-up|2|||
30684353|NCT00721968|58698379|FG001|Overall Study|Lost to Follow-up|0|||
30684354|NCT00743288|58698385|FG000|Overall Study|Adverse Event|1|||
30684355|NCT00743288|58698386|FG001|Overall Study|Adverse Event|1|||
30684356|NCT00743288|58698387|FG002|Overall Study|Adverse Event|2|||
30684357|NCT00743288|58698388|FG003|Overall Study|Adverse Event|2|||
30684358|NCT00743288|58698389|FG004|Overall Study|Adverse Event|1|||
30684359|NCT00743288|58698390|FG005|Overall Study|Adverse Event|1|||
30684360|NCT00743288|58698391|FG006|Overall Study|Adverse Event|2|||
30684361|NCT00743288|58698385|FG000|Overall Study|Withdrawal by Subject|0|||
30684362|NCT00743288|58698386|FG001|Overall Study|Withdrawal by Subject|0|||
30684363|NCT00743288|58698387|FG002|Overall Study|Withdrawal by Subject|1|||
30783805|NCT04493684|58795887|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783806|NCT04493684|58795888|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783807|NCT04493684|58795889|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783808|NCT04493684|58795890|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30597409|NCT01095835|58609078|FG002|Overall Study|Withdrawal by Subject|0|||
30597410|NCT01095835|58609076|FG000|Overall Study|Non study compliance|0|||
30597411|NCT01095835|58609077|FG001|Overall Study|Non study compliance|0|||
30597412|NCT01095835|58609078|FG002|Overall Study|Non study compliance|1|||
30597413|NCT01095835|58609076|FG000|Overall Study|Protocol Violation|1|||
30684364|NCT00743288|58698388|FG003|Overall Study|Withdrawal by Subject|0|||
30684365|NCT00743288|58698389|FG004|Overall Study|Withdrawal by Subject|0|||
30684366|NCT00743288|58698390|FG005|Overall Study|Withdrawal by Subject|1|||
30684367|NCT00743288|58698391|FG006|Overall Study|Withdrawal by Subject|1|||
30684368|NCT00743288|58698385|FG000|Overall Study|Progressive disease (PD)|2|||
30684369|NCT00743288|58698386|FG001|Overall Study|Progressive disease (PD)|0|||
30959207|NCT02684370|59024554|FG000|Part B|Adverse Event|0|||
30684370|NCT00743288|58698387|FG002|Overall Study|Progressive disease (PD)|1|||
30684371|NCT00743288|58698388|FG003|Overall Study|Progressive disease (PD)|4|||
30684372|NCT00743288|58698389|FG004|Overall Study|Progressive disease (PD)|5|||
30597414|NCT01095835|58609077|FG001|Overall Study|Protocol Violation|2|||
30597415|NCT01095835|58609078|FG002|Overall Study|Protocol Violation|0|||
30684373|NCT00743288|58698390|FG005|Overall Study|Progressive disease (PD)|3|||
30684374|NCT00743288|58698391|FG006|Overall Study|Progressive disease (PD)|6|||
30684375|NCT00743288|58698385|FG000|Overall Study|Worsening of condition (Not PD)|0|||
30597416|NCT01324232|58609091|FG000|Overall Study|Protocol Violation|0|||
30597417|NCT01324232|58609092|FG001|Overall Study|Protocol Violation|0|||
30597418|NCT01324232|58609093|FG002|Overall Study|Protocol Violation|0|||
30597419|NCT01324232|58609094|FG003|Overall Study|Protocol Violation|2|||
30597420|NCT01324232|58609091|FG000|Overall Study|Missing|0|||
30597421|NCT01324232|58609092|FG001|Overall Study|Missing|0|||
30597422|NCT01324232|58609093|FG002|Overall Study|Missing|1|||
30684376|NCT00743288|58698386|FG001|Overall Study|Worsening of condition (Not PD)|2|||
30684377|NCT00743288|58698387|FG002|Overall Study|Worsening of condition (Not PD)|1|||
30684378|NCT00743288|58698388|FG003|Overall Study|Worsening of condition (Not PD)|1|||
30684379|NCT00743288|58698389|FG004|Overall Study|Worsening of condition (Not PD)|0|||
30684380|NCT00743288|58698390|FG005|Overall Study|Worsening of condition (Not PD)|0|||
30684381|NCT00743288|58698391|FG006|Overall Study|Worsening of condition (Not PD)|0|||
30684382|NCT00750308|58698402|FG000|First Treatment|Adverse Event|0|||
30684383|NCT00750308|58698403|FG001|First Treatment|Adverse Event|1|||
30684384|NCT00750308|58698404|FG002|First Treatment|Adverse Event|0|||
30684385|NCT00750308|58698405|FG003|First Treatment|Adverse Event|0|||
30684386|NCT00750308|58698406|FG004|First Treatment|Adverse Event|0|||
30684387|NCT00750308|58698407|FG005|First Treatment|Adverse Event|0|||
30684388|NCT00750308|58698408|FG006|First Treatment|Adverse Event|0|||
30684389|NCT00750308|58698409|FG007|First Treatment|Adverse Event|0|||
30684390|NCT00750308|58698410|FG008|First Treatment|Adverse Event|0|||
30684391|NCT00750308|58698411|FG009|First Treatment|Adverse Event|0|||
30684392|NCT00750308|58698412|FG010|First Treatment|Adverse Event|1|||
30684393|NCT00750308|58698413|FG011|First Treatment|Adverse Event|1|||
30684394|NCT00750308|58698402|FG000|First Treatment|Withdrawal by Subject|0|||
30684395|NCT00750308|58698403|FG001|First Treatment|Withdrawal by Subject|0|||
30684396|NCT00750308|58698404|FG002|First Treatment|Withdrawal by Subject|0|||
30783809|NCT04493684|58795891|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783810|NCT04493684|58795892|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
30783811|NCT04493684|58795893|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
30783812|NCT04289298|58795958|FG000|Overall Study|Lost to Follow-up|5|||
30783813|NCT04289298|58795959|FG001|Overall Study|Lost to Follow-up|0|||
30783814|NCT04289298|58795958|FG000|Overall Study|Withdrawal by Subject|2|||
30783815|NCT04289298|58795959|FG001|Overall Study|Withdrawal by Subject|0|||
30597423|NCT01324232|58609094|FG003|Overall Study|Missing|0|||
30597424|NCT01324232|58609091|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
30783816|NCT04116710|58795970|FG000|Overall Study|Death|4|||
30783817|NCT04116710|58795971|FG001|Overall Study|Death|6|||
30783818|NCT04116710|58795972|FG002|Overall Study|Death|3|||
30783819|NCT04116710|58795973|FG003|Overall Study|Death|1|||
30783820|NCT04116710|58795970|FG000|Overall Study|Withdrawal by Subject|0|||
30783821|NCT04116710|58795971|FG001|Overall Study|Withdrawal by Subject|0|||
30783822|NCT04116710|58795972|FG002|Overall Study|Withdrawal by Subject|0|||
30783823|NCT04116710|58795973|FG003|Overall Study|Withdrawal by Subject|1|||
30783824|NCT03476798|58796006|FG000|Overall Study|Death|1|||
30783825|NCT03476798|58796006|FG000|Overall Study|Withdrawal by Subject|2|||
30783826|NCT03476798|58796006|FG000|Overall Study|Protocol Violation|2|||
30783827|NCT02946515|58796016|FG000|Overall Study|Lost to Follow-up|2|||
30783828|NCT02946515|58796017|FG001|Overall Study|Lost to Follow-up|1|||
30783829|NCT02677896|58796029|FG000|Double Blind Period (up to 35 Months)|Death|113|||
30783830|NCT02677896|58796030|FG001|Double Blind Period (up to 35 Months)|Death|189|||
30783831|NCT02677896|58796029|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
30783832|NCT02677896|58796030|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
30783833|NCT02677896|58796029|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
30783834|NCT02677896|58796030|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
30597425|NCT01324232|58609092|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
30684397|NCT00750308|58698405|FG003|First Treatment|Withdrawal by Subject|1|||
30684398|NCT00750308|58698406|FG004|First Treatment|Withdrawal by Subject|0|||
30684399|NCT00750308|58698407|FG005|First Treatment|Withdrawal by Subject|0|||
30684400|NCT00750308|58698408|FG006|First Treatment|Withdrawal by Subject|0|||
30684401|NCT00750308|58698409|FG007|First Treatment|Withdrawal by Subject|1|||
30783835|NCT02677896|58796029|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
30783836|NCT02677896|58796030|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
30684402|NCT00750308|58698410|FG008|First Treatment|Withdrawal by Subject|0|||
30684403|NCT00750308|58698411|FG009|First Treatment|Withdrawal by Subject|0|||
30684404|NCT00750308|58698412|FG010|First Treatment|Withdrawal by Subject|0|||
30783837|NCT02677896|58796029|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
30783838|NCT02677896|58796030|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
30783839|NCT02677896|58796029|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
30783840|NCT02677896|58796030|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
30783841|NCT02677896|58796029|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
30597426|NCT01324232|58609093|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
30597427|NCT01324232|58609094|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
30597428|NCT01324232|58609091|FG000|Overall Study|Lack of Efficacy|2|||
30597429|NCT01324232|58609092|FG001|Overall Study|Lack of Efficacy|1|||
30783842|NCT02677896|58796030|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
30783843|NCT02677896|58796029|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
30856199|NCT03296527|58884066|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
30856200|NCT03296527|58884067|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
30856201|NCT03296527|58884066|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
30856202|NCT03296527|58884067|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
30856203|NCT03296527|58884066|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
30856204|NCT03296527|58884067|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
30856205|NCT03296527|58884066|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
30856206|NCT03296527|58884067|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
30856207|NCT03296527|58884066|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
30856208|NCT03296527|58884067|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
30856209|NCT03228680|58884076|FG000|Overall Study|Adverse Event|13|||
30856210|NCT03228680|58884077|FG001|Overall Study|Adverse Event|18|||
30856211|NCT03228680|58884076|FG000|Overall Study|Randomization failure|0|||
30856212|NCT03228680|58884077|FG001|Overall Study|Randomization failure|1|||
30856213|NCT03228680|58884076|FG000|Overall Study|Withdrawal by Subject|1|||
30856214|NCT03228680|58884077|FG001|Overall Study|Withdrawal by Subject|0|||
30856215|NCT03228680|58884076|FG000|Overall Study|Other|9|||
30856216|NCT03228680|58884077|FG001|Overall Study|Other|16|||
30856217|NCT03194542|58884088|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
30856218|NCT03194542|58884089|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
30856219|NCT03194542|58884090|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
30856220|NCT03194542|58884091|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
30856221|NCT03194542|58884088|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
30856222|NCT03194542|58884089|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
30856223|NCT03194542|58884090|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
30856224|NCT03194542|58884091|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
30597430|NCT01324232|58609093|FG002|Overall Study|Lack of Efficacy|2|||
30597431|NCT01324232|58609094|FG003|Overall Study|Lack of Efficacy|2|||
30597432|NCT01324232|58609091|FG000|Overall Study|Participant Refused Medication|0|||
30783844|NCT02677896|58796030|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
30783845|NCT02677896|58796029|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
30783846|NCT02677896|58796030|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
30783847|NCT02677896|58796029|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
30597433|NCT01324232|58609092|FG001|Overall Study|Participant Refused Medication|1|||
30597434|NCT01324232|58609093|FG002|Overall Study|Participant Refused Medication|0|||
30597435|NCT01324232|58609094|FG003|Overall Study|Participant Refused Medication|0|||
30597436|NCT01324232|58609091|FG000|Overall Study|Intercurrent illness|0|||
30597437|NCT01324232|58609092|FG001|Overall Study|Intercurrent illness|0|||
30597438|NCT01324232|58609093|FG002|Overall Study|Intercurrent illness|0|||
30597439|NCT01324232|58609094|FG003|Overall Study|Intercurrent illness|1|||
30597440|NCT01324232|58609091|FG000|Overall Study|Adverse Event|2|||
30597441|NCT01324232|58609092|FG001|Overall Study|Adverse Event|5|||
30597442|NCT01324232|58609093|FG002|Overall Study|Adverse Event|6|||
30597443|NCT01324232|58609094|FG003|Overall Study|Adverse Event|6|||
30597444|NCT01324232|58609091|FG000|Overall Study|Withdrawal by Subject|0|||
30597445|NCT01324232|58609092|FG001|Overall Study|Withdrawal by Subject|3|||
30684405|NCT00750308|58698413|FG011|First Treatment|Withdrawal by Subject|0|||
30684406|NCT00750308|58698402|FG000|Second Treatment|Adverse Event|0|||
30684407|NCT00750308|58698403|FG001|Second Treatment|Adverse Event|0|||
30684408|NCT00750308|58698404|FG002|Second Treatment|Adverse Event|0|||
30684409|NCT00750308|58698405|FG003|Second Treatment|Adverse Event|0|||
30684410|NCT00750308|58698406|FG004|Second Treatment|Adverse Event|0|||
30684411|NCT00750308|58698407|FG005|Second Treatment|Adverse Event|1|||
30783848|NCT02677896|58796030|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
30783849|NCT02677896|58796029|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
30783850|NCT02677896|58796030|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
30783851|NCT02677896|58796029|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
30783852|NCT02677896|58796030|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
30783853|NCT02677896|58796029|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
30783854|NCT02677896|58796030|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
30597446|NCT01324232|58609093|FG002|Overall Study|Withdrawal by Subject|4|||
30597447|NCT01324232|58609094|FG003|Overall Study|Withdrawal by Subject|0|||
30597448|NCT01324232|58609091|FG000|Overall Study|Lost to Follow-up|1|||
30597449|NCT01324232|58609092|FG001|Overall Study|Lost to Follow-up|0|||
30684412|NCT00750308|58698408|FG006|Second Treatment|Adverse Event|0|||
30597450|NCT01324232|58609093|FG002|Overall Study|Lost to Follow-up|0|||
30684413|NCT00750308|58698409|FG007|Second Treatment|Adverse Event|0|||
30684414|NCT00750308|58698410|FG008|Second Treatment|Adverse Event|1|||
30684415|NCT00750308|58698411|FG009|Second Treatment|Adverse Event|0|||
30684416|NCT00750308|58698412|FG010|Second Treatment|Adverse Event|0|||
30684417|NCT00750308|58698413|FG011|Second Treatment|Adverse Event|0|||
30684418|NCT00750308|58698402|FG000|Second Treatment|Withdrawal by Subject|0|||
30684419|NCT00750308|58698403|FG001|Second Treatment|Withdrawal by Subject|0|||
30684420|NCT00750308|58698404|FG002|Second Treatment|Withdrawal by Subject|0|||
30684421|NCT00750308|58698405|FG003|Second Treatment|Withdrawal by Subject|0|||
30684422|NCT00750308|58698406|FG004|Second Treatment|Withdrawal by Subject|1|||
30684423|NCT00750308|58698407|FG005|Second Treatment|Withdrawal by Subject|0|||
30684424|NCT00750308|58698408|FG006|Second Treatment|Withdrawal by Subject|0|||
30684425|NCT00750308|58698409|FG007|Second Treatment|Withdrawal by Subject|0|||
30684426|NCT00750308|58698410|FG008|Second Treatment|Withdrawal by Subject|0|||
30684427|NCT00750308|58698411|FG009|Second Treatment|Withdrawal by Subject|0|||
30684428|NCT00750308|58698412|FG010|Second Treatment|Withdrawal by Subject|0|||
30684429|NCT00750308|58698413|FG011|Second Treatment|Withdrawal by Subject|0|||
30684430|NCT00750308|58698402|FG000|Third Treatment|Withdrawal by Subject|0|||
30684431|NCT00750308|58698403|FG001|Third Treatment|Withdrawal by Subject|1|||
30684432|NCT00750308|58698404|FG002|Third Treatment|Withdrawal by Subject|0|||
30684433|NCT00750308|58698405|FG003|Third Treatment|Withdrawal by Subject|0|||
30684434|NCT00750308|58698406|FG004|Third Treatment|Withdrawal by Subject|0|||
30684435|NCT00750308|58698407|FG005|Third Treatment|Withdrawal by Subject|0|||
30684436|NCT00750308|58698408|FG006|Third Treatment|Withdrawal by Subject|0|||
30684437|NCT00750308|58698409|FG007|Third Treatment|Withdrawal by Subject|0|||
30684438|NCT00750308|58698410|FG008|Third Treatment|Withdrawal by Subject|0|||
30684439|NCT00750308|58698411|FG009|Third Treatment|Withdrawal by Subject|0|||
30684440|NCT00750308|58698412|FG010|Third Treatment|Withdrawal by Subject|0|||
30684441|NCT00750308|58698413|FG011|Third Treatment|Withdrawal by Subject|0|||
30684442|NCT00750152|58698429|FG000|Overall Study|Adverse Event|2|||
30684443|NCT00750152|58698430|FG001|Overall Study|Adverse Event|1|||
30684444|NCT00750152|58698429|FG000|Overall Study|Lost to Follow-up|8|||
30684445|NCT00750152|58698430|FG001|Overall Study|Lost to Follow-up|13|||
30684446|NCT00750152|58698429|FG000|Overall Study|Withdrawal by Subject|3|||
30684447|NCT00750152|58698430|FG001|Overall Study|Withdrawal by Subject|3|||
30684448|NCT00750152|58698429|FG000|Overall Study|Physician Decision|1|||
30684449|NCT00750152|58698430|FG001|Overall Study|Physician Decision|1|||
30684450|NCT00750152|58698429|FG000|Overall Study|Non-compliance|0|||
30684451|NCT00750152|58698430|FG001|Overall Study|Non-compliance|1|||
30597451|NCT01324232|58609094|FG003|Overall Study|Lost to Follow-up|0|||
30597452|NCT01094119|58609111|FG000|Overall Study|Lack of Efficacy|2|||
30597453|NCT01094119|58609112|FG001|Overall Study|Lack of Efficacy|4|||
30597454|NCT01323920|58609118|FG000|Overall Study|Death|5|||
30597455|NCT01323920|58609118|FG000|Overall Study|Withdrawal by Subject|1|||
30597456|NCT01093885|58609122|FG000|Overall Study|Adverse Event|4|||
30597457|NCT01093885|58609122|FG000|Overall Study|Lost to Follow-up|1|||
30597458|NCT01101997|58609127|FG000|Overall Study|Withdrawal by Subject|2|||
30597459|NCT01324830|58609157|FG000|Overall Study|Progressive Disease|3|||
30597460|NCT01324830|58609158|FG001|Overall Study|Progressive Disease|2|||
30597461|NCT01324830|58609159|FG002|Overall Study|Progressive Disease|3|||
30597462|NCT01324830|58609160|FG003|Overall Study|Progressive Disease|3|||
30597463|NCT01324830|58609161|FG004|Overall Study|Progressive Disease|6|||
30597464|NCT01324830|58609162|FG005|Overall Study|Progressive Disease|6|||
30597465|NCT01324830|58609163|FG006|Overall Study|Progressive Disease|3|||
30597466|NCT01324830|58609164|FG007|Overall Study|Progressive Disease|3|||
30597467|NCT01324830|58609165|FG008|Overall Study|Progressive Disease|3|||
30597468|NCT01324830|58609166|FG009|Overall Study|Progressive Disease|6|||
30597469|NCT01324830|58609167|FG010|Overall Study|Progressive Disease|2|||
30597470|NCT01324830|58609168|FG011|Overall Study|Progressive Disease|1|||
30597471|NCT01324830|58609169|FG012|Overall Study|Progressive Disease|1|||
30597472|NCT01324830|58609170|FG013|Overall Study|Progressive Disease|1|||
30597473|NCT01324830|58609171|FG014|Overall Study|Progressive Disease|1|||
30597474|NCT01324830|58609172|FG015|Overall Study|Progressive Disease|3|||
30684452|NCT00750152|58698429|FG000|Overall Study|Termination by sponsor|1|||
30597475|NCT01324830|58609173|FG016|Overall Study|Progressive Disease|2|||
30597476|NCT01324830|58609174|FG017|Overall Study|Progressive Disease|3|||
30684453|NCT00750152|58698430|FG001|Overall Study|Termination by sponsor|0|||
30684454|NCT00750152|58698429|FG000|Overall Study|Other|7|||
30684455|NCT00750152|58698430|FG001|Overall Study|Other|8|||
30597477|NCT01324830|58609175|FG018|Overall Study|Progressive Disease|4|||
30684456|NCT00749996|58698438|FG000|Overall Study|Lost to Follow-up|7|||
30684457|NCT00749996|58698439|FG001|Overall Study|Lost to Follow-up|4|||
30684458|NCT00749996|58698438|FG000|Overall Study|Withdrawal by Subject|5|||
30684459|NCT00749996|58698439|FG001|Overall Study|Withdrawal by Subject|4|||
30959208|NCT02684370|59024555|FG001|Part B|Adverse Event|0|||
30597478|NCT01324830|58609157|FG000|Overall Study|Dose limiting toxicity|0|||
30597479|NCT01324830|58609158|FG001|Overall Study|Dose limiting toxicity|0|||
30684460|NCT00749996|58698438|FG000|Overall Study|Protocol Violation|2|||
30684461|NCT00749996|58698439|FG001|Overall Study|Protocol Violation|3|||
30684462|NCT00749996|58698438|FG000|Overall Study|Physician Decision|2|||
30684463|NCT00749996|58698439|FG001|Overall Study|Physician Decision|0|||
30684464|NCT00749996|58698438|FG000|Overall Study|Pregnancy|0|||
30684465|NCT00749996|58698439|FG001|Overall Study|Pregnancy|2|||
30684466|NCT00749996|58698438|FG000|Overall Study|Adverse Event|1|||
30684467|NCT00749996|58698439|FG001|Overall Study|Adverse Event|0|||
30684468|NCT00749996|58698438|FG000|Overall Study|Death|1|||
30684469|NCT00749996|58698439|FG001|Overall Study|Death|0|||
30684470|NCT00749684|58698445|FG000|Overall Study|Death|1|||
30684471|NCT00749684|58698445|FG000|Overall Study|Adverse Event|27|||
30684472|NCT00749684|58698445|FG000|Overall Study|Participant's Wish|10|||
30684473|NCT00749684|58698445|FG000|Overall Study|Not Documented|1|||
30684474|NCT00749684|58698445|FG000|Overall Study|Progressive Desease|31|||
30684475|NCT00749684|58698445|FG000|Overall Study|Therapy according to protocol + AE|2|||
30684476|NCT00749684|58698445|FG000|Overall Study|AE+discontinuation on participants wish|1|||
30684477|NCT00749684|58698445|FG000|Overall Study|Missing|9|||
30684478|NCT00746798|58698453|FG000|Overall Study|Protocol Violation|0|||
30684479|NCT00746798|58698454|FG001|Overall Study|Protocol Violation|1|||
30684480|NCT00746798|58698455|FG002|Overall Study|Protocol Violation|0|||
30684481|NCT00746798|58698456|FG003|Overall Study|Protocol Violation|0|||
30684482|NCT00746798|58698453|FG000|Overall Study|Withdrawal by Subject|0|||
30684483|NCT00746798|58698454|FG001|Overall Study|Withdrawal by Subject|1|||
30684484|NCT00746798|58698455|FG002|Overall Study|Withdrawal by Subject|1|||
30684485|NCT00746798|58698456|FG003|Overall Study|Withdrawal by Subject|0|||
30684486|NCT00746798|58698453|FG000|Overall Study|Death|0|||
30684487|NCT00746798|58698454|FG001|Overall Study|Death|0|||
30684488|NCT00746798|58698455|FG002|Overall Study|Death|2|||
30684489|NCT00746798|58698456|FG003|Overall Study|Death|0|||
30684490|NCT00746798|58698453|FG000|Overall Study|Participant unable to return for visit|1|||
30684491|NCT00746798|58698454|FG001|Overall Study|Participant unable to return for visit|0|||
30684492|NCT00746798|58698455|FG002|Overall Study|Participant unable to return for visit|0|||
30684493|NCT00746798|58698456|FG003|Overall Study|Participant unable to return for visit|0|||
30684494|NCT00716274|58698469|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
30684495|NCT00716274|58698470|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
30684496|NCT00716274|58698471|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
30684497|NCT00716274|58698472|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
30684498|NCT00716274|58698473|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
30684499|NCT00716274|58698474|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
30684500|NCT00716274|58698469|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
30684501|NCT00716274|58698470|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
30684502|NCT00716274|58698471|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
30684503|NCT00716274|58698472|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
30684504|NCT00716274|58698473|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
30684505|NCT00716274|58698474|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
30684506|NCT00716274|58698469|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
30684507|NCT00716274|58698470|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
30684508|NCT00716274|58698471|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
30684509|NCT00716274|58698472|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
30684510|NCT00716274|58698473|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
30684511|NCT00716274|58698474|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
30684512|NCT00716274|58698469|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
30684513|NCT00716274|58698470|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
30684514|NCT00716274|58698471|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
30684515|NCT00716274|58698472|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
30684516|NCT00716274|58698473|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
30684517|NCT00716274|58698474|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
30684518|NCT00716274|58698469|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
30684519|NCT00716274|58698470|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
30684520|NCT00716274|58698471|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
30684521|NCT00716274|58698472|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
30684522|NCT00716274|58698473|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
30684523|NCT00716274|58698474|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
30684524|NCT00716274|58698469|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
30684525|NCT00716274|58698470|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
30684526|NCT00716274|58698471|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
30684527|NCT00716274|58698472|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
30856225|NCT03194542|58884088|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
30856226|NCT03194542|58884089|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
30684528|NCT00716274|58698473|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
30684529|NCT00716274|58698474|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
30684530|NCT00716274|58698469|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
30684531|NCT00716274|58698470|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
30684532|NCT00716274|58698471|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
30684533|NCT00716274|58698472|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
30684534|NCT00716274|58698473|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
30684535|NCT00716274|58698474|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
30684536|NCT00716274|58698469|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
30684537|NCT00716274|58698470|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
30684538|NCT00716274|58698471|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
30684539|NCT00716274|58698472|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
30684540|NCT00716274|58698473|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
30684541|NCT00716274|58698474|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
30684542|NCT00716274|58698469|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
30684543|NCT00716274|58698470|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
30684544|NCT00716274|58698471|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
30684545|NCT00716274|58698472|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
30684546|NCT00716274|58698473|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
30684547|NCT00716274|58698474|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
30684548|NCT00716274|58698469|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
30684549|NCT00716274|58698470|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
30684550|NCT00716274|58698471|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
30684551|NCT00716274|58698472|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
30684552|NCT00716274|58698473|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
30684553|NCT00716274|58698474|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
30684554|NCT00746564|58698491|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
30684555|NCT01298193|58698497|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
30684556|NCT01298193|58698497|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
30684557|NCT01298193|58698497|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
30684558|NCT01298193|58698497|FG000|Efficacy Phase (Second Cycle)|Death|1|||
30684559|NCT00719862|58698506|FG000|Overall Study|Adverse Event|1|||
30684560|NCT00719862|58698507|FG001|Overall Study|Adverse Event|2|||
30684561|NCT00719862|58698506|FG000|Overall Study|Lack of Efficacy|3|||
30684562|NCT00719862|58698507|FG001|Overall Study|Lack of Efficacy|0|||
30684563|NCT00719862|58698506|FG000|Overall Study|Non-Compliance|1|||
30684564|NCT00719862|58698507|FG001|Overall Study|Non-Compliance|0|||
30684565|NCT00719862|58698506|FG000|Overall Study|Withdrawal by Subject|1|||
30684566|NCT00719862|58698507|FG001|Overall Study|Withdrawal by Subject|0|||
30684567|NCT00719862|58698506|FG000|Overall Study|Lost to Follow-up|0|||
30684568|NCT00719862|58698507|FG001|Overall Study|Lost to Follow-up|1|||
30684569|NCT00719862|58698506|FG000|Overall Study|Other|2|||
30684570|NCT00719862|58698507|FG001|Overall Study|Other|3|||
30684571|NCT00742508|58698515|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
30684572|NCT00742508|58698516|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
30684573|NCT00742508|58698515|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
30684574|NCT00742508|58698516|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
30597480|NCT01324830|58609159|FG002|Overall Study|Dose limiting toxicity|0|||
30597481|NCT01324830|58609160|FG003|Overall Study|Dose limiting toxicity|0|||
30597482|NCT01324830|58609161|FG004|Overall Study|Dose limiting toxicity|1|||
30597483|NCT01324830|58609162|FG005|Overall Study|Dose limiting toxicity|0|||
30684575|NCT00742508|58698515|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
30684576|NCT00742508|58698516|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
30684577|NCT00742508|58698515|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
30684578|NCT00742508|58698516|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
30684579|NCT00742508|58698515|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
30684580|NCT00742508|58698516|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
30684581|NCT00719706|58698524|FG000|Overall Study|Adverse Event|5|||
30684582|NCT00719706|58698525|FG001|Overall Study|Adverse Event|4|||
30783855|NCT02677896|58796029|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
30597484|NCT01324830|58609163|FG006|Overall Study|Dose limiting toxicity|0|||
30597485|NCT01324830|58609164|FG007|Overall Study|Dose limiting toxicity|0|||
30597486|NCT01324830|58609165|FG008|Overall Study|Dose limiting toxicity|0|||
30597487|NCT01324830|58609166|FG009|Overall Study|Dose limiting toxicity|0|||
30597488|NCT01324830|58609167|FG010|Overall Study|Dose limiting toxicity|0|||
30597489|NCT01324830|58609168|FG011|Overall Study|Dose limiting toxicity|0|||
30597490|NCT01324830|58609169|FG012|Overall Study|Dose limiting toxicity|0|||
30597491|NCT01324830|58609170|FG013|Overall Study|Dose limiting toxicity|0|||
30783856|NCT02677896|58796030|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
30783857|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
30783858|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
30597492|NCT01324830|58609171|FG014|Overall Study|Dose limiting toxicity|0|||
30684583|NCT00719706|58698524|FG000|Overall Study|Withdrawal by Subject|1|||
30684584|NCT00719706|58698525|FG001|Overall Study|Withdrawal by Subject|2|||
30684585|NCT00719706|58698524|FG000|Overall Study|Protocol Violation|3|||
30684586|NCT00719706|58698525|FG001|Overall Study|Protocol Violation|0|||
30684587|NCT00742274|58698533|FG000|Overall Study|Death|1|||
30684588|NCT00742274|58698534|FG001|Overall Study|Death|0|||
30684589|NCT00742274|58698533|FG000|Overall Study|Withdrawal by Subject|1|||
30684590|NCT00742274|58698534|FG001|Overall Study|Withdrawal by Subject|2|||
30684591|NCT00742274|58698533|FG000|Overall Study|Removed for medical reasons|1|||
30684592|NCT00742274|58698534|FG001|Overall Study|Removed for medical reasons|1|||
30783859|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
30783860|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
30783861|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
30783862|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
30783863|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
30783864|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
30783865|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
30783866|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
30783867|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
30783868|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
30783869|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
30783870|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
30783871|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
30783872|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
30783873|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
30783874|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
30783875|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
30783876|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
30783877|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
30783878|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
30783879|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
30783880|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
30783881|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
30783882|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
30783883|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
30783884|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
30783885|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
30783886|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
30783887|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
30783888|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
30783889|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
30783890|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
30597493|NCT01324830|58609172|FG015|Overall Study|Dose limiting toxicity|0|||
30597494|NCT01324830|58609173|FG016|Overall Study|Dose limiting toxicity|1|||
30597495|NCT01324830|58609174|FG017|Overall Study|Dose limiting toxicity|1|||
30597496|NCT01324830|58609175|FG018|Overall Study|Dose limiting toxicity|1|||
30597497|NCT01324830|58609157|FG000|Overall Study|Reason not mentioned above|0|||
30597498|NCT01324830|58609158|FG001|Overall Study|Reason not mentioned above|0|||
30597499|NCT01324830|58609159|FG002|Overall Study|Reason not mentioned above|0|||
30597500|NCT01324830|58609160|FG003|Overall Study|Reason not mentioned above|0|||
30597501|NCT01324830|58609161|FG004|Overall Study|Reason not mentioned above|0|||
30597502|NCT01324830|58609162|FG005|Overall Study|Reason not mentioned above|0|||
30597503|NCT01324830|58609163|FG006|Overall Study|Reason not mentioned above|0|||
30597504|NCT01324830|58609164|FG007|Overall Study|Reason not mentioned above|0|||
30597505|NCT01324830|58609165|FG008|Overall Study|Reason not mentioned above|0|||
30597506|NCT01324830|58609166|FG009|Overall Study|Reason not mentioned above|0|||
30597507|NCT01324830|58609167|FG010|Overall Study|Reason not mentioned above|0|||
30597508|NCT01324830|58609168|FG011|Overall Study|Reason not mentioned above|0|||
30597509|NCT01324830|58609169|FG012|Overall Study|Reason not mentioned above|0|||
30783891|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
30783892|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
30783893|NCT02586623|58796040|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
30783894|NCT02586623|58796041|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
30783895|NCT02586623|58796042|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
30783896|NCT02586623|58796040|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
30783897|NCT02586623|58796041|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
30783898|NCT02586623|58796042|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
30783899|NCT02586623|58796040|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
30959209|NCT02684370|59024556|FG002|Part B|Adverse Event|0|||
30597510|NCT01324830|58609170|FG013|Overall Study|Reason not mentioned above|0|||
30597511|NCT01324830|58609171|FG014|Overall Study|Reason not mentioned above|0|||
30959210|NCT02684370|59024557|FG003|Part B|Adverse Event|0|||
30597512|NCT01324830|58609172|FG015|Overall Study|Reason not mentioned above|0|||
30597513|NCT01324830|58609173|FG016|Overall Study|Reason not mentioned above|0|||
30597514|NCT01324830|58609174|FG017|Overall Study|Reason not mentioned above|1|||
30684593|NCT00719472|58698540|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
30684594|NCT00719472|58698540|FG000|Enrolled in Study|Subject decision to withdraw|8|||
30684595|NCT00719472|58698540|FG000|Enrolled in Study|Various Reasons|17|||
30684596|NCT00719472|58698540|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
30684597|NCT00719472|58698540|FG000|Received Cycle 1 Treatment|Death|5|||
30684598|NCT00719472|58698540|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
30684599|NCT00719472|58698540|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
30684600|NCT00719472|58698540|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
30684601|NCT00719472|58698540|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
30684602|NCT00719472|58698540|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
30684603|NCT00719472|58698540|FG000|Received Cycle 2 Treatment|Death|6|||
30684604|NCT00719472|58698540|FG000|Received Cycle 2 Treatment|Disease progression|3|||
30684605|NCT00719472|58698540|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
30684606|NCT00719472|58698540|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
30684607|NCT00719472|58698540|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
30684608|NCT00719472|58698540|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
30597515|NCT01324830|58609175|FG018|Overall Study|Reason not mentioned above|0|||
30597516|NCT01324830|58609157|FG000|Overall Study|Adverse Event, serious fatal|0|||
30597517|NCT01324830|58609158|FG001|Overall Study|Adverse Event, serious fatal|1|||
30597518|NCT01324830|58609159|FG002|Overall Study|Adverse Event, serious fatal|0|||
30597519|NCT01324830|58609160|FG003|Overall Study|Adverse Event, serious fatal|0|||
30684609|NCT00579501|58698544|FG000|Overall Study|Death|1|||
30684610|NCT00579501|58698544|FG000|Overall Study|End of neoadjuvant therapy|25|||
30684611|NCT00579501|58698544|FG000|Overall Study|toxicity|1|||
30597520|NCT01324830|58609161|FG004|Overall Study|Adverse Event, serious fatal|0|||
30597521|NCT01324830|58609162|FG005|Overall Study|Adverse Event, serious fatal|0|||
30597522|NCT01324830|58609163|FG006|Overall Study|Adverse Event, serious fatal|0|||
30597523|NCT01324830|58609164|FG007|Overall Study|Adverse Event, serious fatal|0|||
30597524|NCT01324830|58609165|FG008|Overall Study|Adverse Event, serious fatal|0|||
30597525|NCT01324830|58609166|FG009|Overall Study|Adverse Event, serious fatal|0|||
30597526|NCT01324830|58609167|FG010|Overall Study|Adverse Event, serious fatal|0|||
30597527|NCT01324830|58609168|FG011|Overall Study|Adverse Event, serious fatal|0|||
30597528|NCT01324830|58609169|FG012|Overall Study|Adverse Event, serious fatal|0|||
30597529|NCT01324830|58609170|FG013|Overall Study|Adverse Event, serious fatal|0|||
30597530|NCT01324830|58609171|FG014|Overall Study|Adverse Event, serious fatal|0|||
30597531|NCT01324830|58609172|FG015|Overall Study|Adverse Event, serious fatal|0|||
30597532|NCT01324830|58609173|FG016|Overall Study|Adverse Event, serious fatal|0|||
30597533|NCT01324830|58609174|FG017|Overall Study|Adverse Event, serious fatal|0|||
30597534|NCT01324830|58609175|FG018|Overall Study|Adverse Event, serious fatal|0|||
30684612|NCT00579501|58698544|FG000|Overall Study|Secondary lesion|1|||
30684613|NCT00579501|58698544|FG000|Overall Study|Radiation therapy before surgery|1|||
30684614|NCT00741338|58698550|FG000|Overall Study|Adverse Event|0|||
30684615|NCT00741338|58698551|FG001|Overall Study|Adverse Event|1|||
30684616|NCT00746330|58698561|FG000|Period 1|Abnormal test procedure result|0|||
30684617|NCT00746330|58698562|FG001|Period 1|Abnormal test procedure result|0|||
30684618|NCT00746330|58698563|FG002|Period 1|Abnormal test procedure result|1|||
30684619|NCT00746330|58698564|FG003|Period 1|Abnormal test procedure result|0|||
30684620|NCT00746252|58698577|FG000|Overall Study|weight gain >7.5 %|1|||
30684621|NCT00746252|58698578|FG001|Overall Study|weight gain >7.5 %|2|||
30684622|NCT00718770|58698584|FG000|Overall Study|Adverse Event|1|||
30684623|NCT00718770|58698584|FG000|Overall Study|Lack of Efficacy|1|||
30684624|NCT00718770|58698584|FG000|Overall Study|Lack of Efficacy|1|||
30684625|NCT00718770|58698584|FG000|Overall Study|Adverse Event|1|||
30684626|NCT00718770|58698584|FG000|Overall Study|Lack of Efficacy|1|||
30684627|NCT00718770|58698584|FG000|Overall Study|Adverse Event|1|||
30684628|NCT00718770|58698584|FG000|Overall Study|Lack of Efficacy|1|||
30684629|NCT00718770|58698584|FG000|Overall Study|Adverse Event|1|||
30684630|NCT00746096|58698590|FG000|Overall Study|Adverse Event|1|||
30597535|NCT01324830|58609157|FG000|Overall Study|Adverse Event, non-fatal|0|||
30684631|NCT00746096|58698591|FG001|Overall Study|Adverse Event|0|||
30684632|NCT00746096|58698590|FG000|Overall Study|Withdrawal by Subject|5|||
30684633|NCT00746096|58698591|FG001|Overall Study|Withdrawal by Subject|1|||
30684634|NCT00746096|58698590|FG000|Overall Study|Lost to Follow-up|2|||
30684635|NCT00746096|58698591|FG001|Overall Study|Lost to Follow-up|1|||
30684636|NCT00746096|58698590|FG000|Overall Study|Protocol Violation|1|||
30684637|NCT00746096|58698591|FG001|Overall Study|Protocol Violation|0|||
30684638|NCT00746096|58698590|FG000|Overall Study|No study drug treatment|1|||
30684639|NCT00746096|58698591|FG001|Overall Study|No study drug treatment|1|||
30684640|NCT00715026|58698597|FG000|Overall Study|Withdrawal by Subject|5|||
30684641|NCT00715026|58698597|FG000|Overall Study|Lost to Follow-up|3|||
30684642|NCT00715026|58698597|FG000|Overall Study|Protocol Violation|1|||
30597536|NCT01324830|58609158|FG001|Overall Study|Adverse Event, non-fatal|0|||
30597537|NCT01324830|58609159|FG002|Overall Study|Adverse Event, non-fatal|0|||
30597538|NCT01324830|58609160|FG003|Overall Study|Adverse Event, non-fatal|0|||
30597539|NCT01324830|58609161|FG004|Overall Study|Adverse Event, non-fatal|0|||
30597540|NCT01324830|58609162|FG005|Overall Study|Adverse Event, non-fatal|0|||
30597541|NCT01324830|58609163|FG006|Overall Study|Adverse Event, non-fatal|0|||
30783900|NCT02586623|58796041|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
30783901|NCT02586623|58796042|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
30783902|NCT02586623|58796040|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
30783903|NCT02586623|58796041|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
30783904|NCT02586623|58796042|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
30783905|NCT02586623|58796040|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
30783906|NCT02586623|58796041|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
30783907|NCT02586623|58796042|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
30783908|NCT02586623|58796040|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
30783909|NCT02586623|58796041|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
30783910|NCT02586623|58796042|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
30783911|NCT02586623|58796040|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
30783912|NCT02586623|58796041|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
30783913|NCT02586623|58796042|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
30783914|NCT02586623|58796040|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
30783915|NCT02586623|58796041|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
30783916|NCT02586623|58796042|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
30783917|NCT02586623|58796040|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
30783918|NCT02586623|58796041|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
30783919|NCT02586623|58796042|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
30783920|NCT01819831|58796049|FG000|Overall Study|Withdrawal by Subject|1|||
30783921|NCT00078949|58796066|FG000|Overall Study|No treated|4|||
30783922|NCT00078949|58796067|FG001|Overall Study|No treated|5|||
30783923|NCT00078949|58796068|FG002|Overall Study|No treated|3|||
30783924|NCT00078949|58796069|FG003|Overall Study|No treated|3|||
30783925|NCT03739203|58796084|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
30783926|NCT03739203|58796085|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
30959211|NCT02684370|59024558|FG004|Part B|Adverse Event|2|||
30597542|NCT01324830|58609164|FG007|Overall Study|Adverse Event, non-fatal|0|||
30597543|NCT01324830|58609165|FG008|Overall Study|Adverse Event, non-fatal|2|||
30597544|NCT01324830|58609166|FG009|Overall Study|Adverse Event, non-fatal|0|||
30597545|NCT01324830|58609167|FG010|Overall Study|Adverse Event, non-fatal|1|||
30597546|NCT01324830|58609168|FG011|Overall Study|Adverse Event, non-fatal|0|||
30597547|NCT01324830|58609169|FG012|Overall Study|Adverse Event, non-fatal|0|||
30597548|NCT01324830|58609170|FG013|Overall Study|Adverse Event, non-fatal|0|||
30597549|NCT01324830|58609171|FG014|Overall Study|Adverse Event, non-fatal|0|||
30597550|NCT01324830|58609172|FG015|Overall Study|Adverse Event, non-fatal|0|||
30597551|NCT01324830|58609173|FG016|Overall Study|Adverse Event, non-fatal|0|||
30597552|NCT01324830|58609174|FG017|Overall Study|Adverse Event, non-fatal|1|||
30684643|NCT00715026|58698597|FG000|Overall Study|Surgery done on non-study consented hip|1|||
30684644|NCT00714948|58698601|FG000|Overall Study|Adverse Event|2|||
30684645|NCT00714870|58698607|FG000|Overall Study|Lost to Follow-up|22|||
30684646|NCT00714870|58698608|FG001|Overall Study|Lost to Follow-up|5|||
30684647|NCT00714870|58698607|FG000|Overall Study|patient unable to come b/c back pain|1|||
30684648|NCT00714870|58698608|FG001|Overall Study|patient unable to come b/c back pain|0|||
30684649|NCT00714870|58698607|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
30684650|NCT00714870|58698608|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
30684651|NCT00714714|58698614|FG000|Overall Study|Adverse Event|1|||
30684652|NCT00441337|58698624|FG000|Overall Study|Disease Progression|6|||
30684653|NCT00441337|58698625|FG001|Overall Study|Disease Progression|6|||
30684654|NCT00441337|58698626|FG002|Overall Study|Disease Progression|4|||
30783927|NCT03739203|58796086|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
30783928|NCT03739203|58796084|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
30783929|NCT03739203|58796085|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
30783930|NCT03739203|58796086|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
30783931|NCT03739203|58796084|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
30783932|NCT03739203|58796085|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
30783933|NCT03739203|58796086|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
30783934|NCT03739203|58796084|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
30783935|NCT03739203|58796085|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
30783936|NCT03739203|58796086|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
30783937|NCT03739203|58796084|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
30684655|NCT00441337|58698627|FG003|Overall Study|Disease Progression|18|||
30783938|NCT03739203|58796085|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
30597553|NCT01324830|58609175|FG018|Overall Study|Adverse Event, non-fatal|0|||
30597554|NCT01324830|58609157|FG000|Overall Study|Withdrawal by Subject|0|||
30597555|NCT01324830|58609158|FG001|Overall Study|Withdrawal by Subject|0|||
30597556|NCT01324830|58609159|FG002|Overall Study|Withdrawal by Subject|0|||
30597557|NCT01324830|58609160|FG003|Overall Study|Withdrawal by Subject|0|||
30597558|NCT01324830|58609161|FG004|Overall Study|Withdrawal by Subject|0|||
30597559|NCT01324830|58609162|FG005|Overall Study|Withdrawal by Subject|1|||
30597560|NCT01324830|58609163|FG006|Overall Study|Withdrawal by Subject|0|||
30597561|NCT01324830|58609164|FG007|Overall Study|Withdrawal by Subject|0|||
30597562|NCT01324830|58609165|FG008|Overall Study|Withdrawal by Subject|0|||
30597563|NCT01324830|58609166|FG009|Overall Study|Withdrawal by Subject|0|||
30597564|NCT01324830|58609167|FG010|Overall Study|Withdrawal by Subject|1|||
30597565|NCT01324830|58609168|FG011|Overall Study|Withdrawal by Subject|0|||
30597566|NCT01324830|58609169|FG012|Overall Study|Withdrawal by Subject|0|||
30597567|NCT01324830|58609170|FG013|Overall Study|Withdrawal by Subject|0|||
30597568|NCT01324830|58609171|FG014|Overall Study|Withdrawal by Subject|0|||
30597569|NCT01324830|58609172|FG015|Overall Study|Withdrawal by Subject|0|||
30597570|NCT01324830|58609173|FG016|Overall Study|Withdrawal by Subject|0|||
30684656|NCT00441337|58698624|FG000|Overall Study|Lost to Follow-up|0|||
30684657|NCT00441337|58698625|FG001|Overall Study|Lost to Follow-up|0|||
30684658|NCT00441337|58698626|FG002|Overall Study|Lost to Follow-up|0|||
30684659|NCT00441337|58698627|FG003|Overall Study|Lost to Follow-up|1|||
30684660|NCT00441337|58698624|FG000|Overall Study|Sponsor Decision|0|||
30684661|NCT00441337|58698625|FG001|Overall Study|Sponsor Decision|0|||
30684662|NCT00441337|58698626|FG002|Overall Study|Sponsor Decision|1|||
30684663|NCT00441337|58698627|FG003|Overall Study|Sponsor Decision|2|||
30684664|NCT00441337|58698624|FG000|Overall Study|Did not meet inclusion criteria|0|||
30684665|NCT00441337|58698625|FG001|Overall Study|Did not meet inclusion criteria|0|||
30684666|NCT00441337|58698626|FG002|Overall Study|Did not meet inclusion criteria|1|||
30684667|NCT00441337|58698627|FG003|Overall Study|Did not meet inclusion criteria|0|||
30684668|NCT00578877|58698647|FG000|Overall Study|Lost to Follow-up|8|||
30684669|NCT00578877|58698648|FG001|Overall Study|Lost to Follow-up|10|||
30684670|NCT00578877|58698647|FG000|Overall Study|early discontinue|61|||
30684671|NCT00578877|58698648|FG001|Overall Study|early discontinue|101|||
30684672|NCT00578877|58698647|FG000|Overall Study|did not provide follow-up data|12|||
30684673|NCT00578877|58698648|FG001|Overall Study|did not provide follow-up data|17|||
30684674|NCT00468481|58698656|FG000|Overall Study|Adverse Event|13|||
30597571|NCT01324830|58609174|FG017|Overall Study|Withdrawal by Subject|0|||
30597572|NCT01324830|58609175|FG018|Overall Study|Withdrawal by Subject|1|||
30597573|NCT01324440|58609223|FG000|Overall Study|Subject moved|0|||
30597574|NCT01324440|58609224|FG001|Overall Study|Subject moved|1|||
30597575|NCT01325493|58609232|FG000|Overall Study|Protocol Violation|0|||
30597576|NCT01325493|58609233|FG001|Overall Study|Protocol Violation|1|||
30597577|NCT01325493|58609232|FG000|Overall Study|loss of neuromonitoring signals|0|||
30597578|NCT01325493|58609233|FG001|Overall Study|loss of neuromonitoring signals|2|||
30684675|NCT00468481|58698657|FG001|Overall Study|Adverse Event|3|||
30684676|NCT00468481|58698656|FG000|Overall Study|Lost to Follow-up|25|||
30684677|NCT00468481|58698657|FG001|Overall Study|Lost to Follow-up|8|||
30684678|NCT00468481|58698656|FG000|Overall Study|Pregnancy|2|||
30684679|NCT00468481|58698657|FG001|Overall Study|Pregnancy|0|||
30684680|NCT00468481|58698656|FG000|Overall Study|Protocol Violation|18|||
30684681|NCT00468481|58698657|FG001|Overall Study|Protocol Violation|8|||
30684682|NCT00468481|58698656|FG000|Overall Study|Withdrawal by Subject|12|||
30684683|NCT00468481|58698657|FG001|Overall Study|Withdrawal by Subject|3|||
30684684|NCT00468481|58698656|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
30684685|NCT00468481|58698657|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
30684686|NCT00468481|58698656|FG000|Overall Study|Prohibited Medication|1|||
30684687|NCT00468481|58698657|FG001|Overall Study|Prohibited Medication|1|||
30684688|NCT00468481|58698656|FG000|Overall Study|Egg Donor|1|||
30684689|NCT00468481|58698657|FG001|Overall Study|Egg Donor|0|||
30684690|NCT00468481|58698656|FG000|Overall Study|Moved out of area|4|||
30684691|NCT00468481|58698657|FG001|Overall Study|Moved out of area|1|||
30684692|NCT00468481|58698656|FG000|Overall Study|Non-Compliance|5|||
30684693|NCT00468481|58698657|FG001|Overall Study|Non-Compliance|0|||
30684694|NCT00468481|58698656|FG000|Overall Study|Other|6|||
30684695|NCT00468481|58698657|FG001|Overall Study|Other|0|||
30684696|NCT00714168|58698665|FG000|Overall Study|Pregnancy|5|||
30684697|NCT00714168|58698666|FG001|Overall Study|Pregnancy|4|||
30684698|NCT00714168|58698665|FG000|Overall Study|Lost to Follow-up|32|||
30684699|NCT00714168|58698666|FG001|Overall Study|Lost to Follow-up|50|||
30783939|NCT03739203|58796086|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
30684700|NCT00714168|58698665|FG000|Overall Study|Relocation|4|||
30684701|NCT00714168|58698666|FG001|Overall Study|Relocation|3|||
30597579|NCT01325493|58609232|FG000|Overall Study|Allergy|1|||
30597580|NCT01325493|58609233|FG001|Overall Study|Allergy|0|||
30684702|NCT00714168|58698665|FG000|Overall Study|Non-study medical condition|3|||
30684703|NCT00714168|58698666|FG001|Overall Study|Non-study medical condition|2|||
30684704|NCT00713700|58698672|FG000|Overall Study|Lost to Follow-up|3|||
30597581|NCT01323972|58609243|FG000|Overall Study|Withdrawal by Subject|1|||
30597582|NCT01323972|58609244|FG001|Overall Study|Withdrawal by Subject|0|||
30684705|NCT00713700|58698672|FG000|Overall Study|Withdrawal by Subject|1|||
30684706|NCT00468169|58698678|FG000|Overall Study|Withdrawal by Subject|1|||
30684707|NCT00468169|58698679|FG001|Overall Study|Withdrawal by Subject|0|||
30684708|NCT00435487|58698689|FG000|Overall Study|Death|3|||
30684709|NCT00435487|58698690|FG001|Overall Study|Death|4|||
30684710|NCT00435487|58698689|FG000|Overall Study|Adverse Event|0|||
30684711|NCT00435487|58698690|FG001|Overall Study|Adverse Event|3|||
30684712|NCT00435487|58698689|FG000|Overall Study|Lost to Follow-up|2|||
30684713|NCT00435487|58698690|FG001|Overall Study|Lost to Follow-up|2|||
30684714|NCT00435487|58698689|FG000|Overall Study|Other|5|||
30684715|NCT00435487|58698690|FG001|Overall Study|Other|2|||
30684716|NCT00435487|58698689|FG000|Overall Study|Withdrawal by Subject|2|||
30684717|NCT00435487|58698690|FG001|Overall Study|Withdrawal by Subject|1|||
30684718|NCT00435487|58698689|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
30684719|NCT00435487|58698690|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
30684720|NCT00435487|58698689|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
30684721|NCT00435487|58698690|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
30684722|NCT00579345|58698704|FG000|Overall Study|Withdrawal by Subject|2|||
30684723|NCT00579345|58698705|FG001|Overall Study|Withdrawal by Subject|0|||
30684724|NCT00579345|58698706|FG002|Overall Study|Withdrawal by Subject|0|||
30684725|NCT00579345|58698707|FG003|Overall Study|Withdrawal by Subject|0|||
30684726|NCT00579345|58698708|FG004|Overall Study|Withdrawal by Subject|0|||
30684727|NCT00579345|58698709|FG005|Overall Study|Withdrawal by Subject|0|||
30684728|NCT00579345|58698710|FG006|Overall Study|Withdrawal by Subject|0|||
30684729|NCT00579345|58698711|FG007|Overall Study|Withdrawal by Subject|1|||
30684730|NCT00579345|58698704|FG000|Overall Study|Lost to Follow-up|1|||
30684731|NCT00579345|58698705|FG001|Overall Study|Lost to Follow-up|0|||
30684732|NCT00579345|58698706|FG002|Overall Study|Lost to Follow-up|0|||
30684733|NCT00579345|58698707|FG003|Overall Study|Lost to Follow-up|0|||
30783940|NCT03739203|58796084|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
30783941|NCT03739203|58796085|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
30783942|NCT03739203|58796086|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
30783943|NCT03739203|58796084|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
30783944|NCT03739203|58796085|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
30783945|NCT03739203|58796086|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
30783946|NCT03739203|58796084|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
30783947|NCT03739203|58796085|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
30783948|NCT03739203|58796086|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
30783949|NCT03739203|58796084|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
30783950|NCT03739203|58796085|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
30783951|NCT03739203|58796086|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
30783952|NCT03739203|58796084|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
30783953|NCT03739203|58796085|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
30783954|NCT03739203|58796086|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
30783955|NCT03739203|58796084|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
30783956|NCT03739203|58796085|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
30783957|NCT03739203|58796086|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
30783958|NCT02942264|58796103|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
30783959|NCT02942264|58796104|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
30783960|NCT02942264|58796105|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
30684734|NCT00579345|58698708|FG004|Overall Study|Lost to Follow-up|0|||
30684735|NCT00579345|58698709|FG005|Overall Study|Lost to Follow-up|0|||
30684736|NCT00579345|58698710|FG006|Overall Study|Lost to Follow-up|0|||
30783961|NCT02942264|58796106|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
30783962|NCT02942264|58796107|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
30783963|NCT02942264|58796108|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
30783964|NCT02942264|58796109|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
30597583|NCT01323972|58609245|FG002|Overall Study|Withdrawal by Subject|1|||
30597584|NCT01323972|58609246|FG003|Overall Study|Withdrawal by Subject|0|||
30597585|NCT01323972|58609243|FG000|Overall Study|Migrated/moved from study area|1|||
30597586|NCT01323972|58609244|FG001|Overall Study|Migrated/moved from study area|2|||
30597587|NCT01323972|58609245|FG002|Overall Study|Migrated/moved from study area|0|||
30597588|NCT01323972|58609246|FG003|Overall Study|Migrated/moved from study area|0|||
30597589|NCT01323972|58609243|FG000|Overall Study|Lost to Follow-up|0|||
30597590|NCT01323972|58609244|FG001|Overall Study|Lost to Follow-up|1|||
30597591|NCT01323972|58609245|FG002|Overall Study|Lost to Follow-up|1|||
30684737|NCT00579345|58698711|FG007|Overall Study|Lost to Follow-up|0|||
30684738|NCT00579345|58698704|FG000|Overall Study|Adverse Event|0|||
30684739|NCT00579345|58698705|FG001|Overall Study|Adverse Event|0|||
30684740|NCT00579345|58698706|FG002|Overall Study|Adverse Event|1|||
30684741|NCT00579345|58698707|FG003|Overall Study|Adverse Event|0|||
30684742|NCT00579345|58698708|FG004|Overall Study|Adverse Event|0|||
30684743|NCT00579345|58698709|FG005|Overall Study|Adverse Event|0|||
30856227|NCT03194542|58884090|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
30597592|NCT01323972|58609246|FG003|Overall Study|Lost to Follow-up|1|||
30684744|NCT00579345|58698710|FG006|Overall Study|Adverse Event|0|||
30684745|NCT00579345|58698711|FG007|Overall Study|Adverse Event|0|||
30684746|NCT00579345|58698704|FG000|Overall Study|Protocol Violation|1|||
30684747|NCT00579345|58698705|FG001|Overall Study|Protocol Violation|0|||
30684748|NCT00579345|58698706|FG002|Overall Study|Protocol Violation|0|||
30684749|NCT00579345|58698707|FG003|Overall Study|Protocol Violation|0|||
30684750|NCT00579345|58698708|FG004|Overall Study|Protocol Violation|0|||
30684751|NCT00579345|58698709|FG005|Overall Study|Protocol Violation|0|||
30684752|NCT00579345|58698710|FG006|Overall Study|Protocol Violation|0|||
30684753|NCT00579345|58698711|FG007|Overall Study|Protocol Violation|1|||
30684754|NCT00579345|58698704|FG000|Overall Study|Death|1|||
30684755|NCT00579345|58698705|FG001|Overall Study|Death|1|||
30684756|NCT00579345|58698706|FG002|Overall Study|Death|1|||
30684757|NCT00579345|58698707|FG003|Overall Study|Death|1|||
30684758|NCT00579345|58698708|FG004|Overall Study|Death|0|||
30684759|NCT00579345|58698709|FG005|Overall Study|Death|0|||
30684760|NCT00579345|58698710|FG006|Overall Study|Death|0|||
30684761|NCT00579345|58698711|FG007|Overall Study|Death|0|||
30684762|NCT00795821|58698759|FG000|Acute Treatment Phase|Adverse Event|23|||
30684763|NCT00795821|58698760|FG001|Acute Treatment Phase|Adverse Event|4|||
30684764|NCT00795821|58698759|FG000|Acute Treatment Phase|Death|1|||
30684765|NCT00795821|58698760|FG001|Acute Treatment Phase|Death|0|||
30684766|NCT00795821|58698759|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
30684767|NCT00795821|58698760|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
30684768|NCT00795821|58698759|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
30684769|NCT00795821|58698760|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
30684770|NCT00795821|58698759|FG000|Acute Treatment Phase|Physician Decision|1|||
30684771|NCT00795821|58698760|FG001|Acute Treatment Phase|Physician Decision|1|||
30684772|NCT00795821|58698759|FG000|Acute Treatment Phase|Protocol Violation|1|||
30684773|NCT00795821|58698760|FG001|Acute Treatment Phase|Protocol Violation|2|||
30684774|NCT00795821|58698759|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
30597593|NCT01325337|58609263|FG000|Overall Study|Adverse Event|0|||
30597594|NCT01325337|58609264|FG001|Overall Study|Adverse Event|2|||
30597595|NCT01325337|58609265|FG002|Overall Study|Adverse Event|2|||
30597596|NCT01325337|58609266|FG003|Overall Study|Adverse Event|1|||
30597597|NCT01325337|58609267|FG004|Overall Study|Adverse Event|2|||
30597598|NCT01325337|58609263|FG000|Overall Study|Lost to Follow-up|2|||
30597599|NCT01325337|58609264|FG001|Overall Study|Lost to Follow-up|2|||
30597600|NCT01325337|58609265|FG002|Overall Study|Lost to Follow-up|2|||
30597601|NCT01325337|58609266|FG003|Overall Study|Lost to Follow-up|1|||
30597602|NCT01325337|58609267|FG004|Overall Study|Lost to Follow-up|2|||
30597603|NCT01325337|58609263|FG000|Overall Study|Personal Reasons|2|||
30597604|NCT01325337|58609264|FG001|Overall Study|Personal Reasons|5|||
30597605|NCT01325337|58609265|FG002|Overall Study|Personal Reasons|4|||
30597606|NCT01325337|58609266|FG003|Overall Study|Personal Reasons|8|||
30597607|NCT01325337|58609267|FG004|Overall Study|Personal Reasons|3|||
30597608|NCT01325337|58609263|FG000|Overall Study|Withdrawal by Subject|1|||
30597609|NCT01325337|58609264|FG001|Overall Study|Withdrawal by Subject|0|||
30597610|NCT01325337|58609265|FG002|Overall Study|Withdrawal by Subject|1|||
30597611|NCT01325337|58609266|FG003|Overall Study|Withdrawal by Subject|0|||
30597612|NCT01325337|58609267|FG004|Overall Study|Withdrawal by Subject|1|||
30597613|NCT01324947|58609279|FG000|Overall Study|Adverse Event|7|||
30597614|NCT01324947|58609279|FG000|Overall Study|Death|10|||
30597615|NCT01324947|58609279|FG000|Overall Study|Other|3|||
30597616|NCT01324947|58609279|FG000|Overall Study|Progressive Disease|50|||
30597617|NCT01324947|58609279|FG000|Overall Study|Withdrawal by Subject|3|||
30597618|NCT01324947|58609279|FG000|Overall Study|1 discontinued before starting drug|1|||
30597619|NCT01101841|58609287|FG000|Overall Study|Adverse Event|15|||
30597620|NCT01101841|58609288|FG001|Overall Study|Adverse Event|15|||
30597621|NCT01101841|58609287|FG000|Overall Study|Lost to Follow-up|9|||
30597622|NCT01101841|58609288|FG001|Overall Study|Lost to Follow-up|3|||
30597623|NCT01101841|58609287|FG000|Overall Study|Withdrawal by Subject|21|||
30597624|NCT01101841|58609288|FG001|Overall Study|Withdrawal by Subject|40|||
30597625|NCT01101841|58609287|FG000|Overall Study|Protocol Violation|1|||
30597626|NCT01101841|58609288|FG001|Overall Study|Protocol Violation|1|||
30597627|NCT01101841|58609287|FG000|Overall Study|Physician Decision|0|||
30684775|NCT00795821|58698760|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
30684776|NCT00795821|58698759|FG000|Long-term Extension Phase|Adverse Event|25|||
30684777|NCT00795821|58698760|FG001|Long-term Extension Phase|Adverse Event|32|||
30684778|NCT00795821|58698759|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
30597628|NCT01101841|58609288|FG001|Overall Study|Physician Decision|2|||
30597629|NCT01101841|58609287|FG000|Overall Study|Lack of Efficacy|0|||
30684779|NCT00795821|58698760|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
30684780|NCT00795821|58698759|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
30684781|NCT00795821|58698760|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
30684782|NCT00795821|58698759|FG000|Long-term Extension Phase|Physician Decision|1|||
30597630|NCT01101841|58609288|FG001|Overall Study|Lack of Efficacy|2|||
30597631|NCT01101841|58609287|FG000|Overall Study|Other|0|||
30597632|NCT01101841|58609288|FG001|Overall Study|Other|1|||
30597633|NCT01101841|58609287|FG000|Overall Study|Suicidality Tracking Scale|3|||
30597634|NCT01101841|58609288|FG001|Overall Study|Suicidality Tracking Scale|1|||
30597635|NCT01101841|58609287|FG000|Overall Study|Eligibility Criteria|1|||
30597636|NCT01101841|58609288|FG001|Overall Study|Eligibility Criteria|2|||
30597637|NCT01324401|58609297|FG000|Overall Study|Withdrawn before any treatment|0|||
30597638|NCT01324401|58609298|FG001|Overall Study|Withdrawn before any treatment|3|||
30597639|NCT01324401|58609297|FG000|Overall Study|Adverse Event|1|||
30597640|NCT01324401|58609298|FG001|Overall Study|Adverse Event|3|||
30684783|NCT00795821|58698760|FG001|Long-term Extension Phase|Physician Decision|2|||
30684784|NCT00795821|58698759|FG000|Long-term Extension Phase|Protocol Violation|3|||
30684785|NCT00795821|58698760|FG001|Long-term Extension Phase|Protocol Violation|5|||
30684786|NCT00795821|58698759|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
30684787|NCT00795821|58698760|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
30684788|NCT00795821|58698759|FG000|Taper Phase|Adverse Event|2|||
30684789|NCT00795821|58698760|FG001|Taper Phase|Adverse Event|0|||
30684790|NCT00795821|58698759|FG000|Taper Phase|Lost to Follow-up|1|||
30684791|NCT00795821|58698760|FG001|Taper Phase|Lost to Follow-up|0|||
30684792|NCT00795821|58698759|FG000|Taper Phase|Physician Decision|2|||
30684793|NCT00795821|58698760|FG001|Taper Phase|Physician Decision|0|||
30684794|NCT00795821|58698759|FG000|Taper Phase|Withdrawal by Subject|4|||
30684795|NCT00795821|58698760|FG001|Taper Phase|Withdrawal by Subject|0|||
30684796|NCT00578643|58698776|FG000|Overall Study|Death|1|||
30684797|NCT00578643|58698776|FG000|Overall Study|Lost to Follow-up|1|||
30684798|NCT00578565|58698780|FG000|Overall Study|Adverse Event|3|||
30684799|NCT00741260|58698792|FG000|Overall Study|Disease Progression|3|||
30684800|NCT00741260|58698793|FG001|Overall Study|Disease Progression|5|||
30684801|NCT00741260|58698794|FG002|Overall Study|Disease Progression|3|||
30684802|NCT00741260|58698795|FG003|Overall Study|Disease Progression|3|||
30684803|NCT00741260|58698796|FG004|Overall Study|Disease Progression|5|||
30684804|NCT00741260|58698797|FG005|Overall Study|Disease Progression|37|||
30684805|NCT00741260|58698798|FG006|Overall Study|Disease Progression|4|||
30684806|NCT00741260|58698792|FG000|Overall Study|Death|0|||
30684807|NCT00741260|58698793|FG001|Overall Study|Death|1|||
30684808|NCT00741260|58698794|FG002|Overall Study|Death|0|||
30684809|NCT00741260|58698795|FG003|Overall Study|Death|1|||
30684810|NCT00741260|58698796|FG004|Overall Study|Death|2|||
30684811|NCT00741260|58698797|FG005|Overall Study|Death|2|||
30684812|NCT00741260|58698798|FG006|Overall Study|Death|1|||
30684813|NCT00741260|58698792|FG000|Overall Study|Withdrawal by Subject|0|||
30684814|NCT00741260|58698793|FG001|Overall Study|Withdrawal by Subject|0|||
30684815|NCT00741260|58698794|FG002|Overall Study|Withdrawal by Subject|0|||
30684816|NCT00741260|58698795|FG003|Overall Study|Withdrawal by Subject|0|||
30684817|NCT00741260|58698796|FG004|Overall Study|Withdrawal by Subject|1|||
30684818|NCT00741260|58698797|FG005|Overall Study|Withdrawal by Subject|3|||
30684819|NCT00741260|58698798|FG006|Overall Study|Withdrawal by Subject|1|||
30684820|NCT00741260|58698792|FG000|Overall Study|Physician Decision|1|||
30684821|NCT00741260|58698793|FG001|Overall Study|Physician Decision|1|||
30684822|NCT00741260|58698794|FG002|Overall Study|Physician Decision|0|||
30684823|NCT00741260|58698795|FG003|Overall Study|Physician Decision|0|||
30684824|NCT00741260|58698796|FG004|Overall Study|Physician Decision|0|||
30684825|NCT00741260|58698797|FG005|Overall Study|Physician Decision|0|||
30684826|NCT00741260|58698798|FG006|Overall Study|Physician Decision|0|||
30684827|NCT00741260|58698792|FG000|Overall Study|Other|2|||
30684828|NCT00741260|58698793|FG001|Overall Study|Other|1|||
30684829|NCT00741260|58698794|FG002|Overall Study|Other|1|||
30684830|NCT00741260|58698795|FG003|Overall Study|Other|2|||
30684831|NCT00741260|58698796|FG004|Overall Study|Other|1|||
30684832|NCT00741260|58698797|FG005|Overall Study|Other|3|||
30684833|NCT00741260|58698798|FG006|Overall Study|Other|1|||
30684834|NCT00740870|58698819|FG000|Overall Study|Not Catheterized|4|||
30684835|NCT00740870|58698819|FG000|Overall Study|Further testing contraindicated implant|17|||
30684836|NCT00740792|58698830|FG000|Overall Study|Adverse Event|3|||
30684837|NCT00740792|58698831|FG001|Overall Study|Adverse Event|1|||
30684838|NCT00740792|58698832|FG002|Overall Study|Adverse Event|1|||
30597641|NCT01323660|58609304|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
30597642|NCT01323660|58609305|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
30684839|NCT00740792|58698833|FG003|Overall Study|Adverse Event|3|||
30597643|NCT01323660|58609306|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
30684840|NCT00740792|58698830|FG000|Overall Study|Lack of Efficacy|1|||
30684841|NCT00740792|58698831|FG001|Overall Study|Lack of Efficacy|1|||
30684842|NCT00740792|58698832|FG002|Overall Study|Lack of Efficacy|0|||
30684843|NCT00740792|58698833|FG003|Overall Study|Lack of Efficacy|3|||
30684844|NCT00740792|58698830|FG000|Overall Study|Lost to Follow-up|2|||
30684845|NCT00740792|58698831|FG001|Overall Study|Lost to Follow-up|1|||
30684846|NCT00740792|58698832|FG002|Overall Study|Lost to Follow-up|0|||
30684847|NCT00740792|58698833|FG003|Overall Study|Lost to Follow-up|0|||
30684848|NCT00740792|58698830|FG000|Overall Study|Protocol Violation|0|||
30684849|NCT00740792|58698831|FG001|Overall Study|Protocol Violation|1|||
30684850|NCT00740792|58698832|FG002|Overall Study|Protocol Violation|0|||
30684851|NCT00740792|58698833|FG003|Overall Study|Protocol Violation|2|||
30684852|NCT00740792|58698830|FG000|Overall Study|Withdrawal by Subject|1|||
30684853|NCT00740792|58698831|FG001|Overall Study|Withdrawal by Subject|1|||
30684854|NCT00740792|58698832|FG002|Overall Study|Withdrawal by Subject|0|||
30684855|NCT00740792|58698833|FG003|Overall Study|Withdrawal by Subject|0|||
30684856|NCT00740792|58698830|FG000|Overall Study|administrative|3|||
30684857|NCT00740792|58698831|FG001|Overall Study|administrative|3|||
30684858|NCT00740792|58698832|FG002|Overall Study|administrative|8|||
30684859|NCT00740792|58698833|FG003|Overall Study|administrative|2|||
30684860|NCT00740714|58698846|FG000|Overall Study|Withdrawal by Subject|17|||
30684861|NCT00740714|58698847|FG001|Overall Study|Withdrawal by Subject|19|||
30684862|NCT00740714|58698848|FG002|Overall Study|Withdrawal by Subject|29|||
30684863|NCT00788957|58698860|FG000|Part 1|Death|8|||
30684864|NCT00788957|58698861|FG001|Part 1|Death|0|||
30684865|NCT00788957|58698862|FG002|Part 1|Death|0|||
30684866|NCT00788957|58698863|FG003|Part 1|Death|0|||
30684867|NCT00788957|58698864|FG004|Part 1|Death|0|||
30684868|NCT00788957|58698865|FG005|Part 1|Death|0|||
30684869|NCT00788957|58698860|FG000|Part 1|Lost to Follow-up|1|||
30783965|NCT02942264|58796110|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
30783966|NCT02942264|58796111|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
30783967|NCT02942264|58796103|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
30783968|NCT02942264|58796104|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
30783969|NCT02942264|58796105|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
30783970|NCT02942264|58796106|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
30783971|NCT02942264|58796107|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
30783972|NCT02942264|58796108|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
30783973|NCT02942264|58796109|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
30783974|NCT02942264|58796110|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
30597644|NCT01323660|58609307|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
30597645|NCT01323660|58609308|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
30597646|NCT01323660|58609309|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
30597647|NCT01323660|58609304|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
30597648|NCT01323660|58609305|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
30597649|NCT01323660|58609306|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
30783975|NCT02942264|58796111|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
30783976|NCT03322514|58796138|FG000|Overall Study|Withdrawal by Subject|1|||
30783977|NCT03322514|58796139|FG001|Overall Study|Withdrawal by Subject|1|||
30783978|NCT03325712|58796153|FG000|Overall Study|Protocol Violation|0|||
30783979|NCT03325712|58796154|FG001|Overall Study|Protocol Violation|0|||
30783980|NCT03325712|58796155|FG002|Overall Study|Protocol Violation|0|||
30783981|NCT03325712|58796156|FG003|Overall Study|Protocol Violation|0|||
30597650|NCT01323660|58609307|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
30597651|NCT01323660|58609308|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
30597652|NCT01323660|58609309|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
30597653|NCT01323660|58609304|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
30597654|NCT01323660|58609305|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
30597655|NCT01323660|58609306|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
30597656|NCT01323660|58609307|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
30597657|NCT01323660|58609308|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
30597658|NCT01323660|58609309|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
30597659|NCT01323660|58609304|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
30597660|NCT01323660|58609305|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
30597661|NCT01323660|58609306|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
30597662|NCT01323660|58609307|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
30597663|NCT01323660|58609308|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
30597664|NCT01323660|58609309|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
30597665|NCT01323660|58609304|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30597666|NCT01323660|58609305|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30597667|NCT01323660|58609306|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30597668|NCT01323660|58609307|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30597669|NCT01323660|58609308|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
30597670|NCT01323660|58609309|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
30597671|NCT01323660|58609304|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
30684870|NCT00788957|58698861|FG001|Part 1|Lost to Follow-up|0|||
30783982|NCT03325712|58796157|FG004|Overall Study|Protocol Violation|1|||
30684871|NCT00788957|58698862|FG002|Part 1|Lost to Follow-up|0|||
30684872|NCT00788957|58698863|FG003|Part 1|Lost to Follow-up|0|||
30684873|NCT00788957|58698864|FG004|Part 1|Lost to Follow-up|0|||
30684874|NCT00788957|58698865|FG005|Part 1|Lost to Follow-up|0|||
30684875|NCT00788957|58698860|FG000|Part 2|Withdrawal by Subject|0|||
30684876|NCT00788957|58698861|FG001|Part 2|Withdrawal by Subject|9|||
30684877|NCT00788957|58698862|FG002|Part 2|Withdrawal by Subject|5|||
30684878|NCT00788957|58698863|FG003|Part 2|Withdrawal by Subject|3|||
30684879|NCT00788957|58698864|FG004|Part 2|Withdrawal by Subject|0|||
30684880|NCT00788957|58698865|FG005|Part 2|Withdrawal by Subject|0|||
30684881|NCT00788957|58698860|FG000|Part 2|Death|0|||
30597672|NCT01323660|58609305|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
30597673|NCT01323660|58609306|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
30597674|NCT01323660|58609307|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
30597675|NCT01323660|58609308|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
30597676|NCT01323660|58609309|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
30597677|NCT01323660|58609304|FG000|Washout Period (14 Days)|Adverse Event|0|||
30597678|NCT01323660|58609305|FG001|Washout Period (14 Days)|Adverse Event|0|||
30597679|NCT01323660|58609306|FG002|Washout Period (14 Days)|Adverse Event|0|||
30597680|NCT01323660|58609307|FG003|Washout Period (14 Days)|Adverse Event|0|||
30684882|NCT00788957|58698861|FG001|Part 2|Death|32|||
30684883|NCT00788957|58698862|FG002|Part 2|Death|35|||
30684884|NCT00788957|58698863|FG003|Part 2|Death|37|||
30684885|NCT00788957|58698864|FG004|Part 2|Death|0|||
30684886|NCT00788957|58698865|FG005|Part 2|Death|0|||
30684887|NCT00788957|58698860|FG000|Part 2|Lost to Follow-up|0|||
30684888|NCT00788957|58698861|FG001|Part 2|Lost to Follow-up|0|||
30684889|NCT00788957|58698862|FG002|Part 2|Lost to Follow-up|3|||
30684890|NCT00788957|58698863|FG003|Part 2|Lost to Follow-up|0|||
30684891|NCT00788957|58698864|FG004|Part 2|Lost to Follow-up|0|||
30684892|NCT00788957|58698865|FG005|Part 2|Lost to Follow-up|0|||
30684893|NCT00788957|58698860|FG000|Part 2|On-study at time of data cut-off|0|||
30684894|NCT00788957|58698861|FG001|Part 2|On-study at time of data cut-off|1|||
30684895|NCT00788957|58698862|FG002|Part 2|On-study at time of data cut-off|1|||
30684896|NCT00788957|58698863|FG003|Part 2|On-study at time of data cut-off|1|||
30684897|NCT00788957|58698864|FG004|Part 2|On-study at time of data cut-off|0|||
30684898|NCT00788957|58698865|FG005|Part 2|On-study at time of data cut-off|0|||
30684899|NCT00788957|58698860|FG000|Part 3|Withdrawal by Subject|0|||
30684900|NCT00788957|58698861|FG001|Part 3|Withdrawal by Subject|0|||
30684901|NCT00788957|58698862|FG002|Part 3|Withdrawal by Subject|0|||
30684902|NCT00788957|58698863|FG003|Part 3|Withdrawal by Subject|0|||
30684903|NCT00788957|58698864|FG004|Part 3|Withdrawal by Subject|0|||
30684904|NCT00788957|58698865|FG005|Part 3|Withdrawal by Subject|2|||
30684905|NCT00788957|58698860|FG000|Part 3|Death|0|||
30684906|NCT00788957|58698861|FG001|Part 3|Death|0|||
30684907|NCT00788957|58698862|FG002|Part 3|Death|0|||
30684908|NCT00788957|58698863|FG003|Part 3|Death|0|||
30684909|NCT00788957|58698864|FG004|Part 3|Death|8|||
30684910|NCT00788957|58698865|FG005|Part 3|Death|9|||
30684911|NCT00788957|58698860|FG000|Part 3|On-study at time of data cut-off|0|||
30684912|NCT00788957|58698861|FG001|Part 3|On-study at time of data cut-off|0|||
30684913|NCT00788957|58698862|FG002|Part 3|On-study at time of data cut-off|0|||
30684914|NCT00788957|58698863|FG003|Part 3|On-study at time of data cut-off|0|||
30684915|NCT00788957|58698864|FG004|Part 3|On-study at time of data cut-off|1|||
30684916|NCT00788957|58698865|FG005|Part 3|On-study at time of data cut-off|0|||
30684917|NCT00740636|58698884|FG000|Overall Study|Adverse Event|0|||
30684918|NCT00740636|58698885|FG001|Overall Study|Adverse Event|2|||
30684919|NCT00740636|58698884|FG000|Overall Study|Patient Ineligible|0|||
30684920|NCT00740636|58698885|FG001|Overall Study|Patient Ineligible|1|||
30684921|NCT00740636|58698884|FG000|Overall Study|Patient Not Treated|0|||
30684922|NCT00740636|58698885|FG001|Overall Study|Patient Not Treated|1|||
30684923|NCT00740636|58698884|FG000|Overall Study|Progressive Disease|1|||
30597681|NCT01323660|58609308|FG004|Washout Period (14 Days)|Adverse Event|1|||
30597682|NCT01323660|58609309|FG005|Washout Period (14 Days)|Adverse Event|0|||
30597683|NCT01323660|58609304|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
30597684|NCT01323660|58609305|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
30597685|NCT01323660|58609306|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
30597686|NCT01323660|58609307|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
30597687|NCT01323660|58609308|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
30597688|NCT01323660|58609309|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
30597689|NCT01323660|58609304|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
30597690|NCT01323660|58609305|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
30597691|NCT01323660|58609306|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
30684924|NCT00740636|58698885|FG001|Overall Study|Progressive Disease|0|||
30684925|NCT00740636|58698884|FG000|Overall Study|Death|1|||
30684926|NCT00740636|58698885|FG001|Overall Study|Death|0|||
30684927|NCT00735254|58698895|FG000|Overall Study|Protocol Violation|1|||
30684928|NCT00735254|58698896|FG001|Overall Study|Protocol Violation|1|||
30684929|NCT00735254|58698897|FG002|Overall Study|Protocol Violation|1|||
30684930|NCT00735254|58698898|FG003|Overall Study|Protocol Violation|0|||
30684931|NCT00795509|58698908|FG000|Overall Study|Protocol Violation|31|||
30684932|NCT00787787|58698912|FG000|Overall Study|Lack of Efficacy|4|||
30684933|NCT00787787|58698912|FG000|Overall Study|Adverse Event|3|||
30684934|NCT00787319|58698916|FG000|Overall Study|Lost to Follow-up|2|||
30684935|NCT00787319|58698916|FG000|Overall Study|Withdrawal by Subject|15|||
30684936|NCT00787319|58698916|FG000|Overall Study|Adverse Event|3|||
30684937|NCT00787319|58698916|FG000|Overall Study|Objective progression or relapse|30|||
30684938|NCT00787319|58698916|FG000|Overall Study|Lack of Efficacy|1|||
30684939|NCT00787319|58698916|FG000|Overall Study|Budget exhausted/exceeded|1|||
30684940|NCT00787319|58698916|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
30684941|NCT00787319|58698916|FG000|Overall Study|No health insurance reimbursement|2|||
30684942|NCT00787319|58698916|FG000|Overall Study|Stabilized disease findings|3|||
30684943|NCT00787319|58698916|FG000|Overall Study|Inactive disease|5|||
30597692|NCT01323660|58609307|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
30597693|NCT01323660|58609308|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
30597694|NCT01323660|58609309|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
30597695|NCT01323660|58609304|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
30597696|NCT01323660|58609305|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
30597697|NCT01323660|58609306|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
30597698|NCT01323660|58609307|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
30597699|NCT01323660|58609308|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
30597700|NCT01323660|58609309|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
30684944|NCT00794963|58698922|FG000|Overall Study|Withdrawal by Subject|1|||
30684945|NCT00794963|58698923|FG001|Overall Study|Withdrawal by Subject|4|||
30684946|NCT00794573|58698931|FG000|Overall Study|Death|3|||
30684947|NCT00794573|58698932|FG001|Overall Study|Death|0|||
30684948|NCT00794573|58698931|FG000|Overall Study|Withdrawal by Subject|9|||
30684949|NCT00794573|58698932|FG001|Overall Study|Withdrawal by Subject|12|||
30684950|NCT00794573|58698931|FG000|Overall Study|Lost to Follow-up|26|||
30684951|NCT00794573|58698932|FG001|Overall Study|Lost to Follow-up|33|||
30684952|NCT00584844|58698938|FG000|Overall Study|Withdrawal by Subject|59|||
30684953|NCT00584844|58698938|FG000|Overall Study|Screen Failure|20|||
30684954|NCT00739934|58698946|FG000|Voriconazole IV|Adverse Event|6|||
30684955|NCT00739934|58698946|FG000|Voriconazole Oral|Other|3|||
30684956|NCT00739310|58698955|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
30684957|NCT00739310|58698955|FG000|Overall Study|Withdrawal by Subject|1|||
30684958|NCT00739310|58698955|FG000|Overall Study|Lost to Follow-up|2|||
30684959|NCT00734630|58698962|FG000|Overall Study|Lack of Efficacy|4|||
30684960|NCT00734630|58698963|FG001|Overall Study|Lack of Efficacy|4|||
30684961|NCT00734630|58698962|FG000|Overall Study|Withdrawal by Subject|7|||
30684962|NCT00734630|58698963|FG001|Overall Study|Withdrawal by Subject|9|||
30684963|NCT00734630|58698962|FG000|Overall Study|Lost to Follow-up|13|||
30684964|NCT00734630|58698963|FG001|Overall Study|Lost to Follow-up|7|||
30684965|NCT00734630|58698962|FG000|Overall Study|Protocol Violation|0|||
30684966|NCT00734630|58698963|FG001|Overall Study|Protocol Violation|3|||
30684967|NCT00734630|58698962|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
30684968|NCT00734630|58698963|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
30684969|NCT00734630|58698962|FG000|Overall Study|Adverse Event|3|||
30684970|NCT00734630|58698963|FG001|Overall Study|Adverse Event|6|||
30684971|NCT00734630|58698962|FG000|Overall Study|Randomized in Error|0|||
30684972|NCT00734630|58698963|FG001|Overall Study|Randomized in Error|1|||
30684973|NCT00734630|58698962|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
30684974|NCT00734630|58698963|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
30684975|NCT00734630|58698962|FG000|Overall Study|Poor Compliance|1|||
30684976|NCT00734630|58698963|FG001|Overall Study|Poor Compliance|1|||
30684977|NCT00584454|58698969|FG000|Overall Study|Adverse Event|1|||
30684978|NCT00584454|58698969|FG000|Overall Study|Relocation|1|||
30684979|NCT00584454|58698969|FG000|Overall Study|Clinical Hold|2|||
30684980|NCT00578175|58698976|FG000|Overall Study|Adverse Event|0|||
30684981|NCT00578175|58698977|FG001|Overall Study|Adverse Event|1|||
30684982|NCT00578175|58698978|FG002|Overall Study|Adverse Event|1|||
30684983|NCT00578175|58698976|FG000|Overall Study|Other reasons|70|||
30684984|NCT00578175|58698977|FG001|Overall Study|Other reasons|42|||
30684985|NCT00578175|58698978|FG002|Overall Study|Other reasons|23|||
30684986|NCT00435409|58698990|FG000|Overall Study|Protocol Violation|1|||
30684987|NCT00435409|58698991|FG001|Overall Study|Protocol Violation|2|||
30684988|NCT00435409|58698992|FG002|Overall Study|Protocol Violation|0|||
30684989|NCT00435409|58698990|FG000|Overall Study|Lost to Follow-up|1|||
30684990|NCT00435409|58698991|FG001|Overall Study|Lost to Follow-up|2|||
30684991|NCT00435409|58698992|FG002|Overall Study|Lost to Follow-up|0|||
30684992|NCT00435409|58698990|FG000|Overall Study|Death|8|||
30684993|NCT00435409|58698991|FG001|Overall Study|Death|6|||
30684994|NCT00435409|58698992|FG002|Overall Study|Death|6|||
30856228|NCT03194542|58884091|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
30684995|NCT00435409|58698990|FG000|Overall Study|Objective progression or relapse|158|||
30684996|NCT00435409|58698991|FG001|Overall Study|Objective progression or relapse|93|||
30684997|NCT00435409|58698992|FG002|Overall Study|Objective progression or relapse|58|||
30684998|NCT00435409|58698990|FG000|Overall Study|Global deterioration of health status|0|||
30684999|NCT00435409|58698991|FG001|Overall Study|Global deterioration of health status|0|||
30685000|NCT00435409|58698992|FG002|Overall Study|Global deterioration of health status|4|||
30685001|NCT00435409|58698990|FG000|Overall Study|Withdrawal by Subject|8|||
30685002|NCT00435409|58698991|FG001|Overall Study|Withdrawal by Subject|7|||
30685003|NCT00435409|58698992|FG002|Overall Study|Withdrawal by Subject|1|||
30685004|NCT00435409|58698990|FG000|Overall Study|Other|45|||
30685005|NCT00435409|58698991|FG001|Overall Study|Other|30|||
30685006|NCT00435409|58698992|FG002|Overall Study|Other|1|||
30685007|NCT00435409|58698990|FG000|Overall Study|Adverse Event|0|||
30685008|NCT00435409|58698991|FG001|Overall Study|Adverse Event|0|||
30685009|NCT00435409|58698992|FG002|Overall Study|Adverse Event|8|||
30685010|NCT00435409|58698990|FG000|Overall Study|Sponsor decision|0|||
30685011|NCT00435409|58698991|FG001|Overall Study|Sponsor decision|3|||
30685012|NCT00435409|58698992|FG002|Overall Study|Sponsor decision|0|||
30685013|NCT00467857|58699009|FG000|Overall Study|Adverse Event|1|||
30685014|NCT00467857|58699010|FG001|Overall Study|Adverse Event|0|||
30685015|NCT00467857|58699009|FG000|Overall Study|Withdrew consent|2|||
30685016|NCT00467857|58699010|FG001|Overall Study|Withdrew consent|0|||
30685017|NCT00467857|58699009|FG000|Overall Study|Death|0|||
30685018|NCT00467857|58699010|FG001|Overall Study|Death|1|||
30685019|NCT00467857|58699009|FG000|Overall Study|Discharged from court service|0|||
30685020|NCT00467857|58699010|FG001|Overall Study|Discharged from court service|1|||
30685021|NCT00467857|58699009|FG000|Overall Study|Emergency care required|0|||
30685022|NCT00467857|58699010|FG001|Overall Study|Emergency care required|1|||
30685023|NCT00467857|58699009|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
30685024|NCT00467857|58699010|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
30685025|NCT00467857|58699009|FG000|Overall Study|Discontinuation reason missing|0|||
30685026|NCT00467857|58699010|FG001|Overall Study|Discontinuation reason missing|3|||
30685027|NCT00435019|58699018|FG000|Overall Study|Adverse Event|1|||
30685028|NCT00435019|58699019|FG001|Overall Study|Adverse Event|0|||
30685029|NCT00435019|58699018|FG000|Overall Study|Lack of Efficacy|1|||
30685030|NCT00435019|58699019|FG001|Overall Study|Lack of Efficacy|2|||
30685031|NCT00435019|58699018|FG000|Overall Study|Protocol Violation|3|||
30685032|NCT00435019|58699019|FG001|Overall Study|Protocol Violation|1|||
30685033|NCT00435019|58699018|FG000|Overall Study|Personal reasons for withdrawal|8|||
30685034|NCT00435019|58699019|FG001|Overall Study|Personal reasons for withdrawal|7|||
30597701|NCT01323660|58609304|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
30597702|NCT01323660|58609305|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
30597703|NCT01323660|58609306|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
30597704|NCT01323660|58609307|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
30685035|NCT00577863|58699027|FG000|Overall Study|Adverse Event|4|||
30597705|NCT01323660|58609308|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
30597706|NCT01323660|58609309|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
30597707|NCT01323660|58609304|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
30597708|NCT01323660|58609305|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
30597709|NCT01323660|58609306|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
30597710|NCT01323660|58609307|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
30685036|NCT00577863|58699028|FG001|Overall Study|Adverse Event|2|||
30685037|NCT00577863|58699027|FG000|Overall Study|Death|1|||
30685038|NCT00577863|58699028|FG001|Overall Study|Death|0|||
30685039|NCT00577863|58699027|FG000|Overall Study|Lost to Follow-up|2|||
30685040|NCT00577863|58699028|FG001|Overall Study|Lost to Follow-up|2|||
30685041|NCT00577863|58699027|FG000|Overall Study|Entry Criteria Exclusion|1|||
30685042|NCT00577863|58699028|FG001|Overall Study|Entry Criteria Exclusion|0|||
30685043|NCT00577863|58699027|FG000|Overall Study|Withdrawal by Subject|0|||
30685044|NCT00577863|58699028|FG001|Overall Study|Withdrawal by Subject|2|||
30685045|NCT00577863|58699027|FG000|Overall Study|Sponsor Decision|2|||
30685046|NCT00577863|58699028|FG001|Overall Study|Sponsor Decision|7|||
30685047|NCT00577863|58699027|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
30685048|NCT00577863|58699028|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
30783983|NCT03325712|58796158|FG005|Overall Study|Protocol Violation|0|||
30783984|NCT03325712|58796159|FG006|Overall Study|Protocol Violation|0|||
30783985|NCT03325712|58796160|FG007|Overall Study|Protocol Violation|0|||
30783986|NCT03325712|58796153|FG000|Overall Study|Adverse Event|0|||
30783987|NCT03325712|58796154|FG001|Overall Study|Adverse Event|0|||
30783988|NCT03325712|58796155|FG002|Overall Study|Adverse Event|0|||
30685049|NCT00794417|58699038|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
30685050|NCT00794417|58699039|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
30685051|NCT00794417|58699040|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
30685052|NCT00794417|58699041|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
30685053|NCT00794417|58699038|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
30685054|NCT00794417|58699039|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
30685055|NCT00794417|58699040|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
30685056|NCT00794417|58699041|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
30685057|NCT00794417|58699038|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
30685058|NCT00794417|58699039|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
30685059|NCT00794417|58699040|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
30685060|NCT00794417|58699041|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
30783989|NCT03325712|58796156|FG003|Overall Study|Adverse Event|0|||
30783990|NCT03325712|58796157|FG004|Overall Study|Adverse Event|1|||
30685061|NCT00794417|58699038|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
30685062|NCT00794417|58699039|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
30685063|NCT00794417|58699040|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
30685064|NCT00794417|58699041|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
30685065|NCT00794417|58699038|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
30685066|NCT00794417|58699039|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
30685067|NCT00794417|58699040|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
30685068|NCT00794417|58699041|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
30685069|NCT00794417|58699038|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
30685070|NCT00794417|58699039|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
30685071|NCT00794417|58699040|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
30685072|NCT00794417|58699041|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
30685073|NCT00790907|58699056|FG000|Overall Study|Adverse Event|9|||
30685074|NCT00790907|58699057|FG001|Overall Study|Adverse Event|7|||
30685075|NCT00790907|58699058|FG002|Overall Study|Adverse Event|6|||
30685076|NCT00790907|58699056|FG000|Overall Study|Physician Decision|304|||
30685077|NCT00790907|58699057|FG001|Overall Study|Physician Decision|271|||
30685078|NCT00790907|58699058|FG002|Overall Study|Physician Decision|255|||
30685079|NCT00790907|58699056|FG000|Overall Study|Withdrawal by Subject|1|||
30685080|NCT00790907|58699057|FG001|Overall Study|Withdrawal by Subject|7|||
30685081|NCT00790907|58699058|FG002|Overall Study|Withdrawal by Subject|5|||
30685082|NCT00790907|58699056|FG000|Overall Study|Bleeding Event|11|||
30685083|NCT00790907|58699057|FG001|Overall Study|Bleeding Event|16|||
30685084|NCT00790907|58699058|FG002|Overall Study|Bleeding Event|21|||
30685085|NCT00790907|58699056|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
30685086|NCT00790907|58699057|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
30685087|NCT00790907|58699058|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
30685088|NCT00790907|58699056|FG000|Overall Study|Qualifying Condition Not Present|29|||
30685089|NCT00790907|58699057|FG001|Overall Study|Qualifying Condition Not Present|14|||
30685090|NCT00790907|58699058|FG002|Overall Study|Qualifying Condition Not Present|16|||
30685091|NCT00790907|58699056|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
30685092|NCT00790907|58699057|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
30685093|NCT00790907|58699058|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
30685094|NCT00790907|58699056|FG000|Overall Study|Did Not Receive Study Drug|10|||
30685095|NCT00790907|58699057|FG001|Overall Study|Did Not Receive Study Drug|0|||
30685096|NCT00790907|58699058|FG002|Overall Study|Did Not Receive Study Drug|0|||
30685097|NCT00793871|58699076|FG000|Overall Study|Death|50|||
30685098|NCT00793871|58699076|FG000|Overall Study|Lost to Follow-up|3|||
30685099|NCT00793871|58699076|FG000|Overall Study|Study terminated by the Sponsor|7|||
30685100|NCT00577707|58699084|FG000|Overall Study|Withdrawal by Subject|3|||
30685101|NCT00713349|58699088|FG000|Overall Study|Protocol Violation|1|||
30685102|NCT00712959|58699096|FG000|Overall Study|Protocol Violation|3|||
30685103|NCT00712959|58699097|FG001|Overall Study|Protocol Violation|1|||
30685104|NCT00712959|58699096|FG000|Overall Study|Lost to Follow-up|13|||
30597711|NCT01323660|58609308|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
30597712|NCT01323660|58609309|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
30597713|NCT01323660|58609304|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
30597714|NCT01323660|58609305|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
30597715|NCT01323660|58609306|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
30597716|NCT01323660|58609307|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30597717|NCT01323660|58609308|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
30597718|NCT01323660|58609309|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
30597719|NCT01092637|58609325|FG000|Overall Study|Death|47|||
30597720|NCT01092637|58609326|FG001|Overall Study|Death|49|||
30597721|NCT01324323|58609333|FG000|Overall Study|Withdrawal by Subject|1|||
30597722|NCT01323582|58609347|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
30597723|NCT01323582|58609348|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
30597724|NCT01323582|58609347|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
30597725|NCT01323582|58609348|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
30597726|NCT01323582|58609347|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
30597727|NCT01323582|58609348|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
30597728|NCT01323621|58609358|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
30685105|NCT00712959|58699097|FG001|Overall Study|Lost to Follow-up|2|||
30685106|NCT00712959|58699096|FG000|Overall Study|Withdrawal by Subject|3|||
30685107|NCT00712959|58699097|FG001|Overall Study|Withdrawal by Subject|0|||
30685108|NCT00712725|58699111|FG000|Overall Study|Adverse Event|1|||
30685109|NCT00712725|58699112|FG001|Overall Study|Adverse Event|0|||
30685110|NCT00712725|58699113|FG002|Overall Study|Adverse Event|0|||
30685111|NCT00712725|58699114|FG003|Overall Study|Adverse Event|1|||
30685112|NCT00712725|58699115|FG004|Overall Study|Adverse Event|0|||
30685113|NCT00712725|58699116|FG005|Overall Study|Adverse Event|0|||
30685114|NCT00712725|58699117|FG006|Overall Study|Adverse Event|0|||
30685115|NCT00712725|58699118|FG007|Overall Study|Adverse Event|0|||
30685116|NCT00712725|58699111|FG000|Overall Study|Lost to Follow-up|3|||
30685117|NCT00712725|58699112|FG001|Overall Study|Lost to Follow-up|2|||
30685118|NCT00712725|58699113|FG002|Overall Study|Lost to Follow-up|1|||
30685119|NCT00712725|58699114|FG003|Overall Study|Lost to Follow-up|1|||
30685120|NCT00712725|58699115|FG004|Overall Study|Lost to Follow-up|2|||
30597729|NCT01323621|58609359|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
30597730|NCT01323621|58609360|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
30597731|NCT01323621|58609358|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
30597732|NCT01323621|58609359|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
30597733|NCT01323621|58609360|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
30597734|NCT01323621|58609358|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
30597735|NCT01323621|58609359|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
30783991|NCT03325712|58796158|FG005|Overall Study|Adverse Event|0|||
30783992|NCT03325712|58796159|FG006|Overall Study|Adverse Event|0|||
30597736|NCT01323621|58609360|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
30597737|NCT01323621|58609358|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
30597738|NCT01323621|58609359|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
30597739|NCT01323621|58609360|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
30597740|NCT01323621|58609358|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
30597741|NCT01323621|58609359|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
30597742|NCT01323621|58609360|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
30597743|NCT01323621|58609358|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
30597744|NCT01323621|58609359|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
30597745|NCT01323621|58609360|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
30597746|NCT01323621|58609358|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
30685121|NCT00712725|58699116|FG005|Overall Study|Lost to Follow-up|2|||
30685122|NCT00712725|58699117|FG006|Overall Study|Lost to Follow-up|3|||
30685123|NCT00712725|58699118|FG007|Overall Study|Lost to Follow-up|1|||
30685124|NCT00712725|58699111|FG000|Overall Study|Physician Decision|2|||
30685125|NCT00712725|58699112|FG001|Overall Study|Physician Decision|0|||
30685126|NCT00712725|58699113|FG002|Overall Study|Physician Decision|0|||
30685127|NCT00712725|58699114|FG003|Overall Study|Physician Decision|0|||
30685128|NCT00712725|58699115|FG004|Overall Study|Physician Decision|1|||
30597747|NCT01323621|58609359|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
30597748|NCT01323621|58609360|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
30597749|NCT01323621|58609358|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
30597750|NCT01323621|58609359|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
30597751|NCT01323621|58609360|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
30597752|NCT01323621|58609358|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
30597753|NCT01323621|58609359|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
30597754|NCT01323621|58609360|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
30597755|NCT01323621|58609358|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30597756|NCT01323621|58609359|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
30597757|NCT01323621|58609360|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30597758|NCT01323621|58609358|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
30597759|NCT01323621|58609359|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
30597760|NCT01323621|58609360|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
30597761|NCT01323621|58609358|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
30597762|NCT01323621|58609359|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
30597763|NCT01323621|58609360|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
30597764|NCT01323192|58609368|FG000|Overall Study|Adverse Event|6|||
30597765|NCT01323192|58609369|FG001|Overall Study|Adverse Event|1|||
30597766|NCT01323192|58609368|FG000|Overall Study|Withdrawal by Subject|3|||
30597767|NCT01323192|58609369|FG001|Overall Study|Withdrawal by Subject|1|||
30597768|NCT01323192|58609368|FG000|Overall Study|Noncompliance with study medication|0|||
30597769|NCT01323192|58609369|FG001|Overall Study|Noncompliance with study medication|3|||
30597770|NCT01323192|58609368|FG000|Overall Study|Nonmedical reasons|0|||
30597771|NCT01323192|58609369|FG001|Overall Study|Nonmedical reasons|1|||
30597772|NCT01323387|58609375|FG000|Overall Study|Withdrawal by Subject|41|||
30597773|NCT01323387|58609375|FG000|Overall Study|Radiographic Data Unavailable|1|||
30597774|NCT01323387|58609375|FG000|Overall Study|Revision|14|||
30597775|NCT01323387|58609375|FG000|Overall Study|Protocol Violation|12|||
30597776|NCT01323387|58609375|FG000|Overall Study|Randomized but Never Treated|16|||
30597777|NCT01321749|58609383|FG000|Overall Study|Lost to Follow-up|4|||
30597778|NCT01321749|58609384|FG001|Overall Study|Lost to Follow-up|11|||
30685129|NCT00712725|58699116|FG005|Overall Study|Physician Decision|0|||
30685130|NCT00712725|58699117|FG006|Overall Study|Physician Decision|2|||
30685131|NCT00712725|58699118|FG007|Overall Study|Physician Decision|0|||
30685132|NCT00712725|58699111|FG000|Overall Study|Pregnancy|0|||
30856229|NCT03194542|58884088|FG000|Overall Study|Loss of Response|4|||
30685133|NCT00712725|58699112|FG001|Overall Study|Pregnancy|1|||
30685134|NCT00712725|58699113|FG002|Overall Study|Pregnancy|0|||
30685135|NCT00712725|58699114|FG003|Overall Study|Pregnancy|0|||
30685136|NCT00712725|58699115|FG004|Overall Study|Pregnancy|1|||
30685137|NCT00712725|58699116|FG005|Overall Study|Pregnancy|0|||
30685138|NCT00712725|58699117|FG006|Overall Study|Pregnancy|2|||
30685139|NCT00712725|58699118|FG007|Overall Study|Pregnancy|0|||
30685140|NCT00712725|58699111|FG000|Overall Study|Protocol Violation|2|||
30685141|NCT00712725|58699112|FG001|Overall Study|Protocol Violation|0|||
30685142|NCT00712725|58699113|FG002|Overall Study|Protocol Violation|1|||
30685143|NCT00712725|58699114|FG003|Overall Study|Protocol Violation|3|||
30685144|NCT00712725|58699115|FG004|Overall Study|Protocol Violation|2|||
30685145|NCT00712725|58699116|FG005|Overall Study|Protocol Violation|0|||
30685146|NCT00712725|58699117|FG006|Overall Study|Protocol Violation|1|||
30685147|NCT00712725|58699118|FG007|Overall Study|Protocol Violation|1|||
30685148|NCT00712725|58699111|FG000|Overall Study|Withdrawal by Subject|2|||
30685149|NCT00712725|58699112|FG001|Overall Study|Withdrawal by Subject|1|||
30685150|NCT00712725|58699113|FG002|Overall Study|Withdrawal by Subject|1|||
30685151|NCT00712725|58699114|FG003|Overall Study|Withdrawal by Subject|2|||
30685152|NCT00712725|58699115|FG004|Overall Study|Withdrawal by Subject|1|||
30685153|NCT00712725|58699116|FG005|Overall Study|Withdrawal by Subject|1|||
30685154|NCT00712725|58699117|FG006|Overall Study|Withdrawal by Subject|1|||
30685155|NCT00712725|58699118|FG007|Overall Study|Withdrawal by Subject|2|||
30685156|NCT00712725|58699111|FG000|Overall Study|Lack of Qualifying Event|16|||
30685157|NCT00712725|58699112|FG001|Overall Study|Lack of Qualifying Event|2|||
30685158|NCT00712725|58699113|FG002|Overall Study|Lack of Qualifying Event|6|||
30685159|NCT00712725|58699114|FG003|Overall Study|Lack of Qualifying Event|8|||
30685160|NCT00712725|58699115|FG004|Overall Study|Lack of Qualifying Event|11|||
30685161|NCT00712725|58699116|FG005|Overall Study|Lack of Qualifying Event|13|||
30685162|NCT00712725|58699117|FG006|Overall Study|Lack of Qualifying Event|11|||
30685163|NCT00712725|58699118|FG007|Overall Study|Lack of Qualifying Event|6|||
30685164|NCT00712725|58699111|FG000|Overall Study|Protocol Specified Criteria|3|||
30685165|NCT00712725|58699112|FG001|Overall Study|Protocol Specified Criteria|0|||
30685166|NCT00712725|58699113|FG002|Overall Study|Protocol Specified Criteria|1|||
30685167|NCT00712725|58699114|FG003|Overall Study|Protocol Specified Criteria|2|||
30597779|NCT01321749|58609383|FG000|Overall Study|Protocol Violation|4|||
30597780|NCT01321749|58609384|FG001|Overall Study|Protocol Violation|7|||
30597781|NCT01321749|58609383|FG000|Overall Study|Withdrawal by Subject|5|||
30597782|NCT01321749|58609384|FG001|Overall Study|Withdrawal by Subject|4|||
30597783|NCT01320735|58609390|FG000|Overall Study|Adverse Event|3|||
30597784|NCT01320735|58609390|FG000|Overall Study|Withdrawal by Subject|3|||
30597785|NCT01320735|58609390|FG000|Overall Study|Lost to Follow-up|13|||
30685168|NCT00712725|58699115|FG004|Overall Study|Protocol Specified Criteria|1|||
30685169|NCT00712725|58699116|FG005|Overall Study|Protocol Specified Criteria|0|||
30685170|NCT00712725|58699117|FG006|Overall Study|Protocol Specified Criteria|2|||
30685171|NCT00712725|58699118|FG007|Overall Study|Protocol Specified Criteria|1|||
30685172|NCT00712335|58699141|FG000|Overall Study|Withdrawal by Subject|0|||
30685173|NCT00712335|58699142|FG001|Overall Study|Withdrawal by Subject|7|||
30685174|NCT00712335|58699143|FG002|Overall Study|Withdrawal by Subject|2|||
30685175|NCT00712335|58699144|FG003|Overall Study|Withdrawal by Subject|3|||
30685176|NCT00712335|58699145|FG004|Overall Study|Withdrawal by Subject|0|||
30685177|NCT00712335|58699141|FG000|Overall Study|Lost to Follow-up|2|||
30685178|NCT00712335|58699142|FG001|Overall Study|Lost to Follow-up|5|||
30685179|NCT00712335|58699143|FG002|Overall Study|Lost to Follow-up|0|||
30685180|NCT00712335|58699144|FG003|Overall Study|Lost to Follow-up|1|||
30685181|NCT00712335|58699145|FG004|Overall Study|Lost to Follow-up|0|||
30685182|NCT00712335|58699141|FG000|Overall Study|Protocol Violation|1|||
30685183|NCT00712335|58699142|FG001|Overall Study|Protocol Violation|2|||
30685184|NCT00712335|58699143|FG002|Overall Study|Protocol Violation|1|||
30685185|NCT00712335|58699144|FG003|Overall Study|Protocol Violation|0|||
30685186|NCT00712335|58699145|FG004|Overall Study|Protocol Violation|0|||
30685187|NCT00712335|58699141|FG000|Overall Study|Lack of Efficacy|0|||
30597786|NCT01320735|58609390|FG000|Overall Study|Administrative Reason|6|||
30597787|NCT01320735|58609390|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
30685188|NCT00712335|58699142|FG001|Overall Study|Lack of Efficacy|0|||
30685189|NCT00712335|58699143|FG002|Overall Study|Lack of Efficacy|1|||
30685190|NCT00712335|58699144|FG003|Overall Study|Lack of Efficacy|1|||
30685191|NCT00712335|58699145|FG004|Overall Study|Lack of Efficacy|0|||
30685192|NCT00712335|58699141|FG000|Overall Study|Other Reason|0|||
30685193|NCT00712335|58699142|FG001|Overall Study|Other Reason|3|||
30685194|NCT00712335|58699143|FG002|Overall Study|Other Reason|1|||
30685195|NCT00712335|58699144|FG003|Overall Study|Other Reason|0|||
30685196|NCT00712335|58699145|FG004|Overall Study|Other Reason|0|||
30685197|NCT00577629|58699157|FG000|Treatment Period|Death|1|||
30597788|NCT01320735|58609390|FG000|Overall Study|Protocol Violation|1|||
30597789|NCT01320735|58609390|FG000|Overall Study|Other|1|||
30685198|NCT00577629|58699157|FG000|Long Term Follow-Up|Death|15|||
30685199|NCT00577629|58699157|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
30685200|NCT00577629|58699157|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
30685201|NCT00577629|58699157|FG000|Long Term Follow-Up|Physician Decision|1|||
30685202|NCT00710385|58699163|FG000|Overall Study|Did not qualify|1|||
30685203|NCT00710385|58699163|FG000|Overall Study|Withdrawal by Subject|1|||
30597790|NCT01320735|58609390|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
30597791|NCT01320735|58609390|FG000|Overall Study|Investigator Unable to be Contacted|17|||
30597792|NCT01320033|58609397|FG000|Overall Study|Lack of Efficacy|0|||
30597793|NCT01320033|58609398|FG001|Overall Study|Lack of Efficacy|0|||
30597794|NCT01320033|58609399|FG002|Overall Study|Lack of Efficacy|1|||
30597795|NCT01320033|58609397|FG000|Overall Study|Adverse Event|9|||
30597796|NCT01320033|58609398|FG001|Overall Study|Adverse Event|7|||
30597797|NCT01320033|58609399|FG002|Overall Study|Adverse Event|8|||
30685204|NCT00710385|58699163|FG000|Overall Study|Undisclosed back pain|1|||
30685205|NCT00710385|58699163|FG000|Overall Study|Physician Decision|1|||
30685206|NCT00710385|58699163|FG000|Overall Study|Undisclosed excessive methadone use|1|||
30685207|NCT00701415|58699175|FG000|Overall Study|Adverse Event|0|||
30685208|NCT00701415|58699176|FG001|Overall Study|Adverse Event|1|||
30685209|NCT00701415|58699175|FG000|Overall Study|Social/family issues and needle phobia|1|||
30685210|NCT00701415|58699176|FG001|Overall Study|Social/family issues and needle phobia|0|||
30685211|NCT00700011|58699184|FG000|Overall Study|Death|0|||
30685212|NCT00700011|58699185|FG001|Overall Study|Death|1|||
30685213|NCT00707031|58699193|FG000|Overall Study|Adverse Event|45|||
30685214|NCT00707031|58699194|FG001|Overall Study|Adverse Event|45|||
30685215|NCT00707031|58699193|FG000|Overall Study|Lack of Efficacy|19|||
30685216|NCT00707031|58699194|FG001|Overall Study|Lack of Efficacy|6|||
30685217|NCT00707031|58699193|FG000|Overall Study|Lost to Follow-up|2|||
30685218|NCT00707031|58699194|FG001|Overall Study|Lost to Follow-up|1|||
30685219|NCT00707031|58699193|FG000|Overall Study|Protocol Violation|1|||
30685220|NCT00707031|58699194|FG001|Overall Study|Protocol Violation|0|||
30685221|NCT00707031|58699193|FG000|Overall Study|Withdrawal by Subject|7|||
30685222|NCT00707031|58699194|FG001|Overall Study|Withdrawal by Subject|8|||
30685223|NCT00707031|58699193|FG000|Overall Study|Poor Compliance to Protocol|7|||
30685224|NCT00707031|58699194|FG001|Overall Study|Poor Compliance to Protocol|13|||
30685225|NCT00707031|58699193|FG000|Overall Study|Familial or Personal Reasons|12|||
30685226|NCT00707031|58699194|FG001|Overall Study|Familial or Personal Reasons|15|||
30685227|NCT00707031|58699193|FG000|Overall Study|Serious Noncompliance|2|||
30685228|NCT00707031|58699194|FG001|Overall Study|Serious Noncompliance|3|||
30685229|NCT00707031|58699193|FG000|Overall Study|Sponsor Decision|9|||
30685230|NCT00707031|58699194|FG001|Overall Study|Sponsor Decision|8|||
30685231|NCT00711477|58699203|FG000|Overall Study|Adverse Event|3|||
30685232|NCT00711477|58699204|FG001|Overall Study|Adverse Event|1|||
30685233|NCT00711477|58699203|FG000|Overall Study|Lost to Follow-up|0|||
30685234|NCT00711477|58699204|FG001|Overall Study|Lost to Follow-up|1|||
30685235|NCT00711477|58699203|FG000|Overall Study|Noncompliance|0|||
30685236|NCT00711477|58699204|FG001|Overall Study|Noncompliance|1|||
30685237|NCT00699699|58699212|FG000|Overall Study|Adverse Event|36|||
30685238|NCT00699699|58699212|FG000|Overall Study|Individual different reasons|21|||
30685239|NCT00734474|58699225|FG000|Overall Study|Entry Criteria Not Met|0|||
30685240|NCT00734474|58699226|FG001|Overall Study|Entry Criteria Not Met|0|||
30685241|NCT00734474|58699227|FG002|Overall Study|Entry Criteria Not Met|5|||
30685242|NCT00734474|58699228|FG003|Overall Study|Entry Criteria Not Met|0|||
30685243|NCT00734474|58699229|FG004|Overall Study|Entry Criteria Not Met|3|||
30597798|NCT01320033|58609397|FG000|Overall Study|Withdrawal by Subject|22|||
30597799|NCT01320033|58609398|FG001|Overall Study|Withdrawal by Subject|23|||
30597800|NCT01320033|58609399|FG002|Overall Study|Withdrawal by Subject|23|||
30597801|NCT01320033|58609397|FG000|Overall Study|Protocol Violation|3|||
30597802|NCT01320033|58609398|FG001|Overall Study|Protocol Violation|5|||
30597803|NCT01320033|58609399|FG002|Overall Study|Protocol Violation|3|||
30597804|NCT01320033|58609397|FG000|Overall Study|Lost to Follow-up|22|||
30597805|NCT01320033|58609398|FG001|Overall Study|Lost to Follow-up|26|||
30685244|NCT00734474|58699230|FG005|Overall Study|Entry Criteria Not Met|1|||
30685245|NCT00734474|58699231|FG006|Overall Study|Entry Criteria Not Met|0|||
30685246|NCT00734474|58699232|FG007|Overall Study|Entry Criteria Not Met|1|||
30685247|NCT00734474|58699233|FG008|Overall Study|Entry Criteria Not Met|1|||
30685248|NCT00734474|58699225|FG000|Overall Study|Lost to Follow-up|1|||
30685249|NCT00734474|58699226|FG001|Overall Study|Lost to Follow-up|0|||
30685250|NCT00734474|58699227|FG002|Overall Study|Lost to Follow-up|13|||
30685251|NCT00734474|58699228|FG003|Overall Study|Lost to Follow-up|0|||
30685252|NCT00734474|58699229|FG004|Overall Study|Lost to Follow-up|11|||
30685253|NCT00734474|58699230|FG005|Overall Study|Lost to Follow-up|1|||
30685254|NCT00734474|58699231|FG006|Overall Study|Lost to Follow-up|0|||
30685255|NCT00734474|58699232|FG007|Overall Study|Lost to Follow-up|9|||
30685256|NCT00734474|58699233|FG008|Overall Study|Lost to Follow-up|4|||
30685257|NCT00734474|58699225|FG000|Overall Study|Withdrawal by Subject|2|||
30597806|NCT01320033|58609399|FG002|Overall Study|Lost to Follow-up|17|||
30597807|NCT01320033|58609397|FG000|Overall Study|Other|2|||
30597808|NCT01320033|58609398|FG001|Overall Study|Other|3|||
30597809|NCT01320033|58609399|FG002|Overall Study|Other|1|||
30597810|NCT01101061|58609413|FG000|Overall Study|Adverse Event|0|||
30597811|NCT01101061|58609414|FG001|Overall Study|Adverse Event|0|||
30597812|NCT01101061|58609415|FG002|Overall Study|Adverse Event|1|||
30597813|NCT01101061|58609416|FG003|Overall Study|Adverse Event|0|||
30597814|NCT01101061|58609417|FG004|Overall Study|Adverse Event|0|||
30597815|NCT01101061|58609418|FG005|Overall Study|Adverse Event|0|||
30597816|NCT01317615|58609436|FG000|Overall Study|Disease progression|25|||
30597817|NCT01317615|58609436|FG000|Overall Study|New cancer therapy|5|||
30597818|NCT01317615|58609436|FG000|Overall Study|Death|6|||
30597819|NCT01317615|58609436|FG000|Overall Study|Withdrawal by Subject|5|||
30597820|NCT01317615|58609436|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30685258|NCT00734474|58699226|FG001|Overall Study|Withdrawal by Subject|1|||
30685259|NCT00734474|58699227|FG002|Overall Study|Withdrawal by Subject|18|||
30685260|NCT00734474|58699228|FG003|Overall Study|Withdrawal by Subject|0|||
30685261|NCT00734474|58699229|FG004|Overall Study|Withdrawal by Subject|24|||
30685262|NCT00734474|58699230|FG005|Overall Study|Withdrawal by Subject|2|||
30685263|NCT00734474|58699231|FG006|Overall Study|Withdrawal by Subject|0|||
30685264|NCT00734474|58699232|FG007|Overall Study|Withdrawal by Subject|36|||
30685265|NCT00734474|58699233|FG008|Overall Study|Withdrawal by Subject|21|||
30685266|NCT00734474|58699225|FG000|Overall Study|Physician Decision|0|||
30685267|NCT00734474|58699226|FG001|Overall Study|Physician Decision|0|||
30685268|NCT00734474|58699227|FG002|Overall Study|Physician Decision|4|||
30685269|NCT00734474|58699228|FG003|Overall Study|Physician Decision|1|||
30685270|NCT00734474|58699229|FG004|Overall Study|Physician Decision|11|||
30685271|NCT00734474|58699230|FG005|Overall Study|Physician Decision|0|||
30685272|NCT00734474|58699231|FG006|Overall Study|Physician Decision|0|||
30685273|NCT00734474|58699232|FG007|Overall Study|Physician Decision|9|||
30597821|NCT01317615|58609436|FG000|Overall Study|Adverse Event|7|||
30597822|NCT01078675|58609442|FG000|Overall Study|Withdrawal by Subject|7|||
30597823|NCT01078675|58609443|FG001|Overall Study|Withdrawal by Subject|3|||
30597824|NCT01078675|58609442|FG000|Overall Study|Protocol Violation|56|||
30597825|NCT01078675|58609443|FG001|Overall Study|Protocol Violation|0|||
30597826|NCT01078675|58609442|FG000|Overall Study|Provided in CRF for specific reasons|2|||
30685274|NCT00734474|58699233|FG008|Overall Study|Physician Decision|9|||
30685275|NCT00734474|58699225|FG000|Overall Study|Adverse Event|4|||
30685276|NCT00734474|58699226|FG001|Overall Study|Adverse Event|4|||
30685277|NCT00734474|58699227|FG002|Overall Study|Adverse Event|63|||
30685278|NCT00734474|58699228|FG003|Overall Study|Adverse Event|1|||
30685279|NCT00734474|58699229|FG004|Overall Study|Adverse Event|64|||
30685280|NCT00734474|58699230|FG005|Overall Study|Adverse Event|0|||
30685281|NCT00734474|58699231|FG006|Overall Study|Adverse Event|1|||
30685282|NCT00734474|58699232|FG007|Overall Study|Adverse Event|65|||
30685283|NCT00734474|58699233|FG008|Overall Study|Adverse Event|39|||
30685284|NCT00734474|58699225|FG000|Overall Study|Protocol Violation|0|||
30685285|NCT00734474|58699226|FG001|Overall Study|Protocol Violation|0|||
30685286|NCT00734474|58699227|FG002|Overall Study|Protocol Violation|4|||
30685287|NCT00734474|58699228|FG003|Overall Study|Protocol Violation|0|||
30685288|NCT00734474|58699229|FG004|Overall Study|Protocol Violation|3|||
30783993|NCT03325712|58796160|FG007|Overall Study|Adverse Event|0|||
30783994|NCT03734679|58796188|FG000|Overall Study|Missed Visit|1|||
30597827|NCT01078675|58609443|FG001|Overall Study|Provided in CRF for specific reasons|3|||
30597828|NCT01078675|58609442|FG000|Overall Study|Adverse Event|3|||
30597829|NCT01078675|58609443|FG001|Overall Study|Adverse Event|0|||
30597830|NCT01100437|58609449|FG000|Titration/Stabilization|Adverse Event|0|||
30597831|NCT01100437|58609450|FG001|Titration/Stabilization|Adverse Event|0|||
30597832|NCT01100437|58609451|FG002|Titration/Stabilization|Adverse Event|4|||
30597833|NCT01100437|58609449|FG000|Titration/Stabilization|Non-compliance|0|||
30597834|NCT01100437|58609450|FG001|Titration/Stabilization|Non-compliance|0|||
30597835|NCT01100437|58609451|FG002|Titration/Stabilization|Non-compliance|1|||
30597836|NCT01100437|58609449|FG000|Titration/Stabilization|Sponsor canceled study|0|||
30597837|NCT01100437|58609450|FG001|Titration/Stabilization|Sponsor canceled study|0|||
30597838|NCT01100437|58609451|FG002|Titration/Stabilization|Sponsor canceled study|1|||
30597839|NCT01100437|58609449|FG000|Maintenance|Withdrawal by Subject|0|||
30685289|NCT00734474|58699230|FG005|Overall Study|Protocol Violation|0|||
30685290|NCT00734474|58699231|FG006|Overall Study|Protocol Violation|0|||
30783995|NCT03325556|58796192|FG000|Open-label Period|Lack of Response in OL period|70|||
30597840|NCT01100437|58609450|FG001|Maintenance|Withdrawal by Subject|0|||
30597841|NCT01100437|58609451|FG002|Maintenance|Withdrawal by Subject|1|||
30597842|NCT01100437|58609449|FG000|Maintenance|Sponsor termination of study|0|||
30597843|NCT01100437|58609450|FG001|Maintenance|Sponsor termination of study|0|||
30685291|NCT00734474|58699232|FG007|Overall Study|Protocol Violation|3|||
30783996|NCT03325556|58796193|FG001|Open-label Period|Lack of Response in OL period|0|||
30597844|NCT01100437|58609451|FG002|Maintenance|Sponsor termination of study|1|||
30685292|NCT00734474|58699233|FG008|Overall Study|Protocol Violation|1|||
30685293|NCT00734474|58699225|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
30685294|NCT00734474|58699226|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
30685295|NCT00734474|58699227|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
30685296|NCT00734474|58699228|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
30856230|NCT03194542|58884089|FG001|Overall Study|Loss of Response|2|||
30597845|NCT01322490|58609463|FG000|Treatment Period|Adverse Event|12|||
30597846|NCT01322490|58609464|FG001|Treatment Period|Adverse Event|18|||
30597847|NCT01322490|58609465|FG002|Treatment Period|Adverse Event|15|||
30597848|NCT01322490|58609463|FG000|Treatment Period|Death|5|||
30597849|NCT01322490|58609464|FG001|Treatment Period|Death|7|||
30597850|NCT01322490|58609465|FG002|Treatment Period|Death|3|||
30597851|NCT01322490|58609463|FG000|Treatment Period|Lack of Efficacy|89|||
30597852|NCT01322490|58609464|FG001|Treatment Period|Lack of Efficacy|100|||
30597853|NCT01322490|58609465|FG002|Treatment Period|Lack of Efficacy|112|||
30685297|NCT00734474|58699229|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
30685298|NCT00734474|58699230|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
30685299|NCT00734474|58699231|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
30685300|NCT00734474|58699232|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
30685301|NCT00734474|58699233|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
30685302|NCT00734474|58699225|FG000|Overall Study|Sponsor Decision|0|||
30685303|NCT00734474|58699226|FG001|Overall Study|Sponsor Decision|0|||
30685304|NCT00734474|58699227|FG002|Overall Study|Sponsor Decision|0|||
30685305|NCT00734474|58699228|FG003|Overall Study|Sponsor Decision|0|||
30685306|NCT00734474|58699229|FG004|Overall Study|Sponsor Decision|2|||
30685307|NCT00734474|58699230|FG005|Overall Study|Sponsor Decision|0|||
30685308|NCT00734474|58699231|FG006|Overall Study|Sponsor Decision|0|||
30685309|NCT00734474|58699232|FG007|Overall Study|Sponsor Decision|0|||
30685310|NCT00734474|58699233|FG008|Overall Study|Sponsor Decision|0|||
30685311|NCT00734474|58699225|FG000|Overall Study|Death|0|||
30685312|NCT00734474|58699226|FG001|Overall Study|Death|0|||
30685313|NCT00734474|58699227|FG002|Overall Study|Death|1|||
30685314|NCT00734474|58699228|FG003|Overall Study|Death|0|||
30685315|NCT00734474|58699229|FG004|Overall Study|Death|0|||
30597854|NCT01322490|58609463|FG000|Treatment Period|Physician Decision|0|||
30597855|NCT01322490|58609464|FG001|Treatment Period|Physician Decision|2|||
30685316|NCT00734474|58699230|FG005|Overall Study|Death|0|||
30685317|NCT00734474|58699231|FG006|Overall Study|Death|0|||
30685318|NCT00734474|58699232|FG007|Overall Study|Death|2|||
30685319|NCT00734474|58699233|FG008|Overall Study|Death|1|||
30685320|NCT00734474|58699225|FG000|Overall Study|Lack of Efficacy|0|||
30685321|NCT00734474|58699226|FG001|Overall Study|Lack of Efficacy|0|||
30685322|NCT00734474|58699227|FG002|Overall Study|Lack of Efficacy|4|||
30685323|NCT00734474|58699228|FG003|Overall Study|Lack of Efficacy|0|||
30685324|NCT00734474|58699229|FG004|Overall Study|Lack of Efficacy|0|||
30685325|NCT00734474|58699230|FG005|Overall Study|Lack of Efficacy|0|||
30685326|NCT00734474|58699231|FG006|Overall Study|Lack of Efficacy|0|||
30685327|NCT00734474|58699232|FG007|Overall Study|Lack of Efficacy|4|||
30685328|NCT00734474|58699233|FG008|Overall Study|Lack of Efficacy|6|||
30685329|NCT00583362|58699259|FG000|Overall Study|Adverse Event|44|||
30685330|NCT00583362|58699259|FG000|Overall Study|Lack of Efficacy|22|||
30685331|NCT00583362|58699259|FG000|Overall Study|Lost to Follow-up|4|||
30685332|NCT00583362|58699259|FG000|Overall Study|Non-compliance with study drug|28|||
30685333|NCT00583362|58699259|FG000|Overall Study|Pregnancy|7|||
30685334|NCT00583362|58699259|FG000|Overall Study|Miscommunication of visit window|5|||
30685335|NCT00583362|58699259|FG000|Overall Study|Current site closed|7|||
30685336|NCT00583362|58699259|FG000|Overall Study|Subject not dosed in LBSL99|1|||
30597856|NCT01322490|58609465|FG002|Treatment Period|Physician Decision|1|||
30597857|NCT01322490|58609463|FG000|Treatment Period|Protocol Violation|7|||
30597858|NCT01322490|58609464|FG001|Treatment Period|Protocol Violation|5|||
30597859|NCT01322490|58609465|FG002|Treatment Period|Protocol Violation|4|||
30597860|NCT01322490|58609463|FG000|Treatment Period|Withdrawal by Subject|14|||
30597861|NCT01322490|58609464|FG001|Treatment Period|Withdrawal by Subject|16|||
30597862|NCT01322490|58609465|FG002|Treatment Period|Withdrawal by Subject|11|||
30597863|NCT01322490|58609463|FG000|Treatment Period|Non-compliance with study drug|0|||
30597864|NCT01322490|58609464|FG001|Treatment Period|Non-compliance with study drug|0|||
30597865|NCT01322490|58609465|FG002|Treatment Period|Non-compliance with study drug|1|||
30685337|NCT00583362|58699259|FG000|Overall Study|Subject moved out of the country/state|2|||
30685338|NCT00583362|58699259|FG000|Overall Study|Missed visits due to staff changes|1|||
30685339|NCT00583362|58699259|FG000|Overall Study|Misunderstanding of protocol|1|||
30685340|NCT00583362|58699259|FG000|Overall Study|Behavioral problems and non-compliance|1|||
30685341|NCT00583362|58699259|FG000|Overall Study|Sponsor request due to missed doses|1|||
30685342|NCT00583362|58699259|FG000|Overall Study|Physician Decision|19|||
30685343|NCT00583362|58699259|FG000|Overall Study|Protocol Violation|2|||
30685344|NCT00583362|58699259|FG000|Overall Study|Withdrawal by Subject|57|||
30597866|NCT01322490|58609463|FG000|Treatment Period|Other per report|2|||
30597867|NCT01322490|58609464|FG001|Treatment Period|Other per report|2|||
30597868|NCT01322490|58609465|FG002|Treatment Period|Other per report|1|||
30597869|NCT01322490|58609463|FG000|Treatment Period|Randomized but Not Treated|3|||
30685345|NCT00577473|58699265|FG000|Overall Study|Protocol Violation|1|||
30685346|NCT00577473|58699266|FG001|Overall Study|Protocol Violation|4|||
30685347|NCT00577473|58699265|FG000|Overall Study|Adverse Event|8|||
30685348|NCT00577473|58699266|FG001|Overall Study|Adverse Event|5|||
30685349|NCT00577473|58699265|FG000|Overall Study|Withdrawal by Subject|2|||
30856231|NCT03194542|58884090|FG002|Overall Study|Loss of Response|3|||
30685350|NCT00577473|58699266|FG001|Overall Study|Withdrawal by Subject|6|||
30685351|NCT00577473|58699265|FG000|Overall Study|Physician Decision|2|||
30685352|NCT00577473|58699266|FG001|Overall Study|Physician Decision|2|||
30685353|NCT00577473|58699265|FG000|Overall Study|Lack of Efficacy|8|||
30685354|NCT00577473|58699266|FG001|Overall Study|Lack of Efficacy|7|||
30685355|NCT00785291|58699275|FG000|Overall Study|Never began treatment|8|||
30685356|NCT00785291|58699276|FG001|Overall Study|Never began treatment|4|||
30685357|NCT00785291|58699277|FG002|Overall Study|Never began treatment|4|||
30685358|NCT00785291|58699275|FG000|Overall Study|Adverse Event|39|||
30685359|NCT00785291|58699276|FG001|Overall Study|Adverse Event|70|||
30685360|NCT00785291|58699277|FG002|Overall Study|Adverse Event|56|||
30685361|NCT00785291|58699275|FG000|Overall Study|Death|7|||
30685362|NCT00785291|58699276|FG001|Overall Study|Death|4|||
30685363|NCT00785291|58699277|FG002|Overall Study|Death|3|||
30685364|NCT00785291|58699275|FG000|Overall Study|Withdrawal by Subject|35|||
30597870|NCT01322490|58609464|FG001|Treatment Period|Randomized but Not Treated|3|||
30597871|NCT01322490|58609465|FG002|Treatment Period|Randomized but Not Treated|5|||
30597872|NCT01322490|58609463|FG000|Long Term Follow-up Period|Death|235|||
30685365|NCT00785291|58699276|FG001|Overall Study|Withdrawal by Subject|36|||
30685366|NCT00785291|58699277|FG002|Overall Study|Withdrawal by Subject|17|||
30685367|NCT00785291|58699275|FG000|Overall Study|Alternative Therapy|12|||
30685368|NCT00785291|58699276|FG001|Overall Study|Alternative Therapy|6|||
30685369|NCT00785291|58699277|FG002|Overall Study|Alternative Therapy|7|||
30685370|NCT00785291|58699275|FG000|Overall Study|Complicating illness|6|||
30685371|NCT00785291|58699276|FG001|Overall Study|Complicating illness|4|||
30685372|NCT00785291|58699277|FG002|Overall Study|Complicating illness|4|||
30685373|NCT00785291|58699275|FG000|Overall Study|Other Medical Reasons|29|||
30685374|NCT00785291|58699276|FG001|Overall Study|Other Medical Reasons|25|||
30685375|NCT00785291|58699277|FG002|Overall Study|Other Medical Reasons|15|||
30685376|NCT00705939|58699288|FG000|Overall Study|Protocol Violation|0|||
30685377|NCT00705939|58699289|FG001|Overall Study|Protocol Violation|0|||
30685378|NCT00705939|58699290|FG002|Overall Study|Protocol Violation|1|||
30685379|NCT00705939|58699288|FG000|Overall Study|Withdrawal by Subject|0|||
30685380|NCT00705939|58699289|FG001|Overall Study|Withdrawal by Subject|1|||
30685381|NCT00705939|58699290|FG002|Overall Study|Withdrawal by Subject|3|||
30685382|NCT00705939|58699288|FG000|Overall Study|Physician Decision|0|||
30685383|NCT00705939|58699289|FG001|Overall Study|Physician Decision|1|||
30685384|NCT00705939|58699290|FG002|Overall Study|Physician Decision|0|||
30685385|NCT00785213|58699299|FG000|Quinine Sulfate Alone|Adverse Event|4|||
30685386|NCT00785213|58699299|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
30685387|NCT00577317|58699308|FG000|Overall Study|Study Terminated|0|||
30685388|NCT00577317|58699309|FG001|Overall Study|Study Terminated|2|||
30685389|NCT00734162|58699319|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
30685390|NCT00734162|58699320|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
30685391|NCT00734162|58699321|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
30685392|NCT00734162|58699322|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
30685393|NCT00734162|58699319|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
30685394|NCT00734162|58699320|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
30685395|NCT00734162|58699321|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
30685396|NCT00734162|58699322|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
30685397|NCT00734162|58699319|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
30597873|NCT01322490|58609464|FG001|Long Term Follow-up Period|Death|239|||
30685398|NCT00734162|58699320|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
30685399|NCT00734162|58699321|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
30685400|NCT00734162|58699322|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
30597874|NCT01322490|58609465|FG002|Long Term Follow-up Period|Death|236|||
30597875|NCT01322490|58609463|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
30597876|NCT01322490|58609464|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
30597877|NCT01322490|58609465|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
30597878|NCT01322490|58609463|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
30597879|NCT01322490|58609464|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
30597880|NCT01322490|58609465|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
30597881|NCT01322490|58609463|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
30597882|NCT01322490|58609464|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
30597883|NCT01322490|58609465|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
30685401|NCT00734162|58699319|FG000|Open-Label Phase|Withdrew Consent|1|||
30685402|NCT00734162|58699320|FG001|Open-Label Phase|Withdrew Consent|0|||
30685403|NCT00734162|58699321|FG002|Open-Label Phase|Withdrew Consent|1|||
30685404|NCT00734162|58699322|FG003|Open-Label Phase|Withdrew Consent|1|||
30783997|NCT03325556|58796194|FG002|Open-label Period|Lack of Response in OL period|0|||
30685405|NCT00734162|58699319|FG000|Open-Label Phase|Lost to Follow-up|1|||
30783998|NCT03325556|58796192|FG000|Open-label Period|Adverse Event|27|||
30783999|NCT03325556|58796193|FG001|Open-label Period|Adverse Event|0|||
30784000|NCT03325556|58796194|FG002|Open-label Period|Adverse Event|0|||
30685406|NCT00734162|58699320|FG001|Open-Label Phase|Lost to Follow-up|2|||
30685407|NCT00734162|58699321|FG002|Open-Label Phase|Lost to Follow-up|0|||
30685408|NCT00734162|58699322|FG003|Open-Label Phase|Lost to Follow-up|1|||
30685409|NCT00734162|58699319|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
30685410|NCT00734162|58699320|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
30959212|NCT02684370|59024559|FG005|Part B|Adverse Event|1|||
30959213|NCT02684370|59024554|FG000|Part B|Lost to Follow-up|0|||
30959214|NCT02684370|59024555|FG001|Part B|Lost to Follow-up|0|||
30959215|NCT02684370|59024556|FG002|Part B|Lost to Follow-up|0|||
30959216|NCT02684370|59024557|FG003|Part B|Lost to Follow-up|1|||
30959217|NCT02684370|59024558|FG004|Part B|Lost to Follow-up|2|||
30597884|NCT01322490|58609463|FG000|Long Term Follow-up Period|Other per report|3|||
30597885|NCT01322490|58609464|FG001|Long Term Follow-up Period|Other per report|2|||
30597886|NCT01322490|58609465|FG002|Long Term Follow-up Period|Other per report|2|||
30597887|NCT01322490|58609463|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
30597888|NCT01322490|58609464|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
30597889|NCT01322490|58609465|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
30597890|NCT01314261|58609477|FG000|Overall Study|Adverse Event|1|||
30597891|NCT01314261|58609478|FG001|Overall Study|Adverse Event|0|||
30597892|NCT01314261|58609479|FG002|Overall Study|Adverse Event|0|||
30597893|NCT01314261|58609480|FG003|Overall Study|Adverse Event|0|||
30597894|NCT01314261|58609477|FG000|Overall Study|Withdrawal by Subject|0|||
30597895|NCT01314261|58609478|FG001|Overall Study|Withdrawal by Subject|3|||
30597896|NCT01314261|58609479|FG002|Overall Study|Withdrawal by Subject|1|||
30597897|NCT01314261|58609480|FG003|Overall Study|Withdrawal by Subject|0|||
30597898|NCT01314261|58609477|FG000|Overall Study|Lost to Follow-up|1|||
30597899|NCT01314261|58609478|FG001|Overall Study|Lost to Follow-up|0|||
30597900|NCT01314261|58609479|FG002|Overall Study|Lost to Follow-up|2|||
30597901|NCT01314261|58609480|FG003|Overall Study|Lost to Follow-up|2|||
30597902|NCT01314261|58609477|FG000|Overall Study|Virologic Failure|0|||
30597903|NCT01314261|58609478|FG001|Overall Study|Virologic Failure|1|||
30597904|NCT01314261|58609479|FG002|Overall Study|Virologic Failure|0|||
30597905|NCT01314261|58609480|FG003|Overall Study|Virologic Failure|1|||
30597906|NCT01321710|58609493|FG000|Overall Study|Lost to Follow-up|4|||
30597907|NCT01321710|58609494|FG001|Overall Study|Lost to Follow-up|5|||
30597908|NCT01321710|58609495|FG002|Overall Study|Lost to Follow-up|0|||
30597909|NCT01321008|58609505|FG000|Overall Study|Early Study Termination|1|||
30597910|NCT01320150|58609511|FG000|Overall Study|Protocol Violation|15|||
30597911|NCT01320150|58609511|FG000|Overall Study|Withdrawal by Subject|5|||
30597912|NCT01320150|58609511|FG000|Overall Study|Death|2|||
30597913|NCT01320150|58609511|FG000|Overall Study|Lost to Follow-up|44|||
30597914|NCT01323530|58609522|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
30597915|NCT01323530|58609523|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
30597916|NCT01323530|58609524|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
30597917|NCT01323530|58609525|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
30597918|NCT01323530|58609526|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
30597919|NCT01323530|58609527|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
30597920|NCT01323530|58609528|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
30597921|NCT01323530|58609522|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
30597922|NCT01323530|58609523|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
30597923|NCT01323530|58609524|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
30597924|NCT01323530|58609525|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
30597925|NCT01323530|58609526|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
30597926|NCT01323530|58609527|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
30597927|NCT01323530|58609528|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
30597928|NCT01323530|58609522|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
30597929|NCT01323530|58609523|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
30597930|NCT01323530|58609524|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
30597931|NCT01323530|58609525|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
30597932|NCT01323530|58609526|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
30597933|NCT01323530|58609527|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
30597934|NCT01323530|58609528|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
30597935|NCT01323530|58609522|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
30597936|NCT01323530|58609523|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
30597937|NCT01323530|58609524|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
30685411|NCT00734162|58699321|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
30959218|NCT02684370|59024559|FG005|Part B|Lost to Follow-up|5|||
30597938|NCT01323530|58609525|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
30597939|NCT01323530|58609526|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
30597940|NCT01323530|58609527|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
30597941|NCT01323530|58609528|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
30597942|NCT01323530|58609522|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
30959219|NCT02684370|59024554|FG000|Part B|Subject Withdrawal|0|||
30959220|NCT02684370|59024555|FG001|Part B|Subject Withdrawal|0|||
30597943|NCT01323530|58609523|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
30597944|NCT01323530|58609524|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
30597945|NCT01323530|58609525|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
30597946|NCT01323530|58609526|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
30597947|NCT01323530|58609527|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
30597948|NCT01323530|58609528|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
30597949|NCT01323530|58609522|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
30597950|NCT01323530|58609523|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
30597951|NCT01323530|58609524|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
30597952|NCT01323530|58609525|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
30597953|NCT01323530|58609526|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
30597954|NCT01323530|58609527|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
30597955|NCT01323530|58609528|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
30597956|NCT01323530|58609522|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
30597957|NCT01323530|58609523|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
30597958|NCT01323530|58609524|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
30597959|NCT01323530|58609525|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
30597960|NCT01323530|58609526|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
30597961|NCT01323530|58609527|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
30597962|NCT01323530|58609528|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
30597963|NCT01323530|58609522|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
30597964|NCT01323530|58609523|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
30597965|NCT01323530|58609524|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
30597966|NCT01323530|58609525|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
30597967|NCT01323530|58609526|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
30597968|NCT01323530|58609527|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
30597969|NCT01323530|58609528|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
30597970|NCT01313637|58609549|FG000|Overall Study|Adverse Event|17|||
30597971|NCT01313637|58609550|FG001|Overall Study|Adverse Event|24|||
30597972|NCT01313637|58609551|FG002|Overall Study|Adverse Event|25|||
30597973|NCT01313637|58609552|FG003|Overall Study|Adverse Event|18|||
30597974|NCT01313637|58609549|FG000|Overall Study|Lack of Efficacy|44|||
30597975|NCT01313637|58609550|FG001|Overall Study|Lack of Efficacy|38|||
30597976|NCT01313637|58609551|FG002|Overall Study|Lack of Efficacy|37|||
30597977|NCT01313637|58609552|FG003|Overall Study|Lack of Efficacy|24|||
30597978|NCT01313637|58609549|FG000|Overall Study|Protocol Violation|4|||
30597979|NCT01313637|58609550|FG001|Overall Study|Protocol Violation|3|||
30597980|NCT01313637|58609551|FG002|Overall Study|Protocol Violation|11|||
30597981|NCT01313637|58609552|FG003|Overall Study|Protocol Violation|5|||
30597982|NCT01313637|58609549|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
30597983|NCT01313637|58609550|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
30597984|NCT01313637|58609551|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
30597985|NCT01313637|58609552|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
30597986|NCT01313637|58609549|FG000|Overall Study|Lost to Follow-up|0|||
30597987|NCT01313637|58609550|FG001|Overall Study|Lost to Follow-up|2|||
30597988|NCT01313637|58609551|FG002|Overall Study|Lost to Follow-up|1|||
30597989|NCT01313637|58609552|FG003|Overall Study|Lost to Follow-up|3|||
30597990|NCT01313637|58609549|FG000|Overall Study|Withdrawal by Subject|11|||
30597991|NCT01313637|58609550|FG001|Overall Study|Withdrawal by Subject|13|||
30597992|NCT01313637|58609551|FG002|Overall Study|Withdrawal by Subject|18|||
30597993|NCT01313637|58609552|FG003|Overall Study|Withdrawal by Subject|15|||
30597994|NCT01320722|58609567|FG000|Overall Study|Did not Receive Intervention|3|||
30597995|NCT01320722|58609568|FG001|Overall Study|Did not Receive Intervention|2|||
30597996|NCT01320722|58609569|FG002|Overall Study|Did not Receive Intervention|1|||
30685412|NCT00734162|58699322|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
30685413|NCT00790751|58699340|FG000|Overall Study|Protocol non-compliance|16|||
30685414|NCT00790751|58699341|FG001|Overall Study|Protocol non-compliance|16|||
30685415|NCT00790751|58699342|FG002|Overall Study|Protocol non-compliance|10|||
30685416|NCT00790751|58699343|FG003|Overall Study|Protocol non-compliance|11|||
30685417|NCT00790751|58699340|FG000|Overall Study|Lost to Follow-up|4|||
30685418|NCT00790751|58699341|FG001|Overall Study|Lost to Follow-up|9|||
30685419|NCT00790751|58699342|FG002|Overall Study|Lost to Follow-up|4|||
30685420|NCT00790751|58699343|FG003|Overall Study|Lost to Follow-up|5|||
30685421|NCT00790751|58699340|FG000|Overall Study|Adverse Event|5|||
30685422|NCT00790751|58699341|FG001|Overall Study|Adverse Event|3|||
30784001|NCT03325556|58796192|FG000|Open-label Period|Death|1|||
30784002|NCT03325556|58796193|FG001|Open-label Period|Death|0|||
30597997|NCT01320722|58609570|FG003|Overall Study|Did not Receive Intervention|1|||
30597998|NCT01320722|58609571|FG004|Overall Study|Did not Receive Intervention|2|||
30597999|NCT01320722|58609567|FG000|Overall Study|Lost to Follow-up|0|||
30784003|NCT03325556|58796194|FG002|Open-label Period|Death|0|||
30784004|NCT03325556|58796192|FG000|Open-label Period|Lost to Follow-up|1|||
30598000|NCT01320722|58609568|FG001|Overall Study|Lost to Follow-up|1|||
30598001|NCT01320722|58609569|FG002|Overall Study|Lost to Follow-up|0|||
30598002|NCT01320722|58609570|FG003|Overall Study|Lost to Follow-up|1|||
30598003|NCT01320722|58609571|FG004|Overall Study|Lost to Follow-up|3|||
30598004|NCT01320722|58609567|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
30598005|NCT01320722|58609568|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
30598006|NCT01320722|58609569|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
30598007|NCT01320722|58609570|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
30598008|NCT01320722|58609571|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
30598009|NCT01320722|58609567|FG000|Overall Study|Participant Developed a Rash|0|||
30598010|NCT01320722|58609568|FG001|Overall Study|Participant Developed a Rash|0|||
30598011|NCT01320722|58609569|FG002|Overall Study|Participant Developed a Rash|2|||
30598012|NCT01320722|58609570|FG003|Overall Study|Participant Developed a Rash|1|||
30598013|NCT01320722|58609571|FG004|Overall Study|Participant Developed a Rash|1|||
30598014|NCT01320722|58609567|FG000|Overall Study|Non-compliant with Medication|0|||
30598015|NCT01320722|58609568|FG001|Overall Study|Non-compliant with Medication|0|||
30598016|NCT01320722|58609569|FG002|Overall Study|Non-compliant with Medication|1|||
30598017|NCT01320722|58609570|FG003|Overall Study|Non-compliant with Medication|0|||
30598018|NCT01320722|58609571|FG004|Overall Study|Non-compliant with Medication|0|||
30598019|NCT01320722|58609567|FG000|Overall Study|Adverse Event|0|||
30598020|NCT01320722|58609568|FG001|Overall Study|Adverse Event|0|||
30598021|NCT01320722|58609569|FG002|Overall Study|Adverse Event|3|||
30598022|NCT01320722|58609570|FG003|Overall Study|Adverse Event|6|||
30598023|NCT01320722|58609571|FG004|Overall Study|Adverse Event|0|||
30598024|NCT01320722|58609567|FG000|Overall Study|Not Compliant with Study Procedures|0|||
30598025|NCT01320722|58609568|FG001|Overall Study|Not Compliant with Study Procedures|0|||
30598026|NCT01320722|58609569|FG002|Overall Study|Not Compliant with Study Procedures|0|||
30598027|NCT01320722|58609570|FG003|Overall Study|Not Compliant with Study Procedures|4|||
30598028|NCT01320722|58609571|FG004|Overall Study|Not Compliant with Study Procedures|0|||
30598029|NCT01320722|58609567|FG000|Overall Study|Pregnancy|0|||
30598030|NCT01320722|58609568|FG001|Overall Study|Pregnancy|0|||
30598031|NCT01320722|58609569|FG002|Overall Study|Pregnancy|0|||
30598032|NCT01320722|58609570|FG003|Overall Study|Pregnancy|1|||
30598033|NCT01320722|58609571|FG004|Overall Study|Pregnancy|0|||
30598034|NCT01320722|58609567|FG000|Overall Study|Started an Exclusionary Medication|0|||
30598035|NCT01320722|58609568|FG001|Overall Study|Started an Exclusionary Medication|0|||
30598036|NCT01320722|58609569|FG002|Overall Study|Started an Exclusionary Medication|0|||
30598037|NCT01320722|58609570|FG003|Overall Study|Started an Exclusionary Medication|0|||
30598038|NCT01320722|58609571|FG004|Overall Study|Started an Exclusionary Medication|1|||
30598039|NCT01320722|58609567|FG000|Overall Study|Withdrew due to Health Condition|0|||
30598040|NCT01320722|58609568|FG001|Overall Study|Withdrew due to Health Condition|0|||
30598041|NCT01320722|58609569|FG002|Overall Study|Withdrew due to Health Condition|0|||
30598042|NCT01320722|58609570|FG003|Overall Study|Withdrew due to Health Condition|0|||
30598043|NCT01320722|58609571|FG004|Overall Study|Withdrew due to Health Condition|1|||
30598044|NCT01313559|58609588|FG000|Overall Study|Withdrawal by Subject|1|||
30598045|NCT01313559|58609589|FG001|Overall Study|Withdrawal by Subject|2|||
30598046|NCT01313559|58609588|FG000|Overall Study|Disease progression|1|||
30685423|NCT00790751|58699342|FG002|Overall Study|Adverse Event|5|||
30685424|NCT00790751|58699343|FG003|Overall Study|Adverse Event|4|||
30685425|NCT00790751|58699340|FG000|Overall Study|Requirement for restricted medication|0|||
30685426|NCT00790751|58699341|FG001|Overall Study|Requirement for restricted medication|2|||
30685427|NCT00790751|58699342|FG002|Overall Study|Requirement for restricted medication|0|||
30685428|NCT00790751|58699343|FG003|Overall Study|Requirement for restricted medication|0|||
30685429|NCT00790751|58699340|FG000|Overall Study|Death|0|||
30685430|NCT00790751|58699341|FG001|Overall Study|Death|0|||
30685431|NCT00790751|58699342|FG002|Overall Study|Death|1|||
30685432|NCT00790751|58699343|FG003|Overall Study|Death|0|||
30685433|NCT00790751|58699340|FG000|Overall Study|Physician Decision|0|||
30685434|NCT00790751|58699341|FG001|Overall Study|Physician Decision|0|||
30685435|NCT00790751|58699342|FG002|Overall Study|Physician Decision|0|||
30685436|NCT00790751|58699343|FG003|Overall Study|Physician Decision|1|||
30685437|NCT00784979|58699353|FG000|Overall Study|incomplete data|6|||
30685438|NCT00738920|58699360|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
30685439|NCT00738920|58699361|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
30685440|NCT00738920|58699362|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
30685441|NCT00738920|58699360|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
30685442|NCT00738920|58699361|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
30685443|NCT00738920|58699362|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
30598047|NCT01313559|58609589|FG001|Overall Study|Disease progression|0|||
30598048|NCT01313559|58609588|FG000|Overall Study|Rising PSA|2|||
30598049|NCT01313559|58609589|FG001|Overall Study|Rising PSA|0|||
30598050|NCT01312779|58609595|FG000|Overall Study|Withdrawal by Subject|2|||
30685444|NCT00738920|58699360|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
30685445|NCT00738920|58699361|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
30685446|NCT00738920|58699362|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
30685447|NCT00738920|58699360|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
30685448|NCT00738920|58699361|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
30685449|NCT00738920|58699362|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
30685450|NCT00738920|58699360|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
30685451|NCT00738920|58699361|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
30685452|NCT00738920|58699362|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
30685453|NCT00738920|58699360|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
30685454|NCT00738920|58699361|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
30685455|NCT00738920|58699362|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
30685456|NCT00738920|58699360|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
30685457|NCT00738920|58699361|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
30685458|NCT00738920|58699362|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
30685459|NCT00738920|58699360|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
30685460|NCT00738920|58699361|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
30685461|NCT00738920|58699362|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
30685462|NCT00738920|58699360|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
30685463|NCT00738920|58699361|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
30685464|NCT00738920|58699362|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
30685465|NCT00738920|58699360|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
30685466|NCT00738920|58699361|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
30685467|NCT00738920|58699362|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
30685468|NCT00582972|58699370|FG000|Overall Study|Protocol Violation|2|||
30685469|NCT04319718|58699377|FG000|Overall Study|Adverse Event|0|||
30685470|NCT04319718|58699378|FG001|Overall Study|Adverse Event|2|||
30685471|NCT04319718|58699377|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
30685472|NCT04319718|58699378|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
30685473|NCT04372602|58699386|FG000|Overall Study|Withdrawal by Subject|1|||
30685474|NCT04372602|58699387|FG001|Overall Study|Withdrawal by Subject|1|||
30685475|NCT04372602|58699386|FG000|Overall Study|Adverse Event|0|||
30685476|NCT04372602|58699387|FG001|Overall Study|Adverse Event|1|||
30685477|NCT04372602|58699386|FG000|Overall Study|Transitioned to comfort care|0|||
30685478|NCT04372602|58699387|FG001|Overall Study|Transitioned to comfort care|1|||
30685479|NCT00733304|58699396|FG000|Overall Study|Adverse Event|3|||
30685480|NCT00733304|58699397|FG001|Overall Study|Adverse Event|0|||
30685481|NCT00733304|58699398|FG002|Overall Study|Adverse Event|0|||
30685482|NCT00733304|58699396|FG000|Overall Study|Lack of Efficacy|0|||
30685483|NCT00733304|58699397|FG001|Overall Study|Lack of Efficacy|0|||
30685484|NCT00733304|58699398|FG002|Overall Study|Lack of Efficacy|2|||
30685485|NCT00733304|58699396|FG000|Overall Study|Lost to Follow-up|0|||
30685486|NCT00733304|58699397|FG001|Overall Study|Lost to Follow-up|1|||
30685487|NCT00733304|58699398|FG002|Overall Study|Lost to Follow-up|0|||
30685488|NCT00733304|58699396|FG000|Overall Study|Physician Decision|3|||
30685489|NCT00733304|58699397|FG001|Overall Study|Physician Decision|1|||
30685490|NCT00733304|58699398|FG002|Overall Study|Physician Decision|3|||
30685491|NCT00733304|58699396|FG000|Overall Study|Withdrawal by Subject|1|||
30685492|NCT00733304|58699397|FG001|Overall Study|Withdrawal by Subject|1|||
30685493|NCT00733304|58699398|FG002|Overall Study|Withdrawal by Subject|0|||
30685494|NCT00711243|58699412|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
30685495|NCT00711243|58699413|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
30685496|NCT00711243|58699414|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
30685497|NCT00711243|58699415|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
30685498|NCT00711243|58699416|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
30685499|NCT00711243|58699417|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
30685500|NCT00711243|58699412|FG000|Reached First Response/4 Cycles|Death|0|||
30685501|NCT00711243|58699413|FG001|Reached First Response/4 Cycles|Death|0|||
30685502|NCT00711243|58699414|FG002|Reached First Response/4 Cycles|Death|0|||
30685503|NCT00711243|58699415|FG003|Reached First Response/4 Cycles|Death|0|||
30685504|NCT00711243|58699416|FG004|Reached First Response/4 Cycles|Death|0|||
30685505|NCT00711243|58699417|FG005|Reached First Response/4 Cycles|Death|2|||
30685506|NCT00711243|58699412|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
30685507|NCT00711243|58699413|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
30685508|NCT00711243|58699414|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
30685509|NCT00711243|58699415|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
30685510|NCT00711243|58699416|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
30685511|NCT00711243|58699417|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
30685512|NCT00711243|58699412|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
30685513|NCT00711243|58699413|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
30685514|NCT00711243|58699414|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
30685515|NCT00711243|58699415|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
30685516|NCT00711243|58699416|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
30685517|NCT00711243|58699417|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
30685518|NCT00711243|58699412|FG000|Treated Cycle 5 After First Response|Death|0|||
30685519|NCT00711243|58699413|FG001|Treated Cycle 5 After First Response|Death|0|||
30685520|NCT00711243|58699414|FG002|Treated Cycle 5 After First Response|Death|0|||
30685521|NCT00711243|58699415|FG003|Treated Cycle 5 After First Response|Death|0|||
30685522|NCT00711243|58699416|FG004|Treated Cycle 5 After First Response|Death|0|||
30685523|NCT00711243|58699417|FG005|Treated Cycle 5 After First Response|Death|2|||
30685524|NCT00711243|58699412|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
30685525|NCT00711243|58699413|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
30685526|NCT00711243|58699414|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
30685527|NCT00711243|58699415|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
30685528|NCT00711243|58699416|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
30685529|NCT00711243|58699417|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
30685530|NCT00711243|58699412|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
30685531|NCT00711243|58699413|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
30685532|NCT00711243|58699414|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
30598051|NCT01312779|58609595|FG000|Overall Study|Death|3|||
30598052|NCT01312779|58609595|FG000|Overall Study|Not Implanted with Device|27|||
30598053|NCT01312467|58609608|FG000|Overall Study|Adverse Event|4|||
30598054|NCT01312467|58609608|FG000|Overall Study|Lost to Follow-up|1|||
30598055|NCT01312467|58609608|FG000|Overall Study|Withdrawal by Subject|2|||
30598056|NCT01312467|58609608|FG000|Overall Study|Deported to country of origin|1|||
30598057|NCT01312467|58609608|FG000|Overall Study|Another medical condition|1|||
30598058|NCT01312467|58609608|FG000|Overall Study|Ineligible|4|||
30598059|NCT01310127|58609615|FG000|Overall Study|Protocol Violation|1|||
30598060|NCT01310127|58609616|FG001|Overall Study|Protocol Violation|1|||
30598061|NCT01310127|58609615|FG000|Overall Study|advanced psc cataract outlier|1|||
30598062|NCT01310127|58609616|FG001|Overall Study|advanced psc cataract outlier|0|||
30598063|NCT01309893|58609622|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
30598064|NCT01309893|58609623|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
30598065|NCT01309893|58609622|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
30598066|NCT01309893|58609623|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
30598067|NCT01318902|58609633|FG000|Overall Study|Symptomatic Deterioration|0|||
30598068|NCT01318902|58609634|FG001|Overall Study|Symptomatic Deterioration|1|||
30598069|NCT01318902|58609635|FG002|Overall Study|Symptomatic Deterioration|1|||
30598070|NCT01318902|58609636|FG003|Overall Study|Symptomatic Deterioration|2|||
30598071|NCT01318902|58609633|FG000|Overall Study|Withdrawal by Patient|0|||
30598072|NCT01318902|58609634|FG001|Overall Study|Withdrawal by Patient|1|||
30598073|NCT01318902|58609635|FG002|Overall Study|Withdrawal by Patient|0|||
30598074|NCT01318902|58609636|FG003|Overall Study|Withdrawal by Patient|3|||
30598075|NCT01318902|58609633|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
30598076|NCT01318902|58609634|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
30598077|NCT01318902|58609635|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
30598078|NCT01318902|58609636|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
30598079|NCT01318902|58609633|FG000|Overall Study|Adverse Event|0|||
30598080|NCT01318902|58609634|FG001|Overall Study|Adverse Event|1|||
30685533|NCT00711243|58699415|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
30685534|NCT00711243|58699416|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
30685535|NCT00711243|58699417|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
30685536|NCT00733226|58699435|FG000|Overall Study|Withdrawal by Subject|1|||
30685537|NCT00733226|58699436|FG001|Overall Study|Withdrawal by Subject|0|||
30685538|NCT00733226|58699435|FG000|Overall Study|Lost to Follow-up|2|||
30685539|NCT00733226|58699436|FG001|Overall Study|Lost to Follow-up|0|||
30685540|NCT00733226|58699435|FG000|Overall Study|moved to another place|2|||
30685541|NCT00733226|58699436|FG001|Overall Study|moved to another place|0|||
30685542|NCT00732992|58699444|FG000|Overall Study|Adverse Event|1|||
30685543|NCT00732992|58699445|FG001|Overall Study|Adverse Event|1|||
30685544|NCT00732992|58699444|FG000|Overall Study|Objective Progression or Relapse|3|||
30685545|NCT00732992|58699445|FG001|Overall Study|Objective Progression or Relapse|5|||
30685546|NCT00732992|58699444|FG000|Overall Study|Global Deterioration of Health Status|1|||
30598081|NCT01318902|58609635|FG002|Overall Study|Adverse Event|0|||
30598082|NCT01318902|58609636|FG003|Overall Study|Adverse Event|0|||
30598083|NCT01318902|58609633|FG000|Overall Study|Terminated by Sponsor|0|||
30598084|NCT01318902|58609634|FG001|Overall Study|Terminated by Sponsor|0|||
30598085|NCT01318902|58609635|FG002|Overall Study|Terminated by Sponsor|1|||
30598086|NCT01318902|58609636|FG003|Overall Study|Terminated by Sponsor|0|||
30598087|NCT01313858|58609651|FG000|Overall Study|Premature Treatment Termination|251|||
30598088|NCT01313858|58609652|FG001|Overall Study|Premature Treatment Termination|219|||
30598089|NCT01313858|58609653|FG002|Overall Study|Premature Treatment Termination|191|||
30685547|NCT00732992|58699445|FG001|Overall Study|Global Deterioration of Health Status|0|||
30685548|NCT00732992|58699444|FG000|Overall Study|Withdrawal by Subject|1|||
30685549|NCT00732992|58699445|FG001|Overall Study|Withdrawal by Subject|0|||
30685550|NCT00732758|58699454|FG000|Overall Study|Lost to Follow-up|8|||
30685551|NCT00732758|58699455|FG001|Overall Study|Lost to Follow-up|16|||
30685552|NCT00699153|58699463|FG000|Overall Study|Lost to Follow-up|1|||
30685553|NCT00699153|58699464|FG001|Overall Study|Lost to Follow-up|0|||
30685554|NCT00699153|58699463|FG000|Overall Study|Adverse Event|0|||
30685555|NCT00699153|58699464|FG001|Overall Study|Adverse Event|2|||
30685556|NCT00699153|58699463|FG000|Overall Study|Protocol Violation|1|||
30685557|NCT00699153|58699464|FG001|Overall Study|Protocol Violation|0|||
30685558|NCT00699153|58699463|FG000|Overall Study|Travel Problem|1|||
30685559|NCT00699153|58699464|FG001|Overall Study|Travel Problem|0|||
30685560|NCT00698997|58699472|FG000|Overall Study|Lost to Follow-up|3|||
30685561|NCT00698997|58699473|FG001|Overall Study|Lost to Follow-up|0|||
30685562|NCT00698997|58699472|FG000|Overall Study|Withdrawal by Subject|7|||
30685563|NCT00698997|58699473|FG001|Overall Study|Withdrawal by Subject|27|||
30685564|NCT00711087|58699482|FG000|Overall Study|Lost to Follow-up|1|||
30685565|NCT00711087|58699483|FG001|Overall Study|Lost to Follow-up|0|||
30685566|NCT00738530|58699491|FG000|Overall Study|Death|220|||
30685567|NCT00738530|58699492|FG001|Overall Study|Death|224|||
30685568|NCT00738530|58699491|FG000|Overall Study|Lost to Follow-up|8|||
30685569|NCT00738530|58699492|FG001|Overall Study|Lost to Follow-up|6|||
30685570|NCT00738530|58699491|FG000|Overall Study|Withdrawal by Subject|6|||
30598090|NCT01313858|58609651|FG000|Overall Study|Lost to Follow-up|35|||
30598091|NCT01313858|58609652|FG001|Overall Study|Lost to Follow-up|51|||
30598092|NCT01313858|58609653|FG002|Overall Study|Lost to Follow-up|47|||
30598093|NCT01090765|58609665|FG000|Overall Study|Patient withdrew consent|0|||
30598094|NCT01090765|58609666|FG001|Overall Study|Patient withdrew consent|0|||
30598095|NCT01090765|58609667|FG002|Overall Study|Patient withdrew consent|0|||
30685571|NCT00738530|58699492|FG001|Overall Study|Withdrawal by Subject|8|||
30685572|NCT00711009|58699500|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
30685573|NCT00711009|58699501|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
30685574|NCT00711009|58699500|FG000|Overall Study|Withdrawal by Subject|4|||
30685575|NCT00711009|58699501|FG001|Overall Study|Withdrawal by Subject|2|||
30685576|NCT00711009|58699500|FG000|Overall Study|Lost to Follow-up|3|||
30685577|NCT00711009|58699501|FG001|Overall Study|Lost to Follow-up|9|||
30685578|NCT00711009|58699500|FG000|Overall Study|Participant Noncompliant|0|||
30959221|NCT02684370|59024556|FG002|Part B|Subject Withdrawal|0|||
30959222|NCT02684370|59024557|FG003|Part B|Subject Withdrawal|1|||
30959223|NCT02684370|59024558|FG004|Part B|Subject Withdrawal|1|||
30959224|NCT02684370|59024559|FG005|Part B|Subject Withdrawal|2|||
30598096|NCT01090765|58609668|FG003|Overall Study|Patient withdrew consent|0|||
30598097|NCT01090765|58609669|FG004|Overall Study|Patient withdrew consent|1|||
30598098|NCT01090765|58609670|FG005|Overall Study|Patient withdrew consent|1|||
30598099|NCT01090765|58609665|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
30685579|NCT00711009|58699501|FG001|Overall Study|Participant Noncompliant|1|||
30685580|NCT00711009|58699500|FG000|Overall Study|Virologic Failure|2|||
30685581|NCT00711009|58699501|FG001|Overall Study|Virologic Failure|1|||
30685582|NCT00711009|58699500|FG000|Overall Study|Pregnancy|1|||
30598100|NCT01090765|58609666|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
30685583|NCT00711009|58699501|FG001|Overall Study|Pregnancy|0|||
30685584|NCT00711009|58699500|FG000|Overall Study|Site closing|0|||
30685585|NCT00711009|58699501|FG001|Overall Study|Site closing|1|||
30685586|NCT00711009|58699500|FG000|Overall Study|Dose adjustment|1|||
30784005|NCT03325556|58796193|FG001|Open-label Period|Lost to Follow-up|0|||
30959225|NCT01686581|59024586|FG000|Overall Study|Side-effects or Health Problems|15|||
30598101|NCT01090765|58609667|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
30598102|NCT01090765|58609668|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
30598103|NCT01090765|58609669|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
30598104|NCT01090765|58609670|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
30598105|NCT01090765|58609665|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
30598106|NCT01090765|58609666|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
30598107|NCT01090765|58609667|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
30598108|NCT01090765|58609668|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
30598109|NCT01090765|58609669|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
30598110|NCT01090765|58609670|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
30685587|NCT00711009|58699501|FG001|Overall Study|Dose adjustment|0|||
30685588|NCT00577005|58699509|FG000|Overall Study|Lost to Follow-up|3|||
30685589|NCT00577005|58699510|FG001|Overall Study|Lost to Follow-up|2|||
30685590|NCT00577005|58699509|FG000|Overall Study|Withdrawal by Subject|2|||
30685591|NCT00577005|58699510|FG001|Overall Study|Withdrawal by Subject|1|||
30685592|NCT00576927|58699521|FG000|Clinical Assessment|Lack of Efficacy|24|||
30685593|NCT00576927|58699521|FG000|Clinical Assessment|Death|1|||
30959226|NCT01686581|59024586|FG000|Overall Study|Lack of Efficacy|90|||
30685594|NCT00576927|58699521|FG000|Clinical Assessment|Withdrawal by Subject|10|||
30685595|NCT00576927|58699521|FG000|Clinical Assessment|Physician Decision|1|||
30685596|NCT00576927|58699521|FG000|Baseline|Physician Decision|9|||
30685597|NCT00576927|58699521|FG000|Baseline|Medication Change by PCP of subject|1|||
30685598|NCT00576927|58699521|FG000|Baseline|Withdrawal by Subject|3|||
30685599|NCT00576927|58699521|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
30685600|NCT00576927|58699521|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
30685601|NCT00576927|58699521|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
30685602|NCT00576927|58699521|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
30685603|NCT00576927|58699521|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
30685604|NCT00698841|58699527|FG000|Overall Study|Withdrawal by Subject|2|||
30685605|NCT00698841|58699527|FG000|Overall Study|Adverse Event|3|||
30685606|NCT00698841|58699527|FG000|Overall Study|Disease progression|7|||
30685607|NCT00698841|58699527|FG000|Overall Study|Failure to meet eligibility criteria|2|||
30685608|NCT00698841|58699527|FG000|Overall Study|Study drug toxicity|2|||
30685609|NCT00698841|58699527|FG000|Overall Study|Other|2|||
30685610|NCT00577395|58699533|FG000|Overall Study|Study was terminated early by Sponsor|7|||
30685611|NCT00577395|58699534|FG001|Overall Study|Study was terminated early by Sponsor|6|||
30685612|NCT00738374|58699543|FG000|Induction Treatment Phase|Adverse Event|14|||
30598111|NCT01313780|58609687|FG000|Overall Study|Lack of Efficacy|4|||
30598112|NCT01313780|58609688|FG001|Overall Study|Lack of Efficacy|2|||
30598113|NCT01313780|58609687|FG000|Overall Study|Adverse Event|6|||
30598114|NCT01313780|58609688|FG001|Overall Study|Adverse Event|11|||
30598115|NCT01313780|58609687|FG000|Overall Study|Withdrawal by Subject|2|||
30598116|NCT01313780|58609688|FG001|Overall Study|Withdrawal by Subject|8|||
30598117|NCT01313780|58609687|FG000|Overall Study|Protocol Violation|10|||
30598118|NCT01313780|58609688|FG001|Overall Study|Protocol Violation|4|||
30598119|NCT01313780|58609687|FG000|Overall Study|missing data|3|||
30598120|NCT01313780|58609688|FG001|Overall Study|missing data|3|||
30598121|NCT01090453|58609696|FG000|Overall Study|Withdrawal by Subject|1|||
30598122|NCT01090453|58609697|FG001|Overall Study|Withdrawal by Subject|2|||
30598123|NCT01090453|58609696|FG000|Overall Study|Lost to Follow-up|7|||
30598124|NCT01090453|58609697|FG001|Overall Study|Lost to Follow-up|7|||
30598125|NCT01090453|58609696|FG000|Overall Study|Non serious AEs|1|||
30598126|NCT01090453|58609697|FG001|Overall Study|Non serious AEs|0|||
30598127|NCT01090453|58609696|FG000|Overall Study|Protocol Violation|2|||
30598128|NCT01090453|58609697|FG001|Overall Study|Protocol Violation|0|||
30598129|NCT01090453|58609696|FG000|Overall Study|Other|2|||
30598130|NCT01090453|58609697|FG001|Overall Study|Other|4|||
30598131|NCT01090453|58609696|FG000|Overall Study|Eligibility Criteria|0|||
30598132|NCT01090453|58609697|FG001|Overall Study|Eligibility Criteria|1|||
30598133|NCT01171612|58609703|FG000|Overall Study|Lost to Follow-up|51|||
30598134|NCT01171534|58609712|FG000|Overall Study|Lost to Follow-up|0|||
30598135|NCT01171534|58609713|FG001|Overall Study|Lost to Follow-up|2|||
30598136|NCT01171534|58609712|FG000|Overall Study|screen failure|0|||
30598137|NCT01171534|58609713|FG001|Overall Study|screen failure|1|||
30598138|NCT01170598|58609719|FG000|Overall Study|Withdrawal by Subject|1|||
30598139|NCT01170598|58609719|FG000|Overall Study|Death|3|||
30598140|NCT01170598|58609719|FG000|Overall Study|Lost to Follow-up|1|||
30598141|NCT01170598|58609719|FG000|Overall Study|Refused|1|||
30598142|NCT01170364|58609725|FG000|Overall Study|Protocol Violation|4|||
30598143|NCT01170364|58609726|FG001|Overall Study|Protocol Violation|1|||
30598144|NCT01076179|58609732|FG000|Overall Study|Withdrawal by Subject|1|||
30598145|NCT01170208|58609740|FG000|Overall Study|Withdrawal by Subject|5|||
30598146|NCT01170208|58609741|FG001|Overall Study|Withdrawal by Subject|0|||
30598147|NCT01170208|58609742|FG002|Overall Study|Withdrawal by Subject|1|||
30598148|NCT01170208|58609740|FG000|Overall Study|Protocol Violation|1|||
30685613|NCT00738374|58699544|FG001|Induction Treatment Phase|Adverse Event|0|||
30598149|NCT01170208|58609741|FG001|Overall Study|Protocol Violation|0|||
30598150|NCT01170208|58609742|FG002|Overall Study|Protocol Violation|1|||
30598151|NCT01313624|58609755|FG000|Double-Blind Phase|Adverse Event|27|||
30598152|NCT01313624|58609756|FG001|Double-Blind Phase|Adverse Event|4|||
30598153|NCT01313624|58609755|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
30598154|NCT01313624|58609756|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
30598155|NCT01313624|58609755|FG000|Double-Blind Phase|Lost to Follow-up|0|||
30598156|NCT01313624|58609756|FG001|Double-Blind Phase|Lost to Follow-up|2|||
30598157|NCT01313624|58609755|FG000|Double-Blind Phase|Physician Decision|1|||
30598158|NCT01313624|58609756|FG001|Double-Blind Phase|Physician Decision|0|||
30598159|NCT01313624|58609755|FG000|Double-Blind Phase|Lack of Efficacy|1|||
30598160|NCT01313624|58609756|FG001|Double-Blind Phase|Lack of Efficacy|0|||
30598161|NCT01313624|58609755|FG000|Open-Label Phase|Adverse Event|1|||
30685614|NCT00738374|58699545|FG002|Induction Treatment Phase|Adverse Event|0|||
30685615|NCT00738374|58699546|FG003|Induction Treatment Phase|Adverse Event|0|||
30959227|NCT01686581|59024586|FG000|Overall Study|Participant Concerned about Risks|6|||
30598162|NCT01313624|58609756|FG001|Open-Label Phase|Adverse Event|10|||
30598163|NCT01313624|58609755|FG000|Open-Label Phase|Withdrawal by Subject|2|||
30598164|NCT01313624|58609756|FG001|Open-Label Phase|Withdrawal by Subject|2|||
30598165|NCT01313624|58609755|FG000|Open-Label Phase|Lost to Follow-up|1|||
30685616|NCT00738374|58699543|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
30685617|NCT00738374|58699544|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
30685618|NCT00738374|58699545|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
30685619|NCT00738374|58699546|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
30685620|NCT00738374|58699543|FG000|Induction Treatment Phase|Physician Decision|2|||
30685621|NCT00738374|58699544|FG001|Induction Treatment Phase|Physician Decision|0|||
30685622|NCT00738374|58699545|FG002|Induction Treatment Phase|Physician Decision|0|||
30685623|NCT00738374|58699546|FG003|Induction Treatment Phase|Physician Decision|0|||
30685624|NCT00738374|58699543|FG000|Induction Treatment Phase|Protocol Violation|2|||
30685625|NCT00738374|58699544|FG001|Induction Treatment Phase|Protocol Violation|0|||
30685626|NCT00738374|58699545|FG002|Induction Treatment Phase|Protocol Violation|0|||
30598166|NCT01313624|58609756|FG001|Open-Label Phase|Lost to Follow-up|1|||
30598167|NCT01169350|58609764|FG000|Overall Study|Physician Decision|3|||
30598168|NCT01169350|58609764|FG000|Overall Study|Lost to Follow-up|2|||
30598169|NCT01169038|58609768|FG000|Overall Study|Death|1|||
30598170|NCT01169038|58609768|FG000|Overall Study|Adverse Event|5|||
30685627|NCT00738374|58699546|FG003|Induction Treatment Phase|Protocol Violation|0|||
30685628|NCT00738374|58699543|FG000|Induction Treatment Phase|Non-compliance|1|||
30598171|NCT01169038|58609768|FG000|Overall Study|Required antibiotic administration|1|||
30598172|NCT01167634|58609776|FG000|Overall Study|Lost to Follow-up|1|||
30685629|NCT00738374|58699544|FG001|Induction Treatment Phase|Non-compliance|0|||
30685630|NCT00738374|58699545|FG002|Induction Treatment Phase|Non-compliance|0|||
30685631|NCT00738374|58699546|FG003|Induction Treatment Phase|Non-compliance|0|||
30685632|NCT00738374|58699543|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
30685633|NCT00738374|58699544|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
30685634|NCT00738374|58699545|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
30685635|NCT00738374|58699546|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
30685636|NCT00738374|58699543|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
30685637|NCT00738374|58699544|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
30685638|NCT00738374|58699545|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
30685639|NCT00738374|58699546|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
30685640|NCT00738374|58699543|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
30685641|NCT00738374|58699544|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
30685642|NCT00738374|58699545|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
30685643|NCT00738374|58699546|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
30598173|NCT01167634|58609777|FG001|Overall Study|Lost to Follow-up|3|||
30685644|NCT00738374|58699543|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
30685645|NCT00738374|58699544|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
30685646|NCT00738374|58699545|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
30685647|NCT00738374|58699546|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
30685648|NCT00738374|58699543|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
30685649|NCT00738374|58699544|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
30685650|NCT00738374|58699545|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
30685651|NCT00738374|58699546|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
30685652|NCT00738374|58699543|FG000|Maintenance Treatment/Observation Phase|Other|0|||
30685653|NCT00738374|58699544|FG001|Maintenance Treatment/Observation Phase|Other|1|||
30685654|NCT00738374|58699545|FG002|Maintenance Treatment/Observation Phase|Other|0|||
30685655|NCT00738374|58699546|FG003|Maintenance Treatment/Observation Phase|Other|0|||
30685656|NCT00697593|58699555|FG000|Overall Study|Adverse Event|3|||
30685657|NCT00697593|58699555|FG000|Overall Study|Protocol Violation|1|||
30685658|NCT00697593|58699555|FG000|Overall Study|Lack of Efficacy|3|||
30685659|NCT00697593|58699555|FG000|Overall Study|Suspension of the study by sponsor|12|||
30685660|NCT00697515|58699559|FG000|Dose Optimization Period|Adverse Event|4|||
30685661|NCT00697515|58699560|FG001|Dose Optimization Period|Adverse Event|0|||
30685662|NCT00697515|58699559|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
30685663|NCT00697515|58699560|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
30685664|NCT00697515|58699559|FG000|Dose Optimization Period|Lost to Follow-up|2|||
30685665|NCT00697515|58699560|FG001|Dose Optimization Period|Lost to Follow-up|0|||
30685666|NCT00697515|58699559|FG000|Dose Optimization Period|sponsor request|2|||
30685667|NCT00697515|58699560|FG001|Dose Optimization Period|sponsor request|0|||
30685668|NCT00697515|58699559|FG000|Dose Optimization Period|called to active duty|1|||
30598174|NCT01167634|58609778|FG002|Overall Study|Lost to Follow-up|3|||
30685669|NCT00697515|58699560|FG001|Dose Optimization Period|called to active duty|0|||
30685670|NCT00697515|58699559|FG000|Dose Optimization Period|elevated QTc|1|||
30685671|NCT00697515|58699560|FG001|Dose Optimization Period|elevated QTc|0|||
30598175|NCT01167634|58609779|FG003|Overall Study|Lost to Follow-up|4|||
30598176|NCT01167634|58609776|FG000|Overall Study|Withdrawal by Subject|1|||
30598177|NCT01167634|58609777|FG001|Overall Study|Withdrawal by Subject|1|||
30685672|NCT00697515|58699559|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
30685673|NCT00697515|58699560|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
30685674|NCT00697515|58699559|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
30598178|NCT01167634|58609778|FG002|Overall Study|Withdrawal by Subject|0|||
30598179|NCT01167634|58609779|FG003|Overall Study|Withdrawal by Subject|0|||
30685675|NCT00697515|58699560|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
30685676|NCT00697515|58699559|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
30685677|NCT00697515|58699560|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
30685678|NCT00697515|58699559|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
30685679|NCT00697515|58699560|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
30685680|NCT00738062|58699569|FG000|Open Label Treatment|Lack of Efficacy|5|||
30685681|NCT00738062|58699570|FG001|Open Label Treatment|Lack of Efficacy|0|||
30685682|NCT00738062|58699571|FG002|Open Label Treatment|Lack of Efficacy|0|||
30685683|NCT00738062|58699569|FG000|Open Label Treatment|Adverse Event|11|||
30685684|NCT00738062|58699570|FG001|Open Label Treatment|Adverse Event|0|||
30685685|NCT00738062|58699571|FG002|Open Label Treatment|Adverse Event|0|||
30685686|NCT00738062|58699569|FG000|Open Label Treatment|Protocol Violation|2|||
30685687|NCT00738062|58699570|FG001|Open Label Treatment|Protocol Violation|0|||
30598180|NCT01166386|58609791|FG000|Overall Study|Withdrawal by Subject|3|||
30598181|NCT01166386|58609792|FG001|Overall Study|Withdrawal by Subject|5|||
30598182|NCT01114828|58609800|FG000|Overall Study|Adverse Event|1|||
30598183|NCT01114828|58609801|FG001|Overall Study|Adverse Event|1|||
30598184|NCT01114828|58609800|FG000|Overall Study|Lack of Efficacy|0|||
30598185|NCT01114828|58609801|FG001|Overall Study|Lack of Efficacy|2|||
30685688|NCT00738062|58699571|FG002|Open Label Treatment|Protocol Violation|0|||
30685689|NCT00738062|58699569|FG000|Open Label Treatment|Withdrawal by Subject|9|||
30685690|NCT00738062|58699570|FG001|Open Label Treatment|Withdrawal by Subject|0|||
30685691|NCT00738062|58699571|FG002|Open Label Treatment|Withdrawal by Subject|0|||
30685692|NCT00738062|58699569|FG000|Open Label Treatment|Investigator Decision|1|||
30685693|NCT00738062|58699570|FG001|Open Label Treatment|Investigator Decision|0|||
30685694|NCT00738062|58699571|FG002|Open Label Treatment|Investigator Decision|0|||
30685695|NCT00738062|58699569|FG000|Open-Label Extension|Adverse Event|5|||
30685696|NCT00738062|58699570|FG001|Open-Label Extension|Adverse Event|0|||
30685697|NCT00738062|58699571|FG002|Open-Label Extension|Adverse Event|0|||
30685698|NCT00738062|58699569|FG000|Open-Label Extension|Physician Decision|1|||
30685699|NCT00738062|58699570|FG001|Open-Label Extension|Physician Decision|0|||
30685700|NCT00738062|58699571|FG002|Open-Label Extension|Physician Decision|0|||
30685701|NCT00738062|58699569|FG000|Open-Label Extension|Lack of Efficacy|2|||
30598186|NCT01114828|58609800|FG000|Overall Study|Protocol Violation|2|||
30598187|NCT01114828|58609801|FG001|Overall Study|Protocol Violation|0|||
30685702|NCT00738062|58699570|FG001|Open-Label Extension|Lack of Efficacy|0|||
30685703|NCT00738062|58699571|FG002|Open-Label Extension|Lack of Efficacy|0|||
30685704|NCT00738062|58699569|FG000|Open-Label Extension|Withdrawal by Subject|6|||
30685705|NCT00738062|58699570|FG001|Open-Label Extension|Withdrawal by Subject|0|||
30685706|NCT00738062|58699571|FG002|Open-Label Extension|Withdrawal by Subject|0|||
30685707|NCT00738062|58699569|FG000|Open-Label Extension|Protocol Violation|1|||
30685708|NCT00738062|58699570|FG001|Open-Label Extension|Protocol Violation|0|||
30685709|NCT00738062|58699571|FG002|Open-Label Extension|Protocol Violation|0|||
30685710|NCT00738062|58699569|FG000|Open-Label Extension|Study Terminated|2|||
30685711|NCT00738062|58699570|FG001|Open-Label Extension|Study Terminated|0|||
30685712|NCT00738062|58699571|FG002|Open-Label Extension|Study Terminated|0|||
30685713|NCT04245345|58699580|FG000|Overall Study|Death|1|||
30685714|NCT04245345|58699580|FG000|Overall Study|Exited prior to implant|5|||
30685715|NCT04245345|58699580|FG000|Overall Study|Exited prior to 1-month|9|||
30685716|NCT04245345|58699580|FG000|Overall Study|Missed 1-month visit|3|||
30685717|NCT04245345|58699580|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
30685718|NCT04245345|58699580|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
30685719|NCT00698685|58699586|FG000|Overall Study|Sister withdrew as donor|1|||
30685720|NCT00698685|58699586|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
30685721|NCT00737672|58699592|FG000|Overall Study|Graft Abandonment|48|||
30685722|NCT00737672|58699593|FG001|Overall Study|Graft Abandonment|56|||
30685723|NCT00737672|58699592|FG000|Overall Study|Death|23|||
30685724|NCT00737672|58699593|FG001|Overall Study|Death|22|||
30685725|NCT00737672|58699592|FG000|Overall Study|Withdrawal by Subject|1|||
30685726|NCT00737672|58699593|FG001|Overall Study|Withdrawal by Subject|2|||
30959228|NCT01686581|59024586|FG000|Overall Study|Thinks Injections Too Painful|8|||
30959229|NCT01686581|59024586|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
30959230|NCT01686581|59024586|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
30598188|NCT01114828|58609800|FG000|Overall Study|Withdrawal by Subject|0|||
30598189|NCT01114828|58609801|FG001|Overall Study|Withdrawal by Subject|1|||
30598190|NCT01313312|58609807|FG000|Overall Study|Adverse Event|5|||
30598191|NCT01313312|58609807|FG000|Overall Study|Withdrawal by Subject|18|||
30598192|NCT01313312|58609807|FG000|Overall Study|Lack of Efficacy|3|||
30685727|NCT00737672|58699592|FG000|Overall Study|Lost to Follow-up|1|||
30685728|NCT00737672|58699593|FG001|Overall Study|Lost to Follow-up|0|||
30685729|NCT00737672|58699592|FG000|Overall Study|Miscellaneous|7|||
30685730|NCT00737672|58699593|FG001|Overall Study|Miscellaneous|1|||
30685731|NCT00737672|58699592|FG000|Overall Study|Physician Decision|0|||
30685732|NCT00737672|58699593|FG001|Overall Study|Physician Decision|2|||
30685733|NCT00737438|58699599|FG000|Overall Study|Withdrawal by Subject|2|||
30685734|NCT00737438|58699599|FG000|Overall Study|Patient ineligible|1|||
30685735|NCT00737282|58699605|FG000|Overall Study|Study prematurely terminated|175|||
30685736|NCT03884478|58699614|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
30685737|NCT03884478|58699615|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
30685738|NCT03884478|58699616|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
30685739|NCT03884478|58699614|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
30685740|NCT03884478|58699615|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
30685741|NCT03884478|58699616|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
30685742|NCT03884478|58699614|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
30685743|NCT03884478|58699615|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
30685744|NCT03884478|58699616|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
30685745|NCT03884478|58699614|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
30685746|NCT03884478|58699615|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
30685747|NCT03884478|58699616|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
30685748|NCT00582816|58699637|FG000|Overall Study|Engraftment Failure|3|||
30685749|NCT00737048|58699644|FG000|Overall Study|Physician Decision|0|||
30685750|NCT00737048|58699645|FG001|Overall Study|Physician Decision|0|||
30685751|NCT00737048|58699646|FG002|Overall Study|Physician Decision|1|||
30685752|NCT00737048|58699644|FG000|Overall Study|Adverse Event|0|||
30685753|NCT00737048|58699645|FG001|Overall Study|Adverse Event|1|||
30685754|NCT00737048|58699646|FG002|Overall Study|Adverse Event|0|||
30685755|NCT00737048|58699644|FG000|Overall Study|Worsening of the symptoms|3|||
30685756|NCT00737048|58699645|FG001|Overall Study|Worsening of the symptoms|5|||
30685757|NCT00737048|58699646|FG002|Overall Study|Worsening of the symptoms|3|||
30685758|NCT00731822|58699656|FG000|Overall Study|Adverse Event|2|||
30685759|NCT00731822|58699657|FG001|Overall Study|Adverse Event|1|||
30685760|NCT00731822|58699656|FG000|Overall Study|Protocol Violation|1|||
30685761|NCT00731822|58699657|FG001|Overall Study|Protocol Violation|0|||
30685762|NCT00731822|58699656|FG000|Overall Study|Lost to Follow-up|1|||
30685763|NCT00731822|58699657|FG001|Overall Study|Lost to Follow-up|0|||
30685764|NCT00731666|58699663|FG000|Overall Study|Adverse Event|2|||
30685765|NCT00731666|58699663|FG000|Overall Study|Lost to Follow-up|8|||
30685766|NCT00731666|58699663|FG000|Overall Study|Withdrawal by Subject|2|||
30685767|NCT00731120|58699670|FG000|Overall Study|Adverse Event|7|||
30685768|NCT00731120|58699671|FG001|Overall Study|Adverse Event|6|||
30685769|NCT00731120|58699672|FG002|Overall Study|Adverse Event|8|||
30685770|NCT00731120|58699670|FG000|Overall Study|Lack of Efficacy|4|||
30685771|NCT00731120|58699671|FG001|Overall Study|Lack of Efficacy|5|||
30685772|NCT00731120|58699672|FG002|Overall Study|Lack of Efficacy|4|||
30685773|NCT00731120|58699670|FG000|Overall Study|Noncompliance with Study Drug|3|||
30685774|NCT00731120|58699671|FG001|Overall Study|Noncompliance with Study Drug|3|||
30685775|NCT00731120|58699672|FG002|Overall Study|Noncompliance with Study Drug|1|||
30685776|NCT00731120|58699670|FG000|Overall Study|Protocol Deviations|1|||
30685777|NCT00731120|58699671|FG001|Overall Study|Protocol Deviations|6|||
30784006|NCT03325556|58796194|FG002|Open-label Period|Lost to Follow-up|0|||
30784007|NCT03325556|58796192|FG000|Open-label Period|Non-compliance with study drug|5|||
30784008|NCT03325556|58796193|FG001|Open-label Period|Non-compliance with study drug|0|||
30784009|NCT03325556|58796194|FG002|Open-label Period|Non-compliance with study drug|0|||
30685778|NCT00731120|58699672|FG002|Overall Study|Protocol Deviations|1|||
30685779|NCT00731120|58699670|FG000|Overall Study|Withdrawal of Consent|13|||
30685780|NCT00731120|58699671|FG001|Overall Study|Withdrawal of Consent|8|||
30685781|NCT00731120|58699672|FG002|Overall Study|Withdrawal of Consent|4|||
30685782|NCT00731120|58699670|FG000|Overall Study|Lost to Follow-up|10|||
30685783|NCT00731120|58699671|FG001|Overall Study|Lost to Follow-up|15|||
30685784|NCT00731120|58699672|FG002|Overall Study|Lost to Follow-up|17|||
30685785|NCT00731120|58699670|FG000|Overall Study|Other|4|||
30685786|NCT00731120|58699671|FG001|Overall Study|Other|0|||
30685787|NCT00731120|58699672|FG002|Overall Study|Other|1|||
30685788|NCT00731042|58699682|FG000|Second Intervention|Did not meet inclusion criteria|0|||
30685789|NCT00731042|58699683|FG001|Second Intervention|Did not meet inclusion criteria|2|||
30685790|NCT00726986|58699689|FG000|Induction Phase|Adverse Event|4|||
30784010|NCT03325556|58796192|FG000|Open-label Period|Use of prohibited medication|1|||
30784011|NCT03325556|58796193|FG001|Open-label Period|Use of prohibited medication|0|||
30784012|NCT03325556|58796194|FG002|Open-label Period|Use of prohibited medication|0|||
30685791|NCT00726986|58699689|FG000|Induction Phase|Withdrawal by Subject|2|||
30685792|NCT00726986|58699689|FG000|Induction Phase|Death|2|||
30685793|NCT00726986|58699689|FG000|Induction Phase|Lack of Efficacy|5|||
30685794|NCT00726986|58699689|FG000|Induction Phase|Secondary Disease|2|||
30685795|NCT00726986|58699689|FG000|Maintenance Phase|Adverse Event|1|||
30685796|NCT00726986|58699689|FG000|Maintenance Phase|Lack of Efficacy|2|||
30685797|NCT00696657|58699702|FG000|Overall Study|Protocol Violation|0|||
30685798|NCT00696657|58699703|FG001|Overall Study|Protocol Violation|0|||
30685799|NCT00696657|58699704|FG002|Overall Study|Protocol Violation|0|||
30685800|NCT00696657|58699705|FG003|Overall Study|Protocol Violation|0|||
30685801|NCT00696657|58699706|FG004|Overall Study|Protocol Violation|0|||
30685802|NCT00696657|58699707|FG005|Overall Study|Protocol Violation|1|||
30685803|NCT00696657|58699708|FG006|Overall Study|Protocol Violation|0|||
30685804|NCT00696657|58699709|FG007|Overall Study|Protocol Violation|0|||
30685805|NCT00696657|58699710|FG008|Overall Study|Protocol Violation|1|||
30685806|NCT00696657|58699702|FG000|Overall Study|Lack of Efficacy|0|||
30685807|NCT00696657|58699703|FG001|Overall Study|Lack of Efficacy|1|||
30685808|NCT00696657|58699704|FG002|Overall Study|Lack of Efficacy|0|||
30685809|NCT00696657|58699705|FG003|Overall Study|Lack of Efficacy|0|||
30685810|NCT00696657|58699706|FG004|Overall Study|Lack of Efficacy|0|||
30685811|NCT00696657|58699707|FG005|Overall Study|Lack of Efficacy|0|||
30685812|NCT00696657|58699708|FG006|Overall Study|Lack of Efficacy|0|||
30685813|NCT00696657|58699709|FG007|Overall Study|Lack of Efficacy|0|||
30685814|NCT00696657|58699710|FG008|Overall Study|Lack of Efficacy|0|||
30685815|NCT00696657|58699702|FG000|Overall Study|Withdrawal criteria|1|||
30685816|NCT00696657|58699703|FG001|Overall Study|Withdrawal criteria|3|||
30685817|NCT00696657|58699704|FG002|Overall Study|Withdrawal criteria|2|||
30685818|NCT00696657|58699705|FG003|Overall Study|Withdrawal criteria|2|||
30685819|NCT00696657|58699706|FG004|Overall Study|Withdrawal criteria|0|||
30685820|NCT00696657|58699707|FG005|Overall Study|Withdrawal criteria|0|||
30685821|NCT00696657|58699708|FG006|Overall Study|Withdrawal criteria|1|||
30598193|NCT01313312|58609807|FG000|Overall Study|Investigator Decision|1|||
30598194|NCT01313312|58609807|FG000|Overall Study|Observational Phase|1|||
30598195|NCT01313312|58609807|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
30598196|NCT01313312|58609807|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
30598197|NCT01114672|58609813|FG000|Overall Study|Death|0|||
30598198|NCT01114672|58609814|FG001|Overall Study|Death|1|||
30685822|NCT00696657|58699709|FG007|Overall Study|Withdrawal criteria|1|||
30685823|NCT00696657|58699710|FG008|Overall Study|Withdrawal criteria|2|||
30685824|NCT00696657|58699702|FG000|Overall Study|Unclassified|0|||
30685825|NCT00696657|58699703|FG001|Overall Study|Unclassified|1|||
30685826|NCT00696657|58699704|FG002|Overall Study|Unclassified|3|||
30685827|NCT00696657|58699705|FG003|Overall Study|Unclassified|2|||
30685828|NCT00696657|58699706|FG004|Overall Study|Unclassified|4|||
30685829|NCT00696657|58699707|FG005|Overall Study|Unclassified|2|||
30685830|NCT00696657|58699708|FG006|Overall Study|Unclassified|0|||
30685831|NCT00696657|58699709|FG007|Overall Study|Unclassified|0|||
30685832|NCT00696657|58699710|FG008|Overall Study|Unclassified|1|||
30685833|NCT00696657|58699702|FG000|Overall Study|Adverse Event|0|||
30685834|NCT00696657|58699703|FG001|Overall Study|Adverse Event|0|||
30685835|NCT00696657|58699704|FG002|Overall Study|Adverse Event|3|||
30685836|NCT00696657|58699705|FG003|Overall Study|Adverse Event|7|||
30685837|NCT00696657|58699706|FG004|Overall Study|Adverse Event|6|||
30685838|NCT00696657|58699707|FG005|Overall Study|Adverse Event|9|||
30598199|NCT01114672|58609813|FG000|Overall Study|Withdrawal by Subject|2|||
30598200|NCT01114672|58609814|FG001|Overall Study|Withdrawal by Subject|1|||
30598201|NCT01114672|58609813|FG000|Overall Study|Lost to Follow-up|1|||
30598202|NCT01114672|58609814|FG001|Overall Study|Lost to Follow-up|0|||
30598203|NCT01114672|58609813|FG000|Overall Study|transplanted|1|||
30598204|NCT01114672|58609814|FG001|Overall Study|transplanted|0|||
30598205|NCT01114516|58609822|FG000|Overall Study|Lost to Follow-up|2|||
30598206|NCT01114516|58609823|FG001|Overall Study|Lost to Follow-up|1|||
30598207|NCT01114438|58609829|FG000|Overall Study|Adverse Event|10|||
30598208|NCT01114438|58609829|FG000|Overall Study|concomitant medication|1|||
30598209|NCT01114438|58609829|FG000|Overall Study|Physician Decision|1|||
30598210|NCT01114438|58609829|FG000|Overall Study|Withdrawal by Subject|2|||
30598211|NCT01313078|58609838|FG000|Overall Study|Death|1|||
30598212|NCT01313078|58609838|FG000|Overall Study|Discontinued study drug|1|||
30598213|NCT01313078|58609838|FG000|Overall Study|Withdrawal by Subject|1|||
30598214|NCT01114360|58609842|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
30685839|NCT00696657|58699708|FG006|Overall Study|Adverse Event|14|||
30784013|NCT03325556|58796192|FG000|Open-label Period|Protocol Violation|4|||
30598215|NCT01114360|58609843|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
30685840|NCT00696657|58699709|FG007|Overall Study|Adverse Event|2|||
30685841|NCT00696657|58699710|FG008|Overall Study|Adverse Event|5|||
30685842|NCT00730886|58699732|FG000|Overall Study|Lost to Follow-up|1|||
30685843|NCT00730886|58699733|FG001|Overall Study|Lost to Follow-up|0|||
30598216|NCT01310036|58609863|FG000|Overall Study|Administrative/other|10|||
30598217|NCT01310036|58609863|FG000|Overall Study|Withdrew Consent|11|||
30598218|NCT01310036|58609863|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
30598219|NCT01310036|58609863|FG000|Overall Study|Progression of Disease|164|||
30598220|NCT01310036|58609863|FG000|Overall Study|Death|1|||
30685844|NCT00730886|58699732|FG000|Overall Study|Physician Decision|1|||
30685845|NCT00730886|58699733|FG001|Overall Study|Physician Decision|0|||
30685846|NCT00726752|58699739|FG000|Overall Study|Lack of Efficacy|6|||
30685847|NCT00730028|58699757|FG000|Overall Study|Adverse Event|23|||
30598221|NCT01310036|58609863|FG000|Overall Study|Adverse event or intercurrent illness|12|||
30598222|NCT01309100|58609867|FG000|Overall Study|Protocol Violation|1|||
30598223|NCT01309100|58609867|FG000|Overall Study|Positive Slit lamp finding|1|||
30598224|NCT01308788|58609876|FG000|2-year Treatment|medication change by treating physician|4|||
30598225|NCT01308788|58609877|FG001|2-year Treatment|medication change by treating physician|11|||
30598226|NCT01075321|58609883|FG000|Overall Study|Withdrawal by Subject|0|||
30598227|NCT01075321|58609884|FG001|Overall Study|Withdrawal by Subject|0|||
30685848|NCT00730028|58699758|FG001|Overall Study|Adverse Event|26|||
30685849|NCT00730028|58699759|FG002|Overall Study|Adverse Event|16|||
30598228|NCT01075321|58609885|FG002|Overall Study|Withdrawal by Subject|1|||
30598229|NCT01075321|58609886|FG003|Overall Study|Withdrawal by Subject|1|||
30598230|NCT01075321|58609883|FG000|Overall Study|Protocol Violation|0|||
30598231|NCT01075321|58609884|FG001|Overall Study|Protocol Violation|0|||
30598232|NCT01075321|58609885|FG002|Overall Study|Protocol Violation|1|||
30598233|NCT01075321|58609886|FG003|Overall Study|Protocol Violation|0|||
30598234|NCT01075321|58609883|FG000|Overall Study|Treatment Incomplete due to progression|1|||
30598235|NCT01075321|58609884|FG001|Overall Study|Treatment Incomplete due to progression|0|||
30598236|NCT01075321|58609885|FG002|Overall Study|Treatment Incomplete due to progression|0|||
30598237|NCT01075321|58609886|FG003|Overall Study|Treatment Incomplete due to progression|0|||
30598238|NCT01075321|58609883|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
30598239|NCT01075321|58609884|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
30598240|NCT01075321|58609885|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
30598241|NCT01075321|58609886|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
30598242|NCT01114204|58609900|FG000|Overall Study|Adverse Event|3|||
30598243|NCT01114204|58609901|FG001|Overall Study|Adverse Event|2|||
30598244|NCT01114204|58609900|FG000|Overall Study|Lost to Follow-up|1|||
30598245|NCT01114204|58609901|FG001|Overall Study|Lost to Follow-up|0|||
30598246|NCT01114204|58609900|FG000|Overall Study|Withdrawal by Subject|10|||
30598247|NCT01114204|58609901|FG001|Overall Study|Withdrawal by Subject|6|||
30598248|NCT01114204|58609900|FG000|Overall Study|Death|1|||
30598249|NCT01114204|58609901|FG001|Overall Study|Death|0|||
30598250|NCT01114204|58609900|FG000|Overall Study|Other-Personal reasons|2|||
30598251|NCT01114204|58609901|FG001|Overall Study|Other-Personal reasons|0|||
30598252|NCT01114204|58609900|FG000|Overall Study|Other-Medical monitor request|1|||
30598253|NCT01114204|58609901|FG001|Overall Study|Other-Medical monitor request|0|||
30598254|NCT01114204|58609900|FG000|Overall Study|Other-Participant request|2|||
30598255|NCT01114204|58609901|FG001|Overall Study|Other-Participant request|0|||
30598256|NCT01114204|58609900|FG000|Overall Study|Other-Protocol Violation|1|||
30598257|NCT01114204|58609901|FG001|Overall Study|Other-Protocol Violation|0|||
30598258|NCT01075243|58609910|FG000|Overall Study|Lost to Follow-up|5|||
30598259|NCT01075243|58609911|FG001|Overall Study|Lost to Follow-up|2|||
30598260|NCT01075243|58609912|FG002|Overall Study|Lost to Follow-up|0|||
30598261|NCT01075243|58609910|FG000|Overall Study|Withdrawal by Subject|1|||
30598262|NCT01075243|58609911|FG001|Overall Study|Withdrawal by Subject|1|||
30598263|NCT01075243|58609912|FG002|Overall Study|Withdrawal by Subject|0|||
30598264|NCT01308476|58609924|FG000|Overall Study|Lost to Follow-up|2|||
30685850|NCT00730028|58699760|FG003|Overall Study|Adverse Event|20|||
30685851|NCT00730028|58699761|FG004|Overall Study|Adverse Event|43|||
30685852|NCT00730028|58699757|FG000|Overall Study|Lost to Follow-up|13|||
30685853|NCT00730028|58699758|FG001|Overall Study|Lost to Follow-up|26|||
30685854|NCT00730028|58699759|FG002|Overall Study|Lost to Follow-up|22|||
30685855|NCT00730028|58699760|FG003|Overall Study|Lost to Follow-up|26|||
30685856|NCT00730028|58699761|FG004|Overall Study|Lost to Follow-up|25|||
30685857|NCT00730028|58699757|FG000|Overall Study|Protocol Violation|6|||
30685858|NCT00730028|58699758|FG001|Overall Study|Protocol Violation|1|||
30685859|NCT00730028|58699759|FG002|Overall Study|Protocol Violation|1|||
30685860|NCT00730028|58699760|FG003|Overall Study|Protocol Violation|2|||
30685861|NCT00730028|58699761|FG004|Overall Study|Protocol Violation|0|||
30685862|NCT00730028|58699757|FG000|Overall Study|Withdrawal by Subject|9|||
30685863|NCT00730028|58699758|FG001|Overall Study|Withdrawal by Subject|5|||
30685864|NCT00730028|58699759|FG002|Overall Study|Withdrawal by Subject|4|||
30685865|NCT00730028|58699760|FG003|Overall Study|Withdrawal by Subject|5|||
30598265|NCT01308476|58609925|FG001|Overall Study|Lost to Follow-up|2|||
30685866|NCT00730028|58699761|FG004|Overall Study|Withdrawal by Subject|9|||
30685867|NCT00730028|58699757|FG000|Overall Study|Physician Decision|3|||
30685868|NCT00730028|58699758|FG001|Overall Study|Physician Decision|3|||
30598266|NCT01308476|58609924|FG000|Overall Study|Other|1|||
30598267|NCT01308476|58609925|FG001|Overall Study|Other|0|||
30598268|NCT01078441|58609931|FG000|Overall Study|Withdrawal by Subject|1|||
30598269|NCT01308008|58609937|FG000|4 Weeks|Illness, disinterest, time|9|||
30598270|NCT01308008|58609938|FG001|4 Weeks|Illness, disinterest, time|2|||
30598271|NCT01113892|58609946|FG000|Overall Study|Lost to Follow-up|2|||
30598272|NCT01113892|58609947|FG001|Overall Study|Lost to Follow-up|2|||
30598273|NCT01113892|58609946|FG000|Overall Study|Withdrawal by Subject|1|||
30685869|NCT00730028|58699759|FG002|Overall Study|Physician Decision|2|||
30685870|NCT00730028|58699760|FG003|Overall Study|Physician Decision|3|||
30685871|NCT00730028|58699761|FG004|Overall Study|Physician Decision|2|||
30685872|NCT00730028|58699757|FG000|Overall Study|Treatment Failure|5|||
30685873|NCT00730028|58699758|FG001|Overall Study|Treatment Failure|5|||
30685874|NCT00730028|58699759|FG002|Overall Study|Treatment Failure|0|||
30685875|NCT00730028|58699760|FG003|Overall Study|Treatment Failure|0|||
30685876|NCT00730028|58699761|FG004|Overall Study|Treatment Failure|1|||
30685877|NCT00730028|58699757|FG000|Overall Study|Randomization Error|1|||
30685878|NCT00730028|58699758|FG001|Overall Study|Randomization Error|0|||
30685879|NCT00730028|58699759|FG002|Overall Study|Randomization Error|0|||
30685880|NCT00730028|58699760|FG003|Overall Study|Randomization Error|0|||
30685881|NCT00730028|58699761|FG004|Overall Study|Randomization Error|2|||
30685882|NCT00736502|58699773|FG000|Overall Study|Adverse Event|22|||
30685883|NCT00736502|58699773|FG000|Overall Study|Lack of Efficacy|16|||
30685884|NCT00736502|58699773|FG000|Overall Study|Lost to Follow-up|27|||
30685885|NCT00729560|58699777|FG000|Overall Study|Withdrawal by Subject|3|||
30685886|NCT00736190|58699781|FG000|Overall Study|Pregnancy|1|||
30685887|NCT00736190|58699781|FG000|Overall Study|Withdrawal by Subject|1|||
30685888|NCT00736190|58699781|FG000|Overall Study|Adverse Event|1|||
30685889|NCT00729326|58699787|FG000|Overall Study|Lost to Follow-up|2|||
30685890|NCT00729326|58699788|FG001|Overall Study|Lost to Follow-up|0|||
30685891|NCT00729326|58699787|FG000|Overall Study|Physician Decision|0|||
30685892|NCT00729326|58699788|FG001|Overall Study|Physician Decision|1|||
30685893|NCT00729326|58699787|FG000|Overall Study|Protocol Violation|3|||
30685894|NCT00729326|58699788|FG001|Overall Study|Protocol Violation|2|||
30685895|NCT00729326|58699787|FG000|Overall Study|Subject Decision|4|||
30685896|NCT00729326|58699788|FG001|Overall Study|Subject Decision|4|||
30685897|NCT00729326|58699787|FG000|Overall Study|Sponsor Decision|1|||
30685898|NCT00729326|58699788|FG001|Overall Study|Sponsor Decision|2|||
30685899|NCT00729248|58699794|FG000|Overall Study|Physician Decision|2|||
30685900|NCT00696423|58699801|FG000|Overall Study|Lost to Follow-up|0|||
30685901|NCT00696423|58699802|FG001|Overall Study|Lost to Follow-up|5|||
30685902|NCT00736034|58699808|FG000|Overall Study|Adverse Event|2|||
30685903|NCT00576693|58699814|FG000|Overall Study|Lost to Follow-up|7|||
30685904|NCT00576693|58699815|FG001|Overall Study|Lost to Follow-up|11|||
30685905|NCT00576693|58699814|FG000|Overall Study|Withdrawal by Subject|3|||
30685906|NCT00576693|58699815|FG001|Overall Study|Withdrawal by Subject|13|||
30685907|NCT00698451|58699821|FG000|Overall Study|Adverse Event|22|||
30685908|NCT00698451|58699821|FG000|Overall Study|Physician Decision|2|||
30685909|NCT00698451|58699821|FG000|Overall Study|Protocol Violation|6|||
30685910|NCT00698451|58699821|FG000|Overall Study|Withdrawal by Subject|6|||
30685911|NCT00698451|58699821|FG000|Overall Study|Disease progression|3|||
30685912|NCT00697827|58699827|FG000|Overall Study|enrolled but not treated|2|||
30685913|NCT00697827|58699828|FG001|Overall Study|enrolled but not treated|1|||
30685914|NCT00728936|58699841|FG000|Overall Study|Withdrawal by Subject|0|||
30685915|NCT00728936|58699842|FG001|Overall Study|Withdrawal by Subject|0|||
30685916|NCT00728936|58699843|FG002|Overall Study|Withdrawal by Subject|0|||
30685917|NCT00728936|58699844|FG003|Overall Study|Withdrawal by Subject|0|||
30685918|NCT00728936|58699845|FG004|Overall Study|Withdrawal by Subject|0|||
30685919|NCT00728936|58699846|FG005|Overall Study|Withdrawal by Subject|1|||
30685920|NCT00728936|58699847|FG006|Overall Study|Withdrawal by Subject|0|||
30685921|NCT00693693|58699866|FG000|Overall Study|Lost to Follow-up|1|||
30685922|NCT00693693|58699867|FG001|Overall Study|Lost to Follow-up|1|||
30598274|NCT01113892|58609947|FG001|Overall Study|Withdrawal by Subject|1|||
30598275|NCT01113892|58609946|FG000|Overall Study|Death|2|||
30598276|NCT01113892|58609947|FG001|Overall Study|Death|4|||
30598277|NCT01113892|58609946|FG000|Overall Study|Graft no longer evaluable|9|||
30598278|NCT01113892|58609947|FG001|Overall Study|Graft no longer evaluable|9|||
30598279|NCT01090063|58609953|FG000|Screen|Screen Failed|4|||
30598280|NCT01090063|58609953|FG000|Treatment|Withdrawal by Subject|4|||
30598281|NCT01113580|58609969|FG000|Overall Study|Protocol Violation|1|||
30598282|NCT01113580|58609970|FG001|Overall Study|Protocol Violation|0|||
30685923|NCT00693693|58699868|FG002|Overall Study|Lost to Follow-up|2|||
30685924|NCT00728468|58699876|FG000|Overall Study|Enrolled but not treated|1|||
30685925|NCT00728468|58699876|FG000|Overall Study|Death|1|||
30685926|NCT00728468|58699876|FG000|Overall Study|Protocol Violation|4|||
30685927|NCT00728468|58699876|FG000|Overall Study|Objective progression or relapse|9|||
30685928|NCT00728468|58699876|FG000|Overall Study|Study terminated by sponsor|1|||
30685929|NCT00727844|58699882|FG000|Initial Randomization|Physician Decision|2|||
30685930|NCT00727844|58699883|FG001|Initial Randomization|Physician Decision|0|||
30685931|NCT00727844|58699884|FG002|Initial Randomization|Physician Decision|0|||
30685932|NCT00727844|58699885|FG003|Initial Randomization|Physician Decision|0|||
30598283|NCT01306214|58609979|FG000|Overall Study|Death|0|||
30598284|NCT01306214|58609980|FG001|Overall Study|Death|0|||
30598285|NCT01306214|58609981|FG002|Overall Study|Death|1|||
30685933|NCT00735878|58699893|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
30598286|NCT01306214|58609979|FG000|Overall Study|Lost to Follow-up|3|||
30598287|NCT01306214|58609980|FG001|Overall Study|Lost to Follow-up|5|||
30598288|NCT01306214|58609981|FG002|Overall Study|Lost to Follow-up|4|||
30685934|NCT00735878|58699894|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
30685935|NCT00735878|58699895|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
30685936|NCT00695955|58699906|FG000|Cohort 1|Adverse Event|26|||
30598289|NCT01306214|58609979|FG000|Overall Study|Withdrawal by Subject|24|||
30685937|NCT00695955|58699906|FG000|Cohort 1|Protocol Violation|2|||
30685938|NCT00695955|58699906|FG000|Cohort 1|Lost to Follow-up|30|||
30685939|NCT00695955|58699906|FG000|Cohort 1|Withdrawal by Subject|25|||
30685940|NCT00695955|58699906|FG000|Cohort 1|Lack of Efficacy|3|||
30685941|NCT00695955|58699906|FG000|Cohort 1|Other|16|||
30685942|NCT00695955|58699906|FG000|Cohort 2|Adverse Event|24|||
30685943|NCT00695955|58699906|FG000|Cohort 2|Protocol Violation|5|||
30685944|NCT00695955|58699906|FG000|Cohort 2|Lost to Follow-up|38|||
30685945|NCT00695955|58699906|FG000|Cohort 2|Withdrawal by Subject|28|||
30685946|NCT00695955|58699906|FG000|Cohort 2|Lack of Efficacy|4|||
30685947|NCT00695955|58699906|FG000|Cohort 2|Other|5|||
30685948|NCT00693225|58699914|FG000|Overall Study|Lost to Follow-up|1|||
30685949|NCT00693225|58699915|FG001|Overall Study|Lost to Follow-up|2|||
30784014|NCT03325556|58796193|FG001|Open-label Period|Protocol Violation|0|||
30784015|NCT03325556|58796194|FG002|Open-label Period|Protocol Violation|0|||
30784016|NCT03325556|58796192|FG000|Open-label Period|Withdrawal by Subject|17|||
30784017|NCT03325556|58796193|FG001|Open-label Period|Withdrawal by Subject|0|||
30784018|NCT03325556|58796194|FG002|Open-label Period|Withdrawal by Subject|0|||
30784019|NCT03325556|58796192|FG000|Open-label Period|Not otherwise specified|8|||
30784020|NCT03325556|58796193|FG001|Open-label Period|Not otherwise specified|0|||
30784021|NCT03325556|58796194|FG002|Open-label Period|Not otherwise specified|0|||
30784022|NCT03325556|58796192|FG000|Open-label Period|Administrative discont. at study termination|41|||
30784023|NCT03325556|58796193|FG001|Open-label Period|Administrative discont. at study termination|0|||
30784024|NCT03325556|58796194|FG002|Open-label Period|Administrative discont. at study termination|0|||
30784025|NCT03325556|58796192|FG000|Double-blind Period|Relapse|0|||
30784026|NCT03325556|58796193|FG001|Double-blind Period|Relapse|15|||
30784027|NCT03325556|58796194|FG002|Double-blind Period|Relapse|34|||
30784028|NCT03325556|58796192|FG000|Double-blind Period|Adverse Event|0|||
30784029|NCT03325556|58796193|FG001|Double-blind Period|Adverse Event|3|||
30784030|NCT03325556|58796194|FG002|Double-blind Period|Adverse Event|1|||
30784031|NCT03325556|58796192|FG000|Double-blind Period|Noncompliance with study drug|0|||
30784032|NCT03325556|58796193|FG001|Double-blind Period|Noncompliance with study drug|0|||
30784033|NCT03325556|58796194|FG002|Double-blind Period|Noncompliance with study drug|1|||
30784034|NCT03325556|58796192|FG000|Double-blind Period|Use of prohibited medication|0|||
30784035|NCT03325556|58796193|FG001|Double-blind Period|Use of prohibited medication|1|||
30784036|NCT03325556|58796194|FG002|Double-blind Period|Use of prohibited medication|0|||
30784037|NCT03325556|58796192|FG000|Double-blind Period|Physician Decision|0|||
30784038|NCT03325556|58796193|FG001|Double-blind Period|Physician Decision|0|||
30784039|NCT03325556|58796194|FG002|Double-blind Period|Physician Decision|1|||
30784040|NCT03325556|58796192|FG000|Double-blind Period|Withdrawal by Subject|0|||
30784041|NCT03325556|58796193|FG001|Double-blind Period|Withdrawal by Subject|6|||
30784042|NCT03325556|58796194|FG002|Double-blind Period|Withdrawal by Subject|4|||
30598290|NCT01306214|58609980|FG001|Overall Study|Withdrawal by Subject|22|||
30598291|NCT01306214|58609981|FG002|Overall Study|Withdrawal by Subject|16|||
30598292|NCT01306214|58609979|FG000|Overall Study|Not treated|1|||
30598293|NCT01306214|58609980|FG001|Overall Study|Not treated|1|||
30598294|NCT01306214|58609981|FG002|Overall Study|Not treated|1|||
30598295|NCT01077739|58609991|FG000|Overall Study|Premature withdrawal|1|||
30598296|NCT01077739|58609992|FG001|Overall Study|Premature withdrawal|3|||
30598297|NCT01077739|58609991|FG000|Overall Study|Withdrawal by Subject|1|||
30598298|NCT01077739|58609992|FG001|Overall Study|Withdrawal by Subject|0|||
30598299|NCT01077739|58609991|FG000|Overall Study|Death|0|||
30598300|NCT01077739|58609992|FG001|Overall Study|Death|3|||
30598301|NCT01077739|58609991|FG000|Overall Study|Unacceptable toxicity|1|||
30598302|NCT01077739|58609992|FG001|Overall Study|Unacceptable toxicity|2|||
30598303|NCT01077739|58609991|FG000|Overall Study|Other|2|||
30598304|NCT01077739|58609992|FG001|Overall Study|Other|2|||
30598305|NCT01306058|58609998|FG000|Overall Study|Death|1|||
30598306|NCT01306058|58609998|FG000|Overall Study|Enrolled but did not get treatment|1|||
30598307|NCT01305200|58610005|FG000|Overall Study|Physician Decision|4|||
30598308|NCT01305200|58610006|FG001|Overall Study|Physician Decision|6|||
30685950|NCT00693225|58699914|FG000|Overall Study|Adverse Event|1|||
30784043|NCT03325556|58796192|FG000|Double-blind Period|Not otherwise specified|0|||
30784044|NCT03325556|58796193|FG001|Double-blind Period|Not otherwise specified|1|||
30685951|NCT00693225|58699915|FG001|Overall Study|Adverse Event|3|||
30685952|NCT00735644|58699926|FG000|Overall Study|Did not receive study vaccine|0|||
30685953|NCT00735644|58699927|FG001|Overall Study|Did not receive study vaccine|1|||
30784045|NCT03325556|58796194|FG002|Double-blind Period|Not otherwise specified|5|||
30784046|NCT03325556|58796192|FG000|Double-blind Period|Administrative discont. at study termination|0|||
30598309|NCT01305200|58610007|FG002|Overall Study|Physician Decision|1|||
30598310|NCT01305200|58610005|FG000|Overall Study|Withdrawal by Subject|24|||
30598311|NCT01305200|58610006|FG001|Overall Study|Withdrawal by Subject|21|||
30685954|NCT00735644|58699928|FG002|Overall Study|Did not receive study vaccine|0|||
30685955|NCT00735644|58699929|FG003|Overall Study|Did not receive study vaccine|0|||
30685956|NCT00735644|58699930|FG004|Overall Study|Did not receive study vaccine|0|||
30685957|NCT00735644|58699926|FG000|Overall Study|Withdrawal by Subject|0|||
30685958|NCT00735644|58699927|FG001|Overall Study|Withdrawal by Subject|1|||
30598312|NCT01305200|58610007|FG002|Overall Study|Withdrawal by Subject|1|||
30598313|NCT01305200|58610005|FG000|Overall Study|Ineligible|1|||
30685959|NCT00735644|58699928|FG002|Overall Study|Withdrawal by Subject|1|||
30685960|NCT00735644|58699929|FG003|Overall Study|Withdrawal by Subject|1|||
30685961|NCT00735644|58699930|FG004|Overall Study|Withdrawal by Subject|0|||
30685962|NCT03718299|58699949|FG000|Overall Study|Adverse Event|1|||
30685963|NCT03718299|58699949|FG000|Overall Study|Withdrawal by Subject|6|||
30685964|NCT03718299|58699949|FG000|Overall Study|Physician Decision|2|||
30685965|NCT03718299|58699949|FG000|Overall Study|Lost to Follow-up|1|||
30685966|NCT00724958|58699953|FG000|Overall Study|Adverse Event|28|||
30685967|NCT00724958|58699953|FG000|Overall Study|Loss of Response|40|||
30685968|NCT00724958|58699953|FG000|Overall Study|No Response|18|||
30685969|NCT00724958|58699953|FG000|Overall Study|Remission|7|||
30685970|NCT00724958|58699953|FG000|Overall Study|Other Reason|76|||
30685971|NCT00724958|58699953|FG000|Overall Study|No documentation for end of therapy|13|||
30685972|NCT00695565|58699959|FG000|Overall Study|Lost to Follow-up|4|||
30685973|NCT00695565|58699960|FG001|Overall Study|Lost to Follow-up|4|||
30685974|NCT00695565|58699959|FG000|Overall Study|Adverse Event|3|||
30685975|NCT00695565|58699960|FG001|Overall Study|Adverse Event|1|||
30685976|NCT00695565|58699959|FG000|Overall Study|Protocol Violation|3|||
30959231|NCT01686581|59024586|FG000|Overall Study|Thinks it is Inconvenient|17|||
30959232|NCT01686581|59024586|FG000|Overall Study|Other Miscellaneous Reasons|36|||
30959233|NCT01686581|59024586|FG000|Overall Study|Reason Missing|1|||
30959234|NCT02691936|59024604|FG000|Overall Study|Withdrawal by Subject|2|||
30959235|NCT02691936|59024605|FG001|Overall Study|Withdrawal by Subject|5|||
30959236|NCT01685801|59024652|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
30959237|NCT01685801|59024653|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
30959238|NCT01685801|59024654|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
30959239|NCT01685801|59024655|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
30959240|NCT01685801|59024652|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
30959241|NCT01685801|59024653|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
30598314|NCT01305200|58610006|FG001|Overall Study|Ineligible|2|||
30685977|NCT00695565|58699960|FG001|Overall Study|Protocol Violation|1|||
30784047|NCT03325556|58796193|FG001|Double-blind Period|Administrative discont. at study termination|35|||
30784048|NCT03325556|58796194|FG002|Double-blind Period|Administrative discont. at study termination|31|||
30784049|NCT03320564|58796201|FG000|Overall Study|Protocol Violation|1|||
30784050|NCT03325166|58796205|FG000|Overall Study|Adverse Event|1|||
30784051|NCT02888756|58796212|FG000|Analytical Treatment Interruption|Physician Decision|10|||
30784052|NCT02888756|58796213|FG001|Analytical Treatment Interruption|Physician Decision|6|||
30784053|NCT02888756|58796214|FG002|Analytical Treatment Interruption|Physician Decision|5|||
30784054|NCT03305666|58796224|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
30784055|NCT03305666|58796225|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
30784056|NCT03304184|58796233|FG000|Overall Study|Withdrawal by Subject|1|||
30784057|NCT03304184|58796234|FG001|Overall Study|Withdrawal by Subject|2|||
30784058|NCT03736785|58796244|FG000|Overall Study|Adverse Event|1|||
30784059|NCT03736785|58796245|FG001|Overall Study|Adverse Event|1|||
30784060|NCT03736785|58796246|FG002|Overall Study|Adverse Event|1|||
30784061|NCT03736785|58796244|FG000|Overall Study|Death|1|||
30784062|NCT03736785|58796245|FG001|Overall Study|Death|0|||
30598315|NCT01305200|58610007|FG002|Overall Study|Ineligible|1|||
30598316|NCT01305200|58610005|FG000|Overall Study|Death|0|||
30598317|NCT01305200|58610006|FG001|Overall Study|Death|2|||
30598318|NCT01305200|58610007|FG002|Overall Study|Death|0|||
30598319|NCT01077271|58610017|FG000|Overall Study|Parental desire|8|||
30598320|NCT01077271|58610017|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
30598321|NCT01077271|58610017|FG000|Overall Study|Noncompliance|2|||
30598322|NCT01077271|58610017|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
30598323|NCT01077271|58610017|FG000|Overall Study|Changed doctors|2|||
30598324|NCT01077271|58610017|FG000|Overall Study|Parents thought too many injections|2|||
30685978|NCT00695565|58699959|FG000|Overall Study|Withdrawal by Subject|1|||
30685979|NCT00695565|58699960|FG001|Overall Study|Withdrawal by Subject|1|||
30685980|NCT00695565|58699959|FG000|Overall Study|Lack of Efficacy|1|||
30685981|NCT00695565|58699960|FG001|Overall Study|Lack of Efficacy|1|||
30685982|NCT00695565|58699959|FG000|Overall Study|Subject did not follow instructions|1|||
30685983|NCT00695565|58699960|FG001|Overall Study|Subject did not follow instructions|1|||
30685984|NCT00727532|58699966|FG000|Overall Study|Adverse Event|1|||
30685985|NCT00727532|58699966|FG000|Overall Study|Withdrawal by Subject|1|||
30685986|NCT00721214|58699970|FG000|Overall Study|Chose another center for transplant|1|||
30685987|NCT00721214|58699970|FG000|Overall Study|Death|3|||
30685988|NCT00720902|58699976|FG000|Overall Study|Withdrawal by Subject|1|||
30685989|NCT00720902|58699977|FG001|Overall Study|Withdrawal by Subject|0|||
30784063|NCT03736785|58796246|FG002|Overall Study|Death|1|||
30784064|NCT03736785|58796244|FG000|Overall Study|Lost to Follow-up|0|||
30959242|NCT01685801|59024654|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
30685990|NCT00720902|58699976|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
30685991|NCT00720902|58699977|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
30685992|NCT00695019|58699986|FG000|Overall Study|Withdrawal by Subject|8|||
30685993|NCT00695019|58699987|FG001|Overall Study|Withdrawal by Subject|6|||
30685994|NCT00695019|58699988|FG002|Overall Study|Withdrawal by Subject|4|||
30685995|NCT00695019|58699986|FG000|Overall Study|Protocol Violation|1|||
30685996|NCT00695019|58699987|FG001|Overall Study|Protocol Violation|3|||
30685997|NCT00695019|58699988|FG002|Overall Study|Protocol Violation|1|||
30685998|NCT00695019|58699986|FG000|Overall Study|Lack of Efficacy|0|||
30685999|NCT00695019|58699987|FG001|Overall Study|Lack of Efficacy|0|||
30686000|NCT00695019|58699988|FG002|Overall Study|Lack of Efficacy|1|||
30686001|NCT00695019|58699986|FG000|Overall Study|Various|4|||
30598325|NCT01077271|58610017|FG000|Overall Study|End of RSV season nearly reached|1|||
30598326|NCT01077271|58610017|FG000|Overall Study|Mother unconvinced of the necessity|1|||
30598327|NCT01305044|58610031|FG000|Overall Study|Withdrawal by Subject|3|||
30598328|NCT01305044|58610032|FG001|Overall Study|Withdrawal by Subject|6|||
30598329|NCT01304498|58610040|FG000|Overall Study|Adverse Event|1|||
30598330|NCT01304498|58610041|FG001|Overall Study|Adverse Event|1|||
30598331|NCT01304498|58610040|FG000|Overall Study|Withdrawal by Subject|2|||
30598332|NCT01304498|58610041|FG001|Overall Study|Withdrawal by Subject|3|||
30598333|NCT01304498|58610040|FG000|Overall Study|Protocol Violation|1|||
30598334|NCT01304498|58610041|FG001|Overall Study|Protocol Violation|0|||
30598335|NCT01304498|58610040|FG000|Overall Study|Lost to Follow-up|2|||
30598336|NCT01304498|58610041|FG001|Overall Study|Lost to Follow-up|1|||
30598337|NCT01077193|58610047|FG000|Overall Study|Lost to Follow-up|1|||
30598338|NCT01077193|58610047|FG000|Overall Study|Withdrawal by Subject|2|||
30598339|NCT01077193|58610047|FG000|Overall Study|Lack of Efficacy|1|||
30598340|NCT01077193|58610047|FG000|Overall Study|Study Terminated by Sponsor|40|||
30598341|NCT01074931|58610051|FG000|Overall Study|Economic reasons|1|||
30598342|NCT01074931|58610051|FG000|Overall Study|Death|5|||
30598343|NCT01303172|58610061|FG000|Overall Study|Physician Decision|9|||
30598344|NCT01303172|58610062|FG001|Overall Study|Physician Decision|6|||
30598345|NCT01303172|58610061|FG000|Overall Study|Adverse Event|5|||
30598346|NCT01303172|58610062|FG001|Overall Study|Adverse Event|2|||
30598347|NCT01303172|58610061|FG000|Overall Study|Withdrawal by Subject|4|||
30598348|NCT01303172|58610062|FG001|Overall Study|Withdrawal by Subject|2|||
30598349|NCT01303172|58610061|FG000|Overall Study|Death|20|||
30598350|NCT01303172|58610062|FG001|Overall Study|Death|7|||
30598351|NCT01303172|58610061|FG000|Overall Study|Lack of Efficacy|25|||
30598352|NCT01303172|58610062|FG001|Overall Study|Lack of Efficacy|17|||
30598353|NCT01302938|58610071|FG000|Overall Study|Withdrawal by Subject|1|||
30598354|NCT01302938|58610072|FG001|Overall Study|Withdrawal by Subject|0|||
30598355|NCT01302938|58610071|FG000|Overall Study|Adverse Event|1|||
30598356|NCT01302938|58610072|FG001|Overall Study|Adverse Event|0|||
30686002|NCT00695019|58699987|FG001|Overall Study|Various|5|||
30686003|NCT00695019|58699988|FG002|Overall Study|Various|4|||
30686004|NCT00694707|58700001|FG000|Overall Study|Did Not Receive Treatment|0|||
30686005|NCT00694707|58700002|FG001|Overall Study|Did Not Receive Treatment|0|||
30686006|NCT00694707|58700003|FG002|Overall Study|Did Not Receive Treatment|1|||
30686007|NCT00694707|58700004|FG003|Overall Study|Did Not Receive Treatment|1|||
30686008|NCT00694707|58700005|FG004|Overall Study|Did Not Receive Treatment|1|||
30686009|NCT00694707|58700001|FG000|Overall Study|Adverse Event|22|||
30686010|NCT00694707|58700002|FG001|Overall Study|Adverse Event|14|||
30686011|NCT00694707|58700003|FG002|Overall Study|Adverse Event|8|||
30686012|NCT00694707|58700004|FG003|Overall Study|Adverse Event|12|||
30686013|NCT00694707|58700005|FG004|Overall Study|Adverse Event|13|||
30686014|NCT00694707|58700001|FG000|Overall Study|Insufficient Therapeutic Response|33|||
30686015|NCT00694707|58700002|FG001|Overall Study|Insufficient Therapeutic Response|18|||
30686016|NCT00694707|58700003|FG002|Overall Study|Insufficient Therapeutic Response|17|||
30686017|NCT00694707|58700004|FG003|Overall Study|Insufficient Therapeutic Response|15|||
30686018|NCT00694707|58700005|FG004|Overall Study|Insufficient Therapeutic Response|10|||
30686019|NCT00694707|58700001|FG000|Overall Study|Protocol Violation|1|||
30686020|NCT00694707|58700002|FG001|Overall Study|Protocol Violation|2|||
30784065|NCT03736785|58796245|FG001|Overall Study|Lost to Follow-up|2|||
30598357|NCT01302548|58610081|FG000|Overall Study|Lost to Follow-up|2|||
30598358|NCT01302548|58610082|FG001|Overall Study|Lost to Follow-up|1|||
30598359|NCT01076959|58610088|FG000|Overall Study|Adverse Event|767|||
30598360|NCT01076959|58610088|FG000|Overall Study|Lack of Efficacy|849|||
30598361|NCT01076959|58610088|FG000|Overall Study|Non-compliance|274|||
30598362|NCT01076959|58610088|FG000|Overall Study|Lost to Follow-up|241|||
30598363|NCT01076959|58610088|FG000|Overall Study|Other|119|||
30598364|NCT01302392|58610107|FG000|Overall Study|Lost to Follow-up|1|||
30598365|NCT01302392|58610108|FG001|Overall Study|Lost to Follow-up|0|||
30686021|NCT00694707|58700003|FG002|Overall Study|Protocol Violation|1|||
30598366|NCT01302392|58610107|FG000|Overall Study|Withdrawal by Subject|6|||
30598367|NCT01302392|58610108|FG001|Overall Study|Withdrawal by Subject|1|||
30686022|NCT00694707|58700004|FG003|Overall Study|Protocol Violation|3|||
30686023|NCT00694707|58700005|FG004|Overall Study|Protocol Violation|1|||
30686024|NCT00694707|58700001|FG000|Overall Study|Withdrawal of Consent|14|||
30686025|NCT00694707|58700002|FG001|Overall Study|Withdrawal of Consent|18|||
30686026|NCT00694707|58700003|FG002|Overall Study|Withdrawal of Consent|22|||
30686027|NCT00694707|58700004|FG003|Overall Study|Withdrawal of Consent|16|||
30686028|NCT00694707|58700005|FG004|Overall Study|Withdrawal of Consent|15|||
30686029|NCT00694707|58700001|FG000|Overall Study|Lost to Follow-up|0|||
30686030|NCT00694707|58700002|FG001|Overall Study|Lost to Follow-up|1|||
30686031|NCT00694707|58700003|FG002|Overall Study|Lost to Follow-up|2|||
30686032|NCT00694707|58700004|FG003|Overall Study|Lost to Follow-up|0|||
30686033|NCT00694707|58700005|FG004|Overall Study|Lost to Follow-up|0|||
30686034|NCT00694707|58700001|FG000|Overall Study|Jeopardizing Parole Status|1|||
30686035|NCT00694707|58700002|FG001|Overall Study|Jeopardizing Parole Status|0|||
30686036|NCT00694707|58700003|FG002|Overall Study|Jeopardizing Parole Status|0|||
30686037|NCT00694707|58700004|FG003|Overall Study|Jeopardizing Parole Status|0|||
30686038|NCT00694707|58700005|FG004|Overall Study|Jeopardizing Parole Status|0|||
30686039|NCT00694707|58700001|FG000|Overall Study|Death in the Family|1|||
30686040|NCT00694707|58700002|FG001|Overall Study|Death in the Family|0|||
30686041|NCT00694707|58700003|FG002|Overall Study|Death in the Family|0|||
30686042|NCT00694707|58700004|FG003|Overall Study|Death in the Family|0|||
30686043|NCT00694707|58700005|FG004|Overall Study|Death in the Family|0|||
30686044|NCT00694707|58700001|FG000|Overall Study|Arrest by Police|0|||
30686045|NCT00694707|58700002|FG001|Overall Study|Arrest by Police|1|||
30686046|NCT00694707|58700003|FG002|Overall Study|Arrest by Police|0|||
30686047|NCT00694707|58700004|FG003|Overall Study|Arrest by Police|0|||
30686048|NCT00694707|58700005|FG004|Overall Study|Arrest by Police|0|||
30686049|NCT00694707|58700001|FG000|Overall Study|Administrative Reasons|0|||
30686050|NCT00694707|58700002|FG001|Overall Study|Administrative Reasons|1|||
30686051|NCT00694707|58700003|FG002|Overall Study|Administrative Reasons|0|||
30686052|NCT00694707|58700004|FG003|Overall Study|Administrative Reasons|2|||
30686053|NCT00694707|58700005|FG004|Overall Study|Administrative Reasons|0|||
30598368|NCT01076647|58610116|FG000|Overall Study|Adverse Event|4|||
30598369|NCT01076647|58610117|FG001|Overall Study|Adverse Event|1|||
30598370|NCT01076647|58610116|FG000|Overall Study|Lack of Efficacy|0|||
30598371|NCT01076647|58610117|FG001|Overall Study|Lack of Efficacy|1|||
30598372|NCT01076647|58610116|FG000|Overall Study|Protocol Violation|7|||
30598373|NCT01076647|58610117|FG001|Overall Study|Protocol Violation|9|||
30598374|NCT01076647|58610116|FG000|Overall Study|Withdrawal criteria|2|||
30598375|NCT01076647|58610117|FG001|Overall Study|Withdrawal criteria|2|||
30686054|NCT00694707|58700001|FG000|Overall Study|Notification of Past Head Injury|0|||
30686055|NCT00694707|58700002|FG001|Overall Study|Notification of Past Head Injury|0|||
30686056|NCT00694707|58700003|FG002|Overall Study|Notification of Past Head Injury|0|||
30686057|NCT00694707|58700004|FG003|Overall Study|Notification of Past Head Injury|1|||
30686058|NCT00694707|58700005|FG004|Overall Study|Notification of Past Head Injury|0|||
30686059|NCT00692913|58700019|FG000|Overall Study|Adverse Event|8|||
30686060|NCT00692913|58700020|FG001|Overall Study|Adverse Event|4|||
30686061|NCT00692913|58700019|FG000|Overall Study|Lost to Follow-up|3|||
30686062|NCT00692913|58700020|FG001|Overall Study|Lost to Follow-up|5|||
30686063|NCT00692913|58700019|FG000|Overall Study|Physician Decision|2|||
30686064|NCT00692913|58700020|FG001|Overall Study|Physician Decision|0|||
30686065|NCT00692913|58700019|FG000|Overall Study|Protocol Violation|1|||
30686066|NCT00692913|58700020|FG001|Overall Study|Protocol Violation|1|||
30686067|NCT00692913|58700019|FG000|Overall Study|Withdrawal by Subject|15|||
30598376|NCT01076647|58610116|FG000|Overall Study|Unclassified|12|||
30598377|NCT01076647|58610117|FG001|Overall Study|Unclassified|12|||
30598378|NCT01074307|58610125|FG000|Overall Study|No primary endpoint evaluation|14|||
30598379|NCT01074307|58610126|FG001|Overall Study|No primary endpoint evaluation|6|||
30598380|NCT01074307|58610125|FG000|Overall Study|Exclusion criterion|0|||
30598381|NCT01074307|58610126|FG001|Overall Study|Exclusion criterion|1|||
30598382|NCT01074307|58610125|FG000|Overall Study|Protocol Violation|8|||
30686068|NCT00692913|58700020|FG001|Overall Study|Withdrawal by Subject|20|||
30686069|NCT00694551|58700029|FG000|Overall Study|Disease Progression|1|||
30686070|NCT00694551|58700030|FG001|Overall Study|Disease Progression|0|||
30686071|NCT00694551|58700031|FG002|Overall Study|Disease Progression|1|||
30686072|NCT00689871|58700044|FG000|Overall Study|Lost to Follow-up|123|||
30686073|NCT00689871|58700045|FG001|Overall Study|Lost to Follow-up|13|||
30686074|NCT00689871|58700046|FG002|Overall Study|Lost to Follow-up|37|||
30686075|NCT00689871|58700047|FG003|Overall Study|Lost to Follow-up|1|||
30686076|NCT00689871|58700044|FG000|Overall Study|Explanted of All Study Devices|36|||
30686077|NCT00689871|58700045|FG001|Overall Study|Explanted of All Study Devices|25|||
30598383|NCT01074307|58610126|FG001|Overall Study|Protocol Violation|5|||
30598384|NCT01076335|58610132|FG000|Overall Study|Withdrawal by Subject|3|||
30598385|NCT01076335|58610132|FG000|Overall Study|Withdrawal without treatment|1|||
30598386|NCT01309737|58610139|FG000|Week 0 to 16|Death|1|||
30598387|NCT01309737|58610140|FG001|Week 0 to 16|Death|0|||
30686078|NCT00689871|58700046|FG002|Overall Study|Explanted of All Study Devices|29|||
30686079|NCT00689871|58700047|FG003|Overall Study|Explanted of All Study Devices|3|||
30686080|NCT00689871|58700044|FG000|Overall Study|Withdrawal by Subject|13|||
30686081|NCT00689871|58700045|FG001|Overall Study|Withdrawal by Subject|3|||
30598388|NCT01309737|58610141|FG002|Week 0 to 16|Death|1|||
30686082|NCT00689871|58700046|FG002|Overall Study|Withdrawal by Subject|4|||
30686083|NCT00689871|58700047|FG003|Overall Study|Withdrawal by Subject|1|||
30686084|NCT00689871|58700044|FG000|Overall Study|Death|1|||
30686085|NCT00689871|58700045|FG001|Overall Study|Death|10|||
30686086|NCT00689871|58700046|FG002|Overall Study|Death|2|||
30686087|NCT00689871|58700047|FG003|Overall Study|Death|2|||
30686088|NCT00689871|58700044|FG000|Overall Study|Physician Decision|2|||
30686089|NCT00689871|58700045|FG001|Overall Study|Physician Decision|1|||
30686090|NCT00689871|58700046|FG002|Overall Study|Physician Decision|1|||
30686091|NCT00689871|58700047|FG003|Overall Study|Physician Decision|0|||
30686092|NCT00793793|58700069|FG000|Overall Study|Adverse Event|0|||
30686093|NCT00793793|58700070|FG001|Overall Study|Adverse Event|0|||
30686094|NCT00793793|58700071|FG002|Overall Study|Adverse Event|1|||
30686095|NCT00793793|58700072|FG003|Overall Study|Adverse Event|1|||
30686096|NCT00793793|58700073|FG004|Overall Study|Adverse Event|0|||
30686097|NCT00793793|58700074|FG005|Overall Study|Adverse Event|1|||
30686098|NCT00793793|58700075|FG006|Overall Study|Adverse Event|2|||
30959243|NCT01685801|59024655|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
30959244|NCT01353222|59024674|FG000|Overall Study|Death|30|||
30686099|NCT00793793|58700076|FG007|Overall Study|Adverse Event|0|||
30686100|NCT00793793|58700077|FG008|Overall Study|Adverse Event|0|||
30686101|NCT00793793|58700078|FG009|Overall Study|Adverse Event|0|||
30686102|NCT00793793|58700079|FG010|Overall Study|Adverse Event|0|||
30686103|NCT00793793|58700080|FG011|Overall Study|Adverse Event|2|||
30686104|NCT00793793|58700069|FG000|Overall Study|Protocol Violation|0|||
30686105|NCT00793793|58700070|FG001|Overall Study|Protocol Violation|0|||
30686106|NCT00793793|58700071|FG002|Overall Study|Protocol Violation|0|||
30686107|NCT00793793|58700072|FG003|Overall Study|Protocol Violation|1|||
30686108|NCT00793793|58700073|FG004|Overall Study|Protocol Violation|0|||
30686109|NCT00793793|58700074|FG005|Overall Study|Protocol Violation|0|||
30686110|NCT00793793|58700075|FG006|Overall Study|Protocol Violation|0|||
30686111|NCT00793793|58700076|FG007|Overall Study|Protocol Violation|0|||
30686112|NCT00793793|58700077|FG008|Overall Study|Protocol Violation|0|||
30686113|NCT00793793|58700078|FG009|Overall Study|Protocol Violation|0|||
30686114|NCT00793793|58700079|FG010|Overall Study|Protocol Violation|0|||
30686115|NCT00793793|58700080|FG011|Overall Study|Protocol Violation|0|||
30686116|NCT00793793|58700069|FG000|Overall Study|Lost to Follow-up|0|||
30686117|NCT00793793|58700070|FG001|Overall Study|Lost to Follow-up|0|||
30686118|NCT00793793|58700071|FG002|Overall Study|Lost to Follow-up|1|||
30686119|NCT00793793|58700072|FG003|Overall Study|Lost to Follow-up|0|||
30686120|NCT00793793|58700073|FG004|Overall Study|Lost to Follow-up|0|||
30686121|NCT00793793|58700074|FG005|Overall Study|Lost to Follow-up|0|||
30686122|NCT00793793|58700075|FG006|Overall Study|Lost to Follow-up|0|||
30686123|NCT00793793|58700076|FG007|Overall Study|Lost to Follow-up|0|||
30686124|NCT00793793|58700077|FG008|Overall Study|Lost to Follow-up|1|||
30686125|NCT00793793|58700078|FG009|Overall Study|Lost to Follow-up|3|||
30686126|NCT00793793|58700079|FG010|Overall Study|Lost to Follow-up|1|||
30686127|NCT00793793|58700080|FG011|Overall Study|Lost to Follow-up|0|||
30686128|NCT00793793|58700069|FG000|Overall Study|Withdrawal by Subject|0|||
30686129|NCT00793793|58700070|FG001|Overall Study|Withdrawal by Subject|0|||
30686130|NCT00793793|58700071|FG002|Overall Study|Withdrawal by Subject|0|||
30686131|NCT00793793|58700072|FG003|Overall Study|Withdrawal by Subject|0|||
30598389|NCT01309737|58610142|FG003|Week 0 to 16|Death|0|||
30598390|NCT01309737|58610143|FG004|Week 0 to 16|Death|0|||
30598391|NCT01309737|58610139|FG000|Week 0 to 16|Adverse Event|11|||
30598392|NCT01309737|58610140|FG001|Week 0 to 16|Adverse Event|10|||
30598393|NCT01309737|58610141|FG002|Week 0 to 16|Adverse Event|5|||
30598394|NCT01309737|58610142|FG003|Week 0 to 16|Adverse Event|0|||
30598395|NCT01309737|58610143|FG004|Week 0 to 16|Adverse Event|0|||
30598396|NCT01309737|58610139|FG000|Week 0 to 16|Lack of Efficacy|15|||
30686132|NCT00793793|58700073|FG004|Overall Study|Withdrawal by Subject|1|||
30686133|NCT00793793|58700074|FG005|Overall Study|Withdrawal by Subject|0|||
30686134|NCT00793793|58700075|FG006|Overall Study|Withdrawal by Subject|0|||
30686135|NCT00793793|58700076|FG007|Overall Study|Withdrawal by Subject|0|||
30686136|NCT00793793|58700077|FG008|Overall Study|Withdrawal by Subject|1|||
30686137|NCT00793793|58700078|FG009|Overall Study|Withdrawal by Subject|0|||
30856232|NCT03194542|58884091|FG003|Overall Study|Loss of Response|4|||
30686138|NCT00793793|58700079|FG010|Overall Study|Withdrawal by Subject|0|||
30598397|NCT01309737|58610140|FG001|Week 0 to 16|Lack of Efficacy|2|||
30598398|NCT01309737|58610141|FG002|Week 0 to 16|Lack of Efficacy|24|||
30598399|NCT01309737|58610142|FG003|Week 0 to 16|Lack of Efficacy|0|||
30686139|NCT00793793|58700080|FG011|Overall Study|Withdrawal by Subject|0|||
30686140|NCT00793793|58700069|FG000|Overall Study|reason not specified|0|||
30686141|NCT00793793|58700070|FG001|Overall Study|reason not specified|1|||
30959245|NCT01353222|59024675|FG001|Overall Study|Death|30|||
30598400|NCT01309737|58610143|FG004|Week 0 to 16|Lack of Efficacy|0|||
30686142|NCT00793793|58700071|FG002|Overall Study|reason not specified|0|||
30686143|NCT00793793|58700072|FG003|Overall Study|reason not specified|1|||
30686144|NCT00793793|58700073|FG004|Overall Study|reason not specified|1|||
30686145|NCT00793793|58700074|FG005|Overall Study|reason not specified|1|||
30686146|NCT00793793|58700075|FG006|Overall Study|reason not specified|2|||
30686147|NCT00793793|58700076|FG007|Overall Study|reason not specified|0|||
30686148|NCT00793793|58700077|FG008|Overall Study|reason not specified|7|||
30686149|NCT00793793|58700078|FG009|Overall Study|reason not specified|6|||
30686150|NCT00793793|58700079|FG010|Overall Study|reason not specified|2|||
30686151|NCT00793793|58700080|FG011|Overall Study|reason not specified|4|||
30686152|NCT00776789|58700128|FG000|Overall Study|Consent refusal|2|||
30686153|NCT00776789|58700129|FG001|Overall Study|Consent refusal|2|||
30686154|NCT00776789|58700128|FG000|Overall Study|Poor quality video|1|||
30686155|NCT00776789|58700129|FG001|Overall Study|Poor quality video|1|||
30686156|NCT00776555|58700139|FG000|Overall Study|Study terminated|3|||
30686157|NCT00776555|58700140|FG001|Overall Study|Study terminated|0|||
30686158|NCT00720434|58700150|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
30686159|NCT00720434|58700151|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
30686160|NCT00720434|58700152|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
30686161|NCT00720434|58700153|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
30686162|NCT00720434|58700150|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
30686163|NCT00720434|58700151|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
30686164|NCT00720434|58700152|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
30686165|NCT00720434|58700153|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
30686166|NCT00720434|58700150|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
30686167|NCT00720434|58700151|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
30686168|NCT00720434|58700152|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
30686169|NCT00720434|58700153|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
30686170|NCT00720434|58700150|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
30686171|NCT00720434|58700151|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
30686172|NCT00720434|58700152|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
30686173|NCT00720434|58700153|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
30686174|NCT00720434|58700150|FG000|Open-Label Period (Week 5-72)|Other|4|||
30686175|NCT00720434|58700151|FG001|Open-Label Period (Week 5-72)|Other|3|||
30686176|NCT00720434|58700152|FG002|Open-Label Period (Week 5-72)|Other|3|||
30686177|NCT00720434|58700153|FG003|Open-Label Period (Week 5-72)|Other|2|||
30686178|NCT00776009|58700169|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
30686179|NCT00776009|58700170|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
30686180|NCT00776009|58700171|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
30686181|NCT00776009|58700172|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
30686182|NCT00776009|58700173|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
30686183|NCT00776009|58700174|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
30686184|NCT00776009|58700169|FG000|Period 1: First Intervention|Protocol Violation|0|||
30686185|NCT00776009|58700170|FG001|Period 1: First Intervention|Protocol Violation|1|||
30686186|NCT00776009|58700171|FG002|Period 1: First Intervention|Protocol Violation|0|||
30686187|NCT00776009|58700172|FG003|Period 1: First Intervention|Protocol Violation|0|||
30686188|NCT00776009|58700173|FG004|Period 1: First Intervention|Protocol Violation|1|||
30686189|NCT00776009|58700174|FG005|Period 1: First Intervention|Protocol Violation|0|||
30686190|NCT00776009|58700169|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
30686191|NCT00776009|58700170|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
30686192|NCT00776009|58700171|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
30686193|NCT00776009|58700172|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
30686194|NCT00776009|58700173|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
30686195|NCT00776009|58700174|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
30784066|NCT03736785|58796246|FG002|Overall Study|Lost to Follow-up|3|||
30784067|NCT03736785|58796244|FG000|Overall Study|Non compliance with study drug|1|||
30784068|NCT03736785|58796245|FG001|Overall Study|Non compliance with study drug|1|||
30784069|NCT03736785|58796246|FG002|Overall Study|Non compliance with study drug|0|||
30784070|NCT03736785|58796244|FG000|Overall Study|Physician Decision|0|||
30784071|NCT03736785|58796245|FG001|Overall Study|Physician Decision|1|||
30784072|NCT03736785|58796246|FG002|Overall Study|Physician Decision|1|||
30784073|NCT03736785|58796244|FG000|Overall Study|Protocol Violation|1|||
30784074|NCT03736785|58796245|FG001|Overall Study|Protocol Violation|4|||
30598401|NCT01309737|58610139|FG000|Week 0 to 16|Lost to Follow-up|7|||
30598402|NCT01309737|58610140|FG001|Week 0 to 16|Lost to Follow-up|8|||
30598403|NCT01309737|58610141|FG002|Week 0 to 16|Lost to Follow-up|3|||
30598404|NCT01309737|58610142|FG003|Week 0 to 16|Lost to Follow-up|0|||
30598405|NCT01309737|58610143|FG004|Week 0 to 16|Lost to Follow-up|0|||
30598406|NCT01309737|58610139|FG000|Week 0 to 16|Withdrawal by Subject|7|||
30598407|NCT01309737|58610140|FG001|Week 0 to 16|Withdrawal by Subject|6|||
30598408|NCT01309737|58610141|FG002|Week 0 to 16|Withdrawal by Subject|7|||
30598409|NCT01309737|58610142|FG003|Week 0 to 16|Withdrawal by Subject|0|||
30598410|NCT01309737|58610143|FG004|Week 0 to 16|Withdrawal by Subject|0|||
30598411|NCT01309737|58610139|FG000|Week 0 to 16|Other|10|||
30598412|NCT01309737|58610140|FG001|Week 0 to 16|Other|14|||
30686196|NCT00776009|58700169|FG000|Period 2: Second Intervention|Protocol Violation|1|||
30686197|NCT00776009|58700170|FG001|Period 2: Second Intervention|Protocol Violation|0|||
30686198|NCT00776009|58700171|FG002|Period 2: Second Intervention|Protocol Violation|1|||
30686199|NCT00776009|58700172|FG003|Period 2: Second Intervention|Protocol Violation|0|||
30686200|NCT00776009|58700173|FG004|Period 2: Second Intervention|Protocol Violation|0|||
30686201|NCT00776009|58700174|FG005|Period 2: Second Intervention|Protocol Violation|0|||
30686202|NCT00776009|58700169|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
30686203|NCT00776009|58700170|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
30686204|NCT00776009|58700171|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
30784075|NCT03736785|58796246|FG002|Overall Study|Protocol Violation|3|||
30784076|NCT03736785|58796244|FG000|Overall Study|Sponsor Decision|1|||
30784077|NCT03736785|58796245|FG001|Overall Study|Sponsor Decision|0|||
30784078|NCT03736785|58796246|FG002|Overall Study|Sponsor Decision|0|||
30784079|NCT03736785|58796244|FG000|Overall Study|Unknown/Missing data|3|||
30784080|NCT03736785|58796245|FG001|Overall Study|Unknown/Missing data|2|||
30784081|NCT03736785|58796246|FG002|Overall Study|Unknown/Missing data|1|||
30784082|NCT03736785|58796244|FG000|Overall Study|Withdrawal by Subject|9|||
30784083|NCT03736785|58796245|FG001|Overall Study|Withdrawal by Subject|6|||
30784084|NCT03736785|58796246|FG002|Overall Study|Withdrawal by Subject|4|||
30784085|NCT03734991|58796257|FG000|Overall Study|Adverse Event|4|||
30784086|NCT03734991|58796258|FG001|Overall Study|Adverse Event|0|||
30784087|NCT03734991|58796257|FG000|Overall Study|Lost to Follow-up|4|||
30784088|NCT03734991|58796258|FG001|Overall Study|Lost to Follow-up|0|||
30784089|NCT03734991|58796257|FG000|Overall Study|Physician Decision|0|||
30784090|NCT03734991|58796258|FG001|Overall Study|Physician Decision|1|||
30784091|NCT03734991|58796257|FG000|Overall Study|Pregnancy|1|||
30784092|NCT03734991|58796258|FG001|Overall Study|Pregnancy|0|||
30784093|NCT03734991|58796257|FG000|Overall Study|Withdrawal by Subject|6|||
30784094|NCT03734991|58796258|FG001|Overall Study|Withdrawal by Subject|3|||
30784095|NCT03734991|58796257|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
30784096|NCT03734991|58796258|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
30784097|NCT03734991|58796257|FG000|Overall Study|Other|2|||
30784098|NCT03734991|58796258|FG001|Overall Study|Other|2|||
30784099|NCT03303092|58796267|FG000|Overall Study|Adverse Event|1|||
30784100|NCT03303092|58796268|FG001|Overall Study|Adverse Event|0|||
30784101|NCT03303092|58796269|FG002|Overall Study|Adverse Event|1|||
30784102|NCT03303092|58796267|FG000|Overall Study|Protocol Violation|1|||
30784103|NCT03303092|58796268|FG001|Overall Study|Protocol Violation|5|||
30784104|NCT03303092|58796269|FG002|Overall Study|Protocol Violation|1|||
30784105|NCT03303092|58796267|FG000|Overall Study|Withdrawal by Subject|1|||
30784106|NCT03303092|58796268|FG001|Overall Study|Withdrawal by Subject|1|||
30784107|NCT03303092|58796269|FG002|Overall Study|Withdrawal by Subject|3|||
30784108|NCT03302936|58796279|FG000|Overall Study|Protocol Violation|3|||
30784109|NCT03302936|58796280|FG001|Overall Study|Protocol Violation|4|||
30784110|NCT03733899|58796290|FG000|Period 1|Protocol Violation|0|||
30784111|NCT03733899|58796291|FG001|Period 1|Protocol Violation|0|||
30784112|NCT03733899|58796292|FG002|Period 1|Protocol Violation|0|||
30784113|NCT03733899|58796293|FG003|Period 1|Protocol Violation|0|||
30784114|NCT03733899|58796294|FG004|Period 1|Protocol Violation|0|||
30784115|NCT03733899|58796295|FG005|Period 1|Protocol Violation|1|||
30784116|NCT03733899|58796290|FG000|Period 2|Unscuccessful Treatment|0|||
30856233|NCT03194542|58884088|FG000|Overall Study|Physician Decision|0|||
30856234|NCT03194542|58884089|FG001|Overall Study|Physician Decision|1|||
30856235|NCT03194542|58884090|FG002|Overall Study|Physician Decision|0|||
30856236|NCT03194542|58884091|FG003|Overall Study|Physician Decision|0|||
30856237|NCT03194542|58884088|FG000|Overall Study|Lack of Efficacy|2|||
30856238|NCT03194542|58884089|FG001|Overall Study|Lack of Efficacy|2|||
30856239|NCT03194542|58884090|FG002|Overall Study|Lack of Efficacy|2|||
30856240|NCT03194542|58884091|FG003|Overall Study|Lack of Efficacy|6|||
30686205|NCT00776009|58700172|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
30784117|NCT03733899|58796291|FG001|Period 2|Unscuccessful Treatment|1|||
30784118|NCT03733899|58796292|FG002|Period 2|Unscuccessful Treatment|0|||
30784119|NCT03733899|58796293|FG003|Period 2|Unscuccessful Treatment|0|||
30784120|NCT03733899|58796294|FG004|Period 2|Unscuccessful Treatment|0|||
30784121|NCT03733899|58796295|FG005|Period 2|Unscuccessful Treatment|0|||
30784122|NCT03733899|58796290|FG000|Period 3|Withdrawal by Subject|1|||
30784123|NCT03733899|58796291|FG001|Period 3|Withdrawal by Subject|0|||
30784124|NCT03733899|58796292|FG002|Period 3|Withdrawal by Subject|0|||
30856241|NCT03194542|58884088|FG000|Overall Study|Withdrawal by Subject|2|||
30784125|NCT03733899|58796293|FG003|Period 3|Withdrawal by Subject|0|||
30784126|NCT03733899|58796294|FG004|Period 3|Withdrawal by Subject|0|||
30856242|NCT03194542|58884089|FG001|Overall Study|Withdrawal by Subject|1|||
30856243|NCT03194542|58884090|FG002|Overall Study|Withdrawal by Subject|5|||
30784127|NCT03733899|58796295|FG005|Period 3|Withdrawal by Subject|0|||
30784128|NCT03727347|58796308|FG000|Overall Study|Withdrawal by Subject|2|||
30784129|NCT03727347|58796308|FG000|Overall Study|Lost to Follow-up|1|||
30784130|NCT03302234|58796323|FG000|Overall Study|Death|137|||
30784131|NCT03302234|58796324|FG001|Overall Study|Death|135|||
30686206|NCT00776009|58700173|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
30686207|NCT00776009|58700174|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
30686208|NCT00694161|58700182|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
30686209|NCT00694161|58700182|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
30686210|NCT00694161|58700182|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
30686211|NCT00720356|58700186|FG000|Registration to Study|Determined to have methylated MGMT|67|||
30686212|NCT00720356|58700186|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
30686213|NCT00720356|58700186|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
30686214|NCT00720356|58700186|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
30686215|NCT00720356|58700186|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
30686216|NCT00720356|58700186|FG000|Follow up Until Death|Withdrawal by Subject|1|||
30686217|NCT00720356|58700186|FG000|Follow up Until Death|Alive at last data collection|4|||
30686218|NCT00720278|58700193|FG000|Overall Study|Adverse Event|5|||
30686219|NCT00720278|58700194|FG001|Overall Study|Adverse Event|3|||
30686220|NCT00720278|58700195|FG002|Overall Study|Adverse Event|4|||
30686221|NCT00720278|58700193|FG000|Overall Study|Withdrawal by Subject|0|||
30686222|NCT00720278|58700194|FG001|Overall Study|Withdrawal by Subject|1|||
30686223|NCT00720278|58700195|FG002|Overall Study|Withdrawal by Subject|0|||
30686224|NCT00720278|58700193|FG000|Overall Study|Lost to Follow-up|0|||
30784132|NCT03302234|58796323|FG000|Overall Study|Withdrawal by Subject|1|||
30784133|NCT03302234|58796324|FG001|Overall Study|Withdrawal by Subject|1|||
30784134|NCT03302234|58796323|FG000|Overall Study|Laryngeal carcinoma|0|||
30784135|NCT03302234|58796324|FG001|Overall Study|Laryngeal carcinoma|1|||
30784136|NCT03915626|58796331|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
30784137|NCT03301844|58796343|FG000|Overall Study|suspected colon cancer|1|||
30784138|NCT03301844|58796344|FG001|Overall Study|suspected colon cancer|1|||
30784139|NCT03313310|58796352|FG000|Phase 2|Lost to Follow-up|4|||
30784140|NCT03313310|58796353|FG001|Phase 2|Lost to Follow-up|0|||
30784141|NCT03313310|58796352|FG000|Phase 3|Lost to Follow-up|0|||
30784142|NCT03313310|58796353|FG001|Phase 3|Lost to Follow-up|1|||
30784143|NCT03313076|58796363|FG000|Overall Study|Withdrawal by Subject|2|||
30784144|NCT03313076|58796364|FG001|Overall Study|Withdrawal by Subject|0|||
30784145|NCT03313076|58796365|FG002|Overall Study|Withdrawal by Subject|0|||
30784146|NCT03313076|58796366|FG003|Overall Study|Withdrawal by Subject|0|||
30784147|NCT03313076|58796363|FG000|Overall Study|Lost to Follow-up|0|||
30784148|NCT03313076|58796364|FG001|Overall Study|Lost to Follow-up|2|||
30784149|NCT03313076|58796365|FG002|Overall Study|Lost to Follow-up|2|||
30784150|NCT03313076|58796366|FG003|Overall Study|Lost to Follow-up|2|||
30784151|NCT02940626|58796384|FG000|Overall Study|Death|40|||
30784152|NCT02940626|58796385|FG001|Overall Study|Death|32|||
30784153|NCT02940626|58796384|FG000|Overall Study|Lost to Follow-up|5|||
30784154|NCT02940626|58796385|FG001|Overall Study|Lost to Follow-up|2|||
30784155|NCT02940626|58796384|FG000|Overall Study|Withdrawal by Subject|1|||
30784156|NCT02940626|58796385|FG001|Overall Study|Withdrawal by Subject|0|||
30784157|NCT02940626|58796384|FG000|Overall Study|Transfer to Hospice Care|1|||
30784158|NCT02940626|58796385|FG001|Overall Study|Transfer to Hospice Care|0|||
30784159|NCT02940626|58796384|FG000|Overall Study|Prohibited Concomitant Medication|0|||
30784160|NCT02940626|58796385|FG001|Overall Study|Prohibited Concomitant Medication|1|||
30784161|NCT03300050|58796398|FG000|Overall Study|Lost to Follow-up|2|||
30784162|NCT03300050|58796399|FG001|Overall Study|Lost to Follow-up|1|||
30784163|NCT03300050|58796400|FG002|Overall Study|Lost to Follow-up|0|||
30784164|NCT03300050|58796401|FG003|Overall Study|Lost to Follow-up|0|||
30784165|NCT03300050|58796402|FG004|Overall Study|Lost to Follow-up|1|||
30784166|NCT03300050|58796398|FG000|Overall Study|Withdrawal by Subject|1|||
30784167|NCT03300050|58796399|FG001|Overall Study|Withdrawal by Subject|1|||
30784168|NCT03300050|58796400|FG002|Overall Study|Withdrawal by Subject|1|||
30784169|NCT03300050|58796401|FG003|Overall Study|Withdrawal by Subject|0|||
30784170|NCT03300050|58796402|FG004|Overall Study|Withdrawal by Subject|0|||
30784171|NCT03300050|58796398|FG000|Overall Study|Death|0|||
30784172|NCT03300050|58796399|FG001|Overall Study|Death|0|||
30784173|NCT03300050|58796400|FG002|Overall Study|Death|1|||
30784174|NCT03300050|58796401|FG003|Overall Study|Death|0|||
30784175|NCT03300050|58796402|FG004|Overall Study|Death|0|||
30686225|NCT00720278|58700194|FG001|Overall Study|Lost to Follow-up|0|||
30686226|NCT00720278|58700195|FG002|Overall Study|Lost to Follow-up|1|||
30686227|NCT00720278|58700193|FG000|Overall Study|Non-compliance|1|||
30686228|NCT00720278|58700194|FG001|Overall Study|Non-compliance|0|||
30784176|NCT03300050|58796398|FG000|Overall Study|Not Eligible at Randomization|0|||
30784177|NCT03300050|58796399|FG001|Overall Study|Not Eligible at Randomization|0|||
30959246|NCT01353222|59024674|FG000|Overall Study|Withdrawal by Subject|8|||
30784178|NCT03300050|58796400|FG002|Overall Study|Not Eligible at Randomization|1|||
30784179|NCT03300050|58796401|FG003|Overall Study|Not Eligible at Randomization|1|||
30784180|NCT03300050|58796402|FG004|Overall Study|Not Eligible at Randomization|0|||
30784181|NCT03725085|58796414|FG000|Overall Study|Lost to Follow-up|2|||
30784182|NCT02940392|58796419|FG000|Overall Study|Lost to Follow-up|3|||
30784183|NCT02940392|58796419|FG000|Overall Study|Retreatment|3|||
30686229|NCT00720278|58700195|FG002|Overall Study|Non-compliance|0|||
30686230|NCT00720278|58700193|FG000|Overall Study|eligibility criteria violation|1|||
30686231|NCT00720278|58700194|FG001|Overall Study|eligibility criteria violation|0|||
30686232|NCT00720278|58700195|FG002|Overall Study|eligibility criteria violation|1|||
30686233|NCT00720122|58700203|FG000|Overall Study|Lost to Follow-up|1|||
30686234|NCT00720122|58700203|FG000|Overall Study|Physician Decision|1|||
30686235|NCT00720122|58700203|FG000|Overall Study|Withdrawal by Subject|7|||
30686236|NCT00717860|58700209|FG000|Overall Study|Clinical adverse experience|5|||
30686237|NCT00717860|58700210|FG001|Overall Study|Clinical adverse experience|9|||
30686238|NCT00717860|58700209|FG000|Overall Study|Laboratory adverse experience|2|||
30686239|NCT00717860|58700210|FG001|Overall Study|Laboratory adverse experience|2|||
30686240|NCT00717860|58700209|FG000|Overall Study|Lack of Efficacy|7|||
30686241|NCT00717860|58700210|FG001|Overall Study|Lack of Efficacy|13|||
30686242|NCT00717860|58700209|FG000|Overall Study|Discontinued for other reason|6|||
30686243|NCT00717860|58700210|FG001|Overall Study|Discontinued for other reason|1|||
30686244|NCT00717860|58700209|FG000|Overall Study|Withdrew consent|7|||
30686245|NCT00717860|58700210|FG001|Overall Study|Withdrew consent|3|||
30686246|NCT00717314|58700218|FG000|Overall Study|Adverse Event|3|||
30686247|NCT00717314|58700219|FG001|Overall Study|Adverse Event|2|||
30686248|NCT00717314|58700218|FG000|Overall Study|Protocol Violation|1|||
30686249|NCT00717314|58700219|FG001|Overall Study|Protocol Violation|0|||
30686250|NCT00717314|58700218|FG000|Overall Study|Lost to Follow-up|1|||
30686251|NCT00717314|58700219|FG001|Overall Study|Lost to Follow-up|5|||
30686252|NCT00717314|58700218|FG000|Overall Study|Withdrawal by Subject|1|||
30686253|NCT00717314|58700219|FG001|Overall Study|Withdrawal by Subject|3|||
30686254|NCT00689793|58700227|FG000|Overall Study|Lost to Follow-up|4|||
30686255|NCT00689793|58700228|FG001|Overall Study|Lost to Follow-up|5|||
30686256|NCT00723944|58700238|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
30686257|NCT00723944|58700239|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
30686258|NCT00723944|58700238|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
30686259|NCT00723944|58700239|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
30686260|NCT00723944|58700238|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
30686261|NCT00723944|58700239|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
30686262|NCT00689481|58700247|FG000|Overall Study|Adverse Event|7|||
30598413|NCT01309737|58610141|FG002|Week 0 to 16|Other|4|||
30598414|NCT01309737|58610142|FG003|Week 0 to 16|Other|0|||
30598415|NCT01309737|58610143|FG004|Week 0 to 16|Other|0|||
30686263|NCT00689481|58700248|FG001|Overall Study|Adverse Event|1|||
30686264|NCT00689481|58700247|FG000|Overall Study|Lost to Follow-up|4|||
30686265|NCT00689481|58700248|FG001|Overall Study|Lost to Follow-up|3|||
30686266|NCT00689481|58700247|FG000|Overall Study|Lack of Efficacy|4|||
30784184|NCT02940392|58796419|FG000|Overall Study|Death|2|||
30598416|NCT01309737|58610139|FG000|Week 0 to 16|Randomized, but not treated|1|||
30598417|NCT01309737|58610140|FG001|Week 0 to 16|Randomized, but not treated|0|||
30598418|NCT01309737|58610141|FG002|Week 0 to 16|Randomized, but not treated|0|||
30598419|NCT01309737|58610142|FG003|Week 0 to 16|Randomized, but not treated|0|||
30598420|NCT01309737|58610143|FG004|Week 0 to 16|Randomized, but not treated|0|||
30598421|NCT01309737|58610139|FG000|Week 16 to 52|Death|0|||
30598422|NCT01309737|58610140|FG001|Week 16 to 52|Death|0|||
30598423|NCT01309737|58610141|FG002|Week 16 to 52|Death|0|||
30598424|NCT01309737|58610142|FG003|Week 16 to 52|Death|0|||
30598425|NCT01309737|58610143|FG004|Week 16 to 52|Death|1|||
30598426|NCT01309737|58610139|FG000|Week 16 to 52|Adverse Event|7|||
30598427|NCT01309737|58610140|FG001|Week 16 to 52|Adverse Event|7|||
30598428|NCT01309737|58610141|FG002|Week 16 to 52|Adverse Event|0|||
30598429|NCT01309737|58610142|FG003|Week 16 to 52|Adverse Event|6|||
30598430|NCT01309737|58610143|FG004|Week 16 to 52|Adverse Event|5|||
30598431|NCT01309737|58610139|FG000|Week 16 to 52|Lack of Efficacy|107|||
30598432|NCT01309737|58610140|FG001|Week 16 to 52|Lack of Efficacy|76|||
30598433|NCT01309737|58610141|FG002|Week 16 to 52|Lack of Efficacy|0|||
30598434|NCT01309737|58610142|FG003|Week 16 to 52|Lack of Efficacy|25|||
30598435|NCT01309737|58610143|FG004|Week 16 to 52|Lack of Efficacy|21|||
30686267|NCT00689481|58700248|FG001|Overall Study|Lack of Efficacy|3|||
30686268|NCT00689481|58700247|FG000|Overall Study|Non-compliance with study treatment|1|||
30686269|NCT00689481|58700248|FG001|Overall Study|Non-compliance with study treatment|1|||
30686270|NCT00689481|58700247|FG000|Overall Study|Withdrawal by Subject|8|||
30686271|NCT00689481|58700248|FG001|Overall Study|Withdrawal by Subject|4|||
30686272|NCT00689481|58700247|FG000|Overall Study|Excluded medication started during study|0|||
30784185|NCT03298412|58796432|FG000|Run-in Period|Other, Not Specified|1|||
30784186|NCT03298412|58796432|FG000|Run-in Period|Disease Progression|1|||
30598436|NCT01309737|58610139|FG000|Week 16 to 52|Lost to Follow-up|4|||
30598437|NCT01309737|58610140|FG001|Week 16 to 52|Lost to Follow-up|2|||
30598438|NCT01309737|58610141|FG002|Week 16 to 52|Lost to Follow-up|0|||
30598439|NCT01309737|58610142|FG003|Week 16 to 52|Lost to Follow-up|1|||
30598440|NCT01309737|58610143|FG004|Week 16 to 52|Lost to Follow-up|4|||
30784187|NCT03298412|58796432|FG000|Run-in Period|Ineligibility Determined|1|||
30598441|NCT01309737|58610139|FG000|Week 16 to 52|Withdrawal by Subject|5|||
30598442|NCT01309737|58610140|FG001|Week 16 to 52|Withdrawal by Subject|6|||
30686273|NCT00689481|58700248|FG001|Overall Study|Excluded medication started during study|1|||
30686274|NCT00689481|58700247|FG000|Overall Study|Subject early term, left on vacation|0|||
30686275|NCT00689481|58700248|FG001|Overall Study|Subject early term, left on vacation|1|||
30686276|NCT00688701|58700257|FG000|Overall Study|Adverse Event|1|||
30686277|NCT00688701|58700258|FG001|Overall Study|Adverse Event|0|||
30686278|NCT00688701|58700259|FG002|Overall Study|Adverse Event|5|||
30686279|NCT00688701|58700260|FG003|Overall Study|Adverse Event|3|||
30686280|NCT00688701|58700257|FG000|Overall Study|Lack of Efficacy|0|||
30686281|NCT00688701|58700258|FG001|Overall Study|Lack of Efficacy|1|||
30686282|NCT00688701|58700259|FG002|Overall Study|Lack of Efficacy|0|||
30686283|NCT00688701|58700260|FG003|Overall Study|Lack of Efficacy|0|||
30686284|NCT00688701|58700257|FG000|Overall Study|Withdrawal by Subject|3|||
30686285|NCT00688701|58700258|FG001|Overall Study|Withdrawal by Subject|3|||
30686286|NCT00688701|58700259|FG002|Overall Study|Withdrawal by Subject|4|||
30686287|NCT00688701|58700260|FG003|Overall Study|Withdrawal by Subject|8|||
30686288|NCT00688701|58700257|FG000|Overall Study|Poor compliance to protocol|0|||
30686289|NCT00688701|58700258|FG001|Overall Study|Poor compliance to protocol|1|||
30686290|NCT00688701|58700259|FG002|Overall Study|Poor compliance to protocol|1|||
30686291|NCT00688701|58700260|FG003|Overall Study|Poor compliance to protocol|0|||
30686292|NCT00688623|58700280|FG000|Overall Study|Adverse Event|22|||
30686293|NCT00688623|58700280|FG000|Overall Study|abnormal lab value|1|||
30686294|NCT00688623|58700280|FG000|Overall Study|Withdrawal by Subject|4|||
30686295|NCT00688623|58700280|FG000|Overall Study|Death|3|||
30686296|NCT00688623|58700280|FG000|Overall Study|disease progression|23|||
30686297|NCT00688623|58700280|FG000|Overall Study|Protocol Violation|2|||
30686298|NCT00717236|58700286|FG000|Double-Blind Period|Adverse Event|33|||
30686299|NCT00717236|58700287|FG001|Double-Blind Period|Adverse Event|6|||
30686300|NCT00717236|58700286|FG000|Double-Blind Period|Lack of Efficacy|6|||
30686301|NCT00717236|58700287|FG001|Double-Blind Period|Lack of Efficacy|6|||
30686302|NCT00717236|58700286|FG000|Double-Blind Period|Lost to Follow-up|3|||
30686303|NCT00717236|58700287|FG001|Double-Blind Period|Lost to Follow-up|5|||
30686304|NCT00717236|58700286|FG000|Double-Blind Period|Withdrawal by Subject|10|||
30686305|NCT00717236|58700287|FG001|Double-Blind Period|Withdrawal by Subject|2|||
30686306|NCT00717236|58700286|FG000|Double-Blind Period|Loss of efficacy|3|||
30686307|NCT00717236|58700287|FG001|Double-Blind Period|Loss of efficacy|0|||
30686308|NCT00717236|58700286|FG000|Double-Blind Period|Other: Death|1|||
30686309|NCT00717236|58700287|FG001|Double-Blind Period|Other: Death|0|||
30686310|NCT00717236|58700286|FG000|Double-Blind Period|Other: Pregnancy|1|||
30784188|NCT03298412|58796432|FG000|Run-in Period|Decision by Sponsor|6|||
30784189|NCT03297398|58796439|FG000|Overall Study|Sponsor's decision|6|||
30784190|NCT03297398|58796440|FG001|Overall Study|Sponsor's decision|9|||
30784191|NCT03297398|58796441|FG002|Overall Study|Sponsor's decision|7|||
30784192|NCT03297398|58796439|FG000|Overall Study|Adverse Event|1|||
30784193|NCT03297398|58796440|FG001|Overall Study|Adverse Event|4|||
30784194|NCT03297398|58796441|FG002|Overall Study|Adverse Event|4|||
30784195|NCT03297398|58796439|FG000|Overall Study|Withdrawal by Subject|1|||
30784196|NCT03297398|58796440|FG001|Overall Study|Withdrawal by Subject|2|||
30784197|NCT03297398|58796441|FG002|Overall Study|Withdrawal by Subject|2|||
30784198|NCT03297398|58796439|FG000|Overall Study|Protocol Violation|0|||
30784199|NCT03297398|58796440|FG001|Overall Study|Protocol Violation|2|||
30784200|NCT03297398|58796441|FG002|Overall Study|Protocol Violation|0|||
30784201|NCT03297398|58796439|FG000|Overall Study|Physician Decision|0|||
30784202|NCT03297398|58796440|FG001|Overall Study|Physician Decision|0|||
30784203|NCT03297398|58796441|FG002|Overall Study|Physician Decision|1|||
30784204|NCT03297398|58796439|FG000|Overall Study|Lost to Follow-up|0|||
30784205|NCT03297398|58796440|FG001|Overall Study|Lost to Follow-up|0|||
30784206|NCT03297398|58796441|FG002|Overall Study|Lost to Follow-up|1|||
30784207|NCT03293654|58796452|FG000|Overall Study|Lost to Follow-up|0|||
30784208|NCT03293654|58796453|FG001|Overall Study|Lost to Follow-up|1|||
30784209|NCT03293654|58796454|FG002|Overall Study|Lost to Follow-up|0|||
30686311|NCT00717236|58700287|FG001|Double-Blind Period|Other: Pregnancy|0|||
30686312|NCT00717236|58700286|FG000|Double-Blind Period|Other: Protocol Violation|2|||
30686313|NCT00717236|58700287|FG001|Double-Blind Period|Other: Protocol Violation|0|||
30686314|NCT00717236|58700286|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
30686315|NCT00717236|58700287|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
30686316|NCT00717236|58700286|FG000|Double-Blind Period|Other: Site withdrew|2|||
30686317|NCT00717236|58700287|FG001|Double-Blind Period|Other: Site withdrew|0|||
30686318|NCT00717236|58700286|FG000|Double-Blind Period|Other: Screening failure|1|||
30686319|NCT00717236|58700287|FG001|Double-Blind Period|Other: Screening failure|0|||
30686320|NCT00717236|58700286|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
30686321|NCT00717236|58700287|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
30686322|NCT00717236|58700286|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
30784210|NCT03312218|58796464|FG000|Overall Study|Never signed in to access the app|54|||
30784211|NCT03312218|58796465|FG001|Overall Study|Never signed in to access the app|58|||
30784212|NCT03930615|58796473|FG000|Overall Study|Death|9|||
30784213|NCT03930615|58796474|FG001|Overall Study|Death|3|||
30784214|NCT03930615|58796473|FG000|Overall Study|Lost to Follow-up|1|||
30686323|NCT00717236|58700287|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
30686324|NCT00717236|58700286|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
30686325|NCT00717236|58700287|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
30686326|NCT00717236|58700286|FG000|Double-Blind Period|Other: History of cancer|1|||
30686327|NCT00717236|58700287|FG001|Double-Blind Period|Other: History of cancer|0|||
30686328|NCT00717236|58700286|FG000|Double-Blind Period|Other: Sponsor request|1|||
30686329|NCT00717236|58700287|FG001|Double-Blind Period|Other: Sponsor request|0|||
30686330|NCT00717236|58700286|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
30686331|NCT00717236|58700287|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
30686332|NCT00717236|58700286|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
30686333|NCT00717236|58700287|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
30686334|NCT00717236|58700286|FG000|Double-Blind Period|Other: Subject moved|1|||
30686335|NCT00717236|58700287|FG001|Double-Blind Period|Other: Subject moved|1|||
30686336|NCT00717236|58700286|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
30686337|NCT00717236|58700287|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
30686338|NCT00717236|58700286|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
30686339|NCT00717236|58700287|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
30686340|NCT00717236|58700286|FG000|Double-Blind Period|Other: Transportation problems|0|||
30686341|NCT00717236|58700287|FG001|Double-Blind Period|Other: Transportation problems|1|||
30686342|NCT00717236|58700286|FG000|Double-Blind Period|Other: Investigator Decision|0|||
30686343|NCT00717236|58700287|FG001|Double-Blind Period|Other: Investigator Decision|1|||
30686344|NCT00717236|58700286|FG000|Open-Label Period|Adverse Event|29|||
30686345|NCT00717236|58700287|FG001|Open-Label Period|Adverse Event|4|||
30686346|NCT00717236|58700286|FG000|Open-Label Period|Lack of Efficacy|30|||
30686347|NCT00717236|58700287|FG001|Open-Label Period|Lack of Efficacy|8|||
30686348|NCT00717236|58700286|FG000|Open-Label Period|Lost to Follow-up|28|||
30686349|NCT00717236|58700287|FG001|Open-Label Period|Lost to Follow-up|4|||
30686350|NCT00717236|58700286|FG000|Open-Label Period|Withdrawal by Subject|20|||
30686351|NCT00717236|58700287|FG001|Open-Label Period|Withdrawal by Subject|2|||
30686352|NCT00717236|58700286|FG000|Open-Label Period|Loss of Efficacy|6|||
30686353|NCT00717236|58700287|FG001|Open-Label Period|Loss of Efficacy|1|||
30686354|NCT00717236|58700286|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
30686355|NCT00717236|58700287|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
30686356|NCT00717236|58700286|FG000|Open-Label Period|Other: Lack of Compliance|1|||
30686357|NCT00717236|58700287|FG001|Open-Label Period|Other: Lack of Compliance|1|||
30686358|NCT00717236|58700286|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
30686359|NCT00717236|58700287|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
30686360|NCT00717236|58700286|FG000|Open-Label Period|Other: Moved|1|||
30686361|NCT00717236|58700287|FG001|Open-Label Period|Other: Moved|0|||
30686362|NCT00717236|58700286|FG000|Open-Label Period|Other: Investigator Decision|1|||
30686363|NCT00717236|58700287|FG001|Open-Label Period|Other: Investigator Decision|0|||
30686364|NCT00717236|58700286|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
30686365|NCT00717236|58700287|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
30686366|NCT00717236|58700286|FG000|Open-Label Period|Other: Sponsor Request|3|||
30784215|NCT03930615|58796474|FG001|Overall Study|Lost to Follow-up|2|||
30784216|NCT03930615|58796473|FG000|Overall Study|Physician Decision|3|||
30784217|NCT03930615|58796474|FG001|Overall Study|Physician Decision|4|||
30784218|NCT03930615|58796473|FG000|Overall Study|Withdrawal by Subject|13|||
30784219|NCT03930615|58796474|FG001|Overall Study|Withdrawal by Subject|2|||
30784220|NCT03930615|58796473|FG000|Overall Study|Not treated|1|||
30784221|NCT03930615|58796474|FG001|Overall Study|Not treated|1|||
30784222|NCT03292640|58796482|FG000|Overall Study|Withdrawal by Subject|17|||
30784223|NCT03292640|58796483|FG001|Overall Study|Withdrawal by Subject|16|||
30784224|NCT03292640|58796482|FG000|Overall Study|Adverse Event|20|||
30784225|NCT03292640|58796483|FG001|Overall Study|Adverse Event|2|||
30784226|NCT03292640|58796482|FG000|Overall Study|Lost to Follow-up|24|||
30784227|NCT03292640|58796483|FG001|Overall Study|Lost to Follow-up|24|||
30784228|NCT03292406|58796496|FG000|Overall Study|Progressive Disease|6|||
30784229|NCT03292406|58796497|FG001|Overall Study|Progressive Disease|3|||
30784230|NCT03292406|58796498|FG002|Overall Study|Progressive Disease|4|||
30784231|NCT03292406|58796496|FG000|Overall Study|Adverse Event|7|||
30784232|NCT03292406|58796497|FG001|Overall Study|Adverse Event|1|||
30784233|NCT03292406|58796498|FG002|Overall Study|Adverse Event|4|||
30784234|NCT03292406|58796496|FG000|Overall Study|Withdrawal by Subject|0|||
30686367|NCT00717236|58700287|FG001|Open-Label Period|Other: Sponsor Request|0|||
30686368|NCT00717236|58700286|FG000|Open-Label Period|Other: Cataract Surgery|1|||
30686369|NCT00717236|58700287|FG001|Open-Label Period|Other: Cataract Surgery|0|||
30686370|NCT00717236|58700286|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
30784235|NCT03292406|58796497|FG001|Overall Study|Withdrawal by Subject|7|||
30784236|NCT03292406|58796498|FG002|Overall Study|Withdrawal by Subject|2|||
30784237|NCT03292406|58796496|FG000|Overall Study|Protocol Violation|0|||
30784238|NCT03292406|58796497|FG001|Overall Study|Protocol Violation|1|||
30784239|NCT03292406|58796498|FG002|Overall Study|Protocol Violation|1|||
30784240|NCT03292406|58796496|FG000|Overall Study|Other|0|||
30686371|NCT00717236|58700287|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
30686372|NCT00717236|58700286|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
30686373|NCT00717236|58700287|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
30686374|NCT00717236|58700286|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
30686375|NCT00717236|58700287|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
30686376|NCT00719810|58700298|FG000|Overall Study|Adverse Event|0|||
30686377|NCT00719810|58700299|FG001|Overall Study|Adverse Event|2|||
30686378|NCT00719810|58700300|FG002|Overall Study|Adverse Event|3|||
30686379|NCT00719810|58700298|FG000|Overall Study|Lost to Follow-up|2|||
30686380|NCT00719810|58700299|FG001|Overall Study|Lost to Follow-up|0|||
30686381|NCT00719810|58700300|FG002|Overall Study|Lost to Follow-up|3|||
30686382|NCT00719810|58700298|FG000|Overall Study|Physician Decision|0|||
30686383|NCT00719810|58700299|FG001|Overall Study|Physician Decision|1|||
30686384|NCT00719810|58700300|FG002|Overall Study|Physician Decision|0|||
30686385|NCT00719810|58700298|FG000|Overall Study|Withdrawal by Subject|1|||
30686386|NCT00719810|58700299|FG001|Overall Study|Withdrawal by Subject|1|||
30686387|NCT00719810|58700300|FG002|Overall Study|Withdrawal by Subject|2|||
30686388|NCT00719732|58700308|FG000|Overall Study|Lost to Follow-up|20|||
30686389|NCT00719732|58700308|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
30686390|NCT00719732|58700308|FG000|Overall Study|Illness not associated with device|1|||
30686391|NCT00723710|58700312|FG000|Overall Study|Disease progression|48|||
30686392|NCT00723710|58700312|FG000|Overall Study|Adverse Event|88|||
30686393|NCT00723710|58700312|FG000|Overall Study|Withdrawal by Subject|36|||
30686394|NCT00723710|58700312|FG000|Overall Study|Physician Decision|2|||
30686395|NCT00688545|58700318|FG000|Overall Study|Lost to Follow-up|1|||
30686396|NCT00688545|58700319|FG001|Overall Study|Lost to Follow-up|4|||
30686397|NCT00688545|58700318|FG000|Overall Study|Insurance/cost of drug|0|||
30686398|NCT00688545|58700319|FG001|Overall Study|Insurance/cost of drug|1|||
30686399|NCT00688545|58700318|FG000|Overall Study|Withdrawal by Subject|2|||
30686400|NCT00688545|58700319|FG001|Overall Study|Withdrawal by Subject|3|||
30598443|NCT01309737|58610141|FG002|Week 16 to 52|Withdrawal by Subject|0|||
30598444|NCT01309737|58610142|FG003|Week 16 to 52|Withdrawal by Subject|0|||
30598445|NCT01309737|58610143|FG004|Week 16 to 52|Withdrawal by Subject|2|||
30598446|NCT01309737|58610139|FG000|Week 16 to 52|Other|10|||
30598447|NCT01309737|58610140|FG001|Week 16 to 52|Other|12|||
30598448|NCT01309737|58610141|FG002|Week 16 to 52|Other|0|||
30686401|NCT00688545|58700318|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
30686402|NCT00688545|58700319|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
30686403|NCT00688467|58700329|FG000|Treatment Period 1|Adverse Event|2|||
30686404|NCT00688467|58700330|FG001|Treatment Period 1|Adverse Event|1|||
30686405|NCT00688467|58700329|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
30686406|NCT00688467|58700330|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
30686407|NCT00688467|58700329|FG000|Treatment Period 2|Protocol Violation|0|||
30686408|NCT00688467|58700330|FG001|Treatment Period 2|Protocol Violation|1|||
30686409|NCT00688467|58700329|FG000|Treatment Period 2|Adverse Event|0|||
30686410|NCT00688467|58700330|FG001|Treatment Period 2|Adverse Event|1|||
30686411|NCT00688155|58700340|FG000|Overall Study|Withdrawal by Subject|2|||
30686412|NCT00688155|58700341|FG001|Overall Study|Withdrawal by Subject|2|||
30686413|NCT00688155|58700342|FG002|Overall Study|Withdrawal by Subject|1|||
30686414|NCT00688155|58700343|FG003|Overall Study|Withdrawal by Subject|1|||
30686415|NCT00690573|58700353|FG000|Overall Study|Lack of Efficacy|8|||
30686416|NCT00690573|58700353|FG000|Overall Study|Withdrawal by Subject|1|||
30686417|NCT00719264|58700359|FG000|Overall Study|Adverse Event|41|||
30686418|NCT00719264|58700360|FG001|Overall Study|Adverse Event|49|||
30686419|NCT00719264|58700359|FG000|Overall Study|Death|13|||
30686420|NCT00719264|58700360|FG001|Overall Study|Death|10|||
30686421|NCT00719264|58700359|FG000|Overall Study|Administrative Problems|6|||
30686422|NCT00719264|58700360|FG001|Overall Study|Administrative Problems|4|||
30686423|NCT00719264|58700359|FG000|Overall Study|Lost to Follow-up|1|||
30686424|NCT00719264|58700360|FG001|Overall Study|Lost to Follow-up|1|||
30686425|NCT00719264|58700359|FG000|Overall Study|Withdrawal by Subject|12|||
30686426|NCT00719264|58700360|FG001|Overall Study|Withdrawal by Subject|7|||
30686427|NCT00719264|58700359|FG000|Overall Study|Protocol Deviation|1|||
30686428|NCT00719264|58700360|FG001|Overall Study|Protocol Deviation|3|||
30686429|NCT00719264|58700359|FG000|Overall Study|New Cancer Therapy|4|||
30598449|NCT01309737|58610142|FG003|Week 16 to 52|Other|2|||
30686430|NCT00719264|58700360|FG001|Overall Study|New Cancer Therapy|2|||
30686431|NCT00719264|58700359|FG000|Overall Study|Disease Progression|104|||
30686432|NCT00719264|58700360|FG001|Overall Study|Disease Progression|107|||
30686433|NCT00687609|58700366|FG000|Overall Study|Physician Decision|1|||
30686434|NCT00687609|58700366|FG000|Overall Study|Withdrawal by Subject|2|||
30686435|NCT00723554|58700370|FG000|Overall Study|Adverse Event|12|||
30686436|NCT00723554|58700370|FG000|Overall Study|Investigator's judgement|5|||
30598450|NCT01309737|58610143|FG004|Week 16 to 52|Other|0|||
30598451|NCT01074229|58610169|FG000|Overall Study|Lost to Follow-up|1|||
30598452|NCT01074229|58610170|FG001|Overall Study|Lost to Follow-up|0|||
30686437|NCT00723554|58700370|FG000|Overall Study|Inhaled medication other than iloprost|4|||
30686438|NCT00723554|58700370|FG000|Overall Study|Withdrawal of consent|3|||
30686439|NCT00723554|58700370|FG000|Overall Study|Other|3|||
30686440|NCT00723554|58700370|FG000|Overall Study|Lost to Follow-up|1|||
30686441|NCT00723554|58700370|FG000|Overall Study|Non-compliance|1|||
30686442|NCT00687219|58700376|FG000|Overall Study|Adverse Event|8|||
30686443|NCT00687219|58700376|FG000|Overall Study|Discontinuance criteria met|7|||
30686444|NCT00687219|58700376|FG000|Overall Study|HCV-RNA positive conversion|34|||
30686445|NCT00687219|58700376|FG000|Overall Study|Withdrawal by Subject|1|||
30686446|NCT00687219|58700376|FG000|Overall Study|Lack of Efficacy|1|||
30686447|NCT00723398|58700385|FG000|Overall Study|Withdrawal by Subject|2|||
30686448|NCT00723398|58700386|FG001|Overall Study|Withdrawal by Subject|6|||
30686449|NCT00723398|58700387|FG002|Overall Study|Withdrawal by Subject|4|||
30686450|NCT00723398|58700388|FG003|Overall Study|Withdrawal by Subject|4|||
30686451|NCT00723398|58700389|FG004|Overall Study|Withdrawal by Subject|4|||
30686452|NCT00723398|58700385|FG000|Overall Study|Protocol Violation|2|||
30686453|NCT00723398|58700386|FG001|Overall Study|Protocol Violation|1|||
30686454|NCT00723398|58700387|FG002|Overall Study|Protocol Violation|5|||
30686455|NCT00723398|58700388|FG003|Overall Study|Protocol Violation|0|||
30686456|NCT00723398|58700389|FG004|Overall Study|Protocol Violation|0|||
30686457|NCT00723398|58700385|FG000|Overall Study|Physician Decision|2|||
30686458|NCT00723398|58700386|FG001|Overall Study|Physician Decision|2|||
30686459|NCT00723398|58700387|FG002|Overall Study|Physician Decision|5|||
30686460|NCT00723398|58700388|FG003|Overall Study|Physician Decision|0|||
30686461|NCT00723398|58700389|FG004|Overall Study|Physician Decision|1|||
30686462|NCT00723398|58700385|FG000|Overall Study|Adverse Event|0|||
30686463|NCT00723398|58700386|FG001|Overall Study|Adverse Event|5|||
30686464|NCT00723398|58700387|FG002|Overall Study|Adverse Event|3|||
30686465|NCT00723398|58700388|FG003|Overall Study|Adverse Event|1|||
30686466|NCT00723398|58700389|FG004|Overall Study|Adverse Event|4|||
30686467|NCT00723398|58700385|FG000|Overall Study|Lost to Follow-up|0|||
30598453|NCT01074229|58610171|FG002|Overall Study|Lost to Follow-up|0|||
30598454|NCT01074229|58610169|FG000|Overall Study|Change to open surgical procedure|1|||
30598455|NCT01074229|58610170|FG001|Overall Study|Change to open surgical procedure|3|||
30598456|NCT01074229|58610171|FG002|Overall Study|Change to open surgical procedure|4|||
30598457|NCT01106014|58610183|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
30598458|NCT01106014|58610184|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
30686468|NCT00723398|58700386|FG001|Overall Study|Lost to Follow-up|1|||
30686469|NCT00723398|58700387|FG002|Overall Study|Lost to Follow-up|0|||
30686470|NCT00723398|58700388|FG003|Overall Study|Lost to Follow-up|0|||
30686471|NCT00723398|58700389|FG004|Overall Study|Lost to Follow-up|0|||
30686472|NCT00716456|58700404|FG000|Overall Study|Adverse Event|0|||
30686473|NCT00716456|58700405|FG001|Overall Study|Adverse Event|2|||
30686474|NCT00716456|58700406|FG002|Overall Study|Adverse Event|0|||
30686475|NCT00684645|58700414|FG000|Overall Study|Death|2|||
30686476|NCT00684645|58700414|FG000|Overall Study|Progressive disease|67|||
30686477|NCT00684645|58700414|FG000|Overall Study|Adverse Event|27|||
30686478|NCT00684645|58700414|FG000|Overall Study|Lost to Follow-up|3|||
30686479|NCT00684645|58700414|FG000|Overall Study|Other|15|||
30686480|NCT00716144|58700422|FG000|Overall Study|Withdrawal by Subject|4|||
30686481|NCT00716144|58700423|FG001|Overall Study|Withdrawal by Subject|2|||
30598459|NCT01106014|58610183|FG000|Overall Study|Adverse Event|78|||
30598460|NCT01106014|58610184|FG001|Overall Study|Adverse Event|42|||
30598461|NCT01106014|58610183|FG000|Overall Study|Withdrawal by Subject|43|||
30598462|NCT01106014|58610184|FG001|Overall Study|Withdrawal by Subject|37|||
30598463|NCT01106014|58610183|FG000|Overall Study|Administrative reason|7|||
30598464|NCT01106014|58610184|FG001|Overall Study|Administrative reason|6|||
30598465|NCT01106014|58610183|FG000|Overall Study|Lost to Follow-up|2|||
30598466|NCT01106014|58610184|FG001|Overall Study|Lost to Follow-up|3|||
30598467|NCT01073605|58610193|FG000|Overall Study|Ongoing at Cutoff Date|1|||
30598468|NCT01073605|58610194|FG001|Overall Study|Ongoing at Cutoff Date|1|||
30598469|NCT01073605|58610195|FG002|Overall Study|Ongoing at Cutoff Date|0|||
30598470|NCT01073605|58610193|FG000|Overall Study|Adverse Event|2|||
30686482|NCT00716144|58700424|FG002|Overall Study|Withdrawal by Subject|6|||
30686483|NCT00716144|58700425|FG003|Overall Study|Withdrawal by Subject|6|||
30686484|NCT00716144|58700422|FG000|Overall Study|Lost to Follow-up|2|||
30784241|NCT03292406|58796497|FG001|Overall Study|Other|1|||
30598471|NCT01073605|58610194|FG001|Overall Study|Adverse Event|1|||
30598472|NCT01073605|58610195|FG002|Overall Study|Adverse Event|0|||
30598473|NCT01073605|58610193|FG000|Overall Study|Lost to Follow-up|3|||
30598474|NCT01073605|58610194|FG001|Overall Study|Lost to Follow-up|4|||
30598475|NCT01073605|58610195|FG002|Overall Study|Lost to Follow-up|9|||
30598476|NCT01073605|58610193|FG000|Overall Study|Other|25|||
30598477|NCT01073605|58610194|FG001|Overall Study|Other|21|||
30598478|NCT01073605|58610195|FG002|Overall Study|Other|29|||
30686485|NCT00716144|58700423|FG001|Overall Study|Lost to Follow-up|2|||
30686486|NCT00716144|58700424|FG002|Overall Study|Lost to Follow-up|1|||
30686487|NCT00716144|58700425|FG003|Overall Study|Lost to Follow-up|2|||
30686488|NCT00716144|58700422|FG000|Overall Study|Adverse Event|0|||
30686489|NCT00716144|58700423|FG001|Overall Study|Adverse Event|0|||
30686490|NCT00716144|58700424|FG002|Overall Study|Adverse Event|0|||
30686491|NCT00716144|58700425|FG003|Overall Study|Adverse Event|2|||
30686492|NCT00716144|58700422|FG000|Overall Study|Non-compliance|1|||
30686493|NCT00716144|58700423|FG001|Overall Study|Non-compliance|0|||
30686494|NCT00716144|58700424|FG002|Overall Study|Non-compliance|0|||
30686495|NCT00716144|58700425|FG003|Overall Study|Non-compliance|0|||
30686496|NCT00716144|58700422|FG000|Overall Study|Protocol Violation|2|||
30686497|NCT00716144|58700423|FG001|Overall Study|Protocol Violation|0|||
30686498|NCT00716144|58700424|FG002|Overall Study|Protocol Violation|1|||
30686499|NCT00716144|58700425|FG003|Overall Study|Protocol Violation|0|||
30686500|NCT00716144|58700422|FG000|Overall Study|Physician Decision|0|||
30686501|NCT00716144|58700423|FG001|Overall Study|Physician Decision|1|||
30686502|NCT00716144|58700424|FG002|Overall Study|Physician Decision|2|||
30686503|NCT00716144|58700425|FG003|Overall Study|Physician Decision|2|||
30686504|NCT00716144|58700422|FG000|Overall Study|Intercurrent illness|0|||
30686505|NCT00716144|58700423|FG001|Overall Study|Intercurrent illness|0|||
30686506|NCT00716144|58700424|FG002|Overall Study|Intercurrent illness|1|||
30686507|NCT00716144|58700425|FG003|Overall Study|Intercurrent illness|0|||
30686508|NCT00716144|58700422|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
30686509|NCT00716144|58700423|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
30686510|NCT00716144|58700424|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
30686511|NCT00716144|58700425|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
30686512|NCT00716144|58700422|FG000|Overall Study|Adverse event: left foot pain|0|||
30686513|NCT00716144|58700423|FG001|Overall Study|Adverse event: left foot pain|1|||
30686514|NCT00716144|58700424|FG002|Overall Study|Adverse event: left foot pain|0|||
30686515|NCT00716144|58700425|FG003|Overall Study|Adverse event: left foot pain|0|||
30686516|NCT00716144|58700422|FG000|Overall Study|Clinical Depression|0|||
30686517|NCT00716144|58700423|FG001|Overall Study|Clinical Depression|1|||
30686518|NCT00716144|58700424|FG002|Overall Study|Clinical Depression|0|||
30686519|NCT00716144|58700425|FG003|Overall Study|Clinical Depression|0|||
30686520|NCT00576381|58700435|FG000|Overall Study|Reoperation|3|||
30686521|NCT00576381|58700435|FG000|Overall Study|Adverse Event|4|||
30686522|NCT00684567|58700439|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
30686523|NCT00684567|58700439|FG000|Monotherapy Period|Adverse Event|2|||
30686524|NCT00684567|58700439|FG000|Monotherapy Period|Death|1|||
30686525|NCT00684567|58700439|FG000|Monotherapy Period|Progression of primary disease|11|||
30686526|NCT00684411|58700443|FG000|Overall Study|New Primary Cancer|1|||
30686527|NCT00684411|58700443|FG000|Overall Study|Disease Progression|10|||
30686528|NCT00684411|58700443|FG000|Overall Study|Adverse Event|1|||
30686529|NCT00686829|58700447|FG000|Overall Study|Adverse Event|5|||
30686530|NCT00686829|58700447|FG000|Overall Study|Lack of Efficacy|6|||
30686531|NCT00686829|58700447|FG000|Overall Study|Lost to Follow-up|4|||
30686532|NCT00686829|58700447|FG000|Overall Study|Withdrawal by Subject|14|||
30686533|NCT00686829|58700447|FG000|Overall Study|Protocol Violation|3|||
30686534|NCT00686829|58700447|FG000|Overall Study|Sponsor discontinued VCV|47|||
30686535|NCT00687297|58700453|FG000|Randomization|Withdrawal by Subject|2|||
30686536|NCT00687297|58700454|FG001|Randomization|Withdrawal by Subject|0|||
30686537|NCT00687297|58700453|FG000|Randomization|Withdrew before treatment, ineligible|1|||
30686538|NCT00687297|58700454|FG001|Randomization|Withdrew before treatment, ineligible|1|||
30686539|NCT00687297|58700453|FG000|Induction|Withdrawal by Subject|4|||
30686540|NCT00687297|58700454|FG001|Induction|Withdrawal by Subject|4|||
30686541|NCT00687297|58700453|FG000|Induction|Adverse Event|16|||
30686542|NCT00687297|58700454|FG001|Induction|Adverse Event|15|||
30686543|NCT00687297|58700453|FG000|Induction|Death|7|||
30686544|NCT00687297|58700454|FG001|Induction|Death|11|||
30686545|NCT00687297|58700453|FG000|Induction|Lack of Efficacy|17|||
30686546|NCT00687297|58700454|FG001|Induction|Lack of Efficacy|21|||
30686547|NCT00687297|58700453|FG000|Induction|Ineligible|0|||
30686548|NCT00687297|58700454|FG001|Induction|Ineligible|1|||
30686549|NCT00687297|58700453|FG000|Induction|Patient Noncompliance|1|||
30686550|NCT00687297|58700454|FG001|Induction|Patient Noncompliance|0|||
30686551|NCT00687297|58700453|FG000|Induction|Physician Decision|0|||
30686552|NCT00687297|58700454|FG001|Induction|Physician Decision|2|||
30686553|NCT00687297|58700453|FG000|Induction|Other|0|||
30686554|NCT00687297|58700454|FG001|Induction|Other|1|||
30686555|NCT00684177|58700464|FG000|Overall Study|Adverse Event|4|||
30686556|NCT00684177|58700465|FG001|Overall Study|Adverse Event|3|||
30686557|NCT00684177|58700464|FG000|Overall Study|Lack of Efficacy|10|||
30686558|NCT00684177|58700465|FG001|Overall Study|Lack of Efficacy|15|||
30856244|NCT03194542|58884091|FG003|Overall Study|Withdrawal by Subject|4|||
30856245|NCT03194542|58884088|FG000|Overall Study|Progressive Disease|1|||
30686559|NCT00684177|58700464|FG000|Overall Study|Protocol Violation|1|||
30686560|NCT00684177|58700465|FG001|Overall Study|Protocol Violation|0|||
30686561|NCT00684177|58700464|FG000|Overall Study|Lost to Follow-up|2|||
30686562|NCT00684177|58700465|FG001|Overall Study|Lost to Follow-up|1|||
30686563|NCT00684177|58700464|FG000|Overall Study|Physician Decision|2|||
30686564|NCT00684177|58700465|FG001|Overall Study|Physician Decision|0|||
30686565|NCT00684177|58700464|FG000|Overall Study|Withdrawal by Subject|1|||
30686566|NCT00684177|58700465|FG001|Overall Study|Withdrawal by Subject|2|||
30686567|NCT00684177|58700464|FG000|Overall Study|Other|1|||
30686568|NCT00684177|58700465|FG001|Overall Study|Other|2|||
30686569|NCT00684021|58700475|FG000|Overall Study|MRI Contraindicated|1|||
30686570|NCT00684021|58700476|FG001|Overall Study|MRI Contraindicated|1|||
30686571|NCT00684021|58700477|FG002|Overall Study|MRI Contraindicated|1|||
30686572|NCT00684021|58700478|FG003|Overall Study|MRI Contraindicated|0|||
30686573|NCT00684021|58700475|FG000|Overall Study|MRI not performed|0|||
30686574|NCT00684021|58700476|FG001|Overall Study|MRI not performed|1|||
30686575|NCT00684021|58700477|FG002|Overall Study|MRI not performed|1|||
30686576|NCT00684021|58700478|FG003|Overall Study|MRI not performed|2|||
30686577|NCT00684021|58700475|FG000|Overall Study|Death|1|||
30686578|NCT00684021|58700476|FG001|Overall Study|Death|0|||
30686579|NCT00684021|58700477|FG002|Overall Study|Death|0|||
30686580|NCT00684021|58700478|FG003|Overall Study|Death|0|||
30686581|NCT00576303|58700488|FG000|Dose Titration Period|Early withdrawal|17|||
30686582|NCT00576303|58700488|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
30686583|NCT00576303|58700488|FG000|Long Term Safety Period|Early withdrawal|16|||
30686584|NCT00686517|58700495|FG000|Treatment|Serious Adverse Event|1|||
30686585|NCT00686517|58700496|FG001|Treatment|Serious Adverse Event|2|||
30686586|NCT00686517|58700497|FG002|Treatment|Serious Adverse Event|1|||
30686587|NCT00686517|58700495|FG000|Treatment|Adverse Event|2|||
30686588|NCT00686517|58700496|FG001|Treatment|Adverse Event|0|||
30686589|NCT00686517|58700497|FG002|Treatment|Adverse Event|0|||
30686590|NCT00686517|58700495|FG000|Treatment|Poor Protocol Compliance|1|||
30686591|NCT00686517|58700496|FG001|Treatment|Poor Protocol Compliance|0|||
30686592|NCT00686517|58700497|FG002|Treatment|Poor Protocol Compliance|0|||
30686593|NCT00686517|58700495|FG000|Treatment|Protocol Violation|2|||
30686594|NCT00686517|58700496|FG001|Treatment|Protocol Violation|1|||
30686595|NCT00686517|58700497|FG002|Treatment|Protocol Violation|0|||
30686596|NCT00686205|58700507|FG000|Overall Study|Protocol Violation|127|||
30686597|NCT00686205|58700508|FG001|Overall Study|Protocol Violation|0|||
30686598|NCT00686205|58700507|FG000|Overall Study|Withdrawal by Subject|2|||
30686599|NCT00686205|58700508|FG001|Overall Study|Withdrawal by Subject|0|||
30686600|NCT00686205|58700507|FG000|Overall Study|Specimen handling procedure altered|5878|||
30686601|NCT00686205|58700508|FG001|Overall Study|Specimen handling procedure altered|0|||
30686602|NCT00686205|58700507|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
30686603|NCT00686205|58700508|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
30686604|NCT00571701|58700516|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
30686605|NCT00571701|58700517|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
30598479|NCT01073605|58610193|FG000|Overall Study|Withdrawal by Subject|31|||
30598480|NCT01073605|58610194|FG001|Overall Study|Withdrawal by Subject|39|||
30598481|NCT01073605|58610195|FG002|Overall Study|Withdrawal by Subject|22|||
30598482|NCT01073605|58610193|FG000|Overall Study|Randomized But Not Treated|0|||
30598483|NCT01073605|58610194|FG001|Overall Study|Randomized But Not Treated|1|||
30598484|NCT01073605|58610195|FG002|Overall Study|Randomized But Not Treated|1|||
30598485|NCT01073293|58610205|FG000|Overall Study|Lost to Follow-up|0|||
30598486|NCT01073293|58610206|FG001|Overall Study|Lost to Follow-up|1|||
30598487|NCT01073293|58610205|FG000|Overall Study|Withdrawal by Subject|5|||
30598488|NCT01073293|58610206|FG001|Overall Study|Withdrawal by Subject|10|||
30598489|NCT01105936|58610212|FG000|Period 1|Adverse Event|0|||
30598490|NCT01105936|58610213|FG001|Period 1|Adverse Event|0|||
30598491|NCT01105936|58610214|FG002|Period 1|Adverse Event|0|||
30598492|NCT01105936|58610215|FG003|Period 1|Adverse Event|1|||
30598493|NCT01105936|58610212|FG000|Period 2|Adverse Event|1|||
30598494|NCT01105936|58610213|FG001|Period 2|Adverse Event|0|||
30598495|NCT01105936|58610214|FG002|Period 2|Adverse Event|0|||
30598496|NCT01105936|58610215|FG003|Period 2|Adverse Event|0|||
30686606|NCT00571701|58700516|FG000|First Intervention 12 Months|Death|1|||
30686607|NCT00571701|58700517|FG001|First Intervention 12 Months|Death|0|||
30686608|NCT00571701|58700516|FG000|Second Intervention 12 Months|Adverse Event|0|||
30686609|NCT00571701|58700517|FG001|Second Intervention 12 Months|Adverse Event|1|||
30686610|NCT00571701|58700516|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
30686611|NCT00571701|58700517|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
30598497|NCT01105936|58610212|FG000|Period 3|Protocol Violation|0|||
30598498|NCT01105936|58610213|FG001|Period 3|Protocol Violation|2|||
30598499|NCT01105936|58610214|FG002|Period 3|Protocol Violation|0|||
30598500|NCT01105936|58610215|FG003|Period 3|Protocol Violation|0|||
30598501|NCT01309659|58610226|FG000|Overall Study|Protocol Violation|0|||
30598502|NCT01309659|58610227|FG001|Overall Study|Protocol Violation|1|||
30598503|NCT01104766|58610237|FG000|Overall Study|Did not meet inc/exc criteria|1|||
30598504|NCT01104766|58610238|FG001|Overall Study|Did not meet inc/exc criteria|0|||
30686612|NCT00686127|58700543|FG000|Overall Study|Withdrawal by Subject|14|||
30686613|NCT00686127|58700544|FG001|Overall Study|Withdrawal by Subject|6|||
30686614|NCT00718718|58700557|FG000|Prior to Week 12|Adverse Event|0|||
30686615|NCT00718718|58700558|FG001|Prior to Week 12|Adverse Event|0|||
30686616|NCT00718718|58700559|FG002|Prior to Week 12|Adverse Event|0|||
30686617|NCT00718718|58700560|FG003|Prior to Week 12|Adverse Event|0|||
30686618|NCT00718718|58700561|FG004|Prior to Week 12|Adverse Event|0|||
30686619|NCT00718718|58700562|FG005|Prior to Week 12|Adverse Event|0|||
30686620|NCT00718718|58700563|FG006|Prior to Week 12|Adverse Event|0|||
30686621|NCT00718718|58700564|FG007|Prior to Week 12|Adverse Event|1|||
30686622|NCT00718718|58700565|FG008|Prior to Week 12|Adverse Event|1|||
30686623|NCT00718718|58700566|FG009|Prior to Week 12|Adverse Event|0|||
30686624|NCT00718718|58700557|FG000|Prior to Week 12|Withdrawal by Subject|0|||
30686625|NCT00718718|58700558|FG001|Prior to Week 12|Withdrawal by Subject|0|||
30686626|NCT00718718|58700559|FG002|Prior to Week 12|Withdrawal by Subject|0|||
30686627|NCT00718718|58700560|FG003|Prior to Week 12|Withdrawal by Subject|0|||
30686628|NCT00718718|58700561|FG004|Prior to Week 12|Withdrawal by Subject|3|||
30686629|NCT00718718|58700562|FG005|Prior to Week 12|Withdrawal by Subject|0|||
30686630|NCT00718718|58700563|FG006|Prior to Week 12|Withdrawal by Subject|1|||
30686631|NCT00718718|58700564|FG007|Prior to Week 12|Withdrawal by Subject|1|||
30686632|NCT00718718|58700565|FG008|Prior to Week 12|Withdrawal by Subject|1|||
30686633|NCT00718718|58700566|FG009|Prior to Week 12|Withdrawal by Subject|0|||
30784242|NCT03292406|58796498|FG002|Overall Study|Other|2|||
30784243|NCT03292016|58796535|FG000|Second Washout|Adverse Event|0|||
30784244|NCT03292016|58796536|FG001|Second Washout|Adverse Event|1|||
30784245|NCT03292016|58796537|FG002|Second Washout|Adverse Event|0|||
30784246|NCT03292016|58796538|FG003|Second Washout|Adverse Event|0|||
30784247|NCT03292016|58796539|FG004|Second Washout|Adverse Event|0|||
30784248|NCT03292016|58796540|FG005|Second Washout|Adverse Event|0|||
30784249|NCT03290300|58796548|FG000|Overall Study|Lost to Follow-up|3|||
30598505|NCT01104766|58610239|FG002|Overall Study|Did not meet inc/exc criteria|0|||
30598506|NCT01104766|58610240|FG003|Overall Study|Did not meet inc/exc criteria|0|||
30598507|NCT01104766|58610237|FG000|Overall Study|Adverse Event|17|||
30598508|NCT01104766|58610238|FG001|Overall Study|Adverse Event|15|||
30598509|NCT01104766|58610239|FG002|Overall Study|Adverse Event|20|||
30598510|NCT01104766|58610240|FG003|Overall Study|Adverse Event|14|||
30598511|NCT01104766|58610237|FG000|Overall Study|Lack of Efficacy|20|||
30598512|NCT01104766|58610238|FG001|Overall Study|Lack of Efficacy|15|||
30598513|NCT01104766|58610239|FG002|Overall Study|Lack of Efficacy|14|||
30598514|NCT01104766|58610240|FG003|Overall Study|Lack of Efficacy|8|||
30598515|NCT01104766|58610237|FG000|Overall Study|Protocol Violation|2|||
30598516|NCT01104766|58610238|FG001|Overall Study|Protocol Violation|0|||
30598517|NCT01104766|58610239|FG002|Overall Study|Protocol Violation|0|||
30598518|NCT01104766|58610240|FG003|Overall Study|Protocol Violation|0|||
30598519|NCT01104766|58610237|FG000|Overall Study|Withdrawal by Subject|17|||
30598520|NCT01104766|58610238|FG001|Overall Study|Withdrawal by Subject|19|||
30598521|NCT01104766|58610239|FG002|Overall Study|Withdrawal by Subject|25|||
30598522|NCT01104766|58610240|FG003|Overall Study|Withdrawal by Subject|15|||
30598523|NCT01104766|58610237|FG000|Overall Study|Lost to Follow-up|1|||
30598524|NCT01104766|58610238|FG001|Overall Study|Lost to Follow-up|2|||
30598525|NCT01104766|58610239|FG002|Overall Study|Lost to Follow-up|1|||
30598526|NCT01104766|58610240|FG003|Overall Study|Lost to Follow-up|1|||
30598527|NCT01104376|58610250|FG000|Overall Study|Withdrawal by Subject|15|||
30598528|NCT01104376|58610250|FG000|Overall Study|Consented but excluded after labs|13|||
30598529|NCT01072357|58610256|FG000|Overall Study|Lost to Follow-up|0|||
30598530|NCT01072357|58610257|FG001|Overall Study|Lost to Follow-up|1|||
30598531|NCT01072201|58610265|FG000|Overall Study|Lost to Follow-up|0|||
30686634|NCT00718718|58700557|FG000|Prior to Week 12|Other|1|||
30686635|NCT00718718|58700558|FG001|Prior to Week 12|Other|0|||
30686636|NCT00718718|58700559|FG002|Prior to Week 12|Other|1|||
30686637|NCT00718718|58700560|FG003|Prior to Week 12|Other|0|||
30856246|NCT03194542|58884089|FG001|Overall Study|Progressive Disease|0|||
30598532|NCT01072201|58610266|FG001|Overall Study|Lost to Follow-up|1|||
30598533|NCT01103362|58610272|FG000|Overall Study|study terminated|596|||
30598534|NCT01103284|58610278|FG000|Overall Study|Death|2|||
30598535|NCT01103284|58610279|FG001|Overall Study|Death|0|||
30598536|NCT01103284|58610278|FG000|Overall Study|Lost to Follow-up|9|||
30598537|NCT01103284|58610279|FG001|Overall Study|Lost to Follow-up|10|||
30598538|NCT01103284|58610278|FG000|Overall Study|Pregnancy|3|||
30598539|NCT01103284|58610279|FG001|Overall Study|Pregnancy|1|||
30598540|NCT01103284|58610278|FG000|Overall Study|Protocol Violation|12|||
30598541|NCT01103284|58610279|FG001|Overall Study|Protocol Violation|5|||
30598542|NCT01103284|58610278|FG000|Overall Study|Adverse Event|0|||
30598543|NCT01103284|58610279|FG001|Overall Study|Adverse Event|5|||
30598544|NCT01103284|58610278|FG000|Overall Study|Withdrawal by Subject|14|||
30598545|NCT01103284|58610279|FG001|Overall Study|Withdrawal by Subject|18|||
30598546|NCT01103284|58610278|FG000|Overall Study|Dermal Hypersensitivity|0|||
30598547|NCT01103284|58610279|FG001|Overall Study|Dermal Hypersensitivity|1|||
30598548|NCT01103284|58610278|FG000|Overall Study|Termination by the Sponsor|0|||
30686638|NCT00718718|58700561|FG004|Prior to Week 12|Other|0|||
30784250|NCT03289676|58796561|FG000|Overall Study|Withdrawal by Subject|2|||
30784251|NCT03289676|58796562|FG001|Overall Study|Withdrawal by Subject|0|||
30598549|NCT01103284|58610279|FG001|Overall Study|Termination by the Sponsor|1|||
30598550|NCT01103284|58610278|FG000|Overall Study|Not described|2|||
30686639|NCT00718718|58700562|FG005|Prior to Week 12|Other|0|||
30686640|NCT00718718|58700563|FG006|Prior to Week 12|Other|0|||
30784252|NCT03289676|58796561|FG000|Overall Study|Protocol Violation|2|||
30686641|NCT00718718|58700564|FG007|Prior to Week 12|Other|0|||
30686642|NCT00718718|58700565|FG008|Prior to Week 12|Other|0|||
30686643|NCT00718718|58700566|FG009|Prior to Week 12|Other|0|||
30686644|NCT00718718|58700557|FG000|Week 12 to End of Study|Adverse Event|0|||
30598551|NCT01103284|58610279|FG001|Overall Study|Not described|1|||
30598552|NCT01103284|58610278|FG000|Overall Study|Missing CRF entries for study completion|0|||
30598553|NCT01103284|58610279|FG001|Overall Study|Missing CRF entries for study completion|2|||
30598554|NCT01070953|58610285|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
30598555|NCT01070953|58610285|FG000|Participants for Safety Evaluation|Off-label use|283|||
30598556|NCT01070953|58610285|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
30598557|NCT01070953|58610285|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
30598558|NCT01070953|58610285|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
30598559|NCT01070953|58610285|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
30598560|NCT01070953|58610285|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
30598561|NCT01070953|58610285|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
30598562|NCT01070953|58610285|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
30598563|NCT01070953|58610285|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
30598564|NCT01089361|58610297|FG000|Overall Study|Death|1|||
30598565|NCT01089361|58610298|FG001|Overall Study|Death|0|||
30598566|NCT01102972|58610308|FG000|Overall Study|Adverse Event|8|||
30598567|NCT01102972|58610309|FG001|Overall Study|Adverse Event|2|||
30598568|NCT01102972|58610308|FG000|Overall Study|Lack of Efficacy|2|||
30598569|NCT01102972|58610309|FG001|Overall Study|Lack of Efficacy|1|||
30598570|NCT01102972|58610308|FG000|Overall Study|Protocol Violation|1|||
30598571|NCT01102972|58610309|FG001|Overall Study|Protocol Violation|0|||
30598572|NCT01102972|58610308|FG000|Overall Study|Lost to Follow-up|10|||
30598573|NCT01102972|58610309|FG001|Overall Study|Lost to Follow-up|5|||
30598574|NCT01102972|58610308|FG000|Overall Study|Investigator Discretion|2|||
30598575|NCT01102972|58610309|FG001|Overall Study|Investigator Discretion|0|||
30598576|NCT01102972|58610308|FG000|Overall Study|Withdrawal by Subject|6|||
30598577|NCT01102972|58610309|FG001|Overall Study|Withdrawal by Subject|6|||
30598578|NCT01309269|58610315|FG000|Overall Study|Adverse Event|56|||
30598579|NCT01309269|58610315|FG000|Overall Study|Withdrawal by Subject|25|||
30598580|NCT01309269|58610315|FG000|Overall Study|Lack of Acceptance|15|||
30598581|NCT01309269|58610315|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
30598582|NCT01309269|58610315|FG000|Overall Study|Kidney Transplant|25|||
30598583|NCT01309269|58610315|FG000|Overall Study|Administrative Problems|141|||
30598584|NCT01309269|58610315|FG000|Overall Study|Other|256|||
30686645|NCT00718718|58700558|FG001|Week 12 to End of Study|Adverse Event|0|||
30686646|NCT00718718|58700559|FG002|Week 12 to End of Study|Adverse Event|0|||
30686647|NCT00718718|58700560|FG003|Week 12 to End of Study|Adverse Event|0|||
30686648|NCT00718718|58700561|FG004|Week 12 to End of Study|Adverse Event|0|||
30686649|NCT00718718|58700562|FG005|Week 12 to End of Study|Adverse Event|0|||
30686650|NCT00718718|58700563|FG006|Week 12 to End of Study|Adverse Event|0|||
30686651|NCT00718718|58700564|FG007|Week 12 to End of Study|Adverse Event|1|||
30686652|NCT00718718|58700565|FG008|Week 12 to End of Study|Adverse Event|0|||
30686653|NCT00718718|58700566|FG009|Week 12 to End of Study|Adverse Event|0|||
30686654|NCT00718718|58700557|FG000|Week 12 to End of Study|Death|0|||
30686655|NCT00718718|58700558|FG001|Week 12 to End of Study|Death|0|||
30686656|NCT00718718|58700559|FG002|Week 12 to End of Study|Death|0|||
30686657|NCT00718718|58700560|FG003|Week 12 to End of Study|Death|0|||
30686658|NCT00718718|58700561|FG004|Week 12 to End of Study|Death|0|||
30686659|NCT00718718|58700562|FG005|Week 12 to End of Study|Death|1|||
30686660|NCT00718718|58700563|FG006|Week 12 to End of Study|Death|0|||
30686661|NCT00718718|58700564|FG007|Week 12 to End of Study|Death|0|||
30686662|NCT00718718|58700565|FG008|Week 12 to End of Study|Death|0|||
30686663|NCT00718718|58700566|FG009|Week 12 to End of Study|Death|0|||
30686664|NCT00718718|58700557|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
30686665|NCT00718718|58700558|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
30686666|NCT00718718|58700559|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
30686667|NCT00718718|58700560|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
30686668|NCT00718718|58700561|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
30686669|NCT00718718|58700562|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
30686670|NCT00718718|58700563|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
30686671|NCT00718718|58700564|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
30686672|NCT00718718|58700565|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
30598585|NCT01309269|58610315|FG000|Overall Study|Other|1|||
30598586|NCT01309269|58610315|FG000|Overall Study|Study Completion Data Not Recorded|95|||
30598587|NCT01309269|58610315|FG000|Overall Study|Enrolled but not Treated|107|||
30598588|NCT01088503|58610322|FG000|Overall Study|Withdrawal by Subject|118|||
30686673|NCT00718718|58700566|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
30598589|NCT01088503|58610323|FG001|Overall Study|Withdrawal by Subject|327|||
30598590|NCT01088503|58610324|FG002|Overall Study|Withdrawal by Subject|10|||
30686674|NCT00718718|58700557|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
30686675|NCT00718718|58700558|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
30686676|NCT00718718|58700559|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
30686677|NCT00718718|58700560|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
30686678|NCT00718718|58700561|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
30686679|NCT00718718|58700562|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
30686680|NCT00718718|58700563|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
30686681|NCT00718718|58700564|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
30686682|NCT00718718|58700565|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
30686683|NCT00718718|58700566|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
30686684|NCT00718718|58700557|FG000|Week 12 to End of Study|Other|0|||
30686685|NCT00718718|58700558|FG001|Week 12 to End of Study|Other|1|||
30686686|NCT00718718|58700559|FG002|Week 12 to End of Study|Other|0|||
30686687|NCT00718718|58700560|FG003|Week 12 to End of Study|Other|1|||
30686688|NCT00718718|58700561|FG004|Week 12 to End of Study|Other|0|||
30686689|NCT00718718|58700562|FG005|Week 12 to End of Study|Other|0|||
30686690|NCT00718718|58700563|FG006|Week 12 to End of Study|Other|1|||
30686691|NCT00718718|58700564|FG007|Week 12 to End of Study|Other|0|||
30686692|NCT00718718|58700565|FG008|Week 12 to End of Study|Other|0|||
30686693|NCT00718718|58700566|FG009|Week 12 to End of Study|Other|0|||
30686694|NCT00683787|58700595|FG000|Overall Study|Progression|3|||
30686695|NCT00683787|58700596|FG001|Overall Study|Progression|3|||
30686696|NCT00683787|58700597|FG002|Overall Study|Progression|0|||
30686697|NCT00683787|58700595|FG000|Overall Study|Adverse Event|0|||
30686698|NCT00683787|58700596|FG001|Overall Study|Adverse Event|0|||
30686699|NCT00683787|58700597|FG002|Overall Study|Adverse Event|2|||
30686700|NCT00723008|58700607|FG000|Enrollment|Lost to Follow-up|1|||
30686701|NCT00723008|58700608|FG001|Enrollment|Lost to Follow-up|0|||
30686702|NCT00723008|58700607|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
30686703|NCT00723008|58700608|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
30686704|NCT00723008|58700607|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
30686705|NCT00723008|58700608|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
30686706|NCT00723008|58700607|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
30686707|NCT00723008|58700608|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
30686708|NCT00723008|58700607|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
30686709|NCT00723008|58700608|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
30686710|NCT00723008|58700607|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
30686711|NCT00723008|58700608|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
30686712|NCT00718640|58700622|FG000|Overall Study|Adverse Event|4|||
30598591|NCT01088503|58610322|FG000|Overall Study|Death|64|||
30598592|NCT01088503|58610323|FG001|Overall Study|Death|358|||
30598593|NCT01088503|58610324|FG002|Overall Study|Death|7|||
30598594|NCT01087489|58610330|FG000|Overall Study|enrolled in another VA study|0|||
30598595|NCT01087489|58610331|FG001|Overall Study|enrolled in another VA study|1|||
30598596|NCT01087489|58610330|FG000|Overall Study|Death|0|||
30598597|NCT01087489|58610331|FG001|Overall Study|Death|1|||
30598598|NCT01087489|58610330|FG000|Overall Study|unable to survey by telephone|0|||
30598599|NCT01087489|58610331|FG001|Overall Study|unable to survey by telephone|1|||
30598600|NCT01082965|58610339|FG000|Overall Study|Protocol Violation|0|||
30598601|NCT01082965|58610340|FG001|Overall Study|Protocol Violation|1|||
30598602|NCT01082965|58610339|FG000|Overall Study|Other|1|||
30598603|NCT01082965|58610340|FG001|Overall Study|Other|1|||
30598604|NCT01102426|58610348|FG000|Overall Study|Randomized but not treated|4|||
30598605|NCT01102426|58610349|FG001|Overall Study|Randomized but not treated|1|||
30598606|NCT01102426|58610348|FG000|Overall Study|Adverse Events (treatment-related)|15|||
30598607|NCT01102426|58610349|FG001|Overall Study|Adverse Events (treatment-related)|8|||
30598608|NCT01102426|58610348|FG000|Overall Study|Physician Decision|9|||
30598609|NCT01102426|58610349|FG001|Overall Study|Physician Decision|6|||
30598610|NCT01102426|58610348|FG000|Overall Study|Progressive Disease|85|||
30598611|NCT01102426|58610349|FG001|Overall Study|Progressive Disease|44|||
30598612|NCT01102426|58610348|FG000|Overall Study|Adverse Events (unrelated to|9|||
30598613|NCT01102426|58610349|FG001|Overall Study|Adverse Events (unrelated to|1|||
30598614|NCT01102426|58610348|FG000|Overall Study|Patient Refusal|24|||
30598615|NCT01102426|58610349|FG001|Overall Study|Patient Refusal|12|||
30598616|NCT01102426|58610348|FG000|Overall Study|Death (due to adverse events|0|||
30686713|NCT00718640|58700622|FG000|Overall Study|Death|1|||
30686714|NCT00718640|58700622|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
30598617|NCT01102426|58610349|FG001|Overall Study|Death (due to adverse events|1|||
30598618|NCT01102426|58610348|FG000|Overall Study|Death (non-related to the study|19|||
30598619|NCT01102426|58610349|FG001|Overall Study|Death (non-related to the study|8|||
30598620|NCT01101334|58610357|FG000|Overall Study|Adverse Event|9|||
30686715|NCT00715910|58700630|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
30686716|NCT00715910|58700631|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
30686717|NCT00715910|58700632|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
30686718|NCT00715910|58700633|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
30686719|NCT00715910|58700634|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
30686720|NCT00715910|58700635|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
30686721|NCT00715910|58700630|FG000|Booster and ESFU Phase|Other|0|||
30686722|NCT00715910|58700631|FG001|Booster and ESFU Phase|Other|0|||
30686723|NCT00715910|58700632|FG002|Booster and ESFU Phase|Other|0|||
30598621|NCT01101334|58610358|FG001|Overall Study|Adverse Event|4|||
30598622|NCT01101334|58610357|FG000|Overall Study|Death|7|||
30598623|NCT01101334|58610358|FG001|Overall Study|Death|1|||
30598624|NCT01101334|58610357|FG000|Overall Study|Withdrawal by Subject|4|||
30598625|NCT01101334|58610358|FG001|Overall Study|Withdrawal by Subject|3|||
30598626|NCT01101334|58610357|FG000|Overall Study|Withdrawal by Sponsor|1|||
30598627|NCT01101334|58610358|FG001|Overall Study|Withdrawal by Sponsor|1|||
30686724|NCT00715910|58700633|FG003|Booster and ESFU Phase|Other|5|||
30686725|NCT00715910|58700634|FG004|Booster and ESFU Phase|Other|1|||
30686726|NCT00715910|58700635|FG005|Booster and ESFU Phase|Other|0|||
30686727|NCT00715676|58700654|FG000|Overall Study|Adverse Event|3|||
30686728|NCT00715676|58700655|FG001|Overall Study|Adverse Event|5|||
30686729|NCT00715676|58700656|FG002|Overall Study|Adverse Event|21|||
30686730|NCT00715676|58700654|FG000|Overall Study|Withdrawal by Subject|1|||
30686731|NCT00715676|58700655|FG001|Overall Study|Withdrawal by Subject|3|||
30686732|NCT00715676|58700656|FG002|Overall Study|Withdrawal by Subject|8|||
30686733|NCT00715676|58700654|FG000|Overall Study|Lost to Follow-up|1|||
30686734|NCT00715676|58700655|FG001|Overall Study|Lost to Follow-up|2|||
30686735|NCT00715676|58700656|FG002|Overall Study|Lost to Follow-up|1|||
30686736|NCT00715676|58700654|FG000|Overall Study|Terminated by Sponsor|1|||
30686737|NCT00715676|58700655|FG001|Overall Study|Terminated by Sponsor|0|||
30686738|NCT00715676|58700656|FG002|Overall Study|Terminated by Sponsor|0|||
30686739|NCT00715676|58700654|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
30686740|NCT00715676|58700655|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
30686741|NCT00715676|58700656|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
30686742|NCT00715676|58700654|FG000|Overall Study|Use of Exclusionary Medication|0|||
30686743|NCT00715676|58700655|FG001|Overall Study|Use of Exclusionary Medication|0|||
30686744|NCT00715676|58700656|FG002|Overall Study|Use of Exclusionary Medication|1|||
30686745|NCT00715676|58700654|FG000|Overall Study|Elevated Blood Glucose|0|||
30686746|NCT00715676|58700655|FG001|Overall Study|Elevated Blood Glucose|1|||
30686747|NCT00715676|58700656|FG002|Overall Study|Elevated Blood Glucose|0|||
30686748|NCT00718328|58700666|FG000|Overall Study|Lost to Follow-up|1|||
30686749|NCT00718328|58700667|FG001|Overall Study|Lost to Follow-up|0|||
30686750|NCT00715520|58700676|FG000|Overall Study|Screen failure|8|||
30686751|NCT00715520|58700677|FG001|Overall Study|Screen failure|1|||
30686752|NCT00715520|58700678|FG002|Overall Study|Screen failure|1|||
30686753|NCT00715520|58700676|FG000|Overall Study|Withdrawal by Subject|2|||
30686754|NCT00715520|58700677|FG001|Overall Study|Withdrawal by Subject|0|||
30686755|NCT00715520|58700678|FG002|Overall Study|Withdrawal by Subject|1|||
30686756|NCT00790205|58700688|FG000|Overall Study|Lost to Follow-up|61|||
30686757|NCT00790205|58700689|FG001|Overall Study|Lost to Follow-up|71|||
30686758|NCT00790205|58700688|FG000|Overall Study|Withdrawal by Subject|299|||
30686759|NCT00790205|58700689|FG001|Overall Study|Withdrawal by Subject|363|||
30686760|NCT00715208|58700697|FG000|Overall Study|Withdrawal by Subject|1|||
30686761|NCT00715208|58700698|FG001|Overall Study|Withdrawal by Subject|1|||
30686762|NCT00715208|58700697|FG000|Overall Study|Adverse Event|0|||
30686763|NCT00715208|58700698|FG001|Overall Study|Adverse Event|6|||
30686764|NCT00715208|58700697|FG000|Overall Study|Lack of Efficacy|0|||
30686765|NCT00715208|58700698|FG001|Overall Study|Lack of Efficacy|2|||
30686766|NCT00775463|58700706|FG000|Overall Study|Withdrawal by Subject|0|||
30686767|NCT00775463|58700707|FG001|Overall Study|Withdrawal by Subject|1|||
30686768|NCT00775463|58700706|FG000|Overall Study|Adverse Event|7|||
30686769|NCT00775463|58700707|FG001|Overall Study|Adverse Event|9|||
30686770|NCT00775463|58700706|FG000|Overall Study|Protocol Violation|2|||
30686771|NCT00775463|58700707|FG001|Overall Study|Protocol Violation|2|||
30686772|NCT00775463|58700706|FG000|Overall Study|Lost to Follow-up|1|||
30686773|NCT00775463|58700707|FG001|Overall Study|Lost to Follow-up|0|||
30686774|NCT00775463|58700706|FG000|Overall Study|Lack of Efficacy|1|||
30686775|NCT00775463|58700707|FG001|Overall Study|Lack of Efficacy|1|||
30598628|NCT01101334|58610357|FG000|Overall Study|Progressive Disease|22|||
30598629|NCT01101334|58610358|FG001|Overall Study|Progressive Disease|35|||
30598630|NCT01101334|58610357|FG000|Overall Study|Other|2|||
30598631|NCT01101334|58610358|FG001|Overall Study|Other|1|||
30598632|NCT01327547|58610366|FG000|Overall Study|Adverse Event|4|||
30598633|NCT01327547|58610367|FG001|Overall Study|Adverse Event|1|||
30598634|NCT01327547|58610366|FG000|Overall Study|Death|1|||
30598635|NCT01327547|58610367|FG001|Overall Study|Death|2|||
30686776|NCT00587795|58700722|FG000|Overall Study|Withdrawal by Subject|1|||
30686777|NCT00587795|58700723|FG001|Overall Study|Withdrawal by Subject|0|||
30686778|NCT00587639|58700729|FG000|Overall Study|Withdrawal by Subject|1|||
30686779|NCT00774995|58700737|FG000|Overall Study|Protocol Violation|0|||
30686780|NCT00774995|58700738|FG001|Overall Study|Protocol Violation|0|||
30686781|NCT00774995|58700739|FG002|Overall Study|Protocol Violation|1|||
30686782|NCT00774995|58700740|FG003|Overall Study|Protocol Violation|0|||
30686783|NCT00713648|58700750|FG000|Overall Study|Adverse Event|1|||
30686784|NCT00713648|58700750|FG000|Overall Study|Unclassified|2|||
30686785|NCT00713648|58700750|FG000|Overall Study|According to Protocol|2|||
30686786|NCT00713648|58700750|FG000|Overall Study|Development of antibodies|3|||
30686787|NCT00768053|58700754|FG000|Overall Study|Adverse Event|10|||
30686788|NCT00768053|58700754|FG000|Overall Study|Lost to Follow-up|1|||
30686789|NCT00683475|58700760|FG000|Overall Study|Withdrawal by Subject|1|||
30686790|NCT00683475|58700761|FG001|Overall Study|Withdrawal by Subject|0|||
30686791|NCT00683475|58700760|FG000|Overall Study|Never Treated: Adverse Event|2|||
30686792|NCT00683475|58700761|FG001|Overall Study|Never Treated: Adverse Event|3|||
30686793|NCT00683475|58700760|FG000|Overall Study|Never Treated: Progressive Disease|1|||
30686794|NCT00683475|58700761|FG001|Overall Study|Never Treated: Progressive Disease|0|||
30686795|NCT00685035|58700768|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
30686796|NCT00685035|58700769|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
30686797|NCT00773747|58700795|FG000|Overall Study|Lack of Efficacy|112|||
30686798|NCT00773747|58700796|FG001|Overall Study|Lack of Efficacy|144|||
30686799|NCT00773747|58700795|FG000|Overall Study|Physician Decision|26|||
30686800|NCT00773747|58700796|FG001|Overall Study|Physician Decision|18|||
30686801|NCT00773747|58700795|FG000|Overall Study|Lost to Follow-up|0|||
30686802|NCT00773747|58700796|FG001|Overall Study|Lost to Follow-up|1|||
30686803|NCT00773747|58700795|FG000|Overall Study|Protocol Violation|2|||
30686804|NCT00773747|58700796|FG001|Overall Study|Protocol Violation|2|||
30686805|NCT00773747|58700795|FG000|Overall Study|Withdrawal by Subject|89|||
30686806|NCT00773747|58700796|FG001|Overall Study|Withdrawal by Subject|61|||
30686807|NCT00773747|58700795|FG000|Overall Study|Adverse Event|61|||
30686808|NCT00773747|58700796|FG001|Overall Study|Adverse Event|62|||
30598636|NCT01327547|58610366|FG000|Overall Study|Lost to Follow-up|6|||
30598637|NCT01327547|58610367|FG001|Overall Study|Lost to Follow-up|6|||
30598638|NCT01327547|58610366|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
30598639|NCT01327547|58610367|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
30598640|NCT01327547|58610366|FG000|Overall Study|Withdrawal by Subject|3|||
30598641|NCT01327547|58610367|FG001|Overall Study|Withdrawal by Subject|7|||
30598642|NCT01327547|58610366|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
30598643|NCT01327547|58610367|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
30598644|NCT01327547|58610366|FG000|Overall Study|Protocol Violation|1|||
30598645|NCT01327547|58610367|FG001|Overall Study|Protocol Violation|0|||
30598646|NCT01327547|58610366|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
30598647|NCT01327547|58610367|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
30598648|NCT01327547|58610366|FG000|Overall Study|Required prohibited medication|2|||
30598649|NCT01327547|58610367|FG001|Overall Study|Required prohibited medication|0|||
30686809|NCT00773747|58700795|FG000|Overall Study|Death|5|||
30686810|NCT00773747|58700796|FG001|Overall Study|Death|8|||
30686811|NCT00773747|58700795|FG000|Overall Study|Not Treated|2|||
30686812|NCT00773747|58700796|FG001|Overall Study|Not Treated|0|||
30686813|NCT00784277|58700806|FG000|IR Treatment|Adverse Event|4|||
30686814|NCT00784277|58700807|FG001|IR Treatment|Adverse Event|8|||
30686815|NCT00784277|58700808|FG002|IR Treatment|Adverse Event|19|||
30686816|NCT00784277|58700809|FG003|IR Treatment|Adverse Event|35|||
30686817|NCT00784277|58700810|FG004|IR Treatment|Adverse Event|0|||
30686818|NCT00784277|58700811|FG005|IR Treatment|Adverse Event|0|||
30686819|NCT00784277|58700812|FG006|IR Treatment|Adverse Event|0|||
30686820|NCT00784277|58700806|FG000|IR Treatment|Lack of Efficacy|4|||
30686821|NCT00784277|58700807|FG001|IR Treatment|Lack of Efficacy|4|||
30686822|NCT00784277|58700808|FG002|IR Treatment|Lack of Efficacy|1|||
30686823|NCT00784277|58700809|FG003|IR Treatment|Lack of Efficacy|0|||
30686824|NCT00784277|58700810|FG004|IR Treatment|Lack of Efficacy|0|||
30686825|NCT00784277|58700811|FG005|IR Treatment|Lack of Efficacy|0|||
30686826|NCT00784277|58700812|FG006|IR Treatment|Lack of Efficacy|0|||
30686827|NCT00784277|58700806|FG000|IR Treatment|Lost to Follow-up|1|||
30686828|NCT00784277|58700807|FG001|IR Treatment|Lost to Follow-up|0|||
30686829|NCT00784277|58700808|FG002|IR Treatment|Lost to Follow-up|1|||
30686830|NCT00784277|58700809|FG003|IR Treatment|Lost to Follow-up|0|||
30686831|NCT00784277|58700810|FG004|IR Treatment|Lost to Follow-up|0|||
30686832|NCT00784277|58700811|FG005|IR Treatment|Lost to Follow-up|0|||
30598650|NCT01327547|58610366|FG000|Overall Study|Non-compliance with study procedures|1|||
30598651|NCT01327547|58610367|FG001|Overall Study|Non-compliance with study procedures|0|||
30598652|NCT01327547|58610366|FG000|Overall Study|By investigator in subject's interest|0|||
30598653|NCT01327547|58610367|FG001|Overall Study|By investigator in subject's interest|1|||
30598654|NCT01308567|58610389|FG000|Overall Study|Lost to Follow-up|2|||
30598655|NCT01308567|58610390|FG001|Overall Study|Lost to Follow-up|4|||
30959247|NCT01353222|59024675|FG001|Overall Study|Withdrawal by Subject|5|||
30598656|NCT01308567|58610391|FG002|Overall Study|Lost to Follow-up|4|||
30686833|NCT00784277|58700812|FG006|IR Treatment|Lost to Follow-up|0|||
30686834|NCT00784277|58700806|FG000|IR Treatment|Withdrawal by Subject|5|||
30686835|NCT00784277|58700807|FG001|IR Treatment|Withdrawal by Subject|1|||
30686836|NCT00784277|58700808|FG002|IR Treatment|Withdrawal by Subject|4|||
30686837|NCT00784277|58700809|FG003|IR Treatment|Withdrawal by Subject|6|||
30686838|NCT00784277|58700810|FG004|IR Treatment|Withdrawal by Subject|0|||
30686839|NCT00784277|58700811|FG005|IR Treatment|Withdrawal by Subject|0|||
30686840|NCT00784277|58700812|FG006|IR Treatment|Withdrawal by Subject|0|||
30686841|NCT00784277|58700806|FG000|IR Treatment|Resolution Of Pain|0|||
30686842|NCT00784277|58700807|FG001|IR Treatment|Resolution Of Pain|1|||
30686843|NCT00784277|58700808|FG002|IR Treatment|Resolution Of Pain|0|||
30686844|NCT00784277|58700809|FG003|IR Treatment|Resolution Of Pain|0|||
30686845|NCT00784277|58700810|FG004|IR Treatment|Resolution Of Pain|0|||
30686846|NCT00784277|58700811|FG005|IR Treatment|Resolution Of Pain|0|||
30686847|NCT00784277|58700812|FG006|IR Treatment|Resolution Of Pain|0|||
30686848|NCT00784277|58700806|FG000|IR Treatment|Other|2|||
30686849|NCT00784277|58700807|FG001|IR Treatment|Other|3|||
30686850|NCT00784277|58700808|FG002|IR Treatment|Other|3|||
30686851|NCT00784277|58700809|FG003|IR Treatment|Other|2|||
30686852|NCT00784277|58700810|FG004|IR Treatment|Other|0|||
30686853|NCT00784277|58700811|FG005|IR Treatment|Other|0|||
30686854|NCT00784277|58700812|FG006|IR Treatment|Other|0|||
30686855|NCT00784277|58700806|FG000|ER Treatment|Adverse Event|0|||
30686856|NCT00784277|58700807|FG001|ER Treatment|Adverse Event|0|||
30686857|NCT00784277|58700808|FG002|ER Treatment|Adverse Event|0|||
30686858|NCT00784277|58700809|FG003|ER Treatment|Adverse Event|0|||
30686859|NCT00784277|58700810|FG004|ER Treatment|Adverse Event|1|||
30686860|NCT00784277|58700811|FG005|ER Treatment|Adverse Event|7|||
30686861|NCT00784277|58700812|FG006|ER Treatment|Adverse Event|7|||
30686862|NCT00784277|58700806|FG000|ER Treatment|Lack of Efficacy|0|||
30686863|NCT00784277|58700807|FG001|ER Treatment|Lack of Efficacy|0|||
30686864|NCT00784277|58700808|FG002|ER Treatment|Lack of Efficacy|0|||
30686865|NCT00784277|58700809|FG003|ER Treatment|Lack of Efficacy|0|||
30686866|NCT00784277|58700810|FG004|ER Treatment|Lack of Efficacy|3|||
30686867|NCT00784277|58700811|FG005|ER Treatment|Lack of Efficacy|4|||
30686868|NCT00784277|58700812|FG006|ER Treatment|Lack of Efficacy|0|||
30686869|NCT00784277|58700806|FG000|ER Treatment|Lost to Follow-up|0|||
30686870|NCT00784277|58700807|FG001|ER Treatment|Lost to Follow-up|0|||
30686871|NCT00784277|58700808|FG002|ER Treatment|Lost to Follow-up|0|||
30686872|NCT00784277|58700809|FG003|ER Treatment|Lost to Follow-up|0|||
30686873|NCT00784277|58700810|FG004|ER Treatment|Lost to Follow-up|0|||
30686874|NCT00784277|58700811|FG005|ER Treatment|Lost to Follow-up|2|||
30686875|NCT00784277|58700812|FG006|ER Treatment|Lost to Follow-up|0|||
30686876|NCT00784277|58700806|FG000|ER Treatment|Withdrawal by Subject|0|||
30686877|NCT00784277|58700807|FG001|ER Treatment|Withdrawal by Subject|0|||
30686878|NCT00784277|58700808|FG002|ER Treatment|Withdrawal by Subject|0|||
30686879|NCT00784277|58700809|FG003|ER Treatment|Withdrawal by Subject|0|||
30686880|NCT00784277|58700810|FG004|ER Treatment|Withdrawal by Subject|2|||
30686881|NCT00784277|58700811|FG005|ER Treatment|Withdrawal by Subject|5|||
30686882|NCT00784277|58700812|FG006|ER Treatment|Withdrawal by Subject|3|||
30686883|NCT00784277|58700806|FG000|ER Treatment|Study Medication Non-Compliant|0|||
30686884|NCT00784277|58700807|FG001|ER Treatment|Study Medication Non-Compliant|0|||
30686885|NCT00784277|58700808|FG002|ER Treatment|Study Medication Non-Compliant|0|||
30686886|NCT00784277|58700809|FG003|ER Treatment|Study Medication Non-Compliant|0|||
30686887|NCT00784277|58700810|FG004|ER Treatment|Study Medication Non-Compliant|2|||
30686888|NCT00784277|58700811|FG005|ER Treatment|Study Medication Non-Compliant|3|||
30686889|NCT00784277|58700812|FG006|ER Treatment|Study Medication Non-Compliant|3|||
30686890|NCT00784277|58700806|FG000|ER Treatment|Other|0|||
30686891|NCT00784277|58700807|FG001|ER Treatment|Other|0|||
30686892|NCT00784277|58700808|FG002|ER Treatment|Other|0|||
30686893|NCT00784277|58700809|FG003|ER Treatment|Other|0|||
30686894|NCT00784277|58700810|FG004|ER Treatment|Other|1|||
30686895|NCT00784277|58700811|FG005|ER Treatment|Other|3|||
30959248|NCT01353222|59024674|FG000|Overall Study|Study Terminated|31|||
30598657|NCT01307319|58610402|FG000|Overall Study|Adverse Event|2|||
30598658|NCT01307319|58610403|FG001|Overall Study|Adverse Event|2|||
30598659|NCT01307319|58610404|FG002|Overall Study|Adverse Event|1|||
30598660|NCT01307319|58610402|FG000|Overall Study|Lost to Follow-up|1|||
30598661|NCT01307319|58610403|FG001|Overall Study|Lost to Follow-up|0|||
30598662|NCT01307319|58610404|FG002|Overall Study|Lost to Follow-up|1|||
30598663|NCT01307319|58610402|FG000|Overall Study|Protocol Violation|1|||
30598664|NCT01307319|58610403|FG001|Overall Study|Protocol Violation|1|||
30598665|NCT01307319|58610404|FG002|Overall Study|Protocol Violation|0|||
30598666|NCT01307319|58610402|FG000|Overall Study|Withdrawal by Subject|0|||
30686896|NCT00784277|58700812|FG006|ER Treatment|Other|2|||
30686897|NCT00682929|58700828|FG000|Overall Study|Adverse Event|4|||
30686898|NCT00682929|58700829|FG001|Overall Study|Adverse Event|1|||
30686899|NCT00682929|58700830|FG002|Overall Study|Adverse Event|1|||
30686900|NCT00682929|58700828|FG000|Overall Study|Withdrawal by Subject|1|||
30686901|NCT00682929|58700829|FG001|Overall Study|Withdrawal by Subject|2|||
30686902|NCT00682929|58700830|FG002|Overall Study|Withdrawal by Subject|1|||
30686903|NCT00682929|58700828|FG000|Overall Study|dosing compliance < 80%|0|||
30686904|NCT00682929|58700829|FG001|Overall Study|dosing compliance < 80%|2|||
30686905|NCT00682929|58700830|FG002|Overall Study|dosing compliance < 80%|0|||
30686906|NCT00682929|58700828|FG000|Overall Study|lag in DEA renewal|1|||
30686907|NCT00682929|58700829|FG001|Overall Study|lag in DEA renewal|0|||
30686908|NCT00682929|58700830|FG002|Overall Study|lag in DEA renewal|0|||
30686909|NCT00680745|58700842|FG000|Overall Study|Withdrawal by Subject|8|||
30686910|NCT00680745|58700843|FG001|Overall Study|Withdrawal by Subject|3|||
30686911|NCT00680745|58700844|FG002|Overall Study|Withdrawal by Subject|2|||
30686912|NCT00680745|58700845|FG003|Overall Study|Withdrawal by Subject|8|||
30686913|NCT00680745|58700842|FG000|Overall Study|Lost to Follow-up|0|||
30686914|NCT00680745|58700843|FG001|Overall Study|Lost to Follow-up|1|||
30686915|NCT00680745|58700844|FG002|Overall Study|Lost to Follow-up|1|||
30686916|NCT00680745|58700845|FG003|Overall Study|Lost to Follow-up|0|||
30686917|NCT00680745|58700842|FG000|Overall Study|Death|1|||
30686918|NCT00680745|58700843|FG001|Overall Study|Death|0|||
30686919|NCT00680745|58700844|FG002|Overall Study|Death|1|||
30686920|NCT00680745|58700845|FG003|Overall Study|Death|0|||
30686921|NCT00680745|58700842|FG000|Overall Study|Adverse Event|5|||
30686922|NCT00680745|58700843|FG001|Overall Study|Adverse Event|3|||
30686923|NCT00680745|58700844|FG002|Overall Study|Adverse Event|3|||
30686924|NCT00680745|58700845|FG003|Overall Study|Adverse Event|3|||
30686925|NCT00680745|58700842|FG000|Overall Study|Poor/Non-compliance|0|||
30686926|NCT00680745|58700843|FG001|Overall Study|Poor/Non-compliance|3|||
30686927|NCT00680745|58700844|FG002|Overall Study|Poor/Non-compliance|0|||
30598667|NCT01307319|58610403|FG001|Overall Study|Withdrawal by Subject|1|||
30598668|NCT01307319|58610404|FG002|Overall Study|Withdrawal by Subject|2|||
30598669|NCT01307319|58610402|FG000|Overall Study|Other|0|||
30686928|NCT00680745|58700845|FG003|Overall Study|Poor/Non-compliance|0|||
30686929|NCT00680745|58700842|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
30686930|NCT00680745|58700843|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
30686931|NCT00680745|58700844|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
30686932|NCT00680745|58700845|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
30686933|NCT00680745|58700842|FG000|Overall Study|False Treatment|0|||
30686934|NCT00680745|58700843|FG001|Overall Study|False Treatment|1|||
30686935|NCT00680745|58700844|FG002|Overall Study|False Treatment|3|||
30686936|NCT00680745|58700845|FG003|Overall Study|False Treatment|0|||
30686937|NCT00680121|58700858|FG000|Overall Study|Lost to Follow-up|27|||
30686938|NCT00680121|58700859|FG001|Overall Study|Lost to Follow-up|23|||
30686939|NCT00767819|58700868|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
30686940|NCT00767819|58700869|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
30686941|NCT00767819|58700870|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
30598670|NCT01307319|58610403|FG001|Overall Study|Other|4|||
30598671|NCT01307319|58610404|FG002|Overall Study|Other|3|||
30598672|NCT01080391|58610414|FG000|Overall Study|Randomized but not treated|7|||
30686942|NCT00767819|58700868|FG000|Overall Study|Withdrawal by Subject|1|||
30686943|NCT00767819|58700869|FG001|Overall Study|Withdrawal by Subject|1|||
30686944|NCT00767819|58700870|FG002|Overall Study|Withdrawal by Subject|0|||
30686945|NCT00767819|58700868|FG000|Overall Study|Administrative problems|0|||
30686946|NCT00767819|58700869|FG001|Overall Study|Administrative problems|1|||
30686947|NCT00767819|58700870|FG002|Overall Study|Administrative problems|0|||
30686948|NCT00767819|58700868|FG000|Overall Study|Death|2|||
30686949|NCT00767819|58700869|FG001|Overall Study|Death|3|||
30686950|NCT00767819|58700870|FG002|Overall Study|Death|0|||
30598673|NCT01080391|58610415|FG001|Overall Study|Randomized but not treated|4|||
30598674|NCT01070329|58610423|FG000|Overall Study|Adverse Event|13|||
30598675|NCT01070329|58610424|FG001|Overall Study|Adverse Event|10|||
30598676|NCT01070329|58610423|FG000|Overall Study|Lost to Follow-up|22|||
30598677|NCT01070329|58610424|FG001|Overall Study|Lost to Follow-up|12|||
30598678|NCT01070329|58610423|FG000|Overall Study|Withdrawal by Subject|9|||
30598679|NCT01070329|58610424|FG001|Overall Study|Withdrawal by Subject|11|||
30598680|NCT01070329|58610423|FG000|Overall Study|Protocol Violation|3|||
30598681|NCT01070329|58610424|FG001|Overall Study|Protocol Violation|8|||
30598682|NCT01070329|58610423|FG000|Overall Study|Lack of Efficacy|2|||
30598683|NCT01070329|58610424|FG001|Overall Study|Lack of Efficacy|6|||
30598684|NCT01070329|58610423|FG000|Overall Study|Physician Decision|2|||
30598685|NCT01070329|58610424|FG001|Overall Study|Physician Decision|1|||
30598686|NCT01070329|58610423|FG000|Overall Study|Entry Criteria Not Met|1|||
30598687|NCT01070329|58610424|FG001|Overall Study|Entry Criteria Not Met|0|||
30686951|NCT00767819|58700868|FG000|Overall Study|Adverse Event|2|||
30686952|NCT00767819|58700869|FG001|Overall Study|Adverse Event|0|||
30686953|NCT00767819|58700870|FG002|Overall Study|Adverse Event|0|||
30598688|NCT01070329|58610423|FG000|Overall Study|Sponsor Decision|0|||
30598689|NCT01070329|58610424|FG001|Overall Study|Sponsor Decision|1|||
30598690|NCT01069861|58610430|FG000|Overall Study|Death|1|||
30598691|NCT01069861|58610430|FG000|Overall Study|Adverse Event|1|||
30686954|NCT00767819|58700868|FG000|Overall Study|Abnormal lab values|1|||
30686955|NCT00767819|58700869|FG001|Overall Study|Abnormal lab values|0|||
30686956|NCT00767819|58700870|FG002|Overall Study|Abnormal lab values|0|||
30686957|NCT00767819|58700868|FG000|Overall Study|Lost to Follow-up|1|||
30686958|NCT00767819|58700869|FG001|Overall Study|Lost to Follow-up|0|||
30686959|NCT00767819|58700870|FG002|Overall Study|Lost to Follow-up|0|||
30686960|NCT00584870|58700881|FG000|Overall Study|Adverse Event|4|||
30686961|NCT00584870|58700882|FG001|Overall Study|Adverse Event|3|||
30686962|NCT00584870|58700883|FG002|Overall Study|Adverse Event|2|||
30686963|NCT00584870|58700881|FG000|Overall Study|Lost to Follow-up|4|||
30686964|NCT00584870|58700882|FG001|Overall Study|Lost to Follow-up|1|||
30686965|NCT00584870|58700883|FG002|Overall Study|Lost to Follow-up|1|||
30686966|NCT00584870|58700881|FG000|Overall Study|Lack of Efficacy|7|||
30686967|NCT00584870|58700882|FG001|Overall Study|Lack of Efficacy|14|||
30686968|NCT00584870|58700883|FG002|Overall Study|Lack of Efficacy|8|||
30686969|NCT00584870|58700881|FG000|Overall Study|Withdrawal by Subject|10|||
30686970|NCT00584870|58700882|FG001|Overall Study|Withdrawal by Subject|5|||
30686971|NCT00584870|58700883|FG002|Overall Study|Withdrawal by Subject|3|||
30686972|NCT00584870|58700881|FG000|Overall Study|Protocol Violation|1|||
30686973|NCT00584870|58700882|FG001|Overall Study|Protocol Violation|1|||
30686974|NCT00584870|58700883|FG002|Overall Study|Protocol Violation|2|||
30686975|NCT00584870|58700881|FG000|Overall Study|Did not met entrance criteria|1|||
30856247|NCT03194542|58884090|FG002|Overall Study|Progressive Disease|1|||
30856248|NCT03194542|58884091|FG003|Overall Study|Progressive Disease|1|||
30856249|NCT03194542|58884088|FG000|Overall Study|Adverse Event|1|||
30856250|NCT03194542|58884089|FG001|Overall Study|Adverse Event|2|||
30856251|NCT03194542|58884090|FG002|Overall Study|Adverse Event|0|||
30856252|NCT03194542|58884091|FG003|Overall Study|Adverse Event|5|||
30856253|NCT03194542|58884088|FG000|Overall Study|Death|1|||
30598692|NCT01069861|58610430|FG000|Overall Study|Did not meet entrance criteria|1|||
30598693|NCT01306929|58610434|FG000|Overall Study|Withdrawal by Subject|23|||
30686976|NCT00584870|58700882|FG001|Overall Study|Did not met entrance criteria|0|||
30686977|NCT00584870|58700883|FG002|Overall Study|Did not met entrance criteria|0|||
30686978|NCT00584870|58700881|FG000|Overall Study|Other|2|||
30686979|NCT00584870|58700882|FG001|Overall Study|Other|0|||
30686980|NCT00584870|58700883|FG002|Overall Study|Other|0|||
30686981|NCT00584870|58700881|FG000|Overall Study|Randomized but not treated|0|||
30686982|NCT00584870|58700882|FG001|Overall Study|Randomized but not treated|1|||
30686983|NCT00584870|58700883|FG002|Overall Study|Randomized but not treated|2|||
30686984|NCT00679341|58700893|FG000|Overall Study|Disease progression|42|||
30686985|NCT00679341|58700894|FG001|Overall Study|Disease progression|36|||
30686986|NCT00679341|58700893|FG000|Overall Study|Adverse Event|5|||
30686987|NCT00679341|58700894|FG001|Overall Study|Adverse Event|6|||
30686988|NCT00679341|58700893|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
30686989|NCT00679341|58700894|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
30686990|NCT00679341|58700893|FG000|Overall Study|Death|1|||
30686991|NCT00679341|58700894|FG001|Overall Study|Death|1|||
30686992|NCT00679341|58700893|FG000|Overall Study|Other|1|||
30686993|NCT00679341|58700894|FG001|Overall Study|Other|0|||
30686994|NCT00679341|58700893|FG000|Overall Study|Physician Decision|1|||
30686995|NCT00679341|58700894|FG001|Overall Study|Physician Decision|0|||
30686996|NCT00679341|58700893|FG000|Overall Study|Not treated|0|||
30686997|NCT00679341|58700894|FG001|Overall Study|Not treated|2|||
30686998|NCT00679341|58700893|FG000|Overall Study|Physician/patient decision to withdraw|0|||
30686999|NCT00679341|58700894|FG001|Overall Study|Physician/patient decision to withdraw|6|||
30687000|NCT00679263|58700904|FG000|Visit 2/Dose 1|Adverse Event|1|||
30687001|NCT00679263|58700905|FG001|Visit 2/Dose 1|Adverse Event|0|||
30598694|NCT01306929|58610434|FG000|Overall Study|Adverse Event|21|||
30598695|NCT01306929|58610434|FG000|Overall Study|Physician Decision|13|||
30598696|NCT01306929|58610434|FG000|Overall Study|Death|8|||
30598697|NCT01306929|58610434|FG000|Overall Study|Withdrawal by parent/guardian|5|||
30598698|NCT01306929|58610434|FG000|Overall Study|Protocol Violation|3|||
30598699|NCT01306929|58610434|FG000|Overall Study|Non-compliance with study drug|2|||
30598700|NCT01306929|58610434|FG000|Overall Study|Lost to Follow-up|2|||
30598701|NCT01306929|58610434|FG000|Overall Study|Various|17|||
30598702|NCT01064401|58610440|FG000|Overall Study|Adverse Event|47|||
30598703|NCT01064401|58610441|FG001|Overall Study|Adverse Event|56|||
30598704|NCT01064401|58610440|FG000|Overall Study|Lack of Efficacy|46|||
30598705|NCT01064401|58610441|FG001|Overall Study|Lack of Efficacy|23|||
30687002|NCT00679263|58700906|FG002|Visit 2/Dose 1|Adverse Event|0|||
30687003|NCT00679263|58700904|FG000|Visit 2/Dose 1|subject not compliance|1|||
30687004|NCT00679263|58700905|FG001|Visit 2/Dose 1|subject not compliance|1|||
30687005|NCT00679263|58700906|FG002|Visit 2/Dose 1|subject not compliance|0|||
30687006|NCT00680043|58700917|FG000|Overall Study|Withdrawal by Subject|1|||
30687007|NCT00680043|58700918|FG001|Overall Study|Withdrawal by Subject|0|||
30856254|NCT03194542|58884089|FG001|Overall Study|Death|2|||
30598706|NCT01064401|58610440|FG000|Overall Study|Lost to Follow-up|12|||
30598707|NCT01064401|58610441|FG001|Overall Study|Lost to Follow-up|9|||
30598708|NCT01064401|58610440|FG000|Overall Study|Consent Withdrawn|98|||
30598709|NCT01064401|58610441|FG001|Overall Study|Consent Withdrawn|80|||
30687008|NCT00680043|58700919|FG002|Overall Study|Withdrawal by Subject|0|||
30687009|NCT00680043|58700917|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
30687010|NCT00680043|58700918|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
30687011|NCT00680043|58700919|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
30687012|NCT00680043|58700917|FG000|Overall Study|Renal Transplant|1|||
30687013|NCT00680043|58700918|FG001|Overall Study|Renal Transplant|0|||
30687014|NCT00680043|58700919|FG002|Overall Study|Renal Transplant|4|||
30784253|NCT03289676|58796562|FG001|Overall Study|Protocol Violation|0|||
30856255|NCT03194542|58884090|FG002|Overall Study|Death|0|||
30598710|NCT01064401|58610440|FG000|Overall Study|Investigator Decision|4|||
30598711|NCT01064401|58610441|FG001|Overall Study|Investigator Decision|6|||
30598712|NCT01064401|58610440|FG000|Overall Study|Death|4|||
30598713|NCT01064401|58610441|FG001|Overall Study|Death|0|||
30598714|NCT01064401|58610440|FG000|Overall Study|Pregnancy|4|||
30598715|NCT01064401|58610441|FG001|Overall Study|Pregnancy|7|||
30598716|NCT01064401|58610440|FG000|Overall Study|Noncompliance|7|||
30598717|NCT01064401|58610441|FG001|Overall Study|Noncompliance|8|||
30598718|NCT01064401|58610440|FG000|Overall Study|Site Closure|4|||
30598719|NCT01064401|58610441|FG001|Overall Study|Site Closure|5|||
30687015|NCT00682539|58700930|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
30687016|NCT00682539|58700931|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
30598720|NCT01064401|58610440|FG000|Overall Study|Other|2|||
30598721|NCT01064401|58610441|FG001|Overall Study|Other|1|||
30687017|NCT00682539|58700932|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
30687018|NCT00682539|58700930|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
30687019|NCT00682539|58700931|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
30687020|NCT00682539|58700932|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
30687021|NCT00682461|58700942|FG000|Overall Study|Adverse Event|5|||
30687022|NCT00682461|58700943|FG001|Overall Study|Adverse Event|7|||
30687023|NCT00682461|58700942|FG000|Overall Study|Lost to Follow-up|8|||
30687024|NCT00682461|58700943|FG001|Overall Study|Lost to Follow-up|5|||
30687025|NCT00682461|58700942|FG000|Overall Study|Withdrawal by Subject|12|||
30687026|NCT00682461|58700943|FG001|Overall Study|Withdrawal by Subject|19|||
30687027|NCT00679029|58700950|FG000|Overall Study|Adverse Event|3|||
30687028|NCT00679029|58700950|FG000|Overall Study|Withdrawal by Subject|1|||
30687029|NCT00679029|58700950|FG000|Overall Study|Lost to Follow-up|1|||
30687030|NCT00677235|58700956|FG000|Overall Study|Withdrawal by Subject|1|||
30687031|NCT00677235|58700957|FG001|Overall Study|Withdrawal by Subject|1|||
30784254|NCT03289676|58796561|FG000|Overall Study|Lost to Follow-up|0|||
30784255|NCT03289676|58796562|FG001|Overall Study|Lost to Follow-up|1|||
30784256|NCT03287804|58796578|FG000|Overall Study|Death|1|||
30784257|NCT03287804|58796578|FG000|Overall Study|Physician Decision|2|||
30784258|NCT03287804|58796578|FG000|Overall Study|Progressive disease|8|||
30784259|NCT03286400|58796583|FG000|Overall Study|Death|10|||
30784260|NCT03286400|58796583|FG000|Overall Study|Lost to Follow-up|10|||
30784261|NCT03286400|58796583|FG000|Overall Study|Physician Decision|1|||
30784262|NCT03286400|58796583|FG000|Overall Study|Scheduling difficulty|4|||
30784263|NCT03310970|58796587|FG000|Overall Study|Withdrawal by Subject|0|||
30784264|NCT03310970|58796588|FG001|Overall Study|Withdrawal by Subject|1|||
30784265|NCT03285308|58796597|FG000|Overall Study|Adverse Event|3|||
30784266|NCT03285308|58796598|FG001|Overall Study|Adverse Event|7|||
30784267|NCT03285308|58796597|FG000|Overall Study|Withdrawal by Subject|8|||
30784268|NCT03285308|58796598|FG001|Overall Study|Withdrawal by Subject|9|||
30784269|NCT03285308|58796597|FG000|Overall Study|Lost to Follow-up|3|||
30784270|NCT03285308|58796598|FG001|Overall Study|Lost to Follow-up|1|||
30784271|NCT03285308|58796597|FG000|Overall Study|Protocol Deviation|6|||
30784272|NCT03285308|58796598|FG001|Overall Study|Protocol Deviation|5|||
30784273|NCT03285308|58796597|FG000|Overall Study|Reason not Specified|0|||
30784274|NCT03285308|58796598|FG001|Overall Study|Reason not Specified|1|||
30784275|NCT03537651|58796605|FG000|Overall Study|Adverse Event|2|||
30784276|NCT03537651|58796605|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
30784277|NCT03537651|58796605|FG000|Overall Study|Commercial Drug is Available for Participant|56|||
30784278|NCT03537651|58796605|FG000|Overall Study|Other|1|||
30784279|NCT03723915|58796621|FG000|Screening|Failed to meet screening requirements.|2|||
30784280|NCT03723915|58796621|FG000|On Treatment|Failed to meet treatment requirements|2|||
30784281|NCT03281876|58796627|FG000|Overall Study|Adverse Event|4|||
30784282|NCT03281876|58796628|FG001|Overall Study|Adverse Event|15|||
30784283|NCT03281876|58796627|FG000|Overall Study|Lost to Follow-up|1|||
30784284|NCT03281876|58796628|FG001|Overall Study|Lost to Follow-up|4|||
30784285|NCT03281876|58796627|FG000|Overall Study|Withdrawal by Subject|11|||
30784286|NCT03281876|58796628|FG001|Overall Study|Withdrawal by Subject|15|||
30784287|NCT03281876|58796627|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
30784288|NCT03281876|58796628|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
30784289|NCT03281876|58796627|FG000|Overall Study|OTHER|5|||
30598722|NCT01306617|58610451|FG000|Overall Study|Adverse Event|1|||
30687032|NCT00677235|58700956|FG000|Overall Study|Lost to Follow-up|2|||
30687033|NCT00677235|58700957|FG001|Overall Study|Lost to Follow-up|1|||
30784290|NCT03281876|58796628|FG001|Overall Study|OTHER|5|||
30784291|NCT02819518|58796639|FG000|Overall Study|Death|9|||
30784292|NCT02819518|58796640|FG001|Overall Study|Death|11|||
30598723|NCT01306617|58610452|FG001|Overall Study|Adverse Event|0|||
30598724|NCT01306617|58610453|FG002|Overall Study|Adverse Event|0|||
30598725|NCT01306617|58610451|FG000|Overall Study|Virologic Failure|0|||
30598726|NCT01306617|58610452|FG001|Overall Study|Virologic Failure|0|||
30687034|NCT00677235|58700956|FG000|Overall Study|Death|37|||
30687035|NCT00677235|58700957|FG001|Overall Study|Death|36|||
30687036|NCT00677235|58700956|FG000|Overall Study|Adverse Experience|1|||
30784293|NCT02819518|58796641|FG002|Overall Study|Death|9|||
30598727|NCT01306617|58610453|FG002|Overall Study|Virologic Failure|5|||
30598728|NCT01306617|58610451|FG000|Overall Study|Non-compliance|0|||
30598729|NCT01306617|58610452|FG001|Overall Study|Non-compliance|1|||
30598730|NCT01306617|58610453|FG002|Overall Study|Non-compliance|0|||
30687037|NCT00677235|58700957|FG001|Overall Study|Adverse Experience|0|||
30687038|NCT00676689|58700963|FG000|Overall Study|Screen Failure|2|||
30687039|NCT00676689|58700963|FG000|Overall Study|Death|2|||
30687040|NCT00676689|58700963|FG000|Overall Study|Lost to Follow-up|4|||
30687041|NCT00676689|58700963|FG000|Overall Study|Physician Decision|1|||
30687042|NCT00676689|58700963|FG000|Overall Study|Withdrawal by Subject|3|||
30687043|NCT00676689|58700963|FG000|Overall Study|Continuing FU|49|||
30687044|NCT00678795|58700969|FG000|Overall Study|Adverse Event|7|||
30687045|NCT00678795|58700970|FG001|Overall Study|Adverse Event|3|||
30687046|NCT00678795|58700969|FG000|Overall Study|Withdrawal by Subject|3|||
30687047|NCT00678795|58700970|FG001|Overall Study|Withdrawal by Subject|0|||
30687048|NCT00678795|58700969|FG000|Overall Study|Protocol Violation|0|||
30687049|NCT00678795|58700970|FG001|Overall Study|Protocol Violation|1|||
30687050|NCT00678795|58700969|FG000|Overall Study|Lost to Follow-up|0|||
30687051|NCT00678795|58700970|FG001|Overall Study|Lost to Follow-up|1|||
30687052|NCT00678795|58700969|FG000|Overall Study|Lack of Efficacy|1|||
30687053|NCT00678795|58700970|FG001|Overall Study|Lack of Efficacy|1|||
30687054|NCT00678639|58700978|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
30687055|NCT00678639|58700979|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
30687056|NCT00678561|58701029|FG000|Overall Study|Adverse Event|0|||
30687057|NCT00678561|58701030|FG001|Overall Study|Adverse Event|1|||
30687058|NCT00678561|58701031|FG002|Overall Study|Adverse Event|1|||
30687059|NCT00678561|58701032|FG003|Overall Study|Adverse Event|0|||
30687060|NCT00678561|58701033|FG004|Overall Study|Adverse Event|1|||
30687061|NCT00678561|58701034|FG005|Overall Study|Adverse Event|0|||
30687062|NCT00678561|58701035|FG006|Overall Study|Adverse Event|0|||
30687063|NCT00678561|58701036|FG007|Overall Study|Adverse Event|0|||
30687064|NCT00678561|58701029|FG000|Overall Study|Protocol Violation|0|||
30687065|NCT00678561|58701030|FG001|Overall Study|Protocol Violation|0|||
30687066|NCT00678561|58701031|FG002|Overall Study|Protocol Violation|0|||
30687067|NCT00678561|58701032|FG003|Overall Study|Protocol Violation|0|||
30687068|NCT00678561|58701033|FG004|Overall Study|Protocol Violation|1|||
30687069|NCT00678561|58701034|FG005|Overall Study|Protocol Violation|1|||
30687070|NCT00678561|58701035|FG006|Overall Study|Protocol Violation|0|||
30687071|NCT00678561|58701036|FG007|Overall Study|Protocol Violation|0|||
30687072|NCT00678561|58701029|FG000|Overall Study|Withdrawal by Subject|0|||
30687073|NCT00678561|58701030|FG001|Overall Study|Withdrawal by Subject|0|||
30687074|NCT00678561|58701031|FG002|Overall Study|Withdrawal by Subject|0|||
30687075|NCT00678561|58701032|FG003|Overall Study|Withdrawal by Subject|0|||
30687076|NCT00678561|58701033|FG004|Overall Study|Withdrawal by Subject|0|||
30687077|NCT00678561|58701034|FG005|Overall Study|Withdrawal by Subject|0|||
30784294|NCT02819518|58796642|FG003|Overall Study|Death|447|||
30784295|NCT02819518|58796643|FG004|Overall Study|Death|233|||
30784296|NCT02819518|58796639|FG000|Overall Study|Withdrawal by Subject|0|||
30784297|NCT02819518|58796640|FG001|Overall Study|Withdrawal by Subject|0|||
30784298|NCT02819518|58796641|FG002|Overall Study|Withdrawal by Subject|0|||
30784299|NCT02819518|58796642|FG003|Overall Study|Withdrawal by Subject|21|||
30784300|NCT02819518|58796643|FG004|Overall Study|Withdrawal by Subject|6|||
30784301|NCT02819518|58796639|FG000|Overall Study|Ongoing in Study|2|||
30784302|NCT02819518|58796640|FG001|Overall Study|Ongoing in Study|3|||
30784303|NCT02819518|58796641|FG002|Overall Study|Ongoing in Study|1|||
30784304|NCT02819518|58796642|FG003|Overall Study|Ongoing in Study|98|||
30784305|NCT02819518|58796643|FG004|Overall Study|Ongoing in Study|42|||
30784306|NCT03310580|58796660|FG000|Overall Study|Adverse Event|0|||
30784307|NCT03310580|58796661|FG001|Overall Study|Adverse Event|1|||
30784308|NCT03310580|58796662|FG002|Overall Study|Adverse Event|0|||
30856256|NCT03194542|58884091|FG003|Overall Study|Death|5|||
30959249|NCT01353222|59024675|FG001|Overall Study|Study Terminated|37|||
30687078|NCT00678561|58701035|FG006|Overall Study|Withdrawal by Subject|0|||
30687079|NCT00678561|58701036|FG007|Overall Study|Withdrawal by Subject|1|||
30687080|NCT00676143|58701063|FG000|Overall Study|Adverse Event|34|||
30687081|NCT00676143|58701064|FG001|Overall Study|Adverse Event|60|||
30687082|NCT00676143|58701063|FG000|Overall Study|Death|4|||
30856257|NCT03194542|58884088|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
30687083|NCT00676143|58701064|FG001|Overall Study|Death|4|||
30687084|NCT00676143|58701063|FG000|Overall Study|Lack of Efficacy|0|||
30687085|NCT00676143|58701064|FG001|Overall Study|Lack of Efficacy|6|||
30687086|NCT00676143|58701063|FG000|Overall Study|Lost to Follow-up|0|||
30687087|NCT00676143|58701064|FG001|Overall Study|Lost to Follow-up|13|||
30687088|NCT00676143|58701063|FG000|Overall Study|Physician Decision|5|||
30687089|NCT00676143|58701064|FG001|Overall Study|Physician Decision|8|||
30687090|NCT00676143|58701063|FG000|Overall Study|Protocol Violation|4|||
30687091|NCT00676143|58701064|FG001|Overall Study|Protocol Violation|8|||
30687092|NCT00676143|58701063|FG000|Overall Study|Withdrawal by Subject|24|||
30784309|NCT03415022|58796685|FG000|Overall Study|Withdrawal by Subject|1|||
30598731|NCT01306305|58610463|FG000|Overall Study|Lost to Follow-up|1|||
30598732|NCT01306305|58610464|FG001|Overall Study|Lost to Follow-up|0|||
30598733|NCT01306305|58610463|FG000|Overall Study|Withdrew consent|1|||
30598734|NCT01306305|58610464|FG001|Overall Study|Withdrew consent|0|||
30598735|NCT01038427|58610473|FG000|Overall Study|Lost to follow up|1|||
30598736|NCT01038427|58610474|FG001|Overall Study|Lost to follow up|1|||
30598737|NCT01038427|58610475|FG002|Overall Study|Lost to follow up|0|||
30598738|NCT01038427|58610473|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
30687093|NCT00676143|58701064|FG001|Overall Study|Withdrawal by Subject|42|||
30687094|NCT00676143|58701063|FG000|Overall Study|Discontinuation of study by sponsor|65|||
30687095|NCT00676143|58701064|FG001|Overall Study|Discontinuation of study by sponsor|88|||
30687096|NCT00676143|58701063|FG000|Overall Study|Failed to return|2|||
30687097|NCT00676143|58701064|FG001|Overall Study|Failed to return|1|||
30687098|NCT00676143|58701063|FG000|Overall Study|Loss of caregiver|5|||
30598739|NCT01038427|58610474|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
30598740|NCT01038427|58610475|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
30598741|NCT01038427|58610473|FG000|Overall Study|Withdrew consent|0|||
30598742|NCT01038427|58610474|FG001|Overall Study|Withdrew consent|0|||
30598743|NCT01038427|58610475|FG002|Overall Study|Withdrew consent|1|||
30598744|NCT01038427|58610473|FG000|Overall Study|Adverse Event|2|||
30598745|NCT01038427|58610474|FG001|Overall Study|Adverse Event|2|||
30598746|NCT01038427|58610475|FG002|Overall Study|Adverse Event|1|||
30598747|NCT01038427|58610473|FG000|Overall Study|Enrolled in error|0|||
30598748|NCT01038427|58610474|FG001|Overall Study|Enrolled in error|1|||
30598749|NCT01038427|58610475|FG002|Overall Study|Enrolled in error|1|||
30598750|NCT01038427|58610473|FG000|Overall Study|Other|0|||
30598751|NCT01038427|58610474|FG001|Overall Study|Other|2|||
30687099|NCT00676143|58701064|FG001|Overall Study|Loss of caregiver|3|||
30784310|NCT03415022|58796686|FG001|Overall Study|Withdrawal by Subject|2|||
30784311|NCT03415022|58796685|FG000|Overall Study|COVID-19 Suspension|2|||
30784312|NCT03415022|58796686|FG001|Overall Study|COVID-19 Suspension|3|||
30784313|NCT03415022|58796685|FG000|Overall Study|Lost to Follow-up|2|||
30784314|NCT03415022|58796686|FG001|Overall Study|Lost to Follow-up|0|||
30784315|NCT02816398|58796692|FG000|Overall Study|Death|5|||
30784316|NCT02816398|58796692|FG000|Overall Study|Lack of Efficacy|8|||
30784317|NCT02816398|58796692|FG000|Overall Study|Lost to Follow-up|1|||
30784318|NCT02812186|58796698|FG000|Period 1|Post randomization screen failure|5|||
30784319|NCT02812186|58796699|FG001|Period 1|Post randomization screen failure|9|||
30784320|NCT02812186|58796698|FG000|Period 1|nonevaluable data sets|6|||
30784321|NCT02812186|58796699|FG001|Period 1|nonevaluable data sets|6|||
30784322|NCT02811640|58796708|FG000|Overall Study|Technology malfunction|2|||
30784323|NCT03310268|58796715|FG000|Overall Study|(Not specified)|1|||
30784324|NCT03310268|58796716|FG001|Overall Study|(Not specified)|5|||
30784325|NCT03310268|58796717|FG002|Overall Study|(Not specified)|0|||
30784326|NCT02810392|58796727|FG000|Overall Study|Subject too ill to continue|1|||
30784327|NCT02810392|58796728|FG001|Overall Study|Subject too ill to continue|0|||
30784328|NCT02810392|58796727|FG000|Overall Study|COVID 19 research restrictions|0|||
30784329|NCT02810392|58796728|FG001|Overall Study|COVID 19 research restrictions|1|||
30784330|NCT02815540|58796734|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
30784331|NCT03280550|58796740|FG000|Overall Study|Withdrawal by Subject|2|||
30784332|NCT03280550|58796741|FG001|Overall Study|Withdrawal by Subject|2|||
30784333|NCT03280550|58796740|FG000|Overall Study|Physician Decision|0|||
30784334|NCT03280550|58796741|FG001|Overall Study|Physician Decision|1|||
30784335|NCT03276026|58796749|FG000|Overall Study|Protocol Violation|1|||
30784336|NCT03276026|58796750|FG001|Overall Study|Protocol Violation|0|||
30784337|NCT01589523|58796756|FG000|Overall Study|Withdrawal by Subject|1|||
30784338|NCT03277352|58796762|FG000|Overall Study|Study Terminated By Sponsor|2|||
30784339|NCT03277352|58796762|FG000|Overall Study|Withdrawal by Subject|4|||
30784340|NCT03277352|58796762|FG000|Overall Study|Death|4|||
30784341|NCT02814838|58796769|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
30784342|NCT02814838|58796770|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
30784343|NCT02814838|58796769|FG000|Overall Study|Consent withdrawal|1|||
30784344|NCT02814838|58796770|FG001|Overall Study|Consent withdrawal|1|||
30784345|NCT03276728|58796784|FG000|Overall Study|Lost to Follow-up|0|||
30784346|NCT03276728|58796785|FG001|Overall Study|Lost to Follow-up|0|||
30598752|NCT01038427|58610475|FG002|Overall Study|Other|0|||
30598753|NCT01037413|58610483|FG000|Part A: Skin Testing|Adverse Event|1|||
30598754|NCT01037413|58610484|FG001|Part A: Skin Testing|Adverse Event|0|||
30598755|NCT01037413|58610483|FG000|Part A: Skin Testing|Protocol Violation|1|||
30784347|NCT03276728|58796786|FG002|Overall Study|Lost to Follow-up|2|||
30784348|NCT03276728|58796787|FG003|Overall Study|Lost to Follow-up|2|||
30784349|NCT03276728|58796788|FG004|Overall Study|Lost to Follow-up|0|||
30784350|NCT03276728|58796789|FG005|Overall Study|Lost to Follow-up|0|||
30784351|NCT03276728|58796790|FG006|Overall Study|Lost to Follow-up|0|||
30784352|NCT03276728|58796791|FG007|Overall Study|Lost to Follow-up|0|||
30687100|NCT00676143|58701063|FG000|Overall Study|Other|11|||
30687101|NCT00676143|58701064|FG001|Overall Study|Other|20|||
30687102|NCT00676143|58701063|FG000|Overall Study|Participant participation unknown|1|||
30687103|NCT00676143|58701064|FG001|Overall Study|Participant participation unknown|4|||
30687104|NCT00676143|58701063|FG000|Overall Study|Vasogenic edema recurrence|1|||
30687105|NCT00676143|58701064|FG001|Overall Study|Vasogenic edema recurrence|3|||
30687106|NCT00675597|58701089|FG000|Overall Study|Withdrawal by Subject|3|||
30687107|NCT00675441|58701097|FG000|Overall Study|Withdrawal by Subject|2|||
30687108|NCT00675441|58701097|FG000|Overall Study|Death|1|||
30687109|NCT00674973|58701112|FG000|Overall Study|Insufficient Therapeutic Response|77|||
30687110|NCT00674973|58701113|FG001|Overall Study|Insufficient Therapeutic Response|72|||
30687111|NCT00674973|58701112|FG000|Overall Study|Refused Treatment|1|||
30687112|NCT00674973|58701113|FG001|Overall Study|Refused Treatment|5|||
30687113|NCT00674973|58701112|FG000|Overall Study|Failure to Return|1|||
30687114|NCT00674973|58701113|FG001|Overall Study|Failure to Return|0|||
30687115|NCT00674973|58701112|FG000|Overall Study|Adverse Event|2|||
30687116|NCT00674973|58701113|FG001|Overall Study|Adverse Event|9|||
30687117|NCT00674973|58701112|FG000|Overall Study|Death|19|||
30687118|NCT00674973|58701113|FG001|Overall Study|Death|15|||
30687119|NCT00674973|58701112|FG000|Overall Study|Protocol Violation|0|||
30687120|NCT00674973|58701113|FG001|Overall Study|Protocol Violation|1|||
30687121|NCT00673179|58701121|FG000|Overall Study|Toxicity/Complications|3|||
30687122|NCT00673179|58701122|FG001|Overall Study|Toxicity/Complications|0|||
30687123|NCT00584012|58701128|FG000|Overall Study|Withdrawal by Subject|1|||
30687124|NCT00674817|58701132|FG000|Period 1|Withdrawal by Subject|2|||
30687125|NCT00674817|58701132|FG000|Period 1|Protocol Violation|1|||
30687126|NCT00674817|58701132|FG000|Period 3|Adverse Event|1|||
30687127|NCT00674817|58701132|FG000|Period 3|Protocol Violation|1|||
30687128|NCT00674817|58701132|FG000|Period 4|Adverse Event|1|||
30687129|NCT00672633|58701148|FG000|Overall Study|Withdrawal by Subject|0|||
30687130|NCT00672633|58701149|FG001|Overall Study|Withdrawal by Subject|1|||
30687131|NCT00672555|58701155|FG000|Overall Study|Lost to Follow-up|4|||
30687132|NCT00672555|58701155|FG000|Overall Study|Did not want to answer questionnaire|2|||
30687133|NCT00672477|58701161|FG000|Overall Study|Adverse Event|10|||
30687134|NCT00672477|58701162|FG001|Overall Study|Adverse Event|7|||
30687135|NCT00672477|58701161|FG000|Overall Study|Death|7|||
30687136|NCT00672477|58701162|FG001|Overall Study|Death|11|||
30687137|NCT00672477|58701161|FG000|Overall Study|Physician Decision|2|||
30687138|NCT00672477|58701162|FG001|Overall Study|Physician Decision|0|||
30687139|NCT00672477|58701161|FG000|Overall Study|Protocol Violation|1|||
30687140|NCT00672477|58701162|FG001|Overall Study|Protocol Violation|1|||
30687141|NCT00672477|58701161|FG000|Overall Study|Withdrawal by Subject|5|||
30687142|NCT00672477|58701162|FG001|Overall Study|Withdrawal by Subject|3|||
30784353|NCT03276728|58796784|FG000|Overall Study|Withdrawal by Subject|0|||
30784354|NCT03276728|58796785|FG001|Overall Study|Withdrawal by Subject|0|||
30598756|NCT01037413|58610484|FG001|Part A: Skin Testing|Protocol Violation|0|||
30598757|NCT01037413|58610483|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
30598758|NCT01037413|58610484|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
30598759|NCT01037413|58610483|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
30598760|NCT01037413|58610484|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
30598761|NCT01326845|58610499|FG000|Overall Study|Administrative Problems|5|||
30598762|NCT01326845|58610500|FG001|Overall Study|Administrative Problems|2|||
30598763|NCT01326845|58610499|FG000|Overall Study|Adverse Event|1|||
30598764|NCT01326845|58610500|FG001|Overall Study|Adverse Event|0|||
30598765|NCT01326845|58610499|FG000|Overall Study|Misisng|1|||
30598766|NCT01326845|58610500|FG001|Overall Study|Misisng|3|||
30598767|NCT01062763|58610508|FG000|Overall Study|Adverse Event|3|||
30598768|NCT01062763|58610509|FG001|Overall Study|Adverse Event|4|||
30598769|NCT01048099|58610515|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
30598770|NCT01048099|58610515|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
30598771|NCT01303965|58610523|FG000|Overall Study|Adverse Event|1|||
30598772|NCT01303965|58610524|FG001|Overall Study|Adverse Event|1|||
30598773|NCT01303965|58610523|FG000|Overall Study|Death|0|||
30598774|NCT01303965|58610524|FG001|Overall Study|Death|3|||
30598775|NCT01303965|58610523|FG000|Overall Study|Withdrawal by Subject|1|||
30598776|NCT01303965|58610524|FG001|Overall Study|Withdrawal by Subject|0|||
30784355|NCT03276728|58796786|FG002|Overall Study|Withdrawal by Subject|0|||
30598777|NCT01303965|58610523|FG000|Overall Study|Disease Progression|1|||
30598778|NCT01303965|58610524|FG001|Overall Study|Disease Progression|6|||
30959250|NCT01353222|59024674|FG000|Overall Study|Site closed research department|1|||
30687143|NCT00672477|58701161|FG000|Overall Study|Lack of Efficacy|1|||
30687144|NCT00672477|58701162|FG001|Overall Study|Lack of Efficacy|1|||
30687145|NCT00672477|58701161|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
30687146|NCT00672477|58701162|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
30687147|NCT00674661|58701170|FG000|Overall Study|Other|5|||
30687148|NCT00674661|58701171|FG001|Overall Study|Other|7|||
30687149|NCT00674661|58701170|FG000|Overall Study|Lost to Follow-up|6|||
30687150|NCT00674661|58701171|FG001|Overall Study|Lost to Follow-up|3|||
30687151|NCT00674661|58701170|FG000|Overall Study|Withdrawal by Subject|0|||
30687152|NCT00674661|58701171|FG001|Overall Study|Withdrawal by Subject|5|||
30687153|NCT00671931|58701182|FG000|Overall Study|Physician Decision|1|||
30784356|NCT03276728|58796787|FG003|Overall Study|Withdrawal by Subject|3|||
30784357|NCT03276728|58796788|FG004|Overall Study|Withdrawal by Subject|0|||
30784358|NCT03276728|58796789|FG005|Overall Study|Withdrawal by Subject|0|||
30784359|NCT03276728|58796790|FG006|Overall Study|Withdrawal by Subject|0|||
30784360|NCT03276728|58796791|FG007|Overall Study|Withdrawal by Subject|0|||
30784361|NCT03276728|58796784|FG000|Overall Study|Decision by sponsor|0|||
30784362|NCT03276728|58796785|FG001|Overall Study|Decision by sponsor|0|||
30784363|NCT03276728|58796786|FG002|Overall Study|Decision by sponsor|0|||
30784364|NCT03276728|58796787|FG003|Overall Study|Decision by sponsor|0|||
30784365|NCT03276728|58796788|FG004|Overall Study|Decision by sponsor|1|||
30784366|NCT03276728|58796789|FG005|Overall Study|Decision by sponsor|0|||
30784367|NCT03276728|58796790|FG006|Overall Study|Decision by sponsor|2|||
30784368|NCT03276728|58796791|FG007|Overall Study|Decision by sponsor|1|||
30784369|NCT03275246|58796811|FG000|Overall Study|Protocol Violation|5|||
30784370|NCT03275246|58796811|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
30784371|NCT02940860|58796817|FG000|Overall Study|Non-serious AE|1|||
30784372|NCT02940860|58796818|FG001|Overall Study|Non-serious AE|2|||
30784373|NCT02940860|58796817|FG000|Overall Study|Serious AE|7|||
30784374|NCT02940860|58796818|FG001|Overall Study|Serious AE|3|||
30784375|NCT02940860|58796817|FG000|Overall Study|Withdrawal by Subject|19|||
30784376|NCT02940860|58796818|FG001|Overall Study|Withdrawal by Subject|9|||
30784377|NCT02940860|58796817|FG000|Overall Study|Lost to Follow-up|13|||
30784378|NCT02940860|58796818|FG001|Overall Study|Lost to Follow-up|7|||
30784379|NCT02940860|58796817|FG000|Overall Study|Physician Decision|5|||
30784380|NCT02940860|58796818|FG001|Overall Study|Physician Decision|3|||
30784381|NCT02940860|58796817|FG000|Overall Study|Sponsor Decision|0|||
30784382|NCT02940860|58796818|FG001|Overall Study|Sponsor Decision|1|||
30784383|NCT02940860|58796817|FG000|Overall Study|Protocol Violation|0|||
30784384|NCT02940860|58796818|FG001|Overall Study|Protocol Violation|2|||
30784385|NCT02940860|58796817|FG000|Overall Study|Death|3|||
30784386|NCT02940860|58796818|FG001|Overall Study|Death|2|||
30784387|NCT02940860|58796817|FG000|Overall Study|Moved, poor venous access, transport|6|||
30784388|NCT02940860|58796818|FG001|Overall Study|Moved, poor venous access, transport|4|||
30784389|NCT02940860|58796817|FG000|Overall Study|Not treated|2|||
30784390|NCT02940860|58796818|FG001|Overall Study|Not treated|2|||
30784391|NCT03309020|58796828|FG000|Overall Study|Death|1|||
30784392|NCT03309020|58796829|FG001|Overall Study|Death|0|||
30784393|NCT03309020|58796828|FG000|Overall Study|Did not undergo surgery|2|||
30784394|NCT03309020|58796829|FG001|Overall Study|Did not undergo surgery|1|||
30784395|NCT02806960|58796837|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
30784396|NCT02806960|58796838|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
30784397|NCT02806960|58796839|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
30784398|NCT02806960|58796840|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
30784399|NCT03718143|58796850|FG000|Overall Study|Death|1|||
30784400|NCT03718143|58796851|FG001|Overall Study|Death|0|||
30784401|NCT03718143|58796852|FG002|Overall Study|Death|0|||
30784402|NCT03718143|58796850|FG000|Overall Study|Progression of Disease|1|||
30784403|NCT03718143|58796851|FG001|Overall Study|Progression of Disease|0|||
30784404|NCT03718143|58796852|FG002|Overall Study|Progression of Disease|0|||
30784405|NCT03718143|58796850|FG000|Overall Study|Withdrawal of Informed Consent|1|||
30598779|NCT01045993|58610534|FG000|Overall Study|Treated-later found eligibility not met|0|||
30598780|NCT01045993|58610535|FG001|Overall Study|Treated-later found eligibility not met|1|||
30598781|NCT01045993|58610536|FG002|Overall Study|Treated-later found eligibility not met|0|||
30598782|NCT01045993|58610537|FG003|Overall Study|Treated-later found eligibility not met|0|||
30598783|NCT01303419|58610547|FG000|Overall Study|Discontinuation of study|60|||
30598784|NCT01303419|58610547|FG000|Overall Study|Did not complete both imaging methods|5|||
30598785|NCT01303419|58610547|FG000|Overall Study|Did not meet all I/E after screening|31|||
30598786|NCT01326533|58610553|FG000|Overall Study|Lost to Follow-up|2|||
30687154|NCT00671931|58701183|FG001|Overall Study|Physician Decision|0|||
30784406|NCT03718143|58796851|FG001|Overall Study|Withdrawal of Informed Consent|2|||
30784407|NCT03718143|58796852|FG002|Overall Study|Withdrawal of Informed Consent|1|||
30784408|NCT03274466|58796862|FG000|Overall Study|Withdrawal by Subject|7|||
30784409|NCT03274466|58796863|FG001|Overall Study|Withdrawal by Subject|3|||
30784410|NCT03274466|58796862|FG000|Overall Study|Protocol Specified Withdrawal|5|||
30598787|NCT01326533|58610554|FG001|Overall Study|Lost to Follow-up|0|||
30687155|NCT00671931|58701184|FG002|Overall Study|Physician Decision|0|||
30784411|NCT03274466|58796863|FG001|Overall Study|Protocol Specified Withdrawal|11|||
30784412|NCT03274466|58796862|FG000|Overall Study|Lost to Follow-up|5|||
30784413|NCT03274466|58796863|FG001|Overall Study|Lost to Follow-up|7|||
30784414|NCT03274466|58796862|FG000|Overall Study|Subject Non-compliance|0|||
30784415|NCT03274466|58796863|FG001|Overall Study|Subject Non-compliance|1|||
30784416|NCT03274466|58796862|FG000|Overall Study|Adverse Event|3|||
30784417|NCT03274466|58796863|FG001|Overall Study|Adverse Event|3|||
30784418|NCT03274466|58796862|FG000|Overall Study|Physician Decision|0|||
30784419|NCT03274466|58796863|FG001|Overall Study|Physician Decision|1|||
30687156|NCT00671931|58701185|FG003|Overall Study|Physician Decision|2|||
30687157|NCT00671931|58701186|FG004|Overall Study|Physician Decision|1|||
30687158|NCT00673881|58701202|FG000|Overall Study|Withdrawal by Subject|1|||
30687159|NCT00671853|58701208|FG000|Overall Study|Lack of Efficacy|3|||
30687160|NCT00671853|58701209|FG001|Overall Study|Lack of Efficacy|7|||
30687161|NCT00671853|58701208|FG000|Overall Study|Adverse Event|7|||
30687162|NCT00671853|58701209|FG001|Overall Study|Adverse Event|1|||
30687163|NCT00671853|58701208|FG000|Overall Study|Withdrawal by Subject|1|||
30687164|NCT00671853|58701209|FG001|Overall Study|Withdrawal by Subject|5|||
30687165|NCT00671853|58701208|FG000|Overall Study|Lost to Follow-up|8|||
30687166|NCT00671853|58701209|FG001|Overall Study|Lost to Follow-up|8|||
30687167|NCT00671853|58701208|FG000|Overall Study|Physician Decision|0|||
30687168|NCT00671853|58701209|FG001|Overall Study|Physician Decision|2|||
30687169|NCT00671853|58701208|FG000|Overall Study|Non-adherence with study procedures|1|||
30687170|NCT00671853|58701209|FG001|Overall Study|Non-adherence with study procedures|4|||
30687171|NCT00570921|58701217|FG000|Overall Study|Protocol Violation|1|||
30687172|NCT00570921|58701217|FG000|Overall Study|Physician Decision|1|||
30687173|NCT00670449|58701225|FG000|Overall Study|Adverse Event|6|||
30687174|NCT00670449|58701226|FG001|Overall Study|Adverse Event|2|||
30687175|NCT00670449|58701227|FG002|Overall Study|Adverse Event|8|||
30687176|NCT00670449|58701228|FG003|Overall Study|Adverse Event|5|||
30687177|NCT00670449|58701225|FG000|Overall Study|Protocol Deviation|1|||
30687178|NCT00670449|58701226|FG001|Overall Study|Protocol Deviation|2|||
30687179|NCT00670449|58701227|FG002|Overall Study|Protocol Deviation|0|||
30687180|NCT00670449|58701228|FG003|Overall Study|Protocol Deviation|1|||
30687181|NCT00670449|58701225|FG000|Overall Study|Administrative Problems|0|||
30687182|NCT00670449|58701226|FG001|Overall Study|Administrative Problems|2|||
30687183|NCT00670449|58701227|FG002|Overall Study|Administrative Problems|0|||
30687184|NCT00670449|58701228|FG003|Overall Study|Administrative Problems|1|||
30687185|NCT00670449|58701225|FG000|Overall Study|Subject Withdrew Consent|0|||
30687186|NCT00670449|58701226|FG001|Overall Study|Subject Withdrew Consent|2|||
30687187|NCT00670449|58701227|FG002|Overall Study|Subject Withdrew Consent|0|||
30687188|NCT00670449|58701228|FG003|Overall Study|Subject Withdrew Consent|1|||
30687189|NCT00670449|58701225|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
30687190|NCT00670449|58701226|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
30687191|NCT00670449|58701227|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
30687192|NCT00670449|58701228|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
30687193|NCT00670449|58701225|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
30687194|NCT00670449|58701226|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
30687195|NCT00670449|58701227|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
30687196|NCT00670449|58701228|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
30687197|NCT00668733|58701239|FG000|Overall Study|Lost to Follow-up|2|||
30687198|NCT00668733|58701240|FG001|Overall Study|Lost to Follow-up|3|||
30687199|NCT00668733|58701239|FG000|Overall Study|Withdrawal by Subject|0|||
30687200|NCT00668733|58701240|FG001|Overall Study|Withdrawal by Subject|4|||
30687201|NCT00673257|58701246|FG000|Overall Study|Withdrawal by Subject|4|||
30687202|NCT00673257|58701246|FG000|Overall Study|Unable to obtain specimen|1|||
30687203|NCT00667875|58701253|FG000|Overall Study|Adverse Event|0|||
30687204|NCT00667875|58701254|FG001|Overall Study|Adverse Event|2|||
30687205|NCT00667875|58701255|FG002|Overall Study|Adverse Event|6|||
30687206|NCT00667875|58701253|FG000|Overall Study|Withdrawal by Subject|10|||
30687207|NCT00667875|58701254|FG001|Overall Study|Withdrawal by Subject|9|||
30687208|NCT00667875|58701255|FG002|Overall Study|Withdrawal by Subject|7|||
30598788|NCT01326533|58610553|FG000|Overall Study|Withdrawal by Subject|1|||
30598789|NCT01326533|58610554|FG001|Overall Study|Withdrawal by Subject|0|||
30598790|NCT01326533|58610553|FG000|Overall Study|Adverse Event|1|||
30598791|NCT01326533|58610554|FG001|Overall Study|Adverse Event|0|||
30598792|NCT01045447|58610562|FG000|Overall Study|Adverse Event|0|||
30598793|NCT01045447|58610563|FG001|Overall Study|Adverse Event|1|||
30598794|NCT01045447|58610562|FG000|Overall Study|Lack of Efficacy|3|||
30598795|NCT01045447|58610563|FG001|Overall Study|Lack of Efficacy|1|||
30598796|NCT01045447|58610562|FG000|Overall Study|Protocol Violation|6|||
30598797|NCT01045447|58610563|FG001|Overall Study|Protocol Violation|3|||
30598798|NCT01045447|58610562|FG000|Overall Study|Withdrawal Criteria|10|||
30598799|NCT01045447|58610563|FG001|Overall Study|Withdrawal Criteria|10|||
30687209|NCT03468998|58701275|FG000|Overall Study|Withdrawal by Subject|1|||
30687210|NCT03468998|58701276|FG001|Overall Study|Withdrawal by Subject|1|||
30687211|NCT03468998|58701277|FG002|Overall Study|Withdrawal by Subject|0|||
30687212|NCT03468998|58701278|FG003|Overall Study|Withdrawal by Subject|4|||
30687213|NCT03468998|58701279|FG004|Overall Study|Withdrawal by Subject|1|||
30687214|NCT03468998|58701280|FG005|Overall Study|Withdrawal by Subject|0|||
30687215|NCT00667251|58701294|FG000|Overall Study|Adverse Event|13|||
30687216|NCT00667251|58701295|FG001|Overall Study|Adverse Event|4|||
30687217|NCT00667251|58701294|FG000|Overall Study|Withdrawal by Subject|6|||
30687218|NCT00667251|58701295|FG001|Overall Study|Withdrawal by Subject|2|||
30687219|NCT00667251|58701294|FG000|Overall Study|Other/missing|46|||
30687220|NCT00667251|58701295|FG001|Overall Study|Other/missing|84|||
30598800|NCT01045447|58610562|FG000|Overall Study|Unclassified|17|||
30598801|NCT01045447|58610563|FG001|Overall Study|Unclassified|13|||
30687221|NCT00667251|58701294|FG000|Overall Study|Intercurrent Illness|4|||
30687222|NCT00667251|58701295|FG001|Overall Study|Intercurrent Illness|3|||
30687223|NCT00667251|58701294|FG000|Overall Study|Symptomatic progression|1|||
30687224|NCT00667251|58701295|FG001|Overall Study|Symptomatic progression|2|||
30687225|NCT00669903|58701313|FG000|Overall Study|Adverse Event|0|||
30687226|NCT00669903|58701314|FG001|Overall Study|Adverse Event|1|||
30687227|NCT00669903|58701315|FG002|Overall Study|Adverse Event|3|||
30687228|NCT00669903|58701316|FG003|Overall Study|Adverse Event|1|||
30687229|NCT00669903|58701313|FG000|Overall Study|Withdrawal by Subject|0|||
30687230|NCT00669903|58701314|FG001|Overall Study|Withdrawal by Subject|2|||
30687231|NCT00669903|58701315|FG002|Overall Study|Withdrawal by Subject|2|||
30687232|NCT00669903|58701316|FG003|Overall Study|Withdrawal by Subject|2|||
30687233|NCT00669903|58701313|FG000|Overall Study|Lost to Follow-up|1|||
30687234|NCT00669903|58701314|FG001|Overall Study|Lost to Follow-up|1|||
30687235|NCT00669903|58701315|FG002|Overall Study|Lost to Follow-up|0|||
30687236|NCT00669903|58701316|FG003|Overall Study|Lost to Follow-up|1|||
30687237|NCT00669903|58701313|FG000|Overall Study|Protocol Violation|0|||
30687238|NCT00669903|58701314|FG001|Overall Study|Protocol Violation|1|||
30687239|NCT00669903|58701315|FG002|Overall Study|Protocol Violation|0|||
30687240|NCT00669903|58701316|FG003|Overall Study|Protocol Violation|0|||
30687241|NCT03759392|58701328|FG000|Overall Study|Adverse Event|12|||
30687242|NCT03759392|58701329|FG001|Overall Study|Adverse Event|4|||
30687243|NCT03759392|58701328|FG000|Overall Study|Death|2|||
30687244|NCT03759392|58701329|FG001|Overall Study|Death|1|||
30687245|NCT03759392|58701328|FG000|Overall Study|Withdrawal by Subject|2|||
30687246|NCT03759392|58701329|FG001|Overall Study|Withdrawal by Subject|0|||
30687247|NCT03759392|58701328|FG000|Overall Study|Protocol Violation|2|||
30687248|NCT03759392|58701329|FG001|Overall Study|Protocol Violation|0|||
30687249|NCT03759392|58701328|FG000|Overall Study|Physician Decision|0|||
30687250|NCT03759392|58701329|FG001|Overall Study|Physician Decision|1|||
30687251|NCT03759392|58701328|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
30687252|NCT03759392|58701329|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
30687253|NCT03759392|58701328|FG000|Overall Study|No longer able to take medicines|1|||
30687254|NCT03759392|58701329|FG001|Overall Study|No longer able to take medicines|0|||
30687255|NCT03759392|58701328|FG000|Overall Study|Stopped taking study drug|1|||
30687256|NCT03759392|58701329|FG001|Overall Study|Stopped taking study drug|0|||
30687257|NCT00667719|58701335|FG000|Overall Study|Adverse Event|39|||
30687258|NCT00667719|58701335|FG000|Overall Study|Abnormal Test Procedure|1|||
30784420|NCT03274466|58796862|FG000|Overall Study|Protocol Violation|3|||
30598802|NCT01301625|58610569|FG000|Overall Study|Death|5|||
30598803|NCT01301625|58610569|FG000|Overall Study|Not Due|21|||
30598804|NCT01301625|58610569|FG000|Overall Study|Expected|8|||
30598805|NCT01301625|58610569|FG000|Overall Study|Lost to Follow-up|1|||
30598806|NCT01301391|58610573|FG000|Overall Study|Death|13|||
30598807|NCT01301391|58610573|FG000|Overall Study|Lost to Follow-up|3|||
30598808|NCT01301391|58610573|FG000|Overall Study|Physician Decision|2|||
30598809|NCT01301391|58610573|FG000|Overall Study|Sponsor's decision|8|||
30598810|NCT01036321|58610579|FG000|Overall Study|Ineligible after randomization|0|||
30598811|NCT01036321|58610580|FG001|Overall Study|Ineligible after randomization|1|||
30598812|NCT01036321|58610579|FG000|Overall Study|Withdrawal by Subject|3|||
30598813|NCT01036321|58610580|FG001|Overall Study|Withdrawal by Subject|2|||
30598814|NCT01036321|58610579|FG000|Overall Study|Adverse Event|2|||
30598815|NCT01036321|58610580|FG001|Overall Study|Adverse Event|1|||
30598816|NCT01061359|58610586|FG000|Overall Study|Death|32|||
30598817|NCT01061359|58610586|FG000|Overall Study|Lost to Follow-up|1072|||
30598818|NCT01061359|58610586|FG000|Overall Study|Relapse|187|||
30598819|NCT01061359|58610586|FG000|Overall Study|Secondary neoplasm|11|||
30598820|NCT01301079|58610592|FG000|Overall Study|Lost to Follow-up|2|||
30598821|NCT01301079|58610593|FG001|Overall Study|Lost to Follow-up|2|||
30598822|NCT01036165|58610603|FG000|Overall Study|Adverse Event|6|||
30598823|NCT01036165|58610603|FG000|Overall Study|Lost to Follow-up|2|||
30598824|NCT01036165|58610603|FG000|Overall Study|Withdrawal by Subject|3|||
30598825|NCT01036165|58610603|FG000|Overall Study|Device Related Issues|3|||
30598826|NCT01036165|58610603|FG000|Overall Study|Problems finding proper area to inject|1|||
30598827|NCT01301001|58610607|FG000|First Intervention|Lost to Follow-up|4|||
30687259|NCT00667719|58701335|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
30687260|NCT00667719|58701335|FG000|Overall Study|Protocol Violation|3|||
30687261|NCT00667719|58701335|FG000|Overall Study|Withdrawal by Subject|17|||
30598828|NCT01301001|58610608|FG001|First Intervention|Lost to Follow-up|4|||
30687262|NCT00667719|58701335|FG000|Overall Study|Lost to Follow-up|8|||
30687263|NCT00669669|58701344|FG000|Overall Study|To late to start treatment|1|||
30687264|NCT00467779|58701363|FG000|Stage 1|Adverse Event|1|||
30687265|NCT00467779|58701364|FG001|Stage 1|Adverse Event|0|||
30687266|NCT00467779|58701365|FG002|Stage 1|Adverse Event|0|||
30687267|NCT00467779|58701366|FG003|Stage 1|Adverse Event|0|||
30598829|NCT01301001|58610607|FG000|First Intervention|Withdrawal by Subject|1|||
30784421|NCT03274466|58796863|FG001|Overall Study|Protocol Violation|3|||
30784422|NCT02806726|58796869|FG000|Overall Study|Lost to Follow-up|1|||
30784423|NCT02806414|58796874|FG000|Overall Study|Lost to Follow-up|2|||
30784424|NCT02806024|58796880|FG000|Overall Study|Night Delivery|1|||
30784425|NCT02806024|58796881|FG001|Overall Study|Night Delivery|1|||
30784426|NCT02806024|58796880|FG000|Overall Study|DVT during antepartum admission|0|||
30784427|NCT02806024|58796881|FG001|Overall Study|DVT during antepartum admission|1|||
30784428|NCT02805790|58796889|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
30784429|NCT02805790|58796890|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
30784430|NCT02802592|58796896|FG000|Overall Study|Study terminated due to loss of funding|4|||
30784431|NCT02803138|58796901|FG000|Overall Study|Failure to return|38|||
30687268|NCT00467779|58701367|FG004|Stage 1|Adverse Event|0|||
30687269|NCT00467779|58701368|FG005|Stage 1|Adverse Event|1|||
30784432|NCT02803138|58796901|FG000|Overall Study|Insufficient virological response|2|||
30784433|NCT02803138|58796901|FG000|Overall Study|Withdrawn consent|1|||
30784434|NCT02803138|58796901|FG000|Overall Study|Death|1|||
30687270|NCT00467779|58701369|FG006|Stage 1|Adverse Event|2|||
30687271|NCT00467779|58701370|FG007|Stage 1|Adverse Event|1|||
30784435|NCT02803138|58796901|FG000|Overall Study|Other, not specified|28|||
30784436|NCT02801578|58796907|FG000|Overall Study|Adverse Event|2|||
30784437|NCT02799472|58796913|FG000|Overall Study|Withdrawal by Subject|2|||
30784438|NCT02799472|58796914|FG001|Overall Study|Withdrawal by Subject|4|||
30784439|NCT02799472|58796913|FG000|Overall Study|Lack of Efficacy|2|||
30784440|NCT02799472|58796914|FG001|Overall Study|Lack of Efficacy|0|||
30784441|NCT02799472|58796913|FG000|Overall Study|Lost to Follow-up|0|||
30784442|NCT02799472|58796914|FG001|Overall Study|Lost to Follow-up|1|||
30784443|NCT03245450|58796927|FG000|Overall Study|Radiological disease progression|3|||
30784444|NCT03245450|58796928|FG001|Overall Study|Radiological disease progression|3|||
30784445|NCT03245450|58796929|FG002|Overall Study|Radiological disease progression|2|||
30784446|NCT03245450|58796930|FG003|Overall Study|Radiological disease progression|2|||
30784447|NCT03245450|58796931|FG004|Overall Study|Radiological disease progression|7|||
30784448|NCT03245450|58796932|FG005|Overall Study|Radiological disease progression|6|||
30784449|NCT03245450|58796933|FG006|Overall Study|Radiological disease progression|6|||
30784450|NCT03245450|58796927|FG000|Overall Study|Clinical disease progression|0|||
30784451|NCT03245450|58796928|FG001|Overall Study|Clinical disease progression|0|||
30784452|NCT03245450|58796929|FG002|Overall Study|Clinical disease progression|1|||
30784453|NCT03245450|58796930|FG003|Overall Study|Clinical disease progression|0|||
30784454|NCT03245450|58796931|FG004|Overall Study|Clinical disease progression|0|||
30784455|NCT03245450|58796932|FG005|Overall Study|Clinical disease progression|2|||
30784456|NCT03245450|58796933|FG006|Overall Study|Clinical disease progression|0|||
30784457|NCT03245450|58796927|FG000|Overall Study|Other|0|||
30784458|NCT03245450|58796928|FG001|Overall Study|Other|0|||
30784459|NCT03245450|58796929|FG002|Overall Study|Other|0|||
30784460|NCT03245450|58796930|FG003|Overall Study|Other|1|||
30784461|NCT03245450|58796931|FG004|Overall Study|Other|1|||
30784462|NCT03245450|58796932|FG005|Overall Study|Other|1|||
30784463|NCT03245450|58796933|FG006|Overall Study|Other|1|||
30784464|NCT03245450|58796927|FG000|Overall Study|Withdrawal by Subject|0|||
30784465|NCT03245450|58796928|FG001|Overall Study|Withdrawal by Subject|1|||
30784466|NCT03245450|58796929|FG002|Overall Study|Withdrawal by Subject|0|||
30784467|NCT03245450|58796930|FG003|Overall Study|Withdrawal by Subject|0|||
30877168|NCT00106691|58908830|FG000|Overall Study|Withdrawal by Subject|75|||
30959251|NCT01353222|59024675|FG001|Overall Study|Site closed research department|0|||
30598830|NCT01301001|58610608|FG001|First Intervention|Withdrawal by Subject|4|||
30598831|NCT01301001|58610607|FG000|First Intervention|Adverse Event|5|||
30598832|NCT01301001|58610608|FG001|First Intervention|Adverse Event|0|||
30598833|NCT01301001|58610607|FG000|First Intervention|Protocol Violation|0|||
30598834|NCT01301001|58610608|FG001|First Intervention|Protocol Violation|1|||
30598835|NCT01301001|58610607|FG000|Second Intervention|Adverse Event|2|||
30598836|NCT01301001|58610608|FG001|Second Intervention|Adverse Event|0|||
30598837|NCT01301001|58610607|FG000|Second Intervention|Withdrawal by Subject|2|||
30598838|NCT01301001|58610608|FG001|Second Intervention|Withdrawal by Subject|0|||
30687272|NCT00467779|58701371|FG008|Stage 1|Adverse Event|0|||
30784468|NCT03245450|58796931|FG004|Overall Study|Withdrawal by Subject|0|||
30784469|NCT03245450|58796932|FG005|Overall Study|Withdrawal by Subject|0|||
30784470|NCT03245450|58796933|FG006|Overall Study|Withdrawal by Subject|0|||
30784471|NCT03245450|58796927|FG000|Overall Study|Adverse Event|0|||
30784472|NCT03245450|58796928|FG001|Overall Study|Adverse Event|0|||
30784473|NCT03245450|58796929|FG002|Overall Study|Adverse Event|0|||
30784474|NCT03245450|58796930|FG003|Overall Study|Adverse Event|0|||
30784475|NCT03245450|58796931|FG004|Overall Study|Adverse Event|1|||
30784476|NCT03245450|58796932|FG005|Overall Study|Adverse Event|0|||
30784477|NCT03245450|58796933|FG006|Overall Study|Adverse Event|2|||
30784478|NCT03712917|58796958|FG000|Overall Study|Pregnancy|0|||
30598839|NCT01035463|58610617|FG000|Overall Study|Adverse Event|0|||
30598840|NCT01035463|58610618|FG001|Overall Study|Adverse Event|0|||
30687273|NCT00467779|58701372|FG009|Stage 1|Adverse Event|0|||
30687274|NCT00467779|58701373|FG010|Stage 1|Adverse Event|0|||
30784479|NCT03712917|58796959|FG001|Overall Study|Pregnancy|0|||
30784480|NCT03712917|58796960|FG002|Overall Study|Pregnancy|1|||
30784481|NCT03712917|58796958|FG000|Overall Study|Adverse Event|0|||
30784482|NCT03712917|58796959|FG001|Overall Study|Adverse Event|4|||
30784483|NCT03712917|58796960|FG002|Overall Study|Adverse Event|3|||
30784484|NCT03712917|58796958|FG000|Overall Study|Lost to Follow-up|9|||
30784485|NCT03712917|58796959|FG001|Overall Study|Lost to Follow-up|4|||
30784486|NCT03712917|58796960|FG002|Overall Study|Lost to Follow-up|5|||
30784487|NCT02748694|58796983|FG000|Overall Study|Voluntary Withdrawal|0|||
30784488|NCT02748694|58796984|FG001|Overall Study|Voluntary Withdrawal|0|||
30784489|NCT02748694|58796985|FG002|Overall Study|Voluntary Withdrawal|0|||
30784490|NCT02748694|58796986|FG003|Overall Study|Voluntary Withdrawal|0|||
30784491|NCT02748694|58796987|FG004|Overall Study|Voluntary Withdrawal|0|||
30784492|NCT02748694|58796988|FG005|Overall Study|Voluntary Withdrawal|0|||
30784493|NCT02748694|58796989|FG006|Overall Study|Voluntary Withdrawal|0|||
30784494|NCT02748694|58796990|FG007|Overall Study|Voluntary Withdrawal|0|||
30784495|NCT02748694|58796991|FG008|Overall Study|Voluntary Withdrawal|0|||
30784496|NCT02748694|58796992|FG009|Overall Study|Voluntary Withdrawal|0|||
30784497|NCT02748694|58796993|FG010|Overall Study|Voluntary Withdrawal|0|||
30784498|NCT02748694|58796994|FG011|Overall Study|Voluntary Withdrawal|0|||
30784499|NCT02748694|58796995|FG012|Overall Study|Voluntary Withdrawal|0|||
30784500|NCT02748694|58796996|FG013|Overall Study|Voluntary Withdrawal|0|||
30784501|NCT02748694|58796997|FG014|Overall Study|Voluntary Withdrawal|2|||
30784502|NCT02800642|58797053|FG000|Overall Study|Death|3|||
30784503|NCT02800642|58797053|FG000|Overall Study|Other|10|||
30784504|NCT02800642|58797053|FG000|Overall Study|Physician Decision|2|||
30784505|NCT02800642|58797053|FG000|Overall Study|Adverse Event|6|||
30784506|NCT02800642|58797053|FG000|Overall Study|Withdrawal by Subject|3|||
30784507|NCT02800642|58797053|FG000|Overall Study|Lost to Follow-up|1|||
30784508|NCT02799784|58797057|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
30784509|NCT02799784|58797058|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
30784510|NCT02799784|58797057|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
30784511|NCT02799784|58797058|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
30784512|NCT02799784|58797057|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
30784513|NCT02799784|58797058|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
30784514|NCT02799784|58797057|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
30784515|NCT02799784|58797058|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
30784516|NCT02799784|58797057|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
30784517|NCT02799784|58797058|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
30784518|NCT02799784|58797057|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
30784519|NCT02799784|58797058|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
30784520|NCT01333072|58797066|FG000|Overall Study|Lost to Follow-up|3|||
30784521|NCT01333072|58797067|FG001|Overall Study|Lost to Follow-up|0|||
30784522|NCT01333072|58797066|FG000|Overall Study|Adverse Event|2|||
30784523|NCT01333072|58797067|FG001|Overall Study|Adverse Event|4|||
30784524|NCT01333072|58797066|FG000|Overall Study|Physician Decision|1|||
30784525|NCT01333072|58797067|FG001|Overall Study|Physician Decision|0|||
30784526|NCT01315353|58797076|FG000|Overall Study|Death|2|||
30784527|NCT01315353|58797077|FG001|Overall Study|Death|1|||
30784528|NCT01315353|58797078|FG002|Overall Study|Death|0|||
30784529|NCT01315353|58797076|FG000|Overall Study|Withdrawal by Subject|2|||
30784530|NCT01315353|58797077|FG001|Overall Study|Withdrawal by Subject|6|||
30784531|NCT01315353|58797078|FG002|Overall Study|Withdrawal by Subject|1|||
30784532|NCT01315353|58797076|FG000|Overall Study|Lost to Follow-up|13|||
30784533|NCT01315353|58797077|FG001|Overall Study|Lost to Follow-up|6|||
30784534|NCT01315353|58797078|FG002|Overall Study|Lost to Follow-up|6|||
30784535|NCT01315353|58797076|FG000|Overall Study|Unwilling to adhere to requirements|5|||
30784536|NCT01315353|58797077|FG001|Overall Study|Unwilling to adhere to requirements|5|||
30784537|NCT01315353|58797078|FG002|Overall Study|Unwilling to adhere to requirements|4|||
30784538|NCT01315353|58797076|FG000|Overall Study|Site closing|7|||
30784539|NCT01315353|58797077|FG001|Overall Study|Site closing|4|||
30784540|NCT01315353|58797078|FG002|Overall Study|Site closing|0|||
30784541|NCT01315353|58797076|FG000|Overall Study|Taken off study by site in error|0|||
30784542|NCT01315353|58797077|FG001|Overall Study|Taken off study by site in error|1|||
30784543|NCT01315353|58797078|FG002|Overall Study|Taken off study by site in error|0|||
30784544|NCT01315353|58797076|FG000|Overall Study|Inadvertent randomization/assignment|0|||
30784545|NCT01315353|58797077|FG001|Overall Study|Inadvertent randomization/assignment|0|||
30784546|NCT01315353|58797078|FG002|Overall Study|Inadvertent randomization/assignment|2|||
30784547|NCT03712449|58797088|FG000|Overall Study|Withdraw Consent|0|||
30784548|NCT03712449|58797089|FG001|Overall Study|Withdraw Consent|1|||
30784549|NCT03517540|58797099|FG000|Overall Study|Protocol Violation|2|||
30784550|NCT03517540|58797100|FG001|Overall Study|Protocol Violation|0|||
30784551|NCT03517540|58797101|FG002|Overall Study|Protocol Violation|0|||
30784552|NCT03517540|58797102|FG003|Overall Study|Protocol Violation|1|||
30784553|NCT03517540|58797099|FG000|Overall Study|Adverse Event|9|||
30784554|NCT03517540|58797100|FG001|Overall Study|Adverse Event|3|||
30784555|NCT03517540|58797101|FG002|Overall Study|Adverse Event|8|||
30784556|NCT03517540|58797102|FG003|Overall Study|Adverse Event|1|||
30784557|NCT03517540|58797099|FG000|Overall Study|Withdrawal by Subject|3|||
30784558|NCT03517540|58797100|FG001|Overall Study|Withdrawal by Subject|4|||
30598841|NCT01035463|58610619|FG002|Overall Study|Adverse Event|4|||
30598842|NCT01035463|58610620|FG003|Overall Study|Adverse Event|1|||
30598843|NCT01035463|58610621|FG004|Overall Study|Adverse Event|5|||
30598844|NCT01035463|58610622|FG005|Overall Study|Adverse Event|7|||
30598845|NCT01035463|58610617|FG000|Overall Study|Withdrawal by Subject|0|||
30687275|NCT00467779|58701374|FG011|Stage 1|Adverse Event|0|||
30687276|NCT00467779|58701375|FG012|Stage 1|Adverse Event|0|||
30687277|NCT00467779|58701376|FG013|Stage 1|Adverse Event|0|||
30687278|NCT00467779|58701377|FG014|Stage 1|Adverse Event|0|||
30687279|NCT00467779|58701363|FG000|Stage 1|Disease Progression|2|||
30687280|NCT00467779|58701364|FG001|Stage 1|Disease Progression|2|||
30687281|NCT00467779|58701365|FG002|Stage 1|Disease Progression|2|||
30687282|NCT00467779|58701366|FG003|Stage 1|Disease Progression|3|||
30687283|NCT00467779|58701367|FG004|Stage 1|Disease Progression|2|||
30687284|NCT00467779|58701368|FG005|Stage 1|Disease Progression|2|||
30687285|NCT00467779|58701369|FG006|Stage 1|Disease Progression|4|||
30687286|NCT00467779|58701370|FG007|Stage 1|Disease Progression|5|||
30687287|NCT00467779|58701371|FG008|Stage 1|Disease Progression|0|||
30687288|NCT00467779|58701372|FG009|Stage 1|Disease Progression|0|||
30687289|NCT00467779|58701373|FG010|Stage 1|Disease Progression|0|||
30687290|NCT00467779|58701374|FG011|Stage 1|Disease Progression|0|||
30687291|NCT00467779|58701375|FG012|Stage 1|Disease Progression|0|||
30687292|NCT00467779|58701376|FG013|Stage 1|Disease Progression|0|||
30687293|NCT00467779|58701377|FG014|Stage 1|Disease Progression|0|||
30687294|NCT00467779|58701363|FG000|Stage 1|Unspecified Reason|1|||
30687295|NCT00467779|58701364|FG001|Stage 1|Unspecified Reason|0|||
30687296|NCT00467779|58701365|FG002|Stage 1|Unspecified Reason|1|||
30687297|NCT00467779|58701366|FG003|Stage 1|Unspecified Reason|0|||
30687298|NCT00467779|58701367|FG004|Stage 1|Unspecified Reason|1|||
30687299|NCT00467779|58701368|FG005|Stage 1|Unspecified Reason|2|||
30687300|NCT00467779|58701369|FG006|Stage 1|Unspecified Reason|0|||
30687301|NCT00467779|58701370|FG007|Stage 1|Unspecified Reason|0|||
30687302|NCT00467779|58701371|FG008|Stage 1|Unspecified Reason|0|||
30687303|NCT00467779|58701372|FG009|Stage 1|Unspecified Reason|0|||
30687304|NCT00467779|58701373|FG010|Stage 1|Unspecified Reason|0|||
30687305|NCT00467779|58701374|FG011|Stage 1|Unspecified Reason|0|||
30687306|NCT00467779|58701375|FG012|Stage 1|Unspecified Reason|0|||
30687307|NCT00467779|58701376|FG013|Stage 1|Unspecified Reason|0|||
30687308|NCT00467779|58701377|FG014|Stage 1|Unspecified Reason|0|||
30687309|NCT00467779|58701363|FG000|Stage 1|Physician Decision|0|||
30687310|NCT00467779|58701364|FG001|Stage 1|Physician Decision|1|||
30687311|NCT00467779|58701365|FG002|Stage 1|Physician Decision|0|||
30687312|NCT00467779|58701366|FG003|Stage 1|Physician Decision|0|||
30687313|NCT00467779|58701367|FG004|Stage 1|Physician Decision|0|||
30687314|NCT00467779|58701368|FG005|Stage 1|Physician Decision|0|||
30687315|NCT00467779|58701369|FG006|Stage 1|Physician Decision|0|||
30687316|NCT00467779|58701370|FG007|Stage 1|Physician Decision|0|||
30687317|NCT00467779|58701371|FG008|Stage 1|Physician Decision|0|||
30687318|NCT00467779|58701372|FG009|Stage 1|Physician Decision|0|||
30687319|NCT00467779|58701373|FG010|Stage 1|Physician Decision|0|||
30784559|NCT03517540|58797101|FG002|Overall Study|Withdrawal by Subject|1|||
30598846|NCT01035463|58610618|FG001|Overall Study|Withdrawal by Subject|2|||
30598847|NCT01035463|58610619|FG002|Overall Study|Withdrawal by Subject|1|||
30598848|NCT01035463|58610620|FG003|Overall Study|Withdrawal by Subject|0|||
30598849|NCT01035463|58610621|FG004|Overall Study|Withdrawal by Subject|1|||
30598850|NCT01035463|58610622|FG005|Overall Study|Withdrawal by Subject|4|||
30598851|NCT01035463|58610617|FG000|Overall Study|Disease progression|0|||
30598852|NCT01035463|58610618|FG001|Overall Study|Disease progression|0|||
30598853|NCT01035463|58610619|FG002|Overall Study|Disease progression|0|||
30687320|NCT00467779|58701374|FG011|Stage 1|Physician Decision|0|||
30687321|NCT00467779|58701375|FG012|Stage 1|Physician Decision|0|||
30687322|NCT00467779|58701376|FG013|Stage 1|Physician Decision|0|||
30687323|NCT00467779|58701377|FG014|Stage 1|Physician Decision|0|||
30687324|NCT00467779|58701363|FG000|Stage 1|Withdrawal by Subject|0|||
30687325|NCT00467779|58701364|FG001|Stage 1|Withdrawal by Subject|0|||
30687326|NCT00467779|58701365|FG002|Stage 1|Withdrawal by Subject|0|||
30687327|NCT00467779|58701366|FG003|Stage 1|Withdrawal by Subject|0|||
30687328|NCT00467779|58701367|FG004|Stage 1|Withdrawal by Subject|0|||
30687329|NCT00467779|58701368|FG005|Stage 1|Withdrawal by Subject|0|||
30687330|NCT00467779|58701369|FG006|Stage 1|Withdrawal by Subject|1|||
30784560|NCT03517540|58797102|FG003|Overall Study|Withdrawal by Subject|3|||
30598854|NCT01035463|58610620|FG003|Overall Study|Disease progression|0|||
30598855|NCT01035463|58610621|FG004|Overall Study|Disease progression|0|||
30687331|NCT00467779|58701370|FG007|Stage 1|Withdrawal by Subject|1|||
30687332|NCT00467779|58701371|FG008|Stage 1|Withdrawal by Subject|0|||
30687333|NCT00467779|58701372|FG009|Stage 1|Withdrawal by Subject|0|||
30598856|NCT01035463|58610622|FG005|Overall Study|Disease progression|3|||
30598857|NCT01035463|58610617|FG000|Overall Study|Other Malignancy|0|||
30598858|NCT01035463|58610618|FG001|Overall Study|Other Malignancy|0|||
30598859|NCT01035463|58610619|FG002|Overall Study|Other Malignancy|0|||
30784561|NCT02799082|58797114|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
30784562|NCT02799082|58797115|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
30784563|NCT02799082|58797114|FG000|Overall Study|Protocol Violation|0|||
30784564|NCT02799082|58797115|FG001|Overall Study|Protocol Violation|1|||
30784565|NCT03710889|58797121|FG000|Overall Study|Adverse Event|2|||
30784566|NCT03710889|58797121|FG000|Overall Study|Protocol Deviation|1|||
30784567|NCT02797678|58797125|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
30784568|NCT02797678|58797126|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
30784569|NCT02797678|58797127|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
30784570|NCT02797678|58797128|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
30784571|NCT02797678|58797125|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
30784572|NCT02797678|58797126|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
30784573|NCT02797678|58797127|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
30784574|NCT02797678|58797128|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
30784575|NCT02797678|58797125|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
30784576|NCT02797678|58797126|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
30784577|NCT02797678|58797127|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
30784578|NCT02797678|58797128|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
30784579|NCT03308942|58797146|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
30784580|NCT03308942|58797147|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
30784581|NCT03308942|58797148|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
30784582|NCT03308942|58797149|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
30784583|NCT03308942|58797150|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
30784584|NCT03308942|58797146|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
30784585|NCT03308942|58797147|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
30784586|NCT03308942|58797148|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
30784587|NCT03308942|58797149|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
30784588|NCT03308942|58797150|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
30784589|NCT03308942|58797146|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
30784590|NCT03308942|58797147|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
30784591|NCT03308942|58797148|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
30784592|NCT03308942|58797149|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
30784593|NCT03308942|58797150|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
30784594|NCT03308942|58797146|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
30784595|NCT03308942|58797147|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
30784596|NCT03308942|58797148|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
30784597|NCT03308942|58797149|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
30784598|NCT03308942|58797150|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
30784599|NCT03308942|58797146|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
30784600|NCT03308942|58797147|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
30784601|NCT03308942|58797148|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
30784602|NCT03308942|58797149|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
30784603|NCT03308942|58797150|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
30784604|NCT03308942|58797146|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
30784605|NCT03308942|58797147|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
30784606|NCT03308942|58797148|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
30784607|NCT03308942|58797149|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
30784608|NCT03308942|58797150|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
30784609|NCT03308942|58797146|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
30784610|NCT03308942|58797147|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
30784611|NCT03308942|58797148|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
30784612|NCT03308942|58797149|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
30784613|NCT03308942|58797150|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
30784614|NCT03308786|58797163|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
30784615|NCT03274076|58797170|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
30784616|NCT03274076|58797171|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
30784617|NCT03274076|58797172|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
30784618|NCT03274076|58797173|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
30784619|NCT03274076|58797170|FG000|24 Weeks Open Label|Adverse Event|0|||
30784620|NCT03274076|58797171|FG001|24 Weeks Open Label|Adverse Event|0|||
30784621|NCT03274076|58797172|FG002|24 Weeks Open Label|Adverse Event|2|||
30959252|NCT01684943|59024705|FG000|Overall Study|Inadequate Venous Access|3|||
30598860|NCT01035463|58610620|FG003|Overall Study|Other Malignancy|0|||
30784622|NCT03274076|58797173|FG003|24 Weeks Open Label|Adverse Event|0|||
30856258|NCT03194542|58884089|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
30784623|NCT03274076|58797170|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
30784624|NCT03274076|58797171|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
30784625|NCT03274076|58797172|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
30784626|NCT03274076|58797173|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
30784627|NCT02797522|58797203|FG000|Overall Study|Study Terminated by Sponsor|0|||
30784628|NCT02797522|58797204|FG001|Overall Study|Study Terminated by Sponsor|0|||
30784629|NCT02797522|58797205|FG002|Overall Study|Study Terminated by Sponsor|0|||
30784630|NCT02797522|58797206|FG003|Overall Study|Study Terminated by Sponsor|0|||
30784631|NCT02797522|58797207|FG004|Overall Study|Study Terminated by Sponsor|0|||
30784632|NCT02797522|58797208|FG005|Overall Study|Study Terminated by Sponsor|0|||
30784633|NCT02797522|58797209|FG006|Overall Study|Study Terminated by Sponsor|0|||
30784634|NCT02797522|58797210|FG007|Overall Study|Study Terminated by Sponsor|4|||
30784635|NCT02797522|58797211|FG008|Overall Study|Study Terminated by Sponsor|2|||
30784636|NCT02797522|58797212|FG009|Overall Study|Study Terminated by Sponsor|4|||
30784637|NCT02797522|58797213|FG010|Overall Study|Study Terminated by Sponsor|1|||
30784638|NCT02659514|58797252|FG000|Overall Study|Adverse Event|3|||
30784639|NCT02659514|58797253|FG001|Overall Study|Adverse Event|12|||
30784640|NCT02659514|58797252|FG000|Overall Study|Disease Progression|23|||
30784641|NCT02659514|58797253|FG001|Overall Study|Disease Progression|13|||
30784642|NCT02659514|58797252|FG000|Overall Study|Withdrawal by Subject|0|||
30784643|NCT02659514|58797253|FG001|Overall Study|Withdrawal by Subject|4|||
30784644|NCT02659514|58797252|FG000|Overall Study|Lost to Follow-up|0|||
30856259|NCT03194542|58884090|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
30856260|NCT03194542|58884091|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
30959253|NCT01684943|59024706|FG001|Overall Study|Inadequate Venous Access|0|||
30784645|NCT02659514|58797253|FG001|Overall Study|Lost to Follow-up|1|||
30784646|NCT02659514|58797252|FG000|Overall Study|Death|6|||
30784647|NCT02659514|58797253|FG001|Overall Study|Death|1|||
30784648|NCT02659514|58797252|FG000|Overall Study|Reason Unspecified|0|||
30784649|NCT02659514|58797253|FG001|Overall Study|Reason Unspecified|3|||
30784650|NCT04570670|58797261|FG000|Overall Study|Withdrawal by Subject|1|||
30784651|NCT04570670|58797262|FG001|Overall Study|Withdrawal by Subject|0|||
30784652|NCT02797132|58797268|FG000|Part A (15 Days)|Adverse Event|1|||
30784653|NCT02797132|58797268|FG000|Part B (24 Weeks)|Adverse Event|3|||
30784654|NCT03270644|58797281|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
30784655|NCT03270644|58797281|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
30784656|NCT03269552|58797292|FG000|Overall Study|Adverse Event|2|||
30784657|NCT02796664|58797299|FG000|Overall Study|Withdrawal by Subject|0|||
30784658|NCT02796664|58797300|FG001|Overall Study|Withdrawal by Subject|3|||
30784659|NCT02796664|58797299|FG000|Overall Study|Noncompliance|1|||
30784660|NCT02796664|58797300|FG001|Overall Study|Noncompliance|1|||
30784661|NCT02796664|58797299|FG000|Overall Study|Death|0|||
30784662|NCT02796664|58797300|FG001|Overall Study|Death|1|||
30784663|NCT01370356|58797310|FG000|Overall Study|Death|1|||
30784664|NCT01370356|58797311|FG001|Overall Study|Death|0|||
30784665|NCT01370356|58797310|FG000|Overall Study|Lack of Efficacy|6|||
30784666|NCT01370356|58797311|FG001|Overall Study|Lack of Efficacy|28|||
30784667|NCT01370356|58797310|FG000|Overall Study|Lost to Follow-up|76|||
30784668|NCT01370356|58797311|FG001|Overall Study|Lost to Follow-up|81|||
30784669|NCT01370356|58797310|FG000|Overall Study|Withdrawal by Subject|54|||
30784670|NCT01370356|58797311|FG001|Overall Study|Withdrawal by Subject|59|||
30784671|NCT01370356|58797310|FG000|Overall Study|Reason not specified|39|||
30784672|NCT01370356|58797311|FG001|Overall Study|Reason not specified|43|||
30784673|NCT01370356|58797310|FG000|Overall Study|Protocol Violation|3|||
30784674|NCT01370356|58797311|FG001|Overall Study|Protocol Violation|3|||
30784675|NCT01370356|58797310|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
30784676|NCT01370356|58797311|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
30784677|NCT01370356|58797310|FG000|Overall Study|AE Not Related to Study Drug|1|||
30784678|NCT01370356|58797311|FG001|Overall Study|AE Not Related to Study Drug|4|||
30784679|NCT02794870|58797319|FG000|Overall Study|Withdrawal by Subject|2|||
30784680|NCT02794870|58797320|FG001|Overall Study|Withdrawal by Subject|0|||
30784681|NCT01370590|58797328|FG000|Period 1|Adverse Event|8|||
30784682|NCT01370590|58797329|FG001|Period 1|Adverse Event|4|||
30784683|NCT01370590|58797328|FG000|Period 1|Lost to Follow-up|2|||
30784684|NCT01370590|58797329|FG001|Period 1|Lost to Follow-up|2|||
30784685|NCT01370590|58797328|FG000|Period 1|Protocol Violation|2|||
30784686|NCT01370590|58797329|FG001|Period 1|Protocol Violation|2|||
30784687|NCT01370590|58797328|FG000|Period 1|Withdrawal by Subject|4|||
30784688|NCT01370590|58797329|FG001|Period 1|Withdrawal by Subject|2|||
30784689|NCT01370590|58797328|FG000|Period 1|Could not access randomization system|0|||
30784690|NCT01370590|58797329|FG001|Period 1|Could not access randomization system|1|||
30784691|NCT01370590|58797328|FG000|Crossover Washout Period|Adverse Event|1|||
30784692|NCT01370590|58797329|FG001|Crossover Washout Period|Adverse Event|4|||
30784693|NCT01370590|58797328|FG000|Crossover Washout Period|Lost to Follow-up|2|||
30784694|NCT01370590|58797329|FG001|Crossover Washout Period|Lost to Follow-up|0|||
30784695|NCT01370590|58797328|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
30784696|NCT01370590|58797329|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
30784697|NCT01370590|58797328|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
30784698|NCT01370590|58797329|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
30784699|NCT01370590|58797328|FG000|Period 2|Adverse Event|0|||
30784700|NCT01370590|58797329|FG001|Period 2|Adverse Event|1|||
30784701|NCT01370590|58797328|FG000|Period 2|Withdrawal by Subject|1|||
30784702|NCT01370590|58797329|FG001|Period 2|Withdrawal by Subject|1|||
30784703|NCT05200455|58797340|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
30784704|NCT04646109|58797347|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
30784705|NCT04646109|58797348|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
30784706|NCT04502979|58797357|FG000|Overall Study|Lost to Follow-up|1|||
30784707|NCT04502979|58797358|FG001|Overall Study|Lost to Follow-up|3|||
30784708|NCT04502979|58797357|FG000|Overall Study|Withdrawal by Subject|2|||
30784709|NCT04502979|58797358|FG001|Overall Study|Withdrawal by Subject|1|||
30784710|NCT04590027|58797366|FG000|Overall Study|Lost to Follow-up|17|||
30784711|NCT04590027|58797367|FG001|Overall Study|Lost to Follow-up|14|||
30784712|NCT04590027|58797366|FG000|Overall Study|Protocol Violation|0|||
30784713|NCT04590027|58797367|FG001|Overall Study|Protocol Violation|3|||
30784714|NCT04587453|58797379|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
30784715|NCT04587453|58797380|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
30784716|NCT02793232|58797397|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
30784717|NCT02793232|58797398|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
30784718|NCT02793232|58797399|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
30784719|NCT02793232|58797400|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
30784720|NCT02793232|58797401|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
30784721|NCT02793232|58797402|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
30784722|NCT02793232|58797403|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
30784723|NCT02793232|58797404|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
30784724|NCT02793232|58797405|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
30784725|NCT04584645|58797441|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
30784726|NCT04584645|58797442|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
30784727|NCT03695367|58797468|FG000|Overall Study|Missed the Day 28 visit.|1|||
30784728|NCT03695367|58797469|FG001|Overall Study|Missed the Day 28 visit.|0|||
30784729|NCT03695367|58797468|FG000|Overall Study|Lost to Follow-up|0|||
30784730|NCT03695367|58797469|FG001|Overall Study|Lost to Follow-up|1|||
30784731|NCT03695367|58797468|FG000|Overall Study|Withdrawal by Subject|0|||
30784732|NCT03695367|58797469|FG001|Overall Study|Withdrawal by Subject|1|||
30784733|NCT03695367|58797468|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
30784734|NCT03695367|58797469|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
30687334|NCT00467779|58701373|FG010|Stage 1|Withdrawal by Subject|0|||
30687335|NCT00467779|58701374|FG011|Stage 1|Withdrawal by Subject|0|||
30687336|NCT00467779|58701375|FG012|Stage 1|Withdrawal by Subject|0|||
30687337|NCT00467779|58701376|FG013|Stage 1|Withdrawal by Subject|0|||
30687338|NCT00467779|58701377|FG014|Stage 1|Withdrawal by Subject|0|||
30687339|NCT00467779|58701363|FG000|Stage 1A|Adverse Event|0|||
30687340|NCT00467779|58701364|FG001|Stage 1A|Adverse Event|0|||
30687341|NCT00467779|58701365|FG002|Stage 1A|Adverse Event|0|||
30687342|NCT00467779|58701366|FG003|Stage 1A|Adverse Event|0|||
30687343|NCT00467779|58701367|FG004|Stage 1A|Adverse Event|0|||
30687344|NCT00467779|58701368|FG005|Stage 1A|Adverse Event|0|||
30687345|NCT00467779|58701369|FG006|Stage 1A|Adverse Event|0|||
30687346|NCT00467779|58701370|FG007|Stage 1A|Adverse Event|0|||
30687347|NCT00467779|58701371|FG008|Stage 1A|Adverse Event|0|||
30687348|NCT00467779|58701372|FG009|Stage 1A|Adverse Event|0|||
30687349|NCT00467779|58701373|FG010|Stage 1A|Adverse Event|0|||
30687350|NCT00467779|58701374|FG011|Stage 1A|Adverse Event|0|||
30687351|NCT00467779|58701375|FG012|Stage 1A|Adverse Event|1|||
30687352|NCT00467779|58701376|FG013|Stage 1A|Adverse Event|0|||
30687353|NCT00467779|58701377|FG014|Stage 1A|Adverse Event|0|||
30687354|NCT00467779|58701363|FG000|Stage 1A|Death|0|||
30687355|NCT00467779|58701364|FG001|Stage 1A|Death|0|||
30687356|NCT00467779|58701365|FG002|Stage 1A|Death|0|||
30687357|NCT00467779|58701366|FG003|Stage 1A|Death|0|||
30784735|NCT02794480|58797477|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
30687358|NCT00467779|58701367|FG004|Stage 1A|Death|0|||
30687359|NCT00467779|58701368|FG005|Stage 1A|Death|0|||
30687360|NCT00467779|58701369|FG006|Stage 1A|Death|0|||
30687361|NCT00467779|58701370|FG007|Stage 1A|Death|0|||
30687362|NCT00467779|58701371|FG008|Stage 1A|Death|0|||
30687363|NCT00467779|58701372|FG009|Stage 1A|Death|0|||
30687364|NCT00467779|58701373|FG010|Stage 1A|Death|0|||
30687365|NCT00467779|58701374|FG011|Stage 1A|Death|1|||
30687366|NCT00467779|58701375|FG012|Stage 1A|Death|1|||
30687367|NCT00467779|58701376|FG013|Stage 1A|Death|0|||
30687368|NCT00467779|58701377|FG014|Stage 1A|Death|0|||
30687369|NCT00467779|58701363|FG000|Stage 1A|Disease Progression|0|||
30687370|NCT00467779|58701364|FG001|Stage 1A|Disease Progression|0|||
30687371|NCT00467779|58701365|FG002|Stage 1A|Disease Progression|0|||
30687372|NCT00467779|58701366|FG003|Stage 1A|Disease Progression|0|||
30687373|NCT00467779|58701367|FG004|Stage 1A|Disease Progression|0|||
30687374|NCT00467779|58701368|FG005|Stage 1A|Disease Progression|0|||
30687375|NCT00467779|58701369|FG006|Stage 1A|Disease Progression|0|||
30687376|NCT00467779|58701370|FG007|Stage 1A|Disease Progression|0|||
30687377|NCT00467779|58701371|FG008|Stage 1A|Disease Progression|0|||
30687378|NCT00467779|58701372|FG009|Stage 1A|Disease Progression|2|||
30687379|NCT00467779|58701373|FG010|Stage 1A|Disease Progression|2|||
30687380|NCT00467779|58701374|FG011|Stage 1A|Disease Progression|5|||
30687381|NCT00467779|58701375|FG012|Stage 1A|Disease Progression|2|||
30687382|NCT00467779|58701376|FG013|Stage 1A|Disease Progression|0|||
30687383|NCT00467779|58701377|FG014|Stage 1A|Disease Progression|0|||
30687384|NCT00467779|58701363|FG000|Stage 1A|Physician Decision|0|||
30687385|NCT00467779|58701364|FG001|Stage 1A|Physician Decision|0|||
30687386|NCT00467779|58701365|FG002|Stage 1A|Physician Decision|0|||
30687387|NCT00467779|58701366|FG003|Stage 1A|Physician Decision|0|||
30687388|NCT00467779|58701367|FG004|Stage 1A|Physician Decision|0|||
30687389|NCT00467779|58701368|FG005|Stage 1A|Physician Decision|0|||
30687390|NCT00467779|58701369|FG006|Stage 1A|Physician Decision|0|||
30687391|NCT00467779|58701370|FG007|Stage 1A|Physician Decision|0|||
30687392|NCT00467779|58701371|FG008|Stage 1A|Physician Decision|0|||
30687393|NCT00467779|58701372|FG009|Stage 1A|Physician Decision|1|||
30687394|NCT00467779|58701373|FG010|Stage 1A|Physician Decision|0|||
30687395|NCT00467779|58701374|FG011|Stage 1A|Physician Decision|0|||
30687396|NCT00467779|58701375|FG012|Stage 1A|Physician Decision|0|||
30687397|NCT00467779|58701376|FG013|Stage 1A|Physician Decision|0|||
30687398|NCT00467779|58701377|FG014|Stage 1A|Physician Decision|0|||
30687399|NCT00467779|58701363|FG000|Stage 1A|Withdrawal by Subject|0|||
30687400|NCT00467779|58701364|FG001|Stage 1A|Withdrawal by Subject|0|||
30687401|NCT00467779|58701365|FG002|Stage 1A|Withdrawal by Subject|0|||
30687402|NCT00467779|58701366|FG003|Stage 1A|Withdrawal by Subject|0|||
30687403|NCT00467779|58701367|FG004|Stage 1A|Withdrawal by Subject|0|||
30687404|NCT00467779|58701368|FG005|Stage 1A|Withdrawal by Subject|0|||
30687405|NCT00467779|58701369|FG006|Stage 1A|Withdrawal by Subject|0|||
30687406|NCT00467779|58701370|FG007|Stage 1A|Withdrawal by Subject|0|||
30687407|NCT00467779|58701371|FG008|Stage 1A|Withdrawal by Subject|0|||
30687408|NCT00467779|58701372|FG009|Stage 1A|Withdrawal by Subject|0|||
30687409|NCT00467779|58701373|FG010|Stage 1A|Withdrawal by Subject|1|||
30687410|NCT00467779|58701374|FG011|Stage 1A|Withdrawal by Subject|1|||
30687411|NCT00467779|58701375|FG012|Stage 1A|Withdrawal by Subject|1|||
30687412|NCT00467779|58701376|FG013|Stage 1A|Withdrawal by Subject|0|||
30687413|NCT00467779|58701377|FG014|Stage 1A|Withdrawal by Subject|0|||
30687414|NCT00467779|58701363|FG000|Stage 1A|Unspecified Reason|0|||
30687415|NCT00467779|58701364|FG001|Stage 1A|Unspecified Reason|0|||
30784736|NCT02794480|58797478|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
30784737|NCT02794480|58797479|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
30784738|NCT02794480|58797480|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
30784739|NCT02794480|58797477|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
30784740|NCT02794480|58797478|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
30784741|NCT02794480|58797479|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
30784742|NCT02794480|58797480|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
30784743|NCT02794480|58797477|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30784744|NCT02794480|58797478|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30784745|NCT02794480|58797479|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
30784746|NCT02794480|58797480|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
30784747|NCT02794480|58797477|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30784748|NCT02794480|58797478|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
30687416|NCT00467779|58701365|FG002|Stage 1A|Unspecified Reason|0|||
30687417|NCT00467779|58701366|FG003|Stage 1A|Unspecified Reason|0|||
30687418|NCT00467779|58701367|FG004|Stage 1A|Unspecified Reason|0|||
30687419|NCT00467779|58701368|FG005|Stage 1A|Unspecified Reason|0|||
30687420|NCT00467779|58701369|FG006|Stage 1A|Unspecified Reason|0|||
30687421|NCT00467779|58701370|FG007|Stage 1A|Unspecified Reason|0|||
30687422|NCT00467779|58701371|FG008|Stage 1A|Unspecified Reason|0|||
30687423|NCT00467779|58701372|FG009|Stage 1A|Unspecified Reason|0|||
30687424|NCT00467779|58701373|FG010|Stage 1A|Unspecified Reason|0|||
30687425|NCT00467779|58701374|FG011|Stage 1A|Unspecified Reason|1|||
30687426|NCT00467779|58701375|FG012|Stage 1A|Unspecified Reason|1|||
30687427|NCT00467779|58701376|FG013|Stage 1A|Unspecified Reason|0|||
30687428|NCT00467779|58701377|FG014|Stage 1A|Unspecified Reason|0|||
30687429|NCT00467779|58701363|FG000|Stage 2|Adverse Event|0|||
30687430|NCT00467779|58701364|FG001|Stage 2|Adverse Event|0|||
30687431|NCT00467779|58701365|FG002|Stage 2|Adverse Event|0|||
30687432|NCT00467779|58701366|FG003|Stage 2|Adverse Event|0|||
30687433|NCT00467779|58701367|FG004|Stage 2|Adverse Event|0|||
30687434|NCT00467779|58701368|FG005|Stage 2|Adverse Event|0|||
30687435|NCT00467779|58701369|FG006|Stage 2|Adverse Event|0|||
30687436|NCT00467779|58701370|FG007|Stage 2|Adverse Event|0|||
30687437|NCT00467779|58701371|FG008|Stage 2|Adverse Event|1|||
30687438|NCT00467779|58701372|FG009|Stage 2|Adverse Event|0|||
30687439|NCT00467779|58701373|FG010|Stage 2|Adverse Event|0|||
30687440|NCT00467779|58701374|FG011|Stage 2|Adverse Event|0|||
30687441|NCT00467779|58701375|FG012|Stage 2|Adverse Event|0|||
30687442|NCT00467779|58701376|FG013|Stage 2|Adverse Event|0|||
30687443|NCT00467779|58701377|FG014|Stage 2|Adverse Event|0|||
30687444|NCT00467779|58701363|FG000|Stage 2|Death|0|||
30687445|NCT00467779|58701364|FG001|Stage 2|Death|0|||
30687446|NCT00467779|58701365|FG002|Stage 2|Death|0|||
30687447|NCT00467779|58701366|FG003|Stage 2|Death|0|||
30687448|NCT00467779|58701367|FG004|Stage 2|Death|0|||
30687449|NCT00467779|58701368|FG005|Stage 2|Death|0|||
30687450|NCT00467779|58701369|FG006|Stage 2|Death|0|||
30687451|NCT00467779|58701370|FG007|Stage 2|Death|0|||
30687452|NCT00467779|58701371|FG008|Stage 2|Death|1|||
30687453|NCT00467779|58701372|FG009|Stage 2|Death|0|||
30687454|NCT00467779|58701373|FG010|Stage 2|Death|0|||
30687455|NCT00467779|58701374|FG011|Stage 2|Death|0|||
30687456|NCT00467779|58701375|FG012|Stage 2|Death|0|||
30687457|NCT00467779|58701376|FG013|Stage 2|Death|0|||
30687458|NCT00467779|58701377|FG014|Stage 2|Death|0|||
30687459|NCT00467779|58701363|FG000|Stage 2|Disease Progression|0|||
30687460|NCT00467779|58701364|FG001|Stage 2|Disease Progression|0|||
30687461|NCT00467779|58701365|FG002|Stage 2|Disease Progression|0|||
30687462|NCT00467779|58701366|FG003|Stage 2|Disease Progression|0|||
30687463|NCT00467779|58701367|FG004|Stage 2|Disease Progression|0|||
30687464|NCT00467779|58701368|FG005|Stage 2|Disease Progression|0|||
30687465|NCT00467779|58701369|FG006|Stage 2|Disease Progression|0|||
30687466|NCT00467779|58701370|FG007|Stage 2|Disease Progression|0|||
30687467|NCT00467779|58701371|FG008|Stage 2|Disease Progression|16|||
30784749|NCT02794480|58797479|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
30784750|NCT02794480|58797480|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
30784751|NCT02794480|58797477|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
30784752|NCT02794480|58797478|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30784753|NCT02794480|58797479|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
30784754|NCT02794480|58797480|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
30784755|NCT04558125|58797488|FG000|Overall Study|Death|1|||
30784756|NCT02793622|58797494|FG000|Overall Study|Lost to Follow-up|31|||
30784757|NCT02793622|58797495|FG001|Overall Study|Lost to Follow-up|19|||
30784758|NCT02793622|58797494|FG000|Overall Study|Withdrawal by Subject|21|||
30784759|NCT02793622|58797495|FG001|Overall Study|Withdrawal by Subject|17|||
30784760|NCT02793622|58797494|FG000|Overall Study|Adverse Event|0|||
30784761|NCT02793622|58797495|FG001|Overall Study|Adverse Event|1|||
30784762|NCT02793622|58797494|FG000|Overall Study|Protocol Violation|1|||
30784763|NCT02793622|58797495|FG001|Overall Study|Protocol Violation|5|||
30784764|NCT04493931|58797508|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
30784765|NCT04493931|58797509|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
30784766|NCT04493931|58797510|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
30784767|NCT04493931|58797511|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
30784768|NCT04493931|58797512|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
30784769|NCT04493931|58797513|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
30784770|NCT04493931|58797514|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
30784771|NCT04493931|58797508|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
30784772|NCT04493931|58797509|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
30856261|NCT02717611|58884108|FG000|Overall Study|Death|13|||
30856262|NCT02717611|58884108|FG000|Overall Study|Withdrawal by Subject|6|||
30856263|NCT02717611|58884108|FG000|Overall Study|Active, not recruiting|40|||
30687468|NCT00467779|58701372|FG009|Stage 2|Disease Progression|0|||
30687469|NCT00467779|58701373|FG010|Stage 2|Disease Progression|0|||
30687470|NCT00467779|58701374|FG011|Stage 2|Disease Progression|0|||
30687471|NCT00467779|58701375|FG012|Stage 2|Disease Progression|0|||
30687472|NCT00467779|58701376|FG013|Stage 2|Disease Progression|0|||
30687473|NCT00467779|58701377|FG014|Stage 2|Disease Progression|0|||
30687474|NCT00467779|58701363|FG000|Stage 2|Unspecified Reason|0|||
30687475|NCT00467779|58701364|FG001|Stage 2|Unspecified Reason|0|||
30687476|NCT00467779|58701365|FG002|Stage 2|Unspecified Reason|0|||
30687477|NCT00467779|58701366|FG003|Stage 2|Unspecified Reason|0|||
30687478|NCT00467779|58701367|FG004|Stage 2|Unspecified Reason|0|||
30687479|NCT00467779|58701368|FG005|Stage 2|Unspecified Reason|0|||
30687480|NCT00467779|58701369|FG006|Stage 2|Unspecified Reason|0|||
30687481|NCT00467779|58701370|FG007|Stage 2|Unspecified Reason|0|||
30687482|NCT00467779|58701371|FG008|Stage 2|Unspecified Reason|3|||
30687483|NCT00467779|58701372|FG009|Stage 2|Unspecified Reason|0|||
30687484|NCT00467779|58701373|FG010|Stage 2|Unspecified Reason|0|||
30784773|NCT04493931|58797510|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
30784774|NCT04493931|58797511|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
30784775|NCT04493931|58797512|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
30784776|NCT04493931|58797513|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
30784777|NCT04493931|58797514|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
30784778|NCT04493931|58797508|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
30784779|NCT04493931|58797509|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
30784780|NCT04493931|58797510|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
30784781|NCT04493931|58797511|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
30784782|NCT04493931|58797512|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
30784783|NCT04493931|58797513|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
30784784|NCT04493931|58797514|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
30784785|NCT04493931|58797508|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
30784786|NCT04493931|58797509|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
30784787|NCT04493931|58797510|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
30784788|NCT04493931|58797511|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
30784789|NCT04493931|58797512|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
30784790|NCT04493931|58797513|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
30784791|NCT04493931|58797514|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
30784792|NCT03437278|58797547|FG000|Overall Study|Adverse Event|0|||
30784793|NCT03437278|58797548|FG001|Overall Study|Adverse Event|0|||
30784794|NCT03437278|58797549|FG002|Overall Study|Adverse Event|1|||
30784795|NCT03437278|58797547|FG000|Overall Study|Progressive disease|1|||
30784796|NCT03437278|58797548|FG001|Overall Study|Progressive disease|0|||
30784797|NCT03437278|58797549|FG002|Overall Study|Progressive disease|0|||
30784798|NCT03437278|58797547|FG000|Overall Study|Physician Decision|1|||
30784799|NCT03437278|58797548|FG001|Overall Study|Physician Decision|0|||
30784800|NCT03437278|58797549|FG002|Overall Study|Physician Decision|1|||
30784801|NCT04553913|58797559|FG000|Overall Study|patient's block resolved prior to PACU|1|||
30784802|NCT04553913|58797559|FG000|Overall Study|did not use the device properly|5|||
30784803|NCT04490499|58797564|FG000|Overall Study|Withdrawal by Subject|2|||
30784804|NCT01332994|58797568|FG000|Overall Study|Adverse Event|34|||
30598861|NCT01035463|58610621|FG004|Overall Study|Other Malignancy|0|||
30687485|NCT00467779|58701374|FG011|Stage 2|Unspecified Reason|0|||
30687486|NCT00467779|58701375|FG012|Stage 2|Unspecified Reason|0|||
30687487|NCT00467779|58701376|FG013|Stage 2|Unspecified Reason|0|||
30687488|NCT00467779|58701377|FG014|Stage 2|Unspecified Reason|0|||
30687489|NCT00467779|58701363|FG000|Stage 2A|Adverse Event|0|||
30687490|NCT00467779|58701364|FG001|Stage 2A|Adverse Event|0|||
30687491|NCT00467779|58701365|FG002|Stage 2A|Adverse Event|0|||
30687492|NCT00467779|58701366|FG003|Stage 2A|Adverse Event|0|||
30687493|NCT00467779|58701367|FG004|Stage 2A|Adverse Event|0|||
30687494|NCT00467779|58701368|FG005|Stage 2A|Adverse Event|0|||
30687495|NCT00467779|58701369|FG006|Stage 2A|Adverse Event|0|||
30687496|NCT00467779|58701370|FG007|Stage 2A|Adverse Event|0|||
30687497|NCT00467779|58701371|FG008|Stage 2A|Adverse Event|0|||
30687498|NCT00467779|58701372|FG009|Stage 2A|Adverse Event|0|||
30687499|NCT00467779|58701373|FG010|Stage 2A|Adverse Event|0|||
30687500|NCT00467779|58701374|FG011|Stage 2A|Adverse Event|0|||
30687501|NCT00467779|58701375|FG012|Stage 2A|Adverse Event|0|||
30687502|NCT00467779|58701376|FG013|Stage 2A|Adverse Event|2|||
30687503|NCT00467779|58701377|FG014|Stage 2A|Adverse Event|0|||
30687504|NCT00467779|58701363|FG000|Stage 2A|Death|0|||
30687505|NCT00467779|58701364|FG001|Stage 2A|Death|0|||
30687506|NCT00467779|58701365|FG002|Stage 2A|Death|0|||
30687507|NCT00467779|58701366|FG003|Stage 2A|Death|0|||
30856264|NCT02717611|58884108|FG000|Overall Study|Complicating disease|1|||
30598862|NCT01035463|58610622|FG005|Overall Study|Other Malignancy|2|||
30598863|NCT01035463|58610617|FG000|Overall Study|Other|0|||
30598864|NCT01035463|58610618|FG001|Overall Study|Other|0|||
30598865|NCT01035463|58610619|FG002|Overall Study|Other|0|||
30598866|NCT01035463|58610620|FG003|Overall Study|Other|1|||
30598867|NCT01035463|58610621|FG004|Overall Study|Other|0|||
30598868|NCT01035463|58610622|FG005|Overall Study|Other|2|||
30598869|NCT01300923|58610629|FG000|Overall Study|Physician Decision|0|||
30687508|NCT00467779|58701367|FG004|Stage 2A|Death|0|||
30687509|NCT00467779|58701368|FG005|Stage 2A|Death|0|||
30687510|NCT00467779|58701369|FG006|Stage 2A|Death|0|||
30598870|NCT01300923|58610630|FG001|Overall Study|Physician Decision|2|||
30598871|NCT01300767|58610635|FG000|Overall Study|Discomfort|2|||
30687511|NCT00467779|58701370|FG007|Stage 2A|Death|0|||
30687512|NCT00467779|58701371|FG008|Stage 2A|Death|0|||
30598872|NCT01300767|58610635|FG000|Overall Study|Biomicroscopy|1|||
30687513|NCT00467779|58701372|FG009|Stage 2A|Death|0|||
30687514|NCT00467779|58701373|FG010|Stage 2A|Death|0|||
30687515|NCT00467779|58701374|FG011|Stage 2A|Death|0|||
30687516|NCT00467779|58701375|FG012|Stage 2A|Death|0|||
30687517|NCT00467779|58701376|FG013|Stage 2A|Death|1|||
30784805|NCT01332994|58797568|FG000|Overall Study|Death|1|||
30784806|NCT01332994|58797568|FG000|Overall Study|Lack of Efficacy|1|||
30784807|NCT01332994|58797568|FG000|Overall Study|Lost to Follow-up|4|||
30784808|NCT01332994|58797568|FG000|Overall Study|Protocol Violation|6|||
30784809|NCT01332994|58797568|FG000|Overall Study|Withdrawal by Subject|15|||
30784810|NCT01332994|58797568|FG000|Overall Study|Administrative Problem|2|||
30784811|NCT01332994|58797568|FG000|Overall Study|Other|8|||
30784812|NCT03698331|58797574|FG000|Overall Study|Adverse Event|2|||
30784813|NCT03698331|58797575|FG001|Overall Study|Adverse Event|3|||
30784814|NCT03698331|58797574|FG000|Overall Study|Withdrawal by Subject|1|||
30784815|NCT03698331|58797575|FG001|Overall Study|Withdrawal by Subject|1|||
30784816|NCT03698331|58797574|FG000|Overall Study|Lost to Follow-up|0|||
30784817|NCT03698331|58797575|FG001|Overall Study|Lost to Follow-up|2|||
30784818|NCT03698331|58797574|FG000|Overall Study|Non-compliance with study drug|1|||
30784819|NCT03698331|58797575|FG001|Overall Study|Non-compliance with study drug|0|||
30784820|NCT04889625|58797581|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
30784821|NCT04889625|58797582|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
30784822|NCT04889625|58797581|FG000|Period 1|Subject out of window|0|||
30784823|NCT04889625|58797582|FG001|Period 1|Subject out of window|1|||
30784824|NCT04889625|58797581|FG000|Period 1|Wrong add power dispensed|0|||
30784825|NCT04889625|58797582|FG001|Period 1|Wrong add power dispensed|1|||
30784826|NCT04889625|58797581|FG000|Period 1|Discontinued due to fitting guide error|1|||
30784827|NCT04889625|58797582|FG001|Period 1|Discontinued due to fitting guide error|1|||
30784828|NCT04889625|58797581|FG000|Period 2|Test article no longer available|1|||
30784829|NCT04889625|58797582|FG001|Period 2|Test article no longer available|0|||
30784830|NCT04889625|58797581|FG000|Period 2|Incorrect lens dispensed|1|||
30784831|NCT04889625|58797582|FG001|Period 2|Incorrect lens dispensed|0|||
30784832|NCT04889625|58797581|FG000|Period 2|Wrong add power dispensed|0|||
30784833|NCT04889625|58797582|FG001|Period 2|Wrong add power dispensed|1|||
30784834|NCT04883541|58797590|FG000|Overall Study|Not attending regular yoga class|16|||
30784835|NCT04883541|58797591|FG001|Overall Study|Not attending regular yoga class|0|||
30784836|NCT04883541|58797590|FG000|Overall Study|Not attending the pregnancy school|0|||
30784837|NCT04883541|58797591|FG001|Overall Study|Not attending the pregnancy school|9|||
30784838|NCT04882995|58797599|FG000|Overall Study|Withdrawal by Subject|1|||
30784839|NCT04882995|58797600|FG001|Overall Study|Withdrawal by Subject|2|||
30784840|NCT04882995|58797599|FG000|Overall Study|Protocol Violation|4|||
30784841|NCT04882995|58797600|FG001|Overall Study|Protocol Violation|4|||
30784842|NCT04882995|58797599|FG000|Overall Study|Surgery postponed due to COVID|1|||
30784843|NCT04882995|58797600|FG001|Overall Study|Surgery postponed due to COVID|1|||
30687518|NCT00467779|58701377|FG014|Stage 2A|Death|0|||
30687519|NCT00467779|58701363|FG000|Stage 2A|Disease Progression|0|||
30687520|NCT00467779|58701364|FG001|Stage 2A|Disease Progression|0|||
30687521|NCT00467779|58701365|FG002|Stage 2A|Disease Progression|0|||
30687522|NCT00467779|58701366|FG003|Stage 2A|Disease Progression|0|||
30687523|NCT00467779|58701367|FG004|Stage 2A|Disease Progression|0|||
30687524|NCT00467779|58701368|FG005|Stage 2A|Disease Progression|0|||
30687525|NCT00467779|58701369|FG006|Stage 2A|Disease Progression|0|||
30687526|NCT00467779|58701370|FG007|Stage 2A|Disease Progression|0|||
30784844|NCT04483011|58797608|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
30784845|NCT04483011|58797609|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
30784846|NCT04545567|58797619|FG000|Overall Study|tested positive for SARS-co-V2|1|||
30784847|NCT04545567|58797620|FG001|Overall Study|tested positive for SARS-co-V2|1|||
30784848|NCT04545567|58797619|FG000|Overall Study|Withdrawal by Subject|0|||
30784849|NCT04545567|58797620|FG001|Overall Study|Withdrawal by Subject|1|||
30784850|NCT04534491|58797626|FG000|Overall Study|Not completed end-of-study interview|24|||
30784851|NCT04534491|58797626|FG000|Overall Study|Non-users|70|||
30784852|NCT04534491|58797626|FG000|Overall Study|Non-verifiable users|58|||
30784853|NCT03694821|58797633|FG000|Overall Study|Study terminated|4|||
30784854|NCT03694821|58797634|FG001|Overall Study|Study terminated|8|||
30784855|NCT03694821|58797635|FG002|Overall Study|Study terminated|4|||
30784856|NCT04531527|58797643|FG000|Overall Study|Found to be Ineligible|3|||
30784857|NCT04474197|58797651|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
30856265|NCT02362035|58884112|FG000|Overall Study|Death|67|||
30687527|NCT00467779|58701371|FG008|Stage 2A|Disease Progression|0|||
30687528|NCT00467779|58701372|FG009|Stage 2A|Disease Progression|0|||
30784858|NCT04474197|58797652|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
30687529|NCT00467779|58701373|FG010|Stage 2A|Disease Progression|0|||
30784859|NCT04474197|58797653|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
30784860|NCT04474197|58797654|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
30784861|NCT02079766|58797671|FG000|Overall Study|Physician Decision|1|||
30784862|NCT02079766|58797672|FG001|Overall Study|Physician Decision|0|||
30784863|NCT02079766|58797671|FG000|Overall Study|Withdrawal by Subject|1|||
30784864|NCT02079766|58797672|FG001|Overall Study|Withdrawal by Subject|0|||
30784865|NCT04841577|58797680|FG000|Overall Study|Adverse Event|5|||
30687530|NCT00467779|58701374|FG011|Stage 2A|Disease Progression|0|||
30784866|NCT04841577|58797681|FG001|Overall Study|Adverse Event|10|||
30784867|NCT04841577|58797680|FG000|Overall Study|Lost to Follow-up|8|||
30784868|NCT04841577|58797681|FG001|Overall Study|Lost to Follow-up|7|||
30784869|NCT04841577|58797680|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
30784870|NCT04841577|58797681|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
30784871|NCT04841577|58797680|FG000|Overall Study|Other|0|||
30784872|NCT04841577|58797681|FG001|Overall Study|Other|1|||
30784873|NCT04529109|58797687|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
30784874|NCT04529109|58797688|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
30784875|NCT04528641|58797700|FG000|Overall Study|Withdrawal by Subject|0|||
30784876|NCT04528641|58797701|FG001|Overall Study|Withdrawal by Subject|0|||
30784877|NCT04528641|58797702|FG002|Overall Study|Withdrawal by Subject|0|||
30784878|NCT04528641|58797703|FG003|Overall Study|Withdrawal by Subject|1|||
30784879|NCT04528641|58797704|FG004|Overall Study|Withdrawal by Subject|0|||
30784880|NCT04528641|58797705|FG005|Overall Study|Withdrawal by Subject|1|||
30784881|NCT04527471|58797724|FG000|Overall Study|Adverse Event|1|||
30784882|NCT04527471|58797725|FG001|Overall Study|Adverse Event|0|||
30784883|NCT04527471|58797724|FG000|Overall Study|Lost to Follow-up|1|||
30784884|NCT04527471|58797725|FG001|Overall Study|Lost to Follow-up|0|||
30784885|NCT04471935|58797731|FG000|Overall Study|Withdrawal by Subject|1|||
30784886|NCT04471935|58797731|FG000|Overall Study|Deemed ineligible to participate|1|||
30784887|NCT04468347|58797739|FG000|Overall Study|Withdrawal by Subject|0|||
30784888|NCT04468347|58797740|FG001|Overall Study|Withdrawal by Subject|1|||
30784889|NCT04468347|58797741|FG002|Overall Study|Withdrawal by Subject|3|||
30784890|NCT04468347|58797742|FG003|Overall Study|Withdrawal by Subject|3|||
30598873|NCT01300767|58610635|FG000|Overall Study|Unacceptable fit|1|||
30598874|NCT01300455|58610643|FG000|Washout|Withdrawal by Subject|1|||
30598875|NCT01300455|58610644|FG001|Washout|Withdrawal by Subject|0|||
30598876|NCT01107418|58610654|FG000|Overall Study|Disease Progression|45|||
30598877|NCT01107418|58610654|FG000|Overall Study|Adverse Event|3|||
30598878|NCT01107418|58610654|FG000|Overall Study|Withdrawal by Subject|1|||
30687531|NCT00467779|58701375|FG012|Stage 2A|Disease Progression|0|||
30687532|NCT00467779|58701376|FG013|Stage 2A|Disease Progression|10|||
30687533|NCT00467779|58701377|FG014|Stage 2A|Disease Progression|0|||
30687534|NCT00467779|58701363|FG000|Stage 2A|Unspecified Reason|0|||
30687535|NCT00467779|58701364|FG001|Stage 2A|Unspecified Reason|0|||
30687536|NCT00467779|58701365|FG002|Stage 2A|Unspecified Reason|0|||
30687537|NCT00467779|58701366|FG003|Stage 2A|Unspecified Reason|0|||
30687538|NCT00467779|58701367|FG004|Stage 2A|Unspecified Reason|0|||
30687539|NCT00467779|58701368|FG005|Stage 2A|Unspecified Reason|0|||
30687540|NCT00467779|58701369|FG006|Stage 2A|Unspecified Reason|0|||
30687541|NCT00467779|58701370|FG007|Stage 2A|Unspecified Reason|0|||
30687542|NCT00467779|58701371|FG008|Stage 2A|Unspecified Reason|0|||
30687543|NCT00467779|58701372|FG009|Stage 2A|Unspecified Reason|0|||
30687544|NCT00467779|58701373|FG010|Stage 2A|Unspecified Reason|0|||
30687545|NCT00467779|58701374|FG011|Stage 2A|Unspecified Reason|0|||
30687546|NCT00467779|58701375|FG012|Stage 2A|Unspecified Reason|0|||
30687547|NCT00467779|58701376|FG013|Stage 2A|Unspecified Reason|7|||
30687548|NCT00467779|58701377|FG014|Stage 2A|Unspecified Reason|0|||
30687549|NCT00467779|58701363|FG000|Stage 2A|Withdrawal by Subject|0|||
30687550|NCT00467779|58701364|FG001|Stage 2A|Withdrawal by Subject|0|||
30687551|NCT00467779|58701365|FG002|Stage 2A|Withdrawal by Subject|0|||
30687552|NCT00467779|58701366|FG003|Stage 2A|Withdrawal by Subject|0|||
30687553|NCT00467779|58701367|FG004|Stage 2A|Withdrawal by Subject|0|||
30687554|NCT00467779|58701368|FG005|Stage 2A|Withdrawal by Subject|0|||
30687555|NCT00467779|58701369|FG006|Stage 2A|Withdrawal by Subject|0|||
30687556|NCT00467779|58701370|FG007|Stage 2A|Withdrawal by Subject|0|||
30687557|NCT00467779|58701371|FG008|Stage 2A|Withdrawal by Subject|0|||
30687558|NCT00467779|58701372|FG009|Stage 2A|Withdrawal by Subject|0|||
30687559|NCT00467779|58701373|FG010|Stage 2A|Withdrawal by Subject|0|||
30784891|NCT04468347|58797739|FG000|Overall Study|Lost to Follow-up|0|||
30598879|NCT01107418|58610654|FG000|Overall Study|Study Closing|1|||
30598880|NCT01107418|58610654|FG000|Overall Study|Started Other Therapy|1|||
30598881|NCT01107418|58610654|FG000|Overall Study|Entered Extension Study|1|||
30687560|NCT00467779|58701374|FG011|Stage 2A|Withdrawal by Subject|0|||
30687561|NCT00467779|58701375|FG012|Stage 2A|Withdrawal by Subject|0|||
30687562|NCT00467779|58701376|FG013|Stage 2A|Withdrawal by Subject|1|||
30687563|NCT00467779|58701377|FG014|Stage 2A|Withdrawal by Subject|0|||
30687564|NCT00467779|58701363|FG000|Stage 3|Adverse Event|0|||
30687565|NCT00467779|58701364|FG001|Stage 3|Adverse Event|0|||
30784892|NCT04468347|58797740|FG001|Overall Study|Lost to Follow-up|0|||
30784893|NCT04468347|58797741|FG002|Overall Study|Lost to Follow-up|1|||
30784894|NCT04468347|58797742|FG003|Overall Study|Lost to Follow-up|1|||
30598882|NCT01101178|58610669|FG000|Period 1|Withdrawal by Subject|1|||
30784895|NCT04468347|58797739|FG000|Overall Study|Physician Decision|1|||
30784896|NCT04468347|58797740|FG001|Overall Study|Physician Decision|0|||
30687566|NCT00467779|58701365|FG002|Stage 3|Adverse Event|0|||
30687567|NCT00467779|58701366|FG003|Stage 3|Adverse Event|0|||
30687568|NCT00467779|58701367|FG004|Stage 3|Adverse Event|0|||
30784897|NCT04468347|58797741|FG002|Overall Study|Physician Decision|2|||
30784898|NCT04468347|58797742|FG003|Overall Study|Physician Decision|0|||
30784899|NCT04468347|58797739|FG000|Overall Study|Protocol Violation|1|||
30784900|NCT04468347|58797740|FG001|Overall Study|Protocol Violation|0|||
30784901|NCT04468347|58797741|FG002|Overall Study|Protocol Violation|0|||
30784902|NCT04468347|58797742|FG003|Overall Study|Protocol Violation|0|||
30784903|NCT04822701|58797758|FG000|Overall Study|Not treated|2|||
30784904|NCT04822701|58797759|FG001|Overall Study|Not treated|0|||
30784905|NCT04822701|58797758|FG000|Overall Study|Lost to Follow-up|1|||
30784906|NCT04822701|58797759|FG001|Overall Study|Lost to Follow-up|0|||
30784907|NCT04822701|58797758|FG000|Overall Study|Withdrawal by Subject|1|||
30784908|NCT04822701|58797759|FG001|Overall Study|Withdrawal by Subject|0|||
30784909|NCT04461795|58797765|FG000|Overall Study|Lost to Follow-up|2|||
30784910|NCT04461795|58797765|FG000|Overall Study|Withdrawal by Subject|2|||
30784911|NCT04461795|58797765|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
30784912|NCT04461015|58797772|FG000|Overall Study|IV access lost during the study|0|||
30784913|NCT04461015|58797773|FG001|Overall Study|IV access lost during the study|1|||
30784914|NCT04461015|58797772|FG000|Overall Study|Withdrawal by Subject|0|||
30784915|NCT04461015|58797773|FG001|Overall Study|Withdrawal by Subject|1|||
30784916|NCT04810221|58797779|FG000|Overall Study|Physician Decision|3|||
30687569|NCT00467779|58701368|FG005|Stage 3|Adverse Event|0|||
30687570|NCT00467779|58701369|FG006|Stage 3|Adverse Event|0|||
30784917|NCT03694353|58797783|FG000|Overall Study|Withdrawal by Subject|1|||
30687571|NCT00467779|58701370|FG007|Stage 3|Adverse Event|0|||
30784918|NCT03694353|58797783|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
30784919|NCT04521777|58797787|FG000|Overall Study|Death|2|||
30784920|NCT04521777|58797787|FG000|Overall Study|Withdrawal by Subject|2|||
30784921|NCT03700671|58797793|FG000|Overall Study|Lack of Efficacy|1|||
30784922|NCT03700671|58797794|FG001|Overall Study|Lack of Efficacy|2|||
30784923|NCT04764669|58797806|FG000|Overall Study|Adverse Event|1|||
30784924|NCT04764669|58797807|FG001|Overall Study|Adverse Event|0|||
30784925|NCT04764669|58797808|FG002|Overall Study|Adverse Event|1|||
30784926|NCT04764669|58797809|FG003|Overall Study|Adverse Event|0|||
30784927|NCT04764669|58797806|FG000|Overall Study|Subject Choice|0|||
30784928|NCT04764669|58797807|FG001|Overall Study|Subject Choice|0|||
30784929|NCT04764669|58797808|FG002|Overall Study|Subject Choice|1|||
30784930|NCT04764669|58797809|FG003|Overall Study|Subject Choice|0|||
30784931|NCT04764669|58797806|FG000|Overall Study|Withdrawal by Subject|2|||
30784932|NCT04764669|58797807|FG001|Overall Study|Withdrawal by Subject|0|||
30784933|NCT04764669|58797808|FG002|Overall Study|Withdrawal by Subject|0|||
30784934|NCT04764669|58797809|FG003|Overall Study|Withdrawal by Subject|0|||
30784935|NCT04439253|58797819|FG000|Overall Study|Adverse Event|1|||
30784936|NCT04439253|58797819|FG000|Overall Study|Disease progression|2|||
30784937|NCT04439253|58797819|FG000|Overall Study|Complicating disease|1|||
30784938|NCT04438785|58797825|FG000|Overall Study|change of weight, give up intervention|2|||
30784939|NCT04438785|58797826|FG001|Overall Study|change of weight, give up intervention|10|||
30784940|NCT04741503|58797834|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
30784941|NCT04741503|58797835|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
30784942|NCT04741503|58797836|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
30784943|NCT04741503|58797834|FG000|Initial Enrollment|Overquotas removed|0|||
30856266|NCT02362035|58884112|FG000|Overall Study|Lost to Follow-up|3|||
30856267|NCT02362035|58884112|FG000|Overall Study|Adverse Event|1|||
30687572|NCT00467779|58701371|FG008|Stage 3|Adverse Event|0|||
30687573|NCT00467779|58701372|FG009|Stage 3|Adverse Event|0|||
30687574|NCT00467779|58701373|FG010|Stage 3|Adverse Event|0|||
30687575|NCT00467779|58701374|FG011|Stage 3|Adverse Event|0|||
30687576|NCT00467779|58701375|FG012|Stage 3|Adverse Event|0|||
30687577|NCT00467779|58701376|FG013|Stage 3|Adverse Event|0|||
30687578|NCT00467779|58701377|FG014|Stage 3|Adverse Event|2|||
30687579|NCT00467779|58701363|FG000|Stage 3|Death|0|||
30687580|NCT00467779|58701364|FG001|Stage 3|Death|0|||
30687581|NCT00467779|58701365|FG002|Stage 3|Death|0|||
30687582|NCT00467779|58701366|FG003|Stage 3|Death|0|||
30687583|NCT00467779|58701367|FG004|Stage 3|Death|0|||
30687584|NCT00467779|58701368|FG005|Stage 3|Death|0|||
30687585|NCT00467779|58701369|FG006|Stage 3|Death|0|||
30687586|NCT00467779|58701370|FG007|Stage 3|Death|0|||
30856268|NCT02362035|58884112|FG000|Overall Study|Physician Decision|1|||
30784944|NCT04741503|58797835|FG001|Initial Enrollment|Overquotas removed|0|||
30784945|NCT04741503|58797836|FG002|Initial Enrollment|Overquotas removed|186|||
30784946|NCT04741503|58797834|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
30784947|NCT04741503|58797835|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
30856269|NCT02362035|58884112|FG000|Overall Study|Subject started another cancer therapy|10|||
30687587|NCT00467779|58701371|FG008|Stage 3|Death|0|||
30687588|NCT00467779|58701372|FG009|Stage 3|Death|0|||
30687589|NCT00467779|58701373|FG010|Stage 3|Death|0|||
30687590|NCT00467779|58701374|FG011|Stage 3|Death|0|||
30687591|NCT00467779|58701375|FG012|Stage 3|Death|0|||
30687592|NCT00467779|58701376|FG013|Stage 3|Death|0|||
30687593|NCT00467779|58701377|FG014|Stage 3|Death|1|||
30687594|NCT00467779|58701363|FG000|Stage 3|Disease Progression|0|||
30687595|NCT00467779|58701364|FG001|Stage 3|Disease Progression|0|||
30687596|NCT00467779|58701365|FG002|Stage 3|Disease Progression|0|||
30687597|NCT00467779|58701366|FG003|Stage 3|Disease Progression|0|||
30687598|NCT00467779|58701367|FG004|Stage 3|Disease Progression|0|||
30687599|NCT00467779|58701368|FG005|Stage 3|Disease Progression|0|||
30687600|NCT00467779|58701369|FG006|Stage 3|Disease Progression|0|||
30687601|NCT00467779|58701370|FG007|Stage 3|Disease Progression|0|||
30687602|NCT00467779|58701371|FG008|Stage 3|Disease Progression|0|||
30784948|NCT04741503|58797836|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
30784949|NCT04734873|58797845|FG000|Overall Study|Lost to Follow-up|1|||
30784950|NCT04734873|58797846|FG001|Overall Study|Lost to Follow-up|3|||
30784951|NCT04734873|58797847|FG002|Overall Study|Lost to Follow-up|2|||
30784952|NCT04734873|58797845|FG000|Overall Study|Randomized but not dosed|1|||
30784953|NCT04734873|58797846|FG001|Overall Study|Randomized but not dosed|0|||
30784954|NCT04734873|58797847|FG002|Overall Study|Randomized but not dosed|1|||
30784955|NCT04435665|58797859|FG000|Overall Study|Lost to Follow-up|0|||
30784956|NCT04435665|58797860|FG001|Overall Study|Lost to Follow-up|0|||
30784957|NCT04435665|58797861|FG002|Overall Study|Lost to Follow-up|0|||
30784958|NCT04435665|58797862|FG003|Overall Study|Lost to Follow-up|1|||
30784959|NCT04428411|58797872|FG000|Overall Study|Lost to Follow-up|114|||
30784960|NCT04422561|58797881|FG000|Overall Study|Lost to Follow-up|25|||
30784961|NCT04422561|58797882|FG001|Overall Study|Lost to Follow-up|11|||
30784962|NCT01369498|58797892|FG000|Overall Study|Lack of Efficacy|9|||
30784963|NCT01369498|58797893|FG001|Overall Study|Lack of Efficacy|9|||
30784964|NCT01369498|58797894|FG002|Overall Study|Lack of Efficacy|1|||
30784965|NCT01369498|58797895|FG003|Overall Study|Lack of Efficacy|3|||
30784966|NCT01369498|58797892|FG000|Overall Study|Adverse Event|1|||
30784967|NCT01369498|58797893|FG001|Overall Study|Adverse Event|2|||
30598883|NCT01101178|58610670|FG001|Period 1|Withdrawal by Subject|2|||
30598884|NCT01101178|58610669|FG000|Period 1|Positive drug screen|1|||
30598885|NCT01101178|58610670|FG001|Period 1|Positive drug screen|1|||
30598886|NCT01101178|58610669|FG000|Period 1|Adverse Event|2|||
30598887|NCT01101178|58610670|FG001|Period 1|Adverse Event|1|||
30598888|NCT01101178|58610669|FG000|Period 2|Withdrawal by Subject|0|||
30598889|NCT01101178|58610670|FG001|Period 2|Withdrawal by Subject|1|||
30598890|NCT01101022|58610679|FG000|Overall Study|Adverse Event|6|||
30598891|NCT01101022|58610680|FG001|Overall Study|Adverse Event|2|||
30687603|NCT00467779|58701372|FG009|Stage 3|Disease Progression|0|||
30687604|NCT00467779|58701373|FG010|Stage 3|Disease Progression|0|||
30687605|NCT00467779|58701374|FG011|Stage 3|Disease Progression|0|||
30687606|NCT00467779|58701375|FG012|Stage 3|Disease Progression|0|||
30687607|NCT00467779|58701376|FG013|Stage 3|Disease Progression|0|||
30687608|NCT00467779|58701377|FG014|Stage 3|Disease Progression|9|||
30687609|NCT00467779|58701363|FG000|Stage 3|Unspecified Reason|0|||
30598892|NCT01101022|58610679|FG000|Overall Study|Protocol Violation|4|||
30598893|NCT01101022|58610680|FG001|Overall Study|Protocol Violation|3|||
30598894|NCT01101022|58610679|FG000|Overall Study|Withdrawal by Subject|3|||
30598895|NCT01101022|58610680|FG001|Overall Study|Withdrawal by Subject|8|||
30598896|NCT01101022|58610679|FG000|Overall Study|Lost to Follow-up|1|||
30598897|NCT01101022|58610680|FG001|Overall Study|Lost to Follow-up|4|||
30598898|NCT01101022|58610679|FG000|Overall Study|Lack of Efficacy|0|||
30598899|NCT01101022|58610680|FG001|Overall Study|Lack of Efficacy|7|||
30598900|NCT01101022|58610679|FG000|Overall Study|Sponsor decision|1|||
30598901|NCT01101022|58610680|FG001|Overall Study|Sponsor decision|1|||
30598902|NCT01101022|58610679|FG000|Overall Study|Non-compliance|1|||
30598903|NCT01101022|58610680|FG001|Overall Study|Non-compliance|0|||
30598904|NCT01101022|58610679|FG000|Overall Study|Work schedule|1|||
30598905|NCT01101022|58610680|FG001|Overall Study|Work schedule|1|||
30598906|NCT01101022|58610679|FG000|Overall Study|Vacation|0|||
30598907|NCT01101022|58610680|FG001|Overall Study|Vacation|1|||
30687610|NCT00467779|58701364|FG001|Stage 3|Unspecified Reason|0|||
30687611|NCT00467779|58701365|FG002|Stage 3|Unspecified Reason|0|||
30687612|NCT00467779|58701366|FG003|Stage 3|Unspecified Reason|0|||
30687613|NCT00467779|58701367|FG004|Stage 3|Unspecified Reason|0|||
30784968|NCT01369498|58797894|FG002|Overall Study|Adverse Event|0|||
30784969|NCT01369498|58797895|FG003|Overall Study|Adverse Event|1|||
30784970|NCT01369498|58797892|FG000|Overall Study|Withdrawal of Consent|0|||
30598908|NCT01299909|58610689|FG000|Overall Study|Lost to Follow-up|22|||
30598909|NCT01299909|58610690|FG001|Overall Study|Lost to Follow-up|18|||
30598910|NCT01299909|58610691|FG002|Overall Study|Lost to Follow-up|17|||
30598911|NCT01298661|58610701|FG000|Overall Study|Withdrawal by Subject|2|||
30598912|NCT01298661|58610702|FG001|Overall Study|Withdrawal by Subject|0|||
30687614|NCT00467779|58701368|FG005|Stage 3|Unspecified Reason|0|||
30784971|NCT01369498|58797893|FG001|Overall Study|Withdrawal of Consent|1|||
30598913|NCT01298661|58610703|FG002|Overall Study|Withdrawal by Subject|2|||
30598914|NCT01100944|58610712|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
30687615|NCT00467779|58701369|FG006|Stage 3|Unspecified Reason|0|||
30784972|NCT01369498|58797894|FG002|Overall Study|Withdrawal of Consent|1|||
30784973|NCT01369498|58797895|FG003|Overall Study|Withdrawal of Consent|1|||
30784974|NCT01369498|58797892|FG000|Overall Study|Death|0|||
30784975|NCT01369498|58797893|FG001|Overall Study|Death|0|||
30784976|NCT01369498|58797894|FG002|Overall Study|Death|1|||
30784977|NCT01369498|58797895|FG003|Overall Study|Death|0|||
30784978|NCT01369498|58797892|FG000|Overall Study|Investigator's Discretion|1|||
30784979|NCT01369498|58797893|FG001|Overall Study|Investigator's Discretion|0|||
30784980|NCT01369498|58797894|FG002|Overall Study|Investigator's Discretion|1|||
30784981|NCT01369498|58797895|FG003|Overall Study|Investigator's Discretion|3|||
30784982|NCT01369498|58797892|FG000|Overall Study|Unknown Reason|1|||
30784983|NCT01369498|58797893|FG001|Overall Study|Unknown Reason|0|||
30784984|NCT01369498|58797894|FG002|Overall Study|Unknown Reason|11|||
30784985|NCT01369498|58797895|FG003|Overall Study|Unknown Reason|6|||
30784986|NCT01369498|58797892|FG000|Overall Study|Disease Progression|0|||
30784987|NCT01369498|58797893|FG001|Overall Study|Disease Progression|0|||
30784988|NCT01369498|58797894|FG002|Overall Study|Disease Progression|0|||
30784989|NCT01369498|58797895|FG003|Overall Study|Disease Progression|1|||
30784990|NCT04709835|58797909|FG000|Overall Study|Withdrawal by Subject|0|||
30784991|NCT04709835|58797910|FG001|Overall Study|Withdrawal by Subject|1|||
30784992|NCT04709835|58797911|FG002|Overall Study|Withdrawal by Subject|0|||
30784993|NCT04407507|58797925|FG000|Overall Study|Withdrawal by Subject|0|||
30784994|NCT04407507|58797926|FG001|Overall Study|Withdrawal by Subject|1|||
30784995|NCT04698993|58797934|FG000|Overall Study|PCR results not accessible|2|||
30784996|NCT04698993|58797935|FG001|Overall Study|PCR results not accessible|7|||
30784997|NCT04698993|58797934|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
30784998|NCT04698993|58797935|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
30784999|NCT04359771|58797943|FG000|Overall Study|Lack of Efficacy|2|||
30785000|NCT04359771|58797944|FG001|Overall Study|Lack of Efficacy|2|||
30785001|NCT04356573|58797952|FG000|Overall Study|Didn't Qualify|1|||
30785002|NCT04356573|58797953|FG001|Overall Study|Didn't Qualify|0|||
30785003|NCT04352127|58797969|FG000|Overall Study|Unable to obtain readings|4|||
30785004|NCT04352127|58797970|FG001|Overall Study|Unable to obtain readings|1|||
30785005|NCT04351269|58797979|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
30785006|NCT04351269|58797980|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
30785007|NCT04351269|58797981|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
30785008|NCT04351269|58797979|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
30785009|NCT04351269|58797980|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
30785010|NCT04351269|58797981|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
30785011|NCT04351269|58797979|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
30785012|NCT04351269|58797980|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
30785013|NCT04351269|58797981|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
30785014|NCT04351269|58797979|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
30785015|NCT04351269|58797980|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
30856270|NCT02362035|58884112|FG000|Overall Study|Study terminated by sponsor|45|||
30856271|NCT02362035|58884112|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
30856272|NCT02362035|58884112|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
30856273|NCT02362035|58884112|FG000|Overall Study|Disease progression|11|||
30856274|NCT02362035|58884112|FG000|Overall Study|Withdrawal by Subject|20|||
30856275|NCT02328014|58884120|FG000|Overall Study|Adverse Event|1|||
30856276|NCT02328014|58884121|FG001|Overall Study|Adverse Event|0|||
30856277|NCT02328014|58884122|FG002|Overall Study|Adverse Event|0|||
30856278|NCT02328014|58884123|FG003|Overall Study|Adverse Event|1|||
30856279|NCT02328014|58884120|FG000|Overall Study|Death|0|||
30856280|NCT02328014|58884121|FG001|Overall Study|Death|0|||
30856281|NCT02328014|58884122|FG002|Overall Study|Death|0|||
30856282|NCT02328014|58884123|FG003|Overall Study|Death|4|||
30856283|NCT02328014|58884120|FG000|Overall Study|Physician Decision|0|||
30856284|NCT02328014|58884121|FG001|Overall Study|Physician Decision|0|||
30856285|NCT02328014|58884122|FG002|Overall Study|Physician Decision|0|||
30856286|NCT02328014|58884123|FG003|Overall Study|Physician Decision|1|||
30856287|NCT02328014|58884120|FG000|Overall Study|Disease Progression|1|||
30687616|NCT00467779|58701370|FG007|Stage 3|Unspecified Reason|0|||
30856288|NCT02328014|58884121|FG001|Overall Study|Disease Progression|0|||
30856289|NCT02328014|58884122|FG002|Overall Study|Disease Progression|1|||
30856290|NCT02328014|58884123|FG003|Overall Study|Disease Progression|3|||
30856291|NCT02328014|58884120|FG000|Overall Study|Study Terminated by Sponsor|4|||
30856292|NCT02328014|58884121|FG001|Overall Study|Study Terminated by Sponsor|1|||
30785016|NCT04351269|58797981|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
30785017|NCT04351269|58797979|FG000|Overall Study|Lost to Follow-up|1|||
30785018|NCT04351269|58797980|FG001|Overall Study|Lost to Follow-up|3|||
30785019|NCT04351269|58797981|FG002|Overall Study|Lost to Follow-up|0|||
30785020|NCT04348851|58797996|FG000|Post-Test 1|Withdrawal by Subject|0|||
30856293|NCT02328014|58884122|FG002|Overall Study|Study Terminated by Sponsor|1|||
30785021|NCT04348851|58797997|FG001|Post-Test 1|Withdrawal by Subject|1|||
30785022|NCT04348851|58797998|FG002|Post-Test 1|Withdrawal by Subject|0|||
30785023|NCT04348851|58797999|FG003|Post-Test 1|Withdrawal by Subject|0|||
30785024|NCT04348851|58797996|FG000|Post-Test 1|Lost to Follow-up|0|||
30785025|NCT04348851|58797997|FG001|Post-Test 1|Lost to Follow-up|1|||
30785026|NCT04348851|58797998|FG002|Post-Test 1|Lost to Follow-up|0|||
30785027|NCT04348851|58797999|FG003|Post-Test 1|Lost to Follow-up|0|||
30785028|NCT04348851|58797996|FG000|Post-Test 2|Stroke survivor death|0|||
30785029|NCT04348851|58797997|FG001|Post-Test 2|Stroke survivor death|1|||
30785030|NCT04348851|58797998|FG002|Post-Test 2|Stroke survivor death|0|||
30785031|NCT04348851|58797999|FG003|Post-Test 2|Stroke survivor death|1|||
30785032|NCT04346199|58798011|FG000|Overall Study|Death|8|||
30785033|NCT04346199|58798012|FG001|Overall Study|Death|9|||
30785034|NCT04346199|58798011|FG000|Overall Study|Lost to Follow-up|0|||
30785035|NCT04346199|58798012|FG001|Overall Study|Lost to Follow-up|1|||
30785036|NCT04346199|58798011|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
30785037|NCT04346199|58798012|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
30785038|NCT04346199|58798011|FG000|Overall Study|Withdrawal by Subject|5|||
30785039|NCT04346199|58798012|FG001|Overall Study|Withdrawal by Subject|1|||
30785040|NCT04345653|58798018|FG000|Overall Study|Withdrawal by Subject|2|||
30785041|NCT04342689|58798025|FG000|Overall Study|Withdrawal by Subject|32|||
30785042|NCT04342689|58798026|FG001|Overall Study|Withdrawal by Subject|33|||
30785043|NCT04342689|58798025|FG000|Overall Study|Lost to Follow-up|10|||
30785044|NCT04342689|58798026|FG001|Overall Study|Lost to Follow-up|12|||
30785045|NCT04169061|58798034|FG000|Overall Study|Adverse Event|2|||
30785046|NCT04169061|58798034|FG000|Overall Study|Death|1|||
30785047|NCT04169061|58798034|FG000|Overall Study|Withdrawal by Subject|1|||
30785048|NCT04169061|58798034|FG000|Overall Study|Protocol Violation|1|||
30785049|NCT02792218|58798040|FG000|Overall Study|Patient/guardian decision|15|||
30785050|NCT02792218|58798041|FG001|Overall Study|Patient/guardian decision|42|||
30785051|NCT02792218|58798040|FG000|Overall Study|Adverse Event|15|||
30785052|NCT02792218|58798041|FG001|Overall Study|Adverse Event|14|||
30785053|NCT02792218|58798040|FG000|Overall Study|Lost to Follow-up|10|||
30785054|NCT02792218|58798041|FG001|Overall Study|Lost to Follow-up|5|||
30785055|NCT02792218|58798040|FG000|Overall Study|Lack of Efficacy|1|||
30785056|NCT02792218|58798041|FG001|Overall Study|Lack of Efficacy|12|||
30785057|NCT02792218|58798040|FG000|Overall Study|Physician Decision|4|||
30785058|NCT02792218|58798041|FG001|Overall Study|Physician Decision|4|||
30785059|NCT02792218|58798040|FG000|Overall Study|Protocol deviation|3|||
30785060|NCT02792218|58798041|FG001|Overall Study|Protocol deviation|2|||
30785061|NCT02792218|58798040|FG000|Overall Study|New therapy for study indication|0|||
30785062|NCT02792218|58798041|FG001|Overall Study|New therapy for study indication|1|||
30785063|NCT02792218|58798040|FG000|Overall Study|Non-compliance with study treatment|0|||
30785064|NCT02792218|58798041|FG001|Overall Study|Non-compliance with study treatment|1|||
30785065|NCT02792218|58798040|FG000|Overall Study|Pregnancy|1|||
30785066|NCT02792218|58798041|FG001|Overall Study|Pregnancy|0|||
30785067|NCT00153101|58798052|FG000|Overall Study|Lost to Follow-up|14|||
30785068|NCT00153101|58798053|FG001|Overall Study|Lost to Follow-up|14|||
30785069|NCT00153101|58798054|FG002|Overall Study|Lost to Follow-up|12|||
30785070|NCT00153101|58798055|FG003|Overall Study|Lost to Follow-up|5|||
30785071|NCT00153101|58798056|FG004|Overall Study|Lost to Follow-up|5|||
30785072|NCT00153101|58798052|FG000|Overall Study|Withdrawal by Subject|3|||
30785073|NCT00153101|58798053|FG001|Overall Study|Withdrawal by Subject|4|||
30785074|NCT00153101|58798054|FG002|Overall Study|Withdrawal by Subject|3|||
30785075|NCT00153101|58798055|FG003|Overall Study|Withdrawal by Subject|3|||
30785076|NCT00153101|58798056|FG004|Overall Study|Withdrawal by Subject|5|||
30785077|NCT04401579|58798072|FG000|Overall Study|Death|23|||
30785078|NCT04401579|58798073|FG001|Overall Study|Death|36|||
30785079|NCT04401579|58798072|FG000|Overall Study|Lost to Follow-up|40|||
30785080|NCT04401579|58798073|FG001|Overall Study|Lost to Follow-up|41|||
30785081|NCT04401579|58798072|FG000|Overall Study|Withdrawal by Subject|8|||
30785082|NCT04401579|58798073|FG001|Overall Study|Withdrawal by Subject|16|||
30785083|NCT04401579|58798072|FG000|Overall Study|Physician Decision|1|||
30598915|NCT01100944|58610713|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
30856294|NCT02328014|58884123|FG003|Overall Study|Study Terminated by Sponsor|0|||
30785084|NCT04401579|58798073|FG001|Overall Study|Physician Decision|2|||
30785085|NCT04401579|58798072|FG000|Overall Study|Became ineligible after enrollment|1|||
30785086|NCT04401579|58798073|FG001|Overall Study|Became ineligible after enrollment|1|||
30785087|NCT04401579|58798072|FG000|Overall Study|Enrolled but treatment not administered|7|||
30785088|NCT04401579|58798073|FG001|Overall Study|Enrolled but treatment not administered|9|||
30785089|NCT04401579|58798072|FG000|Overall Study|Adverse Event|2|||
30785090|NCT04401579|58798073|FG001|Overall Study|Adverse Event|1|||
30785091|NCT04401579|58798072|FG000|Overall Study|Scheduling error|1|||
30785092|NCT04401579|58798073|FG001|Overall Study|Scheduling error|2|||
30785093|NCT04401579|58798072|FG000|Overall Study|Transferred to another hospital|1|||
30785094|NCT04401579|58798073|FG001|Overall Study|Transferred to another hospital|2|||
30785095|NCT04161807|58798079|FG000|Overall Study|Withdrawal by Subject|2|||
30598916|NCT01100944|58610714|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
30598917|NCT01100944|58610712|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
30598918|NCT01100944|58610713|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
30687617|NCT00467779|58701371|FG008|Stage 3|Unspecified Reason|0|||
30687618|NCT00467779|58701372|FG009|Stage 3|Unspecified Reason|0|||
30687619|NCT00467779|58701373|FG010|Stage 3|Unspecified Reason|0|||
30687620|NCT00467779|58701374|FG011|Stage 3|Unspecified Reason|0|||
30687621|NCT00467779|58701375|FG012|Stage 3|Unspecified Reason|0|||
30687622|NCT00467779|58701376|FG013|Stage 3|Unspecified Reason|0|||
30687623|NCT00467779|58701377|FG014|Stage 3|Unspecified Reason|5|||
30687624|NCT00570687|58701417|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687625|NCT00570687|58701418|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687626|NCT00570687|58701419|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687627|NCT00570687|58701420|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687628|NCT00570687|58701421|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
30687629|NCT00570687|58701422|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
30687630|NCT00570687|58701423|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
30687631|NCT00570687|58701424|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
30687632|NCT00570687|58701425|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
30687633|NCT00570687|58701426|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
30687634|NCT00570687|58701417|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687635|NCT00570687|58701418|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687636|NCT00570687|58701419|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687637|NCT00570687|58701420|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687638|NCT00570687|58701421|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687639|NCT00570687|58701422|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687640|NCT00570687|58701423|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687641|NCT00570687|58701424|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687642|NCT00570687|58701425|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
30687643|NCT00570687|58701426|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687644|NCT00570687|58701417|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687645|NCT00570687|58701418|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687646|NCT00570687|58701419|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687647|NCT00570687|58701420|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687648|NCT00570687|58701421|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687649|NCT00570687|58701422|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687650|NCT00570687|58701423|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
30687651|NCT00570687|58701424|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687652|NCT00570687|58701425|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687653|NCT00570687|58701426|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
30687654|NCT03836677|58701440|FG000|Period 1|Adverse Event|0|||
30687655|NCT03836677|58701441|FG001|Period 1|Adverse Event|1|||
30687656|NCT03836677|58701440|FG000|Period 2|Severe non-compliance to protocol|1|||
30687657|NCT03836677|58701441|FG001|Period 2|Severe non-compliance to protocol|0|||
30687658|NCT00434161|58701472|FG000|Overall Study|Adverse Event|5|||
30687659|NCT00434161|58701473|FG001|Overall Study|Adverse Event|1|||
30687660|NCT00434161|58701474|FG002|Overall Study|Adverse Event|4|||
30687661|NCT00434161|58701472|FG000|Overall Study|Lost to Follow-up|0|||
30687662|NCT00434161|58701473|FG001|Overall Study|Lost to Follow-up|1|||
30687663|NCT00434161|58701474|FG002|Overall Study|Lost to Follow-up|0|||
30687664|NCT00434161|58701472|FG000|Overall Study|Death|1|||
30687665|NCT00434161|58701473|FG001|Overall Study|Death|0|||
30687666|NCT00434161|58701474|FG002|Overall Study|Death|1|||
30687667|NCT00434161|58701472|FG000|Overall Study|Non-Compliance|1|||
30598919|NCT01100944|58610714|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
30598920|NCT01100944|58610712|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
30598921|NCT01100944|58610713|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
30598922|NCT01100944|58610714|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
30687668|NCT00434161|58701473|FG001|Overall Study|Non-Compliance|1|||
30687669|NCT00434161|58701474|FG002|Overall Study|Non-Compliance|0|||
30687670|NCT00434161|58701472|FG000|Overall Study|Withdrawal by Subject|2|||
30687671|NCT00434161|58701473|FG001|Overall Study|Withdrawal by Subject|0|||
30687672|NCT00434161|58701474|FG002|Overall Study|Withdrawal by Subject|3|||
30687673|NCT00434161|58701472|FG000|Overall Study|Logistical error study assessments|1|||
30687674|NCT00434161|58701473|FG001|Overall Study|Logistical error study assessments|0|||
30687675|NCT00434161|58701474|FG002|Overall Study|Logistical error study assessments|3|||
30687676|NCT00441103|58701491|FG000|Overall Study|Adverse Event|2|||
30687677|NCT00441103|58701492|FG001|Overall Study|Adverse Event|1|||
30687678|NCT00441103|58701491|FG000|Overall Study|Death|1|||
30687679|NCT00441103|58701492|FG001|Overall Study|Death|0|||
30687680|NCT00441103|58701491|FG000|Overall Study|Disease Progression|2|||
30785096|NCT04161807|58798079|FG000|Overall Study|Performed only 1 treatment|2|||
30785097|NCT04401423|58798085|FG000|Overall Study|Withdrawal by Subject|3|||
30785098|NCT04401423|58798086|FG001|Overall Study|Withdrawal by Subject|1|||
30785099|NCT04401423|58798085|FG000|Overall Study|Physician Decision|2|||
30785100|NCT04401423|58798086|FG001|Overall Study|Physician Decision|1|||
30785101|NCT04399161|58798097|FG000|Overall Study|Withdrawal by Subject|1|||
30856295|NCT02328014|58884120|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
30856296|NCT02328014|58884121|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
30856297|NCT02328014|58884122|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
30856298|NCT02328014|58884123|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
30687681|NCT00441103|58701492|FG001|Overall Study|Disease Progression|0|||
30687682|NCT00441103|58701491|FG000|Overall Study|Lost to Follow-up|1|||
30687683|NCT00441103|58701492|FG001|Overall Study|Lost to Follow-up|0|||
30687684|NCT00441103|58701491|FG000|Overall Study|Protocol Violation|1|||
30687685|NCT00441103|58701492|FG001|Overall Study|Protocol Violation|0|||
30687686|NCT00441103|58701491|FG000|Overall Study|Participant unable to use Rebiject II|1|||
30687687|NCT00441103|58701492|FG001|Overall Study|Participant unable to use Rebiject II|0|||
30687688|NCT00441103|58701491|FG000|Overall Study|Participant refused MRI|1|||
30687689|NCT00441103|58701492|FG001|Overall Study|Participant refused MRI|0|||
30687690|NCT00441103|58701491|FG000|Overall Study|Inclusion criteria absent|1|||
30687691|NCT00441103|58701492|FG001|Overall Study|Inclusion criteria absent|0|||
30687692|NCT00441103|58701491|FG000|Overall Study|Non-compliant|0|||
30687693|NCT00441103|58701492|FG001|Overall Study|Non-compliant|1|||
30687694|NCT00441103|58701491|FG000|Overall Study|Participant decided to withdraw|1|||
30687695|NCT00441103|58701492|FG001|Overall Study|Participant decided to withdraw|0|||
30687696|NCT00441103|58701491|FG000|Overall Study|Participant's reason|0|||
30687697|NCT00441103|58701492|FG001|Overall Study|Participant's reason|1|||
30687698|NCT00441103|58701491|FG000|Overall Study|Participant decided to stop|0|||
30687699|NCT00441103|58701492|FG001|Overall Study|Participant decided to stop|1|||
30687700|NCT00433771|58701499|FG000|Overall Study|screen fail|14|||
30687701|NCT00433771|58701499|FG000|Overall Study|Treated and later found to be ineligible|2|||
30687702|NCT00433771|58701499|FG000|Overall Study|Death|2|||
30687703|NCT00433771|58701499|FG000|Overall Study|Failure to deploy stent|1|||
30687704|NCT00433537|58701503|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
30687705|NCT00433537|58701504|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
30687706|NCT00433537|58701505|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
30687707|NCT00433537|58701503|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
30687708|NCT00433537|58701504|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
30687709|NCT00433537|58701505|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
30687710|NCT00433537|58701503|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
30687711|NCT00433537|58701504|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
30687712|NCT00433537|58701505|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
30687713|NCT00433537|58701503|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
30687714|NCT00433537|58701504|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
30687715|NCT00433537|58701505|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
30687716|NCT00433537|58701503|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
30687717|NCT00433537|58701504|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
30687718|NCT00433537|58701505|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
30687719|NCT00433537|58701503|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
30687720|NCT00433537|58701504|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
30687721|NCT00433537|58701505|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
30687722|NCT00433537|58701503|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
30687723|NCT00433537|58701504|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
30687724|NCT00433537|58701505|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
30785102|NCT04399161|58798098|FG001|Overall Study|Withdrawal by Subject|0|||
30785103|NCT04399161|58798099|FG002|Overall Study|Withdrawal by Subject|2|||
30856299|NCT02328014|58884120|FG000|Overall Study|Withdrawal by Subject|0|||
30598923|NCT01100944|58610712|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
30598924|NCT01100944|58610713|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
30598925|NCT01100944|58610714|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
30598926|NCT01100320|58610735|FG000|Period 1|Withdrawal by Subject|2|||
30598927|NCT01100320|58610736|FG001|Period 1|Withdrawal by Subject|4|||
30598928|NCT01100320|58610735|FG000|Period 1|Positive Drug Screen|1|||
30598929|NCT01100320|58610736|FG001|Period 1|Positive Drug Screen|1|||
30598930|NCT01100320|58610735|FG000|Period 1|Adverse Event|2|||
30687725|NCT00433537|58701503|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
30687726|NCT00433537|58701504|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
30687727|NCT00433537|58701505|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
30687728|NCT00433537|58701503|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
30785104|NCT04399161|58798097|FG000|Overall Study|Protocol Violation|1|||
30856300|NCT02328014|58884121|FG001|Overall Study|Withdrawal by Subject|0|||
30687729|NCT00433537|58701504|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
30687730|NCT00433537|58701505|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
30687731|NCT00570765|58701515|FG000|DB Phase|Withdrawal by Subject|1|||
30687732|NCT00570765|58701516|FG001|DB Phase|Withdrawal by Subject|0|||
30687733|NCT00570765|58701517|FG002|DB Phase|Withdrawal by Subject|0|||
30687734|NCT00570765|58701518|FG003|DB Phase|Withdrawal by Subject|0|||
30687735|NCT00570765|58701515|FG000|DB Phase|Protocol Violation|0|||
30687736|NCT00570765|58701516|FG001|DB Phase|Protocol Violation|1|||
30687737|NCT00570765|58701517|FG002|DB Phase|Protocol Violation|0|||
30687738|NCT00570765|58701518|FG003|DB Phase|Protocol Violation|0|||
30687739|NCT00570765|58701515|FG000|DB Phase|Adverse Event|3|||
30687740|NCT00570765|58701516|FG001|DB Phase|Adverse Event|6|||
30687741|NCT00570765|58701517|FG002|DB Phase|Adverse Event|0|||
30687742|NCT00570765|58701518|FG003|DB Phase|Adverse Event|0|||
30687743|NCT00570765|58701515|FG000|DB Phase|Did Not Receive Study Drug|0|||
30687744|NCT00570765|58701516|FG001|DB Phase|Did Not Receive Study Drug|0|||
30687745|NCT00570765|58701517|FG002|DB Phase|Did Not Receive Study Drug|1|||
30687746|NCT00570765|58701518|FG003|DB Phase|Did Not Receive Study Drug|0|||
30687747|NCT00570765|58701515|FG000|LTSE Phase|Withdrawal by Subject|0|||
30687748|NCT00570765|58701516|FG001|LTSE Phase|Withdrawal by Subject|0|||
30687749|NCT00570765|58701517|FG002|LTSE Phase|Withdrawal by Subject|0|||
30687750|NCT00570765|58701518|FG003|LTSE Phase|Withdrawal by Subject|1|||
30687751|NCT00570765|58701515|FG000|LTSE Phase|Adverse Event|0|||
30687752|NCT00570765|58701516|FG001|LTSE Phase|Adverse Event|0|||
30687753|NCT00570765|58701517|FG002|LTSE Phase|Adverse Event|0|||
30687754|NCT00570765|58701518|FG003|LTSE Phase|Adverse Event|7|||
30687755|NCT00570765|58701515|FG000|LTSE Phase|Physician Decision|0|||
30687756|NCT00570765|58701516|FG001|LTSE Phase|Physician Decision|0|||
30687757|NCT00570765|58701517|FG002|LTSE Phase|Physician Decision|0|||
30687758|NCT00570765|58701518|FG003|LTSE Phase|Physician Decision|4|||
30687759|NCT00667563|58701529|FG000|Overall Study|Protocol Violation|24|||
30687760|NCT00667095|58701535|FG000|Overall Study|Withdrawal by Subject|0|||
30687761|NCT00667095|58701536|FG001|Overall Study|Withdrawal by Subject|1|||
30687762|NCT00433381|58701544|FG000|Overall Study|Ineligible / no protocol treatment|3|||
30687763|NCT00433381|58701545|FG001|Overall Study|Ineligible / no protocol treatment|3|||
30687764|NCT00667017|58701559|FG000|Overall Study|Withdrawal by Subject|1|||
30687765|NCT00666705|58701563|FG000|Overall Study|Withdrawal by Subject|1|||
30687766|NCT00433147|58701576|FG000|Overall Study|Adverse Event|0|||
30687767|NCT00433147|58701577|FG001|Overall Study|Adverse Event|1|||
30687768|NCT00433147|58701578|FG002|Overall Study|Adverse Event|0|||
30687769|NCT00433147|58701579|FG003|Overall Study|Adverse Event|0|||
30687770|NCT00666237|58701591|FG000|Overall Study|Death|5|||
30687771|NCT00666237|58701592|FG001|Overall Study|Death|5|||
30687772|NCT00666237|58701591|FG000|Overall Study|Lost to Follow-up|29|||
30687773|NCT00666237|58701592|FG001|Overall Study|Lost to Follow-up|25|||
30687774|NCT00662025|58701598|FG000|Overall Study|Objective progression or relapse|51|||
30687775|NCT00662025|58701598|FG000|Overall Study|Adverse Event|7|||
30687776|NCT00662025|58701598|FG000|Overall Study|Withdrawal by Subject|1|||
30687777|NCT00662025|58701598|FG000|Overall Study|Results of other clinical study|2|||
30687778|NCT00662025|58701598|FG000|Overall Study|Target lesion cannot be evaluated|1|||
30687779|NCT00662025|58701598|FG000|Overall Study|Domestic circumstances|1|||
30687780|NCT00440947|58701602|FG000|36-Week Induction Phase|Adverse Event|16|||
30687781|NCT00440947|58701603|FG001|36-Week Induction Phase|Adverse Event|0|||
30687782|NCT00440947|58701604|FG002|36-Week Induction Phase|Adverse Event|0|||
30687783|NCT00440947|58701605|FG003|36-Week Induction Phase|Adverse Event|0|||
30687784|NCT00440947|58701606|FG004|36-Week Induction Phase|Adverse Event|0|||
30687785|NCT00440947|58701602|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
30856301|NCT02328014|58884122|FG002|Overall Study|Withdrawal by Subject|0|||
30598931|NCT01100320|58610736|FG001|Period 1|Adverse Event|2|||
30598932|NCT01100320|58610735|FG000|Period 2|Withdrawal by Subject|1|||
30598933|NCT01100320|58610736|FG001|Period 2|Withdrawal by Subject|1|||
30598934|NCT01100086|58610742|FG000|Period 1|Withdrawal by Subject|1|||
30598935|NCT01100086|58610743|FG001|Period 1|Withdrawal by Subject|0|||
30598936|NCT01297959|58610751|FG000|Overall Study|Adverse Event|0|||
30687786|NCT00440947|58701603|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
30687787|NCT00440947|58701604|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
30687788|NCT00440947|58701605|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
30687789|NCT00440947|58701606|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
30856302|NCT02328014|58884123|FG003|Overall Study|Withdrawal by Subject|1|||
30598937|NCT01297959|58610752|FG001|Overall Study|Adverse Event|1|||
30598938|NCT01297959|58610751|FG000|Overall Study|Protocol Violation|2|||
30598939|NCT01297959|58610752|FG001|Overall Study|Protocol Violation|1|||
30687790|NCT00440947|58701602|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
30687791|NCT00440947|58701603|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
30687792|NCT00440947|58701604|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
30687793|NCT00440947|58701605|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
30687794|NCT00440947|58701606|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
30687795|NCT00440947|58701602|FG000|36-Week Induction Phase|Non-compliance|10|||
30687796|NCT00440947|58701603|FG001|36-Week Induction Phase|Non-compliance|0|||
30687797|NCT00440947|58701604|FG002|36-Week Induction Phase|Non-compliance|0|||
30687798|NCT00440947|58701605|FG003|36-Week Induction Phase|Non-compliance|0|||
30687799|NCT00440947|58701606|FG004|36-Week Induction Phase|Non-compliance|0|||
30687800|NCT00440947|58701602|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
30687801|NCT00440947|58701603|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
30687802|NCT00440947|58701604|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
30687803|NCT00440947|58701605|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
30687804|NCT00440947|58701606|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
30687805|NCT00440947|58701602|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
30687806|NCT00440947|58701603|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
30687807|NCT00440947|58701604|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
30687808|NCT00440947|58701605|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
30687809|NCT00440947|58701606|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
30687810|NCT00440947|58701602|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
30687811|NCT00440947|58701603|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
30687812|NCT00440947|58701604|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
30687813|NCT00440947|58701605|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
30687814|NCT00440947|58701606|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
30687815|NCT00440947|58701602|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
30687816|NCT00440947|58701603|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
30687817|NCT00440947|58701604|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
30687818|NCT00440947|58701605|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
30687819|NCT00440947|58701606|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
30687820|NCT00440947|58701602|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
30687821|NCT00440947|58701603|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
30687822|NCT00440947|58701604|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
30687823|NCT00440947|58701605|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
30687824|NCT00440947|58701606|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
30687825|NCT00440947|58701602|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
30687826|NCT00440947|58701603|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
30687827|NCT00440947|58701604|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
30687828|NCT00440947|58701605|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
30687829|NCT00440947|58701606|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
30687830|NCT00440947|58701602|FG000|36-Week Induction Phase|Incarceration|3|||
30687831|NCT00440947|58701603|FG001|36-Week Induction Phase|Incarceration|0|||
30687832|NCT00440947|58701604|FG002|36-Week Induction Phase|Incarceration|0|||
30687833|NCT00440947|58701605|FG003|36-Week Induction Phase|Incarceration|0|||
30687834|NCT00440947|58701606|FG004|36-Week Induction Phase|Incarceration|0|||
30687835|NCT00440947|58701602|FG000|36-Week Induction Phase|Pregnancy|1|||
30687836|NCT00440947|58701603|FG001|36-Week Induction Phase|Pregnancy|0|||
30687837|NCT00440947|58701604|FG002|36-Week Induction Phase|Pregnancy|0|||
30687838|NCT00440947|58701605|FG003|36-Week Induction Phase|Pregnancy|0|||
30687839|NCT00440947|58701606|FG004|36-Week Induction Phase|Pregnancy|0|||
30687840|NCT00440947|58701602|FG000|48-Week Randomization Phase|Adverse Event|0|||
30687841|NCT00440947|58701603|FG001|48-Week Randomization Phase|Adverse Event|2|||
30687842|NCT00440947|58701604|FG002|48-Week Randomization Phase|Adverse Event|5|||
30687843|NCT00440947|58701605|FG003|48-Week Randomization Phase|Adverse Event|0|||
30687844|NCT00440947|58701606|FG004|48-Week Randomization Phase|Adverse Event|0|||
30687845|NCT00440947|58701602|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
30687846|NCT00440947|58701603|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
30687847|NCT00440947|58701604|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
30687848|NCT00440947|58701605|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
30687849|NCT00440947|58701606|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
30687850|NCT00440947|58701602|FG000|48-Week Randomization Phase|Non-compliance|0|||
30687851|NCT00440947|58701603|FG001|48-Week Randomization Phase|Non-compliance|3|||
30687852|NCT00440947|58701604|FG002|48-Week Randomization Phase|Non-compliance|4|||
30687853|NCT00440947|58701605|FG003|48-Week Randomization Phase|Non-compliance|0|||
30687854|NCT00440947|58701606|FG004|48-Week Randomization Phase|Non-compliance|0|||
30687855|NCT00440947|58701602|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
30687856|NCT00440947|58701603|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
30785105|NCT04399161|58798098|FG001|Overall Study|Protocol Violation|2|||
30785106|NCT04399161|58798099|FG002|Overall Study|Protocol Violation|0|||
30687857|NCT00440947|58701604|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
30687858|NCT00440947|58701605|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
30687859|NCT00440947|58701606|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
30785107|NCT02076178|58798109|FG000|Oral Phase|Adverse Event|0|||
30785108|NCT02076178|58798110|FG001|Oral Phase|Adverse Event|7|||
30785109|NCT02076178|58798109|FG000|Oral Phase|Withdrawal by Subject|0|||
30687860|NCT00440947|58701602|FG000|48-Week Randomization Phase|Protocol Violation|0|||
30687861|NCT00440947|58701603|FG001|48-Week Randomization Phase|Protocol Violation|0|||
30687862|NCT00440947|58701604|FG002|48-Week Randomization Phase|Protocol Violation|1|||
30687863|NCT00440947|58701605|FG003|48-Week Randomization Phase|Protocol Violation|0|||
30687864|NCT00440947|58701606|FG004|48-Week Randomization Phase|Protocol Violation|0|||
30687865|NCT00440947|58701602|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
30687866|NCT00440947|58701603|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
30687867|NCT00440947|58701604|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
30687868|NCT00440947|58701605|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
30687869|NCT00440947|58701606|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
30687870|NCT00440947|58701602|FG000|48-Week Randomization Phase|Pregnancy|0|||
30687871|NCT00440947|58701603|FG001|48-Week Randomization Phase|Pregnancy|0|||
30687872|NCT00440947|58701604|FG002|48-Week Randomization Phase|Pregnancy|1|||
30687873|NCT00440947|58701605|FG003|48-Week Randomization Phase|Pregnancy|0|||
30687874|NCT00440947|58701606|FG004|48-Week Randomization Phase|Pregnancy|0|||
30687875|NCT00440947|58701602|FG000|48-Week Randomization Phase|Incarceration|0|||
30687876|NCT00440947|58701603|FG001|48-Week Randomization Phase|Incarceration|3|||
30687877|NCT00440947|58701604|FG002|48-Week Randomization Phase|Incarceration|0|||
30687878|NCT00440947|58701605|FG003|48-Week Randomization Phase|Incarceration|0|||
30687879|NCT00440947|58701606|FG004|48-Week Randomization Phase|Incarceration|0|||
30687880|NCT00440947|58701602|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
30687881|NCT00440947|58701603|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
30687882|NCT00440947|58701604|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
30687883|NCT00440947|58701605|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
30687884|NCT00440947|58701606|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
30687885|NCT00440947|58701602|FG000|48-Week Randomization Phase|Physician Decision|0|||
30687886|NCT00440947|58701603|FG001|48-Week Randomization Phase|Physician Decision|2|||
30687887|NCT00440947|58701604|FG002|48-Week Randomization Phase|Physician Decision|0|||
30687888|NCT00440947|58701605|FG003|48-Week Randomization Phase|Physician Decision|0|||
30687889|NCT00440947|58701606|FG004|48-Week Randomization Phase|Physician Decision|0|||
30687890|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
30687891|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
30687892|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
30687893|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
30687894|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
30687895|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
30687896|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
30687897|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
30687898|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
30687899|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
30687900|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
30687901|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
30687902|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
30687903|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
30687904|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
30687905|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
30687906|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
30687907|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
30687908|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
30687909|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
30687910|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
30687911|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
30687912|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
30687913|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
30687914|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
30687915|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
30687916|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
30687917|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
30687918|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
30687919|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
30687920|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
30687921|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
30687922|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
30687923|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
30687924|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
30687925|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
30687926|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
30687927|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
30687928|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
30687929|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
30687930|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
30687931|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
30687932|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
30687933|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
30687934|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
30687935|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
30687936|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
30687937|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
30687938|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
30687939|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
30687940|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
30687941|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
30687942|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
30687943|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
30687944|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
30687945|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Other|0|||
30687946|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Other|0|||
30687947|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Other|0|||
30687948|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Other|1|||
30687949|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Other|0|||
30687950|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
30687951|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
30687952|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
30687953|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
30687954|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
30687955|NCT00440947|58701602|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
30687956|NCT00440947|58701603|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
30687957|NCT00440947|58701604|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
30687958|NCT00440947|58701605|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
30687959|NCT00440947|58701606|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
30687960|NCT00664521|58701629|FG000|Overall Study|Adverse Event|4|||
30687961|NCT00664521|58701630|FG001|Overall Study|Adverse Event|1|||
30687962|NCT00664521|58701629|FG000|Overall Study|Lost to Follow-up|1|||
30687963|NCT00664521|58701630|FG001|Overall Study|Lost to Follow-up|0|||
30687964|NCT00664521|58701629|FG000|Overall Study|Other|1|||
30687965|NCT00664521|58701630|FG001|Overall Study|Other|0|||
30687966|NCT00664209|58701636|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
30687967|NCT00664209|58701636|FG000|Study Treatment Period|Physician Decision|4|||
30687968|NCT00664209|58701636|FG000|Study Treatment Period|Withdrawal by Subject|2|||
30687969|NCT00440557|58701644|FG000|Overall Study|Withdrawal by Subject|10|||
30687970|NCT00440557|58701645|FG001|Overall Study|Withdrawal by Subject|5|||
30687971|NCT00440557|58701646|FG002|Overall Study|Withdrawal by Subject|11|||
30687972|NCT00440557|58701644|FG000|Overall Study|Lost to Follow-up|1|||
30687973|NCT00440557|58701645|FG001|Overall Study|Lost to Follow-up|2|||
30687974|NCT00440557|58701646|FG002|Overall Study|Lost to Follow-up|6|||
30687975|NCT00440557|58701644|FG000|Overall Study|Adverse Event|3|||
30687976|NCT00440557|58701645|FG001|Overall Study|Adverse Event|3|||
30687977|NCT00440557|58701646|FG002|Overall Study|Adverse Event|5|||
30687978|NCT00440557|58701644|FG000|Overall Study|Death|2|||
30785110|NCT02076178|58798110|FG001|Oral Phase|Withdrawal by Subject|4|||
30785111|NCT02076178|58798109|FG000|Oral Phase|Physician Decision|0|||
30785112|NCT02076178|58798110|FG001|Oral Phase|Physician Decision|1|||
30785113|NCT02076178|58798109|FG000|Injection Phase|Protocol defined stopping criteria|1|||
30785114|NCT02076178|58798110|FG001|Injection Phase|Protocol defined stopping criteria|0|||
30785115|NCT02076178|58798109|FG000|Injection Phase|Withdrawal by Subject|0|||
30785116|NCT02076178|58798110|FG001|Injection Phase|Withdrawal by Subject|3|||
30785117|NCT02076178|58798109|FG000|Injection Phase|Physician Decision|0|||
30785118|NCT02076178|58798110|FG001|Injection Phase|Physician Decision|3|||
30598940|NCT01297959|58610751|FG000|Overall Study|Withdrawal by Subject|5|||
30598941|NCT01297959|58610752|FG001|Overall Study|Withdrawal by Subject|4|||
30598942|NCT01297959|58610751|FG000|Overall Study|Physician Decision|0|||
30598943|NCT01297959|58610752|FG001|Overall Study|Physician Decision|1|||
30598944|NCT01297959|58610751|FG000|Overall Study|Unrelated medical illness / complication|0|||
30598945|NCT01297959|58610752|FG001|Overall Study|Unrelated medical illness / complication|2|||
30598946|NCT01297959|58610751|FG000|Overall Study|Other|13|||
30598947|NCT01297959|58610752|FG001|Overall Study|Other|7|||
30598948|NCT01035229|58610760|FG000|Overall Study|Adverse Event|61|||
30785119|NCT02076178|58798109|FG000|Injection Phase|Lost to Follow-up|0|||
30598949|NCT01035229|58610761|FG001|Overall Study|Adverse Event|14|||
30598950|NCT01035229|58610760|FG000|Overall Study|Withdrawal by Subject|20|||
30785120|NCT02076178|58798110|FG001|Injection Phase|Lost to Follow-up|1|||
30785121|NCT04160091|58798122|FG000|Overall Study|Terminated by Sponsor|7|||
30785122|NCT04160091|58798123|FG001|Overall Study|Terminated by Sponsor|3|||
30785123|NCT04160091|58798124|FG002|Overall Study|Terminated by Sponsor|5|||
30785124|NCT04160091|58798125|FG003|Overall Study|Terminated by Sponsor|2|||
30785125|NCT04160091|58798122|FG000|Overall Study|Noncompliance|0|||
30785126|NCT04160091|58798123|FG001|Overall Study|Noncompliance|0|||
30785127|NCT04160091|58798124|FG002|Overall Study|Noncompliance|0|||
30785128|NCT04160091|58798125|FG003|Overall Study|Noncompliance|1|||
30785129|NCT04160091|58798122|FG000|Overall Study|Withdrawal by Subject|0|||
30785130|NCT04160091|58798123|FG001|Overall Study|Withdrawal by Subject|0|||
30785131|NCT04160091|58798124|FG002|Overall Study|Withdrawal by Subject|0|||
30785132|NCT04160091|58798125|FG003|Overall Study|Withdrawal by Subject|1|||
30785133|NCT00149825|58798137|FG000|Overall Study|Intolerance to medication side effects|1|||
30785134|NCT00149825|58798138|FG001|Overall Study|Intolerance to medication side effects|2|||
30785135|NCT00149825|58798137|FG000|Overall Study|Time commitments|2|||
30785136|NCT00149825|58798138|FG001|Overall Study|Time commitments|1|||
30785137|NCT00149825|58798137|FG000|Overall Study|Not liking insomnia therapy|1|||
30785138|NCT00149825|58798138|FG001|Overall Study|Not liking insomnia therapy|0|||
30785139|NCT00149825|58798137|FG000|Overall Study|Other|1|||
30785140|NCT00149825|58798138|FG001|Overall Study|Other|0|||
30785141|NCT04397757|58798146|FG000|Overall Study|Death|3|||
30785142|NCT04397757|58798147|FG001|Overall Study|Death|11|||
30785143|NCT04397757|58798146|FG000|Overall Study|Withdrawal by Subject|2|||
30785144|NCT04397757|58798147|FG001|Overall Study|Withdrawal by Subject|0|||
30785145|NCT04397757|58798146|FG000|Overall Study|Lost to Follow-up|4|||
30785146|NCT04397757|58798147|FG001|Overall Study|Lost to Follow-up|3|||
30785147|NCT02792062|58798164|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
30785148|NCT02792062|58798165|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
30785149|NCT02792062|58798166|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
30785150|NCT02792062|58798167|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
30785151|NCT02792062|58798168|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
30785152|NCT02792062|58798169|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
30785153|NCT00196937|58798180|FG000|Overall Study|Serious Adverse Event|1|||
30785154|NCT00196937|58798181|FG001|Overall Study|Serious Adverse Event|0|||
30785155|NCT00196937|58798182|FG002|Overall Study|Serious Adverse Event|0|||
30856303|NCT02213926|58884133|FG000|Overall Study|Death|59|||
30856304|NCT02213926|58884133|FG000|Overall Study|Withdrawal by Subject|10|||
30856305|NCT02213926|58884133|FG000|Overall Study|study terminated by sponsor|51|||
30856306|NCT02213926|58884133|FG000|Overall Study|Lost to Follow-up|3|||
30856307|NCT02213926|58884133|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
30856308|NCT02180724|58884139|FG000|Overall Study|Death|26|||
30856309|NCT02180724|58884140|FG001|Overall Study|Death|1|||
30856310|NCT02180724|58884139|FG000|Overall Study|Lost to Follow-up|3|||
30856311|NCT02180724|58884140|FG001|Overall Study|Lost to Follow-up|1|||
30856312|NCT02180724|58884139|FG000|Overall Study|Withdrawal by Subject|4|||
30856313|NCT02180724|58884140|FG001|Overall Study|Withdrawal by Subject|2|||
30856314|NCT02180724|58884139|FG000|Overall Study|PI Decision|5|||
30856315|NCT02180724|58884140|FG001|Overall Study|PI Decision|2|||
30856316|NCT02180724|58884139|FG000|Overall Study|Study terminated by sponsor|54|||
30856317|NCT02180724|58884140|FG001|Overall Study|Study terminated by sponsor|8|||
30856318|NCT01892085|58884155|FG000|Overall Study|Death|4|||
30856319|NCT01892085|58884156|FG001|Overall Study|Death|1|||
30856320|NCT01892085|58884157|FG002|Overall Study|Death|3|||
30856321|NCT01892085|58884155|FG000|Overall Study|Withdrawal by Subject|2|||
30856322|NCT01892085|58884156|FG001|Overall Study|Withdrawal by Subject|0|||
30856323|NCT01892085|58884157|FG002|Overall Study|Withdrawal by Subject|2|||
30856324|NCT01267955|58884165|FG000|Stage 1 (6 Months)|Death|3|||
30856325|NCT01267955|58884165|FG000|Stage 2 (6 Months)|Death|5|||
30856326|NCT01267955|58884165|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
30856327|NCT00381641|58884189|FG000|Overall Study|Withdrawal by Subject|0|||
30856328|NCT00381641|58884190|FG001|Overall Study|Withdrawal by Subject|2|||
30856329|NCT04510285|58884211|FG000|Overall Study|Death|1|||
30856330|NCT02576054|58884215|FG000|Overall Study|Withdrawal by Subject|1|||
30856331|NCT01606202|58884223|FG000|Overall Study|Adverse Event|5|||
30856332|NCT01606202|58884224|FG001|Overall Study|Adverse Event|0|||
30856333|NCT01606202|58884223|FG000|Overall Study|Withdrawal by Subject|2|||
30856334|NCT01606202|58884224|FG001|Overall Study|Withdrawal by Subject|1|||
30856335|NCT01606202|58884223|FG000|Overall Study|Personal problems|0|||
30856336|NCT01606202|58884224|FG001|Overall Study|Personal problems|1|||
30785156|NCT00196937|58798180|FG000|Overall Study|Non-serious adverse event|1|||
30785157|NCT00196937|58798181|FG001|Overall Study|Non-serious adverse event|1|||
30856337|NCT01606202|58884223|FG000|Overall Study|Problems with administration|0|||
30785158|NCT00196937|58798182|FG002|Overall Study|Non-serious adverse event|1|||
30785159|NCT00196937|58798180|FG000|Overall Study|Withdrawal by Subject|0|||
30785160|NCT00196937|58798181|FG001|Overall Study|Withdrawal by Subject|0|||
30856338|NCT01606202|58884224|FG001|Overall Study|Problems with administration|1|||
30785161|NCT00196937|58798182|FG002|Overall Study|Withdrawal by Subject|2|||
30785162|NCT00196937|58798180|FG000|Overall Study|Lost to Follow-up|4|||
30785163|NCT00196937|58798181|FG001|Overall Study|Lost to Follow-up|3|||
30785164|NCT00196937|58798182|FG002|Overall Study|Lost to Follow-up|3|||
30785165|NCT00196937|58798180|FG000|Overall Study|Other|3|||
30785166|NCT00196937|58798181|FG001|Overall Study|Other|1|||
30785167|NCT00196937|58798182|FG002|Overall Study|Other|1|||
30785168|NCT04397445|58798191|FG000|Overall Study|Withdrawal by Subject|1|||
30785169|NCT04397445|58798192|FG001|Overall Study|Withdrawal by Subject|0|||
30785170|NCT04397445|58798193|FG002|Overall Study|Withdrawal by Subject|0|||
30785171|NCT04397445|58798194|FG003|Overall Study|Withdrawal by Subject|0|||
30785172|NCT00191945|58798211|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
30785173|NCT00191945|58798212|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
30785174|NCT00191945|58798211|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
30785175|NCT00191945|58798212|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
30785176|NCT00191945|58798211|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
30785177|NCT00191945|58798212|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
30785178|NCT00191945|58798211|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
30785179|NCT00191945|58798212|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
30785180|NCT01369342|58798222|FG000|Overall Study|Withdrawal by Subject|7|||
30785181|NCT01369342|58798223|FG001|Overall Study|Withdrawal by Subject|7|||
30856339|NCT01493960|58884232|FG000|Overall Study|Adverse Event|0|||
30687979|NCT00440557|58701645|FG001|Overall Study|Death|6|||
30687980|NCT00440557|58701646|FG002|Overall Study|Death|3|||
30687981|NCT00440557|58701644|FG000|Overall Study|Began Dialysis|4|||
30687982|NCT00440557|58701645|FG001|Overall Study|Began Dialysis|1|||
30687983|NCT00440557|58701646|FG002|Overall Study|Began Dialysis|4|||
30687984|NCT00440557|58701644|FG000|Overall Study|Principal Investigator decision|0|||
30687985|NCT00440557|58701645|FG001|Overall Study|Principal Investigator decision|3|||
30687986|NCT00440557|58701646|FG002|Overall Study|Principal Investigator decision|1|||
30687987|NCT00440557|58701644|FG000|Overall Study|Patient moved|1|||
30687988|NCT00440557|58701645|FG001|Overall Study|Patient moved|2|||
30687989|NCT00440557|58701646|FG002|Overall Study|Patient moved|1|||
30687990|NCT00440557|58701644|FG000|Overall Study|Principal Investigator's office closed|3|||
30687991|NCT00440557|58701645|FG001|Overall Study|Principal Investigator's office closed|6|||
30687992|NCT00440557|58701646|FG002|Overall Study|Principal Investigator's office closed|4|||
30687993|NCT00440557|58701644|FG000|Overall Study|Patient transferred to nursing home|0|||
30687994|NCT00440557|58701645|FG001|Overall Study|Patient transferred to nursing home|1|||
30687995|NCT00440557|58701646|FG002|Overall Study|Patient transferred to nursing home|0|||
30687996|NCT00440557|58701644|FG000|Overall Study|Patient had surgery|1|||
30687997|NCT00440557|58701645|FG001|Overall Study|Patient had surgery|0|||
30687998|NCT00440557|58701646|FG002|Overall Study|Patient had surgery|0|||
30687999|NCT00582608|58701706|FG000|Overall Study|Not Treated|7|||
30688000|NCT00582608|58701706|FG000|Overall Study|Patient Ineligible|1|||
30688001|NCT00582608|58701706|FG000|Overall Study|Lack of accrual|4|||
30688002|NCT03014570|58701712|FG000|Overall Study|COVID-19 Restrictions|38|||
30688003|NCT03014570|58701713|FG001|Overall Study|COVID-19 Restrictions|24|||
30785182|NCT01369342|58798224|FG002|Overall Study|Withdrawal by Subject|2|||
30785183|NCT01369342|58798222|FG000|Overall Study|Lost to Follow-up|5|||
30785184|NCT01369342|58798223|FG001|Overall Study|Lost to Follow-up|2|||
30856340|NCT01493960|58884233|FG001|Overall Study|Adverse Event|1|||
30856341|NCT01493960|58884232|FG000|Overall Study|Lack of Efficacy|15|||
30856342|NCT01493960|58884233|FG001|Overall Study|Lack of Efficacy|9|||
30598951|NCT01035229|58610761|FG001|Overall Study|Withdrawal by Subject|7|||
30598952|NCT01035229|58610760|FG000|Overall Study|Lost to Follow-up|1|||
30598953|NCT01035229|58610761|FG001|Overall Study|Lost to Follow-up|0|||
30856343|NCT01493960|58884232|FG000|Overall Study|Protocol Violation|3|||
30856344|NCT01493960|58884233|FG001|Overall Study|Protocol Violation|0|||
30598954|NCT01035229|58610760|FG000|Overall Study|Administrative problems|1|||
30598955|NCT01035229|58610761|FG001|Overall Study|Administrative problems|1|||
30598956|NCT01035229|58610760|FG000|Overall Study|Death|13|||
30598957|NCT01035229|58610761|FG001|Overall Study|Death|5|||
30598958|NCT01035229|58610760|FG000|Overall Study|New cancer therapy|2|||
30598959|NCT01035229|58610761|FG001|Overall Study|New cancer therapy|0|||
30598960|NCT01035229|58610760|FG000|Overall Study|Protocol Violation|0|||
30598961|NCT01035229|58610761|FG001|Overall Study|Protocol Violation|2|||
30598962|NCT01035229|58610760|FG000|Overall Study|Sponsor's decision to end study|3|||
30598963|NCT01035229|58610761|FG001|Overall Study|Sponsor's decision to end study|3|||
30688004|NCT03014570|58701712|FG000|Overall Study|Death|70|||
30785185|NCT01369342|58798224|FG002|Overall Study|Lost to Follow-up|1|||
30856345|NCT01493960|58884232|FG000|Overall Study|Withdrawal by Subject|10|||
30598964|NCT01035229|58610760|FG000|Overall Study|Disease Progression|261|||
30688005|NCT03014570|58701713|FG001|Overall Study|Death|79|||
30688006|NCT03014570|58701712|FG000|Overall Study|Transfer from facility|11|||
30688007|NCT03014570|58701713|FG001|Overall Study|Transfer from facility|14|||
30598965|NCT01035229|58610761|FG001|Overall Study|Disease Progression|152|||
30598966|NCT01106404|58610771|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
30785186|NCT01369342|58798222|FG000|Overall Study|Not Treated|1|||
30785187|NCT01369342|58798223|FG001|Overall Study|Not Treated|0|||
30785188|NCT01369342|58798224|FG002|Overall Study|Not Treated|0|||
30785189|NCT00191477|58798234|FG000|Overall Study|Tumor Recurrence|49|||
30785190|NCT00191477|58798235|FG001|Overall Study|Tumor Recurrence|48|||
30785191|NCT00191477|58798234|FG000|Overall Study|Death, Study Disease|1|||
30785192|NCT00191477|58798235|FG001|Overall Study|Death, Study Disease|1|||
30785193|NCT00191477|58798234|FG000|Overall Study|Death, Other Cause|3|||
30785194|NCT00191477|58798235|FG001|Overall Study|Death, Other Cause|6|||
30785195|NCT00191477|58798234|FG000|Overall Study|Lost to Follow-up|23|||
30785196|NCT00191477|58798235|FG001|Overall Study|Lost to Follow-up|21|||
30785197|NCT00191477|58798234|FG000|Overall Study|Protocol Violation|1|||
30785198|NCT00191477|58798235|FG001|Overall Study|Protocol Violation|1|||
30785199|NCT00191477|58798234|FG000|Overall Study|Treatment Change|2|||
30785200|NCT00191477|58798235|FG001|Overall Study|Treatment Change|0|||
30785201|NCT00191477|58798234|FG000|Overall Study|Withdrawal by Subject|2|||
30785202|NCT00191477|58798235|FG001|Overall Study|Withdrawal by Subject|0|||
30856346|NCT01493960|58884233|FG001|Overall Study|Withdrawal by Subject|4|||
30856347|NCT01493960|58884232|FG000|Overall Study|Non-specified|4|||
30688008|NCT03014570|58701712|FG000|Overall Study|Hospitalized|5|||
30688009|NCT03014570|58701713|FG001|Overall Study|Hospitalized|3|||
30688010|NCT03014570|58701712|FG000|Overall Study|Transfer within facility|1|||
30688011|NCT03014570|58701713|FG001|Overall Study|Transfer within facility|0|||
30688012|NCT03014570|58701712|FG000|Overall Study|Site refusal|0|||
30688013|NCT03014570|58701713|FG001|Overall Study|Site refusal|11|||
30688014|NCT00427999|58701720|FG000|Overall Study|Adverse Event|6|||
30688015|NCT00427999|58701720|FG000|Overall Study|Abnormal laboratory values|1|||
30688016|NCT00427999|58701720|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
30688017|NCT00427999|58701720|FG000|Overall Study|Protocol Violation|2|||
30688018|NCT00427999|58701720|FG000|Overall Study|Withdrawal by Subject|9|||
30688019|NCT00427999|58701720|FG000|Overall Study|Death|1|||
30688020|NCT00661713|58701733|FG000|Overall Study|Death|1|||
30688021|NCT00661713|58701734|FG001|Overall Study|Death|0|||
30688022|NCT00661713|58701735|FG002|Overall Study|Death|0|||
30688023|NCT00661713|58701736|FG003|Overall Study|Death|0|||
30688024|NCT00661713|58701737|FG004|Overall Study|Death|1|||
30688025|NCT00661713|58701738|FG005|Overall Study|Death|0|||
30688026|NCT00661713|58701739|FG006|Overall Study|Death|0|||
30688027|NCT00661713|58701740|FG007|Overall Study|Death|0|||
30688028|NCT00661713|58701733|FG000|Overall Study|Unable to Classify|1|||
30688029|NCT00661713|58701734|FG001|Overall Study|Unable to Classify|0|||
30688030|NCT00661713|58701735|FG002|Overall Study|Unable to Classify|0|||
30688031|NCT00661713|58701736|FG003|Overall Study|Unable to Classify|0|||
30688032|NCT00661713|58701737|FG004|Overall Study|Unable to Classify|0|||
30688033|NCT00661713|58701738|FG005|Overall Study|Unable to Classify|0|||
30688034|NCT00661713|58701739|FG006|Overall Study|Unable to Classify|0|||
30688035|NCT00661713|58701740|FG007|Overall Study|Unable to Classify|0|||
30688036|NCT00661713|58701733|FG000|Overall Study|Protocol Violation|1|||
30688037|NCT00661713|58701734|FG001|Overall Study|Protocol Violation|6|||
30688038|NCT00661713|58701735|FG002|Overall Study|Protocol Violation|3|||
30688039|NCT00661713|58701736|FG003|Overall Study|Protocol Violation|3|||
30688040|NCT00661713|58701737|FG004|Overall Study|Protocol Violation|0|||
30688041|NCT00661713|58701738|FG005|Overall Study|Protocol Violation|2|||
30688042|NCT00661713|58701739|FG006|Overall Study|Protocol Violation|2|||
30688043|NCT00661713|58701740|FG007|Overall Study|Protocol Violation|1|||
30688044|NCT00661713|58701733|FG000|Overall Study|Withdrawal by Subject|11|||
30688045|NCT00661713|58701734|FG001|Overall Study|Withdrawal by Subject|25|||
30688046|NCT00661713|58701735|FG002|Overall Study|Withdrawal by Subject|12|||
30688047|NCT00661713|58701736|FG003|Overall Study|Withdrawal by Subject|21|||
30688048|NCT00661713|58701737|FG004|Overall Study|Withdrawal by Subject|12|||
30688049|NCT00661713|58701738|FG005|Overall Study|Withdrawal by Subject|26|||
30688050|NCT00661713|58701739|FG006|Overall Study|Withdrawal by Subject|45|||
30688051|NCT00661713|58701740|FG007|Overall Study|Withdrawal by Subject|9|||
30785203|NCT00191477|58798234|FG000|Overall Study|Other|2|||
30785204|NCT00191477|58798235|FG001|Overall Study|Other|0|||
30785205|NCT00191477|58798234|FG000|Overall Study|Not Eligible|41|||
30785206|NCT00191477|58798235|FG001|Overall Study|Not Eligible|38|||
30688052|NCT00661713|58701733|FG000|Overall Study|Lost to Follow-up|2|||
30688053|NCT00661713|58701734|FG001|Overall Study|Lost to Follow-up|7|||
30688054|NCT00661713|58701735|FG002|Overall Study|Lost to Follow-up|2|||
30688055|NCT00661713|58701736|FG003|Overall Study|Lost to Follow-up|2|||
30688056|NCT00661713|58701737|FG004|Overall Study|Lost to Follow-up|5|||
30688057|NCT00661713|58701738|FG005|Overall Study|Lost to Follow-up|7|||
30688058|NCT00661713|58701739|FG006|Overall Study|Lost to Follow-up|14|||
30785207|NCT00191477|58798234|FG000|Overall Study|Pathological Specimen Lost|1|||
30785208|NCT00191477|58798235|FG001|Overall Study|Pathological Specimen Lost|0|||
30785209|NCT00191477|58798234|FG000|Overall Study|Discontinued Prior to Instillation|13|||
30688059|NCT00661713|58701740|FG007|Overall Study|Lost to Follow-up|1|||
30688060|NCT00661713|58701733|FG000|Overall Study|Administrative Reason|0|||
30688061|NCT00661713|58701734|FG001|Overall Study|Administrative Reason|1|||
30688062|NCT00661713|58701735|FG002|Overall Study|Administrative Reason|0|||
30688063|NCT00661713|58701736|FG003|Overall Study|Administrative Reason|2|||
30785210|NCT00191477|58798235|FG001|Overall Study|Discontinued Prior to Instillation|14|||
30785211|NCT04320615|58798243|FG000|Overall Study|Withdrawal by Subject|4|||
30785212|NCT04320615|58798244|FG001|Overall Study|Withdrawal by Subject|10|||
30785213|NCT04320615|58798243|FG000|Overall Study|Physician Decision|2|||
30785214|NCT04320615|58798244|FG001|Overall Study|Physician Decision|0|||
30785215|NCT04320615|58798243|FG000|Overall Study|Other|2|||
30785216|NCT04320615|58798244|FG001|Overall Study|Other|0|||
30785217|NCT04320615|58798243|FG000|Overall Study|Lost to Follow-up|5|||
30785218|NCT04320615|58798244|FG001|Overall Study|Lost to Follow-up|23|||
30785219|NCT04320615|58798243|FG000|Overall Study|Death|35|||
30785220|NCT04320615|58798244|FG001|Overall Study|Death|71|||
30856348|NCT01493960|58884233|FG001|Overall Study|Non-specified|4|||
30856349|NCT02630459|58884243|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
30856350|NCT02630459|58884244|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
30856351|NCT02630459|58884245|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
30856352|NCT02630459|58884246|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
30856353|NCT02630459|58884247|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
30856354|NCT02630459|58884248|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
30856355|NCT02630459|58884249|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
30598967|NCT01106404|58610772|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
30785221|NCT00149747|58798256|FG000|Overall Study|Death|1|||
30785222|NCT00149747|58798257|FG001|Overall Study|Death|0|||
30785223|NCT00149747|58798256|FG000|Overall Study|Withdrawal by Subject|3|||
30785224|NCT00149747|58798257|FG001|Overall Study|Withdrawal by Subject|3|||
30785225|NCT00187889|58798265|FG000|Overall Study|Withdrawal by Subject|6|||
30785226|NCT00187889|58798266|FG001|Overall Study|Withdrawal by Subject|4|||
30785227|NCT00148343|58798275|FG000|Overall Study|Withdrawal by Subject|12|||
30785228|NCT00148343|58798276|FG001|Overall Study|Withdrawal by Subject|7|||
30785229|NCT00148343|58798275|FG000|Overall Study|Physician Decision|3|||
30785230|NCT00148343|58798276|FG001|Overall Study|Physician Decision|4|||
30785231|NCT04150341|58798282|FG000|Overall Study|Physician Decision|0|||
30785232|NCT04150341|58798283|FG001|Overall Study|Physician Decision|0|||
30785233|NCT04150341|58798284|FG002|Overall Study|Physician Decision|1|||
30785234|NCT04150341|58798285|FG003|Overall Study|Physician Decision|0|||
30785235|NCT04150341|58798286|FG004|Overall Study|Physician Decision|0|||
30785236|NCT04150341|58798287|FG005|Overall Study|Physician Decision|0|||
30785237|NCT04150341|58798282|FG000|Overall Study|Adverse Event|0|||
30785238|NCT04150341|58798283|FG001|Overall Study|Adverse Event|0|||
30785239|NCT04150341|58798284|FG002|Overall Study|Adverse Event|0|||
30785240|NCT04150341|58798285|FG003|Overall Study|Adverse Event|0|||
30785241|NCT04150341|58798286|FG004|Overall Study|Adverse Event|1|||
30785242|NCT04150341|58798287|FG005|Overall Study|Adverse Event|0|||
30785243|NCT00148109|58798299|FG000|Overall Study|Lack of Efficacy|10|||
30785244|NCT00148109|58798300|FG001|Overall Study|Lack of Efficacy|18|||
30785245|NCT00148109|58798299|FG000|Overall Study|Adverse Event|0|||
30785246|NCT00148109|58798300|FG001|Overall Study|Adverse Event|2|||
30785247|NCT00148109|58798299|FG000|Overall Study|Withdrawal by Subject|2|||
30785248|NCT00148109|58798300|FG001|Overall Study|Withdrawal by Subject|0|||
30785249|NCT00186485|58798306|FG000|Overall Study|Lost to Follow-up|3|||
30785250|NCT00147251|58798312|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
30785251|NCT00147251|58798313|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
30785252|NCT04390191|58798323|FG000|Overall Study|Withdrawal by Subject|1|||
30785253|NCT04390191|58798324|FG001|Overall Study|Withdrawal by Subject|0|||
30785254|NCT04405076|58798336|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
30785255|NCT04405076|58798337|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
30785256|NCT04405076|58798338|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
30785257|NCT04405076|58798339|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
30598968|NCT01106404|58610771|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
30598969|NCT01106404|58610772|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
30598970|NCT01106404|58610771|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
30785258|NCT04405076|58798340|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
30856356|NCT02630459|58884250|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
30598971|NCT01106404|58610772|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
30598972|NCT01106404|58610771|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
30598973|NCT01106404|58610772|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
30598974|NCT01059799|58610786|FG000|Overall Study|Adverse Event|2|||
30598975|NCT01059799|58610787|FG001|Overall Study|Adverse Event|3|||
30598976|NCT01059799|58610786|FG000|Overall Study|Lack of Efficacy|1|||
30688064|NCT00661713|58701737|FG004|Overall Study|Administrative Reason|2|||
30598977|NCT01059799|58610787|FG001|Overall Study|Lack of Efficacy|0|||
30785259|NCT04405076|58798341|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
30785260|NCT04405076|58798342|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
30785261|NCT04405076|58798343|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
30688065|NCT00661713|58701738|FG005|Overall Study|Administrative Reason|2|||
30688066|NCT00661713|58701739|FG006|Overall Study|Administrative Reason|1|||
30688067|NCT00661713|58701740|FG007|Overall Study|Administrative Reason|0|||
30785262|NCT04405076|58798344|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
30785263|NCT04405076|58798336|FG000|Part A (Blinded Phase)|Physician Decision|1|||
30785264|NCT04405076|58798337|FG001|Part A (Blinded Phase)|Physician Decision|2|||
30785265|NCT04405076|58798338|FG002|Part A (Blinded Phase)|Physician Decision|0|||
30785266|NCT04405076|58798339|FG003|Part A (Blinded Phase)|Physician Decision|0|||
30785267|NCT04405076|58798340|FG004|Part A (Blinded Phase)|Physician Decision|0|||
30785268|NCT04405076|58798341|FG005|Part A (Blinded Phase)|Physician Decision|0|||
30785269|NCT04405076|58798342|FG006|Part A (Blinded Phase)|Physician Decision|0|||
30785270|NCT04405076|58798343|FG007|Part A (Blinded Phase)|Physician Decision|0|||
30785271|NCT04405076|58798344|FG008|Part A (Blinded Phase)|Physician Decision|0|||
30785272|NCT04405076|58798336|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
30785273|NCT04405076|58798337|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
30785274|NCT04405076|58798338|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
30785275|NCT04405076|58798339|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
30785276|NCT04405076|58798340|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
30785277|NCT04405076|58798341|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
30785278|NCT04405076|58798342|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
30785279|NCT04405076|58798343|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
30785280|NCT04405076|58798344|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
30785281|NCT04405076|58798336|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
30688068|NCT00661713|58701733|FG000|Overall Study|Adverse Event|0|||
30688069|NCT00661713|58701734|FG001|Overall Study|Adverse Event|0|||
30688070|NCT00661713|58701735|FG002|Overall Study|Adverse Event|0|||
30688071|NCT00661713|58701736|FG003|Overall Study|Adverse Event|0|||
30688072|NCT00661713|58701737|FG004|Overall Study|Adverse Event|0|||
30688073|NCT00661713|58701738|FG005|Overall Study|Adverse Event|0|||
30688074|NCT00661713|58701739|FG006|Overall Study|Adverse Event|1|||
30688075|NCT00661713|58701740|FG007|Overall Study|Adverse Event|0|||
30688076|NCT00661713|58701733|FG000|Overall Study|Inappropriate Enrollment|0|||
30688077|NCT00661713|58701734|FG001|Overall Study|Inappropriate Enrollment|0|||
30688078|NCT00661713|58701735|FG002|Overall Study|Inappropriate Enrollment|0|||
30688079|NCT00661713|58701736|FG003|Overall Study|Inappropriate Enrollment|0|||
30598978|NCT01059799|58610786|FG000|Overall Study|Protocol Violation|3|||
30598979|NCT01059799|58610787|FG001|Overall Study|Protocol Violation|2|||
30598980|NCT01059799|58610786|FG000|Overall Study|Withdrawal criteria|13|||
30598981|NCT01059799|58610787|FG001|Overall Study|Withdrawal criteria|2|||
30598982|NCT01059799|58610786|FG000|Overall Study|Other|12|||
30598983|NCT01059799|58610787|FG001|Overall Study|Other|3|||
30598984|NCT01106248|58610793|FG000|Overall Study|Adverse Event|1|||
30598985|NCT01106248|58610793|FG000|Overall Study|Administrative|2|||
30598986|NCT01059175|58610799|FG000|Overall Study|Death|17|||
30598987|NCT01059175|58610800|FG001|Overall Study|Death|17|||
30598988|NCT01059175|58610799|FG000|Overall Study|Adverse Event|4|||
30598989|NCT01059175|58610800|FG001|Overall Study|Adverse Event|2|||
30598990|NCT01059175|58610799|FG000|Overall Study|Lost to Follow-up|0|||
30598991|NCT01059175|58610800|FG001|Overall Study|Lost to Follow-up|1|||
30598992|NCT01297491|58610808|FG000|Overall Study|Adverse Event|11|||
30598993|NCT01297491|58610809|FG001|Overall Study|Adverse Event|6|||
30598994|NCT01297491|58610808|FG000|Overall Study|Physician Decision|3|||
30598995|NCT01297491|58610809|FG001|Overall Study|Physician Decision|2|||
30598996|NCT01297491|58610808|FG000|Overall Study|Progressive disease|11|||
30598997|NCT01297491|58610809|FG001|Overall Study|Progressive disease|20|||
30598998|NCT01297491|58610808|FG000|Overall Study|Patient/Guardian decision|3|||
30598999|NCT01297491|58610809|FG001|Overall Study|Patient/Guardian decision|4|||
30599000|NCT01297491|58610808|FG000|Overall Study|Death|2|||
30599001|NCT01297491|58610809|FG001|Overall Study|Death|1|||
30688080|NCT00661713|58701737|FG004|Overall Study|Inappropriate Enrollment|0|||
30688081|NCT00661713|58701738|FG005|Overall Study|Inappropriate Enrollment|0|||
30785282|NCT04405076|58798337|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
30785283|NCT04405076|58798338|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
30785284|NCT04405076|58798339|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
30856357|NCT02630459|58884243|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
30599002|NCT01106092|58610819|FG000|Overall Study|Withdrawal by Subject|0|||
30599003|NCT01106092|58610820|FG001|Overall Study|Withdrawal by Subject|0|||
30599004|NCT01106092|58610821|FG002|Overall Study|Withdrawal by Subject|0|||
30599005|NCT01106092|58610822|FG003|Overall Study|Withdrawal by Subject|1|||
30599006|NCT01097668|58610834|FG000|Overall Study|Withdrawal by Subject|1|||
30599007|NCT01097668|58610835|FG001|Overall Study|Withdrawal by Subject|2|||
30599008|NCT01097668|58610834|FG000|Overall Study|Lost to Follow-up|1|||
30688082|NCT00661713|58701739|FG006|Overall Study|Inappropriate Enrollment|1|||
30688083|NCT00661713|58701740|FG007|Overall Study|Inappropriate Enrollment|0|||
30688084|NCT03835975|58701765|FG000|Overall Study|Lost to Follow-up|1|||
30785285|NCT04405076|58798340|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
30785286|NCT04405076|58798341|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
30785287|NCT04405076|58798342|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
30785288|NCT04405076|58798343|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
30785289|NCT04405076|58798344|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
30785290|NCT04405076|58798336|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
30785291|NCT04405076|58798337|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
30785292|NCT04405076|58798338|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
30785293|NCT04405076|58798339|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
30785294|NCT04405076|58798340|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
30785295|NCT04405076|58798341|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
30785296|NCT04405076|58798342|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
30785297|NCT04405076|58798343|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
30785298|NCT04405076|58798344|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
30785299|NCT04405076|58798336|FG000|Part A (Blinded Phase)|Other than Specified|0|||
30785300|NCT04405076|58798337|FG001|Part A (Blinded Phase)|Other than Specified|0|||
30785301|NCT04405076|58798338|FG002|Part A (Blinded Phase)|Other than Specified|3|||
30785302|NCT04405076|58798339|FG003|Part A (Blinded Phase)|Other than Specified|0|||
30785303|NCT04405076|58798340|FG004|Part A (Blinded Phase)|Other than Specified|0|||
30785304|NCT04405076|58798341|FG005|Part A (Blinded Phase)|Other than Specified|0|||
30785305|NCT04405076|58798342|FG006|Part A (Blinded Phase)|Other than Specified|0|||
30785306|NCT04405076|58798343|FG007|Part A (Blinded Phase)|Other than Specified|0|||
30785307|NCT04405076|58798344|FG008|Part A (Blinded Phase)|Other than Specified|0|||
30785308|NCT04405076|58798336|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
30785309|NCT04405076|58798337|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
30785310|NCT04405076|58798338|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
30785311|NCT04405076|58798339|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
30785312|NCT04405076|58798340|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
30785313|NCT04405076|58798341|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
30785314|NCT04405076|58798342|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
30785315|NCT04405076|58798343|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
30785316|NCT04405076|58798344|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
30785317|NCT04405076|58798336|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
30785318|NCT04405076|58798337|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
30785319|NCT04405076|58798338|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
30785320|NCT04405076|58798339|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
30785321|NCT04405076|58798340|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
30785322|NCT04405076|58798341|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
30785323|NCT04405076|58798342|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
30785324|NCT04405076|58798343|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
30785325|NCT04405076|58798344|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
30785326|NCT04405076|58798336|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
30785327|NCT04405076|58798337|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
30785328|NCT04405076|58798338|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
30856358|NCT02630459|58884244|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
30856359|NCT02630459|58884245|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
30856360|NCT02630459|58884246|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
30856361|NCT02630459|58884247|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
30856362|NCT02630459|58884248|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
30856363|NCT02630459|58884249|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
30856364|NCT02630459|58884250|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
30856365|NCT02630459|58884243|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
30856366|NCT02630459|58884244|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
30856367|NCT02630459|58884245|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
30959254|NCT01684943|59024707|FG002|Overall Study|Inadequate Venous Access|0|||
30959255|NCT01684943|59024705|FG000|Overall Study|Principal Investigator Determination|1|||
30959256|NCT01684943|59024706|FG001|Overall Study|Principal Investigator Determination|0|||
30959257|NCT01684943|59024707|FG002|Overall Study|Principal Investigator Determination|0|||
30959258|NCT01684943|59024705|FG000|Overall Study|Excluded from Analysis|1|||
30959259|NCT01684943|59024706|FG001|Overall Study|Excluded from Analysis|1|||
30959260|NCT01684943|59024707|FG002|Overall Study|Excluded from Analysis|1|||
30959261|NCT01684943|59024705|FG000|Overall Study|Lost to Follow-up|3|||
30959262|NCT01684943|59024706|FG001|Overall Study|Lost to Follow-up|0|||
30959263|NCT01684943|59024707|FG002|Overall Study|Lost to Follow-up|0|||
30959264|NCT01684943|59024705|FG000|Overall Study|Planning Pregnancy|1|||
30959265|NCT01684943|59024706|FG001|Overall Study|Planning Pregnancy|0|||
30959266|NCT01684943|59024707|FG002|Overall Study|Planning Pregnancy|0|||
30785329|NCT04405076|58798339|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
30785330|NCT04405076|58798340|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
30785331|NCT04405076|58798341|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
30785332|NCT04405076|58798342|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
30785333|NCT04405076|58798343|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
30785334|NCT04405076|58798344|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
30785335|NCT04405076|58798336|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
30785336|NCT04405076|58798337|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
30785337|NCT04405076|58798338|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
30785338|NCT04405076|58798339|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
30785339|NCT04405076|58798340|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
30785340|NCT04405076|58798341|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
30785341|NCT04405076|58798342|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
30959267|NCT01683383|59024722|FG000|Overall Study|Infant was not transported|1|||
30599009|NCT01097668|58610835|FG001|Overall Study|Lost to Follow-up|0|||
30599010|NCT01325207|58610851|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
30599011|NCT01325207|58610852|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
30599012|NCT01325207|58610853|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
30688085|NCT03835975|58701766|FG001|Overall Study|Lost to Follow-up|1|||
30688086|NCT03835975|58701767|FG002|Overall Study|Lost to Follow-up|0|||
30599013|NCT01325207|58610854|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
30599014|NCT01325207|58610855|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
30599015|NCT01325207|58610856|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
30599016|NCT01325207|58610851|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
30599017|NCT01325207|58610852|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
30599018|NCT01325207|58610853|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
30599019|NCT01325207|58610854|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
30599020|NCT01325207|58610855|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
30599021|NCT01325207|58610856|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
30599022|NCT01325207|58610851|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
30599023|NCT01325207|58610852|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
30599024|NCT01325207|58610853|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
30599025|NCT01325207|58610854|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
30599026|NCT01325207|58610855|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
30599027|NCT01325207|58610856|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
30599028|NCT01325207|58610851|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
30599029|NCT01325207|58610852|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
30599030|NCT01325207|58610853|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
30599031|NCT01325207|58610854|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
30599032|NCT01325207|58610855|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
30599033|NCT01325207|58610856|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
30599034|NCT01325207|58610851|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
30599035|NCT01325207|58610852|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
30599036|NCT01325207|58610853|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
30599037|NCT01325207|58610854|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
30599038|NCT01325207|58610855|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
30599039|NCT01325207|58610856|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
30599040|NCT01325207|58610851|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
30599041|NCT01325207|58610852|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
30599042|NCT01325207|58610853|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
30599043|NCT01325207|58610854|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
30599044|NCT01325207|58610855|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
30688087|NCT03835975|58701768|FG003|Overall Study|Lost to Follow-up|0|||
30688088|NCT03835975|58701769|FG004|Overall Study|Lost to Follow-up|0|||
30688089|NCT03835975|58701765|FG000|Overall Study|No longer met eligibility criteria|0|||
30688090|NCT03835975|58701766|FG001|Overall Study|No longer met eligibility criteria|1|||
30688091|NCT03835975|58701767|FG002|Overall Study|No longer met eligibility criteria|0|||
30688092|NCT03835975|58701768|FG003|Overall Study|No longer met eligibility criteria|0|||
30688093|NCT03835975|58701769|FG004|Overall Study|No longer met eligibility criteria|0|||
30688094|NCT03835975|58701765|FG000|Overall Study|Protocol Violation|1|||
30688095|NCT03835975|58701766|FG001|Overall Study|Protocol Violation|1|||
30688096|NCT03835975|58701767|FG002|Overall Study|Protocol Violation|2|||
30688097|NCT03835975|58701768|FG003|Overall Study|Protocol Violation|0|||
30688098|NCT03835975|58701769|FG004|Overall Study|Protocol Violation|0|||
30959268|NCT01683383|59024723|FG001|Overall Study|Infant was not transported|0|||
30959269|NCT02694744|59024731|FG000|Overall Study|Adverse Event|2|||
30959270|NCT02694744|59024732|FG001|Overall Study|Adverse Event|1|||
30785342|NCT04405076|58798343|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
30785343|NCT04405076|58798344|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
30785344|NCT04405076|58798336|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
30785345|NCT04405076|58798337|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
30785346|NCT04405076|58798338|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
30785347|NCT04405076|58798339|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
30785348|NCT04405076|58798340|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
30785349|NCT04405076|58798341|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
30785350|NCT04405076|58798342|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
30785351|NCT04405076|58798343|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
30785352|NCT04405076|58798344|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
30785353|NCT04311177|58798372|FG000|Overall Study|Adverse Event|3|||
30785354|NCT04311177|58798373|FG001|Overall Study|Adverse Event|1|||
30785355|NCT04311177|58798372|FG000|Overall Study|Physician Decision|4|||
30688099|NCT03835975|58701765|FG000|Overall Study|Withdrawal by Subject|1|||
30688100|NCT03835975|58701766|FG001|Overall Study|Withdrawal by Subject|0|||
30688101|NCT03835975|58701767|FG002|Overall Study|Withdrawal by Subject|1|||
30688102|NCT03835975|58701768|FG003|Overall Study|Withdrawal by Subject|1|||
30688103|NCT03835975|58701769|FG004|Overall Study|Withdrawal by Subject|0|||
30688104|NCT00427921|58701783|FG000|Overall Study|Adverse Event|26|||
30688105|NCT00427921|58701783|FG000|Overall Study|Withdrawal by Subject|4|||
30688106|NCT00427921|58701783|FG000|Overall Study|Lost to Follow-up|2|||
30688107|NCT00427921|58701783|FG000|Overall Study|Other reason not specified|10|||
30688108|NCT00427921|58701783|FG000|Overall Study|Adverse Event + Hospitalization|1|||
30688109|NCT00427921|58701783|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
30688110|NCT00427921|58701783|FG000|Overall Study|Adverse Event + No Response|1|||
30688111|NCT00427921|58701783|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
30688112|NCT00427921|58701783|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
30688113|NCT00427921|58701783|FG000|Overall Study|Adverse Event + Lost Response|1|||
30688114|NCT00427921|58701783|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
30688115|NCT00427921|58701783|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
30688116|NCT00432991|58701789|FG000|Overall Study|Protocol Violation|7|||
30688117|NCT00432991|58701790|FG001|Overall Study|Protocol Violation|12|||
30785356|NCT04311177|58798373|FG001|Overall Study|Physician Decision|3|||
30785357|NCT04311177|58798372|FG000|Overall Study|Withdrawal by Subject|1|||
30785358|NCT04311177|58798373|FG001|Overall Study|Withdrawal by Subject|0|||
30785359|NCT03267212|58798379|FG000|First Intervention|Lost to Follow-up|0|||
30785360|NCT03267212|58798380|FG001|First Intervention|Lost to Follow-up|2|||
30785361|NCT03267212|58798379|FG000|First Intervention|Withdrawal by Subject|1|||
30785362|NCT03267212|58798380|FG001|First Intervention|Withdrawal by Subject|1|||
30785363|NCT03267212|58798379|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
30785364|NCT03267212|58798380|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
30785365|NCT04292535|58798400|FG000|Overall Study|Withdrawal by Subject|0|||
30785366|NCT04292535|58798401|FG001|Overall Study|Withdrawal by Subject|0|||
30856368|NCT02630459|58884246|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
30856369|NCT02630459|58884247|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
30856370|NCT02630459|58884248|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
30856371|NCT02630459|58884249|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
30856372|NCT02630459|58884250|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
30856373|NCT02630459|58884243|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
30856374|NCT02630459|58884244|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
30856375|NCT02630459|58884245|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
30856376|NCT02630459|58884246|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
30856377|NCT02630459|58884247|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
30856378|NCT02630459|58884248|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
30856379|NCT02630459|58884249|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
30856380|NCT02630459|58884250|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
30856381|NCT02630459|58884243|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
30856382|NCT02630459|58884244|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
30856383|NCT02630459|58884245|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
30856384|NCT02630459|58884246|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
30856385|NCT02630459|58884247|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
30688118|NCT00432835|58701798|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
30785367|NCT04292535|58798402|FG002|Overall Study|Withdrawal by Subject|0|||
30785368|NCT04292535|58798403|FG003|Overall Study|Withdrawal by Subject|0|||
30785369|NCT04292535|58798404|FG004|Overall Study|Withdrawal by Subject|0|||
30785370|NCT04292535|58798405|FG005|Overall Study|Withdrawal by Subject|0|||
30785371|NCT04292535|58798406|FG006|Overall Study|Withdrawal by Subject|0|||
30785372|NCT04292535|58798407|FG007|Overall Study|Withdrawal by Subject|1|||
30785373|NCT04292535|58798408|FG008|Overall Study|Withdrawal by Subject|0|||
30785374|NCT04292535|58798409|FG009|Overall Study|Withdrawal by Subject|0|||
30785375|NCT04292535|58798410|FG010|Overall Study|Withdrawal by Subject|0|||
30785376|NCT04292535|58798411|FG011|Overall Study|Withdrawal by Subject|0|||
30785377|NCT04292535|58798412|FG012|Overall Study|Withdrawal by Subject|0|||
30785378|NCT04292535|58798413|FG013|Overall Study|Withdrawal by Subject|0|||
30785379|NCT04292535|58798400|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
30785380|NCT04292535|58798401|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
30785381|NCT04292535|58798402|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
30785382|NCT04292535|58798403|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
30785383|NCT04292535|58798404|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
30785384|NCT04292535|58798405|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
30785385|NCT04292535|58798406|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
30785386|NCT04292535|58798407|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
30785387|NCT04292535|58798408|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
30785388|NCT04292535|58798409|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
30785389|NCT04292535|58798410|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
30785390|NCT04292535|58798411|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
30785391|NCT04292535|58798412|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
30785392|NCT04292535|58798413|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
30785393|NCT04292535|58798400|FG000|Overall Study|Report of Dizziness|0|||
30785394|NCT04292535|58798401|FG001|Overall Study|Report of Dizziness|0|||
30785395|NCT04292535|58798402|FG002|Overall Study|Report of Dizziness|0|||
30785396|NCT04292535|58798403|FG003|Overall Study|Report of Dizziness|0|||
30785397|NCT04292535|58798404|FG004|Overall Study|Report of Dizziness|0|||
30785398|NCT04292535|58798405|FG005|Overall Study|Report of Dizziness|0|||
30785399|NCT04292535|58798406|FG006|Overall Study|Report of Dizziness|0|||
30785400|NCT04292535|58798407|FG007|Overall Study|Report of Dizziness|0|||
30785401|NCT04292535|58798408|FG008|Overall Study|Report of Dizziness|0|||
30785402|NCT04292535|58798409|FG009|Overall Study|Report of Dizziness|0|||
30785403|NCT04292535|58798410|FG010|Overall Study|Report of Dizziness|0|||
30785404|NCT04292535|58798411|FG011|Overall Study|Report of Dizziness|0|||
30785405|NCT04292535|58798412|FG012|Overall Study|Report of Dizziness|0|||
30785406|NCT04292535|58798413|FG013|Overall Study|Report of Dizziness|1|||
30785407|NCT04292535|58798400|FG000|Overall Study|Equipment Failure|0|||
30785408|NCT04292535|58798401|FG001|Overall Study|Equipment Failure|0|||
30785409|NCT04292535|58798402|FG002|Overall Study|Equipment Failure|0|||
30785410|NCT04292535|58798403|FG003|Overall Study|Equipment Failure|0|||
30688119|NCT00432835|58701799|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
30688120|NCT00580970|58701807|FG000|Pre-treatment|Non-compliance|1|||
30688121|NCT00580970|58701807|FG000|Treatment (Lovastatin)|Non-compliance|6|||
30688122|NCT00580970|58701807|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
30688123|NCT00580970|58701807|FG000|Treatment (Lovastatin)|Physician Decision|4|||
30785411|NCT04292535|58798404|FG004|Overall Study|Equipment Failure|0|||
30599045|NCT01325207|58610856|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
30599046|NCT01325207|58610851|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
30599047|NCT01325207|58610852|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
30599048|NCT01325207|58610853|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
30599049|NCT01325207|58610854|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
30599050|NCT01325207|58610855|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
30599051|NCT01325207|58610856|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
30785412|NCT04292535|58798405|FG005|Overall Study|Equipment Failure|0|||
30785413|NCT04292535|58798406|FG006|Overall Study|Equipment Failure|0|||
30785414|NCT04292535|58798407|FG007|Overall Study|Equipment Failure|0|||
30785415|NCT04292535|58798408|FG008|Overall Study|Equipment Failure|0|||
30785416|NCT04292535|58798409|FG009|Overall Study|Equipment Failure|0|||
30856386|NCT02630459|58884248|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
30599052|NCT01324349|58610873|FG000|Overall Study|Death|1|||
30599053|NCT01324349|58610874|FG001|Overall Study|Death|1|||
30599054|NCT01324349|58610873|FG000|Overall Study|Withdrawal by Subject|0|||
30599055|NCT01324349|58610874|FG001|Overall Study|Withdrawal by Subject|1|||
30599056|NCT01095250|58610884|FG000|Overall Study|administrative reasons|8|||
30599057|NCT01095250|58610885|FG001|Overall Study|administrative reasons|10|||
30856387|NCT02630459|58884249|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
30688124|NCT00580970|58701807|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
30785417|NCT04292535|58798410|FG010|Overall Study|Equipment Failure|0|||
30785418|NCT04292535|58798411|FG011|Overall Study|Equipment Failure|1|||
30785419|NCT04292535|58798412|FG012|Overall Study|Equipment Failure|0|||
30785420|NCT04292535|58798413|FG013|Overall Study|Equipment Failure|0|||
30785421|NCT04385199|58798445|FG000|Overall Study|Withdrawal by Subject|1|||
30856388|NCT02630459|58884250|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
30688125|NCT00580970|58701807|FG000|Treatment (Lovastatin)|Death|1|||
30688126|NCT00665925|58701815|FG000|Overall Study|Lack of Efficacy|10|||
30688127|NCT00665925|58701816|FG001|Overall Study|Lack of Efficacy|8|||
30688128|NCT00665925|58701817|FG002|Overall Study|Lack of Efficacy|9|||
30688129|NCT00665925|58701818|FG003|Overall Study|Lack of Efficacy|8|||
30688130|NCT00665925|58701815|FG000|Overall Study|Lost to Follow-up|1|||
30688131|NCT00665925|58701816|FG001|Overall Study|Lost to Follow-up|2|||
30688132|NCT00665925|58701817|FG002|Overall Study|Lost to Follow-up|2|||
30688133|NCT00665925|58701818|FG003|Overall Study|Lost to Follow-up|2|||
30688134|NCT00665925|58701815|FG000|Overall Study|Withdrawal by Subject|2|||
30688135|NCT00665925|58701816|FG001|Overall Study|Withdrawal by Subject|2|||
30688136|NCT00665925|58701817|FG002|Overall Study|Withdrawal by Subject|3|||
30785422|NCT04385199|58798446|FG001|Overall Study|Withdrawal by Subject|0|||
30785423|NCT04284813|58798452|FG000|Overall Study|Withdrawal by Subject|1|||
30785424|NCT03263780|58798456|FG000|Overall Study|Withdrawal by Subject|3|||
30785425|NCT03263780|58798456|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
30785426|NCT02791438|58798462|FG000|Treatment Period|Adverse Event|1|||
30785427|NCT02791438|58798463|FG001|Treatment Period|Adverse Event|0|||
30785428|NCT02791438|58798462|FG000|Treatment Period|Withdrawal by Subject|0|||
30785429|NCT02791438|58798463|FG001|Treatment Period|Withdrawal by Subject|1|||
30785430|NCT02791438|58798462|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
30785431|NCT02791438|58798463|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
30785432|NCT03712124|58798471|FG000|Overall Study|Protocol Violation|1|||
30785433|NCT03712124|58798472|FG001|Overall Study|Protocol Violation|0|||
30785434|NCT02791516|58798486|FG000|Overall Study|Withdrawal by Subject|1|||
30785435|NCT02791516|58798487|FG001|Overall Study|Withdrawal by Subject|1|||
30785436|NCT03263702|58798495|FG000|Overall Study|Lost to Follow-up|2|||
30785437|NCT03263702|58798496|FG001|Overall Study|Lost to Follow-up|2|||
30785438|NCT03263702|58798495|FG000|Overall Study|Withdrawal by Subject|1|||
30785439|NCT03263702|58798496|FG001|Overall Study|Withdrawal by Subject|2|||
30785440|NCT04130919|58798505|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
30785441|NCT04130919|58798506|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
30785442|NCT04130919|58798507|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
30785443|NCT04130919|58798508|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
30785444|NCT04130919|58798509|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
30785445|NCT04130919|58798510|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
30785446|NCT04130919|58798505|FG000|Blinded Treatment Phase|Adverse Event|0|||
30785447|NCT04130919|58798506|FG001|Blinded Treatment Phase|Adverse Event|0|||
30785448|NCT04130919|58798507|FG002|Blinded Treatment Phase|Adverse Event|1|||
30785449|NCT04130919|58798508|FG003|Blinded Treatment Phase|Adverse Event|0|||
30785450|NCT04130919|58798509|FG004|Blinded Treatment Phase|Adverse Event|0|||
30785451|NCT04130919|58798510|FG005|Blinded Treatment Phase|Adverse Event|0|||
30785452|NCT04130919|58798505|FG000|Blinded Treatment Phase|Disease worsening|0|||
30785453|NCT04130919|58798506|FG001|Blinded Treatment Phase|Disease worsening|0|||
30785454|NCT04130919|58798507|FG002|Blinded Treatment Phase|Disease worsening|1|||
30785455|NCT04130919|58798508|FG003|Blinded Treatment Phase|Disease worsening|0|||
30785456|NCT04130919|58798509|FG004|Blinded Treatment Phase|Disease worsening|0|||
30785457|NCT04130919|58798510|FG005|Blinded Treatment Phase|Disease worsening|0|||
30785458|NCT04130919|58798505|FG000|Blinded Treatment Phase|Investigator's decision|0|||
30785459|NCT04130919|58798506|FG001|Blinded Treatment Phase|Investigator's decision|1|||
30688137|NCT00665925|58701818|FG003|Overall Study|Withdrawal by Subject|2|||
30688138|NCT00665925|58701815|FG000|Overall Study|Physician Decision|0|||
30688139|NCT00665925|58701816|FG001|Overall Study|Physician Decision|0|||
30688140|NCT00665925|58701817|FG002|Overall Study|Physician Decision|1|||
30688141|NCT00665925|58701818|FG003|Overall Study|Physician Decision|2|||
30688142|NCT00665925|58701815|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
30688143|NCT00665925|58701816|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
30688144|NCT00665925|58701817|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
30688145|NCT00665925|58701818|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
30688146|NCT00665925|58701815|FG000|Overall Study|Adverse Event|1|||
30688147|NCT00665925|58701816|FG001|Overall Study|Adverse Event|5|||
30785460|NCT04130919|58798507|FG002|Blinded Treatment Phase|Investigator's decision|0|||
30785461|NCT04130919|58798508|FG003|Blinded Treatment Phase|Investigator's decision|0|||
30785462|NCT04130919|58798509|FG004|Blinded Treatment Phase|Investigator's decision|0|||
30856389|NCT02630459|58884243|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
30856390|NCT02630459|58884244|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
30688148|NCT00665925|58701817|FG002|Overall Study|Adverse Event|10|||
30688149|NCT00665925|58701818|FG003|Overall Study|Adverse Event|5|||
30785463|NCT04130919|58798510|FG005|Blinded Treatment Phase|Investigator's decision|0|||
30785464|NCT04130919|58798505|FG000|Blinded Treatment Phase|Withdrew consent|1|||
30785465|NCT04130919|58798506|FG001|Blinded Treatment Phase|Withdrew consent|0|||
30785466|NCT04130919|58798507|FG002|Blinded Treatment Phase|Withdrew consent|0|||
30785467|NCT04130919|58798508|FG003|Blinded Treatment Phase|Withdrew consent|0|||
30688150|NCT00665925|58701815|FG000|Overall Study|Enrolled by mistake|0|||
30688151|NCT00665925|58701816|FG001|Overall Study|Enrolled by mistake|0|||
30785468|NCT04130919|58798509|FG004|Blinded Treatment Phase|Withdrew consent|0|||
30785469|NCT04130919|58798510|FG005|Blinded Treatment Phase|Withdrew consent|0|||
30785470|NCT04130919|58798505|FG000|Open-label Treatment Phase|Withdrew consent|0|||
30785471|NCT04130919|58798506|FG001|Open-label Treatment Phase|Withdrew consent|0|||
30785472|NCT04130919|58798507|FG002|Open-label Treatment Phase|Withdrew consent|0|||
30785473|NCT04130919|58798508|FG003|Open-label Treatment Phase|Withdrew consent|1|||
30785474|NCT04130919|58798509|FG004|Open-label Treatment Phase|Withdrew consent|1|||
30785475|NCT04130919|58798510|FG005|Open-label Treatment Phase|Withdrew consent|1|||
30785476|NCT04130919|58798505|FG000|Open-label Treatment Phase|Disease worsening|0|||
30785477|NCT04130919|58798506|FG001|Open-label Treatment Phase|Disease worsening|0|||
30785478|NCT04130919|58798507|FG002|Open-label Treatment Phase|Disease worsening|0|||
30785479|NCT04130919|58798508|FG003|Open-label Treatment Phase|Disease worsening|1|||
30785480|NCT04130919|58798509|FG004|Open-label Treatment Phase|Disease worsening|0|||
30785481|NCT04130919|58798510|FG005|Open-label Treatment Phase|Disease worsening|1|||
30785482|NCT04130919|58798505|FG000|Open-label Treatment Phase|Investigator's decision|0|||
30856391|NCT02630459|58884245|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
30856392|NCT02630459|58884246|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
30856393|NCT02630459|58884247|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
30856394|NCT02630459|58884248|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
30856395|NCT02630459|58884249|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
30856396|NCT02630459|58884250|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
30856397|NCT02630459|58884243|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
30688152|NCT00665925|58701817|FG002|Overall Study|Enrolled by mistake|0|||
30688153|NCT00665925|58701818|FG003|Overall Study|Enrolled by mistake|1|||
30688154|NCT00665925|58701815|FG000|Overall Study|Due to exclusion criteria|1|||
30688155|NCT00665925|58701816|FG001|Overall Study|Due to exclusion criteria|0|||
30688156|NCT00665925|58701817|FG002|Overall Study|Due to exclusion criteria|0|||
30688157|NCT00665925|58701818|FG003|Overall Study|Due to exclusion criteria|0|||
30688158|NCT00426751|58701831|FG000|Overall Study|Adverse Event|8|||
30688159|NCT00426751|58701832|FG001|Overall Study|Adverse Event|1|||
30688160|NCT00426751|58701831|FG000|Overall Study|Lost to Follow-up|7|||
30688161|NCT00426751|58701832|FG001|Overall Study|Lost to Follow-up|6|||
30688162|NCT00426751|58701831|FG000|Overall Study|Consent Withdrawn|0|||
30688163|NCT00426751|58701832|FG001|Overall Study|Consent Withdrawn|1|||
30688164|NCT00426751|58701831|FG000|Overall Study|Other Reasons|7|||
30688165|NCT00426751|58701832|FG001|Overall Study|Other Reasons|12|||
30688166|NCT00440401|58701840|FG000|Overall Study|Adverse Event|2|||
30688167|NCT00440401|58701841|FG001|Overall Study|Adverse Event|1|||
30688168|NCT00440401|58701840|FG000|Overall Study|Other|2|||
30688169|NCT00440401|58701841|FG001|Overall Study|Other|5|||
30688170|NCT02598960|58701860|FG000|Treatment Period|Disease Progression|4|||
30688171|NCT02598960|58701861|FG001|Treatment Period|Disease Progression|4|||
30688172|NCT02598960|58701862|FG002|Treatment Period|Disease Progression|4|||
30688173|NCT02598960|58701863|FG003|Treatment Period|Disease Progression|6|||
30688174|NCT02598960|58701864|FG004|Treatment Period|Disease Progression|8|||
30688175|NCT02598960|58701865|FG005|Treatment Period|Disease Progression|2|||
30688176|NCT02598960|58701866|FG006|Treatment Period|Disease Progression|2|||
30688177|NCT02598960|58701867|FG007|Treatment Period|Disease Progression|3|||
30688178|NCT02598960|58701868|FG008|Treatment Period|Disease Progression|7|||
30688179|NCT02598960|58701869|FG009|Treatment Period|Disease Progression|9|||
30688180|NCT02598960|58701870|FG010|Treatment Period|Disease Progression|7|||
30688181|NCT02598960|58701871|FG011|Treatment Period|Disease Progression|143|||
30688182|NCT02598960|58701872|FG012|Treatment Period|Disease Progression|23|||
30688183|NCT02598960|58701860|FG000|Treatment Period|Study drug toxicity|0|||
30688184|NCT02598960|58701861|FG001|Treatment Period|Study drug toxicity|0|||
30688185|NCT02598960|58701862|FG002|Treatment Period|Study drug toxicity|0|||
30688186|NCT02598960|58701863|FG003|Treatment Period|Study drug toxicity|0|||
30688187|NCT02598960|58701864|FG004|Treatment Period|Study drug toxicity|0|||
30688188|NCT02598960|58701865|FG005|Treatment Period|Study drug toxicity|0|||
30688189|NCT02598960|58701866|FG006|Treatment Period|Study drug toxicity|0|||
30688190|NCT02598960|58701867|FG007|Treatment Period|Study drug toxicity|0|||
30688191|NCT02598960|58701868|FG008|Treatment Period|Study drug toxicity|0|||
30688192|NCT02598960|58701869|FG009|Treatment Period|Study drug toxicity|1|||
30688193|NCT02598960|58701870|FG010|Treatment Period|Study drug toxicity|0|||
30856398|NCT02630459|58884244|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
30688194|NCT02598960|58701871|FG011|Treatment Period|Study drug toxicity|3|||
30688195|NCT02598960|58701872|FG012|Treatment Period|Study drug toxicity|0|||
30688196|NCT02598960|58701860|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
30688197|NCT02598960|58701861|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
30785483|NCT04130919|58798506|FG001|Open-label Treatment Phase|Investigator's decision|0|||
30856399|NCT02630459|58884245|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
30688198|NCT02598960|58701862|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
30688199|NCT02598960|58701863|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
30785484|NCT04130919|58798507|FG002|Open-label Treatment Phase|Investigator's decision|0|||
30785485|NCT04130919|58798508|FG003|Open-label Treatment Phase|Investigator's decision|1|||
30785486|NCT04130919|58798509|FG004|Open-label Treatment Phase|Investigator's decision|0|||
30785487|NCT04130919|58798510|FG005|Open-label Treatment Phase|Investigator's decision|0|||
30785488|NCT04130919|58798505|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
30785489|NCT04130919|58798506|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
30785490|NCT04130919|58798507|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
30785491|NCT04130919|58798508|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
30785492|NCT04130919|58798509|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
30785493|NCT04130919|58798510|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
30785494|NCT04130919|58798505|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
30785495|NCT04130919|58798506|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
30785496|NCT04130919|58798507|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
30785497|NCT04130919|58798508|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
30785498|NCT04130919|58798509|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
30785499|NCT04130919|58798510|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
30785500|NCT04128267|58798524|FG000|Overall Study|Withdrawal by Subject|6|||
30785501|NCT04128267|58798524|FG000|Overall Study|Death|2|||
30785502|NCT04128267|58798524|FG000|Overall Study|Disease progression|1|||
30785503|NCT04128267|58798524|FG000|Overall Study|Participant had other medical issues|4|||
30785504|NCT04128267|58798524|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
30785505|NCT03691779|58798528|FG000|Part B (24 Weeks)|Adverse Event|0|||
30785506|NCT03691779|58798529|FG001|Part B (24 Weeks)|Adverse Event|1|||
30785507|NCT03691779|58798528|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
30785508|NCT03691779|58798529|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
30785509|NCT04258995|58798538|FG000|Overall Study|Lost to Follow-up|1|||
30785510|NCT04258995|58798539|FG001|Overall Study|Lost to Follow-up|1|||
30785511|NCT04247061|58798545|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
30785512|NCT04247061|58798545|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
30785513|NCT04247061|58798545|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
30785514|NCT04241133|58798551|FG000|Overall Study|COVID19 Precautions|14|||
30785515|NCT04241133|58798552|FG001|Overall Study|COVID19 Precautions|34|||
30785516|NCT04123665|58798560|FG000|Overall Study|Withdrawal by Subject|7|||
30785517|NCT04123665|58798561|FG001|Overall Study|Withdrawal by Subject|0|||
30785518|NCT04123665|58798560|FG000|Overall Study|Lost to Follow-up|1|||
30785519|NCT04123665|58798561|FG001|Overall Study|Lost to Follow-up|0|||
30785520|NCT04232943|58798570|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
30785521|NCT04232943|58798571|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
30785522|NCT04232943|58798572|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
30785523|NCT04232943|58798570|FG000|Overall Study|Withdrawal by Subject|1|||
30785524|NCT04232943|58798571|FG001|Overall Study|Withdrawal by Subject|1|||
30785525|NCT04232943|58798572|FG002|Overall Study|Withdrawal by Subject|0|||
30688200|NCT02598960|58701864|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
30688201|NCT02598960|58701865|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
30688202|NCT02598960|58701866|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
30688203|NCT02598960|58701867|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
30688204|NCT02598960|58701868|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
30688205|NCT02598960|58701869|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
30688206|NCT02598960|58701870|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
30688207|NCT02598960|58701871|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
30688208|NCT02598960|58701872|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
30688209|NCT02598960|58701860|FG000|Treatment Period|participant request to discontinue|0|||
30688210|NCT02598960|58701861|FG001|Treatment Period|participant request to discontinue|1|||
30688211|NCT02598960|58701862|FG002|Treatment Period|participant request to discontinue|0|||
30688212|NCT02598960|58701863|FG003|Treatment Period|participant request to discontinue|0|||
30688213|NCT02598960|58701864|FG004|Treatment Period|participant request to discontinue|1|||
30688214|NCT02598960|58701865|FG005|Treatment Period|participant request to discontinue|0|||
30688215|NCT02598960|58701866|FG006|Treatment Period|participant request to discontinue|0|||
30688216|NCT02598960|58701867|FG007|Treatment Period|participant request to discontinue|0|||
30688217|NCT02598960|58701868|FG008|Treatment Period|participant request to discontinue|0|||
30688218|NCT02598960|58701869|FG009|Treatment Period|participant request to discontinue|0|||
30688219|NCT02598960|58701870|FG010|Treatment Period|participant request to discontinue|1|||
30785526|NCT03694275|58798583|FG000|Overall Study|Adverse Event|0|||
30785527|NCT03694275|58798584|FG001|Overall Study|Adverse Event|1|||
30785528|NCT03694275|58798583|FG000|Overall Study|Reason not Specified|0|||
30785529|NCT03694275|58798584|FG001|Overall Study|Reason not Specified|1|||
30785530|NCT04230213|58798591|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
30688220|NCT02598960|58701871|FG011|Treatment Period|participant request to discontinue|4|||
30688221|NCT02598960|58701872|FG012|Treatment Period|participant request to discontinue|0|||
30688222|NCT02598960|58701860|FG000|Treatment Period|participant withdrew consent|0|||
30688223|NCT02598960|58701861|FG001|Treatment Period|participant withdrew consent|0|||
30688224|NCT02598960|58701862|FG002|Treatment Period|participant withdrew consent|0|||
30688225|NCT02598960|58701863|FG003|Treatment Period|participant withdrew consent|0|||
30688226|NCT02598960|58701864|FG004|Treatment Period|participant withdrew consent|0|||
30688227|NCT02598960|58701865|FG005|Treatment Period|participant withdrew consent|0|||
30688228|NCT02598960|58701866|FG006|Treatment Period|participant withdrew consent|0|||
30688229|NCT02598960|58701867|FG007|Treatment Period|participant withdrew consent|0|||
30688230|NCT02598960|58701868|FG008|Treatment Period|participant withdrew consent|0|||
30688231|NCT02598960|58701869|FG009|Treatment Period|participant withdrew consent|0|||
30688232|NCT02598960|58701870|FG010|Treatment Period|participant withdrew consent|0|||
30785531|NCT04230213|58798592|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
30785532|NCT04230213|58798593|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
30785533|NCT04230213|58798591|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
30785534|NCT04230213|58798592|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
30785535|NCT04230213|58798593|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
30785536|NCT04230213|58798591|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
30785537|NCT04230213|58798592|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
30688233|NCT02598960|58701871|FG011|Treatment Period|participant withdrew consent|3|||
30688234|NCT02598960|58701872|FG012|Treatment Period|participant withdrew consent|0|||
30688235|NCT02598960|58701860|FG000|Treatment Period|No longer meets study criteria|0|||
30688236|NCT02598960|58701861|FG001|Treatment Period|No longer meets study criteria|0|||
30688237|NCT02598960|58701862|FG002|Treatment Period|No longer meets study criteria|0|||
30688238|NCT02598960|58701863|FG003|Treatment Period|No longer meets study criteria|0|||
30688239|NCT02598960|58701864|FG004|Treatment Period|No longer meets study criteria|0|||
30688240|NCT02598960|58701865|FG005|Treatment Period|No longer meets study criteria|0|||
30785538|NCT04230213|58798593|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
30785539|NCT04230213|58798591|FG000|TP2: Week 10 to Week 16|Other|0|||
30785540|NCT04230213|58798592|FG001|TP2: Week 10 to Week 16|Other|2|||
30785541|NCT04230213|58798593|FG002|TP2: Week 10 to Week 16|Other|1|||
30785542|NCT04230213|58798591|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
30785543|NCT04230213|58798592|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
30785544|NCT04230213|58798593|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
30785545|NCT04230213|58798591|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
30785546|NCT04230213|58798592|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
30785547|NCT04230213|58798593|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
30785548|NCT04230213|58798591|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
30785549|NCT04230213|58798592|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
30785550|NCT04230213|58798593|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
30785551|NCT04230213|58798591|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
30785552|NCT04230213|58798592|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
30599058|NCT01095250|58610886|FG002|Overall Study|administrative reasons|7|||
30599059|NCT01095250|58610887|FG003|Overall Study|administrative reasons|5|||
30599060|NCT01095250|58610884|FG000|Overall Study|Withdrawal by Subject|0|||
30785553|NCT04230213|58798593|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
30785554|NCT04230213|58798591|FG000|TP3: Week 16 to Week 22|Other|0|||
30785555|NCT04230213|58798592|FG001|TP3: Week 16 to Week 22|Other|1|||
30785556|NCT04230213|58798593|FG002|TP3: Week 16 to Week 22|Other|3|||
30785557|NCT04230213|58798591|FG000|TP4: Week 22 to Week 32|Other|0|||
30599061|NCT01095250|58610885|FG001|Overall Study|Withdrawal by Subject|0|||
30599062|NCT01095250|58610886|FG002|Overall Study|Withdrawal by Subject|1|||
30599063|NCT01095250|58610887|FG003|Overall Study|Withdrawal by Subject|0|||
30599064|NCT01324271|58610897|FG000|Overall Study|Lost to Follow-up|3|||
30599065|NCT01324271|58610898|FG001|Overall Study|Lost to Follow-up|0|||
30599066|NCT01324271|58610897|FG000|Overall Study|Physician Decision|1|||
30599067|NCT01324271|58610898|FG001|Overall Study|Physician Decision|0|||
30599068|NCT01095094|58610904|FG000|Overall Study|Withdrawal by Subject|1|||
30599069|NCT01095094|58610904|FG000|Overall Study|Death|1|||
30599070|NCT01095094|58610904|FG000|Overall Study|Physician Decision|1|||
30599071|NCT01323647|58610910|FG000|Overall Study|Migrated/moved from study area|2|||
30599072|NCT01323647|58610911|FG001|Overall Study|Migrated/moved from study area|0|||
30599073|NCT01323647|58610910|FG000|Overall Study|Withdrawal by Subject|5|||
30599074|NCT01323647|58610911|FG001|Overall Study|Withdrawal by Subject|0|||
30599075|NCT01323647|58610910|FG000|Overall Study|Lost to Follow-up|2|||
30688241|NCT02598960|58701866|FG006|Treatment Period|No longer meets study criteria|0|||
30688242|NCT02598960|58701867|FG007|Treatment Period|No longer meets study criteria|0|||
30785558|NCT04230213|58798592|FG001|TP4: Week 22 to Week 32|Other|5|||
30785559|NCT04230213|58798593|FG002|TP4: Week 22 to Week 32|Other|5|||
30785560|NCT04230213|58798591|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
30599076|NCT01323647|58610911|FG001|Overall Study|Lost to Follow-up|0|||
30599077|NCT01094782|58610923|FG000|Overall Study|Withdrawal by Subject|5|||
30785561|NCT04230213|58798592|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
30785562|NCT04230213|58798593|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
30785563|NCT04230213|58798591|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
30785564|NCT04230213|58798592|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
30785565|NCT04230213|58798593|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
30785566|NCT04230213|58798591|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
30785567|NCT04230213|58798592|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
30785568|NCT04230213|58798593|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
30785569|NCT04230213|58798591|FG000|Follow up: Week 32 to Week 36|Other|0|||
30785570|NCT04230213|58798592|FG001|Follow up: Week 32 to Week 36|Other|1|||
30785571|NCT04230213|58798593|FG002|Follow up: Week 32 to Week 36|Other|1|||
30785572|NCT04222725|58798605|FG000|Overall Study|Adverse Event|0|||
30785573|NCT04222725|58798606|FG001|Overall Study|Adverse Event|1|||
30785574|NCT04222725|58798607|FG002|Overall Study|Adverse Event|0|||
30785575|NCT04222725|58798608|FG003|Overall Study|Adverse Event|0|||
30785576|NCT04213989|58798620|FG000|Overall Study|Withdrawal by Subject|3|||
30785577|NCT04213989|58798621|FG001|Overall Study|Withdrawal by Subject|2|||
30785578|NCT04213989|58798620|FG000|Overall Study|Physician Decision|1|||
30785579|NCT04213989|58798621|FG001|Overall Study|Physician Decision|0|||
30785580|NCT04213989|58798620|FG000|Overall Study|Lost to Follow-up|0|||
30785581|NCT04213989|58798621|FG001|Overall Study|Lost to Follow-up|4|||
30785582|NCT03242252|58798630|FG000|Overall Study|At the Participant's own Request|18|||
30785583|NCT03242252|58798631|FG001|Overall Study|At the Participant's own Request|10|||
30785584|NCT03242252|58798632|FG002|Overall Study|At the Participant's own Request|15|||
30785585|NCT03242252|58798630|FG000|Overall Study|Adverse Event|8|||
30785586|NCT03242252|58798631|FG001|Overall Study|Adverse Event|6|||
30785587|NCT03242252|58798632|FG002|Overall Study|Adverse Event|9|||
30785588|NCT03242252|58798630|FG000|Overall Study|Poor Compliance to Protocol|0|||
30785589|NCT03242252|58798631|FG001|Overall Study|Poor Compliance to Protocol|2|||
30785590|NCT03242252|58798632|FG002|Overall Study|Poor Compliance to Protocol|3|||
30785591|NCT03242252|58798630|FG000|Overall Study|Study Terminated by Sponsor|1|||
30785592|NCT03242252|58798631|FG001|Overall Study|Study Terminated by Sponsor|0|||
30785593|NCT03242252|58798632|FG002|Overall Study|Study Terminated by Sponsor|0|||
30785594|NCT03242252|58798630|FG000|Overall Study|Reason not Specified|4|||
30785595|NCT03242252|58798631|FG001|Overall Study|Reason not Specified|4|||
30785596|NCT03242252|58798632|FG002|Overall Study|Reason not Specified|1|||
30785597|NCT03242252|58798630|FG000|Overall Study|Lost to Follow-up|5|||
30785598|NCT03242252|58798631|FG001|Overall Study|Lost to Follow-up|1|||
30785599|NCT03242252|58798632|FG002|Overall Study|Lost to Follow-up|4|||
30785600|NCT04109391|58798649|FG000|Overall Study|Adverse Event|2|||
30785601|NCT04109391|58798650|FG001|Overall Study|Adverse Event|2|||
30785602|NCT04109391|58798651|FG002|Overall Study|Adverse Event|0|||
30785603|NCT04109391|58798649|FG000|Overall Study|Withdrawal by Subject|2|||
30785604|NCT04109391|58798650|FG001|Overall Study|Withdrawal by Subject|0|||
30785605|NCT04109391|58798651|FG002|Overall Study|Withdrawal by Subject|0|||
30785606|NCT04109391|58798649|FG000|Overall Study|Pregnancy|1|||
30785607|NCT04109391|58798650|FG001|Overall Study|Pregnancy|0|||
30785608|NCT04109391|58798651|FG002|Overall Study|Pregnancy|0|||
30785609|NCT04109391|58798649|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
30688243|NCT02598960|58701868|FG008|Treatment Period|No longer meets study criteria|0|||
30688244|NCT02598960|58701869|FG009|Treatment Period|No longer meets study criteria|0|||
30688245|NCT02598960|58701870|FG010|Treatment Period|No longer meets study criteria|0|||
30688246|NCT02598960|58701871|FG011|Treatment Period|No longer meets study criteria|1|||
30688247|NCT02598960|58701872|FG012|Treatment Period|No longer meets study criteria|0|||
30688248|NCT02598960|58701860|FG000|Treatment Period|Other Reasons|0|||
30688249|NCT02598960|58701861|FG001|Treatment Period|Other Reasons|0|||
30688250|NCT02598960|58701862|FG002|Treatment Period|Other Reasons|0|||
30688251|NCT02598960|58701863|FG003|Treatment Period|Other Reasons|0|||
30688252|NCT02598960|58701864|FG004|Treatment Period|Other Reasons|0|||
30688253|NCT02598960|58701865|FG005|Treatment Period|Other Reasons|0|||
30688254|NCT02598960|58701866|FG006|Treatment Period|Other Reasons|0|||
30785610|NCT04109391|58798650|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
30785611|NCT04109391|58798651|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
30785612|NCT04109391|58798649|FG000|Overall Study|Lost to Follow-up|0|||
30785613|NCT04109391|58798650|FG001|Overall Study|Lost to Follow-up|0|||
30785614|NCT04109391|58798651|FG002|Overall Study|Lost to Follow-up|1|||
30785615|NCT04109391|58798649|FG000|Overall Study|Lack of Efficacy|2|||
30785616|NCT04109391|58798650|FG001|Overall Study|Lack of Efficacy|2|||
30785617|NCT04109391|58798651|FG002|Overall Study|Lack of Efficacy|3|||
30785618|NCT04106817|58798662|FG000|Overall Study|Lost to Follow-up|1|||
30785619|NCT04106817|58798663|FG001|Overall Study|Lost to Follow-up|0|||
30785620|NCT04106817|58798664|FG002|Overall Study|Lost to Follow-up|0|||
30688255|NCT02598960|58701867|FG007|Treatment Period|Other Reasons|0|||
30688256|NCT02598960|58701868|FG008|Treatment Period|Other Reasons|0|||
30785621|NCT04097925|58798672|FG000|Overall Study|Withdrawal by Subject|1|||
30785622|NCT04195893|58798676|FG000|Second Intervention|Withdrawal by Subject|1|||
30785623|NCT04195893|58798677|FG001|Second Intervention|Withdrawal by Subject|0|||
30785624|NCT04195581|58798683|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
30785625|NCT04195581|58798683|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
30785626|NCT04195581|58798683|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
30785627|NCT04195581|58798683|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
30785628|NCT04195581|58798683|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
30785629|NCT04195581|58798683|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
30785630|NCT04096365|58798701|FG000|Overall Study|Adverse Event|1|||
30785631|NCT04194489|58798705|FG000|Overall Study|Withdrawal by Subject|5|||
30785632|NCT04194489|58798705|FG000|Overall Study|Lost to Follow-up|48|||
30785633|NCT04094883|58798709|FG000|Overall Study|Withdrawal by Subject|1|||
30785634|NCT01368562|58798713|FG000|Overall Study|Adverse Event|1|||
30785635|NCT01368562|58798713|FG000|Overall Study|Disease progression|1|||
30785636|NCT01368562|58798713|FG000|Overall Study|Lost to Follow-up|1|||
30785637|NCT01368562|58798713|FG000|Overall Study|Death|6|||
30785638|NCT01368562|58798713|FG000|Overall Study|Unresponsive to treatment|5|||
30785639|NCT01368562|58798713|FG000|Overall Study|Other|3|||
30785640|NCT01368562|58798713|FG000|Overall Study|Other than specified|2|||
30785641|NCT03242018|58798720|FG000|Overall Study|Adverse Event|7|||
30785642|NCT03242018|58798721|FG001|Overall Study|Adverse Event|7|||
30785643|NCT03242018|58798722|FG002|Overall Study|Adverse Event|6|||
30785644|NCT03242018|58798720|FG000|Overall Study|Lost to Follow-up|2|||
30785645|NCT03242018|58798721|FG001|Overall Study|Lost to Follow-up|2|||
30785646|NCT03242018|58798722|FG002|Overall Study|Lost to Follow-up|2|||
30785647|NCT03242018|58798720|FG000|Overall Study|At the Participant's Own Request|5|||
30785648|NCT03242018|58798721|FG001|Overall Study|At the Participant's Own Request|1|||
30785649|NCT03242018|58798722|FG002|Overall Study|At the Participant's Own Request|4|||
30785650|NCT03242018|58798720|FG000|Overall Study|Reason Not Specified|3|||
30785651|NCT03242018|58798721|FG001|Overall Study|Reason Not Specified|4|||
30785652|NCT03242018|58798722|FG002|Overall Study|Reason Not Specified|1|||
30785653|NCT03242018|58798720|FG000|Overall Study|Study Terminated by Sponsor|1|||
30785654|NCT03242018|58798721|FG001|Overall Study|Study Terminated by Sponsor|0|||
30785655|NCT03242018|58798722|FG002|Overall Study|Study Terminated by Sponsor|1|||
30785656|NCT02789176|58798735|FG000|Overall Study|Death|0|||
30785657|NCT02789176|58798736|FG001|Overall Study|Death|0|||
30785658|NCT02789176|58798737|FG002|Overall Study|Death|3|||
30785659|NCT02789176|58798738|FG003|Overall Study|Death|0|||
30959271|NCT02694744|59024731|FG000|Overall Study|Withdrawal by Subject|2|||
30959272|NCT02694744|59024732|FG001|Overall Study|Withdrawal by Subject|1|||
30959273|NCT02694744|59024731|FG000|Overall Study|Physician Decision|1|||
30959274|NCT02694744|59024732|FG001|Overall Study|Physician Decision|2|||
30959275|NCT02694744|59024731|FG000|Overall Study|Lost to Follow-up|1|||
30959276|NCT02694744|59024732|FG001|Overall Study|Lost to Follow-up|0|||
30959277|NCT02694744|59024731|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
30959278|NCT02694744|59024732|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
30959279|NCT01683071|59024746|FG000|Part 1|Lack of Efficacy|1|||
30959280|NCT01683071|59024747|FG001|Part 1|Lack of Efficacy|0|||
30959281|NCT01683071|59024748|FG002|Part 1|Lack of Efficacy|0|||
30959282|NCT01683071|59024749|FG003|Part 1|Lack of Efficacy|3|||
30959283|NCT01683071|59024750|FG004|Part 1|Lack of Efficacy|0|||
30959284|NCT01683071|59024751|FG005|Part 1|Lack of Efficacy|0|||
30959285|NCT01683071|59024746|FG000|Part 1|Withdrawal by Subject|1|||
30959286|NCT01683071|59024747|FG001|Part 1|Withdrawal by Subject|2|||
30959287|NCT01683071|59024748|FG002|Part 1|Withdrawal by Subject|2|||
30959288|NCT01683071|59024749|FG003|Part 1|Withdrawal by Subject|1|||
30959289|NCT01683071|59024750|FG004|Part 1|Withdrawal by Subject|0|||
30959290|NCT01683071|59024751|FG005|Part 1|Withdrawal by Subject|0|||
30959291|NCT01683071|59024746|FG000|Part 1|Surgery Cancelled|1|||
30688257|NCT02598960|58701869|FG009|Treatment Period|Other Reasons|0|||
30785660|NCT02789176|58798735|FG000|Overall Study|Withdrawal by Subject|0|||
30785661|NCT02789176|58798736|FG001|Overall Study|Withdrawal by Subject|0|||
30959292|NCT01683071|59024747|FG001|Part 1|Surgery Cancelled|0|||
30959293|NCT01683071|59024748|FG002|Part 1|Surgery Cancelled|0|||
30785662|NCT02789176|58798737|FG002|Overall Study|Withdrawal by Subject|1|||
30856400|NCT02630459|58884246|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
30785663|NCT02789176|58798738|FG003|Overall Study|Withdrawal by Subject|0|||
30785664|NCT02789176|58798735|FG000|Overall Study|Lost to Follow-up|8|||
30785665|NCT02789176|58798736|FG001|Overall Study|Lost to Follow-up|2|||
30785666|NCT02789176|58798737|FG002|Overall Study|Lost to Follow-up|6|||
30785667|NCT02789176|58798738|FG003|Overall Study|Lost to Follow-up|1|||
30785668|NCT03259490|58798750|FG000|Period 1|Withdrawal by Subject|0|||
30785669|NCT03259490|58798751|FG001|Period 1|Withdrawal by Subject|1|||
30785670|NCT03259490|58798750|FG000|Period 2|Protocol Violation|1|||
30959294|NCT01683071|59024749|FG003|Part 1|Surgery Cancelled|0|||
30959295|NCT01683071|59024750|FG004|Part 1|Surgery Cancelled|0|||
30959296|NCT01683071|59024751|FG005|Part 1|Surgery Cancelled|0|||
30959297|NCT01683071|59024746|FG000|Part 1|Did not receive study drug|1|||
30959298|NCT01683071|59024747|FG001|Part 1|Did not receive study drug|0|||
30785671|NCT03259490|58798751|FG001|Period 2|Protocol Violation|0|||
30785672|NCT03259334|58798760|FG000|Overall Study|Adverse Event|3|||
30785673|NCT03259334|58798761|FG001|Overall Study|Adverse Event|8|||
30785674|NCT03259334|58798762|FG002|Overall Study|Adverse Event|5|||
30785675|NCT03259334|58798760|FG000|Overall Study|Withdrawal by Subject|4|||
30785676|NCT03259334|58798761|FG001|Overall Study|Withdrawal by Subject|2|||
30785677|NCT03259334|58798762|FG002|Overall Study|Withdrawal by Subject|4|||
30785678|NCT03259334|58798760|FG000|Overall Study|Physician Decision|1|||
30785679|NCT03259334|58798761|FG001|Overall Study|Physician Decision|0|||
30785680|NCT03259334|58798762|FG002|Overall Study|Physician Decision|0|||
30785681|NCT03259334|58798760|FG000|Overall Study|Lost to Follow-up|0|||
30785682|NCT03259334|58798761|FG001|Overall Study|Lost to Follow-up|2|||
30785683|NCT03259334|58798762|FG002|Overall Study|Lost to Follow-up|1|||
30785684|NCT03259334|58798760|FG000|Overall Study|Protocol Deviation|0|||
30785685|NCT03259334|58798761|FG001|Overall Study|Protocol Deviation|3|||
30785686|NCT03259334|58798762|FG002|Overall Study|Protocol Deviation|2|||
30785687|NCT03259334|58798760|FG000|Overall Study|Lack of Efficacy|2|||
30785688|NCT03259334|58798761|FG001|Overall Study|Lack of Efficacy|0|||
30785689|NCT03259334|58798762|FG002|Overall Study|Lack of Efficacy|1|||
30785690|NCT03259334|58798760|FG000|Overall Study|Randomized but never treated|0|||
30785691|NCT03259334|58798761|FG001|Overall Study|Randomized but never treated|2|||
30785692|NCT03259334|58798762|FG002|Overall Study|Randomized but never treated|0|||
30785693|NCT01331824|58798770|FG000|Overall Study|Adverse Event|2|||
30785694|NCT01331824|58798770|FG000|Overall Study|Death|1|||
30785695|NCT01331824|58798770|FG000|Overall Study|Disease Progression|9|||
30785696|NCT01331824|58798770|FG000|Overall Study|Withdrawal by Subject|1|||
30785697|NCT03258710|58798774|FG000|Overall Study|Adverse Event|1|||
30785698|NCT03258710|58798774|FG000|Overall Study|Protocol-defined stopping criteria|1|||
30785699|NCT03258710|58798774|FG000|Overall Study|Physician Decision|1|||
30785700|NCT03240692|58798778|FG000|Overall Study|Physician Decision|1|||
30785701|NCT03240692|58798778|FG000|Overall Study|Withdrawal by Subject|1|||
30785702|NCT03233048|58798782|FG000|Overall Study|Withdrawal by Subject|1|||
30785703|NCT02937740|58798788|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
30785704|NCT02937740|58798789|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
30785705|NCT02937740|58798788|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
30785706|NCT02937740|58798789|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
30688258|NCT02598960|58701870|FG010|Treatment Period|Other Reasons|0|||
30785707|NCT02937740|58798788|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
30785708|NCT02937740|58798789|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
30785709|NCT02937740|58798788|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
30785710|NCT02937740|58798789|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
30785711|NCT02937740|58798788|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
30959299|NCT01683071|59024748|FG002|Part 1|Did not receive study drug|0|||
30959300|NCT01683071|59024749|FG003|Part 1|Did not receive study drug|1|||
30959301|NCT01683071|59024750|FG004|Part 1|Did not receive study drug|0|||
30959302|NCT01683071|59024751|FG005|Part 1|Did not receive study drug|0|||
30959303|NCT01683071|59024746|FG000|Part 1|Early termination; met exclusion criteria|0|||
30959304|NCT01683071|59024747|FG001|Part 1|Early termination; met exclusion criteria|2|||
30959305|NCT01683071|59024748|FG002|Part 1|Early termination; met exclusion criteria|1|||
30959306|NCT01683071|59024749|FG003|Part 1|Early termination; met exclusion criteria|0|||
30959307|NCT01683071|59024750|FG004|Part 1|Early termination; met exclusion criteria|0|||
30959308|NCT01683071|59024751|FG005|Part 1|Early termination; met exclusion criteria|0|||
30959309|NCT01683071|59024746|FG000|Part 2|Lack of Efficacy|0|||
30959310|NCT01683071|59024747|FG001|Part 2|Lack of Efficacy|0|||
30959311|NCT01683071|59024748|FG002|Part 2|Lack of Efficacy|0|||
30959312|NCT01683071|59024749|FG003|Part 2|Lack of Efficacy|0|||
30959313|NCT01683071|59024750|FG004|Part 2|Lack of Efficacy|3|||
30959314|NCT01683071|59024751|FG005|Part 2|Lack of Efficacy|4|||
30959315|NCT01683071|59024746|FG000|Part 2|Lost to Follow-up|0|||
30785712|NCT02937740|58798789|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
30785713|NCT02937740|58798788|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
30785714|NCT02937740|58798789|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
30785715|NCT04173741|58798812|FG000|Overall Study|IVC measurement cannot be done|1|||
30959316|NCT01683071|59024747|FG001|Part 2|Lost to Follow-up|0|||
30959317|NCT01683071|59024748|FG002|Part 2|Lost to Follow-up|0|||
30959318|NCT01683071|59024749|FG003|Part 2|Lost to Follow-up|0|||
30959319|NCT01683071|59024750|FG004|Part 2|Lost to Follow-up|2|||
30599078|NCT01094782|58610924|FG001|Overall Study|Withdrawal by Subject|5|||
30599079|NCT01094782|58610925|FG002|Overall Study|Withdrawal by Subject|1|||
30599080|NCT01094782|58610926|FG003|Overall Study|Withdrawal by Subject|5|||
30599081|NCT01094782|58610927|FG004|Overall Study|Withdrawal by Subject|5|||
30599082|NCT01094782|58610928|FG005|Overall Study|Withdrawal by Subject|0|||
30599083|NCT01094782|58610923|FG000|Overall Study|Lost to Follow-up|1|||
30599084|NCT01094782|58610924|FG001|Overall Study|Lost to Follow-up|0|||
30599085|NCT01094782|58610925|FG002|Overall Study|Lost to Follow-up|0|||
30599086|NCT01094782|58610926|FG003|Overall Study|Lost to Follow-up|2|||
30599087|NCT01094782|58610927|FG004|Overall Study|Lost to Follow-up|1|||
30785716|NCT04173741|58798813|FG001|Overall Study|IVC measurement cannot be done|1|||
30688259|NCT02598960|58701871|FG011|Treatment Period|Other Reasons|0|||
30688260|NCT02598960|58701872|FG012|Treatment Period|Other Reasons|1|||
30688261|NCT02598960|58701860|FG000|Participants Entering Follow Up Period|Death|1|||
30688262|NCT02598960|58701861|FG001|Participants Entering Follow Up Period|Death|0|||
30688263|NCT02598960|58701862|FG002|Participants Entering Follow Up Period|Death|0|||
30688264|NCT02598960|58701863|FG003|Participants Entering Follow Up Period|Death|0|||
30688265|NCT02598960|58701864|FG004|Participants Entering Follow Up Period|Death|0|||
30688266|NCT02598960|58701865|FG005|Participants Entering Follow Up Period|Death|0|||
30688267|NCT02598960|58701866|FG006|Participants Entering Follow Up Period|Death|0|||
30688268|NCT02598960|58701867|FG007|Participants Entering Follow Up Period|Death|0|||
30688269|NCT02598960|58701868|FG008|Participants Entering Follow Up Period|Death|0|||
30688270|NCT02598960|58701869|FG009|Participants Entering Follow Up Period|Death|1|||
30688271|NCT02598960|58701870|FG010|Participants Entering Follow Up Period|Death|0|||
30688272|NCT02598960|58701871|FG011|Participants Entering Follow Up Period|Death|11|||
30688273|NCT02598960|58701872|FG012|Participants Entering Follow Up Period|Death|2|||
30688274|NCT02598960|58701860|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
30688275|NCT02598960|58701861|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
30688276|NCT02598960|58701862|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
30688277|NCT02598960|58701863|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
30688278|NCT02598960|58701864|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
30688279|NCT02598960|58701865|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
30688280|NCT02598960|58701866|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
30688281|NCT02598960|58701867|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
30599088|NCT01094782|58610928|FG005|Overall Study|Lost to Follow-up|4|||
30856401|NCT02630459|58884247|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
30856402|NCT02630459|58884248|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
30856403|NCT02630459|58884249|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
30599089|NCT01094782|58610923|FG000|Overall Study|Positive Drug Screen|2|||
30599090|NCT01094782|58610924|FG001|Overall Study|Positive Drug Screen|2|||
30688282|NCT02598960|58701868|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
30688283|NCT02598960|58701869|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
30688284|NCT02598960|58701870|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
30688285|NCT02598960|58701871|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
30688286|NCT02598960|58701872|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
30688287|NCT02598960|58701860|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
30688288|NCT02598960|58701861|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
30688289|NCT02598960|58701862|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
30688290|NCT02598960|58701863|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
30688291|NCT02598960|58701864|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
30688292|NCT02598960|58701865|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
30688293|NCT02598960|58701866|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
30688294|NCT02598960|58701867|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
30688295|NCT02598960|58701868|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
30688296|NCT02598960|58701869|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
30688297|NCT02598960|58701870|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
30688298|NCT02598960|58701871|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
30688299|NCT02598960|58701872|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
30785717|NCT03231800|58798821|FG000|Overall Study|Lost to Follow-up|0|||
30785718|NCT03231800|58798822|FG001|Overall Study|Lost to Follow-up|2|||
30785719|NCT03231800|58798821|FG000|Overall Study|Protocol Violation|1|||
30785720|NCT03231800|58798822|FG001|Overall Study|Protocol Violation|1|||
30785721|NCT03231800|58798821|FG000|Overall Study|reason not provided|2|||
30785722|NCT03231800|58798822|FG001|Overall Study|reason not provided|0|||
30785723|NCT04085601|58798830|FG000|Overall Study|Lost to Follow-up|1|||
30785724|NCT04085601|58798831|FG001|Overall Study|Lost to Follow-up|0|||
30856404|NCT02630459|58884250|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
30856405|NCT02573948|58884275|FG000|Longitudinal Cohort|Death|9|||
30856406|NCT02573948|58884275|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
30856407|NCT02573948|58884275|FG000|Longitudinal Cohort|Incarcerated|25|||
30599091|NCT01094782|58610925|FG002|Overall Study|Positive Drug Screen|1|||
30599092|NCT01094782|58610926|FG003|Overall Study|Positive Drug Screen|1|||
30599093|NCT01094782|58610927|FG004|Overall Study|Positive Drug Screen|3|||
30599094|NCT01094782|58610928|FG005|Overall Study|Positive Drug Screen|2|||
30599095|NCT01094782|58610923|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
30599096|NCT01094782|58610924|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
30688300|NCT02598960|58701860|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30785725|NCT04085601|58798830|FG000|Overall Study|Death|1|||
30785726|NCT04085601|58798831|FG001|Overall Study|Death|1|||
30785727|NCT03230864|58798840|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
30785728|NCT03230864|58798841|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
30785729|NCT03230864|58798842|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
30785730|NCT03230864|58798843|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
30785731|NCT03230864|58798840|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
30785732|NCT03230864|58798841|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
30785733|NCT03230864|58798842|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
30785734|NCT03230864|58798843|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
30785735|NCT03230864|58798840|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
30785736|NCT03230864|58798841|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
30785737|NCT03230864|58798842|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
30785738|NCT03230864|58798843|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
30785739|NCT03230864|58798840|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
30785740|NCT03230864|58798841|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
30785741|NCT03230864|58798842|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
30785742|NCT03230864|58798843|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
30785743|NCT03230864|58798840|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
30785744|NCT03230864|58798841|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
30785745|NCT03230864|58798842|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
30785746|NCT03230864|58798843|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
30785747|NCT03230864|58798840|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
30785748|NCT03230864|58798841|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
30785749|NCT03230864|58798842|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
30785750|NCT03230864|58798843|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
30785751|NCT03230864|58798840|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
30785752|NCT03230864|58798841|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
30785753|NCT03230864|58798842|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
30785754|NCT03230864|58798843|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
30785755|NCT03230864|58798840|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
30785756|NCT03230864|58798841|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
30785757|NCT03230864|58798842|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
30785758|NCT03230864|58798843|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
30785759|NCT03230864|58798840|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
30785760|NCT03230864|58798841|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
30785761|NCT03230864|58798842|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
30785762|NCT03230864|58798843|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
30785763|NCT03230864|58798840|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
30785764|NCT03230864|58798841|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
30785765|NCT03230864|58798842|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
30785766|NCT03230864|58798843|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
30785767|NCT04085367|58798855|FG000|Overall Study|Adverse Event|1|||
30785768|NCT04085367|58798856|FG001|Overall Study|Adverse Event|1|||
30785769|NCT04085367|58798855|FG000|Overall Study|Withdrawal by Subject|13|||
30785770|NCT04085367|58798856|FG001|Overall Study|Withdrawal by Subject|4|||
30785771|NCT04085367|58798855|FG000|Overall Study|Lost to Follow-up|3|||
30785772|NCT04085367|58798856|FG001|Overall Study|Lost to Follow-up|1|||
30785773|NCT04085367|58798855|FG000|Overall Study|Other unspecified|2|||
30785774|NCT04085367|58798856|FG001|Overall Study|Other unspecified|1|||
30785775|NCT04085367|58798855|FG000|Overall Study|Status Unknown|1|||
30785776|NCT04085367|58798856|FG001|Overall Study|Status Unknown|1|||
30785777|NCT03228836|58798862|FG000|Overall Study|Adverse Event|3|||
30785778|NCT03228836|58798862|FG000|Overall Study|Withdrawal by Subject|1|||
30785779|NCT03228836|58798862|FG000|Overall Study|Death|1|||
30785780|NCT03228836|58798862|FG000|Overall Study|Physician Decision|1|||
30785781|NCT03228836|58798862|FG000|Overall Study|Disease Progression|7|||
30785782|NCT03228836|58798862|FG000|Overall Study|Other|4|||
30785783|NCT02937350|58798869|FG000|Overall Study|Withdrawal by Subject|0|||
30785784|NCT02937350|58798870|FG001|Overall Study|Withdrawal by Subject|1|||
30785785|NCT02937350|58798871|FG002|Overall Study|Withdrawal by Subject|0|||
30785786|NCT04085289|58798880|FG000|Overall Study|Withdrawal by Subject|0|||
30785787|NCT04085289|58798881|FG001|Overall Study|Withdrawal by Subject|0|||
30785788|NCT04085289|58798882|FG002|Overall Study|Withdrawal by Subject|1|||
30785789|NCT04080297|58798891|FG000|Overall Study|Adverse Event|1|||
30785790|NCT04080297|58798892|FG001|Overall Study|Adverse Event|3|||
30785791|NCT04080297|58798891|FG000|Overall Study|concurrent illness|1|||
30599097|NCT01094782|58610925|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
30785792|NCT04080297|58798892|FG001|Overall Study|concurrent illness|0|||
30785793|NCT04013529|58798900|FG000|Overall Study|Withdrawal by Subject|1|||
30785794|NCT04013529|58798901|FG001|Overall Study|Withdrawal by Subject|1|||
30785795|NCT04011735|58798910|FG000|Overall Study|Withdrawal by Subject|1|||
30785796|NCT04011735|58798911|FG001|Overall Study|Withdrawal by Subject|0|||
30785797|NCT04011735|58798912|FG002|Overall Study|Withdrawal by Subject|1|||
30785798|NCT04011735|58798910|FG000|Overall Study|Met exclusion criteria after study entry|0|||
30785799|NCT04011735|58798911|FG001|Overall Study|Met exclusion criteria after study entry|1|||
30785800|NCT04011735|58798912|FG002|Overall Study|Met exclusion criteria after study entry|0|||
30785801|NCT04009629|58798924|FG000|Overall Study|Withdrawal by Subject|2|||
30785802|NCT04009629|58798925|FG001|Overall Study|Withdrawal by Subject|0|||
30785803|NCT04007367|58798934|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
30785804|NCT04007367|58798935|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
30785805|NCT04007367|58798936|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
30785806|NCT04007367|58798934|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
30785807|NCT04007367|58798935|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
30785808|NCT04007367|58798936|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
30785809|NCT04007367|58798934|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
30785810|NCT04007367|58798935|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
30785811|NCT04007367|58798936|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
30785812|NCT04007367|58798934|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
30785813|NCT04007367|58798935|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
30785814|NCT04007367|58798936|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
30785815|NCT04007367|58798934|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
30785816|NCT04007367|58798935|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
30785817|NCT04007367|58798936|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
30785818|NCT03694197|58798946|FG000|Overall Study|Adverse Event|9|||
30785819|NCT03694197|58798946|FG000|Overall Study|Protocol became inconvenient to participate|1|||
30785820|NCT03694197|58798946|FG000|Overall Study|Physician Decision|4|||
30785821|NCT03694197|58798946|FG000|Overall Study|Study terminated by sponsor|1350|||
30785822|NCT03694197|58798946|FG000|Overall Study|Participant moved|5|||
30785823|NCT03694197|58798946|FG000|Overall Study|Participant withdrew consent|10|||
30785824|NCT03694197|58798946|FG000|Overall Study|Related to IMP administration|1|||
30785825|NCT03694197|58798946|FG000|Overall Study|Not disclosed|5|||
30785826|NCT04365699|58798953|FG000|Overall Study|Death|2|||
30785827|NCT04365699|58798954|FG001|Overall Study|Death|5|||
30785828|NCT04365699|58798955|FG002|Overall Study|Death|15|||
30785829|NCT04005885|58798963|FG000|First Intervention|Withdrawal by Subject|1|||
30785830|NCT04005885|58798964|FG001|First Intervention|Withdrawal by Subject|1|||
30785831|NCT04005885|58798963|FG000|Second Intervention|Withdrawal by Subject|0|||
30785832|NCT04005885|58798964|FG001|Second Intervention|Withdrawal by Subject|2|||
30785833|NCT04003623|58798977|FG000|Overall Study|Withdrawal by Subject|1|||
30785834|NCT04003623|58798978|FG001|Overall Study|Withdrawal by Subject|0|||
30785835|NCT04480424|58798986|FG000|Overall Study|Withdrawal by Subject|0|||
30785836|NCT04480424|58798987|FG001|Overall Study|Withdrawal by Subject|2|||
30785837|NCT04480424|58798986|FG000|Overall Study|Lost to Follow-up|3|||
30785838|NCT04480424|58798987|FG001|Overall Study|Lost to Follow-up|3|||
30785839|NCT04480424|58798986|FG000|Overall Study|Death|14|||
30785840|NCT04480424|58798987|FG001|Overall Study|Death|16|||
30785841|NCT04480424|58798986|FG000|Overall Study|Reason not Specified|5|||
30785842|NCT04480424|58798987|FG001|Overall Study|Reason not Specified|5|||
30785843|NCT03256526|58798996|FG000|Overall Study|Adverse Event|1|||
30785844|NCT03256526|58798997|FG001|Overall Study|Adverse Event|0|||
30785845|NCT03256526|58798998|FG002|Overall Study|Adverse Event|1|||
30785846|NCT03256526|58798996|FG000|Overall Study|Lost to Follow-up|1|||
30785847|NCT03256526|58798997|FG001|Overall Study|Lost to Follow-up|0|||
30785848|NCT03256526|58798998|FG002|Overall Study|Lost to Follow-up|2|||
30785849|NCT03255980|58799010|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
30785850|NCT03255980|58799011|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
30785851|NCT03255980|58799012|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
30785852|NCT03255980|58799013|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
30785853|NCT03255980|58799010|FG000|Overall Study|Adverse Event|1|||
30785854|NCT03255980|58799011|FG001|Overall Study|Adverse Event|1|||
30785855|NCT03255980|58799012|FG002|Overall Study|Adverse Event|0|||
30785856|NCT03255980|58799013|FG003|Overall Study|Adverse Event|1|||
30785857|NCT03255980|58799010|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
30785858|NCT03255980|58799011|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
30785859|NCT03255980|58799012|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
30785860|NCT03255980|58799013|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
30785861|NCT03255980|58799010|FG000|Overall Study|Lost to Follow-up|1|||
30785862|NCT03255980|58799011|FG001|Overall Study|Lost to Follow-up|1|||
30785863|NCT03255980|58799012|FG002|Overall Study|Lost to Follow-up|0|||
30785864|NCT03255980|58799013|FG003|Overall Study|Lost to Follow-up|3|||
30785865|NCT03255980|58799010|FG000|Overall Study|Withdrawal by Subject|0|||
30785866|NCT03255980|58799011|FG001|Overall Study|Withdrawal by Subject|1|||
30785867|NCT03255980|58799012|FG002|Overall Study|Withdrawal by Subject|0|||
30785868|NCT03255980|58799013|FG003|Overall Study|Withdrawal by Subject|3|||
30785869|NCT03228212|58799023|FG000|Period 1|Adverse Event|1|||
30785870|NCT03228212|58799024|FG001|Period 1|Adverse Event|0|||
30785871|NCT03228212|58799023|FG000|Period 1|no longer meets eligibility criteria|0|||
30785872|NCT03228212|58799024|FG001|Period 1|no longer meets eligibility criteria|1|||
30785873|NCT03228212|58799023|FG000|Period 2|Lost to Follow-up|1|||
30785874|NCT03228212|58799024|FG001|Period 2|Lost to Follow-up|0|||
30785875|NCT04003155|58799033|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
30785876|NCT04003155|58799034|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
30785877|NCT04003155|58799035|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
30785878|NCT04003155|58799036|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
30785879|NCT04003155|58799037|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
30785880|NCT04003155|58799033|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
30785881|NCT04003155|58799034|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
30785882|NCT04003155|58799035|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
30785883|NCT04003155|58799036|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
30785884|NCT04003155|58799037|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
30785885|NCT04003155|58799033|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
30785886|NCT04003155|58799034|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
30785887|NCT04003155|58799035|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
30785888|NCT04003155|58799036|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
30785889|NCT04003155|58799037|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
30785890|NCT04003155|58799033|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
30785891|NCT04003155|58799034|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
30785892|NCT04003155|58799035|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
30785893|NCT04003155|58799036|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
30785894|NCT04003155|58799037|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
30785895|NCT04003155|58799033|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
30785896|NCT04003155|58799034|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
30785897|NCT04003155|58799035|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
30785898|NCT04003155|58799036|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
30785899|NCT04003155|58799037|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
30785900|NCT04003155|58799033|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
30785901|NCT04003155|58799034|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
30785902|NCT04003155|58799035|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
30785903|NCT04003155|58799036|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
30785904|NCT04003155|58799037|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
30785905|NCT04003155|58799033|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
30785906|NCT04003155|58799034|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
30785907|NCT04003155|58799035|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
30785908|NCT04003155|58799036|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
30785909|NCT04003155|58799037|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
30785910|NCT04003155|58799033|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
30785911|NCT04003155|58799034|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
30785912|NCT04003155|58799035|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
30785913|NCT04003155|58799036|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
30785914|NCT04003155|58799037|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
30785915|NCT04003155|58799033|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
30785916|NCT04003155|58799034|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
30785917|NCT04003155|58799035|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
30785918|NCT04003155|58799036|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
30785919|NCT04003155|58799037|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
30785920|NCT04000815|58799058|FG000|Overall Study|Lost to Follow-up|9|||
30785921|NCT04000815|58799059|FG001|Overall Study|Lost to Follow-up|2|||
30785922|NCT04000815|58799060|FG002|Overall Study|Lost to Follow-up|3|||
30785923|NCT04000815|58799058|FG000|Overall Study|Withdrawal by Subject|4|||
30785924|NCT04000815|58799059|FG001|Overall Study|Withdrawal by Subject|3|||
30785925|NCT04000815|58799060|FG002|Overall Study|Withdrawal by Subject|2|||
30785926|NCT04000815|58799058|FG000|Overall Study|Right ovarian cyst occured|1|||
30785927|NCT04000815|58799059|FG001|Overall Study|Right ovarian cyst occured|0|||
30785928|NCT04000815|58799060|FG002|Overall Study|Right ovarian cyst occured|0|||
30785929|NCT04000815|58799058|FG000|Overall Study|Hypertension occured on follow up|0|||
30785930|NCT04000815|58799059|FG001|Overall Study|Hypertension occured on follow up|0|||
30785931|NCT04000815|58799060|FG002|Overall Study|Hypertension occured on follow up|2|||
30785932|NCT04000581|58799070|FG000|Overall Study|Withdrawal by Subject|0|||
30785933|NCT04000581|58799071|FG001|Overall Study|Withdrawal by Subject|1|||
30785934|NCT03848403|58799077|FG000|Period 2 (Day 8)|Adverse Event|1|||
30959320|NCT01683071|59024751|FG005|Part 2|Lost to Follow-up|0|||
30959321|NCT01683071|59024746|FG000|Part 2|Withdrawal by Subject|0|||
30599098|NCT01094782|58610926|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
30785935|NCT03848403|58799078|FG001|Period 2 (Day 8)|Adverse Event|2|||
30959322|NCT01683071|59024747|FG001|Part 2|Withdrawal by Subject|0|||
30599099|NCT01094782|58610927|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
30785936|NCT03848403|58799079|FG002|Period 2 (Day 8)|Adverse Event|2|||
30785937|NCT03848403|58799077|FG000|Period 2 (Day 8)|Physician Decision|0|||
30785938|NCT03848403|58799078|FG001|Period 2 (Day 8)|Physician Decision|1|||
30785939|NCT03848403|58799079|FG002|Period 2 (Day 8)|Physician Decision|0|||
30785940|NCT03848403|58799077|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
30785941|NCT03848403|58799078|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
30785942|NCT03848403|58799079|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
30785943|NCT04054011|58799087|FG000|Overall Study|COVID|3|||
30785944|NCT04053465|58799095|FG000|Overall Study|Withdrawal by Subject|4|||
30785945|NCT04053465|58799096|FG001|Overall Study|Withdrawal by Subject|4|||
30785946|NCT00143507|58799104|FG000|Overall Study|Death|572|||
30785947|NCT00143507|58799105|FG001|Overall Study|Death|547|||
30785948|NCT00143507|58799104|FG000|Overall Study|Withdrawal by Subject|114|||
30785949|NCT00143507|58799105|FG001|Overall Study|Withdrawal by Subject|102|||
30785950|NCT00143507|58799104|FG000|Overall Study|Lost to Follow-up|1|||
30785951|NCT00143507|58799105|FG001|Overall Study|Lost to Follow-up|0|||
30785952|NCT00143507|58799104|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
30785953|NCT00143507|58799105|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
30785954|NCT03988803|58799111|FG000|Period 2|Prematurely discontinued from medication|2|||
30785955|NCT03988803|58799111|FG000|Period 2|Adverse Event|1|||
30785956|NCT00181883|58799119|FG000|Overall Study|Lack of Efficacy|2|||
30785957|NCT00181883|58799119|FG000|Overall Study|Treatment Limiting AEs|3|||
30785958|NCT00181883|58799119|FG000|Overall Study|Withdrawal by Subject|4|||
30785959|NCT00181883|58799119|FG000|Overall Study|Lost to Follow-up|1|||
30785960|NCT00180713|58799125|FG000|Overall Study|Withdrawal by Subject|2|||
30688301|NCT02598960|58701861|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30785961|NCT00180713|58799126|FG001|Overall Study|Withdrawal by Subject|0|||
30785962|NCT00180713|58799125|FG000|Overall Study|Adverse Event|3|||
30785963|NCT00180713|58799126|FG001|Overall Study|Adverse Event|3|||
30785964|NCT03988023|58799134|FG000|Overall Study|Non-compliance|3|||
30785965|NCT03988023|58799135|FG001|Overall Study|Non-compliance|0|||
30785966|NCT03988023|58799134|FG000|Overall Study|Withdrawal by Subject|39|||
30785967|NCT03988023|58799135|FG001|Overall Study|Withdrawal by Subject|37|||
30785968|NCT03988023|58799134|FG000|Overall Study|Adverse Event|0|||
30785969|NCT03988023|58799135|FG001|Overall Study|Adverse Event|2|||
30785970|NCT03988023|58799134|FG000|Overall Study|Physician Decision|0|||
30785971|NCT03988023|58799135|FG001|Overall Study|Physician Decision|1|||
30785972|NCT03988023|58799134|FG000|Overall Study|Lost to Follow-up|5|||
30785973|NCT03988023|58799135|FG001|Overall Study|Lost to Follow-up|8|||
30785974|NCT03988023|58799134|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
30785975|NCT03988023|58799135|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
30785976|NCT03988023|58799134|FG000|Overall Study|Lack of Efficacy|3|||
30785977|NCT03988023|58799135|FG001|Overall Study|Lack of Efficacy|1|||
30856408|NCT01464593|58884282|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
30856409|NCT01361711|58884286|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
30856410|NCT01361711|58884286|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
30856411|NCT01361711|58884286|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
30856412|NCT01361711|58884286|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
30856413|NCT01361711|58884286|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
30856414|NCT01361711|58884286|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
30856415|NCT01361711|58884286|FG000|Completed Week 18 of Treatment|Other|9|||
30856416|NCT01361711|58884286|FG000|10 Year Follow-up|Still in follow-up|22|||
30856417|NCT01361711|58884286|FG000|10 Year Follow-up|Death|7|||
30856418|NCT01361711|58884286|FG000|10 Year Follow-up|Developed new cancer|1|||
30856419|NCT01361711|58884286|FG000|10 Year Follow-up|Lost to Follow-up|2|||
30856420|NCT01361711|58884286|FG000|10 Year Follow-up|New treatment started|6|||
30785978|NCT03988023|58799134|FG000|Overall Study|COVID-19 pandemic|225|||
30785979|NCT03988023|58799135|FG001|Overall Study|COVID-19 pandemic|227|||
30785980|NCT04052139|58799144|FG000|Overall Study|Lost to Follow-up|2|||
30785981|NCT04052139|58799145|FG001|Overall Study|Lost to Follow-up|0|||
30785982|NCT04052139|58799146|FG002|Overall Study|Lost to Follow-up|0|||
30785983|NCT04052139|58799144|FG000|Overall Study|Withdrawal by Subject|1|||
30856421|NCT01361711|58884286|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
30856422|NCT01361711|58884286|FG000|10 Year Follow-up|Progressive Disease|1|||
30856423|NCT02572388|58884294|FG000|Overall Study|Withdrawal by Subject|1|||
30856424|NCT02572388|58884295|FG001|Overall Study|Withdrawal by Subject|1|||
30856425|NCT02572388|58884296|FG002|Overall Study|Withdrawal by Subject|2|||
30785984|NCT04052139|58799145|FG001|Overall Study|Withdrawal by Subject|0|||
30785985|NCT04052139|58799146|FG002|Overall Study|Withdrawal by Subject|0|||
30785986|NCT03984825|58799154|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
30785987|NCT03984825|58799154|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
30785988|NCT03984825|58799154|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
30785989|NCT03981861|58799163|FG000|Overall Study|Withdrawal by Subject|3|||
30785990|NCT01332266|58799172|FG000|Phase 1b|Death|3|||
30856426|NCT02572388|58884297|FG003|Overall Study|Withdrawal by Subject|2|||
30785991|NCT01332266|58799173|FG001|Phase 1b|Death|3|||
30785992|NCT01332266|58799174|FG002|Phase 1b|Death|2|||
30785993|NCT01332266|58799175|FG003|Phase 1b|Death|0|||
30785994|NCT01332266|58799176|FG004|Phase 1b|Death|0|||
30785995|NCT01332266|58799172|FG000|Phase 1b|Lost to Follow-up|0|||
30785996|NCT01332266|58799173|FG001|Phase 1b|Lost to Follow-up|1|||
30785997|NCT01332266|58799174|FG002|Phase 1b|Lost to Follow-up|0|||
30785998|NCT01332266|58799175|FG003|Phase 1b|Lost to Follow-up|0|||
30785999|NCT01332266|58799176|FG004|Phase 1b|Lost to Follow-up|0|||
30786000|NCT01332266|58799172|FG000|Phase 1b|Withdrawal by Subject|1|||
30786001|NCT01332266|58799173|FG001|Phase 1b|Withdrawal by Subject|1|||
30786002|NCT01332266|58799174|FG002|Phase 1b|Withdrawal by Subject|1|||
30786003|NCT01332266|58799175|FG003|Phase 1b|Withdrawal by Subject|0|||
30786004|NCT01332266|58799176|FG004|Phase 1b|Withdrawal by Subject|0|||
30786005|NCT01332266|58799172|FG000|Phase 2|Death|0|||
30786006|NCT01332266|58799173|FG001|Phase 2|Death|0|||
30786007|NCT01332266|58799174|FG002|Phase 2|Death|0|||
30786008|NCT01332266|58799175|FG003|Phase 2|Death|33|||
30786009|NCT01332266|58799176|FG004|Phase 2|Death|36|||
30786010|NCT01332266|58799172|FG000|Phase 2|Lost to Follow-up|0|||
30786011|NCT01332266|58799173|FG001|Phase 2|Lost to Follow-up|0|||
30856427|NCT02573870|58884309|FG000|Overall Study|Adverse Event|0|||
30856428|NCT02573870|58884310|FG001|Overall Study|Adverse Event|2|||
30856429|NCT02573870|58884309|FG000|Overall Study|Lack of Efficacy|0|||
30856430|NCT02573870|58884310|FG001|Overall Study|Lack of Efficacy|1|||
30856431|NCT02573870|58884309|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
30856432|NCT02573870|58884310|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
30856433|NCT02573870|58884309|FG000|Overall Study|Lost to Follow-up|0|||
30856434|NCT02573870|58884310|FG001|Overall Study|Lost to Follow-up|1|||
30856435|NCT02573870|58884309|FG000|Overall Study|Other: Fail to Meet Visit|0|||
30856436|NCT02573870|58884310|FG001|Overall Study|Other: Fail to Meet Visit|2|||
30856437|NCT02572076|58884316|FG000|Overall Study|Protocol Violation|1|||
30856438|NCT02571452|58884322|FG000|Overall Study Treatment|Protocol Violation|0|||
30856439|NCT02571452|58884323|FG001|Overall Study Treatment|Protocol Violation|1|||
30856440|NCT02571452|58884322|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
30856441|NCT02571452|58884323|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
30856442|NCT02571452|58884322|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
30856443|NCT02571452|58884323|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
30856444|NCT02574260|58884329|FG000|Overall Study|Disease Progression|1|||
30856445|NCT02570126|58884335|FG000|Overall Study|Lost to Follow-up|2|||
30856446|NCT02570126|58884336|FG001|Overall Study|Lost to Follow-up|0|||
30856447|NCT02570126|58884335|FG000|Overall Study|Unable To Arrange Visit 3|1|||
30856448|NCT02570126|58884336|FG001|Overall Study|Unable To Arrange Visit 3|0|||
30856449|NCT02570126|58884335|FG000|Overall Study|Violation Of Procedures GSK|0|||
30856450|NCT02570126|58884336|FG001|Overall Study|Violation Of Procedures GSK|1|||
30856451|NCT02570126|58884335|FG000|Overall Study|Protocol Violation|0|||
30856452|NCT02570126|58884336|FG001|Overall Study|Protocol Violation|1|||
30856453|NCT02570126|58884335|FG000|Overall Study|Withdrawal by Subject|3|||
30856454|NCT02570126|58884336|FG001|Overall Study|Withdrawal by Subject|7|||
30856455|NCT02755831|58884344|FG000|Overall Study|Lost to Follow-up|3|||
30856456|NCT02755831|58884345|FG001|Overall Study|Lost to Follow-up|3|||
30856457|NCT02573246|58884356|FG000|Overall Study|Lost to Follow-up|2|||
30856458|NCT02573246|58884357|FG001|Overall Study|Lost to Follow-up|0|||
30856459|NCT02573246|58884358|FG002|Overall Study|Lost to Follow-up|0|||
30856460|NCT02573246|58884359|FG003|Overall Study|Lost to Follow-up|0|||
30856461|NCT02573246|58884360|FG004|Overall Study|Lost to Follow-up|1|||
30856462|NCT02573246|58884356|FG000|Overall Study|Withdrawal by Subject|0|||
30856463|NCT02573246|58884357|FG001|Overall Study|Withdrawal by Subject|0|||
30856464|NCT02573246|58884358|FG002|Overall Study|Withdrawal by Subject|0|||
30856465|NCT02573246|58884359|FG003|Overall Study|Withdrawal by Subject|0|||
30856466|NCT02573246|58884360|FG004|Overall Study|Withdrawal by Subject|1|||
30856467|NCT02573246|58884356|FG000|Overall Study|Physician Decision|1|||
30856468|NCT02573246|58884357|FG001|Overall Study|Physician Decision|1|||
30856469|NCT02573246|58884358|FG002|Overall Study|Physician Decision|3|||
30856470|NCT02573246|58884359|FG003|Overall Study|Physician Decision|2|||
30856471|NCT02573246|58884360|FG004|Overall Study|Physician Decision|2|||
30856472|NCT02570750|58884379|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
30856473|NCT02570750|58884380|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
30856474|NCT02570750|58884379|FG000|Overall Study|Protocol deviation|4|||
30959323|NCT01683071|59024748|FG002|Part 2|Withdrawal by Subject|0|||
30786012|NCT01332266|58799174|FG002|Phase 2|Lost to Follow-up|0|||
30856475|NCT02570750|58884380|FG001|Overall Study|Protocol deviation|2|||
30856476|NCT02570750|58884379|FG000|Overall Study|Withdrawal by Subject|5|||
30856477|NCT02570750|58884380|FG001|Overall Study|Withdrawal by Subject|0|||
30856478|NCT02570750|58884379|FG000|Overall Study|Lost to Follow-up|2|||
30959324|NCT01683071|59024749|FG003|Part 2|Withdrawal by Subject|0|||
30786013|NCT01332266|58799175|FG003|Phase 2|Lost to Follow-up|2|||
30786014|NCT01332266|58799176|FG004|Phase 2|Lost to Follow-up|0|||
30786015|NCT01332266|58799172|FG000|Phase 2|Physician Decision|0|||
30786016|NCT01332266|58799173|FG001|Phase 2|Physician Decision|0|||
30786017|NCT01332266|58799174|FG002|Phase 2|Physician Decision|0|||
30786018|NCT01332266|58799175|FG003|Phase 2|Physician Decision|3|||
30786019|NCT01332266|58799176|FG004|Phase 2|Physician Decision|1|||
30786020|NCT01332266|58799172|FG000|Phase 2|Symptomatic deterioration|0|||
30786021|NCT01332266|58799173|FG001|Phase 2|Symptomatic deterioration|0|||
30786022|NCT01332266|58799174|FG002|Phase 2|Symptomatic deterioration|0|||
30786023|NCT01332266|58799175|FG003|Phase 2|Symptomatic deterioration|0|||
30786024|NCT01332266|58799176|FG004|Phase 2|Symptomatic deterioration|1|||
30786025|NCT01332266|58799172|FG000|Phase 2|Progression Disease|0|||
30786026|NCT01332266|58799173|FG001|Phase 2|Progression Disease|0|||
30786027|NCT01332266|58799174|FG002|Phase 2|Progression Disease|0|||
30786028|NCT01332266|58799175|FG003|Phase 2|Progression Disease|2|||
30786029|NCT01332266|58799176|FG004|Phase 2|Progression Disease|1|||
30786030|NCT01332266|58799172|FG000|Phase 2|Withdrawal by Subject|0|||
30786031|NCT01332266|58799173|FG001|Phase 2|Withdrawal by Subject|0|||
30786032|NCT01332266|58799174|FG002|Phase 2|Withdrawal by Subject|0|||
30786033|NCT01332266|58799175|FG003|Phase 2|Withdrawal by Subject|2|||
30786034|NCT01332266|58799176|FG004|Phase 2|Withdrawal by Subject|2|||
30786035|NCT03255824|58799191|FG000|Overall Study|Under-sedation|2|||
30786036|NCT03255824|58799192|FG001|Overall Study|Under-sedation|1|||
30786037|NCT03238352|58799201|FG000|Overall Study|Lost to Follow-up|0|||
30786038|NCT03238352|58799202|FG001|Overall Study|Lost to Follow-up|2|||
30786039|NCT03238352|58799203|FG002|Overall Study|Lost to Follow-up|1|||
30786040|NCT03238352|58799201|FG000|Overall Study|Withdrawal by Subject|0|||
30786041|NCT03238352|58799202|FG001|Overall Study|Withdrawal by Subject|1|||
30786042|NCT03238352|58799203|FG002|Overall Study|Withdrawal by Subject|0|||
30786043|NCT00180479|58799213|FG000|Overall Study|Death|4|||
30786044|NCT00180479|58799214|FG001|Overall Study|Death|2|||
30856479|NCT02570750|58884380|FG001|Overall Study|Lost to Follow-up|2|||
30856480|NCT02570750|58884379|FG000|Overall Study|Adverse Event|2|||
30856481|NCT02570750|58884380|FG001|Overall Study|Adverse Event|1|||
30856482|NCT02573012|58884388|FG000|Overall Study|Adverse Event|5|||
30856483|NCT02573012|58884389|FG001|Overall Study|Adverse Event|5|||
30856484|NCT02573012|58884388|FG000|Overall Study|Lack of Efficacy|5|||
30856485|NCT02573012|58884389|FG001|Overall Study|Lack of Efficacy|4|||
30856486|NCT02573012|58884388|FG000|Overall Study|Non-compliance|1|||
30856487|NCT02573012|58884389|FG001|Overall Study|Non-compliance|2|||
30856488|NCT02573012|58884388|FG000|Overall Study|Withdrawal by Subject|2|||
30856489|NCT02573012|58884389|FG001|Overall Study|Withdrawal by Subject|2|||
30856490|NCT02573012|58884388|FG000|Overall Study|Study Ended per Protocol|1|||
30856491|NCT02573012|58884389|FG001|Overall Study|Study Ended per Protocol|0|||
30856492|NCT02573012|58884388|FG000|Overall Study|Physician Decision|1|||
30856493|NCT02573012|58884389|FG001|Overall Study|Physician Decision|2|||
30856494|NCT02752633|58884395|FG000|Overall Study|Withdrawal by Subject|1|||
30856495|NCT02752087|58884399|FG000|Washout|Physician Decision|1|||
30856496|NCT02752087|58884400|FG001|Washout|Physician Decision|0|||
30856497|NCT04766996|58884409|FG000|Overall Study|Withdrawal by Subject|1|||
30856498|NCT04766996|58884410|FG001|Overall Study|Withdrawal by Subject|0|||
30856499|NCT04766996|58884411|FG002|Overall Study|Withdrawal by Subject|13|||
30959325|NCT01683071|59024750|FG004|Part 2|Withdrawal by Subject|3|||
30786045|NCT00180479|58799213|FG000|Overall Study|Lost to Follow-up|9|||
30786046|NCT00180479|58799214|FG001|Overall Study|Lost to Follow-up|7|||
30786047|NCT00180479|58799213|FG000|Overall Study|Withdrawal by Subject|3|||
30786048|NCT00180479|58799214|FG001|Overall Study|Withdrawal by Subject|3|||
30786049|NCT00180479|58799213|FG000|Overall Study|Informed consent not signed|0|||
30786050|NCT00180479|58799214|FG001|Overall Study|Informed consent not signed|1|||
30786051|NCT03224234|58799224|FG000|Main Study|Lost to Follow-up|5|||
30786052|NCT03224234|58799225|FG001|Main Study|Lost to Follow-up|5|||
30786053|NCT02955069|58799239|FG000|Overall Study|Adverse Event|7|||
30786054|NCT02955069|58799240|FG001|Overall Study|Adverse Event|2|||
30786055|NCT02955069|58799239|FG000|Overall Study|Death|7|||
30786056|NCT02955069|58799240|FG001|Overall Study|Death|3|||
30959326|NCT01683071|59024751|FG005|Part 2|Withdrawal by Subject|3|||
30959327|NCT01683071|59024746|FG000|Part 2|Surgery cancelled|0|||
30786057|NCT02955069|58799239|FG000|Overall Study|Physician Decision|10|||
30786058|NCT02955069|58799240|FG001|Overall Study|Physician Decision|2|||
30786059|NCT02955069|58799239|FG000|Overall Study|Progressive disease|64|||
30786060|NCT02955069|58799240|FG001|Overall Study|Progressive disease|13|||
30786061|NCT02955069|58799239|FG000|Overall Study|Study terminated by sponsor|4|||
30786062|NCT02955069|58799240|FG001|Overall Study|Study terminated by sponsor|0|||
30786063|NCT02955069|58799239|FG000|Overall Study|Subject/Guardian decision|3|||
30856500|NCT02563028|58884417|FG000|Overall Study|Lack of equipment|1|||
30856501|NCT02563028|58884417|FG000|Overall Study|Unable to elicit VEP post induction|1|||
30856502|NCT02192827|58884423|FG000|Overall Study|Lost to Follow-up|25|||
30786064|NCT02955069|58799240|FG001|Overall Study|Subject/Guardian decision|1|||
30786065|NCT03254108|58799253|FG000|Overall Study|Adverse Event|0|||
30786066|NCT03254108|58799254|FG001|Overall Study|Adverse Event|2|||
30786067|NCT03254108|58799255|FG002|Overall Study|Adverse Event|0|||
30856503|NCT02192827|58884424|FG001|Overall Study|Lost to Follow-up|27|||
30959328|NCT01683071|59024747|FG001|Part 2|Surgery cancelled|0|||
30786068|NCT03254108|58799256|FG003|Overall Study|Adverse Event|1|||
30786069|NCT03254108|58799257|FG004|Overall Study|Adverse Event|1|||
30786070|NCT03254108|58799253|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
30786071|NCT03254108|58799254|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
30786072|NCT03254108|58799255|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
30786073|NCT03254108|58799256|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
30786074|NCT03254108|58799257|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
30786075|NCT03773978|58799281|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
30786076|NCT03773978|58799282|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
30786077|NCT03773978|58799281|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
30786078|NCT03773978|58799282|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
30786079|NCT03773978|58799281|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
30786080|NCT03773978|58799282|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
30786081|NCT03773978|58799281|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
30786082|NCT03773978|58799282|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
30786083|NCT03773978|58799281|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
30786084|NCT03773978|58799282|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
30786085|NCT03773978|58799281|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
30786086|NCT03773978|58799282|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
30786087|NCT03773978|58799281|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
30786088|NCT03773978|58799282|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
30786089|NCT03773978|58799281|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
30786090|NCT03773978|58799282|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
30786091|NCT03773978|58799281|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
30786092|NCT03773978|58799282|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
30786093|NCT03773978|58799281|FG000|DBW Period|Adverse Event|2|||
30786094|NCT03773978|58799282|FG001|DBW Period|Adverse Event|2|||
30786095|NCT03773978|58799281|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
30786096|NCT03773978|58799282|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
30786097|NCT03773978|58799281|FG000|DBW Period|Withdrawal by Subject|2|||
30786098|NCT03773978|58799282|FG001|DBW Period|Withdrawal by Subject|1|||
30786099|NCT03773978|58799281|FG000|DBW Period|Due to epidemic or pandemic|5|||
30786100|NCT03773978|58799282|FG001|DBW Period|Due to epidemic or pandemic|6|||
30786101|NCT03773978|58799281|FG000|DBW Period|Study team decision|1|||
30786102|NCT03773978|58799282|FG001|DBW Period|Study team decision|0|||
30786103|NCT03682107|58799298|FG000|Overall Study|Withdrawal by Subject|0|||
30786104|NCT03682107|58799299|FG001|Overall Study|Withdrawal by Subject|1|||
30786105|NCT03682107|58799300|FG002|Overall Study|Withdrawal by Subject|0|||
30786106|NCT03682107|58799301|FG003|Overall Study|Withdrawal by Subject|0|||
30688302|NCT02598960|58701862|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30688303|NCT02598960|58701863|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30688304|NCT02598960|58701864|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30688305|NCT02598960|58701865|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30688306|NCT02598960|58701866|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30688307|NCT02598960|58701867|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30786107|NCT03682107|58799302|FG004|Overall Study|Withdrawal by Subject|0|||
30786108|NCT03673046|58799316|FG000|Overall Study|Adverse Event|1|||
30786109|NCT03673046|58799317|FG001|Overall Study|Adverse Event|1|||
30786110|NCT03673046|58799316|FG000|Overall Study|Withdrawal by Subject|8|||
30786111|NCT03673046|58799317|FG001|Overall Study|Withdrawal by Subject|2|||
30786112|NCT02956005|58799323|FG000|Overall Study|Not eligible|1|||
30688308|NCT02598960|58701868|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30688309|NCT02598960|58701869|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30688310|NCT02598960|58701870|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30688311|NCT02598960|58701871|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
30688312|NCT02598960|58701872|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
30688313|NCT02598960|58701860|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
30688314|NCT02598960|58701861|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
30688315|NCT02598960|58701862|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
30688316|NCT02598960|58701863|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
30688317|NCT02598960|58701864|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
30688318|NCT02598960|58701865|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
30688319|NCT02598960|58701866|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
30688320|NCT02598960|58701867|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
30786113|NCT02956005|58799323|FG000|Overall Study|Withdrawal by Subject|3|||
30786114|NCT02956005|58799323|FG000|Overall Study|Physician Decision|12|||
30786115|NCT03253094|58799333|FG000|Overall Study|Adverse Event|2|||
30786116|NCT03253094|58799334|FG001|Overall Study|Adverse Event|0|||
30786117|NCT03253094|58799335|FG002|Overall Study|Adverse Event|0|||
30786118|NCT03253094|58799336|FG003|Overall Study|Adverse Event|0|||
30786119|NCT03253094|58799337|FG004|Overall Study|Adverse Event|0|||
30786120|NCT03253094|58799338|FG005|Overall Study|Adverse Event|0|||
30786121|NCT03253094|58799333|FG000|Overall Study|Lack of Efficacy|0|||
30786122|NCT03253094|58799334|FG001|Overall Study|Lack of Efficacy|0|||
30786123|NCT03253094|58799335|FG002|Overall Study|Lack of Efficacy|2|||
30786124|NCT03253094|58799336|FG003|Overall Study|Lack of Efficacy|1|||
30786125|NCT03253094|58799337|FG004|Overall Study|Lack of Efficacy|2|||
30856504|NCT02192827|58884423|FG000|Overall Study|Given additional steroids with admission|13|||
30856505|NCT02192827|58884424|FG001|Overall Study|Given additional steroids with admission|11|||
30856506|NCT02562482|58884432|FG000|Overall Study|Enrolled, but did not receive product|4|||
30856507|NCT02562482|58884433|FG001|Overall Study|Enrolled, but did not receive product|0|||
30856508|NCT02562482|58884432|FG000|Overall Study|Lost to Follow-up|9|||
30856509|NCT02562482|58884433|FG001|Overall Study|Lost to Follow-up|6|||
30856510|NCT02562482|58884432|FG000|Overall Study|Moved from area|2|||
30856511|NCT02562482|58884433|FG001|Overall Study|Moved from area|3|||
30856512|NCT02562482|58884432|FG000|Overall Study|Withdrawal by Subject|5|||
30856513|NCT02562482|58884433|FG001|Overall Study|Withdrawal by Subject|3|||
30856514|NCT02562482|58884432|FG000|Overall Study|Physician Decision|1|||
30856515|NCT02562482|58884433|FG001|Overall Study|Physician Decision|3|||
30856516|NCT02562482|58884432|FG000|Overall Study|Illness/Injury unrelated to product|0|||
30856517|NCT02562482|58884433|FG001|Overall Study|Illness/Injury unrelated to product|1|||
30856518|NCT02568254|58884448|FG000|Period 2|Adverse Event|0|||
30856519|NCT02568254|58884449|FG001|Period 2|Adverse Event|0|||
30856520|NCT02568254|58884450|FG002|Period 2|Adverse Event|1|||
30856521|NCT02568254|58884451|FG003|Period 2|Adverse Event|0|||
30856522|NCT02568254|58884452|FG004|Period 2|Adverse Event|0|||
30856523|NCT02568254|58884453|FG005|Period 2|Adverse Event|0|||
30856524|NCT02568254|58884448|FG000|Period 3|Unstatisfactory Lens fitting|0|||
30856525|NCT02568254|58884449|FG001|Period 3|Unstatisfactory Lens fitting|0|||
30856526|NCT02568254|58884450|FG002|Period 3|Unstatisfactory Lens fitting|0|||
30856527|NCT02568254|58884451|FG003|Period 3|Unstatisfactory Lens fitting|0|||
30856528|NCT02568254|58884452|FG004|Period 3|Unstatisfactory Lens fitting|1|||
30856529|NCT02568254|58884453|FG005|Period 3|Unstatisfactory Lens fitting|0|||
30856530|NCT02567708|58884461|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
30856531|NCT02567708|58884462|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
30856532|NCT02567708|58884461|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
30856533|NCT02567708|58884462|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
30856534|NCT02567708|58884461|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
30856535|NCT02567708|58884462|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
30856536|NCT02567708|58884461|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
30856537|NCT02567708|58884462|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
30856538|NCT02562716|58884471|FG000|Overall Study|Adverse Event|7|||
30856539|NCT02562716|58884472|FG001|Overall Study|Adverse Event|14|||
30856540|NCT02562716|58884471|FG000|Overall Study|Withdrawal unrelated to AE|7|||
30856541|NCT02562716|58884472|FG001|Overall Study|Withdrawal unrelated to AE|1|||
30856542|NCT02562716|58884471|FG000|Overall Study|Progression|8|||
30856543|NCT02562716|58884472|FG001|Overall Study|Progression|10|||
30786126|NCT03253094|58799338|FG005|Overall Study|Lack of Efficacy|1|||
30786127|NCT03253094|58799333|FG000|Overall Study|Lost to Follow-up|0|||
30786128|NCT03253094|58799334|FG001|Overall Study|Lost to Follow-up|0|||
30786129|NCT03253094|58799335|FG002|Overall Study|Lost to Follow-up|1|||
30786130|NCT03253094|58799336|FG003|Overall Study|Lost to Follow-up|1|||
30786131|NCT03253094|58799337|FG004|Overall Study|Lost to Follow-up|0|||
30786132|NCT03253094|58799338|FG005|Overall Study|Lost to Follow-up|1|||
30786133|NCT03253094|58799333|FG000|Overall Study|Physician Decision|1|||
30786134|NCT03253094|58799334|FG001|Overall Study|Physician Decision|0|||
30786135|NCT03253094|58799335|FG002|Overall Study|Physician Decision|0|||
30786136|NCT03253094|58799336|FG003|Overall Study|Physician Decision|1|||
30786137|NCT03253094|58799337|FG004|Overall Study|Physician Decision|0|||
30856544|NCT02562716|58884471|FG000|Overall Study|Death|2|||
30856545|NCT02562716|58884472|FG001|Overall Study|Death|1|||
30959329|NCT01683071|59024748|FG002|Part 2|Surgery cancelled|0|||
30959330|NCT01683071|59024749|FG003|Part 2|Surgery cancelled|0|||
30959331|NCT01683071|59024750|FG004|Part 2|Surgery cancelled|4|||
30786138|NCT03253094|58799338|FG005|Overall Study|Physician Decision|2|||
30856546|NCT02562716|58884471|FG000|Overall Study|Not protocol specified|4|||
30856547|NCT02562716|58884472|FG001|Overall Study|Not protocol specified|2|||
30856548|NCT02751931|58884482|FG000|Overall Study|Adverse Event|3|||
30856549|NCT02751931|58884483|FG001|Overall Study|Adverse Event|0|||
30856550|NCT02751931|58884482|FG000|Overall Study|Other: Miscelleneous|10|||
30786139|NCT03253094|58799333|FG000|Overall Study|Withdrawal by Subject|1|||
30959332|NCT01683071|59024751|FG005|Part 2|Surgery cancelled|2|||
30786140|NCT03253094|58799334|FG001|Overall Study|Withdrawal by Subject|2|||
30786141|NCT03253094|58799335|FG002|Overall Study|Withdrawal by Subject|1|||
30786142|NCT03253094|58799336|FG003|Overall Study|Withdrawal by Subject|0|||
30786143|NCT03253094|58799337|FG004|Overall Study|Withdrawal by Subject|3|||
30786144|NCT03253094|58799338|FG005|Overall Study|Withdrawal by Subject|0|||
30786145|NCT03253094|58799333|FG000|Overall Study|Other|0|||
30786146|NCT03253094|58799334|FG001|Overall Study|Other|1|||
30786147|NCT03253094|58799335|FG002|Overall Study|Other|2|||
30786148|NCT03253094|58799336|FG003|Overall Study|Other|1|||
30786149|NCT03253094|58799337|FG004|Overall Study|Other|0|||
30786150|NCT03253094|58799338|FG005|Overall Study|Other|0|||
30786151|NCT03654885|58799354|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
30786152|NCT03654885|58799355|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
30856551|NCT02751931|58884483|FG001|Overall Study|Other: Miscelleneous|8|||
30856552|NCT02561156|58884508|FG000|Part 2|Adverse Event|0|||
30856553|NCT02561156|58884509|FG001|Part 2|Adverse Event|0|||
30856554|NCT02561156|58884510|FG002|Part 2|Adverse Event|0|||
30856555|NCT02561156|58884511|FG003|Part 2|Adverse Event|0|||
30856556|NCT02561156|58884512|FG004|Part 2|Adverse Event|0|||
30856557|NCT02561156|58884513|FG005|Part 2|Adverse Event|0|||
30856558|NCT02561156|58884514|FG006|Part 2|Adverse Event|0|||
30856559|NCT02561156|58884515|FG007|Part 2|Adverse Event|0|||
30856560|NCT02561156|58884516|FG008|Part 2|Adverse Event|0|||
30786153|NCT03654885|58799354|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
30786154|NCT03654885|58799355|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
30786155|NCT03654885|58799354|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
30786156|NCT03654885|58799355|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
30786157|NCT03654885|58799354|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
30786158|NCT03654885|58799355|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
30786159|NCT03654885|58799354|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
30786160|NCT03654885|58799355|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
30786161|NCT03654885|58799354|FG000|Overall Study|Adverse Event in Study Eye|3|||
30786162|NCT03654885|58799355|FG001|Overall Study|Adverse Event in Study Eye|0|||
30786163|NCT03654885|58799354|FG000|Overall Study|Consent Withdrawn|1|||
30786164|NCT03654885|58799355|FG001|Overall Study|Consent Withdrawn|0|||
30786165|NCT03654885|58799354|FG000|Overall Study|Death|3|||
30786166|NCT03654885|58799355|FG001|Overall Study|Death|1|||
30786167|NCT03654885|58799354|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
30786168|NCT03654885|58799355|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
30786169|NCT03654885|58799354|FG000|Overall Study|Lost to Follow-up|3|||
30786170|NCT03654885|58799355|FG001|Overall Study|Lost to Follow-up|3|||
30786171|NCT03236246|58799363|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
30786172|NCT03236246|58799364|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
30786173|NCT03236246|58799363|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
30786174|NCT03236246|58799364|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
30786175|NCT03236246|58799363|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
30786176|NCT03236246|58799364|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
30786177|NCT03236246|58799363|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
30786178|NCT03236246|58799364|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
30856561|NCT02561156|58884517|FG009|Part 2|Adverse Event|0|||
30856562|NCT02561156|58884518|FG010|Part 2|Adverse Event|0|||
30856563|NCT02561156|58884519|FG011|Part 2|Adverse Event|1|||
30856564|NCT02561156|58884520|FG012|Part 2|Adverse Event|0|||
30856565|NCT02561078|58884566|FG000|Overall Study|Adverse Event|5|||
30856566|NCT02561078|58884567|FG001|Overall Study|Adverse Event|2|||
30856567|NCT02561078|58884566|FG000|Overall Study|Death|2|||
30856568|NCT02561078|58884567|FG001|Overall Study|Death|1|||
30599100|NCT01094782|58610928|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
30599101|NCT01094782|58610923|FG000|Overall Study|Unable to Complete Questionnaires|0|||
30599102|NCT01094782|58610924|FG001|Overall Study|Unable to Complete Questionnaires|1|||
30786179|NCT03236246|58799363|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
30786180|NCT03236246|58799364|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
30856569|NCT02561078|58884566|FG000|Overall Study|Lost to Follow-up|2|||
30856570|NCT02561078|58884567|FG001|Overall Study|Lost to Follow-up|6|||
30856571|NCT02561078|58884566|FG000|Overall Study|Non-Compliance with Study Drug|6|||
30856572|NCT02561078|58884567|FG001|Overall Study|Non-Compliance with Study Drug|3|||
30856573|NCT02561078|58884566|FG000|Overall Study|Physician Decision|2|||
30856574|NCT02561078|58884567|FG001|Overall Study|Physician Decision|3|||
30856575|NCT02561078|58884566|FG000|Overall Study|Withdrawal by Subject|13|||
30856576|NCT02561078|58884567|FG001|Overall Study|Withdrawal by Subject|10|||
30856577|NCT04907227|58884575|FG000|Overall Study|Death|10|||
30856578|NCT04907227|58884576|FG001|Overall Study|Death|7|||
30856579|NCT04907227|58884575|FG000|Overall Study|Withdrawal by Subject|1|||
30599103|NCT01094782|58610925|FG002|Overall Study|Unable to Complete Questionnaires|0|||
30786181|NCT03236246|58799363|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
30786182|NCT03236246|58799364|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
30786183|NCT03236246|58799363|FG000|24-Week Dose Titration Period|Death|3|||
30786184|NCT03236246|58799364|FG001|24-Week Dose Titration Period|Death|1|||
30786185|NCT03236246|58799363|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
30786186|NCT03236246|58799364|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
30786187|NCT03236246|58799363|FG000|24-Week Dose Titration Period|Adverse Event|7|||
30786188|NCT03236246|58799364|FG001|24-Week Dose Titration Period|Adverse Event|8|||
30786189|NCT03236246|58799363|FG000|24-Week Dose Titration Period|Captured as Other|1|||
30786190|NCT03236246|58799364|FG001|24-Week Dose Titration Period|Captured as Other|2|||
30786191|NCT03236246|58799363|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
30786192|NCT03236246|58799364|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
30786193|NCT03236246|58799363|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
30786194|NCT03236246|58799364|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
30786195|NCT03236246|58799363|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
30786196|NCT03236246|58799364|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
30786197|NCT03236246|58799363|FG000|24-Week Dose Maintenance Period|Death|0|||
30786198|NCT03236246|58799364|FG001|24-Week Dose Maintenance Period|Death|1|||
30786199|NCT03236246|58799363|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
30786200|NCT03236246|58799364|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
30786201|NCT02937584|58799370|FG000|Period 1|Adverse Event|1|||
30786202|NCT02937584|58799371|FG001|Period 1|Adverse Event|2|||
30786203|NCT02937584|58799370|FG000|Washout|Adverse Event|0|||
30786204|NCT02937584|58799371|FG001|Washout|Adverse Event|1|||
30786205|NCT00179621|58799380|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
30786206|NCT00179621|58799381|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
30786207|NCT00179621|58799382|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
30786208|NCT00179621|58799383|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
30786209|NCT00179621|58799380|FG000|Double-Blind Period|Adverse Event|2|||
30786210|NCT00179621|58799381|FG001|Double-Blind Period|Adverse Event|7|||
30786211|NCT00179621|58799382|FG002|Double-Blind Period|Adverse Event|4|||
30786212|NCT00179621|58799383|FG003|Double-Blind Period|Adverse Event|0|||
30856580|NCT04907227|58884576|FG001|Overall Study|Withdrawal by Subject|0|||
30856581|NCT04907227|58884575|FG000|Overall Study|Participants ongoing in the study|30|||
30599104|NCT01094782|58610926|FG003|Overall Study|Unable to Complete Questionnaires|0|||
30856582|NCT04907227|58884576|FG001|Overall Study|Participants ongoing in the study|33|||
30856583|NCT04886596|58884584|FG000|Overall Study|Adverse Event|73|||
30856584|NCT04886596|58884585|FG001|Overall Study|Adverse Event|78|||
30856585|NCT04886596|58884584|FG000|Overall Study|Lost to Follow-up|104|||
30856586|NCT04886596|58884585|FG001|Overall Study|Lost to Follow-up|104|||
30856587|NCT04886596|58884584|FG000|Overall Study|Ongoing|12095|||
30856588|NCT04886596|58884585|FG001|Overall Study|Ongoing|12107|||
30856589|NCT04886596|58884584|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
30856590|NCT04886596|58884585|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
30856591|NCT04886596|58884584|FG000|Overall Study|Migrated / Moved from the study area|17|||
30856592|NCT04886596|58884585|FG001|Overall Study|Migrated / Moved from the study area|14|||
30856593|NCT04886596|58884584|FG000|Overall Study|Unknown reason|16|||
30856594|NCT04886596|58884585|FG001|Overall Study|Unknown reason|23|||
30856595|NCT04881448|58884591|FG000|Overall Study|Study cancelled by sponsor|220|||
30856596|NCT04881448|58884591|FG000|Overall Study|Withdrawal by Subject|2|||
30856597|NCT04881448|58884591|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
30856598|NCT04275310|58884622|FG000|Overall Study|Non-randomized due to running out of funding|4|||
30856599|NCT04275310|58884623|FG001|Overall Study|Non-randomized due to running out of funding|0|||
30856600|NCT04157088|58884629|FG000|Overall Study|Study terminated by sponsor|23|||
30856601|NCT04157088|58884629|FG000|Overall Study|Withdrawal by Subject|4|||
30856602|NCT04157088|58884629|FG000|Overall Study|Lost to Follow-up|2|||
30856603|NCT04157088|58884629|FG000|Overall Study|Death|1|||
30856604|NCT04140266|58884637|FG000|Overall Study|Physician Decision|2|||
30856605|NCT04140266|58884638|FG001|Overall Study|Physician Decision|0|||
30599105|NCT01094782|58610927|FG004|Overall Study|Unable to Complete Questionnaires|0|||
30599106|NCT01094782|58610928|FG005|Overall Study|Unable to Complete Questionnaires|0|||
30599107|NCT01094782|58610923|FG000|Overall Study|Healthy Subject Had Pain|0|||
30856606|NCT04140266|58884637|FG000|Overall Study|Withdrawal by Subject|4|||
30599108|NCT01094782|58610924|FG001|Overall Study|Healthy Subject Had Pain|1|||
30599109|NCT01094782|58610925|FG002|Overall Study|Healthy Subject Had Pain|0|||
30599110|NCT01094782|58610926|FG003|Overall Study|Healthy Subject Had Pain|0|||
30599111|NCT01094782|58610927|FG004|Overall Study|Healthy Subject Had Pain|0|||
30786213|NCT00179621|58799380|FG000|Double-Blind Period|Withdrawal by Subject|2|||
30786214|NCT00179621|58799381|FG001|Double-Blind Period|Withdrawal by Subject|1|||
30856607|NCT04140266|58884638|FG001|Overall Study|Withdrawal by Subject|2|||
30856608|NCT04034004|58884663|FG000|Overall Study|Withdrawal by Subject|1|||
30856609|NCT04034004|58884664|FG001|Overall Study|Withdrawal by Subject|2|||
30599112|NCT01094782|58610928|FG005|Overall Study|Healthy Subject Had Pain|0|||
30688321|NCT02598960|58701868|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
30688322|NCT02598960|58701869|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
30688323|NCT02598960|58701870|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
30786215|NCT00179621|58799382|FG002|Double-Blind Period|Withdrawal by Subject|3|||
30786216|NCT00179621|58799383|FG003|Double-Blind Period|Withdrawal by Subject|0|||
30786217|NCT00179621|58799380|FG000|Double-Blind Period|Death|0|||
30786218|NCT00179621|58799381|FG001|Double-Blind Period|Death|1|||
30786219|NCT00179621|58799382|FG002|Double-Blind Period|Death|2|||
30786220|NCT00179621|58799383|FG003|Double-Blind Period|Death|0|||
30786221|NCT00179621|58799380|FG000|Double-Blind Period|Protocol Violation|1|||
30599113|NCT01094782|58610923|FG000|Overall Study|Hypertension|0|||
30599114|NCT01094782|58610924|FG001|Overall Study|Hypertension|0|||
30599115|NCT01094782|58610925|FG002|Overall Study|Hypertension|1|||
30599116|NCT01094782|58610926|FG003|Overall Study|Hypertension|0|||
30599117|NCT01094782|58610927|FG004|Overall Study|Hypertension|0|||
30786222|NCT00179621|58799381|FG001|Double-Blind Period|Protocol Violation|0|||
30786223|NCT00179621|58799382|FG002|Double-Blind Period|Protocol Violation|0|||
30786224|NCT00179621|58799383|FG003|Double-Blind Period|Protocol Violation|0|||
30786225|NCT00179621|58799380|FG000|Double-Blind Period|Other|0|||
30786226|NCT00179621|58799381|FG001|Double-Blind Period|Other|2|||
30786227|NCT00179621|58799382|FG002|Double-Blind Period|Other|2|||
30786228|NCT00179621|58799383|FG003|Double-Blind Period|Other|0|||
30786229|NCT00179621|58799380|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
30959333|NCT01683071|59024746|FG000|Part 2|Did not receive study drug|0|||
30599118|NCT01094782|58610928|FG005|Overall Study|Hypertension|0|||
30599119|NCT01094782|58610923|FG000|Overall Study|Wrong Pain Condition|0|||
30599120|NCT01094782|58610924|FG001|Overall Study|Wrong Pain Condition|0|||
30599121|NCT01094782|58610925|FG002|Overall Study|Wrong Pain Condition|0|||
30599122|NCT01094782|58610926|FG003|Overall Study|Wrong Pain Condition|2|||
30688324|NCT02598960|58701871|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
30688325|NCT02598960|58701872|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
30688326|NCT00426361|58701903|FG000|Overall Study|Lost to Follow-up|3|||
30688327|NCT00426361|58701904|FG001|Overall Study|Lost to Follow-up|2|||
30688328|NCT00426361|58701905|FG002|Overall Study|Lost to Follow-up|5|||
30786230|NCT00179621|58799381|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
30786231|NCT00179621|58799382|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
30786232|NCT00179621|58799383|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
30599123|NCT01094782|58610927|FG004|Overall Study|Wrong Pain Condition|1|||
30599124|NCT01094782|58610928|FG005|Overall Study|Wrong Pain Condition|1|||
30599125|NCT01094782|58610923|FG000|Overall Study|Recent Interventional Injection|0|||
30599126|NCT01094782|58610924|FG001|Overall Study|Recent Interventional Injection|0|||
30599127|NCT01094782|58610925|FG002|Overall Study|Recent Interventional Injection|0|||
30599128|NCT01094782|58610926|FG003|Overall Study|Recent Interventional Injection|0|||
30599129|NCT01094782|58610927|FG004|Overall Study|Recent Interventional Injection|0|||
30599130|NCT01094782|58610928|FG005|Overall Study|Recent Interventional Injection|1|||
30599131|NCT01094782|58610923|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
30599132|NCT01094782|58610924|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
30599133|NCT01094782|58610925|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
30599134|NCT01094782|58610926|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
30599135|NCT01094782|58610927|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
30599136|NCT01094782|58610928|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
30599137|NCT01094782|58610923|FG000|Overall Study|Noncompliance With Study Schedule|0|||
30599138|NCT01094782|58610924|FG001|Overall Study|Noncompliance With Study Schedule|0|||
30599139|NCT01094782|58610925|FG002|Overall Study|Noncompliance With Study Schedule|0|||
30599140|NCT01094782|58610926|FG003|Overall Study|Noncompliance With Study Schedule|1|||
30599141|NCT01094782|58610927|FG004|Overall Study|Noncompliance With Study Schedule|0|||
30599142|NCT01094782|58610928|FG005|Overall Study|Noncompliance With Study Schedule|0|||
30599143|NCT01097044|58610944|FG000|Overall Study|Withdrawal by Subject|4|||
30599144|NCT01097044|58610945|FG001|Overall Study|Withdrawal by Subject|4|||
30599145|NCT01097044|58610944|FG000|Overall Study|Lost to Follow-up|1|||
30599146|NCT01097044|58610945|FG001|Overall Study|Lost to Follow-up|0|||
30599147|NCT01097044|58610944|FG000|Overall Study|Withdrawal by Sponsor|0|||
30599148|NCT01097044|58610945|FG001|Overall Study|Withdrawal by Sponsor|1|||
30599149|NCT01322009|58610955|FG000|Overall Study|Death|0|||
30599150|NCT01322009|58610956|FG001|Overall Study|Death|1|||
30599151|NCT01322009|58610955|FG000|Overall Study|Adverse Event|0|||
30599152|NCT01322009|58610956|FG001|Overall Study|Adverse Event|1|||
30599153|NCT01322009|58610955|FG000|Overall Study|ng tube discontinued|0|||
30599154|NCT01322009|58610956|FG001|Overall Study|ng tube discontinued|1|||
30599155|NCT01321697|58610962|FG000|Overall Study|Study Terminated|7|||
30599156|NCT01320683|58610966|FG000|Overall Study|Positive antibody response|1|||
30786233|NCT00179621|58799380|FG000|Open-Label Period|Adverse Event|0|||
30786234|NCT00179621|58799381|FG001|Open-Label Period|Adverse Event|6|||
30599157|NCT01320293|58610970|FG000|Overall Study|Lack of Efficacy|1|||
30599158|NCT01320293|58610970|FG000|Overall Study|Adverse Event|1|||
30599159|NCT01318811|58610976|FG000|Overall Study|Physician Decision|1|||
30786235|NCT00179621|58799382|FG002|Open-Label Period|Adverse Event|5|||
30786236|NCT00179621|58799383|FG003|Open-Label Period|Adverse Event|6|||
30786237|NCT00179621|58799380|FG000|Open-Label Period|Withdrawal by Subject|0|||
30786238|NCT00179621|58799381|FG001|Open-Label Period|Withdrawal by Subject|2|||
30786239|NCT00179621|58799382|FG002|Open-Label Period|Withdrawal by Subject|2|||
30786240|NCT00179621|58799383|FG003|Open-Label Period|Withdrawal by Subject|2|||
30786241|NCT00179621|58799380|FG000|Open-Label Period|Death|0|||
30786242|NCT00179621|58799381|FG001|Open-Label Period|Death|0|||
30786243|NCT00179621|58799382|FG002|Open-Label Period|Death|1|||
30786244|NCT00179621|58799383|FG003|Open-Label Period|Death|2|||
30786245|NCT00179621|58799380|FG000|Open-Label Period|Other|0|||
30786246|NCT00179621|58799381|FG001|Open-Label Period|Other|1|||
30786247|NCT00179621|58799382|FG002|Open-Label Period|Other|1|||
30786248|NCT00179621|58799383|FG003|Open-Label Period|Other|2|||
30786249|NCT00179309|58799394|FG000|Treatment|Toxicity|2|||
30786250|NCT00179309|58799395|FG001|Treatment|Toxicity|3|||
30786251|NCT00179309|58799394|FG000|Treatment|Withdrawal by Subject|1|||
30786252|NCT00179309|58799395|FG001|Treatment|Withdrawal by Subject|2|||
30786253|NCT00179309|58799394|FG000|Treatment|Allergy|1|||
30786254|NCT00179309|58799395|FG001|Treatment|Allergy|0|||
30786255|NCT00178685|58799416|FG000|Overall Study|Death|3|||
30786256|NCT00178685|58799417|FG001|Overall Study|Death|3|||
30786257|NCT00178685|58799418|FG002|Overall Study|Death|6|||
30786258|NCT00178685|58799416|FG000|Overall Study|Lost to Follow-up|100|||
30786259|NCT00178685|58799417|FG001|Overall Study|Lost to Follow-up|187|||
30786260|NCT00178685|58799418|FG002|Overall Study|Lost to Follow-up|183|||
30786261|NCT00178685|58799416|FG000|Overall Study|Withdrawal by Subject|8|||
30786262|NCT00178685|58799417|FG001|Overall Study|Withdrawal by Subject|14|||
30786263|NCT00178685|58799418|FG002|Overall Study|Withdrawal by Subject|7|||
30786264|NCT02933528|58799426|FG000|Overall Study|Lost to Follow-up|2|||
30786265|NCT00177671|58799432|FG000|Overall Study|Withdrawal by Subject|5|||
30786266|NCT00177671|58799433|FG001|Overall Study|Withdrawal by Subject|6|||
30786267|NCT00177671|58799432|FG000|Overall Study|medical complications|2|||
30786268|NCT00177671|58799433|FG001|Overall Study|medical complications|0|||
30786269|NCT00177671|58799432|FG000|Overall Study|Adverse Event|6|||
30786270|NCT00177671|58799433|FG001|Overall Study|Adverse Event|0|||
30786271|NCT00177671|58799432|FG000|Overall Study|Physician Decision|12|||
30786272|NCT00177671|58799433|FG001|Overall Study|Physician Decision|8|||
30786273|NCT02933060|58799441|FG000|Overall Study|Withdrawal by Subject|0|||
30786274|NCT02933060|58799442|FG001|Overall Study|Withdrawal by Subject|1|||
30786275|NCT03235154|58799448|FG000|Overall Study|Withdrawal by Subject|1|||
30688329|NCT00426361|58701903|FG000|Overall Study|Withdrawal by Subject|1|||
30688330|NCT00426361|58701904|FG001|Overall Study|Withdrawal by Subject|3|||
30688331|NCT00426361|58701905|FG002|Overall Study|Withdrawal by Subject|0|||
30688332|NCT00665847|58701913|FG000|Overall Study|Adverse Event|8|||
30688333|NCT00665847|58701913|FG000|Overall Study|Withdrawal by Subject|2|||
30688334|NCT00665847|58701913|FG000|Overall Study|Subject non-compliant|8|||
30688335|NCT00665847|58701913|FG000|Overall Study|Subject reached a virologic endpoint|4|||
30688336|NCT00665847|58701913|FG000|Overall Study|Resistance to TMC125|1|||
30688337|NCT00665847|58701913|FG000|Overall Study|Subject ineligible to continue the trial|1|||
30786276|NCT03235154|58799448|FG000|Overall Study|Adverse Event|1|||
30786277|NCT03235154|58799448|FG000|Overall Study|Lost to Follow-up|2|||
30786278|NCT03234608|58799456|FG000|Overall Study|Lost to Follow-up|23|||
30786279|NCT03234608|58799457|FG001|Overall Study|Lost to Follow-up|21|||
30786280|NCT03248882|58799468|FG000|Overall Study|Adverse Event|3|||
30786281|NCT03248882|58799469|FG001|Overall Study|Adverse Event|3|||
30786282|NCT03248882|58799470|FG002|Overall Study|Adverse Event|2|||
30786283|NCT03248882|58799471|FG003|Overall Study|Adverse Event|6|||
30786284|NCT03248882|58799472|FG004|Overall Study|Adverse Event|9|||
30786285|NCT03248882|58799468|FG000|Overall Study|Lost to Follow-up|0|||
30786286|NCT03248882|58799469|FG001|Overall Study|Lost to Follow-up|0|||
30786287|NCT03248882|58799470|FG002|Overall Study|Lost to Follow-up|0|||
30959334|NCT01683071|59024747|FG001|Part 2|Did not receive study drug|0|||
30786288|NCT03248882|58799471|FG003|Overall Study|Lost to Follow-up|0|||
30786289|NCT03248882|58799472|FG004|Overall Study|Lost to Follow-up|1|||
30786290|NCT03248882|58799468|FG000|Overall Study|Protocol Violation|2|||
30786291|NCT03248882|58799469|FG001|Overall Study|Protocol Violation|0|||
30786292|NCT03248882|58799470|FG002|Overall Study|Protocol Violation|2|||
30856610|NCT04034004|58884665|FG002|Overall Study|Withdrawal by Subject|2|||
30688338|NCT00665847|58701913|FG000|Overall Study|Switch to Commercial Medication|1|||
30786293|NCT03248882|58799471|FG003|Overall Study|Protocol Violation|0|||
30786294|NCT03248882|58799472|FG004|Overall Study|Protocol Violation|1|||
30786295|NCT03248882|58799468|FG000|Overall Study|Withdrawal by Subject|2|||
30786296|NCT03248882|58799469|FG001|Overall Study|Withdrawal by Subject|2|||
30786297|NCT03248882|58799470|FG002|Overall Study|Withdrawal by Subject|3|||
30786298|NCT03248882|58799471|FG003|Overall Study|Withdrawal by Subject|4|||
30786299|NCT03248882|58799472|FG004|Overall Study|Withdrawal by Subject|2|||
30786300|NCT03233438|58799486|FG000|Overall Study|Lost to Follow-up|4|||
30786301|NCT03233438|58799487|FG001|Overall Study|Lost to Follow-up|9|||
30856611|NCT04034004|58884666|FG003|Overall Study|Withdrawal by Subject|3|||
30786302|NCT03233438|58799486|FG000|Overall Study|Withdrawal by Subject|2|||
30786303|NCT03233438|58799487|FG001|Overall Study|Withdrawal by Subject|1|||
30786304|NCT03233438|58799486|FG000|Overall Study|No recording of dalbavancin|0|||
30786305|NCT03233438|58799487|FG001|Overall Study|No recording of dalbavancin|1|||
30786306|NCT01368406|58799495|FG000|Overall Study|Lost to Follow-up|8|||
30786307|NCT01368406|58799496|FG001|Overall Study|Lost to Follow-up|4|||
30786308|NCT01368406|58799495|FG000|Overall Study|Withdrawal by Subject|8|||
30786309|NCT01368406|58799496|FG001|Overall Study|Withdrawal by Subject|4|||
30786310|NCT01368406|58799495|FG000|Overall Study|relapse of the disease|3|||
30786311|NCT01368406|58799496|FG001|Overall Study|relapse of the disease|2|||
30786312|NCT01368406|58799495|FG000|Overall Study|started working|2|||
30786313|NCT01368406|58799496|FG001|Overall Study|started working|3|||
30786314|NCT00175877|58799502|FG000|Overall Study|Adverse Event|136|||
30786315|NCT00175877|58799502|FG000|Overall Study|Withdrawal by Subject|141|||
30786316|NCT00175877|58799502|FG000|Overall Study|Lost to Follow-up|9|||
30786317|NCT00175877|58799502|FG000|Overall Study|Lack of Efficacy|26|||
30786318|NCT00175877|58799502|FG000|Overall Study|Protocol Violation|15|||
30786319|NCT00175877|58799502|FG000|Overall Study|Other Reason|20|||
30786320|NCT00175877|58799502|FG000|Overall Study|AE & Other|1|||
30786321|NCT00175877|58799502|FG000|Overall Study|Withdrawal by subject & Other|1|||
30786322|NCT02788474|58799508|FG000|Double Blind Treatment Period|Not treated|1|||
30786323|NCT02788474|58799509|FG001|Double Blind Treatment Period|Not treated|0|||
30786324|NCT02788474|58799508|FG000|Double Blind Treatment Period|Patient's refusal|3|||
30786325|NCT02788474|58799509|FG001|Double Blind Treatment Period|Patient's refusal|0|||
30786326|NCT02788474|58799508|FG000|Double Blind Treatment Period|Adverse Event|6|||
30786327|NCT02788474|58799509|FG001|Double Blind Treatment Period|Adverse Event|4|||
30786328|NCT02788474|58799508|FG000|Open Label Treatment Period|Adverse Event|29|||
30786329|NCT02788474|58799509|FG001|Open Label Treatment Period|Adverse Event|9|||
30786330|NCT02788474|58799508|FG000|Open Label Treatment Period|Other than reason specified|1|||
30786331|NCT02788474|58799509|FG001|Open Label Treatment Period|Other than reason specified|0|||
30786332|NCT02788474|58799508|FG000|Open Label Treatment Period|Patient's refusal|1|||
30786333|NCT02788474|58799509|FG001|Open Label Treatment Period|Patient's refusal|3|||
30786334|NCT02788474|58799508|FG000|Open Label Treatment Period|Non-compliance|1|||
30786335|NCT02788474|58799509|FG001|Open Label Treatment Period|Non-compliance|0|||
30786336|NCT03248492|58799521|FG000|Overall Study|Ongoing|23|||
30786337|NCT03248492|58799522|FG001|Overall Study|Ongoing|26|||
30786338|NCT03248492|58799523|FG002|Overall Study|Ongoing|3|||
30786339|NCT03248492|58799524|FG003|Overall Study|Ongoing|85|||
30688339|NCT00426127|58701917|FG000|Overall Study|Adverse Event|1|||
30688340|NCT00426127|58701917|FG000|Overall Study|Removed due to disease progression|1|||
30688341|NCT00425503|58701921|FG000|Overall Study|Adverse Event|2|||
30688342|NCT00425503|58701921|FG000|Overall Study|Protocol Violation|1|||
30688343|NCT00425269|58701927|FG000|Overall Study|Pregnancy|5|||
30688344|NCT00425269|58701928|FG001|Overall Study|Pregnancy|7|||
30688345|NCT00425269|58701927|FG000|Overall Study|Lost to Follow-up|9|||
30688346|NCT00425269|58701928|FG001|Overall Study|Lost to Follow-up|9|||
30688347|NCT00425269|58701927|FG000|Overall Study|moved or medical reason|5|||
30688348|NCT00425269|58701928|FG001|Overall Study|moved or medical reason|4|||
30786340|NCT03248492|58799525|FG004|Overall Study|Ongoing|2|||
30786341|NCT03248492|58799521|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
30856612|NCT04034004|58884663|FG000|Overall Study|could not find vein to administer IV|2|||
30856613|NCT04034004|58884664|FG001|Overall Study|could not find vein to administer IV|1|||
30856614|NCT04034004|58884665|FG002|Overall Study|could not find vein to administer IV|0|||
30856615|NCT04034004|58884666|FG003|Overall Study|could not find vein to administer IV|0|||
30599160|NCT01318811|58610977|FG001|Overall Study|Physician Decision|1|||
30599161|NCT01318811|58610976|FG000|Overall Study|CRRT stopped for head CT|0|||
30599162|NCT01318811|58610977|FG001|Overall Study|CRRT stopped for head CT|1|||
30599163|NCT01318811|58610976|FG000|Overall Study|Death|0|||
30599164|NCT01318811|58610977|FG001|Overall Study|Death|1|||
30599165|NCT01318811|58610976|FG000|Overall Study|CRRT stopped for head MRI|0|||
30599166|NCT01318811|58610977|FG001|Overall Study|CRRT stopped for head MRI|1|||
30599167|NCT01093846|58610986|FG000|Overall Study|Adverse Event|0|||
30688349|NCT00430573|58701934|FG000|Overall Study|Withdrawal by Subject|5|||
30688350|NCT02075840|58701958|FG000|Overall Study|Withdrawal by Subject|13|||
30786342|NCT03248492|58799522|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
30786343|NCT03248492|58799523|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
30786344|NCT03248492|58799524|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
30786345|NCT03248492|58799525|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
30786346|NCT03248492|58799521|FG000|Overall Study|Adverse Event|6|||
30786347|NCT03248492|58799522|FG001|Overall Study|Adverse Event|6|||
30786348|NCT03248492|58799523|FG002|Overall Study|Adverse Event|8|||
30786349|NCT03248492|58799524|FG003|Overall Study|Adverse Event|8|||
30786350|NCT03248492|58799525|FG004|Overall Study|Adverse Event|1|||
30786351|NCT03248492|58799521|FG000|Overall Study|Withdrawal by Subject|3|||
30786352|NCT03248492|58799522|FG001|Overall Study|Withdrawal by Subject|3|||
30856616|NCT04034004|58884663|FG000|Overall Study|nurse accidentally unblinded subject|0|||
30688351|NCT02075840|58701959|FG001|Overall Study|Withdrawal by Subject|22|||
30688352|NCT02075840|58701958|FG000|Overall Study|Reason not specified|1|||
30786353|NCT03248492|58799523|FG002|Overall Study|Withdrawal by Subject|0|||
30786354|NCT03248492|58799524|FG003|Overall Study|Withdrawal by Subject|3|||
30786355|NCT03248492|58799525|FG004|Overall Study|Withdrawal by Subject|1|||
30786356|NCT03248492|58799521|FG000|Overall Study|Physician Decision|1|||
30786357|NCT03248492|58799522|FG001|Overall Study|Physician Decision|0|||
30786358|NCT03248492|58799523|FG002|Overall Study|Physician Decision|1|||
30786359|NCT03248492|58799524|FG003|Overall Study|Physician Decision|2|||
30786360|NCT03248492|58799525|FG004|Overall Study|Physician Decision|0|||
30688353|NCT02075840|58701959|FG001|Overall Study|Reason not specified|0|||
30688354|NCT02075840|58701958|FG000|Overall Study|Adverse Event|0|||
30688355|NCT02075840|58701959|FG001|Overall Study|Adverse Event|2|||
30688356|NCT02075840|58701958|FG000|Overall Study|Death|35|||
30786361|NCT03248492|58799521|FG000|Overall Study|Death|1|||
30786362|NCT03248492|58799522|FG001|Overall Study|Death|0|||
30786363|NCT03248492|58799523|FG002|Overall Study|Death|0|||
30786364|NCT03248492|58799524|FG003|Overall Study|Death|6|||
30786365|NCT03248492|58799525|FG004|Overall Study|Death|0|||
30786366|NCT03248492|58799521|FG000|Overall Study|Other|0|||
30786367|NCT03248492|58799522|FG001|Overall Study|Other|1|||
30786368|NCT03248492|58799523|FG002|Overall Study|Other|0|||
30786369|NCT03248492|58799524|FG003|Overall Study|Other|4|||
30786370|NCT03248492|58799525|FG004|Overall Study|Other|0|||
30786371|NCT03247556|58799548|FG000|Overall Study|Adverse Event|1|||
30786372|NCT03247556|58799549|FG001|Overall Study|Adverse Event|4|||
30786373|NCT03247556|58799550|FG002|Overall Study|Adverse Event|5|||
30786374|NCT03247556|58799548|FG000|Overall Study|Lost to Follow-up|5|||
30786375|NCT03247556|58799549|FG001|Overall Study|Lost to Follow-up|5|||
30786376|NCT03247556|58799550|FG002|Overall Study|Lost to Follow-up|4|||
30786377|NCT03247556|58799548|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
30688357|NCT02075840|58701959|FG001|Overall Study|Death|40|||
30688358|NCT02075840|58701958|FG000|Overall Study|Lost to Follow-up|3|||
30688359|NCT02075840|58701959|FG001|Overall Study|Lost to Follow-up|2|||
30688360|NCT02075840|58701958|FG000|Overall Study|Physician Decision|1|||
30688361|NCT02075840|58701959|FG001|Overall Study|Physician Decision|3|||
30688362|NCT02075840|58701958|FG000|Overall Study|Ongoing at CCOD|99|||
30688363|NCT02075840|58701959|FG001|Overall Study|Ongoing at CCOD|82|||
30688364|NCT00430495|58701969|FG000|Overall Study|Adverse Event|2|||
30688365|NCT00430495|58701970|FG001|Overall Study|Adverse Event|3|||
30688366|NCT00430495|58701971|FG002|Overall Study|Adverse Event|2|||
30688367|NCT00430495|58701972|FG003|Overall Study|Adverse Event|0|||
30688368|NCT00430495|58701969|FG000|Overall Study|Death|0|||
30688369|NCT00430495|58701970|FG001|Overall Study|Death|0|||
30688370|NCT00430495|58701971|FG002|Overall Study|Death|1|||
30688371|NCT00430495|58701972|FG003|Overall Study|Death|0|||
30688372|NCT00430495|58701969|FG000|Overall Study|Lost to Follow-up|0|||
30688373|NCT00430495|58701970|FG001|Overall Study|Lost to Follow-up|1|||
30688374|NCT00430495|58701971|FG002|Overall Study|Lost to Follow-up|4|||
30688375|NCT00430495|58701972|FG003|Overall Study|Lost to Follow-up|0|||
30688376|NCT00430495|58701969|FG000|Overall Study|Protocol Violation|1|||
30688377|NCT00430495|58701970|FG001|Overall Study|Protocol Violation|0|||
30688378|NCT00430495|58701971|FG002|Overall Study|Protocol Violation|1|||
30688379|NCT00430495|58701972|FG003|Overall Study|Protocol Violation|0|||
30688380|NCT00430495|58701969|FG000|Overall Study|Disease Progression|1|||
30688381|NCT00430495|58701970|FG001|Overall Study|Disease Progression|1|||
30688382|NCT00430495|58701971|FG002|Overall Study|Disease Progression|0|||
30688383|NCT00430495|58701972|FG003|Overall Study|Disease Progression|0|||
30688384|NCT00430495|58701969|FG000|Overall Study|Other|8|||
30688385|NCT00430495|58701970|FG001|Overall Study|Other|2|||
30786378|NCT03247556|58799549|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
30786379|NCT03247556|58799550|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
30786380|NCT03247556|58799548|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
30786381|NCT03247556|58799549|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
30786382|NCT03247556|58799550|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
30786383|NCT03247556|58799548|FG000|Overall Study|Protocol Violation|2|||
30786384|NCT03247556|58799549|FG001|Overall Study|Protocol Violation|0|||
30786385|NCT03247556|58799550|FG002|Overall Study|Protocol Violation|1|||
30786386|NCT03247556|58799548|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
30786387|NCT03247556|58799549|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
30786388|NCT03247556|58799550|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
30786389|NCT03216746|58799562|FG000|Overall Study|Lost to Follow-up|6|||
30786390|NCT03216746|58799563|FG001|Overall Study|Lost to Follow-up|8|||
30786391|NCT03216746|58799564|FG002|Overall Study|Lost to Follow-up|5|||
30786392|NCT03216746|58799565|FG003|Overall Study|Lost to Follow-up|6|||
30688386|NCT00430495|58701971|FG002|Overall Study|Other|5|||
30786393|NCT02787304|58799579|FG000|Overall Study|Adverse Event|9|||
30688387|NCT00430495|58701972|FG003|Overall Study|Other|4|||
30688388|NCT00430495|58701969|FG000|Overall Study|Randomized but not Treated|2|||
30786394|NCT02787304|58799580|FG001|Overall Study|Adverse Event|3|||
30786395|NCT02787304|58799581|FG002|Overall Study|Adverse Event|8|||
30688389|NCT00430495|58701970|FG001|Overall Study|Randomized but not Treated|0|||
30688390|NCT00430495|58701971|FG002|Overall Study|Randomized but not Treated|0|||
30786396|NCT02787304|58799582|FG003|Overall Study|Adverse Event|1|||
30786397|NCT02787304|58799579|FG000|Overall Study|Withdrawal by Subject|1|||
30688391|NCT00430495|58701972|FG003|Overall Study|Randomized but not Treated|0|||
30688392|NCT00425113|58701984|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
30688393|NCT00425113|58701985|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
30688394|NCT00425113|58701984|FG000|Overall Study|diagnosis of abdominal TB|0|||
30688395|NCT00425113|58701985|FG001|Overall Study|diagnosis of abdominal TB|1|||
30688396|NCT00425113|58701984|FG000|Overall Study|missing study drug more than 14 days|0|||
30688397|NCT00425113|58701985|FG001|Overall Study|missing study drug more than 14 days|1|||
30688398|NCT00425113|58701984|FG000|Overall Study|Withdrawal by Subject|1|||
30688399|NCT00425113|58701985|FG001|Overall Study|Withdrawal by Subject|0|||
30688400|NCT00440011|58701994|FG000|Overall Study|Adverse Event|2|||
30688401|NCT00440011|58701995|FG001|Overall Study|Adverse Event|0|||
30688402|NCT00440011|58701994|FG000|Overall Study|Lost to Follow-up|0|||
30786398|NCT02787304|58799580|FG001|Overall Study|Withdrawal by Subject|4|||
30786399|NCT02787304|58799581|FG002|Overall Study|Withdrawal by Subject|0|||
30786400|NCT02787304|58799582|FG003|Overall Study|Withdrawal by Subject|0|||
30786401|NCT02787304|58799579|FG000|Overall Study|Lost to Follow-up|1|||
30786402|NCT02787304|58799580|FG001|Overall Study|Lost to Follow-up|0|||
30786403|NCT02787304|58799581|FG002|Overall Study|Lost to Follow-up|0|||
30786404|NCT02787304|58799582|FG003|Overall Study|Lost to Follow-up|1|||
30786405|NCT02787304|58799579|FG000|Overall Study|Noncompliance with study drug|0|||
30786406|NCT02787304|58799580|FG001|Overall Study|Noncompliance with study drug|0|||
30786407|NCT02787304|58799581|FG002|Overall Study|Noncompliance with study drug|1|||
30786408|NCT02787304|58799582|FG003|Overall Study|Noncompliance with study drug|0|||
30786409|NCT02787304|58799579|FG000|Overall Study|Physician Decision|0|||
30786410|NCT02787304|58799580|FG001|Overall Study|Physician Decision|0|||
30786411|NCT02787304|58799581|FG002|Overall Study|Physician Decision|1|||
30786412|NCT02787304|58799582|FG003|Overall Study|Physician Decision|0|||
30786413|NCT02787304|58799579|FG000|Overall Study|Study terminated by sponsor|25|||
30786414|NCT02787304|58799580|FG001|Overall Study|Study terminated by sponsor|31|||
30786415|NCT02787304|58799581|FG002|Overall Study|Study terminated by sponsor|31|||
30786416|NCT02787304|58799582|FG003|Overall Study|Study terminated by sponsor|32|||
30786417|NCT02932904|58799596|FG000|Overall Study|Reason not Specified|1|||
30786418|NCT02932904|58799597|FG001|Overall Study|Reason not Specified|0|||
30786419|NCT02932904|58799598|FG002|Overall Study|Reason not Specified|2|||
30786420|NCT02932904|58799599|FG003|Overall Study|Reason not Specified|2|||
30786421|NCT02932904|58799596|FG000|Overall Study|Noncompliance with Study Drug|2|||
30786422|NCT02932904|58799597|FG001|Overall Study|Noncompliance with Study Drug|3|||
30786423|NCT02932904|58799598|FG002|Overall Study|Noncompliance with Study Drug|3|||
30786424|NCT02932904|58799599|FG003|Overall Study|Noncompliance with Study Drug|4|||
30786425|NCT02932904|58799596|FG000|Overall Study|Pregnancy|0|||
30786426|NCT02932904|58799597|FG001|Overall Study|Pregnancy|1|||
30786427|NCT02932904|58799598|FG002|Overall Study|Pregnancy|1|||
30786428|NCT02932904|58799599|FG003|Overall Study|Pregnancy|0|||
30786429|NCT02932904|58799596|FG000|Overall Study|Study Termination|0|||
30786430|NCT02932904|58799597|FG001|Overall Study|Study Termination|1|||
30786431|NCT02932904|58799598|FG002|Overall Study|Study Termination|0|||
30599168|NCT01093846|58610987|FG001|Overall Study|Adverse Event|0|||
30599169|NCT01093846|58610988|FG002|Overall Study|Adverse Event|1|||
30599170|NCT01093846|58610986|FG000|Overall Study|Lack of Efficacy|0|||
30599171|NCT01093846|58610987|FG001|Overall Study|Lack of Efficacy|0|||
30599172|NCT01093846|58610988|FG002|Overall Study|Lack of Efficacy|4|||
30599173|NCT01093846|58610986|FG000|Overall Study|Condition no longer required study drug|1|||
30599174|NCT01093846|58610987|FG001|Overall Study|Condition no longer required study drug|1|||
30599175|NCT01093846|58610988|FG002|Overall Study|Condition no longer required study drug|1|||
30599176|NCT01093846|58610986|FG000|Overall Study|Administrative Problems|18|||
30599177|NCT01093846|58610987|FG001|Overall Study|Administrative Problems|17|||
30599178|NCT01093846|58610988|FG002|Overall Study|Administrative Problems|15|||
30599179|NCT01315847|58610996|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
30786432|NCT02932904|58799599|FG003|Overall Study|Study Termination|0|||
30786433|NCT02932904|58799596|FG000|Overall Study|Voluntary Withdrawal|2|||
30786434|NCT02932904|58799597|FG001|Overall Study|Voluntary Withdrawal|1|||
30786435|NCT02932904|58799598|FG002|Overall Study|Voluntary Withdrawal|4|||
30786436|NCT02932904|58799599|FG003|Overall Study|Voluntary Withdrawal|2|||
30786437|NCT02932904|58799596|FG000|Overall Study|Lost to Follow-up|5|||
30856617|NCT04034004|58884664|FG001|Overall Study|nurse accidentally unblinded subject|0|||
30688403|NCT00440011|58701995|FG001|Overall Study|Lost to Follow-up|2|||
30688404|NCT00440011|58701994|FG000|Overall Study|Protocol Violation|1|||
30786438|NCT02932904|58799597|FG001|Overall Study|Lost to Follow-up|3|||
30786439|NCT02932904|58799598|FG002|Overall Study|Lost to Follow-up|6|||
30786440|NCT02932904|58799599|FG003|Overall Study|Lost to Follow-up|0|||
30786441|NCT02932904|58799596|FG000|Overall Study|Significant Protocol Deviation|2|||
30786442|NCT02932904|58799597|FG001|Overall Study|Significant Protocol Deviation|3|||
30786443|NCT02932904|58799598|FG002|Overall Study|Significant Protocol Deviation|6|||
30786444|NCT02932904|58799599|FG003|Overall Study|Significant Protocol Deviation|1|||
30786445|NCT02932904|58799596|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
30786446|NCT02932904|58799597|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
30786447|NCT02932904|58799598|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
30786448|NCT02932904|58799599|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
30786449|NCT02932904|58799596|FG000|Overall Study|Randomized But Not Treated|1|||
30786450|NCT02932904|58799597|FG001|Overall Study|Randomized But Not Treated|1|||
30786451|NCT02932904|58799598|FG002|Overall Study|Randomized But Not Treated|0|||
30786452|NCT02932904|58799599|FG003|Overall Study|Randomized But Not Treated|2|||
30786453|NCT00688376|58799614|FG000|Double-Blind Phase|Adverse Event|4|||
30786454|NCT00688376|58799615|FG001|Double-Blind Phase|Adverse Event|4|||
30786455|NCT00688376|58799614|FG000|Double-Blind Phase|Protocol Violation|1|||
30786456|NCT00688376|58799615|FG001|Double-Blind Phase|Protocol Violation|2|||
30786457|NCT00688376|58799614|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
30786458|NCT00688376|58799615|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
30786459|NCT00688376|58799614|FG000|Double-Blind Phase|Not treated|0|||
30786460|NCT00688376|58799615|FG001|Double-Blind Phase|Not treated|1|||
30786461|NCT00688376|58799614|FG000|Blinded Extension Phase|Adverse Event|3|||
30786462|NCT00688376|58799615|FG001|Blinded Extension Phase|Adverse Event|4|||
30786463|NCT00688376|58799614|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
30786464|NCT00688376|58799615|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
30786465|NCT00688376|58799614|FG000|Blinded Extension Phase|Physician Decision|1|||
30786466|NCT00688376|58799615|FG001|Blinded Extension Phase|Physician Decision|0|||
30786467|NCT00688376|58799614|FG000|Blinded Extension Phase|Other|1|||
30786468|NCT00688376|58799615|FG001|Blinded Extension Phase|Other|0|||
30786469|NCT03214952|58799623|FG000|Overall Study|Protocol Deviation|45|||
30786470|NCT03214952|58799623|FG000|Overall Study|Case Report Forms Uncollected|13|||
30786471|NCT01367704|58799629|FG000|Overall Study|Lost to Follow-up|47|||
30786472|NCT01367704|58799630|FG001|Overall Study|Lost to Follow-up|161|||
30786473|NCT03214094|58799636|FG000|Overall Study|Case Report Forms Uncollected|14|||
30786474|NCT03214094|58799636|FG000|Overall Study|Protocol Deviation|46|||
30786475|NCT01367236|58799642|FG000|Overall Study|Withdrawal by Subject|3|||
30786476|NCT01367236|58799643|FG001|Overall Study|Withdrawal by Subject|1|||
30786477|NCT03681951|58799657|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
30786478|NCT03681951|58799658|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
30786479|NCT03681951|58799659|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
30786480|NCT03681951|58799660|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
30786481|NCT03681951|58799661|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
30786482|NCT03681951|58799662|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
30786483|NCT03681951|58799663|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
30786484|NCT03681951|58799664|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
30786485|NCT03681951|58799657|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
30786486|NCT03681951|58799658|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
30786487|NCT03681951|58799659|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
30786488|NCT03681951|58799660|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
30786489|NCT03681951|58799661|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
30786490|NCT03681951|58799662|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
30786491|NCT03681951|58799663|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
30786492|NCT03681951|58799664|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
30786493|NCT03681951|58799657|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
30786494|NCT03681951|58799658|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
30786495|NCT03681951|58799659|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
30959335|NCT01683071|59024748|FG002|Part 2|Did not receive study drug|0|||
30959336|NCT01683071|59024749|FG003|Part 2|Did not receive study drug|0|||
30599180|NCT01315847|58610997|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
30599181|NCT01315847|58610996|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
30599182|NCT01315847|58610997|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
30599183|NCT01093534|58611006|FG000|Overall Study|Adverse Event|2|||
30599184|NCT01093534|58611007|FG001|Overall Study|Adverse Event|5|||
30786496|NCT03681951|58799660|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
30786497|NCT03681951|58799661|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
30786498|NCT03681951|58799662|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
30786499|NCT03681951|58799663|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
30786500|NCT03681951|58799664|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
30786501|NCT03681405|58799689|FG000|Overall Study|Found to be ineligible after randomized|1|||
30959337|NCT01683071|59024750|FG004|Part 2|Did not receive study drug|2|||
30959338|NCT01683071|59024751|FG005|Part 2|Did not receive study drug|1|||
30599185|NCT01093534|58611008|FG002|Overall Study|Adverse Event|2|||
30599186|NCT01093534|58611006|FG000|Overall Study|Lack of Efficacy|2|||
30599187|NCT01093534|58611007|FG001|Overall Study|Lack of Efficacy|1|||
30786502|NCT03681405|58799690|FG001|Overall Study|Found to be ineligible after randomized|0|||
30786503|NCT00174785|58799700|FG000|Overall Study|Adverse Event|293|||
30786504|NCT00174785|58799701|FG001|Overall Study|Adverse Event|191|||
30786505|NCT00174785|58799700|FG000|Overall Study|Protocol Violation|14|||
30786506|NCT00174785|58799701|FG001|Overall Study|Protocol Violation|14|||
30786507|NCT00174785|58799700|FG000|Overall Study|Withdrawal by Subject|173|||
30786508|NCT00174785|58799701|FG001|Overall Study|Withdrawal by Subject|175|||
30786509|NCT00174785|58799700|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
30786510|NCT00174785|58799701|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
30786511|NCT00174785|58799700|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
30786512|NCT00174785|58799701|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
30786513|NCT00174785|58799700|FG000|Overall Study|Other prohibited medication|5|||
30786514|NCT00174785|58799701|FG001|Overall Study|Other prohibited medication|3|||
30786515|NCT00174785|58799700|FG000|Overall Study|Family request|6|||
30786516|NCT00174785|58799701|FG001|Overall Study|Family request|8|||
30786517|NCT00174785|58799700|FG000|Overall Study|Not pre-specified/Not coded|56|||
30786518|NCT00174785|58799701|FG001|Overall Study|Not pre-specified/Not coded|70|||
30786519|NCT03681093|58799710|FG000|Overall Study|Subject decision|0|||
30786520|NCT03681093|58799711|FG001|Overall Study|Subject decision|2|||
30856618|NCT04034004|58884665|FG002|Overall Study|nurse accidentally unblinded subject|0|||
30856619|NCT04034004|58884666|FG003|Overall Study|nurse accidentally unblinded subject|1|||
30856620|NCT03926143|58884674|FG000|Overall Study|Physician Decision|3|||
30856621|NCT03926143|58884674|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
30856622|NCT03926143|58884674|FG000|Overall Study|Adverse Event|2|||
30856623|NCT03926143|58884674|FG000|Overall Study|Progressive disease|3|||
30856624|NCT03213691|58884689|FG000|Overall Study|Adverse Event|2|||
30856625|NCT03213691|58884689|FG000|Overall Study|Death|3|||
30786521|NCT03681093|58799712|FG002|Overall Study|Subject decision|1|||
30856626|NCT03213691|58884689|FG000|Overall Study|Physician Decision|1|||
30856627|NCT03213691|58884689|FG000|Overall Study|Progressive Disease|14|||
30856628|NCT03213691|58884689|FG000|Overall Study|Ineligible|1|||
30856629|NCT03018080|58884695|FG000|Overall Study|Death|12|||
30856630|NCT03018080|58884696|FG001|Overall Study|Death|19|||
30856631|NCT02781090|58884704|FG000|3-Month Follow-Up|Missed Visit|20|||
30856632|NCT02781090|58884705|FG001|3-Month Follow-Up|Missed Visit|20|||
30856633|NCT02781090|58884704|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
30856634|NCT02781090|58884705|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
30856635|NCT02781090|58884704|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
30856636|NCT02781090|58884705|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
30856637|NCT02781090|58884704|FG000|3-Month Follow-Up|Death|1|||
30856638|NCT02781090|58884705|FG001|3-Month Follow-Up|Death|0|||
30856639|NCT02781090|58884704|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
30856640|NCT02781090|58884705|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
30856641|NCT02781090|58884704|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
30856642|NCT02781090|58884705|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
30856643|NCT02781090|58884704|FG000|6-Month Follow-Up|Death|0|||
30856644|NCT02781090|58884705|FG001|6-Month Follow-Up|Death|1|||
30856645|NCT02774291|58884713|FG000|Overall Study|Lost to Follow-up|1|||
30856646|NCT01897571|58884729|FG000|Overall Study|Lost to Follow-up|3|||
30856647|NCT01897571|58884730|FG001|Overall Study|Lost to Follow-up|0|||
30856648|NCT01897571|58884731|FG002|Overall Study|Lost to Follow-up|0|||
30856649|NCT01897571|58884732|FG003|Overall Study|Lost to Follow-up|0|||
30856650|NCT01897571|58884733|FG004|Overall Study|Lost to Follow-up|2|||
30856651|NCT01897571|58884734|FG005|Overall Study|Lost to Follow-up|0|||
30856652|NCT01897571|58884735|FG006|Overall Study|Lost to Follow-up|0|||
30856653|NCT01897571|58884736|FG007|Overall Study|Lost to Follow-up|0|||
30856654|NCT01897571|58884737|FG008|Overall Study|Lost to Follow-up|1|||
30856655|NCT01897571|58884738|FG009|Overall Study|Lost to Follow-up|2|||
30856656|NCT01897571|58884739|FG010|Overall Study|Lost to Follow-up|4|||
30856657|NCT01897571|58884729|FG000|Overall Study|Withdrawal by Subject|0|||
30856658|NCT01897571|58884730|FG001|Overall Study|Withdrawal by Subject|0|||
30856659|NCT01897571|58884731|FG002|Overall Study|Withdrawal by Subject|0|||
30856660|NCT01897571|58884732|FG003|Overall Study|Withdrawal by Subject|0|||
30856661|NCT01897571|58884733|FG004|Overall Study|Withdrawal by Subject|0|||
30856662|NCT01897571|58884734|FG005|Overall Study|Withdrawal by Subject|0|||
30856663|NCT01897571|58884735|FG006|Overall Study|Withdrawal by Subject|0|||
30856664|NCT01897571|58884736|FG007|Overall Study|Withdrawal by Subject|1|||
30959339|NCT01683071|59024746|FG000|Part 2|Met exclusion criterion|0|||
30856665|NCT01897571|58884737|FG008|Overall Study|Withdrawal by Subject|4|||
30856666|NCT01897571|58884738|FG009|Overall Study|Withdrawal by Subject|3|||
30856667|NCT01897571|58884739|FG010|Overall Study|Withdrawal by Subject|1|||
30856668|NCT01897571|58884729|FG000|Overall Study|Other|1|||
30856669|NCT01897571|58884730|FG001|Overall Study|Other|0|||
30856670|NCT01897571|58884731|FG002|Overall Study|Other|0|||
30856671|NCT01897571|58884732|FG003|Overall Study|Other|3|||
30856672|NCT01897571|58884733|FG004|Overall Study|Other|3|||
30856673|NCT01897571|58884734|FG005|Overall Study|Other|4|||
30856674|NCT01897571|58884735|FG006|Overall Study|Other|7|||
30856675|NCT01897571|58884736|FG007|Overall Study|Other|0|||
30856676|NCT01897571|58884737|FG008|Overall Study|Other|0|||
30856677|NCT01897571|58884738|FG009|Overall Study|Other|0|||
30856678|NCT01897571|58884739|FG010|Overall Study|Other|0|||
30856679|NCT01897571|58884729|FG000|Overall Study|Enrolled in rollover study|0|||
30856680|NCT01897571|58884730|FG001|Overall Study|Enrolled in rollover study|0|||
30856681|NCT01897571|58884731|FG002|Overall Study|Enrolled in rollover study|0|||
30688405|NCT00440011|58701995|FG001|Overall Study|Protocol Violation|1|||
30688406|NCT00440011|58701994|FG000|Overall Study|Withdrawal by Subject|1|||
30688407|NCT00440011|58701995|FG001|Overall Study|Withdrawal by Subject|0|||
30688408|NCT00663117|58702032|FG000|Overall Study|Lack of Efficacy|1|||
30688409|NCT00663117|58702033|FG001|Overall Study|Lack of Efficacy|0|||
30688410|NCT00570141|58702054|FG000|Overall Study|Adverse Event|1|||
30688411|NCT00570141|58702054|FG000|Overall Study|Missed visits|1|||
30688412|NCT00570141|58702054|FG000|Overall Study|Lost to Follow-up|1|||
30856682|NCT01897571|58884732|FG003|Overall Study|Enrolled in rollover study|0|||
30599188|NCT01093534|58611008|FG002|Overall Study|Lack of Efficacy|1|||
30599189|NCT01093534|58611006|FG000|Overall Study|Withdrawal by Subject|5|||
30599190|NCT01093534|58611007|FG001|Overall Study|Withdrawal by Subject|7|||
30599191|NCT01093534|58611008|FG002|Overall Study|Withdrawal by Subject|2|||
30599192|NCT01093534|58611006|FG000|Overall Study|Other|1|||
30599193|NCT01093534|58611007|FG001|Overall Study|Other|3|||
30599194|NCT01093534|58611008|FG002|Overall Study|Other|4|||
30599195|NCT01314911|58611019|FG000|Overall Study|Lost to Follow-up|3|||
30599196|NCT01314911|58611020|FG001|Overall Study|Lost to Follow-up|2|||
30599197|NCT01314911|58611019|FG000|Overall Study|Withdrawal by Subject|1|||
30599198|NCT01314911|58611020|FG001|Overall Study|Withdrawal by Subject|3|||
30599199|NCT01314911|58611019|FG000|Overall Study|Received Non-randomized Study Drug|0|||
30599200|NCT01314911|58611020|FG001|Overall Study|Received Non-randomized Study Drug|1|||
30599201|NCT01314911|58611019|FG000|Overall Study|Never Started Treatment|1|||
30599202|NCT01314911|58611020|FG001|Overall Study|Never Started Treatment|0|||
30599203|NCT01093222|58611026|FG000|Overall Study|Ineligible|6|||
30599204|NCT01093222|58611026|FG000|Overall Study|Adverse Event|7|||
30599205|NCT01093222|58611026|FG000|Overall Study|Progression/relapse|24|||
30599206|NCT01093222|58611026|FG000|Overall Study|Death|2|||
30599207|NCT01093222|58611026|FG000|Overall Study|Not protocol specified|1|||
30599208|NCT01313663|58611032|FG000|Overall Study|Study Closed/Terminated|2|||
30599209|NCT01313663|58611033|FG001|Overall Study|Study Closed/Terminated|4|||
30599210|NCT01313663|58611032|FG000|Overall Study|Lost to Follow-up|0|||
30599211|NCT01313663|58611033|FG001|Overall Study|Lost to Follow-up|1|||
30599212|NCT01313663|58611032|FG000|Overall Study|Physician Decision|0|||
30599213|NCT01313663|58611033|FG001|Overall Study|Physician Decision|2|||
30599214|NCT01313663|58611032|FG000|Overall Study|Withdrawal by Subject|2|||
30599215|NCT01313663|58611033|FG001|Overall Study|Withdrawal by Subject|1|||
30599216|NCT01092832|58611041|FG000|Overall Study|Other|1|||
30599217|NCT01092832|58611042|FG001|Overall Study|Other|0|||
30599218|NCT01313273|58611050|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
30599219|NCT01313273|58611051|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
30599220|NCT01313273|58611050|FG000|Overall Study|Withdrawal by Subject|1|||
30599221|NCT01313273|58611051|FG001|Overall Study|Withdrawal by Subject|0|||
30599222|NCT01313273|58611050|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
30599223|NCT01313273|58611051|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
30599224|NCT01091974|58611061|FG000|Overall Study|Did not start intervention|3|||
30599225|NCT01091974|58611062|FG001|Overall Study|Did not start intervention|1|||
30599226|NCT01091974|58611063|FG002|Overall Study|Did not start intervention|3|||
30599227|NCT01091974|58611064|FG003|Overall Study|Did not start intervention|1|||
30599228|NCT01091974|58611061|FG000|Overall Study|resumed sleep medication|0|||
30599229|NCT01091974|58611062|FG001|Overall Study|resumed sleep medication|0|||
30599230|NCT01091974|58611063|FG002|Overall Study|resumed sleep medication|1|||
30688413|NCT00579254|58702058|FG000|Overall Study|Lost to Follow-up|39|||
30688414|NCT00579254|58702058|FG000|Overall Study|Discontinued when study terminated|73|||
30688415|NCT00661089|58702064|FG000|Overall Study|1 subject withdrawal|0|||
30599231|NCT01091974|58611064|FG003|Overall Study|resumed sleep medication|2|||
30599232|NCT01091974|58611061|FG000|Overall Study|Withdrawal by Subject|1|||
30599233|NCT01091974|58611062|FG001|Overall Study|Withdrawal by Subject|3|||
30599234|NCT01091974|58611063|FG002|Overall Study|Withdrawal by Subject|2|||
30599235|NCT01091974|58611064|FG003|Overall Study|Withdrawal by Subject|2|||
30599236|NCT01091974|58611061|FG000|Overall Study|side-effects|1|||
30856683|NCT01897571|58884733|FG004|Overall Study|Enrolled in rollover study|0|||
30599237|NCT01091974|58611062|FG001|Overall Study|side-effects|1|||
30856684|NCT01897571|58884734|FG005|Overall Study|Enrolled in rollover study|0|||
30959340|NCT01683071|59024747|FG001|Part 2|Met exclusion criterion|0|||
30599238|NCT01091974|58611063|FG002|Overall Study|side-effects|0|||
30599239|NCT01091974|58611064|FG003|Overall Study|side-effects|2|||
30688416|NCT00661089|58702065|FG001|Overall Study|1 subject withdrawal|1|||
30688417|NCT00661089|58702064|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
30688418|NCT00661089|58702065|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
30688419|NCT00582426|58702078|FG000|Overall Study|Lost to Follow-up|0|||
30856685|NCT01897571|58884735|FG006|Overall Study|Enrolled in rollover study|0|||
30856686|NCT01897571|58884736|FG007|Overall Study|Enrolled in rollover study|9|||
30856687|NCT01897571|58884737|FG008|Overall Study|Enrolled in rollover study|7|||
30856688|NCT01897571|58884738|FG009|Overall Study|Enrolled in rollover study|9|||
30856689|NCT01897571|58884739|FG010|Overall Study|Enrolled in rollover study|1|||
30856690|NCT01897571|58884729|FG000|Overall Study|Death|2|||
30856691|NCT01897571|58884730|FG001|Overall Study|Death|2|||
30856692|NCT01897571|58884731|FG002|Overall Study|Death|3|||
30856693|NCT01897571|58884732|FG003|Overall Study|Death|6|||
30856694|NCT01897571|58884733|FG004|Overall Study|Death|7|||
30856695|NCT01897571|58884734|FG005|Overall Study|Death|9|||
30856696|NCT01897571|58884735|FG006|Overall Study|Death|5|||
30856697|NCT01897571|58884736|FG007|Overall Study|Death|22|||
30856698|NCT01897571|58884737|FG008|Overall Study|Death|23|||
30856699|NCT01897571|58884738|FG009|Overall Study|Death|129|||
30856700|NCT01897571|58884739|FG010|Overall Study|Death|59|||
30856701|NCT01651403|58884760|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
30856702|NCT01651403|58884761|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
30856703|NCT01651403|58884760|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
30856704|NCT01651403|58884761|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
30856705|NCT01651403|58884760|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
30856706|NCT01651403|58884761|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
30856707|NCT01651403|58884760|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
30856708|NCT01651403|58884761|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
30856709|NCT01651403|58884760|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
30856710|NCT01651403|58884761|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
30856711|NCT01651403|58884760|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
30856712|NCT01651403|58884761|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
30856713|NCT01207778|58884775|FG000|Overall Study|Lost to Follow-up|0|||
30856714|NCT01207778|58884776|FG001|Overall Study|Lost to Follow-up|3|||
30856715|NCT01207778|58884777|FG002|Overall Study|Lost to Follow-up|3|||
30856716|NCT00953771|58884787|FG000|Overall Study|Death|1|||
30856717|NCT00953771|58884788|FG001|Overall Study|Death|0|||
30856718|NCT02567552|58884796|FG000|Overall Study|Adverse Event|0|||
30856719|NCT02567552|58884797|FG001|Overall Study|Adverse Event|1|||
30856720|NCT02561000|58884811|FG000|Overall Study|Withdrawal by Subject|2|||
30856721|NCT02561000|58884812|FG001|Overall Study|Withdrawal by Subject|3|||
30856722|NCT02561000|58884813|FG002|Overall Study|Withdrawal by Subject|0|||
30856723|NCT02561000|58884811|FG000|Overall Study|Adverse Event|0|||
30856724|NCT02561000|58884812|FG001|Overall Study|Adverse Event|1|||
30856725|NCT02561000|58884813|FG002|Overall Study|Adverse Event|0|||
30856726|NCT01663532|58884823|FG000|Overall Study|Lost to Follow-up|9|||
30856727|NCT01663532|58884824|FG001|Overall Study|Lost to Follow-up|10|||
30856728|NCT01663532|58884823|FG000|Overall Study|Adverse Event|7|||
30856729|NCT01663532|58884824|FG001|Overall Study|Adverse Event|13|||
30856730|NCT01663532|58884823|FG000|Overall Study|Met Withdrawal Criteria|7|||
30856731|NCT01663532|58884824|FG001|Overall Study|Met Withdrawal Criteria|6|||
30856732|NCT01663532|58884823|FG000|Overall Study|Physician Decision|1|||
30856733|NCT01663532|58884824|FG001|Overall Study|Physician Decision|1|||
30856734|NCT01663532|58884823|FG000|Overall Study|Withdrawal by Subject|35|||
30856735|NCT01663532|58884824|FG001|Overall Study|Withdrawal by Subject|17|||
30856736|NCT01663532|58884823|FG000|Overall Study|Lack of Efficacy|15|||
30856737|NCT01663532|58884824|FG001|Overall Study|Lack of Efficacy|60|||
30856738|NCT02525939|58884832|FG000|Overall Study|Lost to Follow-up|27|||
30599240|NCT01313117|58611074|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
30856739|NCT02525939|58884833|FG001|Overall Study|Lost to Follow-up|24|||
30856740|NCT02525939|58884832|FG000|Overall Study|Physician Decision|0|||
30856741|NCT02525939|58884833|FG001|Overall Study|Physician Decision|1|||
30856742|NCT02525939|58884832|FG000|Overall Study|Withdrawal by Subject|24|||
30856743|NCT02525939|58884833|FG001|Overall Study|Withdrawal by Subject|39|||
30856744|NCT02525939|58884832|FG000|Overall Study|Death|180|||
30856745|NCT02525939|58884833|FG001|Overall Study|Death|179|||
30856746|NCT02697591|58884870|FG000|Overall Study|Lost to Follow-up|0|||
30856747|NCT02697591|58884871|FG001|Overall Study|Lost to Follow-up|0|||
30856748|NCT02697591|58884872|FG002|Overall Study|Lost to Follow-up|0|||
30856749|NCT02697591|58884873|FG003|Overall Study|Lost to Follow-up|0|||
30856750|NCT02697591|58884874|FG004|Overall Study|Lost to Follow-up|0|||
30599241|NCT01313117|58611074|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
30599242|NCT01313039|58611079|FG000|Overall Study|Physician Decision|1|||
30599243|NCT01313039|58611079|FG000|Overall Study|Adverse Event|1|||
30599244|NCT01091662|58611085|FG000|Overall Study|Adverse Event|1|||
30599245|NCT01091662|58611086|FG001|Overall Study|Adverse Event|9|||
30599246|NCT01091662|58611085|FG000|Overall Study|Physician Decision|1|||
30599247|NCT01091662|58611086|FG001|Overall Study|Physician Decision|1|||
30599248|NCT01091662|58611085|FG000|Overall Study|Withdrawal by Subject|7|||
30856751|NCT02697591|58884875|FG005|Overall Study|Lost to Follow-up|1|||
30856752|NCT02697591|58884876|FG006|Overall Study|Lost to Follow-up|1|||
30856753|NCT02697591|58884877|FG007|Overall Study|Lost to Follow-up|0|||
30856754|NCT02697591|58884878|FG008|Overall Study|Lost to Follow-up|0|||
30856755|NCT02697591|58884879|FG009|Overall Study|Lost to Follow-up|1|||
30856756|NCT02697591|58884870|FG000|Overall Study|Withdrawal by Subject|1|||
30856757|NCT02697591|58884871|FG001|Overall Study|Withdrawal by Subject|1|||
30856758|NCT02697591|58884872|FG002|Overall Study|Withdrawal by Subject|2|||
30856759|NCT02697591|58884873|FG003|Overall Study|Withdrawal by Subject|1|||
30856760|NCT02697591|58884874|FG004|Overall Study|Withdrawal by Subject|7|||
30856761|NCT02697591|58884875|FG005|Overall Study|Withdrawal by Subject|6|||
30856762|NCT02697591|58884876|FG006|Overall Study|Withdrawal by Subject|9|||
30856763|NCT02697591|58884877|FG007|Overall Study|Withdrawal by Subject|1|||
30856764|NCT02697591|58884878|FG008|Overall Study|Withdrawal by Subject|6|||
30856765|NCT02697591|58884879|FG009|Overall Study|Withdrawal by Subject|10|||
30856766|NCT02697591|58884870|FG000|Overall Study|Physician Decision|1|||
30856767|NCT02697591|58884871|FG001|Overall Study|Physician Decision|0|||
30856768|NCT02697591|58884872|FG002|Overall Study|Physician Decision|0|||
30856769|NCT02697591|58884873|FG003|Overall Study|Physician Decision|0|||
30856770|NCT02697591|58884874|FG004|Overall Study|Physician Decision|1|||
30856771|NCT02697591|58884875|FG005|Overall Study|Physician Decision|2|||
30856772|NCT02697591|58884876|FG006|Overall Study|Physician Decision|0|||
30856773|NCT02697591|58884877|FG007|Overall Study|Physician Decision|0|||
30856774|NCT02697591|58884878|FG008|Overall Study|Physician Decision|1|||
30856775|NCT02697591|58884879|FG009|Overall Study|Physician Decision|1|||
30856776|NCT02697591|58884870|FG000|Overall Study|Death|2|||
30856777|NCT02697591|58884871|FG001|Overall Study|Death|3|||
30856778|NCT02697591|58884872|FG002|Overall Study|Death|1|||
30856779|NCT02697591|58884873|FG003|Overall Study|Death|1|||
30856780|NCT02697591|58884874|FG004|Overall Study|Death|4|||
30856781|NCT02697591|58884875|FG005|Overall Study|Death|5|||
30856782|NCT02697591|58884876|FG006|Overall Study|Death|3|||
30856783|NCT02697591|58884877|FG007|Overall Study|Death|1|||
30856784|NCT02697591|58884878|FG008|Overall Study|Death|1|||
30856785|NCT02697591|58884879|FG009|Overall Study|Death|5|||
30856786|NCT02697591|58884870|FG000|Overall Study|Reason not Specified|0|||
30856787|NCT02697591|58884871|FG001|Overall Study|Reason not Specified|0|||
30856788|NCT02697591|58884872|FG002|Overall Study|Reason not Specified|0|||
30856789|NCT02697591|58884873|FG003|Overall Study|Reason not Specified|1|||
30856790|NCT02697591|58884874|FG004|Overall Study|Reason not Specified|1|||
30856791|NCT02697591|58884875|FG005|Overall Study|Reason not Specified|2|||
30856792|NCT02697591|58884876|FG006|Overall Study|Reason not Specified|3|||
30856793|NCT02697591|58884877|FG007|Overall Study|Reason not Specified|1|||
30856794|NCT02697591|58884878|FG008|Overall Study|Reason not Specified|1|||
30856795|NCT02697591|58884879|FG009|Overall Study|Reason not Specified|3|||
30856796|NCT02697435|58884904|FG000|Overall Study|Withdrawal by Subject|1|||
30856797|NCT02697435|58884905|FG001|Overall Study|Withdrawal by Subject|0|||
30856798|NCT02697435|58884904|FG000|Overall Study|Physician Decision|0|||
30856799|NCT02697435|58884905|FG001|Overall Study|Physician Decision|4|||
30856800|NCT02174861|58884912|FG000|Overall Study|Decision by sponsor|8|||
30856801|NCT02174861|58884912|FG000|Overall Study|Withdrawal by Subject|124|||
30856802|NCT02174861|58884912|FG000|Overall Study|Lost to Follow-up|26|||
30856803|NCT00140855|58884918|FG000|Overall Study|Progressive disease|2|||
30856804|NCT00700635|58884925|FG000|Overall Study|Adverse Event|1|||
30856805|NCT00700635|58884926|FG001|Overall Study|Adverse Event|0|||
30856806|NCT00700635|58884927|FG002|Overall Study|Adverse Event|0|||
30856807|NCT00700635|58884925|FG000|Overall Study|Lost to Follow-up|1|||
30856808|NCT00700635|58884926|FG001|Overall Study|Lost to Follow-up|3|||
30856809|NCT00700635|58884927|FG002|Overall Study|Lost to Follow-up|0|||
30856810|NCT00700635|58884925|FG000|Overall Study|Protocol Violation|2|||
30856811|NCT00700635|58884926|FG001|Overall Study|Protocol Violation|2|||
30856812|NCT00700635|58884927|FG002|Overall Study|Protocol Violation|0|||
30856813|NCT00700635|58884925|FG000|Overall Study|Withdrawal by Subject|7|||
30856814|NCT00700635|58884926|FG001|Overall Study|Withdrawal by Subject|3|||
30856815|NCT00700635|58884927|FG002|Overall Study|Withdrawal by Subject|1|||
30856816|NCT02780687|58884937|FG000|Overall Study|Adverse Event|1|||
30856817|NCT02780687|58884938|FG001|Overall Study|Adverse Event|1|||
30856818|NCT02780687|58884937|FG000|Overall Study|Withdrawal by Subject|2|||
30856819|NCT02780687|58884938|FG001|Overall Study|Withdrawal by Subject|1|||
30856820|NCT02780687|58884937|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
30856821|NCT02780687|58884938|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
30856822|NCT02780687|58884937|FG000|Overall Study|progressive disease|29|||
30856823|NCT02780687|58884938|FG001|Overall Study|progressive disease|6|||
30856824|NCT02698371|58884943|FG000|All Participants Flow|Lost to Follow-up|3|||
30856825|NCT02698371|58884943|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
30856826|NCT02698371|58884943|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
30856827|NCT02698371|58884943|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
30856828|NCT02698371|58884943|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
30856829|NCT02698371|58884943|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
30856830|NCT02698371|58884943|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
30856831|NCT02781311|58884962|FG000|Overall Study|Adverse Event|2|||
30856832|NCT02781311|58884963|FG001|Overall Study|Adverse Event|6|||
30856833|NCT02781311|58884964|FG002|Overall Study|Adverse Event|1|||
30856834|NCT02781311|58884962|FG000|Overall Study|Withdrawal of Consent|11|||
30856835|NCT02781311|58884963|FG001|Overall Study|Withdrawal of Consent|12|||
30856836|NCT02781311|58884964|FG002|Overall Study|Withdrawal of Consent|2|||
30856837|NCT02781311|58884962|FG000|Overall Study|Lost to Follow-up|11|||
30856838|NCT02781311|58884963|FG001|Overall Study|Lost to Follow-up|8|||
30856839|NCT02781311|58884964|FG002|Overall Study|Lost to Follow-up|1|||
30856840|NCT02781311|58884962|FG000|Overall Study|Non-Compliance with Study Drug|2|||
30856841|NCT02781311|58884963|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30856842|NCT02781311|58884964|FG002|Overall Study|Non-Compliance with Study Drug|0|||
30856843|NCT02564198|58884974|FG000|Overall Study|Withdrawal by Subject|2|||
30856844|NCT02564198|58884975|FG001|Overall Study|Withdrawal by Subject|4|||
30856845|NCT02564198|58884976|FG002|Overall Study|Withdrawal by Subject|0|||
30856846|NCT02564198|58884974|FG000|Overall Study|Adverse Event|0|||
30856847|NCT02564198|58884975|FG001|Overall Study|Adverse Event|1|||
30856848|NCT02564198|58884976|FG002|Overall Study|Adverse Event|0|||
30856849|NCT02564120|58884991|FG000|Overall Study|Did not return release forms|160|||
30856850|NCT02564120|58884991|FG000|Overall Study|Death|58|||
30856851|NCT02564120|58884991|FG000|Overall Study|Withdrawal by Subject|204|||
30856852|NCT02564120|58884991|FG000|Overall Study|Other medical condition|24|||
30856853|NCT00705783|58885007|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
30856854|NCT00705783|58885008|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
30856855|NCT00705783|58885009|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
30856856|NCT00705783|58885007|FG000|Conversion Phase|Lost to Follow-up|13|||
30856857|NCT00705783|58885008|FG001|Conversion Phase|Lost to Follow-up|0|||
30856858|NCT00705783|58885009|FG002|Conversion Phase|Lost to Follow-up|0|||
30856859|NCT00705783|58885007|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
30856860|NCT00705783|58885008|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
30856861|NCT00705783|58885009|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
30856862|NCT00705783|58885007|FG000|Conversion Phase|Withdrawn by Investigator|4|||
30856863|NCT00705783|58885008|FG001|Conversion Phase|Withdrawn by Investigator|0|||
30856864|NCT00705783|58885009|FG002|Conversion Phase|Withdrawn by Investigator|0|||
30856865|NCT00705783|58885007|FG000|Conversion Phase|Withdrew Consent|24|||
30856866|NCT00705783|58885008|FG001|Conversion Phase|Withdrew Consent|0|||
30856867|NCT00705783|58885009|FG002|Conversion Phase|Withdrew Consent|0|||
30856868|NCT00705783|58885007|FG000|Conversion Phase|Protocol Deviation|2|||
30856869|NCT00705783|58885008|FG001|Conversion Phase|Protocol Deviation|0|||
30856870|NCT00705783|58885009|FG002|Conversion Phase|Protocol Deviation|0|||
30856871|NCT00705783|58885007|FG000|Conversion Phase|Adverse Event|11|||
30856872|NCT00705783|58885008|FG001|Conversion Phase|Adverse Event|0|||
30856873|NCT00705783|58885009|FG002|Conversion Phase|Adverse Event|0|||
30856874|NCT00705783|58885007|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
30856875|NCT00705783|58885008|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
30856876|NCT00705783|58885009|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
30856877|NCT00705783|58885007|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
30856878|NCT00705783|58885008|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
30856879|NCT00705783|58885009|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
30856880|NCT00705783|58885007|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
30856881|NCT00705783|58885008|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
30599249|NCT01091662|58611086|FG001|Overall Study|Withdrawal by Subject|6|||
30599250|NCT01091662|58611085|FG000|Overall Study|met exit criteria|7|||
30599251|NCT01091662|58611086|FG001|Overall Study|met exit criteria|13|||
30599252|NCT01091662|58611085|FG000|Overall Study|met exclusion criteria|1|||
30599253|NCT01091662|58611086|FG001|Overall Study|met exclusion criteria|0|||
30856882|NCT00705783|58885009|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
30599254|NCT01091662|58611085|FG000|Overall Study|Lost to Follow-up|0|||
30599255|NCT01091662|58611086|FG001|Overall Study|Lost to Follow-up|1|||
30599256|NCT01091662|58611085|FG000|Overall Study|Pregnancy|0|||
30599257|NCT01091662|58611086|FG001|Overall Study|Pregnancy|1|||
30599258|NCT01091662|58611085|FG000|Overall Study|Protocol Violation|0|||
30599259|NCT01091662|58611086|FG001|Overall Study|Protocol Violation|2|||
30599260|NCT01091662|58611085|FG000|Overall Study|unable to swallow capsule|0|||
30856883|NCT00705783|58885007|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
30856884|NCT00705783|58885008|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
30856885|NCT00705783|58885009|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
30856886|NCT00705783|58885007|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
30959341|NCT01683071|59024748|FG002|Part 2|Met exclusion criterion|0|||
30856887|NCT00705783|58885008|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
30856888|NCT00705783|58885009|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
30599261|NCT01091662|58611086|FG001|Overall Study|unable to swallow capsule|1|||
30856889|NCT00705783|58885007|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
30856890|NCT00705783|58885008|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
30856891|NCT00705783|58885009|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
30856892|NCT00705783|58885007|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
30856893|NCT00705783|58885008|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
30856894|NCT00705783|58885009|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
30856895|NCT00705783|58885007|FG000|Oral Stabilization Phase|Adverse Event|14|||
30856896|NCT00705783|58885008|FG001|Oral Stabilization Phase|Adverse Event|0|||
30856897|NCT00705783|58885009|FG002|Oral Stabilization Phase|Adverse Event|0|||
30856898|NCT00705783|58885007|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
30856899|NCT00705783|58885008|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
30856900|NCT00705783|58885009|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
30856901|NCT00705783|58885007|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
30688420|NCT00582426|58702079|FG001|Overall Study|Lost to Follow-up|2|||
30688421|NCT00582426|58702078|FG000|Overall Study|Adverse Event|4|||
30688422|NCT00582426|58702079|FG001|Overall Study|Adverse Event|2|||
30688423|NCT00582426|58702078|FG000|Overall Study|Protocol Violation|6|||
30688424|NCT00582426|58702079|FG001|Overall Study|Protocol Violation|2|||
30688425|NCT00582426|58702078|FG000|Overall Study|Death|4|||
30688426|NCT00582426|58702079|FG001|Overall Study|Death|3|||
30688427|NCT00582426|58702078|FG000|Overall Study|Withdrawal by Subject|3|||
30688428|NCT00582426|58702079|FG001|Overall Study|Withdrawal by Subject|2|||
30688429|NCT00582426|58702078|FG000|Overall Study|Disease Progression|2|||
30688430|NCT00582426|58702079|FG001|Overall Study|Disease Progression|2|||
30688431|NCT00582426|58702078|FG000|Overall Study|Use of illicit drugs|1|||
30688432|NCT00582426|58702079|FG001|Overall Study|Use of illicit drugs|0|||
30688433|NCT02387970|58702087|FG000|Overall Study|Did not complete 1-year follow up|1|||
30688434|NCT02387970|58702088|FG001|Overall Study|Did not complete 1-year follow up|2|||
30688435|NCT00580034|58702094|FG000|Overall Study|Toxicity|10|||
30688436|NCT00580034|58702095|FG001|Overall Study|Toxicity|0|||
30688437|NCT00773513|58702101|FG000|Overall Study|Renal Transplant|254|||
30688438|NCT00773513|58702102|FG001|Overall Study|Renal Transplant|263|||
30688439|NCT00773513|58702101|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
30688440|NCT00773513|58702102|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
30688441|NCT00773513|58702101|FG000|Overall Study|Withdrew Consent|68|||
30688442|NCT00773513|58702102|FG001|Overall Study|Withdrew Consent|69|||
30688443|NCT00773513|58702101|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
30688444|NCT00773513|58702102|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
30688445|NCT00773513|58702101|FG000|Overall Study|Failure to Return|22|||
30688446|NCT00773513|58702102|FG001|Overall Study|Failure to Return|8|||
30688447|NCT00773513|58702101|FG000|Overall Study|Insufficient Therapeutic Response|1|||
30688448|NCT00773513|58702102|FG001|Overall Study|Insufficient Therapeutic Response|18|||
30688449|NCT00773513|58702101|FG000|Overall Study|Reason Not Specified|159|||
30688450|NCT00773513|58702102|FG001|Overall Study|Reason Not Specified|126|||
30688451|NCT00773513|58702101|FG000|Overall Study|Death|531|||
30688452|NCT00773513|58702102|FG001|Overall Study|Death|545|||
30688453|NCT00767039|58702110|FG000|Overall Study|Death|5|||
30688454|NCT00767039|58702111|FG001|Overall Study|Death|2|||
30688455|NCT00662649|58702121|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
30688456|NCT00662649|58702122|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
30688457|NCT00662649|58702123|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
30688458|NCT00662649|58702124|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
30688459|NCT00662649|58702125|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
30688460|NCT00662649|58702121|FG000|Core Study (24 Months)|Adverse Event|22|||
30688461|NCT00662649|58702122|FG001|Core Study (24 Months)|Adverse Event|13|||
30688462|NCT00662649|58702123|FG002|Core Study (24 Months)|Adverse Event|18|||
30688463|NCT00662649|58702124|FG003|Core Study (24 Months)|Adverse Event|0|||
30688464|NCT00662649|58702125|FG004|Core Study (24 Months)|Adverse Event|0|||
30688465|NCT00662649|58702121|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
30688466|NCT00662649|58702122|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
30688467|NCT00662649|58702123|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
30688468|NCT00662649|58702124|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
30688469|NCT00662649|58702125|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
30688470|NCT00662649|58702121|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
30688471|NCT00662649|58702122|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
30856902|NCT00705783|58885008|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
30856903|NCT00705783|58885009|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
30688472|NCT00662649|58702123|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
30688473|NCT00662649|58702124|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
30688474|NCT00662649|58702125|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
30688475|NCT00662649|58702121|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
30688476|NCT00662649|58702122|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
30688477|NCT00662649|58702123|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
30688478|NCT00662649|58702124|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
30688479|NCT00662649|58702125|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
30688480|NCT00662649|58702121|FG000|Core Study (24 Months)|Protocol Violation|5|||
30688481|NCT00662649|58702122|FG001|Core Study (24 Months)|Protocol Violation|5|||
30688482|NCT00662649|58702123|FG002|Core Study (24 Months)|Protocol Violation|4|||
30688483|NCT00662649|58702124|FG003|Core Study (24 Months)|Protocol Violation|0|||
30688484|NCT00662649|58702125|FG004|Core Study (24 Months)|Protocol Violation|0|||
30688485|NCT00662649|58702121|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
30688486|NCT00662649|58702122|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
30688487|NCT00662649|58702123|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
30688488|NCT00662649|58702124|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
30688489|NCT00662649|58702125|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
30856904|NCT00705783|58885007|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
30856905|NCT00705783|58885008|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
30856906|NCT00705783|58885009|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
30856907|NCT00705783|58885007|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
30856908|NCT00705783|58885008|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
30856909|NCT00705783|58885009|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
30856910|NCT00705783|58885007|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
30856911|NCT00705783|58885008|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
30856912|NCT00705783|58885009|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
30856913|NCT00705783|58885007|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
30856914|NCT00705783|58885008|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
30856915|NCT00705783|58885009|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
30856916|NCT00705783|58885007|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
30856917|NCT00705783|58885008|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
30856918|NCT00705783|58885009|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
30856919|NCT00705783|58885007|FG000|Depot Stabilization Phase|Adverse Event|17|||
30856920|NCT00705783|58885008|FG001|Depot Stabilization Phase|Adverse Event|0|||
30856921|NCT00705783|58885009|FG002|Depot Stabilization Phase|Adverse Event|0|||
30856922|NCT00705783|58885007|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
30856923|NCT00705783|58885008|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
30856924|NCT00705783|58885009|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
30856925|NCT00705783|58885007|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
30856926|NCT00705783|58885008|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
30856927|NCT00705783|58885009|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
30856928|NCT00705783|58885007|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
30856929|NCT00705783|58885008|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
30856930|NCT00705783|58885009|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
30856931|NCT00705783|58885007|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
30856932|NCT00705783|58885008|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
30856933|NCT00705783|58885009|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
30856934|NCT00705783|58885007|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
30856935|NCT00705783|58885008|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
30856936|NCT00705783|58885009|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
30856937|NCT00705783|58885007|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
30959342|NCT01683071|59024749|FG003|Part 2|Met exclusion criterion|0|||
30688490|NCT00662649|58702121|FG000|Core Study (24 Months)|Death|1|||
30688491|NCT00662649|58702122|FG001|Core Study (24 Months)|Death|0|||
30688492|NCT00662649|58702123|FG002|Core Study (24 Months)|Death|2|||
30688493|NCT00662649|58702124|FG003|Core Study (24 Months)|Death|0|||
30688494|NCT00662649|58702125|FG004|Core Study (24 Months)|Death|0|||
30688495|NCT00662649|58702121|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
30688496|NCT00662649|58702122|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
30688497|NCT00662649|58702123|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
30688498|NCT00662649|58702124|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
30688499|NCT00662649|58702125|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
30688500|NCT00662649|58702121|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
30688501|NCT00662649|58702122|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
30688502|NCT00662649|58702123|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
30688503|NCT00662649|58702124|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
30688504|NCT00662649|58702125|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
30786522|NCT00166517|58799722|FG000|Overall Study|Lost to Follow-up|1|||
30786523|NCT00166517|58799723|FG001|Overall Study|Lost to Follow-up|0|||
30786524|NCT00166517|58799722|FG000|Overall Study|Protocol Violation|4|||
30786525|NCT00166517|58799723|FG001|Overall Study|Protocol Violation|1|||
30786526|NCT00166517|58799722|FG000|Overall Study|Withdrawal by Subject|0|||
30786527|NCT00166517|58799723|FG001|Overall Study|Withdrawal by Subject|1|||
30786528|NCT00166439|58799729|FG000|Overall Study|Ineligible|5|||
30786529|NCT00138671|58799735|FG000|Overall Study|Death|0|||
30786530|NCT00138671|58799736|FG001|Overall Study|Death|3|||
30688505|NCT00662649|58702121|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
30688506|NCT00662649|58702122|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
30688507|NCT00662649|58702123|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
30688508|NCT00662649|58702124|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
30688509|NCT00662649|58702125|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
30688510|NCT00662649|58702121|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
30688511|NCT00662649|58702122|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
30688512|NCT00662649|58702123|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
30688513|NCT00662649|58702124|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
30688514|NCT00662649|58702125|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
30688515|NCT00662649|58702121|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
30688516|NCT00662649|58702122|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
30688517|NCT00662649|58702123|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
30688518|NCT00662649|58702124|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
30688519|NCT00662649|58702125|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
30688520|NCT00662649|58702121|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
30688521|NCT00662649|58702122|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
30688522|NCT00662649|58702123|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
30688523|NCT00662649|58702124|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
30688524|NCT00662649|58702125|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
30688525|NCT00662649|58702121|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
30688526|NCT00662649|58702122|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
30688527|NCT00662649|58702123|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
30688528|NCT00662649|58702124|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
30688529|NCT00662649|58702125|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
30688530|NCT00662649|58702121|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
30688531|NCT00662649|58702122|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
30688532|NCT00662649|58702123|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
30688533|NCT00662649|58702124|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
30688534|NCT00662649|58702125|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
30688535|NCT00662649|58702121|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
30688536|NCT00662649|58702122|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
30688537|NCT00662649|58702123|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
30688538|NCT00662649|58702124|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
30688539|NCT00662649|58702125|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
30688540|NCT00766493|58702139|FG000|30 Days Post-Procedure|Discontinued|7|||
30688541|NCT00766493|58702139|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
30688542|NCT00766493|58702139|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
30688543|NCT03070392|58702145|FG000|Overall Study|Not Treated|7|||
30688544|NCT03070392|58702146|FG001|Overall Study|Not Treated|0|||
30688545|NCT03070392|58702147|FG002|Overall Study|Not Treated|3|||
30688546|NCT03070392|58702148|FG003|Overall Study|Not Treated|12|||
30688547|NCT03070392|58702145|FG000|Overall Study|Death|3|||
30688548|NCT03070392|58702146|FG001|Overall Study|Death|0|||
30688549|NCT03070392|58702147|FG002|Overall Study|Death|0|||
30688550|NCT03070392|58702148|FG003|Overall Study|Death|1|||
30688551|NCT03070392|58702145|FG000|Overall Study|Withdrawal by Subject|7|||
30688552|NCT03070392|58702146|FG001|Overall Study|Withdrawal by Subject|0|||
30688553|NCT03070392|58702147|FG002|Overall Study|Withdrawal by Subject|0|||
30688554|NCT03070392|58702148|FG003|Overall Study|Withdrawal by Subject|3|||
30688555|NCT03070392|58702145|FG000|Overall Study|Physician Decision|1|||
30688556|NCT03070392|58702146|FG001|Overall Study|Physician Decision|0|||
30688557|NCT03070392|58702147|FG002|Overall Study|Physician Decision|0|||
30688558|NCT03070392|58702148|FG003|Overall Study|Physician Decision|2|||
30688559|NCT03070392|58702145|FG000|Overall Study|Progressive Disease|154|||
30688560|NCT03070392|58702146|FG001|Overall Study|Progressive Disease|6|||
30688561|NCT03070392|58702147|FG002|Overall Study|Progressive Disease|2|||
30688562|NCT03070392|58702148|FG003|Overall Study|Progressive Disease|70|||
30688563|NCT03070392|58702145|FG000|Overall Study|Adverse Event|6|||
30688564|NCT03070392|58702146|FG001|Overall Study|Adverse Event|1|||
30688565|NCT03070392|58702147|FG002|Overall Study|Adverse Event|1|||
30688566|NCT03070392|58702148|FG003|Overall Study|Adverse Event|3|||
30688567|NCT03070392|58702145|FG000|Overall Study|Alternate anticancer treatment|1|||
30688568|NCT03070392|58702146|FG001|Overall Study|Alternate anticancer treatment|0|||
30688569|NCT03070392|58702147|FG002|Overall Study|Alternate anticancer treatment|0|||
30688570|NCT03070392|58702148|FG003|Overall Study|Alternate anticancer treatment|1|||
30688571|NCT03070392|58702145|FG000|Overall Study|Ongoing|73|||
30688572|NCT03070392|58702146|FG001|Overall Study|Ongoing|0|||
30688573|NCT03070392|58702147|FG002|Overall Study|Ongoing|0|||
30688574|NCT03070392|58702148|FG003|Overall Study|Ongoing|11|||
30688575|NCT00784043|58702156|FG000|Overall Study|Withdrawal by Subject|8|||
30688576|NCT00784043|58702157|FG001|Overall Study|Withdrawal by Subject|5|||
30688577|NCT00784043|58702156|FG000|Overall Study|Protocol Terminated|23|||
30688578|NCT00784043|58702157|FG001|Overall Study|Protocol Terminated|1|||
30688579|NCT00773279|58702163|FG000|Period 1|Adverse Event|2|||
30688580|NCT00773279|58702164|FG001|Period 1|Adverse Event|1|||
30688581|NCT00773279|58702163|FG000|Period 1|Lack of Efficacy|0|||
30688582|NCT00773279|58702164|FG001|Period 1|Lack of Efficacy|2|||
30688583|NCT00773279|58702163|FG000|Period 1|Unclassified|5|||
30856938|NCT00705783|58885008|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
30856939|NCT00705783|58885009|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
30856940|NCT00705783|58885007|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
30856941|NCT00705783|58885008|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
30856942|NCT00705783|58885009|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
30856943|NCT00705783|58885007|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
30856944|NCT00705783|58885008|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
30856945|NCT00705783|58885009|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
30688584|NCT00773279|58702164|FG001|Period 1|Unclassified|1|||
30688585|NCT00773279|58702163|FG000|Period 2|Adverse Event|0|||
30688586|NCT00773279|58702164|FG001|Period 2|Adverse Event|1|||
30856946|NCT00705783|58885007|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
30856947|NCT00705783|58885008|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
30856948|NCT00705783|58885009|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
30959343|NCT01683071|59024750|FG004|Part 2|Met exclusion criterion|1|||
30688587|NCT00773279|58702163|FG000|Period 2|Lack of Efficacy|1|||
30688588|NCT00773279|58702164|FG001|Period 2|Lack of Efficacy|0|||
30688589|NCT00773279|58702163|FG000|Period 2|Protocol Violation|0|||
30688590|NCT00773279|58702164|FG001|Period 2|Protocol Violation|3|||
30856949|NCT00705783|58885007|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
30856950|NCT00705783|58885008|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
30856951|NCT00705783|58885009|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
30856952|NCT00705783|58885007|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
30856953|NCT00705783|58885008|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
30856954|NCT00705783|58885009|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
30856955|NCT02694549|58885018|FG000|Overall Study|screen failures|2|||
30856956|NCT02782325|58885024|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
30856957|NCT02782325|58885025|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
30856958|NCT02782325|58885026|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
30856959|NCT02782325|58885024|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
30856960|NCT02782325|58885025|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
30856961|NCT02782325|58885026|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
30856962|NCT02693691|58885034|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
30856963|NCT02693691|58885034|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
30856964|NCT02693691|58885034|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
30856965|NCT02693691|58885034|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
30856966|NCT02693691|58885034|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
30856967|NCT02693691|58885034|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
30856968|NCT02693691|58885034|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
30856969|NCT04203667|58885038|FG000|Overall Study|Withdrawal by Subject|1|||
30856970|NCT04203667|58885038|FG000|Overall Study|Lost to Follow-up|1|||
30856971|NCT04203667|58885038|FG000|Overall Study|Death|1|||
30856972|NCT04203667|58885038|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
30856973|NCT02782169|58885045|FG000|Overall Study|Lost to Follow-up|1|||
30856974|NCT02782169|58885046|FG001|Overall Study|Lost to Follow-up|2|||
30856975|NCT02564042|58885058|FG000|Overall Study|Adverse Event|4|||
30856976|NCT02564042|58885059|FG001|Overall Study|Adverse Event|4|||
30856977|NCT02564042|58885060|FG002|Overall Study|Adverse Event|3|||
30856978|NCT02564042|58885061|FG003|Overall Study|Adverse Event|0|||
30959344|NCT01683071|59024751|FG005|Part 2|Met exclusion criterion|1|||
30688591|NCT00773279|58702163|FG000|Period 2|Unclassified|2|||
30688592|NCT00773279|58702164|FG001|Period 2|Unclassified|2|||
30688593|NCT00766415|58702173|FG000|Overall Study|Withdrawal by Subject|0|||
30688594|NCT00766415|58702174|FG001|Overall Study|Withdrawal by Subject|1|||
30688595|NCT00772967|58702180|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
30688596|NCT00772967|58702181|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
30688597|NCT00772967|58702182|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
30688598|NCT00772967|58702183|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
30688599|NCT00772967|58702184|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
30688600|NCT00772967|58702185|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
30856979|NCT02564042|58885062|FG004|Overall Study|Adverse Event|0|||
30856980|NCT02564042|58885063|FG005|Overall Study|Adverse Event|1|||
30856981|NCT02564042|58885058|FG000|Overall Study|Lost to Follow-up|1|||
30856982|NCT02564042|58885059|FG001|Overall Study|Lost to Follow-up|1|||
30856983|NCT02564042|58885060|FG002|Overall Study|Lost to Follow-up|1|||
30959345|NCT01683071|59024746|FG000|Part 2|Protocol deviation|0|||
30856984|NCT02564042|58885061|FG003|Overall Study|Lost to Follow-up|0|||
30856985|NCT02564042|58885062|FG004|Overall Study|Lost to Follow-up|1|||
30856986|NCT02564042|58885063|FG005|Overall Study|Lost to Follow-up|1|||
30856987|NCT02564042|58885058|FG000|Overall Study|Physician Decision|1|||
30856988|NCT02564042|58885059|FG001|Overall Study|Physician Decision|0|||
30856989|NCT02564042|58885060|FG002|Overall Study|Physician Decision|0|||
30856990|NCT02564042|58885061|FG003|Overall Study|Physician Decision|1|||
30856991|NCT02564042|58885062|FG004|Overall Study|Physician Decision|0|||
30856992|NCT02564042|58885063|FG005|Overall Study|Physician Decision|0|||
30856993|NCT02564042|58885058|FG000|Overall Study|Withdrawal by Subject|5|||
30856994|NCT02564042|58885059|FG001|Overall Study|Withdrawal by Subject|3|||
30856995|NCT02564042|58885060|FG002|Overall Study|Withdrawal by Subject|2|||
30856996|NCT02564042|58885061|FG003|Overall Study|Withdrawal by Subject|2|||
30856997|NCT02564042|58885062|FG004|Overall Study|Withdrawal by Subject|10|||
30856998|NCT02564042|58885063|FG005|Overall Study|Withdrawal by Subject|12|||
30856999|NCT02695719|58885096|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
30857000|NCT02695719|58885097|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
30857001|NCT02695719|58885096|FG000|Overall Study|Significant Protocol Deviation|0|||
30857002|NCT02695719|58885097|FG001|Overall Study|Significant Protocol Deviation|1|||
30857003|NCT02695719|58885096|FG000|Overall Study|Voluntary Withdrawal|1|||
30857004|NCT02695719|58885097|FG001|Overall Study|Voluntary Withdrawal|0|||
30857005|NCT02563106|58885114|FG000|Overall Study|Withdrawal by Subject|7|||
30857006|NCT02563106|58885115|FG001|Overall Study|Withdrawal by Subject|8|||
30857007|NCT02563106|58885114|FG000|Overall Study|Adverse Event|17|||
30857008|NCT02563106|58885115|FG001|Overall Study|Adverse Event|15|||
30688601|NCT00772967|58702180|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
30688602|NCT00772967|58702181|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
30688603|NCT00772967|58702182|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
30688604|NCT00772967|58702183|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
30688605|NCT00772967|58702184|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
30688606|NCT00772967|58702185|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
30857009|NCT02563106|58885114|FG000|Overall Study|Protocol Violation|1|||
30857010|NCT02563106|58885115|FG001|Overall Study|Protocol Violation|0|||
30857011|NCT02563106|58885114|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
30857012|NCT02563106|58885115|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
30857013|NCT02563106|58885114|FG000|Overall Study|Lost to Follow-up|3|||
30857014|NCT02563106|58885115|FG001|Overall Study|Lost to Follow-up|2|||
30857015|NCT02563106|58885114|FG000|Overall Study|Physician Decision|3|||
30688607|NCT00772967|58702180|FG000|Crossover Treatment 3|Adverse Event|0|||
30688608|NCT00772967|58702181|FG001|Crossover Treatment 3|Adverse Event|0|||
30688609|NCT00772967|58702182|FG002|Crossover Treatment 3|Adverse Event|0|||
30688610|NCT00772967|58702183|FG003|Crossover Treatment 3|Adverse Event|0|||
30688611|NCT00772967|58702184|FG004|Crossover Treatment 3|Adverse Event|1|||
30688612|NCT00772967|58702185|FG005|Crossover Treatment 3|Adverse Event|0|||
30688613|NCT00662259|58702208|FG000|Overall Study|Adverse Event|2|||
30688614|NCT00662259|58702209|FG001|Overall Study|Adverse Event|0|||
30688615|NCT00660699|58702215|FG000|Overall Study|Withdrawal by Subject|2|||
30688616|NCT00582114|58702221|FG000|Overall Study|Death|4|||
30688617|NCT00582114|58702222|FG001|Overall Study|Death|4|||
30688618|NCT00582114|58702221|FG000|Overall Study|Kidney Transplant|3|||
30688619|NCT00582114|58702222|FG001|Overall Study|Kidney Transplant|1|||
30688620|NCT00582114|58702221|FG000|Overall Study|Lost to Follow-up|7|||
30688621|NCT00582114|58702222|FG001|Overall Study|Lost to Follow-up|6|||
30688622|NCT00582114|58702221|FG000|Overall Study|Withdrawal by Subject|8|||
30688623|NCT00582114|58702222|FG001|Overall Study|Withdrawal by Subject|16|||
30688624|NCT00582114|58702221|FG000|Overall Study|Adverse Event|1|||
30688625|NCT00582114|58702222|FG001|Overall Study|Adverse Event|1|||
30857016|NCT02563106|58885115|FG001|Overall Study|Physician Decision|1|||
30857017|NCT02563106|58885114|FG000|Overall Study|Other reason - not specified|2|||
30857018|NCT02563106|58885115|FG001|Overall Study|Other reason - not specified|1|||
30857019|NCT02691741|58885123|FG000|Overall Study|Adverse Event|0|||
30857020|NCT02691741|58885124|FG001|Overall Study|Adverse Event|2|||
30857021|NCT02691741|58885123|FG000|Overall Study|Lost to Follow-up|1|||
30857022|NCT02691741|58885124|FG001|Overall Study|Lost to Follow-up|0|||
30857023|NCT02691741|58885123|FG000|Overall Study|Physician Decision|0|||
30857024|NCT02691741|58885124|FG001|Overall Study|Physician Decision|1|||
30857025|NCT02691741|58885123|FG000|Overall Study|Withdrawal by Subject|0|||
30688626|NCT00582114|58702221|FG000|Overall Study|Physician Decision|0|||
30688627|NCT00582114|58702222|FG001|Overall Study|Physician Decision|6|||
30688628|NCT00582114|58702221|FG000|Overall Study|Stopped by data safety monitoring board|19|||
30688629|NCT00582114|58702222|FG001|Overall Study|Stopped by data safety monitoring board|20|||
30857026|NCT02691741|58885124|FG001|Overall Study|Withdrawal by Subject|4|||
30688630|NCT00582036|58702230|FG000|Overall Study|Withdrawal by Subject|0|||
30688631|NCT00582036|58702231|FG001|Overall Study|Withdrawal by Subject|1|||
30688632|NCT00581360|58702237|FG000|Overall Study|Withdrawal by Subject|1|||
30857027|NCT02691507|58885137|FG000|Overall Study|Missed Visit 3|0|||
30857028|NCT02691507|58885138|FG001|Overall Study|Missed Visit 3|1|||
30688633|NCT00660387|58702243|FG000|Overall Study|Adverse Event|1|||
30688634|NCT00660387|58702244|FG001|Overall Study|Adverse Event|2|||
30688635|NCT00660387|58702243|FG000|Overall Study|Lack of Efficacy|0|||
30857029|NCT04579393|58885146|FG000|Overall Study|Withdrawal by Subject|2|||
30857030|NCT04579393|58885147|FG001|Overall Study|Withdrawal by Subject|2|||
30857031|NCT04579393|58885146|FG000|Overall Study|Death|1|||
30857032|NCT04579393|58885147|FG001|Overall Study|Death|3|||
30857033|NCT02776553|58885156|FG000|Overall Study|Lost to Follow-up|1|||
30857034|NCT02776553|58885157|FG001|Overall Study|Lost to Follow-up|0|||
30857035|NCT02776553|58885156|FG000|Overall Study|got liver transplant|1|||
30857036|NCT02776553|58885157|FG001|Overall Study|got liver transplant|2|||
30857037|NCT02776553|58885156|FG000|Overall Study|had other surgery|1|||
30857038|NCT02776553|58885157|FG001|Overall Study|had other surgery|0|||
30857039|NCT02776553|58885156|FG000|Overall Study|Protocol Violation|0|||
30857040|NCT02776553|58885157|FG001|Overall Study|Protocol Violation|1|||
30857041|NCT02690727|58885163|FG000|Overall Study|Adverse Event|2|||
30857042|NCT02690727|58885164|FG001|Overall Study|Adverse Event|2|||
30857043|NCT02777333|58885174|FG000|Overall Study|Withdrawal by Subject|0|||
30857044|NCT02777333|58885175|FG001|Overall Study|Withdrawal by Subject|1|||
30857045|NCT02777333|58885174|FG000|Overall Study|Lost to Follow-up|0|||
30857046|NCT02777333|58885175|FG001|Overall Study|Lost to Follow-up|1|||
30857047|NCT02695329|58885183|FG000|Overall Study|Adverse Event|1|||
30857048|NCT02695329|58885184|FG001|Overall Study|Adverse Event|0|||
30857049|NCT02695329|58885183|FG000|Overall Study|Poor X-ray quality for measurement|4|||
30857050|NCT02695329|58885184|FG001|Overall Study|Poor X-ray quality for measurement|5|||
30857051|NCT02690649|58885192|FG000|Overall Study|Withdrawal by Subject|1|||
30857052|NCT02690649|58885193|FG001|Overall Study|Withdrawal by Subject|1|||
30857053|NCT02690649|58885192|FG000|Overall Study|Protocol Violation|0|||
30857054|NCT02690649|58885193|FG001|Overall Study|Protocol Violation|3|||
30857055|NCT01358864|58885209|FG000|Overall Study|Adverse Event|0|||
30857056|NCT01358864|58885210|FG001|Overall Study|Adverse Event|6|||
30857057|NCT01358864|58885211|FG002|Overall Study|Adverse Event|9|||
30857058|NCT01358864|58885212|FG003|Overall Study|Adverse Event|0|||
30857059|NCT01358864|58885213|FG004|Overall Study|Adverse Event|4|||
30857060|NCT01358864|58885214|FG005|Overall Study|Adverse Event|8|||
30857061|NCT01358864|58885215|FG006|Overall Study|Adverse Event|12|||
30857062|NCT01358864|58885216|FG007|Overall Study|Adverse Event|7|||
30857063|NCT01358864|58885209|FG000|Overall Study|Lack of Efficacy|26|||
30857064|NCT01358864|58885210|FG001|Overall Study|Lack of Efficacy|3|||
30857065|NCT01358864|58885211|FG002|Overall Study|Lack of Efficacy|4|||
30857066|NCT01358864|58885212|FG003|Overall Study|Lack of Efficacy|19|||
30857067|NCT01358864|58885213|FG004|Overall Study|Lack of Efficacy|7|||
30857068|NCT01358864|58885214|FG005|Overall Study|Lack of Efficacy|4|||
30857069|NCT01358864|58885215|FG006|Overall Study|Lack of Efficacy|49|||
30857070|NCT01358864|58885216|FG007|Overall Study|Lack of Efficacy|44|||
30857071|NCT01358864|58885209|FG000|Overall Study|Lost to Follow-up|0|||
30857072|NCT01358864|58885210|FG001|Overall Study|Lost to Follow-up|0|||
30857073|NCT01358864|58885211|FG002|Overall Study|Lost to Follow-up|1|||
30857074|NCT01358864|58885212|FG003|Overall Study|Lost to Follow-up|0|||
30857075|NCT01358864|58885213|FG004|Overall Study|Lost to Follow-up|0|||
30857076|NCT01358864|58885214|FG005|Overall Study|Lost to Follow-up|0|||
30857077|NCT01358864|58885215|FG006|Overall Study|Lost to Follow-up|0|||
30857078|NCT01358864|58885216|FG007|Overall Study|Lost to Follow-up|1|||
30857079|NCT01358864|58885209|FG000|Overall Study|Withdrawal by Subject|3|||
30857080|NCT01358864|58885210|FG001|Overall Study|Withdrawal by Subject|4|||
30857081|NCT01358864|58885211|FG002|Overall Study|Withdrawal by Subject|2|||
30857082|NCT01358864|58885212|FG003|Overall Study|Withdrawal by Subject|0|||
30857083|NCT01358864|58885213|FG004|Overall Study|Withdrawal by Subject|0|||
30857084|NCT01358864|58885214|FG005|Overall Study|Withdrawal by Subject|1|||
30857085|NCT01358864|58885215|FG006|Overall Study|Withdrawal by Subject|1|||
30857086|NCT01358864|58885216|FG007|Overall Study|Withdrawal by Subject|3|||
30857087|NCT01358864|58885209|FG000|Overall Study|Other reason not defined above|2|||
30857088|NCT01358864|58885210|FG001|Overall Study|Other reason not defined above|0|||
30857089|NCT01358864|58885211|FG002|Overall Study|Other reason not defined above|0|||
30857090|NCT01358864|58885212|FG003|Overall Study|Other reason not defined above|0|||
30599262|NCT01312961|58611099|FG000|Overall Study|Adverse Event|3|||
30599263|NCT01312961|58611100|FG001|Overall Study|Adverse Event|3|||
30599264|NCT01312961|58611099|FG000|Overall Study|Lack of Efficacy|11|||
30599265|NCT01312961|58611100|FG001|Overall Study|Lack of Efficacy|1|||
30599266|NCT01312961|58611099|FG000|Overall Study|Poor compliance to protocol|1|||
30599267|NCT01312961|58611100|FG001|Overall Study|Poor compliance to protocol|0|||
30599268|NCT01312961|58611099|FG000|Overall Study|Other than specified above|2|||
30599269|NCT01312961|58611100|FG001|Overall Study|Other than specified above|3|||
30599270|NCT01311557|58611109|FG000|Overall Study|Serious adverse event|0|||
30599271|NCT01311557|58611110|FG001|Overall Study|Serious adverse event|1|||
30599272|NCT01311557|58611109|FG000|Overall Study|Protocol Violation|4|||
30857091|NCT01358864|58885213|FG004|Overall Study|Other reason not defined above|0|||
30857092|NCT01358864|58885214|FG005|Overall Study|Other reason not defined above|0|||
30857093|NCT01358864|58885215|FG006|Overall Study|Other reason not defined above|2|||
30857094|NCT01358864|58885216|FG007|Overall Study|Other reason not defined above|0|||
30857095|NCT01358864|58885209|FG000|Overall Study|Not treated|0|||
30857096|NCT01358864|58885210|FG001|Overall Study|Not treated|0|||
30857097|NCT01358864|58885211|FG002|Overall Study|Not treated|0|||
30857098|NCT01358864|58885212|FG003|Overall Study|Not treated|0|||
30857099|NCT01358864|58885213|FG004|Overall Study|Not treated|0|||
30857100|NCT01358864|58885214|FG005|Overall Study|Not treated|0|||
30857101|NCT01358864|58885215|FG006|Overall Study|Not treated|1|||
30857102|NCT01358864|58885216|FG007|Overall Study|Not treated|0|||
30857103|NCT02750761|58885242|FG000|Overall Study|Lost to Follow-up|0|||
30857104|NCT02750761|58885243|FG001|Overall Study|Lost to Follow-up|0|||
30857105|NCT02750761|58885244|FG002|Overall Study|Lost to Follow-up|1|||
30857106|NCT02750761|58885245|FG003|Overall Study|Lost to Follow-up|0|||
30857107|NCT02750761|58885246|FG004|Overall Study|Lost to Follow-up|0|||
30857108|NCT02750761|58885247|FG005|Overall Study|Lost to Follow-up|0|||
30857109|NCT02688933|58885290|FG000|Overall Study|Adverse Event|3|||
30857110|NCT02688933|58885291|FG001|Overall Study|Adverse Event|1|||
30857111|NCT02688933|58885290|FG000|Overall Study|Lack of Efficacy|2|||
30857112|NCT02688933|58885291|FG001|Overall Study|Lack of Efficacy|2|||
30857113|NCT02688933|58885290|FG000|Overall Study|Poor compliance to protocol|7|||
30857114|NCT02688933|58885291|FG001|Overall Study|Poor compliance to protocol|4|||
30857115|NCT02688933|58885290|FG000|Overall Study|Hypoglycemia|2|||
30857116|NCT02688933|58885291|FG001|Overall Study|Hypoglycemia|0|||
30857117|NCT02688933|58885290|FG000|Overall Study|Other than Specified|14|||
30857118|NCT02688933|58885291|FG001|Overall Study|Other than Specified|25|||
30857119|NCT02688933|58885290|FG000|Overall Study|Lost to Follow-up|1|||
30857120|NCT02688933|58885291|FG001|Overall Study|Lost to Follow-up|5|||
30857121|NCT02688621|58885311|FG000|Overall Study|Pregnancy|1|||
30857122|NCT02688621|58885312|FG001|Overall Study|Pregnancy|3|||
30857123|NCT02688621|58885311|FG000|Overall Study|Lost to Follow-up|38|||
30857124|NCT02688621|58885312|FG001|Overall Study|Lost to Follow-up|15|||
30857125|NCT02688621|58885311|FG000|Overall Study|Withdrawal by Subject|1|||
30857126|NCT02688621|58885312|FG001|Overall Study|Withdrawal by Subject|0|||
30857127|NCT04227704|58885324|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
30857128|NCT04227704|58885325|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
30857129|NCT04227704|58885326|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
30857130|NCT04227704|58885324|FG000|Overall Study|due to C/S being cancelled|1|||
30857131|NCT04227704|58885325|FG001|Overall Study|due to C/S being cancelled|0|||
30857132|NCT04227704|58885326|FG002|Overall Study|due to C/S being cancelled|0|||
30857133|NCT03530293|58885336|FG000|Pre-randomization|Adverse Event|12|||
30857134|NCT03530293|58885337|FG001|Pre-randomization|Adverse Event|0|||
30857135|NCT03530293|58885338|FG002|Pre-randomization|Adverse Event|0|||
30857136|NCT03530293|58885336|FG000|Pre-randomization|Protocol Violation|2|||
30857137|NCT03530293|58885337|FG001|Pre-randomization|Protocol Violation|0|||
30857138|NCT03530293|58885338|FG002|Pre-randomization|Protocol Violation|0|||
30857139|NCT03530293|58885336|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
30857140|NCT03530293|58885337|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
30857141|NCT03530293|58885338|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
30857142|NCT03530293|58885336|FG000|Pre-randomization|Withdrawal by Subject|5|||
30857143|NCT03530293|58885337|FG001|Pre-randomization|Withdrawal by Subject|0|||
30857144|NCT03530293|58885338|FG002|Pre-randomization|Withdrawal by Subject|0|||
30857145|NCT03530293|58885336|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
30857146|NCT03530293|58885337|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
30857147|NCT03530293|58885338|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
30857148|NCT03530293|58885336|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
30857149|NCT03530293|58885337|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
30857150|NCT03530293|58885338|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
30857151|NCT03530293|58885336|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
30857152|NCT03530293|58885337|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
30857153|NCT03530293|58885338|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
30857154|NCT03530293|58885336|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
30857155|NCT03530293|58885337|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
30857156|NCT03530293|58885338|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
30857157|NCT03530293|58885336|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
30857158|NCT03530293|58885337|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
30857159|NCT03530293|58885338|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
30857160|NCT03335371|58885367|FG000|Overall Study|Lost to Follow-up|0|||
30857161|NCT03335371|58885368|FG001|Overall Study|Lost to Follow-up|0|||
30857162|NCT03335371|58885369|FG002|Overall Study|Lost to Follow-up|0|||
30857163|NCT03335371|58885370|FG003|Overall Study|Lost to Follow-up|0|||
30857164|NCT03335371|58885371|FG004|Overall Study|Lost to Follow-up|1|||
30857165|NCT03335371|58885367|FG000|Overall Study|Withdrawal by Subject|0|||
30857166|NCT03335371|58885368|FG001|Overall Study|Withdrawal by Subject|0|||
30857167|NCT03335371|58885369|FG002|Overall Study|Withdrawal by Subject|0|||
30857168|NCT03335371|58885370|FG003|Overall Study|Withdrawal by Subject|0|||
30857169|NCT03335371|58885371|FG004|Overall Study|Withdrawal by Subject|1|||
30857170|NCT03335371|58885367|FG000|Overall Study|Randomization Error|0|||
30857171|NCT03335371|58885368|FG001|Overall Study|Randomization Error|0|||
30857172|NCT03335371|58885369|FG002|Overall Study|Randomization Error|1|||
30857173|NCT03335371|58885370|FG003|Overall Study|Randomization Error|0|||
30857174|NCT03335371|58885371|FG004|Overall Study|Randomization Error|0|||
30688636|NCT00660387|58702244|FG001|Overall Study|Lack of Efficacy|1|||
30688637|NCT00660387|58702243|FG000|Overall Study|Protocol Violation|1|||
30688638|NCT00660387|58702244|FG001|Overall Study|Protocol Violation|0|||
30688639|NCT00582738|58702252|FG000|Overall Study|Administrative Problems|7|||
30688640|NCT00582738|58702253|FG001|Overall Study|Administrative Problems|8|||
30688641|NCT00582738|58702252|FG000|Overall Study|Adverse Event|0|||
30688642|NCT00582738|58702253|FG001|Overall Study|Adverse Event|5|||
30688643|NCT00582738|58702252|FG000|Overall Study|Graft Lost|0|||
30688644|NCT00582738|58702253|FG001|Overall Study|Graft Lost|1|||
30688645|NCT00582738|58702252|FG000|Overall Study|Other|1|||
30688646|NCT00582738|58702253|FG001|Overall Study|Other|0|||
30688647|NCT00582738|58702252|FG000|Overall Study|Protocol Violation|1|||
30688648|NCT00582738|58702253|FG001|Overall Study|Protocol Violation|1|||
30688649|NCT00582738|58702252|FG000|Overall Study|Withdrawal by Subject|0|||
30688650|NCT00582738|58702253|FG001|Overall Study|Withdrawal by Subject|3|||
30688651|NCT00772889|58702268|FG000|Overall Study|Adverse Event|7|||
30688652|NCT00772889|58702269|FG001|Overall Study|Adverse Event|4|||
30857175|NCT03301051|58885399|FG000|Overall Study|Adverse Event|0|||
30857176|NCT03301051|58885400|FG001|Overall Study|Adverse Event|4|||
30857177|NCT03301051|58885399|FG000|Overall Study|Withdrawal by Subject|59|||
30857178|NCT03301051|58885400|FG001|Overall Study|Withdrawal by Subject|65|||
30857179|NCT03301051|58885399|FG000|Overall Study|Lost to Follow-up|263|||
30857180|NCT03301051|58885400|FG001|Overall Study|Lost to Follow-up|282|||
30857181|NCT03301051|58885399|FG000|Overall Study|Protocol Violation|1|||
30857182|NCT03301051|58885400|FG001|Overall Study|Protocol Violation|3|||
30857183|NCT03301051|58885399|FG000|Overall Study|Physician Decision|1|||
30857184|NCT03301051|58885400|FG001|Overall Study|Physician Decision|3|||
30857185|NCT03301051|58885399|FG000|Overall Study|Death|1|||
30857186|NCT03301051|58885400|FG001|Overall Study|Death|1|||
30857187|NCT03301051|58885399|FG000|Overall Study|Miscellaneous|8|||
30857188|NCT03301051|58885400|FG001|Overall Study|Miscellaneous|4|||
30857189|NCT03301051|58885399|FG000|Overall Study|Randomized, not vaccinated|13|||
30857190|NCT03301051|58885400|FG001|Overall Study|Randomized, not vaccinated|10|||
30857191|NCT01662986|58885408|FG000|Overall Study|Adverse Event|5|||
30857192|NCT01662986|58885409|FG001|Overall Study|Adverse Event|4|||
30857193|NCT01662986|58885408|FG000|Overall Study|Protocol Violation|2|||
30857194|NCT01662986|58885409|FG001|Overall Study|Protocol Violation|3|||
30857195|NCT01662986|58885408|FG000|Overall Study|Lost to Follow-up|5|||
30857196|NCT01662986|58885409|FG001|Overall Study|Lost to Follow-up|4|||
30857197|NCT01662986|58885408|FG000|Overall Study|Withdrawal by Subject|2|||
30599273|NCT01311557|58611110|FG001|Overall Study|Protocol Violation|2|||
30599274|NCT01311557|58611109|FG000|Overall Study|Lost to Follow-up|0|||
30599275|NCT01311557|58611110|FG001|Overall Study|Lost to Follow-up|1|||
30599276|NCT01311557|58611109|FG000|Overall Study|Withdrawal by Subject|1|||
30599277|NCT01311557|58611110|FG001|Overall Study|Withdrawal by Subject|2|||
30599278|NCT01310777|58611119|FG000|Overall Study|Adverse Event|23|||
30599279|NCT01310777|58611120|FG001|Overall Study|Adverse Event|1|||
30599280|NCT01310777|58611121|FG002|Overall Study|Adverse Event|15|||
30599281|NCT01310777|58611119|FG000|Overall Study|Lost to Follow-up|0|||
30599282|NCT01310777|58611120|FG001|Overall Study|Lost to Follow-up|4|||
30599283|NCT01310777|58611121|FG002|Overall Study|Lost to Follow-up|1|||
30599284|NCT01310777|58611119|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
30599285|NCT01310777|58611120|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
30599286|NCT01310777|58611121|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
30599287|NCT01310777|58611119|FG000|Overall Study|Inadequate Control of IOP|5|||
30599288|NCT01310777|58611120|FG001|Overall Study|Inadequate Control of IOP|7|||
30688653|NCT00772889|58702270|FG002|Overall Study|Adverse Event|0|||
30857198|NCT01662986|58885409|FG001|Overall Study|Withdrawal by Subject|2|||
30959346|NCT01683071|59024747|FG001|Part 2|Protocol deviation|0|||
30599289|NCT01310777|58611121|FG002|Overall Study|Inadequate Control of IOP|10|||
30599290|NCT01310777|58611119|FG000|Overall Study|Other|4|||
30599291|NCT01310777|58611120|FG001|Overall Study|Other|1|||
30688654|NCT00772889|58702268|FG000|Overall Study|Withdrawal by Subject|9|||
30857199|NCT01662986|58885408|FG000|Overall Study|Not Treated|1|||
30688655|NCT00772889|58702269|FG001|Overall Study|Withdrawal by Subject|8|||
30688656|NCT00772889|58702270|FG002|Overall Study|Withdrawal by Subject|9|||
30857200|NCT01662986|58885409|FG001|Overall Study|Not Treated|0|||
30688657|NCT00772889|58702268|FG000|Overall Study|Lost to Follow-up|6|||
30599292|NCT01310777|58611121|FG002|Overall Study|Other|2|||
30857201|NCT01662986|58885408|FG000|Overall Study|Other than stated above|3|||
30857202|NCT01662986|58885409|FG001|Overall Study|Other than stated above|0|||
30857203|NCT01337167|58885417|FG000|Infant Series|Adverse Event|1|||
30857204|NCT01337167|58885418|FG001|Infant Series|Adverse Event|1|||
30857205|NCT01337167|58885417|FG000|Infant Series|Death|1|||
30857206|NCT01337167|58885418|FG001|Infant Series|Death|1|||
30857207|NCT01337167|58885417|FG000|Infant Series|Lost to Follow-up|13|||
30857208|NCT01337167|58885418|FG001|Infant Series|Lost to Follow-up|7|||
30857209|NCT01337167|58885417|FG000|Infant Series|Non-compliance with study drug|2|||
30857210|NCT01337167|58885418|FG001|Infant Series|Non-compliance with study drug|1|||
30857211|NCT01337167|58885417|FG000|Infant Series|Physician Decision|3|||
30857212|NCT01337167|58885418|FG001|Infant Series|Physician Decision|1|||
30857213|NCT01337167|58885417|FG000|Infant Series|Protocol Violation|22|||
30857214|NCT01337167|58885418|FG001|Infant Series|Protocol Violation|9|||
30857215|NCT01337167|58885417|FG000|Infant Series|Withdrawal by Subject|15|||
30857216|NCT01337167|58885418|FG001|Infant Series|Withdrawal by Subject|4|||
30857217|NCT01337167|58885417|FG000|Infant Series|Randomized but not vaccinated|5|||
30857218|NCT01337167|58885418|FG001|Infant Series|Randomized but not vaccinated|3|||
30857219|NCT01337167|58885417|FG000|Interim Period|Lost to Follow-up|51|||
30857220|NCT01337167|58885418|FG001|Interim Period|Lost to Follow-up|23|||
30857221|NCT01337167|58885417|FG000|Interim Period|Non-compliance with study drug|1|||
30857222|NCT01337167|58885418|FG001|Interim Period|Non-compliance with study drug|0|||
30857223|NCT01337167|58885417|FG000|Interim Period|Physician Decision|6|||
30857224|NCT01337167|58885418|FG001|Interim Period|Physician Decision|3|||
30857225|NCT01337167|58885417|FG000|Interim Period|Protocol Violation|5|||
30857226|NCT01337167|58885418|FG001|Interim Period|Protocol Violation|3|||
30857227|NCT01337167|58885417|FG000|Interim Period|Withdrawal by Subject|18|||
30857228|NCT01337167|58885418|FG001|Interim Period|Withdrawal by Subject|10|||
30857229|NCT01337167|58885417|FG000|Interim Period|Other protocol criterion not met|0|||
30857230|NCT01337167|58885418|FG001|Interim Period|Other protocol criterion not met|1|||
30857231|NCT01337167|58885417|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
30857232|NCT01337167|58885418|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
30857233|NCT01337167|58885417|FG000|Toddler Vaccinations|Protocol Violation|0|||
30857234|NCT01337167|58885418|FG001|Toddler Vaccinations|Protocol Violation|1|||
30857235|NCT01337167|58885417|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
30857236|NCT01337167|58885418|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
30857237|NCT01338025|58885426|FG000|Overall Study|Unexpected closure of study|10|||
30857238|NCT01338025|58885427|FG001|Overall Study|Unexpected closure of study|9|||
30857239|NCT01338025|58885426|FG000|Overall Study|Withdrawal by Subject|0|||
30857240|NCT01338025|58885427|FG001|Overall Study|Withdrawal by Subject|2|||
30857241|NCT01338025|58885426|FG000|Overall Study|Found ineligible after starting|1|||
30857242|NCT01338025|58885427|FG001|Overall Study|Found ineligible after starting|0|||
30857243|NCT02559206|58885471|FG000|Overall Study|Adverse Event|0|||
30857244|NCT02559206|58885472|FG001|Overall Study|Adverse Event|4|||
30857245|NCT02559206|58885473|FG002|Overall Study|Adverse Event|1|||
30857246|NCT02559206|58885474|FG003|Overall Study|Adverse Event|5|||
30857247|NCT02559206|58885475|FG004|Overall Study|Adverse Event|3|||
30857248|NCT02559206|58885476|FG005|Overall Study|Adverse Event|0|||
30857249|NCT02559206|58885477|FG006|Overall Study|Adverse Event|1|||
30857250|NCT02559206|58885478|FG007|Overall Study|Adverse Event|0|||
30857251|NCT02559206|58885471|FG000|Overall Study|Protocol Violation|1|||
30857252|NCT02559206|58885472|FG001|Overall Study|Protocol Violation|0|||
30857253|NCT02559206|58885473|FG002|Overall Study|Protocol Violation|1|||
30857254|NCT02559206|58885474|FG003|Overall Study|Protocol Violation|0|||
30857255|NCT02559206|58885475|FG004|Overall Study|Protocol Violation|0|||
30857256|NCT02559206|58885476|FG005|Overall Study|Protocol Violation|2|||
30857257|NCT02559206|58885477|FG006|Overall Study|Protocol Violation|0|||
30857258|NCT02559206|58885478|FG007|Overall Study|Protocol Violation|0|||
30857259|NCT02559206|58885471|FG000|Overall Study|Withdrawal by Subject|3|||
30857260|NCT02559206|58885472|FG001|Overall Study|Withdrawal by Subject|3|||
30857261|NCT02559206|58885473|FG002|Overall Study|Withdrawal by Subject|1|||
30857262|NCT02559206|58885474|FG003|Overall Study|Withdrawal by Subject|3|||
30857263|NCT02559206|58885475|FG004|Overall Study|Withdrawal by Subject|5|||
30857264|NCT02559206|58885476|FG005|Overall Study|Withdrawal by Subject|4|||
30599293|NCT01310699|58611131|FG000|Overall Study|Patients did not complete tandem.|4|||
30599294|NCT01310699|58611132|FG001|Overall Study|Patients did not complete tandem.|6|||
30599295|NCT01310075|58611142|FG000|Overall Study|Lost to Follow-up|1|||
30599296|NCT01310075|58611143|FG001|Overall Study|Lost to Follow-up|0|||
30599297|NCT01310075|58611142|FG000|Overall Study|Physician Decision|10|||
30599298|NCT01310075|58611143|FG001|Overall Study|Physician Decision|7|||
30857265|NCT02559206|58885477|FG006|Overall Study|Withdrawal by Subject|1|||
30599299|NCT01310075|58611142|FG000|Overall Study|Protocol Violation|2|||
30599300|NCT01310075|58611143|FG001|Overall Study|Protocol Violation|2|||
30857266|NCT02559206|58885478|FG007|Overall Study|Withdrawal by Subject|2|||
30857267|NCT02559206|58885471|FG000|Overall Study|Lost to Follow-up|3|||
30857268|NCT02559206|58885472|FG001|Overall Study|Lost to Follow-up|5|||
30857269|NCT02559206|58885473|FG002|Overall Study|Lost to Follow-up|3|||
30857270|NCT02559206|58885474|FG003|Overall Study|Lost to Follow-up|3|||
30857271|NCT02559206|58885475|FG004|Overall Study|Lost to Follow-up|2|||
30857272|NCT02559206|58885476|FG005|Overall Study|Lost to Follow-up|5|||
30857273|NCT02559206|58885477|FG006|Overall Study|Lost to Follow-up|1|||
30857274|NCT02559206|58885478|FG007|Overall Study|Lost to Follow-up|4|||
30857275|NCT02559206|58885471|FG000|Overall Study|Lack of Efficacy|1|||
30857276|NCT02559206|58885472|FG001|Overall Study|Lack of Efficacy|0|||
30857277|NCT02559206|58885473|FG002|Overall Study|Lack of Efficacy|3|||
30857278|NCT02559206|58885474|FG003|Overall Study|Lack of Efficacy|2|||
30857279|NCT02559206|58885475|FG004|Overall Study|Lack of Efficacy|2|||
30857280|NCT02559206|58885476|FG005|Overall Study|Lack of Efficacy|3|||
30857281|NCT02559206|58885477|FG006|Overall Study|Lack of Efficacy|3|||
30857282|NCT02559206|58885478|FG007|Overall Study|Lack of Efficacy|3|||
30857283|NCT02559206|58885471|FG000|Overall Study|Other Not Specified|0|||
30857284|NCT02559206|58885472|FG001|Overall Study|Other Not Specified|0|||
30857285|NCT02559206|58885473|FG002|Overall Study|Other Not Specified|0|||
30857286|NCT02559206|58885474|FG003|Overall Study|Other Not Specified|1|||
30857287|NCT02559206|58885475|FG004|Overall Study|Other Not Specified|0|||
30857288|NCT02559206|58885476|FG005|Overall Study|Other Not Specified|0|||
30857289|NCT02559206|58885477|FG006|Overall Study|Other Not Specified|0|||
30857290|NCT02559206|58885478|FG007|Overall Study|Other Not Specified|0|||
30857291|NCT02558894|58885498|FG000|Overall Study|Death; any cause, entire study duration|28|||
30857292|NCT02558894|58885499|FG001|Overall Study|Death; any cause, entire study duration|31|||
30857293|NCT02558894|58885498|FG000|Overall Study|Withdrawal by Subject|2|||
30857294|NCT02558894|58885499|FG001|Overall Study|Withdrawal by Subject|1|||
30857295|NCT02558894|58885498|FG000|Overall Study|Closure of Part A|2|||
30857296|NCT02558894|58885499|FG001|Overall Study|Closure of Part A|1|||
30857297|NCT02688387|58885509|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857298|NCT02688387|58885510|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857299|NCT02688387|58885511|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
30857300|NCT02688387|58885512|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857301|NCT02688387|58885513|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857302|NCT02688387|58885514|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857303|NCT02688387|58885515|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857304|NCT02688387|58885516|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857305|NCT02688387|58885517|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857306|NCT02688387|58885518|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857307|NCT02688387|58885519|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857308|NCT02688387|58885520|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857309|NCT02688387|58885521|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857310|NCT02688387|58885522|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857311|NCT02688387|58885523|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857312|NCT02688387|58885524|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857313|NCT02688387|58885525|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857314|NCT02688387|58885526|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857315|NCT02688387|58885527|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857316|NCT02688387|58885528|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857317|NCT02688387|58885529|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857318|NCT02688387|58885530|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
30857319|NCT02688387|58885509|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30599301|NCT01310075|58611142|FG000|Overall Study|Withdrawal by Subject|1|||
30599302|NCT01310075|58611143|FG001|Overall Study|Withdrawal by Subject|1|||
30599303|NCT01309997|58611151|FG000|Overall Study|Adverse Event|1|||
30599304|NCT01309997|58611152|FG001|Overall Study|Adverse Event|0|||
30599305|NCT01309997|58611151|FG000|Overall Study|Death|1|||
30599306|NCT01309997|58611152|FG001|Overall Study|Death|3|||
30599307|NCT01309997|58611151|FG000|Overall Study|Lack of Efficacy|2|||
30599308|NCT01309997|58611152|FG001|Overall Study|Lack of Efficacy|2|||
30599309|NCT01309997|58611151|FG000|Overall Study|Withdrawal by Subject|1|||
30599310|NCT01309997|58611152|FG001|Overall Study|Withdrawal by Subject|1|||
30688658|NCT00772889|58702269|FG001|Overall Study|Lost to Follow-up|6|||
30688659|NCT00772889|58702270|FG002|Overall Study|Lost to Follow-up|7|||
30688660|NCT01247324|58702280|FG000|Overall Study|Death|1|||
30688661|NCT01247324|58702281|FG001|Overall Study|Death|0|||
30688662|NCT01247324|58702280|FG000|Overall Study|Physician Decision|0|||
30688663|NCT01247324|58702281|FG001|Overall Study|Physician Decision|1|||
30688664|NCT01247324|58702280|FG000|Overall Study|Non-compliance with study drug|3|||
30688665|NCT01247324|58702281|FG001|Overall Study|Non-compliance with study drug|0|||
30688666|NCT01247324|58702280|FG000|Overall Study|Lack of Efficacy|12|||
30857320|NCT02688387|58885510|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857321|NCT02688387|58885511|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857322|NCT02688387|58885512|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
30857323|NCT02688387|58885513|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857324|NCT02688387|58885514|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857325|NCT02688387|58885515|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857326|NCT02688387|58885516|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30959347|NCT01683071|59024748|FG002|Part 2|Protocol deviation|0|||
30688667|NCT01247324|58702281|FG001|Overall Study|Lack of Efficacy|8|||
30688668|NCT01247324|58702280|FG000|Overall Study|Non-compliance|2|||
30857327|NCT02688387|58885517|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857328|NCT02688387|58885518|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857329|NCT02688387|58885519|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857330|NCT02688387|58885520|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857331|NCT02688387|58885521|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857332|NCT02688387|58885522|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857333|NCT02688387|58885523|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857334|NCT02688387|58885524|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857335|NCT02688387|58885525|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857336|NCT02688387|58885526|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857337|NCT02688387|58885527|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857338|NCT02688387|58885528|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857339|NCT02688387|58885529|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857340|NCT02688387|58885530|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857341|NCT02688387|58885509|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857342|NCT02688387|58885510|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
30857343|NCT02688387|58885511|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857344|NCT02688387|58885512|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857345|NCT02688387|58885513|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857346|NCT02688387|58885514|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857347|NCT02688387|58885515|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857348|NCT02688387|58885516|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857349|NCT02688387|58885517|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857350|NCT02688387|58885518|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30877169|NCT00106691|58908831|FG001|Overall Study|Withdrawal by Subject|70|||
30599311|NCT01309919|58611171|FG000|Overall Study|Did not receive a postpartum IUD|17|||
30599312|NCT01309919|58611172|FG001|Overall Study|Did not receive a postpartum IUD|48|||
30599313|NCT01309841|58611181|FG000|Overall Study|Other|0|||
30599314|NCT01309841|58611182|FG001|Overall Study|Other|1|||
30599315|NCT01309841|58611183|FG002|Overall Study|Other|1|||
30599316|NCT01309841|58611181|FG000|Overall Study|Lost to Follow-up|7|||
30599317|NCT01309841|58611182|FG001|Overall Study|Lost to Follow-up|6|||
30599318|NCT01309841|58611183|FG002|Overall Study|Lost to Follow-up|4|||
30599319|NCT01309841|58611181|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
30599320|NCT01309841|58611182|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
30599321|NCT01309841|58611183|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
30688669|NCT01247324|58702281|FG001|Overall Study|Non-compliance|0|||
30688670|NCT01247324|58702280|FG000|Overall Study|Pregnancy|2|||
30688671|NCT01247324|58702281|FG001|Overall Study|Pregnancy|3|||
30688672|NCT01247324|58702280|FG000|Overall Study|Protocol Violation|1|||
30688673|NCT01247324|58702281|FG001|Overall Study|Protocol Violation|2|||
30688674|NCT01247324|58702280|FG000|Overall Study|Reason not specified|11|||
30688675|NCT01247324|58702281|FG001|Overall Study|Reason not specified|8|||
30688676|NCT01247324|58702280|FG000|Overall Study|Consent withdrawn by participant|13|||
30688677|NCT01247324|58702281|FG001|Overall Study|Consent withdrawn by participant|8|||
30688678|NCT01247324|58702280|FG000|Overall Study|Adverse Event|25|||
30688679|NCT01247324|58702281|FG001|Overall Study|Adverse Event|13|||
30688680|NCT01247324|58702280|FG000|Overall Study|Lost to Follow-up|1|||
30688681|NCT01247324|58702281|FG001|Overall Study|Lost to Follow-up|1|||
30688682|NCT00772577|58702290|FG000|Overall Study|Adverse Event|6|||
30688683|NCT00772577|58702291|FG001|Overall Study|Adverse Event|3|||
30688684|NCT00772577|58702290|FG000|Overall Study|Abnormal laboratory values|0|||
30688685|NCT00772577|58702291|FG001|Overall Study|Abnormal laboratory values|1|||
30688686|NCT00772577|58702290|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30688687|NCT00772577|58702291|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
30688688|NCT00772577|58702290|FG000|Overall Study|Patient withdrew consent|8|||
30688689|NCT00772577|58702291|FG001|Overall Study|Patient withdrew consent|5|||
30688690|NCT00772577|58702290|FG000|Overall Study|Lost to Follow-up|4|||
30688691|NCT00772577|58702291|FG001|Overall Study|Lost to Follow-up|3|||
30688692|NCT00772577|58702290|FG000|Overall Study|Administrative problems|2|||
30688693|NCT00772577|58702291|FG001|Overall Study|Administrative problems|1|||
30599322|NCT01309841|58611181|FG000|Overall Study|Lack of Efficacy|0|||
30688694|NCT00772577|58702290|FG000|Overall Study|Protocol Deviation|3|||
30599323|NCT01309841|58611182|FG001|Overall Study|Lack of Efficacy|0|||
30599324|NCT01309841|58611183|FG002|Overall Study|Lack of Efficacy|2|||
30599325|NCT01309841|58611181|FG000|Overall Study|Adverse Event|9|||
30688695|NCT00772577|58702291|FG001|Overall Study|Protocol Deviation|2|||
30688696|NCT02345850|58702300|FG000|Overall Study|Not transplanted|10|||
30688697|NCT02345850|58702301|FG001|Overall Study|Not transplanted|5|||
30688698|NCT02345850|58702302|FG002|Overall Study|Not transplanted|4|||
30688699|NCT02345850|58702300|FG000|Overall Study|Lost to Follow-up|2|||
30688700|NCT02345850|58702301|FG001|Overall Study|Lost to Follow-up|3|||
30857351|NCT02688387|58885519|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857352|NCT02688387|58885520|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857353|NCT02688387|58885521|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857354|NCT02688387|58885522|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857355|NCT02688387|58885523|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857356|NCT02688387|58885524|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857357|NCT02688387|58885525|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857358|NCT02688387|58885526|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857359|NCT02688387|58885527|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857360|NCT02688387|58885528|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857361|NCT02688387|58885529|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857362|NCT02688387|58885530|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
30857363|NCT02688387|58885509|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857364|NCT02688387|58885510|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857365|NCT02688387|58885511|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
30857366|NCT02688387|58885512|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857367|NCT02688387|58885513|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
30857368|NCT02688387|58885514|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857369|NCT02688387|58885515|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857370|NCT02688387|58885516|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857371|NCT02688387|58885517|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857372|NCT02688387|58885518|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857373|NCT02688387|58885519|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857374|NCT02688387|58885520|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857375|NCT02688387|58885521|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857376|NCT02688387|58885522|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857377|NCT02688387|58885523|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857378|NCT02688387|58885524|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857379|NCT02688387|58885525|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857380|NCT02688387|58885526|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857381|NCT02688387|58885527|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857382|NCT02688387|58885528|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857383|NCT02688387|58885529|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857384|NCT02688387|58885530|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
30857385|NCT02688387|58885509|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
30857386|NCT02688387|58885510|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857387|NCT02688387|58885511|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857388|NCT02688387|58885512|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857389|NCT02688387|58885513|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857390|NCT02688387|58885514|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857391|NCT02688387|58885515|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857392|NCT02688387|58885516|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857393|NCT02688387|58885517|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857394|NCT02688387|58885518|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857395|NCT02688387|58885519|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857396|NCT02688387|58885520|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30599326|NCT01309841|58611182|FG001|Overall Study|Adverse Event|22|||
30599327|NCT01309841|58611183|FG002|Overall Study|Adverse Event|11|||
30857397|NCT02688387|58885521|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30599328|NCT01309841|58611181|FG000|Overall Study|Death|1|||
30599329|NCT01309841|58611182|FG001|Overall Study|Death|0|||
30599330|NCT01309841|58611183|FG002|Overall Study|Death|0|||
30599331|NCT01309841|58611181|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
30599332|NCT01309841|58611182|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
30857398|NCT02688387|58885522|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857399|NCT02688387|58885523|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857400|NCT02688387|58885524|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857401|NCT02688387|58885525|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857402|NCT02688387|58885526|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857403|NCT02688387|58885527|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857404|NCT02688387|58885528|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857405|NCT02688387|58885529|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857406|NCT02688387|58885530|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
30857407|NCT02688387|58885509|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857408|NCT02688387|58885510|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857409|NCT02688387|58885511|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857410|NCT02688387|58885512|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857411|NCT02688387|58885513|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857412|NCT02688387|58885514|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857413|NCT02688387|58885515|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857414|NCT02688387|58885516|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857415|NCT02688387|58885517|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857416|NCT02688387|58885518|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857417|NCT02688387|58885519|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
30857418|NCT02688387|58885520|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857419|NCT02688387|58885521|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857420|NCT02688387|58885522|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857421|NCT02688387|58885523|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857422|NCT02688387|58885524|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857423|NCT02688387|58885525|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857424|NCT02688387|58885526|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857425|NCT02688387|58885527|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857426|NCT02688387|58885528|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857427|NCT02688387|58885529|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857428|NCT02688387|58885530|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
30857429|NCT02688387|58885509|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857430|NCT02688387|58885510|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857431|NCT02688387|58885511|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857432|NCT02688387|58885512|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857433|NCT02688387|58885513|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857434|NCT02688387|58885514|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857435|NCT02688387|58885515|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857436|NCT02688387|58885516|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857437|NCT02688387|58885517|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857438|NCT02688387|58885518|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857439|NCT02688387|58885519|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857440|NCT02688387|58885520|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857441|NCT02688387|58885521|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857442|NCT02688387|58885522|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857443|NCT02688387|58885523|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
30857444|NCT02688387|58885524|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857445|NCT02688387|58885525|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857446|NCT02688387|58885526|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857447|NCT02688387|58885527|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857448|NCT02688387|58885528|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857449|NCT02688387|58885529|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857450|NCT02688387|58885530|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
30857451|NCT02688387|58885509|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857452|NCT02688387|58885510|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857453|NCT02688387|58885511|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857454|NCT02688387|58885512|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857455|NCT02688387|58885513|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857456|NCT02688387|58885514|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857457|NCT02688387|58885515|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857458|NCT02688387|58885516|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857459|NCT02688387|58885517|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857460|NCT02688387|58885518|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857461|NCT02688387|58885519|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857462|NCT02688387|58885520|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857463|NCT02688387|58885521|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857464|NCT02688387|58885522|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857465|NCT02688387|58885523|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857466|NCT02688387|58885524|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30959348|NCT01683071|59024749|FG003|Part 2|Protocol deviation|0|||
30857467|NCT02688387|58885525|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857468|NCT02688387|58885526|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857469|NCT02688387|58885527|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857470|NCT02688387|58885528|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857471|NCT02688387|58885529|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
30857472|NCT02688387|58885530|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
30857473|NCT02688387|58885509|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857474|NCT02688387|58885510|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857475|NCT02688387|58885511|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857476|NCT02688387|58885512|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857477|NCT02688387|58885513|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857478|NCT02688387|58885514|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857479|NCT02688387|58885515|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857480|NCT02688387|58885516|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857481|NCT02688387|58885517|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857482|NCT02688387|58885518|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857483|NCT02688387|58885519|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857484|NCT02688387|58885520|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857485|NCT02688387|58885521|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857486|NCT02688387|58885522|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857487|NCT02688387|58885523|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857488|NCT02688387|58885524|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857489|NCT02688387|58885525|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857490|NCT02688387|58885526|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857491|NCT02688387|58885527|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
30857492|NCT02688387|58885528|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857493|NCT02688387|58885529|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
30857494|NCT02688387|58885530|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
30857495|NCT02688387|58885509|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857496|NCT02688387|58885510|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857497|NCT02688387|58885511|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857498|NCT02688387|58885512|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857499|NCT02688387|58885513|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857500|NCT02688387|58885514|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857501|NCT02688387|58885515|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857502|NCT02688387|58885516|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857503|NCT02688387|58885517|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857504|NCT02688387|58885518|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857505|NCT02688387|58885519|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857506|NCT02688387|58885520|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857507|NCT02688387|58885521|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857508|NCT02688387|58885522|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857509|NCT02688387|58885523|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857510|NCT02688387|58885524|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857511|NCT02688387|58885525|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857512|NCT02688387|58885526|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857513|NCT02688387|58885527|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857514|NCT02688387|58885528|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
30857515|NCT02688387|58885529|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857516|NCT02688387|58885530|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
30857517|NCT02476201|58885576|FG000|Overall Study|Unable to program MPP|9|||
30599333|NCT01309841|58611183|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
30599334|NCT01309841|58611181|FG000|Overall Study|Withdrawal by Subject|17|||
30599335|NCT01309841|58611182|FG001|Overall Study|Withdrawal by Subject|6|||
30599336|NCT01309841|58611183|FG002|Overall Study|Withdrawal by Subject|13|||
30599337|NCT01309841|58611181|FG000|Overall Study|Did Not Receive Treatment|2|||
30599338|NCT01309841|58611182|FG001|Overall Study|Did Not Receive Treatment|0|||
30599339|NCT01309841|58611183|FG002|Overall Study|Did Not Receive Treatment|1|||
30599340|NCT01309841|58611181|FG000|Overall Study|Severe non-compliance with protocol|0|||
30599341|NCT01309841|58611182|FG001|Overall Study|Severe non-compliance with protocol|5|||
30599342|NCT01309841|58611183|FG002|Overall Study|Severe non-compliance with protocol|2|||
30857518|NCT02476201|58885576|FG000|Overall Study|Study echo not performed|5|||
30857519|NCT02476201|58885576|FG000|Overall Study|Adverse Event|4|||
30857520|NCT02476201|58885576|FG000|Overall Study|Death|2|||
30857521|NCT02476201|58885576|FG000|Overall Study|Lost to Follow-up|2|||
30688701|NCT02345850|58702302|FG002|Overall Study|Lost to Follow-up|2|||
30857522|NCT02476201|58885576|FG000|Overall Study|MPP programmed to OFF|2|||
30857523|NCT02476201|58885576|FG000|Overall Study|Withdrawal by Subject|1|||
30688702|NCT02345850|58702300|FG000|Overall Study|Withdrawal by Subject|1|||
30688703|NCT02345850|58702301|FG001|Overall Study|Withdrawal by Subject|0|||
30688704|NCT02345850|58702302|FG002|Overall Study|Withdrawal by Subject|0|||
30688705|NCT00659607|58702310|FG000|Overall Study|No blood pressure recorded|147|||
30688706|NCT00659607|58702310|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
30688707|NCT00659607|58702310|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
30688708|NCT00659607|58702310|FG000|Overall Study|No recorded efficacy data|15|||
30688709|NCT00659607|58702310|FG000|Overall Study|Inconsistent BP measuring date|2|||
30857524|NCT02476201|58885576|FG000|Overall Study|Unsuccessful implant|1|||
30857525|NCT04112173|58885581|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
30688710|NCT02848092|58702318|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
30688711|NCT02848092|58702319|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
30688712|NCT02848092|58702318|FG000|1-month Post-training Follow-up|Adverse Event|2|||
30688713|NCT02848092|58702319|FG001|1-month Post-training Follow-up|Adverse Event|1|||
30688714|NCT02848092|58702318|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
30688715|NCT02848092|58702319|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
30688716|NCT02848092|58702318|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
30688717|NCT02848092|58702319|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
30688718|NCT02848092|58702318|FG000|1-month Post-training Follow-up|fatigue|0|||
30857526|NCT02688153|58885587|FG000|Overall Study|Death|7|||
30857527|NCT02688153|58885588|FG001|Overall Study|Death|5|||
30857528|NCT02688153|58885587|FG000|Overall Study|Withdrawal by Subject|4|||
30857529|NCT02688153|58885588|FG001|Overall Study|Withdrawal by Subject|2|||
30857530|NCT02688153|58885587|FG000|Overall Study|Valve Explant|1|||
30857531|NCT02688153|58885588|FG001|Overall Study|Valve Explant|0|||
30857532|NCT02688153|58885587|FG000|Overall Study|Conversion to Commercial Valve|3|||
30857533|NCT02688153|58885588|FG001|Overall Study|Conversion to Commercial Valve|0|||
30857534|NCT02687919|58885597|FG000|Overall Study|Withdrawal by Subject|6|||
30857535|NCT02687919|58885598|FG001|Overall Study|Withdrawal by Subject|6|||
30857536|NCT02687919|58885597|FG000|Overall Study|Protocol Violation|2|||
30857537|NCT02687919|58885598|FG001|Overall Study|Protocol Violation|0|||
30857538|NCT02687451|58885610|FG000|Overall Study|Withdrawal by Subject|1|||
30857539|NCT02687451|58885611|FG001|Overall Study|Withdrawal by Subject|0|||
30857540|NCT02687451|58885612|FG002|Overall Study|Withdrawal by Subject|0|||
30857541|NCT02687451|58885613|FG003|Overall Study|Withdrawal by Subject|0|||
30857542|NCT02687451|58885614|FG004|Overall Study|Withdrawal by Subject|0|||
30857543|NCT02687451|58885615|FG005|Overall Study|Withdrawal by Subject|1|||
30857544|NCT02557646|58885631|FG000|Overall Study|Adverse Event|40|||
30857545|NCT02557646|58885631|FG000|Overall Study|Death|1|||
30857546|NCT02557646|58885631|FG000|Overall Study|Lack of Efficacy|186|||
30857547|NCT02557646|58885631|FG000|Overall Study|Withdrawal by Subject|18|||
30857548|NCT02557646|58885631|FG000|Overall Study|Lost to Follow-up|17|||
30857549|NCT02557646|58885631|FG000|Overall Study|Other|14|||
30857550|NCT02679573|58885637|FG000|Overall Study|Adverse Event|13|||
30857551|NCT02679573|58885638|FG001|Overall Study|Adverse Event|6|||
30857552|NCT02679573|58885637|FG000|Overall Study|Lack of Efficacy|12|||
30857553|NCT02679573|58885638|FG001|Overall Study|Lack of Efficacy|15|||
30857554|NCT02679573|58885637|FG000|Overall Study|Could not complete required study visits|6|||
30857555|NCT02679573|58885638|FG001|Overall Study|Could not complete required study visits|2|||
30857556|NCT02679573|58885637|FG000|Overall Study|Withdrawal by Subject|2|||
30599343|NCT01308749|58611193|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
30599344|NCT01308749|58611194|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
30599345|NCT01308749|58611193|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
30599346|NCT01308749|58611194|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
30599347|NCT01308749|58611193|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
30599348|NCT01308749|58611194|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
30599349|NCT01307891|58611216|FG000|Overall Study|Progressive Disease|3|||
30857557|NCT02679573|58885638|FG001|Overall Study|Withdrawal by Subject|9|||
30857558|NCT02679573|58885637|FG000|Overall Study|Death|2|||
30857559|NCT02679573|58885638|FG001|Overall Study|Death|0|||
30857560|NCT02679573|58885637|FG000|Overall Study|Physician Decision|2|||
30599350|NCT01307891|58611217|FG001|Overall Study|Progressive Disease|1|||
30599351|NCT01307579|58611225|FG000|Overall Study|Death|3|||
30599352|NCT01307579|58611226|FG001|Overall Study|Death|6|||
30599353|NCT01307579|58611225|FG000|Overall Study|Physician Decision|26|||
30688719|NCT02848092|58702319|FG001|1-month Post-training Follow-up|fatigue|1|||
30857561|NCT02679573|58885638|FG001|Overall Study|Physician Decision|4|||
30857562|NCT02679573|58885637|FG000|Overall Study|Lost to Follow-up|0|||
30688720|NCT02848092|58702318|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
30857563|NCT02679573|58885638|FG001|Overall Study|Lost to Follow-up|3|||
30857564|NCT02685033|58885646|FG000|Overall Study|Withdrawal of Consent|0|||
30857565|NCT02685033|58885647|FG001|Overall Study|Withdrawal of Consent|1|||
30857566|NCT02685033|58885646|FG000|Overall Study|Lost to Follow-up|2|||
30688721|NCT02848092|58702319|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
30688722|NCT02848092|58702318|FG000|6-month Post-training Follow-up|Adverse Event|1|||
30688723|NCT02848092|58702319|FG001|6-month Post-training Follow-up|Adverse Event|1|||
30688724|NCT02848092|58702318|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
30688725|NCT02848092|58702319|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
30688726|NCT02848092|58702318|FG000|6-month Post-training Follow-up|frustrated with task|1|||
30688727|NCT02848092|58702319|FG001|6-month Post-training Follow-up|frustrated with task|0|||
30688728|NCT02848092|58702318|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
30688729|NCT02848092|58702319|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
30688730|NCT02848092|58702318|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
30688731|NCT02848092|58702319|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
30688732|NCT00660309|58702327|FG000|Overall Study|Adverse Event|2|||
30688733|NCT00660309|58702328|FG001|Overall Study|Adverse Event|0|||
30688734|NCT00660309|58702327|FG000|Overall Study|Withdrawal by Subject|0|||
30688735|NCT00660309|58702328|FG001|Overall Study|Withdrawal by Subject|3|||
30688736|NCT00581100|58702337|FG000|Overall Study|Death|1|||
30688737|NCT00581100|58702338|FG001|Overall Study|Death|0|||
30688738|NCT00581100|58702337|FG000|Overall Study|Adverse Event|2|||
30688739|NCT00581100|58702338|FG001|Overall Study|Adverse Event|1|||
30688740|NCT00581100|58702337|FG000|Overall Study|Withdrawal by Subject|1|||
30688741|NCT00581100|58702338|FG001|Overall Study|Withdrawal by Subject|4|||
30857567|NCT02685033|58885647|FG001|Overall Study|Lost to Follow-up|1|||
30857568|NCT02685033|58885646|FG000|Overall Study|Adverse Event|1|||
30857569|NCT02685033|58885647|FG001|Overall Study|Adverse Event|0|||
30857570|NCT02684097|58885655|FG000|Overall Study|Lack of Efficacy|13|||
30857571|NCT02684097|58885656|FG001|Overall Study|Lack of Efficacy|6|||
30857572|NCT02555618|58885664|FG000|Overall Study|Sponsor's Circumstances|1|||
30857573|NCT02555618|58885665|FG001|Overall Study|Sponsor's Circumstances|0|||
30857574|NCT02557100|58885691|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
30857575|NCT02557100|58885692|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
30857576|NCT02557100|58885693|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
30857577|NCT02557100|58885691|FG000|Single Blind Treatment Period|Death|0|||
30857578|NCT02557100|58885692|FG001|Single Blind Treatment Period|Death|1|||
30857579|NCT02557100|58885693|FG002|Single Blind Treatment Period|Death|0|||
30599354|NCT01307579|58611226|FG001|Overall Study|Physician Decision|29|||
30599355|NCT01307579|58611225|FG000|Overall Study|Withdrawal by Subject|7|||
30599356|NCT01307579|58611226|FG001|Overall Study|Withdrawal by Subject|3|||
30599357|NCT01307579|58611225|FG000|Overall Study|Institutional diagnosis of IFD|21|||
30599358|NCT01307579|58611226|FG001|Overall Study|Institutional diagnosis of IFD|36|||
30599359|NCT01307579|58611225|FG000|Overall Study|Begin conditioning for HSCT|42|||
30599360|NCT01307579|58611226|FG001|Overall Study|Begin conditioning for HSCT|44|||
30599361|NCT01307579|58611225|FG000|Overall Study|Refractory or relapsed AML|38|||
30599362|NCT01307579|58611226|FG001|Overall Study|Refractory or relapsed AML|23|||
30599363|NCT01307579|58611225|FG000|Overall Study|Ineligible|3|||
30599364|NCT01307579|58611226|FG001|Overall Study|Ineligible|4|||
30599365|NCT01057693|58611232|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
30599366|NCT01057693|58611233|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
30599367|NCT01057693|58611234|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
30599368|NCT01057693|58611232|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
30599369|NCT01057693|58611233|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
30599370|NCT01057693|58611234|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
30599371|NCT01057693|58611232|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
30599372|NCT01057693|58611233|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
30599373|NCT01057693|58611234|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
30599374|NCT01057693|58611232|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
30599375|NCT01057693|58611233|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
30599376|NCT01057693|58611234|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
30599377|NCT01057693|58611232|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
30599378|NCT01057693|58611233|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
30599379|NCT01057693|58611234|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
30599380|NCT01057693|58611232|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
30599381|NCT01057693|58611233|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
30599382|NCT01057693|58611234|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
30599383|NCT01057693|58611232|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
30599384|NCT01057693|58611233|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
30599385|NCT01057693|58611234|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
30599386|NCT01057693|58611232|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
30857580|NCT02557100|58885691|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
30688742|NCT00581100|58702337|FG000|Overall Study|Other|3|||
30688743|NCT00581100|58702338|FG001|Overall Study|Other|0|||
30857581|NCT02557100|58885692|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
30857582|NCT02557100|58885693|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
30857583|NCT02557100|58885691|FG000|Single Blind Treatment Period|Adverse Event|0|||
30857584|NCT02557100|58885692|FG001|Single Blind Treatment Period|Adverse Event|1|||
30857585|NCT02557100|58885693|FG002|Single Blind Treatment Period|Adverse Event|0|||
30857586|NCT02557100|58885691|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
30857587|NCT02557100|58885692|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
30857588|NCT02557100|58885693|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
30857589|NCT02557100|58885691|FG000|Cumulative Abatacept Period|Other Reasons|0|||
30857590|NCT02557100|58885692|FG001|Cumulative Abatacept Period|Other Reasons|0|||
30857591|NCT02557100|58885693|FG002|Cumulative Abatacept Period|Other Reasons|1|||
30857592|NCT02557100|58885691|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
30857593|NCT02557100|58885692|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
30857594|NCT02557100|58885693|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
30857595|NCT02557100|58885691|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
30857596|NCT02557100|58885692|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
30857597|NCT02557100|58885693|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
30857598|NCT01337635|58885703|FG000|Overall Study|Lost to Follow-up|0|||
30857599|NCT01337635|58885704|FG001|Overall Study|Lost to Follow-up|1|||
30857600|NCT02556710|58885712|FG000|Overall Study|Surgical treatment|3|||
30857601|NCT02556710|58885713|FG001|Overall Study|Surgical treatment|0|||
30857602|NCT02556710|58885712|FG000|Overall Study|Required proscribed pain medication|2|||
30857603|NCT02556710|58885713|FG001|Overall Study|Required proscribed pain medication|1|||
30857604|NCT02556710|58885712|FG000|Overall Study|Lack of Efficacy|1|||
30857605|NCT02556710|58885713|FG001|Overall Study|Lack of Efficacy|0|||
30857606|NCT02556710|58885712|FG000|Overall Study|Worsening osteoarthritis|1|||
30857607|NCT02556710|58885713|FG001|Overall Study|Worsening osteoarthritis|0|||
30857608|NCT02556710|58885712|FG000|Overall Study|Moved out of state|1|||
30857609|NCT02556710|58885713|FG001|Overall Study|Moved out of state|0|||
30688744|NCT00579098|58702346|FG000|Overall Study|Lost to Follow-up|2|||
30688745|NCT00579098|58702347|FG001|Overall Study|Lost to Follow-up|0|||
30688746|NCT00579098|58702346|FG000|Overall Study|Adverse Event|2|||
30688747|NCT00579098|58702347|FG001|Overall Study|Adverse Event|3|||
30688748|NCT00579098|58702346|FG000|Overall Study|Withdrawal by Subject|2|||
30688749|NCT00579098|58702347|FG001|Overall Study|Withdrawal by Subject|3|||
30688750|NCT00579098|58702346|FG000|Overall Study|AF returned after ablation|3|||
30688751|NCT00579098|58702347|FG001|Overall Study|AF returned after ablation|2|||
30688752|NCT00772109|58702357|FG000|Overall Study|Serious adverse event|1|||
30688753|NCT00772109|58702358|FG001|Overall Study|Serious adverse event|0|||
30688754|NCT00772109|58702359|FG002|Overall Study|Serious adverse event|1|||
30688755|NCT00772109|58702360|FG003|Overall Study|Serious adverse event|0|||
30688756|NCT00772109|58702357|FG000|Overall Study|Protocol Violation|5|||
30688757|NCT00772109|58702358|FG001|Overall Study|Protocol Violation|8|||
30688758|NCT00772109|58702359|FG002|Overall Study|Protocol Violation|7|||
30688759|NCT00772109|58702360|FG003|Overall Study|Protocol Violation|6|||
30688760|NCT00772109|58702357|FG000|Overall Study|Lost to Follow-up|7|||
30688761|NCT00772109|58702358|FG001|Overall Study|Lost to Follow-up|3|||
30688762|NCT00772109|58702359|FG002|Overall Study|Lost to Follow-up|5|||
30688763|NCT00772109|58702360|FG003|Overall Study|Lost to Follow-up|9|||
30857610|NCT02556710|58885712|FG000|Overall Study|Missing reason|3|||
30857611|NCT02556710|58885713|FG001|Overall Study|Missing reason|1|||
30857612|NCT02556710|58885712|FG000|Overall Study|Pain as lack of efficacy|0|||
30857613|NCT02556710|58885713|FG001|Overall Study|Pain as lack of efficacy|4|||
30857614|NCT02556632|58885724|FG000|Overall Study|Lost to Follow-up|1|||
30857615|NCT02556632|58885725|FG001|Overall Study|Lost to Follow-up|0|||
30688764|NCT00772109|58702357|FG000|Overall Study|Withdrawal by Subject|8|||
30688765|NCT00772109|58702358|FG001|Overall Study|Withdrawal by Subject|8|||
30857616|NCT02556632|58885726|FG002|Overall Study|Lost to Follow-up|0|||
30857617|NCT02556632|58885724|FG000|Overall Study|Disliked Intervention|1|||
30857618|NCT02556632|58885725|FG001|Overall Study|Disliked Intervention|1|||
30857619|NCT02556632|58885726|FG002|Overall Study|Disliked Intervention|1|||
30688766|NCT00772109|58702359|FG002|Overall Study|Withdrawal by Subject|6|||
30688767|NCT00772109|58702360|FG003|Overall Study|Withdrawal by Subject|16|||
30857620|NCT02556632|58885724|FG000|Overall Study|No Reason|1|||
30857621|NCT02556632|58885725|FG001|Overall Study|No Reason|0|||
30857622|NCT02556632|58885726|FG002|Overall Study|No Reason|1|||
30857623|NCT02556632|58885724|FG000|Overall Study|Personal Issues|0|||
30857624|NCT02556632|58885725|FG001|Overall Study|Personal Issues|1|||
30857625|NCT02556632|58885726|FG002|Overall Study|Personal Issues|1|||
30857626|NCT02556632|58885724|FG000|Overall Study|Changed Mind|0|||
30857627|NCT02556632|58885725|FG001|Overall Study|Changed Mind|1|||
30959349|NCT01683071|59024750|FG004|Part 2|Protocol deviation|1|||
30688768|NCT00772031|58702372|FG000|Overall Study|Early termination of trial|12|||
30857628|NCT02556632|58885726|FG002|Overall Study|Changed Mind|0|||
30857629|NCT02556632|58885724|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
30857630|NCT02556632|58885725|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
30857631|NCT02556632|58885726|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
30857632|NCT02556632|58885724|FG000|Overall Study|Unrelated Adverse Event|1|||
30857633|NCT02556632|58885725|FG001|Overall Study|Unrelated Adverse Event|0|||
30857634|NCT02556632|58885726|FG002|Overall Study|Unrelated Adverse Event|3|||
30688769|NCT00772031|58702373|FG001|Overall Study|Early termination of trial|10|||
30688770|NCT00772031|58702372|FG000|Overall Study|Lost to Follow-up|20|||
30688771|NCT00772031|58702373|FG001|Overall Study|Lost to Follow-up|33|||
30688772|NCT00580866|58702387|FG000|Overall Study|Lost to Follow-up|2|||
30688773|NCT00580866|58702388|FG001|Overall Study|Lost to Follow-up|2|||
30688774|NCT00771953|58702396|FG000|Overall Study|Adverse Event|5|||
30688775|NCT00771953|58702397|FG001|Overall Study|Adverse Event|3|||
30688776|NCT00771953|58702396|FG000|Overall Study|Death|2|||
30857635|NCT02556632|58885724|FG000|Overall Study|Related Adverse Event|0|||
30857636|NCT02556632|58885725|FG001|Overall Study|Related Adverse Event|1|||
30857637|NCT02556632|58885726|FG002|Overall Study|Related Adverse Event|0|||
30857638|NCT02556632|58885724|FG000|Overall Study|Possibly Related Adverse Event|0|||
30857639|NCT02556632|58885725|FG001|Overall Study|Possibly Related Adverse Event|0|||
30857640|NCT02556632|58885726|FG002|Overall Study|Possibly Related Adverse Event|1|||
30857641|NCT02556632|58885724|FG000|Overall Study|Did Not Start RT|0|||
30857642|NCT02556632|58885725|FG001|Overall Study|Did Not Start RT|1|||
30857643|NCT02556632|58885726|FG002|Overall Study|Did Not Start RT|0|||
30857644|NCT02556632|58885724|FG000|Overall Study|Ineligible|0|||
30857645|NCT02556632|58885725|FG001|Overall Study|Ineligible|1|||
30857646|NCT02556632|58885726|FG002|Overall Study|Ineligible|0|||
30857647|NCT02556632|58885724|FG000|Overall Study|Disliked Study Procedures|0|||
30857648|NCT02556632|58885725|FG001|Overall Study|Disliked Study Procedures|0|||
30857649|NCT02556632|58885726|FG002|Overall Study|Disliked Study Procedures|1|||
30857650|NCT02556632|58885724|FG000|Overall Study|Treatment or Change Delay|0|||
30857651|NCT02556632|58885725|FG001|Overall Study|Treatment or Change Delay|0|||
30857652|NCT02556632|58885726|FG002|Overall Study|Treatment or Change Delay|1|||
30857653|NCT01662440|58885738|FG000|Overall Study|Adverse Event|1|||
30857654|NCT01662440|58885739|FG001|Overall Study|Adverse Event|0|||
30857655|NCT01662440|58885740|FG002|Overall Study|Adverse Event|0|||
30857656|NCT01662440|58885741|FG003|Overall Study|Adverse Event|1|||
30857657|NCT01662440|58885738|FG000|Overall Study|Death|0|||
30857658|NCT01662440|58885739|FG001|Overall Study|Death|1|||
30857659|NCT01662440|58885740|FG002|Overall Study|Death|0|||
30857660|NCT01662440|58885741|FG003|Overall Study|Death|0|||
30857661|NCT01662440|58885738|FG000|Overall Study|Lost to Follow-up|2|||
30857662|NCT01662440|58885739|FG001|Overall Study|Lost to Follow-up|2|||
30857663|NCT01662440|58885740|FG002|Overall Study|Lost to Follow-up|4|||
30857664|NCT01662440|58885741|FG003|Overall Study|Lost to Follow-up|1|||
30857665|NCT01662440|58885738|FG000|Overall Study|Subject moved to another country.|0|||
30857666|NCT01662440|58885739|FG001|Overall Study|Subject moved to another country.|1|||
30857667|NCT01662440|58885740|FG002|Overall Study|Subject moved to another country.|0|||
30857668|NCT01662440|58885741|FG003|Overall Study|Subject moved to another country.|0|||
30857669|NCT01662440|58885738|FG000|Overall Study|Protocol Violation|1|||
30857670|NCT01662440|58885739|FG001|Overall Study|Protocol Violation|0|||
30857671|NCT01662440|58885740|FG002|Overall Study|Protocol Violation|0|||
30857672|NCT01662440|58885741|FG003|Overall Study|Protocol Violation|0|||
30857673|NCT01662440|58885738|FG000|Overall Study|Withdrawal by Subject|5|||
30857674|NCT01662440|58885739|FG001|Overall Study|Withdrawal by Subject|2|||
30857675|NCT01662440|58885740|FG002|Overall Study|Withdrawal by Subject|2|||
30857676|NCT01662440|58885741|FG003|Overall Study|Withdrawal by Subject|2|||
30857677|NCT01662362|58885761|FG000|Overall Study|Lost to Follow-up|38|||
30857678|NCT02554682|58885776|FG000|Overall Study|Lost to Follow-up|11|||
30857679|NCT02554682|58885777|FG001|Overall Study|Lost to Follow-up|9|||
30857680|NCT02554682|58885778|FG002|Overall Study|Lost to Follow-up|4|||
30857681|NCT02554682|58885779|FG003|Overall Study|Lost to Follow-up|3|||
30857682|NCT02554682|58885780|FG004|Overall Study|Lost to Follow-up|2|||
30857683|NCT02554682|58885781|FG005|Overall Study|Lost to Follow-up|1|||
30959350|NCT01683071|59024751|FG005|Part 2|Protocol deviation|2|||
30857684|NCT02554682|58885782|FG006|Overall Study|Lost to Follow-up|6|||
30857685|NCT02554682|58885783|FG007|Overall Study|Lost to Follow-up|6|||
30688777|NCT00771953|58702397|FG001|Overall Study|Death|2|||
30857686|NCT02554682|58885784|FG008|Overall Study|Lost to Follow-up|2|||
30857687|NCT02554682|58885785|FG009|Overall Study|Lost to Follow-up|2|||
30857688|NCT02554682|58885776|FG000|Overall Study|Withdrawal by Subject|2|||
30857689|NCT02554682|58885777|FG001|Overall Study|Withdrawal by Subject|1|||
30857690|NCT02554682|58885778|FG002|Overall Study|Withdrawal by Subject|0|||
30857691|NCT02554682|58885779|FG003|Overall Study|Withdrawal by Subject|0|||
30857692|NCT02554682|58885780|FG004|Overall Study|Withdrawal by Subject|0|||
30857693|NCT02554682|58885781|FG005|Overall Study|Withdrawal by Subject|0|||
30857694|NCT02554682|58885782|FG006|Overall Study|Withdrawal by Subject|0|||
30857695|NCT02554682|58885783|FG007|Overall Study|Withdrawal by Subject|0|||
30857696|NCT02554682|58885784|FG008|Overall Study|Withdrawal by Subject|0|||
30857697|NCT02554682|58885785|FG009|Overall Study|Withdrawal by Subject|0|||
30857698|NCT02554682|58885776|FG000|Overall Study|Physician Decision|2|||
30857699|NCT02554682|58885777|FG001|Overall Study|Physician Decision|2|||
30857700|NCT02554682|58885778|FG002|Overall Study|Physician Decision|0|||
30857701|NCT02554682|58885779|FG003|Overall Study|Physician Decision|0|||
30857702|NCT02554682|58885780|FG004|Overall Study|Physician Decision|0|||
30857703|NCT02554682|58885781|FG005|Overall Study|Physician Decision|0|||
30857704|NCT02554682|58885782|FG006|Overall Study|Physician Decision|0|||
30857705|NCT02554682|58885783|FG007|Overall Study|Physician Decision|0|||
30857706|NCT02554682|58885784|FG008|Overall Study|Physician Decision|0|||
30857707|NCT02554682|58885785|FG009|Overall Study|Physician Decision|0|||
30857708|NCT00154063|58885821|FG000|Overall Study|Adverse Event|4|||
30688778|NCT00771953|58702396|FG000|Overall Study|Progression before active Tx|1|||
30688779|NCT00771953|58702397|FG001|Overall Study|Progression before active Tx|2|||
30688780|NCT00771953|58702396|FG000|Overall Study|Sponsor decision|1|||
30688781|NCT00771953|58702397|FG001|Overall Study|Sponsor decision|0|||
30688782|NCT00771953|58702396|FG000|Overall Study|Other complicating disease|1|||
30688783|NCT00771953|58702397|FG001|Overall Study|Other complicating disease|0|||
30688784|NCT00771953|58702396|FG000|Overall Study|Withdrawal by Subject|0|||
30688785|NCT00771953|58702397|FG001|Overall Study|Withdrawal by Subject|3|||
30688786|NCT00621244|58702409|FG000|Overall Study|Withdrawal by Subject|7|||
30857709|NCT00154063|58885822|FG001|Overall Study|Adverse Event|8|||
30857710|NCT00154063|58885821|FG000|Overall Study|Protocol Violation|1|||
30857711|NCT00154063|58885822|FG001|Overall Study|Protocol Violation|1|||
30857712|NCT00154063|58885821|FG000|Overall Study|Investigator or Sponsor Request|0|||
30857713|NCT00154063|58885822|FG001|Overall Study|Investigator or Sponsor Request|1|||
30857714|NCT00154063|58885821|FG000|Overall Study|Withdrawal by Subject|4|||
30959351|NCT01683071|59024746|FG000|Part 2|Withdrawal by investigator decision|0|||
30599387|NCT01057693|58611233|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
30599388|NCT01057693|58611234|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
30599389|NCT01057693|58611232|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
30599390|NCT01057693|58611233|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
30599391|NCT01057693|58611234|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
30599392|NCT01057693|58611232|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
30599393|NCT01057693|58611233|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
30599394|NCT01057693|58611234|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
30599395|NCT01057693|58611232|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
30599396|NCT01057693|58611233|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
30599397|NCT01057693|58611234|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
30688787|NCT00621244|58702410|FG001|Overall Study|Withdrawal by Subject|3|||
30688788|NCT00621244|58702411|FG002|Overall Study|Withdrawal by Subject|3|||
30599398|NCT01057693|58611232|FG000|Between Single-Blind and Double-Blind|Other|6|||
30599399|NCT01057693|58611233|FG001|Between Single-Blind and Double-Blind|Other|0|||
30599400|NCT01057693|58611234|FG002|Between Single-Blind and Double-Blind|Other|0|||
30599401|NCT01057693|58611232|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
30599402|NCT01057693|58611233|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
30599403|NCT01057693|58611234|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
30599404|NCT01057693|58611232|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
30599405|NCT01057693|58611233|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
30599406|NCT01057693|58611234|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
30599407|NCT01057693|58611232|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
30599408|NCT01057693|58611233|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
30599409|NCT01057693|58611234|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
30599410|NCT01057693|58611232|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
30599411|NCT01057693|58611233|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
30599412|NCT01057693|58611234|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
30688789|NCT00621244|58702412|FG003|Overall Study|Withdrawal by Subject|3|||
30688790|NCT00621244|58702409|FG000|Overall Study|Disease progression|44|||
30857715|NCT00154063|58885822|FG001|Overall Study|Withdrawal by Subject|9|||
30857716|NCT00154063|58885821|FG000|Overall Study|Other|3|||
30857717|NCT00154063|58885822|FG001|Overall Study|Other|3|||
30857718|NCT02683941|58885834|FG000|Double-blind Phase|Adverse Event|0|||
30857719|NCT02683941|58885835|FG001|Double-blind Phase|Adverse Event|1|||
30857720|NCT02683941|58885834|FG000|Double-blind Phase|Withdrawal by Subject|4|||
30857721|NCT02683941|58885835|FG001|Double-blind Phase|Withdrawal by Subject|2|||
30857722|NCT02683941|58885834|FG000|Double-blind Phase|Lost to Follow-up|1|||
30857723|NCT02683941|58885835|FG001|Double-blind Phase|Lost to Follow-up|0|||
30857724|NCT02683941|58885834|FG000|Double-blind Phase|Disease Progression|5|||
30857725|NCT02683941|58885835|FG001|Double-blind Phase|Disease Progression|2|||
30959352|NCT01683071|59024747|FG001|Part 2|Withdrawal by investigator decision|0|||
30959353|NCT01683071|59024748|FG002|Part 2|Withdrawal by investigator decision|0|||
30688791|NCT00621244|58702410|FG001|Overall Study|Disease progression|20|||
30857726|NCT02683941|58885834|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
30857727|NCT02683941|58885835|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
30857728|NCT02683941|58885834|FG000|Open-label Treatment Phase|Disease Progression|1|||
30857729|NCT02683941|58885835|FG001|Open-label Treatment Phase|Disease Progression|2|||
30857730|NCT02683941|58885834|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
30857731|NCT02683941|58885835|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
30857732|NCT02683941|58885834|FG000|Open-label Treatment Phase|Other|1|||
30857733|NCT02683941|58885835|FG001|Open-label Treatment Phase|Other|0|||
30857734|NCT02683941|58885834|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
30857735|NCT02683941|58885835|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
30857736|NCT02683941|58885834|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
30857737|NCT02683941|58885835|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
30857738|NCT02683941|58885834|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
30857739|NCT02683941|58885835|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
30857740|NCT02683941|58885834|FG000|Open-label Follow-up Phase|Other|8|||
30857741|NCT02683941|58885835|FG001|Open-label Follow-up Phase|Other|1|||
30857742|NCT02678247|58885847|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
30857743|NCT02678247|58885848|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
30857744|NCT02678247|58885847|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
30857745|NCT02678247|58885848|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
30857746|NCT02678247|58885847|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
30857747|NCT02678247|58885848|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
30857748|NCT02678247|58885847|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
30857749|NCT02678247|58885848|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
30857750|NCT02678247|58885847|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
30857751|NCT02678247|58885848|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
30857752|NCT02678247|58885847|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
30857753|NCT02678247|58885848|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
30857754|NCT02683785|58885861|FG000|Overall Study|Withdrawal by Subject|1|||
30857755|NCT02683785|58885862|FG001|Overall Study|Withdrawal by Subject|1|||
30857756|NCT02683785|58885861|FG000|Overall Study|Lost to Follow-up|0|||
30857757|NCT02683785|58885862|FG001|Overall Study|Lost to Follow-up|1|||
30857758|NCT02683785|58885861|FG000|Overall Study|Adverse Event|0|||
30857759|NCT02683785|58885862|FG001|Overall Study|Adverse Event|2|||
30857760|NCT02543294|58885870|FG000|Overall Study|Lost to Follow-up|3|||
30857761|NCT02543294|58885870|FG000|Overall Study|Physician Decision|2|||
30857762|NCT02543294|58885870|FG000|Overall Study|Withdrawal by Subject|7|||
30857763|NCT02728076|58885875|FG000|Overall Study|Physician Decision|4|||
30857764|NCT02551874|58885881|FG000|Overall Study|Lost to Follow-up|0|||
30857765|NCT02551874|58885882|FG001|Overall Study|Lost to Follow-up|2|||
30857766|NCT02551874|58885881|FG000|Overall Study|Pregnancy|0|||
30857767|NCT02551874|58885882|FG001|Overall Study|Pregnancy|1|||
30857768|NCT02551874|58885881|FG000|Overall Study|Reason not reported|10|||
30857769|NCT02551874|58885882|FG001|Overall Study|Reason not reported|4|||
30857770|NCT02551874|58885881|FG000|Overall Study|Did not receive randomized treatment|0|||
30857771|NCT02551874|58885882|FG001|Overall Study|Did not receive randomized treatment|7|||
30857772|NCT02551874|58885881|FG000|Overall Study|Did not enter long-term study|18|||
30857773|NCT02551874|58885882|FG001|Overall Study|Did not enter long-term study|25|||
30857774|NCT02682927|58885907|FG000|Overall Study|Adverse Event|0|||
30857775|NCT02682927|58885908|FG001|Overall Study|Adverse Event|0|||
30857776|NCT02682927|58885909|FG002|Overall Study|Adverse Event|5|||
30857777|NCT02682927|58885910|FG003|Overall Study|Adverse Event|1|||
30959354|NCT01683071|59024749|FG003|Part 2|Withdrawal by investigator decision|0|||
30959355|NCT01683071|59024750|FG004|Part 2|Withdrawal by investigator decision|1|||
30599413|NCT01057693|58611232|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
30599414|NCT01057693|58611233|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
30599415|NCT01057693|58611234|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
30599416|NCT01057693|58611232|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
30599417|NCT01057693|58611233|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
30599418|NCT01057693|58611234|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
30599419|NCT01057693|58611232|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
30599420|NCT01057693|58611233|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
30599421|NCT01057693|58611234|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
30599422|NCT01307501|58611242|FG000|Overall Study|Treatment Failure|1|||
30688792|NCT00621244|58702411|FG002|Overall Study|Disease progression|20|||
30857778|NCT02682927|58885911|FG004|Overall Study|Adverse Event|0|||
30857779|NCT02682927|58885912|FG005|Overall Study|Adverse Event|2|||
30857780|NCT02682927|58885907|FG000|Overall Study|Death|0|||
30857781|NCT02682927|58885908|FG001|Overall Study|Death|0|||
30857782|NCT02682927|58885909|FG002|Overall Study|Death|0|||
30959356|NCT01683071|59024751|FG005|Part 2|Withdrawal by investigator decision|2|||
30599423|NCT01307501|58611242|FG000|Overall Study|Death|20|||
30599424|NCT01307501|58611242|FG000|Overall Study|Lost to Follow-up|1|||
30688793|NCT00621244|58702412|FG003|Overall Study|Disease progression|15|||
30688794|NCT00621244|58702409|FG000|Overall Study|Death|3|||
30688795|NCT00621244|58702410|FG001|Overall Study|Death|3|||
30688796|NCT00621244|58702411|FG002|Overall Study|Death|1|||
30688797|NCT00621244|58702412|FG003|Overall Study|Death|1|||
30688798|NCT00621244|58702409|FG000|Overall Study|Adverse Event|27|||
30688799|NCT00621244|58702410|FG001|Overall Study|Adverse Event|7|||
30688800|NCT00621244|58702411|FG002|Overall Study|Adverse Event|9|||
30688801|NCT00621244|58702412|FG003|Overall Study|Adverse Event|2|||
30688802|NCT00621244|58702409|FG000|Overall Study|Administrative problems|5|||
30688803|NCT00621244|58702410|FG001|Overall Study|Administrative problems|1|||
30688804|NCT00621244|58702411|FG002|Overall Study|Administrative problems|0|||
30688805|NCT00621244|58702412|FG003|Overall Study|Administrative problems|2|||
30688806|NCT00659529|58702486|FG000|Overall Study|Withdrawal by Subject|4|||
30688807|NCT00659529|58702486|FG000|Overall Study|Protocol Violation|3|||
30688808|NCT00659529|58702486|FG000|Overall Study|Screen failure|9|||
30688809|NCT00578942|58702490|FG000|Overall Study|Lost to Follow-up|1|||
30688810|NCT00765245|58702496|FG000|Overall Study|disease progression|3|||
30688811|NCT00765245|58702497|FG001|Overall Study|disease progression|2|||
30688812|NCT00765245|58702496|FG000|Overall Study|Withdrawal by Subject|3|||
30688813|NCT00765245|58702497|FG001|Overall Study|Withdrawal by Subject|0|||
30688814|NCT00765245|58702496|FG000|Overall Study|Adverse Event|5|||
30688815|NCT00765245|58702497|FG001|Overall Study|Adverse Event|0|||
30688816|NCT00765245|58702496|FG000|Overall Study|Physician Decision|1|||
30688817|NCT00765245|58702497|FG001|Overall Study|Physician Decision|0|||
30688818|NCT00765245|58702496|FG000|Overall Study|Death|1|||
30688819|NCT00765245|58702497|FG001|Overall Study|Death|0|||
30857783|NCT02682927|58885910|FG003|Overall Study|Death|1|||
30857784|NCT02682927|58885911|FG004|Overall Study|Death|0|||
30857785|NCT02682927|58885912|FG005|Overall Study|Death|0|||
30857786|NCT02682927|58885907|FG000|Overall Study|Lack of Efficacy|1|||
30857787|NCT02682927|58885908|FG001|Overall Study|Lack of Efficacy|0|||
30857788|NCT02682927|58885909|FG002|Overall Study|Lack of Efficacy|0|||
30857789|NCT02682927|58885910|FG003|Overall Study|Lack of Efficacy|1|||
30857790|NCT02682927|58885911|FG004|Overall Study|Lack of Efficacy|0|||
30857791|NCT02682927|58885912|FG005|Overall Study|Lack of Efficacy|0|||
30857792|NCT02682927|58885907|FG000|Overall Study|Other|0|||
30857793|NCT02682927|58885908|FG001|Overall Study|Other|0|||
30857794|NCT02682927|58885909|FG002|Overall Study|Other|0|||
30857795|NCT02682927|58885910|FG003|Overall Study|Other|2|||
30857796|NCT02682927|58885911|FG004|Overall Study|Other|0|||
30857797|NCT02682927|58885912|FG005|Overall Study|Other|0|||
30857798|NCT02682927|58885907|FG000|Overall Study|Withdrawal by Subject|2|||
30857799|NCT02682927|58885908|FG001|Overall Study|Withdrawal by Subject|0|||
30857800|NCT02682927|58885909|FG002|Overall Study|Withdrawal by Subject|1|||
30857801|NCT02682927|58885910|FG003|Overall Study|Withdrawal by Subject|0|||
30857802|NCT02682927|58885911|FG004|Overall Study|Withdrawal by Subject|1|||
30857803|NCT02682927|58885912|FG005|Overall Study|Withdrawal by Subject|1|||
30857804|NCT02550938|58885936|FG000|Overall Study|Lost to Follow-up|8|||
30857805|NCT02550938|58885937|FG001|Overall Study|Lost to Follow-up|7|||
30857806|NCT02550938|58885938|FG002|Overall Study|Lost to Follow-up|12|||
30857807|NCT02550938|58885939|FG003|Overall Study|Lost to Follow-up|11|||
30857808|NCT02769065|58885979|FG000|Overall Study|Voluntary Withdrawal|1|||
30857809|NCT02769065|58885980|FG001|Overall Study|Voluntary Withdrawal|0|||
30857810|NCT02769065|58885981|FG002|Overall Study|Voluntary Withdrawal|0|||
30857811|NCT02769065|58885982|FG003|Overall Study|Voluntary Withdrawal|0|||
30857812|NCT02769065|58885983|FG004|Overall Study|Voluntary Withdrawal|0|||
30857813|NCT02769065|58885984|FG005|Overall Study|Voluntary Withdrawal|0|||
30857814|NCT02769065|58885985|FG006|Overall Study|Voluntary Withdrawal|0|||
30857815|NCT02769065|58885986|FG007|Overall Study|Voluntary Withdrawal|0|||
30857816|NCT02769065|58885987|FG008|Overall Study|Voluntary Withdrawal|0|||
30857817|NCT02769065|58885988|FG009|Overall Study|Voluntary Withdrawal|0|||
30857818|NCT02769065|58885989|FG010|Overall Study|Voluntary Withdrawal|0|||
30857819|NCT02769065|58885990|FG011|Overall Study|Voluntary Withdrawal|0|||
30857820|NCT02769065|58885991|FG012|Overall Study|Voluntary Withdrawal|0|||
30857821|NCT02769065|58885992|FG013|Overall Study|Voluntary Withdrawal|0|||
30857822|NCT02769065|58885993|FG014|Overall Study|Voluntary Withdrawal|0|||
30857823|NCT02769065|58885994|FG015|Overall Study|Voluntary Withdrawal|0|||
30857824|NCT02769065|58885995|FG016|Overall Study|Voluntary Withdrawal|0|||
30857825|NCT02769065|58885996|FG017|Overall Study|Voluntary Withdrawal|0|||
30857826|NCT02769065|58885997|FG018|Overall Study|Voluntary Withdrawal|0|||
30857827|NCT02769065|58885998|FG019|Overall Study|Voluntary Withdrawal|0|||
30857828|NCT02769065|58885999|FG020|Overall Study|Voluntary Withdrawal|0|||
30857829|NCT02769065|58886000|FG021|Overall Study|Voluntary Withdrawal|0|||
30857830|NCT02769065|58886001|FG022|Overall Study|Voluntary Withdrawal|0|||
30688820|NCT00782795|58702505|FG000|Overall Study|Withdrawal by Subject|1|||
30857831|NCT02769065|58886002|FG023|Overall Study|Voluntary Withdrawal|0|||
30857832|NCT02769065|58886003|FG024|Overall Study|Voluntary Withdrawal|0|||
30857833|NCT02769065|58886004|FG025|Overall Study|Voluntary Withdrawal|0|||
30688821|NCT00782795|58702506|FG001|Overall Study|Withdrawal by Subject|2|||
30688822|NCT00656799|58702512|FG000|Overall Study|Death|2|||
30688823|NCT00764699|58702516|FG000|Overall Study|PI left and study terminated|3|||
30688824|NCT00782717|58702522|FG000|Overall Study|Adverse Event|2|||
30688825|NCT00782717|58702523|FG001|Overall Study|Adverse Event|5|||
30857834|NCT02769065|58886005|FG026|Overall Study|Voluntary Withdrawal|0|||
30857835|NCT02769065|58886006|FG027|Overall Study|Voluntary Withdrawal|0|||
30857836|NCT02769065|58886007|FG028|Overall Study|Voluntary Withdrawal|0|||
30857837|NCT02769065|58886008|FG029|Overall Study|Voluntary Withdrawal|0|||
30857838|NCT02769065|58885979|FG000|Overall Study|Reason Not Specified|0|||
30857839|NCT02769065|58885980|FG001|Overall Study|Reason Not Specified|0|||
30857840|NCT02769065|58885981|FG002|Overall Study|Reason Not Specified|0|||
30857841|NCT02769065|58885982|FG003|Overall Study|Reason Not Specified|0|||
30857842|NCT02769065|58885983|FG004|Overall Study|Reason Not Specified|0|||
30857843|NCT02769065|58885984|FG005|Overall Study|Reason Not Specified|0|||
30857844|NCT02769065|58885985|FG006|Overall Study|Reason Not Specified|1|||
30857845|NCT02769065|58885986|FG007|Overall Study|Reason Not Specified|0|||
30857846|NCT02769065|58885987|FG008|Overall Study|Reason Not Specified|0|||
30857847|NCT02769065|58885988|FG009|Overall Study|Reason Not Specified|0|||
30857848|NCT02769065|58885989|FG010|Overall Study|Reason Not Specified|0|||
30857849|NCT02769065|58885990|FG011|Overall Study|Reason Not Specified|0|||
30857850|NCT02769065|58885991|FG012|Overall Study|Reason Not Specified|0|||
30857851|NCT02769065|58885992|FG013|Overall Study|Reason Not Specified|0|||
30857852|NCT02769065|58885993|FG014|Overall Study|Reason Not Specified|0|||
30857853|NCT02769065|58885994|FG015|Overall Study|Reason Not Specified|0|||
30857854|NCT02769065|58885995|FG016|Overall Study|Reason Not Specified|0|||
30857855|NCT02769065|58885996|FG017|Overall Study|Reason Not Specified|0|||
30857856|NCT02769065|58885997|FG018|Overall Study|Reason Not Specified|0|||
30857857|NCT02769065|58885998|FG019|Overall Study|Reason Not Specified|0|||
30857858|NCT02769065|58885999|FG020|Overall Study|Reason Not Specified|0|||
30857859|NCT02769065|58886000|FG021|Overall Study|Reason Not Specified|0|||
30857860|NCT02769065|58886001|FG022|Overall Study|Reason Not Specified|0|||
30857861|NCT02769065|58886002|FG023|Overall Study|Reason Not Specified|0|||
30857862|NCT02769065|58886003|FG024|Overall Study|Reason Not Specified|0|||
30857863|NCT02769065|58886004|FG025|Overall Study|Reason Not Specified|0|||
30857864|NCT02769065|58886005|FG026|Overall Study|Reason Not Specified|0|||
30857865|NCT02769065|58886006|FG027|Overall Study|Reason Not Specified|0|||
30857866|NCT02769065|58886007|FG028|Overall Study|Reason Not Specified|0|||
30857867|NCT02769065|58886008|FG029|Overall Study|Reason Not Specified|0|||
30857868|NCT02769065|58885979|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857869|NCT02769065|58885980|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857870|NCT02769065|58885981|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
30959357|NCT01567865|59024775|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
30959358|NCT01567865|59024776|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
30688826|NCT00782717|58702522|FG000|Overall Study|Patient decision unrelated to AE|6|||
30688827|NCT00782717|58702523|FG001|Overall Study|Patient decision unrelated to AE|3|||
30688828|NCT00782717|58702522|FG000|Overall Study|Noncompliance|2|||
30688829|NCT00782717|58702523|FG001|Overall Study|Noncompliance|1|||
30688830|NCT00782717|58702522|FG000|Overall Study|Treatment failure|3|||
30688831|NCT00782717|58702523|FG001|Overall Study|Treatment failure|14|||
30688832|NCT00782717|58702522|FG000|Overall Study|Enrollment close prior to surgery|1|||
30688833|NCT00782717|58702523|FG001|Overall Study|Enrollment close prior to surgery|0|||
30688834|NCT00782717|58702522|FG000|Overall Study|Did not meet entrance criteria|1|||
30688835|NCT00782717|58702523|FG001|Overall Study|Did not meet entrance criteria|3|||
30688836|NCT00782717|58702522|FG000|Overall Study|Exited in error|0|||
30857871|NCT02769065|58885982|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857872|NCT02769065|58885983|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857873|NCT02769065|58885984|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857874|NCT02769065|58885985|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857875|NCT02769065|58885986|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857876|NCT02769065|58885987|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857877|NCT02769065|58885988|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857878|NCT02769065|58885989|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
30857879|NCT02769065|58885990|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857880|NCT02769065|58885991|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857881|NCT02769065|58885992|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857882|NCT02769065|58885993|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857883|NCT02769065|58885994|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857884|NCT02769065|58885995|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857885|NCT02769065|58885996|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857886|NCT02769065|58885997|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857887|NCT02769065|58885998|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857888|NCT02769065|58885999|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857889|NCT02769065|58886000|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857890|NCT02769065|58886001|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857891|NCT02769065|58886002|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857892|NCT02769065|58886003|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857893|NCT02769065|58886004|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857894|NCT02769065|58886005|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857895|NCT02769065|58886006|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857896|NCT02769065|58886007|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857897|NCT02769065|58886008|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
30857898|NCT02681523|58886101|FG000|Overall Study|Adverse Event|1|||
30857899|NCT02681523|58886101|FG000|Overall Study|Patient Non-compliance|1|||
30857900|NCT02540954|58886107|FG000|Overall Study|Physician Decision|3|||
30857901|NCT02540954|58886108|FG001|Overall Study|Physician Decision|1|||
30857902|NCT02540954|58886107|FG000|Overall Study|Withdrawal by Subject|6|||
30857903|NCT02540954|58886108|FG001|Overall Study|Withdrawal by Subject|5|||
30857904|NCT02540954|58886107|FG000|Overall Study|Lost to Follow-up|1|||
30857905|NCT02540954|58886108|FG001|Overall Study|Lost to Follow-up|1|||
30857906|NCT02540954|58886107|FG000|Overall Study|Adverse Event|4|||
30857907|NCT02540954|58886108|FG001|Overall Study|Adverse Event|2|||
30857908|NCT02540954|58886107|FG000|Overall Study|Death|0|||
30857909|NCT02540954|58886108|FG001|Overall Study|Death|3|||
30857910|NCT02540954|58886107|FG000|Overall Study|Treatment failure|1|||
30857911|NCT02540954|58886108|FG001|Overall Study|Treatment failure|0|||
30857912|NCT02540954|58886107|FG000|Overall Study|Other reason|4|||
30857913|NCT02540954|58886108|FG001|Overall Study|Other reason|2|||
30857914|NCT02658812|58886114|FG000|Overall Study|Disease Progression|7|||
30857915|NCT02658812|58886114|FG000|Overall Study|Unrelated to study treatment|1|||
30857916|NCT02658812|58886114|FG000|Overall Study|Adverse Event|1|||
30857917|NCT02680665|58886118|FG000|Overall Study|No visit after the first prescription|5|||
30857918|NCT00154375|58886124|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
30857919|NCT00154375|58886125|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
30857920|NCT00154375|58886124|FG000|Overall Study|Adverse Event|18|||
30857921|NCT00154375|58886125|FG001|Overall Study|Adverse Event|20|||
30857922|NCT00154375|58886124|FG000|Overall Study|Withdrawal by Subject|14|||
30857923|NCT00154375|58886125|FG001|Overall Study|Withdrawal by Subject|10|||
30857924|NCT00154375|58886124|FG000|Overall Study|Death|5|||
30857925|NCT00154375|58886125|FG001|Overall Study|Death|13|||
30857926|NCT00154375|58886124|FG000|Overall Study|Study drug no longer required|5|||
30857927|NCT00154375|58886125|FG001|Overall Study|Study drug no longer required|3|||
30857928|NCT00154375|58886124|FG000|Overall Study|Lost to Follow-up|2|||
30857929|NCT00154375|58886125|FG001|Overall Study|Lost to Follow-up|1|||
30857930|NCT00154375|58886124|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30857931|NCT00154375|58886125|FG001|Overall Study|Abnormal laboratory value(s)|2|||
30857932|NCT00154375|58886124|FG000|Overall Study|Protocol Violation|0|||
30857933|NCT00154375|58886125|FG001|Overall Study|Protocol Violation|1|||
30857934|NCT00154375|58886124|FG000|Overall Study|Suspected progression of disease|44|||
30857935|NCT00154375|58886125|FG001|Overall Study|Suspected progression of disease|30|||
30857936|NCT02765399|58886134|FG000|Overall Study|Nausea|1|||
30857937|NCT02765399|58886135|FG001|Overall Study|Nausea|0|||
30857938|NCT02676765|58886143|FG000|Overall Study|Lost to Follow-up|0|||
30857939|NCT02676765|58886144|FG001|Overall Study|Lost to Follow-up|1|||
30857940|NCT02680041|58886150|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
30857941|NCT02680041|58886150|FG000|Overall Study|Lost to Follow-up|2|||
30857942|NCT02547974|58886159|FG000|Overall Study|Withdrawal by Subject|1|||
30857943|NCT02547974|58886160|FG001|Overall Study|Withdrawal by Subject|0|||
30857944|NCT02547974|58886161|FG002|Overall Study|Withdrawal by Subject|0|||
30857945|NCT02547974|58886162|FG003|Overall Study|Withdrawal by Subject|0|||
30857946|NCT00154297|58886177|FG000|Overall Study|Death|5|||
30857947|NCT00154297|58886178|FG001|Overall Study|Death|2|||
30857948|NCT00154297|58886177|FG000|Overall Study|Withdrawal by Subject|0|||
30857949|NCT00154297|58886178|FG001|Overall Study|Withdrawal by Subject|5|||
30857950|NCT00154297|58886177|FG000|Overall Study|Lost to Follow-up|3|||
30857951|NCT00154297|58886178|FG001|Overall Study|Lost to Follow-up|0|||
30857952|NCT02679729|58886193|FG000|Overall Study|Lost to Follow-up|0|||
30857953|NCT02679729|58886194|FG001|Overall Study|Lost to Follow-up|1|||
30857954|NCT02679729|58886195|FG002|Overall Study|Lost to Follow-up|0|||
30857955|NCT02679729|58886196|FG003|Overall Study|Lost to Follow-up|0|||
30857956|NCT02679729|58886197|FG004|Overall Study|Lost to Follow-up|1|||
30857957|NCT02679729|58886198|FG005|Overall Study|Lost to Follow-up|0|||
30857958|NCT02679729|58886199|FG006|Overall Study|Lost to Follow-up|0|||
30857959|NCT02679729|58886200|FG007|Overall Study|Lost to Follow-up|0|||
30857960|NCT02679729|58886201|FG008|Overall Study|Lost to Follow-up|0|||
30857961|NCT02679729|58886193|FG000|Overall Study|Participant decision|0|||
30857962|NCT02679729|58886194|FG001|Overall Study|Participant decision|1|||
30857963|NCT02679729|58886195|FG002|Overall Study|Participant decision|0|||
30857964|NCT02679729|58886196|FG003|Overall Study|Participant decision|0|||
30857965|NCT02679729|58886197|FG004|Overall Study|Participant decision|0|||
30857966|NCT02679729|58886198|FG005|Overall Study|Participant decision|0|||
30688837|NCT00782717|58702523|FG001|Overall Study|Exited in error|2|||
30688838|NCT00656175|58702531|FG000|Overall Study|Adverse Event|1|||
30688839|NCT00656175|58702532|FG001|Overall Study|Adverse Event|0|||
30688840|NCT00656175|58702531|FG000|Overall Study|Transportation issues|0|||
30688841|NCT00656175|58702532|FG001|Overall Study|Transportation issues|1|||
30688842|NCT00620776|58702540|FG000|Overall Study|Did not receive treatment|3|||
30688843|NCT00620776|58702541|FG001|Overall Study|Did not receive treatment|5|||
30688844|NCT00620776|58702540|FG000|Overall Study|Adverse Event|2|||
30688845|NCT00620776|58702541|FG001|Overall Study|Adverse Event|3|||
30688846|NCT00620776|58702540|FG000|Overall Study|Lack of Efficacy|2|||
30688847|NCT00620776|58702541|FG001|Overall Study|Lack of Efficacy|1|||
30688848|NCT00620776|58702540|FG000|Overall Study|Lost to Follow-up|2|||
30688849|NCT00620776|58702541|FG001|Overall Study|Lost to Follow-up|5|||
30688850|NCT00620776|58702540|FG000|Overall Study|Withdrawal by Subject|3|||
30688851|NCT00620776|58702541|FG001|Overall Study|Withdrawal by Subject|2|||
30688852|NCT00656019|58702551|FG000|Overall Study|Not Eligible|10|||
30688853|NCT00656019|58702552|FG001|Overall Study|Not Eligible|0|||
30688854|NCT00656019|58702553|FG002|Overall Study|Not Eligible|0|||
30688855|NCT00656019|58702554|FG003|Overall Study|Not Eligible|0|||
30688856|NCT00656019|58702551|FG000|Overall Study|Withdrawal by Subject|2|||
30688857|NCT00656019|58702552|FG001|Overall Study|Withdrawal by Subject|0|||
30857967|NCT02679729|58886199|FG006|Overall Study|Participant decision|1|||
30857968|NCT02679729|58886200|FG007|Overall Study|Participant decision|0|||
30857969|NCT02679729|58886201|FG008|Overall Study|Participant decision|0|||
30857970|NCT02765165|58886240|FG000|Treatment Period|Progressive disease|3|||
30857971|NCT02765165|58886241|FG001|Treatment Period|Progressive disease|2|||
30857972|NCT02765165|58886242|FG002|Treatment Period|Progressive disease|3|||
30857973|NCT02765165|58886243|FG003|Treatment Period|Progressive disease|3|||
30857974|NCT02765165|58886244|FG004|Treatment Period|Progressive disease|4|||
30857975|NCT02765165|58886245|FG005|Treatment Period|Progressive disease|2|||
30857976|NCT02765165|58886246|FG006|Treatment Period|Progressive disease|2|||
30857977|NCT02765165|58886240|FG000|Treatment Period|Physician Decision|0|||
30857978|NCT02765165|58886241|FG001|Treatment Period|Physician Decision|1|||
30857979|NCT02765165|58886242|FG002|Treatment Period|Physician Decision|0|||
30857980|NCT02765165|58886243|FG003|Treatment Period|Physician Decision|0|||
30857981|NCT02765165|58886244|FG004|Treatment Period|Physician Decision|0|||
30857982|NCT02765165|58886245|FG005|Treatment Period|Physician Decision|0|||
30857983|NCT02765165|58886246|FG006|Treatment Period|Physician Decision|0|||
30857984|NCT02765165|58886240|FG000|Treatment Period|Adverse Event|0|||
30857985|NCT02765165|58886241|FG001|Treatment Period|Adverse Event|1|||
30857986|NCT02765165|58886242|FG002|Treatment Period|Adverse Event|0|||
30857987|NCT02765165|58886243|FG003|Treatment Period|Adverse Event|0|||
30857988|NCT02765165|58886244|FG004|Treatment Period|Adverse Event|0|||
30857989|NCT02765165|58886245|FG005|Treatment Period|Adverse Event|0|||
30857990|NCT02765165|58886246|FG006|Treatment Period|Adverse Event|0|||
30857991|NCT02765165|58886240|FG000|Treatment Period|Withdrawal by Subject|0|||
30857992|NCT02765165|58886241|FG001|Treatment Period|Withdrawal by Subject|0|||
30857993|NCT02765165|58886242|FG002|Treatment Period|Withdrawal by Subject|0|||
30857994|NCT02765165|58886243|FG003|Treatment Period|Withdrawal by Subject|0|||
30857995|NCT02765165|58886244|FG004|Treatment Period|Withdrawal by Subject|2|||
30857996|NCT02765165|58886245|FG005|Treatment Period|Withdrawal by Subject|0|||
30857997|NCT02765165|58886246|FG006|Treatment Period|Withdrawal by Subject|0|||
30857998|NCT02765165|58886240|FG000|Treatment Period|Study terminated|0|||
30857999|NCT02765165|58886241|FG001|Treatment Period|Study terminated|0|||
30858000|NCT02765165|58886242|FG002|Treatment Period|Study terminated|0|||
30858001|NCT02765165|58886243|FG003|Treatment Period|Study terminated|0|||
30858002|NCT02765165|58886244|FG004|Treatment Period|Study terminated|0|||
30858003|NCT02765165|58886245|FG005|Treatment Period|Study terminated|1|||
30858004|NCT02765165|58886246|FG006|Treatment Period|Study terminated|2|||
30858005|NCT02765165|58886240|FG000|Post-treatment Follow-up|Death|1|||
30858006|NCT02765165|58886241|FG001|Post-treatment Follow-up|Death|2|||
30688858|NCT00656019|58702553|FG002|Overall Study|Withdrawal by Subject|0|||
30688859|NCT00656019|58702554|FG003|Overall Study|Withdrawal by Subject|0|||
30688860|NCT00656019|58702551|FG000|Overall Study|Lost to Follow-up|2|||
30688861|NCT00656019|58702552|FG001|Overall Study|Lost to Follow-up|1|||
30688862|NCT00656019|58702553|FG002|Overall Study|Lost to Follow-up|0|||
30858007|NCT02765165|58886242|FG002|Post-treatment Follow-up|Death|1|||
30858008|NCT02765165|58886243|FG003|Post-treatment Follow-up|Death|1|||
30858009|NCT02765165|58886244|FG004|Post-treatment Follow-up|Death|1|||
30858010|NCT02765165|58886245|FG005|Post-treatment Follow-up|Death|1|||
30858011|NCT02765165|58886246|FG006|Post-treatment Follow-up|Death|0|||
30858012|NCT02765165|58886240|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
30858013|NCT02765165|58886241|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
30858014|NCT02765165|58886242|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
30688863|NCT00656019|58702554|FG003|Overall Study|Lost to Follow-up|0|||
30858015|NCT02765165|58886243|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
30858016|NCT02765165|58886244|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
30858017|NCT02765165|58886245|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
30858018|NCT02765165|58886246|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
30858019|NCT02765165|58886240|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
30858020|NCT02765165|58886241|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
30858021|NCT02765165|58886242|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
30858022|NCT02765165|58886243|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
30858023|NCT02765165|58886244|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
30858024|NCT02765165|58886245|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
30858025|NCT02765165|58886246|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
30858026|NCT02765165|58886240|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
30858027|NCT02765165|58886241|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
30858028|NCT02765165|58886242|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
30858029|NCT02765165|58886243|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
30858030|NCT02765165|58886244|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
30858031|NCT02765165|58886245|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
30858032|NCT02765165|58886246|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
30858033|NCT02765165|58886240|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
30858034|NCT02765165|58886241|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
30858035|NCT02765165|58886242|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
30858036|NCT02765165|58886243|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
30858037|NCT02765165|58886244|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
30858038|NCT02765165|58886245|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
30858039|NCT02765165|58886246|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
30858040|NCT02765165|58886240|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
30858041|NCT02765165|58886241|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
30858042|NCT02765165|58886242|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
30858043|NCT02765165|58886243|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
30858044|NCT02765165|58886244|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
30858045|NCT02765165|58886245|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
30599425|NCT01307501|58611242|FG000|Overall Study|Starting Hospice|1|||
30858046|NCT02765165|58886246|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
30858047|NCT02675907|58886268|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
30858048|NCT02675907|58886269|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
30858049|NCT02675907|58886268|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
30858050|NCT02675907|58886269|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
30858051|NCT02675907|58886268|FG000|Study Overall|Lack of Efficacy|1|||
30858052|NCT02675907|58886269|FG001|Study Overall|Lack of Efficacy|0|||
30858053|NCT02675907|58886268|FG000|Study Overall|Withdrawal by Subject|2|||
30858054|NCT02675907|58886269|FG001|Study Overall|Withdrawal by Subject|2|||
30858055|NCT02675907|58886268|FG000|Study Overall|Lost to Follow-up|0|||
30858056|NCT02675907|58886269|FG001|Study Overall|Lost to Follow-up|2|||
30858057|NCT02675517|58886275|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
30858058|NCT02675517|58886275|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
30858059|NCT02764775|58886279|FG000|Overall Study|Death|1|||
30858060|NCT02764775|58886279|FG000|Overall Study|Lost to Follow-up|2|||
30858061|NCT02764775|58886279|FG000|Overall Study|Withdrawal by Subject|3|||
30858062|NCT02774681|58886283|FG000|Treatment on Study|Progressive Disease|7|||
30858063|NCT02774681|58886283|FG000|Follow-Up for 3 Years|Death|11|||
30858064|NCT02774681|58886283|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
30858065|NCT02547428|58886289|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
30858066|NCT02547428|58886290|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
30858067|NCT02547428|58886289|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
30858068|NCT02547428|58886290|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
30858069|NCT02547428|58886289|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
30858070|NCT02547428|58886290|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
30858071|NCT02547428|58886289|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
30858072|NCT02547428|58886290|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
30858073|NCT02547428|58886289|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
30858074|NCT02547428|58886290|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
30858075|NCT02547428|58886289|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
30858076|NCT02547428|58886290|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
30858077|NCT02547428|58886289|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
30858078|NCT02547428|58886290|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
30858079|NCT02547428|58886289|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
30858080|NCT02547428|58886290|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
30599426|NCT01034137|58611249|FG000|Overall Study|Adverse Event|9|||
30858081|NCT01374087|58886305|FG000|Overall Study|Adverse Event|1|||
30858082|NCT01374087|58886306|FG001|Overall Study|Adverse Event|0|||
30858083|NCT01374087|58886305|FG000|Overall Study|Disease progression|2|||
30858084|NCT01374087|58886306|FG001|Overall Study|Disease progression|2|||
30858085|NCT01374087|58886305|FG000|Overall Study|Study discontinued|13|||
30858086|NCT01374087|58886306|FG001|Overall Study|Study discontinued|13|||
30858087|NCT00152971|58886315|FG000|Overall Study|Adverse Event|12|||
30858088|NCT00152971|58886316|FG001|Overall Study|Adverse Event|10|||
30858089|NCT00152971|58886317|FG002|Overall Study|Adverse Event|9|||
30858090|NCT00152971|58886315|FG000|Overall Study|Protocol Violation|10|||
30858091|NCT00152971|58886316|FG001|Overall Study|Protocol Violation|11|||
30858092|NCT00152971|58886317|FG002|Overall Study|Protocol Violation|8|||
30858093|NCT00152971|58886315|FG000|Overall Study|Lost to Follow-up|17|||
30858094|NCT00152971|58886316|FG001|Overall Study|Lost to Follow-up|14|||
30858095|NCT00152971|58886317|FG002|Overall Study|Lost to Follow-up|13|||
30858096|NCT00152971|58886315|FG000|Overall Study|Withdrawal by Subject|9|||
30858097|NCT00152971|58886316|FG001|Overall Study|Withdrawal by Subject|8|||
30858098|NCT00152971|58886317|FG002|Overall Study|Withdrawal by Subject|14|||
30858099|NCT00152971|58886315|FG000|Overall Study|Other|3|||
30858100|NCT00152971|58886316|FG001|Overall Study|Other|5|||
30858101|NCT00152971|58886317|FG002|Overall Study|Other|5|||
30858102|NCT00152971|58886315|FG000|Treatment|Adverse Event|49|||
30858103|NCT00152971|58886316|FG001|Treatment|Adverse Event|40|||
30858104|NCT00152971|58886317|FG002|Treatment|Adverse Event|54|||
30858105|NCT00152971|58886315|FG000|Treatment|Protocol Violation|8|||
30858106|NCT00152971|58886316|FG001|Treatment|Protocol Violation|6|||
30688864|NCT00782483|58702564|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
30688865|NCT00782171|58702570|FG000|Overall Study|Lost to Follow-up|2|||
30688866|NCT00782171|58702571|FG001|Overall Study|Lost to Follow-up|2|||
30858107|NCT00152971|58886317|FG002|Treatment|Protocol Violation|10|||
30858108|NCT00152971|58886315|FG000|Treatment|Lost to Follow-up|1|||
30858109|NCT00152971|58886316|FG001|Treatment|Lost to Follow-up|2|||
30858110|NCT00152971|58886317|FG002|Treatment|Lost to Follow-up|1|||
30858111|NCT00152971|58886315|FG000|Treatment|Withdrawal by Subject|4|||
30858112|NCT00152971|58886316|FG001|Treatment|Withdrawal by Subject|4|||
30858113|NCT00152971|58886317|FG002|Treatment|Withdrawal by Subject|5|||
30858114|NCT00152971|58886315|FG000|Treatment|Other|9|||
30858115|NCT00152971|58886316|FG001|Treatment|Other|11|||
30858116|NCT00152971|58886317|FG002|Treatment|Other|10|||
30858117|NCT02538614|58886325|FG000|Overall Study|Progressive Disease|2|||
30858118|NCT04620135|58886333|FG000|Study Completion|Adverse Event|2|||
30858119|NCT04620135|58886334|FG001|Study Completion|Adverse Event|3|||
30858120|NCT04620135|58886333|FG000|Study Completion|Withdrawal by Subject|2|||
30858121|NCT04620135|58886334|FG001|Study Completion|Withdrawal by Subject|0|||
30858122|NCT02552966|58886340|FG000|Overall Study|Lost to Follow-up|2|||
30858123|NCT02552966|58886340|FG000|Overall Study|Withdrawal by Subject|3|||
30858124|NCT02552888|58886346|FG000|Overall Study|Lost to Follow-up|1|||
30858125|NCT02552888|58886347|FG001|Overall Study|Lost to Follow-up|1|||
30858126|NCT01373931|58886366|FG000|Lead-in Period|Adverse Event|2|||
30858127|NCT01373931|58886367|FG001|Lead-in Period|Adverse Event|0|||
30858128|NCT01373931|58886366|FG000|Period 1|Adverse Event|2|||
30858129|NCT01373931|58886367|FG001|Period 1|Adverse Event|0|||
30858130|NCT01373931|58886366|FG000|Period 1|Withdrawal by Subject|0|||
30858131|NCT01373931|58886367|FG001|Period 1|Withdrawal by Subject|2|||
30858132|NCT02552732|58886374|FG000|Overall Study|Lost to Follow-up|2|||
30858133|NCT02552732|58886374|FG000|Overall Study|Physician Decision|1|||
30858134|NCT02552732|58886374|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
30858135|NCT02552732|58886374|FG000|Overall Study|Withdrawal by Subject|6|||
30858136|NCT02547038|58886381|FG000|Overall Study|Lost to Follow-up|3|||
30858137|NCT02547038|58886382|FG001|Overall Study|Lost to Follow-up|2|||
30858138|NCT02764697|58886388|FG000|Overall Study|Lack of Efficacy|3|||
30858139|NCT02673489|58886394|FG000|Treatment Period|Lost to Follow-up|3|||
30599427|NCT01034137|58611250|FG001|Overall Study|Adverse Event|10|||
30599428|NCT01034137|58611251|FG002|Overall Study|Adverse Event|8|||
30599429|NCT01034137|58611249|FG000|Overall Study|Withdrawal by Subject|4|||
30599430|NCT01034137|58611250|FG001|Overall Study|Withdrawal by Subject|3|||
30599431|NCT01034137|58611251|FG002|Overall Study|Withdrawal by Subject|3|||
30599432|NCT01034137|58611249|FG000|Overall Study|Lack of Efficacy|9|||
30599433|NCT01034137|58611250|FG001|Overall Study|Lack of Efficacy|4|||
30599434|NCT01034137|58611251|FG002|Overall Study|Lack of Efficacy|13|||
30858140|NCT02673489|58886395|FG001|Treatment Period|Lost to Follow-up|0|||
30858141|NCT02673489|58886394|FG000|Treatment Period|Participant request to discontinue|1|||
30858142|NCT02673489|58886395|FG001|Treatment Period|Participant request to discontinue|1|||
30858143|NCT02673489|58886394|FG000|Treatment Period|Participant moved to another province|1|||
30858144|NCT02673489|58886395|FG001|Treatment Period|Participant moved to another province|0|||
30858145|NCT02673489|58886394|FG000|Treatment Period|Participant was incarcerated|0|||
30858146|NCT02673489|58886395|FG001|Treatment Period|Participant was incarcerated|1|||
30858147|NCT02673489|58886394|FG000|Treatment Period|Adverse Event|0|||
30858148|NCT02673489|58886395|FG001|Treatment Period|Adverse Event|1|||
30858149|NCT02673489|58886394|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
30858150|NCT02673489|58886395|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
30858151|NCT02673489|58886394|FG000|Follow Up Period|Unable to return for follow-up|0|||
30858152|NCT02673489|58886395|FG001|Follow Up Period|Unable to return for follow-up|1|||
30858153|NCT02772809|58886402|FG000|Overall Study|not completed some tasks|6|||
30858154|NCT02537678|58886413|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
30858155|NCT02537678|58886414|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
30858156|NCT02537678|58886413|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
30858157|NCT02537678|58886414|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
30858158|NCT02537678|58886413|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
30858159|NCT02537678|58886414|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
30858160|NCT02537678|58886413|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
30858161|NCT02537678|58886414|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
30858162|NCT02537678|58886413|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
30858163|NCT02537678|58886414|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
30858164|NCT02537678|58886413|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
30858165|NCT02537678|58886414|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
30858166|NCT02537678|58886413|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
30858167|NCT02537678|58886414|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
30858168|NCT02766023|58886426|FG000|Overall Study|Lost to Follow-up|23|||
30858169|NCT02766023|58886427|FG001|Overall Study|Lost to Follow-up|11|||
30858170|NCT02766023|58886426|FG000|Overall Study|Pregnancy|1|||
30858171|NCT02766023|58886427|FG001|Overall Study|Pregnancy|0|||
30858172|NCT02766023|58886426|FG000|Overall Study|Adverse Event|1|||
30858173|NCT02766023|58886427|FG001|Overall Study|Adverse Event|0|||
30858174|NCT02766023|58886426|FG000|Overall Study|Withdrawal by Subject|4|||
30858175|NCT02766023|58886427|FG001|Overall Study|Withdrawal by Subject|5|||
30858176|NCT02766023|58886426|FG000|Overall Study|Physician Decision|1|||
30858177|NCT02766023|58886427|FG001|Overall Study|Physician Decision|0|||
30858178|NCT02766023|58886426|FG000|Overall Study|Not Eligible at Enrollment|0|||
30858179|NCT02766023|58886427|FG001|Overall Study|Not Eligible at Enrollment|1|||
30858180|NCT02764229|58886433|FG000|Overall Study|Withdrawal by Subject|15|||
30858181|NCT02764229|58886433|FG000|Overall Study|Adverse Event|9|||
30858182|NCT02764229|58886433|FG000|Overall Study|Physician Decision|5|||
30858183|NCT02764229|58886433|FG000|Overall Study|Lost to Follow-up|3|||
30858184|NCT02764229|58886433|FG000|Overall Study|Lack of Efficacy|1|||
30858185|NCT02764229|58886433|FG000|Overall Study|Study Stopped by Sponsor|69|||
30858186|NCT02537522|58886437|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
30858187|NCT02537522|58886438|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
30858188|NCT02537522|58886439|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
30858189|NCT02537522|58886440|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
30858190|NCT02537522|58886437|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
30858191|NCT02537522|58886438|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
30858192|NCT02537522|58886439|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
30858193|NCT02537522|58886440|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
30858194|NCT02537522|58886437|FG000|Phase I - Contralateral|incorrect randomization|0|||
30858195|NCT02537522|58886438|FG001|Phase I - Contralateral|incorrect randomization|1|||
30858196|NCT02537522|58886439|FG002|Phase I - Contralateral|incorrect randomization|0|||
30858197|NCT02537522|58886440|FG003|Phase I - Contralateral|incorrect randomization|0|||
30858198|NCT02537522|58886437|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
30858199|NCT02537522|58886438|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
30858200|NCT02537522|58886439|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
30858201|NCT02537522|58886440|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
30858202|NCT02537522|58886437|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
30858203|NCT02537522|58886438|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
30858204|NCT02537522|58886439|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
30858205|NCT02537522|58886440|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
30858206|NCT02536976|58886448|FG000|Overall Study|Physician Decision|0|||
30858207|NCT02536976|58886449|FG001|Overall Study|Physician Decision|1|||
30858208|NCT02672553|58886459|FG000|Overall Study|Death|3|||
30858209|NCT02672553|58886460|FG001|Overall Study|Death|5|||
30858210|NCT02672553|58886459|FG000|Overall Study|Valve Explant|1|||
30858211|NCT02672553|58886460|FG001|Overall Study|Valve Explant|0|||
30858212|NCT02672553|58886459|FG000|Overall Study|Conversion to Commercial Valve|3|||
30858213|NCT02672553|58886460|FG001|Overall Study|Conversion to Commercial Valve|0|||
30858214|NCT02672553|58886459|FG000|Overall Study|Withdrawal by Subject|3|||
30858215|NCT02672553|58886460|FG001|Overall Study|Withdrawal by Subject|3|||
30858216|NCT02672553|58886459|FG000|Overall Study|Intraoperative screen failure|2|||
30858217|NCT02672553|58886460|FG001|Overall Study|Intraoperative screen failure|0|||
30858218|NCT01373229|58886467|FG000|Overall Study|Death|3|||
30858219|NCT01373229|58886467|FG000|Overall Study|Physician Decision|3|||
30858220|NCT02671461|58886474|FG000|Treatment|Adverse Event|0|||
30688867|NCT00782171|58702570|FG000|Overall Study|Withdrawal by Subject|2|||
30688868|NCT00782171|58702571|FG001|Overall Study|Withdrawal by Subject|1|||
30688869|NCT00782171|58702570|FG000|Overall Study|complications|3|||
30688870|NCT00782171|58702571|FG001|Overall Study|complications|1|||
30688871|NCT00782171|58702570|FG000|Overall Study|others|7|||
30688872|NCT00782171|58702571|FG001|Overall Study|others|9|||
30688873|NCT00782171|58702570|FG000|Overall Study|not eligible|8|||
30688874|NCT00782171|58702571|FG001|Overall Study|not eligible|6|||
30688875|NCT00764465|58702583|FG000|Overall Study|Adverse Event|2|||
30688876|NCT00764465|58702584|FG001|Overall Study|Adverse Event|0|||
30688877|NCT00764465|58702585|FG002|Overall Study|Adverse Event|0|||
30688878|NCT00764465|58702586|FG003|Overall Study|Adverse Event|1|||
30688879|NCT00764465|58702587|FG004|Overall Study|Adverse Event|1|||
30858221|NCT02671461|58886475|FG001|Treatment|Adverse Event|0|||
30858222|NCT02671461|58886476|FG002|Treatment|Adverse Event|1|||
30858223|NCT02671461|58886474|FG000|Treatment|Administrative Reason by Sponsor|1|||
30858224|NCT02671461|58886475|FG001|Treatment|Administrative Reason by Sponsor|3|||
30858225|NCT02671461|58886476|FG002|Treatment|Administrative Reason by Sponsor|4|||
30858226|NCT02671461|58886474|FG000|Treatment|Randomized, not treated|1|||
30858227|NCT02671461|58886475|FG001|Treatment|Randomized, not treated|0|||
30858228|NCT02671461|58886476|FG002|Treatment|Randomized, not treated|0|||
30858229|NCT02671461|58886474|FG000|Follow-up|Withdrawal by Subject|1|||
30858230|NCT02671461|58886475|FG001|Follow-up|Withdrawal by Subject|0|||
30858231|NCT02671461|58886476|FG002|Follow-up|Withdrawal by Subject|0|||
30858232|NCT02671461|58886474|FG000|Follow-up|Lost to Follow-up|0|||
30858233|NCT02671461|58886475|FG001|Follow-up|Lost to Follow-up|0|||
30858234|NCT02671461|58886476|FG002|Follow-up|Lost to Follow-up|1|||
30858235|NCT02671461|58886474|FG000|Follow-up|Administrative Reason by Sponsor|0|||
30858236|NCT02671461|58886475|FG001|Follow-up|Administrative Reason by Sponsor|1|||
30858237|NCT02671461|58886476|FG002|Follow-up|Administrative Reason by Sponsor|0|||
30858238|NCT02535416|58886493|FG000|Overall Study|Family bereavement overseas|1|||
30858239|NCT02535416|58886494|FG001|Overall Study|Family bereavement overseas|0|||
30858240|NCT02535416|58886495|FG002|Overall Study|Family bereavement overseas|0|||
30858241|NCT02535416|58886496|FG003|Overall Study|Family bereavement overseas|0|||
30858242|NCT02535416|58886497|FG004|Overall Study|Family bereavement overseas|0|||
30858243|NCT02535416|58886498|FG005|Overall Study|Family bereavement overseas|0|||
30858244|NCT02535416|58886499|FG006|Overall Study|Family bereavement overseas|0|||
30858245|NCT02535416|58886500|FG007|Overall Study|Family bereavement overseas|0|||
30858246|NCT02535416|58886501|FG008|Overall Study|Family bereavement overseas|0|||
30858247|NCT02670915|58886551|FG000|Overall Study|Withdrawal by Subject|0|||
30858248|NCT02670915|58886552|FG001|Overall Study|Withdrawal by Subject|1|||
30858249|NCT02670915|58886553|FG002|Overall Study|Withdrawal by Subject|4|||
30858250|NCT02670915|58886551|FG000|Overall Study|Withdrawal by parent/guardian|4|||
30858251|NCT02670915|58886552|FG001|Overall Study|Withdrawal by parent/guardian|4|||
30858252|NCT02670915|58886553|FG002|Overall Study|Withdrawal by parent/guardian|1|||
30858253|NCT02670915|58886551|FG000|Overall Study|Unclassified|0|||
30858254|NCT02670915|58886552|FG001|Overall Study|Unclassified|3|||
30858255|NCT02670915|58886553|FG002|Overall Study|Unclassified|0|||
30858256|NCT02545868|58886564|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33|||
30858257|NCT02545868|58886565|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35|||
30858258|NCT02545868|58886566|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34|||
30858259|NCT02764151|58886583|FG000|Overall Study|Subject refused further follow-up|0|||
30959359|NCT01567865|59024777|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
30858260|NCT02764151|58886584|FG001|Overall Study|Subject refused further follow-up|0|||
30858261|NCT02764151|58886585|FG002|Overall Study|Subject refused further follow-up|0|||
30688880|NCT00764465|58702588|FG005|Overall Study|Adverse Event|1|||
30688881|NCT00764465|58702583|FG000|Overall Study|Withdrawal by Subject|0|||
30786531|NCT00138671|58799735|FG000|Overall Study|Adverse Event|6|||
30786532|NCT00138671|58799736|FG001|Overall Study|Adverse Event|3|||
30786533|NCT00138671|58799735|FG000|Overall Study|Lost to Follow-up|1|||
30786534|NCT00138671|58799736|FG001|Overall Study|Lost to Follow-up|2|||
30786535|NCT00138671|58799735|FG000|Overall Study|Withdrawal by Subject|3|||
30786536|NCT00138671|58799736|FG001|Overall Study|Withdrawal by Subject|5|||
30786537|NCT00138671|58799735|FG000|Overall Study|Other|3|||
30786538|NCT00138671|58799736|FG001|Overall Study|Other|3|||
30786539|NCT01367158|58799755|FG000|Overall Study|Withdrew consent|0|||
30786540|NCT01367158|58799756|FG001|Overall Study|Withdrew consent|2|||
30786541|NCT01367158|58799757|FG002|Overall Study|Withdrew consent|1|||
30786542|NCT01367158|58799758|FG003|Overall Study|Withdrew consent|0|||
30786543|NCT01367158|58799759|FG004|Overall Study|Withdrew consent|2|||
30786544|NCT01367158|58799760|FG005|Overall Study|Withdrew consent|0|||
30786545|NCT01367158|58799761|FG006|Overall Study|Withdrew consent|0|||
30786546|NCT01367158|58799762|FG007|Overall Study|Withdrew consent|1|||
30786547|NCT01367158|58799763|FG008|Overall Study|Withdrew consent|0|||
30786548|NCT01367158|58799764|FG009|Overall Study|Withdrew consent|0|||
30786549|NCT01367158|58799765|FG010|Overall Study|Withdrew consent|0|||
30688882|NCT00764465|58702584|FG001|Overall Study|Withdrawal by Subject|1|||
30688883|NCT00764465|58702585|FG002|Overall Study|Withdrawal by Subject|1|||
30688884|NCT00764465|58702586|FG003|Overall Study|Withdrawal by Subject|0|||
30688885|NCT00764465|58702587|FG004|Overall Study|Withdrawal by Subject|0|||
30688886|NCT00764465|58702588|FG005|Overall Study|Withdrawal by Subject|0|||
30688887|NCT00655863|58702608|FG000|Overall Study|Lost to Follow-up|0|||
30688888|NCT00655863|58702609|FG001|Overall Study|Lost to Follow-up|0|||
30688889|NCT00655863|58702610|FG002|Overall Study|Lost to Follow-up|1|||
30688890|NCT00781937|58702620|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
30688891|NCT00781937|58702621|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
30688892|NCT00781937|58702620|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
30688893|NCT00781937|58702621|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
30688894|NCT00781937|58702620|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
30688895|NCT00781937|58702621|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
30688896|NCT00781937|58702620|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
30688897|NCT00781937|58702621|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
30688898|NCT00781937|58702620|FG000|Main Trial Period Through Week 56|Unclassified|10|||
30688899|NCT00781937|58702621|FG001|Main Trial Period Through Week 56|Unclassified|15|||
30688900|NCT00781937|58702620|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
30688901|NCT00781937|58702621|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
30688902|NCT00781937|58702620|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
30688903|NCT00781937|58702621|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
30688904|NCT00659373|58702629|FG000|Overall Study|Withdrawal by Subject|3|||
30688905|NCT00659373|58702630|FG001|Overall Study|Withdrawal by Subject|5|||
30688906|NCT00659373|58702629|FG000|Overall Study|Assessment Missed|2|||
30688907|NCT00659373|58702630|FG001|Overall Study|Assessment Missed|2|||
30688908|NCT00439777|58702638|FG000|Treatment Period|Death|29|||
30688909|NCT00439777|58702639|FG001|Treatment Period|Death|21|||
30688910|NCT00439777|58702638|FG000|Treatment Period|Study terminated by sponsor|125|||
30688911|NCT00439777|58702639|FG001|Treatment Period|Study terminated by sponsor|132|||
30688912|NCT00439777|58702638|FG000|Treatment Period|Site closed by investigator|0|||
30688913|NCT00439777|58702639|FG001|Treatment Period|Site closed by investigator|1|||
30688914|NCT00439777|58702638|FG000|Treatment Period|Did not take study treatment|7|||
30688915|NCT00439777|58702639|FG001|Treatment Period|Did not take study treatment|8|||
30688916|NCT00439777|58702638|FG000|Treatment Period|Adverse Event|111|||
30688917|NCT00439777|58702639|FG001|Treatment Period|Adverse Event|92|||
30688918|NCT00439777|58702638|FG000|Treatment Period|Protocol Violation|23|||
30688919|NCT00439777|58702639|FG001|Treatment Period|Protocol Violation|30|||
30688920|NCT00439777|58702638|FG000|Treatment Period|Withdrawal by Subject|66|||
30688921|NCT00439777|58702639|FG001|Treatment Period|Withdrawal by Subject|118|||
30688922|NCT00439777|58702638|FG000|Treatment Period|Lack of Efficacy|1|||
30688923|NCT00439777|58702639|FG001|Treatment Period|Lack of Efficacy|4|||
30688924|NCT00439777|58702638|FG000|Treatment Period|Lost to Follow-up|8|||
30688925|NCT00439777|58702639|FG001|Treatment Period|Lost to Follow-up|10|||
30688926|NCT00439777|58702638|FG000|Treatment Period|Protocol driven decision point|1|||
30688927|NCT00439777|58702639|FG001|Treatment Period|Protocol driven decision point|3|||
30688928|NCT00439777|58702638|FG000|Treatment Period|Physician Decision|7|||
30688929|NCT00439777|58702639|FG001|Treatment Period|Physician Decision|18|||
30688930|NCT00439777|58702638|FG000|Treatment Period|Clinical endpoint reached|26|||
30688931|NCT00439777|58702639|FG001|Treatment Period|Clinical endpoint reached|13|||
30688932|NCT00439777|58702638|FG000|Treatment Period|Technical problems|3|||
30688933|NCT00439777|58702639|FG001|Treatment Period|Technical problems|1|||
30858262|NCT02764151|58886586|FG003|Overall Study|Subject refused further follow-up|1|||
30858263|NCT02764151|58886583|FG000|Overall Study|Other|0|||
30858264|NCT02764151|58886584|FG001|Overall Study|Other|0|||
30858265|NCT02764151|58886585|FG002|Overall Study|Other|0|||
30858266|NCT02764151|58886586|FG003|Overall Study|Other|2|||
30858267|NCT02545322|58886596|FG000|Overall Study|Withdrawal by Subject|3|||
30858268|NCT02763215|58886600|FG000|Overall Study|Participants withdrew from study|3|||
30858269|NCT02763215|58886600|FG000|Overall Study|Missed visit|1|||
30858270|NCT02763215|58886600|FG000|Overall Study|Visit outside visit-window|1|||
30858271|NCT02763215|58886600|FG000|Overall Study|Death|1|||
30858272|NCT02763215|58886600|FG000|Overall Study|Lost to Follow-up|1|||
30858273|NCT02770547|58886619|FG000|Overall Study|Patient non-compliant|1|||
30858274|NCT02770547|58886620|FG001|Overall Study|Patient non-compliant|0|||
30858275|NCT02770547|58886619|FG000|Overall Study|Adverse Event|0|||
30688934|NCT00439777|58702638|FG000|Treatment Period|Participant convenience|12|||
30688935|NCT00439777|58702639|FG001|Treatment Period|Participant convenience|8|||
30688936|NCT00439777|58702638|FG000|Observational Period|Protocol Violation|0|||
30688937|NCT00439777|58702639|FG001|Observational Period|Protocol Violation|2|||
30688938|NCT00439777|58702638|FG000|Observational Period|Withdrawal by Subject|9|||
30688939|NCT00439777|58702639|FG001|Observational Period|Withdrawal by Subject|5|||
30858276|NCT02770547|58886620|FG001|Overall Study|Adverse Event|1|||
30858277|NCT01661972|58886628|FG000|Overall Study|Adverse Event|1|||
30858278|NCT01661972|58886629|FG001|Overall Study|Adverse Event|2|||
30858279|NCT01661972|58886628|FG000|Overall Study|Death during Treatment period|1|||
30858280|NCT01661972|58886629|FG001|Overall Study|Death during Treatment period|1|||
30858281|NCT01661972|58886628|FG000|Overall Study|Withdrawal by Subject|0|||
30858282|NCT01661972|58886629|FG001|Overall Study|Withdrawal by Subject|1|||
30858283|NCT00888355|58886641|FG000|Overall Study|Adverse Event|10|||
30858284|NCT00888355|58886642|FG001|Overall Study|Adverse Event|0|||
30858285|NCT00888355|58886643|FG002|Overall Study|Adverse Event|3|||
30858286|NCT00888355|58886644|FG003|Overall Study|Adverse Event|3|||
30858287|NCT00888355|58886641|FG000|Overall Study|Lack of Efficacy|9|||
30858288|NCT00888355|58886642|FG001|Overall Study|Lack of Efficacy|2|||
30858289|NCT00888355|58886643|FG002|Overall Study|Lack of Efficacy|5|||
30858290|NCT00888355|58886644|FG003|Overall Study|Lack of Efficacy|2|||
30858291|NCT00888355|58886641|FG000|Overall Study|Lost to Follow-up|0|||
30858292|NCT00888355|58886642|FG001|Overall Study|Lost to Follow-up|2|||
30858293|NCT00888355|58886643|FG002|Overall Study|Lost to Follow-up|2|||
30858294|NCT00888355|58886644|FG003|Overall Study|Lost to Follow-up|0|||
30858295|NCT00888355|58886641|FG000|Overall Study|Protocol Violation|3|||
30858296|NCT00888355|58886642|FG001|Overall Study|Protocol Violation|2|||
30858297|NCT00888355|58886643|FG002|Overall Study|Protocol Violation|1|||
30858298|NCT00888355|58886644|FG003|Overall Study|Protocol Violation|2|||
30858299|NCT00888355|58886641|FG000|Overall Study|Withdrawal by Subject|0|||
30858300|NCT00888355|58886642|FG001|Overall Study|Withdrawal by Subject|3|||
30858301|NCT00888355|58886643|FG002|Overall Study|Withdrawal by Subject|1|||
30858302|NCT00888355|58886644|FG003|Overall Study|Withdrawal by Subject|3|||
30858303|NCT00794677|58886652|FG000|First Intervention|Withdrawal by Subject|2|||
30858304|NCT00794677|58886653|FG001|First Intervention|Withdrawal by Subject|0|||
30858305|NCT02770391|58886657|FG000|Overall Study|Lost to Follow-up|2|||
30858306|NCT02770391|58886657|FG000|Overall Study|Withdrawal by Subject|1|||
30858307|NCT02770391|58886657|FG000|Overall Study|Surgery delayed unevaluable|2|||
30858308|NCT02770391|58886657|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
30858309|NCT02536508|58886664|FG000|Overall Study|Withdrawal by Subject|18|||
30858310|NCT02536508|58886665|FG001|Overall Study|Withdrawal by Subject|13|||
30858311|NCT02536508|58886666|FG002|Overall Study|Withdrawal by Subject|7|||
30858312|NCT02536508|58886664|FG000|Overall Study|Adverse Event|14|||
30858313|NCT02536508|58886665|FG001|Overall Study|Adverse Event|13|||
30858314|NCT02536508|58886666|FG002|Overall Study|Adverse Event|6|||
30858315|NCT02536508|58886664|FG000|Overall Study|Lost to Follow-up|12|||
30858316|NCT02536508|58886665|FG001|Overall Study|Lost to Follow-up|4|||
30858317|NCT02536508|58886666|FG002|Overall Study|Lost to Follow-up|0|||
30858318|NCT02536508|58886664|FG000|Overall Study|Lack of Efficacy|3|||
30858319|NCT02536508|58886665|FG001|Overall Study|Lack of Efficacy|5|||
30858320|NCT02536508|58886666|FG002|Overall Study|Lack of Efficacy|4|||
30858321|NCT02536508|58886664|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
30858322|NCT02536508|58886665|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
30858323|NCT02536508|58886666|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
30858324|NCT02536508|58886664|FG000|Overall Study|Physician Decision|0|||
30858325|NCT02536508|58886665|FG001|Overall Study|Physician Decision|4|||
30858326|NCT02536508|58886666|FG002|Overall Study|Physician Decision|2|||
30858327|NCT02536508|58886664|FG000|Overall Study|Major Protocol Deviation|2|||
30858328|NCT02536508|58886665|FG001|Overall Study|Major Protocol Deviation|2|||
30858329|NCT02536508|58886666|FG002|Overall Study|Major Protocol Deviation|2|||
30858330|NCT02536508|58886664|FG000|Overall Study|Administrative Reasons|0|||
30858331|NCT02536508|58886665|FG001|Overall Study|Administrative Reasons|1|||
30858332|NCT02536508|58886666|FG002|Overall Study|Administrative Reasons|0|||
30858333|NCT00103259|58886683|FG000|Overall Study|Death|3|||
30858334|NCT00103259|58886684|FG001|Overall Study|Death|2|||
30858335|NCT00103259|58886683|FG000|Overall Study|Withdrawal by Subject|2|||
30858336|NCT00103259|58886684|FG001|Overall Study|Withdrawal by Subject|3|||
30858337|NCT00103259|58886683|FG000|Overall Study|alternative therapy|1|||
30858338|NCT00103259|58886684|FG001|Overall Study|alternative therapy|0|||
30858339|NCT00103259|58886683|FG000|Overall Study|other (reasons were not specified)|2|||
30858340|NCT00103259|58886684|FG001|Overall Study|other (reasons were not specified)|1|||
30858341|NCT00103259|58886683|FG000|Overall Study|ineligible/no protocol therapy|4|||
30858342|NCT00103259|58886684|FG001|Overall Study|ineligible/no protocol therapy|6|||
30858343|NCT02544152|58886694|FG000|Overall Study|Adverse Event|0|||
30858344|NCT02544152|58886695|FG001|Overall Study|Adverse Event|4|||
30858345|NCT02544152|58886694|FG000|Overall Study|Withdrawal by Subject|0|||
30858346|NCT02544152|58886695|FG001|Overall Study|Withdrawal by Subject|3|||
30858347|NCT02544152|58886694|FG000|Overall Study|Other|1|||
30858348|NCT02544152|58886695|FG001|Overall Study|Other|0|||
30858349|NCT02534324|58886703|FG000|Overall Study|Protocol Violation|4|||
30858350|NCT02534324|58886704|FG001|Overall Study|Protocol Violation|1|||
30858351|NCT02534324|58886703|FG000|Overall Study|Lost to Follow-up|20|||
30858352|NCT02534324|58886704|FG001|Overall Study|Lost to Follow-up|7|||
30858353|NCT02534324|58886703|FG000|Overall Study|Adverse Event|1|||
30858354|NCT02534324|58886704|FG001|Overall Study|Adverse Event|0|||
30858355|NCT02761733|58886714|FG000|Overall Study|Death|3|||
30858356|NCT02761733|58886715|FG001|Overall Study|Death|5|||
30858357|NCT02761733|58886716|FG002|Overall Study|Death|1|||
30858358|NCT02761733|58886717|FG003|Overall Study|Death|1|||
30858359|NCT02761733|58886714|FG000|Overall Study|Lost to Follow-up|6|||
30858360|NCT02761733|58886715|FG001|Overall Study|Lost to Follow-up|7|||
30858361|NCT02761733|58886716|FG002|Overall Study|Lost to Follow-up|0|||
30858362|NCT02761733|58886717|FG003|Overall Study|Lost to Follow-up|3|||
30858363|NCT02761733|58886714|FG000|Overall Study|Physician Decision|4|||
30858364|NCT02761733|58886715|FG001|Overall Study|Physician Decision|0|||
30858365|NCT02761733|58886716|FG002|Overall Study|Physician Decision|0|||
30858366|NCT02761733|58886717|FG003|Overall Study|Physician Decision|0|||
30858367|NCT02761733|58886714|FG000|Overall Study|Withdrawal by Subject|2|||
30858368|NCT02761733|58886715|FG001|Overall Study|Withdrawal by Subject|0|||
30858369|NCT02761733|58886716|FG002|Overall Study|Withdrawal by Subject|0|||
30858370|NCT02761733|58886717|FG003|Overall Study|Withdrawal by Subject|0|||
30858371|NCT02761733|58886714|FG000|Overall Study|Discharged from Study Site|10|||
30858372|NCT02761733|58886715|FG001|Overall Study|Discharged from Study Site|9|||
30858373|NCT02761733|58886716|FG002|Overall Study|Discharged from Study Site|25|||
30858374|NCT02761733|58886717|FG003|Overall Study|Discharged from Study Site|11|||
30858375|NCT02761733|58886714|FG000|Overall Study|Cognitive Impairment|5|||
30858376|NCT02761733|58886715|FG001|Overall Study|Cognitive Impairment|0|||
30858377|NCT02761733|58886716|FG002|Overall Study|Cognitive Impairment|1|||
30858378|NCT02761733|58886717|FG003|Overall Study|Cognitive Impairment|0|||
30858379|NCT03715465|58886729|FG000|Overall Study|Withdrawal by Subject|1|||
30858380|NCT03715465|58886730|FG001|Overall Study|Withdrawal by Subject|2|||
30858381|NCT00840073|58886738|FG000|Second Intervention|Missed 72 hour blood draw|1|||
30858382|NCT00840073|58886739|FG001|Second Intervention|Missed 72 hour blood draw|1|||
30858383|NCT00838279|58886745|FG000|Washout|Protocol Violation|1|||
30858384|NCT00838279|58886746|FG001|Washout|Protocol Violation|0|||
30858385|NCT00838279|58886745|FG000|Washout|Withdrawal by Subject|0|||
30858386|NCT00838279|58886746|FG001|Washout|Withdrawal by Subject|1|||
30858387|NCT02759939|58886754|FG000|Overall Study|Missing data on first outcome assessed|11|||
30858388|NCT02759939|58886755|FG001|Overall Study|Missing data on first outcome assessed|2|||
30858389|NCT02759939|58886756|FG002|Overall Study|Missing data on first outcome assessed|5|||
30858390|NCT02759939|58886757|FG003|Overall Study|Missing data on first outcome assessed|2|||
30858391|NCT02759939|58886754|FG000|Overall Study|Ineligible for T2 and T3|310|||
30858392|NCT02759939|58886755|FG001|Overall Study|Ineligible for T2 and T3|179|||
30858393|NCT02759939|58886756|FG002|Overall Study|Ineligible for T2 and T3|366|||
30858394|NCT02759939|58886757|FG003|Overall Study|Ineligible for T2 and T3|391|||
30858395|NCT02759939|58886754|FG000|Overall Study|Lost to Follow-up|735|||
30858396|NCT02759939|58886755|FG001|Overall Study|Lost to Follow-up|791|||
30858397|NCT02759939|58886756|FG002|Overall Study|Lost to Follow-up|783|||
30858398|NCT02759939|58886757|FG003|Overall Study|Lost to Follow-up|650|||
30858399|NCT00835705|58886776|FG000|First Intervention|Difficulty with vein|1|||
30858400|NCT00835705|58886777|FG001|First Intervention|Difficulty with vein|0|||
30858401|NCT00835705|58886776|FG000|Second Intervention|Difficulty with vein|1|||
30858402|NCT00835705|58886777|FG001|Second Intervention|Difficulty with vein|0|||
30858417|NCT02759471|58886793|FG000|Overall Study|discomfort|2|||
30858418|NCT00835549|58886801|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
30858419|NCT00835549|58886802|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
30858420|NCT03945825|58886812|FG000|Overall Study|Enrolled but treatment not administered|0|||
30858421|NCT03945825|58886813|FG001|Overall Study|Enrolled but treatment not administered|0|||
30858422|NCT03945825|58886814|FG002|Overall Study|Enrolled but treatment not administered|0|||
30858423|NCT03945825|58886815|FG003|Overall Study|Enrolled but treatment not administered|0|||
30858424|NCT03945825|58886816|FG004|Overall Study|Enrolled but treatment not administered|1|||
30858425|NCT03945825|58886817|FG005|Overall Study|Enrolled but treatment not administered|0|||
30858426|NCT03945825|58886812|FG000|Overall Study|Lost to Follow-up|1|||
30858427|NCT03945825|58886813|FG001|Overall Study|Lost to Follow-up|5|||
30858428|NCT03945825|58886814|FG002|Overall Study|Lost to Follow-up|0|||
30858429|NCT03945825|58886815|FG003|Overall Study|Lost to Follow-up|1|||
30959360|NCT01567865|59024778|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
30959361|NCT01567865|59024775|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
30858430|NCT03945825|58886816|FG004|Overall Study|Lost to Follow-up|2|||
30858431|NCT03945825|58886817|FG005|Overall Study|Lost to Follow-up|2|||
30858432|NCT03945825|58886812|FG000|Overall Study|Withdrawal by Subject|1|||
30858433|NCT03945825|58886813|FG001|Overall Study|Withdrawal by Subject|0|||
30858434|NCT03945825|58886814|FG002|Overall Study|Withdrawal by Subject|1|||
30858435|NCT03945825|58886815|FG003|Overall Study|Withdrawal by Subject|1|||
30858436|NCT03945825|58886816|FG004|Overall Study|Withdrawal by Subject|0|||
30858437|NCT03945825|58886817|FG005|Overall Study|Withdrawal by Subject|1|||
30858438|NCT02759315|58886845|FG000|Overall Study|Adverse Event|0|||
30858439|NCT02759315|58886846|FG001|Overall Study|Adverse Event|0|||
30858440|NCT02759315|58886847|FG002|Overall Study|Adverse Event|0|||
30858441|NCT02759315|58886848|FG003|Overall Study|Adverse Event|1|||
30858442|NCT02759315|58886849|FG004|Overall Study|Adverse Event|0|||
30858443|NCT02759315|58886845|FG000|Overall Study|Death|0|||
30858444|NCT02759315|58886846|FG001|Overall Study|Death|0|||
30858445|NCT02759315|58886847|FG002|Overall Study|Death|1|||
30858446|NCT02759315|58886848|FG003|Overall Study|Death|0|||
30858447|NCT02759315|58886849|FG004|Overall Study|Death|0|||
30858448|NCT02759315|58886845|FG000|Overall Study|Lost to Follow-up|2|||
30858449|NCT02759315|58886846|FG001|Overall Study|Lost to Follow-up|0|||
30858450|NCT02759315|58886847|FG002|Overall Study|Lost to Follow-up|4|||
30858451|NCT02759315|58886848|FG003|Overall Study|Lost to Follow-up|0|||
30858452|NCT02759315|58886849|FG004|Overall Study|Lost to Follow-up|0|||
30858453|NCT02759315|58886845|FG000|Overall Study|Protocol Violation|0|||
30858454|NCT02759315|58886846|FG001|Overall Study|Protocol Violation|1|||
30858455|NCT02759315|58886847|FG002|Overall Study|Protocol Violation|0|||
30858456|NCT02759315|58886848|FG003|Overall Study|Protocol Violation|0|||
30858457|NCT02759315|58886849|FG004|Overall Study|Protocol Violation|0|||
30858458|NCT02759315|58886845|FG000|Overall Study|Study terminated prior to completion|2|||
30688940|NCT00439777|58702638|FG000|Observational Period|Lost to Follow-up|1|||
30688941|NCT00439777|58702639|FG001|Observational Period|Lost to Follow-up|11|||
30688942|NCT00439777|58702638|FG000|Observational Period|Death|27|||
30688943|NCT00439777|58702639|FG001|Observational Period|Death|20|||
30688944|NCT00439777|58702638|FG000|Observational Period|Study terminated by sponsor|3|||
30688945|NCT00439777|58702639|FG001|Observational Period|Study terminated by sponsor|1|||
30688946|NCT00439777|58702638|FG000|Observational Period|Protocol driven decision point|0|||
30688947|NCT00439777|58702639|FG001|Observational Period|Protocol driven decision point|1|||
30688948|NCT00439777|58702638|FG000|Observational Period|Lack of Efficacy|1|||
30688949|NCT00439777|58702639|FG001|Observational Period|Lack of Efficacy|0|||
30688950|NCT00439777|58702638|FG000|Observational Period|Technical problems|0|||
30858459|NCT02759315|58886846|FG001|Overall Study|Study terminated prior to completion|0|||
30858460|NCT02759315|58886847|FG002|Overall Study|Study terminated prior to completion|5|||
30858461|NCT02759315|58886848|FG003|Overall Study|Study terminated prior to completion|0|||
30858462|NCT02759315|58886849|FG004|Overall Study|Study terminated prior to completion|1|||
30858463|NCT00835081|58886865|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
30858464|NCT00835081|58886866|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
30858465|NCT02543918|58886872|FG000|Overall Study|Never treated|0|||
30858466|NCT02543918|58886873|FG001|Overall Study|Never treated|1|||
30858467|NCT02543918|58886872|FG000|Overall Study|Lost to Follow-up|1|||
30858468|NCT02543918|58886873|FG001|Overall Study|Lost to Follow-up|1|||
30858469|NCT02543918|58886872|FG000|Overall Study|Withdrawal by Subject|1|||
30858470|NCT02543918|58886873|FG001|Overall Study|Withdrawal by Subject|1|||
30959362|NCT01567865|59024776|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
30959363|NCT01567865|59024777|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
30599435|NCT01034137|58611249|FG000|Overall Study|Protocol Violation|2|||
30599436|NCT01034137|58611250|FG001|Overall Study|Protocol Violation|2|||
30599437|NCT01034137|58611251|FG002|Overall Study|Protocol Violation|1|||
30599438|NCT01034137|58611249|FG000|Overall Study|Refused treatment or did not cooperate|2|||
30599439|NCT01034137|58611250|FG001|Overall Study|Refused treatment or did not cooperate|0|||
30599440|NCT01034137|58611251|FG002|Overall Study|Refused treatment or did not cooperate|1|||
30599441|NCT01034137|58611249|FG000|Overall Study|Administrative or other|2|||
30599442|NCT01034137|58611250|FG001|Overall Study|Administrative or other|3|||
30599443|NCT01034137|58611251|FG002|Overall Study|Administrative or other|4|||
30599444|NCT01056289|58611260|FG000|Open-label Phase|Adverse Event|29|||
30599445|NCT01056289|58611261|FG001|Open-label Phase|Adverse Event|0|||
30599446|NCT01056289|58611262|FG002|Open-label Phase|Adverse Event|0|||
30599447|NCT01056289|58611263|FG003|Open-label Phase|Adverse Event|0|||
30688951|NCT00439777|58702639|FG001|Observational Period|Technical problems|1|||
30599448|NCT01056289|58611260|FG000|Open-label Phase|Lost to Follow-up|30|||
30688952|NCT00620854|58702651|FG000|Washout 1|Withdrawal by Subject|0|||
30858471|NCT02543918|58886872|FG000|Overall Study|Adverse Event|1|||
30858472|NCT02543918|58886873|FG001|Overall Study|Adverse Event|1|||
30858473|NCT01372995|58886882|FG000|Overall Study|Spouse withdrew participant from study|0|||
30858474|NCT01372995|58886883|FG001|Overall Study|Spouse withdrew participant from study|1|||
30858475|NCT01372995|58886884|FG002|Overall Study|Spouse withdrew participant from study|0|||
30858476|NCT01372995|58886882|FG000|Overall Study|Physician Decision|0|||
30858477|NCT01372995|58886883|FG001|Overall Study|Physician Decision|0|||
30688953|NCT00620854|58702652|FG001|Washout 1|Withdrawal by Subject|0|||
30959364|NCT01567865|59024778|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
30959365|NCT01567163|59024789|FG000|Overall Study|Progressive Disease|2|||
30959366|NCT01567163|59024789|FG000|Overall Study|Lost to Follow-up|2|||
30688954|NCT00620854|58702653|FG002|Washout 1|Withdrawal by Subject|1|||
30688955|NCT00620854|58702654|FG003|Washout 1|Withdrawal by Subject|1|||
30688956|NCT00620854|58702655|FG004|Washout 1|Withdrawal by Subject|0|||
30599449|NCT01056289|58611261|FG001|Open-label Phase|Lost to Follow-up|0|||
30599450|NCT01056289|58611262|FG002|Open-label Phase|Lost to Follow-up|0|||
30599451|NCT01056289|58611263|FG003|Open-label Phase|Lost to Follow-up|0|||
30599452|NCT01056289|58611260|FG000|Open-label Phase|Other|9|||
30599453|NCT01056289|58611261|FG001|Open-label Phase|Other|0|||
30599454|NCT01056289|58611262|FG002|Open-label Phase|Other|0|||
30599455|NCT01056289|58611263|FG003|Open-label Phase|Other|0|||
30599456|NCT01056289|58611260|FG000|Open-label Phase|Protocol Violation|6|||
30599457|NCT01056289|58611261|FG001|Open-label Phase|Protocol Violation|0|||
30599458|NCT01056289|58611262|FG002|Open-label Phase|Protocol Violation|0|||
30599459|NCT01056289|58611263|FG003|Open-label Phase|Protocol Violation|0|||
30599460|NCT01056289|58611260|FG000|Open-label Phase|Withdrawal by Subject|26|||
30599461|NCT01056289|58611261|FG001|Open-label Phase|Withdrawal by Subject|0|||
30599462|NCT01056289|58611262|FG002|Open-label Phase|Withdrawal by Subject|0|||
30599463|NCT01056289|58611263|FG003|Open-label Phase|Withdrawal by Subject|0|||
30688957|NCT00620854|58702656|FG005|Washout 1|Withdrawal by Subject|0|||
30688958|NCT00430027|58702667|FG000|Overall Study|Study terminated|8|||
30688959|NCT00429793|58702671|FG000|Overall Study|Improper pre-protocol treatment|3|||
30688960|NCT00429793|58702671|FG000|Overall Study|Required test not done|1|||
30688961|NCT00429793|58702671|FG000|Overall Study|Never treated|1|||
30688962|NCT00429793|58702671|FG000|Overall Study|Non-measurable|1|||
30858478|NCT01372995|58886884|FG002|Overall Study|Physician Decision|1|||
30858479|NCT02757521|58886894|FG000|Overall Study|Adverse Event|1|||
30959367|NCT01567085|59024798|FG000|Overall Study|Death|6|||
30959368|NCT01567085|59024798|FG000|Overall Study|Adverse Event|6|||
30959369|NCT01567085|59024798|FG000|Overall Study|Lost to Follow-up|3|||
30959370|NCT01567085|59024798|FG000|Overall Study|Graft loss|2|||
30959371|NCT01567085|59024798|FG000|Overall Study|Renal transplantectomy|1|||
30959372|NCT01567085|59024798|FG000|Overall Study|Returned to chronic dialysis|1|||
30599464|NCT01056289|58611260|FG000|Open-label Phase|Lack of Efficacy|18|||
30599465|NCT01056289|58611261|FG001|Open-label Phase|Lack of Efficacy|0|||
30599466|NCT01056289|58611262|FG002|Open-label Phase|Lack of Efficacy|0|||
30599467|NCT01056289|58611263|FG003|Open-label Phase|Lack of Efficacy|0|||
30599468|NCT01056289|58611260|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
30599469|NCT01056289|58611261|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
30599470|NCT01056289|58611262|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
30599471|NCT01056289|58611263|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
30599472|NCT01056289|58611260|FG000|Double-blind Phase|Adverse Event|0|||
30858480|NCT02757521|58886895|FG001|Overall Study|Adverse Event|0|||
30858481|NCT00834613|58886903|FG000|First Intervention|Protocol Violation|1|||
30858482|NCT00834613|58886904|FG001|First Intervention|Protocol Violation|0|||
30858483|NCT00834067|58886921|FG000|Washout of 21 Days|Protocol Violation|0|||
30858484|NCT00834067|58886922|FG001|Washout of 21 Days|Protocol Violation|1|||
30858485|NCT02758613|58886930|FG000|Treatment|Physician and Sponsor Decision|1|||
30858486|NCT02758613|58886931|FG001|Treatment|Physician and Sponsor Decision|0|||
30858487|NCT02758613|58886932|FG002|Treatment|Physician and Sponsor Decision|0|||
30858488|NCT02758613|58886933|FG003|Treatment|Physician and Sponsor Decision|0|||
30858489|NCT02758613|58886930|FG000|Treatment|Withdrawal by Subject|1|||
30858490|NCT02758613|58886931|FG001|Treatment|Withdrawal by Subject|0|||
30858491|NCT02758613|58886932|FG002|Treatment|Withdrawal by Subject|1|||
30858492|NCT02758613|58886933|FG003|Treatment|Withdrawal by Subject|0|||
30858493|NCT02758301|58886948|FG000|Overall Study|Death|12|||
30858494|NCT02758301|58886949|FG001|Overall Study|Death|0|||
30858495|NCT02758301|58886948|FG000|Overall Study|Physician Decision|10|||
30858496|NCT02758301|58886949|FG001|Overall Study|Physician Decision|1|||
30858497|NCT02758301|58886948|FG000|Overall Study|Withdrawal by Subject|5|||
30858498|NCT02758301|58886949|FG001|Overall Study|Withdrawal by Subject|6|||
30858499|NCT02758301|58886948|FG000|Overall Study|Lost to Follow-up|7|||
30858500|NCT02758301|58886949|FG001|Overall Study|Lost to Follow-up|0|||
30858501|NCT02758301|58886948|FG000|Overall Study|Protocol Violation|0|||
30858502|NCT02758301|58886949|FG001|Overall Study|Protocol Violation|1|||
30858503|NCT02669667|58886969|FG000|Overall Study|Lost to Follow-up|0|||
30858504|NCT02669667|58886970|FG001|Overall Study|Lost to Follow-up|0|||
30858505|NCT02669667|58886971|FG002|Overall Study|Lost to Follow-up|0|||
30858506|NCT02669667|58886972|FG003|Overall Study|Lost to Follow-up|0|||
30599473|NCT01056289|58611261|FG001|Double-blind Phase|Adverse Event|1|||
30688963|NCT00424645|58702682|FG000|Overall Study|Death|1|||
30688964|NCT00424645|58702683|FG001|Overall Study|Death|0|||
30858507|NCT02669667|58886973|FG004|Overall Study|Lost to Follow-up|0|||
30858508|NCT02669667|58886974|FG005|Overall Study|Lost to Follow-up|1|||
30959373|NCT01567085|59024798|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
30858509|NCT02669667|58886975|FG006|Overall Study|Lost to Follow-up|0|||
30858510|NCT02669433|58887000|FG000|Overall Study|Protocol Violation|0|||
30858511|NCT02669433|58887001|FG001|Overall Study|Protocol Violation|4|||
30858512|NCT02669433|58887002|FG002|Overall Study|Protocol Violation|1|||
30858513|NCT02669433|58887000|FG000|Overall Study|Disease Progression|1|||
30858514|NCT02669433|58887001|FG001|Overall Study|Disease Progression|0|||
30858515|NCT02669433|58887002|FG002|Overall Study|Disease Progression|0|||
30858516|NCT02669433|58887000|FG000|Overall Study|Physician Decision|1|||
30858517|NCT02669433|58887001|FG001|Overall Study|Physician Decision|1|||
30858518|NCT02669433|58887002|FG002|Overall Study|Physician Decision|0|||
30858519|NCT02669433|58887000|FG000|Overall Study|Adverse Event|6|||
30858520|NCT02669433|58887001|FG001|Overall Study|Adverse Event|7|||
30858521|NCT02669433|58887002|FG002|Overall Study|Adverse Event|10|||
30858522|NCT02669433|58887000|FG000|Overall Study|Sponsor Termination|1|||
30858523|NCT02669433|58887001|FG001|Overall Study|Sponsor Termination|0|||
30858524|NCT02669433|58887002|FG002|Overall Study|Sponsor Termination|1|||
30858525|NCT02669433|58887000|FG000|Overall Study|Withdrawal by Subject|5|||
30858526|NCT02669433|58887001|FG001|Overall Study|Withdrawal by Subject|1|||
30858527|NCT02669433|58887002|FG002|Overall Study|Withdrawal by Subject|0|||
30858528|NCT02669433|58887000|FG000|Overall Study|Withdrawal by Caregiver|1|||
30858529|NCT02669433|58887001|FG001|Overall Study|Withdrawal by Caregiver|0|||
30858530|NCT02669433|58887002|FG002|Overall Study|Withdrawal by Caregiver|2|||
30858531|NCT02669433|58887000|FG000|Overall Study|Death|0|||
30858532|NCT02669433|58887001|FG001|Overall Study|Death|1|||
30858533|NCT02669433|58887002|FG002|Overall Study|Death|1|||
30858534|NCT02756819|58887010|FG000|Overall Study|Lost for observation|23|||
30858535|NCT02756819|58887010|FG000|Overall Study|Patient's unwillingness|16|||
30858536|NCT02756819|58887010|FG000|Overall Study|Insufficient efficacy|2|||
30858537|NCT02756819|58887010|FG000|Overall Study|Adverse Event|2|||
30858538|NCT02756819|58887010|FG000|Overall Study|Reason not Specified|9|||
30858539|NCT00829309|58887016|FG000|Washout: 7 Days|Protocol Violation|1|||
30858540|NCT00829309|58887017|FG001|Washout: 7 Days|Protocol Violation|0|||
30858541|NCT02669121|58887023|FG000|Overall Study|Adverse Event|4|||
30858542|NCT02669121|58887024|FG001|Overall Study|Adverse Event|5|||
30858543|NCT02669121|58887023|FG000|Overall Study|Lost to Follow-up|15|||
30858544|NCT02669121|58887024|FG001|Overall Study|Lost to Follow-up|27|||
30858545|NCT02669121|58887023|FG000|Overall Study|Withdrawal by Subject|132|||
30858546|NCT02669121|58887024|FG001|Overall Study|Withdrawal by Subject|140|||
30858547|NCT02669121|58887023|FG000|Overall Study|Pregnancy|0|||
30858548|NCT02669121|58887024|FG001|Overall Study|Pregnancy|1|||
30858549|NCT02669121|58887023|FG000|Overall Study|Discharged from US Military Active Service|117|||
30858550|NCT02669121|58887024|FG001|Overall Study|Discharged from US Military Active Service|91|||
30858551|NCT02669121|58887023|FG000|Overall Study|Reason not Specified|22|||
30858552|NCT02669121|58887024|FG001|Overall Study|Reason not Specified|18|||
30858553|NCT02743117|58887032|FG000|Overall Study|Lost to Follow-up|0|||
30858554|NCT02743117|58887033|FG001|Overall Study|Lost to Follow-up|1|||
30858555|NCT02743117|58887032|FG000|Overall Study|Other|1|||
30858556|NCT02743117|58887033|FG001|Overall Study|Other|0|||
30858557|NCT02669043|58887048|FG000|Overall Study|Didn't meet I/E criteria|4|||
30858558|NCT02760407|58887056|FG000|Overall Study|Death|2|||
30858559|NCT02760407|58887057|FG001|Overall Study|Death|3|||
30858560|NCT02760407|58887058|FG002|Overall Study|Death|1|||
30858561|NCT02760407|58887059|FG003|Overall Study|Death|1|||
30858562|NCT02760407|58887056|FG000|Overall Study|Lost to Follow-up|1|||
30858563|NCT02760407|58887057|FG001|Overall Study|Lost to Follow-up|7|||
30858564|NCT02760407|58887058|FG002|Overall Study|Lost to Follow-up|4|||
30858565|NCT02760407|58887059|FG003|Overall Study|Lost to Follow-up|6|||
30858566|NCT02760407|58887056|FG000|Overall Study|Withdrawal by Subject|25|||
30858567|NCT02760407|58887057|FG001|Overall Study|Withdrawal by Subject|31|||
30858568|NCT02760407|58887058|FG002|Overall Study|Withdrawal by Subject|37|||
30858569|NCT02760407|58887059|FG003|Overall Study|Withdrawal by Subject|25|||
30858570|NCT02760407|58887056|FG000|Overall Study|Violation of Eligibility criteria|0|||
30858571|NCT02760407|58887057|FG001|Overall Study|Violation of Eligibility criteria|0|||
30858572|NCT02760407|58887058|FG002|Overall Study|Violation of Eligibility criteria|1|||
30858573|NCT02760407|58887059|FG003|Overall Study|Violation of Eligibility criteria|1|||
30858574|NCT02760407|58887056|FG000|Overall Study|Personal reasons|0|||
30858575|NCT02760407|58887057|FG001|Overall Study|Personal reasons|0|||
30959374|NCT01566773|59024802|FG000|Overall Study|Protocol specified criteria|4|||
30959375|NCT01566773|59024802|FG000|Overall Study|Protocol Violation|4|||
30858576|NCT02760407|58887058|FG002|Overall Study|Personal reasons|0|||
30858577|NCT02760407|58887059|FG003|Overall Study|Personal reasons|1|||
30858578|NCT02760407|58887056|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
30858579|NCT02760407|58887057|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
30858580|NCT02760407|58887058|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
30858581|NCT02760407|58887059|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
30858582|NCT02760407|58887056|FG000|Overall Study|Use of prohibited Medication|0|||
30858583|NCT02760407|58887057|FG001|Overall Study|Use of prohibited Medication|0|||
30858584|NCT02760407|58887058|FG002|Overall Study|Use of prohibited Medication|1|||
30858585|NCT02760407|58887059|FG003|Overall Study|Use of prohibited Medication|0|||
30858586|NCT02760407|58887056|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
30858587|NCT02760407|58887057|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
30858588|NCT02760407|58887058|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
30858589|NCT02760407|58887059|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
30858590|NCT02760407|58887056|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
30858591|NCT02760407|58887057|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
30858592|NCT02760407|58887058|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
30858593|NCT02760407|58887059|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
30858594|NCT02760407|58887056|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
30858595|NCT02760407|58887057|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
30858596|NCT02760407|58887058|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
30858597|NCT02760407|58887059|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
30858598|NCT02760407|58887056|FG000|Overall Study|Inadequately Enrolled|0|||
30858599|NCT02760407|58887057|FG001|Overall Study|Inadequately Enrolled|0|||
30858600|NCT02760407|58887058|FG002|Overall Study|Inadequately Enrolled|0|||
30858601|NCT02760407|58887059|FG003|Overall Study|Inadequately Enrolled|1|||
30858602|NCT02760407|58887056|FG000|Overall Study|Withdrawal By PI's Decision|0|||
30858603|NCT02760407|58887057|FG001|Overall Study|Withdrawal By PI's Decision|1|||
30858604|NCT02760407|58887058|FG002|Overall Study|Withdrawal By PI's Decision|0|||
30858605|NCT02760407|58887059|FG003|Overall Study|Withdrawal By PI's Decision|0|||
30858606|NCT02760407|58887056|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
30858607|NCT02760407|58887057|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
30858608|NCT02760407|58887058|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
30858609|NCT02760407|58887059|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
30858610|NCT02760407|58887056|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
30858611|NCT02760407|58887057|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
30858612|NCT02760407|58887058|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
30858613|NCT02760407|58887059|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
30858614|NCT02760407|58887056|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
30858615|NCT02760407|58887057|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
30858616|NCT02760407|58887058|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
30858617|NCT02760407|58887059|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
30858618|NCT02760407|58887056|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
30858619|NCT02760407|58887057|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
30858620|NCT02760407|58887058|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
30858621|NCT02760407|58887059|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
30858622|NCT02760407|58887056|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
30858623|NCT02760407|58887057|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
30858624|NCT02760407|58887058|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
30858625|NCT02760407|58887059|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
30858626|NCT02760407|58887056|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
30858627|NCT02760407|58887057|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
30858628|NCT02760407|58887058|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
30599474|NCT01056289|58611262|FG002|Double-blind Phase|Adverse Event|2|||
30599475|NCT01056289|58611263|FG003|Double-blind Phase|Adverse Event|1|||
30599476|NCT01056289|58611260|FG000|Double-blind Phase|Lost to Follow-up|0|||
30599477|NCT01056289|58611261|FG001|Double-blind Phase|Lost to Follow-up|2|||
30599478|NCT01056289|58611262|FG002|Double-blind Phase|Lost to Follow-up|2|||
30599479|NCT01056289|58611263|FG003|Double-blind Phase|Lost to Follow-up|2|||
30599480|NCT01056289|58611260|FG000|Double-blind Phase|Other|0|||
30599481|NCT01056289|58611261|FG001|Double-blind Phase|Other|0|||
30599482|NCT01056289|58611262|FG002|Double-blind Phase|Other|1|||
30599483|NCT01056289|58611263|FG003|Double-blind Phase|Other|2|||
30599484|NCT01056289|58611260|FG000|Double-blind Phase|Protocol Violation|0|||
30599485|NCT01056289|58611261|FG001|Double-blind Phase|Protocol Violation|0|||
30599486|NCT01056289|58611262|FG002|Double-blind Phase|Protocol Violation|1|||
30599487|NCT01056289|58611263|FG003|Double-blind Phase|Protocol Violation|1|||
30599488|NCT01056289|58611260|FG000|Double-blind Phase|Withdrawal by Subject|0|||
30858629|NCT02760407|58887059|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
30858630|NCT02760407|58887056|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
30858631|NCT02760407|58887057|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
30858632|NCT02760407|58887058|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
30858633|NCT02760407|58887059|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
30858634|NCT02760407|58887056|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
30858635|NCT02760407|58887057|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
30858636|NCT02760407|58887058|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
30858637|NCT02760407|58887059|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
30858638|NCT02760407|58887056|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
30858639|NCT02760407|58887057|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
30858640|NCT02760407|58887058|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
30858641|NCT02760407|58887059|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
30858642|NCT00805129|58887070|FG000|Overall Study|Not treated|1|||
30858643|NCT02668185|58887074|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
30858644|NCT02668185|58887075|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
30858645|NCT02668185|58887074|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
30858646|NCT02668185|58887075|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
30858647|NCT02668185|58887074|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
30858648|NCT02668185|58887075|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
30858649|NCT02668185|58887074|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
30858650|NCT02668185|58887075|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
30858651|NCT02742181|58887086|FG000|Overall Study|Physician Decision|1|||
30858652|NCT02742181|58887087|FG001|Overall Study|Physician Decision|0|||
30858653|NCT02742103|58887095|FG000|Overall Study|Protocol Violation|1|||
30858654|NCT02742103|58887096|FG001|Overall Study|Protocol Violation|0|||
30858655|NCT02742103|58887095|FG000|Overall Study|Death|2|||
30858656|NCT02742103|58887096|FG001|Overall Study|Death|2|||
30858657|NCT02742103|58887095|FG000|Overall Study|Adverse Event|1|||
30858658|NCT02742103|58887096|FG001|Overall Study|Adverse Event|0|||
30858659|NCT02742103|58887095|FG000|Overall Study|Moved to another town|0|||
30858660|NCT02742103|58887096|FG001|Overall Study|Moved to another town|1|||
30858661|NCT02742103|58887095|FG000|Overall Study|Withdrawal by Subject|5|||
30858662|NCT02742103|58887096|FG001|Overall Study|Withdrawal by Subject|2|||
30858663|NCT02741713|58887104|FG000|Overall Study|Surgery type changed intra-operatively|2|||
30858664|NCT02741713|58887105|FG001|Overall Study|Surgery type changed intra-operatively|1|||
30858665|NCT02663271|58887112|FG000|Overall Study|Withdrawal by Subject|5|||
30858666|NCT02663271|58887112|FG000|Overall Study|Lack of Efficacy|1|||
30858667|NCT02742649|58887119|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
30858668|NCT02742649|58887120|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
30858669|NCT02742649|58887121|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
30858670|NCT02742649|58887122|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
30858671|NCT02742649|58887123|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
30858672|NCT02742649|58887119|FG000|Double-Blind Treatment Period|Adverse Event|0|||
30858673|NCT02742649|58887120|FG001|Double-Blind Treatment Period|Adverse Event|1|||
30858674|NCT02742649|58887121|FG002|Double-Blind Treatment Period|Adverse Event|0|||
30858675|NCT02742649|58887122|FG003|Double-Blind Treatment Period|Adverse Event|0|||
30858676|NCT02742649|58887123|FG004|Double-Blind Treatment Period|Adverse Event|0|||
30959376|NCT01566773|59024802|FG000|Overall Study|Withdrawal by Subject|9|||
30858677|NCT02742649|58887119|FG000|Open-Label Period|Lost to Follow-up|0|||
30858678|NCT02742649|58887120|FG001|Open-Label Period|Lost to Follow-up|0|||
30858679|NCT02742649|58887121|FG002|Open-Label Period|Lost to Follow-up|0|||
30858680|NCT02742649|58887122|FG003|Open-Label Period|Lost to Follow-up|0|||
30858681|NCT02742649|58887123|FG004|Open-Label Period|Lost to Follow-up|1|||
30858682|NCT02665689|58887136|FG000|Overall Study|Adverse Event|1|||
30858683|NCT02665689|58887137|FG001|Overall Study|Adverse Event|0|||
30858684|NCT02665689|58887136|FG000|Overall Study|Trial termination|1|||
30858685|NCT02665689|58887137|FG001|Overall Study|Trial termination|1|||
30858686|NCT02665689|58887136|FG000|Overall Study|Lost to Follow-up|0|||
30858687|NCT02665689|58887137|FG001|Overall Study|Lost to Follow-up|1|||
30959377|NCT01566773|59024802|FG000|Overall Study|Administrative reason|1|||
30959378|NCT01566773|59024802|FG000|Overall Study|Adverse Event|10|||
30858688|NCT02665455|58887143|FG000|Overall Study|Withdrawal by Subject|6|||
30858689|NCT02665455|58887143|FG000|Overall Study|Lost to Follow-up|1|||
30858690|NCT02665455|58887143|FG000|Overall Study|Adverse Event|1|||
30858691|NCT02665455|58887143|FG000|Overall Study|Protocol Violation|1|||
30858692|NCT02755805|58887149|FG000|Overall Study|Lost to Follow-up|1|||
30858693|NCT02755805|58887150|FG001|Overall Study|Lost to Follow-up|2|||
30858694|NCT02755805|58887149|FG000|Overall Study|Refused assessments|1|||
30858695|NCT02755805|58887150|FG001|Overall Study|Refused assessments|0|||
30858696|NCT02755805|58887149|FG000|Overall Study|Withdrawal by Subject|0|||
30858697|NCT02755805|58887150|FG001|Overall Study|Withdrawal by Subject|2|||
30858698|NCT02755649|58887159|FG000|Overall Study|Transitioned into OLE study|99|||
30858699|NCT02755649|58887160|FG001|Overall Study|Transitioned into OLE study|98|||
30858700|NCT02755649|58887161|FG002|Overall Study|Transitioned into OLE study|100|||
30858701|NCT02755649|58887159|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
30858702|NCT02755649|58887160|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
30858703|NCT02755649|58887161|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
30858704|NCT02755649|58887159|FG000|Overall Study|Physician Decision|0|||
30858705|NCT02755649|58887160|FG001|Overall Study|Physician Decision|0|||
30858706|NCT02755649|58887161|FG002|Overall Study|Physician Decision|2|||
30858707|NCT02755649|58887159|FG000|Overall Study|Withdrawal by Subject|0|||
30858708|NCT02755649|58887160|FG001|Overall Study|Withdrawal by Subject|1|||
30858709|NCT02755649|58887161|FG002|Overall Study|Withdrawal by Subject|0|||
30858710|NCT02755649|58887159|FG000|Overall Study|Undecided|1|||
30858711|NCT02755649|58887160|FG001|Overall Study|Undecided|0|||
30858712|NCT02755649|58887161|FG002|Overall Study|Undecided|0|||
30858713|NCT00151411|58887171|FG000|Overall Study|Lost to Follow-up|15|||
30858714|NCT00151411|58887172|FG001|Overall Study|Lost to Follow-up|19|||
30858715|NCT00151411|58887171|FG000|Overall Study|Withdrawal by Subject|12|||
30858716|NCT00151411|58887172|FG001|Overall Study|Withdrawal by Subject|20|||
30858717|NCT00151411|58887171|FG000|Overall Study|Adverse Event|6|||
30858718|NCT00151411|58887172|FG001|Overall Study|Adverse Event|0|||
30858719|NCT00151411|58887171|FG000|Overall Study|Pregnancy|0|||
30858720|NCT00151411|58887172|FG001|Overall Study|Pregnancy|4|||
30858721|NCT02662569|58887182|FG000|Overall Study|Withdrawal by Subject|6|||
30858722|NCT02662569|58887183|FG001|Overall Study|Withdrawal by Subject|1|||
30858723|NCT02662569|58887184|FG002|Overall Study|Withdrawal by Subject|6|||
30858724|NCT02662569|58887185|FG003|Overall Study|Withdrawal by Subject|4|||
30858725|NCT02662569|58887182|FG000|Overall Study|Lost to Follow-up|1|||
30858726|NCT02662569|58887183|FG001|Overall Study|Lost to Follow-up|0|||
30858727|NCT02662569|58887184|FG002|Overall Study|Lost to Follow-up|0|||
30858728|NCT02662569|58887185|FG003|Overall Study|Lost to Follow-up|0|||
30858729|NCT02741635|58887195|FG000|Overall Study|Withdrawal by Subject|1|||
30858730|NCT02753075|58887203|FG000|Overall Study|Adverse Event|2|||
30858731|NCT02753075|58887204|FG001|Overall Study|Adverse Event|1|||
30858732|NCT02753075|58887205|FG002|Overall Study|Adverse Event|0|||
30858733|NCT02753075|58887203|FG000|Overall Study|Lost to Follow-up|2|||
30858734|NCT02753075|58887204|FG001|Overall Study|Lost to Follow-up|0|||
30858735|NCT02753075|58887205|FG002|Overall Study|Lost to Follow-up|0|||
30858736|NCT02753075|58887203|FG000|Overall Study|Withdrawal of Consent|1|||
30858737|NCT02753075|58887204|FG001|Overall Study|Withdrawal of Consent|1|||
30858738|NCT02753075|58887205|FG002|Overall Study|Withdrawal of Consent|3|||
30858739|NCT02753075|58887203|FG000|Overall Study|Physician Decision|3|||
30858740|NCT02753075|58887204|FG001|Overall Study|Physician Decision|1|||
30858741|NCT02753075|58887205|FG002|Overall Study|Physician Decision|0|||
30858742|NCT02332720|58887237|FG000|Part A and Part B|Lost to Follow-up|1|||
30858743|NCT02332720|58887238|FG001|Part A and Part B|Lost to Follow-up|0|||
30858744|NCT02332720|58887239|FG002|Part A and Part B|Lost to Follow-up|0|||
30858745|NCT02332720|58887240|FG003|Part A and Part B|Lost to Follow-up|0|||
30858746|NCT02332720|58887241|FG004|Part A and Part B|Lost to Follow-up|0|||
30858747|NCT02332720|58887242|FG005|Part A and Part B|Lost to Follow-up|2|||
30959379|NCT01566773|59024802|FG000|Overall Study|Physician Decision|2|||
30959380|NCT01566149|59024824|FG000|Overall Study|Adverse Event|0|||
30688965|NCT00763451|58702693|FG000|Overall Study|Adverse Event|4|||
30688966|NCT00763451|58702694|FG001|Overall Study|Adverse Event|6|||
30688967|NCT00763451|58702695|FG002|Overall Study|Adverse Event|19|||
30688968|NCT00763451|58702696|FG003|Overall Study|Adverse Event|14|||
30688969|NCT00763451|58702693|FG000|Overall Study|Lack of Efficacy|1|||
30688970|NCT00763451|58702694|FG001|Overall Study|Lack of Efficacy|4|||
30688971|NCT00763451|58702695|FG002|Overall Study|Lack of Efficacy|3|||
30688972|NCT00763451|58702696|FG003|Overall Study|Lack of Efficacy|2|||
30688973|NCT00763451|58702693|FG000|Overall Study|Withdrawal by Subject|1|||
30688974|NCT00763451|58702694|FG001|Overall Study|Withdrawal by Subject|6|||
30688975|NCT00763451|58702695|FG002|Overall Study|Withdrawal by Subject|9|||
30688976|NCT00763451|58702696|FG003|Overall Study|Withdrawal by Subject|7|||
30688977|NCT00763451|58702693|FG000|Overall Study|Protocol Violation|0|||
30688978|NCT00763451|58702694|FG001|Overall Study|Protocol Violation|0|||
30858748|NCT02332720|58887243|FG006|Part A and Part B|Lost to Follow-up|1|||
30858749|NCT02332720|58887244|FG007|Part A and Part B|Lost to Follow-up|1|||
30858750|NCT02332720|58887245|FG008|Part A and Part B|Lost to Follow-up|0|||
30858751|NCT02332720|58887246|FG009|Part A and Part B|Lost to Follow-up|0|||
30858752|NCT02332720|58887247|FG010|Part A and Part B|Lost to Follow-up|0|||
30858753|NCT02332720|58887248|FG011|Part A and Part B|Lost to Follow-up|0|||
30858754|NCT02332720|58887249|FG012|Part A and Part B|Lost to Follow-up|0|||
30858755|NCT02332720|58887250|FG013|Part A and Part B|Lost to Follow-up|0|||
30858756|NCT02332720|58887251|FG014|Part A and Part B|Lost to Follow-up|0|||
30858757|NCT02332720|58887252|FG015|Part A and Part B|Lost to Follow-up|1|||
30858758|NCT02332720|58887253|FG016|Part A and Part B|Lost to Follow-up|0|||
30858759|NCT02332720|58887254|FG017|Part A and Part B|Lost to Follow-up|0|||
30858760|NCT02332720|58887255|FG018|Part A and Part B|Lost to Follow-up|0|||
30858761|NCT02332720|58887256|FG019|Part A and Part B|Lost to Follow-up|0|||
30688979|NCT00763451|58702695|FG002|Overall Study|Protocol Violation|1|||
30688980|NCT00763451|58702696|FG003|Overall Study|Protocol Violation|0|||
30688981|NCT00763451|58702693|FG000|Overall Study|Poor Compliance to Protocol|1|||
30688982|NCT00763451|58702694|FG001|Overall Study|Poor Compliance to Protocol|1|||
30688983|NCT00763451|58702695|FG002|Overall Study|Poor Compliance to Protocol|2|||
30858762|NCT02332720|58887257|FG020|Part A and Part B|Lost to Follow-up|0|||
30858763|NCT02332720|58887258|FG021|Part A and Part B|Lost to Follow-up|0|||
30858764|NCT02332720|58887259|FG022|Part A and Part B|Lost to Follow-up|0|||
30858765|NCT02332720|58887237|FG000|Part A and Part B|Adverse Event|0|||
30858766|NCT02332720|58887238|FG001|Part A and Part B|Adverse Event|0|||
30858767|NCT02332720|58887239|FG002|Part A and Part B|Adverse Event|0|||
30858768|NCT02332720|58887240|FG003|Part A and Part B|Adverse Event|0|||
30858769|NCT02332720|58887241|FG004|Part A and Part B|Adverse Event|0|||
30858770|NCT02332720|58887242|FG005|Part A and Part B|Adverse Event|0|||
30858771|NCT02332720|58887243|FG006|Part A and Part B|Adverse Event|0|||
30858772|NCT02332720|58887244|FG007|Part A and Part B|Adverse Event|0|||
30858773|NCT02332720|58887245|FG008|Part A and Part B|Adverse Event|0|||
30858774|NCT02332720|58887246|FG009|Part A and Part B|Adverse Event|0|||
30858775|NCT02332720|58887247|FG010|Part A and Part B|Adverse Event|0|||
30858776|NCT02332720|58887248|FG011|Part A and Part B|Adverse Event|0|||
30858777|NCT02332720|58887249|FG012|Part A and Part B|Adverse Event|0|||
30858778|NCT02332720|58887250|FG013|Part A and Part B|Adverse Event|0|||
30858779|NCT02332720|58887251|FG014|Part A and Part B|Adverse Event|0|||
30858780|NCT02332720|58887252|FG015|Part A and Part B|Adverse Event|0|||
30858781|NCT02332720|58887253|FG016|Part A and Part B|Adverse Event|0|||
30858782|NCT02332720|58887254|FG017|Part A and Part B|Adverse Event|1|||
30858783|NCT02332720|58887255|FG018|Part A and Part B|Adverse Event|0|||
30858784|NCT02332720|58887256|FG019|Part A and Part B|Adverse Event|0|||
30858785|NCT02332720|58887257|FG020|Part A and Part B|Adverse Event|0|||
30858786|NCT02332720|58887258|FG021|Part A and Part B|Adverse Event|0|||
30858787|NCT02332720|58887259|FG022|Part A and Part B|Adverse Event|0|||
30858788|NCT02332720|58887237|FG000|Part A and Part B|Physician Decision|0|||
30858789|NCT02332720|58887238|FG001|Part A and Part B|Physician Decision|0|||
30858790|NCT02332720|58887239|FG002|Part A and Part B|Physician Decision|0|||
30858791|NCT02332720|58887240|FG003|Part A and Part B|Physician Decision|0|||
30858792|NCT02332720|58887241|FG004|Part A and Part B|Physician Decision|0|||
30858793|NCT02332720|58887242|FG005|Part A and Part B|Physician Decision|0|||
30858794|NCT02332720|58887243|FG006|Part A and Part B|Physician Decision|0|||
30858795|NCT02332720|58887244|FG007|Part A and Part B|Physician Decision|0|||
30858796|NCT02332720|58887245|FG008|Part A and Part B|Physician Decision|0|||
30858797|NCT02332720|58887246|FG009|Part A and Part B|Physician Decision|0|||
30858798|NCT02332720|58887247|FG010|Part A and Part B|Physician Decision|0|||
30858799|NCT02332720|58887248|FG011|Part A and Part B|Physician Decision|0|||
30858800|NCT02332720|58887249|FG012|Part A and Part B|Physician Decision|0|||
30858801|NCT02332720|58887250|FG013|Part A and Part B|Physician Decision|0|||
30858802|NCT02332720|58887251|FG014|Part A and Part B|Physician Decision|0|||
30858803|NCT02332720|58887252|FG015|Part A and Part B|Physician Decision|0|||
30858804|NCT02332720|58887253|FG016|Part A and Part B|Physician Decision|0|||
30858805|NCT02332720|58887254|FG017|Part A and Part B|Physician Decision|0|||
30858806|NCT02332720|58887255|FG018|Part A and Part B|Physician Decision|1|||
30599489|NCT01056289|58611261|FG001|Double-blind Phase|Withdrawal by Subject|0|||
30599490|NCT01056289|58611262|FG002|Double-blind Phase|Withdrawal by Subject|4|||
30599491|NCT01056289|58611263|FG003|Double-blind Phase|Withdrawal by Subject|2|||
30599492|NCT01056289|58611260|FG000|Double-blind Phase|Discontinuation symptom|0|||
30599493|NCT01056289|58611261|FG001|Double-blind Phase|Discontinuation symptom|1|||
30599494|NCT01056289|58611262|FG002|Double-blind Phase|Discontinuation symptom|2|||
30599495|NCT01056289|58611263|FG003|Double-blind Phase|Discontinuation symptom|2|||
30599496|NCT01056289|58611260|FG000|Double-blind Phase|Physician Decision|0|||
30599497|NCT01056289|58611261|FG001|Double-blind Phase|Physician Decision|0|||
30599498|NCT01056289|58611262|FG002|Double-blind Phase|Physician Decision|1|||
30599499|NCT01056289|58611263|FG003|Double-blind Phase|Physician Decision|0|||
30599500|NCT01039675|58611275|FG000|Overall Study|Adverse Event|0|||
30599501|NCT01039675|58611276|FG001|Overall Study|Adverse Event|2|||
30688984|NCT00763451|58702696|FG003|Overall Study|Poor Compliance to Protocol|2|||
30688985|NCT00763451|58702693|FG000|Overall Study|Familial and Personal Reasons|5|||
30688986|NCT00763451|58702694|FG001|Overall Study|Familial and Personal Reasons|3|||
30688987|NCT00763451|58702695|FG002|Overall Study|Familial and Personal Reasons|5|||
30858807|NCT02332720|58887256|FG019|Part A and Part B|Physician Decision|0|||
30858808|NCT02332720|58887257|FG020|Part A and Part B|Physician Decision|0|||
30858809|NCT02332720|58887258|FG021|Part A and Part B|Physician Decision|0|||
30858810|NCT02332720|58887259|FG022|Part A and Part B|Physician Decision|0|||
30858811|NCT02332720|58887237|FG000|Part A and Part B|Withdrawal by Subject|0|||
30858812|NCT02332720|58887238|FG001|Part A and Part B|Withdrawal by Subject|0|||
30858813|NCT02332720|58887239|FG002|Part A and Part B|Withdrawal by Subject|0|||
30858814|NCT02332720|58887240|FG003|Part A and Part B|Withdrawal by Subject|0|||
30688988|NCT00763451|58702696|FG003|Overall Study|Familial and Personal Reasons|4|||
30688989|NCT00763451|58702693|FG000|Overall Study|Randomized but not Treated|1|||
30858815|NCT02332720|58887241|FG004|Part A and Part B|Withdrawal by Subject|0|||
30858816|NCT02332720|58887242|FG005|Part A and Part B|Withdrawal by Subject|1|||
30858817|NCT02332720|58887243|FG006|Part A and Part B|Withdrawal by Subject|0|||
30858818|NCT02332720|58887244|FG007|Part A and Part B|Withdrawal by Subject|0|||
30959381|NCT01566149|59024825|FG001|Overall Study|Adverse Event|1|||
30688990|NCT00763451|58702694|FG001|Overall Study|Randomized but not Treated|1|||
30688991|NCT00763451|58702695|FG002|Overall Study|Randomized but not Treated|0|||
30688992|NCT00763451|58702696|FG003|Overall Study|Randomized but not Treated|0|||
30688993|NCT00763451|58702693|FG000|Overall Study|Study Site Reason|0|||
30688994|NCT00763451|58702694|FG001|Overall Study|Study Site Reason|1|||
30688995|NCT00763451|58702695|FG002|Overall Study|Study Site Reason|1|||
30688996|NCT00763451|58702696|FG003|Overall Study|Study Site Reason|1|||
30688997|NCT00762762|58702709|FG000|Overall Study|Did not return for appointments|6|||
30688998|NCT00762762|58702710|FG001|Overall Study|Did not return for appointments|8|||
30688999|NCT00424489|58702718|FG000|Overall Study|Death|3|||
30689000|NCT00578864|58702724|FG000|Overall Study|Death|1|||
30689001|NCT00578864|58702725|FG001|Overall Study|Death|0|||
30689002|NCT00770315|58702748|FG000|Overall Study|Adverse Event|11|||
30689003|NCT00770315|58702749|FG001|Overall Study|Adverse Event|17|||
30689004|NCT00770315|58702750|FG002|Overall Study|Adverse Event|16|||
30689005|NCT00770315|58702751|FG003|Overall Study|Adverse Event|6|||
30599502|NCT01039675|58611275|FG000|Overall Study|Lack of Efficacy|0|||
30599503|NCT01039675|58611276|FG001|Overall Study|Lack of Efficacy|2|||
30599504|NCT01039675|58611275|FG000|Overall Study|Withdrawal by Subject|0|||
30599505|NCT01039675|58611276|FG001|Overall Study|Withdrawal by Subject|1|||
30599506|NCT01039675|58611275|FG000|Overall Study|Lost to Follow-up|0|||
30599507|NCT01039675|58611276|FG001|Overall Study|Lost to Follow-up|1|||
30599508|NCT01039675|58611275|FG000|Overall Study|Physician Decision|0|||
30599509|NCT01039675|58611276|FG001|Overall Study|Physician Decision|1|||
30599510|NCT01033825|58611289|FG000|Overall Study|Withdrawal by Subject|2|||
30599511|NCT01033825|58611290|FG001|Overall Study|Withdrawal by Subject|3|||
30599512|NCT01033825|58611291|FG002|Overall Study|Withdrawal by Subject|2|||
30599513|NCT01033825|58611292|FG003|Overall Study|Withdrawal by Subject|1|||
30599514|NCT01033825|58611293|FG004|Overall Study|Withdrawal by Subject|1|||
30599515|NCT01033825|58611294|FG005|Overall Study|Withdrawal by Subject|0|||
30599516|NCT01033825|58611295|FG006|Overall Study|Withdrawal by Subject|0|||
30599517|NCT01033825|58611289|FG000|Overall Study|Adverse Event|0|||
30599518|NCT01033825|58611290|FG001|Overall Study|Adverse Event|0|||
30599519|NCT01033825|58611291|FG002|Overall Study|Adverse Event|0|||
30599520|NCT01033825|58611292|FG003|Overall Study|Adverse Event|1|||
30599521|NCT01033825|58611293|FG004|Overall Study|Adverse Event|0|||
30599522|NCT01033825|58611294|FG005|Overall Study|Adverse Event|0|||
30599523|NCT01033825|58611295|FG006|Overall Study|Adverse Event|0|||
30599524|NCT01033825|58611289|FG000|Overall Study|Protocol Violation|1|||
30599525|NCT01033825|58611290|FG001|Overall Study|Protocol Violation|0|||
30599526|NCT01033825|58611291|FG002|Overall Study|Protocol Violation|0|||
30599527|NCT01033825|58611292|FG003|Overall Study|Protocol Violation|0|||
30599528|NCT01033825|58611293|FG004|Overall Study|Protocol Violation|0|||
30599529|NCT01033825|58611294|FG005|Overall Study|Protocol Violation|0|||
30599530|NCT01033825|58611295|FG006|Overall Study|Protocol Violation|0|||
30599531|NCT01033825|58611289|FG000|Overall Study|Other|0|||
30599532|NCT01033825|58611290|FG001|Overall Study|Other|0|||
30599533|NCT01033825|58611291|FG002|Overall Study|Other|0|||
30599534|NCT01033825|58611292|FG003|Overall Study|Other|0|||
30599535|NCT01033825|58611293|FG004|Overall Study|Other|1|||
30599536|NCT01033825|58611294|FG005|Overall Study|Other|0|||
30599537|NCT01033825|58611295|FG006|Overall Study|Other|0|||
30599538|NCT01033747|58611315|FG000|Overall Study|Adverse Event|9|||
30599539|NCT01033747|58611316|FG001|Overall Study|Adverse Event|4|||
30599540|NCT01033747|58611315|FG000|Overall Study|Abnormal Laboratory Value|1|||
30599541|NCT01033747|58611316|FG001|Overall Study|Abnormal Laboratory Value|0|||
30599542|NCT01033747|58611315|FG000|Overall Study|Abnormal test procedure|0|||
30599543|NCT01033747|58611316|FG001|Overall Study|Abnormal test procedure|1|||
30599544|NCT01033747|58611315|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
30599545|NCT01033747|58611316|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
30599546|NCT01033747|58611315|FG000|Overall Study|Protocol Violation|1|||
30599547|NCT01033747|58611316|FG001|Overall Study|Protocol Violation|0|||
30599548|NCT01033747|58611315|FG000|Overall Study|Withdrawal by Subject|9|||
30689006|NCT00770315|58702748|FG000|Overall Study|Lost to Follow-up|9|||
30689007|NCT00770315|58702749|FG001|Overall Study|Lost to Follow-up|5|||
30689008|NCT00770315|58702750|FG002|Overall Study|Lost to Follow-up|10|||
30689009|NCT00770315|58702751|FG003|Overall Study|Lost to Follow-up|3|||
30689010|NCT00770315|58702748|FG000|Overall Study|Withdrawal by Subject|13|||
30689011|NCT00770315|58702749|FG001|Overall Study|Withdrawal by Subject|17|||
30689012|NCT00770315|58702750|FG002|Overall Study|Withdrawal by Subject|24|||
30689013|NCT00770315|58702751|FG003|Overall Study|Withdrawal by Subject|20|||
30599549|NCT01033747|58611316|FG001|Overall Study|Withdrawal by Subject|6|||
30689014|NCT00770315|58702748|FG000|Overall Study|Noncompliance with Protocol|7|||
30689015|NCT00770315|58702749|FG001|Overall Study|Noncompliance with Protocol|4|||
30689016|NCT00770315|58702750|FG002|Overall Study|Noncompliance with Protocol|7|||
30689017|NCT00770315|58702751|FG003|Overall Study|Noncompliance with Protocol|9|||
30689018|NCT00587171|58702763|FG000|Overall Study|Lost to Follow-up|1|||
30689019|NCT00587171|58702764|FG001|Overall Study|Lost to Follow-up|1|||
30689020|NCT00763139|58702770|FG000|Overall Study|Adverse Event|4|||
30689021|NCT00763139|58702771|FG001|Overall Study|Adverse Event|2|||
30689022|NCT00763139|58702770|FG000|Overall Study|Withdrawal by Subject|0|||
30689023|NCT00763139|58702771|FG001|Overall Study|Withdrawal by Subject|1|||
30689024|NCT00763139|58702770|FG000|Overall Study|med change not allowed by protocol|1|||
30858819|NCT02332720|58887245|FG008|Part A and Part B|Withdrawal by Subject|0|||
30858820|NCT02332720|58887246|FG009|Part A and Part B|Withdrawal by Subject|0|||
30858821|NCT02332720|58887247|FG010|Part A and Part B|Withdrawal by Subject|0|||
30858822|NCT02332720|58887248|FG011|Part A and Part B|Withdrawal by Subject|0|||
30858823|NCT02332720|58887249|FG012|Part A and Part B|Withdrawal by Subject|0|||
30858824|NCT02332720|58887250|FG013|Part A and Part B|Withdrawal by Subject|0|||
30858825|NCT02332720|58887251|FG014|Part A and Part B|Withdrawal by Subject|0|||
30858826|NCT02332720|58887252|FG015|Part A and Part B|Withdrawal by Subject|0|||
30858827|NCT02332720|58887253|FG016|Part A and Part B|Withdrawal by Subject|0|||
30858828|NCT02332720|58887254|FG017|Part A and Part B|Withdrawal by Subject|0|||
30858829|NCT02332720|58887255|FG018|Part A and Part B|Withdrawal by Subject|0|||
30858830|NCT02332720|58887256|FG019|Part A and Part B|Withdrawal by Subject|1|||
30858831|NCT02332720|58887257|FG020|Part A and Part B|Withdrawal by Subject|0|||
30858832|NCT02332720|58887258|FG021|Part A and Part B|Withdrawal by Subject|0|||
30858833|NCT02332720|58887259|FG022|Part A and Part B|Withdrawal by Subject|0|||
30858834|NCT02331394|58887331|FG000|Overall Study|Disease progression|1|||
30858835|NCT01645930|58887342|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
30858836|NCT01645930|58887342|FG000|Overall Study|Progressive Disease|12|||
30858837|NCT01645930|58887342|FG000|Overall Study|Adverse Event|4|||
30858838|NCT01645930|58887342|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
30858839|NCT01645930|58887342|FG000|Overall Study|Withdrawal by Participant|2|||
30858840|NCT01645930|58887342|FG000|Overall Study|Reason not Defined|1|||
30858841|NCT02299336|58887346|FG000|Overall Study|Withdrawal by Subject|11|||
30858842|NCT02299336|58887346|FG000|Overall Study|Adverse Event|1|||
30858843|NCT02299336|58887346|FG000|Overall Study|Death|1|||
30858844|NCT02299336|58887346|FG000|Overall Study|Lost to Follow-up|1|||
30858845|NCT02664441|58887352|FG000|Randomization|Withdrawal by Subject|0|||
30858846|NCT02664441|58887353|FG001|Randomization|Withdrawal by Subject|1|||
30858847|NCT02664441|58887352|FG000|36-week Randomized Trial|Adverse Event|2|||
30858848|NCT02664441|58887353|FG001|36-week Randomized Trial|Adverse Event|0|||
30858849|NCT02664441|58887352|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
30858850|NCT02664441|58887353|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
30858851|NCT02664441|58887352|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
30858852|NCT02664441|58887353|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
30959382|NCT01566149|59024824|FG000|Overall Study|Non-compliance with study medication|2|||
30959383|NCT01566149|59024825|FG001|Overall Study|Non-compliance with study medication|0|||
30959384|NCT01566149|59024824|FG000|Overall Study|Protocol Violation|0|||
30959385|NCT01566149|59024825|FG001|Overall Study|Protocol Violation|1|||
30599550|NCT01033747|58611315|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
30599551|NCT01033747|58611316|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
30599552|NCT01033747|58611315|FG000|Overall Study|Stopped at end of Extension 1|2|||
30599553|NCT01033747|58611316|FG001|Overall Study|Stopped at end of Extension 1|0|||
30599554|NCT01091428|58611326|FG000|Phase 1|Progressive Disease|24|||
30599555|NCT01091428|58611327|FG001|Phase 1|Progressive Disease|8|||
30858853|NCT02664441|58887352|FG000|18-week Open Label Extension|Adverse Event|1|||
30858854|NCT02664441|58887353|FG001|18-week Open Label Extension|Adverse Event|0|||
30599556|NCT01091428|58611328|FG002|Phase 1|Progressive Disease|0|||
30599557|NCT01091428|58611329|FG003|Phase 1|Progressive Disease|0|||
30599558|NCT01091428|58611326|FG000|Phase 1|Symptomatic Deterioration|3|||
30599559|NCT01091428|58611327|FG001|Phase 1|Symptomatic Deterioration|2|||
30599560|NCT01091428|58611328|FG002|Phase 1|Symptomatic Deterioration|0|||
30599561|NCT01091428|58611329|FG003|Phase 1|Symptomatic Deterioration|0|||
30599562|NCT01091428|58611326|FG000|Phase 1|Adverse Event|2|||
30858855|NCT02664441|58887352|FG000|18-week Open Label Extension|Physician Decision|1|||
30858856|NCT02664441|58887353|FG001|18-week Open Label Extension|Physician Decision|0|||
30858857|NCT02664441|58887352|FG000|18-week Open Label Extension|Death|1|||
30858858|NCT02664441|58887353|FG001|18-week Open Label Extension|Death|0|||
30959386|NCT01566149|59024824|FG000|Overall Study|Withdrawal by Subject|1|||
30959387|NCT01566149|59024825|FG001|Overall Study|Withdrawal by Subject|0|||
30599563|NCT01091428|58611327|FG001|Phase 1|Adverse Event|0|||
30599564|NCT01091428|58611328|FG002|Phase 1|Adverse Event|0|||
30689025|NCT00763139|58702771|FG001|Overall Study|med change not allowed by protocol|0|||
30689026|NCT01366092|58702782|FG000|Overall Study|Progressive cGVHD|2|||
30689027|NCT01366092|58702782|FG000|Overall Study|Physician Decision|1|||
30689028|NCT01366092|58702782|FG000|Overall Study|Withdrawal by Subject|1|||
30858859|NCT02664441|58887352|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
30858860|NCT02664441|58887353|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
30858861|NCT02298946|58887362|FG000|Overall Study|Did not receive treatment|2|||
30858862|NCT02298946|58887363|FG001|Overall Study|Did not receive treatment|0|||
30858863|NCT02298946|58887362|FG000|Overall Study|Unevaluable|2|||
30858864|NCT02298946|58887363|FG001|Overall Study|Unevaluable|1|||
30858865|NCT02328040|58887370|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
30858866|NCT02328040|58887371|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
30858867|NCT01647958|58887379|FG000|Initial Study|Lost to Follow-up|2|||
30858868|NCT01647958|58887380|FG001|Initial Study|Lost to Follow-up|3|||
30858869|NCT01647958|58887379|FG000|Continuation Phase|treatment received during Overall Study|39|||
30858870|NCT01647958|58887380|FG001|Continuation Phase|treatment received during Overall Study|0|||
30858871|NCT01647958|58887379|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
30858872|NCT01647958|58887380|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
30858873|NCT02298868|58887395|FG000|Overall Study|Adverse Event|1|||
30858874|NCT02298868|58887395|FG000|Overall Study|Death|1|||
30858875|NCT02298868|58887395|FG000|Overall Study|Patient underwent transplant|1|||
30858876|NCT02327260|58887402|FG000|Overall Study|Lost to Follow-up|2|||
30858877|NCT02327260|58887403|FG001|Overall Study|Lost to Follow-up|3|||
30858878|NCT02327260|58887404|FG002|Overall Study|Lost to Follow-up|2|||
30858879|NCT02327260|58887402|FG000|Overall Study|invalid phone number|1|||
30858880|NCT02327260|58887403|FG001|Overall Study|invalid phone number|1|||
30858881|NCT02327260|58887404|FG002|Overall Study|invalid phone number|0|||
30858882|NCT02327260|58887402|FG000|Overall Study|non-adherence to protocol|2|||
30858883|NCT02327260|58887403|FG001|Overall Study|non-adherence to protocol|0|||
30858884|NCT02327260|58887404|FG002|Overall Study|non-adherence to protocol|0|||
30858885|NCT02327260|58887402|FG000|Overall Study|cognitive concerns|1|||
30858886|NCT02327260|58887403|FG001|Overall Study|cognitive concerns|0|||
30858887|NCT02327260|58887404|FG002|Overall Study|cognitive concerns|0|||
30858888|NCT02296840|58887415|FG000|Overall Study|Adverse Event|1|||
30858889|NCT02296840|58887416|FG001|Overall Study|Adverse Event|1|||
30858890|NCT02296840|58887415|FG000|Overall Study|Protocol Violation|2|||
30858891|NCT02296840|58887416|FG001|Overall Study|Protocol Violation|1|||
30858892|NCT02296840|58887415|FG000|Overall Study|Lost to Follow-up|6|||
30858893|NCT02296840|58887416|FG001|Overall Study|Lost to Follow-up|17|||
30858894|NCT02663895|58887425|FG000|Overall Study|Adverse Event|3|||
30858895|NCT02663895|58887425|FG000|Overall Study|Physician Decision|2|||
30858896|NCT02663895|58887425|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
30858897|NCT02663895|58887425|FG000|Overall Study|Withdrawal by Subject|1|||
30858898|NCT02663817|58887430|FG000|Overall Study|Screen failure|2|||
30858899|NCT01372605|58887438|FG000|Overall Study|Death|1|||
30858900|NCT01372605|58887439|FG001|Overall Study|Death|2|||
30858901|NCT01372605|58887438|FG000|Overall Study|Lost to Follow-up|2|||
30858902|NCT01372605|58887439|FG001|Overall Study|Lost to Follow-up|1|||
30858903|NCT01372605|58887438|FG000|Overall Study|Withdrawal by Subject|4|||
30858904|NCT01372605|58887439|FG001|Overall Study|Withdrawal by Subject|7|||
30858905|NCT01372605|58887438|FG000|Overall Study|Moved|3|||
30858906|NCT01372605|58887439|FG001|Overall Study|Moved|0|||
30858907|NCT01372605|58887438|FG000|Overall Study|Changed medical home|2|||
30858908|NCT01372605|58887439|FG001|Overall Study|Changed medical home|0|||
30858909|NCT02751983|58887447|FG000|Treatment|Stopped ACT, but Remained in study|2|||
30858910|NCT02751983|58887448|FG001|Treatment|Stopped ACT, but Remained in study|0|||
30858911|NCT02751983|58887447|FG000|Treatment|Discharged prior to beginning ACT|2|||
30858912|NCT02751983|58887448|FG001|Treatment|Discharged prior to beginning ACT|0|||
30858913|NCT02751983|58887447|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
30858914|NCT02751983|58887448|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
30858915|NCT02751983|58887447|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
30858916|NCT02751983|58887448|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
30858917|NCT02751983|58887447|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
30858918|NCT02751983|58887448|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
30858919|NCT00232141|58887468|FG000|Overall Study|Adverse Event|9|||
30959388|NCT01565993|59024833|FG000|Overall Study|Physician Decision|0|||
30858920|NCT00232141|58887469|FG001|Overall Study|Adverse Event|4|||
30858921|NCT00232141|58887468|FG000|Overall Study|Lack of Efficacy|0|||
30858922|NCT00232141|58887469|FG001|Overall Study|Lack of Efficacy|3|||
30858923|NCT00232141|58887468|FG000|Overall Study|Lost to Follow-up|9|||
30858924|NCT00232141|58887469|FG001|Overall Study|Lost to Follow-up|6|||
30858925|NCT00232141|58887468|FG000|Overall Study|Other|8|||
30858926|NCT00232141|58887469|FG001|Overall Study|Other|10|||
30858927|NCT00232141|58887468|FG000|Overall Study|Withdrawal by Subject|5|||
30858928|NCT00232141|58887469|FG001|Overall Study|Withdrawal by Subject|3|||
30858929|NCT02741245|58887498|FG000|Overall Study|Adverse Event|0|||
30858930|NCT02741245|58887499|FG001|Overall Study|Adverse Event|0|||
30858931|NCT02741245|58887500|FG002|Overall Study|Adverse Event|0|||
30858932|NCT02741245|58887501|FG003|Overall Study|Adverse Event|2|||
30858933|NCT02741245|58887502|FG004|Overall Study|Adverse Event|2|||
30858934|NCT02741245|58887498|FG000|Overall Study|Protocol Violation|0|||
30858935|NCT02741245|58887499|FG001|Overall Study|Protocol Violation|1|||
30858936|NCT02741245|58887500|FG002|Overall Study|Protocol Violation|0|||
30858937|NCT02741245|58887501|FG003|Overall Study|Protocol Violation|1|||
30689029|NCT00781859|58702788|FG000|Overall Study|Adverse Event|2|||
30689030|NCT00781859|58702789|FG001|Overall Study|Adverse Event|2|||
30689031|NCT00781859|58702788|FG000|Overall Study|Withdrawal by Subject|8|||
30689032|NCT00781859|58702789|FG001|Overall Study|Withdrawal by Subject|4|||
30689033|NCT00781859|58702788|FG000|Overall Study|Lost to Follow-up|6|||
30689034|NCT00781859|58702789|FG001|Overall Study|Lost to Follow-up|3|||
30689035|NCT00781859|58702788|FG000|Overall Study|Death|3|||
30689036|NCT00781859|58702789|FG001|Overall Study|Death|0|||
30689037|NCT00580788|58702799|FG000|Overall Study|Adverse Event|0|||
30689038|NCT00580788|58702800|FG001|Overall Study|Adverse Event|0|||
30689039|NCT00580788|58702801|FG002|Overall Study|Adverse Event|0|||
30689040|NCT00580788|58702802|FG003|Overall Study|Adverse Event|1|||
30689041|NCT00417079|58702821|FG000|Overall Study|Disease progression|267|||
30689042|NCT00417079|58702822|FG001|Overall Study|Disease progression|180|||
30689043|NCT00417079|58702821|FG000|Overall Study|Adverse Event|32|||
30689044|NCT00417079|58702822|FG001|Overall Study|Adverse Event|67|||
30689045|NCT00417079|58702821|FG000|Overall Study|Non-compliance to protocol|0|||
30689046|NCT00417079|58702822|FG001|Overall Study|Non-compliance to protocol|1|||
30689047|NCT00417079|58702821|FG000|Overall Study|Lost to Follow-up|2|||
30689048|NCT00417079|58702822|FG001|Overall Study|Lost to Follow-up|0|||
30689049|NCT00417079|58702821|FG000|Overall Study|Withdrawal by Subject|17|||
30689050|NCT00417079|58702822|FG001|Overall Study|Withdrawal by Subject|8|||
30689051|NCT00417079|58702821|FG000|Overall Study|Not treated|6|||
30689052|NCT00417079|58702822|FG001|Overall Study|Not treated|7|||
30689053|NCT00417079|58702821|FG000|Overall Study|Screened failure|2|||
30689054|NCT00417079|58702822|FG001|Overall Study|Screened failure|1|||
30689055|NCT00417079|58702821|FG000|Overall Study|Investigator's decision|1|||
30689056|NCT00417079|58702822|FG001|Overall Study|Investigator's decision|4|||
30689057|NCT00417079|58702821|FG000|Overall Study|Non-confirmed Disease progression|1|||
30689058|NCT00417079|58702822|FG001|Overall Study|Non-confirmed Disease progression|1|||
30689059|NCT00417079|58702821|FG000|Overall Study|Clinical deterioration|1|||
30689060|NCT00417079|58702822|FG001|Overall Study|Clinical deterioration|0|||
30689061|NCT00417079|58702821|FG000|Overall Study|Screening error|2|||
30689062|NCT00417079|58702822|FG001|Overall Study|Screening error|1|||
30689063|NCT00417079|58702821|FG000|Overall Study|Withdrawal by subject's family|0|||
30689064|NCT00417079|58702822|FG001|Overall Study|Withdrawal by subject's family|1|||
30689065|NCT00417079|58702821|FG000|Overall Study|Patient unable to come to the clinic|0|||
30689066|NCT00417079|58702822|FG001|Overall Study|Patient unable to come to the clinic|1|||
30689067|NCT00417079|58702821|FG000|Overall Study|abnormal liver function tests|0|||
30689068|NCT00417079|58702822|FG001|Overall Study|abnormal liver function tests|1|||
30689069|NCT00429169|58702830|FG000|Overall Study|Lost to Follow-up|0|||
30689070|NCT00429169|58702831|FG001|Overall Study|Lost to Follow-up|1|||
30689071|NCT00429169|58702830|FG000|Overall Study|Ineligibility discovered after entry|2|||
30689072|NCT00429169|58702831|FG001|Overall Study|Ineligibility discovered after entry|1|||
30689073|NCT00416455|58702841|FG000|Overall Study|PET / CT not done|3|||
30689074|NCT00416455|58702842|FG001|Overall Study|PET / CT not done|5|||
30689075|NCT00416455|58702841|FG000|Overall Study|PET / CT poor quality|2|||
30689076|NCT00416455|58702842|FG001|Overall Study|PET / CT poor quality|1|||
30689077|NCT00416455|58702841|FG000|Overall Study|Inadequate pathology|11|||
30689078|NCT00416455|58702842|FG001|Overall Study|Inadequate pathology|2|||
30689079|NCT00415909|58702859|FG000|Overall Study|Withdrawal by Subject|2|||
30689080|NCT00415909|58702859|FG000|Overall Study|Death|1|||
30689081|NCT00415597|58702863|FG000|Enrollment|Withdrawal by Subject|1|||
30689082|NCT00415597|58702863|FG000|Enrollment|Protocol Violation|1|||
30689083|NCT00415597|58702863|FG000|Treatment|Adverse Event|110|||
30689084|NCT00415597|58702863|FG000|Treatment|Lack of Efficacy|39|||
30689085|NCT00415597|58702863|FG000|Treatment|Protocol Violation|67|||
30689086|NCT00415597|58702863|FG000|Treatment|Physician Decision|3|||
30689087|NCT00415597|58702863|FG000|Treatment|Withdrawal by Subject|51|||
30689088|NCT00415597|58702863|FG000|Treatment|Lost to Follow-up|28|||
30858938|NCT02741245|58887502|FG004|Overall Study|Protocol Violation|0|||
30689089|NCT00415597|58702863|FG000|Treatment|Drug Screen|2|||
30689090|NCT00415597|58702863|FG000|Treatment|Administrative|3|||
30689091|NCT00415597|58702863|FG000|Treatment|Sponsor Decision|1|||
30689092|NCT00415597|58702863|FG000|Treatment|Multiple Reasons|1|||
30689093|NCT00620542|58702869|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
30959389|NCT01565993|59024834|FG001|Overall Study|Physician Decision|3|||
30959390|NCT01565291|59024842|FG000|Overall Study|Withdrawal by Subject|1|||
30689094|NCT00620542|58702870|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
30689095|NCT00620542|58702871|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
30689096|NCT00620542|58702872|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
30689097|NCT00620542|58702869|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
30689098|NCT00620542|58702870|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
30786550|NCT01367158|58799755|FG000|Overall Study|Lost to Follow-up|0|||
30786551|NCT01367158|58799756|FG001|Overall Study|Lost to Follow-up|0|||
30689099|NCT00620542|58702871|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
30689100|NCT00620542|58702872|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
30689101|NCT00620542|58702869|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
30689102|NCT00620542|58702870|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
30689103|NCT00620542|58702871|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
30689104|NCT00620542|58702872|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
30689105|NCT00620542|58702869|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
30689106|NCT00620542|58702870|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
30689107|NCT00620542|58702871|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
30689108|NCT00620542|58702872|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
30689109|NCT00620542|58702869|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
30689110|NCT00620542|58702870|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
30689111|NCT00620542|58702871|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
30689112|NCT00620542|58702872|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
30689113|NCT00620542|58702869|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
30689114|NCT00620542|58702870|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
30689115|NCT00620542|58702871|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
30689116|NCT00620542|58702872|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
30689117|NCT00620542|58702869|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
30689118|NCT00620542|58702870|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
30689119|NCT00620542|58702871|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
30689120|NCT00620542|58702872|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
30689121|NCT00620542|58702869|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
30689122|NCT00620542|58702870|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
30689123|NCT00620542|58702871|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
30689124|NCT00620542|58702872|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
30689125|NCT00620542|58702869|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
30689126|NCT00620542|58702870|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
30689127|NCT00620542|58702871|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
30689128|NCT00620542|58702872|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
30689129|NCT00620542|58702869|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
30689130|NCT00620542|58702870|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
30689131|NCT00620542|58702871|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
30689132|NCT00620542|58702872|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
30689133|NCT00620542|58702869|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
30689134|NCT00620542|58702870|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
30689135|NCT00620542|58702871|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
30689136|NCT00620542|58702872|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
30689137|NCT00620542|58702869|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
30689138|NCT00620542|58702870|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
30689139|NCT00620542|58702871|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
30689140|NCT00620542|58702872|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
30689141|NCT00620542|58702869|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
30689142|NCT00620542|58702870|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
30689143|NCT00620542|58702871|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
30689144|NCT00620542|58702872|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
30689145|NCT00620542|58702869|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
30689146|NCT00620542|58702870|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
30689147|NCT00620542|58702871|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
30689148|NCT00620542|58702872|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
30689149|NCT00620542|58702869|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
30689150|NCT00620542|58702870|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
30689151|NCT00620542|58702871|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
30689152|NCT00620542|58702872|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
30689153|NCT05096208|58702884|FG000|Overall Study|Lost to Follow-up|3|||
30689154|NCT05096208|58702885|FG001|Overall Study|Lost to Follow-up|5|||
30689155|NCT05096208|58702886|FG002|Overall Study|Lost to Follow-up|5|||
30689156|NCT05096208|58702887|FG003|Overall Study|Lost to Follow-up|2|||
30689157|NCT05096208|58702884|FG000|Overall Study|Withdrawal by Subject|0|||
30599565|NCT01091428|58611329|FG003|Phase 1|Adverse Event|0|||
30599566|NCT01091428|58611326|FG000|Phase 1|Withdrawal by Subject|7|||
30599567|NCT01091428|58611327|FG001|Phase 1|Withdrawal by Subject|0|||
30599568|NCT01091428|58611328|FG002|Phase 1|Withdrawal by Subject|0|||
30599569|NCT01091428|58611329|FG003|Phase 1|Withdrawal by Subject|0|||
30599570|NCT01091428|58611326|FG000|Phase 1|Reason not specified|0|||
30599571|NCT01091428|58611327|FG001|Phase 1|Reason not specified|1|||
30599572|NCT01091428|58611328|FG002|Phase 1|Reason not specified|0|||
30599573|NCT01091428|58611329|FG003|Phase 1|Reason not specified|0|||
30599574|NCT01091428|58611326|FG000|Phase 1|Single-Patient IND|2|||
30689158|NCT05096208|58702885|FG001|Overall Study|Withdrawal by Subject|1|||
30689159|NCT05096208|58702886|FG002|Overall Study|Withdrawal by Subject|2|||
30689160|NCT05096208|58702887|FG003|Overall Study|Withdrawal by Subject|3|||
30689161|NCT05096208|58702884|FG000|Overall Study|No longer met eligibility criteria|1|||
30689162|NCT05096208|58702885|FG001|Overall Study|No longer met eligibility criteria|0|||
30689163|NCT05096208|58702886|FG002|Overall Study|No longer met eligibility criteria|0|||
30689164|NCT05096208|58702887|FG003|Overall Study|No longer met eligibility criteria|0|||
30689165|NCT05096208|58702884|FG000|Overall Study|Other|0|||
30689166|NCT05096208|58702885|FG001|Overall Study|Other|0|||
30689167|NCT05096208|58702886|FG002|Overall Study|Other|1|||
30689168|NCT05096208|58702887|FG003|Overall Study|Other|0|||
30689169|NCT04555616|58702906|FG000|Overall Study|Death|1|||
30689170|NCT04555616|58702907|FG001|Overall Study|Death|0|||
30689171|NCT04555616|58702908|FG002|Overall Study|Death|1|||
30689172|NCT04555616|58702906|FG000|Overall Study|Withdrawal by Subject|2|||
30689173|NCT04555616|58702907|FG001|Overall Study|Withdrawal by Subject|1|||
30689174|NCT04555616|58702908|FG002|Overall Study|Withdrawal by Subject|0|||
30689175|NCT04177758|58702932|FG000|Overall Study|Lost to Follow-up|19|||
30689176|NCT04177758|58702933|FG001|Overall Study|Lost to Follow-up|11|||
30689177|NCT04003103|58702942|FG000|Overall Study|Death|1|||
30689178|NCT04003103|58702943|FG001|Overall Study|Death|0|||
30689179|NCT04003103|58702944|FG002|Overall Study|Death|0|||
30689180|NCT04003103|58702942|FG000|Overall Study|Lost to Follow-up|4|||
30689181|NCT04003103|58702943|FG001|Overall Study|Lost to Follow-up|3|||
30689182|NCT04003103|58702944|FG002|Overall Study|Lost to Follow-up|2|||
30689183|NCT04003103|58702942|FG000|Overall Study|Withdrawal by Subject|10|||
30689184|NCT04003103|58702943|FG001|Overall Study|Withdrawal by Subject|1|||
30689185|NCT04003103|58702944|FG002|Overall Study|Withdrawal by Subject|1|||
30689186|NCT04003103|58702942|FG000|Overall Study|Status not recorded|0|||
30689187|NCT04003103|58702943|FG001|Overall Study|Status not recorded|2|||
30689188|NCT04003103|58702944|FG002|Overall Study|Status not recorded|0|||
30689189|NCT03921528|58702993|FG000|Overall Study|Withdrawal by Subject|0|||
30689190|NCT03921528|58702994|FG001|Overall Study|Withdrawal by Subject|1|||
30689191|NCT03921528|58702995|FG002|Overall Study|Withdrawal by Subject|0|||
30689192|NCT03921528|58702996|FG003|Overall Study|Withdrawal by Subject|0|||
30689193|NCT03921528|58702997|FG004|Overall Study|Withdrawal by Subject|0|||
30689194|NCT03832322|58703015|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
30689195|NCT03832322|58703016|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
30689196|NCT03642990|58703032|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
30689197|NCT03642990|58703032|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
30689198|NCT03639311|58703038|FG000|Overall Study|Ongoing at the time of analysis|88|||
30689199|NCT03639311|58703039|FG001|Overall Study|Ongoing at the time of analysis|0|||
30689200|NCT03639311|58703038|FG000|Overall Study|Lost to Follow-up|1|||
30689201|NCT03639311|58703039|FG001|Overall Study|Lost to Follow-up|0|||
30689202|NCT03639311|58703038|FG000|Overall Study|Adverse Event|1|||
30689203|NCT03639311|58703039|FG001|Overall Study|Adverse Event|0|||
30689204|NCT03633825|58703050|FG000|Enrollment|Did not post on network|5066|||
30689205|NCT03633825|58703051|FG001|Enrollment|Did not post on network|5080|||
30689206|NCT03633825|58703050|FG000|Enrollment|Post not classified as crisis|13967|||
30689207|NCT03633825|58703051|FG001|Enrollment|Post not classified as crisis|13757|||
30689208|NCT03633825|58703050|FG000|Follow up|Lost to Follow-up|478|||
30689209|NCT03633825|58703051|FG001|Follow up|Lost to Follow-up|450|||
30689210|NCT03465540|58703063|FG000|Overall Study|Withdrawal by Subject|0|||
30689211|NCT03465540|58703064|FG001|Overall Study|Withdrawal by Subject|0|||
30689212|NCT03465540|58703065|FG002|Overall Study|Withdrawal by Subject|1|||
30689213|NCT03465540|58703066|FG003|Overall Study|Withdrawal by Subject|1|||
30689214|NCT03465540|58703067|FG004|Overall Study|Withdrawal by Subject|1|||
30689215|NCT03465540|58703068|FG005|Overall Study|Withdrawal by Subject|0|||
30689216|NCT03465540|58703063|FG000|Overall Study|Lost to Follow-up|0|||
30689217|NCT03465540|58703064|FG001|Overall Study|Lost to Follow-up|1|||
30689218|NCT03465540|58703065|FG002|Overall Study|Lost to Follow-up|0|||
30689219|NCT03465540|58703066|FG003|Overall Study|Lost to Follow-up|0|||
30689220|NCT03465540|58703067|FG004|Overall Study|Lost to Follow-up|1|||
30689221|NCT03465540|58703068|FG005|Overall Study|Lost to Follow-up|0|||
30599575|NCT01091428|58611327|FG001|Phase 1|Single-Patient IND|0|||
30599576|NCT01091428|58611328|FG002|Phase 1|Single-Patient IND|0|||
30599577|NCT01091428|58611329|FG003|Phase 1|Single-Patient IND|0|||
30599578|NCT01091428|58611326|FG000|Phase 2|Progressive Disease|0|||
30599579|NCT01091428|58611327|FG001|Phase 2|Progressive Disease|0|||
30599580|NCT01091428|58611328|FG002|Phase 2|Progressive Disease|44|||
30599581|NCT01091428|58611329|FG003|Phase 2|Progressive Disease|46|||
30599582|NCT01091428|58611326|FG000|Phase 2|Symptomatic Deterioration|0|||
30599583|NCT01091428|58611327|FG001|Phase 2|Symptomatic Deterioration|0|||
30599584|NCT01091428|58611328|FG002|Phase 2|Symptomatic Deterioration|1|||
30599585|NCT01091428|58611329|FG003|Phase 2|Symptomatic Deterioration|6|||
30599586|NCT01091428|58611326|FG000|Phase 2|Adverse Event|0|||
30599587|NCT01091428|58611327|FG001|Phase 2|Adverse Event|0|||
30599588|NCT01091428|58611328|FG002|Phase 2|Adverse Event|12|||
30689222|NCT03465540|58703063|FG000|Overall Study|Death|1|||
30689223|NCT03465540|58703064|FG001|Overall Study|Death|1|||
30689224|NCT03465540|58703065|FG002|Overall Study|Death|0|||
30689225|NCT03465540|58703066|FG003|Overall Study|Death|2|||
30689226|NCT03465540|58703067|FG004|Overall Study|Death|0|||
30689227|NCT03465540|58703068|FG005|Overall Study|Death|2|||
30689228|NCT03465540|58703063|FG000|Overall Study|Protocol specified criteria|0|||
30689229|NCT03465540|58703064|FG001|Overall Study|Protocol specified criteria|2|||
30689230|NCT03465540|58703065|FG002|Overall Study|Protocol specified criteria|2|||
30689231|NCT03465540|58703066|FG003|Overall Study|Protocol specified criteria|0|||
30689232|NCT03465540|58703067|FG004|Overall Study|Protocol specified criteria|2|||
30689233|NCT03465540|58703068|FG005|Overall Study|Protocol specified criteria|0|||
30689234|NCT03055832|58703116|FG000|Week 2|Withdrawal by Subject|1|||
30689235|NCT03055832|58703117|FG001|Week 2|Withdrawal by Subject|0|||
30689236|NCT03052049|58703137|FG000|Overall Study|Withdrawal by Subject|2|||
30689237|NCT02771275|58703162|FG000|Overall Study|Reoperation|2|||
30858939|NCT02741245|58887498|FG000|Overall Study|Withdrawal by Subject|0|||
30858940|NCT02741245|58887499|FG001|Overall Study|Withdrawal by Subject|0|||
30858941|NCT02741245|58887500|FG002|Overall Study|Withdrawal by Subject|0|||
30858942|NCT02741245|58887501|FG003|Overall Study|Withdrawal by Subject|1|||
30858943|NCT02741245|58887502|FG004|Overall Study|Withdrawal by Subject|0|||
30858944|NCT03227757|58887514|FG000|Overall Study|Death|7|||
30858945|NCT03227757|58887514|FG000|Overall Study|Withdrawal|5|||
30858946|NCT03227757|58887514|FG000|Overall Study|Missed visits|4|||
30858947|NCT02751827|58887521|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
30599589|NCT01091428|58611329|FG003|Phase 2|Adverse Event|5|||
30599590|NCT01091428|58611326|FG000|Phase 2|Withdrawal by Subject|0|||
30858948|NCT02751827|58887522|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
30858949|NCT02751827|58887523|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
30858950|NCT04896593|58887540|FG000|Overall Study|Withdrawal by Subject|2|||
30858951|NCT04896593|58887540|FG000|Overall Study|Lost to Follow-up|1|||
30858952|NCT04896593|58887540|FG000|Overall Study|Did not complete onboarding|2|||
30858953|NCT04601272|58887556|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
30858954|NCT04601272|58887557|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
30599591|NCT01091428|58611327|FG001|Phase 2|Withdrawal by Subject|0|||
30599592|NCT01091428|58611328|FG002|Phase 2|Withdrawal by Subject|9|||
30599593|NCT01091428|58611329|FG003|Phase 2|Withdrawal by Subject|8|||
30599594|NCT01091428|58611326|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
30599595|NCT01091428|58611327|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
30599596|NCT01091428|58611328|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
30599597|NCT01091428|58611329|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
30599598|NCT01091428|58611326|FG000|Phase 2|Reason not specified|0|||
30599599|NCT01091428|58611327|FG001|Phase 2|Reason not specified|0|||
30599600|NCT01091428|58611328|FG002|Phase 2|Reason not specified|4|||
30599601|NCT01091428|58611329|FG003|Phase 2|Reason not specified|3|||
30599602|NCT01091428|58611326|FG000|Phase 2|Physician Decision|0|||
30599603|NCT01091428|58611327|FG001|Phase 2|Physician Decision|0|||
30599604|NCT01091428|58611328|FG002|Phase 2|Physician Decision|2|||
30599605|NCT01091428|58611329|FG003|Phase 2|Physician Decision|0|||
30599606|NCT01096342|58611348|FG000|Overall Study|Protocol Violation|1|||
30599607|NCT01039519|58611352|FG000|Treatment|Progressive disease|20|||
30599608|NCT01039519|58611352|FG000|Treatment|Treatment failure|2|||
30599609|NCT01039519|58611352|FG000|Treatment|Adverse Event|3|||
30599610|NCT01039519|58611352|FG000|Treatment|Physician Decision|2|||
30599611|NCT01039519|58611352|FG000|Survival Follow-up|Death|23|||
30599612|NCT01039519|58611352|FG000|Survival Follow-up|Sponsor decision|4|||
30599613|NCT01096186|58611356|FG000|Overall Study|Adverse Event|16|||
30599614|NCT01096186|58611356|FG000|Overall Study|Death|4|||
30689238|NCT02771275|58703162|FG000|Overall Study|On Study|11|||
30689239|NCT02768870|58703166|FG000|Overall Study|Not Implanted with Device|2|||
30689240|NCT02768870|58703166|FG000|Overall Study|Death|1|||
30689241|NCT02768870|58703166|FG000|Overall Study|Reoperation|4|||
30689242|NCT02768870|58703166|FG000|Overall Study|On Study|19|||
30858955|NCT04601272|58887558|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
30858956|NCT03965091|58887578|FG000|Overall Study|Adverse Event|0|||
30858957|NCT03965091|58887579|FG001|Overall Study|Adverse Event|2|||
30858958|NCT03965091|58887580|FG002|Overall Study|Adverse Event|3|||
30858959|NCT03965091|58887578|FG000|Overall Study|Withdrawal by Subject|11|||
30858960|NCT03965091|58887579|FG001|Overall Study|Withdrawal by Subject|3|||
30599615|NCT01096186|58611356|FG000|Overall Study|Lack of Efficacy|4|||
30599616|NCT01096186|58611356|FG000|Overall Study|Lost to Follow-up|2|||
30599617|NCT01096186|58611356|FG000|Overall Study|Withdrawal by Subject|22|||
30599618|NCT01096186|58611356|FG000|Overall Study|Physician Decision|1|||
30599619|NCT01096186|58611356|FG000|Overall Study|Noncompliance with study drug|1|||
30689243|NCT02750618|58703170|FG000|Overall Study|Withdrawal by Subject|1|||
30689244|NCT02537431|58703174|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
30858961|NCT03965091|58887580|FG002|Overall Study|Withdrawal by Subject|5|||
30599620|NCT01032889|58611363|FG000|Overall Study|Adverse Event|2|||
30599621|NCT01032889|58611364|FG001|Overall Study|Adverse Event|2|||
30689245|NCT02526160|58703180|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
30689246|NCT02526160|58703181|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
30689247|NCT02526160|58703180|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
30689248|NCT02526160|58703181|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
30689249|NCT02526160|58703180|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
30689250|NCT02526160|58703181|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
30689251|NCT02526160|58703180|FG000|Open-Label Treatment Extension Period I|Death|0|||
30689252|NCT02526160|58703181|FG001|Open-Label Treatment Extension Period I|Death|1|||
30689253|NCT02526160|58703180|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
30689254|NCT02526160|58703181|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
30689255|NCT02526160|58703180|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
30689256|NCT02526160|58703181|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
30689257|NCT02526160|58703180|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
30689258|NCT02526160|58703181|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
30689259|NCT02526160|58703180|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
30689260|NCT02526160|58703181|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
30689261|NCT02432196|58703192|FG000|Overall Study|Not Implanted with Device|1|||
30689262|NCT02432196|58703192|FG000|Overall Study|Death|2|||
30689263|NCT02432196|58703192|FG000|Overall Study|Reoperation|3|||
30689264|NCT02432196|58703192|FG000|Overall Study|On Study|20|||
30689265|NCT02157610|58703207|FG000|Overall Study|Death|4|||
30689266|NCT02157610|58703208|FG001|Overall Study|Death|4|||
30689267|NCT01511250|58703251|FG000|Overall Study|Withdrawal of Consent|1|||
30689268|NCT01511250|58703252|FG001|Overall Study|Withdrawal of Consent|0|||
30689269|NCT01511250|58703253|FG002|Overall Study|Withdrawal of Consent|0|||
30689270|NCT01511250|58703254|FG003|Overall Study|Withdrawal of Consent|0|||
30689271|NCT01511250|58703255|FG004|Overall Study|Withdrawal of Consent|0|||
30689272|NCT01511250|58703256|FG005|Overall Study|Withdrawal of Consent|0|||
30689273|NCT01511250|58703257|FG006|Overall Study|Withdrawal of Consent|0|||
30689274|NCT01511250|58703258|FG007|Overall Study|Withdrawal of Consent|1|||
30689275|NCT01511250|58703259|FG008|Overall Study|Withdrawal of Consent|1|||
30689276|NCT01511250|58703260|FG009|Overall Study|Withdrawal of Consent|0|||
30689277|NCT01511250|58703251|FG000|Overall Study|Sponsor/Investigator Decision|1|||
30689278|NCT01511250|58703252|FG001|Overall Study|Sponsor/Investigator Decision|0|||
30689279|NCT01511250|58703253|FG002|Overall Study|Sponsor/Investigator Decision|0|||
30689280|NCT01511250|58703254|FG003|Overall Study|Sponsor/Investigator Decision|0|||
30689281|NCT01511250|58703255|FG004|Overall Study|Sponsor/Investigator Decision|0|||
30689282|NCT01511250|58703256|FG005|Overall Study|Sponsor/Investigator Decision|0|||
30689283|NCT01511250|58703257|FG006|Overall Study|Sponsor/Investigator Decision|0|||
30689284|NCT01511250|58703258|FG007|Overall Study|Sponsor/Investigator Decision|0|||
30689285|NCT01511250|58703259|FG008|Overall Study|Sponsor/Investigator Decision|0|||
30689286|NCT01511250|58703260|FG009|Overall Study|Sponsor/Investigator Decision|0|||
30689287|NCT01511250|58703251|FG000|Overall Study|Lost to Follow-up|7|||
30689288|NCT01511250|58703252|FG001|Overall Study|Lost to Follow-up|3|||
30689289|NCT01511250|58703253|FG002|Overall Study|Lost to Follow-up|3|||
30689290|NCT01511250|58703254|FG003|Overall Study|Lost to Follow-up|3|||
30599622|NCT01032889|58611365|FG002|Overall Study|Adverse Event|0|||
30599623|NCT01032889|58611363|FG000|Overall Study|Withdrawal of Consent|1|||
30599624|NCT01032889|58611364|FG001|Overall Study|Withdrawal of Consent|2|||
30599625|NCT01032889|58611365|FG002|Overall Study|Withdrawal of Consent|1|||
30599626|NCT01032889|58611363|FG000|Overall Study|Patient Request|0|||
30599627|NCT01032889|58611364|FG001|Overall Study|Patient Request|1|||
30599628|NCT01032889|58611365|FG002|Overall Study|Patient Request|0|||
30599629|NCT01032889|58611363|FG000|Overall Study|Lost to Follow-up|1|||
30599630|NCT01032889|58611364|FG001|Overall Study|Lost to Follow-up|1|||
30599631|NCT01032889|58611365|FG002|Overall Study|Lost to Follow-up|0|||
30599632|NCT01032889|58611363|FG000|Overall Study|Lack of Submental Fat|2|||
30599633|NCT01032889|58611364|FG001|Overall Study|Lack of Submental Fat|8|||
30599634|NCT01032889|58611365|FG002|Overall Study|Lack of Submental Fat|1|||
30599635|NCT01032889|58611363|FG000|Overall Study|Miscellaneous Reasons|2|||
30599636|NCT01032889|58611364|FG001|Overall Study|Miscellaneous Reasons|1|||
30599637|NCT01032889|58611365|FG002|Overall Study|Miscellaneous Reasons|1|||
30599638|NCT01049503|58611379|FG000|Overall Study|Lost to Follow-up|11|||
30599639|NCT01049503|58611380|FG001|Overall Study|Lost to Follow-up|12|||
30599640|NCT01049503|58611381|FG002|Overall Study|Lost to Follow-up|24|||
30689291|NCT01511250|58703255|FG004|Overall Study|Lost to Follow-up|0|||
30689292|NCT01511250|58703256|FG005|Overall Study|Lost to Follow-up|0|||
30689293|NCT01511250|58703257|FG006|Overall Study|Lost to Follow-up|2|||
30689294|NCT01511250|58703258|FG007|Overall Study|Lost to Follow-up|3|||
30599641|NCT01049503|58611382|FG003|Overall Study|Lost to Follow-up|26|||
30599642|NCT01049503|58611383|FG004|Overall Study|Lost to Follow-up|27|||
30599643|NCT01049503|58611384|FG005|Overall Study|Lost to Follow-up|8|||
30689295|NCT01511250|58703259|FG008|Overall Study|Lost to Follow-up|13|||
30599644|NCT01029925|58611407|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
30689296|NCT01511250|58703260|FG009|Overall Study|Lost to Follow-up|5|||
30689297|NCT01511250|58703251|FG000|Overall Study|Protocol Violation|0|||
30689298|NCT01511250|58703252|FG001|Overall Study|Protocol Violation|2|||
30689299|NCT01511250|58703253|FG002|Overall Study|Protocol Violation|1|||
30689300|NCT01511250|58703254|FG003|Overall Study|Protocol Violation|0|||
30689301|NCT01511250|58703255|FG004|Overall Study|Protocol Violation|0|||
30689302|NCT01511250|58703256|FG005|Overall Study|Protocol Violation|0|||
30689303|NCT01511250|58703257|FG006|Overall Study|Protocol Violation|0|||
30689304|NCT01511250|58703258|FG007|Overall Study|Protocol Violation|0|||
30689305|NCT01511250|58703259|FG008|Overall Study|Protocol Violation|0|||
30689306|NCT01511250|58703260|FG009|Overall Study|Protocol Violation|0|||
30858962|NCT03965091|58887578|FG000|Overall Study|Non-compliance with study drug|0|||
30858963|NCT03965091|58887579|FG001|Overall Study|Non-compliance with study drug|0|||
30858964|NCT03965091|58887580|FG002|Overall Study|Non-compliance with study drug|1|||
30858965|NCT03965091|58887578|FG000|Overall Study|Lost to Follow-up|1|||
30858966|NCT03965091|58887579|FG001|Overall Study|Lost to Follow-up|1|||
30858967|NCT03965091|58887580|FG002|Overall Study|Lost to Follow-up|1|||
30858968|NCT03965091|58887578|FG000|Overall Study|Lack of Efficacy|2|||
30858969|NCT03965091|58887579|FG001|Overall Study|Lack of Efficacy|0|||
30858970|NCT03965091|58887580|FG002|Overall Study|Lack of Efficacy|0|||
30858971|NCT03965091|58887578|FG000|Overall Study|Other than specified|9|||
30858972|NCT03965091|58887579|FG001|Overall Study|Other than specified|11|||
30858973|NCT03965091|58887580|FG002|Overall Study|Other than specified|8|||
30858974|NCT03359096|58887607|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
30858975|NCT03359096|58887608|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
30858976|NCT03359096|58887607|FG000|First Intervention (4 Weeks)|Death|1|||
30858977|NCT03359096|58887608|FG001|First Intervention (4 Weeks)|Death|0|||
30858978|NCT03359096|58887607|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
30858979|NCT03359096|58887608|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
30858980|NCT03019588|58887625|FG000|Overall Study|Death|44|||
30858981|NCT03019588|58887626|FG001|Overall Study|Death|46|||
30858982|NCT03019588|58887625|FG000|Overall Study|Study terminated by Sponsor|3|||
30858983|NCT03019588|58887626|FG001|Overall Study|Study terminated by Sponsor|1|||
30858984|NCT02455557|58887658|FG000|Overall Study|Withdrawal by Subject|2|||
30858985|NCT02270450|58887666|FG000|Overall Study|Refusal unrelated to adverse event|3|||
30858986|NCT02270450|58887667|FG001|Overall Study|Refusal unrelated to adverse event|1|||
30858987|NCT02270450|58887668|FG002|Overall Study|Refusal unrelated to adverse event|5|||
30858988|NCT02270450|58887669|FG003|Overall Study|Refusal unrelated to adverse event|14|||
30858989|NCT02270450|58887666|FG000|Overall Study|Progression/relapse|1|||
30858990|NCT02270450|58887667|FG001|Overall Study|Progression/relapse|2|||
30858991|NCT02270450|58887668|FG002|Overall Study|Progression/relapse|4|||
30858992|NCT02270450|58887669|FG003|Overall Study|Progression/relapse|9|||
30858993|NCT02270450|58887666|FG000|Overall Study|Death|19|||
30858994|NCT02270450|58887667|FG001|Overall Study|Death|19|||
30858995|NCT02270450|58887668|FG002|Overall Study|Death|31|||
30858996|NCT02270450|58887669|FG003|Overall Study|Death|59|||
30858997|NCT01570868|58887692|FG000|Overall Study|Adverse Event|8|||
30858998|NCT01570868|58887693|FG001|Overall Study|Adverse Event|1|||
30858999|NCT01570868|58887692|FG000|Overall Study|FDA Recommendation|23|||
30859000|NCT01570868|58887693|FG001|Overall Study|FDA Recommendation|3|||
30859001|NCT01570868|58887692|FG000|Overall Study|Physician Decision|10|||
30859002|NCT01570868|58887693|FG001|Overall Study|Physician Decision|4|||
30859003|NCT01570868|58887692|FG000|Overall Study|Lost to Follow-up|1|||
30859004|NCT01570868|58887693|FG001|Overall Study|Lost to Follow-up|0|||
30859005|NCT01570868|58887692|FG000|Overall Study|Withdrawal by Subject|1|||
30859006|NCT01570868|58887693|FG001|Overall Study|Withdrawal by Subject|0|||
30859007|NCT01565499|58887703|FG000|Overall Study|Physician Decision|1|||
30859008|NCT01565499|58887703|FG000|Overall Study|Adverse Event|5|||
30859009|NCT01565499|58887703|FG000|Overall Study|Withdrawal by Subject|2|||
30859010|NCT01036087|58887707|FG000|Overall Study|Adverse Event|2|||
30959391|NCT01565291|59024843|FG001|Overall Study|Withdrawal by Subject|0|||
30689307|NCT01424566|58703282|FG000|Single-blind Treatment|Adverse Event|71|||
30859011|NCT01036087|58887707|FG000|Overall Study|Lack of Efficacy|1|||
30859012|NCT00572156|58887724|FG000|Overall Study|Adverse Event|3|||
30859013|NCT00572156|58887725|FG001|Overall Study|Adverse Event|1|||
30859014|NCT00572156|58887726|FG002|Overall Study|Adverse Event|5|||
30859015|NCT00572156|58887727|FG003|Overall Study|Adverse Event|1|||
30859016|NCT00572156|58887724|FG000|Overall Study|Lost to Follow-up|1|||
30859017|NCT00572156|58887725|FG001|Overall Study|Lost to Follow-up|1|||
30859018|NCT00572156|58887726|FG002|Overall Study|Lost to Follow-up|1|||
30859019|NCT00572156|58887727|FG003|Overall Study|Lost to Follow-up|0|||
30859020|NCT00572156|58887724|FG000|Overall Study|Protocol Violation|1|||
30859021|NCT00572156|58887725|FG001|Overall Study|Protocol Violation|2|||
30959392|NCT02691702|59024860|FG000|Overall Study|Adverse Event|1|||
30689308|NCT01424566|58703283|FG001|Single-blind Treatment|Adverse Event|0|||
30689309|NCT01424566|58703284|FG002|Single-blind Treatment|Adverse Event|0|||
30689310|NCT01424566|58703282|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
30859022|NCT00572156|58887726|FG002|Overall Study|Protocol Violation|0|||
30959393|NCT02691702|59024861|FG001|Overall Study|Adverse Event|0|||
30859023|NCT00572156|58887727|FG003|Overall Study|Protocol Violation|2|||
30859024|NCT00572156|58887724|FG000|Overall Study|Patient/Parent Decision|1|||
30859025|NCT00572156|58887725|FG001|Overall Study|Patient/Parent Decision|6|||
30859026|NCT00572156|58887726|FG002|Overall Study|Patient/Parent Decision|4|||
30859027|NCT00572156|58887727|FG003|Overall Study|Patient/Parent Decision|3|||
30859028|NCT00572156|58887724|FG000|Overall Study|Sponsor Decision|20|||
30599645|NCT01029925|58611407|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
30599646|NCT01029925|58611407|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
30599647|NCT01029691|58611414|FG000|Continued APAP to Delivery|Death|0|||
30599648|NCT01029691|58611415|FG001|Continued APAP to Delivery|Death|0|||
30859029|NCT00572156|58887725|FG001|Overall Study|Sponsor Decision|16|||
30689311|NCT01424566|58703283|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
30859030|NCT00572156|58887726|FG002|Overall Study|Sponsor Decision|17|||
30859031|NCT00572156|58887727|FG003|Overall Study|Sponsor Decision|19|||
30859032|NCT00447772|58887737|FG000|Overall Study|Lack of Efficacy|3|||
30859033|NCT00447772|58887737|FG000|Overall Study|Insufficient compliance|6|||
30859034|NCT00447772|58887737|FG000|Overall Study|Discontinuation of drug therapy|1|||
30859035|NCT00447772|58887737|FG000|Overall Study|Lost to Follow-up|9|||
30859036|NCT00447772|58887737|FG000|Overall Study|Withdrawal by Subject|1|||
30859037|NCT00447772|58887737|FG000|Overall Study|Unable to attend all study visits|2|||
30859038|NCT00447772|58887737|FG000|Overall Study|Adverse Event|1|||
30859039|NCT00447772|58887737|FG000|Overall Study|Patient relocated|1|||
30859040|NCT00447772|58887737|FG000|Overall Study|Incomplete documentation at visit 1|1|||
30859041|NCT00447772|58887737|FG000|Overall Study|Chemotherapy for lung cancer|1|||
30859042|NCT00447772|58887737|FG000|Overall Study|Premature re-injection required|1|||
30859043|NCT02296138|58887746|FG000|Overall Study|Adverse Event|348|||
30859044|NCT02296138|58887747|FG001|Overall Study|Adverse Event|259|||
30859045|NCT02296138|58887746|FG000|Overall Study|Lack of Efficacy|59|||
30859046|NCT02296138|58887747|FG001|Overall Study|Lack of Efficacy|37|||
30859047|NCT02296138|58887746|FG000|Overall Study|Protocol Violation|35|||
30859048|NCT02296138|58887747|FG001|Overall Study|Protocol Violation|36|||
30859049|NCT02296138|58887746|FG000|Overall Study|Lost to Follow-up|9|||
30859050|NCT02296138|58887747|FG001|Overall Study|Lost to Follow-up|12|||
30859051|NCT02296138|58887746|FG000|Overall Study|Withdrawal by Subject|184|||
30859052|NCT02296138|58887747|FG001|Overall Study|Withdrawal by Subject|131|||
30859053|NCT02296138|58887746|FG000|Overall Study|Not Treated|1|||
30859054|NCT02296138|58887747|FG001|Overall Study|Not Treated|1|||
30859055|NCT02296138|58887746|FG000|Overall Study|Patients with data irregularities|10|||
30859056|NCT02296138|58887747|FG001|Overall Study|Patients with data irregularities|11|||
30859057|NCT02296138|58887746|FG000|Overall Study|Other than specified|15|||
30859058|NCT02296138|58887747|FG001|Overall Study|Other than specified|13|||
30859059|NCT01306942|58887756|FG000|Phase I|Adverse Event|2|||
30859060|NCT01306942|58887757|FG001|Phase I|Adverse Event|2|||
30859061|NCT01306942|58887758|FG002|Phase I|Adverse Event|0|||
30859062|NCT01306942|58887759|FG003|Phase I|Adverse Event|0|||
30859063|NCT01306942|58887756|FG000|Phase I|Physician Decision|3|||
30859064|NCT01306942|58887757|FG001|Phase I|Physician Decision|1|||
30859065|NCT01306942|58887758|FG002|Phase I|Physician Decision|0|||
30859066|NCT01306942|58887759|FG003|Phase I|Physician Decision|0|||
30859067|NCT01306942|58887756|FG000|Phase II|Adverse Event|0|||
30859068|NCT01306942|58887757|FG001|Phase II|Adverse Event|0|||
30859069|NCT01306942|58887758|FG002|Phase II|Adverse Event|0|||
30859070|NCT01306942|58887759|FG003|Phase II|Adverse Event|6|||
30859071|NCT01306942|58887756|FG000|Phase II|Physician Decision|2|||
30859072|NCT01306942|58887757|FG001|Phase II|Physician Decision|0|||
30859073|NCT01306942|58887758|FG002|Phase II|Physician Decision|0|||
30859074|NCT01306942|58887759|FG003|Phase II|Physician Decision|5|||
30859075|NCT01306942|58887756|FG000|Phase II|Withdrawal by Subject|0|||
30859076|NCT01306942|58887757|FG001|Phase II|Withdrawal by Subject|0|||
30859077|NCT01306942|58887758|FG002|Phase II|Withdrawal by Subject|0|||
30859078|NCT01306942|58887759|FG003|Phase II|Withdrawal by Subject|2|||
30859079|NCT01306942|58887756|FG000|Phase II|Death|0|||
30599649|NCT01029691|58611416|FG002|Continued APAP to Delivery|Death|1|||
30599650|NCT01029535|58611425|FG000|Overall Study|Lost to Follow-up|24|||
30599651|NCT01029535|58611425|FG000|Overall Study|Protocol Violation|2|||
30599652|NCT01029535|58611425|FG000|Overall Study|Participant Withdrew Consent|2|||
30599653|NCT01029535|58611425|FG000|Overall Study|Adverse Event|1|||
30599654|NCT01029535|58611425|FG000|Overall Study|Use of Another Treatment|1|||
30599655|NCT01029535|58611425|FG000|Overall Study|Death|1|||
30859080|NCT01306942|58887757|FG001|Phase II|Death|0|||
30599656|NCT01028053|58611430|FG000|Overall Study|Screen Failure|113|||
30599657|NCT01028053|58611430|FG000|Overall Study|Patient Request|11|||
30599658|NCT01028053|58611430|FG000|Overall Study|Protocol Violation|1|||
30859081|NCT01306942|58887758|FG002|Phase II|Death|0|||
30859082|NCT01306942|58887759|FG003|Phase II|Death|1|||
30859083|NCT01306942|58887756|FG000|Phase II|Not finished treatment|0|||
30599659|NCT01028053|58611430|FG000|Overall Study|Physician Decision|2|||
30859084|NCT01306942|58887757|FG001|Phase II|Not finished treatment|0|||
30859085|NCT01306942|58887758|FG002|Phase II|Not finished treatment|0|||
30859086|NCT01306942|58887759|FG003|Phase II|Not finished treatment|1|||
30859087|NCT01306942|58887756|FG000|Phase II|Protocol Violation|0|||
30859088|NCT01306942|58887757|FG001|Phase II|Protocol Violation|0|||
30859089|NCT01306942|58887758|FG002|Phase II|Protocol Violation|0|||
30859090|NCT01306942|58887759|FG003|Phase II|Protocol Violation|1|||
30859091|NCT02324842|58887774|FG000|Overall Study|Lost to Follow-up|1|||
30859092|NCT02324842|58887775|FG001|Overall Study|Lost to Follow-up|1|||
30859093|NCT02324842|58887776|FG002|Overall Study|Lost to Follow-up|2|||
30859094|NCT02295280|58887786|FG000|Overall Study|Adverse Event|0|||
30859095|NCT02295280|58887787|FG001|Overall Study|Adverse Event|1|||
30859096|NCT02294734|58887795|FG000|Overall Study|Adverse Event|5|||
30859097|NCT02294734|58887796|FG001|Overall Study|Adverse Event|5|||
30859098|NCT02294734|58887795|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
30859099|NCT02294734|58887796|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
30859100|NCT02294734|58887795|FG000|Overall Study|Lost to Follow-up|2|||
30859101|NCT02294734|58887796|FG001|Overall Study|Lost to Follow-up|0|||
30859102|NCT02294734|58887795|FG000|Overall Study|Physician Decision|2|||
30859103|NCT02294734|58887796|FG001|Overall Study|Physician Decision|1|||
30859104|NCT02294734|58887795|FG000|Overall Study|Withdrawal by Subject|4|||
30859105|NCT02294734|58887796|FG001|Overall Study|Withdrawal by Subject|2|||
30859106|NCT02323204|58887817|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
30859107|NCT02323204|58887818|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
30859108|NCT02323204|58887819|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
30859109|NCT02323204|58887820|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
30859110|NCT02323204|58887817|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
30859111|NCT02323204|58887818|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
30859112|NCT02323204|58887819|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
30859113|NCT02323204|58887820|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
30859114|NCT02323204|58887817|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
30859115|NCT02323204|58887818|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
30859116|NCT02323204|58887819|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
30859117|NCT02323204|58887820|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
30859118|NCT02323204|58887817|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
30859119|NCT02323204|58887818|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
30859120|NCT02323204|58887819|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
30859121|NCT02323204|58887820|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
30859122|NCT02323204|58887817|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
30859123|NCT02323204|58887818|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
30859124|NCT02323204|58887819|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
30859125|NCT02323204|58887820|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
30859126|NCT02323204|58887817|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
30859127|NCT02323204|58887818|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
30859128|NCT02323204|58887819|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
30859129|NCT02323204|58887820|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
30859130|NCT02323204|58887817|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
30859131|NCT02323204|58887818|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
30859132|NCT02323204|58887819|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
30859133|NCT02323204|58887820|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
30859134|NCT02323204|58887817|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
30859135|NCT02323204|58887818|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
30859136|NCT02323204|58887819|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
30859137|NCT02323204|58887820|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
30859138|NCT02323204|58887817|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
30859139|NCT02323204|58887818|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
30859140|NCT02323204|58887819|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
30859141|NCT02323204|58887820|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
30859142|NCT02322892|58887832|FG000|Overall Study|Surgery cancelled|1|||
30859143|NCT02322892|58887833|FG001|Overall Study|Surgery cancelled|2|||
30859144|NCT02322892|58887832|FG000|Overall Study|Met exclusion criteria|0|||
30859145|NCT02322892|58887833|FG001|Overall Study|Met exclusion criteria|1|||
30859146|NCT02322892|58887832|FG000|Overall Study|Protocol Violation|1|||
30859147|NCT02322892|58887833|FG001|Overall Study|Protocol Violation|0|||
30859148|NCT03916081|58887842|FG000|Overall Study|Adverse Event|1|||
30859149|NCT03916081|58887843|FG001|Overall Study|Adverse Event|0|||
30859150|NCT03916081|58887844|FG002|Overall Study|Adverse Event|0|||
30859151|NCT03916081|58887842|FG000|Overall Study|Physician Decision|0|||
30859152|NCT03916081|58887843|FG001|Overall Study|Physician Decision|0|||
30859153|NCT03916081|58887844|FG002|Overall Study|Physician Decision|1|||
30859154|NCT03916081|58887842|FG000|Overall Study|Lost to Follow-up|0|||
30859155|NCT03916081|58887843|FG001|Overall Study|Lost to Follow-up|1|||
30859156|NCT03916081|58887844|FG002|Overall Study|Lost to Follow-up|0|||
30859157|NCT03916081|58887842|FG000|Overall Study|Withdrawal by Subject|3|||
30859158|NCT03916081|58887843|FG001|Overall Study|Withdrawal by Subject|0|||
30859159|NCT03916081|58887844|FG002|Overall Study|Withdrawal by Subject|1|||
30859160|NCT03916081|58887842|FG000|Overall Study|Worsening of AD|0|||
30859161|NCT03916081|58887843|FG001|Overall Study|Worsening of AD|0|||
30859162|NCT03916081|58887844|FG002|Overall Study|Worsening of AD|1|||
30859163|NCT02739997|58887852|FG000|Overall Study|Death|1|||
30859164|NCT02739997|58887852|FG000|Overall Study|Withdrawal by Subject|1|||
30859165|NCT02221037|58887860|FG000|Overall Study|Physician Decision|0|||
30859166|NCT02221037|58887861|FG001|Overall Study|Physician Decision|0|||
30859167|NCT02221037|58887862|FG002|Overall Study|Physician Decision|1|||
30859168|NCT02221037|58887863|FG003|Overall Study|Physician Decision|0|||
30859169|NCT02704429|58887879|FG000|Part A: 24 Weeks|Adverse Event|3|||
30859170|NCT02704429|58887880|FG001|Part A: 24 Weeks|Adverse Event|0|||
30859171|NCT02704429|58887879|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
30859172|NCT02704429|58887880|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
30859173|NCT02751359|58887887|FG000|Overall Study|Lost to Follow-up|1|||
30859174|NCT02750813|58887906|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
30859175|NCT02750813|58887907|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
30859176|NCT02750813|58887906|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
30859177|NCT02750813|58887907|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
30859178|NCT00503035|58887923|FG000|Overall Study|Lost to Follow-up|2|||
30859179|NCT00503035|58887923|FG000|Overall Study|Physician Decision|3|||
30859180|NCT00503035|58887923|FG000|Overall Study|Ineligible|15|||
30859181|NCT03137381|58887932|FG000|Overall Study|Adverse Event|3|||
30859182|NCT03137381|58887933|FG001|Overall Study|Adverse Event|0|||
30859183|NCT03137381|58887934|FG002|Overall Study|Adverse Event|2|||
30859184|NCT03137381|58887935|FG003|Overall Study|Adverse Event|0|||
30859185|NCT03137381|58887932|FG000|Overall Study|Lost to Follow-up|2|||
30859186|NCT03137381|58887933|FG001|Overall Study|Lost to Follow-up|1|||
30859187|NCT03137381|58887934|FG002|Overall Study|Lost to Follow-up|1|||
30859188|NCT03137381|58887935|FG003|Overall Study|Lost to Follow-up|0|||
30959394|NCT02691702|59024862|FG002|Overall Study|Adverse Event|0|||
30959395|NCT02691702|59024863|FG003|Overall Study|Adverse Event|0|||
30959396|NCT02691702|59024864|FG004|Overall Study|Adverse Event|0|||
30959397|NCT02691702|59024865|FG005|Overall Study|Adverse Event|0|||
30959398|NCT02691702|59024866|FG006|Overall Study|Adverse Event|0|||
30959399|NCT02691702|59024867|FG007|Overall Study|Adverse Event|0|||
30959400|NCT02691702|59024868|FG008|Overall Study|Adverse Event|1|||
30959401|NCT02691702|59024869|FG009|Overall Study|Adverse Event|0|||
30959402|NCT02691702|59024870|FG010|Overall Study|Adverse Event|1|||
30959403|NCT02691702|59024860|FG000|Overall Study|Lost to Follow-up|0|||
30959404|NCT02691702|59024861|FG001|Overall Study|Lost to Follow-up|0|||
30959405|NCT02691702|59024862|FG002|Overall Study|Lost to Follow-up|1|||
30959406|NCT02691702|59024863|FG003|Overall Study|Lost to Follow-up|0|||
30959407|NCT02691702|59024864|FG004|Overall Study|Lost to Follow-up|0|||
30959408|NCT02691702|59024865|FG005|Overall Study|Lost to Follow-up|2|||
30689312|NCT01424566|58703284|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
30689313|NCT01424566|58703282|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
30689314|NCT01424566|58703283|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
30689315|NCT01424566|58703284|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
30689316|NCT01424566|58703282|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
30689317|NCT01424566|58703283|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
30959409|NCT02691702|59024866|FG006|Overall Study|Lost to Follow-up|0|||
30959410|NCT02691702|59024867|FG007|Overall Study|Lost to Follow-up|0|||
30689318|NCT01424566|58703284|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
30689319|NCT01424566|58703282|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
30689320|NCT01424566|58703283|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
30689321|NCT01424566|58703284|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
30689322|NCT01424566|58703282|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
30689323|NCT01424566|58703283|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
30689324|NCT01424566|58703284|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
30689325|NCT01424566|58703282|FG000|Double-blind Treatment|Adverse Event|0|||
30689326|NCT01424566|58703283|FG001|Double-blind Treatment|Adverse Event|21|||
30689327|NCT01424566|58703284|FG002|Double-blind Treatment|Adverse Event|13|||
30959411|NCT02691702|59024868|FG008|Overall Study|Lost to Follow-up|0|||
30959412|NCT02691702|59024869|FG009|Overall Study|Lost to Follow-up|0|||
30959413|NCT02691702|59024870|FG010|Overall Study|Lost to Follow-up|1|||
30959414|NCT02691702|59024860|FG000|Overall Study|Withdrawal by Subject|1|||
30689328|NCT01424566|58703282|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
30689329|NCT01424566|58703283|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
30689330|NCT01424566|58703284|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
30859189|NCT03137381|58887932|FG000|Overall Study|Protocol deviation|1|||
30859190|NCT03137381|58887933|FG001|Overall Study|Protocol deviation|1|||
30959415|NCT02691702|59024861|FG001|Overall Study|Withdrawal by Subject|1|||
30959416|NCT02691702|59024862|FG002|Overall Study|Withdrawal by Subject|0|||
30959417|NCT02691702|59024863|FG003|Overall Study|Withdrawal by Subject|0|||
30959418|NCT02691702|59024864|FG004|Overall Study|Withdrawal by Subject|0|||
30689331|NCT01424566|58703282|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
30689332|NCT01424566|58703283|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
30859191|NCT03137381|58887934|FG002|Overall Study|Protocol deviation|0|||
30859192|NCT03137381|58887935|FG003|Overall Study|Protocol deviation|1|||
30859193|NCT03137381|58887932|FG000|Overall Study|Withdrawal by Investigator|0|||
30859194|NCT03137381|58887933|FG001|Overall Study|Withdrawal by Investigator|1|||
30859195|NCT03137381|58887934|FG002|Overall Study|Withdrawal by Investigator|1|||
30859196|NCT03137381|58887935|FG003|Overall Study|Withdrawal by Investigator|0|||
30959419|NCT02691702|59024865|FG005|Overall Study|Withdrawal by Subject|1|||
30959420|NCT02691702|59024866|FG006|Overall Study|Withdrawal by Subject|2|||
30959421|NCT02691702|59024867|FG007|Overall Study|Withdrawal by Subject|0|||
30959422|NCT02691702|59024868|FG008|Overall Study|Withdrawal by Subject|0|||
30959423|NCT02691702|59024869|FG009|Overall Study|Withdrawal by Subject|0|||
30959424|NCT02691702|59024870|FG010|Overall Study|Withdrawal by Subject|0|||
30959425|NCT02691702|59024860|FG000|Overall Study|Other|0|||
30959426|NCT02691702|59024861|FG001|Overall Study|Other|0|||
30959427|NCT02691702|59024862|FG002|Overall Study|Other|0|||
30959428|NCT02691702|59024863|FG003|Overall Study|Other|0|||
30959429|NCT02691702|59024864|FG004|Overall Study|Other|0|||
30959430|NCT02691702|59024865|FG005|Overall Study|Other|0|||
30959431|NCT02691702|59024866|FG006|Overall Study|Other|1|||
30959432|NCT02691702|59024867|FG007|Overall Study|Other|0|||
30959433|NCT02691702|59024868|FG008|Overall Study|Other|1|||
30959434|NCT02691702|59024869|FG009|Overall Study|Other|0|||
30959435|NCT02691702|59024870|FG010|Overall Study|Other|0|||
30959436|NCT02691702|59024860|FG000|Overall Study|Protocol Violation|0|||
30959437|NCT02691702|59024861|FG001|Overall Study|Protocol Violation|0|||
30959438|NCT02691702|59024862|FG002|Overall Study|Protocol Violation|0|||
30959439|NCT02691702|59024863|FG003|Overall Study|Protocol Violation|0|||
30959440|NCT02691702|59024864|FG004|Overall Study|Protocol Violation|0|||
30959441|NCT02691702|59024865|FG005|Overall Study|Protocol Violation|0|||
30959442|NCT02691702|59024866|FG006|Overall Study|Protocol Violation|0|||
30959443|NCT02691702|59024867|FG007|Overall Study|Protocol Violation|0|||
30959444|NCT02691702|59024868|FG008|Overall Study|Protocol Violation|0|||
30959445|NCT02691702|59024869|FG009|Overall Study|Protocol Violation|2|||
30959446|NCT02691702|59024870|FG010|Overall Study|Protocol Violation|0|||
30959447|NCT01564277|59024904|FG000|Overall Study|Protocol Violation|0|||
30959448|NCT01564277|59024905|FG001|Overall Study|Protocol Violation|1|||
30959449|NCT01564277|59024904|FG000|Overall Study|Physician Decision|1|||
30959450|NCT01564277|59024905|FG001|Overall Study|Physician Decision|0|||
30959451|NCT02679222|59024911|FG000|Overall Study|No time for project|1|||
30959452|NCT01563185|59024923|FG000|Overall Study|Withdrawal by Subject|1|||
30959453|NCT01563185|59024923|FG000|Overall Study|Non-Compliance with study drug|1|||
30959454|NCT03305848|59024927|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
30959455|NCT03305848|59024927|FG000|Overall Study|Physician Decision|2|||
30959456|NCT01563029|59024936|FG000|Overall Study|Adverse Event|1|||
30959457|NCT01563029|59024937|FG001|Overall Study|Adverse Event|0|||
30959458|NCT01563029|59024938|FG002|Overall Study|Adverse Event|1|||
30959459|NCT01563029|59024939|FG003|Overall Study|Adverse Event|2|||
30959460|NCT01563029|59024940|FG004|Overall Study|Adverse Event|1|||
30959461|NCT01563029|59024936|FG000|Overall Study|Lack of Efficacy|42|||
30959462|NCT01563029|59024937|FG001|Overall Study|Lack of Efficacy|16|||
30959463|NCT01563029|59024938|FG002|Overall Study|Lack of Efficacy|23|||
30959464|NCT01563029|59024939|FG003|Overall Study|Lack of Efficacy|21|||
30689333|NCT01424566|58703284|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
30689334|NCT01424566|58703282|FG000|Double-blind Treatment|Lack of Efficacy|0|||
30689335|NCT01424566|58703283|FG001|Double-blind Treatment|Lack of Efficacy|1|||
30689336|NCT01424566|58703284|FG002|Double-blind Treatment|Lack of Efficacy|1|||
30689337|NCT01361607|58703293|FG000|Overall Study|Adverse Event|38|||
30689338|NCT01361607|58703294|FG001|Overall Study|Adverse Event|29|||
30689339|NCT01361607|58703293|FG000|Overall Study|Withdrawal by Subject|19|||
30689340|NCT01361607|58703294|FG001|Overall Study|Withdrawal by Subject|8|||
30689341|NCT01361607|58703293|FG000|Overall Study|Withdrawal by Investigator|5|||
30689342|NCT01361607|58703294|FG001|Overall Study|Withdrawal by Investigator|3|||
30689343|NCT01361607|58703293|FG000|Overall Study|Lost to Follow-up|1|||
30689344|NCT01361607|58703294|FG001|Overall Study|Lost to Follow-up|0|||
30689345|NCT01361607|58703293|FG000|Overall Study|Met Withdrawal Criteria|1|||
30689346|NCT01361607|58703294|FG001|Overall Study|Met Withdrawal Criteria|1|||
30689347|NCT01337089|58703301|FG000|Overall Study|Adverse Event|237|||
30959465|NCT01563029|59024940|FG004|Overall Study|Lack of Efficacy|19|||
30959466|NCT01563029|59024936|FG000|Overall Study|Protocol Violation|1|||
30959467|NCT01563029|59024937|FG001|Overall Study|Protocol Violation|2|||
30959468|NCT01563029|59024938|FG002|Overall Study|Protocol Violation|3|||
30959469|NCT01563029|59024939|FG003|Overall Study|Protocol Violation|1|||
30959470|NCT01563029|59024940|FG004|Overall Study|Protocol Violation|3|||
30959471|NCT01563029|59024936|FG000|Overall Study|Protocol defined stopping criteria|1|||
30959472|NCT01563029|59024937|FG001|Overall Study|Protocol defined stopping criteria|0|||
30959473|NCT01563029|59024938|FG002|Overall Study|Protocol defined stopping criteria|0|||
30959474|NCT01563029|59024939|FG003|Overall Study|Protocol defined stopping criteria|0|||
30689348|NCT01337089|58703301|FG000|Overall Study|Withdrawal by Subject|129|||
30689349|NCT01337089|58703301|FG000|Overall Study|Withdrawal by Investigator|33|||
30689350|NCT01337089|58703301|FG000|Overall Study|Met Withdrawal Criteria|3|||
30689351|NCT01337089|58703301|FG000|Overall Study|Lost to Follow-up|2|||
30689352|NCT00114530|58703315|FG000|Overall Study|Death|3|||
30689353|NCT00114530|58703316|FG001|Overall Study|Death|11|||
30689354|NCT00114530|58703315|FG000|Overall Study|Lost to Follow-up|1|||
30689355|NCT00114530|58703316|FG001|Overall Study|Lost to Follow-up|1|||
30689356|NCT00114530|58703315|FG000|Overall Study|Physician Decision|1|||
30689357|NCT00114530|58703316|FG001|Overall Study|Physician Decision|1|||
30859197|NCT03137381|58887932|FG000|Overall Study|Withdrawal by Subject|3|||
30859198|NCT03137381|58887933|FG001|Overall Study|Withdrawal by Subject|4|||
30859199|NCT03137381|58887934|FG002|Overall Study|Withdrawal by Subject|3|||
30859200|NCT03137381|58887935|FG003|Overall Study|Withdrawal by Subject|0|||
30859201|NCT03137381|58887932|FG000|Overall Study|Pregnancy|0|||
30859202|NCT03137381|58887933|FG001|Overall Study|Pregnancy|0|||
30859203|NCT03137381|58887934|FG002|Overall Study|Pregnancy|1|||
30859204|NCT03137381|58887935|FG003|Overall Study|Pregnancy|0|||
30859205|NCT03926117|58887949|FG000|Overall Study|Unclassified|1|||
30859206|NCT03926117|58887950|FG001|Overall Study|Unclassified|4|||
30859207|NCT03926117|58887951|FG002|Overall Study|Unclassified|1|||
30859208|NCT03926117|58887952|FG003|Overall Study|Unclassified|4|||
30859209|NCT03926117|58887949|FG000|Overall Study|Withdrawal by Subject|3|||
30859210|NCT03926117|58887950|FG001|Overall Study|Withdrawal by Subject|0|||
30859211|NCT03926117|58887951|FG002|Overall Study|Withdrawal by Subject|1|||
30859212|NCT03926117|58887952|FG003|Overall Study|Withdrawal by Subject|1|||
30859213|NCT03926117|58887949|FG000|Overall Study|Lost to Follow-up|0|||
30859214|NCT03926117|58887950|FG001|Overall Study|Lost to Follow-up|2|||
30859215|NCT03926117|58887951|FG002|Overall Study|Lost to Follow-up|1|||
30859216|NCT03926117|58887952|FG003|Overall Study|Lost to Follow-up|0|||
30859217|NCT03926117|58887949|FG000|Overall Study|Adverse Event|1|||
30859218|NCT03926117|58887950|FG001|Overall Study|Adverse Event|2|||
30859219|NCT03926117|58887951|FG002|Overall Study|Adverse Event|3|||
30859220|NCT03926117|58887952|FG003|Overall Study|Adverse Event|1|||
30859221|NCT03926117|58887949|FG000|Overall Study|Randomized but not treated|1|||
30859222|NCT03926117|58887950|FG001|Overall Study|Randomized but not treated|1|||
30859223|NCT03926117|58887951|FG002|Overall Study|Randomized but not treated|0|||
30859224|NCT03926117|58887952|FG003|Overall Study|Randomized but not treated|1|||
30859225|NCT02750501|58887979|FG000|Overall Study|Adverse Event|4|||
30859226|NCT02750501|58887979|FG000|Overall Study|Physician Decision|1|||
30859227|NCT02750501|58887979|FG000|Overall Study|Protocol Violation|1|||
30859228|NCT02750501|58887979|FG000|Overall Study|G-tube came out|1|||
30859229|NCT02750501|58887979|FG000|Overall Study|Non-compliant use of PERT|1|||
30859230|NCT01337297|58888002|FG000|Overall Study|They entered to single anodal tDCS|4|||
30859231|NCT01337297|58888003|FG001|Overall Study|They entered to single anodal tDCS|3|||
30859232|NCT01337297|58888002|FG000|Overall Study|Lost to Follow-up|1|||
30859233|NCT01337297|58888003|FG001|Overall Study|Lost to Follow-up|3|||
30859234|NCT02302963|58888011|FG000|Overall Study|Withdrawal by Subject|2|||
30859235|NCT02302963|58888012|FG001|Overall Study|Withdrawal by Subject|1|||
30859236|NCT02302963|58888011|FG000|Overall Study|Steroid injection|0|||
30859237|NCT02302963|58888012|FG001|Overall Study|Steroid injection|1|||
30859238|NCT02302963|58888011|FG000|Overall Study|Physician Decision|1|||
30859239|NCT02302963|58888012|FG001|Overall Study|Physician Decision|0|||
30689358|NCT00114530|58703315|FG000|Overall Study|Withdrawal by Subject|2|||
30689359|NCT00114530|58703316|FG001|Overall Study|Withdrawal by Subject|6|||
30689360|NCT00114530|58703315|FG000|Overall Study|Breast Cancer|1|||
30689361|NCT00114530|58703316|FG001|Overall Study|Breast Cancer|0|||
30689362|NCT00114530|58703315|FG000|Overall Study|Subject decision after endpoint failure|0|||
30689363|NCT00114530|58703316|FG001|Overall Study|Subject decision after endpoint failure|1|||
30689364|NCT00114530|58703315|FG000|Overall Study|Ineligible|1|||
30689365|NCT00114530|58703316|FG001|Overall Study|Ineligible|0|||
30689366|NCT00618982|58703339|FG000|Overall Study|Adverse Event|23|||
30689367|NCT00618982|58703339|FG000|Overall Study|Withdrawal by Subject|1|||
30689368|NCT00618982|58703339|FG000|Overall Study|Protocol Violation|1|||
30689369|NCT00618982|58703339|FG000|Overall Study|ongoing, still treated with study med.|25|||
30689370|NCT00578786|58703349|FG000|Overall Study|Adverse Event|27|||
30689371|NCT00578786|58703350|FG001|Overall Study|Adverse Event|37|||
30689372|NCT00578786|58703351|FG002|Overall Study|Adverse Event|17|||
30689373|NCT00578786|58703349|FG000|Overall Study|Lack of Efficacy|2|||
30859240|NCT04702997|58888020|FG000|Overall Study|Withdrawal by Subject|1|||
30689374|NCT00578786|58703350|FG001|Overall Study|Lack of Efficacy|5|||
30689375|NCT00578786|58703351|FG002|Overall Study|Lack of Efficacy|2|||
30689376|NCT00578786|58703349|FG000|Overall Study|Early Escape from Prior Study|2|||
30689377|NCT00578786|58703350|FG001|Overall Study|Early Escape from Prior Study|1|||
30859241|NCT04702997|58888021|FG001|Overall Study|Withdrawal by Subject|1|||
30859242|NCT03507439|58888042|FG000|Overall Study|Other|2|||
30859243|NCT03507439|58888043|FG001|Overall Study|Other|1|||
30859244|NCT03507439|58888042|FG000|Overall Study|Withdrawal by Subject|1|||
30859245|NCT03507439|58888043|FG001|Overall Study|Withdrawal by Subject|0|||
30689378|NCT00578786|58703351|FG002|Overall Study|Early Escape from Prior Study|2|||
30689379|NCT00578786|58703349|FG000|Overall Study|Withdrawal by Subject|7|||
30689380|NCT00578786|58703350|FG001|Overall Study|Withdrawal by Subject|8|||
30689381|NCT00578786|58703351|FG002|Overall Study|Withdrawal by Subject|5|||
30689382|NCT00578786|58703349|FG000|Overall Study|Protocol Violation|0|||
30689383|NCT00578786|58703350|FG001|Overall Study|Protocol Violation|3|||
30689384|NCT00578786|58703351|FG002|Overall Study|Protocol Violation|1|||
30689385|NCT00578786|58703349|FG000|Overall Study|Physician Decision|1|||
30689386|NCT00578786|58703350|FG001|Overall Study|Physician Decision|0|||
30689387|NCT00578786|58703351|FG002|Overall Study|Physician Decision|1|||
30689388|NCT00578786|58703349|FG000|Overall Study|Sponsor Decision|0|||
30689389|NCT00578786|58703350|FG001|Overall Study|Sponsor Decision|0|||
30689390|NCT00578786|58703351|FG002|Overall Study|Sponsor Decision|1|||
30859246|NCT03507439|58888042|FG000|Overall Study|Death|1|||
30859247|NCT03507439|58888043|FG001|Overall Study|Death|1|||
30859248|NCT03507127|58888051|FG000|Overall Study|Withdrawal by Subject|1|||
30859249|NCT03507127|58888052|FG001|Overall Study|Withdrawal by Subject|0|||
30859250|NCT03507127|58888051|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
30859251|NCT03507127|58888052|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
30859252|NCT02322190|58888075|FG000|Overall Study|Death on study|1|||
30859253|NCT02322190|58888076|FG001|Overall Study|Death on study|0|||
30859254|NCT02321800|58888092|FG000|Overall Study|Withdrawal by Subject|3|||
30859255|NCT02321800|58888093|FG001|Overall Study|Withdrawal by Subject|3|||
30859256|NCT02321800|58888092|FG000|Overall Study|Death|1|||
30859257|NCT02321800|58888093|FG001|Overall Study|Death|0|||
30859258|NCT02321800|58888092|FG000|Overall Study|Protocol Violation|1|||
30859259|NCT02321800|58888093|FG001|Overall Study|Protocol Violation|0|||
30859260|NCT02321800|58888092|FG000|Overall Study|Lost to Follow-up|10|||
30859261|NCT02321800|58888093|FG001|Overall Study|Lost to Follow-up|4|||
30859262|NCT02321800|58888092|FG000|Overall Study|Adverse Event|2|||
30859263|NCT02321800|58888093|FG001|Overall Study|Adverse Event|3|||
30859264|NCT02321800|58888092|FG000|Overall Study|Other, Miscellaneous|3|||
30859265|NCT02321800|58888093|FG001|Overall Study|Other, Miscellaneous|1|||
30859266|NCT02292784|58888139|FG000|Overall Study|Lost to Follow-up|1|||
30859267|NCT02292784|58888140|FG001|Overall Study|Lost to Follow-up|17|||
30959475|NCT01563029|59024940|FG004|Overall Study|Protocol defined stopping criteria|0|||
30959476|NCT01563029|59024936|FG000|Overall Study|Lost to Follow-up|1|||
30959477|NCT01563029|59024937|FG001|Overall Study|Lost to Follow-up|0|||
30599660|NCT01028053|58611430|FG000|Overall Study|Technical Problem|1|||
30599661|NCT01028053|58611430|FG000|Overall Study|Terminated by Sponsor|1|||
30599662|NCT01028053|58611430|FG000|Overall Study|Various reasons|4|||
30599663|NCT01023217|58611438|FG000|Overall Study|Withdrawal by Subject|1|||
30599664|NCT01023217|58611439|FG001|Overall Study|Withdrawal by Subject|0|||
30599665|NCT01095796|58611447|FG000|Overall Study|Randomized but Not Treated|5|||
30599666|NCT01095796|58611448|FG001|Overall Study|Randomized but Not Treated|2|||
30599667|NCT01095796|58611447|FG000|Overall Study|Adverse Event|9|||
30599668|NCT01095796|58611448|FG001|Overall Study|Adverse Event|19|||
30599669|NCT01095796|58611447|FG000|Overall Study|Death|3|||
30599670|NCT01095796|58611448|FG001|Overall Study|Death|2|||
30599671|NCT01095796|58611447|FG000|Overall Study|Pregnancy|2|||
30599672|NCT01095796|58611448|FG001|Overall Study|Pregnancy|0|||
30599673|NCT01095796|58611447|FG000|Overall Study|Lack of Efficacy|5|||
30599674|NCT01095796|58611448|FG001|Overall Study|Lack of Efficacy|3|||
30599675|NCT01095796|58611447|FG000|Overall Study|Investigator's Discretion|7|||
30599676|NCT01095796|58611448|FG001|Overall Study|Investigator's Discretion|2|||
30599677|NCT01095796|58611447|FG000|Overall Study|Withdrew Consent|16|||
30599678|NCT01095796|58611448|FG001|Overall Study|Withdrew Consent|22|||
30599679|NCT01095796|58611447|FG000|Overall Study|Lost to Follow-up|27|||
30599680|NCT01095796|58611448|FG001|Overall Study|Lost to Follow-up|29|||
30599681|NCT01095796|58611447|FG000|Overall Study|Participant Noncompliance|5|||
30599682|NCT01095796|58611448|FG001|Overall Study|Participant Noncompliance|10|||
30599683|NCT01095796|58611447|FG000|Overall Study|Protocol Violation|1|||
30599684|NCT01095796|58611448|FG001|Overall Study|Protocol Violation|0|||
30599685|NCT01095796|58611447|FG000|Overall Study|Participant Transferred to Another Study|215|||
30599686|NCT01095796|58611448|FG001|Overall Study|Participant Transferred to Another Study|200|||
30599687|NCT01023061|58611454|FG000|Overall Study|Withdrawal prior to treatment|2|||
30599688|NCT01027897|58611458|FG000|Overall Study|Protocol Violation|1|||
30599689|NCT01027897|58611458|FG000|Overall Study|Withdrawal by Subject|1|||
30599690|NCT01027351|58611468|FG000|Overall Study|Withdrawal by Subject|1|||
30599691|NCT01027351|58611469|FG001|Overall Study|Withdrawal by Subject|0|||
30599692|NCT01027351|58611470|FG002|Overall Study|Withdrawal by Subject|1|||
30599693|NCT01027351|58611471|FG003|Overall Study|Withdrawal by Subject|0|||
30689391|NCT00578786|58703349|FG000|Overall Study|Lost to Follow-up|0|||
30599694|NCT01027351|58611472|FG004|Overall Study|Withdrawal by Subject|3|||
30689392|NCT00578786|58703350|FG001|Overall Study|Lost to Follow-up|4|||
30689393|NCT00578786|58703351|FG002|Overall Study|Lost to Follow-up|0|||
30689394|NCT00578786|58703349|FG000|Overall Study|Pregnancy|0|||
30859268|NCT02292784|58888141|FG002|Overall Study|Lost to Follow-up|18|||
30959478|NCT01563029|59024938|FG002|Overall Study|Lost to Follow-up|1|||
30859269|NCT02292784|58888139|FG000|Overall Study|Withdrawal by Subject|0|||
30859270|NCT02292784|58888140|FG001|Overall Study|Withdrawal by Subject|3|||
30859271|NCT02292784|58888141|FG002|Overall Study|Withdrawal by Subject|3|||
30859272|NCT02320396|58888151|FG000|Overall Study|Adverse Event|2|||
30859273|NCT02320396|58888152|FG001|Overall Study|Adverse Event|2|||
30859274|NCT02320396|58888151|FG000|Overall Study|Pregnancy|0|||
30859275|NCT02320396|58888152|FG001|Overall Study|Pregnancy|1|||
30859276|NCT02320396|58888151|FG000|Overall Study|Protocol Violation|0|||
30859277|NCT02320396|58888152|FG001|Overall Study|Protocol Violation|1|||
30859278|NCT02320396|58888151|FG000|Overall Study|Withdrawal by Subject|2|||
30859279|NCT02320396|58888152|FG001|Overall Study|Withdrawal by Subject|0|||
30599695|NCT01027351|58611473|FG005|Overall Study|Withdrawal by Subject|5|||
30599696|NCT01027351|58611468|FG000|Overall Study|Lost to Follow-up|1|||
30599697|NCT01027351|58611469|FG001|Overall Study|Lost to Follow-up|1|||
30599698|NCT01027351|58611470|FG002|Overall Study|Lost to Follow-up|0|||
30599699|NCT01027351|58611471|FG003|Overall Study|Lost to Follow-up|1|||
30599700|NCT01027351|58611472|FG004|Overall Study|Lost to Follow-up|6|||
30599701|NCT01027351|58611473|FG005|Overall Study|Lost to Follow-up|0|||
30599702|NCT01027351|58611468|FG000|Overall Study|Inappropriate enrollment|0|||
30599703|NCT01027351|58611469|FG001|Overall Study|Inappropriate enrollment|0|||
30599704|NCT01027351|58611470|FG002|Overall Study|Inappropriate enrollment|0|||
30599705|NCT01027351|58611471|FG003|Overall Study|Inappropriate enrollment|0|||
30599706|NCT01027351|58611472|FG004|Overall Study|Inappropriate enrollment|1|||
30599707|NCT01027351|58611473|FG005|Overall Study|Inappropriate enrollment|0|||
30599708|NCT01027351|58611468|FG000|Overall Study|Protocol Violation|1|||
30599709|NCT01027351|58611469|FG001|Overall Study|Protocol Violation|0|||
30599710|NCT01027351|58611470|FG002|Overall Study|Protocol Violation|0|||
30599711|NCT01027351|58611471|FG003|Overall Study|Protocol Violation|1|||
30599712|NCT01027351|58611472|FG004|Overall Study|Protocol Violation|1|||
30599713|NCT01027351|58611473|FG005|Overall Study|Protocol Violation|0|||
30599714|NCT01027273|58611496|FG000|Overall Study|Lost to Follow-up|57|||
30599715|NCT01027273|58611497|FG001|Overall Study|Lost to Follow-up|31|||
30599716|NCT01027273|58611496|FG000|Overall Study|Death|2|||
30599717|NCT01027273|58611497|FG001|Overall Study|Death|2|||
30599718|NCT01022203|58611505|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
30599719|NCT01022203|58611506|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
30599720|NCT01022203|58611505|FG000|Post Treatment Assessment|Physician Decision|2|||
30599721|NCT01022203|58611506|FG001|Post Treatment Assessment|Physician Decision|0|||
30599722|NCT01022203|58611505|FG000|Post Treatment Assessment|Adverse Event|0|||
30599723|NCT01022203|58611506|FG001|Post Treatment Assessment|Adverse Event|2|||
30599724|NCT01022203|58611505|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
30599725|NCT01022203|58611506|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
30599726|NCT01296711|58611523|FG000|Overall Study|Adverse Event|3|||
30599727|NCT01296711|58611524|FG001|Overall Study|Adverse Event|1|||
30599728|NCT01296711|58611525|FG002|Overall Study|Adverse Event|4|||
30859280|NCT02292238|58888160|FG000|Overall Study|Protocol Violation|1|||
30859281|NCT02292238|58888161|FG001|Overall Study|Protocol Violation|2|||
30859282|NCT02292238|58888160|FG000|Overall Study|Withdrawal by Subject|2|||
30859283|NCT02292238|58888161|FG001|Overall Study|Withdrawal by Subject|1|||
30859284|NCT02292238|58888160|FG000|Overall Study|Lost to Follow-up|1|||
30859285|NCT02292238|58888161|FG001|Overall Study|Lost to Follow-up|0|||
30859286|NCT02292238|58888160|FG000|Overall Study|Physician Decision|0|||
30859287|NCT02292238|58888161|FG001|Overall Study|Physician Decision|1|||
30859288|NCT02234843|58888198|FG000|Overall Study|Death|1|||
30859289|NCT02234843|58888199|FG001|Overall Study|Death|0|||
30859290|NCT02234843|58888200|FG002|Overall Study|Death|0|||
30859291|NCT02234843|58888201|FG003|Overall Study|Death|0|||
30859292|NCT02234843|58888202|FG004|Overall Study|Death|0|||
30859293|NCT02234843|58888203|FG005|Overall Study|Death|0|||
30859294|NCT02234843|58888204|FG006|Overall Study|Death|0|||
30599729|NCT01296711|58611526|FG003|Overall Study|Adverse Event|3|||
30599730|NCT01296711|58611527|FG004|Overall Study|Adverse Event|1|||
30599731|NCT01296711|58611528|FG005|Overall Study|Adverse Event|6|||
30599732|NCT01296711|58611529|FG006|Overall Study|Adverse Event|11|||
30599733|NCT01296711|58611530|FG007|Overall Study|Adverse Event|3|||
30599734|NCT01296711|58611523|FG000|Overall Study|Lack of Efficacy|1|||
30599735|NCT01296711|58611524|FG001|Overall Study|Lack of Efficacy|4|||
30599736|NCT01296711|58611525|FG002|Overall Study|Lack of Efficacy|1|||
30859295|NCT02234843|58888205|FG007|Overall Study|Death|0|||
30859296|NCT02234843|58888206|FG008|Overall Study|Death|0|||
30599737|NCT01296711|58611526|FG003|Overall Study|Lack of Efficacy|1|||
30859297|NCT02234843|58888207|FG009|Overall Study|Death|0|||
30859298|NCT02234843|58888198|FG000|Overall Study|Protocol Violation|1|||
30599738|NCT01296711|58611527|FG004|Overall Study|Lack of Efficacy|1|||
30599739|NCT01296711|58611528|FG005|Overall Study|Lack of Efficacy|0|||
30689395|NCT00578786|58703350|FG001|Overall Study|Pregnancy|1|||
30859299|NCT02234843|58888199|FG001|Overall Study|Protocol Violation|0|||
30859300|NCT02234843|58888200|FG002|Overall Study|Protocol Violation|1|||
30859301|NCT02234843|58888201|FG003|Overall Study|Protocol Violation|0|||
30859302|NCT02234843|58888202|FG004|Overall Study|Protocol Violation|0|||
30859303|NCT02234843|58888203|FG005|Overall Study|Protocol Violation|0|||
30859304|NCT02234843|58888204|FG006|Overall Study|Protocol Violation|0|||
30859305|NCT02234843|58888205|FG007|Overall Study|Protocol Violation|0|||
30859306|NCT02234843|58888206|FG008|Overall Study|Protocol Violation|0|||
30859307|NCT02234843|58888207|FG009|Overall Study|Protocol Violation|0|||
30859308|NCT02234843|58888198|FG000|Overall Study|Efficacy outcome reached|2|||
30859309|NCT02234843|58888199|FG001|Overall Study|Efficacy outcome reached|0|||
30859310|NCT02234843|58888200|FG002|Overall Study|Efficacy outcome reached|0|||
30859311|NCT02234843|58888201|FG003|Overall Study|Efficacy outcome reached|0|||
30859312|NCT02234843|58888202|FG004|Overall Study|Efficacy outcome reached|0|||
30859313|NCT02234843|58888203|FG005|Overall Study|Efficacy outcome reached|2|||
30859314|NCT02234843|58888204|FG006|Overall Study|Efficacy outcome reached|0|||
30859315|NCT02234843|58888205|FG007|Overall Study|Efficacy outcome reached|0|||
30859316|NCT02234843|58888206|FG008|Overall Study|Efficacy outcome reached|0|||
30859317|NCT02234843|58888207|FG009|Overall Study|Efficacy outcome reached|0|||
30859318|NCT02234843|58888198|FG000|Overall Study|Patient convenience|2|||
30859319|NCT02234843|58888199|FG001|Overall Study|Patient convenience|0|||
30859320|NCT02234843|58888200|FG002|Overall Study|Patient convenience|0|||
30859321|NCT02234843|58888201|FG003|Overall Study|Patient convenience|0|||
30859322|NCT02234843|58888202|FG004|Overall Study|Patient convenience|0|||
30859323|NCT02234843|58888203|FG005|Overall Study|Patient convenience|1|||
30859324|NCT02234843|58888204|FG006|Overall Study|Patient convenience|0|||
30859325|NCT02234843|58888205|FG007|Overall Study|Patient convenience|0|||
30859326|NCT02234843|58888206|FG008|Overall Study|Patient convenience|0|||
30859327|NCT02234843|58888207|FG009|Overall Study|Patient convenience|0|||
30859328|NCT02234843|58888198|FG000|Overall Study|Withdrawal by Subject|5|||
30859329|NCT02234843|58888199|FG001|Overall Study|Withdrawal by Subject|1|||
30859330|NCT02234843|58888200|FG002|Overall Study|Withdrawal by Subject|1|||
30859331|NCT02234843|58888201|FG003|Overall Study|Withdrawal by Subject|0|||
30859332|NCT02234843|58888202|FG004|Overall Study|Withdrawal by Subject|0|||
30859333|NCT02234843|58888203|FG005|Overall Study|Withdrawal by Subject|7|||
30859334|NCT02234843|58888204|FG006|Overall Study|Withdrawal by Subject|0|||
30859335|NCT02234843|58888205|FG007|Overall Study|Withdrawal by Subject|0|||
30859336|NCT02234843|58888206|FG008|Overall Study|Withdrawal by Subject|0|||
30859337|NCT02234843|58888207|FG009|Overall Study|Withdrawal by Subject|0|||
30859338|NCT02234843|58888198|FG000|Overall Study|Recovery|1|||
30859339|NCT02234843|58888199|FG001|Overall Study|Recovery|0|||
30859340|NCT02234843|58888200|FG002|Overall Study|Recovery|0|||
30859341|NCT02234843|58888201|FG003|Overall Study|Recovery|0|||
30859342|NCT02234843|58888202|FG004|Overall Study|Recovery|0|||
30859343|NCT02234843|58888203|FG005|Overall Study|Recovery|0|||
30859344|NCT02234843|58888204|FG006|Overall Study|Recovery|0|||
30599740|NCT01296711|58611529|FG006|Overall Study|Lack of Efficacy|2|||
30599741|NCT01296711|58611530|FG007|Overall Study|Lack of Efficacy|3|||
30599742|NCT01296711|58611523|FG000|Overall Study|Lost to Follow-up|0|||
30599743|NCT01296711|58611524|FG001|Overall Study|Lost to Follow-up|0|||
30599744|NCT01296711|58611525|FG002|Overall Study|Lost to Follow-up|1|||
30599745|NCT01296711|58611526|FG003|Overall Study|Lost to Follow-up|1|||
30859345|NCT02234843|58888205|FG007|Overall Study|Recovery|0|||
30859346|NCT02234843|58888206|FG008|Overall Study|Recovery|0|||
30859347|NCT02234843|58888207|FG009|Overall Study|Recovery|0|||
30859348|NCT02234843|58888198|FG000|Overall Study|Other|0|||
30859349|NCT02234843|58888199|FG001|Overall Study|Other|2|||
30859350|NCT02234843|58888200|FG002|Overall Study|Other|0|||
30859351|NCT02234843|58888201|FG003|Overall Study|Other|1|||
30859352|NCT02234843|58888202|FG004|Overall Study|Other|0|||
30859353|NCT02234843|58888203|FG005|Overall Study|Other|1|||
30859354|NCT02234843|58888204|FG006|Overall Study|Other|0|||
30859355|NCT02234843|58888205|FG007|Overall Study|Other|1|||
30859356|NCT02234843|58888206|FG008|Overall Study|Other|0|||
30859357|NCT02234843|58888207|FG009|Overall Study|Other|0|||
30859358|NCT02234843|58888198|FG000|Overall Study|Physician Decision|4|||
30859359|NCT02234843|58888199|FG001|Overall Study|Physician Decision|1|||
30859360|NCT02234843|58888200|FG002|Overall Study|Physician Decision|0|||
30859361|NCT02234843|58888201|FG003|Overall Study|Physician Decision|1|||
30859362|NCT02234843|58888202|FG004|Overall Study|Physician Decision|0|||
30859363|NCT02234843|58888203|FG005|Overall Study|Physician Decision|0|||
30859364|NCT02234843|58888204|FG006|Overall Study|Physician Decision|0|||
30599746|NCT01296711|58611527|FG004|Overall Study|Lost to Follow-up|2|||
30599747|NCT01296711|58611528|FG005|Overall Study|Lost to Follow-up|0|||
30599748|NCT01296711|58611529|FG006|Overall Study|Lost to Follow-up|4|||
30859365|NCT02234843|58888205|FG007|Overall Study|Physician Decision|1|||
30859366|NCT02234843|58888206|FG008|Overall Study|Physician Decision|0|||
30859367|NCT02234843|58888207|FG009|Overall Study|Physician Decision|0|||
30599749|NCT01296711|58611530|FG007|Overall Study|Lost to Follow-up|2|||
30599750|NCT01296711|58611523|FG000|Overall Study|Protocol Violation|0|||
30859368|NCT02234843|58888198|FG000|Overall Study|Adverse Event|5|||
30859369|NCT02234843|58888199|FG001|Overall Study|Adverse Event|1|||
30859370|NCT02234843|58888200|FG002|Overall Study|Adverse Event|1|||
30859371|NCT02234843|58888201|FG003|Overall Study|Adverse Event|3|||
30859372|NCT02234843|58888202|FG004|Overall Study|Adverse Event|2|||
30599751|NCT01296711|58611524|FG001|Overall Study|Protocol Violation|0|||
30599752|NCT01296711|58611525|FG002|Overall Study|Protocol Violation|0|||
30599753|NCT01296711|58611526|FG003|Overall Study|Protocol Violation|1|||
30859373|NCT02234843|58888203|FG005|Overall Study|Adverse Event|1|||
30859374|NCT02234843|58888204|FG006|Overall Study|Adverse Event|0|||
30859375|NCT02234843|58888205|FG007|Overall Study|Adverse Event|0|||
30859376|NCT02234843|58888206|FG008|Overall Study|Adverse Event|1|||
30859377|NCT02234843|58888207|FG009|Overall Study|Adverse Event|0|||
30859378|NCT02234843|58888198|FG000|Overall Study|Non-compliance with study drug|1|||
30859379|NCT02234843|58888199|FG001|Overall Study|Non-compliance with study drug|0|||
30859380|NCT02234843|58888200|FG002|Overall Study|Non-compliance with study drug|0|||
30859381|NCT02234843|58888201|FG003|Overall Study|Non-compliance with study drug|0|||
30859382|NCT02234843|58888202|FG004|Overall Study|Non-compliance with study drug|0|||
30859383|NCT02234843|58888203|FG005|Overall Study|Non-compliance with study drug|1|||
30859384|NCT02234843|58888204|FG006|Overall Study|Non-compliance with study drug|1|||
30859385|NCT02234843|58888205|FG007|Overall Study|Non-compliance with study drug|0|||
30859386|NCT02234843|58888206|FG008|Overall Study|Non-compliance with study drug|0|||
30859387|NCT02234843|58888207|FG009|Overall Study|Non-compliance with study drug|0|||
30859388|NCT02234843|58888198|FG000|Overall Study|Lost to Follow-up|0|||
30859389|NCT02234843|58888199|FG001|Overall Study|Lost to Follow-up|1|||
30859390|NCT02234843|58888200|FG002|Overall Study|Lost to Follow-up|0|||
30859391|NCT02234843|58888201|FG003|Overall Study|Lost to Follow-up|0|||
30859392|NCT02234843|58888202|FG004|Overall Study|Lost to Follow-up|0|||
30859393|NCT02234843|58888203|FG005|Overall Study|Lost to Follow-up|0|||
30859394|NCT02234843|58888204|FG006|Overall Study|Lost to Follow-up|1|||
30859395|NCT02234843|58888205|FG007|Overall Study|Lost to Follow-up|0|||
30859396|NCT02234843|58888206|FG008|Overall Study|Lost to Follow-up|0|||
30859397|NCT02234843|58888207|FG009|Overall Study|Lost to Follow-up|0|||
30859398|NCT02740231|58888244|FG000|Overall Study|Withdrawal by Subject|1|||
30859399|NCT02740231|58888245|FG001|Overall Study|Withdrawal by Subject|1|||
30859400|NCT02740231|58888246|FG002|Overall Study|Withdrawal by Subject|1|||
30859401|NCT02740231|58888247|FG003|Overall Study|Withdrawal by Subject|0|||
30859402|NCT02740231|58888244|FG000|Overall Study|Lack of Efficacy|0|||
30859403|NCT02740231|58888245|FG001|Overall Study|Lack of Efficacy|1|||
30859404|NCT02740231|58888246|FG002|Overall Study|Lack of Efficacy|0|||
30859405|NCT02740231|58888247|FG003|Overall Study|Lack of Efficacy|4|||
30859406|NCT02740231|58888244|FG000|Overall Study|Lost to Follow-up|1|||
30859407|NCT02740231|58888245|FG001|Overall Study|Lost to Follow-up|3|||
30859408|NCT02740231|58888246|FG002|Overall Study|Lost to Follow-up|0|||
30859409|NCT02740231|58888247|FG003|Overall Study|Lost to Follow-up|3|||
30859410|NCT02740231|58888244|FG000|Overall Study|Adverse Event|0|||
30859411|NCT02740231|58888245|FG001|Overall Study|Adverse Event|1|||
30859412|NCT02740231|58888246|FG002|Overall Study|Adverse Event|0|||
30859413|NCT02740231|58888247|FG003|Overall Study|Adverse Event|1|||
30859414|NCT02750345|58888257|FG000|Intervention 1|Adverse Event|0|||
30859415|NCT02750345|58888258|FG001|Intervention 1|Adverse Event|0|||
30859416|NCT02750345|58888259|FG002|Intervention 1|Adverse Event|0|||
30859417|NCT02750345|58888260|FG003|Intervention 1|Adverse Event|0|||
30859418|NCT02750345|58888261|FG004|Intervention 1|Adverse Event|1|||
30859419|NCT02750345|58888262|FG005|Intervention 1|Adverse Event|0|||
30859420|NCT02640625|58888272|FG000|Overall Study|Adverse Event|1|||
30859421|NCT01329263|58888279|FG000|Overall Study|Lost to Follow-up|4|||
30859422|NCT01329263|58888280|FG001|Overall Study|Lost to Follow-up|21|||
30859423|NCT01329263|58888279|FG000|Overall Study|Withdrawal by Subject|1|||
30859424|NCT01329263|58888280|FG001|Overall Study|Withdrawal by Subject|2|||
30859425|NCT02474329|58888288|FG000|Overall Study|Withdraw or did not contribute data.|13|||
30689396|NCT00578786|58703351|FG002|Overall Study|Pregnancy|0|||
30859426|NCT01388491|58888295|FG000|Overall Study|Adverse Event|10|||
30859427|NCT01388491|58888296|FG001|Overall Study|Adverse Event|9|||
30859428|NCT01388491|58888295|FG000|Overall Study|Sponsor Request|9|||
30599754|NCT01296711|58611527|FG004|Overall Study|Protocol Violation|1|||
30599755|NCT01296711|58611528|FG005|Overall Study|Protocol Violation|0|||
30599756|NCT01296711|58611529|FG006|Overall Study|Protocol Violation|0|||
30599757|NCT01296711|58611530|FG007|Overall Study|Protocol Violation|0|||
30599758|NCT01296711|58611523|FG000|Overall Study|Withdrawal by Subject|4|||
30599759|NCT01296711|58611524|FG001|Overall Study|Withdrawal by Subject|2|||
30599760|NCT01296711|58611525|FG002|Overall Study|Withdrawal by Subject|2|||
30599761|NCT01296711|58611526|FG003|Overall Study|Withdrawal by Subject|1|||
30689397|NCT00578786|58703349|FG000|Overall Study|Not Otherwise Specified|0|||
30859429|NCT01388491|58888296|FG001|Overall Study|Sponsor Request|7|||
30859430|NCT01388491|58888295|FG000|Overall Study|Withdrawal by Subject|6|||
30859431|NCT01388491|58888296|FG001|Overall Study|Withdrawal by Subject|10|||
30599762|NCT01296711|58611527|FG004|Overall Study|Withdrawal by Subject|1|||
30859432|NCT01388491|58888295|FG000|Overall Study|Lost to Follow-up|4|||
30859433|NCT01388491|58888296|FG001|Overall Study|Lost to Follow-up|3|||
30859434|NCT01388491|58888295|FG000|Overall Study|Protocol Violation|2|||
30599763|NCT01296711|58611528|FG005|Overall Study|Withdrawal by Subject|1|||
30859435|NCT01388491|58888296|FG001|Overall Study|Protocol Violation|0|||
30859436|NCT01388491|58888295|FG000|Overall Study|Noncompliance|2|||
30859437|NCT01388491|58888296|FG001|Overall Study|Noncompliance|0|||
30859438|NCT01388491|58888295|FG000|Overall Study|Pregnancy|1|||
30859439|NCT01388491|58888296|FG001|Overall Study|Pregnancy|0|||
30859440|NCT02749799|58888302|FG000|Overall Study|Adverse Event|2|||
30859441|NCT02749799|58888302|FG000|Overall Study|Lost to Follow-up|4|||
30859442|NCT02749799|58888302|FG000|Overall Study|Protocol Violation|1|||
30859443|NCT02749799|58888302|FG000|Overall Study|Withdrawal by Subject|1|||
30859444|NCT03253393|58888309|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
30689398|NCT00578786|58703350|FG001|Overall Study|Not Otherwise Specified|4|||
30689399|NCT00578786|58703351|FG002|Overall Study|Not Otherwise Specified|1|||
30689400|NCT00578786|58703349|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
30689401|NCT00578786|58703350|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
30689402|NCT00578786|58703351|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
30689403|NCT00424255|58703371|FG000|Overall Study|Death|115|||
30859445|NCT03253393|58888310|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
30859446|NCT03253393|58888311|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
30859447|NCT03128671|58888327|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
30859448|NCT03128671|58888328|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
30859449|NCT03128671|58888327|FG000|Allocation|Death|1|||
30859450|NCT03128671|58888328|FG001|Allocation|Death|0|||
30859451|NCT03128671|58888327|FG000|Allocation|Withdrawal by Subject|4|||
30859452|NCT03128671|58888328|FG001|Allocation|Withdrawal by Subject|0|||
30859453|NCT03128671|58888327|FG000|Intervention|Withdrawal by Subject|11|||
30859454|NCT03128671|58888328|FG001|Intervention|Withdrawal by Subject|10|||
30859455|NCT03128671|58888327|FG000|Intervention|Palliative/hospice care initiated|9|||
30859456|NCT03128671|58888328|FG001|Intervention|Palliative/hospice care initiated|10|||
30859457|NCT03128671|58888327|FG000|Intervention|Death|13|||
30859458|NCT03128671|58888328|FG001|Intervention|Death|11|||
30859459|NCT03128671|58888327|FG000|Intervention|Interrupted by hurricane|1|||
30859460|NCT03128671|58888328|FG001|Intervention|Interrupted by hurricane|0|||
30859461|NCT03128671|58888327|FG000|Intervention|Physician Decision|2|||
30859462|NCT03128671|58888328|FG001|Intervention|Physician Decision|3|||
30859463|NCT02925338|58888339|FG000|Overall Study|Death|0|||
30859464|NCT02925338|58888340|FG001|Overall Study|Death|2|||
30859465|NCT02925338|58888341|FG002|Overall Study|Death|1|||
30859466|NCT02925338|58888342|FG003|Overall Study|Death|0|||
30689404|NCT00424255|58703372|FG001|Overall Study|Death|111|||
30689405|NCT00424255|58703371|FG000|Overall Study|Lost to Follow-up|26|||
30689406|NCT00424255|58703372|FG001|Overall Study|Lost to Follow-up|20|||
30689407|NCT00424255|58703371|FG000|Overall Study|Protocol Violation|0|||
30689408|NCT00424255|58703372|FG001|Overall Study|Protocol Violation|1|||
30689409|NCT00424255|58703371|FG000|Overall Study|Withdrawal by Subject|34|||
30859467|NCT02925338|58888343|FG004|Overall Study|Death|0|||
30859468|NCT02925338|58888339|FG000|Overall Study|Lost to Follow-up|30|||
30859469|NCT02925338|58888340|FG001|Overall Study|Lost to Follow-up|10|||
30859470|NCT02925338|58888341|FG002|Overall Study|Lost to Follow-up|1|||
30859471|NCT02925338|58888342|FG003|Overall Study|Lost to Follow-up|16|||
30859472|NCT02925338|58888343|FG004|Overall Study|Lost to Follow-up|3|||
30859473|NCT02925338|58888339|FG000|Overall Study|Withdrawal by Subject|3|||
30859474|NCT02925338|58888340|FG001|Overall Study|Withdrawal by Subject|0|||
30859475|NCT02925338|58888341|FG002|Overall Study|Withdrawal by Subject|3|||
30859476|NCT02925338|58888342|FG003|Overall Study|Withdrawal by Subject|2|||
30859477|NCT02925338|58888343|FG004|Overall Study|Withdrawal by Subject|2|||
30859478|NCT02925338|58888339|FG000|Overall Study|Missing|38|||
30859479|NCT02925338|58888340|FG001|Overall Study|Missing|27|||
30859480|NCT02925338|58888341|FG002|Overall Study|Missing|0|||
30599764|NCT01296711|58611529|FG006|Overall Study|Withdrawal by Subject|2|||
30599765|NCT01296711|58611530|FG007|Overall Study|Withdrawal by Subject|1|||
30599766|NCT01296711|58611523|FG000|Overall Study|Study termination|8|||
30599767|NCT01296711|58611524|FG001|Overall Study|Study termination|1|||
30599768|NCT01296711|58611525|FG002|Overall Study|Study termination|5|||
30599769|NCT01296711|58611526|FG003|Overall Study|Study termination|4|||
30599770|NCT01296711|58611527|FG004|Overall Study|Study termination|4|||
30599771|NCT01296711|58611528|FG005|Overall Study|Study termination|4|||
30689410|NCT00424255|58703372|FG001|Overall Study|Withdrawal by Subject|38|||
30689411|NCT00424255|58703371|FG000|Overall Study|Physician Decision|3|||
30689412|NCT00424255|58703372|FG001|Overall Study|Physician Decision|7|||
30859481|NCT02925338|58888342|FG003|Overall Study|Missing|3|||
30859482|NCT02925338|58888343|FG004|Overall Study|Missing|2|||
30859483|NCT02925338|58888339|FG000|Overall Study|Participant's Decision|11|||
30859484|NCT02925338|58888340|FG001|Overall Study|Participant's Decision|7|||
30599772|NCT01296711|58611529|FG006|Overall Study|Study termination|8|||
30599773|NCT01296711|58611530|FG007|Overall Study|Study termination|10|||
30859485|NCT02925338|58888341|FG002|Overall Study|Participant's Decision|3|||
30859486|NCT02925338|58888342|FG003|Overall Study|Participant's Decision|8|||
30859487|NCT02925338|58888343|FG004|Overall Study|Participant's Decision|1|||
30859488|NCT02925338|58888339|FG000|Overall Study|Treatment Discontinuation|144|||
30859489|NCT02925338|58888340|FG001|Overall Study|Treatment Discontinuation|65|||
30859490|NCT02925338|58888341|FG002|Overall Study|Treatment Discontinuation|56|||
30859491|NCT02925338|58888342|FG003|Overall Study|Treatment Discontinuation|131|||
30859492|NCT02925338|58888343|FG004|Overall Study|Treatment Discontinuation|22|||
30859493|NCT02543528|58888361|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
30859494|NCT02543528|58888362|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
30859495|NCT02543528|58888363|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
30859496|NCT02543528|58888364|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
30859497|NCT02543528|58888365|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
30689413|NCT00424255|58703371|FG000|Overall Study|Cognitive Disturbance|1|||
30689414|NCT00424255|58703372|FG001|Overall Study|Cognitive Disturbance|0|||
30689415|NCT00424255|58703371|FG000|Overall Study|Non-compliance by Participants|1|||
30689416|NCT00424255|58703372|FG001|Overall Study|Non-compliance by Participants|0|||
30689417|NCT00424255|58703371|FG000|Overall Study|Fatigue|1|||
30689418|NCT00424255|58703372|FG001|Overall Study|Fatigue|0|||
30689419|NCT00424255|58703371|FG000|Overall Study|Disease Progression|0|||
30689420|NCT00424255|58703372|FG001|Overall Study|Disease Progression|2|||
30689421|NCT00424255|58703371|FG000|Overall Study|Sponsor Terminated Study|161|||
30689422|NCT00424255|58703372|FG001|Overall Study|Sponsor Terminated Study|167|||
30689423|NCT00620074|58703378|FG000|Overall Study|Adverse Event|1|||
30689424|NCT00424177|58703382|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
30689425|NCT00424177|58703382|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
30689426|NCT00424177|58703382|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
30689427|NCT00424177|58703382|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
30689428|NCT00424177|58703382|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
30689429|NCT00424177|58703382|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
30689430|NCT00424177|58703382|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
30689431|NCT00424177|58703382|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
30689432|NCT00424177|58703382|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
30689433|NCT00424177|58703382|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
30689434|NCT00618826|58703394|FG000|Overall Study|Adverse Event|1|||
30689435|NCT00578448|58703399|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
30689436|NCT00578448|58703399|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
30689437|NCT00578448|58703399|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
30689438|NCT00578448|58703399|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
30689439|NCT00578318|58703407|FG000|Overall Study|Lost to Follow-up|2|||
30689440|NCT00578318|58703408|FG001|Overall Study|Lost to Follow-up|0|||
30689441|NCT00578318|58703407|FG000|Overall Study|Physician Decision|1|||
30689442|NCT00578318|58703408|FG001|Overall Study|Physician Decision|0|||
30689443|NCT00618748|58703417|FG000|Overall Study|Adverse Event|4|||
30689444|NCT00618748|58703418|FG001|Overall Study|Adverse Event|3|||
30689445|NCT00618748|58703419|FG002|Overall Study|Adverse Event|8|||
30689446|NCT00618748|58703417|FG000|Overall Study|Physician Decision|3|||
30689447|NCT00618748|58703418|FG001|Overall Study|Physician Decision|1|||
30689448|NCT00618748|58703419|FG002|Overall Study|Physician Decision|1|||
30689449|NCT00618748|58703417|FG000|Overall Study|Withdrawal by Subject|4|||
30689450|NCT00618748|58703418|FG001|Overall Study|Withdrawal by Subject|1|||
30689451|NCT00618748|58703419|FG002|Overall Study|Withdrawal by Subject|5|||
30689452|NCT00658359|58703430|FG000|Overall Study|Death|3|||
30689453|NCT00658359|58703431|FG001|Overall Study|Death|1|||
30689454|NCT00658359|58703432|FG002|Overall Study|Death|2|||
30689455|NCT00658359|58703430|FG000|Overall Study|Adverse Event|13|||
30689456|NCT00658359|58703431|FG001|Overall Study|Adverse Event|6|||
30859498|NCT02543528|58888361|FG000|Adaptation Period|Lens Handling Difficultes|0|||
30859499|NCT02543528|58888362|FG001|Adaptation Period|Lens Handling Difficultes|0|||
30859500|NCT02543528|58888363|FG002|Adaptation Period|Lens Handling Difficultes|0|||
30859501|NCT02543528|58888364|FG003|Adaptation Period|Lens Handling Difficultes|0|||
30859502|NCT02543528|58888365|FG004|Adaptation Period|Lens Handling Difficultes|8|||
30859503|NCT02543528|58888361|FG000|Adaptation Period|Lost to Follow-up|0|||
30859504|NCT02543528|58888362|FG001|Adaptation Period|Lost to Follow-up|0|||
30859505|NCT02543528|58888363|FG002|Adaptation Period|Lost to Follow-up|0|||
30859506|NCT02543528|58888364|FG003|Adaptation Period|Lost to Follow-up|0|||
30859507|NCT02543528|58888365|FG004|Adaptation Period|Lost to Follow-up|14|||
30859508|NCT02543528|58888361|FG000|Adaptation Period|Adverse Event|0|||
30689457|NCT00658359|58703432|FG002|Overall Study|Adverse Event|9|||
30859509|NCT02543528|58888362|FG001|Adaptation Period|Adverse Event|0|||
30689458|NCT00658359|58703430|FG000|Overall Study|Protocol Violation|1|||
30689459|NCT00658359|58703431|FG001|Overall Study|Protocol Violation|0|||
30689460|NCT00658359|58703432|FG002|Overall Study|Protocol Violation|0|||
30689461|NCT00658359|58703430|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
30689462|NCT00658359|58703431|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
30689463|NCT00658359|58703432|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
30689464|NCT00658359|58703430|FG000|Overall Study|Withdrawal by Subject|7|||
30859510|NCT02543528|58888363|FG002|Adaptation Period|Adverse Event|0|||
30689465|NCT00658359|58703431|FG001|Overall Study|Withdrawal by Subject|4|||
30689466|NCT00658359|58703432|FG002|Overall Study|Withdrawal by Subject|2|||
30689467|NCT00658359|58703430|FG000|Overall Study|Lost to Follow-up|2|||
30689468|NCT00658359|58703431|FG001|Overall Study|Lost to Follow-up|2|||
30689469|NCT00658359|58703432|FG002|Overall Study|Lost to Follow-up|4|||
30689470|NCT00658359|58703430|FG000|Overall Study|Lack of Efficacy|0|||
30689471|NCT00658359|58703431|FG001|Overall Study|Lack of Efficacy|1|||
30689472|NCT00658359|58703432|FG002|Overall Study|Lack of Efficacy|0|||
30689473|NCT00619918|58703444|FG000|Overall Study|Withdrawal by Subject|4|||
30689474|NCT00619918|58703445|FG001|Overall Study|Withdrawal by Subject|3|||
30689475|NCT00619918|58703444|FG000|Overall Study|Physician Decision|8|||
30689476|NCT00619918|58703445|FG001|Overall Study|Physician Decision|8|||
30689477|NCT00619918|58703444|FG000|Overall Study|Transfer to outside facility|3|||
30689478|NCT00619918|58703445|FG001|Overall Study|Transfer to outside facility|3|||
30689479|NCT00619918|58703444|FG000|Overall Study|Left before receiving first dose|5|||
30689480|NCT00619918|58703445|FG001|Overall Study|Left before receiving first dose|8|||
30689481|NCT01005914|58703451|FG000|Overall Study|Adverse Event|4|||
30859511|NCT02543528|58888364|FG003|Adaptation Period|Adverse Event|0|||
30859512|NCT02543528|58888365|FG004|Adaptation Period|Adverse Event|2|||
30859513|NCT02543528|58888361|FG000|Extended Wear Period|Adverse Event|17|||
30859514|NCT02543528|58888362|FG001|Extended Wear Period|Adverse Event|11|||
30859515|NCT02543528|58888363|FG002|Extended Wear Period|Adverse Event|16|||
30859516|NCT02543528|58888364|FG003|Extended Wear Period|Adverse Event|3|||
30859517|NCT02543528|58888365|FG004|Extended Wear Period|Adverse Event|0|||
30859518|NCT02543528|58888361|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
30859519|NCT02543528|58888362|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
30859520|NCT02543528|58888363|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
30859521|NCT02543528|58888364|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
30859522|NCT02543528|58888365|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
30859523|NCT02543528|58888361|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
30859524|NCT02543528|58888362|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
30859525|NCT02543528|58888363|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
30859526|NCT02543528|58888364|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
30859527|NCT02543528|58888365|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
30859528|NCT02543528|58888361|FG000|Extended Wear Period|Lost to Follow-up|0|||
30859529|NCT02543528|58888362|FG001|Extended Wear Period|Lost to Follow-up|1|||
30859530|NCT02543528|58888363|FG002|Extended Wear Period|Lost to Follow-up|2|||
30859531|NCT02543528|58888364|FG003|Extended Wear Period|Lost to Follow-up|1|||
30859532|NCT02543528|58888365|FG004|Extended Wear Period|Lost to Follow-up|0|||
30859533|NCT02543528|58888361|FG000|Extended Wear Period|Withdrawal by Subject|10|||
30859534|NCT02543528|58888362|FG001|Extended Wear Period|Withdrawal by Subject|9|||
30859535|NCT02543528|58888363|FG002|Extended Wear Period|Withdrawal by Subject|4|||
30859536|NCT02543528|58888364|FG003|Extended Wear Period|Withdrawal by Subject|5|||
30859537|NCT02543528|58888365|FG004|Extended Wear Period|Withdrawal by Subject|0|||
30859538|NCT00156533|58888383|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
30859539|NCT00156533|58888384|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
30859540|NCT00156533|58888385|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
30859541|NCT00156533|58888386|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
30859542|NCT00156533|58888383|FG000|Overall Study|Withdrawal by Subject|1|||
30689482|NCT01005914|58703451|FG000|Overall Study|Death|4|||
30689483|NCT01005914|58703451|FG000|Overall Study|Lack of Efficacy|1|||
30689484|NCT01005914|58703451|FG000|Overall Study|Withdrawal by Subject|1|||
30689485|NCT00618514|58703462|FG000|Overall Study|Lost to Follow-up|11|||
30689486|NCT00618514|58703463|FG001|Overall Study|Lost to Follow-up|12|||
30689487|NCT00618514|58703464|FG002|Overall Study|Lost to Follow-up|4|||
30689488|NCT00655629|58703472|FG000|Overall Study|Adverse Event|4|||
30689489|NCT00655629|58703473|FG001|Overall Study|Adverse Event|1|||
30689490|NCT00655629|58703472|FG000|Overall Study|Lack of Efficacy|2|||
30689491|NCT00655629|58703473|FG001|Overall Study|Lack of Efficacy|12|||
30689492|NCT00655629|58703472|FG000|Overall Study|Lost to Follow-up|4|||
30689493|NCT00655629|58703473|FG001|Overall Study|Lost to Follow-up|3|||
30689494|NCT00655629|58703472|FG000|Overall Study|Protocol Violation|5|||
30689495|NCT00655629|58703473|FG001|Overall Study|Protocol Violation|3|||
30689496|NCT00655629|58703472|FG000|Overall Study|consent withdrawn|6|||
30689497|NCT00655629|58703473|FG001|Overall Study|consent withdrawn|4|||
30689498|NCT00578292|58703479|FG000|Overall Study|Death|1|||
30689499|NCT00578292|58703479|FG000|Overall Study|Graft failure|2|||
30689500|NCT00570063|58703485|FG000|Overall Study|Adverse Event|4|||
30689501|NCT00570063|58703486|FG001|Overall Study|Adverse Event|1|||
30689502|NCT00570063|58703485|FG000|Overall Study|Lack of Efficacy|0|||
30689503|NCT00570063|58703486|FG001|Overall Study|Lack of Efficacy|1|||
30859543|NCT00156533|58888384|FG001|Overall Study|Withdrawal by Subject|0|||
30859544|NCT00156533|58888385|FG002|Overall Study|Withdrawal by Subject|0|||
30859545|NCT00156533|58888386|FG003|Overall Study|Withdrawal by Subject|1|||
30859546|NCT00156533|58888383|FG000|Overall Study|Failed Screening|1|||
30859547|NCT00156533|58888384|FG001|Overall Study|Failed Screening|0|||
30859548|NCT00156533|58888385|FG002|Overall Study|Failed Screening|1|||
30859549|NCT00156533|58888386|FG003|Overall Study|Failed Screening|1|||
30859550|NCT01660022|58888404|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
30859551|NCT01660022|58888405|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
30859552|NCT01660022|58888406|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
30859553|NCT01660022|58888407|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
30859554|NCT01660022|58888408|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
30859555|NCT01660022|58888409|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
30859556|NCT01660022|58888404|FG000|First Sequence (7 Days)|Adverse Event|0|||
30859557|NCT01660022|58888405|FG001|First Sequence (7 Days)|Adverse Event|0|||
30859558|NCT01660022|58888406|FG002|First Sequence (7 Days)|Adverse Event|0|||
30859559|NCT01660022|58888407|FG003|First Sequence (7 Days)|Adverse Event|0|||
30859560|NCT01660022|58888408|FG004|First Sequence (7 Days)|Adverse Event|1|||
30859561|NCT01660022|58888409|FG005|First Sequence (7 Days)|Adverse Event|3|||
30859562|NCT01660022|58888404|FG000|First Sequence (7 Days)|Protocol Violation|0|||
30859563|NCT01660022|58888405|FG001|First Sequence (7 Days)|Protocol Violation|0|||
30859564|NCT01660022|58888406|FG002|First Sequence (7 Days)|Protocol Violation|0|||
30859565|NCT01660022|58888407|FG003|First Sequence (7 Days)|Protocol Violation|0|||
30859566|NCT01660022|58888408|FG004|First Sequence (7 Days)|Protocol Violation|0|||
30859567|NCT01660022|58888409|FG005|First Sequence (7 Days)|Protocol Violation|1|||
30859568|NCT00156065|58888438|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
30859569|NCT00156065|58888439|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
30859570|NCT00156065|58888440|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
30859571|NCT00156065|58888438|FG000|Overall Study|Adverse Event|8|||
30859572|NCT00156065|58888439|FG001|Overall Study|Adverse Event|11|||
30859573|NCT00156065|58888440|FG002|Overall Study|Adverse Event|4|||
30859574|NCT00156065|58888438|FG000|Overall Study|Lack of Efficacy|2|||
30859575|NCT00156065|58888439|FG001|Overall Study|Lack of Efficacy|9|||
30859576|NCT00156065|58888440|FG002|Overall Study|Lack of Efficacy|3|||
30859577|NCT00156065|58888438|FG000|Overall Study|Withdrawal by Subject|13|||
30859578|NCT00156065|58888439|FG001|Overall Study|Withdrawal by Subject|26|||
30859579|NCT00156065|58888440|FG002|Overall Study|Withdrawal by Subject|16|||
30859580|NCT00156065|58888438|FG000|Overall Study|Lost to Follow-up|5|||
30859581|NCT00156065|58888439|FG001|Overall Study|Lost to Follow-up|7|||
30859582|NCT00156065|58888440|FG002|Overall Study|Lost to Follow-up|1|||
30859583|NCT00156065|58888438|FG000|Overall Study|Other|2|||
30859584|NCT00156065|58888439|FG001|Overall Study|Other|9|||
30859585|NCT00156065|58888440|FG002|Overall Study|Other|3|||
30859586|NCT01554956|58888451|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
30859587|NCT01554956|58888452|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
30859588|NCT01554956|58888453|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
30859589|NCT01554956|58888451|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
30859590|NCT01554956|58888452|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
30859591|NCT01554956|58888453|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
30859592|NCT01554956|58888451|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
30859593|NCT01554956|58888452|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
30859594|NCT01554956|58888453|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
30859595|NCT02138786|58888474|FG000|Overall Study|Adverse Event|0|||
30859596|NCT02138786|58888475|FG001|Overall Study|Adverse Event|2|||
30859597|NCT02138786|58888476|FG002|Overall Study|Adverse Event|1|||
30859598|NCT02138786|58888474|FG000|Overall Study|Death|1|||
30859599|NCT02138786|58888475|FG001|Overall Study|Death|7|||
30859600|NCT02138786|58888476|FG002|Overall Study|Death|2|||
30859601|NCT02138786|58888474|FG000|Overall Study|Disease Progression|1|||
30859602|NCT02138786|58888475|FG001|Overall Study|Disease Progression|1|||
30859603|NCT02138786|58888476|FG002|Overall Study|Disease Progression|3|||
30859604|NCT02138786|58888474|FG000|Overall Study|Withdrawal by Subject|1|||
30859605|NCT02138786|58888475|FG001|Overall Study|Withdrawal by Subject|2|||
30859606|NCT02138786|58888476|FG002|Overall Study|Withdrawal by Subject|0|||
30859607|NCT02138786|58888474|FG000|Overall Study|Patient's Wish|0|||
30859608|NCT02138786|58888475|FG001|Overall Study|Patient's Wish|2|||
30859609|NCT02138786|58888476|FG002|Overall Study|Patient's Wish|0|||
30859610|NCT02138786|58888474|FG000|Overall Study|Sponsor Terminated Study|0|||
30859611|NCT02138786|58888475|FG001|Overall Study|Sponsor Terminated Study|1|||
30859612|NCT02138786|58888476|FG002|Overall Study|Sponsor Terminated Study|1|||
30859613|NCT02138786|58888474|FG000|Overall Study|Non-Compliance|0|||
30859614|NCT02138786|58888475|FG001|Overall Study|Non-Compliance|0|||
30859615|NCT02138786|58888476|FG002|Overall Study|Non-Compliance|1|||
30859616|NCT02529488|58888482|FG000|Overall Study|Adverse Event|1|||
30859617|NCT02529488|58888482|FG000|Overall Study|Death|3|||
30859618|NCT01329419|58888490|FG000|Overall Study|Protocol Violation|235|||
30859619|NCT01329341|58888495|FG000|Overall Study|Withdrawal by Subject|44|||
30859620|NCT02532764|58888509|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
30959479|NCT01563029|59024939|FG003|Overall Study|Lost to Follow-up|1|||
30859621|NCT02532764|58888510|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
30859622|NCT02532764|58888511|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
30859623|NCT02532764|58888512|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
30859624|NCT02532764|58888513|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
30859625|NCT02532764|58888514|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
30859626|NCT02532764|58888515|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
30859627|NCT02532764|58888516|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
30859628|NCT02532764|58888517|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
30859629|NCT02532764|58888518|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
30859630|NCT02528942|58888545|FG000|Overall Study|Did not meet imaging criteria|9|||
30859631|NCT02528942|58888545|FG000|Overall Study|Lost to Follow-up|25|||
30859632|NCT02527148|58888551|FG000|Overall Study|Did not receive study intervention|1|||
30859633|NCT02527148|58888552|FG001|Overall Study|Did not receive study intervention|0|||
30859634|NCT02291614|58888571|FG000|Overall Study|Lost to Follow-up|0|||
30859635|NCT02291614|58888572|FG001|Overall Study|Lost to Follow-up|0|||
30859636|NCT02291614|58888573|FG002|Overall Study|Lost to Follow-up|0|||
30859637|NCT02291614|58888574|FG003|Overall Study|Lost to Follow-up|0|||
30859638|NCT02291614|58888575|FG004|Overall Study|Lost to Follow-up|0|||
30859639|NCT02291614|58888576|FG005|Overall Study|Lost to Follow-up|0|||
30859640|NCT02291614|58888577|FG006|Overall Study|Lost to Follow-up|0|||
30859641|NCT02291614|58888578|FG007|Overall Study|Lost to Follow-up|1|||
30859642|NCT02291614|58888579|FG008|Overall Study|Lost to Follow-up|0|||
30859643|NCT02291614|58888580|FG009|Overall Study|Lost to Follow-up|0|||
30859644|NCT02291614|58888581|FG010|Overall Study|Lost to Follow-up|0|||
30859645|NCT02291614|58888571|FG000|Overall Study|Withdrawal by Subject|0|||
30859646|NCT02291614|58888572|FG001|Overall Study|Withdrawal by Subject|1|||
30859647|NCT02291614|58888573|FG002|Overall Study|Withdrawal by Subject|0|||
30859648|NCT02291614|58888574|FG003|Overall Study|Withdrawal by Subject|0|||
30859649|NCT02291614|58888575|FG004|Overall Study|Withdrawal by Subject|0|||
30859650|NCT02291614|58888576|FG005|Overall Study|Withdrawal by Subject|0|||
30859651|NCT02291614|58888577|FG006|Overall Study|Withdrawal by Subject|0|||
30859652|NCT02291614|58888578|FG007|Overall Study|Withdrawal by Subject|0|||
30859653|NCT02291614|58888579|FG008|Overall Study|Withdrawal by Subject|0|||
30859654|NCT02291614|58888580|FG009|Overall Study|Withdrawal by Subject|2|||
30859655|NCT02291614|58888581|FG010|Overall Study|Withdrawal by Subject|2|||
30859656|NCT02291614|58888571|FG000|Overall Study|Decision by sponsor|0|||
30859657|NCT02291614|58888572|FG001|Overall Study|Decision by sponsor|0|||
30859658|NCT02291614|58888573|FG002|Overall Study|Decision by sponsor|0|||
30859659|NCT02291614|58888574|FG003|Overall Study|Decision by sponsor|1|||
30859660|NCT02291614|58888575|FG004|Overall Study|Decision by sponsor|0|||
30689504|NCT00570063|58703485|FG000|Overall Study|Withdrawal by Subject|4|||
30689505|NCT00570063|58703486|FG001|Overall Study|Withdrawal by Subject|3|||
30689506|NCT00570063|58703485|FG000|Overall Study|Sponsor's Decision|7|||
30689507|NCT00570063|58703486|FG001|Overall Study|Sponsor's Decision|3|||
30689508|NCT00577772|58703503|FG000|Overall Study|Lost to Follow-up|0|||
30689509|NCT00577772|58703504|FG001|Overall Study|Lost to Follow-up|1|||
30689510|NCT00578136|58703512|FG000|Overall Study|Not given intervention|1|||
30689511|NCT00578136|58703513|FG001|Overall Study|Not given intervention|1|||
30689512|NCT00655551|58703522|FG000|All Periods Combined|Adverse Event|0|||
30689513|NCT00655551|58703523|FG001|All Periods Combined|Adverse Event|3|||
30689514|NCT00655551|58703524|FG002|All Periods Combined|Adverse Event|4|||
30689515|NCT00655551|58703522|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
30689516|NCT00655551|58703523|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
30689517|NCT00655551|58703524|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
30689518|NCT00655551|58703522|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
30859661|NCT02291614|58888576|FG005|Overall Study|Decision by sponsor|0|||
30859662|NCT02291614|58888577|FG006|Overall Study|Decision by sponsor|0|||
30859663|NCT02291614|58888578|FG007|Overall Study|Decision by sponsor|0|||
30859664|NCT02291614|58888579|FG008|Overall Study|Decision by sponsor|0|||
30859665|NCT02291614|58888580|FG009|Overall Study|Decision by sponsor|0|||
30859666|NCT02291614|58888581|FG010|Overall Study|Decision by sponsor|0|||
30859667|NCT02291614|58888571|FG000|Overall Study|Death|0|||
30859668|NCT02291614|58888572|FG001|Overall Study|Death|0|||
30859669|NCT02291614|58888573|FG002|Overall Study|Death|1|||
30859670|NCT02291614|58888574|FG003|Overall Study|Death|0|||
30859671|NCT02291614|58888575|FG004|Overall Study|Death|1|||
30859672|NCT02291614|58888576|FG005|Overall Study|Death|1|||
30859673|NCT02291614|58888577|FG006|Overall Study|Death|1|||
30859674|NCT02291614|58888578|FG007|Overall Study|Death|0|||
30859675|NCT02291614|58888579|FG008|Overall Study|Death|0|||
30859676|NCT02291614|58888580|FG009|Overall Study|Death|0|||
30859677|NCT02291614|58888581|FG010|Overall Study|Death|0|||
30859678|NCT02526524|58888617|FG000|Overall Study|Withdrawal by Subject|3|||
30859679|NCT02526524|58888618|FG001|Overall Study|Withdrawal by Subject|3|||
30859680|NCT02526524|58888619|FG002|Overall Study|Withdrawal by Subject|6|||
30859681|NCT02526524|58888620|FG003|Overall Study|Withdrawal by Subject|1|||
30859682|NCT02526524|58888621|FG004|Overall Study|Withdrawal by Subject|9|||
30859683|NCT02526524|58888622|FG005|Overall Study|Withdrawal by Subject|5|||
30859684|NCT02526524|58888617|FG000|Overall Study|Adverse Event|3|||
30859685|NCT02526524|58888618|FG001|Overall Study|Adverse Event|2|||
30859686|NCT02526524|58888619|FG002|Overall Study|Adverse Event|4|||
30859687|NCT02526524|58888620|FG003|Overall Study|Adverse Event|2|||
30859688|NCT02526524|58888621|FG004|Overall Study|Adverse Event|6|||
30859689|NCT02526524|58888622|FG005|Overall Study|Adverse Event|8|||
30859690|NCT02526524|58888617|FG000|Overall Study|Lost to Follow-up|2|||
30859691|NCT02526524|58888618|FG001|Overall Study|Lost to Follow-up|3|||
30859692|NCT02526524|58888619|FG002|Overall Study|Lost to Follow-up|8|||
30859693|NCT02526524|58888620|FG003|Overall Study|Lost to Follow-up|1|||
30859694|NCT02526524|58888621|FG004|Overall Study|Lost to Follow-up|2|||
30859695|NCT02526524|58888622|FG005|Overall Study|Lost to Follow-up|5|||
30859696|NCT02526524|58888617|FG000|Overall Study|Protocol Violation|3|||
30859697|NCT02526524|58888618|FG001|Overall Study|Protocol Violation|1|||
30859698|NCT02526524|58888619|FG002|Overall Study|Protocol Violation|5|||
30859699|NCT02526524|58888620|FG003|Overall Study|Protocol Violation|3|||
30859700|NCT02526524|58888621|FG004|Overall Study|Protocol Violation|4|||
30859701|NCT02526524|58888622|FG005|Overall Study|Protocol Violation|3|||
30859702|NCT02526524|58888617|FG000|Overall Study|Loss of Glucose Control|0|||
30859703|NCT02526524|58888618|FG001|Overall Study|Loss of Glucose Control|0|||
30859704|NCT02526524|58888619|FG002|Overall Study|Loss of Glucose Control|3|||
30859705|NCT02526524|58888620|FG003|Overall Study|Loss of Glucose Control|0|||
30859706|NCT02526524|58888621|FG004|Overall Study|Loss of Glucose Control|2|||
30859707|NCT02526524|58888622|FG005|Overall Study|Loss of Glucose Control|0|||
30859708|NCT02526524|58888617|FG000|Overall Study|Physician Decision|0|||
30859709|NCT02526524|58888618|FG001|Overall Study|Physician Decision|0|||
30859710|NCT02526524|58888619|FG002|Overall Study|Physician Decision|0|||
30689519|NCT00655551|58703523|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
30689520|NCT00655551|58703524|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
30689521|NCT00655551|58703522|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
30689522|NCT00655551|58703523|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
30689523|NCT00655551|58703524|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
30689524|NCT00312728|58703532|FG000|Overall Study|Progressive disease|53|||
30689525|NCT00312728|58703532|FG000|Overall Study|Adverse Event|32|||
30689526|NCT00312728|58703532|FG000|Overall Study|Withdrawal by Subject|10|||
30689527|NCT00312728|58703532|FG000|Overall Study|Required non-protocol cancer treatment|2|||
30689528|NCT00312728|58703532|FG000|Overall Study|Protocol Violation|2|||
30689529|NCT00312728|58703532|FG000|Overall Study|Other|10|||
30689530|NCT00312728|58703532|FG000|Overall Study|Other|1|||
30689531|NCT00577824|58703539|FG000|Overall Study|Adverse Event|6|||
30689532|NCT00577824|58703540|FG001|Overall Study|Adverse Event|18|||
30689533|NCT00577824|58703541|FG002|Overall Study|Adverse Event|1|||
30689534|NCT00577824|58703539|FG000|Overall Study|Patient decision|0|||
30689535|NCT00577824|58703540|FG001|Overall Study|Patient decision|1|||
30689536|NCT00577824|58703541|FG002|Overall Study|Patient decision|1|||
30689537|NCT00577824|58703539|FG000|Overall Study|Protocol Violation|1|||
30689538|NCT00577824|58703540|FG001|Overall Study|Protocol Violation|1|||
30689539|NCT00577824|58703541|FG002|Overall Study|Protocol Violation|0|||
30689540|NCT00617344|58703552|FG000|Overall Study|Serious adverse event|1|||
30689541|NCT00617344|58703553|FG001|Overall Study|Serious adverse event|0|||
30689542|NCT00617344|58703554|FG002|Overall Study|Serious adverse event|0|||
30689543|NCT00617344|58703552|FG000|Overall Study|Other Adverse Event|1|||
30689544|NCT00617344|58703553|FG001|Overall Study|Other Adverse Event|1|||
30689545|NCT00617344|58703554|FG002|Overall Study|Other Adverse Event|0|||
30689546|NCT00617344|58703552|FG000|Overall Study|Protocol Violation|10|||
30689547|NCT00617344|58703553|FG001|Overall Study|Protocol Violation|8|||
30689548|NCT00617344|58703554|FG002|Overall Study|Protocol Violation|5|||
30689549|NCT00617344|58703552|FG000|Overall Study|Lost to Follow-up|5|||
30689550|NCT00617344|58703553|FG001|Overall Study|Lost to Follow-up|4|||
30689551|NCT00617344|58703554|FG002|Overall Study|Lost to Follow-up|1|||
30689552|NCT00617344|58703552|FG000|Overall Study|Withdrawal by Subject|8|||
30689553|NCT00617344|58703553|FG001|Overall Study|Withdrawal by Subject|9|||
30689554|NCT00617344|58703554|FG002|Overall Study|Withdrawal by Subject|2|||
30689555|NCT00654381|58703622|FG000|1st Stage|Adverse Event|3|||
30859711|NCT02526524|58888620|FG003|Overall Study|Physician Decision|0|||
30859712|NCT02526524|58888621|FG004|Overall Study|Physician Decision|1|||
30689556|NCT00654381|58703623|FG001|1st Stage|Adverse Event|3|||
30689557|NCT00654381|58703624|FG002|1st Stage|Adverse Event|3|||
30689558|NCT00654381|58703625|FG003|1st Stage|Adverse Event|3|||
30689559|NCT00654381|58703626|FG004|1st Stage|Adverse Event|2|||
30689560|NCT00654381|58703627|FG005|1st Stage|Adverse Event|1|||
30689561|NCT00654381|58703622|FG000|1st Stage|Withdrawal by Subject|0|||
30859713|NCT02526524|58888622|FG005|Overall Study|Physician Decision|0|||
30959480|NCT01563029|59024940|FG004|Overall Study|Lost to Follow-up|1|||
30689562|NCT00654381|58703623|FG001|1st Stage|Withdrawal by Subject|0|||
30689563|NCT00654381|58703624|FG002|1st Stage|Withdrawal by Subject|0|||
30689564|NCT00654381|58703625|FG003|1st Stage|Withdrawal by Subject|1|||
30859714|NCT02526524|58888617|FG000|Overall Study|Sponsor Decision|1|||
30859715|NCT02526524|58888618|FG001|Overall Study|Sponsor Decision|0|||
30689565|NCT00654381|58703626|FG004|1st Stage|Withdrawal by Subject|0|||
30689566|NCT00654381|58703627|FG005|1st Stage|Withdrawal by Subject|1|||
30689567|NCT00654381|58703622|FG000|1st Stage|Investigator's decision|0|||
30689568|NCT00654381|58703623|FG001|1st Stage|Investigator's decision|0|||
30689569|NCT00654381|58703624|FG002|1st Stage|Investigator's decision|0|||
30689570|NCT00654381|58703625|FG003|1st Stage|Investigator's decision|1|||
30689571|NCT00654381|58703626|FG004|1st Stage|Investigator's decision|0|||
30689572|NCT00654381|58703627|FG005|1st Stage|Investigator's decision|0|||
30689573|NCT00654381|58703622|FG000|2nd Stage|Adverse Event|2|||
30689574|NCT00654381|58703623|FG001|2nd Stage|Adverse Event|0|||
30689575|NCT00654381|58703624|FG002|2nd Stage|Adverse Event|2|||
30689576|NCT00654381|58703625|FG003|2nd Stage|Adverse Event|3|||
30689577|NCT00654381|58703626|FG004|2nd Stage|Adverse Event|7|||
30689578|NCT00654381|58703627|FG005|2nd Stage|Adverse Event|2|||
30689579|NCT00654381|58703622|FG000|2nd Stage|Withdrawal by Subject|0|||
30689580|NCT00654381|58703623|FG001|2nd Stage|Withdrawal by Subject|0|||
30689581|NCT00654381|58703624|FG002|2nd Stage|Withdrawal by Subject|0|||
30689582|NCT00654381|58703625|FG003|2nd Stage|Withdrawal by Subject|0|||
30689583|NCT00654381|58703626|FG004|2nd Stage|Withdrawal by Subject|1|||
30689584|NCT00654381|58703627|FG005|2nd Stage|Withdrawal by Subject|1|||
30689585|NCT00654381|58703622|FG000|2nd Stage|Investigator's decision|0|||
30689586|NCT00654381|58703623|FG001|2nd Stage|Investigator's decision|0|||
30689587|NCT00654381|58703624|FG002|2nd Stage|Investigator's decision|1|||
30689588|NCT00654381|58703625|FG003|2nd Stage|Investigator's decision|1|||
30689589|NCT00654381|58703626|FG004|2nd Stage|Investigator's decision|0|||
30689590|NCT00654381|58703627|FG005|2nd Stage|Investigator's decision|0|||
30689591|NCT00654381|58703622|FG000|Extension Stage|Adverse Event|1|||
30689592|NCT00654381|58703623|FG001|Extension Stage|Adverse Event|2|||
30689593|NCT00654381|58703624|FG002|Extension Stage|Adverse Event|9|||
30689594|NCT00654381|58703625|FG003|Extension Stage|Adverse Event|7|||
30689595|NCT00654381|58703626|FG004|Extension Stage|Adverse Event|1|||
30689596|NCT00654381|58703627|FG005|Extension Stage|Adverse Event|1|||
30689597|NCT00654381|58703622|FG000|Extension Stage|Protocol Violation|0|||
30689598|NCT00654381|58703623|FG001|Extension Stage|Protocol Violation|0|||
30689599|NCT00654381|58703624|FG002|Extension Stage|Protocol Violation|0|||
30689600|NCT00654381|58703625|FG003|Extension Stage|Protocol Violation|1|||
30689601|NCT00654381|58703626|FG004|Extension Stage|Protocol Violation|0|||
30689602|NCT00654381|58703627|FG005|Extension Stage|Protocol Violation|0|||
30689603|NCT00654381|58703622|FG000|Extension Stage|Lack of Efficacy|0|||
30689604|NCT00654381|58703623|FG001|Extension Stage|Lack of Efficacy|0|||
30689605|NCT00654381|58703624|FG002|Extension Stage|Lack of Efficacy|1|||
30689606|NCT00654381|58703625|FG003|Extension Stage|Lack of Efficacy|0|||
30689607|NCT00654381|58703626|FG004|Extension Stage|Lack of Efficacy|0|||
30689608|NCT00654381|58703627|FG005|Extension Stage|Lack of Efficacy|0|||
30689609|NCT00654381|58703622|FG000|Extension Stage|Withdrawal by Subject|0|||
30689610|NCT00654381|58703623|FG001|Extension Stage|Withdrawal by Subject|0|||
30689611|NCT00654381|58703624|FG002|Extension Stage|Withdrawal by Subject|1|||
30689612|NCT00654381|58703625|FG003|Extension Stage|Withdrawal by Subject|1|||
30689613|NCT00654381|58703626|FG004|Extension Stage|Withdrawal by Subject|1|||
30689614|NCT00654381|58703627|FG005|Extension Stage|Withdrawal by Subject|1|||
30689615|NCT00654381|58703622|FG000|Extension Stage|Closure of the trial site|0|||
30689616|NCT00654381|58703623|FG001|Extension Stage|Closure of the trial site|0|||
30689617|NCT00654381|58703624|FG002|Extension Stage|Closure of the trial site|0|||
30689618|NCT00654381|58703625|FG003|Extension Stage|Closure of the trial site|0|||
30689619|NCT00654381|58703626|FG004|Extension Stage|Closure of the trial site|1|||
30689620|NCT00654381|58703627|FG005|Extension Stage|Closure of the trial site|1|||
30689621|NCT00657267|58703644|FG000|Overall Study|Progressive disease|45|||
30689622|NCT00657267|58703644|FG000|Overall Study|Adverse Event|9|||
30689623|NCT00653991|58703652|FG000|3 Month Follow-up|Participant would not respond|150|||
30689624|NCT00653991|58703653|FG001|3 Month Follow-up|Participant would not respond|157|||
30689625|NCT00653991|58703652|FG000|6 Month Follow-up|Participant would not respond|133|||
30689626|NCT00653991|58703653|FG001|6 Month Follow-up|Participant would not respond|141|||
30689627|NCT00652899|58703661|FG000|Overall Study|Death|1|||
30689628|NCT00652899|58703661|FG000|Overall Study|Treating physician decision|1|||
30689629|NCT00617890|58703673|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
30689630|NCT00617890|58703674|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
30689631|NCT00617890|58703675|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
30689632|NCT00617890|58703676|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
30689633|NCT00617890|58703673|FG000|Overall Study|Lack of Efficacy|23|||
30689634|NCT00617890|58703674|FG001|Overall Study|Lack of Efficacy|26|||
30689635|NCT00617890|58703675|FG002|Overall Study|Lack of Efficacy|30|||
30689636|NCT00617890|58703676|FG003|Overall Study|Lack of Efficacy|97|||
30689637|NCT00617890|58703673|FG000|Overall Study|Lost to Follow-up|0|||
30689638|NCT00617890|58703674|FG001|Overall Study|Lost to Follow-up|0|||
30689639|NCT00617890|58703675|FG002|Overall Study|Lost to Follow-up|1|||
30689640|NCT00617890|58703676|FG003|Overall Study|Lost to Follow-up|2|||
30689641|NCT00617890|58703673|FG000|Overall Study|Withdrawal by Subject|4|||
30689642|NCT00617890|58703674|FG001|Overall Study|Withdrawal by Subject|1|||
30689643|NCT00617890|58703675|FG002|Overall Study|Withdrawal by Subject|0|||
30689644|NCT00617890|58703676|FG003|Overall Study|Withdrawal by Subject|2|||
30689645|NCT00617890|58703673|FG000|Overall Study|Protocol Violation|2|||
30689646|NCT00617890|58703674|FG001|Overall Study|Protocol Violation|1|||
30689647|NCT00617890|58703675|FG002|Overall Study|Protocol Violation|0|||
30689648|NCT00617890|58703676|FG003|Overall Study|Protocol Violation|0|||
30689649|NCT00617890|58703673|FG000|Overall Study|Adverse Event|1|||
30689650|NCT00617890|58703674|FG001|Overall Study|Adverse Event|0|||
30689651|NCT00617890|58703675|FG002|Overall Study|Adverse Event|3|||
30689652|NCT00617890|58703676|FG003|Overall Study|Adverse Event|8|||
30689653|NCT00617890|58703673|FG000|Overall Study|Not treated|1|||
30689654|NCT00617890|58703674|FG001|Overall Study|Not treated|0|||
30689655|NCT00617890|58703675|FG002|Overall Study|Not treated|1|||
30689656|NCT00617890|58703676|FG003|Overall Study|Not treated|1|||
30689657|NCT00712166|58703691|FG000|Overall Study|Noncompliance|0|||
30689658|NCT00712166|58703692|FG001|Overall Study|Noncompliance|1|||
30689659|NCT00652743|58703703|FG000|Months 12-18|Lost to Follow-up|1|||
30859716|NCT02526524|58888619|FG002|Overall Study|Sponsor Decision|0|||
30859717|NCT02526524|58888620|FG003|Overall Study|Sponsor Decision|0|||
30859718|NCT02526524|58888621|FG004|Overall Study|Sponsor Decision|0|||
30859719|NCT02526524|58888622|FG005|Overall Study|Sponsor Decision|0|||
30859720|NCT02526290|58888636|FG000|Overall Study|Adverse Event|3|||
30859721|NCT02526290|58888636|FG000|Overall Study|Withdrawal by Subject|4|||
30859722|NCT02526290|58888636|FG000|Overall Study|Physician Decision|1|||
30859723|NCT02319148|58888643|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
30859724|NCT02319148|58888644|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
30859725|NCT02319148|58888645|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
30859726|NCT02319148|58888646|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
30859727|NCT02319148|58888643|FG000|Second Intervention Period|No longer willing to participate|0|||
30859728|NCT02319148|58888644|FG001|Second Intervention Period|No longer willing to participate|1|||
30859729|NCT02319148|58888645|FG002|Second Intervention Period|No longer willing to participate|0|||
30859730|NCT02319148|58888646|FG003|Second Intervention Period|No longer willing to participate|0|||
30859731|NCT02319148|58888643|FG000|Second Intervention Period|Other|0|||
30859732|NCT02319148|58888644|FG001|Second Intervention Period|Other|0|||
30859733|NCT02319148|58888645|FG002|Second Intervention Period|Other|0|||
30859734|NCT02319148|58888646|FG003|Second Intervention Period|Other|1|||
30859735|NCT02526212|58888667|FG000|Overall Study|Incarceration|1|||
30859736|NCT02526212|58888668|FG001|Overall Study|Incarceration|0|||
30859737|NCT02526212|58888667|FG000|Overall Study|Lost to Follow-up|1|||
30599774|NCT01296711|58611523|FG000|Overall Study|Continued elevated liver enzymes|0|||
30599775|NCT01296711|58611524|FG001|Overall Study|Continued elevated liver enzymes|0|||
30599776|NCT01296711|58611525|FG002|Overall Study|Continued elevated liver enzymes|0|||
30599777|NCT01296711|58611526|FG003|Overall Study|Continued elevated liver enzymes|1|||
30599778|NCT01296711|58611527|FG004|Overall Study|Continued elevated liver enzymes|0|||
30599779|NCT01296711|58611528|FG005|Overall Study|Continued elevated liver enzymes|0|||
30599780|NCT01296711|58611529|FG006|Overall Study|Continued elevated liver enzymes|0|||
30599781|NCT01296711|58611530|FG007|Overall Study|Continued elevated liver enzymes|0|||
30689660|NCT00652743|58703704|FG001|Months 12-18|Lost to Follow-up|2|||
30689661|NCT00652743|58703705|FG002|Months 12-18|Lost to Follow-up|7|||
30689662|NCT00652743|58703703|FG000|Months 24-30|Other|5|||
30689663|NCT00652743|58703704|FG001|Months 24-30|Other|1|||
30859738|NCT02526212|58888668|FG001|Overall Study|Lost to Follow-up|0|||
30859739|NCT02526212|58888667|FG000|Overall Study|Death|0|||
30859740|NCT02526212|58888668|FG001|Overall Study|Death|1|||
30859741|NCT02532374|58888674|FG000|Overall Study|Withdrawal by Subject|1|||
30859742|NCT02532374|58888674|FG000|Overall Study|Physician Decision|1|||
30859743|NCT02525744|58888686|FG000|Period 1|Physician Decision|0|||
30859744|NCT02525744|58888687|FG001|Period 1|Physician Decision|0|||
30859745|NCT02525744|58888688|FG002|Period 1|Physician Decision|1|||
30859746|NCT02525744|58888689|FG003|Period 1|Physician Decision|0|||
30859747|NCT02525744|58888686|FG000|Period 3|Adverse Event|0|||
30859748|NCT02525744|58888687|FG001|Period 3|Adverse Event|1|||
30859749|NCT02525744|58888688|FG002|Period 3|Adverse Event|0|||
30859750|NCT02525744|58888689|FG003|Period 3|Adverse Event|0|||
30859751|NCT02525744|58888686|FG000|Period 4|Withdrawal by Subject|1|||
30859752|NCT02525744|58888687|FG001|Period 4|Withdrawal by Subject|0|||
30859753|NCT02525744|58888688|FG002|Period 4|Withdrawal by Subject|0|||
30859754|NCT02525744|58888689|FG003|Period 4|Withdrawal by Subject|0|||
30599782|NCT01296711|58611523|FG000|Overall Study|Methotrexate discontinued|0|||
30859755|NCT02525744|58888686|FG000|Period 5|Physician Decision|1|||
30689664|NCT00652743|58703705|FG002|Months 24-30|Other|11|||
30689665|NCT00652743|58703703|FG000|Months 36-42|Serious Adverse Events|0|||
30689666|NCT00652743|58703704|FG001|Months 36-42|Serious Adverse Events|1|||
30689667|NCT00652743|58703705|FG002|Months 36-42|Serious Adverse Events|1|||
30859756|NCT02525744|58888687|FG001|Period 5|Physician Decision|0|||
30859757|NCT02525744|58888688|FG002|Period 5|Physician Decision|0|||
30689668|NCT00652743|58703703|FG000|Months 36-42|Withdrawal by Subject|1|||
30689669|NCT00652743|58703704|FG001|Months 36-42|Withdrawal by Subject|1|||
30689670|NCT00652743|58703705|FG002|Months 36-42|Withdrawal by Subject|0|||
30689671|NCT00652743|58703703|FG000|Months 36-42|Lost to Follow-up|0|||
30689672|NCT00652743|58703704|FG001|Months 36-42|Lost to Follow-up|1|||
30689673|NCT00652743|58703705|FG002|Months 36-42|Lost to Follow-up|0|||
30689674|NCT00652743|58703703|FG000|Months 36-42|Migrated/moved from study area|1|||
30859758|NCT02525744|58888689|FG003|Period 5|Physician Decision|0|||
30859759|NCT00152477|58888702|FG000|Chemotherapy Period|Adverse Event|9|||
30859760|NCT00152477|58888703|FG001|Chemotherapy Period|Adverse Event|4|||
30859761|NCT00152477|58888704|FG002|Chemotherapy Period|Adverse Event|5|||
30859762|NCT00152477|58888702|FG000|Chemotherapy Period|Death|1|||
30859763|NCT00152477|58888703|FG001|Chemotherapy Period|Death|3|||
30859764|NCT00152477|58888704|FG002|Chemotherapy Period|Death|3|||
30859765|NCT00152477|58888702|FG000|Chemotherapy Period|Lack of Efficacy|4|||
30859766|NCT00152477|58888703|FG001|Chemotherapy Period|Lack of Efficacy|5|||
30859767|NCT00152477|58888704|FG002|Chemotherapy Period|Lack of Efficacy|6|||
30859768|NCT00152477|58888702|FG000|Chemotherapy Period|Lost to Follow-up|1|||
30859769|NCT00152477|58888703|FG001|Chemotherapy Period|Lost to Follow-up|0|||
30859770|NCT00152477|58888704|FG002|Chemotherapy Period|Lost to Follow-up|1|||
30859771|NCT00152477|58888702|FG000|Chemotherapy Period|Protocol Violation|1|||
30859772|NCT00152477|58888703|FG001|Chemotherapy Period|Protocol Violation|1|||
30859773|NCT00152477|58888704|FG002|Chemotherapy Period|Protocol Violation|0|||
30859774|NCT00152477|58888702|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
30959481|NCT01563029|59024936|FG000|Overall Study|Physician Decision|3|||
30599783|NCT01296711|58611524|FG001|Overall Study|Methotrexate discontinued|0|||
30599784|NCT01296711|58611525|FG002|Overall Study|Methotrexate discontinued|0|||
30599785|NCT01296711|58611526|FG003|Overall Study|Methotrexate discontinued|1|||
30599786|NCT01296711|58611527|FG004|Overall Study|Methotrexate discontinued|0|||
30599787|NCT01296711|58611528|FG005|Overall Study|Methotrexate discontinued|0|||
30599788|NCT01296711|58611529|FG006|Overall Study|Methotrexate discontinued|0|||
30599789|NCT01296711|58611530|FG007|Overall Study|Methotrexate discontinued|0|||
30599790|NCT01296711|58611523|FG000|Overall Study|Investigator discretion|0|||
30599791|NCT01296711|58611524|FG001|Overall Study|Investigator discretion|0|||
30599792|NCT01296711|58611525|FG002|Overall Study|Investigator discretion|0|||
30599793|NCT01296711|58611526|FG003|Overall Study|Investigator discretion|0|||
30599794|NCT01296711|58611527|FG004|Overall Study|Investigator discretion|0|||
30599795|NCT01296711|58611528|FG005|Overall Study|Investigator discretion|0|||
30599796|NCT01296711|58611529|FG006|Overall Study|Investigator discretion|1|||
30599797|NCT01296711|58611530|FG007|Overall Study|Investigator discretion|0|||
30599798|NCT01296711|58611523|FG000|Overall Study|Other|0|||
30599799|NCT01296711|58611524|FG001|Overall Study|Other|0|||
30599800|NCT01296711|58611525|FG002|Overall Study|Other|0|||
30599801|NCT01296711|58611526|FG003|Overall Study|Other|0|||
30599802|NCT01296711|58611527|FG004|Overall Study|Other|0|||
30599803|NCT01296711|58611528|FG005|Overall Study|Other|0|||
30599804|NCT01296711|58611529|FG006|Overall Study|Other|1|||
30599805|NCT01296711|58611530|FG007|Overall Study|Other|0|||
30599806|NCT01296711|58611523|FG000|Overall Study|Required restricted steroid injections|0|||
30599807|NCT01296711|58611524|FG001|Overall Study|Required restricted steroid injections|0|||
30599808|NCT01296711|58611525|FG002|Overall Study|Required restricted steroid injections|0|||
30599809|NCT01296711|58611526|FG003|Overall Study|Required restricted steroid injections|0|||
30599810|NCT01296711|58611527|FG004|Overall Study|Required restricted steroid injections|0|||
30599811|NCT01296711|58611528|FG005|Overall Study|Required restricted steroid injections|0|||
30599812|NCT01296711|58611529|FG006|Overall Study|Required restricted steroid injections|1|||
30599813|NCT01296711|58611530|FG007|Overall Study|Required restricted steroid injections|0|||
30689675|NCT00652743|58703704|FG001|Months 36-42|Migrated/moved from study area|0|||
30689676|NCT00652743|58703705|FG002|Months 36-42|Migrated/moved from study area|0|||
30689677|NCT00652743|58703703|FG000|Months 36-42|Other|4|||
30689678|NCT00652743|58703704|FG001|Months 36-42|Other|2|||
30689679|NCT00652743|58703705|FG002|Months 36-42|Other|8|||
30689680|NCT00712010|58703716|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
30689681|NCT00653523|58703732|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
30689682|NCT00653523|58703732|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
30859775|NCT00152477|58888703|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
30859776|NCT00152477|58888704|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
30959482|NCT01563029|59024937|FG001|Overall Study|Physician Decision|5|||
30599814|NCT01296711|58611523|FG000|Overall Study|Ongoing missed appointments|0|||
30599815|NCT01296711|58611524|FG001|Overall Study|Ongoing missed appointments|0|||
30689683|NCT00653523|58703732|FG000|Overall Study|Adverse Event|7|||
30689684|NCT00653523|58703732|FG000|Overall Study|Withdrawal by Subject|6|||
30859777|NCT00152477|58888702|FG000|Chemotherapy Period|Progression of Disease|6|||
30859778|NCT00152477|58888703|FG001|Chemotherapy Period|Progression of Disease|8|||
30859779|NCT00152477|58888704|FG002|Chemotherapy Period|Progression of Disease|4|||
30859780|NCT00152477|58888702|FG000|Chemotherapy Period|Investigator decision|0|||
30599816|NCT01296711|58611525|FG002|Overall Study|Ongoing missed appointments|0|||
30599817|NCT01296711|58611526|FG003|Overall Study|Ongoing missed appointments|0|||
30689685|NCT00653523|58703732|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
30689686|NCT00653523|58703732|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
30689687|NCT02717442|58703738|FG000|Overall Study|Study Terminated by Sponsor|31|||
30689688|NCT02717442|58703739|FG001|Overall Study|Study Terminated by Sponsor|29|||
30689689|NCT02717442|58703738|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
30689690|NCT02717442|58703739|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
30689691|NCT02717442|58703738|FG000|Overall Study|Other - Not Specified|2|||
30689692|NCT02717442|58703739|FG001|Overall Study|Other - Not Specified|0|||
30689693|NCT00616018|58703752|FG000|Overall Study|Protocol Violation|3|||
30689694|NCT00424021|58703761|FG000|NCT00046319 Study Period|Adverse Event|1|||
30689695|NCT00424021|58703762|FG001|NCT00046319 Study Period|Adverse Event|0|||
30689696|NCT00424021|58703763|FG002|NCT00046319 Study Period|Adverse Event|1|||
30689697|NCT00424021|58703764|FG003|NCT00046319 Study Period|Adverse Event|1|||
30689698|NCT00424021|58703761|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
30689699|NCT00424021|58703762|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
30689700|NCT00424021|58703763|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
30689701|NCT00424021|58703764|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
30689702|NCT00424021|58703761|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
30689703|NCT00424021|58703762|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
30689704|NCT00424021|58703763|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
30689705|NCT00424021|58703764|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
30689706|NCT00424021|58703761|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
30689707|NCT00424021|58703762|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
30689708|NCT00424021|58703763|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
30689709|NCT00424021|58703764|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
30689710|NCT00424021|58703761|FG000|AMB-220-E Study Period|Adverse Event|1|||
30689711|NCT00424021|58703762|FG001|AMB-220-E Study Period|Adverse Event|1|||
30689712|NCT00424021|58703763|FG002|AMB-220-E Study Period|Adverse Event|3|||
30859781|NCT00152477|58888703|FG001|Chemotherapy Period|Investigator decision|0|||
30859782|NCT00152477|58888704|FG002|Chemotherapy Period|Investigator decision|1|||
30859783|NCT00152477|58888702|FG000|Chemotherapy Period|Patient condition worsened|1|||
30859784|NCT00152477|58888703|FG001|Chemotherapy Period|Patient condition worsened|0|||
30859785|NCT00152477|58888704|FG002|Chemotherapy Period|Patient condition worsened|0|||
30859786|NCT00152477|58888702|FG000|Monotherapy Period|Adverse Event|1|||
30859787|NCT00152477|58888703|FG001|Monotherapy Period|Adverse Event|0|||
30859788|NCT00152477|58888704|FG002|Monotherapy Period|Adverse Event|5|||
30859789|NCT00152477|58888702|FG000|Monotherapy Period|Death|2|||
30859790|NCT00152477|58888703|FG001|Monotherapy Period|Death|0|||
30859791|NCT00152477|58888704|FG002|Monotherapy Period|Death|1|||
30859792|NCT00152477|58888702|FG000|Monotherapy Period|Lack of Efficacy|7|||
30859793|NCT00152477|58888703|FG001|Monotherapy Period|Lack of Efficacy|16|||
30859794|NCT00152477|58888704|FG002|Monotherapy Period|Lack of Efficacy|10|||
30859795|NCT00152477|58888702|FG000|Monotherapy Period|Protocol Violation|0|||
30859796|NCT00152477|58888703|FG001|Monotherapy Period|Protocol Violation|1|||
30859797|NCT00152477|58888704|FG002|Monotherapy Period|Protocol Violation|0|||
30859798|NCT00152477|58888702|FG000|Monotherapy Period|Withdrawal by Subject|0|||
30859799|NCT00152477|58888703|FG001|Monotherapy Period|Withdrawal by Subject|0|||
30859800|NCT00152477|58888704|FG002|Monotherapy Period|Withdrawal by Subject|4|||
30859801|NCT00152477|58888702|FG000|Monotherapy Period|Progression of Disease|5|||
30859802|NCT00152477|58888703|FG001|Monotherapy Period|Progression of Disease|11|||
30859803|NCT00152477|58888704|FG002|Monotherapy Period|Progression of Disease|12|||
30859804|NCT00152477|58888702|FG000|Monotherapy Period|Patient decision|0|||
30859805|NCT00152477|58888703|FG001|Monotherapy Period|Patient decision|1|||
30859806|NCT00152477|58888704|FG002|Monotherapy Period|Patient decision|1|||
30859807|NCT00152477|58888702|FG000|Monotherapy Period|Study personel decision|0|||
30859808|NCT00152477|58888703|FG001|Monotherapy Period|Study personel decision|0|||
30859809|NCT00152477|58888704|FG002|Monotherapy Period|Study personel decision|1|||
30859810|NCT02525588|58888717|FG000|Overall Study|Death|3|||
30859811|NCT02525588|58888718|FG001|Overall Study|Death|1|||
30859812|NCT02525588|58888717|FG000|Overall Study|Lost to Follow-up|2|||
30859813|NCT02525588|58888718|FG001|Overall Study|Lost to Follow-up|0|||
30859814|NCT02525588|58888717|FG000|Overall Study|Withdrawal by Subject|1|||
30859815|NCT02525588|58888718|FG001|Overall Study|Withdrawal by Subject|1|||
30859816|NCT02525588|58888717|FG000|Overall Study|Adverse Event|0|||
30859817|NCT02525588|58888718|FG001|Overall Study|Adverse Event|1|||
30859818|NCT00153179|58888726|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
30689713|NCT00424021|58703764|FG003|AMB-220-E Study Period|Adverse Event|7|||
30689714|NCT00424021|58703761|FG000|AMB-220-E Study Period|Death|0|||
30689715|NCT00424021|58703762|FG001|AMB-220-E Study Period|Death|0|||
30859819|NCT00153179|58888727|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
30859820|NCT00153179|58888728|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
30859821|NCT00153179|58888729|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
30689716|NCT00424021|58703763|FG002|AMB-220-E Study Period|Death|1|||
30689717|NCT00424021|58703764|FG003|AMB-220-E Study Period|Death|1|||
30859822|NCT02531594|58888739|FG000|Overall Study|Withdrawal by Subject|7|||
30859823|NCT02531594|58888740|FG001|Overall Study|Withdrawal by Subject|8|||
30859824|NCT02743949|58888749|FG000|Overall Study|Adverse Event|0|||
30859825|NCT02743949|58888750|FG001|Overall Study|Adverse Event|0|||
30859826|NCT02743949|58888751|FG002|Overall Study|Adverse Event|2|||
30859827|NCT02743949|58888749|FG000|Overall Study|Significant Protocol Deviation|2|||
30859828|NCT02743949|58888750|FG001|Overall Study|Significant Protocol Deviation|0|||
30859829|NCT02743949|58888751|FG002|Overall Study|Significant Protocol Deviation|1|||
30859830|NCT02743949|58888749|FG000|Overall Study|Voluntary Withdrawal|2|||
30859831|NCT02743949|58888750|FG001|Overall Study|Voluntary Withdrawal|1|||
30859832|NCT02743949|58888751|FG002|Overall Study|Voluntary Withdrawal|0|||
30859833|NCT02531438|58888761|FG000|Overall Study|Adverse Event|7|||
30859834|NCT02531438|58888762|FG001|Overall Study|Adverse Event|9|||
30859835|NCT02531438|58888761|FG000|Overall Study|Lost to Follow-up|0|||
30859836|NCT02531438|58888762|FG001|Overall Study|Lost to Follow-up|3|||
30859837|NCT02531438|58888761|FG000|Overall Study|Withdrawal by Subject|7|||
30859838|NCT02531438|58888762|FG001|Overall Study|Withdrawal by Subject|8|||
30859839|NCT02531438|58888761|FG000|Overall Study|Physician Decision|0|||
30859840|NCT02531438|58888762|FG001|Overall Study|Physician Decision|1|||
30859841|NCT02531438|58888761|FG000|Overall Study|Death|6|||
30859842|NCT02531438|58888762|FG001|Overall Study|Death|3|||
30859843|NCT02531438|58888761|FG000|Overall Study|Randomized, but Not Treated|4|||
30859844|NCT02531438|58888762|FG001|Overall Study|Randomized, but Not Treated|0|||
30859845|NCT02531438|58888761|FG000|Overall Study|Missed EOT/PTE Visit|5|||
30859846|NCT02531438|58888762|FG001|Overall Study|Missed EOT/PTE Visit|2|||
30859847|NCT02531438|58888761|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
30859848|NCT02531438|58888762|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
30859849|NCT02289898|58888771|FG000|Overall Study|Death|5|||
30859850|NCT02289898|58888772|FG001|Overall Study|Death|4|||
30859851|NCT02289898|58888773|FG002|Overall Study|Death|3|||
30859852|NCT02289898|58888771|FG000|Overall Study|Physician Decision|2|||
30859853|NCT02289898|58888772|FG001|Overall Study|Physician Decision|5|||
30859854|NCT02289898|58888773|FG002|Overall Study|Physician Decision|2|||
30859855|NCT02289898|58888771|FG000|Overall Study|Withdrawal by Subject|0|||
30859856|NCT02289898|58888772|FG001|Overall Study|Withdrawal by Subject|4|||
30859857|NCT02289898|58888773|FG002|Overall Study|Withdrawal by Subject|1|||
30859858|NCT02289898|58888771|FG000|Overall Study|Adverse Event|3|||
30859859|NCT02289898|58888772|FG001|Overall Study|Adverse Event|5|||
30859860|NCT02289898|58888773|FG002|Overall Study|Adverse Event|5|||
30859861|NCT02289898|58888771|FG000|Overall Study|Disease progression|34|||
30859862|NCT02289898|58888772|FG001|Overall Study|Disease progression|28|||
30859863|NCT02289898|58888773|FG002|Overall Study|Disease progression|34|||
30859864|NCT02289898|58888771|FG000|Overall Study|Use of another anticancer therapy|0|||
30859865|NCT02289898|58888772|FG001|Overall Study|Use of another anticancer therapy|0|||
30859866|NCT02289898|58888773|FG002|Overall Study|Use of another anticancer therapy|1|||
30859867|NCT02289898|58888771|FG000|Overall Study|Other|8|||
30859868|NCT02289898|58888772|FG001|Overall Study|Other|7|||
30859869|NCT02289898|58888773|FG002|Overall Study|Other|10|||
30859870|NCT01660412|58888780|FG000|Overall Study|Protocol Violation|0|||
30859871|NCT01660412|58888781|FG001|Overall Study|Protocol Violation|3|||
30859872|NCT01659554|58888787|FG000|Overall Study|Study Termination|4|||
30859873|NCT01659320|58888791|FG000|Overall Study|Withdrawal by Subject|2|||
30859874|NCT01659320|58888791|FG000|Overall Study|Physician Decision|1|||
30859875|NCT01660334|58888795|FG000|Overall Study|Lost to Follow-up|1|||
30859876|NCT01660256|58888802|FG000|Overall Study|Adverse Event|4|||
30859877|NCT01660256|58888803|FG001|Overall Study|Adverse Event|0|||
30859878|NCT01660256|58888804|FG002|Overall Study|Adverse Event|2|||
30859879|NCT01660256|58888802|FG000|Overall Study|Withdrawal by Subject|1|||
30859880|NCT01660256|58888803|FG001|Overall Study|Withdrawal by Subject|0|||
30859881|NCT01660256|58888804|FG002|Overall Study|Withdrawal by Subject|2|||
30859882|NCT02034123|58888830|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859883|NCT02034123|58888831|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859884|NCT02034123|58888832|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859885|NCT02034123|58888833|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859886|NCT02034123|58888834|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
30859887|NCT02034123|58888835|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859888|NCT02034123|58888836|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859889|NCT02034123|58888837|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
30859890|NCT02034123|58888838|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
30859891|NCT02034123|58888839|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859892|NCT02034123|58888840|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859893|NCT02034123|58888841|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859894|NCT02034123|58888842|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859895|NCT02034123|58888843|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859896|NCT02034123|58888844|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859897|NCT02034123|58888845|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859898|NCT02034123|58888846|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859899|NCT02034123|58888847|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
30859900|NCT02034123|58888830|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859901|NCT02034123|58888831|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859902|NCT02034123|58888832|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859903|NCT02034123|58888833|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
30859904|NCT02034123|58888834|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30689718|NCT00424021|58703761|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
30859905|NCT02034123|58888835|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859906|NCT02034123|58888836|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859907|NCT02034123|58888837|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859908|NCT02034123|58888838|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859909|NCT02034123|58888839|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859910|NCT02034123|58888840|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859911|NCT02034123|58888841|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859912|NCT02034123|58888842|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859913|NCT02034123|58888843|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859914|NCT02034123|58888844|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859915|NCT02034123|58888845|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859916|NCT02034123|58888846|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859917|NCT02034123|58888847|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
30859918|NCT02034123|58888830|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859919|NCT02034123|58888831|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859920|NCT02034123|58888832|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859921|NCT02034123|58888833|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859922|NCT02034123|58888834|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859923|NCT02034123|58888835|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859924|NCT02034123|58888836|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859925|NCT02034123|58888837|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859926|NCT02034123|58888838|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
30859927|NCT02034123|58888839|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859928|NCT02034123|58888840|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859929|NCT02034123|58888841|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859930|NCT02034123|58888842|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859931|NCT02034123|58888843|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859932|NCT02034123|58888844|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859933|NCT02034123|58888845|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859934|NCT02034123|58888846|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859935|NCT02034123|58888847|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
30859936|NCT02034123|58888830|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859937|NCT02034123|58888831|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859938|NCT02034123|58888832|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859939|NCT02034123|58888833|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
30859940|NCT02034123|58888834|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
30859941|NCT02034123|58888835|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859942|NCT02034123|58888836|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859943|NCT02034123|58888837|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859944|NCT02034123|58888838|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859945|NCT02034123|58888839|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859946|NCT02034123|58888840|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859947|NCT02034123|58888841|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30959483|NCT01563029|59024938|FG002|Overall Study|Physician Decision|2|||
30959484|NCT01563029|59024939|FG003|Overall Study|Physician Decision|4|||
30599818|NCT01296711|58611527|FG004|Overall Study|Ongoing missed appointments|0|||
30599819|NCT01296711|58611528|FG005|Overall Study|Ongoing missed appointments|0|||
30599820|NCT01296711|58611529|FG006|Overall Study|Ongoing missed appointments|1|||
30599821|NCT01296711|58611530|FG007|Overall Study|Ongoing missed appointments|0|||
30599822|NCT01296711|58611523|FG000|Overall Study|Failure to comply with visits|0|||
30599823|NCT01296711|58611524|FG001|Overall Study|Failure to comply with visits|0|||
30599824|NCT01296711|58611525|FG002|Overall Study|Failure to comply with visits|0|||
30689719|NCT00424021|58703762|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
30689720|NCT00424021|58703763|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
30689721|NCT00424021|58703764|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
30689722|NCT00424021|58703761|FG000|AMB-220-E Study Period|Physician Decision|0|||
30599825|NCT01296711|58611526|FG003|Overall Study|Failure to comply with visits|0|||
30689723|NCT00424021|58703762|FG001|AMB-220-E Study Period|Physician Decision|0|||
30689724|NCT00424021|58703763|FG002|AMB-220-E Study Period|Physician Decision|0|||
30689725|NCT00424021|58703764|FG003|AMB-220-E Study Period|Physician Decision|1|||
30689726|NCT00617734|58703783|FG000|Overall Study|Withdrew Consent|2|||
30689727|NCT00617734|58703784|FG001|Overall Study|Withdrew Consent|0|||
30689728|NCT00617734|58703783|FG000|Overall Study|Adverse Event|4|||
30689729|NCT00617734|58703784|FG001|Overall Study|Adverse Event|1|||
30689730|NCT00617734|58703783|FG000|Overall Study|Protocol Violation|1|||
30689731|NCT00617734|58703784|FG001|Overall Study|Protocol Violation|0|||
30689732|NCT00617734|58703783|FG000|Overall Study|Found Ineligible After Randomization|1|||
30689733|NCT00617734|58703784|FG001|Overall Study|Found Ineligible After Randomization|4|||
30689734|NCT00617734|58703783|FG000|Overall Study|Lost to Follow-up|0|||
30689735|NCT00617734|58703784|FG001|Overall Study|Lost to Follow-up|1|||
30859948|NCT02034123|58888842|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859949|NCT02034123|58888843|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859950|NCT02034123|58888844|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859951|NCT02034123|58888845|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859952|NCT02034123|58888846|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859953|NCT02034123|58888847|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
30859954|NCT02318602|58888893|FG000|Overall Study|Adverse Event|0|||
30689736|NCT00577460|58703793|FG000|Overall Study|Adverse Event|11|||
30689737|NCT00577460|58703794|FG001|Overall Study|Adverse Event|7|||
30689738|NCT00577460|58703795|FG002|Overall Study|Adverse Event|14|||
30859955|NCT02318602|58888894|FG001|Overall Study|Adverse Event|1|||
30859956|NCT02318602|58888895|FG002|Overall Study|Adverse Event|1|||
30859957|NCT02318602|58888893|FG000|Overall Study|Withdrawal by Subject|0|||
30859958|NCT02318602|58888894|FG001|Overall Study|Withdrawal by Subject|3|||
30859959|NCT02318602|58888895|FG002|Overall Study|Withdrawal by Subject|0|||
30859960|NCT02318602|58888893|FG000|Overall Study|Death|1|||
30859961|NCT02318602|58888894|FG001|Overall Study|Death|0|||
30859962|NCT02318602|58888895|FG002|Overall Study|Death|0|||
30859963|NCT02318602|58888893|FG000|Overall Study|Guardian decision to withdraw|0|||
30859964|NCT02318602|58888894|FG001|Overall Study|Guardian decision to withdraw|0|||
30859965|NCT02318602|58888895|FG002|Overall Study|Guardian decision to withdraw|1|||
30859966|NCT02318368|58888911|FG000|Overall Study|Withdrawal by Subject|2|||
30859967|NCT02318368|58888912|FG001|Overall Study|Withdrawal by Subject|0|||
30859968|NCT02318368|58888911|FG000|Overall Study|Study terminated by the sponsor|5|||
30859969|NCT02318368|58888912|FG001|Overall Study|Study terminated by the sponsor|2|||
30859970|NCT02318368|58888911|FG000|Overall Study|Death|0|||
30859971|NCT02318368|58888912|FG001|Overall Study|Death|1|||
30859972|NCT02318134|58888920|FG000|Overall Study|Withdrawal by Subject|2|||
30859973|NCT02318134|58888921|FG001|Overall Study|Withdrawal by Subject|1|||
30859974|NCT02317510|58888931|FG000|Overall Study|Adverse Event|0|||
30859975|NCT02317510|58888932|FG001|Overall Study|Adverse Event|1|||
30859976|NCT02317432|58888943|FG000|Overall Study|Death|4|||
30859977|NCT02317432|58888944|FG001|Overall Study|Death|1|||
30859978|NCT02317432|58888943|FG000|Overall Study|Lost to Follow-up|0|||
30859979|NCT02317432|58888944|FG001|Overall Study|Lost to Follow-up|5|||
30859980|NCT02317432|58888943|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
30859981|NCT02317432|58888944|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
30859982|NCT00494234|58888952|FG000|Overall Study|Lack of Efficacy|12|||
30859983|NCT00494234|58888953|FG001|Overall Study|Lack of Efficacy|9|||
30859984|NCT00494234|58888952|FG000|Overall Study|Withdrawal by Subject|1|||
30859985|NCT00494234|58888953|FG001|Overall Study|Withdrawal by Subject|0|||
30859986|NCT00494234|58888952|FG000|Overall Study|Death|2|||
30859987|NCT00494234|58888953|FG001|Overall Study|Death|1|||
30859988|NCT02289820|58888970|FG000|Overall Study|Withdrawal by Subject|2|||
30859989|NCT02289820|58888971|FG001|Overall Study|Withdrawal by Subject|1|||
30859990|NCT02289820|58888972|FG002|Overall Study|Withdrawal by Subject|2|||
30859991|NCT02289820|58888973|FG003|Overall Study|Withdrawal by Subject|1|||
30859992|NCT02289820|58888974|FG004|Overall Study|Withdrawal by Subject|0|||
30859993|NCT02289820|58888975|FG005|Overall Study|Withdrawal by Subject|0|||
30859994|NCT02289820|58888976|FG006|Overall Study|Withdrawal by Subject|1|||
30859995|NCT02289820|58888970|FG000|Overall Study|Death|0|||
30859996|NCT02289820|58888971|FG001|Overall Study|Death|0|||
30859997|NCT02289820|58888972|FG002|Overall Study|Death|1|||
30859998|NCT02289820|58888973|FG003|Overall Study|Death|0|||
30859999|NCT02289820|58888974|FG004|Overall Study|Death|0|||
30689739|NCT00577460|58703793|FG000|Overall Study|Protocol Violation|0|||
30860000|NCT02289820|58888975|FG005|Overall Study|Death|0|||
30689740|NCT00577460|58703794|FG001|Overall Study|Protocol Violation|1|||
30689741|NCT00577460|58703795|FG002|Overall Study|Protocol Violation|1|||
30689742|NCT00577460|58703793|FG000|Overall Study|Lost to Follow-up|0|||
30860001|NCT02289820|58888976|FG006|Overall Study|Death|0|||
30860002|NCT02289820|58888970|FG000|Overall Study|Lost to Follow-up|0|||
30860003|NCT02289820|58888971|FG001|Overall Study|Lost to Follow-up|0|||
30860004|NCT02289820|58888972|FG002|Overall Study|Lost to Follow-up|3|||
30860005|NCT02289820|58888973|FG003|Overall Study|Lost to Follow-up|1|||
30860006|NCT02289820|58888974|FG004|Overall Study|Lost to Follow-up|0|||
30860007|NCT02289820|58888975|FG005|Overall Study|Lost to Follow-up|1|||
30860008|NCT02289820|58888976|FG006|Overall Study|Lost to Follow-up|1|||
30860009|NCT02289820|58888970|FG000|Overall Study|withdrawal of consent|0|||
30860010|NCT02289820|58888971|FG001|Overall Study|withdrawal of consent|1|||
30860011|NCT02289820|58888972|FG002|Overall Study|withdrawal of consent|0|||
30860012|NCT02289820|58888973|FG003|Overall Study|withdrawal of consent|0|||
30860013|NCT02289820|58888974|FG004|Overall Study|withdrawal of consent|0|||
30860014|NCT02289820|58888975|FG005|Overall Study|withdrawal of consent|0|||
30860015|NCT02289820|58888976|FG006|Overall Study|withdrawal of consent|0|||
30860016|NCT02289742|58888998|FG000|First Wear Period|Adverse event prior to treatment|0|||
30860017|NCT02289742|58888999|FG001|First Wear Period|Adverse event prior to treatment|1|||
30860018|NCT02289742|58889000|FG002|First Wear Period|Adverse event prior to treatment|0|||
30860019|NCT02289742|58889001|FG003|First Wear Period|Adverse event prior to treatment|0|||
30860020|NCT02289742|58888998|FG000|First Wear Period|Adverse Event|0|||
30860021|NCT02289742|58888999|FG001|First Wear Period|Adverse Event|0|||
30599826|NCT01296711|58611527|FG004|Overall Study|Failure to comply with visits|0|||
30599827|NCT01296711|58611528|FG005|Overall Study|Failure to comply with visits|0|||
30599828|NCT01296711|58611529|FG006|Overall Study|Failure to comply with visits|0|||
30599829|NCT01296711|58611530|FG007|Overall Study|Failure to comply with visits|1|||
30599830|NCT01296711|58611523|FG000|Overall Study|Patient decision due to transport|0|||
30599831|NCT01296711|58611524|FG001|Overall Study|Patient decision due to transport|0|||
30860022|NCT02289742|58889000|FG002|First Wear Period|Adverse Event|1|||
30860023|NCT02289742|58889001|FG003|First Wear Period|Adverse Event|0|||
30860024|NCT02289742|58888998|FG000|First Wear Period|Other prior to treatment|0|||
30860025|NCT02289742|58888999|FG001|First Wear Period|Other prior to treatment|0|||
30860026|NCT02289742|58889000|FG002|First Wear Period|Other prior to treatment|0|||
30860027|NCT02289742|58889001|FG003|First Wear Period|Other prior to treatment|1|||
30860028|NCT02289742|58888998|FG000|Third Wear Period|Adverse Event|0|||
30860029|NCT02289742|58888999|FG001|Third Wear Period|Adverse Event|1|||
30860030|NCT02289742|58889000|FG002|Third Wear Period|Adverse Event|0|||
30860031|NCT02289742|58889001|FG003|Third Wear Period|Adverse Event|0|||
30860032|NCT02289742|58888998|FG000|Third Wear Period|Reason not given|0|||
30959485|NCT01563029|59024940|FG004|Overall Study|Physician Decision|2|||
30599832|NCT01296711|58611525|FG002|Overall Study|Patient decision due to transport|0|||
30689743|NCT00577460|58703794|FG001|Overall Study|Lost to Follow-up|3|||
30689744|NCT00577460|58703795|FG002|Overall Study|Lost to Follow-up|4|||
30689745|NCT00577460|58703793|FG000|Overall Study|Withdrawal by Subject|5|||
30689746|NCT00577460|58703794|FG001|Overall Study|Withdrawal by Subject|5|||
30689747|NCT00577460|58703795|FG002|Overall Study|Withdrawal by Subject|6|||
30689748|NCT00577460|58703793|FG000|Overall Study|Other|0|||
30689749|NCT00577460|58703794|FG001|Overall Study|Other|3|||
30689750|NCT00577460|58703795|FG002|Overall Study|Other|2|||
30599833|NCT01296711|58611526|FG003|Overall Study|Patient decision due to transport|0|||
30599834|NCT01296711|58611527|FG004|Overall Study|Patient decision due to transport|0|||
30599835|NCT01296711|58611528|FG005|Overall Study|Patient decision due to transport|0|||
30599836|NCT01296711|58611529|FG006|Overall Study|Patient decision due to transport|0|||
30599837|NCT01296711|58611530|FG007|Overall Study|Patient decision due to transport|1|||
30599838|NCT01294917|58611548|FG000|Overall Study|Relocation|5|||
30599839|NCT01294917|58611548|FG000|Overall Study|Inconvenience|1|||
30599840|NCT01294683|58611556|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
30599841|NCT01294683|58611557|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
30599842|NCT01294683|58611556|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
30599843|NCT01294683|58611557|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
30599844|NCT01294683|58611556|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
30599845|NCT01294683|58611557|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
30599846|NCT01294683|58611556|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
30599847|NCT01294683|58611557|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
30599848|NCT01294683|58611556|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
30599849|NCT01294683|58611557|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
30599850|NCT01294683|58611556|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
30599851|NCT01294683|58611557|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
30689751|NCT00415519|58703812|FG000|Overall Study|Adverse Event|1|||
30860033|NCT02289742|58888999|FG001|Third Wear Period|Reason not given|0|||
30860034|NCT02289742|58889000|FG002|Third Wear Period|Reason not given|0|||
30860035|NCT02289742|58889001|FG003|Third Wear Period|Reason not given|1|||
30599852|NCT01294683|58611556|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
30860036|NCT02289352|58889018|FG000|Overall Study|Withdrawal by Subject|1|||
30599853|NCT01294683|58611557|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
30689752|NCT00415519|58703813|FG001|Overall Study|Adverse Event|0|||
30689753|NCT00415519|58703812|FG000|Overall Study|Withdrawal by Subject|2|||
30689754|NCT00415519|58703813|FG001|Overall Study|Withdrawal by Subject|0|||
30689755|NCT00415519|58703812|FG000|Overall Study|Patient's convenience|1|||
30689756|NCT00415519|58703813|FG001|Overall Study|Patient's convenience|0|||
30689757|NCT00423943|58703821|FG000|Overall Study|Withdrawal by Subject|3|||
30689758|NCT00423943|58703822|FG001|Overall Study|Withdrawal by Subject|1|||
30689759|NCT00428389|58703830|FG000|Core Phase|Adverse Event|6|||
30689760|NCT00428389|58703831|FG001|Core Phase|Adverse Event|4|||
30689761|NCT00428389|58703830|FG000|Core Phase|Lack of Efficacy|2|||
30860037|NCT02289352|58889019|FG001|Overall Study|Withdrawal by Subject|1|||
30860038|NCT02289352|58889020|FG002|Overall Study|Withdrawal by Subject|0|||
30860039|NCT02315560|58889029|FG000|Overall Study|noncompliance by subjects|3|||
30860040|NCT02522624|58889035|FG000|Overall Study|Technical failure|1|||
30860041|NCT02522624|58889036|FG001|Overall Study|Technical failure|0|||
30860042|NCT02287402|58889042|FG000|Treatment Period|Adverse Event|17|||
30860043|NCT02287402|58889042|FG000|Treatment Period|Voluntary Withdrawal|10|||
30860044|NCT02287402|58889042|FG000|Follow-up|Lost to Follow-up|1|||
30860045|NCT02287402|58889042|FG000|Follow-up|Voluntary Withdrawal|2|||
30860046|NCT02314780|58889049|FG000|Overall Study|organizational reasons|0|||
30860047|NCT02314780|58889050|FG001|Overall Study|organizational reasons|2|||
30860048|NCT02314780|58889051|FG002|Overall Study|organizational reasons|0|||
30860049|NCT02314780|58889049|FG000|Overall Study|Adverse Event|0|||
30860050|NCT02314780|58889050|FG001|Overall Study|Adverse Event|1|||
30599854|NCT01294683|58611556|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
30599855|NCT01294683|58611557|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
30860051|NCT02314780|58889051|FG002|Overall Study|Adverse Event|0|||
30860052|NCT02288182|58889061|FG000|Overall Study|Adverse Event|0|||
30860053|NCT02288182|58889062|FG001|Overall Study|Adverse Event|1|||
30860054|NCT02288182|58889061|FG000|Overall Study|Lost to Follow-up|0|||
30860055|NCT02288182|58889062|FG001|Overall Study|Lost to Follow-up|1|||
30860056|NCT02286466|58889072|FG000|Overall Study|Death|1|||
30860057|NCT02286466|58889073|FG001|Overall Study|Death|3|||
30860058|NCT02286466|58889072|FG000|Overall Study|Withdrawal by Subject|5|||
30860059|NCT02286466|58889073|FG001|Overall Study|Withdrawal by Subject|2|||
30860060|NCT02286466|58889072|FG000|Overall Study|Lost to Follow-up|1|||
30860061|NCT02286466|58889073|FG001|Overall Study|Lost to Follow-up|4|||
30860062|NCT02286466|58889072|FG000|Overall Study|Declined Clinician Assessment|0|||
30860063|NCT02286466|58889073|FG001|Overall Study|Declined Clinician Assessment|1|||
30860064|NCT02313766|58889082|FG000|Overall Study|surgery cancelled|1|||
30860065|NCT02313766|58889083|FG001|Overall Study|surgery cancelled|0|||
30860066|NCT02313766|58889084|FG002|Overall Study|surgery cancelled|0|||
30860067|NCT02313766|58889082|FG000|Overall Study|Lost to Follow-up|0|||
30860068|NCT02313766|58889083|FG001|Overall Study|Lost to Follow-up|2|||
30860069|NCT02313766|58889084|FG002|Overall Study|Lost to Follow-up|0|||
30959486|NCT01563029|59024936|FG000|Overall Study|Withdrawal by Subject|4|||
30599856|NCT01294683|58611556|FG000|Post Crossover (Period III)|Adverse Event|6|||
30599857|NCT01294683|58611557|FG001|Post Crossover (Period III)|Adverse Event|6|||
30599858|NCT01294683|58611556|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
30599859|NCT01294683|58611557|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
30599860|NCT01294683|58611556|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
30599861|NCT01294683|58611557|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
30599862|NCT01294683|58611556|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
30599863|NCT01294683|58611557|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
30599864|NCT01294449|58611571|FG000|Overall Study|Death|11|||
30689762|NCT00428389|58703831|FG001|Core Phase|Lack of Efficacy|0|||
30689763|NCT00428389|58703830|FG000|Core Phase|Abnormal test procedure result(s)|0|||
30860070|NCT02313766|58889082|FG000|Overall Study|Adverse Event|0|||
30860071|NCT02313766|58889083|FG001|Overall Study|Adverse Event|1|||
30860072|NCT02313766|58889084|FG002|Overall Study|Adverse Event|0|||
30860073|NCT01646398|58889094|FG000|Overall Study|Withdrawal by Subject|1|||
30860074|NCT01646398|58889095|FG001|Overall Study|Withdrawal by Subject|0|||
30860075|NCT01646320|58889103|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
30860076|NCT01646320|58889104|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
30860077|NCT01646320|58889103|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
30860078|NCT01646320|58889104|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
30860079|NCT01646320|58889103|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
30860080|NCT01646320|58889104|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
30860081|NCT01646320|58889103|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
30860082|NCT01646320|58889104|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
30860083|NCT01646320|58889103|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
30860084|NCT01646320|58889104|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
30860085|NCT01646320|58889103|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
30599865|NCT01294449|58611572|FG001|Overall Study|Death|12|||
30599866|NCT01294449|58611571|FG000|Overall Study|Withdrawal by Subject|1|||
30599867|NCT01294449|58611572|FG001|Overall Study|Withdrawal by Subject|3|||
30689764|NCT00428389|58703831|FG001|Core Phase|Abnormal test procedure result(s)|1|||
30689765|NCT00428389|58703830|FG000|Core Phase|Withdrawal by Subject|3|||
30860086|NCT01646320|58889104|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
30860087|NCT01646320|58889103|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
30860088|NCT01646320|58889104|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
30860089|NCT01646320|58889103|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
30860090|NCT01646320|58889104|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
30860091|NCT01646320|58889103|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
30860092|NCT01646320|58889104|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
30860093|NCT01646320|58889103|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
30860094|NCT01646320|58889104|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
30860095|NCT01646320|58889103|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
30689766|NCT00428389|58703831|FG001|Core Phase|Withdrawal by Subject|4|||
30689767|NCT00428389|58703830|FG000|Core Phase|Protocol deviation|0|||
30689768|NCT00428389|58703831|FG001|Core Phase|Protocol deviation|2|||
30689769|NCT00428389|58703830|FG000|Extension Phase|Adverse Event|17|||
30689770|NCT00428389|58703831|FG001|Extension Phase|Adverse Event|11|||
30689771|NCT00428389|58703830|FG000|Extension Phase|Lack of Efficacy|4|||
30689772|NCT00428389|58703831|FG001|Extension Phase|Lack of Efficacy|3|||
30689773|NCT00428389|58703830|FG000|Extension Phase|Withdrawal by Subject|6|||
30689774|NCT00428389|58703831|FG001|Extension Phase|Withdrawal by Subject|6|||
30689775|NCT00428389|58703830|FG000|Extension Phase|Lost to Follow-up|0|||
30689776|NCT00428389|58703831|FG001|Extension Phase|Lost to Follow-up|3|||
30689777|NCT00428389|58703830|FG000|Extension Phase|Death|1|||
30860096|NCT01646320|58889104|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
30860097|NCT02524730|58889110|FG000|Overall Study|Lost to Follow-up|5|||
30860098|NCT02524730|58889110|FG000|Overall Study|Withdrawal by Subject|18|||
30860099|NCT02524730|58889110|FG000|Overall Study|Death|10|||
30860100|NCT02524730|58889110|FG000|Overall Study|Adverse Event|8|||
30860101|NCT02524730|58889110|FG000|Overall Study|Protocol Violation|1|||
30860102|NCT02524730|58889110|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
30860103|NCT01658150|58889114|FG000|Overall Study|Withdrawal by Subject|1|||
30860104|NCT02285998|58889121|FG000|Overall Study|Adverse Event|9|||
30860105|NCT02285998|58889122|FG001|Overall Study|Adverse Event|8|||
30860106|NCT02285998|58889121|FG000|Overall Study|Physician Decision|1|||
30860107|NCT02285998|58889122|FG001|Overall Study|Physician Decision|2|||
30860108|NCT02285998|58889121|FG000|Overall Study|Lost to Follow-up|176|||
30860109|NCT02285998|58889122|FG001|Overall Study|Lost to Follow-up|172|||
30860110|NCT02285998|58889121|FG000|Overall Study|Withdrawal by Subject|53|||
30860111|NCT02285998|58889122|FG001|Overall Study|Withdrawal by Subject|61|||
30860112|NCT02285998|58889121|FG000|Overall Study|Other Reasons|7|||
30860113|NCT02285998|58889122|FG001|Overall Study|Other Reasons|10|||
30860114|NCT01658072|58889130|FG000|Overall Study|Protocol Violation|4|||
30860115|NCT01658072|58889131|FG001|Overall Study|Protocol Violation|2|||
30860116|NCT02285920|58889141|FG000|Overall Study|Kidney transplantation|2|||
30860117|NCT02285920|58889142|FG001|Overall Study|Kidney transplantation|2|||
30860118|NCT02285920|58889143|FG002|Overall Study|Kidney transplantation|2|||
30860119|NCT02285920|58889144|FG003|Overall Study|Kidney transplantation|0|||
30860120|NCT02285920|58889141|FG000|Overall Study|Change to peritoneal dialysis|0|||
30860121|NCT02285920|58889142|FG001|Overall Study|Change to peritoneal dialysis|0|||
30860122|NCT02285920|58889143|FG002|Overall Study|Change to peritoneal dialysis|1|||
30860123|NCT02285920|58889144|FG003|Overall Study|Change to peritoneal dialysis|0|||
30959487|NCT01563029|59024937|FG001|Overall Study|Withdrawal by Subject|1|||
30959488|NCT01563029|59024938|FG002|Overall Study|Withdrawal by Subject|3|||
30959489|NCT01563029|59024939|FG003|Overall Study|Withdrawal by Subject|4|||
30959490|NCT01563029|59024940|FG004|Overall Study|Withdrawal by Subject|3|||
30959491|NCT01562873|59024953|FG000|Overall Study|Disease Progression per RECIST|10|||
30959492|NCT01562873|59024954|FG001|Overall Study|Disease Progression per RECIST|0|||
30959493|NCT01562873|59024953|FG000|Overall Study|Adverse Event|1|||
30959494|NCT01562873|59024954|FG001|Overall Study|Adverse Event|0|||
30959495|NCT01562873|59024953|FG000|Overall Study|Clinical Disease Progression|9|||
30959496|NCT01562873|59024954|FG001|Overall Study|Clinical Disease Progression|0|||
30959497|NCT01562873|59024953|FG000|Overall Study|Clinical PD and adverse event|1|||
30959498|NCT01562873|59024954|FG001|Overall Study|Clinical PD and adverse event|0|||
30959499|NCT03273712|59024958|FG000|Overall Study|Death|5|||
30959500|NCT03273712|59024958|FG000|Overall Study|Adverse Event|1|||
30959501|NCT03273712|59024958|FG000|Overall Study|Disease Progression|1|||
30959502|NCT01562327|59024963|FG000|Overall Study|Adverse Event|2|||
30689778|NCT00428389|58703831|FG001|Extension Phase|Death|0|||
30689779|NCT00428389|58703830|FG000|Extension Phase|Protocol Violation|3|||
30860124|NCT02285920|58889141|FG000|Overall Study|Transfer to non-participating unit|0|||
30959503|NCT01562327|59024963|FG000|Overall Study|Lack of Efficacy|1|||
30689780|NCT00428389|58703831|FG001|Extension Phase|Protocol Violation|2|||
30689781|NCT00428389|58703830|FG000|Extension Phase|Administrative problems|1|||
30689782|NCT00428389|58703831|FG001|Extension Phase|Administrative problems|1|||
30959504|NCT01562327|59024963|FG000|Overall Study|Participant drop-out|1|||
30959505|NCT01562327|59024963|FG000|Overall Study|Infusion not received at 6 month window|4|||
30689783|NCT00616642|58703839|FG000|Overall Study|Withdrawal by Subject|0|||
30860125|NCT02285920|58889142|FG001|Overall Study|Transfer to non-participating unit|1|||
30860126|NCT02285920|58889143|FG002|Overall Study|Transfer to non-participating unit|0|||
30860127|NCT02285920|58889144|FG003|Overall Study|Transfer to non-participating unit|0|||
30860128|NCT02285920|58889141|FG000|Overall Study|Dialysis discontinuation|0|||
30860129|NCT02285920|58889142|FG001|Overall Study|Dialysis discontinuation|1|||
30860130|NCT02285920|58889143|FG002|Overall Study|Dialysis discontinuation|0|||
30860131|NCT02285920|58889144|FG003|Overall Study|Dialysis discontinuation|0|||
30860132|NCT02285920|58889141|FG000|Overall Study|Death|2|||
30860133|NCT02285920|58889142|FG001|Overall Study|Death|0|||
30860134|NCT02285920|58889143|FG002|Overall Study|Death|2|||
30689784|NCT00616642|58703840|FG001|Overall Study|Withdrawal by Subject|1|||
30860135|NCT02285920|58889144|FG003|Overall Study|Death|1|||
30860136|NCT02035137|58889157|FG000|Overall Study|Physician Decision|0|||
30860137|NCT02035137|58889158|FG001|Overall Study|Physician Decision|0|||
30860138|NCT02035137|58889159|FG002|Overall Study|Physician Decision|1|||
30860139|NCT02035137|58889157|FG000|Overall Study|Withdrawal by Subject|0|||
30860140|NCT02035137|58889158|FG001|Overall Study|Withdrawal by Subject|1|||
30860141|NCT02035137|58889159|FG002|Overall Study|Withdrawal by Subject|2|||
30860142|NCT02035137|58889157|FG000|Overall Study|Ineligible|0|||
30860143|NCT02035137|58889158|FG001|Overall Study|Ineligible|1|||
30860144|NCT02035137|58889159|FG002|Overall Study|Ineligible|2|||
30860145|NCT02035137|58889157|FG000|Overall Study|Disease progression prior to treatment start|2|||
30860146|NCT02035137|58889158|FG001|Overall Study|Disease progression prior to treatment start|0|||
30860147|NCT02035137|58889159|FG002|Overall Study|Disease progression prior to treatment start|0|||
30860148|NCT02522780|58889169|FG000|Overall Study|Consent withdrawn by subject|5|||
30860149|NCT02522780|58889170|FG001|Overall Study|Consent withdrawn by subject|7|||
30860150|NCT02522780|58889169|FG000|Overall Study|Protocol deviation|1|||
30860151|NCT02522780|58889170|FG001|Overall Study|Protocol deviation|3|||
30860152|NCT02522780|58889169|FG000|Overall Study|Subject refused endoscopic procedure|0|||
30860153|NCT02522780|58889170|FG001|Overall Study|Subject refused endoscopic procedure|1|||
30860154|NCT02522780|58889169|FG000|Overall Study|Adverse event, non-fatal|11|||
30860155|NCT02522780|58889170|FG001|Overall Study|Adverse event, non-fatal|16|||
30860156|NCT02285062|58889190|FG000|Pre-Treatment Period|Protocol Violation|0|||
30860157|NCT02285062|58889191|FG001|Pre-Treatment Period|Protocol Violation|2|||
30860158|NCT02285062|58889190|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
30860159|NCT02285062|58889191|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
30860160|NCT01352741|58889197|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
30860161|NCT01352741|58889198|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
30860162|NCT01352741|58889197|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
30860163|NCT01352741|58889198|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
30860164|NCT01352741|58889197|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
30689785|NCT00406315|58703846|FG000|Overall Study|Death|1|||
30689786|NCT00406315|58703846|FG000|Overall Study|Adverse Event|39|||
30689787|NCT00406315|58703846|FG000|Overall Study|Laboratory Abnormality|4|||
30689788|NCT00406315|58703846|FG000|Overall Study|Lack of Efficacy|13|||
30689789|NCT00406315|58703846|FG000|Overall Study|Other|33|||
30689790|NCT00406315|58703846|FG000|Overall Study|Lost to Follow-up|21|||
30689791|NCT00406315|58703846|FG000|Overall Study|Withdrawal by Subject|30|||
30689792|NCT00711594|58703854|FG000|Overall Study|Progressive disease|2|||
30689793|NCT00711594|58703855|FG001|Overall Study|Progressive disease|2|||
30689794|NCT00711594|58703856|FG002|Overall Study|Progressive disease|6|||
30860165|NCT01352741|58889198|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
30860166|NCT01352741|58889197|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
30860167|NCT01352741|58889198|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
30860168|NCT01352741|58889197|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
30860169|NCT01352741|58889198|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
30860170|NCT01352741|58889197|FG000|Open-label Tapentadol Titration Period|Other|4|||
30860171|NCT01352741|58889198|FG001|Open-label Tapentadol Titration Period|Other|0|||
30860172|NCT01352741|58889197|FG000|Double-blind Comparative Period|Protocol Violation|2|||
30860173|NCT01352741|58889198|FG001|Double-blind Comparative Period|Protocol Violation|0|||
30860174|NCT01352741|58889197|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
30860175|NCT01352741|58889198|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
30860176|NCT01352741|58889197|FG000|Double-blind Comparative Period|Adverse Event|16|||
30860177|NCT01352741|58889198|FG001|Double-blind Comparative Period|Adverse Event|17|||
30689795|NCT00711594|58703857|FG003|Overall Study|Progressive disease|44|||
30689796|NCT00711594|58703854|FG000|Overall Study|Other Adverse Event|1|||
30689797|NCT00711594|58703855|FG001|Overall Study|Other Adverse Event|0|||
30689798|NCT00711594|58703856|FG002|Overall Study|Other Adverse Event|0|||
30689799|NCT00711594|58703857|FG003|Overall Study|Other Adverse Event|16|||
30689800|NCT00711594|58703854|FG000|Overall Study|Withdrawal by Subject|0|||
30860178|NCT01352741|58889197|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
30860179|NCT01352741|58889198|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
30860180|NCT01352741|58889197|FG000|Double-blind Comparative Period|Death|0|||
30860181|NCT01352741|58889198|FG001|Double-blind Comparative Period|Death|1|||
30860182|NCT01352741|58889197|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
30860183|NCT01352741|58889198|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
30860184|NCT01352741|58889197|FG000|Double-blind Comparative Period|Other|1|||
30860185|NCT01352741|58889198|FG001|Double-blind Comparative Period|Other|2|||
30860186|NCT01352741|58889197|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
30860187|NCT01352741|58889198|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
30860188|NCT01352741|58889197|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
30860189|NCT01352741|58889198|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
30860190|NCT01352741|58889197|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
30860191|NCT01352741|58889198|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
30860192|NCT01352741|58889197|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
30860193|NCT01352741|58889198|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
30860194|NCT01657292|58889218|FG000|Overall Study|Adverse Event|6|||
30860195|NCT01657292|58889218|FG000|Overall Study|Withdrawal by Subject|2|||
30860196|NCT01657292|58889218|FG000|Overall Study|Violation of eligibility criteria|1|||
30860197|NCT01657292|58889218|FG000|Overall Study|Change of therapy|1|||
30860198|NCT00905567|58889234|FG000|Washout|Withdrawal by Subject|0|||
30860199|NCT00905567|58889235|FG001|Washout|Withdrawal by Subject|1|||
30860200|NCT02282020|58889241|FG000|Overall Study|Objective Disease Progression|128|||
30860201|NCT02282020|58889242|FG001|Overall Study|Objective Disease Progression|30|||
30689801|NCT00711594|58703855|FG001|Overall Study|Withdrawal by Subject|1|||
30860202|NCT02282020|58889241|FG000|Overall Study|Adverse Event|18|||
30860203|NCT02282020|58889242|FG001|Overall Study|Adverse Event|15|||
30860204|NCT02282020|58889241|FG000|Overall Study|Withdrawal by Subject|7|||
30860205|NCT02282020|58889242|FG001|Overall Study|Withdrawal by Subject|10|||
30860206|NCT02282020|58889241|FG000|Overall Study|Miscellaneous|5|||
30860207|NCT02282020|58889242|FG001|Overall Study|Miscellaneous|19|||
30860208|NCT02282020|58889241|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
30860209|NCT02282020|58889242|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
30860210|NCT02282020|58889241|FG000|Overall Study|Developed Discontinuation Criteria|0|||
30860211|NCT02282020|58889242|FG001|Overall Study|Developed Discontinuation Criteria|2|||
30860212|NCT02282020|58889241|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
30860213|NCT02282020|58889242|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
30860214|NCT02281552|58889258|FG000|Overall Study|Medication error|1|||
30860215|NCT02281552|58889259|FG001|Overall Study|Medication error|0|||
30860216|NCT02281552|58889258|FG000|Overall Study|Insufficient clinical response|0|||
30860217|NCT02281552|58889259|FG001|Overall Study|Insufficient clinical response|1|||
30860218|NCT02281552|58889258|FG000|Overall Study|Adverse Event|3|||
30860219|NCT02281552|58889259|FG001|Overall Study|Adverse Event|9|||
30959506|NCT01561313|59024970|FG000|Overall Study|Withdrawal by Subject|1|||
30959507|NCT01561313|59024971|FG001|Overall Study|Withdrawal by Subject|0|||
30959508|NCT01561313|59024970|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
30689802|NCT00711594|58703856|FG002|Overall Study|Withdrawal by Subject|0|||
30689803|NCT00711594|58703857|FG003|Overall Study|Withdrawal by Subject|2|||
30689804|NCT00710762|58703871|FG000|Overall Study|Progressive disease|27|||
30689805|NCT00710762|58703872|FG001|Overall Study|Progressive disease|30|||
30689806|NCT00710762|58703871|FG000|Overall Study|Adverse Event other disease worsening|2|||
30689807|NCT00710762|58703872|FG001|Overall Study|Adverse Event other disease worsening|1|||
30689808|NCT00710762|58703871|FG000|Overall Study|Other Adverse Event|7|||
30689809|NCT00710762|58703872|FG001|Overall Study|Other Adverse Event|7|||
30689810|NCT00710762|58703871|FG000|Overall Study|Lost to Follow-up|1|||
30689811|NCT00710762|58703872|FG001|Overall Study|Lost to Follow-up|0|||
30860220|NCT00890591|58889265|FG000|Overall Study|Lack of Efficacy|20|||
30860221|NCT02284906|58889274|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
30860222|NCT02284906|58889275|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
30860223|NCT02284906|58889276|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
30860224|NCT02284906|58889274|FG000|Overall Study|Major Protocol Deviation|0|||
30860225|NCT02284906|58889275|FG001|Overall Study|Major Protocol Deviation|1|||
30860226|NCT02284906|58889276|FG002|Overall Study|Major Protocol Deviation|0|||
30860227|NCT02284906|58889274|FG000|Overall Study|Voluntary Withdrawal|2|||
30860228|NCT02284906|58889275|FG001|Overall Study|Voluntary Withdrawal|4|||
30860229|NCT02284906|58889276|FG002|Overall Study|Voluntary Withdrawal|5|||
30689812|NCT00710762|58703871|FG000|Overall Study|Reason other than listed above|2|||
30689813|NCT00710762|58703872|FG001|Overall Study|Reason other than listed above|2|||
30689814|NCT00573430|58703881|FG000|Overall Study|Incorrect enrollment of randomization|0|||
30689815|NCT00573430|58703882|FG001|Overall Study|Incorrect enrollment of randomization|4|||
30689816|NCT00573430|58703883|FG002|Overall Study|Incorrect enrollment of randomization|3|||
30689817|NCT00573430|58703881|FG000|Overall Study|Adverse Event|0|||
30860230|NCT02284906|58889274|FG000|Overall Study|Study Termination|0|||
30860231|NCT02284906|58889275|FG001|Overall Study|Study Termination|11|||
30860232|NCT02284906|58889276|FG002|Overall Study|Study Termination|14|||
30860233|NCT02284906|58889274|FG000|Overall Study|Reason not Specified|1|||
30860234|NCT02284906|58889275|FG001|Overall Study|Reason not Specified|1|||
30860235|NCT02284906|58889276|FG002|Overall Study|Reason not Specified|0|||
30860236|NCT02879305|58889286|FG000|Overall Study|Investigator Site Closed|55|||
30860237|NCT02879305|58889287|FG001|Overall Study|Investigator Site Closed|57|||
30860238|NCT02879305|58889286|FG000|Overall Study|Withdrawal by Subject|44|||
30860239|NCT02879305|58889287|FG001|Overall Study|Withdrawal by Subject|42|||
30860240|NCT02879305|58889286|FG000|Overall Study|Lost to Follow-up|17|||
30860241|NCT02879305|58889287|FG001|Overall Study|Lost to Follow-up|12|||
30860242|NCT02879305|58889286|FG000|Overall Study|Other|1|||
30860243|NCT02879305|58889287|FG001|Overall Study|Other|0|||
30860244|NCT02281318|58889295|FG000|Overall Study|Adverse Event|2|||
30860245|NCT02281318|58889296|FG001|Overall Study|Adverse Event|2|||
30860246|NCT02281318|58889295|FG000|Overall Study|Lack of Efficacy|2|||
30860247|NCT02281318|58889296|FG001|Overall Study|Lack of Efficacy|0|||
30860248|NCT02281318|58889295|FG000|Overall Study|Lost to Follow-up|2|||
30860249|NCT02281318|58889296|FG001|Overall Study|Lost to Follow-up|1|||
30860250|NCT02281318|58889295|FG000|Overall Study|Physician Decision|2|||
30860251|NCT02281318|58889296|FG001|Overall Study|Physician Decision|0|||
30860252|NCT02281318|58889295|FG000|Overall Study|Withdrawal by Subject|6|||
30860253|NCT02281318|58889296|FG001|Overall Study|Withdrawal by Subject|2|||
30599868|NCT01294371|58611578|FG000|Overall Study|Adverse Event|1|||
30599869|NCT01294371|58611578|FG000|Overall Study|Withdrawal by Subject|12|||
30599870|NCT01294371|58611578|FG000|Overall Study|Lost to Follow-up|6|||
30599871|NCT01294371|58611578|FG000|Overall Study|Administrative Reason|1|||
30599872|NCT01294371|58611578|FG000|Overall Study|Other|14|||
30599873|NCT01293123|58611587|FG000|Overall Study|Lost to Follow-up|0|||
30599874|NCT01293123|58611588|FG001|Overall Study|Lost to Follow-up|1|||
30599875|NCT01292187|58611596|FG000|Overall Study|Adverse Event|10|||
30599876|NCT01292187|58611597|FG001|Overall Study|Adverse Event|5|||
30599877|NCT01292187|58611596|FG000|Overall Study|Withdrawal by Subject|6|||
30599878|NCT01292187|58611597|FG001|Overall Study|Withdrawal by Subject|5|||
30599879|NCT01292187|58611596|FG000|Overall Study|All other reasons|1|||
30599880|NCT01292187|58611597|FG001|Overall Study|All other reasons|3|||
30599881|NCT01026493|58611612|FG000|Overall Study|Protocol Violation|0|||
30599882|NCT01026493|58611613|FG001|Overall Study|Protocol Violation|1|||
30599883|NCT01026493|58611614|FG002|Overall Study|Protocol Violation|0|||
30599884|NCT01026493|58611615|FG003|Overall Study|Protocol Violation|0|||
30599885|NCT01026493|58611616|FG004|Overall Study|Protocol Violation|2|||
30599886|NCT01026493|58611617|FG005|Overall Study|Protocol Violation|3|||
30599887|NCT01026493|58611618|FG006|Overall Study|Protocol Violation|4|||
30599888|NCT01026493|58611619|FG007|Overall Study|Protocol Violation|1|||
30599889|NCT01026103|58611637|FG000|Overall Study|Physician Decision|1|||
30599890|NCT01026103|58611637|FG000|Overall Study|did not receive study device bc of error|1|||
30599891|NCT01291173|58611645|FG000|Overall Study|Adverse Event|0|||
30599892|NCT01291173|58611646|FG001|Overall Study|Adverse Event|3|||
30599893|NCT01291173|58611647|FG002|Overall Study|Adverse Event|1|||
30599894|NCT01291173|58611648|FG003|Overall Study|Adverse Event|3|||
30599895|NCT01291173|58611645|FG000|Overall Study|Protocol Violation|7|||
30860254|NCT01657760|58889304|FG000|Overall Study|Withdrawal by Subject|0|||
30860255|NCT01657760|58889305|FG001|Overall Study|Withdrawal by Subject|0|||
30860256|NCT01657760|58889306|FG002|Overall Study|Withdrawal by Subject|0|||
30860257|NCT01657760|58889307|FG003|Overall Study|Withdrawal by Subject|1|||
30860258|NCT01657760|58889304|FG000|Overall Study|Physician Decision|1|||
30860259|NCT01657760|58889305|FG001|Overall Study|Physician Decision|1|||
30860260|NCT01657760|58889306|FG002|Overall Study|Physician Decision|1|||
30860261|NCT01657760|58889307|FG003|Overall Study|Physician Decision|2|||
30860262|NCT02280304|58889334|FG000|Overall Study|Lost to Follow-up|7|||
30860263|NCT02280304|58889335|FG001|Overall Study|Lost to Follow-up|8|||
30860264|NCT02283658|58889355|FG000|Overall Study|Withdrawal by Subject|1|||
30860265|NCT02279524|58889382|FG000|Overall Study|Withdrawal by Subject|3|||
30860266|NCT02279524|58889383|FG001|Overall Study|Withdrawal by Subject|6|||
30860267|NCT02279524|58889384|FG002|Overall Study|Withdrawal by Subject|3|||
30860268|NCT02279524|58889382|FG000|Overall Study|Adverse Event|4|||
30599896|NCT01291173|58611646|FG001|Overall Study|Protocol Violation|2|||
30599897|NCT01291173|58611647|FG002|Overall Study|Protocol Violation|2|||
30599898|NCT01291173|58611648|FG003|Overall Study|Protocol Violation|5|||
30599899|NCT01291173|58611645|FG000|Overall Study|Withdrawal by Subject|6|||
30599900|NCT01291173|58611646|FG001|Overall Study|Withdrawal by Subject|4|||
30599901|NCT01291173|58611647|FG002|Overall Study|Withdrawal by Subject|4|||
30599902|NCT01291173|58611648|FG003|Overall Study|Withdrawal by Subject|2|||
30599903|NCT01291173|58611645|FG000|Overall Study|Lost to Follow-up|4|||
30860269|NCT02279524|58889383|FG001|Overall Study|Adverse Event|3|||
30860270|NCT02279524|58889384|FG002|Overall Study|Adverse Event|2|||
30860271|NCT02279524|58889382|FG000|Overall Study|Lost to Follow-up|1|||
30860272|NCT02279524|58889383|FG001|Overall Study|Lost to Follow-up|1|||
30860273|NCT02279524|58889384|FG002|Overall Study|Lost to Follow-up|0|||
30860274|NCT02279524|58889382|FG000|Overall Study|Disallowed medication|1|||
30860275|NCT02279524|58889383|FG001|Overall Study|Disallowed medication|1|||
30860276|NCT02279524|58889384|FG002|Overall Study|Disallowed medication|2|||
30860277|NCT02279524|58889382|FG000|Overall Study|Bariatric surgery|1|||
30860278|NCT02279524|58889383|FG001|Overall Study|Bariatric surgery|0|||
30860279|NCT02279524|58889384|FG002|Overall Study|Bariatric surgery|0|||
30860280|NCT02283268|58889392|FG000|Overall Study|Withdrawal by Subject|1|||
30860281|NCT00857285|58889406|FG000|Overall Study|Adverse Event|4|||
30860282|NCT00857285|58889407|FG001|Overall Study|Adverse Event|2|||
30860283|NCT00857285|58889406|FG000|Overall Study|Lack of Efficacy|0|||
30860284|NCT00857285|58889407|FG001|Overall Study|Lack of Efficacy|2|||
30860285|NCT00857285|58889406|FG000|Overall Study|Protocol Violation|3|||
30860286|NCT00857285|58889407|FG001|Overall Study|Protocol Violation|1|||
30860287|NCT00857285|58889406|FG000|Overall Study|Withdrawal by Subject|4|||
30860288|NCT00857285|58889407|FG001|Overall Study|Withdrawal by Subject|0|||
30860289|NCT00857285|58889406|FG000|Overall Study|Randomization criteria not met|1|||
30860290|NCT00857285|58889407|FG001|Overall Study|Randomization criteria not met|1|||
30860291|NCT02278354|58889413|FG000|Overall Study|Lost to Follow-up|2|||
30860292|NCT02278354|58889414|FG001|Overall Study|Lost to Follow-up|2|||
30860293|NCT02278354|58889413|FG000|Overall Study|Withdrawal by Subject|0|||
30860294|NCT02278354|58889414|FG001|Overall Study|Withdrawal by Subject|1|||
30860295|NCT02278354|58889413|FG000|Overall Study|<10 professional fights|2|||
30860296|NCT02278354|58889414|FG001|Overall Study|<10 professional fights|0|||
30860297|NCT01657370|58889433|FG000|Overall Study|Withdrawal by Subject|0|||
30860298|NCT01657370|58889434|FG001|Overall Study|Withdrawal by Subject|0|||
30860299|NCT01657370|58889435|FG002|Overall Study|Withdrawal by Subject|1|||
30860300|NCT01657370|58889436|FG003|Overall Study|Withdrawal by Subject|0|||
30860301|NCT01657370|58889437|FG004|Overall Study|Withdrawal by Subject|0|||
30860302|NCT01657370|58889438|FG005|Overall Study|Withdrawal by Subject|1|||
30860303|NCT01657370|58889433|FG000|Overall Study|Physician Decision|2|||
30860304|NCT01657370|58889434|FG001|Overall Study|Physician Decision|3|||
30860305|NCT01657370|58889435|FG002|Overall Study|Physician Decision|1|||
30860306|NCT01657370|58889436|FG003|Overall Study|Physician Decision|2|||
30860307|NCT01657370|58889437|FG004|Overall Study|Physician Decision|5|||
30860308|NCT01657370|58889438|FG005|Overall Study|Physician Decision|0|||
30860309|NCT01657370|58889433|FG000|Overall Study|Lack of Qualifying Event|1|||
30860310|NCT01657370|58889434|FG001|Overall Study|Lack of Qualifying Event|0|||
30860311|NCT01657370|58889435|FG002|Overall Study|Lack of Qualifying Event|3|||
30860312|NCT01657370|58889436|FG003|Overall Study|Lack of Qualifying Event|2|||
30860313|NCT01657370|58889437|FG004|Overall Study|Lack of Qualifying Event|1|||
30860314|NCT01657370|58889438|FG005|Overall Study|Lack of Qualifying Event|2|||
30860315|NCT01657370|58889433|FG000|Overall Study|Adverse Event|0|||
30860316|NCT01657370|58889434|FG001|Overall Study|Adverse Event|0|||
30860317|NCT01657370|58889435|FG002|Overall Study|Adverse Event|0|||
30860318|NCT01657370|58889436|FG003|Overall Study|Adverse Event|0|||
30860319|NCT01657370|58889437|FG004|Overall Study|Adverse Event|1|||
30860320|NCT01657370|58889438|FG005|Overall Study|Adverse Event|0|||
30860321|NCT01657370|58889433|FG000|Overall Study|Protocol Violation|1|||
30860322|NCT01657370|58889434|FG001|Overall Study|Protocol Violation|1|||
30860323|NCT01657370|58889435|FG002|Overall Study|Protocol Violation|1|||
30860324|NCT01657370|58889436|FG003|Overall Study|Protocol Violation|1|||
30860325|NCT01657370|58889437|FG004|Overall Study|Protocol Violation|0|||
30860326|NCT01657370|58889438|FG005|Overall Study|Protocol Violation|0|||
30860327|NCT01657370|58889433|FG000|Overall Study|Lost to Follow-up|2|||
30860328|NCT01657370|58889434|FG001|Overall Study|Lost to Follow-up|0|||
30860329|NCT01657370|58889435|FG002|Overall Study|Lost to Follow-up|1|||
30860330|NCT01657370|58889436|FG003|Overall Study|Lost to Follow-up|0|||
30860331|NCT01657370|58889437|FG004|Overall Study|Lost to Follow-up|0|||
30860332|NCT01657370|58889438|FG005|Overall Study|Lost to Follow-up|1|||
30860333|NCT00849797|58889480|FG000|First Intervention|bad veins|1|||
30860334|NCT00849797|58889481|FG001|First Intervention|bad veins|0|||
30860335|NCT00849797|58889480|FG000|First Intervention|Adverse Event|0|||
30860336|NCT00849797|58889481|FG001|First Intervention|Adverse Event|1|||
30860337|NCT00849797|58889480|FG000|Washout: One Week|Withdrawal by Subject|0|||
30860338|NCT00849797|58889481|FG001|Washout: One Week|Withdrawal by Subject|2|||
30860339|NCT00840203|58889502|FG000|First Intervention|Protocol Violation|1|||
30860340|NCT00840203|58889503|FG001|First Intervention|Protocol Violation|1|||
30860341|NCT00840203|58889502|FG000|Washout|Protocol Violation|1|||
30860342|NCT00840203|58889503|FG001|Washout|Protocol Violation|0|||
30860343|NCT00835991|58889509|FG000|First Intervention|Adverse Event|0|||
30860344|NCT00835991|58889510|FG001|First Intervention|Adverse Event|1|||
30860345|NCT00835991|58889509|FG000|Washout|Protocol Violation|0|||
30599904|NCT01291173|58611646|FG001|Overall Study|Lost to Follow-up|6|||
30860346|NCT00835991|58889510|FG001|Washout|Protocol Violation|2|||
30860347|NCT00835991|58889509|FG000|Washout|Withdrawal by Subject|3|||
30860348|NCT00835991|58889510|FG001|Washout|Withdrawal by Subject|1|||
30860349|NCT02276872|58889517|FG000|Overall Study|Adverse Event|1|||
30860350|NCT02276872|58889518|FG001|Overall Study|Adverse Event|0|||
30860351|NCT02276872|58889519|FG002|Overall Study|Adverse Event|0|||
30860352|NCT00835367|58889534|FG000|Washout|Adverse Event|2|||
30860353|NCT00835367|58889535|FG001|Washout|Adverse Event|0|||
30860354|NCT00835367|58889534|FG000|Washout|Withdrawal by Subject|1|||
30860355|NCT00835367|58889535|FG001|Washout|Withdrawal by Subject|0|||
30860356|NCT00835367|58889534|FG000|Second Intervention|Adverse Event|1|||
30860357|NCT00835367|58889535|FG001|Second Intervention|Adverse Event|1|||
30860358|NCT02276560|58889542|FG000|Overall Study|Adverse Event|1|||
30860359|NCT02276560|58889543|FG001|Overall Study|Adverse Event|0|||
30599905|NCT01291173|58611647|FG002|Overall Study|Lost to Follow-up|3|||
30599906|NCT01291173|58611648|FG003|Overall Study|Lost to Follow-up|2|||
30599907|NCT01291173|58611645|FG000|Overall Study|Unable to meet visit schedule|0|||
30599908|NCT01291173|58611646|FG001|Overall Study|Unable to meet visit schedule|0|||
30599909|NCT01291173|58611647|FG002|Overall Study|Unable to meet visit schedule|1|||
30599910|NCT01291173|58611648|FG003|Overall Study|Unable to meet visit schedule|0|||
30689818|NCT00573430|58703882|FG001|Overall Study|Adverse Event|0|||
30860360|NCT02276560|58889544|FG002|Overall Study|Adverse Event|0|||
30860361|NCT02276482|58889554|FG000|Overall Study|Adverse Event|1|||
30860362|NCT02276482|58889555|FG001|Overall Study|Adverse Event|0|||
30860363|NCT02276482|58889554|FG000|Overall Study|Withdrawal by Subject|1|||
30860364|NCT02276482|58889555|FG001|Overall Study|Withdrawal by Subject|0|||
30860365|NCT02276482|58889554|FG000|Overall Study|Gram-negative infection|1|||
30860366|NCT02276482|58889555|FG001|Overall Study|Gram-negative infection|0|||
30860367|NCT02276482|58889554|FG000|Overall Study|Reason not specified|0|||
30860368|NCT02276482|58889555|FG001|Overall Study|Reason not specified|1|||
30860369|NCT00835211|58889573|FG000|First Intervention|Withdrawal by Subject|0|||
30860370|NCT00835211|58889574|FG001|First Intervention|Withdrawal by Subject|1|||
30860371|NCT00835211|58889573|FG000|Washout: 7 Days|Adverse Event|2|||
30860372|NCT00835211|58889574|FG001|Washout: 7 Days|Adverse Event|1|||
30860373|NCT00835211|58889573|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
30860374|NCT00835211|58889574|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
30860375|NCT00834743|58889587|FG000|Second Intervention|Withdrawal by Subject|1|||
30860376|NCT00834743|58889588|FG001|Second Intervention|Withdrawal by Subject|0|||
30860377|NCT00834587|58889594|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
30860378|NCT00834587|58889595|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
30860379|NCT00834431|58889601|FG000|First Intervention|Adverse Event|0|||
30860380|NCT00834431|58889602|FG001|First Intervention|Adverse Event|1|||
30860381|NCT00834431|58889601|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
30860382|NCT00834431|58889602|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
30860383|NCT00830219|58889622|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
30860384|NCT00830219|58889623|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
30860385|NCT02274766|58889629|FG000|Overall Study|Withdrawal by Subject|3|||
30860386|NCT02274766|58889630|FG001|Overall Study|Withdrawal by Subject|6|||
30860387|NCT02274766|58889629|FG000|Overall Study|Did Not Receive Study Drug|1|||
30860388|NCT02274766|58889630|FG001|Overall Study|Did Not Receive Study Drug|1|||
30860389|NCT02274766|58889629|FG000|Overall Study|Subject Unwilling to Proceed|0|||
30860390|NCT02274766|58889630|FG001|Overall Study|Subject Unwilling to Proceed|1|||
30860391|NCT02274766|58889629|FG000|Overall Study|Adverse Event|0|||
30860392|NCT02274766|58889630|FG001|Overall Study|Adverse Event|1|||
30860393|NCT00829673|58889638|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
30689819|NCT00573430|58703883|FG002|Overall Study|Adverse Event|2|||
30689820|NCT00573430|58703881|FG000|Overall Study|Withdrawal by Subject|1|||
30689821|NCT00573430|58703882|FG001|Overall Study|Withdrawal by Subject|0|||
30689822|NCT00573430|58703883|FG002|Overall Study|Withdrawal by Subject|1|||
30689823|NCT00573430|58703881|FG000|Overall Study|Protocol Violation|0|||
30860394|NCT00829673|58889639|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
30860395|NCT02370238|58889645|FG000|Overall Study|Death|42|||
30860396|NCT02370238|58889646|FG001|Overall Study|Death|35|||
30860397|NCT02370238|58889645|FG000|Overall Study|Lost to Follow-up|1|||
30860398|NCT02370238|58889646|FG001|Overall Study|Lost to Follow-up|3|||
30860399|NCT02370238|58889645|FG000|Overall Study|Withdrawal by Subject|2|||
30860400|NCT02370238|58889646|FG001|Overall Study|Withdrawal by Subject|6|||
30860401|NCT02370238|58889645|FG000|Overall Study|Other|2|||
30599911|NCT01291173|58611645|FG000|Overall Study|Lack of compliance|0|||
30599912|NCT01291173|58611646|FG001|Overall Study|Lack of compliance|0|||
30599913|NCT01291173|58611647|FG002|Overall Study|Lack of compliance|0|||
30599914|NCT01291173|58611648|FG003|Overall Study|Lack of compliance|1|||
30599915|NCT01291173|58611645|FG000|Overall Study|Subject was unblinded|0|||
30689824|NCT00573430|58703882|FG001|Overall Study|Protocol Violation|1|||
30689825|NCT00573430|58703883|FG002|Overall Study|Protocol Violation|1|||
30860402|NCT02370238|58889646|FG001|Overall Study|Other|1|||
30860403|NCT02370160|58889656|FG000|Overall Study|Death|3|||
30860404|NCT02370160|58889657|FG001|Overall Study|Death|4|||
30860405|NCT02370160|58889658|FG002|Overall Study|Death|1|||
30599916|NCT01291173|58611646|FG001|Overall Study|Subject was unblinded|0|||
30599917|NCT01291173|58611647|FG002|Overall Study|Subject was unblinded|1|||
30689826|NCT00573430|58703881|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30860406|NCT02273908|58889673|FG000|Overall Study|Adverse Event|16|||
30860407|NCT02273908|58889674|FG001|Overall Study|Adverse Event|0|||
30860408|NCT02273908|58889673|FG000|Overall Study|Lost to Follow-up|10|||
30860409|NCT02273908|58889674|FG001|Overall Study|Lost to Follow-up|1|||
30860410|NCT02273908|58889673|FG000|Overall Study|Did not meet entrance criteria|3|||
30860411|NCT02273908|58889674|FG001|Overall Study|Did not meet entrance criteria|2|||
30860412|NCT02273908|58889673|FG000|Overall Study|Withdrawal by Subject|4|||
30860413|NCT02273908|58889674|FG001|Overall Study|Withdrawal by Subject|2|||
30860414|NCT02273752|58889684|FG000|Overall Study|Trial was terminated early|2|||
30860415|NCT05180630|58889688|FG000|First Intervention|Physician Decision|0|||
30860416|NCT05180630|58889689|FG001|First Intervention|Physician Decision|0|||
30860417|NCT05180630|58889690|FG002|First Intervention|Physician Decision|3|||
30860418|NCT02273596|58889699|FG000|24-Week Treatment Period|Adverse Event|3|||
30860419|NCT02273596|58889699|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
30860420|NCT02273596|58889699|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
30860421|NCT02273596|58889699|FG000|24-Week Treatment Period|Physician Decision|1|||
30860422|NCT02273596|58889699|FG000|24-Week Treatment Period|Protocol Deviation|1|||
30860423|NCT02273596|58889699|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
30860424|NCT02273596|58889699|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
30860425|NCT02273596|58889699|FG000|Extension Period|Lost to Follow-up|1|||
30860426|NCT02273596|58889699|FG000|Extension Period|Protocol Deviation|1|||
30860427|NCT01656200|58889709|FG000|Overall Study|Withdrawal by Subject|1|||
30860428|NCT02369848|58889713|FG000|Overall Study|Death|1|||
30860429|NCT02369848|58889713|FG000|Overall Study|Withdrawal by Subject|2|||
30860430|NCT02369848|58889713|FG000|Overall Study|Lost to Follow-up|1|||
30860431|NCT02368210|58889719|FG000|Overall Study|Withdrawal by Subject|1|||
30860432|NCT02368210|58889720|FG001|Overall Study|Withdrawal by Subject|0|||
30860433|NCT02368210|58889719|FG000|Overall Study|Adverse Event|0|||
30860434|NCT02368210|58889720|FG001|Overall Study|Adverse Event|1|||
30860435|NCT02273050|58889729|FG000|Overall Study|Adverse Event|4|||
30860436|NCT02273050|58889730|FG001|Overall Study|Adverse Event|3|||
30860437|NCT02273050|58889731|FG002|Overall Study|Adverse Event|3|||
30860438|NCT02273050|58889729|FG000|Overall Study|Death|0|||
30860439|NCT02273050|58889730|FG001|Overall Study|Death|0|||
30860440|NCT02273050|58889731|FG002|Overall Study|Death|1|||
30860441|NCT02273050|58889729|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
30860442|NCT02273050|58889730|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
30860443|NCT02273050|58889731|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
30860444|NCT02273050|58889729|FG000|Overall Study|Lack of Efficacy|0|||
30860445|NCT02273050|58889730|FG001|Overall Study|Lack of Efficacy|1|||
30860446|NCT02273050|58889731|FG002|Overall Study|Lack of Efficacy|1|||
30860447|NCT02273050|58889729|FG000|Overall Study|Withdrawal by Subject|17|||
30860448|NCT02273050|58889730|FG001|Overall Study|Withdrawal by Subject|14|||
30860449|NCT02273050|58889731|FG002|Overall Study|Withdrawal by Subject|16|||
30860450|NCT02273050|58889729|FG000|Overall Study|Lost to Follow-up|0|||
30860451|NCT02273050|58889730|FG001|Overall Study|Lost to Follow-up|2|||
30860452|NCT02273050|58889731|FG002|Overall Study|Lost to Follow-up|3|||
30860453|NCT02273050|58889729|FG000|Overall Study|Protocol Violation|3|||
30860454|NCT02273050|58889730|FG001|Overall Study|Protocol Violation|1|||
30860455|NCT02273050|58889731|FG002|Overall Study|Protocol Violation|4|||
30860456|NCT02272816|58889739|FG000|Overall Study|Adverse Event|1|||
30860457|NCT02271880|58889745|FG000|Overall Study|Premature discontinuation of study|3|||
30860458|NCT02271880|58889746|FG001|Overall Study|Premature discontinuation of study|4|||
30860459|NCT02367352|58889754|FG000|Overall Study|Progressive disease|7|||
30860460|NCT02367352|58889755|FG001|Overall Study|Progressive disease|0|||
30860461|NCT02367352|58889756|FG002|Overall Study|Progressive disease|0|||
30860462|NCT02367352|58889754|FG000|Overall Study|Participant Received Alternative Therapy|1|||
30860463|NCT02367352|58889755|FG001|Overall Study|Participant Received Alternative Therapy|0|||
30860464|NCT02367352|58889756|FG002|Overall Study|Participant Received Alternative Therapy|0|||
30860465|NCT02367352|58889754|FG000|Overall Study|Adverse Event|1|||
30860466|NCT02367352|58889755|FG001|Overall Study|Adverse Event|0|||
30689827|NCT00573430|58703882|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30860467|NCT02367352|58889756|FG002|Overall Study|Adverse Event|0|||
30860468|NCT02365636|58889765|FG000|Overall Study|Adverse Event|3|||
30860469|NCT02365636|58889766|FG001|Overall Study|Adverse Event|3|||
30860470|NCT02365636|58889767|FG002|Overall Study|Adverse Event|2|||
30860471|NCT02365636|58889765|FG000|Overall Study|Protocol Violation|1|||
30860472|NCT02365636|58889766|FG001|Overall Study|Protocol Violation|4|||
30860473|NCT02365636|58889767|FG002|Overall Study|Protocol Violation|0|||
30860474|NCT02365636|58889765|FG000|Overall Study|Lost to Follow-up|0|||
30860475|NCT02365636|58889766|FG001|Overall Study|Lost to Follow-up|0|||
30860476|NCT02365636|58889767|FG002|Overall Study|Lost to Follow-up|1|||
30860477|NCT02365636|58889765|FG000|Overall Study|Other|2|||
30860478|NCT02365636|58889766|FG001|Overall Study|Other|0|||
30860479|NCT02365636|58889767|FG002|Overall Study|Other|0|||
30860480|NCT01655498|58889775|FG000|Overall Study|Unrelated health issue|2|||
30860481|NCT01655498|58889775|FG000|Overall Study|Protocol Violation|2|||
30860482|NCT01655498|58889775|FG000|Overall Study|Withdrawal by Subject|1|||
30860483|NCT02270944|58889784|FG000|Overall Study|Lost to Follow-up|9|||
30860484|NCT02270944|58889785|FG001|Overall Study|Lost to Follow-up|4|||
30860485|NCT02270944|58889784|FG000|Overall Study|Withdrawal by Subject|2|||
30860486|NCT02270944|58889785|FG001|Overall Study|Withdrawal by Subject|1|||
30860487|NCT02365558|58889792|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
30860488|NCT02365558|58889793|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
30860489|NCT02365558|58889792|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
30860490|NCT02365558|58889793|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
30860491|NCT02365480|58889804|FG000|Overall Study|Withdrawal by Subject|2|||
30860492|NCT02365480|58889805|FG001|Overall Study|Withdrawal by Subject|0|||
30860493|NCT02270242|58889813|FG000|Overall Study|Withdrawal by Subject|18|||
30860494|NCT02270242|58889814|FG001|Overall Study|Withdrawal by Subject|25|||
30860495|NCT02270242|58889813|FG000|Overall Study|Lost to Follow-up|41|||
30860496|NCT02270242|58889814|FG001|Overall Study|Lost to Follow-up|27|||
30860497|NCT02270242|58889813|FG000|Overall Study|Physician Decision|0|||
30860498|NCT02270242|58889814|FG001|Overall Study|Physician Decision|1|||
30860499|NCT02364388|58889820|FG000|Overall Study|Protocol Violation|1|||
30860500|NCT02364388|58889820|FG000|Overall Study|Technical Failure|3|||
30860501|NCT02364388|58889820|FG000|Overall Study|No OA/US data|2|||
30860502|NCT02364388|58889820|FG000|Overall Study|No Biopsy|2|||
30860503|NCT02363686|58889824|FG000|Overall Study|Withdrawal by Subject|22|||
30860504|NCT02363686|58889824|FG000|Overall Study|incomplete FEES examinations|13|||
30860505|NCT02268916|58889830|FG000|Overall Study|Lost to Follow-up|1|||
30860506|NCT02268916|58889831|FG001|Overall Study|Lost to Follow-up|1|||
30860507|NCT02268916|58889830|FG000|Overall Study|Withdrawal by Subject|6|||
30860508|NCT02268916|58889831|FG001|Overall Study|Withdrawal by Subject|5|||
30860509|NCT02268916|58889830|FG000|Overall Study|Participant did not have diabetes|1|||
30860510|NCT02268916|58889831|FG001|Overall Study|Participant did not have diabetes|0|||
30860511|NCT02268916|58889830|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
30860512|NCT02268916|58889831|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
30860513|NCT02518490|58889838|FG000|Overall Study|Withdrawal by Subject|1|||
30860514|NCT02518490|58889839|FG001|Overall Study|Withdrawal by Subject|1|||
30860515|NCT01364870|58889849|FG000|Overall Study|Withdrawal by Subject|13|||
30860516|NCT01364870|58889850|FG001|Overall Study|Withdrawal by Subject|24|||
30860517|NCT01364870|58889851|FG002|Overall Study|Withdrawal by Subject|10|||
30860518|NCT01364870|58889849|FG000|Overall Study|Adverse Event|8|||
30860519|NCT01364870|58889850|FG001|Overall Study|Adverse Event|6|||
30860520|NCT01364870|58889851|FG002|Overall Study|Adverse Event|4|||
30860521|NCT01364870|58889849|FG000|Overall Study|Protocol Violation|1|||
30860522|NCT01364870|58889850|FG001|Overall Study|Protocol Violation|0|||
30860523|NCT01364870|58889851|FG002|Overall Study|Protocol Violation|0|||
30860524|NCT02268526|58889862|FG000|Overall Study|Adverse Event|0|||
30860525|NCT02268526|58889863|FG001|Overall Study|Adverse Event|2|||
30860526|NCT02268526|58889864|FG002|Overall Study|Adverse Event|1|||
30860527|NCT02268526|58889862|FG000|Overall Study|Death|1|||
30959509|NCT01561313|59024971|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
30959510|NCT01561079|59024977|FG000|Overall Study|Physician Decision|17|||
30689828|NCT00573430|58703883|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
30689829|NCT00711516|58703893|FG000|Overall Study|Adverse Event|1|||
30689830|NCT00711516|58703894|FG001|Overall Study|Adverse Event|1|||
30689831|NCT00711516|58703893|FG000|Overall Study|Withdrawal by Subject|0|||
30689832|NCT00711516|58703894|FG001|Overall Study|Withdrawal by Subject|1|||
30689833|NCT00711516|58703893|FG000|Overall Study|Protocol Violation|0|||
30860528|NCT02268526|58889863|FG001|Overall Study|Death|11|||
30959511|NCT01561079|59024977|FG000|Overall Study|Withdrawal by Subject|59|||
30959512|NCT01561079|59024977|FG000|Overall Study|Protocol Violation|2|||
30959513|NCT01559675|59025022|FG000|Overall Study|Protocol Violation|1|||
30599918|NCT01291173|58611648|FG003|Overall Study|Subject was unblinded|0|||
30599919|NCT01291173|58611645|FG000|Overall Study|Excluded therapy|0|||
30599920|NCT01291173|58611646|FG001|Overall Study|Excluded therapy|0|||
30599921|NCT01291173|58611647|FG002|Overall Study|Excluded therapy|1|||
30599922|NCT01291173|58611648|FG003|Overall Study|Excluded therapy|0|||
30599923|NCT01291017|58611658|FG000|Overall Study|Lost to Follow-up|2|||
30599924|NCT01291017|58611658|FG000|Overall Study|Withdrawal by Subject|3|||
30599925|NCT01290315|58611666|FG000|Overall Study|Adverse Event|0|||
30599926|NCT01290315|58611667|FG001|Overall Study|Adverse Event|0|||
30599927|NCT01290315|58611668|FG002|Overall Study|Adverse Event|0|||
30599928|NCT01290315|58611669|FG003|Overall Study|Adverse Event|3|||
30689834|NCT00711516|58703894|FG001|Overall Study|Protocol Violation|1|||
30689835|NCT00615550|58703902|FG000|Overall Study|Lost to Follow-up|6|||
30689836|NCT00615550|58703903|FG001|Overall Study|Lost to Follow-up|1|||
30860529|NCT02268526|58889864|FG002|Overall Study|Death|0|||
30860530|NCT02268526|58889862|FG000|Overall Study|protocol deviation|0|||
30860531|NCT02268526|58889863|FG001|Overall Study|protocol deviation|1|||
30860532|NCT02268526|58889864|FG002|Overall Study|protocol deviation|0|||
30860533|NCT02268526|58889862|FG000|Overall Study|Physician Decision|0|||
30860534|NCT02268526|58889863|FG001|Overall Study|Physician Decision|0|||
30860535|NCT02268526|58889864|FG002|Overall Study|Physician Decision|1|||
30959514|NCT01559675|59025023|FG001|Overall Study|Protocol Violation|2|||
30860536|NCT02268526|58889862|FG000|Overall Study|Subject/guardian decision|0|||
30860537|NCT02268526|58889863|FG001|Overall Study|Subject/guardian decision|7|||
30860538|NCT02268526|58889864|FG002|Overall Study|Subject/guardian decision|3|||
30860539|NCT02268214|58889877|FG000|Overall Study|Subject no longer meets study criteria|0|||
30860540|NCT02268214|58889878|FG001|Overall Study|Subject no longer meets study criteria|2|||
30860541|NCT02268214|58889879|FG002|Overall Study|Subject no longer meets study criteria|0|||
30860542|NCT02268214|58889877|FG000|Overall Study|Pregnancy|2|||
30860543|NCT02268214|58889878|FG001|Overall Study|Pregnancy|2|||
30860544|NCT02268214|58889879|FG002|Overall Study|Pregnancy|1|||
30860545|NCT02268214|58889877|FG000|Overall Study|Lost to Follow-up|3|||
30860546|NCT02268214|58889878|FG001|Overall Study|Lost to Follow-up|3|||
30860547|NCT02268214|58889879|FG002|Overall Study|Lost to Follow-up|4|||
30860548|NCT02268214|58889877|FG000|Overall Study|Lack of Efficacy|1|||
30860549|NCT02268214|58889878|FG001|Overall Study|Lack of Efficacy|0|||
30860550|NCT02268214|58889879|FG002|Overall Study|Lack of Efficacy|2|||
30860551|NCT02268214|58889877|FG000|Overall Study|Adverse Event|11|||
30860552|NCT02268214|58889878|FG001|Overall Study|Adverse Event|14|||
30860553|NCT02268214|58889879|FG002|Overall Study|Adverse Event|9|||
30860554|NCT02268214|58889877|FG000|Overall Study|Withdrawal by Subject|4|||
30860555|NCT02268214|58889878|FG001|Overall Study|Withdrawal by Subject|5|||
30599929|NCT01290315|58611666|FG000|Overall Study|Selection criteria/compliance|2|||
30599930|NCT01290315|58611667|FG001|Overall Study|Selection criteria/compliance|1|||
30599931|NCT01290315|58611668|FG002|Overall Study|Selection criteria/compliance|0|||
30599932|NCT01290315|58611669|FG003|Overall Study|Selection criteria/compliance|2|||
30599933|NCT01290315|58611666|FG000|Overall Study|Lost to Follow-up|0|||
30599934|NCT01290315|58611667|FG001|Overall Study|Lost to Follow-up|1|||
30599935|NCT01290315|58611668|FG002|Overall Study|Lost to Follow-up|0|||
30599936|NCT01290315|58611669|FG003|Overall Study|Lost to Follow-up|0|||
30599937|NCT01290315|58611666|FG000|Overall Study|Withdrawal by Subject|1|||
30599938|NCT01290315|58611667|FG001|Overall Study|Withdrawal by Subject|1|||
30599939|NCT01290315|58611668|FG002|Overall Study|Withdrawal by Subject|0|||
30599940|NCT01290315|58611669|FG003|Overall Study|Withdrawal by Subject|0|||
30599941|NCT01289847|58611678|FG000|Overall Study|Patient could not comply with visits|1|||
30599942|NCT01079182|58611682|FG000|Overall Study|Lost to Follow-up|1634|||
30599943|NCT01079182|58611682|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
30599944|NCT01079182|58611682|FG000|Overall Study|Lack of Efficacy|514|||
30599945|NCT01079182|58611682|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
30599946|NCT01079182|58611682|FG000|Overall Study|Reasons not Evaluated|271|||
30599947|NCT01021813|58611688|FG000|DB Treatment Phase|Adverse Event|60|||
30599948|NCT01021813|58611689|FG001|DB Treatment Phase|Adverse Event|22|||
30599949|NCT01021813|58611690|FG002|DB Treatment Phase|Adverse Event|0|||
30599950|NCT01021813|58611691|FG003|DB Treatment Phase|Adverse Event|0|||
30599951|NCT01021813|58611692|FG004|DB Treatment Phase|Adverse Event|0|||
30599952|NCT01021813|58611688|FG000|DB Treatment Phase|Lack of Efficacy|44|||
30599953|NCT01021813|58611689|FG001|DB Treatment Phase|Lack of Efficacy|28|||
30599954|NCT01021813|58611690|FG002|DB Treatment Phase|Lack of Efficacy|0|||
30599955|NCT01021813|58611691|FG003|DB Treatment Phase|Lack of Efficacy|0|||
30599956|NCT01021813|58611692|FG004|DB Treatment Phase|Lack of Efficacy|0|||
30599957|NCT01021813|58611688|FG000|DB Treatment Phase|Lost to Follow-up|14|||
30599958|NCT01021813|58611689|FG001|DB Treatment Phase|Lost to Follow-up|12|||
30860556|NCT02268214|58889879|FG002|Overall Study|Withdrawal by Subject|10|||
30860557|NCT02268214|58889877|FG000|Overall Study|Subject request to discontinue treatment|10|||
30860558|NCT02268214|58889878|FG001|Overall Study|Subject request to discontinue treatment|8|||
30860559|NCT02268214|58889879|FG002|Overall Study|Subject request to discontinue treatment|6|||
30860560|NCT02268214|58889877|FG000|Overall Study|Poor/non-compliance|2|||
30860561|NCT02268214|58889878|FG001|Overall Study|Poor/non-compliance|1|||
30860562|NCT02268214|58889879|FG002|Overall Study|Poor/non-compliance|2|||
30860563|NCT02268214|58889877|FG000|Overall Study|Other reasons|7|||
30860564|NCT02268214|58889878|FG001|Overall Study|Other reasons|3|||
30860565|NCT02268214|58889879|FG002|Overall Study|Other reasons|3|||
30860566|NCT02268214|58889877|FG000|Overall Study|Not entering long-term period|2|||
30860567|NCT02268214|58889878|FG001|Overall Study|Not entering long-term period|3|||
30860568|NCT02268214|58889879|FG002|Overall Study|Not entering long-term period|5|||
30599959|NCT01021813|58611690|FG002|DB Treatment Phase|Lost to Follow-up|0|||
30599960|NCT01021813|58611691|FG003|DB Treatment Phase|Lost to Follow-up|0|||
30599961|NCT01021813|58611692|FG004|DB Treatment Phase|Lost to Follow-up|0|||
30599962|NCT01021813|58611688|FG000|DB Treatment Phase|Physician Decision|17|||
30959515|NCT01559675|59025022|FG000|Overall Study|2nd operation on same patient excluded|14|||
30599963|NCT01021813|58611689|FG001|DB Treatment Phase|Physician Decision|8|||
30599964|NCT01021813|58611690|FG002|DB Treatment Phase|Physician Decision|0|||
30860569|NCT02521376|58889891|FG000|Overall Study|Enrolled, But Not Treated|1|||
30860570|NCT02521376|58889892|FG001|Overall Study|Enrolled, But Not Treated|0|||
30860571|NCT02521376|58889893|FG002|Overall Study|Enrolled, But Not Treated|0|||
30860572|NCT02521376|58889894|FG003|Overall Study|Enrolled, But Not Treated|0|||
30860573|NCT02268058|58889916|FG000|Overall Study|Protocol Violation|1|||
30860574|NCT02268058|58889917|FG001|Overall Study|Protocol Violation|0|||
30689837|NCT00186888|58703912|FG000|Overall Study|Toxicity|0|||
30689838|NCT00186888|58703913|FG001|Overall Study|Toxicity|1|||
30689839|NCT00186888|58703914|FG002|Overall Study|Toxicity|0|||
30689840|NCT00186888|58703912|FG000|Overall Study|Relapse or progression of disease|4|||
30689841|NCT00186888|58703913|FG001|Overall Study|Relapse or progression of disease|2|||
30689842|NCT00186888|58703914|FG002|Overall Study|Relapse or progression of disease|0|||
30689843|NCT00577382|58703951|FG000|Overall Study|Adverse Event|0|||
30689844|NCT00577382|58703952|FG001|Overall Study|Adverse Event|6|||
30689845|NCT00577382|58703951|FG000|Overall Study|Withdrawal by Subject|0|||
30860575|NCT02268058|58889918|FG002|Overall Study|Protocol Violation|0|||
30860576|NCT02268058|58889919|FG003|Overall Study|Protocol Violation|0|||
30860577|NCT02267824|58889931|FG000|Overall Study|Pregnancy|1|||
30860578|NCT02267824|58889932|FG001|Overall Study|Pregnancy|1|||
30860579|NCT02267824|58889931|FG000|Overall Study|Lost to Follow-up|4|||
30860580|NCT02267824|58889932|FG001|Overall Study|Lost to Follow-up|0|||
30860581|NCT02267824|58889931|FG000|Overall Study|Protocol Violation|3|||
30860582|NCT02267824|58889932|FG001|Overall Study|Protocol Violation|0|||
30860583|NCT02267824|58889931|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
30860584|NCT02267824|58889932|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
30860585|NCT02267746|58889941|FG000|Overall Study|Adverse Event|0|||
30860586|NCT02267746|58889942|FG001|Overall Study|Adverse Event|2|||
30860587|NCT02267746|58889943|FG002|Overall Study|Adverse Event|1|||
30860588|NCT02267746|58889941|FG000|Overall Study|Protocol Violation|8|||
30860589|NCT02267746|58889942|FG001|Overall Study|Protocol Violation|7|||
30860590|NCT02267746|58889943|FG002|Overall Study|Protocol Violation|3|||
30860591|NCT02267746|58889941|FG000|Overall Study|Lack of Efficacy|11|||
30860592|NCT02267746|58889942|FG001|Overall Study|Lack of Efficacy|11|||
30860593|NCT02267746|58889943|FG002|Overall Study|Lack of Efficacy|15|||
30860594|NCT02267746|58889941|FG000|Overall Study|Protocol Violation|1|||
30860595|NCT02267746|58889942|FG001|Overall Study|Protocol Violation|2|||
30860596|NCT02267746|58889943|FG002|Overall Study|Protocol Violation|1|||
30860597|NCT02267746|58889941|FG000|Overall Study|Miscellaneous|1|||
30860598|NCT02267746|58889942|FG001|Overall Study|Miscellaneous|0|||
30860599|NCT02267746|58889943|FG002|Overall Study|Miscellaneous|1|||
30860600|NCT02362360|58889953|FG000|Period 1|Lack of Efficacy|1|||
30860601|NCT02362360|58889954|FG001|Period 1|Lack of Efficacy|0|||
30860602|NCT02362360|58889953|FG000|Period 1|Withdrawal by Subject|2|||
30860603|NCT02362360|58889954|FG001|Period 1|Withdrawal by Subject|1|||
30860604|NCT02362282|58889962|FG000|Overall Study|Withdrawal by Subject|1|||
30860605|NCT02362282|58889963|FG001|Overall Study|Withdrawal by Subject|0|||
30860606|NCT02361580|58889971|FG000|Overall Study|Lost to Follow-up|6|||
30860607|NCT02361580|58889972|FG001|Overall Study|Lost to Follow-up|3|||
30860608|NCT02520284|58889981|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
30860609|NCT02520284|58889982|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
30860610|NCT02520284|58889983|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
30860611|NCT02520284|58889981|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
30860612|NCT02520284|58889982|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
30860613|NCT02520284|58889983|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
30860614|NCT02520284|58889981|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
30860615|NCT02520284|58889982|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
30860616|NCT02520284|58889983|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
30860617|NCT02520284|58889981|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
30860618|NCT02520284|58889982|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
30860619|NCT02520284|58889983|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
30860620|NCT02520284|58889981|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
30860621|NCT02520284|58889982|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
30860622|NCT02520284|58889983|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
30860623|NCT02520284|58889981|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
30860624|NCT02520284|58889982|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
30860625|NCT02520284|58889983|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
30860626|NCT02520284|58889981|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
30860627|NCT02520284|58889982|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
30860628|NCT02520284|58889983|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
30860629|NCT02520284|58889981|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
30860630|NCT02520284|58889982|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
30860631|NCT02520284|58889983|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
30860632|NCT02520284|58889981|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
30860633|NCT02520284|58889982|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
30860634|NCT02520284|58889983|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
30689846|NCT00577382|58703952|FG001|Overall Study|Withdrawal by Subject|1|||
30689847|NCT00577382|58703951|FG000|Overall Study|Progressive Disease|17|||
30689848|NCT00577382|58703952|FG001|Overall Study|Progressive Disease|19|||
30599965|NCT01021813|58611691|FG003|DB Treatment Phase|Physician Decision|0|||
30599966|NCT01021813|58611692|FG004|DB Treatment Phase|Physician Decision|0|||
30599967|NCT01021813|58611688|FG000|DB Treatment Phase|Pregnancy|1|||
30599968|NCT01021813|58611689|FG001|DB Treatment Phase|Pregnancy|0|||
30599969|NCT01021813|58611690|FG002|DB Treatment Phase|Pregnancy|0|||
30599970|NCT01021813|58611691|FG003|DB Treatment Phase|Pregnancy|0|||
30599971|NCT01021813|58611692|FG004|DB Treatment Phase|Pregnancy|0|||
30599972|NCT01021813|58611688|FG000|DB Treatment Phase|Protocol Violation|4|||
30599973|NCT01021813|58611689|FG001|DB Treatment Phase|Protocol Violation|3|||
30599974|NCT01021813|58611690|FG002|DB Treatment Phase|Protocol Violation|0|||
30599975|NCT01021813|58611691|FG003|DB Treatment Phase|Protocol Violation|0|||
30599976|NCT01021813|58611692|FG004|DB Treatment Phase|Protocol Violation|0|||
30599977|NCT01021813|58611688|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
30599978|NCT01021813|58611689|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
30599979|NCT01021813|58611690|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
30599980|NCT01021813|58611691|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
30599981|NCT01021813|58611692|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
30599982|NCT01021813|58611688|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
30599983|NCT01021813|58611689|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
30599984|NCT01021813|58611690|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
30599985|NCT01021813|58611691|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
30599986|NCT01021813|58611692|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
30599987|NCT01021813|58611688|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
30599988|NCT01021813|58611689|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
30599989|NCT01021813|58611690|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
30599990|NCT01021813|58611691|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
30599991|NCT01021813|58611692|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
30599992|NCT01021813|58611688|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
30599993|NCT01021813|58611689|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
30599994|NCT01021813|58611690|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
30599995|NCT01021813|58611691|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
30599996|NCT01021813|58611692|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
30599997|NCT01021813|58611688|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
30599998|NCT01021813|58611689|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
30599999|NCT01021813|58611690|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
30600000|NCT01021813|58611691|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
30600001|NCT01021813|58611692|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
30600002|NCT01021813|58611688|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
30600003|NCT01021813|58611689|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
30600004|NCT01021813|58611690|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
30600005|NCT01021813|58611691|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
30600006|NCT01021813|58611692|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
30600007|NCT01025635|58611711|FG000|Overall Study|Withdrawal by Subject|6|||
30600008|NCT01025635|58611712|FG001|Overall Study|Withdrawal by Subject|7|||
30600009|NCT01025635|58611711|FG000|Overall Study|Protocol Violation|4|||
30600010|NCT01025635|58611712|FG001|Overall Study|Protocol Violation|2|||
30600011|NCT01025635|58611711|FG000|Overall Study|Lack of Efficacy|0|||
30600012|NCT01025635|58611712|FG001|Overall Study|Lack of Efficacy|1|||
30600013|NCT01025635|58611711|FG000|Overall Study|Lost to Follow-up|9|||
30600014|NCT01025635|58611712|FG001|Overall Study|Lost to Follow-up|13|||
30600015|NCT01025635|58611711|FG000|Overall Study|Reason not known|4|||
30600016|NCT01025635|58611712|FG001|Overall Study|Reason not known|2|||
30600017|NCT01021423|58611720|FG000|Overall Study|Study terminated|4|||
30600018|NCT01021423|58611721|FG001|Overall Study|Study terminated|5|||
30600019|NCT01020877|58611729|FG000|Second Intervention|Withdrawal by Subject|1|||
30600020|NCT01020877|58611730|FG001|Second Intervention|Withdrawal by Subject|0|||
30600021|NCT01020799|58611739|FG000|Overall Study|Adverse Event|4|||
30600022|NCT01020799|58611740|FG001|Overall Study|Adverse Event|3|||
30600023|NCT01020799|58611741|FG002|Overall Study|Adverse Event|2|||
30600024|NCT01020799|58611739|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
30600025|NCT01020799|58611740|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
30600026|NCT01020799|58611741|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
30600027|NCT01020799|58611739|FG000|Overall Study|Protocol Violation|3|||
30860635|NCT02520284|58889981|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
30600028|NCT01020799|58611740|FG001|Overall Study|Protocol Violation|2|||
30860636|NCT02520284|58889982|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
30860637|NCT02520284|58889983|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
30860638|NCT02520284|58889981|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
30860639|NCT02520284|58889982|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
30860640|NCT02520284|58889983|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
30860641|NCT02517866|58889997|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
30860642|NCT02517866|58889998|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
30860643|NCT02517866|58889999|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
30860644|NCT02517866|58889997|FG000|Overall Study|Significant Protocol Deviation|4|||
30860645|NCT02517866|58889998|FG001|Overall Study|Significant Protocol Deviation|1|||
30860646|NCT02517866|58889999|FG002|Overall Study|Significant Protocol Deviation|0|||
30860647|NCT02517866|58889997|FG000|Overall Study|Lost to Follow-up|1|||
30860648|NCT02517866|58889998|FG001|Overall Study|Lost to Follow-up|0|||
30860649|NCT02517866|58889999|FG002|Overall Study|Lost to Follow-up|0|||
30860650|NCT02517866|58889997|FG000|Overall Study|Voluntary Withdrawal|2|||
30860651|NCT02517866|58889998|FG001|Overall Study|Voluntary Withdrawal|2|||
30860652|NCT02517866|58889999|FG002|Overall Study|Voluntary Withdrawal|0|||
30860653|NCT02517866|58889997|FG000|Overall Study|Investigator Decision|2|||
30860654|NCT02517866|58889998|FG001|Overall Study|Investigator Decision|1|||
30860655|NCT02517866|58889999|FG002|Overall Study|Investigator Decision|0|||
30860656|NCT02517866|58889997|FG000|Overall Study|Reason not specified|2|||
30860657|NCT02517866|58889998|FG001|Overall Study|Reason not specified|0|||
30860658|NCT02517866|58889999|FG002|Overall Study|Reason not specified|0|||
30860659|NCT02515994|58890011|FG000|Overall Study|Protocol Violation|3|||
30860660|NCT02515994|58890012|FG001|Overall Study|Protocol Violation|5|||
30860661|NCT02515994|58890011|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
30860662|NCT02515994|58890012|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
30860663|NCT02515994|58890011|FG000|Overall Study|Adverse Event|3|||
30860664|NCT02515994|58890012|FG001|Overall Study|Adverse Event|1|||
30860665|NCT02515994|58890011|FG000|Overall Study|Withdrawal by Subject|2|||
30860666|NCT02515994|58890012|FG001|Overall Study|Withdrawal by Subject|0|||
30860667|NCT02516306|58890020|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
30860668|NCT02516306|58890021|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
30860669|NCT02516228|58890027|FG000|Overall Study|Lost to Follow-up|1|||
30689849|NCT00577382|58703951|FG000|Overall Study|Intercurrent Illness|1|||
30689850|NCT00577382|58703952|FG001|Overall Study|Intercurrent Illness|2|||
30689851|NCT00577382|58703951|FG000|Overall Study|Death|1|||
30689852|NCT00577382|58703952|FG001|Overall Study|Death|1|||
30689853|NCT00577382|58703951|FG000|Overall Study|Lost to Follow-up|2|||
30689854|NCT00577382|58703952|FG001|Overall Study|Lost to Follow-up|2|||
30689855|NCT00614926|58703960|FG000|Overall Study|Burden of travel|1|||
30689856|NCT00614926|58703961|FG001|Overall Study|Burden of travel|0|||
30689857|NCT00614926|58703960|FG000|Overall Study|Adverse Event|3|||
30689858|NCT00614926|58703961|FG001|Overall Study|Adverse Event|0|||
30689859|NCT00423319|58703969|FG000|Overall Study|Death|2|||
30689860|NCT00423319|58703970|FG001|Overall Study|Death|0|||
30689861|NCT00423319|58703969|FG000|Overall Study|Adverse Event|93|||
30689862|NCT00423319|58703970|FG001|Overall Study|Adverse Event|112|||
30689863|NCT00423319|58703969|FG000|Overall Study|Withdrawal by Subject|86|||
30689864|NCT00423319|58703970|FG001|Overall Study|Withdrawal by Subject|99|||
30689865|NCT00423319|58703969|FG000|Overall Study|Lost to Follow-up|4|||
30689866|NCT00423319|58703970|FG001|Overall Study|Lost to Follow-up|3|||
30689867|NCT00423319|58703969|FG000|Overall Study|Poor compliance or noncompliance|1|||
30689868|NCT00423319|58703970|FG001|Overall Study|Poor compliance or noncompliance|1|||
30689869|NCT00423319|58703969|FG000|Overall Study|No longer meets study criteria|15|||
30689870|NCT00423319|58703970|FG001|Overall Study|No longer meets study criteria|15|||
30689871|NCT00423319|58703969|FG000|Overall Study|Other|23|||
30689872|NCT00423319|58703970|FG001|Overall Study|Other|22|||
30689873|NCT00710684|58703980|FG000|Overall Study|Adverse Event|11|||
30860670|NCT02516228|58890027|FG000|Overall Study|Withdrawal by Subject|1|||
30860671|NCT02516228|58890027|FG000|Overall Study|Physician Decision|1|||
30860672|NCT02519504|58890033|FG000|Overall Study|Protocol Violation|6|||
30860673|NCT02519504|58890034|FG001|Overall Study|Protocol Violation|5|||
30860674|NCT02519504|58890033|FG000|Overall Study|Ineligible for direct testing|12|||
30860675|NCT02519504|58890034|FG001|Overall Study|Ineligible for direct testing|12|||
30860676|NCT02519504|58890033|FG000|Overall Study|Did not participate in direct testing|95|||
30860677|NCT02519504|58890034|FG001|Overall Study|Did not participate in direct testing|86|||
30860678|NCT02514824|58890042|FG000|Overall Study|Withdrawal by Subject|1|||
30860679|NCT02514824|58890043|FG001|Overall Study|Withdrawal by Subject|0|||
30860680|NCT02514824|58890044|FG002|Overall Study|Withdrawal by Subject|0|||
30860681|NCT02514824|58890045|FG003|Overall Study|Withdrawal by Subject|0|||
30860682|NCT02514824|58890042|FG000|Overall Study|Dose-Limiting Toxicity|0|||
30860683|NCT02514824|58890043|FG001|Overall Study|Dose-Limiting Toxicity|1|||
30860684|NCT02514824|58890044|FG002|Overall Study|Dose-Limiting Toxicity|0|||
30860685|NCT02514824|58890045|FG003|Overall Study|Dose-Limiting Toxicity|0|||
30860686|NCT02514746|58890054|FG000|Overall Study|Chronically Ill|1|||
30860687|NCT02514746|58890055|FG001|Overall Study|Chronically Ill|2|||
30860688|NCT02514746|58890054|FG000|Overall Study|Physician Decision|4|||
30860689|NCT02514746|58890055|FG001|Overall Study|Physician Decision|2|||
30860690|NCT02514746|58890054|FG000|Overall Study|Withdrawal by Subject|12|||
30860691|NCT02514746|58890055|FG001|Overall Study|Withdrawal by Subject|10|||
30860692|NCT02514746|58890054|FG000|Overall Study|Other|5|||
30860693|NCT02514746|58890055|FG001|Overall Study|Other|1|||
30860694|NCT02483078|58890065|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
30860695|NCT02483078|58890066|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
30860696|NCT02483078|58890065|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
30860697|NCT02483078|58890066|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
30860698|NCT02483078|58890065|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
30860699|NCT02483078|58890066|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
30860700|NCT02483078|58890065|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
30860701|NCT02483078|58890066|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
30860702|NCT02483078|58890065|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
30860703|NCT02483078|58890066|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
30860704|NCT02483078|58890065|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
30860705|NCT02483078|58890066|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
30860706|NCT02452190|58890080|FG000|Overall Study|Withdrawal by Sponsor|1|||
30860707|NCT02452190|58890081|FG001|Overall Study|Withdrawal by Sponsor|3|||
30860708|NCT02452190|58890080|FG000|Overall Study|Pregnancy|1|||
30860709|NCT02452190|58890081|FG001|Overall Study|Pregnancy|0|||
30860710|NCT02452190|58890080|FG000|Overall Study|Investigator's Decision|2|||
30860711|NCT02452190|58890081|FG001|Overall Study|Investigator's Decision|0|||
30860712|NCT02452190|58890080|FG000|Overall Study|Lack of Efficacy|3|||
30860713|NCT02452190|58890081|FG001|Overall Study|Lack of Efficacy|1|||
30860714|NCT02452190|58890080|FG000|Overall Study|Lost to Follow-up|4|||
30860715|NCT02452190|58890081|FG001|Overall Study|Lost to Follow-up|3|||
30860716|NCT02452190|58890080|FG000|Overall Study|Adverse Event|2|||
30860717|NCT02452190|58890081|FG001|Overall Study|Adverse Event|5|||
30860718|NCT02452190|58890080|FG000|Overall Study|Withdrawal by Subject|20|||
30860719|NCT02452190|58890081|FG001|Overall Study|Withdrawal by Subject|11|||
30860720|NCT02452190|58890080|FG000|Overall Study|Noncompliance with study drug|1|||
30860721|NCT02452190|58890081|FG001|Overall Study|Noncompliance with study drug|0|||
30860722|NCT02452190|58890080|FG000|Overall Study|Participant traveled abroad|1|||
30860723|NCT02452190|58890081|FG001|Overall Study|Participant traveled abroad|0|||
30860724|NCT02452190|58890080|FG000|Overall Study|Death|0|||
30860725|NCT02452190|58890081|FG001|Overall Study|Death|1|||
30860726|NCT02514122|58890089|FG000|Overall Study|Withdrawal by Subject|2|||
30860727|NCT02514122|58890090|FG001|Overall Study|Withdrawal by Subject|0|||
30860728|NCT00730639|58890101|FG000|Overall Study|Adverse Event|3|||
30860729|NCT00730639|58890102|FG001|Overall Study|Adverse Event|0|||
30860730|NCT00730639|58890103|FG002|Overall Study|Adverse Event|9|||
30860731|NCT00730639|58890104|FG003|Overall Study|Adverse Event|8|||
30860732|NCT00730639|58890105|FG004|Overall Study|Adverse Event|23|||
30860733|NCT00730639|58890101|FG000|Overall Study|Complete Response|0|||
30860734|NCT00730639|58890102|FG001|Overall Study|Complete Response|0|||
30860735|NCT00730639|58890103|FG002|Overall Study|Complete Response|2|||
30860736|NCT00730639|58890104|FG003|Overall Study|Complete Response|2|||
30860737|NCT00730639|58890105|FG004|Overall Study|Complete Response|1|||
30860738|NCT00730639|58890101|FG000|Overall Study|Completed Maximum Cycles|0|||
30860739|NCT00730639|58890102|FG001|Overall Study|Completed Maximum Cycles|0|||
30860740|NCT00730639|58890103|FG002|Overall Study|Completed Maximum Cycles|11|||
30860741|NCT00730639|58890104|FG003|Overall Study|Completed Maximum Cycles|3|||
30860742|NCT00730639|58890105|FG004|Overall Study|Completed Maximum Cycles|6|||
30860743|NCT00730639|58890101|FG000|Overall Study|Death|0|||
30860744|NCT00730639|58890102|FG001|Overall Study|Death|0|||
30959516|NCT01559675|59025023|FG001|Overall Study|2nd operation on same patient excluded|12|||
30959517|NCT01374906|59025031|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30959518|NCT01374906|59025032|FG001|Overall Study|Abnormal laboratory value(s)|3|||
30959519|NCT01374906|59025031|FG000|Overall Study|Administrative problems|2|||
30959520|NCT01374906|59025032|FG001|Overall Study|Administrative problems|2|||
30959521|NCT01374906|59025031|FG000|Overall Study|Adverse Event|10|||
30959522|NCT01374906|59025032|FG001|Overall Study|Adverse Event|11|||
30959523|NCT01374906|59025031|FG000|Overall Study|Death|0|||
30959524|NCT01374906|59025032|FG001|Overall Study|Death|2|||
30600029|NCT01020799|58611741|FG002|Overall Study|Protocol Violation|0|||
30600030|NCT01020799|58611739|FG000|Overall Study|Withdrawal by Subject|2|||
30600031|NCT01020799|58611740|FG001|Overall Study|Withdrawal by Subject|2|||
30600032|NCT01020799|58611741|FG002|Overall Study|Withdrawal by Subject|3|||
30959525|NCT01374906|59025031|FG000|Overall Study|Protocol Violation|2|||
30959526|NCT01374906|59025032|FG001|Overall Study|Protocol Violation|2|||
30959527|NCT01374906|59025031|FG000|Overall Study|Withdrawal by Subject|15|||
30959528|NCT01374906|59025032|FG001|Overall Study|Withdrawal by Subject|9|||
30959529|NCT01374906|59025031|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
30959530|NCT01374906|59025032|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
30959531|NCT02683746|59025062|FG000|Overall Study|Adverse Event|3|||
30959532|NCT02683746|59025063|FG001|Overall Study|Adverse Event|2|||
30860745|NCT00730639|58890103|FG002|Overall Study|Death|0|||
30959533|NCT02683746|59025062|FG000|Overall Study|Lost to Follow-up|5|||
30959534|NCT02683746|59025063|FG001|Overall Study|Lost to Follow-up|6|||
30959535|NCT02683746|59025062|FG000|Overall Study|Withdrawal by Subject|6|||
30860746|NCT00730639|58890104|FG003|Overall Study|Death|0|||
30860747|NCT00730639|58890105|FG004|Overall Study|Death|2|||
30860748|NCT00730639|58890101|FG000|Overall Study|Disease Progression|12|||
30860749|NCT00730639|58890102|FG001|Overall Study|Disease Progression|13|||
30860750|NCT00730639|58890103|FG002|Overall Study|Disease Progression|48|||
30860751|NCT00730639|58890104|FG003|Overall Study|Disease Progression|32|||
30860752|NCT00730639|58890105|FG004|Overall Study|Disease Progression|88|||
30860753|NCT00730639|58890101|FG000|Overall Study|non-specified|0|||
30860754|NCT00730639|58890102|FG001|Overall Study|non-specified|0|||
30860755|NCT00730639|58890103|FG002|Overall Study|non-specified|4|||
30860756|NCT00730639|58890104|FG003|Overall Study|non-specified|2|||
30860757|NCT00730639|58890105|FG004|Overall Study|non-specified|3|||
30860758|NCT00730639|58890101|FG000|Overall Study|Protocol Violation|0|||
30860759|NCT00730639|58890102|FG001|Overall Study|Protocol Violation|0|||
30860760|NCT00730639|58890103|FG002|Overall Study|Protocol Violation|1|||
30860761|NCT00730639|58890104|FG003|Overall Study|Protocol Violation|0|||
30860762|NCT00730639|58890105|FG004|Overall Study|Protocol Violation|0|||
30860763|NCT00730639|58890101|FG000|Overall Study|Withdrawal by Subject|0|||
30860764|NCT00730639|58890102|FG001|Overall Study|Withdrawal by Subject|0|||
30860765|NCT00730639|58890103|FG002|Overall Study|Withdrawal by Subject|6|||
30860766|NCT00730639|58890104|FG003|Overall Study|Withdrawal by Subject|3|||
30860767|NCT00730639|58890105|FG004|Overall Study|Withdrawal by Subject|4|||
30860768|NCT00730639|58890101|FG000|Overall Study|Treatment on-going|2|||
30860769|NCT00730639|58890102|FG001|Overall Study|Treatment on-going|5|||
30860770|NCT00730639|58890103|FG002|Overall Study|Treatment on-going|5|||
30860771|NCT00730639|58890104|FG003|Overall Study|Treatment on-going|4|||
30860772|NCT00730639|58890105|FG004|Overall Study|Treatment on-going|4|||
30860773|NCT02536339|58890128|FG000|Overall Study|Death|20|||
30860774|NCT02536339|58890128|FG000|Overall Study|Withdrawal by Subject|3|||
30860775|NCT02536339|58890128|FG000|Overall Study|Lost to Follow-up|2|||
30860776|NCT02536339|58890128|FG000|Overall Study|Treatment discontinued|2|||
30860777|NCT02536339|58890128|FG000|Overall Study|Physician Decision|1|||
30860778|NCT02743871|58890162|FG000|Overall Study|Lost to Follow-up|0|||
30860779|NCT02743871|58890163|FG001|Overall Study|Lost to Follow-up|0|||
30860780|NCT02743871|58890164|FG002|Overall Study|Lost to Follow-up|0|||
30860781|NCT02743871|58890165|FG003|Overall Study|Lost to Follow-up|1|||
30860782|NCT02743871|58890166|FG004|Overall Study|Lost to Follow-up|0|||
30860783|NCT02743871|58890167|FG005|Overall Study|Lost to Follow-up|0|||
30860784|NCT02743871|58890168|FG006|Overall Study|Lost to Follow-up|1|||
30860785|NCT02743871|58890169|FG007|Overall Study|Lost to Follow-up|0|||
30860786|NCT02743871|58890170|FG008|Overall Study|Lost to Follow-up|0|||
30860787|NCT02743871|58890171|FG009|Overall Study|Lost to Follow-up|0|||
30860788|NCT02743871|58890172|FG010|Overall Study|Lost to Follow-up|0|||
30860789|NCT02743871|58890173|FG011|Overall Study|Lost to Follow-up|2|||
30860790|NCT02743871|58890174|FG012|Overall Study|Lost to Follow-up|0|||
30860791|NCT02743871|58890175|FG013|Overall Study|Lost to Follow-up|0|||
30860792|NCT02743871|58890162|FG000|Overall Study|Withdrawal by Subject|0|||
30860793|NCT02743871|58890163|FG001|Overall Study|Withdrawal by Subject|0|||
30860794|NCT02743871|58890164|FG002|Overall Study|Withdrawal by Subject|0|||
30860795|NCT02743871|58890165|FG003|Overall Study|Withdrawal by Subject|0|||
30860796|NCT02743871|58890166|FG004|Overall Study|Withdrawal by Subject|0|||
30860797|NCT02743871|58890167|FG005|Overall Study|Withdrawal by Subject|0|||
30860798|NCT02743871|58890168|FG006|Overall Study|Withdrawal by Subject|0|||
30860799|NCT02743871|58890169|FG007|Overall Study|Withdrawal by Subject|0|||
30860800|NCT02743871|58890170|FG008|Overall Study|Withdrawal by Subject|0|||
30860801|NCT02743871|58890171|FG009|Overall Study|Withdrawal by Subject|0|||
30860802|NCT02743871|58890172|FG010|Overall Study|Withdrawal by Subject|1|||
30860803|NCT02743871|58890173|FG011|Overall Study|Withdrawal by Subject|0|||
30860804|NCT02743871|58890174|FG012|Overall Study|Withdrawal by Subject|12|||
30860805|NCT02743871|58890175|FG013|Overall Study|Withdrawal by Subject|6|||
30860806|NCT02743871|58890162|FG000|Overall Study|Adverse Event|1|||
30860807|NCT02743871|58890163|FG001|Overall Study|Adverse Event|0|||
30860808|NCT02743871|58890164|FG002|Overall Study|Adverse Event|0|||
30959536|NCT02683746|59025063|FG001|Overall Study|Withdrawal by Subject|5|||
30959537|NCT02683746|59025062|FG000|Overall Study|Physician Decision|2|||
30860809|NCT02743871|58890165|FG003|Overall Study|Adverse Event|0|||
30860810|NCT02743871|58890166|FG004|Overall Study|Adverse Event|0|||
30860811|NCT02743871|58890167|FG005|Overall Study|Adverse Event|0|||
30860812|NCT02743871|58890168|FG006|Overall Study|Adverse Event|0|||
30860813|NCT02743871|58890169|FG007|Overall Study|Adverse Event|0|||
30860814|NCT02743871|58890170|FG008|Overall Study|Adverse Event|0|||
30860815|NCT02743871|58890171|FG009|Overall Study|Adverse Event|0|||
30860816|NCT02743871|58890172|FG010|Overall Study|Adverse Event|0|||
30860817|NCT02743871|58890173|FG011|Overall Study|Adverse Event|0|||
30860818|NCT02743871|58890174|FG012|Overall Study|Adverse Event|0|||
30860819|NCT02743871|58890175|FG013|Overall Study|Adverse Event|0|||
30860820|NCT02743871|58890162|FG000|Overall Study|Other|0|||
30860821|NCT02743871|58890163|FG001|Overall Study|Other|0|||
30860822|NCT02743871|58890164|FG002|Overall Study|Other|0|||
30860823|NCT02743871|58890165|FG003|Overall Study|Other|0|||
30860824|NCT02743871|58890166|FG004|Overall Study|Other|0|||
30860825|NCT02743871|58890167|FG005|Overall Study|Other|0|||
30860826|NCT02743871|58890168|FG006|Overall Study|Other|0|||
30860827|NCT02743871|58890169|FG007|Overall Study|Other|0|||
30860828|NCT02743871|58890170|FG008|Overall Study|Other|0|||
30860829|NCT02743871|58890171|FG009|Overall Study|Other|0|||
30860830|NCT02743871|58890172|FG010|Overall Study|Other|0|||
30860831|NCT02743871|58890173|FG011|Overall Study|Other|1|||
30860832|NCT02743871|58890174|FG012|Overall Study|Other|1|||
30860833|NCT02743871|58890175|FG013|Overall Study|Other|1|||
30860834|NCT02743871|58890162|FG000|Overall Study|Protocol Violation|0|||
30860835|NCT02743871|58890163|FG001|Overall Study|Protocol Violation|0|||
30860836|NCT02743871|58890164|FG002|Overall Study|Protocol Violation|0|||
30860837|NCT02743871|58890165|FG003|Overall Study|Protocol Violation|0|||
30860838|NCT02743871|58890166|FG004|Overall Study|Protocol Violation|0|||
30860839|NCT02743871|58890167|FG005|Overall Study|Protocol Violation|0|||
30860840|NCT02743871|58890168|FG006|Overall Study|Protocol Violation|0|||
30860841|NCT02743871|58890169|FG007|Overall Study|Protocol Violation|0|||
30860842|NCT02743871|58890170|FG008|Overall Study|Protocol Violation|0|||
30860843|NCT02743871|58890171|FG009|Overall Study|Protocol Violation|0|||
30860844|NCT02743871|58890172|FG010|Overall Study|Protocol Violation|0|||
30860845|NCT02743871|58890173|FG011|Overall Study|Protocol Violation|0|||
30860846|NCT02743871|58890174|FG012|Overall Study|Protocol Violation|2|||
30860847|NCT02743871|58890175|FG013|Overall Study|Protocol Violation|0|||
30860848|NCT01704547|58890217|FG000|Overall Study|Physician Decision|4|||
30860849|NCT01704547|58890217|FG000|Overall Study|Withdrawal by Subject|1|||
30860850|NCT00796523|58890237|FG000|Overall Study|Lost to Follow-up|9|||
30860851|NCT00796523|58890238|FG001|Overall Study|Lost to Follow-up|7|||
30860852|NCT01352585|58890253|FG000|Overall Study|Adverse Event|2|||
30860853|NCT01352585|58890254|FG001|Overall Study|Adverse Event|1|||
30860854|NCT01352585|58890253|FG000|Overall Study|Lost to Follow-up|1|||
30860855|NCT01352585|58890254|FG001|Overall Study|Lost to Follow-up|0|||
30860856|NCT01352585|58890253|FG000|Overall Study|Other|5|||
30860857|NCT01352585|58890254|FG001|Overall Study|Other|2|||
30860858|NCT01352507|58890263|FG000|Treatment Period 1|Adverse Event|3|||
30600033|NCT01020799|58611739|FG000|Overall Study|Lost to Follow-up|6|||
30600034|NCT01020799|58611740|FG001|Overall Study|Lost to Follow-up|4|||
30600035|NCT01020799|58611741|FG002|Overall Study|Lost to Follow-up|2|||
30600036|NCT01288989|58611754|FG000|Overall Study|Death|0|||
30600037|NCT01288989|58611755|FG001|Overall Study|Death|0|||
30600038|NCT01288989|58611756|FG002|Overall Study|Death|0|||
30600039|NCT01288989|58611757|FG003|Overall Study|Death|1|||
30600040|NCT01288989|58611758|FG004|Overall Study|Death|0|||
30600041|NCT01288989|58611754|FG000|Overall Study|Dose limiting toxicity|1|||
30600042|NCT01288989|58611755|FG001|Overall Study|Dose limiting toxicity|0|||
30600043|NCT01288989|58611756|FG002|Overall Study|Dose limiting toxicity|0|||
30600044|NCT01288989|58611757|FG003|Overall Study|Dose limiting toxicity|0|||
30600045|NCT01288989|58611758|FG004|Overall Study|Dose limiting toxicity|0|||
30600046|NCT01288989|58611754|FG000|Overall Study|Adverse Event|0|||
30600047|NCT01288989|58611755|FG001|Overall Study|Adverse Event|0|||
30600048|NCT01288989|58611756|FG002|Overall Study|Adverse Event|0|||
30600049|NCT01288989|58611757|FG003|Overall Study|Adverse Event|0|||
30600050|NCT01288989|58611758|FG004|Overall Study|Adverse Event|2|||
30600051|NCT01288989|58611754|FG000|Overall Study|Physician Decision|0|||
30600052|NCT01288989|58611755|FG001|Overall Study|Physician Decision|0|||
30600053|NCT01288989|58611756|FG002|Overall Study|Physician Decision|0|||
30600054|NCT01288989|58611757|FG003|Overall Study|Physician Decision|0|||
30600055|NCT01288989|58611758|FG004|Overall Study|Physician Decision|1|||
30600056|NCT01288989|58611754|FG000|Overall Study|Withdrawal by Subject|0|||
30600057|NCT01288989|58611755|FG001|Overall Study|Withdrawal by Subject|0|||
30600058|NCT01288989|58611756|FG002|Overall Study|Withdrawal by Subject|0|||
30600059|NCT01288989|58611757|FG003|Overall Study|Withdrawal by Subject|0|||
30600060|NCT01288989|58611758|FG004|Overall Study|Withdrawal by Subject|3|||
30600061|NCT01020487|58611779|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
30600062|NCT01020487|58611780|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
30860859|NCT01352507|58890264|FG001|Treatment Period 1|Adverse Event|0|||
30860860|NCT01352507|58890263|FG000|Treatment Period 1|Lost to Follow-up|3|||
30600063|NCT01020487|58611781|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
30600064|NCT01020487|58611779|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
30600065|NCT01020487|58611780|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
30600066|NCT01020487|58611781|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
30600067|NCT01020487|58611779|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
30860861|NCT01352507|58890264|FG001|Treatment Period 1|Lost to Follow-up|4|||
30860862|NCT01352507|58890263|FG000|Treatment Period 1|Withdrawal by Subject|7|||
30600068|NCT01020487|58611780|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
30600069|NCT01020487|58611781|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
30860863|NCT01352507|58890264|FG001|Treatment Period 1|Withdrawal by Subject|5|||
30860864|NCT01352507|58890263|FG000|Treatment Period 1|Physician Decision|1|||
30860865|NCT01352507|58890264|FG001|Treatment Period 1|Physician Decision|0|||
30860866|NCT01352507|58890263|FG000|Washout Period|Withdrawal by Subject|0|||
30860867|NCT01352507|58890264|FG001|Washout Period|Withdrawal by Subject|1|||
30860868|NCT01352507|58890263|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
30860869|NCT01352507|58890264|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
30860870|NCT01352507|58890263|FG000|Treatment Period 2|Withdrawal by Subject|4|||
30860871|NCT01352507|58890264|FG001|Treatment Period 2|Withdrawal by Subject|3|||
30860872|NCT01352507|58890263|FG000|Treatment Period 2|Lack of Efficacy|1|||
30860873|NCT01352507|58890264|FG001|Treatment Period 2|Lack of Efficacy|0|||
30860874|NCT02361346|58890285|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
30860875|NCT02361346|58890286|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
30860876|NCT02361346|58890287|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
30860877|NCT02361346|58890288|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
30860878|NCT02361346|58890289|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
30860879|NCT02361346|58890290|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
30860880|NCT02361346|58890291|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
30689874|NCT00710684|58703981|FG001|Overall Study|Adverse Event|19|||
30689875|NCT00710684|58703982|FG002|Overall Study|Adverse Event|16|||
30860881|NCT02361346|58890292|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
30860882|NCT02361346|58890293|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
30860883|NCT02361346|58890285|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
30860884|NCT02361346|58890286|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
30860885|NCT02361346|58890287|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
30860886|NCT02361346|58890288|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
30860887|NCT02361346|58890289|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
30860888|NCT02361346|58890290|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
30860889|NCT02361346|58890291|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
30860890|NCT02361346|58890292|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
30860891|NCT02361346|58890293|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
30860892|NCT02361346|58890285|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
30860893|NCT02361346|58890286|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
30860894|NCT02361346|58890287|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
30860895|NCT02361346|58890288|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
30860896|NCT02361346|58890289|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
30860897|NCT02361346|58890290|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
30860898|NCT02361346|58890291|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
30860899|NCT02361346|58890292|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
30860900|NCT02361346|58890293|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
30860901|NCT02361346|58890285|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
30860902|NCT02361346|58890286|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
30860903|NCT02361346|58890287|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
30860904|NCT02361346|58890288|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
30860905|NCT02361346|58890289|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
30860906|NCT02361346|58890290|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
30860907|NCT02361346|58890291|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
30860908|NCT02361346|58890292|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
30860909|NCT02361346|58890293|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
30860910|NCT02361346|58890285|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
30860911|NCT02361346|58890286|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
30860912|NCT02361346|58890287|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
30860913|NCT02361346|58890288|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
30689876|NCT00710684|58703980|FG000|Overall Study|Lack of Efficacy|4|||
30689877|NCT00710684|58703981|FG001|Overall Study|Lack of Efficacy|3|||
30689878|NCT00710684|58703982|FG002|Overall Study|Lack of Efficacy|5|||
30689879|NCT00710684|58703980|FG000|Overall Study|Protocol Violation|5|||
30689880|NCT00710684|58703981|FG001|Overall Study|Protocol Violation|5|||
30689881|NCT00710684|58703982|FG002|Overall Study|Protocol Violation|5|||
30689882|NCT00710684|58703980|FG000|Overall Study|Lost to Follow-up|4|||
30689883|NCT00710684|58703981|FG001|Overall Study|Lost to Follow-up|6|||
30689884|NCT00710684|58703982|FG002|Overall Study|Lost to Follow-up|7|||
30689885|NCT00710684|58703980|FG000|Overall Study|Physician Decision|0|||
30689886|NCT00710684|58703981|FG001|Overall Study|Physician Decision|2|||
30689887|NCT00710684|58703982|FG002|Overall Study|Physician Decision|4|||
30689888|NCT00710684|58703980|FG000|Overall Study|Withdrawal by Subject|24|||
30860914|NCT02361346|58890289|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
30860915|NCT02361346|58890290|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
30860916|NCT02361346|58890291|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
30860917|NCT02361346|58890292|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
30860918|NCT02361346|58890293|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
30959538|NCT02683746|59025063|FG001|Overall Study|Physician Decision|1|||
30689889|NCT00710684|58703981|FG001|Overall Study|Withdrawal by Subject|18|||
30689890|NCT00710684|58703982|FG002|Overall Study|Withdrawal by Subject|11|||
30689891|NCT00710684|58703980|FG000|Overall Study|Missing|1|||
30860919|NCT02361346|58890285|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
30860920|NCT02361346|58890286|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
30860921|NCT02361346|58890287|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
30860922|NCT02361346|58890288|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
30860923|NCT02361346|58890289|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
30860924|NCT02361346|58890290|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
30860925|NCT02361346|58890291|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
30860926|NCT02361346|58890292|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
30860927|NCT02361346|58890293|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
30860928|NCT02267278|58890335|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
30860929|NCT02267278|58890335|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
30860930|NCT02267278|58890335|FG000|Overall Study|Developed new cancer diagnoses|2|||
30860931|NCT02267278|58890335|FG000|Overall Study|prescribed prohibited medication|1|||
30860932|NCT02360098|58890341|FG000|Overall Study|Physician Decision|7|||
30860933|NCT02266888|58890352|FG000|Overall Study|Death|2|||
30860934|NCT02266888|58890353|FG001|Overall Study|Death|2|||
30860935|NCT02266888|58890354|FG002|Overall Study|Death|4|||
30860936|NCT02266888|58890355|FG003|Overall Study|Death|2|||
30860937|NCT02266888|58890352|FG000|Overall Study|Physician Decision|0|||
30860938|NCT02266888|58890353|FG001|Overall Study|Physician Decision|1|||
30860939|NCT02266888|58890354|FG002|Overall Study|Physician Decision|2|||
30860940|NCT02266888|58890355|FG003|Overall Study|Physician Decision|2|||
30860941|NCT02266888|58890352|FG000|Overall Study|Study Terminated|5|||
30860942|NCT02266888|58890353|FG001|Overall Study|Study Terminated|1|||
30860943|NCT02266888|58890354|FG002|Overall Study|Study Terminated|0|||
30860944|NCT02266888|58890355|FG003|Overall Study|Study Terminated|0|||
30860945|NCT02266888|58890352|FG000|Overall Study|No Longer Eligible|0|||
30860946|NCT02266888|58890353|FG001|Overall Study|No Longer Eligible|0|||
30860947|NCT02266888|58890354|FG002|Overall Study|No Longer Eligible|0|||
30860948|NCT02266888|58890355|FG003|Overall Study|No Longer Eligible|2|||
30860949|NCT02266888|58890352|FG000|Overall Study|Randomization Closed|0|||
30860950|NCT02266888|58890353|FG001|Overall Study|Randomization Closed|0|||
30860951|NCT02266888|58890354|FG002|Overall Study|Randomization Closed|4|||
30860952|NCT02266888|58890355|FG003|Overall Study|Randomization Closed|0|||
30860953|NCT02266888|58890352|FG000|Overall Study|Personnel unavailable at transplant|0|||
30860954|NCT02266888|58890353|FG001|Overall Study|Personnel unavailable at transplant|0|||
30860955|NCT02266888|58890354|FG002|Overall Study|Personnel unavailable at transplant|0|||
30860956|NCT02266888|58890355|FG003|Overall Study|Personnel unavailable at transplant|1|||
30860957|NCT02266888|58890352|FG000|Overall Study|Transfer of care|0|||
30860958|NCT02266888|58890353|FG001|Overall Study|Transfer of care|0|||
30860959|NCT02266888|58890354|FG002|Overall Study|Transfer of care|1|||
30860960|NCT02266888|58890355|FG003|Overall Study|Transfer of care|0|||
30860961|NCT01641952|58890363|FG000|Overall Study|Lost to Follow-up|28|||
30860962|NCT01641952|58890363|FG000|Overall Study|Adverse Event|6|||
30860963|NCT02359552|58890369|FG000|Overall Study|Lost to Follow-up|3|||
30860964|NCT02359552|58890370|FG001|Overall Study|Lost to Follow-up|4|||
30860965|NCT02743793|58890378|FG000|Overall Study|Death|1|||
30860966|NCT02743793|58890379|FG001|Overall Study|Death|1|||
30860967|NCT02743793|58890378|FG000|Overall Study|Withdrawal by Subject|0|||
30860968|NCT02743793|58890379|FG001|Overall Study|Withdrawal by Subject|1|||
30959539|NCT01559129|59025071|FG000|Treatment Phase|Adverse Event|0|||
30860969|NCT02743793|58890378|FG000|Overall Study|Screen Failure|4|||
30860970|NCT02743793|58890379|FG001|Overall Study|Screen Failure|0|||
30860971|NCT02743793|58890378|FG000|Overall Study|No Primary Care Physician|0|||
30860972|NCT02743793|58890379|FG001|Overall Study|No Primary Care Physician|1|||
30860973|NCT02743793|58890378|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
30860974|NCT02743793|58890379|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
30860975|NCT02743793|58890378|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
30860976|NCT02743793|58890379|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
30860977|NCT00152009|58890388|FG000|Overall Study|Adverse Event|9|||
30860978|NCT00152009|58890389|FG001|Overall Study|Adverse Event|13|||
30860979|NCT00152009|58890390|FG002|Overall Study|Adverse Event|20|||
30860980|NCT00152009|58890391|FG003|Overall Study|Adverse Event|1|||
30860981|NCT00152009|58890388|FG000|Overall Study|Protocol Violation|3|||
30860982|NCT00152009|58890389|FG001|Overall Study|Protocol Violation|0|||
30959540|NCT01559129|59025072|FG001|Treatment Phase|Adverse Event|2|||
30689892|NCT00710684|58703981|FG001|Overall Study|Missing|0|||
30689893|NCT00710684|58703982|FG002|Overall Study|Missing|0|||
30860983|NCT00152009|58890390|FG002|Overall Study|Protocol Violation|0|||
30860984|NCT00152009|58890391|FG003|Overall Study|Protocol Violation|1|||
30860985|NCT00152009|58890388|FG000|Overall Study|Withdrawal by Subject|2|||
30860986|NCT00152009|58890389|FG001|Overall Study|Withdrawal by Subject|3|||
30860987|NCT00152009|58890390|FG002|Overall Study|Withdrawal by Subject|4|||
30860988|NCT00152009|58890391|FG003|Overall Study|Withdrawal by Subject|9|||
30860989|NCT00152009|58890388|FG000|Overall Study|Lost to Follow-up|2|||
30860990|NCT00152009|58890389|FG001|Overall Study|Lost to Follow-up|4|||
30860991|NCT00152009|58890390|FG002|Overall Study|Lost to Follow-up|3|||
30860992|NCT00152009|58890391|FG003|Overall Study|Lost to Follow-up|3|||
30860993|NCT00152009|58890388|FG000|Overall Study|Lack of Efficacy|8|||
30860994|NCT00152009|58890389|FG001|Overall Study|Lack of Efficacy|6|||
30860995|NCT00152009|58890390|FG002|Overall Study|Lack of Efficacy|7|||
30860996|NCT00152009|58890391|FG003|Overall Study|Lack of Efficacy|15|||
30860997|NCT00152009|58890388|FG000|Overall Study|ECG abnormalities|2|||
30860998|NCT00152009|58890389|FG001|Overall Study|ECG abnormalities|2|||
30860999|NCT00152009|58890390|FG002|Overall Study|ECG abnormalities|2|||
30861000|NCT00152009|58890391|FG003|Overall Study|ECG abnormalities|1|||
30861001|NCT00152009|58890388|FG000|Overall Study|Sponsor's decision|3|||
30959541|NCT01559129|59025071|FG000|Treatment Phase|Progressive Disease|1|||
30959542|NCT01559129|59025072|FG001|Treatment Phase|Progressive Disease|1|||
30959543|NCT01559129|59025071|FG000|Treatment Phase|Lack of Efficacy|0|||
30959544|NCT01559129|59025072|FG001|Treatment Phase|Lack of Efficacy|1|||
30959545|NCT01559129|59025071|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
30959546|NCT01559129|59025072|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
30959547|NCT01559129|59025071|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
30959548|NCT01559129|59025072|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
30959549|NCT01559129|59025071|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
30959550|NCT01559129|59025072|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
30959551|NCT01559129|59025071|FG000|Open-label Extension Period|Adverse Event|1|||
30959552|NCT01559129|59025072|FG001|Open-label Extension Period|Adverse Event|0|||
30959553|NCT01559129|59025071|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
30959554|NCT01559129|59025072|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
30959555|NCT02691468|59025086|FG000|Overall Study|Bronchial blocker use|2|||
30959556|NCT02691468|59025087|FG001|Overall Study|Bronchial blocker use|1|||
30959557|NCT02691468|59025086|FG000|Overall Study|Lost to Follow-up|2|||
30959558|NCT02691468|59025087|FG001|Overall Study|Lost to Follow-up|1|||
30959559|NCT02691468|59025086|FG000|Overall Study|Failure to advance FOB|2|||
30959560|NCT02691468|59025087|FG001|Overall Study|Failure to advance FOB|0|||
30959561|NCT02678676|59025095|FG000|Overall Study|Death|619|||
30959562|NCT02678676|59025096|FG001|Overall Study|Death|649|||
30959563|NCT02678676|59025095|FG000|Overall Study|Withdrawal by Subject|13|||
30959564|NCT02678676|59025096|FG001|Overall Study|Withdrawal by Subject|5|||
30959565|NCT02678676|59025095|FG000|Overall Study|Lost to Follow-up|171|||
30959566|NCT02678676|59025096|FG001|Overall Study|Lost to Follow-up|151|||
30959567|NCT02678676|59025095|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
30959568|NCT02678676|59025096|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
30959569|NCT01558739|59025102|FG000|Overall Study|Adverse Event|7|||
30959570|NCT01558739|59025102|FG000|Overall Study|Withdrawal by Subject|2|||
30959571|NCT01558739|59025102|FG000|Overall Study|Death|3|||
30959572|NCT01558739|59025102|FG000|Overall Study|Disease Progression|4|||
30959573|NCT01558739|59025102|FG000|Overall Study|Protocol Violation|1|||
30959574|NCT02683668|59025106|FG000|Period 2|Withdrawal by Subject|0|||
30959575|NCT02683668|59025107|FG001|Period 2|Withdrawal by Subject|1|||
30959576|NCT02683668|59025108|FG002|Period 2|Withdrawal by Subject|0|||
30959577|NCT02678286|59025116|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
30959578|NCT02678286|59025117|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
30959579|NCT02678286|59025116|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
30959580|NCT02678286|59025117|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
30959581|NCT02678286|59025116|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
30959582|NCT02678286|59025117|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
30959583|NCT02678286|59025116|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
30959584|NCT02678286|59025117|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
30959585|NCT02678286|59025116|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
30959586|NCT02678286|59025117|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
30959587|NCT02682264|59025125|FG000|Overall Study|Withdrawal by Subject|56|||
30959588|NCT02682264|59025126|FG001|Overall Study|Withdrawal by Subject|45|||
30959589|NCT02682264|59025125|FG000|Overall Study|Lost to Follow-up|49|||
30959590|NCT02682264|59025126|FG001|Overall Study|Lost to Follow-up|41|||
30959591|NCT02682264|59025125|FG000|Overall Study|Lack of Efficacy|14|||
30959592|NCT02682264|59025126|FG001|Overall Study|Lack of Efficacy|16|||
30861002|NCT00152009|58890389|FG001|Overall Study|Sponsor's decision|3|||
30861003|NCT00152009|58890390|FG002|Overall Study|Sponsor's decision|1|||
30861004|NCT00152009|58890391|FG003|Overall Study|Sponsor's decision|3|||
30959593|NCT02682264|59025125|FG000|Overall Study|Withdrawal by Parent|6|||
30959594|NCT02682264|59025126|FG001|Overall Study|Withdrawal by Parent|7|||
30959595|NCT02682264|59025125|FG000|Overall Study|Adverse Event|9|||
30959596|NCT02682264|59025126|FG001|Overall Study|Adverse Event|0|||
30959597|NCT02682264|59025125|FG000|Overall Study|Noncompliance with study drug|1|||
30959598|NCT02682264|59025126|FG001|Overall Study|Noncompliance with study drug|4|||
30959599|NCT02682264|59025125|FG000|Overall Study|Pregnancy|1|||
30959600|NCT02682264|59025126|FG001|Overall Study|Pregnancy|2|||
30959601|NCT02682264|59025125|FG000|Overall Study|Recovery|1|||
30959602|NCT02682264|59025126|FG001|Overall Study|Recovery|2|||
30861005|NCT02265952|58890401|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
30861006|NCT02265952|58890402|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
30861007|NCT02265952|58890401|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
30861008|NCT02265952|58890402|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
30861009|NCT02265796|58890410|FG000|Overall Study|Death|1|||
30861010|NCT02265796|58890411|FG001|Overall Study|Death|0|||
30861011|NCT02265796|58890410|FG000|Overall Study|started on excluded medication|1|||
30861012|NCT02265796|58890411|FG001|Overall Study|started on excluded medication|0|||
30861013|NCT02265796|58890410|FG000|Overall Study|Withdrawal by Subject|1|||
30861014|NCT02265796|58890411|FG001|Overall Study|Withdrawal by Subject|1|||
30861015|NCT02357368|58890421|FG000|Overall Study|Lost to Follow-up|0|||
30861016|NCT02357368|58890422|FG001|Overall Study|Lost to Follow-up|0|||
30861017|NCT02357368|58890423|FG002|Overall Study|Lost to Follow-up|0|||
30861018|NCT02357368|58890424|FG003|Overall Study|Lost to Follow-up|1|||
30861019|NCT02357368|58890421|FG000|Overall Study|Pregnancy|3|||
30861020|NCT02357368|58890422|FG001|Overall Study|Pregnancy|2|||
30861021|NCT02357368|58890423|FG002|Overall Study|Pregnancy|0|||
30861022|NCT02357368|58890424|FG003|Overall Study|Pregnancy|0|||
30861023|NCT02357368|58890421|FG000|Overall Study|Withdrawal by Subject|3|||
30861024|NCT02357368|58890422|FG001|Overall Study|Withdrawal by Subject|1|||
30861025|NCT02357368|58890423|FG002|Overall Study|Withdrawal by Subject|1|||
30861026|NCT02357368|58890424|FG003|Overall Study|Withdrawal by Subject|2|||
30861027|NCT03287245|58890438|FG000|Overall Study|Study terminated by sponsor|3|||
30861028|NCT03287245|58890439|FG001|Overall Study|Study terminated by sponsor|0|||
30861029|NCT03287245|58890440|FG002|Overall Study|Study terminated by sponsor|3|||
30861030|NCT03287245|58890441|FG003|Overall Study|Study terminated by sponsor|1|||
30861031|NCT03287245|58890438|FG000|Overall Study|Adverse Event|1|||
30861032|NCT03287245|58890439|FG001|Overall Study|Adverse Event|0|||
30861033|NCT03287245|58890440|FG002|Overall Study|Adverse Event|0|||
30861034|NCT03287245|58890441|FG003|Overall Study|Adverse Event|0|||
30861035|NCT03287245|58890438|FG000|Overall Study|Withdrawal by Subject|8|||
30861036|NCT03287245|58890439|FG001|Overall Study|Withdrawal by Subject|3|||
30861037|NCT03287245|58890440|FG002|Overall Study|Withdrawal by Subject|3|||
30861038|NCT03287245|58890441|FG003|Overall Study|Withdrawal by Subject|0|||
30861039|NCT03287245|58890438|FG000|Overall Study|Physician Decision|3|||
30861040|NCT03287245|58890439|FG001|Overall Study|Physician Decision|2|||
30861041|NCT03287245|58890440|FG002|Overall Study|Physician Decision|0|||
30861042|NCT03287245|58890441|FG003|Overall Study|Physician Decision|0|||
30861043|NCT04638660|58890473|FG000|Overall Study|Withdrawal by Subject|2|||
30861044|NCT04638660|58890474|FG001|Overall Study|Withdrawal by Subject|0|||
30861045|NCT04638660|58890473|FG000|Overall Study|Lost to Follow-up|1|||
30861046|NCT04638660|58890474|FG001|Overall Study|Lost to Follow-up|0|||
30861047|NCT04495179|58890483|FG000|Overall Study|Lost to Follow-up|0|||
30861048|NCT04495179|58890484|FG001|Overall Study|Lost to Follow-up|1|||
30861049|NCT04495179|58890483|FG000|Overall Study|Withdrawal by Subject|2|||
30861050|NCT04495179|58890484|FG001|Overall Study|Withdrawal by Subject|4|||
30861051|NCT04495179|58890483|FG000|Overall Study|Study terminated by sponsor|0|||
30861052|NCT04495179|58890484|FG001|Overall Study|Study terminated by sponsor|18|||
30861053|NCT04495179|58890483|FG000|Overall Study|Death|0|||
30861054|NCT04495179|58890484|FG001|Overall Study|Death|4|||
30861055|NCT04495179|58890483|FG000|Overall Study|Adverse Event|0|||
30861056|NCT04495179|58890484|FG001|Overall Study|Adverse Event|1|||
30959603|NCT02682264|59025125|FG000|Overall Study|Progressive Disease|1|||
30959604|NCT02682264|59025126|FG001|Overall Study|Progressive Disease|0|||
30959605|NCT02682264|59025125|FG000|Overall Study|Technical Problems|0|||
30959606|NCT02682264|59025126|FG001|Overall Study|Technical Problems|1|||
30959607|NCT02682264|59025125|FG000|Overall Study|Moved abroad and unable to continue|0|||
30959608|NCT02682264|59025126|FG001|Overall Study|Moved abroad and unable to continue|3|||
30959609|NCT02682264|59025125|FG000|Overall Study|Stopped test article application|0|||
30959610|NCT02682264|59025126|FG001|Overall Study|Stopped test article application|1|||
30959611|NCT01566721|59025134|FG000|Treatment Period|Withdrawal by Subject|35|||
30861057|NCT04201262|58890509|FG000|Overall Study|Adverse Event|1|||
30861058|NCT04201262|58890510|FG001|Overall Study|Adverse Event|2|||
30861059|NCT04201262|58890509|FG000|Overall Study|Continuing in the study|57|||
30861060|NCT04201262|58890510|FG001|Overall Study|Continuing in the study|0|||
30861061|NCT04201262|58890509|FG000|Overall Study|Withdrawal by Subject|0|||
30861062|NCT04201262|58890510|FG001|Overall Study|Withdrawal by Subject|1|||
30861063|NCT03831100|58890522|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
30861064|NCT03831100|58890523|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
30861065|NCT03689244|58890542|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
30861066|NCT03689244|58890543|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
30861067|NCT03689244|58890544|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
30861068|NCT03689244|58890545|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
30959612|NCT01566721|59025135|FG001|Treatment Period|Withdrawal by Subject|9|||
30959613|NCT01566721|59025134|FG000|Treatment Period|Disease Progression/Recurrence|37|||
30861069|NCT03689244|58890542|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
30861070|NCT03689244|58890543|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
30861071|NCT03689244|58890544|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
30689894|NCT00710684|58703980|FG000|Overall Study|Did not continue after week 24|25|||
30689895|NCT00710684|58703981|FG001|Overall Study|Did not continue after week 24|21|||
30689896|NCT00710684|58703982|FG002|Overall Study|Did not continue after week 24|16|||
30689897|NCT00710606|58703998|FG000|Overall Study|Adverse Event|0|||
30689898|NCT00710606|58703999|FG001|Overall Study|Adverse Event|2|||
30689899|NCT00713544|58704013|FG000|Overall Study|Adverse Event|5|||
30689900|NCT00713544|58704014|FG001|Overall Study|Adverse Event|3|||
30689901|NCT00713544|58704015|FG002|Overall Study|Adverse Event|7|||
30689902|NCT00713544|58704016|FG003|Overall Study|Adverse Event|7|||
30689903|NCT00713544|58704017|FG004|Overall Study|Adverse Event|3|||
30689904|NCT00713544|58704018|FG005|Overall Study|Adverse Event|5|||
30689905|NCT00713544|58704013|FG000|Overall Study|Withdrawal by Subject|2|||
30689906|NCT00713544|58704014|FG001|Overall Study|Withdrawal by Subject|0|||
30861072|NCT03689244|58890545|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
30861073|NCT03689244|58890542|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
30861074|NCT03689244|58890543|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
30861075|NCT03689244|58890544|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
30861076|NCT03689244|58890545|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
30861077|NCT03689244|58890542|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
30861078|NCT03689244|58890543|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
30861079|NCT03689244|58890544|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
30861080|NCT03689244|58890545|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
30861081|NCT03689244|58890542|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
30861082|NCT03689244|58890543|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
30861083|NCT03689244|58890544|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
30861084|NCT03689244|58890545|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
30861085|NCT03689244|58890542|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
30861086|NCT03689244|58890543|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
30861087|NCT03689244|58890544|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
30861088|NCT03689244|58890545|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
30861089|NCT03689244|58890542|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
30861090|NCT03689244|58890543|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
30861091|NCT03689244|58890544|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
30861092|NCT03689244|58890545|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
30861093|NCT03689244|58890542|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
30861094|NCT03689244|58890543|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
30861095|NCT03689244|58890544|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
30861096|NCT03689244|58890545|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
30861097|NCT03649074|58890555|FG000|Overall Study|Lost to Follow-up|2|||
30861098|NCT03649074|58890556|FG001|Overall Study|Lost to Follow-up|1|||
30861099|NCT03649074|58890555|FG000|Overall Study|Adverse Event|1|||
30861100|NCT03649074|58890556|FG001|Overall Study|Adverse Event|0|||
30861101|NCT03649074|58890555|FG000|Overall Study|Physician Decision|1|||
30861102|NCT03649074|58890556|FG001|Overall Study|Physician Decision|0|||
30861103|NCT03649074|58890555|FG000|Overall Study|Withdrawal by Subject|0|||
30861104|NCT03649074|58890556|FG001|Overall Study|Withdrawal by Subject|2|||
30861105|NCT03649074|58890555|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
30861106|NCT03649074|58890556|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
30861107|NCT03649074|58890555|FG000|Overall Study|Other|1|||
30861108|NCT03649074|58890556|FG001|Overall Study|Other|0|||
30861109|NCT03302156|58890564|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
30861110|NCT03302156|58890565|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
30861111|NCT03302156|58890566|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
30861112|NCT03113968|58890584|FG000|Overall Study|Withdrawal by Subject|31|||
30861113|NCT03113968|58890585|FG001|Overall Study|Withdrawal by Subject|4|||
30861114|NCT02754596|58890594|FG000|Overall Study|Withdrawal by Subject|3|||
30689907|NCT00713544|58704015|FG002|Overall Study|Withdrawal by Subject|3|||
30689908|NCT00713544|58704016|FG003|Overall Study|Withdrawal by Subject|2|||
30861115|NCT02754596|58890595|FG001|Overall Study|Withdrawal by Subject|4|||
30861116|NCT02754596|58890596|FG002|Overall Study|Withdrawal by Subject|0|||
30689909|NCT00713544|58704017|FG004|Overall Study|Withdrawal by Subject|3|||
30689910|NCT00713544|58704018|FG005|Overall Study|Withdrawal by Subject|1|||
30689911|NCT00713544|58704013|FG000|Overall Study|Protocol Violation|0|||
30689912|NCT00713544|58704014|FG001|Overall Study|Protocol Violation|0|||
30861117|NCT02754596|58890594|FG000|Overall Study|Physician Decision|1|||
30861118|NCT02754596|58890595|FG001|Overall Study|Physician Decision|1|||
30861119|NCT02754596|58890596|FG002|Overall Study|Physician Decision|1|||
30861120|NCT02754596|58890594|FG000|Overall Study|Lost to Follow-up|1|||
30861121|NCT02754596|58890595|FG001|Overall Study|Lost to Follow-up|1|||
30689913|NCT00713544|58704015|FG002|Overall Study|Protocol Violation|0|||
30689914|NCT00713544|58704016|FG003|Overall Study|Protocol Violation|0|||
30689915|NCT00713544|58704017|FG004|Overall Study|Protocol Violation|0|||
30689916|NCT00713544|58704018|FG005|Overall Study|Protocol Violation|1|||
30689917|NCT00713544|58704013|FG000|Overall Study|Physician Decision|0|||
30689918|NCT00713544|58704014|FG001|Overall Study|Physician Decision|0|||
30689919|NCT00713544|58704015|FG002|Overall Study|Physician Decision|0|||
30689920|NCT00713544|58704016|FG003|Overall Study|Physician Decision|0|||
30689921|NCT00713544|58704017|FG004|Overall Study|Physician Decision|0|||
30689922|NCT00713544|58704018|FG005|Overall Study|Physician Decision|2|||
30600070|NCT01020487|58611779|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
30600071|NCT01020487|58611780|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
30600072|NCT01020487|58611781|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
30600073|NCT01020487|58611779|FG000|Part 2 Open-label Period|Adverse Event|0|||
30600074|NCT01020487|58611780|FG001|Part 2 Open-label Period|Adverse Event|4|||
30600075|NCT01020487|58611781|FG002|Part 2 Open-label Period|Adverse Event|1|||
30600076|NCT01024855|58611791|FG000|Overall Study|Inclusion/exclusion criteria|1|||
30600077|NCT01014013|58611798|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
30600078|NCT01014013|58611799|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
30600079|NCT01014013|58611798|FG000|Overall Study|Clinical adverse experience|4|||
30600080|NCT01014013|58611799|FG001|Overall Study|Clinical adverse experience|2|||
30600081|NCT01014013|58611798|FG000|Overall Study|Laboratory adverse experience|1|||
30600082|NCT01014013|58611799|FG001|Overall Study|Laboratory adverse experience|1|||
30600083|NCT01014013|58611798|FG000|Overall Study|Protocol Violation|1|||
30600084|NCT01014013|58611799|FG001|Overall Study|Protocol Violation|3|||
30600085|NCT01014013|58611798|FG000|Overall Study|Withdrawal by Subject|7|||
30600086|NCT01014013|58611799|FG001|Overall Study|Withdrawal by Subject|4|||
30600087|NCT01014013|58611798|FG000|Overall Study|Clinical/microbiologic failure|1|||
30600088|NCT01014013|58611799|FG001|Overall Study|Clinical/microbiologic failure|2|||
30600089|NCT01014013|58611798|FG000|Overall Study|Pathogen culture = no growth|26|||
30600090|NCT01014013|58611799|FG001|Overall Study|Pathogen culture = no growth|34|||
30600091|NCT01014013|58611798|FG000|Overall Study|Negative urine culture|2|||
30600092|NCT01014013|58611799|FG001|Overall Study|Negative urine culture|0|||
30600093|NCT01014013|58611798|FG000|Overall Study|Pathogen resistant|7|||
30600094|NCT01014013|58611799|FG001|Overall Study|Pathogen resistant|4|||
30600095|NCT01014013|58611798|FG000|Overall Study|Physician Decision|0|||
30600096|NCT01014013|58611799|FG001|Overall Study|Physician Decision|1|||
30600097|NCT01014013|58611798|FG000|Overall Study|Another antibiotic therapy required|0|||
30600098|NCT01014013|58611799|FG001|Overall Study|Another antibiotic therapy required|1|||
30600099|NCT01014013|58611798|FG000|Overall Study|Appendectomy|1|||
30600100|NCT01014013|58611799|FG001|Overall Study|Appendectomy|0|||
30600101|NCT01014013|58611798|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
30600102|NCT01014013|58611799|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
30600103|NCT01013701|58611807|FG000|Overall Study|study prematurely terminated|7|||
30600104|NCT01020019|58611814|FG000|Overall Study|Lost to Follow-up|21|||
30600105|NCT01020019|58611815|FG001|Overall Study|Lost to Follow-up|18|||
30600106|NCT01020019|58611814|FG000|Overall Study|Adverse Event|1|||
30600107|NCT01020019|58611815|FG001|Overall Study|Adverse Event|5|||
30600108|NCT01020019|58611814|FG000|Overall Study|not interested in treatment|4|||
30600109|NCT01020019|58611815|FG001|Overall Study|not interested in treatment|4|||
30600110|NCT01020019|58611814|FG000|Overall Study|moving|0|||
30600111|NCT01020019|58611815|FG001|Overall Study|moving|2|||
30600112|NCT01024465|58611821|FG000|Overall Study|Adverse Event|2|||
30600113|NCT01024465|58611821|FG000|Overall Study|Physician Decision|1|||
30600114|NCT01024387|58611825|FG000|Overall Study|Radiographic Progression|29|||
30600115|NCT01024387|58611825|FG000|Overall Study|Symptomatic Progression|10|||
30600116|NCT01024387|58611825|FG000|Overall Study|Physician Decision|5|||
30600117|NCT01024387|58611825|FG000|Overall Study|Withdrawal by Subject|5|||
30600118|NCT01024387|58611825|FG000|Overall Study|Death|2|||
30600119|NCT01024387|58611825|FG000|Overall Study|Prolonged Treatment Delay|1|||
30600120|NCT01024387|58611825|FG000|Overall Study|Adverse Event|3|||
30689923|NCT00713544|58704013|FG000|Overall Study|Lack of Efficacy|0|||
30600121|NCT01024387|58611825|FG000|Overall Study|Other|5|||
30600122|NCT01019317|58611829|FG000|Overall Study|Not Eligible|4|||
30600123|NCT01024309|58611835|FG000|Overall Study|Physician Decision|4|||
30689924|NCT00713544|58704014|FG001|Overall Study|Lack of Efficacy|1|||
30689925|NCT00713544|58704015|FG002|Overall Study|Lack of Efficacy|0|||
30689926|NCT00713544|58704016|FG003|Overall Study|Lack of Efficacy|1|||
30600124|NCT01024309|58611836|FG001|Overall Study|Physician Decision|0|||
30689927|NCT00713544|58704017|FG004|Overall Study|Lack of Efficacy|1|||
30689928|NCT00713544|58704018|FG005|Overall Study|Lack of Efficacy|0|||
30600125|NCT01024309|58611835|FG000|Overall Study|Withdrawal by Subject|4|||
30600126|NCT01024309|58611836|FG001|Overall Study|Withdrawal by Subject|4|||
30600127|NCT01090492|58611850|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
30600128|NCT01090492|58611851|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
30600129|NCT01090492|58611852|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
30861122|NCT02754596|58890596|FG002|Overall Study|Lost to Follow-up|2|||
30861123|NCT02754596|58890594|FG000|Overall Study|Death|0|||
30861124|NCT02754596|58890595|FG001|Overall Study|Death|2|||
30861125|NCT02754596|58890596|FG002|Overall Study|Death|0|||
30861126|NCT02754596|58890594|FG000|Overall Study|Adverse Event|1|||
30861127|NCT02754596|58890595|FG001|Overall Study|Adverse Event|0|||
30861128|NCT02754596|58890596|FG002|Overall Study|Adverse Event|1|||
30861129|NCT02754596|58890594|FG000|Overall Study|Other|1|||
30861130|NCT02754596|58890595|FG001|Overall Study|Other|0|||
30861131|NCT02754596|58890596|FG002|Overall Study|Other|0|||
30861132|NCT02133573|58890606|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
30861133|NCT02133573|58890607|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
30861134|NCT02133573|58890606|FG000|Overall Study|Child Deaths|3|||
30861135|NCT02133573|58890607|FG001|Overall Study|Child Deaths|5|||
30861136|NCT02133573|58890606|FG000|Overall Study|Child Declined Follow Ups|2|||
30861137|NCT02133573|58890607|FG001|Overall Study|Child Declined Follow Ups|1|||
30861138|NCT02133573|58890606|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
30861139|NCT02133573|58890607|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
30861140|NCT01932697|58890619|FG000|Overall Study|Received a different amount of tx|1|||
30861141|NCT01932697|58890620|FG001|Overall Study|Received a different amount of tx|0|||
30861142|NCT01932697|58890619|FG000|Overall Study|Ineligible|1|||
30861143|NCT01932697|58890620|FG001|Overall Study|Ineligible|0|||
30861144|NCT00686595|58890656|FG000|Overall Study|Adverse Event|3|||
30861145|NCT00686595|58890656|FG000|Overall Study|Protocol Violation|1|||
30861146|NCT00686595|58890656|FG000|Overall Study|Lost to Follow-up|1|||
30861147|NCT00686595|58890656|FG000|Overall Study|Lack of Efficacy|1|||
30861148|NCT00686595|58890656|FG000|Overall Study|Poor Compliance|1|||
30861149|NCT00640159|58890660|FG000|Overall Study|Lost to Follow-up|2|||
30861150|NCT00374595|58890667|FG000|Overall Study|Death|23|||
30861151|NCT00374595|58890667|FG000|Overall Study|Withdrawal by Subject|39|||
30861152|NCT00374595|58890667|FG000|Overall Study|Lost to Follow-up|3|||
30861153|NCT00374595|58890667|FG000|Overall Study|relocation; transfer care to other clinical site; too much time commitment|5|||
30861154|NCT02262754|58890674|FG000|Overall Study|Adverse Event|3|||
30861155|NCT02262754|58890675|FG001|Overall Study|Adverse Event|4|||
30861156|NCT02262754|58890676|FG002|Overall Study|Adverse Event|0|||
30861157|NCT02262754|58890674|FG000|Overall Study|Lack of Efficacy|2|||
30861158|NCT02262754|58890675|FG001|Overall Study|Lack of Efficacy|0|||
30861159|NCT02262754|58890676|FG002|Overall Study|Lack of Efficacy|1|||
30861160|NCT02262754|58890674|FG000|Overall Study|Lost to Follow-up|0|||
30861161|NCT02262754|58890675|FG001|Overall Study|Lost to Follow-up|0|||
30861162|NCT02262754|58890676|FG002|Overall Study|Lost to Follow-up|1|||
30861163|NCT02262754|58890674|FG000|Overall Study|No longer meets eligibility criteria|0|||
30861164|NCT02262754|58890675|FG001|Overall Study|No longer meets eligibility criteria|1|||
30861165|NCT02262754|58890676|FG002|Overall Study|No longer meets eligibility criteria|0|||
30861166|NCT02262754|58890674|FG000|Overall Study|Study terminated by sponsor|5|||
30861167|NCT02262754|58890675|FG001|Overall Study|Study terminated by sponsor|4|||
30861168|NCT02262754|58890676|FG002|Overall Study|Study terminated by sponsor|4|||
30861169|NCT02262754|58890674|FG000|Overall Study|Protocol Violation|1|||
30861170|NCT02262754|58890675|FG001|Overall Study|Protocol Violation|0|||
30861171|NCT02262754|58890676|FG002|Overall Study|Protocol Violation|0|||
30861172|NCT02262754|58890674|FG000|Overall Study|Withdrawal by Subject|1|||
30861173|NCT02262754|58890675|FG001|Overall Study|Withdrawal by Subject|0|||
30861174|NCT02262754|58890676|FG002|Overall Study|Withdrawal by Subject|1|||
30861175|NCT02262754|58890674|FG000|Overall Study|Other|4|||
30861176|NCT02262754|58890675|FG001|Overall Study|Other|0|||
30861177|NCT02262754|58890676|FG002|Overall Study|Other|2|||
30861178|NCT02262364|58890686|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
30861179|NCT02261974|58890692|FG000|Overall Study|Withdrawal by Subject|3|||
30861180|NCT02261974|58890693|FG001|Overall Study|Withdrawal by Subject|2|||
30861181|NCT02261974|58890692|FG000|Overall Study|Pregnancy|0|||
30861182|NCT02261974|58890693|FG001|Overall Study|Pregnancy|1|||
30861183|NCT02261974|58890692|FG000|Overall Study|Missed treatment cut-off date|6|||
30861184|NCT02261974|58890693|FG001|Overall Study|Missed treatment cut-off date|3|||
30861185|NCT02261974|58890692|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
30861186|NCT02261974|58890693|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
30861187|NCT02261974|58890692|FG000|Overall Study|Lost to Follow-up|2|||
30861188|NCT02261974|58890693|FG001|Overall Study|Lost to Follow-up|0|||
30861189|NCT02261974|58890692|FG000|Overall Study|Adverse Event|1|||
30861190|NCT02261974|58890693|FG001|Overall Study|Adverse Event|0|||
30861191|NCT02356588|58890701|FG000|Overall Study|Lack of Efficacy|4|||
30861192|NCT02356588|58890702|FG001|Overall Study|Lack of Efficacy|10|||
30861193|NCT02356588|58890701|FG000|Overall Study|Adverse Event|0|||
30861194|NCT02356588|58890702|FG001|Overall Study|Adverse Event|2|||
30861195|NCT02356588|58890701|FG000|Overall Study|Withdrawal by Subject|1|||
30861196|NCT02356588|58890702|FG001|Overall Study|Withdrawal by Subject|0|||
30861197|NCT02356588|58890701|FG000|Overall Study|Protocol Violation|0|||
30861198|NCT02356588|58890702|FG001|Overall Study|Protocol Violation|1|||
30861199|NCT02355028|58890710|FG000|Overall Study|Adverse Event|2|||
30861200|NCT02355028|58890711|FG001|Overall Study|Adverse Event|0|||
30861201|NCT02355028|58890710|FG000|Overall Study|Withdrawal by Subject|1|||
30861202|NCT02355028|58890711|FG001|Overall Study|Withdrawal by Subject|1|||
30861203|NCT02355028|58890710|FG000|Overall Study|Deemed ineligible after randomization|8|||
30861204|NCT02355028|58890711|FG001|Overall Study|Deemed ineligible after randomization|4|||
30861205|NCT01643668|58890726|FG000|Overall Study|Death|1|||
30861206|NCT02260882|58890732|FG000|Overall Study|Protocol Violation|0|||
30861207|NCT02260882|58890733|FG001|Overall Study|Protocol Violation|1|||
30861208|NCT02260804|58890742|FG000|Induction Study Period|Protocol Violation|2|||
30861209|NCT02260804|58890743|FG001|Induction Study Period|Protocol Violation|0|||
30861210|NCT02260804|58890742|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
30861211|NCT02260804|58890743|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
30861212|NCT02260804|58890742|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
30861213|NCT02260804|58890743|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
30861214|NCT02260804|58890742|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
30861215|NCT02260804|58890743|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
30861216|NCT02260804|58890742|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
30861217|NCT02260804|58890743|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
30861218|NCT02260804|58890742|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
30861219|NCT02260804|58890743|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
30861220|NCT02260804|58890742|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
30861221|NCT02260804|58890743|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
30861222|NCT02260804|58890742|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
30861223|NCT02260804|58890743|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
30861224|NCT02260804|58890742|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
30861225|NCT02260804|58890743|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
30861226|NCT02260804|58890742|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
30861227|NCT02260804|58890743|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
30861228|NCT02260804|58890742|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
30861229|NCT02260804|58890743|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
30861230|NCT02260648|58890752|FG000|Overall Study|Adverse Event|3|||
30861231|NCT02260648|58890753|FG001|Overall Study|Adverse Event|0|||
30861232|NCT02260648|58890754|FG002|Overall Study|Adverse Event|1|||
30861233|NCT02260648|58890752|FG000|Overall Study|Withdrawal by Subject|1|||
30861234|NCT02260648|58890753|FG001|Overall Study|Withdrawal by Subject|1|||
30861235|NCT02260648|58890754|FG002|Overall Study|Withdrawal by Subject|0|||
30861236|NCT02260648|58890752|FG000|Overall Study|Protocol Violation|1|||
30861237|NCT02260648|58890753|FG001|Overall Study|Protocol Violation|0|||
30861238|NCT02260648|58890754|FG002|Overall Study|Protocol Violation|0|||
30861239|NCT02260648|58890752|FG000|Overall Study|Discontinue Due to Study Termination|13|||
30861240|NCT02260648|58890753|FG001|Overall Study|Discontinue Due to Study Termination|12|||
30861241|NCT02260648|58890754|FG002|Overall Study|Discontinue Due to Study Termination|7|||
30861242|NCT02260492|58890765|FG000|Overall Study|Adverse Event|6|||
30861243|NCT02260492|58890766|FG001|Overall Study|Adverse Event|1|||
30861244|NCT02260492|58890767|FG002|Overall Study|Adverse Event|2|||
30861245|NCT02260492|58890765|FG000|Overall Study|Death|0|||
30861246|NCT02260492|58890766|FG001|Overall Study|Death|1|||
30861247|NCT02260492|58890767|FG002|Overall Study|Death|0|||
30689929|NCT00713544|58704013|FG000|Overall Study|Lost to Follow-up|0|||
30689930|NCT00713544|58704014|FG001|Overall Study|Lost to Follow-up|0|||
30689931|NCT00713544|58704015|FG002|Overall Study|Lost to Follow-up|1|||
30689932|NCT00713544|58704016|FG003|Overall Study|Lost to Follow-up|0|||
30861248|NCT02260492|58890765|FG000|Overall Study|Lost to Follow-up|12|||
30861249|NCT02260492|58890766|FG001|Overall Study|Lost to Follow-up|9|||
30861250|NCT02260492|58890767|FG002|Overall Study|Lost to Follow-up|0|||
30861251|NCT02260492|58890765|FG000|Overall Study|Physician Decision|2|||
30861252|NCT02260492|58890766|FG001|Overall Study|Physician Decision|0|||
30861253|NCT02260492|58890767|FG002|Overall Study|Physician Decision|1|||
30861254|NCT02260492|58890765|FG000|Overall Study|Withdrawal by Subject|3|||
30861255|NCT02260492|58890766|FG001|Overall Study|Withdrawal by Subject|2|||
30861256|NCT02260492|58890767|FG002|Overall Study|Withdrawal by Subject|2|||
30861257|NCT02260258|58890777|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
30861258|NCT02260258|58890778|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
30861259|NCT02260180|58890788|FG000|Overall Study|Adverse Event|2|||
30861260|NCT02260180|58890789|FG001|Overall Study|Adverse Event|0|||
30861261|NCT02260180|58890790|FG002|Overall Study|Adverse Event|1|||
30861262|NCT02353468|58890798|FG000|Overall Study|Study terminated|3|||
30959614|NCT01566721|59025135|FG001|Treatment Period|Disease Progression/Recurrence|13|||
30689933|NCT00713544|58704017|FG004|Overall Study|Lost to Follow-up|0|||
30689934|NCT00713544|58704018|FG005|Overall Study|Lost to Follow-up|0|||
30689935|NCT00713544|58704013|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
30861263|NCT02349412|58890804|FG000|Overall Study|Withdrawal by Subject|7|||
30861264|NCT02349412|58890805|FG001|Overall Study|Withdrawal by Subject|7|||
30861265|NCT02259400|58890813|FG000|Overall Study|Death|0|||
30861266|NCT02259400|58890814|FG001|Overall Study|Death|2|||
30861267|NCT01530997|58890820|FG000|Overall Study|Physician Decision|1|||
30861268|NCT01530997|58890820|FG000|Overall Study|Withdrawal by Subject|1|||
30861269|NCT02259088|58890833|FG000|Overall Study|Adverse Event|6|||
30861270|NCT02259088|58890834|FG001|Overall Study|Adverse Event|4|||
30861271|NCT02259088|58890833|FG000|Overall Study|Lost to Follow-up|2|||
30861272|NCT02259088|58890834|FG001|Overall Study|Lost to Follow-up|0|||
30861273|NCT02259088|58890833|FG000|Overall Study|Death|2|||
30861274|NCT02259088|58890834|FG001|Overall Study|Death|0|||
30861275|NCT02259088|58890833|FG000|Overall Study|Physician Decision|5|||
30861276|NCT02259088|58890834|FG001|Overall Study|Physician Decision|2|||
30861277|NCT02259088|58890833|FG000|Overall Study|Protocol deviation|5|||
30861278|NCT02259088|58890834|FG001|Overall Study|Protocol deviation|0|||
30861279|NCT02259088|58890833|FG000|Overall Study|Subject/guardian decision|8|||
30861280|NCT02259088|58890834|FG001|Overall Study|Subject/guardian decision|8|||
30861281|NCT02880241|58890846|FG000|Overall Study|Lack of Efficacy|1|||
30861282|NCT02880241|58890847|FG001|Overall Study|Lack of Efficacy|0|||
30861283|NCT02880241|58890848|FG002|Overall Study|Lack of Efficacy|0|||
30861284|NCT02880241|58890849|FG003|Overall Study|Lack of Efficacy|0|||
30861285|NCT02880241|58890850|FG004|Overall Study|Lack of Efficacy|0|||
30861286|NCT02880241|58890851|FG005|Overall Study|Lack of Efficacy|0|||
30861287|NCT02259010|58890867|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
30861288|NCT02021773|58890876|FG000|Overall Study|Adverse Event|1|||
30861289|NCT02021773|58890877|FG001|Overall Study|Adverse Event|4|||
30861290|NCT02021773|58890878|FG002|Overall Study|Adverse Event|3|||
30861291|NCT02021773|58890876|FG000|Overall Study|Lack of Efficacy|2|||
30861292|NCT02021773|58890877|FG001|Overall Study|Lack of Efficacy|2|||
30861293|NCT02021773|58890878|FG002|Overall Study|Lack of Efficacy|2|||
30861294|NCT02021773|58890876|FG000|Overall Study|Protocol Violation|2|||
30861295|NCT02021773|58890877|FG001|Overall Study|Protocol Violation|3|||
30861296|NCT02021773|58890878|FG002|Overall Study|Protocol Violation|1|||
30861297|NCT02021773|58890876|FG000|Overall Study|Withdrawal by Subject|3|||
30861298|NCT02021773|58890877|FG001|Overall Study|Withdrawal by Subject|4|||
30861299|NCT02021773|58890878|FG002|Overall Study|Withdrawal by Subject|5|||
30861300|NCT02021773|58890876|FG000|Overall Study|Lost to Follow-up|1|||
30861301|NCT02021773|58890877|FG001|Overall Study|Lost to Follow-up|3|||
30861302|NCT02021773|58890878|FG002|Overall Study|Lost to Follow-up|0|||
30861303|NCT02021773|58890876|FG000|Overall Study|Reason not specified|3|||
30861304|NCT02021773|58890877|FG001|Overall Study|Reason not specified|0|||
30861305|NCT02021773|58890878|FG002|Overall Study|Reason not specified|0|||
30861306|NCT00151775|58890891|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
30861307|NCT00151775|58890892|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
30861308|NCT00151775|58890893|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
30861309|NCT00151775|58890894|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
30861310|NCT00151775|58890895|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
30861311|NCT00151775|58890896|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
30861312|NCT00151775|58890897|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
30861313|NCT00151775|58890898|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
30861314|NCT00151775|58890899|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
30861315|NCT00151775|58890900|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
30861316|NCT00151775|58890901|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
30861317|NCT00151775|58890902|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
30861318|NCT00151775|58890891|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
30861319|NCT00151775|58890892|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
30861320|NCT00151775|58890893|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
30861321|NCT00151775|58890894|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
30861322|NCT00151775|58890895|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
30861323|NCT00151775|58890896|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
30861324|NCT00151775|58890897|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
30861325|NCT00151775|58890898|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
30861326|NCT00151775|58890899|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
30861327|NCT00151775|58890900|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
30861328|NCT00151775|58890901|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
30861329|NCT00151775|58890902|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
30861330|NCT00151775|58890891|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
30861331|NCT00151775|58890892|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
30861332|NCT00151775|58890893|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
30861333|NCT00151775|58890894|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
30861334|NCT00151775|58890895|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
30861335|NCT00151775|58890896|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
30861336|NCT00151775|58890897|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
30861337|NCT00151775|58890898|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
30861338|NCT00151775|58890899|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
30861339|NCT00151775|58890900|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
30861340|NCT00151775|58890901|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
30861341|NCT00151775|58890902|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
30861342|NCT00151775|58890891|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
30861343|NCT00151775|58890892|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
30861344|NCT00151775|58890893|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
30861345|NCT00151775|58890894|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
30861346|NCT00151775|58890895|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
30861347|NCT00151775|58890896|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
30861348|NCT00151775|58890897|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
30861349|NCT00151775|58890898|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
30861350|NCT00151775|58890899|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
30861351|NCT00151775|58890900|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
30861352|NCT00151775|58890901|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
30861353|NCT00151775|58890902|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
30861354|NCT00151775|58890891|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
30861355|NCT00151775|58890892|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
30861356|NCT00151775|58890893|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
30861357|NCT00151775|58890894|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
30861358|NCT00151775|58890895|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
30861359|NCT00151775|58890896|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
30861360|NCT00151775|58890897|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
30861361|NCT00151775|58890898|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
30861362|NCT00151775|58890899|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
30861363|NCT00151775|58890900|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
30861364|NCT00151775|58890901|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
30861365|NCT00151775|58890902|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
30861366|NCT00151775|58890891|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
30861367|NCT00151775|58890892|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
30861368|NCT00151775|58890893|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
30861369|NCT00151775|58890894|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
30861370|NCT00151775|58890895|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
30861371|NCT00151775|58890896|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
30861372|NCT00151775|58890897|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
30861373|NCT00151775|58890898|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
30861374|NCT00151775|58890899|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
30861375|NCT00151775|58890900|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
30861376|NCT00151775|58890901|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
30861377|NCT00151775|58890902|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
30861378|NCT00151775|58890891|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
30861379|NCT00151775|58890892|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
30861380|NCT00151775|58890893|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
30861381|NCT00151775|58890894|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
30861382|NCT00151775|58890895|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
30861383|NCT00151775|58890896|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
30861384|NCT00151775|58890897|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
30861385|NCT00151775|58890898|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
30861386|NCT00151775|58890899|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
30861387|NCT00151775|58890900|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
30861388|NCT00151775|58890901|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
30861389|NCT00151775|58890902|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
30600130|NCT01090492|58611853|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
30600131|NCT01090492|58611854|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
30600132|NCT01090492|58611855|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
30600133|NCT01090492|58611856|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
30600134|NCT01090492|58611857|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
30600135|NCT01090492|58611850|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
30600136|NCT01090492|58611851|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
30861390|NCT00151775|58890891|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
30861391|NCT00151775|58890892|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
30861392|NCT00151775|58890893|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
30861393|NCT00151775|58890894|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
30861394|NCT00151775|58890895|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
30861395|NCT00151775|58890896|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
30861396|NCT00151775|58890897|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
30861397|NCT00151775|58890898|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
30861398|NCT00151775|58890899|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
30861399|NCT00151775|58890900|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
30861400|NCT00151775|58890901|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
30861401|NCT00151775|58890902|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
30861402|NCT00151775|58890891|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
30861403|NCT00151775|58890892|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
30861404|NCT00151775|58890893|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
30861405|NCT00151775|58890894|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
30861406|NCT00151775|58890895|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
30861407|NCT00151775|58890896|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
30861408|NCT00151775|58890897|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
30861409|NCT00151775|58890898|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
30861410|NCT00151775|58890899|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
30861411|NCT00151775|58890900|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
30861412|NCT00151775|58890901|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
30861413|NCT00151775|58890902|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
30861414|NCT00151775|58890891|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
30861415|NCT00151775|58890892|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
30861416|NCT00151775|58890893|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
30861417|NCT00151775|58890894|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
30861418|NCT00151775|58890895|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
30861419|NCT00151775|58890896|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
30861420|NCT00151775|58890897|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
30861421|NCT00151775|58890898|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
30861422|NCT00151775|58890899|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
30861423|NCT00151775|58890900|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
30861424|NCT00151775|58890901|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
30861425|NCT00151775|58890902|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
30861426|NCT00151775|58890891|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
30861427|NCT00151775|58890892|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
30861428|NCT00151775|58890893|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
30861429|NCT00151775|58890894|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
30861430|NCT00151775|58890895|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
30861431|NCT00151775|58890896|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
30861432|NCT00151775|58890897|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
30861433|NCT00151775|58890898|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
30861434|NCT00151775|58890899|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
30861435|NCT00151775|58890900|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
30861436|NCT00151775|58890901|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
30861437|NCT00151775|58890902|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
30861438|NCT00151775|58890891|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
30861439|NCT00151775|58890892|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
30861440|NCT00151775|58890893|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
30861441|NCT00151775|58890894|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
30861442|NCT00151775|58890895|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
30861443|NCT00151775|58890896|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
30861444|NCT00151775|58890897|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
30861445|NCT00151775|58890898|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
30861446|NCT00151775|58890899|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
30861447|NCT00151775|58890900|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
30861448|NCT00151775|58890901|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
30861449|NCT00151775|58890902|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
30861450|NCT00151775|58890891|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
30861451|NCT00151775|58890892|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
30861452|NCT00151775|58890893|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
30861453|NCT00151775|58890894|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
30861454|NCT00151775|58890895|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
30861455|NCT00151775|58890896|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
30861456|NCT00151775|58890897|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
30861457|NCT00151775|58890898|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
30861458|NCT00151775|58890899|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
30861459|NCT00151775|58890900|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
30861460|NCT00151775|58890901|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
30861461|NCT00151775|58890902|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
30861462|NCT00151775|58890891|FG000|Period 4: Open Label|Increased blood pressure|0|||
30861463|NCT00151775|58890892|FG001|Period 4: Open Label|Increased blood pressure|0|||
30861464|NCT00151775|58890893|FG002|Period 4: Open Label|Increased blood pressure|0|||
30861465|NCT00151775|58890894|FG003|Period 4: Open Label|Increased blood pressure|0|||
30861466|NCT00151775|58890895|FG004|Period 4: Open Label|Increased blood pressure|1|||
30861467|NCT00151775|58890896|FG005|Period 4: Open Label|Increased blood pressure|0|||
30861468|NCT00151775|58890897|FG006|Period 4: Open Label|Increased blood pressure|0|||
30861469|NCT00151775|58890898|FG007|Period 4: Open Label|Increased blood pressure|0|||
30861470|NCT00151775|58890899|FG008|Period 4: Open Label|Increased blood pressure|0|||
30861471|NCT00151775|58890900|FG009|Period 4: Open Label|Increased blood pressure|1|||
30861472|NCT00151775|58890901|FG010|Period 4: Open Label|Increased blood pressure|0|||
30861473|NCT00151775|58890902|FG011|Period 4: Open Label|Increased blood pressure|0|||
30861474|NCT00151775|58890891|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
30861475|NCT00151775|58890892|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
30861476|NCT00151775|58890893|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
30861477|NCT00151775|58890894|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
30861478|NCT00151775|58890895|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
30861479|NCT00151775|58890896|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
30861480|NCT00151775|58890897|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
30861481|NCT00151775|58890898|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
30861482|NCT00151775|58890899|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
30861483|NCT00151775|58890900|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
30861484|NCT00151775|58890901|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
30861485|NCT00151775|58890902|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
30861486|NCT00151775|58890891|FG000|Period 4: Open Label|Adverse Event|0|||
30861487|NCT00151775|58890892|FG001|Period 4: Open Label|Adverse Event|0|||
30861488|NCT00151775|58890893|FG002|Period 4: Open Label|Adverse Event|0|||
30861489|NCT00151775|58890894|FG003|Period 4: Open Label|Adverse Event|0|||
30861490|NCT00151775|58890895|FG004|Period 4: Open Label|Adverse Event|1|||
30861491|NCT00151775|58890896|FG005|Period 4: Open Label|Adverse Event|0|||
30861492|NCT00151775|58890897|FG006|Period 4: Open Label|Adverse Event|0|||
30861493|NCT00151775|58890898|FG007|Period 4: Open Label|Adverse Event|0|||
30861494|NCT00151775|58890899|FG008|Period 4: Open Label|Adverse Event|0|||
30861495|NCT00151775|58890900|FG009|Period 4: Open Label|Adverse Event|2|||
30861496|NCT00151775|58890901|FG010|Period 4: Open Label|Adverse Event|0|||
30861497|NCT00151775|58890902|FG011|Period 4: Open Label|Adverse Event|0|||
30861498|NCT00151775|58890891|FG000|Period 4: Open Label|Lost to Follow-up|0|||
30861499|NCT00151775|58890892|FG001|Period 4: Open Label|Lost to Follow-up|0|||
30861500|NCT00151775|58890893|FG002|Period 4: Open Label|Lost to Follow-up|0|||
30861501|NCT00151775|58890894|FG003|Period 4: Open Label|Lost to Follow-up|0|||
30861502|NCT00151775|58890895|FG004|Period 4: Open Label|Lost to Follow-up|17|||
30861503|NCT00151775|58890896|FG005|Period 4: Open Label|Lost to Follow-up|0|||
30861504|NCT00151775|58890897|FG006|Period 4: Open Label|Lost to Follow-up|0|||
30861505|NCT00151775|58890898|FG007|Period 4: Open Label|Lost to Follow-up|0|||
30861506|NCT00151775|58890899|FG008|Period 4: Open Label|Lost to Follow-up|0|||
30861507|NCT00151775|58890900|FG009|Period 4: Open Label|Lost to Follow-up|7|||
30861508|NCT00151775|58890901|FG010|Period 4: Open Label|Lost to Follow-up|0|||
30861509|NCT00151775|58890902|FG011|Period 4: Open Label|Lost to Follow-up|0|||
30861510|NCT00151775|58890891|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
30861511|NCT00151775|58890892|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
30861512|NCT00151775|58890893|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
30861513|NCT00151775|58890894|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
30861514|NCT00151775|58890895|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
30861515|NCT00151775|58890896|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
30861516|NCT00151775|58890897|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
30861517|NCT00151775|58890898|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
30861518|NCT00151775|58890899|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
30861519|NCT00151775|58890900|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
30861520|NCT00151775|58890901|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
30861521|NCT00151775|58890902|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
30861522|NCT00151775|58890891|FG000|Period 4: Open Label|Other|0|||
30959615|NCT01566721|59025134|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
30959616|NCT01566721|59025135|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
30861523|NCT00151775|58890892|FG001|Period 4: Open Label|Other|0|||
30861524|NCT00151775|58890893|FG002|Period 4: Open Label|Other|0|||
30861525|NCT00151775|58890894|FG003|Period 4: Open Label|Other|0|||
30861526|NCT00151775|58890895|FG004|Period 4: Open Label|Other|1|||
30861527|NCT00151775|58890896|FG005|Period 4: Open Label|Other|0|||
30861528|NCT00151775|58890897|FG006|Period 4: Open Label|Other|0|||
30861529|NCT00151775|58890898|FG007|Period 4: Open Label|Other|0|||
30959617|NCT01566721|59025134|FG000|Treatment Period|Other|13|||
30861530|NCT00151775|58890899|FG008|Period 4: Open Label|Other|0|||
30861531|NCT00151775|58890900|FG009|Period 4: Open Label|Other|3|||
30861532|NCT00151775|58890901|FG010|Period 4: Open Label|Other|0|||
30861533|NCT00151775|58890902|FG011|Period 4: Open Label|Other|0|||
30861534|NCT00151775|58890891|FG000|Period 4: Open Label|Physician Decision|0|||
30861535|NCT00151775|58890892|FG001|Period 4: Open Label|Physician Decision|0|||
30861536|NCT00151775|58890893|FG002|Period 4: Open Label|Physician Decision|0|||
30861537|NCT00151775|58890894|FG003|Period 4: Open Label|Physician Decision|0|||
30861538|NCT00151775|58890895|FG004|Period 4: Open Label|Physician Decision|0|||
30861539|NCT00151775|58890896|FG005|Period 4: Open Label|Physician Decision|0|||
30861540|NCT00151775|58890897|FG006|Period 4: Open Label|Physician Decision|0|||
30861541|NCT00151775|58890898|FG007|Period 4: Open Label|Physician Decision|0|||
30861542|NCT00151775|58890899|FG008|Period 4: Open Label|Physician Decision|0|||
30861543|NCT00151775|58890900|FG009|Period 4: Open Label|Physician Decision|2|||
30861544|NCT00151775|58890901|FG010|Period 4: Open Label|Physician Decision|0|||
30861545|NCT00151775|58890902|FG011|Period 4: Open Label|Physician Decision|0|||
30861546|NCT00151775|58890891|FG000|Period 4: Open Label|Protocol Violation|0|||
30861547|NCT00151775|58890892|FG001|Period 4: Open Label|Protocol Violation|0|||
30861548|NCT00151775|58890893|FG002|Period 4: Open Label|Protocol Violation|0|||
30861549|NCT00151775|58890894|FG003|Period 4: Open Label|Protocol Violation|0|||
30861550|NCT00151775|58890895|FG004|Period 4: Open Label|Protocol Violation|1|||
30861551|NCT00151775|58890896|FG005|Period 4: Open Label|Protocol Violation|0|||
30861552|NCT00151775|58890897|FG006|Period 4: Open Label|Protocol Violation|0|||
30861553|NCT00151775|58890898|FG007|Period 4: Open Label|Protocol Violation|0|||
30861554|NCT00151775|58890899|FG008|Period 4: Open Label|Protocol Violation|0|||
30861555|NCT00151775|58890900|FG009|Period 4: Open Label|Protocol Violation|0|||
30861556|NCT00151775|58890901|FG010|Period 4: Open Label|Protocol Violation|0|||
30861557|NCT00151775|58890902|FG011|Period 4: Open Label|Protocol Violation|0|||
30861558|NCT02258464|58890945|FG000|Overall Study|Progressive disease (PD)|9|||
30861559|NCT02258464|58890946|FG001|Overall Study|Progressive disease (PD)|17|||
30861560|NCT02258464|58890945|FG000|Overall Study|Study drug never administered|1|||
30861561|NCT02258464|58890946|FG001|Overall Study|Study drug never administered|1|||
30861562|NCT02258464|58890945|FG000|Overall Study|AE not related to clinical PD|1|||
30861563|NCT02258464|58890946|FG001|Overall Study|AE not related to clinical PD|3|||
30861564|NCT02258464|58890945|FG000|Overall Study|Withdrawal by Subject|5|||
30861565|NCT02258464|58890946|FG001|Overall Study|Withdrawal by Subject|4|||
30861566|NCT02258464|58890945|FG000|Overall Study|AE related to clinical PD|1|||
30861567|NCT02258464|58890946|FG001|Overall Study|AE related to clinical PD|0|||
30861568|NCT02682901|58890954|FG000|Overall Study|Adverse Event|10|||
30861569|NCT02682901|58890955|FG001|Overall Study|Adverse Event|3|||
30861570|NCT02682901|58890954|FG000|Overall Study|Lack of Efficacy|0|||
30861571|NCT02682901|58890955|FG001|Overall Study|Lack of Efficacy|1|||
30861572|NCT02258074|58890965|FG000|Overall Study|Withdrawal by Subject|1|||
30861573|NCT02258074|58890966|FG001|Overall Study|Withdrawal by Subject|0|||
30861574|NCT02258074|58890967|FG002|Overall Study|Withdrawal by Subject|0|||
30861575|NCT02258074|58890968|FG003|Overall Study|Withdrawal by Subject|0|||
30861576|NCT01643044|58890980|FG000|Overall Study|Lost to Follow-up|1|||
30861577|NCT01643044|58890981|FG001|Overall Study|Lost to Follow-up|1|||
30861578|NCT01643044|58890980|FG000|Overall Study|Miscarried baby|2|||
30861579|NCT01643044|58890981|FG001|Overall Study|Miscarried baby|2|||
30861580|NCT01643044|58890980|FG000|Overall Study|Delivered outside of hospital|1|||
30861581|NCT01643044|58890981|FG001|Overall Study|Delivered outside of hospital|2|||
30861582|NCT01642732|58890987|FG000|Overall Study|Withdrawal by Subject|1|||
30861583|NCT02257684|58890991|FG000|Overall Study|Adverse Event|2|||
30861584|NCT02257684|58890991|FG000|Overall Study|Lack of Efficacy|1|||
30861585|NCT02257684|58890991|FG000|Overall Study|Sponsor's Decision|1|||
30861586|NCT02190721|58890998|FG000|Overall Study|Patient was out of the city|0|||
30861587|NCT02190721|58890999|FG001|Overall Study|Patient was out of the city|1|||
30861588|NCT02190721|58891000|FG002|Overall Study|Patient was out of the city|0|||
30861589|NCT00581477|58891008|FG000|Overall Study|Physician Decision|2|||
30861590|NCT02348008|58891024|FG000|Overall Study|Adverse Event|2|||
30861591|NCT02348008|58891025|FG001|Overall Study|Adverse Event|3|||
30861592|NCT02348008|58891026|FG002|Overall Study|Adverse Event|3|||
30861593|NCT02348008|58891024|FG000|Overall Study|Disease Progression|1|||
30861594|NCT02348008|58891025|FG001|Overall Study|Disease Progression|5|||
30861595|NCT02348008|58891026|FG002|Overall Study|Disease Progression|16|||
30861596|NCT02348008|58891024|FG000|Overall Study|Withdrawal by Subject|0|||
30861597|NCT02348008|58891025|FG001|Overall Study|Withdrawal by Subject|1|||
30861598|NCT02348008|58891026|FG002|Overall Study|Withdrawal by Subject|0|||
30861599|NCT02348008|58891024|FG000|Overall Study|Symptomatic Deterioration|0|||
30861600|NCT02348008|58891025|FG001|Overall Study|Symptomatic Deterioration|1|||
30861601|NCT02348008|58891026|FG002|Overall Study|Symptomatic Deterioration|0|||
30861602|NCT04962022|58891032|FG000|Period 1|Withdrawal by Subject|1|||
30861603|NCT04962022|58891033|FG001|Period 1|Withdrawal by Subject|0|||
30861604|NCT04210843|58891085|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
30861605|NCT04210843|58891086|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
30861606|NCT04210843|58891085|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
30861607|NCT04210843|58891086|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
30861608|NCT04210843|58891085|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
30861609|NCT04210843|58891086|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
30861610|NCT04210843|58891085|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
30861611|NCT04210843|58891086|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
30861612|NCT04210843|58891085|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
30861613|NCT04210843|58891086|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
30861614|NCT04210843|58891085|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
30861615|NCT04210843|58891086|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
30861616|NCT04210843|58891085|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
30861617|NCT04210843|58891086|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
30861618|NCT04210843|58891085|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
30861619|NCT04210843|58891086|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
30861620|NCT04210843|58891085|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
30861621|NCT04210843|58891086|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
30861622|NCT04210843|58891085|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
30861623|NCT04210843|58891086|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
30861624|NCT04210843|58891085|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
30861625|NCT04210843|58891086|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
30861626|NCT04210843|58891085|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
30861627|NCT04210843|58891086|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
30861628|NCT04210843|58891085|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
30861629|NCT04210843|58891086|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
30861630|NCT04210843|58891085|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
30861631|NCT04210843|58891086|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
30861632|NCT04210843|58891085|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
30861633|NCT04210843|58891086|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
30861634|NCT04210843|58891085|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
30861635|NCT04210843|58891086|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
30861636|NCT04210843|58891085|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
30861637|NCT04210843|58891086|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
30861638|NCT04210843|58891085|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
30861639|NCT04210843|58891086|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
30861640|NCT04210843|58891085|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
30861641|NCT04210843|58891086|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
30861642|NCT04210843|58891085|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
30861643|NCT04210843|58891086|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
30861644|NCT04210843|58891085|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
30861645|NCT04210843|58891086|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
30861646|NCT04210843|58891085|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
30861647|NCT04210843|58891086|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
30861648|NCT04210843|58891085|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
30861649|NCT04210843|58891086|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
30861650|NCT04210843|58891085|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
30861651|NCT04210843|58891086|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
30861652|NCT03538041|58891104|FG000|12-Week Treatment Period|Adverse Event|1|||
30861653|NCT03538041|58891105|FG001|12-Week Treatment Period|Adverse Event|1|||
30861654|NCT03538041|58891104|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
30861655|NCT03538041|58891105|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
30861656|NCT03538041|58891104|FG000|Treatment Extension Period|Adverse Event|4|||
30861657|NCT03538041|58891105|FG001|Treatment Extension Period|Adverse Event|0|||
30861658|NCT03538041|58891104|FG000|Treatment Extension Period|Physician Decision|1|||
30861659|NCT03538041|58891105|FG001|Treatment Extension Period|Physician Decision|0|||
30861660|NCT03538041|58891104|FG000|Treatment Extension Period|Lack of Efficacy|1|||
30861661|NCT03538041|58891105|FG001|Treatment Extension Period|Lack of Efficacy|3|||
30861662|NCT03538041|58891104|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
30861663|NCT03538041|58891105|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
30861664|NCT03091192|58891120|FG000|Overall Study|Study terminated by sponsor|21|||
30861665|NCT03091192|58891121|FG001|Overall Study|Study terminated by sponsor|14|||
30861666|NCT03091192|58891120|FG000|Overall Study|Death|9|||
30861667|NCT03091192|58891121|FG001|Overall Study|Death|13|||
30861668|NCT03091192|58891120|FG000|Overall Study|Withdrawal by Subject|2|||
30861669|NCT03091192|58891121|FG001|Overall Study|Withdrawal by Subject|0|||
30861670|NCT03091192|58891120|FG000|Overall Study|Lost to Follow-up|1|||
30861671|NCT03091192|58891121|FG001|Overall Study|Lost to Follow-up|0|||
30689936|NCT00713544|58704014|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
30861672|NCT02838420|58891129|FG000|Overall Study|Ongoing in Study|113|||
30861673|NCT02838420|58891130|FG001|Overall Study|Ongoing in Study|45|||
30861674|NCT02838420|58891129|FG000|Overall Study|Lost to Follow-up|1|||
30861675|NCT02838420|58891130|FG001|Overall Study|Lost to Follow-up|0|||
30861676|NCT02838420|58891129|FG000|Overall Study|Withdrawal by Subject|3|||
30861677|NCT02838420|58891130|FG001|Overall Study|Withdrawal by Subject|4|||
30861678|NCT02838420|58891129|FG000|Overall Study|Death|8|||
30861679|NCT02838420|58891130|FG001|Overall Study|Death|13|||
30861680|NCT02651675|58891139|FG000|Overall Study|Death|0|||
30861681|NCT02651675|58891140|FG001|Overall Study|Death|0|||
30861682|NCT02651675|58891141|FG002|Overall Study|Death|1|||
30861683|NCT02611960|58891151|FG000|Overall Study|Adverse Event|7|||
30861684|NCT02611960|58891152|FG001|Overall Study|Adverse Event|8|||
30861685|NCT02611960|58891151|FG000|Overall Study|Death|98|||
30861686|NCT02611960|58891152|FG001|Overall Study|Death|92|||
30861687|NCT02611960|58891151|FG000|Overall Study|Withdrawal by Subject|1|||
30861688|NCT02611960|58891152|FG001|Overall Study|Withdrawal by Subject|5|||
30861689|NCT02611960|58891151|FG000|Overall Study|Sponsor Decision|11|||
30861690|NCT02611960|58891152|FG001|Overall Study|Sponsor Decision|11|||
30861691|NCT01909453|58891164|FG000|Overall Study|Ongoing|118|||
30861692|NCT01909453|58891165|FG001|Overall Study|Ongoing|103|||
30861693|NCT01909453|58891166|FG002|Overall Study|Ongoing|83|||
30861694|NCT01909453|58891167|FG003|Overall Study|Ongoing|164|||
30861695|NCT01909453|58891168|FG004|Overall Study|Ongoing|50|||
30861696|NCT01909453|58891164|FG000|Overall Study|Death|69|||
30861697|NCT01909453|58891165|FG001|Overall Study|Death|74|||
30861698|NCT01909453|58891166|FG002|Overall Study|Death|88|||
30861699|NCT01909453|58891167|FG003|Overall Study|Death|86|||
30861700|NCT01909453|58891168|FG004|Overall Study|Death|29|||
30861701|NCT01909453|58891164|FG000|Overall Study|Lost to Follow-up|3|||
30861702|NCT01909453|58891165|FG001|Overall Study|Lost to Follow-up|4|||
30861703|NCT01909453|58891166|FG002|Overall Study|Lost to Follow-up|4|||
30861704|NCT01909453|58891167|FG003|Overall Study|Lost to Follow-up|3|||
30861705|NCT01909453|58891168|FG004|Overall Study|Lost to Follow-up|3|||
30861706|NCT01909453|58891164|FG000|Overall Study|Withdrawal by Subject|2|||
30861707|NCT01909453|58891165|FG001|Overall Study|Withdrawal by Subject|13|||
30861708|NCT01909453|58891166|FG002|Overall Study|Withdrawal by Subject|16|||
30861709|NCT01909453|58891167|FG003|Overall Study|Withdrawal by Subject|5|||
30861710|NCT01909453|58891168|FG004|Overall Study|Withdrawal by Subject|4|||
30861711|NCT01845597|58891186|FG000|Overall Study|Death|8|||
30861712|NCT01845597|58891186|FG000|Overall Study|Lost to Follow-up|22|||
30861713|NCT01275677|58891206|FG000|Overall Study|Not at risk for recurrence.|1|||
30861714|NCT01275677|58891207|FG001|Overall Study|Not at risk for recurrence.|1|||
30861715|NCT01275677|58891206|FG000|Overall Study|No follow-up|26|||
30861716|NCT01275677|58891207|FG001|Overall Study|No follow-up|37|||
30861717|NCT01275677|58891206|FG000|Overall Study|No clinical follow up.|1|||
30861718|NCT01275677|58891207|FG001|Overall Study|No clinical follow up.|4|||
30861719|NCT00713206|58891223|FG000|Overall Study|Lost to Follow-up|4|||
30861720|NCT00713206|58891224|FG001|Overall Study|Lost to Follow-up|4|||
30861721|NCT00713206|58891223|FG000|Overall Study|Death|1|||
30861722|NCT00713206|58891224|FG001|Overall Study|Death|0|||
30861723|NCT00644228|58891232|FG000|Randomization & Eligibility|Ineligible|31|||
30861724|NCT00644228|58891233|FG001|Randomization & Eligibility|Ineligible|21|||
30861725|NCT00644228|58891232|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
30861726|NCT00644228|58891233|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
30861727|NCT00644228|58891232|FG000|Randomization & Eligibility|Invalid Consent|0|||
30861728|NCT00644228|58891233|FG001|Randomization & Eligibility|Invalid Consent|1|||
30861729|NCT00644228|58891232|FG000|Induction Therapy|Adverse Event|22|||
30861730|NCT00644228|58891233|FG001|Induction Therapy|Adverse Event|55|||
30861731|NCT00644228|58891232|FG000|Induction Therapy|Withdrawal by Subject|10|||
30861732|NCT00644228|58891233|FG001|Induction Therapy|Withdrawal by Subject|3|||
30861733|NCT00644228|58891232|FG000|Induction Therapy|Progression/Relapse|24|||
30861734|NCT00644228|58891233|FG001|Induction Therapy|Progression/Relapse|12|||
30861735|NCT00644228|58891232|FG000|Induction Therapy|Death|3|||
30861736|NCT00644228|58891233|FG001|Induction Therapy|Death|7|||
30861737|NCT00644228|58891232|FG000|Induction Therapy|Not Protocol-Specified|24|||
30861738|NCT00644228|58891233|FG001|Induction Therapy|Not Protocol-Specified|28|||
30861739|NCT00644228|58891232|FG000|Maintenance|Adverse Event|27|||
30861740|NCT00644228|58891233|FG001|Maintenance|Adverse Event|31|||
30861741|NCT00644228|58891232|FG000|Maintenance|Withdrawal by Subject|6|||
30861742|NCT00644228|58891233|FG001|Maintenance|Withdrawal by Subject|4|||
30861743|NCT00644228|58891232|FG000|Maintenance|Progression/Relapse|67|||
30861744|NCT00644228|58891233|FG001|Maintenance|Progression/Relapse|42|||
30861745|NCT00644228|58891232|FG000|Maintenance|Death|3|||
30861746|NCT00644228|58891233|FG001|Maintenance|Death|3|||
30861747|NCT00644228|58891232|FG000|Maintenance|Not Protocol-Specified|14|||
30861748|NCT00644228|58891233|FG001|Maintenance|Not Protocol-Specified|15|||
30861749|NCT00644228|58891232|FG000|Maintenance|On Treatment|26|||
30861750|NCT00644228|58891233|FG001|Maintenance|On Treatment|40|||
30861751|NCT00495131|58891241|FG000|Overall Study|Adverse Event|6|||
30861752|NCT00495131|58891242|FG001|Overall Study|Adverse Event|2|||
30861753|NCT00495131|58891241|FG000|Overall Study|Lack of Efficacy|0|||
30861754|NCT00495131|58891242|FG001|Overall Study|Lack of Efficacy|2|||
30861755|NCT00495131|58891241|FG000|Overall Study|Lost to Follow-up|0|||
30600137|NCT01090492|58611852|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
30600138|NCT01090492|58611853|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
30600139|NCT01090492|58611854|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
30600140|NCT01090492|58611855|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
30600141|NCT01090492|58611856|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
30600142|NCT01090492|58611857|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
30600143|NCT01090492|58611850|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600144|NCT01090492|58611851|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600145|NCT01090492|58611852|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
30600146|NCT01090492|58611853|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600147|NCT01090492|58611854|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600148|NCT01090492|58611855|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600149|NCT01090492|58611856|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600150|NCT01090492|58611857|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600151|NCT01090492|58611850|FG000|First Intervention Period (4 Weeks)|Other|0|||
30600152|NCT01090492|58611851|FG001|First Intervention Period (4 Weeks)|Other|0|||
30600153|NCT01090492|58611852|FG002|First Intervention Period (4 Weeks)|Other|1|||
30600154|NCT01090492|58611853|FG003|First Intervention Period (4 Weeks)|Other|1|||
30600155|NCT01090492|58611854|FG004|First Intervention Period (4 Weeks)|Other|2|||
30600156|NCT01090492|58611855|FG005|First Intervention Period (4 Weeks)|Other|0|||
30600157|NCT01090492|58611856|FG006|First Intervention Period (4 Weeks)|Other|0|||
30600158|NCT01090492|58611857|FG007|First Intervention Period (4 Weeks)|Other|0|||
30600159|NCT01090492|58611850|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
30600160|NCT01090492|58611851|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
30600161|NCT01090492|58611852|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
30600162|NCT01090492|58611853|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
30600163|NCT01090492|58611854|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
30600164|NCT01090492|58611855|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
30600165|NCT01090492|58611856|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
30600166|NCT01090492|58611857|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
30600167|NCT01090492|58611850|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
30600168|NCT01090492|58611851|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
30600169|NCT01090492|58611852|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
30600170|NCT01090492|58611853|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
30600171|NCT01090492|58611854|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
30600172|NCT01090492|58611855|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
30600173|NCT01090492|58611856|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
30600174|NCT01090492|58611857|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
30600175|NCT01090492|58611850|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
30600176|NCT01090492|58611851|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
30600177|NCT01090492|58611852|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
30600178|NCT01090492|58611853|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
30600179|NCT01090492|58611854|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
30600180|NCT01090492|58611855|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
30600181|NCT01090492|58611856|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
30600182|NCT01090492|58611857|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
30600183|NCT01090492|58611850|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
30600184|NCT01090492|58611851|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
30600185|NCT01090492|58611852|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
30600186|NCT01090492|58611853|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
30600187|NCT01090492|58611854|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
30600188|NCT01090492|58611855|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
30600189|NCT01090492|58611856|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
30600190|NCT01090492|58611857|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
30600191|NCT01090492|58611850|FG000|Second Intervention Period (4 Weeks)|Other|0|||
30861756|NCT00495131|58891242|FG001|Overall Study|Lost to Follow-up|2|||
30861757|NCT00495131|58891241|FG000|Overall Study|Withdrawal by Subject|1|||
30861758|NCT00495131|58891242|FG001|Overall Study|Withdrawal by Subject|0|||
30861759|NCT02257372|58891248|FG000|Overall Study|Adverse Event|3|||
30861760|NCT02257372|58891249|FG001|Overall Study|Adverse Event|7|||
30861761|NCT02257372|58891248|FG000|Overall Study|Lack of Efficacy|2|||
30861762|NCT02257372|58891249|FG001|Overall Study|Lack of Efficacy|1|||
30861763|NCT02257372|58891248|FG000|Overall Study|Protocol Violation|1|||
30861764|NCT02257372|58891249|FG001|Overall Study|Protocol Violation|1|||
30861765|NCT02257372|58891248|FG000|Overall Study|Lost to Follow-up|0|||
30959618|NCT01566721|59025135|FG001|Treatment Period|Other|2|||
30959619|NCT01566721|59025134|FG000|Treatment Period|Lack of Compliance|5|||
30861766|NCT02257372|58891249|FG001|Overall Study|Lost to Follow-up|1|||
30861767|NCT02257372|58891248|FG000|Overall Study|Withdrew consent|1|||
30861768|NCT02257372|58891249|FG001|Overall Study|Withdrew consent|0|||
30861769|NCT02256982|58891257|FG000|Overall Study|Disease Progression|0|||
30861770|NCT02256982|58891258|FG001|Overall Study|Disease Progression|1|||
30861771|NCT02736721|58891264|FG000|Overall Study|Adverse Event|8|||
30861772|NCT02736721|58891264|FG000|Overall Study|Lost to Follow-up|3|||
30861773|NCT02736721|58891264|FG000|Overall Study|Other|5|||
30861774|NCT04176445|58891268|FG000|Overall Study|Adverse Event|0|||
30861775|NCT04176445|58891269|FG001|Overall Study|Adverse Event|1|||
30861776|NCT04176445|58891268|FG000|Overall Study|change plans weaning after first intervention|0|||
30861777|NCT04176445|58891269|FG001|Overall Study|change plans weaning after first intervention|1|||
30861778|NCT02738203|58891277|FG000|Overall Study|Failed IUD Insertion|2|||
30861779|NCT02738203|58891278|FG001|Overall Study|Failed IUD Insertion|2|||
30861780|NCT02738203|58891277|FG000|Overall Study|Protocol Violation|0|||
30861781|NCT02738203|58891278|FG001|Overall Study|Protocol Violation|1|||
30861782|NCT02452034|58891290|FG000|Overall Study|Adverse Event|0|||
30861783|NCT02452034|58891291|FG001|Overall Study|Adverse Event|0|||
30861784|NCT02452034|58891292|FG002|Overall Study|Adverse Event|0|||
30861785|NCT02452034|58891293|FG003|Overall Study|Adverse Event|0|||
30861786|NCT02452034|58891294|FG004|Overall Study|Adverse Event|0|||
30861787|NCT02452034|58891295|FG005|Overall Study|Adverse Event|1|||
30861788|NCT02452034|58891290|FG000|Overall Study|Death|0|||
30861789|NCT02452034|58891291|FG001|Overall Study|Death|0|||
30861790|NCT02452034|58891292|FG002|Overall Study|Death|0|||
30861791|NCT02452034|58891293|FG003|Overall Study|Death|0|||
30861792|NCT02452034|58891294|FG004|Overall Study|Death|1|||
30861793|NCT02452034|58891295|FG005|Overall Study|Death|1|||
30861794|NCT02452034|58891290|FG000|Overall Study|Physician Decision|0|||
30861795|NCT02452034|58891291|FG001|Overall Study|Physician Decision|1|||
30861796|NCT02452034|58891292|FG002|Overall Study|Physician Decision|1|||
30861797|NCT02452034|58891293|FG003|Overall Study|Physician Decision|0|||
30861798|NCT02452034|58891294|FG004|Overall Study|Physician Decision|0|||
30861799|NCT02452034|58891295|FG005|Overall Study|Physician Decision|0|||
30861800|NCT02452034|58891290|FG000|Overall Study|Protocol Violation|0|||
30861801|NCT02452034|58891291|FG001|Overall Study|Protocol Violation|0|||
30861802|NCT02452034|58891292|FG002|Overall Study|Protocol Violation|0|||
30861803|NCT02452034|58891293|FG003|Overall Study|Protocol Violation|0|||
30861804|NCT02452034|58891294|FG004|Overall Study|Protocol Violation|0|||
30861805|NCT02452034|58891295|FG005|Overall Study|Protocol Violation|1|||
30861806|NCT02452034|58891290|FG000|Overall Study|Screen Failure|1|||
30861807|NCT02452034|58891291|FG001|Overall Study|Screen Failure|0|||
30861808|NCT02452034|58891292|FG002|Overall Study|Screen Failure|0|||
30861809|NCT02452034|58891293|FG003|Overall Study|Screen Failure|1|||
30861810|NCT02452034|58891294|FG004|Overall Study|Screen Failure|0|||
30861811|NCT02452034|58891295|FG005|Overall Study|Screen Failure|0|||
30861812|NCT02452034|58891290|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
30861813|NCT02452034|58891291|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
30861814|NCT02452034|58891292|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
30861815|NCT02452034|58891293|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
30861816|NCT02452034|58891294|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
30861817|NCT02452034|58891295|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
30861818|NCT02482298|58891322|FG000|Overall Study|Withdrawal by Subject|2|||
30861819|NCT02482298|58891323|FG001|Overall Study|Withdrawal by Subject|1|||
30861820|NCT02482298|58891324|FG002|Overall Study|Withdrawal by Subject|2|||
30861821|NCT02482298|58891322|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
30861822|NCT02482298|58891323|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
30861823|NCT02482298|58891324|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
30861824|NCT02482298|58891322|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
30861825|NCT02482298|58891323|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
30861826|NCT02482298|58891324|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
30861827|NCT02482298|58891322|FG000|Overall Study|Lost to Follow-up|0|||
30861828|NCT02482298|58891323|FG001|Overall Study|Lost to Follow-up|1|||
30959620|NCT01566721|59025135|FG001|Treatment Period|Lack of Compliance|1|||
30959621|NCT01566721|59025134|FG000|Treatment Period|Adverse Event|100|||
30861829|NCT02482298|58891324|FG002|Overall Study|Lost to Follow-up|0|||
30861830|NCT00440531|58891335|FG000|Overall Study|Adverse Event|1|||
30861831|NCT00440531|58891336|FG001|Overall Study|Adverse Event|0|||
30861832|NCT00440531|58891337|FG002|Overall Study|Adverse Event|2|||
30861833|NCT00440531|58891335|FG000|Overall Study|Withdrawal by Subject|2|||
30959622|NCT01566721|59025135|FG001|Treatment Period|Adverse Event|30|||
30959623|NCT01566721|59025134|FG000|Treatment Period|Pregnancy|1|||
30861834|NCT00440531|58891336|FG001|Overall Study|Withdrawal by Subject|0|||
30861835|NCT00440531|58891337|FG002|Overall Study|Withdrawal by Subject|0|||
30861836|NCT00440531|58891335|FG000|Overall Study|Protocol Violation|1|||
30861837|NCT00440531|58891336|FG001|Overall Study|Protocol Violation|2|||
30861838|NCT00440531|58891337|FG002|Overall Study|Protocol Violation|0|||
30959624|NCT01566721|59025135|FG001|Treatment Period|Pregnancy|0|||
30861839|NCT00440531|58891335|FG000|Overall Study|Lost to Follow-up|4|||
30861840|NCT00440531|58891336|FG001|Overall Study|Lost to Follow-up|3|||
30861841|NCT00440531|58891337|FG002|Overall Study|Lost to Follow-up|5|||
30861842|NCT00440531|58891335|FG000|Overall Study|see pre-assignment details|2|||
30861843|NCT00440531|58891336|FG001|Overall Study|see pre-assignment details|0|||
30861844|NCT00440531|58891337|FG002|Overall Study|see pre-assignment details|0|||
30861845|NCT02513732|58891343|FG000|Overall Study|Lost to Follow-up|11|||
30861846|NCT02513732|58891343|FG000|Overall Study|Death|9|||
30861847|NCT02513732|58891343|FG000|Overall Study|Changing hospital|2|||
30861848|NCT00429923|58891350|FG000|Overall Study|Adverse Event|0|||
30861849|NCT00429923|58891351|FG001|Overall Study|Adverse Event|2|||
30861850|NCT00429923|58891352|FG002|Overall Study|Adverse Event|3|||
30861851|NCT00429923|58891350|FG000|Overall Study|Lack of Efficacy|4|||
30861852|NCT00429923|58891351|FG001|Overall Study|Lack of Efficacy|1|||
30861853|NCT00429923|58891352|FG002|Overall Study|Lack of Efficacy|33|||
30861854|NCT00429923|58891350|FG000|Overall Study|Lost to Follow-up|0|||
30861855|NCT00429923|58891351|FG001|Overall Study|Lost to Follow-up|0|||
30861856|NCT00429923|58891352|FG002|Overall Study|Lost to Follow-up|2|||
30861857|NCT00429923|58891350|FG000|Overall Study|Withdrew Consent|1|||
30861858|NCT00429923|58891351|FG001|Overall Study|Withdrew Consent|0|||
30861859|NCT00429923|58891352|FG002|Overall Study|Withdrew Consent|1|||
30861860|NCT00429923|58891350|FG000|Overall Study|Early Termination|0|||
30861861|NCT00429923|58891351|FG001|Overall Study|Early Termination|1|||
30861862|NCT00429923|58891352|FG002|Overall Study|Early Termination|0|||
30861863|NCT02256436|58891359|FG000|Overall Study|Adverse Event|9|||
30861864|NCT02256436|58891360|FG001|Overall Study|Adverse Event|14|||
30861865|NCT02256436|58891359|FG000|Overall Study|Death|216|||
30861866|NCT02256436|58891360|FG001|Overall Study|Death|208|||
30861867|NCT02256436|58891359|FG000|Overall Study|Lost to Follow-up|1|||
30861868|NCT02256436|58891360|FG001|Overall Study|Lost to Follow-up|2|||
30861869|NCT02256436|58891359|FG000|Overall Study|Physician Decision|1|||
30861870|NCT02256436|58891360|FG001|Overall Study|Physician Decision|0|||
30861871|NCT02256436|58891359|FG000|Overall Study|Protocol Violation|0|||
30861872|NCT02256436|58891360|FG001|Overall Study|Protocol Violation|1|||
30861873|NCT02256436|58891359|FG000|Overall Study|Withdrawal by Subject|26|||
30861874|NCT02256436|58891360|FG001|Overall Study|Withdrawal by Subject|10|||
30861875|NCT02256436|58891359|FG000|Overall Study|Transferred to Extension Study|11|||
30861876|NCT02256436|58891360|FG001|Overall Study|Transferred to Extension Study|23|||
30861877|NCT02256436|58891359|FG000|Overall Study|Did Not Continue on Extension Study|8|||
30861878|NCT02256436|58891360|FG001|Overall Study|Did Not Continue on Extension Study|12|||
30861879|NCT00326183|58891369|FG000|Overall Study|Lost to Follow-up|104|||
30861880|NCT00326183|58891370|FG001|Overall Study|Lost to Follow-up|56|||
30861881|NCT00326183|58891369|FG000|Overall Study|Protocol Violation|6|||
30861882|NCT00326183|58891370|FG001|Overall Study|Protocol Violation|3|||
30861883|NCT00326183|58891369|FG000|Overall Study|Withdrawal by Subject|35|||
30861884|NCT00326183|58891370|FG001|Overall Study|Withdrawal by Subject|7|||
30861885|NCT00326183|58891369|FG000|Overall Study|Subject Moved|7|||
30861886|NCT00326183|58891370|FG001|Overall Study|Subject Moved|4|||
30861887|NCT00326183|58891369|FG000|Overall Study|Other|47|||
30861888|NCT00326183|58891370|FG001|Overall Study|Other|13|||
30861889|NCT00326183|58891369|FG000|Overall Study|Adverse Event|1|||
30861890|NCT00326183|58891370|FG001|Overall Study|Adverse Event|0|||
30861891|NCT02481050|58891374|FG000|Overall Study|Adverse Event|1|||
30861892|NCT02481050|58891374|FG000|Overall Study|Disease Progression|47|||
30861893|NCT02481050|58891374|FG000|Overall Study|Withdrawal by Subject|7|||
30861894|NCT02481050|58891374|FG000|Overall Study|Other|3|||
30861895|NCT02511782|58891381|FG000|Overall Study|Withdrawal by Subject|1|||
30861896|NCT02511782|58891382|FG001|Overall Study|Withdrawal by Subject|0|||
30861897|NCT02511782|58891383|FG002|Overall Study|Withdrawal by Subject|0|||
30861898|NCT02480114|58891393|FG000|Overall Study|Not completing surveys|3|||
30861899|NCT02480114|58891394|FG001|Overall Study|Not completing surveys|2|||
30861900|NCT02480114|58891393|FG000|Overall Study|Withdrawal by Subject|2|||
30861901|NCT02480114|58891394|FG001|Overall Study|Withdrawal by Subject|4|||
30861902|NCT02480114|58891393|FG000|Overall Study|Disease progression|3|||
30861903|NCT02480114|58891394|FG001|Overall Study|Disease progression|0|||
30861904|NCT02480114|58891393|FG000|Overall Study|Improper completion of survey|1|||
30861905|NCT02480114|58891394|FG001|Overall Study|Improper completion of survey|1|||
30861906|NCT02480114|58891393|FG000|Overall Study|Not eligible|0|||
30861907|NCT02480114|58891394|FG001|Overall Study|Not eligible|1|||
30861908|NCT02479880|58891402|FG000|Overall Study|Study Terminated by Sponsor|13|||
30861909|NCT02479880|58891403|FG001|Overall Study|Study Terminated by Sponsor|12|||
30861910|NCT02479880|58891402|FG000|Overall Study|Pregnancy|0|||
30861911|NCT02479880|58891403|FG001|Overall Study|Pregnancy|1|||
30861912|NCT02479802|58891409|FG000|Overall Study|Lost to Follow-up|1|||
30861913|NCT02479802|58891409|FG000|Overall Study|Adverse Event|1|||
30861914|NCT02479412|58891422|FG000|Overall Study|Adverse Event|0|||
30861915|NCT02479412|58891423|FG001|Overall Study|Adverse Event|0|||
30861916|NCT02479412|58891424|FG002|Overall Study|Adverse Event|1|||
30861917|NCT02479412|58891425|FG003|Overall Study|Adverse Event|0|||
30861918|NCT02479412|58891426|FG004|Overall Study|Adverse Event|0|||
30861919|NCT02479412|58891427|FG005|Overall Study|Adverse Event|0|||
30861920|NCT02479412|58891428|FG006|Overall Study|Adverse Event|0|||
30861921|NCT02479412|58891429|FG007|Overall Study|Adverse Event|0|||
30861922|NCT02479412|58891430|FG008|Overall Study|Adverse Event|0|||
30861923|NCT02479412|58891422|FG000|Overall Study|Study-specific withdrawal criteria|0|||
30861924|NCT02479412|58891423|FG001|Overall Study|Study-specific withdrawal criteria|0|||
30861925|NCT02479412|58891424|FG002|Overall Study|Study-specific withdrawal criteria|1|||
30861926|NCT02479412|58891425|FG003|Overall Study|Study-specific withdrawal criteria|1|||
30861927|NCT02479412|58891426|FG004|Overall Study|Study-specific withdrawal criteria|0|||
30861928|NCT02479412|58891427|FG005|Overall Study|Study-specific withdrawal criteria|0|||
30861929|NCT02479412|58891428|FG006|Overall Study|Study-specific withdrawal criteria|0|||
30861930|NCT02479412|58891429|FG007|Overall Study|Study-specific withdrawal criteria|1|||
30861931|NCT02479412|58891430|FG008|Overall Study|Study-specific withdrawal criteria|1|||
30861932|NCT02479412|58891422|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
30861933|NCT02479412|58891423|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
30861934|NCT02479412|58891424|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
30861935|NCT02479412|58891425|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
30861936|NCT02479412|58891426|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
30861937|NCT02479412|58891427|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
30861938|NCT02479412|58891428|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
30861939|NCT02479412|58891429|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
30861940|NCT02479412|58891430|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
30861941|NCT00224003|58891446|FG000|Overall Study|Adverse Event|1|||
30861942|NCT00224003|58891446|FG000|Overall Study|Protocol Violation|2|||
30861943|NCT00224003|58891446|FG000|Overall Study|Withdrawal by Subject|1|||
30861944|NCT00224003|58891446|FG000|Overall Study|unk|3|||
30861945|NCT02450552|58891452|FG000|Overall Study|Withdrawal by Subject|4|||
30861946|NCT02450552|58891453|FG001|Overall Study|Withdrawal by Subject|0|||
30861947|NCT02450552|58891454|FG002|Overall Study|Withdrawal by Subject|4|||
30861948|NCT02450552|58891452|FG000|Overall Study|Physician Decision|1|||
30861949|NCT02450552|58891453|FG001|Overall Study|Physician Decision|0|||
30861950|NCT02450552|58891454|FG002|Overall Study|Physician Decision|1|||
30861951|NCT02508428|58891464|FG000|Overall Study|Death|32|||
30861952|NCT02508428|58891465|FG001|Overall Study|Death|33|||
30861953|NCT02508428|58891464|FG000|Overall Study|Liner revised|3|||
30861954|NCT02508428|58891465|FG001|Overall Study|Liner revised|19|||
30861955|NCT02508428|58891464|FG000|Overall Study|Incomplete follow-up|17|||
30861956|NCT02508428|58891465|FG001|Overall Study|Incomplete follow-up|15|||
30861957|NCT02448680|58891473|FG000|Overall Study|Physician Decision|1|||
30861958|NCT02448680|58891474|FG001|Overall Study|Physician Decision|1|||
30861959|NCT02448680|58891473|FG000|Overall Study|Withdrawal by Subject|0|||
30861960|NCT02448680|58891474|FG001|Overall Study|Withdrawal by Subject|2|||
30861961|NCT02448446|58891484|FG000|Overall Study|Withdrawal by Subject|1|||
30861962|NCT02448446|58891485|FG001|Overall Study|Withdrawal by Subject|0|||
30861963|NCT02447744|58891493|FG000|Overall Study|Withdrawal by Subject|3|||
30861964|NCT02447744|58891494|FG001|Overall Study|Withdrawal by Subject|1|||
30861965|NCT02447744|58891493|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
30861966|NCT02447744|58891494|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
30861967|NCT02478632|58891502|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
30861968|NCT02478632|58891503|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
30861969|NCT02478632|58891502|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
30861970|NCT02478632|58891503|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
30861971|NCT02478632|58891502|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
30861972|NCT02478632|58891503|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
30861973|NCT02478398|58891514|FG000|Overall Study|Adverse Event|20|||
30861974|NCT02478398|58891515|FG001|Overall Study|Adverse Event|5|||
30861975|NCT02478398|58891514|FG000|Overall Study|Lost to Follow-up|5|||
30861976|NCT02478398|58891515|FG001|Overall Study|Lost to Follow-up|4|||
30861977|NCT02478398|58891514|FG000|Overall Study|Non-Compliance With Study Drug|5|||
30861978|NCT02478398|58891515|FG001|Overall Study|Non-Compliance With Study Drug|1|||
30861979|NCT02478398|58891514|FG000|Overall Study|Protocol Violation|3|||
30861980|NCT02478398|58891515|FG001|Overall Study|Protocol Violation|1|||
30861981|NCT02478398|58891514|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
30861982|NCT02478398|58891515|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
30861983|NCT02478398|58891514|FG000|Overall Study|Withdrawal By Participant|10|||
30861984|NCT02478398|58891515|FG001|Overall Study|Withdrawal By Participant|4|||
30861985|NCT02478164|58891522|FG000|Overall Study|Lack of Efficacy|13|||
30861986|NCT02478164|58891522|FG000|Overall Study|Adverse Event|1|||
30861987|NCT02478164|58891522|FG000|Overall Study|Withdrawal by Subject|1|||
30861988|NCT02476994|58891528|FG000|Overall Study|Based on feedback from FDA|1|||
30861989|NCT02476994|58891529|FG001|Overall Study|Based on feedback from FDA|0|||
30861990|NCT02508194|58891537|FG000|Overall Study|Death|5|||
30861991|NCT02508194|58891538|FG001|Overall Study|Death|3|||
30861992|NCT02508194|58891537|FG000|Overall Study|Lost to Follow-up|25|||
30861993|NCT02508194|58891538|FG001|Overall Study|Lost to Follow-up|18|||
30861994|NCT02508194|58891537|FG000|Overall Study|Withdrawal by Subject|20|||
30861995|NCT02508194|58891538|FG001|Overall Study|Withdrawal by Subject|18|||
30861996|NCT02508194|58891537|FG000|Overall Study|Error in Randomization|1|||
30861997|NCT02508194|58891538|FG001|Overall Study|Error in Randomization|3|||
30861998|NCT02508194|58891537|FG000|Overall Study|Principal Investigator Decision|1|||
30861999|NCT02508194|58891538|FG001|Overall Study|Principal Investigator Decision|2|||
30862000|NCT02508116|58891546|FG000|Overall Study|Lost to Follow-up|2|||
30862001|NCT02508116|58891547|FG001|Overall Study|Lost to Follow-up|3|||
30862002|NCT02508116|58891546|FG000|Overall Study|Withdrawal by Subject|3|||
30862003|NCT02508116|58891547|FG001|Overall Study|Withdrawal by Subject|2|||
30862004|NCT02508116|58891546|FG000|Overall Study|Protocol Violation|1|||
30862005|NCT02508116|58891547|FG001|Overall Study|Protocol Violation|2|||
30862006|NCT02508116|58891546|FG000|Overall Study|Physician Decision|2|||
30862007|NCT02508116|58891547|FG001|Overall Study|Physician Decision|0|||
30862008|NCT01653782|58891556|FG000|Overall Study|Withdrawal by Subject|9|||
30862009|NCT01653782|58891557|FG001|Overall Study|Withdrawal by Subject|15|||
30862010|NCT01653782|58891558|FG002|Overall Study|Withdrawal by Subject|4|||
30862011|NCT01653782|58891556|FG000|Overall Study|Lost to Follow-up|7|||
30862012|NCT01653782|58891557|FG001|Overall Study|Lost to Follow-up|3|||
30862013|NCT01653782|58891558|FG002|Overall Study|Lost to Follow-up|2|||
30862014|NCT02318329|58891576|FG000|Overall Study|Progressive Disease|2|||
30862015|NCT02318329|58891577|FG001|Overall Study|Progressive Disease|3|||
30862016|NCT02318329|58891578|FG002|Overall Study|Progressive Disease|2|||
30862017|NCT02318329|58891579|FG003|Overall Study|Progressive Disease|3|||
30862018|NCT02318329|58891580|FG004|Overall Study|Progressive Disease|3|||
30862019|NCT02318329|58891581|FG005|Overall Study|Progressive Disease|3|||
30862020|NCT02318329|58891582|FG006|Overall Study|Progressive Disease|1|||
30862021|NCT02318329|58891583|FG007|Overall Study|Progressive Disease|1|||
30959625|NCT01566721|59025134|FG000|Safety Follow-up|Physician Decision|6|||
30959626|NCT01566721|59025135|FG001|Safety Follow-up|Physician Decision|4|||
30959627|NCT01566721|59025134|FG000|Safety Follow-up|Lost to Follow-up|101|||
30959628|NCT01566721|59025135|FG001|Safety Follow-up|Lost to Follow-up|48|||
30959629|NCT01566721|59025134|FG000|Safety Follow-up|Withdrawal by Subject|155|||
30959630|NCT01566721|59025135|FG001|Safety Follow-up|Withdrawal by Subject|49|||
30959631|NCT01566721|59025134|FG000|Safety Follow-up|Death|28|||
30959632|NCT01566721|59025135|FG001|Safety Follow-up|Death|4|||
30959633|NCT01566721|59025134|FG000|Safety Follow-up|Non-compliance|7|||
30959634|NCT01566721|59025135|FG001|Safety Follow-up|Non-compliance|3|||
30959635|NCT01566721|59025134|FG000|Safety Follow-up|Protocol Violation|7|||
30959636|NCT01566721|59025135|FG001|Safety Follow-up|Protocol Violation|0|||
30959637|NCT01566721|59025134|FG000|Safety Follow-up|Site closure|2|||
30959638|NCT01566721|59025135|FG001|Safety Follow-up|Site closure|3|||
30959639|NCT01566721|59025134|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
30959640|NCT01566721|59025135|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
30959641|NCT01566721|59025134|FG000|Safety Follow-up|Missing|7|||
30959642|NCT01566721|59025135|FG001|Safety Follow-up|Missing|2|||
30959643|NCT01566721|59025134|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
30959644|NCT01566721|59025135|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
30959645|NCT01566721|59025134|FG000|Safety Follow-up|Sponsor decision|1|||
30959646|NCT01566721|59025135|FG001|Safety Follow-up|Sponsor decision|0|||
30959647|NCT01566721|59025134|FG000|Safety Follow-up|Adverse Event|8|||
30959648|NCT01566721|59025135|FG001|Safety Follow-up|Adverse Event|4|||
30959649|NCT01541215|59025150|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
30959650|NCT01541215|59025151|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
30959651|NCT01541215|59025150|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
30959652|NCT01541215|59025151|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
30959653|NCT01541215|59025150|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
30959654|NCT01541215|59025151|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
30959655|NCT01541215|59025150|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
30959656|NCT01541215|59025151|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
30959657|NCT01541215|59025150|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
30959658|NCT01541215|59025151|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
30959659|NCT01541215|59025150|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
30959660|NCT01541215|59025151|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
30862022|NCT02318329|58891584|FG008|Overall Study|Progressive Disease|5|||
30862023|NCT02318329|58891585|FG009|Overall Study|Progressive Disease|39|||
30862024|NCT02318329|58891576|FG000|Overall Study|Death|0|||
30862025|NCT02318329|58891577|FG001|Overall Study|Death|0|||
30862026|NCT02318329|58891578|FG002|Overall Study|Death|0|||
30862027|NCT02318329|58891579|FG003|Overall Study|Death|0|||
30959661|NCT01540981|59025163|FG000|Overall Study|Withdrawal by Subject|1|||
30959662|NCT01540981|59025164|FG001|Overall Study|Withdrawal by Subject|0|||
30959663|NCT01585987|59025172|FG000|Randomized|Withdrawal by Subject|0|||
30959664|NCT01585987|59025173|FG001|Randomized|Withdrawal by Subject|4|||
30959665|NCT01585987|59025172|FG000|Randomized|No longer met criteria|0|||
30862028|NCT02318329|58891580|FG004|Overall Study|Death|0|||
30862029|NCT02318329|58891581|FG005|Overall Study|Death|0|||
30862030|NCT02318329|58891582|FG006|Overall Study|Death|0|||
30862031|NCT02318329|58891583|FG007|Overall Study|Death|0|||
30862032|NCT02318329|58891584|FG008|Overall Study|Death|0|||
30862033|NCT02318329|58891585|FG009|Overall Study|Death|5|||
30862034|NCT02318329|58891576|FG000|Overall Study|Lost to Follow-up|0|||
30862035|NCT02318329|58891577|FG001|Overall Study|Lost to Follow-up|0|||
30862036|NCT02318329|58891578|FG002|Overall Study|Lost to Follow-up|0|||
30862037|NCT02318329|58891579|FG003|Overall Study|Lost to Follow-up|0|||
30862038|NCT02318329|58891580|FG004|Overall Study|Lost to Follow-up|0|||
30862039|NCT02318329|58891581|FG005|Overall Study|Lost to Follow-up|0|||
30862040|NCT02318329|58891582|FG006|Overall Study|Lost to Follow-up|0|||
30862041|NCT02318329|58891583|FG007|Overall Study|Lost to Follow-up|0|||
30862042|NCT02318329|58891584|FG008|Overall Study|Lost to Follow-up|0|||
30862043|NCT02318329|58891585|FG009|Overall Study|Lost to Follow-up|1|||
30862044|NCT02318329|58891576|FG000|Overall Study|Withdrawal by Subject|0|||
30862045|NCT02318329|58891577|FG001|Overall Study|Withdrawal by Subject|0|||
30862046|NCT02318329|58891578|FG002|Overall Study|Withdrawal by Subject|0|||
30862047|NCT02318329|58891579|FG003|Overall Study|Withdrawal by Subject|0|||
30862048|NCT02318329|58891580|FG004|Overall Study|Withdrawal by Subject|0|||
30862049|NCT02318329|58891581|FG005|Overall Study|Withdrawal by Subject|0|||
30862050|NCT02318329|58891582|FG006|Overall Study|Withdrawal by Subject|0|||
30862051|NCT02318329|58891583|FG007|Overall Study|Withdrawal by Subject|0|||
30862052|NCT02318329|58891584|FG008|Overall Study|Withdrawal by Subject|0|||
30862053|NCT02318329|58891585|FG009|Overall Study|Withdrawal by Subject|6|||
30862054|NCT02318329|58891576|FG000|Overall Study|Other|1|||
30862055|NCT02318329|58891577|FG001|Overall Study|Other|1|||
30862056|NCT02318329|58891578|FG002|Overall Study|Other|1|||
30862057|NCT02318329|58891579|FG003|Overall Study|Other|0|||
30862058|NCT02318329|58891580|FG004|Overall Study|Other|0|||
30862059|NCT02318329|58891581|FG005|Overall Study|Other|0|||
30862060|NCT02318329|58891582|FG006|Overall Study|Other|0|||
30959666|NCT01585987|59025173|FG001|Randomized|No longer met criteria|2|||
30959667|NCT01585987|59025172|FG000|Treated|Disease Progression|39|||
30959668|NCT01585987|59025173|FG001|Treated|Disease Progression|36|||
30959669|NCT01585987|59025172|FG000|Treated|Study Drug Toxicity|9|||
30959670|NCT01585987|59025173|FG001|Treated|Study Drug Toxicity|5|||
30959671|NCT01585987|59025172|FG000|Treated|Adverse Event|3|||
30959672|NCT01585987|59025173|FG001|Treated|Adverse Event|0|||
30959673|NCT01585987|59025172|FG000|Treated|Withdrawal by Subject|1|||
30959674|NCT01585987|59025173|FG001|Treated|Withdrawal by Subject|2|||
30959675|NCT01585987|59025172|FG000|Treated|Death|1|||
30959676|NCT01585987|59025173|FG001|Treated|Death|0|||
30959677|NCT01585987|59025172|FG000|Treated|Lost to Follow-up|0|||
30959678|NCT01585987|59025173|FG001|Treated|Lost to Follow-up|1|||
30959679|NCT01585987|59025172|FG000|Treated|Maximum Clinical Benefit|0|||
30959680|NCT01585987|59025173|FG001|Treated|Maximum Clinical Benefit|1|||
30959681|NCT01585987|59025172|FG000|Treated|Non-Specified|1|||
30959682|NCT01585987|59025173|FG001|Treated|Non-Specified|2|||
30959683|NCT01585987|59025172|FG000|Treated|Subject Request|0|||
30959684|NCT01585987|59025173|FG001|Treated|Subject Request|1|||
30959685|NCT01585987|59025172|FG000|Treated|Poor/Non-Compliance|0|||
30959686|NCT01585987|59025173|FG001|Treated|Poor/Non-Compliance|1|||
30959687|NCT01585831|59025182|FG000|Overall Study|Physician Decision|0|||
30959688|NCT01585831|59025183|FG001|Overall Study|Physician Decision|1|||
30959689|NCT01585831|59025182|FG000|Overall Study|Withdrawal by Subject|2|||
30959690|NCT01585831|59025183|FG001|Overall Study|Withdrawal by Subject|1|||
30959691|NCT01565941|59025191|FG000|Overall Study|Withdrawn by parent/guardian|3|||
30862061|NCT02318329|58891583|FG007|Overall Study|Other|0|||
30862062|NCT02318329|58891584|FG008|Overall Study|Other|1|||
30862063|NCT02318329|58891585|FG009|Overall Study|Other|1|||
30862064|NCT02255656|58891626|FG000|Overall Study|Adverse Event|11|||
30862065|NCT02255656|58891626|FG000|Overall Study|Poor compliance to protocol|3|||
30862066|NCT02255656|58891626|FG000|Overall Study|Lost to Follow-up|30|||
30862067|NCT02255656|58891626|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
30862068|NCT02255656|58891626|FG000|Overall Study|Other|126|||
30862069|NCT02255500|58891639|FG000|Overall Study|Withdrawal by Subject|1|||
30862070|NCT02255500|58891640|FG001|Overall Study|Withdrawal by Subject|0|||
30862071|NCT02505542|58891646|FG000|Part A: Open-Label Period|Adverse Event|31|||
30862072|NCT02505542|58891647|FG001|Part A: Open-Label Period|Adverse Event|0|||
30862073|NCT02505542|58891648|FG002|Part A: Open-Label Period|Adverse Event|0|||
30862074|NCT02505542|58891649|FG003|Part A: Open-Label Period|Adverse Event|0|||
30862075|NCT02505542|58891646|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
30959692|NCT01565941|59025192|FG001|Overall Study|Withdrawn by parent/guardian|2|||
30959693|NCT01565941|59025191|FG000|Overall Study|Randomized; did not receive intevention|8|||
30959694|NCT01565941|59025192|FG001|Overall Study|Randomized; did not receive intevention|2|||
30959695|NCT01558271|59025203|FG000|Overall Study|Adverse Event|6|||
30959696|NCT01558271|59025204|FG001|Overall Study|Adverse Event|3|||
30959697|NCT01558271|59025205|FG002|Overall Study|Adverse Event|4|||
30959698|NCT01558271|59025203|FG000|Overall Study|Lost to Follow-up|1|||
30862076|NCT02505542|58891647|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
30862077|NCT02505542|58891648|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
30862078|NCT02505542|58891649|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
30862079|NCT02505542|58891646|FG000|Part A: Open-Label Period|Protocol Violation|1|||
30862080|NCT02505542|58891647|FG001|Part A: Open-Label Period|Protocol Violation|0|||
30862081|NCT02505542|58891648|FG002|Part A: Open-Label Period|Protocol Violation|0|||
30600192|NCT01090492|58611851|FG001|Second Intervention Period (4 Weeks)|Other|1|||
30600193|NCT01090492|58611852|FG002|Second Intervention Period (4 Weeks)|Other|1|||
30600194|NCT01090492|58611853|FG003|Second Intervention Period (4 Weeks)|Other|0|||
30862082|NCT02505542|58891649|FG003|Part A: Open-Label Period|Protocol Violation|0|||
30862083|NCT02505542|58891646|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
30862084|NCT02505542|58891647|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
30862085|NCT02505542|58891648|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
30862086|NCT02505542|58891649|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
30862087|NCT02505542|58891646|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
30862088|NCT02505542|58891647|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
30862089|NCT02505542|58891648|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
30862090|NCT02505542|58891649|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
30862091|NCT02505542|58891646|FG000|Part A: Open-Label Period|New medical history available|1|||
30862092|NCT02505542|58891647|FG001|Part A: Open-Label Period|New medical history available|0|||
30862093|NCT02505542|58891648|FG002|Part A: Open-Label Period|New medical history available|0|||
30862094|NCT02505542|58891649|FG003|Part A: Open-Label Period|New medical history available|0|||
30600195|NCT01090492|58611854|FG004|Second Intervention Period (4 Weeks)|Other|0|||
30600196|NCT01090492|58611855|FG005|Second Intervention Period (4 Weeks)|Other|0|||
30600197|NCT01090492|58611856|FG006|Second Intervention Period (4 Weeks)|Other|0|||
30600198|NCT01090492|58611857|FG007|Second Intervention Period (4 Weeks)|Other|0|||
30600199|NCT01090492|58611850|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
30600200|NCT01090492|58611851|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
30600201|NCT01090492|58611852|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
30600202|NCT01090492|58611853|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
30600203|NCT01090492|58611854|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
30600204|NCT01090492|58611855|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
30600205|NCT01090492|58611856|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
30600206|NCT01090492|58611857|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
30600207|NCT01090492|58611850|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600208|NCT01090492|58611851|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600209|NCT01090492|58611852|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600210|NCT01090492|58611853|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600211|NCT01090492|58611854|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600212|NCT01090492|58611855|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600213|NCT01090492|58611856|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
30600214|NCT01090492|58611857|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
30600215|NCT01288911|58611878|FG000|Double-blind Period|Death|11|||
30600216|NCT01288911|58611879|FG001|Double-blind Period|Death|7|||
30600217|NCT01288911|58611878|FG000|Double-blind Period|Lost to Follow-up|0|||
30600218|NCT01288911|58611879|FG001|Double-blind Period|Lost to Follow-up|2|||
30600219|NCT01288911|58611878|FG000|Double-blind Period|Progressive Disease|75|||
30600220|NCT01288911|58611879|FG001|Double-blind Period|Progressive Disease|103|||
30600221|NCT01288911|58611878|FG000|Double-blind Period|Protocol Violation|1|||
30600222|NCT01288911|58611879|FG001|Double-blind Period|Protocol Violation|0|||
30600223|NCT01288911|58611878|FG000|Double-blind Period|Withdrawal by Subject|25|||
30600224|NCT01288911|58611879|FG001|Double-blind Period|Withdrawal by Subject|26|||
30600225|NCT01288911|58611878|FG000|Double-blind Period|Miscellaneous Reason|29|||
30600226|NCT01288911|58611879|FG001|Double-blind Period|Miscellaneous Reason|42|||
30600227|NCT01288911|58611878|FG000|Double-blind Period|Randomized but never received study drug|1|||
30600228|NCT01288911|58611879|FG001|Double-blind Period|Randomized but never received study drug|2|||
30600229|NCT01288911|58611878|FG000|Open-label Period (All Enzalutamide)|Death|0|||
30600230|NCT01288911|58611879|FG001|Open-label Period (All Enzalutamide)|Death|1|||
30600231|NCT01288911|58611878|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
30600232|NCT01288911|58611879|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
30600233|NCT01288911|58611878|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
30862095|NCT02505542|58891646|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
30862096|NCT02505542|58891647|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
30862097|NCT02505542|58891648|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
30862098|NCT02505542|58891649|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
30862099|NCT02505542|58891646|FG000|Part A: Open-Label Period|Pregnancy|2|||
30862100|NCT02505542|58891647|FG001|Part A: Open-Label Period|Pregnancy|0|||
30862101|NCT02505542|58891648|FG002|Part A: Open-Label Period|Pregnancy|0|||
30862102|NCT02505542|58891649|FG003|Part A: Open-Label Period|Pregnancy|0|||
30862103|NCT02505542|58891646|FG000|Part A: Open-Label Period|Sponsor directive|1|||
30862104|NCT02505542|58891647|FG001|Part A: Open-Label Period|Sponsor directive|0|||
30862105|NCT02505542|58891648|FG002|Part A: Open-Label Period|Sponsor directive|0|||
30862106|NCT02505542|58891649|FG003|Part A: Open-Label Period|Sponsor directive|0|||
30862107|NCT02505542|58891646|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
30862108|NCT02505542|58891647|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
30862109|NCT02505542|58891648|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
30862110|NCT02505542|58891649|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
30862111|NCT02505542|58891646|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
30862112|NCT02505542|58891647|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
30862113|NCT02505542|58891648|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
30862114|NCT02505542|58891649|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
30862115|NCT02505542|58891646|FG000|Part A: Open-Label Period|Non-compliance|1|||
30862116|NCT02505542|58891647|FG001|Part A: Open-Label Period|Non-compliance|0|||
30862117|NCT02505542|58891648|FG002|Part A: Open-Label Period|Non-compliance|0|||
30862118|NCT02505542|58891649|FG003|Part A: Open-Label Period|Non-compliance|0|||
30862119|NCT02505542|58891646|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
30862120|NCT02505542|58891647|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
30862121|NCT02505542|58891648|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
30862122|NCT02505542|58891649|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
30862123|NCT02505542|58891646|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
30862124|NCT02505542|58891647|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
30862125|NCT02505542|58891648|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
30862126|NCT02505542|58891649|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
30862127|NCT02505542|58891646|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
30862128|NCT02505542|58891647|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
30862129|NCT02505542|58891648|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
30862130|NCT02505542|58891649|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
30862131|NCT02505542|58891646|FG000|Part B: Double-Blind Period|Adverse Event|0|||
30862132|NCT02505542|58891647|FG001|Part B: Double-Blind Period|Adverse Event|0|||
30862133|NCT02505542|58891648|FG002|Part B: Double-Blind Period|Adverse Event|1|||
30862134|NCT02505542|58891649|FG003|Part B: Double-Blind Period|Adverse Event|3|||
30862135|NCT02505542|58891646|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
30862136|NCT02505542|58891647|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
30862137|NCT02505542|58891648|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
30862138|NCT02505542|58891649|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
30862139|NCT02505542|58891646|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
30862140|NCT02505542|58891647|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
30862141|NCT02505542|58891648|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
30862142|NCT02505542|58891649|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
30862143|NCT02505542|58891646|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
30862144|NCT02505542|58891647|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
30862145|NCT02505542|58891648|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
30862146|NCT02505542|58891649|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
30862147|NCT02505542|58891646|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
30862148|NCT02505542|58891647|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
30862149|NCT02505542|58891648|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
30862150|NCT02505542|58891649|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
30862151|NCT02505542|58891646|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
30862152|NCT02505542|58891647|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
30862153|NCT02505542|58891648|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
30862154|NCT02505542|58891649|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
30862155|NCT02505542|58891646|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
30862156|NCT02505542|58891647|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
30862157|NCT02505542|58891648|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
30959699|NCT01558271|59025204|FG001|Overall Study|Lost to Follow-up|0|||
30600234|NCT01288911|58611879|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
30862158|NCT02505542|58891649|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
30862159|NCT02505542|58891646|FG000|Part B: Double-Blind Period|Miscalculation|0|||
30862160|NCT02505542|58891647|FG001|Part B: Double-Blind Period|Miscalculation|1|||
30862161|NCT02505542|58891648|FG002|Part B: Double-Blind Period|Miscalculation|0|||
30862162|NCT02505542|58891649|FG003|Part B: Double-Blind Period|Miscalculation|0|||
30862163|NCT02505542|58891646|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
30862164|NCT02505542|58891647|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
30862165|NCT02505542|58891648|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
30862166|NCT02505542|58891649|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
30862167|NCT02475980|58891698|FG000|Overall Study|Lost to Follow-up|4|||
30862168|NCT02475980|58891698|FG000|Overall Study|Withdrawal by Subject|1|||
30862169|NCT02447432|58891704|FG000|Epoch 001|Adverse Event|1|||
30862170|NCT02447432|58891705|FG001|Epoch 001|Adverse Event|1|||
30862171|NCT02447432|58891704|FG000|Epoch 001|Withdrawal by Subject|0|||
30862172|NCT02447432|58891705|FG001|Epoch 001|Withdrawal by Subject|4|||
30862173|NCT02447432|58891704|FG000|Epoch 001|Migrated/moved from study area|3|||
30862174|NCT02447432|58891705|FG001|Epoch 001|Migrated/moved from study area|5|||
30862175|NCT02447432|58891704|FG000|Epoch 001|Lost to Follow-up|1|||
30862176|NCT02447432|58891705|FG001|Epoch 001|Lost to Follow-up|3|||
30862177|NCT02446886|58891713|FG000|Overall Study|Adverse Event|1|||
30862178|NCT02446886|58891714|FG001|Overall Study|Adverse Event|3|||
30862179|NCT02446886|58891713|FG000|Overall Study|Withdrawal by Subject|1|||
30862180|NCT02446886|58891714|FG001|Overall Study|Withdrawal by Subject|1|||
30862181|NCT03448939|58891732|FG000|Overall Study|Adverse Event|5|||
30862182|NCT03448939|58891733|FG001|Overall Study|Adverse Event|1|||
30862183|NCT03448939|58891732|FG000|Overall Study|Lost to Follow-up|6|||
30862184|NCT03448939|58891733|FG001|Overall Study|Lost to Follow-up|6|||
30862185|NCT03448939|58891732|FG000|Overall Study|Pregnancy|1|||
30862186|NCT03448939|58891733|FG001|Overall Study|Pregnancy|1|||
30862187|NCT03448939|58891732|FG000|Overall Study|Withdrawal by Subject|9|||
30862188|NCT03448939|58891733|FG001|Overall Study|Withdrawal by Subject|3|||
30862189|NCT02504294|58891751|FG000|Overall Study|Adverse Event|15|||
30862190|NCT02504294|58891752|FG001|Overall Study|Adverse Event|12|||
30862191|NCT02504294|58891751|FG000|Overall Study|Withdrawal by Subject|7|||
30862192|NCT02504294|58891752|FG001|Overall Study|Withdrawal by Subject|1|||
30862193|NCT02504294|58891751|FG000|Overall Study|Protocol Violation|27|||
30862194|NCT02504294|58891752|FG001|Overall Study|Protocol Violation|26|||
30862195|NCT02504294|58891751|FG000|Overall Study|Physician Decision|1|||
30862196|NCT02504294|58891752|FG001|Overall Study|Physician Decision|2|||
30862197|NCT02504294|58891751|FG000|Overall Study|Lost to Follow-up|6|||
30862198|NCT02504294|58891752|FG001|Overall Study|Lost to Follow-up|7|||
30862199|NCT02446418|58891760|FG000|Overall Study|Adverse Event|4|||
30862200|NCT02446418|58891761|FG001|Overall Study|Adverse Event|8|||
30862201|NCT02446418|58891760|FG000|Overall Study|Physician Decision|5|||
30862202|NCT02446418|58891761|FG001|Overall Study|Physician Decision|1|||
30862203|NCT02446418|58891760|FG000|Overall Study|Withdrawal by Subject|3|||
30862204|NCT02446418|58891761|FG001|Overall Study|Withdrawal by Subject|3|||
30862205|NCT02446418|58891760|FG000|Overall Study|Lost to Follow-up|2|||
30862206|NCT02446418|58891761|FG001|Overall Study|Lost to Follow-up|2|||
30862207|NCT02446418|58891760|FG000|Overall Study|Protocol Violation|1|||
30862208|NCT02446418|58891761|FG001|Overall Study|Protocol Violation|2|||
30862209|NCT02446418|58891760|FG000|Overall Study|Lack of Efficacy|2|||
30862210|NCT02446418|58891761|FG001|Overall Study|Lack of Efficacy|0|||
30862211|NCT02446418|58891760|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
30862212|NCT02446418|58891761|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
30862213|NCT02255422|58891774|FG000|Overall Study|Withdrawal by Subject|0|||
30862214|NCT02255422|58891775|FG001|Overall Study|Withdrawal by Subject|0|||
30862215|NCT02255422|58891776|FG002|Overall Study|Withdrawal by Subject|0|||
30862216|NCT02255422|58891777|FG003|Overall Study|Withdrawal by Subject|0|||
30862217|NCT02255422|58891778|FG004|Overall Study|Withdrawal by Subject|0|||
30862218|NCT02255422|58891779|FG005|Overall Study|Withdrawal by Subject|0|||
30862219|NCT02255422|58891780|FG006|Overall Study|Withdrawal by Subject|2|||
30862220|NCT02255422|58891774|FG000|Overall Study|Lost to Follow-up|0|||
30862221|NCT02255422|58891775|FG001|Overall Study|Lost to Follow-up|0|||
30862222|NCT02255422|58891776|FG002|Overall Study|Lost to Follow-up|1|||
30862223|NCT02255422|58891777|FG003|Overall Study|Lost to Follow-up|0|||
30862224|NCT02255422|58891778|FG004|Overall Study|Lost to Follow-up|0|||
30862225|NCT02255422|58891779|FG005|Overall Study|Lost to Follow-up|0|||
30862226|NCT02255422|58891780|FG006|Overall Study|Lost to Follow-up|0|||
30862227|NCT02445794|58891800|FG000|Overall Study|Adverse Event|0|||
30862228|NCT02445794|58891801|FG001|Overall Study|Adverse Event|0|||
30862229|NCT02445794|58891802|FG002|Overall Study|Adverse Event|2|||
30862230|NCT02445794|58891803|FG003|Overall Study|Adverse Event|0|||
30862231|NCT02475278|58891818|FG000|Overall Study|Lost to Follow-up|1|||
30959700|NCT01558271|59025205|FG002|Overall Study|Lost to Follow-up|0|||
30862232|NCT02475278|58891818|FG000|Overall Study|Reason Not Specified|1|||
30862233|NCT02254486|58891824|FG000|Overall Study|Adverse Event|1|||
30862234|NCT02254486|58891825|FG001|Overall Study|Adverse Event|1|||
30862235|NCT02254486|58891824|FG000|Overall Study|Lack of Efficacy|1|||
30862236|NCT02254486|58891825|FG001|Overall Study|Lack of Efficacy|0|||
30862237|NCT02254486|58891824|FG000|Overall Study|Lost to Follow-up|2|||
30862238|NCT02254486|58891825|FG001|Overall Study|Lost to Follow-up|4|||
30862239|NCT02254486|58891824|FG000|Overall Study|Protocol Violation|1|||
30862240|NCT02254486|58891825|FG001|Overall Study|Protocol Violation|2|||
30862241|NCT02254486|58891824|FG000|Overall Study|Withdrawal by Subject|17|||
30862242|NCT02254486|58891825|FG001|Overall Study|Withdrawal by Subject|15|||
30862243|NCT02254486|58891824|FG000|Overall Study|GFR<60mL/min|16|||
30862244|NCT02254486|58891825|FG001|Overall Study|GFR<60mL/min|21|||
30862245|NCT02254486|58891824|FG000|Overall Study|Various|12|||
30862246|NCT02254486|58891825|FG001|Overall Study|Various|12|||
30862247|NCT01641640|58891831|FG000|Overall Study|Enrolled but not treated|1|||
30862248|NCT01641640|58891831|FG000|Overall Study|Efficacy failure|29|||
30862249|NCT01641640|58891831|FG000|Overall Study|Lost to Follow-up|3|||
30862250|NCT01641640|58891831|FG000|Overall Study|Withdrawal by Subject|2|||
30862251|NCT01641640|58891831|FG000|Overall Study|Adverse Event|1|||
30862252|NCT01639144|58891837|FG000|Overall Study|Withdrawal by Subject|4|||
30862253|NCT01639144|58891838|FG001|Overall Study|Withdrawal by Subject|2|||
30862254|NCT01639144|58891837|FG000|Overall Study|Physician Decision|2|||
30862255|NCT01639144|58891838|FG001|Overall Study|Physician Decision|0|||
30862256|NCT01639144|58891837|FG000|Overall Study|Met postoperative exclusion criteria|4|||
30862257|NCT01639144|58891838|FG001|Overall Study|Met postoperative exclusion criteria|3|||
30862258|NCT01601626|58891847|FG000|Overall Study|Death|1|||
30862259|NCT01601626|58891848|FG001|Overall Study|Death|1|||
30862260|NCT01601626|58891849|FG002|Overall Study|Death|1|||
30862261|NCT01601626|58891847|FG000|Overall Study|Lost to Follow-up|1|||
30862262|NCT01601626|58891848|FG001|Overall Study|Lost to Follow-up|2|||
30862263|NCT01601626|58891849|FG002|Overall Study|Lost to Follow-up|0|||
30862264|NCT01601626|58891847|FG000|Overall Study|Unable to Get to Clinic|0|||
30862265|NCT01601626|58891848|FG001|Overall Study|Unable to Get to Clinic|1|||
30862266|NCT01601626|58891849|FG002|Overall Study|Unable to Get to Clinic|0|||
30862267|NCT01601626|58891847|FG000|Overall Study|Withdrawal by Subject|0|||
30862268|NCT01601626|58891848|FG001|Overall Study|Withdrawal by Subject|1|||
30862269|NCT01601626|58891849|FG002|Overall Study|Withdrawal by Subject|1|||
30600235|NCT01288911|58611878|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
30600236|NCT01288911|58611879|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
30600237|NCT01288911|58611878|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
30600238|NCT01288911|58611879|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
30600239|NCT01288911|58611878|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
30600240|NCT01288911|58611879|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
30600241|NCT01288443|58611894|FG000|Overall Study|Adverse Event|0|||
30600242|NCT01288443|58611895|FG001|Overall Study|Adverse Event|0|||
30600243|NCT01288443|58611896|FG002|Overall Study|Adverse Event|1|||
30600244|NCT01288443|58611897|FG003|Overall Study|Adverse Event|1|||
30600245|NCT01288443|58611898|FG004|Overall Study|Adverse Event|3|||
30600246|NCT01288443|58611899|FG005|Overall Study|Adverse Event|1|||
30600247|NCT01288443|58611894|FG000|Overall Study|Poor compliance to protocol|0|||
30600248|NCT01288443|58611895|FG001|Overall Study|Poor compliance to protocol|0|||
30600249|NCT01288443|58611896|FG002|Overall Study|Poor compliance to protocol|0|||
30600250|NCT01288443|58611897|FG003|Overall Study|Poor compliance to protocol|0|||
30600251|NCT01288443|58611898|FG004|Overall Study|Poor compliance to protocol|0|||
30600252|NCT01288443|58611899|FG005|Overall Study|Poor compliance to protocol|1|||
30600253|NCT01288443|58611894|FG000|Overall Study|Participant Moved|0|||
30600254|NCT01288443|58611895|FG001|Overall Study|Participant Moved|0|||
30600255|NCT01288443|58611896|FG002|Overall Study|Participant Moved|0|||
30600256|NCT01288443|58611897|FG003|Overall Study|Participant Moved|1|||
30600257|NCT01288443|58611898|FG004|Overall Study|Participant Moved|2|||
30600258|NCT01288443|58611899|FG005|Overall Study|Participant Moved|1|||
30600259|NCT01288443|58611894|FG000|Overall Study|Consent withdrawn by Participant|0|||
30600260|NCT01288443|58611895|FG001|Overall Study|Consent withdrawn by Participant|0|||
30600261|NCT01288443|58611896|FG002|Overall Study|Consent withdrawn by Participant|0|||
30600262|NCT01288443|58611897|FG003|Overall Study|Consent withdrawn by Participant|0|||
30600263|NCT01288443|58611898|FG004|Overall Study|Consent withdrawn by Participant|0|||
30600264|NCT01288443|58611899|FG005|Overall Study|Consent withdrawn by Participant|1|||
30600265|NCT01288443|58611894|FG000|Overall Study|Lost to Follow-up|0|||
30600266|NCT01288443|58611895|FG001|Overall Study|Lost to Follow-up|1|||
30600267|NCT01288443|58611896|FG002|Overall Study|Lost to Follow-up|0|||
30600268|NCT01288443|58611897|FG003|Overall Study|Lost to Follow-up|0|||
30600269|NCT01288443|58611898|FG004|Overall Study|Lost to Follow-up|0|||
30600270|NCT01288443|58611899|FG005|Overall Study|Lost to Follow-up|0|||
30600271|NCT01288443|58611894|FG000|Overall Study|Study drug auto-injector administration|0|||
30600272|NCT01288443|58611895|FG001|Overall Study|Study drug auto-injector administration|0|||
30600273|NCT01288443|58611896|FG002|Overall Study|Study drug auto-injector administration|0|||
30600274|NCT01288443|58611897|FG003|Overall Study|Study drug auto-injector administration|0|||
30600275|NCT01288443|58611898|FG004|Overall Study|Study drug auto-injector administration|1|||
30786552|NCT01367158|58799757|FG002|Overall Study|Lost to Follow-up|0|||
30786553|NCT01367158|58799758|FG003|Overall Study|Lost to Follow-up|1|||
30786554|NCT01367158|58799759|FG004|Overall Study|Lost to Follow-up|0|||
30786555|NCT01367158|58799760|FG005|Overall Study|Lost to Follow-up|2|||
30786556|NCT01367158|58799761|FG006|Overall Study|Lost to Follow-up|0|||
30786557|NCT01367158|58799762|FG007|Overall Study|Lost to Follow-up|1|||
30786558|NCT01367158|58799763|FG008|Overall Study|Lost to Follow-up|0|||
30786559|NCT01367158|58799764|FG009|Overall Study|Lost to Follow-up|0|||
30786560|NCT01367158|58799765|FG010|Overall Study|Lost to Follow-up|1|||
30786561|NCT01367158|58799755|FG000|Overall Study|Protocol Violation|0|||
30862270|NCT01601626|58891847|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
30862271|NCT01601626|58891848|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
30862272|NCT01601626|58891849|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
30862273|NCT02737501|58891859|FG000|Randomized Phase|Died|41|||
30862274|NCT02737501|58891860|FG001|Randomized Phase|Died|29|||
30862275|NCT02737501|58891861|FG002|Randomized Phase|Died|0|||
30862276|NCT02737501|58891859|FG000|Randomized Phase|Withdrawal by Subject|16|||
30862277|NCT02737501|58891860|FG001|Randomized Phase|Withdrawal by Subject|6|||
30862278|NCT02737501|58891861|FG002|Randomized Phase|Withdrawal by Subject|0|||
30862279|NCT02737501|58891859|FG000|Randomized Phase|Lost to Follow-up|0|||
30862280|NCT02737501|58891860|FG001|Randomized Phase|Lost to Follow-up|1|||
30862281|NCT02737501|58891861|FG002|Randomized Phase|Lost to Follow-up|0|||
30862282|NCT02737501|58891859|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
30862283|NCT02737501|58891860|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
30862284|NCT02737501|58891861|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
30862285|NCT02737501|58891859|FG000|Randomized Phase|Reason not Specified|1|||
30862286|NCT02737501|58891860|FG001|Randomized Phase|Reason not Specified|1|||
30862287|NCT02737501|58891861|FG002|Randomized Phase|Reason not Specified|0|||
30862288|NCT02737501|58891859|FG000|Randomized Phase|Never Treated|1|||
30862289|NCT02737501|58891860|FG001|Randomized Phase|Never Treated|1|||
30862290|NCT02737501|58891861|FG002|Randomized Phase|Never Treated|0|||
30862291|NCT02737501|58891859|FG000|Crossover Phase|Died|0|||
30862292|NCT02737501|58891860|FG001|Crossover Phase|Died|0|||
30862293|NCT02737501|58891861|FG002|Crossover Phase|Died|22|||
30862294|NCT02737501|58891859|FG000|Crossover Phase|Withdrew Consent|0|||
30862295|NCT02737501|58891860|FG001|Crossover Phase|Withdrew Consent|0|||
30862296|NCT02737501|58891861|FG002|Crossover Phase|Withdrew Consent|9|||
30862297|NCT02737501|58891859|FG000|Crossover Phase|Physician Decision|0|||
30862298|NCT02737501|58891860|FG001|Crossover Phase|Physician Decision|0|||
30862299|NCT02737501|58891861|FG002|Crossover Phase|Physician Decision|1|||
30862300|NCT02737501|58891859|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
30862301|NCT02737501|58891860|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
30862302|NCT02737501|58891861|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
30862303|NCT01640314|58891871|FG000|Overall Study|Protocol Violation|0|||
30862304|NCT01640314|58891872|FG001|Overall Study|Protocol Violation|1|||
30862305|NCT02740049|58891954|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
30862306|NCT01601704|58891960|FG000|Overall Study|Randomized but not dispensed study med|1|||
30862307|NCT01601704|58891961|FG001|Overall Study|Randomized but not dispensed study med|4|||
30862308|NCT04969276|58891970|FG000|Overall Study|Protocol Deviation|0|||
30862309|NCT04969276|58891971|FG001|Overall Study|Protocol Deviation|1|||
30862310|NCT04969276|58891972|FG002|Overall Study|Protocol Deviation|0|||
30862311|NCT04969276|58891970|FG000|Overall Study|Withdrawal by Subject|1|||
30862312|NCT04969276|58891971|FG001|Overall Study|Withdrawal by Subject|10|||
30862313|NCT04969276|58891972|FG002|Overall Study|Withdrawal by Subject|0|||
30862314|NCT04969276|58891970|FG000|Overall Study|Lost to Follow-up|0|||
30862315|NCT04969276|58891971|FG001|Overall Study|Lost to Follow-up|1|||
30862316|NCT04969276|58891972|FG002|Overall Study|Lost to Follow-up|0|||
30862317|NCT01601470|58891980|FG000|Period 2 - LCZ696|Physician Decision|1|||
30862318|NCT03248375|58892004|FG000|Overall Study|Lost to Follow-up|5|||
30862319|NCT01637272|58892008|FG000|Overall Study|Adverse Event|6|||
30862320|NCT01637272|58892008|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
30862321|NCT01637272|58892008|FG000|Overall Study|Withdrawal by Subject|3|||
30862322|NCT01637272|58892008|FG000|Overall Study|Lost to Follow-up|2|||
30862323|NCT01637272|58892008|FG000|Overall Study|completed core, did not enter ext. phase|4|||
30862324|NCT01637272|58892008|FG000|Overall Study|Administrative problems|1|||
30862325|NCT01637272|58892008|FG000|Overall Study|Protocol Violation|2|||
30862326|NCT01636960|58892027|FG000|Induction Phase|Adverse Event|2|||
30862327|NCT01636960|58892027|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
30862328|NCT01636960|58892027|FG000|Maintenance Phase|Adverse Event|3|||
30862329|NCT01636960|58892027|FG000|Maintenance Phase|Progressive disease|1|||
30862330|NCT01636258|58892033|FG000|Overall Study|Lost to Follow-up|1|||
30862331|NCT01636258|58892034|FG001|Overall Study|Lost to Follow-up|0|||
30862332|NCT02504216|58892043|FG000|Overall Study|Lost to Follow-up|3|||
30862333|NCT02504216|58892044|FG001|Overall Study|Lost to Follow-up|3|||
30862334|NCT02504216|58892043|FG000|Overall Study|Withdrawal by Subject|8|||
30862335|NCT02504216|58892044|FG001|Overall Study|Withdrawal by Subject|12|||
30600276|NCT01288443|58611899|FG005|Overall Study|Study drug auto-injector administration|1|||
30862336|NCT04354870|58892052|FG000|Overall Study|Lost to Follow-up|32|||
30862337|NCT04354870|58892053|FG001|Overall Study|Lost to Follow-up|12|||
30862338|NCT04354870|58892052|FG000|Overall Study|Withdrawal by Subject|10|||
30862339|NCT04354870|58892053|FG001|Overall Study|Withdrawal by Subject|16|||
30862340|NCT04354870|58892052|FG000|Overall Study|Did not complete all study visits|6|||
30862341|NCT04354870|58892053|FG001|Overall Study|Did not complete all study visits|5|||
30862342|NCT02473952|58892061|FG000|Overall Study|Adverse Event|2|||
30600277|NCT01288443|58611894|FG000|Overall Study|Other than above|0|||
30862343|NCT02473952|58892062|FG001|Overall Study|Adverse Event|2|||
30862344|NCT02473952|58892061|FG000|Overall Study|Withdrawal by Subject|0|||
30862345|NCT02473952|58892062|FG001|Overall Study|Withdrawal by Subject|6|||
30862346|NCT02473640|58892068|FG000|Treatment Period 1|Adverse Event|1|||
30862347|NCT01637584|58892077|FG000|Overall Study|Withdrawal by Subject|1|||
30862348|NCT01637584|58892078|FG001|Overall Study|Withdrawal by Subject|3|||
30862349|NCT03883906|58892085|FG000|Overall Study|Withdrawal by Subject|2|||
30862350|NCT03883906|58892085|FG000|Overall Study|Physician Decision|5|||
30862351|NCT03875092|58892091|FG000|Overall Study|Adverse Event|2|||
30862352|NCT03875092|58892092|FG001|Overall Study|Adverse Event|5|||
30862353|NCT03875092|58892091|FG000|Overall Study|Death|28|||
30862354|NCT03875092|58892092|FG001|Overall Study|Death|41|||
30862355|NCT03875092|58892091|FG000|Overall Study|Ongoing in Study|35|||
30862356|NCT03875092|58892092|FG001|Overall Study|Ongoing in Study|14|||
30862357|NCT02503202|58892103|FG000|Base Study: Up to Month 6|Death|1|||
30862358|NCT02503202|58892104|FG001|Base Study: Up to Month 6|Death|1|||
30862359|NCT02503202|58892105|FG002|Base Study: Up to Month 6|Death|0|||
30862360|NCT02503202|58892106|FG003|Base Study: Up to Month 6|Death|0|||
30862361|NCT02503202|58892107|FG004|Base Study: Up to Month 6|Death|0|||
30862362|NCT02503202|58892103|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
30862363|NCT02503202|58892104|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
30862364|NCT02503202|58892105|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
30862365|NCT02503202|58892106|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
30862366|NCT02503202|58892107|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
30862367|NCT02503202|58892103|FG000|Base Study: Up to Month 6|Physician Decision|0|||
30862368|NCT02503202|58892104|FG001|Base Study: Up to Month 6|Physician Decision|0|||
30862369|NCT02503202|58892105|FG002|Base Study: Up to Month 6|Physician Decision|0|||
30862370|NCT02503202|58892106|FG003|Base Study: Up to Month 6|Physician Decision|0|||
30862371|NCT02503202|58892107|FG004|Base Study: Up to Month 6|Physician Decision|1|||
30862372|NCT02503202|58892103|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
30862373|NCT02503202|58892104|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
30862374|NCT02503202|58892105|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
30862375|NCT02503202|58892106|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
30862376|NCT02503202|58892107|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
30862377|NCT02503202|58892103|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
30862378|NCT02503202|58892104|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
30862379|NCT02503202|58892105|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
30862380|NCT02503202|58892106|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
30862381|NCT02503202|58892107|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
30862382|NCT02503202|58892103|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
30862383|NCT02503202|58892104|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
30862384|NCT02503202|58892105|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
30862385|NCT02503202|58892106|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
30862386|NCT02503202|58892107|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
30862387|NCT02503202|58892103|FG000|Extension: Month 6 to 24|Death|1|||
30862388|NCT02503202|58892104|FG001|Extension: Month 6 to 24|Death|0|||
30862389|NCT02503202|58892105|FG002|Extension: Month 6 to 24|Death|0|||
30862390|NCT02503202|58892106|FG003|Extension: Month 6 to 24|Death|0|||
30862391|NCT02503202|58892107|FG004|Extension: Month 6 to 24|Death|0|||
30862392|NCT02503202|58892103|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
30862393|NCT02503202|58892104|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
30862394|NCT02503202|58892105|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
30862395|NCT02503202|58892106|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
30862396|NCT02503202|58892107|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
30862397|NCT02503202|58892103|FG000|Extension: Month 6 to 24|Physician Decision|1|||
30862398|NCT02503202|58892104|FG001|Extension: Month 6 to 24|Physician Decision|0|||
30862399|NCT02503202|58892105|FG002|Extension: Month 6 to 24|Physician Decision|1|||
30862400|NCT02503202|58892106|FG003|Extension: Month 6 to 24|Physician Decision|3|||
30862401|NCT02503202|58892107|FG004|Extension: Month 6 to 24|Physician Decision|0|||
30862402|NCT02503202|58892103|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
30862403|NCT02503202|58892104|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
30862404|NCT02503202|58892105|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
30862405|NCT02503202|58892106|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
30862406|NCT02503202|58892107|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
30862407|NCT02728102|58892122|FG000|Overall Study|Death|3|||
30862408|NCT02728102|58892123|FG001|Overall Study|Death|0|||
30862409|NCT02728102|58892124|FG002|Overall Study|Death|1|||
30862410|NCT02728102|58892122|FG000|Overall Study|Withdrawal by Subject|0|||
30862411|NCT02728102|58892123|FG001|Overall Study|Withdrawal by Subject|2|||
30862412|NCT02728102|58892124|FG002|Overall Study|Withdrawal by Subject|3|||
30862413|NCT02728102|58892122|FG000|Overall Study|Physician Decision|1|||
30862414|NCT02728102|58892123|FG001|Overall Study|Physician Decision|1|||
30862415|NCT02728102|58892124|FG002|Overall Study|Physician Decision|0|||
30862416|NCT02728102|58892122|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
30862417|NCT02728102|58892123|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
30862418|NCT02728102|58892124|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
30862419|NCT02728102|58892122|FG000|Overall Study|Covid|0|||
30862420|NCT02728102|58892123|FG001|Overall Study|Covid|0|||
30862421|NCT02728102|58892124|FG002|Overall Study|Covid|1|||
30862422|NCT02502734|58892133|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
30862423|NCT02502734|58892134|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
30862424|NCT02502734|58892133|FG000|Washout Period|Adverse Event|1|||
30862425|NCT02502734|58892134|FG001|Washout Period|Adverse Event|0|||
30862426|NCT02473250|58892142|FG000|Overall Study|Lost to Follow-up|10|||
30862427|NCT02473250|58892142|FG000|Overall Study|Physician Decision|5|||
30862428|NCT02473250|58892142|FG000|Overall Study|Did not tolerate medication washout|3|||
30862429|NCT02473250|58892142|FG000|Overall Study|Antidepressant effect of divalproex|2|||
30862430|NCT02706730|58892147|FG000|Overall Study|Adverse Event|3|||
30862431|NCT02706730|58892147|FG000|Overall Study|Lack of Efficacy|5|||
30862432|NCT02706730|58892147|FG000|Overall Study|Withdrawal by Subject|11|||
30862433|NCT02706730|58892147|FG000|Overall Study|Study Terminated by Sponsor|11|||
30862434|NCT02706730|58892147|FG000|Overall Study|Subject chose not to receive injection|3|||
30862435|NCT02443688|58892154|FG000|Overall Study|Adverse Event|2|||
30862436|NCT02443688|58892155|FG001|Overall Study|Adverse Event|3|||
30862437|NCT02443688|58892156|FG002|Overall Study|Adverse Event|2|||
30862438|NCT02443688|58892154|FG000|Overall Study|Lost to Follow-up|1|||
30862439|NCT02443688|58892155|FG001|Overall Study|Lost to Follow-up|0|||
30862440|NCT02443688|58892156|FG002|Overall Study|Lost to Follow-up|0|||
30862441|NCT02443688|58892154|FG000|Overall Study|Physician Decision|3|||
30862442|NCT02443688|58892155|FG001|Overall Study|Physician Decision|0|||
30862443|NCT02443688|58892156|FG002|Overall Study|Physician Decision|1|||
30862444|NCT02443688|58892154|FG000|Overall Study|Pregnancy|0|||
30862445|NCT02443688|58892155|FG001|Overall Study|Pregnancy|0|||
30862446|NCT02443688|58892156|FG002|Overall Study|Pregnancy|1|||
30862447|NCT02443688|58892154|FG000|Overall Study|Withdrawal by Subject|3|||
30862448|NCT02443688|58892155|FG001|Overall Study|Withdrawal by Subject|3|||
30862449|NCT02443688|58892156|FG002|Overall Study|Withdrawal by Subject|4|||
30862450|NCT02443688|58892154|FG000|Overall Study|Non-compliance with study drug|1|||
30862451|NCT02443688|58892155|FG001|Overall Study|Non-compliance with study drug|2|||
30862452|NCT02443688|58892156|FG002|Overall Study|Non-compliance with study drug|4|||
30862453|NCT02443688|58892154|FG000|Overall Study|Sponsor Request|2|||
30862454|NCT02443688|58892155|FG001|Overall Study|Sponsor Request|1|||
30862455|NCT02443688|58892156|FG002|Overall Study|Sponsor Request|0|||
30862456|NCT02443298|58892170|FG000|Overall Study|Adverse Event|3|||
30862457|NCT02443298|58892171|FG001|Overall Study|Adverse Event|3|||
30862458|NCT02443298|58892170|FG000|Overall Study|Withdrawal by Subject|1|||
30862459|NCT02443298|58892171|FG001|Overall Study|Withdrawal by Subject|2|||
30862460|NCT02500706|58892180|FG000|Overall Study|Adverse Event|0|||
30862461|NCT02500706|58892181|FG001|Overall Study|Adverse Event|0|||
30862462|NCT02500706|58892182|FG002|Overall Study|Adverse Event|1|||
30862463|NCT02500706|58892180|FG000|Overall Study|Lost to Follow-up|0|||
30862464|NCT02500706|58892181|FG001|Overall Study|Lost to Follow-up|1|||
30689937|NCT00713544|58704015|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
30862465|NCT02500706|58892182|FG002|Overall Study|Lost to Follow-up|1|||
30862466|NCT02500706|58892180|FG000|Overall Study|Withdrawal by Subject|4|||
30862467|NCT02500706|58892181|FG001|Overall Study|Withdrawal by Subject|6|||
30862468|NCT02500706|58892182|FG002|Overall Study|Withdrawal by Subject|4|||
30862469|NCT02500706|58892180|FG000|Overall Study|Unclassified|0|||
30862470|NCT02500706|58892181|FG001|Overall Study|Unclassified|0|||
30862471|NCT02500706|58892182|FG002|Overall Study|Unclassified|1|||
30862472|NCT02442830|58892192|FG000|Overall Study|Technical Failure|0|||
30862473|NCT02442830|58892193|FG001|Overall Study|Technical Failure|1|||
30862474|NCT02471612|58892200|FG000|Overall Study|Lost to Follow-up|2|||
30862475|NCT02500550|58892217|FG000|Overall Study|Death|7|||
30862476|NCT02499770|58892223|FG000|Overall Study|Death|17|||
30862477|NCT02499770|58892224|FG001|Overall Study|Death|56|||
30862478|NCT02499770|58892223|FG000|Overall Study|Study completion|1|||
30862479|NCT02499770|58892224|FG001|Overall Study|Study completion|10|||
30862480|NCT02499770|58892223|FG000|Overall Study|Withdrawal by Subject|0|||
30862481|NCT02499770|58892224|FG001|Overall Study|Withdrawal by Subject|7|||
30862482|NCT02499770|58892223|FG000|Overall Study|Lost to Follow-up|0|||
30862483|NCT02499770|58892224|FG001|Overall Study|Lost to Follow-up|2|||
30862484|NCT02499770|58892223|FG000|Overall Study|Subject declined further treatment|1|||
30862485|NCT02499770|58892224|FG001|Overall Study|Subject declined further treatment|0|||
30862486|NCT02499770|58892223|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
30862487|NCT02499770|58892224|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
30689938|NCT00713544|58704016|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
30862488|NCT02499770|58892223|FG000|Overall Study|Randomized but not enrolled|0|||
30862489|NCT02499770|58892224|FG001|Overall Study|Randomized but not enrolled|1|||
30862490|NCT02442284|58892236|FG000|Overall Study|Adverse Event|1|||
30862491|NCT02442284|58892236|FG000|Overall Study|Withdrew Consent|2|||
30862492|NCT02442284|58892236|FG000|Overall Study|Lost to Follow-up|3|||
30862493|NCT02442284|58892236|FG000|Overall Study|Other|1|||
30862494|NCT02442206|58892246|FG000|Period 1|Adverse Event|1|||
30862495|NCT02442206|58892247|FG001|Period 1|Adverse Event|1|||
30862496|NCT02442206|58892246|FG000|Period 1|withdrew consent|0|||
30862497|NCT02442206|58892247|FG001|Period 1|withdrew consent|1|||
30862498|NCT02442206|58892246|FG000|Period 1|COPD exacerbation|0|||
30862499|NCT02442206|58892247|FG001|Period 1|COPD exacerbation|1|||
30862500|NCT02442206|58892246|FG000|Period 2|Adverse Event|1|||
30862501|NCT02442206|58892247|FG001|Period 2|Adverse Event|0|||
30862502|NCT02499146|58892254|FG000|Overall Study|Lost to Follow-up|1|||
30862503|NCT02499146|58892254|FG000|Overall Study|Withdrawal by Subject|1|||
30862504|NCT02499146|58892254|FG000|Overall Study|Other|2|||
30862505|NCT02499146|58892254|FG000|Overall Study|Ongoing at date of cut-off|9|||
30862506|NCT02499146|58892254|FG000|Overall Study|Began other treatment/therapy|13|||
30862507|NCT03544138|58892258|FG000|Overall Study|Lost to Follow-up|29|||
30862508|NCT01634854|58892264|FG000|Overall Study|Cesarean delivery|2|||
30862509|NCT01634854|58892265|FG001|Overall Study|Cesarean delivery|7|||
30862510|NCT02469896|58892273|FG000|Overall Study|Withdrawal by Subject|2|||
30862511|NCT02469896|58892274|FG001|Overall Study|Withdrawal by Subject|0|||
30862512|NCT02441114|58892284|FG000|Washout2|Withdrawal by Subject|4|||
30862513|NCT02498678|58892290|FG000|Overall Study|interference from the surgical team|0|||
30862514|NCT02498678|58892291|FG001|Overall Study|interference from the surgical team|2|||
30862515|NCT02441036|58892302|FG000|Overall Study|No tissue resected|0|||
30862516|NCT02441036|58892303|FG001|Overall Study|No tissue resected|1|||
30862517|NCT02441036|58892304|FG002|Overall Study|No tissue resected|0|||
30862518|NCT02441036|58892305|FG003|Overall Study|No tissue resected|1|||
30862519|NCT02441036|58892306|FG004|Overall Study|No tissue resected|0|||
30862520|NCT02498444|58892321|FG000|Overall Study|Withdrawal by Subject|3|||
30862521|NCT02498444|58892322|FG001|Overall Study|Withdrawal by Subject|0|||
30862522|NCT02498444|58892321|FG000|Overall Study|Physician Decision|1|||
30600278|NCT01288443|58611895|FG001|Overall Study|Other than above|0|||
30600279|NCT01288443|58611896|FG002|Overall Study|Other than above|0|||
30600280|NCT01288443|58611897|FG003|Overall Study|Other than above|2|||
30600281|NCT01288443|58611898|FG004|Overall Study|Other than above|1|||
30600282|NCT01288443|58611899|FG005|Overall Study|Other than above|0|||
30600283|NCT01288287|58611913|FG000|Overall Study|Lost to Follow-up|8|||
30600284|NCT01288287|58611913|FG000|Overall Study|Withdrawal by Subject|4|||
30600285|NCT01288287|58611913|FG000|Overall Study|Lack of Efficacy|13|||
30600286|NCT01288287|58611913|FG000|Overall Study|Other Reason|13|||
30600287|NCT01288287|58611913|FG000|Overall Study|Unknown Reason|1|||
30600288|NCT01288287|58611913|FG000|Overall Study|Unknown Status|7|||
30600289|NCT01288209|58611920|FG000|Overall Study|Withdrawal by Subject|1|||
30600290|NCT01288209|58611921|FG001|Overall Study|Withdrawal by Subject|3|||
30600291|NCT01288209|58611920|FG000|Overall Study|Other|1|||
30600292|NCT01288209|58611921|FG001|Overall Study|Other|0|||
30600293|NCT01288053|58611927|FG000|Overall Study|Death|1|||
30600294|NCT01287195|58611931|FG000|Overall Study|Withdrawal by Subject|2|||
30600295|NCT01287117|58611939|FG000|Overall Study|Adverse Event|2|||
30600296|NCT01287117|58611940|FG001|Overall Study|Adverse Event|1|||
30600297|NCT01287117|58611941|FG002|Overall Study|Adverse Event|1|||
30600298|NCT01287117|58611942|FG003|Overall Study|Adverse Event|1|||
30600299|NCT01287117|58611939|FG000|Overall Study|Lost to Follow-up|1|||
30600300|NCT01287117|58611940|FG001|Overall Study|Lost to Follow-up|1|||
30600301|NCT01287117|58611941|FG002|Overall Study|Lost to Follow-up|0|||
30600302|NCT01287117|58611942|FG003|Overall Study|Lost to Follow-up|0|||
30600303|NCT01287117|58611939|FG000|Overall Study|Physician Decision|0|||
30600304|NCT01287117|58611940|FG001|Overall Study|Physician Decision|1|||
30600305|NCT01287117|58611941|FG002|Overall Study|Physician Decision|1|||
30600306|NCT01287117|58611942|FG003|Overall Study|Physician Decision|1|||
30600307|NCT01287117|58611939|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
30600308|NCT01287117|58611940|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
30600309|NCT01287117|58611941|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
30600310|NCT01287117|58611942|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
30600311|NCT01287117|58611939|FG000|Overall Study|Disease Progression|10|||
30600312|NCT01287117|58611940|FG001|Overall Study|Disease Progression|5|||
30862523|NCT02498444|58892322|FG001|Overall Study|Physician Decision|0|||
30862524|NCT02497976|58892330|FG000|Overall Study|Withdrawal by Subject|2|||
30862525|NCT02497976|58892331|FG001|Overall Study|Withdrawal by Subject|0|||
30862526|NCT02497976|58892330|FG000|Overall Study|Moved out of area|0|||
30862527|NCT02497976|58892331|FG001|Overall Study|Moved out of area|1|||
30862528|NCT03347188|58892339|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
30862529|NCT03347188|58892340|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
30862530|NCT03347188|58892339|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
30600313|NCT01287117|58611941|FG002|Overall Study|Disease Progression|6|||
30600314|NCT01287117|58611942|FG003|Overall Study|Disease Progression|5|||
30600315|NCT01287039|58611954|FG000|Overall Study|Noncompliance with study procedures|0|||
30600316|NCT01287039|58611955|FG001|Overall Study|Noncompliance with study procedures|1|||
30600317|NCT01287039|58611954|FG000|Overall Study|Change of location/residence|0|||
30600318|NCT01287039|58611955|FG001|Overall Study|Change of location/residence|3|||
30862531|NCT03347188|58892340|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
30862532|NCT03347188|58892339|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
30862533|NCT03347188|58892340|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
30862534|NCT03347188|58892339|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
30862535|NCT03347188|58892340|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
30862536|NCT03347188|58892339|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
30862537|NCT03347188|58892340|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
30862538|NCT03347188|58892339|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
30862539|NCT03347188|58892340|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
30862540|NCT03347188|58892339|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
30862541|NCT03347188|58892340|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
30862542|NCT03347188|58892339|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
30862543|NCT03347188|58892340|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
30862544|NCT02440568|58892350|FG000|Overall Study|Death|1|||
30862545|NCT02440568|58892351|FG001|Overall Study|Death|3|||
30862546|NCT02440568|58892352|FG002|Overall Study|Death|4|||
30862547|NCT02440568|58892353|FG003|Overall Study|Death|2|||
30862548|NCT02440568|58892350|FG000|Overall Study|Lack of Efficacy|2|||
30862549|NCT02440568|58892351|FG001|Overall Study|Lack of Efficacy|0|||
30862550|NCT02440568|58892352|FG002|Overall Study|Lack of Efficacy|1|||
30862551|NCT02440568|58892353|FG003|Overall Study|Lack of Efficacy|0|||
30862552|NCT02440568|58892350|FG000|Overall Study|Lost to Follow-up|1|||
30862553|NCT02440568|58892351|FG001|Overall Study|Lost to Follow-up|0|||
30862554|NCT02440568|58892352|FG002|Overall Study|Lost to Follow-up|0|||
30862555|NCT02440568|58892353|FG003|Overall Study|Lost to Follow-up|0|||
30862556|NCT03090191|58892366|FG000|Overall Study|Adverse Event|90|||
30862557|NCT03090191|58892367|FG001|Overall Study|Adverse Event|72|||
30862558|NCT03090191|58892366|FG000|Overall Study|Death|365|||
30862559|NCT03090191|58892367|FG001|Overall Study|Death|358|||
30862560|NCT03090191|58892366|FG000|Overall Study|Lost to Follow-up|382|||
30862561|NCT03090191|58892367|FG001|Overall Study|Lost to Follow-up|394|||
30862562|NCT03090191|58892366|FG000|Overall Study|Physician Decision|77|||
30862563|NCT03090191|58892367|FG001|Overall Study|Physician Decision|66|||
30862564|NCT03090191|58892366|FG000|Overall Study|Protocol Violation|43|||
30862565|NCT03090191|58892367|FG001|Overall Study|Protocol Violation|52|||
30862566|NCT03090191|58892366|FG000|Overall Study|Withdrawal by Subject|2160|||
30862567|NCT03090191|58892367|FG001|Overall Study|Withdrawal by Subject|2133|||
30862568|NCT03090191|58892366|FG000|Overall Study|Site terminated|7|||
30862569|NCT03090191|58892367|FG001|Overall Study|Site terminated|8|||
30862570|NCT03090191|58892366|FG000|Overall Study|Other|66|||
30862571|NCT03090191|58892367|FG001|Overall Study|Other|60|||
30862572|NCT03090191|58892366|FG000|Overall Study|Withdrawn before any study vaccination|43|||
30862573|NCT03090191|58892367|FG001|Overall Study|Withdrawn before any study vaccination|52|||
30862574|NCT02439320|58892389|FG000|Overall Study|Adverse Event|0|||
30862575|NCT02439320|58892390|FG001|Overall Study|Adverse Event|2|||
30862576|NCT02439320|58892391|FG002|Overall Study|Adverse Event|0|||
30862577|NCT02439320|58892389|FG000|Overall Study|Lost to Follow-up|37|||
30862578|NCT02439320|58892390|FG001|Overall Study|Lost to Follow-up|34|||
30862579|NCT02439320|58892391|FG002|Overall Study|Lost to Follow-up|42|||
30862580|NCT02439320|58892389|FG000|Overall Study|Death|0|||
30862581|NCT02439320|58892390|FG001|Overall Study|Death|1|||
30862582|NCT02439320|58892391|FG002|Overall Study|Death|0|||
30862583|NCT02439320|58892389|FG000|Overall Study|Noncompliance with Protocol|10|||
30862584|NCT02439320|58892390|FG001|Overall Study|Noncompliance with Protocol|11|||
30862585|NCT02439320|58892391|FG002|Overall Study|Noncompliance with Protocol|7|||
30862586|NCT02439320|58892389|FG000|Overall Study|Pregnancy|0|||
30862587|NCT02439320|58892390|FG001|Overall Study|Pregnancy|1|||
30862588|NCT02439320|58892391|FG002|Overall Study|Pregnancy|1|||
30862589|NCT02439320|58892389|FG000|Overall Study|Withdrawal by Subject|12|||
30862590|NCT02439320|58892390|FG001|Overall Study|Withdrawal by Subject|16|||
30862591|NCT02439320|58892391|FG002|Overall Study|Withdrawal by Subject|14|||
30862592|NCT02439320|58892389|FG000|Overall Study|Physician Decision|2|||
30862593|NCT02439320|58892390|FG001|Overall Study|Physician Decision|1|||
30862594|NCT02439320|58892391|FG002|Overall Study|Physician Decision|0|||
30862595|NCT02439320|58892389|FG000|Overall Study|Sponsor Request|0|||
30862596|NCT02439320|58892390|FG001|Overall Study|Sponsor Request|2|||
30862597|NCT02439320|58892391|FG002|Overall Study|Sponsor Request|1|||
30862598|NCT02439320|58892389|FG000|Overall Study|Randomization Failure|35|||
30862599|NCT02439320|58892390|FG001|Overall Study|Randomization Failure|46|||
30862600|NCT02439320|58892391|FG002|Overall Study|Randomization Failure|34|||
30862601|NCT02469038|58892407|FG000|Overall Study|Physician Decision|4|||
30862602|NCT02469038|58892408|FG001|Overall Study|Physician Decision|5|||
30862603|NCT02468648|58892414|FG000|Overall Study|Death|1|||
30862604|NCT02468414|58892420|FG000|Overall Study|Early Study Termination by Sponsor|1|||
30959701|NCT01558271|59025203|FG000|Overall Study|Protocol Violation|1|||
30959702|NCT01558271|59025204|FG001|Overall Study|Protocol Violation|0|||
30862605|NCT02468414|58892421|FG001|Overall Study|Early Study Termination by Sponsor|0|||
30862606|NCT02468414|58892420|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
30600319|NCT01287039|58611954|FG000|Overall Study|Elective surgery|0|||
30600320|NCT01287039|58611955|FG001|Overall Study|Elective surgery|1|||
30600321|NCT01287039|58611954|FG000|Overall Study|Protocol Violation|2|||
30600322|NCT01287039|58611955|FG001|Overall Study|Protocol Violation|3|||
30600323|NCT01287039|58611954|FG000|Overall Study|Excluded medication taken|1|||
30600324|NCT01287039|58611955|FG001|Overall Study|Excluded medication taken|0|||
30600325|NCT01287039|58611954|FG000|Overall Study|Noncompliance with study medication|0|||
30600326|NCT01287039|58611955|FG001|Overall Study|Noncompliance with study medication|1|||
30600327|NCT01287039|58611954|FG000|Overall Study|Problem with travel|0|||
30600328|NCT01287039|58611955|FG001|Overall Study|Problem with travel|1|||
30600329|NCT01287039|58611954|FG000|Overall Study|Death|1|||
30600330|NCT01287039|58611955|FG001|Overall Study|Death|0|||
30600331|NCT01287039|58611954|FG000|Overall Study|Change of residence|1|||
30600332|NCT01287039|58611955|FG001|Overall Study|Change of residence|0|||
30600333|NCT01287039|58611954|FG000|Overall Study|Adverse Event|7|||
30600334|NCT01287039|58611955|FG001|Overall Study|Adverse Event|4|||
30600335|NCT01287039|58611954|FG000|Overall Study|Withdrawal by Subject|14|||
30600336|NCT01287039|58611955|FG001|Overall Study|Withdrawal by Subject|11|||
30600337|NCT01287039|58611954|FG000|Overall Study|Lost to Follow-up|3|||
30600338|NCT01287039|58611955|FG001|Overall Study|Lost to Follow-up|2|||
30600339|NCT01285401|58611963|FG000|Overall Study|Prematurely withdrawn from the study|17|||
30600340|NCT01285401|58611964|FG001|Overall Study|Prematurely withdrawn from the study|29|||
30600341|NCT01285323|58611972|FG000|Overall Study|Adverse Event|9|||
30600342|NCT01285323|58611973|FG001|Overall Study|Adverse Event|8|||
30600343|NCT01285323|58611972|FG000|Overall Study|Lack of Efficacy|4|||
30600344|NCT01285323|58611973|FG001|Overall Study|Lack of Efficacy|2|||
30600345|NCT01285323|58611972|FG000|Overall Study|Withdrawal by Subject|15|||
30600346|NCT01285323|58611973|FG001|Overall Study|Withdrawal by Subject|11|||
30600347|NCT01285323|58611972|FG000|Overall Study|Protocol Violation|1|||
30600348|NCT01285323|58611973|FG001|Overall Study|Protocol Violation|2|||
30600349|NCT01285323|58611972|FG000|Overall Study|Non-compliance with study procedures|2|||
30600350|NCT01285323|58611973|FG001|Overall Study|Non-compliance with study procedures|3|||
30600351|NCT01285323|58611972|FG000|Overall Study|Lost to Follow-up|1|||
30600352|NCT01285323|58611973|FG001|Overall Study|Lost to Follow-up|1|||
30600353|NCT01285323|58611972|FG000|Overall Study|Other|1|||
30600354|NCT01285323|58611973|FG001|Overall Study|Other|3|||
30600355|NCT01284621|58611979|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
30600356|NCT01284621|58611980|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
30600357|NCT01284621|58611981|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
30600358|NCT01284621|58611982|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
30600359|NCT01284621|58611983|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
30600360|NCT01284621|58611984|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
30600361|NCT01283139|58611998|FG000|Overall Study|Lost to Follow-up|5|||
30600362|NCT01283139|58611999|FG001|Overall Study|Lost to Follow-up|2|||
30600363|NCT01283139|58612000|FG002|Overall Study|Lost to Follow-up|3|||
30600364|NCT01283139|58612001|FG003|Overall Study|Lost to Follow-up|1|||
30600365|NCT01283139|58611998|FG000|Overall Study|Withdrawal by Subject|8|||
30600366|NCT01283139|58611999|FG001|Overall Study|Withdrawal by Subject|8|||
30600367|NCT01283139|58612000|FG002|Overall Study|Withdrawal by Subject|6|||
30600368|NCT01283139|58612001|FG003|Overall Study|Withdrawal by Subject|8|||
30600369|NCT01283139|58611998|FG000|Overall Study|Death|2|||
30600370|NCT01283139|58611999|FG001|Overall Study|Death|0|||
30600371|NCT01283139|58612000|FG002|Overall Study|Death|2|||
30600372|NCT01283139|58612001|FG003|Overall Study|Death|2|||
30600373|NCT01283139|58611998|FG000|Overall Study|Lack of Efficacy|1|||
30600374|NCT01283139|58611999|FG001|Overall Study|Lack of Efficacy|2|||
30600375|NCT01283139|58612000|FG002|Overall Study|Lack of Efficacy|2|||
30600376|NCT01283139|58612001|FG003|Overall Study|Lack of Efficacy|1|||
30600377|NCT01283139|58611998|FG000|Overall Study|Early termination due to AE/SAE|1|||
30600378|NCT01283139|58611999|FG001|Overall Study|Early termination due to AE/SAE|1|||
30600379|NCT01283139|58612000|FG002|Overall Study|Early termination due to AE/SAE|0|||
30600380|NCT01283139|58612001|FG003|Overall Study|Early termination due to AE/SAE|0|||
30600381|NCT01283139|58611998|FG000|Overall Study|Participant's refusal to continue|0|||
30600382|NCT01283139|58611999|FG001|Overall Study|Participant's refusal to continue|3|||
30689939|NCT00713544|58704017|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
30862607|NCT02468414|58892421|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
30862608|NCT02468414|58892420|FG000|Overall Study|Screen Failure|1|||
30862609|NCT02468414|58892421|FG001|Overall Study|Screen Failure|0|||
30862610|NCT02466386|58892427|FG000|Overall Study|Adverse Event|5|||
30862611|NCT02466386|58892427|FG000|Overall Study|Protocol Violation|2|||
30862612|NCT02466386|58892427|FG000|Overall Study|Withdrawal by Subject|14|||
30862613|NCT02466386|58892427|FG000|Overall Study|Lost to Follow-up|5|||
30862614|NCT02466386|58892427|FG000|Overall Study|Lack of Efficacy|8|||
30600383|NCT01283139|58612000|FG002|Overall Study|Participant's refusal to continue|1|||
30600384|NCT01283139|58612001|FG003|Overall Study|Participant's refusal to continue|1|||
30862615|NCT02466386|58892427|FG000|Overall Study|Other|10|||
30862616|NCT01633060|58892433|FG000|Randomization Phase|Protocol deviation|1|||
30862617|NCT01633060|58892434|FG001|Randomization Phase|Protocol deviation|2|||
30862618|NCT01633060|58892433|FG000|Randomization Phase|Technical problem|0|||
30862619|NCT01633060|58892434|FG001|Randomization Phase|Technical problem|1|||
30862620|NCT01633060|58892433|FG000|Treatment Phase|Adverse Event|24|||
30862621|NCT01633060|58892434|FG001|Treatment Phase|Adverse Event|3|||
30862622|NCT01633060|58892433|FG000|Treatment Phase|Lost to Follow-up|1|||
30862623|NCT01633060|58892434|FG001|Treatment Phase|Lost to Follow-up|0|||
30862624|NCT01633060|58892433|FG000|Treatment Phase|Physician Decision|16|||
30862625|NCT01633060|58892434|FG001|Treatment Phase|Physician Decision|7|||
30862626|NCT01633060|58892433|FG000|Treatment Phase|Progressive Disease|210|||
30862627|NCT01633060|58892434|FG001|Treatment Phase|Progressive Disease|120|||
30862628|NCT01633060|58892433|FG000|Treatment Phase|Protocol Deviation|1|||
30862629|NCT01633060|58892434|FG001|Treatment Phase|Protocol Deviation|0|||
30862630|NCT01633060|58892433|FG000|Treatment Phase|Study Terminated by sponsor|7|||
30862631|NCT01633060|58892434|FG001|Treatment Phase|Study Terminated by sponsor|3|||
30862632|NCT01633060|58892433|FG000|Treatment Phase|Subject/guardian decision|25|||
30862633|NCT01633060|58892434|FG001|Treatment Phase|Subject/guardian decision|4|||
30862634|NCT01633060|58892433|FG000|Treatment Phase|Death|4|||
30862635|NCT01633060|58892434|FG001|Treatment Phase|Death|3|||
30862636|NCT01633060|58892433|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
30862637|NCT01633060|58892434|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
30862638|NCT01633060|58892433|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
30862639|NCT01633060|58892434|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
30862640|NCT01633060|58892433|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
30862641|NCT01633060|58892434|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
30862642|NCT01633060|58892433|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
30862643|NCT01633060|58892434|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
30862644|NCT01633060|58892433|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
30862645|NCT01633060|58892434|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
30862646|NCT01633060|58892433|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
30862647|NCT01633060|58892434|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
30862648|NCT01632904|58892443|FG000|Overall Study|Adverse Event|4|||
30862649|NCT01632904|58892444|FG001|Overall Study|Adverse Event|1|||
30862650|NCT01632904|58892443|FG000|Overall Study|Physician Decision|0|||
30862651|NCT01632904|58892444|FG001|Overall Study|Physician Decision|1|||
30862652|NCT01632904|58892443|FG000|Overall Study|Subject decision|3|||
30862653|NCT01632904|58892444|FG001|Overall Study|Subject decision|2|||
30862654|NCT01632904|58892443|FG000|Overall Study|Disease Progression|0|||
30862655|NCT01632904|58892444|FG001|Overall Study|Disease Progression|1|||
30862656|NCT01632904|58892443|FG000|Overall Study|Reason for discontinuation not available|0|||
30862657|NCT01632904|58892444|FG001|Overall Study|Reason for discontinuation not available|1|||
30862658|NCT03834779|58892452|FG000|Overall Study|Death|1|||
30862659|NCT03834779|58892453|FG001|Overall Study|Death|2|||
30862660|NCT03834779|58892452|FG000|Overall Study|Lost to Follow-up|6|||
30862661|NCT03834779|58892453|FG001|Overall Study|Lost to Follow-up|4|||
30862662|NCT03726437|58892462|FG000|Overall Study|Lost to Follow-up|85|||
30862663|NCT03726437|58892463|FG001|Overall Study|Lost to Follow-up|76|||
30862664|NCT02465528|58892473|FG000|Overall Study|Progressive disease|0|||
30862665|NCT02465528|58892474|FG001|Overall Study|Progressive disease|2|||
30862666|NCT02465528|58892475|FG002|Overall Study|Progressive disease|9|||
30862667|NCT02465528|58892476|FG003|Overall Study|Progressive disease|4|||
30862668|NCT02465528|58892473|FG000|Overall Study|Study terminated by sponsor|1|||
30862669|NCT02465528|58892474|FG001|Overall Study|Study terminated by sponsor|2|||
30862670|NCT02465528|58892475|FG002|Overall Study|Study terminated by sponsor|0|||
30862671|NCT02465528|58892476|FG003|Overall Study|Study terminated by sponsor|0|||
30862672|NCT02465528|58892473|FG000|Overall Study|Withdrawal by Subject|0|||
30862673|NCT02465528|58892474|FG001|Overall Study|Withdrawal by Subject|0|||
30862674|NCT02465528|58892475|FG002|Overall Study|Withdrawal by Subject|2|||
30959703|NCT01558271|59025205|FG002|Overall Study|Protocol Violation|0|||
30959704|NCT01558271|59025203|FG000|Overall Study|Withdrawal by Subject|10|||
30862675|NCT02465528|58892476|FG003|Overall Study|Withdrawal by Subject|0|||
30862676|NCT02465528|58892473|FG000|Overall Study|Adverse Event|0|||
30862677|NCT02465528|58892474|FG001|Overall Study|Adverse Event|0|||
30862678|NCT02465528|58892475|FG002|Overall Study|Adverse Event|0|||
30862679|NCT02465528|58892476|FG003|Overall Study|Adverse Event|1|||
30862680|NCT02465528|58892473|FG000|Overall Study|Physician Decision|0|||
30862681|NCT02465528|58892474|FG001|Overall Study|Physician Decision|0|||
30862682|NCT02465528|58892475|FG002|Overall Study|Physician Decision|1|||
30862683|NCT02465528|58892476|FG003|Overall Study|Physician Decision|0|||
30862684|NCT02438384|58892491|FG000|Overall Study|Lost to Follow-up|8|||
30862685|NCT02438384|58892492|FG001|Overall Study|Lost to Follow-up|6|||
30862686|NCT02438384|58892493|FG002|Overall Study|Lost to Follow-up|4|||
30862687|NCT02463032|58892503|FG000|Overall Study|Lack of Efficacy|61|||
30959705|NCT01558271|59025204|FG001|Overall Study|Withdrawal by Subject|6|||
30862688|NCT02463032|58892504|FG001|Overall Study|Lack of Efficacy|50|||
30862689|NCT02463032|58892503|FG000|Overall Study|Death|8|||
30862690|NCT02463032|58892504|FG001|Overall Study|Death|8|||
30862691|NCT02463032|58892503|FG000|Overall Study|Adverse Event|2|||
30862692|NCT02463032|58892504|FG001|Overall Study|Adverse Event|6|||
30862693|NCT02496884|58892514|FG000|Overall Study|Counted twice as enrolled|2|||
30862694|NCT02496884|58892515|FG001|Overall Study|Counted twice as enrolled|0|||
30862695|NCT02496884|58892516|FG002|Overall Study|Counted twice as enrolled|0|||
30862696|NCT02496884|58892517|FG003|Overall Study|Counted twice as enrolled|0|||
30862697|NCT02496884|58892514|FG000|Overall Study|Withdrawal by Subject|0|||
30862698|NCT02496884|58892515|FG001|Overall Study|Withdrawal by Subject|3|||
30862699|NCT02496884|58892516|FG002|Overall Study|Withdrawal by Subject|0|||
30862700|NCT02496884|58892517|FG003|Overall Study|Withdrawal by Subject|0|||
30862701|NCT02462876|58892527|FG000|Overall Study|Death|3|||
30862702|NCT02462876|58892527|FG000|Overall Study|Lost to Follow-up|7|||
30862703|NCT02462876|58892527|FG000|Overall Study|Surgical Bypass|9|||
30862704|NCT02462876|58892527|FG000|Overall Study|Amputation Above the Metatarsals|1|||
30862705|NCT02462876|58892527|FG000|Overall Study|36 months follow-up visit missed|1|||
30862706|NCT02462876|58892527|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
30862707|NCT02462876|58892527|FG000|Overall Study|Patient did not come back to the vascular department|1|||
30862708|NCT02462876|58892527|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
30862709|NCT02462876|58892527|FG000|Overall Study|Patient refused to come back|1|||
30862710|NCT02462876|58892527|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
30862711|NCT02462876|58892527|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
30862712|NCT03386721|58892546|FG000|Overall Study|Death|12|||
30862713|NCT03386721|58892547|FG001|Overall Study|Death|21|||
30862714|NCT03386721|58892548|FG002|Overall Study|Death|2|||
30862715|NCT03386721|58892549|FG003|Overall Study|Death|5|||
30862716|NCT03386721|58892550|FG004|Overall Study|Death|1|||
30862717|NCT03386721|58892551|FG005|Overall Study|Death|12|||
30862718|NCT03386721|58892552|FG006|Overall Study|Death|1|||
30862719|NCT03386721|58892553|FG007|Overall Study|Death|1|||
30862720|NCT03386721|58892554|FG008|Overall Study|Death|12|||
30862721|NCT03386721|58892555|FG009|Overall Study|Death|20|||
30862722|NCT03386721|58892556|FG010|Overall Study|Death|21|||
30862723|NCT03386721|58892557|FG011|Overall Study|Death|21|||
30862724|NCT03386721|58892558|FG012|Overall Study|Death|14|||
30862725|NCT03386721|58892559|FG013|Overall Study|Death|2|||
30862726|NCT03386721|58892560|FG014|Overall Study|Death|1|||
30862727|NCT03386721|58892546|FG000|Overall Study|Lost to Follow-up|1|||
30862728|NCT03386721|58892547|FG001|Overall Study|Lost to Follow-up|3|||
30862729|NCT03386721|58892548|FG002|Overall Study|Lost to Follow-up|0|||
30862730|NCT03386721|58892549|FG003|Overall Study|Lost to Follow-up|0|||
30862731|NCT03386721|58892550|FG004|Overall Study|Lost to Follow-up|0|||
30862732|NCT03386721|58892551|FG005|Overall Study|Lost to Follow-up|2|||
30862733|NCT03386721|58892552|FG006|Overall Study|Lost to Follow-up|1|||
30862734|NCT03386721|58892553|FG007|Overall Study|Lost to Follow-up|0|||
30862735|NCT03386721|58892554|FG008|Overall Study|Lost to Follow-up|1|||
30862736|NCT03386721|58892555|FG009|Overall Study|Lost to Follow-up|2|||
30862737|NCT03386721|58892556|FG010|Overall Study|Lost to Follow-up|1|||
30600385|NCT01283139|58611998|FG000|Overall Study|Pregnancy|0|||
30600386|NCT01283139|58611999|FG001|Overall Study|Pregnancy|1|||
30600387|NCT01283139|58612000|FG002|Overall Study|Pregnancy|1|||
30600388|NCT01283139|58612001|FG003|Overall Study|Pregnancy|0|||
30600389|NCT01283139|58611998|FG000|Overall Study|Missed follow-up visit|0|||
30689940|NCT00713544|58704018|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
30689941|NCT00713544|58704013|FG000|Overall Study|Incorrect enrollment|0|||
30600390|NCT01283139|58611999|FG001|Overall Study|Missed follow-up visit|1|||
30600391|NCT01283139|58612000|FG002|Overall Study|Missed follow-up visit|2|||
30600392|NCT01283139|58612001|FG003|Overall Study|Missed follow-up visit|2|||
30600393|NCT01283139|58611998|FG000|Overall Study|Participant randomized in error|0|||
30600394|NCT01283139|58611999|FG001|Overall Study|Participant randomized in error|0|||
30600395|NCT01283139|58612000|FG002|Overall Study|Participant randomized in error|1|||
30862738|NCT03386721|58892557|FG011|Overall Study|Lost to Follow-up|0|||
30600396|NCT01283139|58612001|FG003|Overall Study|Participant randomized in error|0|||
30689942|NCT00713544|58704014|FG001|Overall Study|Incorrect enrollment|1|||
30862739|NCT03386721|58892558|FG012|Overall Study|Lost to Follow-up|0|||
30862740|NCT03386721|58892559|FG013|Overall Study|Lost to Follow-up|0|||
30862741|NCT03386721|58892560|FG014|Overall Study|Lost to Follow-up|0|||
30862742|NCT03386721|58892546|FG000|Overall Study|Reason not specified|3|||
30862743|NCT03386721|58892547|FG001|Overall Study|Reason not specified|0|||
30862744|NCT03386721|58892548|FG002|Overall Study|Reason not specified|0|||
30862745|NCT03386721|58892549|FG003|Overall Study|Reason not specified|0|||
30862746|NCT03386721|58892550|FG004|Overall Study|Reason not specified|0|||
30862747|NCT03386721|58892551|FG005|Overall Study|Reason not specified|3|||
30862748|NCT03386721|58892552|FG006|Overall Study|Reason not specified|1|||
30600397|NCT01282203|58612011|FG000|Overall Study|Adverse Event|1|||
30862749|NCT03386721|58892553|FG007|Overall Study|Reason not specified|0|||
30862750|NCT03386721|58892554|FG008|Overall Study|Reason not specified|0|||
30862751|NCT03386721|58892555|FG009|Overall Study|Reason not specified|1|||
30862752|NCT03386721|58892556|FG010|Overall Study|Reason not specified|2|||
30862753|NCT03386721|58892557|FG011|Overall Study|Reason not specified|6|||
30862754|NCT03386721|58892558|FG012|Overall Study|Reason not specified|1|||
30862755|NCT03386721|58892559|FG013|Overall Study|Reason not specified|0|||
30862756|NCT03386721|58892560|FG014|Overall Study|Reason not specified|0|||
30862757|NCT03386721|58892546|FG000|Overall Study|Progressive Disease|0|||
30862758|NCT03386721|58892547|FG001|Overall Study|Progressive Disease|0|||
30862759|NCT03386721|58892548|FG002|Overall Study|Progressive Disease|1|||
30862760|NCT03386721|58892549|FG003|Overall Study|Progressive Disease|0|||
30862761|NCT03386721|58892550|FG004|Overall Study|Progressive Disease|0|||
30862762|NCT03386721|58892551|FG005|Overall Study|Progressive Disease|1|||
30862763|NCT03386721|58892552|FG006|Overall Study|Progressive Disease|0|||
30600398|NCT01281969|58612020|FG000|Overall Study|not randomized didn't meet criteria|0|||
30600399|NCT01281969|58612021|FG001|Overall Study|not randomized didn't meet criteria|0|||
30600400|NCT01281969|58612022|FG002|Overall Study|not randomized didn't meet criteria|7|||
30600401|NCT01281969|58612020|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
30600402|NCT01281969|58612021|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
30600403|NCT01281969|58612022|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
30600404|NCT01281969|58612020|FG000|Overall Study|not randomized, child consent not given|0|||
30600405|NCT01281969|58612021|FG001|Overall Study|not randomized, child consent not given|0|||
30600406|NCT01281969|58612022|FG002|Overall Study|not randomized, child consent not given|2|||
30600407|NCT01281813|58612033|FG000|Overall Study|Adverse Event|0|||
30600408|NCT01281813|58612034|FG001|Overall Study|Adverse Event|0|||
30600409|NCT01281813|58612035|FG002|Overall Study|Adverse Event|10|||
30600410|NCT01281813|58612033|FG000|Overall Study|Lost to Follow-up|0|||
30600411|NCT01281813|58612034|FG001|Overall Study|Lost to Follow-up|0|||
30600412|NCT01281813|58612035|FG002|Overall Study|Lost to Follow-up|31|||
30600413|NCT01281813|58612033|FG000|Overall Study|Withdrawal by Subject|0|||
30600414|NCT01281813|58612034|FG001|Overall Study|Withdrawal by Subject|0|||
30600415|NCT01281813|58612035|FG002|Overall Study|Withdrawal by Subject|13|||
30600416|NCT01281813|58612033|FG000|Overall Study|Subject Non-Compliant|0|||
30600417|NCT01281813|58612034|FG001|Overall Study|Subject Non-Compliant|0|||
30600418|NCT01281813|58612035|FG002|Overall Study|Subject Non-Compliant|6|||
30600419|NCT01281813|58612033|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
30600420|NCT01281813|58612034|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
30600421|NCT01281813|58612035|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
30600422|NCT01281813|58612033|FG000|Overall Study|Sponsor's Decision|4|||
30600423|NCT01281813|58612034|FG001|Overall Study|Sponsor's Decision|3|||
30600424|NCT01281813|58612035|FG002|Overall Study|Sponsor's Decision|7|||
30600425|NCT01281813|58612033|FG000|Overall Study|Switched to Commercially Available Medication|0|||
30600426|NCT01281813|58612034|FG001|Overall Study|Switched to Commercially Available Medication|0|||
30600427|NCT01281813|58612035|FG002|Overall Study|Switched to Commercially Available Medication|26|||
30600428|NCT01281813|58612033|FG000|Overall Study|Other|0|||
30600429|NCT01281813|58612034|FG001|Overall Study|Other|1|||
30600430|NCT01281813|58612035|FG002|Overall Study|Other|39|||
30600431|NCT01090414|58612047|FG000|Study 101-99|Progressive Disease|28|||
30600432|NCT01090414|58612048|FG001|Study 101-99|Progressive Disease|48|||
30600433|NCT01090414|58612049|FG002|Study 101-99|Progressive Disease|10|||
30600434|NCT01090414|58612050|FG003|Study 101-99|Progressive Disease|4|||
30600435|NCT01090414|58612047|FG000|Study 101-99|Adverse Event|10|||
30600436|NCT01090414|58612048|FG001|Study 101-99|Adverse Event|28|||
30600437|NCT01090414|58612049|FG002|Study 101-99|Adverse Event|18|||
30600438|NCT01090414|58612050|FG003|Study 101-99|Adverse Event|0|||
30600439|NCT01090414|58612047|FG000|Study 101-99|Investigator Request|1|||
30600440|NCT01090414|58612048|FG001|Study 101-99|Investigator Request|11|||
30600441|NCT01090414|58612049|FG002|Study 101-99|Investigator Request|4|||
30600442|NCT01090414|58612050|FG003|Study 101-99|Investigator Request|0|||
30600443|NCT01090414|58612047|FG000|Study 101-99|Death|3|||
30600444|NCT01090414|58612048|FG001|Study 101-99|Death|8|||
30600445|NCT01090414|58612049|FG002|Study 101-99|Death|1|||
30600446|NCT01090414|58612050|FG003|Study 101-99|Death|0|||
30600447|NCT01090414|58612047|FG000|Study 101-99|Sponsor Discontinued Study|0|||
30600448|NCT01090414|58612048|FG001|Study 101-99|Sponsor Discontinued Study|7|||
30600449|NCT01090414|58612049|FG002|Study 101-99|Sponsor Discontinued Study|5|||
30600450|NCT01090414|58612050|FG003|Study 101-99|Sponsor Discontinued Study|0|||
30600451|NCT01090414|58612047|FG000|Study 101-99|Other (Unknown Reasons)|3|||
30600452|NCT01090414|58612048|FG001|Study 101-99|Other (Unknown Reasons)|3|||
30600453|NCT01090414|58612049|FG002|Study 101-99|Other (Unknown Reasons)|0|||
30862764|NCT03386721|58892553|FG007|Overall Study|Progressive Disease|0|||
30862765|NCT03386721|58892554|FG008|Overall Study|Progressive Disease|2|||
30862766|NCT03386721|58892555|FG009|Overall Study|Progressive Disease|1|||
30600454|NCT01090414|58612050|FG003|Study 101-99|Other (Unknown Reasons)|0|||
30600455|NCT01090414|58612047|FG000|Study 101-99|Withdrew Consent|0|||
30862767|NCT03386721|58892556|FG010|Overall Study|Progressive Disease|1|||
30862768|NCT03386721|58892557|FG011|Overall Study|Progressive Disease|0|||
30862769|NCT03386721|58892558|FG012|Overall Study|Progressive Disease|1|||
30862770|NCT03386721|58892559|FG013|Overall Study|Progressive Disease|0|||
30862771|NCT03386721|58892560|FG014|Overall Study|Progressive Disease|0|||
30862772|NCT03386721|58892546|FG000|Overall Study|Site Terminated by Sponsor|5|||
30862773|NCT03386721|58892547|FG001|Overall Study|Site Terminated by Sponsor|5|||
30862774|NCT03386721|58892548|FG002|Overall Study|Site Terminated by Sponsor|0|||
30862775|NCT03386721|58892549|FG003|Overall Study|Site Terminated by Sponsor|0|||
30862776|NCT03386721|58892550|FG004|Overall Study|Site Terminated by Sponsor|1|||
30862777|NCT03386721|58892551|FG005|Overall Study|Site Terminated by Sponsor|3|||
30862778|NCT03386721|58892552|FG006|Overall Study|Site Terminated by Sponsor|0|||
30862779|NCT03386721|58892553|FG007|Overall Study|Site Terminated by Sponsor|1|||
30862780|NCT03386721|58892554|FG008|Overall Study|Site Terminated by Sponsor|4|||
30862781|NCT03386721|58892555|FG009|Overall Study|Site Terminated by Sponsor|5|||
30862782|NCT03386721|58892556|FG010|Overall Study|Site Terminated by Sponsor|3|||
30862783|NCT03386721|58892557|FG011|Overall Study|Site Terminated by Sponsor|11|||
30862784|NCT03386721|58892558|FG012|Overall Study|Site Terminated by Sponsor|6|||
30862785|NCT03386721|58892559|FG013|Overall Study|Site Terminated by Sponsor|0|||
30862786|NCT03386721|58892560|FG014|Overall Study|Site Terminated by Sponsor|0|||
30862787|NCT03386721|58892546|FG000|Overall Study|Symptomatic Deterioration|0|||
30862788|NCT03386721|58892547|FG001|Overall Study|Symptomatic Deterioration|0|||
30862789|NCT03386721|58892548|FG002|Overall Study|Symptomatic Deterioration|0|||
30862790|NCT03386721|58892549|FG003|Overall Study|Symptomatic Deterioration|0|||
30862791|NCT03386721|58892550|FG004|Overall Study|Symptomatic Deterioration|0|||
30862792|NCT03386721|58892551|FG005|Overall Study|Symptomatic Deterioration|0|||
30862793|NCT03386721|58892552|FG006|Overall Study|Symptomatic Deterioration|0|||
30862794|NCT03386721|58892553|FG007|Overall Study|Symptomatic Deterioration|0|||
30862795|NCT03386721|58892554|FG008|Overall Study|Symptomatic Deterioration|1|||
30862796|NCT03386721|58892555|FG009|Overall Study|Symptomatic Deterioration|0|||
30862797|NCT03386721|58892556|FG010|Overall Study|Symptomatic Deterioration|0|||
30862798|NCT03386721|58892557|FG011|Overall Study|Symptomatic Deterioration|1|||
30862799|NCT03386721|58892558|FG012|Overall Study|Symptomatic Deterioration|0|||
30862800|NCT03386721|58892559|FG013|Overall Study|Symptomatic Deterioration|0|||
30862801|NCT03386721|58892560|FG014|Overall Study|Symptomatic Deterioration|0|||
30862802|NCT03386721|58892546|FG000|Overall Study|Withdrawal by Subject|1|||
30862803|NCT03386721|58892547|FG001|Overall Study|Withdrawal by Subject|2|||
30862804|NCT03386721|58892548|FG002|Overall Study|Withdrawal by Subject|0|||
30862805|NCT03386721|58892549|FG003|Overall Study|Withdrawal by Subject|0|||
30862806|NCT03386721|58892550|FG004|Overall Study|Withdrawal by Subject|0|||
30862807|NCT03386721|58892551|FG005|Overall Study|Withdrawal by Subject|0|||
30862808|NCT03386721|58892552|FG006|Overall Study|Withdrawal by Subject|0|||
30862809|NCT03386721|58892553|FG007|Overall Study|Withdrawal by Subject|0|||
30862810|NCT03386721|58892554|FG008|Overall Study|Withdrawal by Subject|2|||
30862811|NCT03386721|58892555|FG009|Overall Study|Withdrawal by Subject|1|||
30862812|NCT03386721|58892556|FG010|Overall Study|Withdrawal by Subject|3|||
30862813|NCT03386721|58892557|FG011|Overall Study|Withdrawal by Subject|2|||
30862814|NCT03386721|58892558|FG012|Overall Study|Withdrawal by Subject|3|||
30862815|NCT03386721|58892559|FG013|Overall Study|Withdrawal by Subject|0|||
30862816|NCT03386721|58892560|FG014|Overall Study|Withdrawal by Subject|0|||
30862817|NCT02462720|58892592|FG000|Part 2|Withdrawal by Subject|1|||
30862818|NCT02462720|58892593|FG001|Part 2|Withdrawal by Subject|0|||
30862819|NCT02462720|58892592|FG000|Part 2|Protocol Violation|0|||
30862820|NCT02462720|58892593|FG001|Part 2|Protocol Violation|1|||
30862821|NCT02246218|58892603|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30862822|NCT02246218|58892604|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
30862823|NCT02246218|58892603|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
30862824|NCT02246218|58892604|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
30862825|NCT02246218|58892603|FG000|Overall Study|Adverse Event|1|||
30862826|NCT02246218|58892604|FG001|Overall Study|Adverse Event|1|||
30862827|NCT02246218|58892603|FG000|Overall Study|Lost to Follow-up|1|||
30862828|NCT02246218|58892604|FG001|Overall Study|Lost to Follow-up|0|||
30862829|NCT02244580|58892610|FG000|Overall Study|No cancer tissues available|241|||
30862830|NCT02244424|58892620|FG000|Overall Study|Lost to Follow-up|20|||
30862831|NCT02244424|58892621|FG001|Overall Study|Lost to Follow-up|10|||
30862832|NCT00159783|58892630|FG000|Overall Study|Adverse Event|5|||
30862833|NCT00159783|58892631|FG001|Overall Study|Adverse Event|7|||
30862834|NCT00159783|58892632|FG002|Overall Study|Adverse Event|9|||
30862835|NCT00159783|58892630|FG000|Overall Study|Lack of Efficacy|1|||
30862836|NCT00159783|58892631|FG001|Overall Study|Lack of Efficacy|2|||
30862837|NCT00159783|58892632|FG002|Overall Study|Lack of Efficacy|3|||
30862838|NCT00159783|58892630|FG000|Overall Study|Withdrawal by Subject|7|||
30862839|NCT00159783|58892631|FG001|Overall Study|Withdrawal by Subject|11|||
30862840|NCT00159783|58892632|FG002|Overall Study|Withdrawal by Subject|12|||
30862841|NCT00159783|58892630|FG000|Overall Study|Lost to Follow-up|6|||
30862842|NCT00159783|58892631|FG001|Overall Study|Lost to Follow-up|5|||
30862843|NCT00159783|58892632|FG002|Overall Study|Lost to Follow-up|11|||
30862844|NCT00159783|58892630|FG000|Overall Study|Other|0|||
30862845|NCT00159783|58892631|FG001|Overall Study|Other|2|||
30862846|NCT00159783|58892632|FG002|Overall Study|Other|4|||
30862847|NCT00646204|58892643|FG000|Overall Study|Adverse Event|3|||
30862848|NCT00646204|58892644|FG001|Overall Study|Adverse Event|0|||
30862849|NCT00646204|58892643|FG000|Overall Study|Withdrawal by Subject|1|||
30862850|NCT00646204|58892644|FG001|Overall Study|Withdrawal by Subject|0|||
30862851|NCT02936323|58892661|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
30862852|NCT02936323|58892662|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
30862853|NCT02936323|58892663|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
30862854|NCT02936323|58892664|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
30862855|NCT02936323|58892665|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
30862856|NCT02936323|58892666|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
30862857|NCT02936323|58892667|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
30862858|NCT02936323|58892668|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
30862859|NCT02936323|58892669|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
30862860|NCT02936323|58892670|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
30862861|NCT02936323|58892661|FG000|Phase 1 Dose Escalation|Death|2|||
30862862|NCT02936323|58892662|FG001|Phase 1 Dose Escalation|Death|1|||
30862863|NCT02936323|58892663|FG002|Phase 1 Dose Escalation|Death|3|||
30862864|NCT02936323|58892664|FG003|Phase 1 Dose Escalation|Death|1|||
30862865|NCT02936323|58892665|FG004|Phase 1 Dose Escalation|Death|2|||
30862866|NCT02936323|58892666|FG005|Phase 1 Dose Escalation|Death|3|||
30959706|NCT01558271|59025205|FG002|Overall Study|Withdrawal by Subject|12|||
30959707|NCT01558271|59025203|FG000|Overall Study|Physician Decision|0|||
30959708|NCT01558271|59025204|FG001|Overall Study|Physician Decision|2|||
30959709|NCT01558271|59025205|FG002|Overall Study|Physician Decision|1|||
30959710|NCT01565707|59025221|FG000|Overall Study|Adverse Event|1|||
30959711|NCT01565707|59025222|FG001|Overall Study|Adverse Event|6|||
30959712|NCT01565707|59025223|FG002|Overall Study|Adverse Event|2|||
30959713|NCT01565707|59025224|FG003|Overall Study|Adverse Event|1|||
30959714|NCT01565707|59025221|FG000|Overall Study|Lost to Follow-up|1|||
30959715|NCT01565707|59025222|FG001|Overall Study|Lost to Follow-up|0|||
30959716|NCT01565707|59025223|FG002|Overall Study|Lost to Follow-up|0|||
30959717|NCT01565707|59025224|FG003|Overall Study|Lost to Follow-up|0|||
30959718|NCT01565707|59025221|FG000|Overall Study|Protocol Violation|1|||
30959719|NCT01565707|59025222|FG001|Overall Study|Protocol Violation|0|||
30959720|NCT01565707|59025223|FG002|Overall Study|Protocol Violation|0|||
30959721|NCT01565707|59025224|FG003|Overall Study|Protocol Violation|1|||
30959722|NCT01565707|59025221|FG000|Overall Study|Withdrawal by Subject|3|||
30959723|NCT01565707|59025222|FG001|Overall Study|Withdrawal by Subject|1|||
30959724|NCT01565707|59025223|FG002|Overall Study|Withdrawal by Subject|1|||
30959725|NCT01565707|59025224|FG003|Overall Study|Withdrawal by Subject|1|||
30959726|NCT01565707|59025221|FG000|Overall Study|Randomized but not evaluable|2|||
30959727|NCT01565707|59025222|FG001|Overall Study|Randomized but not evaluable|0|||
30959728|NCT01565707|59025223|FG002|Overall Study|Randomized but not evaluable|0|||
30959729|NCT01565707|59025224|FG003|Overall Study|Randomized but not evaluable|0|||
30959730|NCT01565707|59025221|FG000|Overall Study|Miscellaneous|1|||
30959731|NCT01565707|59025222|FG001|Overall Study|Miscellaneous|1|||
30959732|NCT01565707|59025223|FG002|Overall Study|Miscellaneous|0|||
30959733|NCT01565707|59025224|FG003|Overall Study|Miscellaneous|2|||
30959734|NCT01557569|59025243|FG000|Overall Study|Adverse Event|2|||
30959735|NCT01557569|59025244|FG001|Overall Study|Adverse Event|0|||
30959736|NCT01557569|59025243|FG000|Overall Study|high blood pressure|0|||
30959737|NCT01557569|59025244|FG001|Overall Study|high blood pressure|1|||
30862867|NCT02936323|58892667|FG006|Phase 1 Dose Escalation|Death|3|||
30862868|NCT02936323|58892668|FG007|Phase 1 Dose Escalation|Death|0|||
30862869|NCT02936323|58892669|FG008|Phase 1 Dose Escalation|Death|0|||
30862870|NCT02936323|58892670|FG009|Phase 1 Dose Escalation|Death|0|||
30862871|NCT02936323|58892661|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
30862872|NCT02936323|58892662|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
30862873|NCT02936323|58892663|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
30862874|NCT02936323|58892664|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
30862875|NCT02936323|58892665|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
30862876|NCT02936323|58892666|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
30862877|NCT02936323|58892667|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
30862878|NCT02936323|58892668|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
30959738|NCT01557569|59025243|FG000|Overall Study|Withdrawal by Subject|3|||
30959739|NCT01557569|59025244|FG001|Overall Study|Withdrawal by Subject|5|||
30959740|NCT01557569|59025243|FG000|Overall Study|noncompliance with rules of residential|0|||
30959741|NCT01557569|59025244|FG001|Overall Study|noncompliance with rules of residential|1|||
30959742|NCT01538719|59025252|FG000|Overall Study|Lost to Follow-up|2|||
30959743|NCT01538719|59025253|FG001|Overall Study|Lost to Follow-up|0|||
30959744|NCT01537783|59025261|FG000|Overall Study|Lost to Follow-up|11|||
30959745|NCT01537783|59025262|FG001|Overall Study|Lost to Follow-up|2|||
30862879|NCT02936323|58892669|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
30862880|NCT02936323|58892670|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
30862881|NCT02936323|58892661|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
30862882|NCT02936323|58892662|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
30862883|NCT02936323|58892663|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
30862884|NCT02936323|58892664|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
30862885|NCT02936323|58892665|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
30862886|NCT02936323|58892666|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
30862887|NCT02936323|58892667|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
30862888|NCT02936323|58892668|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
30862889|NCT02936323|58892669|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
30862890|NCT02936323|58892670|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
30862891|NCT02936323|58892661|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
30862892|NCT02936323|58892662|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
30862893|NCT02936323|58892663|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
30862894|NCT02936323|58892664|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
30862895|NCT02936323|58892665|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
30862896|NCT02936323|58892666|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
30862897|NCT02936323|58892667|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
30862898|NCT02936323|58892668|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
30862899|NCT02936323|58892669|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
30862900|NCT02936323|58892670|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
30862901|NCT02936323|58892661|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
30862902|NCT02936323|58892662|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
30862903|NCT02936323|58892663|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
30862904|NCT02936323|58892664|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
30862905|NCT02936323|58892665|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
30862906|NCT02936323|58892666|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
30862907|NCT02936323|58892667|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
30862908|NCT02936323|58892668|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
30862909|NCT02936323|58892669|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
30862910|NCT02936323|58892670|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
30862911|NCT02936323|58892661|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
30862912|NCT02936323|58892662|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
30862913|NCT02936323|58892663|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
30862914|NCT02936323|58892664|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
30862915|NCT02936323|58892665|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
30862916|NCT02936323|58892666|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
30862917|NCT02936323|58892667|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
30862918|NCT02936323|58892668|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
30862919|NCT02936323|58892669|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
30862920|NCT02936323|58892670|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
30862921|NCT02936323|58892661|FG000|Phase 2a Dose Expansion|Death|0|||
30862922|NCT02936323|58892662|FG001|Phase 2a Dose Expansion|Death|0|||
30862923|NCT02936323|58892663|FG002|Phase 2a Dose Expansion|Death|0|||
30862924|NCT02936323|58892664|FG003|Phase 2a Dose Expansion|Death|0|||
30862925|NCT02936323|58892665|FG004|Phase 2a Dose Expansion|Death|0|||
30862926|NCT02936323|58892666|FG005|Phase 2a Dose Expansion|Death|0|||
30862927|NCT02936323|58892667|FG006|Phase 2a Dose Expansion|Death|0|||
30862928|NCT02936323|58892668|FG007|Phase 2a Dose Expansion|Death|4|||
30862929|NCT02936323|58892669|FG008|Phase 2a Dose Expansion|Death|8|||
30862930|NCT02936323|58892670|FG009|Phase 2a Dose Expansion|Death|10|||
30862931|NCT02243176|58892704|FG000|Overall Study|Other reason|1|||
30862932|NCT02243176|58892705|FG001|Overall Study|Other reason|2|||
30862933|NCT02243176|58892704|FG000|Overall Study|protocol specified withdrawal critera|1|||
30862934|NCT02243176|58892705|FG001|Overall Study|protocol specified withdrawal critera|3|||
30862935|NCT02243176|58892704|FG000|Overall Study|Protocol Violation|2|||
30862936|NCT02243176|58892705|FG001|Overall Study|Protocol Violation|1|||
30862937|NCT02243176|58892704|FG000|Overall Study|Withdrawal by Subject|8|||
30862938|NCT02243176|58892705|FG001|Overall Study|Withdrawal by Subject|7|||
30862939|NCT02243176|58892704|FG000|Overall Study|Adverse Event|2|||
30862940|NCT02243176|58892705|FG001|Overall Study|Adverse Event|2|||
30862941|NCT00002663|58892716|FG000|Overall Study|Death|4|||
30862942|NCT00002663|58892717|FG001|Overall Study|Death|1|||
30862943|NCT00002663|58892718|FG002|Overall Study|Death|1|||
30862944|NCT00002663|58892719|FG003|Overall Study|Death|0|||
30862945|NCT00002663|58892720|FG004|Overall Study|Death|0|||
30862946|NCT00002663|58892721|FG005|Overall Study|Death|13|||
30862947|NCT00002663|58892722|FG006|Overall Study|Death|0|||
30862948|NCT00002663|58892723|FG007|Overall Study|Death|1|||
30862949|NCT00002663|58892724|FG008|Overall Study|Death|1|||
30862950|NCT00002663|58892725|FG009|Overall Study|Death|1|||
30862951|NCT00002663|58892716|FG000|Overall Study|Lost to Follow-up|3|||
30862952|NCT00002663|58892717|FG001|Overall Study|Lost to Follow-up|0|||
30862953|NCT00002663|58892718|FG002|Overall Study|Lost to Follow-up|0|||
30862954|NCT00002663|58892719|FG003|Overall Study|Lost to Follow-up|1|||
30862955|NCT00002663|58892720|FG004|Overall Study|Lost to Follow-up|0|||
30862956|NCT00002663|58892721|FG005|Overall Study|Lost to Follow-up|1|||
30862957|NCT00002663|58892722|FG006|Overall Study|Lost to Follow-up|0|||
30862958|NCT00002663|58892723|FG007|Overall Study|Lost to Follow-up|0|||
30862959|NCT00002663|58892724|FG008|Overall Study|Lost to Follow-up|0|||
30862960|NCT00002663|58892725|FG009|Overall Study|Lost to Follow-up|0|||
30862961|NCT00002663|58892716|FG000|Overall Study|Other|0|||
30862962|NCT00002663|58892717|FG001|Overall Study|Other|1|||
30862963|NCT00002663|58892718|FG002|Overall Study|Other|0|||
30862964|NCT00002663|58892719|FG003|Overall Study|Other|0|||
30862965|NCT00002663|58892720|FG004|Overall Study|Other|0|||
30862966|NCT00002663|58892721|FG005|Overall Study|Other|1|||
30862967|NCT00002663|58892722|FG006|Overall Study|Other|1|||
30862968|NCT00002663|58892723|FG007|Overall Study|Other|0|||
30862969|NCT00002663|58892724|FG008|Overall Study|Other|0|||
30862970|NCT00002663|58892725|FG009|Overall Study|Other|0|||
30862971|NCT00002663|58892716|FG000|Overall Study|Physician Decision|0|||
30862972|NCT00002663|58892717|FG001|Overall Study|Physician Decision|0|||
30862973|NCT00002663|58892718|FG002|Overall Study|Physician Decision|0|||
30862974|NCT00002663|58892719|FG003|Overall Study|Physician Decision|0|||
30862975|NCT00002663|58892720|FG004|Overall Study|Physician Decision|1|||
30862976|NCT00002663|58892721|FG005|Overall Study|Physician Decision|0|||
30862977|NCT00002663|58892722|FG006|Overall Study|Physician Decision|0|||
30862978|NCT00002663|58892723|FG007|Overall Study|Physician Decision|0|||
30862979|NCT00002663|58892724|FG008|Overall Study|Physician Decision|1|||
30862980|NCT00002663|58892725|FG009|Overall Study|Physician Decision|1|||
30862981|NCT00002663|58892716|FG000|Overall Study|Adverse Event|0|||
30862982|NCT00002663|58892717|FG001|Overall Study|Adverse Event|0|||
30862983|NCT00002663|58892718|FG002|Overall Study|Adverse Event|0|||
30862984|NCT00002663|58892719|FG003|Overall Study|Adverse Event|1|||
30862985|NCT00002663|58892720|FG004|Overall Study|Adverse Event|0|||
30862986|NCT00002663|58892721|FG005|Overall Study|Adverse Event|0|||
30862987|NCT00002663|58892722|FG006|Overall Study|Adverse Event|0|||
30862988|NCT00002663|58892723|FG007|Overall Study|Adverse Event|1|||
30862989|NCT00002663|58892724|FG008|Overall Study|Adverse Event|0|||
30862990|NCT00002663|58892725|FG009|Overall Study|Adverse Event|0|||
30862991|NCT02240680|58892736|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
30862992|NCT02240680|58892737|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
30862993|NCT02240680|58892738|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
30862994|NCT02240680|58892739|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
30862995|NCT02240680|58892736|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
30862996|NCT02240680|58892737|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
30862997|NCT02240680|58892738|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
30862998|NCT02240680|58892739|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
30862999|NCT02240680|58892736|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
30863000|NCT02240680|58892737|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
30863001|NCT02240680|58892738|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
30863002|NCT02240680|58892739|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
30863003|NCT02240680|58892736|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
30863004|NCT02240680|58892737|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
30863005|NCT02240680|58892738|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
30863006|NCT02240680|58892739|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
30863007|NCT02240680|58892736|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
30863008|NCT02240680|58892737|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
30863009|NCT02240680|58892738|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
30863010|NCT02240680|58892739|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
30863011|NCT02240680|58892736|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
30863012|NCT02240680|58892737|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
30863013|NCT02240680|58892738|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
30863014|NCT02240680|58892739|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
30863015|NCT02240680|58892736|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
30959746|NCT01556165|59025270|FG000|Overall Study|Adverse Event|5|||
30959747|NCT01556165|59025271|FG001|Overall Study|Adverse Event|3|||
30863016|NCT02240680|58892737|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
30863017|NCT02240680|58892738|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
30863018|NCT02240680|58892739|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
30863019|NCT02240680|58892736|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
30863020|NCT02240680|58892737|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
30863021|NCT02240680|58892738|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
30863022|NCT02240680|58892739|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
30863023|NCT02240368|58892750|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
30863024|NCT02240368|58892751|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
30863025|NCT02240368|58892752|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
30863026|NCT02240368|58892750|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
30863027|NCT02240368|58892751|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
30863028|NCT02240368|58892752|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
30863029|NCT02239978|58892762|FG000|Overall Study|Withdrawal by Subject|2|||
30863030|NCT02239978|58892763|FG001|Overall Study|Withdrawal by Subject|0|||
30863031|NCT02239510|58892773|FG000|Overall Study|Lost to Follow-up|2|||
30863032|NCT02239510|58892774|FG001|Overall Study|Lost to Follow-up|1|||
30863033|NCT02462486|58892783|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
30863034|NCT02462486|58892784|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
30863035|NCT02462486|58892785|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
30863036|NCT02462486|58892783|FG000|Overall Study|Adverse Event|53|||
30863037|NCT02462486|58892784|FG001|Overall Study|Adverse Event|48|||
30863038|NCT02462486|58892785|FG002|Overall Study|Adverse Event|21|||
30863039|NCT02462486|58892783|FG000|Overall Study|Lack of Efficacy|6|||
30863040|NCT02462486|58892784|FG001|Overall Study|Lack of Efficacy|12|||
30863041|NCT02462486|58892785|FG002|Overall Study|Lack of Efficacy|3|||
30863042|NCT02462486|58892783|FG000|Overall Study|Lost to Follow-up|3|||
30863043|NCT02462486|58892784|FG001|Overall Study|Lost to Follow-up|4|||
30863044|NCT02462486|58892785|FG002|Overall Study|Lost to Follow-up|2|||
30863045|NCT02462486|58892783|FG000|Overall Study|Withdrawal by Subject|25|||
30863046|NCT02462486|58892784|FG001|Overall Study|Withdrawal by Subject|22|||
30863047|NCT02462486|58892785|FG002|Overall Study|Withdrawal by Subject|19|||
30863048|NCT02462486|58892783|FG000|Overall Study|Protocol Violation|3|||
30863049|NCT02462486|58892784|FG001|Overall Study|Protocol Violation|1|||
30863050|NCT02462486|58892785|FG002|Overall Study|Protocol Violation|1|||
30863051|NCT02462486|58892783|FG000|Overall Study|Reason not Specified|3|||
30863052|NCT02462486|58892784|FG001|Overall Study|Reason not Specified|4|||
30863053|NCT02462486|58892785|FG002|Overall Study|Reason not Specified|3|||
30863054|NCT02495948|58892793|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
30863055|NCT02495948|58892794|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
30863056|NCT02495948|58892793|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
30863057|NCT02495948|58892794|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
30863058|NCT02461628|58892803|FG000|Overall Study|Refused to complete survey|4|||
30863059|NCT02461628|58892804|FG001|Overall Study|Refused to complete survey|7|||
30863060|NCT02429791|58892812|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
30863061|NCT02429791|58892813|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
30863062|NCT02429791|58892812|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
30863063|NCT02429791|58892813|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
30863064|NCT02429791|58892812|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
30863065|NCT02429791|58892813|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
30863066|NCT02429791|58892812|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
30863067|NCT02429791|58892813|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
30863068|NCT02429791|58892812|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
30863069|NCT02429791|58892813|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
30863070|NCT02429791|58892812|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
30863071|NCT02429791|58892813|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
30863072|NCT02429791|58892812|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
30863073|NCT02429791|58892813|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
30863074|NCT02429791|58892812|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
30863075|NCT02429791|58892813|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
30863076|NCT02429791|58892812|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
30863077|NCT02429791|58892813|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
30863078|NCT02429791|58892812|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
30863079|NCT02429791|58892813|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
30863080|NCT02429791|58892812|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
30863081|NCT02429791|58892813|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
30863082|NCT02429791|58892812|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
30863083|NCT02429791|58892813|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
30863084|NCT02461160|58892839|FG000|Overall Study|Lost to Follow-up|0|||
30863085|NCT02461160|58892840|FG001|Overall Study|Lost to Follow-up|0|||
30863086|NCT02461160|58892841|FG002|Overall Study|Lost to Follow-up|0|||
30863087|NCT02461160|58892842|FG003|Overall Study|Lost to Follow-up|0|||
30863088|NCT02461160|58892843|FG004|Overall Study|Lost to Follow-up|0|||
30863089|NCT02461160|58892844|FG005|Overall Study|Lost to Follow-up|0|||
30863090|NCT02461160|58892845|FG006|Overall Study|Lost to Follow-up|0|||
30863091|NCT02461160|58892846|FG007|Overall Study|Lost to Follow-up|1|||
30863092|NCT02461160|58892847|FG008|Overall Study|Lost to Follow-up|0|||
30863093|NCT02461160|58892848|FG009|Overall Study|Lost to Follow-up|0|||
30863094|NCT02461160|58892849|FG010|Overall Study|Lost to Follow-up|0|||
30863095|NCT02461160|58892850|FG011|Overall Study|Lost to Follow-up|0|||
30863096|NCT02461160|58892851|FG012|Overall Study|Lost to Follow-up|0|||
30863097|NCT01653704|58892902|FG000|Overall Study|Technical failure during recording|1|||
30863098|NCT01653704|58892903|FG001|Overall Study|Technical failure during recording|1|||
30863099|NCT01653704|58892902|FG000|Overall Study|Performance not reflective of training|1|||
30863100|NCT01653704|58892903|FG001|Overall Study|Performance not reflective of training|0|||
30863101|NCT02495168|58892912|FG000|Overall Study|Other than Specified|18|||
30863102|NCT02495168|58892913|FG001|Overall Study|Other than Specified|22|||
30863103|NCT02495168|58892914|FG002|Overall Study|Other than Specified|5|||
30863104|NCT02495168|58892912|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
30863105|NCT02495168|58892913|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
30863106|NCT02495168|58892914|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
30863107|NCT02495168|58892912|FG000|Overall Study|Physician Decision|1|||
30863108|NCT02495168|58892913|FG001|Overall Study|Physician Decision|1|||
30863109|NCT02495168|58892914|FG002|Overall Study|Physician Decision|0|||
30863110|NCT02495168|58892912|FG000|Overall Study|Lost to Follow-up|10|||
30863111|NCT02495168|58892913|FG001|Overall Study|Lost to Follow-up|6|||
30863112|NCT02495168|58892914|FG002|Overall Study|Lost to Follow-up|1|||
30863113|NCT02495168|58892912|FG000|Overall Study|Withdrawal by Subject|1|||
30863114|NCT02495168|58892913|FG001|Overall Study|Withdrawal by Subject|4|||
30863115|NCT02495168|58892914|FG002|Overall Study|Withdrawal by Subject|2|||
30863116|NCT02495168|58892912|FG000|Overall Study|Protocol Violation|0|||
30863117|NCT02495168|58892913|FG001|Overall Study|Protocol Violation|10|||
30863118|NCT02495168|58892914|FG002|Overall Study|Protocol Violation|1|||
30863119|NCT02495168|58892912|FG000|Overall Study|Adverse Event|4|||
30863120|NCT02495168|58892913|FG001|Overall Study|Adverse Event|8|||
30863121|NCT02495168|58892914|FG002|Overall Study|Adverse Event|3|||
30863122|NCT02495168|58892912|FG000|Overall Study|Lack of Efficacy|0|||
30863123|NCT02495168|58892913|FG001|Overall Study|Lack of Efficacy|0|||
30863124|NCT02495168|58892914|FG002|Overall Study|Lack of Efficacy|3|||
30863125|NCT02494778|58892922|FG000|Overall Study|Death|3|||
30863126|NCT02494778|58892922|FG000|Overall Study|Other|173|||
30863127|NCT02494778|58892922|FG000|Overall Study|Lack of Efficacy|4|||
30863128|NCT02494778|58892922|FG000|Overall Study|Adverse Event|18|||
30863129|NCT02494778|58892922|FG000|Overall Study|Withdrawal by Subject|20|||
30863130|NCT02494778|58892922|FG000|Overall Study|Lost to Follow-up|2|||
30863131|NCT02494778|58892922|FG000|Overall Study|Noncompliant with study drug admin.|1|||
30863132|NCT02493764|58892928|FG000|Overall Study|Adverse Event|2|||
30863133|NCT02493764|58892929|FG001|Overall Study|Adverse Event|2|||
30863134|NCT02493764|58892928|FG000|Overall Study|Death|44|||
30863135|NCT02493764|58892929|FG001|Overall Study|Death|58|||
30863136|NCT02493764|58892928|FG000|Overall Study|Lost to Follow-up|2|||
30863137|NCT02493764|58892929|FG001|Overall Study|Lost to Follow-up|1|||
30863138|NCT02493764|58892928|FG000|Overall Study|Protocol Violation|6|||
30863139|NCT02493764|58892929|FG001|Overall Study|Protocol Violation|7|||
30863140|NCT02493764|58892928|FG000|Overall Study|Physician Decision|1|||
30863141|NCT02493764|58892929|FG001|Overall Study|Physician Decision|1|||
30863142|NCT02493764|58892928|FG000|Overall Study|Participant moved|17|||
30863143|NCT02493764|58892929|FG001|Overall Study|Participant moved|5|||
30863144|NCT02493764|58892928|FG000|Overall Study|Withdrawal parent/guardian|0|||
30863145|NCT02493764|58892929|FG001|Overall Study|Withdrawal parent/guardian|1|||
30863146|NCT02493764|58892928|FG000|Overall Study|Withdrawal by Subject|11|||
30863147|NCT02493764|58892929|FG001|Overall Study|Withdrawal by Subject|7|||
30863148|NCT02460380|58892937|FG000|Overall Study|Withdrawal by Subject|10|||
30863149|NCT02460380|58892938|FG001|Overall Study|Withdrawal by Subject|5|||
30863150|NCT02493062|58892945|FG000|Overall Study|Physician Decision|12|||
30863151|NCT02492984|58892951|FG000|Overall Study|Adverse Event|1|||
30863152|NCT02492984|58892952|FG001|Overall Study|Adverse Event|0|||
30863153|NCT02492984|58892951|FG000|Overall Study|Protocol Violation|1|||
30863154|NCT02492984|58892952|FG001|Overall Study|Protocol Violation|0|||
30863155|NCT02492984|58892951|FG000|Overall Study|Withdrawal by Subject|1|||
30863156|NCT02492984|58892952|FG001|Overall Study|Withdrawal by Subject|0|||
30863157|NCT01680159|58892965|FG000|Screening Period|Not meet criteria for dose-up period|7|||
30863158|NCT01680159|58892965|FG000|Increased Dose Period|Adverse Event|6|||
30863159|NCT01680159|58892965|FG000|Increased Dose Period|Withdrawal by Subject|2|||
30863160|NCT02491892|58892987|FG000|Overall Study|Adverse Event|1|||
30863161|NCT02491892|58892988|FG001|Overall Study|Adverse Event|1|||
30863162|NCT02491892|58892987|FG000|Overall Study|Death|1|||
30863163|NCT02491892|58892988|FG001|Overall Study|Death|1|||
30863164|NCT02491892|58892987|FG000|Overall Study|Lack of Efficacy|37|||
30863165|NCT02491892|58892988|FG001|Overall Study|Lack of Efficacy|36|||
30863166|NCT02491892|58892987|FG000|Overall Study|Refused Treatment|1|||
30863167|NCT02491892|58892988|FG001|Overall Study|Refused Treatment|0|||
30863168|NCT02491892|58892987|FG000|Overall Study|Lost to Follow-up|1|||
30863169|NCT02491892|58892988|FG001|Overall Study|Lost to Follow-up|0|||
30863170|NCT02436356|58893004|FG000|Overall Study|Excluded by MRI Screening|0|||
30863171|NCT02436356|58893005|FG001|Overall Study|Excluded by MRI Screening|0|||
30863172|NCT02436356|58893006|FG002|Overall Study|Excluded by MRI Screening|2|||
30863173|NCT02436356|58893004|FG000|Overall Study|Lost to Follow-up|0|||
30863174|NCT02436356|58893005|FG001|Overall Study|Lost to Follow-up|1|||
30863175|NCT02436356|58893006|FG002|Overall Study|Lost to Follow-up|0|||
30863176|NCT02436356|58893004|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
30863177|NCT02436356|58893005|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
30863178|NCT02436356|58893006|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
30863179|NCT02436356|58893004|FG000|Overall Study|Excluded due to other medical conditions|3|||
30863180|NCT02436356|58893005|FG001|Overall Study|Excluded due to other medical conditions|0|||
30863181|NCT02436356|58893006|FG002|Overall Study|Excluded due to other medical conditions|0|||
30863182|NCT02436356|58893004|FG000|Overall Study|Withdrawal by Subject|1|||
30863183|NCT02436356|58893005|FG001|Overall Study|Withdrawal by Subject|0|||
30863184|NCT02436356|58893006|FG002|Overall Study|Withdrawal by Subject|0|||
30863185|NCT02436200|58893019|FG000|Overall Study|Significant outlier|1|||
30863186|NCT01679613|58893023|FG000|Overall Study|other than stated above|0|||
30863187|NCT01679613|58893024|FG001|Overall Study|other than stated above|1|||
30863188|NCT01679613|58893025|FG002|Overall Study|other than stated above|2|||
30863189|NCT01679613|58893026|FG003|Overall Study|other than stated above|2|||
30863190|NCT02489630|58893035|FG000|Overall Study|Oversedation|1|||
30863191|NCT02489630|58893036|FG001|Overall Study|Oversedation|1|||
30863192|NCT02489630|58893035|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
30863193|NCT02489630|58893036|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
30863194|NCT02739347|58893044|FG000|Overall Study|Adverse Event|3|||
30863195|NCT02739347|58893045|FG001|Overall Study|Adverse Event|0|||
30863196|NCT02739347|58893044|FG000|Overall Study|Protocol Violation|0|||
30863197|NCT02739347|58893045|FG001|Overall Study|Protocol Violation|1|||
30863198|NCT02739347|58893044|FG000|Overall Study|Lost to Follow-up|0|||
30863199|NCT02739347|58893045|FG001|Overall Study|Lost to Follow-up|2|||
30863200|NCT02435966|58893054|FG000|Overall Study|Withdrawal by Subject|0|||
30863201|NCT02435966|58893055|FG001|Overall Study|Withdrawal by Subject|1|||
30863202|NCT02435966|58893056|FG002|Overall Study|Withdrawal by Subject|0|||
30863203|NCT01679301|58893064|FG000|Screening Period|screen failure|3|||
30863204|NCT01679301|58893065|FG001|Screening Period|screen failure|0|||
30863205|NCT01679301|58893066|FG002|Screening Period|screen failure|0|||
30863206|NCT01678911|58893072|FG000|Second Intervention|Lost to Follow-up|2|||
30863207|NCT01678911|58893073|FG001|Second Intervention|Lost to Follow-up|0|||
30863208|NCT02487446|58893079|FG000|Period 1|Physician Decision|0|||
30863209|NCT02487446|58893080|FG001|Period 1|Physician Decision|1|||
30863210|NCT02487446|58893079|FG000|Period 1|Lack of Efficacy|1|||
30863211|NCT02487446|58893080|FG001|Period 1|Lack of Efficacy|0|||
30863212|NCT02487446|58893079|FG000|Period 1|Protocol deviation|3|||
30863213|NCT02487446|58893080|FG001|Period 1|Protocol deviation|2|||
30863214|NCT02487446|58893079|FG000|Period 1|Lost to Follow-up|2|||
30863215|NCT02487446|58893080|FG001|Period 1|Lost to Follow-up|0|||
30863216|NCT02487446|58893079|FG000|Period 1|Withdrawal by Subject|2|||
30863217|NCT02487446|58893080|FG001|Period 1|Withdrawal by Subject|0|||
30863218|NCT02487446|58893079|FG000|Period 1|Adverse Event|5|||
30863219|NCT02487446|58893080|FG001|Period 1|Adverse Event|5|||
30863220|NCT02487446|58893079|FG000|Washout|Lost to Follow-up|0|||
30863221|NCT02487446|58893080|FG001|Washout|Lost to Follow-up|2|||
30863222|NCT02487446|58893079|FG000|Washout|Withdrawal by Subject|1|||
30863223|NCT02487446|58893080|FG001|Washout|Withdrawal by Subject|4|||
30863224|NCT02487446|58893079|FG000|Washout|Adverse Event|2|||
30863225|NCT02487446|58893080|FG001|Washout|Adverse Event|2|||
30863226|NCT02487446|58893079|FG000|Period 2|Protocol deviation|0|||
30863227|NCT02487446|58893080|FG001|Period 2|Protocol deviation|1|||
30863228|NCT02487446|58893079|FG000|Period 2|Lost to Follow-up|1|||
30863229|NCT02487446|58893080|FG001|Period 2|Lost to Follow-up|1|||
30863230|NCT02487446|58893079|FG000|Period 2|Withdrawal by Subject|1|||
30863231|NCT02487446|58893080|FG001|Period 2|Withdrawal by Subject|1|||
30863232|NCT02487446|58893079|FG000|Period 2|Adverse Event|6|||
30863233|NCT02487446|58893080|FG001|Period 2|Adverse Event|2|||
30863234|NCT02739269|58893089|FG000|Overall Study|Protocol Violation|5|||
30863235|NCT02739269|58893090|FG001|Overall Study|Protocol Violation|0|||
30863236|NCT02739269|58893089|FG000|Overall Study|Cycle cancellation|2|||
30863237|NCT02739269|58893090|FG001|Overall Study|Cycle cancellation|2|||
30863238|NCT02739269|58893089|FG000|Overall Study|Withdrawal by Subject|0|||
30863239|NCT02739269|58893090|FG001|Overall Study|Withdrawal by Subject|2|||
30863240|NCT03318523|58893100|FG000|PC Period: Up to Year 1|Adverse Event|1|||
30863241|NCT03318523|58893101|FG001|PC Period: Up to Year 1|Adverse Event|0|||
30863242|NCT03318523|58893102|FG002|PC Period: Up to Year 1|Adverse Event|2|||
30600456|NCT01090414|58612048|FG001|Study 101-99|Withdrew Consent|2|||
30600457|NCT01090414|58612049|FG002|Study 101-99|Withdrew Consent|3|||
30600458|NCT01090414|58612050|FG003|Study 101-99|Withdrew Consent|1|||
30600459|NCT01090414|58612047|FG000|Study 101-99|Participant Request|3|||
30600460|NCT01090414|58612048|FG001|Study 101-99|Participant Request|1|||
30863243|NCT03318523|58893103|FG003|PC Period: Up to Year 1|Adverse Event|0|||
30863244|NCT03318523|58893104|FG004|PC Period: Up to Year 1|Adverse Event|0|||
30863245|NCT03318523|58893105|FG005|PC Period: Up to Year 1|Adverse Event|0|||
30863246|NCT03318523|58893106|FG006|PC Period: Up to Year 1|Adverse Event|0|||
30863247|NCT03318523|58893107|FG007|PC Period: Up to Year 1|Adverse Event|0|||
30863248|NCT03318523|58893108|FG008|PC Period: Up to Year 1|Adverse Event|0|||
30863249|NCT03318523|58893109|FG009|PC Period: Up to Year 1|Adverse Event|0|||
30863250|NCT03318523|58893100|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
30863251|NCT03318523|58893101|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
30863252|NCT03318523|58893102|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
30863253|NCT03318523|58893103|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
30863254|NCT03318523|58893104|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
30863255|NCT03318523|58893105|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
30863256|NCT03318523|58893106|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
30863257|NCT03318523|58893107|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
30863258|NCT03318523|58893108|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
30863259|NCT03318523|58893109|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
30863260|NCT03318523|58893100|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
30863261|NCT03318523|58893101|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
30863262|NCT03318523|58893102|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
30863263|NCT03318523|58893103|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
30863264|NCT03318523|58893104|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
30863265|NCT03318523|58893105|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
30863266|NCT03318523|58893106|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
30863267|NCT03318523|58893107|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
30863268|NCT03318523|58893108|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
30863269|NCT03318523|58893109|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
30863270|NCT03318523|58893100|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
30863271|NCT03318523|58893101|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
30863272|NCT03318523|58893102|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
30863273|NCT03318523|58893103|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
30863274|NCT03318523|58893104|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
30863275|NCT03318523|58893105|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
30863276|NCT03318523|58893106|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
30863277|NCT03318523|58893107|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
30863278|NCT03318523|58893108|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
30863279|NCT03318523|58893109|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
30863280|NCT03318523|58893100|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
30863281|NCT03318523|58893101|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
30863282|NCT03318523|58893102|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
30863283|NCT03318523|58893103|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
30863284|NCT03318523|58893104|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
30863285|NCT03318523|58893105|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
30863286|NCT03318523|58893106|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
30863287|NCT03318523|58893107|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
30863288|NCT03318523|58893108|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
30863289|NCT03318523|58893109|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
30863290|NCT03318523|58893100|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
30863291|NCT03318523|58893101|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
30863292|NCT03318523|58893102|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
30863293|NCT03318523|58893103|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
30863294|NCT03318523|58893104|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
30863295|NCT03318523|58893105|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
30863296|NCT03318523|58893106|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
30863297|NCT03318523|58893107|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
30863298|NCT03318523|58893108|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
30863299|NCT03318523|58893109|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
30863300|NCT03318523|58893100|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
30863301|NCT03318523|58893101|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
30863302|NCT03318523|58893102|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
30863303|NCT03318523|58893103|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
30863304|NCT03318523|58893104|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
30863305|NCT03318523|58893105|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
30863306|NCT03318523|58893106|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
30863307|NCT03318523|58893107|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
30863308|NCT03318523|58893108|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
30863309|NCT03318523|58893109|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
30863310|NCT03318523|58893100|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
30863311|NCT03318523|58893101|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
30863312|NCT03318523|58893102|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
30863313|NCT03318523|58893103|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
30863314|NCT03318523|58893104|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
30863315|NCT03318523|58893105|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
30863316|NCT03318523|58893106|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
30863317|NCT03318523|58893107|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
30863318|NCT03318523|58893108|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
30863319|NCT03318523|58893109|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
30863320|NCT01678209|58893136|FG000|Overall Study|could not scan twice|1|||
30863321|NCT01678209|58893137|FG001|Overall Study|could not scan twice|1|||
30863322|NCT01678209|58893138|FG002|Overall Study|could not scan twice|1|||
30863323|NCT01678209|58893136|FG000|Overall Study|scheduling conflicts|0|||
30863324|NCT01678209|58893137|FG001|Overall Study|scheduling conflicts|0|||
30863325|NCT01678209|58893138|FG002|Overall Study|scheduling conflicts|1|||
30863326|NCT01678209|58893136|FG000|Overall Study|screen fail|16|||
30863327|NCT01678209|58893137|FG001|Overall Study|screen fail|17|||
30863328|NCT01678209|58893138|FG002|Overall Study|screen fail|16|||
30863329|NCT02239120|58893148|FG000|Overall Study|Death|56|||
30863330|NCT02239120|58893149|FG001|Overall Study|Death|58|||
30863331|NCT02239120|58893148|FG000|Overall Study|Lost to Follow-up|19|||
30863332|NCT02239120|58893149|FG001|Overall Study|Lost to Follow-up|14|||
30863333|NCT01603407|58893158|FG000|Overall Study|Adverse Event|1|||
30863334|NCT01603407|58893159|FG001|Overall Study|Adverse Event|1|||
30863335|NCT01603407|58893160|FG002|Overall Study|Adverse Event|1|||
30863336|NCT01603407|58893158|FG000|Overall Study|Protocol Violation|2|||
30863337|NCT01603407|58893159|FG001|Overall Study|Protocol Violation|2|||
30863338|NCT01603407|58893160|FG002|Overall Study|Protocol Violation|0|||
30863339|NCT01603407|58893158|FG000|Overall Study|Withdrawal by Subject|8|||
30863340|NCT01603407|58893159|FG001|Overall Study|Withdrawal by Subject|5|||
30863341|NCT01603407|58893160|FG002|Overall Study|Withdrawal by Subject|7|||
30863342|NCT01603407|58893158|FG000|Overall Study|Lost to Follow-up|0|||
30863343|NCT01603407|58893159|FG001|Overall Study|Lost to Follow-up|3|||
30863344|NCT01603407|58893160|FG002|Overall Study|Lost to Follow-up|2|||
30863345|NCT02235454|58893190|FG000|Overall Study|Withdrawal by Subject|2|||
30863346|NCT02235298|58893196|FG000|Overall Study|Lost to Follow-up|6|||
30863347|NCT02235298|58893197|FG001|Overall Study|Lost to Follow-up|5|||
30863348|NCT02235298|58893196|FG000|Overall Study|Adverse Event|2|||
30863349|NCT02235298|58893197|FG001|Overall Study|Adverse Event|2|||
30863350|NCT02235298|58893196|FG000|Overall Study|Withdrawal by Subject|0|||
30863351|NCT02235298|58893197|FG001|Overall Study|Withdrawal by Subject|1|||
30863352|NCT02234596|58893203|FG000|Overall Study|Participant not treated|2|||
30863353|NCT02234362|58893207|FG000|Overall Study|Not eligible after first screening visit|17|||
30863354|NCT02234362|58893207|FG000|Overall Study|Lost to Follow-up|6|||
30863355|NCT02234362|58893207|FG000|Overall Study|Withdrawal by Subject|3|||
30863356|NCT02234284|58893213|FG000|Overall Study|Death|4|||
30863357|NCT02234284|58893214|FG001|Overall Study|Death|2|||
30863358|NCT02234284|58893213|FG000|Overall Study|Withdrawal by Subject|1|||
30863359|NCT02234284|58893214|FG001|Overall Study|Withdrawal by Subject|0|||
30863360|NCT02234284|58893213|FG000|Overall Study|Lost to Follow-up|20|||
30863361|NCT02234284|58893214|FG001|Overall Study|Lost to Follow-up|7|||
30863362|NCT02232880|58893224|FG000|Overall Study|study stopped prior to randomization|1|||
30863363|NCT02896855|58893230|FG000|Overall Study|Death|50|||
30863364|NCT02896855|58893231|FG001|Overall Study|Death|40|||
30863365|NCT02896855|58893230|FG000|Overall Study|Lost to Follow-up|15|||
30863366|NCT02896855|58893231|FG001|Overall Study|Lost to Follow-up|9|||
30863367|NCT02896855|58893230|FG000|Overall Study|Withdrawal by Subject|7|||
30863368|NCT02896855|58893231|FG001|Overall Study|Withdrawal by Subject|4|||
30863369|NCT02232802|58893242|FG000|Period 1|Sponsor request|1|||
30863370|NCT02232802|58893243|FG001|Period 1|Sponsor request|0|||
30863371|NCT02232802|58893242|FG000|Period 1|Adverse Event|1|||
30600461|NCT01090414|58612049|FG002|Study 101-99|Participant Request|0|||
30600462|NCT01090414|58612050|FG003|Study 101-99|Participant Request|0|||
30600463|NCT01090102|58612074|FG000|First 12 Weeks|Withdrawal by Subject|1|||
30600464|NCT01090102|58612075|FG001|First 12 Weeks|Withdrawal by Subject|1|||
30600465|NCT01090102|58612074|FG000|First 12 Weeks|Adverse Event|2|||
30863372|NCT02232802|58893243|FG001|Period 1|Adverse Event|1|||
30863373|NCT02434328|58893251|FG000|Overall Study|Adverse Event|9|||
30863374|NCT02434328|58893252|FG001|Overall Study|Adverse Event|4|||
30863375|NCT02434328|58893251|FG000|Overall Study|Lack of Efficacy|0|||
30863376|NCT02434328|58893252|FG001|Overall Study|Lack of Efficacy|2|||
30863377|NCT02434328|58893251|FG000|Overall Study|Physician Decision|0|||
30863378|NCT02434328|58893252|FG001|Overall Study|Physician Decision|1|||
30863379|NCT02434328|58893251|FG000|Overall Study|Withdrawal by Subject|12|||
30863380|NCT02434328|58893252|FG001|Overall Study|Withdrawal by Subject|21|||
30863381|NCT02434328|58893251|FG000|Overall Study|Death|4|||
30863382|NCT02434328|58893252|FG001|Overall Study|Death|7|||
30863383|NCT02434328|58893251|FG000|Overall Study|Lost to Follow-up|1|||
30863384|NCT02434328|58893252|FG001|Overall Study|Lost to Follow-up|6|||
30863385|NCT02434328|58893251|FG000|Overall Study|Other|4|||
30863386|NCT02434328|58893252|FG001|Overall Study|Other|1|||
30863387|NCT02660229|58893261|FG000|Overall Study|Adverse Event|2|||
30863388|NCT02660229|58893262|FG001|Overall Study|Adverse Event|0|||
30863389|NCT02660229|58893261|FG000|Overall Study|Withdrawal by Subject|0|||
30863390|NCT02660229|58893262|FG001|Overall Study|Withdrawal by Subject|1|||
30863391|NCT02232178|58893271|FG000|Overall Study|Lost to Follow-up|0|||
30863392|NCT02232178|58893272|FG001|Overall Study|Lost to Follow-up|1|||
30863393|NCT02232178|58893273|FG002|Overall Study|Lost to Follow-up|0|||
30863394|NCT02232178|58893271|FG000|Overall Study|ineligibility|0|||
30863395|NCT02232178|58893272|FG001|Overall Study|ineligibility|0|||
30863396|NCT02232178|58893273|FG002|Overall Study|ineligibility|1|||
30863397|NCT02232178|58893271|FG000|Overall Study|surgical complication|1|||
30863398|NCT02232178|58893272|FG001|Overall Study|surgical complication|0|||
30863399|NCT02232178|58893273|FG002|Overall Study|surgical complication|0|||
30863400|NCT01678131|58893284|FG000|Overall Study|Adverse Event|0|||
30863401|NCT01678131|58893285|FG001|Overall Study|Adverse Event|1|||
30863402|NCT01678131|58893286|FG002|Overall Study|Adverse Event|0|||
30863403|NCT01678131|58893284|FG000|Overall Study|Withdrawal by Subject|0|||
30863404|NCT01678131|58893285|FG001|Overall Study|Withdrawal by Subject|0|||
30863405|NCT01678131|58893286|FG002|Overall Study|Withdrawal by Subject|2|||
30863406|NCT02231164|58893296|FG000|Overall Study|Adverse Event|1|||
30863407|NCT02231164|58893297|FG001|Overall Study|Adverse Event|1|||
30863408|NCT02231164|58893296|FG000|Overall Study|Lack of Efficacy|4|||
30863409|NCT02231164|58893297|FG001|Overall Study|Lack of Efficacy|3|||
30863410|NCT02231164|58893296|FG000|Overall Study|Withdrawal by Subject|1|||
30863411|NCT02231164|58893297|FG001|Overall Study|Withdrawal by Subject|2|||
30863412|NCT02457182|58893305|FG000|Overall Study|Lost to Follow-up|1|||
30863413|NCT02457182|58893306|FG001|Overall Study|Lost to Follow-up|0|||
30863414|NCT02230384|58893314|FG000|Phase 1|Lost to Follow-up|1|||
30863415|NCT02230384|58893315|FG001|Phase 1|Lost to Follow-up|0|||
30863416|NCT02230384|58893314|FG000|Phase 1|Physician Decision|0|||
30863417|NCT02230384|58893315|FG001|Phase 1|Physician Decision|1|||
30863418|NCT02230384|58893314|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
30863419|NCT02230384|58893315|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
30863420|NCT02230384|58893314|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
30863421|NCT02230384|58893315|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
30863422|NCT02230384|58893314|FG000|Phase 2 - Switch|Adverse Event|2|||
30863423|NCT02230384|58893315|FG001|Phase 2 - Switch|Adverse Event|0|||
30863424|NCT02738801|58893331|FG000|Overall Study|Adverse Event|1|||
30863425|NCT02738801|58893332|FG001|Overall Study|Adverse Event|1|||
30863426|NCT02738801|58893331|FG000|Overall Study|Withdrawal by Subject|0|||
30863427|NCT02738801|58893332|FG001|Overall Study|Withdrawal by Subject|1|||
30863428|NCT02230306|58893348|FG000|Overall Study|Did not receive study treatment|1|||
30863429|NCT01680861|58893354|FG000|Early Post-transplant Period|Protocol Violation|1|||
30863430|NCT01680861|58893355|FG001|Early Post-transplant Period|Protocol Violation|1|||
30863431|NCT02229214|58893365|FG000|Overall Study|Adverse Event|2|||
30863432|NCT02229214|58893366|FG001|Overall Study|Adverse Event|0|||
30863433|NCT02229214|58893365|FG000|Overall Study|Withdrawal by Subject|4|||
30863434|NCT02229214|58893366|FG001|Overall Study|Withdrawal by Subject|0|||
30863435|NCT02228980|58893378|FG000|Overall Study|Adverse Event|14|||
30863436|NCT02228980|58893379|FG001|Overall Study|Adverse Event|0|||
30863437|NCT02228980|58893380|FG002|Overall Study|Adverse Event|0|||
30863438|NCT02228980|58893381|FG003|Overall Study|Adverse Event|0|||
30863439|NCT02228980|58893378|FG000|Overall Study|Protocol Violation|7|||
30863440|NCT02228980|58893379|FG001|Overall Study|Protocol Violation|0|||
30863441|NCT02228980|58893380|FG002|Overall Study|Protocol Violation|0|||
30863442|NCT02228980|58893381|FG003|Overall Study|Protocol Violation|0|||
30863443|NCT02228980|58893378|FG000|Overall Study|Withdrawal by Subject|3|||
30863444|NCT02228980|58893379|FG001|Overall Study|Withdrawal by Subject|3|||
30863445|NCT02228980|58893380|FG002|Overall Study|Withdrawal by Subject|2|||
30863446|NCT02228980|58893381|FG003|Overall Study|Withdrawal by Subject|3|||
30863447|NCT02228590|58893395|FG000|Overall Study|Withdrawal by Subject|1|||
30863448|NCT02227108|58893400|FG000|Overall Study|Did not receive treatment|2|||
30863449|NCT02227108|58893400|FG000|Overall Study|Other|3|||
30689943|NCT00713544|58704015|FG002|Overall Study|Incorrect enrollment|0|||
30863450|NCT02227108|58893400|FG000|Overall Study|Progressive disease|17|||
30863451|NCT02227108|58893400|FG000|Overall Study|Initiation of alternative therapy|2|||
30863452|NCT02227108|58893400|FG000|Overall Study|Investigator discretion|1|||
30863453|NCT02227108|58893400|FG000|Overall Study|Adverse Event|6|||
30863454|NCT03564145|58893404|FG000|Overall Study|Adverse Event|4|||
30863455|NCT03564145|58893404|FG000|Overall Study|Lost to Follow-up|21|||
30863456|NCT03564145|58893404|FG000|Overall Study|Protocol Violation|2|||
30863457|NCT03564145|58893404|FG000|Overall Study|Withdrawal by Subject|48|||
30863458|NCT03564145|58893404|FG000|Overall Study|Study Terminated by Sponsor|146|||
30863459|NCT03564145|58893404|FG000|Overall Study|Physician Decision|1|||
30863460|NCT03564145|58893404|FG000|Overall Study|Other Than Specified|1|||
30863461|NCT03564145|58893404|FG000|Overall Study|Pregnancy|1|||
30863462|NCT02226562|58893410|FG000|Overall Study|Lost to Follow-up|0|||
30863463|NCT02226562|58893411|FG001|Overall Study|Lost to Follow-up|1|||
30863464|NCT02456636|58893445|FG000|Overall Study|Death|0|||
30863465|NCT02456636|58893446|FG001|Overall Study|Death|3|||
30863466|NCT02456636|58893447|FG002|Overall Study|Death|0|||
30863467|NCT02456636|58893445|FG000|Overall Study|Pregnancy|1|||
30863468|NCT02456636|58893446|FG001|Overall Study|Pregnancy|3|||
30959748|NCT01556165|59025270|FG000|Overall Study|Protocol Violation|0|||
30959749|NCT01556165|59025271|FG001|Overall Study|Protocol Violation|3|||
30959750|NCT01556165|59025270|FG000|Overall Study|Withdrawal of Consent|7|||
30959751|NCT01556165|59025271|FG001|Overall Study|Withdrawal of Consent|1|||
30959752|NCT01537549|59025277|FG000|Overall Study|Lost to Follow-up|1|||
30959753|NCT01537549|59025277|FG000|Overall Study|Withdrawal by Subject|2|||
30959754|NCT01555931|59025285|FG000|Overall Study|Lost to Follow-up|2|||
30959755|NCT01555931|59025286|FG001|Overall Study|Lost to Follow-up|5|||
30959756|NCT01583179|59025294|FG000|Overall Study|Screen failure|1|||
30959757|NCT01583179|59025295|FG001|Overall Study|Screen failure|2|||
30959758|NCT01582945|59025301|FG000|Overall Study|Intolerable side-effects|1|||
30959759|NCT01582945|59025301|FG000|Overall Study|Scheduling conflicts|1|||
30959760|NCT01565083|59025307|FG000|Overall Study|Withdrawal by Subject|6|||
30959761|NCT01565083|59025308|FG001|Overall Study|Withdrawal by Subject|4|||
30959762|NCT01565083|59025307|FG000|Overall Study|Lost to Follow-up|2|||
30959763|NCT01565083|59025308|FG001|Overall Study|Lost to Follow-up|7|||
30959764|NCT01565083|59025307|FG000|Overall Study|Death|22|||
30959765|NCT01565083|59025308|FG001|Overall Study|Death|23|||
30959766|NCT01565083|59025307|FG000|Overall Study|Other|3|||
30959767|NCT01565083|59025308|FG001|Overall Study|Other|5|||
30959768|NCT01582789|59025314|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
30959769|NCT01582789|59025315|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
30959770|NCT01537393|59025325|FG000|Overall Study|Exclude prior to study|32|||
30689944|NCT00713544|58704016|FG003|Overall Study|Incorrect enrollment|0|||
30689945|NCT00713544|58704017|FG004|Overall Study|Incorrect enrollment|0|||
30689946|NCT00713544|58704018|FG005|Overall Study|Incorrect enrollment|0|||
30689947|NCT00713544|58704013|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
30689948|NCT00713544|58704014|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
30689949|NCT00713544|58704015|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
30689950|NCT00713544|58704016|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
30689951|NCT00713544|58704017|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
30689952|NCT00713544|58704018|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
30689953|NCT00415363|58704034|FG000|Overall Study|Withdrawal by Subject|4|||
30689954|NCT00415363|58704035|FG001|Overall Study|Withdrawal by Subject|4|||
30689955|NCT00415363|58704034|FG000|Overall Study|Adverse Event|4|||
30689956|NCT00415363|58704035|FG001|Overall Study|Adverse Event|4|||
30689957|NCT00415363|58704034|FG000|Overall Study|Lost to Follow-up|2|||
30863469|NCT02456636|58893447|FG002|Overall Study|Pregnancy|5|||
30959771|NCT01537393|59025326|FG001|Overall Study|Exclude prior to study|44|||
30959772|NCT01537393|59025325|FG000|Overall Study|Death|20|||
30959773|NCT01537393|59025326|FG001|Overall Study|Death|32|||
30959774|NCT01537393|59025325|FG000|Overall Study|Withdrawal by Subject|18|||
30959775|NCT01537393|59025326|FG001|Overall Study|Withdrawal by Subject|17|||
30959776|NCT01537393|59025325|FG000|Overall Study|Lost to Follow-up|53|||
30959777|NCT01537393|59025326|FG001|Overall Study|Lost to Follow-up|48|||
30959778|NCT01537393|59025325|FG000|Overall Study|Failure - Regrafted|28|||
30959779|NCT01537393|59025326|FG001|Overall Study|Failure - Regrafted|43|||
30959780|NCT01537393|59025325|FG000|Overall Study|Failure - Not regrafted|2|||
30959781|NCT01537393|59025326|FG001|Overall Study|Failure - Not regrafted|6|||
30959782|NCT01537393|59025325|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
30959783|NCT01537393|59025326|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
30689958|NCT00415363|58704035|FG001|Overall Study|Lost to Follow-up|1|||
30689959|NCT00415363|58704034|FG000|Overall Study|Physician Decision|3|||
30863470|NCT02456636|58893445|FG000|Overall Study|Physician Decision|4|||
30863471|NCT02456636|58893446|FG001|Overall Study|Physician Decision|5|||
30863472|NCT02456636|58893447|FG002|Overall Study|Physician Decision|4|||
30863473|NCT02456636|58893445|FG000|Overall Study|Withdrawal by Subject|13|||
30863474|NCT02456636|58893446|FG001|Overall Study|Withdrawal by Subject|14|||
30863475|NCT02456636|58893447|FG002|Overall Study|Withdrawal by Subject|16|||
30863476|NCT02456636|58893445|FG000|Overall Study|Lost to Follow-up|50|||
30863477|NCT02456636|58893446|FG001|Overall Study|Lost to Follow-up|44|||
30863478|NCT02456636|58893447|FG002|Overall Study|Lost to Follow-up|50|||
30863479|NCT02226172|58893455|FG000|Overall Study|Participant refused further follow-up|4|||
30863480|NCT02226172|58893455|FG000|Overall Study|Other|5|||
30863481|NCT02226172|58893455|FG000|Overall Study|Death|1|||
30863482|NCT02226172|58893455|FG000|Overall Study|Study terminated by sponsor|1|||
30863483|NCT02226172|58893455|FG000|Overall Study|Adverse Event|6|||
30959784|NCT01555151|59025336|FG000|Overall Study|Withdrawal by Subject|6|||
30959785|NCT01555151|59025337|FG001|Overall Study|Withdrawal by Subject|2|||
30959786|NCT01555151|59025338|FG002|Overall Study|Withdrawal by Subject|0|||
30959787|NCT01555151|59025339|FG003|Overall Study|Withdrawal by Subject|2|||
30959788|NCT01555151|59025336|FG000|Overall Study|Administrative|3|||
30959789|NCT01555151|59025337|FG001|Overall Study|Administrative|1|||
30959790|NCT01555151|59025338|FG002|Overall Study|Administrative|2|||
30959791|NCT01555151|59025339|FG003|Overall Study|Administrative|0|||
30863484|NCT01676961|58893459|FG000|Overall Study|Death|3|||
30863485|NCT01676961|58893459|FG000|Overall Study|Lost to Follow-up|1|||
30863486|NCT01676961|58893459|FG000|Overall Study|Withdrawal by Subject|1|||
30863487|NCT01676727|58893481|FG000|Overall Study|Death|18|||
30863488|NCT01676727|58893481|FG000|Overall Study|Withdrawal by Subject|6|||
30863489|NCT01676727|58893481|FG000|Overall Study|Screening failure|5|||
30863490|NCT01676727|58893481|FG000|Overall Study|Not willing to attend 1-year visit|2|||
30863491|NCT01676727|58893481|FG000|Overall Study|Valve explanted|1|||
30863492|NCT03745651|58893489|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
30863493|NCT03745651|58893490|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
30863494|NCT03745651|58893491|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
30863495|NCT03745651|58893492|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
30863496|NCT03745651|58893493|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
30863497|NCT03745651|58893494|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
30863498|NCT03745651|58893495|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
30863499|NCT03745651|58893489|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
30863500|NCT03745651|58893490|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
30863501|NCT03745651|58893491|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
30863502|NCT03745651|58893492|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30863503|NCT03745651|58893493|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30863504|NCT03745651|58893494|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30863505|NCT03745651|58893495|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
30863506|NCT03745651|58893489|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
30863507|NCT03745651|58893490|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
30863508|NCT03745651|58893491|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
30863509|NCT03745651|58893492|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
30863510|NCT03745651|58893493|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
30863511|NCT03745651|58893494|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
30863512|NCT03745651|58893495|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
30863513|NCT03745651|58893489|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30863514|NCT03745651|58893490|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
30863515|NCT03745651|58893491|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30863516|NCT03745651|58893492|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30863517|NCT03745651|58893493|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30863518|NCT03745651|58893494|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30863519|NCT03745651|58893495|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
30863520|NCT03745651|58893489|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
30863521|NCT03745651|58893490|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
30863522|NCT03745651|58893491|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
30863523|NCT03745651|58893492|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30863524|NCT03745651|58893493|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30863525|NCT03745651|58893494|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30863526|NCT03745651|58893495|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
30863527|NCT03745651|58893489|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
30863528|NCT03745651|58893490|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
30863529|NCT03745651|58893491|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
30863530|NCT03745651|58893492|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
30863531|NCT03745651|58893493|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
30863532|NCT03745651|58893494|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
30863533|NCT03745651|58893495|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
30863534|NCT03745651|58893489|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
30863535|NCT03745651|58893490|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
30863536|NCT03745651|58893491|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
30863537|NCT03745651|58893492|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
30863538|NCT03745651|58893493|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
30863539|NCT03745651|58893494|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
30863540|NCT03745651|58893495|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
30863541|NCT03745651|58893489|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
30863542|NCT03745651|58893490|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
30863543|NCT03745651|58893491|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
30863544|NCT03745651|58893492|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
30863545|NCT03745651|58893493|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
30863546|NCT03745651|58893494|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
30863547|NCT03745651|58893495|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
30863548|NCT03745651|58893489|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
30863549|NCT03745651|58893490|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
30863550|NCT03745651|58893491|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
30863551|NCT03745651|58893492|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
30863552|NCT03745651|58893493|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
30863553|NCT03745651|58893494|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
30863554|NCT03745651|58893495|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
30863555|NCT03745651|58893489|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
30863556|NCT03745651|58893490|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
30863557|NCT03745651|58893491|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
30863558|NCT03745651|58893492|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
30863559|NCT03745651|58893493|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
30863560|NCT03745651|58893494|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
30863561|NCT03745651|58893495|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
30863562|NCT03745651|58893489|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
30863563|NCT03745651|58893490|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
30863564|NCT03745651|58893491|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
30863565|NCT03745651|58893492|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
30863566|NCT03745651|58893493|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
30863567|NCT03745651|58893494|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
30863568|NCT03745651|58893495|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
30863569|NCT03745651|58893489|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30863570|NCT03745651|58893490|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30863571|NCT03745651|58893491|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30863572|NCT03745651|58893492|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30863573|NCT03745651|58893493|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30863574|NCT03745651|58893494|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
30863575|NCT03745651|58893495|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
30863576|NCT03745651|58893489|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
30863577|NCT03745651|58893490|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
30863578|NCT03745651|58893491|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
30863579|NCT03745651|58893492|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
30863580|NCT03745651|58893493|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
30863581|NCT03745651|58893494|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
30863582|NCT03745651|58893495|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
30863583|NCT03745651|58893489|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
30863584|NCT03745651|58893490|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
30863585|NCT03745651|58893491|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
30863586|NCT03745651|58893492|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
30863587|NCT03745651|58893493|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
30863588|NCT03745651|58893494|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
30863589|NCT03745651|58893495|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
30863590|NCT02738879|58893513|FG000|Overall Study|Adverse Event|1|||
30863591|NCT02738879|58893514|FG001|Overall Study|Adverse Event|1|||
30863592|NCT02738879|58893513|FG000|Overall Study|Death|0|||
30863593|NCT02738879|58893514|FG001|Overall Study|Death|2|||
30863594|NCT02738879|58893513|FG000|Overall Study|Lost to Follow-up|1|||
30863595|NCT02738879|58893514|FG001|Overall Study|Lost to Follow-up|5|||
30863596|NCT02738879|58893513|FG000|Overall Study|Protocol Violation|1|||
30863597|NCT02738879|58893514|FG001|Overall Study|Protocol Violation|3|||
30863598|NCT02738879|58893513|FG000|Overall Study|Physician Decision|3|||
30863599|NCT02738879|58893514|FG001|Overall Study|Physician Decision|4|||
30863600|NCT02738879|58893513|FG000|Overall Study|Pregnancy|0|||
30863601|NCT02738879|58893514|FG001|Overall Study|Pregnancy|1|||
30863602|NCT02738879|58893513|FG000|Overall Study|Screen Failure|1|||
30863603|NCT02738879|58893514|FG001|Overall Study|Screen Failure|2|||
30863604|NCT02738879|58893513|FG000|Overall Study|Site Discontinued Study Participation|1|||
30863605|NCT02738879|58893514|FG001|Overall Study|Site Discontinued Study Participation|0|||
30863606|NCT02738879|58893513|FG000|Overall Study|Withdrawal by Subject|5|||
30863607|NCT02738879|58893514|FG001|Overall Study|Withdrawal by Subject|7|||
30863608|NCT03502811|58893520|FG000|Overall Study|Death|157|||
30863609|NCT03502811|58893520|FG000|Overall Study|Withdrawal by Subject|105|||
30863610|NCT03502811|58893520|FG000|Overall Study|Lost to Follow-up|26|||
30863611|NCT03502811|58893520|FG000|Overall Study|No Visits (Missed)|31|||
30863612|NCT00515671|58893532|FG000|Overall Study|Lost to Follow-up|13|||
30863613|NCT00515671|58893533|FG001|Overall Study|Lost to Follow-up|10|||
30863614|NCT00515671|58893532|FG000|Overall Study|Withdrawal by Subject|3|||
30863615|NCT00515671|58893533|FG001|Overall Study|Withdrawal by Subject|5|||
30863616|NCT00515671|58893532|FG000|Overall Study|incarcerated|1|||
30863617|NCT00515671|58893533|FG001|Overall Study|incarcerated|2|||
30863618|NCT01677195|58893542|FG000|Overall Study|Lost to Follow-up|14|||
30863619|NCT01677195|58893543|FG001|Overall Study|Lost to Follow-up|22|||
30863620|NCT01677195|58893544|FG002|Overall Study|Lost to Follow-up|22|||
30863621|NCT01677195|58893542|FG000|Overall Study|Withdrawal by Subject|1|||
30863622|NCT01677195|58893543|FG001|Overall Study|Withdrawal by Subject|0|||
30863623|NCT01677195|58893544|FG002|Overall Study|Withdrawal by Subject|1|||
30863624|NCT01677195|58893542|FG000|Overall Study|Adverse Event|6|||
30863625|NCT01677195|58893543|FG001|Overall Study|Adverse Event|4|||
30863626|NCT01677195|58893544|FG002|Overall Study|Adverse Event|1|||
30863627|NCT01677195|58893542|FG000|Overall Study|Physician Decision|1|||
30863628|NCT01677195|58893543|FG001|Overall Study|Physician Decision|2|||
30863629|NCT01677195|58893544|FG002|Overall Study|Physician Decision|2|||
30863630|NCT01677195|58893542|FG000|Overall Study|Pregnancy|0|||
30863631|NCT01677195|58893543|FG001|Overall Study|Pregnancy|1|||
30863632|NCT01677195|58893544|FG002|Overall Study|Pregnancy|0|||
30863633|NCT01677195|58893542|FG000|Overall Study|Protocol Violation|7|||
30863634|NCT01677195|58893543|FG001|Overall Study|Protocol Violation|3|||
30863635|NCT01677195|58893544|FG002|Overall Study|Protocol Violation|4|||
30863636|NCT00928447|58893556|FG000|Overall Study|Withdrawal by Subject|1|||
30863637|NCT00928447|58893556|FG000|Overall Study|Investigator's decision|1|||
30863638|NCT02224846|58893562|FG000|Period 1 (Month 3)|Adverse Event|2|||
30863639|NCT02224846|58893563|FG001|Period 1 (Month 3)|Adverse Event|1|||
30863640|NCT02224846|58893562|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
30863641|NCT02224846|58893563|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
30863642|NCT02224846|58893562|FG000|Period 1 (Month 3)|Protocol Violation|4|||
30863643|NCT02224846|58893563|FG001|Period 1 (Month 3)|Protocol Violation|8|||
30863644|NCT02224846|58893562|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
30863645|NCT02224846|58893563|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
30863646|NCT02224846|58893562|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
30863647|NCT02224846|58893563|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
30863648|NCT02224846|58893562|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
30863649|NCT02224846|58893563|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
30863650|NCT02224846|58893562|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
30863651|NCT02224846|58893563|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
30863652|NCT02224846|58893562|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
30863653|NCT02224846|58893563|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
30863654|NCT02224846|58893562|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
30863655|NCT02224846|58893563|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
30863656|NCT02224846|58893562|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
30863657|NCT02224846|58893563|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
30863658|NCT02224846|58893562|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
30863659|NCT02224846|58893563|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
30863660|NCT02224846|58893562|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
30863661|NCT02224846|58893563|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
30863662|NCT02224846|58893562|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
30863663|NCT02224846|58893563|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
30863664|NCT02224846|58893562|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
30863665|NCT02224846|58893563|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
30863666|NCT02224846|58893562|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
30863667|NCT02224846|58893563|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
30863668|NCT02224846|58893562|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
30863669|NCT02224846|58893563|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
30863670|NCT02224846|58893562|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
30600466|NCT01090102|58612075|FG001|First 12 Weeks|Adverse Event|0|||
30600467|NCT01090102|58612074|FG000|First 12 Weeks|Death|1|||
30600468|NCT01090102|58612075|FG001|First 12 Weeks|Death|1|||
30600469|NCT01090102|58612074|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
30600470|NCT01090102|58612075|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
30600471|NCT01287897|58612085|FG000|Overall Study|Adverse Event|5|||
30600472|NCT01287897|58612086|FG001|Overall Study|Adverse Event|3|||
30600473|NCT01287897|58612087|FG002|Overall Study|Adverse Event|6|||
30600474|NCT01287897|58612088|FG003|Overall Study|Adverse Event|4|||
30600475|NCT01287897|58612085|FG000|Overall Study|Lack of Efficacy|2|||
30600476|NCT01287897|58612086|FG001|Overall Study|Lack of Efficacy|0|||
30600477|NCT01287897|58612087|FG002|Overall Study|Lack of Efficacy|0|||
30600478|NCT01287897|58612088|FG003|Overall Study|Lack of Efficacy|0|||
30689960|NCT00415363|58704035|FG001|Overall Study|Physician Decision|1|||
30863671|NCT02224846|58893563|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
30863672|NCT01632280|58893571|FG000|Overall Study|Withdrawal by Subject|1|||
30863673|NCT01632280|58893572|FG001|Overall Study|Withdrawal by Subject|0|||
30863674|NCT02224690|58893580|FG000|Overall Study|Adverse Event|8|||
30863675|NCT02224690|58893581|FG001|Overall Study|Adverse Event|1|||
30863676|NCT02224690|58893580|FG000|Overall Study|Met Withdrawal Criteria|4|||
30863677|NCT02224690|58893581|FG001|Overall Study|Met Withdrawal Criteria|0|||
30863678|NCT02224690|58893580|FG000|Overall Study|Use of G-tube|1|||
30863679|NCT02224690|58893581|FG001|Overall Study|Use of G-tube|0|||
30863680|NCT02224690|58893580|FG000|Overall Study|Did not meet eligibility criteria|1|||
30863681|NCT02224690|58893581|FG001|Overall Study|Did not meet eligibility criteria|0|||
30959792|NCT01555151|59025336|FG000|Overall Study|Protocol Violation|3|||
30959793|NCT01555151|59025337|FG001|Overall Study|Protocol Violation|3|||
30959794|NCT01555151|59025338|FG002|Overall Study|Protocol Violation|3|||
30959795|NCT01555151|59025339|FG003|Overall Study|Protocol Violation|5|||
30959796|NCT01555151|59025336|FG000|Overall Study|Adverse Event|1|||
30959797|NCT01555151|59025337|FG001|Overall Study|Adverse Event|2|||
30959798|NCT01555151|59025338|FG002|Overall Study|Adverse Event|1|||
30959799|NCT01555151|59025339|FG003|Overall Study|Adverse Event|2|||
30959800|NCT01555151|59025336|FG000|Overall Study|Lost to Follow-up|0|||
30959801|NCT01555151|59025337|FG001|Overall Study|Lost to Follow-up|0|||
30959802|NCT01555151|59025338|FG002|Overall Study|Lost to Follow-up|0|||
30959803|NCT01555151|59025339|FG003|Overall Study|Lost to Follow-up|1|||
30959804|NCT01537081|59025353|FG000|Overall Study|Adverse Event|5|||
30959805|NCT01537081|59025354|FG001|Overall Study|Adverse Event|2|||
30959806|NCT01537081|59025355|FG002|Overall Study|Adverse Event|2|||
30959807|NCT01537081|59025353|FG000|Overall Study|Lack of Efficacy|2|||
30959808|NCT01537081|59025354|FG001|Overall Study|Lack of Efficacy|1|||
30959809|NCT01537081|59025355|FG002|Overall Study|Lack of Efficacy|0|||
30959810|NCT01537081|59025353|FG000|Overall Study|Lost to Follow-up|17|||
30959811|NCT01537081|59025354|FG001|Overall Study|Lost to Follow-up|15|||
30959812|NCT01537081|59025355|FG002|Overall Study|Lost to Follow-up|9|||
30959813|NCT01537081|59025353|FG000|Overall Study|Protocol Violation|3|||
30959814|NCT01537081|59025354|FG001|Overall Study|Protocol Violation|2|||
30959815|NCT01537081|59025355|FG002|Overall Study|Protocol Violation|2|||
30959816|NCT01537081|59025353|FG000|Overall Study|Withdrawal by Subject|6|||
30959817|NCT01537081|59025354|FG001|Overall Study|Withdrawal by Subject|11|||
30959818|NCT01537081|59025355|FG002|Overall Study|Withdrawal by Subject|3|||
30959819|NCT01537081|59025353|FG000|Overall Study|Physician Decision|5|||
30959820|NCT01537081|59025354|FG001|Overall Study|Physician Decision|6|||
30959821|NCT01537081|59025355|FG002|Overall Study|Physician Decision|0|||
30600479|NCT01287897|58612085|FG000|Overall Study|Protocol Violation|1|||
30600480|NCT01287897|58612086|FG001|Overall Study|Protocol Violation|1|||
30600481|NCT01287897|58612087|FG002|Overall Study|Protocol Violation|0|||
30600482|NCT01287897|58612088|FG003|Overall Study|Protocol Violation|1|||
30600483|NCT01287897|58612085|FG000|Overall Study|Lost to Follow-up|0|||
30689961|NCT00415363|58704034|FG000|Overall Study|Death|16|||
30689962|NCT00415363|58704035|FG001|Overall Study|Death|12|||
30689963|NCT00415363|58704034|FG000|Overall Study|Progressive disease|26|||
30689964|NCT00415363|58704035|FG001|Overall Study|Progressive disease|32|||
30689965|NCT00415051|58704042|FG000|Overall Study|Protocol Violation|1|||
30689966|NCT00713258|58704048|FG000|Overall Study|Adverse Event|2|||
30689967|NCT00713258|58704049|FG001|Overall Study|Adverse Event|4|||
30689968|NCT00713258|58704048|FG000|Overall Study|Non-Compliance|2|||
30689969|NCT00713258|58704049|FG001|Overall Study|Non-Compliance|1|||
30689970|NCT00713258|58704048|FG000|Overall Study|Other|1|||
30689971|NCT00713258|58704049|FG001|Overall Study|Other|1|||
30689972|NCT00710034|58704057|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
30689973|NCT00710034|58704058|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
30689974|NCT00710034|58704057|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
30689975|NCT00710034|58704058|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
30959822|NCT01537081|59025353|FG000|Overall Study|Sponsor decision|0|||
30600484|NCT01287897|58612086|FG001|Overall Study|Lost to Follow-up|0|||
30600485|NCT01287897|58612087|FG002|Overall Study|Lost to Follow-up|2|||
30600486|NCT01287897|58612088|FG003|Overall Study|Lost to Follow-up|0|||
30600487|NCT01287897|58612085|FG000|Overall Study|Withdrawal by Subject|1|||
30600488|NCT01287897|58612086|FG001|Overall Study|Withdrawal by Subject|5|||
30600489|NCT01287897|58612087|FG002|Overall Study|Withdrawal by Subject|3|||
30600490|NCT01287897|58612088|FG003|Overall Study|Withdrawal by Subject|2|||
30600491|NCT01287897|58612085|FG000|Overall Study|Not consented properly|0|||
30600492|NCT01287897|58612086|FG001|Overall Study|Not consented properly|1|||
30600493|NCT01287897|58612087|FG002|Overall Study|Not consented properly|0|||
30600494|NCT01287897|58612088|FG003|Overall Study|Not consented properly|0|||
30600495|NCT01287897|58612085|FG000|Overall Study|Not meeting entrance criteria|1|||
30689976|NCT00710034|58704057|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
30959823|NCT01537081|59025354|FG001|Overall Study|Sponsor decision|1|||
30959824|NCT01537081|59025355|FG002|Overall Study|Sponsor decision|0|||
30600496|NCT01287897|58612086|FG001|Overall Study|Not meeting entrance criteria|1|||
30600497|NCT01287897|58612087|FG002|Overall Study|Not meeting entrance criteria|0|||
30600498|NCT01287897|58612088|FG003|Overall Study|Not meeting entrance criteria|0|||
30959825|NCT01537081|59025353|FG000|Overall Study|Assigned but never dosed|1|||
30959826|NCT01537081|59025354|FG001|Overall Study|Assigned but never dosed|0|||
30959827|NCT01537081|59025355|FG002|Overall Study|Assigned but never dosed|0|||
30959828|NCT01564459|59025367|FG000|Run-In|Adverse Event|7|||
30959829|NCT01564459|59025368|FG001|Run-In|Adverse Event|0|||
30959830|NCT01564459|59025369|FG002|Run-In|Adverse Event|0|||
30959831|NCT01564459|59025367|FG000|Run-In|Lost to Follow-up|1|||
30959832|NCT01564459|59025368|FG001|Run-In|Lost to Follow-up|0|||
30959833|NCT01564459|59025369|FG002|Run-In|Lost to Follow-up|0|||
30959834|NCT01564459|59025367|FG000|Run-In|Non-compliance with study drug|2|||
30959835|NCT01564459|59025368|FG001|Run-In|Non-compliance with study drug|0|||
30959836|NCT01564459|59025369|FG002|Run-In|Non-compliance with study drug|0|||
30959837|NCT01564459|59025367|FG000|Run-In|Protocol Violation|1|||
30959838|NCT01564459|59025368|FG001|Run-In|Protocol Violation|0|||
30959839|NCT01564459|59025369|FG002|Run-In|Protocol Violation|0|||
30959840|NCT01564459|59025367|FG000|Run-In|Withdrawal by Subject|1|||
30863682|NCT01634152|58893590|FG000|Overall Study|Adverse Event|2|||
30863683|NCT01634152|58893591|FG001|Overall Study|Adverse Event|0|||
30863684|NCT01634152|58893592|FG002|Overall Study|Adverse Event|2|||
30863685|NCT01634152|58893590|FG000|Overall Study|Consent withdrawn not due to AE|1|||
30959841|NCT01564459|59025368|FG001|Run-In|Withdrawal by Subject|0|||
30959842|NCT01564459|59025369|FG002|Run-In|Withdrawal by Subject|0|||
30959843|NCT01564459|59025367|FG000|Double-blind Treatment|Adverse Event|0|||
30959844|NCT01564459|59025368|FG001|Double-blind Treatment|Adverse Event|0|||
30959845|NCT01564459|59025369|FG002|Double-blind Treatment|Adverse Event|1|||
30959846|NCT01555073|59025384|FG000|Overall Study|Lost to Follow-up|1|||
30959847|NCT01555073|59025385|FG001|Overall Study|Lost to Follow-up|2|||
30959848|NCT01555073|59025386|FG002|Overall Study|Lost to Follow-up|0|||
30959849|NCT01555073|59025387|FG003|Overall Study|Lost to Follow-up|5|||
30959850|NCT01582243|59025397|FG000|Overall Study|Withdrawal by Subject|1|||
30959851|NCT01582243|59025397|FG000|Overall Study|Adverse Event|1|||
30959852|NCT01582243|59025397|FG000|Overall Study|Lost to Follow-up|1|||
30959853|NCT01536535|59025403|FG000|Overall Study|Withdrawal by Subject|10|||
30959854|NCT01536535|59025404|FG001|Overall Study|Withdrawal by Subject|5|||
30959855|NCT01536535|59025403|FG000|Overall Study|Lost to Follow-up|4|||
30959856|NCT01536535|59025404|FG001|Overall Study|Lost to Follow-up|6|||
30959857|NCT01536535|59025403|FG000|Overall Study|Physician Decision|1|||
30959858|NCT01536535|59025404|FG001|Overall Study|Physician Decision|1|||
30959859|NCT01536535|59025403|FG000|Overall Study|Participant moved|0|||
30959860|NCT01536535|59025404|FG001|Overall Study|Participant moved|1|||
30959861|NCT01554527|59025414|FG000|Overall Study|Withdrawal by Subject|1|||
30959862|NCT01554527|59025415|FG001|Overall Study|Withdrawal by Subject|0|||
30959863|NCT01554527|59025416|FG002|Overall Study|Withdrawal by Subject|3|||
30959864|NCT01554527|59025414|FG000|Overall Study|Lost to Follow-up|0|||
30959865|NCT01554527|59025415|FG001|Overall Study|Lost to Follow-up|0|||
30959866|NCT01554527|59025416|FG002|Overall Study|Lost to Follow-up|4|||
30959867|NCT01554527|59025414|FG000|Overall Study|Physician Decision|0|||
30959868|NCT01554527|59025415|FG001|Overall Study|Physician Decision|0|||
30959869|NCT01554527|59025416|FG002|Overall Study|Physician Decision|1|||
30959870|NCT01563913|59025427|FG000|Overall Study|Physician Decision|1|||
30959871|NCT01563913|59025428|FG001|Overall Study|Physician Decision|0|||
30959872|NCT01563913|59025427|FG000|Overall Study|Spouse Passed Away|1|||
30959873|NCT01563913|59025428|FG001|Overall Study|Spouse Passed Away|0|||
30959874|NCT01553747|59025437|FG000|Overall Study|Protocol Violation|0|||
30959875|NCT01553747|59025438|FG001|Overall Study|Protocol Violation|2|||
30959876|NCT01553747|59025439|FG002|Overall Study|Protocol Violation|0|||
30959877|NCT01553747|59025437|FG000|Overall Study|Voluntarily withdrew|70|||
30959878|NCT01553747|59025438|FG001|Overall Study|Voluntarily withdrew|66|||
30959879|NCT01553747|59025439|FG002|Overall Study|Voluntarily withdrew|74|||
30959880|NCT01553747|59025437|FG000|Overall Study|Adverse event or SAE|32|||
30959881|NCT01553747|59025438|FG001|Overall Study|Adverse event or SAE|28|||
30959882|NCT01553747|59025439|FG002|Overall Study|Adverse event or SAE|19|||
30959883|NCT01553747|59025437|FG000|Overall Study|Physician decision: other|10|||
30959884|NCT01553747|59025438|FG001|Overall Study|Physician decision: other|8|||
30959885|NCT01553747|59025439|FG002|Overall Study|Physician decision: other|7|||
30959886|NCT01553747|59025437|FG000|Overall Study|Lost to Follow-up|11|||
30959887|NCT01553747|59025438|FG001|Overall Study|Lost to Follow-up|5|||
30959888|NCT01553747|59025439|FG002|Overall Study|Lost to Follow-up|6|||
30959889|NCT01553747|59025437|FG000|Overall Study|Sponsor decision, specify|7|||
30959890|NCT01553747|59025438|FG001|Overall Study|Sponsor decision, specify|5|||
30600499|NCT01287897|58612085|FG000|Overall Study|Other|1|||
30600500|NCT01287897|58612086|FG001|Overall Study|Other|0|||
30863686|NCT01634152|58893591|FG001|Overall Study|Consent withdrawn not due to AE|0|||
30863687|NCT01634152|58893592|FG002|Overall Study|Consent withdrawn not due to AE|1|||
30959891|NCT01553747|59025439|FG002|Overall Study|Sponsor decision, specify|0|||
30959892|NCT01553747|59025437|FG000|Overall Study|Physician decision: lack of efficacy|1|||
30959893|NCT01553747|59025438|FG001|Overall Study|Physician decision: lack of efficacy|5|||
30959894|NCT01553747|59025439|FG002|Overall Study|Physician decision: lack of efficacy|3|||
30959895|NCT01536379|59025452|FG000|Overall Study|Adverse Event|1|||
30959896|NCT01536379|59025453|FG001|Overall Study|Adverse Event|2|||
30959897|NCT01536379|59025452|FG000|Overall Study|Withdrawal by Subject|1|||
30959898|NCT01536379|59025453|FG001|Overall Study|Withdrawal by Subject|1|||
30959899|NCT01536145|59025459|FG000|Overall Study|Progressive disease|3|||
30959900|NCT01536145|59025460|FG001|Overall Study|Progressive disease|4|||
30959901|NCT01536145|59025461|FG002|Overall Study|Progressive disease|1|||
30959902|NCT01536145|59025462|FG003|Overall Study|Progressive disease|2|||
30863688|NCT01634152|58893590|FG000|Overall Study|Not treated|0|||
30863689|NCT01634152|58893591|FG001|Overall Study|Not treated|1|||
30863690|NCT01634152|58893592|FG002|Overall Study|Not treated|0|||
30863691|NCT01634152|58893590|FG000|Overall Study|Other reason not defined above|1|||
30863692|NCT01634152|58893591|FG001|Overall Study|Other reason not defined above|0|||
30863693|NCT01634152|58893592|FG002|Overall Study|Other reason not defined above|1|||
30863694|NCT03862807|58893600|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
30863695|NCT01378429|58893624|FG000|Overall Study|Noncompliance with study drug|1|||
30863696|NCT01378429|58893625|FG001|Overall Study|Noncompliance with study drug|0|||
30863697|NCT01599754|58893636|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
30863698|NCT01599754|58893637|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
30863699|NCT01599754|58893636|FG000|Overall Study|Participant noncompliance|4|||
30863700|NCT01599754|58893637|FG001|Overall Study|Participant noncompliance|4|||
30863701|NCT01599754|58893636|FG000|Overall Study|Lost to Follow-up|13|||
30863702|NCT01599754|58893637|FG001|Overall Study|Lost to Follow-up|6|||
30863703|NCT01599754|58893636|FG000|Overall Study|Death|31|||
30863704|NCT01599754|58893637|FG001|Overall Study|Death|33|||
30863705|NCT01599754|58893636|FG000|Overall Study|Adverse Event|3|||
30863706|NCT01599754|58893637|FG001|Overall Study|Adverse Event|2|||
30863707|NCT01599754|58893636|FG000|Overall Study|Investigator decision|1|||
30863708|NCT01599754|58893637|FG001|Overall Study|Investigator decision|3|||
30863709|NCT01599754|58893636|FG000|Overall Study|Withdrawal by Subject|24|||
30863710|NCT01599754|58893637|FG001|Overall Study|Withdrawal by Subject|25|||
30863711|NCT01599754|58893636|FG000|Overall Study|Study terminated by sponsor|282|||
30863712|NCT01599754|58893637|FG001|Overall Study|Study terminated by sponsor|285|||
30863713|NCT02138110|58893643|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
30863714|NCT02138110|58893643|FG000|Overall Scaffold Implantation|Death|3|||
30863715|NCT02223754|58893649|FG000|Period 1|Adverse Event|1|||
30863716|NCT02223754|58893650|FG001|Period 1|Adverse Event|0|||
30863717|NCT02223754|58893649|FG000|Period 1|Lost to Follow-up|0|||
30863718|NCT02223754|58893650|FG001|Period 1|Lost to Follow-up|1|||
30863719|NCT02223754|58893649|FG000|Period 1|Protocol Violation|2|||
30863720|NCT02223754|58893650|FG001|Period 1|Protocol Violation|4|||
30863721|NCT02223754|58893649|FG000|Period 1|Withdrawal by Subject|0|||
30863722|NCT02223754|58893650|FG001|Period 1|Withdrawal by Subject|4|||
30863723|NCT02223754|58893649|FG000|Period 1|Test Article No Longer Available|1|||
30863724|NCT02223754|58893650|FG001|Period 1|Test Article No Longer Available|5|||
30863725|NCT02223754|58893649|FG000|Period 1|Unsatisfactory Visual Response|0|||
30863726|NCT02223754|58893650|FG001|Period 1|Unsatisfactory Visual Response|1|||
30863727|NCT02223754|58893649|FG000|Period 2|Adverse Event|0|||
30863728|NCT02223754|58893650|FG001|Period 2|Adverse Event|1|||
30863729|NCT02223754|58893649|FG000|Period 2|Protocol Violation|1|||
30863730|NCT02223754|58893650|FG001|Period 2|Protocol Violation|0|||
30863731|NCT02223754|58893649|FG000|Period 2|Lens Discomfort|1|||
30863732|NCT02223754|58893650|FG001|Period 2|Lens Discomfort|1|||
30863733|NCT02223754|58893649|FG000|Period 2|Lost to Follow-up|1|||
30863734|NCT02223754|58893650|FG001|Period 2|Lost to Follow-up|0|||
30863735|NCT02223754|58893649|FG000|Period 2|Test Article No Longer Available|0|||
30863736|NCT02223754|58893650|FG001|Period 2|Test Article No Longer Available|1|||
30863737|NCT02223364|58893660|FG000|Overall Study|Protocol Violation|3|||
30863738|NCT02223364|58893661|FG001|Overall Study|Protocol Violation|0|||
30863739|NCT02223364|58893662|FG002|Overall Study|Protocol Violation|3|||
30863740|NCT02223364|58893660|FG000|Overall Study|subject expired before surgery|1|||
30863741|NCT02223364|58893661|FG001|Overall Study|subject expired before surgery|0|||
30863742|NCT02223364|58893662|FG002|Overall Study|subject expired before surgery|0|||
30863743|NCT02223364|58893660|FG000|Overall Study|Physician Decision|1|||
30863744|NCT02223364|58893661|FG001|Overall Study|Physician Decision|0|||
30863745|NCT02223364|58893662|FG002|Overall Study|Physician Decision|0|||
30863746|NCT01378975|58893672|FG000|Overall Study|Death|77|||
30863747|NCT01378975|58893673|FG001|Overall Study|Death|46|||
30863748|NCT01378975|58893672|FG000|Overall Study|Investigator Request|1|||
30863749|NCT01378975|58893673|FG001|Overall Study|Investigator Request|0|||
30863750|NCT01378975|58893672|FG000|Overall Study|Lost to Follow-up|4|||
30863751|NCT01378975|58893673|FG001|Overall Study|Lost to Follow-up|1|||
30863752|NCT01378975|58893672|FG000|Overall Study|Withdrew Consent|4|||
30863753|NCT01378975|58893673|FG001|Overall Study|Withdrew Consent|3|||
30863754|NCT02222896|58893680|FG000|Abdomen|Did not qualify|34|||
30863755|NCT02222896|58893681|FG001|Abdomen|Did not qualify|10|||
30863756|NCT02222896|58893682|FG002|Abdomen|Did not qualify|32|||
30863757|NCT02222896|58893680|FG000|Groin|Did not qualify|43|||
30863758|NCT02222896|58893681|FG001|Groin|Did not qualify|9|||
30863759|NCT02222896|58893682|FG002|Groin|Did not qualify|40|||
30863760|NCT02222818|58893695|FG000|Period 1|Eligibility criteria not met|0|||
30863761|NCT02222818|58893696|FG001|Period 1|Eligibility criteria not met|3|||
30863762|NCT01378195|58893707|FG000|Overall Study|Lost to Follow-up|29|||
30863763|NCT01378195|58893708|FG001|Overall Study|Lost to Follow-up|18|||
30863764|NCT01378117|58893717|FG000|Overall Study|withdrawal|2|||
30863765|NCT01378117|58893718|FG001|Overall Study|withdrawal|1|||
30863766|NCT01378117|58893719|FG002|Overall Study|withdrawal|2|||
30959903|NCT01536145|59025463|FG004|Overall Study|Progressive disease|1|||
30959904|NCT01536145|59025464|FG005|Overall Study|Progressive disease|2|||
30959905|NCT01536145|59025465|FG006|Overall Study|Progressive disease|1|||
30959906|NCT01536145|59025466|FG007|Overall Study|Progressive disease|2|||
30959907|NCT01536145|59025467|FG008|Overall Study|Progressive disease|1|||
30959908|NCT01536145|59025468|FG009|Overall Study|Progressive disease|3|||
30959909|NCT01536145|59025469|FG010|Overall Study|Progressive disease|3|||
30959910|NCT01536145|59025459|FG000|Overall Study|Withdrawal by Subject|0|||
30959911|NCT01536145|59025460|FG001|Overall Study|Withdrawal by Subject|0|||
30959912|NCT01536145|59025461|FG002|Overall Study|Withdrawal by Subject|1|||
30959913|NCT01536145|59025462|FG003|Overall Study|Withdrawal by Subject|0|||
30959914|NCT01536145|59025463|FG004|Overall Study|Withdrawal by Subject|0|||
30959915|NCT01536145|59025464|FG005|Overall Study|Withdrawal by Subject|1|||
30959916|NCT01536145|59025465|FG006|Overall Study|Withdrawal by Subject|0|||
30959917|NCT01536145|59025466|FG007|Overall Study|Withdrawal by Subject|0|||
30959918|NCT01536145|59025467|FG008|Overall Study|Withdrawal by Subject|2|||
30959919|NCT01536145|59025468|FG009|Overall Study|Withdrawal by Subject|0|||
30959920|NCT01536145|59025469|FG010|Overall Study|Withdrawal by Subject|2|||
30959921|NCT01536145|59025459|FG000|Overall Study|Other|0|||
30959922|NCT01536145|59025460|FG001|Overall Study|Other|0|||
30959923|NCT01536145|59025461|FG002|Overall Study|Other|0|||
30959924|NCT01536145|59025462|FG003|Overall Study|Other|0|||
30959925|NCT01536145|59025463|FG004|Overall Study|Other|1|||
30959926|NCT01536145|59025464|FG005|Overall Study|Other|0|||
30959927|NCT01536145|59025465|FG006|Overall Study|Other|0|||
30959928|NCT01536145|59025466|FG007|Overall Study|Other|0|||
30959929|NCT01536145|59025467|FG008|Overall Study|Other|0|||
30959930|NCT01536145|59025468|FG009|Overall Study|Other|3|||
30959931|NCT01536145|59025469|FG010|Overall Study|Other|2|||
30959932|NCT01536145|59025459|FG000|Overall Study|Death|0|||
30959933|NCT01536145|59025460|FG001|Overall Study|Death|0|||
30959934|NCT01536145|59025461|FG002|Overall Study|Death|0|||
30959935|NCT01536145|59025462|FG003|Overall Study|Death|0|||
30863767|NCT01378117|58893717|FG000|Overall Study|discharged before med given|2|||
30863768|NCT01378117|58893718|FG001|Overall Study|discharged before med given|0|||
30863769|NCT01378117|58893719|FG002|Overall Study|discharged before med given|1|||
30863770|NCT04254809|58893754|FG000|Overall Study|Lost to Follow-up|5|||
30863771|NCT04254809|58893755|FG001|Overall Study|Lost to Follow-up|10|||
30863772|NCT02736409|58893765|FG000|Overall Study|Withdrawal by Subject|4|||
30863773|NCT02736409|58893766|FG001|Overall Study|Withdrawal by Subject|2|||
30863774|NCT02736409|58893767|FG002|Overall Study|Withdrawal by Subject|17|||
30863775|NCT02736409|58893768|FG003|Overall Study|Withdrawal by Subject|3|||
30863776|NCT02736409|58893765|FG000|Overall Study|Non-Compliance with Study Drug|0|||
30863777|NCT02736409|58893766|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30863778|NCT02736409|58893767|FG002|Overall Study|Non-Compliance with Study Drug|0|||
30959936|NCT01536145|59025463|FG004|Overall Study|Death|0|||
30959937|NCT01536145|59025464|FG005|Overall Study|Death|0|||
30959938|NCT01536145|59025465|FG006|Overall Study|Death|1|||
30959939|NCT01536145|59025466|FG007|Overall Study|Death|0|||
30959940|NCT01536145|59025467|FG008|Overall Study|Death|0|||
30959941|NCT01536145|59025468|FG009|Overall Study|Death|0|||
30959942|NCT01536145|59025469|FG010|Overall Study|Death|0|||
30959943|NCT01536145|59025459|FG000|Overall Study|Adverse Event|0|||
30959944|NCT01536145|59025460|FG001|Overall Study|Adverse Event|0|||
30959945|NCT01536145|59025461|FG002|Overall Study|Adverse Event|0|||
30959946|NCT01536145|59025462|FG003|Overall Study|Adverse Event|0|||
30959947|NCT01536145|59025463|FG004|Overall Study|Adverse Event|0|||
30959948|NCT01536145|59025464|FG005|Overall Study|Adverse Event|0|||
30959949|NCT01536145|59025465|FG006|Overall Study|Adverse Event|0|||
30959950|NCT01536145|59025466|FG007|Overall Study|Adverse Event|2|||
30863779|NCT02736409|58893768|FG003|Overall Study|Non-Compliance with Study Drug|1|||
30863780|NCT02736409|58893765|FG000|Overall Study|Adverse Event|0|||
30863781|NCT02736409|58893766|FG001|Overall Study|Adverse Event|1|||
30863782|NCT02736409|58893767|FG002|Overall Study|Adverse Event|5|||
30863783|NCT02736409|58893768|FG003|Overall Study|Adverse Event|4|||
30863784|NCT02736409|58893765|FG000|Overall Study|Other|0|||
30959951|NCT01536145|59025467|FG008|Overall Study|Adverse Event|0|||
30959952|NCT01536145|59025468|FG009|Overall Study|Adverse Event|0|||
30959953|NCT01536145|59025469|FG010|Overall Study|Adverse Event|3|||
30959954|NCT01536067|59025500|FG000|Overall Study|Disease Progression|1|||
30959955|NCT01582009|59025504|FG000|Overall Study|Withdrawal by Subject|1|||
30959956|NCT01582009|59025504|FG000|Overall Study|Physician Decision|1|||
30959957|NCT01553591|59025511|FG000|Overall Study|Voluntarily withdrew|94|||
30959958|NCT01553591|59025512|FG001|Overall Study|Voluntarily withdrew|79|||
30959959|NCT01553591|59025513|FG002|Overall Study|Voluntarily withdrew|96|||
30959960|NCT01553591|59025511|FG000|Overall Study|Adverse Event|36|||
30959961|NCT01553591|59025512|FG001|Overall Study|Adverse Event|45|||
30959962|NCT01553591|59025513|FG002|Overall Study|Adverse Event|16|||
30959963|NCT01553591|59025511|FG000|Overall Study|Lost to Follow-up|25|||
30959964|NCT01553591|59025512|FG001|Overall Study|Lost to Follow-up|23|||
30959965|NCT01553591|59025513|FG002|Overall Study|Lost to Follow-up|16|||
30959966|NCT01553591|59025511|FG000|Overall Study|Physician decision: other|11|||
30959967|NCT01553591|59025512|FG001|Overall Study|Physician decision: other|14|||
30959968|NCT01553591|59025513|FG002|Overall Study|Physician decision: other|16|||
30959969|NCT01553591|59025511|FG000|Overall Study|Physician decision: lack of efficacy|2|||
30959970|NCT01553591|59025512|FG001|Overall Study|Physician decision: lack of efficacy|3|||
30959971|NCT01553591|59025513|FG002|Overall Study|Physician decision: lack of efficacy|7|||
30959972|NCT01553591|59025511|FG000|Overall Study|Protocol Violation|3|||
30959973|NCT01553591|59025512|FG001|Overall Study|Protocol Violation|4|||
30959974|NCT01553591|59025513|FG002|Overall Study|Protocol Violation|4|||
30959975|NCT01553591|59025511|FG000|Overall Study|Sponsor decision|1|||
30959976|NCT01553591|59025512|FG001|Overall Study|Sponsor decision|0|||
30959977|NCT01553591|59025513|FG002|Overall Study|Sponsor decision|3|||
30959978|NCT01553591|59025511|FG000|Overall Study|Randomized and never dispensed drug|0|||
30959979|NCT01553591|59025512|FG001|Overall Study|Randomized and never dispensed drug|1|||
30959980|NCT01553591|59025513|FG002|Overall Study|Randomized and never dispensed drug|0|||
30959981|NCT01581931|59025521|FG000|Washout|Adverse Event|0|||
30959982|NCT01581931|59025522|FG001|Washout|Adverse Event|1|||
30959983|NCT01581619|59025528|FG000|Overall Study|Withdrawal by Subject|1|||
30959984|NCT01581619|59025528|FG000|Overall Study|Lost to Follow-up|1|||
30959985|NCT01581307|59025534|FG000|Overall Study|Withdrawal by Subject|1|||
30959986|NCT01580995|59025540|FG000|Overall Study|Lost to Follow-up|2|||
30959987|NCT01580995|59025541|FG001|Overall Study|Lost to Follow-up|2|||
30959988|NCT01535599|59025549|FG000|Overall Study|Adverse Event|6|||
30959989|NCT01535599|59025550|FG001|Overall Study|Adverse Event|15|||
30959990|NCT01535599|59025549|FG000|Overall Study|Lost to Follow-up|3|||
30959991|NCT01535599|59025550|FG001|Overall Study|Lost to Follow-up|4|||
30959992|NCT01535599|59025549|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
30959993|NCT01535599|59025550|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
30959994|NCT01535599|59025549|FG000|Overall Study|Treatment Failure|33|||
30959995|NCT01535599|59025550|FG001|Overall Study|Treatment Failure|66|||
30959996|NCT01535599|59025549|FG000|Overall Study|BL Culture + for Group A Strep|0|||
30959997|NCT01535599|59025550|FG001|Overall Study|BL Culture + for Group A Strep|1|||
30959998|NCT01535599|59025549|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
30959999|NCT01535599|59025550|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
30960000|NCT01535599|59025549|FG000|Overall Study|Randomized in Error|2|||
30689977|NCT00710034|58704058|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
30689978|NCT00710034|58704057|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
30863785|NCT02736409|58893766|FG001|Overall Study|Other|0|||
30863786|NCT02736409|58893767|FG002|Overall Study|Other|1|||
30863787|NCT02736409|58893768|FG003|Overall Study|Other|1|||
30863788|NCT02736409|58893765|FG000|Overall Study|Pregnancy|0|||
30863789|NCT02736409|58893766|FG001|Overall Study|Pregnancy|0|||
30863790|NCT02736409|58893767|FG002|Overall Study|Pregnancy|1|||
30863791|NCT02736409|58893768|FG003|Overall Study|Pregnancy|0|||
30863792|NCT02736409|58893765|FG000|Overall Study|Lost to Follow-up|0|||
30863793|NCT02736409|58893766|FG001|Overall Study|Lost to Follow-up|0|||
30863794|NCT02736409|58893767|FG002|Overall Study|Lost to Follow-up|2|||
30863795|NCT02736409|58893768|FG003|Overall Study|Lost to Follow-up|1|||
30863796|NCT02736409|58893765|FG000|Overall Study|Physician Decision|0|||
30863797|NCT02736409|58893766|FG001|Overall Study|Physician Decision|0|||
30863798|NCT02736409|58893767|FG002|Overall Study|Physician Decision|0|||
30863799|NCT02736409|58893768|FG003|Overall Study|Physician Decision|2|||
30863800|NCT03099707|58893781|FG000|Overall Study|Withdrawal by Subject|0|||
30863801|NCT03099707|58893782|FG001|Overall Study|Withdrawal by Subject|3|||
30863802|NCT03099707|58893781|FG000|Overall Study|Lost to Follow-up|0|||
30863803|NCT03099707|58893782|FG001|Overall Study|Lost to Follow-up|1|||
30863804|NCT02906033|58893790|FG000|Baseline|Protocol Violation|37|||
30863805|NCT02906033|58893791|FG001|Baseline|Protocol Violation|33|||
30863806|NCT02906033|58893790|FG000|Follow-up|Lost to Follow-up|46|||
30863807|NCT02906033|58893791|FG001|Follow-up|Lost to Follow-up|62|||
30863808|NCT02221882|58893803|FG000|Overall Study|Withdrawal by Subject|0|||
30863809|NCT02221882|58893804|FG001|Overall Study|Withdrawal by Subject|0|||
30863810|NCT02221882|58893805|FG002|Overall Study|Withdrawal by Subject|4|||
30786562|NCT01367158|58799756|FG001|Overall Study|Protocol Violation|1|||
30863811|NCT02221882|58893806|FG003|Overall Study|Withdrawal by Subject|2|||
30863812|NCT02221882|58893807|FG004|Overall Study|Withdrawal by Subject|2|||
30863813|NCT02221882|58893808|FG005|Overall Study|Withdrawal by Subject|2|||
30863814|NCT02221882|58893803|FG000|Overall Study|Death|0|||
30863815|NCT02221882|58893804|FG001|Overall Study|Death|1|||
30863816|NCT02221882|58893805|FG002|Overall Study|Death|0|||
30863817|NCT02221882|58893806|FG003|Overall Study|Death|0|||
30863818|NCT02221882|58893807|FG004|Overall Study|Death|0|||
30960001|NCT01535599|59025550|FG001|Overall Study|Randomized in Error|4|||
30960002|NCT01535599|59025549|FG000|Overall Study|Did not use product|1|||
30960003|NCT01535599|59025550|FG001|Overall Study|Did not use product|0|||
30960004|NCT01535599|59025549|FG000|Overall Study|Other|1|||
30960005|NCT01535599|59025550|FG001|Overall Study|Other|0|||
30960006|NCT01535599|59025549|FG000|Overall Study|Stopped medication|0|||
30960007|NCT01535599|59025550|FG001|Overall Study|Stopped medication|1|||
30960008|NCT01535599|59025549|FG000|Overall Study|Noncompliance|0|||
30960009|NCT01535599|59025550|FG001|Overall Study|Noncompliance|1|||
30960010|NCT01553279|59025558|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
30960011|NCT01553279|59025559|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
30960012|NCT01553279|59025558|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
30960013|NCT01553279|59025559|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
30960014|NCT01553279|59025558|FG000|Interim Period|Withdrawal by Subject|2|||
30960015|NCT01553279|59025559|FG001|Interim Period|Withdrawal by Subject|2|||
30960016|NCT01553279|59025558|FG000|Interim Period|Lost to Follow-up|1|||
30960017|NCT01553279|59025559|FG001|Interim Period|Lost to Follow-up|0|||
30960018|NCT01553279|59025558|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
30960019|NCT01553279|59025559|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
30960020|NCT01553279|59025558|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
30960021|NCT01553279|59025559|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
30960022|NCT01562743|59025566|FG000|Overall Study|Adverse Event|29|||
30960023|NCT01562743|59025566|FG000|Overall Study|Lack of Efficacy|3|||
30960024|NCT01562743|59025566|FG000|Overall Study|Withdrawal by Subject|13|||
30960025|NCT01562743|59025566|FG000|Overall Study|Protocol Violation|1|||
30960026|NCT01562743|59025566|FG000|Overall Study|Discontinuation criteria|2|||
30960027|NCT01562743|59025566|FG000|Overall Study|Lost to Follow-up|2|||
30960028|NCT01562743|59025566|FG000|Overall Study|Physician Decision|2|||
30960029|NCT01535443|59025570|FG000|Overall Study|Physician Decision|3|||
30960030|NCT01535287|59025577|FG000|Overall Study|drug not prepared in time|5|||
30960031|NCT01535287|59025578|FG001|Overall Study|drug not prepared in time|6|||
30960032|NCT01551173|59025586|FG000|Overall Study|Withdrawal by Subject|11|||
30960033|NCT01551173|59025587|FG001|Overall Study|Withdrawal by Subject|16|||
30960034|NCT01551173|59025586|FG000|Overall Study|Adverse Event|7|||
30960035|NCT01551173|59025587|FG001|Overall Study|Adverse Event|6|||
30960036|NCT01551173|59025586|FG000|Overall Study|Lost to Follow-up|5|||
30960037|NCT01551173|59025587|FG001|Overall Study|Lost to Follow-up|7|||
30960038|NCT01551173|59025586|FG000|Overall Study|Other|5|||
30960039|NCT01551173|59025587|FG001|Overall Study|Other|3|||
30960040|NCT01549613|59025596|FG000|Overall Study|Lost to Follow-up|11|||
30960041|NCT01549613|59025597|FG001|Overall Study|Lost to Follow-up|11|||
30960042|NCT01548599|59025605|FG000|Overall Study|Lost to Follow-up|0|||
30960043|NCT01548599|59025606|FG001|Overall Study|Lost to Follow-up|1|||
30960044|NCT01548599|59025605|FG000|Overall Study|Withdrawal by Subject|4|||
30960045|NCT01548599|59025606|FG001|Overall Study|Withdrawal by Subject|0|||
30960046|NCT01548599|59025605|FG000|Overall Study|Death|2|||
30960047|NCT01548599|59025606|FG001|Overall Study|Death|1|||
30960048|NCT01548287|59025619|FG000|Screening|No reason provided|0|||
30960049|NCT01548287|59025620|FG001|Screening|No reason provided|0|||
30960050|NCT01548287|59025621|FG002|Screening|No reason provided|0|||
30960051|NCT01548287|59025622|FG003|Screening|No reason provided|0|||
30960052|NCT01548287|59025623|FG004|Screening|No reason provided|9|||
30960053|NCT01548287|59025619|FG000|Screening|Did not meet eligibility criteria|0|||
30960054|NCT01548287|59025620|FG001|Screening|Did not meet eligibility criteria|0|||
30960055|NCT01548287|59025621|FG002|Screening|Did not meet eligibility criteria|0|||
30960056|NCT01548287|59025622|FG003|Screening|Did not meet eligibility criteria|0|||
30960057|NCT01548287|59025623|FG004|Screening|Did not meet eligibility criteria|74|||
30960058|NCT01548287|59025619|FG000|Randomized Period|Did not meet inclusion criteria|0|||
30960059|NCT01548287|59025620|FG001|Randomized Period|Did not meet inclusion criteria|0|||
30960060|NCT01548287|59025621|FG002|Randomized Period|Did not meet inclusion criteria|2|||
30960061|NCT01548287|59025622|FG003|Randomized Period|Did not meet inclusion criteria|0|||
30960062|NCT01548287|59025623|FG004|Randomized Period|Did not meet inclusion criteria|0|||
30960063|NCT01548287|59025619|FG000|Randomized Period|Adverse Event|0|||
30960064|NCT01548287|59025620|FG001|Randomized Period|Adverse Event|2|||
30960065|NCT01548287|59025621|FG002|Randomized Period|Adverse Event|5|||
30960066|NCT01548287|59025622|FG003|Randomized Period|Adverse Event|0|||
30960067|NCT01548287|59025623|FG004|Randomized Period|Adverse Event|0|||
30960068|NCT01546883|59025633|FG000|Overall Study|Withdrawal by Subject|3|||
30863819|NCT02221882|58893808|FG005|Overall Study|Death|0|||
30960069|NCT01546883|59025633|FG000|Overall Study|Adverse Event|4|||
30960070|NCT01546883|59025633|FG000|Overall Study|Lost to Follow-up|2|||
30960071|NCT01546883|59025633|FG000|Overall Study|early closure of study|2|||
30960072|NCT01546883|59025633|FG000|Overall Study|other unrelated illness|1|||
30960073|NCT01580293|59025644|FG000|Part A_Main Trial|Adverse Event|0|||
30960074|NCT01580293|59025645|FG001|Part A_Main Trial|Adverse Event|2|||
30960075|NCT01580293|59025646|FG002|Part A_Main Trial|Adverse Event|0|||
30960076|NCT01580293|59025644|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
30960077|NCT01580293|59025645|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
30960078|NCT01580293|59025646|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
30960079|NCT01580293|59025644|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
30960080|NCT01580293|59025645|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
30960081|NCT01580293|59025646|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
30960082|NCT01580293|59025644|FG000|Part A_Extension|Adverse Event|0|||
30960083|NCT01580293|59025645|FG001|Part A_Extension|Adverse Event|2|||
30960084|NCT01580293|59025646|FG002|Part A_Extension|Adverse Event|0|||
30960085|NCT01580293|59025644|FG000|Part A_Extension|Withdrawal by Subject|0|||
30960086|NCT01580293|59025645|FG001|Part A_Extension|Withdrawal by Subject|3|||
30960087|NCT01580293|59025646|FG002|Part A_Extension|Withdrawal by Subject|0|||
30960088|NCT01580293|59025644|FG000|Part A_Extension|Lost to Follow-up|0|||
30960089|NCT01580293|59025645|FG001|Part A_Extension|Lost to Follow-up|1|||
30960090|NCT01580293|59025646|FG002|Part A_Extension|Lost to Follow-up|0|||
30960091|NCT01580293|59025644|FG000|Part A_Extension|Other Reason|0|||
30960092|NCT01580293|59025645|FG001|Part A_Extension|Other Reason|1|||
30960093|NCT01580293|59025646|FG002|Part A_Extension|Other Reason|0|||
30960094|NCT01580293|59025644|FG000|Part A_Extension|Completed Japan only|0|||
30960095|NCT01580293|59025645|FG001|Part A_Extension|Completed Japan only|5|||
30960096|NCT01580293|59025646|FG002|Part A_Extension|Completed Japan only|0|||
30960097|NCT01580293|59025644|FG000|Part B|Withdrawal by Subject|0|||
30960098|NCT01580293|59025645|FG001|Part B|Withdrawal by Subject|0|||
30960099|NCT01580293|59025646|FG002|Part B|Withdrawal by Subject|1|||
30960100|NCT01580293|59025644|FG000|Part B|Other reason|0|||
30960101|NCT01580293|59025645|FG001|Part B|Other reason|0|||
30960102|NCT01580293|59025646|FG002|Part B|Other reason|1|||
30960103|NCT01546649|59025675|FG000|Overall Study|Adverse Event|4|||
30960104|NCT01546649|59025676|FG001|Overall Study|Adverse Event|5|||
30960105|NCT01546649|59025675|FG000|Overall Study|Protocol Violation|1|||
30960106|NCT01546649|59025676|FG001|Overall Study|Protocol Violation|0|||
30960107|NCT01546649|59025675|FG000|Overall Study|Lack of Efficacy|1|||
30960108|NCT01546649|59025676|FG001|Overall Study|Lack of Efficacy|0|||
30960109|NCT01546649|59025675|FG000|Overall Study|Recurrence|1|||
30960110|NCT01546649|59025676|FG001|Overall Study|Recurrence|1|||
30960111|NCT01546649|59025675|FG000|Overall Study|Discovery of secondary cancer|0|||
30960112|NCT01546649|59025676|FG001|Overall Study|Discovery of secondary cancer|1|||
30960113|NCT01546649|59025675|FG000|Overall Study|Withdrawal by Subject|1|||
30960114|NCT01546649|59025676|FG001|Overall Study|Withdrawal by Subject|2|||
30960115|NCT01544309|59025684|FG000|Overall Study|Withdrawal by Subject|12|||
30960116|NCT01544309|59025685|FG001|Overall Study|Withdrawal by Subject|7|||
30960117|NCT01544309|59025684|FG000|Overall Study|Protocol Violation|2|||
30960118|NCT01544309|59025685|FG001|Overall Study|Protocol Violation|1|||
30960119|NCT01544309|59025684|FG000|Overall Study|Physician Decision|4|||
30863820|NCT02837783|58893829|FG000|Overall Study|Adverse Event|1|||
30863821|NCT02837783|58893830|FG001|Overall Study|Adverse Event|0|||
30863822|NCT02837783|58893829|FG000|Overall Study|Other, Not Specified|1|||
30863823|NCT02837783|58893830|FG001|Overall Study|Other, Not Specified|2|||
30863824|NCT02221648|58893838|FG000|Overall Study|Withdrawal by Subject|3|||
30863825|NCT02221648|58893839|FG001|Overall Study|Withdrawal by Subject|3|||
30863826|NCT02220712|58893849|FG000|Overall Study|Adverse Event|1|||
30863827|NCT02220712|58893849|FG000|Overall Study|Withdrawal by Subject|2|||
30863828|NCT02220712|58893849|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
30863829|NCT02219932|58893859|FG000|Overall Study|Other|5|||
30863830|NCT02219932|58893860|FG001|Overall Study|Other|11|||
30863831|NCT02219932|58893859|FG000|Overall Study|Death|1|||
30863832|NCT02219932|58893860|FG001|Overall Study|Death|1|||
30863833|NCT02219932|58893859|FG000|Overall Study|Investigator Decision|0|||
30863834|NCT02219932|58893860|FG001|Overall Study|Investigator Decision|1|||
30863835|NCT02219932|58893859|FG000|Overall Study|Consent Withdrawn|11|||
30863836|NCT02219932|58893860|FG001|Overall Study|Consent Withdrawn|7|||
30863837|NCT02219932|58893859|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
30863838|NCT02219932|58893860|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
30863839|NCT02219932|58893859|FG000|Overall Study|Protocol Violation|10|||
30863840|NCT02219932|58893860|FG001|Overall Study|Protocol Violation|6|||
30863841|NCT02219932|58893859|FG000|Overall Study|Pregnancy|1|||
30863842|NCT02219932|58893860|FG001|Overall Study|Pregnancy|0|||
30863843|NCT02219932|58893859|FG000|Overall Study|Lost to Follow-up|4|||
30863844|NCT02219932|58893860|FG001|Overall Study|Lost to Follow-up|2|||
30863845|NCT02219932|58893859|FG000|Overall Study|Adverse Event|23|||
30960120|NCT01544309|59025685|FG001|Overall Study|Physician Decision|1|||
30960121|NCT01544309|59025684|FG000|Overall Study|Not performed pre-dose examination|1|||
30960122|NCT01544309|59025685|FG001|Overall Study|Not performed pre-dose examination|2|||
30863846|NCT02219932|58893860|FG001|Overall Study|Adverse Event|21|||
30863847|NCT02219464|58893872|FG000|Overall Study|Withdrawal by Subject|1|||
30863848|NCT02219464|58893873|FG001|Overall Study|Withdrawal by Subject|0|||
30863849|NCT02219464|58893872|FG000|Overall Study|case cancelled|1|||
30863850|NCT02219464|58893873|FG001|Overall Study|case cancelled|0|||
30960123|NCT01544309|59025684|FG000|Overall Study|Administered prohibit prior medication|1|||
30960124|NCT01544309|59025685|FG001|Overall Study|Administered prohibit prior medication|0|||
30960125|NCT01544153|59025697|FG000|Overall Study|Under 18|0|||
30960126|NCT01544153|59025698|FG001|Overall Study|Under 18|1|||
30960127|NCT01544153|59025699|FG002|Overall Study|Under 18|0|||
30960128|NCT01544153|59025700|FG003|Overall Study|Under 18|0|||
30960129|NCT01544153|59025697|FG000|Overall Study|Non-smoker|0|||
30960130|NCT01544153|59025698|FG001|Overall Study|Non-smoker|0|||
30960131|NCT01544153|59025699|FG002|Overall Study|Non-smoker|1|||
30960132|NCT01544153|59025700|FG003|Overall Study|Non-smoker|0|||
30960133|NCT01543685|59025715|FG000|Overall Study|Lack of Efficacy|1|||
30960134|NCT01543685|59025716|FG001|Overall Study|Lack of Efficacy|2|||
30960135|NCT01543685|59025717|FG002|Overall Study|Lack of Efficacy|2|||
30960136|NCT01543685|59025718|FG003|Overall Study|Lack of Efficacy|0|||
30960137|NCT01543685|59025719|FG004|Overall Study|Lack of Efficacy|2|||
30960138|NCT01543685|59025715|FG000|Overall Study|Adverse Event|2|||
30960139|NCT01543685|59025716|FG001|Overall Study|Adverse Event|1|||
30960140|NCT01543685|59025717|FG002|Overall Study|Adverse Event|0|||
30960141|NCT01543685|59025718|FG003|Overall Study|Adverse Event|0|||
30960142|NCT01543685|59025719|FG004|Overall Study|Adverse Event|2|||
30960143|NCT01541969|59025733|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
30960144|NCT01541969|59025734|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
30960145|NCT01541969|59025733|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
30960146|NCT01541969|59025734|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
30960147|NCT01541969|59025733|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
30960148|NCT01541969|59025734|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
30960149|NCT01541969|59025733|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
30960150|NCT01541969|59025734|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
30960151|NCT01541969|59025733|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
30960152|NCT01541969|59025734|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
30960153|NCT01541969|59025733|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
30960154|NCT01541969|59025734|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
30960155|NCT01541969|59025733|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
30960156|NCT01541969|59025734|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
30960157|NCT01541969|59025733|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
30960158|NCT01541969|59025734|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
30960159|NCT01541969|59025733|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
30960160|NCT01541969|59025734|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
30960161|NCT01541969|59025733|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
30960162|NCT01541969|59025734|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
30960163|NCT01540565|59025743|FG000|Overall Study|Ineligible|2|||
30960164|NCT01540487|59025749|FG000|Overall Study|Protocol Violation|1|||
30960165|NCT01540487|59025750|FG001|Overall Study|Protocol Violation|0|||
30960166|NCT01539863|59025762|FG000|Overall Study|Lost to Follow-up|5|||
30960167|NCT01539863|59025763|FG001|Overall Study|Lost to Follow-up|4|||
30960168|NCT01539317|59025771|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
30960169|NCT01539317|59025772|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
30960170|NCT01539239|59025783|FG000|Overall Study|Death|5|||
30960171|NCT01539239|59025784|FG001|Overall Study|Death|5|||
30960172|NCT01539239|59025783|FG000|Overall Study|Lost to Follow-up|7|||
30960173|NCT01539239|59025784|FG001|Overall Study|Lost to Follow-up|12|||
30960174|NCT01539083|59025790|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
30960175|NCT01539083|59025791|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
30960176|NCT01539083|59025792|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
30960177|NCT01539083|59025790|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
30960178|NCT01539083|59025791|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
30960179|NCT01539083|59025792|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
30960180|NCT01539083|59025790|FG000|Before Randomization (VCD Induction)|Death|6|||
30960181|NCT01539083|59025791|FG001|Before Randomization (VCD Induction)|Death|0|||
30960182|NCT01539083|59025792|FG002|Before Randomization (VCD Induction)|Death|0|||
30960183|NCT01539083|59025790|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
30960184|NCT01539083|59025791|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
30960185|NCT01539083|59025792|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
30960186|NCT01539083|59025790|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
30960187|NCT01539083|59025791|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
30960188|NCT01539083|59025792|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
30960189|NCT01539083|59025790|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
30960190|NCT01539083|59025791|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
30960191|NCT01539083|59025792|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
30960192|NCT01539083|59025790|FG000|Before Randomization (VCD Induction)|Other|5|||
30960193|NCT01539083|59025791|FG001|Before Randomization (VCD Induction)|Other|0|||
30960194|NCT01539083|59025792|FG002|Before Randomization (VCD Induction)|Other|0|||
30960195|NCT01539083|59025790|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
30960196|NCT01539083|59025791|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
30960197|NCT01539083|59025792|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
30960198|NCT01539083|59025790|FG000|After Randomization (TP and VTP)|Other|0|||
30960199|NCT01539083|59025791|FG001|After Randomization (TP and VTP)|Other|1|||
30960200|NCT01539083|59025792|FG002|After Randomization (TP and VTP)|Other|1|||
30960201|NCT01539083|59025790|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
30960202|NCT01539083|59025791|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
30960203|NCT01539083|59025792|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
30960204|NCT01539083|59025790|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
30960205|NCT01539083|59025791|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
30960206|NCT01539083|59025792|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
30960207|NCT01539083|59025790|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
30960208|NCT01539083|59025791|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
30960209|NCT01539083|59025792|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
30960210|NCT01539083|59025790|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
30960211|NCT01539083|59025791|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
30960212|NCT01539083|59025792|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
30960213|NCT01539083|59025790|FG000|After Randomization (TP and VTP)|Death|0|||
30960214|NCT01539083|59025791|FG001|After Randomization (TP and VTP)|Death|6|||
30960215|NCT01539083|59025792|FG002|After Randomization (TP and VTP)|Death|11|||
30960216|NCT01537211|59025801|FG000|Overall Study|Lost to Follow-up|0|||
30960217|NCT01537211|59025802|FG001|Overall Study|Lost to Follow-up|1|||
30960218|NCT01537133|59025816|FG000|Overall Study|Withdrawal by Subject|2|||
30960219|NCT01537133|59025817|FG001|Overall Study|Withdrawal by Subject|0|||
30960220|NCT01537133|59025818|FG002|Overall Study|Withdrawal by Subject|0|||
30960221|NCT01537133|59025819|FG003|Overall Study|Withdrawal by Subject|0|||
30960222|NCT01537133|59025816|FG000|Overall Study|Lost to Follow-up|1|||
30960223|NCT01537133|59025817|FG001|Overall Study|Lost to Follow-up|0|||
30960224|NCT01537133|59025818|FG002|Overall Study|Lost to Follow-up|0|||
30960225|NCT01537133|59025819|FG003|Overall Study|Lost to Follow-up|0|||
30960226|NCT01536587|59025827|FG000|Overall Study|Adverse Event|2|||
30960227|NCT01536119|59025833|FG000|Overall Study|Lost to Follow-up|17|||
30960228|NCT01536119|59025834|FG001|Overall Study|Lost to Follow-up|14|||
30960229|NCT01535729|59025840|FG000|Overall Study|Withdrawal by Subject|2|||
30960230|NCT01535729|59025840|FG000|Overall Study|Disease progression|230|||
30960231|NCT01535729|59025840|FG000|Overall Study|Discontinued treatment|25|||
30960232|NCT01535729|59025840|FG000|Overall Study|Lost to Follow-up|8|||
30960233|NCT01535729|59025840|FG000|Overall Study|Death|52|||
30960234|NCT01535729|59025840|FG000|Overall Study|Other|19|||
30960235|NCT01535729|59025840|FG000|Overall Study|Did not sign informed consent|1|||
30960236|NCT01535729|59025840|FG000|Overall Study|No previous chemotherapy|33|||
30960237|NCT01535729|59025840|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
30960238|NCT01535729|59025840|FG000|Overall Study|Protocol Violation|11|||
30960239|NCT01535729|59025840|FG000|Overall Study|Screening failure|1|||
30960240|NCT01535729|59025840|FG000|Overall Study|Not treated|9|||
30960241|NCT01535729|59025840|FG000|Overall Study|No participant record available|5|||
30960242|NCT01535261|59025844|FG000|Overall Study|Physician Decision|8|||
30960243|NCT01535261|59025844|FG000|Overall Study|Protocol Violation|3|||
30960244|NCT01535261|59025844|FG000|Overall Study|Death|5|||
30960245|NCT01535261|59025844|FG000|Overall Study|Lost to Follow-up|8|||
30960246|NCT01535261|59025844|FG000|Overall Study|Withdrawal by Subject|14|||
30960247|NCT01535261|59025844|FG000|Overall Study|Adverse Event|12|||
30960248|NCT01534637|59025848|FG000|Overall Study|Physician Decision|3|||
30960249|NCT01534637|59025848|FG000|Overall Study|Lack of Efficacy|3|||
30960250|NCT01534637|59025848|FG000|Overall Study|Withdrawal by Subject|1|||
30960251|NCT01534637|59025848|FG000|Overall Study|Adverse Event|1|||
30960252|NCT01534637|59025848|FG000|Overall Study|Liver Mets before treatment|1|||
30960253|NCT02655016|59025854|FG000|Overall Study|Disease progression|6|||
30960254|NCT02655016|59025855|FG001|Overall Study|Disease progression|4|||
30960255|NCT02655016|59025854|FG000|Overall Study|Site closed|0|||
30960256|NCT02655016|59025855|FG001|Overall Study|Site closed|1|||
30960257|NCT02655016|59025854|FG000|Overall Study|Death|30|||
30960258|NCT02655016|59025855|FG001|Overall Study|Death|48|||
30960259|NCT02655016|59025854|FG000|Overall Study|Lost to Follow-up|1|||
30960260|NCT02655016|59025855|FG001|Overall Study|Lost to Follow-up|1|||
30960261|NCT02655016|59025854|FG000|Overall Study|Withdrawal by Subject|18|||
30960262|NCT02655016|59025855|FG001|Overall Study|Withdrawal by Subject|36|||
30960263|NCT01533935|59025862|FG000|Overall Study|Adverse Event|5|||
30960264|NCT01533935|59025863|FG001|Overall Study|Adverse Event|7|||
30960265|NCT01533935|59025864|FG002|Overall Study|Adverse Event|1|||
30960266|NCT01533935|59025865|FG003|Overall Study|Adverse Event|5|||
30960267|NCT01533935|59025866|FG004|Overall Study|Adverse Event|3|||
30960268|NCT01533935|59025862|FG000|Overall Study|Protocol Violation|0|||
30960269|NCT01533935|59025863|FG001|Overall Study|Protocol Violation|2|||
30960270|NCT01533935|59025864|FG002|Overall Study|Protocol Violation|0|||
30960271|NCT01533935|59025865|FG003|Overall Study|Protocol Violation|0|||
30960272|NCT01533935|59025866|FG004|Overall Study|Protocol Violation|0|||
30960273|NCT01533935|59025862|FG000|Overall Study|Lost to Follow-up|0|||
30960274|NCT01533935|59025863|FG001|Overall Study|Lost to Follow-up|0|||
30960275|NCT01533935|59025864|FG002|Overall Study|Lost to Follow-up|1|||
30960276|NCT01533935|59025865|FG003|Overall Study|Lost to Follow-up|0|||
30960277|NCT01533935|59025866|FG004|Overall Study|Lost to Follow-up|0|||
30960278|NCT01533935|59025862|FG000|Overall Study|Withdrawal by Subject|0|||
30960279|NCT01533935|59025863|FG001|Overall Study|Withdrawal by Subject|4|||
30960280|NCT01533935|59025864|FG002|Overall Study|Withdrawal by Subject|5|||
30960281|NCT01533935|59025865|FG003|Overall Study|Withdrawal by Subject|2|||
30960282|NCT01533935|59025866|FG004|Overall Study|Withdrawal by Subject|4|||
30960283|NCT01533935|59025862|FG000|Overall Study|Other reason not defined above|1|||
30960284|NCT01533935|59025863|FG001|Overall Study|Other reason not defined above|0|||
30960285|NCT01533935|59025864|FG002|Overall Study|Other reason not defined above|1|||
30960286|NCT01533935|59025865|FG003|Overall Study|Other reason not defined above|0|||
30960287|NCT01533935|59025866|FG004|Overall Study|Other reason not defined above|1|||
30960288|NCT01532999|59025880|FG000|Overall Study|Lost to Follow-up|14|||
30960289|NCT01532999|59025881|FG001|Overall Study|Lost to Follow-up|8|||
30960290|NCT01532999|59025880|FG000|Overall Study|Physician Decision|1|||
30960291|NCT01532999|59025881|FG001|Overall Study|Physician Decision|2|||
30960292|NCT01532999|59025880|FG000|Overall Study|Withdrawal by Subject|5|||
30960293|NCT01532999|59025881|FG001|Overall Study|Withdrawal by Subject|0|||
30960294|NCT01532999|59025880|FG000|Overall Study|Relocated|2|||
30960295|NCT01532999|59025881|FG001|Overall Study|Relocated|0|||
30960296|NCT01532999|59025880|FG000|Overall Study|should not have been randomized|1|||
30960297|NCT01532999|59025881|FG001|Overall Study|should not have been randomized|0|||
30960298|NCT01532999|59025880|FG000|Overall Study|substantial noncompliance|2|||
30960299|NCT01532999|59025881|FG001|Overall Study|substantial noncompliance|0|||
30960300|NCT01532999|59025880|FG000|Overall Study|no show for week 9 assessments|6|||
30960301|NCT01532999|59025881|FG001|Overall Study|no show for week 9 assessments|4|||
30960302|NCT01532999|59025880|FG000|Overall Study|Adverse Event|0|||
30960303|NCT01532999|59025881|FG001|Overall Study|Adverse Event|1|||
30960304|NCT01532999|59025880|FG000|Overall Study|incarcerated|0|||
30960305|NCT01532999|59025881|FG001|Overall Study|incarcerated|1|||
30960306|NCT01532999|59025880|FG000|Overall Study|New job|0|||
30960307|NCT01532999|59025881|FG001|Overall Study|New job|2|||
30960308|NCT01532921|59025887|FG000|Overall Study|Death|3|||
30960309|NCT01532921|59025887|FG000|Overall Study|Withdrawal by Subject|2|||
30960310|NCT01532921|59025887|FG000|Overall Study|Lost to Follow-up|3|||
30960311|NCT01532921|59025887|FG000|Overall Study|Physician Decision|7|||
30960312|NCT01532921|59025887|FG000|Overall Study|Device was explanted during procedure|1|||
30960313|NCT01532687|59025897|FG000|Overall Study|Death|2|||
30960314|NCT01532687|59025898|FG001|Overall Study|Death|0|||
30960315|NCT01532687|59025897|FG000|Overall Study|Adverse Event|6|||
30960316|NCT01532687|59025898|FG001|Overall Study|Adverse Event|1|||
30960317|NCT01532687|59025897|FG000|Overall Study|Withdrawal by Subject|1|||
30960318|NCT01532687|59025898|FG001|Overall Study|Withdrawal by Subject|0|||
30960319|NCT01532687|59025897|FG000|Overall Study|Physician Decision|2|||
30960320|NCT01532687|59025898|FG001|Overall Study|Physician Decision|1|||
30960321|NCT01532687|59025897|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
30960322|NCT01532687|59025898|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
30960323|NCT02677116|59025915|FG000|Overall Study|Adverse Event|0|||
30960324|NCT02677116|59025916|FG001|Overall Study|Adverse Event|1|||
30960325|NCT02677116|59025917|FG002|Overall Study|Adverse Event|0|||
30960326|NCT02677116|59025918|FG003|Overall Study|Adverse Event|0|||
30960327|NCT02677116|59025919|FG004|Overall Study|Adverse Event|0|||
30960328|NCT02677116|59025920|FG005|Overall Study|Adverse Event|1|||
30960329|NCT02677116|59025921|FG006|Overall Study|Adverse Event|1|||
30960330|NCT02677116|59025922|FG007|Overall Study|Adverse Event|0|||
30960331|NCT02677116|59025923|FG008|Overall Study|Adverse Event|0|||
30960332|NCT02677116|59025915|FG000|Overall Study|Physician Decision|0|||
30960333|NCT02677116|59025916|FG001|Overall Study|Physician Decision|2|||
30960334|NCT02677116|59025917|FG002|Overall Study|Physician Decision|3|||
30960335|NCT02677116|59025918|FG003|Overall Study|Physician Decision|2|||
30960336|NCT02677116|59025919|FG004|Overall Study|Physician Decision|1|||
30960337|NCT02677116|59025920|FG005|Overall Study|Physician Decision|3|||
30960338|NCT02677116|59025921|FG006|Overall Study|Physician Decision|1|||
30960339|NCT02677116|59025922|FG007|Overall Study|Physician Decision|1|||
30960340|NCT02677116|59025923|FG008|Overall Study|Physician Decision|2|||
30960341|NCT02677116|59025915|FG000|Overall Study|Withdrawal by parent or guardian|2|||
30960342|NCT02677116|59025916|FG001|Overall Study|Withdrawal by parent or guardian|1|||
30960343|NCT02677116|59025917|FG002|Overall Study|Withdrawal by parent or guardian|0|||
30960344|NCT02677116|59025918|FG003|Overall Study|Withdrawal by parent or guardian|1|||
30960345|NCT02677116|59025919|FG004|Overall Study|Withdrawal by parent or guardian|0|||
30960346|NCT02677116|59025920|FG005|Overall Study|Withdrawal by parent or guardian|0|||
30960347|NCT02677116|59025921|FG006|Overall Study|Withdrawal by parent or guardian|2|||
30960348|NCT02677116|59025922|FG007|Overall Study|Withdrawal by parent or guardian|1|||
30863851|NCT02219464|58893872|FG000|Overall Study|catheter malfunction|1|||
30960349|NCT02677116|59025923|FG008|Overall Study|Withdrawal by parent or guardian|0|||
30960350|NCT02677116|59025915|FG000|Overall Study|Withdrawal by Subject|1|||
30960351|NCT02677116|59025916|FG001|Overall Study|Withdrawal by Subject|0|||
30960352|NCT02677116|59025917|FG002|Overall Study|Withdrawal by Subject|0|||
30960353|NCT02677116|59025918|FG003|Overall Study|Withdrawal by Subject|0|||
30960354|NCT02677116|59025919|FG004|Overall Study|Withdrawal by Subject|0|||
30960355|NCT02677116|59025920|FG005|Overall Study|Withdrawal by Subject|0|||
30960356|NCT02677116|59025921|FG006|Overall Study|Withdrawal by Subject|0|||
30960357|NCT02677116|59025922|FG007|Overall Study|Withdrawal by Subject|0|||
30960358|NCT02677116|59025923|FG008|Overall Study|Withdrawal by Subject|0|||
30960359|NCT02689518|59025966|FG000|Overall Study|Withdrawal by Subject|3|||
30960360|NCT02681094|59025973|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
30960361|NCT02681094|59025974|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
30960362|NCT02681094|59025975|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
30960363|NCT02681094|59025973|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
30960364|NCT02681094|59025974|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
30960365|NCT02681094|59025975|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
30960366|NCT02681094|59025973|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
30960367|NCT02681094|59025974|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
30960368|NCT02681094|59025975|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
30960369|NCT02681094|59025973|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
30960370|NCT02681094|59025974|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
30960371|NCT02681094|59025975|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
30960372|NCT02681094|59025973|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
30960373|NCT02681094|59025974|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
30960374|NCT02681094|59025975|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
30960375|NCT02681094|59025973|FG000|1 -Modified Enrolled Participants Set|Other|6|||
30960376|NCT02681094|59025974|FG001|1 -Modified Enrolled Participants Set|Other|6|||
30960377|NCT02681094|59025975|FG002|1 -Modified Enrolled Participants Set|Other|7|||
30960378|NCT02681094|59025973|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
30960379|NCT02681094|59025974|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
30960380|NCT02681094|59025975|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
30960381|NCT02681094|59025973|FG000|2 - Enrolled Participants Set|Participant decision|7|||
30960382|NCT02681094|59025974|FG001|2 - Enrolled Participants Set|Participant decision|10|||
30960383|NCT02681094|59025975|FG002|2 - Enrolled Participants Set|Participant decision|9|||
30960384|NCT02681094|59025973|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
30960385|NCT02681094|59025974|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
30960386|NCT02681094|59025975|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
30960387|NCT02681094|59025973|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
30960388|NCT02681094|59025974|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
30960389|NCT02681094|59025975|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
30960390|NCT02681094|59025973|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
30960391|NCT02681094|59025974|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
30600501|NCT01287897|58612087|FG002|Overall Study|Other|1|||
30600502|NCT01287897|58612088|FG003|Overall Study|Other|0|||
30600503|NCT01090024|58612102|FG000|Period 1|Met exclusion criteria|0|||
30600504|NCT01090024|58612103|FG001|Period 1|Met exclusion criteria|0|||
30600505|NCT01090024|58612104|FG002|Period 1|Met exclusion criteria|0|||
30600506|NCT01090024|58612105|FG003|Period 1|Met exclusion criteria|0|||
30600507|NCT01090024|58612106|FG004|Period 1|Met exclusion criteria|0|||
30600508|NCT01090024|58612107|FG005|Period 1|Met exclusion criteria|0|||
30600509|NCT01090024|58612108|FG006|Period 1|Met exclusion criteria|0|||
30600510|NCT01090024|58612109|FG007|Period 1|Met exclusion criteria|0|||
30600511|NCT01090024|58612110|FG008|Period 1|Met exclusion criteria|0|||
30600512|NCT01090024|58612111|FG009|Period 1|Met exclusion criteria|0|||
30600513|NCT01090024|58612112|FG010|Period 1|Met exclusion criteria|0|||
30600514|NCT01090024|58612113|FG011|Period 1|Met exclusion criteria|0|||
30600515|NCT01090024|58612114|FG012|Period 1|Met exclusion criteria|0|||
30600516|NCT01090024|58612115|FG013|Period 1|Met exclusion criteria|0|||
30600517|NCT01090024|58612116|FG014|Period 1|Met exclusion criteria|1|||
30600518|NCT01090024|58612117|FG015|Period 1|Met exclusion criteria|0|||
30600519|NCT01090024|58612118|FG016|Period 1|Met exclusion criteria|0|||
30600520|NCT01090024|58612119|FG017|Period 1|Met exclusion criteria|0|||
30600521|NCT01090024|58612102|FG000|Period 1|Adverse Event|0|||
30600522|NCT01090024|58612103|FG001|Period 1|Adverse Event|0|||
30863852|NCT02219464|58893873|FG001|Overall Study|catheter malfunction|0|||
30863853|NCT02219308|58893881|FG000|Overall Study|Withdrawal by Subject|1|||
30863854|NCT02219308|58893882|FG001|Overall Study|Withdrawal by Subject|2|||
30863855|NCT02218372|58893890|FG000|Overall Study|Adverse Event|1|||
30600523|NCT01090024|58612104|FG002|Period 1|Adverse Event|0|||
30600524|NCT01090024|58612105|FG003|Period 1|Adverse Event|0|||
30600525|NCT01090024|58612106|FG004|Period 1|Adverse Event|0|||
30600526|NCT01090024|58612107|FG005|Period 1|Adverse Event|0|||
30600527|NCT01090024|58612108|FG006|Period 1|Adverse Event|0|||
30600528|NCT01090024|58612109|FG007|Period 1|Adverse Event|0|||
30600529|NCT01090024|58612110|FG008|Period 1|Adverse Event|0|||
30863856|NCT02218372|58893891|FG001|Overall Study|Adverse Event|1|||
30960392|NCT02681094|59025975|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
30960393|NCT02681094|59025973|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
30960394|NCT02681094|59025974|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
30960395|NCT02681094|59025975|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
30960396|NCT02681094|59025973|FG000|2 - Enrolled Participants Set|Other|6|||
30960397|NCT02681094|59025974|FG001|2 - Enrolled Participants Set|Other|6|||
30960398|NCT02681094|59025975|FG002|2 - Enrolled Participants Set|Other|7|||
30960399|NCT02681094|59025973|FG000|2 - Enrolled Participants Set|No treatment given|0|||
30960400|NCT02681094|59025974|FG001|2 - Enrolled Participants Set|No treatment given|1|||
30960401|NCT02681094|59025975|FG002|2 - Enrolled Participants Set|No treatment given|1|||
30960402|NCT02689284|59025986|FG000|Overall Study|Adverse Event|1|||
30960403|NCT02689284|59025987|FG001|Overall Study|Adverse Event|8|||
30960404|NCT02689284|59025986|FG000|Overall Study|Death|0|||
30960405|NCT02689284|59025987|FG001|Overall Study|Death|1|||
30960406|NCT02689284|59025986|FG000|Overall Study|Physician Decision|1|||
30960407|NCT02689284|59025987|FG001|Overall Study|Physician Decision|2|||
30960408|NCT02689284|59025986|FG000|Overall Study|Withdrawal by Subject|0|||
30960409|NCT02689284|59025987|FG001|Overall Study|Withdrawal by Subject|1|||
30960410|NCT02689284|59025986|FG000|Overall Study|progression of cancer|1|||
30960411|NCT02689284|59025987|FG001|Overall Study|progression of cancer|72|||
30960412|NCT02689284|59025986|FG000|Overall Study|decreased heart function|0|||
30960413|NCT02689284|59025987|FG001|Overall Study|decreased heart function|1|||
30960414|NCT02689284|59025986|FG000|Overall Study|concern for anemia|0|||
30960415|NCT02689284|59025987|FG001|Overall Study|concern for anemia|1|||
30960416|NCT02689284|59025986|FG000|Overall Study|no measurable cancer for evaluation|0|||
30960417|NCT02689284|59025987|FG001|Overall Study|no measurable cancer for evaluation|1|||
30960418|NCT02676882|59025996|FG000|Overall Study|Adverse Event|1|||
30960419|NCT02676882|59025997|FG001|Overall Study|Adverse Event|0|||
30960420|NCT02676882|59025996|FG000|Overall Study|Lost to Follow-up|1|||
30960421|NCT02676882|59025997|FG001|Overall Study|Lost to Follow-up|0|||
30960422|NCT02676882|59025996|FG000|Overall Study|Withdrawal by Subject|1|||
30960423|NCT02676882|59025997|FG001|Overall Study|Withdrawal by Subject|2|||
30960424|NCT02674386|59026006|FG000|Overall Study|Lost to Follow-up|0|||
30960425|NCT02674386|59026007|FG001|Overall Study|Lost to Follow-up|1|||
30960426|NCT02674386|59026008|FG002|Overall Study|Lost to Follow-up|1|||
30960427|NCT02674386|59026006|FG000|Overall Study|Withdrawal by Subject|0|||
30960428|NCT02674386|59026007|FG001|Overall Study|Withdrawal by Subject|4|||
30960429|NCT02674386|59026008|FG002|Overall Study|Withdrawal by Subject|0|||
30960430|NCT02674386|59026006|FG000|Overall Study|Other|0|||
30960431|NCT02674386|59026007|FG001|Overall Study|Other|1|||
30960432|NCT02674386|59026008|FG002|Overall Study|Other|0|||
30960433|NCT02674386|59026006|FG000|Overall Study|Enrolled but not evaluated|0|||
30960434|NCT02674386|59026007|FG001|Overall Study|Enrolled but not evaluated|4|||
30960435|NCT02674386|59026008|FG002|Overall Study|Enrolled but not evaluated|0|||
30960436|NCT02680002|59026027|FG000|Overall Study|Lost to Follow-up|5|||
30960437|NCT02680002|59026028|FG001|Overall Study|Lost to Follow-up|1|||
30960438|NCT02680002|59026029|FG002|Overall Study|Lost to Follow-up|4|||
30960439|NCT02680002|59026030|FG003|Overall Study|Lost to Follow-up|2|||
30960440|NCT02680002|59026031|FG004|Overall Study|Lost to Follow-up|0|||
30960441|NCT02680002|59026032|FG005|Overall Study|Lost to Follow-up|2|||
30960442|NCT02680002|59026027|FG000|Overall Study|Physician Decision|5|||
30960443|NCT02680002|59026028|FG001|Overall Study|Physician Decision|1|||
30600530|NCT01090024|58612111|FG009|Period 1|Adverse Event|1|||
30600531|NCT01090024|58612112|FG010|Period 1|Adverse Event|0|||
30600532|NCT01090024|58612113|FG011|Period 1|Adverse Event|1|||
30863857|NCT02218372|58893890|FG000|Overall Study|Miscellaneous|2|||
30863858|NCT02218372|58893891|FG001|Overall Study|Miscellaneous|1|||
30863859|NCT02218372|58893890|FG000|Overall Study|Randomized but did not receive treatment|2|||
30863860|NCT02218372|58893891|FG001|Overall Study|Randomized but did not receive treatment|3|||
30863861|NCT02218372|58893890|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30863862|NCT02218372|58893891|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
30960444|NCT02680002|59026029|FG002|Overall Study|Physician Decision|1|||
30960445|NCT02680002|59026030|FG003|Overall Study|Physician Decision|1|||
30960446|NCT02680002|59026031|FG004|Overall Study|Physician Decision|1|||
30960447|NCT02680002|59026032|FG005|Overall Study|Physician Decision|1|||
30960448|NCT02680002|59026027|FG000|Overall Study|Protocol Violation|1|||
30600533|NCT01090024|58612114|FG012|Period 1|Adverse Event|0|||
30600534|NCT01090024|58612115|FG013|Period 1|Adverse Event|0|||
30600535|NCT01090024|58612116|FG014|Period 1|Adverse Event|0|||
30960449|NCT02680002|59026028|FG001|Overall Study|Protocol Violation|0|||
30960450|NCT02680002|59026029|FG002|Overall Study|Protocol Violation|1|||
30960451|NCT02680002|59026030|FG003|Overall Study|Protocol Violation|0|||
30960452|NCT02680002|59026031|FG004|Overall Study|Protocol Violation|1|||
30600536|NCT01090024|58612117|FG015|Period 1|Adverse Event|0|||
30600537|NCT01090024|58612118|FG016|Period 1|Adverse Event|0|||
30960453|NCT02680002|59026032|FG005|Overall Study|Protocol Violation|2|||
30960454|NCT02680002|59026027|FG000|Overall Study|Withdrawal by Subject|0|||
30960455|NCT02680002|59026028|FG001|Overall Study|Withdrawal by Subject|0|||
30960456|NCT02680002|59026029|FG002|Overall Study|Withdrawal by Subject|1|||
30960457|NCT02680002|59026030|FG003|Overall Study|Withdrawal by Subject|0|||
30960458|NCT02680002|59026031|FG004|Overall Study|Withdrawal by Subject|2|||
30960459|NCT02680002|59026032|FG005|Overall Study|Withdrawal by Subject|2|||
30960460|NCT02680002|59026027|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
30960461|NCT02680002|59026028|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
30960462|NCT02680002|59026029|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
30960463|NCT02680002|59026030|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
30960464|NCT02680002|59026031|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
30960465|NCT02680002|59026032|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
30960466|NCT02680002|59026027|FG000|Overall Study|Other|0|||
30960467|NCT02680002|59026028|FG001|Overall Study|Other|1|||
30960468|NCT02680002|59026029|FG002|Overall Study|Other|0|||
30960469|NCT02680002|59026030|FG003|Overall Study|Other|0|||
30960470|NCT02680002|59026031|FG004|Overall Study|Other|1|||
30960471|NCT02680002|59026032|FG005|Overall Study|Other|0|||
30960472|NCT02680002|59026027|FG000|Overall Study|Adverse Event|0|||
30960473|NCT02680002|59026028|FG001|Overall Study|Adverse Event|0|||
30960474|NCT02680002|59026029|FG002|Overall Study|Adverse Event|0|||
30960475|NCT02680002|59026030|FG003|Overall Study|Adverse Event|0|||
30960476|NCT02680002|59026031|FG004|Overall Study|Adverse Event|1|||
30960477|NCT02680002|59026032|FG005|Overall Study|Adverse Event|2|||
30960478|NCT04557384|59026049|FG000|Overall Study|Study Terminated by Sponsor|1|||
30960479|NCT04557384|59026049|FG000|Overall Study|Death|1|||
30960480|NCT02673684|59026055|FG000|Overall Study|Study not completed d/t loss of funding|9|||
30960481|NCT02673684|59026056|FG001|Overall Study|Study not completed d/t loss of funding|8|||
30960482|NCT02675634|59026064|FG000|Test Period 1|Adverse Event|0|||
30960483|NCT02675634|59026065|FG001|Test Period 1|Adverse Event|1|||
30960484|NCT02675634|59026066|FG002|Test Period 1|Adverse Event|0|||
30960485|NCT02675634|59026067|FG003|Test Period 1|Adverse Event|1|||
30960486|NCT02675634|59026068|FG004|Test Period 1|Adverse Event|0|||
30960487|NCT02675634|59026069|FG005|Test Period 1|Adverse Event|0|||
30960488|NCT02675634|59026064|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
30960489|NCT02675634|59026065|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
30960490|NCT02675634|59026066|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
30960491|NCT02675634|59026067|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
30960492|NCT02675634|59026068|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
30960493|NCT02675634|59026069|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
30960494|NCT02675634|59026064|FG000|Test Period 2|Lack of Efficacy|1|||
30960495|NCT02675634|59026065|FG001|Test Period 2|Lack of Efficacy|0|||
30960496|NCT02675634|59026066|FG002|Test Period 2|Lack of Efficacy|0|||
30960497|NCT02675634|59026067|FG003|Test Period 2|Lack of Efficacy|0|||
30960498|NCT02675634|59026068|FG004|Test Period 2|Lack of Efficacy|0|||
30960499|NCT02675634|59026069|FG005|Test Period 2|Lack of Efficacy|0|||
30960500|NCT02675634|59026064|FG000|Test Period 2|Adverse Event|0|||
30960501|NCT02675634|59026065|FG001|Test Period 2|Adverse Event|0|||
30960502|NCT02675634|59026066|FG002|Test Period 2|Adverse Event|0|||
30960503|NCT02675634|59026067|FG003|Test Period 2|Adverse Event|0|||
30960504|NCT02675634|59026068|FG004|Test Period 2|Adverse Event|0|||
30960505|NCT02675634|59026069|FG005|Test Period 2|Adverse Event|1|||
30960506|NCT02671500|59026077|FG000|Overall Study|Lack of Efficacy|12|||
30960507|NCT02671500|59026077|FG000|Overall Study|Lost to Follow-up|2|||
30960508|NCT02671422|59026085|FG000|Overall Study|Lost to Follow-up|1|||
30960509|NCT02671422|59026085|FG000|Overall Study|Adverse Event|68|||
30960510|NCT02671422|59026085|FG000|Overall Study|Lack of Efficacy|1|||
30960511|NCT02671422|59026085|FG000|Overall Study|Lost to Follow-up|4|||
30960512|NCT02671422|59026085|FG000|Overall Study|Withdrawal by Subject|7|||
30960513|NCT02671422|59026085|FG000|Overall Study|Progressive Disease|156|||
30960514|NCT02671422|59026085|FG000|Overall Study|Worsening of Disease|4|||
30960515|NCT02671422|59026085|FG000|Overall Study|Sponsor decision|5|||
30960516|NCT02671422|59026085|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
30960517|NCT02671422|59026085|FG000|Overall Study|Not treated with Vargatef®|3|||
30960518|NCT02671422|59026085|FG000|Overall Study|Other not defined above|3|||
30960519|NCT02671266|59026091|FG000|Overall Study|Withdrawal by Subject|1|||
30960520|NCT02671266|59026092|FG001|Overall Study|Withdrawal by Subject|1|||
30600538|NCT01090024|58612119|FG017|Period 1|Adverse Event|1|||
30960521|NCT03320070|59026100|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
30960522|NCT03320070|59026101|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
30863863|NCT02218216|58893904|FG000|Overall Study|Study terminated before completed|6|||
30960523|NCT03320070|59026100|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
30960524|NCT03320070|59026101|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
30960525|NCT03320070|59026100|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
30960526|NCT03320070|59026101|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
30960527|NCT03320070|59026100|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
30960528|NCT03320070|59026101|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
30960529|NCT03320070|59026100|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
30960530|NCT03320070|59026101|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
30960531|NCT03320070|59026100|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
30960532|NCT03320070|59026101|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
30960533|NCT02667912|59026112|FG000|Overall Study|Death|3|||
30960534|NCT02667912|59026113|FG001|Overall Study|Death|1|||
30960535|NCT02667912|59026112|FG000|Overall Study|Withdrawal by Subject|1|||
30960536|NCT02667912|59026113|FG001|Overall Study|Withdrawal by Subject|2|||
30960537|NCT02667912|59026112|FG000|Overall Study|Withdrawal by Subject|1|||
30960538|NCT02667912|59026113|FG001|Overall Study|Withdrawal by Subject|0|||
30960539|NCT01373346|59026119|FG000|Overall Study|Death|1|||
30960540|NCT03284424|59026130|FG000|Overall Study|Death|56|||
30960541|NCT03284424|59026131|FG001|Overall Study|Death|13|||
30960542|NCT03284424|59026130|FG000|Overall Study|Lost to Follow-up|1|||
30960543|NCT03284424|59026131|FG001|Overall Study|Lost to Follow-up|0|||
30960544|NCT03284424|59026130|FG000|Overall Study|Physician Decision|1|||
30960545|NCT03284424|59026131|FG001|Overall Study|Physician Decision|0|||
30960546|NCT03284424|59026130|FG000|Overall Study|Withdrawal by Subject|3|||
30960547|NCT03284424|59026131|FG001|Overall Study|Withdrawal by Subject|2|||
30960548|NCT03284424|59026130|FG000|Overall Study|Ongoing in study|44|||
30960549|NCT03284424|59026131|FG001|Overall Study|Ongoing in study|39|||
30960550|NCT02674854|59026139|FG000|Overall Study|Adverse Event|17|||
30960551|NCT02674854|59026140|FG001|Overall Study|Adverse Event|15|||
30960552|NCT02674854|59026141|FG002|Overall Study|Adverse Event|5|||
30960553|NCT02674854|59026139|FG000|Overall Study|Withdrawal by Subject|1|||
30960554|NCT02674854|59026140|FG001|Overall Study|Withdrawal by Subject|5|||
30960555|NCT02674854|59026141|FG002|Overall Study|Withdrawal by Subject|4|||
30960556|NCT02674854|59026139|FG000|Overall Study|No-compliant subject|1|||
30960557|NCT02674854|59026140|FG001|Overall Study|No-compliant subject|0|||
30960558|NCT02674854|59026141|FG002|Overall Study|No-compliant subject|1|||
30960559|NCT02674854|59026139|FG000|Overall Study|Lost to Follow-up|1|||
30960560|NCT02674854|59026140|FG001|Overall Study|Lost to Follow-up|0|||
30960561|NCT02674854|59026141|FG002|Overall Study|Lost to Follow-up|2|||
30960562|NCT02674854|59026139|FG000|Overall Study|Lack of Efficacy|0|||
30960563|NCT02674854|59026140|FG001|Overall Study|Lack of Efficacy|3|||
30960564|NCT02674854|59026141|FG002|Overall Study|Lack of Efficacy|0|||
30960565|NCT02674854|59026139|FG000|Overall Study|Disallowed Concurrent Medication|2|||
30960566|NCT02674854|59026140|FG001|Overall Study|Disallowed Concurrent Medication|2|||
30960567|NCT02674854|59026141|FG002|Overall Study|Disallowed Concurrent Medication|0|||
30960568|NCT02674854|59026139|FG000|Overall Study|Protocol Violation|1|||
30960569|NCT02674854|59026140|FG001|Overall Study|Protocol Violation|1|||
30960570|NCT02674854|59026141|FG002|Overall Study|Protocol Violation|2|||
30960571|NCT02674854|59026139|FG000|Overall Study|Death|0|||
30960572|NCT02674854|59026140|FG001|Overall Study|Death|1|||
30960573|NCT02674854|59026141|FG002|Overall Study|Death|0|||
30960574|NCT02674854|59026139|FG000|Overall Study|Subject missed V6.2|1|||
30960575|NCT02674854|59026140|FG001|Overall Study|Subject missed V6.2|0|||
30960576|NCT02674854|59026141|FG002|Overall Study|Subject missed V6.2|0|||
30960577|NCT02667288|59026149|FG000|Overall Study|Protocol Violation|5|||
30960578|NCT02667288|59026149|FG000|Overall Study|Lost to Follow-up|3|||
30960579|NCT02667288|59026149|FG000|Overall Study|Withdrawal by Subject|5|||
30960580|NCT02670330|59026155|FG000|Overall Study|Protocol Deviation|1|||
30960581|NCT02670330|59026156|FG001|Overall Study|Protocol Deviation|0|||
30960582|NCT02670330|59026155|FG000|Overall Study|Study Terminated By Sponsor|36|||
30960583|NCT02670330|59026156|FG001|Overall Study|Study Terminated By Sponsor|43|||
30960584|NCT02670330|59026155|FG000|Overall Study|Adverse Event|1|||
30960585|NCT02670330|59026156|FG001|Overall Study|Adverse Event|3|||
30960586|NCT02670330|59026155|FG000|Overall Study|Withdrawal by Subject|34|||
30600539|NCT01090024|58612102|FG000|Period 1|Withdrawal by Subject|0|||
30863864|NCT02218216|58893905|FG001|Overall Study|Study terminated before completed|0|||
30863865|NCT02218216|58893906|FG002|Overall Study|Study terminated before completed|0|||
30863866|NCT02217982|58893916|FG000|Overall Study|Trial discontinued|1|||
30863867|NCT02217982|58893917|FG001|Overall Study|Trial discontinued|0|||
30960587|NCT02670330|59026156|FG001|Overall Study|Withdrawal by Subject|29|||
30960588|NCT02670330|59026155|FG000|Overall Study|Lost to Follow-up|3|||
30960589|NCT02670330|59026156|FG001|Overall Study|Lost to Follow-up|2|||
30960590|NCT02669940|59026164|FG000|Overall Study|Failure to return|0|||
30960591|NCT02669940|59026165|FG001|Overall Study|Failure to return|3|||
30960592|NCT02669940|59026164|FG000|Overall Study|Insufficient follow-up data|1|||
30960593|NCT02669940|59026165|FG001|Overall Study|Insufficient follow-up data|0|||
30960594|NCT02669862|59026181|FG000|Overall Study|Lost to Follow-up|0|||
30960595|NCT02669862|59026182|FG001|Overall Study|Lost to Follow-up|2|||
30960596|NCT02669862|59026183|FG002|Overall Study|Lost to Follow-up|1|||
30960597|NCT02669862|59026181|FG000|Overall Study|Withdrawal by Subject|2|||
30960598|NCT02669862|59026182|FG001|Overall Study|Withdrawal by Subject|2|||
30960599|NCT02669862|59026183|FG002|Overall Study|Withdrawal by Subject|3|||
30960600|NCT02669862|59026181|FG000|Overall Study|moved|0|||
30960601|NCT02669862|59026182|FG001|Overall Study|moved|1|||
30960602|NCT02669862|59026183|FG002|Overall Study|moved|0|||
30960603|NCT02669862|59026181|FG000|Overall Study|Protocol Violation|0|||
30960604|NCT02669862|59026182|FG001|Overall Study|Protocol Violation|0|||
30960605|NCT02669862|59026183|FG002|Overall Study|Protocol Violation|1|||
30960606|NCT01531673|59026207|FG000|Overall Study|Non-Compliance|0|||
30960607|NCT01531673|59026208|FG001|Overall Study|Non-Compliance|0|||
30960608|NCT01531673|59026209|FG002|Overall Study|Non-Compliance|0|||
30960609|NCT01531673|59026210|FG003|Overall Study|Non-Compliance|0|||
30960610|NCT01531673|59026211|FG004|Overall Study|Non-Compliance|0|||
30960611|NCT01531673|59026212|FG005|Overall Study|Non-Compliance|1|||
30960612|NCT01531673|59026213|FG006|Overall Study|Non-Compliance|0|||
30960613|NCT01531673|59026214|FG007|Overall Study|Non-Compliance|0|||
30960614|NCT01531673|59026215|FG008|Overall Study|Non-Compliance|0|||
30960615|NCT01531673|59026216|FG009|Overall Study|Non-Compliance|0|||
30960616|NCT01531673|59026217|FG010|Overall Study|Non-Compliance|0|||
30960617|NCT01531673|59026218|FG011|Overall Study|Non-Compliance|0|||
30960618|NCT01531673|59026219|FG012|Overall Study|Non-Compliance|0|||
30960619|NCT01531673|59026207|FG000|Overall Study|Adverse Event|0|||
30960620|NCT01531673|59026208|FG001|Overall Study|Adverse Event|1|||
30960621|NCT01531673|59026209|FG002|Overall Study|Adverse Event|0|||
30960622|NCT01531673|59026210|FG003|Overall Study|Adverse Event|0|||
30960623|NCT01531673|59026211|FG004|Overall Study|Adverse Event|0|||
30960624|NCT01531673|59026212|FG005|Overall Study|Adverse Event|0|||
30960625|NCT01531673|59026213|FG006|Overall Study|Adverse Event|0|||
30960626|NCT01531673|59026214|FG007|Overall Study|Adverse Event|0|||
30960627|NCT01531673|59026215|FG008|Overall Study|Adverse Event|0|||
30960628|NCT01531673|59026216|FG009|Overall Study|Adverse Event|0|||
30960629|NCT01531673|59026217|FG010|Overall Study|Adverse Event|0|||
30960630|NCT01531673|59026218|FG011|Overall Study|Adverse Event|0|||
30960631|NCT01531673|59026219|FG012|Overall Study|Adverse Event|0|||
30960632|NCT01531673|59026207|FG000|Overall Study|Lost to Follow-up|0|||
30960633|NCT01531673|59026208|FG001|Overall Study|Lost to Follow-up|0|||
30960634|NCT01531673|59026209|FG002|Overall Study|Lost to Follow-up|0|||
30960635|NCT01531673|59026210|FG003|Overall Study|Lost to Follow-up|0|||
30960636|NCT01531673|59026211|FG004|Overall Study|Lost to Follow-up|1|||
30960637|NCT01531673|59026212|FG005|Overall Study|Lost to Follow-up|0|||
30960638|NCT01531673|59026213|FG006|Overall Study|Lost to Follow-up|0|||
30960639|NCT01531673|59026214|FG007|Overall Study|Lost to Follow-up|0|||
30960640|NCT01531673|59026215|FG008|Overall Study|Lost to Follow-up|0|||
30960641|NCT01531673|59026216|FG009|Overall Study|Lost to Follow-up|0|||
30960642|NCT01531673|59026217|FG010|Overall Study|Lost to Follow-up|0|||
30960643|NCT01531673|59026218|FG011|Overall Study|Lost to Follow-up|0|||
30960644|NCT01531673|59026219|FG012|Overall Study|Lost to Follow-up|0|||
30960645|NCT01531673|59026207|FG000|Overall Study|Other|0|||
30960646|NCT01531673|59026208|FG001|Overall Study|Other|0|||
30960647|NCT01531673|59026209|FG002|Overall Study|Other|0|||
30960648|NCT01531673|59026210|FG003|Overall Study|Other|1|||
30960649|NCT01531673|59026211|FG004|Overall Study|Other|0|||
30960650|NCT01531673|59026212|FG005|Overall Study|Other|0|||
30960651|NCT01531673|59026213|FG006|Overall Study|Other|0|||
30960652|NCT01531673|59026214|FG007|Overall Study|Other|0|||
30960653|NCT01531673|59026215|FG008|Overall Study|Other|0|||
30960654|NCT01531673|59026216|FG009|Overall Study|Other|1|||
30960655|NCT01531673|59026217|FG010|Overall Study|Other|0|||
30960656|NCT01531673|59026218|FG011|Overall Study|Other|0|||
30960657|NCT01531673|59026219|FG012|Overall Study|Other|0|||
30960658|NCT01531205|59026271|FG000|Overall Study|Did not proceed to surgery|1|||
30960659|NCT01529645|59026287|FG000|Overall Study|Lost to Follow-up|0|||
30960660|NCT01529645|59026288|FG001|Overall Study|Lost to Follow-up|1|||
30960661|NCT01529645|59026289|FG002|Overall Study|Lost to Follow-up|1|||
30960662|NCT01529645|59026290|FG003|Overall Study|Lost to Follow-up|1|||
30960663|NCT01529645|59026291|FG004|Overall Study|Lost to Follow-up|1|||
30960664|NCT01529645|59026292|FG005|Overall Study|Lost to Follow-up|0|||
30600540|NCT01090024|58612103|FG001|Period 1|Withdrawal by Subject|0|||
30600541|NCT01090024|58612104|FG002|Period 1|Withdrawal by Subject|0|||
30600542|NCT01090024|58612105|FG003|Period 1|Withdrawal by Subject|1|||
30600543|NCT01090024|58612106|FG004|Period 1|Withdrawal by Subject|0|||
30960665|NCT01529645|59026293|FG006|Overall Study|Lost to Follow-up|2|||
30960666|NCT01529645|59026294|FG007|Overall Study|Lost to Follow-up|0|||
30960667|NCT01529645|59026295|FG008|Overall Study|Lost to Follow-up|1|||
30960668|NCT01529645|59026296|FG009|Overall Study|Lost to Follow-up|0|||
30960669|NCT01529645|59026287|FG000|Overall Study|SAE - Premature contractions|0|||
30960670|NCT01529645|59026288|FG001|Overall Study|SAE - Premature contractions|0|||
30960671|NCT01529645|59026289|FG002|Overall Study|SAE - Premature contractions|1|||
30960672|NCT01529645|59026290|FG003|Overall Study|SAE - Premature contractions|0|||
30960673|NCT01529645|59026291|FG004|Overall Study|SAE - Premature contractions|0|||
30960674|NCT01529645|59026292|FG005|Overall Study|SAE - Premature contractions|0|||
30960675|NCT01529645|59026293|FG006|Overall Study|SAE - Premature contractions|0|||
30960676|NCT01529645|59026294|FG007|Overall Study|SAE - Premature contractions|0|||
30960677|NCT01529645|59026295|FG008|Overall Study|SAE - Premature contractions|0|||
30960678|NCT01529645|59026296|FG009|Overall Study|SAE - Premature contractions|0|||
30960679|NCT01529645|59026287|FG000|Overall Study|Withdrawal by Subject|2|||
30960680|NCT01529645|59026288|FG001|Overall Study|Withdrawal by Subject|0|||
30960681|NCT01529645|59026289|FG002|Overall Study|Withdrawal by Subject|0|||
30960682|NCT01529645|59026290|FG003|Overall Study|Withdrawal by Subject|1|||
30960683|NCT01529645|59026291|FG004|Overall Study|Withdrawal by Subject|1|||
30960684|NCT01529645|59026292|FG005|Overall Study|Withdrawal by Subject|1|||
30960685|NCT01529645|59026293|FG006|Overall Study|Withdrawal by Subject|0|||
30960686|NCT01529645|59026294|FG007|Overall Study|Withdrawal by Subject|0|||
30960687|NCT01529645|59026295|FG008|Overall Study|Withdrawal by Subject|0|||
30960688|NCT01529645|59026296|FG009|Overall Study|Withdrawal by Subject|0|||
30960689|NCT01528787|59026330|FG000|Overall Study|Withdrawal by Subject|0|||
30960690|NCT01528787|59026331|FG001|Overall Study|Withdrawal by Subject|0|||
30960691|NCT01528787|59026332|FG002|Overall Study|Withdrawal by Subject|0|||
30960692|NCT01528787|59026333|FG003|Overall Study|Withdrawal by Subject|1|||
30960693|NCT01528787|59026330|FG000|Overall Study|Family Emergency|0|||
30960694|NCT01528787|59026331|FG001|Overall Study|Family Emergency|0|||
30960695|NCT01528787|59026332|FG002|Overall Study|Family Emergency|1|||
30960696|NCT01528787|59026333|FG003|Overall Study|Family Emergency|0|||
30960697|NCT01528709|59026345|FG000|Overall Study|Death|2|||
30960698|NCT01528709|59026346|FG001|Overall Study|Death|0|||
30960699|NCT01528709|59026345|FG000|Overall Study|Withdrawal by Subject|10|||
30960700|NCT01528709|59026346|FG001|Overall Study|Withdrawal by Subject|15|||
30960701|NCT01528709|59026345|FG000|Overall Study|allergy|1|||
30960702|NCT01528709|59026346|FG001|Overall Study|allergy|0|||
30960703|NCT01527383|59026354|FG000|Overall Study|Adverse Event|5|||
30960704|NCT01527383|59026355|FG001|Overall Study|Adverse Event|0|||
30960705|NCT01527383|59026354|FG000|Overall Study|Lost to Follow-up|3|||
30960706|NCT01527383|59026355|FG001|Overall Study|Lost to Follow-up|0|||
30960707|NCT01527383|59026354|FG000|Overall Study|Physician Decision|2|||
30960708|NCT01527383|59026355|FG001|Overall Study|Physician Decision|0|||
30960709|NCT01527383|59026354|FG000|Overall Study|Pregnancy|1|||
30960710|NCT01527383|59026355|FG001|Overall Study|Pregnancy|0|||
30960711|NCT01527383|59026354|FG000|Overall Study|Protocol Violation|1|||
30600544|NCT01090024|58612107|FG005|Period 1|Withdrawal by Subject|0|||
30600545|NCT01090024|58612108|FG006|Period 1|Withdrawal by Subject|0|||
30600546|NCT01090024|58612109|FG007|Period 1|Withdrawal by Subject|0|||
30600547|NCT01090024|58612110|FG008|Period 1|Withdrawal by Subject|0|||
30600548|NCT01090024|58612111|FG009|Period 1|Withdrawal by Subject|0|||
30600549|NCT01090024|58612112|FG010|Period 1|Withdrawal by Subject|0|||
30600550|NCT01090024|58612113|FG011|Period 1|Withdrawal by Subject|0|||
30600551|NCT01090024|58612114|FG012|Period 1|Withdrawal by Subject|0|||
30600552|NCT01090024|58612115|FG013|Period 1|Withdrawal by Subject|0|||
30600553|NCT01090024|58612116|FG014|Period 1|Withdrawal by Subject|0|||
30600554|NCT01090024|58612117|FG015|Period 1|Withdrawal by Subject|0|||
30600555|NCT01090024|58612118|FG016|Period 1|Withdrawal by Subject|0|||
30600556|NCT01090024|58612119|FG017|Period 1|Withdrawal by Subject|0|||
30600557|NCT01090024|58612102|FG000|Period 1|Lost to Follow-up|0|||
30600558|NCT01090024|58612103|FG001|Period 1|Lost to Follow-up|1|||
30600559|NCT01090024|58612104|FG002|Period 1|Lost to Follow-up|0|||
30600560|NCT01090024|58612105|FG003|Period 1|Lost to Follow-up|0|||
30600561|NCT01090024|58612106|FG004|Period 1|Lost to Follow-up|0|||
30600562|NCT01090024|58612107|FG005|Period 1|Lost to Follow-up|0|||
30600563|NCT01090024|58612108|FG006|Period 1|Lost to Follow-up|0|||
30600564|NCT01090024|58612109|FG007|Period 1|Lost to Follow-up|0|||
30600565|NCT01090024|58612110|FG008|Period 1|Lost to Follow-up|0|||
30600566|NCT01090024|58612111|FG009|Period 1|Lost to Follow-up|0|||
30600567|NCT01090024|58612112|FG010|Period 1|Lost to Follow-up|0|||
30600568|NCT01090024|58612113|FG011|Period 1|Lost to Follow-up|0|||
30600569|NCT01090024|58612114|FG012|Period 1|Lost to Follow-up|0|||
30600570|NCT01090024|58612115|FG013|Period 1|Lost to Follow-up|0|||
30960712|NCT01527383|59026355|FG001|Overall Study|Protocol Violation|0|||
30960713|NCT01527383|59026354|FG000|Overall Study|Screen failure|1|||
30960714|NCT01527383|59026355|FG001|Overall Study|Screen failure|0|||
30960715|NCT01527383|59026354|FG000|Overall Study|Participant moved|0|||
30600571|NCT01090024|58612116|FG014|Period 1|Lost to Follow-up|0|||
30600572|NCT01090024|58612117|FG015|Period 1|Lost to Follow-up|0|||
30600573|NCT01090024|58612118|FG016|Period 1|Lost to Follow-up|0|||
30600574|NCT01090024|58612119|FG017|Period 1|Lost to Follow-up|0|||
30600575|NCT01090024|58612102|FG000|Period 2|Lost to Follow-up|0|||
30600576|NCT01090024|58612103|FG001|Period 2|Lost to Follow-up|0|||
30600577|NCT01090024|58612104|FG002|Period 2|Lost to Follow-up|0|||
30600578|NCT01090024|58612105|FG003|Period 2|Lost to Follow-up|1|||
30600579|NCT01090024|58612106|FG004|Period 2|Lost to Follow-up|0|||
30600580|NCT01090024|58612107|FG005|Period 2|Lost to Follow-up|0|||
30960716|NCT01527383|59026355|FG001|Overall Study|Participant moved|1|||
30960717|NCT01527383|59026354|FG000|Overall Study|Withdrawal by Subject|2|||
30960718|NCT01527383|59026355|FG001|Overall Study|Withdrawal by Subject|3|||
30960719|NCT01526057|59026364|FG000|Overall Study|Withdrawal by Subject|3|||
30960720|NCT01526057|59026365|FG001|Overall Study|Withdrawal by Subject|2|||
30960721|NCT01526057|59026366|FG002|Overall Study|Withdrawal by Subject|2|||
30960722|NCT01526057|59026364|FG000|Overall Study|Adverse Event|3|||
30600581|NCT01090024|58612108|FG006|Period 2|Lost to Follow-up|0|||
30600582|NCT01090024|58612109|FG007|Period 2|Lost to Follow-up|0|||
30600583|NCT01090024|58612110|FG008|Period 2|Lost to Follow-up|0|||
30600584|NCT01090024|58612111|FG009|Period 2|Lost to Follow-up|0|||
30600585|NCT01090024|58612112|FG010|Period 2|Lost to Follow-up|0|||
30600586|NCT01090024|58612113|FG011|Period 2|Lost to Follow-up|0|||
30600587|NCT01090024|58612114|FG012|Period 2|Lost to Follow-up|0|||
30600588|NCT01090024|58612115|FG013|Period 2|Lost to Follow-up|0|||
30600589|NCT01090024|58612116|FG014|Period 2|Lost to Follow-up|0|||
30600590|NCT01090024|58612117|FG015|Period 2|Lost to Follow-up|0|||
30600591|NCT01090024|58612118|FG016|Period 2|Lost to Follow-up|0|||
30600592|NCT01090024|58612119|FG017|Period 2|Lost to Follow-up|0|||
30600593|NCT01090024|58612102|FG000|Period 2|Adverse Event|1|||
30600594|NCT01090024|58612103|FG001|Period 2|Adverse Event|0|||
30600595|NCT01090024|58612104|FG002|Period 2|Adverse Event|0|||
30600596|NCT01090024|58612105|FG003|Period 2|Adverse Event|0|||
30600597|NCT01090024|58612106|FG004|Period 2|Adverse Event|0|||
30600598|NCT01090024|58612107|FG005|Period 2|Adverse Event|0|||
30600599|NCT01090024|58612108|FG006|Period 2|Adverse Event|0|||
30600600|NCT01090024|58612109|FG007|Period 2|Adverse Event|0|||
30600601|NCT01090024|58612110|FG008|Period 2|Adverse Event|0|||
30600602|NCT01090024|58612111|FG009|Period 2|Adverse Event|0|||
30600603|NCT01090024|58612112|FG010|Period 2|Adverse Event|0|||
30600604|NCT01090024|58612113|FG011|Period 2|Adverse Event|0|||
30600605|NCT01090024|58612114|FG012|Period 2|Adverse Event|0|||
30600606|NCT01090024|58612115|FG013|Period 2|Adverse Event|0|||
30600607|NCT01090024|58612116|FG014|Period 2|Adverse Event|0|||
30600608|NCT01090024|58612117|FG015|Period 2|Adverse Event|0|||
30600609|NCT01090024|58612118|FG016|Period 2|Adverse Event|0|||
30600610|NCT01090024|58612119|FG017|Period 2|Adverse Event|0|||
30600611|NCT01090024|58612102|FG000|Period 3|Withdrawal by Subject|0|||
30600612|NCT01090024|58612103|FG001|Period 3|Withdrawal by Subject|0|||
30600613|NCT01090024|58612104|FG002|Period 3|Withdrawal by Subject|0|||
30600614|NCT01090024|58612105|FG003|Period 3|Withdrawal by Subject|0|||
30600615|NCT01090024|58612106|FG004|Period 3|Withdrawal by Subject|0|||
30600616|NCT01090024|58612107|FG005|Period 3|Withdrawal by Subject|0|||
30600617|NCT01090024|58612108|FG006|Period 3|Withdrawal by Subject|0|||
30600618|NCT01090024|58612109|FG007|Period 3|Withdrawal by Subject|0|||
30600619|NCT01090024|58612110|FG008|Period 3|Withdrawal by Subject|0|||
30600620|NCT01090024|58612111|FG009|Period 3|Withdrawal by Subject|0|||
30600621|NCT01090024|58612112|FG010|Period 3|Withdrawal by Subject|0|||
30600622|NCT01090024|58612113|FG011|Period 3|Withdrawal by Subject|0|||
30600623|NCT01090024|58612114|FG012|Period 3|Withdrawal by Subject|0|||
30600624|NCT01090024|58612115|FG013|Period 3|Withdrawal by Subject|0|||
30600625|NCT01090024|58612116|FG014|Period 3|Withdrawal by Subject|0|||
30600626|NCT01090024|58612117|FG015|Period 3|Withdrawal by Subject|1|||
30600627|NCT01090024|58612118|FG016|Period 3|Withdrawal by Subject|0|||
30600628|NCT01090024|58612119|FG017|Period 3|Withdrawal by Subject|0|||
30600629|NCT01090024|58612102|FG000|Period 3|Protocol Violation|0|||
30600630|NCT01090024|58612103|FG001|Period 3|Protocol Violation|0|||
30600631|NCT01090024|58612104|FG002|Period 3|Protocol Violation|0|||
30600632|NCT01090024|58612105|FG003|Period 3|Protocol Violation|0|||
30600633|NCT01090024|58612106|FG004|Period 3|Protocol Violation|0|||
30600634|NCT01090024|58612107|FG005|Period 3|Protocol Violation|0|||
30600635|NCT01090024|58612108|FG006|Period 3|Protocol Violation|0|||
30600636|NCT01090024|58612109|FG007|Period 3|Protocol Violation|0|||
30600637|NCT01090024|58612110|FG008|Period 3|Protocol Violation|1|||
30600638|NCT01090024|58612111|FG009|Period 3|Protocol Violation|0|||
30600639|NCT01090024|58612112|FG010|Period 3|Protocol Violation|0|||
30600640|NCT01090024|58612113|FG011|Period 3|Protocol Violation|0|||
30600641|NCT01090024|58612114|FG012|Period 3|Protocol Violation|0|||
30600642|NCT01090024|58612115|FG013|Period 3|Protocol Violation|0|||
30600643|NCT01090024|58612116|FG014|Period 3|Protocol Violation|0|||
30600644|NCT01090024|58612117|FG015|Period 3|Protocol Violation|0|||
30600645|NCT01090024|58612118|FG016|Period 3|Protocol Violation|0|||
30600646|NCT01090024|58612119|FG017|Period 3|Protocol Violation|0|||
30600647|NCT01090024|58612102|FG000|Period 3|Adverse Event|0|||
30600648|NCT01090024|58612103|FG001|Period 3|Adverse Event|0|||
30863868|NCT02217982|58893916|FG000|Overall Study|Adverse Event|0|||
30600649|NCT01090024|58612104|FG002|Period 3|Adverse Event|0|||
30600650|NCT01090024|58612105|FG003|Period 3|Adverse Event|0|||
30600651|NCT01090024|58612106|FG004|Period 3|Adverse Event|0|||
30600652|NCT01090024|58612107|FG005|Period 3|Adverse Event|1|||
30600653|NCT01090024|58612108|FG006|Period 3|Adverse Event|0|||
30600654|NCT01090024|58612109|FG007|Period 3|Adverse Event|0|||
30600655|NCT01090024|58612110|FG008|Period 3|Adverse Event|0|||
30600656|NCT01090024|58612111|FG009|Period 3|Adverse Event|0|||
30600657|NCT01090024|58612112|FG010|Period 3|Adverse Event|0|||
30600658|NCT01090024|58612113|FG011|Period 3|Adverse Event|0|||
30600659|NCT01090024|58612114|FG012|Period 3|Adverse Event|0|||
30600660|NCT01090024|58612115|FG013|Period 3|Adverse Event|0|||
30600661|NCT01090024|58612116|FG014|Period 3|Adverse Event|0|||
30600662|NCT01090024|58612117|FG015|Period 3|Adverse Event|0|||
30600663|NCT01090024|58612118|FG016|Period 3|Adverse Event|0|||
30600664|NCT01090024|58612119|FG017|Period 3|Adverse Event|0|||
30600665|NCT04868890|58612131|FG000|Overall Study|Death|2|||
30600666|NCT04868890|58612132|FG001|Overall Study|Death|1|||
30863869|NCT02217982|58893917|FG001|Overall Study|Adverse Event|1|||
30863870|NCT02254408|58893925|FG000|Overall Study|Randomized But Not Treated|1|||
30863871|NCT02254408|58893926|FG001|Overall Study|Randomized But Not Treated|3|||
30863872|NCT02254408|58893925|FG000|Overall Study|Adverse Event|1|||
30863873|NCT02254408|58893926|FG001|Overall Study|Adverse Event|0|||
30863874|NCT02254408|58893925|FG000|Overall Study|Death|2|||
30863875|NCT02254408|58893926|FG001|Overall Study|Death|3|||
30863876|NCT02254408|58893925|FG000|Overall Study|Investigator's Discretion|0|||
30863877|NCT02254408|58893926|FG001|Overall Study|Investigator's Discretion|1|||
30863878|NCT02254408|58893925|FG000|Overall Study|Withdrawal by Subject|3|||
30863879|NCT02254408|58893926|FG001|Overall Study|Withdrawal by Subject|3|||
30863880|NCT02254408|58893925|FG000|Overall Study|Lost to Follow-up|1|||
30863881|NCT02254408|58893926|FG001|Overall Study|Lost to Follow-up|0|||
30863882|NCT02207608|58893934|FG000|Overall Study|Adverse Event|1|||
30863883|NCT02207608|58893935|FG001|Overall Study|Adverse Event|0|||
30863884|NCT03530995|58893943|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
30863885|NCT03530995|58893944|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
30863886|NCT03530995|58893943|FG000|Part 1 Period 3|Protocol Violation|1|||
30863887|NCT03530995|58893944|FG001|Part 1 Period 3|Protocol Violation|0|||
30863888|NCT03530995|58893943|FG000|Part 1 Period 4|Physician Decision|1|||
30863889|NCT03530995|58893944|FG001|Part 1 Period 4|Physician Decision|0|||
30863890|NCT03530995|58893943|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
30863891|NCT03530995|58893944|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
30863892|NCT02217436|58893968|FG000|Overall Study|Protocol Violation|1|||
30863893|NCT02217436|58893969|FG001|Overall Study|Protocol Violation|1|||
30863894|NCT02217436|58893968|FG000|Overall Study|Incomplete data|0|||
30863895|NCT02217436|58893969|FG001|Overall Study|Incomplete data|1|||
30863896|NCT02207530|58893975|FG000|Overall Study|Worsening condition under investigation|78|||
30863897|NCT02207530|58893975|FG000|Overall Study|Patient decision to stop study treatment|5|||
30863898|NCT02207530|58893975|FG000|Overall Study|Adverse Event|8|||
30863899|NCT02207374|58893982|FG000|Overall Study|Withdrawal by Subject|5|||
30863900|NCT02207374|58893983|FG001|Overall Study|Withdrawal by Subject|9|||
30863901|NCT02207374|58893984|FG002|Overall Study|Withdrawal by Subject|4|||
30863902|NCT02207374|58893982|FG000|Overall Study|Death|1|||
30863903|NCT02207374|58893983|FG001|Overall Study|Death|0|||
30863904|NCT02207374|58893984|FG002|Overall Study|Death|1|||
30863905|NCT02207374|58893982|FG000|Overall Study|Missing follow-up information|0|||
30863906|NCT02207374|58893983|FG001|Overall Study|Missing follow-up information|1|||
30863907|NCT02207374|58893984|FG002|Overall Study|Missing follow-up information|1|||
30863908|NCT02217280|58893992|FG000|Overall Study|Withdrawal by Subject|2|||
30863909|NCT02217280|58893992|FG000|Overall Study|Post-consent sceen fail|2|||
30863910|NCT02786537|58894003|FG000|As Randomized|Adverse Event|0|||
30863911|NCT02786537|58894004|FG001|As Randomized|Adverse Event|11|||
30863912|NCT02786537|58894005|FG002|As Randomized|Adverse Event|0|||
30863913|NCT02786537|58894006|FG003|As Randomized|Adverse Event|4|||
30863914|NCT02786537|58894007|FG004|As Randomized|Adverse Event|6|||
30863915|NCT02786537|58894008|FG005|As Randomized|Adverse Event|2|||
30863916|NCT02786537|58894003|FG000|As Randomized|Lack of Efficacy|0|||
30863917|NCT02786537|58894004|FG001|As Randomized|Lack of Efficacy|0|||
30863918|NCT02786537|58894005|FG002|As Randomized|Lack of Efficacy|0|||
30863919|NCT02786537|58894006|FG003|As Randomized|Lack of Efficacy|1|||
30863920|NCT02786537|58894007|FG004|As Randomized|Lack of Efficacy|0|||
30863921|NCT02786537|58894008|FG005|As Randomized|Lack of Efficacy|0|||
30863922|NCT02786537|58894003|FG000|As Randomized|Withdrawal by Subject|1|||
30863923|NCT02786537|58894004|FG001|As Randomized|Withdrawal by Subject|2|||
30863924|NCT02786537|58894005|FG002|As Randomized|Withdrawal by Subject|0|||
30863925|NCT02786537|58894006|FG003|As Randomized|Withdrawal by Subject|1|||
30863926|NCT02786537|58894007|FG004|As Randomized|Withdrawal by Subject|1|||
30863927|NCT02786537|58894008|FG005|As Randomized|Withdrawal by Subject|0|||
30863928|NCT02786537|58894003|FG000|As Randomized|Death|0|||
30863929|NCT02786537|58894004|FG001|As Randomized|Death|2|||
30863930|NCT02786537|58894005|FG002|As Randomized|Death|0|||
30863931|NCT02786537|58894006|FG003|As Randomized|Death|3|||
30863932|NCT02786537|58894007|FG004|As Randomized|Death|1|||
30600667|NCT04868890|58612131|FG000|Overall Study|Withdrawal by Subject|1|||
30600668|NCT04868890|58612132|FG001|Overall Study|Withdrawal by Subject|5|||
30863933|NCT02786537|58894008|FG005|As Randomized|Death|0|||
30863934|NCT02786537|58894003|FG000|As Randomized|Non-compliance with study drug|1|||
30863935|NCT02786537|58894004|FG001|As Randomized|Non-compliance with study drug|11|||
30863936|NCT02786537|58894005|FG002|As Randomized|Non-compliance with study drug|0|||
30863937|NCT02786537|58894006|FG003|As Randomized|Non-compliance with study drug|1|||
30863938|NCT02786537|58894007|FG004|As Randomized|Non-compliance with study drug|0|||
30863939|NCT02786537|58894008|FG005|As Randomized|Non-compliance with study drug|1|||
30863940|NCT02786537|58894003|FG000|As Randomized|Lost to treatment follow-up|4|||
30863941|NCT02786537|58894004|FG001|As Randomized|Lost to treatment follow-up|32|||
30600669|NCT01281189|58612140|FG000|Overall Study|Adverse Event|7|||
30600670|NCT01281189|58612141|FG001|Overall Study|Adverse Event|9|||
30600671|NCT01281189|58612140|FG000|Overall Study|Lost to Follow-up|6|||
30600672|NCT01281189|58612141|FG001|Overall Study|Lost to Follow-up|4|||
30600673|NCT01281189|58612140|FG000|Overall Study|Withdrawal by Subject|21|||
30600674|NCT01281189|58612141|FG001|Overall Study|Withdrawal by Subject|24|||
30600675|NCT01281189|58612140|FG000|Overall Study|Physician Decision|2|||
30600676|NCT01281189|58612141|FG001|Overall Study|Physician Decision|3|||
30600677|NCT01281189|58612140|FG000|Overall Study|Death|103|||
30600678|NCT01281189|58612141|FG001|Overall Study|Death|91|||
30600679|NCT01281189|58612140|FG000|Overall Study|Other|8|||
30600680|NCT01281189|58612141|FG001|Overall Study|Other|12|||
30600681|NCT01280955|58612147|FG000|Overall Study|Death|2|||
30600682|NCT01280955|58612147|FG000|Overall Study|Withdrawal by Subject|1|||
30600683|NCT01280721|58612153|FG000|Overall Study|Adverse Event|4|||
30600684|NCT01280721|58612153|FG000|Overall Study|Physician Decision|3|||
30600685|NCT01280721|58612153|FG000|Overall Study|Withdrawal by Subject|6|||
30600686|NCT01280721|58612153|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
30600687|NCT01280721|58612153|FG000|Overall Study|No tolerability for the lowest dose|2|||
30600688|NCT01087762|58612171|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
30600689|NCT01087762|58612172|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
30600690|NCT01087762|58612173|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
30600691|NCT01087762|58612174|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
30600692|NCT01087762|58612175|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
30600693|NCT01087762|58612171|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
30600694|NCT01087762|58612172|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
30600695|NCT01087762|58612173|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
30600696|NCT01087762|58612174|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
30600697|NCT01087762|58612175|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
30600698|NCT01087762|58612171|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
30600699|NCT01087762|58612172|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
30600700|NCT01087762|58612173|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
30600701|NCT01087762|58612174|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
30600702|NCT01087762|58612175|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
30600703|NCT01087762|58612171|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
30689979|NCT00710034|58704058|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
30689980|NCT00710034|58704057|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
30689981|NCT00710034|58704058|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
30689982|NCT00710034|58704057|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
30689983|NCT00710034|58704058|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
30689984|NCT00710034|58704057|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
30689985|NCT00710034|58704058|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
30689986|NCT00710034|58704057|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
30689987|NCT00710034|58704058|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
30689988|NCT00710034|58704057|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
30689989|NCT00710034|58704058|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
30689990|NCT00710034|58704057|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
30689991|NCT00710034|58704058|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
30689992|NCT00710034|58704057|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
30689993|NCT00710034|58704058|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
30689994|NCT00414973|58704068|FG000|Overall Study|Withdrawal by Subject|14|||
30689995|NCT00414973|58704069|FG001|Overall Study|Withdrawal by Subject|4|||
30689996|NCT00414973|58704070|FG002|Overall Study|Withdrawal by Subject|1|||
30689997|NCT00414973|58704071|FG003|Overall Study|Withdrawal by Subject|0|||
30689998|NCT00414973|58704068|FG000|Overall Study|Adverse Event|10|||
30689999|NCT00414973|58704069|FG001|Overall Study|Adverse Event|0|||
30690000|NCT00414973|58704070|FG002|Overall Study|Adverse Event|1|||
30690001|NCT00414973|58704071|FG003|Overall Study|Adverse Event|0|||
30690002|NCT00414973|58704068|FG000|Overall Study|Protocol Violation|3|||
30690003|NCT00414973|58704069|FG001|Overall Study|Protocol Violation|4|||
30690004|NCT00414973|58704070|FG002|Overall Study|Protocol Violation|0|||
30690005|NCT00414973|58704071|FG003|Overall Study|Protocol Violation|0|||
30690006|NCT00414973|58704068|FG000|Overall Study|Lost to Follow-up|0|||
30690007|NCT00414973|58704069|FG001|Overall Study|Lost to Follow-up|2|||
30690008|NCT00414973|58704070|FG002|Overall Study|Lost to Follow-up|0|||
30690009|NCT00414973|58704071|FG003|Overall Study|Lost to Follow-up|0|||
30690010|NCT00414973|58704068|FG000|Overall Study|Sponsor Decision|1|||
30690011|NCT00414973|58704069|FG001|Overall Study|Sponsor Decision|0|||
30600704|NCT01087762|58612172|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
30600705|NCT01087762|58612173|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
30600706|NCT01087762|58612174|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
30600707|NCT01087762|58612175|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
30600708|NCT01087762|58612171|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
30600709|NCT01087762|58612172|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
30600710|NCT01087762|58612173|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
30600711|NCT01087762|58612174|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
30600712|NCT01087762|58612175|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
30600713|NCT01087762|58612171|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
30600714|NCT01087762|58612172|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
30600715|NCT01087762|58612173|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
30600716|NCT01087762|58612174|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
30600717|NCT01087762|58612175|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
30600718|NCT01087762|58612171|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
30600719|NCT01087762|58612172|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
30600720|NCT01087762|58612173|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
30600721|NCT01087762|58612174|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
30600722|NCT01087762|58612175|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
30600723|NCT01087762|58612171|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
30600724|NCT01087762|58612172|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
30600725|NCT01087762|58612173|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
30600726|NCT01087762|58612174|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
30600727|NCT01087762|58612175|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
30600728|NCT01087762|58612171|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
30600729|NCT01087762|58612172|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
30600730|NCT01087762|58612173|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
30600731|NCT01087762|58612174|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
30600732|NCT01087762|58612175|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
30600733|NCT01087762|58612171|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
30600734|NCT01087762|58612172|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
30600735|NCT01087762|58612173|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
30600736|NCT01087762|58612174|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
30600737|NCT01087762|58612175|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
30600738|NCT01087762|58612171|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
30600739|NCT01087762|58612172|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
30600740|NCT01087762|58612173|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
30600741|NCT01087762|58612174|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
30600742|NCT01087762|58612175|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
30600743|NCT01087762|58612171|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
30600744|NCT01087762|58612172|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
30600745|NCT01087762|58612173|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
30600746|NCT01087762|58612174|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
30600747|NCT01087762|58612175|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
30600748|NCT01087762|58612171|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
30600749|NCT01087762|58612172|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
30600750|NCT01087762|58612173|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
30600751|NCT01087762|58612174|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
30600752|NCT01087762|58612175|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
30600753|NCT01078168|58612187|FG000|Overall Study|Physician Decision|0|||
30600754|NCT01078168|58612188|FG001|Overall Study|Physician Decision|1|||
30600755|NCT01086358|58612194|FG000|First Intervention|Lost to Follow-up|9|||
30600756|NCT01086358|58612195|FG001|First Intervention|Lost to Follow-up|4|||
30600757|NCT01086358|58612194|FG000|First Intervention|Withdrawal by Subject|0|||
30600758|NCT01086358|58612195|FG001|First Intervention|Withdrawal by Subject|1|||
30600759|NCT01086358|58612194|FG000|Second Intervention|Lost to Follow-up|4|||
30600760|NCT01086358|58612195|FG001|Second Intervention|Lost to Follow-up|4|||
30600761|NCT01277601|58612205|FG000|Overall Study|Adverse Event|5|||
30600762|NCT01277601|58612206|FG001|Overall Study|Adverse Event|3|||
30600763|NCT01277601|58612207|FG002|Overall Study|Adverse Event|0|||
30600764|NCT01277601|58612208|FG003|Overall Study|Adverse Event|7|||
30600765|NCT01277601|58612205|FG000|Overall Study|Withdrawal by Subject|18|||
30600766|NCT01277601|58612206|FG001|Overall Study|Withdrawal by Subject|21|||
30600767|NCT01277601|58612207|FG002|Overall Study|Withdrawal by Subject|8|||
30600768|NCT01277601|58612208|FG003|Overall Study|Withdrawal by Subject|17|||
30600769|NCT01277601|58612205|FG000|Overall Study|Lost to Follow-up|7|||
30600770|NCT01277601|58612206|FG001|Overall Study|Lost to Follow-up|9|||
30600771|NCT01277601|58612207|FG002|Overall Study|Lost to Follow-up|4|||
30600772|NCT01277601|58612208|FG003|Overall Study|Lost to Follow-up|2|||
30600773|NCT01277601|58612205|FG000|Overall Study|Physician Decision|3|||
30600774|NCT01277601|58612206|FG001|Overall Study|Physician Decision|5|||
30600775|NCT01277601|58612207|FG002|Overall Study|Physician Decision|1|||
30600776|NCT01277601|58612208|FG003|Overall Study|Physician Decision|6|||
30600777|NCT01277601|58612205|FG000|Overall Study|Pregnancy|2|||
30600778|NCT01277601|58612206|FG001|Overall Study|Pregnancy|2|||
30600779|NCT01277601|58612207|FG002|Overall Study|Pregnancy|4|||
30600780|NCT01277601|58612208|FG003|Overall Study|Pregnancy|1|||
30600781|NCT01277601|58612205|FG000|Overall Study|Noncompliance with Study Drug|1|||
30600782|NCT01277601|58612206|FG001|Overall Study|Noncompliance with Study Drug|3|||
30600783|NCT01277601|58612207|FG002|Overall Study|Noncompliance with Study Drug|2|||
30600784|NCT01277601|58612208|FG003|Overall Study|Noncompliance with Study Drug|0|||
30600785|NCT01277601|58612205|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
30600786|NCT01277601|58612206|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
30600787|NCT01277601|58612207|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
30600788|NCT01277601|58612208|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
30600789|NCT01277601|58612205|FG000|Overall Study|Protocol Violation|0|||
30600790|NCT01277601|58612206|FG001|Overall Study|Protocol Violation|2|||
30600791|NCT01277601|58612207|FG002|Overall Study|Protocol Violation|5|||
30600792|NCT01277601|58612208|FG003|Overall Study|Protocol Violation|0|||
30600793|NCT01277601|58612205|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
30600794|NCT01277601|58612206|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
30600795|NCT01277601|58612207|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
30600796|NCT01277601|58612208|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
30600797|NCT01277523|58612238|FG000|Overall Study|Adverse Event|1|||
30600798|NCT01277523|58612239|FG001|Overall Study|Adverse Event|0|||
30600799|NCT01277523|58612240|FG002|Overall Study|Adverse Event|0|||
30600800|NCT01277523|58612238|FG000|Overall Study|Protocol Violation|2|||
30600801|NCT01277523|58612239|FG001|Overall Study|Protocol Violation|0|||
30600802|NCT01277523|58612240|FG002|Overall Study|Protocol Violation|0|||
30600803|NCT01277523|58612238|FG000|Overall Study|Other Reason not Defined|0|||
30600804|NCT01277523|58612239|FG001|Overall Study|Other Reason not Defined|1|||
30600805|NCT01277523|58612240|FG002|Overall Study|Other Reason not Defined|0|||
30600806|NCT01081834|58612253|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
30600807|NCT01081834|58612254|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
30600808|NCT01081834|58612255|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
30600809|NCT01081834|58612256|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
30600810|NCT01081834|58612257|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
30600811|NCT01081834|58612253|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
30600812|NCT01081834|58612254|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
30600813|NCT01081834|58612255|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
30600814|NCT01081834|58612256|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
30600815|NCT01081834|58612257|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
30600816|NCT01081834|58612253|FG000|Core Period: Baseline to Week 26|Death|1|||
30600817|NCT01081834|58612254|FG001|Core Period: Baseline to Week 26|Death|0|||
30600818|NCT01081834|58612255|FG002|Core Period: Baseline to Week 26|Death|0|||
30600819|NCT01081834|58612256|FG003|Core Period: Baseline to Week 26|Death|0|||
30600820|NCT01081834|58612257|FG004|Core Period: Baseline to Week 26|Death|0|||
30600821|NCT01081834|58612253|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
30600822|NCT01081834|58612254|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
30600823|NCT01081834|58612255|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
30600824|NCT01081834|58612256|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
30600825|NCT01081834|58612257|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
30600826|NCT01081834|58612253|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
30600827|NCT01081834|58612254|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
30600828|NCT01081834|58612255|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
30600829|NCT01081834|58612256|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
30600830|NCT01081834|58612257|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
30600831|NCT01081834|58612253|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
30600832|NCT01081834|58612254|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
30600833|NCT01081834|58612255|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
30600834|NCT01081834|58612256|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
30600835|NCT01081834|58612257|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
30690012|NCT00414973|58704070|FG002|Overall Study|Sponsor Decision|0|||
30690013|NCT00414973|58704071|FG003|Overall Study|Sponsor Decision|0|||
30690014|NCT00414973|58704068|FG000|Overall Study|Death|0|||
30690015|NCT00414973|58704069|FG001|Overall Study|Death|0|||
30690016|NCT00414973|58704070|FG002|Overall Study|Death|1|||
30690017|NCT00414973|58704071|FG003|Overall Study|Death|0|||
30690018|NCT00423085|58704084|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
30690019|NCT00423085|58704085|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
30690020|NCT00423085|58704086|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
30863942|NCT02786537|58894005|FG002|As Randomized|Lost to treatment follow-up|0|||
30690021|NCT00423085|58704087|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
30690022|NCT00423085|58704084|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
30690023|NCT00423085|58704085|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
30690024|NCT00423085|58704086|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
30863943|NCT02786537|58894006|FG003|As Randomized|Lost to treatment follow-up|24|||
30600836|NCT01081834|58612253|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
30600837|NCT01081834|58612254|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
30600838|NCT01081834|58612255|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
30600839|NCT01081834|58612256|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
30600840|NCT01081834|58612257|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
30600841|NCT01081834|58612253|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
30600842|NCT01081834|58612254|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
30600843|NCT01081834|58612255|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
30600844|NCT01081834|58612256|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
30600845|NCT01081834|58612257|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
30600846|NCT01081834|58612253|FG000|Core Period: Baseline to Week 26|Other|4|||
30600847|NCT01081834|58612254|FG001|Core Period: Baseline to Week 26|Other|4|||
30600848|NCT01081834|58612255|FG002|Core Period: Baseline to Week 26|Other|3|||
30600849|NCT01081834|58612256|FG003|Core Period: Baseline to Week 26|Other|1|||
30600850|NCT01081834|58612257|FG004|Core Period: Baseline to Week 26|Other|0|||
30863944|NCT02786537|58894007|FG004|As Randomized|Lost to treatment follow-up|4|||
30863945|NCT02786537|58894008|FG005|As Randomized|Lost to treatment follow-up|4|||
30863946|NCT02786537|58894003|FG000|As Randomized|Incarceration|0|||
30863947|NCT02786537|58894004|FG001|As Randomized|Incarceration|1|||
30863948|NCT02786537|58894005|FG002|As Randomized|Incarceration|0|||
30863949|NCT02786537|58894006|FG003|As Randomized|Incarceration|0|||
30863950|NCT02786537|58894007|FG004|As Randomized|Incarceration|0|||
30863951|NCT02786537|58894008|FG005|As Randomized|Incarceration|0|||
30863952|NCT02786537|58894003|FG000|As Randomized|Opiate Dependency Relapse|0|||
30863953|NCT02786537|58894004|FG001|As Randomized|Opiate Dependency Relapse|1|||
30863954|NCT02786537|58894005|FG002|As Randomized|Opiate Dependency Relapse|0|||
30863955|NCT02786537|58894006|FG003|As Randomized|Opiate Dependency Relapse|0|||
30863956|NCT02786537|58894007|FG004|As Randomized|Opiate Dependency Relapse|0|||
30863957|NCT02786537|58894008|FG005|As Randomized|Opiate Dependency Relapse|0|||
30863958|NCT02786537|58894003|FG000|As Randomized|HCV drugs stolen from pt|0|||
30863959|NCT02786537|58894004|FG001|As Randomized|HCV drugs stolen from pt|1|||
30863960|NCT02786537|58894005|FG002|As Randomized|HCV drugs stolen from pt|0|||
30863961|NCT02786537|58894006|FG003|As Randomized|HCV drugs stolen from pt|0|||
30863962|NCT02786537|58894007|FG004|As Randomized|HCV drugs stolen from pt|0|||
30863963|NCT02786537|58894008|FG005|As Randomized|HCV drugs stolen from pt|0|||
30863964|NCT02786537|58894003|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
30863965|NCT02786537|58894004|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
30863966|NCT02786537|58894005|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
30863967|NCT02786537|58894006|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
30863968|NCT02786537|58894007|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
30863969|NCT02786537|58894008|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
30863970|NCT02786537|58894003|FG000|As Randomized|Subject lost insurance|0|||
30863971|NCT02786537|58894004|FG001|As Randomized|Subject lost insurance|0|||
30863972|NCT02786537|58894005|FG002|As Randomized|Subject lost insurance|0|||
30863973|NCT02786537|58894006|FG003|As Randomized|Subject lost insurance|1|||
30863974|NCT02786537|58894007|FG004|As Randomized|Subject lost insurance|0|||
30863975|NCT02786537|58894008|FG005|As Randomized|Subject lost insurance|0|||
30863976|NCT02786537|58894003|FG000|As Treated|Adverse Event|0|||
30863977|NCT02786537|58894004|FG001|As Treated|Adverse Event|11|||
30863978|NCT02786537|58894005|FG002|As Treated|Adverse Event|0|||
30600851|NCT01081834|58612253|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
30600852|NCT01081834|58612254|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
30600853|NCT01081834|58612255|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
30600854|NCT01081834|58612256|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
30600855|NCT01081834|58612257|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
30600856|NCT01081834|58612253|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
30600857|NCT01081834|58612254|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
30600858|NCT01081834|58612255|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
30863979|NCT02786537|58894006|FG003|As Treated|Adverse Event|4|||
30863980|NCT02786537|58894007|FG004|As Treated|Adverse Event|6|||
30863981|NCT02786537|58894008|FG005|As Treated|Adverse Event|2|||
30863982|NCT02786537|58894003|FG000|As Treated|Death|0|||
30863983|NCT02786537|58894004|FG001|As Treated|Death|2|||
30600859|NCT01081834|58612256|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
30600860|NCT01081834|58612257|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
30690025|NCT00423085|58704087|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
30863984|NCT02786537|58894005|FG002|As Treated|Death|0|||
30863985|NCT02786537|58894006|FG003|As Treated|Death|3|||
30863986|NCT02786537|58894007|FG004|As Treated|Death|1|||
30863987|NCT02786537|58894008|FG005|As Treated|Death|0|||
30863988|NCT02786537|58894003|FG000|As Treated|Lack of Efficacy|0|||
30863989|NCT02786537|58894004|FG001|As Treated|Lack of Efficacy|0|||
30600861|NCT01081834|58612253|FG000|Extension Period: Week 26 to Week 52|Death|1|||
30600862|NCT01081834|58612254|FG001|Extension Period: Week 26 to Week 52|Death|0|||
30600863|NCT01081834|58612255|FG002|Extension Period: Week 26 to Week 52|Death|0|||
30600864|NCT01081834|58612256|FG003|Extension Period: Week 26 to Week 52|Death|0|||
30600865|NCT01081834|58612257|FG004|Extension Period: Week 26 to Week 52|Death|0|||
30600866|NCT01081834|58612253|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
30600867|NCT01081834|58612254|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
30600868|NCT01081834|58612255|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
30600869|NCT01081834|58612256|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
30600870|NCT01081834|58612257|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
30600871|NCT01081834|58612253|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
30600872|NCT01081834|58612254|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
30600873|NCT01081834|58612255|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
30600874|NCT01081834|58612256|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
30600875|NCT01081834|58612257|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
30600876|NCT01081834|58612253|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
30600877|NCT01081834|58612254|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
30600878|NCT01081834|58612255|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
30600879|NCT01081834|58612256|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
30600880|NCT01081834|58612257|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
30600881|NCT01081834|58612253|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
30600882|NCT01081834|58612254|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
30600883|NCT01081834|58612255|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
30600884|NCT01081834|58612256|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
30600885|NCT01081834|58612257|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
30600886|NCT01081834|58612253|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
30600887|NCT01081834|58612254|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
30600888|NCT01081834|58612255|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
30600889|NCT01081834|58612256|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
30600890|NCT01081834|58612257|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
30600891|NCT01081834|58612253|FG000|Extension Period: Week 26 to Week 52|Other|4|||
30600892|NCT01081834|58612254|FG001|Extension Period: Week 26 to Week 52|Other|5|||
30600893|NCT01081834|58612255|FG002|Extension Period: Week 26 to Week 52|Other|4|||
30600894|NCT01081834|58612256|FG003|Extension Period: Week 26 to Week 52|Other|0|||
30600895|NCT01081834|58612257|FG004|Extension Period: Week 26 to Week 52|Other|0|||
30600896|NCT01081834|58612253|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
30600897|NCT01081834|58612254|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
30600898|NCT01081834|58612255|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
30600899|NCT01081834|58612256|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
30600900|NCT01081834|58612257|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
30600901|NCT01081834|58612253|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
30600902|NCT01081834|58612254|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
30600903|NCT01081834|58612255|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
30600904|NCT01081834|58612256|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
30600905|NCT01081834|58612257|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
30600906|NCT01276509|58612280|FG000|Overall Study|Adverse Event|9|||
30600907|NCT01276509|58612281|FG001|Overall Study|Adverse Event|8|||
30600908|NCT01276509|58612282|FG002|Overall Study|Adverse Event|4|||
30600909|NCT01276509|58612283|FG003|Overall Study|Adverse Event|3|||
30600910|NCT01276509|58612280|FG000|Overall Study|Lack of Efficacy|2|||
30600911|NCT01276509|58612281|FG001|Overall Study|Lack of Efficacy|1|||
30600912|NCT01276509|58612282|FG002|Overall Study|Lack of Efficacy|1|||
30600913|NCT01276509|58612283|FG003|Overall Study|Lack of Efficacy|2|||
30600914|NCT01276509|58612280|FG000|Overall Study|Pregnancy|1|||
30600915|NCT01276509|58612281|FG001|Overall Study|Pregnancy|0|||
30600916|NCT01276509|58612282|FG002|Overall Study|Pregnancy|0|||
30600917|NCT01276509|58612283|FG003|Overall Study|Pregnancy|0|||
30600918|NCT01276509|58612280|FG000|Overall Study|Withdrawal by Subject|1|||
30600919|NCT01276509|58612281|FG001|Overall Study|Withdrawal by Subject|2|||
30600920|NCT01276509|58612282|FG002|Overall Study|Withdrawal by Subject|0|||
30600921|NCT01276509|58612283|FG003|Overall Study|Withdrawal by Subject|0|||
30600922|NCT01276509|58612280|FG000|Overall Study|Other|0|||
30600923|NCT01276509|58612281|FG001|Overall Study|Other|1|||
30600924|NCT01276509|58612282|FG002|Overall Study|Other|0|||
30600925|NCT01276509|58612283|FG003|Overall Study|Other|0|||
30600926|NCT01079962|58612295|FG000|Overall Study|Adverse Event|2|||
30600927|NCT01079962|58612296|FG001|Overall Study|Adverse Event|2|||
30600928|NCT01079962|58612295|FG000|Overall Study|Withdrawal by Subject|5|||
30600929|NCT01079962|58612296|FG001|Overall Study|Withdrawal by Subject|7|||
30600930|NCT01079962|58612295|FG000|Overall Study|Protocol Violation|2|||
30600931|NCT01079962|58612296|FG001|Overall Study|Protocol Violation|2|||
30600932|NCT01079962|58612295|FG000|Overall Study|No blood pressure (BP) control|3|||
30600933|NCT01079962|58612296|FG001|Overall Study|No blood pressure (BP) control|0|||
30600934|NCT01079962|58612295|FG000|Overall Study|Inclusion/exclusion criteria|1|||
30600935|NCT01079962|58612296|FG001|Overall Study|Inclusion/exclusion criteria|3|||
30600936|NCT01079962|58612295|FG000|Overall Study|Participant not returning for next visit|1|||
30600937|NCT01079962|58612296|FG001|Overall Study|Participant not returning for next visit|0|||
30600938|NCT01079962|58612295|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
30600939|NCT01079962|58612296|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
30600940|NCT01274637|58612304|FG000|Overall Study|Withdrawal by Subject|0|||
30600941|NCT01274637|58612305|FG001|Overall Study|Withdrawal by Subject|1|||
30600942|NCT01274637|58612304|FG000|Overall Study|Lost to Follow-up|0|||
30600943|NCT01274637|58612305|FG001|Overall Study|Lost to Follow-up|1|||
30600944|NCT01079806|58612313|FG000|Day 1 to Week 96|Adverse Event|0|||
30600945|NCT01079806|58612314|FG001|Day 1 to Week 96|Adverse Event|3|||
30600946|NCT01079806|58612313|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
30600947|NCT01079806|58612314|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
30600948|NCT01079806|58612313|FG000|Day 1 to Week 96|Pregnancy|0|||
30600949|NCT01079806|58612314|FG001|Day 1 to Week 96|Pregnancy|1|||
30600950|NCT01079806|58612313|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
30600951|NCT01079806|58612314|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
30600952|NCT01079806|58612313|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
30600953|NCT01079806|58612314|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
30600954|NCT01079806|58612313|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
30600955|NCT01079806|58612314|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
30600956|NCT01079806|58612313|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
30600957|NCT01079806|58612314|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
30600958|NCT01079806|58612313|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
30600959|NCT01079806|58612314|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
30600960|NCT01079806|58612313|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
30600961|NCT01079806|58612314|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
30600962|NCT01079806|58612313|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
30600963|NCT01079806|58612314|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
30600964|NCT01078090|58612322|FG000|Overall Study|Lost to Follow-up|2363|||
30600965|NCT01078090|58612322|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
30600966|NCT01078090|58612322|FG000|Overall Study|Lack of Efficacy|1193|||
30600967|NCT01078090|58612322|FG000|Overall Study|ADR and lack of efficacy|61|||
30600968|NCT01078090|58612322|FG000|Overall Study|Other|523|||
30600969|NCT01077622|58612340|FG000|Overall Study|Physician Decision|2|||
30600970|NCT01077622|58612340|FG000|Overall Study|Withdrawal by Subject|1|||
30600971|NCT01313676|58612348|FG000|Overall Study|Adverse Event|395|||
30600972|NCT01313676|58612349|FG001|Overall Study|Adverse Event|365|||
30600973|NCT01313676|58612350|FG002|Overall Study|Adverse Event|372|||
30600974|NCT01313676|58612351|FG003|Overall Study|Adverse Event|333|||
30600975|NCT01313676|58612348|FG000|Overall Study|Lack of Efficacy|98|||
30600976|NCT01313676|58612349|FG001|Overall Study|Lack of Efficacy|90|||
30600977|NCT01313676|58612350|FG002|Overall Study|Lack of Efficacy|65|||
30600978|NCT01313676|58612351|FG003|Overall Study|Lack of Efficacy|46|||
30600979|NCT01313676|58612348|FG000|Overall Study|Protocol Violation|37|||
30690026|NCT00423085|58704084|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
30690027|NCT00423085|58704085|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
30690028|NCT00423085|58704086|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
30690029|NCT00423085|58704087|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
30690030|NCT00423085|58704084|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
30690031|NCT00423085|58704085|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
30690032|NCT00423085|58704086|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
30690033|NCT00423085|58704087|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
30690034|NCT00423085|58704084|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
30690035|NCT00423085|58704085|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
30690036|NCT00423085|58704086|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
30690037|NCT00423085|58704087|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
30690038|NCT00423085|58704084|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
30690039|NCT00423085|58704085|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
30600980|NCT01313676|58612349|FG001|Overall Study|Protocol Violation|44|||
30600981|NCT01313676|58612350|FG002|Overall Study|Protocol Violation|46|||
30600982|NCT01313676|58612351|FG003|Overall Study|Protocol Violation|44|||
30600983|NCT01313676|58612348|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
30600984|NCT01313676|58612349|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
30600985|NCT01313676|58612350|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
30600986|NCT01313676|58612351|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
30600987|NCT01313676|58612348|FG000|Overall Study|Study Closed/terminated|7|||
30600988|NCT01313676|58612349|FG001|Overall Study|Study Closed/terminated|6|||
30600989|NCT01313676|58612350|FG002|Overall Study|Study Closed/terminated|9|||
30600990|NCT01313676|58612351|FG003|Overall Study|Study Closed/terminated|9|||
30600991|NCT01313676|58612348|FG000|Overall Study|Lost to Follow-up|0|||
30600992|NCT01313676|58612349|FG001|Overall Study|Lost to Follow-up|0|||
30600993|NCT01313676|58612350|FG002|Overall Study|Lost to Follow-up|1|||
30600994|NCT01313676|58612351|FG003|Overall Study|Lost to Follow-up|0|||
30600995|NCT01313676|58612348|FG000|Overall Study|Physician Decision|53|||
30600996|NCT01313676|58612349|FG001|Overall Study|Physician Decision|64|||
30863990|NCT02786537|58894005|FG002|As Treated|Lack of Efficacy|0|||
30863991|NCT02786537|58894006|FG003|As Treated|Lack of Efficacy|1|||
30863992|NCT02786537|58894007|FG004|As Treated|Lack of Efficacy|0|||
30600997|NCT01313676|58612350|FG002|Overall Study|Physician Decision|62|||
30600998|NCT01313676|58612351|FG003|Overall Study|Physician Decision|48|||
30600999|NCT01313676|58612348|FG000|Overall Study|Decision by Participant or Proxy|643|||
30601000|NCT01313676|58612349|FG001|Overall Study|Decision by Participant or Proxy|527|||
30601001|NCT01313676|58612350|FG002|Overall Study|Decision by Participant or Proxy|515|||
30601002|NCT01313676|58612351|FG003|Overall Study|Decision by Participant or Proxy|492|||
30601003|NCT01313676|58612348|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
30601004|NCT01313676|58612349|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
30601005|NCT01313676|58612350|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
30601006|NCT01313676|58612351|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
30601007|NCT01313676|58612348|FG000|Overall Study|Investigator Site Closed|12|||
30601008|NCT01313676|58612349|FG001|Overall Study|Investigator Site Closed|11|||
30601009|NCT01313676|58612350|FG002|Overall Study|Investigator Site Closed|15|||
30601010|NCT01313676|58612351|FG003|Overall Study|Investigator Site Closed|10|||
30601011|NCT01313676|58612348|FG000|Overall Study|Missing|1|||
30601012|NCT01313676|58612349|FG001|Overall Study|Missing|1|||
30601013|NCT01313676|58612350|FG002|Overall Study|Missing|1|||
30601014|NCT01313676|58612351|FG003|Overall Study|Missing|0|||
30601015|NCT01313286|58612362|FG000|Period 1|Withdrawal by Subject|2|||
30601016|NCT01313286|58612363|FG001|Period 1|Withdrawal by Subject|0|||
30601017|NCT01313208|58612371|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
30601018|NCT01313208|58612372|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
30601019|NCT01313208|58612371|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
30601020|NCT01313208|58612372|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
30601021|NCT01313208|58612371|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
30601022|NCT01313208|58612372|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
30601023|NCT01313208|58612371|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
30601024|NCT01313208|58612372|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
30601025|NCT01313208|58612371|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
30601026|NCT01313208|58612372|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
30601027|NCT01313208|58612371|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
30601028|NCT01313208|58612372|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
30601029|NCT01313208|58612371|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
30601030|NCT01313208|58612372|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
30601031|NCT01313208|58612371|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
30601032|NCT01313208|58612372|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
30601033|NCT01313208|58612371|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
30601034|NCT01313208|58612372|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
30601035|NCT01312428|58612382|FG000|Overall Study|Study Termination|3|||
30601036|NCT01312428|58612383|FG001|Overall Study|Study Termination|4|||
30601037|NCT01075984|58612396|FG000|Treatment Phase|Adverse Event|0|||
30601038|NCT01075984|58612397|FG001|Treatment Phase|Adverse Event|1|||
30601039|NCT01075984|58612398|FG002|Treatment Phase|Adverse Event|3|||
30601040|NCT01075984|58612399|FG003|Treatment Phase|Adverse Event|7|||
30601041|NCT01075984|58612400|FG004|Treatment Phase|Adverse Event|35|||
30601042|NCT01075984|58612396|FG000|Treatment Phase|Protocol Violation|0|||
30601043|NCT01075984|58612397|FG001|Treatment Phase|Protocol Violation|0|||
30601044|NCT01075984|58612398|FG002|Treatment Phase|Protocol Violation|1|||
30863993|NCT02786537|58894008|FG005|As Treated|Lack of Efficacy|0|||
30863994|NCT02786537|58894003|FG000|As Treated|Lost to Follow-up|4|||
30601045|NCT01075984|58612399|FG003|Treatment Phase|Protocol Violation|0|||
30601046|NCT01075984|58612400|FG004|Treatment Phase|Protocol Violation|3|||
30601047|NCT01075984|58612396|FG000|Treatment Phase|Withdrawal by Subject|0|||
30601048|NCT01075984|58612397|FG001|Treatment Phase|Withdrawal by Subject|0|||
30601049|NCT01075984|58612398|FG002|Treatment Phase|Withdrawal by Subject|2|||
30601050|NCT01075984|58612399|FG003|Treatment Phase|Withdrawal by Subject|0|||
30601051|NCT01075984|58612400|FG004|Treatment Phase|Withdrawal by Subject|15|||
30601052|NCT01075984|58612396|FG000|Treatment Phase|Treatment Failure|0|||
30601053|NCT01075984|58612397|FG001|Treatment Phase|Treatment Failure|0|||
30601054|NCT01075984|58612398|FG002|Treatment Phase|Treatment Failure|1|||
30863995|NCT02786537|58894004|FG001|As Treated|Lost to Follow-up|32|||
30601055|NCT01075984|58612399|FG003|Treatment Phase|Treatment Failure|0|||
30601056|NCT01075984|58612400|FG004|Treatment Phase|Treatment Failure|5|||
30601057|NCT01075984|58612396|FG000|Treatment Phase|Progression of disease|0|||
30601058|NCT01075984|58612397|FG001|Treatment Phase|Progression of disease|0|||
30601059|NCT01075984|58612398|FG002|Treatment Phase|Progression of disease|0|||
30601060|NCT01075984|58612399|FG003|Treatment Phase|Progression of disease|0|||
30601061|NCT01075984|58612400|FG004|Treatment Phase|Progression of disease|2|||
30601062|NCT01075984|58612396|FG000|Follow-up Phase|Protocol Violation|0|||
30601063|NCT01075984|58612397|FG001|Follow-up Phase|Protocol Violation|0|||
30601064|NCT01075984|58612398|FG002|Follow-up Phase|Protocol Violation|1|||
30601065|NCT01075984|58612399|FG003|Follow-up Phase|Protocol Violation|0|||
30601066|NCT01075984|58612400|FG004|Follow-up Phase|Protocol Violation|3|||
30601067|NCT01075984|58612396|FG000|Follow-up Phase|Adverse Event|0|||
30601068|NCT01075984|58612397|FG001|Follow-up Phase|Adverse Event|0|||
30601069|NCT01075984|58612398|FG002|Follow-up Phase|Adverse Event|0|||
30601070|NCT01075984|58612399|FG003|Follow-up Phase|Adverse Event|2|||
30601071|NCT01075984|58612400|FG004|Follow-up Phase|Adverse Event|27|||
30601072|NCT01075984|58612396|FG000|Follow-up Phase|Administrative|0|||
30601073|NCT01075984|58612397|FG001|Follow-up Phase|Administrative|0|||
30601074|NCT01075984|58612398|FG002|Follow-up Phase|Administrative|0|||
30601075|NCT01075984|58612399|FG003|Follow-up Phase|Administrative|0|||
30601076|NCT01075984|58612400|FG004|Follow-up Phase|Administrative|1|||
30601077|NCT01075984|58612396|FG000|Follow-up Phase|Withdrawal by Subject|0|||
30601078|NCT01075984|58612397|FG001|Follow-up Phase|Withdrawal by Subject|0|||
30601079|NCT01075984|58612398|FG002|Follow-up Phase|Withdrawal by Subject|0|||
30601080|NCT01075984|58612399|FG003|Follow-up Phase|Withdrawal by Subject|0|||
30601081|NCT01075984|58612400|FG004|Follow-up Phase|Withdrawal by Subject|10|||
30601082|NCT01075984|58612396|FG000|Follow-up Phase|Progression of disease|0|||
30601083|NCT01075984|58612397|FG001|Follow-up Phase|Progression of disease|0|||
30601084|NCT01075984|58612398|FG002|Follow-up Phase|Progression of disease|0|||
30601085|NCT01075984|58612399|FG003|Follow-up Phase|Progression of disease|0|||
30601086|NCT01075984|58612400|FG004|Follow-up Phase|Progression of disease|2|||
30601087|NCT01075984|58612396|FG000|Follow-up Phase|Treatment failure|0|||
30601088|NCT01075984|58612397|FG001|Follow-up Phase|Treatment failure|0|||
30601089|NCT01075984|58612398|FG002|Follow-up Phase|Treatment failure|0|||
30601090|NCT01075984|58612399|FG003|Follow-up Phase|Treatment failure|0|||
30601091|NCT01075984|58612400|FG004|Follow-up Phase|Treatment failure|4|||
30601092|NCT01024231|58612419|FG000|Overall Study|Other Reasons|1|||
30601093|NCT01024231|58612420|FG001|Overall Study|Other Reasons|2|||
30601094|NCT01024231|58612421|FG002|Overall Study|Other Reasons|0|||
30601095|NCT01024231|58612422|FG003|Overall Study|Other Reasons|0|||
30601096|NCT01024231|58612423|FG004|Overall Study|Other Reasons|2|||
30601097|NCT01024231|58612424|FG005|Overall Study|Other Reasons|0|||
30601098|NCT01024231|58612425|FG006|Overall Study|Other Reasons|1|||
30601099|NCT01024231|58612419|FG000|Overall Study|Maximum Clinical Benefit|1|||
30601100|NCT01024231|58612420|FG001|Overall Study|Maximum Clinical Benefit|2|||
30601101|NCT01024231|58612421|FG002|Overall Study|Maximum Clinical Benefit|0|||
30601102|NCT01024231|58612422|FG003|Overall Study|Maximum Clinical Benefit|1|||
30601103|NCT01024231|58612423|FG004|Overall Study|Maximum Clinical Benefit|1|||
30601104|NCT01024231|58612424|FG005|Overall Study|Maximum Clinical Benefit|0|||
30601105|NCT01024231|58612425|FG006|Overall Study|Maximum Clinical Benefit|0|||
30601106|NCT01024231|58612419|FG000|Overall Study|Disease Progression|3|||
30601107|NCT01024231|58612420|FG001|Overall Study|Disease Progression|1|||
30601108|NCT01024231|58612421|FG002|Overall Study|Disease Progression|3|||
30601109|NCT01024231|58612422|FG003|Overall Study|Disease Progression|0|||
30601110|NCT01024231|58612423|FG004|Overall Study|Disease Progression|4|||
30601111|NCT01024231|58612424|FG005|Overall Study|Disease Progression|11|||
30601112|NCT01024231|58612425|FG006|Overall Study|Disease Progression|6|||
30601113|NCT01024231|58612419|FG000|Overall Study|AE unrelated to Study Drug|0|||
30601114|NCT01024231|58612420|FG001|Overall Study|AE unrelated to Study Drug|1|||
30601115|NCT01024231|58612421|FG002|Overall Study|AE unrelated to Study Drug|0|||
30601116|NCT01024231|58612422|FG003|Overall Study|AE unrelated to Study Drug|0|||
30601117|NCT01024231|58612423|FG004|Overall Study|AE unrelated to Study Drug|0|||
30690040|NCT00423085|58704086|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
30786563|NCT01367158|58799757|FG002|Overall Study|Protocol Violation|0|||
30601118|NCT01024231|58612424|FG005|Overall Study|AE unrelated to Study Drug|0|||
30601119|NCT01024231|58612425|FG006|Overall Study|AE unrelated to Study Drug|0|||
30601120|NCT01024231|58612419|FG000|Overall Study|No longer meets criteria|0|||
30601121|NCT01024231|58612420|FG001|Overall Study|No longer meets criteria|0|||
30601122|NCT01024231|58612421|FG002|Overall Study|No longer meets criteria|0|||
30601123|NCT01024231|58612422|FG003|Overall Study|No longer meets criteria|0|||
30601124|NCT01024231|58612423|FG004|Overall Study|No longer meets criteria|1|||
30601125|NCT01024231|58612424|FG005|Overall Study|No longer meets criteria|0|||
30601126|NCT01024231|58612425|FG006|Overall Study|No longer meets criteria|1|||
30601127|NCT01024231|58612419|FG000|Overall Study|Study Drug Toxicity|1|||
30601128|NCT01024231|58612420|FG001|Overall Study|Study Drug Toxicity|6|||
30601129|NCT01024231|58612421|FG002|Overall Study|Study Drug Toxicity|6|||
30601130|NCT01024231|58612422|FG003|Overall Study|Study Drug Toxicity|4|||
30601131|NCT01024231|58612423|FG004|Overall Study|Study Drug Toxicity|2|||
30601132|NCT01024231|58612424|FG005|Overall Study|Study Drug Toxicity|0|||
30601133|NCT01024231|58612425|FG006|Overall Study|Study Drug Toxicity|7|||
30601134|NCT01024231|58612419|FG000|Overall Study|Death|6|||
30601135|NCT01024231|58612420|FG001|Overall Study|Death|2|||
30601136|NCT01024231|58612421|FG002|Overall Study|Death|1|||
30601137|NCT01024231|58612422|FG003|Overall Study|Death|0|||
30601138|NCT01024231|58612423|FG004|Overall Study|Death|4|||
30601139|NCT01024231|58612424|FG005|Overall Study|Death|3|||
30601140|NCT01024231|58612425|FG006|Overall Study|Death|5|||
30601141|NCT01024231|58612419|FG000|Overall Study|Lost to Follow-up|0|||
30601142|NCT01024231|58612420|FG001|Overall Study|Lost to Follow-up|0|||
30601143|NCT01024231|58612421|FG002|Overall Study|Lost to Follow-up|0|||
30601144|NCT01024231|58612422|FG003|Overall Study|Lost to Follow-up|0|||
30601145|NCT01024231|58612423|FG004|Overall Study|Lost to Follow-up|0|||
30601146|NCT01024231|58612424|FG005|Overall Study|Lost to Follow-up|0|||
30601147|NCT01024231|58612425|FG006|Overall Study|Lost to Follow-up|1|||
30601148|NCT01024231|58612419|FG000|Overall Study|Withdrew Consent|0|||
30601149|NCT01024231|58612420|FG001|Overall Study|Withdrew Consent|1|||
30601150|NCT01024231|58612421|FG002|Overall Study|Withdrew Consent|0|||
30601151|NCT01024231|58612422|FG003|Overall Study|Withdrew Consent|0|||
30601152|NCT01024231|58612423|FG004|Overall Study|Withdrew Consent|0|||
30601153|NCT01024231|58612424|FG005|Overall Study|Withdrew Consent|0|||
30601154|NCT01024231|58612425|FG006|Overall Study|Withdrew Consent|0|||
30601155|NCT01024231|58612419|FG000|Overall Study|Continuing on Treatment|0|||
30601156|NCT01024231|58612420|FG001|Overall Study|Continuing on Treatment|0|||
30601157|NCT01024231|58612421|FG002|Overall Study|Continuing on Treatment|0|||
30601158|NCT01024231|58612422|FG003|Overall Study|Continuing on Treatment|0|||
30601159|NCT01024231|58612423|FG004|Overall Study|Continuing on Treatment|3|||
30601160|NCT01024231|58612424|FG005|Overall Study|Continuing on Treatment|2|||
30601161|NCT01024231|58612425|FG006|Overall Study|Continuing on Treatment|0|||
30601162|NCT01077544|58612448|FG000|Overall Study|New Cancer Therapy|3|||
30601163|NCT01077544|58612449|FG001|Overall Study|New Cancer Therapy|3|||
30601164|NCT01077544|58612448|FG000|Overall Study|Adverse Event|0|||
30601165|NCT01077544|58612449|FG001|Overall Study|Adverse Event|1|||
30601166|NCT01077544|58612448|FG000|Overall Study|Disease Progression|0|||
30601167|NCT01077544|58612449|FG001|Overall Study|Disease Progression|1|||
30601168|NCT01075516|58612457|FG000|Overall Study|Death|5|||
30601169|NCT01075516|58612458|FG001|Overall Study|Death|9|||
30601170|NCT01075516|58612457|FG000|Overall Study|Lost to Follow-up|10|||
30601171|NCT01075516|58612458|FG001|Overall Study|Lost to Follow-up|2|||
30601172|NCT01075516|58612457|FG000|Overall Study|Withdrawal by Subject|3|||
30601173|NCT01075516|58612458|FG001|Overall Study|Withdrawal by Subject|5|||
30601174|NCT01012999|58612464|FG000|Overall Study|Protocol Violation|1|||
30601175|NCT01017601|58612470|FG000|Overall Study|Disease Progression|12|||
30601176|NCT01017601|58612471|FG001|Overall Study|Disease Progression|12|||
30601177|NCT01017601|58612470|FG000|Overall Study|Withdrawal by Subject|0|||
30601178|NCT01017601|58612471|FG001|Overall Study|Withdrawal by Subject|1|||
30601179|NCT01016977|58612479|FG000|Overall Study|Lost to Follow-up|1|||
30601180|NCT01016977|58612480|FG001|Overall Study|Lost to Follow-up|0|||
30601181|NCT01016977|58612479|FG000|Overall Study|Withdrawal by Subject|2|||
30601182|NCT01016977|58612480|FG001|Overall Study|Withdrawal by Subject|2|||
30601183|NCT01012765|58612489|FG000|Treatment Period 1|Adverse Event|1|||
30601184|NCT01012765|58612490|FG001|Treatment Period 1|Adverse Event|0|||
30601185|NCT01012765|58612491|FG002|Treatment Period 1|Adverse Event|1|||
30601186|NCT01012765|58612492|FG003|Treatment Period 1|Adverse Event|0|||
30960723|NCT01526057|59026365|FG001|Overall Study|Adverse Event|1|||
30601187|NCT01012765|58612493|FG004|Treatment Period 1|Adverse Event|0|||
30601188|NCT01012765|58612494|FG005|Treatment Period 1|Adverse Event|0|||
30601189|NCT01012765|58612489|FG000|Treatment Period 1|Withdrawal by Subject|2|||
30601190|NCT01012765|58612490|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30601191|NCT01012765|58612491|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30601192|NCT01012765|58612492|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30601193|NCT01012765|58612493|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30601194|NCT01012765|58612494|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30601195|NCT01012765|58612489|FG000|Treatment Period 1|Administrative problems|0|||
30690041|NCT00423085|58704087|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
30690042|NCT00423085|58704084|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
30601196|NCT01012765|58612490|FG001|Treatment Period 1|Administrative problems|0|||
30601197|NCT01012765|58612491|FG002|Treatment Period 1|Administrative problems|1|||
30601198|NCT01012765|58612492|FG003|Treatment Period 1|Administrative problems|1|||
30601199|NCT01012765|58612493|FG004|Treatment Period 1|Administrative problems|1|||
30601200|NCT01012765|58612494|FG005|Treatment Period 1|Administrative problems|0|||
30601201|NCT01012765|58612489|FG000|Treatment Period 1|Protocol Violation|0|||
30601202|NCT01012765|58612490|FG001|Treatment Period 1|Protocol Violation|0|||
30601203|NCT01012765|58612491|FG002|Treatment Period 1|Protocol Violation|0|||
30601204|NCT01012765|58612492|FG003|Treatment Period 1|Protocol Violation|2|||
30601205|NCT01012765|58612493|FG004|Treatment Period 1|Protocol Violation|1|||
30601206|NCT01012765|58612494|FG005|Treatment Period 1|Protocol Violation|0|||
30601207|NCT01012765|58612489|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
30601208|NCT01012765|58612490|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
30601209|NCT01012765|58612491|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
30601210|NCT01012765|58612492|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
30601211|NCT01012765|58612493|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
30601212|NCT01012765|58612494|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
30601213|NCT01012765|58612489|FG000|Treatment Period 2|Withdrawal by Subject|1|||
30601214|NCT01012765|58612490|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30601215|NCT01012765|58612491|FG002|Treatment Period 2|Withdrawal by Subject|1|||
30601216|NCT01012765|58612492|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30601217|NCT01012765|58612493|FG004|Treatment Period 2|Withdrawal by Subject|1|||
30601218|NCT01012765|58612494|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30601219|NCT01012765|58612489|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
30601220|NCT01012765|58612490|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
30601221|NCT01012765|58612491|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
30601222|NCT01012765|58612492|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
30601223|NCT01012765|58612493|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
30601224|NCT01012765|58612494|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
30601225|NCT01012765|58612489|FG000|Treatment Period 2|Adverse Event|0|||
30601226|NCT01012765|58612490|FG001|Treatment Period 2|Adverse Event|1|||
30601227|NCT01012765|58612491|FG002|Treatment Period 2|Adverse Event|1|||
30601228|NCT01012765|58612492|FG003|Treatment Period 2|Adverse Event|0|||
30601229|NCT01012765|58612493|FG004|Treatment Period 2|Adverse Event|0|||
30601230|NCT01012765|58612494|FG005|Treatment Period 2|Adverse Event|0|||
30601231|NCT01012765|58612489|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
30601232|NCT01012765|58612490|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
30601233|NCT01012765|58612491|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
30601234|NCT01012765|58612492|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
30601235|NCT01012765|58612493|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
30601236|NCT01012765|58612494|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
30601237|NCT01010503|58612502|FG000|Overall Study|Adverse Event|1|||
30601238|NCT01010503|58612502|FG000|Overall Study|Death|1|||
30601239|NCT01009645|58612510|FG000|Overall Study|Lost to Follow-up|2|||
30601240|NCT01009645|58612511|FG001|Overall Study|Lost to Follow-up|8|||
30601241|NCT01009645|58612512|FG002|Overall Study|Lost to Follow-up|4|||
30601242|NCT01009645|58612513|FG003|Overall Study|Lost to Follow-up|5|||
30601243|NCT01006291|58612526|FG000|Overall Study|Adverse Event|2|||
30601244|NCT01006291|58612527|FG001|Overall Study|Adverse Event|1|||
30601245|NCT01006291|58612528|FG002|Overall Study|Adverse Event|2|||
30601246|NCT01006291|58612526|FG000|Overall Study|Lack of Efficacy|2|||
30601247|NCT01006291|58612527|FG001|Overall Study|Lack of Efficacy|2|||
30601248|NCT01006291|58612528|FG002|Overall Study|Lack of Efficacy|1|||
30601249|NCT01006291|58612526|FG000|Overall Study|Protocol Violation|3|||
30601250|NCT01006291|58612527|FG001|Overall Study|Protocol Violation|3|||
30601251|NCT01006291|58612528|FG002|Overall Study|Protocol Violation|3|||
30601252|NCT01006291|58612526|FG000|Overall Study|Withdrawal criteria|5|||
30601253|NCT01006291|58612527|FG001|Overall Study|Withdrawal criteria|4|||
30601254|NCT01006291|58612528|FG002|Overall Study|Withdrawal criteria|4|||
30601255|NCT01006291|58612526|FG000|Overall Study|Other|14|||
30601256|NCT01006291|58612527|FG001|Overall Study|Other|14|||
30601257|NCT01006291|58612528|FG002|Overall Study|Other|17|||
30601258|NCT01006135|58612536|FG000|Overall Study|Adverse Event|22|||
30601259|NCT01006135|58612536|FG000|Overall Study|Protocol Violation|14|||
30601260|NCT01006135|58612536|FG000|Overall Study|Lost to Follow-up|32|||
30601261|NCT01006135|58612536|FG000|Overall Study|Other|72|||
30601262|NCT01012609|58612542|FG000|Overall Study|Withdrawal by Subject|1|||
30601263|NCT01012609|58612543|FG001|Overall Study|Withdrawal by Subject|1|||
30601264|NCT01012219|58612550|FG000|Period 1|Withdrawal by Subject|1|||
30601265|NCT01012219|58612550|FG000|Period 2|Withdrawal by Subject|1|||
30601266|NCT01011907|58612559|FG000|Overall Study|Withdrawal by Subject|13|||
30601267|NCT01011907|58612560|FG001|Overall Study|Withdrawal by Subject|11|||
30601268|NCT01011907|58612559|FG000|Overall Study|Adverse Event|1|||
30601269|NCT01011907|58612560|FG001|Overall Study|Adverse Event|4|||
30601270|NCT01011673|58612568|FG000|Randomized|Secondary headache|2|||
30601271|NCT01011673|58612569|FG001|Randomized|Secondary headache|1|||
30601272|NCT01011673|58612568|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
30601273|NCT01011673|58612569|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
30690043|NCT00423085|58704085|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
30690044|NCT00423085|58704086|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
30601274|NCT01311648|58612578|FG000|Main Study|Protocol Violation|0|||
30601275|NCT01311648|58612579|FG001|Main Study|Protocol Violation|1|||
30601276|NCT01311648|58612578|FG000|Main Study|Adverse Event|0|||
30601277|NCT01311648|58612579|FG001|Main Study|Adverse Event|1|||
30601278|NCT01311648|58612578|FG000|Main Study|Inhibitor management|0|||
30601279|NCT01311648|58612579|FG001|Main Study|Inhibitor management|17|||
30601280|NCT01311648|58612578|FG000|Main Study|Withdrawal by Subject|0|||
30601281|NCT01311648|58612579|FG001|Main Study|Withdrawal by Subject|2|||
30601282|NCT01311648|58612578|FG000|Extension Study|Physician Decision|0|||
30601283|NCT01311648|58612579|FG001|Extension Study|Physician Decision|1|||
30601284|NCT01311648|58612578|FG000|Extension Study|ITI therapy with marketed product|0|||
30601285|NCT01311648|58612579|FG001|Extension Study|ITI therapy with marketed product|1|||
30601286|NCT01311648|58612578|FG000|Extension Study|Incorrect visit planning|0|||
30601287|NCT01311648|58612579|FG001|Extension Study|Incorrect visit planning|1|||
30601288|NCT01311648|58612578|FG000|Extension Study|Family's decision|0|||
30601289|NCT01311648|58612579|FG001|Extension Study|Family's decision|1|||
30601290|NCT01311648|58612578|FG000|Extension Study|Failure of ITI therapy|0|||
30601291|NCT01311648|58612579|FG001|Extension Study|Failure of ITI therapy|3|||
30601292|NCT01311648|58612578|FG000|Extension Study|Long travel|0|||
30601293|NCT01311648|58612579|FG001|Extension Study|Long travel|1|||
30601294|NCT01311648|58612578|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
30601295|NCT01311648|58612579|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
30601296|NCT01311648|58612578|FG000|Extension Study|Withdrawal by Subject|0|||
30601297|NCT01311648|58612579|FG001|Extension Study|Withdrawal by Subject|1|||
30601298|NCT01311648|58612578|FG000|Extension Study|Inhibitor management|0|||
30601299|NCT01311648|58612579|FG001|Extension Study|Inhibitor management|2|||
30601300|NCT01011439|58612592|FG000|Overall Study|Death|37|||
30601301|NCT01011439|58612592|FG000|Overall Study|Lost to Follow-up|4|||
30601302|NCT01011439|58612592|FG000|Overall Study|Withdrawal by Subject|1|||
30601303|NCT01011439|58612592|FG000|Overall Study|Sponsor's decision|15|||
30601304|NCT01311024|58612599|FG000|Overall Study|Protocol Violation|35|||
30601305|NCT01311024|58612600|FG001|Overall Study|Protocol Violation|22|||
30601306|NCT01310868|58612606|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
30601307|NCT01273155|58612614|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
30601308|NCT01273155|58612615|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
30601309|NCT01273155|58612616|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
30601310|NCT01273155|58612617|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
30601311|NCT01273155|58612618|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
30601312|NCT01273155|58612619|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
30601313|NCT01273155|58612620|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
30601314|NCT01273155|58612614|FG000|Overall Study|Change in liver function/no longer eval.|0|||
30601315|NCT01273155|58612615|FG001|Overall Study|Change in liver function/no longer eval.|1|||
30601316|NCT01273155|58612616|FG002|Overall Study|Change in liver function/no longer eval.|0|||
30601317|NCT01273155|58612617|FG003|Overall Study|Change in liver function/no longer eval.|0|||
30601318|NCT01273155|58612618|FG004|Overall Study|Change in liver function/no longer eval.|1|||
30601319|NCT01273155|58612619|FG005|Overall Study|Change in liver function/no longer eval.|0|||
30601320|NCT01273155|58612620|FG006|Overall Study|Change in liver function/no longer eval.|0|||
30601321|NCT01273155|58612614|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
30601322|NCT01273155|58612615|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
30601323|NCT01273155|58612616|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
30601324|NCT01273155|58612617|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
30601325|NCT01273155|58612618|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
30601326|NCT01273155|58612619|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
30601327|NCT01273155|58612620|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
30601328|NCT01273155|58612614|FG000|Overall Study|Died during Cycle 1|0|||
30601329|NCT01273155|58612615|FG001|Overall Study|Died during Cycle 1|0|||
30601330|NCT01273155|58612616|FG002|Overall Study|Died during Cycle 1|1|||
30601331|NCT01273155|58612617|FG003|Overall Study|Died during Cycle 1|1|||
30601332|NCT01273155|58612618|FG004|Overall Study|Died during Cycle 1|0|||
30601333|NCT01273155|58612619|FG005|Overall Study|Died during Cycle 1|2|||
30601334|NCT01273155|58612620|FG006|Overall Study|Died during Cycle 1|2|||
30601335|NCT01273155|58612614|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
30601336|NCT01273155|58612615|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
30601337|NCT01273155|58612616|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
30601338|NCT01273155|58612617|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
30601339|NCT01273155|58612618|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
30601340|NCT01273155|58612619|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
30601341|NCT01273155|58612620|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
30601342|NCT01005901|58612645|FG000|Overall Study|Withdrawal by Subject|38|||
30601343|NCT01005901|58612646|FG001|Overall Study|Withdrawal by Subject|14|||
30601344|NCT01005901|58612645|FG000|Overall Study|Adverse Event|30|||
30690045|NCT00423085|58704087|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
30786564|NCT01367158|58799758|FG003|Overall Study|Protocol Violation|0|||
30960724|NCT01526057|59026366|FG002|Overall Study|Adverse Event|1|||
30601345|NCT01005901|58612646|FG001|Overall Study|Adverse Event|16|||
30601346|NCT01005901|58612645|FG000|Overall Study|Administrative problems|21|||
30601347|NCT01005901|58612646|FG001|Overall Study|Administrative problems|13|||
30601348|NCT01005901|58612645|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
30601349|NCT01005901|58612646|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
30601350|NCT01005901|58612645|FG000|Overall Study|Protocol Violation|4|||
30601351|NCT01005901|58612646|FG001|Overall Study|Protocol Violation|3|||
30601352|NCT01005901|58612645|FG000|Overall Study|Death|2|||
30601353|NCT01005901|58612646|FG001|Overall Study|Death|3|||
30601354|NCT01005901|58612645|FG000|Overall Study|Lost to Follow-up|1|||
30601355|NCT01005901|58612646|FG001|Overall Study|Lost to Follow-up|2|||
30601356|NCT01005901|58612645|FG000|Overall Study|Patient's inability to use the device|1|||
30601357|NCT01005901|58612646|FG001|Overall Study|Patient's inability to use the device|1|||
30601358|NCT01005901|58612645|FG000|Overall Study|No longer requires study drug|0|||
30601359|NCT01005901|58612646|FG001|Overall Study|No longer requires study drug|1|||
30601360|NCT04968925|58612654|FG000|Phase I- Period 1|COVID-19 related|0|||
30601361|NCT04968925|58612655|FG001|Phase I- Period 1|COVID-19 related|1|||
30601362|NCT04968925|58612656|FG002|Phase I- Period 1|COVID-19 related|0|||
30601363|NCT04968925|58612657|FG003|Phase I- Period 1|COVID-19 related|0|||
30601364|NCT04968925|58612654|FG000|Phase I- Period 1|Subject enrolled in error|1|||
30601365|NCT04968925|58612655|FG001|Phase I- Period 1|Subject enrolled in error|1|||
30601366|NCT04968925|58612656|FG002|Phase I- Period 1|Subject enrolled in error|0|||
30601367|NCT04968925|58612657|FG003|Phase I- Period 1|Subject enrolled in error|0|||
30601368|NCT04968925|58612654|FG000|Phase II- Period 1|COVID-19 Related|0|||
30601369|NCT04968925|58612655|FG001|Phase II- Period 1|COVID-19 Related|0|||
30601370|NCT04968925|58612656|FG002|Phase II- Period 1|COVID-19 Related|6|||
30601371|NCT04968925|58612657|FG003|Phase II- Period 1|COVID-19 Related|6|||
30601372|NCT04968925|58612654|FG000|Phase II- Period 1|Subject enrolled in error|0|||
30601373|NCT04968925|58612655|FG001|Phase II- Period 1|Subject enrolled in error|0|||
30601374|NCT04968925|58612656|FG002|Phase II- Period 1|Subject enrolled in error|1|||
30601375|NCT04968925|58612657|FG003|Phase II- Period 1|Subject enrolled in error|0|||
30601376|NCT04968925|58612654|FG000|Phase II -Period 2|COVID-19 related|0|||
30601377|NCT04968925|58612655|FG001|Phase II -Period 2|COVID-19 related|0|||
30601378|NCT04968925|58612656|FG002|Phase II -Period 2|COVID-19 related|4|||
30601379|NCT04968925|58612657|FG003|Phase II -Period 2|COVID-19 related|3|||
30601380|NCT04968925|58612654|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
30601381|NCT04968925|58612655|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
30863996|NCT02786537|58894005|FG002|As Treated|Lost to Follow-up|0|||
30863997|NCT02786537|58894006|FG003|As Treated|Lost to Follow-up|25|||
30863998|NCT02786537|58894007|FG004|As Treated|Lost to Follow-up|4|||
30863999|NCT02786537|58894008|FG005|As Treated|Lost to Follow-up|4|||
30864000|NCT02786537|58894003|FG000|As Treated|Non-compliance with study drug|1|||
30864001|NCT02786537|58894004|FG001|As Treated|Non-compliance with study drug|11|||
30864002|NCT02786537|58894005|FG002|As Treated|Non-compliance with study drug|0|||
30864003|NCT02786537|58894006|FG003|As Treated|Non-compliance with study drug|1|||
30864004|NCT02786537|58894007|FG004|As Treated|Non-compliance with study drug|0|||
30864005|NCT02786537|58894008|FG005|As Treated|Non-compliance with study drug|1|||
30864006|NCT02786537|58894003|FG000|As Treated|Lost insurance|0|||
30864007|NCT02786537|58894004|FG001|As Treated|Lost insurance|0|||
30864008|NCT02786537|58894005|FG002|As Treated|Lost insurance|0|||
30864009|NCT02786537|58894006|FG003|As Treated|Lost insurance|1|||
30864010|NCT02786537|58894007|FG004|As Treated|Lost insurance|0|||
30864011|NCT02786537|58894008|FG005|As Treated|Lost insurance|0|||
30864012|NCT02786537|58894003|FG000|As Treated|Withdrawal by Subject|1|||
30864013|NCT02786537|58894004|FG001|As Treated|Withdrawal by Subject|2|||
30864014|NCT02786537|58894005|FG002|As Treated|Withdrawal by Subject|0|||
30864015|NCT02786537|58894006|FG003|As Treated|Withdrawal by Subject|0|||
30864016|NCT02786537|58894007|FG004|As Treated|Withdrawal by Subject|1|||
30864017|NCT02786537|58894008|FG005|As Treated|Withdrawal by Subject|0|||
30864018|NCT02786537|58894003|FG000|As Treated|Incarceration|0|||
30864019|NCT02786537|58894004|FG001|As Treated|Incarceration|1|||
30864020|NCT02786537|58894005|FG002|As Treated|Incarceration|0|||
30864021|NCT02786537|58894006|FG003|As Treated|Incarceration|0|||
30864022|NCT02786537|58894007|FG004|As Treated|Incarceration|0|||
30864023|NCT02786537|58894008|FG005|As Treated|Incarceration|0|||
30864024|NCT02786537|58894003|FG000|As Treated|Opiate dependency relapse|0|||
30864025|NCT02786537|58894004|FG001|As Treated|Opiate dependency relapse|1|||
30864026|NCT02786537|58894005|FG002|As Treated|Opiate dependency relapse|0|||
30690046|NCT00423085|58704084|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
30864027|NCT02786537|58894006|FG003|As Treated|Opiate dependency relapse|0|||
30601382|NCT04968925|58612656|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
30601383|NCT04968925|58612657|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
30864028|NCT02786537|58894007|FG004|As Treated|Opiate dependency relapse|0|||
30601384|NCT01266993|58612669|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
30601385|NCT01266993|58612670|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
30601386|NCT01266993|58612669|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
30601387|NCT01266993|58612670|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
30601388|NCT01309386|58612678|FG000|Overall Study|Other|2|||
30601389|NCT01309386|58612679|FG001|Overall Study|Other|0|||
30864029|NCT02786537|58894008|FG005|As Treated|Opiate dependency relapse|0|||
30864030|NCT02786537|58894003|FG000|As Treated|Drugs stolen from patient|0|||
30864031|NCT02786537|58894004|FG001|As Treated|Drugs stolen from patient|1|||
30864032|NCT02786537|58894005|FG002|As Treated|Drugs stolen from patient|0|||
30601390|NCT01309386|58612678|FG000|Overall Study|Withdrawal by Subject|2|||
30601391|NCT01309386|58612679|FG001|Overall Study|Withdrawal by Subject|0|||
30601392|NCT01309386|58612678|FG000|Overall Study|Progressive disease|9|||
30601393|NCT01309386|58612679|FG001|Overall Study|Progressive disease|11|||
30601394|NCT01309386|58612678|FG000|Overall Study|Physician Decision|1|||
30601395|NCT01309386|58612679|FG001|Overall Study|Physician Decision|1|||
30601396|NCT01309386|58612678|FG000|Overall Study|Lack of Efficacy|3|||
30601397|NCT01309386|58612679|FG001|Overall Study|Lack of Efficacy|1|||
30601398|NCT01309386|58612678|FG000|Overall Study|Adverse Event|5|||
30601399|NCT01309386|58612679|FG001|Overall Study|Adverse Event|8|||
30601400|NCT01266603|58612685|FG000|Overall Study|Adverse Event|1|||
30601401|NCT01266603|58612685|FG000|Overall Study|Lack of Efficacy|14|||
30601402|NCT01266603|58612685|FG000|Overall Study|Withdrawal by Subject|1|||
30601403|NCT01266603|58612685|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
30601404|NCT01309308|58612691|FG000|Overall Study|Lost to Follow-up|6|||
30601405|NCT01309308|58612692|FG001|Overall Study|Lost to Follow-up|4|||
30601406|NCT01266291|58612698|FG000|Overall Study|Adverse Event|1|||
30601407|NCT01004263|58612702|FG000|Overall Study|Adverse Event|15|||
30601408|NCT01004263|58612702|FG000|Overall Study|Withdrawal by Subject|58|||
30601409|NCT01004263|58612702|FG000|Overall Study|Protocol Violation|10|||
30601410|NCT01004263|58612702|FG000|Overall Study|Lost to Follow-up|64|||
30601411|NCT01004263|58612702|FG000|Overall Study|Lack of Efficacy|13|||
30601412|NCT01004263|58612702|FG000|Overall Study|Pregnancy|2|||
30601413|NCT01004263|58612702|FG000|Overall Study|Physician Decision|15|||
30601414|NCT01004263|58612702|FG000|Overall Study|Lack of Qualifying Event|2|||
30601415|NCT01308762|58612709|FG000|Overall Study|Protocol Violation|0|||
30601416|NCT01308762|58612710|FG001|Overall Study|Protocol Violation|1|||
30601417|NCT01308762|58612711|FG002|Overall Study|Protocol Violation|0|||
30601418|NCT01265823|58612722|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
30601419|NCT01265823|58612722|FG000|Overall Study|Failure to Return|4|||
30601420|NCT01265823|58612722|FG000|Overall Study|Protocol Violation|1|||
30601421|NCT01265823|58612722|FG000|Overall Study|Participant Request|1|||
30601422|NCT01004185|58612732|FG000|Overall Study|Adverse Event|1|||
30601423|NCT01004185|58612733|FG001|Overall Study|Adverse Event|1|||
30601424|NCT01004185|58612732|FG000|Overall Study|Lost to Follow-up|0|||
30601425|NCT01004185|58612733|FG001|Overall Study|Lost to Follow-up|1|||
30601426|NCT01004185|58612732|FG000|Overall Study|Lack of Efficacy|2|||
30601427|NCT01004185|58612733|FG001|Overall Study|Lack of Efficacy|1|||
30601428|NCT01004185|58612732|FG000|Overall Study|Sponsor Terminated Study|4|||
30601429|NCT01004185|58612733|FG001|Overall Study|Sponsor Terminated Study|5|||
30601430|NCT01004185|58612732|FG000|Overall Study|Withdrawal by Subject|2|||
30601431|NCT01004185|58612733|FG001|Overall Study|Withdrawal by Subject|1|||
30601432|NCT01265511|58612741|FG000|Overall Study|Lack of Efficacy|2|||
30601433|NCT01265511|58612742|FG001|Overall Study|Lack of Efficacy|1|||
30601434|NCT01265511|58612741|FG000|Overall Study|Met stopping rules|0|||
30601435|NCT01265511|58612742|FG001|Overall Study|Met stopping rules|2|||
30601436|NCT01264965|58612748|FG000|Overall Study|Withdrawal by Subject|10|||
30601437|NCT01264887|58612752|FG000|Overall Study|Adverse Event|5|||
30601438|NCT01264887|58612752|FG000|Overall Study|Death|7|||
30601439|NCT01264887|58612752|FG000|Overall Study|Lack of Efficacy|5|||
30601440|NCT01264887|58612752|FG000|Overall Study|Physician Decision|4|||
30601441|NCT01264887|58612752|FG000|Overall Study|Withdrawal by Subject|6|||
30601442|NCT01264887|58612752|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
30601443|NCT01264887|58612752|FG000|Overall Study|Other|2|||
30601444|NCT01306968|58612762|FG000|Overall Study|Lost to Follow-up|1|||
30601445|NCT01306968|58612763|FG001|Overall Study|Lost to Follow-up|1|||
30601446|NCT01306968|58612764|FG002|Overall Study|Lost to Follow-up|0|||
30601447|NCT01306968|58612765|FG003|Overall Study|Lost to Follow-up|0|||
30601448|NCT01306968|58612762|FG000|Overall Study|Physician Decision|0|||
30864033|NCT02786537|58894006|FG003|As Treated|Drugs stolen from patient|0|||
30864034|NCT02786537|58894007|FG004|As Treated|Drugs stolen from patient|0|||
30601449|NCT01306968|58612763|FG001|Overall Study|Physician Decision|1|||
30601450|NCT01306968|58612764|FG002|Overall Study|Physician Decision|0|||
30690047|NCT00423085|58704085|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
30864035|NCT02786537|58894008|FG005|As Treated|Drugs stolen from patient|0|||
30864036|NCT02786537|58894003|FG000|As Treated|Advised to stop tx after loss of meds|0|||
30601451|NCT01306968|58612765|FG003|Overall Study|Physician Decision|0|||
30690048|NCT00423085|58704086|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
30601452|NCT01306968|58612762|FG000|Overall Study|Relocated and left active duty|0|||
30601453|NCT01306968|58612763|FG001|Overall Study|Relocated and left active duty|1|||
30601454|NCT01306968|58612764|FG002|Overall Study|Relocated and left active duty|1|||
30601455|NCT01306968|58612765|FG003|Overall Study|Relocated and left active duty|1|||
30601456|NCT01306968|58612762|FG000|Overall Study|Withdrew - time commitment|0|||
30601457|NCT01306968|58612763|FG001|Overall Study|Withdrew - time commitment|0|||
30601458|NCT01306968|58612764|FG002|Overall Study|Withdrew - time commitment|0|||
30601459|NCT01306968|58612765|FG003|Overall Study|Withdrew - time commitment|2|||
30601460|NCT01306968|58612762|FG000|Overall Study|Withdrew over privacy concerns|0|||
30601461|NCT01306968|58612763|FG001|Overall Study|Withdrew over privacy concerns|0|||
30601462|NCT01306968|58612764|FG002|Overall Study|Withdrew over privacy concerns|0|||
30601463|NCT01306968|58612765|FG003|Overall Study|Withdrew over privacy concerns|1|||
30601464|NCT01264419|58612777|FG000|Overall Study|Lost to Follow-up|3|||
30601465|NCT01263873|58612783|FG000|Overall Study|One provider unable to complete numbers|1|||
30601466|NCT01263873|58612784|FG001|Overall Study|One provider unable to complete numbers|1|||
30601467|NCT01263639|58612792|FG000|Overall Study|Lost to Follow-up|66|||
30601468|NCT01263639|58612793|FG001|Overall Study|Lost to Follow-up|70|||
30601469|NCT01263639|58612792|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
30601470|NCT01263639|58612793|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
30601471|NCT01011283|58612801|FG000|Overall Study|Adverse Event|4|||
30601472|NCT01011283|58612802|FG001|Overall Study|Adverse Event|2|||
30601473|NCT01011283|58612801|FG000|Overall Study|Progressive Disease|0|||
30601474|NCT01011283|58612802|FG001|Overall Study|Progressive Disease|2|||
30601475|NCT01011283|58612801|FG000|Overall Study|Terminated by Sponsor|5|||
30601476|NCT01011283|58612802|FG001|Overall Study|Terminated by Sponsor|5|||
30601477|NCT01011283|58612801|FG000|Overall Study|Other|2|||
30601478|NCT01011283|58612802|FG001|Overall Study|Other|2|||
30690049|NCT00423085|58704087|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
30864037|NCT02786537|58894004|FG001|As Treated|Advised to stop tx after loss of meds|1|||
30864038|NCT02786537|58894005|FG002|As Treated|Advised to stop tx after loss of meds|0|||
30690050|NCT00423085|58704084|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
30690051|NCT00423085|58704085|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
30690052|NCT00423085|58704086|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
30690053|NCT00423085|58704087|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
30690054|NCT00423085|58704084|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
30690055|NCT00423085|58704085|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
30690056|NCT00423085|58704086|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
30690057|NCT00423085|58704087|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
30690058|NCT00423085|58704084|FG000|52-Week Open-Label Extension Phase|Death|0|||
30690059|NCT00423085|58704085|FG001|52-Week Open-Label Extension Phase|Death|0|||
30690060|NCT00423085|58704086|FG002|52-Week Open-Label Extension Phase|Death|0|||
30690061|NCT00423085|58704087|FG003|52-Week Open-Label Extension Phase|Death|2|||
30690062|NCT00414661|58704101|FG000|Overall Study|Death|2|||
30690063|NCT00414661|58704102|FG001|Overall Study|Death|5|||
30690064|NCT00414661|58704103|FG002|Overall Study|Death|0|||
30690065|NCT00414661|58704104|FG003|Overall Study|Death|0|||
30690066|NCT00414661|58704101|FG000|Overall Study|Lost to Follow-up|1|||
30690067|NCT00414661|58704102|FG001|Overall Study|Lost to Follow-up|4|||
30690068|NCT00414661|58704103|FG002|Overall Study|Lost to Follow-up|0|||
30690069|NCT00414661|58704104|FG003|Overall Study|Lost to Follow-up|1|||
30690070|NCT00414661|58704101|FG000|Overall Study|Withdrawal by Subject|5|||
30690071|NCT00414661|58704102|FG001|Overall Study|Withdrawal by Subject|2|||
30690072|NCT00414661|58704103|FG002|Overall Study|Withdrawal by Subject|2|||
30690073|NCT00414661|58704104|FG003|Overall Study|Withdrawal by Subject|2|||
30690074|NCT00414661|58704101|FG000|Overall Study|Other|6|||
30690075|NCT00414661|58704102|FG001|Overall Study|Other|3|||
30690076|NCT00414661|58704103|FG002|Overall Study|Other|0|||
30690077|NCT00414661|58704104|FG003|Overall Study|Other|0|||
30690078|NCT00405067|58704117|FG000|Overall Study|Adverse Event|4|||
30690079|NCT00405067|58704118|FG001|Overall Study|Adverse Event|9|||
30690080|NCT00405067|58704119|FG002|Overall Study|Adverse Event|4|||
30690081|NCT00405067|58704117|FG000|Overall Study|Lost to Follow-up|0|||
30864039|NCT02786537|58894006|FG003|As Treated|Advised to stop tx after loss of meds|0|||
30864040|NCT02786537|58894007|FG004|As Treated|Advised to stop tx after loss of meds|0|||
30864041|NCT02786537|58894008|FG005|As Treated|Advised to stop tx after loss of meds|0|||
30864042|NCT02216812|58894116|FG000|Overall Study|Lost to Follow-up|10|||
30864043|NCT02216812|58894117|FG001|Overall Study|Lost to Follow-up|5|||
30864044|NCT02252536|58894125|FG000|Overall Study|Lost to Follow-up|5|||
30864045|NCT02252536|58894126|FG001|Overall Study|Lost to Follow-up|3|||
30864046|NCT02206828|58894132|FG000|Overall Study|Lost to Follow-up|7|||
30864047|NCT01209767|58894159|FG000|Overall Study|Withdrawal by Subject|1|||
30864048|NCT01209767|58894159|FG000|Overall Study|Lost to Follow-up|3|||
30864049|NCT02252146|58894167|FG000|Overall Study|Lack of Efficacy|4|||
30864050|NCT02252146|58894167|FG000|Overall Study|Entered hospice care|1|||
30864051|NCT02252146|58894167|FG000|Overall Study|Inability to travel to study site|1|||
30960725|NCT01526057|59026364|FG000|Overall Study|Death|1|||
30960726|NCT01526057|59026365|FG001|Overall Study|Death|0|||
30690082|NCT00405067|58704118|FG001|Overall Study|Lost to Follow-up|0|||
30690083|NCT00405067|58704119|FG002|Overall Study|Lost to Follow-up|1|||
30690084|NCT00708708|58704127|FG000|Overall Study|Another therapy instead of Enbrel|141|||
30690085|NCT00708708|58704127|FG000|Overall Study|Lost to Follow-up|52|||
30601479|NCT01263561|58612810|FG000|Overall Study|Death|1|||
30601480|NCT01263561|58612811|FG001|Overall Study|Death|2|||
30601481|NCT01009099|58612819|FG000|Overall Study|Lost to Follow-up|1|||
30601482|NCT01009099|58612820|FG001|Overall Study|Lost to Follow-up|0|||
30864052|NCT02251990|58894173|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
30690086|NCT00708708|58704127|FG000|Overall Study|Withdrawal by Subject|51|||
30690087|NCT00708708|58704127|FG000|Overall Study|Intolerance|42|||
30690088|NCT00708708|58704127|FG000|Overall Study|Another therapy along with Enbrel|15|||
30690089|NCT00708708|58704127|FG000|Overall Study|Other unspecified|11|||
30690090|NCT00708708|58704127|FG000|Overall Study|Good effectiveness|9|||
30690091|NCT00708708|58704127|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
30690092|NCT00708708|58704127|FG000|Overall Study|Administrative reasons|7|||
30690093|NCT00708708|58704127|FG000|Overall Study|Lack of effectiveness|4|||
30690094|NCT00708708|58704127|FG000|Overall Study|Lack of compliance|3|||
30690095|NCT00708708|58704127|FG000|Overall Study|Pregnancy|3|||
30690096|NCT00708708|58704127|FG000|Overall Study|Adverse Event|3|||
30690097|NCT00708708|58704127|FG000|Overall Study|Missing values|392|||
30690098|NCT00404755|58704134|FG000|Phase I (Bupropion)|Adverse Event|3|||
30690099|NCT00404755|58704134|FG000|Phase I (Bupropion)|Other|1|||
30690100|NCT00404755|58704134|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
30690101|NCT00614614|58704144|FG000|Primary Vaccination Phase|Adverse Event|6|||
30690102|NCT00614614|58704145|FG001|Primary Vaccination Phase|Adverse Event|0|||
30690103|NCT00614614|58704146|FG002|Primary Vaccination Phase|Adverse Event|0|||
30690104|NCT00614614|58704147|FG003|Primary Vaccination Phase|Adverse Event|0|||
30690105|NCT00614614|58704148|FG004|Primary Vaccination Phase|Adverse Event|0|||
30690106|NCT00614614|58704144|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
30690107|NCT00614614|58704145|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
30690108|NCT00614614|58704146|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
30690109|NCT00614614|58704147|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
30690110|NCT00614614|58704148|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
30864053|NCT02251990|58894174|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
30864054|NCT02251990|58894173|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
30864055|NCT02251990|58894174|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
30864056|NCT02251990|58894173|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
30864057|NCT02251990|58894174|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
30864058|NCT02251990|58894173|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
30864059|NCT02251990|58894174|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
30864060|NCT02251990|58894173|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
30864061|NCT02251990|58894174|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
30864062|NCT02251990|58894173|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
30864063|NCT02251990|58894174|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
30864064|NCT02251912|58894183|FG000|Overall Study|Withdrawal by Subject|2|||
30864065|NCT02251912|58894184|FG001|Overall Study|Withdrawal by Subject|3|||
30864066|NCT02251912|58894183|FG000|Overall Study|Adverse Event|0|||
30864067|NCT02251912|58894184|FG001|Overall Study|Adverse Event|2|||
30864068|NCT02206048|58894199|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
30864069|NCT02205814|58894211|FG000|Overall Study|Lost to Follow-up|0|||
30690111|NCT00614614|58704144|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
30690112|NCT00614614|58704145|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
30864070|NCT02205814|58894212|FG001|Overall Study|Lost to Follow-up|0|||
30864071|NCT02205814|58894213|FG002|Overall Study|Lost to Follow-up|0|||
30864072|NCT02205814|58894214|FG003|Overall Study|Lost to Follow-up|1|||
30864073|NCT02205814|58894211|FG000|Overall Study|Lack of Efficacy|1|||
30864074|NCT02205814|58894212|FG001|Overall Study|Lack of Efficacy|0|||
30864075|NCT02205814|58894213|FG002|Overall Study|Lack of Efficacy|1|||
30864076|NCT02205814|58894214|FG003|Overall Study|Lack of Efficacy|1|||
30864077|NCT02205814|58894211|FG000|Overall Study|Physician Decision|0|||
30864078|NCT02205814|58894212|FG001|Overall Study|Physician Decision|0|||
30864079|NCT02205814|58894213|FG002|Overall Study|Physician Decision|1|||
30864080|NCT02205814|58894214|FG003|Overall Study|Physician Decision|0|||
30864081|NCT02205814|58894211|FG000|Overall Study|Protocol Violation|1|||
30864082|NCT02205814|58894212|FG001|Overall Study|Protocol Violation|0|||
30864083|NCT02205814|58894213|FG002|Overall Study|Protocol Violation|0|||
30864084|NCT02205814|58894214|FG003|Overall Study|Protocol Violation|1|||
30864085|NCT02205814|58894211|FG000|Overall Study|Withdrawal by Subject|0|||
30864086|NCT02205814|58894212|FG001|Overall Study|Withdrawal by Subject|1|||
30864087|NCT02205814|58894213|FG002|Overall Study|Withdrawal by Subject|2|||
30690113|NCT00614614|58704146|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
30690114|NCT00614614|58704147|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
30690115|NCT00614614|58704148|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
30690116|NCT00614614|58704144|FG000|Primary Vaccination Phase|Protocol Violation|9|||
30786565|NCT01367158|58799759|FG004|Overall Study|Protocol Violation|0|||
30864088|NCT02205814|58894214|FG003|Overall Study|Withdrawal by Subject|1|||
30864089|NCT02205814|58894211|FG000|Overall Study|not compliant with study procedures|0|||
30864090|NCT02205814|58894212|FG001|Overall Study|not compliant with study procedures|0|||
30864091|NCT02205814|58894213|FG002|Overall Study|not compliant with study procedures|1|||
30864092|NCT02205814|58894214|FG003|Overall Study|not compliant with study procedures|0|||
30864093|NCT02662985|58894226|FG000|Treatment Period 1|Adverse Event|0|||
30960727|NCT01526057|59026366|FG002|Overall Study|Death|0|||
30864094|NCT02662985|58894227|FG001|Treatment Period 1|Adverse Event|2|||
30690117|NCT00614614|58704145|FG001|Primary Vaccination Phase|Protocol Violation|3|||
30690118|NCT00614614|58704146|FG002|Primary Vaccination Phase|Protocol Violation|0|||
30690119|NCT00614614|58704147|FG003|Primary Vaccination Phase|Protocol Violation|0|||
30690120|NCT00614614|58704148|FG004|Primary Vaccination Phase|Protocol Violation|0|||
30690121|NCT00614614|58704144|FG000|Primary Vaccination Phase|Other|4|||
30690122|NCT00614614|58704145|FG001|Primary Vaccination Phase|Other|0|||
30690123|NCT00614614|58704146|FG002|Primary Vaccination Phase|Other|0|||
30690124|NCT00614614|58704147|FG003|Primary Vaccination Phase|Other|0|||
30690125|NCT00614614|58704148|FG004|Primary Vaccination Phase|Other|0|||
30690126|NCT00614614|58704144|FG000|Booster Vaccination Phase|Adverse Event|0|||
30690127|NCT00614614|58704145|FG001|Booster Vaccination Phase|Adverse Event|0|||
30690128|NCT00614614|58704146|FG002|Booster Vaccination Phase|Adverse Event|1|||
30690129|NCT00614614|58704147|FG003|Booster Vaccination Phase|Adverse Event|1|||
30690130|NCT00614614|58704148|FG004|Booster Vaccination Phase|Adverse Event|0|||
30690131|NCT00614614|58704144|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
30690132|NCT00614614|58704145|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
30690133|NCT00614614|58704146|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
30690134|NCT00614614|58704147|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
30690135|NCT00614614|58704148|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
30690136|NCT00614614|58704144|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
30690137|NCT00614614|58704145|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
30690138|NCT00614614|58704146|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
30690139|NCT00614614|58704147|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
30690140|NCT00614614|58704148|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
30690141|NCT00614614|58704144|FG000|Booster Vaccination Phase|Protocol Violation|0|||
30690142|NCT00614614|58704145|FG001|Booster Vaccination Phase|Protocol Violation|0|||
30690143|NCT00614614|58704146|FG002|Booster Vaccination Phase|Protocol Violation|2|||
30690144|NCT00614614|58704147|FG003|Booster Vaccination Phase|Protocol Violation|3|||
30690145|NCT00614614|58704148|FG004|Booster Vaccination Phase|Protocol Violation|0|||
30690146|NCT00614614|58704144|FG000|Booster Vaccination Phase|Other|0|||
30690147|NCT00614614|58704145|FG001|Booster Vaccination Phase|Other|1|||
30690148|NCT00614614|58704146|FG002|Booster Vaccination Phase|Other|3|||
30690149|NCT00614614|58704147|FG003|Booster Vaccination Phase|Other|2|||
30690150|NCT00614614|58704148|FG004|Booster Vaccination Phase|Other|1|||
30690151|NCT00713310|58704165|FG000|Overall Study|Adverse Event|5|||
30690152|NCT00713310|58704166|FG001|Overall Study|Adverse Event|2|||
30690153|NCT00713310|58704165|FG000|Overall Study|Lack of Efficacy|0|||
30690154|NCT00713310|58704166|FG001|Overall Study|Lack of Efficacy|2|||
30690155|NCT00713310|58704165|FG000|Overall Study|Withdrawal by Subject|0|||
30690156|NCT00713310|58704166|FG001|Overall Study|Withdrawal by Subject|2|||
30690157|NCT00422461|58704176|FG000|Overall Study|Adverse Event|1|||
30690158|NCT00422461|58704177|FG001|Overall Study|Adverse Event|2|||
30690159|NCT00422461|58704178|FG002|Overall Study|Adverse Event|1|||
30690160|NCT00422461|58704179|FG003|Overall Study|Adverse Event|1|||
30690161|NCT00422461|58704176|FG000|Overall Study|Other|0|||
30690162|NCT00422461|58704177|FG001|Overall Study|Other|0|||
30690163|NCT00422461|58704178|FG002|Overall Study|Other|0|||
30690164|NCT00422461|58704179|FG003|Overall Study|Other|2|||
30690165|NCT00422461|58704176|FG000|Overall Study|Participants no longer willing to participate in study|1|||
30690166|NCT00422461|58704177|FG001|Overall Study|Participants no longer willing to participate in study|0|||
30690167|NCT00422461|58704178|FG002|Overall Study|Participants no longer willing to participate in study|0|||
30690168|NCT00422461|58704179|FG003|Overall Study|Participants no longer willing to participate in study|0|||
30960728|NCT01526057|59026364|FG000|Overall Study|Lost to Follow-up|1|||
30960729|NCT01526057|59026365|FG001|Overall Study|Lost to Follow-up|0|||
30601483|NCT01009099|58612819|FG000|Overall Study|Physician Decision|3|||
30601484|NCT01009099|58612820|FG001|Overall Study|Physician Decision|2|||
30601485|NCT01009099|58612819|FG000|Overall Study|Withdrawal by Subject|1|||
30601486|NCT01009099|58612820|FG001|Overall Study|Withdrawal by Subject|1|||
30601487|NCT01009099|58612819|FG000|Overall Study|Death|0|||
30601488|NCT01009099|58612820|FG001|Overall Study|Death|1|||
30601489|NCT01263483|58612829|FG000|Overall Study|Adverse Event|4|||
30601490|NCT01263483|58612830|FG001|Overall Study|Adverse Event|0|||
30601491|NCT01263483|58612831|FG002|Overall Study|Adverse Event|3|||
30601492|NCT01263483|58612829|FG000|Overall Study|Withdrawal by Subject|1|||
30601493|NCT01263483|58612830|FG001|Overall Study|Withdrawal by Subject|0|||
30690169|NCT00422461|58704176|FG000|Overall Study|Randomized but not treated|1|||
30690170|NCT00422461|58704177|FG001|Overall Study|Randomized but not treated|1|||
30690171|NCT00422461|58704178|FG002|Overall Study|Randomized but not treated|0|||
30690172|NCT00422461|58704179|FG003|Overall Study|Randomized but not treated|0|||
30690173|NCT00712920|58704192|FG000|Overall Study|Adverse Event|3|||
30690174|NCT00712920|58704193|FG001|Overall Study|Adverse Event|4|||
30690175|NCT00712920|58704194|FG002|Overall Study|Adverse Event|7|||
30690176|NCT00712920|58704192|FG000|Overall Study|Withdrawal by Subject|4|||
30601494|NCT01263483|58612831|FG002|Overall Study|Withdrawal by Subject|0|||
30601495|NCT01263483|58612829|FG000|Overall Study|Lack of Efficacy|2|||
30601496|NCT01263483|58612830|FG001|Overall Study|Lack of Efficacy|0|||
30690177|NCT00712920|58704193|FG001|Overall Study|Withdrawal by Subject|2|||
30690178|NCT00712920|58704194|FG002|Overall Study|Withdrawal by Subject|1|||
30690179|NCT00712920|58704192|FG000|Overall Study|Lost to Follow-up|1|||
30690180|NCT00712920|58704193|FG001|Overall Study|Lost to Follow-up|4|||
30690181|NCT00712920|58704194|FG002|Overall Study|Lost to Follow-up|0|||
30690182|NCT00712920|58704192|FG000|Overall Study|Lack of Efficacy|1|||
30690183|NCT00712920|58704193|FG001|Overall Study|Lack of Efficacy|0|||
30690184|NCT00712920|58704194|FG002|Overall Study|Lack of Efficacy|1|||
30690185|NCT00712920|58704192|FG000|Overall Study|Other|5|||
30690186|NCT00712920|58704193|FG001|Overall Study|Other|7|||
30690187|NCT00712920|58704194|FG002|Overall Study|Other|3|||
30690188|NCT00712920|58704192|FG000|Overall Study|Non-compliance|3|||
30690189|NCT00712920|58704193|FG001|Overall Study|Non-compliance|0|||
30690190|NCT00712920|58704194|FG002|Overall Study|Non-compliance|0|||
30690191|NCT00612586|58704213|FG000|Overall Study|Adverse Event|6|||
30690192|NCT00612586|58704214|FG001|Overall Study|Adverse Event|2|||
30690193|NCT00612586|58704213|FG000|Overall Study|Death|1|||
30690194|NCT00612586|58704214|FG001|Overall Study|Death|0|||
30690195|NCT00612586|58704213|FG000|Overall Study|Entry Criteria Not Met|0|||
30690196|NCT00612586|58704214|FG001|Overall Study|Entry Criteria Not Met|2|||
30690197|NCT00612586|58704213|FG000|Overall Study|Withdrawal by Subject|7|||
30690198|NCT00612586|58704214|FG001|Overall Study|Withdrawal by Subject|9|||
30690199|NCT00612586|58704213|FG000|Overall Study|Physician Decision|1|||
30690200|NCT00612586|58704214|FG001|Overall Study|Physician Decision|2|||
30690201|NCT00612586|58704213|FG000|Overall Study|Sponsor Decision|1|||
30690202|NCT00612586|58704214|FG001|Overall Study|Sponsor Decision|1|||
30690203|NCT00612586|58704213|FG000|Overall Study|Progressive Disease|26|||
30690204|NCT00612586|58704214|FG001|Overall Study|Progressive Disease|24|||
30690205|NCT00612586|58704213|FG000|Overall Study|Randomized and Not Treated|1|||
30690206|NCT00612586|58704214|FG001|Overall Study|Randomized and Not Treated|1|||
30690207|NCT00614380|58704225|FG000|Overall Study|Adverse Event|14|||
30690208|NCT00614380|58704226|FG001|Overall Study|Adverse Event|4|||
30690209|NCT00614380|58704227|FG002|Overall Study|Adverse Event|0|||
30690210|NCT00614380|58704228|FG003|Overall Study|Adverse Event|0|||
30690211|NCT00614380|58704225|FG000|Overall Study|Lost to Follow-up|6|||
30690212|NCT00614380|58704226|FG001|Overall Study|Lost to Follow-up|1|||
30690213|NCT00614380|58704227|FG002|Overall Study|Lost to Follow-up|0|||
30690214|NCT00614380|58704228|FG003|Overall Study|Lost to Follow-up|0|||
30690215|NCT00614380|58704225|FG000|Overall Study|Non compliant with the protocol|12|||
30601497|NCT01263483|58612831|FG002|Overall Study|Lack of Efficacy|0|||
30601498|NCT01263483|58612829|FG000|Overall Study|Protocol Violation|0|||
30601499|NCT01263483|58612830|FG001|Overall Study|Protocol Violation|1|||
30601500|NCT01263483|58612831|FG002|Overall Study|Protocol Violation|1|||
30601501|NCT01263483|58612829|FG000|Overall Study|Participant Unavailability|0|||
30601502|NCT01263483|58612830|FG001|Overall Study|Participant Unavailability|1|||
30601503|NCT01263483|58612831|FG002|Overall Study|Participant Unavailability|1|||
30601504|NCT01306890|58612839|FG000|Overall Study|Adverse Event|2|||
30601505|NCT01306890|58612839|FG000|Overall Study|Death|1223|||
30601506|NCT01306890|58612839|FG000|Overall Study|Lost to Follow-up|58|||
30601507|NCT01306890|58612839|FG000|Overall Study|Withdrawal by Subject|88|||
30601508|NCT01306890|58612839|FG000|Overall Study|Unspecified reasons|104|||
30601509|NCT01306890|58612839|FG000|Overall Study|Study Termination|3|||
30690216|NCT00614380|58704226|FG001|Overall Study|Non compliant with the protocol|2|||
30690217|NCT00614380|58704227|FG002|Overall Study|Non compliant with the protocol|1|||
30690218|NCT00614380|58704228|FG003|Overall Study|Non compliant with the protocol|2|||
30690219|NCT00614380|58704225|FG000|Overall Study|Consent withdrawn|3|||
30690220|NCT00614380|58704226|FG001|Overall Study|Consent withdrawn|1|||
30690221|NCT00614380|58704227|FG002|Overall Study|Consent withdrawn|0|||
30690222|NCT00614380|58704228|FG003|Overall Study|Consent withdrawn|0|||
30690223|NCT00612508|58704245|FG000|Overall Study|Withdrawal by Subject|3|||
30690224|NCT00612508|58704246|FG001|Overall Study|Withdrawal by Subject|4|||
30690225|NCT00613834|58704256|FG000|Overall Study|Withdrawal by Subject|0|||
30690226|NCT00613834|58704257|FG001|Overall Study|Withdrawal by Subject|3|||
30690227|NCT00613366|58704271|FG000|Overall Study|Withdrawal by Subject|3|||
30690228|NCT00613366|58704272|FG001|Overall Study|Withdrawal by Subject|2|||
30690229|NCT00612352|58704280|FG000|Overall Study|Adverse Event|1|||
30690230|NCT00612352|58704281|FG001|Overall Study|Adverse Event|0|||
30690231|NCT00612352|58704280|FG000|Overall Study|Withdrawal by Subject|3|||
30690232|NCT00612352|58704281|FG001|Overall Study|Withdrawal by Subject|5|||
30690233|NCT00612352|58704280|FG000|Overall Study|moved out of state|1|||
30690234|NCT00612352|58704281|FG001|Overall Study|moved out of state|0|||
30690235|NCT00612352|58704280|FG000|Overall Study|didn't return calls/show up on test date|4|||
30690236|NCT00612352|58704281|FG001|Overall Study|didn't return calls/show up on test date|1|||
30690237|NCT00704730|58704289|FG000|Overall Study|Adverse Event|35|||
30601510|NCT01306890|58612839|FG000|Overall Study|No discontinuation documentation|41|||
30601511|NCT01011049|58612847|FG000|Overall Study|Protocol Violation|0|||
30601512|NCT01011049|58612848|FG001|Overall Study|Protocol Violation|0|||
30601513|NCT01011049|58612849|FG002|Overall Study|Protocol Violation|2|||
30690238|NCT00704730|58704290|FG001|Overall Study|Adverse Event|9|||
30690239|NCT00704730|58704289|FG000|Overall Study|Death|11|||
30690240|NCT00704730|58704290|FG001|Overall Study|Death|5|||
30690241|NCT00704730|58704289|FG000|Overall Study|Physician Decision|2|||
30690242|NCT00704730|58704290|FG001|Overall Study|Physician Decision|0|||
30690243|NCT00704730|58704289|FG000|Overall Study|Did not receive drug|5|||
30690244|NCT00704730|58704290|FG001|Overall Study|Did not receive drug|2|||
30690245|NCT00704730|58704289|FG000|Overall Study|Disease progression per PI|58|||
30690246|NCT00704730|58704290|FG001|Overall Study|Disease progression per PI|67|||
30690247|NCT00704730|58704289|FG000|Overall Study|data unavailable|1|||
30690248|NCT00704730|58704290|FG001|Overall Study|data unavailable|0|||
30690249|NCT00704730|58704289|FG000|Overall Study|Withdrawal by Subject|9|||
30690250|NCT00704730|58704290|FG001|Overall Study|Withdrawal by Subject|13|||
30690251|NCT00651261|58704299|FG000|Overall Study|Adverse Event|32|||
30690252|NCT00651261|58704300|FG001|Overall Study|Adverse Event|22|||
30690253|NCT00651261|58704299|FG000|Overall Study|Death|18|||
30690254|NCT00651261|58704300|FG001|Overall Study|Death|18|||
30690255|NCT00651261|58704299|FG000|Overall Study|Withdrawal by Subject|22|||
30690256|NCT00651261|58704300|FG001|Overall Study|Withdrawal by Subject|40|||
30690257|NCT00651261|58704299|FG000|Overall Study|Induction failure|24|||
30690258|NCT00651261|58704300|FG001|Overall Study|Induction failure|35|||
30690259|NCT00651261|58704299|FG000|Overall Study|Disease progression|58|||
30690260|NCT00651261|58704300|FG001|Overall Study|Disease progression|58|||
30690261|NCT00651261|58704299|FG000|Overall Study|Alternative therapy|109|||
30690262|NCT00651261|58704300|FG001|Overall Study|Alternative therapy|107|||
30690263|NCT00651261|58704299|FG000|Overall Study|Other disease or participant decisions|23|||
30690264|NCT00651261|58704300|FG001|Overall Study|Other disease or participant decisions|23|||
30690265|NCT00651261|58704299|FG000|Overall Study|Never treated|5|||
30690266|NCT00651261|58704300|FG001|Overall Study|Never treated|3|||
30690267|NCT00651183|58704308|FG000|Overall Study|Lack of Efficacy|1|||
30690268|NCT00651183|58704309|FG001|Overall Study|Lack of Efficacy|0|||
30690269|NCT00651183|58704308|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
30690270|NCT00651183|58704309|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
30690271|NCT00651183|58704308|FG000|Overall Study|Tolerability insufficient|5|||
30690272|NCT00651183|58704309|FG001|Overall Study|Tolerability insufficient|2|||
30690273|NCT00651183|58704308|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
30690274|NCT00651183|58704309|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
30690275|NCT00651183|58704308|FG000|Overall Study|Withdrawal by Subject|6|||
30690276|NCT00651183|58704309|FG001|Overall Study|Withdrawal by Subject|3|||
30690277|NCT00651183|58704308|FG000|Overall Study|Lost to Follow-up|3|||
30690278|NCT00651183|58704309|FG001|Overall Study|Lost to Follow-up|1|||
30690279|NCT00651183|58704308|FG000|Overall Study|Other reasons|4|||
30690280|NCT00651183|58704309|FG001|Overall Study|Other reasons|2|||
30690281|NCT00651183|58704308|FG000|Overall Study|missing|1|||
30690282|NCT00651183|58704309|FG001|Overall Study|missing|0|||
30690283|NCT00699972|58704318|FG000|Overall Study|Adverse Event|7|||
30690284|NCT00699972|58704319|FG001|Overall Study|Adverse Event|9|||
30690285|NCT00699972|58704320|FG002|Overall Study|Adverse Event|24|||
30690286|NCT00699972|58704318|FG000|Overall Study|Lost to Follow-up|0|||
30690287|NCT00699972|58704319|FG001|Overall Study|Lost to Follow-up|2|||
30690288|NCT00699972|58704320|FG002|Overall Study|Lost to Follow-up|0|||
30690289|NCT00699972|58704318|FG000|Overall Study|Withdrawal by Subject|3|||
30690290|NCT00699972|58704319|FG001|Overall Study|Withdrawal by Subject|7|||
30690291|NCT00699972|58704320|FG002|Overall Study|Withdrawal by Subject|4|||
30690292|NCT00699972|58704318|FG000|Overall Study|Lack of Efficacy|2|||
30690293|NCT00699972|58704319|FG001|Overall Study|Lack of Efficacy|0|||
30690294|NCT00699972|58704320|FG002|Overall Study|Lack of Efficacy|2|||
30864095|NCT02662985|58894226|FG000|Treatment Period 1|Protocol Violation|0|||
30960730|NCT01526057|59026366|FG002|Overall Study|Lost to Follow-up|1|||
30690295|NCT00699972|58704318|FG000|Overall Study|Administrative/Other|3|||
30690296|NCT00699972|58704319|FG001|Overall Study|Administrative/Other|1|||
30690297|NCT00699972|58704320|FG002|Overall Study|Administrative/Other|4|||
30690298|NCT00699972|58704318|FG000|Overall Study|Randomized, Not Treated|1|||
30690299|NCT00699972|58704319|FG001|Overall Study|Randomized, Not Treated|0|||
30690300|NCT00699972|58704320|FG002|Overall Study|Randomized, Not Treated|1|||
30690301|NCT00642759|58704328|FG000|Overall Study|Protocol Violation|1|||
30690302|NCT00611026|58704336|FG000|Randomized to Double-blind Treatment|Not treated|2|||
30690303|NCT00611026|58704337|FG001|Randomized to Double-blind Treatment|Not treated|1|||
30690304|NCT00611026|58704338|FG002|Randomized to Double-blind Treatment|Not treated|3|||
30690305|NCT00611026|58704336|FG000|Double-blind Treatment Period|Death|1|||
30690306|NCT00611026|58704337|FG001|Double-blind Treatment Period|Death|0|||
30690307|NCT00611026|58704338|FG002|Double-blind Treatment Period|Death|0|||
30690308|NCT00611026|58704336|FG000|Double-blind Treatment Period|Adverse Event|9|||
30690309|NCT00611026|58704337|FG001|Double-blind Treatment Period|Adverse Event|28|||
30690310|NCT00611026|58704338|FG002|Double-blind Treatment Period|Adverse Event|46|||
30690311|NCT00611026|58704336|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
30960731|NCT01526057|59026364|FG000|Overall Study|Other|1|||
30690312|NCT00611026|58704337|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
30690313|NCT00611026|58704338|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
30690314|NCT00611026|58704336|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
30690315|NCT00611026|58704337|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
30690316|NCT00611026|58704338|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
30690317|NCT00611026|58704336|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
30864096|NCT02662985|58894227|FG001|Treatment Period 1|Protocol Violation|1|||
30864097|NCT02662985|58894226|FG000|Treatment Period 1|Physician Decision|1|||
30864098|NCT02662985|58894227|FG001|Treatment Period 1|Physician Decision|0|||
30864099|NCT02662985|58894226|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30690318|NCT00611026|58704337|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
30690319|NCT00611026|58704338|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
30690320|NCT00611026|58704336|FG000|Double-blind Treatment Period|Other|13|||
30690321|NCT00611026|58704337|FG001|Double-blind Treatment Period|Other|20|||
30690322|NCT00611026|58704338|FG002|Double-blind Treatment Period|Other|18|||
30690323|NCT00646113|58704348|FG000|Overall Study|Lost to Follow-up|5|||
30690324|NCT00646113|58704348|FG000|Overall Study|Adverse Event|3|||
30690325|NCT00422383|58704357|FG000|Overall Study|Adverse Event|5|||
30690326|NCT00422383|58704358|FG001|Overall Study|Adverse Event|3|||
30690327|NCT00422383|58704359|FG002|Overall Study|Adverse Event|1|||
30690328|NCT00422383|58704360|FG003|Overall Study|Adverse Event|1|||
30690329|NCT00422383|58704361|FG004|Overall Study|Adverse Event|0|||
30690330|NCT00422383|58704357|FG000|Overall Study|Lack of Efficacy|4|||
30690331|NCT00422383|58704358|FG001|Overall Study|Lack of Efficacy|4|||
30690332|NCT00422383|58704359|FG002|Overall Study|Lack of Efficacy|2|||
30690333|NCT00422383|58704360|FG003|Overall Study|Lack of Efficacy|1|||
30690334|NCT00422383|58704361|FG004|Overall Study|Lack of Efficacy|1|||
30690335|NCT00422383|58704357|FG000|Overall Study|Lost to Follow-up|0|||
30690336|NCT00422383|58704358|FG001|Overall Study|Lost to Follow-up|1|||
30690337|NCT00422383|58704359|FG002|Overall Study|Lost to Follow-up|0|||
30690338|NCT00422383|58704360|FG003|Overall Study|Lost to Follow-up|0|||
30690339|NCT00422383|58704361|FG004|Overall Study|Lost to Follow-up|1|||
30690340|NCT00422383|58704357|FG000|Overall Study|Protocol Violation|1|||
30690341|NCT00422383|58704358|FG001|Overall Study|Protocol Violation|1|||
30690342|NCT00422383|58704359|FG002|Overall Study|Protocol Violation|1|||
30864100|NCT02662985|58894227|FG001|Treatment Period 1|Withdrawal by Subject|1|||
30864101|NCT02662985|58894226|FG000|Treatment Period 2|Lack of Efficacy|0|||
30864102|NCT02662985|58894227|FG001|Treatment Period 2|Lack of Efficacy|1|||
30864103|NCT02662985|58894226|FG000|Treatment Period 2|Lost to Follow-up|1|||
30864104|NCT02662985|58894227|FG001|Treatment Period 2|Lost to Follow-up|0|||
30864105|NCT02662985|58894226|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
30864106|NCT02662985|58894227|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
30864107|NCT02662985|58894226|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
30864108|NCT02662985|58894227|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
30864109|NCT02662985|58894226|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
30864110|NCT02662985|58894227|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
30864111|NCT02662985|58894226|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
30864112|NCT02662985|58894227|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
30864113|NCT02662985|58894226|FG000|Treatment Period 3 (Extension Period)|Death|0|||
30864114|NCT02662985|58894227|FG001|Treatment Period 3 (Extension Period)|Death|1|||
30864115|NCT01631812|58894233|FG000|Overall Study|Adverse Event|25|||
30864116|NCT01631812|58894233|FG000|Overall Study|Lack of Efficacy|5|||
30864117|NCT01631812|58894233|FG000|Overall Study|Withdrawal by Subject|4|||
30864118|NCT01631812|58894233|FG000|Overall Study|Physician Decision|3|||
30864119|NCT02323295|58894239|FG000|Overall Study|Adverse Event|0|||
30864120|NCT02323295|58894240|FG001|Overall Study|Adverse Event|1|||
30864121|NCT02323295|58894239|FG000|Overall Study|Withdrawal by Subject|0|||
30864122|NCT02323295|58894240|FG001|Overall Study|Withdrawal by Subject|1|||
30864123|NCT02323295|58894239|FG000|Overall Study|Patient did not have surgery as planned.|0|||
30864124|NCT02323295|58894240|FG001|Overall Study|Patient did not have surgery as planned.|1|||
30864125|NCT02215954|58894249|FG000|Overall Study|Adverse Event|0|||
30864126|NCT02215954|58894250|FG001|Overall Study|Adverse Event|0|||
30864127|NCT02215954|58894251|FG002|Overall Study|Adverse Event|1|||
30864128|NCT02215954|58894249|FG000|Overall Study|Withdrawal by Subject|0|||
30864129|NCT02215954|58894250|FG001|Overall Study|Withdrawal by Subject|0|||
30864130|NCT02215954|58894251|FG002|Overall Study|Withdrawal by Subject|2|||
30864131|NCT02215954|58894249|FG000|Overall Study|Not exposed|1|||
30864132|NCT02215954|58894250|FG001|Overall Study|Not exposed|1|||
30864133|NCT02215954|58894251|FG002|Overall Study|Not exposed|3|||
30690343|NCT00422383|58704360|FG003|Overall Study|Protocol Violation|0|||
30690344|NCT00422383|58704361|FG004|Overall Study|Protocol Violation|0|||
30690345|NCT00422383|58704357|FG000|Overall Study|Withdrawal by Subject|5|||
30690346|NCT00422383|58704358|FG001|Overall Study|Withdrawal by Subject|5|||
30690347|NCT00422383|58704359|FG002|Overall Study|Withdrawal by Subject|0|||
30864134|NCT01941719|58894262|FG000|Overall Study|Lost to Follow-up|20|||
30864135|NCT01941719|58894263|FG001|Overall Study|Lost to Follow-up|19|||
30690348|NCT00422383|58704360|FG003|Overall Study|Withdrawal by Subject|0|||
30690349|NCT00422383|58704361|FG004|Overall Study|Withdrawal by Subject|1|||
30690350|NCT00612040|58704382|FG000|Overall Study|Adverse Event|0|||
30690351|NCT00612040|58704383|FG001|Overall Study|Adverse Event|2|||
30690352|NCT00612040|58704384|FG002|Overall Study|Adverse Event|1|||
30690353|NCT00612040|58704382|FG000|Overall Study|Protocol Violation|1|||
30690354|NCT00612040|58704383|FG001|Overall Study|Protocol Violation|2|||
30690355|NCT00612040|58704384|FG002|Overall Study|Protocol Violation|1|||
30690356|NCT00612040|58704382|FG000|Overall Study|Lack of Efficacy|2|||
30690357|NCT00612040|58704383|FG001|Overall Study|Lack of Efficacy|1|||
30690358|NCT00612040|58704384|FG002|Overall Study|Lack of Efficacy|0|||
30690359|NCT00612040|58704382|FG000|Overall Study|Unclassified|2|||
30690360|NCT00612040|58704383|FG001|Overall Study|Unclassified|2|||
30690361|NCT00612040|58704384|FG002|Overall Study|Unclassified|5|||
30690362|NCT00422227|58704394|FG000|Overall Study|Adverse Event|3|||
30690363|NCT00422227|58704395|FG001|Overall Study|Adverse Event|8|||
30690364|NCT00422227|58704394|FG000|Overall Study|Lost to Follow-up|1|||
30690365|NCT00422227|58704395|FG001|Overall Study|Lost to Follow-up|3|||
30690366|NCT00422227|58704394|FG000|Overall Study|Withdrawal by Subject|0|||
30690367|NCT00422227|58704395|FG001|Overall Study|Withdrawal by Subject|4|||
30690368|NCT00421993|58704405|FG000|Overall Study|Withdrawal by Subject|22|||
30690369|NCT00421993|58704406|FG001|Overall Study|Withdrawal by Subject|23|||
30690370|NCT00421993|58704407|FG002|Overall Study|Withdrawal by Subject|23|||
30690371|NCT00421993|58704408|FG003|Overall Study|Withdrawal by Subject|24|||
30690372|NCT00421993|58704405|FG000|Overall Study|Lost to Follow-up|18|||
30690373|NCT00421993|58704406|FG001|Overall Study|Lost to Follow-up|19|||
30690374|NCT00421993|58704407|FG002|Overall Study|Lost to Follow-up|22|||
30690375|NCT00421993|58704408|FG003|Overall Study|Lost to Follow-up|20|||
30690376|NCT00421993|58704405|FG000|Overall Study|Adverse Event|11|||
30690377|NCT00421993|58704406|FG001|Overall Study|Adverse Event|1|||
30690378|NCT00421993|58704407|FG002|Overall Study|Adverse Event|6|||
30690379|NCT00421993|58704408|FG003|Overall Study|Adverse Event|4|||
30690380|NCT00421993|58704405|FG000|Overall Study|Protocol Violation|2|||
30690381|NCT00421993|58704406|FG001|Overall Study|Protocol Violation|2|||
30690382|NCT00421993|58704407|FG002|Overall Study|Protocol Violation|0|||
30690383|NCT00421993|58704408|FG003|Overall Study|Protocol Violation|1|||
30690384|NCT00421993|58704405|FG000|Overall Study|Lack of Efficacy|0|||
30690385|NCT00421993|58704406|FG001|Overall Study|Lack of Efficacy|3|||
30690386|NCT00421993|58704407|FG002|Overall Study|Lack of Efficacy|0|||
30690387|NCT00421993|58704408|FG003|Overall Study|Lack of Efficacy|5|||
30690388|NCT00421993|58704405|FG000|Overall Study|Pregnancy|0|||
30690389|NCT00421993|58704406|FG001|Overall Study|Pregnancy|1|||
30690390|NCT00421993|58704407|FG002|Overall Study|Pregnancy|1|||
30690391|NCT00421993|58704408|FG003|Overall Study|Pregnancy|2|||
30690392|NCT00421993|58704405|FG000|Overall Study|Subject transportation issues|0|||
30690393|NCT00421993|58704406|FG001|Overall Study|Subject transportation issues|0|||
30690394|NCT00421993|58704407|FG002|Overall Study|Subject transportation issues|0|||
30690395|NCT00421993|58704408|FG003|Overall Study|Subject transportation issues|1|||
30690396|NCT00413959|58704418|FG000|Overall Study|Pt had only one cycle.|1|||
30690397|NCT00645567|58704422|FG000|Overall Study|Adverse Event|1|||
30690398|NCT00611884|58704434|FG000|Overall Study|Adverse Event|1|||
30690399|NCT00611884|58704435|FG001|Overall Study|Adverse Event|0|||
30690400|NCT00611884|58704436|FG002|Overall Study|Adverse Event|0|||
30690401|NCT00611884|58704437|FG003|Overall Study|Adverse Event|1|||
30690402|NCT00611884|58704434|FG000|Overall Study|Non-Compliance|1|||
30690403|NCT00611884|58704435|FG001|Overall Study|Non-Compliance|4|||
30690404|NCT00611884|58704436|FG002|Overall Study|Non-Compliance|2|||
30690405|NCT00611884|58704437|FG003|Overall Study|Non-Compliance|2|||
30690406|NCT00611884|58704434|FG000|Overall Study|Lack of Efficacy|0|||
30690407|NCT00611884|58704435|FG001|Overall Study|Lack of Efficacy|1|||
30690408|NCT00611884|58704436|FG002|Overall Study|Lack of Efficacy|0|||
30690409|NCT00611884|58704437|FG003|Overall Study|Lack of Efficacy|0|||
30690410|NCT00611884|58704434|FG000|Overall Study|Unclassified|7|||
30690411|NCT00611884|58704435|FG001|Overall Study|Unclassified|4|||
30690412|NCT00611884|58704436|FG002|Overall Study|Unclassified|2|||
30690413|NCT00611884|58704437|FG003|Overall Study|Unclassified|3|||
30690414|NCT00420745|58704449|FG000|Overall Study|Adverse Event|2|||
30690415|NCT00420745|58704450|FG001|Overall Study|Adverse Event|2|||
30690416|NCT00420745|58704449|FG000|Overall Study|Lost to Follow-up|10|||
30690417|NCT00420745|58704450|FG001|Overall Study|Lost to Follow-up|2|||
30690418|NCT00420745|58704449|FG000|Overall Study|Protocol Violation|1|||
30690419|NCT00420745|58704450|FG001|Overall Study|Protocol Violation|0|||
30690420|NCT00420745|58704449|FG000|Overall Study|Physician Decision|1|||
30690421|NCT00420745|58704450|FG001|Overall Study|Physician Decision|1|||
30690422|NCT00420745|58704449|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
30690423|NCT00420745|58704450|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
30690424|NCT00420745|58704449|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
30690425|NCT00420745|58704450|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
30690426|NCT00611806|58704458|FG000|Overall Study|Withdrawal by Subject|8|||
30690427|NCT00611806|58704459|FG001|Overall Study|Withdrawal by Subject|2|||
30690428|NCT00611806|58704458|FG000|Overall Study|Adverse Event|2|||
30690429|NCT00611806|58704459|FG001|Overall Study|Adverse Event|1|||
30690430|NCT00611806|58704458|FG000|Overall Study|Lost to Follow-up|6|||
30690431|NCT00611806|58704459|FG001|Overall Study|Lost to Follow-up|0|||
30690432|NCT00413413|58704468|FG000|Single-Blind|Adverse Event|0|||
30864136|NCT02215252|58894273|FG000|Overall Study|Adverse Event|1|||
30864137|NCT02215252|58894274|FG001|Overall Study|Adverse Event|5|||
30864138|NCT02215252|58894275|FG002|Overall Study|Adverse Event|2|||
30864139|NCT02215252|58894273|FG000|Overall Study|Lost to Follow-up|0|||
30864140|NCT02215252|58894274|FG001|Overall Study|Lost to Follow-up|0|||
30864141|NCT02215252|58894275|FG002|Overall Study|Lost to Follow-up|1|||
30864142|NCT02215252|58894273|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
30864143|NCT02215252|58894274|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
30864144|NCT02215252|58894275|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
30864145|NCT02215252|58894273|FG000|Overall Study|Protocol Violation|0|||
30864146|NCT02215252|58894274|FG001|Overall Study|Protocol Violation|1|||
30864147|NCT02215252|58894275|FG002|Overall Study|Protocol Violation|0|||
30864148|NCT02215252|58894273|FG000|Overall Study|Withdrawal by Subject|1|||
30864149|NCT02215252|58894274|FG001|Overall Study|Withdrawal by Subject|0|||
30864150|NCT02215252|58894275|FG002|Overall Study|Withdrawal by Subject|0|||
30864151|NCT02215252|58894273|FG000|Overall Study|Other|0|||
30864152|NCT02215252|58894274|FG001|Overall Study|Other|1|||
30864153|NCT02215252|58894275|FG002|Overall Study|Other|1|||
30864154|NCT02204410|58894283|FG000|Overall Study|Lost to Follow-up|5|||
30864155|NCT02204410|58894283|FG000|Overall Study|Physician Decision|2|||
30864156|NCT02204410|58894283|FG000|Overall Study|Protocol Violation|1|||
30864157|NCT02204410|58894283|FG000|Overall Study|Withdrawal by Subject|3|||
30864158|NCT02250274|58894289|FG000|Overall Study|Insufficient blood draw amount|7|||
30864159|NCT02250274|58894290|FG001|Overall Study|Insufficient blood draw amount|6|||
30864160|NCT02213458|58894304|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
30864161|NCT02213458|58894305|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
30864162|NCT02213458|58894304|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
30864163|NCT02213458|58894305|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
30864164|NCT02213458|58894304|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
30864165|NCT02213458|58894305|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
30864166|NCT02213458|58894304|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
30864167|NCT02213458|58894305|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
30864168|NCT02213458|58894304|FG000|Overall Study|Refused re-consent|6|||
30864169|NCT02213458|58894305|FG001|Overall Study|Refused re-consent|0|||
30864170|NCT02213458|58894304|FG000|Overall Study|Lost to Follow-up|2|||
30864171|NCT02213458|58894305|FG001|Overall Study|Lost to Follow-up|2|||
30864172|NCT02213458|58894304|FG000|Overall Study|Withdrawal by Subject|26|||
30864173|NCT02213458|58894305|FG001|Overall Study|Withdrawal by Subject|8|||
30864174|NCT02213380|58894313|FG000|Underwent Randomization|Withdrawal by Subject|2|||
30864175|NCT02213380|58894314|FG001|Underwent Randomization|Withdrawal by Subject|0|||
30864176|NCT02213380|58894313|FG000|Underwent Randomization|Not treated|3|||
30864177|NCT02213380|58894314|FG001|Underwent Randomization|Not treated|3|||
30864178|NCT02213380|58894313|FG000|Per-protocol Analysis|Protocol Violation|32|||
30864179|NCT02213380|58894314|FG001|Per-protocol Analysis|Protocol Violation|36|||
30864180|NCT02202850|58894322|FG000|Overall Study|Other|2|||
30864181|NCT02202850|58894323|FG001|Overall Study|Other|2|||
30864182|NCT02202850|58894322|FG000|Overall Study|Enbrel treatment discontinued|15|||
30864183|NCT02202850|58894323|FG001|Overall Study|Enbrel treatment discontinued|3|||
30864184|NCT02202850|58894322|FG000|Overall Study|Lost to Follow-up|7|||
30864185|NCT02202850|58894323|FG001|Overall Study|Lost to Follow-up|1|||
30864186|NCT02212678|58894329|FG000|Overall Study|Adverse Event|1|||
30864187|NCT03104075|58894335|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
30864188|NCT03104075|58894336|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
30864189|NCT03038087|58894343|FG000|Overall Study|lost data|1|||
30864190|NCT02249182|58894354|FG000|Treatment Phase|Lost to Follow-up|4|||
30864191|NCT02249182|58894355|FG001|Treatment Phase|Lost to Follow-up|0|||
30864192|NCT02249182|58894356|FG002|Treatment Phase|Lost to Follow-up|0|||
30864193|NCT02249182|58894357|FG003|Treatment Phase|Lost to Follow-up|0|||
30690433|NCT00413413|58704469|FG001|Single-Blind|Adverse Event|9|||
30864194|NCT02249182|58894358|FG004|Treatment Phase|Lost to Follow-up|0|||
30864195|NCT03641339|58894398|FG000|Overall Study|Physician Decision|1|||
30864196|NCT03641339|58894399|FG001|Overall Study|Physician Decision|0|||
30864197|NCT03641339|58894400|FG002|Overall Study|Physician Decision|0|||
30864198|NCT03641339|58894401|FG003|Overall Study|Physician Decision|0|||
30864199|NCT03641339|58894402|FG004|Overall Study|Physician Decision|0|||
30864200|NCT03641339|58894403|FG005|Overall Study|Physician Decision|0|||
30960732|NCT01526057|59026365|FG001|Overall Study|Other|0|||
30690434|NCT00413413|58704470|FG002|Single-Blind|Adverse Event|0|||
30690435|NCT00413413|58704468|FG000|Single-Blind|Lack of Efficacy|0|||
30690436|NCT00413413|58704469|FG001|Single-Blind|Lack of Efficacy|5|||
30690437|NCT00413413|58704470|FG002|Single-Blind|Lack of Efficacy|0|||
30690438|NCT00413413|58704468|FG000|Single-Blind|Subject no longer requires study drug|0|||
30690439|NCT00413413|58704469|FG001|Single-Blind|Subject no longer requires study drug|151|||
30690440|NCT00413413|58704470|FG002|Single-Blind|Subject no longer requires study drug|0|||
30690441|NCT00413413|58704468|FG000|Single-Blind|Protocol Violation|0|||
30690442|NCT00413413|58704469|FG001|Single-Blind|Protocol Violation|16|||
30690443|NCT00413413|58704470|FG002|Single-Blind|Protocol Violation|0|||
30690444|NCT00413413|58704468|FG000|Single-Blind|Withdrawal by Subject|0|||
30690445|NCT00413413|58704469|FG001|Single-Blind|Withdrawal by Subject|27|||
30690446|NCT00413413|58704470|FG002|Single-Blind|Withdrawal by Subject|0|||
30690447|NCT00413413|58704468|FG000|Single-Blind|Lost to Follow-up|0|||
30690448|NCT00413413|58704469|FG001|Single-Blind|Lost to Follow-up|8|||
30690449|NCT00413413|58704470|FG002|Single-Blind|Lost to Follow-up|0|||
30690450|NCT00413413|58704468|FG000|Double-Blind|Adverse Event|6|||
30690451|NCT00413413|58704469|FG001|Double-Blind|Adverse Event|0|||
30690452|NCT00413413|58704470|FG002|Double-Blind|Adverse Event|5|||
30690453|NCT00413413|58704468|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
30690454|NCT00413413|58704469|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
30690455|NCT00413413|58704470|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
30690456|NCT00413413|58704468|FG000|Double-Blind|Protocol deviation|1|||
30690457|NCT00413413|58704469|FG001|Double-Blind|Protocol deviation|2|||
30690458|NCT00413413|58704470|FG002|Double-Blind|Protocol deviation|1|||
30690459|NCT00413413|58704468|FG000|Double-Blind|Subject withdrew consent|4|||
30690460|NCT00413413|58704469|FG001|Double-Blind|Subject withdrew consent|6|||
30690461|NCT00413413|58704470|FG002|Double-Blind|Subject withdrew consent|9|||
30690462|NCT00413413|58704468|FG000|Double-Blind|Lost to Follow-up|3|||
30690463|NCT00413413|58704469|FG001|Double-Blind|Lost to Follow-up|4|||
30690464|NCT00413413|58704470|FG002|Double-Blind|Lost to Follow-up|2|||
30690465|NCT00610714|58704480|FG000|Overall Study|Adverse Event|3|||
30690466|NCT00610714|58704481|FG001|Overall Study|Adverse Event|1|||
30690467|NCT00610714|58704480|FG000|Overall Study|Death|12|||
30601514|NCT01011049|58612850|FG003|Overall Study|Protocol Violation|0|||
30601515|NCT01011049|58612847|FG000|Overall Study|Lost to Follow-up|1|||
30601516|NCT01011049|58612848|FG001|Overall Study|Lost to Follow-up|2|||
30601517|NCT01011049|58612849|FG002|Overall Study|Lost to Follow-up|1|||
30601518|NCT01011049|58612850|FG003|Overall Study|Lost to Follow-up|0|||
30601519|NCT01011049|58612847|FG000|Overall Study|Withdrawal by Subject|0|||
30601520|NCT01011049|58612848|FG001|Overall Study|Withdrawal by Subject|0|||
30601521|NCT01011049|58612849|FG002|Overall Study|Withdrawal by Subject|1|||
30601522|NCT01011049|58612850|FG003|Overall Study|Withdrawal by Subject|0|||
30601523|NCT01263093|58612862|FG000|Washout|Physician Decision|1|||
30601524|NCT01263093|58612863|FG001|Washout|Physician Decision|0|||
30601525|NCT01263093|58612862|FG000|Period 2|Adverse Event|1|||
30601526|NCT01263093|58612863|FG001|Period 2|Adverse Event|0|||
30601527|NCT01010971|58612873|FG000|Overall Study|Adverse Event|2|||
30601528|NCT01010971|58612874|FG001|Overall Study|Adverse Event|4|||
30601529|NCT01010971|58612875|FG002|Overall Study|Adverse Event|3|||
30601530|NCT01010971|58612873|FG000|Overall Study|Withdrawal by Subject|0|||
30601531|NCT01010971|58612874|FG001|Overall Study|Withdrawal by Subject|2|||
30601532|NCT01010971|58612875|FG002|Overall Study|Withdrawal by Subject|5|||
30601533|NCT01010971|58612873|FG000|Overall Study|Lost to Follow-up|0|||
30601534|NCT01010971|58612874|FG001|Overall Study|Lost to Follow-up|2|||
30601535|NCT01010971|58612875|FG002|Overall Study|Lost to Follow-up|3|||
30601536|NCT01010971|58612873|FG000|Overall Study|Other|1|||
30601537|NCT01010971|58612874|FG001|Overall Study|Other|0|||
30601538|NCT01010971|58612875|FG002|Overall Study|Other|2|||
30601539|NCT01306656|58612885|FG000|Overall Study|Lost to Follow-up|1|||
30601540|NCT01306656|58612886|FG001|Overall Study|Lost to Follow-up|0|||
30601541|NCT01008943|58612894|FG000|Overall Study|Withdrawal by Subject|1|||
30601542|NCT01003639|58612900|FG000|Overall Study|Lost to Follow-up|6|||
30601543|NCT01003639|58612901|FG001|Overall Study|Lost to Follow-up|9|||
30601544|NCT01003639|58612900|FG000|Overall Study|Withdrawal by Subject|9|||
30601545|NCT01003639|58612901|FG001|Overall Study|Withdrawal by Subject|5|||
30601546|NCT01003639|58612900|FG000|Overall Study|Lack of Efficacy|1|||
30601547|NCT01003639|58612901|FG001|Overall Study|Lack of Efficacy|6|||
30601548|NCT01003639|58612900|FG000|Overall Study|Adverse Event|0|||
30601549|NCT01003639|58612901|FG001|Overall Study|Adverse Event|1|||
30601550|NCT01003639|58612900|FG000|Overall Study|Protocol Violation|0|||
30601551|NCT01003639|58612901|FG001|Overall Study|Protocol Violation|1|||
30601552|NCT01003639|58612900|FG000|Overall Study|Physician Decision|1|||
30601553|NCT01003639|58612901|FG001|Overall Study|Physician Decision|0|||
30601554|NCT01003249|58612907|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
30690468|NCT00610714|58704481|FG001|Overall Study|Death|18|||
30690469|NCT00610714|58704480|FG000|Overall Study|Withdrawal by Subject|9|||
30690470|NCT00610714|58704481|FG001|Overall Study|Withdrawal by Subject|3|||
30690471|NCT00610714|58704480|FG000|Overall Study|Study completion at 120 PFS events|2|||
30690472|NCT00610714|58704481|FG001|Overall Study|Study completion at 120 PFS events|2|||
30786566|NCT01367158|58799760|FG005|Overall Study|Protocol Violation|0|||
30690473|NCT00403585|58704487|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
30690474|NCT00403585|58704487|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
30690475|NCT00403585|58704487|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
30690476|NCT00645411|58704495|FG000|Overall Study|Adverse Event|0|||
30690477|NCT00645411|58704496|FG001|Overall Study|Adverse Event|0|||
30690478|NCT00645411|58704497|FG002|Overall Study|Adverse Event|0|||
30690479|NCT00645411|58704498|FG003|Overall Study|Adverse Event|2|||
30690480|NCT00645411|58704495|FG000|Overall Study|Withdrawal by Subject|2|||
30690481|NCT00645411|58704496|FG001|Overall Study|Withdrawal by Subject|1|||
30690482|NCT00645411|58704497|FG002|Overall Study|Withdrawal by Subject|19|||
30690483|NCT00645411|58704498|FG003|Overall Study|Withdrawal by Subject|21|||
30690484|NCT00645411|58704495|FG000|Overall Study|Lost to Follow-up|10|||
30690485|NCT00645411|58704496|FG001|Overall Study|Lost to Follow-up|5|||
30690486|NCT00645411|58704497|FG002|Overall Study|Lost to Follow-up|124|||
30690487|NCT00645411|58704498|FG003|Overall Study|Lost to Follow-up|75|||
30690488|NCT00645411|58704495|FG000|Overall Study|Protocol Violation|1|||
30690489|NCT00645411|58704496|FG001|Overall Study|Protocol Violation|0|||
30690490|NCT00645411|58704497|FG002|Overall Study|Protocol Violation|1|||
30690491|NCT00645411|58704498|FG003|Overall Study|Protocol Violation|0|||
30690492|NCT00645411|58704495|FG000|Overall Study|Inappropriate enrollment|0|||
30690493|NCT00645411|58704496|FG001|Overall Study|Inappropriate enrollment|0|||
30690494|NCT00645411|58704497|FG002|Overall Study|Inappropriate enrollment|4|||
30690495|NCT00645411|58704498|FG003|Overall Study|Inappropriate enrollment|1|||
30690496|NCT00645411|58704495|FG000|Overall Study|Unable to classify|0|||
30690497|NCT00645411|58704496|FG001|Overall Study|Unable to classify|0|||
30690498|NCT00645411|58704497|FG002|Overall Study|Unable to classify|3|||
30690499|NCT00645411|58704498|FG003|Overall Study|Unable to classify|4|||
30690500|NCT00403273|58704517|FG000|Overall Study|Lost to Follow-up|3|||
30690501|NCT00403273|58704518|FG001|Overall Study|Lost to Follow-up|2|||
30690502|NCT00403273|58704517|FG000|Overall Study|Physician Decision|0|||
30690503|NCT00403273|58704518|FG001|Overall Study|Physician Decision|1|||
30690504|NCT00403273|58704517|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
30690505|NCT00403273|58704518|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
30690506|NCT00402727|58704541|FG000|Overall Study|Adverse Event|10|||
30690507|NCT00402727|58704542|FG001|Overall Study|Adverse Event|6|||
30690508|NCT00402727|58704541|FG000|Overall Study|Death|1|||
30690509|NCT00402727|58704542|FG001|Overall Study|Death|0|||
30690510|NCT00402727|58704541|FG000|Overall Study|Lack of Efficacy|1|||
30690511|NCT00402727|58704542|FG001|Overall Study|Lack of Efficacy|3|||
30690512|NCT00402727|58704541|FG000|Overall Study|Lost to Follow-up|24|||
30690513|NCT00402727|58704542|FG001|Overall Study|Lost to Follow-up|11|||
30690514|NCT00402727|58704541|FG000|Overall Study|Physician Decision|1|||
30601555|NCT01003249|58612908|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
30601556|NCT01003249|58612907|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
30601557|NCT01003249|58612908|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
30601558|NCT01003249|58612907|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
30601559|NCT01003249|58612908|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
30601560|NCT01003249|58612907|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
30601561|NCT01003249|58612908|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
30601562|NCT01001767|58612920|FG000|Overall Study|no baseline study performed|1|||
30601563|NCT01001767|58612921|FG001|Overall Study|no baseline study performed|0|||
30601564|NCT01001767|58612920|FG000|Overall Study|Protocol Violation|1|||
30601565|NCT01001767|58612921|FG001|Overall Study|Protocol Violation|0|||
30601566|NCT01001767|58612920|FG000|Overall Study|Lost to Follow-up|1|||
30601567|NCT01001767|58612921|FG001|Overall Study|Lost to Follow-up|0|||
30601568|NCT01001767|58612920|FG000|Overall Study|Physician Decision|1|||
30601569|NCT01001767|58612921|FG001|Overall Study|Physician Decision|0|||
30601570|NCT01306032|58612933|FG000|First Intervention|Adverse Event|1|||
30601571|NCT01306032|58612934|FG001|First Intervention|Adverse Event|0|||
30601572|NCT01306032|58612935|FG002|First Intervention|Adverse Event|1|||
30601573|NCT01306032|58612936|FG003|First Intervention|Adverse Event|0|||
30601574|NCT01306032|58612937|FG004|First Intervention|Adverse Event|0|||
30601575|NCT01306032|58612938|FG005|First Intervention|Adverse Event|1|||
30601576|NCT01306032|58612933|FG000|First Intervention|Withdrawal by Subject|0|||
30690515|NCT00402727|58704542|FG001|Overall Study|Physician Decision|1|||
30690516|NCT00402727|58704541|FG000|Overall Study|Protocol Violation|0|||
30690517|NCT00402727|58704542|FG001|Overall Study|Protocol Violation|4|||
30690518|NCT00402727|58704541|FG000|Overall Study|Withdrawal by Subject|3|||
30690519|NCT00402727|58704542|FG001|Overall Study|Withdrawal by Subject|7|||
30690520|NCT00402727|58704541|FG000|Overall Study|supply problems|2|||
30864201|NCT03641339|58894398|FG000|Overall Study|Withdrawal by Subject|0|||
30601577|NCT01306032|58612934|FG001|First Intervention|Withdrawal by Subject|2|||
30601578|NCT01306032|58612935|FG002|First Intervention|Withdrawal by Subject|0|||
30601579|NCT01306032|58612936|FG003|First Intervention|Withdrawal by Subject|1|||
30601580|NCT01306032|58612937|FG004|First Intervention|Withdrawal by Subject|0|||
30601581|NCT01306032|58612938|FG005|First Intervention|Withdrawal by Subject|0|||
30690521|NCT00402727|58704542|FG001|Overall Study|supply problems|1|||
30960733|NCT01526057|59026366|FG002|Overall Study|Other|1|||
30601582|NCT01306032|58612933|FG000|First Intervention|Death|0|||
30601583|NCT01306032|58612934|FG001|First Intervention|Death|0|||
30601584|NCT01306032|58612935|FG002|First Intervention|Death|1|||
30601585|NCT01306032|58612936|FG003|First Intervention|Death|0|||
30601586|NCT01306032|58612937|FG004|First Intervention|Death|0|||
30601587|NCT01306032|58612938|FG005|First Intervention|Death|0|||
30601588|NCT01306032|58612933|FG000|First Intervention|Ineligible|0|||
30601589|NCT01306032|58612934|FG001|First Intervention|Ineligible|0|||
30601590|NCT01306032|58612935|FG002|First Intervention|Ineligible|0|||
30601591|NCT01306032|58612936|FG003|First Intervention|Ineligible|0|||
30601592|NCT01306032|58612937|FG004|First Intervention|Ineligible|0|||
30601593|NCT01306032|58612938|FG005|First Intervention|Ineligible|1|||
30601594|NCT01306032|58612933|FG000|First Intervention|Progressive disease|0|||
30601595|NCT01306032|58612934|FG001|First Intervention|Progressive disease|0|||
30601596|NCT01306032|58612935|FG002|First Intervention|Progressive disease|0|||
30601597|NCT01306032|58612936|FG003|First Intervention|Progressive disease|0|||
30601598|NCT01306032|58612937|FG004|First Intervention|Progressive disease|2|||
30601599|NCT01306032|58612938|FG005|First Intervention|Progressive disease|0|||
30601600|NCT01306032|58612933|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
30601601|NCT01306032|58612934|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
30601602|NCT01306032|58612935|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
30601603|NCT01306032|58612936|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
30601604|NCT01306032|58612937|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
30601605|NCT01306032|58612938|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
30601606|NCT01306032|58612933|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
30601607|NCT01306032|58612934|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
30601608|NCT01306032|58612935|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
30601609|NCT01306032|58612936|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
30601610|NCT01306032|58612937|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
30601611|NCT01306032|58612938|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
30601612|NCT01263015|58612966|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
30601613|NCT01263015|58612967|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
30601614|NCT01263015|58612966|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
30601615|NCT01263015|58612967|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
30601616|NCT01263015|58612966|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
30601617|NCT01263015|58612967|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
30601618|NCT01263015|58612966|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
30601619|NCT01263015|58612967|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
30601620|NCT01263015|58612966|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
30601621|NCT01263015|58612967|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
30601622|NCT01263015|58612966|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
30601623|NCT01263015|58612967|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
30601624|NCT01263015|58612966|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
30601625|NCT01263015|58612967|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
30601626|NCT01263015|58612966|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
30601627|NCT01263015|58612967|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
30601628|NCT01263015|58612966|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
30601629|NCT01263015|58612967|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
30601630|NCT01263015|58612966|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
30601631|NCT01263015|58612967|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
30601632|NCT01263015|58612966|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
30601633|NCT01263015|58612967|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
30601634|NCT01263015|58612966|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
30601635|NCT01263015|58612967|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
30601636|NCT01305564|58612973|FG000|Overall Study|Death|21|||
30601637|NCT01305564|58612973|FG000|Overall Study|Lost to Follow-up|12|||
30601638|NCT01305564|58612973|FG000|Overall Study|Withdrawal by Subject|1|||
30601639|NCT01305564|58612973|FG000|Overall Study|Physician Decision|3|||
30601640|NCT01305408|58612990|FG000|Overall Study|Adverse Event|10|||
30601641|NCT01305408|58612991|FG001|Overall Study|Adverse Event|7|||
30601642|NCT01305408|58612990|FG000|Overall Study|Lack of Efficacy|3|||
30601643|NCT01305408|58612991|FG001|Overall Study|Lack of Efficacy|4|||
30601644|NCT01305408|58612990|FG000|Overall Study|Withdrawal by Subject|9|||
30601645|NCT01305408|58612991|FG001|Overall Study|Withdrawal by Subject|9|||
30601646|NCT01305408|58612990|FG000|Overall Study|Protocol Violation|4|||
30601647|NCT01305408|58612991|FG001|Overall Study|Protocol Violation|6|||
30601648|NCT01305408|58612990|FG000|Overall Study|Lost to Follow-up|5|||
30601649|NCT01305408|58612991|FG001|Overall Study|Lost to Follow-up|3|||
30601650|NCT01305408|58612990|FG000|Overall Study|Noncompliance with study medication|0|||
30601651|NCT01305408|58612991|FG001|Overall Study|Noncompliance with study medication|1|||
30690522|NCT00402727|58704541|FG000|Overall Study|non-compliance|0|||
30690523|NCT00402727|58704542|FG001|Overall Study|non-compliance|1|||
30690524|NCT00402649|58704548|FG000|Overall Study|Lost to Follow-up|1|||
30690525|NCT00402649|58704548|FG000|Overall Study|Withdrawal by Subject|1|||
30690526|NCT00402337|58704557|FG000|Overall Study|Adverse Event|0|||
30690527|NCT00402337|58704558|FG001|Overall Study|Adverse Event|2|||
30690528|NCT00402337|58704559|FG002|Overall Study|Adverse Event|2|||
30690529|NCT00402337|58704560|FG003|Overall Study|Adverse Event|3|||
30690530|NCT00402337|58704561|FG004|Overall Study|Adverse Event|2|||
30690531|NCT00402337|58704557|FG000|Overall Study|Noncompliance|0|||
30690532|NCT00402337|58704558|FG001|Overall Study|Noncompliance|0|||
30690533|NCT00402337|58704559|FG002|Overall Study|Noncompliance|0|||
30690534|NCT00402337|58704560|FG003|Overall Study|Noncompliance|0|||
30690535|NCT00402337|58704561|FG004|Overall Study|Noncompliance|2|||
30690536|NCT00402337|58704557|FG000|Overall Study|Withdrawal by Subject|5|||
30690537|NCT00402337|58704558|FG001|Overall Study|Withdrawal by Subject|3|||
30690538|NCT00402337|58704559|FG002|Overall Study|Withdrawal by Subject|1|||
30690539|NCT00402337|58704560|FG003|Overall Study|Withdrawal by Subject|6|||
30690540|NCT00402337|58704561|FG004|Overall Study|Withdrawal by Subject|4|||
30690541|NCT00402337|58704557|FG000|Overall Study|Lost to Follow-up|0|||
30690542|NCT00402337|58704558|FG001|Overall Study|Lost to Follow-up|0|||
30690543|NCT00402337|58704559|FG002|Overall Study|Lost to Follow-up|1|||
30690544|NCT00402337|58704560|FG003|Overall Study|Lost to Follow-up|2|||
30690545|NCT00402337|58704561|FG004|Overall Study|Lost to Follow-up|0|||
30690546|NCT00402337|58704557|FG000|Overall Study|Physician Decision|0|||
30690547|NCT00402337|58704558|FG001|Overall Study|Physician Decision|0|||
30690548|NCT00402337|58704559|FG002|Overall Study|Physician Decision|0|||
30690549|NCT00402337|58704560|FG003|Overall Study|Physician Decision|1|||
30690550|NCT00402337|58704561|FG004|Overall Study|Physician Decision|0|||
30690551|NCT00402337|58704557|FG000|Overall Study|Other Reason|0|||
30690552|NCT00402337|58704558|FG001|Overall Study|Other Reason|1|||
30690553|NCT00402337|58704559|FG002|Overall Study|Other Reason|0|||
30690554|NCT00402337|58704560|FG003|Overall Study|Other Reason|0|||
30690555|NCT00402337|58704561|FG004|Overall Study|Other Reason|0|||
30690556|NCT00650091|58704575|FG000|Amended Study Design|Withdrawal by Subject|12|||
30690557|NCT00650091|58704576|FG001|Amended Study Design|Withdrawal by Subject|11|||
30690558|NCT00650091|58704577|FG002|Amended Study Design|Withdrawal by Subject|0|||
30690559|NCT00650091|58704575|FG000|Amended Study Design|Physician Decision|5|||
30690560|NCT00650091|58704576|FG001|Amended Study Design|Physician Decision|0|||
30690561|NCT00650091|58704577|FG002|Amended Study Design|Physician Decision|0|||
30690562|NCT00650091|58704575|FG000|Amended Study Design|Adverse Event|1|||
30690563|NCT00650091|58704576|FG001|Amended Study Design|Adverse Event|4|||
30690564|NCT00650091|58704577|FG002|Amended Study Design|Adverse Event|0|||
30690565|NCT00650091|58704575|FG000|Amended Study Design|Lung transplantation|4|||
30690566|NCT00650091|58704576|FG001|Amended Study Design|Lung transplantation|2|||
30690567|NCT00650091|58704577|FG002|Amended Study Design|Lung transplantation|0|||
30690568|NCT00650091|58704575|FG000|Amended Study Design|Other|1|||
30690569|NCT00650091|58704576|FG001|Amended Study Design|Other|3|||
30690570|NCT00650091|58704577|FG002|Amended Study Design|Other|0|||
30690571|NCT00642369|58704587|FG000|Overall Study|Adverse Event|2|||
30690572|NCT00642369|58704588|FG001|Overall Study|Adverse Event|3|||
30690573|NCT00642369|58704587|FG000|Overall Study|Withdrawal by Subject|1|||
30690574|NCT00642369|58704588|FG001|Overall Study|Withdrawal by Subject|0|||
30690575|NCT00642369|58704587|FG000|Overall Study|misdiagnosis|0|||
30690576|NCT00642369|58704588|FG001|Overall Study|misdiagnosis|1|||
30690577|NCT00642369|58704587|FG000|Overall Study|Lack of Efficacy|2|||
30690578|NCT00642369|58704588|FG001|Overall Study|Lack of Efficacy|2|||
30690579|NCT00645099|58704613|FG000|Overall Study|Lack of Efficacy|15|||
30690580|NCT00645099|58704614|FG001|Overall Study|Lack of Efficacy|6|||
30690581|NCT00645099|58704613|FG000|Overall Study|Withdrawal by Subject|30|||
30690582|NCT00645099|58704614|FG001|Overall Study|Withdrawal by Subject|22|||
30690583|NCT00645099|58704613|FG000|Overall Study|Lost to Follow-up|6|||
30690584|NCT00645099|58704614|FG001|Overall Study|Lost to Follow-up|4|||
30690585|NCT00645099|58704613|FG000|Overall Study|Adverse Event|11|||
30690586|NCT00645099|58704614|FG001|Overall Study|Adverse Event|5|||
30690587|NCT00645099|58704613|FG000|Overall Study|Other|9|||
30690588|NCT00645099|58704614|FG001|Overall Study|Other|5|||
30690589|NCT00420511|58704622|FG000|Overall Study|Adverse Event|1|||
30960734|NCT01526057|59026364|FG000|Overall Study|Protocol Violation|0|||
30960735|NCT01526057|59026365|FG001|Overall Study|Protocol Violation|0|||
30690590|NCT00420511|58704623|FG001|Overall Study|Adverse Event|1|||
30690591|NCT00420511|58704622|FG000|Overall Study|Lost to Follow-up|1|||
30690592|NCT00420511|58704623|FG001|Overall Study|Lost to Follow-up|0|||
30690593|NCT00420199|58704633|FG000|Overall Study|Participant no longer met study criteria|1|||
30690594|NCT00420199|58704634|FG001|Overall Study|Participant no longer met study criteria|0|||
30690595|NCT00649389|58704649|FG000|Overall Study|Adverse Event|22|||
30690596|NCT00649389|58704650|FG001|Overall Study|Adverse Event|46|||
30690597|NCT00649389|58704651|FG002|Overall Study|Adverse Event|38|||
30690598|NCT00649389|58704652|FG003|Overall Study|Adverse Event|48|||
30690599|NCT00649389|58704649|FG000|Overall Study|Lost to Follow-up|15|||
30690600|NCT00649389|58704650|FG001|Overall Study|Lost to Follow-up|17|||
30690601|NCT00649389|58704651|FG002|Overall Study|Lost to Follow-up|21|||
30690602|NCT00649389|58704652|FG003|Overall Study|Lost to Follow-up|26|||
30690603|NCT00649389|58704649|FG000|Overall Study|Protocol Violation|11|||
30690604|NCT00649389|58704650|FG001|Overall Study|Protocol Violation|13|||
30690605|NCT00649389|58704651|FG002|Overall Study|Protocol Violation|9|||
30690606|NCT00649389|58704652|FG003|Overall Study|Protocol Violation|8|||
30690607|NCT00649389|58704649|FG000|Overall Study|Withdrawal by Subject|20|||
30690608|NCT00649389|58704650|FG001|Overall Study|Withdrawal by Subject|21|||
30690609|NCT00649389|58704651|FG002|Overall Study|Withdrawal by Subject|19|||
30690610|NCT00649389|58704652|FG003|Overall Study|Withdrawal by Subject|23|||
30690611|NCT00649389|58704649|FG000|Overall Study|Other|3|||
30690612|NCT00649389|58704650|FG001|Overall Study|Other|9|||
30690613|NCT00649389|58704651|FG002|Overall Study|Other|1|||
30690614|NCT00649389|58704652|FG003|Overall Study|Other|6|||
30690615|NCT00402103|58704664|FG000|Overall Study|Adverse Event|60|||
30690616|NCT00402103|58704665|FG001|Overall Study|Adverse Event|7|||
30690617|NCT00402103|58704664|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30690618|NCT00402103|58704665|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
30690619|NCT00402103|58704664|FG000|Overall Study|Condition no longer requires study drug|2|||
30690620|NCT00402103|58704665|FG001|Overall Study|Condition no longer requires study drug|0|||
30690621|NCT00402103|58704664|FG000|Overall Study|Protocol Deviation|8|||
30690622|NCT00402103|58704665|FG001|Overall Study|Protocol Deviation|0|||
30690623|NCT00402103|58704664|FG000|Overall Study|Patient withdrew consent|12|||
30690624|NCT00402103|58704665|FG001|Overall Study|Patient withdrew consent|1|||
30690625|NCT00402103|58704664|FG000|Overall Study|Lost to Follow-up|6|||
30690626|NCT00402103|58704665|FG001|Overall Study|Lost to Follow-up|3|||
30690627|NCT00402103|58704664|FG000|Overall Study|Administrative problems|2|||
30690628|NCT00402103|58704665|FG001|Overall Study|Administrative problems|0|||
30690629|NCT00641667|58704675|FG000|Overall Study|Withdrawal by Subject|1|||
30690630|NCT00641667|58704675|FG000|Overall Study|Adverse Event|1|||
30690631|NCT00641667|58704675|FG000|Overall Study|Physician Decision|1|||
30690632|NCT00641667|58704675|FG000|Overall Study|Worsening of underlying disease|3|||
30690633|NCT00704184|58704684|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
30690634|NCT00704184|58704685|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
30690635|NCT00704184|58704686|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
30690636|NCT00704184|58704687|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
30690637|NCT00704184|58704688|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
30690638|NCT00704184|58704684|FG000|Open-Label Treatment|Adverse Event|0|||
30690639|NCT00704184|58704685|FG001|Open-Label Treatment|Adverse Event|0|||
30690640|NCT00704184|58704686|FG002|Open-Label Treatment|Adverse Event|2|||
30690641|NCT00704184|58704687|FG003|Open-Label Treatment|Adverse Event|0|||
30690642|NCT00704184|58704688|FG004|Open-Label Treatment|Adverse Event|1|||
30690643|NCT00704184|58704684|FG000|Open-Label Treatment|Lack of Efficacy|0|||
30690644|NCT00704184|58704685|FG001|Open-Label Treatment|Lack of Efficacy|2|||
30690645|NCT00704184|58704686|FG002|Open-Label Treatment|Lack of Efficacy|2|||
30690646|NCT00704184|58704687|FG003|Open-Label Treatment|Lack of Efficacy|2|||
30690647|NCT00704184|58704688|FG004|Open-Label Treatment|Lack of Efficacy|1|||
30690648|NCT00704184|58704684|FG000|Open-Label Treatment|Physician Decision|0|||
30690649|NCT00704184|58704685|FG001|Open-Label Treatment|Physician Decision|0|||
30690650|NCT00704184|58704686|FG002|Open-Label Treatment|Physician Decision|0|||
30690651|NCT00704184|58704687|FG003|Open-Label Treatment|Physician Decision|0|||
30690652|NCT00704184|58704688|FG004|Open-Label Treatment|Physician Decision|1|||
30690653|NCT00704184|58704684|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
30690654|NCT00704184|58704685|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
30690655|NCT00704184|58704686|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
30690656|NCT00704184|58704687|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
30690657|NCT00704184|58704688|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
30690658|NCT00641043|58704702|FG000|Overall Study|Adverse Event|6|||
30690659|NCT00641043|58704703|FG001|Overall Study|Adverse Event|4|||
30690660|NCT00641043|58704702|FG000|Overall Study|Protocol Violation|2|||
30690661|NCT00641043|58704703|FG001|Overall Study|Protocol Violation|3|||
30690662|NCT00641043|58704702|FG000|Overall Study|Lost to Follow-up|3|||
30690663|NCT00641043|58704703|FG001|Overall Study|Lost to Follow-up|2|||
30690664|NCT00641043|58704702|FG000|Overall Study|Withdrawal by Subject|4|||
30690665|NCT00641043|58704703|FG001|Overall Study|Withdrawal by Subject|4|||
30690666|NCT00641043|58704702|FG000|Overall Study|Other incl. lack of efficacy|4|||
30690667|NCT00641043|58704703|FG001|Overall Study|Other incl. lack of efficacy|2|||
30690668|NCT00402025|58704712|FG000|Overall Study|Adverse Event|0|||
30690669|NCT00402025|58704713|FG001|Overall Study|Adverse Event|0|||
30690670|NCT00402025|58704714|FG002|Overall Study|Adverse Event|2|||
30690671|NCT00402025|58704712|FG000|Overall Study|Death|0|||
30690672|NCT00402025|58704713|FG001|Overall Study|Death|1|||
30690673|NCT00402025|58704714|FG002|Overall Study|Death|5|||
30690674|NCT00402025|58704712|FG000|Overall Study|Disease Progression|1|||
30690675|NCT00402025|58704713|FG001|Overall Study|Disease Progression|1|||
30690676|NCT00402025|58704714|FG002|Overall Study|Disease Progression|2|||
30690677|NCT00402025|58704712|FG000|Overall Study|Physician Decision|1|||
30690678|NCT00402025|58704713|FG001|Overall Study|Physician Decision|1|||
30690679|NCT00402025|58704714|FG002|Overall Study|Physician Decision|0|||
30690680|NCT00402025|58704712|FG000|Overall Study|Participant Decision|0|||
30690681|NCT00402025|58704713|FG001|Overall Study|Participant Decision|0|||
30690682|NCT00402025|58704714|FG002|Overall Study|Participant Decision|1|||
30690683|NCT00609622|58704724|FG000|Overall Study|Adverse Event|14|||
30690684|NCT00609622|58704725|FG001|Overall Study|Adverse Event|10|||
30690685|NCT00609622|58704724|FG000|Overall Study|Withdrawal by Subject|4|||
30690686|NCT00609622|58704725|FG001|Overall Study|Withdrawal by Subject|20|||
30690687|NCT00609622|58704724|FG000|Overall Study|Death|1|||
30690688|NCT00609622|58704725|FG001|Overall Study|Death|4|||
30690689|NCT00609622|58704724|FG000|Overall Study|Protocol Violation|1|||
30690690|NCT00609622|58704725|FG001|Overall Study|Protocol Violation|1|||
30690691|NCT00609622|58704724|FG000|Overall Study|Objective progression or relapse|47|||
30690692|NCT00609622|58704725|FG001|Overall Study|Objective progression or relapse|41|||
30690693|NCT00609622|58704724|FG000|Overall Study|Study terminated by sponsor|16|||
30690694|NCT00609622|58704725|FG001|Overall Study|Study terminated by sponsor|3|||
30690695|NCT00609622|58704724|FG000|Overall Study|Other|7|||
30690696|NCT00609622|58704725|FG001|Overall Study|Other|14|||
30690697|NCT00609622|58704724|FG000|Overall Study|Global deterioration of health status|6|||
30690698|NCT00609622|58704725|FG001|Overall Study|Global deterioration of health status|2|||
30690699|NCT00699660|58704733|FG000|Overall Study|Lost to Follow-up|4|||
30690700|NCT00699660|58704734|FG001|Overall Study|Lost to Follow-up|2|||
30690701|NCT00699660|58704733|FG000|Overall Study|missing reports and recording failures|10|||
30690702|NCT00699660|58704734|FG001|Overall Study|missing reports and recording failures|6|||
30690703|NCT00627705|58704742|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
30690704|NCT00627705|58704743|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
30690705|NCT00627705|58704742|FG000|Overall Study|Adverse Event|1|||
30690706|NCT00627705|58704743|FG001|Overall Study|Adverse Event|0|||
30690707|NCT00627705|58704742|FG000|Overall Study|Withdrawal by Subject|0|||
30690708|NCT00627705|58704743|FG001|Overall Study|Withdrawal by Subject|2|||
30690709|NCT00627705|58704742|FG000|Overall Study|Lost to Follow-up|0|||
30690710|NCT00627705|58704743|FG001|Overall Study|Lost to Follow-up|1|||
30690711|NCT00610168|58704751|FG000|Overall Study|Withdrawal by Subject|2|||
30690712|NCT00610168|58704752|FG001|Overall Study|Withdrawal by Subject|0|||
30690713|NCT00644787|58704758|FG000|Period 1: Titration Phase|Adverse Event|11|||
30690714|NCT00644787|58704759|FG001|Period 1: Titration Phase|Adverse Event|0|||
30690715|NCT00644787|58704760|FG002|Period 1: Titration Phase|Adverse Event|0|||
30690716|NCT00644787|58704758|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
30690717|NCT00644787|58704759|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
30690718|NCT00644787|58704760|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
30690719|NCT00644787|58704758|FG000|Period 1: Titration Phase|Physician Decision|1|||
30690720|NCT00644787|58704759|FG001|Period 1: Titration Phase|Physician Decision|0|||
30690721|NCT00644787|58704760|FG002|Period 1: Titration Phase|Physician Decision|0|||
30690722|NCT00644787|58704758|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
30690723|NCT00644787|58704759|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
30690724|NCT00644787|58704760|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
30690725|NCT00644787|58704758|FG000|Period 1: Titration Phase|Worsening of complications|1|||
30690726|NCT00644787|58704759|FG001|Period 1: Titration Phase|Worsening of complications|0|||
30690727|NCT00644787|58704760|FG002|Period 1: Titration Phase|Worsening of complications|0|||
30690728|NCT00644787|58704758|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
30690729|NCT00644787|58704759|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
30690730|NCT00644787|58704760|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
30690731|NCT00644787|58704758|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
30690732|NCT00644787|58704759|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
30690733|NCT00644787|58704760|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
30690734|NCT00644787|58704758|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
30690735|NCT00644787|58704759|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
30690736|NCT00644787|58704760|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
30690737|NCT00644787|58704758|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
30601652|NCT01305408|58612990|FG000|Overall Study|Noncompliance with study procedures|0|||
30601653|NCT01305408|58612991|FG001|Overall Study|Noncompliance with study procedures|1|||
30601654|NCT01305408|58612990|FG000|Overall Study|Other|1|||
30601655|NCT01305408|58612991|FG001|Overall Study|Other|0|||
30601656|NCT01304940|58612999|FG000|Overall Study|not meet symptom severity requirement|3|||
30601657|NCT01304940|58613000|FG001|Overall Study|not meet symptom severity requirement|0|||
30601658|NCT01261611|58613009|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
30601659|NCT01261611|58613010|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
30601660|NCT01261611|58613011|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
30601661|NCT01261611|58613009|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
30601662|NCT01261611|58613010|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
30690738|NCT00644787|58704759|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
30690739|NCT00644787|58704760|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
30690740|NCT00644787|58704758|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
30690741|NCT00644787|58704759|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
30690742|NCT00644787|58704760|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
30690743|NCT00644787|58704758|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
30690744|NCT00644787|58704759|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
30690745|NCT00644787|58704760|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
30690746|NCT00644787|58704758|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
30690747|NCT00644787|58704759|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
30690748|NCT00644787|58704760|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
30690749|NCT00699582|58704771|FG000|Overall Study|Adverse Event|4|||
30690750|NCT00699582|58704772|FG001|Overall Study|Adverse Event|11|||
30690751|NCT00699582|58704773|FG002|Overall Study|Adverse Event|23|||
30690752|NCT00699582|58704771|FG000|Overall Study|Withdrawal by Subject|6|||
30690753|NCT00699582|58704772|FG001|Overall Study|Withdrawal by Subject|7|||
30690754|NCT00699582|58704773|FG002|Overall Study|Withdrawal by Subject|4|||
30690755|NCT00699582|58704771|FG000|Overall Study|Lack of Efficacy|1|||
30690756|NCT00699582|58704772|FG001|Overall Study|Lack of Efficacy|0|||
30690757|NCT00699582|58704773|FG002|Overall Study|Lack of Efficacy|1|||
30690758|NCT00699582|58704771|FG000|Overall Study|Progressive Disease|1|||
30690759|NCT00699582|58704772|FG001|Overall Study|Progressive Disease|0|||
30690760|NCT00699582|58704773|FG002|Overall Study|Progressive Disease|0|||
30690761|NCT00699582|58704771|FG000|Overall Study|Administrative/Other|4|||
30690762|NCT00699582|58704772|FG001|Overall Study|Administrative/Other|3|||
30690763|NCT00699582|58704773|FG002|Overall Study|Administrative/Other|0|||
30690764|NCT00699582|58704771|FG000|Overall Study|Randomized, Not Treated|2|||
30690765|NCT00699582|58704772|FG001|Overall Study|Randomized, Not Treated|1|||
30690766|NCT00699582|58704773|FG002|Overall Study|Randomized, Not Treated|0|||
30690767|NCT00640341|58704784|FG000|Overall Study|Adverse Event|0|||
30690768|NCT00640341|58704785|FG001|Overall Study|Adverse Event|0|||
30690769|NCT00640341|58704786|FG002|Overall Study|Adverse Event|1|||
30690770|NCT00640341|58704784|FG000|Overall Study|Positive Slit Lamp Findings|0|||
30690771|NCT00640341|58704785|FG001|Overall Study|Positive Slit Lamp Findings|0|||
30690772|NCT00640341|58704786|FG002|Overall Study|Positive Slit Lamp Findings|1|||
30690773|NCT00640341|58704784|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
30690774|NCT00640341|58704785|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
30690775|NCT00640341|58704786|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
30690776|NCT00640341|58704784|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
30690777|NCT00640341|58704785|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
30690778|NCT00640341|58704786|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
30690779|NCT00640341|58704784|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
30690780|NCT00640341|58704785|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
30690781|NCT00640341|58704786|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
30690782|NCT00640341|58704784|FG000|Overall Study|Lost to Follow-up|2|||
30690783|NCT00640341|58704785|FG001|Overall Study|Lost to Follow-up|0|||
30690784|NCT00640341|58704786|FG002|Overall Study|Lost to Follow-up|0|||
30690785|NCT00640341|58704784|FG000|Overall Study|Withdrawal by Subject|4|||
30690786|NCT00640341|58704785|FG001|Overall Study|Withdrawal by Subject|0|||
30690787|NCT00640341|58704786|FG002|Overall Study|Withdrawal by Subject|1|||
30690788|NCT00640341|58704784|FG000|Overall Study|Unacceptable Lens Movement|1|||
30690789|NCT00640341|58704785|FG001|Overall Study|Unacceptable Lens Movement|0|||
30690790|NCT00640341|58704786|FG002|Overall Study|Unacceptable Lens Movement|0|||
30690791|NCT00640341|58704784|FG000|Overall Study|Poor fit/Uncomfortable|4|||
30690792|NCT00640341|58704785|FG001|Overall Study|Poor fit/Uncomfortable|0|||
30690793|NCT00640341|58704786|FG002|Overall Study|Poor fit/Uncomfortable|0|||
30690794|NCT00640341|58704784|FG000|Overall Study|Ineligable at Baseline|5|||
30690795|NCT00640341|58704785|FG001|Overall Study|Ineligable at Baseline|3|||
30690796|NCT00640341|58704786|FG002|Overall Study|Ineligable at Baseline|2|||
30690797|NCT00640341|58704784|FG000|Overall Study|Adverse event and positive slit lamp|1|||
30690798|NCT00640341|58704785|FG001|Overall Study|Adverse event and positive slit lamp|0|||
30690799|NCT00640341|58704786|FG002|Overall Study|Adverse event and positive slit lamp|0|||
30690800|NCT00699348|58704794|FG000|Overall Study|Death|6|||
30690801|NCT00699348|58704794|FG000|Overall Study|Adverse Event|15|||
30690802|NCT00699348|58704794|FG000|Overall Study|Withdrawal by Subject|11|||
30690803|NCT00699348|58704794|FG000|Overall Study|Protocol Violation|10|||
30690804|NCT00699348|58704794|FG000|Overall Study|Lack of Efficacy|8|||
30960736|NCT01526057|59026366|FG002|Overall Study|Protocol Violation|1|||
30960737|NCT01525901|59026378|FG000|Period 2: 12 Weeks|Adverse Event|0|||
30690805|NCT00699348|58704794|FG000|Overall Study|Failure to return|1|||
30690806|NCT00699348|58704794|FG000|Overall Study|Blood transfusion|24|||
30690807|NCT00699348|58704794|FG000|Overall Study|Renal transplantation|10|||
30960738|NCT01525901|59026379|FG001|Period 2: 12 Weeks|Adverse Event|1|||
30690808|NCT00699348|58704794|FG000|Overall Study|Other|5|||
30690809|NCT00643851|58704801|FG000|Overall Study|Death|0|||
30690810|NCT00643851|58704802|FG001|Overall Study|Death|1|||
30690811|NCT00643851|58704803|FG002|Overall Study|Death|0|||
30690812|NCT00643851|58704801|FG000|Overall Study|Lack of Efficacy|0|||
30690813|NCT00643851|58704802|FG001|Overall Study|Lack of Efficacy|1|||
30690814|NCT00643851|58704803|FG002|Overall Study|Lack of Efficacy|0|||
30690815|NCT00643851|58704801|FG000|Overall Study|Adverse Event|2|||
30690816|NCT00643851|58704802|FG001|Overall Study|Adverse Event|6|||
30690817|NCT00643851|58704803|FG002|Overall Study|Adverse Event|6|||
30690818|NCT00643851|58704801|FG000|Overall Study|Lost to Follow-up|4|||
30690819|NCT00643851|58704802|FG001|Overall Study|Lost to Follow-up|6|||
30690820|NCT00643851|58704803|FG002|Overall Study|Lost to Follow-up|9|||
30690821|NCT00643851|58704801|FG000|Overall Study|Withdrawal by Subject|8|||
30690822|NCT00643851|58704802|FG001|Overall Study|Withdrawal by Subject|15|||
30690823|NCT00643851|58704803|FG002|Overall Study|Withdrawal by Subject|9|||
30690824|NCT00643851|58704801|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
30690825|NCT00643851|58704802|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
30690826|NCT00643851|58704803|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
30690827|NCT03667690|58704813|FG000|Overall Study|Adverse Event|0|||
30690828|NCT03667690|58704814|FG001|Overall Study|Adverse Event|3|||
30690829|NCT03667690|58704813|FG000|Overall Study|Death|22|||
30690830|NCT03667690|58704814|FG001|Overall Study|Death|21|||
30690831|NCT03667690|58704813|FG000|Overall Study|Lost to Follow-up|4|||
30690832|NCT03667690|58704814|FG001|Overall Study|Lost to Follow-up|5|||
30690833|NCT03667690|58704813|FG000|Overall Study|Withdrawal by Subject|7|||
30690834|NCT03667690|58704814|FG001|Overall Study|Withdrawal by Subject|8|||
30690835|NCT03667690|58704813|FG000|Overall Study|Subject could not return for additional investigational product|1|||
30690836|NCT03667690|58704814|FG001|Overall Study|Subject could not return for additional investigational product|0|||
30690837|NCT03667690|58704813|FG000|Overall Study|Subject discharged to hospice care|2|||
30690838|NCT03667690|58704814|FG001|Overall Study|Subject discharged to hospice care|0|||
30690839|NCT03667690|58704813|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
30690840|NCT03667690|58704814|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
30690841|NCT03667690|58704813|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
30690842|NCT03667690|58704814|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
30690843|NCT03667690|58704813|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
30690844|NCT03667690|58704814|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
30690845|NCT03667690|58704813|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
30690846|NCT03667690|58704814|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
30690847|NCT03667690|58704813|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
30690848|NCT03667690|58704814|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
30690849|NCT00627393|58704822|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
30690850|NCT00627393|58704823|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
30690851|NCT00627393|58704822|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
30690852|NCT00627393|58704823|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
30690853|NCT00627393|58704822|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
30690854|NCT00627393|58704823|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
30690855|NCT00627393|58704822|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
30690856|NCT00627393|58704823|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
30690857|NCT00577122|58704833|FG000|Overall Study|Adverse Event|0|||
30690858|NCT00577122|58704834|FG001|Overall Study|Adverse Event|2|||
30690859|NCT00577122|58704833|FG000|Overall Study|Progression, relapse during active trt|6|||
30690860|NCT00577122|58704834|FG001|Overall Study|Progression, relapse during active trt|8|||
30690861|NCT00577122|58704833|FG000|Overall Study|Prog, refract disease during active trt|8|||
30690862|NCT00577122|58704834|FG001|Overall Study|Prog, refract disease during active trt|5|||
30690863|NCT00577122|58704833|FG000|Overall Study|Alternative Therapy|0|||
30690864|NCT00577122|58704834|FG001|Overall Study|Alternative Therapy|1|||
30690865|NCT00696774|58704844|FG000|Period II|Adverse Event|0|||
30690866|NCT00696774|58704845|FG001|Period II|Adverse Event|0|||
30690867|NCT00696774|58704846|FG002|Period II|Adverse Event|15|||
30690868|NCT00696774|58704844|FG000|Period II|Lost to Follow-up|0|||
30690869|NCT00696774|58704845|FG001|Period II|Lost to Follow-up|0|||
30690870|NCT00696774|58704846|FG002|Period II|Lost to Follow-up|4|||
30864202|NCT03641339|58894399|FG001|Overall Study|Withdrawal by Subject|2|||
30864203|NCT03641339|58894400|FG002|Overall Study|Withdrawal by Subject|0|||
30864204|NCT03641339|58894401|FG003|Overall Study|Withdrawal by Subject|2|||
30690871|NCT00696774|58704844|FG000|Period II|Protocol Violation|0|||
30690872|NCT00696774|58704845|FG001|Period II|Protocol Violation|0|||
30690873|NCT00696774|58704846|FG002|Period II|Protocol Violation|11|||
30864205|NCT03641339|58894402|FG004|Overall Study|Withdrawal by Subject|0|||
30864206|NCT03641339|58894403|FG005|Overall Study|Withdrawal by Subject|1|||
30690874|NCT00696774|58704844|FG000|Period II|Withdrawal by Subject|0|||
30690875|NCT00696774|58704845|FG001|Period II|Withdrawal by Subject|0|||
30690876|NCT00696774|58704846|FG002|Period II|Withdrawal by Subject|4|||
30690877|NCT00696774|58704844|FG000|Period II|Sponsor Decision|0|||
30690878|NCT00696774|58704845|FG001|Period II|Sponsor Decision|0|||
30690879|NCT00696774|58704846|FG002|Period II|Sponsor Decision|0|||
30690880|NCT00696774|58704844|FG000|Period II|Lack of Efficacy|0|||
30690881|NCT00696774|58704845|FG001|Period II|Lack of Efficacy|0|||
30690882|NCT00696774|58704846|FG002|Period II|Lack of Efficacy|2|||
30690883|NCT00696774|58704844|FG000|Period III|Adverse Event|1|||
30690884|NCT00696774|58704845|FG001|Period III|Adverse Event|1|||
30690885|NCT00696774|58704846|FG002|Period III|Adverse Event|0|||
30690886|NCT00696774|58704844|FG000|Period III|Lost to Follow-up|2|||
30690887|NCT00696774|58704845|FG001|Period III|Lost to Follow-up|1|||
30690888|NCT00696774|58704846|FG002|Period III|Lost to Follow-up|0|||
30690889|NCT00696774|58704844|FG000|Period III|Protocol Violation|1|||
30690890|NCT00696774|58704845|FG001|Period III|Protocol Violation|1|||
30690891|NCT00696774|58704846|FG002|Period III|Protocol Violation|0|||
30690892|NCT00696774|58704844|FG000|Period III|Withdrawal by Subject|1|||
30690893|NCT00696774|58704845|FG001|Period III|Withdrawal by Subject|2|||
30864207|NCT02248480|58894419|FG000|Overall Study|Lack of Efficacy|4|||
30864208|NCT02248480|58894420|FG001|Overall Study|Lack of Efficacy|6|||
30864209|NCT02248480|58894419|FG000|Overall Study|Adverse Event|11|||
30690894|NCT00696774|58704846|FG002|Period III|Withdrawal by Subject|0|||
30690895|NCT00696774|58704844|FG000|Period III|Sponsor Decision|2|||
30690896|NCT00696774|58704845|FG001|Period III|Sponsor Decision|0|||
30690897|NCT00696774|58704846|FG002|Period III|Sponsor Decision|0|||
30690898|NCT00696774|58704844|FG000|Period III|Lack of Efficacy|0|||
30690899|NCT00696774|58704845|FG001|Period III|Lack of Efficacy|2|||
30690900|NCT00696774|58704846|FG002|Period III|Lack of Efficacy|0|||
30690901|NCT00608842|58704858|FG000|Overall Study|Participant's Request|0|||
30690902|NCT00608842|58704859|FG001|Overall Study|Participant's Request|1|||
30690903|NCT00608842|58704860|FG002|Overall Study|Participant's Request|2|||
30690904|NCT00608842|58704861|FG003|Overall Study|Participant's Request|1|||
30690905|NCT00608842|58704858|FG000|Overall Study|Lost to Follow-up|1|||
30690906|NCT00608842|58704859|FG001|Overall Study|Lost to Follow-up|0|||
30690907|NCT00608842|58704860|FG002|Overall Study|Lost to Follow-up|0|||
30690908|NCT00608842|58704861|FG003|Overall Study|Lost to Follow-up|0|||
30690909|NCT00626925|58704873|FG000|Overall Study|Lost to Follow-up|1|||
30690910|NCT00626925|58704874|FG001|Overall Study|Lost to Follow-up|2|||
30690911|NCT00626925|58704873|FG000|Overall Study|relapse|1|||
30690912|NCT00626925|58704874|FG001|Overall Study|relapse|0|||
30864210|NCT02248480|58894420|FG001|Overall Study|Adverse Event|2|||
30864211|NCT02248480|58894419|FG000|Overall Study|Withdrawal by Subject|2|||
30864212|NCT02248480|58894420|FG001|Overall Study|Withdrawal by Subject|4|||
30864213|NCT02248480|58894419|FG000|Overall Study|Entry Criteria Not Met|0|||
30864214|NCT02248480|58894420|FG001|Overall Study|Entry Criteria Not Met|1|||
30864215|NCT02248480|58894419|FG000|Overall Study|Other:Physician Decision|0|||
30690913|NCT00626925|58704873|FG000|Overall Study|Adverse effect|6|||
30690914|NCT00626925|58704874|FG001|Overall Study|Adverse effect|2|||
30690915|NCT00626925|58704873|FG000|Overall Study|Lack of Efficacy|1|||
30690916|NCT00626925|58704874|FG001|Overall Study|Lack of Efficacy|4|||
30690917|NCT00626925|58704873|FG000|Overall Study|Time constraints|3|||
30864216|NCT02248480|58894420|FG001|Overall Study|Other:Physician Decision|1|||
30690918|NCT00626925|58704874|FG001|Overall Study|Time constraints|1|||
30690919|NCT00698646|58704897|FG000|Overall Study|Adverse Event|8|||
30690920|NCT00698646|58704898|FG001|Overall Study|Adverse Event|7|||
30690921|NCT00698646|58704899|FG002|Overall Study|Adverse Event|8|||
30690922|NCT00698646|58704897|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
30690923|NCT00698646|58704898|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
30690924|NCT00698646|58704899|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
30690925|NCT00698646|58704897|FG000|Overall Study|Protocol Deviation|6|||
30690926|NCT00698646|58704898|FG001|Overall Study|Protocol Deviation|2|||
30864217|NCT01653158|58894427|FG000|Overall Study|Death|0|||
30864218|NCT01653158|58894428|FG001|Overall Study|Death|0|||
30864219|NCT01653158|58894429|FG002|Overall Study|Death|0|||
30864220|NCT01653158|58894430|FG003|Overall Study|Death|1|||
30864221|NCT01653158|58894431|FG004|Overall Study|Death|0|||
30864222|NCT01653158|58894432|FG005|Overall Study|Death|0|||
30864223|NCT01653158|58894433|FG006|Overall Study|Death|0|||
30864224|NCT01653158|58894434|FG007|Overall Study|Death|2|||
30864225|NCT01653158|58894427|FG000|Overall Study|Adverse Event|0|||
30864226|NCT01653158|58894428|FG001|Overall Study|Adverse Event|0|||
30864227|NCT01653158|58894429|FG002|Overall Study|Adverse Event|0|||
30864228|NCT01653158|58894430|FG003|Overall Study|Adverse Event|1|||
30864229|NCT01653158|58894431|FG004|Overall Study|Adverse Event|0|||
30864230|NCT01653158|58894432|FG005|Overall Study|Adverse Event|0|||
30864231|NCT01653158|58894433|FG006|Overall Study|Adverse Event|0|||
30864232|NCT01653158|58894434|FG007|Overall Study|Adverse Event|3|||
30690927|NCT00698646|58704899|FG002|Overall Study|Protocol Deviation|3|||
30690928|NCT00698646|58704897|FG000|Overall Study|Withdrawal by Subject|10|||
30690929|NCT00698646|58704898|FG001|Overall Study|Withdrawal by Subject|11|||
30690930|NCT00698646|58704899|FG002|Overall Study|Withdrawal by Subject|8|||
30690931|NCT00698646|58704897|FG000|Overall Study|Lost to Follow-up|0|||
30690932|NCT00698646|58704898|FG001|Overall Study|Lost to Follow-up|0|||
30690933|NCT00698646|58704899|FG002|Overall Study|Lost to Follow-up|2|||
30690934|NCT00698646|58704897|FG000|Overall Study|Administrative problems|1|||
30690935|NCT00698646|58704898|FG001|Overall Study|Administrative problems|0|||
30690936|NCT00698646|58704899|FG002|Overall Study|Administrative problems|1|||
30690937|NCT00609466|58704910|FG000|Overall Study|Withdrawal by Subject|0|||
30690938|NCT00609466|58704911|FG001|Overall Study|Withdrawal by Subject|1|||
30690939|NCT00609466|58704912|FG002|Overall Study|Withdrawal by Subject|1|||
30690940|NCT00609466|58704910|FG000|Overall Study|Adverse Event|2|||
30690941|NCT00609466|58704911|FG001|Overall Study|Adverse Event|3|||
30690942|NCT00609466|58704912|FG002|Overall Study|Adverse Event|1|||
30690943|NCT00609466|58704910|FG000|Overall Study|Lack of Efficacy|0|||
30690944|NCT00609466|58704911|FG001|Overall Study|Lack of Efficacy|2|||
30690945|NCT00609466|58704912|FG002|Overall Study|Lack of Efficacy|2|||
30690946|NCT00608530|58704924|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
30690947|NCT00608530|58704925|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
30690948|NCT00608530|58704926|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
30690949|NCT00608530|58704927|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
30690950|NCT00608530|58704924|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
30690951|NCT00608530|58704925|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
30690952|NCT00608530|58704926|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
30690953|NCT00608530|58704927|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
30690954|NCT00608530|58704924|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
30690955|NCT00608530|58704925|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
30690956|NCT00608530|58704926|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
30690957|NCT00608530|58704927|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
30690958|NCT00608530|58704924|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
30690959|NCT00608530|58704925|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
30690960|NCT00608530|58704926|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
30690961|NCT00608530|58704927|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
30690962|NCT00608530|58704924|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
30690963|NCT00608530|58704925|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
30690964|NCT00608530|58704926|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
30690965|NCT00608530|58704927|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
30690966|NCT00608530|58704924|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
30690967|NCT00608530|58704925|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
30690968|NCT00608530|58704926|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
30690969|NCT00608530|58704927|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
30690970|NCT00642993|58704944|FG000|Overall Study|Adverse Event|85|||
30690971|NCT00642993|58704945|FG001|Overall Study|Adverse Event|4|||
30690972|NCT00642993|58704944|FG000|Overall Study|Lost to Follow-up|8|||
30690973|NCT00642993|58704945|FG001|Overall Study|Lost to Follow-up|4|||
30690974|NCT00642993|58704944|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
30690975|NCT00642993|58704945|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
30690976|NCT00642993|58704944|FG000|Overall Study|Protocol Violation|1|||
30690977|NCT00642993|58704945|FG001|Overall Study|Protocol Violation|4|||
30690978|NCT00642993|58704944|FG000|Overall Study|Did not meet protocol eligibility|0|||
30690979|NCT00642993|58704945|FG001|Overall Study|Did not meet protocol eligibility|1|||
30690980|NCT00642993|58704944|FG000|Overall Study|Administrative|1|||
30690981|NCT00642993|58704945|FG001|Overall Study|Administrative|0|||
30690982|NCT00696696|58704951|FG000|Overall Study|Adverse Event|5|||
30690983|NCT00696696|58704951|FG000|Overall Study|Withdrawal by Subject|8|||
30690984|NCT00696696|58704951|FG000|Overall Study|Physician Decision|2|||
30864233|NCT01653158|58894427|FG000|Overall Study|Other|0|||
30690985|NCT00696696|58704951|FG000|Overall Study|Death|3|||
30690986|NCT00699192|58704958|FG000|Overall Study|Missing|1|||
30690987|NCT00699192|58704959|FG001|Overall Study|Missing|1|||
30690988|NCT00699192|58704960|FG002|Overall Study|Missing|1|||
30690989|NCT00699192|58704958|FG000|Overall Study|Adverse Event|9|||
30690990|NCT00699192|58704959|FG001|Overall Study|Adverse Event|4|||
30690991|NCT00699192|58704960|FG002|Overall Study|Adverse Event|3|||
30690992|NCT00699192|58704958|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30690993|NCT00699192|58704959|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30690994|NCT00699192|58704960|FG002|Overall Study|Abnormal test procedure result(s)|1|||
30690995|NCT00699192|58704958|FG000|Overall Study|Lack of Efficacy|0|||
30690996|NCT00699192|58704959|FG001|Overall Study|Lack of Efficacy|0|||
30690997|NCT00699192|58704960|FG002|Overall Study|Lack of Efficacy|1|||
30690998|NCT00699192|58704958|FG000|Overall Study|Withdrawal by Subject|3|||
30690999|NCT00699192|58704959|FG001|Overall Study|Withdrawal by Subject|2|||
30864234|NCT01653158|58894428|FG001|Overall Study|Other|0|||
30864235|NCT01653158|58894429|FG002|Overall Study|Other|0|||
30691000|NCT00699192|58704960|FG002|Overall Study|Withdrawal by Subject|4|||
30691001|NCT00699192|58704958|FG000|Overall Study|Administrative problems|1|||
30691002|NCT00699192|58704959|FG001|Overall Study|Administrative problems|3|||
30691003|NCT00699192|58704960|FG002|Overall Study|Administrative problems|1|||
30691004|NCT00699192|58704958|FG000|Overall Study|Protocol Violation|2|||
30691005|NCT00699192|58704959|FG001|Overall Study|Protocol Violation|2|||
30691006|NCT00699192|58704960|FG002|Overall Study|Protocol Violation|0|||
30691007|NCT00401245|58704976|FG000|Double Blind Titration Phase|Adverse Event|3|||
30691008|NCT00401245|58704977|FG001|Double Blind Titration Phase|Adverse Event|2|||
30691009|NCT00401245|58704978|FG002|Double Blind Titration Phase|Adverse Event|5|||
30691010|NCT00401245|58704979|FG003|Double Blind Titration Phase|Adverse Event|12|||
30691011|NCT00401245|58704980|FG004|Double Blind Titration Phase|Adverse Event|0|||
30691012|NCT00401245|58704981|FG005|Double Blind Titration Phase|Adverse Event|0|||
30691013|NCT00401245|58704982|FG006|Double Blind Titration Phase|Adverse Event|0|||
30691014|NCT00401245|58704983|FG007|Double Blind Titration Phase|Adverse Event|0|||
30691015|NCT00401245|58704976|FG000|Double Blind Titration Phase|Other|0|||
30691016|NCT00401245|58704977|FG001|Double Blind Titration Phase|Other|0|||
30691017|NCT00401245|58704978|FG002|Double Blind Titration Phase|Other|1|||
30691018|NCT00401245|58704979|FG003|Double Blind Titration Phase|Other|0|||
30691019|NCT00401245|58704980|FG004|Double Blind Titration Phase|Other|0|||
30691020|NCT00401245|58704981|FG005|Double Blind Titration Phase|Other|0|||
30691021|NCT00401245|58704982|FG006|Double Blind Titration Phase|Other|0|||
30691022|NCT00401245|58704983|FG007|Double Blind Titration Phase|Other|0|||
30691023|NCT00401245|58704976|FG000|Double Blind Titration Phase|Protocol Violation|0|||
30691024|NCT00401245|58704977|FG001|Double Blind Titration Phase|Protocol Violation|0|||
30691025|NCT00401245|58704978|FG002|Double Blind Titration Phase|Protocol Violation|0|||
30691026|NCT00401245|58704979|FG003|Double Blind Titration Phase|Protocol Violation|1|||
30691027|NCT00401245|58704980|FG004|Double Blind Titration Phase|Protocol Violation|0|||
30691028|NCT00401245|58704981|FG005|Double Blind Titration Phase|Protocol Violation|0|||
30691029|NCT00401245|58704982|FG006|Double Blind Titration Phase|Protocol Violation|0|||
30691030|NCT00401245|58704983|FG007|Double Blind Titration Phase|Protocol Violation|0|||
30691031|NCT00401245|58704976|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
30691032|NCT00401245|58704977|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
30691033|NCT00401245|58704978|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
30691034|NCT00401245|58704979|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
30691035|NCT00401245|58704980|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
30691036|NCT00401245|58704981|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
30691037|NCT00401245|58704982|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
30691038|NCT00401245|58704983|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
30691039|NCT00401245|58704976|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
30691040|NCT00401245|58704977|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
30691041|NCT00401245|58704978|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
30691042|NCT00401245|58704979|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
30691043|NCT00401245|58704980|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
30691044|NCT00401245|58704981|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
30691045|NCT00401245|58704982|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
30691046|NCT00401245|58704983|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
30691047|NCT00401245|58704976|FG000|Open Label Phase|Adverse Event|5|||
30691048|NCT00401245|58704977|FG001|Open Label Phase|Adverse Event|14|||
30691049|NCT00401245|58704978|FG002|Open Label Phase|Adverse Event|6|||
30691050|NCT00401245|58704979|FG003|Open Label Phase|Adverse Event|7|||
30691051|NCT00401245|58704980|FG004|Open Label Phase|Adverse Event|0|||
30691052|NCT00401245|58704981|FG005|Open Label Phase|Adverse Event|0|||
30691053|NCT00401245|58704982|FG006|Open Label Phase|Adverse Event|0|||
30691054|NCT00401245|58704983|FG007|Open Label Phase|Adverse Event|0|||
30691055|NCT00401245|58704976|FG000|Open Label Phase|Lost to Follow-up|5|||
30691056|NCT00401245|58704977|FG001|Open Label Phase|Lost to Follow-up|7|||
30691057|NCT00401245|58704978|FG002|Open Label Phase|Lost to Follow-up|5|||
30864236|NCT01653158|58894430|FG003|Overall Study|Other|0|||
30864237|NCT01653158|58894431|FG004|Overall Study|Other|0|||
30601663|NCT01261611|58613011|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
30601664|NCT01261611|58613009|FG000|Treatment Cycle 1|Adverse Event|0|||
30601665|NCT01261611|58613010|FG001|Treatment Cycle 1|Adverse Event|1|||
30601666|NCT01261611|58613011|FG002|Treatment Cycle 1|Adverse Event|0|||
30601667|NCT01261611|58613009|FG000|Treatment Cycle 1|Protocol Violation|0|||
30601668|NCT01261611|58613010|FG001|Treatment Cycle 1|Protocol Violation|0|||
30601669|NCT01261611|58613011|FG002|Treatment Cycle 1|Protocol Violation|2|||
30601670|NCT01261611|58613009|FG000|Treatment Cycle 2|Completed study|4|||
30691058|NCT00401245|58704979|FG003|Open Label Phase|Lost to Follow-up|4|||
30691059|NCT00401245|58704980|FG004|Open Label Phase|Lost to Follow-up|0|||
30864238|NCT01653158|58894432|FG005|Overall Study|Other|0|||
30601671|NCT01261611|58613010|FG001|Treatment Cycle 2|Completed study|0|||
30691060|NCT00401245|58704981|FG005|Open Label Phase|Lost to Follow-up|0|||
30691061|NCT00401245|58704982|FG006|Open Label Phase|Lost to Follow-up|0|||
30691062|NCT00401245|58704983|FG007|Open Label Phase|Lost to Follow-up|0|||
30691063|NCT00401245|58704976|FG000|Open Label Phase|Other|4|||
30691064|NCT00401245|58704977|FG001|Open Label Phase|Other|8|||
30691065|NCT00401245|58704978|FG002|Open Label Phase|Other|7|||
30691066|NCT00401245|58704979|FG003|Open Label Phase|Other|8|||
30691067|NCT00401245|58704980|FG004|Open Label Phase|Other|0|||
30691068|NCT00401245|58704981|FG005|Open Label Phase|Other|0|||
30691069|NCT00401245|58704982|FG006|Open Label Phase|Other|0|||
30691070|NCT00401245|58704983|FG007|Open Label Phase|Other|0|||
30691071|NCT00401245|58704976|FG000|Open Label Phase|Protocol Violation|0|||
30691072|NCT00401245|58704977|FG001|Open Label Phase|Protocol Violation|1|||
30691073|NCT00401245|58704978|FG002|Open Label Phase|Protocol Violation|0|||
30691074|NCT00401245|58704979|FG003|Open Label Phase|Protocol Violation|1|||
30691075|NCT00401245|58704980|FG004|Open Label Phase|Protocol Violation|0|||
30691076|NCT00401245|58704981|FG005|Open Label Phase|Protocol Violation|0|||
30691077|NCT00401245|58704982|FG006|Open Label Phase|Protocol Violation|0|||
30691078|NCT00401245|58704983|FG007|Open Label Phase|Protocol Violation|0|||
30691079|NCT00401245|58704976|FG000|Open Label Phase|Withdrawal by Subject|3|||
30691080|NCT00401245|58704977|FG001|Open Label Phase|Withdrawal by Subject|3|||
30691081|NCT00401245|58704978|FG002|Open Label Phase|Withdrawal by Subject|2|||
30691082|NCT00401245|58704979|FG003|Open Label Phase|Withdrawal by Subject|1|||
30691083|NCT00401245|58704980|FG004|Open Label Phase|Withdrawal by Subject|0|||
30691084|NCT00401245|58704981|FG005|Open Label Phase|Withdrawal by Subject|0|||
30691085|NCT00401245|58704982|FG006|Open Label Phase|Withdrawal by Subject|0|||
30691086|NCT00401245|58704983|FG007|Open Label Phase|Withdrawal by Subject|0|||
30691087|NCT00401245|58704976|FG000|Open Label Phase|Lack of Efficacy|4|||
30691088|NCT00401245|58704977|FG001|Open Label Phase|Lack of Efficacy|2|||
30691089|NCT00401245|58704978|FG002|Open Label Phase|Lack of Efficacy|3|||
30691090|NCT00401245|58704979|FG003|Open Label Phase|Lack of Efficacy|0|||
30691091|NCT00401245|58704980|FG004|Open Label Phase|Lack of Efficacy|0|||
30691092|NCT00401245|58704981|FG005|Open Label Phase|Lack of Efficacy|0|||
30691093|NCT00401245|58704982|FG006|Open Label Phase|Lack of Efficacy|0|||
30691094|NCT00401245|58704983|FG007|Open Label Phase|Lack of Efficacy|0|||
30691095|NCT00401245|58704976|FG000|Double Blind Tapering Phase|Adverse Event|0|||
30691096|NCT00401245|58704977|FG001|Double Blind Tapering Phase|Adverse Event|0|||
30691097|NCT00401245|58704978|FG002|Double Blind Tapering Phase|Adverse Event|0|||
30691098|NCT00401245|58704979|FG003|Double Blind Tapering Phase|Adverse Event|0|||
30691099|NCT00401245|58704980|FG004|Double Blind Tapering Phase|Adverse Event|1|||
30691100|NCT00401245|58704981|FG005|Double Blind Tapering Phase|Adverse Event|1|||
30691101|NCT00401245|58704982|FG006|Double Blind Tapering Phase|Adverse Event|2|||
30691102|NCT00401245|58704983|FG007|Double Blind Tapering Phase|Adverse Event|4|||
30691103|NCT00401245|58704976|FG000|Double Blind Tapering Phase|Investigator request|0|||
30691104|NCT00401245|58704977|FG001|Double Blind Tapering Phase|Investigator request|0|||
30691105|NCT00401245|58704978|FG002|Double Blind Tapering Phase|Investigator request|0|||
30691106|NCT00401245|58704979|FG003|Double Blind Tapering Phase|Investigator request|0|||
30691107|NCT00401245|58704980|FG004|Double Blind Tapering Phase|Investigator request|0|||
30691108|NCT00401245|58704981|FG005|Double Blind Tapering Phase|Investigator request|0|||
30691109|NCT00401245|58704982|FG006|Double Blind Tapering Phase|Investigator request|0|||
30691110|NCT00401245|58704983|FG007|Double Blind Tapering Phase|Investigator request|1|||
30691111|NCT00401245|58704976|FG000|Double Blind Tapering Phase|Other|0|||
30691112|NCT00401245|58704977|FG001|Double Blind Tapering Phase|Other|0|||
30691113|NCT00401245|58704978|FG002|Double Blind Tapering Phase|Other|0|||
30864239|NCT01653158|58894433|FG006|Overall Study|Other|0|||
30864240|NCT01653158|58894434|FG007|Overall Study|Other|1|||
30864241|NCT01653158|58894427|FG000|Overall Study|Progressive disease|0|||
30864242|NCT01653158|58894428|FG001|Overall Study|Progressive disease|0|||
30864243|NCT01653158|58894429|FG002|Overall Study|Progressive disease|0|||
30864244|NCT01653158|58894430|FG003|Overall Study|Progressive disease|0|||
30864245|NCT01653158|58894431|FG004|Overall Study|Progressive disease|1|||
30864246|NCT01653158|58894432|FG005|Overall Study|Progressive disease|1|||
30691114|NCT00401245|58704979|FG003|Double Blind Tapering Phase|Other|0|||
30864247|NCT01653158|58894433|FG006|Overall Study|Progressive disease|2|||
30864248|NCT01653158|58894434|FG007|Overall Study|Progressive disease|9|||
30864249|NCT01653158|58894427|FG000|Overall Study|Withdrawal by Subject|1|||
30864250|NCT01653158|58894428|FG001|Overall Study|Withdrawal by Subject|0|||
30960739|NCT01525901|59026380|FG002|Period 2: 12 Weeks|Adverse Event|0|||
30691115|NCT00401245|58704980|FG004|Double Blind Tapering Phase|Other|1|||
30691116|NCT00401245|58704981|FG005|Double Blind Tapering Phase|Other|0|||
30691117|NCT00401245|58704982|FG006|Double Blind Tapering Phase|Other|2|||
30691118|NCT00401245|58704983|FG007|Double Blind Tapering Phase|Other|2|||
30691119|NCT00401245|58704976|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
30691120|NCT00401245|58704977|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
30691121|NCT00401245|58704978|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
30960740|NCT01525901|59026381|FG003|Period 2: 12 Weeks|Adverse Event|0|||
30691122|NCT00401245|58704979|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
30960741|NCT01525589|59026494|FG000|Overall Study|Non-treatment-related AE|1|||
30691123|NCT00401245|58704980|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
30691124|NCT00401245|58704981|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
30691125|NCT00401245|58704982|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
30864251|NCT01653158|58894429|FG002|Overall Study|Withdrawal by Subject|0|||
30864252|NCT01653158|58894430|FG003|Overall Study|Withdrawal by Subject|0|||
30864253|NCT01653158|58894431|FG004|Overall Study|Withdrawal by Subject|0|||
30864254|NCT01653158|58894432|FG005|Overall Study|Withdrawal by Subject|0|||
30864255|NCT01653158|58894433|FG006|Overall Study|Withdrawal by Subject|0|||
30864256|NCT01653158|58894434|FG007|Overall Study|Withdrawal by Subject|0|||
30864257|NCT02247466|58894459|FG000|Overall Study|Procedure changed to open surgery|0|||
30864258|NCT02247466|58894460|FG001|Overall Study|Procedure changed to open surgery|3|||
30864259|NCT03317795|58894468|FG000|Overall Study|IUD Expulsion|1|||
30864260|NCT03317795|58894469|FG001|Overall Study|IUD Expulsion|0|||
30864261|NCT03317795|58894468|FG000|Overall Study|Lost to Follow-up|1|||
30864262|NCT03317795|58894469|FG001|Overall Study|Lost to Follow-up|3|||
30864263|NCT03317795|58894468|FG000|Overall Study|Treatment change|0|||
30864264|NCT03317795|58894469|FG001|Overall Study|Treatment change|3|||
30864265|NCT03317795|58894468|FG000|Overall Study|Intolerance of medication|0|||
30864266|NCT03317795|58894469|FG001|Overall Study|Intolerance of medication|1|||
30864267|NCT02202616|58894475|FG000|Overall Study|Screen failed|24|||
30864268|NCT02202616|58894475|FG000|Overall Study|Adverse Event|32|||
30864269|NCT02202616|58894475|FG000|Overall Study|Protocol deviation|18|||
30864270|NCT02202616|58894475|FG000|Overall Study|Patient withdrew consent|12|||
30864271|NCT02202616|58894475|FG000|Overall Study|Lost to Follow-up|6|||
30864272|NCT02202616|58894475|FG000|Overall Study|Administrative problems|6|||
30864273|NCT02202616|58894475|FG000|Overall Study|Abnormal test procedure result|1|||
30864274|NCT02202616|58894475|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30864275|NCT02455388|58894482|FG000|Overall Study|Protocol Violation|1|||
30864276|NCT02455388|58894483|FG001|Overall Study|Protocol Violation|0|||
30864277|NCT02455388|58894484|FG002|Overall Study|Protocol Violation|4|||
30691126|NCT00401245|58704983|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
30691127|NCT00401245|58704976|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
30691128|NCT00401245|58704977|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
30691129|NCT00401245|58704978|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
30691130|NCT00401245|58704979|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
30691131|NCT00401245|58704980|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
30691132|NCT00401245|58704981|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
30691133|NCT00401245|58704982|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
30691134|NCT00401245|58704983|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
30691135|NCT00696384|58705003|FG000|Open Label Phase|Adverse Event|27|||
30691136|NCT00696384|58705004|FG001|Open Label Phase|Adverse Event|0|||
30691137|NCT00696384|58705005|FG002|Open Label Phase|Adverse Event|0|||
30691138|NCT00696384|58705003|FG000|Open Label Phase|Protocol Violation|18|||
30691139|NCT00696384|58705004|FG001|Open Label Phase|Protocol Violation|0|||
30691140|NCT00696384|58705005|FG002|Open Label Phase|Protocol Violation|0|||
30691141|NCT00696384|58705003|FG000|Open Label Phase|Lost to Follow-up|24|||
30691142|NCT00696384|58705004|FG001|Open Label Phase|Lost to Follow-up|0|||
30691143|NCT00696384|58705005|FG002|Open Label Phase|Lost to Follow-up|0|||
30691144|NCT00696384|58705003|FG000|Open Label Phase|Withdrawal by Subject|37|||
30691145|NCT00696384|58705004|FG001|Open Label Phase|Withdrawal by Subject|0|||
30691146|NCT00696384|58705005|FG002|Open Label Phase|Withdrawal by Subject|0|||
30691147|NCT00696384|58705003|FG000|Open Label Phase|Other|6|||
30691148|NCT00696384|58705004|FG001|Open Label Phase|Other|0|||
30691149|NCT00696384|58705005|FG002|Open Label Phase|Other|0|||
30691150|NCT00696384|58705003|FG000|Open Label Phase|Lack of Efficacy|3|||
30691151|NCT00696384|58705004|FG001|Open Label Phase|Lack of Efficacy|0|||
30691152|NCT00696384|58705005|FG002|Open Label Phase|Lack of Efficacy|0|||
30691153|NCT00696384|58705003|FG000|Open Label Phase|Physician Decision|4|||
30864278|NCT02455388|58894482|FG000|Overall Study|Withdrawal by Subject|0|||
30864279|NCT02455388|58894483|FG001|Overall Study|Withdrawal by Subject|0|||
30864280|NCT02455388|58894484|FG002|Overall Study|Withdrawal by Subject|7|||
30864281|NCT02455076|58894497|FG000|Inpatient|Withdrawal by Subject|1|||
30864282|NCT02455076|58894498|FG001|Inpatient|Withdrawal by Subject|0|||
30864283|NCT02455076|58894499|FG002|Inpatient|Withdrawal by Subject|0|||
30864284|NCT02455076|58894500|FG003|Inpatient|Withdrawal by Subject|0|||
30960742|NCT01525589|59026495|FG001|Overall Study|Non-treatment-related AE|0|||
30691154|NCT00696384|58705004|FG001|Open Label Phase|Physician Decision|0|||
30691155|NCT00696384|58705005|FG002|Open Label Phase|Physician Decision|0|||
30691156|NCT00696384|58705003|FG000|Double Blind Phase|Adverse Event|0|||
30691157|NCT00696384|58705004|FG001|Double Blind Phase|Adverse Event|2|||
30691158|NCT00696384|58705005|FG002|Double Blind Phase|Adverse Event|2|||
30864285|NCT02455076|58894501|FG004|Inpatient|Withdrawal by Subject|0|||
30864286|NCT02455076|58894497|FG000|Inpatient|Discharged <24 h after admission|0|||
30864287|NCT02455076|58894498|FG001|Inpatient|Discharged <24 h after admission|1|||
30864288|NCT02455076|58894499|FG002|Inpatient|Discharged <24 h after admission|0|||
30864289|NCT02455076|58894500|FG003|Inpatient|Discharged <24 h after admission|0|||
30691159|NCT00696384|58705003|FG000|Double Blind Phase|Lost to Follow-up|0|||
30691160|NCT00696384|58705004|FG001|Double Blind Phase|Lost to Follow-up|2|||
30691161|NCT00696384|58705005|FG002|Double Blind Phase|Lost to Follow-up|1|||
30691162|NCT00696384|58705003|FG000|Double Blind Phase|Withdrawal by Subject|0|||
30691163|NCT00696384|58705004|FG001|Double Blind Phase|Withdrawal by Subject|4|||
30691164|NCT00696384|58705005|FG002|Double Blind Phase|Withdrawal by Subject|3|||
30691165|NCT00696384|58705003|FG000|Double Blind Phase|Lack of Efficacy|0|||
30691166|NCT00696384|58705004|FG001|Double Blind Phase|Lack of Efficacy|1|||
30691167|NCT00696384|58705005|FG002|Double Blind Phase|Lack of Efficacy|0|||
30691168|NCT00696384|58705003|FG000|Double Blind Phase|Physician Decision|0|||
30691169|NCT00696384|58705004|FG001|Double Blind Phase|Physician Decision|2|||
30691170|NCT00696384|58705005|FG002|Double Blind Phase|Physician Decision|0|||
30691171|NCT00636675|58705016|FG000|Overall Study|Lost to Follow-up|121|||
30691172|NCT00636675|58705017|FG001|Overall Study|Lost to Follow-up|31|||
30691173|NCT00636675|58705016|FG000|Overall Study|Withdrawal by Subject|19|||
30691174|NCT00636675|58705017|FG001|Overall Study|Withdrawal by Subject|10|||
30691175|NCT00699998|58705027|FG000|Overall Study|Withdrawal by Subject|194|||
30691176|NCT00699998|58705028|FG001|Overall Study|Withdrawal by Subject|83|||
30691177|NCT00699998|58705029|FG002|Overall Study|Withdrawal by Subject|202|||
30691178|NCT00699998|58705030|FG003|Overall Study|Withdrawal by Subject|80|||
30691179|NCT00699998|58705027|FG000|Overall Study|Physician Decision|3|||
30691180|NCT00699998|58705028|FG001|Overall Study|Physician Decision|2|||
30691181|NCT00699998|58705029|FG002|Overall Study|Physician Decision|1|||
30691182|NCT00699998|58705030|FG003|Overall Study|Physician Decision|1|||
30691183|NCT00699998|58705027|FG000|Overall Study|Lost to Follow-up|2|||
30691184|NCT00699998|58705028|FG001|Overall Study|Lost to Follow-up|1|||
30691185|NCT00699998|58705029|FG002|Overall Study|Lost to Follow-up|3|||
30691186|NCT00699998|58705030|FG003|Overall Study|Lost to Follow-up|1|||
30691187|NCT00696072|58705047|FG000|Overall Study|continuing active treatment|10|||
30691188|NCT00696072|58705048|FG001|Overall Study|continuing active treatment|13|||
30691189|NCT00696072|58705047|FG000|Overall Study|Adverse Event|10|||
30691190|NCT00696072|58705048|FG001|Overall Study|Adverse Event|6|||
30691191|NCT00696072|58705047|FG000|Overall Study|Patient Request|3|||
30691192|NCT00696072|58705048|FG001|Overall Study|Patient Request|7|||
30691193|NCT00696072|58705047|FG000|Overall Study|Investigator Request|1|||
30691194|NCT00696072|58705048|FG001|Overall Study|Investigator Request|4|||
30691195|NCT00696072|58705047|FG000|Overall Study|Sponsor Request|0|||
30691196|NCT00696072|58705048|FG001|Overall Study|Sponsor Request|1|||
30691197|NCT00696072|58705047|FG000|Overall Study|Disease Progression|32|||
30691198|NCT00696072|58705048|FG001|Overall Study|Disease Progression|30|||
30691199|NCT00696072|58705047|FG000|Overall Study|Non-specified|1|||
30691200|NCT00696072|58705048|FG001|Overall Study|Non-specified|2|||
30691201|NCT00634647|58705055|FG000|Overall Study|death on study|3|||
30691202|NCT00634647|58705055|FG000|Overall Study|refused further treatment|3|||
30691203|NCT00634647|58705055|FG000|Overall Study|declined to participate before treatment|1|||
30691204|NCT00576732|58705062|FG000|DOUBLE BLIND|Adverse Event|0|||
30691205|NCT00576732|58705063|FG001|DOUBLE BLIND|Adverse Event|0|||
30691206|NCT00576732|58705064|FG002|DOUBLE BLIND|Adverse Event|1|||
30691207|NCT00576732|58705065|FG003|DOUBLE BLIND|Adverse Event|0|||
30691208|NCT00576732|58705066|FG004|DOUBLE BLIND|Adverse Event|0|||
30691209|NCT00576732|58705067|FG005|DOUBLE BLIND|Adverse Event|0|||
30691210|NCT00576732|58705062|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
30691211|NCT00576732|58705063|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
30691212|NCT00576732|58705064|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
30691213|NCT00576732|58705065|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
30691214|NCT00576732|58705066|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
30691215|NCT00576732|58705067|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
30691216|NCT00576732|58705062|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
30691217|NCT00576732|58705063|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
30691218|NCT00576732|58705064|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
30691219|NCT00576732|58705065|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
30691220|NCT00576732|58705066|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
30691221|NCT00576732|58705067|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
30691222|NCT00576732|58705062|FG000|DOUBLE BLIND|OTHER|0|||
30691223|NCT00576732|58705063|FG001|DOUBLE BLIND|OTHER|2|||
30691224|NCT00576732|58705064|FG002|DOUBLE BLIND|OTHER|1|||
30691225|NCT00576732|58705065|FG003|DOUBLE BLIND|OTHER|0|||
30691226|NCT00576732|58705066|FG004|DOUBLE BLIND|OTHER|0|||
30691227|NCT00576732|58705067|FG005|DOUBLE BLIND|OTHER|0|||
30691228|NCT00576732|58705062|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
30691229|NCT00576732|58705063|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
30691230|NCT00576732|58705064|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
30691231|NCT00576732|58705065|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
30691232|NCT00576732|58705066|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
30691233|NCT00576732|58705067|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
30691234|NCT00576732|58705062|FG000|DOUBLE BLIND|Protocol Violation|1|||
30691235|NCT00576732|58705063|FG001|DOUBLE BLIND|Protocol Violation|0|||
30691236|NCT00576732|58705064|FG002|DOUBLE BLIND|Protocol Violation|0|||
30691237|NCT00576732|58705065|FG003|DOUBLE BLIND|Protocol Violation|0|||
30691238|NCT00576732|58705066|FG004|DOUBLE BLIND|Protocol Violation|0|||
30691239|NCT00576732|58705067|FG005|DOUBLE BLIND|Protocol Violation|0|||
30691240|NCT00576732|58705062|FG000|OPEN LABEL|Adverse Event|0|||
30691241|NCT00576732|58705063|FG001|OPEN LABEL|Adverse Event|0|||
30691242|NCT00576732|58705064|FG002|OPEN LABEL|Adverse Event|0|||
30691243|NCT00576732|58705065|FG003|OPEN LABEL|Adverse Event|4|||
30691244|NCT00576732|58705066|FG004|OPEN LABEL|Adverse Event|0|||
30691245|NCT00576732|58705067|FG005|OPEN LABEL|Adverse Event|1|||
30691246|NCT00576732|58705062|FG000|OPEN LABEL|Lost to Follow-up|0|||
30691247|NCT00576732|58705063|FG001|OPEN LABEL|Lost to Follow-up|0|||
30691248|NCT00576732|58705064|FG002|OPEN LABEL|Lost to Follow-up|0|||
30691249|NCT00576732|58705065|FG003|OPEN LABEL|Lost to Follow-up|2|||
30691250|NCT00576732|58705066|FG004|OPEN LABEL|Lost to Follow-up|1|||
30691251|NCT00576732|58705067|FG005|OPEN LABEL|Lost to Follow-up|1|||
30691252|NCT00576732|58705062|FG000|OPEN LABEL|Withdrawal by Subject|0|||
30691253|NCT00576732|58705063|FG001|OPEN LABEL|Withdrawal by Subject|0|||
30691254|NCT00576732|58705064|FG002|OPEN LABEL|Withdrawal by Subject|0|||
30691255|NCT00576732|58705065|FG003|OPEN LABEL|Withdrawal by Subject|1|||
30691256|NCT00576732|58705066|FG004|OPEN LABEL|Withdrawal by Subject|0|||
30691257|NCT00576732|58705067|FG005|OPEN LABEL|Withdrawal by Subject|1|||
30691258|NCT00576732|58705062|FG000|OPEN LABEL|OTHER|0|||
30691259|NCT00576732|58705063|FG001|OPEN LABEL|OTHER|0|||
30691260|NCT00576732|58705064|FG002|OPEN LABEL|OTHER|0|||
30691261|NCT00576732|58705065|FG003|OPEN LABEL|OTHER|0|||
30691262|NCT00576732|58705066|FG004|OPEN LABEL|OTHER|0|||
30691263|NCT00576732|58705067|FG005|OPEN LABEL|OTHER|2|||
30691264|NCT00576732|58705062|FG000|OPEN LABEL|Lack of Efficacy|0|||
30691265|NCT00576732|58705063|FG001|OPEN LABEL|Lack of Efficacy|0|||
30691266|NCT00576732|58705064|FG002|OPEN LABEL|Lack of Efficacy|0|||
30691267|NCT00576732|58705065|FG003|OPEN LABEL|Lack of Efficacy|2|||
30691268|NCT00576732|58705066|FG004|OPEN LABEL|Lack of Efficacy|2|||
30691269|NCT00576732|58705067|FG005|OPEN LABEL|Lack of Efficacy|3|||
30691270|NCT00576732|58705062|FG000|OPEN LABEL|Protocol Violation|0|||
30691271|NCT00576732|58705063|FG001|OPEN LABEL|Protocol Violation|0|||
30691272|NCT00576732|58705064|FG002|OPEN LABEL|Protocol Violation|0|||
30691273|NCT00576732|58705065|FG003|OPEN LABEL|Protocol Violation|2|||
30691274|NCT00576732|58705066|FG004|OPEN LABEL|Protocol Violation|1|||
30691275|NCT00576732|58705067|FG005|OPEN LABEL|Protocol Violation|0|||
30691276|NCT00697788|58705079|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
30691277|NCT00697788|58705080|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
30691278|NCT00697788|58705081|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
30691279|NCT00697788|58705082|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
30691280|NCT00697788|58705083|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
30691281|NCT00697788|58705084|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
30691282|NCT00697788|58705085|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
30691283|NCT00697788|58705086|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
30691284|NCT00697788|58705079|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
30691285|NCT00697788|58705080|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
30691286|NCT00697788|58705081|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
30691287|NCT00697788|58705082|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
30691288|NCT00697788|58705083|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
30691289|NCT00697788|58705084|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
30691290|NCT00697788|58705085|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
30691291|NCT00697788|58705086|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
30691292|NCT00400153|58705116|FG000|Overall Study|AE due to study disease worsening|14|||
30691293|NCT00400153|58705117|FG001|Overall Study|AE due to study disease worsening|19|||
30691294|NCT00400153|58705118|FG002|Overall Study|AE due to study disease worsening|20|||
30691295|NCT00400153|58705116|FG000|Overall Study|AE due to other disease worsening|2|||
30691296|NCT00400153|58705117|FG001|Overall Study|AE due to other disease worsening|1|||
30691297|NCT00400153|58705118|FG002|Overall Study|AE due to other disease worsening|0|||
30960743|NCT01525589|59026496|FG002|Overall Study|Non-treatment-related AE|0|||
30691298|NCT00400153|58705116|FG000|Overall Study|AE due to other condition|3|||
30691299|NCT00400153|58705117|FG001|Overall Study|AE due to other condition|14|||
30691300|NCT00400153|58705118|FG002|Overall Study|AE due to other condition|15|||
30691301|NCT00400153|58705116|FG000|Overall Study|Protocol Violation|7|||
30691302|NCT00400153|58705117|FG001|Overall Study|Protocol Violation|4|||
30691303|NCT00400153|58705118|FG002|Overall Study|Protocol Violation|9|||
30691304|NCT00400153|58705116|FG000|Overall Study|Lost to Follow-up|2|||
30691305|NCT00400153|58705117|FG001|Overall Study|Lost to Follow-up|1|||
30691306|NCT00400153|58705118|FG002|Overall Study|Lost to Follow-up|4|||
30691307|NCT00400153|58705116|FG000|Overall Study|Withdrawal by Subject|12|||
30691308|NCT00400153|58705117|FG001|Overall Study|Withdrawal by Subject|11|||
30691309|NCT00400153|58705118|FG002|Overall Study|Withdrawal by Subject|10|||
30691310|NCT00400153|58705116|FG000|Overall Study|Other reasons - not mentioned above|8|||
30691311|NCT00400153|58705117|FG001|Overall Study|Other reasons - not mentioned above|5|||
30691312|NCT00400153|58705118|FG002|Overall Study|Other reasons - not mentioned above|3|||
30691313|NCT00631917|58705133|FG000|Overall Study|Adverse Event|34|||
30691314|NCT00631917|58705134|FG001|Overall Study|Adverse Event|45|||
30691315|NCT00631917|58705133|FG000|Overall Study|Abnormal laboratory value(s)|2|||
30691316|NCT00631917|58705134|FG001|Overall Study|Abnormal laboratory value(s)|1|||
30691317|NCT00631917|58705133|FG000|Overall Study|Abnormal test procedure result(s)|3|||
30691318|NCT00631917|58705134|FG001|Overall Study|Abnormal test procedure result(s)|2|||
30691319|NCT00631917|58705133|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
30691320|NCT00631917|58705134|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
30691321|NCT00631917|58705133|FG000|Overall Study|No longer required study drug|0|||
30691322|NCT00631917|58705134|FG001|Overall Study|No longer required study drug|1|||
30691323|NCT00631917|58705133|FG000|Overall Study|Protocol deviation|6|||
30691324|NCT00631917|58705134|FG001|Overall Study|Protocol deviation|5|||
30691325|NCT00631917|58705133|FG000|Overall Study|Subject withdrew consent|25|||
30691326|NCT00631917|58705134|FG001|Overall Study|Subject withdrew consent|33|||
30691327|NCT00631917|58705133|FG000|Overall Study|Lost to Follow-up|7|||
30691328|NCT00631917|58705134|FG001|Overall Study|Lost to Follow-up|7|||
30691329|NCT00631917|58705133|FG000|Overall Study|Administrative problems|2|||
30691330|NCT00631917|58705134|FG001|Overall Study|Administrative problems|0|||
30691331|NCT00631917|58705133|FG000|Overall Study|Death|1|||
30691332|NCT00631917|58705134|FG001|Overall Study|Death|0|||
30691333|NCT00419341|58705151|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
30691334|NCT00419341|58705151|FG000|Wash in/Wash Out Period|Adverse Event|2|||
30691335|NCT00419341|58705151|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
30691336|NCT00419341|58705151|FG000|Efficacy Period|Withdrawal by Subject|6|||
30691337|NCT00419341|58705151|FG000|Efficacy Period|Protocol Violation|1|||
30691338|NCT00419341|58705151|FG000|Efficacy Period|Lost to Follow-up|1|||
30691339|NCT00419341|58705151|FG000|Efficacy Period|Non-compliance|1|||
30691340|NCT00419341|58705151|FG000|Efficacy Period|Termination of study site|1|||
30691341|NCT00694122|58705157|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
30691342|NCT00694122|58705158|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
30691343|NCT00694122|58705157|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
30691344|NCT00694122|58705158|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
30691345|NCT00694122|58705157|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
30691346|NCT00694122|58705158|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
30691347|NCT03922620|58705171|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
30691348|NCT03922620|58705172|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
30691349|NCT00419263|58705181|FG000|Overall Study|Lost to Follow-up|2|||
30691350|NCT00419263|58705182|FG001|Overall Study|Lost to Follow-up|1|||
30691351|NCT00419263|58705183|FG002|Overall Study|Lost to Follow-up|1|||
30691352|NCT00419263|58705181|FG000|Overall Study|Randomized in Error, Not Treated|1|||
30691353|NCT00419263|58705182|FG001|Overall Study|Randomized in Error, Not Treated|1|||
30691354|NCT00419263|58705183|FG002|Overall Study|Randomized in Error, Not Treated|0|||
30691355|NCT00419263|58705181|FG000|Overall Study|Adverse Event|0|||
30691356|NCT00419263|58705182|FG001|Overall Study|Adverse Event|0|||
30691357|NCT00419263|58705183|FG002|Overall Study|Adverse Event|1|||
30691358|NCT00419263|58705181|FG000|Overall Study|Withdrawal by Subject|0|||
30691359|NCT00419263|58705182|FG001|Overall Study|Withdrawal by Subject|0|||
30691360|NCT00419263|58705183|FG002|Overall Study|Withdrawal by Subject|1|||
30691361|NCT00399763|58705194|FG000|Overall Study|Lost to Follow-up|2|||
30691362|NCT00399763|58705195|FG001|Overall Study|Lost to Follow-up|3|||
30691363|NCT00699842|58705204|FG000|Overall Study|Death|0|||
30691364|NCT00699842|58705205|FG001|Overall Study|Death|1|||
30691365|NCT00699842|58705206|FG002|Overall Study|Death|0|||
30691366|NCT00399529|58705214|FG000|Overall Study|Off Study Prior to Treatment|2|||
30691367|NCT00712712|58705219|FG000|Overall Study|Protocol Violation|11|||
30691368|NCT00712712|58705219|FG000|Overall Study|Radiofrequency not done|3|||
30691369|NCT00712712|58705219|FG000|Overall Study|Death|8|||
30691370|NCT00712712|58705219|FG000|Overall Study|Withdrawal by Subject|1|||
30864290|NCT02455076|58894501|FG004|Inpatient|Discharged <24 h after admission|0|||
30864291|NCT02455076|58894497|FG000|Inpatient|Adverse Event|3|||
30960744|NCT01525589|59026494|FG000|Overall Study|Progressive disease|48|||
30691371|NCT00411151|58705223|FG000|Overall Study|Death|38|||
30691372|NCT00411151|58705223|FG000|Overall Study|Withdrawal by Subject|2|||
30691373|NCT00411151|58705223|FG000|Overall Study|Lost to Follow-up|2|||
30691374|NCT00411151|58705223|FG000|Overall Study|Protocol Violation|1|||
30691375|NCT00411151|58705223|FG000|Overall Study|Trial prematurely closed|4|||
30864292|NCT02455076|58894498|FG001|Inpatient|Adverse Event|0|||
30864293|NCT02455076|58894499|FG002|Inpatient|Adverse Event|0|||
30864294|NCT02455076|58894500|FG003|Inpatient|Adverse Event|0|||
30864295|NCT02455076|58894501|FG004|Inpatient|Adverse Event|0|||
30864296|NCT02455076|58894497|FG000|Outpatient|Adverse Event|0|||
30864297|NCT02455076|58894498|FG001|Outpatient|Adverse Event|0|||
30691376|NCT00607048|58705229|FG000|Overall Study|Adverse Event|0|||
30691377|NCT00607048|58705230|FG001|Overall Study|Adverse Event|1|||
30691378|NCT00607048|58705231|FG002|Overall Study|Adverse Event|0|||
30691379|NCT00607048|58705232|FG003|Overall Study|Adverse Event|0|||
30691380|NCT00607048|58705233|FG004|Overall Study|Adverse Event|4|||
30691381|NCT00607048|58705234|FG005|Overall Study|Adverse Event|0|||
30691382|NCT00607048|58705229|FG000|Overall Study|Global deterioration of health|1|||
30691383|NCT00607048|58705230|FG001|Overall Study|Global deterioration of health|0|||
30691384|NCT00607048|58705231|FG002|Overall Study|Global deterioration of health|0|||
30691385|NCT00607048|58705232|FG003|Overall Study|Global deterioration of health|0|||
30691386|NCT00607048|58705233|FG004|Overall Study|Global deterioration of health|0|||
30691387|NCT00607048|58705234|FG005|Overall Study|Global deterioration of health|0|||
30691388|NCT00607048|58705229|FG000|Overall Study|Objective disease progression - relapse|1|||
30691389|NCT00607048|58705230|FG001|Overall Study|Objective disease progression - relapse|2|||
30691390|NCT00607048|58705231|FG002|Overall Study|Objective disease progression - relapse|4|||
30691391|NCT00607048|58705232|FG003|Overall Study|Objective disease progression - relapse|2|||
30691392|NCT00607048|58705233|FG004|Overall Study|Objective disease progression - relapse|2|||
30691393|NCT00607048|58705234|FG005|Overall Study|Objective disease progression - relapse|2|||
30691394|NCT00607048|58705229|FG000|Overall Study|Withdrawal by Subject|0|||
30691395|NCT00607048|58705230|FG001|Overall Study|Withdrawal by Subject|0|||
30691396|NCT00607048|58705231|FG002|Overall Study|Withdrawal by Subject|0|||
30691397|NCT00607048|58705232|FG003|Overall Study|Withdrawal by Subject|1|||
30691398|NCT00607048|58705233|FG004|Overall Study|Withdrawal by Subject|0|||
30691399|NCT00607048|58705234|FG005|Overall Study|Withdrawal by Subject|2|||
30691400|NCT00607048|58705229|FG000|Overall Study|Other|1|||
30691401|NCT00607048|58705230|FG001|Overall Study|Other|1|||
30691402|NCT00607048|58705231|FG002|Overall Study|Other|0|||
30691403|NCT00607048|58705232|FG003|Overall Study|Other|0|||
30691404|NCT00607048|58705233|FG004|Overall Study|Other|0|||
30691405|NCT00607048|58705234|FG005|Overall Study|Other|1|||
30691406|NCT00699608|58705250|FG000|First Intervention|Withdrawal by Subject|0|||
30691407|NCT00699608|58705251|FG001|First Intervention|Withdrawal by Subject|0|||
30691408|NCT00699608|58705252|FG002|First Intervention|Withdrawal by Subject|1|||
30691409|NCT00699608|58705253|FG003|First Intervention|Withdrawal by Subject|0|||
30691410|NCT00699608|58705254|FG004|First Intervention|Withdrawal by Subject|0|||
30691411|NCT00699608|58705255|FG005|First Intervention|Withdrawal by Subject|0|||
30691412|NCT00699608|58705250|FG000|First Intervention|Protocol Violation|0|||
30691413|NCT00699608|58705251|FG001|First Intervention|Protocol Violation|0|||
30691414|NCT00699608|58705252|FG002|First Intervention|Protocol Violation|0|||
30691415|NCT00699608|58705253|FG003|First Intervention|Protocol Violation|0|||
30691416|NCT00699608|58705254|FG004|First Intervention|Protocol Violation|1|||
30691417|NCT00699608|58705255|FG005|First Intervention|Protocol Violation|0|||
30691418|NCT00699608|58705250|FG000|Second Intervention|Adverse Event|0|||
30691419|NCT00699608|58705251|FG001|Second Intervention|Adverse Event|0|||
30691420|NCT00699608|58705252|FG002|Second Intervention|Adverse Event|1|||
30691421|NCT00699608|58705253|FG003|Second Intervention|Adverse Event|0|||
30691422|NCT00699608|58705254|FG004|Second Intervention|Adverse Event|0|||
30691423|NCT00699608|58705255|FG005|Second Intervention|Adverse Event|0|||
30691424|NCT00699608|58705250|FG000|Second Intervention|Withdrawal by Subject|0|||
30691425|NCT00699608|58705251|FG001|Second Intervention|Withdrawal by Subject|0|||
30691426|NCT00699608|58705252|FG002|Second Intervention|Withdrawal by Subject|0|||
30691427|NCT00699608|58705253|FG003|Second Intervention|Withdrawal by Subject|1|||
30691428|NCT00699608|58705254|FG004|Second Intervention|Withdrawal by Subject|0|||
30691429|NCT00699608|58705255|FG005|Second Intervention|Withdrawal by Subject|0|||
30691430|NCT03823404|58705266|FG000|Overall Study|Lost to Follow-up|1|||
30691431|NCT03823404|58705267|FG001|Overall Study|Lost to Follow-up|2|||
30691432|NCT03823404|58705268|FG002|Overall Study|Lost to Follow-up|3|||
30691433|NCT03823404|58705266|FG000|Overall Study|Protocol Violation|2|||
30691434|NCT03823404|58705267|FG001|Overall Study|Protocol Violation|0|||
30691435|NCT03823404|58705268|FG002|Overall Study|Protocol Violation|2|||
30691436|NCT03823404|58705266|FG000|Overall Study|Adverse Event|35|||
30691437|NCT03823404|58705267|FG001|Overall Study|Adverse Event|38|||
30691438|NCT03823404|58705268|FG002|Overall Study|Adverse Event|8|||
30691439|NCT03823404|58705266|FG000|Overall Study|Withdrawal by Subject|38|||
30691440|NCT03823404|58705267|FG001|Overall Study|Withdrawal by Subject|40|||
30691441|NCT03823404|58705268|FG002|Overall Study|Withdrawal by Subject|35|||
30691442|NCT03823404|58705266|FG000|Overall Study|Death|4|||
30691443|NCT03823404|58705267|FG001|Overall Study|Death|0|||
30691444|NCT03823404|58705268|FG002|Overall Study|Death|0|||
30691445|NCT03823404|58705266|FG000|Overall Study|Other: Various reasons provided|5|||
30691446|NCT03823404|58705267|FG001|Overall Study|Other: Various reasons provided|5|||
30691447|NCT03823404|58705268|FG002|Overall Study|Other: Various reasons provided|6|||
30864298|NCT02455076|58894499|FG002|Outpatient|Adverse Event|0|||
30864299|NCT02455076|58894500|FG003|Outpatient|Adverse Event|5|||
30864300|NCT02455076|58894501|FG004|Outpatient|Adverse Event|0|||
30691448|NCT00706706|58705276|FG000|Overall Study|Death|53|||
30691449|NCT00706706|58705276|FG000|Overall Study|Lost to Follow-up|7|||
30691450|NCT00706706|58705276|FG000|Overall Study|Study endpoint had reached|45|||
30691451|NCT00410761|58705282|FG000|Overall Study|Adverse Event|29|||
30691452|NCT00410761|58705283|FG001|Overall Study|Adverse Event|3|||
30691453|NCT00410761|58705282|FG000|Overall Study|objective disease progression|71|||
30786567|NCT01367158|58799761|FG006|Overall Study|Protocol Violation|0|||
30691454|NCT00410761|58705283|FG001|Overall Study|objective disease progression|55|||
30691455|NCT00410761|58705282|FG000|Overall Study|Withdrawal by Subject|8|||
30691456|NCT00410761|58705283|FG001|Overall Study|Withdrawal by Subject|4|||
30691457|NCT00410761|58705282|FG000|Overall Study|Other|12|||
30691458|NCT00410761|58705283|FG001|Overall Study|Other|9|||
30691459|NCT00410761|58705282|FG000|Overall Study|Never received randomised treatment|0|||
30864301|NCT02455076|58894497|FG000|Outpatient|Lost to Follow-up|0|||
30864302|NCT02455076|58894498|FG001|Outpatient|Lost to Follow-up|0|||
30864303|NCT02455076|58894499|FG002|Outpatient|Lost to Follow-up|0|||
30601672|NCT01261611|58613011|FG002|Treatment Cycle 2|Completed study|0|||
30601673|NCT01261611|58613009|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
30601674|NCT01261611|58613010|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
30601675|NCT01261611|58613011|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
30601676|NCT01261611|58613009|FG000|Treatment Cycle 2|Adverse Event|1|||
30601677|NCT01261611|58613010|FG001|Treatment Cycle 2|Adverse Event|0|||
30601678|NCT01261611|58613011|FG002|Treatment Cycle 2|Adverse Event|0|||
30601679|NCT01261611|58613009|FG000|Treatment Cycle 2|Protocol Violation|2|||
30601680|NCT01261611|58613010|FG001|Treatment Cycle 2|Protocol Violation|0|||
30601681|NCT01261611|58613011|FG002|Treatment Cycle 2|Protocol Violation|0|||
30601682|NCT01261611|58613009|FG000|Treatment Cycle 2|Not otherwise specified|2|||
30601683|NCT01261611|58613010|FG001|Treatment Cycle 2|Not otherwise specified|0|||
30601684|NCT01261611|58613011|FG002|Treatment Cycle 2|Not otherwise specified|0|||
30601685|NCT01261611|58613009|FG000|Treatment Cycle 3|Completed study|24|||
30601686|NCT01261611|58613010|FG001|Treatment Cycle 3|Completed study|0|||
30601687|NCT01261611|58613011|FG002|Treatment Cycle 3|Completed study|0|||
30601688|NCT01261611|58613009|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
30601689|NCT01261611|58613010|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
30601690|NCT01261611|58613011|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
30601691|NCT01261611|58613009|FG000|Treatment Cycle 3|Adverse Event|1|||
30601692|NCT01261611|58613010|FG001|Treatment Cycle 3|Adverse Event|0|||
30601693|NCT01261611|58613011|FG002|Treatment Cycle 3|Adverse Event|0|||
30601694|NCT01261611|58613009|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
30601695|NCT01261611|58613010|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
30601696|NCT01261611|58613011|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
30601697|NCT01261611|58613009|FG000|Treatment Cycle 4|Completed study|87|||
30601698|NCT01261611|58613010|FG001|Treatment Cycle 4|Completed study|0|||
30601699|NCT01261611|58613011|FG002|Treatment Cycle 4|Completed study|0|||
30601700|NCT01261611|58613009|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
30601701|NCT01261611|58613010|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
30601702|NCT01261611|58613011|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
30601703|NCT01261611|58613009|FG000|Treatment Cycle 4|Adverse Event|1|||
30601704|NCT01261611|58613010|FG001|Treatment Cycle 4|Adverse Event|0|||
30601705|NCT01261611|58613011|FG002|Treatment Cycle 4|Adverse Event|0|||
30601706|NCT01261611|58613009|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
30601707|NCT01261611|58613010|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
30601708|NCT01261611|58613011|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
30601709|NCT01261611|58613009|FG000|Treatment Cycle 4|Not otherwise specified|3|||
30601710|NCT01261611|58613010|FG001|Treatment Cycle 4|Not otherwise specified|0|||
30601711|NCT01261611|58613011|FG002|Treatment Cycle 4|Not otherwise specified|0|||
30601712|NCT01261611|58613009|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
30601713|NCT01261611|58613010|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
30601714|NCT01261611|58613011|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
30601715|NCT01261611|58613009|FG000|Treatment Cycle 5|Adverse Event|1|||
30601716|NCT01261611|58613010|FG001|Treatment Cycle 5|Adverse Event|0|||
30601717|NCT01261611|58613011|FG002|Treatment Cycle 5|Adverse Event|0|||
30601718|NCT01261611|58613009|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
30601719|NCT01261611|58613010|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
30601720|NCT01261611|58613011|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
30601721|NCT01304706|58613023|FG000|Overall Study|Adverse Event|2|||
30601722|NCT01304706|58613023|FG000|Overall Study|Lack of Efficacy|1|||
30601723|NCT01304706|58613023|FG000|Overall Study|Death|3|||
30601724|NCT01304706|58613023|FG000|Overall Study|Withdrawal by Subject|3|||
30601725|NCT01304706|58613023|FG000|Overall Study|Lost to Follow-up|7|||
30601726|NCT01304706|58613023|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
30601727|NCT01303380|58613027|FG000|Overall Study|Lack of compliance to study procedures|1|||
30691460|NCT00410761|58705283|FG001|Overall Study|Never received randomised treatment|1|||
30601728|NCT01008553|58613031|FG000|Period 1 (Titration Period)|Physician Decision|2|||
30601729|NCT01008553|58613032|FG001|Period 1 (Titration Period)|Physician Decision|0|||
30601730|NCT01008553|58613033|FG002|Period 1 (Titration Period)|Physician Decision|0|||
30601731|NCT01008553|58613031|FG000|Period 1 (Titration Period)|Adverse Event|33|||
30601732|NCT01008553|58613032|FG001|Period 1 (Titration Period)|Adverse Event|0|||
30601733|NCT01008553|58613033|FG002|Period 1 (Titration Period)|Adverse Event|0|||
30864304|NCT02455076|58894500|FG003|Outpatient|Lost to Follow-up|1|||
30601734|NCT01008553|58613031|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
30601735|NCT01008553|58613032|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
30601736|NCT01008553|58613033|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
30864305|NCT02455076|58894501|FG004|Outpatient|Lost to Follow-up|12|||
30691461|NCT00410605|58705289|FG000|Overall Study|Adverse Event|12|||
30691462|NCT00410605|58705289|FG000|Overall Study|Physician Decision|3|||
30691463|NCT00410605|58705289|FG000|Overall Study|Withdrawal by Subject|5|||
30691464|NCT00410605|58705289|FG000|Overall Study|Started Non-Protocol Therapy|3|||
30691465|NCT00410605|58705289|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
30691466|NCT00410605|58705289|FG000|Overall Study|Transferred to another Institution|1|||
30691467|NCT00418717|58705293|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
30691468|NCT00418717|58705293|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
30691469|NCT00572572|58705299|FG000|Overall Study|Withdrawal by Subject|3|||
30691470|NCT00572572|58705300|FG001|Overall Study|Withdrawal by Subject|6|||
30691471|NCT00418561|58705309|FG000|Overall Study|Participant's (guardian's) decision|0|||
30691472|NCT00418561|58705310|FG001|Overall Study|Participant's (guardian's) decision|1|||
30691473|NCT00418561|58705311|FG002|Overall Study|Participant's (guardian's) decision|0|||
30691474|NCT00398047|58705319|FG000|Overall Study|all patient progressed before completion|3|||
30691475|NCT00631371|58705326|FG000|Overall Study|Lost to Follow-up|24|||
30691476|NCT00631371|58705327|FG001|Overall Study|Lost to Follow-up|19|||
30691477|NCT00631371|58705326|FG000|Overall Study|Other reason|5|||
30691478|NCT00631371|58705327|FG001|Overall Study|Other reason|12|||
30691479|NCT00631371|58705326|FG000|Overall Study|subject request|38|||
30691480|NCT00631371|58705327|FG001|Overall Study|subject request|45|||
30691481|NCT00631371|58705326|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
30691482|NCT00631371|58705327|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
30691483|NCT00631371|58705326|FG000|Overall Study|Death|263|||
30691484|NCT00631371|58705327|FG001|Overall Study|Death|239|||
30691485|NCT00409747|58705333|FG000|Overall Study|Withdrawal by Subject|1|||
30691486|NCT00630747|58705337|FG000|Overall Study|Death|1|||
30691487|NCT00630747|58705337|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
30691488|NCT00630747|58705337|FG000|Overall Study|Returned to country of origin|1|||
30691489|NCT00397891|58705346|FG000|Overall Study|Withdrawal by Subject|1|||
30691490|NCT00397891|58705347|FG001|Overall Study|Withdrawal by Subject|0|||
30691491|NCT00397891|58705348|FG002|Overall Study|Withdrawal by Subject|0|||
30691492|NCT00397891|58705349|FG003|Overall Study|Withdrawal by Subject|0|||
30691493|NCT00397891|58705350|FG004|Overall Study|Withdrawal by Subject|1|||
30691494|NCT00397189|58705364|FG000|3 Weeks Period|Lost to Follow-up|5|||
30691495|NCT00397189|58705365|FG001|3 Weeks Period|Lost to Follow-up|4|||
30691496|NCT00397189|58705364|FG000|3 Weeks Period|Adverse Event|3|||
30691497|NCT00397189|58705365|FG001|3 Weeks Period|Adverse Event|2|||
30864306|NCT02433080|58894515|FG000|Overall Study|Lost to Follow-up|1|||
30864307|NCT02433080|58894516|FG001|Overall Study|Lost to Follow-up|2|||
30864308|NCT02433080|58894515|FG000|Overall Study|Withdrawal by Subject|0|||
30864309|NCT02433080|58894516|FG001|Overall Study|Withdrawal by Subject|2|||
30864310|NCT03092219|58894525|FG000|Overall Study|Protocol Violation|7|||
30864311|NCT03092219|58894526|FG001|Overall Study|Protocol Violation|4|||
30877170|NCT00106691|58908830|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
30877171|NCT00106691|58908831|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
30877172|NCT00106691|58908830|FG000|Overall Study|QTc>480|3|||
30877173|NCT00106691|58908831|FG001|Overall Study|QTc>480|1|||
30877174|NCT00106691|58908830|FG000|Overall Study|mililtary deployment|2|||
30877175|NCT00106691|58908831|FG001|Overall Study|mililtary deployment|0|||
30877176|NCT00106691|58908830|FG000|Overall Study|Study Site Closing/PI Moved|1|||
30877177|NCT00106691|58908831|FG001|Overall Study|Study Site Closing/PI Moved|2|||
30877178|NCT00106691|58908830|FG000|Overall Study|Cardiologist recommendation|1|||
30877179|NCT00106691|58908831|FG001|Overall Study|Cardiologist recommendation|0|||
30877180|NCT00106691|58908830|FG000|Overall Study|Pt. moved to another state|1|||
30877181|NCT00106691|58908831|FG001|Overall Study|Pt. moved to another state|0|||
30877182|NCT00106691|58908830|FG000|Overall Study|Taking exclusionary avodart|1|||
30877183|NCT00106691|58908831|FG001|Overall Study|Taking exclusionary avodart|0|||
30877184|NCT00106691|58908830|FG000|Overall Study|Not able to discontinue plavix|0|||
30877185|NCT00106691|58908831|FG001|Overall Study|Not able to discontinue plavix|1|||
30877186|NCT04209725|58908839|FG000|Overall Study|Adverse Event|1|||
30877187|NCT02644967|58908932|FG000|Overall Study|Death|26|||
30877188|NCT02644967|58908932|FG000|Overall Study|Physician Decision|1|||
30960745|NCT01525589|59026495|FG001|Overall Study|Progressive disease|15|||
30960746|NCT01525589|59026496|FG002|Overall Study|Progressive disease|29|||
30960747|NCT01525589|59026494|FG000|Overall Study|Never treated|2|||
30960748|NCT01525589|59026495|FG001|Overall Study|Never treated|0|||
30691498|NCT00397189|58705364|FG000|3 Weeks Period|Withdrawal by Subject|13|||
30691499|NCT00397189|58705365|FG001|3 Weeks Period|Withdrawal by Subject|9|||
30691500|NCT00397189|58705364|FG000|3 Weeks Period|Physician Decision|0|||
30691501|NCT00397189|58705365|FG001|3 Weeks Period|Physician Decision|2|||
30691502|NCT00397189|58705364|FG000|3 Weeks Period|Protocol Violation|0|||
30691503|NCT00397189|58705365|FG001|3 Weeks Period|Protocol Violation|3|||
30960749|NCT01525589|59026496|FG002|Overall Study|Never treated|0|||
30691504|NCT00397189|58705364|FG000|3 Weeks Period|Other|0|||
30691505|NCT00397189|58705365|FG001|3 Weeks Period|Other|2|||
30691506|NCT00606034|58705373|FG000|Overall Study|incarceration|1|||
30691507|NCT00397033|58705382|FG000|Overall Study|Adverse Event|7|||
30691508|NCT00397033|58705383|FG001|Overall Study|Adverse Event|10|||
30691509|NCT00397033|58705384|FG002|Overall Study|Adverse Event|4|||
30691510|NCT00397033|58705382|FG000|Overall Study|Lack of Efficacy|22|||
30691511|NCT00397033|58705383|FG001|Overall Study|Lack of Efficacy|12|||
30691512|NCT00397033|58705384|FG002|Overall Study|Lack of Efficacy|9|||
30691513|NCT00397033|58705382|FG000|Overall Study|Lost to Follow-up|3|||
30691514|NCT00397033|58705383|FG001|Overall Study|Lost to Follow-up|3|||
30691515|NCT00397033|58705384|FG002|Overall Study|Lost to Follow-up|3|||
30691516|NCT00397033|58705382|FG000|Overall Study|Withdrawal by Subject|12|||
30691517|NCT00397033|58705383|FG001|Overall Study|Withdrawal by Subject|7|||
30691518|NCT00397033|58705384|FG002|Overall Study|Withdrawal by Subject|5|||
30691519|NCT00397033|58705382|FG000|Overall Study|Other|0|||
30691520|NCT00397033|58705383|FG001|Overall Study|Other|5|||
30691521|NCT00397033|58705384|FG002|Overall Study|Other|2|||
30691522|NCT00572728|58705392|FG000|Overall Study|Withdrawal by Subject|10|||
30691523|NCT00572728|58705392|FG000|Overall Study|Ineligible|3|||
30691524|NCT00572728|58705392|FG000|Overall Study|Enrolled under Amendment 4|5|||
30691525|NCT00572728|58705392|FG000|Overall Study|Offstudy due to complicating disease|1|||
30691526|NCT00572728|58705392|FG000|Overall Study|FLT1 not completed|4|||
30691527|NCT00572728|58705392|FG000|Overall Study|First Chemotherapy not initiated|2|||
30691528|NCT00572728|58705392|FG000|Overall Study|FLT2 not completed|5|||
30691529|NCT00572728|58705392|FG000|Overall Study|Second chemotherapy not initiated|1|||
30691530|NCT00572728|58705392|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
30691531|NCT00572728|58705392|FG000|Overall Study|Pathology missing|1|||
30691532|NCT00699374|58705400|FG000|Overall Study|Death|93|||
30691533|NCT00699374|58705401|FG001|Overall Study|Death|83|||
30691534|NCT00699374|58705400|FG000|Overall Study|Adverse Event|70|||
30691535|NCT00699374|58705401|FG001|Overall Study|Adverse Event|67|||
30691536|NCT00699374|58705400|FG000|Overall Study|Global deterioration of health status|7|||
30691537|NCT00699374|58705401|FG001|Overall Study|Global deterioration of health status|8|||
30691538|NCT00699374|58705400|FG000|Overall Study|Lost to Follow-up|3|||
30691539|NCT00699374|58705401|FG001|Overall Study|Lost to Follow-up|5|||
30691540|NCT00699374|58705400|FG000|Overall Study|Withdrawal by Subject|34|||
30691541|NCT00699374|58705401|FG001|Overall Study|Withdrawal by Subject|44|||
30691542|NCT00699374|58705400|FG000|Overall Study|Objective progression or relapse|281|||
30691543|NCT00699374|58705401|FG001|Overall Study|Objective progression or relapse|277|||
30864312|NCT02432846|58894541|FG000|Overall Study (4 Arms/Strata)|Death|3|||
30601737|NCT01008553|58613031|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
30601738|NCT01008553|58613032|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
30601739|NCT01008553|58613033|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
30601740|NCT01008553|58613031|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
30601741|NCT01008553|58613032|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
30601742|NCT01008553|58613033|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
30601743|NCT01008553|58613031|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
30601744|NCT01008553|58613032|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
30601745|NCT01008553|58613033|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
30601746|NCT01008553|58613031|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
30601747|NCT01008553|58613032|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
30601748|NCT01008553|58613033|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
30601749|NCT01008553|58613031|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
30601750|NCT01008553|58613032|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
30601751|NCT01008553|58613033|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
30601752|NCT01008553|58613031|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
30601753|NCT01008553|58613032|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
30601754|NCT01008553|58613033|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
30601755|NCT01008553|58613031|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
30601756|NCT01008553|58613032|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
30601757|NCT01008553|58613033|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
30601758|NCT01008553|58613031|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
30601759|NCT01008553|58613032|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
30601760|NCT01008553|58613033|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
30601761|NCT01008553|58613031|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
30691544|NCT00699374|58705400|FG000|Overall Study|Other|18|||
30691545|NCT00699374|58705401|FG001|Overall Study|Other|15|||
30691546|NCT00699374|58705400|FG000|Overall Study|Protocol Violation|2|||
30691547|NCT00699374|58705401|FG001|Overall Study|Protocol Violation|6|||
30691548|NCT00699374|58705400|FG000|Overall Study|Study terminated by sponsor|13|||
30864313|NCT02432846|58894542|FG001|Overall Study (4 Arms/Strata)|Death|2|||
30864314|NCT02432846|58894543|FG002|Overall Study (4 Arms/Strata)|Death|4|||
30691549|NCT00699374|58705401|FG001|Overall Study|Study terminated by sponsor|28|||
30691550|NCT00699374|58705400|FG000|Overall Study|Randomized but not treated|4|||
30691551|NCT00699374|58705401|FG001|Overall Study|Randomized but not treated|2|||
30691552|NCT00699374|58705400|FG000|Overall Study|Died 28 days after last dose|5|||
30691553|NCT00699374|58705401|FG001|Overall Study|Died 28 days after last dose|9|||
30691554|NCT00606892|58705407|FG000|First Intervention|Protocol Violation|1|||
30691555|NCT00606892|58705408|FG001|First Intervention|Protocol Violation|4|||
30691556|NCT00625443|58705443|FG000|Overall Study|Adverse Event|1|||
30691557|NCT00625443|58705444|FG001|Overall Study|Adverse Event|4|||
30691558|NCT00625443|58705445|FG002|Overall Study|Adverse Event|0|||
30691559|NCT00625443|58705443|FG000|Overall Study|Non-compliance with protocol|0|||
30691560|NCT00625443|58705444|FG001|Overall Study|Non-compliance with protocol|1|||
30691561|NCT00625443|58705445|FG002|Overall Study|Non-compliance with protocol|0|||
30691562|NCT00625443|58705443|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
30691563|NCT00625443|58705444|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
30691564|NCT00625443|58705445|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
30691565|NCT00625443|58705443|FG000|Overall Study|Withdrawal by Subject|0|||
30691566|NCT00625443|58705444|FG001|Overall Study|Withdrawal by Subject|1|||
30691567|NCT00625443|58705445|FG002|Overall Study|Withdrawal by Subject|2|||
30691568|NCT00625443|58705443|FG000|Overall Study|Physician Decision|0|||
30691569|NCT00625443|58705444|FG001|Overall Study|Physician Decision|4|||
30601762|NCT01008553|58613032|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
30691570|NCT00625443|58705445|FG002|Overall Study|Physician Decision|2|||
30691571|NCT00625443|58705443|FG000|Overall Study|Other|0|||
30691572|NCT00625443|58705444|FG001|Overall Study|Other|1|||
30691573|NCT00625443|58705445|FG002|Overall Study|Other|1|||
30691574|NCT00625365|58705456|FG000|Overall Study|Withdrawal by Subject|1|||
30691575|NCT00625365|58705456|FG000|Overall Study|No IV access|5|||
30691576|NCT00625365|58705456|FG000|Overall Study|VSD|1|||
30691577|NCT00606580|58705463|FG000|Overall Study|Lost to Follow-up|1|||
30691578|NCT00606580|58705464|FG001|Overall Study|Lost to Follow-up|1|||
30691579|NCT00606580|58705465|FG002|Overall Study|Lost to Follow-up|4|||
30691580|NCT00606580|58705463|FG000|Overall Study|Clinical failures|1|||
30691581|NCT00606580|58705464|FG001|Overall Study|Clinical failures|0|||
30691582|NCT00606580|58705465|FG002|Overall Study|Clinical failures|12|||
30691583|NCT00606580|58705463|FG000|Overall Study|Withdrawal by investigator|0|||
30691584|NCT00606580|58705464|FG001|Overall Study|Withdrawal by investigator|1|||
30691585|NCT00606580|58705465|FG002|Overall Study|Withdrawal by investigator|6|||
30691586|NCT00606580|58705463|FG000|Overall Study|Withdrawal by Subject|0|||
30691587|NCT00606580|58705464|FG001|Overall Study|Withdrawal by Subject|1|||
30691588|NCT00606580|58705465|FG002|Overall Study|Withdrawal by Subject|0|||
30691589|NCT00629265|58705475|FG000|Overall Study|Lost to Follow-up|4|||
30691590|NCT00629265|58705476|FG001|Overall Study|Lost to Follow-up|5|||
30691591|NCT00629265|58705475|FG000|Overall Study|Withdrawal by Subject|11|||
30691592|NCT00629265|58705476|FG001|Overall Study|Withdrawal by Subject|8|||
30691593|NCT00629265|58705475|FG000|Overall Study|Death|1|||
30691594|NCT00629265|58705476|FG001|Overall Study|Death|0|||
30691595|NCT00629265|58705475|FG000|Overall Study|Adverse Event|2|||
30601763|NCT01008553|58613033|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
30601764|NCT01008553|58613031|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
30601765|NCT01008553|58613032|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
30601766|NCT01008553|58613033|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
30601767|NCT01008553|58613031|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
30601768|NCT01008553|58613032|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
30601769|NCT01008553|58613033|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
30601770|NCT01302834|58613044|FG000|Overall Study|Protocol Violation|17|||
30601771|NCT01302834|58613045|FG001|Overall Study|Protocol Violation|23|||
30601772|NCT01302834|58613044|FG000|Overall Study|HIV positive|1|||
30601773|NCT01302834|58613045|FG001|Overall Study|HIV positive|3|||
30601774|NCT01259115|58613051|FG000|Period 1|Adverse Event|1|||
30601775|NCT01259115|58613052|FG001|Period 1|Adverse Event|0|||
30601776|NCT01259115|58613051|FG000|Period 1|Protocol Violation|2|||
30601777|NCT01259115|58613052|FG001|Period 1|Protocol Violation|0|||
30601778|NCT01259115|58613051|FG000|Period 1|Lost to Follow-up|0|||
30691596|NCT00629265|58705476|FG001|Overall Study|Adverse Event|0|||
30691597|NCT00629265|58705475|FG000|Overall Study|HNC Recurrence|4|||
30601779|NCT01259115|58613052|FG001|Period 1|Lost to Follow-up|1|||
30691598|NCT00629265|58705476|FG001|Overall Study|HNC Recurrence|0|||
30691599|NCT00629265|58705475|FG000|Overall Study|Other CA Requiring Treatment|1|||
30691600|NCT00629265|58705476|FG001|Overall Study|Other CA Requiring Treatment|3|||
30601780|NCT01259115|58613051|FG000|Period 2|Adverse Event|1|||
30601781|NCT01259115|58613052|FG001|Period 2|Adverse Event|0|||
30691601|NCT00629265|58705475|FG000|Overall Study|Needed Esophageal Dilation|4|||
30691602|NCT00629265|58705476|FG001|Overall Study|Needed Esophageal Dilation|1|||
30691603|NCT00629265|58705475|FG000|Overall Study|Unrelated Medical Complications|3|||
30691604|NCT00629265|58705476|FG001|Overall Study|Unrelated Medical Complications|1|||
30691605|NCT00629265|58705475|FG000|Overall Study|Unknown Reason|2|||
30691606|NCT00629265|58705476|FG001|Overall Study|Unknown Reason|2|||
30691607|NCT00606502|58705484|FG000|Randomization|Randomized but not treated|3|||
30691608|NCT00606502|58705485|FG001|Randomization|Randomized but not treated|0|||
30691609|NCT00606502|58705484|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
30691610|NCT00606502|58705485|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
30691611|NCT00605722|58705491|FG000|Overall Study|Adverse Event|6|||
30691612|NCT00605722|58705491|FG000|Overall Study|Insufficient therapeutic response|44|||
30691613|NCT00605722|58705491|FG000|Overall Study|Failure to return|1|||
30691614|NCT00605566|58705495|FG000|Overall Study|Adverse Event|1|||
30691615|NCT00605566|58705495|FG000|Overall Study|Clinical deterioration|1|||
30691616|NCT00605566|58705495|FG000|Overall Study|Poor compliance in run-in period|1|||
30691617|NCT00396877|58705501|FG000|Overall Study|Lost to Follow-up|2|||
30691618|NCT00396877|58705502|FG001|Overall Study|Lost to Follow-up|1|||
30691619|NCT00396877|58705501|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
30691620|NCT00396877|58705502|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
30691621|NCT00628251|58705511|FG000|Randomised Part|Withdrawal by Subject|0|||
30691622|NCT00628251|58705512|FG001|Randomised Part|Withdrawal by Subject|0|||
30691623|NCT00628251|58705513|FG002|Randomised Part|Withdrawal by Subject|1|||
30691624|NCT00628251|58705511|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
30691625|NCT00628251|58705512|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
30691626|NCT00628251|58705513|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
30691627|NCT00628251|58705511|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
30691628|NCT00628251|58705512|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
30691629|NCT00628251|58705513|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
30691630|NCT00628251|58705511|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
30691631|NCT00628251|58705512|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
30691632|NCT00628251|58705513|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
30691633|NCT00628251|58705511|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
30691634|NCT00628251|58705512|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
30691635|NCT00628251|58705513|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
30691636|NCT00628251|58705511|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
30691637|NCT00628251|58705512|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
30691638|NCT00628251|58705513|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
30691639|NCT00625131|58705525|FG000|Overall Study|Lost to Follow-up|3|||
30691640|NCT00625131|58705526|FG001|Overall Study|Lost to Follow-up|2|||
30691641|NCT00625131|58705527|FG002|Overall Study|Lost to Follow-up|0|||
30691642|NCT00625131|58705525|FG000|Overall Study|Withdrawal by Subject|1|||
30691643|NCT00625131|58705526|FG001|Overall Study|Withdrawal by Subject|0|||
30691644|NCT00625131|58705527|FG002|Overall Study|Withdrawal by Subject|5|||
30691645|NCT00408499|58705533|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
30691646|NCT00408499|58705534|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
30691647|NCT00408499|58705535|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
30691648|NCT00408499|58705536|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
30691649|NCT00408499|58705537|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
30691650|NCT00408499|58705533|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
30691651|NCT00408499|58705534|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
30691652|NCT00408499|58705535|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
30691653|NCT00408499|58705536|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
30691654|NCT00408499|58705537|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
30691655|NCT00408499|58705533|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
30691656|NCT00408499|58705534|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
30691657|NCT00408499|58705535|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
30691658|NCT00408499|58705536|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
30691659|NCT00408499|58705537|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
30691660|NCT00408499|58705533|FG000|Phase II- MTD Expansion|Adverse Event|0|||
30691661|NCT00408499|58705534|FG001|Phase II- MTD Expansion|Adverse Event|0|||
30691662|NCT00408499|58705535|FG002|Phase II- MTD Expansion|Adverse Event|0|||
30864315|NCT02432846|58894544|FG003|Overall Study (4 Arms/Strata)|Death|3|||
30864316|NCT02432846|58894545|FG004|Overall Study (4 Arms/Strata)|Death|0|||
30864317|NCT02432846|58894546|FG005|Overall Study (4 Arms/Strata)|Death|0|||
30864318|NCT02432846|58894541|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
30864319|NCT02432846|58894542|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
30864320|NCT02432846|58894543|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
30864321|NCT02432846|58894544|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
30864322|NCT02432846|58894545|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
30864323|NCT02432846|58894546|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
30864324|NCT02432846|58894541|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
30864325|NCT02432846|58894542|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
30864326|NCT02432846|58894543|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
30864327|NCT02432846|58894544|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
30864328|NCT02432846|58894545|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
30691663|NCT00408499|58705536|FG003|Phase II- MTD Expansion|Adverse Event|0|||
30691664|NCT00408499|58705537|FG004|Phase II- MTD Expansion|Adverse Event|9|||
30691665|NCT00408499|58705533|FG000|Phase II- MTD Expansion|Death|0|||
30691666|NCT00408499|58705534|FG001|Phase II- MTD Expansion|Death|0|||
30691667|NCT00408499|58705535|FG002|Phase II- MTD Expansion|Death|0|||
30691668|NCT00408499|58705536|FG003|Phase II- MTD Expansion|Death|0|||
30691669|NCT00408499|58705537|FG004|Phase II- MTD Expansion|Death|2|||
30691670|NCT00408499|58705533|FG000|Phase II- MTD Expansion|Physician Decision|0|||
30691671|NCT00408499|58705534|FG001|Phase II- MTD Expansion|Physician Decision|0|||
30691672|NCT00408499|58705535|FG002|Phase II- MTD Expansion|Physician Decision|0|||
30691673|NCT00408499|58705536|FG003|Phase II- MTD Expansion|Physician Decision|0|||
30691674|NCT00408499|58705537|FG004|Phase II- MTD Expansion|Physician Decision|1|||
30691675|NCT00408499|58705533|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
30691676|NCT00408499|58705534|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
30691677|NCT00408499|58705535|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
30691678|NCT00408499|58705536|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
30691679|NCT00408499|58705537|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
30691680|NCT00408499|58705533|FG000|Phase II- MTD Expansion|treatment delay|0|||
30691681|NCT00408499|58705534|FG001|Phase II- MTD Expansion|treatment delay|0|||
30691682|NCT00408499|58705535|FG002|Phase II- MTD Expansion|treatment delay|0|||
30691683|NCT00408499|58705536|FG003|Phase II- MTD Expansion|treatment delay|0|||
30691684|NCT00408499|58705537|FG004|Phase II- MTD Expansion|treatment delay|3|||
30691685|NCT00621777|58705557|FG000|Open Phase|Adverse Event|20|||
30691686|NCT00621777|58705558|FG001|Open Phase|Adverse Event|0|||
30691687|NCT00621777|58705557|FG000|Open Phase|Did not abstain during open phase|56|||
30691688|NCT00621777|58705558|FG001|Open Phase|Did not abstain during open phase|0|||
30691689|NCT00621777|58705557|FG000|Open Phase|Withdrawal by Subject|17|||
30691690|NCT00621777|58705558|FG001|Open Phase|Withdrawal by Subject|0|||
30691691|NCT00621777|58705557|FG000|Open Phase|administrative|13|||
30691692|NCT00621777|58705558|FG001|Open Phase|administrative|0|||
30691693|NCT00621777|58705557|FG000|Open Phase|Lost to Follow-up|10|||
30691694|NCT00621777|58705558|FG001|Open Phase|Lost to Follow-up|0|||
30691695|NCT00621777|58705557|FG000|Randomized Phase|Adverse Event|3|||
30691696|NCT00621777|58705558|FG001|Randomized Phase|Adverse Event|3|||
30691697|NCT00621777|58705557|FG000|Randomized Phase|Lost to Follow-up|3|||
30691698|NCT00621777|58705558|FG001|Randomized Phase|Lost to Follow-up|3|||
30691699|NCT00621777|58705557|FG000|Randomized Phase|Withdrawal by Subject|1|||
30691700|NCT00621777|58705558|FG001|Randomized Phase|Withdrawal by Subject|9|||
30691701|NCT00621777|58705557|FG000|Randomized Phase|administrative|0|||
30691702|NCT00621777|58705558|FG001|Randomized Phase|administrative|3|||
30691703|NCT00621777|58705557|FG000|Randomized Phase|Death|0|||
30691704|NCT00621777|58705558|FG001|Randomized Phase|Death|1|||
30691705|NCT00408421|58705568|FG000|Treatment Initial Randomization|Adverse Event|5|||
30691706|NCT00408421|58705569|FG001|Treatment Initial Randomization|Adverse Event|9|||
30691707|NCT00408421|58705570|FG002|Treatment Initial Randomization|Adverse Event|0|||
30691708|NCT00408421|58705568|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
30864329|NCT02432846|58894546|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
30864330|NCT02432846|58894541|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
30864331|NCT02432846|58894542|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
30864332|NCT02432846|58894543|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
30864333|NCT02432846|58894544|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
30864334|NCT02432846|58894545|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
30864335|NCT02432846|58894546|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
30864336|NCT02432846|58894541|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
30864337|NCT02432846|58894542|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
30864338|NCT02432846|58894543|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
30864339|NCT02432846|58894544|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
30864340|NCT02432846|58894545|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
30864341|NCT02432846|58894546|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
30864342|NCT02432846|58894541|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
30864343|NCT02432846|58894542|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
30864344|NCT02432846|58894543|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
30864345|NCT02432846|58894544|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
30864346|NCT02432846|58894545|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
30864347|NCT02432846|58894546|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
30691709|NCT00408421|58705569|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
30691710|NCT00408421|58705570|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
30691711|NCT00408421|58705568|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
30691712|NCT00408421|58705569|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
30691713|NCT00408421|58705570|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
30691714|NCT00408421|58705568|FG000|Treatment Initial Randomization|Physician Decision|1|||
30691715|NCT00408421|58705569|FG001|Treatment Initial Randomization|Physician Decision|0|||
30691716|NCT00408421|58705570|FG002|Treatment Initial Randomization|Physician Decision|0|||
30691717|NCT00408421|58705568|FG000|Treatment Initial Randomization|Protocol Violation|0|||
30691718|NCT00408421|58705569|FG001|Treatment Initial Randomization|Protocol Violation|1|||
30691719|NCT00408421|58705570|FG002|Treatment Initial Randomization|Protocol Violation|0|||
30864348|NCT02432846|58894541|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
30864349|NCT02432846|58894542|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
30864350|NCT02432846|58894543|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
30864351|NCT02432846|58894544|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
30864352|NCT02432846|58894545|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
30864353|NCT02432846|58894546|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
30864354|NCT02432846|58894541|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
30864355|NCT02432846|58894542|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
30864356|NCT02432846|58894543|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
30864357|NCT02432846|58894544|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
30864358|NCT02432846|58894545|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
30864359|NCT02432846|58894546|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
30864360|NCT02432846|58894541|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
30864361|NCT02432846|58894542|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
30864362|NCT02432846|58894543|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
30864363|NCT02432846|58894544|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
30864364|NCT02432846|58894545|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
30864365|NCT02432846|58894546|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
30864366|NCT02432846|58894541|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
30691720|NCT00408421|58705568|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
30691721|NCT00408421|58705569|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
30691722|NCT00408421|58705570|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
30691723|NCT00408421|58705568|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
30691724|NCT00408421|58705569|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
30691725|NCT00408421|58705570|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
30691726|NCT00408421|58705568|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
30691727|NCT00408421|58705569|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
30691728|NCT00408421|58705570|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
30691729|NCT00408421|58705568|FG000|Treatment Re-Randomization|Adverse Event|2|||
30691730|NCT00408421|58705569|FG001|Treatment Re-Randomization|Adverse Event|2|||
30691731|NCT00408421|58705570|FG002|Treatment Re-Randomization|Adverse Event|4|||
30691732|NCT00408421|58705568|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
30691733|NCT00408421|58705569|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
30864367|NCT02432846|58894542|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
30864368|NCT02432846|58894543|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
30864369|NCT02432846|58894544|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
30864370|NCT02432846|58894545|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
30864371|NCT02432846|58894546|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
30864372|NCT02432846|58894541|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
30864373|NCT02432846|58894542|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
30864374|NCT02432846|58894543|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
30864375|NCT02432846|58894544|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
30864376|NCT02432846|58894545|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
30864377|NCT02432846|58894546|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
30864378|NCT02432846|58894541|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
30864379|NCT02432846|58894542|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
30864380|NCT02432846|58894543|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
30864381|NCT02432846|58894544|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
30864382|NCT02432846|58894545|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
30864383|NCT02432846|58894546|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
30864384|NCT02432846|58894541|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
30864385|NCT02432846|58894542|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
30864386|NCT02432846|58894543|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
30864387|NCT02432846|58894544|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
30864388|NCT02432846|58894545|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
30864389|NCT02432846|58894546|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
30864390|NCT02432846|58894541|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
30864391|NCT02432846|58894542|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
30864392|NCT02432846|58894543|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
30864393|NCT02432846|58894544|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
30864394|NCT02432846|58894545|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
30691734|NCT00408421|58705570|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
30691735|NCT00408421|58705568|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
30691736|NCT00408421|58705569|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
30691737|NCT00408421|58705570|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
30691738|NCT00408421|58705568|FG000|Treatment Re-Randomization|Physician Decision|1|||
30691739|NCT00408421|58705569|FG001|Treatment Re-Randomization|Physician Decision|3|||
30691740|NCT00408421|58705570|FG002|Treatment Re-Randomization|Physician Decision|0|||
30691741|NCT00408421|58705568|FG000|Treatment Re-Randomization|Protocol Violation|1|||
30691742|NCT00408421|58705569|FG001|Treatment Re-Randomization|Protocol Violation|1|||
30691743|NCT00408421|58705570|FG002|Treatment Re-Randomization|Protocol Violation|0|||
30691744|NCT00408421|58705568|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
30691745|NCT00408421|58705569|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
30864395|NCT02432846|58894546|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
30864396|NCT02432144|58894559|FG000|Overall Study|Participant Non-Compliance|1|||
30864397|NCT02246998|58894567|FG000|Overall Study|Adverse Event|0|||
30864398|NCT02246998|58894568|FG001|Overall Study|Adverse Event|1|||
30864399|NCT02246998|58894569|FG002|Overall Study|Adverse Event|1|||
30864400|NCT02246998|58894570|FG003|Overall Study|Adverse Event|0|||
30864401|NCT02246998|58894567|FG000|Overall Study|Lost to Follow-up|1|||
30864402|NCT02246998|58894568|FG001|Overall Study|Lost to Follow-up|0|||
30864403|NCT02246998|58894569|FG002|Overall Study|Lost to Follow-up|0|||
30864404|NCT02246998|58894570|FG003|Overall Study|Lost to Follow-up|1|||
30864405|NCT02246998|58894567|FG000|Overall Study|Randomized but Never Dosed|1|||
30864406|NCT02246998|58894568|FG001|Overall Study|Randomized but Never Dosed|2|||
30864407|NCT02246998|58894569|FG002|Overall Study|Randomized but Never Dosed|2|||
30864408|NCT02246998|58894570|FG003|Overall Study|Randomized but Never Dosed|1|||
30864409|NCT02486588|58894589|FG000|Overall Study|Randomized in error- ineligible|738|||
30864410|NCT02486588|58894590|FG001|Overall Study|Randomized in error- ineligible|750|||
30864411|NCT02486588|58894591|FG002|Overall Study|Randomized in error- ineligible|755|||
30864412|NCT02486588|58894592|FG003|Overall Study|Randomized in error- ineligible|738|||
30864413|NCT02486588|58894593|FG004|Overall Study|Randomized in error- ineligible|746|||
30864414|NCT02486588|58894594|FG005|Overall Study|Randomized in error- ineligible|746|||
30864415|NCT00805961|58894613|FG000|Modality Therapy|Withdrawal by Subject|1|||
30864416|NCT00805961|58894613|FG000|Modality Therapy|Adverse Event|1|||
30864417|NCT00805961|58894613|FG000|Modality Therapy|Disease Progression|2|||
30864418|NCT00805961|58894613|FG000|Treatment-Free Interval|Adverse Event|3|||
30864419|NCT00805961|58894613|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
30864420|NCT00805961|58894613|FG000|Treatment-Free Interval|Physician Decision|1|||
30864421|NCT00805961|58894613|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
30864422|NCT00805961|58894613|FG000|Maintenance Treatment|Lack of Efficacy|13|||
30601782|NCT01302366|58613063|FG000|Overall Study|patient choice or noncompliance|5|||
30601783|NCT01302054|58613067|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
30601784|NCT01302054|58613068|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
30601785|NCT01302054|58613069|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
30601786|NCT01302054|58613067|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
30601787|NCT01302054|58613068|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
30601788|NCT01302054|58613069|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
30601789|NCT01302054|58613067|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
30601790|NCT01302054|58613068|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
30601791|NCT01302054|58613069|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
30601792|NCT01302054|58613067|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
30601793|NCT01302054|58613068|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
30601794|NCT01302054|58613069|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
30601795|NCT01302054|58613067|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
30601796|NCT01302054|58613068|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
30601797|NCT01302054|58613069|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
30601798|NCT01302054|58613067|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
30601799|NCT01302054|58613068|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
30601800|NCT01302054|58613069|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
30601801|NCT01302054|58613067|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
30601802|NCT01302054|58613068|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
30601803|NCT01302054|58613069|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
30601804|NCT01302054|58613067|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
30601805|NCT01302054|58613068|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
30601806|NCT01302054|58613069|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
30691746|NCT00408421|58705570|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
30691747|NCT00604786|58705580|FG000|Overall Study|Lost to Follow-up|2|||
30691748|NCT00604786|58705581|FG001|Overall Study|Lost to Follow-up|0|||
30691749|NCT00604708|58705589|FG000|Overall Study|Withdrawal by Subject|9|||
30864423|NCT00805961|58894613|FG000|Maintenance Treatment|Intercurrent Illness|7|||
30864424|NCT00805961|58894613|FG000|Maintenance Treatment|Adverse Event|6|||
30864425|NCT00805961|58894613|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
30864426|NCT00805961|58894613|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
30864427|NCT00805961|58894613|FG000|Maintenance Treatment|Withdrawn Consent|1|||
30864428|NCT02202538|58894617|FG000|Overall Study|Withdrawal by Subject|5|||
30864429|NCT02202538|58894617|FG000|Overall Study|Did not meet all inclusion criteria|2|||
30864430|NCT02202538|58894617|FG000|Overall Study|Investigator Decision|1|||
30864431|NCT02454608|58894624|FG000|Double-Blind Period|Lack of Efficacy|0|||
30864432|NCT02454608|58894625|FG001|Double-Blind Period|Lack of Efficacy|2|||
30864433|NCT02454608|58894626|FG002|Double-Blind Period|Lack of Efficacy|0|||
30864434|NCT02454608|58894624|FG000|Open Label Period|Lost to Follow-up|0|||
30864435|NCT02454608|58894625|FG001|Open Label Period|Lost to Follow-up|0|||
30864436|NCT02454608|58894626|FG002|Open Label Period|Lost to Follow-up|11|||
30864437|NCT02454608|58894624|FG000|Open Label Period|Withdrawal by Subject|0|||
30864438|NCT02454608|58894625|FG001|Open Label Period|Withdrawal by Subject|0|||
30864439|NCT02454608|58894626|FG002|Open Label Period|Withdrawal by Subject|8|||
30864440|NCT02246764|58894637|FG000|Overall Study|Adverse Event|15|||
30864441|NCT02246764|58894638|FG001|Overall Study|Adverse Event|29|||
30864442|NCT02246764|58894639|FG002|Overall Study|Adverse Event|1|||
30864443|NCT02246764|58894637|FG000|Overall Study|Withdrawal by Subject|0|||
30864444|NCT02246764|58894638|FG001|Overall Study|Withdrawal by Subject|0|||
30864445|NCT02246764|58894639|FG002|Overall Study|Withdrawal by Subject|1|||
30864446|NCT02246764|58894637|FG000|Overall Study|Disallowed Concomitant Medication|1|||
30864447|NCT02246764|58894638|FG001|Overall Study|Disallowed Concomitant Medication|0|||
30864448|NCT02246764|58894639|FG002|Overall Study|Disallowed Concomitant Medication|0|||
30864449|NCT02246764|58894637|FG000|Overall Study|Physician Decision|0|||
30864450|NCT02246764|58894638|FG001|Overall Study|Physician Decision|2|||
30864451|NCT02246764|58894639|FG002|Overall Study|Physician Decision|1|||
30864452|NCT02246764|58894637|FG000|Overall Study|Protocol Violation|2|||
30864453|NCT02246764|58894638|FG001|Overall Study|Protocol Violation|1|||
30864454|NCT02246764|58894639|FG002|Overall Study|Protocol Violation|1|||
30864455|NCT02454530|58894649|FG000|Overall Study|Other|8|||
30864456|NCT02454530|58894650|FG001|Overall Study|Other|13|||
30864457|NCT02454530|58894649|FG000|Overall Study|Missing information|56|||
30864458|NCT02454530|58894650|FG001|Overall Study|Missing information|69|||
30864459|NCT02454530|58894649|FG000|Overall Study|Death|2|||
30864460|NCT02454530|58894650|FG001|Overall Study|Death|41|||
30864461|NCT02454530|58894649|FG000|Overall Study|Lost to Follow-up|4|||
30864462|NCT02454530|58894650|FG001|Overall Study|Lost to Follow-up|4|||
30864463|NCT02431676|58894660|FG000|Overall Study|no lab obtained|0|||
30864464|NCT02431676|58894661|FG001|Overall Study|no lab obtained|1|||
30864465|NCT02431676|58894662|FG002|Overall Study|no lab obtained|2|||
30864466|NCT01654250|58894672|FG000|Overall Study|Lost to Follow-up|1|||
30864467|NCT01654250|58894673|FG001|Overall Study|Lost to Follow-up|0|||
30864468|NCT01652690|58894682|FG000|Overall Study|Withdrawal by Subject|16|||
30864469|NCT01652690|58894683|FG001|Overall Study|Withdrawal by Subject|4|||
30864470|NCT01652690|58894682|FG000|Overall Study|Other|8|||
30864471|NCT01652690|58894683|FG001|Overall Study|Other|9|||
30864472|NCT01652690|58894682|FG000|Overall Study|Lost to Follow-up|6|||
30864473|NCT01652690|58894683|FG001|Overall Study|Lost to Follow-up|6|||
30864474|NCT01652690|58894682|FG000|Overall Study|Death|5|||
30864475|NCT01652690|58894683|FG001|Overall Study|Death|2|||
30864476|NCT02429258|58894691|FG000|Overall Study|Withdrawal by Subject|2|||
30864477|NCT02429258|58894692|FG001|Overall Study|Withdrawal by Subject|0|||
30864478|NCT02429258|58894691|FG000|Overall Study|Protocol Violation|0|||
30864479|NCT02429258|58894692|FG001|Overall Study|Protocol Violation|1|||
30864480|NCT02201524|58894702|FG000|Overall Study|Adverse Event|0|||
30864481|NCT02201524|58894703|FG001|Overall Study|Adverse Event|2|||
30864482|NCT02201524|58894704|FG002|Overall Study|Adverse Event|1|||
30864483|NCT02201524|58894705|FG003|Overall Study|Adverse Event|0|||
30864484|NCT02201524|58894702|FG000|Overall Study|Insufficient clinical response|1|||
30864485|NCT02201524|58894703|FG001|Overall Study|Insufficient clinical response|0|||
30864486|NCT02201524|58894704|FG002|Overall Study|Insufficient clinical response|0|||
30864487|NCT02201524|58894705|FG003|Overall Study|Insufficient clinical response|0|||
30864488|NCT02201524|58894702|FG000|Overall Study|Lost to Follow-up|0|||
30864489|NCT02201524|58894703|FG001|Overall Study|Lost to Follow-up|0|||
30864490|NCT02201524|58894704|FG002|Overall Study|Lost to Follow-up|2|||
30864491|NCT02201524|58894705|FG003|Overall Study|Lost to Follow-up|0|||
30864492|NCT02201524|58894702|FG000|Overall Study|No longer meets eligibility criteria|0|||
30864493|NCT02201524|58894703|FG001|Overall Study|No longer meets eligibility criteria|0|||
30864494|NCT02201524|58894704|FG002|Overall Study|No longer meets eligibility criteria|0|||
30864495|NCT02201524|58894705|FG003|Overall Study|No longer meets eligibility criteria|2|||
30960750|NCT01525589|59026494|FG000|Overall Study|Physician Decision|4|||
30864496|NCT02201524|58894702|FG000|Overall Study|Protocol Violation|0|||
30864497|NCT02201524|58894703|FG001|Overall Study|Protocol Violation|0|||
30960751|NCT01525589|59026495|FG001|Overall Study|Physician Decision|2|||
30864498|NCT02201524|58894704|FG002|Overall Study|Protocol Violation|0|||
30864499|NCT02201524|58894705|FG003|Overall Study|Protocol Violation|1|||
30864500|NCT02201524|58894702|FG000|Overall Study|Withdrawal by Subject|0|||
30691750|NCT00604708|58705590|FG001|Overall Study|Withdrawal by Subject|10|||
30691751|NCT00604708|58705589|FG000|Overall Study|Protocol Violation|2|||
30691752|NCT00604708|58705590|FG001|Overall Study|Protocol Violation|8|||
30691753|NCT00604708|58705589|FG000|Overall Study|Lost to Follow-up|5|||
30691754|NCT00604708|58705590|FG001|Overall Study|Lost to Follow-up|5|||
30691755|NCT00604708|58705589|FG000|Overall Study|administrative reasons|9|||
30691756|NCT00604708|58705590|FG001|Overall Study|administrative reasons|11|||
30691757|NCT00604708|58705589|FG000|Overall Study|Adverse Event|6|||
30691758|NCT00604708|58705590|FG001|Overall Study|Adverse Event|6|||
30691759|NCT00407797|58705596|FG000|Overall Study|Lost to Follow-up|2|||
30691760|NCT00407797|58705596|FG000|Overall Study|Adverse Event|6|||
30691761|NCT00407797|58705596|FG000|Overall Study|Other|7|||
30691762|NCT00407797|58705596|FG000|Overall Study|Withdrawal by Subject|3|||
30691763|NCT00568126|58705602|FG000|Overall Study|Adverse Event|3|||
30691764|NCT00568126|58705603|FG001|Overall Study|Adverse Event|0|||
30691765|NCT00568126|58705602|FG000|Overall Study|Withdrawal by Subject|2|||
30691766|NCT00568126|58705603|FG001|Overall Study|Withdrawal by Subject|3|||
30691767|NCT00568126|58705602|FG000|Overall Study|Lost to Follow-up|4|||
30691768|NCT00568126|58705603|FG001|Overall Study|Lost to Follow-up|3|||
30691769|NCT00568126|58705602|FG000|Overall Study|Lack of Efficacy|0|||
30691770|NCT00568126|58705603|FG001|Overall Study|Lack of Efficacy|1|||
30691771|NCT00568126|58705602|FG000|Overall Study|Physician Decision|2|||
30691772|NCT00568126|58705603|FG001|Overall Study|Physician Decision|2|||
30691773|NCT00407563|58705609|FG000|Overall Study|Patient continues on treatment|1|||
30691774|NCT00567892|58705615|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
30691775|NCT00567892|58705616|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
30691776|NCT00567892|58705617|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
30691777|NCT00567892|58705618|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
30691778|NCT00567892|58705615|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
30691779|NCT00567892|58705616|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
30691780|NCT00567892|58705617|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
30691781|NCT00567892|58705618|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
30691782|NCT00623103|58705632|FG000|Overall Study|Adverse Event|70|||
30691783|NCT00623103|58705633|FG001|Overall Study|Adverse Event|60|||
30691784|NCT00623103|58705632|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
30691785|NCT00623103|58705633|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
30691786|NCT00623103|58705632|FG000|Overall Study|Withdrawal by Subject|18|||
30691787|NCT00623103|58705633|FG001|Overall Study|Withdrawal by Subject|24|||
30691788|NCT00623103|58705632|FG000|Overall Study|Lost to Follow-up|4|||
30691789|NCT00623103|58705633|FG001|Overall Study|Lost to Follow-up|1|||
30691790|NCT00623103|58705632|FG000|Overall Study|Administrative problems|2|||
30691791|NCT00623103|58705633|FG001|Overall Study|Administrative problems|4|||
30691792|NCT00623103|58705632|FG000|Overall Study|Death|11|||
30691793|NCT00623103|58705633|FG001|Overall Study|Death|11|||
30691794|NCT00623103|58705632|FG000|Overall Study|Protocol deviation|2|||
30691795|NCT00623103|58705633|FG001|Overall Study|Protocol deviation|1|||
30691796|NCT00396565|58705642|FG000|Overall Study|Physician Decision|3|||
30691797|NCT00396565|58705643|FG001|Overall Study|Physician Decision|1|||
30691798|NCT00396565|58705644|FG002|Overall Study|Physician Decision|2|||
30691799|NCT00396565|58705642|FG000|Overall Study|Adverse Event|5|||
30691800|NCT00396565|58705643|FG001|Overall Study|Adverse Event|13|||
30691801|NCT00396565|58705644|FG002|Overall Study|Adverse Event|3|||
30691802|NCT00396565|58705642|FG000|Overall Study|Withdrawal by Subject|8|||
30691803|NCT00396565|58705643|FG001|Overall Study|Withdrawal by Subject|13|||
30691804|NCT00396565|58705644|FG002|Overall Study|Withdrawal by Subject|1|||
30960752|NCT01525589|59026496|FG002|Overall Study|Physician Decision|2|||
30601807|NCT01302054|58613067|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
30601808|NCT01302054|58613068|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
30601809|NCT01302054|58613069|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
30601810|NCT01302054|58613067|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
30601811|NCT01302054|58613068|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
30601812|NCT01302054|58613069|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
30601813|NCT01302054|58613067|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
30601814|NCT01302054|58613068|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
30691805|NCT00396565|58705642|FG000|Overall Study|Lack of Efficacy|32|||
30691806|NCT00396565|58705643|FG001|Overall Study|Lack of Efficacy|64|||
30691807|NCT00396565|58705644|FG002|Overall Study|Lack of Efficacy|11|||
30691808|NCT00394771|58705656|FG000|Overall Study|Did not meet protocol requirements|1|||
30960753|NCT01525589|59026494|FG000|Overall Study|Death|0|||
30960754|NCT01525589|59026495|FG001|Overall Study|Death|0|||
30691809|NCT00394771|58705657|FG001|Overall Study|Did not meet protocol requirements|0|||
30691810|NCT00394771|58705658|FG002|Overall Study|Did not meet protocol requirements|2|||
30691811|NCT00394771|58705659|FG003|Overall Study|Did not meet protocol requirements|0|||
30691812|NCT00394771|58705656|FG000|Overall Study|Protocol Violation|2|||
30691813|NCT00394771|58705657|FG001|Overall Study|Protocol Violation|4|||
30691814|NCT00394771|58705658|FG002|Overall Study|Protocol Violation|9|||
30691815|NCT00394771|58705659|FG003|Overall Study|Protocol Violation|7|||
30691816|NCT00394771|58705656|FG000|Overall Study|Withdrawal by Subject|10|||
30691817|NCT00394771|58705657|FG001|Overall Study|Withdrawal by Subject|6|||
30691818|NCT00394771|58705658|FG002|Overall Study|Withdrawal by Subject|8|||
30691819|NCT00394771|58705659|FG003|Overall Study|Withdrawal by Subject|12|||
30691820|NCT00394771|58705656|FG000|Overall Study|Adverse Event|10|||
30691821|NCT00394771|58705657|FG001|Overall Study|Adverse Event|5|||
30691822|NCT00394771|58705658|FG002|Overall Study|Adverse Event|12|||
30691823|NCT00394771|58705659|FG003|Overall Study|Adverse Event|8|||
30691824|NCT00394771|58705656|FG000|Overall Study|Participant pregnant|0|||
30691825|NCT00394771|58705657|FG001|Overall Study|Participant pregnant|1|||
30691826|NCT00394771|58705658|FG002|Overall Study|Participant pregnant|2|||
30691827|NCT00394771|58705659|FG003|Overall Study|Participant pregnant|2|||
30691828|NCT00394771|58705656|FG000|Overall Study|Lost to Follow-up|15|||
30691829|NCT00394771|58705657|FG001|Overall Study|Lost to Follow-up|15|||
30691830|NCT00394771|58705658|FG002|Overall Study|Lost to Follow-up|13|||
30691831|NCT00394771|58705659|FG003|Overall Study|Lost to Follow-up|10|||
30691832|NCT00394771|58705656|FG000|Overall Study|Other|3|||
30691833|NCT00394771|58705657|FG001|Overall Study|Other|3|||
30691834|NCT00394771|58705658|FG002|Overall Study|Other|1|||
30691835|NCT00394771|58705659|FG003|Overall Study|Other|0|||
30691836|NCT00396409|58705671|FG000|Period 1 - 2007|Adverse Event|0|||
30691837|NCT00396409|58705672|FG001|Period 1 - 2007|Adverse Event|1|||
30691838|NCT00396409|58705671|FG000|Period 1 - 2007|Lack of Efficacy|0|||
30691839|NCT00396409|58705672|FG001|Period 1 - 2007|Lack of Efficacy|1|||
30691840|NCT00396409|58705671|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
30691841|NCT00396409|58705672|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
30691842|NCT00396409|58705671|FG000|Period 1 - 2007|Lost to Follow-up|2|||
30691843|NCT00396409|58705672|FG001|Period 1 - 2007|Lost to Follow-up|3|||
30691844|NCT00396409|58705671|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
30691845|NCT00396409|58705672|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
30691846|NCT00396409|58705671|FG000|Period 2 - 2008|Protocol Violation|1|||
30691847|NCT00396409|58705672|FG001|Period 2 - 2008|Protocol Violation|0|||
30691848|NCT00396409|58705671|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
30691849|NCT00396409|58705672|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
30691850|NCT00396409|58705671|FG000|Period 2 - 2008|Lost to Follow-up|3|||
30691851|NCT00396409|58705672|FG001|Period 2 - 2008|Lost to Follow-up|1|||
30691852|NCT02924376|58705684|FG000|Overall Study|Progressive Disease|4|||
30691853|NCT02924376|58705685|FG001|Overall Study|Progressive Disease|0|||
30691854|NCT02924376|58705686|FG002|Overall Study|Progressive Disease|1|||
30691855|NCT02924376|58705687|FG003|Overall Study|Progressive Disease|0|||
30691856|NCT02924376|58705684|FG000|Overall Study|Death|73|||
30691857|NCT02924376|58705685|FG001|Overall Study|Death|18|||
30691858|NCT02924376|58705686|FG002|Overall Study|Death|15|||
30691859|NCT02924376|58705687|FG003|Overall Study|Death|2|||
30691860|NCT02924376|58705684|FG000|Overall Study|Lost to Follow-up|3|||
30691861|NCT02924376|58705685|FG001|Overall Study|Lost to Follow-up|0|||
30691862|NCT02924376|58705686|FG002|Overall Study|Lost to Follow-up|0|||
30691863|NCT02924376|58705687|FG003|Overall Study|Lost to Follow-up|0|||
30691864|NCT02924376|58705684|FG000|Overall Study|Study Terminated by Sponsor|19|||
30691865|NCT02924376|58705685|FG001|Overall Study|Study Terminated by Sponsor|0|||
30691866|NCT02924376|58705686|FG002|Overall Study|Study Terminated by Sponsor|0|||
30691867|NCT02924376|58705687|FG003|Overall Study|Study Terminated by Sponsor|0|||
30691868|NCT02924376|58705684|FG000|Overall Study|Physician Decision|1|||
30691869|NCT02924376|58705685|FG001|Overall Study|Physician Decision|0|||
30691870|NCT02924376|58705686|FG002|Overall Study|Physician Decision|0|||
30691871|NCT02924376|58705687|FG003|Overall Study|Physician Decision|0|||
30691872|NCT02924376|58705684|FG000|Overall Study|Withdrawal by Subject|7|||
30691873|NCT02924376|58705685|FG001|Overall Study|Withdrawal by Subject|2|||
30691874|NCT02924376|58705686|FG002|Overall Study|Withdrawal by Subject|1|||
30691875|NCT02924376|58705687|FG003|Overall Study|Withdrawal by Subject|0|||
30691876|NCT02924376|58705684|FG000|Overall Study|Rolled Over to Another Study|1|||
30691877|NCT02924376|58705685|FG001|Overall Study|Rolled Over to Another Study|0|||
30691878|NCT02924376|58705686|FG002|Overall Study|Rolled Over to Another Study|0|||
30691879|NCT02924376|58705687|FG003|Overall Study|Rolled Over to Another Study|0|||
30691880|NCT00693420|58705702|FG000|Overall Study|Adverse Event|4|||
30691881|NCT00693420|58705703|FG001|Overall Study|Adverse Event|4|||
30691882|NCT00693420|58705702|FG000|Overall Study|Lost to Follow-up|0|||
30691883|NCT00693420|58705703|FG001|Overall Study|Lost to Follow-up|3|||
30864501|NCT02201524|58894703|FG001|Overall Study|Withdrawal by Subject|0|||
30864502|NCT02201524|58894704|FG002|Overall Study|Withdrawal by Subject|1|||
30691884|NCT00693420|58705702|FG000|Overall Study|Withdrawal by Subject|1|||
30691885|NCT00693420|58705703|FG001|Overall Study|Withdrawal by Subject|0|||
30691886|NCT00693420|58705702|FG000|Overall Study|Protocol Violation|0|||
30691887|NCT00693420|58705703|FG001|Overall Study|Protocol Violation|2|||
30691888|NCT00693420|58705702|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
30691889|NCT00693420|58705703|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
30691890|NCT00693420|58705702|FG000|Overall Study|Personal Reasons|1|||
30691891|NCT00693420|58705703|FG001|Overall Study|Personal Reasons|4|||
30691892|NCT00695136|58705709|FG000|Overall Study|Withdrawal by Subject|1|||
30691893|NCT00695136|58705709|FG000|Overall Study|unrelated adverse event|1|||
30691894|NCT00605176|58705725|FG000|Overall Study|Adverse Event|2|||
30691895|NCT00605176|58705726|FG001|Overall Study|Adverse Event|1|||
30691896|NCT00605176|58705727|FG002|Overall Study|Adverse Event|3|||
30691897|NCT00605176|58705725|FG000|Overall Study|Withdrawal by Subject|4|||
30691898|NCT00605176|58705726|FG001|Overall Study|Withdrawal by Subject|2|||
30691899|NCT00605176|58705727|FG002|Overall Study|Withdrawal by Subject|4|||
30691900|NCT00605176|58705725|FG000|Overall Study|Lost to Follow-up|2|||
30691901|NCT00605176|58705726|FG001|Overall Study|Lost to Follow-up|2|||
30691902|NCT00605176|58705727|FG002|Overall Study|Lost to Follow-up|1|||
30691903|NCT00605176|58705725|FG000|Overall Study|Non-complicance with study procedures|1|||
30691904|NCT00605176|58705726|FG001|Overall Study|Non-complicance with study procedures|0|||
30691905|NCT00605176|58705727|FG002|Overall Study|Non-complicance with study procedures|0|||
30691906|NCT00605176|58705725|FG000|Overall Study|Use of concomitant therapy|1|||
30691907|NCT00605176|58705726|FG001|Overall Study|Use of concomitant therapy|0|||
30691908|NCT00605176|58705727|FG002|Overall Study|Use of concomitant therapy|1|||
30691909|NCT00605176|58705725|FG000|Overall Study|Other (not due to AE)|1|||
30691910|NCT00605176|58705726|FG001|Overall Study|Other (not due to AE)|1|||
30864503|NCT02201524|58894705|FG003|Overall Study|Withdrawal by Subject|1|||
30864504|NCT02201524|58894702|FG000|Overall Study|Other|1|||
30864505|NCT02201524|58894703|FG001|Overall Study|Other|1|||
30864506|NCT02201524|58894704|FG002|Overall Study|Other|0|||
30864507|NCT02201524|58894705|FG003|Overall Study|Other|0|||
30864508|NCT02453048|58894720|FG000|Overall Study|Only part of initial 6 mo. study|0|||
30864509|NCT02453048|58894721|FG001|Overall Study|Only part of initial 6 mo. study|0|||
30864510|NCT02453048|58894722|FG002|Overall Study|Only part of initial 6 mo. study|0|||
30864511|NCT02453048|58894723|FG003|Overall Study|Only part of initial 6 mo. study|0|||
30864512|NCT02453048|58894724|FG004|Overall Study|Only part of initial 6 mo. study|6|||
30864513|NCT02453048|58894720|FG000|Overall Study|Lost to Follow-up|0|||
30864514|NCT02453048|58894721|FG001|Overall Study|Lost to Follow-up|1|||
30864515|NCT02453048|58894722|FG002|Overall Study|Lost to Follow-up|2|||
30864516|NCT02453048|58894723|FG003|Overall Study|Lost to Follow-up|0|||
30864517|NCT02453048|58894724|FG004|Overall Study|Lost to Follow-up|0|||
30864518|NCT02137252|58894738|FG000|Overall Study|trial terminated early|2|||
30864519|NCT02137252|58894739|FG001|Overall Study|trial terminated early|1|||
30864520|NCT02201290|58894745|FG000|Overall Study|Withdrawal by Subject|2|||
30864521|NCT02201290|58894745|FG000|Overall Study|Lack of Efficacy|2|||
30864522|NCT02201290|58894745|FG000|Overall Study|Adverse Event|1|||
30864523|NCT02200510|58894751|FG000|Overall Study|Death|1|||
30864524|NCT02200510|58894752|FG001|Overall Study|Death|1|||
30864525|NCT02200510|58894751|FG000|Overall Study|Protocol Violation|0|||
30864526|NCT02200510|58894752|FG001|Overall Study|Protocol Violation|1|||
30864527|NCT02200510|58894751|FG000|Overall Study|Lost to Follow-up|7|||
30864528|NCT02200510|58894752|FG001|Overall Study|Lost to Follow-up|1|||
30864529|NCT02200510|58894751|FG000|Overall Study|potential COI - joined study team|1|||
30864530|NCT02200510|58894752|FG001|Overall Study|potential COI - joined study team|0|||
30864531|NCT02452892|58894762|FG000|Week 1 Initial Randommization|Adverse Event|1|||
30864532|NCT02452892|58894763|FG001|Week 1 Initial Randommization|Adverse Event|0|||
30864533|NCT02452892|58894764|FG002|Week 1 Initial Randommization|Adverse Event|0|||
30864534|NCT02452892|58894765|FG003|Week 1 Initial Randommization|Adverse Event|0|||
30864535|NCT02452892|58894762|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
30864536|NCT02452892|58894763|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
30864537|NCT02452892|58894764|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
30864538|NCT02452892|58894765|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
30864539|NCT02452892|58894762|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
30864540|NCT02452892|58894763|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
30864541|NCT02452892|58894764|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
30864542|NCT02452892|58894765|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
30864543|NCT02452892|58894762|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
30864544|NCT02452892|58894763|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
30864545|NCT02452892|58894764|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
30864546|NCT02452892|58894765|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
30864547|NCT02452892|58894762|FG000|Follow-up|Withdrawal by Subject|0|||
30864548|NCT02452892|58894763|FG001|Follow-up|Withdrawal by Subject|0|||
30864549|NCT02452892|58894764|FG002|Follow-up|Withdrawal by Subject|0|||
30864550|NCT02452892|58894765|FG003|Follow-up|Withdrawal by Subject|1|||
30864551|NCT02452892|58894762|FG000|Follow-up|Subject left town on Day 42|1|||
30864552|NCT02452892|58894763|FG001|Follow-up|Subject left town on Day 42|0|||
30864553|NCT02452892|58894764|FG002|Follow-up|Subject left town on Day 42|0|||
30691911|NCT00605176|58705727|FG002|Overall Study|Other (not due to AE)|0|||
30691912|NCT00694356|58705738|FG000|Overall Study|Adverse Event|1|||
30691913|NCT00694356|58705739|FG001|Overall Study|Adverse Event|0|||
30864554|NCT02452892|58894765|FG003|Follow-up|Subject left town on Day 42|0|||
30864555|NCT02135848|58894780|FG000|Overall Study|Adverse Event|2|||
30864556|NCT02135848|58894781|FG001|Overall Study|Adverse Event|0|||
30864557|NCT02135848|58894780|FG000|Overall Study|Withdrawal by Subject|1|||
30864558|NCT02135848|58894781|FG001|Overall Study|Withdrawal by Subject|1|||
30864559|NCT02738333|58894801|FG000|Overall Study|Death|1|||
30864560|NCT02738333|58894802|FG001|Overall Study|Death|0|||
30864561|NCT02738333|58894803|FG002|Overall Study|Death|0|||
30864562|NCT02738333|58894801|FG000|Overall Study|Lost to Follow-up|1|||
30864563|NCT02738333|58894802|FG001|Overall Study|Lost to Follow-up|0|||
30864564|NCT02738333|58894803|FG002|Overall Study|Lost to Follow-up|0|||
30864565|NCT02135692|58894811|FG000|Overall Study|Adverse Event|3|||
30864566|NCT02135692|58894811|FG000|Overall Study|Lack of Efficacy|2|||
30864567|NCT02135692|58894811|FG000|Overall Study|Protocol Violation|2|||
30864568|NCT02135692|58894811|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
30864569|NCT02135692|58894811|FG000|Overall Study|Product commercially available|159|||
30864570|NCT02135692|58894811|FG000|Overall Study|Study closed/terminated|153|||
30864571|NCT02135692|58894811|FG000|Overall Study|Lost to Follow-up|4|||
30864572|NCT02135692|58894811|FG000|Overall Study|Withdrawal by Subject|15|||
30864573|NCT02429414|58894817|FG000|Overall Study|Physician Decision|0|||
30864574|NCT02429414|58894818|FG001|Overall Study|Physician Decision|1|||
30864575|NCT02135614|58894826|FG000|Overall Study|Randomized but Not Treated|2|||
30864576|NCT02135614|58894827|FG001|Overall Study|Randomized but Not Treated|1|||
30864577|NCT02135614|58894826|FG000|Overall Study|Adverse Event|0|||
30864578|NCT02135614|58894827|FG001|Overall Study|Adverse Event|1|||
30864579|NCT02135614|58894826|FG000|Overall Study|Death|1|||
30864580|NCT02135614|58894827|FG001|Overall Study|Death|0|||
30960755|NCT01525589|59026496|FG002|Overall Study|Death|2|||
30601815|NCT01302054|58613069|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
30601816|NCT01302054|58613067|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
30691914|NCT00694356|58705740|FG002|Overall Study|Adverse Event|0|||
30691915|NCT00694356|58705738|FG000|Overall Study|Progressive Disease|2|||
30691916|NCT00694356|58705739|FG001|Overall Study|Progressive Disease|6|||
30691917|NCT00694356|58705740|FG002|Overall Study|Progressive Disease|6|||
30691918|NCT00692406|58705748|FG000|Overall Study|PI dropped, bad data|57|||
30691919|NCT00567502|58705765|FG000|Overall Study|Lost to Follow-up|91|||
30691920|NCT00567502|58705766|FG001|Overall Study|Lost to Follow-up|14|||
30691921|NCT00567502|58705767|FG002|Overall Study|Lost to Follow-up|351|||
30691922|NCT00567502|58705768|FG003|Overall Study|Lost to Follow-up|2|||
30691923|NCT00567502|58705765|FG000|Overall Study|Death|65|||
30691924|NCT00567502|58705766|FG001|Overall Study|Death|16|||
30691925|NCT00567502|58705767|FG002|Overall Study|Death|360|||
30691926|NCT00567502|58705768|FG003|Overall Study|Death|5|||
30691927|NCT00567502|58705765|FG000|Overall Study|Other|64|||
30691928|NCT00567502|58705766|FG001|Overall Study|Other|2|||
30691929|NCT00567502|58705767|FG002|Overall Study|Other|134|||
30601817|NCT01302054|58613068|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
30601818|NCT01302054|58613069|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
30601819|NCT01302054|58613067|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
30601820|NCT01302054|58613068|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
30601821|NCT01302054|58613069|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
30601822|NCT01302054|58613067|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
30601823|NCT01302054|58613068|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
30601824|NCT01302054|58613069|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
30601825|NCT01302054|58613067|FG000|Double-Blind Treatment Phase|Other|0|||
30601826|NCT01302054|58613068|FG001|Double-Blind Treatment Phase|Other|4|||
30601827|NCT01302054|58613069|FG002|Double-Blind Treatment Phase|Other|9|||
30601828|NCT01301508|58613080|FG000|Overall Study|Withdrawal by Subject|1|||
30601829|NCT01301508|58613081|FG001|Overall Study|Withdrawal by Subject|2|||
30601830|NCT01301508|58613080|FG000|Overall Study|Lost to Follow-up|0|||
30601831|NCT01301508|58613081|FG001|Overall Study|Lost to Follow-up|1|||
30601832|NCT01301274|58613089|FG000|Overall Study|Physician Decision|2|||
30601833|NCT01301274|58613090|FG001|Overall Study|Physician Decision|1|||
30864581|NCT02135614|58894826|FG000|Overall Study|Investigator's Discretion|0|||
30864582|NCT02135614|58894827|FG001|Overall Study|Investigator's Discretion|1|||
30864583|NCT02135614|58894826|FG000|Overall Study|Withdrew Consent|2|||
30864584|NCT02135614|58894827|FG001|Overall Study|Withdrew Consent|2|||
30864585|NCT02135614|58894826|FG000|Overall Study|Lost to Follow-up|3|||
30864586|NCT02135614|58894827|FG001|Overall Study|Lost to Follow-up|0|||
30601834|NCT01300650|58613101|FG000|Overall Study|Adverse Event|1|||
30601835|NCT01300572|58613106|FG000|Overall Study|HAMA + post dosimetry|1|||
30601836|NCT01077154|58613113|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
30691930|NCT00567502|58705768|FG003|Overall Study|Other|6|||
30691931|NCT00567502|58705765|FG000|Overall Study|Participant request|12|||
30691932|NCT00567502|58705766|FG001|Overall Study|Participant request|1|||
30691933|NCT00567502|58705767|FG002|Overall Study|Participant request|33|||
30691934|NCT00567502|58705768|FG003|Overall Study|Participant request|1|||
30691935|NCT00567502|58705765|FG000|Overall Study|Sponsor request|9|||
30691936|NCT00567502|58705766|FG001|Overall Study|Sponsor request|0|||
30691937|NCT00567502|58705767|FG002|Overall Study|Sponsor request|30|||
30691938|NCT00567502|58705768|FG003|Overall Study|Sponsor request|1|||
30691939|NCT00567502|58705765|FG000|Overall Study|Never Initiated Treatment|0|||
30691940|NCT00567502|58705766|FG001|Overall Study|Never Initiated Treatment|0|||
30691941|NCT00567502|58705767|FG002|Overall Study|Never Initiated Treatment|0|||
30691942|NCT00567502|58705768|FG003|Overall Study|Never Initiated Treatment|72|||
30691943|NCT00396331|58705793|FG000|Overall Study|Failed to mobilize - no transplant|8|||
30691944|NCT00396331|58705793|FG000|Overall Study|Did not go on to transplant|5|||
30691945|NCT00396331|58705793|FG000|Overall Study|Lost to Follow-up|3|||
30691946|NCT00396331|58705793|FG000|Overall Study|Death|16|||
30691947|NCT00396253|58705805|FG000|Overall Study|Protocol Violation|1|||
30691948|NCT00396253|58705805|FG000|Overall Study|Withdrawal by Subject|7|||
30691949|NCT00396253|58705805|FG000|Overall Study|Death|3|||
30864587|NCT02168842|58894835|FG000|Overall Study|Withdrawal by Subject|5|||
30864588|NCT02168842|58894836|FG001|Overall Study|Withdrawal by Subject|3|||
30864589|NCT02168842|58894835|FG000|Overall Study|Lost to Follow-up|0|||
30864590|NCT02168842|58894836|FG001|Overall Study|Lost to Follow-up|2|||
30864591|NCT02168842|58894835|FG000|Overall Study|Death|2|||
30864592|NCT02168842|58894836|FG001|Overall Study|Death|1|||
30864593|NCT02168842|58894835|FG000|Overall Study|Physician Decision|1|||
30864594|NCT02168842|58894836|FG001|Overall Study|Physician Decision|2|||
30864595|NCT02200042|58894846|FG000|Overall Study|Withdrawal by Subject|0|||
30864596|NCT02200042|58894847|FG001|Overall Study|Withdrawal by Subject|1|||
30864597|NCT02199028|58894855|FG000|Week 1|Adverse Event|1|||
30864598|NCT02199028|58894856|FG001|Week 1|Adverse Event|0|||
30864599|NCT02199028|58894855|FG000|Week 3|Adverse Event|1|||
30864600|NCT02199028|58894856|FG001|Week 3|Adverse Event|0|||
30864601|NCT03347123|58894865|FG000|Overall Study|Death|1|||
30864602|NCT03347123|58894866|FG001|Overall Study|Death|2|||
30864603|NCT03347123|58894867|FG002|Overall Study|Death|0|||
30864604|NCT03347123|58894868|FG003|Overall Study|Death|0|||
30864605|NCT03347123|58894869|FG004|Overall Study|Death|0|||
30864606|NCT03347123|58894870|FG005|Overall Study|Death|0|||
30864607|NCT03347123|58894871|FG006|Overall Study|Death|0|||
30864608|NCT03347123|58894865|FG000|Overall Study|Withdrawal by Subject|1|||
30864609|NCT03347123|58894866|FG001|Overall Study|Withdrawal by Subject|0|||
30864610|NCT03347123|58894867|FG002|Overall Study|Withdrawal by Subject|0|||
30864611|NCT03347123|58894868|FG003|Overall Study|Withdrawal by Subject|0|||
30864612|NCT03347123|58894869|FG004|Overall Study|Withdrawal by Subject|0|||
30864613|NCT03347123|58894870|FG005|Overall Study|Withdrawal by Subject|0|||
30864614|NCT03347123|58894871|FG006|Overall Study|Withdrawal by Subject|0|||
30864615|NCT03347123|58894865|FG000|Overall Study|Reason not Specified|3|||
30864616|NCT03347123|58894866|FG001|Overall Study|Reason not Specified|4|||
30864617|NCT03347123|58894867|FG002|Overall Study|Reason not Specified|0|||
30864618|NCT03347123|58894868|FG003|Overall Study|Reason not Specified|0|||
30864619|NCT03347123|58894869|FG004|Overall Study|Reason not Specified|0|||
30864620|NCT03347123|58894870|FG005|Overall Study|Reason not Specified|0|||
30864621|NCT03347123|58894871|FG006|Overall Study|Reason not Specified|0|||
30864622|NCT02198794|58894882|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
30864623|NCT02198794|58894883|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
30864624|NCT02198794|58894884|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
30864625|NCT02198794|58894885|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
30864626|NCT02198794|58894882|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
30864627|NCT02198794|58894883|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
30864628|NCT02198794|58894884|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
30960756|NCT01525589|59026494|FG000|Overall Study|Treatment-related AE|1|||
30960757|NCT01525589|59026495|FG001|Overall Study|Treatment-related AE|1|||
30960758|NCT01525589|59026496|FG002|Overall Study|Treatment-related AE|2|||
30960759|NCT01525589|59026494|FG000|Overall Study|Other reasons|0|||
30960760|NCT01525589|59026495|FG001|Overall Study|Other reasons|1|||
30691950|NCT00396253|58705805|FG000|Overall Study|Physician Decision|1|||
30691951|NCT00396253|58705805|FG000|Overall Study|Change in eligibility status|1|||
30691952|NCT00604162|58705809|FG000|Overall Study|Physician Decision|3|||
30864629|NCT02198794|58894885|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
30864630|NCT02198794|58894882|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
30864631|NCT02198794|58894883|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
30864632|NCT02198794|58894884|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
30864633|NCT02198794|58894885|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
30864634|NCT02198794|58894882|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
30864635|NCT02198794|58894883|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
30864636|NCT02198794|58894884|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
30864637|NCT02198794|58894885|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
30864638|NCT02198794|58894882|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
30864639|NCT02198794|58894883|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
30864640|NCT02198794|58894884|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
30960761|NCT01525589|59026496|FG002|Overall Study|Other reasons|0|||
30691953|NCT00604162|58705809|FG000|Overall Study|Withdrawal by Subject|1|||
30691954|NCT00396097|58705818|FG000|Overall Study|Withdrawal by Subject|17|||
30691955|NCT00396097|58705819|FG001|Overall Study|Withdrawal by Subject|17|||
30691956|NCT00396097|58705818|FG000|Overall Study|Lost to Follow-up|4|||
30691957|NCT00396097|58705819|FG001|Overall Study|Lost to Follow-up|9|||
30691958|NCT00396097|58705818|FG000|Overall Study|Other|3|||
30691959|NCT00396097|58705819|FG001|Overall Study|Other|5|||
30691960|NCT00396097|58705818|FG000|Overall Study|Protocol Violation|0|||
30691961|NCT00396097|58705819|FG001|Overall Study|Protocol Violation|6|||
30691962|NCT00396097|58705818|FG000|Overall Study|Adverse Event|1|||
30691963|NCT00396097|58705819|FG001|Overall Study|Adverse Event|5|||
30691964|NCT00396097|58705818|FG000|Overall Study|Insufficient Clinical Response|1|||
30691965|NCT00396097|58705819|FG001|Overall Study|Insufficient Clinical Response|4|||
30691966|NCT00375505|58705831|FG000|Overall Study|Adverse Event|1|||
30691967|NCT00375505|58705832|FG001|Overall Study|Adverse Event|2|||
30691968|NCT00375427|58705840|FG000|Overall Study|Adverse Event|21|||
30691969|NCT00375427|58705841|FG001|Overall Study|Adverse Event|27|||
30691970|NCT00375427|58705840|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30691971|NCT00375427|58705841|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30691972|NCT00375427|58705840|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30691973|NCT00375427|58705841|FG001|Overall Study|Abnormal laboratory value(s)|2|||
30691974|NCT00375427|58705840|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
30691975|NCT00375427|58705841|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
30864641|NCT02198794|58894885|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
30864642|NCT02198794|58894882|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
30864643|NCT02198794|58894883|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
30864644|NCT02198794|58894884|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
30864645|NCT02198794|58894885|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
30864646|NCT02198794|58894882|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
30864647|NCT02198794|58894883|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
30864648|NCT02198794|58894884|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
30864649|NCT02198794|58894885|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
30864650|NCT02198794|58894882|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
30864651|NCT02198794|58894883|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
30864652|NCT02198794|58894884|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
30864653|NCT02198794|58894885|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
30864654|NCT02198794|58894882|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
30864655|NCT02198794|58894883|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
30864656|NCT02198794|58894884|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
30864657|NCT02198794|58894885|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
30864658|NCT02198794|58894882|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
30864659|NCT02198794|58894883|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
30864660|NCT02198794|58894884|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
30864661|NCT02198794|58894885|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
30864662|NCT02198794|58894882|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
30864663|NCT02198794|58894883|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
30864664|NCT02198794|58894884|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
30864665|NCT02198794|58894885|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
30864666|NCT02198794|58894882|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
30864667|NCT02198794|58894883|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
30864668|NCT02198794|58894884|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
30864669|NCT02198794|58894885|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
30864670|NCT02198794|58894882|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
30864671|NCT02198794|58894883|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
30864672|NCT02198794|58894884|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
30864673|NCT02198794|58894885|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
30864674|NCT02198794|58894882|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
30864675|NCT02198794|58894883|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
30864676|NCT02198794|58894884|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
30601837|NCT01077154|58613114|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
30601838|NCT01077154|58613113|FG000|Overall Study|Withdrawal by Subject|369|||
30601839|NCT01077154|58613114|FG001|Overall Study|Withdrawal by Subject|385|||
30601840|NCT01077154|58613113|FG000|Overall Study|Death|215|||
30601841|NCT01077154|58613114|FG001|Overall Study|Death|214|||
30601842|NCT01077154|58613113|FG000|Overall Study|Lost to Follow-up|43|||
30601843|NCT01077154|58613114|FG001|Overall Study|Lost to Follow-up|35|||
30601844|NCT01077154|58613113|FG000|Overall Study|Noncompliance|22|||
30601845|NCT01077154|58613114|FG001|Overall Study|Noncompliance|20|||
30691976|NCT00375427|58705840|FG000|Overall Study|Patient no longer requires study drug|3|||
30691977|NCT00375427|58705841|FG001|Overall Study|Patient no longer requires study drug|7|||
30601846|NCT01077154|58613113|FG000|Overall Study|Disease Progression|18|||
30601847|NCT01077154|58613114|FG001|Overall Study|Disease Progression|20|||
30601848|NCT01077154|58613113|FG000|Overall Study|Ineligibility Determined|10|||
30691978|NCT00375427|58705840|FG000|Overall Study|Protocol Violation|10|||
30691979|NCT00375427|58705841|FG001|Overall Study|Protocol Violation|8|||
30691980|NCT00375427|58705840|FG000|Overall Study|Withdrawal by Subject|9|||
30691981|NCT00375427|58705841|FG001|Overall Study|Withdrawal by Subject|13|||
30691982|NCT00375427|58705840|FG000|Overall Study|Lost to Follow-up|1|||
30691983|NCT00375427|58705841|FG001|Overall Study|Lost to Follow-up|1|||
30691984|NCT00375427|58705840|FG000|Overall Study|Administrative reasons|0|||
30691985|NCT00375427|58705841|FG001|Overall Study|Administrative reasons|1|||
30691986|NCT00375427|58705840|FG000|Overall Study|Death|11|||
30691987|NCT00375427|58705841|FG001|Overall Study|Death|10|||
30691988|NCT00393913|58705847|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
30691989|NCT00393913|58705847|FG000|Initial Assessment|Withdrawal by Subject|16|||
30691990|NCT00393913|58705847|FG000|CPAP|Withdrawal by Subject|3|||
30691991|NCT00393913|58705847|FG000|CPAP|Physician Decision|1|||
30691992|NCT00393913|58705847|FG000|CPAP|TEchnical problem with CPAP|3|||
30691993|NCT00567268|58705852|FG000|Overall Study|Protocol Violation|7|||
30691994|NCT00567268|58705852|FG000|Overall Study|Lost to Follow-up|36|||
30691995|NCT00567268|58705852|FG000|Overall Study|No Visit After First Day of Treatment|2|||
30691996|NCT00567268|58705852|FG000|Overall Study|No Drug Administration|4|||
30691997|NCT00567268|58705852|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
30691998|NCT03976648|58705893|FG000|Overall Study|Adverse Event|0|||
30691999|NCT03976648|58705894|FG001|Overall Study|Adverse Event|2|||
30692000|NCT03976648|58705893|FG000|Overall Study|Study terminated by sponsor|21|||
30692001|NCT03976648|58705894|FG001|Overall Study|Study terminated by sponsor|8|||
30692002|NCT00566254|58705902|FG000|Overall Study|Adverse Event|3|||
30692003|NCT00566254|58705903|FG001|Overall Study|Adverse Event|1|||
30692004|NCT00566254|58705902|FG000|Overall Study|Protocol Violation|1|||
30692005|NCT00566254|58705903|FG001|Overall Study|Protocol Violation|3|||
30692006|NCT00566254|58705902|FG000|Overall Study|Withdrawal by Subject|1|||
30692007|NCT00566254|58705903|FG001|Overall Study|Withdrawal by Subject|2|||
30692008|NCT00566254|58705902|FG000|Overall Study|Lack of Efficacy|5|||
30692009|NCT00566254|58705903|FG001|Overall Study|Lack of Efficacy|6|||
30692010|NCT00566254|58705902|FG000|Overall Study|Other|0|||
30692011|NCT00566254|58705903|FG001|Overall Study|Other|2|||
30692012|NCT00393523|58705914|FG000|Overall Study|Lost to Follow-up|0|||
30692013|NCT00393523|58705915|FG001|Overall Study|Lost to Follow-up|0|||
30692014|NCT00393523|58705916|FG002|Overall Study|Lost to Follow-up|0|||
30692015|NCT00393523|58705917|FG003|Overall Study|Lost to Follow-up|2|||
30692016|NCT00393523|58705918|FG004|Overall Study|Lost to Follow-up|1|||
30692017|NCT00393523|58705914|FG000|Overall Study|Protocol Violation|6|||
30692018|NCT00393523|58705915|FG001|Overall Study|Protocol Violation|2|||
30692019|NCT00393523|58705916|FG002|Overall Study|Protocol Violation|0|||
30692020|NCT00393523|58705917|FG003|Overall Study|Protocol Violation|1|||
30692021|NCT00393523|58705918|FG004|Overall Study|Protocol Violation|0|||
30692022|NCT00393523|58705914|FG000|Overall Study|Withdrawal by Subject|6|||
30601849|NCT01077154|58613114|FG001|Overall Study|Ineligibility Determined|14|||
30601850|NCT01077154|58613113|FG000|Overall Study|Other|14|||
30601851|NCT01077154|58613114|FG001|Overall Study|Other|11|||
30601852|NCT01077154|58613113|FG000|Overall Study|Adverse Event|9|||
30601853|NCT01077154|58613114|FG001|Overall Study|Adverse Event|9|||
30601854|NCT01077154|58613113|FG000|Overall Study|Administrative Decision|1|||
30601855|NCT01077154|58613114|FG001|Overall Study|Administrative Decision|6|||
30601856|NCT01077154|58613113|FG000|Overall Study|Protocol Deviation|1|||
30601857|NCT01077154|58613114|FG001|Overall Study|Protocol Deviation|0|||
30601858|NCT01258101|58613124|FG000|Overall Study|Adverse Event|5|||
30601859|NCT01258101|58613125|FG001|Overall Study|Adverse Event|6|||
30601860|NCT01258101|58613126|FG002|Overall Study|Adverse Event|0|||
30601861|NCT01258101|58613127|FG003|Overall Study|Adverse Event|0|||
30601862|NCT01258101|58613124|FG000|Overall Study|Extra exclusion criterion amended|2|||
30601863|NCT01258101|58613125|FG001|Overall Study|Extra exclusion criterion amended|1|||
30601864|NCT01258101|58613126|FG002|Overall Study|Extra exclusion criterion amended|1|||
30601865|NCT01258101|58613127|FG003|Overall Study|Extra exclusion criterion amended|1|||
30692023|NCT00393523|58705915|FG001|Overall Study|Withdrawal by Subject|7|||
30692024|NCT00393523|58705916|FG002|Overall Study|Withdrawal by Subject|2|||
30692025|NCT00393523|58705917|FG003|Overall Study|Withdrawal by Subject|3|||
30692026|NCT00393523|58705918|FG004|Overall Study|Withdrawal by Subject|0|||
30692027|NCT00393523|58705914|FG000|Overall Study|Difficulties in specimen collection|0|||
30692028|NCT00393523|58705915|FG001|Overall Study|Difficulties in specimen collection|0|||
30692029|NCT00393523|58705916|FG002|Overall Study|Difficulties in specimen collection|1|||
30601866|NCT01258101|58613124|FG000|Overall Study|Informed consent has been withdrawn|2|||
30601867|NCT01258101|58613125|FG001|Overall Study|Informed consent has been withdrawn|2|||
30601868|NCT01258101|58613126|FG002|Overall Study|Informed consent has been withdrawn|1|||
30601869|NCT01258101|58613127|FG003|Overall Study|Informed consent has been withdrawn|1|||
30601870|NCT01258101|58613124|FG000|Overall Study|Patient is not able to attend visits|8|||
30692030|NCT00393523|58705917|FG003|Overall Study|Difficulties in specimen collection|0|||
30692031|NCT00393523|58705918|FG004|Overall Study|Difficulties in specimen collection|0|||
30692032|NCT00393523|58705914|FG000|Overall Study|Vaccine supply issue|0|||
30692033|NCT00393523|58705915|FG001|Overall Study|Vaccine supply issue|0|||
30692034|NCT00393523|58705916|FG002|Overall Study|Vaccine supply issue|1|||
30692035|NCT00393523|58705917|FG003|Overall Study|Vaccine supply issue|0|||
30692036|NCT00393523|58705918|FG004|Overall Study|Vaccine supply issue|0|||
30692037|NCT00393367|58705931|FG000|Overall Study|Protocol Violation|2|||
30692038|NCT00393367|58705932|FG001|Overall Study|Protocol Violation|5|||
30692039|NCT00393367|58705931|FG000|Overall Study|Withdrawal by Subject|0|||
30692040|NCT00393367|58705932|FG001|Overall Study|Withdrawal by Subject|2|||
30692041|NCT00395863|58705942|FG000|Overall Study|Patients did not complete both exams|2|||
30692042|NCT00395863|58705943|FG001|Overall Study|Patients did not complete both exams|3|||
30692043|NCT00395629|58705955|FG000|Core Study|Adverse Event|0|||
30692044|NCT00395629|58705956|FG001|Core Study|Adverse Event|3|||
30692045|NCT00395629|58705957|FG002|Core Study|Adverse Event|4|||
30692046|NCT00395629|58705955|FG000|Core Study|Abnormal laboratory value(s)|0|||
30692047|NCT00395629|58705956|FG001|Core Study|Abnormal laboratory value(s)|0|||
30692048|NCT00395629|58705957|FG002|Core Study|Abnormal laboratory value(s)|1|||
30692049|NCT00395629|58705955|FG000|Core Study|Protocol Violation|1|||
30692050|NCT00395629|58705956|FG001|Core Study|Protocol Violation|0|||
30692051|NCT00395629|58705957|FG002|Core Study|Protocol Violation|0|||
30692052|NCT00395629|58705955|FG000|Core Study|Withdrawal by Subject|0|||
30692053|NCT00395629|58705956|FG001|Core Study|Withdrawal by Subject|1|||
30692054|NCT00395629|58705957|FG002|Core Study|Withdrawal by Subject|1|||
30692055|NCT00395629|58705955|FG000|Core Study|Lost to Follow-up|0|||
30692056|NCT00395629|58705956|FG001|Core Study|Lost to Follow-up|0|||
30692057|NCT00395629|58705957|FG002|Core Study|Lost to Follow-up|1|||
30692058|NCT00395629|58705955|FG000|Extension Study|Adverse Event|0|||
30692059|NCT00395629|58705956|FG001|Extension Study|Adverse Event|0|||
30692060|NCT00395629|58705957|FG002|Extension Study|Adverse Event|2|||
30692061|NCT00395629|58705955|FG000|Extension Study|Administrative problems|0|||
30692062|NCT00395629|58705956|FG001|Extension Study|Administrative problems|0|||
30692063|NCT00395629|58705957|FG002|Extension Study|Administrative problems|1|||
30692064|NCT00392665|58705970|FG000|Overall Study|Death|16|||
30692065|NCT00392665|58705971|FG001|Overall Study|Death|14|||
30692066|NCT00392665|58705970|FG000|Overall Study|Lost to Follow-up|1|||
30692067|NCT00392665|58705971|FG001|Overall Study|Lost to Follow-up|1|||
30692068|NCT00622869|58705980|FG000|Overall Study|Subject Withdrew Consent|13|||
30692069|NCT00622869|58705981|FG001|Overall Study|Subject Withdrew Consent|17|||
30692070|NCT00622869|58705982|FG002|Overall Study|Subject Withdrew Consent|11|||
30692071|NCT00622869|58705980|FG000|Overall Study|Administrative Problems|11|||
30692072|NCT00622869|58705981|FG001|Overall Study|Administrative Problems|17|||
30692073|NCT00622869|58705982|FG002|Overall Study|Administrative Problems|13|||
30692074|NCT00622869|58705980|FG000|Overall Study|Death|12|||
30692075|NCT00622869|58705981|FG001|Overall Study|Death|15|||
30692076|NCT00622869|58705982|FG002|Overall Study|Death|10|||
30692077|NCT00622869|58705980|FG000|Overall Study|Lost to Follow-up|2|||
30692078|NCT00622869|58705981|FG001|Overall Study|Lost to Follow-up|4|||
30692079|NCT00622869|58705982|FG002|Overall Study|Lost to Follow-up|2|||
30692080|NCT00622869|58705980|FG000|Overall Study|Graft Loss|5|||
30692081|NCT00622869|58705981|FG001|Overall Study|Graft Loss|3|||
30692082|NCT00622869|58705982|FG002|Overall Study|Graft Loss|2|||
30692083|NCT00622869|58705980|FG000|Overall Study|Missing|0|||
30692084|NCT00622869|58705981|FG001|Overall Study|Missing|1|||
30692085|NCT00622869|58705982|FG002|Overall Study|Missing|1|||
30692086|NCT00395083|58705992|FG000|Overall Study|Withdrawal by Subject|6|||
30692087|NCT00395083|58705993|FG001|Overall Study|Withdrawal by Subject|5|||
30692088|NCT00395083|58705992|FG000|Overall Study|Developed another disease|4|||
30692089|NCT00395083|58705993|FG001|Overall Study|Developed another disease|3|||
30692090|NCT00366457|58705999|FG000|Overall Study|never began study therapy|2|||
30692091|NCT00624819|58706007|FG000|Follow-up Period: Year 4|Parents decision|0|||
30692092|NCT00624819|58706008|FG001|Follow-up Period: Year 4|Parents decision|0|||
30692093|NCT00624819|58706009|FG002|Follow-up Period: Year 4|Parents decision|1|||
30692094|NCT00624819|58706010|FG003|Follow-up Period: Year 4|Parents decision|0|||
30692095|NCT00624819|58706007|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
30692096|NCT00624819|58706008|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
30692097|NCT00624819|58706009|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
30692098|NCT00624819|58706010|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
30692099|NCT03832387|58706022|FG000|Overall Study|Protocol Violation|2|||
30692100|NCT03832387|58706023|FG001|Overall Study|Protocol Violation|6|||
30692101|NCT03832387|58706022|FG000|Overall Study|EXCLUSION CRITERIA|3|||
30692102|NCT03832387|58706023|FG001|Overall Study|EXCLUSION CRITERIA|1|||
30692103|NCT00366301|58706033|FG000|Overall Study|Lost to Follow-up|4|||
30692104|NCT00366301|58706034|FG001|Overall Study|Lost to Follow-up|4|||
30692105|NCT00366301|58706035|FG002|Overall Study|Lost to Follow-up|3|||
30692106|NCT00366301|58706036|FG003|Overall Study|Lost to Follow-up|7|||
30786568|NCT01367158|58799762|FG007|Overall Study|Protocol Violation|0|||
30692107|NCT00366301|58706033|FG000|Overall Study|Withdrawal by Subject|4|||
30692108|NCT00366301|58706034|FG001|Overall Study|Withdrawal by Subject|2|||
30692109|NCT00366301|58706035|FG002|Overall Study|Withdrawal by Subject|1|||
30692110|NCT00366301|58706036|FG003|Overall Study|Withdrawal by Subject|1|||
30692111|NCT00365989|58706046|FG000|Overall Study|Withdrawal by Subject|1|||
30692112|NCT00365989|58706046|FG000|Overall Study|Non-compliance|1|||
30692113|NCT00622713|58706051|FG000|Overall Study|Adverse Event|35|||
30692114|NCT00622713|58706051|FG000|Overall Study|Administrative problems|4|||
30692115|NCT00622713|58706051|FG000|Overall Study|Withdrawal by Subject|11|||
30692116|NCT00622713|58706051|FG000|Overall Study|Lost to Follow-up|5|||
30692117|NCT00622713|58706051|FG000|Overall Study|Death|2|||
30692118|NCT00622713|58706051|FG000|Overall Study|Subject no longer required study drug|1|||
30692119|NCT00622713|58706051|FG000|Overall Study|Did not meet eligibility criteria|1|||
30692120|NCT00392197|58706057|FG000|Overall Study|Adverse Event|4|||
30692121|NCT00392197|58706058|FG001|Overall Study|Adverse Event|12|||
30692122|NCT00392197|58706057|FG000|Overall Study|Lack of Efficacy|3|||
30692123|NCT00392197|58706058|FG001|Overall Study|Lack of Efficacy|4|||
30692124|NCT00392197|58706057|FG000|Overall Study|Lost to Follow-up|0|||
30692125|NCT00392197|58706058|FG001|Overall Study|Lost to Follow-up|1|||
30692126|NCT00392197|58706057|FG000|Overall Study|Physician Decision|3|||
30692127|NCT00392197|58706058|FG001|Overall Study|Physician Decision|2|||
30692128|NCT00392197|58706057|FG000|Overall Study|Protocol Violation|7|||
30692129|NCT00392197|58706058|FG001|Overall Study|Protocol Violation|5|||
30692130|NCT00392197|58706057|FG000|Overall Study|Withdrawal by Subject|4|||
30692131|NCT00392197|58706058|FG001|Overall Study|Withdrawal by Subject|6|||
30692132|NCT00391807|58706064|FG000|Overall Study|Did not receive study medication|23|||
30692133|NCT00391807|58706064|FG000|Overall Study|Adverse Event|177|||
30692134|NCT00391807|58706064|FG000|Overall Study|Pregnancy|25|||
30692135|NCT00391807|58706064|FG000|Overall Study|Lost to Follow-up|227|||
30692136|NCT00391807|58706064|FG000|Overall Study|Withdrawal by Subject|147|||
30960762|NCT01525589|59026494|FG000|Overall Study|Withdrawal by Subject|0|||
30601871|NCT01258101|58613125|FG001|Overall Study|Patient is not able to attend visits|9|||
30601872|NCT01258101|58613126|FG002|Overall Study|Patient is not able to attend visits|7|||
30601873|NCT01258101|58613127|FG003|Overall Study|Patient is not able to attend visits|6|||
30601874|NCT01258101|58613124|FG000|Overall Study|Patient´s compliance|4|||
30601875|NCT01258101|58613125|FG001|Overall Study|Patient´s compliance|3|||
30601876|NCT01258101|58613126|FG002|Overall Study|Patient´s compliance|1|||
30601877|NCT01258101|58613127|FG003|Overall Study|Patient´s compliance|2|||
30601878|NCT01258101|58613124|FG000|Overall Study|Lost to Follow-up|5|||
30601879|NCT01258101|58613125|FG001|Overall Study|Lost to Follow-up|5|||
30601880|NCT01258101|58613126|FG002|Overall Study|Lost to Follow-up|0|||
30601881|NCT01258101|58613127|FG003|Overall Study|Lost to Follow-up|6|||
30601882|NCT01258101|58613124|FG000|Overall Study|PCR positive at week 24|0|||
30601883|NCT01258101|58613125|FG001|Overall Study|PCR positive at week 24|0|||
30601884|NCT01258101|58613126|FG002|Overall Study|PCR positive at week 24|0|||
30601885|NCT01258101|58613127|FG003|Overall Study|PCR positive at week 24|1|||
30601886|NCT01258101|58613124|FG000|Overall Study|Other reason|7|||
30601887|NCT01258101|58613125|FG001|Overall Study|Other reason|8|||
30601888|NCT01258101|58613126|FG002|Overall Study|Other reason|1|||
30601889|NCT01258101|58613127|FG003|Overall Study|Other reason|8|||
30601890|NCT01300338|58613139|FG000|Overall Study|Lost to Follow-up|5|||
30601891|NCT01300338|58613140|FG001|Overall Study|Lost to Follow-up|0|||
30601892|NCT01300260|58613148|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
30601893|NCT01300260|58613149|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
30601894|NCT01300260|58613148|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
30601895|NCT01300260|58613149|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
30601896|NCT01300260|58613148|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
30692137|NCT00391807|58706064|FG000|Overall Study|Protocol Violation|20|||
30692138|NCT00391807|58706064|FG000|Overall Study|Various|96|||
30692139|NCT00624585|58706068|FG000|Overall Study|Death|3|||
30692140|NCT00624585|58706068|FG000|Overall Study|Disease Progression|6|||
30692141|NCT00624585|58706068|FG000|Overall Study|Adverse Event|3|||
30692142|NCT00622635|58706072|FG000|Treatment Period 1|Adverse Event|0|||
30692143|NCT00622635|58706073|FG001|Treatment Period 1|Adverse Event|0|||
30692144|NCT00622635|58706074|FG002|Treatment Period 1|Adverse Event|1|||
30692145|NCT00622635|58706075|FG003|Treatment Period 1|Adverse Event|0|||
30960763|NCT01525589|59026495|FG001|Overall Study|Withdrawal by Subject|1|||
30601897|NCT01300260|58613149|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
30601898|NCT01256385|58613168|FG000|Overall Study|Physician Decision|1|||
30601899|NCT01256385|58613169|FG001|Overall Study|Physician Decision|1|||
30692146|NCT00622635|58706076|FG004|Treatment Period 1|Adverse Event|0|||
30692147|NCT00622635|58706077|FG005|Treatment Period 1|Adverse Event|0|||
30692148|NCT00622635|58706072|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30692149|NCT00622635|58706073|FG001|Treatment Period 1|Withdrawal by Subject|1|||
30692150|NCT00622635|58706074|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30692151|NCT00622635|58706075|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30692152|NCT00622635|58706076|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30692153|NCT00622635|58706077|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30692154|NCT00622635|58706072|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
30692155|NCT00622635|58706073|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
30692156|NCT00622635|58706074|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
30692157|NCT00622635|58706075|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
30692158|NCT00622635|58706076|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
30692159|NCT00622635|58706077|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
30692160|NCT00622635|58706072|FG000|Treatment Period 2|Adverse Event|1|||
30692161|NCT00622635|58706073|FG001|Treatment Period 2|Adverse Event|0|||
30692162|NCT00622635|58706074|FG002|Treatment Period 2|Adverse Event|0|||
30692163|NCT00622635|58706075|FG003|Treatment Period 2|Adverse Event|0|||
30692164|NCT00622635|58706076|FG004|Treatment Period 2|Adverse Event|0|||
30692165|NCT00622635|58706077|FG005|Treatment Period 2|Adverse Event|0|||
30692166|NCT00622635|58706072|FG000|Treatment Period 3|Adverse Event|0|||
30692167|NCT00622635|58706073|FG001|Treatment Period 3|Adverse Event|0|||
30692168|NCT00622635|58706074|FG002|Treatment Period 3|Adverse Event|0|||
30692169|NCT00622635|58706075|FG003|Treatment Period 3|Adverse Event|2|||
30692170|NCT00622635|58706076|FG004|Treatment Period 3|Adverse Event|0|||
30692171|NCT00622635|58706077|FG005|Treatment Period 3|Adverse Event|0|||
30692172|NCT00622635|58706072|FG000|Treatment Period 3|Withdrawal by Subject|0|||
30692173|NCT00622635|58706073|FG001|Treatment Period 3|Withdrawal by Subject|0|||
30692174|NCT00622635|58706074|FG002|Treatment Period 3|Withdrawal by Subject|0|||
30692175|NCT00622635|58706075|FG003|Treatment Period 3|Withdrawal by Subject|1|||
30692176|NCT00622635|58706076|FG004|Treatment Period 3|Withdrawal by Subject|0|||
30692177|NCT00622635|58706077|FG005|Treatment Period 3|Withdrawal by Subject|0|||
30692178|NCT00391027|58706087|FG000|Overall Study|Adverse Event|8|||
30692179|NCT00391027|58706088|FG001|Overall Study|Adverse Event|8|||
30692180|NCT00391027|58706087|FG000|Overall Study|Lack of Efficacy|3|||
30692181|NCT00391027|58706088|FG001|Overall Study|Lack of Efficacy|0|||
30692182|NCT00391027|58706087|FG000|Overall Study|Withdrawal by Subject|10|||
30692183|NCT00391027|58706088|FG001|Overall Study|Withdrawal by Subject|1|||
30692184|NCT00391027|58706087|FG000|Overall Study|Other|4|||
30692185|NCT00391027|58706088|FG001|Overall Study|Other|3|||
30692186|NCT00622401|58706097|FG000|Overall Study|Disease progression prior to treatment|3|||
30692187|NCT00622401|58706098|FG001|Overall Study|Disease progression prior to treatment|2|||
30692188|NCT00622401|58706099|FG002|Overall Study|Disease progression prior to treatment|0|||
30692189|NCT00621621|58706109|FG000|Overall Study|Subjects were exited at EP study|30|||
30692190|NCT00621621|58706110|FG001|Overall Study|Subjects were exited at EP study|0|||
30692191|NCT00621543|58706118|FG000|Overall Study|Lost to Follow-up|23|||
30692192|NCT00623805|58706124|FG000|Overall Study|Adverse Event|9|||
30692193|NCT00623805|58706125|FG001|Overall Study|Adverse Event|6|||
30692194|NCT00623805|58706124|FG000|Overall Study|Death|2|||
30692195|NCT00623805|58706125|FG001|Overall Study|Death|0|||
30692196|NCT00623805|58706124|FG000|Overall Study|Lack of Efficacy|3|||
30692197|NCT00623805|58706125|FG001|Overall Study|Lack of Efficacy|7|||
30692198|NCT00623805|58706124|FG000|Overall Study|Lost to Follow-up|2|||
30692199|NCT00623805|58706125|FG001|Overall Study|Lost to Follow-up|2|||
30692200|NCT00623805|58706124|FG000|Overall Study|Protocol Violation|1|||
30692201|NCT00623805|58706125|FG001|Overall Study|Protocol Violation|1|||
30692202|NCT00623805|58706124|FG000|Overall Study|Reason not Specified|3|||
30692203|NCT00623805|58706125|FG001|Overall Study|Reason not Specified|6|||
30692204|NCT00621309|58706131|FG000|Overall Study|Withdrawal by Subject|2|||
30692205|NCT00621309|58706132|FG001|Overall Study|Withdrawal by Subject|0|||
30692206|NCT00621309|58706133|FG002|Overall Study|Withdrawal by Subject|1|||
30692207|NCT00621309|58706134|FG003|Overall Study|Withdrawal by Subject|1|||
30692208|NCT00621309|58706135|FG004|Overall Study|Withdrawal by Subject|1|||
30692209|NCT00621309|58706136|FG005|Overall Study|Withdrawal by Subject|1|||
30692210|NCT00567190|58706144|FG000|Overall Study|Death|235|||
30692211|NCT00567190|58706145|FG001|Overall Study|Death|280|||
30692212|NCT00567190|58706144|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
30692213|NCT00567190|58706145|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
30692214|NCT00691938|58706163|FG000|Overall Study|QTc prolongation|1|||
30692215|NCT00691938|58706164|FG001|Overall Study|QTc prolongation|0|||
30692216|NCT00691938|58706165|FG002|Overall Study|QTc prolongation|0|||
30692217|NCT00691938|58706166|FG003|Overall Study|QTc prolongation|0|||
30692218|NCT00691938|58706167|FG004|Overall Study|QTc prolongation|0|||
30692219|NCT00691938|58706168|FG005|Overall Study|QTc prolongation|0|||
30692220|NCT00691938|58706169|FG006|Overall Study|QTc prolongation|0|||
30692221|NCT00365365|58706183|FG000|Overall Study|Randomized but not treated|0|||
30692222|NCT00365365|58706184|FG001|Overall Study|Randomized but not treated|2|||
30692223|NCT00365365|58706185|FG002|Overall Study|Randomized but not treated|0|||
30692224|NCT00365365|58706183|FG000|Overall Study|Poor compliance to protocol|0|||
30692225|NCT00365365|58706184|FG001|Overall Study|Poor compliance to protocol|1|||
30692226|NCT00365365|58706185|FG002|Overall Study|Poor compliance to protocol|0|||
30692227|NCT00365365|58706183|FG000|Overall Study|Lost to Follow-up|3|||
30692228|NCT00365365|58706184|FG001|Overall Study|Lost to Follow-up|3|||
30692229|NCT00365365|58706185|FG002|Overall Study|Lost to Follow-up|3|||
30692230|NCT00365365|58706183|FG000|Overall Study|Death|1|||
30692231|NCT00365365|58706184|FG001|Overall Study|Death|3|||
30692232|NCT00365365|58706185|FG002|Overall Study|Death|0|||
30692233|NCT00365365|58706183|FG000|Overall Study|Subject's request|11|||
30692234|NCT00365365|58706184|FG001|Overall Study|Subject's request|13|||
30692235|NCT00365365|58706185|FG002|Overall Study|Subject's request|1|||
30692236|NCT00365365|58706183|FG000|Overall Study|Disease progression/relapse|9|||
30692237|NCT00365365|58706184|FG001|Overall Study|Disease progression/relapse|6|||
30692238|NCT00365365|58706185|FG002|Overall Study|Disease progression/relapse|7|||
30692239|NCT00365365|58706183|FG000|Overall Study|Adverse Event|6|||
30692240|NCT00365365|58706184|FG001|Overall Study|Adverse Event|6|||
30692241|NCT00365365|58706185|FG002|Overall Study|Adverse Event|3|||
30692242|NCT00365365|58706183|FG000|Overall Study|Moved|2|||
30692243|NCT00365365|58706184|FG001|Overall Study|Moved|0|||
30692244|NCT00365365|58706185|FG002|Overall Study|Moved|0|||
30692245|NCT00365365|58706183|FG000|Overall Study|New cancer|1|||
30692246|NCT00365365|58706184|FG001|Overall Study|New cancer|0|||
30692247|NCT00365365|58706185|FG002|Overall Study|New cancer|0|||
30692248|NCT00365365|58706183|FG000|Overall Study|Withdrew consent|1|||
30692249|NCT00365365|58706184|FG001|Overall Study|Withdrew consent|1|||
30692250|NCT00365365|58706185|FG002|Overall Study|Withdrew consent|0|||
30692251|NCT00365365|58706183|FG000|Overall Study|Second malignancy|0|||
30692252|NCT00365365|58706184|FG001|Overall Study|Second malignancy|1|||
30692253|NCT00365365|58706185|FG002|Overall Study|Second malignancy|0|||
30692254|NCT00365365|58706183|FG000|Overall Study|Patient/physician decision|0|||
30692255|NCT00365365|58706184|FG001|Overall Study|Patient/physician decision|0|||
30692256|NCT00365365|58706185|FG002|Overall Study|Patient/physician decision|1|||
30692257|NCT00623727|58706195|FG000|Double Blind (DB)|Adverse Event|1|||
30692258|NCT00623727|58706196|FG001|Double Blind (DB)|Adverse Event|3|||
30692259|NCT00623727|58706195|FG000|Double Blind (DB)|Physician Decision|0|||
30692260|NCT00623727|58706196|FG001|Double Blind (DB)|Physician Decision|1|||
30692261|NCT00623727|58706195|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
30692262|NCT00623727|58706196|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
30692263|NCT00623727|58706195|FG000|Double Blind (DB)|Lack of Efficacy|2|||
30692264|NCT00623727|58706196|FG001|Double Blind (DB)|Lack of Efficacy|2|||
30692265|NCT00623727|58706195|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
30692266|NCT00623727|58706196|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
30692267|NCT00623727|58706195|FG000|Double Blind (DB)|Lost to Follow-up|1|||
30692268|NCT00623727|58706196|FG001|Double Blind (DB)|Lost to Follow-up|1|||
30692269|NCT00623727|58706195|FG000|Double Blind (DB)|Protocol Violation|2|||
30692270|NCT00623727|58706196|FG001|Double Blind (DB)|Protocol Violation|2|||
30692271|NCT00623727|58706195|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
30692272|NCT00623727|58706196|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
30692273|NCT00623727|58706195|FG000|Open Label Follow-up|Study termination|0|||
30692274|NCT00623727|58706196|FG001|Open Label Follow-up|Study termination|6|||
30692275|NCT00623727|58706195|FG000|Open Label Follow-up|Participant convenience|0|||
30692276|NCT00623727|58706196|FG001|Open Label Follow-up|Participant convenience|1|||
30692277|NCT00372775|58706204|FG000|Overall Study|Adverse Event|8|||
30692278|NCT00372775|58706204|FG000|Overall Study|Death|15|||
30692279|NCT00372775|58706204|FG000|Overall Study|Objective progression or relapse|30|||
30692280|NCT00372775|58706204|FG000|Overall Study|Global deterioration of health status|6|||
30692281|NCT00372775|58706204|FG000|Overall Study|Withdrawal by Subject|1|||
30960764|NCT01525589|59026496|FG002|Overall Study|Withdrawal by Subject|0|||
30960765|NCT01524887|59026507|FG000|Overall Study|Withdrawal by Subject|6|||
30601900|NCT01256385|58613168|FG000|Overall Study|Withdrawal by Subject|2|||
30601901|NCT01256385|58613169|FG001|Overall Study|Withdrawal by Subject|2|||
30601902|NCT01298778|58613177|FG000|Overall Study|Lost to Follow-up|2|||
30601903|NCT01298778|58613178|FG001|Overall Study|Lost to Follow-up|3|||
30601904|NCT01298778|58613177|FG000|Overall Study|Incorrect use of VAS|1|||
30601905|NCT01298778|58613178|FG001|Overall Study|Incorrect use of VAS|0|||
30601906|NCT01298778|58613177|FG000|Overall Study|Withdrawal by Subject|0|||
30601907|NCT01298778|58613178|FG001|Overall Study|Withdrawal by Subject|1|||
30601908|NCT01298778|58613177|FG000|Overall Study|Protocol Violation|0|||
30692282|NCT00372775|58706204|FG000|Overall Study|Other|1|||
30692283|NCT00372775|58706204|FG000|Overall Study|Not Treated|2|||
30601909|NCT01298778|58613178|FG001|Overall Study|Protocol Violation|1|||
30601910|NCT01298778|58613177|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
30692284|NCT00372697|58706210|FG000|Overall Study|Protocol Violation|1|||
30692285|NCT00372697|58706211|FG001|Overall Study|Protocol Violation|1|||
30692286|NCT00690378|58706223|FG000|Overall Study|Adverse Event|1|||
30692287|NCT00690378|58706224|FG001|Overall Study|Adverse Event|0|||
30692288|NCT00690378|58706223|FG000|Overall Study|Withdrawal by Subject|2|||
30692289|NCT00690378|58706224|FG001|Overall Study|Withdrawal by Subject|0|||
30692290|NCT00690378|58706223|FG000|Overall Study|Protocol Violation|1|||
30692291|NCT00690378|58706224|FG001|Overall Study|Protocol Violation|0|||
30692292|NCT00690378|58706223|FG000|Overall Study|Lost to Follow-up|2|||
30692293|NCT00690378|58706224|FG001|Overall Study|Lost to Follow-up|3|||
30692294|NCT00690378|58706223|FG000|Overall Study|Did not meet inc/exc criteria|13|||
30692295|NCT00690378|58706224|FG001|Overall Study|Did not meet inc/exc criteria|11|||
30692296|NCT00690378|58706223|FG000|Overall Study|Social problem|1|||
30692297|NCT00690378|58706224|FG001|Overall Study|Social problem|0|||
30692298|NCT00574275|58706232|FG000|Overall Study|Randomized but not treated|2|||
30692299|NCT00574275|58706233|FG001|Overall Study|Randomized but not treated|3|||
30692300|NCT00574275|58706232|FG000|Overall Study|Adverse Event|32|||
30692301|NCT00574275|58706233|FG001|Overall Study|Adverse Event|76|||
30692302|NCT00574275|58706232|FG000|Overall Study|Disease progression|160|||
30692303|NCT00574275|58706233|FG001|Overall Study|Disease progression|146|||
30692304|NCT00574275|58706232|FG000|Overall Study|Lost to Follow-up|2|||
30692305|NCT00574275|58706233|FG001|Overall Study|Lost to Follow-up|1|||
30692306|NCT00574275|58706232|FG000|Overall Study|Study stopped based on DMC decision|62|||
30692307|NCT00574275|58706233|FG001|Overall Study|Study stopped based on DMC decision|23|||
30692308|NCT00574275|58706232|FG000|Overall Study|Withdrawal by Subject|15|||
30692309|NCT00574275|58706233|FG001|Overall Study|Withdrawal by Subject|17|||
30692310|NCT00574275|58706232|FG000|Overall Study|Error calculating tumor measurement|1|||
30692311|NCT00574275|58706233|FG001|Overall Study|Error calculating tumor measurement|0|||
30692312|NCT00574275|58706232|FG000|Overall Study|Physician Decision|1|||
30692313|NCT00574275|58706233|FG001|Overall Study|Physician Decision|1|||
30692314|NCT00574275|58706232|FG000|Overall Study|Protocol Violation|0|||
30692315|NCT00574275|58706233|FG001|Overall Study|Protocol Violation|1|||
30692316|NCT00574275|58706232|FG000|Overall Study|Patient and Investigator decision|0|||
30692317|NCT00574275|58706233|FG001|Overall Study|Patient and Investigator decision|1|||
30692318|NCT00574275|58706232|FG000|Overall Study|Insurance change|0|||
30692319|NCT00574275|58706233|FG001|Overall Study|Insurance change|1|||
30692320|NCT00574275|58706232|FG000|Overall Study|Operation for curative intent|0|||
30692321|NCT00574275|58706233|FG001|Overall Study|Operation for curative intent|1|||
30692322|NCT00567112|58706239|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
30692323|NCT00567112|58706240|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
30692324|NCT00567112|58706241|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
30692325|NCT00567112|58706239|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
30692326|NCT00567112|58706240|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
30692327|NCT00567112|58706241|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
30692328|NCT00567112|58706239|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
30692329|NCT00567112|58706240|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
30692330|NCT00567112|58706241|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
30692331|NCT01618656|58706261|FG000|Overall Study|Withdrawal by Subject|7|||
30692332|NCT01618656|58706262|FG001|Overall Study|Withdrawal by Subject|3|||
30692333|NCT01618656|58706261|FG000|Overall Study|Physician Decision|1|||
30692334|NCT01618656|58706262|FG001|Overall Study|Physician Decision|1|||
30692335|NCT03978832|58706268|FG000|Overall Study|Adverse Event|1|||
30692336|NCT03978832|58706268|FG000|Overall Study|Lost to Follow-up|1|||
30692337|NCT03978832|58706268|FG000|Overall Study|Withdrawal by Subject|6|||
30692338|NCT03978832|58706268|FG000|Overall Study|Physician Decision|2|||
30692339|NCT03978832|58706268|FG000|Overall Study|did not pass screening criteria|44|||
30692340|NCT00566722|58706275|FG000|Overall Study|Adverse Event|0|||
30692341|NCT00566722|58706276|FG001|Overall Study|Adverse Event|1|||
30692342|NCT00566722|58706277|FG002|Overall Study|Adverse Event|0|||
30692343|NCT00566722|58706275|FG000|Overall Study|Withdrawal by Subject|0|||
30692344|NCT00566722|58706276|FG001|Overall Study|Withdrawal by Subject|0|||
30692345|NCT00566722|58706277|FG002|Overall Study|Withdrawal by Subject|1|||
30692346|NCT00566722|58706275|FG000|Overall Study|Lost to Follow-up|1|||
30692347|NCT00566722|58706276|FG001|Overall Study|Lost to Follow-up|1|||
30692348|NCT00566722|58706277|FG002|Overall Study|Lost to Follow-up|1|||
30692349|NCT00566722|58706275|FG000|Overall Study|Lack of Efficacy|1|||
30692350|NCT00566722|58706276|FG001|Overall Study|Lack of Efficacy|2|||
30692351|NCT00566722|58706277|FG002|Overall Study|Lack of Efficacy|4|||
30692352|NCT00566722|58706275|FG000|Overall Study|Did not meet exclusion criteria|0|||
30692353|NCT00566722|58706276|FG001|Overall Study|Did not meet exclusion criteria|0|||
30692354|NCT00566722|58706277|FG002|Overall Study|Did not meet exclusion criteria|2|||
30692355|NCT00566722|58706275|FG000|Overall Study|Serious adverse event|0|||
30692356|NCT00566722|58706276|FG001|Overall Study|Serious adverse event|1|||
30692357|NCT00566722|58706277|FG002|Overall Study|Serious adverse event|0|||
30692358|NCT00566722|58706275|FG000|Overall Study|Noncompliant with drug administration|0|||
30692359|NCT00566722|58706276|FG001|Overall Study|Noncompliant with drug administration|0|||
30692360|NCT00566722|58706277|FG002|Overall Study|Noncompliant with drug administration|1|||
30692361|NCT00691704|58706288|FG000|Induction Therapy|Disease Progression|1|||
30692362|NCT00691704|58706288|FG000|Induction Therapy|Active Hepatitis|1|||
30692363|NCT00691704|58706288|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
30692364|NCT00691704|58706288|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
30692365|NCT00691704|58706288|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
30692366|NCT00566020|58706292|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
30692367|NCT00566020|58706293|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
30692368|NCT00566020|58706292|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
30692369|NCT00566020|58706293|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
30692370|NCT00566020|58706292|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
30692371|NCT00566020|58706293|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
30692372|NCT00566020|58706292|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
30692373|NCT00566020|58706293|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
30692374|NCT00566020|58706292|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
30692375|NCT00566020|58706293|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
30692376|NCT00566020|58706292|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
30692377|NCT00566020|58706293|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
30692378|NCT00564070|58706300|FG000|Overall Study|Lost to Follow-up|9|||
30692379|NCT00564070|58706301|FG001|Overall Study|Lost to Follow-up|7|||
30692380|NCT00564070|58706300|FG000|Overall Study|Worsening depression, referred to care|3|||
30692381|NCT00564070|58706301|FG001|Overall Study|Worsening depression, referred to care|0|||
30692382|NCT00690612|58706307|FG000|Overall Study|Adverse Event|1|||
30692383|NCT00690612|58706307|FG000|Overall Study|Withdrawal by Subject|2|||
30692384|NCT00621153|58706313|FG000|Overall Study|Safety Reason|8|||
30692385|NCT00621153|58706314|FG001|Overall Study|Safety Reason|7|||
30692386|NCT00621153|58706313|FG000|Overall Study|Adverse Event|3|||
30692387|NCT00621153|58706314|FG001|Overall Study|Adverse Event|2|||
30692388|NCT00621153|58706313|FG000|Overall Study|Lost to Follow-up|5|||
30692389|NCT00621153|58706314|FG001|Overall Study|Lost to Follow-up|1|||
30692390|NCT00621153|58706313|FG000|Overall Study|Withdrawal by Subject|4|||
30692391|NCT00621153|58706314|FG001|Overall Study|Withdrawal by Subject|5|||
30692392|NCT00574119|58706320|FG000|Overall Study|Adverse Event|1|||
30692393|NCT00574119|58706320|FG000|Overall Study|Protocol Violation|1|||
30692394|NCT00574119|58706320|FG000|Overall Study|Withdrawal by Subject|1|||
30692395|NCT00574119|58706320|FG000|Overall Study|Physician Decision|1|||
30692396|NCT00705614|58706326|FG000|Initial Intervention|Adverse Event|40|||
30692397|NCT00705614|58706327|FG001|Initial Intervention|Adverse Event|21|||
30692398|NCT00705614|58706326|FG000|Initial Intervention|Lost to Follow-up|310|||
30692399|NCT00705614|58706327|FG001|Initial Intervention|Lost to Follow-up|191|||
30692400|NCT00705614|58706326|FG000|Initial Intervention|Withdrawal by Subject|114|||
30692401|NCT00705614|58706327|FG001|Initial Intervention|Withdrawal by Subject|71|||
30692402|NCT00705614|58706326|FG000|Initial Intervention|Administrative Reason|51|||
30692403|NCT00705614|58706327|FG001|Initial Intervention|Administrative Reason|38|||
30692404|NCT00705614|58706326|FG000|Initial Intervention|Status completion unknown|3|||
30692405|NCT00705614|58706327|FG001|Initial Intervention|Status completion unknown|0|||
30692406|NCT00705614|58706326|FG000|Switch to Remicade|Adverse Event|0|||
30601911|NCT01298778|58613178|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
30601912|NCT01298700|58613188|FG000|Overall Study|Adverse Event|50|||
30601913|NCT01298700|58613189|FG001|Overall Study|Adverse Event|51|||
30601914|NCT01298700|58613188|FG000|Overall Study|Lack of Efficacy|9|||
30601915|NCT01298700|58613189|FG001|Overall Study|Lack of Efficacy|14|||
30601916|NCT01298700|58613188|FG000|Overall Study|Lost to Follow-up|5|||
30601917|NCT01298700|58613189|FG001|Overall Study|Lost to Follow-up|2|||
30601918|NCT01298700|58613188|FG000|Overall Study|Withdrawal by Subject|12|||
30601919|NCT01298700|58613189|FG001|Overall Study|Withdrawal by Subject|9|||
30601920|NCT01298700|58613188|FG000|Overall Study|Protocol Violation|6|||
30601921|NCT01298700|58613189|FG001|Overall Study|Protocol Violation|4|||
30601922|NCT01298700|58613188|FG000|Overall Study|Other Miscellaneous Reasons|16|||
30601923|NCT01298700|58613189|FG001|Overall Study|Other Miscellaneous Reasons|15|||
30601924|NCT01298700|58613188|FG000|Overall Study|Did not Receive Study Drug|3|||
30601925|NCT01298700|58613189|FG001|Overall Study|Did not Receive Study Drug|5|||
30601926|NCT01297920|58613198|FG000|Overall Study|Adverse Event|42|||
30601927|NCT01297920|58613199|FG001|Overall Study|Adverse Event|10|||
30601928|NCT01297920|58613200|FG002|Overall Study|Adverse Event|38|||
30601929|NCT01297920|58613198|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
30601930|NCT01297920|58613199|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
30601931|NCT01297920|58613200|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
30601932|NCT01297920|58613198|FG000|Overall Study|Noncompliance|1|||
30601933|NCT01297920|58613199|FG001|Overall Study|Noncompliance|0|||
30692407|NCT00705614|58706327|FG001|Switch to Remicade|Adverse Event|5|||
30692408|NCT00705614|58706326|FG000|Switch to Remicade|Lost to Follow-up|0|||
30692409|NCT00705614|58706327|FG001|Switch to Remicade|Lost to Follow-up|23|||
30601934|NCT01297920|58613200|FG002|Overall Study|Noncompliance|0|||
30601935|NCT01297920|58613198|FG000|Overall Study|Protocol Violation|1|||
30601936|NCT01297920|58613199|FG001|Overall Study|Protocol Violation|3|||
30601937|NCT01297920|58613200|FG002|Overall Study|Protocol Violation|0|||
30601938|NCT01297920|58613198|FG000|Overall Study|Inadequate Control of IOP|7|||
30692410|NCT00705614|58706326|FG000|Switch to Remicade|Withdrawal by Subject|0|||
30692411|NCT00705614|58706327|FG001|Switch to Remicade|Withdrawal by Subject|12|||
30692412|NCT00705614|58706326|FG000|Switch to Remicade|Administrative Reason|0|||
30692413|NCT00705614|58706327|FG001|Switch to Remicade|Administrative Reason|9|||
30692414|NCT00620763|58706335|FG000|Period: First Intervention|Withdrawal by Subject|0|||
30692415|NCT00620763|58706336|FG001|Period: First Intervention|Withdrawal by Subject|2|||
30692416|NCT00620763|58706335|FG000|Period: First Intervention|Protocol Violation|0|||
30692417|NCT00620763|58706336|FG001|Period: First Intervention|Protocol Violation|3|||
30692418|NCT00620763|58706335|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
30864677|NCT02198794|58894885|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
30864678|NCT02198794|58894882|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
30864679|NCT02198794|58894883|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
30864680|NCT02198794|58894884|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
30864681|NCT02198794|58894885|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
30864682|NCT02133664|58894896|FG000|Overall Study|Lost to Follow-up|2|||
30864683|NCT02133664|58894897|FG001|Overall Study|Lost to Follow-up|1|||
30864684|NCT02133664|58894896|FG000|Overall Study|Adverse Event|3|||
30864685|NCT02133664|58894897|FG001|Overall Study|Adverse Event|6|||
30864686|NCT02133508|58894903|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
30864687|NCT02133508|58894903|FG000|Overall Study|Death|12|||
30864688|NCT02133508|58894903|FG000|Overall Study|Lost to Follow-up|2|||
30864689|NCT02133352|58894907|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
30864690|NCT02167594|58894914|FG000|Overall Study|Withdrawal by Subject|2|||
30864691|NCT02167594|58894915|FG001|Overall Study|Withdrawal by Subject|0|||
30864692|NCT02167594|58894916|FG002|Overall Study|Withdrawal by Subject|0|||
30864693|NCT02167594|58894914|FG000|Overall Study|Death|0|||
30864694|NCT02167594|58894915|FG001|Overall Study|Death|1|||
30864695|NCT02167594|58894916|FG002|Overall Study|Death|0|||
30864696|NCT02555657|58894927|FG000|Overall Study|Death|274|||
30864697|NCT02555657|58894928|FG001|Overall Study|Death|262|||
30864698|NCT02555657|58894927|FG000|Overall Study|Physician Decision|0|||
30864699|NCT02555657|58894928|FG001|Overall Study|Physician Decision|1|||
30864700|NCT02555657|58894927|FG000|Overall Study|Sponsor Decision|27|||
30864701|NCT02555657|58894928|FG001|Overall Study|Sponsor Decision|15|||
30864702|NCT02555657|58894927|FG000|Overall Study|Withdrawal by Subject|11|||
30864703|NCT02555657|58894928|FG001|Overall Study|Withdrawal by Subject|32|||
30864704|NCT02195518|58894960|FG000|Overall Study|Adverse Event|1|||
30864705|NCT02195518|58894960|FG000|Overall Study|Protocol Violation|4|||
30864706|NCT02195518|58894960|FG000|Overall Study|Pregnancy|2|||
30864707|NCT02195518|58894960|FG000|Overall Study|Withdrawal by Subject|1|||
30864708|NCT02195518|58894960|FG000|Overall Study|Lost to Follow-up|1|||
30864709|NCT02133742|58894990|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
30864710|NCT02133742|58894990|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
30864711|NCT02133742|58894990|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
30864712|NCT02133742|58894990|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
30864713|NCT02133742|58894990|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
30864714|NCT03032705|58894998|FG000|Overall Study|Lost to Follow-up|16|||
30864715|NCT03032705|58894999|FG001|Overall Study|Lost to Follow-up|17|||
30864716|NCT03032705|58894998|FG000|Overall Study|did not quality|6|||
30864717|NCT03032705|58894999|FG001|Overall Study|did not quality|6|||
30864718|NCT04476251|58895005|FG000|Overall Study|Not treated|1|||
30864719|NCT03795233|58895011|FG000|Overall Study|Withdrawal by Subject|2|||
30864720|NCT03795233|58895012|FG001|Overall Study|Withdrawal by Subject|1|||
30864721|NCT03795233|58895011|FG000|Overall Study|Lost to Follow-up|1|||
30864722|NCT03795233|58895012|FG001|Overall Study|Lost to Follow-up|0|||
30864723|NCT03795233|58895011|FG000|Overall Study|Death|1|||
30864724|NCT03795233|58895012|FG001|Overall Study|Death|0|||
30864725|NCT03645863|58895021|FG000|Overall Study|Withdrawal by Subject|1|||
30864726|NCT03645863|58895022|FG001|Overall Study|Withdrawal by Subject|0|||
30864727|NCT03645863|58895023|FG002|Overall Study|Withdrawal by Subject|0|||
30864728|NCT03564119|58895033|FG000|Overall Study|Adverse Event|4|||
30864729|NCT03564119|58895034|FG001|Overall Study|Adverse Event|0|||
30864730|NCT03564119|58895033|FG000|Overall Study|Lost to Follow-up|1|||
30864731|NCT03564119|58895034|FG001|Overall Study|Lost to Follow-up|4|||
30864732|NCT03564119|58895033|FG000|Overall Study|Protocol Violation|1|||
30864733|NCT03564119|58895034|FG001|Overall Study|Protocol Violation|0|||
30864734|NCT03564119|58895033|FG000|Overall Study|Withdrawal by Subject|9|||
30864735|NCT03564119|58895034|FG001|Overall Study|Withdrawal by Subject|4|||
30864736|NCT03564119|58895033|FG000|Overall Study|Other Than Specified|0|||
30864737|NCT03564119|58895034|FG001|Overall Study|Other Than Specified|1|||
30864738|NCT04531241|58895040|FG000|Period 1|Withdrawal by Subject|2|||
30692419|NCT00620763|58706336|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
30692420|NCT00562978|58706344|FG000|Overall Study|Patient had imaging dose only|1|||
30692421|NCT00562978|58706345|FG001|Overall Study|Patient had imaging dose only|11|||
30692422|NCT00620373|58706351|FG000|Overall Study|Unverified cancer status|33|||
30864739|NCT04531241|58895041|FG001|Period 1|Withdrawal by Subject|0|||
30864740|NCT04531241|58895040|FG000|Period 1|Dispesed incorrect lens power|1|||
30864741|NCT04531241|58895041|FG001|Period 1|Dispesed incorrect lens power|0|||
30864742|NCT04531241|58895040|FG000|Period 1|Protocol Violation|1|||
30692423|NCT00372619|58706365|FG000|Overall Study|Ineligible|0|||
30692424|NCT00372619|58706366|FG001|Overall Study|Ineligible|0|||
30864743|NCT04531241|58895041|FG001|Period 1|Protocol Violation|0|||
30864744|NCT04531241|58895040|FG000|Period 1|No longer eligible|0|||
30692425|NCT00372619|58706367|FG002|Overall Study|Ineligible|0|||
30692426|NCT00372619|58706368|FG003|Overall Study|Ineligible|0|||
30692427|NCT00372619|58706369|FG004|Overall Study|Ineligible|0|||
30692428|NCT00372619|58706370|FG005|Overall Study|Ineligible|2|||
30692429|NCT00372619|58706371|FG006|Overall Study|Ineligible|0|||
30864745|NCT04531241|58895041|FG001|Period 1|No longer eligible|1|||
30864746|NCT04531241|58895040|FG000|Period 1|Lens Discomfort|0|||
30864747|NCT04531241|58895041|FG001|Period 1|Lens Discomfort|1|||
30864748|NCT04531241|58895040|FG000|Period 2|Covid-19 Related|1|||
30864749|NCT04531241|58895041|FG001|Period 2|Covid-19 Related|1|||
30864750|NCT03181529|58895049|FG000|Overall Study|Withdrawal by Subject|1|||
30864751|NCT03181529|58895050|FG001|Overall Study|Withdrawal by Subject|1|||
30864752|NCT03181529|58895049|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
30864753|NCT03181529|58895050|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
30864754|NCT03470441|58895064|FG000|Overall Study|Death|0|||
30864755|NCT03470441|58895065|FG001|Overall Study|Death|1|||
30864756|NCT03470441|58895066|FG002|Overall Study|Death|1|||
30864757|NCT03470441|58895067|FG003|Overall Study|Death|0|||
30864758|NCT03470441|58895064|FG000|Overall Study|Adverse Event|0|||
30864759|NCT03470441|58895065|FG001|Overall Study|Adverse Event|0|||
30864760|NCT03470441|58895066|FG002|Overall Study|Adverse Event|0|||
30864761|NCT03470441|58895067|FG003|Overall Study|Adverse Event|1|||
30864762|NCT03470441|58895064|FG000|Overall Study|Withdrawal by Subject|1|||
30864763|NCT03470441|58895065|FG001|Overall Study|Withdrawal by Subject|4|||
30864764|NCT03470441|58895066|FG002|Overall Study|Withdrawal by Subject|1|||
30864765|NCT03470441|58895067|FG003|Overall Study|Withdrawal by Subject|3|||
30864766|NCT03361865|58895079|FG000|Overall Study|Death|17|||
30864767|NCT03361865|58895080|FG001|Overall Study|Death|18|||
30864768|NCT03361865|58895079|FG000|Overall Study|Physician Decision|1|||
30864769|NCT03361865|58895080|FG001|Overall Study|Physician Decision|9|||
30864770|NCT03361865|58895079|FG000|Overall Study|Withdrawal by Subject|1|||
30864771|NCT03361865|58895080|FG001|Overall Study|Withdrawal by Subject|0|||
30864772|NCT02149121|58895094|FG000|Main Study Period|Lack of Efficacy|2|||
30864773|NCT02149121|58895095|FG001|Main Study Period|Lack of Efficacy|2|||
30864774|NCT02149121|58895096|FG002|Main Study Period|Lack of Efficacy|1|||
30864775|NCT02149121|58895097|FG003|Main Study Period|Lack of Efficacy|0|||
30864776|NCT02149121|58895098|FG004|Main Study Period|Lack of Efficacy|0|||
30864777|NCT02149121|58895099|FG005|Main Study Period|Lack of Efficacy|0|||
30864778|NCT02149121|58895100|FG006|Main Study Period|Lack of Efficacy|0|||
30864779|NCT02149121|58895094|FG000|Main Study Period|Withdrawal by Subject|9|||
30864780|NCT02149121|58895095|FG001|Main Study Period|Withdrawal by Subject|5|||
30864781|NCT02149121|58895096|FG002|Main Study Period|Withdrawal by Subject|1|||
30692430|NCT00372619|58706365|FG000|Overall Study|Inevaluable|0|||
30692431|NCT00372619|58706366|FG001|Overall Study|Inevaluable|0|||
30692432|NCT00372619|58706367|FG002|Overall Study|Inevaluable|0|||
30864782|NCT02149121|58895097|FG003|Main Study Period|Withdrawal by Subject|0|||
30692433|NCT00372619|58706368|FG003|Overall Study|Inevaluable|0|||
30692434|NCT00372619|58706369|FG004|Overall Study|Inevaluable|0|||
30692435|NCT00372619|58706370|FG005|Overall Study|Inevaluable|1|||
30692436|NCT00372619|58706371|FG006|Overall Study|Inevaluable|0|||
30692437|NCT00562588|58706389|FG000|Overall Study|Adverse Event|40|||
30692438|NCT00562588|58706390|FG001|Overall Study|Adverse Event|58|||
30692439|NCT00562588|58706389|FG000|Overall Study|Protocol Violation|30|||
30692440|NCT00562588|58706390|FG001|Overall Study|Protocol Violation|26|||
30692441|NCT00562588|58706389|FG000|Overall Study|Lost to Follow-up|12|||
30692442|NCT00562588|58706390|FG001|Overall Study|Lost to Follow-up|4|||
30692443|NCT00562588|58706389|FG000|Overall Study|Withdrawal by Subject|10|||
30692444|NCT00562588|58706390|FG001|Overall Study|Withdrawal by Subject|9|||
30692445|NCT00562588|58706389|FG000|Overall Study|Other|0|||
30692446|NCT00562588|58706390|FG001|Overall Study|Other|2|||
30692447|NCT00622167|58706396|FG000|Overall Study|Did not meet angiographic criteria|20|||
30692448|NCT00562354|58706402|FG000|Overall Study|Physician Decision|0|||
30692449|NCT00562354|58706403|FG001|Overall Study|Physician Decision|1|||
30692450|NCT00562354|58706402|FG000|Overall Study|Lost to Follow-up|0|||
30692451|NCT00562354|58706403|FG001|Overall Study|Lost to Follow-up|1|||
30864783|NCT02149121|58895098|FG004|Main Study Period|Withdrawal by Subject|0|||
30864784|NCT02149121|58895099|FG005|Main Study Period|Withdrawal by Subject|0|||
30864785|NCT02149121|58895100|FG006|Main Study Period|Withdrawal by Subject|0|||
30864786|NCT02149121|58895094|FG000|Main Study Period|Adverse Event|2|||
30692452|NCT00372385|58706415|FG000|Overall Study|Adverse Event|6|||
30692453|NCT00372385|58706416|FG001|Overall Study|Adverse Event|11|||
30692454|NCT00372385|58706417|FG002|Overall Study|Adverse Event|9|||
30692455|NCT00372385|58706418|FG003|Overall Study|Adverse Event|7|||
30692456|NCT00372385|58706415|FG000|Overall Study|Noncompliance|0|||
30864787|NCT02149121|58895095|FG001|Main Study Period|Adverse Event|5|||
30692457|NCT00372385|58706416|FG001|Overall Study|Noncompliance|1|||
30692458|NCT00372385|58706417|FG002|Overall Study|Noncompliance|1|||
30692459|NCT00372385|58706418|FG003|Overall Study|Noncompliance|1|||
30692460|NCT00372385|58706415|FG000|Overall Study|Physician Decision|1|||
30692461|NCT00372385|58706416|FG001|Overall Study|Physician Decision|0|||
30692462|NCT00372385|58706417|FG002|Overall Study|Physician Decision|0|||
30692463|NCT00372385|58706418|FG003|Overall Study|Physician Decision|0|||
30692464|NCT00372385|58706415|FG000|Overall Study|Lost to Follow-up|2|||
30692465|NCT00372385|58706416|FG001|Overall Study|Lost to Follow-up|0|||
30692466|NCT00372385|58706417|FG002|Overall Study|Lost to Follow-up|0|||
30692467|NCT00372385|58706418|FG003|Overall Study|Lost to Follow-up|0|||
30864788|NCT02149121|58895096|FG002|Main Study Period|Adverse Event|1|||
30864789|NCT02149121|58895097|FG003|Main Study Period|Adverse Event|0|||
30864790|NCT02149121|58895098|FG004|Main Study Period|Adverse Event|0|||
30864791|NCT02149121|58895099|FG005|Main Study Period|Adverse Event|0|||
30864792|NCT02149121|58895100|FG006|Main Study Period|Adverse Event|0|||
30864793|NCT02149121|58895094|FG000|Main Study Period|Protocol Violation|2|||
30864794|NCT02149121|58895095|FG001|Main Study Period|Protocol Violation|0|||
30864795|NCT02149121|58895096|FG002|Main Study Period|Protocol Violation|0|||
30864796|NCT02149121|58895097|FG003|Main Study Period|Protocol Violation|0|||
30864797|NCT02149121|58895098|FG004|Main Study Period|Protocol Violation|0|||
30864798|NCT02149121|58895099|FG005|Main Study Period|Protocol Violation|0|||
30864799|NCT02149121|58895100|FG006|Main Study Period|Protocol Violation|0|||
30864800|NCT02149121|58895094|FG000|Main Study Period|Lost to Follow-up|2|||
30864801|NCT02149121|58895095|FG001|Main Study Period|Lost to Follow-up|1|||
30864802|NCT02149121|58895096|FG002|Main Study Period|Lost to Follow-up|0|||
30864803|NCT02149121|58895097|FG003|Main Study Period|Lost to Follow-up|0|||
30864804|NCT02149121|58895098|FG004|Main Study Period|Lost to Follow-up|0|||
30864805|NCT02149121|58895099|FG005|Main Study Period|Lost to Follow-up|0|||
30864806|NCT02149121|58895100|FG006|Main Study Period|Lost to Follow-up|0|||
30864807|NCT02149121|58895094|FG000|Main Study Period|Death|1|||
30864808|NCT02149121|58895095|FG001|Main Study Period|Death|0|||
30864809|NCT02149121|58895096|FG002|Main Study Period|Death|0|||
30864810|NCT02149121|58895097|FG003|Main Study Period|Death|0|||
30864811|NCT02149121|58895098|FG004|Main Study Period|Death|0|||
30864812|NCT02149121|58895099|FG005|Main Study Period|Death|0|||
30864813|NCT02149121|58895100|FG006|Main Study Period|Death|0|||
30864814|NCT02149121|58895094|FG000|Main Study Period|Physician Decision|1|||
30864815|NCT02149121|58895095|FG001|Main Study Period|Physician Decision|0|||
30864816|NCT02149121|58895096|FG002|Main Study Period|Physician Decision|0|||
30864817|NCT02149121|58895097|FG003|Main Study Period|Physician Decision|0|||
30864818|NCT02149121|58895098|FG004|Main Study Period|Physician Decision|0|||
30864819|NCT02149121|58895099|FG005|Main Study Period|Physician Decision|0|||
30864820|NCT02149121|58895100|FG006|Main Study Period|Physician Decision|0|||
30864821|NCT02149121|58895094|FG000|Main Study Period|Developed any malignancy|0|||
30864822|NCT02149121|58895095|FG001|Main Study Period|Developed any malignancy|1|||
30864823|NCT02149121|58895096|FG002|Main Study Period|Developed any malignancy|1|||
30864824|NCT02149121|58895097|FG003|Main Study Period|Developed any malignancy|0|||
30864825|NCT02149121|58895098|FG004|Main Study Period|Developed any malignancy|0|||
30864826|NCT02149121|58895099|FG005|Main Study Period|Developed any malignancy|0|||
30864827|NCT02149121|58895100|FG006|Main Study Period|Developed any malignancy|0|||
30864828|NCT02149121|58895094|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
30864829|NCT02149121|58895095|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
30864830|NCT02149121|58895096|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
30864831|NCT02149121|58895097|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
30864832|NCT02149121|58895098|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
30864833|NCT02149121|58895099|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
30864834|NCT02149121|58895100|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
30864835|NCT02149121|58895094|FG000|Main Study Period|Disease progression|0|||
30864836|NCT02149121|58895095|FG001|Main Study Period|Disease progression|1|||
30864837|NCT02149121|58895096|FG002|Main Study Period|Disease progression|0|||
30864838|NCT02149121|58895097|FG003|Main Study Period|Disease progression|0|||
30864839|NCT02149121|58895098|FG004|Main Study Period|Disease progression|0|||
30864840|NCT02149121|58895099|FG005|Main Study Period|Disease progression|0|||
30864841|NCT02149121|58895100|FG006|Main Study Period|Disease progression|0|||
30864842|NCT02149121|58895094|FG000|Extension Study Period|Withdrawal by Subject|0|||
30864843|NCT02149121|58895095|FG001|Extension Study Period|Withdrawal by Subject|0|||
30864844|NCT02149121|58895096|FG002|Extension Study Period|Withdrawal by Subject|0|||
30864845|NCT02149121|58895097|FG003|Extension Study Period|Withdrawal by Subject|1|||
30864846|NCT02149121|58895098|FG004|Extension Study Period|Withdrawal by Subject|0|||
30864847|NCT02149121|58895099|FG005|Extension Study Period|Withdrawal by Subject|2|||
30960766|NCT01524887|59026508|FG001|Overall Study|Withdrawal by Subject|2|||
30692468|NCT00372385|58706415|FG000|Overall Study|Withdrawal by Subject|2|||
30864848|NCT02149121|58895100|FG006|Extension Study Period|Withdrawal by Subject|0|||
30864849|NCT01865617|58895152|FG000|Overall Study|Death|27|||
30864850|NCT01865617|58895153|FG001|Overall Study|Death|3|||
30864851|NCT01865617|58895154|FG002|Overall Study|Death|1|||
30864852|NCT01865617|58895155|FG003|Overall Study|Death|1|||
30864853|NCT01865617|58895156|FG004|Overall Study|Death|5|||
30864854|NCT01865617|58895157|FG005|Overall Study|Death|1|||
30692469|NCT00372385|58706416|FG001|Overall Study|Withdrawal by Subject|1|||
30692470|NCT00372385|58706417|FG002|Overall Study|Withdrawal by Subject|0|||
30692471|NCT00372385|58706418|FG003|Overall Study|Withdrawal by Subject|0|||
30692472|NCT00372385|58706415|FG000|Overall Study|Refusal of Treatment|3|||
30692473|NCT00372385|58706416|FG001|Overall Study|Refusal of Treatment|6|||
30692474|NCT00372385|58706417|FG002|Overall Study|Refusal of Treatment|0|||
30692475|NCT00372385|58706418|FG003|Overall Study|Refusal of Treatment|0|||
30692476|NCT00372385|58706415|FG000|Overall Study|No Response|1|||
30692477|NCT00372385|58706416|FG001|Overall Study|No Response|1|||
30692478|NCT00372385|58706417|FG002|Overall Study|No Response|0|||
30692479|NCT00372385|58706418|FG003|Overall Study|No Response|0|||
30692480|NCT00372385|58706415|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
30692481|NCT00372385|58706416|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
30692482|NCT00372385|58706417|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
30692483|NCT00372385|58706418|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
30692484|NCT00372385|58706415|FG000|Overall Study|Virologic Stopping Rule|17|||
30692485|NCT00372385|58706416|FG001|Overall Study|Virologic Stopping Rule|0|||
30692486|NCT00372385|58706417|FG002|Overall Study|Virologic Stopping Rule|0|||
30692487|NCT00372385|58706418|FG003|Overall Study|Virologic Stopping Rule|0|||
30692488|NCT03830281|58706431|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
30692489|NCT03830281|58706432|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
30692490|NCT03830281|58706431|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
30692491|NCT03830281|58706432|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
30692492|NCT03830281|58706431|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
30692493|NCT03830281|58706432|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
30692494|NCT03830281|58706431|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
30692495|NCT03830281|58706432|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
30692496|NCT03830281|58706431|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
30692497|NCT03830281|58706432|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
30692498|NCT03830281|58706431|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
30692499|NCT03830281|58706432|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
30692500|NCT03830281|58706431|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
30692501|NCT03830281|58706432|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
30692502|NCT03830281|58706431|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
30692503|NCT03830281|58706432|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
30692504|NCT03830281|58706431|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
30692505|NCT03830281|58706432|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
30692506|NCT00563368|58706446|FG000|Overall Study|Lost to Follow-up|14|||
30692507|NCT00563368|58706447|FG001|Overall Study|Lost to Follow-up|14|||
30692508|NCT00563368|58706448|FG002|Overall Study|Lost to Follow-up|12|||
30692509|NCT00563368|58706449|FG003|Overall Study|Lost to Follow-up|6|||
30692510|NCT00563368|58706450|FG004|Overall Study|Lost to Follow-up|9|||
30864855|NCT01865617|58895158|FG006|Overall Study|Death|11|||
30864856|NCT01865617|58895159|FG007|Overall Study|Death|1|||
30864857|NCT01865617|58895160|FG008|Overall Study|Death|11|||
30864858|NCT01865617|58895161|FG009|Overall Study|Death|3|||
30864859|NCT01865617|58895162|FG010|Overall Study|Death|32|||
30864860|NCT01865617|58895163|FG011|Overall Study|Death|6|||
30864861|NCT01865617|58895164|FG012|Overall Study|Death|13|||
30864862|NCT01865617|58895152|FG000|Overall Study|Lost to Follow-up|2|||
30864863|NCT01865617|58895153|FG001|Overall Study|Lost to Follow-up|0|||
30864864|NCT01865617|58895154|FG002|Overall Study|Lost to Follow-up|0|||
30864865|NCT01865617|58895155|FG003|Overall Study|Lost to Follow-up|0|||
30864866|NCT01865617|58895156|FG004|Overall Study|Lost to Follow-up|0|||
30864867|NCT01865617|58895157|FG005|Overall Study|Lost to Follow-up|0|||
30864868|NCT01865617|58895158|FG006|Overall Study|Lost to Follow-up|0|||
30864869|NCT01865617|58895159|FG007|Overall Study|Lost to Follow-up|0|||
30864870|NCT01865617|58895160|FG008|Overall Study|Lost to Follow-up|0|||
30692511|NCT00563368|58706451|FG005|Overall Study|Lost to Follow-up|8|||
30692512|NCT00563368|58706452|FG006|Overall Study|Lost to Follow-up|9|||
30692513|NCT00563368|58706446|FG000|Overall Study|Adverse Event|3|||
30692514|NCT00563368|58706447|FG001|Overall Study|Adverse Event|4|||
30692515|NCT00563368|58706448|FG002|Overall Study|Adverse Event|5|||
30864871|NCT01865617|58895161|FG009|Overall Study|Lost to Follow-up|0|||
30864872|NCT01865617|58895162|FG010|Overall Study|Lost to Follow-up|0|||
30864873|NCT01865617|58895163|FG011|Overall Study|Lost to Follow-up|0|||
30864874|NCT01865617|58895164|FG012|Overall Study|Lost to Follow-up|0|||
30864875|NCT01865617|58895152|FG000|Overall Study|Withdrawal by Subject|1|||
30960767|NCT01524887|59026509|FG002|Overall Study|Withdrawal by Subject|3|||
30692516|NCT00563368|58706449|FG003|Overall Study|Adverse Event|9|||
30692517|NCT00563368|58706450|FG004|Overall Study|Adverse Event|6|||
30692518|NCT00563368|58706451|FG005|Overall Study|Adverse Event|10|||
30692519|NCT00563368|58706452|FG006|Overall Study|Adverse Event|17|||
30692520|NCT00563368|58706446|FG000|Overall Study|Withdrawal by Subject|11|||
30692521|NCT00563368|58706447|FG001|Overall Study|Withdrawal by Subject|6|||
30692522|NCT00563368|58706448|FG002|Overall Study|Withdrawal by Subject|5|||
30864876|NCT01865617|58895153|FG001|Overall Study|Withdrawal by Subject|0|||
30692523|NCT00563368|58706449|FG003|Overall Study|Withdrawal by Subject|7|||
30692524|NCT00563368|58706450|FG004|Overall Study|Withdrawal by Subject|8|||
30692525|NCT00563368|58706451|FG005|Overall Study|Withdrawal by Subject|5|||
30692526|NCT00563368|58706452|FG006|Overall Study|Withdrawal by Subject|4|||
30692527|NCT00563368|58706446|FG000|Overall Study|protocol non-compliance|1|||
30692528|NCT00563368|58706447|FG001|Overall Study|protocol non-compliance|1|||
30692529|NCT00563368|58706448|FG002|Overall Study|protocol non-compliance|2|||
30692530|NCT00563368|58706449|FG003|Overall Study|protocol non-compliance|1|||
30692531|NCT00563368|58706450|FG004|Overall Study|protocol non-compliance|0|||
30692532|NCT00563368|58706451|FG005|Overall Study|protocol non-compliance|1|||
30692533|NCT00563368|58706452|FG006|Overall Study|protocol non-compliance|3|||
30692534|NCT00563368|58706446|FG000|Overall Study|Pregnancy|1|||
30692535|NCT00563368|58706447|FG001|Overall Study|Pregnancy|0|||
30692536|NCT00563368|58706448|FG002|Overall Study|Pregnancy|1|||
30692537|NCT00563368|58706449|FG003|Overall Study|Pregnancy|2|||
30692538|NCT00563368|58706450|FG004|Overall Study|Pregnancy|1|||
30692539|NCT00563368|58706451|FG005|Overall Study|Pregnancy|2|||
30692540|NCT00563368|58706452|FG006|Overall Study|Pregnancy|0|||
30692541|NCT00563368|58706446|FG000|Overall Study|requirement for restricted medication|0|||
30692542|NCT00563368|58706447|FG001|Overall Study|requirement for restricted medication|0|||
30692543|NCT00563368|58706448|FG002|Overall Study|requirement for restricted medication|2|||
30692544|NCT00563368|58706449|FG003|Overall Study|requirement for restricted medication|0|||
30692545|NCT00563368|58706450|FG004|Overall Study|requirement for restricted medication|0|||
30692546|NCT00563368|58706451|FG005|Overall Study|requirement for restricted medication|0|||
30692547|NCT00563368|58706452|FG006|Overall Study|requirement for restricted medication|0|||
30692548|NCT00563368|58706446|FG000|Overall Study|Other|5|||
30692549|NCT00563368|58706447|FG001|Overall Study|Other|5|||
30692550|NCT00563368|58706448|FG002|Overall Study|Other|3|||
30692551|NCT00563368|58706449|FG003|Overall Study|Other|4|||
30692552|NCT00563368|58706450|FG004|Overall Study|Other|4|||
30692553|NCT00563368|58706451|FG005|Overall Study|Other|4|||
30692554|NCT00563368|58706452|FG006|Overall Study|Other|0|||
30692555|NCT00390013|58706471|FG000|Phase 1|tired|0|||
30692556|NCT00390013|58706472|FG001|Phase 1|tired|0|||
30692557|NCT00390013|58706473|FG002|Phase 1|tired|0|||
30692558|NCT00390013|58706474|FG003|Phase 1|tired|1|||
30692559|NCT00390013|58706471|FG000|Phase 2 First Treatment|tired|1|||
30692560|NCT00390013|58706472|FG001|Phase 2 First Treatment|tired|0|||
30692561|NCT00390013|58706473|FG002|Phase 2 First Treatment|tired|0|||
30692562|NCT00390013|58706474|FG003|Phase 2 First Treatment|tired|0|||
30692563|NCT00390013|58706471|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
30692564|NCT00390013|58706472|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
30692565|NCT00390013|58706473|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
30692566|NCT00390013|58706474|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
30692567|NCT00561652|58706482|FG000|Overall Study|Withdrawal by Subject|0|||
30692568|NCT00561652|58706483|FG001|Overall Study|Withdrawal by Subject|1|||
30692569|NCT00697346|58706492|FG000|Overall Study|Adverse Event|4|||
30692570|NCT00697346|58706493|FG001|Overall Study|Adverse Event|5|||
30692571|NCT00697346|58706494|FG002|Overall Study|Adverse Event|0|||
30692572|NCT00697346|58706492|FG000|Overall Study|Progressive Disease|19|||
30692573|NCT00697346|58706493|FG001|Overall Study|Progressive Disease|18|||
30692574|NCT00697346|58706494|FG002|Overall Study|Progressive Disease|0|||
30692575|NCT00697346|58706492|FG000|Overall Study|Symptomatic Deterioration|0|||
30692576|NCT00697346|58706493|FG001|Overall Study|Symptomatic Deterioration|1|||
30692577|NCT00697346|58706494|FG002|Overall Study|Symptomatic Deterioration|0|||
30692578|NCT00697346|58706492|FG000|Overall Study|Withdrawal by Subject|2|||
30692579|NCT00697346|58706493|FG001|Overall Study|Withdrawal by Subject|2|||
30692580|NCT00697346|58706494|FG002|Overall Study|Withdrawal by Subject|0|||
30692581|NCT00697346|58706492|FG000|Overall Study|Reason not Specified|3|||
30692582|NCT00697346|58706493|FG001|Overall Study|Reason not Specified|0|||
30692583|NCT00697346|58706494|FG002|Overall Study|Reason not Specified|1|||
30864877|NCT01865617|58895154|FG002|Overall Study|Withdrawal by Subject|0|||
30864878|NCT01865617|58895155|FG003|Overall Study|Withdrawal by Subject|0|||
30864879|NCT01865617|58895156|FG004|Overall Study|Withdrawal by Subject|0|||
30864880|NCT01865617|58895157|FG005|Overall Study|Withdrawal by Subject|0|||
30692584|NCT00562120|58706521|FG000|First Intervention Period|Adverse Event|1|||
30692585|NCT00562120|58706522|FG001|First Intervention Period|Adverse Event|0|||
30692586|NCT00562120|58706523|FG002|First Intervention Period|Adverse Event|0|||
30692587|NCT00562120|58706524|FG003|First Intervention Period|Adverse Event|0|||
30692588|NCT00562120|58706521|FG000|First Intervention Period|Randomized but not Treated|1|||
30692589|NCT00562120|58706522|FG001|First Intervention Period|Randomized but not Treated|0|||
30692590|NCT00562120|58706523|FG002|First Intervention Period|Randomized but not Treated|0|||
30692591|NCT00562120|58706524|FG003|First Intervention Period|Randomized but not Treated|0|||
30692592|NCT00561730|58706534|FG000|Overall Study|Adverse Event|2|||
30692593|NCT00561730|58706534|FG000|Overall Study|Handling of the drug|1|||
30692594|NCT00561730|58706534|FG000|Overall Study|Lost to Follow-up|5|||
30786569|NCT01367158|58799763|FG008|Overall Study|Protocol Violation|0|||
30692595|NCT00561730|58706534|FG000|Overall Study|Not specified reasons|1|||
30692596|NCT00697112|58706540|FG000|Overall Study|Adverse Event|8|||
30692597|NCT00697112|58706540|FG000|Overall Study|Lost to Follow-up|1|||
30692598|NCT00697112|58706540|FG000|Overall Study|Did not meet inclusion criteria|1|||
30692599|NCT00621855|58706549|FG000|Overall Study|Adverse Event|32|||
30692600|NCT00621855|58706550|FG001|Overall Study|Adverse Event|31|||
30692601|NCT00621855|58706551|FG002|Overall Study|Adverse Event|48|||
30692602|NCT00621855|58706552|FG003|Overall Study|Adverse Event|34|||
30692603|NCT00621855|58706553|FG004|Overall Study|Adverse Event|31|||
30864881|NCT01865617|58895158|FG006|Overall Study|Withdrawal by Subject|0|||
30864882|NCT01865617|58895159|FG007|Overall Study|Withdrawal by Subject|0|||
30864883|NCT01865617|58895160|FG008|Overall Study|Withdrawal by Subject|0|||
30864884|NCT01865617|58895161|FG009|Overall Study|Withdrawal by Subject|0|||
30864885|NCT01865617|58895162|FG010|Overall Study|Withdrawal by Subject|0|||
30864886|NCT01865617|58895163|FG011|Overall Study|Withdrawal by Subject|0|||
30864887|NCT01865617|58895164|FG012|Overall Study|Withdrawal by Subject|0|||
30864888|NCT01865617|58895152|FG000|Overall Study|Patient proceeded to new therapy|0|||
30864889|NCT01865617|58895153|FG001|Overall Study|Patient proceeded to new therapy|0|||
30864890|NCT01865617|58895154|FG002|Overall Study|Patient proceeded to new therapy|0|||
30864891|NCT01865617|58895155|FG003|Overall Study|Patient proceeded to new therapy|0|||
30864892|NCT01865617|58895156|FG004|Overall Study|Patient proceeded to new therapy|2|||
30864893|NCT01865617|58895157|FG005|Overall Study|Patient proceeded to new therapy|0|||
30864894|NCT01865617|58895158|FG006|Overall Study|Patient proceeded to new therapy|0|||
30864895|NCT01865617|58895159|FG007|Overall Study|Patient proceeded to new therapy|0|||
30864896|NCT01865617|58895160|FG008|Overall Study|Patient proceeded to new therapy|0|||
30864897|NCT01865617|58895161|FG009|Overall Study|Patient proceeded to new therapy|0|||
30864898|NCT01865617|58895162|FG010|Overall Study|Patient proceeded to new therapy|0|||
30864899|NCT01865617|58895163|FG011|Overall Study|Patient proceeded to new therapy|0|||
30864900|NCT01865617|58895164|FG012|Overall Study|Patient proceeded to new therapy|0|||
30864901|NCT01865617|58895152|FG000|Overall Study|Other|0|||
30864902|NCT01865617|58895153|FG001|Overall Study|Other|0|||
30864903|NCT01865617|58895154|FG002|Overall Study|Other|0|||
30864904|NCT01865617|58895155|FG003|Overall Study|Other|0|||
30864905|NCT01865617|58895156|FG004|Overall Study|Other|0|||
30864906|NCT01865617|58895157|FG005|Overall Study|Other|0|||
30864907|NCT01865617|58895158|FG006|Overall Study|Other|1|||
30864908|NCT01865617|58895159|FG007|Overall Study|Other|0|||
30864909|NCT01865617|58895160|FG008|Overall Study|Other|0|||
30864910|NCT01865617|58895161|FG009|Overall Study|Other|0|||
30864911|NCT01865617|58895162|FG010|Overall Study|Other|0|||
30864912|NCT01865617|58895163|FG011|Overall Study|Other|0|||
30864913|NCT01865617|58895164|FG012|Overall Study|Other|0|||
30864914|NCT02458313|58895197|FG000|Overall Study|Withdrawal by Subject|6|||
30864915|NCT02458313|58895198|FG001|Overall Study|Withdrawal by Subject|8|||
30864916|NCT02458313|58895197|FG000|Overall Study|Excluded for motion during MRI|1|||
30864917|NCT02458313|58895198|FG001|Overall Study|Excluded for motion during MRI|2|||
30864918|NCT01328431|58895215|FG000|Baseline|Protocol Violation|0|||
30864919|NCT01328431|58895216|FG001|Baseline|Protocol Violation|2|||
30864920|NCT01328431|58895215|FG000|1 Month (1M)|Lost to Follow-up|55|||
30864921|NCT01328431|58895216|FG001|1 Month (1M)|Lost to Follow-up|58|||
30864922|NCT01328431|58895215|FG000|3 Month (3M)|Death|2|||
30864923|NCT01328431|58895216|FG001|3 Month (3M)|Death|2|||
30864924|NCT01328431|58895215|FG000|3 Month (3M)|Lost to Follow-up|75|||
30864925|NCT01328431|58895216|FG001|3 Month (3M)|Lost to Follow-up|70|||
30864926|NCT01328431|58895215|FG000|12 Month (12M)|Death|2|||
30864927|NCT01328431|58895216|FG001|12 Month (12M)|Death|6|||
30864928|NCT01328431|58895215|FG000|12 Month (12M)|Lost to Follow-up|82|||
30864929|NCT01328431|58895216|FG001|12 Month (12M)|Lost to Follow-up|91|||
30864930|NCT00893789|58895226|FG000|Overall Study|Withdrawal by Subject|3|||
30864931|NCT00893789|58895227|FG001|Overall Study|Withdrawal by Subject|1|||
30864932|NCT00893789|58895228|FG002|Overall Study|Withdrawal by Subject|3|||
30864933|NCT00893789|58895229|FG003|Overall Study|Withdrawal by Subject|1|||
30864934|NCT00893789|58895226|FG000|Overall Study|Noncompliance With Study Drug|1|||
30864935|NCT00893789|58895227|FG001|Overall Study|Noncompliance With Study Drug|0|||
30864936|NCT00893789|58895228|FG002|Overall Study|Noncompliance With Study Drug|1|||
30864937|NCT00893789|58895229|FG003|Overall Study|Noncompliance With Study Drug|2|||
30864938|NCT00893789|58895226|FG000|Overall Study|Noncompliance With Study Procedures|1|||
30864939|NCT00893789|58895227|FG001|Overall Study|Noncompliance With Study Procedures|0|||
30864940|NCT00893789|58895228|FG002|Overall Study|Noncompliance With Study Procedures|0|||
30864941|NCT00893789|58895229|FG003|Overall Study|Noncompliance With Study Procedures|0|||
30864942|NCT00893789|58895226|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
30864943|NCT00893789|58895227|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
30864944|NCT00893789|58895228|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
30864945|NCT00893789|58895229|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
30692604|NCT00621855|58706549|FG000|Overall Study|Lost to Follow-up|0|||
30692605|NCT00621855|58706550|FG001|Overall Study|Lost to Follow-up|1|||
30864946|NCT00893789|58895226|FG000|Overall Study|Adverse Event|0|||
30692606|NCT00621855|58706551|FG002|Overall Study|Lost to Follow-up|3|||
30692607|NCT00621855|58706552|FG003|Overall Study|Lost to Follow-up|4|||
30692608|NCT00621855|58706553|FG004|Overall Study|Lost to Follow-up|1|||
30692609|NCT00621855|58706549|FG000|Overall Study|Protocol Violation|16|||
30692610|NCT00621855|58706550|FG001|Overall Study|Protocol Violation|8|||
30692611|NCT00621855|58706551|FG002|Overall Study|Protocol Violation|6|||
30692612|NCT00621855|58706552|FG003|Overall Study|Protocol Violation|7|||
30692613|NCT00621855|58706553|FG004|Overall Study|Protocol Violation|8|||
30692614|NCT00621855|58706549|FG000|Overall Study|Withdrawal by Subject|16|||
30692615|NCT00621855|58706550|FG001|Overall Study|Withdrawal by Subject|11|||
30692616|NCT00621855|58706551|FG002|Overall Study|Withdrawal by Subject|13|||
30692617|NCT00621855|58706552|FG003|Overall Study|Withdrawal by Subject|13|||
30692618|NCT00621855|58706553|FG004|Overall Study|Withdrawal by Subject|9|||
30692619|NCT00621855|58706549|FG000|Overall Study|Other|9|||
30692620|NCT00621855|58706550|FG001|Overall Study|Other|7|||
30692621|NCT00621855|58706551|FG002|Overall Study|Other|6|||
30692622|NCT00621855|58706552|FG003|Overall Study|Other|5|||
30692623|NCT00621855|58706553|FG004|Overall Study|Other|4|||
30692624|NCT00621855|58706549|FG000|Overall Study|Patients did not receive study drug|3|||
30692625|NCT00621855|58706550|FG001|Overall Study|Patients did not receive study drug|3|||
30692626|NCT00621855|58706551|FG002|Overall Study|Patients did not receive study drug|5|||
30692627|NCT00621855|58706552|FG003|Overall Study|Patients did not receive study drug|4|||
30692628|NCT00621855|58706553|FG004|Overall Study|Patients did not receive study drug|2|||
30692629|NCT00561574|58706567|FG000|Overall Study|Adverse Event|21|||
30692630|NCT00561574|58706568|FG001|Overall Study|Adverse Event|24|||
30692631|NCT00561574|58706567|FG000|Overall Study|Lack of Efficacy|11|||
30692632|NCT00561574|58706568|FG001|Overall Study|Lack of Efficacy|21|||
30692633|NCT00561574|58706567|FG000|Overall Study|Withdrawal by Subject|4|||
30692634|NCT00561574|58706568|FG001|Overall Study|Withdrawal by Subject|4|||
30692635|NCT00561574|58706567|FG000|Overall Study|Reason Unrelated to Trial|6|||
30692636|NCT00561574|58706568|FG001|Overall Study|Reason Unrelated to Trial|2|||
30692637|NCT00561574|58706567|FG000|Overall Study|Lost to Follow-up|1|||
30692638|NCT00561574|58706568|FG001|Overall Study|Lost to Follow-up|0|||
30692639|NCT00561574|58706567|FG000|Overall Study|Other|5|||
30692640|NCT00561574|58706568|FG001|Overall Study|Other|7|||
30692641|NCT00619827|58706576|FG000|Overall Study|Adverse Event|1|||
30692642|NCT00619827|58706577|FG001|Overall Study|Adverse Event|2|||
30692643|NCT00619827|58706576|FG000|Overall Study|Withdrawal by Subject|2|||
30692644|NCT00619827|58706577|FG001|Overall Study|Withdrawal by Subject|2|||
30692645|NCT00687804|58706586|FG000|Core Study|Adverse Event|5|||
30692646|NCT00687804|58706587|FG001|Core Study|Adverse Event|3|||
30692647|NCT00687804|58706588|FG002|Core Study|Adverse Event|3|||
30692648|NCT00687804|58706586|FG000|Core Study|Abnormal laboratory value(s)|1|||
30692649|NCT00687804|58706587|FG001|Core Study|Abnormal laboratory value(s)|0|||
30692650|NCT00687804|58706588|FG002|Core Study|Abnormal laboratory value(s)|0|||
30692651|NCT00687804|58706586|FG000|Core Study|Lack of Efficacy|1|||
30692652|NCT00687804|58706587|FG001|Core Study|Lack of Efficacy|1|||
30692653|NCT00687804|58706588|FG002|Core Study|Lack of Efficacy|1|||
30692654|NCT00687804|58706586|FG000|Core Study|Withdrawal by Subject|4|||
30692655|NCT00687804|58706587|FG001|Core Study|Withdrawal by Subject|7|||
30692656|NCT00687804|58706588|FG002|Core Study|Withdrawal by Subject|7|||
30692657|NCT00687804|58706586|FG000|Core Study|Lost to Follow-up|0|||
30692658|NCT00687804|58706587|FG001|Core Study|Lost to Follow-up|1|||
30692659|NCT00687804|58706588|FG002|Core Study|Lost to Follow-up|0|||
30692660|NCT00687804|58706586|FG000|Core Study|Death|2|||
30692661|NCT00687804|58706587|FG001|Core Study|Death|2|||
30692662|NCT00687804|58706588|FG002|Core Study|Death|2|||
30692663|NCT00687804|58706586|FG000|Core Study|Protocol Violation|1|||
30864947|NCT00893789|58895227|FG001|Overall Study|Adverse Event|2|||
30864948|NCT00893789|58895228|FG002|Overall Study|Adverse Event|1|||
30864949|NCT00893789|58895229|FG003|Overall Study|Adverse Event|5|||
30864950|NCT00893789|58895226|FG000|Overall Study|Protocol Violation|0|||
30864951|NCT00893789|58895227|FG001|Overall Study|Protocol Violation|1|||
30864952|NCT00893789|58895228|FG002|Overall Study|Protocol Violation|1|||
30692664|NCT00687804|58706587|FG001|Core Study|Protocol Violation|1|||
30692665|NCT00687804|58706588|FG002|Core Study|Protocol Violation|0|||
30692666|NCT00687804|58706586|FG000|Open-Label Extension Study|Adverse Event|2|||
30692667|NCT00687804|58706587|FG001|Open-Label Extension Study|Adverse Event|2|||
30692668|NCT00687804|58706588|FG002|Open-Label Extension Study|Adverse Event|2|||
30692669|NCT00687804|58706586|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
30692670|NCT00687804|58706587|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
30864953|NCT00893789|58895229|FG003|Overall Study|Protocol Violation|4|||
30692671|NCT00687804|58706588|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
30692672|NCT00687804|58706586|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
30692673|NCT00687804|58706587|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
30692674|NCT00687804|58706588|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
30692675|NCT00687804|58706586|FG000|Open-Label Extension Study|Administrative problems|1|||
30692676|NCT00687804|58706587|FG001|Open-Label Extension Study|Administrative problems|1|||
30864954|NCT00893789|58895226|FG000|Overall Study|Lost to Follow-up|0|||
30692677|NCT00687804|58706588|FG002|Open-Label Extension Study|Administrative problems|0|||
30692678|NCT00687804|58706586|FG000|Open-Label Extension Study|Death|2|||
30692679|NCT00687804|58706587|FG001|Open-Label Extension Study|Death|3|||
30692680|NCT00687804|58706588|FG002|Open-Label Extension Study|Death|3|||
30692681|NCT00689052|58706615|FG000|Overall Study|Adverse Event|4|||
30692682|NCT00689052|58706616|FG001|Overall Study|Adverse Event|6|||
30692683|NCT00689052|58706615|FG000|Overall Study|Protocol Violation|1|||
30692684|NCT00689052|58706616|FG001|Overall Study|Protocol Violation|0|||
30692685|NCT00689052|58706615|FG000|Overall Study|Lost to Follow-up|2|||
30692686|NCT00689052|58706616|FG001|Overall Study|Lost to Follow-up|0|||
30692687|NCT00689052|58706615|FG000|Overall Study|Withdrawal by Subject|2|||
30692688|NCT00689052|58706616|FG001|Overall Study|Withdrawal by Subject|0|||
30692689|NCT00689052|58706615|FG000|Overall Study|Early termination of the trial|22|||
30692690|NCT00689052|58706616|FG001|Overall Study|Early termination of the trial|24|||
30692691|NCT00560950|58706626|FG000|Overall Study|Lost to Follow-up|1|||
30692692|NCT00560950|58706627|FG001|Overall Study|Lost to Follow-up|0|||
30692693|NCT00576758|58706637|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
30692694|NCT00576758|58706638|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
30692695|NCT00576758|58706637|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
30692696|NCT00576758|58706638|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
30692697|NCT00576758|58706637|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
30692698|NCT00576758|58706638|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
30692699|NCT00576758|58706637|FG000|Induction Treatment Period|Death|1|||
30692700|NCT00576758|58706638|FG001|Induction Treatment Period|Death|0|||
30692701|NCT00576758|58706637|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
30692702|NCT00576758|58706638|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
30692703|NCT00576758|58706637|FG000|Induction Treatment Period|Withdrew consent|1|||
30692704|NCT00576758|58706638|FG001|Induction Treatment Period|Withdrew consent|0|||
30692705|NCT00576758|58706637|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
30692706|NCT00576758|58706638|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
30692707|NCT00576758|58706637|FG000|Extension Treatment Period|Death|1|||
30692708|NCT00576758|58706638|FG001|Extension Treatment Period|Death|1|||
30692709|NCT00576758|58706637|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
30692710|NCT00576758|58706638|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
30692711|NCT00576758|58706637|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
30692712|NCT00576758|58706638|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
30692713|NCT00576758|58706637|FG000|Extension Treatment Period|Administrative/Other|3|||
30692714|NCT00576758|58706638|FG001|Extension Treatment Period|Administrative/Other|1|||
30692715|NCT00576758|58706637|FG000|Follow-up Period|Administrative/Other|6|||
30692716|NCT00576758|58706638|FG001|Follow-up Period|Administrative/Other|8|||
30692717|NCT00576758|58706637|FG000|Follow-up Period|Death|3|||
30692718|NCT00576758|58706638|FG001|Follow-up Period|Death|3|||
30692719|NCT00576758|58706637|FG000|Follow-up Period|Insufficient therapeutic response|16|||
30692720|NCT00576758|58706638|FG001|Follow-up Period|Insufficient therapeutic response|5|||
30692721|NCT00576758|58706637|FG000|Follow-up Period|Withdrew consent|2|||
30692722|NCT00576758|58706638|FG001|Follow-up Period|Withdrew consent|1|||
30692723|NCT00560794|58706645|FG000|Overall Study|Adverse Event|2|||
30692724|NCT00560794|58706645|FG000|Overall Study|Patient was not Compliant|1|||
30692725|NCT00560794|58706645|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
30692726|NCT00560794|58706645|FG000|Overall Study|Hematological Relapse|1|||
30692727|NCT00560794|58706645|FG000|Overall Study|Received Bone Marrow Transplant|6|||
30692728|NCT00619359|58706653|FG000|Overall Study|Adverse Event|32|||
30692729|NCT00619359|58706654|FG001|Overall Study|Adverse Event|36|||
30692730|NCT00619359|58706653|FG000|Overall Study|Lost to Follow-up|12|||
30692731|NCT00619359|58706654|FG001|Overall Study|Lost to Follow-up|16|||
30692732|NCT00619359|58706653|FG000|Overall Study|Physician Decision|0|||
30692733|NCT00619359|58706654|FG001|Overall Study|Physician Decision|7|||
30692734|NCT00619359|58706653|FG000|Overall Study|Protocol Violation|1|||
30692735|NCT00619359|58706654|FG001|Overall Study|Protocol Violation|1|||
30692736|NCT00619359|58706653|FG000|Overall Study|Withdrawal by Subject|19|||
30864955|NCT00893789|58895227|FG001|Overall Study|Lost to Follow-up|0|||
30864956|NCT00893789|58895228|FG002|Overall Study|Lost to Follow-up|0|||
30692737|NCT00619359|58706654|FG001|Overall Study|Withdrawal by Subject|20|||
30692738|NCT00619359|58706653|FG000|Overall Study|Progressive Disease|3|||
30692739|NCT00619359|58706654|FG001|Overall Study|Progressive Disease|1|||
30692740|NCT00372229|58706662|FG000|Study Phase|Graft loss|0|||
30692741|NCT00372229|58706663|FG001|Study Phase|Graft loss|3|||
30692742|NCT00372229|58706662|FG000|Study Phase|Protocol Violation|3|||
30692743|NCT00372229|58706663|FG001|Study Phase|Protocol Violation|4|||
30692744|NCT00372229|58706662|FG000|Study Phase|Consent withdrawn|16|||
30692745|NCT00372229|58706663|FG001|Study Phase|Consent withdrawn|14|||
30692746|NCT00372229|58706662|FG000|Study Phase|Refused treatment/did not cooperate|3|||
30692747|NCT00372229|58706663|FG001|Study Phase|Refused treatment/did not cooperate|1|||
30692748|NCT00372229|58706662|FG000|Study Phase|Death|3|||
30692749|NCT00372229|58706663|FG001|Study Phase|Death|2|||
30692750|NCT00372229|58706662|FG000|Study Phase|Reason not specified|3|||
30692751|NCT00372229|58706663|FG001|Study Phase|Reason not specified|2|||
30692752|NCT00372229|58706662|FG000|Study Phase|Lost to Follow-up|3|||
30692753|NCT00372229|58706663|FG001|Study Phase|Lost to Follow-up|3|||
30692754|NCT00372229|58706662|FG000|Follow-Up Phase|Graft loss|8|||
30692755|NCT00372229|58706663|FG001|Follow-Up Phase|Graft loss|7|||
30692756|NCT00372229|58706662|FG000|Follow-Up Phase|Consent withdrawn|13|||
30692757|NCT00372229|58706663|FG001|Follow-Up Phase|Consent withdrawn|19|||
30692758|NCT00372229|58706662|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
30692759|NCT00372229|58706663|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
30692760|NCT00372229|58706662|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
30692761|NCT00372229|58706663|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
30692762|NCT00372229|58706662|FG000|Follow-Up Phase|Death|9|||
30692763|NCT00372229|58706663|FG001|Follow-Up Phase|Death|12|||
30692764|NCT00372229|58706662|FG000|Follow-Up Phase|Administrative|1|||
30692765|NCT00372229|58706663|FG001|Follow-Up Phase|Administrative|0|||
30692766|NCT00372229|58706662|FG000|Follow-Up Phase|Reason not specified|2|||
30692767|NCT00372229|58706663|FG001|Follow-Up Phase|Reason not specified|3|||
30692768|NCT00372229|58706662|FG000|Follow-Up Phase|Lost to Follow-up|12|||
30692769|NCT00372229|58706663|FG001|Follow-Up Phase|Lost to Follow-up|10|||
30692770|NCT00698828|58706676|FG000|Overall Study|Adverse Event|3|||
30692771|NCT00698828|58706677|FG001|Overall Study|Adverse Event|4|||
30692772|NCT00698828|58706678|FG002|Overall Study|Adverse Event|4|||
30692773|NCT00698828|58706676|FG000|Overall Study|Death|0|||
30692774|NCT00698828|58706677|FG001|Overall Study|Death|0|||
30692775|NCT00698828|58706678|FG002|Overall Study|Death|1|||
30692776|NCT00698828|58706676|FG000|Overall Study|Exacerbation of COPD|1|||
30692777|NCT00698828|58706677|FG001|Overall Study|Exacerbation of COPD|3|||
30692778|NCT00698828|58706678|FG002|Overall Study|Exacerbation of COPD|0|||
30864957|NCT00893789|58895229|FG003|Overall Study|Lost to Follow-up|1|||
30864958|NCT02164864|58895242|FG000|Overall Study|Trial disease worsening|7|||
30692779|NCT00698828|58706676|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
30692780|NCT00698828|58706677|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
30692781|NCT00698828|58706678|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
30692782|NCT00698828|58706676|FG000|Overall Study|Investigator/Sponsor decision|1|||
30692783|NCT00698828|58706677|FG001|Overall Study|Investigator/Sponsor decision|0|||
30692784|NCT00698828|58706678|FG002|Overall Study|Investigator/Sponsor decision|2|||
30692785|NCT00698828|58706676|FG000|Overall Study|Lost to Follow-up|1|||
30692786|NCT00698828|58706677|FG001|Overall Study|Lost to Follow-up|1|||
30692787|NCT00698828|58706678|FG002|Overall Study|Lost to Follow-up|0|||
30864959|NCT02164864|58895243|FG001|Overall Study|Trial disease worsening|5|||
30864960|NCT02164864|58895244|FG002|Overall Study|Trial disease worsening|1|||
30864961|NCT02164864|58895242|FG000|Overall Study|Other pre-existing disease worsening|6|||
30864962|NCT02164864|58895243|FG001|Overall Study|Other pre-existing disease worsening|4|||
30692788|NCT00698828|58706676|FG000|Overall Study|Withdrew consent|0|||
30692789|NCT00698828|58706677|FG001|Overall Study|Withdrew consent|7|||
30692790|NCT00698828|58706678|FG002|Overall Study|Withdrew consent|4|||
30692791|NCT00698828|58706676|FG000|Overall Study|Withdrew consent (not treated)|2|||
30692792|NCT00698828|58706677|FG001|Overall Study|Withdrew consent (not treated)|0|||
30692793|NCT00698828|58706678|FG002|Overall Study|Withdrew consent (not treated)|0|||
30692794|NCT00619515|58706686|FG000|Overall Study|Study Termination by IRB|73|||
30692795|NCT03167606|58706692|FG000|Overall Study|Lost to Follow-up|73|||
30864963|NCT02164864|58895244|FG002|Overall Study|Other pre-existing disease worsening|9|||
30864964|NCT02164864|58895242|FG000|Overall Study|Other Adverse Event (AE)|52|||
30864965|NCT02164864|58895243|FG001|Overall Study|Other Adverse Event (AE)|32|||
30864966|NCT02164864|58895244|FG002|Overall Study|Other Adverse Event (AE)|49|||
30692796|NCT03167606|58706693|FG001|Overall Study|Lost to Follow-up|64|||
30692797|NCT03167606|58706692|FG000|Overall Study|Withdrawal by Subject|6|||
30692798|NCT03167606|58706693|FG001|Overall Study|Withdrawal by Subject|5|||
30692799|NCT03167606|58706692|FG000|Overall Study|Withdrawal by Investigator|0|||
30692800|NCT03167606|58706693|FG001|Overall Study|Withdrawal by Investigator|2|||
30864967|NCT02164864|58895242|FG000|Overall Study|Protocol Violation|2|||
30864968|NCT02164864|58895243|FG001|Overall Study|Protocol Violation|4|||
30864969|NCT02164864|58895244|FG002|Overall Study|Protocol Violation|1|||
30864970|NCT02164864|58895242|FG000|Overall Study|Lost to Follow-up|4|||
30864971|NCT02164864|58895243|FG001|Overall Study|Lost to Follow-up|3|||
30864972|NCT02164864|58895244|FG002|Overall Study|Lost to Follow-up|2|||
30864973|NCT02164864|58895242|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
30864974|NCT02164864|58895243|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
30864975|NCT02164864|58895244|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
30864976|NCT02164864|58895242|FG000|Overall Study|Other than stated|3|||
30864977|NCT02164864|58895243|FG001|Overall Study|Other than stated|4|||
30692801|NCT00688740|58706701|FG000|Overall Study|Adverse Event|45|||
30692802|NCT00688740|58706702|FG001|Overall Study|Adverse Event|8|||
30692803|NCT00688740|58706701|FG000|Overall Study|Death|2|||
30692804|NCT00688740|58706702|FG001|Overall Study|Death|2|||
30692805|NCT00688740|58706701|FG000|Overall Study|Lost to Follow-up|0|||
30692806|NCT00688740|58706702|FG001|Overall Study|Lost to Follow-up|1|||
30692807|NCT00688740|58706701|FG000|Overall Study|Consent Withdrawn|17|||
30692808|NCT00688740|58706702|FG001|Overall Study|Consent Withdrawn|17|||
30692809|NCT00688740|58706701|FG000|Overall Study|Breast Cancer Relapse|1|||
30692810|NCT00688740|58706702|FG001|Overall Study|Breast Cancer Relapse|4|||
30692811|NCT00688740|58706701|FG000|Overall Study|Violation of Inclusion Criteria|1|||
30692812|NCT00688740|58706702|FG001|Overall Study|Violation of Inclusion Criteria|3|||
30692813|NCT00552760|58706710|FG000|Overall Study|Adverse Event|3|||
30692814|NCT00552760|58706711|FG001|Overall Study|Adverse Event|5|||
30692815|NCT00552760|58706710|FG000|Overall Study|Relapsed- Depressed Event|10|||
30692816|NCT00552760|58706711|FG001|Overall Study|Relapsed- Depressed Event|16|||
30692817|NCT00552760|58706710|FG000|Overall Study|Relapse- Manic Event|3|||
30692818|NCT00552760|58706711|FG001|Overall Study|Relapse- Manic Event|3|||
30692819|NCT00552760|58706710|FG000|Overall Study|Relapsed- Mixed Event|3|||
30692820|NCT00552760|58706711|FG001|Overall Study|Relapsed- Mixed Event|5|||
30692821|NCT00552760|58706710|FG000|Overall Study|Protocol Violation|0|||
30692822|NCT00552760|58706711|FG001|Overall Study|Protocol Violation|1|||
30692823|NCT00552760|58706710|FG000|Overall Study|Lost to Follow-up|1|||
30692824|NCT00552760|58706711|FG001|Overall Study|Lost to Follow-up|1|||
30692825|NCT00552760|58706710|FG000|Overall Study|Non-compliance|1|||
30692826|NCT00552760|58706711|FG001|Overall Study|Non-compliance|1|||
30692827|NCT00552760|58706710|FG000|Overall Study|Medical Condition|1|||
30692828|NCT00552760|58706711|FG001|Overall Study|Medical Condition|1|||
30692829|NCT00552760|58706710|FG000|Overall Study|Withdrawal by Subject|3|||
30692830|NCT00552760|58706711|FG001|Overall Study|Withdrawal by Subject|0|||
30692831|NCT00552760|58706710|FG000|Overall Study|Medication Change|1|||
30692832|NCT00552760|58706711|FG001|Overall Study|Medication Change|0|||
30692833|NCT00686790|58706717|FG000|Overall Study|Adverse Event|2|||
30692834|NCT00686790|58706717|FG000|Overall Study|Withdrawal by Subject|1|||
30692835|NCT00686790|58706717|FG000|Overall Study|Death|1|||
30692836|NCT00686790|58706717|FG000|Overall Study|Lost to Follow-up|12|||
30692837|NCT00686712|58706724|FG000|Overall Study|Protocol Violation|8|||
30692838|NCT00686712|58706725|FG001|Overall Study|Protocol Violation|8|||
30692839|NCT00686712|58706726|FG002|Overall Study|Protocol Violation|10|||
30692840|NCT00686712|58706724|FG000|Overall Study|Lost to Follow-up|1|||
30692841|NCT00686712|58706725|FG001|Overall Study|Lost to Follow-up|2|||
30692842|NCT00686712|58706726|FG002|Overall Study|Lost to Follow-up|3|||
30692843|NCT00686712|58706724|FG000|Overall Study|Adverse Event|1|||
30864978|NCT02164864|58895244|FG002|Overall Study|Other than stated|14|||
30864979|NCT02419807|58895255|FG000|Overall Study|Withdrawal by Subject|4|||
30864980|NCT02419807|58895255|FG000|Overall Study|Physician Decision|1|||
30864981|NCT02419807|58895255|FG000|Overall Study|Protocol Violation|5|||
30864982|NCT03857867|58895259|FG000|Overall Study|Physician Decision|1|||
30864983|NCT01628926|58895267|FG000|Overall Study|Adverse Event|13|||
30864984|NCT01628926|58895268|FG001|Overall Study|Adverse Event|11|||
30864985|NCT01628926|58895269|FG002|Overall Study|Adverse Event|9|||
30864986|NCT01628926|58895267|FG000|Overall Study|Lack of Efficacy|2|||
30864987|NCT01628926|58895268|FG001|Overall Study|Lack of Efficacy|1|||
30864988|NCT01628926|58895269|FG002|Overall Study|Lack of Efficacy|5|||
30864989|NCT01628926|58895267|FG000|Overall Study|Withdrawal by Subject|6|||
30864990|NCT01628926|58895268|FG001|Overall Study|Withdrawal by Subject|4|||
30864991|NCT01628926|58895269|FG002|Overall Study|Withdrawal by Subject|2|||
30864992|NCT01628926|58895267|FG000|Overall Study|Protocol Violation|0|||
30864993|NCT01628926|58895268|FG001|Overall Study|Protocol Violation|1|||
30864994|NCT01628926|58895269|FG002|Overall Study|Protocol Violation|0|||
30864995|NCT01628926|58895267|FG000|Overall Study|Discontinuation criteria|3|||
30864996|NCT01628926|58895268|FG001|Overall Study|Discontinuation criteria|4|||
30601939|NCT01297920|58613199|FG001|Overall Study|Inadequate Control of IOP|9|||
30601940|NCT01297920|58613200|FG002|Overall Study|Inadequate Control of IOP|17|||
30601941|NCT01297920|58613198|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
30601942|NCT01297920|58613199|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
30601943|NCT01297920|58613200|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
30601944|NCT01255761|58613210|FG000|Overall Study|Adverse Event|29|||
30601945|NCT01255761|58613211|FG001|Overall Study|Adverse Event|43|||
30601946|NCT01255761|58613210|FG000|Overall Study|Lack of Efficacy|86|||
30601947|NCT01255761|58613211|FG001|Overall Study|Lack of Efficacy|74|||
30601948|NCT01255761|58613210|FG000|Overall Study|Protocol Violation|9|||
30601949|NCT01255761|58613211|FG001|Overall Study|Protocol Violation|5|||
30601950|NCT01255761|58613210|FG000|Overall Study|Lost to Follow-up|10|||
30601951|NCT01255761|58613211|FG001|Overall Study|Lost to Follow-up|8|||
30601952|NCT01255761|58613210|FG000|Overall Study|Withdrawal by Subject|11|||
30601953|NCT01255761|58613211|FG001|Overall Study|Withdrawal by Subject|27|||
30601954|NCT01255761|58613210|FG000|Overall Study|Other Reasons|37|||
30601955|NCT01255761|58613211|FG001|Overall Study|Other Reasons|18|||
30601956|NCT01297062|58613223|FG000|Overall Study|Adverse Event|2|||
30601957|NCT01297062|58613224|FG001|Overall Study|Adverse Event|0|||
30601958|NCT01297062|58613225|FG002|Overall Study|Adverse Event|1|||
30692844|NCT00686712|58706725|FG001|Overall Study|Adverse Event|1|||
30692845|NCT00686712|58706726|FG002|Overall Study|Adverse Event|0|||
30692846|NCT00686634|58706737|FG000|Overall Study|Protocol Violation|6|||
30692847|NCT00560404|58706744|FG000|Overall Study|Adverse Event|2|||
30692848|NCT00560404|58706745|FG001|Overall Study|Adverse Event|3|||
30692849|NCT00560404|58706744|FG000|Overall Study|Death|3|||
30692850|NCT00560404|58706745|FG001|Overall Study|Death|3|||
30692851|NCT00560404|58706744|FG000|Overall Study|Protocol Violation|12|||
30692852|NCT00560404|58706745|FG001|Overall Study|Protocol Violation|7|||
30864997|NCT01628926|58895269|FG002|Overall Study|Discontinuation criteria|0|||
30864998|NCT01628926|58895267|FG000|Overall Study|Physician Decision|2|||
30864999|NCT01628926|58895268|FG001|Overall Study|Physician Decision|2|||
30865000|NCT01628926|58895269|FG002|Overall Study|Physician Decision|1|||
30865001|NCT01628848|58895280|FG000|Overall Study|Adverse Event|9|||
30865002|NCT01628848|58895281|FG001|Overall Study|Adverse Event|7|||
30865003|NCT01628848|58895280|FG000|Overall Study|Lack of Efficacy|0|||
30865004|NCT01628848|58895281|FG001|Overall Study|Lack of Efficacy|4|||
30865005|NCT01628848|58895280|FG000|Overall Study|Withdrawal by Subject|0|||
30865006|NCT01628848|58895281|FG001|Overall Study|Withdrawal by Subject|2|||
30865007|NCT01628848|58895280|FG000|Overall Study|Physician Decision|3|||
30865008|NCT01628848|58895281|FG001|Overall Study|Physician Decision|1|||
30865009|NCT02164318|58895291|FG000|Overall Study|Withdrawal by Subject|0|||
30865010|NCT02164318|58895292|FG001|Overall Study|Withdrawal by Subject|1|||
30865011|NCT02164318|58895293|FG002|Overall Study|Withdrawal by Subject|0|||
30865012|NCT02164318|58895294|FG003|Overall Study|Withdrawal by Subject|1|||
30865013|NCT03436199|58895307|FG000|Overall Study|Adverse Event|15|||
30865014|NCT03436199|58895308|FG001|Overall Study|Adverse Event|40|||
30865015|NCT03436199|58895309|FG002|Overall Study|Adverse Event|7|||
30865016|NCT03436199|58895307|FG000|Overall Study|Withdrawal by Subject|4|||
30865017|NCT03436199|58895308|FG001|Overall Study|Withdrawal by Subject|10|||
30865018|NCT03436199|58895309|FG002|Overall Study|Withdrawal by Subject|3|||
30865019|NCT03436199|58895307|FG000|Overall Study|Lost to Follow-up|1|||
30865020|NCT03436199|58895308|FG001|Overall Study|Lost to Follow-up|0|||
30865021|NCT03436199|58895309|FG002|Overall Study|Lost to Follow-up|2|||
30865022|NCT03436199|58895307|FG000|Overall Study|Protocol Violation|1|||
30692853|NCT00560404|58706744|FG000|Overall Study|Administrative Reasons|1|||
30692854|NCT00560404|58706745|FG001|Overall Study|Administrative Reasons|1|||
30865023|NCT03436199|58895308|FG001|Overall Study|Protocol Violation|1|||
30865024|NCT03436199|58895309|FG002|Overall Study|Protocol Violation|0|||
30865025|NCT03436199|58895307|FG000|Overall Study|Physician Decision|0|||
30865026|NCT03436199|58895308|FG001|Overall Study|Physician Decision|1|||
30865027|NCT03436199|58895309|FG002|Overall Study|Physician Decision|0|||
30865028|NCT03436199|58895307|FG000|Overall Study|Could not return to clinic|1|||
30865029|NCT03436199|58895308|FG001|Overall Study|Could not return to clinic|0|||
30865030|NCT03436199|58895309|FG002|Overall Study|Could not return to clinic|0|||
30865031|NCT03436199|58895307|FG000|Overall Study|Withdrawn per physician|0|||
30865032|NCT03436199|58895308|FG001|Overall Study|Withdrawn per physician|1|||
30692855|NCT00560404|58706744|FG000|Overall Study|Withdrew Consent|4|||
30692856|NCT00560404|58706745|FG001|Overall Study|Withdrew Consent|0|||
30692857|NCT00560404|58706744|FG000|Overall Study|Failure to return|1|||
30692858|NCT00560404|58706745|FG001|Overall Study|Failure to return|2|||
30692859|NCT00560404|58706744|FG000|Overall Study|Other withdrawal reason|13|||
30692860|NCT00560404|58706745|FG001|Overall Study|Other withdrawal reason|5|||
30692861|NCT03967444|58706753|FG000|Overall Study|Lost to Follow-up|1|||
30692862|NCT03967444|58706754|FG001|Overall Study|Lost to Follow-up|2|||
30692863|NCT00619983|58706764|FG000|Test Drug Alone|Withdrawal by Subject|1|||
30692864|NCT00619983|58706765|FG001|Test Drug Alone|Withdrawal by Subject|0|||
30692865|NCT00619983|58706766|FG002|Test Drug Alone|Withdrawal by Subject|0|||
30692866|NCT00619983|58706767|FG003|Test Drug Alone|Withdrawal by Subject|1|||
30692867|NCT00619983|58706764|FG000|Test Drug Alone|Failure of daily diary device|1|||
30692868|NCT00619983|58706765|FG001|Test Drug Alone|Failure of daily diary device|1|||
30692869|NCT00619983|58706766|FG002|Test Drug Alone|Failure of daily diary device|2|||
30692870|NCT00619983|58706767|FG003|Test Drug Alone|Failure of daily diary device|2|||
30692871|NCT00576420|58706780|FG000|Overall Study|Death|0|||
30692872|NCT00576420|58706781|FG001|Overall Study|Death|0|||
30692873|NCT00576420|58706782|FG002|Overall Study|Death|1|||
30692874|NCT03961204|58706831|FG000|Overall Study|Withdrawal by Subject|2|||
30692875|NCT03961204|58706831|FG000|Overall Study|Lost to Follow-up|3|||
30692876|NCT03961204|58706831|FG000|Overall Study|Other|1|||
30692877|NCT03961204|58706831|FG000|Overall Study|Missing|1|||
30692878|NCT00364351|58706837|FG000|Overall Study|Adverse Event|90|||
30865033|NCT03436199|58895309|FG002|Overall Study|Withdrawn per physician|0|||
30865034|NCT02131636|58895319|FG000|Overall Study|Personal Reasons|4|||
30865035|NCT02131636|58895320|FG001|Overall Study|Personal Reasons|4|||
30960768|NCT01524887|59026507|FG000|Overall Study|Adverse Event|5|||
30865036|NCT02131636|58895319|FG000|Overall Study|Lost to Follow-up|4|||
30865037|NCT02131636|58895320|FG001|Overall Study|Lost to Follow-up|0|||
30865038|NCT02131636|58895319|FG000|Overall Study|Adverse Event|4|||
30865039|NCT02131636|58895320|FG001|Overall Study|Adverse Event|1|||
30692879|NCT00364351|58706838|FG001|Overall Study|Adverse Event|44|||
30692880|NCT00364351|58706837|FG000|Overall Study|Condition under investigation worsened|469|||
30692881|NCT00364351|58706838|FG001|Overall Study|Condition under investigation worsened|497|||
30692882|NCT00364351|58706837|FG000|Overall Study|Prohibited concomitant medication|0|||
30692883|NCT00364351|58706838|FG001|Overall Study|Prohibited concomitant medication|2|||
30692884|NCT00364351|58706837|FG000|Overall Study|Lost to Follow-up|1|||
30692885|NCT00364351|58706838|FG001|Overall Study|Lost to Follow-up|1|||
30692886|NCT00364351|58706837|FG000|Overall Study|Withdrawal by Subject|30|||
30692887|NCT00364351|58706838|FG001|Overall Study|Withdrawal by Subject|29|||
30692888|NCT00364351|58706837|FG000|Overall Study|Incorrect enrollment|1|||
30692889|NCT00364351|58706838|FG001|Overall Study|Incorrect enrollment|1|||
30692890|NCT00364351|58706837|FG000|Overall Study|Sponsor decision|1|||
30692891|NCT00364351|58706838|FG001|Overall Study|Sponsor decision|0|||
30692892|NCT00364351|58706837|FG000|Overall Study|Poor treatment compliance|0|||
30692893|NCT00364351|58706838|FG001|Overall Study|Poor treatment compliance|3|||
30692894|NCT00364351|58706837|FG000|Overall Study|Investigator error|0|||
30692895|NCT00364351|58706838|FG001|Overall Study|Investigator error|2|||
30692896|NCT00364351|58706837|FG000|Overall Study|Patient could not travel to site|0|||
30692897|NCT00364351|58706838|FG001|Overall Study|Patient could not travel to site|1|||
30692898|NCT00364351|58706837|FG000|Overall Study|Randomised treatment not started|0|||
30692899|NCT00364351|58706838|FG001|Overall Study|Randomised treatment not started|3|||
30692900|NCT00388297|58706848|FG000|Overall Study|Lost to Follow-up|16|||
30692901|NCT00388297|58706849|FG001|Overall Study|Lost to Follow-up|12|||
30692902|NCT00388297|58706850|FG002|Overall Study|Lost to Follow-up|11|||
30692903|NCT00388297|58706851|FG003|Overall Study|Lost to Follow-up|8|||
30692904|NCT00686166|58706861|FG000|Overall Study|Adverse Event|7|||
30692905|NCT00686166|58706861|FG000|Overall Study|Withdrawal by Subject|1|||
30692906|NCT00686166|58706861|FG000|Overall Study|Progression/Relapse|1|||
30692907|NCT00686166|58706861|FG000|Overall Study|Death|1|||
30692908|NCT00686166|58706861|FG000|Overall Study|Not Protocol Specified|1|||
30692909|NCT00686166|58706861|FG000|Overall Study|Ineligible|5|||
30692910|NCT00686166|58706861|FG000|Overall Study|Did not begin protocol therapy|4|||
30692911|NCT00363649|58706872|FG000|Overall Study|Withdrawal by Subject|1|||
30692912|NCT00363649|58706873|FG001|Overall Study|Withdrawal by Subject|1|||
30692913|NCT00363649|58706872|FG000|Overall Study|Adverse Event|6|||
30692914|NCT00363649|58706873|FG001|Overall Study|Adverse Event|0|||
30692915|NCT00684060|58706881|FG000|Overall Study|Lost to Follow-up|1|||
30692916|NCT00684060|58706882|FG001|Overall Study|Lost to Follow-up|0|||
30692917|NCT00684060|58706881|FG000|Overall Study|New stenosis identified|1|||
30692918|NCT00684060|58706882|FG001|Overall Study|New stenosis identified|0|||
30692919|NCT00684060|58706881|FG000|Overall Study|Unable to collect MRI|1|||
30692920|NCT00684060|58706882|FG001|Overall Study|Unable to collect MRI|2|||
30692921|NCT00684060|58706881|FG000|Overall Study|Death|0|||
30692922|NCT00684060|58706882|FG001|Overall Study|Death|1|||
30692923|NCT03131648|58706890|FG000|Initial Treatment Period|Not dosed|2|||
30692924|NCT03131648|58706891|FG001|Initial Treatment Period|Not dosed|2|||
30692925|NCT03131648|58706892|FG002|Initial Treatment Period|Not dosed|0|||
30692926|NCT03131648|58706893|FG003|Initial Treatment Period|Not dosed|0|||
30692927|NCT03131648|58706894|FG004|Initial Treatment Period|Not dosed|0|||
30692928|NCT03131648|58706895|FG005|Initial Treatment Period|Not dosed|0|||
30692929|NCT03131648|58706896|FG006|Initial Treatment Period|Not dosed|0|||
30692930|NCT03131648|58706897|FG007|Initial Treatment Period|Not dosed|0|||
30692931|NCT03131648|58706890|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
30865040|NCT02131324|58895328|FG000|Overall Study|Withdrawal by Subject|1|||
30865041|NCT02131324|58895329|FG001|Overall Study|Withdrawal by Subject|2|||
30865042|NCT02131324|58895328|FG000|Overall Study|Lost to Follow-up|1|||
30865043|NCT02131324|58895329|FG001|Overall Study|Lost to Follow-up|1|||
30865044|NCT02734693|58895338|FG000|Overall Study|Adverse Event|1|||
30865045|NCT02734693|58895339|FG001|Overall Study|Adverse Event|3|||
30601959|NCT01297062|58613226|FG003|Overall Study|Adverse Event|0|||
30601960|NCT01297062|58613227|FG004|Overall Study|Adverse Event|0|||
30601961|NCT01297062|58613228|FG005|Overall Study|Adverse Event|0|||
30601962|NCT01297062|58613229|FG006|Overall Study|Adverse Event|0|||
30601963|NCT01297062|58613223|FG000|Overall Study|Physician Decision|1|||
30601964|NCT01297062|58613224|FG001|Overall Study|Physician Decision|0|||
30601965|NCT01297062|58613225|FG002|Overall Study|Physician Decision|1|||
30601966|NCT01297062|58613226|FG003|Overall Study|Physician Decision|0|||
30601967|NCT01297062|58613227|FG004|Overall Study|Physician Decision|0|||
30601968|NCT01297062|58613228|FG005|Overall Study|Physician Decision|0|||
30601969|NCT01297062|58613229|FG006|Overall Study|Physician Decision|6|||
30692932|NCT03131648|58706891|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
30692933|NCT03131648|58706892|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
30692934|NCT03131648|58706893|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
30692935|NCT03131648|58706894|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
30692936|NCT03131648|58706895|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
30692937|NCT03131648|58706896|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
30692938|NCT03131648|58706897|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
30692939|NCT03131648|58706890|FG000|Open-label Treatment|Discontinued IMP|0|||
30692940|NCT03131648|58706891|FG001|Open-label Treatment|Discontinued IMP|0|||
30692941|NCT03131648|58706892|FG002|Open-label Treatment|Discontinued IMP|0|||
30692942|NCT03131648|58706893|FG003|Open-label Treatment|Discontinued IMP|0|||
30692943|NCT03131648|58706894|FG004|Open-label Treatment|Discontinued IMP|0|||
30692944|NCT03131648|58706895|FG005|Open-label Treatment|Discontinued IMP|0|||
30692945|NCT03131648|58706896|FG006|Open-label Treatment|Discontinued IMP|112|||
30692946|NCT03131648|58706897|FG007|Open-label Treatment|Discontinued IMP|0|||
30692947|NCT03131648|58706890|FG000|Open-label Treatment|Completed Week 50|0|||
30692948|NCT03131648|58706891|FG001|Open-label Treatment|Completed Week 50|0|||
30692949|NCT03131648|58706892|FG002|Open-label Treatment|Completed Week 50|0|||
30692950|NCT03131648|58706893|FG003|Open-label Treatment|Completed Week 50|0|||
30692951|NCT03131648|58706894|FG004|Open-label Treatment|Completed Week 50|0|||
30692952|NCT03131648|58706895|FG005|Open-label Treatment|Completed Week 50|0|||
30692953|NCT03131648|58706896|FG006|Open-label Treatment|Completed Week 50|6|||
30692954|NCT03131648|58706897|FG007|Open-label Treatment|Completed Week 50|0|||
30692955|NCT03131648|58706890|FG000|Maintenance Treatment Period|Not dosed|0|||
30692956|NCT03131648|58706891|FG001|Maintenance Treatment Period|Not dosed|0|||
30865046|NCT02734693|58895340|FG002|Overall Study|Adverse Event|3|||
30865047|NCT02734693|58895338|FG000|Overall Study|Lack of Efficacy|1|||
30865048|NCT02734693|58895339|FG001|Overall Study|Lack of Efficacy|0|||
30865049|NCT02734693|58895340|FG002|Overall Study|Lack of Efficacy|0|||
30865050|NCT02734693|58895338|FG000|Overall Study|Lost to Follow-up|2|||
30865051|NCT02734693|58895339|FG001|Overall Study|Lost to Follow-up|0|||
30865052|NCT02734693|58895340|FG002|Overall Study|Lost to Follow-up|0|||
30865053|NCT02734693|58895338|FG000|Overall Study|Protocol Violation|1|||
30865054|NCT02734693|58895339|FG001|Overall Study|Protocol Violation|0|||
30865055|NCT02734693|58895340|FG002|Overall Study|Protocol Violation|0|||
30865056|NCT02734693|58895338|FG000|Overall Study|Withdrawal by Subject|1|||
30865057|NCT02734693|58895339|FG001|Overall Study|Withdrawal by Subject|0|||
30865058|NCT02734693|58895340|FG002|Overall Study|Withdrawal by Subject|0|||
30865059|NCT02193880|58895348|FG000|Overall Study|patients did not collect enough HPC|3|||
30865060|NCT01378325|58895354|FG000|Overall Study|Protocol Violation|0|||
30865061|NCT01378325|58895355|FG001|Overall Study|Protocol Violation|1|||
30865062|NCT01093573|58895364|FG000|Overall Study|Physician Decision|0|||
30865063|NCT01093573|58895365|FG001|Overall Study|Physician Decision|0|||
30865064|NCT01093573|58895366|FG002|Overall Study|Physician Decision|1|||
30865065|NCT01093573|58895364|FG000|Overall Study|Insurance Denied|0|||
30865066|NCT01093573|58895365|FG001|Overall Study|Insurance Denied|0|||
30692957|NCT03131648|58706892|FG002|Maintenance Treatment Period|Not dosed|3|||
30692958|NCT03131648|58706893|FG003|Maintenance Treatment Period|Not dosed|2|||
30692959|NCT03131648|58706894|FG004|Maintenance Treatment Period|Not dosed|1|||
30692960|NCT03131648|58706895|FG005|Maintenance Treatment Period|Not dosed|0|||
30692961|NCT03131648|58706896|FG006|Maintenance Treatment Period|Not dosed|0|||
30865067|NCT01093573|58895366|FG002|Overall Study|Insurance Denied|1|||
30865068|NCT02733367|58895394|FG000|Overall Study|Withdrawal by Subject|6|||
30865069|NCT03688555|58895401|FG000|Treatment Period|Adverse Event|0|||
30865070|NCT03688555|58895402|FG001|Treatment Period|Adverse Event|0|||
30865071|NCT03688555|58895403|FG002|Treatment Period|Adverse Event|1|||
30865072|NCT01328951|58895445|FG000|Overall Study|Disease Progression|17|||
30865073|NCT01328951|58895446|FG001|Overall Study|Disease Progression|14|||
30865074|NCT01328951|58895445|FG000|Overall Study|Adverse Event|2|||
30865075|NCT01328951|58895446|FG001|Overall Study|Adverse Event|0|||
30865076|NCT01328951|58895445|FG000|Overall Study|Death|243|||
30865077|NCT01328951|58895446|FG001|Overall Study|Death|258|||
30601970|NCT01297062|58613223|FG000|Overall Study|Protocol Violation|0|||
30601971|NCT01297062|58613224|FG001|Overall Study|Protocol Violation|0|||
30601972|NCT01297062|58613225|FG002|Overall Study|Protocol Violation|0|||
30601973|NCT01297062|58613226|FG003|Overall Study|Protocol Violation|0|||
30601974|NCT01297062|58613227|FG004|Overall Study|Protocol Violation|1|||
30601975|NCT01297062|58613228|FG005|Overall Study|Protocol Violation|0|||
30601976|NCT01297062|58613229|FG006|Overall Study|Protocol Violation|0|||
30601977|NCT01297062|58613223|FG000|Overall Study|Subject Decision|1|||
30601978|NCT01297062|58613224|FG001|Overall Study|Subject Decision|1|||
30601979|NCT01297062|58613225|FG002|Overall Study|Subject Decision|0|||
30601980|NCT01297062|58613226|FG003|Overall Study|Subject Decision|1|||
30601981|NCT01297062|58613227|FG004|Overall Study|Subject Decision|1|||
30601982|NCT01297062|58613228|FG005|Overall Study|Subject Decision|1|||
30692962|NCT03131648|58706897|FG007|Maintenance Treatment Period|Not dosed|0|||
30692963|NCT03131648|58706890|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
30692964|NCT03131648|58706891|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
30865078|NCT01328951|58895445|FG000|Overall Study|Lost to Follow-up|6|||
30865079|NCT01328951|58895446|FG001|Overall Study|Lost to Follow-up|7|||
30865080|NCT01328951|58895445|FG000|Overall Study|Withdrawal by Subject|6|||
30865081|NCT01328951|58895446|FG001|Overall Study|Withdrawal by Subject|6|||
30865082|NCT01328951|58895445|FG000|Overall Study|Study Closed by the Sponsor|36|||
30865083|NCT01328951|58895446|FG001|Overall Study|Study Closed by the Sponsor|31|||
30692965|NCT03131648|58706892|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
30692966|NCT03131648|58706893|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
30692967|NCT03131648|58706894|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
30692968|NCT03131648|58706895|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
30692969|NCT03131648|58706896|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
30692970|NCT03131648|58706897|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
30692971|NCT03131648|58706890|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
30692972|NCT03131648|58706891|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
30692973|NCT03131648|58706892|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
30692974|NCT03131648|58706893|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
30692975|NCT03131648|58706894|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
30692976|NCT03131648|58706895|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
30692977|NCT03131648|58706896|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
30692978|NCT03131648|58706897|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
30692979|NCT03131648|58706890|FG000|Maintenance Treatment Period|Completed Week 50|0|||
30692980|NCT03131648|58706891|FG001|Maintenance Treatment Period|Completed Week 50|0|||
30692981|NCT03131648|58706892|FG002|Maintenance Treatment Period|Completed Week 50|0|||
30692982|NCT03131648|58706893|FG003|Maintenance Treatment Period|Completed Week 50|0|||
30692983|NCT03131648|58706894|FG004|Maintenance Treatment Period|Completed Week 50|1|||
30692984|NCT03131648|58706895|FG005|Maintenance Treatment Period|Completed Week 50|0|||
30692985|NCT03131648|58706896|FG006|Maintenance Treatment Period|Completed Week 50|0|||
30692986|NCT03131648|58706897|FG007|Maintenance Treatment Period|Completed Week 50|0|||
30692987|NCT03131648|58706890|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
30692988|NCT03131648|58706891|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
30692989|NCT03131648|58706892|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
30692990|NCT03131648|58706893|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
30692991|NCT03131648|58706894|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
30692992|NCT03131648|58706895|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
30692993|NCT03131648|58706896|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
30692994|NCT03131648|58706897|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
30692995|NCT00618813|58706914|FG000|Overall Study|Lack of Efficacy|1|||
30692996|NCT00618813|58706914|FG000|Overall Study|Physician Decision|2|||
30692997|NCT00618813|58706914|FG000|Overall Study|Withdrawal by Subject|1|||
30692998|NCT00554788|58706921|FG000|Overall Study|Adverse Event|0|||
30692999|NCT00554788|58706922|FG001|Overall Study|Adverse Event|1|||
30693000|NCT00554788|58706923|FG002|Overall Study|Adverse Event|2|||
30693001|NCT00554788|58706921|FG000|Overall Study|Lost to Follow-up|4|||
30693002|NCT00554788|58706922|FG001|Overall Study|Lost to Follow-up|3|||
30693003|NCT00554788|58706923|FG002|Overall Study|Lost to Follow-up|3|||
30693004|NCT00554788|58706921|FG000|Overall Study|Physician Decision|1|||
30693005|NCT00554788|58706922|FG001|Overall Study|Physician Decision|1|||
30693006|NCT00554788|58706923|FG002|Overall Study|Physician Decision|3|||
30693007|NCT00554788|58706921|FG000|Overall Study|Withdrawal by Subject|0|||
30693008|NCT00554788|58706922|FG001|Overall Study|Withdrawal by Subject|0|||
30693009|NCT00554788|58706923|FG002|Overall Study|Withdrawal by Subject|1|||
30693010|NCT00554788|58706921|FG000|Overall Study|Refusal of further protocol therapy|0|||
30693011|NCT00554788|58706922|FG001|Overall Study|Refusal of further protocol therapy|1|||
30693012|NCT00554788|58706923|FG002|Overall Study|Refusal of further protocol therapy|1|||
30693013|NCT00554788|58706921|FG000|Overall Study|Progressive disease|0|||
30693014|NCT00554788|58706922|FG001|Overall Study|Progressive disease|0|||
30693015|NCT00554788|58706923|FG002|Overall Study|Progressive disease|3|||
30693016|NCT00554788|58706921|FG000|Overall Study|Ineligible|2|||
30693017|NCT00554788|58706922|FG001|Overall Study|Ineligible|0|||
30693018|NCT00554788|58706923|FG002|Overall Study|Ineligible|1|||
30693019|NCT00685698|58706932|FG000|Overall Study|Withdrawal by Subject|1|||
30693020|NCT00685698|58706932|FG000|Overall Study|Protocol Violation|6|||
30693021|NCT00685698|58706932|FG000|Overall Study|Adverse Event|3|||
30693022|NCT00685698|58706932|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
30693023|NCT00685698|58706932|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
30693024|NCT00685698|58706932|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
30693025|NCT00549328|58706948|FG000|Overall Study|Adverse Event|2|||
30693026|NCT00549328|58706948|FG000|Overall Study|Disease Progression|10|||
30693027|NCT00549328|58706948|FG000|Overall Study|Death|1|||
30693028|NCT00549328|58706948|FG000|Overall Study|Use of Prohibited Medication|1|||
30693029|NCT00696410|58706954|FG000|Overall Study|Lost to Follow-up|2|||
30693030|NCT00696410|58706955|FG001|Overall Study|Lost to Follow-up|0|||
30693031|NCT00696410|58706954|FG000|Overall Study|Withdrawal by Subject|8|||
30693032|NCT00696410|58706955|FG001|Overall Study|Withdrawal by Subject|0|||
30693033|NCT00696410|58706954|FG000|Overall Study|Physician Decision|3|||
30693034|NCT00696410|58706955|FG001|Overall Study|Physician Decision|0|||
30693035|NCT00683904|58706968|FG000|Dose Level 1|Disease progression|2|||
30865084|NCT01328951|58895445|FG000|Overall Study|Other|11|||
30865085|NCT01328951|58895446|FG001|Overall Study|Other|6|||
30693036|NCT00683904|58706969|FG001|Dose Level 1|Disease progression|0|||
30693037|NCT00683904|58706968|FG000|Dose Level 1|Adverse Event|1|||
30693038|NCT00683904|58706969|FG001|Dose Level 1|Adverse Event|0|||
30693039|NCT00683904|58706968|FG000|Dose Level 2|Adverse Event|0|||
30693040|NCT00683904|58706969|FG001|Dose Level 2|Adverse Event|2|||
30693041|NCT00363415|58706983|FG000|Overall Study|Progressive Disease|196|||
30693042|NCT00363415|58706984|FG001|Overall Study|Progressive Disease|107|||
30693043|NCT00363415|58706983|FG000|Overall Study|Sponsor Decision|67|||
30693044|NCT00363415|58706984|FG001|Overall Study|Sponsor Decision|31|||
30693045|NCT00363415|58706983|FG000|Overall Study|Death|32|||
30693046|NCT00363415|58706984|FG001|Overall Study|Death|29|||
30693047|NCT00363415|58706983|FG000|Overall Study|Adverse Event|24|||
30693048|NCT00363415|58706984|FG001|Overall Study|Adverse Event|15|||
30693049|NCT00363415|58706983|FG000|Overall Study|Physician Decision|18|||
30865086|NCT02611817|58895459|FG000|Open-label Induction Phase|Reason not Specified|9|||
30865087|NCT02611817|58895460|FG001|Open-label Induction Phase|Reason not Specified|0|||
30865088|NCT02611817|58895461|FG002|Open-label Induction Phase|Reason not Specified|0|||
30865089|NCT02611817|58895459|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
30865090|NCT02611817|58895460|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
30865091|NCT02611817|58895461|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
30865092|NCT02611817|58895459|FG000|Open-label Induction Phase|Pregnancy|1|||
30865093|NCT02611817|58895460|FG001|Open-label Induction Phase|Pregnancy|0|||
30865094|NCT02611817|58895461|FG002|Open-label Induction Phase|Pregnancy|0|||
30865095|NCT02611817|58895459|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
30865096|NCT02611817|58895460|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
30960769|NCT01524887|59026508|FG001|Overall Study|Adverse Event|1|||
30960770|NCT01524887|59026509|FG002|Overall Study|Adverse Event|1|||
30960771|NCT01524887|59026507|FG000|Overall Study|Protocol Violation|0|||
30960772|NCT01524887|59026508|FG001|Overall Study|Protocol Violation|0|||
30960773|NCT01524887|59026509|FG002|Overall Study|Protocol Violation|1|||
30960774|NCT01524887|59026507|FG000|Overall Study|Study termination|73|||
30601983|NCT01297062|58613229|FG006|Overall Study|Subject Decision|2|||
30601984|NCT01254747|58613241|FG000|Overall Study|Unacceptable subjective vision|0|||
30865097|NCT02611817|58895461|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
30865098|NCT02611817|58895459|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
30865099|NCT02611817|58895460|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
30865100|NCT02611817|58895461|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
30865101|NCT02611817|58895459|FG000|Open-label Induction Phase|Protocol Violation|5|||
30865102|NCT02611817|58895460|FG001|Open-label Induction Phase|Protocol Violation|0|||
30865103|NCT02611817|58895461|FG002|Open-label Induction Phase|Protocol Violation|0|||
30865104|NCT02611817|58895459|FG000|Open-label Induction Phase|Adverse Event|16|||
30865105|NCT02611817|58895460|FG001|Open-label Induction Phase|Adverse Event|0|||
30601985|NCT01254747|58613242|FG001|Overall Study|Unacceptable subjective vision|0|||
30601986|NCT01254747|58613243|FG002|Overall Study|Unacceptable subjective vision|0|||
30601987|NCT01254747|58613244|FG003|Overall Study|Unacceptable subjective vision|2|||
30601988|NCT01254747|58613241|FG000|Overall Study|Difficult removal handling|0|||
30601989|NCT01254747|58613242|FG001|Overall Study|Difficult removal handling|0|||
30601990|NCT01254747|58613243|FG002|Overall Study|Difficult removal handling|1|||
30601991|NCT01254747|58613244|FG003|Overall Study|Difficult removal handling|0|||
30601992|NCT01254747|58613241|FG000|Overall Study|Symptoms and problems|0|||
30601993|NCT01254747|58613242|FG001|Overall Study|Symptoms and problems|2|||
30601994|NCT01254747|58613243|FG002|Overall Study|Symptoms and problems|1|||
30601995|NCT01254747|58613244|FG003|Overall Study|Symptoms and problems|0|||
30601996|NCT01254747|58613241|FG000|Overall Study|Lost to Follow-up|0|||
30601997|NCT01254747|58613242|FG001|Overall Study|Lost to Follow-up|0|||
30601998|NCT01254747|58613243|FG002|Overall Study|Lost to Follow-up|1|||
30601999|NCT01254747|58613244|FG003|Overall Study|Lost to Follow-up|0|||
30602000|NCT01254747|58613241|FG000|Overall Study|Biomicroscopy|0|||
30602001|NCT01254747|58613242|FG001|Overall Study|Biomicroscopy|0|||
30602002|NCT01254747|58613243|FG002|Overall Study|Biomicroscopy|1|||
30602003|NCT01254747|58613244|FG003|Overall Study|Biomicroscopy|0|||
30602004|NCT01254747|58613241|FG000|Overall Study|Discomfort|0|||
30602005|NCT01254747|58613242|FG001|Overall Study|Discomfort|4|||
30602006|NCT01254747|58613243|FG002|Overall Study|Discomfort|0|||
30602007|NCT01254747|58613244|FG003|Overall Study|Discomfort|0|||
30602008|NCT01296672|58613256|FG000|Overall Study|Lost to Follow-up|73|||
30865106|NCT02611817|58895461|FG002|Open-label Induction Phase|Adverse Event|0|||
30960775|NCT01524887|59026508|FG001|Overall Study|Study termination|87|||
30960776|NCT01524887|59026509|FG002|Overall Study|Study termination|79|||
30960777|NCT01524887|59026507|FG000|Overall Study|Withdrawal by Caregiver|0|||
30602009|NCT01296672|58613257|FG001|Overall Study|Lost to Follow-up|18|||
30602010|NCT01254669|58613267|FG000|Overall Study|Withdrawal by Subject|0|||
30602011|NCT01254669|58613268|FG001|Overall Study|Withdrawal by Subject|1|||
30602012|NCT01254669|58613267|FG000|Overall Study|time constraint|2|||
30693050|NCT00363415|58706984|FG001|Overall Study|Physician Decision|35|||
30693051|NCT00363415|58706983|FG000|Overall Study|Entry Criteria Not Met|11|||
30693052|NCT00363415|58706984|FG001|Overall Study|Entry Criteria Not Met|10|||
30693053|NCT00363415|58706983|FG000|Overall Study|Withdrawal by Subject|9|||
30693054|NCT00363415|58706984|FG001|Overall Study|Withdrawal by Subject|15|||
30693055|NCT00363415|58706983|FG000|Overall Study|Lost to Follow-up|3|||
30693056|NCT00363415|58706984|FG001|Overall Study|Lost to Follow-up|3|||
30693057|NCT00363415|58706983|FG000|Overall Study|Protocol Violation|1|||
30693058|NCT00363415|58706984|FG001|Overall Study|Protocol Violation|4|||
30693059|NCT00696020|58706994|FG000|Overall Study|Adverse Event|3|||
30693060|NCT00696020|58706995|FG001|Overall Study|Adverse Event|1|||
30693061|NCT00696020|58706996|FG002|Overall Study|Adverse Event|2|||
30693062|NCT00696020|58706997|FG003|Overall Study|Adverse Event|1|||
30693063|NCT00696020|58706994|FG000|Overall Study|Lack of Efficacy|1|||
30693064|NCT00696020|58706995|FG001|Overall Study|Lack of Efficacy|0|||
30693065|NCT00696020|58706996|FG002|Overall Study|Lack of Efficacy|0|||
30693066|NCT00696020|58706997|FG003|Overall Study|Lack of Efficacy|0|||
30693067|NCT00696020|58706994|FG000|Overall Study|Protocol Violation|0|||
30693068|NCT00696020|58706995|FG001|Overall Study|Protocol Violation|0|||
30693069|NCT00696020|58706996|FG002|Overall Study|Protocol Violation|0|||
30693070|NCT00696020|58706997|FG003|Overall Study|Protocol Violation|1|||
30602013|NCT01254669|58613268|FG001|Overall Study|time constraint|2|||
30602014|NCT01254669|58613267|FG000|Overall Study|called to clinic during intervention|1|||
30602015|NCT01254669|58613268|FG001|Overall Study|called to clinic during intervention|1|||
30602016|NCT01295814|58613278|FG000|Overall Study|Lack of Efficacy|0|||
30602017|NCT01295814|58613279|FG001|Overall Study|Lack of Efficacy|2|||
30602018|NCT01295814|58613278|FG000|Overall Study|Withdrawal by Subject|2|||
30602019|NCT01295814|58613279|FG001|Overall Study|Withdrawal by Subject|0|||
30602020|NCT01254045|58613285|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
30602021|NCT01254045|58613286|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
30602022|NCT01254045|58613287|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
30602023|NCT01254045|58613288|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
30602024|NCT01254045|58613289|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
30602025|NCT01254045|58613290|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
30602026|NCT01075282|58613303|FG000|Overall Study|Withdrawal by Subject|11|||
30602027|NCT01075282|58613304|FG001|Overall Study|Withdrawal by Subject|7|||
30602028|NCT01075282|58613305|FG002|Overall Study|Withdrawal by Subject|11|||
30602029|NCT01075282|58613303|FG000|Overall Study|Adverse Event|9|||
30602030|NCT01075282|58613304|FG001|Overall Study|Adverse Event|8|||
30602031|NCT01075282|58613305|FG002|Overall Study|Adverse Event|5|||
30602032|NCT01075282|58613303|FG000|Overall Study|Entry Criteria Not Met|3|||
30602033|NCT01075282|58613304|FG001|Overall Study|Entry Criteria Not Met|2|||
30602034|NCT01075282|58613305|FG002|Overall Study|Entry Criteria Not Met|0|||
30602035|NCT01075282|58613303|FG000|Overall Study|Lost to Follow-up|3|||
30602036|NCT01075282|58613304|FG001|Overall Study|Lost to Follow-up|3|||
30602037|NCT01075282|58613305|FG002|Overall Study|Lost to Follow-up|3|||
30602038|NCT01075282|58613303|FG000|Overall Study|Physician Decision|3|||
30602039|NCT01075282|58613304|FG001|Overall Study|Physician Decision|3|||
30602040|NCT01075282|58613305|FG002|Overall Study|Physician Decision|3|||
30602041|NCT01075282|58613303|FG000|Overall Study|Lack of Efficacy|1|||
30602042|NCT01075282|58613304|FG001|Overall Study|Lack of Efficacy|1|||
30602043|NCT01075282|58613305|FG002|Overall Study|Lack of Efficacy|0|||
30602044|NCT01075282|58613303|FG000|Overall Study|Treatment Non-compliance|1|||
30602045|NCT01075282|58613304|FG001|Overall Study|Treatment Non-compliance|2|||
30602046|NCT01075282|58613305|FG002|Overall Study|Treatment Non-compliance|2|||
30602047|NCT01075282|58613303|FG000|Overall Study|Protocol Violation|0|||
30602048|NCT01075282|58613304|FG001|Overall Study|Protocol Violation|2|||
30602049|NCT01075282|58613305|FG002|Overall Study|Protocol Violation|1|||
30602050|NCT01075282|58613303|FG000|Overall Study|Death|0|||
30602051|NCT01075282|58613304|FG001|Overall Study|Death|1|||
30602052|NCT01075282|58613305|FG002|Overall Study|Death|2|||
30602053|NCT01253811|58613314|FG000|Overall Study|Withdrawal criteria|1|||
30602054|NCT01295580|58613320|FG000|Overall Study|Protocol Violation|4|||
30602055|NCT01295580|58613321|FG001|Overall Study|Protocol Violation|2|||
30602056|NCT01295580|58613320|FG000|Overall Study|Withdrawal by Subject|1|||
30602057|NCT01295580|58613321|FG001|Overall Study|Withdrawal by Subject|4|||
30602058|NCT01295580|58613320|FG000|Overall Study|Adverse Event|2|||
30602059|NCT01295580|58613321|FG001|Overall Study|Adverse Event|1|||
30602060|NCT01295580|58613320|FG000|Overall Study|Lost to Follow-up|1|||
30693071|NCT00696020|58706994|FG000|Overall Study|Withdrawal by Subject|0|||
30602061|NCT01295580|58613321|FG001|Overall Study|Lost to Follow-up|0|||
30602062|NCT01295580|58613320|FG000|Overall Study|Lack of Efficacy|1|||
30602063|NCT01295580|58613321|FG001|Overall Study|Lack of Efficacy|0|||
30602064|NCT01295580|58613320|FG000|Overall Study|Other: inconvenience|1|||
30602065|NCT01295580|58613321|FG001|Overall Study|Other: inconvenience|0|||
30602066|NCT01295580|58613320|FG000|Overall Study|Other: family objection|0|||
30602067|NCT01295580|58613321|FG001|Overall Study|Other: family objection|1|||
30602068|NCT01253577|58613327|FG000|Overall Study|Lost to Follow-up|3|||
30602069|NCT01295034|58613335|FG000|Overall Study|Lost to Follow-up|5|||
30602070|NCT01295034|58613336|FG001|Overall Study|Lost to Follow-up|5|||
30693072|NCT00696020|58706995|FG001|Overall Study|Withdrawal by Subject|1|||
30693073|NCT00696020|58706996|FG002|Overall Study|Withdrawal by Subject|0|||
30693074|NCT00696020|58706997|FG003|Overall Study|Withdrawal by Subject|1|||
30693075|NCT00696020|58706994|FG000|Overall Study|Other not stated above|0|||
30693076|NCT00696020|58706995|FG001|Overall Study|Other not stated above|0|||
30693077|NCT00696020|58706996|FG002|Overall Study|Other not stated above|1|||
30693078|NCT00696020|58706997|FG003|Overall Study|Other not stated above|1|||
30693079|NCT00576576|58707009|FG000|Overall Study|Lost to Follow-up|6|||
30693080|NCT00576576|58707009|FG000|Overall Study|Protocol Violation|1|||
30693081|NCT00695864|58707028|FG000|Placebo|Withdrawal by Subject|1|||
30693082|NCT00695864|58707028|FG000|Placebo|Physician Decision|4|||
30693083|NCT00684996|58707034|FG000|Overall Study|Adverse Event|1|||
30693084|NCT00684996|58707034|FG000|Overall Study|Refusal unrelated to adverse event|1|||
30693085|NCT00684996|58707034|FG000|Overall Study|Progression/relapse|2|||
30693086|NCT00684996|58707034|FG000|Overall Study|Other reasons not protocol specified|1|||
30693087|NCT00684762|58707041|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
30693088|NCT00684762|58707042|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
30693089|NCT00695786|58707052|FG000|Overall Study|Adverse Event|0|||
30693090|NCT00695786|58707053|FG001|Overall Study|Adverse Event|3|||
30693091|NCT00695786|58707054|FG002|Overall Study|Adverse Event|4|||
30693092|NCT00695786|58707055|FG003|Overall Study|Adverse Event|2|||
30693093|NCT00695786|58707052|FG000|Overall Study|Lost to Follow-up|0|||
30693094|NCT00695786|58707053|FG001|Overall Study|Lost to Follow-up|5|||
30693095|NCT00695786|58707054|FG002|Overall Study|Lost to Follow-up|1|||
30693096|NCT00695786|58707055|FG003|Overall Study|Lost to Follow-up|1|||
30693097|NCT00695786|58707052|FG000|Overall Study|Withdrawal by Subject|0|||
30693098|NCT00695786|58707053|FG001|Overall Study|Withdrawal by Subject|4|||
30693099|NCT00695786|58707054|FG002|Overall Study|Withdrawal by Subject|3|||
30693100|NCT00695786|58707055|FG003|Overall Study|Withdrawal by Subject|1|||
30693101|NCT00695786|58707052|FG000|Overall Study|Deemed Ineligible|1|||
30693102|NCT00695786|58707053|FG001|Overall Study|Deemed Ineligible|0|||
30693103|NCT00695786|58707054|FG002|Overall Study|Deemed Ineligible|0|||
30693104|NCT00695786|58707055|FG003|Overall Study|Deemed Ineligible|0|||
30693105|NCT00695786|58707052|FG000|Overall Study|Lack of Efficacy|0|||
30693106|NCT00695786|58707053|FG001|Overall Study|Lack of Efficacy|0|||
30693107|NCT00695786|58707054|FG002|Overall Study|Lack of Efficacy|0|||
30693108|NCT00695786|58707055|FG003|Overall Study|Lack of Efficacy|4|||
30693109|NCT00387127|58707067|FG000|Overall Study|Lost to Follow-up|0|||
30693110|NCT00387127|58707068|FG001|Overall Study|Lost to Follow-up|4|||
30693111|NCT00387127|58707067|FG000|Overall Study|Death|16|||
30693112|NCT00387127|58707068|FG001|Overall Study|Death|16|||
30693113|NCT00387127|58707067|FG000|Overall Study|Physician Decision|0|||
30693114|NCT00387127|58707068|FG001|Overall Study|Physician Decision|1|||
30693115|NCT00387127|58707067|FG000|Overall Study|Withdrawal by Subject|3|||
30693116|NCT00387127|58707068|FG001|Overall Study|Withdrawal by Subject|2|||
30693117|NCT00387127|58707067|FG000|Overall Study|Required by Protocol Amendment #4|12|||
30693118|NCT00387127|58707068|FG001|Overall Study|Required by Protocol Amendment #4|10|||
30693119|NCT00387127|58707067|FG000|Overall Study|Serious Adverse Event|1|||
30693120|NCT00387127|58707068|FG001|Overall Study|Serious Adverse Event|1|||
30693121|NCT00387127|58707067|FG000|Overall Study|Sponsor Unblinded|1|||
30693122|NCT00387127|58707068|FG001|Overall Study|Sponsor Unblinded|0|||
30693123|NCT00683592|58707078|FG000|Overall Study|Adverse Event|12|||
30693124|NCT00683592|58707079|FG001|Overall Study|Adverse Event|4|||
30693125|NCT00683592|58707078|FG000|Overall Study|Withdrawal by Subject|11|||
30693126|NCT00683592|58707079|FG001|Overall Study|Withdrawal by Subject|11|||
30693127|NCT00683592|58707078|FG000|Overall Study|Lost to Follow-up|17|||
30693128|NCT00683592|58707079|FG001|Overall Study|Lost to Follow-up|17|||
30693129|NCT00683592|58707078|FG000|Overall Study|Lack of Efficacy|3|||
30693130|NCT00683592|58707079|FG001|Overall Study|Lack of Efficacy|7|||
30693131|NCT00683592|58707078|FG000|Overall Study|Physician Decision|0|||
30693132|NCT00683592|58707079|FG001|Overall Study|Physician Decision|1|||
30693133|NCT00683592|58707078|FG000|Overall Study|Non-compliance|3|||
30693134|NCT00683592|58707079|FG001|Overall Study|Non-compliance|5|||
30693135|NCT00683592|58707078|FG000|Overall Study|Other|1|||
30693136|NCT00683592|58707079|FG001|Overall Study|Other|1|||
30693137|NCT00695396|58707088|FG000|Overall Study|Study Closed Prematurely|5|||
30602071|NCT01253421|58613347|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
30602072|NCT01253421|58613348|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
30693138|NCT00695396|58707089|FG001|Overall Study|Study Closed Prematurely|6|||
30602073|NCT01253421|58613349|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
30602074|NCT01253421|58613350|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
30602075|NCT01253421|58613351|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
30602076|NCT01253421|58613347|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
30602077|NCT01253421|58613348|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
30602078|NCT01253421|58613349|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
30602079|NCT01253421|58613350|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
30693139|NCT00695396|58707090|FG002|Overall Study|Study Closed Prematurely|8|||
30693140|NCT00695396|58707088|FG000|Overall Study|Withdrawal by Subject|2|||
30693141|NCT00695396|58707089|FG001|Overall Study|Withdrawal by Subject|2|||
30693142|NCT00695396|58707090|FG002|Overall Study|Withdrawal by Subject|0|||
30693143|NCT02656706|58707098|FG000|Overall Study|Insurance Denial|1|||
30693144|NCT00575328|58707104|FG000|Overall Study|Adverse Event|1|||
30693145|NCT00575328|58707105|FG001|Overall Study|Adverse Event|1|||
30693146|NCT00575328|58707104|FG000|Overall Study|Lost to Follow-up|2|||
30693147|NCT00575328|58707105|FG001|Overall Study|Lost to Follow-up|1|||
30693148|NCT00575094|58707111|FG000|Overall Study|Adverse Event|2|||
30693149|NCT00575094|58707111|FG000|Overall Study|Withdrawal by Subject|1|||
30693150|NCT00553696|58707119|FG000|Overall Study|Adverse Event|2|||
30693151|NCT00553696|58707120|FG001|Overall Study|Adverse Event|4|||
30693152|NCT00553696|58707121|FG002|Overall Study|Adverse Event|0|||
30693153|NCT00553696|58707122|FG003|Overall Study|Adverse Event|1|||
30693154|NCT00553696|58707119|FG000|Overall Study|Global deterioration of health status|0|||
30693155|NCT00553696|58707120|FG001|Overall Study|Global deterioration of health status|2|||
30693156|NCT00553696|58707121|FG002|Overall Study|Global deterioration of health status|0|||
30693157|NCT00553696|58707122|FG003|Overall Study|Global deterioration of health status|0|||
30693158|NCT00553696|58707119|FG000|Overall Study|Objective progression or relapse|2|||
30693159|NCT00553696|58707120|FG001|Overall Study|Objective progression or relapse|9|||
30693160|NCT00553696|58707121|FG002|Overall Study|Objective progression or relapse|6|||
30693161|NCT00553696|58707122|FG003|Overall Study|Objective progression or relapse|0|||
30693162|NCT00553696|58707119|FG000|Overall Study|Withdrawal by Subject|0|||
30693163|NCT00553696|58707120|FG001|Overall Study|Withdrawal by Subject|1|||
30865107|NCT02611817|58895459|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
30865108|NCT02611817|58895460|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
30865109|NCT02611817|58895461|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
30865110|NCT02611817|58895459|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
30865111|NCT02611817|58895460|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
30865112|NCT02611817|58895461|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
30865113|NCT02611817|58895459|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
30865114|NCT02611817|58895460|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
30865115|NCT02611817|58895461|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
30865116|NCT02611817|58895459|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
30865117|NCT02611817|58895460|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
30865118|NCT02611817|58895461|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
30865119|NCT02611817|58895459|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
30865120|NCT02611817|58895460|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
30865121|NCT02611817|58895461|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
30865122|NCT02611817|58895459|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
30865123|NCT02611817|58895460|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
30865124|NCT02611817|58895461|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
30865125|NCT02611817|58895459|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
30865126|NCT02611817|58895460|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
30865127|NCT02611817|58895461|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
30865128|NCT02735915|58895468|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
30865129|NCT02735915|58895468|FG000|Overall Study|Withdrawal following SAE|2|||
30865130|NCT02735915|58895468|FG000|Overall Study|Withdrawal by Subject|1|||
30865131|NCT02557139|58895477|FG000|Overall Study|Significant liver elevation|1|||
30865132|NCT02557139|58895478|FG001|Overall Study|Significant liver elevation|0|||
30865133|NCT02557139|58895479|FG002|Overall Study|Significant liver elevation|1|||
30865134|NCT02557139|58895477|FG000|Overall Study|Withdrawal by Subject|1|||
30865135|NCT02557139|58895478|FG001|Overall Study|Withdrawal by Subject|0|||
30865136|NCT02557139|58895479|FG002|Overall Study|Withdrawal by Subject|0|||
30865137|NCT02557139|58895477|FG000|Overall Study|Illness of prohibited medication|0|||
30865138|NCT02557139|58895478|FG001|Overall Study|Illness of prohibited medication|0|||
30865139|NCT02557139|58895479|FG002|Overall Study|Illness of prohibited medication|1|||
30693164|NCT00553696|58707121|FG002|Overall Study|Withdrawal by Subject|0|||
30865140|NCT01328717|58895496|FG000|Overall Study|Adverse Event|1|||
30865141|NCT01677741|58895508|FG000|Overall Study|Death|0|||
30865142|NCT01677741|58895509|FG001|Overall Study|Death|0|||
30865143|NCT01677741|58895510|FG002|Overall Study|Death|0|||
30865144|NCT01677741|58895511|FG003|Overall Study|Death|1|||
30865145|NCT01677741|58895512|FG004|Overall Study|Death|0|||
30865146|NCT01677741|58895513|FG005|Overall Study|Death|1|||
30865147|NCT01677741|58895514|FG006|Overall Study|Death|0|||
30865148|NCT01677741|58895515|FG007|Overall Study|Death|0|||
30865149|NCT01677741|58895508|FG000|Overall Study|Withdrawal by Subject|2|||
30865150|NCT01677741|58895509|FG001|Overall Study|Withdrawal by Subject|7|||
30865151|NCT01677741|58895510|FG002|Overall Study|Withdrawal by Subject|5|||
30865152|NCT01677741|58895511|FG003|Overall Study|Withdrawal by Subject|4|||
30865153|NCT01677741|58895512|FG004|Overall Study|Withdrawal by Subject|11|||
30865154|NCT01677741|58895513|FG005|Overall Study|Withdrawal by Subject|20|||
30693165|NCT00553696|58707122|FG003|Overall Study|Withdrawal by Subject|0|||
30693166|NCT00553540|58707137|FG000|Overall Study|discharged after first visit|2|||
30693167|NCT00553540|58707138|FG001|Overall Study|discharged after first visit|5|||
30693168|NCT00617409|58707147|FG000|Overall Study|Withdrawal by Subject|4|||
30693169|NCT00617409|58707148|FG001|Overall Study|Withdrawal by Subject|1|||
30693170|NCT00617409|58707149|FG002|Overall Study|Withdrawal by Subject|2|||
30693171|NCT00617409|58707147|FG000|Overall Study|Adverse Event|0|||
30693172|NCT00617409|58707148|FG001|Overall Study|Adverse Event|2|||
30693173|NCT00617409|58707149|FG002|Overall Study|Adverse Event|3|||
30693174|NCT00617409|58707147|FG000|Overall Study|Disease Progression|8|||
30693175|NCT00617409|58707148|FG001|Overall Study|Disease Progression|8|||
30693176|NCT00617409|58707149|FG002|Overall Study|Disease Progression|18|||
30693177|NCT00617409|58707147|FG000|Overall Study|Death|3|||
30693178|NCT00617409|58707148|FG001|Overall Study|Death|5|||
30693179|NCT00617409|58707149|FG002|Overall Study|Death|4|||
30693180|NCT00617409|58707147|FG000|Overall Study|Alternative Therapy|1|||
30693181|NCT00617409|58707148|FG001|Overall Study|Alternative Therapy|2|||
30693182|NCT00617409|58707149|FG002|Overall Study|Alternative Therapy|0|||
30693183|NCT00695318|58707160|FG000|Overall Study|Lost to Follow-up|1|||
30693184|NCT00695318|58707161|FG001|Overall Study|Lost to Follow-up|0|||
30693185|NCT00695318|58707160|FG000|Overall Study|Withdrawal by Subject|2|||
30693186|NCT00695318|58707161|FG001|Overall Study|Withdrawal by Subject|0|||
30693187|NCT00695318|58707160|FG000|Overall Study|Death|1|||
30693188|NCT00695318|58707161|FG001|Overall Study|Death|1|||
30693189|NCT00695318|58707160|FG000|Overall Study|Study Terminated|1|||
30693190|NCT00695318|58707161|FG001|Overall Study|Study Terminated|0|||
30693191|NCT00386425|58707175|FG000|Overall Study|Physician Decision|3|||
30693192|NCT00386425|58707176|FG001|Overall Study|Physician Decision|0|||
30693193|NCT00386425|58707177|FG002|Overall Study|Physician Decision|0|||
30693194|NCT00386425|58707175|FG000|Overall Study|Withdrawal by Subject|0|||
30693195|NCT00386425|58707176|FG001|Overall Study|Withdrawal by Subject|1|||
30693196|NCT00386425|58707177|FG002|Overall Study|Withdrawal by Subject|0|||
30693197|NCT00694304|58707189|FG000|Overall Study|Adverse Event|42|||
30693198|NCT00694304|58707189|FG000|Overall Study|Lack of Efficacy|35|||
30693199|NCT00694304|58707189|FG000|Overall Study|Non-compliance With Study Product|16|||
30693200|NCT00694304|58707189|FG000|Overall Study|Protocol Violation|6|||
30693201|NCT00694304|58707189|FG000|Overall Study|Withdrawal of Consent|61|||
30693202|NCT00694304|58707189|FG000|Overall Study|Lost to Follow-up|15|||
30693203|NCT00694304|58707189|FG000|Overall Study|Administrative or Other Reasons|32|||
30693204|NCT00371839|58707196|FG000|Overall Study|Death|4|||
30693205|NCT00371839|58707197|FG001|Overall Study|Death|0|||
30693206|NCT00371839|58707198|FG002|Overall Study|Death|0|||
30693207|NCT00371839|58707196|FG000|Overall Study|Withdrawal by Subject|7|||
30693208|NCT00371839|58707197|FG001|Overall Study|Withdrawal by Subject|4|||
30693209|NCT00371839|58707198|FG002|Overall Study|Withdrawal by Subject|0|||
30693210|NCT00371839|58707196|FG000|Overall Study|Lost to Follow-up|6|||
30693211|NCT00371839|58707197|FG001|Overall Study|Lost to Follow-up|3|||
30693212|NCT00371839|58707198|FG002|Overall Study|Lost to Follow-up|2|||
30693213|NCT00682890|58707206|FG000|Overall Study|Lost to Follow-up|1|||
30693214|NCT00682890|58707207|FG001|Overall Study|Lost to Follow-up|1|||
30693215|NCT00682890|58707206|FG000|Overall Study|subject moved away|0|||
30693216|NCT00682890|58707207|FG001|Overall Study|subject moved away|1|||
30693217|NCT00682890|58707206|FG000|Overall Study|heavy menstrual bleeding|1|||
30693218|NCT00682890|58707207|FG001|Overall Study|heavy menstrual bleeding|0|||
30693219|NCT00385723|58707216|FG000|Overall Study|Lost to Follow-up|1|||
30693220|NCT00385723|58707217|FG001|Overall Study|Lost to Follow-up|1|||
30693221|NCT00385723|58707218|FG002|Overall Study|Lost to Follow-up|0|||
30693222|NCT00385723|58707216|FG000|Overall Study|Withdrawal by Subject|1|||
30693223|NCT00385723|58707217|FG001|Overall Study|Withdrawal by Subject|0|||
30693224|NCT00385723|58707218|FG002|Overall Study|Withdrawal by Subject|2|||
30693225|NCT00698516|58707226|FG000|Overall Study|Study Termination|2|||
30693226|NCT00698516|58707226|FG000|Overall Study|Withdrawal by Subject|3|||
30693227|NCT00679302|58707236|FG000|Overall Study|Lost to Follow-up|8|||
30693228|NCT00679302|58707237|FG001|Overall Study|Lost to Follow-up|4|||
30693229|NCT00690482|58707266|FG000|Overall Study|Adverse Event|2|||
30693230|NCT00690482|58707267|FG001|Overall Study|Adverse Event|1|||
30693231|NCT00690482|58707266|FG000|Overall Study|Incorrect enrolment|0|||
30693232|NCT00690482|58707267|FG001|Overall Study|Incorrect enrolment|1|||
30693233|NCT00690482|58707266|FG000|Overall Study|Study-specific discontinuation criteria|1|||
30693234|NCT00690482|58707267|FG001|Overall Study|Study-specific discontinuation criteria|0|||
30693235|NCT00690482|58707266|FG000|Overall Study|Intake of prohibited medicine|1|||
30693236|NCT00690482|58707267|FG001|Overall Study|Intake of prohibited medicine|0|||
30693237|NCT00690482|58707266|FG000|Overall Study|withdrew consent at rand.day|0|||
30693238|NCT00690482|58707267|FG001|Overall Study|withdrew consent at rand.day|1|||
30693239|NCT00385255|58707275|FG000|Overall Study|Serious Adverse Event|1|||
30693240|NCT00385255|58707276|FG001|Overall Study|Serious Adverse Event|2|||
30693241|NCT00385255|58707275|FG000|Overall Study|Protocol Violation|0|||
30693242|NCT00385255|58707276|FG001|Overall Study|Protocol Violation|4|||
30693243|NCT00385255|58707275|FG000|Overall Study|Withdrawal by Subject|0|||
30786570|NCT01367158|58799764|FG009|Overall Study|Protocol Violation|0|||
30693244|NCT00385255|58707276|FG001|Overall Study|Withdrawal by Subject|8|||
30693245|NCT00385255|58707275|FG000|Overall Study|Migrated/moved from study area|0|||
30693246|NCT00385255|58707276|FG001|Overall Study|Migrated/moved from study area|1|||
30693247|NCT00385255|58707275|FG000|Overall Study|Lost to Follow-up|20|||
30693248|NCT00385255|58707276|FG001|Overall Study|Lost to Follow-up|58|||
30693249|NCT00571662|58707286|FG000|Overall Study|Withdrawal by Subject|2|||
30693250|NCT00571662|58707286|FG000|Overall Study|psychiatric instability|1|||
30693251|NCT00571662|58707286|FG000|Overall Study|Adverse Event|5|||
30693252|NCT00698204|58707294|FG000|Overall Study|Withdrawal by Subject|1|||
30693253|NCT00698204|58707295|FG001|Overall Study|Withdrawal by Subject|0|||
30693254|NCT00549718|58707307|FG000|Overall Study|Insufficient clinical response|20|||
30693255|NCT00549718|58707308|FG001|Overall Study|Insufficient clinical response|7|||
30693256|NCT00549718|58707309|FG002|Overall Study|Insufficient clinical response|18|||
30865155|NCT01677741|58895514|FG006|Overall Study|Withdrawal by Subject|4|||
30865156|NCT01677741|58895515|FG007|Overall Study|Withdrawal by Subject|2|||
30865157|NCT01677741|58895508|FG000|Overall Study|Enrolled in a rollover study|0|||
30865158|NCT01677741|58895509|FG001|Overall Study|Enrolled in a rollover study|3|||
30865159|NCT01677741|58895510|FG002|Overall Study|Enrolled in a rollover study|2|||
30865160|NCT01677741|58895511|FG003|Overall Study|Enrolled in a rollover study|1|||
30865161|NCT01677741|58895512|FG004|Overall Study|Enrolled in a rollover study|6|||
30865162|NCT01677741|58895513|FG005|Overall Study|Enrolled in a rollover study|6|||
30865163|NCT01677741|58895514|FG006|Overall Study|Enrolled in a rollover study|7|||
30865164|NCT01677741|58895515|FG007|Overall Study|Enrolled in a rollover study|0|||
30865165|NCT01677741|58895508|FG000|Overall Study|Progressive disease|1|||
30865166|NCT01677741|58895509|FG001|Overall Study|Progressive disease|0|||
30865167|NCT01677741|58895510|FG002|Overall Study|Progressive disease|1|||
30865168|NCT01677741|58895511|FG003|Overall Study|Progressive disease|0|||
30865169|NCT01677741|58895512|FG004|Overall Study|Progressive disease|0|||
30865170|NCT01677741|58895513|FG005|Overall Study|Progressive disease|1|||
30865171|NCT01677741|58895514|FG006|Overall Study|Progressive disease|0|||
30865172|NCT01677741|58895515|FG007|Overall Study|Progressive disease|0|||
30865173|NCT01677507|58895567|FG000|Initial Assignment|Adverse Event|0|||
30865174|NCT01677507|58895568|FG001|Initial Assignment|Adverse Event|1|||
30865175|NCT01677507|58895567|FG000|Initial Assignment|Protocol Violation|0|||
30865176|NCT01677507|58895568|FG001|Initial Assignment|Protocol Violation|1|||
30865177|NCT01677507|58895567|FG000|Second Assigment|Withdrawal by Subject|2|||
30865178|NCT01677507|58895568|FG001|Second Assigment|Withdrawal by Subject|2|||
30865179|NCT01677507|58895567|FG000|Second Assigment|Adverse Event|1|||
30865180|NCT01677507|58895568|FG001|Second Assigment|Adverse Event|3|||
30865181|NCT02732951|58895578|FG000|Overall Study|Other than listed|1|||
30865182|NCT02732951|58895579|FG001|Overall Study|Other than listed|0|||
30865183|NCT02732951|58895578|FG000|Overall Study|Lost to Follow-up|0|||
30865184|NCT02732951|58895579|FG001|Overall Study|Lost to Follow-up|1|||
30865185|NCT02732951|58895578|FG000|Overall Study|Adverse Event|4|||
30865186|NCT02732951|58895579|FG001|Overall Study|Adverse Event|4|||
30865187|NCT02732951|58895578|FG000|Overall Study|Protocol Violation|0|||
30865188|NCT02732951|58895579|FG001|Overall Study|Protocol Violation|1|||
30865189|NCT01377233|58895590|FG000|Open-label|Adverse Event|1|||
30865190|NCT01377233|58895591|FG001|Open-label|Adverse Event|0|||
30865191|NCT01377233|58895592|FG002|Open-label|Adverse Event|0|||
30865192|NCT01377233|58895593|FG003|Open-label|Adverse Event|0|||
30865193|NCT01377233|58895594|FG004|Open-label|Adverse Event|0|||
30865194|NCT01377233|58895590|FG000|Open-label|Withdrawal by Subject|3|||
30865195|NCT01377233|58895591|FG001|Open-label|Withdrawal by Subject|0|||
30865196|NCT01377233|58895592|FG002|Open-label|Withdrawal by Subject|0|||
30865197|NCT01377233|58895593|FG003|Open-label|Withdrawal by Subject|0|||
30693257|NCT00549718|58707310|FG003|Overall Study|Insufficient clinical response|32|||
30693258|NCT00549718|58707307|FG000|Overall Study|Adverse Event|6|||
30693259|NCT00549718|58707308|FG001|Overall Study|Adverse Event|8|||
30693260|NCT00549718|58707309|FG002|Overall Study|Adverse Event|7|||
30693261|NCT00549718|58707310|FG003|Overall Study|Adverse Event|3|||
30865198|NCT01377233|58895594|FG004|Open-label|Withdrawal by Subject|0|||
30865199|NCT01377233|58895590|FG000|Double-blind|Adverse Event|0|||
30960778|NCT01524887|59026508|FG001|Overall Study|Withdrawal by Caregiver|0|||
30960779|NCT01524887|59026509|FG002|Overall Study|Withdrawal by Caregiver|2|||
30865200|NCT01377233|58895591|FG001|Double-blind|Adverse Event|1|||
30865201|NCT01377233|58895592|FG002|Double-blind|Adverse Event|2|||
30960780|NCT01524887|59026507|FG000|Overall Study|Use of prohibited medication|1|||
30693262|NCT00549718|58707307|FG000|Overall Study|Lost to Follow-up|4|||
30865202|NCT01377233|58895593|FG003|Double-blind|Adverse Event|2|||
30865203|NCT01377233|58895594|FG004|Double-blind|Adverse Event|0|||
30693263|NCT00549718|58707308|FG001|Overall Study|Lost to Follow-up|2|||
30693264|NCT00549718|58707309|FG002|Overall Study|Lost to Follow-up|0|||
30693265|NCT00549718|58707310|FG003|Overall Study|Lost to Follow-up|6|||
30865204|NCT01377233|58895590|FG000|Double-blind|Protocol Violation|0|||
30865205|NCT01377233|58895591|FG001|Double-blind|Protocol Violation|0|||
30693266|NCT00549718|58707307|FG000|Overall Study|Withdrawal by Subject|9|||
30693267|NCT00549718|58707308|FG001|Overall Study|Withdrawal by Subject|18|||
30693268|NCT00549718|58707309|FG002|Overall Study|Withdrawal by Subject|12|||
30693269|NCT00549718|58707310|FG003|Overall Study|Withdrawal by Subject|13|||
30693270|NCT00549718|58707307|FG000|Overall Study|Administrative|2|||
30693271|NCT00549718|58707308|FG001|Overall Study|Administrative|2|||
30693272|NCT00549718|58707309|FG002|Overall Study|Administrative|2|||
30693273|NCT00549718|58707310|FG003|Overall Study|Administrative|1|||
30693274|NCT00371761|58707322|FG000|Overall Study|Adverse Event|1|||
30693275|NCT00371761|58707323|FG001|Overall Study|Adverse Event|1|||
30693276|NCT00371761|58707322|FG000|Overall Study|Withdrawal by Subject|1|||
30693277|NCT00371761|58707323|FG001|Overall Study|Withdrawal by Subject|3|||
30693278|NCT00371761|58707322|FG000|Overall Study|Investigator Judgment|2|||
30693279|NCT00371761|58707323|FG001|Overall Study|Investigator Judgment|3|||
30693280|NCT00371761|58707322|FG000|Overall Study|Study termination|4|||
30693281|NCT00371761|58707323|FG001|Overall Study|Study termination|3|||
30693282|NCT00549640|58707331|FG000|Overall Study|Withdrawal by Subject|6|||
30693283|NCT00549640|58707332|FG001|Overall Study|Withdrawal by Subject|12|||
30693284|NCT00549640|58707331|FG000|Overall Study|Adverse Event|5|||
30693285|NCT00549640|58707332|FG001|Overall Study|Adverse Event|0|||
30693286|NCT00549640|58707331|FG000|Overall Study|Lost to Follow-up|7|||
30693287|NCT00549640|58707332|FG001|Overall Study|Lost to Follow-up|4|||
30693288|NCT00549562|58707354|FG000|Overall Study|Adverse Event|1|||
30693289|NCT00549562|58707354|FG000|Overall Study|Lack of Efficacy|1|||
30693290|NCT00681564|58707360|FG000|Overall Study|Lost to Follow-up|6|||
30693291|NCT00681564|58707361|FG001|Overall Study|Lost to Follow-up|6|||
30693292|NCT00681564|58707360|FG000|Overall Study|Withdrawal by Subject|0|||
30693293|NCT00681564|58707361|FG001|Overall Study|Withdrawal by Subject|1|||
30693294|NCT00681564|58707360|FG000|Overall Study|Death|0|||
30693295|NCT00681564|58707361|FG001|Overall Study|Death|1|||
30693296|NCT00677352|58707369|FG000|Treatment Phase|Adverse Event|14|||
30693297|NCT00677352|58707370|FG001|Treatment Phase|Adverse Event|22|||
30693298|NCT00677352|58707369|FG000|Treatment Phase|Lack of Efficacy|2|||
30693299|NCT00677352|58707370|FG001|Treatment Phase|Lack of Efficacy|3|||
30693300|NCT00677352|58707369|FG000|Treatment Phase|Lost to Follow-up|0|||
30693301|NCT00677352|58707370|FG001|Treatment Phase|Lost to Follow-up|1|||
30693302|NCT00677352|58707369|FG000|Treatment Phase|Withdrawal by Subject|7|||
30693303|NCT00677352|58707370|FG001|Treatment Phase|Withdrawal by Subject|7|||
30693304|NCT00677352|58707369|FG000|Treatment Phase|Physician Decision|1|||
30693305|NCT00677352|58707370|FG001|Treatment Phase|Physician Decision|0|||
30693306|NCT00677352|58707369|FG000|Treatment Phase|Pregnancy|0|||
30693307|NCT00677352|58707370|FG001|Treatment Phase|Pregnancy|1|||
30693308|NCT00677352|58707369|FG000|Treatment Phase|Protocol Violation|1|||
30693309|NCT00677352|58707370|FG001|Treatment Phase|Protocol Violation|1|||
30693310|NCT00677352|58707369|FG000|Treatment Phase|Transference or work related matter|0|||
30693311|NCT00677352|58707370|FG001|Treatment Phase|Transference or work related matter|5|||
30693312|NCT00677352|58707369|FG000|Treatment Phase|Not treated|0|||
30693313|NCT00677352|58707370|FG001|Treatment Phase|Not treated|2|||
30693314|NCT00677352|58707369|FG000|Tapering Phase|Adverse Event|1|||
30693315|NCT00677352|58707370|FG001|Tapering Phase|Adverse Event|5|||
30693316|NCT00677352|58707369|FG000|Tapering Phase|Withdrawal by Subject|5|||
30693317|NCT00677352|58707370|FG001|Tapering Phase|Withdrawal by Subject|3|||
30693318|NCT00677352|58707369|FG000|Tapering Phase|Pregnancy|0|||
30865206|NCT01377233|58895592|FG002|Double-blind|Protocol Violation|0|||
30865207|NCT01377233|58895593|FG003|Double-blind|Protocol Violation|0|||
30865208|NCT01377233|58895594|FG004|Double-blind|Protocol Violation|1|||
30865209|NCT01377233|58895590|FG000|Double-blind|Withdrawal by Subject|0|||
30865210|NCT01377233|58895591|FG001|Double-blind|Withdrawal by Subject|0|||
30865211|NCT01377233|58895592|FG002|Double-blind|Withdrawal by Subject|0|||
30865212|NCT01377233|58895593|FG003|Double-blind|Withdrawal by Subject|1|||
30865213|NCT01377233|58895594|FG004|Double-blind|Withdrawal by Subject|0|||
30865214|NCT01377233|58895590|FG000|Double-blind|Administrative or other|0|||
30865215|NCT01377233|58895591|FG001|Double-blind|Administrative or other|0|||
30693319|NCT00677352|58707370|FG001|Tapering Phase|Pregnancy|1|||
30693320|NCT00677352|58707369|FG000|Tapering Phase|Job transfer|0|||
30693321|NCT00677352|58707370|FG001|Tapering Phase|Job transfer|1|||
30693322|NCT00371683|58707383|FG000|DB Treatment Period-Randomized Patients|Death|1|||
30693323|NCT00371683|58707384|FG001|DB Treatment Period-Randomized Patients|Death|1|||
30693324|NCT00371683|58707383|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
30693325|NCT00371683|58707384|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
30693326|NCT00371683|58707383|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
30693327|NCT00371683|58707384|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
30865216|NCT01377233|58895592|FG002|Double-blind|Administrative or other|0|||
30865217|NCT01377233|58895593|FG003|Double-blind|Administrative or other|1|||
30865218|NCT01377233|58895594|FG004|Double-blind|Administrative or other|1|||
30865219|NCT03248531|58895613|FG000|Overall Study|Adverse Event|0|||
30865220|NCT03248531|58895614|FG001|Overall Study|Adverse Event|0|||
30693328|NCT00371683|58707383|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
30693329|NCT00371683|58707384|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
30693330|NCT00371683|58707383|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
30693331|NCT00371683|58707384|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
30693332|NCT00371683|58707383|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
30693333|NCT00371683|58707384|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
30693334|NCT00371683|58707383|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
30693335|NCT00371683|58707384|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
30693336|NCT00371683|58707383|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
30693337|NCT00371683|58707384|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
30693338|NCT00371683|58707383|FG000|Follow-Up Period - Randomized Patients|Death|0|||
30693339|NCT00371683|58707384|FG001|Follow-Up Period - Randomized Patients|Death|2|||
30693340|NCT00371683|58707383|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
30693341|NCT00371683|58707384|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
30693342|NCT00371683|58707383|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
30693343|NCT00371683|58707384|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
30693344|NCT03951766|58707400|FG000|Treatment Phase|Lost to Follow-up|1|||
30693345|NCT03951766|58707400|FG000|Follow-up Phase|Lost to Follow-up|10|||
30693346|NCT00371137|58707409|FG000|Overall Study|Adverse Event|20|||
30693347|NCT00371137|58707410|FG001|Overall Study|Adverse Event|35|||
30693348|NCT00371137|58707411|FG002|Overall Study|Adverse Event|42|||
30693349|NCT00371137|58707409|FG000|Overall Study|Withdrawal by Subject|11|||
30693350|NCT00371137|58707410|FG001|Overall Study|Withdrawal by Subject|10|||
30693351|NCT00371137|58707411|FG002|Overall Study|Withdrawal by Subject|15|||
30693352|NCT00371137|58707409|FG000|Overall Study|Lost to Follow-up|6|||
30693353|NCT00371137|58707410|FG001|Overall Study|Lost to Follow-up|3|||
30693354|NCT00371137|58707411|FG002|Overall Study|Lost to Follow-up|5|||
30693355|NCT00371137|58707409|FG000|Overall Study|Lack of Efficacy|30|||
30693356|NCT00371137|58707410|FG001|Overall Study|Lack of Efficacy|12|||
30693357|NCT00371137|58707411|FG002|Overall Study|Lack of Efficacy|13|||
30693358|NCT00371137|58707409|FG000|Overall Study|Sponsor Decision|2|||
30693359|NCT00371137|58707410|FG001|Overall Study|Sponsor Decision|1|||
30693360|NCT00371137|58707411|FG002|Overall Study|Sponsor Decision|2|||
30693361|NCT00371137|58707409|FG000|Overall Study|Physician Decision|1|||
30693362|NCT00371137|58707410|FG001|Overall Study|Physician Decision|1|||
30693363|NCT00371137|58707411|FG002|Overall Study|Physician Decision|1|||
30693364|NCT00371137|58707409|FG000|Overall Study|Protocol Violation|2|||
30693365|NCT00371137|58707410|FG001|Overall Study|Protocol Violation|1|||
30693366|NCT00371137|58707411|FG002|Overall Study|Protocol Violation|1|||
30693367|NCT00616239|58707419|FG000|Overall Study|Withdrawal by Subject|2|||
30693368|NCT00547534|58707423|FG000|Overall Study|Adverse Event|7|||
30693369|NCT00547534|58707423|FG000|Overall Study|Disease Progression|4|||
30693370|NCT00384397|58707431|FG000|Overall Study|Adverse Event|0|||
30693371|NCT00384397|58707432|FG001|Overall Study|Adverse Event|1|||
30693372|NCT00384397|58707433|FG002|Overall Study|Adverse Event|2|||
30693373|NCT00384397|58707431|FG000|Overall Study|Protocol Violation|7|||
30693374|NCT00384397|58707432|FG001|Overall Study|Protocol Violation|15|||
30693375|NCT00384397|58707433|FG002|Overall Study|Protocol Violation|13|||
30693376|NCT00384397|58707431|FG000|Overall Study|Lost to Follow-up|11|||
30693377|NCT00384397|58707432|FG001|Overall Study|Lost to Follow-up|13|||
30693378|NCT00384397|58707433|FG002|Overall Study|Lost to Follow-up|3|||
30693379|NCT00384397|58707431|FG000|Overall Study|Withdrawal by Subject|14|||
30693380|NCT00384397|58707432|FG001|Overall Study|Withdrawal by Subject|17|||
30693381|NCT00384397|58707433|FG002|Overall Study|Withdrawal by Subject|15|||
30693382|NCT00384085|58707444|FG000|Overall Study|Adverse Event|5|||
30693383|NCT00384085|58707445|FG001|Overall Study|Adverse Event|5|||
30693384|NCT00384085|58707446|FG002|Overall Study|Adverse Event|4|||
30865221|NCT03248531|58895615|FG002|Overall Study|Adverse Event|1|||
30865222|NCT03248531|58895613|FG000|Overall Study|Lost to Follow-up|1|||
30865223|NCT03248531|58895614|FG001|Overall Study|Lost to Follow-up|0|||
30865224|NCT03248531|58895615|FG002|Overall Study|Lost to Follow-up|5|||
30865225|NCT03248531|58895613|FG000|Overall Study|Withdrawal by Subject|3|||
30865226|NCT03248531|58895614|FG001|Overall Study|Withdrawal by Subject|3|||
30865227|NCT03248531|58895615|FG002|Overall Study|Withdrawal by Subject|2|||
30865228|NCT03248531|58895613|FG000|Overall Study|Sponsor Request|0|||
30693385|NCT00384085|58707444|FG000|Overall Study|Lack of Efficacy|0|||
30693386|NCT00384085|58707445|FG001|Overall Study|Lack of Efficacy|3|||
30693387|NCT00384085|58707446|FG002|Overall Study|Lack of Efficacy|2|||
30693388|NCT00384085|58707444|FG000|Overall Study|No longer Requires Study Treatment|1|||
30693389|NCT00384085|58707445|FG001|Overall Study|No longer Requires Study Treatment|0|||
30693390|NCT00384085|58707446|FG002|Overall Study|No longer Requires Study Treatment|1|||
30693391|NCT00384085|58707444|FG000|Overall Study|Protocol Violation|2|||
30693392|NCT00384085|58707445|FG001|Overall Study|Protocol Violation|2|||
30693393|NCT00384085|58707446|FG002|Overall Study|Protocol Violation|2|||
30693394|NCT00384085|58707444|FG000|Overall Study|Lost to Follow-up|9|||
30693395|NCT00384085|58707445|FG001|Overall Study|Lost to Follow-up|9|||
30865229|NCT03248531|58895614|FG001|Overall Study|Sponsor Request|2|||
30865230|NCT03248531|58895615|FG002|Overall Study|Sponsor Request|0|||
30693396|NCT00384085|58707446|FG002|Overall Study|Lost to Follow-up|10|||
30693397|NCT00384085|58707444|FG000|Overall Study|Progressive Disease|0|||
30693398|NCT00384085|58707445|FG001|Overall Study|Progressive Disease|1|||
30693399|NCT00384085|58707446|FG002|Overall Study|Progressive Disease|0|||
30693400|NCT00384085|58707444|FG000|Overall Study|Withdrawal by Subject|14|||
30693401|NCT00384085|58707445|FG001|Overall Study|Withdrawal by Subject|19|||
30693402|NCT00384085|58707446|FG002|Overall Study|Withdrawal by Subject|29|||
30693403|NCT00384085|58707444|FG000|Overall Study|Patient non-compliant|4|||
30693404|NCT00384085|58707445|FG001|Overall Study|Patient non-compliant|4|||
30693405|NCT00384085|58707446|FG002|Overall Study|Patient non-compliant|5|||
30693406|NCT00384085|58707444|FG000|Overall Study|Physician Decision|1|||
30693407|NCT00384085|58707445|FG001|Overall Study|Physician Decision|0|||
30693408|NCT00384085|58707446|FG002|Overall Study|Physician Decision|0|||
30693409|NCT00384085|58707444|FG000|Overall Study|Loss of site personnel|1|||
30693410|NCT00384085|58707445|FG001|Overall Study|Loss of site personnel|0|||
30693411|NCT00384085|58707446|FG002|Overall Study|Loss of site personnel|1|||
30693412|NCT00384085|58707444|FG000|Overall Study|Sponsor decision|1|||
30693413|NCT00384085|58707445|FG001|Overall Study|Sponsor decision|2|||
30693414|NCT00384085|58707446|FG002|Overall Study|Sponsor decision|1|||
30693415|NCT00384085|58707444|FG000|Overall Study|Patient moved|1|||
30693416|NCT00384085|58707445|FG001|Overall Study|Patient moved|0|||
30693417|NCT00384085|58707446|FG002|Overall Study|Patient moved|1|||
30693418|NCT00384085|58707444|FG000|Overall Study|Patient required surgery|0|||
30693419|NCT00384085|58707445|FG001|Overall Study|Patient required surgery|1|||
30693420|NCT00384085|58707446|FG002|Overall Study|Patient required surgery|0|||
30693421|NCT00361231|58707456|FG000|Overall Study|Physician Decision|3|||
30693422|NCT00361231|58707456|FG000|Overall Study|Symptomatic deterioration|5|||
30693423|NCT00361231|58707456|FG000|Overall Study|Radiographic disease progression|16|||
30693424|NCT00361231|58707456|FG000|Overall Study|Withdrawal by Subject|4|||
30693425|NCT00361231|58707456|FG000|Overall Study|Adverse Event|6|||
30693426|NCT00676650|58707462|FG000|Overall Study|Death|45|||
30693427|NCT00676650|58707463|FG001|Overall Study|Death|14|||
30693428|NCT00676650|58707462|FG000|Overall Study|Adverse Event|159|||
30693429|NCT00676650|58707463|FG001|Overall Study|Adverse Event|21|||
30693430|NCT00676650|58707462|FG000|Overall Study|Global deterioration of health status|66|||
30693431|NCT00676650|58707463|FG001|Overall Study|Global deterioration of health status|31|||
30693432|NCT00676650|58707462|FG000|Overall Study|Lost to Follow-up|0|||
30693433|NCT00676650|58707463|FG001|Overall Study|Lost to Follow-up|1|||
30693434|NCT00676650|58707462|FG000|Overall Study|Objective progression or relapse|189|||
30693435|NCT00676650|58707463|FG001|Overall Study|Objective progression or relapse|140|||
30693436|NCT00676650|58707462|FG000|Overall Study|Other|14|||
30693437|NCT00676650|58707463|FG001|Overall Study|Other|10|||
30693438|NCT00676650|58707462|FG000|Overall Study|Protocol Violation|3|||
30693439|NCT00676650|58707463|FG001|Overall Study|Protocol Violation|1|||
30693440|NCT00676650|58707462|FG000|Overall Study|Study terminated by sponsor|57|||
30693441|NCT00676650|58707463|FG001|Overall Study|Study terminated by sponsor|43|||
30693442|NCT00676650|58707462|FG000|Overall Study|Withdrawal by Subject|48|||
30693443|NCT00676650|58707463|FG001|Overall Study|Withdrawal by Subject|24|||
30693444|NCT00676650|58707462|FG000|Overall Study|Randomized but not treated|3|||
30693445|NCT00676650|58707463|FG001|Overall Study|Randomized but not treated|4|||
30693446|NCT00573183|58707471|FG000|Overall Study|Lost to Follow-up|52|||
30693447|NCT00573183|58707472|FG001|Overall Study|Lost to Follow-up|50|||
30693448|NCT00573183|58707471|FG000|Overall Study|Withdrawal by Subject|8|||
30693449|NCT00573183|58707472|FG001|Overall Study|Withdrawal by Subject|2|||
30693450|NCT00573183|58707471|FG000|Overall Study|Death|0|||
30602080|NCT01253421|58613351|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
30602081|NCT01253421|58613347|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
30602082|NCT01253421|58613348|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
30602083|NCT01253421|58613349|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
30602084|NCT01253421|58613350|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
30602085|NCT01253421|58613351|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
30602086|NCT01253421|58613347|FG000|Assessment and Scheduling|Physician Decision|1|||
30602087|NCT01253421|58613348|FG001|Assessment and Scheduling|Physician Decision|0|||
30693451|NCT00573183|58707472|FG001|Overall Study|Death|1|||
30693452|NCT00573183|58707471|FG000|Overall Study|Adverse Event|2|||
30693453|NCT00573183|58707472|FG001|Overall Study|Adverse Event|0|||
30693454|NCT00573183|58707471|FG000|Overall Study|Incarceration|5|||
30602088|NCT01253421|58613349|FG002|Assessment and Scheduling|Physician Decision|0|||
30602089|NCT01253421|58613350|FG003|Assessment and Scheduling|Physician Decision|0|||
30693455|NCT00573183|58707472|FG001|Overall Study|Incarceration|8|||
30693456|NCT00573183|58707471|FG000|Overall Study|Other|5|||
30693457|NCT00573183|58707472|FG001|Overall Study|Other|2|||
30693458|NCT00615459|58707480|FG000|Period I|Adverse Event|2|||
30693459|NCT00615459|58707481|FG001|Period I|Adverse Event|0|||
30693460|NCT00615459|58707482|FG002|Period I|Adverse Event|1|||
30693461|NCT00615459|58707483|FG003|Period I|Adverse Event|0|||
30693462|NCT00615459|58707480|FG000|Period I|Subject withdrew consent|1|||
30693463|NCT00615459|58707481|FG001|Period I|Subject withdrew consent|0|||
30602090|NCT01253421|58613351|FG004|Assessment and Scheduling|Physician Decision|0|||
30602091|NCT01253421|58613347|FG000|Drug+Scanning Visit|Physician Decision|0|||
30602092|NCT01253421|58613348|FG001|Drug+Scanning Visit|Physician Decision|0|||
30602093|NCT01253421|58613349|FG002|Drug+Scanning Visit|Physician Decision|0|||
30602094|NCT01253421|58613350|FG003|Drug+Scanning Visit|Physician Decision|0|||
30602095|NCT01253421|58613351|FG004|Drug+Scanning Visit|Physician Decision|1|||
30602096|NCT01077076|58613361|FG000|First Intervention|Withdrawal by Subject|1|||
30602097|NCT01077076|58613362|FG001|First Intervention|Withdrawal by Subject|0|||
30602098|NCT01077076|58613363|FG002|First Intervention|Withdrawal by Subject|0|||
30693464|NCT00615459|58707482|FG002|Period I|Subject withdrew consent|0|||
30693465|NCT00615459|58707483|FG003|Period I|Subject withdrew consent|1|||
30693466|NCT00615459|58707480|FG000|Period I|Abnormal test procedure results|1|||
30693467|NCT00615459|58707481|FG001|Period I|Abnormal test procedure results|1|||
30693468|NCT00615459|58707482|FG002|Period I|Abnormal test procedure results|1|||
30693469|NCT00615459|58707483|FG003|Period I|Abnormal test procedure results|0|||
30693470|NCT00615459|58707480|FG000|Period II|Adverse Event|1|||
30693471|NCT00615459|58707481|FG001|Period II|Adverse Event|0|||
30693472|NCT00615459|58707482|FG002|Period II|Adverse Event|0|||
30693473|NCT00615459|58707483|FG003|Period II|Adverse Event|0|||
30693474|NCT00615459|58707480|FG000|Period II|Lost to Follow-up|0|||
30693475|NCT00615459|58707481|FG001|Period II|Lost to Follow-up|0|||
30693476|NCT00615459|58707482|FG002|Period II|Lost to Follow-up|0|||
30693477|NCT00615459|58707483|FG003|Period II|Lost to Follow-up|1|||
30693478|NCT00615459|58707480|FG000|Period III|Adverse Event|0|||
30693479|NCT00615459|58707481|FG001|Period III|Adverse Event|1|||
30693480|NCT00615459|58707482|FG002|Period III|Adverse Event|0|||
30693481|NCT00615459|58707483|FG003|Period III|Adverse Event|0|||
30693482|NCT00615459|58707480|FG000|Period III|Administrative problems|0|||
30693483|NCT00615459|58707481|FG001|Period III|Administrative problems|1|||
30693484|NCT00615459|58707482|FG002|Period III|Administrative problems|1|||
30693485|NCT00615459|58707483|FG003|Period III|Administrative problems|0|||
30693486|NCT00615459|58707480|FG000|Period III|Unsatisfactory therapeutic effect|0|||
30693487|NCT00615459|58707481|FG001|Period III|Unsatisfactory therapeutic effect|1|||
30693488|NCT00615459|58707482|FG002|Period III|Unsatisfactory therapeutic effect|0|||
30693489|NCT00615459|58707483|FG003|Period III|Unsatisfactory therapeutic effect|0|||
30693490|NCT00383149|58707497|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
30693491|NCT00383149|58707497|FG000|Overall Study|Death|2|||
30693492|NCT00383149|58707497|FG000|Overall Study|Disease Progression|38|||
30693493|NCT00383149|58707497|FG000|Overall Study|Lost to Follow-up|1|||
30693494|NCT00383149|58707497|FG000|Overall Study|Other|1|||
30865231|NCT02656329|58895632|FG000|Overall Study|Lost to Follow-up|2|||
30865232|NCT02656329|58895633|FG001|Overall Study|Lost to Follow-up|3|||
30865233|NCT02656329|58895632|FG000|Overall Study|Withdrawal by Subject|7|||
30865234|NCT02656329|58895633|FG001|Overall Study|Withdrawal by Subject|6|||
30693495|NCT00383149|58707497|FG000|Overall Study|Study Drug Toxicity|4|||
30693496|NCT00383149|58707497|FG000|Overall Study|Request to Discontinue Treatment|4|||
30865235|NCT02656329|58895632|FG000|Overall Study|Study termination by Sponsor|150|||
30865236|NCT02656329|58895633|FG001|Overall Study|Study termination by Sponsor|142|||
30865237|NCT02656329|58895632|FG000|Overall Study|Other than specified above|5|||
30865238|NCT02656329|58895633|FG001|Overall Study|Other than specified above|6|||
30865239|NCT02712905|58895658|FG000|Monotherapy|Death|2|||
30865240|NCT02712905|58895659|FG001|Monotherapy|Death|5|||
30865241|NCT02712905|58895660|FG002|Monotherapy|Death|0|||
30865242|NCT02712905|58895661|FG003|Monotherapy|Death|3|||
30865243|NCT02712905|58895662|FG004|Monotherapy|Death|15|||
30865244|NCT02712905|58895663|FG005|Monotherapy|Death|1|||
30602099|NCT01077076|58613364|FG003|First Intervention|Withdrawal by Subject|0|||
30693497|NCT00383149|58707497|FG000|Overall Study|Participant Withdrew Consent|1|||
30693498|NCT00382993|58707503|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
30693499|NCT00382993|58707504|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
30693500|NCT00382993|58707503|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
30693501|NCT00382993|58707504|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
30693502|NCT00382993|58707503|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
30693503|NCT00382993|58707504|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
30693504|NCT00382993|58707503|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
30865245|NCT02712905|58895664|FG006|Monotherapy|Death|3|||
30865246|NCT02712905|58895665|FG007|Monotherapy|Death|3|||
30865247|NCT02712905|58895666|FG008|Monotherapy|Death|0|||
30602100|NCT01077076|58613365|FG004|First Intervention|Withdrawal by Subject|0|||
30602101|NCT01077076|58613366|FG005|First Intervention|Withdrawal by Subject|0|||
30602102|NCT01077076|58613361|FG000|Third Intervention|Death in the participant's family|0|||
30693505|NCT00382993|58707504|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
30865248|NCT02712905|58895667|FG009|Monotherapy|Death|27|||
30865249|NCT02712905|58895668|FG010|Monotherapy|Death|2|||
30865250|NCT02712905|58895669|FG011|Monotherapy|Death|5|||
30865251|NCT02712905|58895670|FG012|Monotherapy|Death|0|||
30865252|NCT02712905|58895671|FG013|Monotherapy|Death|0|||
30865253|NCT02712905|58895672|FG014|Monotherapy|Death|0|||
30865254|NCT02712905|58895673|FG015|Monotherapy|Death|0|||
30693506|NCT00382993|58707503|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
30693507|NCT00382993|58707504|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
30693508|NCT00382993|58707503|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
30693509|NCT00382993|58707504|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
30693510|NCT00382993|58707503|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
30693511|NCT00382993|58707504|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
30693512|NCT00382993|58707503|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
30693513|NCT00382993|58707504|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
30693514|NCT00382993|58707503|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
30693515|NCT00382993|58707504|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
30693516|NCT00382993|58707503|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
30693517|NCT00382993|58707504|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
30693518|NCT00369967|58707512|FG000|Overall Study|Lost to Follow-up|23|||
30693519|NCT00369967|58707513|FG001|Overall Study|Lost to Follow-up|12|||
30693520|NCT00616629|58707528|FG000|Overall Study|Protocol Violation|1|||
30693521|NCT00616629|58707529|FG001|Overall Study|Protocol Violation|2|||
30693522|NCT00616629|58707530|FG002|Overall Study|Protocol Violation|1|||
30693523|NCT00616629|58707531|FG003|Overall Study|Protocol Violation|0|||
30693524|NCT00616629|58707532|FG004|Overall Study|Protocol Violation|0|||
30693525|NCT00616629|58707528|FG000|Overall Study|AV-block|1|||
30693526|NCT00616629|58707529|FG001|Overall Study|AV-block|0|||
30693527|NCT00616629|58707530|FG002|Overall Study|AV-block|0|||
30693528|NCT00616629|58707531|FG003|Overall Study|AV-block|0|||
30693529|NCT00616629|58707532|FG004|Overall Study|AV-block|0|||
30693530|NCT00369655|58707544|FG000|Overall Study|Refusal of further treatment|2|||
30693531|NCT00615069|58707548|FG000|Overall Study|Death|10|||
30693532|NCT00615069|58707548|FG000|Overall Study|Physician Decision|2|||
30693533|NCT00615069|58707548|FG000|Overall Study|Withdrawal by Subject|4|||
30693534|NCT00676338|58707556|FG000|Overall Study|Adverse Event|6|||
30693535|NCT00676338|58707557|FG001|Overall Study|Adverse Event|6|||
30693536|NCT00676338|58707558|FG002|Overall Study|Adverse Event|5|||
30693537|NCT00676338|58707559|FG003|Overall Study|Adverse Event|1|||
30693538|NCT00676338|58707556|FG000|Overall Study|Lost to Follow-up|4|||
30693539|NCT00676338|58707557|FG001|Overall Study|Lost to Follow-up|1|||
30693540|NCT00676338|58707558|FG002|Overall Study|Lost to Follow-up|3|||
30693541|NCT00676338|58707559|FG003|Overall Study|Lost to Follow-up|4|||
30693542|NCT00676338|58707556|FG000|Overall Study|Physician Decision|3|||
30693543|NCT00676338|58707557|FG001|Overall Study|Physician Decision|3|||
30693544|NCT00676338|58707558|FG002|Overall Study|Physician Decision|2|||
30693545|NCT00676338|58707559|FG003|Overall Study|Physician Decision|3|||
30693546|NCT00676338|58707556|FG000|Overall Study|Protocol Violation|5|||
30693547|NCT00676338|58707557|FG001|Overall Study|Protocol Violation|9|||
30693548|NCT00676338|58707558|FG002|Overall Study|Protocol Violation|2|||
30693549|NCT00676338|58707559|FG003|Overall Study|Protocol Violation|5|||
30693550|NCT00676338|58707556|FG000|Overall Study|Withdrawal by Subject|17|||
30693551|NCT00676338|58707557|FG001|Overall Study|Withdrawal by Subject|9|||
30693552|NCT00676338|58707558|FG002|Overall Study|Withdrawal by Subject|12|||
30693553|NCT00676338|58707559|FG003|Overall Study|Withdrawal by Subject|6|||
30693554|NCT00676338|58707556|FG000|Overall Study|Entry Criteria Not Met|0|||
30693555|NCT00676338|58707557|FG001|Overall Study|Entry Criteria Not Met|2|||
30693556|NCT00676338|58707558|FG002|Overall Study|Entry Criteria Not Met|1|||
30693557|NCT00676338|58707559|FG003|Overall Study|Entry Criteria Not Met|1|||
30693558|NCT00676338|58707556|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
30693559|NCT00676338|58707557|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
30693560|NCT00676338|58707558|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
30693561|NCT00676338|58707559|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
30693562|NCT00382291|58707572|FG000|Overall Study|Adverse Event|1|||
30693563|NCT00382291|58707573|FG001|Overall Study|Adverse Event|2|||
30693564|NCT00382291|58707574|FG002|Overall Study|Adverse Event|2|||
30693565|NCT00382291|58707572|FG000|Overall Study|Protocol Violation|1|||
30693566|NCT00382291|58707573|FG001|Overall Study|Protocol Violation|0|||
30960781|NCT01524887|59026508|FG001|Overall Study|Use of prohibited medication|0|||
30693567|NCT00382291|58707574|FG002|Overall Study|Protocol Violation|0|||
30693568|NCT00382291|58707572|FG000|Overall Study|Temporary study suspension|2|||
30693569|NCT00382291|58707573|FG001|Overall Study|Temporary study suspension|2|||
30693570|NCT00382291|58707574|FG002|Overall Study|Temporary study suspension|5|||
30693571|NCT00382291|58707572|FG000|Overall Study|Withdrawal by Subject|0|||
30693572|NCT00382291|58707573|FG001|Overall Study|Withdrawal by Subject|2|||
30960782|NCT01524887|59026509|FG002|Overall Study|Use of prohibited medication|0|||
30693573|NCT00382291|58707574|FG002|Overall Study|Withdrawal by Subject|0|||
30693574|NCT00382291|58707572|FG000|Overall Study|Physician Decision|0|||
30693575|NCT00382291|58707573|FG001|Overall Study|Physician Decision|1|||
30693576|NCT00382291|58707574|FG002|Overall Study|Physician Decision|0|||
30693577|NCT00382291|58707572|FG000|Overall Study|Lack of Efficacy|0|||
30693578|NCT00382291|58707573|FG001|Overall Study|Lack of Efficacy|0|||
30693579|NCT00382291|58707574|FG002|Overall Study|Lack of Efficacy|1|||
30693580|NCT00547378|58707596|FG000|Randomized Cohort|Withdrawal by Subject|7|||
30693581|NCT00547378|58707597|FG001|Randomized Cohort|Withdrawal by Subject|5|||
30693582|NCT00547378|58707598|FG002|Randomized Cohort|Withdrawal by Subject|0|||
30693583|NCT00547378|58707596|FG000|Randomized Cohort|Death|0|||
30693584|NCT00547378|58707597|FG001|Randomized Cohort|Death|1|||
30693585|NCT00547378|58707598|FG002|Randomized Cohort|Death|0|||
30693586|NCT00547378|58707596|FG000|Randomized Cohort|Lost to Follow-up|1|||
30693587|NCT00547378|58707597|FG001|Randomized Cohort|Lost to Follow-up|0|||
30693588|NCT00547378|58707598|FG002|Randomized Cohort|Lost to Follow-up|0|||
30693589|NCT00547378|58707596|FG000|Randomized Cohort|Adverse Event|1|||
30693590|NCT00547378|58707597|FG001|Randomized Cohort|Adverse Event|0|||
30693591|NCT00547378|58707598|FG002|Randomized Cohort|Adverse Event|0|||
30693592|NCT00547378|58707596|FG000|Randomized Cohort|Other reasons|2|||
30693593|NCT00547378|58707597|FG001|Randomized Cohort|Other reasons|0|||
30693594|NCT00547378|58707598|FG002|Randomized Cohort|Other reasons|0|||
30693595|NCT00547378|58707596|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
30693596|NCT00547378|58707597|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
30693597|NCT00547378|58707598|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
30693598|NCT00547378|58707596|FG000|All Implanted Cohort|Adverse Event|4|||
30693599|NCT00547378|58707597|FG001|All Implanted Cohort|Adverse Event|10|||
30693600|NCT00547378|58707598|FG002|All Implanted Cohort|Adverse Event|17|||
30693601|NCT00547378|58707596|FG000|All Implanted Cohort|Lost to Follow-up|0|||
30693602|NCT00547378|58707597|FG001|All Implanted Cohort|Lost to Follow-up|1|||
30693603|NCT00547378|58707598|FG002|All Implanted Cohort|Lost to Follow-up|14|||
30693604|NCT00547378|58707596|FG000|All Implanted Cohort|Death|3|||
30693605|NCT00547378|58707597|FG001|All Implanted Cohort|Death|1|||
30693606|NCT00547378|58707598|FG002|All Implanted Cohort|Death|4|||
30693607|NCT00547378|58707596|FG000|All Implanted Cohort|Physician Decision|0|||
30693608|NCT00547378|58707597|FG001|All Implanted Cohort|Physician Decision|2|||
30693609|NCT00547378|58707598|FG002|All Implanted Cohort|Physician Decision|6|||
30693610|NCT00547378|58707596|FG000|All Implanted Cohort|Site closure|2|||
30693611|NCT00547378|58707597|FG001|All Implanted Cohort|Site closure|0|||
30693612|NCT00547378|58707598|FG002|All Implanted Cohort|Site closure|1|||
30693613|NCT00547378|58707596|FG000|All Implanted Cohort|Other reasons|1|||
30693614|NCT00547378|58707597|FG001|All Implanted Cohort|Other reasons|0|||
30693615|NCT00547378|58707598|FG002|All Implanted Cohort|Other reasons|1|||
30693616|NCT00381043|58707608|FG000|Overall Study|Lost to Follow-up|8|||
30693617|NCT00381043|58707609|FG001|Overall Study|Lost to Follow-up|6|||
30693618|NCT00381043|58707608|FG000|Overall Study|Withdrawal by Subject|3|||
30693619|NCT00381043|58707609|FG001|Overall Study|Withdrawal by Subject|1|||
30693620|NCT00381043|58707608|FG000|Overall Study|wanted more care|0|||
30693621|NCT00381043|58707609|FG001|Overall Study|wanted more care|1|||
30693622|NCT00381043|58707608|FG000|Overall Study|incarcerated|1|||
30693623|NCT00381043|58707609|FG001|Overall Study|incarcerated|0|||
30693624|NCT00614991|58707621|FG000|Overall Study|Adverse Event|3|||
30693625|NCT00614991|58707622|FG001|Overall Study|Adverse Event|3|||
30693626|NCT00614991|58707623|FG002|Overall Study|Adverse Event|0|||
30693627|NCT00614991|58707624|FG003|Overall Study|Adverse Event|0|||
30693628|NCT00614991|58707625|FG004|Overall Study|Adverse Event|1|||
30693629|NCT00614991|58707626|FG005|Overall Study|Adverse Event|0|||
30693630|NCT00360529|58707648|FG000|Overall Study|Adverse Event|10|||
30693631|NCT00360529|58707649|FG001|Overall Study|Adverse Event|23|||
30693632|NCT00360529|58707650|FG002|Overall Study|Adverse Event|33|||
30693633|NCT00360529|58707648|FG000|Overall Study|Protocol Violation|3|||
30693634|NCT00360529|58707649|FG001|Overall Study|Protocol Violation|3|||
30693635|NCT00360529|58707650|FG002|Overall Study|Protocol Violation|11|||
30693636|NCT00360529|58707648|FG000|Overall Study|Lost to Follow-up|14|||
30693637|NCT00360529|58707649|FG001|Overall Study|Lost to Follow-up|10|||
30693638|NCT00360529|58707650|FG002|Overall Study|Lost to Follow-up|13|||
30693639|NCT00360529|58707648|FG000|Overall Study|Withdrawal by Subject|22|||
30693640|NCT00360529|58707649|FG001|Overall Study|Withdrawal by Subject|14|||
30693641|NCT00360529|58707650|FG002|Overall Study|Withdrawal by Subject|18|||
30693642|NCT00360529|58707648|FG000|Overall Study|Lack of Efficacy|8|||
30693643|NCT00360529|58707649|FG001|Overall Study|Lack of Efficacy|6|||
30693644|NCT00360529|58707650|FG002|Overall Study|Lack of Efficacy|5|||
30693645|NCT00360529|58707648|FG000|Overall Study|Reason discontinued not explained above|4|||
30693646|NCT00360529|58707649|FG001|Overall Study|Reason discontinued not explained above|9|||
30693647|NCT00360529|58707650|FG002|Overall Study|Reason discontinued not explained above|11|||
30693648|NCT00369577|58707661|FG000|Overall Study|Withdrawal by Subject|0|||
30693649|NCT00369577|58707662|FG001|Overall Study|Withdrawal by Subject|0|||
30693650|NCT00369577|58707663|FG002|Overall Study|Withdrawal by Subject|1|||
30693651|NCT00678288|58707673|FG000|Overall Study|Adverse Event|0|||
30693652|NCT00678288|58707674|FG001|Overall Study|Adverse Event|2|||
30693653|NCT00678288|58707673|FG000|Overall Study|Withdrawal by Subject|1|||
30693654|NCT00678288|58707674|FG001|Overall Study|Withdrawal by Subject|1|||
30693655|NCT00678288|58707673|FG000|Overall Study|Study terminated by the sponsor|2|||
30693656|NCT00678288|58707674|FG001|Overall Study|Study terminated by the sponsor|0|||
30693657|NCT00678288|58707673|FG000|Overall Study|Not compliant with study medication|0|||
30693658|NCT00678288|58707674|FG001|Overall Study|Not compliant with study medication|1|||
30693659|NCT00678288|58707673|FG000|Overall Study|Switch to commercial drug|0|||
30693660|NCT00678288|58707674|FG001|Overall Study|Switch to commercial drug|1|||
30693661|NCT00678288|58707673|FG000|Overall Study|Reason not reported|1|||
30693662|NCT00678288|58707674|FG001|Overall Study|Reason not reported|0|||
30693663|NCT00678288|58707673|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
30693664|NCT00678288|58707674|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
30693665|NCT00369343|58707682|FG000|Double-blind Phase|Adverse Event|19|||
30693666|NCT00369343|58707683|FG001|Double-blind Phase|Adverse Event|4|||
30693667|NCT00369343|58707682|FG000|Double-blind Phase|Failed to return|2|||
30693668|NCT00369343|58707683|FG001|Double-blind Phase|Failed to return|0|||
30693669|NCT00369343|58707682|FG000|Double-blind Phase|Lost to Follow-up|9|||
30693670|NCT00369343|58707683|FG001|Double-blind Phase|Lost to Follow-up|2|||
30693671|NCT00369343|58707682|FG000|Double-blind Phase|Protocol Violation|2|||
30693672|NCT00369343|58707683|FG001|Double-blind Phase|Protocol Violation|0|||
30693673|NCT00369343|58707682|FG000|Double-blind Phase|Withdrawal by Subject|8|||
30693674|NCT00369343|58707683|FG001|Double-blind Phase|Withdrawal by Subject|6|||
30693675|NCT00369343|58707682|FG000|Double-blind Phase|Lack of Efficacy|0|||
30693676|NCT00369343|58707683|FG001|Double-blind Phase|Lack of Efficacy|4|||
30693677|NCT00369343|58707682|FG000|Double-blind Phase|Protocol deviation|4|||
30693678|NCT00369343|58707683|FG001|Double-blind Phase|Protocol deviation|0|||
30693679|NCT00369343|58707682|FG000|Open-label Phase|Adverse Event|19|||
30693680|NCT00369343|58707683|FG001|Open-label Phase|Adverse Event|7|||
30693681|NCT00369343|58707682|FG000|Open-label Phase|Failed to return|4|||
30693682|NCT00369343|58707683|FG001|Open-label Phase|Failed to return|0|||
30693683|NCT00369343|58707682|FG000|Open-label Phase|Physician Decision|2|||
30693684|NCT00369343|58707683|FG001|Open-label Phase|Physician Decision|0|||
30693685|NCT00369343|58707682|FG000|Open-label Phase|Lost to Follow-up|5|||
30693686|NCT00369343|58707683|FG001|Open-label Phase|Lost to Follow-up|3|||
30693687|NCT00369343|58707682|FG000|Open-label Phase|inadvertently reported study completers|3|||
30693688|NCT00369343|58707683|FG001|Open-label Phase|inadvertently reported study completers|2|||
30693689|NCT00369343|58707682|FG000|Open-label Phase|Protocol Violation|1|||
30693690|NCT00369343|58707683|FG001|Open-label Phase|Protocol Violation|3|||
30693691|NCT00369343|58707682|FG000|Open-label Phase|Withdrawal by Subject|15|||
30693692|NCT00369343|58707683|FG001|Open-label Phase|Withdrawal by Subject|6|||
30693693|NCT00369343|58707682|FG000|Open-label Phase|Lack of Efficacy|4|||
30693694|NCT00369343|58707683|FG001|Open-label Phase|Lack of Efficacy|3|||
30693695|NCT00369343|58707682|FG000|Open-label Phase|Lack of continuance tolerability|3|||
30693696|NCT00369343|58707683|FG001|Open-label Phase|Lack of continuance tolerability|4|||
30693697|NCT00369343|58707682|FG000|Open-label Phase|did not take study drug|1|||
30693698|NCT00369343|58707683|FG001|Open-label Phase|did not take study drug|2|||
30693699|NCT00369265|58707698|FG000|Overall Study|Study terminated|4|||
30693700|NCT00369265|58707699|FG001|Overall Study|Study terminated|7|||
30693701|NCT00368875|58707705|FG000|Overall Study|Adverse Event|0|||
30693702|NCT00368875|58707706|FG001|Overall Study|Adverse Event|12|||
30693703|NCT00368875|58707705|FG000|Overall Study|Progressive disease|3|||
30693704|NCT00368875|58707706|FG001|Overall Study|Progressive disease|27|||
30693705|NCT00368875|58707705|FG000|Overall Study|Withdrawal by Subject|2|||
30693706|NCT00368875|58707706|FG001|Overall Study|Withdrawal by Subject|6|||
30693707|NCT00368875|58707705|FG000|Overall Study|Other Reason|0|||
30693708|NCT00368875|58707706|FG001|Overall Study|Other Reason|2|||
30693709|NCT00368875|58707705|FG000|Overall Study|Alternative Therapy|1|||
30693710|NCT00368875|58707706|FG001|Overall Study|Alternative Therapy|1|||
30693711|NCT00614055|58707715|FG000|Overall Study|Adverse Event|1|||
30693712|NCT00614055|58707716|FG001|Overall Study|Adverse Event|0|||
30693713|NCT00614055|58707717|FG002|Overall Study|Adverse Event|0|||
30693714|NCT00614055|58707715|FG000|Overall Study|Protocol Violation|2|||
30693715|NCT00614055|58707716|FG001|Overall Study|Protocol Violation|2|||
30693716|NCT00614055|58707717|FG002|Overall Study|Protocol Violation|1|||
30693717|NCT00614055|58707715|FG000|Overall Study|Lack of Efficacy|0|||
30693718|NCT00614055|58707716|FG001|Overall Study|Lack of Efficacy|0|||
30693719|NCT00614055|58707717|FG002|Overall Study|Lack of Efficacy|2|||
30693720|NCT00614055|58707715|FG000|Overall Study|Unclassified|1|||
30693721|NCT00614055|58707716|FG001|Overall Study|Unclassified|4|||
30865255|NCT02712905|58895674|FG016|Monotherapy|Death|0|||
30865256|NCT02712905|58895675|FG017|Monotherapy|Death|0|||
30865257|NCT02712905|58895658|FG000|Monotherapy|Lost to Follow-up|0|||
30865258|NCT02712905|58895659|FG001|Monotherapy|Lost to Follow-up|1|||
30865259|NCT02712905|58895660|FG002|Monotherapy|Lost to Follow-up|0|||
30865260|NCT02712905|58895661|FG003|Monotherapy|Lost to Follow-up|1|||
30865261|NCT02712905|58895662|FG004|Monotherapy|Lost to Follow-up|0|||
30693722|NCT00614055|58707717|FG002|Overall Study|Unclassified|2|||
30693723|NCT00613821|58707730|FG000|Overall Study|Withdrawal by Subject|1|||
30693724|NCT00613821|58707731|FG001|Overall Study|Withdrawal by Subject|0|||
30865262|NCT02712905|58895663|FG005|Monotherapy|Lost to Follow-up|0|||
30693725|NCT00613821|58707730|FG000|Overall Study|Physician Decision|1|||
30693726|NCT00613821|58707731|FG001|Overall Study|Physician Decision|1|||
30693727|NCT00548548|58707739|FG000|Overall Study|Death|345|||
30693728|NCT00548548|58707740|FG001|Overall Study|Death|348|||
30693729|NCT00548548|58707739|FG000|Overall Study|Lost to Follow-up|17|||
30693730|NCT00548548|58707740|FG001|Overall Study|Lost to Follow-up|18|||
30693731|NCT00613509|58707748|FG000|Cycle 1|Adverse Event|2|||
30693732|NCT00613509|58707749|FG001|Cycle 1|Adverse Event|1|||
30693733|NCT00613509|58707748|FG000|Cycle 1|Disease Progression|2|||
30693734|NCT00613509|58707749|FG001|Cycle 1|Disease Progression|6|||
30693735|NCT00613509|58707748|FG000|Cycle 1|Unacceptable Toxicity|1|||
30693736|NCT00613509|58707749|FG001|Cycle 1|Unacceptable Toxicity|0|||
30693737|NCT00613509|58707748|FG000|Cycle 1|Other administrative reason|0|||
30693738|NCT00613509|58707749|FG001|Cycle 1|Other administrative reason|1|||
30693739|NCT00547300|58707774|FG000|Overall Study|Study was Administratively Terminated|25|||
30693740|NCT00547300|58707775|FG001|Overall Study|Study was Administratively Terminated|24|||
30693741|NCT00547300|58707774|FG000|Overall Study|Did not Meet Entry Criteria|0|||
30693742|NCT00547300|58707775|FG001|Overall Study|Did not Meet Entry Criteria|2|||
30693743|NCT00612807|58707783|FG000|Overall Study|Withdrawal by Subject|2|||
30693744|NCT00612807|58707784|FG001|Overall Study|Withdrawal by Subject|0|||
30693745|NCT00678210|58707794|FG000|Overall Study|Adverse Event|1|||
30693746|NCT00678210|58707795|FG001|Overall Study|Adverse Event|2|||
30693747|NCT00678210|58707796|FG002|Overall Study|Adverse Event|3|||
30693748|NCT00678210|58707797|FG003|Overall Study|Adverse Event|3|||
30693749|NCT00678210|58707794|FG000|Overall Study|Lack of Efficacy|2|||
30693750|NCT00678210|58707795|FG001|Overall Study|Lack of Efficacy|3|||
30693751|NCT00678210|58707796|FG002|Overall Study|Lack of Efficacy|1|||
30693752|NCT00678210|58707797|FG003|Overall Study|Lack of Efficacy|9|||
30693753|NCT00678210|58707794|FG000|Overall Study|Lost to Follow-up|4|||
30693754|NCT00678210|58707795|FG001|Overall Study|Lost to Follow-up|2|||
30693755|NCT00678210|58707796|FG002|Overall Study|Lost to Follow-up|0|||
30693756|NCT00678210|58707797|FG003|Overall Study|Lost to Follow-up|1|||
30693757|NCT00678210|58707794|FG000|Overall Study|Withdrawal by Subject|3|||
30693758|NCT00678210|58707795|FG001|Overall Study|Withdrawal by Subject|4|||
30693759|NCT00678210|58707796|FG002|Overall Study|Withdrawal by Subject|1|||
30693760|NCT00678210|58707797|FG003|Overall Study|Withdrawal by Subject|7|||
30693761|NCT00678210|58707794|FG000|Overall Study|Other|1|||
30693762|NCT00678210|58707795|FG001|Overall Study|Other|0|||
30693763|NCT00678210|58707796|FG002|Overall Study|Other|1|||
30693764|NCT00678210|58707797|FG003|Overall Study|Other|0|||
30693765|NCT00611715|58707809|FG000|Overall Study|Disease Progression|24|||
30693766|NCT00611715|58707810|FG001|Overall Study|Disease Progression|4|||
30693767|NCT00611715|58707809|FG000|Overall Study|Withdrawal by Subject|5|||
30693768|NCT00611715|58707810|FG001|Overall Study|Withdrawal by Subject|1|||
30693769|NCT00611715|58707809|FG000|Overall Study|Adverse Event|9|||
30693770|NCT00611715|58707810|FG001|Overall Study|Adverse Event|1|||
30693771|NCT00611715|58707809|FG000|Overall Study|Death|1|||
30693772|NCT00611715|58707810|FG001|Overall Study|Death|0|||
30693773|NCT00611715|58707809|FG000|Overall Study|two patients are still on treatment|2|||
30693774|NCT00611715|58707810|FG001|Overall Study|two patients are still on treatment|0|||
30693775|NCT00677820|58707824|FG000|Overall Study|Lost to Follow-up|1|||
30693776|NCT00677820|58707825|FG001|Overall Study|Lost to Follow-up|0|||
30693777|NCT00611559|58707834|FG000|Overall Study|Lost to Follow-up|0|||
30693778|NCT00611559|58707835|FG001|Overall Study|Lost to Follow-up|1|||
30693779|NCT00611559|58707836|FG002|Overall Study|Lost to Follow-up|0|||
30693780|NCT00611559|58707834|FG000|Overall Study|Protocol Violation|1|||
30693781|NCT00611559|58707835|FG001|Overall Study|Protocol Violation|0|||
30693782|NCT00611559|58707836|FG002|Overall Study|Protocol Violation|1|||
30693783|NCT00611247|58707846|FG000|Overall Study|Death|1|||
30693784|NCT00611247|58707847|FG001|Overall Study|Death|5|||
30693785|NCT00611247|58707846|FG000|Overall Study|Lack of Efficacy|1|||
30693786|NCT00611247|58707847|FG001|Overall Study|Lack of Efficacy|16|||
30693787|NCT00675948|58707856|FG000|Overall Study|Adverse Event|23|||
30693788|NCT00675948|58707857|FG001|Overall Study|Adverse Event|1|||
30693789|NCT00675948|58707856|FG000|Overall Study|Lack of Efficacy|3|||
30693790|NCT00675948|58707857|FG001|Overall Study|Lack of Efficacy|0|||
30693791|NCT00675948|58707856|FG000|Overall Study|Withdrawal by Subject|7|||
30693792|NCT00675948|58707857|FG001|Overall Study|Withdrawal by Subject|0|||
30693793|NCT00675948|58707856|FG000|Overall Study|Lost to Follow-up|2|||
30693794|NCT00675948|58707857|FG001|Overall Study|Lost to Follow-up|0|||
30693795|NCT00675948|58707856|FG000|Overall Study|Protocol Violation|1|||
30693796|NCT00675948|58707857|FG001|Overall Study|Protocol Violation|0|||
30693797|NCT00675948|58707856|FG000|Overall Study|Pain under control|1|||
30693798|NCT00675948|58707857|FG001|Overall Study|Pain under control|0|||
30693799|NCT00675948|58707856|FG000|Overall Study|Sponsor decision|0|||
30693800|NCT00675948|58707857|FG001|Overall Study|Sponsor decision|1|||
30693801|NCT00675948|58707856|FG000|Overall Study|Patient died|1|||
30693802|NCT00675948|58707857|FG001|Overall Study|Patient died|0|||
30693803|NCT00675948|58707856|FG000|Overall Study|Patient unable to comply with diaries|1|||
30693804|NCT00675948|58707857|FG001|Overall Study|Patient unable to comply with diaries|0|||
30693805|NCT00675948|58707856|FG000|Overall Study|Patient feels unable to take medication|0|||
30693806|NCT00675948|58707857|FG001|Overall Study|Patient feels unable to take medication|1|||
30693807|NCT00610935|58707866|FG000|Overall Study|Lost to Follow-up|0|||
30693808|NCT00610935|58707867|FG001|Overall Study|Lost to Follow-up|1|||
30693809|NCT00610935|58707866|FG000|Overall Study|Withdrawal by Subject|0|||
30693810|NCT00610935|58707867|FG001|Overall Study|Withdrawal by Subject|2|||
30693811|NCT00610935|58707866|FG000|Overall Study|Sponsor Discontinuation|1|||
30693812|NCT00610935|58707867|FG001|Overall Study|Sponsor Discontinuation|0|||
30693813|NCT00610857|58707882|FG000|Overall Study|Not evaluable for response|2|||
30693814|NCT00672984|58707889|FG000|First Intervention|Adverse Event|5|||
30693815|NCT00672984|58707890|FG001|First Intervention|Adverse Event|0|||
30693816|NCT00672984|58707891|FG002|First Intervention|Adverse Event|0|||
30693817|NCT00672984|58707889|FG000|First Intervention|Withdrawal by Subject|1|||
30693818|NCT00672984|58707890|FG001|First Intervention|Withdrawal by Subject|2|||
30693819|NCT00672984|58707891|FG002|First Intervention|Withdrawal by Subject|2|||
30693820|NCT00672984|58707889|FG000|First Intervention|Sponsor decision|3|||
30693821|NCT00672984|58707890|FG001|First Intervention|Sponsor decision|0|||
30693822|NCT00672984|58707891|FG002|First Intervention|Sponsor decision|0|||
30693823|NCT00672984|58707889|FG000|Second Intervention|Non-compliance with facility policies|0|||
30693824|NCT00672984|58707890|FG001|Second Intervention|Non-compliance with facility policies|2|||
30693825|NCT00672984|58707891|FG002|Second Intervention|Non-compliance with facility policies|0|||
30693826|NCT00672984|58707889|FG000|Second Intervention|Withdrawal by Subject|0|||
30693827|NCT00672984|58707890|FG001|Second Intervention|Withdrawal by Subject|3|||
30693828|NCT00672984|58707891|FG002|Second Intervention|Withdrawal by Subject|0|||
30693829|NCT00672984|58707889|FG000|Second Intervention|Protocol Violation|0|||
30693830|NCT00672984|58707890|FG001|Second Intervention|Protocol Violation|1|||
30693831|NCT00672984|58707891|FG002|Second Intervention|Protocol Violation|1|||
30693832|NCT00672984|58707889|FG000|Third Intervention|Adverse Event|1|||
30693833|NCT00672984|58707890|FG001|Third Intervention|Adverse Event|0|||
30693834|NCT00672984|58707891|FG002|Third Intervention|Adverse Event|1|||
30693835|NCT00546364|58707904|FG000|Overall Study|Disease progression|5|||
30693836|NCT00546364|58707905|FG001|Overall Study|Disease progression|11|||
30693837|NCT00546364|58707906|FG002|Overall Study|Disease progression|8|||
30693838|NCT00546364|58707904|FG000|Overall Study|Completed and off treatment|1|||
30693839|NCT00546364|58707905|FG001|Overall Study|Completed and off treatment|0|||
30693840|NCT00546364|58707906|FG002|Overall Study|Completed and off treatment|2|||
30602103|NCT01077076|58613362|FG001|Third Intervention|Death in the participant's family|0|||
30602104|NCT01077076|58613363|FG002|Third Intervention|Death in the participant's family|0|||
30602105|NCT01077076|58613364|FG003|Third Intervention|Death in the participant's family|0|||
30602106|NCT01077076|58613365|FG004|Third Intervention|Death in the participant's family|0|||
30602107|NCT01077076|58613366|FG005|Third Intervention|Death in the participant's family|1|||
30602108|NCT01294800|58613378|FG000|Overall Study|Adverse Event|7|||
30602109|NCT01294800|58613379|FG001|Overall Study|Adverse Event|6|||
30602110|NCT01294800|58613380|FG002|Overall Study|Adverse Event|12|||
30602111|NCT01294800|58613381|FG003|Overall Study|Adverse Event|5|||
30602112|NCT01294800|58613378|FG000|Overall Study|Subject Withdrew Consent|2|||
30602113|NCT01294800|58613379|FG001|Overall Study|Subject Withdrew Consent|2|||
30602114|NCT01294800|58613380|FG002|Overall Study|Subject Withdrew Consent|2|||
30602115|NCT01294800|58613381|FG003|Overall Study|Subject Withdrew Consent|11|||
30602116|NCT01294800|58613378|FG000|Overall Study|Lost to Follow-up|0|||
30602117|NCT01294800|58613379|FG001|Overall Study|Lost to Follow-up|0|||
30602118|NCT01294800|58613380|FG002|Overall Study|Lost to Follow-up|1|||
30602119|NCT01294800|58613381|FG003|Overall Study|Lost to Follow-up|0|||
30602120|NCT01294800|58613378|FG000|Overall Study|Non-compliance With Protocol|0|||
30602121|NCT01294800|58613379|FG001|Overall Study|Non-compliance With Protocol|1|||
30602122|NCT01294800|58613380|FG002|Overall Study|Non-compliance With Protocol|1|||
30602123|NCT01294800|58613381|FG003|Overall Study|Non-compliance With Protocol|0|||
30602124|NCT01294800|58613378|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
30602125|NCT01294800|58613379|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
30602126|NCT01294800|58613380|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
30602127|NCT01294800|58613381|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
30602128|NCT01294644|58613394|FG000|Overall Study|Adverse Event|2|||
30602129|NCT01294644|58613395|FG001|Overall Study|Adverse Event|0|||
30602130|NCT01294644|58613396|FG002|Overall Study|Adverse Event|1|||
30602131|NCT01294644|58613394|FG000|Overall Study|Withdrawal by Subject|3|||
30693841|NCT00546364|58707904|FG000|Overall Study|Administrative reason by sponsor|1|||
30693842|NCT00546364|58707905|FG001|Overall Study|Administrative reason by sponsor|0|||
30865263|NCT02712905|58895664|FG006|Monotherapy|Lost to Follow-up|0|||
30602132|NCT01294644|58613395|FG001|Overall Study|Withdrawal by Subject|7|||
30602133|NCT01294644|58613396|FG002|Overall Study|Withdrawal by Subject|4|||
30693843|NCT00546364|58707906|FG002|Overall Study|Administrative reason by sponsor|0|||
30693844|NCT00546364|58707904|FG000|Overall Study|Poor compliance/noncompliance|0|||
30693845|NCT00546364|58707905|FG001|Overall Study|Poor compliance/noncompliance|0|||
30693846|NCT00546364|58707906|FG002|Overall Study|Poor compliance/noncompliance|1|||
30693847|NCT00546364|58707904|FG000|Overall Study|No longer meets study criteria|1|||
30693848|NCT00546364|58707905|FG001|Overall Study|No longer meets study criteria|1|||
30786571|NCT01367158|58799765|FG010|Overall Study|Protocol Violation|0|||
30865264|NCT02712905|58895665|FG007|Monotherapy|Lost to Follow-up|0|||
30693849|NCT00546364|58707906|FG002|Overall Study|No longer meets study criteria|0|||
30693850|NCT00546364|58707904|FG000|Overall Study|Withdrawal by Subject|5|||
30693851|NCT00546364|58707905|FG001|Overall Study|Withdrawal by Subject|6|||
30693852|NCT00546364|58707906|FG002|Overall Study|Withdrawal by Subject|3|||
30693853|NCT00546364|58707904|FG000|Overall Study|Prior taxotere|1|||
30693854|NCT00546364|58707905|FG001|Overall Study|Prior taxotere|0|||
30693855|NCT00546364|58707906|FG002|Overall Study|Prior taxotere|0|||
30693856|NCT00546364|58707904|FG000|Overall Study|Mixed response|1|||
30693857|NCT00546364|58707905|FG001|Overall Study|Mixed response|0|||
30693858|NCT00546364|58707906|FG002|Overall Study|Mixed response|0|||
30693859|NCT00546364|58707904|FG000|Overall Study|Palliative treatment|1|||
30693860|NCT00546364|58707905|FG001|Overall Study|Palliative treatment|0|||
30693861|NCT00546364|58707906|FG002|Overall Study|Palliative treatment|1|||
30693862|NCT00546364|58707904|FG000|Overall Study|Target lesions resected|1|||
30693863|NCT00546364|58707905|FG001|Overall Study|Target lesions resected|0|||
30693864|NCT00546364|58707906|FG002|Overall Study|Target lesions resected|0|||
30693865|NCT00546364|58707904|FG000|Overall Study|Physician Decision|0|||
30693866|NCT00546364|58707905|FG001|Overall Study|Physician Decision|0|||
30693867|NCT00546364|58707906|FG002|Overall Study|Physician Decision|1|||
30693868|NCT00546364|58707904|FG000|Overall Study|Sponsor decision|0|||
30693869|NCT00546364|58707905|FG001|Overall Study|Sponsor decision|0|||
30693870|NCT00546364|58707906|FG002|Overall Study|Sponsor decision|1|||
30693871|NCT05020327|58707936|FG000|Overall Study|Physician Decision|3|||
30693872|NCT05020327|58707937|FG001|Overall Study|Physician Decision|0|||
30693873|NCT05020327|58707938|FG002|Overall Study|Physician Decision|0|||
30693874|NCT05020327|58707936|FG000|Overall Study|Withdrawal by Subject|1|||
30693875|NCT05020327|58707937|FG001|Overall Study|Withdrawal by Subject|1|||
30693876|NCT05020327|58707938|FG002|Overall Study|Withdrawal by Subject|0|||
30693877|NCT05020327|58707936|FG000|Overall Study|personal/cultural, ineligible|12|||
30693878|NCT05020327|58707937|FG001|Overall Study|personal/cultural, ineligible|0|||
30693879|NCT05020327|58707938|FG002|Overall Study|personal/cultural, ineligible|0|||
30693880|NCT04907032|58707952|FG000|Overall Study|Withdrawal by Subject|7|||
30693881|NCT04907032|58707953|FG001|Overall Study|Withdrawal by Subject|1|||
30693882|NCT04739709|58707974|FG000|Overall Study|Physician Decision|1|||
30693883|NCT04739709|58707975|FG001|Overall Study|Physician Decision|0|||
30693884|NCT04710927|58707992|FG000|Overall Study|Lost to Follow-up|7|||
30693885|NCT04710927|58707993|FG001|Overall Study|Lost to Follow-up|6|||
30693886|NCT04710927|58707994|FG002|Overall Study|Lost to Follow-up|5|||
30693887|NCT04657666|58708005|FG000|Period 1|Withdrawal of participant consent|2|||
30693888|NCT04657666|58708006|FG001|Period 1|Withdrawal of participant consent|1|||
30693889|NCT04657666|58708005|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
30693890|NCT04657666|58708006|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
30693891|NCT04657666|58708005|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
30693892|NCT04657666|58708006|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
30693893|NCT04657666|58708005|FG000|Period 2|Other|2|||
30693894|NCT04657666|58708006|FG001|Period 2|Other|0|||
30693895|NCT04657666|58708005|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
30693896|NCT04657666|58708006|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
30693897|NCT04495829|58708025|FG000|Overall Study|Lost to Follow-up|2|||
30693898|NCT04495829|58708025|FG000|Overall Study|Inclusion criterion not met|3|||
30865265|NCT02712905|58895666|FG008|Monotherapy|Lost to Follow-up|0|||
30865266|NCT02712905|58895667|FG009|Monotherapy|Lost to Follow-up|2|||
30865267|NCT02712905|58895668|FG010|Monotherapy|Lost to Follow-up|0|||
30865268|NCT02712905|58895669|FG011|Monotherapy|Lost to Follow-up|0|||
30865269|NCT02712905|58895670|FG012|Monotherapy|Lost to Follow-up|0|||
30693899|NCT04101721|58708040|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
30693900|NCT04101721|58708041|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
30865270|NCT02712905|58895671|FG013|Monotherapy|Lost to Follow-up|0|||
30865271|NCT02712905|58895672|FG014|Monotherapy|Lost to Follow-up|0|||
30865272|NCT02712905|58895673|FG015|Monotherapy|Lost to Follow-up|0|||
30865273|NCT02712905|58895674|FG016|Monotherapy|Lost to Follow-up|0|||
30865274|NCT02712905|58895675|FG017|Monotherapy|Lost to Follow-up|0|||
30865275|NCT02712905|58895658|FG000|Monotherapy|Physician Decision|1|||
30693901|NCT04101721|58708040|FG000|Overall Study|Death|0|||
30693902|NCT04101721|58708041|FG001|Overall Study|Death|1|||
30693903|NCT04101721|58708040|FG000|Overall Study|Lost to Follow-up|0|||
30693904|NCT04101721|58708041|FG001|Overall Study|Lost to Follow-up|3|||
30693905|NCT03864926|58708049|FG000|Overall Study|Death|0|||
30693906|NCT03864926|58708050|FG001|Overall Study|Death|2|||
30693907|NCT03623243|58708065|FG000|Overall Study|Adverse Event|15|||
30693908|NCT03623243|58708065|FG000|Overall Study|Guardian Decision|1|||
30693909|NCT03623243|58708065|FG000|Overall Study|New Therapy for Study Indication|1|||
30693910|NCT03623243|58708065|FG000|Overall Study|Protocol Deviation|3|||
30865276|NCT02712905|58895659|FG001|Monotherapy|Physician Decision|0|||
30865277|NCT02712905|58895660|FG002|Monotherapy|Physician Decision|0|||
30693911|NCT03623243|58708065|FG000|Overall Study|Physician Decision|4|||
30865278|NCT02712905|58895661|FG003|Monotherapy|Physician Decision|1|||
30693912|NCT03623243|58708065|FG000|Overall Study|Patient Decision|15|||
30693913|NCT03258853|58708071|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
30693914|NCT03258853|58708072|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
30693915|NCT03089606|58708113|FG000|Overall Study|Progression after Cycle 1|1|||
30693916|NCT03006848|58708145|FG000|Overall Study|Adverse Event|1|||
30693917|NCT03006848|58708145|FG000|Overall Study|Physician Decision|1|||
30693918|NCT03006848|58708145|FG000|Overall Study|Lack of Efficacy|16|||
30693919|NCT02828358|58708185|FG000|Overall Study|Physician Decision|7|||
30693920|NCT02828358|58708186|FG001|Overall Study|Physician Decision|1|||
30693921|NCT02828358|58708185|FG000|Overall Study|Treatment Failure|6|||
30693922|NCT02828358|58708186|FG001|Overall Study|Treatment Failure|0|||
30693923|NCT02828358|58708185|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
30693924|NCT02828358|58708186|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
30693925|NCT02828358|58708185|FG000|Overall Study|Refusal of further protocol therapy|2|||
30693926|NCT02828358|58708186|FG001|Overall Study|Refusal of further protocol therapy|0|||
30693927|NCT02828358|58708185|FG000|Overall Study|Relapse|25|||
30693928|NCT02828358|58708186|FG001|Overall Study|Relapse|0|||
30693929|NCT02828358|58708185|FG000|Overall Study|Still on therapy|5|||
30693930|NCT02828358|58708186|FG001|Overall Study|Still on therapy|0|||
30693931|NCT02810444|58708191|FG000|Overall Study|Screen Failures|14|||
30693932|NCT02810444|58708191|FG000|Overall Study|Withdrawal by Subject|4|||
30693933|NCT02810444|58708191|FG000|Overall Study|Adverse Event|3|||
30693934|NCT02501096|58708217|FG000|Overall Study|Lost to Follow-up|0|||
30693935|NCT02501096|58708218|FG001|Overall Study|Lost to Follow-up|0|||
30693936|NCT02501096|58708219|FG002|Overall Study|Lost to Follow-up|0|||
30693937|NCT02501096|58708220|FG003|Overall Study|Lost to Follow-up|0|||
30693938|NCT02501096|58708221|FG004|Overall Study|Lost to Follow-up|1|||
30693939|NCT02501096|58708222|FG005|Overall Study|Lost to Follow-up|1|||
30693940|NCT02501096|58708223|FG006|Overall Study|Lost to Follow-up|3|||
30693941|NCT02501096|58708224|FG007|Overall Study|Lost to Follow-up|0|||
30693942|NCT02501096|58708225|FG008|Overall Study|Lost to Follow-up|0|||
30693943|NCT02501096|58708217|FG000|Overall Study|Withdrawal by Subject|1|||
30693944|NCT02501096|58708218|FG001|Overall Study|Withdrawal by Subject|0|||
30693945|NCT02501096|58708219|FG002|Overall Study|Withdrawal by Subject|7|||
30693946|NCT02501096|58708220|FG003|Overall Study|Withdrawal by Subject|13|||
30693947|NCT02501096|58708221|FG004|Overall Study|Withdrawal by Subject|2|||
30693948|NCT02501096|58708222|FG005|Overall Study|Withdrawal by Subject|2|||
30693949|NCT02501096|58708223|FG006|Overall Study|Withdrawal by Subject|2|||
30693950|NCT02501096|58708224|FG007|Overall Study|Withdrawal by Subject|3|||
30693951|NCT02501096|58708225|FG008|Overall Study|Withdrawal by Subject|0|||
30693952|NCT02501096|58708217|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
30693953|NCT02501096|58708218|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
30693954|NCT02501096|58708219|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
30693955|NCT02501096|58708220|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
30693956|NCT02501096|58708221|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
30693957|NCT02501096|58708222|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
30693958|NCT02501096|58708223|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
30693959|NCT02501096|58708224|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
30693960|NCT02501096|58708225|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
30693961|NCT02501096|58708217|FG000|Overall Study|Death|1|||
30693962|NCT02501096|58708218|FG001|Overall Study|Death|1|||
30693963|NCT02501096|58708219|FG002|Overall Study|Death|88|||
30693964|NCT02501096|58708220|FG003|Overall Study|Death|74|||
30693965|NCT02501096|58708221|FG004|Overall Study|Death|15|||
30693966|NCT02501096|58708222|FG005|Overall Study|Death|16|||
30693967|NCT02501096|58708223|FG006|Overall Study|Death|15|||
30693968|NCT02501096|58708224|FG007|Overall Study|Death|16|||
30693969|NCT02501096|58708225|FG008|Overall Study|Death|1|||
30693970|NCT01991977|58708257|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
30693971|NCT01991977|58708257|FG000|Overall Study|Withdrew after start of treatment|5|||
30693972|NCT01633541|58708263|FG000|Overall Study|Death|1|||
30693973|NCT01633541|58708264|FG001|Overall Study|Death|0|||
30693974|NCT01466036|58708274|FG000|Overall Study|Death|1|||
30693975|NCT01466036|58708275|FG001|Overall Study|Death|1|||
30865279|NCT02712905|58895662|FG004|Monotherapy|Physician Decision|0|||
30693976|NCT01466036|58708274|FG000|Overall Study|Physician Decision|0|||
30693977|NCT01466036|58708275|FG001|Overall Study|Physician Decision|4|||
30693978|NCT01466036|58708274|FG000|Overall Study|Adverse Event|2|||
30693979|NCT01466036|58708275|FG001|Overall Study|Adverse Event|6|||
30693980|NCT01466036|58708274|FG000|Overall Study|Withdrawal by Subject|2|||
30693981|NCT01466036|58708275|FG001|Overall Study|Withdrawal by Subject|8|||
30693982|NCT01466036|58708274|FG000|Overall Study|progression/relapse|14|||
30693983|NCT01466036|58708275|FG001|Overall Study|progression/relapse|21|||
30693984|NCT01466036|58708274|FG000|Overall Study|prolonged treatment delay|1|||
30693985|NCT01466036|58708275|FG001|Overall Study|prolonged treatment delay|1|||
30693986|NCT01399372|58708284|FG000|Overall Study|Protocol Violation|3|||
30693987|NCT01399372|58708285|FG001|Overall Study|Protocol Violation|1|||
30693988|NCT01063517|58708293|FG000|Overall Study|Consent withdrawal|1|||
30693989|NCT01063517|58708294|FG001|Overall Study|Consent withdrawal|0|||
30693990|NCT01063517|58708293|FG000|Overall Study|Study reached data cut-off|19|||
30693991|NCT01063517|58708294|FG001|Overall Study|Study reached data cut-off|7|||
30693992|NCT01063517|58708293|FG000|Overall Study|Lost to Follow-up|4|||
30693993|NCT01063517|58708294|FG001|Overall Study|Lost to Follow-up|3|||
30693994|NCT01063517|58708293|FG000|Overall Study|Withdrawal by Subject|1|||
30693995|NCT01063517|58708294|FG001|Overall Study|Withdrawal by Subject|2|||
30693996|NCT01063517|58708293|FG000|Overall Study|Death|33|||
30693997|NCT01063517|58708294|FG001|Overall Study|Death|48|||
30693998|NCT00920621|58708304|FG000|Overall Study|Lost to Follow-up|16|||
30693999|NCT00920621|58708305|FG001|Overall Study|Lost to Follow-up|17|||
30694000|NCT00920621|58708306|FG002|Overall Study|Lost to Follow-up|19|||
30694001|NCT00920621|58708307|FG003|Overall Study|Lost to Follow-up|21|||
30694002|NCT00920621|58708304|FG000|Overall Study|Fetal/neonatal deaths|16|||
30694003|NCT00920621|58708305|FG001|Overall Study|Fetal/neonatal deaths|14|||
30694004|NCT00920621|58708306|FG002|Overall Study|Fetal/neonatal deaths|16|||
30694005|NCT00920621|58708307|FG003|Overall Study|Fetal/neonatal deaths|14|||
30694006|NCT00920621|58708304|FG000|Overall Study|Blood sample not collected|22|||
30694007|NCT00920621|58708305|FG001|Overall Study|Blood sample not collected|14|||
30694008|NCT00920621|58708306|FG002|Overall Study|Blood sample not collected|0|||
30694009|NCT00920621|58708307|FG003|Overall Study|Blood sample not collected|0|||
30694010|NCT00612105|58708320|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
30694011|NCT00612105|58708321|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
30694012|NCT00612105|58708320|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
30694013|NCT00612105|58708321|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
30694014|NCT00612105|58708320|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
30694015|NCT00612105|58708321|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
30694016|NCT00612105|58708320|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
30694017|NCT00612105|58708321|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
30694018|NCT00612105|58708320|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
30694019|NCT00612105|58708321|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
30694020|NCT00612105|58708320|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
30694021|NCT00612105|58708321|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
30694022|NCT00612105|58708320|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
30694023|NCT00612105|58708321|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
30694024|NCT00612105|58708320|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
30694025|NCT00612105|58708321|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
30694026|NCT00612105|58708320|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
30694027|NCT00612105|58708321|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
30694028|NCT00612105|58708320|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
30694029|NCT00612105|58708321|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
30694030|NCT00612105|58708320|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
30694031|NCT00612105|58708321|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
30694032|NCT00612105|58708320|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
30694033|NCT00612105|58708321|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
30694034|NCT00546052|58708327|FG000|Overall Study|Adverse Event|47|||
30694035|NCT00546052|58708327|FG000|Overall Study|Lost to Follow-up|144|||
30694036|NCT00546052|58708327|FG000|Overall Study|Protocol Violation|9|||
30694037|NCT00546052|58708327|FG000|Overall Study|Withdrawal by Subject|20|||
30694038|NCT00546052|58708327|FG000|Overall Study|Non Compliance|7|||
30694039|NCT00673920|58708342|FG000|Baseline up to Week 48|Withdrew consent|1|||
30694040|NCT00673920|58708343|FG001|Baseline up to Week 48|Withdrew consent|0|||
30694041|NCT00673920|58708344|FG002|Baseline up to Week 48|Withdrew consent|2|||
30694042|NCT00673920|58708345|FG003|Baseline up to Week 48|Withdrew consent|0|||
30694043|NCT00673920|58708346|FG004|Baseline up to Week 48|Withdrew consent|0|||
30694044|NCT00673920|58708347|FG005|Baseline up to Week 48|Withdrew consent|0|||
30694045|NCT00673920|58708348|FG006|Baseline up to Week 48|Withdrew consent|0|||
30694046|NCT00673920|58708349|FG007|Baseline up to Week 48|Withdrew consent|0|||
30694047|NCT00673920|58708342|FG000|Baseline up to Week 48|Refused treatment|1|||
30694048|NCT00673920|58708343|FG001|Baseline up to Week 48|Refused treatment|0|||
30694049|NCT00673920|58708344|FG002|Baseline up to Week 48|Refused treatment|0|||
30694050|NCT00673920|58708345|FG003|Baseline up to Week 48|Refused treatment|0|||
30694051|NCT00673920|58708346|FG004|Baseline up to Week 48|Refused treatment|0|||
30694052|NCT00673920|58708347|FG005|Baseline up to Week 48|Refused treatment|0|||
30694053|NCT00673920|58708348|FG006|Baseline up to Week 48|Refused treatment|0|||
30694054|NCT00673920|58708349|FG007|Baseline up to Week 48|Refused treatment|0|||
30694055|NCT00673920|58708342|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
30694056|NCT00673920|58708343|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
30865280|NCT02712905|58895663|FG005|Monotherapy|Physician Decision|0|||
30865281|NCT02712905|58895664|FG006|Monotherapy|Physician Decision|0|||
30865282|NCT02712905|58895665|FG007|Monotherapy|Physician Decision|0|||
30694057|NCT00673920|58708344|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
30602134|NCT01294644|58613394|FG000|Overall Study|Lost to Follow-up|3|||
30602135|NCT01294644|58613395|FG001|Overall Study|Lost to Follow-up|2|||
30602136|NCT01294644|58613396|FG002|Overall Study|Lost to Follow-up|5|||
30602137|NCT01294644|58613394|FG000|Overall Study|Miscellaneous Reason|2|||
30602138|NCT01294644|58613395|FG001|Overall Study|Miscellaneous Reason|1|||
30602139|NCT01294644|58613396|FG002|Overall Study|Miscellaneous Reason|4|||
30602140|NCT01293240|58613404|FG000|Overall Study|Noncompliance|2|||
30694058|NCT00673920|58708345|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
30694059|NCT00673920|58708346|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
30694060|NCT00673920|58708347|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
30694061|NCT00673920|58708348|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
30694062|NCT00673920|58708349|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
30694063|NCT00673920|58708342|FG000|Baseline up to Week 48|Protocol Violation|0|||
30694064|NCT00673920|58708343|FG001|Baseline up to Week 48|Protocol Violation|0|||
30694065|NCT00673920|58708344|FG002|Baseline up to Week 48|Protocol Violation|1|||
30694066|NCT00673920|58708345|FG003|Baseline up to Week 48|Protocol Violation|0|||
30694067|NCT00673920|58708346|FG004|Baseline up to Week 48|Protocol Violation|0|||
30694068|NCT00673920|58708347|FG005|Baseline up to Week 48|Protocol Violation|0|||
30694069|NCT00673920|58708348|FG006|Baseline up to Week 48|Protocol Violation|0|||
30694070|NCT00673920|58708349|FG007|Baseline up to Week 48|Protocol Violation|0|||
30694071|NCT00673920|58708342|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
30694072|NCT00673920|58708343|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
30694073|NCT00673920|58708344|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
30694074|NCT00673920|58708345|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
30694075|NCT00673920|58708346|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
30694076|NCT00673920|58708347|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
30694077|NCT00673920|58708348|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
30694078|NCT00673920|58708349|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
30694079|NCT00673920|58708342|FG000|Baseline up to Week 48|Administrative/Other|0|||
30694080|NCT00673920|58708343|FG001|Baseline up to Week 48|Administrative/Other|1|||
30694081|NCT00673920|58708344|FG002|Baseline up to Week 48|Administrative/Other|2|||
30694082|NCT00673920|58708345|FG003|Baseline up to Week 48|Administrative/Other|0|||
30694083|NCT00673920|58708346|FG004|Baseline up to Week 48|Administrative/Other|0|||
30694084|NCT00673920|58708347|FG005|Baseline up to Week 48|Administrative/Other|0|||
30694085|NCT00673920|58708348|FG006|Baseline up to Week 48|Administrative/Other|0|||
30694086|NCT00673920|58708349|FG007|Baseline up to Week 48|Administrative/Other|0|||
30694087|NCT00673920|58708342|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
30694088|NCT00673920|58708343|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
30694089|NCT00673920|58708344|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
30694090|NCT00673920|58708345|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
30694091|NCT00673920|58708346|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
30694092|NCT00673920|58708347|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
30694093|NCT00673920|58708348|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
30694094|NCT00673920|58708349|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
30694095|NCT00673920|58708342|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
30865283|NCT02712905|58895666|FG008|Monotherapy|Physician Decision|0|||
30865284|NCT02712905|58895667|FG009|Monotherapy|Physician Decision|1|||
30865285|NCT02712905|58895668|FG010|Monotherapy|Physician Decision|0|||
30865286|NCT02712905|58895669|FG011|Monotherapy|Physician Decision|0|||
30865287|NCT02712905|58895670|FG012|Monotherapy|Physician Decision|0|||
30865288|NCT02712905|58895671|FG013|Monotherapy|Physician Decision|0|||
30865289|NCT02712905|58895672|FG014|Monotherapy|Physician Decision|0|||
30865290|NCT02712905|58895673|FG015|Monotherapy|Physician Decision|0|||
30865291|NCT02712905|58895674|FG016|Monotherapy|Physician Decision|0|||
30865292|NCT02712905|58895675|FG017|Monotherapy|Physician Decision|0|||
30602141|NCT01253265|58613413|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
30602142|NCT01253265|58613414|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
30865293|NCT02712905|58895658|FG000|Monotherapy|Study Terminated by Sponsor|0|||
30865294|NCT02712905|58895659|FG001|Monotherapy|Study Terminated by Sponsor|0|||
30865295|NCT02712905|58895660|FG002|Monotherapy|Study Terminated by Sponsor|0|||
30865296|NCT02712905|58895661|FG003|Monotherapy|Study Terminated by Sponsor|0|||
30865297|NCT02712905|58895662|FG004|Monotherapy|Study Terminated by Sponsor|1|||
30865298|NCT02712905|58895663|FG005|Monotherapy|Study Terminated by Sponsor|0|||
30865299|NCT02712905|58895664|FG006|Monotherapy|Study Terminated by Sponsor|0|||
30865300|NCT02712905|58895665|FG007|Monotherapy|Study Terminated by Sponsor|0|||
30865301|NCT02712905|58895666|FG008|Monotherapy|Study Terminated by Sponsor|0|||
30865302|NCT02712905|58895667|FG009|Monotherapy|Study Terminated by Sponsor|2|||
30865303|NCT02712905|58895668|FG010|Monotherapy|Study Terminated by Sponsor|0|||
30865304|NCT02712905|58895669|FG011|Monotherapy|Study Terminated by Sponsor|0|||
30865305|NCT02712905|58895670|FG012|Monotherapy|Study Terminated by Sponsor|0|||
30694096|NCT00673920|58708343|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
30694097|NCT00673920|58708344|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
30694098|NCT00673920|58708345|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
30694099|NCT00673920|58708346|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
30694100|NCT00673920|58708347|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
30694101|NCT00673920|58708348|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
30694102|NCT00673920|58708349|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
30694103|NCT00673920|58708342|FG000|Week 24 to Week 48|Failure to return|0|||
30694104|NCT00673920|58708343|FG001|Week 24 to Week 48|Failure to return|0|||
30694105|NCT00673920|58708344|FG002|Week 24 to Week 48|Failure to return|0|||
30694106|NCT00673920|58708345|FG003|Week 24 to Week 48|Failure to return|0|||
30694107|NCT00673920|58708346|FG004|Week 24 to Week 48|Failure to return|0|||
30694108|NCT00673920|58708347|FG005|Week 24 to Week 48|Failure to return|1|||
30694109|NCT00673920|58708348|FG006|Week 24 to Week 48|Failure to return|0|||
30694110|NCT00673920|58708349|FG007|Week 24 to Week 48|Failure to return|0|||
30694111|NCT00673920|58708342|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
30694112|NCT00673920|58708343|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
30694113|NCT00673920|58708344|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
30694114|NCT00673920|58708345|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
30694115|NCT00673920|58708346|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
30694116|NCT00673920|58708347|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
30694117|NCT00673920|58708348|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
30694118|NCT00673920|58708349|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
30865306|NCT02712905|58895671|FG013|Monotherapy|Study Terminated by Sponsor|0|||
30865307|NCT02712905|58895672|FG014|Monotherapy|Study Terminated by Sponsor|0|||
30865308|NCT02712905|58895673|FG015|Monotherapy|Study Terminated by Sponsor|0|||
30865309|NCT02712905|58895674|FG016|Monotherapy|Study Terminated by Sponsor|0|||
30602143|NCT01253265|58613415|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
30602144|NCT01253265|58613416|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
30602145|NCT01253265|58613417|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
30602146|NCT01253265|58613413|FG000|Overall Study|Withdrawal by Subject|0|||
30602147|NCT01253265|58613414|FG001|Overall Study|Withdrawal by Subject|0|||
30602148|NCT01253265|58613415|FG002|Overall Study|Withdrawal by Subject|0|||
30602149|NCT01253265|58613416|FG003|Overall Study|Withdrawal by Subject|0|||
30602150|NCT01253265|58613417|FG004|Overall Study|Withdrawal by Subject|1|||
30602151|NCT01293084|58613429|FG000|Overall Study|Physician Decision|3|||
30602152|NCT01293084|58613429|FG000|Overall Study|Withdrawal by Subject|2|||
30602153|NCT01293006|58613439|FG000|Period 2|Lost to Follow-up|1|||
30602154|NCT01293006|58613440|FG001|Period 2|Lost to Follow-up|0|||
30602155|NCT01293006|58613441|FG002|Period 2|Lost to Follow-up|0|||
30602156|NCT01293006|58613442|FG003|Period 2|Lost to Follow-up|0|||
30602157|NCT01253187|58613461|FG000|Period 2|Withdrawal by Subject|0|||
30602158|NCT01253187|58613462|FG001|Period 2|Withdrawal by Subject|0|||
30602159|NCT01253187|58613463|FG002|Period 2|Withdrawal by Subject|0|||
30602160|NCT01253187|58613464|FG003|Period 2|Withdrawal by Subject|0|||
30602161|NCT01253187|58613465|FG004|Period 2|Withdrawal by Subject|1|||
30602162|NCT01253187|58613466|FG005|Period 2|Withdrawal by Subject|0|||
30602163|NCT01253187|58613461|FG000|Period 3|Pregnancy|1|||
30602164|NCT01253187|58613462|FG001|Period 3|Pregnancy|0|||
30694119|NCT00673920|58708342|FG000|Week 24 to Week 48|Death|0|||
30865310|NCT02712905|58895675|FG017|Monotherapy|Study Terminated by Sponsor|0|||
30865311|NCT02712905|58895658|FG000|Monotherapy|Withdrawal by Subject|0|||
30865312|NCT02712905|58895659|FG001|Monotherapy|Withdrawal by Subject|0|||
30865313|NCT02712905|58895660|FG002|Monotherapy|Withdrawal by Subject|1|||
30865314|NCT02712905|58895661|FG003|Monotherapy|Withdrawal by Subject|0|||
30865315|NCT02712905|58895662|FG004|Monotherapy|Withdrawal by Subject|2|||
30865316|NCT02712905|58895663|FG005|Monotherapy|Withdrawal by Subject|0|||
30865317|NCT02712905|58895664|FG006|Monotherapy|Withdrawal by Subject|0|||
30865318|NCT02712905|58895665|FG007|Monotherapy|Withdrawal by Subject|0|||
30865319|NCT02712905|58895666|FG008|Monotherapy|Withdrawal by Subject|0|||
30865320|NCT02712905|58895667|FG009|Monotherapy|Withdrawal by Subject|4|||
30865321|NCT02712905|58895668|FG010|Monotherapy|Withdrawal by Subject|1|||
30865322|NCT02712905|58895669|FG011|Monotherapy|Withdrawal by Subject|2|||
30865323|NCT02712905|58895670|FG012|Monotherapy|Withdrawal by Subject|0|||
30865324|NCT02712905|58895671|FG013|Monotherapy|Withdrawal by Subject|0|||
30865325|NCT02712905|58895672|FG014|Monotherapy|Withdrawal by Subject|0|||
30865326|NCT02712905|58895673|FG015|Monotherapy|Withdrawal by Subject|0|||
30865327|NCT02712905|58895674|FG016|Monotherapy|Withdrawal by Subject|0|||
30865328|NCT02712905|58895675|FG017|Monotherapy|Withdrawal by Subject|0|||
30865329|NCT02712905|58895658|FG000|Monotherapy|Started New Cancer Drug|0|||
30865330|NCT02712905|58895659|FG001|Monotherapy|Started New Cancer Drug|0|||
30602165|NCT01253187|58613463|FG002|Period 3|Pregnancy|0|||
30602166|NCT01253187|58613464|FG003|Period 3|Pregnancy|0|||
30602167|NCT01253187|58613465|FG004|Period 3|Pregnancy|0|||
30602168|NCT01253187|58613466|FG005|Period 3|Pregnancy|0|||
30602169|NCT01253187|58613461|FG000|Period 3|difficulty with blood sampling|0|||
30694120|NCT00673920|58708343|FG001|Week 24 to Week 48|Death|0|||
30694121|NCT00673920|58708344|FG002|Week 24 to Week 48|Death|0|||
30694122|NCT00673920|58708345|FG003|Week 24 to Week 48|Death|0|||
30694123|NCT00673920|58708346|FG004|Week 24 to Week 48|Death|0|||
30694124|NCT00673920|58708347|FG005|Week 24 to Week 48|Death|1|||
30694125|NCT00673920|58708348|FG006|Week 24 to Week 48|Death|0|||
30694126|NCT00673920|58708349|FG007|Week 24 to Week 48|Death|0|||
30694127|NCT00673920|58708342|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
30694128|NCT00673920|58708343|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
30694129|NCT00673920|58708344|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
30694130|NCT00673920|58708345|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
30694131|NCT00673920|58708346|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
30694132|NCT00673920|58708347|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
30694133|NCT00673920|58708348|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
30694134|NCT00673920|58708349|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
30694135|NCT00379795|58708376|FG000|Overall Study|Death|31|||
30694136|NCT00379795|58708377|FG001|Overall Study|Death|8|||
30694137|NCT00379795|58708378|FG002|Overall Study|Death|6|||
30694138|NCT00379795|58708379|FG003|Overall Study|Death|4|||
30694139|NCT00379795|58708380|FG004|Overall Study|Death|7|||
30694140|NCT00379795|58708376|FG000|Overall Study|Adverse Event|17|||
30694141|NCT00379795|58708377|FG001|Overall Study|Adverse Event|3|||
30694142|NCT00379795|58708378|FG002|Overall Study|Adverse Event|3|||
30694143|NCT00379795|58708379|FG003|Overall Study|Adverse Event|1|||
30694144|NCT00379795|58708380|FG004|Overall Study|Adverse Event|4|||
30694145|NCT00379795|58708376|FG000|Overall Study|Lost to Follow-up|8|||
30694146|NCT00379795|58708377|FG001|Overall Study|Lost to Follow-up|1|||
30694147|NCT00379795|58708378|FG002|Overall Study|Lost to Follow-up|2|||
30694148|NCT00379795|58708379|FG003|Overall Study|Lost to Follow-up|1|||
30694149|NCT00379795|58708380|FG004|Overall Study|Lost to Follow-up|4|||
30694150|NCT00379795|58708376|FG000|Overall Study|Physician Decision|25|||
30694151|NCT00379795|58708377|FG001|Overall Study|Physician Decision|0|||
30694152|NCT00379795|58708378|FG002|Overall Study|Physician Decision|2|||
30694153|NCT00379795|58708379|FG003|Overall Study|Physician Decision|2|||
30694154|NCT00379795|58708380|FG004|Overall Study|Physician Decision|2|||
30694155|NCT00379795|58708376|FG000|Overall Study|Withdrawal by Subject|94|||
30694156|NCT00379795|58708377|FG001|Overall Study|Withdrawal by Subject|11|||
30694157|NCT00379795|58708378|FG002|Overall Study|Withdrawal by Subject|19|||
30694158|NCT00379795|58708379|FG003|Overall Study|Withdrawal by Subject|7|||
30694159|NCT00379795|58708380|FG004|Overall Study|Withdrawal by Subject|14|||
30694160|NCT00379795|58708376|FG000|Overall Study|Subject non-compliance|7|||
30694161|NCT00379795|58708377|FG001|Overall Study|Subject non-compliance|2|||
30694162|NCT00379795|58708378|FG002|Overall Study|Subject non-compliance|0|||
30694163|NCT00379795|58708379|FG003|Overall Study|Subject non-compliance|0|||
30694164|NCT00379795|58708380|FG004|Overall Study|Subject non-compliance|1|||
30694165|NCT00379795|58708376|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
30694166|NCT00379795|58708377|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
30694167|NCT00379795|58708378|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
30694168|NCT00379795|58708379|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
30694169|NCT00379795|58708380|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
30694170|NCT00379795|58708376|FG000|Overall Study|Subjects condition mandated intervention|34|||
30694171|NCT00379795|58708377|FG001|Overall Study|Subjects condition mandated intervention|9|||
30694172|NCT00379795|58708378|FG002|Overall Study|Subjects condition mandated intervention|7|||
30694173|NCT00379795|58708379|FG003|Overall Study|Subjects condition mandated intervention|5|||
30694174|NCT00379795|58708380|FG004|Overall Study|Subjects condition mandated intervention|7|||
30694175|NCT00379795|58708376|FG000|Overall Study|Sponsor's decision|257|||
30694176|NCT00379795|58708377|FG001|Overall Study|Sponsor's decision|17|||
30694177|NCT00379795|58708378|FG002|Overall Study|Sponsor's decision|54|||
30694178|NCT00379795|58708379|FG003|Overall Study|Sponsor's decision|47|||
30694179|NCT00379795|58708380|FG004|Overall Study|Sponsor's decision|10|||
30694180|NCT00610155|58708395|FG000|Period 1|Withdrawal by Subject|0|||
30694181|NCT00610155|58708396|FG001|Period 1|Withdrawal by Subject|0|||
30694182|NCT00610155|58708397|FG002|Period 1|Withdrawal by Subject|1|||
30865331|NCT02712905|58895660|FG002|Monotherapy|Started New Cancer Drug|0|||
30602170|NCT01253187|58613462|FG001|Period 3|difficulty with blood sampling|1|||
30694183|NCT00610155|58708398|FG003|Period 1|Withdrawal by Subject|0|||
30694184|NCT00610155|58708399|FG004|Period 1|Withdrawal by Subject|0|||
30694185|NCT00610155|58708400|FG005|Period 1|Withdrawal by Subject|0|||
30694186|NCT00610155|58708395|FG000|Period 3|Adverse Event|1|||
30694187|NCT00610155|58708396|FG001|Period 3|Adverse Event|0|||
30694188|NCT00610155|58708397|FG002|Period 3|Adverse Event|0|||
30694189|NCT00610155|58708398|FG003|Period 3|Adverse Event|0|||
30865332|NCT02712905|58895661|FG003|Monotherapy|Started New Cancer Drug|0|||
30865333|NCT02712905|58895662|FG004|Monotherapy|Started New Cancer Drug|0|||
30694190|NCT00610155|58708399|FG004|Period 3|Adverse Event|0|||
30694191|NCT00610155|58708400|FG005|Period 3|Adverse Event|0|||
30694192|NCT00674700|58708411|FG000|Year 1|Adverse Event|17|||
30694193|NCT00674700|58708412|FG001|Year 1|Adverse Event|20|||
30694194|NCT00674700|58708413|FG002|Year 1|Adverse Event|5|||
30694195|NCT00674700|58708411|FG000|Year 1|Withdrawal by Subject|7|||
30694196|NCT00674700|58708412|FG001|Year 1|Withdrawal by Subject|7|||
30694197|NCT00674700|58708413|FG002|Year 1|Withdrawal by Subject|6|||
30694198|NCT00674700|58708411|FG000|Year 1|Any other reason not above-mentioned|7|||
30694199|NCT00674700|58708412|FG001|Year 1|Any other reason not above-mentioned|7|||
30694200|NCT00674700|58708413|FG002|Year 1|Any other reason not above-mentioned|6|||
30694201|NCT00674700|58708411|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
30694202|NCT00674700|58708412|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
30694203|NCT00674700|58708413|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
30694204|NCT00674700|58708411|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
30694205|NCT00674700|58708412|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
30694206|NCT00674700|58708413|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
30694207|NCT00674700|58708411|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
30694208|NCT00674700|58708412|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
30694209|NCT00674700|58708413|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
30694210|NCT00546910|58708423|FG000|Overall Study|Adverse Event|2|||
30694211|NCT00546910|58708424|FG001|Overall Study|Adverse Event|3|||
30694212|NCT00546910|58708423|FG000|Overall Study|Lack of Efficacy|5|||
30694213|NCT00546910|58708424|FG001|Overall Study|Lack of Efficacy|7|||
30694214|NCT00546910|58708423|FG000|Overall Study|Physician Decision|0|||
30694215|NCT00546910|58708424|FG001|Overall Study|Physician Decision|1|||
30694216|NCT00546910|58708423|FG000|Overall Study|Withdrawal by Subject|2|||
30694217|NCT00546910|58708424|FG001|Overall Study|Withdrawal by Subject|0|||
30694218|NCT00379639|58708435|FG000|Overall Study|Disease Progression|3|||
30694219|NCT00379639|58708436|FG001|Overall Study|Disease Progression|3|||
30694220|NCT00379639|58708437|FG002|Overall Study|Disease Progression|3|||
30694221|NCT00379639|58708438|FG003|Overall Study|Disease Progression|4|||
30694222|NCT00379639|58708439|FG004|Overall Study|Disease Progression|4|||
30694223|NCT00379639|58708435|FG000|Overall Study|Physician Decision|0|||
30694224|NCT00379639|58708436|FG001|Overall Study|Physician Decision|2|||
30865334|NCT02712905|58895663|FG005|Monotherapy|Started New Cancer Drug|1|||
30865335|NCT02712905|58895664|FG006|Monotherapy|Started New Cancer Drug|0|||
30865336|NCT02712905|58895665|FG007|Monotherapy|Started New Cancer Drug|0|||
30865337|NCT02712905|58895666|FG008|Monotherapy|Started New Cancer Drug|0|||
30865338|NCT02712905|58895667|FG009|Monotherapy|Started New Cancer Drug|0|||
30865339|NCT02712905|58895668|FG010|Monotherapy|Started New Cancer Drug|0|||
30865340|NCT02712905|58895669|FG011|Monotherapy|Started New Cancer Drug|0|||
30865341|NCT02712905|58895670|FG012|Monotherapy|Started New Cancer Drug|0|||
30865342|NCT02712905|58895671|FG013|Monotherapy|Started New Cancer Drug|0|||
30865343|NCT02712905|58895672|FG014|Monotherapy|Started New Cancer Drug|0|||
30865344|NCT02712905|58895673|FG015|Monotherapy|Started New Cancer Drug|0|||
30865345|NCT02712905|58895674|FG016|Monotherapy|Started New Cancer Drug|0|||
30865346|NCT02712905|58895675|FG017|Monotherapy|Started New Cancer Drug|0|||
30865347|NCT02712905|58895658|FG000|Monotherapy|Adverse Event|0|||
30865348|NCT02712905|58895659|FG001|Monotherapy|Adverse Event|0|||
30865349|NCT02712905|58895660|FG002|Monotherapy|Adverse Event|0|||
30865350|NCT02712905|58895661|FG003|Monotherapy|Adverse Event|0|||
30865351|NCT02712905|58895662|FG004|Monotherapy|Adverse Event|0|||
30865352|NCT02712905|58895663|FG005|Monotherapy|Adverse Event|0|||
30960783|NCT01523873|59026535|FG000|Overall Study|Protocol Violation|422|||
30602171|NCT01253187|58613463|FG002|Period 3|difficulty with blood sampling|0|||
30602172|NCT01253187|58613464|FG003|Period 3|difficulty with blood sampling|0|||
30602173|NCT01253187|58613465|FG004|Period 3|difficulty with blood sampling|0|||
30602174|NCT01253187|58613466|FG005|Period 3|difficulty with blood sampling|0|||
30602175|NCT01253187|58613461|FG000|Period 3|non-compliance|0|||
30602176|NCT01253187|58613462|FG001|Period 3|non-compliance|0|||
30602177|NCT01253187|58613463|FG002|Period 3|non-compliance|0|||
30602178|NCT01253187|58613464|FG003|Period 3|non-compliance|0|||
30602179|NCT01253187|58613465|FG004|Period 3|non-compliance|1|||
30602180|NCT01253187|58613466|FG005|Period 3|non-compliance|0|||
30602181|NCT01252563|58613477|FG000|Overall Study|Contract Deviation|41|||
30694225|NCT00379639|58708437|FG002|Overall Study|Physician Decision|1|||
30694226|NCT00379639|58708438|FG003|Overall Study|Physician Decision|1|||
30694227|NCT00379639|58708439|FG004|Overall Study|Physician Decision|0|||
30694228|NCT00379639|58708435|FG000|Overall Study|Symptomatic Deterioration|0|||
30694229|NCT00379639|58708436|FG001|Overall Study|Symptomatic Deterioration|0|||
30694230|NCT00379639|58708437|FG002|Overall Study|Symptomatic Deterioration|1|||
30694231|NCT00379639|58708438|FG003|Overall Study|Symptomatic Deterioration|0|||
30694232|NCT00379639|58708439|FG004|Overall Study|Symptomatic Deterioration|1|||
30694233|NCT00379639|58708435|FG000|Overall Study|Adverse Event|0|||
30694234|NCT00379639|58708436|FG001|Overall Study|Adverse Event|0|||
30865353|NCT02712905|58895664|FG006|Monotherapy|Adverse Event|0|||
30865354|NCT02712905|58895665|FG007|Monotherapy|Adverse Event|0|||
30960784|NCT01522235|59026560|FG000|Overall Study|Physician Decision|1|||
30865355|NCT02712905|58895666|FG008|Monotherapy|Adverse Event|1|||
30602182|NCT01252563|58613477|FG000|Overall Study|Centralized Registration Deviation|30|||
30865356|NCT02712905|58895667|FG009|Monotherapy|Adverse Event|0|||
30960785|NCT01522235|59026561|FG001|Overall Study|Physician Decision|1|||
30694235|NCT00379639|58708437|FG002|Overall Study|Adverse Event|1|||
30694236|NCT00379639|58708438|FG003|Overall Study|Adverse Event|0|||
30694237|NCT00379639|58708439|FG004|Overall Study|Adverse Event|1|||
30694238|NCT00379639|58708435|FG000|Overall Study|Lost to Follow-up|0|||
30694239|NCT00379639|58708436|FG001|Overall Study|Lost to Follow-up|0|||
30694240|NCT00379639|58708437|FG002|Overall Study|Lost to Follow-up|0|||
30694241|NCT00379639|58708438|FG003|Overall Study|Lost to Follow-up|1|||
30694242|NCT00379639|58708439|FG004|Overall Study|Lost to Follow-up|0|||
30694243|NCT00379639|58708435|FG000|Overall Study|Other|0|||
30694244|NCT00379639|58708436|FG001|Overall Study|Other|0|||
30694245|NCT00379639|58708437|FG002|Overall Study|Other|3|||
30694246|NCT00379639|58708438|FG003|Overall Study|Other|0|||
30694247|NCT00379639|58708439|FG004|Overall Study|Other|0|||
30694248|NCT03948334|58708453|FG000|Overall Study|Adverse Event|1|||
30694249|NCT03948334|58708454|FG001|Overall Study|Adverse Event|4|||
30694250|NCT03948334|58708453|FG000|Overall Study|Lack of Efficacy|2|||
30865357|NCT02712905|58895668|FG010|Monotherapy|Adverse Event|0|||
30865358|NCT02712905|58895669|FG011|Monotherapy|Adverse Event|0|||
30865359|NCT02712905|58895670|FG012|Monotherapy|Adverse Event|0|||
30865360|NCT02712905|58895671|FG013|Monotherapy|Adverse Event|0|||
30865361|NCT02712905|58895672|FG014|Monotherapy|Adverse Event|0|||
30865362|NCT02712905|58895673|FG015|Monotherapy|Adverse Event|0|||
30865363|NCT02712905|58895674|FG016|Monotherapy|Adverse Event|0|||
30865364|NCT02712905|58895675|FG017|Monotherapy|Adverse Event|0|||
30865365|NCT02712905|58895658|FG000|Combination Therapy|Death|0|||
30865366|NCT02712905|58895659|FG001|Combination Therapy|Death|0|||
30865367|NCT02712905|58895660|FG002|Combination Therapy|Death|0|||
30865368|NCT02712905|58895661|FG003|Combination Therapy|Death|0|||
30865369|NCT02712905|58895662|FG004|Combination Therapy|Death|0|||
30865370|NCT02712905|58895663|FG005|Combination Therapy|Death|0|||
30865371|NCT02712905|58895664|FG006|Combination Therapy|Death|0|||
30865372|NCT02712905|58895665|FG007|Combination Therapy|Death|0|||
30865373|NCT02712905|58895666|FG008|Combination Therapy|Death|0|||
30865374|NCT02712905|58895667|FG009|Combination Therapy|Death|0|||
30865375|NCT02712905|58895668|FG010|Combination Therapy|Death|0|||
30865376|NCT02712905|58895669|FG011|Combination Therapy|Death|0|||
30865377|NCT02712905|58895670|FG012|Combination Therapy|Death|5|||
30865378|NCT02712905|58895671|FG013|Combination Therapy|Death|6|||
30865379|NCT02712905|58895672|FG014|Combination Therapy|Death|1|||
30865380|NCT02712905|58895673|FG015|Combination Therapy|Death|3|||
30865381|NCT02712905|58895674|FG016|Combination Therapy|Death|1|||
30865382|NCT02712905|58895675|FG017|Combination Therapy|Death|3|||
30865383|NCT02712905|58895658|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
30865384|NCT02712905|58895659|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
30865385|NCT02712905|58895660|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
30865386|NCT02712905|58895661|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
30865387|NCT02712905|58895662|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
30602183|NCT01252563|58613477|FG000|Overall Study|Lost to Follow-up|161|||
30602184|NCT01252563|58613477|FG000|Overall Study|No visit after first day of treatment|194|||
30602185|NCT01252563|58613477|FG000|Overall Study|No drug administration|6|||
30602186|NCT01292226|58613512|FG000|Overall Study|Adverse Event|5|||
30602187|NCT01292226|58613512|FG000|Overall Study|Death|1|||
30602188|NCT01292226|58613512|FG000|Overall Study|Graft loss|1|||
30602189|NCT01292226|58613512|FG000|Overall Study|Protocol Violation|3|||
30602190|NCT01292226|58613512|FG000|Overall Study|Withdrawal by Subject|1|||
30602191|NCT01292226|58613512|FG000|Overall Study|Other|2|||
30865388|NCT02712905|58895663|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
30865389|NCT02712905|58895664|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
30865390|NCT02712905|58895665|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
30865391|NCT02712905|58895666|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
30865392|NCT02712905|58895667|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
30865393|NCT02712905|58895668|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
30865394|NCT02712905|58895669|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
30865395|NCT02712905|58895670|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
30865396|NCT02712905|58895671|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
30865397|NCT02712905|58895672|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
30865398|NCT02712905|58895673|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
30865399|NCT02712905|58895674|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
30865400|NCT02712905|58895675|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
30865401|NCT02712905|58895658|FG000|Combination Therapy|Withdrawal by Subject|0|||
30602192|NCT01290822|58613516|FG000|Overall Study|Withdrawal by Subject|1|||
30694251|NCT03948334|58708454|FG001|Overall Study|Lack of Efficacy|0|||
30694252|NCT03948334|58708453|FG000|Overall Study|Lost to Follow-up|1|||
30694253|NCT03948334|58708454|FG001|Overall Study|Lost to Follow-up|0|||
30694254|NCT03948334|58708453|FG000|Overall Study|Physician Decision|1|||
30694255|NCT03948334|58708454|FG001|Overall Study|Physician Decision|0|||
30865402|NCT02712905|58895659|FG001|Combination Therapy|Withdrawal by Subject|0|||
30865403|NCT02712905|58895660|FG002|Combination Therapy|Withdrawal by Subject|0|||
30694256|NCT03948334|58708453|FG000|Overall Study|Pregnancy|0|||
30865404|NCT02712905|58895661|FG003|Combination Therapy|Withdrawal by Subject|0|||
30865405|NCT02712905|58895662|FG004|Combination Therapy|Withdrawal by Subject|0|||
30865406|NCT02712905|58895663|FG005|Combination Therapy|Withdrawal by Subject|0|||
30865407|NCT02712905|58895664|FG006|Combination Therapy|Withdrawal by Subject|0|||
30865408|NCT02712905|58895665|FG007|Combination Therapy|Withdrawal by Subject|0|||
30865409|NCT02712905|58895666|FG008|Combination Therapy|Withdrawal by Subject|0|||
30865410|NCT02712905|58895667|FG009|Combination Therapy|Withdrawal by Subject|0|||
30865411|NCT02712905|58895668|FG010|Combination Therapy|Withdrawal by Subject|0|||
30865412|NCT02712905|58895669|FG011|Combination Therapy|Withdrawal by Subject|0|||
30865413|NCT02712905|58895670|FG012|Combination Therapy|Withdrawal by Subject|0|||
30865414|NCT02712905|58895671|FG013|Combination Therapy|Withdrawal by Subject|0|||
30865415|NCT02712905|58895672|FG014|Combination Therapy|Withdrawal by Subject|0|||
30865416|NCT02712905|58895673|FG015|Combination Therapy|Withdrawal by Subject|1|||
30865417|NCT02712905|58895674|FG016|Combination Therapy|Withdrawal by Subject|0|||
30865418|NCT02712905|58895675|FG017|Combination Therapy|Withdrawal by Subject|2|||
30865419|NCT02712905|58895658|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865420|NCT02712905|58895659|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865421|NCT02712905|58895660|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865422|NCT02712905|58895661|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865423|NCT02712905|58895662|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865424|NCT02712905|58895663|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865425|NCT02712905|58895664|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865426|NCT02712905|58895665|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865427|NCT02712905|58895666|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865428|NCT02712905|58895667|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865429|NCT02712905|58895668|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865430|NCT02712905|58895669|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865431|NCT02712905|58895670|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865432|NCT02712905|58895671|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865433|NCT02712905|58895672|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865434|NCT02712905|58895673|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
30865435|NCT02712905|58895674|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865436|NCT02712905|58895675|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
30865437|NCT03776357|58895713|FG000|Overall Study|Lost to Follow-up|3|||
30865438|NCT04520997|58895719|FG000|Overall Study|Lost to Follow-up|1|||
30865439|NCT04520997|58895720|FG001|Overall Study|Lost to Follow-up|1|||
30865440|NCT04520997|58895719|FG000|Overall Study|Withdrawal by Subject|1|||
30865441|NCT04520997|58895720|FG001|Overall Study|Withdrawal by Subject|0|||
30865442|NCT04520997|58895719|FG000|Overall Study|Not Treated|0|||
30865443|NCT04520997|58895720|FG001|Overall Study|Not Treated|1|||
30865444|NCT02734433|58895731|FG000|Overall Study|Disease progression|1|||
30865445|NCT02734433|58895732|FG001|Overall Study|Disease progression|5|||
30865446|NCT02734433|58895731|FG000|Overall Study|Clinical progression|0|||
30865447|NCT02734433|58895732|FG001|Overall Study|Clinical progression|1|||
30865448|NCT02734433|58895731|FG000|Overall Study|Withdrawal by Subject|1|||
30865449|NCT02734433|58895732|FG001|Overall Study|Withdrawal by Subject|2|||
30865450|NCT02452424|58895758|FG000|Overall Study|Death|2|||
30865451|NCT02452424|58895759|FG001|Overall Study|Death|2|||
30865452|NCT02452424|58895760|FG002|Overall Study|Death|2|||
30865453|NCT02452424|58895761|FG003|Overall Study|Death|6|||
30865454|NCT02452424|58895762|FG004|Overall Study|Death|2|||
30865455|NCT02452424|58895763|FG005|Overall Study|Death|0|||
30865456|NCT02452424|58895764|FG006|Overall Study|Death|5|||
30865457|NCT02452424|58895765|FG007|Overall Study|Death|1|||
30865458|NCT02452424|58895766|FG008|Overall Study|Death|3|||
30865459|NCT02452424|58895767|FG009|Overall Study|Death|1|||
30865460|NCT02452424|58895768|FG010|Overall Study|Death|0|||
30865461|NCT02452424|58895758|FG000|Overall Study|Lost to Follow-up|0|||
30865462|NCT02452424|58895759|FG001|Overall Study|Lost to Follow-up|1|||
30865463|NCT02452424|58895760|FG002|Overall Study|Lost to Follow-up|1|||
30865464|NCT02452424|58895761|FG003|Overall Study|Lost to Follow-up|0|||
30865465|NCT02452424|58895762|FG004|Overall Study|Lost to Follow-up|0|||
30865466|NCT02452424|58895763|FG005|Overall Study|Lost to Follow-up|0|||
30865467|NCT02452424|58895764|FG006|Overall Study|Lost to Follow-up|0|||
30865468|NCT02452424|58895765|FG007|Overall Study|Lost to Follow-up|0|||
30865469|NCT02452424|58895766|FG008|Overall Study|Lost to Follow-up|0|||
30865470|NCT02452424|58895767|FG009|Overall Study|Lost to Follow-up|0|||
30865471|NCT02452424|58895768|FG010|Overall Study|Lost to Follow-up|0|||
30865472|NCT02452424|58895758|FG000|Overall Study|Withdrawal by Subject|0|||
30865473|NCT02452424|58895759|FG001|Overall Study|Withdrawal by Subject|0|||
30694257|NCT03948334|58708454|FG001|Overall Study|Pregnancy|1|||
30694258|NCT03948334|58708453|FG000|Overall Study|Protocol Deviation|1|||
30694259|NCT03948334|58708454|FG001|Overall Study|Protocol Deviation|0|||
30694260|NCT03948334|58708453|FG000|Overall Study|Study terminated by Sponsor|50|||
30694261|NCT03948334|58708454|FG001|Overall Study|Study terminated by Sponsor|51|||
30694262|NCT03948334|58708453|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
30694263|NCT03948334|58708454|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
30694264|NCT00609765|58708468|FG000|Overall Study|Study ended prior to 12 months|1|||
30694265|NCT00608829|58708472|FG000|Overall Study|Death|6|||
30694266|NCT00608829|58708472|FG000|Overall Study|Withdrawal by Subject|4|||
30694267|NCT00608829|58708472|FG000|Overall Study|Subject refuses to follow up or return.|5|||
30694268|NCT00545818|58708478|FG000|Overall Study|Protocol Violation|1|||
30694269|NCT00545818|58708479|FG001|Overall Study|Protocol Violation|0|||
30694270|NCT00545818|58708478|FG000|Overall Study|Adverse Event|1|||
30694271|NCT00545818|58708479|FG001|Overall Study|Adverse Event|1|||
30694272|NCT00545818|58708478|FG000|Overall Study|Lost to Follow-up|1|||
30694273|NCT00545818|58708479|FG001|Overall Study|Lost to Follow-up|6|||
30694274|NCT00674154|58708487|FG000|Overall Study|Withdrawal by Subject|3|||
30694275|NCT00674154|58708488|FG001|Overall Study|Withdrawal by Subject|1|||
30694276|NCT00674154|58708487|FG000|Overall Study|Did not want parathyroidectomy|0|||
30694277|NCT00674154|58708488|FG001|Overall Study|Did not want parathyroidectomy|2|||
30694278|NCT00608517|58708497|FG000|Overall Study|Death|1|||
30694279|NCT00608517|58708498|FG001|Overall Study|Death|0|||
30694280|NCT00608517|58708499|FG002|Overall Study|Death|0|||
30694281|NCT00608205|58708510|FG000|Overall Study|Adverse Event|3|||
30694282|NCT00608205|58708511|FG001|Overall Study|Adverse Event|2|||
30694283|NCT00608205|58708510|FG000|Overall Study|Patient non-compliant|0|||
30694284|NCT00608205|58708511|FG001|Overall Study|Patient non-compliant|1|||
30694285|NCT00670800|58708521|FG000|Overall Study|2 controls were insulin resistant|0|||
30694286|NCT00670800|58708522|FG001|Overall Study|2 controls were insulin resistant|2|||
30694287|NCT00607893|58708532|FG000|Overall Study|Lost to Follow-up|4|||
30694288|NCT00607893|58708533|FG001|Overall Study|Lost to Follow-up|0|||
30694289|NCT00607893|58708532|FG000|Overall Study|withdrew due to loss of interest|0|||
30694290|NCT00607893|58708533|FG001|Overall Study|withdrew due to loss of interest|1|||
30694291|NCT00607893|58708532|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
30694292|NCT00607893|58708533|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
30694293|NCT00607893|58708532|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
30694294|NCT00607893|58708533|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
30694295|NCT00607893|58708532|FG000|Overall Study|Declined to be treated|1|||
30694296|NCT00607893|58708533|FG001|Overall Study|Declined to be treated|0|||
30694297|NCT00607893|58708532|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
30694298|NCT00607893|58708533|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
30694299|NCT00571038|58708543|FG000|Overall Study|Lost to Follow-up|1|||
30694300|NCT00571038|58708544|FG001|Overall Study|Lost to Follow-up|4|||
30694301|NCT00571038|58708543|FG000|Overall Study|Death|7|||
30694302|NCT00571038|58708544|FG001|Overall Study|Death|5|||
30694303|NCT00571038|58708543|FG000|Overall Study|Withdrawal by Subject|1|||
30694304|NCT00571038|58708544|FG001|Overall Study|Withdrawal by Subject|3|||
30694305|NCT00571038|58708543|FG000|Overall Study|Moved out of state|2|||
30694306|NCT00571038|58708544|FG001|Overall Study|Moved out of state|2|||
30694307|NCT00545740|58708554|FG000|Overall Study|Lack of Efficacy|34|||
30694308|NCT00545740|58708555|FG001|Overall Study|Lack of Efficacy|35|||
30694309|NCT00545740|58708556|FG002|Overall Study|Lack of Efficacy|47|||
30694310|NCT00545740|58708557|FG003|Overall Study|Lack of Efficacy|36|||
30694311|NCT00545740|58708554|FG000|Overall Study|Withdrawal by Subject|17|||
30694312|NCT00545740|58708555|FG001|Overall Study|Withdrawal by Subject|15|||
30694313|NCT00545740|58708556|FG002|Overall Study|Withdrawal by Subject|16|||
30694314|NCT00545740|58708557|FG003|Overall Study|Withdrawal by Subject|18|||
30694315|NCT00545740|58708554|FG000|Overall Study|Adverse Event|10|||
30694316|NCT00545740|58708555|FG001|Overall Study|Adverse Event|18|||
30694317|NCT00545740|58708556|FG002|Overall Study|Adverse Event|19|||
30694318|NCT00545740|58708557|FG003|Overall Study|Adverse Event|9|||
30694319|NCT00545740|58708554|FG000|Overall Study|Lost to Follow-up|7|||
30694320|NCT00545740|58708555|FG001|Overall Study|Lost to Follow-up|5|||
30694321|NCT00545740|58708556|FG002|Overall Study|Lost to Follow-up|5|||
30694322|NCT00545740|58708557|FG003|Overall Study|Lost to Follow-up|6|||
30694323|NCT00545740|58708554|FG000|Overall Study|Protocol Violation|1|||
30694324|NCT00545740|58708555|FG001|Overall Study|Protocol Violation|3|||
30694325|NCT00545740|58708556|FG002|Overall Study|Protocol Violation|1|||
30694326|NCT00545740|58708557|FG003|Overall Study|Protocol Violation|0|||
30694327|NCT00545740|58708554|FG000|Overall Study|Non-compliance|0|||
30865474|NCT02452424|58895760|FG002|Overall Study|Withdrawal by Subject|3|||
30865475|NCT02452424|58895761|FG003|Overall Study|Withdrawal by Subject|2|||
30694328|NCT00545740|58708555|FG001|Overall Study|Non-compliance|2|||
30694329|NCT00545740|58708556|FG002|Overall Study|Non-compliance|1|||
30694330|NCT00545740|58708557|FG003|Overall Study|Non-compliance|0|||
30694331|NCT00545740|58708554|FG000|Overall Study|Moved|2|||
30694332|NCT00545740|58708555|FG001|Overall Study|Moved|0|||
30694333|NCT00545740|58708556|FG002|Overall Study|Moved|1|||
30694334|NCT00545740|58708557|FG003|Overall Study|Moved|0|||
30694335|NCT00545740|58708554|FG000|Overall Study|Diverticulitis attack|0|||
30694336|NCT00545740|58708555|FG001|Overall Study|Diverticulitis attack|0|||
30694337|NCT00545740|58708556|FG002|Overall Study|Diverticulitis attack|1|||
30694338|NCT00545740|58708557|FG003|Overall Study|Diverticulitis attack|1|||
30694339|NCT00545740|58708554|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
30694340|NCT00545740|58708555|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
30694341|NCT00545740|58708556|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
30694342|NCT00545740|58708557|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
30694343|NCT00545740|58708554|FG000|Overall Study|Site closure|1|||
30694344|NCT00545740|58708555|FG001|Overall Study|Site closure|0|||
30694345|NCT00545740|58708556|FG002|Overall Study|Site closure|0|||
30694346|NCT00545740|58708557|FG003|Overall Study|Site closure|0|||
30694347|NCT00545740|58708554|FG000|Overall Study|Missed visit|1|||
30694348|NCT00545740|58708555|FG001|Overall Study|Missed visit|0|||
30694349|NCT00545740|58708556|FG002|Overall Study|Missed visit|0|||
30694350|NCT00545740|58708557|FG003|Overall Study|Missed visit|0|||
30694351|NCT00545740|58708554|FG000|Overall Study|Physician Decision|0|||
30694352|NCT00545740|58708555|FG001|Overall Study|Physician Decision|0|||
30694353|NCT00545740|58708556|FG002|Overall Study|Physician Decision|3|||
30694354|NCT00545740|58708557|FG003|Overall Study|Physician Decision|0|||
30694355|NCT00545740|58708554|FG000|Overall Study|Accepted only monthly telephone calls|1|||
30694356|NCT00545740|58708555|FG001|Overall Study|Accepted only monthly telephone calls|0|||
30694357|NCT00545740|58708556|FG002|Overall Study|Accepted only monthly telephone calls|0|||
30694358|NCT00545740|58708557|FG003|Overall Study|Accepted only monthly telephone calls|0|||
30694359|NCT00545740|58708554|FG000|Overall Study|Sponsor decision|0|||
30694360|NCT00545740|58708555|FG001|Overall Study|Sponsor decision|1|||
30694361|NCT00545740|58708556|FG002|Overall Study|Sponsor decision|0|||
30694362|NCT00545740|58708557|FG003|Overall Study|Sponsor decision|0|||
30694363|NCT00545740|58708554|FG000|Overall Study|Lack of time|0|||
30694364|NCT00545740|58708555|FG001|Overall Study|Lack of time|1|||
30694365|NCT00545740|58708556|FG002|Overall Study|Lack of time|0|||
30694366|NCT00545740|58708557|FG003|Overall Study|Lack of time|0|||
30694367|NCT00545740|58708554|FG000|Overall Study|Non-adherence to visits|0|||
30865476|NCT02452424|58895762|FG004|Overall Study|Withdrawal by Subject|0|||
30865477|NCT02452424|58895763|FG005|Overall Study|Withdrawal by Subject|0|||
30865478|NCT02452424|58895764|FG006|Overall Study|Withdrawal by Subject|1|||
30865479|NCT02452424|58895765|FG007|Overall Study|Withdrawal by Subject|0|||
30865480|NCT02452424|58895766|FG008|Overall Study|Withdrawal by Subject|1|||
30865481|NCT02452424|58895767|FG009|Overall Study|Withdrawal by Subject|1|||
30865482|NCT02452424|58895768|FG010|Overall Study|Withdrawal by Subject|0|||
30865483|NCT02452424|58895758|FG000|Overall Study|Other|0|||
30865484|NCT02452424|58895759|FG001|Overall Study|Other|0|||
30865485|NCT02452424|58895760|FG002|Overall Study|Other|1|||
30865486|NCT02452424|58895761|FG003|Overall Study|Other|0|||
30865487|NCT02452424|58895762|FG004|Overall Study|Other|0|||
30865488|NCT02452424|58895763|FG005|Overall Study|Other|1|||
30865489|NCT02452424|58895764|FG006|Overall Study|Other|4|||
30865490|NCT02452424|58895765|FG007|Overall Study|Other|3|||
30865491|NCT02452424|58895766|FG008|Overall Study|Other|0|||
30865492|NCT02452424|58895767|FG009|Overall Study|Other|0|||
30865493|NCT02452424|58895768|FG010|Overall Study|Other|1|||
30865494|NCT02452424|58895758|FG000|Overall Study|Progressive disease (per RECIST)|0|||
30865495|NCT02452424|58895759|FG001|Overall Study|Progressive disease (per RECIST)|0|||
30865496|NCT02452424|58895760|FG002|Overall Study|Progressive disease (per RECIST)|0|||
30865497|NCT02452424|58895761|FG003|Overall Study|Progressive disease (per RECIST)|0|||
30865498|NCT02452424|58895762|FG004|Overall Study|Progressive disease (per RECIST)|0|||
30865499|NCT02452424|58895763|FG005|Overall Study|Progressive disease (per RECIST)|0|||
30865500|NCT02452424|58895764|FG006|Overall Study|Progressive disease (per RECIST)|0|||
30865501|NCT02452424|58895765|FG007|Overall Study|Progressive disease (per RECIST)|0|||
30865502|NCT02452424|58895766|FG008|Overall Study|Progressive disease (per RECIST)|2|||
30865503|NCT02452424|58895767|FG009|Overall Study|Progressive disease (per RECIST)|0|||
30865504|NCT02452424|58895768|FG010|Overall Study|Progressive disease (per RECIST)|0|||
30694368|NCT00545740|58708555|FG001|Overall Study|Non-adherence to visits|1|||
30694369|NCT00545740|58708556|FG002|Overall Study|Non-adherence to visits|0|||
30694370|NCT00545740|58708557|FG003|Overall Study|Non-adherence to visits|0|||
30694371|NCT00545740|58708554|FG000|Overall Study|Patient difficulties|0|||
30694372|NCT00545740|58708555|FG001|Overall Study|Patient difficulties|1|||
30694373|NCT00545740|58708556|FG002|Overall Study|Patient difficulties|0|||
30694374|NCT00545740|58708557|FG003|Overall Study|Patient difficulties|0|||
30694375|NCT00545740|58708554|FG000|Overall Study|Husband against study|0|||
30865505|NCT02452424|58895758|FG000|Overall Study|Adverse Event|0|||
30865506|NCT02452424|58895759|FG001|Overall Study|Adverse Event|0|||
30865507|NCT02452424|58895760|FG002|Overall Study|Adverse Event|0|||
30865508|NCT02452424|58895761|FG003|Overall Study|Adverse Event|0|||
30865509|NCT02452424|58895762|FG004|Overall Study|Adverse Event|0|||
30694376|NCT00545740|58708555|FG001|Overall Study|Husband against study|0|||
30694377|NCT00545740|58708556|FG002|Overall Study|Husband against study|1|||
30694378|NCT00545740|58708557|FG003|Overall Study|Husband against study|0|||
30694379|NCT00609609|58708569|FG000|Overall Study|Withdrawal by Subject|2|||
30694380|NCT00609609|58708570|FG001|Overall Study|Withdrawal by Subject|0|||
30694381|NCT00609609|58708569|FG000|Overall Study|Progression|4|||
30694382|NCT00609609|58708570|FG001|Overall Study|Progression|2|||
30694383|NCT00673452|58708578|FG000|Acute Double-Blind Phase|Adverse Event|41|||
30694384|NCT00673452|58708579|FG001|Acute Double-Blind Phase|Adverse Event|24|||
30694385|NCT00673452|58708578|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
30694386|NCT00673452|58708579|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
30694387|NCT00673452|58708578|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
30694388|NCT00673452|58708579|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
30694389|NCT00673452|58708578|FG000|Acute Double-Blind Phase|Physician Decision|0|||
30694390|NCT00673452|58708579|FG001|Acute Double-Blind Phase|Physician Decision|6|||
30694391|NCT00673452|58708578|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
30694392|NCT00673452|58708579|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
30694393|NCT00673452|58708578|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
30694394|NCT00673452|58708579|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
30694395|NCT00673452|58708578|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
30694396|NCT00673452|58708579|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
30694397|NCT00673452|58708578|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
30694398|NCT00673452|58708579|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
30694399|NCT00673452|58708578|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
30694400|NCT00673452|58708579|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
30694401|NCT00673452|58708578|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
30694402|NCT00673452|58708579|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
30694403|NCT00673452|58708578|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
30694404|NCT00673452|58708579|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
30694405|NCT00673452|58708578|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
30694406|NCT00673452|58708579|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
30694407|NCT00673452|58708578|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
30694408|NCT00673452|58708579|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
30694409|NCT00673452|58708578|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
30694410|NCT00673452|58708579|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
30694411|NCT00673452|58708578|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
30694412|NCT00673452|58708579|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
30694413|NCT00545584|58708588|FG000|Overall Study|Only one reason for discontinuation|62|||
30694414|NCT00545584|58708589|FG001|Overall Study|Only one reason for discontinuation|61|||
30694415|NCT00545584|58708590|FG002|Overall Study|Only one reason for discontinuation|48|||
30694416|NCT00545584|58708588|FG000|Overall Study|Two or more reasons for discontinuation|17|||
30865510|NCT02452424|58895763|FG005|Overall Study|Adverse Event|0|||
30865511|NCT02452424|58895764|FG006|Overall Study|Adverse Event|0|||
30602193|NCT01290822|58613516|FG000|Overall Study|Physician Decision|10|||
30602194|NCT01075048|58613523|FG000|Overall Study|Death|4|||
30602195|NCT01075048|58613524|FG001|Overall Study|Death|17|||
30602196|NCT01075048|58613525|FG002|Overall Study|Death|12|||
30602197|NCT01075048|58613523|FG000|Overall Study|Start of other or new therapy|4|||
30602198|NCT01075048|58613524|FG001|Overall Study|Start of other or new therapy|36|||
30602199|NCT01075048|58613525|FG002|Overall Study|Start of other or new therapy|46|||
30602200|NCT01075048|58613523|FG000|Overall Study|Withdrawal by Subject|1|||
30694417|NCT00545584|58708589|FG001|Overall Study|Two or more reasons for discontinuation|19|||
30602201|NCT01075048|58613524|FG001|Overall Study|Withdrawal by Subject|6|||
30602202|NCT01075048|58613525|FG002|Overall Study|Withdrawal by Subject|3|||
30602203|NCT01075048|58613523|FG000|Overall Study|Lost to Follow-up|0|||
30602204|NCT01075048|58613524|FG001|Overall Study|Lost to Follow-up|1|||
30602205|NCT01075048|58613525|FG002|Overall Study|Lost to Follow-up|1|||
30602206|NCT01290666|58613536|FG000|Overall Study|Lost to Follow-up|11|||
30602207|NCT01290666|58613536|FG000|Overall Study|Withdrawal by Subject|23|||
30602208|NCT01290666|58613536|FG000|Overall Study|Early Termination of Study|4|||
30786572|NCT00130637|58799800|FG000|Overall Study|Adverse Event|2|||
30786573|NCT00130637|58799800|FG000|Overall Study|Withdrawal by Subject|1|||
30786574|NCT03679767|58799808|FG000|Overall Study|Death|16|||
30786575|NCT03679767|58799809|FG001|Overall Study|Death|11|||
30602209|NCT01252251|58613540|FG000|Overall Study|Withdrawal by Subject|1|||
30786576|NCT03679767|58799810|FG002|Overall Study|Death|17|||
30602210|NCT01289574|58613547|FG000|Overall Study|Lack of Efficacy|4|||
30786577|NCT03679767|58799811|FG003|Overall Study|Death|10|||
30786578|NCT03679767|58799808|FG000|Overall Study|Lost to Follow-up|1|||
30786579|NCT03679767|58799809|FG001|Overall Study|Lost to Follow-up|1|||
30786580|NCT03679767|58799810|FG002|Overall Study|Lost to Follow-up|1|||
30786581|NCT03679767|58799811|FG003|Overall Study|Lost to Follow-up|1|||
30786582|NCT03679767|58799808|FG000|Overall Study|Withdrawal by Subject|0|||
30786583|NCT03679767|58799809|FG001|Overall Study|Withdrawal by Subject|0|||
30694418|NCT00545584|58708590|FG002|Overall Study|Two or more reasons for discontinuation|8|||
30694419|NCT00378703|58708602|FG000|Overall Study|Disease progression|59|||
30694420|NCT00378703|58708603|FG001|Overall Study|Disease progression|43|||
30694421|NCT00378703|58708604|FG002|Overall Study|Disease progression|48|||
30694422|NCT00378703|58708605|FG003|Overall Study|Disease progression|49|||
30694423|NCT00378703|58708602|FG000|Overall Study|Adverse Event|11|||
30694424|NCT00378703|58708603|FG001|Overall Study|Adverse Event|17|||
30694425|NCT00378703|58708604|FG002|Overall Study|Adverse Event|20|||
30694426|NCT00378703|58708605|FG003|Overall Study|Adverse Event|18|||
30694427|NCT00378703|58708602|FG000|Overall Study|Death|2|||
30694428|NCT00378703|58708603|FG001|Overall Study|Death|2|||
30694429|NCT00378703|58708604|FG002|Overall Study|Death|4|||
30694430|NCT00378703|58708605|FG003|Overall Study|Death|3|||
30694431|NCT00378703|58708602|FG000|Overall Study|Withdrawal by Subject|4|||
30694432|NCT00378703|58708603|FG001|Overall Study|Withdrawal by Subject|8|||
30694433|NCT00378703|58708604|FG002|Overall Study|Withdrawal by Subject|5|||
30694434|NCT00378703|58708605|FG003|Overall Study|Withdrawal by Subject|7|||
30694435|NCT00378703|58708602|FG000|Overall Study|Physician Decision|1|||
30694436|NCT00378703|58708603|FG001|Overall Study|Physician Decision|4|||
30694437|NCT00378703|58708604|FG002|Overall Study|Physician Decision|1|||
30694438|NCT00378703|58708605|FG003|Overall Study|Physician Decision|0|||
30694439|NCT00378703|58708602|FG000|Overall Study|Alternative therapy|4|||
30694440|NCT00378703|58708603|FG001|Overall Study|Alternative therapy|2|||
30694441|NCT00378703|58708604|FG002|Overall Study|Alternative therapy|0|||
30694442|NCT00378703|58708605|FG003|Overall Study|Alternative therapy|0|||
30694443|NCT00378703|58708602|FG000|Overall Study|Other complicated disease|0|||
30694444|NCT00378703|58708603|FG001|Overall Study|Other complicated disease|2|||
30694445|NCT00378703|58708604|FG002|Overall Study|Other complicated disease|2|||
30694446|NCT00378703|58708605|FG003|Overall Study|Other complicated disease|0|||
30694447|NCT00378703|58708602|FG000|Overall Study|Symptomatic deterioration|0|||
30694448|NCT00378703|58708603|FG001|Overall Study|Symptomatic deterioration|1|||
30694449|NCT00378703|58708604|FG002|Overall Study|Symptomatic deterioration|0|||
30694450|NCT00378703|58708605|FG003|Overall Study|Symptomatic deterioration|2|||
30694451|NCT00378703|58708602|FG000|Overall Study|Surgery|1|||
30694452|NCT00378703|58708603|FG001|Overall Study|Surgery|0|||
30694453|NCT00378703|58708604|FG002|Overall Study|Surgery|0|||
30694454|NCT00378703|58708605|FG003|Overall Study|Surgery|1|||
30694455|NCT00378703|58708602|FG000|Overall Study|Joint decision of physician and patient|1|||
30694456|NCT00378703|58708603|FG001|Overall Study|Joint decision of physician and patient|0|||
30694457|NCT00378703|58708604|FG002|Overall Study|Joint decision of physician and patient|0|||
30694458|NCT00378703|58708605|FG003|Overall Study|Joint decision of physician and patient|0|||
30694459|NCT00378703|58708602|FG000|Overall Study|Adverse events and progressive disease|0|||
30694460|NCT00378703|58708603|FG001|Overall Study|Adverse events and progressive disease|0|||
30694461|NCT00378703|58708604|FG002|Overall Study|Adverse events and progressive disease|0|||
30694462|NCT00378703|58708605|FG003|Overall Study|Adverse events and progressive disease|1|||
30694463|NCT00378703|58708602|FG000|Overall Study|Relocation|0|||
30694464|NCT00378703|58708603|FG001|Overall Study|Relocation|0|||
30694465|NCT00378703|58708604|FG002|Overall Study|Relocation|1|||
30694466|NCT00378703|58708605|FG003|Overall Study|Relocation|0|||
30694467|NCT00378703|58708602|FG000|Overall Study|Ineligible|4|||
30694468|NCT00378703|58708603|FG001|Overall Study|Ineligible|7|||
30694469|NCT00378703|58708604|FG002|Overall Study|Ineligible|7|||
30694470|NCT00378703|58708605|FG003|Overall Study|Ineligible|7|||
30694471|NCT00378703|58708602|FG000|Overall Study|Never started treatment|1|||
30694472|NCT00378703|58708603|FG001|Overall Study|Never started treatment|4|||
30694473|NCT00378703|58708604|FG002|Overall Study|Never started treatment|0|||
30694474|NCT00378703|58708605|FG003|Overall Study|Never started treatment|0|||
30694475|NCT00378703|58708602|FG000|Overall Study|Other|1|||
30694476|NCT00378703|58708603|FG001|Overall Study|Other|1|||
30694477|NCT00378703|58708604|FG002|Overall Study|Other|2|||
30694478|NCT00378703|58708605|FG003|Overall Study|Other|3|||
30694479|NCT00368641|58708621|FG000|Overall Study|Adverse Event|2|||
30694480|NCT00368641|58708622|FG001|Overall Study|Adverse Event|1|||
30694481|NCT00368641|58708621|FG000|Overall Study|Death|1|||
30694482|NCT00368641|58708622|FG001|Overall Study|Death|0|||
30694483|NCT00368641|58708621|FG000|Overall Study|Withdrawal by Subject|1|||
30694484|NCT00368641|58708622|FG001|Overall Study|Withdrawal by Subject|0|||
30694485|NCT00368641|58708621|FG000|Overall Study|Sponsor decision to terminate study|2|||
30694486|NCT00368641|58708622|FG001|Overall Study|Sponsor decision to terminate study|5|||
30694487|NCT00608985|58708632|FG000|Overall Study|Adverse Event|2|||
30694488|NCT00608985|58708633|FG001|Overall Study|Adverse Event|7|||
30694489|NCT00608985|58708634|FG002|Overall Study|Adverse Event|4|||
30694490|NCT00608985|58708635|FG003|Overall Study|Adverse Event|6|||
30694491|NCT00608985|58708632|FG000|Overall Study|Administrative/Other|7|||
30694492|NCT00608985|58708633|FG001|Overall Study|Administrative/Other|4|||
30694493|NCT00608985|58708634|FG002|Overall Study|Administrative/Other|1|||
30694494|NCT00608985|58708635|FG003|Overall Study|Administrative/Other|2|||
30694495|NCT00608985|58708632|FG000|Overall Study|Withdrawal of Consent|5|||
30694496|NCT00608985|58708633|FG001|Overall Study|Withdrawal of Consent|1|||
30694497|NCT00608985|58708634|FG002|Overall Study|Withdrawal of Consent|1|||
30694498|NCT00608985|58708635|FG003|Overall Study|Withdrawal of Consent|1|||
30694499|NCT00608985|58708632|FG000|Overall Study|Lost to Follow-up|2|||
30694500|NCT00608985|58708633|FG001|Overall Study|Lost to Follow-up|1|||
30694501|NCT00608985|58708634|FG002|Overall Study|Lost to Follow-up|0|||
30694502|NCT00608985|58708635|FG003|Overall Study|Lost to Follow-up|0|||
30694503|NCT00368251|58708648|FG000|Overall Study|SAE, non-fatal|1|||
30694504|NCT00368251|58708649|FG001|Overall Study|SAE, non-fatal|0|||
30694505|NCT00368251|58708650|FG002|Overall Study|SAE, non-fatal|0|||
30694506|NCT00368251|58708648|FG000|Overall Study|AE, non-serious non-fatal|0|||
30694507|NCT00368251|58708649|FG001|Overall Study|AE, non-serious non-fatal|0|||
30865512|NCT02452424|58895765|FG007|Overall Study|Adverse Event|0|||
30865513|NCT02452424|58895766|FG008|Overall Study|Adverse Event|0|||
30865514|NCT02452424|58895767|FG009|Overall Study|Adverse Event|0|||
30865515|NCT02452424|58895768|FG010|Overall Study|Adverse Event|1|||
30865516|NCT02419508|58895796|FG000|Overall Study|Adverse Event|9|||
30865517|NCT02419508|58895797|FG001|Overall Study|Adverse Event|3|||
30865518|NCT02419508|58895796|FG000|Overall Study|Withdrawal by Subject|1|||
30865519|NCT02419508|58895797|FG001|Overall Study|Withdrawal by Subject|0|||
30865520|NCT02419508|58895796|FG000|Overall Study|Other - Reason not specified|0|||
30865521|NCT02419508|58895797|FG001|Overall Study|Other - Reason not specified|1|||
30865522|NCT01328249|58895805|FG000|Overall Study|Adverse Event|3|||
30865523|NCT01328249|58895806|FG001|Overall Study|Adverse Event|0|||
30865524|NCT01328249|58895805|FG000|Overall Study|Disease progression|1|||
30865525|NCT01328249|58895806|FG001|Overall Study|Disease progression|0|||
30865526|NCT01328249|58895805|FG000|Overall Study|Withdrawal by Subject|1|||
30865527|NCT01328249|58895806|FG001|Overall Study|Withdrawal by Subject|1|||
30865528|NCT01328249|58895805|FG000|Overall Study|Moved before end of treatment visit|1|||
30865529|NCT01328249|58895806|FG001|Overall Study|Moved before end of treatment visit|0|||
30865530|NCT01328249|58895805|FG000|Overall Study|Subject choice|1|||
30865531|NCT01328249|58895806|FG001|Overall Study|Subject choice|1|||
30865532|NCT01328249|58895805|FG000|Overall Study|Protocol Violation|0|||
30865533|NCT01328249|58895806|FG001|Overall Study|Protocol Violation|1|||
30865534|NCT01651052|58895814|FG000|Overall Study|Death|21|||
30865535|NCT01651052|58895814|FG000|Overall Study|Explant|1|||
30865536|NCT01651052|58895814|FG000|Overall Study|Withdrawal by Subject|1|||
30865537|NCT01651052|58895814|FG000|Overall Study|Lost to Follow-up|3|||
30865538|NCT02388074|58895818|FG000|Overall Study|Lost in Transit|2|||
30865539|NCT02388074|58895818|FG000|Overall Study|Sample Not Returned|1|||
30865540|NCT01602549|58895824|FG000|Overall Study|Protocol Violation|0|||
30865541|NCT01602549|58895825|FG001|Overall Study|Protocol Violation|1|||
30865542|NCT01602549|58895824|FG000|Overall Study|Withdrawal by Subject|1|||
30865543|NCT01602549|58895825|FG001|Overall Study|Withdrawal by Subject|0|||
30865544|NCT02427464|58895835|FG000|Overall Study|Adverse Event|6|||
30865545|NCT02427464|58895836|FG001|Overall Study|Adverse Event|1|||
30865546|NCT02427464|58895835|FG000|Overall Study|Lost to Follow-up|16|||
30865547|NCT02427464|58895836|FG001|Overall Study|Lost to Follow-up|5|||
30865548|NCT02427464|58895835|FG000|Overall Study|Physician Decision|2|||
30865549|NCT02427464|58895836|FG001|Overall Study|Physician Decision|0|||
30865550|NCT02427464|58895835|FG000|Overall Study|Withdrawal by Subject|10|||
30865551|NCT02427464|58895836|FG001|Overall Study|Withdrawal by Subject|8|||
30865552|NCT02427464|58895835|FG000|Overall Study|Noncompliance|16|||
30865553|NCT02427464|58895836|FG001|Overall Study|Noncompliance|10|||
30865554|NCT02426918|58895845|FG000|Overall Study|Adverse Event|2|||
30865555|NCT02426918|58895846|FG001|Overall Study|Adverse Event|2|||
30865556|NCT02426918|58895847|FG002|Overall Study|Adverse Event|0|||
30865557|NCT02426918|58895845|FG000|Overall Study|Physician Decision|1|||
30865558|NCT02426918|58895846|FG001|Overall Study|Physician Decision|1|||
30865559|NCT02426918|58895847|FG002|Overall Study|Physician Decision|1|||
30865560|NCT02426918|58895845|FG000|Overall Study|Withdrawal by Subject|5|||
30602211|NCT01289574|58613548|FG001|Overall Study|Lack of Efficacy|0|||
30602212|NCT01289574|58613549|FG002|Overall Study|Lack of Efficacy|1|||
30602213|NCT01289574|58613547|FG000|Overall Study|Lost to Follow-up|2|||
30602214|NCT01289574|58613548|FG001|Overall Study|Lost to Follow-up|0|||
30602215|NCT01289574|58613549|FG002|Overall Study|Lost to Follow-up|1|||
30694508|NCT00368251|58708650|FG002|Overall Study|AE, non-serious non-fatal|1|||
30694509|NCT00378079|58708661|FG000|Overall Study|Lost to Follow-up|6|||
30865561|NCT02426918|58895846|FG001|Overall Study|Withdrawal by Subject|5|||
30865562|NCT02426918|58895847|FG002|Overall Study|Withdrawal by Subject|4|||
30865563|NCT02426918|58895845|FG000|Overall Study|Other|9|||
30865564|NCT02426918|58895846|FG001|Overall Study|Other|11|||
30865565|NCT02426918|58895847|FG002|Overall Study|Other|9|||
30865566|NCT02387840|58895861|FG000|Overall Study|Death|0|||
30865567|NCT02387840|58895862|FG001|Overall Study|Death|0|||
30865568|NCT02387840|58895863|FG002|Overall Study|Death|0|||
30865569|NCT02387840|58895864|FG003|Overall Study|Death|0|||
30865570|NCT02387840|58895865|FG004|Overall Study|Death|0|||
30602216|NCT01289574|58613547|FG000|Overall Study|Withdrawal by Subject|1|||
30865571|NCT02387840|58895866|FG005|Overall Study|Death|1|||
30865572|NCT02387762|58895888|FG000|Overall Study|Withdrawal by Subject|1|||
30865573|NCT02387762|58895889|FG001|Overall Study|Withdrawal by Subject|0|||
30865574|NCT02418182|58895897|FG000|Overall Study|Unable to re-consent|18|||
30865575|NCT02418182|58895898|FG001|Overall Study|Unable to re-consent|15|||
30865576|NCT02418182|58895897|FG000|Overall Study|Lost to Follow-up|0|||
30865577|NCT02418182|58895898|FG001|Overall Study|Lost to Follow-up|2|||
30865578|NCT02387372|58895919|FG000|Overall Study|Not Treated|1|||
30865579|NCT02387372|58895920|FG001|Overall Study|Not Treated|0|||
30865580|NCT02426138|58895936|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
30865581|NCT02426138|58895937|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
30865582|NCT02426684|58895950|FG000|Overall Study|Physician Decision|1|||
30865583|NCT02656173|58895956|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
30865584|NCT02656173|58895957|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
30865585|NCT02656173|58895956|FG000|Overall Study|Adverse Event|7|||
30865586|NCT02656173|58895957|FG001|Overall Study|Adverse Event|5|||
30865587|NCT02656173|58895956|FG000|Overall Study|Withdrawal by Subject|1|||
30865588|NCT02656173|58895957|FG001|Overall Study|Withdrawal by Subject|3|||
30865589|NCT02656173|58895956|FG000|Overall Study|Protocol Violation|0|||
30865590|NCT02656173|58895957|FG001|Overall Study|Protocol Violation|1|||
30865591|NCT02656173|58895956|FG000|Overall Study|Miscellaneous|2|||
30865592|NCT02656173|58895957|FG001|Overall Study|Miscellaneous|0|||
30865593|NCT02656017|58895967|FG000|Overall Study|Study burden|3|||
30865594|NCT02656017|58895968|FG001|Overall Study|Study burden|3|||
30865595|NCT02656017|58895967|FG000|Overall Study|Adverse Event|2|||
30865596|NCT02656017|58895968|FG001|Overall Study|Adverse Event|1|||
30865597|NCT02656017|58895967|FG000|Overall Study|Unable/unwilling to take study medication|2|||
30865598|NCT02656017|58895968|FG001|Overall Study|Unable/unwilling to take study medication|1|||
30865599|NCT02656017|58895967|FG000|Overall Study|Began Tolvaptan|1|||
30865600|NCT02656017|58895968|FG001|Overall Study|Began Tolvaptan|1|||
30865601|NCT02656017|58895967|FG000|Overall Study|Withdrawal by Subject|1|||
30865602|NCT02656017|58895968|FG001|Overall Study|Withdrawal by Subject|0|||
30865603|NCT02657343|58895980|FG000|Overall Study|Death|0|||
30865604|NCT02657343|58895981|FG001|Overall Study|Death|2|||
30865605|NCT02657343|58895982|FG002|Overall Study|Death|0|||
30865606|NCT02657343|58895983|FG003|Overall Study|Death|0|||
30865607|NCT02657343|58895984|FG004|Overall Study|Death|0|||
30865608|NCT02657343|58895985|FG005|Overall Study|Death|0|||
30865609|NCT02657343|58895980|FG000|Overall Study|Patient went to hospice|1|||
30865610|NCT02657343|58895981|FG001|Overall Study|Patient went to hospice|0|||
30865611|NCT02657343|58895982|FG002|Overall Study|Patient went to hospice|0|||
30865612|NCT02657343|58895983|FG003|Overall Study|Patient went to hospice|0|||
30865613|NCT02657343|58895984|FG004|Overall Study|Patient went to hospice|0|||
30865614|NCT02657343|58895985|FG005|Overall Study|Patient went to hospice|0|||
30865615|NCT02657343|58895980|FG000|Overall Study|Withdrawal by Subject|0|||
30865616|NCT02657343|58895981|FG001|Overall Study|Withdrawal by Subject|0|||
30865617|NCT02657343|58895982|FG002|Overall Study|Withdrawal by Subject|0|||
30865618|NCT02657343|58895983|FG003|Overall Study|Withdrawal by Subject|0|||
30865619|NCT02657343|58895984|FG004|Overall Study|Withdrawal by Subject|1|||
30865620|NCT02657343|58895985|FG005|Overall Study|Withdrawal by Subject|0|||
30865621|NCT02655237|58896001|FG000|Overall Study|Adverse Event|10|||
30865622|NCT02655237|58896002|FG001|Overall Study|Adverse Event|7|||
30865623|NCT02655237|58896001|FG000|Overall Study|Protocol Deviation|2|||
30865624|NCT02655237|58896002|FG001|Overall Study|Protocol Deviation|0|||
30865625|NCT02655237|58896001|FG000|Overall Study|Withdrawal by Participant|1|||
30865626|NCT02655237|58896002|FG001|Overall Study|Withdrawal by Participant|2|||
30865627|NCT02655237|58896001|FG000|Overall Study|Lack of Efficacy|0|||
30865628|NCT02655237|58896002|FG001|Overall Study|Lack of Efficacy|1|||
30865629|NCT02655237|58896001|FG000|Overall Study|Recovery Leading to Surgery|2|||
30865630|NCT02655237|58896002|FG001|Overall Study|Recovery Leading to Surgery|1|||
30865631|NCT02655237|58896001|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
30865632|NCT02655237|58896002|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
30865633|NCT02655237|58896001|FG000|Overall Study|Randomized but Not Treated|1|||
30865634|NCT02655237|58896002|FG001|Overall Study|Randomized but Not Treated|0|||
30865635|NCT02657031|58896010|FG000|Overall Study|Adverse Event|1|||
30865636|NCT02657031|58896011|FG001|Overall Study|Adverse Event|2|||
30865637|NCT04375397|58896039|FG000|Overall Study|Death|1|||
30865638|NCT04375397|58896040|FG001|Overall Study|Death|1|||
30865639|NCT04375397|58896039|FG000|Overall Study|Withdrew consent|2|||
30865640|NCT04375397|58896040|FG001|Overall Study|Withdrew consent|0|||
30865641|NCT04375397|58896039|FG000|Overall Study|Lost to Follow-up|6|||
30865642|NCT04375397|58896040|FG001|Overall Study|Lost to Follow-up|4|||
30865643|NCT04375397|58896039|FG000|Overall Study|Other, not specified|0|||
30865644|NCT04375397|58896040|FG001|Overall Study|Other, not specified|1|||
30865645|NCT02387216|58896048|FG000|Overall Study|Progressive disease|2|||
30865646|NCT02387216|58896049|FG001|Overall Study|Progressive disease|0|||
30865647|NCT02387216|58896048|FG000|Overall Study|Withdrawal by Subject|3|||
30865648|NCT02387216|58896049|FG001|Overall Study|Withdrawal by Subject|5|||
30865649|NCT02387216|58896048|FG000|Overall Study|Physician Decision|2|||
30865650|NCT02387216|58896049|FG001|Overall Study|Physician Decision|0|||
30865651|NCT02387216|58896048|FG000|Overall Study|Sponsor Decision|28|||
30865652|NCT02387216|58896049|FG001|Overall Study|Sponsor Decision|12|||
30865653|NCT02387216|58896048|FG000|Overall Study|Death|60|||
30865654|NCT02387216|58896049|FG001|Overall Study|Death|23|||
30865655|NCT02387216|58896048|FG000|Overall Study|Other|5|||
30865656|NCT02387216|58896049|FG001|Overall Study|Other|4|||
30865657|NCT02387216|58896048|FG000|Overall Study|Lost to Follow-up|0|||
30865658|NCT02387216|58896049|FG001|Overall Study|Lost to Follow-up|3|||
30865659|NCT02417246|58896057|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
30865660|NCT02417246|58896058|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
30865661|NCT02417246|58896057|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
30865662|NCT02417246|58896058|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
30865663|NCT02417246|58896057|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
30865664|NCT02417246|58896058|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
30865665|NCT02417246|58896057|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
30865666|NCT02417246|58896058|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
30865667|NCT02424734|58896069|FG000|Overall Study|Treatment stopped to be discharged home|2|||
30865668|NCT02424734|58896070|FG001|Overall Study|Treatment stopped to be discharged home|2|||
30865669|NCT02424734|58896071|FG002|Overall Study|Treatment stopped to be discharged home|0|||
30865670|NCT02424578|58896082|FG000|Overall Study|Withdrawal by Subject|0|||
30865671|NCT02424578|58896083|FG001|Overall Study|Withdrawal by Subject|1|||
30865672|NCT02416934|58896091|FG000|Overall Study|given steroids|1|||
30865673|NCT02416934|58896092|FG001|Overall Study|given steroids|2|||
30865674|NCT02416934|58896091|FG000|Overall Study|Lost to Follow-up|0|||
30865675|NCT02416934|58896092|FG001|Overall Study|Lost to Follow-up|2|||
30865676|NCT02416934|58896091|FG000|Overall Study|Withdrawal by Subject|1|||
30865677|NCT02416934|58896092|FG001|Overall Study|Withdrawal by Subject|0|||
30865678|NCT02416934|58896091|FG000|Overall Study|recruited during continuing renewal proc|0|||
30865679|NCT02416934|58896092|FG001|Overall Study|recruited during continuing renewal proc|1|||
30865680|NCT02416934|58896091|FG000|Overall Study|Protocol Violation|0|||
30865681|NCT02416934|58896092|FG001|Overall Study|Protocol Violation|1|||
30865682|NCT02416934|58896091|FG000|Overall Study|surgery started late|0|||
30865683|NCT02416934|58896092|FG001|Overall Study|surgery started late|1|||
30865684|NCT02416934|58896091|FG000|Overall Study|re-operation|1|||
30865685|NCT02416934|58896092|FG001|Overall Study|re-operation|0|||
30865686|NCT02819635|58896112|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
30865687|NCT02819635|58896113|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
30865688|NCT02819635|58896114|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
30865689|NCT02819635|58896115|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
30865690|NCT02819635|58896116|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
30960786|NCT01521923|59026598|FG000|Overall Study|AE, serious fatal|1|||
30960787|NCT01521923|59026599|FG001|Overall Study|AE, serious fatal|0|||
30694510|NCT00378079|58708662|FG001|Overall Study|Lost to Follow-up|1|||
30694511|NCT00378079|58708663|FG002|Overall Study|Lost to Follow-up|0|||
30694512|NCT03936244|58708673|FG000|Overall Study|Lost to Follow-up|5|||
30694513|NCT03936244|58708674|FG001|Overall Study|Lost to Follow-up|1|||
30694514|NCT03936244|58708673|FG000|Overall Study|Physician Decision|7|||
30694515|NCT03936244|58708674|FG001|Overall Study|Physician Decision|3|||
30694516|NCT03923530|58708681|FG000|Overall Study|Withdrawal by Subject|1|||
30694517|NCT03923530|58708681|FG000|Overall Study|screen failure|3|||
30694518|NCT00608907|58708688|FG000|Overall Study|Adverse Event|6|||
30694519|NCT00608907|58708689|FG001|Overall Study|Adverse Event|0|||
30694520|NCT00608907|58708690|FG002|Overall Study|Adverse Event|1|||
30694521|NCT00608907|58708688|FG000|Overall Study|Death|1|||
30865691|NCT02819635|58896117|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
30865692|NCT02819635|58896118|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
30865693|NCT02819635|58896119|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
30865694|NCT02819635|58896120|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
30865695|NCT02819635|58896121|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
30865696|NCT02819635|58896122|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
30865697|NCT02819635|58896123|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
30865698|NCT02819635|58896112|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
30865699|NCT02819635|58896113|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
30865700|NCT02819635|58896114|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
30865701|NCT02819635|58896115|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
30865702|NCT02819635|58896116|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
30865703|NCT02819635|58896117|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
30865704|NCT02819635|58896118|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
30865705|NCT02819635|58896119|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
30865706|NCT02819635|58896120|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
30865707|NCT02819635|58896121|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
30865708|NCT02819635|58896122|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
30960788|NCT01521923|59026600|FG002|Overall Study|AE, serious fatal|0|||
30694522|NCT00608907|58708689|FG001|Overall Study|Death|0|||
30694523|NCT00608907|58708690|FG002|Overall Study|Death|0|||
30694524|NCT00608907|58708688|FG000|Overall Study|Withdrawal by Subject|4|||
30694525|NCT00608907|58708689|FG001|Overall Study|Withdrawal by Subject|0|||
30865709|NCT02819635|58896123|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
30865710|NCT02819635|58896112|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
30865711|NCT02819635|58896113|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
30865712|NCT02819635|58896114|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
30865713|NCT02819635|58896115|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
30865714|NCT02819635|58896116|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
30865715|NCT02819635|58896117|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
30865716|NCT02819635|58896118|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
30865717|NCT02819635|58896119|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
30865718|NCT02819635|58896120|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
30865719|NCT02819635|58896121|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
30865720|NCT02819635|58896122|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
30865721|NCT02819635|58896123|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
30865722|NCT02819635|58896112|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
30865723|NCT02819635|58896113|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
30865724|NCT02819635|58896114|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
30865725|NCT02819635|58896115|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
30865726|NCT02819635|58896116|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
30865727|NCT02819635|58896117|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
30865728|NCT02819635|58896118|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
30865729|NCT02819635|58896119|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
30865730|NCT02819635|58896120|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
30865731|NCT02819635|58896121|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
30865732|NCT02819635|58896122|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
30865733|NCT02819635|58896123|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
30865734|NCT02819635|58896112|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
30865735|NCT02819635|58896113|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
30865736|NCT02819635|58896114|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
30865737|NCT02819635|58896115|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
30865738|NCT02819635|58896116|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
30865739|NCT02819635|58896117|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
30865740|NCT02819635|58896118|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
30865741|NCT02819635|58896119|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
30865742|NCT02819635|58896120|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
30865743|NCT02819635|58896121|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
30865744|NCT02819635|58896122|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
30865745|NCT02819635|58896123|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
30865746|NCT02819635|58896112|FG000|Substudy 2, Part 2|Adverse Event|0|||
30865747|NCT02819635|58896113|FG001|Substudy 2, Part 2|Adverse Event|0|||
30865748|NCT02819635|58896114|FG002|Substudy 2, Part 2|Adverse Event|0|||
30865749|NCT02819635|58896115|FG003|Substudy 2, Part 2|Adverse Event|0|||
30865750|NCT02819635|58896116|FG004|Substudy 2, Part 2|Adverse Event|0|||
30865751|NCT02819635|58896117|FG005|Substudy 2, Part 2|Adverse Event|4|||
30865752|NCT02819635|58896118|FG006|Substudy 2, Part 2|Adverse Event|0|||
30865753|NCT02819635|58896119|FG007|Substudy 2, Part 2|Adverse Event|0|||
30865754|NCT02819635|58896120|FG008|Substudy 2, Part 2|Adverse Event|0|||
30865755|NCT02819635|58896121|FG009|Substudy 2, Part 2|Adverse Event|0|||
30865756|NCT02819635|58896122|FG010|Substudy 2, Part 2|Adverse Event|0|||
30960789|NCT01521923|59026601|FG003|Overall Study|AE, serious fatal|0|||
30960790|NCT01521923|59026598|FG000|Overall Study|SAE, non-fatal|0|||
30960791|NCT01521923|59026599|FG001|Overall Study|SAE, non-fatal|2|||
30960792|NCT01521923|59026600|FG002|Overall Study|SAE, non-fatal|2|||
30960793|NCT01521923|59026601|FG003|Overall Study|SAE, non-fatal|0|||
30960794|NCT01521923|59026598|FG000|Overall Study|AE, non-serious, non-fatal|1|||
30960795|NCT01521923|59026599|FG001|Overall Study|AE, non-serious, non-fatal|3|||
30960796|NCT01521923|59026600|FG002|Overall Study|AE, non-serious, non-fatal|6|||
30960797|NCT01521923|59026601|FG003|Overall Study|AE, non-serious, non-fatal|2|||
30960798|NCT01521923|59026598|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
30960799|NCT01521923|59026599|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
30960800|NCT01521923|59026600|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
30960801|NCT01521923|59026601|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
30865757|NCT02819635|58896123|FG011|Substudy 2, Part 2|Adverse Event|0|||
30865758|NCT02819635|58896112|FG000|Substudy 2, Part 2|Withdrew consent|0|||
30960802|NCT01521923|59026598|FG000|Overall Study|Lack of Efficacy|1|||
30960803|NCT01521923|59026599|FG001|Overall Study|Lack of Efficacy|1|||
30865759|NCT02819635|58896113|FG001|Substudy 2, Part 2|Withdrew consent|0|||
30865760|NCT02819635|58896114|FG002|Substudy 2, Part 2|Withdrew consent|0|||
30865761|NCT02819635|58896115|FG003|Substudy 2, Part 2|Withdrew consent|0|||
30865762|NCT02819635|58896116|FG004|Substudy 2, Part 2|Withdrew consent|0|||
30865763|NCT02819635|58896117|FG005|Substudy 2, Part 2|Withdrew consent|3|||
30865764|NCT02819635|58896118|FG006|Substudy 2, Part 2|Withdrew consent|1|||
30865765|NCT02819635|58896119|FG007|Substudy 2, Part 2|Withdrew consent|0|||
30865766|NCT02819635|58896120|FG008|Substudy 2, Part 2|Withdrew consent|0|||
30865767|NCT02819635|58896121|FG009|Substudy 2, Part 2|Withdrew consent|0|||
30865768|NCT02819635|58896122|FG010|Substudy 2, Part 2|Withdrew consent|0|||
30865769|NCT02819635|58896123|FG011|Substudy 2, Part 2|Withdrew consent|0|||
30865770|NCT02819635|58896112|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
30865771|NCT02819635|58896113|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
30865772|NCT02819635|58896114|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
30865773|NCT02819635|58896115|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
30865774|NCT02819635|58896116|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
30865775|NCT02819635|58896117|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
30865776|NCT02819635|58896118|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
30865777|NCT02819635|58896119|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
30865778|NCT02819635|58896120|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
30865779|NCT02819635|58896121|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
30865780|NCT02819635|58896122|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
30865781|NCT02819635|58896123|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
30865782|NCT02819635|58896112|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
30865783|NCT02819635|58896113|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
30865784|NCT02819635|58896114|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
30865785|NCT02819635|58896115|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
30865786|NCT02819635|58896116|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
30865787|NCT02819635|58896117|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
30865788|NCT02819635|58896118|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
30865789|NCT02819635|58896119|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
30865790|NCT02819635|58896120|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
30865791|NCT02819635|58896121|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
30865792|NCT02819635|58896122|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
30865793|NCT02819635|58896123|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
30865794|NCT02819635|58896112|FG000|Substudy 2, Part 2|Other, not specified|0|||
30865795|NCT02819635|58896113|FG001|Substudy 2, Part 2|Other, not specified|0|||
30865796|NCT02819635|58896114|FG002|Substudy 2, Part 2|Other, not specified|0|||
30865797|NCT02819635|58896115|FG003|Substudy 2, Part 2|Other, not specified|0|||
30865798|NCT02819635|58896116|FG004|Substudy 2, Part 2|Other, not specified|0|||
30865799|NCT02819635|58896117|FG005|Substudy 2, Part 2|Other, not specified|4|||
30865800|NCT02819635|58896118|FG006|Substudy 2, Part 2|Other, not specified|8|||
30865801|NCT02819635|58896119|FG007|Substudy 2, Part 2|Other, not specified|0|||
30865802|NCT02819635|58896120|FG008|Substudy 2, Part 2|Other, not specified|0|||
30865803|NCT02819635|58896121|FG009|Substudy 2, Part 2|Other, not specified|0|||
30865804|NCT02819635|58896122|FG010|Substudy 2, Part 2|Other, not specified|0|||
30865805|NCT02819635|58896123|FG011|Substudy 2, Part 2|Other, not specified|0|||
30865806|NCT02819635|58896112|FG000|Substudy 3|Adverse Event|0|||
30865807|NCT02819635|58896113|FG001|Substudy 3|Adverse Event|0|||
30865808|NCT02819635|58896114|FG002|Substudy 3|Adverse Event|0|||
30865809|NCT02819635|58896115|FG003|Substudy 3|Adverse Event|0|||
30865810|NCT02819635|58896116|FG004|Substudy 3|Adverse Event|0|||
30865811|NCT02819635|58896117|FG005|Substudy 3|Adverse Event|0|||
30865812|NCT02819635|58896118|FG006|Substudy 3|Adverse Event|0|||
30865813|NCT02819635|58896119|FG007|Substudy 3|Adverse Event|0|||
30865814|NCT02819635|58896120|FG008|Substudy 3|Adverse Event|32|||
30865815|NCT02819635|58896121|FG009|Substudy 3|Adverse Event|3|||
30865816|NCT02819635|58896122|FG010|Substudy 3|Adverse Event|12|||
30865817|NCT02819635|58896123|FG011|Substudy 3|Adverse Event|18|||
30865818|NCT02819635|58896112|FG000|Substudy 3|Withdrew consent|0|||
30865819|NCT02819635|58896113|FG001|Substudy 3|Withdrew consent|0|||
30865820|NCT02819635|58896114|FG002|Substudy 3|Withdrew consent|0|||
30865821|NCT02819635|58896115|FG003|Substudy 3|Withdrew consent|0|||
30865822|NCT02819635|58896116|FG004|Substudy 3|Withdrew consent|0|||
30865823|NCT02819635|58896117|FG005|Substudy 3|Withdrew consent|0|||
30865824|NCT02819635|58896118|FG006|Substudy 3|Withdrew consent|0|||
30865825|NCT02819635|58896119|FG007|Substudy 3|Withdrew consent|0|||
30865826|NCT02819635|58896120|FG008|Substudy 3|Withdrew consent|11|||
30865827|NCT02819635|58896121|FG009|Substudy 3|Withdrew consent|1|||
30865828|NCT02819635|58896122|FG010|Substudy 3|Withdrew consent|4|||
30865829|NCT02819635|58896123|FG011|Substudy 3|Withdrew consent|9|||
30865830|NCT02819635|58896112|FG000|Substudy 3|Lost to Follow-up|0|||
30865831|NCT02819635|58896113|FG001|Substudy 3|Lost to Follow-up|0|||
30865832|NCT02819635|58896114|FG002|Substudy 3|Lost to Follow-up|0|||
30960804|NCT01521923|59026600|FG002|Overall Study|Lack of Efficacy|0|||
30865833|NCT02819635|58896115|FG003|Substudy 3|Lost to Follow-up|0|||
30865834|NCT02819635|58896116|FG004|Substudy 3|Lost to Follow-up|0|||
30865835|NCT02819635|58896117|FG005|Substudy 3|Lost to Follow-up|0|||
30865836|NCT02819635|58896118|FG006|Substudy 3|Lost to Follow-up|0|||
30865837|NCT02819635|58896119|FG007|Substudy 3|Lost to Follow-up|0|||
30865838|NCT02819635|58896120|FG008|Substudy 3|Lost to Follow-up|1|||
30865839|NCT02819635|58896121|FG009|Substudy 3|Lost to Follow-up|0|||
30865840|NCT02819635|58896122|FG010|Substudy 3|Lost to Follow-up|1|||
30865841|NCT02819635|58896123|FG011|Substudy 3|Lost to Follow-up|1|||
30865842|NCT02819635|58896112|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
30865843|NCT02819635|58896113|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
30865844|NCT02819635|58896114|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
30865845|NCT02819635|58896115|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
30865846|NCT02819635|58896116|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
30865847|NCT02819635|58896117|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
30865848|NCT02819635|58896118|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
30865849|NCT02819635|58896119|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
30865850|NCT02819635|58896120|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
30865851|NCT02819635|58896121|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
30865852|NCT02819635|58896122|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
30865853|NCT02819635|58896123|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
30865854|NCT02819635|58896112|FG000|Substudy 3|Other, not specified|0|||
30865855|NCT02819635|58896113|FG001|Substudy 3|Other, not specified|0|||
30865856|NCT02819635|58896114|FG002|Substudy 3|Other, not specified|0|||
30865857|NCT02819635|58896115|FG003|Substudy 3|Other, not specified|0|||
30865858|NCT02819635|58896116|FG004|Substudy 3|Other, not specified|0|||
30865859|NCT02819635|58896117|FG005|Substudy 3|Other, not specified|0|||
30865860|NCT02819635|58896118|FG006|Substudy 3|Other, not specified|0|||
30865861|NCT02819635|58896119|FG007|Substudy 3|Other, not specified|0|||
30865862|NCT02819635|58896120|FG008|Substudy 3|Other, not specified|202|||
30865863|NCT02819635|58896121|FG009|Substudy 3|Other, not specified|5|||
30865864|NCT02819635|58896122|FG010|Substudy 3|Other, not specified|89|||
30865865|NCT02819635|58896123|FG011|Substudy 3|Other, not specified|39|||
30865866|NCT02424344|58896158|FG000|Overall Study|Lack of Efficacy|0|||
30865867|NCT02424344|58896159|FG001|Overall Study|Lack of Efficacy|1|||
30865868|NCT02424344|58896158|FG000|Overall Study|Withdrawal by Subject|2|||
30865869|NCT02424344|58896159|FG001|Overall Study|Withdrawal by Subject|1|||
30865870|NCT02424344|58896158|FG000|Overall Study|Lost to Follow-up|1|||
30865871|NCT02424344|58896159|FG001|Overall Study|Lost to Follow-up|0|||
30865872|NCT02424344|58896158|FG000|Overall Study|Adverse Event|4|||
30865873|NCT02424344|58896159|FG001|Overall Study|Adverse Event|8|||
30865874|NCT02423798|58896165|FG000|Overall Study|Withdrawal by Subject|3|||
30865875|NCT01651208|58896188|FG000|Overall Study|Lost to Follow-up|14|||
30865876|NCT01651208|58896189|FG001|Overall Study|Lost to Follow-up|16|||
30865877|NCT02383940|58896198|FG000|Overall Study|Adverse Event|1|||
30865878|NCT02383940|58896199|FG001|Overall Study|Adverse Event|0|||
30865879|NCT02383940|58896198|FG000|Overall Study|Lost to Follow-up|2|||
30865880|NCT02383940|58896199|FG001|Overall Study|Lost to Follow-up|2|||
30865881|NCT02383940|58896198|FG000|Overall Study|Physician Decision|2|||
30865882|NCT02383940|58896199|FG001|Overall Study|Physician Decision|0|||
30865883|NCT02383940|58896198|FG000|Overall Study|Withdrawal by Subject|1|||
30865884|NCT02383940|58896199|FG001|Overall Study|Withdrawal by Subject|1|||
30865885|NCT02383940|58896198|FG000|Overall Study|Randomized but not treated|2|||
30865886|NCT02383940|58896199|FG001|Overall Study|Randomized but not treated|0|||
30865887|NCT02383940|58896198|FG000|Overall Study|Other than specified above|1|||
30865888|NCT02383940|58896199|FG001|Overall Study|Other than specified above|0|||
30865889|NCT02383862|58896207|FG000|3 Month Follow up|Lost to Follow-up|23|||
30865890|NCT02383862|58896208|FG001|3 Month Follow up|Lost to Follow-up|21|||
30865891|NCT02383472|58896223|FG000|Overall Study|Withdrawal by Subject|1|||
30865892|NCT02383472|58896224|FG001|Overall Study|Withdrawal by Subject|1|||
30865893|NCT02234323|58896232|FG000|All Enrolled|Not Treated: Completed study in database|2|||
30865894|NCT02234323|58896232|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
30865895|NCT02234323|58896232|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
30865896|NCT02234323|58896232|FG000|All Treated|Death|1|||
30865897|NCT02234323|58896232|FG000|All Treated|Physician Decision|5|||
30865898|NCT02234323|58896232|FG000|All Treated|Lack of Efficacy|3|||
30865899|NCT02234323|58896232|FG000|All Treated|Exceeded lab value limit|2|||
30865900|NCT02234323|58896232|FG000|All Treated|Other|7|||
30865901|NCT02414828|58896242|FG000|Overall Study|Lost to Follow-up|0|||
30865902|NCT02414828|58896243|FG001|Overall Study|Lost to Follow-up|1|||
30865903|NCT02414828|58896244|FG002|Overall Study|Lost to Follow-up|1|||
30865904|NCT02414828|58896245|FG003|Overall Study|Lost to Follow-up|2|||
30865905|NCT02413346|58896258|FG000|Overall Study|Adverse Event|6|||
30865906|NCT02413346|58896259|FG001|Overall Study|Adverse Event|6|||
30865907|NCT02413346|58896258|FG000|Overall Study|Withdrawal by Subject|30|||
30865908|NCT02413346|58896259|FG001|Overall Study|Withdrawal by Subject|40|||
30865909|NCT02413346|58896258|FG000|Overall Study|Lost to Follow-up|17|||
30865910|NCT02413346|58896259|FG001|Overall Study|Lost to Follow-up|21|||
30865911|NCT02413346|58896258|FG000|Overall Study|Protocol Violation|2|||
30865912|NCT02413346|58896259|FG001|Overall Study|Protocol Violation|0|||
30865913|NCT02413346|58896258|FG000|Overall Study|Other Miscellaneous Reasons|4|||
30865914|NCT02413346|58896259|FG001|Overall Study|Other Miscellaneous Reasons|3|||
30865915|NCT03390101|58896272|FG000|Weeks 0-12|Withdrawal by Subject|0|||
30865916|NCT03390101|58896273|FG001|Weeks 0-12|Withdrawal by Subject|1|||
30865917|NCT03390101|58896274|FG002|Weeks 0-12|Withdrawal by Subject|1|||
30865918|NCT03390101|58896272|FG000|Weeks 0-12|Lost to Follow-up|0|||
30865919|NCT03390101|58896273|FG001|Weeks 0-12|Lost to Follow-up|1|||
30865920|NCT03390101|58896274|FG002|Weeks 0-12|Lost to Follow-up|0|||
30865921|NCT03390101|58896272|FG000|Weeks 12-54|Withdrawal by Subject|0|||
30865922|NCT03390101|58896273|FG001|Weeks 12-54|Withdrawal by Subject|3|||
30865923|NCT03390101|58896274|FG002|Weeks 12-54|Withdrawal by Subject|1|||
30865924|NCT03390101|58896272|FG000|Weeks 12-54|Pregnancy|1|||
30865925|NCT03390101|58896273|FG001|Weeks 12-54|Pregnancy|0|||
30865926|NCT03390101|58896274|FG002|Weeks 12-54|Pregnancy|0|||
30865927|NCT03390101|58896272|FG000|Weeks 12-54|Adverse Event|2|||
30865928|NCT03390101|58896273|FG001|Weeks 12-54|Adverse Event|1|||
30865929|NCT03390101|58896274|FG002|Weeks 12-54|Adverse Event|1|||
30865930|NCT02732639|58896282|FG000|Overall Study|Lost to Follow-up|1|||
30865931|NCT02732561|58896288|FG000|Overall Study|Lost to Follow-up|1|||
30865932|NCT02732561|58896289|FG001|Overall Study|Lost to Follow-up|1|||
30865933|NCT02732561|58896288|FG000|Overall Study|Withdrawal by Subject|1|||
30865934|NCT02732561|58896289|FG001|Overall Study|Withdrawal by Subject|0|||
30865935|NCT02412878|58896297|FG000|Overall Study|Withdrawal by Subject|19|||
30865936|NCT02412878|58896298|FG001|Overall Study|Withdrawal by Subject|10|||
30865937|NCT02412878|58896297|FG000|Overall Study|Lost to Follow-up|2|||
30865938|NCT02412878|58896298|FG001|Overall Study|Lost to Follow-up|3|||
30865939|NCT02380742|58896306|FG000|Overall Study|Withdrawal by Subject|1|||
30865940|NCT02380742|58896307|FG001|Overall Study|Withdrawal by Subject|0|||
30865941|NCT02922725|58896316|FG000|Overall Study|Withdrawal by Subject|1|||
30865942|NCT02922725|58896317|FG001|Overall Study|Withdrawal by Subject|0|||
30865943|NCT02922725|58896318|FG002|Overall Study|Withdrawal by Subject|0|||
30865944|NCT02805257|58896327|FG000|Overall Study|Lost to Follow-up|7|||
30865945|NCT02805257|58896328|FG001|Overall Study|Lost to Follow-up|6|||
30865946|NCT02805257|58896327|FG000|Overall Study|Death|0|||
30865947|NCT02805257|58896328|FG001|Overall Study|Death|1|||
30865948|NCT04794803|58896336|FG000|Overall Study|Death|1|||
30865949|NCT04794803|58896337|FG001|Overall Study|Death|3|||
30865950|NCT04794803|58896336|FG000|Overall Study|Lost to Follow-up|2|||
30865951|NCT04794803|58896337|FG001|Overall Study|Lost to Follow-up|2|||
30865952|NCT04794803|58896336|FG000|Overall Study|Withdrawal by Subject|1|||
30865953|NCT04794803|58896337|FG001|Overall Study|Withdrawal by Subject|0|||
30865954|NCT04794803|58896336|FG000|Overall Study|Physician Decision|1|||
30865955|NCT04794803|58896337|FG001|Overall Study|Physician Decision|1|||
30865956|NCT04794803|58896336|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
30865957|NCT04794803|58896337|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
30865958|NCT04794803|58896336|FG000|Overall Study|Refused to continue the treatment|1|||
30865959|NCT04794803|58896337|FG001|Overall Study|Refused to continue the treatment|0|||
30865960|NCT04794803|58896336|FG000|Overall Study|Patient admitted to ICU|0|||
30865961|NCT04794803|58896337|FG001|Overall Study|Patient admitted to ICU|1|||
30865962|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
30865963|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
30865964|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
30865965|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
30865966|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
30865967|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
30865968|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
30865969|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
30865970|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
30865971|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
30865972|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
30865973|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
30865974|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
30865975|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
30865976|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
30865977|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
30865978|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
30865979|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
30865980|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
30865981|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
30865982|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
30865983|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
30865984|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
30960805|NCT01521923|59026601|FG003|Overall Study|Lack of Efficacy|0|||
30865985|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
30865986|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
30865987|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
30865988|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
30865989|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
30865990|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
30865991|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
30865992|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
30865993|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
30865994|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
30865995|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
30865996|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
30865997|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
30865998|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
30865999|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
30866000|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
30866001|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
30866002|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
30866003|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
30866004|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
30866005|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
30866006|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
30866007|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
30866008|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
30866009|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
30866010|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
30866011|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
30866012|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
30866013|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
30866014|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
30866015|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
30866016|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
30866017|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
30866018|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
30866019|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
30866020|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
30866021|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
30866022|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
30866023|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
30866024|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
30866025|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
30866026|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
30866027|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
30866028|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
30866029|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
30866030|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
30866031|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
30866032|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
30866033|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
30866034|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
30866035|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
30866036|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
30866037|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
30866038|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
30866039|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
30866040|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
30866041|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
30866042|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
30866043|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
30866044|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
30866045|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
30866046|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
30866047|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
30866048|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
30866049|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
30866050|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
30866051|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
30866052|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
30866053|NCT01791595|58896350|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
30866054|NCT01791595|58896351|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
30866055|NCT01791595|58896352|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
30866056|NCT01791595|58896353|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
30866057|NCT01791595|58896354|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
30866058|NCT01791595|58896355|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
30866059|NCT01791595|58896356|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
30866060|NCT01791595|58896350|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
30866061|NCT01791595|58896351|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
30866062|NCT01791595|58896352|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
30866063|NCT01791595|58896353|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
30866064|NCT01791595|58896354|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
30866065|NCT01791595|58896355|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
30866066|NCT01791595|58896356|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
30866067|NCT01791595|58896350|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
30866068|NCT01791595|58896351|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
30866069|NCT01791595|58896352|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
30866070|NCT01791595|58896353|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
30866071|NCT01791595|58896354|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
30866072|NCT01791595|58896355|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
30866073|NCT01791595|58896356|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
30866074|NCT01791595|58896350|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
30866075|NCT01791595|58896351|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
30866076|NCT01791595|58896352|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
30866077|NCT01791595|58896353|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
30866078|NCT01791595|58896354|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
30866079|NCT01791595|58896355|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
30866080|NCT01791595|58896356|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
30866081|NCT01791595|58896350|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
30866082|NCT01791595|58896351|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
30866083|NCT01791595|58896352|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
30866084|NCT01791595|58896353|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
30866085|NCT01791595|58896354|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
30866086|NCT01791595|58896355|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
30866087|NCT01791595|58896356|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
30866088|NCT01559363|58896409|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
30866089|NCT01559363|58896410|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
30866090|NCT01559363|58896411|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
30866091|NCT01559363|58896412|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
30866092|NCT01559363|58896413|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
30866093|NCT01559363|58896414|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
30866094|NCT01559363|58896409|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
30866095|NCT01559363|58896410|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
30866096|NCT01559363|58896411|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
30866097|NCT01559363|58896412|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
30866098|NCT01559363|58896413|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
30866099|NCT01559363|58896414|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
30866100|NCT01559363|58896409|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
30866101|NCT01559363|58896410|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
30866102|NCT01559363|58896411|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
30866103|NCT01559363|58896412|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
30866104|NCT01559363|58896413|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
30866105|NCT01559363|58896414|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
30866106|NCT01559363|58896409|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
30866107|NCT01559363|58896410|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
30866108|NCT01559363|58896411|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
30866109|NCT01559363|58896412|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
30866110|NCT01559363|58896413|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
30866111|NCT01559363|58896414|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
30866112|NCT01559363|58896409|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
30866113|NCT01559363|58896410|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
30866114|NCT01559363|58896411|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
30866115|NCT01559363|58896412|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
30866116|NCT01559363|58896413|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
30866117|NCT01559363|58896414|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
30866118|NCT01559363|58896409|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
30866119|NCT01559363|58896410|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
30866120|NCT01559363|58896411|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
30866121|NCT01559363|58896412|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
30866122|NCT01559363|58896413|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
30866123|NCT01559363|58896414|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
30866124|NCT01559363|58896409|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
30866125|NCT01559363|58896410|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
30866126|NCT01559363|58896411|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
30866127|NCT01559363|58896412|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
30866128|NCT01559363|58896413|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
30866129|NCT01559363|58896414|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
30866130|NCT02732327|58896436|FG000|Overall Study|Protocol Violation|0|||
30866131|NCT02732327|58896437|FG001|Overall Study|Protocol Violation|1|||
30866132|NCT03179605|58896443|FG000|Overall Study|Withdrawal by Subject|1|||
30866133|NCT02412722|58896453|FG000|Overall Study|Adverse Event|0|||
30866134|NCT02412722|58896454|FG001|Overall Study|Adverse Event|2|||
30866135|NCT02412722|58896455|FG002|Overall Study|Adverse Event|0|||
30866136|NCT02412722|58896456|FG003|Overall Study|Adverse Event|3|||
30866137|NCT02412722|58896457|FG004|Overall Study|Adverse Event|0|||
30866138|NCT02412722|58896458|FG005|Overall Study|Adverse Event|3|||
30866139|NCT02412722|58896453|FG000|Overall Study|Progressive Disease|6|||
30866140|NCT02412722|58896454|FG001|Overall Study|Progressive Disease|4|||
30866141|NCT02412722|58896455|FG002|Overall Study|Progressive Disease|4|||
30866142|NCT02412722|58896456|FG003|Overall Study|Progressive Disease|9|||
30866143|NCT02412722|58896457|FG004|Overall Study|Progressive Disease|3|||
30866144|NCT02412722|58896458|FG005|Overall Study|Progressive Disease|3|||
30866145|NCT02412722|58896453|FG000|Overall Study|Withdrawal by Subject|2|||
30866146|NCT02412722|58896454|FG001|Overall Study|Withdrawal by Subject|0|||
30866147|NCT02412722|58896455|FG002|Overall Study|Withdrawal by Subject|1|||
30866148|NCT02412722|58896456|FG003|Overall Study|Withdrawal by Subject|2|||
30866149|NCT02412722|58896457|FG004|Overall Study|Withdrawal by Subject|1|||
30866150|NCT02412722|58896458|FG005|Overall Study|Withdrawal by Subject|1|||
30866151|NCT02412722|58896453|FG000|Overall Study|Lost to Follow-up|0|||
30866152|NCT02412722|58896454|FG001|Overall Study|Lost to Follow-up|0|||
30866153|NCT02412722|58896455|FG002|Overall Study|Lost to Follow-up|0|||
30866154|NCT02412722|58896456|FG003|Overall Study|Lost to Follow-up|0|||
30866155|NCT02412722|58896457|FG004|Overall Study|Lost to Follow-up|1|||
30866156|NCT02412722|58896458|FG005|Overall Study|Lost to Follow-up|0|||
30960806|NCT01521923|59026598|FG000|Overall Study|Protocol Violation|0|||
30960807|NCT01521923|59026599|FG001|Overall Study|Protocol Violation|0|||
30960808|NCT01521923|59026600|FG002|Overall Study|Protocol Violation|1|||
30960809|NCT01521923|59026601|FG003|Overall Study|Protocol Violation|0|||
30960810|NCT01521923|59026598|FG000|Overall Study|Lost to Follow-up|1|||
30960811|NCT01521923|59026599|FG001|Overall Study|Lost to Follow-up|0|||
30960812|NCT01521923|59026600|FG002|Overall Study|Lost to Follow-up|2|||
30866157|NCT02412722|58896453|FG000|Overall Study|Received drug in run-in and discontinued|0|||
30866158|NCT02412722|58896454|FG001|Overall Study|Received drug in run-in and discontinued|2|||
30866159|NCT02412722|58896455|FG002|Overall Study|Received drug in run-in and discontinued|0|||
30866160|NCT02412722|58896456|FG003|Overall Study|Received drug in run-in and discontinued|0|||
30866161|NCT02412722|58896457|FG004|Overall Study|Received drug in run-in and discontinued|0|||
30866162|NCT02412722|58896458|FG005|Overall Study|Received drug in run-in and discontinued|0|||
30866163|NCT02412722|58896453|FG000|Overall Study|Reason not Specified|3|||
30866164|NCT02412722|58896454|FG001|Overall Study|Reason not Specified|0|||
30866165|NCT02412722|58896455|FG002|Overall Study|Reason not Specified|2|||
30866166|NCT02412722|58896456|FG003|Overall Study|Reason not Specified|1|||
30866167|NCT02412722|58896457|FG004|Overall Study|Reason not Specified|2|||
30866168|NCT02412722|58896458|FG005|Overall Study|Reason not Specified|6|||
30866169|NCT03074695|58896494|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
30866170|NCT03074695|58896495|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
30866171|NCT03074695|58896494|FG000|Overall Study|Research staff not available|1|||
30866172|NCT03074695|58896495|FG001|Overall Study|Research staff not available|2|||
30866173|NCT03074695|58896494|FG000|Overall Study|Did not receive neuraxial block|2|||
30866174|NCT03074695|58896495|FG001|Overall Study|Did not receive neuraxial block|2|||
30866175|NCT03469999|58896501|FG000|Overall Study|Lost to Follow-up|2|||
30866176|NCT02379728|58896508|FG000|Overall Study|Lost to Follow-up|1|||
30866177|NCT02379728|58896509|FG001|Overall Study|Lost to Follow-up|0|||
30866178|NCT02379728|58896510|FG002|Overall Study|Lost to Follow-up|3|||
30960813|NCT01521923|59026601|FG003|Overall Study|Lost to Follow-up|1|||
30960814|NCT01521923|59026598|FG000|Overall Study|Withdrawal by Subject|1|||
30866179|NCT02379728|58896511|FG003|Overall Study|Lost to Follow-up|0|||
30866180|NCT02379728|58896508|FG000|Overall Study|Withdrawal by Subject|5|||
30866181|NCT02379728|58896509|FG001|Overall Study|Withdrawal by Subject|0|||
30866182|NCT02379728|58896510|FG002|Overall Study|Withdrawal by Subject|5|||
30866183|NCT02379728|58896511|FG003|Overall Study|Withdrawal by Subject|3|||
30866184|NCT02379728|58896508|FG000|Overall Study|Protocol Violation|0|||
30866185|NCT02379728|58896509|FG001|Overall Study|Protocol Violation|0|||
30866186|NCT02379728|58896510|FG002|Overall Study|Protocol Violation|2|||
30866187|NCT02379728|58896511|FG003|Overall Study|Protocol Violation|0|||
30866188|NCT03463993|58896522|FG000|Overall Study|Lost to Follow-up|7|||
30866189|NCT03463993|58896523|FG001|Overall Study|Lost to Follow-up|8|||
30866190|NCT03463993|58896522|FG000|Overall Study|Withdrawal by Subject|2|||
30866191|NCT03463993|58896523|FG001|Overall Study|Withdrawal by Subject|0|||
30866192|NCT03463993|58896522|FG000|Overall Study|Protocol Violation|4|||
30866193|NCT03463993|58896523|FG001|Overall Study|Protocol Violation|1|||
30866194|NCT03463993|58896522|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
30866195|NCT03463993|58896523|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
30866196|NCT03463993|58896522|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
30866197|NCT03463993|58896523|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
30866198|NCT02412488|58896538|FG000|Overall Study|Lost to Follow-up|10|||
30866199|NCT02412488|58896538|FG000|Overall Study|Withdrawal by Subject|5|||
30866200|NCT02412488|58896538|FG000|Overall Study|Physician Decision|1|||
30866201|NCT02412488|58896538|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
30866202|NCT02412488|58896538|FG000|Overall Study|Reveal LINQ explant|1|||
30866203|NCT02378480|58896544|FG000|Overall Study|Physician Decision|1|||
30866204|NCT02378480|58896545|FG001|Overall Study|Physician Decision|1|||
30866205|NCT02378480|58896544|FG000|Overall Study|Death|1|||
30866206|NCT02378480|58896545|FG001|Overall Study|Death|2|||
30866207|NCT02378480|58896544|FG000|Overall Study|Randomized, but Not Treated|6|||
30866208|NCT02378480|58896545|FG001|Overall Study|Randomized, but Not Treated|4|||
30866209|NCT02378480|58896544|FG000|Overall Study|Adverse Event|0|||
30866210|NCT02378480|58896545|FG001|Overall Study|Adverse Event|1|||
30866211|NCT02378480|58896544|FG000|Overall Study|Missed EOT/PTE Visit|1|||
30866212|NCT02378480|58896545|FG001|Overall Study|Missed EOT/PTE Visit|2|||
30866213|NCT02378480|58896544|FG000|Overall Study|Withdrawal by Subject|9|||
30866214|NCT02378480|58896545|FG001|Overall Study|Withdrawal by Subject|4|||
30866215|NCT02378480|58896544|FG000|Overall Study|Lost to Follow-up|10|||
30866216|NCT02378480|58896545|FG001|Overall Study|Lost to Follow-up|18|||
30866217|NCT02411396|58896551|FG000|Overall Study|Lost to Follow-up|31|||
30866218|NCT02411396|58896551|FG000|Overall Study|Death|10|||
30866219|NCT02345252|58896572|FG000|Double-Blind Phase|Adverse Event|2|||
30866220|NCT02345252|58896573|FG001|Double-Blind Phase|Adverse Event|3|||
30866221|NCT02345252|58896572|FG000|Double-Blind Phase|Death|1|||
30694526|NCT00608907|58708690|FG002|Overall Study|Withdrawal by Subject|0|||
30694527|NCT00608907|58708688|FG000|Overall Study|Progressive Disease|1|||
30694528|NCT00608907|58708689|FG001|Overall Study|Progressive Disease|0|||
30694529|NCT00608907|58708690|FG002|Overall Study|Progressive Disease|0|||
30694530|NCT00377611|58708700|FG000|Overall Study|Adverse Event|2|||
30694531|NCT00377611|58708701|FG001|Overall Study|Adverse Event|9|||
30694532|NCT00377611|58708700|FG000|Overall Study|Protocol Violation|2|||
30694533|NCT00377611|58708701|FG001|Overall Study|Protocol Violation|0|||
30694534|NCT00377611|58708700|FG000|Overall Study|Withdrawal by Subject|0|||
30694535|NCT00377611|58708701|FG001|Overall Study|Withdrawal by Subject|5|||
30694536|NCT00377611|58708700|FG000|Overall Study|Lost to Follow-up|18|||
30694537|NCT00377611|58708701|FG001|Overall Study|Lost to Follow-up|16|||
30866222|NCT02345252|58896573|FG001|Double-Blind Phase|Death|2|||
30866223|NCT02345252|58896572|FG000|Double-Blind Phase|Lack of Efficacy|1|||
30866224|NCT02345252|58896573|FG001|Double-Blind Phase|Lack of Efficacy|0|||
30866225|NCT02345252|58896572|FG000|Double-Blind Phase|Investigator's Discretion|4|||
30866226|NCT02345252|58896573|FG001|Double-Blind Phase|Investigator's Discretion|6|||
30866227|NCT02345252|58896572|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
30866228|NCT02345252|58896573|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
30866229|NCT02345252|58896572|FG000|Double-Blind Phase|Protocol Violation|2|||
30866230|NCT02345252|58896573|FG001|Double-Blind Phase|Protocol Violation|1|||
30866231|NCT02345252|58896572|FG000|Double-Blind Phase|Withdrew Consent|21|||
30866232|NCT02345252|58896573|FG001|Double-Blind Phase|Withdrew Consent|23|||
30866233|NCT02345252|58896572|FG000|Double-Blind Phase|Lost to Follow-up|8|||
30866234|NCT02345252|58896573|FG001|Double-Blind Phase|Lost to Follow-up|10|||
30866235|NCT02345252|58896572|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
30866236|NCT02345252|58896573|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
30960815|NCT01521923|59026599|FG001|Overall Study|Withdrawal by Subject|1|||
30866237|NCT01239797|58896583|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
30960816|NCT01521923|59026600|FG002|Overall Study|Withdrawal by Subject|1|||
30694538|NCT00377611|58708700|FG000|Overall Study|Other|0|||
30866238|NCT01239797|58896584|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
30866239|NCT01239797|58896583|FG000|Randomized Participants|Participant withdrew consent|1|||
30866240|NCT01239797|58896584|FG001|Randomized Participants|Participant withdrew consent|7|||
30866241|NCT01239797|58896583|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
30866242|NCT01239797|58896584|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
30866243|NCT01239797|58896583|FG000|Treated Participants|Disease progression|185|||
30866244|NCT01239797|58896584|FG001|Treated Participants|Disease progression|185|||
30866245|NCT01239797|58896583|FG000|Treated Participants|Study drug toxicity|39|||
30866246|NCT01239797|58896584|FG001|Treated Participants|Study drug toxicity|45|||
30866247|NCT01239797|58896583|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
30866248|NCT01239797|58896584|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
30866249|NCT01239797|58896583|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
30866250|NCT01239797|58896584|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
30866251|NCT01239797|58896583|FG000|Treated Participants|Administrative reason by sponsor|13|||
30866252|NCT01239797|58896584|FG001|Treated Participants|Administrative reason by sponsor|4|||
30866253|NCT01239797|58896583|FG000|Treated Participants|Other reasons|14|||
30866254|NCT01239797|58896584|FG001|Treated Participants|Other reasons|14|||
30866255|NCT01239797|58896583|FG000|Treated Participants|Participant withdrew consent|6|||
30866256|NCT01239797|58896584|FG001|Treated Participants|Participant withdrew consent|11|||
30866257|NCT01239797|58896583|FG000|Treated Participants|Death|1|||
30866258|NCT01239797|58896584|FG001|Treated Participants|Death|1|||
30866259|NCT01239797|58896583|FG000|Treated Participants|Participant no longer meets study criteria|1|||
30866260|NCT01239797|58896584|FG001|Treated Participants|Participant no longer meets study criteria|1|||
30866261|NCT01239797|58896583|FG000|Treated Participants|Poor/non-compliance|0|||
30866262|NCT01239797|58896584|FG001|Treated Participants|Poor/non-compliance|1|||
30866263|NCT02639065|58896590|FG000|Study Treatment|Disease Progression|11|||
30866264|NCT02639065|58896590|FG000|Study Treatment|Adverse Event|8|||
30866265|NCT02639065|58896590|FG000|Study Treatment|Withdrawal by Subject|1|||
30866266|NCT02639065|58896590|FG000|Follow up|Withdrawal by Subject|1|||
30866267|NCT02639065|58896590|FG000|Follow up|Symptomatic Deterioration|2|||
30866268|NCT02639065|58896590|FG000|Follow up|Death|2|||
30866269|NCT02639065|58896590|FG000|Follow up|Study Terminated|1|||
30866270|NCT02639065|58896590|FG000|Follow up|Disease Progression|3|||
30866271|NCT01092143|58896599|FG000|Overall Study|Adverse Event|10|||
30866272|NCT01092143|58896600|FG001|Overall Study|Adverse Event|5|||
30866273|NCT01092143|58896601|FG002|Overall Study|Adverse Event|1|||
30866274|NCT01092143|58896602|FG003|Overall Study|Adverse Event|4|||
30866275|NCT01092143|58896603|FG004|Overall Study|Adverse Event|3|||
30866276|NCT01092143|58896599|FG000|Overall Study|Lost to Follow-up|1|||
30866277|NCT01092143|58896600|FG001|Overall Study|Lost to Follow-up|0|||
30866278|NCT01092143|58896601|FG002|Overall Study|Lost to Follow-up|1|||
30866279|NCT01092143|58896602|FG003|Overall Study|Lost to Follow-up|0|||
30866280|NCT01092143|58896603|FG004|Overall Study|Lost to Follow-up|0|||
30866281|NCT01092143|58896599|FG000|Overall Study|Consent withdrawn|2|||
30866282|NCT01092143|58896600|FG001|Overall Study|Consent withdrawn|1|||
30866283|NCT01092143|58896601|FG002|Overall Study|Consent withdrawn|0|||
30866284|NCT01092143|58896602|FG003|Overall Study|Consent withdrawn|1|||
30866285|NCT01092143|58896603|FG004|Overall Study|Consent withdrawn|3|||
30866286|NCT01092143|58896599|FG000|Overall Study|Not treated|0|||
30866287|NCT01092143|58896600|FG001|Overall Study|Not treated|0|||
30866288|NCT01092143|58896601|FG002|Overall Study|Not treated|1|||
30866289|NCT01092143|58896602|FG003|Overall Study|Not treated|0|||
30866290|NCT01092143|58896603|FG004|Overall Study|Not treated|0|||
30866291|NCT01092143|58896599|FG000|Overall Study|did not reversibility criteria|0|||
30866292|NCT01092143|58896600|FG001|Overall Study|did not reversibility criteria|0|||
30866293|NCT01092143|58896601|FG002|Overall Study|did not reversibility criteria|1|||
30866294|NCT01092143|58896602|FG003|Overall Study|did not reversibility criteria|0|||
30866295|NCT01092143|58896603|FG004|Overall Study|did not reversibility criteria|0|||
30866296|NCT01092143|58896599|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
30866297|NCT01092143|58896600|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
30866298|NCT01092143|58896601|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
30866299|NCT01092143|58896602|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
30866300|NCT01092143|58896603|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
30866301|NCT01092143|58896599|FG000|Overall Study|Ineligible patient|1|||
30866302|NCT01092143|58896600|FG001|Overall Study|Ineligible patient|0|||
30866303|NCT01092143|58896601|FG002|Overall Study|Ineligible patient|0|||
30866304|NCT01092143|58896602|FG003|Overall Study|Ineligible patient|0|||
30866305|NCT01092143|58896603|FG004|Overall Study|Ineligible patient|0|||
30866306|NCT01092143|58896599|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
30866307|NCT01092143|58896600|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
30866308|NCT01092143|58896601|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
30866309|NCT01092143|58896602|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
30866310|NCT01092143|58896603|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
30866311|NCT01092143|58896599|FG000|Overall Study|Patient travel|0|||
30866312|NCT01092143|58896600|FG001|Overall Study|Patient travel|0|||
30866313|NCT01092143|58896601|FG002|Overall Study|Patient travel|0|||
30866314|NCT01092143|58896602|FG003|Overall Study|Patient travel|0|||
30866315|NCT01092143|58896603|FG004|Overall Study|Patient travel|1|||
30866316|NCT01092143|58896599|FG000|Overall Study|Non compliance with study medication|0|||
30866317|NCT01092143|58896600|FG001|Overall Study|Non compliance with study medication|0|||
30866318|NCT01092143|58896601|FG002|Overall Study|Non compliance with study medication|0|||
30866319|NCT01092143|58896602|FG003|Overall Study|Non compliance with study medication|0|||
30866320|NCT01092143|58896603|FG004|Overall Study|Non compliance with study medication|1|||
30866321|NCT01092143|58896599|FG000|Overall Study|Randomized by mistake|0|||
30866322|NCT01092143|58896600|FG001|Overall Study|Randomized by mistake|0|||
30866323|NCT01092143|58896601|FG002|Overall Study|Randomized by mistake|0|||
30866324|NCT01092143|58896602|FG003|Overall Study|Randomized by mistake|1|||
30866325|NCT01092143|58896603|FG004|Overall Study|Randomized by mistake|0|||
30866326|NCT01092143|58896599|FG000|Overall Study|Pregnancy|0|||
30866327|NCT01092143|58896600|FG001|Overall Study|Pregnancy|0|||
30866328|NCT01092143|58896601|FG002|Overall Study|Pregnancy|0|||
30866329|NCT01092143|58896602|FG003|Overall Study|Pregnancy|1|||
30866330|NCT01092143|58896603|FG004|Overall Study|Pregnancy|0|||
30866331|NCT02377466|58896617|FG000|Overall Study|Other: Randomized and not treated|0|||
30866332|NCT02377466|58896618|FG001|Overall Study|Other: Randomized and not treated|2|||
30866333|NCT00950989|58896635|FG000|Overall Study|Death|0|||
30866334|NCT00950989|58896636|FG001|Overall Study|Death|0|||
30866335|NCT00950989|58896637|FG002|Overall Study|Death|1|||
30866336|NCT00950989|58896638|FG003|Overall Study|Death|0|||
30866337|NCT00950989|58896635|FG000|Overall Study|Administrative Decision|0|||
30866338|NCT00950989|58896636|FG001|Overall Study|Administrative Decision|1|||
30866339|NCT00950989|58896637|FG002|Overall Study|Administrative Decision|0|||
30866340|NCT00950989|58896638|FG003|Overall Study|Administrative Decision|0|||
30866341|NCT00950989|58896635|FG000|Overall Study|Disease Progression|0|||
30866342|NCT00950989|58896636|FG001|Overall Study|Disease Progression|0|||
30866343|NCT00950989|58896637|FG002|Overall Study|Disease Progression|1|||
30866344|NCT00950989|58896638|FG003|Overall Study|Disease Progression|0|||
30866345|NCT00950989|58896635|FG000|Overall Study|Withdrawal by Subject|2|||
30866346|NCT00950989|58896636|FG001|Overall Study|Withdrawal by Subject|1|||
30866347|NCT00950989|58896637|FG002|Overall Study|Withdrawal by Subject|0|||
30866348|NCT00950989|58896638|FG003|Overall Study|Withdrawal by Subject|0|||
30866349|NCT00950989|58896635|FG000|Overall Study|Adverse Event|2|||
30866350|NCT00950989|58896636|FG001|Overall Study|Adverse Event|1|||
30866351|NCT00950989|58896637|FG002|Overall Study|Adverse Event|1|||
30866352|NCT00950989|58896638|FG003|Overall Study|Adverse Event|0|||
30866353|NCT00593567|58896653|FG000|Overall Study|Adverse Event|2|||
30866354|NCT00593567|58896654|FG001|Overall Study|Adverse Event|0|||
30866355|NCT00593567|58896653|FG000|Overall Study|Physician Decision|2|||
30866356|NCT00593567|58896654|FG001|Overall Study|Physician Decision|0|||
30866357|NCT00593567|58896653|FG000|Overall Study|Protocol Violation|13|||
30866358|NCT00593567|58896654|FG001|Overall Study|Protocol Violation|7|||
30866359|NCT00593567|58896653|FG000|Overall Study|Lack of Efficacy|2|||
30866360|NCT00593567|58896654|FG001|Overall Study|Lack of Efficacy|1|||
30866361|NCT00593567|58896653|FG000|Overall Study|Withdrawal by Subject|1|||
30866362|NCT00593567|58896654|FG001|Overall Study|Withdrawal by Subject|2|||
30866363|NCT02411084|58896662|FG000|Overall Study|Lack of Efficacy|6|||
30866364|NCT02411084|58896663|FG001|Overall Study|Lack of Efficacy|3|||
30866365|NCT02411084|58896662|FG000|Overall Study|Death|5|||
30866366|NCT02411084|58896663|FG001|Overall Study|Death|4|||
30866367|NCT02411084|58896662|FG000|Overall Study|Adverse Event|2|||
30866368|NCT02411084|58896663|FG001|Overall Study|Adverse Event|1|||
30866369|NCT02411084|58896662|FG000|Overall Study|Other reasons|0|||
30866370|NCT02411084|58896663|FG001|Overall Study|Other reasons|5|||
30866371|NCT01602315|58896676|FG000|Overall Study|Protocol Violation|0|||
30866372|NCT01602315|58896677|FG001|Overall Study|Protocol Violation|0|||
30866373|NCT01602315|58896678|FG002|Overall Study|Protocol Violation|0|||
30866374|NCT01602315|58896679|FG003|Overall Study|Protocol Violation|0|||
30866375|NCT01602315|58896680|FG004|Overall Study|Protocol Violation|0|||
30866376|NCT01602315|58896681|FG005|Overall Study|Protocol Violation|1|||
30866377|NCT01602315|58896682|FG006|Overall Study|Protocol Violation|0|||
30866378|NCT01602315|58896676|FG000|Overall Study|Physician Decision|2|||
30866379|NCT01602315|58896677|FG001|Overall Study|Physician Decision|0|||
30866380|NCT01602315|58896678|FG002|Overall Study|Physician Decision|0|||
30866381|NCT01602315|58896679|FG003|Overall Study|Physician Decision|0|||
30866382|NCT01602315|58896680|FG004|Overall Study|Physician Decision|2|||
30866383|NCT01602315|58896681|FG005|Overall Study|Physician Decision|1|||
30866384|NCT01602315|58896682|FG006|Overall Study|Physician Decision|1|||
30866385|NCT01602315|58896676|FG000|Overall Study|Disease progression|6|||
30866386|NCT01602315|58896677|FG001|Overall Study|Disease progression|3|||
30866387|NCT01602315|58896678|FG002|Overall Study|Disease progression|10|||
30866388|NCT01602315|58896679|FG003|Overall Study|Disease progression|1|||
30866389|NCT01602315|58896680|FG004|Overall Study|Disease progression|41|||
30866390|NCT01602315|58896681|FG005|Overall Study|Disease progression|12|||
30866391|NCT01602315|58896682|FG006|Overall Study|Disease progression|15|||
30866392|NCT01602315|58896676|FG000|Overall Study|Death|1|||
30866393|NCT01602315|58896677|FG001|Overall Study|Death|1|||
30866394|NCT01602315|58896678|FG002|Overall Study|Death|1|||
30866395|NCT01602315|58896679|FG003|Overall Study|Death|1|||
30866396|NCT01602315|58896680|FG004|Overall Study|Death|7|||
30866397|NCT01602315|58896681|FG005|Overall Study|Death|2|||
30866398|NCT01602315|58896682|FG006|Overall Study|Death|2|||
30866399|NCT01602315|58896676|FG000|Overall Study|Withdrawal by Subject|2|||
30866400|NCT01602315|58896677|FG001|Overall Study|Withdrawal by Subject|0|||
30866401|NCT01602315|58896678|FG002|Overall Study|Withdrawal by Subject|2|||
30866402|NCT01602315|58896679|FG003|Overall Study|Withdrawal by Subject|0|||
30866403|NCT01602315|58896680|FG004|Overall Study|Withdrawal by Subject|6|||
30866404|NCT01602315|58896681|FG005|Overall Study|Withdrawal by Subject|0|||
30866405|NCT01602315|58896682|FG006|Overall Study|Withdrawal by Subject|1|||
30866406|NCT01602315|58896676|FG000|Overall Study|Adverse Event|5|||
30866407|NCT01602315|58896677|FG001|Overall Study|Adverse Event|1|||
30866408|NCT01602315|58896678|FG002|Overall Study|Adverse Event|5|||
30866409|NCT01602315|58896679|FG003|Overall Study|Adverse Event|4|||
30866410|NCT01602315|58896680|FG004|Overall Study|Adverse Event|15|||
30866411|NCT01602315|58896681|FG005|Overall Study|Adverse Event|3|||
30866412|NCT01602315|58896682|FG006|Overall Study|Adverse Event|9|||
30866413|NCT01602315|58896676|FG000|Overall Study|Subject/guardian decision|0|||
30866414|NCT01602315|58896677|FG001|Overall Study|Subject/guardian decision|0|||
30866415|NCT01602315|58896678|FG002|Overall Study|Subject/guardian decision|0|||
30866416|NCT01602315|58896679|FG003|Overall Study|Subject/guardian decision|0|||
30866417|NCT01602315|58896680|FG004|Overall Study|Subject/guardian decision|0|||
30866418|NCT01602315|58896681|FG005|Overall Study|Subject/guardian decision|0|||
30866419|NCT01602315|58896682|FG006|Overall Study|Subject/guardian decision|1|||
30866420|NCT01602315|58896676|FG000|Overall Study|Cross-over patients to combo treatment|0|||
30866421|NCT01602315|58896677|FG001|Overall Study|Cross-over patients to combo treatment|0|||
30866422|NCT01602315|58896678|FG002|Overall Study|Cross-over patients to combo treatment|0|||
30866423|NCT01602315|58896679|FG003|Overall Study|Cross-over patients to combo treatment|0|||
30866424|NCT01602315|58896680|FG004|Overall Study|Cross-over patients to combo treatment|0|||
30866425|NCT01602315|58896681|FG005|Overall Study|Cross-over patients to combo treatment|16|||
30866426|NCT01602315|58896682|FG006|Overall Study|Cross-over patients to combo treatment|0|||
30866427|NCT02344004|58896729|FG000|Overall Study|Adverse Event|11|||
30866428|NCT02344004|58896730|FG001|Overall Study|Adverse Event|1|||
30866429|NCT02344004|58896729|FG000|Overall Study|Death|9|||
30866430|NCT02344004|58896730|FG001|Overall Study|Death|7|||
30866431|NCT02344004|58896729|FG000|Overall Study|Physician Decision|4|||
30866432|NCT02344004|58896730|FG001|Overall Study|Physician Decision|1|||
30866433|NCT02344004|58896729|FG000|Overall Study|Withdrawal by Subject|22|||
30866434|NCT02344004|58896730|FG001|Overall Study|Withdrawal by Subject|5|||
30866435|NCT02344004|58896729|FG000|Overall Study|Rescue Medication|2|||
30866436|NCT02344004|58896730|FG001|Overall Study|Rescue Medication|0|||
30866437|NCT02344004|58896729|FG000|Overall Study|Other Not Specified|12|||
30866438|NCT02344004|58896730|FG001|Overall Study|Other Not Specified|0|||
30866439|NCT02344004|58896729|FG000|Overall Study|Protocol Violation|1|||
30866440|NCT02344004|58896730|FG001|Overall Study|Protocol Violation|0|||
30866441|NCT01328093|58896739|FG000|Double-Blind Phase|Adverse Event|78|||
30866442|NCT01328093|58896740|FG001|Double-Blind Phase|Adverse Event|15|||
30866443|NCT01328093|58896739|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
30866444|NCT01328093|58896740|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
30866445|NCT01328093|58896739|FG000|Double-Blind Phase|Lost to Follow-up|39|||
30866446|NCT01328093|58896740|FG001|Double-Blind Phase|Lost to Follow-up|14|||
30866447|NCT01328093|58896739|FG000|Double-Blind Phase|Protocol Violation|30|||
30866448|NCT01328093|58896740|FG001|Double-Blind Phase|Protocol Violation|10|||
30866449|NCT01328093|58896739|FG000|Double-Blind Phase|Lack of Efficacy|55|||
30866450|NCT01328093|58896740|FG001|Double-Blind Phase|Lack of Efficacy|13|||
30866451|NCT01328093|58896739|FG000|Double-Blind Phase|Sponsor Decision|17|||
30866452|NCT01328093|58896740|FG001|Double-Blind Phase|Sponsor Decision|3|||
30866453|NCT01328093|58896739|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
30866454|NCT01328093|58896740|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
30866455|NCT01328093|58896739|FG000|Double-Blind Phase|Scheduling conflict|8|||
30866456|NCT01328093|58896740|FG001|Double-Blind Phase|Scheduling conflict|3|||
30866457|NCT01328093|58896739|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
30866458|NCT01328093|58896740|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
30866459|NCT01328093|58896739|FG000|Double-Blind Phase|Death|1|||
30866460|NCT01328093|58896740|FG001|Double-Blind Phase|Death|0|||
30866461|NCT01328093|58896739|FG000|Open-Label Phase|Sponsor Decision|98|||
30866462|NCT01328093|58896740|FG001|Open-Label Phase|Sponsor Decision|34|||
30866463|NCT01328093|58896739|FG000|Open-Label Phase|Protocol Violation|8|||
30866464|NCT01328093|58896740|FG001|Open-Label Phase|Protocol Violation|3|||
30866465|NCT01328093|58896739|FG000|Open-Label Phase|Lost to Follow-up|10|||
30866466|NCT01328093|58896740|FG001|Open-Label Phase|Lost to Follow-up|1|||
30866467|NCT01328093|58896739|FG000|Open-Label Phase|Adverse Event|10|||
30866468|NCT01328093|58896740|FG001|Open-Label Phase|Adverse Event|4|||
30866469|NCT01328093|58896739|FG000|Open-Label Phase|Lack of Efficacy|5|||
30866470|NCT01328093|58896740|FG001|Open-Label Phase|Lack of Efficacy|6|||
30866471|NCT01328093|58896739|FG000|Open-Label Phase|Withdrawal by Subject|4|||
30866472|NCT01328093|58896740|FG001|Open-Label Phase|Withdrawal by Subject|1|||
30866473|NCT01328093|58896739|FG000|Open-Label Phase|Scheduling conflict|2|||
30866474|NCT01328093|58896740|FG001|Open-Label Phase|Scheduling conflict|1|||
30866475|NCT01328093|58896739|FG000|Open-Label Phase|Subject is moving or has moved|2|||
30866476|NCT01328093|58896740|FG001|Open-Label Phase|Subject is moving or has moved|0|||
30866477|NCT01328093|58896739|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
30866478|NCT01328093|58896740|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
30866479|NCT02654145|58896747|FG000|Overall Study|Lack of Efficacy|1|||
30866480|NCT02654145|58896747|FG000|Overall Study|Protocol Violation|1|||
30866481|NCT02654145|58896747|FG000|Overall Study|Withdrawal by Subject|5|||
30866482|NCT01111565|58896751|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
30866483|NCT01111565|58896752|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
30866484|NCT01111565|58896753|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
30866485|NCT01111565|58896754|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
30866486|NCT01111565|58896755|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
30866487|NCT01111565|58896751|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
30866488|NCT01111565|58896752|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
30866489|NCT01111565|58896753|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
30866490|NCT01111565|58896754|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
30866491|NCT01111565|58896755|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
30866492|NCT01111565|58896751|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
30866493|NCT01111565|58896752|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
30866494|NCT01111565|58896753|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
30866495|NCT01111565|58896754|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
30866496|NCT01111565|58896755|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
30866497|NCT01111565|58896751|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
30866498|NCT01111565|58896752|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
30866499|NCT01111565|58896753|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
30866500|NCT01111565|58896754|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
30866501|NCT01111565|58896755|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
30866502|NCT01111565|58896751|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
30866503|NCT01111565|58896752|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
30866504|NCT01111565|58896753|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
30866505|NCT01111565|58896754|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
30866506|NCT01111565|58896755|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
30866507|NCT01111565|58896751|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
30866508|NCT01111565|58896752|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
30866509|NCT01111565|58896753|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
30866510|NCT01111565|58896754|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
30866511|NCT01111565|58896755|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
30866512|NCT01111565|58896751|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
30866513|NCT01111565|58896752|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
30866514|NCT01111565|58896753|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
30866515|NCT01111565|58896754|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
30866516|NCT01111565|58896755|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
30866517|NCT01111565|58896751|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
30866518|NCT01111565|58896752|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
30866519|NCT01111565|58896753|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
30866520|NCT01111565|58896754|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
30866521|NCT01111565|58896755|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
30866522|NCT01111565|58896751|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
30866523|NCT01111565|58896752|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
30866524|NCT01111565|58896753|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
30866525|NCT01111565|58896754|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
30866526|NCT01111565|58896755|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
30866527|NCT01111565|58896751|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
30866528|NCT01111565|58896752|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
30866529|NCT01111565|58896753|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
30866530|NCT01111565|58896754|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
30866531|NCT01111565|58896755|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
30866532|NCT01111565|58896751|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
30866533|NCT01111565|58896752|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
30866534|NCT01111565|58896753|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
30866535|NCT01111565|58896754|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
30866536|NCT01111565|58896755|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
30866537|NCT01111565|58896751|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
30866538|NCT01111565|58896752|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
30602217|NCT01289574|58613548|FG001|Overall Study|Withdrawal by Subject|1|||
30866539|NCT01111565|58896753|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
30866540|NCT01111565|58896754|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
30866541|NCT01111565|58896755|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
30866542|NCT02343458|58896769|FG000|Overall Study|Adverse Event|15|||
30866543|NCT02343458|58896770|FG001|Overall Study|Adverse Event|14|||
30866544|NCT02343458|58896771|FG002|Overall Study|Adverse Event|15|||
30866545|NCT02343458|58896772|FG003|Overall Study|Adverse Event|3|||
30866546|NCT02343458|58896769|FG000|Overall Study|Lack of Efficacy|3|||
30866547|NCT02343458|58896770|FG001|Overall Study|Lack of Efficacy|8|||
30866548|NCT02343458|58896771|FG002|Overall Study|Lack of Efficacy|4|||
30866549|NCT02343458|58896772|FG003|Overall Study|Lack of Efficacy|8|||
30866550|NCT02343458|58896769|FG000|Overall Study|Withdrawal by Subject|18|||
30866551|NCT02343458|58896770|FG001|Overall Study|Withdrawal by Subject|17|||
30866552|NCT02343458|58896771|FG002|Overall Study|Withdrawal by Subject|23|||
30866553|NCT02343458|58896772|FG003|Overall Study|Withdrawal by Subject|14|||
30866554|NCT02343458|58896769|FG000|Overall Study|Physician Decision|1|||
30866555|NCT02343458|58896770|FG001|Overall Study|Physician Decision|4|||
30866556|NCT02343458|58896771|FG002|Overall Study|Physician Decision|2|||
30866557|NCT02343458|58896772|FG003|Overall Study|Physician Decision|2|||
30866558|NCT02343458|58896769|FG000|Overall Study|Lost to Follow-up|5|||
30866559|NCT02343458|58896770|FG001|Overall Study|Lost to Follow-up|5|||
30866560|NCT02343458|58896771|FG002|Overall Study|Lost to Follow-up|3|||
30866561|NCT02343458|58896772|FG003|Overall Study|Lost to Follow-up|1|||
30866562|NCT02343458|58896769|FG000|Overall Study|Protocol Violation|2|||
30866563|NCT02343458|58896770|FG001|Overall Study|Protocol Violation|5|||
30866564|NCT02343458|58896771|FG002|Overall Study|Protocol Violation|2|||
30866565|NCT02343458|58896772|FG003|Overall Study|Protocol Violation|2|||
30866566|NCT02343458|58896769|FG000|Overall Study|Protocol Specified Criteria|17|||
30866567|NCT02343458|58896770|FG001|Overall Study|Protocol Specified Criteria|13|||
30866568|NCT02343458|58896771|FG002|Overall Study|Protocol Specified Criteria|14|||
30866569|NCT02343458|58896772|FG003|Overall Study|Protocol Specified Criteria|8|||
30866570|NCT01328041|58896795|FG000|Overall Study|Adverse Event|7|||
30866571|NCT01328041|58896795|FG000|Overall Study|Lack of Efficacy|27|||
30866572|NCT01328041|58896795|FG000|Overall Study|Protocol Violation|7|||
30866573|NCT01328041|58896795|FG000|Overall Study|Lost to Follow-up|7|||
30866574|NCT01328041|58896795|FG000|Overall Study|Physician Decision|2|||
30866575|NCT01328041|58896795|FG000|Overall Study|Withdrawal by Subject|7|||
30866576|NCT02410772|58896802|FG000|Overall Study|Death|3|||
30694539|NCT00377611|58708701|FG001|Overall Study|Other|3|||
30694540|NCT00545272|58708714|FG000|Overall Study|Protocol deviation|0|||
30694541|NCT00545272|58708715|FG001|Overall Study|Protocol deviation|1|||
30694542|NCT00545272|58708716|FG002|Overall Study|Protocol deviation|0|||
30694543|NCT00545272|58708717|FG003|Overall Study|Protocol deviation|1|||
30694544|NCT00545272|58708718|FG004|Overall Study|Protocol deviation|0|||
30694545|NCT00545272|58708719|FG005|Overall Study|Protocol deviation|1|||
30866577|NCT02410772|58896803|FG001|Overall Study|Death|4|||
30866578|NCT02410772|58896804|FG002|Overall Study|Death|8|||
30866579|NCT02410772|58896802|FG000|Overall Study|Lost to Follow-up|31|||
30866580|NCT02410772|58896803|FG001|Overall Study|Lost to Follow-up|23|||
30866581|NCT02410772|58896804|FG002|Overall Study|Lost to Follow-up|22|||
30866582|NCT02410772|58896802|FG000|Overall Study|Pregnancy|8|||
30866583|NCT02410772|58896803|FG001|Overall Study|Pregnancy|4|||
30866584|NCT02410772|58896804|FG002|Overall Study|Pregnancy|5|||
30866585|NCT02410772|58896802|FG000|Overall Study|Protocol Violation|8|||
30866586|NCT02410772|58896803|FG001|Overall Study|Protocol Violation|8|||
30866587|NCT02410772|58896804|FG002|Overall Study|Protocol Violation|4|||
30866588|NCT02410772|58896802|FG000|Overall Study|Baseline Drug Resistance|49|||
30866589|NCT02410772|58896803|FG001|Overall Study|Baseline Drug Resistance|40|||
30866590|NCT02410772|58896804|FG002|Overall Study|Baseline Drug Resistance|51|||
30866591|NCT02410772|58896802|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
30866592|NCT02410772|58896803|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
30866593|NCT02410772|58896804|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
30866594|NCT02410772|58896802|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
30866595|NCT02410772|58896803|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
30866596|NCT02410772|58896804|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
30866597|NCT01648790|58896821|FG000|Treatment 3|Withdrawal by Subject|0|||
30866598|NCT01648790|58896822|FG001|Treatment 3|Withdrawal by Subject|0|||
30866599|NCT01648790|58896823|FG002|Treatment 3|Withdrawal by Subject|0|||
30866600|NCT01648790|58896824|FG003|Treatment 3|Withdrawal by Subject|1|||
30866601|NCT01648790|58896825|FG004|Treatment 3|Withdrawal by Subject|0|||
30866602|NCT01936857|58896848|FG000|Overall Study|Sent to prison or 06 center|11|||
30866603|NCT01936857|58896849|FG001|Overall Study|Sent to prison or 06 center|12|||
30960817|NCT01521923|59026601|FG003|Overall Study|Withdrawal by Subject|2|||
30694546|NCT00545272|58708714|FG000|Overall Study|Adverse Event|0|||
30694547|NCT00545272|58708715|FG001|Overall Study|Adverse Event|0|||
30866604|NCT01936857|58896848|FG000|Overall Study|Lost to Follow-up|10|||
30866605|NCT01936857|58896849|FG001|Overall Study|Lost to Follow-up|7|||
30866606|NCT01936857|58896848|FG000|Overall Study|Death|7|||
30866607|NCT01936857|58896849|FG001|Overall Study|Death|3|||
30866608|NCT01936857|58896848|FG000|Overall Study|Moved|2|||
30866609|NCT01936857|58896849|FG001|Overall Study|Moved|1|||
30866610|NCT01936857|58896848|FG000|Overall Study|Withdrawal by Subject|1|||
30866611|NCT01936857|58896849|FG001|Overall Study|Withdrawal by Subject|0|||
30866612|NCT01936857|58896848|FG000|Overall Study|Side effect of medication|1|||
30866613|NCT01936857|58896849|FG001|Overall Study|Side effect of medication|0|||
30866614|NCT01936857|58896848|FG000|Overall Study|Other|2|||
30866615|NCT01936857|58896849|FG001|Overall Study|Other|2|||
30866616|NCT01602224|58896858|FG000|Overall Study|Adverse Event|0|||
30866617|NCT01602224|58896859|FG001|Overall Study|Adverse Event|1|||
30866618|NCT01602224|58896860|FG002|Overall Study|Adverse Event|0|||
30866619|NCT01602224|58896858|FG000|Overall Study|Investigator Decison|1|||
30866620|NCT01602224|58896859|FG001|Overall Study|Investigator Decison|0|||
30866621|NCT01602224|58896860|FG002|Overall Study|Investigator Decison|0|||
30866622|NCT01602224|58896858|FG000|Overall Study|Lost to Follow-up|0|||
30866623|NCT01602224|58896859|FG001|Overall Study|Lost to Follow-up|0|||
30866624|NCT01602224|58896860|FG002|Overall Study|Lost to Follow-up|1|||
30866625|NCT01602224|58896858|FG000|Overall Study|Protocol Violation|0|||
30866626|NCT01602224|58896859|FG001|Overall Study|Protocol Violation|1|||
30866627|NCT01602224|58896860|FG002|Overall Study|Protocol Violation|0|||
30866628|NCT01602224|58896858|FG000|Overall Study|Sponsor Decision|2|||
30866629|NCT01602224|58896859|FG001|Overall Study|Sponsor Decision|3|||
30866630|NCT01602224|58896860|FG002|Overall Study|Sponsor Decision|2|||
30866631|NCT01602224|58896858|FG000|Overall Study|Withdrawal by Subject|5|||
30866632|NCT01602224|58896859|FG001|Overall Study|Withdrawal by Subject|3|||
30866633|NCT01602224|58896860|FG002|Overall Study|Withdrawal by Subject|3|||
30866634|NCT04498247|58896878|FG000|Overall Study|Lost to Follow-up|0|||
30866635|NCT04498247|58896879|FG001|Overall Study|Lost to Follow-up|0|||
30866636|NCT04498247|58896880|FG002|Overall Study|Lost to Follow-up|0|||
30866637|NCT04498247|58896881|FG003|Overall Study|Lost to Follow-up|1|||
30866638|NCT04498247|58896882|FG004|Overall Study|Lost to Follow-up|0|||
30866639|NCT04498247|58896883|FG005|Overall Study|Lost to Follow-up|0|||
30866640|NCT04498247|58896884|FG006|Overall Study|Lost to Follow-up|0|||
30866641|NCT04498247|58896885|FG007|Overall Study|Lost to Follow-up|0|||
30866642|NCT04498247|58896878|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
30866643|NCT04498247|58896879|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
30866644|NCT04498247|58896880|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
30866645|NCT04498247|58896881|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
30866646|NCT04498247|58896882|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
30866647|NCT04498247|58896883|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
30866648|NCT04498247|58896884|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
30866649|NCT04498247|58896885|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
30866650|NCT04498247|58896878|FG000|Overall Study|Withdrawal by Subject|0|||
30866651|NCT04498247|58896879|FG001|Overall Study|Withdrawal by Subject|8|||
30866652|NCT04498247|58896880|FG002|Overall Study|Withdrawal by Subject|0|||
30866653|NCT04498247|58896881|FG003|Overall Study|Withdrawal by Subject|7|||
30866654|NCT04498247|58896882|FG004|Overall Study|Withdrawal by Subject|0|||
30866655|NCT04498247|58896883|FG005|Overall Study|Withdrawal by Subject|0|||
30866656|NCT04498247|58896884|FG006|Overall Study|Withdrawal by Subject|1|||
30866657|NCT04498247|58896885|FG007|Overall Study|Withdrawal by Subject|0|||
30866658|NCT04498247|58896878|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
30866659|NCT04498247|58896879|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
30866660|NCT04498247|58896880|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
30866661|NCT04498247|58896881|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
30866662|NCT04498247|58896882|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
30866663|NCT04498247|58896883|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
30866664|NCT04498247|58896884|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
30866665|NCT04498247|58896885|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
30866666|NCT03887117|58896913|FG000|Overall Study|Discontinued prematurely|0|||
30866667|NCT03887117|58896914|FG001|Overall Study|Discontinued prematurely|1|||
30866668|NCT03887117|58896915|FG002|Overall Study|Discontinued prematurely|1|||
30866669|NCT03887117|58896916|FG003|Overall Study|Discontinued prematurely|2|||
30866670|NCT04038385|58896937|FG000|Overall Study|Completed baseline assessment only|7|||
30866671|NCT04038385|58896938|FG001|Overall Study|Completed baseline assessment only|4|||
30866672|NCT04038385|58896937|FG000|Overall Study|Moved out of area|4|||
30866673|NCT04038385|58896938|FG001|Overall Study|Moved out of area|2|||
30866674|NCT04038385|58896937|FG000|Overall Study|Discontinued study involvement|6|||
30866675|NCT04038385|58896938|FG001|Overall Study|Discontinued study involvement|1|||
30866676|NCT00783263|58896948|FG000|Overall Study|Adverse Event|3|||
30866677|NCT00783263|58896949|FG001|Overall Study|Adverse Event|0|||
30866678|NCT00783263|58896950|FG002|Overall Study|Adverse Event|2|||
30866679|NCT00783263|58896951|FG003|Overall Study|Adverse Event|1|||
30866680|NCT00783263|58896948|FG000|Overall Study|Lost to Follow-up|1|||
30866681|NCT00783263|58896949|FG001|Overall Study|Lost to Follow-up|1|||
30866682|NCT00783263|58896950|FG002|Overall Study|Lost to Follow-up|0|||
30866683|NCT00783263|58896951|FG003|Overall Study|Lost to Follow-up|0|||
30866684|NCT00783263|58896948|FG000|Overall Study|Withdrawal by Subject|0|||
30866685|NCT00783263|58896949|FG001|Overall Study|Withdrawal by Subject|1|||
30866686|NCT00783263|58896950|FG002|Overall Study|Withdrawal by Subject|1|||
30866687|NCT00783263|58896951|FG003|Overall Study|Withdrawal by Subject|2|||
30866688|NCT03987919|58896978|FG000|Overall Study|Adverse Event|1|||
30866689|NCT03987919|58896979|FG001|Overall Study|Adverse Event|4|||
30866690|NCT03987919|58896980|FG002|Overall Study|Adverse Event|1|||
30866691|NCT03987919|58896981|FG003|Overall Study|Adverse Event|3|||
30866692|NCT03987919|58896978|FG000|Overall Study|Death|4|||
30866693|NCT03987919|58896979|FG001|Overall Study|Death|4|||
30866694|NCT03987919|58896980|FG002|Overall Study|Death|4|||
30866695|NCT03987919|58896981|FG003|Overall Study|Death|1|||
30866696|NCT03987919|58896978|FG000|Overall Study|Lost to Follow-up|5|||
30866697|NCT03987919|58896979|FG001|Overall Study|Lost to Follow-up|6|||
30866698|NCT03987919|58896980|FG002|Overall Study|Lost to Follow-up|8|||
30694548|NCT00545272|58708716|FG002|Overall Study|Adverse Event|1|||
30694549|NCT00545272|58708717|FG003|Overall Study|Adverse Event|0|||
30694550|NCT00545272|58708718|FG004|Overall Study|Adverse Event|0|||
30694551|NCT00545272|58708719|FG005|Overall Study|Adverse Event|1|||
30866699|NCT03987919|58896981|FG003|Overall Study|Lost to Follow-up|12|||
30866700|NCT03987919|58896978|FG000|Overall Study|Physician Decision|0|||
30866701|NCT03987919|58896979|FG001|Overall Study|Physician Decision|2|||
30866702|NCT03987919|58896980|FG002|Overall Study|Physician Decision|0|||
30866703|NCT03987919|58896981|FG003|Overall Study|Physician Decision|4|||
30866704|NCT03987919|58896978|FG000|Overall Study|Pregnancy|1|||
30866705|NCT03987919|58896979|FG001|Overall Study|Pregnancy|0|||
30866706|NCT03987919|58896980|FG002|Overall Study|Pregnancy|1|||
30866707|NCT03987919|58896981|FG003|Overall Study|Pregnancy|1|||
30866708|NCT03987919|58896978|FG000|Overall Study|Protocol Violation|0|||
30866709|NCT03987919|58896979|FG001|Overall Study|Protocol Violation|1|||
30866710|NCT03987919|58896980|FG002|Overall Study|Protocol Violation|0|||
30866711|NCT03987919|58896981|FG003|Overall Study|Protocol Violation|0|||
30866712|NCT03987919|58896978|FG000|Overall Study|Site terminated by Sponsor|0|||
30866713|NCT03987919|58896979|FG001|Overall Study|Site terminated by Sponsor|0|||
30866714|NCT03987919|58896980|FG002|Overall Study|Site terminated by Sponsor|0|||
30866715|NCT03987919|58896981|FG003|Overall Study|Site terminated by Sponsor|1|||
30866716|NCT03987919|58896978|FG000|Overall Study|Withdrawal by Subject|7|||
30866717|NCT03987919|58896979|FG001|Overall Study|Withdrawal by Subject|7|||
30866718|NCT03987919|58896980|FG002|Overall Study|Withdrawal by Subject|8|||
30866719|NCT03987919|58896981|FG003|Overall Study|Withdrawal by Subject|4|||
30866720|NCT03987919|58896978|FG000|Overall Study|Other - as reported by the investigator|1|||
30866721|NCT03987919|58896979|FG001|Overall Study|Other - as reported by the investigator|3|||
30866722|NCT03987919|58896980|FG002|Overall Study|Other - as reported by the investigator|2|||
30866723|NCT03987919|58896981|FG003|Overall Study|Other - as reported by the investigator|0|||
30866724|NCT00535405|58897001|FG000|Overall Study|Adverse Event|6|||
30866725|NCT00535405|58897002|FG001|Overall Study|Adverse Event|8|||
30866726|NCT00535405|58897003|FG002|Overall Study|Adverse Event|3|||
30866727|NCT00535405|58897004|FG003|Overall Study|Adverse Event|8|||
30866728|NCT00535405|58897005|FG004|Overall Study|Adverse Event|6|||
30866729|NCT00535405|58897001|FG000|Overall Study|Lost to Follow-up|1|||
30866730|NCT00535405|58897002|FG001|Overall Study|Lost to Follow-up|3|||
30866731|NCT00535405|58897003|FG002|Overall Study|Lost to Follow-up|3|||
30866732|NCT00535405|58897004|FG003|Overall Study|Lost to Follow-up|2|||
30866733|NCT00535405|58897005|FG004|Overall Study|Lost to Follow-up|1|||
30866734|NCT00535405|58897001|FG000|Overall Study|Physician Decision|3|||
30866735|NCT00535405|58897002|FG001|Overall Study|Physician Decision|2|||
30866736|NCT00535405|58897003|FG002|Overall Study|Physician Decision|0|||
30866737|NCT00535405|58897004|FG003|Overall Study|Physician Decision|1|||
30866738|NCT00535405|58897005|FG004|Overall Study|Physician Decision|1|||
30866739|NCT00535405|58897001|FG000|Overall Study|Protocol Violation|2|||
30866740|NCT00535405|58897002|FG001|Overall Study|Protocol Violation|2|||
30866741|NCT00535405|58897003|FG002|Overall Study|Protocol Violation|2|||
30866742|NCT00535405|58897004|FG003|Overall Study|Protocol Violation|1|||
30960818|NCT01521923|59026598|FG000|Overall Study|Other|2|||
30866743|NCT00535405|58897005|FG004|Overall Study|Protocol Violation|0|||
30866744|NCT00535405|58897001|FG000|Overall Study|Withdrawal by Subject|5|||
30866745|NCT00535405|58897002|FG001|Overall Study|Withdrawal by Subject|11|||
30866746|NCT00535405|58897003|FG002|Overall Study|Withdrawal by Subject|10|||
30866747|NCT00535405|58897004|FG003|Overall Study|Withdrawal by Subject|10|||
30866748|NCT00535405|58897005|FG004|Overall Study|Withdrawal by Subject|8|||
30960819|NCT01521923|59026599|FG001|Overall Study|Other|1|||
30866749|NCT00271817|58897020|FG000|Part 1|Adverse Event|68|||
30866750|NCT00271817|58897021|FG001|Part 1|Adverse Event|25|||
30866751|NCT00271817|58897022|FG002|Part 1|Adverse Event|156|||
30866752|NCT00271817|58897020|FG000|Part 1|Lost to Follow-up|6|||
30866753|NCT00271817|58897021|FG001|Part 1|Lost to Follow-up|8|||
30866754|NCT00271817|58897022|FG002|Part 1|Lost to Follow-up|24|||
30866755|NCT00271817|58897020|FG000|Part 1|Protocol Violation|5|||
30866756|NCT00271817|58897021|FG001|Part 1|Protocol Violation|4|||
30866757|NCT00271817|58897022|FG002|Part 1|Protocol Violation|7|||
30866758|NCT00271817|58897020|FG000|Part 1|Patient Moved|3|||
30866759|NCT00271817|58897021|FG001|Part 1|Patient Moved|1|||
30866760|NCT00271817|58897022|FG002|Part 1|Patient Moved|5|||
30866761|NCT00271817|58897020|FG000|Part 1|Withdrawal by Subject|23|||
30866762|NCT00271817|58897021|FG001|Part 1|Withdrawal by Subject|17|||
30866763|NCT00271817|58897022|FG002|Part 1|Withdrawal by Subject|45|||
30866764|NCT00271817|58897020|FG000|Part 1|LDL < 50 mg/dL|1|||
30866765|NCT00271817|58897021|FG001|Part 1|LDL < 50 mg/dL|4|||
30866766|NCT00271817|58897022|FG002|Part 1|LDL < 50 mg/dL|48|||
30866767|NCT00271817|58897020|FG000|Part 2|Adverse Event|0|||
30866768|NCT00271817|58897021|FG001|Part 2|Adverse Event|17|||
30866769|NCT00271817|58897022|FG002|Part 2|Adverse Event|33|||
30866770|NCT00271817|58897020|FG000|Part 2|Lack of Efficacy|0|||
30866771|NCT00271817|58897021|FG001|Part 2|Lack of Efficacy|1|||
30866772|NCT00271817|58897022|FG002|Part 2|Lack of Efficacy|6|||
30866773|NCT00271817|58897020|FG000|Part 2|Lost to Follow-up|0|||
30866774|NCT00271817|58897021|FG001|Part 2|Lost to Follow-up|6|||
30866775|NCT00271817|58897022|FG002|Part 2|Lost to Follow-up|18|||
30866776|NCT00271817|58897020|FG000|Part 2|Protocol Violation|0|||
30866777|NCT00271817|58897021|FG001|Part 2|Protocol Violation|3|||
30866778|NCT00271817|58897022|FG002|Part 2|Protocol Violation|5|||
30866779|NCT00271817|58897020|FG000|Part 2|Patient Moved|0|||
30866780|NCT00271817|58897021|FG001|Part 2|Patient Moved|0|||
30866781|NCT00271817|58897022|FG002|Part 2|Patient Moved|5|||
30866782|NCT00271817|58897020|FG000|Part 2|Withdrawal by Subject|0|||
30866783|NCT00271817|58897021|FG001|Part 2|Withdrawal by Subject|2|||
30866784|NCT00271817|58897022|FG002|Part 2|Withdrawal by Subject|13|||
30866785|NCT00271817|58897020|FG000|Part 2|LDL < 50 mg/dL|0|||
30866786|NCT00271817|58897021|FG001|Part 2|LDL < 50 mg/dL|3|||
30866787|NCT00271817|58897022|FG002|Part 2|LDL < 50 mg/dL|4|||
30866788|NCT02731157|58897034|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
30866789|NCT03268811|58897042|FG000|Overall Study|Adverse Event|0|||
30866790|NCT03268811|58897043|FG001|Overall Study|Adverse Event|1|||
30866791|NCT02732015|58897052|FG000|Overall Study|Lost to Follow-up|0|||
30866792|NCT02732015|58897053|FG001|Overall Study|Lost to Follow-up|1|||
30866793|NCT01441115|58897073|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
30866794|NCT02006147|58897084|FG000|Overall Study|Protocol Violation|1|||
30866795|NCT02006147|58897085|FG001|Overall Study|Protocol Violation|1|||
30866796|NCT02006147|58897086|FG002|Overall Study|Protocol Violation|0|||
30866797|NCT02006147|58897087|FG003|Overall Study|Protocol Violation|0|||
30866798|NCT02006147|58897084|FG000|Overall Study|Withdrawal by Subject|0|||
30866799|NCT02006147|58897085|FG001|Overall Study|Withdrawal by Subject|1|||
30866800|NCT02006147|58897086|FG002|Overall Study|Withdrawal by Subject|0|||
30866801|NCT02006147|58897087|FG003|Overall Study|Withdrawal by Subject|0|||
30866802|NCT02006147|58897084|FG000|Overall Study|Withdrawal by Sponsor|1|||
30866803|NCT02006147|58897085|FG001|Overall Study|Withdrawal by Sponsor|0|||
30866804|NCT02006147|58897086|FG002|Overall Study|Withdrawal by Sponsor|0|||
30866805|NCT02006147|58897087|FG003|Overall Study|Withdrawal by Sponsor|0|||
30866806|NCT02732119|58897098|FG000|Phase I|Adverse Event|1|||
30866807|NCT02732119|58897099|FG001|Phase I|Adverse Event|3|||
30866808|NCT02732119|58897100|FG002|Phase I|Adverse Event|1|||
30866809|NCT02732119|58897101|FG003|Phase I|Adverse Event|0|||
30866810|NCT02732119|58897102|FG004|Phase I|Adverse Event|0|||
30866811|NCT02732119|58897098|FG000|Phase I|Progressive disease|7|||
30866812|NCT02732119|58897099|FG001|Phase I|Progressive disease|3|||
30866813|NCT02732119|58897100|FG002|Phase I|Progressive disease|2|||
30866814|NCT02732119|58897101|FG003|Phase I|Progressive disease|0|||
30866815|NCT02732119|58897102|FG004|Phase I|Progressive disease|0|||
30866816|NCT02732119|58897098|FG000|Phase I|Protocol deviation|0|||
30866817|NCT02732119|58897099|FG001|Phase I|Protocol deviation|1|||
30866818|NCT02732119|58897100|FG002|Phase I|Protocol deviation|0|||
30866819|NCT02732119|58897101|FG003|Phase I|Protocol deviation|0|||
30866820|NCT02732119|58897102|FG004|Phase I|Protocol deviation|0|||
30866821|NCT02732119|58897098|FG000|Phase I|Physician Decision|0|||
30866822|NCT02732119|58897099|FG001|Phase I|Physician Decision|3|||
30960820|NCT01521923|59026600|FG002|Overall Study|Other|3|||
30866823|NCT02732119|58897100|FG002|Phase I|Physician Decision|4|||
30866824|NCT02732119|58897101|FG003|Phase I|Physician Decision|0|||
30866825|NCT02732119|58897102|FG004|Phase I|Physician Decision|0|||
30866826|NCT02732119|58897098|FG000|Phase II|Adverse Event|0|||
30866827|NCT02732119|58897099|FG001|Phase II|Adverse Event|0|||
30866828|NCT02732119|58897100|FG002|Phase II|Adverse Event|0|||
30866829|NCT02732119|58897101|FG003|Phase II|Adverse Event|3|||
30866830|NCT02732119|58897102|FG004|Phase II|Adverse Event|3|||
30866831|NCT02732119|58897098|FG000|Phase II|Death|0|||
30866832|NCT02732119|58897099|FG001|Phase II|Death|0|||
30866833|NCT02732119|58897100|FG002|Phase II|Death|0|||
30866834|NCT02732119|58897101|FG003|Phase II|Death|1|||
30866835|NCT02732119|58897102|FG004|Phase II|Death|0|||
30866836|NCT02732119|58897098|FG000|Phase II|Progressive dissease|0|||
30866837|NCT02732119|58897099|FG001|Phase II|Progressive dissease|0|||
30866838|NCT02732119|58897100|FG002|Phase II|Progressive dissease|0|||
30866839|NCT02732119|58897101|FG003|Phase II|Progressive dissease|30|||
30866840|NCT02732119|58897102|FG004|Phase II|Progressive dissease|23|||
30866841|NCT02732119|58897098|FG000|Phase II|Study terminated by sponsor|0|||
30866842|NCT02732119|58897099|FG001|Phase II|Study terminated by sponsor|0|||
30866843|NCT02732119|58897100|FG002|Phase II|Study terminated by sponsor|0|||
30866844|NCT02732119|58897101|FG003|Phase II|Study terminated by sponsor|2|||
30866845|NCT02732119|58897102|FG004|Phase II|Study terminated by sponsor|2|||
30866846|NCT02732119|58897098|FG000|Phase II|Other|0|||
30866847|NCT02732119|58897099|FG001|Phase II|Other|0|||
30866848|NCT02732119|58897100|FG002|Phase II|Other|0|||
30866849|NCT02732119|58897101|FG003|Phase II|Other|2|||
30866850|NCT02732119|58897102|FG004|Phase II|Other|0|||
30866851|NCT02732119|58897098|FG000|Phase II|Physician Decision|0|||
30866852|NCT02732119|58897099|FG001|Phase II|Physician Decision|0|||
30866853|NCT02732119|58897100|FG002|Phase II|Physician Decision|0|||
30866854|NCT02732119|58897101|FG003|Phase II|Physician Decision|8|||
30866855|NCT02732119|58897102|FG004|Phase II|Physician Decision|5|||
30866856|NCT03252925|58897125|FG000|Overall Study|Withdrawal by Subject|1|||
30866857|NCT03252925|58897126|FG001|Overall Study|Withdrawal by Subject|0|||
30866858|NCT03252925|58897125|FG000|Overall Study|Protocol Violation|6|||
30866859|NCT03252925|58897126|FG001|Overall Study|Protocol Violation|0|||
30866860|NCT03252925|58897125|FG000|Overall Study|Adverse Event|1|||
30866861|NCT03252925|58897126|FG001|Overall Study|Adverse Event|0|||
30866862|NCT03252925|58897125|FG000|Overall Study|Lost to Follow-up|6|||
30866863|NCT03252925|58897126|FG001|Overall Study|Lost to Follow-up|6|||
30866864|NCT01327885|58897134|FG000|Overall Study|Disease progression-according to RECIST|173|||
30866865|NCT01327885|58897135|FG001|Overall Study|Disease progression-according to RECIST|165|||
30866866|NCT01327885|58897134|FG000|Overall Study|Clinical progression|24|||
30866867|NCT01327885|58897135|FG001|Overall Study|Clinical progression|27|||
30866868|NCT01327885|58897134|FG000|Overall Study|Adverse Event|14|||
30866869|NCT01327885|58897135|FG001|Overall Study|Adverse Event|10|||
30866870|NCT01327885|58897134|FG000|Overall Study|Subject choice|5|||
30866871|NCT01327885|58897135|FG001|Overall Study|Subject choice|10|||
30866872|NCT01327885|58897134|FG000|Overall Study|Other|8|||
30866873|NCT01327885|58897135|FG001|Overall Study|Other|6|||
30866874|NCT01327885|58897134|FG000|Overall Study|Withdrawal of consent from study|3|||
30866875|NCT01327885|58897135|FG001|Overall Study|Withdrawal of consent from study|4|||
30866876|NCT01327885|58897134|FG000|Overall Study|Not treated|1|||
30866877|NCT01327885|58897135|FG001|Overall Study|Not treated|1|||
30866878|NCT01327885|58897134|FG000|Overall Study|Administrative decision|0|||
30866879|NCT01327885|58897135|FG001|Overall Study|Administrative decision|1|||
30866880|NCT03420781|58897153|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
30866881|NCT03420781|58897154|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
30866882|NCT03420781|58897155|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
30866883|NCT03420781|58897156|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
30866884|NCT03420781|58897157|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
30866885|NCT03420781|58897153|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
30866886|NCT03420781|58897154|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
30866887|NCT03420781|58897155|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
30866888|NCT03420781|58897156|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
30866889|NCT03420781|58897157|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
30866890|NCT03420781|58897153|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
30866891|NCT03420781|58897154|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
30866892|NCT03420781|58897155|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
30866893|NCT03420781|58897156|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
30866894|NCT03420781|58897157|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
30866895|NCT03420781|58897153|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
30866896|NCT03420781|58897154|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
30866897|NCT03420781|58897155|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
30866898|NCT03420781|58897156|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
30866899|NCT03420781|58897157|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
30866900|NCT03420781|58897153|FG000|Treatment Period (40 Weeks)|Death|2|||
30866901|NCT03420781|58897154|FG001|Treatment Period (40 Weeks)|Death|2|||
30866902|NCT03420781|58897155|FG002|Treatment Period (40 Weeks)|Death|0|||
30866903|NCT03420781|58897156|FG003|Treatment Period (40 Weeks)|Death|0|||
30866904|NCT03420781|58897157|FG004|Treatment Period (40 Weeks)|Death|0|||
30866905|NCT03420781|58897153|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
30866906|NCT03420781|58897154|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
30866907|NCT03420781|58897155|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
30866908|NCT03420781|58897156|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
30866909|NCT03420781|58897157|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
30866910|NCT03420781|58897153|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
30866911|NCT03420781|58897154|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
30866912|NCT03420781|58897155|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
30866913|NCT03420781|58897156|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
30866914|NCT03420781|58897157|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
30866915|NCT03420781|58897153|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
30866916|NCT03420781|58897154|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
30866917|NCT03420781|58897155|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
30866918|NCT03420781|58897156|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
30866919|NCT03420781|58897157|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
30866920|NCT03420781|58897153|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
30866921|NCT03420781|58897154|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
30866922|NCT03420781|58897155|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
30866923|NCT03420781|58897156|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
30866924|NCT03420781|58897157|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
30866925|NCT03420781|58897153|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
30866926|NCT03420781|58897154|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
30866927|NCT03420781|58897155|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
30866928|NCT03420781|58897156|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
30866929|NCT03420781|58897157|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
30866930|NCT03420781|58897153|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
30866931|NCT03420781|58897154|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
30866932|NCT03420781|58897155|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
30866933|NCT03420781|58897156|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
30866934|NCT03420781|58897157|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
30866935|NCT03420781|58897153|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
30866936|NCT03420781|58897154|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
30866937|NCT03420781|58897155|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
30866938|NCT03420781|58897156|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
30866939|NCT03420781|58897157|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
30866940|NCT03420781|58897153|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
30866941|NCT03420781|58897154|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
30866942|NCT03420781|58897155|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
30866943|NCT03420781|58897156|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
30866944|NCT03420781|58897157|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
30866945|NCT03269695|58897175|FG000|Overall Study|Adverse Event|2|||
30866946|NCT03269695|58897176|FG001|Overall Study|Adverse Event|1|||
30866947|NCT03269695|58897175|FG000|Overall Study|Lack of Efficacy|0|||
30866948|NCT03269695|58897176|FG001|Overall Study|Lack of Efficacy|1|||
30866949|NCT03269695|58897175|FG000|Overall Study|Withdrawal by Subject|0|||
30866950|NCT03269695|58897176|FG001|Overall Study|Withdrawal by Subject|1|||
30866951|NCT00462943|58897186|FG000|Overall Study|Failure to achieve a response|5|||
30866952|NCT00462943|58897187|FG001|Overall Study|Failure to achieve a response|5|||
30866953|NCT00462943|58897188|FG002|Overall Study|Failure to achieve a response|1|||
30866954|NCT00462943|58897186|FG000|Overall Study|Adverse Event|6|||
30866955|NCT00462943|58897187|FG001|Overall Study|Adverse Event|4|||
30866956|NCT00462943|58897188|FG002|Overall Study|Adverse Event|1|||
30866957|NCT00462943|58897186|FG000|Overall Study|Protocol Violation|1|||
30866958|NCT00462943|58897187|FG001|Overall Study|Protocol Violation|0|||
30866959|NCT00462943|58897188|FG002|Overall Study|Protocol Violation|0|||
30866960|NCT00462943|58897186|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
30866961|NCT00462943|58897187|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
30866962|NCT00462943|58897188|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
30866963|NCT00462943|58897186|FG000|Overall Study|Disease Progression|15|||
30866964|NCT00462943|58897187|FG001|Overall Study|Disease Progression|15|||
30866965|NCT00462943|58897188|FG002|Overall Study|Disease Progression|9|||
30866966|NCT00462943|58897186|FG000|Overall Study|Death|5|||
30866967|NCT00462943|58897187|FG001|Overall Study|Death|2|||
30866968|NCT00462943|58897188|FG002|Overall Study|Death|7|||
30866969|NCT00462943|58897186|FG000|Overall Study|Stem Cell Transplant|1|||
30866970|NCT00462943|58897187|FG001|Overall Study|Stem Cell Transplant|1|||
30866971|NCT00462943|58897188|FG002|Overall Study|Stem Cell Transplant|0|||
30866972|NCT00462943|58897186|FG000|Overall Study|Bone Marrow Transplant|1|||
30866973|NCT00462943|58897187|FG001|Overall Study|Bone Marrow Transplant|0|||
30866974|NCT00462943|58897188|FG002|Overall Study|Bone Marrow Transplant|0|||
30866975|NCT00462943|58897186|FG000|Overall Study|Required Lymphocyte Infusion|1|||
30866976|NCT00462943|58897187|FG001|Overall Study|Required Lymphocyte Infusion|0|||
30866977|NCT00462943|58897188|FG002|Overall Study|Required Lymphocyte Infusion|0|||
30866978|NCT00462943|58897186|FG000|Overall Study|Transplant - not specified|1|||
30866979|NCT00462943|58897187|FG001|Overall Study|Transplant - not specified|0|||
30602218|NCT01289574|58613549|FG002|Overall Study|Withdrawal by Subject|1|||
30602219|NCT01289574|58613547|FG000|Overall Study|Adverse Event|0|||
30602220|NCT01289574|58613548|FG001|Overall Study|Adverse Event|1|||
30602221|NCT01289574|58613549|FG002|Overall Study|Adverse Event|0|||
30602222|NCT01289574|58613547|FG000|Overall Study|Subject wanted alternate treatment|0|||
30602223|NCT01289574|58613548|FG001|Overall Study|Subject wanted alternate treatment|1|||
30866980|NCT00462943|58897188|FG002|Overall Study|Transplant - not specified|1|||
30866981|NCT00462943|58897186|FG000|Overall Study|Physician Decision|1|||
30866982|NCT00462943|58897187|FG001|Overall Study|Physician Decision|0|||
30866983|NCT00462943|58897188|FG002|Overall Study|Physician Decision|0|||
30866984|NCT00462943|58897186|FG000|Overall Study|Withdrawal by Subject|0|||
30866985|NCT00462943|58897187|FG001|Overall Study|Withdrawal by Subject|1|||
30866986|NCT00462943|58897188|FG002|Overall Study|Withdrawal by Subject|0|||
30866987|NCT02730793|58897212|FG000|Overall Study|Physician Decision|0|||
30866988|NCT02730793|58897213|FG001|Overall Study|Physician Decision|1|||
30866989|NCT02730793|58897212|FG000|Overall Study|Withdrawal by Subject|0|||
30866990|NCT02730793|58897213|FG001|Overall Study|Withdrawal by Subject|1|||
30866991|NCT02855125|58897221|FG000|Overall Study|Withdrawal by Subject|2|||
30866992|NCT02855125|58897222|FG001|Overall Study|Withdrawal by Subject|2|||
30866993|NCT02855125|58897221|FG000|Overall Study|Clinical Disease Progression|5|||
30866994|NCT02855125|58897222|FG001|Overall Study|Clinical Disease Progression|4|||
30866995|NCT02855125|58897221|FG000|Overall Study|Radiologic Disease Progression|36|||
30866996|NCT02855125|58897222|FG001|Overall Study|Radiologic Disease Progression|39|||
30866997|NCT02855125|58897221|FG000|Overall Study|Adverse Event|11|||
30866998|NCT02855125|58897222|FG001|Overall Study|Adverse Event|7|||
30866999|NCT02855125|58897221|FG000|Overall Study|Physician Decision|1|||
30867000|NCT02855125|58897222|FG001|Overall Study|Physician Decision|0|||
30867001|NCT02855125|58897221|FG000|Overall Study|On Treatment|9|||
30867002|NCT02855125|58897222|FG001|Overall Study|On Treatment|11|||
30867003|NCT02855125|58897221|FG000|Overall Study|Randomized but not treated|0|||
30867004|NCT02855125|58897222|FG001|Overall Study|Randomized but not treated|1|||
30867005|NCT02730871|58897245|FG000|Overall Study|Adverse Event|6|||
30867006|NCT02730871|58897246|FG001|Overall Study|Adverse Event|0|||
30867007|NCT03376789|58897254|FG000|Overall Study|Withdrawal by Subject|3|||
30867008|NCT03376789|58897255|FG001|Overall Study|Withdrawal by Subject|5|||
30867009|NCT03376789|58897254|FG000|Overall Study|Protocol Violation|0|||
30867010|NCT03376789|58897255|FG001|Overall Study|Protocol Violation|1|||
30867011|NCT03376789|58897254|FG000|Overall Study|Adverse Event|0|||
30867012|NCT03376789|58897255|FG001|Overall Study|Adverse Event|1|||
30867013|NCT03376789|58897254|FG000|Overall Study|Lost to Follow-up|1|||
30867014|NCT03376789|58897255|FG001|Overall Study|Lost to Follow-up|1|||
30867015|NCT03376789|58897254|FG000|Overall Study|Per sponsor due to noncompliance|1|||
30867016|NCT03376789|58897255|FG001|Overall Study|Per sponsor due to noncompliance|0|||
30867017|NCT03376789|58897254|FG000|Overall Study|Subject off study medication|0|||
30867018|NCT03376789|58897255|FG001|Overall Study|Subject off study medication|1|||
30867019|NCT04032093|58897271|FG000|Overall Study|Lost to Follow-up|7|||
30867020|NCT04032093|58897272|FG001|Overall Study|Lost to Follow-up|7|||
30867021|NCT04032093|58897273|FG002|Overall Study|Lost to Follow-up|6|||
30867022|NCT04032093|58897274|FG003|Overall Study|Lost to Follow-up|10|||
30867023|NCT04032093|58897275|FG004|Overall Study|Lost to Follow-up|13|||
30867024|NCT04032093|58897276|FG005|Overall Study|Lost to Follow-up|7|||
30867025|NCT04032093|58897277|FG006|Overall Study|Lost to Follow-up|7|||
30867026|NCT04032093|58897278|FG007|Overall Study|Lost to Follow-up|5|||
30867027|NCT04032093|58897279|FG008|Overall Study|Lost to Follow-up|9|||
30867028|NCT04032093|58897280|FG009|Overall Study|Lost to Follow-up|12|||
30867029|NCT04032093|58897271|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
30867030|NCT04032093|58897272|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
30867031|NCT04032093|58897273|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
30867032|NCT04032093|58897274|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
30867033|NCT04032093|58897275|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
30867034|NCT04032093|58897276|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
30867035|NCT04032093|58897277|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
30867036|NCT04032093|58897278|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
30867037|NCT04032093|58897279|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
30867038|NCT04032093|58897280|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
30867039|NCT04032093|58897271|FG000|Overall Study|Other|1|||
30867040|NCT04032093|58897272|FG001|Overall Study|Other|0|||
30867041|NCT04032093|58897273|FG002|Overall Study|Other|0|||
30867042|NCT04032093|58897274|FG003|Overall Study|Other|1|||
30960821|NCT01521923|59026601|FG003|Overall Study|Other|6|||
30960822|NCT01521923|59026598|FG000|Overall Study|AE, captured in Period 1|0|||
30602224|NCT01289574|58613549|FG002|Overall Study|Subject wanted alternate treatment|0|||
30602225|NCT01252095|58613560|FG000|Overall Study|Disease progression|1|||
30867043|NCT04032093|58897275|FG004|Overall Study|Other|1|||
30867044|NCT04032093|58897276|FG005|Overall Study|Other|0|||
30867045|NCT04032093|58897277|FG006|Overall Study|Other|0|||
30867046|NCT04032093|58897278|FG007|Overall Study|Other|0|||
30867047|NCT04032093|58897279|FG008|Overall Study|Other|0|||
30867048|NCT04032093|58897280|FG009|Overall Study|Other|1|||
30867049|NCT04032093|58897271|FG000|Overall Study|Withdrawal by Subject|1|||
30867050|NCT04032093|58897272|FG001|Overall Study|Withdrawal by Subject|3|||
30867051|NCT04032093|58897273|FG002|Overall Study|Withdrawal by Subject|2|||
30867052|NCT04032093|58897274|FG003|Overall Study|Withdrawal by Subject|2|||
30867053|NCT04032093|58897275|FG004|Overall Study|Withdrawal by Subject|3|||
30867054|NCT04032093|58897276|FG005|Overall Study|Withdrawal by Subject|0|||
30867055|NCT04032093|58897277|FG006|Overall Study|Withdrawal by Subject|0|||
30867056|NCT04032093|58897278|FG007|Overall Study|Withdrawal by Subject|0|||
30867057|NCT04032093|58897279|FG008|Overall Study|Withdrawal by Subject|0|||
30867058|NCT04032093|58897280|FG009|Overall Study|Withdrawal by Subject|0|||
30867059|NCT04032093|58897271|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
30867060|NCT04032093|58897272|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
30867061|NCT04032093|58897273|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
30867062|NCT04032093|58897274|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
30867063|NCT04032093|58897275|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
30867064|NCT04032093|58897276|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
30867065|NCT04032093|58897277|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
30867066|NCT04032093|58897278|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
30867067|NCT04032093|58897279|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
30867068|NCT04032093|58897280|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
30867069|NCT04032093|58897271|FG000|Overall Study|Adverse Event|0|||
30867070|NCT04032093|58897272|FG001|Overall Study|Adverse Event|0|||
30867071|NCT04032093|58897273|FG002|Overall Study|Adverse Event|0|||
30867072|NCT04032093|58897274|FG003|Overall Study|Adverse Event|0|||
30867073|NCT04032093|58897275|FG004|Overall Study|Adverse Event|0|||
30602226|NCT01252095|58613561|FG001|Overall Study|Disease progression|0|||
30602227|NCT01289418|58613570|FG000|Day 8 Survey|email address invalid|283|||
30867074|NCT04032093|58897276|FG005|Overall Study|Adverse Event|0|||
30867075|NCT04032093|58897277|FG006|Overall Study|Adverse Event|0|||
30867076|NCT04032093|58897278|FG007|Overall Study|Adverse Event|0|||
30867077|NCT04032093|58897279|FG008|Overall Study|Adverse Event|0|||
30867078|NCT04032093|58897280|FG009|Overall Study|Adverse Event|1|||
30867079|NCT04032093|58897271|FG000|Overall Study|Physician Decision|0|||
30867080|NCT04032093|58897272|FG001|Overall Study|Physician Decision|0|||
30867081|NCT04032093|58897273|FG002|Overall Study|Physician Decision|0|||
30867082|NCT04032093|58897274|FG003|Overall Study|Physician Decision|0|||
30867083|NCT04032093|58897275|FG004|Overall Study|Physician Decision|0|||
30867084|NCT04032093|58897276|FG005|Overall Study|Physician Decision|1|||
30867085|NCT04032093|58897277|FG006|Overall Study|Physician Decision|0|||
30867086|NCT04032093|58897278|FG007|Overall Study|Physician Decision|0|||
30867087|NCT04032093|58897279|FG008|Overall Study|Physician Decision|0|||
30867088|NCT04032093|58897280|FG009|Overall Study|Physician Decision|0|||
30867089|NCT01675167|58897304|FG000|Open-label Titration Phase|Adverse Event|81|||
30867090|NCT01675167|58897305|FG001|Open-label Titration Phase|Adverse Event|0|||
30867091|NCT01675167|58897306|FG002|Open-label Titration Phase|Adverse Event|0|||
30867092|NCT01675167|58897304|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
30867093|NCT01675167|58897305|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
30867094|NCT01675167|58897306|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
30867095|NCT01675167|58897304|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
30867096|NCT01675167|58897305|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
30867097|NCT01675167|58897306|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
30867098|NCT01675167|58897304|FG000|Open-label Titration Phase|Protocol Violation|43|||
30867099|NCT01675167|58897305|FG001|Open-label Titration Phase|Protocol Violation|0|||
30694552|NCT00545272|58708714|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30694553|NCT00545272|58708715|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30694554|NCT00545272|58708716|FG002|Overall Study|Abnormal laboratory value(s)|0|||
30867100|NCT01675167|58897306|FG002|Open-label Titration Phase|Protocol Violation|0|||
30867101|NCT01675167|58897304|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
30867102|NCT01675167|58897305|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
30867103|NCT01675167|58897306|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
30867104|NCT01675167|58897304|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
30867105|NCT01675167|58897305|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
30867106|NCT01675167|58897306|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
30867107|NCT01675167|58897304|FG000|Open-label Titration Phase|Other|55|||
30867108|NCT01675167|58897305|FG001|Open-label Titration Phase|Other|0|||
30867109|NCT01675167|58897306|FG002|Open-label Titration Phase|Other|0|||
30867110|NCT01675167|58897304|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
30867111|NCT01675167|58897305|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
30867112|NCT01675167|58897306|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
30867113|NCT01675167|58897304|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
30867114|NCT01675167|58897305|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
30867115|NCT01675167|58897306|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
30867116|NCT01675167|58897304|FG000|Double-blind Treatment Phase|Adverse Event|0|||
30867117|NCT01675167|58897305|FG001|Double-blind Treatment Phase|Adverse Event|5|||
30867118|NCT01675167|58897306|FG002|Double-blind Treatment Phase|Adverse Event|13|||
30867119|NCT01675167|58897304|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
30867120|NCT01675167|58897305|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
30867121|NCT01675167|58897306|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
30867122|NCT01675167|58897304|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
30867123|NCT01675167|58897305|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
30867124|NCT01675167|58897306|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
30867125|NCT01675167|58897304|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
30867126|NCT01675167|58897305|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
30867127|NCT01675167|58897306|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
30867128|NCT01675167|58897304|FG000|Double-blind Treatment Phase|Other|0|||
30867129|NCT01675167|58897305|FG001|Double-blind Treatment Phase|Other|7|||
30867130|NCT01675167|58897306|FG002|Double-blind Treatment Phase|Other|5|||
30867131|NCT01675011|58897316|FG000|Overall Study|Trial terminated by Sponsor|3|||
30867132|NCT01675011|58897317|FG001|Overall Study|Trial terminated by Sponsor|1|||
30867133|NCT02649231|58897354|FG000|Overall Study|Adverse Event|0|||
30867134|NCT02649231|58897355|FG001|Overall Study|Adverse Event|0|||
30867135|NCT02649231|58897356|FG002|Overall Study|Adverse Event|0|||
30867136|NCT02649231|58897357|FG003|Overall Study|Adverse Event|1|||
30867137|NCT02649231|58897354|FG000|Overall Study|Lost to Follow-up|2|||
30867138|NCT02649231|58897355|FG001|Overall Study|Lost to Follow-up|1|||
30867139|NCT02649231|58897356|FG002|Overall Study|Lost to Follow-up|1|||
30867140|NCT02649231|58897357|FG003|Overall Study|Lost to Follow-up|0|||
30867141|NCT02649231|58897354|FG000|Overall Study|Withdrawal by Subject|0|||
30867142|NCT02649231|58897355|FG001|Overall Study|Withdrawal by Subject|1|||
30867143|NCT02649231|58897356|FG002|Overall Study|Withdrawal by Subject|0|||
30867144|NCT02649231|58897357|FG003|Overall Study|Withdrawal by Subject|1|||
30867145|NCT02649231|58897354|FG000|Overall Study|Protocol Violation|2|||
30867146|NCT02649231|58897355|FG001|Overall Study|Protocol Violation|1|||
30867147|NCT02649231|58897356|FG002|Overall Study|Protocol Violation|1|||
30867148|NCT02649231|58897357|FG003|Overall Study|Protocol Violation|0|||
30867149|NCT01376245|58897371|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
30867150|NCT01376245|58897372|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
30867151|NCT01376245|58897373|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
30867152|NCT01376245|58897374|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
30867153|NCT01376245|58897375|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
30867154|NCT01376245|58897371|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
30867155|NCT01376245|58897372|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
30867156|NCT01376245|58897373|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
30867157|NCT01376245|58897374|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
30867158|NCT01376245|58897375|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
30867159|NCT01376245|58897371|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
30867160|NCT01376245|58897372|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
30867161|NCT01376245|58897373|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
30867162|NCT01376245|58897374|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
30867163|NCT01376245|58897375|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
30867164|NCT01376245|58897371|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
30867165|NCT01376245|58897372|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
30867166|NCT01376245|58897373|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
30867167|NCT01376245|58897374|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
30867168|NCT01376245|58897375|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
30867169|NCT01376245|58897371|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
30867170|NCT01376245|58897372|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
30867171|NCT01376245|58897373|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
30867172|NCT01376245|58897374|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
30867173|NCT01376245|58897375|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
30867174|NCT01376245|58897371|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
30867175|NCT01376245|58897372|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
30867176|NCT01376245|58897373|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
30867177|NCT01376245|58897374|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
30867178|NCT01376245|58897375|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
30867179|NCT01376245|58897371|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
30867180|NCT01376245|58897372|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
30867181|NCT01376245|58897373|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
30867182|NCT01376245|58897374|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
30867183|NCT01376245|58897375|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
30867184|NCT01376245|58897371|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
30867185|NCT01376245|58897372|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
30602228|NCT01289418|58613570|FG000|Day 8 Survey|participants did not complete the survey|1935|||
30602229|NCT01289418|58613570|FG000|Day 29 Survey|email address invalid|283|||
30867186|NCT01376245|58897373|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
30867187|NCT01376245|58897374|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
30867188|NCT01376245|58897375|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
30867189|NCT01376245|58897371|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
30867190|NCT01376245|58897372|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
30867191|NCT01376245|58897373|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
30867192|NCT01376245|58897374|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
30867193|NCT01376245|58897375|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
30867194|NCT01376245|58897371|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30867195|NCT01376245|58897372|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
30867196|NCT01376245|58897373|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30867197|NCT01376245|58897374|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
30867198|NCT01376245|58897375|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
30867199|NCT01376245|58897371|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
30867200|NCT01376245|58897372|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
30867201|NCT01376245|58897373|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
30867202|NCT01376245|58897374|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
30867203|NCT01376245|58897375|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
30867204|NCT01376245|58897371|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
30867205|NCT01376245|58897372|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
30867206|NCT01376245|58897373|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
30867207|NCT01376245|58897374|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
30867208|NCT01376245|58897375|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
30867209|NCT01674621|58897390|FG000|Overall Study|Adverse Event|3|||
30867210|NCT01674621|58897391|FG001|Overall Study|Adverse Event|2|||
30867211|NCT01674621|58897392|FG002|Overall Study|Adverse Event|5|||
30867212|NCT01674621|58897393|FG003|Overall Study|Adverse Event|5|||
30867213|NCT01674621|58897394|FG004|Overall Study|Adverse Event|1|||
30867214|NCT01674621|58897390|FG000|Overall Study|Inability to Complete Study Procedures|0|||
30867215|NCT01674621|58897391|FG001|Overall Study|Inability to Complete Study Procedures|0|||
30867216|NCT01674621|58897392|FG002|Overall Study|Inability to Complete Study Procedures|0|||
30867217|NCT01674621|58897393|FG003|Overall Study|Inability to Complete Study Procedures|0|||
30867218|NCT01674621|58897394|FG004|Overall Study|Inability to Complete Study Procedures|2|||
30867219|NCT01674621|58897390|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
30867220|NCT01674621|58897391|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
30867221|NCT01674621|58897392|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
30867222|NCT01674621|58897393|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
30867223|NCT01674621|58897394|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
30867224|NCT01674621|58897390|FG000|Overall Study|Withdrawal by Subject|2|||
30867225|NCT01674621|58897391|FG001|Overall Study|Withdrawal by Subject|5|||
30867226|NCT01674621|58897392|FG002|Overall Study|Withdrawal by Subject|2|||
30867227|NCT01674621|58897393|FG003|Overall Study|Withdrawal by Subject|0|||
30867228|NCT01674621|58897394|FG004|Overall Study|Withdrawal by Subject|1|||
30867229|NCT01674621|58897390|FG000|Overall Study|Other than specified|0|||
30867230|NCT01674621|58897391|FG001|Overall Study|Other than specified|1|||
30867231|NCT01674621|58897392|FG002|Overall Study|Other than specified|0|||
30867232|NCT01674621|58897393|FG003|Overall Study|Other than specified|0|||
30867233|NCT01674621|58897394|FG004|Overall Study|Other than specified|2|||
30867234|NCT02730169|58897411|FG000|Overall Study|Protocol Violation|1|||
30867235|NCT02730169|58897412|FG001|Overall Study|Protocol Violation|0|||
30867236|NCT02730169|58897413|FG002|Overall Study|Protocol Violation|0|||
30867237|NCT02730169|58897414|FG003|Overall Study|Protocol Violation|1|||
30867238|NCT02730169|58897411|FG000|Overall Study|Adverse Event|2|||
30867239|NCT02730169|58897412|FG001|Overall Study|Adverse Event|3|||
30867240|NCT02730169|58897413|FG002|Overall Study|Adverse Event|3|||
30867241|NCT02730169|58897414|FG003|Overall Study|Adverse Event|0|||
30867242|NCT02730169|58897411|FG000|Overall Study|Adverse Event of Special Interest|0|||
30867243|NCT02730169|58897412|FG001|Overall Study|Adverse Event of Special Interest|1|||
30867244|NCT02730169|58897413|FG002|Overall Study|Adverse Event of Special Interest|2|||
30867245|NCT02730169|58897414|FG003|Overall Study|Adverse Event of Special Interest|0|||
30867246|NCT02730169|58897411|FG000|Overall Study|Withdrawal by Subject|6|||
30867247|NCT02730169|58897412|FG001|Overall Study|Withdrawal by Subject|11|||
30867248|NCT02730169|58897413|FG002|Overall Study|Withdrawal by Subject|6|||
30867249|NCT02730169|58897414|FG003|Overall Study|Withdrawal by Subject|8|||
30867250|NCT02730169|58897411|FG000|Overall Study|Lost to Follow-up|5|||
30867251|NCT02730169|58897412|FG001|Overall Study|Lost to Follow-up|6|||
30867252|NCT02730169|58897413|FG002|Overall Study|Lost to Follow-up|5|||
30867253|NCT02730169|58897414|FG003|Overall Study|Lost to Follow-up|6|||
30867254|NCT02730169|58897411|FG000|Overall Study|Other|0|||
30867255|NCT02730169|58897412|FG001|Overall Study|Other|0|||
30867256|NCT02730169|58897413|FG002|Overall Study|Other|1|||
30867257|NCT02730169|58897414|FG003|Overall Study|Other|1|||
30867258|NCT02648217|58897426|FG000|Overall Study|Adverse Event|0|||
30867259|NCT02648217|58897427|FG001|Overall Study|Adverse Event|1|||
30867260|NCT02648217|58897426|FG000|Overall Study|Lost to Follow-up|1|||
30867261|NCT02648217|58897427|FG001|Overall Study|Lost to Follow-up|1|||
30867262|NCT02648217|58897426|FG000|Overall Study|Withdrawal by Subject|4|||
30867263|NCT02648217|58897427|FG001|Overall Study|Withdrawal by Subject|3|||
30867264|NCT02648217|58897426|FG000|Overall Study|Unclassified|5|||
30867265|NCT02648217|58897427|FG001|Overall Study|Unclassified|0|||
30867266|NCT00709735|58897435|FG000|Overall Study|Lost to Follow-up|1|||
30867267|NCT00709735|58897436|FG001|Overall Study|Lost to Follow-up|1|||
30867268|NCT00709735|58897435|FG000|Overall Study|Relapse into Opioid Abuse|0|||
30867269|NCT00709735|58897436|FG001|Overall Study|Relapse into Opioid Abuse|1|||
30867270|NCT00709735|58897435|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
30867271|NCT00709735|58897436|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
30867272|NCT02647905|58897442|FG000|Overall Study|Lost to Follow-up|1|||
30867273|NCT02647905|58897442|FG000|Overall Study|Withdrawal by Subject|2|||
30867274|NCT04185909|58897455|FG000|Overall Study|Lost to Follow-up|1|||
30867275|NCT04076943|58897459|FG000|Overall Study|Withdrawal by Subject|12|||
30867276|NCT04076943|58897459|FG000|Overall Study|Adverse Event|1|||
30867277|NCT04076943|58897459|FG000|Overall Study|Progressive Disease|2|||
30867278|NCT04076943|58897459|FG000|Overall Study|Death|13|||
30867279|NCT04076943|58897459|FG000|Overall Study|Other than specified|6|||
30867280|NCT00708643|58897465|FG000|Overall Study|Adverse Event|0|||
30867281|NCT00708643|58897466|FG001|Overall Study|Adverse Event|1|||
30867282|NCT01285557|58897529|FG000|Overall Study|Death|173|||
30867283|NCT01285557|58897530|FG001|Overall Study|Death|90|||
30867284|NCT01285557|58897529|FG000|Overall Study|Lost to Follow-up|6|||
30867285|NCT01285557|58897530|FG001|Overall Study|Lost to Follow-up|2|||
30867286|NCT01285557|58897529|FG000|Overall Study|Withdrew Consent|6|||
30867287|NCT01285557|58897530|FG001|Overall Study|Withdrew Consent|1|||
30867288|NCT01285557|58897529|FG000|Overall Study|Sponsor Study Termination|23|||
30867289|NCT01285557|58897530|FG001|Overall Study|Sponsor Study Termination|13|||
30867290|NCT01285557|58897529|FG000|Overall Study|Randomized but not treated|1|||
30867291|NCT01285557|58897530|FG001|Overall Study|Randomized but not treated|1|||
30867292|NCT01285557|58897529|FG000|Overall Study|Study follow-up ongoing|28|||
30867293|NCT01285557|58897530|FG001|Overall Study|Study follow-up ongoing|14|||
30867294|NCT01285557|58897529|FG000|Overall Study|Sponsor Decision|2|||
30867295|NCT01285557|58897530|FG001|Overall Study|Sponsor Decision|1|||
30867296|NCT01376167|58897592|FG000|Overall Study|Lost to Follow-up|2|||
30867297|NCT01376167|58897593|FG001|Overall Study|Lost to Follow-up|4|||
30867298|NCT01376167|58897594|FG002|Overall Study|Lost to Follow-up|2|||
30867299|NCT01376167|58897592|FG000|Overall Study|Physician Decision|1|||
30867300|NCT01376167|58897593|FG001|Overall Study|Physician Decision|1|||
30867301|NCT01376167|58897594|FG002|Overall Study|Physician Decision|0|||
30867302|NCT01376167|58897592|FG000|Overall Study|Withdrawal by Subject|1|||
30867303|NCT01376167|58897593|FG001|Overall Study|Withdrawal by Subject|5|||
30867304|NCT01376167|58897594|FG002|Overall Study|Withdrawal by Subject|4|||
30867305|NCT02647281|58897614|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
30867306|NCT02647281|58897615|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
30867307|NCT02647281|58897616|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
30867308|NCT02647281|58897617|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
30867309|NCT02647281|58897618|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
30867310|NCT02647281|58897619|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
30867311|NCT02647281|58897620|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
30867312|NCT02647281|58897621|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
30867313|NCT02647281|58897622|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
30867314|NCT02729545|58897653|FG000|Overall Study|Pregnancy|1|||
30867315|NCT02729545|58897654|FG001|Overall Study|Pregnancy|1|||
30867316|NCT02729545|58897653|FG000|Overall Study|Lost to Follow-up|0|||
30867317|NCT02729545|58897654|FG001|Overall Study|Lost to Follow-up|1|||
30867318|NCT02729545|58897653|FG000|Overall Study|Withdrawal by Subject|2|||
30867319|NCT02729545|58897654|FG001|Overall Study|Withdrawal by Subject|3|||
30867320|NCT01376089|58897662|FG000|Overall Study|Patient received no contrast media|3|||
30867321|NCT01376089|58897663|FG001|Overall Study|Patient received no contrast media|4|||
30867322|NCT00706849|58897675|FG000|Treatment Period|Adverse Event|0|||
30960823|NCT01521923|59026599|FG001|Overall Study|AE, captured in Period 1|1|||
30867323|NCT00706849|58897676|FG001|Treatment Period|Adverse Event|9|||
30867324|NCT00706849|58897675|FG000|Treatment Period|Other|0|||
30867325|NCT00706849|58897676|FG001|Treatment Period|Other|1|||
30867326|NCT00706849|58897675|FG000|Follow-up Period|Withdrawal by Subject|0|||
30867327|NCT00706849|58897676|FG001|Follow-up Period|Withdrawal by Subject|2|||
30867328|NCT00706849|58897675|FG000|Follow-up Period|Protocol non-compliance|0|||
30867329|NCT00706849|58897676|FG001|Follow-up Period|Protocol non-compliance|1|||
30867330|NCT00707161|58897682|FG000|Overall Study|Physician Decision|6|||
30867331|NCT02130466|58897700|FG000|Overall Study|Death|4|||
30867332|NCT02130466|58897701|FG001|Overall Study|Death|1|||
30867333|NCT02130466|58897702|FG002|Overall Study|Death|1|||
30867334|NCT02130466|58897703|FG003|Overall Study|Death|3|||
30867335|NCT02130466|58897704|FG004|Overall Study|Death|2|||
30867336|NCT02130466|58897705|FG005|Overall Study|Death|30|||
30867337|NCT02130466|58897706|FG006|Overall Study|Death|45|||
30867338|NCT02130466|58897707|FG007|Overall Study|Death|2|||
30867339|NCT02130466|58897708|FG008|Overall Study|Death|3|||
30867340|NCT02130466|58897709|FG009|Overall Study|Death|4|||
30867341|NCT02130466|58897710|FG010|Overall Study|Death|5|||
30867342|NCT02130466|58897711|FG011|Overall Study|Death|3|||
30867343|NCT02130466|58897712|FG012|Overall Study|Death|11|||
30867344|NCT02130466|58897713|FG013|Overall Study|Death|7|||
30867345|NCT02130466|58897700|FG000|Overall Study|Lost to Follow-up|1|||
30867346|NCT02130466|58897701|FG001|Overall Study|Lost to Follow-up|0|||
30867347|NCT02130466|58897702|FG002|Overall Study|Lost to Follow-up|0|||
30867348|NCT02130466|58897703|FG003|Overall Study|Lost to Follow-up|0|||
30867349|NCT02130466|58897704|FG004|Overall Study|Lost to Follow-up|0|||
30867350|NCT02130466|58897705|FG005|Overall Study|Lost to Follow-up|1|||
30867351|NCT02130466|58897706|FG006|Overall Study|Lost to Follow-up|0|||
30867352|NCT02130466|58897707|FG007|Overall Study|Lost to Follow-up|0|||
30867353|NCT02130466|58897708|FG008|Overall Study|Lost to Follow-up|0|||
30867354|NCT02130466|58897709|FG009|Overall Study|Lost to Follow-up|0|||
30867355|NCT02130466|58897710|FG010|Overall Study|Lost to Follow-up|0|||
30867356|NCT02130466|58897711|FG011|Overall Study|Lost to Follow-up|0|||
30867357|NCT02130466|58897712|FG012|Overall Study|Lost to Follow-up|1|||
30867358|NCT02130466|58897713|FG013|Overall Study|Lost to Follow-up|0|||
30867359|NCT02130466|58897700|FG000|Overall Study|Physician Decision|0|||
30867360|NCT02130466|58897701|FG001|Overall Study|Physician Decision|0|||
30867361|NCT02130466|58897702|FG002|Overall Study|Physician Decision|0|||
30867362|NCT02130466|58897703|FG003|Overall Study|Physician Decision|0|||
30867363|NCT02130466|58897704|FG004|Overall Study|Physician Decision|0|||
30867364|NCT02130466|58897705|FG005|Overall Study|Physician Decision|1|||
30867365|NCT02130466|58897706|FG006|Overall Study|Physician Decision|1|||
30867366|NCT02130466|58897707|FG007|Overall Study|Physician Decision|0|||
30867367|NCT02130466|58897708|FG008|Overall Study|Physician Decision|0|||
30867368|NCT02130466|58897709|FG009|Overall Study|Physician Decision|0|||
30867369|NCT02130466|58897710|FG010|Overall Study|Physician Decision|0|||
30867370|NCT02130466|58897711|FG011|Overall Study|Physician Decision|0|||
30867371|NCT02130466|58897712|FG012|Overall Study|Physician Decision|0|||
30867372|NCT02130466|58897713|FG013|Overall Study|Physician Decision|0|||
30867373|NCT02130466|58897700|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
30867374|NCT02130466|58897701|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
30867375|NCT02130466|58897702|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
30867376|NCT02130466|58897703|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
30867377|NCT02130466|58897704|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
30867378|NCT02130466|58897705|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
30867379|NCT02130466|58897706|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
30867380|NCT02130466|58897707|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
30867381|NCT02130466|58897708|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
30867382|NCT02130466|58897709|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
30867383|NCT02130466|58897710|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
30867384|NCT02130466|58897711|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
30867385|NCT02130466|58897712|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
30867386|NCT02130466|58897713|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
30867387|NCT02130466|58897700|FG000|Overall Study|Withdrawal by Subject|1|||
30867388|NCT02130466|58897701|FG001|Overall Study|Withdrawal by Subject|0|||
30867389|NCT02130466|58897702|FG002|Overall Study|Withdrawal by Subject|0|||
30867390|NCT02130466|58897703|FG003|Overall Study|Withdrawal by Subject|0|||
30867391|NCT02130466|58897704|FG004|Overall Study|Withdrawal by Subject|0|||
30867392|NCT02130466|58897705|FG005|Overall Study|Withdrawal by Subject|1|||
30867393|NCT02130466|58897706|FG006|Overall Study|Withdrawal by Subject|0|||
30867394|NCT02130466|58897707|FG007|Overall Study|Withdrawal by Subject|0|||
30867395|NCT02130466|58897708|FG008|Overall Study|Withdrawal by Subject|1|||
30867396|NCT02130466|58897709|FG009|Overall Study|Withdrawal by Subject|0|||
30867397|NCT02130466|58897710|FG010|Overall Study|Withdrawal by Subject|0|||
30867398|NCT02130466|58897711|FG011|Overall Study|Withdrawal by Subject|0|||
30867399|NCT02130466|58897712|FG012|Overall Study|Withdrawal by Subject|0|||
30960824|NCT01521923|59026600|FG002|Overall Study|AE, captured in Period 1|0|||
30867400|NCT02130466|58897713|FG013|Overall Study|Withdrawal by Subject|0|||
30867401|NCT02163538|58897762|FG000|Overall Study|Protocol Violation|1|||
30867402|NCT02163538|58897763|FG001|Overall Study|Protocol Violation|0|||
30867403|NCT02163538|58897762|FG000|Overall Study|Physician Decision|0|||
30867404|NCT02163538|58897763|FG001|Overall Study|Physician Decision|1|||
30867405|NCT02163226|58897771|FG000|Overall Study|Death|2|||
30867406|NCT02163226|58897772|FG001|Overall Study|Death|1|||
30867407|NCT02163226|58897771|FG000|Overall Study|Withdrawal by Subject|5|||
30867408|NCT02163226|58897772|FG001|Overall Study|Withdrawal by Subject|2|||
30867409|NCT02163226|58897771|FG000|Overall Study|Returned home, local radiotherapy|3|||
30867410|NCT02163226|58897772|FG001|Overall Study|Returned home, local radiotherapy|0|||
30867411|NCT02163226|58897771|FG000|Overall Study|Repeat imaging showed no disease|2|||
30867412|NCT02163226|58897772|FG001|Overall Study|Repeat imaging showed no disease|0|||
30867413|NCT02163226|58897771|FG000|Overall Study|Incomplete radiotherapy|3|||
30867414|NCT02163226|58897772|FG001|Overall Study|Incomplete radiotherapy|0|||
30867415|NCT02163226|58897771|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
30867416|NCT02163226|58897772|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
30867417|NCT02163226|58897771|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
30867418|NCT02163226|58897772|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
30867419|NCT02163226|58897771|FG000|Overall Study|ineligible|0|||
30867420|NCT02163226|58897772|FG001|Overall Study|ineligible|3|||
30867421|NCT02193178|58897778|FG000|Overall Study|Lost to Follow-up|1|||
30867422|NCT02193178|58897778|FG000|Overall Study|Dry eyes|1|||
30867423|NCT02129608|58897799|FG000|Overall Study|Lost to Follow-up|0|||
30867424|NCT02129608|58897800|FG001|Overall Study|Lost to Follow-up|1|||
30867425|NCT02129608|58897801|FG002|Overall Study|Lost to Follow-up|1|||
30867426|NCT02129608|58897799|FG000|Overall Study|Withdrawal by Subject|0|||
30867427|NCT02129608|58897800|FG001|Overall Study|Withdrawal by Subject|0|||
30867428|NCT02129608|58897801|FG002|Overall Study|Withdrawal by Subject|2|||
30867429|NCT01631188|58897809|FG000|Overall Study|Physician Decision|75|||
30867430|NCT02129062|58897813|FG000|Overall Study|Death|1|||
30867431|NCT02129062|58897813|FG000|Overall Study|Disease Progression|2|||
30867432|NCT02162758|58897819|FG000|Overall Study|Study termination|0|||
30867433|NCT02162758|58897820|FG001|Overall Study|Study termination|1|||
30867434|NCT02192164|58897826|FG000|Overall Study|Other|8|||
30867435|NCT02192164|58897826|FG000|Overall Study|Withdrawal by Subject|1|||
30867436|NCT02192164|58897826|FG000|Overall Study|Physician Decision|4|||
30867437|NCT02192164|58897826|FG000|Overall Study|Did not meet the exclusion criteria|1|||
30867438|NCT02191618|58897833|FG000|Overall Study|Withdrawal by Subject|3|||
30867439|NCT02191618|58897833|FG000|Overall Study|Missed Visit|4|||
30867440|NCT02646891|58897847|FG000|Overall Study|Adverse Event|0|||
30867441|NCT02646891|58897848|FG001|Overall Study|Adverse Event|1|||
30867442|NCT02646891|58897849|FG002|Overall Study|Adverse Event|0|||
30867443|NCT02646891|58897850|FG003|Overall Study|Adverse Event|0|||
30867444|NCT02646891|58897851|FG004|Overall Study|Adverse Event|0|||
30867445|NCT02646891|58897852|FG005|Overall Study|Adverse Event|0|||
30867446|NCT02646891|58897853|FG006|Overall Study|Adverse Event|0|||
30867447|NCT02646891|58897854|FG007|Overall Study|Adverse Event|0|||
30867448|NCT02646891|58897855|FG008|Overall Study|Adverse Event|0|||
30867449|NCT02646891|58897856|FG009|Overall Study|Adverse Event|0|||
30867450|NCT02646891|58897847|FG000|Overall Study|Lost to Follow-up|0|||
30867451|NCT02646891|58897848|FG001|Overall Study|Lost to Follow-up|0|||
30867452|NCT02646891|58897849|FG002|Overall Study|Lost to Follow-up|0|||
30867453|NCT02646891|58897850|FG003|Overall Study|Lost to Follow-up|0|||
30867454|NCT02646891|58897851|FG004|Overall Study|Lost to Follow-up|0|||
30867455|NCT02646891|58897852|FG005|Overall Study|Lost to Follow-up|0|||
30867456|NCT02646891|58897853|FG006|Overall Study|Lost to Follow-up|2|||
30867457|NCT02646891|58897854|FG007|Overall Study|Lost to Follow-up|2|||
30867458|NCT02646891|58897855|FG008|Overall Study|Lost to Follow-up|2|||
30867459|NCT02646891|58897856|FG009|Overall Study|Lost to Follow-up|2|||
30867460|NCT02646891|58897847|FG000|Overall Study|Protocol Violation|0|||
30867461|NCT02646891|58897848|FG001|Overall Study|Protocol Violation|0|||
30867462|NCT02646891|58897849|FG002|Overall Study|Protocol Violation|0|||
30867463|NCT02646891|58897850|FG003|Overall Study|Protocol Violation|0|||
30867464|NCT02646891|58897851|FG004|Overall Study|Protocol Violation|0|||
30867465|NCT02646891|58897852|FG005|Overall Study|Protocol Violation|0|||
30867466|NCT02646891|58897853|FG006|Overall Study|Protocol Violation|1|||
30867467|NCT02646891|58897854|FG007|Overall Study|Protocol Violation|1|||
30867468|NCT02646891|58897855|FG008|Overall Study|Protocol Violation|0|||
30867469|NCT02646891|58897856|FG009|Overall Study|Protocol Violation|0|||
30867470|NCT02646891|58897847|FG000|Overall Study|Withdrawal by Subject|2|||
30867471|NCT02646891|58897848|FG001|Overall Study|Withdrawal by Subject|0|||
30867472|NCT02646891|58897849|FG002|Overall Study|Withdrawal by Subject|1|||
30867473|NCT02646891|58897850|FG003|Overall Study|Withdrawal by Subject|0|||
30867474|NCT02646891|58897851|FG004|Overall Study|Withdrawal by Subject|0|||
30867475|NCT02646891|58897852|FG005|Overall Study|Withdrawal by Subject|0|||
30867476|NCT02646891|58897853|FG006|Overall Study|Withdrawal by Subject|5|||
30867477|NCT02646891|58897854|FG007|Overall Study|Withdrawal by Subject|9|||
30867478|NCT02646891|58897855|FG008|Overall Study|Withdrawal by Subject|7|||
30867479|NCT02646891|58897856|FG009|Overall Study|Withdrawal by Subject|3|||
30867480|NCT02646891|58897847|FG000|Overall Study|Death|0|||
30867481|NCT02646891|58897848|FG001|Overall Study|Death|0|||
30867482|NCT02646891|58897849|FG002|Overall Study|Death|0|||
30867483|NCT02646891|58897850|FG003|Overall Study|Death|0|||
30867484|NCT02646891|58897851|FG004|Overall Study|Death|0|||
30867485|NCT02646891|58897852|FG005|Overall Study|Death|0|||
30867486|NCT02646891|58897853|FG006|Overall Study|Death|1|||
30867487|NCT02646891|58897854|FG007|Overall Study|Death|1|||
30867488|NCT02646891|58897855|FG008|Overall Study|Death|1|||
30867489|NCT02646891|58897856|FG009|Overall Study|Death|0|||
30867490|NCT02646423|58897892|FG000|Overall Study|Adverse Event|5|||
30867491|NCT02646423|58897893|FG001|Overall Study|Adverse Event|7|||
30867492|NCT02646423|58897892|FG000|Overall Study|Ineligible|2|||
30867493|NCT02646423|58897893|FG001|Overall Study|Ineligible|1|||
30867494|NCT02647359|58897919|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
30867495|NCT02647359|58897920|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
30867496|NCT02647359|58897919|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
30867497|NCT02647359|58897920|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
30867498|NCT02647359|58897919|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
30867499|NCT02647359|58897920|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
30867500|NCT02647359|58897919|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
30867501|NCT02647359|58897920|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
30867502|NCT02647359|58897919|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
30867503|NCT02647359|58897920|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
30867504|NCT02647359|58897919|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
30867505|NCT02647359|58897920|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
30867506|NCT02645409|58897932|FG000|Overall Study|Withdrawal by Subject|3|||
30867507|NCT02645409|58897933|FG001|Overall Study|Withdrawal by Subject|0|||
30867508|NCT02645409|58897932|FG000|Overall Study|Physician Decision|1|||
30867509|NCT02645409|58897933|FG001|Overall Study|Physician Decision|0|||
30867510|NCT01597479|58897940|FG000|Overall Study|Protocol Violation|1|||
30867511|NCT01597479|58897941|FG001|Overall Study|Protocol Violation|0|||
30867512|NCT01597479|58897940|FG000|Overall Study|Lost to Follow-up|1|||
30867513|NCT01597479|58897941|FG001|Overall Study|Lost to Follow-up|0|||
30867514|NCT04248465|58897950|FG000|Randomized-Controlled Period|Death|12|||
30867515|NCT04248465|58897951|FG001|Randomized-Controlled Period|Death|5|||
30867516|NCT04248465|58897950|FG000|Randomized-Controlled Period|Adverse Event|2|||
30867517|NCT04248465|58897951|FG001|Randomized-Controlled Period|Adverse Event|0|||
30867518|NCT04248465|58897950|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
30867519|NCT04248465|58897951|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
30867520|NCT04248465|58897950|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
30867521|NCT04248465|58897951|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
30867522|NCT04248465|58897950|FG000|Randomized-Controlled Period|Physician Decision|1|||
30867523|NCT04248465|58897951|FG001|Randomized-Controlled Period|Physician Decision|1|||
30867524|NCT04248465|58897950|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
30867525|NCT04248465|58897951|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
30867526|NCT04248465|58897950|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
30867527|NCT04248465|58897951|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
30867528|NCT04248465|58897950|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
30867529|NCT04248465|58897951|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
30867530|NCT02643693|58897959|FG000|Overall Study|Physician Decision|0|||
30867531|NCT02643693|58897960|FG001|Overall Study|Physician Decision|1|||
30867532|NCT02643693|58897961|FG002|Overall Study|Physician Decision|0|||
30867533|NCT02643693|58897962|FG003|Overall Study|Physician Decision|0|||
30867534|NCT02643693|58897963|FG004|Overall Study|Physician Decision|0|||
30867535|NCT02643693|58897964|FG005|Overall Study|Physician Decision|0|||
30867536|NCT02643693|58897959|FG000|Overall Study|Withdrawal by Subject|0|||
30867537|NCT02643693|58897960|FG001|Overall Study|Withdrawal by Subject|1|||
30867538|NCT02643693|58897961|FG002|Overall Study|Withdrawal by Subject|0|||
30867539|NCT02643693|58897962|FG003|Overall Study|Withdrawal by Subject|0|||
30867540|NCT02643693|58897963|FG004|Overall Study|Withdrawal by Subject|0|||
30867541|NCT02643693|58897964|FG005|Overall Study|Withdrawal by Subject|0|||
30867542|NCT02643693|58897959|FG000|Overall Study|Protocol Adherence Issues|2|||
30867543|NCT02643693|58897960|FG001|Overall Study|Protocol Adherence Issues|0|||
30867544|NCT02643693|58897961|FG002|Overall Study|Protocol Adherence Issues|1|||
30867545|NCT02643693|58897962|FG003|Overall Study|Protocol Adherence Issues|0|||
30867546|NCT02643693|58897963|FG004|Overall Study|Protocol Adherence Issues|0|||
30867547|NCT02643693|58897964|FG005|Overall Study|Protocol Adherence Issues|1|||
30867548|NCT02726113|58897974|FG000|Total Enrollment|Physician Decision|0|||
30867549|NCT02726113|58897975|FG001|Total Enrollment|Physician Decision|1|||
30867550|NCT02726113|58897974|FG000|Total Enrollment|Protocol Violation|1|||
30867551|NCT02726113|58897975|FG001|Total Enrollment|Protocol Violation|0|||
30867552|NCT02726113|58897974|FG000|Total Enrollment|Withdrawal by Subject|2|||
30867553|NCT02726113|58897975|FG001|Total Enrollment|Withdrawal by Subject|1|||
30867554|NCT02726113|58897974|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
30867555|NCT02726113|58897975|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
30867556|NCT02726113|58897974|FG000|Genomic Analysis|Protocol Violation|1|||
30867557|NCT02726113|58897975|FG001|Genomic Analysis|Protocol Violation|0|||
30602230|NCT01289418|58613570|FG000|Day 29 Survey|participants did not complete the survey|2185|||
30867558|NCT02726113|58897974|FG000|Genomic Analysis|Withdrawal by Subject|2|||
30867559|NCT02726113|58897975|FG001|Genomic Analysis|Withdrawal by Subject|1|||
30867560|NCT02726113|58897974|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
30867561|NCT02726113|58897975|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
30867562|NCT01361919|58897993|FG000|Overall Study|technical issues|10|||
30867563|NCT01361919|58897994|FG001|Overall Study|technical issues|12|||
30867564|NCT01361919|58897995|FG002|Overall Study|technical issues|10|||
30867565|NCT02642679|58898003|FG000|Overall Study|Withdrawal by Subject|1|||
30867566|NCT02642679|58898003|FG000|Overall Study|Physician Decision|1|||
30867567|NCT02642679|58898003|FG000|Overall Study|Physician Decision|1|||
30867568|NCT00705523|58898009|FG000|Overall Study|Lost to Follow-up|2|||
30867569|NCT00705523|58898010|FG001|Overall Study|Lost to Follow-up|3|||
30867570|NCT02725411|58898019|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
30867571|NCT02725411|58898020|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
30867572|NCT02725411|58898021|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
30867573|NCT02725411|58898019|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
30867574|NCT02725411|58898020|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
30867575|NCT02725411|58898021|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
30867576|NCT02725411|58898019|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
30867577|NCT02725411|58898020|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
30867578|NCT02725411|58898021|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
30867579|NCT02725411|58898019|FG000|Treatment Period (56 Weeks)|Other|1|||
30867580|NCT02725411|58898020|FG001|Treatment Period (56 Weeks)|Other|4|||
30867581|NCT02725411|58898021|FG002|Treatment Period (56 Weeks)|Other|5|||
30867582|NCT02725411|58898019|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
30867583|NCT02725411|58898020|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
30867584|NCT02725411|58898021|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
30867585|NCT02725411|58898019|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
30867586|NCT02725411|58898020|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
30867587|NCT02725411|58898021|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
30867588|NCT02725411|58898019|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
30867589|NCT02725411|58898020|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
30867590|NCT02725411|58898021|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
30867591|NCT02725411|58898019|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
30867592|NCT02725411|58898020|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
30867593|NCT02725411|58898021|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
30867594|NCT02725411|58898019|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
30867595|NCT02725411|58898020|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
30867596|NCT02725411|58898021|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
30867597|NCT02725411|58898019|FG000|Follow-up Period (24 Weeks)|Other|1|||
30867598|NCT02725411|58898020|FG001|Follow-up Period (24 Weeks)|Other|4|||
30867599|NCT02725411|58898021|FG002|Follow-up Period (24 Weeks)|Other|2|||
30867600|NCT02725411|58898019|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
30867601|NCT02725411|58898020|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
30867602|NCT02725411|58898021|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
30867603|NCT02190604|58898057|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867604|NCT02190604|58898058|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867605|NCT02190604|58898059|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867606|NCT02190604|58898060|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867607|NCT02190604|58898061|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867608|NCT02190604|58898062|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867609|NCT02190604|58898063|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867610|NCT02190604|58898064|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867611|NCT02190604|58898065|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867612|NCT02190604|58898066|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867613|NCT02190604|58898067|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867614|NCT02190604|58898068|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867615|NCT02190604|58898069|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867616|NCT02190604|58898070|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867617|NCT02190604|58898071|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
30867618|NCT02190604|58898072|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867619|NCT02190604|58898073|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867620|NCT02190604|58898074|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867621|NCT02190604|58898075|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
30867622|NCT02190604|58898057|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867623|NCT02190604|58898058|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867624|NCT02190604|58898059|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867625|NCT02190604|58898060|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867626|NCT02190604|58898061|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867627|NCT02190604|58898062|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867628|NCT02190604|58898063|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867629|NCT02190604|58898064|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867630|NCT02190604|58898065|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867631|NCT02190604|58898066|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867632|NCT02190604|58898067|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867633|NCT02190604|58898068|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867634|NCT02190604|58898069|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867635|NCT02190604|58898070|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
30867636|NCT02190604|58898071|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867637|NCT02190604|58898072|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867638|NCT02190604|58898073|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867639|NCT02190604|58898074|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867640|NCT02190604|58898075|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
30867641|NCT02127970|58898134|FG000|Overall Study|Adverse Event|2|||
30867642|NCT02127970|58898135|FG001|Overall Study|Adverse Event|1|||
30867643|NCT02127970|58898134|FG000|Overall Study|Death|1|||
30867644|NCT02127970|58898135|FG001|Overall Study|Death|1|||
30867645|NCT02127970|58898134|FG000|Overall Study|Lost to Follow-up|14|||
30867646|NCT02127970|58898135|FG001|Overall Study|Lost to Follow-up|14|||
30867647|NCT02127970|58898134|FG000|Overall Study|Reason not Specified|4|||
30867648|NCT02127970|58898135|FG001|Overall Study|Reason not Specified|7|||
30867649|NCT02127970|58898134|FG000|Overall Study|Pregnancy|0|||
30867650|NCT02127970|58898135|FG001|Overall Study|Pregnancy|1|||
30867651|NCT02127970|58898134|FG000|Overall Study|Subject Withdrew Consent|5|||
30867652|NCT02127970|58898135|FG001|Overall Study|Subject Withdrew Consent|3|||
30867653|NCT03549871|58898143|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
30867654|NCT03549871|58898144|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
30867655|NCT03549871|58898143|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
30867656|NCT03549871|58898144|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
30867657|NCT03549871|58898143|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
30867658|NCT03549871|58898144|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
30867659|NCT03549871|58898143|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
30867660|NCT03549871|58898144|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
30867661|NCT03549871|58898143|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
30867662|NCT03549871|58898144|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
30867663|NCT03549871|58898143|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
30867664|NCT03549871|58898144|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
30867665|NCT03549871|58898143|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
30867666|NCT03549871|58898144|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
30867667|NCT03549871|58898143|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
30867668|NCT03549871|58898144|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
30867669|NCT03549871|58898143|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
30867670|NCT03549871|58898144|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
30867671|NCT03549871|58898143|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
30867672|NCT03549871|58898144|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
30867673|NCT03549871|58898143|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
30867674|NCT03549871|58898144|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
30867675|NCT00705367|58898167|FG000|Long-term Extension Period|Adverse Event|2|||
30867676|NCT00705367|58898168|FG001|Long-term Extension Period|Adverse Event|0|||
30867677|NCT00705367|58898167|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
30867678|NCT00705367|58898168|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
30867679|NCT00705367|58898167|FG000|Long-term Extension Period|Lack of Efficacy|1|||
30867680|NCT00705367|58898168|FG001|Long-term Extension Period|Lack of Efficacy|0|||
30867681|NCT00705367|58898167|FG000|Long-term Extension Period|No longer met study criteria|1|||
30867682|NCT00705367|58898168|FG001|Long-term Extension Period|No longer met study criteria|0|||
30867683|NCT00705367|58898167|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
30867684|NCT00705367|58898168|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
30867685|NCT02864251|58898179|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
30867686|NCT02864251|58898180|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
30867687|NCT02864251|58898181|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
30867688|NCT02864251|58898179|FG000|Pre-Treatment|Withdrawal by Participant|0|||
30867689|NCT02864251|58898180|FG001|Pre-Treatment|Withdrawal by Participant|0|||
30867690|NCT02864251|58898181|FG002|Pre-Treatment|Withdrawal by Participant|4|||
30867691|NCT02864251|58898179|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
30867692|NCT02864251|58898180|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
30867693|NCT02864251|58898181|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
30867694|NCT02864251|58898179|FG000|Pre-Treatment|Other Reasons|0|||
30960825|NCT01521923|59026601|FG003|Overall Study|AE, captured in Period 1|1|||
30867695|NCT02864251|58898180|FG001|Pre-Treatment|Other Reasons|1|||
30867696|NCT02864251|58898181|FG002|Pre-Treatment|Other Reasons|1|||
30867697|NCT02864251|58898179|FG000|Treatment|Disease Progression|109|||
30867698|NCT02864251|58898180|FG001|Treatment|Disease Progression|52|||
30867699|NCT02864251|58898181|FG002|Treatment|Disease Progression|100|||
30867700|NCT02864251|58898179|FG000|Treatment|Study Drug Toxicity|9|||
30867701|NCT02864251|58898180|FG001|Treatment|Study Drug Toxicity|4|||
30867702|NCT02864251|58898181|FG002|Treatment|Study Drug Toxicity|10|||
30867703|NCT02864251|58898179|FG000|Treatment|Death|0|||
30867704|NCT02864251|58898180|FG001|Treatment|Death|2|||
30867705|NCT02864251|58898181|FG002|Treatment|Death|3|||
30867706|NCT02864251|58898179|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
30867707|NCT02864251|58898180|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
30867708|NCT02864251|58898181|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
30867709|NCT02864251|58898179|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
30867710|NCT02864251|58898180|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
30867711|NCT02864251|58898181|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
30867712|NCT02864251|58898179|FG000|Treatment|Withdrawal by Participant|8|||
30867713|NCT02864251|58898180|FG001|Treatment|Withdrawal by Participant|5|||
30867714|NCT02864251|58898181|FG002|Treatment|Withdrawal by Participant|13|||
30867715|NCT02864251|58898179|FG000|Treatment|Maximum Clinical Benefit|1|||
30867716|NCT02864251|58898180|FG001|Treatment|Maximum Clinical Benefit|0|||
30867717|NCT02864251|58898181|FG002|Treatment|Maximum Clinical Benefit|1|||
30867718|NCT02864251|58898179|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
30867719|NCT02864251|58898180|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
30867720|NCT02864251|58898181|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
30867721|NCT02864251|58898179|FG000|Treatment|Other Reasons|0|||
30867722|NCT02864251|58898180|FG001|Treatment|Other Reasons|1|||
30867723|NCT02864251|58898181|FG002|Treatment|Other Reasons|3|||
30867724|NCT02864251|58898179|FG000|Treatment|Not Reported|1|||
30867725|NCT02864251|58898180|FG001|Treatment|Not Reported|0|||
30867726|NCT02864251|58898181|FG002|Treatment|Not Reported|0|||
30867727|NCT02864251|58898179|FG000|Treatment|Ongoing Treatment|1|||
30867728|NCT02864251|58898180|FG001|Treatment|Ongoing Treatment|0|||
30867729|NCT02864251|58898181|FG002|Treatment|Ongoing Treatment|2|||
30867730|NCT00705289|58898189|FG000|Overall Study|Subject or treating physician's choice|131|||
30867731|NCT02038777|58898218|FG000|Overall Study|Death|0|||
30867732|NCT02038777|58898219|FG001|Overall Study|Death|2|||
30867733|NCT02038777|58898220|FG002|Overall Study|Death|0|||
30867734|NCT02038777|58898221|FG003|Overall Study|Death|1|||
30867735|NCT02038777|58898222|FG004|Overall Study|Death|2|||
30867736|NCT02038777|58898223|FG005|Overall Study|Death|4|||
30867737|NCT02038777|58898224|FG006|Overall Study|Death|0|||
30867738|NCT02038777|58898225|FG007|Overall Study|Death|10|||
30867739|NCT02038777|58898218|FG000|Overall Study|Lost to Follow-up|0|||
30867740|NCT02038777|58898219|FG001|Overall Study|Lost to Follow-up|0|||
30867741|NCT02038777|58898220|FG002|Overall Study|Lost to Follow-up|0|||
30867742|NCT02038777|58898221|FG003|Overall Study|Lost to Follow-up|1|||
30867743|NCT02038777|58898222|FG004|Overall Study|Lost to Follow-up|0|||
30867744|NCT02038777|58898223|FG005|Overall Study|Lost to Follow-up|0|||
30867745|NCT02038777|58898224|FG006|Overall Study|Lost to Follow-up|0|||
30867746|NCT02038777|58898225|FG007|Overall Study|Lost to Follow-up|0|||
30867747|NCT02038777|58898218|FG000|Overall Study|Other|0|||
30867748|NCT02038777|58898219|FG001|Overall Study|Other|1|||
30867749|NCT02038777|58898220|FG002|Overall Study|Other|0|||
30867750|NCT02038777|58898221|FG003|Overall Study|Other|2|||
30867751|NCT02038777|58898222|FG004|Overall Study|Other|1|||
30867752|NCT02038777|58898223|FG005|Overall Study|Other|0|||
30867753|NCT02038777|58898224|FG006|Overall Study|Other|0|||
30867754|NCT02038777|58898225|FG007|Overall Study|Other|0|||
30867755|NCT02038777|58898218|FG000|Overall Study|Randomized but not treated|0|||
30867756|NCT02038777|58898219|FG001|Overall Study|Randomized but not treated|1|||
30867757|NCT02038777|58898220|FG002|Overall Study|Randomized but not treated|0|||
30867758|NCT02038777|58898221|FG003|Overall Study|Randomized but not treated|0|||
30867759|NCT02038777|58898222|FG004|Overall Study|Randomized but not treated|0|||
30867760|NCT02038777|58898223|FG005|Overall Study|Randomized but not treated|0|||
30867761|NCT02038777|58898224|FG006|Overall Study|Randomized but not treated|0|||
30867762|NCT02038777|58898225|FG007|Overall Study|Randomized but not treated|0|||
30867763|NCT02038777|58898218|FG000|Overall Study|Started Chemotherapy|1|||
30867764|NCT02038777|58898219|FG001|Overall Study|Started Chemotherapy|0|||
30867765|NCT02038777|58898220|FG002|Overall Study|Started Chemotherapy|3|||
30867766|NCT02038777|58898221|FG003|Overall Study|Started Chemotherapy|0|||
30867767|NCT02038777|58898222|FG004|Overall Study|Started Chemotherapy|0|||
30867768|NCT02038777|58898223|FG005|Overall Study|Started Chemotherapy|0|||
30867769|NCT02038777|58898224|FG006|Overall Study|Started Chemotherapy|0|||
30867770|NCT02038777|58898225|FG007|Overall Study|Started Chemotherapy|0|||
30867771|NCT00703963|58898244|FG000|Overall Study|Withdrawal by Subject|7|||
30867772|NCT00703963|58898245|FG001|Overall Study|Withdrawal by Subject|13|||
30867773|NCT00703963|58898244|FG000|Overall Study|Physician Decision|0|||
30867774|NCT00703963|58898245|FG001|Overall Study|Physician Decision|1|||
30867775|NCT02721355|58898253|FG000|Overall Study|Lost to Follow-up|6|||
30867776|NCT02721355|58898254|FG001|Overall Study|Lost to Follow-up|1|||
30867777|NCT02733991|58898262|FG000|Overall Study|Adverse Event|1|||
30867778|NCT02733991|58898263|FG001|Overall Study|Adverse Event|0|||
30867779|NCT02733991|58898262|FG000|Overall Study|Withdrawal by Subject|0|||
30867780|NCT02733991|58898263|FG001|Overall Study|Withdrawal by Subject|5|||
30867781|NCT00702949|58898272|FG000|Overall Study|Refusal|3|||
30867782|NCT00702949|58898273|FG001|Overall Study|Refusal|2|||
30867783|NCT00702949|58898274|FG002|Overall Study|Refusal|2|||
30867784|NCT00702949|58898272|FG000|Overall Study|Adverse Event|1|||
30867785|NCT00702949|58898273|FG001|Overall Study|Adverse Event|6|||
30867786|NCT00702949|58898274|FG002|Overall Study|Adverse Event|3|||
30867787|NCT00702949|58898272|FG000|Overall Study|Other Medical Reason/unknown|1|||
30867788|NCT00702949|58898273|FG001|Overall Study|Other Medical Reason/unknown|1|||
30867789|NCT00702949|58898274|FG002|Overall Study|Other Medical Reason/unknown|3|||
30867790|NCT00702715|58898286|FG000|Overall Study|Lost to Follow-up|1|||
30867791|NCT00702715|58898287|FG001|Overall Study|Lost to Follow-up|0|||
30867792|NCT00702403|58898293|FG000|From Consent to Engraftment|Progressive leukemia|6|||
30867793|NCT00702403|58898293|FG000|From Consent to Engraftment|Critically ill|2|||
30867794|NCT00702403|58898293|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
30867795|NCT00702403|58898293|FG000|From Consent to Engraftment|Myocardial infarction|1|||
30867796|NCT00702403|58898293|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
30867797|NCT00702403|58898293|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
30867798|NCT00702403|58898293|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
30867799|NCT00702403|58898293|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
30867800|NCT00702403|58898293|FG000|From Engraftment to Study Completion|Non-compliance|2|||
30867801|NCT00702403|58898293|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
30867802|NCT00702403|58898293|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
30867803|NCT00702403|58898293|FG000|From Engraftment to Study Completion|Suicide|1|||
30867804|NCT00702403|58898293|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
30867805|NCT00702403|58898293|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
30867806|NCT00702403|58898293|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
30867807|NCT00702325|58898302|FG000|Overall Study|Adverse Event|1|||
30867808|NCT00702325|58898303|FG001|Overall Study|Adverse Event|0|||
30867809|NCT00702325|58898302|FG000|Overall Study|Withdrawal by Subject|7|||
30867810|NCT00702325|58898303|FG001|Overall Study|Withdrawal by Subject|7|||
30867811|NCT00702325|58898302|FG000|Overall Study|Lost to Follow-up|3|||
30867812|NCT00702325|58898303|FG001|Overall Study|Lost to Follow-up|4|||
30867813|NCT00702325|58898302|FG000|Overall Study|Incorrect enrollment|5|||
30867814|NCT00702325|58898303|FG001|Overall Study|Incorrect enrollment|7|||
30867815|NCT00702325|58898302|FG000|Overall Study|Developed study discontinuation criteria|18|||
30867816|NCT00702325|58898303|FG001|Overall Study|Developed study discontinuation criteria|28|||
30867817|NCT00702325|58898302|FG000|Overall Study|Severe noncompliance to protocol|3|||
30867818|NCT00702325|58898303|FG001|Overall Study|Severe noncompliance to protocol|3|||
30867819|NCT00702325|58898302|FG000|Overall Study|Termination due to lab results|1|||
30867820|NCT00702325|58898303|FG001|Overall Study|Termination due to lab results|0|||
30867821|NCT00702325|58898302|FG000|Overall Study|Didn't follow study medication dosage|0|||
30867822|NCT00702325|58898303|FG001|Overall Study|Didn't follow study medication dosage|2|||
30867823|NCT00702325|58898302|FG000|Overall Study|Withdrew consent|0|||
30867824|NCT00702325|58898303|FG001|Overall Study|Withdrew consent|1|||
30867825|NCT00702325|58898302|FG000|Overall Study|Incorrectly Discontinued|0|||
30867826|NCT00702325|58898303|FG001|Overall Study|Incorrectly Discontinued|1|||
30867827|NCT02719171|58898314|FG000|Overall Study|Adverse Event|1|||
30867828|NCT02719171|58898315|FG001|Overall Study|Adverse Event|2|||
30867829|NCT02719171|58898316|FG002|Overall Study|Adverse Event|0|||
30694555|NCT00545272|58708717|FG003|Overall Study|Abnormal laboratory value(s)|0|||
30694556|NCT00545272|58708718|FG004|Overall Study|Abnormal laboratory value(s)|0|||
30694557|NCT00545272|58708719|FG005|Overall Study|Abnormal laboratory value(s)|1|||
30694558|NCT00545272|58708714|FG000|Overall Study|Abnormal test procedure result(s)|0|||
30694559|NCT00545272|58708715|FG001|Overall Study|Abnormal test procedure result(s)|0|||
30694560|NCT00545272|58708716|FG002|Overall Study|Abnormal test procedure result(s)|0|||
30694561|NCT00545272|58708717|FG003|Overall Study|Abnormal test procedure result(s)|0|||
30694562|NCT00545272|58708718|FG004|Overall Study|Abnormal test procedure result(s)|1|||
30867830|NCT02719171|58898317|FG003|Overall Study|Adverse Event|0|||
30867831|NCT02719171|58898318|FG004|Overall Study|Adverse Event|2|||
30867832|NCT02719171|58898314|FG000|Overall Study|Lost to Follow-up|0|||
30867833|NCT02719171|58898315|FG001|Overall Study|Lost to Follow-up|0|||
30867834|NCT02719171|58898316|FG002|Overall Study|Lost to Follow-up|1|||
30694563|NCT00545272|58708719|FG005|Overall Study|Abnormal test procedure result(s)|0|||
30867835|NCT02719171|58898317|FG003|Overall Study|Lost to Follow-up|0|||
30867836|NCT02719171|58898318|FG004|Overall Study|Lost to Follow-up|0|||
30867837|NCT02719171|58898314|FG000|Overall Study|Subject Withdrawal|0|||
30867838|NCT02719171|58898315|FG001|Overall Study|Subject Withdrawal|2|||
30867839|NCT02719171|58898316|FG002|Overall Study|Subject Withdrawal|2|||
30867840|NCT02719171|58898317|FG003|Overall Study|Subject Withdrawal|1|||
30867841|NCT02719171|58898318|FG004|Overall Study|Subject Withdrawal|0|||
30867842|NCT02719171|58898314|FG000|Overall Study|Other|0|||
30867843|NCT02719171|58898315|FG001|Overall Study|Other|0|||
30867844|NCT02719171|58898316|FG002|Overall Study|Other|0|||
30867845|NCT02719171|58898317|FG003|Overall Study|Other|1|||
30867846|NCT02719171|58898318|FG004|Overall Study|Other|0|||
30867847|NCT02718625|58898335|FG000|Overall Study|Adverse Event|0|||
30867848|NCT02718625|58898336|FG001|Overall Study|Adverse Event|1|||
30867849|NCT02718625|58898335|FG000|Overall Study|Termination of Study by Sponsor|0|||
30867850|NCT02718625|58898336|FG001|Overall Study|Termination of Study by Sponsor|1|||
30867851|NCT02716987|58898348|FG000|Overall Study|Ligand synthesis failure|0|||
30867852|NCT02716987|58898349|FG001|Overall Study|Ligand synthesis failure|0|||
30867853|NCT02716987|58898350|FG002|Overall Study|Ligand synthesis failure|1|||
30867854|NCT02716987|58898351|FG003|Overall Study|Ligand synthesis failure|0|||
30867855|NCT02716987|58898352|FG004|Overall Study|Ligand synthesis failure|0|||
30867856|NCT02716987|58898353|FG005|Overall Study|Ligand synthesis failure|0|||
30867857|NCT02716987|58898348|FG000|Overall Study|Withdrawal by Subject|0|||
30867858|NCT02716987|58898349|FG001|Overall Study|Withdrawal by Subject|0|||
30867859|NCT02716987|58898350|FG002|Overall Study|Withdrawal by Subject|0|||
30867860|NCT02716987|58898351|FG003|Overall Study|Withdrawal by Subject|0|||
30867861|NCT02716987|58898352|FG004|Overall Study|Withdrawal by Subject|1|||
30867862|NCT02716987|58898353|FG005|Overall Study|Withdrawal by Subject|1|||
30867863|NCT00701779|58898378|FG000|Overall Study|Adverse Event|6|||
30867864|NCT00701779|58898378|FG000|Overall Study|Lost to Follow-up|1|||
30867865|NCT00701779|58898378|FG000|Overall Study|Withdrawal by Subject|2|||
30867866|NCT03707977|58898401|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
30867867|NCT03707977|58898402|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
30867868|NCT03707977|58898403|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
30867869|NCT03707977|58898401|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
30867870|NCT03707977|58898402|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
30867871|NCT03707977|58898403|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
30867872|NCT03332095|58898419|FG000|Overall Study|Lost to Follow-up|1|||
30867873|NCT03332095|58898420|FG001|Overall Study|Lost to Follow-up|0|||
30867874|NCT03332095|58898419|FG000|Overall Study|Pregnancy|0|||
30867875|NCT03332095|58898420|FG001|Overall Study|Pregnancy|1|||
30867876|NCT02764489|58898427|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
30867877|NCT02764489|58898428|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
30867878|NCT02764489|58898427|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
30867879|NCT02764489|58898428|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
30867880|NCT02764489|58898427|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
30867881|NCT02764489|58898428|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
30867882|NCT02764489|58898427|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
30867883|NCT02764489|58898428|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
30867884|NCT02001623|58898453|FG000|Overall Study|Disease Progression|2|||
30867885|NCT02001623|58898454|FG001|Overall Study|Disease Progression|2|||
30867886|NCT02001623|58898455|FG002|Overall Study|Disease Progression|3|||
30867887|NCT02001623|58898456|FG003|Overall Study|Disease Progression|2|||
30867888|NCT02001623|58898457|FG004|Overall Study|Disease Progression|3|||
30867889|NCT02001623|58898458|FG005|Overall Study|Disease Progression|2|||
30867890|NCT02001623|58898459|FG006|Overall Study|Disease Progression|3|||
30867891|NCT02001623|58898460|FG007|Overall Study|Disease Progression|3|||
30867892|NCT02001623|58898461|FG008|Overall Study|Disease Progression|7|||
30867893|NCT02001623|58898462|FG009|Overall Study|Disease Progression|40|||
30867894|NCT02001623|58898463|FG010|Overall Study|Disease Progression|5|||
30867895|NCT02001623|58898464|FG011|Overall Study|Disease Progression|9|||
30867896|NCT02001623|58898465|FG012|Overall Study|Disease Progression|9|||
30867897|NCT02001623|58898466|FG013|Overall Study|Disease Progression|20|||
30867898|NCT02001623|58898467|FG014|Overall Study|Disease Progression|9|||
30867899|NCT02001623|58898453|FG000|Overall Study|Physician Decision|0|||
30867900|NCT02001623|58898454|FG001|Overall Study|Physician Decision|0|||
30867901|NCT02001623|58898455|FG002|Overall Study|Physician Decision|0|||
30867902|NCT02001623|58898456|FG003|Overall Study|Physician Decision|0|||
30867903|NCT02001623|58898457|FG004|Overall Study|Physician Decision|0|||
30867904|NCT02001623|58898458|FG005|Overall Study|Physician Decision|0|||
30867905|NCT02001623|58898459|FG006|Overall Study|Physician Decision|0|||
30867906|NCT02001623|58898460|FG007|Overall Study|Physician Decision|0|||
30867907|NCT02001623|58898461|FG008|Overall Study|Physician Decision|3|||
30867908|NCT02001623|58898462|FG009|Overall Study|Physician Decision|2|||
30867909|NCT02001623|58898463|FG010|Overall Study|Physician Decision|3|||
30867910|NCT02001623|58898464|FG011|Overall Study|Physician Decision|3|||
30867911|NCT02001623|58898465|FG012|Overall Study|Physician Decision|1|||
30867912|NCT02001623|58898466|FG013|Overall Study|Physician Decision|2|||
30867913|NCT02001623|58898467|FG014|Overall Study|Physician Decision|1|||
30867914|NCT02001623|58898453|FG000|Overall Study|Death|0|||
30867915|NCT02001623|58898454|FG001|Overall Study|Death|1|||
30867916|NCT02001623|58898455|FG002|Overall Study|Death|0|||
30867917|NCT02001623|58898456|FG003|Overall Study|Death|0|||
30867918|NCT02001623|58898457|FG004|Overall Study|Death|0|||
30867919|NCT02001623|58898458|FG005|Overall Study|Death|0|||
30867920|NCT02001623|58898459|FG006|Overall Study|Death|0|||
30867921|NCT02001623|58898460|FG007|Overall Study|Death|0|||
30867922|NCT02001623|58898461|FG008|Overall Study|Death|0|||
30867923|NCT02001623|58898462|FG009|Overall Study|Death|0|||
30867924|NCT02001623|58898463|FG010|Overall Study|Death|0|||
30867925|NCT02001623|58898464|FG011|Overall Study|Death|0|||
30867926|NCT02001623|58898465|FG012|Overall Study|Death|0|||
30867927|NCT02001623|58898466|FG013|Overall Study|Death|0|||
30867928|NCT02001623|58898467|FG014|Overall Study|Death|0|||
30867929|NCT02001623|58898453|FG000|Overall Study|Adverse Event|0|||
30867930|NCT02001623|58898454|FG001|Overall Study|Adverse Event|0|||
30867931|NCT02001623|58898455|FG002|Overall Study|Adverse Event|0|||
30867932|NCT02001623|58898456|FG003|Overall Study|Adverse Event|0|||
30867933|NCT02001623|58898457|FG004|Overall Study|Adverse Event|0|||
30867934|NCT02001623|58898458|FG005|Overall Study|Adverse Event|1|||
30867935|NCT02001623|58898459|FG006|Overall Study|Adverse Event|0|||
30867936|NCT02001623|58898460|FG007|Overall Study|Adverse Event|3|||
30867937|NCT02001623|58898461|FG008|Overall Study|Adverse Event|4|||
30867938|NCT02001623|58898462|FG009|Overall Study|Adverse Event|6|||
30867939|NCT02001623|58898463|FG010|Overall Study|Adverse Event|4|||
30867940|NCT02001623|58898464|FG011|Overall Study|Adverse Event|0|||
30867941|NCT02001623|58898465|FG012|Overall Study|Adverse Event|3|||
30867942|NCT02001623|58898466|FG013|Overall Study|Adverse Event|5|||
30867943|NCT02001623|58898467|FG014|Overall Study|Adverse Event|6|||
30867944|NCT02001623|58898453|FG000|Overall Study|Other - Miscellaneous|0|||
30867945|NCT02001623|58898454|FG001|Overall Study|Other - Miscellaneous|0|||
30867946|NCT02001623|58898455|FG002|Overall Study|Other - Miscellaneous|0|||
30867947|NCT02001623|58898456|FG003|Overall Study|Other - Miscellaneous|0|||
30867948|NCT02001623|58898457|FG004|Overall Study|Other - Miscellaneous|0|||
30867949|NCT02001623|58898458|FG005|Overall Study|Other - Miscellaneous|0|||
30867950|NCT02001623|58898459|FG006|Overall Study|Other - Miscellaneous|0|||
30867951|NCT02001623|58898460|FG007|Overall Study|Other - Miscellaneous|0|||
30867952|NCT02001623|58898461|FG008|Overall Study|Other - Miscellaneous|0|||
30867953|NCT02001623|58898462|FG009|Overall Study|Other - Miscellaneous|1|||
30867954|NCT02001623|58898463|FG010|Overall Study|Other - Miscellaneous|0|||
30867955|NCT02001623|58898464|FG011|Overall Study|Other - Miscellaneous|0|||
30867956|NCT02001623|58898465|FG012|Overall Study|Other - Miscellaneous|0|||
30867957|NCT02001623|58898466|FG013|Overall Study|Other - Miscellaneous|1|||
30867958|NCT02001623|58898467|FG014|Overall Study|Other - Miscellaneous|0|||
30867959|NCT02001623|58898453|FG000|Overall Study|Withdrawal by Subject|1|||
30867960|NCT02001623|58898454|FG001|Overall Study|Withdrawal by Subject|0|||
30867961|NCT02001623|58898455|FG002|Overall Study|Withdrawal by Subject|0|||
30867962|NCT02001623|58898456|FG003|Overall Study|Withdrawal by Subject|0|||
30867963|NCT02001623|58898457|FG004|Overall Study|Withdrawal by Subject|0|||
30867964|NCT02001623|58898458|FG005|Overall Study|Withdrawal by Subject|0|||
30867965|NCT02001623|58898459|FG006|Overall Study|Withdrawal by Subject|0|||
30867966|NCT02001623|58898460|FG007|Overall Study|Withdrawal by Subject|0|||
30867967|NCT02001623|58898461|FG008|Overall Study|Withdrawal by Subject|1|||
30867968|NCT02001623|58898462|FG009|Overall Study|Withdrawal by Subject|3|||
30867969|NCT02001623|58898463|FG010|Overall Study|Withdrawal by Subject|2|||
30867970|NCT02001623|58898464|FG011|Overall Study|Withdrawal by Subject|2|||
30867971|NCT02001623|58898465|FG012|Overall Study|Withdrawal by Subject|1|||
30867972|NCT02001623|58898466|FG013|Overall Study|Withdrawal by Subject|5|||
30867973|NCT02001623|58898467|FG014|Overall Study|Withdrawal by Subject|2|||
30867974|NCT02001623|58898453|FG000|Overall Study|Lost to Follow-up|0|||
30867975|NCT02001623|58898454|FG001|Overall Study|Lost to Follow-up|0|||
30867976|NCT02001623|58898455|FG002|Overall Study|Lost to Follow-up|0|||
30867977|NCT02001623|58898456|FG003|Overall Study|Lost to Follow-up|0|||
30867978|NCT02001623|58898457|FG004|Overall Study|Lost to Follow-up|0|||
30867979|NCT02001623|58898458|FG005|Overall Study|Lost to Follow-up|0|||
30694564|NCT00545272|58708714|FG000|Overall Study|Lost to Follow-up|0|||
30867980|NCT02001623|58898459|FG006|Overall Study|Lost to Follow-up|0|||
30694565|NCT00545272|58708715|FG001|Overall Study|Lost to Follow-up|0|||
30694566|NCT00545272|58708716|FG002|Overall Study|Lost to Follow-up|0|||
30867981|NCT02001623|58898460|FG007|Overall Study|Lost to Follow-up|0|||
30867982|NCT02001623|58898461|FG008|Overall Study|Lost to Follow-up|0|||
30867983|NCT02001623|58898462|FG009|Overall Study|Lost to Follow-up|1|||
30867984|NCT02001623|58898463|FG010|Overall Study|Lost to Follow-up|0|||
30867985|NCT02001623|58898464|FG011|Overall Study|Lost to Follow-up|0|||
30867986|NCT02001623|58898465|FG012|Overall Study|Lost to Follow-up|0|||
30867987|NCT02001623|58898466|FG013|Overall Study|Lost to Follow-up|0|||
30867988|NCT02001623|58898467|FG014|Overall Study|Lost to Follow-up|0|||
30867989|NCT02001623|58898453|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
30867990|NCT02001623|58898454|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
30867991|NCT02001623|58898455|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
30867992|NCT02001623|58898456|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
30867993|NCT02001623|58898457|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
30867994|NCT02001623|58898458|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
30867995|NCT02001623|58898459|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
30867996|NCT02001623|58898460|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
30867997|NCT02001623|58898461|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
30867998|NCT02001623|58898462|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
30867999|NCT02001623|58898463|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
30868000|NCT02001623|58898464|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
30868001|NCT02001623|58898465|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
30868002|NCT02001623|58898466|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
30868003|NCT02001623|58898467|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
30868004|NCT02001623|58898453|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
30868005|NCT02001623|58898454|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
30868006|NCT02001623|58898455|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
30868007|NCT02001623|58898456|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
30868008|NCT02001623|58898457|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
30868009|NCT02001623|58898458|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
30868010|NCT02001623|58898459|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
30868011|NCT02001623|58898460|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
30868012|NCT02001623|58898461|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
30868013|NCT02001623|58898462|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
30868014|NCT02001623|58898463|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
30868015|NCT02001623|58898464|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
30868016|NCT02001623|58898465|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
30868017|NCT02001623|58898466|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
30868018|NCT02001623|58898467|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
30868019|NCT02713867|58898518|FG000|Randomization|Other Reason|2|||
30868020|NCT02713867|58898519|FG001|Randomization|Other Reason|1|||
30868021|NCT02713867|58898518|FG000|Randomization|Participant Withdrew consent|0|||
30868022|NCT02713867|58898519|FG001|Randomization|Participant Withdrew consent|2|||
30868023|NCT02713867|58898518|FG000|Treatment Period|Other Reasons|22|||
30868024|NCT02713867|58898519|FG001|Treatment Period|Other Reasons|28|||
30868025|NCT02713867|58898518|FG000|Treatment Period|Administrative reason by sponsor|21|||
30868026|NCT02713867|58898519|FG001|Treatment Period|Administrative reason by sponsor|16|||
30868027|NCT02713867|58898518|FG000|Treatment Period|No longer meets study criteria|2|||
30868028|NCT02713867|58898519|FG001|Treatment Period|No longer meets study criteria|1|||
30868029|NCT02713867|58898518|FG000|Treatment Period|Poor/Non Compliance|1|||
30868030|NCT02713867|58898519|FG001|Treatment Period|Poor/Non Compliance|0|||
30868031|NCT02713867|58898518|FG000|Treatment Period|Maximum Clinical Benefit|5|||
30868032|NCT02713867|58898519|FG001|Treatment Period|Maximum Clinical Benefit|6|||
30868033|NCT02713867|58898518|FG000|Treatment Period|Withdrew consent|3|||
30868034|NCT02713867|58898519|FG001|Treatment Period|Withdrew consent|6|||
30868035|NCT02713867|58898518|FG000|Treatment Period|Requested to Discontinue|8|||
30868036|NCT02713867|58898519|FG001|Treatment Period|Requested to Discontinue|8|||
30868037|NCT02713867|58898518|FG000|Treatment Period|AE unrelated to Study Drug|11|||
30868038|NCT02713867|58898519|FG001|Treatment Period|AE unrelated to Study Drug|10|||
30868039|NCT02713867|58898518|FG000|Treatment Period|Death|7|||
30868040|NCT02713867|58898519|FG001|Treatment Period|Death|3|||
30868041|NCT02713867|58898518|FG000|Treatment Period|Study Drug Toxicity|16|||
30868042|NCT02713867|58898519|FG001|Treatment Period|Study Drug Toxicity|19|||
30868043|NCT02713867|58898518|FG000|Treatment Period|Disease Progression|82|||
30868044|NCT02713867|58898519|FG001|Treatment Period|Disease Progression|83|||
30868045|NCT02730455|58898528|FG000|Overall Study|Death|5|||
30868046|NCT02730455|58898529|FG001|Overall Study|Death|6|||
30868047|NCT02730455|58898530|FG002|Overall Study|Death|4|||
30868048|NCT02730455|58898528|FG000|Overall Study|Consent withdrawn|2|||
30868049|NCT02730455|58898529|FG001|Overall Study|Consent withdrawn|4|||
30868050|NCT02730455|58898530|FG002|Overall Study|Consent withdrawn|1|||
30868051|NCT02730455|58898528|FG000|Overall Study|Lost to Follow-up|3|||
30868052|NCT02730455|58898529|FG001|Overall Study|Lost to Follow-up|1|||
30868053|NCT02730455|58898530|FG002|Overall Study|Lost to Follow-up|4|||
30868054|NCT02730455|58898528|FG000|Overall Study|Other|1|||
30868055|NCT02730455|58898529|FG001|Overall Study|Other|1|||
30868056|NCT02730455|58898530|FG002|Overall Study|Other|2|||
30868057|NCT02730455|58898528|FG000|Overall Study|Other|2|||
30868058|NCT02730455|58898529|FG001|Overall Study|Other|2|||
30868059|NCT02730455|58898530|FG002|Overall Study|Other|0|||
30868060|NCT04440449|58898540|FG000|Overall Study|Lost to Follow-up|2|||
30868061|NCT04440449|58898541|FG001|Overall Study|Lost to Follow-up|0|||
30868062|NCT00701311|58898548|FG000|Overall Study|Lack of Efficacy|3|||
30868063|NCT00701311|58898548|FG000|Overall Study|Adverse Event|3|||
30868064|NCT00701311|58898548|FG000|Overall Study|Withdrawal by Subject|2|||
30868065|NCT02730377|58898558|FG000|Overall Study|Other|5|||
30868066|NCT02730377|58898559|FG001|Overall Study|Other|4|||
30868067|NCT02730377|58898558|FG000|Overall Study|Death|1|||
30868068|NCT02730377|58898559|FG001|Overall Study|Death|8|||
30868069|NCT02730377|58898558|FG000|Overall Study|Inadequate glycaemic control|368|||
30868070|NCT02730377|58898559|FG001|Overall Study|Inadequate glycaemic control|473|||
30868071|NCT02730377|58898558|FG000|Overall Study|Adverse Event|79|||
30868072|NCT02730377|58898559|FG001|Overall Study|Adverse Event|41|||
30868073|NCT02730377|58898558|FG000|Overall Study|Protocol Violation|23|||
30868074|NCT02730377|58898559|FG001|Overall Study|Protocol Violation|30|||
30868075|NCT02730377|58898558|FG000|Overall Study|Lack of Efficacy|4|||
30868076|NCT02730377|58898559|FG001|Overall Study|Lack of Efficacy|13|||
30868077|NCT02730377|58898558|FG000|Overall Study|Pregnancy|0|||
30868078|NCT02730377|58898559|FG001|Overall Study|Pregnancy|1|||
30868079|NCT02730377|58898558|FG000|Overall Study|Withdrawal by Subject|45|||
30868080|NCT02730377|58898559|FG001|Overall Study|Withdrawal by Subject|42|||
30868081|NCT02730377|58898558|FG000|Overall Study|Lost to Follow-up|25|||
30868082|NCT02730377|58898559|FG001|Overall Study|Lost to Follow-up|21|||
30868083|NCT02714569|58898576|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
30868084|NCT02714569|58898577|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
30868085|NCT02714569|58898578|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
30868086|NCT02714569|58898579|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
30868087|NCT02714569|58898580|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
30868088|NCT02714569|58898581|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
30868089|NCT02714569|58898582|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
30868090|NCT02714569|58898583|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
30868091|NCT02714569|58898584|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
30868092|NCT02714569|58898585|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
30868093|NCT02714569|58898586|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
30868094|NCT02714569|58898576|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
30868095|NCT02714569|58898577|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
30868096|NCT02714569|58898578|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
30868097|NCT02714569|58898579|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
30868098|NCT02714569|58898580|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
30694567|NCT00545272|58708717|FG003|Overall Study|Lost to Follow-up|0|||
30694568|NCT00545272|58708718|FG004|Overall Study|Lost to Follow-up|1|||
30694569|NCT00545272|58708719|FG005|Overall Study|Lost to Follow-up|0|||
30694570|NCT00377455|58708733|FG000|Overall Study|Withdrawal by Subject|1|||
30694571|NCT00377299|58708739|FG000|Overall Study|Lost to Follow-up|14|||
30694572|NCT00377299|58708740|FG001|Overall Study|Lost to Follow-up|19|||
30694573|NCT00377299|58708739|FG000|Overall Study|Adverse Event|0|||
30694574|NCT00377299|58708740|FG001|Overall Study|Adverse Event|1|||
30694575|NCT00377299|58708739|FG000|Overall Study|Withdrawal by Subject|5|||
30694576|NCT00377299|58708740|FG001|Overall Study|Withdrawal by Subject|4|||
30694577|NCT00376675|58708749|FG000|Overall Study|Withdrawal by Subject|9|||
30694578|NCT00376675|58708750|FG001|Overall Study|Withdrawal by Subject|2|||
30868099|NCT02714569|58898581|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
30868100|NCT02714569|58898582|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
30868101|NCT02714569|58898583|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
30868102|NCT02714569|58898584|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
30868103|NCT02714569|58898585|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
30868104|NCT02714569|58898586|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
30868105|NCT02714569|58898576|FG000|Part A Third Intervention|Adverse Event|0|||
30868106|NCT02714569|58898577|FG001|Part A Third Intervention|Adverse Event|0|||
30868107|NCT02714569|58898578|FG002|Part A Third Intervention|Adverse Event|1|||
30868108|NCT02714569|58898579|FG003|Part A Third Intervention|Adverse Event|0|||
30868109|NCT02714569|58898580|FG004|Part A Third Intervention|Adverse Event|0|||
30868110|NCT02714569|58898581|FG005|Part A Third Intervention|Adverse Event|0|||
30868111|NCT02714569|58898582|FG006|Part A Third Intervention|Adverse Event|0|||
30868112|NCT02714569|58898583|FG007|Part A Third Intervention|Adverse Event|0|||
30868113|NCT02714569|58898584|FG008|Part A Third Intervention|Adverse Event|0|||
30868114|NCT02714569|58898585|FG009|Part A Third Intervention|Adverse Event|0|||
30868115|NCT02714569|58898586|FG010|Part A Third Intervention|Adverse Event|0|||
30868116|NCT02714569|58898576|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
30868117|NCT02714569|58898577|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
30868118|NCT02714569|58898578|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
30868119|NCT02714569|58898579|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
30868120|NCT02714569|58898580|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
30868121|NCT02714569|58898581|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
30868122|NCT02714569|58898582|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
30868123|NCT02714569|58898583|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
30868124|NCT02714569|58898584|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
30694579|NCT00376675|58708749|FG000|Overall Study|Adverse Event|10|||
30694580|NCT00376675|58708750|FG001|Overall Study|Adverse Event|5|||
30868125|NCT02714569|58898585|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
30868126|NCT02714569|58898586|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
30868127|NCT02714569|58898576|FG000|Part B (Overall)|Lost to Follow-up|0|||
30868128|NCT02714569|58898577|FG001|Part B (Overall)|Lost to Follow-up|0|||
30868129|NCT02714569|58898578|FG002|Part B (Overall)|Lost to Follow-up|0|||
30868130|NCT02714569|58898579|FG003|Part B (Overall)|Lost to Follow-up|0|||
30868131|NCT02714569|58898580|FG004|Part B (Overall)|Lost to Follow-up|0|||
30868132|NCT02714569|58898581|FG005|Part B (Overall)|Lost to Follow-up|0|||
30868133|NCT02714569|58898582|FG006|Part B (Overall)|Lost to Follow-up|1|||
30868134|NCT02714569|58898583|FG007|Part B (Overall)|Lost to Follow-up|0|||
30868135|NCT02714569|58898584|FG008|Part B (Overall)|Lost to Follow-up|0|||
30868136|NCT02714569|58898585|FG009|Part B (Overall)|Lost to Follow-up|0|||
30868137|NCT02714569|58898586|FG010|Part B (Overall)|Lost to Follow-up|0|||
30868138|NCT02714569|58898576|FG000|Part B (Overall)|Withdrawal by Subject|0|||
30868139|NCT02714569|58898577|FG001|Part B (Overall)|Withdrawal by Subject|0|||
30868140|NCT02714569|58898578|FG002|Part B (Overall)|Withdrawal by Subject|0|||
30868141|NCT02714569|58898579|FG003|Part B (Overall)|Withdrawal by Subject|0|||
30868142|NCT02714569|58898580|FG004|Part B (Overall)|Withdrawal by Subject|0|||
30868143|NCT02714569|58898581|FG005|Part B (Overall)|Withdrawal by Subject|0|||
30868144|NCT02714569|58898582|FG006|Part B (Overall)|Withdrawal by Subject|0|||
30868145|NCT02714569|58898583|FG007|Part B (Overall)|Withdrawal by Subject|1|||
30868146|NCT02714569|58898584|FG008|Part B (Overall)|Withdrawal by Subject|0|||
30868147|NCT02714569|58898585|FG009|Part B (Overall)|Withdrawal by Subject|1|||
30868148|NCT02714569|58898586|FG010|Part B (Overall)|Withdrawal by Subject|0|||
30868149|NCT02714569|58898576|FG000|Part B (Overall)|Adverse Event|0|||
30868150|NCT02714569|58898577|FG001|Part B (Overall)|Adverse Event|0|||
30868151|NCT02714569|58898578|FG002|Part B (Overall)|Adverse Event|0|||
30868152|NCT02714569|58898579|FG003|Part B (Overall)|Adverse Event|0|||
30868153|NCT02714569|58898580|FG004|Part B (Overall)|Adverse Event|0|||
30868154|NCT02714569|58898581|FG005|Part B (Overall)|Adverse Event|0|||
30868155|NCT02714569|58898582|FG006|Part B (Overall)|Adverse Event|0|||
30868156|NCT02714569|58898583|FG007|Part B (Overall)|Adverse Event|0|||
30868157|NCT02714569|58898584|FG008|Part B (Overall)|Adverse Event|0|||
30868158|NCT02714569|58898585|FG009|Part B (Overall)|Adverse Event|1|||
30868159|NCT02714569|58898586|FG010|Part B (Overall)|Adverse Event|0|||
30868160|NCT02713789|58898649|FG000|Overall Study|Lost to Follow-up|0|||
30868161|NCT02713789|58898650|FG001|Overall Study|Lost to Follow-up|1|||
30868162|NCT02713789|58898651|FG002|Overall Study|Lost to Follow-up|1|||
30868163|NCT04445051|58898661|FG000|Overall Study|Adverse Event|0|||
30868164|NCT04445051|58898662|FG001|Overall Study|Adverse Event|0|||
30868165|NCT04445051|58898663|FG002|Overall Study|Adverse Event|1|||
30868166|NCT04445051|58898664|FG003|Overall Study|Adverse Event|0|||
30868167|NCT04445051|58898665|FG004|Overall Study|Adverse Event|0|||
30868168|NCT04445051|58898666|FG005|Overall Study|Adverse Event|0|||
30868169|NCT04086121|58898680|FG000|Overall Study|Other than listed|8|||
30868170|NCT04086121|58898680|FG000|Overall Study|Withdrawal by Subject|3|||
30868171|NCT04086121|58898680|FG000|Overall Study|Lost to Follow-up|2|||
30868172|NCT04086121|58898680|FG000|Overall Study|Adverse Event|1|||
30868173|NCT02729909|58898687|FG000|Overall Study|Lost to Follow-up|0|||
30868174|NCT02729909|58898688|FG001|Overall Study|Lost to Follow-up|1|||
30868175|NCT02729909|58898687|FG000|Overall Study|Lack of Efficacy|0|||
30868176|NCT02729909|58898688|FG001|Overall Study|Lack of Efficacy|2|||
30868177|NCT02729909|58898687|FG000|Overall Study|Significant Protocol Deviation|0|||
30868178|NCT02729909|58898688|FG001|Overall Study|Significant Protocol Deviation|2|||
30868179|NCT02729909|58898687|FG000|Overall Study|Voluntary Withdrawal|1|||
30868180|NCT02729909|58898688|FG001|Overall Study|Voluntary Withdrawal|0|||
30868181|NCT02713243|58898696|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
30868182|NCT02713243|58898697|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
30868183|NCT02713243|58898696|FG000|Overall Study|Administrative problems|0|||
30868184|NCT02713243|58898697|FG001|Overall Study|Administrative problems|1|||
30868185|NCT02713243|58898696|FG000|Overall Study|Protocol deviation|0|||
30868186|NCT02713243|58898697|FG001|Overall Study|Protocol deviation|1|||
30868187|NCT03434041|58898705|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
30868188|NCT03434041|58898706|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
30868189|NCT03434041|58898705|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
30868190|NCT03434041|58898706|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
30868191|NCT03434041|58898705|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
30868192|NCT03434041|58898706|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
30868193|NCT03434041|58898705|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
30868194|NCT03434041|58898706|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
30868195|NCT03434041|58898705|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
30868196|NCT03434041|58898706|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
30868197|NCT03434041|58898705|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
30868198|NCT03434041|58898706|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
30877189|NCT02644967|58908932|FG000|Overall Study|Withdrawal by Subject|2|||
30868199|NCT03434041|58898705|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
30868200|NCT03434041|58898706|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
30868201|NCT03434041|58898705|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
30868202|NCT03434041|58898706|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
30868203|NCT03434041|58898705|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
30868204|NCT03434041|58898706|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
30868205|NCT03434041|58898705|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
30868206|NCT03434041|58898706|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
30868207|NCT03434041|58898705|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
30868208|NCT03434041|58898706|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
30868209|NCT00708461|58898721|FG000|Overall Study|Lost to Follow-up|18|||
30868210|NCT00708461|58898722|FG001|Overall Study|Lost to Follow-up|11|||
30868211|NCT00708461|58898721|FG000|Overall Study|Withdrawal by Subject|8|||
30868212|NCT00708461|58898722|FG001|Overall Study|Withdrawal by Subject|9|||
30868213|NCT00708461|58898721|FG000|Overall Study|left workforce|115|||
30868214|NCT00708461|58898722|FG001|Overall Study|left workforce|180|||
30868215|NCT00700999|58898730|FG000|Overall Study|Lost to Follow-up|7|||
30868216|NCT00700999|58898731|FG001|Overall Study|Lost to Follow-up|7|||
30868217|NCT00700999|58898730|FG000|Overall Study|Excluded - did not meet study criteria|0|||
30868218|NCT00700999|58898731|FG001|Overall Study|Excluded - did not meet study criteria|1|||
30868219|NCT00700999|58898730|FG000|Overall Study|Withdrawal by Subject|8|||
30868220|NCT00700999|58898731|FG001|Overall Study|Withdrawal by Subject|1|||
30868221|NCT02729831|58898741|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
30868222|NCT02729831|58898742|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
30868223|NCT02729831|58898743|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
30868224|NCT02729831|58898744|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
30868225|NCT02729831|58898741|FG000|1 Week Post-visit|Lost to Follow-up|43|||
30868226|NCT02729831|58898742|FG001|1 Week Post-visit|Lost to Follow-up|40|||
30868227|NCT02729831|58898743|FG002|1 Week Post-visit|Lost to Follow-up|38|||
30868228|NCT02729831|58898744|FG003|1 Week Post-visit|Lost to Follow-up|36|||
30868229|NCT02729831|58898741|FG000|6 Month Follow-up|Lost to Follow-up|54|||
30868230|NCT02729831|58898742|FG001|6 Month Follow-up|Lost to Follow-up|51|||
30868231|NCT02729831|58898743|FG002|6 Month Follow-up|Lost to Follow-up|48|||
30694581|NCT00376675|58708749|FG000|Overall Study|Other Reason|1|||
30694582|NCT00376675|58708750|FG001|Overall Study|Other Reason|7|||
30868232|NCT02729831|58898744|FG003|6 Month Follow-up|Lost to Follow-up|42|||
30868233|NCT02729831|58898741|FG000|6 Month Follow-up|Death|1|||
30868234|NCT02729831|58898742|FG001|6 Month Follow-up|Death|3|||
30868235|NCT02729831|58898743|FG002|6 Month Follow-up|Death|0|||
30868236|NCT02729831|58898744|FG003|6 Month Follow-up|Death|1|||
30868237|NCT02729753|58898756|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
30868238|NCT02729753|58898757|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
30868239|NCT00709319|58898766|FG000|Overall Study|Death|4|||
30868240|NCT00709319|58898766|FG000|Overall Study|Withdrawal by Subject|2|||
30868241|NCT02729051|58898811|FG000|Overall Study|Adverse Event|21|||
30868242|NCT02729051|58898812|FG001|Overall Study|Adverse Event|11|||
30868243|NCT02729051|58898811|FG000|Overall Study|Lack of Efficacy|1|||
30868244|NCT02729051|58898812|FG001|Overall Study|Lack of Efficacy|1|||
30868245|NCT02729051|58898811|FG000|Overall Study|Lost to Follow-up|1|||
30868246|NCT02729051|58898812|FG001|Overall Study|Lost to Follow-up|2|||
30868247|NCT02729051|58898811|FG000|Overall Study|Physician Decision|1|||
30868248|NCT02729051|58898812|FG001|Overall Study|Physician Decision|1|||
30868249|NCT02729051|58898811|FG000|Overall Study|Withdrawal by Subject|6|||
30868250|NCT02729051|58898812|FG001|Overall Study|Withdrawal by Subject|17|||
30868251|NCT00707993|58898820|FG000|Overall Study|Adverse Event|16|||
30868252|NCT00707993|58898821|FG001|Overall Study|Adverse Event|20|||
30868253|NCT00707993|58898820|FG000|Overall Study|Protocol Violation|4|||
30868254|NCT00707993|58898821|FG001|Overall Study|Protocol Violation|7|||
30868255|NCT00707993|58898820|FG000|Overall Study|Lost to Follow-up|0|||
30868256|NCT00707993|58898821|FG001|Overall Study|Lost to Follow-up|4|||
30868257|NCT00707993|58898820|FG000|Overall Study|Withdrawal by Subject|12|||
30868258|NCT00707993|58898821|FG001|Overall Study|Withdrawal by Subject|16|||
30868259|NCT00707993|58898820|FG000|Overall Study|Hyperglycemic Rescue|55|||
30868260|NCT00707993|58898821|FG001|Overall Study|Hyperglycemic Rescue|47|||
30868261|NCT00707993|58898820|FG000|Overall Study|Other|2|||
30868262|NCT00707993|58898821|FG001|Overall Study|Other|0|||
30868263|NCT00708227|58898831|FG000|Overall Study|Physician Decision|0|||
30868264|NCT00708227|58898832|FG001|Overall Study|Physician Decision|3|||
30868265|NCT00708227|58898833|FG002|Overall Study|Physician Decision|1|||
30868266|NCT00708227|58898834|FG003|Overall Study|Physician Decision|2|||
30868267|NCT00708227|58898831|FG000|Overall Study|Withdrawal by Subject|1|||
30868268|NCT00708227|58898832|FG001|Overall Study|Withdrawal by Subject|2|||
30877190|NCT02644967|58908932|FG000|Overall Study|Protocol Violation|1|||
30602231|NCT01074658|58613576|FG000|Overall Study|No implant attempted|19|||
30868269|NCT00708227|58898833|FG002|Overall Study|Withdrawal by Subject|0|||
30868270|NCT00708227|58898834|FG003|Overall Study|Withdrawal by Subject|1|||
30868271|NCT02425891|58898866|FG000|Overall Study|Death|333|||
30868272|NCT02425891|58898867|FG001|Overall Study|Death|314|||
30868273|NCT02425891|58898866|FG000|Overall Study|Lost to Follow-up|4|||
30868274|NCT02425891|58898867|FG001|Overall Study|Lost to Follow-up|6|||
30868275|NCT02425891|58898866|FG000|Overall Study|Non-Compliance|1|||
30868276|NCT02425891|58898867|FG001|Overall Study|Non-Compliance|1|||
30868277|NCT02425891|58898866|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
30868278|NCT02425891|58898867|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
30868279|NCT02425891|58898866|FG000|Overall Study|Physician Decision|0|||
30868280|NCT02425891|58898867|FG001|Overall Study|Physician Decision|1|||
30868281|NCT02425891|58898866|FG000|Overall Study|Protocol Violation|1|||
30868282|NCT02425891|58898867|FG001|Overall Study|Protocol Violation|1|||
30868283|NCT02425891|58898866|FG000|Overall Study|Study Terminated By Sponsor|85|||
30868284|NCT02425891|58898867|FG001|Overall Study|Study Terminated By Sponsor|95|||
30868285|NCT02425891|58898866|FG000|Overall Study|Withdrawal by Subject|27|||
30868286|NCT02425891|58898867|FG001|Overall Study|Withdrawal by Subject|32|||
30868287|NCT03241225|58898877|FG000|Overall Study|Lost to Follow-up|2|||
30868288|NCT03241225|58898878|FG001|Overall Study|Lost to Follow-up|1|||
30868289|NCT03241225|58898877|FG000|Overall Study|Protocol Violation|4|||
30868290|NCT03241225|58898878|FG001|Overall Study|Protocol Violation|1|||
30868291|NCT03241225|58898877|FG000|Overall Study|Withdrawal by Subject|1|||
30868292|NCT03241225|58898878|FG001|Overall Study|Withdrawal by Subject|0|||
30868293|NCT01597245|58898888|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
30868294|NCT01597245|58898889|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
30868295|NCT01597245|58898890|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
30868296|NCT01597245|58898891|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
30868297|NCT01597245|58898892|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868298|NCT01597245|58898893|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868299|NCT01597245|58898894|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868300|NCT01597245|58898895|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868301|NCT01597245|58898896|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868302|NCT01597245|58898897|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868303|NCT01597245|58898898|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868304|NCT01597245|58898899|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868305|NCT01597245|58898900|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868306|NCT01597245|58898901|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868307|NCT01597245|58898902|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868308|NCT01597245|58898903|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868309|NCT01597245|58898904|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868310|NCT01597245|58898905|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868311|NCT01597245|58898906|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868312|NCT01597245|58898907|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868313|NCT01597245|58898908|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
30868314|NCT01597245|58898888|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
30868315|NCT01597245|58898889|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
30868316|NCT01597245|58898890|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
30868317|NCT01597245|58898891|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
30868318|NCT01597245|58898892|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868319|NCT01597245|58898893|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868320|NCT01597245|58898894|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868321|NCT01597245|58898895|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868322|NCT01597245|58898896|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868323|NCT01597245|58898897|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868324|NCT01597245|58898898|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868325|NCT01597245|58898899|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868326|NCT01597245|58898900|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868327|NCT01597245|58898901|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868328|NCT01597245|58898902|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868329|NCT01597245|58898903|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868330|NCT01597245|58898904|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868331|NCT01597245|58898905|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868332|NCT01597245|58898906|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868333|NCT01597245|58898907|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868334|NCT01597245|58898908|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
30868335|NCT01597245|58898888|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
30868336|NCT01597245|58898889|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
30960826|NCT01520987|59026725|FG000|Overall Study|Withdrawal by Subject|1|||
30960827|NCT01520987|59026726|FG001|Overall Study|Withdrawal by Subject|0|||
30960828|NCT01520987|59026727|FG002|Overall Study|Withdrawal by Subject|0|||
30868337|NCT01597245|58898890|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
30868338|NCT01597245|58898891|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
30868339|NCT01597245|58898892|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868340|NCT01597245|58898893|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868341|NCT01597245|58898894|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868342|NCT01597245|58898895|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868343|NCT01597245|58898896|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868344|NCT01597245|58898897|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868345|NCT01597245|58898898|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868346|NCT01597245|58898899|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868347|NCT01597245|58898900|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868348|NCT01597245|58898901|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868349|NCT01597245|58898902|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868350|NCT01597245|58898903|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868351|NCT01597245|58898904|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868352|NCT01597245|58898905|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868353|NCT01597245|58898906|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868354|NCT01597245|58898907|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868355|NCT01597245|58898908|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
30868356|NCT01597245|58898888|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
30868357|NCT01597245|58898889|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
30868358|NCT01597245|58898890|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
30868359|NCT01597245|58898891|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868360|NCT01597245|58898892|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868361|NCT01597245|58898893|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868362|NCT01597245|58898894|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868363|NCT01597245|58898895|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868364|NCT01597245|58898896|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868365|NCT01597245|58898897|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868366|NCT01597245|58898898|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868367|NCT01597245|58898899|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868368|NCT01597245|58898900|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868369|NCT01597245|58898901|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868370|NCT01597245|58898902|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868371|NCT01597245|58898903|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868372|NCT01597245|58898904|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868373|NCT01597245|58898905|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868374|NCT01597245|58898906|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868375|NCT01597245|58898907|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868376|NCT01597245|58898908|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
30868377|NCT01597245|58898888|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
30868378|NCT01597245|58898889|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868379|NCT01597245|58898890|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868380|NCT01597245|58898891|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
30868381|NCT01597245|58898892|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868382|NCT01597245|58898893|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868383|NCT01597245|58898894|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868384|NCT01597245|58898895|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868385|NCT01597245|58898896|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868386|NCT01597245|58898897|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868387|NCT01597245|58898898|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868388|NCT01597245|58898899|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868389|NCT01597245|58898900|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868390|NCT01597245|58898901|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868391|NCT01597245|58898902|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868392|NCT01597245|58898903|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868393|NCT01597245|58898904|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868394|NCT01597245|58898905|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868395|NCT01597245|58898906|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868396|NCT01597245|58898907|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868397|NCT01597245|58898908|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
30868398|NCT01597245|58898888|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
30868399|NCT01597245|58898889|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
30868400|NCT01597245|58898890|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
30868401|NCT01597245|58898891|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30877191|NCT02644967|58908932|FG000|Overall Study|Progressive Disease|1|||
30868402|NCT01597245|58898892|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868403|NCT01597245|58898893|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868404|NCT01597245|58898894|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868405|NCT01597245|58898895|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868406|NCT01597245|58898896|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868407|NCT01597245|58898897|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868408|NCT01597245|58898898|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868409|NCT01597245|58898899|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868410|NCT01597245|58898900|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868411|NCT01597245|58898901|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868412|NCT01597245|58898902|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868413|NCT01597245|58898903|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868414|NCT01597245|58898904|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868415|NCT01597245|58898905|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868416|NCT01597245|58898906|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868417|NCT01597245|58898907|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868418|NCT01597245|58898908|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
30868419|NCT01597245|58898888|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868420|NCT01597245|58898889|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868421|NCT01597245|58898890|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868422|NCT01597245|58898891|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868423|NCT01597245|58898892|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868424|NCT01597245|58898893|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
30868425|NCT01597245|58898894|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
30868426|NCT01597245|58898895|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868427|NCT01597245|58898896|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868428|NCT01597245|58898897|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868429|NCT01597245|58898898|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868430|NCT01597245|58898899|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868431|NCT01597245|58898900|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868432|NCT01597245|58898901|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868433|NCT01597245|58898902|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868434|NCT01597245|58898903|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868435|NCT01597245|58898904|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868436|NCT01597245|58898905|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868437|NCT01597245|58898906|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868438|NCT01597245|58898907|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868439|NCT01597245|58898908|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
30868440|NCT01597245|58898888|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868441|NCT01597245|58898889|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868442|NCT01597245|58898890|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868443|NCT01597245|58898891|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868444|NCT01597245|58898892|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
30868445|NCT01597245|58898893|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
30868446|NCT01597245|58898894|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
30868447|NCT01597245|58898895|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
30868448|NCT01597245|58898896|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868449|NCT01597245|58898897|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
30868450|NCT01597245|58898898|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868451|NCT01597245|58898899|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868452|NCT01597245|58898900|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868453|NCT01597245|58898901|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868454|NCT01597245|58898902|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868455|NCT01597245|58898903|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868456|NCT01597245|58898904|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868457|NCT01597245|58898905|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30694583|NCT03931330|58708756|FG000|Overall Study|Physician Decision|1|||
30694584|NCT00367237|58708763|FG000|Overall Study|Adverse Event|7|||
30868458|NCT01597245|58898906|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868459|NCT01597245|58898907|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868460|NCT01597245|58898908|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
30868461|NCT01597245|58898888|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868462|NCT01597245|58898889|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868463|NCT01597245|58898890|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868464|NCT01597245|58898891|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30960829|NCT01520987|59026728|FG003|Overall Study|Withdrawal by Subject|0|||
30868465|NCT01597245|58898892|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868466|NCT01597245|58898893|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
30868467|NCT01597245|58898894|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868468|NCT01597245|58898895|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868469|NCT01597245|58898896|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
30868470|NCT01597245|58898897|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868471|NCT01597245|58898898|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
30868472|NCT01597245|58898899|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
30868473|NCT01597245|58898900|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
30868474|NCT01597245|58898901|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868475|NCT01597245|58898902|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868476|NCT01597245|58898903|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868477|NCT01597245|58898904|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868478|NCT01597245|58898905|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868479|NCT01597245|58898906|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868480|NCT01597245|58898907|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868481|NCT01597245|58898908|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
30868482|NCT01597245|58898888|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868483|NCT01597245|58898889|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868484|NCT01597245|58898890|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868485|NCT01597245|58898891|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868486|NCT01597245|58898892|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
30868487|NCT01597245|58898893|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
30868488|NCT01597245|58898894|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
30868489|NCT01597245|58898895|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
30868490|NCT01597245|58898896|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
30868491|NCT01597245|58898897|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
30868492|NCT01597245|58898898|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
30868493|NCT01597245|58898899|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
30868494|NCT01597245|58898900|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
30868495|NCT01597245|58898901|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868496|NCT01597245|58898902|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868497|NCT01597245|58898903|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868498|NCT01597245|58898904|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868499|NCT01597245|58898905|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868500|NCT01597245|58898906|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868501|NCT01597245|58898907|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868502|NCT01597245|58898908|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
30868503|NCT01597245|58898888|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868504|NCT01597245|58898889|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868505|NCT01597245|58898890|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868506|NCT01597245|58898891|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868507|NCT01597245|58898892|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
30868508|NCT01597245|58898893|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
30868509|NCT01597245|58898894|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
30868510|NCT01597245|58898895|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868511|NCT01597245|58898896|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
30868512|NCT01597245|58898897|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
30868513|NCT01597245|58898898|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
30868514|NCT01597245|58898899|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
30868515|NCT01597245|58898900|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
30868516|NCT01597245|58898901|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868517|NCT01597245|58898902|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868518|NCT01597245|58898903|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868519|NCT01597245|58898904|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868520|NCT01597245|58898905|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868521|NCT01597245|58898906|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868522|NCT01597245|58898907|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868523|NCT01597245|58898908|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
30868524|NCT01597245|58898888|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868525|NCT01597245|58898889|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868526|NCT01597245|58898890|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868527|NCT01597245|58898891|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868528|NCT01597245|58898892|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
30868529|NCT01597245|58898893|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868530|NCT01597245|58898894|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868531|NCT01597245|58898895|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868532|NCT01597245|58898896|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
30868533|NCT01597245|58898897|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
30868534|NCT01597245|58898898|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
30868535|NCT01597245|58898899|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868536|NCT01597245|58898900|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
30868537|NCT01597245|58898901|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868538|NCT01597245|58898902|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868539|NCT01597245|58898903|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868540|NCT01597245|58898904|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868541|NCT01597245|58898905|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868542|NCT01597245|58898906|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868543|NCT01597245|58898907|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868544|NCT01597245|58898908|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
30868545|NCT01597245|58898888|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868546|NCT01597245|58898889|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868547|NCT01597245|58898890|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868548|NCT01597245|58898891|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868549|NCT01597245|58898892|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
30868550|NCT01597245|58898893|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
30868551|NCT01597245|58898894|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
30868552|NCT01597245|58898895|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868553|NCT01597245|58898896|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
30868554|NCT01597245|58898897|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
30868555|NCT01597245|58898898|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
30868556|NCT01597245|58898899|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
30868557|NCT01597245|58898900|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
30868558|NCT01597245|58898901|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868559|NCT01597245|58898902|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868560|NCT01597245|58898903|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868561|NCT01597245|58898904|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868562|NCT01597245|58898905|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868563|NCT01597245|58898906|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868564|NCT01597245|58898907|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868565|NCT01597245|58898908|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
30868566|NCT01597245|58898888|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868567|NCT01597245|58898889|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868568|NCT01597245|58898890|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868569|NCT01597245|58898891|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868570|NCT01597245|58898892|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868571|NCT01597245|58898893|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
30868572|NCT01597245|58898894|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868573|NCT01597245|58898895|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868574|NCT01597245|58898896|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
30868575|NCT01597245|58898897|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
30868576|NCT01597245|58898898|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
30868577|NCT01597245|58898899|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
30868578|NCT01597245|58898900|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868579|NCT01597245|58898901|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868580|NCT01597245|58898902|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868581|NCT01597245|58898903|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868582|NCT01597245|58898904|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868583|NCT01597245|58898905|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868584|NCT01597245|58898906|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868585|NCT01597245|58898907|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868586|NCT01597245|58898908|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
30868587|NCT01597245|58898888|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868588|NCT01597245|58898889|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868589|NCT01597245|58898890|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868590|NCT01597245|58898891|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30694585|NCT00367237|58708764|FG001|Overall Study|Adverse Event|2|||
30868591|NCT01597245|58898892|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868592|NCT01597245|58898893|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868593|NCT01597245|58898894|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868594|NCT01597245|58898895|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868595|NCT01597245|58898896|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868596|NCT01597245|58898897|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868597|NCT01597245|58898898|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
30868598|NCT01597245|58898899|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868599|NCT01597245|58898900|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868600|NCT01597245|58898901|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868601|NCT01597245|58898902|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868602|NCT01597245|58898903|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868603|NCT01597245|58898904|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868604|NCT01597245|58898905|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868605|NCT01597245|58898906|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868606|NCT01597245|58898907|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868607|NCT01597245|58898908|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
30868608|NCT01597245|58898888|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868609|NCT01597245|58898889|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868610|NCT01597245|58898890|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868611|NCT01597245|58898891|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868612|NCT01597245|58898892|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868613|NCT01597245|58898893|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868614|NCT01597245|58898894|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868615|NCT01597245|58898895|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868616|NCT01597245|58898896|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868617|NCT01597245|58898897|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868618|NCT01597245|58898898|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868619|NCT01597245|58898899|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868620|NCT01597245|58898900|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868621|NCT01597245|58898901|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
30868622|NCT01597245|58898902|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
30868623|NCT01597245|58898903|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
30868624|NCT01597245|58898904|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868625|NCT01597245|58898905|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868626|NCT01597245|58898906|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868627|NCT01597245|58898907|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868628|NCT01597245|58898908|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
30868629|NCT01597245|58898888|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868630|NCT01597245|58898889|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868631|NCT01597245|58898890|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868632|NCT01597245|58898891|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868633|NCT01597245|58898892|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868634|NCT01597245|58898893|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868635|NCT01597245|58898894|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868636|NCT01597245|58898895|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868637|NCT01597245|58898896|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868638|NCT01597245|58898897|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868639|NCT01597245|58898898|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868640|NCT01597245|58898899|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868641|NCT01597245|58898900|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868642|NCT01597245|58898901|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
30868643|NCT01597245|58898902|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
30868644|NCT01597245|58898903|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
30868645|NCT01597245|58898904|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868646|NCT01597245|58898905|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868647|NCT01597245|58898906|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868648|NCT01597245|58898907|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868649|NCT01597245|58898908|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
30868650|NCT01597245|58898888|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868651|NCT01597245|58898889|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868652|NCT01597245|58898890|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30694586|NCT00367237|58708763|FG000|Overall Study|Lost to Follow-up|1|||
30868653|NCT01597245|58898891|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868654|NCT01597245|58898892|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868655|NCT01597245|58898893|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868656|NCT01597245|58898894|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868657|NCT01597245|58898895|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868658|NCT01597245|58898896|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868659|NCT01597245|58898897|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868660|NCT01597245|58898898|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868661|NCT01597245|58898899|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868662|NCT01597245|58898900|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868663|NCT01597245|58898901|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868664|NCT01597245|58898902|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
30868665|NCT01597245|58898903|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
30868666|NCT01597245|58898904|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868667|NCT01597245|58898905|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868668|NCT01597245|58898906|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868669|NCT01597245|58898907|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868670|NCT01597245|58898908|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
30868671|NCT01597245|58898888|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868672|NCT01597245|58898889|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868673|NCT01597245|58898890|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868674|NCT01597245|58898891|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868675|NCT01597245|58898892|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868676|NCT01597245|58898893|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868677|NCT01597245|58898894|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868678|NCT01597245|58898895|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868679|NCT01597245|58898896|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868680|NCT01597245|58898897|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868681|NCT01597245|58898898|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868682|NCT01597245|58898899|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868683|NCT01597245|58898900|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868684|NCT01597245|58898901|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868685|NCT01597245|58898902|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
30868686|NCT01597245|58898903|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
30868687|NCT01597245|58898904|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868688|NCT01597245|58898905|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868689|NCT01597245|58898906|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868690|NCT01597245|58898907|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868691|NCT01597245|58898908|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
30868692|NCT01597245|58898888|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868693|NCT01597245|58898889|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868694|NCT01597245|58898890|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868695|NCT01597245|58898891|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868696|NCT01597245|58898892|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868697|NCT01597245|58898893|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868698|NCT01597245|58898894|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868699|NCT01597245|58898895|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868700|NCT01597245|58898896|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868701|NCT01597245|58898897|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868702|NCT01597245|58898898|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868703|NCT01597245|58898899|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868704|NCT01597245|58898900|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868705|NCT01597245|58898901|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
30868706|NCT01597245|58898902|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
30868707|NCT01597245|58898903|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
30868708|NCT01597245|58898904|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868709|NCT01597245|58898905|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868710|NCT01597245|58898906|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868711|NCT01597245|58898907|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868712|NCT01597245|58898908|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
30868713|NCT01597245|58898888|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868714|NCT01597245|58898889|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868715|NCT01597245|58898890|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
30960830|NCT01520987|59026729|FG004|Overall Study|Withdrawal by Subject|0|||
30868716|NCT01597245|58898891|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868717|NCT01597245|58898892|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868718|NCT01597245|58898893|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868719|NCT01597245|58898894|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868720|NCT01597245|58898895|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868721|NCT01597245|58898896|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868722|NCT01597245|58898897|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868723|NCT01597245|58898898|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868724|NCT01597245|58898899|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868725|NCT01597245|58898900|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868726|NCT01597245|58898901|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868727|NCT01597245|58898902|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
30868728|NCT01597245|58898903|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
30868729|NCT01597245|58898904|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868730|NCT01597245|58898905|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868731|NCT01597245|58898906|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868732|NCT01597245|58898907|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868733|NCT01597245|58898908|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
30868734|NCT01597245|58898888|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868735|NCT01597245|58898889|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868736|NCT01597245|58898890|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868737|NCT01597245|58898891|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868738|NCT01597245|58898892|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868739|NCT01597245|58898893|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868740|NCT01597245|58898894|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868741|NCT01597245|58898895|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868742|NCT01597245|58898896|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868743|NCT01597245|58898897|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868744|NCT01597245|58898898|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868745|NCT01597245|58898899|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868746|NCT01597245|58898900|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868747|NCT01597245|58898901|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868748|NCT01597245|58898902|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
30868749|NCT01597245|58898903|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
30868750|NCT01597245|58898904|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868751|NCT01597245|58898905|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868752|NCT01597245|58898906|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868753|NCT01597245|58898907|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868754|NCT01597245|58898908|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
30868755|NCT01597245|58898888|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868756|NCT01597245|58898889|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868757|NCT01597245|58898890|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868758|NCT01597245|58898891|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868759|NCT01597245|58898892|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868760|NCT01597245|58898893|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868761|NCT01597245|58898894|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868762|NCT01597245|58898895|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868763|NCT01597245|58898896|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868764|NCT01597245|58898897|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868765|NCT01597245|58898898|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868766|NCT01597245|58898899|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868767|NCT01597245|58898900|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868768|NCT01597245|58898901|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868769|NCT01597245|58898902|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
30868770|NCT01597245|58898903|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
30868771|NCT01597245|58898904|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868772|NCT01597245|58898905|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868773|NCT01597245|58898906|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868774|NCT01597245|58898907|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868775|NCT01597245|58898908|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
30868776|NCT01597245|58898888|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868777|NCT01597245|58898889|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868778|NCT01597245|58898890|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868779|NCT01597245|58898891|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868780|NCT01597245|58898892|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868781|NCT01597245|58898893|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868782|NCT01597245|58898894|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868783|NCT01597245|58898895|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868784|NCT01597245|58898896|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868785|NCT01597245|58898897|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868786|NCT01597245|58898898|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868787|NCT01597245|58898899|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868788|NCT01597245|58898900|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868789|NCT01597245|58898901|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868790|NCT01597245|58898902|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
30868791|NCT01597245|58898903|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
30868792|NCT01597245|58898904|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868793|NCT01597245|58898905|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868794|NCT01597245|58898906|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868795|NCT01597245|58898907|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868796|NCT01597245|58898908|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
30868797|NCT01597245|58898888|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868798|NCT01597245|58898889|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868799|NCT01597245|58898890|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868800|NCT01597245|58898891|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868801|NCT01597245|58898892|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868802|NCT01597245|58898893|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868803|NCT01597245|58898894|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868804|NCT01597245|58898895|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868805|NCT01597245|58898896|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868806|NCT01597245|58898897|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868807|NCT01597245|58898898|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868808|NCT01597245|58898899|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868809|NCT01597245|58898900|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868810|NCT01597245|58898901|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
30868811|NCT01597245|58898902|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868812|NCT01597245|58898903|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868813|NCT01597245|58898904|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868814|NCT01597245|58898905|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868815|NCT01597245|58898906|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868816|NCT01597245|58898907|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868817|NCT01597245|58898908|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
30868818|NCT01597245|58898888|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868819|NCT01597245|58898889|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868820|NCT01597245|58898890|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868821|NCT01597245|58898891|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868822|NCT01597245|58898892|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868823|NCT01597245|58898893|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868824|NCT01597245|58898894|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868825|NCT01597245|58898895|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868826|NCT01597245|58898896|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868827|NCT01597245|58898897|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868828|NCT01597245|58898898|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868829|NCT01597245|58898899|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868830|NCT01597245|58898900|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868831|NCT01597245|58898901|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868832|NCT01597245|58898902|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868833|NCT01597245|58898903|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
30868834|NCT01597245|58898904|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
30868835|NCT01597245|58898905|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
30868836|NCT01597245|58898906|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
30868837|NCT01597245|58898907|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
30868838|NCT01597245|58898908|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
30868839|NCT01597245|58898888|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30877495|NCT01998958|58909042|FG021|Open Label Phase (Optional)|Other|0|||
30694587|NCT00367237|58708764|FG001|Overall Study|Lost to Follow-up|0|||
30694588|NCT00367237|58708763|FG000|Overall Study|Withdrawal by Subject|0|||
30694589|NCT00367237|58708764|FG001|Overall Study|Withdrawal by Subject|4|||
30694590|NCT00367237|58708763|FG000|Overall Study|Protocol Violation|2|||
30694591|NCT00367237|58708764|FG001|Overall Study|Protocol Violation|5|||
30868840|NCT01597245|58898889|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868841|NCT01597245|58898890|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868842|NCT01597245|58898891|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868843|NCT01597245|58898892|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868844|NCT01597245|58898893|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868845|NCT01597245|58898894|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868846|NCT01597245|58898895|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868847|NCT01597245|58898896|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868848|NCT01597245|58898897|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868849|NCT01597245|58898898|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868850|NCT01597245|58898899|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868851|NCT01597245|58898900|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868852|NCT01597245|58898901|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868853|NCT01597245|58898902|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868854|NCT01597245|58898903|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868855|NCT01597245|58898904|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
30868856|NCT01597245|58898905|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
30868857|NCT01597245|58898906|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
30868858|NCT01597245|58898907|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
30868859|NCT01597245|58898908|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
30868860|NCT01597245|58898888|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868861|NCT01597245|58898889|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868862|NCT01597245|58898890|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868863|NCT01597245|58898891|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868864|NCT01597245|58898892|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868865|NCT01597245|58898893|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868866|NCT01597245|58898894|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868867|NCT01597245|58898895|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868868|NCT01597245|58898896|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868869|NCT01597245|58898897|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868870|NCT01597245|58898898|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868871|NCT01597245|58898899|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868872|NCT01597245|58898900|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868873|NCT01597245|58898901|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868874|NCT01597245|58898902|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868875|NCT01597245|58898903|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868876|NCT01597245|58898904|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
30868877|NCT01597245|58898905|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868878|NCT01597245|58898906|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
30868879|NCT01597245|58898907|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
30868880|NCT01597245|58898908|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
30868881|NCT01597245|58898888|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868882|NCT01597245|58898889|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868883|NCT01597245|58898890|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868884|NCT01597245|58898891|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868885|NCT01597245|58898892|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868886|NCT01597245|58898893|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868887|NCT01597245|58898894|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868888|NCT01597245|58898895|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30694592|NCT00544882|58708772|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
30694593|NCT00544882|58708773|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
30868889|NCT01597245|58898896|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868890|NCT01597245|58898897|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868891|NCT01597245|58898898|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868892|NCT01597245|58898899|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868893|NCT01597245|58898900|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868894|NCT01597245|58898901|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868895|NCT01597245|58898902|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868896|NCT01597245|58898903|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868897|NCT01597245|58898904|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868898|NCT01597245|58898905|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
30868899|NCT01597245|58898906|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
30960831|NCT01520987|59026730|FG005|Overall Study|Withdrawal by Subject|1|||
30868900|NCT01597245|58898907|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
30868901|NCT01597245|58898908|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
30868902|NCT01597245|58898888|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868903|NCT01597245|58898889|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868904|NCT01597245|58898890|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868905|NCT01597245|58898891|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868906|NCT01597245|58898892|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868907|NCT01597245|58898893|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868908|NCT01597245|58898894|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868909|NCT01597245|58898895|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868910|NCT01597245|58898896|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868911|NCT01597245|58898897|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868912|NCT01597245|58898898|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868913|NCT01597245|58898899|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868914|NCT01597245|58898900|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868915|NCT01597245|58898901|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868916|NCT01597245|58898902|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868917|NCT01597245|58898903|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868918|NCT01597245|58898904|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
30868919|NCT01597245|58898905|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868920|NCT01597245|58898906|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
30868921|NCT01597245|58898907|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
30868922|NCT01597245|58898908|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
30868923|NCT01597245|58898888|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868924|NCT01597245|58898889|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868925|NCT01597245|58898890|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868926|NCT01597245|58898891|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868927|NCT01597245|58898892|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868928|NCT01597245|58898893|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868929|NCT01597245|58898894|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868930|NCT01597245|58898895|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868931|NCT01597245|58898896|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868932|NCT01597245|58898897|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868933|NCT01597245|58898898|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868934|NCT01597245|58898899|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868935|NCT01597245|58898900|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868936|NCT01597245|58898901|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868937|NCT01597245|58898902|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868938|NCT01597245|58898903|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868939|NCT01597245|58898904|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
30868940|NCT01597245|58898905|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868941|NCT01597245|58898906|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
30868942|NCT01597245|58898907|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
30868943|NCT01597245|58898908|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
30868944|NCT01597245|58898888|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868945|NCT01597245|58898889|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868946|NCT01597245|58898890|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868947|NCT01597245|58898891|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868948|NCT01597245|58898892|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868949|NCT01597245|58898893|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868950|NCT01597245|58898894|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868951|NCT01597245|58898895|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868952|NCT01597245|58898896|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868953|NCT01597245|58898897|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868954|NCT01597245|58898898|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868955|NCT01597245|58898899|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868956|NCT01597245|58898900|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868957|NCT01597245|58898901|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868958|NCT01597245|58898902|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868959|NCT01597245|58898903|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868960|NCT01597245|58898904|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
30877496|NCT01998958|58909043|FG022|Open Label Phase (Optional)|Other|5|||
30868961|NCT01597245|58898905|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868962|NCT01597245|58898906|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868963|NCT01597245|58898907|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
30868964|NCT01597245|58898908|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
30868965|NCT01597245|58898888|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868966|NCT01597245|58898889|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868967|NCT01597245|58898890|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868968|NCT01597245|58898891|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868969|NCT01597245|58898892|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868970|NCT01597245|58898893|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868971|NCT01597245|58898894|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868972|NCT01597245|58898895|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868973|NCT01597245|58898896|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868974|NCT01597245|58898897|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868975|NCT01597245|58898898|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868976|NCT01597245|58898899|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868977|NCT01597245|58898900|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868978|NCT01597245|58898901|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868979|NCT01597245|58898902|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868980|NCT01597245|58898903|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868981|NCT01597245|58898904|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
30868982|NCT01597245|58898905|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868983|NCT01597245|58898906|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868984|NCT01597245|58898907|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
30868985|NCT01597245|58898908|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
30868986|NCT01597245|58898888|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868987|NCT01597245|58898889|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868988|NCT01597245|58898890|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868989|NCT01597245|58898891|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868990|NCT01597245|58898892|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868991|NCT01597245|58898893|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868992|NCT01597245|58898894|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868993|NCT01597245|58898895|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868994|NCT01597245|58898896|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868995|NCT01597245|58898897|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868996|NCT01597245|58898898|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868997|NCT01597245|58898899|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868998|NCT01597245|58898900|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30868999|NCT01597245|58898901|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30869000|NCT01597245|58898902|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30869001|NCT01597245|58898903|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30869002|NCT01597245|58898904|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30869003|NCT01597245|58898905|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30869004|NCT01597245|58898906|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30869005|NCT01597245|58898907|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
30869006|NCT01597245|58898908|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
30869007|NCT00707057|58898943|FG000|Overall Study|Withdrawal by Subject|8|||
30869008|NCT00707057|58898944|FG001|Overall Study|Withdrawal by Subject|3|||
30869009|NCT00707057|58898943|FG000|Overall Study|Dosed incorrectly|0|||
30869010|NCT00707057|58898944|FG001|Overall Study|Dosed incorrectly|1|||
30869011|NCT02639247|58898952|FG000|Overall Study|Lost to Follow-up|2|||
30869012|NCT02639247|58898953|FG001|Overall Study|Lost to Follow-up|1|||
30869013|NCT02639247|58898952|FG000|Overall Study|Death|2|||
30869014|NCT02639247|58898953|FG001|Overall Study|Death|0|||
30869015|NCT02639247|58898952|FG000|Overall Study|Withdrew Consent|0|||
30869016|NCT02639247|58898953|FG001|Overall Study|Withdrew Consent|1|||
30869017|NCT02639247|58898952|FG000|Overall Study|Protocol Violation|1|||
30869018|NCT02639247|58898953|FG001|Overall Study|Protocol Violation|0|||
30869019|NCT00706901|58898962|FG000|Overall Study|Lost to Follow-up|2|||
30869020|NCT00706901|58898963|FG001|Overall Study|Lost to Follow-up|3|||
30869021|NCT00706901|58898964|FG002|Overall Study|Lost to Follow-up|2|||
30869022|NCT00706901|58898962|FG000|Overall Study|Withdrawal by Subject|4|||
30869023|NCT00706901|58898963|FG001|Overall Study|Withdrawal by Subject|2|||
30869024|NCT00706901|58898964|FG002|Overall Study|Withdrawal by Subject|5|||
30869025|NCT00706901|58898962|FG000|Overall Study|In Jail|1|||
30602232|NCT01074502|58613580|FG000|Overall Study|Withdrawal by Subject|1|||
30602233|NCT01289028|58613584|FG000|Overall Study|Progressive Disease|49|||
30960832|NCT01520987|59026731|FG006|Overall Study|Withdrawal by Subject|0|||
30869026|NCT00706901|58898963|FG001|Overall Study|In Jail|0|||
30869027|NCT00706901|58898964|FG002|Overall Study|In Jail|1|||
30869028|NCT00706901|58898962|FG000|Overall Study|Death|1|||
30869029|NCT00706901|58898963|FG001|Overall Study|Death|0|||
30869030|NCT00706901|58898964|FG002|Overall Study|Death|0|||
30869031|NCT01673373|58898973|FG000|Overall Study|Death|2|||
30869032|NCT01236547|58898982|FG000|Overall Study|Protocol Violation|0|||
30869033|NCT01236547|58898983|FG001|Overall Study|Protocol Violation|1|||
30869034|NCT01236547|58898984|FG002|Overall Study|Protocol Violation|1|||
30869035|NCT01236547|58898985|FG003|Overall Study|Protocol Violation|6|||
30869036|NCT01236547|58898986|FG004|Overall Study|Protocol Violation|12|||
30869037|NCT02167945|58898999|FG000|Overall Study|Adverse Event|16|||
30869038|NCT02167945|58898999|FG000|Overall Study|Withdrew Consent|42|||
30869039|NCT02167945|58898999|FG000|Overall Study|Lost to Follow-up|122|||
30869040|NCT02167945|58898999|FG000|Overall Study|COVID-19 logistical restrictions|6|||
30869041|NCT02167945|58898999|FG000|Overall Study|Other, not specified|63|||
30869042|NCT01375075|58899017|FG000|Overall Study|Adverse Event|0|||
30869043|NCT01375075|58899018|FG001|Overall Study|Adverse Event|0|||
30869044|NCT01375075|58899019|FG002|Overall Study|Adverse Event|3|||
30869045|NCT01375075|58899020|FG003|Overall Study|Adverse Event|1|||
30869046|NCT01375075|58899021|FG004|Overall Study|Adverse Event|0|||
30869047|NCT01375075|58899022|FG005|Overall Study|Adverse Event|1|||
30869048|NCT01375075|58899017|FG000|Overall Study|Entry Criterion Not Met|1|||
30869049|NCT01375075|58899018|FG001|Overall Study|Entry Criterion Not Met|0|||
30869050|NCT01375075|58899019|FG002|Overall Study|Entry Criterion Not Met|0|||
30869051|NCT01375075|58899020|FG003|Overall Study|Entry Criterion Not Met|0|||
30869052|NCT01375075|58899021|FG004|Overall Study|Entry Criterion Not Met|0|||
30869053|NCT01375075|58899022|FG005|Overall Study|Entry Criterion Not Met|1|||
30869054|NCT01375075|58899017|FG000|Overall Study|Withdrawal by Subject|0|||
30869055|NCT01375075|58899018|FG001|Overall Study|Withdrawal by Subject|1|||
30869056|NCT01375075|58899019|FG002|Overall Study|Withdrawal by Subject|0|||
30869057|NCT01375075|58899020|FG003|Overall Study|Withdrawal by Subject|0|||
30869058|NCT01375075|58899021|FG004|Overall Study|Withdrawal by Subject|0|||
30869059|NCT01375075|58899022|FG005|Overall Study|Withdrawal by Subject|1|||
30869060|NCT00706433|58899044|FG000|Overall Study|Lost to Follow-up|3|||
30869061|NCT00706433|58899045|FG001|Overall Study|Lost to Follow-up|1|||
30869062|NCT00706433|58899046|FG002|Overall Study|Lost to Follow-up|6|||
30869063|NCT00706433|58899047|FG003|Overall Study|Lost to Follow-up|0|||
30869064|NCT00706433|58899044|FG000|Overall Study|Withdrawal by Subject|1|||
30869065|NCT00706433|58899045|FG001|Overall Study|Withdrawal by Subject|2|||
30869066|NCT00706433|58899046|FG002|Overall Study|Withdrawal by Subject|3|||
30869067|NCT00706433|58899047|FG003|Overall Study|Withdrawal by Subject|1|||
30869068|NCT00706433|58899044|FG000|Overall Study|Adverse Event|0|||
30869069|NCT00706433|58899045|FG001|Overall Study|Adverse Event|0|||
30869070|NCT00706433|58899046|FG002|Overall Study|Adverse Event|1|||
30869071|NCT00706433|58899047|FG003|Overall Study|Adverse Event|0|||
30869072|NCT00706433|58899044|FG000|Overall Study|Protocol Violation|1|||
30869073|NCT00706433|58899045|FG001|Overall Study|Protocol Violation|0|||
30869074|NCT00706433|58899046|FG002|Overall Study|Protocol Violation|0|||
30869075|NCT00706433|58899047|FG003|Overall Study|Protocol Violation|0|||
30869076|NCT00706433|58899044|FG000|Overall Study|new job|0|||
30869077|NCT00706433|58899045|FG001|Overall Study|new job|0|||
30869078|NCT00706433|58899046|FG002|Overall Study|new job|0|||
30869079|NCT00706433|58899047|FG003|Overall Study|new job|1|||
30869080|NCT02638623|58899059|FG000|Overall Study|Surgery timing|5|||
30869081|NCT02638623|58899060|FG001|Overall Study|Surgery timing|6|||
30869082|NCT02638623|58899059|FG000|Overall Study|Not given intervention|2|||
30869083|NCT02638623|58899060|FG001|Overall Study|Not given intervention|0|||
30869084|NCT02637141|58899069|FG000|Overall Study|Adverse Event|1|||
30869085|NCT02637141|58899070|FG001|Overall Study|Adverse Event|1|||
30869086|NCT02637141|58899071|FG002|Overall Study|Adverse Event|0|||
30869087|NCT02637141|58899069|FG000|Overall Study|Withdrawal by Subject|1|||
30869088|NCT02637141|58899070|FG001|Overall Study|Withdrawal by Subject|1|||
30869089|NCT02637141|58899071|FG002|Overall Study|Withdrawal by Subject|1|||
30869090|NCT02637063|58899082|FG000|Overall Study|Lost to Follow-up|3|||
30869091|NCT02637063|58899083|FG001|Overall Study|Lost to Follow-up|2|||
30869092|NCT02637063|58899084|FG002|Overall Study|Lost to Follow-up|3|||
30869093|NCT02637063|58899082|FG000|Overall Study|Withdrawal by Subject|2|||
30869094|NCT02637063|58899083|FG001|Overall Study|Withdrawal by Subject|2|||
30869095|NCT02637063|58899084|FG002|Overall Study|Withdrawal by Subject|3|||
30869096|NCT02635737|58899092|FG000|Overall Study|Protocol Violation|1|||
30869097|NCT02636907|58899096|FG000|Autoinjector Assessment Period|Adverse Event|2|||
30869098|NCT02636907|58899096|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
30869099|NCT02636907|58899096|FG000|Extension Phase|Adverse Event|2|||
30869100|NCT02636907|58899096|FG000|Extension Phase|Withdrawal by Subject|4|||
30869101|NCT02636907|58899096|FG000|Extension Phase|Physician Decision|1|||
30869102|NCT02636907|58899096|FG000|Extension Phase|Lost to Follow-up|2|||
30869103|NCT02636907|58899096|FG000|Extension Phase|Lack of Efficacy|1|||
30869104|NCT01374919|58899100|FG000|Overall Study|Withdrawal by Subject|2|||
30869105|NCT02726945|58899111|FG000|Overall Study|Withdrawal by Subject|0|||
30869106|NCT02726945|58899112|FG001|Overall Study|Withdrawal by Subject|0|||
30869107|NCT02726945|58899113|FG002|Overall Study|Withdrawal by Subject|1|||
30869108|NCT02726945|58899111|FG000|Overall Study|Elected to have total knee replacement|0|||
30869109|NCT02726945|58899112|FG001|Overall Study|Elected to have total knee replacement|1|||
30869110|NCT02726945|58899113|FG002|Overall Study|Elected to have total knee replacement|0|||
30869111|NCT02635347|58899123|FG000|Overall Study|Failed screening|20|||
30869112|NCT02635347|58899124|FG001|Overall Study|Failed screening|7|||
30869113|NCT02726399|58899144|FG000|Overall Study|Participant Non-Compliance|1|||
30869114|NCT02726399|58899144|FG000|Overall Study|Adverse Event|2|||
30869115|NCT02726399|58899144|FG000|Overall Study|Progression of disease|4|||
30869116|NCT02634801|58899151|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
30869117|NCT02634801|58899152|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
30869118|NCT02634801|58899153|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
30869119|NCT02634801|58899151|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
30869120|NCT02634801|58899152|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
30869121|NCT02634801|58899153|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
30869122|NCT02634801|58899151|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
30869123|NCT02634801|58899152|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
30869124|NCT02634801|58899153|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
30869125|NCT02634801|58899151|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
30869126|NCT02634801|58899152|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
30869127|NCT02634801|58899153|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
30869128|NCT02634801|58899151|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
30869129|NCT02634801|58899152|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
30869130|NCT02634801|58899153|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
30869131|NCT02634801|58899151|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
30869132|NCT02634801|58899152|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
30869133|NCT02634801|58899153|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
30869134|NCT02634801|58899151|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
30869135|NCT02634801|58899152|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
30869136|NCT02634801|58899153|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
30869137|NCT02634801|58899151|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
30869138|NCT02634801|58899152|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
30869139|NCT02634801|58899153|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
30869140|NCT02634801|58899151|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
30869141|NCT02634801|58899152|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
30869142|NCT02634801|58899153|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
30869143|NCT02634801|58899151|FG000|Follow-up Period|Lost to Follow-up|3|||
30869144|NCT02634801|58899152|FG001|Follow-up Period|Lost to Follow-up|1|||
30869145|NCT02634801|58899153|FG002|Follow-up Period|Lost to Follow-up|2|||
30869146|NCT02634801|58899151|FG000|Follow-up Period|Physician Decision|0|||
30869147|NCT02634801|58899152|FG001|Follow-up Period|Physician Decision|0|||
30869148|NCT02634801|58899153|FG002|Follow-up Period|Physician Decision|1|||
30869149|NCT02634801|58899151|FG000|Follow-up Period|Withdrawal by Subject|1|||
30869150|NCT02634801|58899152|FG001|Follow-up Period|Withdrawal by Subject|2|||
30869151|NCT02634801|58899153|FG002|Follow-up Period|Withdrawal by Subject|5|||
30869152|NCT02634801|58899151|FG000|Follow-up Period|Adverse Event|1|||
30869153|NCT02634801|58899152|FG001|Follow-up Period|Adverse Event|5|||
30869154|NCT02634801|58899153|FG002|Follow-up Period|Adverse Event|0|||
30869155|NCT02724839|58899168|FG000|Overall Study|Withdrawal by Subject|1|||
30869156|NCT02724839|58899169|FG001|Overall Study|Withdrawal by Subject|1|||
30869157|NCT02724839|58899170|FG002|Overall Study|Withdrawal by Subject|0|||
30869158|NCT02724839|58899168|FG000|Overall Study|Lost to Follow-up|0|||
30869159|NCT02724839|58899169|FG001|Overall Study|Lost to Follow-up|3|||
30869160|NCT02724839|58899170|FG002|Overall Study|Lost to Follow-up|2|||
30869161|NCT02724839|58899168|FG000|Overall Study|Physician Decision|0|||
30869162|NCT02724839|58899169|FG001|Overall Study|Physician Decision|0|||
30869163|NCT02724839|58899170|FG002|Overall Study|Physician Decision|3|||
30869164|NCT01375751|58899188|FG000|Overall Study|Other|0|||
30869165|NCT01375751|58899189|FG001|Overall Study|Other|1|||
30869166|NCT01375751|58899190|FG002|Overall Study|Other|0|||
30869167|NCT00705575|58899200|FG000|Overall Study|Abnormal laboratory value(s)|0|||
30869168|NCT00705575|58899201|FG001|Overall Study|Abnormal laboratory value(s)|3|||
30869169|NCT00705575|58899200|FG000|Overall Study|Abnormal test procedure result(s)|2|||
30869170|NCT00705575|58899201|FG001|Overall Study|Abnormal test procedure result(s)|12|||
30869171|NCT00705575|58899200|FG000|Overall Study|Adverse Event|11|||
30869172|NCT00705575|58899201|FG001|Overall Study|Adverse Event|15|||
30869173|NCT00705575|58899200|FG000|Overall Study|Lost to Follow-up|3|||
30869174|NCT00705575|58899201|FG001|Overall Study|Lost to Follow-up|4|||
30869175|NCT00705575|58899200|FG000|Overall Study|Protocol Violation|2|||
30869176|NCT00705575|58899201|FG001|Overall Study|Protocol Violation|2|||
30869177|NCT00705575|58899200|FG000|Overall Study|Withdrawal by Subject|5|||
30869178|NCT00705575|58899201|FG001|Overall Study|Withdrawal by Subject|10|||
30869179|NCT02636595|58899207|FG000|Overall Study|Lost to Follow-up|1|||
30869180|NCT02636595|58899207|FG000|Overall Study|Other|1|||
30869181|NCT02636361|58899211|FG000|Period 4|Physician Decision|0|||
30869182|NCT02636361|58899212|FG001|Period 4|Physician Decision|0|||
30869183|NCT02636361|58899213|FG002|Period 4|Physician Decision|0|||
30869184|NCT02636361|58899214|FG003|Period 4|Physician Decision|1|||
30869185|NCT02636361|58899215|FG004|Period 4|Physician Decision|0|||
30869186|NCT02636283|58899231|FG000|Overall Study|Adverse Event|2|||
30869187|NCT02636283|58899232|FG001|Overall Study|Adverse Event|0|||
30869188|NCT02636283|58899231|FG000|Overall Study|Trial Terminated Prematurely|0|||
30869189|NCT02636283|58899232|FG001|Overall Study|Trial Terminated Prematurely|3|||
30869190|NCT04430855|58899240|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
30869191|NCT04430855|58899241|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
30869192|NCT04430855|58899240|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
30869193|NCT04430855|58899241|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
30869194|NCT04430855|58899240|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
30869195|NCT04430855|58899241|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
30869196|NCT04430855|58899240|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
30869197|NCT04430855|58899241|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
30869198|NCT04430855|58899240|FG000|Period 1 (Weeks 1-12)|Other|0|||
30869199|NCT04430855|58899241|FG001|Period 1 (Weeks 1-12)|Other|1|||
30869200|NCT04430855|58899240|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
30869201|NCT04430855|58899241|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
30869202|NCT04430855|58899240|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
30869203|NCT04430855|58899241|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
30869204|NCT04430855|58899240|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
30869205|NCT04430855|58899241|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
30869206|NCT01375673|58899251|FG000|Overall Study|Withdrawal by Subject|0|||
30869207|NCT01375673|58899252|FG001|Overall Study|Withdrawal by Subject|1|||
30869208|NCT03652961|58899258|FG000|Overall Study|Lost to Follow-up|3|||
30869209|NCT03652961|58899258|FG000|Overall Study|Screen Failure|1|||
30869210|NCT02723591|58899264|FG000|Overall Study|Adverse Event|48|||
30869211|NCT02723591|58899265|FG001|Overall Study|Adverse Event|40|||
30869212|NCT02723591|58899264|FG000|Overall Study|Death|2|||
30869213|NCT02723591|58899265|FG001|Overall Study|Death|2|||
30869214|NCT02723591|58899264|FG000|Overall Study|Lack of Efficacy|4|||
30869215|NCT02723591|58899265|FG001|Overall Study|Lack of Efficacy|3|||
30869216|NCT02723591|58899264|FG000|Overall Study|Lost to Follow-up|1|||
30869217|NCT02723591|58899265|FG001|Overall Study|Lost to Follow-up|7|||
30869218|NCT02723591|58899264|FG000|Overall Study|Protocol Violation|20|||
30869219|NCT02723591|58899265|FG001|Overall Study|Protocol Violation|23|||
30869220|NCT02723591|58899264|FG000|Overall Study|Withdrawal by Subject|4|||
30869221|NCT02723591|58899265|FG001|Overall Study|Withdrawal by Subject|8|||
30869222|NCT02723591|58899264|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
30869223|NCT02723591|58899265|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
30869224|NCT02723591|58899264|FG000|Overall Study|Miscellaneous|5|||
30869225|NCT02723591|58899265|FG001|Overall Study|Miscellaneous|6|||
30869226|NCT00705341|58899273|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
30869227|NCT00705341|58899274|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
30869228|NCT00705341|58899275|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
30869229|NCT00705341|58899276|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
30869230|NCT00705341|58899273|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
30869231|NCT00705341|58899274|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
30869232|NCT00705341|58899275|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
30869233|NCT00705341|58899276|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
30869234|NCT02723201|58899287|FG000|Second Intervention Period|Protocol Violation|1|||
30869235|NCT02723201|58899288|FG001|Second Intervention Period|Protocol Violation|0|||
30869236|NCT02723201|58899289|FG002|Second Intervention Period|Protocol Violation|0|||
30869237|NCT02723201|58899287|FG000|Second Intervention Period|Adverse Event|1|||
30869238|NCT02723201|58899288|FG001|Second Intervention Period|Adverse Event|0|||
30869239|NCT02723201|58899289|FG002|Second Intervention Period|Adverse Event|0|||
30869240|NCT03846479|58899303|FG000|Overall Study|Death|8|||
30869241|NCT03846479|58899303|FG000|Overall Study|Lost to Follow-up|1|||
30869242|NCT00705263|58899307|FG000|Overall Study|Withdrawal by Subject|2|||
30869243|NCT00704405|58899325|FG000|Overall Study (NC Population)|Adverse Event|1|||
30869244|NCT00704405|58899326|FG001|Overall Study (NC Population)|Adverse Event|0|||
30869245|NCT00704405|58899327|FG002|Overall Study (NC Population)|Adverse Event|0|||
30960833|NCT01520987|59026732|FG007|Overall Study|Withdrawal by Subject|0|||
30960834|NCT01562275|59026806|FG000|Stage 1|Adverse Event|0|||
30869246|NCT00704405|58899328|FG003|Overall Study (NC Population)|Adverse Event|0|||
30869247|NCT00704405|58899329|FG004|Overall Study (NC Population)|Adverse Event|0|||
30869248|NCT00704405|58899325|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
30869249|NCT00704405|58899326|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
30869250|NCT00704405|58899327|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
30960835|NCT01562275|59026807|FG001|Stage 1|Adverse Event|0|||
30869251|NCT00704405|58899328|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
30869252|NCT00704405|58899329|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
30869253|NCT00704405|58899325|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
30869254|NCT00704405|58899326|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
30869255|NCT00704405|58899327|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
30869256|NCT00704405|58899328|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
30869257|NCT00704405|58899329|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
30869258|NCT00704405|58899325|FG000|Overall Study (NC Population)|Other|0|||
30869259|NCT00704405|58899326|FG001|Overall Study (NC Population)|Other|0|||
30869260|NCT00704405|58899327|FG002|Overall Study (NC Population)|Other|0|||
30869261|NCT00704405|58899328|FG003|Overall Study (NC Population)|Other|0|||
30869262|NCT00704405|58899329|FG004|Overall Study (NC Population)|Other|1|||
30869263|NCT00704405|58899325|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
30869264|NCT00704405|58899326|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
30869265|NCT00704405|58899327|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
30869266|NCT00704405|58899328|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
30869267|NCT00704405|58899329|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
30869268|NCT00704405|58899325|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
30869269|NCT00704405|58899326|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
30869270|NCT00704405|58899327|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
30869271|NCT00704405|58899328|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
30869272|NCT00704405|58899329|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
30869273|NCT01534481|58899349|FG000|Overall Study|Lost to Follow-up|29|||
30869274|NCT01534481|58899350|FG001|Overall Study|Lost to Follow-up|24|||
30869275|NCT01534481|58899349|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
30869276|NCT01534481|58899350|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
30869277|NCT00704171|58899358|FG000|Overall Study|Withdrawal by Subject|1|||
30869278|NCT00704171|58899359|FG001|Overall Study|Withdrawal by Subject|0|||
30869279|NCT00703781|58899367|FG000|Overall Study|Withdrawal by Subject|1|||
30869280|NCT00703781|58899368|FG001|Overall Study|Withdrawal by Subject|2|||
30869281|NCT00703781|58899367|FG000|Overall Study|Cancelled surgery|1|||
30869282|NCT00703781|58899368|FG001|Overall Study|Cancelled surgery|0|||
30869283|NCT00703157|58899376|FG000|Overall Study|Lost to Follow-up|0|||
30869284|NCT00703157|58899377|FG001|Overall Study|Lost to Follow-up|1|||
30869285|NCT00703157|58899376|FG000|Overall Study|source data permanently lost/ other|4|||
30869286|NCT00703157|58899377|FG001|Overall Study|source data permanently lost/ other|1|||
30869287|NCT03307967|58899385|FG000|Overall Study|Lost to Follow-up|4|||
30869288|NCT02722967|58899392|FG000|Overall Study|Adverse Event|1|||
30869289|NCT02722967|58899393|FG001|Overall Study|Adverse Event|0|||
30869290|NCT02722967|58899394|FG002|Overall Study|Adverse Event|0|||
30869291|NCT02722967|58899392|FG000|Overall Study|Lost to Follow-up|0|||
30869292|NCT02722967|58899393|FG001|Overall Study|Lost to Follow-up|1|||
30869293|NCT02722967|58899394|FG002|Overall Study|Lost to Follow-up|0|||
30869294|NCT02722967|58899392|FG000|Overall Study|Non-compliance with patch wearing|2|||
30869295|NCT02722967|58899393|FG001|Overall Study|Non-compliance with patch wearing|1|||
30869296|NCT02722967|58899394|FG002|Overall Study|Non-compliance with patch wearing|1|||
30869297|NCT02722967|58899392|FG000|Overall Study|Withdrawal by Subject|1|||
30869298|NCT02722967|58899393|FG001|Overall Study|Withdrawal by Subject|0|||
30869299|NCT02722967|58899394|FG002|Overall Study|Withdrawal by Subject|1|||
30869300|NCT02722967|58899392|FG000|Overall Study|Physician Decision|1|||
30869301|NCT02722967|58899393|FG001|Overall Study|Physician Decision|0|||
30869302|NCT02722967|58899394|FG002|Overall Study|Physician Decision|0|||
30869303|NCT02722967|58899392|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
30869304|NCT02722967|58899393|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
30869305|NCT02722967|58899394|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
30869306|NCT02722499|58899405|FG000|Overall Study|Lost to Follow-up|2|||
30869307|NCT02722499|58899406|FG001|Overall Study|Lost to Follow-up|0|||
30869308|NCT02722499|58899407|FG002|Overall Study|Lost to Follow-up|1|||
30869309|NCT02721875|58899417|FG000|Overall Study|Progressive disease/relapse|1|||
30869310|NCT02721875|58899418|FG001|Overall Study|Progressive disease/relapse|0|||
30869311|NCT02721251|58899427|FG000|Overall Study|Withdrawal by Subject|8|||
30869312|NCT02721251|58899428|FG001|Overall Study|Withdrawal by Subject|7|||
30869313|NCT02721251|58899429|FG002|Overall Study|Withdrawal by Subject|9|||
30869314|NCT02721251|58899427|FG000|Overall Study|poor adherence|2|||
30869315|NCT02721251|58899428|FG001|Overall Study|poor adherence|2|||
30869316|NCT02721251|58899429|FG002|Overall Study|poor adherence|2|||
30869317|NCT00702221|58899440|FG000|Overall Study|Adverse Event|4|||
30869318|NCT00702221|58899441|FG001|Overall Study|Adverse Event|3|||
30869319|NCT00702143|58899450|FG000|Overall Study|Lost to Follow-up|0|||
30869320|NCT00702143|58899451|FG001|Overall Study|Lost to Follow-up|0|||
30869321|NCT00702143|58899452|FG002|Overall Study|Lost to Follow-up|1|||
30869322|NCT00702923|58899458|FG000|Overall Study|Adverse Event|1|||
30869323|NCT02633787|58899463|FG000|Overall Study|Withdrawal by Subject|1|||
30869324|NCT02719691|58899474|FG000|Overall Study|Physician Decision|0|||
30869325|NCT02719691|58899475|FG001|Overall Study|Physician Decision|0|||
30869326|NCT02719691|58899476|FG002|Overall Study|Physician Decision|1|||
30869327|NCT02719691|58899477|FG003|Overall Study|Physician Decision|0|||
30869328|NCT02719691|58899478|FG004|Overall Study|Physician Decision|0|||
30869329|NCT02719691|58899479|FG005|Overall Study|Physician Decision|0|||
30869330|NCT02719691|58899480|FG006|Overall Study|Physician Decision|0|||
30869331|NCT02719691|58899474|FG000|Overall Study|Withdrawal by Subject|0|||
30869332|NCT02719691|58899475|FG001|Overall Study|Withdrawal by Subject|0|||
30869333|NCT02719691|58899476|FG002|Overall Study|Withdrawal by Subject|0|||
30869334|NCT02719691|58899477|FG003|Overall Study|Withdrawal by Subject|0|||
30869335|NCT02719691|58899478|FG004|Overall Study|Withdrawal by Subject|0|||
30869336|NCT02719691|58899479|FG005|Overall Study|Withdrawal by Subject|1|||
30869337|NCT02719691|58899480|FG006|Overall Study|Withdrawal by Subject|0|||
30869338|NCT02720081|58899499|FG000|Overall Study|Adverse Event|0|||
30869339|NCT02720081|58899500|FG001|Overall Study|Adverse Event|3|||
30869340|NCT02720081|58899499|FG000|Overall Study|Protocol Violation|4|||
30869341|NCT02720081|58899500|FG001|Overall Study|Protocol Violation|1|||
30869342|NCT04248933|58899506|FG000|Overall Study|Lost to Follow-up|9|||
30869343|NCT04248933|58899506|FG000|Overall Study|Withdrawal by Subject|2|||
30869344|NCT02718131|58899512|FG000|Overall Study|Withdrawal by Subject|1|||
30869345|NCT02718131|58899513|FG001|Overall Study|Withdrawal by Subject|0|||
30869346|NCT02718131|58899512|FG000|Overall Study|Adverse Event|1|||
30869347|NCT02718131|58899513|FG001|Overall Study|Adverse Event|0|||
30869348|NCT02718131|58899512|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
30869349|NCT02718131|58899513|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
30869350|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
30869351|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
30869352|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
30869353|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
30869354|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
30869355|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
30869356|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
30869357|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
30869358|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
30869359|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
30869360|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
30869361|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
30869362|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
30869363|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
30869364|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
30869365|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
30869366|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
30869367|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
30869368|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
30869369|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
30869370|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
30694594|NCT00544882|58708774|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
30694595|NCT00544882|58708772|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
30694596|NCT00544882|58708773|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
30869371|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
30869372|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
30869373|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
30869374|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
30869375|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
30869376|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
30869377|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
30869378|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
30869379|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
30869380|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
30869381|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
30869382|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
30869383|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
30869384|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
30869385|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
30869386|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
30869387|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
30694597|NCT00544882|58708774|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
30869388|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
30869389|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
30869390|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
30869391|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
30869392|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
30869393|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
30869394|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
30869395|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
30869396|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
30869397|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
30869398|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
30869399|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
30869400|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
30869401|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
30869402|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
30869403|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
30869404|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
30869405|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
30869406|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
30869407|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
30869408|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
30869409|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
30869410|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
30869411|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
30869412|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
30869413|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
30869414|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
30869415|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
30869416|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
30869417|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
30869418|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
30869419|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
30869420|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
30869421|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
30869422|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
30869423|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
30869424|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
30869425|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
30869426|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
30869427|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
30869428|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
30869429|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
30869430|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
30869431|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
30869432|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
30869433|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
30869434|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
30869435|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
30869436|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
30869437|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
30869438|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
30869439|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
30869440|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
30869441|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
30869442|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
30869443|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
30869444|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
30869445|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
30869446|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
30869447|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
30869448|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
30869449|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
30869450|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
30869451|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
30869452|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
30869453|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
30869454|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
30869455|NCT02717195|58899548|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
30869456|NCT02717195|58899549|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
30869457|NCT02717195|58899550|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
30869458|NCT02717195|58899551|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
30869459|NCT02717195|58899552|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
30869460|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
30869461|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
30869462|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
30869463|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
30869464|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
30869465|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
30869466|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
30869467|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
30869468|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
30869469|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
30869470|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
30869471|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
30869472|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
30869473|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
30869474|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
30869475|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
30869476|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
30869477|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
30869478|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
30869479|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
30869480|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
30869481|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
30869482|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
30869483|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
30869484|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
30869485|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
30869486|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
30869487|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
30869488|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
30869489|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
30869490|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
30869491|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
30869492|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
30869493|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
30869494|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
30869495|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
30869496|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
30869497|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
30869498|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
30869499|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
30869500|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
30869501|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
30869502|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
30869503|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
30869504|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
30869505|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
30869506|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
30869507|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
30869508|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
30869509|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
30869510|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
30960836|NCT01562275|59026808|FG002|Stage 1|Adverse Event|0|||
30960837|NCT01562275|59026809|FG003|Stage 1|Adverse Event|1|||
30960838|NCT01562275|59026810|FG004|Stage 1|Adverse Event|1|||
30869511|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
30869512|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
30869513|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
30869514|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
30869515|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
30869516|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
30869517|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
30869518|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
30869519|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
30869520|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
30869521|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
30869522|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
30869523|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
30869524|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
30869525|NCT02717195|58899548|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
30869526|NCT02717195|58899549|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
30869527|NCT02717195|58899550|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
30869528|NCT02717195|58899551|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
30869529|NCT02717195|58899552|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
30869530|NCT00701441|58899567|FG000|Overall Study|failure in cpap compliance|0|||
30869531|NCT00701441|58899568|FG001|Overall Study|failure in cpap compliance|4|||
30869532|NCT02628873|58899580|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
30869533|NCT02628873|58899581|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
30869534|NCT02628873|58899580|FG000|Second Test (1 Hour)|Physician Decision|1|||
30869535|NCT02628873|58899581|FG001|Second Test (1 Hour)|Physician Decision|0|||
30869536|NCT02629965|58899591|FG000|Period 1|Adverse Event|1|||
30869537|NCT02629965|58899592|FG001|Period 1|Adverse Event|0|||
30869538|NCT02629965|58899591|FG000|Period 1|Unexpected worsening of disease|2|||
30869539|NCT02629965|58899592|FG001|Period 1|Unexpected worsening of disease|0|||
30869540|NCT02629965|58899591|FG000|Period 1|Other than listed above|1|||
30869541|NCT02629965|58899592|FG001|Period 1|Other than listed above|2|||
30869542|NCT02629965|58899591|FG000|Period 2|Adverse Event|1|||
30869543|NCT02629965|58899592|FG001|Period 2|Adverse Event|0|||
30869544|NCT01671111|58899598|FG000|Overall Study|Adverse Event|2|||
30869545|NCT01671111|58899598|FG000|Overall Study|Lack of Efficacy|1|||
30869546|NCT01671111|58899598|FG000|Overall Study|Withdrawal by Subject|2|||
30869547|NCT01671111|58899598|FG000|Overall Study|Physician Decision|1|||
30869548|NCT01671111|58899598|FG000|Overall Study|Other|24|||
30869549|NCT01671345|58899604|FG000|Overall Study|Lost to Follow-up|10|||
30869550|NCT01671345|58899605|FG001|Overall Study|Lost to Follow-up|6|||
30869551|NCT01671345|58899604|FG000|Overall Study|visit with non-participating physician|3|||
30869552|NCT01671345|58899605|FG001|Overall Study|visit with non-participating physician|3|||
30869553|NCT04338321|58899627|FG000|Overall Study|Adverse Event|4|||
30869554|NCT04338321|58899628|FG001|Overall Study|Adverse Event|10|||
30869555|NCT04338321|58899627|FG000|Overall Study|Death|1|||
30869556|NCT04338321|58899628|FG001|Overall Study|Death|1|||
30869557|NCT04338321|58899627|FG000|Overall Study|Lost to Follow-up|4|||
30869558|NCT04338321|58899628|FG001|Overall Study|Lost to Follow-up|9|||
30869559|NCT04338321|58899627|FG000|Overall Study|Withdrawal by Subject|45|||
30869560|NCT04338321|58899628|FG001|Overall Study|Withdrawal by Subject|69|||
30869561|NCT04338321|58899627|FG000|Overall Study|Physician Decision|5|||
30869562|NCT04338321|58899628|FG001|Overall Study|Physician Decision|9|||
30869563|NCT04338321|58899627|FG000|Overall Study|Other|3|||
30869564|NCT04338321|58899628|FG001|Overall Study|Other|10|||
30869565|NCT02487095|58899644|FG000|Dose Expansion|Unable to scan/restage participant|0|||
30869566|NCT02487095|58899645|FG001|Dose Expansion|Unable to scan/restage participant|0|||
30869567|NCT02487095|58899646|FG002|Dose Expansion|Unable to scan/restage participant|0|||
30869568|NCT02487095|58899647|FG003|Dose Expansion|Unable to scan/restage participant|0|||
30869569|NCT02487095|58899648|FG004|Dose Expansion|Unable to scan/restage participant|1|||
30869570|NCT03855137|58899671|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
30869571|NCT03855137|58899672|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
30869572|NCT03855137|58899673|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
30869573|NCT03855137|58899671|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
30869574|NCT03855137|58899672|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
30602234|NCT01289028|58613584|FG000|Overall Study|Adverse Event|14|||
30602235|NCT01289028|58613584|FG000|Overall Study|Withdrawal by Subject|6|||
30602236|NCT01289028|58613584|FG000|Overall Study|Death|4|||
30602237|NCT01289028|58613584|FG000|Overall Study|Lack of Efficacy|2|||
30602238|NCT01289028|58613584|FG000|Overall Study|No longer required|2|||
30602239|NCT01289028|58613584|FG000|Overall Study|Lost to Follow-up|2|||
30602240|NCT01289028|58613584|FG000|Overall Study|New Cancer Therapy|2|||
30602241|NCT01289028|58613584|FG000|Overall Study|Abnormal Lab Value|1|||
30869575|NCT03855137|58899673|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
30869576|NCT03855137|58899671|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
30869577|NCT03855137|58899672|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
30869578|NCT03855137|58899673|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
30869579|NCT03855137|58899671|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
30869580|NCT03855137|58899672|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
30869581|NCT03855137|58899673|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
30869582|NCT03855137|58899671|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
30869583|NCT03855137|58899672|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
30869584|NCT03855137|58899673|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
30869585|NCT03855137|58899671|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
30869586|NCT03855137|58899672|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
30869587|NCT03855137|58899673|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
30869588|NCT03855137|58899671|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
30869589|NCT03855137|58899672|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
30869590|NCT03855137|58899673|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
30869591|NCT03855137|58899671|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
30869592|NCT03855137|58899672|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
30869593|NCT03855137|58899673|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
30869594|NCT03855137|58899671|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
30869595|NCT03855137|58899672|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
30869596|NCT03855137|58899673|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
30869597|NCT03855137|58899671|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
30869598|NCT03855137|58899672|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
30869599|NCT03855137|58899673|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
30869600|NCT00701363|58899695|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
30869601|NCT00701363|58899696|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
30869602|NCT00701363|58899697|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
30869603|NCT00701363|58899698|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
30869604|NCT00701363|58899695|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
30869605|NCT00701363|58899696|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
30869606|NCT00701363|58899697|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
30869607|NCT00701363|58899698|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
30869608|NCT00701363|58899695|FG000|Treatment Phase 1|Adverse Event|7|||
30869609|NCT00701363|58899696|FG001|Treatment Phase 1|Adverse Event|0|||
30869610|NCT00701363|58899697|FG002|Treatment Phase 1|Adverse Event|0|||
30869611|NCT00701363|58899698|FG003|Treatment Phase 1|Adverse Event|0|||
30869612|NCT00701363|58899695|FG000|Treatment Phase 1|Protocol Violation|1|||
30869613|NCT00701363|58899696|FG001|Treatment Phase 1|Protocol Violation|0|||
30869614|NCT00701363|58899697|FG002|Treatment Phase 1|Protocol Violation|0|||
30869615|NCT00701363|58899698|FG003|Treatment Phase 1|Protocol Violation|0|||
30869616|NCT00701363|58899695|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
30869617|NCT00701363|58899696|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
30869618|NCT00701363|58899697|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
30869619|NCT00701363|58899698|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
30869620|NCT00701363|58899695|FG000|Treatment Phase 1|Lack of Efficacy|1|||
30869621|NCT00701363|58899696|FG001|Treatment Phase 1|Lack of Efficacy|0|||
30869622|NCT00701363|58899697|FG002|Treatment Phase 1|Lack of Efficacy|0|||
30869623|NCT00701363|58899698|FG003|Treatment Phase 1|Lack of Efficacy|0|||
30869624|NCT00701363|58899695|FG000|Treatment Phase 2|Adverse Event|0|||
30869625|NCT00701363|58899696|FG001|Treatment Phase 2|Adverse Event|0|||
30869626|NCT00701363|58899697|FG002|Treatment Phase 2|Adverse Event|1|||
30869627|NCT00701363|58899698|FG003|Treatment Phase 2|Adverse Event|0|||
30869628|NCT00701363|58899695|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
30869629|NCT00701363|58899696|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
30869630|NCT00701363|58899697|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
30869631|NCT00701363|58899698|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
30869632|NCT01670877|58899722|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
30869633|NCT01670877|58899723|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
30869634|NCT01670877|58899724|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
30869635|NCT01670877|58899725|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
30869636|NCT01670877|58899726|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
30869637|NCT01670877|58899727|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
30694598|NCT00544882|58708772|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
30694599|NCT00544882|58708773|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
30869638|NCT01670877|58899722|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
30869639|NCT01670877|58899723|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
30869640|NCT01670877|58899724|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
30869641|NCT01670877|58899725|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
30869642|NCT01670877|58899726|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
30869643|NCT01670877|58899727|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
30869644|NCT01670877|58899722|FG000|Part I and Part 2|Grade 2 vomiting|0|||
30869645|NCT01670877|58899723|FG001|Part I and Part 2|Grade 2 vomiting|0|||
30869646|NCT01670877|58899724|FG002|Part I and Part 2|Grade 2 vomiting|0|||
30869647|NCT01670877|58899725|FG003|Part I and Part 2|Grade 2 vomiting|1|||
30869648|NCT01670877|58899726|FG004|Part I and Part 2|Grade 2 vomiting|0|||
30869649|NCT01670877|58899727|FG005|Part I and Part 2|Grade 2 vomiting|0|||
30869650|NCT01670877|58899722|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
30869651|NCT01670877|58899723|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
30869652|NCT01670877|58899724|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
30869653|NCT01670877|58899725|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
30869654|NCT01670877|58899726|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
30869655|NCT01670877|58899727|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
30869656|NCT01670877|58899722|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
30869657|NCT01670877|58899723|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
30869658|NCT01670877|58899724|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
30869659|NCT01670877|58899725|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
30869660|NCT01670877|58899726|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
30869661|NCT01670877|58899727|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
30869662|NCT00701129|58899741|FG000|Overall Study|Death|2|||
30869663|NCT01670721|58899745|FG000|Overall Study|Participant's decision|15|||
30869664|NCT01670721|58899745|FG000|Overall Study|Other than specified above|38|||
30869665|NCT02711137|58899764|FG000|Overall Study|Death|1|||
30869666|NCT02711137|58899765|FG001|Overall Study|Death|4|||
30869667|NCT02711137|58899766|FG002|Overall Study|Death|5|||
30869668|NCT02711137|58899767|FG003|Overall Study|Death|5|||
30869669|NCT02711137|58899768|FG004|Overall Study|Death|3|||
30869670|NCT02711137|58899769|FG005|Overall Study|Death|1|||
30869671|NCT02711137|58899770|FG006|Overall Study|Death|61|||
30869672|NCT02711137|58899771|FG007|Overall Study|Death|3|||
30869673|NCT02711137|58899772|FG008|Overall Study|Death|0|||
30869674|NCT02711137|58899773|FG009|Overall Study|Death|1|||
30869675|NCT02711137|58899774|FG010|Overall Study|Death|1|||
30869676|NCT02711137|58899775|FG011|Overall Study|Death|1|||
30869677|NCT02711137|58899776|FG012|Overall Study|Death|0|||
30869678|NCT02711137|58899777|FG013|Overall Study|Death|0|||
30869679|NCT02711137|58899778|FG014|Overall Study|Death|0|||
30869680|NCT02711137|58899764|FG000|Overall Study|Study Terminated by Sponsor|0|||
30869681|NCT02711137|58899765|FG001|Overall Study|Study Terminated by Sponsor|0|||
30869682|NCT02711137|58899766|FG002|Overall Study|Study Terminated by Sponsor|1|||
30869683|NCT02711137|58899767|FG003|Overall Study|Study Terminated by Sponsor|0|||
30869684|NCT02711137|58899768|FG004|Overall Study|Study Terminated by Sponsor|0|||
30869685|NCT02711137|58899769|FG005|Overall Study|Study Terminated by Sponsor|0|||
30869686|NCT02711137|58899770|FG006|Overall Study|Study Terminated by Sponsor|1|||
30869687|NCT02711137|58899771|FG007|Overall Study|Study Terminated by Sponsor|0|||
30869688|NCT02711137|58899772|FG008|Overall Study|Study Terminated by Sponsor|0|||
30869689|NCT02711137|58899773|FG009|Overall Study|Study Terminated by Sponsor|0|||
30869690|NCT02711137|58899774|FG010|Overall Study|Study Terminated by Sponsor|0|||
30869691|NCT02711137|58899775|FG011|Overall Study|Study Terminated by Sponsor|0|||
30869692|NCT02711137|58899776|FG012|Overall Study|Study Terminated by Sponsor|0|||
30869693|NCT02711137|58899777|FG013|Overall Study|Study Terminated by Sponsor|0|||
30869694|NCT02711137|58899778|FG014|Overall Study|Study Terminated by Sponsor|0|||
30869695|NCT02711137|58899764|FG000|Overall Study|Physician Decision|1|||
30869696|NCT02711137|58899765|FG001|Overall Study|Physician Decision|0|||
30869697|NCT02711137|58899766|FG002|Overall Study|Physician Decision|2|||
30869698|NCT02711137|58899767|FG003|Overall Study|Physician Decision|1|||
30869699|NCT02711137|58899768|FG004|Overall Study|Physician Decision|1|||
30869700|NCT02711137|58899769|FG005|Overall Study|Physician Decision|0|||
30869701|NCT02711137|58899770|FG006|Overall Study|Physician Decision|12|||
30869702|NCT02711137|58899771|FG007|Overall Study|Physician Decision|2|||
30869703|NCT02711137|58899772|FG008|Overall Study|Physician Decision|1|||
30869704|NCT02711137|58899773|FG009|Overall Study|Physician Decision|1|||
30869705|NCT02711137|58899774|FG010|Overall Study|Physician Decision|3|||
30869706|NCT02711137|58899775|FG011|Overall Study|Physician Decision|2|||
30869707|NCT02711137|58899776|FG012|Overall Study|Physician Decision|1|||
30869708|NCT02711137|58899777|FG013|Overall Study|Physician Decision|1|||
30869709|NCT02711137|58899778|FG014|Overall Study|Physician Decision|2|||
30869710|NCT02711137|58899764|FG000|Overall Study|Other|0|||
30869711|NCT02711137|58899765|FG001|Overall Study|Other|1|||
30869712|NCT02711137|58899766|FG002|Overall Study|Other|0|||
30869713|NCT02711137|58899767|FG003|Overall Study|Other|0|||
30869714|NCT02711137|58899768|FG004|Overall Study|Other|0|||
30869715|NCT02711137|58899769|FG005|Overall Study|Other|0|||
30869716|NCT02711137|58899770|FG006|Overall Study|Other|3|||
30869717|NCT02711137|58899771|FG007|Overall Study|Other|0|||
30869718|NCT02711137|58899772|FG008|Overall Study|Other|0|||
30869719|NCT02711137|58899773|FG009|Overall Study|Other|0|||
30869720|NCT02711137|58899774|FG010|Overall Study|Other|0|||
30869721|NCT02711137|58899775|FG011|Overall Study|Other|0|||
30869722|NCT02711137|58899776|FG012|Overall Study|Other|0|||
30869723|NCT02711137|58899777|FG013|Overall Study|Other|0|||
30869724|NCT02711137|58899778|FG014|Overall Study|Other|1|||
30869725|NCT02711137|58899764|FG000|Overall Study|Withdrawal by Subject|1|||
30869726|NCT02711137|58899765|FG001|Overall Study|Withdrawal by Subject|0|||
30869727|NCT02711137|58899766|FG002|Overall Study|Withdrawal by Subject|0|||
30869728|NCT02711137|58899767|FG003|Overall Study|Withdrawal by Subject|1|||
30869729|NCT02711137|58899768|FG004|Overall Study|Withdrawal by Subject|1|||
30869730|NCT02711137|58899769|FG005|Overall Study|Withdrawal by Subject|0|||
30869731|NCT02711137|58899770|FG006|Overall Study|Withdrawal by Subject|7|||
30869732|NCT02711137|58899771|FG007|Overall Study|Withdrawal by Subject|0|||
30869733|NCT02711137|58899772|FG008|Overall Study|Withdrawal by Subject|0|||
30869734|NCT02711137|58899773|FG009|Overall Study|Withdrawal by Subject|0|||
30869735|NCT02711137|58899774|FG010|Overall Study|Withdrawal by Subject|0|||
30869736|NCT02711137|58899775|FG011|Overall Study|Withdrawal by Subject|0|||
30869737|NCT02711137|58899776|FG012|Overall Study|Withdrawal by Subject|0|||
30869738|NCT02711137|58899777|FG013|Overall Study|Withdrawal by Subject|1|||
30869739|NCT02711137|58899778|FG014|Overall Study|Withdrawal by Subject|0|||
30869740|NCT02711137|58899764|FG000|Overall Study|Lost to Follow-up|1|||
30869741|NCT02711137|58899765|FG001|Overall Study|Lost to Follow-up|0|||
30869742|NCT02711137|58899766|FG002|Overall Study|Lost to Follow-up|0|||
30869743|NCT02711137|58899767|FG003|Overall Study|Lost to Follow-up|0|||
30869744|NCT02711137|58899768|FG004|Overall Study|Lost to Follow-up|0|||
30869745|NCT02711137|58899769|FG005|Overall Study|Lost to Follow-up|0|||
30869746|NCT02711137|58899770|FG006|Overall Study|Lost to Follow-up|2|||
30869747|NCT02711137|58899771|FG007|Overall Study|Lost to Follow-up|0|||
30869748|NCT02711137|58899772|FG008|Overall Study|Lost to Follow-up|0|||
30869749|NCT02711137|58899773|FG009|Overall Study|Lost to Follow-up|0|||
30869750|NCT02711137|58899774|FG010|Overall Study|Lost to Follow-up|0|||
30869751|NCT02711137|58899775|FG011|Overall Study|Lost to Follow-up|0|||
30869752|NCT02711137|58899776|FG012|Overall Study|Lost to Follow-up|0|||
30869753|NCT02711137|58899777|FG013|Overall Study|Lost to Follow-up|0|||
30869754|NCT02711137|58899778|FG014|Overall Study|Lost to Follow-up|0|||
30869755|NCT02710045|58899818|FG000|Overall Study|Death|1|||
30869756|NCT02710045|58899819|FG001|Overall Study|Death|2|||
30869757|NCT02710045|58899820|FG002|Overall Study|Death|0|||
30869758|NCT02710045|58899818|FG000|Overall Study|Withdrawal by Subject|6|||
30869759|NCT02710045|58899819|FG001|Overall Study|Withdrawal by Subject|6|||
30869760|NCT02710045|58899820|FG002|Overall Study|Withdrawal by Subject|2|||
30869761|NCT02710045|58899818|FG000|Overall Study|Protocol Violation|1|||
30869762|NCT02710045|58899819|FG001|Overall Study|Protocol Violation|2|||
30869763|NCT02710045|58899820|FG002|Overall Study|Protocol Violation|3|||
30869764|NCT02710045|58899818|FG000|Overall Study|Lost to Follow-up|3|||
30869765|NCT02710045|58899819|FG001|Overall Study|Lost to Follow-up|6|||
30869766|NCT02710045|58899820|FG002|Overall Study|Lost to Follow-up|7|||
30869767|NCT02710045|58899818|FG000|Overall Study|Physician Decision|0|||
30869768|NCT02710045|58899819|FG001|Overall Study|Physician Decision|0|||
30869769|NCT02710045|58899820|FG002|Overall Study|Physician Decision|1|||
30869770|NCT02710045|58899818|FG000|Overall Study|Poor Attendance|0|||
30869771|NCT02710045|58899819|FG001|Overall Study|Poor Attendance|1|||
30869772|NCT02710045|58899820|FG002|Overall Study|Poor Attendance|0|||
30869773|NCT02714153|58899828|FG000|Overall Study|Death|1|||
30869774|NCT04369469|58899834|FG000|Overall Study|Lost to Follow-up|2|||
30869775|NCT04369469|58899835|FG001|Overall Study|Lost to Follow-up|4|||
30869776|NCT04369469|58899834|FG000|Overall Study|Physician Decision|2|||
30869777|NCT04369469|58899835|FG001|Overall Study|Physician Decision|1|||
30869778|NCT04369469|58899834|FG000|Overall Study|Withdrawal by Subject|2|||
30869779|NCT04369469|58899835|FG001|Overall Study|Withdrawal by Subject|3|||
30869780|NCT04369469|58899834|FG000|Overall Study|Adverse Event|1|||
30869781|NCT04369469|58899835|FG001|Overall Study|Adverse Event|0|||
30869782|NCT04369469|58899834|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
30869783|NCT04369469|58899835|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
30869784|NCT04369469|58899834|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
30869785|NCT04369469|58899835|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
30869786|NCT04369469|58899834|FG000|Overall Study|Unable to Provide Consent|0|||
30869787|NCT04369469|58899835|FG001|Overall Study|Unable to Provide Consent|1|||
30869788|NCT01670097|58899856|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
30869789|NCT01670097|58899857|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
30869790|NCT01670097|58899856|FG000|Overall Study|Study burden|1|||
30869791|NCT01670097|58899857|FG001|Overall Study|Study burden|0|||
30869792|NCT01670097|58899856|FG000|Overall Study|COPD exacerbation|0|||
30869793|NCT01670097|58899857|FG001|Overall Study|COPD exacerbation|1|||
30869794|NCT01670097|58899856|FG000|Overall Study|Neutropenia|0|||
30869795|NCT01670097|58899857|FG001|Overall Study|Neutropenia|1|||
30869796|NCT01670097|58899856|FG000|Overall Study|Clinical deterioration|0|||
30869797|NCT01670097|58899857|FG001|Overall Study|Clinical deterioration|1|||
30869798|NCT01670097|58899856|FG000|Overall Study|Disease progression|0|||
30869799|NCT01670097|58899857|FG001|Overall Study|Disease progression|1|||
30869800|NCT01670019|58899865|FG000|Overall Study|Adverse Event|3|||
30869801|NCT01670019|58899866|FG001|Overall Study|Adverse Event|0|||
30869802|NCT01670019|58899865|FG000|Overall Study|Withdrawal by Subject|6|||
30869803|NCT01670019|58899866|FG001|Overall Study|Withdrawal by Subject|0|||
30869804|NCT01669629|58899872|FG000|Period 1|protocol deviation|1|||
30869805|NCT01669629|58899873|FG001|Period 1|protocol deviation|2|||
30869806|NCT00701051|58899881|FG000|Screening|Failed Screening|40|||
30869807|NCT00701051|58899882|FG001|Screening|Failed Screening|0|||
30869808|NCT00701051|58899883|FG002|Screening|Failed Screening|0|||
30869809|NCT00701051|58899881|FG000|Screening|Time conflicts|19|||
30869810|NCT00701051|58899882|FG001|Screening|Time conflicts|0|||
30869811|NCT00701051|58899883|FG002|Screening|Time conflicts|0|||
30869812|NCT00701051|58899881|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
30869813|NCT00701051|58899882|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
30869814|NCT00701051|58899883|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
30869815|NCT00700817|58899894|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
30869816|NCT00700817|58899895|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
30869817|NCT00700817|58899896|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
30869818|NCT00700817|58899897|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
30869819|NCT00700817|58899898|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
30869820|NCT00700817|58899894|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
30869821|NCT00700817|58899895|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
30869822|NCT00700817|58899896|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
30869823|NCT00700817|58899897|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
30869824|NCT00700817|58899898|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
30869825|NCT00700817|58899894|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
30869826|NCT00700817|58899895|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
30869827|NCT00700817|58899896|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
30869828|NCT00700817|58899897|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
30869829|NCT00700817|58899898|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
30869830|NCT00700817|58899894|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
30869831|NCT00700817|58899895|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
30869832|NCT00700817|58899896|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
30869833|NCT00700817|58899897|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
30869834|NCT00700817|58899898|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
30869835|NCT00700817|58899894|FG000|Week 0-26 (Main Period)|Unclassified|14|||
30869836|NCT00700817|58899895|FG001|Week 0-26 (Main Period)|Unclassified|4|||
30869837|NCT00700817|58899896|FG002|Week 0-26 (Main Period)|Unclassified|8|||
30869838|NCT00700817|58899897|FG003|Week 0-26 (Main Period)|Unclassified|0|||
30869839|NCT00700817|58899898|FG004|Week 0-26 (Main Period)|Unclassified|0|||
30869840|NCT00700817|58899894|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
30869841|NCT00700817|58899895|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
30869842|NCT00700817|58899896|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
30869843|NCT00700817|58899897|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
30869844|NCT00700817|58899898|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
30869845|NCT00700817|58899894|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
30869846|NCT00700817|58899895|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
30869847|NCT00700817|58899896|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
30869848|NCT00700817|58899897|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
30869849|NCT00700817|58899898|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
30869850|NCT00700817|58899894|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
30869851|NCT00700817|58899895|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
30869852|NCT00700817|58899896|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
30869853|NCT00700817|58899897|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
30869854|NCT00700817|58899898|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
30869855|NCT00700817|58899894|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
30869856|NCT00700817|58899895|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
30869857|NCT00700817|58899896|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
30869858|NCT00700817|58899897|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
30869859|NCT00700817|58899898|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
30869860|NCT00700817|58899894|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
30869861|NCT00700817|58899895|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
30869862|NCT00700817|58899896|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
30869863|NCT00700817|58899897|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
30869864|NCT00700817|58899898|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
30869865|NCT00700817|58899894|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
30869866|NCT00700817|58899895|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
30869867|NCT00700817|58899896|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
30869868|NCT00700817|58899897|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
30869869|NCT00700817|58899898|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
30869870|NCT00700817|58899894|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
30869871|NCT00700817|58899895|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
30869872|NCT00700817|58899896|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
30869873|NCT00700817|58899897|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
30869874|NCT00700817|58899898|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
30869875|NCT00700817|58899894|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
30869876|NCT00700817|58899895|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
30869877|NCT00700817|58899896|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
30869878|NCT00700817|58899897|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
30869879|NCT00700817|58899898|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
30869880|NCT00700817|58899894|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
30869881|NCT00700817|58899895|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
30869882|NCT00700817|58899896|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
30869883|NCT00700817|58899897|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
30869884|NCT00700817|58899898|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
30869885|NCT00700817|58899894|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
30869886|NCT00700817|58899895|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
30869887|NCT00700817|58899896|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
30869888|NCT00700817|58899897|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
30869889|NCT00700817|58899898|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
30869890|NCT02625909|58899910|FG000|Overall Study|Death|2|||
30869891|NCT02625909|58899911|FG001|Overall Study|Death|0|||
30869892|NCT02625909|58899910|FG000|Overall Study|Lost to Follow-up|3|||
30869893|NCT02625909|58899911|FG001|Overall Study|Lost to Follow-up|5|||
30869894|NCT02625909|58899910|FG000|Overall Study|Lack of Efficacy|9|||
30869895|NCT02625909|58899911|FG001|Overall Study|Lack of Efficacy|2|||
30869896|NCT02625909|58899910|FG000|Overall Study|Reinfection|3|||
30869897|NCT02625909|58899911|FG001|Overall Study|Reinfection|2|||
30869898|NCT02623959|58899919|FG000|Overall Study|Progression|0|||
30869899|NCT02623959|58899920|FG001|Overall Study|Progression|1|||
30869900|NCT00700739|58899930|FG000|Overall Study|Lost to Follow-up|4|||
30869901|NCT00700739|58899931|FG001|Overall Study|Lost to Follow-up|4|||
30869902|NCT02623335|58899940|FG000|Overall Study|Death|8|||
30869903|NCT02623335|58899941|FG001|Overall Study|Death|7|||
30869904|NCT02623335|58899940|FG000|Overall Study|Lost to Follow-up|15|||
30869905|NCT02623335|58899941|FG001|Overall Study|Lost to Follow-up|23|||
30869906|NCT02623335|58899940|FG000|Overall Study|Withdrawal by Subject|2|||
30869907|NCT02623335|58899941|FG001|Overall Study|Withdrawal by Subject|5|||
30869908|NCT02623335|58899940|FG000|Overall Study|Protocol Violation|2|||
30869909|NCT02623335|58899941|FG001|Overall Study|Protocol Violation|1|||
30869910|NCT00700427|58899951|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
30869911|NCT00700427|58899952|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
30869912|NCT00700427|58899953|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
30869913|NCT00700427|58899954|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
30869914|NCT00700427|58899955|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
30869915|NCT00700427|58899951|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
30869916|NCT00700427|58899952|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
30869917|NCT00700427|58899953|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
30869918|NCT00700427|58899954|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
30869919|NCT00700427|58899955|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
30869920|NCT00700427|58899951|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
30869921|NCT00700427|58899952|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
30869922|NCT00700427|58899953|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
30869923|NCT00700427|58899954|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
30869924|NCT00700427|58899955|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
30869925|NCT00700427|58899951|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
30869926|NCT00700427|58899952|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
30869927|NCT00700427|58899953|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
30869928|NCT00700427|58899954|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
30869929|NCT00700427|58899955|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
30869930|NCT00700427|58899951|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
30869931|NCT00700427|58899952|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
30869932|NCT00700427|58899953|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
30869933|NCT00700427|58899954|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
30869934|NCT00700427|58899955|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
30869935|NCT00700427|58899951|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
30869936|NCT00700427|58899952|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
30869937|NCT00700427|58899953|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
30869938|NCT00700427|58899954|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
30877497|NCT01998958|58909044|FG023|Open Label Phase (Optional)|Other|1|||
30869939|NCT00700427|58899955|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
30869940|NCT00700427|58899951|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
30869941|NCT00700427|58899952|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
30869942|NCT00700427|58899953|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
30869943|NCT00700427|58899954|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
30869944|NCT00700427|58899955|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
30869945|NCT00700427|58899951|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
30869946|NCT00700427|58899952|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
30869947|NCT00700427|58899953|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
30869948|NCT00700427|58899954|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
30869949|NCT00700427|58899955|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
30869950|NCT00700427|58899951|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
30869951|NCT00700427|58899952|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
30869952|NCT00700427|58899953|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
30869953|NCT00700427|58899954|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
30869954|NCT00700427|58899955|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
30869955|NCT00700427|58899951|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
30869956|NCT00700427|58899952|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
30869957|NCT00700427|58899953|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
30869958|NCT00700427|58899954|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
30869959|NCT00700427|58899955|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
30869960|NCT00700427|58899951|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
30869961|NCT00700427|58899952|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
30869962|NCT00700427|58899953|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
30869963|NCT00700427|58899954|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
30869964|NCT00700427|58899955|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
30869965|NCT00700427|58899951|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
30869966|NCT00700427|58899952|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
30869967|NCT00700427|58899953|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
30869968|NCT00700427|58899954|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
30869969|NCT00700427|58899955|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
30869970|NCT00700427|58899951|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
30869971|NCT00700427|58899952|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
30869972|NCT00700427|58899953|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
30869973|NCT00700427|58899954|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
30869974|NCT00700427|58899955|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
30869975|NCT00700427|58899951|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
30869976|NCT00700427|58899952|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
30869977|NCT00700427|58899953|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
30869978|NCT00700427|58899954|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
30869979|NCT00700427|58899955|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
30869980|NCT00700427|58899951|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
30869981|NCT00700427|58899952|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
30869982|NCT00700427|58899953|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
30869983|NCT00700427|58899954|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
30869984|NCT00700427|58899955|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
30869985|NCT00700427|58899951|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
30869986|NCT00700427|58899952|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
30869987|NCT00700427|58899953|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
30869988|NCT00700427|58899954|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
30869989|NCT00700427|58899955|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
30869990|NCT00700427|58899951|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
30869991|NCT00700427|58899952|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
30869992|NCT00700427|58899953|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
30869993|NCT00700427|58899954|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
30869994|NCT00700427|58899955|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
30869995|NCT00700427|58899951|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
30869996|NCT00700427|58899952|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
30869997|NCT00700427|58899953|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
30869998|NCT00700427|58899954|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
30869999|NCT00700427|58899955|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
30870000|NCT00700427|58899951|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
30870001|NCT00700427|58899952|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
30960839|NCT01562275|59026811|FG005|Stage 1|Adverse Event|0|||
30870002|NCT00700427|58899953|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
30870003|NCT00700427|58899954|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
30870004|NCT00700427|58899955|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
30870005|NCT00700427|58899951|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
30870006|NCT00700427|58899952|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
30870007|NCT00700427|58899953|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
30870008|NCT00700427|58899954|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
30870009|NCT00700427|58899955|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
30870010|NCT00700427|58899951|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
30870011|NCT00700427|58899952|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
30870012|NCT00700427|58899953|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
30870013|NCT00700427|58899954|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
30870014|NCT00700427|58899955|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
30870015|NCT00700427|58899951|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
30870016|NCT00700427|58899952|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
30870017|NCT00700427|58899953|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
30870018|NCT00700427|58899954|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
30870019|NCT00700427|58899955|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
30870020|NCT00700427|58899951|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
30870021|NCT00700427|58899952|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
30870022|NCT00700427|58899953|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
30870023|NCT00700427|58899954|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
30870024|NCT00700427|58899955|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
30870025|NCT00700427|58899951|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
30870026|NCT00700427|58899952|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
30870027|NCT00700427|58899953|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
30870028|NCT00700427|58899954|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
30870029|NCT00700427|58899955|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
30870030|NCT00700427|58899951|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
30870031|NCT00700427|58899952|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
30870032|NCT00700427|58899953|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
30870033|NCT00700427|58899954|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
30870034|NCT00700427|58899955|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
30870035|NCT00700427|58899951|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
30870036|NCT00700427|58899952|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
30870037|NCT00700427|58899953|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
30870038|NCT00700427|58899954|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
30870039|NCT00700427|58899955|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
30870040|NCT00700427|58899951|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
30870041|NCT00700427|58899952|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
30870042|NCT00700427|58899953|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
30870043|NCT00700427|58899954|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
30870044|NCT00700427|58899955|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
30870045|NCT00700427|58899951|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
30870046|NCT00700427|58899952|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
30870047|NCT00700427|58899953|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
30870048|NCT00700427|58899954|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
30870049|NCT00700427|58899955|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
30870050|NCT00700427|58899951|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
30870051|NCT00700427|58899952|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
30870052|NCT00700427|58899953|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
30870053|NCT00700427|58899954|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
30870054|NCT00700427|58899955|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
30870055|NCT00700427|58899951|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
30870056|NCT00700427|58899952|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
30870057|NCT00700427|58899953|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
30870058|NCT00700427|58899954|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
30870059|NCT00700427|58899955|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
30870060|NCT00700427|58899951|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
30870061|NCT00700427|58899952|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
30870062|NCT00700427|58899953|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
30870063|NCT00700427|58899954|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
30870064|NCT00700427|58899955|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
30877498|NCT01998958|58909045|FG024|Open Label Phase (Optional)|Other|0|||
30602242|NCT01289028|58613584|FG000|Overall Study|Missing reason for discon|1|||
30870065|NCT00700427|58899951|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
30870066|NCT00700427|58899952|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
30870067|NCT00700427|58899953|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
30870068|NCT00700427|58899954|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
30870069|NCT00700427|58899955|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
30870070|NCT00700427|58899951|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
30870071|NCT00700427|58899952|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
30870072|NCT00700427|58899953|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
30870073|NCT00700427|58899954|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
30870074|NCT00700427|58899955|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
30870075|NCT00700427|58899951|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
30870076|NCT00700427|58899952|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
30870077|NCT00700427|58899953|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
30870078|NCT00700427|58899954|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
30870079|NCT00700427|58899955|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
30870080|NCT00700427|58899951|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
30870081|NCT00700427|58899952|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
30870082|NCT00700427|58899953|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
30870083|NCT00700427|58899954|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
30870084|NCT00700427|58899955|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
30870085|NCT00700427|58899951|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
30870086|NCT00700427|58899952|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
30870087|NCT00700427|58899953|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
30870088|NCT00700427|58899954|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
30870089|NCT00700427|58899955|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
30870090|NCT00700427|58899951|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
30870091|NCT00700427|58899952|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
30870092|NCT00700427|58899953|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
30870093|NCT00700427|58899954|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
30870094|NCT00700427|58899955|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
30870095|NCT00700427|58899951|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
30870096|NCT00700427|58899952|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
30870097|NCT00700427|58899953|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
30870098|NCT00700427|58899954|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
30870099|NCT00700427|58899955|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
30870100|NCT02128763|58899965|FG000|Overall Study|Death|1|||
30870101|NCT02128763|58899966|FG001|Overall Study|Death|0|||
30870102|NCT02128763|58899965|FG000|Overall Study|Lost to Follow-up|19|||
30870103|NCT02128763|58899966|FG001|Overall Study|Lost to Follow-up|16|||
30870104|NCT02124772|58899988|FG000|Overall Study|Lack of Efficacy|2|||
30870105|NCT02124772|58899989|FG001|Overall Study|Lack of Efficacy|0|||
30870106|NCT02124772|58899990|FG002|Overall Study|Lack of Efficacy|0|||
30870107|NCT02124772|58899991|FG003|Overall Study|Lack of Efficacy|1|||
30870108|NCT02124772|58899992|FG004|Overall Study|Lack of Efficacy|2|||
30870109|NCT02124772|58899993|FG005|Overall Study|Lack of Efficacy|3|||
30870110|NCT02124772|58899994|FG006|Overall Study|Lack of Efficacy|0|||
30870111|NCT02124772|58899995|FG007|Overall Study|Lack of Efficacy|2|||
30870112|NCT02124772|58899996|FG008|Overall Study|Lack of Efficacy|0|||
30870113|NCT02124772|58899997|FG009|Overall Study|Lack of Efficacy|1|||
30870114|NCT02124772|58899998|FG010|Overall Study|Lack of Efficacy|0|||
30870115|NCT02124772|58899999|FG011|Overall Study|Lack of Efficacy|0|||
30870116|NCT02124772|58900000|FG012|Overall Study|Lack of Efficacy|1|||
30870117|NCT02124772|58899988|FG000|Overall Study|Adverse Event|1|||
30870118|NCT02124772|58899989|FG001|Overall Study|Adverse Event|4|||
30870119|NCT02124772|58899990|FG002|Overall Study|Adverse Event|1|||
30870120|NCT02124772|58899991|FG003|Overall Study|Adverse Event|5|||
30870121|NCT02124772|58899992|FG004|Overall Study|Adverse Event|2|||
30870122|NCT02124772|58899993|FG005|Overall Study|Adverse Event|1|||
30870123|NCT02124772|58899994|FG006|Overall Study|Adverse Event|1|||
30870124|NCT02124772|58899995|FG007|Overall Study|Adverse Event|5|||
30870125|NCT02124772|58899996|FG008|Overall Study|Adverse Event|0|||
30870126|NCT02124772|58899997|FG009|Overall Study|Adverse Event|3|||
30870127|NCT02124772|58899998|FG010|Overall Study|Adverse Event|1|||
30870128|NCT02124772|58899999|FG011|Overall Study|Adverse Event|3|||
30870129|NCT02124772|58900000|FG012|Overall Study|Adverse Event|1|||
30960840|NCT01562275|59026812|FG006|Stage 1|Adverse Event|0|||
30960841|NCT01562275|59026813|FG007|Stage 1|Adverse Event|0|||
30960842|NCT01562275|59026814|FG008|Stage 1|Adverse Event|0|||
30870130|NCT02124772|58899988|FG000|Overall Study|Withdrawal consent|0|||
30870131|NCT02124772|58899989|FG001|Overall Study|Withdrawal consent|1|||
30960843|NCT01562275|59026815|FG009|Stage 1|Adverse Event|1|||
30960844|NCT01562275|59026816|FG010|Stage 1|Adverse Event|0|||
30960845|NCT01562275|59026817|FG011|Stage 1|Adverse Event|0|||
30870132|NCT02124772|58899990|FG002|Overall Study|Withdrawal consent|1|||
30870133|NCT02124772|58899991|FG003|Overall Study|Withdrawal consent|1|||
30870134|NCT02124772|58899992|FG004|Overall Study|Withdrawal consent|0|||
30870135|NCT02124772|58899993|FG005|Overall Study|Withdrawal consent|1|||
30870136|NCT02124772|58899994|FG006|Overall Study|Withdrawal consent|1|||
30870137|NCT02124772|58899995|FG007|Overall Study|Withdrawal consent|0|||
30870138|NCT02124772|58899996|FG008|Overall Study|Withdrawal consent|0|||
30870139|NCT02124772|58899997|FG009|Overall Study|Withdrawal consent|1|||
30870140|NCT02124772|58899998|FG010|Overall Study|Withdrawal consent|0|||
30870141|NCT02124772|58899999|FG011|Overall Study|Withdrawal consent|1|||
30870142|NCT02124772|58900000|FG012|Overall Study|Withdrawal consent|0|||
30870143|NCT02124772|58899988|FG000|Overall Study|Investigator discretion|0|||
30870144|NCT02124772|58899989|FG001|Overall Study|Investigator discretion|2|||
30870145|NCT02124772|58899990|FG002|Overall Study|Investigator discretion|2|||
30870146|NCT02124772|58899991|FG003|Overall Study|Investigator discretion|1|||
30870147|NCT02124772|58899992|FG004|Overall Study|Investigator discretion|1|||
30870148|NCT02124772|58899993|FG005|Overall Study|Investigator discretion|0|||
30870149|NCT02124772|58899994|FG006|Overall Study|Investigator discretion|1|||
30870150|NCT02124772|58899995|FG007|Overall Study|Investigator discretion|0|||
30870151|NCT02124772|58899996|FG008|Overall Study|Investigator discretion|0|||
30870152|NCT02124772|58899997|FG009|Overall Study|Investigator discretion|1|||
30870153|NCT02124772|58899998|FG010|Overall Study|Investigator discretion|0|||
30870154|NCT02124772|58899999|FG011|Overall Study|Investigator discretion|1|||
30870155|NCT02124772|58900000|FG012|Overall Study|Investigator discretion|0|||
30870156|NCT02124772|58899988|FG000|Overall Study|Progressive disease|0|||
30870157|NCT02124772|58899989|FG001|Overall Study|Progressive disease|0|||
30870158|NCT02124772|58899990|FG002|Overall Study|Progressive disease|0|||
30870159|NCT02124772|58899991|FG003|Overall Study|Progressive disease|0|||
30870160|NCT02124772|58899992|FG004|Overall Study|Progressive disease|0|||
30870161|NCT02124772|58899993|FG005|Overall Study|Progressive disease|0|||
30870162|NCT02124772|58899994|FG006|Overall Study|Progressive disease|1|||
30870163|NCT02124772|58899995|FG007|Overall Study|Progressive disease|1|||
30870164|NCT02124772|58899996|FG008|Overall Study|Progressive disease|0|||
30870165|NCT02124772|58899997|FG009|Overall Study|Progressive disease|0|||
30870166|NCT02124772|58899998|FG010|Overall Study|Progressive disease|0|||
30870167|NCT02124772|58899999|FG011|Overall Study|Progressive disease|0|||
30870168|NCT02124772|58900000|FG012|Overall Study|Progressive disease|0|||
30870169|NCT02124772|58899988|FG000|Overall Study|Other|0|||
30870170|NCT02124772|58899989|FG001|Overall Study|Other|7|||
30870171|NCT02124772|58899990|FG002|Overall Study|Other|2|||
30870172|NCT02124772|58899991|FG003|Overall Study|Other|5|||
30870173|NCT02124772|58899992|FG004|Overall Study|Other|4|||
30870174|NCT02124772|58899993|FG005|Overall Study|Other|3|||
30870175|NCT02124772|58899994|FG006|Overall Study|Other|4|||
30870176|NCT02124772|58899995|FG007|Overall Study|Other|1|||
30870177|NCT02124772|58899996|FG008|Overall Study|Other|1|||
30870178|NCT02124772|58899997|FG009|Overall Study|Other|1|||
30870179|NCT02124772|58899998|FG010|Overall Study|Other|1|||
30870180|NCT02124772|58899999|FG011|Overall Study|Other|1|||
30870181|NCT02124772|58900000|FG012|Overall Study|Other|0|||
30870182|NCT02159482|58900052|FG000|Overall Study|Withdrawal by Subject|2|||
30870183|NCT02159482|58900052|FG000|Overall Study|Physician Decision|3|||
30870184|NCT02622321|58900060|FG000|Overall Study|Withdrawal by Subject|2|||
30870185|NCT02622321|58900061|FG001|Overall Study|Withdrawal by Subject|0|||
30870186|NCT02622321|58900062|FG002|Overall Study|Withdrawal by Subject|0|||
30870187|NCT02622321|58900063|FG003|Overall Study|Withdrawal by Subject|0|||
30870188|NCT02622321|58900060|FG000|Overall Study|Death|0|||
30870189|NCT02622321|58900061|FG001|Overall Study|Death|0|||
30870190|NCT02622321|58900062|FG002|Overall Study|Death|1|||
30870191|NCT02622321|58900063|FG003|Overall Study|Death|0|||
30870192|NCT02622321|58900060|FG000|Overall Study|Physician Decision|1|||
30870193|NCT02622321|58900061|FG001|Overall Study|Physician Decision|0|||
30870194|NCT02622321|58900062|FG002|Overall Study|Physician Decision|0|||
30870195|NCT02622321|58900063|FG003|Overall Study|Physician Decision|0|||
30960846|NCT01562275|59026818|FG012|Stage 1|Adverse Event|0|||
30960847|NCT01562275|59026806|FG000|Stage 1|Death|1|||
30870196|NCT02187172|58900089|FG000|Overall Study|Lost to Follow-up|1|||
30870197|NCT02187172|58900090|FG001|Overall Study|Lost to Follow-up|2|||
30870198|NCT02187172|58900089|FG000|Overall Study|Lack of Efficacy|1|||
30870199|NCT02187172|58900090|FG001|Overall Study|Lack of Efficacy|2|||
30870200|NCT02187172|58900089|FG000|Overall Study|Adverse Event|0|||
30870201|NCT02187172|58900090|FG001|Overall Study|Adverse Event|1|||
30870202|NCT02187172|58900089|FG000|Overall Study|Physician Decision|1|||
30870203|NCT02187172|58900090|FG001|Overall Study|Physician Decision|1|||
30870204|NCT02621931|58900101|FG000|Overall Study|Death|0|||
30870205|NCT02621931|58900102|FG001|Overall Study|Death|1|||
30870206|NCT02621931|58900103|FG002|Overall Study|Death|0|||
30870207|NCT02621931|58900101|FG000|Overall Study|Adverse Event|8|||
30870208|NCT02621931|58900102|FG001|Overall Study|Adverse Event|5|||
30870209|NCT02621931|58900103|FG002|Overall Study|Adverse Event|7|||
30870210|NCT02621931|58900101|FG000|Overall Study|Withdrawal by Subject|12|||
30960848|NCT01562275|59026807|FG001|Stage 1|Death|0|||
30870211|NCT02621931|58900102|FG001|Overall Study|Withdrawal by Subject|10|||
30870212|NCT02621931|58900103|FG002|Overall Study|Withdrawal by Subject|11|||
30870213|NCT02621931|58900101|FG000|Overall Study|Protocol Violation|2|||
30870214|NCT02621931|58900102|FG001|Overall Study|Protocol Violation|2|||
30870215|NCT02621931|58900103|FG002|Overall Study|Protocol Violation|2|||
30870216|NCT02621931|58900101|FG000|Overall Study|Pregnancy|2|||
30870217|NCT02621931|58900102|FG001|Overall Study|Pregnancy|0|||
30870218|NCT02621931|58900103|FG002|Overall Study|Pregnancy|0|||
30870219|NCT02621931|58900101|FG000|Overall Study|Noncompliance to study procedures|0|||
30870220|NCT02621931|58900102|FG001|Overall Study|Noncompliance to study procedures|1|||
30870221|NCT02621931|58900103|FG002|Overall Study|Noncompliance to study procedures|2|||
30870222|NCT02621931|58900101|FG000|Overall Study|Lost to Follow-up|8|||
30870223|NCT02621931|58900102|FG001|Overall Study|Lost to Follow-up|7|||
30870224|NCT02621931|58900103|FG002|Overall Study|Lost to Follow-up|10|||
30870225|NCT02621931|58900101|FG000|Overall Study|Lack of Efficacy|0|||
30870226|NCT02621931|58900102|FG001|Overall Study|Lack of Efficacy|0|||
30870227|NCT02621931|58900103|FG002|Overall Study|Lack of Efficacy|1|||
30870228|NCT02621931|58900101|FG000|Overall Study|Other|1|||
30870229|NCT02621931|58900102|FG001|Overall Study|Other|1|||
30870230|NCT02621931|58900103|FG002|Overall Study|Other|3|||
30870231|NCT02621073|58900115|FG000|Overall Study|Lost to Follow-up|0|||
30870232|NCT02621073|58900116|FG001|Overall Study|Lost to Follow-up|1|||
30870233|NCT02621073|58900115|FG000|Overall Study|Physician Decision|3|||
30870234|NCT02621073|58900116|FG001|Overall Study|Physician Decision|2|||
30870235|NCT02158936|58900124|FG000|Overall Study|Study closed/ terminated|57|||
30870236|NCT02158936|58900125|FG001|Overall Study|Study closed/ terminated|77|||
30870237|NCT02158936|58900124|FG000|Overall Study|Azacitidine tx discontinued|53|||
30870238|NCT02158936|58900125|FG001|Overall Study|Azacitidine tx discontinued|46|||
30870239|NCT02158936|58900124|FG000|Overall Study|Adverse Event|39|||
30870240|NCT02158936|58900125|FG001|Overall Study|Adverse Event|24|||
30870241|NCT02158936|58900124|FG000|Overall Study|Withdrawal by Subject|15|||
30870242|NCT02158936|58900125|FG001|Overall Study|Withdrawal by Subject|16|||
30870243|NCT02158936|58900124|FG000|Overall Study|Physician Decision|15|||
30870244|NCT02158936|58900125|FG001|Overall Study|Physician Decision|13|||
30870245|NCT02158936|58900124|FG000|Overall Study|Lost to Follow-up|0|||
30870246|NCT02158936|58900125|FG001|Overall Study|Lost to Follow-up|1|||
30870247|NCT02158546|58900135|FG000|Overall Study|Physician Decision|0|||
30870248|NCT02158546|58900136|FG001|Overall Study|Physician Decision|1|||
30870249|NCT02158546|58900137|FG002|Overall Study|Physician Decision|0|||
30870250|NCT02158546|58900138|FG003|Overall Study|Physician Decision|0|||
30870251|NCT02158546|58900135|FG000|Overall Study|Non-compliance|0|||
30870252|NCT02158546|58900136|FG001|Overall Study|Non-compliance|1|||
30870253|NCT02158546|58900137|FG002|Overall Study|Non-compliance|0|||
30870254|NCT02158546|58900138|FG003|Overall Study|Non-compliance|1|||
30870255|NCT02158546|58900135|FG000|Overall Study|Failure to meet eligibility criteria|0|||
30870256|NCT02158546|58900136|FG001|Overall Study|Failure to meet eligibility criteria|1|||
30870257|NCT02158546|58900137|FG002|Overall Study|Failure to meet eligibility criteria|0|||
30870258|NCT02158546|58900138|FG003|Overall Study|Failure to meet eligibility criteria|0|||
30870259|NCT02158546|58900135|FG000|Overall Study|Lack of Efficacy|1|||
30870260|NCT02158546|58900136|FG001|Overall Study|Lack of Efficacy|1|||
30870261|NCT02158546|58900137|FG002|Overall Study|Lack of Efficacy|0|||
30870262|NCT02158546|58900138|FG003|Overall Study|Lack of Efficacy|0|||
30870263|NCT02158546|58900135|FG000|Overall Study|Adverse Event|2|||
30870264|NCT02158546|58900136|FG001|Overall Study|Adverse Event|2|||
30870265|NCT02158546|58900137|FG002|Overall Study|Adverse Event|0|||
30870266|NCT02158546|58900138|FG003|Overall Study|Adverse Event|0|||
30870267|NCT02158546|58900135|FG000|Overall Study|Withdrawal by Subject|6|||
30870268|NCT02158546|58900136|FG001|Overall Study|Withdrawal by Subject|2|||
30870269|NCT02158546|58900137|FG002|Overall Study|Withdrawal by Subject|1|||
30870270|NCT02158546|58900138|FG003|Overall Study|Withdrawal by Subject|0|||
30870271|NCT02158546|58900135|FG000|Overall Study|Lost to Follow-up|5|||
30870272|NCT02158546|58900136|FG001|Overall Study|Lost to Follow-up|4|||
30870273|NCT02158546|58900137|FG002|Overall Study|Lost to Follow-up|0|||
30870274|NCT02158546|58900138|FG003|Overall Study|Lost to Follow-up|1|||
30870275|NCT02158546|58900135|FG000|Overall Study|Site Excluded|5|||
30602243|NCT01250925|58613593|FG000|Overall Study|Lost to Follow-up|1|||
30870276|NCT02158546|58900136|FG001|Overall Study|Site Excluded|5|||
30870277|NCT02158546|58900137|FG002|Overall Study|Site Excluded|3|||
30870278|NCT02158546|58900138|FG003|Overall Study|Site Excluded|4|||
30870279|NCT02123446|58900148|FG000|Washout Period (1 Day)|Physician Decision|1|||
30870280|NCT02123446|58900149|FG001|Washout Period (1 Day)|Physician Decision|0|||
30870281|NCT02123134|58900157|FG000|Overall Study|Withdrawal of consent|3|||
30870282|NCT02123134|58900158|FG001|Overall Study|Withdrawal of consent|2|||
30870283|NCT02123134|58900157|FG000|Overall Study|Administrative decision|0|||
30870284|NCT02123134|58900158|FG001|Overall Study|Administrative decision|1|||
30870285|NCT02185534|58900170|FG000|First Period|Withdrawal by Subject|0|||
30870286|NCT02185534|58900171|FG001|First Period|Withdrawal by Subject|0|||
30870287|NCT02185534|58900172|FG002|First Period|Withdrawal by Subject|0|||
30877499|NCT01998958|58909046|FG025|Open Label Phase (Optional)|Other|0|||
30870288|NCT02185534|58900173|FG003|First Period|Withdrawal by Subject|1|||
30870289|NCT02185534|58900174|FG004|First Period|Withdrawal by Subject|0|||
30870290|NCT02185534|58900175|FG005|First Period|Withdrawal by Subject|0|||
30870291|NCT02185534|58900170|FG000|First Washout Period|Withdrawal by Subject|1|||
30870292|NCT02185534|58900171|FG001|First Washout Period|Withdrawal by Subject|0|||
30870293|NCT02185534|58900172|FG002|First Washout Period|Withdrawal by Subject|0|||
30870294|NCT02185534|58900173|FG003|First Washout Period|Withdrawal by Subject|0|||
30870295|NCT02185534|58900174|FG004|First Washout Period|Withdrawal by Subject|1|||
30870296|NCT02185534|58900175|FG005|First Washout Period|Withdrawal by Subject|0|||
30870297|NCT02185534|58900170|FG000|First Washout Period|Protocol Violation|0|||
30870298|NCT02185534|58900171|FG001|First Washout Period|Protocol Violation|0|||
30870299|NCT02185534|58900172|FG002|First Washout Period|Protocol Violation|0|||
30870300|NCT02185534|58900173|FG003|First Washout Period|Protocol Violation|0|||
30870301|NCT02185534|58900174|FG004|First Washout Period|Protocol Violation|0|||
30870302|NCT02185534|58900175|FG005|First Washout Period|Protocol Violation|1|||
30870303|NCT02121808|58900184|FG000|Overall Study|Technical problem|3|||
30870304|NCT02157376|58900195|FG000|Overall Study|Death|10|||
30870305|NCT02157376|58900196|FG001|Overall Study|Death|4|||
30870306|NCT02157376|58900195|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
30870307|NCT02157376|58900196|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
30870308|NCT02157376|58900195|FG000|Overall Study|Withdrawal by Subject|3|||
30870309|NCT02157376|58900196|FG001|Overall Study|Withdrawal by Subject|8|||
30870310|NCT02157376|58900195|FG000|Overall Study|Not treated|8|||
30870311|NCT02157376|58900196|FG001|Overall Study|Not treated|3|||
30870312|NCT02157376|58900195|FG000|Overall Study|Investigator's misjudgement|1|||
30870313|NCT02157376|58900196|FG001|Overall Study|Investigator's misjudgement|2|||
30870314|NCT02157298|58900204|FG000|Overall Study|Adverse Event|1|||
30870315|NCT02157298|58900205|FG001|Overall Study|Adverse Event|0|||
30870316|NCT02157298|58900204|FG000|Overall Study|Subject no longer meets study criteria|1|||
30870317|NCT02157298|58900205|FG001|Overall Study|Subject no longer meets study criteria|2|||
30870318|NCT02157298|58900204|FG000|Overall Study|Poor/Non-compliance|1|||
30870319|NCT02157298|58900205|FG001|Overall Study|Poor/Non-compliance|0|||
30870320|NCT02157298|58900204|FG000|Overall Study|Withdrawal by Subject|1|||
30870321|NCT02157298|58900205|FG001|Overall Study|Withdrawal by Subject|0|||
30870322|NCT02184988|58900211|FG000|Overall Study|Pregnancy|2|||
30870323|NCT02184988|58900211|FG000|Overall Study|Adverse Event|2|||
30870324|NCT02184988|58900211|FG000|Overall Study|moving away/travelling/unable to complet|6|||
30870325|NCT02184988|58900211|FG000|Overall Study|work scheduling issues|4|||
30870326|NCT02184988|58900211|FG000|Overall Study|various other reasons|9|||
30870327|NCT02184988|58900211|FG000|Overall Study|Lost to Follow-up|32|||
30870328|NCT02121262|58900217|FG000|Overall Study|Adverse Event|6|||
30870329|NCT02121262|58900218|FG001|Overall Study|Adverse Event|3|||
30870330|NCT02121262|58900217|FG000|Overall Study|Lack of Efficacy|3|||
30870331|NCT02121262|58900218|FG001|Overall Study|Lack of Efficacy|0|||
30870332|NCT02121262|58900217|FG000|Overall Study|Personal Reasons|19|||
30870333|NCT02121262|58900218|FG001|Overall Study|Personal Reasons|5|||
30870334|NCT02121262|58900217|FG000|Overall Study|Protocol Violation|1|||
30870335|NCT02121262|58900218|FG001|Overall Study|Protocol Violation|1|||
30870336|NCT02121262|58900217|FG000|Overall Study|Participant Dropped-out|0|||
30870337|NCT02121262|58900218|FG001|Overall Study|Participant Dropped-out|1|||
30870338|NCT02121262|58900217|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
30870339|NCT02121262|58900218|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
30870340|NCT02121262|58900217|FG000|Overall Study|Consent Withdrawn|1|||
30870341|NCT02121262|58900218|FG001|Overall Study|Consent Withdrawn|0|||
30870342|NCT02120950|58900226|FG000|Overall Study|Adverse Event|5|||
30870343|NCT02120950|58900227|FG001|Overall Study|Adverse Event|4|||
30870344|NCT02120950|58900228|FG002|Overall Study|Adverse Event|3|||
30870345|NCT02120950|58900226|FG000|Overall Study|Death|3|||
30870346|NCT02120950|58900227|FG001|Overall Study|Death|0|||
30870347|NCT02120950|58900228|FG002|Overall Study|Death|1|||
30870348|NCT02120950|58900226|FG000|Overall Study|Withdrawal by Subject|6|||
30870349|NCT02120950|58900227|FG001|Overall Study|Withdrawal by Subject|3|||
30870350|NCT02120950|58900228|FG002|Overall Study|Withdrawal by Subject|2|||
30870351|NCT02120950|58900226|FG000|Overall Study|Protocol Violation|1|||
30870352|NCT02120950|58900227|FG001|Overall Study|Protocol Violation|1|||
30694600|NCT00544882|58708774|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
30870353|NCT02120950|58900228|FG002|Overall Study|Protocol Violation|7|||
30870354|NCT02120950|58900226|FG000|Overall Study|Other reasons|5|||
30870355|NCT02120950|58900227|FG001|Overall Study|Other reasons|4|||
30870356|NCT02120950|58900228|FG002|Overall Study|Other reasons|1|||
30870357|NCT02120950|58900226|FG000|Overall Study|Lost to Follow-up|0|||
30870358|NCT02120950|58900227|FG001|Overall Study|Lost to Follow-up|2|||
30870359|NCT02120950|58900228|FG002|Overall Study|Lost to Follow-up|1|||
30870360|NCT02120794|58900235|FG000|Overall Study|Withdrawal by Subject|43|||
30870361|NCT02120794|58900235|FG000|Overall Study|Adverse Event|10|||
30870362|NCT02120794|58900235|FG000|Overall Study|Physician Decision|4|||
30870363|NCT02120794|58900235|FG000|Overall Study|Due to insurance coverage|1|||
30870364|NCT02184442|58900241|FG000|Overall Study|Death|61|||
30870365|NCT02184442|58900242|FG001|Overall Study|Death|65|||
30870366|NCT02184442|58900241|FG000|Overall Study|Withdrawal by Subject|3|||
30870367|NCT02184442|58900242|FG001|Overall Study|Withdrawal by Subject|11|||
30870368|NCT02155738|58900252|FG000|Overall Study|Missing critical information|1|||
30870369|NCT02155738|58900253|FG001|Overall Study|Missing critical information|0|||
30870370|NCT02155738|58900254|FG002|Overall Study|Missing critical information|0|||
30870371|NCT02155738|58900255|FG003|Overall Study|Missing critical information|1|||
30870372|NCT02181790|58900267|FG000|Overall Study|study terminated|2|||
30870373|NCT02181790|58900268|FG001|Overall Study|study terminated|0|||
30870374|NCT02618967|58900284|FG000|Overall Study|Lost to Follow-up|0|||
30870375|NCT02618967|58900285|FG001|Overall Study|Lost to Follow-up|0|||
30870376|NCT02618967|58900286|FG002|Overall Study|Lost to Follow-up|1|||
30870377|NCT02618967|58900287|FG003|Overall Study|Lost to Follow-up|0|||
30870378|NCT02618967|58900288|FG004|Overall Study|Lost to Follow-up|2|||
30870379|NCT02618967|58900289|FG005|Overall Study|Lost to Follow-up|0|||
30870380|NCT02618967|58900290|FG006|Overall Study|Lost to Follow-up|0|||
30694601|NCT00544882|58708772|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
30694602|NCT00544882|58708773|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
30694603|NCT00544882|58708774|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
30694604|NCT00544882|58708772|FG000|Cycle 3: Follow-up|Noncompliance|0|||
30870381|NCT02618967|58900291|FG007|Overall Study|Lost to Follow-up|0|||
30870382|NCT02618967|58900284|FG000|Overall Study|Withdrawal by Subject|1|||
30870383|NCT02618967|58900285|FG001|Overall Study|Withdrawal by Subject|0|||
30870384|NCT02618967|58900286|FG002|Overall Study|Withdrawal by Subject|0|||
30870385|NCT02618967|58900287|FG003|Overall Study|Withdrawal by Subject|0|||
30870386|NCT02618967|58900288|FG004|Overall Study|Withdrawal by Subject|0|||
30870387|NCT02618967|58900289|FG005|Overall Study|Withdrawal by Subject|0|||
30870388|NCT02618967|58900290|FG006|Overall Study|Withdrawal by Subject|0|||
30870389|NCT02618967|58900291|FG007|Overall Study|Withdrawal by Subject|0|||
30870390|NCT02616783|58900311|FG000|Overall Study|Randomized but Not Treated|1|||
30870391|NCT02616783|58900312|FG001|Overall Study|Randomized but Not Treated|0|||
30870392|NCT02616783|58900311|FG000|Overall Study|Adverse Event|1|||
30870393|NCT02616783|58900312|FG001|Overall Study|Adverse Event|0|||
30870394|NCT02616783|58900311|FG000|Overall Study|Death|1|||
30870395|NCT02616783|58900312|FG001|Overall Study|Death|0|||
30870396|NCT02616783|58900311|FG000|Overall Study|Non-Compliance with Study Drug|1|||
30870397|NCT02616783|58900312|FG001|Overall Study|Non-Compliance with Study Drug|0|||
30870398|NCT02616783|58900311|FG000|Overall Study|Protocol Violation|1|||
30870399|NCT02616783|58900312|FG001|Overall Study|Protocol Violation|1|||
30870400|NCT02616783|58900311|FG000|Overall Study|Withdrew Consent|1|||
30870401|NCT02616783|58900312|FG001|Overall Study|Withdrew Consent|1|||
30870402|NCT02616393|58900321|FG000|Overall Study|Death|5|||
30870403|NCT02616393|58900322|FG001|Overall Study|Death|12|||
30870404|NCT02616393|58900323|FG002|Overall Study|Death|1|||
30870405|NCT02616393|58900321|FG000|Overall Study|Termination by Sponsor|4|||
30870406|NCT02616393|58900322|FG001|Overall Study|Termination by Sponsor|5|||
30870407|NCT02616393|58900323|FG002|Overall Study|Termination by Sponsor|2|||
30870408|NCT02616393|58900321|FG000|Overall Study|Other|3|||
30870409|NCT02616393|58900322|FG001|Overall Study|Other|0|||
30870410|NCT02616393|58900323|FG002|Overall Study|Other|0|||
30870411|NCT02616393|58900321|FG000|Overall Study|Withdrawal by Subject|1|||
30870412|NCT02616393|58900322|FG001|Overall Study|Withdrawal by Subject|1|||
30870413|NCT02616393|58900323|FG002|Overall Study|Withdrawal by Subject|0|||
30870414|NCT02616393|58900321|FG000|Overall Study|Lost to Follow-up|0|||
30870415|NCT02616393|58900322|FG001|Overall Study|Lost to Follow-up|2|||
30870416|NCT02616393|58900323|FG002|Overall Study|Lost to Follow-up|0|||
30870417|NCT02155660|58900351|FG000|Overall Study|Other Reason|8|||
30870418|NCT02155660|58900352|FG001|Overall Study|Other Reason|6|||
30870419|NCT02155660|58900353|FG002|Overall Study|Other Reason|10|||
30870420|NCT02155660|58900354|FG003|Overall Study|Other Reason|10|||
30870421|NCT02155660|58900351|FG000|Overall Study|Study-specific withdrawal criteria|0|||
30870422|NCT02155660|58900352|FG001|Overall Study|Study-specific withdrawal criteria|1|||
30870423|NCT02155660|58900353|FG002|Overall Study|Study-specific withdrawal criteria|1|||
30870424|NCT02155660|58900354|FG003|Overall Study|Study-specific withdrawal criteria|1|||
30870425|NCT02155660|58900351|FG000|Overall Study|Severe non-compliance|0|||
30870426|NCT02155660|58900352|FG001|Overall Study|Severe non-compliance|4|||
30870427|NCT02155660|58900353|FG002|Overall Study|Severe non-compliance|0|||
30870428|NCT02155660|58900354|FG003|Overall Study|Severe non-compliance|1|||
30870429|NCT02155660|58900351|FG000|Overall Study|Adverse Event|2|||
30870430|NCT02155660|58900352|FG001|Overall Study|Adverse Event|6|||
30870431|NCT02155660|58900353|FG002|Overall Study|Adverse Event|3|||
30870432|NCT02155660|58900354|FG003|Overall Study|Adverse Event|1|||
30870433|NCT02155660|58900351|FG000|Overall Study|Lost to Follow-up|3|||
30870434|NCT02155660|58900352|FG001|Overall Study|Lost to Follow-up|6|||
30870435|NCT02155660|58900353|FG002|Overall Study|Lost to Follow-up|5|||
30870436|NCT02155660|58900354|FG003|Overall Study|Lost to Follow-up|8|||
30870437|NCT02155660|58900351|FG000|Overall Study|Death|17|||
30870438|NCT02155660|58900352|FG001|Overall Study|Death|19|||
30870439|NCT02155660|58900353|FG002|Overall Study|Death|17|||
30870440|NCT02155660|58900354|FG003|Overall Study|Death|19|||
30870441|NCT02155660|58900351|FG000|Overall Study|Withdrawal by Subject|28|||
30870442|NCT02155660|58900352|FG001|Overall Study|Withdrawal by Subject|31|||
30870443|NCT02155660|58900353|FG002|Overall Study|Withdrawal by Subject|24|||
30870444|NCT02155660|58900354|FG003|Overall Study|Withdrawal by Subject|21|||
30870445|NCT02119936|58900364|FG000|Overall Study|Lost to Follow-up|10|||
30870446|NCT02181634|58900368|FG000|Overall Study|Lack of Efficacy|33|||
30870447|NCT02181634|58900368|FG000|Overall Study|Adverse Event|17|||
30870448|NCT02181634|58900368|FG000|Overall Study|Physician Decision|8|||
30870449|NCT02181634|58900368|FG000|Overall Study|Withdrawal by Subject|5|||
30870450|NCT02181634|58900368|FG000|Overall Study|Death|2|||
30870451|NCT02181634|58900368|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
30870452|NCT02181634|58900368|FG000|Overall Study|Ineligible|1|||
30870453|NCT02181634|58900368|FG000|Overall Study|Max number of dose reduction|1|||
30870454|NCT02181634|58900368|FG000|Overall Study|Symptomatic progression|1|||
30870455|NCT02181634|58900368|FG000|Overall Study|Patient opted to proceed to surgery|1|||
30870456|NCT01595529|58900374|FG000|Overall Study|Adverse Event|2|||
30870457|NCT01595529|58900375|FG001|Overall Study|Adverse Event|0|||
30870458|NCT01595529|58900374|FG000|Overall Study|Subject Non-Compliant|2|||
30870459|NCT01595529|58900375|FG001|Overall Study|Subject Non-Compliant|0|||
30870460|NCT01595529|58900374|FG000|Overall Study|Lost to Follow-up|8|||
30870461|NCT01595529|58900375|FG001|Overall Study|Lost to Follow-up|14|||
30870462|NCT01595529|58900374|FG000|Overall Study|Protocol Violation|1|||
30870463|NCT01595529|58900375|FG001|Overall Study|Protocol Violation|2|||
30870464|NCT01595529|58900374|FG000|Overall Study|Physician Decision|1|||
30870465|NCT01595529|58900375|FG001|Overall Study|Physician Decision|0|||
30870466|NCT01595529|58900374|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
30870467|NCT01595529|58900375|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
30870468|NCT01595529|58900374|FG000|Overall Study|Administrative Decision|1|||
30870469|NCT01595529|58900375|FG001|Overall Study|Administrative Decision|0|||
30870470|NCT01595529|58900374|FG000|Overall Study|Entry Failure/Screening Failure|6|||
30870471|NCT01595529|58900375|FG001|Overall Study|Entry Failure/Screening Failure|1|||
30870472|NCT02615145|58900384|FG000|Overall Study|Did Not Start Treatment|0|||
30870473|NCT02615145|58900385|FG001|Overall Study|Did Not Start Treatment|0|||
30870474|NCT02615145|58900386|FG002|Overall Study|Did Not Start Treatment|1|||
30870475|NCT02615145|58900387|FG003|Overall Study|Did Not Start Treatment|1|||
30870476|NCT02615145|58900384|FG000|Overall Study|Failure to Return|20|||
30870477|NCT02615145|58900385|FG001|Overall Study|Failure to Return|10|||
30870478|NCT02615145|58900386|FG002|Overall Study|Failure to Return|7|||
30870479|NCT02615145|58900387|FG003|Overall Study|Failure to Return|0|||
30870480|NCT02615145|58900384|FG000|Overall Study|Death|2|||
30870481|NCT02615145|58900385|FG001|Overall Study|Death|3|||
30870482|NCT02615145|58900386|FG002|Overall Study|Death|0|||
30870483|NCT02615145|58900387|FG003|Overall Study|Death|0|||
30870484|NCT02615145|58900384|FG000|Overall Study|Other, Not Specified|5|||
30870485|NCT02615145|58900385|FG001|Overall Study|Other, Not Specified|2|||
30870486|NCT02615145|58900386|FG002|Overall Study|Other, Not Specified|0|||
30870487|NCT02615145|58900387|FG003|Overall Study|Other, Not Specified|0|||
30870488|NCT02119156|58900416|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
30870489|NCT02119156|58900417|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
30870490|NCT02119156|58900418|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
30870491|NCT02119156|58900416|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
30870492|NCT02119156|58900417|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
30870493|NCT02119156|58900418|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
30870494|NCT02119156|58900416|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
30870495|NCT02119156|58900417|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
30870496|NCT02119156|58900418|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
30870497|NCT02119156|58900416|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
30870498|NCT02119156|58900417|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
30960849|NCT01562275|59026808|FG002|Stage 1|Death|0|||
30870499|NCT02119156|58900418|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
30870500|NCT02119156|58900416|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
30870501|NCT02119156|58900417|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
30870502|NCT02119156|58900418|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
30870503|NCT02181556|58900433|FG000|Overall Study|Withdrawal by Subject|1|||
30870504|NCT02614131|58900444|FG000|Overall Study|Withdrawal by Subject|1|||
30870505|NCT02614131|58900445|FG001|Overall Study|Withdrawal by Subject|0|||
30870506|NCT02614131|58900446|FG002|Overall Study|Withdrawal by Subject|0|||
30870507|NCT02614131|58900447|FG003|Overall Study|Withdrawal by Subject|0|||
30870508|NCT02614131|58900448|FG004|Overall Study|Withdrawal by Subject|0|||
30870509|NCT02614131|58900449|FG005|Overall Study|Withdrawal by Subject|0|||
30870510|NCT02614131|58900450|FG006|Overall Study|Withdrawal by Subject|0|||
30870511|NCT02614131|58900444|FG000|Overall Study|Adverse Event|0|||
30870512|NCT02614131|58900445|FG001|Overall Study|Adverse Event|0|||
30870513|NCT02614131|58900446|FG002|Overall Study|Adverse Event|0|||
30870514|NCT02614131|58900447|FG003|Overall Study|Adverse Event|0|||
30870515|NCT02614131|58900448|FG004|Overall Study|Adverse Event|0|||
30870516|NCT02614131|58900449|FG005|Overall Study|Adverse Event|0|||
30870517|NCT02614131|58900450|FG006|Overall Study|Adverse Event|1|||
30960850|NCT01562275|59026809|FG003|Stage 1|Death|0|||
30960851|NCT01562275|59026810|FG004|Stage 1|Death|0|||
30870518|NCT01903733|58900476|FG000|Overall Study|Death|23|||
30870519|NCT01903733|58900477|FG001|Overall Study|Death|54|||
30870520|NCT01903733|58900478|FG002|Overall Study|Death|30|||
30870521|NCT01903733|58900479|FG003|Overall Study|Death|98|||
30870522|NCT01903733|58900476|FG000|Overall Study|Participant refused further follow-up|35|||
30870523|NCT01903733|58900477|FG001|Overall Study|Participant refused further follow-up|38|||
30870524|NCT01903733|58900478|FG002|Overall Study|Participant refused further follow-up|13|||
30870525|NCT01903733|58900479|FG003|Overall Study|Participant refused further follow-up|9|||
30870526|NCT01903733|58900476|FG000|Overall Study|Lost to Follow-up|18|||
30870527|NCT01903733|58900477|FG001|Overall Study|Lost to Follow-up|19|||
30870528|NCT01903733|58900478|FG002|Overall Study|Lost to Follow-up|6|||
30870529|NCT01903733|58900479|FG003|Overall Study|Lost to Follow-up|9|||
30870530|NCT01903733|58900476|FG000|Overall Study|Other|10|||
30870531|NCT01903733|58900477|FG001|Overall Study|Other|15|||
30870532|NCT01903733|58900478|FG002|Overall Study|Other|12|||
30870533|NCT01903733|58900479|FG003|Overall Study|Other|3|||
30870534|NCT01903733|58900476|FG000|Overall Study|Missing|2|||
30870535|NCT01903733|58900477|FG001|Overall Study|Missing|0|||
30870536|NCT01903733|58900478|FG002|Overall Study|Missing|0|||
30870537|NCT01903733|58900479|FG003|Overall Study|Missing|0|||
30870538|NCT01903733|58900476|FG000|Overall Study|Investigator request|18|||
30870539|NCT01903733|58900477|FG001|Overall Study|Investigator request|0|||
30870540|NCT01903733|58900478|FG002|Overall Study|Investigator request|0|||
30870541|NCT01903733|58900479|FG003|Overall Study|Investigator request|0|||
30870542|NCT01375205|58900501|FG000|Overall Study|Lost to Follow-up|15|||
30870543|NCT01375205|58900502|FG001|Overall Study|Lost to Follow-up|12|||
30870544|NCT01375205|58900501|FG000|Overall Study|Withdrawal by Subject|6|||
30870545|NCT01375205|58900502|FG001|Overall Study|Withdrawal by Subject|1|||
30870546|NCT00700271|58900510|FG000|Overall Study|Adverse Event|4|||
30870547|NCT00700271|58900511|FG001|Overall Study|Adverse Event|6|||
30870548|NCT00700271|58900510|FG000|Overall Study|Protocol Violation|1|||
30870549|NCT00700271|58900511|FG001|Overall Study|Protocol Violation|0|||
30870550|NCT00700271|58900510|FG000|Overall Study|Administrative Reasons|1|||
30870551|NCT00700271|58900511|FG001|Overall Study|Administrative Reasons|0|||
30870552|NCT00700271|58900510|FG000|Overall Study|Withdrawal by Subject|6|||
30870553|NCT00700271|58900511|FG001|Overall Study|Withdrawal by Subject|4|||
30870554|NCT00700271|58900510|FG000|Overall Study|Lost to Follow-up|2|||
30870555|NCT00700271|58900511|FG001|Overall Study|Lost to Follow-up|2|||
30870556|NCT02613507|58900519|FG000|Overall Study|Disease Progression|237|||
30870557|NCT02613507|58900520|FG001|Overall Study|Disease Progression|109|||
30870558|NCT02613507|58900519|FG000|Overall Study|Study Drug Toxicity|15|||
30870559|NCT02613507|58900520|FG001|Overall Study|Study Drug Toxicity|14|||
30870560|NCT02613507|58900519|FG000|Overall Study|Death|3|||
30870561|NCT02613507|58900520|FG001|Overall Study|Death|0|||
30870562|NCT02613507|58900519|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
30870563|NCT02613507|58900520|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
30870564|NCT02613507|58900519|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
30870565|NCT02613507|58900520|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
30870566|NCT02613507|58900519|FG000|Overall Study|Participant Withdrew Consent|0|||
30870567|NCT02613507|58900520|FG001|Overall Study|Participant Withdrew Consent|2|||
30870568|NCT02613507|58900519|FG000|Overall Study|Lost to Follow-up|1|||
30870569|NCT02613507|58900520|FG001|Overall Study|Lost to Follow-up|0|||
30870570|NCT02613507|58900519|FG000|Overall Study|Maximum Clinical Benefit|4|||
30870571|NCT02613507|58900520|FG001|Overall Study|Maximum Clinical Benefit|10|||
30870572|NCT02613507|58900519|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
30870573|NCT02613507|58900520|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
30870574|NCT02613507|58900519|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
30870575|NCT02613507|58900520|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
30870576|NCT02613507|58900519|FG000|Overall Study|Randomized but not Treated|1|||
30870577|NCT02613507|58900520|FG001|Overall Study|Randomized but not Treated|10|||
30870578|NCT01375049|58900526|FG000|Overall Study|Adverse Event|2|||
30870579|NCT01375049|58900526|FG000|Overall Study|Lost to Follow-up|1|||
30870580|NCT01375049|58900526|FG000|Overall Study|Withdrawal by Subject|2|||
30870581|NCT01375049|58900526|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
30870582|NCT01594749|58900536|FG000|Overall Study|Adverse Event|2|||
30870583|NCT01594749|58900537|FG001|Overall Study|Adverse Event|1|||
30870584|NCT01594749|58900536|FG000|Overall Study|Withdrawal by Subject|2|||
30960852|NCT01562275|59026811|FG005|Stage 1|Death|0|||
30870585|NCT01594749|58900537|FG001|Overall Study|Withdrawal by Subject|2|||
30870586|NCT01594749|58900536|FG000|Overall Study|Protocol Violation|2|||
30870587|NCT01594749|58900537|FG001|Overall Study|Protocol Violation|0|||
30870588|NCT01594749|58900536|FG000|Overall Study|Physician Decision|1|||
30870589|NCT01594749|58900537|FG001|Overall Study|Physician Decision|1|||
30870590|NCT01594749|58900536|FG000|Overall Study|Non-compliance with Protocol|0|||
30870591|NCT01594749|58900537|FG001|Overall Study|Non-compliance with Protocol|1|||
30870592|NCT01594749|58900536|FG000|Overall Study|Lost to Follow-up|1|||
30870593|NCT01594749|58900537|FG001|Overall Study|Lost to Follow-up|0|||
30870594|NCT01594749|58900536|FG000|Overall Study|Death|9|||
30870595|NCT01594749|58900537|FG001|Overall Study|Death|3|||
30870596|NCT01594749|58900536|FG000|Overall Study|Not Treated|4|||
30870597|NCT01594749|58900537|FG001|Overall Study|Not Treated|10|||
30870598|NCT01594749|58900536|FG000|Overall Study|Lost Source Documentation|1|||
30870599|NCT01594749|58900537|FG001|Overall Study|Lost Source Documentation|0|||
30870600|NCT02179918|58900548|FG000|Overall Study|Death|0|||
30870601|NCT02179918|58900549|FG001|Overall Study|Death|0|||
30870602|NCT02179918|58900550|FG002|Overall Study|Death|0|||
30870603|NCT02179918|58900551|FG003|Overall Study|Death|1|||
30870604|NCT02179918|58900552|FG004|Overall Study|Death|0|||
30870605|NCT02179918|58900548|FG000|Overall Study|Lost to Follow-up|0|||
30870606|NCT02179918|58900549|FG001|Overall Study|Lost to Follow-up|0|||
30870607|NCT02179918|58900550|FG002|Overall Study|Lost to Follow-up|1|||
30870608|NCT02179918|58900551|FG003|Overall Study|Lost to Follow-up|0|||
30870609|NCT02179918|58900552|FG004|Overall Study|Lost to Follow-up|0|||
30870610|NCT02179918|58900548|FG000|Overall Study|Progressive Disease|4|||
30870611|NCT02179918|58900549|FG001|Overall Study|Progressive Disease|1|||
30870612|NCT02179918|58900550|FG002|Overall Study|Progressive Disease|1|||
30870613|NCT02179918|58900551|FG003|Overall Study|Progressive Disease|2|||
30870614|NCT02179918|58900552|FG004|Overall Study|Progressive Disease|6|||
30870615|NCT02179918|58900548|FG000|Overall Study|Other|0|||
30870616|NCT02179918|58900549|FG001|Overall Study|Other|1|||
30870617|NCT02179918|58900550|FG002|Overall Study|Other|0|||
30870618|NCT02179918|58900551|FG003|Overall Study|Other|0|||
30870619|NCT02179918|58900552|FG004|Overall Study|Other|1|||
30870620|NCT02179918|58900548|FG000|Overall Study|Subject refused further follow-up|0|||
30870621|NCT02179918|58900549|FG001|Overall Study|Subject refused further follow-up|1|||
30870622|NCT02179918|58900550|FG002|Overall Study|Subject refused further follow-up|0|||
30870623|NCT02179918|58900551|FG003|Overall Study|Subject refused further follow-up|0|||
30870624|NCT02179918|58900552|FG004|Overall Study|Subject refused further follow-up|1|||
30870625|NCT02611479|58900565|FG000|Baseline Enrollment|Exited study|13|||
30870626|NCT02611479|58900565|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
30870627|NCT02611479|58900565|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
30870628|NCT02611479|58900565|FG000|Data Cleaning|No baseline function or pain metrics|2|||
30870629|NCT02153788|58900571|FG000|Overall Study|Physician Decision|2|||
30870630|NCT02153788|58900572|FG001|Overall Study|Physician Decision|1|||
30870631|NCT02153398|58900583|FG000|Overall Study|Withdrawal by Subject|1|||
30870632|NCT02153398|58900584|FG001|Overall Study|Withdrawal by Subject|0|||
30870633|NCT02153398|58900585|FG002|Overall Study|Withdrawal by Subject|0|||
30870634|NCT02153398|58900586|FG003|Overall Study|Withdrawal by Subject|0|||
30870635|NCT02153398|58900587|FG004|Overall Study|Withdrawal by Subject|0|||
30870636|NCT02153398|58900583|FG000|Overall Study|Adverse Event|0|||
30870637|NCT02153398|58900584|FG001|Overall Study|Adverse Event|0|||
30870638|NCT02153398|58900585|FG002|Overall Study|Adverse Event|1|||
30870639|NCT02153398|58900586|FG003|Overall Study|Adverse Event|1|||
30870640|NCT02153398|58900587|FG004|Overall Study|Adverse Event|0|||
30870641|NCT02118766|58900601|FG000|Overall Study|Adverse Event|7|||
30870642|NCT02118766|58900602|FG001|Overall Study|Adverse Event|2|||
30870643|NCT02118766|58900601|FG000|Overall Study|Withdrawal by Subject|3|||
30870644|NCT02118766|58900602|FG001|Overall Study|Withdrawal by Subject|6|||
30870645|NCT02118766|58900601|FG000|Overall Study|Lost to Follow-up|5|||
30870646|NCT02118766|58900602|FG001|Overall Study|Lost to Follow-up|4|||
30870647|NCT02118766|58900601|FG000|Overall Study|Withdrawal by parent/guardian|12|||
30870648|NCT02118766|58900602|FG001|Overall Study|Withdrawal by parent/guardian|18|||
30870649|NCT02118766|58900601|FG000|Overall Study|Other|3|||
30870650|NCT02118766|58900602|FG001|Overall Study|Other|1|||
30870651|NCT02614287|58900610|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
30870652|NCT02614287|58900611|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
30870653|NCT02614287|58900610|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
30870654|NCT02614287|58900611|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
30870655|NCT02614287|58900610|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
30870656|NCT02614287|58900611|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
30870657|NCT02614287|58900610|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
30870658|NCT02614287|58900611|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
30870659|NCT02614287|58900610|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
30870660|NCT02614287|58900611|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
30870661|NCT02614287|58900610|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
30870662|NCT02614287|58900611|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
30870663|NCT02614287|58900610|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
30870664|NCT02614287|58900611|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
30870665|NCT02614287|58900610|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
30870666|NCT02614287|58900611|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
30870667|NCT01374971|58900622|FG000|Overall Study|Withdrawal by Subject|1|||
30870668|NCT02178592|58900628|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
30870669|NCT02178592|58900629|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
30870670|NCT02178592|58900628|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
30870671|NCT02178592|58900629|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
30870672|NCT02178592|58900628|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
30870673|NCT02178592|58900629|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
30870674|NCT02178592|58900628|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
30870675|NCT02178592|58900629|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
30870676|NCT02178592|58900628|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
30870677|NCT02178592|58900629|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
30870678|NCT02178592|58900628|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
30870679|NCT02178592|58900629|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
30870680|NCT02178592|58900628|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
30870681|NCT02178592|58900629|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
30870682|NCT02178592|58900628|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
30870683|NCT02178592|58900629|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
30870684|NCT02178592|58900628|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
30870685|NCT02178592|58900629|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
30870686|NCT02178592|58900628|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
30870687|NCT02178592|58900629|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
30870688|NCT02178592|58900628|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
30870689|NCT02178592|58900629|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
30870690|NCT02178592|58900628|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
30870691|NCT02178592|58900629|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
30870692|NCT02610777|58900640|FG000|Overall Study|Lost to Follow-up|1|||
30870693|NCT02610777|58900641|FG001|Overall Study|Lost to Follow-up|0|||
30870694|NCT02610777|58900640|FG000|Overall Study|Site Terminated by Sponsor|9|||
30870695|NCT02610777|58900641|FG001|Overall Study|Site Terminated by Sponsor|8|||
30870696|NCT02610777|58900640|FG000|Overall Study|Withdrawal by Subject|2|||
30870697|NCT02610777|58900641|FG001|Overall Study|Withdrawal by Subject|2|||
30870698|NCT02610777|58900640|FG000|Overall Study|Reason not Specified|0|||
30870699|NCT02610777|58900641|FG001|Overall Study|Reason not Specified|1|||
30870700|NCT02610777|58900640|FG000|Overall Study|Death|50|||
30870701|NCT02610777|58900641|FG001|Overall Study|Death|47|||
30870702|NCT01628692|58900655|FG000|Overall Study|Lack of Efficacy|4|||
30870703|NCT01628692|58900656|FG001|Overall Study|Lack of Efficacy|4|||
30870704|NCT01628692|58900657|FG002|Overall Study|Lack of Efficacy|5|||
30870705|NCT01628692|58900658|FG003|Overall Study|Lack of Efficacy|1|||
30870706|NCT01628692|58900659|FG004|Overall Study|Lack of Efficacy|4|||
30870707|NCT01628692|58900660|FG005|Overall Study|Lack of Efficacy|7|||
30870708|NCT01628692|58900655|FG000|Overall Study|Adverse Event|2|||
30870709|NCT01628692|58900656|FG001|Overall Study|Adverse Event|0|||
30870710|NCT01628692|58900657|FG002|Overall Study|Adverse Event|2|||
30870711|NCT01628692|58900658|FG003|Overall Study|Adverse Event|0|||
30870712|NCT01628692|58900659|FG004|Overall Study|Adverse Event|0|||
30870713|NCT01628692|58900660|FG005|Overall Study|Adverse Event|0|||
30870714|NCT01628692|58900655|FG000|Overall Study|Withdrawal by Subject|0|||
30870715|NCT01628692|58900656|FG001|Overall Study|Withdrawal by Subject|1|||
30870716|NCT01628692|58900657|FG002|Overall Study|Withdrawal by Subject|1|||
30870717|NCT01628692|58900658|FG003|Overall Study|Withdrawal by Subject|0|||
30870718|NCT01628692|58900659|FG004|Overall Study|Withdrawal by Subject|0|||
30870719|NCT01628692|58900660|FG005|Overall Study|Withdrawal by Subject|0|||
30870720|NCT01628692|58900655|FG000|Overall Study|Death|0|||
30870721|NCT01628692|58900656|FG001|Overall Study|Death|1|||
30870722|NCT01628692|58900657|FG002|Overall Study|Death|0|||
30870723|NCT01628692|58900658|FG003|Overall Study|Death|0|||
30870724|NCT01628692|58900659|FG004|Overall Study|Death|0|||
30870725|NCT01628692|58900660|FG005|Overall Study|Death|0|||
30870726|NCT01628692|58900655|FG000|Overall Study|Poor compliance/noncompliance|1|||
30870727|NCT01628692|58900656|FG001|Overall Study|Poor compliance/noncompliance|0|||
30870728|NCT01628692|58900657|FG002|Overall Study|Poor compliance/noncompliance|0|||
30870729|NCT01628692|58900658|FG003|Overall Study|Poor compliance/noncompliance|0|||
30870730|NCT01628692|58900659|FG004|Overall Study|Poor compliance/noncompliance|0|||
30870731|NCT01628692|58900660|FG005|Overall Study|Poor compliance/noncompliance|0|||
30870732|NCT01628692|58900655|FG000|Overall Study|Administrative reason by sponsor|0|||
30870733|NCT01628692|58900656|FG001|Overall Study|Administrative reason by sponsor|0|||
30870734|NCT01628692|58900657|FG002|Overall Study|Administrative reason by sponsor|0|||
30870735|NCT01628692|58900658|FG003|Overall Study|Administrative reason by sponsor|0|||
30870736|NCT01628692|58900659|FG004|Overall Study|Administrative reason by sponsor|0|||
30870737|NCT01628692|58900660|FG005|Overall Study|Administrative reason by sponsor|1|||
30870738|NCT01628692|58900655|FG000|Overall Study|Completed 12 Week only|0|||
30870739|NCT01628692|58900656|FG001|Overall Study|Completed 12 Week only|0|||
30870740|NCT01628692|58900657|FG002|Overall Study|Completed 12 Week only|0|||
30870741|NCT01628692|58900658|FG003|Overall Study|Completed 12 Week only|0|||
30870742|NCT01628692|58900659|FG004|Overall Study|Completed 12 Week only|0|||
30870743|NCT01628692|58900660|FG005|Overall Study|Completed 12 Week only|1|||
30870744|NCT02612727|58900679|FG000|Overall Study|Parent request|4|||
30870745|NCT02612727|58900680|FG001|Overall Study|Parent request|1|||
30870746|NCT02612727|58900679|FG000|Overall Study|Needed treatment incompatible with PT|1|||
30870747|NCT02612727|58900680|FG001|Overall Study|Needed treatment incompatible with PT|1|||
30870748|NCT02612727|58900679|FG000|Overall Study|Direct hyperbilirubinemia|0|||
30870749|NCT02612727|58900680|FG001|Overall Study|Direct hyperbilirubinemia|2|||
30870750|NCT01594827|58900688|FG000|Overall Study|Adverse Event|1|||
30870751|NCT01594827|58900689|FG001|Overall Study|Adverse Event|0|||
30870752|NCT01594827|58900688|FG000|Overall Study|Physician Decision|3|||
30870753|NCT01594827|58900689|FG001|Overall Study|Physician Decision|0|||
30870754|NCT02610231|58900697|FG000|Overall Study|Withdrawal by Subject|27|||
30870755|NCT02610231|58900697|FG000|Overall Study|Adverse Event|20|||
30870756|NCT02610231|58900697|FG000|Overall Study|Death|5|||
30870757|NCT02610231|58900697|FG000|Overall Study|Surgery|2|||
30870758|NCT02610231|58900697|FG000|Overall Study|Physician Decision|1|||
30870759|NCT02610231|58900697|FG000|Overall Study|Non Compliance|2|||
30870760|NCT02610231|58900697|FG000|Overall Study|Other|3|||
30870761|NCT02178358|58900707|FG000|Overall Study|Withdrawal by Subject|0|||
30870762|NCT02178358|58900708|FG001|Overall Study|Withdrawal by Subject|2|||
30870763|NCT02178358|58900709|FG002|Overall Study|Withdrawal by Subject|2|||
30870764|NCT02178358|58900707|FG000|Overall Study|Lost to Follow-up|1|||
30870765|NCT02178358|58900708|FG001|Overall Study|Lost to Follow-up|0|||
30870766|NCT02178358|58900709|FG002|Overall Study|Lost to Follow-up|0|||
30870767|NCT01598896|58900720|FG000|Overall Study|Withdrawal by Subject|0|||
30870768|NCT01598896|58900721|FG001|Overall Study|Withdrawal by Subject|1|||
30870769|NCT01598896|58900720|FG000|Overall Study|Lack of Efficacy|0|||
30870770|NCT01598896|58900721|FG001|Overall Study|Lack of Efficacy|1|||
30870771|NCT01598662|58900729|FG000|Overall Study|Lost to Follow-up|10|||
30870772|NCT01598662|58900730|FG001|Overall Study|Lost to Follow-up|17|||
30870773|NCT01598662|58900729|FG000|Overall Study|Physician Decision|1|||
30870774|NCT01598662|58900730|FG001|Overall Study|Physician Decision|2|||
30870775|NCT01598662|58900729|FG000|Overall Study|IUD expelled before month 6|0|||
30870776|NCT01598662|58900730|FG001|Overall Study|IUD expelled before month 6|2|||
30870777|NCT01629706|58900736|FG000|Phase 1 PureVision|Screen Failure|4|||
30870778|NCT01629706|58900736|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
30870779|NCT01629706|58900736|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
30870780|NCT01629706|58900736|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
30870781|NCT01629706|58900736|FG000|Phase 2 Habitual|Screen Failure|6|||
30870782|NCT01629706|58900736|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
30870783|NCT01629706|58900736|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
30870784|NCT01629706|58900736|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
30870785|NCT01629706|58900736|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
30870786|NCT02153086|58900744|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
30870787|NCT02153086|58900744|FG000|Overall Study|Other|2|||
30870788|NCT02117050|58900748|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
30870789|NCT02728895|58900755|FG000|Overall Study|Other|1|||
30870790|NCT02728895|58900756|FG001|Overall Study|Other|2|||
30870791|NCT02728895|58900755|FG000|Overall Study|Withdrawal by Subject|0|||
30870792|NCT02728895|58900756|FG001|Overall Study|Withdrawal by Subject|3|||
30870793|NCT02606877|58900764|FG000|Overall Study|Adverse Event|3|||
30870794|NCT02606877|58900765|FG001|Overall Study|Adverse Event|0|||
30870795|NCT02606877|58900764|FG000|Overall Study|Non-compliance with protocol|0|||
30870796|NCT02606877|58900765|FG001|Overall Study|Non-compliance with protocol|1|||
30870797|NCT02606877|58900764|FG000|Overall Study|Other than listed above|1|||
30870798|NCT02606877|58900765|FG001|Overall Study|Other than listed above|0|||
30870799|NCT02606643|58900775|FG000|Overall Study|did not meet inclusion criteria|1|||
30870800|NCT02606643|58900776|FG001|Overall Study|did not meet inclusion criteria|3|||
30870801|NCT02609607|58900807|FG000|Overall Study|Lost to Follow-up|0|||
30870802|NCT02609607|58900808|FG001|Overall Study|Lost to Follow-up|1|||
30870803|NCT02606253|58900817|FG000|Overall Study|Adverse Event|2|||
30870804|NCT02606253|58900818|FG001|Overall Study|Adverse Event|0|||
30870805|NCT02606253|58900819|FG002|Overall Study|Adverse Event|0|||
30870806|NCT02606253|58900817|FG000|Overall Study|Protocol Violation|2|||
30870807|NCT02606253|58900818|FG001|Overall Study|Protocol Violation|1|||
30870808|NCT02606253|58900819|FG002|Overall Study|Protocol Violation|0|||
30870809|NCT02606253|58900817|FG000|Overall Study|Physician Decision|1|||
30870810|NCT02606253|58900818|FG001|Overall Study|Physician Decision|1|||
30870811|NCT02606253|58900819|FG002|Overall Study|Physician Decision|0|||
30870812|NCT02607735|58900829|FG000|Primary Study|Randomized but Never Treated|1|||
30870813|NCT02607735|58900830|FG001|Primary Study|Randomized but Never Treated|0|||
30870814|NCT02607735|58900831|FG002|Primary Study|Randomized but Never Treated|0|||
30870815|NCT02607735|58900829|FG000|Primary Study|Lost to Follow-up|4|||
30870816|NCT02607735|58900830|FG001|Primary Study|Lost to Follow-up|0|||
30870817|NCT02607735|58900831|FG002|Primary Study|Lost to Follow-up|0|||
30870818|NCT02607735|58900829|FG000|Primary Study|Withdrew Consent|2|||
30870819|NCT02607735|58900830|FG001|Primary Study|Withdrew Consent|0|||
30870820|NCT02607735|58900831|FG002|Primary Study|Withdrew Consent|0|||
30870821|NCT02607735|58900829|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
30870822|NCT02607735|58900830|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
30870823|NCT02607735|58900831|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
30870824|NCT02607735|58900829|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
30870825|NCT02607735|58900830|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
30870826|NCT02607735|58900831|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
30870827|NCT01668537|58900841|FG000|Overall Study|Request to Discontinue Prematurely|1|||
30870828|NCT01668537|58900842|FG001|Overall Study|Request to Discontinue Prematurely|1|||
30870829|NCT01668537|58900841|FG000|Overall Study|Subject unwilling/unable to comply|5|||
30870830|NCT01668537|58900842|FG001|Overall Study|Subject unwilling/unable to comply|0|||
30870831|NCT01668537|58900841|FG000|Overall Study|Reason Precludes Participation|1|||
30870832|NCT01668537|58900842|FG001|Overall Study|Reason Precludes Participation|0|||
30870833|NCT01668537|58900841|FG000|Overall Study|Lost to Follow-up|13|||
30870834|NCT01668537|58900842|FG001|Overall Study|Lost to Follow-up|6|||
30870835|NCT01668537|58900841|FG000|Overall Study|Other|2|||
30870836|NCT01668537|58900842|FG001|Overall Study|Other|3|||
30870837|NCT01668147|58900848|FG000|Overall Study|Withdrawal by Subject|6|||
30870838|NCT02600559|58900865|FG000|Overall Study|Withdrawal by Subject|3|||
30870839|NCT02600559|58900865|FG000|Overall Study|Lost to Follow-up|20|||
30870840|NCT02601573|58900874|FG000|Overall Study|Lost to Follow-up|0|||
30870841|NCT02601573|58900875|FG001|Overall Study|Lost to Follow-up|3|||
30870842|NCT02601573|58900876|FG002|Overall Study|Lost to Follow-up|1|||
30870843|NCT02601573|58900877|FG003|Overall Study|Lost to Follow-up|0|||
30870844|NCT02601573|58900878|FG004|Overall Study|Lost to Follow-up|2|||
30870845|NCT02601573|58900874|FG000|Overall Study|Withdrawal by Subject|0|||
30870846|NCT02601573|58900875|FG001|Overall Study|Withdrawal by Subject|1|||
30870847|NCT02601573|58900876|FG002|Overall Study|Withdrawal by Subject|0|||
30870848|NCT02601573|58900877|FG003|Overall Study|Withdrawal by Subject|1|||
30870849|NCT02601573|58900878|FG004|Overall Study|Withdrawal by Subject|0|||
30870850|NCT02601027|58900892|FG000|Registration to Surgery|Withdrawal by Subject|20|||
30870851|NCT02601027|58900893|FG001|Registration to Surgery|Withdrawal by Subject|10|||
30870852|NCT02600871|58900901|FG000|Overall Study|Lost to Follow-up|13|||
30870853|NCT02600871|58900902|FG001|Overall Study|Lost to Follow-up|10|||
30870854|NCT02598297|58900911|FG000|Overall Study|Study terminated by Sponsor|21|||
30870855|NCT02598297|58900912|FG001|Overall Study|Study terminated by Sponsor|23|||
30870856|NCT02598297|58900911|FG000|Overall Study|Adverse Event|1|||
30870857|NCT02598297|58900912|FG001|Overall Study|Adverse Event|1|||
30870858|NCT02598297|58900911|FG000|Overall Study|Physician Decision|1|||
30870859|NCT02598297|58900912|FG001|Overall Study|Physician Decision|0|||
30870860|NCT02598297|58900911|FG000|Overall Study|Subject/guardian decision|1|||
30870861|NCT02598297|58900912|FG001|Overall Study|Subject/guardian decision|0|||
30870862|NCT02598297|58900911|FG000|Overall Study|Followed for survival|1|||
30870863|NCT02598297|58900912|FG001|Overall Study|Followed for survival|0|||
30870864|NCT02596893|58900922|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
30870865|NCT02596893|58900923|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
30870866|NCT02596893|58900924|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
30870867|NCT02596893|58900925|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
30870868|NCT02596893|58900922|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
30870869|NCT02596893|58900923|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
30870870|NCT02596893|58900924|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
30870871|NCT02596893|58900925|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
30870872|NCT02596893|58900922|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
30870873|NCT02596893|58900923|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
30870874|NCT02596893|58900924|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
30870875|NCT02596893|58900925|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
30870876|NCT02596893|58900922|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
30870877|NCT02596893|58900923|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
30870878|NCT02596893|58900924|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
30870879|NCT02596893|58900925|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
30870880|NCT02596893|58900922|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
30870881|NCT02596893|58900923|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
30870882|NCT02596893|58900924|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
30870883|NCT02596893|58900925|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
30870884|NCT02596893|58900922|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
30870885|NCT02596893|58900923|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
30870886|NCT02596893|58900924|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
30870887|NCT02596893|58900925|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
30870888|NCT02596893|58900922|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
30870889|NCT02596893|58900923|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
30870890|NCT02596893|58900924|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
30870891|NCT02596893|58900925|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
30870892|NCT02596893|58900922|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
30870893|NCT02596893|58900923|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
30870894|NCT02596893|58900924|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
30870895|NCT02596893|58900925|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
30870896|NCT02596893|58900922|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
30870897|NCT02596893|58900923|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
30870898|NCT02596893|58900924|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
30870899|NCT02596893|58900925|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
30870900|NCT02596893|58900922|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
30870901|NCT02596893|58900923|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
30870902|NCT02596893|58900924|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
30870903|NCT02596893|58900925|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
30870904|NCT02596893|58900922|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
30870905|NCT02596893|58900923|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
30870906|NCT02596893|58900924|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
30870907|NCT02596893|58900925|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
30870908|NCT02592447|58900941|FG000|Overall Study|Lost to Follow-up|1|||
30870909|NCT02592447|58900942|FG001|Overall Study|Lost to Follow-up|0|||
30870910|NCT02592447|58900941|FG000|Overall Study|Ineligible after randomization|1|||
30870911|NCT02592447|58900942|FG001|Overall Study|Ineligible after randomization|0|||
30870912|NCT02592447|58900941|FG000|Overall Study|Withdrawal by Subject|0|||
30870913|NCT02592447|58900942|FG001|Overall Study|Withdrawal by Subject|1|||
30870914|NCT02595723|58900951|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
30870915|NCT02595723|58900952|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
30870916|NCT02595723|58900953|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
30870917|NCT02595723|58900951|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
30870918|NCT02595723|58900952|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
30870919|NCT02595723|58900953|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
30870920|NCT01667679|58900963|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
30870921|NCT01667679|58900964|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
30870922|NCT01667679|58900963|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
30870923|NCT01667679|58900964|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
30870924|NCT01667679|58900963|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
30870925|NCT01667679|58900964|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
30870926|NCT01667679|58900963|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
30870927|NCT01667679|58900964|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
30870928|NCT01667679|58900963|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
30870929|NCT01667679|58900964|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
30870930|NCT01667679|58900963|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
30870931|NCT01667679|58900964|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
30870932|NCT01667679|58900963|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
30870933|NCT01667679|58900964|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
30870934|NCT01667679|58900963|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
30870935|NCT01667679|58900964|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
30870936|NCT01667679|58900963|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
30870937|NCT01667679|58900964|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
30870938|NCT01667679|58900963|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
30870939|NCT01667679|58900964|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
30870940|NCT01667679|58900963|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
30870941|NCT01667679|58900964|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
30870942|NCT01667679|58900963|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
30870943|NCT01667679|58900964|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
30870944|NCT01667679|58900963|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
30870945|NCT01667679|58900964|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
30870946|NCT01667679|58900963|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
30870947|NCT01667679|58900964|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
30870948|NCT01667679|58900963|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
30960853|NCT01562275|59026812|FG006|Stage 1|Death|0|||
30870949|NCT01667679|58900964|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
30870950|NCT01667679|58900963|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
30870951|NCT01667679|58900964|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
30870952|NCT01667679|58900963|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
30870953|NCT01667679|58900964|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
30870954|NCT01667679|58900963|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
30870955|NCT01667679|58900964|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
30870956|NCT01667679|58900963|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
30870957|NCT01667679|58900964|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
30870958|NCT01667679|58900963|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
30870959|NCT01667679|58900964|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
30870960|NCT01667679|58900963|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
30870961|NCT01667679|58900964|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
30870962|NCT02597049|58900975|FG000|Overall Study|Lost to Follow-up|0|||
30870963|NCT02597049|58900976|FG001|Overall Study|Lost to Follow-up|3|||
30870964|NCT02597049|58900977|FG002|Overall Study|Lost to Follow-up|2|||
30870965|NCT02597049|58900975|FG000|Overall Study|Withdrawal by Subject|2|||
30870966|NCT02597049|58900976|FG001|Overall Study|Withdrawal by Subject|2|||
30870967|NCT02597049|58900977|FG002|Overall Study|Withdrawal by Subject|1|||
30870968|NCT02597049|58900975|FG000|Overall Study|Adverse Event|2|||
30870969|NCT02597049|58900976|FG001|Overall Study|Adverse Event|0|||
30870970|NCT02597049|58900977|FG002|Overall Study|Adverse Event|0|||
30870971|NCT02597049|58900975|FG000|Overall Study|Death|2|||
30870972|NCT02597049|58900976|FG001|Overall Study|Death|0|||
30870973|NCT02597049|58900977|FG002|Overall Study|Death|0|||
30870974|NCT02597049|58900975|FG000|Overall Study|Noncompliant with Study Visits|1|||
30870975|NCT02597049|58900976|FG001|Overall Study|Noncompliant with Study Visits|0|||
30870976|NCT02597049|58900977|FG002|Overall Study|Noncompliant with Study Visits|0|||
30870977|NCT02594163|58900987|FG000|Treatment Period|Progressive disease|2|||
30870978|NCT02594163|58900988|FG001|Treatment Period|Progressive disease|3|||
30870979|NCT02594163|58900987|FG000|Treatment Period|Adverse Event|1|||
30870980|NCT02594163|58900988|FG001|Treatment Period|Adverse Event|5|||
30870981|NCT02594163|58900987|FG000|Treatment Period|Physician Decision|1|||
30870982|NCT02594163|58900988|FG001|Treatment Period|Physician Decision|3|||
30870983|NCT02594163|58900987|FG000|Treatment Period|Study termination by sponsor|2|||
30870984|NCT02594163|58900988|FG001|Treatment Period|Study termination by sponsor|1|||
30870985|NCT02594163|58900987|FG000|Treatment Period|Other, Non-AE|1|||
30870986|NCT02594163|58900988|FG001|Treatment Period|Other, Non-AE|0|||
30870987|NCT02594163|58900987|FG000|Follow-up Period|Withdrawal by Subject|0|||
30870988|NCT02594163|58900988|FG001|Follow-up Period|Withdrawal by Subject|1|||
30870989|NCT02594163|58900987|FG000|Follow-up Period|Study Termination by Sponsor|6|||
30870990|NCT02594163|58900988|FG001|Follow-up Period|Study Termination by Sponsor|4|||
30870991|NCT02594163|58900987|FG000|Follow-up Period|Lost to Follow-up|1|||
30870992|NCT02594163|58900988|FG001|Follow-up Period|Lost to Follow-up|0|||
30870993|NCT02594163|58900987|FG000|Follow-up Period|Death|2|||
30870994|NCT02594163|58900988|FG001|Follow-up Period|Death|5|||
30870995|NCT02594163|58900987|FG000|Follow-up Period|Adverse Event|0|||
30870996|NCT02594163|58900988|FG001|Follow-up Period|Adverse Event|1|||
30870997|NCT02594163|58900987|FG000|Follow-up Period|Progressive Disease|2|||
30870998|NCT02594163|58900988|FG001|Follow-up Period|Progressive Disease|0|||
30870999|NCT02594163|58900987|FG000|Follow-up Period|Physician Decision|0|||
30871000|NCT02594163|58900988|FG001|Follow-up Period|Physician Decision|1|||
30871001|NCT02712983|58901003|FG000|Treatment Phase|Adverse Event|3|||
30871002|NCT02712983|58901004|FG001|Treatment Phase|Adverse Event|1|||
30871003|NCT02712983|58901005|FG002|Treatment Phase|Adverse Event|1|||
30871004|NCT02712983|58901006|FG003|Treatment Phase|Adverse Event|4|||
30871005|NCT02712983|58901007|FG004|Treatment Phase|Adverse Event|3|||
30871006|NCT02712983|58901008|FG005|Treatment Phase|Adverse Event|0|||
30871007|NCT02712983|58901009|FG006|Treatment Phase|Adverse Event|6|||
30871008|NCT02712983|58901010|FG007|Treatment Phase|Adverse Event|6|||
30871009|NCT02712983|58901011|FG008|Treatment Phase|Adverse Event|1|||
30871010|NCT02712983|58901003|FG000|Treatment Phase|Protocol Deviation|0|||
30871011|NCT02712983|58901004|FG001|Treatment Phase|Protocol Deviation|0|||
30871012|NCT02712983|58901005|FG002|Treatment Phase|Protocol Deviation|0|||
30871013|NCT02712983|58901006|FG003|Treatment Phase|Protocol Deviation|2|||
30871014|NCT02712983|58901007|FG004|Treatment Phase|Protocol Deviation|0|||
30871015|NCT02712983|58901008|FG005|Treatment Phase|Protocol Deviation|0|||
30871016|NCT02712983|58901009|FG006|Treatment Phase|Protocol Deviation|1|||
30871017|NCT02712983|58901010|FG007|Treatment Phase|Protocol Deviation|0|||
30871018|NCT02712983|58901011|FG008|Treatment Phase|Protocol Deviation|0|||
30871019|NCT02712983|58901003|FG000|Treatment Phase|Technical Problems|0|||
30871020|NCT02712983|58901004|FG001|Treatment Phase|Technical Problems|0|||
30871021|NCT02712983|58901005|FG002|Treatment Phase|Technical Problems|0|||
30871022|NCT02712983|58901006|FG003|Treatment Phase|Technical Problems|0|||
30871023|NCT02712983|58901007|FG004|Treatment Phase|Technical Problems|0|||
30871024|NCT02712983|58901008|FG005|Treatment Phase|Technical Problems|0|||
30871025|NCT02712983|58901009|FG006|Treatment Phase|Technical Problems|1|||
30871026|NCT02712983|58901010|FG007|Treatment Phase|Technical Problems|0|||
30871027|NCT02712983|58901011|FG008|Treatment Phase|Technical Problems|0|||
30871028|NCT02712983|58901003|FG000|Treatment Phase|Physician Decision|0|||
30871029|NCT02712983|58901004|FG001|Treatment Phase|Physician Decision|0|||
30871030|NCT02712983|58901005|FG002|Treatment Phase|Physician Decision|0|||
30871031|NCT02712983|58901006|FG003|Treatment Phase|Physician Decision|0|||
30871032|NCT02712983|58901007|FG004|Treatment Phase|Physician Decision|0|||
30871033|NCT02712983|58901008|FG005|Treatment Phase|Physician Decision|0|||
30871034|NCT02712983|58901009|FG006|Treatment Phase|Physician Decision|0|||
30871035|NCT02712983|58901010|FG007|Treatment Phase|Physician Decision|1|||
30871036|NCT02712983|58901011|FG008|Treatment Phase|Physician Decision|1|||
30871037|NCT02712983|58901003|FG000|Treatment Phase|Subject Decision|2|||
30871038|NCT02712983|58901004|FG001|Treatment Phase|Subject Decision|0|||
30871039|NCT02712983|58901005|FG002|Treatment Phase|Subject Decision|0|||
30871040|NCT02712983|58901006|FG003|Treatment Phase|Subject Decision|2|||
30871041|NCT02712983|58901007|FG004|Treatment Phase|Subject Decision|1|||
30871042|NCT02712983|58901008|FG005|Treatment Phase|Subject Decision|0|||
30871043|NCT02712983|58901009|FG006|Treatment Phase|Subject Decision|1|||
30871044|NCT02712983|58901010|FG007|Treatment Phase|Subject Decision|2|||
30871045|NCT02712983|58901011|FG008|Treatment Phase|Subject Decision|0|||
30871046|NCT02712983|58901003|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
30871047|NCT02712983|58901004|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
30871048|NCT02712983|58901005|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
30871049|NCT02712983|58901006|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
30871050|NCT02712983|58901007|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
30871051|NCT02712983|58901008|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
30871052|NCT02712983|58901009|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
30871053|NCT02712983|58901010|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
30871054|NCT02712983|58901011|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
30871055|NCT02712983|58901003|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
30871056|NCT02712983|58901004|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
30871057|NCT02712983|58901005|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
30871058|NCT02712983|58901006|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
30871059|NCT02712983|58901007|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
30871060|NCT02712983|58901008|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
30871061|NCT02712983|58901009|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
30871062|NCT02712983|58901010|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
30871063|NCT02712983|58901011|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
30871064|NCT02712983|58901003|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
30871065|NCT02712983|58901004|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
30871066|NCT02712983|58901005|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
30871067|NCT02712983|58901006|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
30871068|NCT02712983|58901007|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
30871069|NCT02712983|58901008|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
30871070|NCT02712983|58901009|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
30871071|NCT02712983|58901010|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
30871072|NCT02712983|58901011|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
30871073|NCT02596971|58901034|FG000|Overall Study|Death|5|||
30871074|NCT02596971|58901035|FG001|Overall Study|Death|1|||
30871075|NCT02596971|58901036|FG002|Overall Study|Death|5|||
30871076|NCT02596971|58901034|FG000|Overall Study|Withdrawal by Subject|5|||
30871077|NCT02596971|58901035|FG001|Overall Study|Withdrawal by Subject|1|||
30871078|NCT02596971|58901036|FG002|Overall Study|Withdrawal by Subject|4|||
30871079|NCT02593773|58901047|FG000|Overall Study|Voluntary Withdrawal|3|||
30871080|NCT02593773|58901047|FG000|Overall Study|Study Terminated by Sponsor|31|||
30871081|NCT02593773|58901047|FG000|Overall Study|Death|1|||
30871082|NCT02593539|58901051|FG000|Overall Study|Adverse Event|1|||
30871083|NCT00919763|58901060|FG000|Overall Study|Adverse Event|7|||
30871084|NCT00919763|58901061|FG001|Overall Study|Adverse Event|1|||
30871085|NCT00919763|58901060|FG000|Overall Study|Lost to Follow-up|1|||
30871086|NCT00919763|58901061|FG001|Overall Study|Lost to Follow-up|0|||
30871087|NCT00919763|58901060|FG000|Overall Study|Protocol Violation|1|||
30871088|NCT00919763|58901061|FG001|Overall Study|Protocol Violation|1|||
30871089|NCT00919763|58901060|FG000|Overall Study|Withdrawal by Subject|3|||
30871090|NCT00919763|58901061|FG001|Overall Study|Withdrawal by Subject|1|||
30960854|NCT01562275|59026813|FG007|Stage 1|Death|0|||
30960855|NCT01562275|59026814|FG008|Stage 1|Death|0|||
30960856|NCT01562275|59026815|FG009|Stage 1|Death|0|||
30960857|NCT01562275|59026816|FG010|Stage 1|Death|0|||
30960858|NCT01562275|59026817|FG011|Stage 1|Death|0|||
30871091|NCT00919763|58901060|FG000|Overall Study|Non-compliance|0|||
30871092|NCT00919763|58901061|FG001|Overall Study|Non-compliance|1|||
30871093|NCT02593305|58901079|FG000|Post 1|Comparison only group. No intervention.|0|||
30871094|NCT02593305|58901080|FG001|Post 1|Comparison only group. No intervention.|0|||
30871095|NCT02593305|58901081|FG002|Post 1|Comparison only group. No intervention.|10|||
30871096|NCT02593149|58901092|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
30871097|NCT02593149|58901093|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
30871098|NCT02593149|58901092|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
30871099|NCT02593149|58901093|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
30871100|NCT02177812|58901108|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
30871101|NCT02177812|58901109|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
30871102|NCT02177812|58901110|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
30871103|NCT02177812|58901111|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
30871104|NCT02177812|58901112|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
30871105|NCT02177812|58901113|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
30871106|NCT02177812|58901114|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
30871107|NCT02177812|58901115|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
30871108|NCT02177812|58901116|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
30871109|NCT02177812|58901108|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
30871110|NCT02177812|58901109|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
30871111|NCT02177812|58901110|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
30871112|NCT02177812|58901111|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
30871113|NCT02177812|58901112|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
30871114|NCT02177812|58901113|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
30871115|NCT02177812|58901114|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
30871116|NCT02177812|58901115|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
30871117|NCT02177812|58901116|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
30871118|NCT02177812|58901108|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
30871119|NCT02177812|58901109|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
30871120|NCT02177812|58901110|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
30871121|NCT02177812|58901111|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
30871122|NCT02177812|58901112|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
30871123|NCT02177812|58901113|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
30871124|NCT02177812|58901114|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
30871125|NCT02177812|58901115|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
30871126|NCT02177812|58901116|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
30871127|NCT01626352|58901160|FG000|Overall Study|Disease Progression|3|||
30871128|NCT01626352|58901160|FG000|Overall Study|Intercurrent Illness|2|||
30871129|NCT01626352|58901160|FG000|Overall Study|Death|2|||
30871130|NCT01626352|58901160|FG000|Overall Study|Withdrawal by Subject|1|||
30871131|NCT01626352|58901160|FG000|Overall Study|Non-Compliance|1|||
30871132|NCT01626352|58901160|FG000|Overall Study|Never Treated|1|||
30871133|NCT01626118|58901171|FG000|Overall Study|Lack of Efficacy|1|||
30871134|NCT01626118|58901172|FG001|Overall Study|Lack of Efficacy|0|||
30871135|NCT01626118|58901173|FG002|Overall Study|Lack of Efficacy|1|||
30871136|NCT01626118|58901174|FG003|Overall Study|Lack of Efficacy|3|||
30871137|NCT01626118|58901171|FG000|Overall Study|Lost to Follow-up|1|||
30871138|NCT01626118|58901172|FG001|Overall Study|Lost to Follow-up|0|||
30871139|NCT01626118|58901173|FG002|Overall Study|Lost to Follow-up|0|||
30871140|NCT01626118|58901174|FG003|Overall Study|Lost to Follow-up|0|||
30871141|NCT01626118|58901171|FG000|Overall Study|Adverse Event|0|||
30871142|NCT01626118|58901172|FG001|Overall Study|Adverse Event|1|||
30871143|NCT01626118|58901173|FG002|Overall Study|Adverse Event|1|||
30871144|NCT01626118|58901174|FG003|Overall Study|Adverse Event|0|||
30871145|NCT01626118|58901171|FG000|Overall Study|Investigator Decision|0|||
30871146|NCT01626118|58901172|FG001|Overall Study|Investigator Decision|1|||
30871147|NCT01626118|58901173|FG002|Overall Study|Investigator Decision|0|||
30871148|NCT01626118|58901174|FG003|Overall Study|Investigator Decision|0|||
30871149|NCT02152384|58901184|FG000|Period 1|Withdrawal by Subject|0|||
30871150|NCT02152384|58901185|FG001|Period 1|Withdrawal by Subject|1|||
30871151|NCT02152384|58901184|FG000|Period 1|Adverse Event|1|||
30871152|NCT02152384|58901185|FG001|Period 1|Adverse Event|1|||
30871153|NCT02177266|58901197|FG000|Overall Study|Adverse Event|0|||
30871154|NCT02177266|58901198|FG001|Overall Study|Adverse Event|1|||
30871155|NCT02177266|58901197|FG000|Overall Study|Withdrawal by Subject|1|||
30960859|NCT01562275|59026818|FG012|Stage 1|Death|0|||
30960860|NCT01562275|59026806|FG000|Stage 1|Non Compliance|0|||
30960861|NCT01562275|59026807|FG001|Stage 1|Non Compliance|0|||
30871156|NCT02177266|58901198|FG001|Overall Study|Withdrawal by Subject|0|||
30871157|NCT02177032|58901208|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
30871158|NCT02177032|58901209|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
30871159|NCT02177032|58901210|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
30871160|NCT02177032|58901211|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
30960862|NCT01562275|59026808|FG002|Stage 1|Non Compliance|1|||
30871161|NCT02177032|58901208|FG000|Overall Study|Lost to Follow-up|0|||
30960863|NCT01562275|59026809|FG003|Stage 1|Non Compliance|0|||
30871162|NCT02177032|58901209|FG001|Overall Study|Lost to Follow-up|2|||
30871163|NCT02177032|58901210|FG002|Overall Study|Lost to Follow-up|0|||
30871164|NCT02177032|58901211|FG003|Overall Study|Lost to Follow-up|0|||
30871165|NCT02177032|58901208|FG000|Overall Study|OTHER|2|||
30871166|NCT02177032|58901209|FG001|Overall Study|OTHER|0|||
30871167|NCT02177032|58901210|FG002|Overall Study|OTHER|1|||
30871168|NCT02177032|58901211|FG003|Overall Study|OTHER|0|||
30871169|NCT02177032|58901208|FG000|Overall Study|Withdrawal by Subject|1|||
30871170|NCT02177032|58901209|FG001|Overall Study|Withdrawal by Subject|0|||
30871171|NCT02177032|58901210|FG002|Overall Study|Withdrawal by Subject|1|||
30871172|NCT02177032|58901211|FG003|Overall Study|Withdrawal by Subject|0|||
30871173|NCT02116972|58901235|FG000|Overall Study|Adverse Event|4|||
30871174|NCT02116972|58901236|FG001|Overall Study|Adverse Event|4|||
30871175|NCT02116972|58901237|FG002|Overall Study|Adverse Event|1|||
30871176|NCT02116972|58901235|FG000|Overall Study|Withdrawal by Subject|1|||
30871177|NCT02116972|58901236|FG001|Overall Study|Withdrawal by Subject|1|||
30871178|NCT02116972|58901237|FG002|Overall Study|Withdrawal by Subject|5|||
30871179|NCT02116972|58901235|FG000|Overall Study|Protocol Violation|1|||
30871180|NCT02116972|58901236|FG001|Overall Study|Protocol Violation|0|||
30871181|NCT02116972|58901237|FG002|Overall Study|Protocol Violation|1|||
30871182|NCT02116972|58901235|FG000|Overall Study|Lost to Follow-up|4|||
30871183|NCT02116972|58901236|FG001|Overall Study|Lost to Follow-up|3|||
30871184|NCT02116972|58901237|FG002|Overall Study|Lost to Follow-up|1|||
30871185|NCT02116972|58901235|FG000|Overall Study|Lack of Efficacy|6|||
30871186|NCT02116972|58901236|FG001|Overall Study|Lack of Efficacy|6|||
30871187|NCT02116972|58901237|FG002|Overall Study|Lack of Efficacy|5|||
30871188|NCT02116972|58901235|FG000|Overall Study|scheduling conflicts and relocation|3|||
30871189|NCT02116972|58901236|FG001|Overall Study|scheduling conflicts and relocation|3|||
30871190|NCT02116972|58901237|FG002|Overall Study|scheduling conflicts and relocation|6|||
30871191|NCT02176642|58901249|FG000|Overall Study|Withdrawal by Subject|0|||
30871192|NCT02176642|58901250|FG001|Overall Study|Withdrawal by Subject|1|||
30871193|NCT02116660|58901258|FG000|Overall Study|Deteriorating renal function|0|||
30871194|NCT02116660|58901259|FG001|Overall Study|Deteriorating renal function|1|||
30871195|NCT02116660|58901258|FG000|Overall Study|Adverse Event|1|||
30871196|NCT02116660|58901259|FG001|Overall Study|Adverse Event|1|||
30871197|NCT02116660|58901258|FG000|Overall Study|Withdrawal by Subject|0|||
30871198|NCT02116660|58901259|FG001|Overall Study|Withdrawal by Subject|2|||
30871199|NCT02116660|58901258|FG000|Overall Study|Organization reason|1|||
30871200|NCT02116660|58901259|FG001|Overall Study|Organization reason|0|||
30871201|NCT02589405|58901267|FG000|Overall Study|Adverse Event|3|||
30871202|NCT02589405|58901267|FG000|Overall Study|Withdrawal by Subject|1|||
30871203|NCT02176018|58901273|FG000|Overall Study|Adverse Event|0|||
30871204|NCT02176018|58901274|FG001|Overall Study|Adverse Event|2|||
30871205|NCT02176018|58901273|FG000|Overall Study|Lost to Follow-up|3|||
30871206|NCT02176018|58901274|FG001|Overall Study|Lost to Follow-up|1|||
30871207|NCT02176018|58901273|FG000|Overall Study|Protocol Violation|1|||
30871208|NCT02176018|58901274|FG001|Overall Study|Protocol Violation|1|||
30871209|NCT02176018|58901273|FG000|Overall Study|Withdrawal by Subject|1|||
30871210|NCT02176018|58901274|FG001|Overall Study|Withdrawal by Subject|2|||
30871211|NCT02116582|58901280|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
30871212|NCT02116582|58901280|FG000|Overall Study|Adverse Event|22|||
30871213|NCT02116582|58901280|FG000|Overall Study|Death|9|||
30871214|NCT02116582|58901280|FG000|Overall Study|Progressive Disease|148|||
30871215|NCT02116582|58901280|FG000|Overall Study|Protocol Violation|3|||
30871216|NCT02116582|58901280|FG000|Overall Study|Withdrawal by Subject|8|||
30871217|NCT02116582|58901280|FG000|Overall Study|Other: Miscellaneous|11|||
30871218|NCT02116582|58901280|FG000|Overall Study|Lost to Follow-up|1|||
30871219|NCT02116582|58901280|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
30871220|NCT02589639|58901287|FG000|Overall Study|Lost to Follow-up|1|||
30871221|NCT02589639|58901288|FG001|Overall Study|Lost to Follow-up|0|||
30871222|NCT02589639|58901289|FG002|Overall Study|Lost to Follow-up|0|||
30871223|NCT02589639|58901287|FG000|Overall Study|Protocol Violation|1|||
30871224|NCT02589639|58901288|FG001|Overall Study|Protocol Violation|0|||
30871225|NCT02589639|58901289|FG002|Overall Study|Protocol Violation|0|||
30871226|NCT02589639|58901287|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
30871227|NCT02589639|58901288|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
30871228|NCT02589639|58901289|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
30871229|NCT02589639|58901287|FG000|Overall Study|Adverse Event|4|||
30871230|NCT02589639|58901288|FG001|Overall Study|Adverse Event|5|||
30871231|NCT02589639|58901289|FG002|Overall Study|Adverse Event|3|||
30871232|NCT02589639|58901287|FG000|Overall Study|Other reason than specified above|1|||
30871233|NCT02589639|58901288|FG001|Overall Study|Other reason than specified above|2|||
30871234|NCT02589639|58901289|FG002|Overall Study|Other reason than specified above|1|||
30871235|NCT02589639|58901287|FG000|Overall Study|Not Treated|0|||
30871236|NCT02589639|58901288|FG001|Overall Study|Not Treated|3|||
30871237|NCT02589639|58901289|FG002|Overall Study|Not Treated|0|||
30871238|NCT02151682|58901299|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
30871239|NCT02151682|58901300|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
30871240|NCT02151682|58901301|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
30871241|NCT02151682|58901302|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
30871242|NCT02151682|58901303|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
30871243|NCT02151682|58901304|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
30871244|NCT02151682|58901299|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
30871245|NCT02151682|58901300|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
30871246|NCT02151682|58901301|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
30871247|NCT02151682|58901302|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
30871248|NCT02151682|58901303|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
30871249|NCT02151682|58901304|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
30871250|NCT02151682|58901299|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
30871251|NCT02151682|58901300|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
30871252|NCT02151682|58901301|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
30871253|NCT02151682|58901302|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
30871254|NCT02151682|58901303|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
30871255|NCT02151682|58901304|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
30871256|NCT02151682|58901299|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
30871257|NCT02151682|58901300|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
30871258|NCT02151682|58901301|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
30871259|NCT02151682|58901302|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
30871260|NCT02151682|58901303|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
30871261|NCT02151682|58901304|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
30871262|NCT02151682|58901299|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
30871263|NCT02151682|58901300|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
30871264|NCT02151682|58901301|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
30871265|NCT02151682|58901302|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
30871266|NCT02151682|58901303|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
30871267|NCT02151682|58901304|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
30871268|NCT02151682|58901299|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
30871269|NCT02151682|58901300|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
30871270|NCT02151682|58901301|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
30871271|NCT02151682|58901302|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
30871272|NCT02151682|58901303|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
30871273|NCT02151682|58901304|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
30871274|NCT02151682|58901299|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
30871275|NCT02151682|58901300|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
30871276|NCT02151682|58901301|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
30871277|NCT02151682|58901302|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
30871278|NCT02151682|58901303|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
30871279|NCT02151682|58901304|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
30871280|NCT02151682|58901299|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
30871281|NCT02151682|58901300|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
30877500|NCT01998958|58909047|FG026|Open Label Phase (Optional)|Other|0|||
30960864|NCT01562275|59026810|FG004|Stage 1|Non Compliance|0|||
30960865|NCT01562275|59026811|FG005|Stage 1|Non Compliance|0|||
30960866|NCT01562275|59026812|FG006|Stage 1|Non Compliance|0|||
30960867|NCT01562275|59026813|FG007|Stage 1|Non Compliance|0|||
30960868|NCT01562275|59026814|FG008|Stage 1|Non Compliance|0|||
30960869|NCT01562275|59026815|FG009|Stage 1|Non Compliance|0|||
30960870|NCT01562275|59026816|FG010|Stage 1|Non Compliance|0|||
30960871|NCT01562275|59026817|FG011|Stage 1|Non Compliance|0|||
30960872|NCT01562275|59026818|FG012|Stage 1|Non Compliance|0|||
30960873|NCT01562275|59026806|FG000|Stage 1|Physician Decision|0|||
30960874|NCT01562275|59026807|FG001|Stage 1|Physician Decision|0|||
30960875|NCT01562275|59026808|FG002|Stage 1|Physician Decision|0|||
30960876|NCT01562275|59026809|FG003|Stage 1|Physician Decision|0|||
30960877|NCT01562275|59026810|FG004|Stage 1|Physician Decision|1|||
30960878|NCT01562275|59026811|FG005|Stage 1|Physician Decision|0|||
30960879|NCT01562275|59026812|FG006|Stage 1|Physician Decision|1|||
30960880|NCT01562275|59026813|FG007|Stage 1|Physician Decision|0|||
30960881|NCT01562275|59026814|FG008|Stage 1|Physician Decision|1|||
30960882|NCT01562275|59026815|FG009|Stage 1|Physician Decision|0|||
30960883|NCT01562275|59026816|FG010|Stage 1|Physician Decision|0|||
30960884|NCT01562275|59026817|FG011|Stage 1|Physician Decision|0|||
30960885|NCT01562275|59026818|FG012|Stage 1|Physician Decision|0|||
30960886|NCT01562275|59026806|FG000|Stage 1|Progression of Disease|2|||
30960887|NCT01562275|59026807|FG001|Stage 1|Progression of Disease|6|||
30960888|NCT01562275|59026808|FG002|Stage 1|Progression of Disease|2|||
30960889|NCT01562275|59026809|FG003|Stage 1|Progression of Disease|1|||
30960890|NCT01562275|59026810|FG004|Stage 1|Progression of Disease|2|||
30960891|NCT01562275|59026811|FG005|Stage 1|Progression of Disease|4|||
30960892|NCT01562275|59026812|FG006|Stage 1|Progression of Disease|1|||
30871282|NCT02151682|58901301|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
30871283|NCT02151682|58901302|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
30871284|NCT02151682|58901303|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
30871285|NCT02151682|58901304|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
30871286|NCT02151682|58901299|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
30871287|NCT02151682|58901300|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
30871288|NCT02151682|58901301|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
30871289|NCT02151682|58901302|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
30871290|NCT02151682|58901303|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
30871291|NCT02151682|58901304|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
30871292|NCT02151682|58901299|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
30871293|NCT02151682|58901300|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
30871294|NCT02151682|58901301|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
30871295|NCT02151682|58901302|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
30871296|NCT02151682|58901303|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
30871297|NCT02151682|58901304|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
30871298|NCT02151682|58901299|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
30871299|NCT02151682|58901300|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
30871300|NCT02151682|58901301|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
30871301|NCT02151682|58901302|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
30871302|NCT02151682|58901303|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
30871303|NCT02151682|58901304|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
30871304|NCT02151682|58901299|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
30871305|NCT02151682|58901300|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
30871306|NCT02151682|58901301|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
30871307|NCT02151682|58901302|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
30871308|NCT02151682|58901303|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
30871309|NCT02151682|58901304|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
30871310|NCT02151682|58901299|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
30871311|NCT02151682|58901300|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
30871312|NCT02151682|58901301|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
30871313|NCT02151682|58901302|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
30871314|NCT02151682|58901303|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
30871315|NCT02151682|58901304|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
30871316|NCT02151682|58901299|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
30871317|NCT02151682|58901300|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
30871318|NCT02151682|58901301|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
30871319|NCT02151682|58901302|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
30871320|NCT02151682|58901303|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
30871321|NCT02151682|58901304|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
30871322|NCT02151682|58901299|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
30871323|NCT02151682|58901300|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
30871324|NCT02151682|58901301|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
30871325|NCT02151682|58901302|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
30871326|NCT02151682|58901303|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
30871327|NCT02151682|58901304|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
30871328|NCT02151682|58901299|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
30871329|NCT02151682|58901300|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
30871330|NCT02151682|58901301|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
30871331|NCT02151682|58901302|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
30871332|NCT02151682|58901303|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
30871333|NCT02151682|58901304|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
30871334|NCT02151682|58901299|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
30871335|NCT02151682|58901300|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
30871336|NCT02151682|58901301|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
30871337|NCT02151682|58901302|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
30871338|NCT02151682|58901303|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
30871339|NCT02151682|58901304|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
30871340|NCT02151682|58901299|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
30871341|NCT02151682|58901300|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
30871342|NCT02151682|58901301|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
30871343|NCT02151682|58901302|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
30960893|NCT01562275|59026813|FG007|Stage 1|Progression of Disease|7|||
30960894|NCT01562275|59026814|FG008|Stage 1|Progression of Disease|2|||
30960895|NCT01562275|59026815|FG009|Stage 1|Progression of Disease|5|||
30871344|NCT02151682|58901303|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
30871345|NCT02151682|58901304|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
30871346|NCT02174848|58901324|FG000|Overall Study|Adverse Event|2|||
30871347|NCT02174848|58901325|FG001|Overall Study|Adverse Event|1|||
30871348|NCT02174848|58901324|FG000|Overall Study|Withdrawal by Subject|3|||
30871349|NCT02174848|58901325|FG001|Overall Study|Withdrawal by Subject|3|||
30871350|NCT02174848|58901324|FG000|Overall Study|Lost to Follow-up|0|||
30871351|NCT02174848|58901325|FG001|Overall Study|Lost to Follow-up|1|||
30871352|NCT02174848|58901324|FG000|Overall Study|Worsening of disease|1|||
30871353|NCT02174848|58901325|FG001|Overall Study|Worsening of disease|1|||
30871354|NCT02174848|58901324|FG000|Overall Study|Unable to comply with study requirements|1|||
30871355|NCT02174848|58901325|FG001|Overall Study|Unable to comply with study requirements|0|||
30871356|NCT02151058|58901339|FG000|Overall Study|Withdrawal by Subject|1|||
30871357|NCT02151058|58901340|FG001|Overall Study|Withdrawal by Subject|1|||
30871358|NCT02151058|58901341|FG002|Overall Study|Withdrawal by Subject|3|||
30871359|NCT02151058|58901339|FG000|Overall Study|Lost to Follow-up|1|||
30871360|NCT02151058|58901340|FG001|Overall Study|Lost to Follow-up|0|||
30871361|NCT02151058|58901341|FG002|Overall Study|Lost to Follow-up|2|||
30871362|NCT02149810|58901351|FG000|Overall Study|Physician Decision|1|||
30871363|NCT02149810|58901352|FG001|Overall Study|Physician Decision|2|||
30871364|NCT02149810|58901351|FG000|Overall Study|Lost to Follow-up|2|||
30871365|NCT02149810|58901352|FG001|Overall Study|Lost to Follow-up|1|||
30871366|NCT02149810|58901351|FG000|Overall Study|Withdrawal by Subject|5|||
30871367|NCT02149810|58901352|FG001|Overall Study|Withdrawal by Subject|1|||
30871368|NCT02149420|58901361|FG000|Core Study|Administrative problems|0|||
30871369|NCT02149420|58901362|FG001|Core Study|Administrative problems|1|||
30871370|NCT02149420|58901363|FG002|Core Study|Administrative problems|2|||
30871371|NCT02149420|58901361|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
30871372|NCT02149420|58901362|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
30871373|NCT02149420|58901363|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
30871374|NCT02149264|58901376|FG000|Overall Study|Withdrawal by Subject|9|||
30871375|NCT02149264|58901376|FG000|Overall Study|Adverse Event|7|||
30871376|NCT02149264|58901376|FG000|Overall Study|Physician Decision|3|||
30871377|NCT02149264|58901376|FG000|Overall Study|Protocol Violation|1|||
30871378|NCT02115256|58901382|FG000|Overall Study|Withdrawal by Subject|0|||
30871379|NCT02115256|58901383|FG001|Overall Study|Withdrawal by Subject|1|||
30871380|NCT02173054|58901392|FG000|Overall Study|lack of compliance|1|||
30871381|NCT02173054|58901393|FG001|Overall Study|lack of compliance|0|||
30871382|NCT02173054|58901394|FG002|Overall Study|lack of compliance|0|||
30871383|NCT02173054|58901392|FG000|Overall Study|Withdrawal by Subject|0|||
30871384|NCT02173054|58901393|FG001|Overall Study|Withdrawal by Subject|0|||
30871385|NCT02173054|58901394|FG002|Overall Study|Withdrawal by Subject|1|||
30871386|NCT02149108|58901423|FG000|Overall Study|Not treated|1|||
30871387|NCT02149108|58901424|FG001|Overall Study|Not treated|2|||
30871388|NCT02149108|58901423|FG000|Overall Study|Progressive Disease (PD)|324|||
30871389|NCT02149108|58901424|FG001|Overall Study|Progressive Disease (PD)|318|||
30871390|NCT02149108|58901423|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
30871391|NCT02149108|58901424|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
30871392|NCT02149108|58901423|FG000|Overall Study|Other Adverse Event (AE)|8|||
30871393|NCT02149108|58901424|FG001|Overall Study|Other Adverse Event (AE)|18|||
30871394|NCT02149108|58901423|FG000|Overall Study|Other not defined above|0|||
30871395|NCT02149108|58901424|FG001|Overall Study|Other not defined above|2|||
30871396|NCT02149108|58901423|FG000|Overall Study|Refusal to continue trial medication|15|||
30871397|NCT02149108|58901424|FG001|Overall Study|Refusal to continue trial medication|11|||
30871398|NCT02149108|58901423|FG000|Overall Study|Lost to Follow-up|1|||
30871399|NCT02149108|58901424|FG001|Overall Study|Lost to Follow-up|0|||
30871400|NCT02148952|58901432|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
30871401|NCT02148952|58901433|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
30871402|NCT02148952|58901432|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
30871403|NCT02148952|58901433|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
30871404|NCT02148952|58901432|FG000|Follow-Up|Lost to Follow-up|219|||
30871405|NCT02148952|58901433|FG001|Follow-Up|Lost to Follow-up|231|||
30871406|NCT02148952|58901432|FG000|Follow-Up|Withdrawal by Subject|46|||
30871407|NCT02148952|58901433|FG001|Follow-Up|Withdrawal by Subject|48|||
30871408|NCT02148718|58901457|FG000|Overall Study|Protocol Violation|26|||
30871409|NCT02148718|58901457|FG000|Overall Study|Discontinued Study Prematurely|5|||
30871410|NCT02148250|58901461|FG000|Screening|Withdrawal by Subject|5|||
30871411|NCT02148250|58901462|FG001|Screening|Withdrawal by Subject|0|||
30871412|NCT02147626|58901471|FG000|Overall Study|Lost to Follow-up|4|||
30871413|NCT02147626|58901472|FG001|Overall Study|Lost to Follow-up|4|||
30871414|NCT02147626|58901471|FG000|Overall Study|Pregnancy|1|||
30871415|NCT02147626|58901472|FG001|Overall Study|Pregnancy|2|||
30871416|NCT02147626|58901471|FG000|Overall Study|Withdrawal by Subject|0|||
30871417|NCT02147626|58901472|FG001|Overall Study|Withdrawal by Subject|1|||
30871418|NCT02172664|58901478|FG000|Overall Study|Lost to Follow-up|4|||
30871419|NCT02172664|58901479|FG001|Overall Study|Lost to Follow-up|4|||
30871420|NCT02172664|58901478|FG000|Overall Study|Death|1|||
30871421|NCT02172664|58901479|FG001|Overall Study|Death|1|||
30871422|NCT02172664|58901478|FG000|Overall Study|Moved out of area|1|||
30871423|NCT02172664|58901479|FG001|Overall Study|Moved out of area|1|||
30871424|NCT02172040|58901488|FG000|Overall Study|Adverse Event|0|||
30871425|NCT02172040|58901489|FG001|Overall Study|Adverse Event|2|||
30871426|NCT02172040|58901490|FG002|Overall Study|Adverse Event|0|||
30871427|NCT02172040|58901491|FG003|Overall Study|Adverse Event|0|||
30871428|NCT02172040|58901488|FG000|Overall Study|Protocol Violation|0|||
30871429|NCT02172040|58901489|FG001|Overall Study|Protocol Violation|1|||
30871430|NCT02172040|58901490|FG002|Overall Study|Protocol Violation|0|||
30871431|NCT02172040|58901491|FG003|Overall Study|Protocol Violation|0|||
30871432|NCT02172040|58901488|FG000|Overall Study|Withdrawal by Subject|0|||
30871433|NCT02172040|58901489|FG001|Overall Study|Withdrawal by Subject|0|||
30871434|NCT02172040|58901490|FG002|Overall Study|Withdrawal by Subject|1|||
30871435|NCT02172040|58901491|FG003|Overall Study|Withdrawal by Subject|0|||
30871436|NCT02172040|58901488|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
30871437|NCT02172040|58901489|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
30871438|NCT02172040|58901490|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
30871439|NCT02172040|58901491|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
30871440|NCT02172040|58901488|FG000|Overall Study|Family emergency abroad|0|||
30871441|NCT02172040|58901489|FG001|Overall Study|Family emergency abroad|0|||
30871442|NCT02172040|58901490|FG002|Overall Study|Family emergency abroad|0|||
30871443|NCT02172040|58901491|FG003|Overall Study|Family emergency abroad|1|||
30871444|NCT02112994|58901531|FG000|Overall Study|Progressive Disease|0|||
30871445|NCT02112994|58901532|FG001|Overall Study|Progressive Disease|0|||
30871446|NCT02112994|58901533|FG002|Overall Study|Progressive Disease|1|||
30871447|NCT02112994|58901531|FG000|Overall Study|Pregnancy|0|||
30871448|NCT02112994|58901532|FG001|Overall Study|Pregnancy|1|||
30871449|NCT02112994|58901533|FG002|Overall Study|Pregnancy|1|||
30871450|NCT02112994|58901531|FG000|Overall Study|Liver Transplant|0|||
30871451|NCT02112994|58901532|FG001|Overall Study|Liver Transplant|1|||
30871452|NCT02112994|58901533|FG002|Overall Study|Liver Transplant|0|||
30871453|NCT02112994|58901531|FG000|Overall Study|Withdrawal by Subject|0|||
30871454|NCT02112994|58901532|FG001|Overall Study|Withdrawal by Subject|0|||
30871455|NCT02112994|58901533|FG002|Overall Study|Withdrawal by Subject|1|||
30871456|NCT02147158|58901551|FG000|Treatment Course 1|Adverse Event|1|||
30871457|NCT02147158|58901552|FG001|Treatment Course 1|Adverse Event|4|||
30871458|NCT02147158|58901553|FG002|Treatment Course 1|Adverse Event|3|||
30871459|NCT02147158|58901554|FG003|Treatment Course 1|Adverse Event|4|||
30871460|NCT02147158|58901555|FG004|Treatment Course 1|Adverse Event|1|||
30871461|NCT02147158|58901556|FG005|Treatment Course 1|Adverse Event|2|||
30871462|NCT02147158|58901551|FG000|Treatment Course 1|Lost to Follow-up|2|||
30871463|NCT02147158|58901552|FG001|Treatment Course 1|Lost to Follow-up|4|||
30871464|NCT02147158|58901553|FG002|Treatment Course 1|Lost to Follow-up|3|||
30871465|NCT02147158|58901554|FG003|Treatment Course 1|Lost to Follow-up|3|||
30871466|NCT02147158|58901555|FG004|Treatment Course 1|Lost to Follow-up|2|||
30871467|NCT02147158|58901556|FG005|Treatment Course 1|Lost to Follow-up|4|||
30871468|NCT02147158|58901551|FG000|Treatment Course 1|Protocol Violation|0|||
30871469|NCT02147158|58901552|FG001|Treatment Course 1|Protocol Violation|0|||
30871470|NCT02147158|58901553|FG002|Treatment Course 1|Protocol Violation|1|||
30871471|NCT02147158|58901554|FG003|Treatment Course 1|Protocol Violation|1|||
30871472|NCT02147158|58901555|FG004|Treatment Course 1|Protocol Violation|0|||
30871473|NCT02147158|58901556|FG005|Treatment Course 1|Protocol Violation|0|||
30871474|NCT02147158|58901551|FG000|Treatment Course 1|Withdrawal of Consent|1|||
30871475|NCT02147158|58901552|FG001|Treatment Course 1|Withdrawal of Consent|1|||
30871476|NCT02147158|58901553|FG002|Treatment Course 1|Withdrawal of Consent|1|||
30871477|NCT02147158|58901554|FG003|Treatment Course 1|Withdrawal of Consent|5|||
30871478|NCT02147158|58901555|FG004|Treatment Course 1|Withdrawal of Consent|3|||
30871479|NCT02147158|58901556|FG005|Treatment Course 1|Withdrawal of Consent|2|||
30871480|NCT02147158|58901551|FG000|Off-Treatment Interval 1|Adverse Event|1|||
30871481|NCT02147158|58901552|FG001|Off-Treatment Interval 1|Adverse Event|0|||
30871482|NCT02147158|58901553|FG002|Off-Treatment Interval 1|Adverse Event|0|||
30871483|NCT02147158|58901554|FG003|Off-Treatment Interval 1|Adverse Event|1|||
30871484|NCT02147158|58901555|FG004|Off-Treatment Interval 1|Adverse Event|0|||
30871485|NCT02147158|58901556|FG005|Off-Treatment Interval 1|Adverse Event|0|||
30871486|NCT02147158|58901551|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
30871487|NCT02147158|58901552|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
30871488|NCT02147158|58901553|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
30871489|NCT02147158|58901554|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
30871490|NCT02147158|58901555|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
30871491|NCT02147158|58901556|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
30871492|NCT02147158|58901551|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
30871493|NCT02147158|58901552|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
30871494|NCT02147158|58901553|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
30871495|NCT02147158|58901554|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
30871496|NCT02147158|58901555|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
30871497|NCT02147158|58901556|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
30871498|NCT02147158|58901551|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
30871499|NCT02147158|58901552|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
30871500|NCT02147158|58901553|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
30871501|NCT02147158|58901554|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
30871502|NCT02147158|58901555|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
30871503|NCT02147158|58901556|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
30871504|NCT02147158|58901551|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
30871505|NCT02147158|58901552|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
30871506|NCT02147158|58901553|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
30871507|NCT02147158|58901554|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
30871508|NCT02147158|58901555|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
30871509|NCT02147158|58901556|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
30871510|NCT02147158|58901551|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
30871511|NCT02147158|58901552|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
30871512|NCT02147158|58901553|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
30871513|NCT02147158|58901554|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
30871514|NCT02147158|58901555|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
30871515|NCT02147158|58901556|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
30871516|NCT02147158|58901551|FG000|Treatment Course 2|Adverse Event|0|||
30871517|NCT02147158|58901552|FG001|Treatment Course 2|Adverse Event|4|||
30871518|NCT02147158|58901553|FG002|Treatment Course 2|Adverse Event|2|||
30871519|NCT02147158|58901554|FG003|Treatment Course 2|Adverse Event|1|||
30871520|NCT02147158|58901555|FG004|Treatment Course 2|Adverse Event|0|||
30871521|NCT02147158|58901556|FG005|Treatment Course 2|Adverse Event|1|||
30871522|NCT02147158|58901551|FG000|Treatment Course 2|Withdrawal of Consent|0|||
30871523|NCT02147158|58901552|FG001|Treatment Course 2|Withdrawal of Consent|1|||
30871524|NCT02147158|58901553|FG002|Treatment Course 2|Withdrawal of Consent|2|||
30871525|NCT02147158|58901554|FG003|Treatment Course 2|Withdrawal of Consent|3|||
30871526|NCT02147158|58901555|FG004|Treatment Course 2|Withdrawal of Consent|0|||
30871527|NCT02147158|58901556|FG005|Treatment Course 2|Withdrawal of Consent|0|||
30871528|NCT02147158|58901551|FG000|Treatment Course 2|Lost to Follow-up|1|||
30871529|NCT02147158|58901552|FG001|Treatment Course 2|Lost to Follow-up|0|||
30871530|NCT02147158|58901553|FG002|Treatment Course 2|Lost to Follow-up|1|||
30871531|NCT02147158|58901554|FG003|Treatment Course 2|Lost to Follow-up|1|||
30871532|NCT02147158|58901555|FG004|Treatment Course 2|Lost to Follow-up|0|||
30871533|NCT02147158|58901556|FG005|Treatment Course 2|Lost to Follow-up|1|||
30871534|NCT02147158|58901551|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
30871535|NCT02147158|58901552|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
30871536|NCT02147158|58901553|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
30871537|NCT02147158|58901554|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
30871538|NCT02147158|58901555|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
30871539|NCT02147158|58901556|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
30871540|NCT02147158|58901551|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
30871541|NCT02147158|58901552|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
30871542|NCT02147158|58901553|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
30871543|NCT02147158|58901554|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
30871544|NCT02147158|58901555|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
30871545|NCT02147158|58901556|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
30871546|NCT02147158|58901551|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
30871547|NCT02147158|58901552|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
30871548|NCT02147158|58901553|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
30871549|NCT02147158|58901554|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
30871550|NCT02147158|58901555|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
30871551|NCT02147158|58901556|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
30871552|NCT02147158|58901551|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
30871553|NCT02147158|58901552|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
30871554|NCT02147158|58901553|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
30871555|NCT02147158|58901554|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
30871556|NCT02147158|58901555|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
30871557|NCT02147158|58901556|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
30871558|NCT02147158|58901551|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
30871559|NCT02147158|58901552|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
30871560|NCT02147158|58901553|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
30871561|NCT02147158|58901554|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
30871562|NCT02147158|58901555|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
30871563|NCT02147158|58901556|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
30871564|NCT02112448|58901575|FG000|Overall Study|lab values precluding use of ketorolac|2|||
30871565|NCT02112448|58901576|FG001|Overall Study|lab values precluding use of ketorolac|2|||
30871566|NCT02112448|58901575|FG000|Overall Study|Protocol Violation|1|||
30871567|NCT02112448|58901576|FG001|Overall Study|Protocol Violation|2|||
30871568|NCT02112448|58901575|FG000|Overall Study|Physician Decision|4|||
30871569|NCT02112448|58901576|FG001|Overall Study|Physician Decision|6|||
30871570|NCT02112448|58901575|FG000|Overall Study|required heparin so could not use ketoro|1|||
30871571|NCT02112448|58901576|FG001|Overall Study|required heparin so could not use ketoro|0|||
30871572|NCT02171260|58901588|FG000|Overall Study|Death|0|||
30871573|NCT02171260|58901589|FG001|Overall Study|Death|0|||
30871574|NCT02171260|58901590|FG002|Overall Study|Death|0|||
30871575|NCT02171260|58901591|FG003|Overall Study|Death|1|||
30871576|NCT02171260|58901588|FG000|Overall Study|Physician Decision|1|||
30871577|NCT02171260|58901589|FG001|Overall Study|Physician Decision|0|||
30871578|NCT02171260|58901590|FG002|Overall Study|Physician Decision|1|||
30871579|NCT02171260|58901591|FG003|Overall Study|Physician Decision|0|||
30871580|NCT02171260|58901588|FG000|Overall Study|Withdrawal by Subject|1|||
30871581|NCT02171260|58901589|FG001|Overall Study|Withdrawal by Subject|0|||
30871582|NCT02171260|58901590|FG002|Overall Study|Withdrawal by Subject|0|||
30871583|NCT02171260|58901591|FG003|Overall Study|Withdrawal by Subject|0|||
30871584|NCT02171260|58901588|FG000|Overall Study|Evidence of progressive disease|4|||
30871585|NCT02171260|58901589|FG001|Overall Study|Evidence of progressive disease|6|||
30871586|NCT02171260|58901590|FG002|Overall Study|Evidence of progressive disease|4|||
30871587|NCT02171260|58901591|FG003|Overall Study|Evidence of progressive disease|4|||
30871588|NCT02110732|58901609|FG000|Overall Study|Physician Decision|5|||
30871589|NCT02110732|58901610|FG001|Overall Study|Physician Decision|2|||
30871590|NCT02110732|58901609|FG000|Overall Study|Lost to Follow-up|1|||
30871591|NCT02110732|58901610|FG001|Overall Study|Lost to Follow-up|1|||
30871592|NCT02109562|58901619|FG000|Overall Study|Insufficient clinical response|2|||
30871593|NCT02109562|58901620|FG001|Overall Study|Insufficient clinical response|0|||
30871594|NCT02109562|58901621|FG002|Overall Study|Insufficient clinical response|4|||
30871595|NCT02109562|58901619|FG000|Overall Study|Adverse Event|0|||
30871596|NCT02109562|58901620|FG001|Overall Study|Adverse Event|2|||
30871597|NCT02109562|58901621|FG002|Overall Study|Adverse Event|3|||
30871598|NCT02109562|58901619|FG000|Overall Study|Lost to Follow-up|1|||
30871599|NCT02109562|58901620|FG001|Overall Study|Lost to Follow-up|0|||
30871600|NCT02109562|58901621|FG002|Overall Study|Lost to Follow-up|1|||
30871601|NCT02109562|58901619|FG000|Overall Study|Protocol Violation|0|||
30871602|NCT02109562|58901620|FG001|Overall Study|Protocol Violation|3|||
30871603|NCT02109562|58901621|FG002|Overall Study|Protocol Violation|1|||
30871604|NCT02109562|58901619|FG000|Overall Study|Withdrawal by Subject|20|||
30871605|NCT02109562|58901620|FG001|Overall Study|Withdrawal by Subject|25|||
30871606|NCT02109562|58901621|FG002|Overall Study|Withdrawal by Subject|21|||
30871607|NCT02109562|58901619|FG000|Overall Study|Physician Decision|3|||
30871608|NCT02109562|58901620|FG001|Overall Study|Physician Decision|4|||
30871609|NCT02109562|58901621|FG002|Overall Study|Physician Decision|5|||
30871610|NCT02109484|58901637|FG000|Overall Study|Lost to Follow-up|0|||
30871611|NCT02109484|58901638|FG001|Overall Study|Lost to Follow-up|0|||
30871612|NCT02109484|58901639|FG002|Overall Study|Lost to Follow-up|0|||
30871613|NCT02109484|58901640|FG003|Overall Study|Lost to Follow-up|1|||
30871614|NCT02109484|58901641|FG004|Overall Study|Lost to Follow-up|1|||
30871615|NCT02109484|58901642|FG005|Overall Study|Lost to Follow-up|0|||
30871616|NCT02109484|58901643|FG006|Overall Study|Lost to Follow-up|1|||
30871617|NCT02109484|58901644|FG007|Overall Study|Lost to Follow-up|0|||
30871618|NCT02109484|58901637|FG000|Overall Study|Withdrawal by Subject|0|||
30871619|NCT02109484|58901638|FG001|Overall Study|Withdrawal by Subject|0|||
30871620|NCT02109484|58901639|FG002|Overall Study|Withdrawal by Subject|0|||
30871621|NCT02109484|58901640|FG003|Overall Study|Withdrawal by Subject|0|||
30694605|NCT00544882|58708773|FG001|Cycle 3: Follow-up|Noncompliance|1|||
30694606|NCT00544882|58708774|FG002|Cycle 3: Follow-up|Noncompliance|0|||
30871622|NCT02109484|58901641|FG004|Overall Study|Withdrawal by Subject|1|||
30871623|NCT02109484|58901642|FG005|Overall Study|Withdrawal by Subject|1|||
30871624|NCT02109484|58901643|FG006|Overall Study|Withdrawal by Subject|1|||
30871625|NCT02109484|58901644|FG007|Overall Study|Withdrawal by Subject|0|||
30694607|NCT00544882|58708772|FG000|Cycle 3: Follow-up|Pregnancy|0|||
30694608|NCT00544882|58708773|FG001|Cycle 3: Follow-up|Pregnancy|1|||
30960896|NCT01562275|59026816|FG010|Stage 1|Progression of Disease|3|||
30694609|NCT00544882|58708774|FG002|Cycle 3: Follow-up|Pregnancy|0|||
30694610|NCT00606801|58708782|FG000|Intervention|Protocol Violation|3|||
30871626|NCT02109484|58901637|FG000|Overall Study|Physician Decision|0|||
30694611|NCT00606801|58708783|FG001|Intervention|Protocol Violation|3|||
30694612|NCT00606177|58708795|FG000|Overall Study|Adverse Event|9|||
30871627|NCT02109484|58901638|FG001|Overall Study|Physician Decision|0|||
30871628|NCT02109484|58901639|FG002|Overall Study|Physician Decision|0|||
30871629|NCT02109484|58901640|FG003|Overall Study|Physician Decision|0|||
30871630|NCT02109484|58901641|FG004|Overall Study|Physician Decision|2|||
30871631|NCT02109484|58901642|FG005|Overall Study|Physician Decision|0|||
30871632|NCT02109484|58901643|FG006|Overall Study|Physician Decision|0|||
30871633|NCT02109484|58901644|FG007|Overall Study|Physician Decision|0|||
30871634|NCT02109484|58901637|FG000|Overall Study|Death|0|||
30871635|NCT02109484|58901638|FG001|Overall Study|Death|0|||
30871636|NCT02109484|58901639|FG002|Overall Study|Death|0|||
30871637|NCT02109484|58901640|FG003|Overall Study|Death|0|||
30871638|NCT02109484|58901641|FG004|Overall Study|Death|0|||
30871639|NCT02109484|58901642|FG005|Overall Study|Death|0|||
30871640|NCT02109484|58901643|FG006|Overall Study|Death|0|||
30871641|NCT02109484|58901644|FG007|Overall Study|Death|2|||
30871642|NCT02109484|58901637|FG000|Overall Study|Moved away from study area|0|||
30871643|NCT02109484|58901638|FG001|Overall Study|Moved away from study area|0|||
30871644|NCT02109484|58901639|FG002|Overall Study|Moved away from study area|0|||
30871645|NCT02109484|58901640|FG003|Overall Study|Moved away from study area|0|||
30871646|NCT02109484|58901641|FG004|Overall Study|Moved away from study area|0|||
30871647|NCT02109484|58901642|FG005|Overall Study|Moved away from study area|0|||
30871648|NCT02109484|58901643|FG006|Overall Study|Moved away from study area|1|||
30871649|NCT02109484|58901644|FG007|Overall Study|Moved away from study area|1|||
30871650|NCT02105974|58901681|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
30871651|NCT02105974|58901682|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
30871652|NCT02105974|58901683|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
30871653|NCT02105974|58901681|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
30871654|NCT02105974|58901682|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
30871655|NCT02105974|58901683|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
30871656|NCT02105974|58901681|FG000|2 Week Run-in Period|Adverse Event|6|||
30871657|NCT02105974|58901682|FG001|2 Week Run-in Period|Adverse Event|0|||
30871658|NCT02105974|58901683|FG002|2 Week Run-in Period|Adverse Event|0|||
30871659|NCT02105974|58901681|FG000|2 Week Run-in Period|Study closed/terminated|1|||
30871660|NCT02105974|58901682|FG001|2 Week Run-in Period|Study closed/terminated|0|||
30871661|NCT02105974|58901683|FG002|2 Week Run-in Period|Study closed/terminated|0|||
30871662|NCT02105974|58901681|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
30871663|NCT02105974|58901682|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
30871664|NCT02105974|58901683|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
30871665|NCT02105974|58901681|FG000|2 Week Run-in Period|Withdrew consent|23|||
30871666|NCT02105974|58901682|FG001|2 Week Run-in Period|Withdrew consent|0|||
30871667|NCT02105974|58901683|FG002|2 Week Run-in Period|Withdrew consent|0|||
30871668|NCT02105974|58901681|FG000|2 Week Run-in Period|Investigator discretion|8|||
30871669|NCT02105974|58901682|FG001|2 Week Run-in Period|Investigator discretion|0|||
30871670|NCT02105974|58901683|FG002|2 Week Run-in Period|Investigator discretion|0|||
30871671|NCT02105974|58901681|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
30871672|NCT02105974|58901682|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
30871673|NCT02105974|58901683|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
30871674|NCT02105974|58901681|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
30871675|NCT02105974|58901682|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
30871676|NCT02105974|58901683|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
30871677|NCT02105974|58901681|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
30871678|NCT02105974|58901682|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
30871679|NCT02105974|58901683|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
30871680|NCT02105974|58901681|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
30871681|NCT02105974|58901682|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
30871682|NCT02105974|58901683|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
30871683|NCT02105974|58901681|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
30871684|NCT02105974|58901682|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
30871685|NCT02105974|58901683|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
30871686|NCT02105974|58901681|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
30871687|NCT02105974|58901682|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
30871688|NCT02105974|58901683|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
30871689|NCT02105974|58901681|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
30871690|NCT02105974|58901682|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
30871691|NCT02105974|58901683|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
30871692|NCT02105662|58901689|FG000|Overall Study|Lost to Follow-up|5|||
30871693|NCT02105662|58901689|FG000|Overall Study|Withdrawal by Subject|1|||
30871694|NCT02143102|58901695|FG000|Overall Study|Lost to Follow-up|11|||
30871695|NCT02143102|58901696|FG001|Overall Study|Lost to Follow-up|0|||
30871696|NCT02143024|58901704|FG000|Overall Study|Lost to Follow-up|1|||
30871697|NCT02143024|58901705|FG001|Overall Study|Lost to Follow-up|1|||
30871698|NCT02143024|58901704|FG000|Overall Study|Withdrawal by Subject|1|||
30871699|NCT02143024|58901705|FG001|Overall Study|Withdrawal by Subject|0|||
30871700|NCT02142712|58901714|FG000|Overall Study|Lost to Follow-up|1|||
30871701|NCT02142712|58901715|FG001|Overall Study|Lost to Follow-up|1|||
30871702|NCT02142712|58901716|FG002|Overall Study|Lost to Follow-up|1|||
30871703|NCT02142712|58901717|FG003|Overall Study|Lost to Follow-up|0|||
30871704|NCT02105272|58901728|FG000|Overall Study|Adverse Event|1|||
30871705|NCT02105272|58901729|FG001|Overall Study|Adverse Event|2|||
30871706|NCT02105272|58901728|FG000|Overall Study|Physician Decision|0|||
30871707|NCT02105272|58901729|FG001|Overall Study|Physician Decision|1|||
30960897|NCT01562275|59026817|FG011|Stage 1|Progression of Disease|0|||
30871708|NCT02105272|58901728|FG000|Overall Study|Protocol Violation|2|||
30871709|NCT02105272|58901729|FG001|Overall Study|Protocol Violation|0|||
30871710|NCT02105272|58901728|FG000|Overall Study|Withdrawal by Subject|2|||
30871711|NCT02105272|58901729|FG001|Overall Study|Withdrawal by Subject|0|||
30871712|NCT02141854|58901740|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
30871713|NCT02141854|58901741|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30871714|NCT02141854|58901742|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30871715|NCT02141854|58901743|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30871716|NCT02141854|58901744|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30871717|NCT02141854|58901745|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
30871718|NCT02141854|58901740|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
30871719|NCT02141854|58901741|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30871720|NCT02141854|58901742|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30871721|NCT02141854|58901743|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30871722|NCT02141854|58901744|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30871723|NCT02141854|58901745|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
30871724|NCT02141854|58901740|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
30871725|NCT02141854|58901741|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30871726|NCT02141854|58901742|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30871727|NCT02141854|58901743|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30871728|NCT02141854|58901744|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30871729|NCT02141854|58901745|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
30871730|NCT02141854|58901740|FG000|Run-In Period (Pre-assignment)|Other|14|||
30871731|NCT02141854|58901741|FG001|Run-In Period (Pre-assignment)|Other|0|||
30871732|NCT02141854|58901742|FG002|Run-In Period (Pre-assignment)|Other|0|||
30871733|NCT02141854|58901743|FG003|Run-In Period (Pre-assignment)|Other|0|||
30871734|NCT02141854|58901744|FG004|Run-In Period (Pre-assignment)|Other|0|||
30871735|NCT02141854|58901745|FG005|Run-In Period (Pre-assignment)|Other|0|||
30871736|NCT02141854|58901740|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
30871737|NCT02141854|58901741|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
30871738|NCT02141854|58901742|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
30871739|NCT02141854|58901743|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
30871740|NCT02141854|58901744|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
30871741|NCT02141854|58901745|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
30871742|NCT02141854|58901740|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
30871743|NCT02141854|58901741|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30871744|NCT02141854|58901742|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30871745|NCT02141854|58901743|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30871746|NCT02141854|58901744|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30871747|NCT02141854|58901745|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
30871748|NCT02141854|58901740|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
30871749|NCT02141854|58901741|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30871750|NCT02141854|58901742|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30871751|NCT02141854|58901743|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30871752|NCT02141854|58901744|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30871753|NCT02141854|58901745|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
30871754|NCT02141854|58901740|FG000|Treatment Period|Protocol Violation|0|||
30871755|NCT02141854|58901741|FG001|Treatment Period|Protocol Violation|1|||
30871756|NCT02141854|58901742|FG002|Treatment Period|Protocol Violation|0|||
30871757|NCT02141854|58901743|FG003|Treatment Period|Protocol Violation|2|||
30871758|NCT02141854|58901744|FG004|Treatment Period|Protocol Violation|2|||
30871759|NCT02141854|58901745|FG005|Treatment Period|Protocol Violation|1|||
30871760|NCT02141854|58901740|FG000|Treatment Period|Noncompliance|0|||
30871761|NCT02141854|58901741|FG001|Treatment Period|Noncompliance|0|||
30871762|NCT02141854|58901742|FG002|Treatment Period|Noncompliance|0|||
30871763|NCT02141854|58901743|FG003|Treatment Period|Noncompliance|1|||
30871764|NCT02141854|58901744|FG004|Treatment Period|Noncompliance|0|||
30871765|NCT02141854|58901745|FG005|Treatment Period|Noncompliance|0|||
30871766|NCT02141854|58901740|FG000|Treatment Period|Lack of Efficacy|0|||
30871767|NCT02141854|58901741|FG001|Treatment Period|Lack of Efficacy|0|||
30871768|NCT02141854|58901742|FG002|Treatment Period|Lack of Efficacy|0|||
30871769|NCT02141854|58901743|FG003|Treatment Period|Lack of Efficacy|1|||
30871770|NCT02141854|58901744|FG004|Treatment Period|Lack of Efficacy|1|||
30871771|NCT02141854|58901745|FG005|Treatment Period|Lack of Efficacy|7|||
30871772|NCT02141854|58901740|FG000|Treatment Period|Pregnancy|0|||
30871773|NCT02141854|58901741|FG001|Treatment Period|Pregnancy|1|||
30871774|NCT02141854|58901742|FG002|Treatment Period|Pregnancy|0|||
30871775|NCT02141854|58901743|FG003|Treatment Period|Pregnancy|0|||
30960898|NCT01562275|59026818|FG012|Stage 1|Progression of Disease|0|||
30960899|NCT01562275|59026806|FG000|Stage 1|Withdrawal by Subject|0|||
30960900|NCT01562275|59026807|FG001|Stage 1|Withdrawal by Subject|1|||
30960901|NCT01562275|59026808|FG002|Stage 1|Withdrawal by Subject|0|||
30871776|NCT02141854|58901744|FG004|Treatment Period|Pregnancy|0|||
30871777|NCT02141854|58901745|FG005|Treatment Period|Pregnancy|0|||
30871778|NCT02141854|58901740|FG000|Treatment Period|Other|0|||
30871779|NCT02141854|58901741|FG001|Treatment Period|Other|1|||
30871780|NCT02141854|58901742|FG002|Treatment Period|Other|2|||
30871781|NCT02141854|58901743|FG003|Treatment Period|Other|0|||
30871782|NCT02141854|58901744|FG004|Treatment Period|Other|1|||
30871783|NCT02141854|58901745|FG005|Treatment Period|Other|2|||
30871784|NCT02141854|58901740|FG000|Treatment Period|Adverse Event|0|||
30871785|NCT02141854|58901741|FG001|Treatment Period|Adverse Event|2|||
30871786|NCT02141854|58901742|FG002|Treatment Period|Adverse Event|2|||
30871787|NCT02141854|58901743|FG003|Treatment Period|Adverse Event|0|||
30871788|NCT02141854|58901744|FG004|Treatment Period|Adverse Event|2|||
30871789|NCT02141854|58901745|FG005|Treatment Period|Adverse Event|2|||
30871790|NCT02141854|58901740|FG000|Treatment Period|Withdrawal by Subject|0|||
30871791|NCT02141854|58901741|FG001|Treatment Period|Withdrawal by Subject|2|||
30871792|NCT02141854|58901742|FG002|Treatment Period|Withdrawal by Subject|3|||
30871793|NCT02141854|58901743|FG003|Treatment Period|Withdrawal by Subject|3|||
30871794|NCT02141854|58901744|FG004|Treatment Period|Withdrawal by Subject|4|||
30871795|NCT02141854|58901745|FG005|Treatment Period|Withdrawal by Subject|7|||
30871796|NCT02141854|58901740|FG000|Treatment Period|Disease progression|0|||
30871797|NCT02141854|58901741|FG001|Treatment Period|Disease progression|2|||
30871798|NCT02141854|58901742|FG002|Treatment Period|Disease progression|1|||
30871799|NCT02141854|58901743|FG003|Treatment Period|Disease progression|3|||
30871800|NCT02141854|58901744|FG004|Treatment Period|Disease progression|0|||
30871801|NCT02141854|58901745|FG005|Treatment Period|Disease progression|18|||
30871802|NCT02141854|58901740|FG000|Treatment Period|Lost to Follow-up|0|||
30871803|NCT02141854|58901741|FG001|Treatment Period|Lost to Follow-up|1|||
30871804|NCT02141854|58901742|FG002|Treatment Period|Lost to Follow-up|1|||
30871805|NCT02141854|58901743|FG003|Treatment Period|Lost to Follow-up|1|||
30871806|NCT02141854|58901744|FG004|Treatment Period|Lost to Follow-up|0|||
30871807|NCT02141854|58901745|FG005|Treatment Period|Lost to Follow-up|1|||
30871808|NCT02587221|58901759|FG000|Overall Study|Adverse Event|3|||
30871809|NCT02587221|58901760|FG001|Overall Study|Adverse Event|3|||
30871810|NCT02587221|58901759|FG000|Overall Study|Death|33|||
30871811|NCT02587221|58901760|FG001|Overall Study|Death|34|||
30871812|NCT02587221|58901759|FG000|Overall Study|Withdrawal by Subject|66|||
30871813|NCT02587221|58901760|FG001|Overall Study|Withdrawal by Subject|61|||
30871814|NCT02587221|58901759|FG000|Overall Study|Lost to Follow-up|21|||
30871815|NCT02587221|58901760|FG001|Overall Study|Lost to Follow-up|19|||
30871816|NCT02587221|58901759|FG000|Overall Study|Protocol Violation|6|||
30871817|NCT02587221|58901760|FG001|Overall Study|Protocol Violation|5|||
30871818|NCT02587221|58901759|FG000|Overall Study|Other Reason or Unspecified|2|||
30871819|NCT02587221|58901760|FG001|Overall Study|Other Reason or Unspecified|1|||
30871820|NCT02141620|58901766|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
30871821|NCT02141620|58901767|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
30871822|NCT02106910|58901775|FG000|Overall Study|Lost to Follow-up|1|||
30871823|NCT02106910|58901776|FG001|Overall Study|Lost to Follow-up|1|||
30871824|NCT01664949|58901785|FG000|Overall Study|Adverse Event|11|||
30871825|NCT01664949|58901786|FG001|Overall Study|Adverse Event|12|||
30871826|NCT01664949|58901785|FG000|Overall Study|Lack of Efficacy|1|||
30871827|NCT01664949|58901786|FG001|Overall Study|Lack of Efficacy|1|||
30871828|NCT01664949|58901785|FG000|Overall Study|Lost to Follow-up|1|||
30871829|NCT01664949|58901786|FG001|Overall Study|Lost to Follow-up|2|||
30871830|NCT01664949|58901785|FG000|Overall Study|Personal Reasons|3|||
30871831|NCT01664949|58901786|FG001|Overall Study|Personal Reasons|4|||
30871832|NCT01664949|58901785|FG000|Overall Study|Protocol Violation|5|||
30871833|NCT01664949|58901786|FG001|Overall Study|Protocol Violation|5|||
30871834|NCT01664949|58901785|FG000|Overall Study|Other Miscellaneous Reasons|3|||
30871835|NCT01664949|58901786|FG001|Overall Study|Other Miscellaneous Reasons|1|||
30871836|NCT02587143|58901794|FG000|Overall Study|Adverse Event|1|||
30871837|NCT02587143|58901795|FG001|Overall Study|Adverse Event|0|||
30871843|NCT02106832|58901809|FG000|Overall Study|Adverse Event|1|||
30871844|NCT02106832|58901810|FG001|Overall Study|Adverse Event|2|||
30871845|NCT02106832|58901811|FG002|Overall Study|Adverse Event|3|||
30871846|NCT02106832|58901812|FG003|Overall Study|Adverse Event|0|||
30871847|NCT02106832|58901809|FG000|Overall Study|Death|4|||
30871848|NCT02106832|58901810|FG001|Overall Study|Death|4|||
30871849|NCT02106832|58901811|FG002|Overall Study|Death|1|||
30871850|NCT02106832|58901812|FG003|Overall Study|Death|4|||
30871851|NCT02106832|58901809|FG000|Overall Study|Deterioration of general conditions|0|||
30871852|NCT02106832|58901810|FG001|Overall Study|Deterioration of general conditions|0|||
30871853|NCT02106832|58901811|FG002|Overall Study|Deterioration of general conditions|1|||
30871854|NCT02106832|58901812|FG003|Overall Study|Deterioration of general conditions|0|||
30871855|NCT02106832|58901809|FG000|Overall Study|Lost to Follow-up|0|||
30871856|NCT02106832|58901810|FG001|Overall Study|Lost to Follow-up|1|||
30871857|NCT02106832|58901811|FG002|Overall Study|Lost to Follow-up|1|||
30871858|NCT02106832|58901812|FG003|Overall Study|Lost to Follow-up|3|||
30871859|NCT02106832|58901809|FG000|Overall Study|Physician Decision|1|||
30871860|NCT02106832|58901810|FG001|Overall Study|Physician Decision|0|||
30871861|NCT02106832|58901811|FG002|Overall Study|Physician Decision|0|||
30871862|NCT02106832|58901812|FG003|Overall Study|Physician Decision|0|||
30871863|NCT02106832|58901809|FG000|Overall Study|Protocol Violation|0|||
30871864|NCT02106832|58901810|FG001|Overall Study|Protocol Violation|0|||
30871865|NCT02106832|58901811|FG002|Overall Study|Protocol Violation|0|||
30871866|NCT02106832|58901812|FG003|Overall Study|Protocol Violation|1|||
30871867|NCT02106832|58901809|FG000|Overall Study|Withdrawal by Subject|17|||
30871868|NCT02106832|58901810|FG001|Overall Study|Withdrawal by Subject|17|||
30871869|NCT02106832|58901811|FG002|Overall Study|Withdrawal by Subject|10|||
30871870|NCT02106832|58901812|FG003|Overall Study|Withdrawal by Subject|7|||
30871871|NCT02106832|58901809|FG000|Overall Study|Technical problems|0|||
30871872|NCT02106832|58901810|FG001|Overall Study|Technical problems|1|||
30871873|NCT02106832|58901811|FG002|Overall Study|Technical problems|0|||
30871874|NCT02106832|58901812|FG003|Overall Study|Technical problems|0|||
30871875|NCT02106442|58901824|FG000|Overall Study|Case Report Forms Uncollected|7|||
30871876|NCT02106442|58901824|FG000|Overall Study|Protocol Deviation|30|||
30871877|NCT02105116|58901828|FG000|Overall Study|not eligible for step 2 of trial|5|||
30871878|NCT02105116|58901828|FG000|Overall Study|Death|1|||
30871879|NCT02104804|58901834|FG000|Overall Study|Did not take study medication|0|||
30871880|NCT02104804|58901835|FG001|Overall Study|Did not take study medication|1|||
30871881|NCT02104804|58901834|FG000|Overall Study|Study specific discontinuation criteria|6|||
30871882|NCT02104804|58901835|FG001|Overall Study|Study specific discontinuation criteria|1|||
30871883|NCT02104804|58901834|FG000|Overall Study|Other listed|2|||
30871884|NCT02104804|58901835|FG001|Overall Study|Other listed|1|||
30871885|NCT02104804|58901834|FG000|Overall Study|Protocol Violation|0|||
30871886|NCT02104804|58901835|FG001|Overall Study|Protocol Violation|1|||
30871887|NCT02104804|58901834|FG000|Overall Study|Adverse Event|4|||
30871888|NCT02104804|58901835|FG001|Overall Study|Adverse Event|3|||
30871889|NCT02104804|58901834|FG000|Overall Study|Withdrawal by Subject|4|||
30871890|NCT02104804|58901835|FG001|Overall Study|Withdrawal by Subject|12|||
30871891|NCT02075008|58901841|FG000|Overall Study|Technical problems|1|||
30871892|NCT02075008|58901841|FG000|Overall Study|Pregnancy|1|||
30871893|NCT02075008|58901841|FG000|Overall Study|Physician Decision|1|||
30871894|NCT02075008|58901841|FG000|Overall Study|Lost to Follow-up|1|||
30871895|NCT02075008|58901841|FG000|Overall Study|Lack of Efficacy|1|||
30871896|NCT02075008|58901841|FG000|Overall Study|Death|1|||
30871897|NCT02075008|58901841|FG000|Overall Study|Adverse Event|5|||
30871898|NCT02075008|58901841|FG000|Overall Study|Withdrawal by Subject|6|||
30871899|NCT02075008|58901841|FG000|Overall Study|Study terminated by Sponsor|159|||
30871900|NCT01666119|58901872|FG000|Overall Study|Adverse Event|6|||
30871901|NCT01666119|58901872|FG000|Overall Study|Withdrawal by Subject|16|||
30871902|NCT01666119|58901872|FG000|Overall Study|Lost to Follow-up|7|||
30871903|NCT01666119|58901872|FG000|Overall Study|non compliance with study medication, pa|18|||
30871904|NCT01666119|58901872|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
30871905|NCT05128773|58901876|FG000|Overall Study|Sponsor decision to terminate study|3|||
30871906|NCT01665807|58901884|FG000|Overall Study|Withdrawal by Subject|2|||
30871907|NCT01665807|58901885|FG001|Overall Study|Withdrawal by Subject|0|||
30871908|NCT01665807|58901886|FG002|Overall Study|Withdrawal by Subject|1|||
30871909|NCT02584959|58901897|FG000|Period 1|Withdrawn from study|3|||
30871910|NCT02584959|58901898|FG001|Period 1|Withdrawn from study|4|||
30871911|NCT02584959|58901899|FG002|Period 1|Withdrawn from study|0|||
30871912|NCT02584959|58901897|FG000|Period 2|Withdrawn from study|6|||
30871913|NCT02584959|58901898|FG001|Period 2|Withdrawn from study|1|||
30871914|NCT02584959|58901899|FG002|Period 2|Withdrawn from study|2|||
30871915|NCT02584257|58901916|FG000|Period 1|Withdrawal by Subject|0|||
30871916|NCT02584257|58901917|FG001|Period 1|Withdrawal by Subject|0|||
30871917|NCT02584257|58901918|FG002|Period 1|Withdrawal by Subject|0|||
30871918|NCT02584257|58901919|FG003|Period 1|Withdrawal by Subject|0|||
30871919|NCT02584257|58901920|FG004|Period 1|Withdrawal by Subject|0|||
30871920|NCT02584257|58901921|FG005|Period 1|Withdrawal by Subject|0|||
30871921|NCT02584257|58901922|FG006|Period 1|Withdrawal by Subject|1|||
30871922|NCT02584257|58901923|FG007|Period 1|Withdrawal by Subject|0|||
30871923|NCT02584257|58901924|FG008|Period 1|Withdrawal by Subject|0|||
30871924|NCT02584257|58901916|FG000|Period 2|Physician Decision|1|||
30871925|NCT02584257|58901917|FG001|Period 2|Physician Decision|0|||
30871926|NCT02584257|58901918|FG002|Period 2|Physician Decision|0|||
30871927|NCT02584257|58901919|FG003|Period 2|Physician Decision|0|||
30871928|NCT02584257|58901920|FG004|Period 2|Physician Decision|0|||
30871929|NCT02584257|58901921|FG005|Period 2|Physician Decision|0|||
30871930|NCT02584257|58901922|FG006|Period 2|Physician Decision|0|||
30871931|NCT02584257|58901923|FG007|Period 2|Physician Decision|0|||
30871932|NCT02584257|58901924|FG008|Period 2|Physician Decision|0|||
30871933|NCT02584257|58901916|FG000|Period 2|Adverse Event|0|||
30871934|NCT02584257|58901917|FG001|Period 2|Adverse Event|1|||
30871935|NCT02584257|58901918|FG002|Period 2|Adverse Event|0|||
30871936|NCT02584257|58901919|FG003|Period 2|Adverse Event|0|||
30871937|NCT02584257|58901920|FG004|Period 2|Adverse Event|0|||
30871938|NCT02584257|58901921|FG005|Period 2|Adverse Event|0|||
30871939|NCT02584257|58901922|FG006|Period 2|Adverse Event|0|||
30871940|NCT02584257|58901923|FG007|Period 2|Adverse Event|0|||
30871941|NCT02584257|58901924|FG008|Period 2|Adverse Event|0|||
30871942|NCT02583711|58901939|FG000|Overall Study|Withdrawal by Subject|0|||
30871943|NCT02583711|58901940|FG001|Overall Study|Withdrawal by Subject|10|||
30871944|NCT02583711|58901941|FG002|Overall Study|Withdrawal by Subject|0|||
30871945|NCT02583477|58901953|FG000|Overall Study|Adverse Event|0|||
30871946|NCT02583477|58901954|FG001|Overall Study|Adverse Event|2|||
30871947|NCT02583477|58901953|FG000|Overall Study|Death|1|||
30871948|NCT02583477|58901954|FG001|Overall Study|Death|16|||
30871949|NCT02583477|58901953|FG000|Overall Study|Study terminated|2|||
30871950|NCT02583477|58901954|FG001|Overall Study|Study terminated|2|||
30871951|NCT02583399|58901961|FG000|Overall Study|Able to be discharged|3|||
30871952|NCT02583399|58901961|FG000|Overall Study|Wanted to use a restricted medication|3|||
30871953|NCT02580591|58901969|FG000|Overall Study|Adverse Event|0|||
30871954|NCT02580591|58901970|FG001|Overall Study|Adverse Event|1|||
30871955|NCT02580591|58901971|FG002|Overall Study|Adverse Event|2|||
30871956|NCT02580591|58901972|FG003|Overall Study|Adverse Event|5|||
30871957|NCT02580591|58901969|FG000|Overall Study|Protocol Violation|3|||
30871958|NCT02580591|58901970|FG001|Overall Study|Protocol Violation|2|||
30871959|NCT02580591|58901971|FG002|Overall Study|Protocol Violation|1|||
30871960|NCT02580591|58901972|FG003|Overall Study|Protocol Violation|1|||
30871961|NCT02580591|58901969|FG000|Overall Study|Lost to Follow-up|5|||
30871962|NCT02580591|58901970|FG001|Overall Study|Lost to Follow-up|3|||
30871963|NCT02580591|58901971|FG002|Overall Study|Lost to Follow-up|3|||
30871964|NCT02580591|58901972|FG003|Overall Study|Lost to Follow-up|1|||
30871965|NCT02580591|58901969|FG000|Overall Study|Withdrawal by Subject|6|||
30871966|NCT02580591|58901970|FG001|Overall Study|Withdrawal by Subject|1|||
30871967|NCT02580591|58901971|FG002|Overall Study|Withdrawal by Subject|2|||
30871968|NCT02580591|58901972|FG003|Overall Study|Withdrawal by Subject|3|||
30871969|NCT02580591|58901969|FG000|Overall Study|Not treated|1|||
30871970|NCT02580591|58901970|FG001|Overall Study|Not treated|1|||
30871971|NCT02580591|58901971|FG002|Overall Study|Not treated|0|||
30871972|NCT02580591|58901972|FG003|Overall Study|Not treated|0|||
30871973|NCT02580591|58901969|FG000|Overall Study|Other than specified|3|||
30871974|NCT02580591|58901970|FG001|Overall Study|Other than specified|2|||
30871975|NCT02580591|58901971|FG002|Overall Study|Other than specified|5|||
30871976|NCT02580591|58901972|FG003|Overall Study|Other than specified|2|||
30871977|NCT02580357|58901985|FG000|Overall Study|Lost to Follow-up|2|||
30871978|NCT02580357|58901986|FG001|Overall Study|Lost to Follow-up|0|||
30871979|NCT02580357|58901987|FG002|Overall Study|Lost to Follow-up|0|||
30871980|NCT02580357|58901985|FG000|Overall Study|Protocol Violation|1|||
30871981|NCT02580357|58901986|FG001|Overall Study|Protocol Violation|0|||
30871982|NCT02580357|58901987|FG002|Overall Study|Protocol Violation|0|||
30871983|NCT01664091|58901995|FG000|Overall Study|Death|1|||
30871984|NCT01664091|58901995|FG000|Overall Study|Disease Progression|2|||
30871985|NCT01664091|58901995|FG000|Overall Study|Lost to Follow-up|2|||
30871986|NCT01664091|58901995|FG000|Overall Study|Withdrawal by Subject|1|||
30871987|NCT02577315|58902002|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
30871988|NCT02577315|58902003|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
30871989|NCT02711345|58902019|FG000|Overall Study|Adverse Event|0|||
30871990|NCT02711345|58902020|FG001|Overall Study|Adverse Event|0|||
30871991|NCT02711345|58902021|FG002|Overall Study|Adverse Event|0|||
30871992|NCT02711345|58902022|FG003|Overall Study|Adverse Event|1|||
30871993|NCT02711345|58902023|FG004|Overall Study|Adverse Event|1|||
30871994|NCT02711345|58902024|FG005|Overall Study|Adverse Event|2|||
30871995|NCT02711345|58902025|FG006|Overall Study|Adverse Event|1|||
30960902|NCT01562275|59026809|FG003|Stage 1|Withdrawal by Subject|2|||
30960903|NCT01562275|59026810|FG004|Stage 1|Withdrawal by Subject|0|||
30871996|NCT02711345|58902026|FG007|Overall Study|Adverse Event|0|||
30871997|NCT02711345|58902027|FG008|Overall Study|Adverse Event|0|||
30960904|NCT01562275|59026811|FG005|Stage 1|Withdrawal by Subject|0|||
30960905|NCT01562275|59026812|FG006|Stage 1|Withdrawal by Subject|1|||
30871998|NCT02711345|58902028|FG009|Overall Study|Adverse Event|2|||
30871999|NCT02711345|58902019|FG000|Overall Study|Physician Decision|0|||
30872000|NCT02711345|58902020|FG001|Overall Study|Physician Decision|0|||
30872001|NCT02711345|58902021|FG002|Overall Study|Physician Decision|1|||
30960906|NCT01562275|59026813|FG007|Stage 1|Withdrawal by Subject|0|||
30960907|NCT01562275|59026814|FG008|Stage 1|Withdrawal by Subject|0|||
30872002|NCT02711345|58902022|FG003|Overall Study|Physician Decision|0|||
30872003|NCT02711345|58902023|FG004|Overall Study|Physician Decision|0|||
30872004|NCT02711345|58902024|FG005|Overall Study|Physician Decision|0|||
30872005|NCT02711345|58902025|FG006|Overall Study|Physician Decision|0|||
30872006|NCT02711345|58902026|FG007|Overall Study|Physician Decision|0|||
30872007|NCT02711345|58902027|FG008|Overall Study|Physician Decision|1|||
30872008|NCT02711345|58902028|FG009|Overall Study|Physician Decision|0|||
30872009|NCT02711345|58902019|FG000|Overall Study|Progressive disease|1|||
30872010|NCT02711345|58902020|FG001|Overall Study|Progressive disease|3|||
30872011|NCT02711345|58902021|FG002|Overall Study|Progressive disease|5|||
30872012|NCT02711345|58902022|FG003|Overall Study|Progressive disease|3|||
30872013|NCT02711345|58902023|FG004|Overall Study|Progressive disease|7|||
30872014|NCT02711345|58902024|FG005|Overall Study|Progressive disease|2|||
30872015|NCT02711345|58902025|FG006|Overall Study|Progressive disease|8|||
30872016|NCT02711345|58902026|FG007|Overall Study|Progressive disease|4|||
30872017|NCT02711345|58902027|FG008|Overall Study|Progressive disease|5|||
30872018|NCT02711345|58902028|FG009|Overall Study|Progressive disease|6|||
30872019|NCT02711345|58902019|FG000|Overall Study|Subject/guardian decision|0|||
30872020|NCT02711345|58902020|FG001|Overall Study|Subject/guardian decision|0|||
30872021|NCT02711345|58902021|FG002|Overall Study|Subject/guardian decision|0|||
30872022|NCT02711345|58902022|FG003|Overall Study|Subject/guardian decision|0|||
30872023|NCT02711345|58902023|FG004|Overall Study|Subject/guardian decision|0|||
30872024|NCT02711345|58902024|FG005|Overall Study|Subject/guardian decision|2|||
30872025|NCT02711345|58902025|FG006|Overall Study|Subject/guardian decision|3|||
30872026|NCT02711345|58902026|FG007|Overall Study|Subject/guardian decision|1|||
30872027|NCT02711345|58902027|FG008|Overall Study|Subject/guardian decision|0|||
30872028|NCT02711345|58902028|FG009|Overall Study|Subject/guardian decision|4|||
30872029|NCT02711345|58902019|FG000|Overall Study|Death|1|||
30872030|NCT02711345|58902020|FG001|Overall Study|Death|0|||
30872031|NCT02711345|58902021|FG002|Overall Study|Death|0|||
30872032|NCT02711345|58902022|FG003|Overall Study|Death|0|||
30872033|NCT02711345|58902023|FG004|Overall Study|Death|0|||
30872034|NCT02711345|58902024|FG005|Overall Study|Death|0|||
30872035|NCT02711345|58902025|FG006|Overall Study|Death|0|||
30872036|NCT02711345|58902026|FG007|Overall Study|Death|1|||
30872037|NCT02711345|58902027|FG008|Overall Study|Death|0|||
30872038|NCT02711345|58902028|FG009|Overall Study|Death|0|||
30872039|NCT02581995|58902065|FG000|Overall Study|Unspecified other|3|||
30872040|NCT02581995|58902065|FG000|Overall Study|Adverse Event|6|||
30872041|NCT02581995|58902065|FG000|Overall Study|Lost to Follow-up|5|||
30872042|NCT02581995|58902065|FG000|Overall Study|Withdrawal by participant|12|||
30872043|NCT02581995|58902065|FG000|Overall Study|Physician Decision|1|||
30872044|NCT02581995|58902065|FG000|Overall Study|Death|4|||
30872045|NCT02577003|58902071|FG000|Overall Study|Adverse Event|2|||
30872046|NCT02577003|58902072|FG001|Overall Study|Adverse Event|4|||
30872047|NCT02577003|58902071|FG000|Overall Study|Withdrawal by Subject|0|||
30872048|NCT02577003|58902072|FG001|Overall Study|Withdrawal by Subject|1|||
30872049|NCT02446899|58902080|FG000|Overall Study|Adverse Event|4|||
30872050|NCT02446899|58902081|FG001|Overall Study|Adverse Event|7|||
30872051|NCT02446899|58902080|FG000|Overall Study|Condition Under Investigation Worsened|1|||
30872052|NCT02446899|58902081|FG001|Overall Study|Condition Under Investigation Worsened|4|||
30872053|NCT02446899|58902080|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
30872054|NCT02446899|58902081|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
30872055|NCT02446899|58902080|FG000|Overall Study|Lack of Efficacy|2|||
30872056|NCT02446899|58902081|FG001|Overall Study|Lack of Efficacy|8|||
30872057|NCT02446899|58902080|FG000|Overall Study|Lost to Follow-up|1|||
30872058|NCT02446899|58902081|FG001|Overall Study|Lost to Follow-up|3|||
30872059|NCT02446899|58902080|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
30872060|NCT02446899|58902081|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
30872061|NCT02446899|58902080|FG000|Overall Study|Withdrawal by Subject|11|||
30872062|NCT02446899|58902081|FG001|Overall Study|Withdrawal by Subject|19|||
30872063|NCT02446899|58902080|FG000|Overall Study|Miscellaneous|5|||
30872064|NCT02446899|58902081|FG001|Overall Study|Miscellaneous|4|||
30872065|NCT02446899|58902080|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
30872066|NCT02446899|58902081|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
30872067|NCT02709785|58902090|FG000|Overall Study|Withdrawal by Subject|1|||
30872068|NCT02709785|58902091|FG001|Overall Study|Withdrawal by Subject|2|||
30960908|NCT01562275|59026815|FG009|Stage 1|Withdrawal by Subject|1|||
30872069|NCT02709785|58902092|FG002|Overall Study|Withdrawal by Subject|1|||
30872070|NCT02356887|58902100|FG000|Overall Study|poor compliance|2|||
30872071|NCT01604265|58902112|FG000|Overall Study|Adverse Event|1|||
30872072|NCT01604265|58902113|FG001|Overall Study|Adverse Event|0|||
30872073|NCT01604265|58902112|FG000|Overall Study|Withdrawal by Subject|1|||
30872074|NCT01604265|58902113|FG001|Overall Study|Withdrawal by Subject|0|||
30872075|NCT01664247|58902121|FG000|Overall Study|Adverse Event|5|||
30872076|NCT01664247|58902122|FG001|Overall Study|Adverse Event|3|||
30872077|NCT01664247|58902121|FG000|Overall Study|Protocol Violation|3|||
30872078|NCT01664247|58902122|FG001|Overall Study|Protocol Violation|5|||
30872079|NCT01664247|58902121|FG000|Overall Study|Withdrawal Criteria|1|||
30872080|NCT01664247|58902122|FG001|Overall Study|Withdrawal Criteria|4|||
30872081|NCT01664247|58902121|FG000|Overall Study|Unclassified|5|||
30872082|NCT01664247|58902122|FG001|Overall Study|Unclassified|29|||
30872083|NCT03191903|58902146|FG000|Overall Study|Withdrawal by Subject|6|||
30872084|NCT03191903|58902147|FG001|Overall Study|Withdrawal by Subject|5|||
30872085|NCT03191903|58902148|FG002|Overall Study|Withdrawal by Subject|4|||
30872086|NCT03191903|58902146|FG000|Overall Study|Adverse Event|1|||
30872087|NCT03191903|58902147|FG001|Overall Study|Adverse Event|0|||
30872088|NCT03191903|58902148|FG002|Overall Study|Adverse Event|0|||
30872089|NCT02576535|58902161|FG000|Overall Study|Withdrawal by Subject|2|||
30872090|NCT02576145|58902167|FG000|Overall Study|Adverse Event|1|||
30872091|NCT02576145|58902168|FG001|Overall Study|Adverse Event|0|||
30872092|NCT02576145|58902167|FG000|Overall Study|Withdrawal by Subject|1|||
30872093|NCT02576145|58902168|FG001|Overall Study|Withdrawal by Subject|0|||
30872094|NCT02576145|58902167|FG000|Overall Study|Acute rejection|1|||
30872095|NCT02576145|58902168|FG001|Overall Study|Acute rejection|0|||
30872096|NCT02576145|58902167|FG000|Overall Study|Tetanus Titers Decreased|0|||
30872097|NCT02576145|58902168|FG001|Overall Study|Tetanus Titers Decreased|1|||
30872098|NCT02576067|58902213|FG000|Overall Study|Death|0|||
30872099|NCT02576067|58902214|FG001|Overall Study|Death|1|||
30872100|NCT02576067|58902213|FG000|Overall Study|Lack of Efficacy|1|||
30872101|NCT02576067|58902214|FG001|Overall Study|Lack of Efficacy|0|||
30872102|NCT02576067|58902213|FG000|Overall Study|Lost to Follow-up|11|||
30872103|NCT02576067|58902214|FG001|Overall Study|Lost to Follow-up|0|||
30872104|NCT02576067|58902213|FG000|Overall Study|Withdrawal by Subject|11|||
30872105|NCT02576067|58902214|FG001|Overall Study|Withdrawal by Subject|2|||
30872106|NCT02576067|58902213|FG000|Overall Study|study closure of main CIRT trial)|0|||
30872107|NCT02576067|58902214|FG001|Overall Study|study closure of main CIRT trial)|8|||
30872108|NCT02576067|58902213|FG000|Overall Study|not randomized, failed run-in|7|||
30872109|NCT02576067|58902214|FG001|Overall Study|not randomized, failed run-in|0|||
30872110|NCT02576067|58902213|FG000|Overall Study|screen failure/ re-enrolled|0|||
30872111|NCT02576067|58902214|FG001|Overall Study|screen failure/ re-enrolled|25|||
30872112|NCT02576067|58902213|FG000|Overall Study|Physician Decision|4|||
30872113|NCT02576067|58902214|FG001|Overall Study|Physician Decision|0|||
30872114|NCT02575911|58902220|FG000|Overall Study|Lost to Follow-up|1|||
30872115|NCT02575833|58902234|FG000|Overall Study|Withdrawal by Subject|0|||
30872116|NCT02575833|58902235|FG001|Overall Study|Withdrawal by Subject|1|||
30872117|NCT02575833|58902234|FG000|Overall Study|Lost to Follow-up|1|||
30872118|NCT02575833|58902235|FG001|Overall Study|Lost to Follow-up|0|||
30872119|NCT02709083|58902241|FG000|Overall Study|Original PI left institution|7|||
30872120|NCT02709005|58902247|FG000|Overall Study|Lost to Follow-up|1|||
30872121|NCT02709005|58902248|FG001|Overall Study|Lost to Follow-up|1|||
30872122|NCT02709005|58902247|FG000|Overall Study|Withdrawal by Subject|3|||
30872123|NCT02709005|58902248|FG001|Overall Study|Withdrawal by Subject|0|||
30872124|NCT02573883|58902256|FG000|Six Month Follow Up|Lost to Follow-up|1|||
30872125|NCT02573883|58902257|FG001|Six Month Follow Up|Lost to Follow-up|0|||
30872126|NCT02573883|58902258|FG002|Six Month Follow Up|Lost to Follow-up|0|||
30872127|NCT02573883|58902259|FG003|Six Month Follow Up|Lost to Follow-up|0|||
30872128|NCT02573883|58902256|FG000|One Year Follow Up|Lost to Follow-up|2|||
30872129|NCT02573883|58902257|FG001|One Year Follow Up|Lost to Follow-up|1|||
30872130|NCT02573883|58902258|FG002|One Year Follow Up|Lost to Follow-up|0|||
30872131|NCT02573883|58902259|FG003|One Year Follow Up|Lost to Follow-up|0|||
30872132|NCT02575365|58902274|FG000|Overall Study|Lost to Follow-up|4|||
30872133|NCT02707991|58902280|FG000|Overall Study|Protocol Violation|1|||
30872134|NCT02707991|58902281|FG001|Overall Study|Protocol Violation|0|||
30872135|NCT02707991|58902280|FG000|Overall Study|Became ineligible|0|||
30872136|NCT02707991|58902281|FG001|Overall Study|Became ineligible|1|||
30872137|NCT02707757|58902289|FG000|Overall Study|Protocol Violation|3|||
30872138|NCT02707757|58902290|FG001|Overall Study|Protocol Violation|2|||
30872139|NCT02707757|58902289|FG000|Overall Study|Withdrawal by Subject|2|||
30872140|NCT02707757|58902290|FG001|Overall Study|Withdrawal by Subject|0|||
30872141|NCT02707757|58902289|FG000|Overall Study|Death|0|||
30872142|NCT02707757|58902290|FG001|Overall Study|Death|1|||
30872143|NCT02707757|58902289|FG000|Overall Study|Adverse Event|6|||
30872144|NCT02707757|58902290|FG001|Overall Study|Adverse Event|4|||
30872145|NCT02707757|58902289|FG000|Overall Study|Renal transplant/elective operation|1|||
30872146|NCT02707757|58902290|FG001|Overall Study|Renal transplant/elective operation|5|||
30872147|NCT02572401|58902300|FG000|Overall Study|Lost to Follow-up|5|||
30872148|NCT02572401|58902301|FG001|Overall Study|Lost to Follow-up|8|||
30872149|NCT02572401|58902302|FG002|Overall Study|Lost to Follow-up|9|||
30872150|NCT02572401|58902303|FG003|Overall Study|Lost to Follow-up|9|||
30872151|NCT02572401|58902300|FG000|Overall Study|Death|0|||
30872152|NCT02572401|58902301|FG001|Overall Study|Death|0|||
30872153|NCT02572401|58902302|FG002|Overall Study|Death|0|||
30872154|NCT02572401|58902303|FG003|Overall Study|Death|1|||
30872155|NCT02431325|58902315|FG000|Overall Study|Adverse Event|3|||
30872156|NCT02431325|58902316|FG001|Overall Study|Adverse Event|0|||
30872157|NCT02431325|58902315|FG000|Overall Study|Lost to Follow-up|0|||
30872158|NCT02431325|58902316|FG001|Overall Study|Lost to Follow-up|1|||
30872159|NCT02431325|58902315|FG000|Overall Study|Withdrawal by Subject|1|||
30872160|NCT02431325|58902316|FG001|Overall Study|Withdrawal by Subject|2|||
30872161|NCT02431325|58902315|FG000|Overall Study|Declined to take study medication|1|||
30872162|NCT02431325|58902316|FG001|Overall Study|Declined to take study medication|0|||
30872163|NCT02431325|58902315|FG000|Overall Study|Withdrew before starting study medication|1|||
30872164|NCT02431325|58902316|FG001|Overall Study|Withdrew before starting study medication|0|||
30872165|NCT02431325|58902315|FG000|Overall Study|Placebo shortage|2|||
30872166|NCT02431325|58902316|FG001|Overall Study|Placebo shortage|0|||
30872167|NCT02103478|58902329|FG000|Overall Study|Adverse Event|0|||
30872168|NCT02103478|58902330|FG001|Overall Study|Adverse Event|0|||
30872169|NCT02103478|58902331|FG002|Overall Study|Adverse Event|1|||
30872170|NCT02103478|58902332|FG003|Overall Study|Adverse Event|1|||
30872171|NCT02103478|58902333|FG004|Overall Study|Adverse Event|2|||
30872172|NCT02103478|58902334|FG005|Overall Study|Adverse Event|1|||
30872173|NCT02103478|58902335|FG006|Overall Study|Adverse Event|0|||
30872174|NCT02103478|58902336|FG007|Overall Study|Adverse Event|0|||
30872175|NCT02103478|58902337|FG008|Overall Study|Adverse Event|0|||
30872176|NCT02103478|58902329|FG000|Overall Study|Death|2|||
30872177|NCT02103478|58902330|FG001|Overall Study|Death|2|||
30872178|NCT02103478|58902331|FG002|Overall Study|Death|1|||
30872179|NCT02103478|58902332|FG003|Overall Study|Death|1|||
30872180|NCT02103478|58902333|FG004|Overall Study|Death|5|||
30872181|NCT02103478|58902334|FG005|Overall Study|Death|15|||
30960909|NCT01562275|59026816|FG010|Stage 1|Withdrawal by Subject|0|||
30960910|NCT01562275|59026817|FG011|Stage 1|Withdrawal by Subject|0|||
30960911|NCT01562275|59026818|FG012|Stage 1|Withdrawal by Subject|0|||
30960912|NCT01562275|59026806|FG000|Stage 2|Death|0|||
30960913|NCT01562275|59026807|FG001|Stage 2|Death|0|||
30960914|NCT01562275|59026808|FG002|Stage 2|Death|0|||
30960915|NCT01562275|59026809|FG003|Stage 2|Death|0|||
30960916|NCT01562275|59026810|FG004|Stage 2|Death|0|||
30960917|NCT01562275|59026811|FG005|Stage 2|Death|0|||
30960918|NCT01562275|59026812|FG006|Stage 2|Death|0|||
30960919|NCT01562275|59026813|FG007|Stage 2|Death|0|||
30960920|NCT01562275|59026814|FG008|Stage 2|Death|0|||
30960921|NCT01562275|59026815|FG009|Stage 2|Death|0|||
30960922|NCT01562275|59026816|FG010|Stage 2|Death|0|||
30960923|NCT01562275|59026817|FG011|Stage 2|Death|2|||
30960924|NCT01562275|59026818|FG012|Stage 2|Death|1|||
30960925|NCT01562275|59026806|FG000|Stage 2|Progression of Disease|0|||
30960926|NCT01562275|59026807|FG001|Stage 2|Progression of Disease|0|||
30960927|NCT01562275|59026808|FG002|Stage 2|Progression of Disease|0|||
30960928|NCT01562275|59026809|FG003|Stage 2|Progression of Disease|0|||
30960929|NCT01562275|59026810|FG004|Stage 2|Progression of Disease|0|||
30960930|NCT01562275|59026811|FG005|Stage 2|Progression of Disease|0|||
30960931|NCT01562275|59026812|FG006|Stage 2|Progression of Disease|0|||
30960932|NCT01562275|59026813|FG007|Stage 2|Progression of Disease|0|||
30872182|NCT02103478|58902335|FG006|Overall Study|Death|14|||
30872183|NCT02103478|58902336|FG007|Overall Study|Death|10|||
30872184|NCT02103478|58902337|FG008|Overall Study|Death|11|||
30872185|NCT02103478|58902329|FG000|Overall Study|Progressive Disease|2|||
30872186|NCT02103478|58902330|FG001|Overall Study|Progressive Disease|1|||
30872187|NCT02103478|58902331|FG002|Overall Study|Progressive Disease|2|||
30872188|NCT02103478|58902332|FG003|Overall Study|Progressive Disease|0|||
30872189|NCT02103478|58902333|FG004|Overall Study|Progressive Disease|9|||
30872190|NCT02103478|58902334|FG005|Overall Study|Progressive Disease|1|||
30872191|NCT02103478|58902335|FG006|Overall Study|Progressive Disease|2|||
30872192|NCT02103478|58902336|FG007|Overall Study|Progressive Disease|0|||
30872193|NCT02103478|58902337|FG008|Overall Study|Progressive Disease|1|||
30872194|NCT02103478|58902329|FG000|Overall Study|Withdrawal by Subject|2|||
30872195|NCT02103478|58902330|FG001|Overall Study|Withdrawal by Subject|0|||
30872196|NCT02103478|58902331|FG002|Overall Study|Withdrawal by Subject|0|||
30872197|NCT02103478|58902332|FG003|Overall Study|Withdrawal by Subject|4|||
30872198|NCT02103478|58902333|FG004|Overall Study|Withdrawal by Subject|0|||
30872199|NCT02103478|58902334|FG005|Overall Study|Withdrawal by Subject|0|||
30872200|NCT02103478|58902335|FG006|Overall Study|Withdrawal by Subject|1|||
30872201|NCT02103478|58902336|FG007|Overall Study|Withdrawal by Subject|1|||
30960933|NCT01562275|59026814|FG008|Stage 2|Progression of Disease|0|||
30960934|NCT01562275|59026815|FG009|Stage 2|Progression of Disease|0|||
30960935|NCT01562275|59026816|FG010|Stage 2|Progression of Disease|0|||
30872202|NCT02103478|58902337|FG008|Overall Study|Withdrawal by Subject|0|||
30872203|NCT02103478|58902329|FG000|Overall Study|Lost to Follow-up|0|||
30872204|NCT02103478|58902330|FG001|Overall Study|Lost to Follow-up|0|||
30872205|NCT02103478|58902331|FG002|Overall Study|Lost to Follow-up|0|||
30872206|NCT02103478|58902332|FG003|Overall Study|Lost to Follow-up|0|||
30872207|NCT02103478|58902333|FG004|Overall Study|Lost to Follow-up|0|||
30872208|NCT02103478|58902334|FG005|Overall Study|Lost to Follow-up|0|||
30872209|NCT02103478|58902335|FG006|Overall Study|Lost to Follow-up|0|||
30872210|NCT02103478|58902336|FG007|Overall Study|Lost to Follow-up|1|||
30872211|NCT02103478|58902337|FG008|Overall Study|Lost to Follow-up|0|||
30872212|NCT02103478|58902329|FG000|Overall Study|Other|1|||
30872213|NCT02103478|58902330|FG001|Overall Study|Other|3|||
30872214|NCT02103478|58902331|FG002|Overall Study|Other|2|||
30872215|NCT02103478|58902332|FG003|Overall Study|Other|0|||
30872216|NCT02103478|58902333|FG004|Overall Study|Other|3|||
30872217|NCT02103478|58902334|FG005|Overall Study|Other|8|||
30872218|NCT02103478|58902335|FG006|Overall Study|Other|8|||
30960936|NCT01562275|59026817|FG011|Stage 2|Progression of Disease|12|||
30960937|NCT01562275|59026818|FG012|Stage 2|Progression of Disease|4|||
30960938|NCT01535053|59026850|FG000|Overall Study|Ineligible|1|||
30872219|NCT02103478|58902336|FG007|Overall Study|Other|4|||
30872220|NCT02103478|58902337|FG008|Overall Study|Other|2|||
30872221|NCT02102464|58902369|FG000|Randomized Study|Withdrawal by Subject|0|||
30872222|NCT02102464|58902370|FG001|Randomized Study|Withdrawal by Subject|1|||
30872223|NCT02102464|58902371|FG002|Randomized Study|Withdrawal by Subject|0|||
30872224|NCT02707601|58902382|FG000|Overall Study|Death|0|||
30872225|NCT02707601|58902383|FG001|Overall Study|Death|1|||
30872226|NCT02707601|58902382|FG000|Overall Study|Lack of Efficacy|0|||
30872227|NCT02707601|58902383|FG001|Overall Study|Lack of Efficacy|1|||
30872228|NCT02707601|58902382|FG000|Overall Study|Investigator's Discretion|1|||
30872229|NCT02707601|58902383|FG001|Overall Study|Investigator's Discretion|0|||
30872230|NCT02707601|58902382|FG000|Overall Study|Withdrew Consent|0|||
30872231|NCT02707601|58902383|FG001|Overall Study|Withdrew Consent|1|||
30872232|NCT02707601|58902382|FG000|Overall Study|Lost to Follow-up|1|||
30872233|NCT02707601|58902383|FG001|Overall Study|Lost to Follow-up|1|||
30872234|NCT02707601|58902382|FG000|Overall Study|Participants Randomized but Not Treated|2|||
30872235|NCT02707601|58902383|FG001|Overall Study|Participants Randomized but Not Treated|0|||
30872236|NCT02707055|58902395|FG000|Phase 1|Withdrawal by Subject|1|||
30872237|NCT02707055|58902396|FG001|Phase 1|Withdrawal by Subject|2|||
30872238|NCT02707055|58902395|FG000|Phase 1|Physician Decision|0|||
30872239|NCT02707055|58902396|FG001|Phase 1|Physician Decision|1|||
30872240|NCT02707055|58902395|FG000|Phase 2|Adverse Event|1|||
30872241|NCT02707055|58902396|FG001|Phase 2|Adverse Event|2|||
30872242|NCT02073682|58902404|FG000|Overall Study|Low Creatinine Clearance|1|||
30872243|NCT02073682|58902405|FG001|Overall Study|Low Creatinine Clearance|2|||
30872244|NCT02073682|58902404|FG000|Overall Study|Death|86|||
30872245|NCT02073682|58902405|FG001|Overall Study|Death|100|||
30872246|NCT02073682|58902404|FG000|Overall Study|Cancer Cured|10|||
30872247|NCT02073682|58902405|FG001|Overall Study|Cancer Cured|15|||
30872248|NCT02073682|58902404|FG000|Overall Study|ID: Patient Noncompliance|1|||
30872249|NCT02073682|58902405|FG001|Overall Study|ID: Patient Noncompliance|2|||
30872250|NCT02073682|58902404|FG000|Overall Study|ID: Palliative Treatment Only|10|||
30872251|NCT02073682|58902405|FG001|Overall Study|ID: Palliative Treatment Only|7|||
30872252|NCT02073682|58902404|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
30872253|NCT02073682|58902405|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
30872254|NCT02073682|58902404|FG000|Overall Study|Platelet Count <50,000/mL|1|||
30872255|NCT02073682|58902405|FG001|Overall Study|Platelet Count <50,000/mL|2|||
30872256|NCT02073682|58902404|FG000|Overall Study|Surgery/Medical Procedure|3|||
30872257|NCT02073682|58902405|FG001|Overall Study|Surgery/Medical Procedure|1|||
30872258|NCT02073682|58902404|FG000|Overall Study|Withdrawal by Subject|6|||
30872259|NCT02073682|58902405|FG001|Overall Study|Withdrawal by Subject|8|||
30872260|NCT02073682|58902404|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
30872261|NCT02073682|58902405|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
30872262|NCT02073682|58902404|FG000|Overall Study|Cancer Progression|53|||
30872263|NCT02073682|58902405|FG001|Overall Study|Cancer Progression|33|||
30872264|NCT02073682|58902404|FG000|Overall Study|Protocol Violation|1|||
30872265|NCT02073682|58902405|FG001|Overall Study|Protocol Violation|0|||
30872266|NCT02073682|58902404|FG000|Overall Study|Adverse Event|79|||
30872267|NCT02073682|58902405|FG001|Overall Study|Adverse Event|62|||
30872268|NCT02073682|58902404|FG000|Overall Study|No reason provided|11|||
30872269|NCT02073682|58902405|FG001|Overall Study|No reason provided|9|||
30872270|NCT02073682|58902404|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
30872271|NCT02073682|58902405|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
30872272|NCT02073682|58902404|FG000|Overall Study|Lost to Follow-up|1|||
30872273|NCT02073682|58902405|FG001|Overall Study|Lost to Follow-up|1|||
30872274|NCT02073682|58902404|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
30872275|NCT02073682|58902405|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
30872276|NCT02072980|58902411|FG000|Period 2, Second Wear|Adverse Event|0|||
30872277|NCT02072980|58902412|FG001|Period 2, Second Wear|Adverse Event|1|||
30872278|NCT02706899|58902420|FG000|Overall Study|Withdrawal by Subject|1|||
30872279|NCT02706899|58902421|FG001|Overall Study|Withdrawal by Subject|0|||
30872280|NCT02706899|58902420|FG000|Overall Study|Death|8|||
30872281|NCT02706899|58902421|FG001|Overall Study|Death|0|||
30872282|NCT02706899|58902420|FG000|Overall Study|Study Termination by Sponsor|4|||
30694613|NCT00606177|58708796|FG001|Overall Study|Adverse Event|5|||
30872283|NCT02706899|58902421|FG001|Overall Study|Study Termination by Sponsor|6|||
30872284|NCT02072824|58902430|FG000|Overall Study|Insufficient clinical response|1|||
30872285|NCT02072824|58902431|FG001|Overall Study|Insufficient clinical response|0|||
30872286|NCT02072824|58902432|FG002|Overall Study|Insufficient clinical response|1|||
30872287|NCT02072824|58902430|FG000|Overall Study|No longer willing to participate|1|||
30872288|NCT02072824|58902431|FG001|Overall Study|No longer willing to participate|0|||
30872289|NCT02072824|58902432|FG002|Overall Study|No longer willing to participate|1|||
30872290|NCT02072824|58902430|FG000|Overall Study|Medication error|0|||
30872291|NCT02072824|58902431|FG001|Overall Study|Medication error|1|||
30872292|NCT02072824|58902432|FG002|Overall Study|Medication error|0|||
30872293|NCT02072824|58902430|FG000|Overall Study|Adverse Event|0|||
30872294|NCT02072824|58902431|FG001|Overall Study|Adverse Event|0|||
30872295|NCT02072824|58902432|FG002|Overall Study|Adverse Event|1|||
30872296|NCT02072668|58902440|FG000|Second Intervention|Lost to Follow-up|1|||
30872297|NCT02072668|58902441|FG001|Second Intervention|Lost to Follow-up|0|||
30872298|NCT02140762|58902451|FG000|Overall Study|Adverse Event|1|||
30872299|NCT02140762|58902452|FG001|Overall Study|Adverse Event|1|||
30872300|NCT02140762|58902451|FG000|Overall Study|Lost to Follow-up|9|||
30872301|NCT02140762|58902452|FG001|Overall Study|Lost to Follow-up|5|||
30872302|NCT02140762|58902451|FG000|Overall Study|Protocol Violation|1|||
30872303|NCT02140762|58902452|FG001|Overall Study|Protocol Violation|1|||
30872304|NCT02140762|58902451|FG000|Overall Study|Withdrawal by Subject|6|||
30872305|NCT02140762|58902452|FG001|Overall Study|Withdrawal by Subject|4|||
30872306|NCT02140762|58902451|FG000|Overall Study|Other|0|||
30872307|NCT02140762|58902452|FG001|Overall Study|Other|1|||
30872308|NCT02101294|58902463|FG000|Overall Study|Withdrawal by Subject|5|||
30872309|NCT02101294|58902463|FG000|Overall Study|Lost to Follow-up|6|||
30872310|NCT01598506|58902470|FG000|Overall Study|Withdrawal by Subject|2|||
30872311|NCT02140060|58902481|FG000|Overall Study|Adverse Event|0|||
30872312|NCT02140060|58902482|FG001|Overall Study|Adverse Event|0|||
30872313|NCT02140060|58902483|FG002|Overall Study|Adverse Event|0|||
30872314|NCT02140060|58902484|FG003|Overall Study|Adverse Event|1|||
30872315|NCT02140060|58902485|FG004|Overall Study|Adverse Event|1|||
30872316|NCT02140060|58902486|FG005|Overall Study|Adverse Event|1|||
30872317|NCT02140060|58902481|FG000|Overall Study|Lack of Efficacy|0|||
30872318|NCT02140060|58902482|FG001|Overall Study|Lack of Efficacy|0|||
30872319|NCT02140060|58902483|FG002|Overall Study|Lack of Efficacy|0|||
30872320|NCT02140060|58902484|FG003|Overall Study|Lack of Efficacy|1|||
30872321|NCT02140060|58902485|FG004|Overall Study|Lack of Efficacy|0|||
30872322|NCT02140060|58902486|FG005|Overall Study|Lack of Efficacy|0|||
30872323|NCT02139982|58902511|FG000|Overall Study|Lack of Efficacy|0|||
30872324|NCT02139982|58902512|FG001|Overall Study|Lack of Efficacy|1|||
30872325|NCT02139982|58902513|FG002|Overall Study|Lack of Efficacy|0|||
30872326|NCT02139982|58902514|FG003|Overall Study|Lack of Efficacy|1|||
30872327|NCT02139982|58902515|FG004|Overall Study|Lack of Efficacy|0|||
30872328|NCT02139982|58902516|FG005|Overall Study|Lack of Efficacy|0|||
30872329|NCT02139982|58902517|FG006|Overall Study|Lack of Efficacy|0|||
30872330|NCT02139982|58902518|FG007|Overall Study|Lack of Efficacy|0|||
30872331|NCT02139982|58902519|FG008|Overall Study|Lack of Efficacy|0|||
30872332|NCT02139982|58902520|FG009|Overall Study|Lack of Efficacy|0|||
30872333|NCT02139826|58902542|FG000|Overall Study|Adverse Event|1|||
30872334|NCT02139592|58902552|FG000|Overall Study|Case Report Forms Uncollected|8|||
30872335|NCT02139280|58902558|FG000|Overall Study|No longer eligible|2|||
30872336|NCT02139280|58902559|FG001|Overall Study|No longer eligible|0|||
30872337|NCT02072434|58902567|FG000|Overall Study|Protocol Violation|10|||
30872338|NCT02072434|58902568|FG001|Overall Study|Protocol Violation|9|||
30872339|NCT02072434|58902567|FG000|Overall Study|Physician Decision|5|||
30872340|NCT02072434|58902568|FG001|Overall Study|Physician Decision|10|||
30872341|NCT02072434|58902567|FG000|Overall Study|Adverse event, serious fatal|1|||
30872342|NCT02072434|58902568|FG001|Overall Study|Adverse event, serious fatal|6|||
30872343|NCT02072434|58902567|FG000|Overall Study|Adverse Event|7|||
30872344|NCT02072434|58902568|FG001|Overall Study|Adverse Event|6|||
30872345|NCT02072434|58902567|FG000|Overall Study|Withdrawal by Subject|17|||
30872346|NCT02072434|58902568|FG001|Overall Study|Withdrawal by Subject|29|||
30694614|NCT00606177|58708795|FG000|Overall Study|Lack of Efficacy|3|||
30694615|NCT00606177|58708796|FG001|Overall Study|Lack of Efficacy|7|||
30694616|NCT00606177|58708795|FG000|Overall Study|Physician Decision|1|||
30872347|NCT02072434|58902567|FG000|Overall Study|Other|14|||
30872348|NCT02072434|58902568|FG001|Overall Study|Other|29|||
30872349|NCT02072434|58902567|FG000|Overall Study|Lost to Follow-up|0|||
30872350|NCT02072434|58902568|FG001|Overall Study|Lost to Follow-up|1|||
30872351|NCT02101060|58902576|FG000|Overall Study|Adverse Event|1|||
30872352|NCT02101060|58902577|FG001|Overall Study|Adverse Event|0|||
30872353|NCT02101060|58902576|FG000|Overall Study|Withdrawal by Subject|1|||
30872354|NCT02101060|58902577|FG001|Overall Study|Withdrawal by Subject|1|||
30872355|NCT02101060|58902576|FG000|Overall Study|Lost to Follow-up|3|||
30872356|NCT02101060|58902577|FG001|Overall Study|Lost to Follow-up|3|||
30872357|NCT02139124|58902588|FG000|Overall Study|Adverse Event|2|||
30872358|NCT02139124|58902589|FG001|Overall Study|Adverse Event|0|||
30872359|NCT02139124|58902590|FG002|Overall Study|Adverse Event|1|||
30872360|NCT02139124|58902591|FG003|Overall Study|Adverse Event|2|||
30872361|NCT02139124|58902592|FG004|Overall Study|Adverse Event|5|||
30872362|NCT02139124|58902588|FG000|Overall Study|Withdrawal by Subject|2|||
30872363|NCT02139124|58902589|FG001|Overall Study|Withdrawal by Subject|2|||
30872364|NCT02139124|58902590|FG002|Overall Study|Withdrawal by Subject|2|||
30872365|NCT02139124|58902591|FG003|Overall Study|Withdrawal by Subject|2|||
30872366|NCT02139124|58902592|FG004|Overall Study|Withdrawal by Subject|3|||
30872367|NCT02139124|58902588|FG000|Overall Study|Protocol Violation|0|||
30872368|NCT02139124|58902589|FG001|Overall Study|Protocol Violation|0|||
30872369|NCT02139124|58902590|FG002|Overall Study|Protocol Violation|0|||
30872370|NCT02139124|58902591|FG003|Overall Study|Protocol Violation|1|||
30872371|NCT02139124|58902592|FG004|Overall Study|Protocol Violation|1|||
30872372|NCT02139124|58902588|FG000|Overall Study|non-compliant|1|||
30872373|NCT02139124|58902589|FG001|Overall Study|non-compliant|0|||
30872374|NCT02139124|58902590|FG002|Overall Study|non-compliant|0|||
30872375|NCT02139124|58902591|FG003|Overall Study|non-compliant|2|||
30872376|NCT02139124|58902592|FG004|Overall Study|non-compliant|0|||
30872377|NCT02139124|58902588|FG000|Overall Study|incarceration|0|||
30872378|NCT02139124|58902589|FG001|Overall Study|incarceration|0|||
30872379|NCT02139124|58902590|FG002|Overall Study|incarceration|1|||
30872380|NCT02139124|58902591|FG003|Overall Study|incarceration|0|||
30872381|NCT02139124|58902592|FG004|Overall Study|incarceration|0|||
30872382|NCT02139124|58902588|FG000|Overall Study|subject moved|1|||
30872383|NCT02139124|58902589|FG001|Overall Study|subject moved|0|||
30872384|NCT02139124|58902590|FG002|Overall Study|subject moved|0|||
30872385|NCT02139124|58902591|FG003|Overall Study|subject moved|0|||
30872386|NCT02139124|58902592|FG004|Overall Study|subject moved|0|||
30872387|NCT02139124|58902588|FG000|Overall Study|Lost to Follow-up|3|||
30872388|NCT02139124|58902589|FG001|Overall Study|Lost to Follow-up|2|||
30872389|NCT02139124|58902590|FG002|Overall Study|Lost to Follow-up|0|||
30872390|NCT02139124|58902591|FG003|Overall Study|Lost to Follow-up|5|||
30872391|NCT02139124|58902592|FG004|Overall Study|Lost to Follow-up|4|||
30872392|NCT02139046|58902609|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
30872393|NCT02139046|58902610|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
30872394|NCT02139046|58902611|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
30872395|NCT02139046|58902612|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
30872396|NCT02139046|58902613|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
30872397|NCT02139046|58902609|FG000|Overall Study|Major Protocol Deviation|9|||
30872398|NCT02139046|58902610|FG001|Overall Study|Major Protocol Deviation|10|||
30872399|NCT02139046|58902611|FG002|Overall Study|Major Protocol Deviation|16|||
30872400|NCT02139046|58902612|FG003|Overall Study|Major Protocol Deviation|12|||
30872401|NCT02139046|58902613|FG004|Overall Study|Major Protocol Deviation|6|||
30872402|NCT02139046|58902609|FG000|Overall Study|Lost to Follow-up|13|||
30872403|NCT02139046|58902610|FG001|Overall Study|Lost to Follow-up|16|||
30872404|NCT02139046|58902611|FG002|Overall Study|Lost to Follow-up|16|||
30872405|NCT02139046|58902612|FG003|Overall Study|Lost to Follow-up|18|||
30872406|NCT02139046|58902613|FG004|Overall Study|Lost to Follow-up|13|||
30872407|NCT02139046|58902609|FG000|Overall Study|Voluntary Withdrawal|20|||
30872408|NCT02139046|58902610|FG001|Overall Study|Voluntary Withdrawal|8|||
30872409|NCT02139046|58902611|FG002|Overall Study|Voluntary Withdrawal|10|||
30872410|NCT02139046|58902612|FG003|Overall Study|Voluntary Withdrawal|15|||
30872411|NCT02139046|58902613|FG004|Overall Study|Voluntary Withdrawal|16|||
30872412|NCT02139046|58902609|FG000|Overall Study|Lack of Efficacy|0|||
30872413|NCT02139046|58902610|FG001|Overall Study|Lack of Efficacy|1|||
30872414|NCT02139046|58902611|FG002|Overall Study|Lack of Efficacy|2|||
30872415|NCT02139046|58902612|FG003|Overall Study|Lack of Efficacy|1|||
30872416|NCT02139046|58902613|FG004|Overall Study|Lack of Efficacy|2|||
30872417|NCT02139046|58902609|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
30872418|NCT02139046|58902610|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
30872419|NCT02139046|58902611|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
30872420|NCT02139046|58902612|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
30872421|NCT02139046|58902613|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
30960939|NCT01535053|59026851|FG001|Overall Study|Ineligible|2|||
30960940|NCT01534663|59026859|FG000|Overall Study|Lost to Follow-up|0|||
30960941|NCT01534663|59026860|FG001|Overall Study|Lost to Follow-up|2|||
30960942|NCT01534663|59026859|FG000|Overall Study|Adverse Event|2|||
30960943|NCT01534663|59026860|FG001|Overall Study|Adverse Event|1|||
30960944|NCT01520909|59026868|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
30960945|NCT01520909|59026869|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
30960946|NCT01520909|59026870|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
30960947|NCT01520909|59026868|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
30694617|NCT00606177|58708796|FG001|Overall Study|Physician Decision|0|||
30694618|NCT00606177|58708795|FG000|Overall Study|Protocol Violation|1|||
30872422|NCT02139046|58902609|FG000|Overall Study|Other Miscellaneous Reasons|10|||
30872423|NCT02139046|58902610|FG001|Overall Study|Other Miscellaneous Reasons|9|||
30872424|NCT02139046|58902611|FG002|Overall Study|Other Miscellaneous Reasons|4|||
30872425|NCT02139046|58902612|FG003|Overall Study|Other Miscellaneous Reasons|9|||
30872426|NCT02139046|58902613|FG004|Overall Study|Other Miscellaneous Reasons|12|||
30872427|NCT02138890|58902627|FG000|Overall Study|Adverse Event|1|||
30872428|NCT02138890|58902628|FG001|Overall Study|Adverse Event|0|||
30872429|NCT02100670|58902639|FG000|Overall Study|Adverse Event|10|||
30872430|NCT02100670|58902640|FG001|Overall Study|Adverse Event|3|||
30872431|NCT02100670|58902641|FG002|Overall Study|Adverse Event|3|||
30872432|NCT02100670|58902642|FG003|Overall Study|Adverse Event|0|||
30872433|NCT02100670|58902639|FG000|Overall Study|Lost to Follow-up|1|||
30872434|NCT02100670|58902640|FG001|Overall Study|Lost to Follow-up|0|||
30872435|NCT02100670|58902641|FG002|Overall Study|Lost to Follow-up|0|||
30872436|NCT02100670|58902642|FG003|Overall Study|Lost to Follow-up|0|||
30872437|NCT02100670|58902639|FG000|Overall Study|Protocol Violation|0|||
30872438|NCT02100670|58902640|FG001|Overall Study|Protocol Violation|1|||
30872439|NCT02100670|58902641|FG002|Overall Study|Protocol Violation|0|||
30872440|NCT02100670|58902642|FG003|Overall Study|Protocol Violation|1|||
30872441|NCT02100670|58902639|FG000|Overall Study|Withdrawal of Consent|0|||
30872442|NCT02100670|58902640|FG001|Overall Study|Withdrawal of Consent|1|||
30872443|NCT02100670|58902641|FG002|Overall Study|Withdrawal of Consent|1|||
30872444|NCT02100670|58902642|FG003|Overall Study|Withdrawal of Consent|0|||
30872445|NCT02100670|58902639|FG000|Overall Study|No swelling no pain|1|||
30872446|NCT02100670|58902640|FG001|Overall Study|No swelling no pain|0|||
30872447|NCT02100670|58902641|FG002|Overall Study|No swelling no pain|0|||
30872448|NCT02100670|58902642|FG003|Overall Study|No swelling no pain|0|||
30872449|NCT02100670|58902639|FG000|Overall Study|Poor Efficacy|0|||
30872450|NCT02100670|58902640|FG001|Overall Study|Poor Efficacy|1|||
30872451|NCT02100670|58902641|FG002|Overall Study|Poor Efficacy|0|||
30872452|NCT02100670|58902642|FG003|Overall Study|Poor Efficacy|0|||
30872453|NCT02100670|58902639|FG000|Overall Study|Physician Decision|0|||
30872454|NCT02100670|58902640|FG001|Overall Study|Physician Decision|1|||
30872455|NCT02100670|58902641|FG002|Overall Study|Physician Decision|0|||
30872456|NCT02100670|58902642|FG003|Overall Study|Physician Decision|0|||
30872457|NCT02100670|58902639|FG000|Overall Study|Withdrawal by Subject|1|||
30872458|NCT02100670|58902640|FG001|Overall Study|Withdrawal by Subject|0|||
30872459|NCT02100670|58902641|FG002|Overall Study|Withdrawal by Subject|0|||
30872460|NCT02100670|58902642|FG003|Overall Study|Withdrawal by Subject|0|||
30872461|NCT02070484|58902661|FG000|Overall Study|Withdrawal by Subject|1|||
30872462|NCT02070484|58902662|FG001|Overall Study|Withdrawal by Subject|0|||
30872463|NCT02100514|58902670|FG000|Treatment Period|Adverse Event|0|||
30872464|NCT02100514|58902671|FG001|Treatment Period|Adverse Event|5|||
30872465|NCT02100514|58902672|FG002|Treatment Period|Adverse Event|0|||
30872466|NCT02100514|58902673|FG003|Treatment Period|Adverse Event|0|||
30872467|NCT02100514|58902674|FG004|Treatment Period|Adverse Event|0|||
30872468|NCT02100514|58902670|FG000|Treatment Period|Death|2|||
30872469|NCT02100514|58902671|FG001|Treatment Period|Death|2|||
30872470|NCT02100514|58902672|FG002|Treatment Period|Death|0|||
30872471|NCT02100514|58902673|FG003|Treatment Period|Death|0|||
30872472|NCT02100514|58902674|FG004|Treatment Period|Death|0|||
30872473|NCT02100514|58902670|FG000|Treatment Period|Lost to Follow-up|5|||
30872474|NCT02100514|58902671|FG001|Treatment Period|Lost to Follow-up|17|||
30872475|NCT02100514|58902672|FG002|Treatment Period|Lost to Follow-up|0|||
30872476|NCT02100514|58902673|FG003|Treatment Period|Lost to Follow-up|0|||
30872477|NCT02100514|58902674|FG004|Treatment Period|Lost to Follow-up|0|||
30872478|NCT02100514|58902670|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
30872479|NCT02100514|58902671|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
30872480|NCT02100514|58902672|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
30872481|NCT02100514|58902673|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
30872482|NCT02100514|58902674|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
30872483|NCT02100514|58902670|FG000|Treatment Period|Protocol Violation|1|||
30872484|NCT02100514|58902671|FG001|Treatment Period|Protocol Violation|1|||
30872485|NCT02100514|58902672|FG002|Treatment Period|Protocol Violation|0|||
30872486|NCT02100514|58902673|FG003|Treatment Period|Protocol Violation|0|||
30872487|NCT02100514|58902674|FG004|Treatment Period|Protocol Violation|0|||
30872488|NCT02100514|58902670|FG000|Treatment Period|Withdrawal by Subject|12|||
30872489|NCT02100514|58902671|FG001|Treatment Period|Withdrawal by Subject|37|||
30872490|NCT02100514|58902672|FG002|Treatment Period|Withdrawal by Subject|0|||
30602244|NCT01250925|58613594|FG001|Overall Study|Lost to Follow-up|1|||
30602245|NCT01250925|58613595|FG002|Overall Study|Lost to Follow-up|0|||
30602246|NCT01250925|58613593|FG000|Overall Study|Withdrawal by Subject|2|||
30602247|NCT01250925|58613594|FG001|Overall Study|Withdrawal by Subject|0|||
30602248|NCT01250925|58613595|FG002|Overall Study|Withdrawal by Subject|0|||
30602249|NCT01250925|58613593|FG000|Overall Study|Protocol Violation|2|||
30602250|NCT01250925|58613594|FG001|Overall Study|Protocol Violation|0|||
30602251|NCT01250925|58613595|FG002|Overall Study|Protocol Violation|0|||
30602252|NCT01250925|58613593|FG000|Overall Study|Physician Decision|0|||
30602253|NCT01250925|58613594|FG001|Overall Study|Physician Decision|2|||
30602254|NCT01250925|58613595|FG002|Overall Study|Physician Decision|1|||
30602255|NCT01250925|58613593|FG000|Overall Study|Adverse Event|0|||
30602256|NCT01250925|58613594|FG001|Overall Study|Adverse Event|0|||
30602257|NCT01250925|58613595|FG002|Overall Study|Adverse Event|1|||
30872491|NCT02100514|58902673|FG003|Treatment Period|Withdrawal by Subject|0|||
30872492|NCT02100514|58902674|FG004|Treatment Period|Withdrawal by Subject|0|||
30602258|NCT01285908|58613603|FG000|Baseline Measurement|unable to insert catheter|1|||
30602259|NCT01285908|58613604|FG001|Baseline Measurement|unable to insert catheter|0|||
30872493|NCT02100514|58902670|FG000|Treatment Period|Other|9|||
30872494|NCT02100514|58902671|FG001|Treatment Period|Other|11|||
30872495|NCT02100514|58902672|FG002|Treatment Period|Other|0|||
30872496|NCT02100514|58902673|FG003|Treatment Period|Other|0|||
30872497|NCT02100514|58902674|FG004|Treatment Period|Other|0|||
30872498|NCT02100514|58902670|FG000|Extension Period|Withdrew consent|0|||
30872499|NCT02100514|58902671|FG001|Extension Period|Withdrew consent|0|||
30872500|NCT02100514|58902672|FG002|Extension Period|Withdrew consent|2|||
30872501|NCT02100514|58902673|FG003|Extension Period|Withdrew consent|0|||
30872502|NCT02100514|58902674|FG004|Extension Period|Withdrew consent|0|||
30872503|NCT02069392|58902690|FG000|Overall Study|Withdrawal by Subject|4|||
30872504|NCT02069392|58902691|FG001|Overall Study|Withdrawal by Subject|2|||
30872505|NCT02047318|58902699|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
30872506|NCT02047318|58902699|FG000|Core Study Period|Adverse Event|1|||
30872507|NCT02047318|58902699|FG000|Core Study Period|Withdrawal by caregiver|3|||
30872508|NCT02047318|58902699|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
30872509|NCT02100124|58902717|FG000|Overall Study|Lost to Follow-up|5|||
30872510|NCT02100124|58902718|FG001|Overall Study|Lost to Follow-up|11|||
30872511|NCT02100124|58902719|FG002|Overall Study|Lost to Follow-up|3|||
30872512|NCT02100124|58902717|FG000|Overall Study|Withdrawal by Subject|1|||
30872513|NCT02100124|58902718|FG001|Overall Study|Withdrawal by Subject|0|||
30872514|NCT02100124|58902719|FG002|Overall Study|Withdrawal by Subject|0|||
30872515|NCT02068768|58902727|FG000|Overall Study|Lost to Follow-up|5|||
30872516|NCT02068768|58902727|FG000|Overall Study|Early Termination by Sponsor|2|||
30872517|NCT02046616|58902731|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
30872518|NCT02046616|58902731|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
30872519|NCT02046616|58902731|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
30872520|NCT02046616|58902731|FG000|24-Week Treatment Period|Physician Decision|3|||
30872521|NCT02046616|58902731|FG000|24-Week Treatment Period|Other|1|||
30872522|NCT02046616|58902731|FG000|8-Week FU Period|Lost to Follow-up|1|||
30872523|NCT02099344|58902737|FG000|Overall Study|Physician Decision|1|||
30872524|NCT02099344|58902738|FG001|Overall Study|Physician Decision|0|||
30872525|NCT02068222|58902746|FG000|Overall Study|Lost to Follow-up|1|||
30872526|NCT02099110|58902755|FG000|Overall Study|Protocol Violation|2|||
30872527|NCT02099110|58902756|FG001|Overall Study|Protocol Violation|1|||
30872528|NCT02099110|58902757|FG002|Overall Study|Protocol Violation|0|||
30872529|NCT02099110|58902758|FG003|Overall Study|Protocol Violation|3|||
30872530|NCT02099110|58902759|FG004|Overall Study|Protocol Violation|1|||
30872531|NCT02099110|58902755|FG000|Overall Study|Participant moved|1|||
30872532|NCT02099110|58902756|FG001|Overall Study|Participant moved|1|||
30872533|NCT02099110|58902757|FG002|Overall Study|Participant moved|1|||
30872534|NCT02099110|58902758|FG003|Overall Study|Participant moved|0|||
30872535|NCT02099110|58902759|FG004|Overall Study|Participant moved|2|||
30872536|NCT02099110|58902755|FG000|Overall Study|Withdrawal by Subject|7|||
30872537|NCT02099110|58902756|FG001|Overall Study|Withdrawal by Subject|11|||
30872538|NCT02099110|58902757|FG002|Overall Study|Withdrawal by Subject|13|||
30872539|NCT02099110|58902758|FG003|Overall Study|Withdrawal by Subject|9|||
30872540|NCT02099110|58902759|FG004|Overall Study|Withdrawal by Subject|13|||
30872541|NCT02099110|58902755|FG000|Overall Study|Adverse Event|3|||
30872542|NCT02099110|58902756|FG001|Overall Study|Adverse Event|5|||
30872543|NCT02099110|58902757|FG002|Overall Study|Adverse Event|2|||
30872544|NCT02099110|58902758|FG003|Overall Study|Adverse Event|3|||
30872545|NCT02099110|58902759|FG004|Overall Study|Adverse Event|2|||
30872546|NCT02099110|58902755|FG000|Overall Study|Lost to Follow-up|6|||
30872547|NCT02099110|58902756|FG001|Overall Study|Lost to Follow-up|12|||
30872548|NCT02099110|58902757|FG002|Overall Study|Lost to Follow-up|11|||
30872549|NCT02099110|58902758|FG003|Overall Study|Lost to Follow-up|5|||
30872550|NCT02099110|58902759|FG004|Overall Study|Lost to Follow-up|6|||
30872551|NCT02099110|58902755|FG000|Overall Study|Death|0|||
30872552|NCT02099110|58902756|FG001|Overall Study|Death|1|||
30872553|NCT02099110|58902757|FG002|Overall Study|Death|0|||
30872554|NCT02099110|58902758|FG003|Overall Study|Death|0|||
30872555|NCT02099110|58902759|FG004|Overall Study|Death|0|||
30872556|NCT02099110|58902755|FG000|Overall Study|Screen failure|0|||
30872557|NCT02099110|58902756|FG001|Overall Study|Screen failure|0|||
30872558|NCT02099110|58902757|FG002|Overall Study|Screen failure|0|||
30872559|NCT02099110|58902758|FG003|Overall Study|Screen failure|0|||
30872560|NCT02099110|58902759|FG004|Overall Study|Screen failure|1|||
30872561|NCT02099110|58902755|FG000|Overall Study|Non-compliance with study drug|2|||
30872562|NCT02099110|58902756|FG001|Overall Study|Non-compliance with study drug|0|||
30872563|NCT02099110|58902757|FG002|Overall Study|Non-compliance with study drug|0|||
30872564|NCT02099110|58902758|FG003|Overall Study|Non-compliance with study drug|0|||
30872565|NCT02099110|58902759|FG004|Overall Study|Non-compliance with study drug|1|||
30872566|NCT02099110|58902755|FG000|Overall Study|Physician Decision|3|||
30872567|NCT02099110|58902756|FG001|Overall Study|Physician Decision|0|||
30872568|NCT02099110|58902757|FG002|Overall Study|Physician Decision|1|||
30872569|NCT02099110|58902758|FG003|Overall Study|Physician Decision|2|||
30872570|NCT02099110|58902759|FG004|Overall Study|Physician Decision|1|||
30872571|NCT02098876|58902773|FG000|Overall Study|Withdrawal by Subject|5|||
30872572|NCT02098876|58902774|FG001|Overall Study|Withdrawal by Subject|5|||
30872573|NCT01624090|58902784|FG000|Overall Study|DLT, taken off therapy|0|||
30872574|NCT01624090|58902785|FG001|Overall Study|DLT, taken off therapy|1|||
30872575|NCT01624090|58902786|FG002|Overall Study|DLT, taken off therapy|0|||
30872576|NCT01624090|58902787|FG003|Overall Study|DLT, taken off therapy|0|||
30872577|NCT01624090|58902784|FG000|Overall Study|Withdrew prior to treatment|0|||
30872578|NCT01624090|58902785|FG001|Overall Study|Withdrew prior to treatment|1|||
30877501|NCT01998958|58909048|FG027|Open Label Phase (Optional)|Other|0|||
30872579|NCT01624090|58902786|FG002|Overall Study|Withdrew prior to treatment|0|||
30872580|NCT01624090|58902787|FG003|Overall Study|Withdrew prior to treatment|0|||
30872581|NCT01624090|58902784|FG000|Overall Study|Died on study|0|||
30872582|NCT01624090|58902785|FG001|Overall Study|Died on study|0|||
30872583|NCT01624090|58902786|FG002|Overall Study|Died on study|2|||
30872584|NCT01624090|58902787|FG003|Overall Study|Died on study|0|||
30872585|NCT01624090|58902784|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
30872586|NCT01624090|58902785|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
30872587|NCT01624090|58902786|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
30872588|NCT01624090|58902787|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
30872589|NCT01624090|58902784|FG000|Overall Study|Dose escalated|0|||
30872590|NCT01624090|58902785|FG001|Overall Study|Dose escalated|0|||
30872591|NCT01624090|58902786|FG002|Overall Study|Dose escalated|3|||
30872592|NCT01624090|58902787|FG003|Overall Study|Dose escalated|0|||
30872593|NCT02571777|58902802|FG000|Overall Study|Subject/guardian decision|34|||
30872594|NCT02571777|58902803|FG001|Overall Study|Subject/guardian decision|26|||
30872595|NCT02571777|58902804|FG002|Overall Study|Subject/guardian decision|26|||
30872596|NCT02571777|58902805|FG003|Overall Study|Subject/guardian decision|25|||
30872597|NCT02571777|58902806|FG004|Overall Study|Subject/guardian decision|27|||
30872598|NCT02571777|58902802|FG000|Overall Study|Protocol Deviation|2|||
30872599|NCT02571777|58902803|FG001|Overall Study|Protocol Deviation|3|||
30872600|NCT02571777|58902804|FG002|Overall Study|Protocol Deviation|4|||
30872601|NCT02571777|58902805|FG003|Overall Study|Protocol Deviation|8|||
30872602|NCT02571777|58902806|FG004|Overall Study|Protocol Deviation|4|||
30872603|NCT02571777|58902802|FG000|Overall Study|Death|1|||
30872604|NCT02571777|58902803|FG001|Overall Study|Death|1|||
30872605|NCT02571777|58902804|FG002|Overall Study|Death|4|||
30872606|NCT02571777|58902805|FG003|Overall Study|Death|0|||
30872607|NCT02571777|58902806|FG004|Overall Study|Death|0|||
30872608|NCT02571777|58902802|FG000|Overall Study|Lost to Follow-up|1|||
30872609|NCT02571777|58902803|FG001|Overall Study|Lost to Follow-up|1|||
30872610|NCT02571777|58902804|FG002|Overall Study|Lost to Follow-up|2|||
30872611|NCT02571777|58902805|FG003|Overall Study|Lost to Follow-up|0|||
30872612|NCT02571777|58902806|FG004|Overall Study|Lost to Follow-up|1|||
30872613|NCT02571777|58902802|FG000|Overall Study|Physician Decision|1|||
30872614|NCT02571777|58902803|FG001|Overall Study|Physician Decision|7|||
30872615|NCT02571777|58902804|FG002|Overall Study|Physician Decision|5|||
30872616|NCT02571777|58902805|FG003|Overall Study|Physician Decision|2|||
30872617|NCT02571777|58902806|FG004|Overall Study|Physician Decision|4|||
30872618|NCT02571777|58902802|FG000|Overall Study|Pregnancy|0|||
30872619|NCT02571777|58902803|FG001|Overall Study|Pregnancy|0|||
30872620|NCT02571777|58902804|FG002|Overall Study|Pregnancy|0|||
30872621|NCT02571777|58902805|FG003|Overall Study|Pregnancy|2|||
30872622|NCT02571777|58902806|FG004|Overall Study|Pregnancy|0|||
30872623|NCT02571075|58902820|FG000|Overall Study|Lost to Follow-up|20|||
30872624|NCT02571075|58902821|FG001|Overall Study|Lost to Follow-up|24|||
30872625|NCT02705105|58902835|FG000|Treatment|Objective Disease Progression|1|||
30872626|NCT02705105|58902836|FG001|Treatment|Objective Disease Progression|50|||
30872627|NCT02705105|58902835|FG000|Treatment|Withdrawal by Subject|3|||
30872628|NCT02705105|58902836|FG001|Treatment|Withdrawal by Subject|5|||
30872629|NCT02705105|58902835|FG000|Treatment|Adverse Event|0|||
30872630|NCT02705105|58902836|FG001|Treatment|Adverse Event|17|||
30872631|NCT02705105|58902835|FG000|Treatment|Clinical Disease Progression|0|||
30872632|NCT02705105|58902836|FG001|Treatment|Clinical Disease Progression|32|||
30872633|NCT02705105|58902835|FG000|Treatment|Physician Decision|0|||
30872634|NCT02705105|58902836|FG001|Treatment|Physician Decision|3|||
30872635|NCT02705105|58902835|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
30872636|NCT02705105|58902836|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
30872637|NCT02705105|58902835|FG000|Follow-Up|Death|3|||
30872638|NCT02705105|58902836|FG001|Follow-Up|Death|68|||
30872639|NCT02705105|58902835|FG000|Follow-Up|Withdrawal by Subject|1|||
30872640|NCT02705105|58902836|FG001|Follow-Up|Withdrawal by Subject|14|||
30872641|NCT02705105|58902835|FG000|Follow-Up|Study Terminated|0|||
30872642|NCT02705105|58902836|FG001|Follow-Up|Study Terminated|26|||
30872643|NCT02705105|58902835|FG000|Follow-Up|Discontinued per Amendment 3|0|||
30872644|NCT02705105|58902836|FG001|Follow-Up|Discontinued per Amendment 3|2|||
30872645|NCT02097472|58902862|FG000|Received Vaccination 2|Adverse Event|0|||
30872646|NCT02097472|58902863|FG001|Received Vaccination 2|Adverse Event|0|||
30872647|NCT02097472|58902864|FG002|Received Vaccination 2|Adverse Event|0|||
30872648|NCT02097472|58902865|FG003|Received Vaccination 2|Adverse Event|0|||
30872649|NCT02097472|58902866|FG004|Received Vaccination 2|Adverse Event|0|||
30872650|NCT02097472|58902867|FG005|Received Vaccination 2|Adverse Event|0|||
30872651|NCT02097472|58902868|FG006|Received Vaccination 2|Adverse Event|1|||
30872652|NCT02097472|58902869|FG007|Received Vaccination 2|Adverse Event|0|||
30872653|NCT01623310|58902953|FG000|Overall Study|Adverse Event|21|||
30872654|NCT01623310|58902953|FG000|Overall Study|Lost to Follow-up|18|||
30872655|NCT01623310|58902953|FG000|Overall Study|Lack of Efficacy|6|||
30872656|NCT01623310|58902953|FG000|Overall Study|Protocol Violation|6|||
30872657|NCT01623310|58902953|FG000|Overall Study|Withdrawal by Subject|25|||
30877502|NCT01998958|58909049|FG028|Open Label Phase (Optional)|Other|0|||
30872658|NCT01623310|58902953|FG000|Overall Study|Became potentially child-bearing|1|||
30872659|NCT01623310|58902953|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
30872660|NCT01623310|58902953|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
30872661|NCT02046226|58902957|FG000|Overall Study|Lost to Follow-up|7|||
30872662|NCT02046148|58902964|FG000|Overall Study|Lost to Follow-up|1|||
30872663|NCT02046148|58902965|FG001|Overall Study|Lost to Follow-up|1|||
30872664|NCT02046148|58902964|FG000|Overall Study|Withdrawal by Subject|0|||
30872665|NCT02046148|58902965|FG001|Overall Study|Withdrawal by Subject|2|||
30872666|NCT02097238|58902971|FG000|Overall Study|Death|1|||
30872667|NCT02097238|58902971|FG000|Overall Study|Physician Decision|1|||
30872668|NCT02097238|58902971|FG000|Overall Study|Progressive Disease|17|||
30872669|NCT02704091|58902978|FG000|Overall Study|Adverse Event|4|||
30872670|NCT02704091|58902979|FG001|Overall Study|Adverse Event|3|||
30872671|NCT02704091|58902978|FG000|Overall Study|Protocol Violation|5|||
30872672|NCT02704091|58902979|FG001|Overall Study|Protocol Violation|3|||
30872673|NCT02704091|58902978|FG000|Overall Study|Consent withdrawn|4|||
30872674|NCT02704091|58902979|FG001|Overall Study|Consent withdrawn|4|||
30872675|NCT02704091|58902978|FG000|Overall Study|Lost to Follow-up|13|||
30872676|NCT02704091|58902979|FG001|Overall Study|Lost to Follow-up|5|||
30872677|NCT02704091|58902978|FG000|Overall Study|Other|2|||
30872678|NCT02704091|58902979|FG001|Overall Study|Other|8|||
30872679|NCT02702609|58902987|FG000|Overall Study|Lost to Follow-up|8|||
30872680|NCT02702609|58902988|FG001|Overall Study|Lost to Follow-up|4|||
30872681|NCT02702609|58902987|FG000|Overall Study|Physician Decision|1|||
30872682|NCT02702609|58902988|FG001|Overall Study|Physician Decision|0|||
30872683|NCT02046070|58902997|FG000|Overall Study|Progressive Disease|18|||
30872684|NCT02046070|58902998|FG001|Overall Study|Progressive Disease|11|||
30872685|NCT02046070|58902999|FG002|Overall Study|Progressive Disease|40|||
30872686|NCT02046070|58902997|FG000|Overall Study|Adverse Event|8|||
30872687|NCT02046070|58902998|FG001|Overall Study|Adverse Event|10|||
30872688|NCT02046070|58902999|FG002|Overall Study|Adverse Event|17|||
30872689|NCT02046070|58902997|FG000|Overall Study|Withdrawal by Subject|1|||
30872690|NCT02046070|58902998|FG001|Overall Study|Withdrawal by Subject|2|||
30872691|NCT02046070|58902999|FG002|Overall Study|Withdrawal by Subject|6|||
30872692|NCT02046070|58902997|FG000|Overall Study|Study Terminated by Sponsor|1|||
30872693|NCT02046070|58902998|FG001|Overall Study|Study Terminated by Sponsor|1|||
30872694|NCT02046070|58902999|FG002|Overall Study|Study Terminated by Sponsor|1|||
30872695|NCT02046070|58902997|FG000|Overall Study|Reason not Specified|4|||
30872696|NCT02046070|58902998|FG001|Overall Study|Reason not Specified|4|||
30872697|NCT02046070|58902999|FG002|Overall Study|Reason not Specified|6|||
30872698|NCT01663857|58903011|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
30872699|NCT01663857|58903012|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
30872700|NCT01663857|58903013|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
30872701|NCT01663857|58903014|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
30872702|NCT01663857|58903011|FG000|Overall Study|Lost to Follow-up|0|||
30872703|NCT01663857|58903012|FG001|Overall Study|Lost to Follow-up|0|||
30872704|NCT01663857|58903013|FG002|Overall Study|Lost to Follow-up|3|||
30872705|NCT01663857|58903014|FG003|Overall Study|Lost to Follow-up|1|||
30872706|NCT02094898|58903030|FG000|Overall Study|Clinical Worsening|2|||
30872707|NCT02094898|58903030|FG000|Overall Study|Adverse Event|2|||
30872708|NCT02094898|58903030|FG000|Overall Study|Lack of Efficacy|1|||
30872709|NCT02045836|58903038|FG000|Overall Study|Adverse Event|4|||
30872710|NCT02045836|58903039|FG001|Overall Study|Adverse Event|4|||
30872711|NCT02045836|58903038|FG000|Overall Study|Withdrawal by Subject|1|||
30872712|NCT02045836|58903039|FG001|Overall Study|Withdrawal by Subject|1|||
30872713|NCT02045836|58903038|FG000|Overall Study|Lost to Follow-up|4|||
30872714|NCT02045836|58903039|FG001|Overall Study|Lost to Follow-up|7|||
30872715|NCT02045836|58903038|FG000|Overall Study|Migrated from study area|0|||
30872716|NCT02045836|58903039|FG001|Overall Study|Migrated from study area|2|||
30872717|NCT02569437|58903048|FG000|Overall Study|Lost to Follow-up|12|||
30872718|NCT02569437|58903049|FG001|Overall Study|Lost to Follow-up|14|||
30872719|NCT02045212|58903057|FG000|Overall Study|Adverse Event|0|||
30872720|NCT02045212|58903058|FG001|Overall Study|Adverse Event|1|||
30960948|NCT01520909|59026869|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
30872721|NCT02045212|58903057|FG000|Overall Study|Withdrawal by Subject|1|||
30872722|NCT02045212|58903058|FG001|Overall Study|Withdrawal by Subject|0|||
30872723|NCT02045212|58903057|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
30872724|NCT02045212|58903058|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
30872725|NCT02044822|58903068|FG000|Overall Study|Study Terminated by Sponsor|77|||
30872726|NCT02044822|58903068|FG000|Overall Study|Investigator's Discretion|10|||
30872727|NCT02044822|58903068|FG000|Overall Study|Withdrew Consent|3|||
30872728|NCT02044822|58903068|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
30872729|NCT02044822|58903068|FG000|Overall Study|Lost to Follow-up|1|||
30872730|NCT02044510|58903074|FG000|Overall Study|Adverse Event|1|||
30872731|NCT02044510|58903075|FG001|Overall Study|Adverse Event|2|||
30872732|NCT02067676|58903087|FG000|Overall Study|Withdrawal by Subject|1|||
30872733|NCT02067676|58903088|FG001|Overall Study|Withdrawal by Subject|0|||
30872734|NCT02067676|58903089|FG002|Overall Study|Withdrawal by Subject|0|||
30872735|NCT02067676|58903090|FG003|Overall Study|Withdrawal by Subject|0|||
30872736|NCT02067676|58903091|FG004|Overall Study|Withdrawal by Subject|0|||
30872737|NCT02067676|58903092|FG005|Overall Study|Withdrawal by Subject|0|||
30872738|NCT01623154|58903111|FG000|Overall Study|Did not drink Pranactin Citric|4|||
30872739|NCT00702689|58903117|FG000|Overall Study|Withdrawal by Subject|4|||
30872740|NCT00702689|58903117|FG000|Overall Study|Recurrent malignancy|1|||
30872741|NCT00702689|58903117|FG000|Overall Study|Adverse Event|1|||
30872742|NCT02065570|58903123|FG000|Induction Study|Adverse Event|5|||
30872743|NCT02065570|58903124|FG001|Induction Study|Adverse Event|12|||
30872744|NCT02065570|58903125|FG002|Induction Study|Adverse Event|0|||
30694619|NCT00606177|58708796|FG001|Overall Study|Protocol Violation|4|||
30694620|NCT00606177|58708795|FG000|Overall Study|Withdrawal by Subject|5|||
30694621|NCT00606177|58708796|FG001|Overall Study|Withdrawal by Subject|6|||
30694622|NCT00606177|58708795|FG000|Overall Study|Progression to depressive phase|6|||
30872745|NCT02065570|58903126|FG003|Induction Study|Adverse Event|0|||
30872746|NCT02065570|58903123|FG000|Induction Study|Withdrawal by Subject|2|||
30872747|NCT02065570|58903124|FG001|Induction Study|Withdrawal by Subject|3|||
30872748|NCT02065570|58903125|FG002|Induction Study|Withdrawal by Subject|0|||
30872749|NCT02065570|58903126|FG003|Induction Study|Withdrawal by Subject|0|||
30872750|NCT02065570|58903123|FG000|Induction Study|Lost to Follow-up|1|||
30872751|NCT02065570|58903124|FG001|Induction Study|Lost to Follow-up|1|||
30872752|NCT02065570|58903125|FG002|Induction Study|Lost to Follow-up|0|||
30872753|NCT02065570|58903126|FG003|Induction Study|Lost to Follow-up|0|||
30872754|NCT02065570|58903123|FG000|Induction Study|Other, Not Specified|6|||
30872755|NCT02065570|58903124|FG001|Induction Study|Other, Not Specified|5|||
30872756|NCT02065570|58903125|FG002|Induction Study|Other, Not Specified|0|||
30872757|NCT02065570|58903126|FG003|Induction Study|Other, Not Specified|0|||
30872758|NCT02065570|58903123|FG000|Maintenance Study|Adverse Event|0|||
30872759|NCT02065570|58903124|FG001|Maintenance Study|Adverse Event|0|||
30872760|NCT02065570|58903125|FG002|Maintenance Study|Adverse Event|8|||
30602260|NCT01285908|58613605|FG002|Baseline Measurement|unable to insert catheter|0|||
30602261|NCT01285908|58613603|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
30602262|NCT01285908|58613604|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
30602263|NCT01285908|58613605|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
30602264|NCT01285908|58613603|FG000|Baseline Measurement|unable to tolerate procedure|1|||
30602265|NCT01285908|58613604|FG001|Baseline Measurement|unable to tolerate procedure|0|||
30694623|NCT00606177|58708796|FG001|Overall Study|Progression to depressive phase|1|||
30872761|NCT02065570|58903126|FG003|Maintenance Study|Adverse Event|8|||
30872762|NCT02065570|58903123|FG000|Maintenance Study|Withdrawal by Subject|0|||
30872763|NCT02065570|58903124|FG001|Maintenance Study|Withdrawal by Subject|0|||
30872764|NCT02065570|58903125|FG002|Maintenance Study|Withdrawal by Subject|1|||
30872765|NCT02065570|58903126|FG003|Maintenance Study|Withdrawal by Subject|4|||
30872766|NCT02065570|58903123|FG000|Maintenance Study|Lost to Follow-up|0|||
30872767|NCT02065570|58903124|FG001|Maintenance Study|Lost to Follow-up|0|||
30872768|NCT02065570|58903125|FG002|Maintenance Study|Lost to Follow-up|2|||
30872769|NCT02065570|58903126|FG003|Maintenance Study|Lost to Follow-up|2|||
30872770|NCT02065570|58903123|FG000|Maintenance Study|Other, Not Specified|0|||
30872771|NCT02065570|58903124|FG001|Maintenance Study|Other, Not Specified|0|||
30872772|NCT02065570|58903125|FG002|Maintenance Study|Other, Not Specified|11|||
30872773|NCT02065570|58903126|FG003|Maintenance Study|Other, Not Specified|5|||
30872774|NCT02566005|58903139|FG000|Overall Study|vaginal bleeding|0|||
30872775|NCT02566005|58903140|FG001|Overall Study|vaginal bleeding|1|||
30872776|NCT02566005|58903139|FG000|Overall Study|received foley|8|||
30872777|NCT02566005|58903140|FG001|Overall Study|received foley|0|||
30872778|NCT02566005|58903139|FG000|Overall Study|did not receive foley|0|||
30872779|NCT02566005|58903140|FG001|Overall Study|did not receive foley|1|||
30872780|NCT02566005|58903139|FG000|Overall Study|labor after randomization|0|||
30872781|NCT02566005|58903140|FG001|Overall Study|labor after randomization|4|||
30872782|NCT02065336|58903158|FG000|Extension Phase|Study Terminated by Sponsor|0|||
30872783|NCT02065336|58903159|FG001|Extension Phase|Study Terminated by Sponsor|0|||
30872784|NCT02065336|58903160|FG002|Extension Phase|Study Terminated by Sponsor|0|||
30872785|NCT02065336|58903161|FG003|Extension Phase|Study Terminated by Sponsor|0|||
30872786|NCT02065336|58903162|FG004|Extension Phase|Study Terminated by Sponsor|0|||
30872787|NCT02065336|58903163|FG005|Extension Phase|Study Terminated by Sponsor|0|||
30872788|NCT02065336|58903164|FG006|Extension Phase|Study Terminated by Sponsor|0|||
30872789|NCT02065336|58903165|FG007|Extension Phase|Study Terminated by Sponsor|0|||
30872790|NCT02065336|58903166|FG008|Extension Phase|Study Terminated by Sponsor|2|||
30872791|NCT02065336|58903167|FG009|Extension Phase|Study Terminated by Sponsor|8|||
30872792|NCT02701985|58903200|FG000|Overall Study|Withdrawal by Subject|1|||
30872793|NCT02701985|58903201|FG001|Overall Study|Withdrawal by Subject|1|||
30872794|NCT02701985|58903200|FG000|Overall Study|Lost to Follow-up|1|||
30872795|NCT02701985|58903201|FG001|Overall Study|Lost to Follow-up|0|||
30872796|NCT02701985|58903200|FG000|Overall Study|Death|1|||
30872797|NCT02701985|58903201|FG001|Overall Study|Death|0|||
30872798|NCT02701985|58903200|FG000|Overall Study|Adverse Event|0|||
30872799|NCT02701985|58903201|FG001|Overall Study|Adverse Event|5|||
30872800|NCT02064868|58903210|FG000|Overall Study|Lost to Follow-up|14|||
30872801|NCT02064868|58903211|FG001|Overall Study|Lost to Follow-up|8|||
30872802|NCT02064868|58903210|FG000|Overall Study|Physician Decision|1|||
30872803|NCT02064868|58903211|FG001|Overall Study|Physician Decision|0|||
30872804|NCT02064868|58903210|FG000|Overall Study|Withdrawal by Subject|14|||
30872805|NCT02064868|58903211|FG001|Overall Study|Withdrawal by Subject|3|||
30872806|NCT02064868|58903210|FG000|Overall Study|Technical Problems or Missing|5|||
30872807|NCT02064868|58903211|FG001|Overall Study|Technical Problems or Missing|2|||
30872808|NCT02064166|58903219|FG000|Overall Study|Adverse Event|1|||
30872809|NCT02064166|58903220|FG001|Overall Study|Adverse Event|0|||
30872810|NCT02565615|58903253|FG000|Overall Study|Death|0|||
30872811|NCT02565615|58903254|FG001|Overall Study|Death|1|||
30872812|NCT02565615|58903255|FG002|Overall Study|Death|0|||
30872813|NCT02565615|58903256|FG003|Overall Study|Death|0|||
30872814|NCT02565615|58903257|FG004|Overall Study|Death|4|||
30872815|NCT02565615|58903253|FG000|Overall Study|Not willing to participate in study|2|||
30872816|NCT02565615|58903254|FG001|Overall Study|Not willing to participate in study|21|||
30872817|NCT02565615|58903255|FG002|Overall Study|Not willing to participate in study|0|||
30872818|NCT02565615|58903256|FG003|Overall Study|Not willing to participate in study|1|||
30872819|NCT02565615|58903257|FG004|Overall Study|Not willing to participate in study|169|||
30872820|NCT02565615|58903253|FG000|Overall Study|Lost to Follow-up|0|||
30872821|NCT02565615|58903254|FG001|Overall Study|Lost to Follow-up|4|||
30872822|NCT02565615|58903255|FG002|Overall Study|Lost to Follow-up|0|||
30872823|NCT02565615|58903256|FG003|Overall Study|Lost to Follow-up|1|||
30872824|NCT02565615|58903257|FG004|Overall Study|Lost to Follow-up|765|||
30872825|NCT02565615|58903253|FG000|Overall Study|Not meeting eligibility criteria|0|||
30872826|NCT02565615|58903254|FG001|Overall Study|Not meeting eligibility criteria|7|||
30872827|NCT02565615|58903255|FG002|Overall Study|Not meeting eligibility criteria|0|||
30872828|NCT02565615|58903256|FG003|Overall Study|Not meeting eligibility criteria|0|||
30872829|NCT02565615|58903257|FG004|Overall Study|Not meeting eligibility criteria|25|||
30872830|NCT02565615|58903253|FG000|Overall Study|Reason not defined|0|||
30872831|NCT02565615|58903254|FG001|Overall Study|Reason not defined|2|||
30872832|NCT02565615|58903255|FG002|Overall Study|Reason not defined|0|||
30872833|NCT02565615|58903256|FG003|Overall Study|Reason not defined|1|||
30872834|NCT02565615|58903257|FG004|Overall Study|Reason not defined|62|||
30872835|NCT02565615|58903253|FG000|Overall Study|Adverse Event|1|||
30872836|NCT02565615|58903254|FG001|Overall Study|Adverse Event|1|||
30872837|NCT02565615|58903255|FG002|Overall Study|Adverse Event|0|||
30872838|NCT02565615|58903256|FG003|Overall Study|Adverse Event|0|||
30872839|NCT02565615|58903257|FG004|Overall Study|Adverse Event|9|||
30872840|NCT02565615|58903253|FG000|Overall Study|Untreated|0|||
30872841|NCT02565615|58903254|FG001|Overall Study|Untreated|0|||
30872842|NCT02565615|58903255|FG002|Overall Study|Untreated|0|||
30872843|NCT02565615|58903256|FG003|Overall Study|Untreated|0|||
30872844|NCT02565615|58903257|FG004|Overall Study|Untreated|567|||
30872845|NCT02701361|58903272|FG000|Overall Study|Lost to Follow-up|5|||
30872846|NCT02701361|58903273|FG001|Overall Study|Lost to Follow-up|2|||
30872847|NCT02701361|58903274|FG002|Overall Study|Lost to Follow-up|1|||
30872848|NCT02701361|58903272|FG000|Overall Study|Withdrawal by Subject|4|||
30872849|NCT02701361|58903273|FG001|Overall Study|Withdrawal by Subject|0|||
30872850|NCT02701361|58903274|FG002|Overall Study|Withdrawal by Subject|0|||
30872851|NCT02701361|58903272|FG000|Overall Study|timed out in rehab center|0|||
30872852|NCT02701361|58903273|FG001|Overall Study|timed out in rehab center|1|||
30872853|NCT02701361|58903274|FG002|Overall Study|timed out in rehab center|0|||
30872854|NCT02701361|58903272|FG000|Overall Study|incarceration|0|||
30872855|NCT02701361|58903273|FG001|Overall Study|incarceration|0|||
30872856|NCT02701361|58903274|FG002|Overall Study|incarceration|1|||
30872857|NCT02566785|58903295|FG000|Overall Study|Lost to Follow-up|0|||
30960949|NCT01520909|59026870|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
30872858|NCT02566785|58903296|FG001|Overall Study|Lost to Follow-up|2|||
30872859|NCT02566785|58903295|FG000|Overall Study|Worsening condition|1|||
30872860|NCT02566785|58903296|FG001|Overall Study|Worsening condition|1|||
30872861|NCT01662999|58903308|FG000|Period 3|Withdrawal by Subject|0|||
30872862|NCT01662999|58903309|FG001|Period 3|Withdrawal by Subject|1|||
30872863|NCT01662999|58903310|FG002|Period 3|Withdrawal by Subject|0|||
30872864|NCT01662999|58903311|FG003|Period 3|Withdrawal by Subject|0|||
30872865|NCT01662999|58903312|FG004|Period 3|Withdrawal by Subject|0|||
30872866|NCT01662999|58903313|FG005|Period 3|Withdrawal by Subject|0|||
30872867|NCT02565381|58903346|FG000|Overall Study|Lost to Follow-up|1|||
30872868|NCT02565381|58903347|FG001|Overall Study|Lost to Follow-up|0|||
30872869|NCT02565381|58903348|FG002|Overall Study|Lost to Follow-up|1|||
30872870|NCT02063854|58903363|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
30872871|NCT02063854|58903364|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
30872872|NCT02063854|58903365|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
30872873|NCT02063854|58903366|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
30872874|NCT02063854|58903367|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
30872875|NCT02063854|58903368|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
30872876|NCT02063854|58903369|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
30872877|NCT02063854|58903363|FG000|Overall Study|Major Protocol Deviation|0|||
30872878|NCT02063854|58903364|FG001|Overall Study|Major Protocol Deviation|0|||
30872879|NCT02063854|58903365|FG002|Overall Study|Major Protocol Deviation|3|||
30872880|NCT02063854|58903366|FG003|Overall Study|Major Protocol Deviation|0|||
30872881|NCT02063854|58903367|FG004|Overall Study|Major Protocol Deviation|0|||
30872882|NCT02063854|58903368|FG005|Overall Study|Major Protocol Deviation|0|||
30872883|NCT02063854|58903369|FG006|Overall Study|Major Protocol Deviation|0|||
30872884|NCT02063854|58903363|FG000|Overall Study|Voluntary Withdrawal|2|||
30872885|NCT02063854|58903364|FG001|Overall Study|Voluntary Withdrawal|0|||
30872886|NCT02063854|58903365|FG002|Overall Study|Voluntary Withdrawal|8|||
30872887|NCT02063854|58903366|FG003|Overall Study|Voluntary Withdrawal|1|||
30872888|NCT02063854|58903367|FG004|Overall Study|Voluntary Withdrawal|3|||
30872889|NCT02063854|58903368|FG005|Overall Study|Voluntary Withdrawal|6|||
30872890|NCT02063854|58903369|FG006|Overall Study|Voluntary Withdrawal|1|||
30872891|NCT02063854|58903363|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
30872892|NCT02063854|58903364|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
30872893|NCT02063854|58903365|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
30872894|NCT02063854|58903366|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
30872895|NCT02063854|58903367|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
30872896|NCT02063854|58903368|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
30872897|NCT02063854|58903369|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
30872898|NCT02063854|58903363|FG000|Overall Study|Reason Not Specified|1|||
30872899|NCT02063854|58903364|FG001|Overall Study|Reason Not Specified|0|||
30872900|NCT02063854|58903365|FG002|Overall Study|Reason Not Specified|0|||
30872901|NCT02063854|58903366|FG003|Overall Study|Reason Not Specified|0|||
30872902|NCT02063854|58903367|FG004|Overall Study|Reason Not Specified|0|||
30872903|NCT02063854|58903368|FG005|Overall Study|Reason Not Specified|0|||
30872904|NCT02063854|58903369|FG006|Overall Study|Reason Not Specified|0|||
30872905|NCT02063854|58903363|FG000|Overall Study|Did Not Receive Study Drug|0|||
30872906|NCT02063854|58903364|FG001|Overall Study|Did Not Receive Study Drug|0|||
30872907|NCT02063854|58903365|FG002|Overall Study|Did Not Receive Study Drug|0|||
30872908|NCT02063854|58903366|FG003|Overall Study|Did Not Receive Study Drug|0|||
30872909|NCT02063854|58903367|FG004|Overall Study|Did Not Receive Study Drug|0|||
30872910|NCT02063854|58903368|FG005|Overall Study|Did Not Receive Study Drug|1|||
30872911|NCT02063854|58903369|FG006|Overall Study|Did Not Receive Study Drug|0|||
30872912|NCT02063698|58903389|FG000|Overall Study|did not complete booklet for days 2-8|1|||
30872913|NCT02063698|58903390|FG001|Overall Study|did not complete booklet for days 2-8|2|||
30872914|NCT04701333|58903398|FG000|Overall Study|Lost to Follow-up|3|||
30872915|NCT04701333|58903399|FG001|Overall Study|Lost to Follow-up|7|||
30872916|NCT04701333|58903398|FG000|Overall Study|Withdrawal by Subject|0|||
30872917|NCT04701333|58903399|FG001|Overall Study|Withdrawal by Subject|1|||
30872918|NCT02062450|58903407|FG000|Overall Study|No follow-up visit|124|||
30872919|NCT02561247|58903415|FG000|Overall Study|Protocol Violation|1|||
30872920|NCT02561247|58903415|FG000|Overall Study|Withdrawal by Subject|1|||
30872921|NCT02561247|58903415|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
30872922|NCT02061592|58903421|FG000|Period 1|Withdrawal by Subject|1|||
30872923|NCT02061592|58903422|FG001|Period 1|Withdrawal by Subject|0|||
30872924|NCT02061592|58903421|FG000|Period 1|Protocol Violation|1|||
30872925|NCT02061592|58903422|FG001|Period 1|Protocol Violation|0|||
30872926|NCT02061592|58903421|FG000|Period 2|Lost to Follow-up|0|||
30872927|NCT02061592|58903422|FG001|Period 2|Lost to Follow-up|1|||
30872928|NCT01663623|58903432|FG000|Overall Study|Adverse Event|3|||
30872929|NCT01663623|58903433|FG001|Overall Study|Adverse Event|7|||
30872930|NCT01663623|58903432|FG000|Overall Study|Lack of Efficacy|5|||
30872931|NCT01663623|58903433|FG001|Overall Study|Lack of Efficacy|6|||
30872932|NCT01663623|58903432|FG000|Overall Study|Protocol Violation|0|||
30872933|NCT01663623|58903433|FG001|Overall Study|Protocol Violation|1|||
30872934|NCT01663623|58903432|FG000|Overall Study|Other-Study closed/terminated|1|||
30872935|NCT01663623|58903433|FG001|Overall Study|Other-Study closed/terminated|1|||
30872936|NCT01663623|58903432|FG000|Overall Study|Physician Decision|1|||
30872937|NCT01663623|58903433|FG001|Overall Study|Physician Decision|4|||
30872938|NCT01663623|58903432|FG000|Overall Study|Withdrawal by Subject|2|||
30872939|NCT01663623|58903433|FG001|Overall Study|Withdrawal by Subject|1|||
30872940|NCT02042950|58903439|FG000|Overall Study|Progressive Disease|4|||
30872941|NCT02042404|58903443|FG000|Overall Study|Death|1|||
30872942|NCT02042404|58903444|FG001|Overall Study|Death|0|||
30872943|NCT02042404|58903443|FG000|Overall Study|Unrelated Adverse Event|3|||
30872944|NCT02042404|58903444|FG001|Overall Study|Unrelated Adverse Event|0|||
30872945|NCT02042404|58903443|FG000|Overall Study|Inability to meet time requirements|1|||
30872946|NCT02042404|58903444|FG001|Overall Study|Inability to meet time requirements|0|||
30872947|NCT02042014|58903451|FG000|Overall Study|Adverse Event|1|||
30872948|NCT02042014|58903451|FG000|Overall Study|Physician Decision|7|||
30872949|NCT02041702|58903457|FG000|Overall Study|Lost to Follow-up|1|||
30872950|NCT02041702|58903458|FG001|Overall Study|Lost to Follow-up|6|||
30872951|NCT02041702|58903457|FG000|Overall Study|Death|4|||
30872952|NCT02041702|58903458|FG001|Overall Study|Death|0|||
30872953|NCT02041702|58903457|FG000|Overall Study|Withdrawal by Subject|4|||
30872954|NCT02041702|58903458|FG001|Overall Study|Withdrawal by Subject|3|||
30872955|NCT02041702|58903457|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
30872956|NCT02041702|58903458|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
30872957|NCT02041702|58903457|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
30872958|NCT02041702|58903458|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
30872959|NCT02565147|58903466|FG000|Overall Study|Withdrawal by Subject|5|||
30872960|NCT02565147|58903467|FG001|Overall Study|Withdrawal by Subject|1|||
30872961|NCT02565147|58903466|FG000|Overall Study|Lost to Follow-up|0|||
30872962|NCT02565147|58903467|FG001|Overall Study|Lost to Follow-up|1|||
30872963|NCT02565147|58903466|FG000|Overall Study|Death|1|||
30872964|NCT02565147|58903467|FG001|Overall Study|Death|1|||
30872965|NCT02061280|58903475|FG000|Overall Study|Protocol Violation|12|||
30872966|NCT02061280|58903476|FG001|Overall Study|Protocol Violation|8|||
30872967|NCT02061280|58903475|FG000|Overall Study|moved out of state|0|||
30872968|NCT02061280|58903476|FG001|Overall Study|moved out of state|1|||
30872969|NCT02061280|58903475|FG000|Overall Study|Withdrawal by Subject|1|||
30872970|NCT02061280|58903476|FG001|Overall Study|Withdrawal by Subject|2|||
30872971|NCT02061280|58903475|FG000|Overall Study|Lost to Follow-up|5|||
30872972|NCT02061280|58903476|FG001|Overall Study|Lost to Follow-up|1|||
30872973|NCT02061202|58903487|FG000|Overall Study|Lost to Follow-up|1|||
30872974|NCT02061202|58903488|FG001|Overall Study|Lost to Follow-up|1|||
30872975|NCT02059408|58903497|FG000|Overall Study|Did not get tested|0|||
30872976|NCT02059408|58903498|FG001|Overall Study|Did not get tested|330|||
30872977|NCT02059408|58903499|FG002|Overall Study|Did not get tested|358|||
30872978|NCT01625338|58903512|FG000|Overall Study|Enrolled but not Treated|0|||
30872979|NCT01625338|58903513|FG001|Overall Study|Enrolled but not Treated|0|||
30872980|NCT01625338|58903514|FG002|Overall Study|Enrolled but not Treated|1|||
30872981|NCT01625338|58903512|FG000|Overall Study|Efficacy Failure|27|||
30872982|NCT01625338|58903513|FG001|Overall Study|Efficacy Failure|39|||
30872983|NCT01625338|58903514|FG002|Overall Study|Efficacy Failure|31|||
30872984|NCT01625338|58903512|FG000|Overall Study|Lost to Follow-up|3|||
30872985|NCT01625338|58903513|FG001|Overall Study|Lost to Follow-up|3|||
30872986|NCT01625338|58903514|FG002|Overall Study|Lost to Follow-up|2|||
30872987|NCT01625338|58903512|FG000|Overall Study|Investigator Decision|0|||
30872988|NCT01625338|58903513|FG001|Overall Study|Investigator Decision|2|||
30872989|NCT01625338|58903514|FG002|Overall Study|Investigator Decision|1|||
30872990|NCT01625338|58903512|FG000|Overall Study|Subject Withdrew Consent|1|||
30872991|NCT01625338|58903513|FG001|Overall Study|Subject Withdrew Consent|0|||
30872992|NCT01625338|58903514|FG002|Overall Study|Subject Withdrew Consent|2|||
30872993|NCT01625338|58903512|FG000|Overall Study|Adverse Event|1|||
30872994|NCT01625338|58903513|FG001|Overall Study|Adverse Event|0|||
30872995|NCT01625338|58903514|FG002|Overall Study|Adverse Event|1|||
30872996|NCT01625338|58903512|FG000|Overall Study|Study Discontinued by Sponsor|0|||
30872997|NCT01625338|58903513|FG001|Overall Study|Study Discontinued by Sponsor|0|||
30872998|NCT01625338|58903514|FG002|Overall Study|Study Discontinued by Sponsor|1|||
30872999|NCT02560623|58903526|FG000|Overall Study|Unable to swallow sponge|0|||
30873000|NCT02560623|58903527|FG001|Overall Study|Unable to swallow sponge|1|||
30873001|NCT02560623|58903528|FG002|Overall Study|Unable to swallow sponge|0|||
30873002|NCT02560623|58903529|FG003|Overall Study|Unable to swallow sponge|0|||
30873003|NCT02560623|58903526|FG000|Overall Study|Intervention prior to sponge administration|0|||
30873004|NCT02560623|58903527|FG001|Overall Study|Intervention prior to sponge administration|1|||
30873005|NCT02560623|58903528|FG002|Overall Study|Intervention prior to sponge administration|0|||
30873006|NCT02560623|58903529|FG003|Overall Study|Intervention prior to sponge administration|0|||
30873007|NCT02560389|58903542|FG000|Overall Study|Lost to Follow-up|1|||
30873008|NCT02560389|58903543|FG001|Overall Study|Lost to Follow-up|2|||
30873009|NCT02560389|58903544|FG002|Overall Study|Lost to Follow-up|2|||
30873010|NCT02560389|58903542|FG000|Overall Study|Tested positive for illicit substance|0|||
30873011|NCT02560389|58903543|FG001|Overall Study|Tested positive for illicit substance|1|||
30873012|NCT02560389|58903544|FG002|Overall Study|Tested positive for illicit substance|0|||
30873013|NCT02564211|58903552|FG000|Overall Study|Adverse Event|4|||
30873014|NCT02093026|58903556|FG000|Overall Study|Adverse Event|26|||
30873015|NCT02093026|58903556|FG000|Overall Study|Death|10|||
30873016|NCT02093026|58903556|FG000|Overall Study|Other|157|||
30873017|NCT02040844|58903564|FG000|Overall Study|Adverse Event|0|||
30873018|NCT02040844|58903565|FG001|Overall Study|Adverse Event|0|||
30873019|NCT02040844|58903566|FG002|Overall Study|Adverse Event|1|||
30873020|NCT02040844|58903564|FG000|Overall Study|Withdrawal by Subject|16|||
30873021|NCT02040844|58903565|FG001|Overall Study|Withdrawal by Subject|22|||
30873022|NCT02040844|58903566|FG002|Overall Study|Withdrawal by Subject|25|||
30873023|NCT02040844|58903564|FG000|Overall Study|Lost to Follow-up|12|||
30873024|NCT02040844|58903565|FG001|Overall Study|Lost to Follow-up|9|||
30873025|NCT02040844|58903566|FG002|Overall Study|Lost to Follow-up|13|||
30873026|NCT02040844|58903564|FG000|Overall Study|Missing|13|||
30873027|NCT02040844|58903565|FG001|Overall Study|Missing|3|||
30873028|NCT02040844|58903566|FG002|Overall Study|Missing|2|||
30873029|NCT02040844|58903564|FG000|Overall Study|Non-specified|8|||
30873030|NCT02040844|58903565|FG001|Overall Study|Non-specified|2|||
30873031|NCT02040844|58903566|FG002|Overall Study|Non-specified|5|||
30873032|NCT02040844|58903564|FG000|Overall Study|Concomitant medication|1|||
30873033|NCT02040844|58903565|FG001|Overall Study|Concomitant medication|3|||
30873034|NCT02040844|58903566|FG002|Overall Study|Concomitant medication|1|||
30873035|NCT02059174|58903574|FG000|Period 1|Withdrawal by Subject|0|||
30873036|NCT02059174|58903575|FG001|Period 1|Withdrawal by Subject|2|||
30873037|NCT02059174|58903574|FG000|Period 2|Withdrawal by Subject|0|||
30873038|NCT02059174|58903575|FG001|Period 2|Withdrawal by Subject|2|||
30873039|NCT02059174|58903574|FG000|Period 2|Protocol Violation|1|||
30873040|NCT02059174|58903575|FG001|Period 2|Protocol Violation|0|||
30873041|NCT02059174|58903574|FG000|Period 3|Physician Decision|1|||
30873042|NCT02059174|58903575|FG001|Period 3|Physician Decision|0|||
30873043|NCT02092324|58903583|FG000|Overall Study|Adverse Event|1|||
30873044|NCT02092324|58903583|FG000|Overall Study|Lack of Efficacy|6|||
30873045|NCT02092324|58903583|FG000|Overall Study|Proceed to Transplant|3|||
30873046|NCT02092324|58903583|FG000|Overall Study|Physician Decision|7|||
30873047|NCT02092324|58903583|FG000|Overall Study|Misdiagnosis|2|||
30873048|NCT02040766|58903595|FG000|Overall Study|Adverse Event|1|||
30873049|NCT02040766|58903596|FG001|Overall Study|Adverse Event|1|||
30873050|NCT02040766|58903597|FG002|Overall Study|Adverse Event|1|||
30873051|NCT02040766|58903598|FG003|Overall Study|Adverse Event|0|||
30873052|NCT02040766|58903599|FG004|Overall Study|Adverse Event|2|||
30873053|NCT02040766|58903595|FG000|Overall Study|Withdrawal by Subject|4|||
30873054|NCT02040766|58903596|FG001|Overall Study|Withdrawal by Subject|3|||
30873055|NCT02040766|58903597|FG002|Overall Study|Withdrawal by Subject|2|||
30873056|NCT02040766|58903598|FG003|Overall Study|Withdrawal by Subject|3|||
30873057|NCT02040766|58903599|FG004|Overall Study|Withdrawal by Subject|2|||
30873058|NCT02040766|58903595|FG000|Overall Study|Non-compliance|0|||
30873059|NCT02040766|58903596|FG001|Overall Study|Non-compliance|1|||
30873060|NCT02040766|58903597|FG002|Overall Study|Non-compliance|0|||
30873061|NCT02040766|58903598|FG003|Overall Study|Non-compliance|0|||
30873062|NCT02040766|58903599|FG004|Overall Study|Non-compliance|0|||
30873063|NCT02040766|58903595|FG000|Overall Study|Protocol Violation|2|||
30873064|NCT02040766|58903596|FG001|Overall Study|Protocol Violation|1|||
30873065|NCT02040766|58903597|FG002|Overall Study|Protocol Violation|2|||
30873066|NCT02040766|58903598|FG003|Overall Study|Protocol Violation|3|||
30873067|NCT02040766|58903599|FG004|Overall Study|Protocol Violation|0|||
30873068|NCT02040766|58903595|FG000|Overall Study|Lost to Follow-up|4|||
30873069|NCT02040766|58903596|FG001|Overall Study|Lost to Follow-up|1|||
30873070|NCT02040766|58903597|FG002|Overall Study|Lost to Follow-up|3|||
30873071|NCT02040766|58903598|FG003|Overall Study|Lost to Follow-up|1|||
30873072|NCT02040766|58903599|FG004|Overall Study|Lost to Follow-up|4|||
30873073|NCT02040766|58903595|FG000|Overall Study|Not reported|1|||
30873074|NCT02040766|58903596|FG001|Overall Study|Not reported|0|||
30873075|NCT02040766|58903597|FG002|Overall Study|Not reported|0|||
30873076|NCT02040766|58903598|FG003|Overall Study|Not reported|0|||
30873077|NCT02040766|58903599|FG004|Overall Study|Not reported|0|||
30873078|NCT02040766|58903595|FG000|Overall Study|Lack of Efficacy|6|||
30873079|NCT02040766|58903596|FG001|Overall Study|Lack of Efficacy|3|||
30873080|NCT02040766|58903597|FG002|Overall Study|Lack of Efficacy|4|||
30873081|NCT02040766|58903598|FG003|Overall Study|Lack of Efficacy|6|||
30873082|NCT02040766|58903599|FG004|Overall Study|Lack of Efficacy|5|||
30873083|NCT02040532|58903612|FG000|Overall Study|Lost to Follow-up|1|||
30873084|NCT02040532|58903612|FG000|Overall Study|Physician Decision|4|||
30873085|NCT02040532|58903612|FG000|Overall Study|Adverse Event|4|||
30873086|NCT02040532|58903612|FG000|Overall Study|Withdrawal by Subject|3|||
30873087|NCT02039908|58903616|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
30873088|NCT02039908|58903617|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
30873089|NCT02039908|58903618|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
30694624|NCT00606177|58708795|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
30873090|NCT02039908|58903619|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
30873091|NCT02039908|58903616|FG000|Phase 1-Summer|Protocol Violation|6|||
30873092|NCT02039908|58903617|FG001|Phase 1-Summer|Protocol Violation|0|||
30873093|NCT02039908|58903618|FG002|Phase 1-Summer|Protocol Violation|0|||
30873094|NCT02039908|58903619|FG003|Phase 1-Summer|Protocol Violation|0|||
30873095|NCT02039908|58903616|FG000|Phase 2-School Year|Lost to Follow-up|0|||
30873096|NCT02039908|58903617|FG001|Phase 2-School Year|Lost to Follow-up|0|||
30873097|NCT02039908|58903618|FG002|Phase 2-School Year|Lost to Follow-up|1|||
30873098|NCT02039908|58903619|FG003|Phase 2-School Year|Lost to Follow-up|3|||
30873099|NCT02039908|58903616|FG000|Phase 2-School Year|Protocol Violation|0|||
30873100|NCT02039908|58903617|FG001|Phase 2-School Year|Protocol Violation|0|||
30873101|NCT02039908|58903618|FG002|Phase 2-School Year|Protocol Violation|3|||
30873102|NCT02039908|58903619|FG003|Phase 2-School Year|Protocol Violation|0|||
30873103|NCT02039908|58903616|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
30873104|NCT02039908|58903617|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
30873105|NCT02039908|58903618|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
30873106|NCT02039908|58903619|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
30873107|NCT02058940|58903627|FG000|Overall Study|Discharged from Critical Care Unit|1|||
30873108|NCT02058628|58903633|FG000|Overall Study|Adverse Event|1|||
30873109|NCT02058628|58903634|FG001|Overall Study|Adverse Event|0|||
30873110|NCT02058628|58903633|FG000|Overall Study|Withdrawal by Subject|2|||
30873111|NCT02058628|58903634|FG001|Overall Study|Withdrawal by Subject|2|||
30873112|NCT02058628|58903633|FG000|Overall Study|Lost to Follow-up|2|||
30873113|NCT02058628|58903634|FG001|Overall Study|Lost to Follow-up|4|||
30873114|NCT02058628|58903633|FG000|Overall Study|Not in time schedule|0|||
30873115|NCT02058628|58903634|FG001|Overall Study|Not in time schedule|1|||
30873116|NCT02058628|58903633|FG000|Overall Study|The visit date was not in timeline|0|||
30873117|NCT02058628|58903634|FG001|Overall Study|The visit date was not in timeline|1|||
30873118|NCT02058628|58903633|FG000|Overall Study|A lot of time for study for participant|1|||
30873119|NCT02058628|58903634|FG001|Overall Study|A lot of time for study for participant|0|||
30873120|NCT02058628|58903633|FG000|Overall Study|Non compliance|1|||
30873121|NCT02058628|58903634|FG001|Overall Study|Non compliance|0|||
30873122|NCT02058160|58903645|FG000|Overall Study|Randomized but not treated|2|||
30873123|NCT02058160|58903646|FG001|Overall Study|Randomized but not treated|4|||
30873124|NCT02058160|58903645|FG000|Overall Study|Poor compliance to protocol|4|||
30873125|NCT02058160|58903646|FG001|Overall Study|Poor compliance to protocol|1|||
30873126|NCT02058160|58903645|FG000|Overall Study|Adverse Event|12|||
30873127|NCT02058160|58903646|FG001|Overall Study|Adverse Event|3|||
30873128|NCT02058160|58903645|FG000|Overall Study|Lost to Follow-up|1|||
30873129|NCT02058160|58903646|FG001|Overall Study|Lost to Follow-up|0|||
30873130|NCT02058160|58903645|FG000|Overall Study|Other than specified above|12|||
30873131|NCT02058160|58903646|FG001|Overall Study|Other than specified above|6|||
30873132|NCT02090764|58903654|FG000|Overall Study|Adverse Event|1|||
30873133|NCT02090764|58903655|FG001|Overall Study|Adverse Event|3|||
30873134|NCT02090764|58903654|FG000|Overall Study|Lack of Efficacy|0|||
30873135|NCT02090764|58903655|FG001|Overall Study|Lack of Efficacy|13|||
30873136|NCT02090764|58903654|FG000|Overall Study|Withdrawal by Subject|2|||
30873137|NCT02090764|58903655|FG001|Overall Study|Withdrawal by Subject|1|||
30873138|NCT02090764|58903654|FG000|Overall Study|Intercurrent illness and other|1|||
30873139|NCT02090764|58903655|FG001|Overall Study|Intercurrent illness and other|1|||
30873140|NCT02090764|58903654|FG000|Overall Study|Lost to Follow-up|2|||
30873141|NCT02090764|58903655|FG001|Overall Study|Lost to Follow-up|2|||
30873142|NCT02057692|58903665|FG000|Overall Study|Adverse Event|1|||
30873143|NCT02057692|58903666|FG001|Overall Study|Adverse Event|0|||
30873144|NCT02057692|58903667|FG002|Overall Study|Adverse Event|0|||
30873145|NCT02057692|58903668|FG003|Overall Study|Adverse Event|0|||
30873146|NCT02057692|58903665|FG000|Overall Study|Lost to Follow-up|0|||
30873147|NCT02057692|58903666|FG001|Overall Study|Lost to Follow-up|0|||
30873148|NCT02057692|58903667|FG002|Overall Study|Lost to Follow-up|0|||
30873149|NCT02057692|58903668|FG003|Overall Study|Lost to Follow-up|1|||
30873150|NCT02038036|58903686|FG000|Core Study|Adverse Event|7|||
30873151|NCT02038036|58903687|FG001|Core Study|Adverse Event|7|||
30873152|NCT02038036|58903686|FG000|Core Study|Death|1|||
30873153|NCT02038036|58903687|FG001|Core Study|Death|1|||
30873154|NCT02038036|58903686|FG000|Core Study|Disease progression|2|||
30873155|NCT02038036|58903687|FG001|Core Study|Disease progression|2|||
30873156|NCT02038036|58903686|FG000|Core Study|Lost to Follow-up|0|||
30873157|NCT02038036|58903687|FG001|Core Study|Lost to Follow-up|1|||
30873158|NCT02038036|58903686|FG000|Core Study|Physician Decision|2|||
30873159|NCT02038036|58903687|FG001|Core Study|Physician Decision|1|||
30873160|NCT02038036|58903686|FG000|Core Study|Subject/guardian decision|0|||
30873161|NCT02038036|58903687|FG001|Core Study|Subject/guardian decision|1|||
30873162|NCT02038036|58903686|FG000|Core Study|Withdrawal by Subject|3|||
30873163|NCT02038036|58903687|FG001|Core Study|Withdrawal by Subject|1|||
30873164|NCT02038036|58903686|FG000|Crossover Period|Withdrawal by Subject|0|||
30873165|NCT02038036|58903687|FG001|Crossover Period|Withdrawal by Subject|3|||
30873166|NCT02038036|58903686|FG000|Crossover Period|Adverse Event|0|||
30873167|NCT02038036|58903687|FG001|Crossover Period|Adverse Event|9|||
30873168|NCT02038036|58903686|FG000|Crossover Period|Death|0|||
30873169|NCT02038036|58903687|FG001|Crossover Period|Death|2|||
30873170|NCT02038036|58903686|FG000|Crossover Period|Disease progression|0|||
30873171|NCT02038036|58903687|FG001|Crossover Period|Disease progression|3|||
30873172|NCT02038036|58903686|FG000|Crossover Period|Lost to Follow-up|0|||
30873173|NCT02038036|58903687|FG001|Crossover Period|Lost to Follow-up|1|||
30873174|NCT02038036|58903686|FG000|Crossover Period|Physician Decision|0|||
30873175|NCT02038036|58903687|FG001|Crossover Period|Physician Decision|2|||
30873176|NCT02037568|58903698|FG000|Overall Study|Withdrawal by Subject|17|||
30873177|NCT02037568|58903699|FG001|Overall Study|Withdrawal by Subject|24|||
30873178|NCT02037568|58903698|FG000|Overall Study|Lost to Follow-up|16|||
30873179|NCT02037568|58903699|FG001|Overall Study|Lost to Follow-up|13|||
30960950|NCT01520909|59026868|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
30873180|NCT02037568|58903698|FG000|Overall Study|Screen Failure|3|||
30873181|NCT02037568|58903699|FG001|Overall Study|Screen Failure|1|||
30873182|NCT02037568|58903698|FG000|Overall Study|Patient did not receive transplant|0|||
30873183|NCT02037568|58903699|FG001|Overall Study|Patient did not receive transplant|1|||
30873184|NCT02088034|58903708|FG000|Overall Study|Lost to Follow-up|1|||
30873185|NCT02088034|58903709|FG001|Overall Study|Lost to Follow-up|1|||
30873186|NCT02088034|58903710|FG002|Overall Study|Lost to Follow-up|0|||
30873187|NCT02088034|58903708|FG000|Overall Study|Pregnancy|2|||
30873188|NCT02088034|58903709|FG001|Overall Study|Pregnancy|1|||
30873189|NCT02088034|58903710|FG002|Overall Study|Pregnancy|2|||
30873190|NCT02037256|58903720|FG000|Overall Study|Protocol Violation|0|||
30873191|NCT02037256|58903721|FG001|Overall Study|Protocol Violation|1|||
30873192|NCT02037256|58903720|FG000|Overall Study|Withdrawn prior to Velcade|0|||
30873193|NCT02037256|58903721|FG001|Overall Study|Withdrawn prior to Velcade|2|||
30873194|NCT02035696|58903733|FG000|Overall Study|Lost to Follow-up|0|||
30873195|NCT02035696|58903734|FG001|Overall Study|Lost to Follow-up|3|||
30873196|NCT02035696|58903735|FG002|Overall Study|Lost to Follow-up|1|||
30873197|NCT02035696|58903736|FG003|Overall Study|Lost to Follow-up|2|||
30873198|NCT02035696|58903733|FG000|Overall Study|Withdrawal by Subject|3|||
30873199|NCT02035696|58903734|FG001|Overall Study|Withdrawal by Subject|0|||
30873200|NCT02035696|58903735|FG002|Overall Study|Withdrawal by Subject|2|||
30873201|NCT02035696|58903736|FG003|Overall Study|Withdrawal by Subject|1|||
30873202|NCT02057458|58903750|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
30873203|NCT02057458|58903751|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
30873204|NCT02057458|58903752|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
30873205|NCT02057458|58903750|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
30873206|NCT02057458|58903751|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
30873207|NCT02057458|58903752|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
30873208|NCT02057458|58903750|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
30873209|NCT02057458|58903751|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
30873210|NCT02057458|58903752|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
30873211|NCT02057068|58903784|FG000|Overall Study|Withdrawal by Subject|2|||
30873212|NCT02057068|58903785|FG001|Overall Study|Withdrawal by Subject|2|||
30873213|NCT02057068|58903784|FG000|Overall Study|Caregiver (CG) Health|0|||
30873214|NCT02057068|58903785|FG001|Overall Study|Caregiver (CG) Health|2|||
30873215|NCT02057068|58903784|FG000|Overall Study|Carepartner (CP) Health|4|||
30873216|NCT02057068|58903785|FG001|Overall Study|Carepartner (CP) Health|2|||
30873217|NCT02057068|58903784|FG000|Overall Study|Lost to Follow-up|2|||
30873218|NCT02057068|58903785|FG001|Overall Study|Lost to Follow-up|2|||
30873219|NCT02056834|58903793|FG000|Overall Study|Lost to Follow-up|7|||
30873220|NCT02087176|58903798|FG000|Overall Study|Withdrawal by Subject|1|||
30873221|NCT02087176|58903798|FG000|Overall Study|Death|10|||
30873222|NCT02087176|58903798|FG000|Overall Study|Censored|19|||
30873223|NCT02087176|58903798|FG000|Overall Study|Study Terminated by Sponsor|2|||
30873224|NCT02056288|58903804|FG000|In-Hospital Data|Surgery cancelled|1|||
30873225|NCT02056288|58903805|FG001|In-Hospital Data|Surgery cancelled|0|||
30873226|NCT02056288|58903804|FG000|In-Hospital Data|Protocol Violation|3|||
30873227|NCT02056288|58903805|FG001|In-Hospital Data|Protocol Violation|0|||
30873228|NCT02056288|58903804|FG000|In-Hospital Data|Physician Decision|1|||
30873229|NCT02056288|58903805|FG001|In-Hospital Data|Physician Decision|0|||
30873230|NCT02056288|58903804|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
30873231|NCT02056288|58903805|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
30873232|NCT02086162|58903813|FG000|Overall Study|Withdrawal by Subject|4|||
30873233|NCT02086162|58903814|FG001|Overall Study|Withdrawal by Subject|4|||
30873234|NCT02086162|58903813|FG000|Overall Study|moved|1|||
30873235|NCT02086162|58903814|FG001|Overall Study|moved|1|||
30873236|NCT02086162|58903813|FG000|Overall Study|Lost to Follow-up|4|||
30873237|NCT02086162|58903814|FG001|Overall Study|Lost to Follow-up|2|||
30873238|NCT02086162|58903813|FG000|Overall Study|Death|1|||
30873239|NCT02086162|58903814|FG001|Overall Study|Death|0|||
30873240|NCT02700815|58903828|FG000|Overall Study|Adverse Event|0|||
30873241|NCT02700815|58903829|FG001|Overall Study|Adverse Event|6|||
30602266|NCT01285908|58613605|FG002|Baseline Measurement|unable to tolerate procedure|0|||
30602267|NCT01250769|58613639|FG000|Overall Study|Withdrawal by Subject|0|||
30602268|NCT01250769|58613640|FG001|Overall Study|Withdrawal by Subject|1|||
30873242|NCT02700815|58903830|FG002|Overall Study|Adverse Event|2|||
30873243|NCT02700815|58903831|FG003|Overall Study|Adverse Event|3|||
30873244|NCT02700815|58903828|FG000|Overall Study|Lack of Efficacy|0|||
30873245|NCT02700815|58903829|FG001|Overall Study|Lack of Efficacy|0|||
30873246|NCT02700815|58903830|FG002|Overall Study|Lack of Efficacy|1|||
30873247|NCT02700815|58903831|FG003|Overall Study|Lack of Efficacy|2|||
30873248|NCT02700815|58903828|FG000|Overall Study|Lost to Follow-up|1|||
30873249|NCT02700815|58903829|FG001|Overall Study|Lost to Follow-up|0|||
30873250|NCT02700815|58903830|FG002|Overall Study|Lost to Follow-up|0|||
30873251|NCT02700815|58903831|FG003|Overall Study|Lost to Follow-up|1|||
30873252|NCT02700815|58903828|FG000|Overall Study|Refusal to continue medication|0|||
30873253|NCT02700815|58903829|FG001|Overall Study|Refusal to continue medication|1|||
30873254|NCT02700815|58903830|FG002|Overall Study|Refusal to continue medication|0|||
30873255|NCT02700815|58903831|FG003|Overall Study|Refusal to continue medication|1|||
30873256|NCT02700815|58903828|FG000|Overall Study|Withdrawal by Subject|0|||
30873257|NCT02700815|58903829|FG001|Overall Study|Withdrawal by Subject|0|||
30873258|NCT02700815|58903830|FG002|Overall Study|Withdrawal by Subject|1|||
30873259|NCT02700815|58903831|FG003|Overall Study|Withdrawal by Subject|0|||
30873260|NCT00708305|58903841|FG000|Period 1|Protocol Violation|1|||
30873261|NCT00708305|58903842|FG001|Period 1|Protocol Violation|0|||
30873262|NCT00708305|58903843|FG002|Period 1|Protocol Violation|1|||
30873263|NCT00708305|58903844|FG003|Period 1|Protocol Violation|0|||
30873264|NCT00708305|58903841|FG000|Period 1|Other Reason|0|||
30873265|NCT00708305|58903842|FG001|Period 1|Other Reason|0|||
30873266|NCT00708305|58903843|FG002|Period 1|Other Reason|0|||
30873267|NCT00708305|58903844|FG003|Period 1|Other Reason|2|||
30873268|NCT00708305|58903841|FG000|Period 2|Lost to Follow-up|0|||
30873269|NCT00708305|58903842|FG001|Period 2|Lost to Follow-up|1|||
30873270|NCT00708305|58903843|FG002|Period 2|Lost to Follow-up|0|||
30873271|NCT00708305|58903844|FG003|Period 2|Lost to Follow-up|0|||
30873272|NCT00708305|58903841|FG000|Period 2|Protocol Violation|0|||
30873273|NCT00708305|58903842|FG001|Period 2|Protocol Violation|1|||
30873274|NCT00708305|58903843|FG002|Period 2|Protocol Violation|0|||
30873275|NCT00708305|58903844|FG003|Period 2|Protocol Violation|0|||
30873276|NCT00708305|58903841|FG000|Period 2|Other Reason|1|||
30873277|NCT00708305|58903842|FG001|Period 2|Other Reason|0|||
30873278|NCT00708305|58903843|FG002|Period 2|Other Reason|0|||
30873279|NCT00708305|58903844|FG003|Period 2|Other Reason|1|||
30873280|NCT00708305|58903841|FG000|Period 3|Protocol Violation|0|||
30873281|NCT00708305|58903842|FG001|Period 3|Protocol Violation|2|||
30873282|NCT00708305|58903843|FG002|Period 3|Protocol Violation|0|||
30960951|NCT01520909|59026869|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
30960952|NCT01520909|59026870|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
30873283|NCT00708305|58903844|FG003|Period 3|Protocol Violation|0|||
30873284|NCT00708305|58903841|FG000|Period 3|Other Reason|1|||
30873285|NCT00708305|58903842|FG001|Period 3|Other Reason|0|||
30873286|NCT00708305|58903843|FG002|Period 3|Other Reason|0|||
30873287|NCT00708305|58903844|FG003|Period 3|Other Reason|0|||
30873288|NCT02055976|58903866|FG000|Overall Study|Other|0|||
30873289|NCT02055976|58903867|FG001|Overall Study|Other|0|||
30873290|NCT02055976|58903868|FG002|Overall Study|Other|1|||
30873291|NCT02055976|58903869|FG003|Overall Study|Other|0|||
30873292|NCT02055976|58903870|FG004|Overall Study|Other|0|||
30873293|NCT02055976|58903871|FG005|Overall Study|Other|0|||
30873294|NCT02055976|58903872|FG006|Overall Study|Other|0|||
30873295|NCT02055976|58903873|FG007|Overall Study|Other|0|||
30873296|NCT02055976|58903874|FG008|Overall Study|Other|0|||
30873297|NCT02055976|58903866|FG000|Overall Study|Adverse Event|0|||
30873298|NCT02055976|58903867|FG001|Overall Study|Adverse Event|0|||
30873299|NCT02055976|58903868|FG002|Overall Study|Adverse Event|0|||
30873300|NCT02055976|58903869|FG003|Overall Study|Adverse Event|0|||
30873301|NCT02055976|58903870|FG004|Overall Study|Adverse Event|0|||
30873302|NCT02055976|58903871|FG005|Overall Study|Adverse Event|1|||
30873303|NCT02055976|58903872|FG006|Overall Study|Adverse Event|1|||
30873304|NCT02055976|58903873|FG007|Overall Study|Adverse Event|0|||
30873305|NCT02055976|58903874|FG008|Overall Study|Adverse Event|0|||
30873306|NCT02055976|58903866|FG000|Overall Study|Does not meet entrance criteria|0|||
30873307|NCT02055976|58903867|FG001|Overall Study|Does not meet entrance criteria|0|||
30873308|NCT02055976|58903868|FG002|Overall Study|Does not meet entrance criteria|0|||
30873309|NCT02055976|58903869|FG003|Overall Study|Does not meet entrance criteria|0|||
30873310|NCT02055976|58903870|FG004|Overall Study|Does not meet entrance criteria|0|||
30873311|NCT02055976|58903871|FG005|Overall Study|Does not meet entrance criteria|0|||
30873312|NCT02055976|58903872|FG006|Overall Study|Does not meet entrance criteria|1|||
30873313|NCT02055976|58903873|FG007|Overall Study|Does not meet entrance criteria|0|||
30873314|NCT02055976|58903874|FG008|Overall Study|Does not meet entrance criteria|0|||
30873315|NCT02055976|58903866|FG000|Overall Study|Lost to Follow-up|0|||
30873316|NCT02055976|58903867|FG001|Overall Study|Lost to Follow-up|0|||
30873317|NCT02055976|58903868|FG002|Overall Study|Lost to Follow-up|0|||
30873318|NCT02055976|58903869|FG003|Overall Study|Lost to Follow-up|1|||
30873319|NCT02055976|58903870|FG004|Overall Study|Lost to Follow-up|0|||
30873320|NCT02055976|58903871|FG005|Overall Study|Lost to Follow-up|0|||
30873321|NCT02055976|58903872|FG006|Overall Study|Lost to Follow-up|0|||
30873322|NCT02055976|58903873|FG007|Overall Study|Lost to Follow-up|0|||
30873323|NCT02055976|58903874|FG008|Overall Study|Lost to Follow-up|0|||
30873324|NCT02055898|58903903|FG000|First Intervention (5 Days)|Physician Decision|2|||
30873325|NCT02055898|58903904|FG001|First Intervention (5 Days)|Physician Decision|0|||
30873326|NCT02055898|58903903|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
30873327|NCT02055898|58903904|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
30873328|NCT02564055|58903916|FG000|Overall Study|Adverse Event|1|||
30873329|NCT02564055|58903917|FG001|Overall Study|Adverse Event|0|||
30873330|NCT02564055|58903918|FG002|Overall Study|Adverse Event|4|||
30873331|NCT02564055|58903919|FG003|Overall Study|Adverse Event|1|||
30873332|NCT02564055|58903920|FG004|Overall Study|Adverse Event|4|||
30873333|NCT02564055|58903921|FG005|Overall Study|Adverse Event|1|||
30873334|NCT02564055|58903916|FG000|Overall Study|Protocol Violation|1|||
30873335|NCT02564055|58903917|FG001|Overall Study|Protocol Violation|0|||
30873336|NCT02564055|58903918|FG002|Overall Study|Protocol Violation|0|||
30873337|NCT02564055|58903919|FG003|Overall Study|Protocol Violation|0|||
30873338|NCT02564055|58903920|FG004|Overall Study|Protocol Violation|0|||
30873339|NCT02564055|58903921|FG005|Overall Study|Protocol Violation|0|||
30873340|NCT02564055|58903916|FG000|Overall Study|Reached stopping criteria|0|||
30873341|NCT02564055|58903917|FG001|Overall Study|Reached stopping criteria|0|||
30873342|NCT02564055|58903918|FG002|Overall Study|Reached stopping criteria|0|||
30873343|NCT02564055|58903919|FG003|Overall Study|Reached stopping criteria|0|||
30873344|NCT02564055|58903920|FG004|Overall Study|Reached stopping criteria|0|||
30873345|NCT02564055|58903921|FG005|Overall Study|Reached stopping criteria|1|||
30873346|NCT02564055|58903916|FG000|Overall Study|Lost to Follow-up|0|||
30873347|NCT02564055|58903917|FG001|Overall Study|Lost to Follow-up|1|||
30873348|NCT02564055|58903918|FG002|Overall Study|Lost to Follow-up|4|||
30873349|NCT02564055|58903919|FG003|Overall Study|Lost to Follow-up|2|||
30873350|NCT02564055|58903920|FG004|Overall Study|Lost to Follow-up|1|||
30873351|NCT02564055|58903921|FG005|Overall Study|Lost to Follow-up|0|||
30873352|NCT02564055|58903916|FG000|Overall Study|Physician Decision|0|||
30873353|NCT02564055|58903917|FG001|Overall Study|Physician Decision|0|||
30873354|NCT02564055|58903918|FG002|Overall Study|Physician Decision|1|||
30873355|NCT02564055|58903919|FG003|Overall Study|Physician Decision|0|||
30873356|NCT02564055|58903920|FG004|Overall Study|Physician Decision|0|||
30873357|NCT02564055|58903921|FG005|Overall Study|Physician Decision|0|||
30873358|NCT02564055|58903916|FG000|Overall Study|Withdrawal by Subject|4|||
30873359|NCT02564055|58903917|FG001|Overall Study|Withdrawal by Subject|4|||
30873360|NCT02564055|58903918|FG002|Overall Study|Withdrawal by Subject|3|||
30873361|NCT02564055|58903919|FG003|Overall Study|Withdrawal by Subject|3|||
30873362|NCT02564055|58903920|FG004|Overall Study|Withdrawal by Subject|10|||
30873363|NCT02564055|58903921|FG005|Overall Study|Withdrawal by Subject|10|||
30873364|NCT02563899|58903939|FG000|Overall Study|Protocol Violation|1|||
30873365|NCT02563899|58903940|FG001|Overall Study|Protocol Violation|0|||
30873366|NCT02563899|58903941|FG002|Overall Study|Protocol Violation|0|||
30873367|NCT02563899|58903942|FG003|Overall Study|Protocol Violation|0|||
30873368|NCT02563899|58903939|FG000|Overall Study|Withdrawal by Subject|0|||
30873369|NCT02563899|58903940|FG001|Overall Study|Withdrawal by Subject|0|||
30873370|NCT02563899|58903941|FG002|Overall Study|Withdrawal by Subject|1|||
30873371|NCT02563899|58903942|FG003|Overall Study|Withdrawal by Subject|0|||
30873372|NCT02699099|58903956|FG000|Overall Study|Adverse Event|1|||
30873373|NCT02699099|58903957|FG001|Overall Study|Adverse Event|0|||
30873374|NCT02699099|58903958|FG002|Overall Study|Adverse Event|2|||
30873375|NCT02699099|58903956|FG000|Overall Study|Lost to Follow-up|0|||
30873376|NCT02699099|58903957|FG001|Overall Study|Lost to Follow-up|1|||
30873377|NCT02699099|58903958|FG002|Overall Study|Lost to Follow-up|0|||
30873378|NCT02699099|58903956|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
30873379|NCT02699099|58903957|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
30873380|NCT02699099|58903958|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
30873381|NCT04399551|58903968|FG000|Overall Study|Adverse Event|12|||
30873382|NCT04399551|58903968|FG000|Overall Study|Withdrawal by Subject|6|||
30873383|NCT04399551|58903968|FG000|Overall Study|Physician Decision|3|||
30873384|NCT04399551|58903968|FG000|Overall Study|Lost to Follow-up|1|||
30873385|NCT04399551|58903968|FG000|Overall Study|Protocol Deviation|2|||
30873386|NCT04399551|58903968|FG000|Overall Study|Ongoing|100|||
30873387|NCT02698865|58903982|FG000|Overall Study|Other|11|||
30873388|NCT02698865|58903983|FG001|Overall Study|Other|11|||
30873389|NCT02698865|58903982|FG000|Overall Study|Withdrawal by Subject|20|||
30873390|NCT02698865|58903983|FG001|Overall Study|Withdrawal by Subject|16|||
30873391|NCT02698865|58903982|FG000|Overall Study|Physician Decision|0|||
30873392|NCT02698865|58903983|FG001|Overall Study|Physician Decision|4|||
30873393|NCT02698865|58903982|FG000|Overall Study|Lost to Follow-up|4|||
30873394|NCT02698865|58903983|FG001|Overall Study|Lost to Follow-up|2|||
30873395|NCT02698787|58903991|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
30873396|NCT02698787|58903992|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
30873397|NCT02698475|58903999|FG000|Main Study Period|Lack of Efficacy|1|||
30873398|NCT02698475|58903999|FG000|Main Study Period|Protocol Violation|2|||
30873399|NCT02698475|58903999|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
30873400|NCT02698475|58903999|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
30873401|NCT02698475|58903999|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
30873402|NCT02698475|58903999|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
30873403|NCT02698475|58903999|FG000|Long-Term Extension Period|Other|1|||
30873404|NCT02559687|58904006|FG000|Overall Study|Death|112|||
30873405|NCT02559687|58904006|FG000|Overall Study|Sponsor Decision|5|||
30873406|NCT02559687|58904006|FG000|Overall Study|Withdrawal by Subject|4|||
30873407|NCT04294719|58904020|FG000|Overall Study|Withdrawal by Subject|1|||
30873408|NCT02703311|58904028|FG000|Overall Study|Death|5|||
30873409|NCT02703311|58904028|FG000|Overall Study|Withdrawal by Subject|3|||
30873410|NCT02697617|58904032|FG000|Overall Study|Withdrawal by Subject|0|||
30873411|NCT02697617|58904033|FG001|Overall Study|Withdrawal by Subject|2|||
30873412|NCT02697617|58904032|FG000|Overall Study|Pregnancy|1|||
30873413|NCT02697617|58904033|FG001|Overall Study|Pregnancy|0|||
30873414|NCT02698241|58904043|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
30873415|NCT02698241|58904043|FG000|Overall Study|Screening not met|7|||
30873416|NCT02698241|58904043|FG000|Overall Study|Withdrawal by Subject|7|||
30873417|NCT02698241|58904043|FG000|Overall Study|Physician Decision|2|||
30873418|NCT02698241|58904043|FG000|Overall Study|Subject underwent system modification|2|||
30873419|NCT02698241|58904043|FG000|Overall Study|Lost to Follow-up|3|||
30873420|NCT02698241|58904043|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
30873421|NCT02698241|58904043|FG000|Overall Study|geographic and licensing issue|1|||
30873422|NCT02698241|58904043|FG000|Overall Study|Death|2|||
30873423|NCT01663233|58904049|FG000|Overall Study|Withdrawal by Subject|3|||
30873424|NCT01663233|58904050|FG001|Overall Study|Withdrawal by Subject|2|||
30873425|NCT01663233|58904049|FG000|Overall Study|Protocol Deviation|1|||
30873426|NCT01663233|58904050|FG001|Overall Study|Protocol Deviation|4|||
30873427|NCT01663233|58904049|FG000|Overall Study|Lost to Follow-up|0|||
30873428|NCT01663233|58904050|FG001|Overall Study|Lost to Follow-up|1|||
30873429|NCT02556255|58904069|FG000|Overall Study|Lost to Follow-up|4|||
30873430|NCT02556801|58904077|FG000|Overall Study|Lost to Follow-up|1|||
30873431|NCT02556801|58904078|FG001|Overall Study|Lost to Follow-up|0|||
30873432|NCT02556801|58904079|FG002|Overall Study|Lost to Follow-up|2|||
30873433|NCT02556801|58904080|FG003|Overall Study|Lost to Follow-up|0|||
30873434|NCT02556801|58904077|FG000|Overall Study|Withdrawal by Subject|1|||
30873435|NCT02556801|58904078|FG001|Overall Study|Withdrawal by Subject|1|||
30873436|NCT02556801|58904079|FG002|Overall Study|Withdrawal by Subject|1|||
30873437|NCT02556801|58904080|FG003|Overall Study|Withdrawal by Subject|0|||
30873438|NCT02556801|58904077|FG000|Overall Study|Protocol Violation|0|||
30873439|NCT02556801|58904078|FG001|Overall Study|Protocol Violation|3|||
30873440|NCT02556801|58904079|FG002|Overall Study|Protocol Violation|1|||
30873441|NCT02556801|58904080|FG003|Overall Study|Protocol Violation|1|||
30873442|NCT02556801|58904077|FG000|Overall Study|Adverse Event|0|||
30873443|NCT02556801|58904078|FG001|Overall Study|Adverse Event|2|||
30873444|NCT02556801|58904079|FG002|Overall Study|Adverse Event|0|||
30873445|NCT02556801|58904080|FG003|Overall Study|Adverse Event|3|||
30873446|NCT02556801|58904077|FG000|Overall Study|Pregnancy|0|||
30873447|NCT02556801|58904078|FG001|Overall Study|Pregnancy|1|||
30873448|NCT02556801|58904079|FG002|Overall Study|Pregnancy|0|||
30873449|NCT02556801|58904080|FG003|Overall Study|Pregnancy|0|||
30873450|NCT02556801|58904077|FG000|Overall Study|Personal reasons patient|0|||
30873451|NCT02556801|58904078|FG001|Overall Study|Personal reasons patient|0|||
30873452|NCT02556801|58904079|FG002|Overall Study|Personal reasons patient|0|||
30873453|NCT02556801|58904080|FG003|Overall Study|Personal reasons patient|1|||
30873454|NCT02556177|58904092|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
30873455|NCT02556177|58904093|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
30873456|NCT02554929|58904101|FG000|Overall Study|Lost to Follow-up|4|||
30873457|NCT02554929|58904102|FG001|Overall Study|Lost to Follow-up|4|||
30873458|NCT02554929|58904101|FG000|Overall Study|Withdrawal by Subject|2|||
30873459|NCT02554929|58904102|FG001|Overall Study|Withdrawal by Subject|8|||
30873460|NCT02697773|58904120|FG000|Overall Study|Adverse Event|2|||
30873461|NCT02697773|58904121|FG001|Overall Study|Adverse Event|1|||
30873462|NCT02697773|58904122|FG002|Overall Study|Adverse Event|2|||
30873463|NCT02697773|58904120|FG000|Overall Study|Death|0|||
30873464|NCT02697773|58904121|FG001|Overall Study|Death|0|||
30873465|NCT02697773|58904122|FG002|Overall Study|Death|2|||
30873466|NCT02697773|58904120|FG000|Overall Study|Lack of Efficacy|4|||
30873467|NCT02697773|58904121|FG001|Overall Study|Lack of Efficacy|6|||
30873468|NCT02697773|58904122|FG002|Overall Study|Lack of Efficacy|6|||
30873469|NCT02697773|58904120|FG000|Overall Study|Lost to Follow-up|5|||
30602269|NCT01250769|58613641|FG002|Overall Study|Withdrawal by Subject|1|||
30602270|NCT01250769|58613642|FG003|Overall Study|Withdrawal by Subject|0|||
30873470|NCT02697773|58904121|FG001|Overall Study|Lost to Follow-up|5|||
30873471|NCT02697773|58904122|FG002|Overall Study|Lost to Follow-up|7|||
30873472|NCT02697773|58904120|FG000|Overall Study|Other|15|||
30873473|NCT02697773|58904121|FG001|Overall Study|Other|11|||
30873474|NCT02697773|58904122|FG002|Overall Study|Other|10|||
30873475|NCT02697773|58904120|FG000|Overall Study|Protocol Violation|1|||
30873476|NCT02697773|58904121|FG001|Overall Study|Protocol Violation|1|||
30873477|NCT02697773|58904122|FG002|Overall Study|Protocol Violation|0|||
30873478|NCT02697773|58904120|FG000|Overall Study|Withdrawal by Subject|10|||
30873479|NCT02697773|58904121|FG001|Overall Study|Withdrawal by Subject|13|||
30873480|NCT02697773|58904122|FG002|Overall Study|Withdrawal by Subject|13|||
30873481|NCT02697773|58904120|FG000|Overall Study|Randomized but not treated|1|||
30873482|NCT02697773|58904121|FG001|Overall Study|Randomized but not treated|1|||
30873483|NCT02697773|58904122|FG002|Overall Study|Randomized but not treated|0|||
30873484|NCT02693171|58904130|FG000|Overall Study|Adverse Event|1|||
30873485|NCT02693171|58904130|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
30873486|NCT02692703|58904134|FG000|Overall Study|Lost to Follow-up|1|||
30873487|NCT02692703|58904134|FG000|Overall Study|Other|1|||
30873488|NCT02692235|58904140|FG000|Overall Study|Withdrawal by Subject|2|||
30873489|NCT02692235|58904141|FG001|Overall Study|Withdrawal by Subject|1|||
30873490|NCT02692235|58904140|FG000|Overall Study|Adverse Event|1|||
30873491|NCT02692235|58904141|FG001|Overall Study|Adverse Event|2|||
30873492|NCT02552121|58904155|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
30873493|NCT02552121|58904156|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
30873494|NCT02552121|58904157|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
30873495|NCT02552121|58904158|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
30873496|NCT02552121|58904159|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
30873497|NCT02552121|58904160|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
30873498|NCT02552121|58904161|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
30873499|NCT02552121|58904162|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
30873500|NCT02552121|58904155|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
30873501|NCT02552121|58904156|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
30873502|NCT02552121|58904157|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
30873503|NCT02552121|58904158|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
30873504|NCT02552121|58904159|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
30873505|NCT02552121|58904160|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
30873506|NCT02552121|58904161|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
30873507|NCT02552121|58904162|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
30873508|NCT02552121|58904155|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
30873509|NCT02552121|58904156|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
30873510|NCT02552121|58904157|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
30873511|NCT02552121|58904158|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
30873512|NCT02552121|58904159|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
30873513|NCT02552121|58904160|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
30873514|NCT02552121|58904161|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
30873515|NCT02552121|58904162|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
30873516|NCT02552121|58904155|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
30873517|NCT02552121|58904156|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
30873518|NCT02552121|58904157|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
30873519|NCT02552121|58904158|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
30873520|NCT02552121|58904159|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
30873521|NCT02552121|58904160|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
30873522|NCT02552121|58904161|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
30873523|NCT02552121|58904162|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
30873524|NCT02552121|58904155|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
30873525|NCT02552121|58904156|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
30873526|NCT02552121|58904157|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
30873527|NCT02552121|58904158|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
30873528|NCT02552121|58904159|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
30873529|NCT02552121|58904160|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
30873530|NCT02552121|58904161|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
30873531|NCT02552121|58904162|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
30873532|NCT02552121|58904155|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
30873533|NCT02552121|58904156|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
30960953|NCT01520909|59026868|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
30960954|NCT01520909|59026869|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
30960955|NCT01520909|59026870|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
30960956|NCT01520363|59026892|FG000|Overall Study|Withdrawal by Subject|2|||
30960957|NCT01520363|59026893|FG001|Overall Study|Withdrawal by Subject|0|||
30960958|NCT01578499|59026925|FG000|Overall Study|Reason not Specified|0|||
30873534|NCT02552121|58904157|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
30873535|NCT02552121|58904158|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
30873536|NCT02552121|58904159|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
30873537|NCT02552121|58904160|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
30873538|NCT02552121|58904161|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
30873539|NCT02552121|58904162|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
30873540|NCT02552121|58904155|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
30873541|NCT02552121|58904156|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
30873542|NCT02552121|58904157|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
30873543|NCT02552121|58904158|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
30873544|NCT02552121|58904159|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
30873545|NCT02552121|58904160|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
30873546|NCT02552121|58904161|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
30873547|NCT02552121|58904162|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
30960959|NCT01578499|59026926|FG001|Overall Study|Reason not Specified|1|||
30960960|NCT01578499|59026925|FG000|Overall Study|Lost to Follow-up|2|||
30960961|NCT01578499|59026926|FG001|Overall Study|Lost to Follow-up|1|||
30960962|NCT01578499|59026925|FG000|Overall Study|Withdrawal by Subject|10|||
30960963|NCT01578499|59026926|FG001|Overall Study|Withdrawal by Subject|16|||
30960964|NCT01578499|59026925|FG000|Overall Study|Death|20|||
30960965|NCT01578499|59026926|FG001|Overall Study|Death|25|||
30960966|NCT01578499|59026925|FG000|Overall Study|Died and End of Study Page not Completed|2|||
30960967|NCT01578499|59026926|FG001|Overall Study|Died and End of Study Page not Completed|0|||
30960968|NCT01578187|59026936|FG000|Usability Phase|Withdrawal by Subject|1|||
30960969|NCT01561963|59026942|FG000|Overall Study|Adverse Event|1|||
30960970|NCT01576783|59026953|FG000|Overall Study|Change in Medical Care|1|||
30960971|NCT01576783|59026954|FG001|Overall Study|Change in Medical Care|0|||
30960972|NCT01576783|59026953|FG000|Overall Study|Lost to Follow-up|14|||
30960973|NCT01576783|59026954|FG001|Overall Study|Lost to Follow-up|16|||
30960974|NCT01576783|59026953|FG000|Overall Study|Withdrawal by Subject|5|||
30960975|NCT01576783|59026954|FG001|Overall Study|Withdrawal by Subject|1|||
30960976|NCT01534351|59026963|FG000|Overall Study|Study Terminated Early|1|||
30960977|NCT01534351|59026964|FG001|Overall Study|Study Terminated Early|0|||
30960978|NCT01534351|59026965|FG002|Overall Study|Study Terminated Early|0|||
30960979|NCT01534273|59026977|FG000|Period 1|Physician Decision|0|||
30960980|NCT01534273|59026978|FG001|Period 1|Physician Decision|0|||
30960981|NCT01534273|59026979|FG002|Period 1|Physician Decision|0|||
30960982|NCT01534273|59026980|FG003|Period 1|Physician Decision|1|||
30960983|NCT01534273|59026981|FG004|Period 1|Physician Decision|0|||
30960984|NCT01534273|59026982|FG005|Period 1|Physician Decision|0|||
30960985|NCT01534273|59026983|FG006|Period 1|Physician Decision|0|||
30960986|NCT01534195|59027006|FG000|Overall Study|Withdrawal by Subject|1|||
30960987|NCT01534195|59027007|FG001|Overall Study|Withdrawal by Subject|1|||
30960988|NCT01560949|59027013|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
30960989|NCT01560949|59027013|FG000|Surgery Phase|Physician Decision|3|||
30960990|NCT01372878|59027021|FG000|Overall Study|Withdrawal by Subject|63|||
30960991|NCT01372878|59027021|FG000|Overall Study|Protocol Violation|17|||
30960992|NCT01372878|59027021|FG000|Overall Study|incomplete study procedure|104|||
30960993|NCT01533493|59027027|FG000|Overall Study|Adverse Event|2|||
30960994|NCT01533493|59027028|FG001|Overall Study|Adverse Event|1|||
30960995|NCT01533493|59027027|FG000|Overall Study|Withdrawal by Subject|1|||
30960996|NCT01533493|59027028|FG001|Overall Study|Withdrawal by Subject|2|||
30960997|NCT01533493|59027027|FG000|Overall Study|Lost to Follow-up|2|||
30960998|NCT01533493|59027028|FG001|Overall Study|Lost to Follow-up|0|||
30960999|NCT01533181|59027104|FG000|Overall Study|Disease progression pre-active treatment|0|||
30961000|NCT01533181|59027105|FG001|Overall Study|Disease progression pre-active treatment|1|||
30961001|NCT01533181|59027104|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
30961002|NCT01533181|59027105|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
30961003|NCT02669082|59027111|FG000|Overall Study|Adverse Event|1|||
30961004|NCT02668692|59027175|FG000|Overall Study|Adverse Event|1|||
30961005|NCT02668692|59027176|FG001|Overall Study|Adverse Event|0|||
30961006|NCT02662764|59027190|FG000|Overall Study|Adverse Event|6|||
30961007|NCT02662764|59027190|FG000|Overall Study|Lack of Efficacy|8|||
30961008|NCT02662764|59027190|FG000|Overall Study|Protocol Violation|1|||
30961009|NCT02662764|59027190|FG000|Overall Study|Withdrawal by Subject|5|||
30961010|NCT02662764|59027190|FG000|Overall Study|Device failure|4|||
30961011|NCT02662764|59027190|FG000|Overall Study|Patient changed treatment|1|||
30602271|NCT01250769|58613639|FG000|Overall Study|Adverse Event|0|||
30602272|NCT01250769|58613640|FG001|Overall Study|Adverse Event|0|||
30873548|NCT02552121|58904155|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
30873549|NCT02552121|58904156|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
30873550|NCT02552121|58904157|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
30873551|NCT02552121|58904158|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
30873552|NCT02552121|58904159|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
30873553|NCT02552121|58904160|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
30873554|NCT02552121|58904161|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
30873555|NCT02552121|58904162|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
30873556|NCT02552121|58904155|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
30873557|NCT02552121|58904156|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
30873558|NCT02552121|58904157|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
30961012|NCT02662764|59027190|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
30961013|NCT01519817|59027199|FG000|Overall Study|Withdrawal by Subject|1|||
30961014|NCT01519817|59027200|FG001|Overall Study|Withdrawal by Subject|0|||
30961015|NCT01519817|59027201|FG002|Overall Study|Withdrawal by Subject|0|||
30961016|NCT01519817|59027202|FG003|Overall Study|Withdrawal by Subject|0|||
30602273|NCT01250769|58613641|FG002|Overall Study|Adverse Event|1|||
30873559|NCT02552121|58904158|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
30961017|NCT01519817|59027199|FG000|Overall Study|Off study due to infection|0|||
30961018|NCT01519817|59027200|FG001|Overall Study|Off study due to infection|0|||
30961019|NCT01519817|59027201|FG002|Overall Study|Off study due to infection|0|||
30961020|NCT01519817|59027202|FG003|Overall Study|Off study due to infection|1|||
30961021|NCT01519661|59027212|FG000|Overall Study|Protocol deviation|6|||
30961022|NCT01519661|59027212|FG000|Overall Study|Lost to Follow-up|3|||
30961023|NCT01519661|59027212|FG000|Overall Study|Withdrawal by Subject|17|||
30961024|NCT01519661|59027212|FG000|Overall Study|Lack of Efficacy|6|||
30961025|NCT01519661|59027212|FG000|Overall Study|Adverse Event|29|||
30961026|NCT01519427|59027217|FG000|Overall Study|disease progression|2|||
30961027|NCT01518257|59027223|FG000|Overall Study|Lost to Follow-up|1|||
30961028|NCT01518257|59027224|FG001|Overall Study|Lost to Follow-up|0|||
30961029|NCT01518257|59027223|FG000|Overall Study|Other Miscellaneous Reason|1|||
30961030|NCT01518257|59027224|FG001|Overall Study|Other Miscellaneous Reason|0|||
30961031|NCT02668302|59027232|FG000|Overall Study|Withdrawal by Subject|1|||
30961032|NCT02668302|59027233|FG001|Overall Study|Withdrawal by Subject|0|||
30961033|NCT01517867|59027241|FG000|Overall Study|never started treatment|29|||
30961034|NCT01517867|59027242|FG001|Overall Study|never started treatment|32|||
30961035|NCT01517867|59027241|FG000|Overall Study|Withdrawal by Subject|34|||
30961036|NCT01517867|59027242|FG001|Overall Study|Withdrawal by Subject|30|||
30961037|NCT01517867|59027241|FG000|Overall Study|Still in treatment at study end|0|||
30961038|NCT01517867|59027242|FG001|Overall Study|Still in treatment at study end|3|||
30961039|NCT01514357|59027250|FG000|Overall Study|Screen failure|2|||
30961040|NCT01514357|59027251|FG001|Overall Study|Screen failure|0|||
30961041|NCT01514357|59027250|FG000|Overall Study|Withdrawal by Subject|2|||
30961042|NCT01514357|59027251|FG001|Overall Study|Withdrawal by Subject|0|||
30961043|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
30961044|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
30961045|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
30961046|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
30961047|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
30961048|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
30961049|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
30961050|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
30961051|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
30961052|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
30961053|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
30961054|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
30961055|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
30961056|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
30961057|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
30961058|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
30961059|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
30961060|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
30961061|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
30961062|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
30961063|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
30961064|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
30961065|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
30961066|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
30961067|NCT01532869|59027259|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
30961068|NCT01532869|59027260|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
30961069|NCT01532869|59027259|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
30961070|NCT01532869|59027260|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
30961071|NCT01532869|59027259|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
30961072|NCT01532869|59027260|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
30961073|NCT01532869|59027259|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
30961074|NCT01532869|59027260|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
30602274|NCT01250769|58613642|FG003|Overall Study|Adverse Event|0|||
30873560|NCT02552121|58904159|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
30873561|NCT02552121|58904160|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
30873562|NCT02552121|58904161|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
30873563|NCT02552121|58904162|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
30873564|NCT02552121|58904155|FG000|Part 2: Cohort Expansion|Death|0|||
30873565|NCT02552121|58904156|FG001|Part 2: Cohort Expansion|Death|0|||
30873566|NCT02552121|58904157|FG002|Part 2: Cohort Expansion|Death|1|||
30873567|NCT02552121|58904158|FG003|Part 2: Cohort Expansion|Death|0|||
30873568|NCT02552121|58904159|FG004|Part 2: Cohort Expansion|Death|0|||
30873569|NCT02552121|58904160|FG005|Part 2: Cohort Expansion|Death|0|||
30873570|NCT02552121|58904161|FG006|Part 2: Cohort Expansion|Death|0|||
30873571|NCT02552121|58904162|FG007|Part 2: Cohort Expansion|Death|0|||
30873572|NCT02552355|58904207|FG000|Overall Study|Adverse Event|0|||
30873573|NCT02552355|58904208|FG001|Overall Study|Adverse Event|2|||
30873574|NCT02552355|58904209|FG002|Overall Study|Adverse Event|2|||
30961075|NCT01532869|59027259|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
30961076|NCT01532869|59027260|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
30961077|NCT01531387|59027273|FG000|Overall Study|Early termination of study|11|||
30961078|NCT01531387|59027274|FG001|Overall Study|Early termination of study|11|||
30961079|NCT01531153|59027283|FG000|Overall Study|Withdrawal by Subject|10|||
30961080|NCT01531153|59027284|FG001|Overall Study|Withdrawal by Subject|9|||
30961081|NCT01531153|59027285|FG002|Overall Study|Withdrawal by Subject|15|||
30961082|NCT01529749|59027300|FG000|Overall Study|Lost to Follow-up|0|||
30961083|NCT01529749|59027301|FG001|Overall Study|Lost to Follow-up|1|||
30961084|NCT01529749|59027302|FG002|Overall Study|Lost to Follow-up|1|||
30961085|NCT01529749|59027303|FG003|Overall Study|Lost to Follow-up|0|||
30961086|NCT01529749|59027300|FG000|Overall Study|Physician Decision|0|||
30961087|NCT01529749|59027301|FG001|Overall Study|Physician Decision|0|||
30961088|NCT01529749|59027302|FG002|Overall Study|Physician Decision|0|||
30961089|NCT01529749|59027303|FG003|Overall Study|Physician Decision|1|||
30961090|NCT01529749|59027300|FG000|Overall Study|Withdrawal by Subject|0|||
30961091|NCT01529749|59027301|FG001|Overall Study|Withdrawal by Subject|1|||
30961092|NCT01529749|59027302|FG002|Overall Study|Withdrawal by Subject|1|||
30961093|NCT01529749|59027303|FG003|Overall Study|Withdrawal by Subject|0|||
30961094|NCT01529749|59027300|FG000|Overall Study|Protocol Violation|0|||
30961095|NCT01529749|59027301|FG001|Overall Study|Protocol Violation|0|||
30961096|NCT01529749|59027302|FG002|Overall Study|Protocol Violation|0|||
30961097|NCT01529749|59027303|FG003|Overall Study|Protocol Violation|1|||
30961098|NCT01529515|59027315|FG000|TRANSITION PHASE|Adverse Event|16|||
30873575|NCT02552355|58904210|FG003|Overall Study|Adverse Event|0|||
30873576|NCT02552355|58904207|FG000|Overall Study|Withdrawal by Subject|0|||
30873577|NCT02552355|58904208|FG001|Overall Study|Withdrawal by Subject|0|||
30873578|NCT02552355|58904209|FG002|Overall Study|Withdrawal by Subject|0|||
30873579|NCT02552355|58904210|FG003|Overall Study|Withdrawal by Subject|1|||
30873580|NCT02551731|58904220|FG000|Overall Study|Withdrawal by Subject|2|||
30961099|NCT01529515|59027316|FG001|TRANSITION PHASE|Adverse Event|0|||
30961100|NCT01529515|59027317|FG002|TRANSITION PHASE|Adverse Event|0|||
30961101|NCT01529515|59027318|FG003|TRANSITION PHASE|Adverse Event|0|||
30961102|NCT01529515|59027315|FG000|TRANSITION PHASE|Death|1|||
30961103|NCT01529515|59027316|FG001|TRANSITION PHASE|Death|0|||
30961104|NCT01529515|59027317|FG002|TRANSITION PHASE|Death|0|||
30694625|NCT00606177|58708796|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
30694626|NCT00606177|58708795|FG000|Overall Study|Change of residence or other commitments|1|||
30694627|NCT00606177|58708796|FG001|Overall Study|Change of residence or other commitments|1|||
30873581|NCT02542605|58904224|FG000|Part B: Challenge Phase|Sponsor decision|1|||
30873582|NCT02542605|58904225|FG001|Part B: Challenge Phase|Sponsor decision|0|||
30602275|NCT01074268|58613654|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
30602276|NCT01074268|58613655|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
30694628|NCT00359281|58708811|FG000|Overall Study|Adverse Event|1|||
30873583|NCT02542605|58904226|FG002|Part B: Challenge Phase|Sponsor decision|0|||
30873584|NCT02542605|58904224|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
30873585|NCT02542605|58904225|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
30873586|NCT02542605|58904226|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
30873587|NCT02550873|58904237|FG000|Randomized Double Blind|Adverse Event|3|||
30873588|NCT02550873|58904238|FG001|Randomized Double Blind|Adverse Event|1|||
30873589|NCT02550873|58904239|FG002|Randomized Double Blind|Adverse Event|0|||
30873590|NCT02550873|58904237|FG000|Randomized Double Blind|Disease progression|1|||
30873591|NCT02550873|58904238|FG001|Randomized Double Blind|Disease progression|1|||
30873592|NCT02550873|58904239|FG002|Randomized Double Blind|Disease progression|0|||
30873593|NCT02550873|58904237|FG000|Open Label Extension|Study ongoing|0|||
30873594|NCT02550873|58904238|FG001|Open Label Extension|Study ongoing|0|||
30873595|NCT02550873|58904239|FG002|Open Label Extension|Study ongoing|111|||
30873596|NCT02535741|58904261|FG000|Overall Study|Adverse Event|3|||
30873597|NCT02535741|58904261|FG000|Overall Study|Withdrawal by Subject|9|||
30873598|NCT02535741|58904261|FG000|Overall Study|Lost to Follow-up|10|||
30873599|NCT02535741|58904261|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
30873600|NCT02535741|58904261|FG000|Overall Study|Missing data|6|||
30873601|NCT03299049|58904281|FG000|Overall Study|On-going|486|||
30873602|NCT03299049|58904282|FG001|Overall Study|On-going|481|||
30873603|NCT03299049|58904281|FG000|Overall Study|Withdrawal by Subject|6|||
30873604|NCT03299049|58904282|FG001|Overall Study|Withdrawal by Subject|21|||
30873605|NCT03299049|58904281|FG000|Overall Study|Physician Decision|5|||
30961105|NCT01529515|59027318|FG003|TRANSITION PHASE|Death|0|||
30961106|NCT01529515|59027315|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
30694629|NCT00359281|58708812|FG001|Overall Study|Adverse Event|0|||
30873606|NCT03299049|58904282|FG001|Overall Study|Physician Decision|1|||
30873607|NCT03299049|58904281|FG000|Overall Study|Lost to Follow-up|2|||
30961107|NCT01529515|59027316|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
30961108|NCT01529515|59027317|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
30961109|NCT01529515|59027318|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
30961110|NCT01529515|59027315|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
30961111|NCT01529515|59027316|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
30961112|NCT01529515|59027317|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
30961113|NCT01529515|59027318|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
30961114|NCT01529515|59027315|FG000|TRANSITION PHASE|Protocol Violation|4|||
30961115|NCT01529515|59027316|FG001|TRANSITION PHASE|Protocol Violation|0|||
30961116|NCT01529515|59027317|FG002|TRANSITION PHASE|Protocol Violation|0|||
30961117|NCT01529515|59027318|FG003|TRANSITION PHASE|Protocol Violation|0|||
30961118|NCT01529515|59027315|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
30961119|NCT01529515|59027316|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
30961120|NCT01529515|59027317|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
30961121|NCT01529515|59027318|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
30961122|NCT01529515|59027315|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
30961123|NCT01529515|59027316|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
30961124|NCT01529515|59027317|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
30961125|NCT01529515|59027318|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
30961126|NCT01529515|59027315|FG000|TRANSITION PHASE|Other|9|||
30961127|NCT01529515|59027316|FG001|TRANSITION PHASE|Other|0|||
30961128|NCT01529515|59027317|FG002|TRANSITION PHASE|Other|0|||
30961129|NCT01529515|59027318|FG003|TRANSITION PHASE|Other|0|||
30961130|NCT01529515|59027315|FG000|MAINTENANCE PHASE|Adverse Event|0|||
30961131|NCT01529515|59027316|FG001|MAINTENANCE PHASE|Adverse Event|10|||
30961132|NCT01529515|59027317|FG002|MAINTENANCE PHASE|Adverse Event|0|||
30961133|NCT01529515|59027318|FG003|MAINTENANCE PHASE|Adverse Event|0|||
30961134|NCT01529515|59027315|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
30961135|NCT01529515|59027316|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
30961136|NCT01529515|59027317|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
30961137|NCT01529515|59027318|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
30961138|NCT01529515|59027315|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
30961139|NCT01529515|59027316|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
30961140|NCT01529515|59027317|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
30961141|NCT01529515|59027318|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
30961142|NCT01529515|59027315|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
30961143|NCT01529515|59027316|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
30961144|NCT01529515|59027317|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
30961145|NCT01529515|59027318|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
30961146|NCT01529515|59027315|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
30961147|NCT01529515|59027316|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
30961148|NCT01529515|59027317|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
30961149|NCT01529515|59027318|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
30961150|NCT01529515|59027315|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
30961151|NCT01529515|59027316|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
30961152|NCT01529515|59027317|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
30961153|NCT01529515|59027318|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
30961154|NCT01529515|59027315|FG000|MAINTENANCE PHASE|Other|0|||
30961155|NCT01529515|59027316|FG001|MAINTENANCE PHASE|Other|10|||
30961156|NCT01529515|59027317|FG002|MAINTENANCE PHASE|Other|0|||
30961157|NCT01529515|59027318|FG003|MAINTENANCE PHASE|Other|0|||
30961158|NCT01529515|59027315|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
30961159|NCT01529515|59027316|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
30961160|NCT01529515|59027317|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
30961161|NCT01529515|59027318|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
30694630|NCT00359281|58708813|FG002|Overall Study|Adverse Event|0|||
30873608|NCT03299049|58904282|FG001|Overall Study|Lost to Follow-up|0|||
30873609|NCT03299049|58904281|FG000|Overall Study|Pregnancy|1|||
30873610|NCT03299049|58904282|FG001|Overall Study|Pregnancy|3|||
30873611|NCT03299049|58904281|FG000|Overall Study|Protocol Violation|1|||
30873612|NCT03299049|58904282|FG001|Overall Study|Protocol Violation|1|||
30873613|NCT03299049|58904281|FG000|Overall Study|Lack of Efficacy|9|||
30873614|NCT03299049|58904282|FG001|Overall Study|Lack of Efficacy|3|||
30873615|NCT03299049|58904281|FG000|Overall Study|Adverse Event|12|||
30873616|NCT03299049|58904282|FG001|Overall Study|Adverse Event|13|||
30873617|NCT02550795|58904298|FG000|Overall Study|Physician Decision|0|||
30873618|NCT02550795|58904299|FG001|Overall Study|Physician Decision|1|||
30873619|NCT02550795|58904300|FG002|Overall Study|Physician Decision|0|||
30873620|NCT02541903|58904308|FG000|Overall Study|Death|1|||
30961162|NCT01529515|59027315|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
30961163|NCT01529515|59027316|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
30961164|NCT01529515|59027317|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
30961165|NCT01529515|59027318|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
30961166|NCT01529515|59027315|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
30961167|NCT01529515|59027316|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
30873621|NCT02541669|58904317|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
30873622|NCT02541669|58904318|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
30961168|NCT01529515|59027317|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
30961169|NCT01529515|59027318|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
30961170|NCT01529515|59027315|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
30961171|NCT01529515|59027316|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
30961172|NCT01529515|59027317|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
30961173|NCT01529515|59027318|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
30961174|NCT01529515|59027315|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
30961175|NCT01529515|59027316|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
30961176|NCT01529515|59027317|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
30961177|NCT01529515|59027318|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
30961178|NCT01529515|59027315|FG000|DOUBLE BLIND PHASE|Other|0|||
30961179|NCT01529515|59027316|FG001|DOUBLE BLIND PHASE|Other|0|||
30961180|NCT01529515|59027317|FG002|DOUBLE BLIND PHASE|Other|9|||
30961181|NCT01529515|59027318|FG003|DOUBLE BLIND PHASE|Other|2|||
30961182|NCT01528969|59027327|FG000|Overall Study|absent from the school at baseline|2|||
30961183|NCT01528969|59027328|FG001|Overall Study|absent from the school at baseline|0|||
30961184|NCT01514201|59027338|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
30961185|NCT01514201|59027339|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
30961186|NCT01514201|59027340|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
30961187|NCT01514201|59027341|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
30961188|NCT01514201|59027338|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
30961189|NCT01514201|59027339|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
30961190|NCT01514201|59027340|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
30961191|NCT01514201|59027341|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
30961192|NCT01514201|59027338|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
30961193|NCT01514201|59027339|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
30961194|NCT01514201|59027340|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
30961195|NCT01514201|59027341|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
30961196|NCT01514201|59027338|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
30961197|NCT01514201|59027339|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
30961198|NCT01514201|59027340|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
30961199|NCT01514201|59027341|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
30961200|NCT01514201|59027338|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
30961201|NCT01514201|59027339|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
30961202|NCT01514201|59027340|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
30961203|NCT01514201|59027341|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
30961204|NCT01514201|59027338|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
30961205|NCT01514201|59027339|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
30961206|NCT01514201|59027340|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
30961207|NCT01514201|59027341|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
30961208|NCT01514201|59027338|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
30961209|NCT01514201|59027339|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
30961210|NCT01514201|59027340|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
30961211|NCT01514201|59027341|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
30961212|NCT01514201|59027338|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
30961213|NCT01514201|59027339|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
30961214|NCT01514201|59027340|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
30961215|NCT01514201|59027341|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
30961216|NCT01514201|59027338|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
30961217|NCT01514201|59027339|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
30961218|NCT01514201|59027340|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
30961219|NCT01514201|59027341|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
30961220|NCT01514201|59027338|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
30961221|NCT01514201|59027339|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
30961222|NCT01514201|59027340|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
30961223|NCT01514201|59027341|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
30961224|NCT01514201|59027338|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
30961225|NCT01514201|59027339|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
30961226|NCT01514201|59027340|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
30961227|NCT01514201|59027341|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
30961228|NCT01514201|59027338|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
30961229|NCT01514201|59027339|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
30961230|NCT01514201|59027340|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
30961231|NCT01514201|59027341|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
30961232|NCT02666664|59027363|FG000|Overall Study|Physician Decision|0|||
30961233|NCT02666664|59027364|FG001|Overall Study|Physician Decision|1|||
30961234|NCT02666664|59027363|FG000|Overall Study|Protocol Violation|0|||
30961235|NCT02666664|59027364|FG001|Overall Study|Protocol Violation|2|||
30961236|NCT02666664|59027363|FG000|Overall Study|Other|0|||
30961237|NCT02666664|59027364|FG001|Overall Study|Other|1|||
30961238|NCT02666664|59027363|FG000|Overall Study|Adverse Event|12|||
30961239|NCT02666664|59027364|FG001|Overall Study|Adverse Event|37|||
30961240|NCT02666664|59027363|FG000|Overall Study|Withdrawal by participant|23|||
30961241|NCT02666664|59027364|FG001|Overall Study|Withdrawal by participant|40|||
30602277|NCT01074268|58613654|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
30602278|NCT01074268|58613655|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
30602279|NCT01074268|58613654|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
30602280|NCT01074268|58613655|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
30602281|NCT01074268|58613654|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
30602282|NCT01074268|58613655|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
30602283|NCT01074268|58613654|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
30602284|NCT01074268|58613655|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
30602285|NCT01074268|58613654|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
30602286|NCT01074268|58613655|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
30602287|NCT01074268|58613654|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
30694631|NCT00359281|58708814|FG003|Overall Study|Adverse Event|0|||
30873623|NCT02541669|58904319|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
30873624|NCT02541669|58904320|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
30873625|NCT02541669|58904321|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
30873626|NCT02549859|58904332|FG000|Long-term 60 Hz DBS|Study Closed|1|||
30873627|NCT02688647|58904342|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
30873628|NCT02688647|58904343|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
30873629|NCT02688647|58904342|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
30873630|NCT02688647|58904343|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
30873631|NCT02688647|58904342|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
30873632|NCT02688647|58904343|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
30873633|NCT02688647|58904342|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
30873634|NCT02688647|58904343|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
30873635|NCT02688647|58904342|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
30873636|NCT02688647|58904343|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
30873637|NCT02688647|58904342|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
30873638|NCT02688647|58904343|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
30873639|NCT02688647|58904342|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
30873640|NCT02688647|58904343|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
30873641|NCT02687711|58904361|FG000|Overall Study|Adverse Event|89|||
30873642|NCT02687711|58904361|FG000|Overall Study|Lack of Efficacy|70|||
30873643|NCT02687711|58904361|FG000|Overall Study|Lost to Follow-up|20|||
30873644|NCT02687711|58904361|FG000|Overall Study|Consent withdrawn|15|||
30873645|NCT02687711|58904361|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
30873646|NCT02687711|58904361|FG000|Overall Study|Too expensive|4|||
30873647|NCT02687711|58904361|FG000|Overall Study|Participant moved abroad|1|||
30873648|NCT02687711|58904361|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
30873649|NCT02687711|58904361|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
30873650|NCT02687711|58904361|FG000|Overall Study|Disliked taste|1|||
30873651|NCT02687711|58904361|FG000|Overall Study|Low mood|1|||
30873652|NCT02687711|58904361|FG000|Overall Study|Side effects|1|||
30873653|NCT02687711|58904361|FG000|Overall Study|Change of Hospital|1|||
30873654|NCT02687711|58904361|FG000|Overall Study|Liver Encephalopathy|1|||
30873655|NCT02687711|58904361|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
30873656|NCT02687711|58904361|FG000|Overall Study|Withdrawn due to intake interruption|1|||
30873657|NCT02687711|58904361|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
30873658|NCT02687711|58904361|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
30873659|NCT02687711|58904361|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
30873660|NCT01662063|58904367|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
30873661|NCT01662063|58904368|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
30873662|NCT01662063|58904369|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
30873663|NCT01662063|58904367|FG000|Overall Study|Lack of Efficacy|1|||
30873664|NCT01662063|58904368|FG001|Overall Study|Lack of Efficacy|6|||
30873665|NCT01662063|58904369|FG002|Overall Study|Lack of Efficacy|0|||
30873666|NCT01662063|58904367|FG000|Overall Study|Lost to Follow-up|0|||
30873667|NCT01662063|58904368|FG001|Overall Study|Lost to Follow-up|4|||
30873668|NCT01662063|58904369|FG002|Overall Study|Lost to Follow-up|0|||
30873669|NCT01662063|58904367|FG000|Overall Study|Protocol Violation|1|||
30873670|NCT01662063|58904368|FG001|Overall Study|Protocol Violation|0|||
30873671|NCT01662063|58904369|FG002|Overall Study|Protocol Violation|0|||
30873672|NCT01662063|58904367|FG000|Overall Study|Withdrawal by Subject|2|||
30873673|NCT01662063|58904368|FG001|Overall Study|Withdrawal by Subject|4|||
30873674|NCT01662063|58904369|FG002|Overall Study|Withdrawal by Subject|1|||
30873675|NCT01662063|58904367|FG000|Overall Study|Physician Decision|0|||
30873676|NCT01662063|58904368|FG001|Overall Study|Physician Decision|2|||
30873677|NCT01662063|58904369|FG002|Overall Study|Physician Decision|0|||
30873678|NCT01662063|58904367|FG000|Overall Study|Other|0|||
30873679|NCT01662063|58904368|FG001|Overall Study|Other|1|||
30602288|NCT01074268|58613655|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
30602289|NCT01074268|58613654|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
30602290|NCT01074268|58613655|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
30602291|NCT01074268|58613654|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
30602292|NCT01074268|58613655|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
30602293|NCT01074190|58613664|FG000|Overall Study|Emergency Cesarean Delivery|1|||
30602294|NCT01074190|58613665|FG001|Overall Study|Emergency Cesarean Delivery|2|||
30602295|NCT01074190|58613666|FG002|Overall Study|Emergency Cesarean Delivery|1|||
30602296|NCT01074190|58613664|FG000|Overall Study|Protocol Violation|2|||
30602297|NCT01074190|58613665|FG001|Overall Study|Protocol Violation|1|||
30602298|NCT01074190|58613666|FG002|Overall Study|Protocol Violation|0|||
30602299|NCT01074190|58613664|FG000|Overall Study|Delivered in under 90 minutes|0|||
30602300|NCT01074190|58613665|FG001|Overall Study|Delivered in under 90 minutes|2|||
30602301|NCT01074190|58613666|FG002|Overall Study|Delivered in under 90 minutes|1|||
30602302|NCT01074190|58613664|FG000|Overall Study|Subject withdrew consent|1|||
30602303|NCT01074190|58613665|FG001|Overall Study|Subject withdrew consent|1|||
30602304|NCT01074190|58613666|FG002|Overall Study|Subject withdrew consent|1|||
30602305|NCT01073566|58613679|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
30602306|NCT01073566|58613680|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
30602307|NCT01072396|58613688|FG000|Period One|Adverse Event|1|||
30602308|NCT01072396|58613689|FG001|Period One|Adverse Event|1|||
30602309|NCT01072396|58613688|FG000|Period One|Protocol Violation|2|||
30602310|NCT01072396|58613689|FG001|Period One|Protocol Violation|1|||
30602311|NCT01072396|58613688|FG000|Period One|Withdrawal by Subject|2|||
30602312|NCT01072396|58613689|FG001|Period One|Withdrawal by Subject|0|||
30602313|NCT01072396|58613688|FG000|Washout Period|Missing termination information|0|||
30602314|NCT01072396|58613689|FG001|Washout Period|Missing termination information|1|||
30602315|NCT01072396|58613688|FG000|Period Two|Adverse Event|0|||
30602316|NCT01072396|58613689|FG001|Period Two|Adverse Event|3|||
30602317|NCT01072396|58613688|FG000|Period Two|Lost to Follow-up|1|||
30602318|NCT01072396|58613689|FG001|Period Two|Lost to Follow-up|0|||
30602319|NCT01045096|58613698|FG000|Overall Study|Withdrawal by Subject|2|||
30602320|NCT01045096|58613699|FG001|Overall Study|Withdrawal by Subject|0|||
30602321|NCT01045096|58613700|FG002|Overall Study|Withdrawal by Subject|0|||
30602322|NCT01045096|58613698|FG000|Overall Study|Other|1|||
30602323|NCT01045096|58613699|FG001|Overall Study|Other|0|||
30602324|NCT01045096|58613700|FG002|Overall Study|Other|0|||
30602325|NCT01285518|58613716|FG000|Overall Study|Lost to Follow-up|0|||
30602326|NCT01285518|58613717|FG001|Overall Study|Lost to Follow-up|0|||
30602327|NCT01285518|58613718|FG002|Overall Study|Lost to Follow-up|0|||
30602328|NCT01285518|58613719|FG003|Overall Study|Lost to Follow-up|0|||
30602329|NCT01285518|58613720|FG004|Overall Study|Lost to Follow-up|0|||
30602330|NCT01285518|58613721|FG005|Overall Study|Lost to Follow-up|1|||
30602331|NCT01285518|58613722|FG006|Overall Study|Lost to Follow-up|0|||
30602332|NCT01285518|58613723|FG007|Overall Study|Lost to Follow-up|0|||
30602333|NCT01073020|58613746|FG000|Overall Study|Withdrawal by Subject|6|||
30602334|NCT01073020|58613747|FG001|Overall Study|Withdrawal by Subject|4|||
30602335|NCT01073020|58613748|FG002|Overall Study|Withdrawal by Subject|1|||
30602336|NCT01073020|58613749|FG003|Overall Study|Withdrawal by Subject|2|||
30602337|NCT01073020|58613746|FG000|Overall Study|Physician Decision|1|||
30602338|NCT01073020|58613747|FG001|Overall Study|Physician Decision|0|||
30602339|NCT01073020|58613748|FG002|Overall Study|Physician Decision|2|||
30602340|NCT01073020|58613749|FG003|Overall Study|Physician Decision|0|||
30602341|NCT01073020|58613746|FG000|Overall Study|Death|0|||
30602342|NCT01073020|58613747|FG001|Overall Study|Death|1|||
30602343|NCT01073020|58613748|FG002|Overall Study|Death|0|||
30602344|NCT01073020|58613749|FG003|Overall Study|Death|0|||
30602345|NCT01284114|58613759|FG000|Overall Study|viral infection|1|||
30602346|NCT01284114|58613759|FG000|Overall Study|From the results of ALLTITUDE study|1|||
30602347|NCT01284114|58613759|FG000|Overall Study|Symptomatic hypotension|1|||
30602348|NCT01284114|58613759|FG000|Overall Study|dizziness|1|||
30602349|NCT01283334|58613764|FG000|Overall Study|Withdrawal by Subject|1|||
30602350|NCT01283334|58613764|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
30602351|NCT01283334|58613764|FG000|Overall Study|Adverse Event|4|||
30602352|NCT01283334|58613764|FG000|Overall Study|Physician Decision|1|||
30602353|NCT01282866|58613770|FG000|Overall Study|Adverse Event|1|||
30873680|NCT01662063|58904369|FG002|Overall Study|Other|0|||
30873681|NCT02548455|58904377|FG000|Overall Study|Withdrawal by Subject|27|||
30873682|NCT02548455|58904377|FG000|Overall Study|Death|26|||
30602354|NCT01071070|58613776|FG000|Overall Study|Adverse Event|0|||
30602355|NCT01071070|58613777|FG001|Overall Study|Adverse Event|3|||
30602356|NCT01071070|58613776|FG000|Overall Study|Withdrawal by Subject|1|||
30602357|NCT01071070|58613777|FG001|Overall Study|Withdrawal by Subject|0|||
30602358|NCT01071070|58613776|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
30602359|NCT01071070|58613777|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
30602360|NCT01071070|58613776|FG000|Overall Study|Hypercalcemia|1|||
30602361|NCT01071070|58613777|FG001|Overall Study|Hypercalcemia|0|||
30873683|NCT02548455|58904377|FG000|Overall Study|Lost to Follow-up|14|||
30602362|NCT01282476|58613783|FG000|Overall Study|Death|11|||
30602363|NCT01282164|58613789|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
30602364|NCT01282164|58613790|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
30602365|NCT01250379|58613806|FG000|Overall Study|Death|141|||
30602366|NCT01250379|58613807|FG001|Overall Study|Death|148|||
30602367|NCT01250379|58613806|FG000|Overall Study|Withdrawal by Subject|32|||
30602368|NCT01250379|58613807|FG001|Overall Study|Withdrawal by Subject|20|||
30602369|NCT01250379|58613806|FG000|Overall Study|Physician Decision|11|||
30602370|NCT01250379|58613807|FG001|Overall Study|Physician Decision|3|||
30602371|NCT01250379|58613806|FG000|Overall Study|Protocol Violation|2|||
30602372|NCT01250379|58613807|FG001|Overall Study|Protocol Violation|8|||
30602373|NCT01250379|58613806|FG000|Overall Study|Lost to Follow-up|9|||
30602374|NCT01250379|58613807|FG001|Overall Study|Lost to Follow-up|6|||
30602375|NCT01250379|58613806|FG000|Overall Study|Adverse Event|5|||
30602376|NCT01250379|58613807|FG001|Overall Study|Adverse Event|4|||
30602377|NCT01250379|58613806|FG000|Overall Study|Other|0|||
30602378|NCT01250379|58613807|FG001|Overall Study|Other|4|||
30602379|NCT01250379|58613806|FG000|Overall Study|Participant noncompliance|2|||
30602380|NCT01250379|58613807|FG001|Overall Study|Participant noncompliance|0|||
30602381|NCT01072630|58613816|FG000|Overall Study|Adverse Event|11|||
30602382|NCT01072630|58613817|FG001|Overall Study|Adverse Event|19|||
30602383|NCT01072630|58613818|FG002|Overall Study|Adverse Event|2|||
30602384|NCT01072630|58613816|FG000|Overall Study|Lack of Efficacy|10|||
30602385|NCT01072630|58613817|FG001|Overall Study|Lack of Efficacy|10|||
30602386|NCT01072630|58613818|FG002|Overall Study|Lack of Efficacy|1|||
30602387|NCT01072630|58613816|FG000|Overall Study|Withdrawal by Subject|8|||
30602388|NCT01072630|58613817|FG001|Overall Study|Withdrawal by Subject|7|||
30602389|NCT01072630|58613818|FG002|Overall Study|Withdrawal by Subject|2|||
30602390|NCT01072630|58613816|FG000|Overall Study|Protocol Violation|10|||
30602391|NCT01072630|58613817|FG001|Overall Study|Protocol Violation|8|||
30602392|NCT01072630|58613818|FG002|Overall Study|Protocol Violation|4|||
30602393|NCT01072630|58613816|FG000|Overall Study|Lost to Follow-up|11|||
30602394|NCT01072630|58613817|FG001|Overall Study|Lost to Follow-up|11|||
30602395|NCT01072630|58613818|FG002|Overall Study|Lost to Follow-up|1|||
30602396|NCT01072630|58613816|FG000|Overall Study|Noncompliance with study medication|1|||
30602397|NCT01072630|58613817|FG001|Overall Study|Noncompliance with study medication|1|||
30602398|NCT01072630|58613818|FG002|Overall Study|Noncompliance with study medication|1|||
30602399|NCT01072630|58613816|FG000|Overall Study|Noncompliance with study procedures|1|||
30602400|NCT01072630|58613817|FG001|Overall Study|Noncompliance with study procedures|2|||
30602401|NCT01072630|58613818|FG002|Overall Study|Noncompliance with study procedures|1|||
30602402|NCT01072630|58613816|FG000|Overall Study|Other|3|||
30602403|NCT01072630|58613817|FG001|Overall Study|Other|2|||
30602404|NCT01072630|58613818|FG002|Overall Study|Other|1|||
30602405|NCT01281306|58613834|FG000|Overall Study|Lack of Efficacy|0|||
30602406|NCT01281306|58613835|FG001|Overall Study|Lack of Efficacy|1|||
30602407|NCT01281306|58613836|FG002|Overall Study|Lack of Efficacy|3|||
30602408|NCT01281306|58613837|FG003|Overall Study|Lack of Efficacy|0|||
30602409|NCT01281306|58613838|FG004|Overall Study|Lack of Efficacy|2|||
30602410|NCT01281306|58613839|FG005|Overall Study|Lack of Efficacy|0|||
30602411|NCT01281306|58613840|FG006|Overall Study|Lack of Efficacy|1|||
30602412|NCT01281306|58613834|FG000|Overall Study|Withdrawal by Subject|1|||
30602413|NCT01281306|58613835|FG001|Overall Study|Withdrawal by Subject|0|||
30602414|NCT01281306|58613836|FG002|Overall Study|Withdrawal by Subject|2|||
30602415|NCT01281306|58613837|FG003|Overall Study|Withdrawal by Subject|4|||
30602416|NCT01281306|58613838|FG004|Overall Study|Withdrawal by Subject|1|||
30602417|NCT01281306|58613839|FG005|Overall Study|Withdrawal by Subject|3|||
30602418|NCT01281306|58613840|FG006|Overall Study|Withdrawal by Subject|1|||
30602419|NCT01281306|58613834|FG000|Overall Study|Protocol deviation|0|||
30602420|NCT01281306|58613835|FG001|Overall Study|Protocol deviation|1|||
30602421|NCT01281306|58613836|FG002|Overall Study|Protocol deviation|1|||
30602422|NCT01281306|58613837|FG003|Overall Study|Protocol deviation|1|||
30602423|NCT01281306|58613838|FG004|Overall Study|Protocol deviation|1|||
30873684|NCT02548455|58904377|FG000|Overall Study|Visit not completed|173|||
30873685|NCT02691455|58904383|FG000|Overall Study|Withdrawal by Subject|1|||
30602424|NCT01281306|58613839|FG005|Overall Study|Protocol deviation|0|||
30602425|NCT01281306|58613840|FG006|Overall Study|Protocol deviation|0|||
30602426|NCT01281306|58613834|FG000|Overall Study|Condition no longer requires study drug|1|||
30602427|NCT01281306|58613835|FG001|Overall Study|Condition no longer requires study drug|0|||
30602428|NCT01281306|58613836|FG002|Overall Study|Condition no longer requires study drug|0|||
30602429|NCT01281306|58613837|FG003|Overall Study|Condition no longer requires study drug|0|||
30602430|NCT01281306|58613838|FG004|Overall Study|Condition no longer requires study drug|0|||
30602431|NCT01281306|58613839|FG005|Overall Study|Condition no longer requires study drug|1|||
30602432|NCT01281306|58613840|FG006|Overall Study|Condition no longer requires study drug|1|||
30602433|NCT01281306|58613834|FG000|Overall Study|Lost to Follow-up|1|||
30602434|NCT01281306|58613835|FG001|Overall Study|Lost to Follow-up|0|||
30602435|NCT01281306|58613836|FG002|Overall Study|Lost to Follow-up|0|||
30602436|NCT01281306|58613837|FG003|Overall Study|Lost to Follow-up|2|||
30602437|NCT01281306|58613838|FG004|Overall Study|Lost to Follow-up|0|||
30602438|NCT01281306|58613839|FG005|Overall Study|Lost to Follow-up|0|||
30602439|NCT01281306|58613840|FG006|Overall Study|Lost to Follow-up|1|||
30602440|NCT01281306|58613834|FG000|Overall Study|Death|1|||
30602441|NCT01281306|58613835|FG001|Overall Study|Death|0|||
30694632|NCT00359281|58708815|FG004|Overall Study|Adverse Event|0|||
30694633|NCT00359281|58708816|FG005|Overall Study|Adverse Event|0|||
30694634|NCT00359281|58708817|FG006|Overall Study|Adverse Event|1|||
30694635|NCT00359281|58708818|FG007|Overall Study|Adverse Event|0|||
30694636|NCT00359281|58708819|FG008|Overall Study|Adverse Event|0|||
30694637|NCT00359281|58708811|FG000|Overall Study|Withdrawal by Subject|0|||
30694638|NCT00359281|58708812|FG001|Overall Study|Withdrawal by Subject|0|||
30694639|NCT00359281|58708813|FG002|Overall Study|Withdrawal by Subject|0|||
30694640|NCT00359281|58708814|FG003|Overall Study|Withdrawal by Subject|0|||
30694641|NCT00359281|58708815|FG004|Overall Study|Withdrawal by Subject|0|||
30694642|NCT00359281|58708816|FG005|Overall Study|Withdrawal by Subject|0|||
30694643|NCT00359281|58708817|FG006|Overall Study|Withdrawal by Subject|1|||
30694644|NCT00359281|58708818|FG007|Overall Study|Withdrawal by Subject|0|||
30694645|NCT00359281|58708819|FG008|Overall Study|Withdrawal by Subject|0|||
30694646|NCT00366535|58708848|FG000|First Phase: 12 Weeks|Adverse Event|1|||
30694647|NCT00366535|58708849|FG001|First Phase: 12 Weeks|Adverse Event|3|||
30694648|NCT00366535|58708848|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
30694649|NCT00366535|58708849|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
30694650|NCT00366535|58708848|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
30694651|NCT00366535|58708849|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
30694652|NCT00366535|58708848|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
30694653|NCT00366535|58708849|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
30694654|NCT00350545|58708863|FG000|Overall Study|Withdrawal by Subject|2|||
30694655|NCT00349921|58708871|FG000|First Spinal Injection|Physician Decision|1|||
30694656|NCT00349921|58708872|FG001|First Spinal Injection|Physician Decision|0|||
30694657|NCT00349921|58708873|FG002|First Spinal Injection|Physician Decision|0|||
30694658|NCT00349921|58708874|FG003|First Spinal Injection|Physician Decision|0|||
30694659|NCT00349921|58708871|FG000|First Spinal Injection|Adverse Event|0|||
30694660|NCT00349921|58708872|FG001|First Spinal Injection|Adverse Event|0|||
30694661|NCT00349921|58708873|FG002|First Spinal Injection|Adverse Event|1|||
30694662|NCT00349921|58708874|FG003|First Spinal Injection|Adverse Event|0|||
30694663|NCT00606021|58708885|FG000|Induction Phase|Death|73|||
30694664|NCT00606021|58708886|FG001|Induction Phase|Death|0|||
30694665|NCT00606021|58708887|FG002|Induction Phase|Death|0|||
30694666|NCT00606021|58708885|FG000|Induction Phase|Physician Decision|2|||
30694667|NCT00606021|58708886|FG001|Induction Phase|Physician Decision|0|||
30694668|NCT00606021|58708887|FG002|Induction Phase|Physician Decision|0|||
30694669|NCT00606021|58708885|FG000|Induction Phase|Withdrawal by Subject|2|||
30694670|NCT00606021|58708886|FG001|Induction Phase|Withdrawal by Subject|0|||
30694671|NCT00606021|58708887|FG002|Induction Phase|Withdrawal by Subject|0|||
30694672|NCT00606021|58708885|FG000|Induction Phase|Lost to Follow-up|10|||
30694673|NCT00606021|58708886|FG001|Induction Phase|Lost to Follow-up|0|||
30694674|NCT00606021|58708887|FG002|Induction Phase|Lost to Follow-up|0|||
30694675|NCT00606021|58708885|FG000|Maintenance Phase|Death|0|||
30694676|NCT00606021|58708886|FG001|Maintenance Phase|Death|17|||
30694677|NCT00606021|58708887|FG002|Maintenance Phase|Death|15|||
30694678|NCT00606021|58708885|FG000|Maintenance Phase|Physician Decision|0|||
30694679|NCT00606021|58708886|FG001|Maintenance Phase|Physician Decision|1|||
30694680|NCT00606021|58708887|FG002|Maintenance Phase|Physician Decision|0|||
30694681|NCT00606021|58708885|FG000|Maintenance Phase|Lost to Follow-up|0|||
30694682|NCT00606021|58708886|FG001|Maintenance Phase|Lost to Follow-up|5|||
30694683|NCT00606021|58708887|FG002|Maintenance Phase|Lost to Follow-up|2|||
30694684|NCT00337675|58708898|FG000|Overall Study|Adverse Event|10|||
30694685|NCT00337675|58708899|FG001|Overall Study|Adverse Event|9|||
30694686|NCT00337675|58708900|FG002|Overall Study|Adverse Event|19|||
30694687|NCT00337675|58708898|FG000|Overall Study|Lack of Efficacy|10|||
30694688|NCT00337675|58708899|FG001|Overall Study|Lack of Efficacy|7|||
30694689|NCT00337675|58708900|FG002|Overall Study|Lack of Efficacy|9|||
30694690|NCT00337675|58708898|FG000|Overall Study|Lost to Follow-up|22|||
30694691|NCT00337675|58708899|FG001|Overall Study|Lost to Follow-up|19|||
30694692|NCT00337675|58708900|FG002|Overall Study|Lost to Follow-up|17|||
30694693|NCT00337675|58708898|FG000|Overall Study|Physician Decision|9|||
30694694|NCT00337675|58708899|FG001|Overall Study|Physician Decision|17|||
30694695|NCT00337675|58708900|FG002|Overall Study|Physician Decision|14|||
30694696|NCT00337675|58708898|FG000|Overall Study|Protocol Violation|21|||
30694697|NCT00337675|58708899|FG001|Overall Study|Protocol Violation|24|||
30694698|NCT00337675|58708900|FG002|Overall Study|Protocol Violation|19|||
30694699|NCT00337675|58708898|FG000|Overall Study|Withdrawal by Subject|25|||
30694700|NCT00337675|58708899|FG001|Overall Study|Withdrawal by Subject|25|||
30694701|NCT00337675|58708900|FG002|Overall Study|Withdrawal by Subject|19|||
30602442|NCT01281306|58613836|FG002|Overall Study|Death|0|||
30602443|NCT01281306|58613837|FG003|Overall Study|Death|0|||
30694702|NCT00337675|58708898|FG000|Overall Study|Progressive Disease|0|||
30694703|NCT00337675|58708899|FG001|Overall Study|Progressive Disease|2|||
30602444|NCT01281306|58613838|FG004|Overall Study|Death|0|||
30602445|NCT01281306|58613839|FG005|Overall Study|Death|0|||
30602446|NCT01281306|58613840|FG006|Overall Study|Death|0|||
30602447|NCT01281306|58613834|FG000|Overall Study|Adverse Event|3|||
30602448|NCT01281306|58613835|FG001|Overall Study|Adverse Event|2|||
30602449|NCT01281306|58613836|FG002|Overall Study|Adverse Event|2|||
30602450|NCT01281306|58613837|FG003|Overall Study|Adverse Event|3|||
30602451|NCT01281306|58613838|FG004|Overall Study|Adverse Event|5|||
30602452|NCT01281306|58613839|FG005|Overall Study|Adverse Event|3|||
30602453|NCT01281306|58613840|FG006|Overall Study|Adverse Event|3|||
30602454|NCT01281306|58613834|FG000|Overall Study|Randomized in error|1|||
30602455|NCT01281306|58613835|FG001|Overall Study|Randomized in error|0|||
30602456|NCT01281306|58613836|FG002|Overall Study|Randomized in error|0|||
30602457|NCT01281306|58613837|FG003|Overall Study|Randomized in error|1|||
30602458|NCT01281306|58613838|FG004|Overall Study|Randomized in error|0|||
30602459|NCT01281306|58613839|FG005|Overall Study|Randomized in error|0|||
30602460|NCT01281306|58613840|FG006|Overall Study|Randomized in error|0|||
30602461|NCT01250145|58613858|FG000|Overall Study|Adverse Event|2|||
30602462|NCT01250145|58613859|FG001|Overall Study|Adverse Event|1|||
30602463|NCT01250145|58613858|FG000|Overall Study|Withdrawal by Subject|0|||
30602464|NCT01250145|58613859|FG001|Overall Study|Withdrawal by Subject|4|||
30602465|NCT01067326|58613881|FG000|Overall Study|Adverse Event|0|||
30602466|NCT01067326|58613882|FG001|Overall Study|Adverse Event|2|||
30602467|NCT01067326|58613881|FG000|Overall Study|Withdrawal by Subject|1|||
30602468|NCT01067326|58613882|FG001|Overall Study|Withdrawal by Subject|0|||
30602469|NCT01067326|58613881|FG000|Overall Study|Early Study Termination|1|||
30602470|NCT01067326|58613882|FG001|Overall Study|Early Study Termination|1|||
30602471|NCT01279200|58613890|FG000|Overall Study|Withdrawal by Subject|1|||
30602472|NCT01279200|58613891|FG001|Overall Study|Withdrawal by Subject|3|||
30602473|NCT01279200|58613890|FG000|Overall Study|Patient withdrawal due to high cost|0|||
30602474|NCT01279200|58613891|FG001|Overall Study|Patient withdrawal due to high cost|1|||
30602475|NCT01279200|58613890|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
30602476|NCT01279200|58613891|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
30602477|NCT01279200|58613890|FG000|Overall Study|ultrasound screening failure|0|||
30602478|NCT01279200|58613891|FG001|Overall Study|ultrasound screening failure|1|||
30602479|NCT01279200|58613890|FG000|Overall Study|Lost to Follow-up|0|||
30602480|NCT01279200|58613891|FG001|Overall Study|Lost to Follow-up|1|||
30602481|NCT01279200|58613890|FG000|Overall Study|Adverse Event|1|||
30602482|NCT01279200|58613891|FG001|Overall Study|Adverse Event|0|||
30602483|NCT01273818|58613900|FG000|Overall Study|Physician Decision|13|||
30602484|NCT01273818|58613901|FG001|Overall Study|Physician Decision|2|||
30602485|NCT01273818|58613902|FG002|Overall Study|Physician Decision|9|||
30602486|NCT01245387|58613910|FG000|Overall Study|Lost to Follow-up|106|||
30602487|NCT01245387|58613910|FG000|Overall Study|Lack of Efficacy|195|||
30602488|NCT01245387|58613910|FG000|Overall Study|Adverse Event|9|||
30602489|NCT01245387|58613910|FG000|Overall Study|Death|3|||
30602490|NCT01245387|58613910|FG000|Overall Study|Other|131|||
30602491|NCT01245387|58613910|FG000|Overall Study|Missing discontinuation status|369|||
30602492|NCT01037218|58613918|FG000|Overall Study|Adverse Event|4|||
30602493|NCT01037218|58613919|FG001|Overall Study|Adverse Event|2|||
30602494|NCT01037218|58613920|FG002|Overall Study|Adverse Event|2|||
30602495|NCT01037218|58613921|FG003|Overall Study|Adverse Event|1|||
30602496|NCT01037218|58613918|FG000|Overall Study|Lack of Efficacy|0|||
30602497|NCT01037218|58613919|FG001|Overall Study|Lack of Efficacy|2|||
30602498|NCT01037218|58613920|FG002|Overall Study|Lack of Efficacy|1|||
30602499|NCT01037218|58613921|FG003|Overall Study|Lack of Efficacy|5|||
30602500|NCT01037218|58613918|FG000|Overall Study|Lost to Follow-up|3|||
30602501|NCT01037218|58613919|FG001|Overall Study|Lost to Follow-up|5|||
30602502|NCT01037218|58613920|FG002|Overall Study|Lost to Follow-up|4|||
30602503|NCT01037218|58613921|FG003|Overall Study|Lost to Follow-up|2|||
30602504|NCT01037218|58613918|FG000|Overall Study|Withdrawal by Subject|6|||
30602505|NCT01037218|58613919|FG001|Overall Study|Withdrawal by Subject|7|||
30602506|NCT01037218|58613920|FG002|Overall Study|Withdrawal by Subject|7|||
30602507|NCT01037218|58613921|FG003|Overall Study|Withdrawal by Subject|4|||
30602508|NCT01037218|58613918|FG000|Overall Study|Partner Withdrew Consent|0|||
30602509|NCT01037218|58613919|FG001|Overall Study|Partner Withdrew Consent|3|||
30602510|NCT01037218|58613920|FG002|Overall Study|Partner Withdrew Consent|2|||
30602511|NCT01037218|58613921|FG003|Overall Study|Partner Withdrew Consent|1|||
30602512|NCT01037218|58613918|FG000|Overall Study|Protocol Violation|0|||
30602513|NCT01037218|58613919|FG001|Overall Study|Protocol Violation|0|||
30602514|NCT01037218|58613920|FG002|Overall Study|Protocol Violation|2|||
30602515|NCT01037218|58613921|FG003|Overall Study|Protocol Violation|2|||
30602516|NCT01037218|58613918|FG000|Overall Study|Various|3|||
30602517|NCT01037218|58613919|FG001|Overall Study|Various|2|||
30602518|NCT01037218|58613920|FG002|Overall Study|Various|3|||
30602519|NCT01037218|58613921|FG003|Overall Study|Various|1|||
30602520|NCT01038856|58613931|FG000|Overall Study|Adverse Event|2|||
30602521|NCT01066546|58613937|FG000|Overall Study|Study terminated by sponsor|5|||
30602522|NCT01272804|58613947|FG000|Overall Study|Adverse Event|1|||
30602523|NCT01272804|58613948|FG001|Overall Study|Adverse Event|0|||
30602524|NCT01272804|58613949|FG002|Overall Study|Adverse Event|0|||
30602525|NCT01272804|58613950|FG003|Overall Study|Adverse Event|0|||
30602526|NCT01272804|58613951|FG004|Overall Study|Adverse Event|2|||
30602527|NCT01272804|58613952|FG005|Overall Study|Adverse Event|1|||
30602528|NCT01269918|58613968|FG000|Overall Study|Did not receive study drug|0|||
30602529|NCT01269918|58613969|FG001|Overall Study|Did not receive study drug|3|||
30602530|NCT01036594|58613975|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
30602531|NCT01036594|58613976|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
30602532|NCT01036594|58613975|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
30602533|NCT01036594|58613976|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
30602534|NCT01036594|58613975|FG000|Week 12 Evaluation|Adverse Event|5|||
30602535|NCT01036594|58613976|FG001|Week 12 Evaluation|Adverse Event|0|||
30602536|NCT01036594|58613975|FG000|Week 12 Evaluation|Physician Decision|1|||
30602537|NCT01036594|58613976|FG001|Week 12 Evaluation|Physician Decision|0|||
30602538|NCT01036594|58613975|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
30602539|NCT01036594|58613976|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
30602540|NCT01036594|58613975|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
30602541|NCT01036594|58613976|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
30602542|NCT01036594|58613975|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
30602543|NCT01036594|58613976|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
30602544|NCT01036594|58613975|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
30602545|NCT01036594|58613976|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
30602546|NCT01036594|58613975|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
30602547|NCT01036594|58613976|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
30602548|NCT01036438|58613984|FG000|Overall Study|Adverse Event|7|||
30602549|NCT01036438|58613985|FG001|Overall Study|Adverse Event|8|||
30602550|NCT01036438|58613984|FG000|Overall Study|Death|0|||
30602551|NCT01036438|58613985|FG001|Overall Study|Death|1|||
30602552|NCT01036438|58613984|FG000|Overall Study|No effect of study treatment|3|||
30602553|NCT01036438|58613985|FG001|Overall Study|No effect of study treatment|1|||
30602554|NCT01268514|58613991|FG000|Overall Study|Adverse Event|20|||
30694704|NCT00337675|58708900|FG002|Overall Study|Progressive Disease|0|||
30694705|NCT00337675|58708898|FG000|Overall Study|Trial Terminated|0|||
30694706|NCT00337675|58708899|FG001|Overall Study|Trial Terminated|0|||
30694707|NCT00337675|58708900|FG002|Overall Study|Trial Terminated|2|||
30694708|NCT00337285|58708908|FG000|Overall Study|Withdrawal by Subject|42|||
30694709|NCT00337285|58708908|FG000|Overall Study|Lost to Follow-up|41|||
30694710|NCT00337285|58708908|FG000|Overall Study|Adverse Event|28|||
30694711|NCT00337285|58708908|FG000|Overall Study|Protocol Violation|27|||
30694712|NCT00337285|58708908|FG000|Overall Study|Lack of Efficacy|11|||
30694713|NCT00337285|58708908|FG000|Overall Study|Death|1|||
30694714|NCT00337285|58708908|FG000|Overall Study|Physician Decision|1|||
30694715|NCT00337285|58708908|FG000|Overall Study|Lack of protocol compliance|7|||
30694716|NCT00605865|58708912|FG000|Overall Study|Protocol Violation|115|||
30694717|NCT00348673|58708952|FG000|Stage 1|Randomized but not Treated|0|||
30694718|NCT00348673|58708953|FG001|Stage 1|Randomized but not Treated|0|||
30694719|NCT00348673|58708954|FG002|Stage 1|Randomized but not Treated|1|||
30694720|NCT00348673|58708955|FG003|Stage 1|Randomized but not Treated|0|||
30961242|NCT02666664|59027363|FG000|Overall Study|Sponsor decision|0|||
30961243|NCT02666664|59027364|FG001|Overall Study|Sponsor decision|1|||
30961244|NCT02666664|59027363|FG000|Overall Study|Lost to Follow-up|1|||
30961245|NCT02666664|59027364|FG001|Overall Study|Lost to Follow-up|2|||
30961246|NCT01528735|59027372|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
30961247|NCT01528735|59027373|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
30961248|NCT01528735|59027372|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
30961249|NCT01528735|59027373|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
30961250|NCT02661594|59027385|FG000|Overall Study|Protocol Violation|1|||
30961251|NCT02661594|59027386|FG001|Overall Study|Protocol Violation|0|||
30961252|NCT02661594|59027387|FG002|Overall Study|Protocol Violation|1|||
30961253|NCT02661594|59027388|FG003|Overall Study|Protocol Violation|0|||
30961254|NCT01528345|59027400|FG000|Overall Study|Adverse Event|10|||
30961255|NCT01528345|59027401|FG001|Overall Study|Adverse Event|1|||
30961256|NCT01528345|59027400|FG000|Overall Study|Death|1|||
30694721|NCT00348673|58708956|FG004|Stage 1|Randomized but not Treated|0|||
30694722|NCT00348673|58708957|FG005|Stage 1|Randomized but not Treated|0|||
30694723|NCT00348673|58708958|FG006|Stage 1|Randomized but not Treated|0|||
30602555|NCT01268514|58613991|FG000|Overall Study|Death|8|||
30602556|NCT01268514|58613991|FG000|Overall Study|Lost to Follow-up|5|||
30602557|NCT01268514|58613991|FG000|Overall Study|Withdrawal by Subject|3|||
30602558|NCT01268514|58613991|FG000|Overall Study|Withdrawal by Surgeon|5|||
30602559|NCT01268046|58614001|FG000|Overall Study|Withdrawal by Subject|1|||
30694724|NCT00348673|58708959|FG007|Stage 1|Randomized but not Treated|0|||
30961257|NCT01528345|59027401|FG001|Overall Study|Death|1|||
30961258|NCT01528345|59027400|FG000|Overall Study|Non-compliance with study treatment|1|||
30961259|NCT01528345|59027401|FG001|Overall Study|Non-compliance with study treatment|0|||
30961260|NCT01528345|59027400|FG000|Overall Study|Progressive Disease|26|||
30961261|NCT01528345|59027401|FG001|Overall Study|Progressive Disease|40|||
30961262|NCT01528345|59027400|FG000|Overall Study|Study Terminated by Sponsor|4|||
30961263|NCT01528345|59027401|FG001|Overall Study|Study Terminated by Sponsor|8|||
30961264|NCT01528345|59027400|FG000|Overall Study|Subject/Guardian Decision|5|||
30961265|NCT01528345|59027401|FG001|Overall Study|Subject/Guardian Decision|0|||
30961266|NCT01513967|59027415|FG000|Overall Study|Pregnancy|0|||
30961267|NCT01513967|59027416|FG001|Overall Study|Pregnancy|0|||
30961268|NCT01513967|59027417|FG002|Overall Study|Pregnancy|0|||
30961269|NCT01513967|59027418|FG003|Overall Study|Pregnancy|0|||
30961270|NCT01513967|59027419|FG004|Overall Study|Pregnancy|0|||
30961271|NCT01513967|59027420|FG005|Overall Study|Pregnancy|0|||
30961272|NCT01513967|59027421|FG006|Overall Study|Pregnancy|1|||
30961273|NCT01513967|59027422|FG007|Overall Study|Pregnancy|0|||
30961274|NCT01513967|59027415|FG000|Overall Study|missed a study visit|0|||
30961275|NCT01513967|59027416|FG001|Overall Study|missed a study visit|0|||
30961276|NCT01513967|59027417|FG002|Overall Study|missed a study visit|0|||
30961277|NCT01513967|59027418|FG003|Overall Study|missed a study visit|0|||
30961278|NCT01513967|59027419|FG004|Overall Study|missed a study visit|0|||
30961279|NCT01513967|59027420|FG005|Overall Study|missed a study visit|0|||
30961280|NCT01513967|59027421|FG006|Overall Study|missed a study visit|1|||
30961281|NCT01513967|59027422|FG007|Overall Study|missed a study visit|0|||
30961282|NCT01513967|59027415|FG000|Overall Study|excluded due to positive drug screen|0|||
30961283|NCT01513967|59027416|FG001|Overall Study|excluded due to positive drug screen|0|||
30961284|NCT01513967|59027417|FG002|Overall Study|excluded due to positive drug screen|0|||
30961285|NCT01513967|59027418|FG003|Overall Study|excluded due to positive drug screen|0|||
30961286|NCT01513967|59027419|FG004|Overall Study|excluded due to positive drug screen|0|||
30961287|NCT01513967|59027420|FG005|Overall Study|excluded due to positive drug screen|0|||
30961288|NCT01513967|59027421|FG006|Overall Study|excluded due to positive drug screen|0|||
30961289|NCT01513967|59027422|FG007|Overall Study|excluded due to positive drug screen|2|||
30961290|NCT01513967|59027415|FG000|Overall Study|Physician Decision|0|||
30961291|NCT01513967|59027416|FG001|Overall Study|Physician Decision|0|||
30961292|NCT01513967|59027417|FG002|Overall Study|Physician Decision|0|||
30961293|NCT01513967|59027418|FG003|Overall Study|Physician Decision|0|||
30961294|NCT01513967|59027419|FG004|Overall Study|Physician Decision|0|||
30961295|NCT01513967|59027420|FG005|Overall Study|Physician Decision|1|||
30961296|NCT01513967|59027421|FG006|Overall Study|Physician Decision|0|||
30961297|NCT01513967|59027422|FG007|Overall Study|Physician Decision|0|||
30961298|NCT01511939|59027466|FG000|Overall Study|Withdrawal by Subject|2|||
30961299|NCT01511939|59027467|FG001|Overall Study|Withdrawal by Subject|1|||
30961300|NCT01511939|59027468|FG002|Overall Study|Withdrawal by Subject|0|||
30961301|NCT01576705|59027480|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
30961302|NCT01576705|59027481|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
30961303|NCT01576705|59027482|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
30961304|NCT01576705|59027483|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
30961305|NCT01576705|59027480|FG000|Overall Study|invalid ICF|0|||
30961306|NCT01576705|59027481|FG001|Overall Study|invalid ICF|1|||
30961307|NCT01576705|59027482|FG002|Overall Study|invalid ICF|0|||
30961308|NCT01576705|59027483|FG003|Overall Study|invalid ICF|0|||
30961309|NCT02666430|59027495|FG000|Period 1|Lost to Follow-up|1|||
30961310|NCT02666430|59027496|FG001|Period 1|Lost to Follow-up|0|||
30961311|NCT02666430|59027495|FG000|Period 1|Adverse Event|0|||
30961312|NCT02666430|59027496|FG001|Period 1|Adverse Event|1|||
30961313|NCT02666430|59027495|FG000|Period 2|Withdrawal by Subject|1|||
30961314|NCT02666430|59027496|FG001|Period 2|Withdrawal by Subject|4|||
30961315|NCT02666430|59027495|FG000|Period 3|Lost to Follow-up|1|||
30961316|NCT02666430|59027496|FG001|Period 3|Lost to Follow-up|0|||
30961317|NCT01576549|59027502|FG000|Overall Study|Sponsor Decision|2|||
30961318|NCT01576159|59027515|FG000|Overall Study|Withdrawal by Subject|0|||
30961319|NCT01576159|59027516|FG001|Overall Study|Withdrawal by Subject|1|||
30961320|NCT01576159|59027517|FG002|Overall Study|Withdrawal by Subject|0|||
30961321|NCT01576159|59027518|FG003|Overall Study|Withdrawal by Subject|0|||
30961322|NCT01576159|59027515|FG000|Overall Study|Physician Decision|0|||
30694725|NCT00348673|58708960|FG008|Stage 1|Randomized but not Treated|0|||
30694726|NCT00337207|58708978|FG000|Overall Study|Withdrawal by Subject|3|||
30877503|NCT01998958|58909050|FG029|Open Label Phase (Optional)|Other|0|||
30961323|NCT01576159|59027516|FG001|Overall Study|Physician Decision|0|||
30961324|NCT01576159|59027517|FG002|Overall Study|Physician Decision|1|||
30961325|NCT01576159|59027518|FG003|Overall Study|Physician Decision|0|||
30961326|NCT01576159|59027515|FG000|Overall Study|Lost to Follow-up|0|||
30961327|NCT01576159|59027516|FG001|Overall Study|Lost to Follow-up|0|||
30961328|NCT01576159|59027517|FG002|Overall Study|Lost to Follow-up|0|||
30961329|NCT01576159|59027518|FG003|Overall Study|Lost to Follow-up|1|||
30961330|NCT01576159|59027515|FG000|Overall Study|Protocol Violation|1|||
30961331|NCT01576159|59027516|FG001|Overall Study|Protocol Violation|0|||
30961332|NCT01576159|59027517|FG002|Overall Study|Protocol Violation|0|||
30961333|NCT01576159|59027518|FG003|Overall Study|Protocol Violation|0|||
30961334|NCT01510769|59027549|FG000|Overall Study|Adverse Event|7|||
30961335|NCT01510769|59027550|FG001|Overall Study|Adverse Event|6|||
30961336|NCT01510769|59027551|FG002|Overall Study|Adverse Event|4|||
30961337|NCT01510769|59027549|FG000|Overall Study|Gout Flare|0|||
30961338|NCT01510769|59027550|FG001|Overall Study|Gout Flare|3|||
30961339|NCT01510769|59027551|FG002|Overall Study|Gout Flare|1|||
30961340|NCT01510769|59027549|FG000|Overall Study|Protocol Violation|11|||
30961341|NCT01510769|59027550|FG001|Overall Study|Protocol Violation|10|||
30961342|NCT01510769|59027551|FG002|Overall Study|Protocol Violation|9|||
30961343|NCT01510769|59027549|FG000|Overall Study|Lost to Follow-up|5|||
30961344|NCT01510769|59027550|FG001|Overall Study|Lost to Follow-up|1|||
30961345|NCT01510769|59027551|FG002|Overall Study|Lost to Follow-up|5|||
30961346|NCT01510769|59027549|FG000|Overall Study|Withdrawal by Subject|3|||
30961347|NCT01510769|59027550|FG001|Overall Study|Withdrawal by Subject|4|||
30961348|NCT01510769|59027551|FG002|Overall Study|Withdrawal by Subject|3|||
30961349|NCT01510769|59027549|FG000|Overall Study|Death|1|||
30961350|NCT01510769|59027550|FG001|Overall Study|Death|1|||
30961351|NCT01510769|59027551|FG002|Overall Study|Death|0|||
30961352|NCT01575769|59027559|FG000|Overall Study|Adverse Event|1|||
30961353|NCT01575769|59027559|FG000|Overall Study|Study terminated by sponsor|40|||
30961354|NCT01510145|59027565|FG000|Overall Study|Adverse Event|6|||
30961355|NCT01510145|59027565|FG000|Overall Study|Lost to Follow-up|5|||
30961356|NCT01510145|59027565|FG000|Overall Study|Withdrawal by Subject|6|||
30961357|NCT01510145|59027565|FG000|Overall Study|Relative reported subject withdrew|1|||
30961358|NCT01528033|59027571|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
30961359|NCT01528033|59027572|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
30961360|NCT01528033|59027571|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
30961361|NCT01528033|59027572|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
30961362|NCT01528033|59027571|FG000|Primary Endpoint Assessment ITT|Death|2|||
30961363|NCT01528033|59027572|FG001|Primary Endpoint Assessment ITT|Death|2|||
30961364|NCT01528033|59027571|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
30961365|NCT01528033|59027572|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
30961366|NCT01528033|59027571|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
30961367|NCT01528033|59027572|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
30961368|NCT01528033|59027571|FG000|Follow Up|No data available|46|||
30961369|NCT01528033|59027572|FG001|Follow Up|No data available|44|||
30961370|NCT01560871|59027589|FG000|Overall Study|transportation issues|2|||
30961371|NCT01560871|59027590|FG001|Overall Study|transportation issues|1|||
30961372|NCT01560871|59027589|FG000|Overall Study|relocation|1|||
30961373|NCT01560871|59027590|FG001|Overall Study|relocation|0|||
30961374|NCT01560871|59027589|FG000|Overall Study|readmission to a hospital|2|||
30961375|NCT01560871|59027590|FG001|Overall Study|readmission to a hospital|1|||
30961376|NCT01560871|59027589|FG000|Overall Study|Lost to Follow-up|1|||
30961377|NCT01560871|59027590|FG001|Overall Study|Lost to Follow-up|0|||
30961378|NCT01509053|59027597|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
30961379|NCT01509053|59027597|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
30961380|NCT01509053|59027597|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
30961381|NCT01509053|59027597|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
30961382|NCT01509053|59027597|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
30961383|NCT01509053|59027597|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
30961384|NCT01560403|59027611|FG000|Overall Study|Lost to Follow-up|0|||
30961385|NCT01560403|59027612|FG001|Overall Study|Lost to Follow-up|1|||
30961386|NCT01527487|59027659|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
30961387|NCT01527487|59027660|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
30961388|NCT01527487|59027659|FG000|Overall Study|Disease Progression|4|||
30961389|NCT01527487|59027660|FG001|Overall Study|Disease Progression|1|||
30961390|NCT01527487|59027659|FG000|Overall Study|Adverse Event|1|||
30961391|NCT01527487|59027660|FG001|Overall Study|Adverse Event|1|||
30961392|NCT01527487|59027659|FG000|Overall Study|Death|0|||
30961393|NCT01527487|59027660|FG001|Overall Study|Death|1|||
30961394|NCT01506947|59027671|FG000|Overall Study|Lost to Follow-up|7|||
30961395|NCT01506947|59027671|FG000|Overall Study|Adverse Event|5|||
30961396|NCT01506947|59027671|FG000|Overall Study|Death|1|||
30961397|NCT01506947|59027671|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
30961398|NCT02665338|59027688|FG000|Overall Study|Withdrawal by Subject|0|||
30961399|NCT02665338|59027689|FG001|Overall Study|Withdrawal by Subject|1|||
30961400|NCT01506479|59027698|FG000|Overall Study|Lost to Follow-up|1|||
30961401|NCT01506479|59027699|FG001|Overall Study|Lost to Follow-up|2|||
30961402|NCT01506479|59027700|FG002|Overall Study|Lost to Follow-up|2|||
30961403|NCT01506479|59027698|FG000|Overall Study|Withdrawal by Subject|1|||
30961404|NCT01506479|59027699|FG001|Overall Study|Withdrawal by Subject|2|||
30961405|NCT01506479|59027700|FG002|Overall Study|Withdrawal by Subject|1|||
30961406|NCT01506479|59027698|FG000|Overall Study|Missing assessment|1|||
30961407|NCT01506479|59027699|FG001|Overall Study|Missing assessment|0|||
30961408|NCT01506479|59027700|FG002|Overall Study|Missing assessment|0|||
30961409|NCT01506479|59027698|FG000|Overall Study|Adverse Event|0|||
30961410|NCT01506479|59027699|FG001|Overall Study|Adverse Event|1|||
30961411|NCT01506479|59027700|FG002|Overall Study|Adverse Event|0|||
30961412|NCT01506323|59027724|FG000|Overall Study|Lost to Follow-up|5|||
30961413|NCT01506323|59027725|FG001|Overall Study|Lost to Follow-up|4|||
30961414|NCT01506323|59027724|FG000|Overall Study|Withdrawal by Subject|4|||
30961415|NCT01506323|59027725|FG001|Overall Study|Withdrawal by Subject|4|||
30961416|NCT01506323|59027724|FG000|Overall Study|Lack of Efficacy|1|||
30961417|NCT01506323|59027725|FG001|Overall Study|Lack of Efficacy|3|||
30961418|NCT01506323|59027724|FG000|Overall Study|Moved out of area|5|||
30961419|NCT01506323|59027725|FG001|Overall Study|Moved out of area|2|||
30961420|NCT01506323|59027724|FG000|Overall Study|Schedule or Transportation conflict|8|||
30961421|NCT01506323|59027725|FG001|Overall Study|Schedule or Transportation conflict|0|||
30961422|NCT01506323|59027724|FG000|Overall Study|Started another treatment|1|||
30961423|NCT01506323|59027725|FG001|Overall Study|Started another treatment|0|||
30961424|NCT01505387|59027738|FG000|Overall Study|Protocol Violation|1|||
30961425|NCT01505387|59027739|FG001|Overall Study|Protocol Violation|0|||
30961426|NCT01505387|59027738|FG000|Overall Study|Withdrawal by Subject|1|||
30961427|NCT01505387|59027739|FG001|Overall Study|Withdrawal by Subject|1|||
30961428|NCT01504841|59027827|FG000|Overall Study|Withdrawal by Subject|1|||
30961429|NCT01504841|59027828|FG001|Overall Study|Withdrawal by Subject|1|||
30961430|NCT01504841|59027829|FG002|Overall Study|Withdrawal by Subject|0|||
30961431|NCT01502423|59027842|FG000|Overall Study|Withdrawal by Subject|0|||
30961432|NCT01502423|59027843|FG001|Overall Study|Withdrawal by Subject|1|||
30961433|NCT01502033|59027849|FG000|Overall Study|1 participant had scalp discomfort|1|||
30961434|NCT01502033|59027849|FG000|Overall Study|1 participant had worsening depression|1|||
30961435|NCT01502033|59027849|FG000|Overall Study|1 participant went back to school|1|||
30961436|NCT01500629|59027857|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
30961437|NCT01500629|59027858|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
30961438|NCT01500317|59027874|FG000|Overall Study|Withdrawal by Subject|3|||
30961439|NCT01500317|59027875|FG001|Overall Study|Withdrawal by Subject|2|||
30961440|NCT01500317|59027876|FG002|Overall Study|Withdrawal by Subject|0|||
30961441|NCT01500083|59027931|FG000|Overall Study|Adverse Event|4|||
30961442|NCT01500083|59027932|FG001|Overall Study|Adverse Event|17|||
30961443|NCT01500083|59027931|FG000|Overall Study|Death|0|||
30961444|NCT01500083|59027932|FG001|Overall Study|Death|2|||
30961445|NCT01500083|59027931|FG000|Overall Study|Lost to Follow-up|1|||
30961446|NCT01500083|59027932|FG001|Overall Study|Lost to Follow-up|0|||
30961447|NCT01500083|59027931|FG000|Overall Study|Withdrawal of Consent|0|||
30961448|NCT01500083|59027932|FG001|Overall Study|Withdrawal of Consent|1|||
30961449|NCT01500083|59027931|FG000|Overall Study|Disease Progression|2|||
30961450|NCT01500083|59027932|FG001|Overall Study|Disease Progression|10|||
30602560|NCT01268046|58614002|FG001|Overall Study|Withdrawal by Subject|0|||
30602561|NCT01268046|58614003|FG002|Overall Study|Withdrawal by Subject|0|||
30602562|NCT01268046|58614004|FG003|Overall Study|Withdrawal by Subject|1|||
30602563|NCT01268046|58614001|FG000|Overall Study|Lost to Follow-up|0|||
30602564|NCT01268046|58614002|FG001|Overall Study|Lost to Follow-up|0|||
30602565|NCT01268046|58614003|FG002|Overall Study|Lost to Follow-up|1|||
30873686|NCT02691455|58904384|FG001|Overall Study|Withdrawal by Subject|2|||
30873687|NCT02691455|58904383|FG000|Overall Study|Lost to Follow-up|15|||
30873688|NCT02691455|58904384|FG001|Overall Study|Lost to Follow-up|15|||
30873689|NCT02534883|58904392|FG000|Overall Study|Early Termination|8|||
30873690|NCT02534883|58904393|FG001|Overall Study|Early Termination|3|||
30873691|NCT02685995|58904401|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
30873692|NCT02685995|58904402|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
30873693|NCT02548143|58904410|FG000|Overall Study|Adverse Event|1|||
30873694|NCT02548143|58904411|FG001|Overall Study|Adverse Event|0|||
30873695|NCT02548143|58904410|FG000|Overall Study|Withdrawal by Subject|0|||
30873696|NCT02548143|58904411|FG001|Overall Study|Withdrawal by Subject|1|||
30873697|NCT02547441|58904419|FG000|Double-Blind Study Period|Adverse Event|4|||
30873698|NCT02547441|58904420|FG001|Double-Blind Study Period|Adverse Event|9|||
30873699|NCT02547441|58904419|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
30873700|NCT02547441|58904420|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
30873701|NCT02547441|58904419|FG000|Double-Blind Study Period|Physician Decision|1|||
30873702|NCT02547441|58904420|FG001|Double-Blind Study Period|Physician Decision|0|||
30873703|NCT02547441|58904419|FG000|Double-Blind Study Period|Protocol Violation|1|||
30602566|NCT01268046|58614004|FG003|Overall Study|Lost to Follow-up|0|||
30602567|NCT01267266|58614014|FG000|Enrollment Phase|Withdrawal by Subject|2|||
30602568|NCT01267266|58614015|FG001|Enrollment Phase|Withdrawal by Subject|0|||
30602569|NCT01267266|58614014|FG000|Lead-in Phase|Lack of Efficacy|20|||
30873704|NCT02547441|58904420|FG001|Double-Blind Study Period|Protocol Violation|2|||
30873705|NCT02547441|58904419|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
30873706|NCT02547441|58904420|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
30877504|NCT01998958|58909051|FG030|Open Label Phase (Optional)|Other|0|||
30961451|NCT01500083|59027931|FG000|Overall Study|Investigator Discretion|3|||
30961452|NCT01500083|59027932|FG001|Overall Study|Investigator Discretion|8|||
30602570|NCT01267266|58614015|FG001|Lead-in Phase|Lack of Efficacy|0|||
30602571|NCT01267266|58614014|FG000|Lead-in Phase|Adverse Event|2|||
30602572|NCT01267266|58614015|FG001|Lead-in Phase|Adverse Event|0|||
30602573|NCT01267266|58614014|FG000|Lead-in Phase|Withdrawal by Subject|1|||
30602574|NCT01267266|58614015|FG001|Lead-in Phase|Withdrawal by Subject|0|||
30602575|NCT01034176|58614026|FG000|Overall Study|Physician Decision|2|||
30602576|NCT01034176|58614027|FG001|Overall Study|Physician Decision|0|||
30961453|NCT01500083|59027931|FG000|Overall Study|Other Reasons|2|||
30961454|NCT01500083|59027932|FG001|Overall Study|Other Reasons|5|||
30961455|NCT01499849|59027962|FG000|Overall Study|Adverse Event|28|||
30961456|NCT01499849|59027963|FG001|Overall Study|Adverse Event|32|||
30961457|NCT01499849|59027962|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
30961458|NCT01499849|59027963|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
30961459|NCT01499849|59027962|FG000|Overall Study|Withdrawal by Subject|43|||
30961460|NCT01499849|59027963|FG001|Overall Study|Withdrawal by Subject|43|||
30961461|NCT01499849|59027962|FG000|Overall Study|Death|5|||
30961462|NCT01499849|59027963|FG001|Overall Study|Death|7|||
30961463|NCT01499849|59027962|FG000|Overall Study|Disease Progression|11|||
30961464|NCT01499849|59027963|FG001|Overall Study|Disease Progression|10|||
30602577|NCT01034176|58614026|FG000|Overall Study|Withdrawal by Subject|0|||
30873707|NCT02547441|58904419|FG000|Double-Blind Study Period|Sponsor Decision|1|||
30873708|NCT02547441|58904420|FG001|Double-Blind Study Period|Sponsor Decision|0|||
30873709|NCT02547441|58904419|FG000|Open-Label Study Period|Adverse Event|10|||
30873710|NCT02547441|58904420|FG001|Open-Label Study Period|Adverse Event|11|||
30873711|NCT02547441|58904419|FG000|Open-Label Study Period|Lack of Efficacy|3|||
30873712|NCT02547441|58904420|FG001|Open-Label Study Period|Lack of Efficacy|2|||
30873713|NCT02547441|58904419|FG000|Open-Label Study Period|Lost to Follow-up|7|||
30873714|NCT02547441|58904420|FG001|Open-Label Study Period|Lost to Follow-up|8|||
30873715|NCT02547441|58904419|FG000|Open-Label Study Period|Physician Decision|1|||
30873716|NCT02547441|58904420|FG001|Open-Label Study Period|Physician Decision|0|||
30873717|NCT02547441|58904419|FG000|Open-Label Study Period|Protocol Violation|2|||
30873718|NCT02547441|58904420|FG001|Open-Label Study Period|Protocol Violation|0|||
30873719|NCT02547441|58904419|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
30873720|NCT02547441|58904420|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
30873721|NCT02547441|58904419|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
30873722|NCT02547441|58904420|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
30873723|NCT02540265|58904430|FG000|Overall Study|Lost to Follow-up|0|||
30873724|NCT02540265|58904431|FG001|Overall Study|Lost to Follow-up|0|||
30873725|NCT02540265|58904432|FG002|Overall Study|Lost to Follow-up|1|||
30873726|NCT02547363|58904442|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
30873727|NCT02547363|58904443|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
30873728|NCT02547363|58904442|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
30873729|NCT02547363|58904443|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
30873730|NCT02547363|58904442|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
30873731|NCT02547363|58904443|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
30873732|NCT02547363|58904442|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
30873733|NCT02547363|58904443|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
30873734|NCT02547363|58904442|FG000|12-month Follow-up|Withdrawal by Subject|4|||
30873735|NCT02547363|58904443|FG001|12-month Follow-up|Withdrawal by Subject|3|||
30873736|NCT02547363|58904442|FG000|12-month Follow-up|Lost to Follow-up|4|||
30873737|NCT02547363|58904443|FG001|12-month Follow-up|Lost to Follow-up|1|||
30873738|NCT02547363|58904442|FG000|12-month Follow-up|Lack of Efficacy|1|||
30873739|NCT02547363|58904443|FG001|12-month Follow-up|Lack of Efficacy|1|||
30873740|NCT02547363|58904442|FG000|12-month Follow-up|Other|1|||
30873741|NCT02547363|58904443|FG001|12-month Follow-up|Other|0|||
30873742|NCT02539797|58904451|FG000|Overall Study|Lost to Follow-up|0|||
30873743|NCT02539797|58904452|FG001|Overall Study|Lost to Follow-up|1|||
30873744|NCT02539797|58904453|FG002|Overall Study|Lost to Follow-up|0|||
30873745|NCT02684357|58904464|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
30873746|NCT02684357|58904465|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
30873747|NCT02684357|58904466|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
30873748|NCT02684357|58904467|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
30873749|NCT02684357|58904468|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
30873750|NCT02684357|58904469|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
30873751|NCT02684357|58904464|FG000|Part A|Lost to Follow-up|0|||
30873752|NCT02684357|58904465|FG001|Part A|Lost to Follow-up|2|||
30873753|NCT02684357|58904466|FG002|Part A|Lost to Follow-up|2|||
30873754|NCT02684357|58904467|FG003|Part A|Lost to Follow-up|0|||
30873755|NCT02684357|58904468|FG004|Part A|Lost to Follow-up|0|||
30873756|NCT02684357|58904469|FG005|Part A|Lost to Follow-up|0|||
30873757|NCT02684357|58904464|FG000|Part A|Withdrawal by Subject|3|||
30873758|NCT02684357|58904465|FG001|Part A|Withdrawal by Subject|0|||
30873759|NCT02684357|58904466|FG002|Part A|Withdrawal by Subject|0|||
30873760|NCT02684357|58904467|FG003|Part A|Withdrawal by Subject|0|||
30873761|NCT02684357|58904468|FG004|Part A|Withdrawal by Subject|0|||
30602578|NCT01034176|58614027|FG001|Overall Study|Withdrawal by Subject|1|||
30694727|NCT00604695|58708985|FG000|Overall Study|Did not receive first bolus.|0|||
30961465|NCT01499849|59027962|FG000|Overall Study|Protocol Violation|11|||
30961466|NCT01499849|59027963|FG001|Overall Study|Protocol Violation|11|||
30961467|NCT01499849|59027962|FG000|Overall Study|Physician Decision|20|||
30961468|NCT01499849|59027963|FG001|Overall Study|Physician Decision|19|||
30961469|NCT01499849|59027962|FG000|Overall Study|Lack of Efficacy|3|||
30961470|NCT01499849|59027963|FG001|Overall Study|Lack of Efficacy|4|||
30961471|NCT01499849|59027962|FG000|Overall Study|Lost to Follow-up|6|||
30961472|NCT01499849|59027963|FG001|Overall Study|Lost to Follow-up|3|||
30961473|NCT01499849|59027962|FG000|Overall Study|Other Reasons|27|||
30961474|NCT01499849|59027963|FG001|Overall Study|Other Reasons|30|||
30961475|NCT01499303|59027982|FG000|Overall Study|Ongoing|2|||
30961476|NCT01499303|59027983|FG001|Overall Study|Ongoing|1|||
30961477|NCT01499303|59027982|FG000|Overall Study|Withdrawal by Subject|0|||
30961478|NCT01499303|59027983|FG001|Overall Study|Withdrawal by Subject|1|||
30961479|NCT01499303|59027982|FG000|Overall Study|Adverse Event|1|||
30961480|NCT01499303|59027983|FG001|Overall Study|Adverse Event|4|||
30961481|NCT01499303|59027982|FG000|Overall Study|Other|0|||
30961482|NCT01499303|59027983|FG001|Overall Study|Other|1|||
30961483|NCT01498679|59028004|FG000|Overall Study|Adverse Event|1|||
30961484|NCT01498679|59028005|FG001|Overall Study|Adverse Event|4|||
30961485|NCT01498679|59028004|FG000|Overall Study|Lack of Efficacy|72|||
30961486|NCT01498679|59028005|FG001|Overall Study|Lack of Efficacy|12|||
30961487|NCT01498679|59028004|FG000|Overall Study|Protocol Violation|4|||
30961488|NCT01498679|59028005|FG001|Overall Study|Protocol Violation|0|||
30961489|NCT01498679|59028004|FG000|Overall Study|Physician Decision|0|||
30961490|NCT01498679|59028005|FG001|Overall Study|Physician Decision|2|||
30961491|NCT01498679|59028004|FG000|Overall Study|Withdrawal by Subject|12|||
30961492|NCT01498679|59028005|FG001|Overall Study|Withdrawal by Subject|4|||
30961493|NCT01526785|59028028|FG000|Overall Study|Study Terminated by Sponsor|8|||
30961494|NCT01526785|59028028|FG000|Overall Study|Death|2|||
30961495|NCT01526785|59028028|FG000|Overall Study|Physician Decision|1|||
30961496|NCT01526785|59028028|FG000|Overall Study|Withdrawal by Subject|2|||
30961497|NCT01559389|59028034|FG000|Overall Study|Withdrawal by Subject|20|||
30961498|NCT01559389|59028035|FG001|Overall Study|Withdrawal by Subject|20|||
30961499|NCT01526551|59028045|FG000|Overall Study|Lack of returned parental consent form|424|||
30961500|NCT01559311|59028123|FG000|Overall Study|Protocol Violation|0|||
30961501|NCT01559311|59028124|FG001|Overall Study|Protocol Violation|0|||
30961502|NCT01559311|59028125|FG002|Overall Study|Protocol Violation|2|||
30873762|NCT02684357|58904469|FG005|Part A|Withdrawal by Subject|0|||
30873763|NCT02684357|58904464|FG000|Part A|Other|0|||
30873764|NCT02684357|58904465|FG001|Part A|Other|1|||
30873765|NCT02684357|58904466|FG002|Part A|Other|0|||
30873766|NCT02684357|58904467|FG003|Part A|Other|0|||
30873767|NCT02684357|58904468|FG004|Part A|Other|0|||
30873768|NCT02684357|58904469|FG005|Part A|Other|0|||
30873769|NCT02684357|58904464|FG000|Part B|Adverse Event (Other)|0|||
30873770|NCT02684357|58904465|FG001|Part B|Adverse Event (Other)|0|||
30873771|NCT02684357|58904466|FG002|Part B|Adverse Event (Other)|0|||
30873772|NCT02684357|58904467|FG003|Part B|Adverse Event (Other)|1|||
30873773|NCT02684357|58904468|FG004|Part B|Adverse Event (Other)|1|||
30873774|NCT02684357|58904469|FG005|Part B|Adverse Event (Other)|1|||
30873775|NCT02684357|58904464|FG000|Part B|Lost to Follow-up|0|||
30873776|NCT02684357|58904465|FG001|Part B|Lost to Follow-up|0|||
30873777|NCT02684357|58904466|FG002|Part B|Lost to Follow-up|0|||
30873778|NCT02684357|58904467|FG003|Part B|Lost to Follow-up|1|||
30873779|NCT02684357|58904468|FG004|Part B|Lost to Follow-up|1|||
30873780|NCT02684357|58904469|FG005|Part B|Lost to Follow-up|7|||
30873781|NCT02684357|58904464|FG000|Part B|Withdrawal by Subject|0|||
30873782|NCT02684357|58904465|FG001|Part B|Withdrawal by Subject|0|||
30873783|NCT02684357|58904466|FG002|Part B|Withdrawal by Subject|0|||
30873784|NCT02684357|58904467|FG003|Part B|Withdrawal by Subject|0|||
30873785|NCT02684357|58904468|FG004|Part B|Withdrawal by Subject|2|||
30873786|NCT02684357|58904469|FG005|Part B|Withdrawal by Subject|4|||
30873787|NCT02684357|58904464|FG000|Part B|Other|0|||
30873788|NCT02684357|58904465|FG001|Part B|Other|0|||
30873789|NCT02684357|58904466|FG002|Part B|Other|0|||
30873790|NCT02684357|58904467|FG003|Part B|Other|1|||
30873791|NCT02684357|58904468|FG004|Part B|Other|0|||
30873792|NCT02684357|58904469|FG005|Part B|Other|1|||
30873793|NCT02684279|58904482|FG000|Overall Study|Adverse Event|87|||
30873794|NCT02684279|58904482|FG000|Overall Study|Lack of Efficacy|4|||
30873795|NCT02684279|58904482|FG000|Overall Study|Lost to Follow-up|61|||
30873796|NCT02684279|58904482|FG000|Overall Study|Protocol Violation|6|||
30873797|NCT02684279|58904482|FG000|Overall Study|Pregnancy|8|||
30961503|NCT01559311|59028123|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
30961504|NCT01559311|59028124|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
30961505|NCT01559311|59028125|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
30873798|NCT02684279|58904482|FG000|Overall Study|Withdrawal by Subject|92|||
30873799|NCT02684279|58904482|FG000|Overall Study|non-compliance with study drug|9|||
30873800|NCT02684279|58904482|FG000|Overall Study|non compliance with study visits|2|||
30873801|NCT02684279|58904482|FG000|Overall Study|subject to have surgery|1|||
30873802|NCT02684279|58904482|FG000|Overall Study|family emergency|1|||
30961506|NCT01559311|59028123|FG000|Overall Study|Withdrawal by Subject|2|||
30961507|NCT01559311|59028124|FG001|Overall Study|Withdrawal by Subject|1|||
30961508|NCT01559311|59028125|FG002|Overall Study|Withdrawal by Subject|0|||
30961509|NCT01559311|59028123|FG000|Overall Study|Death|0|||
30961510|NCT01559311|59028124|FG001|Overall Study|Death|2|||
30961511|NCT01559311|59028125|FG002|Overall Study|Death|3|||
30961512|NCT01559311|59028123|FG000|Overall Study|Lost to Follow-up|0|||
30961513|NCT01559311|59028124|FG001|Overall Study|Lost to Follow-up|3|||
30961514|NCT01559311|59028125|FG002|Overall Study|Lost to Follow-up|2|||
30961515|NCT01559311|59028123|FG000|Overall Study|Adverse Event|0|||
30961516|NCT01559311|59028124|FG001|Overall Study|Adverse Event|0|||
30961517|NCT01559311|59028125|FG002|Overall Study|Adverse Event|1|||
30961518|NCT01498445|59028148|FG000|Overall Study|Lack of Efficacy|0|||
30961519|NCT01498445|59028149|FG001|Overall Study|Lack of Efficacy|0|||
30961520|NCT01498445|59028150|FG002|Overall Study|Lack of Efficacy|1|||
30961521|NCT01498445|59028151|FG003|Overall Study|Lack of Efficacy|2|||
30961522|NCT01498445|59028152|FG004|Overall Study|Lack of Efficacy|0|||
30961523|NCT01498445|59028153|FG005|Overall Study|Lack of Efficacy|0|||
30961524|NCT01498445|59028148|FG000|Overall Study|Screen Failure|0|||
30961525|NCT01498445|59028149|FG001|Overall Study|Screen Failure|0|||
30961526|NCT01498445|59028150|FG002|Overall Study|Screen Failure|0|||
30961527|NCT01498445|59028151|FG003|Overall Study|Screen Failure|0|||
30961528|NCT01498445|59028152|FG004|Overall Study|Screen Failure|1|||
30961529|NCT01498445|59028153|FG005|Overall Study|Screen Failure|1|||
30961530|NCT01558297|59028170|FG000|Overall Study|Withdrawal by Subject|2|||
30961531|NCT01558297|59028171|FG001|Overall Study|Withdrawal by Subject|2|||
30961532|NCT01558297|59028172|FG002|Overall Study|Withdrawal by Subject|1|||
30961533|NCT01525849|59028182|FG000|Overall Study|Lost to Follow-up|3|||
30961534|NCT01525849|59028183|FG001|Overall Study|Lost to Follow-up|2|||
30961535|NCT01525849|59028182|FG000|Overall Study|Withdrawal by Subject|1|||
30961536|NCT01525849|59028183|FG001|Overall Study|Withdrawal by Subject|9|||
30961537|NCT01525849|59028182|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
30961538|NCT01525849|59028183|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
30961539|NCT01525849|59028182|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
30961540|NCT01525849|59028183|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
30961541|NCT01525615|59028202|FG000|Overall Study|Adverse Event|11|||
30961542|NCT01525615|59028203|FG001|Overall Study|Adverse Event|7|||
30961543|NCT01525615|59028204|FG002|Overall Study|Adverse Event|5|||
30961544|NCT01525615|59028202|FG000|Overall Study|Lost to Follow-up|1|||
30961545|NCT01525615|59028203|FG001|Overall Study|Lost to Follow-up|0|||
30961546|NCT01525615|59028204|FG002|Overall Study|Lost to Follow-up|0|||
30961547|NCT01525615|59028202|FG000|Overall Study|Withdrawal by Subject|1|||
30961548|NCT01525615|59028203|FG001|Overall Study|Withdrawal by Subject|0|||
30961549|NCT01525615|59028204|FG002|Overall Study|Withdrawal by Subject|0|||
30961550|NCT01525615|59028202|FG000|Overall Study|Other reason not described above|1|||
30961551|NCT01525615|59028203|FG001|Overall Study|Other reason not described above|0|||
30961552|NCT01525615|59028204|FG002|Overall Study|Other reason not described above|1|||
30961553|NCT01525225|59028246|FG000|Enrollment|No longer met study criteria|1|||
30961554|NCT01525225|59028246|FG000|Enrollment|Other|1|||
30961555|NCT02660580|59028265|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
30961556|NCT02660580|59028266|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
30961557|NCT02660580|59028267|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
30961558|NCT02660580|59028268|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
30961559|NCT02660580|59028269|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
30961560|NCT02660580|59028265|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
30961561|NCT02660580|59028266|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
30961562|NCT02660580|59028267|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
30961563|NCT02660580|59028268|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
30961564|NCT02660580|59028269|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
30961565|NCT02660580|59028265|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
30961566|NCT02660580|59028266|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
30873803|NCT02684279|58904482|FG000|Overall Study|Site closures|7|||
30873804|NCT02684279|58904482|FG000|Overall Study|Physician Decision|1|||
30873805|NCT03206073|58904490|FG000|Overall Study|Participant Noncompliance|0|||
30873806|NCT03206073|58904491|FG001|Overall Study|Participant Noncompliance|1|||
30873807|NCT03206073|58904492|FG002|Overall Study|Participant Noncompliance|0|||
30873808|NCT03206073|58904493|FG003|Overall Study|Participant Noncompliance|0|||
30873809|NCT03206073|58904490|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
30961567|NCT02660580|59028267|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
30961568|NCT02660580|59028268|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
30961569|NCT02660580|59028269|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
30961570|NCT02660580|59028265|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
30961571|NCT02660580|59028266|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
30961572|NCT02660580|59028267|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
30961573|NCT02660580|59028268|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
30961574|NCT02660580|59028269|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
30961575|NCT02660580|59028265|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
30961576|NCT02660580|59028266|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
30961577|NCT02660580|59028267|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
30961578|NCT02660580|59028268|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
30961579|NCT02660580|59028269|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
30602579|NCT01034176|58614026|FG000|Overall Study|Lost to Follow-up|0|||
30602580|NCT01034176|58614027|FG001|Overall Study|Lost to Follow-up|1|||
30602581|NCT01033942|58614036|FG000|Overall Study|Withdrawal by Subject|1|||
30602582|NCT01033942|58614037|FG001|Overall Study|Withdrawal by Subject|1|||
30602583|NCT01033942|58614038|FG002|Overall Study|Withdrawal by Subject|1|||
30602584|NCT01033942|58614036|FG000|Overall Study|Lost to Follow-up|1|||
30602585|NCT01033942|58614037|FG001|Overall Study|Lost to Follow-up|0|||
30602586|NCT01033942|58614038|FG002|Overall Study|Lost to Follow-up|0|||
30602587|NCT01033942|58614036|FG000|Overall Study|Enrolled in Extension Study|0|||
30602588|NCT01033942|58614037|FG001|Overall Study|Enrolled in Extension Study|3|||
30602589|NCT01033942|58614038|FG002|Overall Study|Enrolled in Extension Study|0|||
30602590|NCT01062256|58614051|FG000|Overall Study|Adverse Event|1|||
30602591|NCT01062256|58614052|FG001|Overall Study|Adverse Event|0|||
30602592|NCT01062256|58614053|FG002|Overall Study|Adverse Event|0|||
30602593|NCT01062256|58614051|FG000|Overall Study|Withdrawal by Subject|1|||
30602594|NCT01062256|58614052|FG001|Overall Study|Withdrawal by Subject|1|||
30602595|NCT01062256|58614053|FG002|Overall Study|Withdrawal by Subject|1|||
30602596|NCT01062256|58614051|FG000|Overall Study|Ineligible|1|||
30873810|NCT03206073|58904491|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
30873811|NCT03206073|58904492|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
30873812|NCT03206073|58904493|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
30873813|NCT03206073|58904490|FG000|Overall Study|Death|0|||
30873814|NCT03206073|58904491|FG001|Overall Study|Death|0|||
30873815|NCT03206073|58904492|FG002|Overall Study|Death|1|||
30873816|NCT03206073|58904493|FG003|Overall Study|Death|0|||
30873817|NCT03206073|58904490|FG000|Overall Study|Taken off active treatment|0|||
30873818|NCT03206073|58904491|FG001|Overall Study|Taken off active treatment|0|||
30873819|NCT03206073|58904492|FG002|Overall Study|Taken off active treatment|3|||
30873820|NCT03206073|58904493|FG003|Overall Study|Taken off active treatment|0|||
30873821|NCT02534493|58904503|FG000|Overall Study|Lost to Follow-up|1|||
30873822|NCT02534493|58904503|FG000|Overall Study|Withdrawal by Subject|1|||
30873823|NCT02547129|58904511|FG000|Overall Study|Difficulty with ongoing infection|1|||
30873824|NCT02547129|58904512|FG001|Overall Study|Difficulty with ongoing infection|0|||
30873825|NCT02546193|58904520|FG000|Overall Study|Withdrawal by Subject|2|||
30873826|NCT02546193|58904521|FG001|Overall Study|Withdrawal by Subject|0|||
30873827|NCT02546193|58904522|FG002|Overall Study|Withdrawal by Subject|1|||
30873828|NCT02546193|58904523|FG003|Overall Study|Withdrawal by Subject|0|||
30873829|NCT02546193|58904520|FG000|Overall Study|Not eligible at time of induction|4|||
30873830|NCT02546193|58904521|FG001|Overall Study|Not eligible at time of induction|6|||
30873831|NCT02546193|58904522|FG002|Overall Study|Not eligible at time of induction|1|||
30873832|NCT02546193|58904523|FG003|Overall Study|Not eligible at time of induction|0|||
30873833|NCT02538471|58904529|FG000|Overall Study|Progression of disease|2|||
30873834|NCT01661595|58904537|FG000|Phase 1: Week 0-4|Adverse Event|1|||
30873835|NCT01661595|58904538|FG001|Phase 1: Week 0-4|Adverse Event|0|||
30873836|NCT01661595|58904539|FG002|Phase 1: Week 0-4|Adverse Event|0|||
30873837|NCT01661595|58904540|FG003|Phase 1: Week 0-4|Adverse Event|0|||
30873838|NCT01661595|58904537|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
30873839|NCT01661595|58904538|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
30873840|NCT01661595|58904539|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
30873841|NCT01661595|58904540|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
30873842|NCT02213133|58904560|FG000|Overall Study|Participant discontinued study therapy|2|||
30873843|NCT02213133|58904561|FG001|Overall Study|Participant discontinued study therapy|0|||
30873844|NCT02213133|58904562|FG002|Overall Study|Participant discontinued study therapy|0|||
30873845|NCT02213133|58904560|FG000|Overall Study|Participant withdrew informed consent|2|||
30873846|NCT02213133|58904561|FG001|Overall Study|Participant withdrew informed consent|1|||
30873847|NCT02213133|58904562|FG002|Overall Study|Participant withdrew informed consent|2|||
30873848|NCT02213133|58904560|FG000|Overall Study|Disease progression|11|||
30873849|NCT02213133|58904561|FG001|Overall Study|Disease progression|2|||
30873850|NCT02213133|58904562|FG002|Overall Study|Disease progression|0|||
30873851|NCT02213133|58904560|FG000|Overall Study|Adverse Event (AE)|1|||
30873852|NCT02213133|58904561|FG001|Overall Study|Adverse Event (AE)|0|||
30873853|NCT02213133|58904562|FG002|Overall Study|Adverse Event (AE)|0|||
30873854|NCT02213133|58904560|FG000|Overall Study|Death|16|||
30602597|NCT01062256|58614052|FG001|Overall Study|Ineligible|4|||
30602598|NCT01062256|58614053|FG002|Overall Study|Ineligible|3|||
30602599|NCT01062256|58614051|FG000|Overall Study|Administrative|0|||
30602600|NCT01062256|58614052|FG001|Overall Study|Administrative|2|||
30602601|NCT01062256|58614053|FG002|Overall Study|Administrative|0|||
30602602|NCT01029886|58614063|FG000|Overall Study|Adverse Event|12|||
30602603|NCT01029886|58614064|FG001|Overall Study|Adverse Event|25|||
30602604|NCT01029886|58614063|FG000|Overall Study|Lost to Follow-up|1|||
30602605|NCT01029886|58614064|FG001|Overall Study|Lost to Follow-up|0|||
30602606|NCT01029886|58614063|FG000|Overall Study|Physician Decision|2|||
30602607|NCT01029886|58614064|FG001|Overall Study|Physician Decision|6|||
30602608|NCT01029886|58614063|FG000|Overall Study|Protocol Violation|17|||
30602609|NCT01029886|58614064|FG001|Overall Study|Protocol Violation|5|||
30602610|NCT01029886|58614063|FG000|Overall Study|Withdrawal by Subject|8|||
30602611|NCT01029886|58614064|FG001|Overall Study|Withdrawal by Subject|18|||
30602612|NCT01029886|58614063|FG000|Overall Study|Entry Criteria Not Met|13|||
30602613|NCT01029886|58614064|FG001|Overall Study|Entry Criteria Not Met|5|||
30602614|NCT01029886|58614063|FG000|Overall Study|Sponsor Decision|1|||
30602615|NCT01029886|58614064|FG001|Overall Study|Sponsor Decision|0|||
30602616|NCT01029886|58614063|FG000|Overall Study|Loss Glucose Control|7|||
30602617|NCT01029886|58614064|FG001|Overall Study|Loss Glucose Control|1|||
30602618|NCT01244763|58614080|FG000|Overall Study|Adverse Event|1|||
30602619|NCT01244763|58614081|FG001|Overall Study|Adverse Event|0|||
30602620|NCT01244763|58614082|FG002|Overall Study|Adverse Event|0|||
30602621|NCT01244763|58614083|FG003|Overall Study|Adverse Event|0|||
30602622|NCT01244763|58614084|FG004|Overall Study|Adverse Event|0|||
30602623|NCT01244763|58614085|FG005|Overall Study|Adverse Event|1|||
30602624|NCT01244763|58614080|FG000|Overall Study|Death|1|||
30602625|NCT01244763|58614081|FG001|Overall Study|Death|0|||
30602626|NCT01244763|58614082|FG002|Overall Study|Death|1|||
30602627|NCT01244763|58614083|FG003|Overall Study|Death|0|||
30602628|NCT01244763|58614084|FG004|Overall Study|Death|2|||
30602629|NCT01244763|58614085|FG005|Overall Study|Death|0|||
30602630|NCT01244763|58614080|FG000|Overall Study|Physician Decision|0|||
30602631|NCT01244763|58614081|FG001|Overall Study|Physician Decision|0|||
30602632|NCT01244763|58614082|FG002|Overall Study|Physician Decision|1|||
30602633|NCT01244763|58614083|FG003|Overall Study|Physician Decision|0|||
30602634|NCT01244763|58614084|FG004|Overall Study|Physician Decision|0|||
30602635|NCT01244763|58614085|FG005|Overall Study|Physician Decision|0|||
30602636|NCT01244763|58614080|FG000|Overall Study|Withdrawal by Subject|1|||
30602637|NCT01244763|58614081|FG001|Overall Study|Withdrawal by Subject|2|||
30602638|NCT01244763|58614082|FG002|Overall Study|Withdrawal by Subject|0|||
30602639|NCT01244763|58614083|FG003|Overall Study|Withdrawal by Subject|1|||
30602640|NCT01244763|58614084|FG004|Overall Study|Withdrawal by Subject|1|||
30602641|NCT01244763|58614085|FG005|Overall Study|Withdrawal by Subject|2|||
30602642|NCT01244763|58614080|FG000|Overall Study|Lost to Follow-up|0|||
30602643|NCT01244763|58614081|FG001|Overall Study|Lost to Follow-up|1|||
30602644|NCT01244763|58614082|FG002|Overall Study|Lost to Follow-up|0|||
30602645|NCT01244763|58614083|FG003|Overall Study|Lost to Follow-up|0|||
30602646|NCT01244763|58614084|FG004|Overall Study|Lost to Follow-up|0|||
30602647|NCT01244763|58614085|FG005|Overall Study|Lost to Follow-up|0|||
30602648|NCT01244763|58614080|FG000|Overall Study|Enrolled into the Extension Study|0|||
30602649|NCT01244763|58614081|FG001|Overall Study|Enrolled into the Extension Study|0|||
30602650|NCT01244763|58614082|FG002|Overall Study|Enrolled into the Extension Study|0|||
30602651|NCT01244763|58614083|FG003|Overall Study|Enrolled into the Extension Study|0|||
30602652|NCT01244763|58614084|FG004|Overall Study|Enrolled into the Extension Study|0|||
30602653|NCT01244763|58614085|FG005|Overall Study|Enrolled into the Extension Study|1|||
30602654|NCT01244061|58614101|FG000|Overall Study|Death|1|||
30602655|NCT01244061|58614102|FG001|Overall Study|Death|0|||
30602656|NCT01244061|58614101|FG000|Overall Study|Did not meet entrance criteria|1|||
30602657|NCT01244061|58614102|FG001|Overall Study|Did not meet entrance criteria|0|||
30602658|NCT01244061|58614101|FG000|Overall Study|Lack of Efficacy|1|||
30602659|NCT01244061|58614102|FG001|Overall Study|Lack of Efficacy|3|||
30602660|NCT01244061|58614101|FG000|Overall Study|Lost to Follow-up|34|||
30602661|NCT01244061|58614102|FG001|Overall Study|Lost to Follow-up|30|||
30602662|NCT01244061|58614101|FG000|Overall Study|Withdrawal by Subject|29|||
30602663|NCT01244061|58614102|FG001|Overall Study|Withdrawal by Subject|46|||
30602664|NCT01244061|58614101|FG000|Overall Study|Other|8|||
30602665|NCT01244061|58614102|FG001|Overall Study|Other|19|||
30602666|NCT01244061|58614101|FG000|Overall Study|Protocol Violation|1|||
30602667|NCT01244061|58614102|FG001|Overall Study|Protocol Violation|1|||
30602668|NCT01244061|58614101|FG000|Overall Study|Adverse Event|5|||
30602669|NCT01244061|58614102|FG001|Overall Study|Adverse Event|2|||
30602670|NCT01244061|58614101|FG000|Overall Study|Randomized but not treated|2|||
30602671|NCT01244061|58614102|FG001|Overall Study|Randomized but not treated|2|||
30602672|NCT01243671|58614108|FG000|Overall Study|Adverse Event|3|||
30602673|NCT01243671|58614108|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
30602674|NCT01243671|58614108|FG000|Overall Study|Other|1|||
30602675|NCT01240785|58614114|FG000|Overall Study|Lost to Follow-up|1|||
30602676|NCT01240785|58614115|FG001|Overall Study|Lost to Follow-up|0|||
30602677|NCT01240785|58614114|FG000|Overall Study|Protocol Violation|0|||
30694728|NCT00604695|58708986|FG001|Overall Study|Did not receive first bolus.|4|||
30602678|NCT01240785|58614115|FG001|Overall Study|Protocol Violation|3|||
30602679|NCT01240551|58614123|FG000|Overall Study|Refused further treatment|3|||
30602680|NCT01240551|58614124|FG001|Overall Study|Refused further treatment|2|||
30602681|NCT01240551|58614123|FG000|Overall Study|Lost to Follow-up|1|||
30602682|NCT01240551|58614124|FG001|Overall Study|Lost to Follow-up|1|||
30602683|NCT01239381|58614130|FG000|Overall Study|Protocol Violation|1|||
30602684|NCT01239381|58614130|FG000|Overall Study|Withdrawal by Subject|1|||
30602685|NCT01266876|58614140|FG000|Overall Study|Adverse Event|0|||
30961580|NCT02660580|59028265|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
30961581|NCT02660580|59028266|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
30961582|NCT02660580|59028267|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
30961583|NCT02660580|59028268|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
30961584|NCT02660580|59028269|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
30961585|NCT02660580|59028265|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
30961586|NCT02660580|59028266|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
30961587|NCT02660580|59028267|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
30961588|NCT02660580|59028268|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
30961589|NCT02660580|59028269|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
30602686|NCT01266876|58614141|FG001|Overall Study|Adverse Event|0|||
30602687|NCT01266876|58614142|FG002|Overall Study|Adverse Event|0|||
30602688|NCT01266876|58614143|FG003|Overall Study|Adverse Event|1|||
30602689|NCT01266876|58614144|FG004|Overall Study|Adverse Event|0|||
30602690|NCT01033240|58614159|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
30602691|NCT01033240|58614160|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
30602692|NCT01033240|58614161|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
30602693|NCT01033240|58614159|FG000|Overall Study|Death|2|||
30602694|NCT01033240|58614160|FG001|Overall Study|Death|0|||
30602695|NCT01033240|58614161|FG002|Overall Study|Death|0|||
30602696|NCT01033240|58614159|FG000|Overall Study|Withdrew Consent|2|||
30602697|NCT01033240|58614160|FG001|Overall Study|Withdrew Consent|9|||
30602698|NCT01033240|58614161|FG002|Overall Study|Withdrew Consent|2|||
30602699|NCT01033240|58614159|FG000|Overall Study|Disease Progression|35|||
30602700|NCT01033240|58614160|FG001|Overall Study|Disease Progression|32|||
30602701|NCT01033240|58614161|FG002|Overall Study|Disease Progression|41|||
30602702|NCT01033240|58614159|FG000|Overall Study|Investigator Discretion|0|||
30602703|NCT01033240|58614160|FG001|Overall Study|Investigator Discretion|0|||
30602704|NCT01033240|58614161|FG002|Overall Study|Investigator Discretion|2|||
30602705|NCT01033240|58614159|FG000|Overall Study|Other|0|||
30602706|NCT01033240|58614160|FG001|Overall Study|Other|1|||
30602707|NCT01033240|58614161|FG002|Overall Study|Other|2|||
30602708|NCT01266018|58614169|FG000|Overall Study|Physician Decision|1|||
30602709|NCT01266018|58614170|FG001|Overall Study|Physician Decision|0|||
30602710|NCT01266018|58614169|FG000|Overall Study|Progressive disease|0|||
30602711|NCT01266018|58614170|FG001|Overall Study|Progressive disease|1|||
30602712|NCT01032382|58614178|FG000|Overall Study|Disease dissemination|1|||
30602713|NCT01032382|58614179|FG001|Overall Study|Disease dissemination|1|||
30602714|NCT01032382|58614178|FG000|Overall Study|Treatment failure|3|||
30602715|NCT01032382|58614179|FG001|Overall Study|Treatment failure|1|||
30602716|NCT01032382|58614178|FG000|Overall Study|Index lesion relapse|1|||
30602717|NCT01032382|58614179|FG001|Overall Study|Index lesion relapse|3|||
30602718|NCT01029652|58614187|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
30602719|NCT01029652|58614188|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
30602720|NCT01029652|58614187|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
30602721|NCT01029652|58614188|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
30602722|NCT01029652|58614187|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
30602723|NCT01029652|58614188|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
30602724|NCT01029652|58614187|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
30602725|NCT01029652|58614188|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
30602726|NCT01029652|58614187|FG000|Core Study (0-12 Weeks)|Death|0|||
30602727|NCT01029652|58614188|FG001|Core Study (0-12 Weeks)|Death|1|||
30602728|NCT01029652|58614187|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
30602729|NCT01029652|58614188|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
30602730|NCT01029652|58614187|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
30602731|NCT01029652|58614188|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
30602732|NCT01029652|58614187|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
30602733|NCT01029652|58614188|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
30602734|NCT01029652|58614187|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
30602735|NCT01029652|58614188|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
30602736|NCT01029652|58614187|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
30602737|NCT01029652|58614188|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
30602738|NCT01029652|58614187|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
30602739|NCT01029652|58614188|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
30602740|NCT01029652|58614187|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
30602741|NCT01029652|58614188|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
30602742|NCT01029340|58614217|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
30602743|NCT01029340|58614218|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
30602744|NCT01029340|58614219|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
30602745|NCT01029340|58614220|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
30602746|NCT01029340|58614221|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
30602747|NCT01029340|58614222|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
30602748|NCT01029340|58614217|FG000|Part B Treatment Period|Protocol Violation|0|||
30602749|NCT01029340|58614218|FG001|Part B Treatment Period|Protocol Violation|0|||
30602750|NCT01029340|58614219|FG002|Part B Treatment Period|Protocol Violation|1|||
30602751|NCT01029340|58614220|FG003|Part B Treatment Period|Protocol Violation|0|||
30602752|NCT01029340|58614221|FG004|Part B Treatment Period|Protocol Violation|0|||
30602753|NCT01029340|58614222|FG005|Part B Treatment Period|Protocol Violation|0|||
30602754|NCT01029340|58614217|FG000|Extension Period|Adverse Event|0|||
30602755|NCT01029340|58614218|FG001|Extension Period|Adverse Event|0|||
30602756|NCT01029340|58614219|FG002|Extension Period|Adverse Event|0|||
30602757|NCT01029340|58614220|FG003|Extension Period|Adverse Event|0|||
30602758|NCT01029340|58614221|FG004|Extension Period|Adverse Event|0|||
30602759|NCT01029340|58614222|FG005|Extension Period|Adverse Event|1|||
30602760|NCT01029340|58614217|FG000|Extension Period|starting another study|0|||
30602761|NCT01029340|58614218|FG001|Extension Period|starting another study|0|||
30602762|NCT01029340|58614219|FG002|Extension Period|starting another study|0|||
30602763|NCT01029340|58614220|FG003|Extension Period|starting another study|0|||
30602764|NCT01029340|58614221|FG004|Extension Period|starting another study|0|||
30602765|NCT01029340|58614222|FG005|Extension Period|starting another study|8|||
30602766|NCT01029340|58614217|FG000|Extension Period|non-compliance|0|||
30602767|NCT01029340|58614218|FG001|Extension Period|non-compliance|0|||
30602768|NCT01029340|58614219|FG002|Extension Period|non-compliance|0|||
30602769|NCT01029340|58614220|FG003|Extension Period|non-compliance|0|||
30602770|NCT01029340|58614221|FG004|Extension Period|non-compliance|0|||
30602771|NCT01029340|58614222|FG005|Extension Period|non-compliance|1|||
30602772|NCT01029340|58614217|FG000|Extension Period|Withdrawal by Subject|0|||
30602773|NCT01029340|58614218|FG001|Extension Period|Withdrawal by Subject|0|||
30602774|NCT01029340|58614219|FG002|Extension Period|Withdrawal by Subject|0|||
30602775|NCT01029340|58614220|FG003|Extension Period|Withdrawal by Subject|0|||
30602776|NCT01029340|58614221|FG004|Extension Period|Withdrawal by Subject|0|||
30602777|NCT01029340|58614222|FG005|Extension Period|Withdrawal by Subject|1|||
30602778|NCT01029340|58614217|FG000|Extension Period|Physician Decision|0|||
30602779|NCT01029340|58614218|FG001|Extension Period|Physician Decision|0|||
30602780|NCT01029340|58614219|FG002|Extension Period|Physician Decision|0|||
30602781|NCT01029340|58614220|FG003|Extension Period|Physician Decision|0|||
30602782|NCT01029340|58614221|FG004|Extension Period|Physician Decision|0|||
30602783|NCT01029340|58614222|FG005|Extension Period|Physician Decision|1|||
30602784|NCT01265550|58614239|FG000|Pre Randomization|Withdrawal by Subject|0|||
30602785|NCT01265550|58614240|FG001|Pre Randomization|Withdrawal by Subject|0|||
30602786|NCT01265550|58614241|FG002|Pre Randomization|Withdrawal by Subject|0|||
30602787|NCT01265550|58614242|FG003|Pre Randomization|Withdrawal by Subject|70|||
30961590|NCT02660580|59028265|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
30961591|NCT02660580|59028266|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
30961592|NCT02660580|59028267|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
30602788|NCT01265550|58614239|FG000|Pre Randomization|Technical Exclusions|0|||
30602789|NCT01265550|58614240|FG001|Pre Randomization|Technical Exclusions|0|||
30602790|NCT01265550|58614241|FG002|Pre Randomization|Technical Exclusions|0|||
30602791|NCT01265550|58614242|FG003|Pre Randomization|Technical Exclusions|54|||
30602792|NCT01265550|58614239|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
30602793|NCT01265550|58614240|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
30602794|NCT01265550|58614241|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
30602795|NCT01265550|58614242|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
30602796|NCT01265550|58614239|FG000|Pre Randomization|Non-GERD organic disorders|0|||
30602797|NCT01265550|58614240|FG001|Pre Randomization|Non-GERD organic disorders|0|||
30602798|NCT01265550|58614241|FG002|Pre Randomization|Non-GERD organic disorders|0|||
30602799|NCT01265550|58614242|FG003|Pre Randomization|Non-GERD organic disorders|23|||
30602800|NCT01265550|58614239|FG000|Pre Randomization|Functional heartburn|0|||
30602801|NCT01265550|58614240|FG001|Pre Randomization|Functional heartburn|0|||
30602802|NCT01265550|58614241|FG002|Pre Randomization|Functional heartburn|0|||
30602803|NCT01265550|58614242|FG003|Pre Randomization|Functional heartburn|99|||
30602804|NCT01265394|58614256|FG000|Overall Study|Subjects withdrawn|37|||
30602805|NCT01029262|58614263|FG000|Overall Study|Adverse Event|9|||
30602806|NCT01029262|58614264|FG001|Overall Study|Adverse Event|52|||
30602807|NCT01029262|58614263|FG000|Overall Study|Lack of therapeutic effect|57|||
30694729|NCT00348595|58708994|FG000|Overall Study|Adverse Event|5|||
30602808|NCT01029262|58614264|FG001|Overall Study|Lack of therapeutic effect|76|||
30602809|NCT01029262|58614263|FG000|Overall Study|Withdrawal by Subject|10|||
30602810|NCT01029262|58614264|FG001|Overall Study|Withdrawal by Subject|17|||
30602811|NCT01029262|58614263|FG000|Overall Study|Protocol Violation|2|||
30602812|NCT01029262|58614264|FG001|Overall Study|Protocol Violation|3|||
30602813|NCT01029262|58614263|FG000|Overall Study|Miscellaneous|1|||
30602814|NCT01029262|58614264|FG001|Overall Study|Miscellaneous|9|||
30602815|NCT01029262|58614263|FG000|Overall Study|Death|0|||
30602816|NCT01029262|58614264|FG001|Overall Study|Death|3|||
30602817|NCT01028560|58614277|FG000|Overall Study|Lack of Efficacy|3|||
30602818|NCT01028560|58614278|FG001|Overall Study|Lack of Efficacy|6|||
30602819|NCT01028560|58614277|FG000|Overall Study|Withdrawal by Subject|7|||
30602820|NCT01028560|58614278|FG001|Overall Study|Withdrawal by Subject|12|||
30602821|NCT01061710|58614285|FG000|Overall Study|Protocol Violation|14|||
30602822|NCT01028014|58614295|FG000|Overall Study|Lost to Follow-up|1|||
30602823|NCT01028014|58614296|FG001|Overall Study|Lost to Follow-up|2|||
30602824|NCT01028014|58614297|FG002|Overall Study|Lost to Follow-up|0|||
30602825|NCT01028014|58614298|FG003|Overall Study|Lost to Follow-up|1|||
30602826|NCT01028014|58614299|FG004|Overall Study|Lost to Follow-up|1|||
30602827|NCT01028014|58614300|FG005|Overall Study|Lost to Follow-up|2|||
30602828|NCT01264770|58614320|FG000|Overall Study|Not reported|0|||
30602829|NCT01264770|58614321|FG001|Overall Study|Not reported|0|||
30602830|NCT01264770|58614322|FG002|Overall Study|Not reported|1|||
30602831|NCT01264770|58614323|FG003|Overall Study|Not reported|0|||
30602832|NCT01264770|58614324|FG004|Overall Study|Not reported|0|||
30602833|NCT01264770|58614325|FG005|Overall Study|Not reported|0|||
30602834|NCT01264770|58614320|FG000|Overall Study|e.g., change in circumstances|8|||
30602835|NCT01264770|58614321|FG001|Overall Study|e.g., change in circumstances|3|||
30602836|NCT01264770|58614322|FG002|Overall Study|e.g., change in circumstances|3|||
30602837|NCT01264770|58614323|FG003|Overall Study|e.g., change in circumstances|3|||
30602838|NCT01264770|58614324|FG004|Overall Study|e.g., change in circumstances|4|||
30602839|NCT01264770|58614325|FG005|Overall Study|e.g., change in circumstances|4|||
30602840|NCT01264770|58614320|FG000|Overall Study|Severe non-compliance to protocol|0|||
30602841|NCT01264770|58614321|FG001|Overall Study|Severe non-compliance to protocol|0|||
30602842|NCT01264770|58614322|FG002|Overall Study|Severe non-compliance to protocol|1|||
30602843|NCT01264770|58614323|FG003|Overall Study|Severe non-compliance to protocol|1|||
30602844|NCT01264770|58614324|FG004|Overall Study|Severe non-compliance to protocol|0|||
30602845|NCT01264770|58614325|FG005|Overall Study|Severe non-compliance to protocol|0|||
30602846|NCT01264770|58614320|FG000|Overall Study|Lack of therapeutic response|1|||
30602847|NCT01264770|58614321|FG001|Overall Study|Lack of therapeutic response|0|||
30602848|NCT01264770|58614322|FG002|Overall Study|Lack of therapeutic response|2|||
30602849|NCT01264770|58614323|FG003|Overall Study|Lack of therapeutic response|1|||
30602850|NCT01264770|58614324|FG004|Overall Study|Lack of therapeutic response|1|||
30602851|NCT01264770|58614325|FG005|Overall Study|Lack of therapeutic response|0|||
30602852|NCT01264770|58614320|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
30602853|NCT01264770|58614321|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
30602854|NCT01264770|58614322|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
30602855|NCT01264770|58614323|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
30602856|NCT01264770|58614324|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
30602857|NCT01264770|58614325|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
30602858|NCT01264770|58614320|FG000|Overall Study|Lost to Follow-up|0|||
30602859|NCT01264770|58614321|FG001|Overall Study|Lost to Follow-up|0|||
30602860|NCT01264770|58614322|FG002|Overall Study|Lost to Follow-up|1|||
30602861|NCT01264770|58614323|FG003|Overall Study|Lost to Follow-up|1|||
30602862|NCT01264770|58614324|FG004|Overall Study|Lost to Follow-up|0|||
30602863|NCT01264770|58614325|FG005|Overall Study|Lost to Follow-up|0|||
30602864|NCT01264770|58614320|FG000|Overall Study|Adverse Event|7|||
30602865|NCT01264770|58614321|FG001|Overall Study|Adverse Event|7|||
30602866|NCT01264770|58614322|FG002|Overall Study|Adverse Event|8|||
30602867|NCT01264770|58614323|FG003|Overall Study|Adverse Event|0|||
30602868|NCT01264770|58614324|FG004|Overall Study|Adverse Event|2|||
30602869|NCT01264770|58614325|FG005|Overall Study|Adverse Event|1|||
30602870|NCT01027702|58614345|FG000|Overall Study|Received subsequent therapy|1|||
30602871|NCT01027702|58614346|FG001|Overall Study|Received subsequent therapy|2|||
30602872|NCT01027702|58614347|FG002|Overall Study|Received subsequent therapy|0|||
30602873|NCT01027702|58614348|FG003|Overall Study|Received subsequent therapy|4|||
30602874|NCT01027702|58614349|FG004|Overall Study|Received subsequent therapy|1|||
30602875|NCT01027702|58614350|FG005|Overall Study|Received subsequent therapy|0|||
30602876|NCT01027702|58614351|FG006|Overall Study|Received subsequent therapy|1|||
30602877|NCT01027702|58614345|FG000|Overall Study|Death|0|||
30602878|NCT01027702|58614346|FG001|Overall Study|Death|0|||
30602879|NCT01027702|58614347|FG002|Overall Study|Death|1|||
30602880|NCT01027702|58614348|FG003|Overall Study|Death|0|||
30602881|NCT01027702|58614349|FG004|Overall Study|Death|0|||
30602882|NCT01027702|58614350|FG005|Overall Study|Death|0|||
30602883|NCT01027702|58614351|FG006|Overall Study|Death|0|||
30602884|NCT01302080|58614365|FG000|Overall Study|Withdrew Consent|92|||
30602885|NCT01302080|58614366|FG001|Overall Study|Withdrew Consent|39|||
30602886|NCT01302080|58614365|FG000|Overall Study|Patient/Family Moved|28|||
30602887|NCT01302080|58614366|FG001|Overall Study|Patient/Family Moved|3|||
30602888|NCT01302080|58614365|FG000|Overall Study|Lost to Follow-up|192|||
30602889|NCT01302080|58614366|FG001|Overall Study|Lost to Follow-up|93|||
30602890|NCT01302080|58614365|FG000|Overall Study|Death|1|||
30602891|NCT01302080|58614366|FG001|Overall Study|Death|0|||
30602892|NCT01302080|58614365|FG000|Overall Study|Other|52|||
30602893|NCT01302080|58614366|FG001|Overall Study|Other|8|||
30602894|NCT01302080|58614365|FG000|Overall Study|Reason Missing For Discontinuation|1|||
30602895|NCT01302080|58614366|FG001|Overall Study|Reason Missing For Discontinuation|0|||
30602896|NCT01238991|58614406|FG000|Overall Study|Adverse Event|1|||
30602897|NCT01238991|58614407|FG001|Overall Study|Adverse Event|0|||
30602898|NCT01238991|58614408|FG002|Overall Study|Adverse Event|3|||
30602899|NCT01238991|58614409|FG003|Overall Study|Adverse Event|1|||
30602900|NCT01238991|58614410|FG004|Overall Study|Adverse Event|1|||
30602901|NCT01238991|58614411|FG005|Overall Study|Adverse Event|0|||
30602902|NCT01238991|58614412|FG006|Overall Study|Adverse Event|1|||
30602903|NCT01238991|58614413|FG007|Overall Study|Adverse Event|1|||
30602904|NCT01238991|58614414|FG008|Overall Study|Adverse Event|0|||
30602905|NCT01238991|58614415|FG009|Overall Study|Adverse Event|0|||
30602906|NCT01238991|58614406|FG000|Overall Study|Death|0|||
30602907|NCT01238991|58614407|FG001|Overall Study|Death|0|||
30602908|NCT01238991|58614408|FG002|Overall Study|Death|0|||
30602909|NCT01238991|58614409|FG003|Overall Study|Death|1|||
30602910|NCT01238991|58614410|FG004|Overall Study|Death|0|||
30602911|NCT01238991|58614411|FG005|Overall Study|Death|0|||
30602912|NCT01238991|58614412|FG006|Overall Study|Death|0|||
30602913|NCT01238991|58614413|FG007|Overall Study|Death|0|||
30602914|NCT01238991|58614414|FG008|Overall Study|Death|0|||
30602915|NCT01238991|58614415|FG009|Overall Study|Death|0|||
30602916|NCT01238991|58614406|FG000|Overall Study|Lack of Efficacy|0|||
30602917|NCT01238991|58614407|FG001|Overall Study|Lack of Efficacy|0|||
30602918|NCT01238991|58614408|FG002|Overall Study|Lack of Efficacy|1|||
30602919|NCT01238991|58614409|FG003|Overall Study|Lack of Efficacy|0|||
30602920|NCT01238991|58614410|FG004|Overall Study|Lack of Efficacy|0|||
30602921|NCT01238991|58614411|FG005|Overall Study|Lack of Efficacy|0|||
30602922|NCT01238991|58614412|FG006|Overall Study|Lack of Efficacy|0|||
30602923|NCT01238991|58614413|FG007|Overall Study|Lack of Efficacy|0|||
30602924|NCT01238991|58614414|FG008|Overall Study|Lack of Efficacy|1|||
30602925|NCT01238991|58614415|FG009|Overall Study|Lack of Efficacy|0|||
30602926|NCT01238991|58614406|FG000|Overall Study|Withdrawal by Subject|0|||
30602927|NCT01238991|58614407|FG001|Overall Study|Withdrawal by Subject|0|||
30602928|NCT01238991|58614408|FG002|Overall Study|Withdrawal by Subject|1|||
30602929|NCT01238991|58614409|FG003|Overall Study|Withdrawal by Subject|0|||
30602930|NCT01238991|58614410|FG004|Overall Study|Withdrawal by Subject|0|||
30602931|NCT01238991|58614411|FG005|Overall Study|Withdrawal by Subject|0|||
30602932|NCT01238991|58614412|FG006|Overall Study|Withdrawal by Subject|0|||
30602933|NCT01238991|58614413|FG007|Overall Study|Withdrawal by Subject|0|||
30602934|NCT01238991|58614414|FG008|Overall Study|Withdrawal by Subject|0|||
30602935|NCT01238991|58614415|FG009|Overall Study|Withdrawal by Subject|0|||
30602936|NCT01238991|58614406|FG000|Overall Study|Study Terminated by Sponsor|0|||
30602937|NCT01238991|58614407|FG001|Overall Study|Study Terminated by Sponsor|0|||
30602938|NCT01238991|58614408|FG002|Overall Study|Study Terminated by Sponsor|0|||
30602939|NCT01238991|58614409|FG003|Overall Study|Study Terminated by Sponsor|0|||
30602940|NCT01238991|58614410|FG004|Overall Study|Study Terminated by Sponsor|1|||
30602941|NCT01238991|58614411|FG005|Overall Study|Study Terminated by Sponsor|0|||
30602942|NCT01238991|58614412|FG006|Overall Study|Study Terminated by Sponsor|7|||
30602943|NCT01238991|58614413|FG007|Overall Study|Study Terminated by Sponsor|4|||
30602944|NCT01238991|58614414|FG008|Overall Study|Study Terminated by Sponsor|2|||
30602945|NCT01238991|58614415|FG009|Overall Study|Study Terminated by Sponsor|2|||
30602946|NCT01238991|58614406|FG000|Overall Study|Caregiver's request|0|||
30602947|NCT01238991|58614407|FG001|Overall Study|Caregiver's request|0|||
30602948|NCT01238991|58614408|FG002|Overall Study|Caregiver's request|0|||
30602949|NCT01238991|58614409|FG003|Overall Study|Caregiver's request|0|||
30602950|NCT01238991|58614410|FG004|Overall Study|Caregiver's request|0|||
30602951|NCT01238991|58614411|FG005|Overall Study|Caregiver's request|0|||
30602952|NCT01238991|58614412|FG006|Overall Study|Caregiver's request|0|||
30602953|NCT01238991|58614413|FG007|Overall Study|Caregiver's request|0|||
30602954|NCT01238991|58614414|FG008|Overall Study|Caregiver's request|1|||
30602955|NCT01238991|58614415|FG009|Overall Study|Caregiver's request|0|||
30602956|NCT01238991|58614406|FG000|Overall Study|Admission to a nursing home|1|||
30602957|NCT01238991|58614407|FG001|Overall Study|Admission to a nursing home|0|||
30602958|NCT01238991|58614408|FG002|Overall Study|Admission to a nursing home|1|||
30602959|NCT01238991|58614409|FG003|Overall Study|Admission to a nursing home|0|||
30602960|NCT01238991|58614410|FG004|Overall Study|Admission to a nursing home|0|||
30602961|NCT01238991|58614411|FG005|Overall Study|Admission to a nursing home|0|||
30602962|NCT01238991|58614412|FG006|Overall Study|Admission to a nursing home|0|||
30602963|NCT01238991|58614413|FG007|Overall Study|Admission to a nursing home|0|||
30602964|NCT01238991|58614414|FG008|Overall Study|Admission to a nursing home|0|||
30602965|NCT01238991|58614415|FG009|Overall Study|Admission to a nursing home|0|||
30602966|NCT01238835|58614440|FG000|Overall Study|Death|124|||
30602967|NCT01238835|58614440|FG000|Overall Study|Withdrawal by Subject|9|||
30602968|NCT01238835|58614440|FG000|Overall Study|Lost to Follow-up|1|||
30602969|NCT01238835|58614440|FG000|Overall Study|Site early discontinuation|2|||
30602970|NCT01032070|58614446|FG000|Overall Study|Disease progression|13|||
30602971|NCT01032070|58614447|FG001|Overall Study|Disease progression|8|||
30602972|NCT01032070|58614446|FG000|Overall Study|Medical or ethical reasons|0|||
30602973|NCT01032070|58614447|FG001|Overall Study|Medical or ethical reasons|2|||
30602974|NCT01032070|58614446|FG000|Overall Study|Withdrawal by Subject|0|||
30602975|NCT01032070|58614447|FG001|Overall Study|Withdrawal by Subject|2|||
30602976|NCT01237899|58614464|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
30602977|NCT01237899|58614465|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
30602978|NCT01237899|58614466|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
30602979|NCT01237899|58614467|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
30602980|NCT01237899|58614468|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
30602981|NCT01237899|58614469|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
30602982|NCT01237899|58614470|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
30602983|NCT01237899|58614471|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
30602984|NCT01237899|58614472|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
30694730|NCT00348595|58708995|FG001|Overall Study|Adverse Event|8|||
30694731|NCT00337129|58709001|FG000|Overall Study|Adverse Event|4|||
30602985|NCT01237899|58614473|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
30602986|NCT01237899|58614474|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
30602987|NCT01264380|58614492|FG000|Period C|Disease Progression|0|||
30602988|NCT01264380|58614493|FG001|Period C|Disease Progression|0|||
30602989|NCT01264380|58614494|FG002|Period C|Disease Progression|4|||
30602990|NCT01264380|58614492|FG000|Period C|Death|0|||
30602991|NCT01264380|58614493|FG001|Period C|Death|0|||
30602992|NCT01264380|58614494|FG002|Period C|Death|2|||
30602993|NCT01264380|58614492|FG000|Period C|Follow-up for survival status|0|||
30602994|NCT01264380|58614493|FG001|Period C|Follow-up for survival status|0|||
30602995|NCT01264380|58614494|FG002|Period C|Follow-up for survival status|6|||
30602996|NCT01264380|58614492|FG000|Period C|Withdrawal by Subject|0|||
30602997|NCT01264380|58614493|FG001|Period C|Withdrawal by Subject|0|||
30602998|NCT01264380|58614494|FG002|Period C|Withdrawal by Subject|1|||
30602999|NCT01264380|58614492|FG000|Period C|Adverse Event|0|||
30603000|NCT01264380|58614493|FG001|Period C|Adverse Event|0|||
30603001|NCT01264380|58614494|FG002|Period C|Adverse Event|1|||
30603002|NCT01263444|58614502|FG000|Overall Study|Adverse Event|8|||
30603003|NCT01263444|58614502|FG000|Overall Study|Withdrawal by Subject|1|||
30603004|NCT01263444|58614502|FG000|Overall Study|Protocol Violation|1|||
30603005|NCT01263054|58614508|FG000|Overall Study|Death|1|||
30603006|NCT01263054|58614509|FG001|Overall Study|Death|0|||
30603007|NCT01263054|58614508|FG000|Overall Study|Lost to Follow-up|2|||
30603008|NCT01263054|58614509|FG001|Overall Study|Lost to Follow-up|2|||
30603009|NCT01263054|58614508|FG000|Overall Study|Withdrawal by Subject|1|||
30603010|NCT01263054|58614509|FG001|Overall Study|Withdrawal by Subject|3|||
30603011|NCT01263054|58614508|FG000|Overall Study|Qualification Violation|1|||
30603012|NCT01263054|58614509|FG001|Overall Study|Qualification Violation|0|||
30603013|NCT01263054|58614508|FG000|Overall Study|Other|0|||
30603014|NCT01263054|58614509|FG001|Overall Study|Other|1|||
30603015|NCT01031836|58614521|FG000|Stage I|Adverse Event|1|||
30603016|NCT01031836|58614522|FG001|Stage I|Adverse Event|1|||
30603017|NCT01031836|58614523|FG002|Stage I|Adverse Event|0|||
30603018|NCT01031836|58614524|FG003|Stage I|Adverse Event|0|||
30603019|NCT01031836|58614525|FG004|Stage I|Adverse Event|0|||
30603020|NCT01031836|58614526|FG005|Stage I|Adverse Event|0|||
30603021|NCT01031836|58614521|FG000|Stage I|Other|0|||
30603022|NCT01031836|58614522|FG001|Stage I|Other|1|||
30603023|NCT01031836|58614523|FG002|Stage I|Other|0|||
30603024|NCT01031836|58614524|FG003|Stage I|Other|0|||
30603025|NCT01031836|58614525|FG004|Stage I|Other|0|||
30603026|NCT01031836|58614526|FG005|Stage I|Other|1|||
30603027|NCT01031836|58614521|FG000|Stage II|Adverse Event|0|||
30603028|NCT01031836|58614522|FG001|Stage II|Adverse Event|0|||
30603029|NCT01031836|58614523|FG002|Stage II|Adverse Event|2|||
30603030|NCT01031836|58614524|FG003|Stage II|Adverse Event|2|||
30603031|NCT01031836|58614525|FG004|Stage II|Adverse Event|1|||
30603032|NCT01031836|58614526|FG005|Stage II|Adverse Event|1|||
30603033|NCT01031836|58614521|FG000|Stage II|Other|2|||
30603034|NCT01031836|58614522|FG001|Stage II|Other|0|||
30603035|NCT01031836|58614523|FG002|Stage II|Other|0|||
30603036|NCT01031836|58614524|FG003|Stage II|Other|1|||
30603037|NCT01031836|58614525|FG004|Stage II|Other|1|||
30603038|NCT01031836|58614526|FG005|Stage II|Other|0|||
30603039|NCT01237587|58614542|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
30603040|NCT01237587|58614543|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
30603041|NCT01237587|58614542|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
30603042|NCT01237587|58614543|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
30603043|NCT01237587|58614542|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
30603044|NCT01237587|58614543|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
30603045|NCT01237587|58614542|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
30603046|NCT01237587|58614543|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
30603047|NCT01237587|58614542|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
30603048|NCT01237587|58614543|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
30603049|NCT01237587|58614542|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
30603050|NCT01237587|58614543|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
30603051|NCT01237587|58614542|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
30873855|NCT02213133|58904561|FG001|Overall Study|Death|2|||
30603052|NCT01237587|58614543|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
30873856|NCT02213133|58904562|FG002|Overall Study|Death|1|||
30603053|NCT01237587|58614542|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
30603054|NCT01237587|58614543|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
30603055|NCT01237587|58614542|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
30603056|NCT01237587|58614543|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
30603057|NCT01237587|58614542|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
30603058|NCT01237587|58614543|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
30603059|NCT01237587|58614542|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
30603060|NCT01237587|58614543|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
30603061|NCT01237587|58614542|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
30603062|NCT01237587|58614543|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
30603063|NCT01237587|58614542|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
30603064|NCT01237587|58614543|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
30603065|NCT01237587|58614542|FG000|Taper Phase|Adverse Event|0|||
30603066|NCT01237587|58614543|FG001|Taper Phase|Adverse Event|2|||
30603067|NCT01237587|58614542|FG000|Taper Phase|Protocol Violation|2|||
30603068|NCT01237587|58614543|FG001|Taper Phase|Protocol Violation|0|||
30603069|NCT01237587|58614542|FG000|Taper Phase|Lack of Efficacy|2|||
30603070|NCT01237587|58614543|FG001|Taper Phase|Lack of Efficacy|5|||
30603071|NCT01237587|58614542|FG000|Taper Phase|Parent/Guardian Decision|0|||
30603072|NCT01237587|58614543|FG001|Taper Phase|Parent/Guardian Decision|2|||
30603073|NCT01237587|58614542|FG000|Taper Phase|Sponsor Decision|1|||
30603074|NCT01237587|58614543|FG001|Taper Phase|Sponsor Decision|0|||
30603075|NCT01237587|58614542|FG000|Taper Phase|Withdrawal by Subject|0|||
30603076|NCT01237587|58614543|FG001|Taper Phase|Withdrawal by Subject|1|||
30603077|NCT01031680|58614558|FG000|Overall Study|Adverse Event|8|||
30603078|NCT01031680|58614559|FG001|Overall Study|Adverse Event|3|||
30603079|NCT01031680|58614558|FG000|Overall Study|Lost to Follow-up|2|||
30603080|NCT01031680|58614559|FG001|Overall Study|Lost to Follow-up|10|||
30603081|NCT01031680|58614558|FG000|Overall Study|Withdrawal by Subject|12|||
30603082|NCT01031680|58614559|FG001|Overall Study|Withdrawal by Subject|16|||
30603083|NCT01031680|58614558|FG000|Overall Study|Death|2|||
30603084|NCT01031680|58614559|FG001|Overall Study|Death|1|||
30603085|NCT01031680|58614558|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
30603086|NCT01031680|58614559|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
30603087|NCT01031680|58614558|FG000|Overall Study|Poor/Non-compliance|5|||
30603088|NCT01031680|58614559|FG001|Overall Study|Poor/Non-compliance|6|||
30603089|NCT01031680|58614558|FG000|Overall Study|Safety|1|||
30603090|NCT01031680|58614559|FG001|Overall Study|Safety|0|||
30603091|NCT01031680|58614558|FG000|Overall Study|Incorrect Enrolment|1|||
30603092|NCT01031680|58614559|FG001|Overall Study|Incorrect Enrolment|2|||
30603093|NCT01031680|58614558|FG000|Overall Study|Administrative Reason by Sponsor|0|||
30603094|NCT01031680|58614559|FG001|Overall Study|Administrative Reason by Sponsor|1|||
30603095|NCT01031680|58614558|FG000|Overall Study|Various|0|||
30603096|NCT01031680|58614559|FG001|Overall Study|Various|2|||
30603097|NCT01031446|58614565|FG000|Overall Study|Disease Progression|38|||
30603098|NCT01031446|58614565|FG000|Overall Study|Adverse Event|9|||
30603099|NCT01031446|58614565|FG000|Overall Study|Physician Decision|4|||
30603100|NCT01031446|58614565|FG000|Overall Study|Withdrawal by Subject|3|||
30603101|NCT01031446|58614565|FG000|Overall Study|Still on treatment|1|||
30603102|NCT01030900|58614571|FG000|Overall Study|Not treated due to congestive heart failure|1|||
30603103|NCT01030900|58614571|FG000|Overall Study|Not treated due to rapid disease|1|||
30603104|NCT01030822|58614578|FG000|Overall Study|Moved/migrated from study area|6|||
30603105|NCT01030822|58614579|FG001|Overall Study|Moved/migrated from study area|7|||
30603106|NCT01030822|58614580|FG002|Overall Study|Moved/migrated from study area|3|||
30603107|NCT01030822|58614578|FG000|Overall Study|Withdrawal by Subject|16|||
30603108|NCT01030822|58614579|FG001|Overall Study|Withdrawal by Subject|13|||
30603109|NCT01030822|58614580|FG002|Overall Study|Withdrawal by Subject|16|||
30603110|NCT01030822|58614578|FG000|Overall Study|Lost to Follow-up|9|||
30603111|NCT01030822|58614579|FG001|Overall Study|Lost to Follow-up|4|||
30603112|NCT01030822|58614580|FG002|Overall Study|Lost to Follow-up|7|||
30603113|NCT01026454|58614591|FG000|Second Intervention|Pregnancy|1|||
30603114|NCT01026454|58614592|FG001|Second Intervention|Pregnancy|1|||
30603115|NCT01026220|58614598|FG000|Induction|Death|1|||
30603116|NCT01026220|58614599|FG001|Induction|Death|0|||
30603117|NCT01026220|58614600|FG002|Induction|Death|0|||
30603118|NCT01026220|58614598|FG000|Induction|Lack of Efficacy|2|||
30603119|NCT01026220|58614599|FG001|Induction|Lack of Efficacy|0|||
30603120|NCT01026220|58614600|FG002|Induction|Lack of Efficacy|0|||
30603121|NCT01026220|58614598|FG000|Induction|Physician Decision|12|||
30603122|NCT01026220|58614599|FG001|Induction|Physician Decision|0|||
30603123|NCT01026220|58614600|FG002|Induction|Physician Decision|0|||
30603124|NCT01026220|58614598|FG000|Induction|Withdrawal by Subject|9|||
30603125|NCT01026220|58614599|FG001|Induction|Withdrawal by Subject|0|||
30603126|NCT01026220|58614600|FG002|Induction|Withdrawal by Subject|0|||
30603127|NCT01026220|58614598|FG000|Induction|Ineligible|1|||
30603128|NCT01026220|58614599|FG001|Induction|Ineligible|0|||
30603129|NCT01026220|58614600|FG002|Induction|Ineligible|0|||
30603130|NCT01026220|58614598|FG000|Consolidation Maintenance|Death|0|||
30603131|NCT01026220|58614599|FG001|Consolidation Maintenance|Death|1|||
30603132|NCT01026220|58614600|FG002|Consolidation Maintenance|Death|0|||
30603133|NCT01026220|58614598|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
30603134|NCT01026220|58614599|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
30603135|NCT01026220|58614600|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
30603136|NCT01026220|58614598|FG000|Consolidation Maintenance|Physician Decision|0|||
30603137|NCT01026220|58614599|FG001|Consolidation Maintenance|Physician Decision|2|||
30603138|NCT01026220|58614600|FG002|Consolidation Maintenance|Physician Decision|7|||
30603139|NCT01026220|58614598|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
30603140|NCT01026220|58614599|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
30603141|NCT01026220|58614600|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
30603142|NCT01026142|58614617|FG000|Overall Study|Death|136|||
30603143|NCT01026142|58614618|FG001|Overall Study|Death|134|||
30603144|NCT01026142|58614617|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
30603145|NCT01026142|58614618|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
30603146|NCT01030666|58614626|FG000|Overall Study|Lost to Follow-up|3|||
30603147|NCT01030666|58614627|FG001|Overall Study|Lost to Follow-up|2|||
30603148|NCT01025752|58614636|FG000|Overall Study|Lost to Follow-up|7|||
30603149|NCT01025752|58614637|FG001|Overall Study|Lost to Follow-up|10|||
30603150|NCT01025752|58614636|FG000|Overall Study|Physician Decision|1|||
30603151|NCT01025752|58614637|FG001|Overall Study|Physician Decision|3|||
30603152|NCT01030198|58614645|FG000|Overall Study|Could not measure efficacy accurately|0|||
30603153|NCT01030198|58614646|FG001|Overall Study|Could not measure efficacy accurately|7|||
30603154|NCT01301456|58614664|FG000|Stage 1|Withdrawal by Subject|0|||
30603155|NCT01301456|58614665|FG001|Stage 1|Withdrawal by Subject|0|||
30603156|NCT01301456|58614666|FG002|Stage 1|Withdrawal by Subject|1|||
30603157|NCT01301456|58614667|FG003|Stage 1|Withdrawal by Subject|0|||
30603158|NCT01301456|58614668|FG004|Stage 1|Withdrawal by Subject|1|||
30603159|NCT01301456|58614669|FG005|Stage 1|Withdrawal by Subject|0|||
30603160|NCT01301456|58614670|FG006|Stage 1|Withdrawal by Subject|0|||
30603161|NCT01301456|58614671|FG007|Stage 1|Withdrawal by Subject|0|||
30603162|NCT01301456|58614672|FG008|Stage 1|Withdrawal by Subject|0|||
30603163|NCT01301456|58614673|FG009|Stage 1|Withdrawal by Subject|0|||
30603164|NCT01301456|58614674|FG010|Stage 1|Withdrawal by Subject|0|||
30603165|NCT01301456|58614675|FG011|Stage 1|Withdrawal by Subject|0|||
30603166|NCT01301456|58614664|FG000|Stage 1|Randomized but not treated|0|||
30603167|NCT01301456|58614665|FG001|Stage 1|Randomized but not treated|0|||
30603168|NCT01301456|58614666|FG002|Stage 1|Randomized but not treated|0|||
30603169|NCT01301456|58614667|FG003|Stage 1|Randomized but not treated|0|||
30603170|NCT01301456|58614668|FG004|Stage 1|Randomized but not treated|0|||
30603171|NCT01301456|58614669|FG005|Stage 1|Randomized but not treated|0|||
30603172|NCT01301456|58614670|FG006|Stage 1|Randomized but not treated|1|||
30603173|NCT01301456|58614671|FG007|Stage 1|Randomized but not treated|0|||
30603174|NCT01301456|58614672|FG008|Stage 1|Randomized but not treated|0|||
30603175|NCT01301456|58614673|FG009|Stage 1|Randomized but not treated|0|||
30603176|NCT01301456|58614674|FG010|Stage 1|Randomized but not treated|0|||
30694732|NCT00337129|58709001|FG000|Overall Study|Withdrawal by Subject|1|||
30694733|NCT00337129|58709001|FG000|Overall Study|Lack of Efficacy|32|||
30694734|NCT00337129|58709001|FG000|Overall Study|Death|2|||
30694735|NCT00337129|58709001|FG000|Overall Study|not protocol specified|1|||
30694736|NCT00605085|58709007|FG000|Overall Study|Withdrawal by Subject|8|||
30694737|NCT00605085|58709008|FG001|Overall Study|Withdrawal by Subject|5|||
30694738|NCT00605085|58709007|FG000|Overall Study|Adverse Event|9|||
30694739|NCT00605085|58709008|FG001|Overall Study|Adverse Event|5|||
30694740|NCT00605085|58709007|FG000|Overall Study|Pregnancy|2|||
30694741|NCT00605085|58709008|FG001|Overall Study|Pregnancy|0|||
30694742|NCT00605085|58709007|FG000|Overall Study|Protocol Violation|3|||
30694743|NCT00605085|58709008|FG001|Overall Study|Protocol Violation|2|||
30694744|NCT00605085|58709007|FG000|Overall Study|Lost to Follow-up|10|||
30694745|NCT00605085|58709008|FG001|Overall Study|Lost to Follow-up|5|||
30694746|NCT00605085|58709007|FG000|Overall Study|administrative reasons|18|||
30694747|NCT00605085|58709008|FG001|Overall Study|administrative reasons|8|||
30694748|NCT00348283|58709016|FG000|Induction|Adverse Event|0|||
30694749|NCT00348283|58709017|FG001|Induction|Adverse Event|2|||
30694750|NCT00348283|58709016|FG000|Induction|Protocol Violation|0|||
30694751|NCT00348283|58709017|FG001|Induction|Protocol Violation|4|||
30694752|NCT00348283|58709016|FG000|Double Blind|Adverse Event|2|||
30694753|NCT00348283|58709017|FG001|Double Blind|Adverse Event|5|||
30694754|NCT00348283|58709016|FG000|Double Blind|Withdrawal by Subject|1|||
30694755|NCT00348283|58709017|FG001|Double Blind|Withdrawal by Subject|1|||
30694756|NCT00348283|58709016|FG000|Double Blind|Protocol Violation|0|||
30694757|NCT00348283|58709017|FG001|Double Blind|Protocol Violation|1|||
30694758|NCT00348283|58709016|FG000|Double Blind|Lack of Efficacy|2|||
30694759|NCT00348283|58709017|FG001|Double Blind|Lack of Efficacy|2|||
30694760|NCT00348283|58709016|FG000|Double Blind|Pregnancy|0|||
30694761|NCT00348283|58709017|FG001|Double Blind|Pregnancy|1|||
30694762|NCT00348283|58709016|FG000|Open Label|Adverse Event|0|||
30603177|NCT01301456|58614675|FG011|Stage 1|Randomized but not treated|0|||
30603178|NCT01301456|58614664|FG000|Stage 2|Adverse Event|0|||
30603179|NCT01301456|58614665|FG001|Stage 2|Adverse Event|0|||
30603180|NCT01301456|58614666|FG002|Stage 2|Adverse Event|0|||
30603181|NCT01301456|58614667|FG003|Stage 2|Adverse Event|0|||
30603182|NCT01301456|58614668|FG004|Stage 2|Adverse Event|0|||
30603183|NCT01301456|58614669|FG005|Stage 2|Adverse Event|0|||
30603184|NCT01301456|58614670|FG006|Stage 2|Adverse Event|0|||
30603185|NCT01301456|58614671|FG007|Stage 2|Adverse Event|0|||
30603186|NCT01301456|58614672|FG008|Stage 2|Adverse Event|0|||
30603187|NCT01301456|58614673|FG009|Stage 2|Adverse Event|0|||
30694763|NCT00348283|58709017|FG001|Open Label|Adverse Event|8|||
30603188|NCT01301456|58614674|FG010|Stage 2|Adverse Event|1|||
30603189|NCT01301456|58614675|FG011|Stage 2|Adverse Event|0|||
30603190|NCT01023256|58614723|FG000|Overall Study|Protocol Violation|2|||
30603191|NCT01023256|58614724|FG001|Overall Study|Protocol Violation|3|||
30603192|NCT01023256|58614725|FG002|Overall Study|Protocol Violation|0|||
30603193|NCT01023256|58614726|FG003|Overall Study|Protocol Violation|0|||
30603194|NCT01023256|58614723|FG000|Overall Study|Randomized but not treated|1|||
30603195|NCT01023256|58614724|FG001|Overall Study|Randomized but not treated|0|||
30603196|NCT01023256|58614725|FG002|Overall Study|Randomized but not treated|1|||
30603197|NCT01023256|58614726|FG003|Overall Study|Randomized but not treated|0|||
30603198|NCT01023256|58614723|FG000|Overall Study|Other|1|||
30603199|NCT01023256|58614724|FG001|Overall Study|Other|0|||
30603200|NCT01023256|58614725|FG002|Overall Study|Other|0|||
30603201|NCT01023256|58614726|FG003|Overall Study|Other|2|||
30603202|NCT01023256|58614723|FG000|Overall Study|Adverse Event|0|||
30603203|NCT01023256|58614724|FG001|Overall Study|Adverse Event|0|||
30603204|NCT01023256|58614725|FG002|Overall Study|Adverse Event|0|||
30603205|NCT01023256|58614726|FG003|Overall Study|Adverse Event|1|||
30603206|NCT01023256|58614723|FG000|Overall Study|Withdrawal by Subject|0|||
30603207|NCT01023256|58614724|FG001|Overall Study|Withdrawal by Subject|0|||
30603208|NCT01023256|58614725|FG002|Overall Study|Withdrawal by Subject|0|||
30603209|NCT01023256|58614726|FG003|Overall Study|Withdrawal by Subject|2|||
30603210|NCT01023022|58614739|FG000|Overall Study|Death|5|||
30603211|NCT01023022|58614739|FG000|Overall Study|Lost to Follow-up|7|||
30603212|NCT01023022|58614739|FG000|Overall Study|due to technical issues|2|||
30603213|NCT01058668|58614746|FG000|Double-blind Treatment Phase|Adverse Event|8|||
30603214|NCT01058668|58614747|FG001|Double-blind Treatment Phase|Adverse Event|15|||
30603215|NCT01058668|58614748|FG002|Double-blind Treatment Phase|Adverse Event|25|||
30603216|NCT01058668|58614746|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
30603217|NCT01058668|58614747|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
30603218|NCT01058668|58614748|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
30603219|NCT01058668|58614746|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
30603220|NCT01058668|58614747|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
30603221|NCT01058668|58614748|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
30603222|NCT01058668|58614746|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
30603223|NCT01058668|58614747|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
30603224|NCT01058668|58614748|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
30603225|NCT01058668|58614746|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
30603226|NCT01058668|58614747|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
30603227|NCT01058668|58614748|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
30603228|NCT01058668|58614746|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
30603229|NCT01058668|58614747|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
30603230|NCT01058668|58614748|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
30603231|NCT01301066|58614758|FG000|Overall Study|Lost to Follow-up|5|||
30603232|NCT01301066|58614759|FG001|Overall Study|Lost to Follow-up|11|||
30603233|NCT01301066|58614758|FG000|Overall Study|Protocol Violation|8|||
30603234|NCT01301066|58614759|FG001|Overall Study|Protocol Violation|7|||
30603235|NCT01301066|58614758|FG000|Overall Study|Withdrawal by Subject|4|||
30603236|NCT01301066|58614759|FG001|Overall Study|Withdrawal by Subject|9|||
30603237|NCT01301066|58614758|FG000|Overall Study|Adverse Event|6|||
30603238|NCT01301066|58614759|FG001|Overall Study|Adverse Event|6|||
30603239|NCT01301066|58614758|FG000|Overall Study|Sponsor Decision|2|||
30603240|NCT01301066|58614759|FG001|Overall Study|Sponsor Decision|1|||
30603241|NCT01301066|58614758|FG000|Overall Study|Physician Decision|0|||
30603242|NCT01301066|58614759|FG001|Overall Study|Physician Decision|1|||
30603243|NCT01301066|58614758|FG000|Overall Study|Other|2|||
30603244|NCT01301066|58614759|FG001|Overall Study|Other|0|||
30603245|NCT01022398|58614767|FG000|Overall Study|Study terminated|2|||
30603246|NCT01022398|58614768|FG001|Overall Study|Study terminated|2|||
30603247|NCT01262976|58614779|FG000|Up to Month 2|Serious Adverse Event|0|||
30603248|NCT01262976|58614780|FG001|Up to Month 2|Serious Adverse Event|0|||
30603249|NCT01262976|58614781|FG002|Up to Month 2|Serious Adverse Event|1|||
30603250|NCT01262976|58614782|FG003|Up to Month 2|Serious Adverse Event|0|||
30603251|NCT01262976|58614783|FG004|Up to Month 2|Serious Adverse Event|0|||
30603252|NCT01262976|58614784|FG005|Up to Month 2|Serious Adverse Event|0|||
30603253|NCT01262976|58614779|FG000|Up to Month 2|Withdrawal by Subject|1|||
30603254|NCT01262976|58614780|FG001|Up to Month 2|Withdrawal by Subject|0|||
30603255|NCT01262976|58614781|FG002|Up to Month 2|Withdrawal by Subject|0|||
30603256|NCT01262976|58614782|FG003|Up to Month 2|Withdrawal by Subject|0|||
30603257|NCT01262976|58614783|FG004|Up to Month 2|Withdrawal by Subject|0|||
30603258|NCT01262976|58614784|FG005|Up to Month 2|Withdrawal by Subject|0|||
30603259|NCT01262976|58614779|FG000|Up to Month 2|Migrated/moved from study area|0|||
30603260|NCT01262976|58614780|FG001|Up to Month 2|Migrated/moved from study area|1|||
30603261|NCT01262976|58614781|FG002|Up to Month 2|Migrated/moved from study area|0|||
30603262|NCT01262976|58614782|FG003|Up to Month 2|Migrated/moved from study area|0|||
30603263|NCT01262976|58614783|FG004|Up to Month 2|Migrated/moved from study area|1|||
30603264|NCT01262976|58614784|FG005|Up to Month 2|Migrated/moved from study area|1|||
30603265|NCT01262976|58614779|FG000|Up to Month 2|Lost to Follow-up|1|||
30603266|NCT01262976|58614780|FG001|Up to Month 2|Lost to Follow-up|0|||
30603267|NCT01262976|58614781|FG002|Up to Month 2|Lost to Follow-up|0|||
30603268|NCT01262976|58614782|FG003|Up to Month 2|Lost to Follow-up|1|||
30603269|NCT01262976|58614783|FG004|Up to Month 2|Lost to Follow-up|1|||
30603270|NCT01262976|58614784|FG005|Up to Month 2|Lost to Follow-up|1|||
30603271|NCT01262976|58614779|FG000|Up to Month 2|Other|1|||
30603272|NCT01262976|58614780|FG001|Up to Month 2|Other|0|||
30603273|NCT01262976|58614781|FG002|Up to Month 2|Other|0|||
30603274|NCT01262976|58614782|FG003|Up to Month 2|Other|1|||
30603275|NCT01262976|58614783|FG004|Up to Month 2|Other|0|||
30603276|NCT01262976|58614784|FG005|Up to Month 2|Other|2|||
30603277|NCT01262976|58614779|FG000|Up to Month 7|Serious Adverse Event|0|||
30603278|NCT01262976|58614780|FG001|Up to Month 7|Serious Adverse Event|0|||
30603279|NCT01262976|58614781|FG002|Up to Month 7|Serious Adverse Event|2|||
30603280|NCT01262976|58614782|FG003|Up to Month 7|Serious Adverse Event|0|||
30603281|NCT01262976|58614783|FG004|Up to Month 7|Serious Adverse Event|0|||
30603282|NCT01262976|58614784|FG005|Up to Month 7|Serious Adverse Event|0|||
30603283|NCT01262976|58614779|FG000|Up to Month 7|Withdrawal by Subject|1|||
30603284|NCT01262976|58614780|FG001|Up to Month 7|Withdrawal by Subject|0|||
30603285|NCT01262976|58614781|FG002|Up to Month 7|Withdrawal by Subject|0|||
30603286|NCT01262976|58614782|FG003|Up to Month 7|Withdrawal by Subject|0|||
30603287|NCT01262976|58614783|FG004|Up to Month 7|Withdrawal by Subject|0|||
30603288|NCT01262976|58614784|FG005|Up to Month 7|Withdrawal by Subject|0|||
30603289|NCT01262976|58614779|FG000|Up to Month 7|Migrated/moved from study area|0|||
30603290|NCT01262976|58614780|FG001|Up to Month 7|Migrated/moved from study area|0|||
30603291|NCT01262976|58614781|FG002|Up to Month 7|Migrated/moved from study area|1|||
30603292|NCT01262976|58614782|FG003|Up to Month 7|Migrated/moved from study area|3|||
30603293|NCT01262976|58614783|FG004|Up to Month 7|Migrated/moved from study area|1|||
30603294|NCT01262976|58614784|FG005|Up to Month 7|Migrated/moved from study area|1|||
30603295|NCT01262976|58614779|FG000|Up to Month 7|Lost to Follow-up|1|||
30603296|NCT01262976|58614780|FG001|Up to Month 7|Lost to Follow-up|0|||
30603297|NCT01262976|58614781|FG002|Up to Month 7|Lost to Follow-up|1|||
30603298|NCT01262976|58614782|FG003|Up to Month 7|Lost to Follow-up|3|||
30603299|NCT01262976|58614783|FG004|Up to Month 7|Lost to Follow-up|1|||
30603300|NCT01262976|58614784|FG005|Up to Month 7|Lost to Follow-up|3|||
30603301|NCT01262976|58614779|FG000|Up to Month 7|Other|3|||
30603302|NCT01262976|58614780|FG001|Up to Month 7|Other|0|||
30603303|NCT01262976|58614781|FG002|Up to Month 7|Other|2|||
30603304|NCT01262976|58614782|FG003|Up to Month 7|Other|0|||
30603305|NCT01262976|58614783|FG004|Up to Month 7|Other|0|||
30603306|NCT01262976|58614784|FG005|Up to Month 7|Other|0|||
30603307|NCT01262976|58614779|FG000|Up to Year 1|Serious Adverse Event|0|||
30603308|NCT01262976|58614780|FG001|Up to Year 1|Serious Adverse Event|0|||
30603309|NCT01262976|58614781|FG002|Up to Year 1|Serious Adverse Event|2|||
30603310|NCT01262976|58614782|FG003|Up to Year 1|Serious Adverse Event|0|||
30603311|NCT01262976|58614783|FG004|Up to Year 1|Serious Adverse Event|0|||
30603312|NCT01262976|58614784|FG005|Up to Year 1|Serious Adverse Event|0|||
30603313|NCT01262976|58614779|FG000|Up to Year 1|Withdrawal by Subject|1|||
30603314|NCT01262976|58614780|FG001|Up to Year 1|Withdrawal by Subject|0|||
30603315|NCT01262976|58614781|FG002|Up to Year 1|Withdrawal by Subject|0|||
30603316|NCT01262976|58614782|FG003|Up to Year 1|Withdrawal by Subject|0|||
30603317|NCT01262976|58614783|FG004|Up to Year 1|Withdrawal by Subject|0|||
30603318|NCT01262976|58614784|FG005|Up to Year 1|Withdrawal by Subject|0|||
30603319|NCT01262976|58614779|FG000|Up to Year 1|Migrated/moved from study area|1|||
30603320|NCT01262976|58614780|FG001|Up to Year 1|Migrated/moved from study area|0|||
30603321|NCT01262976|58614781|FG002|Up to Year 1|Migrated/moved from study area|0|||
30603322|NCT01262976|58614782|FG003|Up to Year 1|Migrated/moved from study area|3|||
30603323|NCT01262976|58614783|FG004|Up to Year 1|Migrated/moved from study area|3|||
30603324|NCT01262976|58614784|FG005|Up to Year 1|Migrated/moved from study area|2|||
30603325|NCT01262976|58614779|FG000|Up to Year 1|Lost to Follow-up|4|||
30603326|NCT01262976|58614780|FG001|Up to Year 1|Lost to Follow-up|0|||
30603327|NCT01262976|58614781|FG002|Up to Year 1|Lost to Follow-up|0|||
30603328|NCT01262976|58614782|FG003|Up to Year 1|Lost to Follow-up|1|||
30603329|NCT01262976|58614783|FG004|Up to Year 1|Lost to Follow-up|6|||
30603330|NCT01262976|58614784|FG005|Up to Year 1|Lost to Follow-up|5|||
30603331|NCT01262976|58614779|FG000|Up to Year 1|Other|3|||
30603332|NCT01262976|58614780|FG001|Up to Year 1|Other|1|||
30603333|NCT01262976|58614781|FG002|Up to Year 1|Other|0|||
30603334|NCT01262976|58614782|FG003|Up to Year 1|Other|0|||
30603335|NCT01262976|58614783|FG004|Up to Year 1|Other|2|||
30694764|NCT00348283|58709016|FG000|Open Label|Withdrawal by Subject|0|||
30603336|NCT01262976|58614784|FG005|Up to Year 1|Other|1|||
30603337|NCT01262976|58614779|FG000|Up to Year 1|Subjects with unknown completion status|0|||
30603338|NCT01262976|58614780|FG001|Up to Year 1|Subjects with unknown completion status|0|||
30603339|NCT01262976|58614781|FG002|Up to Year 1|Subjects with unknown completion status|1|||
30603340|NCT01262976|58614782|FG003|Up to Year 1|Subjects with unknown completion status|0|||
30603341|NCT01262976|58614783|FG004|Up to Year 1|Subjects with unknown completion status|0|||
30603342|NCT01262976|58614784|FG005|Up to Year 1|Subjects with unknown completion status|1|||
30603343|NCT01262976|58614779|FG000|Up to Year 2|Serious Adverse Event|0|||
30603344|NCT01262976|58614780|FG001|Up to Year 2|Serious Adverse Event|0|||
30603345|NCT01262976|58614781|FG002|Up to Year 2|Serious Adverse Event|2|||
30603346|NCT01262976|58614782|FG003|Up to Year 2|Serious Adverse Event|0|||
30603347|NCT01262976|58614783|FG004|Up to Year 2|Serious Adverse Event|0|||
30603348|NCT01262976|58614784|FG005|Up to Year 2|Serious Adverse Event|0|||
30603349|NCT01262976|58614779|FG000|Up to Year 2|Withdrawal by Subject|1|||
30603350|NCT01262976|58614780|FG001|Up to Year 2|Withdrawal by Subject|0|||
30603351|NCT01262976|58614781|FG002|Up to Year 2|Withdrawal by Subject|0|||
30603352|NCT01262976|58614782|FG003|Up to Year 2|Withdrawal by Subject|0|||
30603353|NCT01262976|58614783|FG004|Up to Year 2|Withdrawal by Subject|0|||
30603354|NCT01262976|58614784|FG005|Up to Year 2|Withdrawal by Subject|0|||
30603355|NCT01262976|58614779|FG000|Up to Year 2|Migrated/moved from study area|0|||
30603356|NCT01262976|58614780|FG001|Up to Year 2|Migrated/moved from study area|0|||
30603357|NCT01262976|58614781|FG002|Up to Year 2|Migrated/moved from study area|0|||
30603358|NCT01262976|58614782|FG003|Up to Year 2|Migrated/moved from study area|2|||
30603359|NCT01262976|58614783|FG004|Up to Year 2|Migrated/moved from study area|1|||
30603360|NCT01262976|58614784|FG005|Up to Year 2|Migrated/moved from study area|2|||
30603361|NCT01262976|58614779|FG000|Up to Year 2|Lost to Follow-up|1|||
30603362|NCT01262976|58614780|FG001|Up to Year 2|Lost to Follow-up|1|||
30603363|NCT01262976|58614781|FG002|Up to Year 2|Lost to Follow-up|2|||
30603364|NCT01262976|58614782|FG003|Up to Year 2|Lost to Follow-up|2|||
30603365|NCT01262976|58614783|FG004|Up to Year 2|Lost to Follow-up|3|||
30603366|NCT01262976|58614784|FG005|Up to Year 2|Lost to Follow-up|3|||
30603367|NCT01262976|58614779|FG000|Up to Year 2|Subjects with unknown completion status|0|||
30603368|NCT01262976|58614780|FG001|Up to Year 2|Subjects with unknown completion status|0|||
30603369|NCT01262976|58614781|FG002|Up to Year 2|Subjects with unknown completion status|1|||
30603370|NCT01262976|58614782|FG003|Up to Year 2|Subjects with unknown completion status|0|||
30603371|NCT01262976|58614783|FG004|Up to Year 2|Subjects with unknown completion status|0|||
30603372|NCT01262976|58614784|FG005|Up to Year 2|Subjects with unknown completion status|0|||
30603373|NCT01262976|58614779|FG000|Up to Year 2|Other|3|||
30603374|NCT01262976|58614780|FG001|Up to Year 2|Other|0|||
30603375|NCT01262976|58614781|FG002|Up to Year 2|Other|0|||
30603376|NCT01262976|58614782|FG003|Up to Year 2|Other|0|||
30603377|NCT01262976|58614783|FG004|Up to Year 2|Other|0|||
30603378|NCT01262976|58614784|FG005|Up to Year 2|Other|0|||
30603379|NCT01262976|58614779|FG000|Up to Year 3|Serious Adverse Event|0|||
30603380|NCT01262976|58614780|FG001|Up to Year 3|Serious Adverse Event|0|||
30603381|NCT01262976|58614781|FG002|Up to Year 3|Serious Adverse Event|2|||
30603382|NCT01262976|58614782|FG003|Up to Year 3|Serious Adverse Event|0|||
30603383|NCT01262976|58614783|FG004|Up to Year 3|Serious Adverse Event|0|||
30603384|NCT01262976|58614784|FG005|Up to Year 3|Serious Adverse Event|0|||
30603385|NCT01262976|58614779|FG000|Up to Year 3|Withdrawal by Subject|1|||
30603386|NCT01262976|58614780|FG001|Up to Year 3|Withdrawal by Subject|0|||
30603387|NCT01262976|58614781|FG002|Up to Year 3|Withdrawal by Subject|0|||
30603388|NCT01262976|58614782|FG003|Up to Year 3|Withdrawal by Subject|0|||
30603389|NCT01262976|58614783|FG004|Up to Year 3|Withdrawal by Subject|0|||
30603390|NCT01262976|58614784|FG005|Up to Year 3|Withdrawal by Subject|0|||
30603391|NCT01262976|58614779|FG000|Up to Year 3|Migrated/moved from study area|0|||
30603392|NCT01262976|58614780|FG001|Up to Year 3|Migrated/moved from study area|0|||
30603393|NCT01262976|58614781|FG002|Up to Year 3|Migrated/moved from study area|0|||
30603394|NCT01262976|58614782|FG003|Up to Year 3|Migrated/moved from study area|2|||
30603395|NCT01262976|58614783|FG004|Up to Year 3|Migrated/moved from study area|1|||
30603396|NCT01262976|58614784|FG005|Up to Year 3|Migrated/moved from study area|1|||
30603397|NCT01262976|58614779|FG000|Up to Year 3|Lost to Follow-up|2|||
30603398|NCT01262976|58614780|FG001|Up to Year 3|Lost to Follow-up|2|||
30603399|NCT01262976|58614781|FG002|Up to Year 3|Lost to Follow-up|4|||
30603400|NCT01262976|58614782|FG003|Up to Year 3|Lost to Follow-up|3|||
30603401|NCT01262976|58614783|FG004|Up to Year 3|Lost to Follow-up|1|||
30603402|NCT01262976|58614784|FG005|Up to Year 3|Lost to Follow-up|3|||
30603403|NCT01262976|58614779|FG000|Up to Year 3|Subjects with unknown completion status|0|||
30603404|NCT01262976|58614780|FG001|Up to Year 3|Subjects with unknown completion status|0|||
30603405|NCT01262976|58614781|FG002|Up to Year 3|Subjects with unknown completion status|1|||
30603406|NCT01262976|58614782|FG003|Up to Year 3|Subjects with unknown completion status|0|||
30603407|NCT01262976|58614783|FG004|Up to Year 3|Subjects with unknown completion status|0|||
30603408|NCT01262976|58614784|FG005|Up to Year 3|Subjects with unknown completion status|0|||
30603409|NCT01262976|58614779|FG000|Up to Year 3|Other|3|||
30603410|NCT01262976|58614780|FG001|Up to Year 3|Other|0|||
30603411|NCT01262976|58614781|FG002|Up to Year 3|Other|0|||
30603412|NCT01262976|58614782|FG003|Up to Year 3|Other|0|||
30694765|NCT00348283|58709017|FG001|Open Label|Withdrawal by Subject|4|||
30603413|NCT01262976|58614783|FG004|Up to Year 3|Other|0|||
30694766|NCT00348283|58709016|FG000|Open Label|Lost to Follow-up|0|||
30603414|NCT01262976|58614784|FG005|Up to Year 3|Other|0|||
30603415|NCT01300286|58614799|FG000|Overall Study|did not get dosed|1|||
30603416|NCT01300052|58614806|FG000|Overall Study|Adverse Event|3|||
30603417|NCT01300052|58614807|FG001|Overall Study|Adverse Event|0|||
30603418|NCT01300052|58614806|FG000|Overall Study|Withdrawal by Subject|2|||
30603419|NCT01300052|58614807|FG001|Overall Study|Withdrawal by Subject|2|||
30603420|NCT01300052|58614806|FG000|Overall Study|Protocol Violation|1|||
30603421|NCT01300052|58614807|FG001|Overall Study|Protocol Violation|1|||
30603422|NCT01299896|58614815|FG000|Overall Study|Withdrawal by Subject|1|||
30603423|NCT01299896|58614816|FG001|Overall Study|Withdrawal by Subject|7|||
30603424|NCT01299896|58614815|FG000|Overall Study|Lost to Follow-up|0|||
30603425|NCT01299896|58614816|FG001|Overall Study|Lost to Follow-up|11|||
30603426|NCT01299584|58614822|FG000|Overall Study|Protocol Violation|9|||
30603427|NCT01236573|58614837|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
30603428|NCT01236573|58614838|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
30603429|NCT01236573|58614839|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
30603430|NCT01236573|58614840|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
30603431|NCT01236573|58614841|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
30603432|NCT01236573|58614842|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
30603433|NCT01236573|58614843|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
30603434|NCT01236573|58614844|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
30603435|NCT01236573|58614845|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
30603436|NCT01236573|58614846|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
30603437|NCT01236573|58614847|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
30603438|NCT01236573|58614837|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
30603439|NCT01236573|58614838|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
30603440|NCT01236573|58614839|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
30603441|NCT01236573|58614840|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
30603442|NCT01236573|58614841|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
30603443|NCT01236573|58614842|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
30603444|NCT01236573|58614843|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
30603445|NCT01236573|58614844|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
30603446|NCT01236573|58614845|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
30603447|NCT01236573|58614846|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
30603448|NCT01236573|58614847|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
30603449|NCT01236573|58614837|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
30603450|NCT01236573|58614838|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
30603451|NCT01236573|58614839|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
30603452|NCT01236573|58614840|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
30603453|NCT01236573|58614841|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
30603454|NCT01236573|58614842|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
30603455|NCT01236573|58614843|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
30603456|NCT01236573|58614844|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
30603457|NCT01236573|58614845|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
30603458|NCT01236573|58614846|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
30603459|NCT01236573|58614847|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
30873857|NCT02213133|58904560|FG000|Overall Study|Other|5|||
30873858|NCT02213133|58904561|FG001|Overall Study|Other|0|||
30873859|NCT02213133|58904562|FG002|Overall Study|Other|0|||
30873860|NCT02684981|58904574|FG000|Overall Study|Permanently discontinued the treatment|157|||
30873861|NCT02684981|58904575|FG001|Overall Study|Permanently discontinued the treatment|161|||
30873862|NCT02684981|58904576|FG002|Overall Study|Permanently discontinued the treatment|110|||
30873863|NCT02684981|58904574|FG000|Overall Study|Other|83|||
30873864|NCT02684981|58904575|FG001|Overall Study|Other|49|||
30873865|NCT02684981|58904576|FG002|Overall Study|Other|17|||
30603460|NCT01236339|58614874|FG000|Overall Study|Termination of study by sponsor|11|||
30603461|NCT01236339|58614875|FG001|Overall Study|Termination of study by sponsor|13|||
30603462|NCT01262898|58614886|FG000|Overall Study|Protocol Violation|1|||
30603463|NCT01262898|58614887|FG001|Overall Study|Protocol Violation|1|||
30603464|NCT01262898|58614888|FG002|Overall Study|Protocol Violation|0|||
30603465|NCT01262898|58614889|FG003|Overall Study|Protocol Violation|0|||
30603466|NCT01262898|58614886|FG000|Overall Study|Lost to Follow-up|1|||
30603467|NCT01262898|58614887|FG001|Overall Study|Lost to Follow-up|0|||
30603468|NCT01262898|58614888|FG002|Overall Study|Lost to Follow-up|0|||
30603469|NCT01262898|58614889|FG003|Overall Study|Lost to Follow-up|0|||
30603470|NCT01262898|58614886|FG000|Overall Study|Withdrawal by Subject|1|||
30603471|NCT01262898|58614887|FG001|Overall Study|Withdrawal by Subject|1|||
30603472|NCT01262898|58614888|FG002|Overall Study|Withdrawal by Subject|0|||
30694767|NCT00348283|58709017|FG001|Open Label|Lost to Follow-up|1|||
30694768|NCT00348283|58709016|FG000|Open Label|Lack of Efficacy|0|||
30873866|NCT02146833|58904590|FG000|Overall Study|Death|10|||
30603473|NCT01262898|58614889|FG003|Overall Study|Withdrawal by Subject|0|||
30603474|NCT01262820|58614902|FG000|Overall Study|Adverse Event|5|||
30603475|NCT01262820|58614902|FG000|Overall Study|Lack of Efficacy|9|||
30603476|NCT01262820|58614902|FG000|Overall Study|Drug held for 21+ days|1|||
30603477|NCT01057810|58614908|FG000|Overall Study|Disease progression|156|||
30603478|NCT01057810|58614909|FG001|Overall Study|Disease progression|197|||
30603479|NCT01057810|58614908|FG000|Overall Study|Study drug toxicity|5|||
30603480|NCT01057810|58614909|FG001|Overall Study|Study drug toxicity|114|||
30603481|NCT01057810|58614908|FG000|Overall Study|Adverse event unrelated to study drug|13|||
30603482|NCT01057810|58614909|FG001|Overall Study|Adverse event unrelated to study drug|29|||
30603483|NCT01057810|58614908|FG000|Overall Study|Withdrawal by Subject|10|||
30603484|NCT01057810|58614909|FG001|Overall Study|Withdrawal by Subject|25|||
30603485|NCT01057810|58614908|FG000|Overall Study|Death|2|||
30603486|NCT01057810|58614909|FG001|Overall Study|Death|12|||
30603487|NCT01057810|58614908|FG000|Overall Study|Maximum clinical benefit|5|||
30603488|NCT01057810|58614909|FG001|Overall Study|Maximum clinical benefit|5|||
30603489|NCT01057810|58614908|FG000|Overall Study|Poor/non-compliance|0|||
30603490|NCT01057810|58614909|FG001|Overall Study|Poor/non-compliance|1|||
30603491|NCT01057810|58614908|FG000|Overall Study|No longer met study criteria|0|||
30603492|NCT01057810|58614909|FG001|Overall Study|No longer met study criteria|1|||
30603493|NCT01057810|58614908|FG000|Overall Study|Other|7|||
30603494|NCT01057810|58614909|FG001|Overall Study|Other|14|||
30603495|NCT01262352|58614917|FG000|Period 1|Illness after randomization|1|||
30603496|NCT01262352|58614918|FG001|Period 1|Illness after randomization|0|||
30603497|NCT01262352|58614917|FG000|Washout|Adverse Event|1|||
30603498|NCT01262352|58614918|FG001|Washout|Adverse Event|1|||
30603499|NCT01262352|58614917|FG000|Washout|Extended Washout|0|||
30603500|NCT01262352|58614918|FG001|Washout|Extended Washout|1|||
30603501|NCT01299272|58614924|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
30603502|NCT01299272|58614925|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
30603503|NCT01299272|58614926|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
30603504|NCT01299272|58614927|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
30603505|NCT01299272|58614924|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
30603506|NCT01299272|58614925|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
30603507|NCT01299272|58614926|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
30603508|NCT01299272|58614927|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
30603509|NCT01299272|58614924|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
30603510|NCT01299272|58614925|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
30603511|NCT01299272|58614926|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
30603512|NCT01299272|58614927|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
30603513|NCT01299272|58614924|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
30603514|NCT01299272|58614925|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
30603515|NCT01299272|58614926|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
30603516|NCT01299272|58614927|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
30603517|NCT01299272|58614924|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
30603518|NCT01299272|58614925|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
30603519|NCT01299272|58614926|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
30603520|NCT01299272|58614927|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
30603521|NCT01299272|58614924|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
30603522|NCT01299272|58614925|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
30603523|NCT01299272|58614926|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
30603524|NCT01299272|58614927|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
30603525|NCT01299272|58614924|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
30603526|NCT01299272|58614925|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
30603527|NCT01299272|58614926|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
30603528|NCT01299272|58614927|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
30603529|NCT01299272|58614924|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
30603530|NCT01299272|58614925|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
30603531|NCT01299272|58614926|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
30603532|NCT01299272|58614927|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
30603533|NCT01299272|58614924|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
30603534|NCT01299272|58614925|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
30694769|NCT00348283|58709017|FG001|Open Label|Lack of Efficacy|13|||
30694770|NCT00348283|58709016|FG000|Open Label|Administrative reasons|0|||
30694771|NCT00348283|58709017|FG001|Open Label|Administrative reasons|5|||
30603535|NCT01299272|58614926|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
30603536|NCT01299272|58614927|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
30603537|NCT01299272|58614924|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
30603538|NCT01299272|58614925|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
30603539|NCT01299272|58614926|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
30603540|NCT01299272|58614927|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
30694772|NCT00348283|58709016|FG000|Open Label|Subject moved to the United States|0|||
30603541|NCT01299272|58614924|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
30603542|NCT01299272|58614925|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
30603543|NCT01299272|58614926|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
30603544|NCT01299272|58614927|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
30603545|NCT01299272|58614924|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
30603546|NCT01299272|58614925|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
30603547|NCT01299272|58614926|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
30603548|NCT01299272|58614927|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
30603549|NCT01299272|58614924|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
30603550|NCT01299272|58614925|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
30603551|NCT01299272|58614926|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
30603552|NCT01299272|58614927|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
30603553|NCT01299272|58614924|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
30603554|NCT01299272|58614925|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
30603555|NCT01299272|58614926|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
30603556|NCT01299272|58614927|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
30603557|NCT01299272|58614924|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
30603558|NCT01299272|58614925|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
30603559|NCT01299272|58614926|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
30603560|NCT01299272|58614927|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
30603561|NCT01299272|58614924|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
30603562|NCT01299272|58614925|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
30603563|NCT01299272|58614926|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
30603564|NCT01299272|58614927|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
30603565|NCT01299272|58614924|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
30603566|NCT01299272|58614925|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
30603567|NCT01299272|58614926|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
30603568|NCT01299272|58614927|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
30603569|NCT01299272|58614924|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
30603570|NCT01299272|58614925|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
30603571|NCT01299272|58614926|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
30603572|NCT01299272|58614927|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
30603573|NCT01299272|58614924|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
30603574|NCT01299272|58614925|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
30603575|NCT01299272|58614926|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
30603576|NCT01299272|58614927|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
30603577|NCT01299272|58614924|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
30603578|NCT01299272|58614925|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
30603579|NCT01299272|58614926|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
30603580|NCT01299272|58614927|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
30603581|NCT01299272|58614924|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
30603582|NCT01299272|58614925|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
30603583|NCT01299272|58614926|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
30603584|NCT01299272|58614927|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
30603585|NCT01299272|58614924|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
30603586|NCT01299272|58614925|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
30603587|NCT01299272|58614926|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
30603588|NCT01299272|58614927|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
30603589|NCT01299272|58614924|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
30603590|NCT01299272|58614925|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
30603591|NCT01299272|58614926|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
30603592|NCT01299272|58614927|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
30603593|NCT01299272|58614924|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
30603594|NCT01299272|58614925|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
30603595|NCT01299272|58614926|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
30603596|NCT01299272|58614927|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
30603597|NCT01299272|58614924|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
30603598|NCT01299272|58614925|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
30603599|NCT01299272|58614926|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
30603600|NCT01299272|58614927|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
30603601|NCT01299116|58614944|FG000|Overall Study|Lost to Follow-up|65|||
30603602|NCT01299116|58614945|FG001|Overall Study|Lost to Follow-up|9|||
30603603|NCT01299116|58614946|FG002|Overall Study|Lost to Follow-up|11|||
30603604|NCT01299038|58614959|FG000|Overall Study|Withdrawal by Subject|1|||
30603605|NCT01299038|58614960|FG001|Overall Study|Withdrawal by Subject|0|||
30603606|NCT01298648|58614966|FG000|Overall Study|Withdrawal by Subject|2|||
30603607|NCT01298648|58614966|FG000|Overall Study|Lost to Follow-up|21|||
30603608|NCT01261338|58614972|FG000|Overall Study|Withdrawal by Subject|3|||
30603609|NCT01261338|58614973|FG001|Overall Study|Withdrawal by Subject|2|||
30603610|NCT01260948|58614981|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
30603611|NCT01260948|58614982|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
30603612|NCT01260948|58614981|FG000|Second Intervention|Emesis|0|||
30603613|NCT01260948|58614982|FG001|Second Intervention|Emesis|1|||
30603614|NCT01025284|58614991|FG000|Overall Study|Investigator Decision|0|||
30603615|NCT01025284|58614992|FG001|Overall Study|Investigator Decision|1|||
30603616|NCT01025284|58614993|FG002|Overall Study|Investigator Decision|0|||
30603617|NCT01025284|58614991|FG000|Overall Study|Withdrawal by Subject|0|||
30603618|NCT01025284|58614992|FG001|Overall Study|Withdrawal by Subject|1|||
30603619|NCT01025284|58614993|FG002|Overall Study|Withdrawal by Subject|0|||
30603620|NCT01021852|58615011|FG000|Treatment Period 1|Adverse Event|3|||
30603621|NCT01021852|58615012|FG001|Treatment Period 1|Adverse Event|1|||
30603622|NCT01021852|58615013|FG002|Treatment Period 1|Adverse Event|1|||
30603623|NCT01021852|58615014|FG003|Treatment Period 1|Adverse Event|0|||
30603624|NCT01021852|58615015|FG004|Treatment Period 1|Adverse Event|2|||
30603625|NCT01021852|58615016|FG005|Treatment Period 1|Adverse Event|2|||
30603626|NCT01021852|58615017|FG006|Treatment Period 1|Adverse Event|0|||
30603627|NCT01021852|58615018|FG007|Treatment Period 1|Adverse Event|0|||
30603628|NCT01021852|58615011|FG000|Treatment Period 1|Pregnancy|0|||
30603629|NCT01021852|58615012|FG001|Treatment Period 1|Pregnancy|0|||
30603630|NCT01021852|58615013|FG002|Treatment Period 1|Pregnancy|1|||
30603631|NCT01021852|58615014|FG003|Treatment Period 1|Pregnancy|0|||
30603632|NCT01021852|58615015|FG004|Treatment Period 1|Pregnancy|0|||
30603633|NCT01021852|58615016|FG005|Treatment Period 1|Pregnancy|0|||
30603634|NCT01021852|58615017|FG006|Treatment Period 1|Pregnancy|0|||
30603635|NCT01021852|58615018|FG007|Treatment Period 1|Pregnancy|0|||
30603636|NCT01021852|58615011|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30603637|NCT01021852|58615012|FG001|Treatment Period 1|Withdrawal by Subject|0|||
30603638|NCT01021852|58615013|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30603639|NCT01021852|58615014|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30603640|NCT01021852|58615015|FG004|Treatment Period 1|Withdrawal by Subject|1|||
30603641|NCT01021852|58615016|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30603642|NCT01021852|58615017|FG006|Treatment Period 1|Withdrawal by Subject|0|||
30603643|NCT01021852|58615018|FG007|Treatment Period 1|Withdrawal by Subject|1|||
30603644|NCT01021852|58615011|FG000|Treatment Period 1|Not Treated|0|||
30603645|NCT01021852|58615012|FG001|Treatment Period 1|Not Treated|0|||
30603646|NCT01021852|58615013|FG002|Treatment Period 1|Not Treated|0|||
30603647|NCT01021852|58615014|FG003|Treatment Period 1|Not Treated|2|||
30603648|NCT01021852|58615015|FG004|Treatment Period 1|Not Treated|0|||
30603649|NCT01021852|58615016|FG005|Treatment Period 1|Not Treated|0|||
30603650|NCT01021852|58615017|FG006|Treatment Period 1|Not Treated|0|||
30603651|NCT01021852|58615018|FG007|Treatment Period 1|Not Treated|0|||
30603652|NCT01021852|58615011|FG000|Washout Period-Placebo|Adverse Event|0|||
30603653|NCT01021852|58615012|FG001|Washout Period-Placebo|Adverse Event|0|||
30603654|NCT01021852|58615013|FG002|Washout Period-Placebo|Adverse Event|0|||
30603655|NCT01021852|58615014|FG003|Washout Period-Placebo|Adverse Event|1|||
30603656|NCT01021852|58615015|FG004|Washout Period-Placebo|Adverse Event|0|||
30603657|NCT01021852|58615016|FG005|Washout Period-Placebo|Adverse Event|1|||
30603658|NCT01021852|58615017|FG006|Washout Period-Placebo|Adverse Event|0|||
30603659|NCT01021852|58615018|FG007|Washout Period-Placebo|Adverse Event|0|||
30603660|NCT01021852|58615011|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
30603661|NCT01021852|58615012|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
30603662|NCT01021852|58615013|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
30603663|NCT01021852|58615014|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
30603664|NCT01021852|58615015|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
30603665|NCT01021852|58615016|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
30603666|NCT01021852|58615017|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
30603667|NCT01021852|58615018|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
30603668|NCT01021852|58615011|FG000|Washout Period-Placebo|Protocol Violation|0|||
30603669|NCT01021852|58615012|FG001|Washout Period-Placebo|Protocol Violation|0|||
30694773|NCT00348283|58709017|FG001|Open Label|Subject moved to the United States|1|||
30694774|NCT00348283|58709016|FG000|Open Label|Pregnancy|0|||
30603670|NCT01021852|58615013|FG002|Washout Period-Placebo|Protocol Violation|0|||
30603671|NCT01021852|58615014|FG003|Washout Period-Placebo|Protocol Violation|0|||
30603672|NCT01021852|58615015|FG004|Washout Period-Placebo|Protocol Violation|0|||
30603673|NCT01021852|58615016|FG005|Washout Period-Placebo|Protocol Violation|0|||
30603674|NCT01021852|58615017|FG006|Washout Period-Placebo|Protocol Violation|1|||
30603675|NCT01021852|58615018|FG007|Washout Period-Placebo|Protocol Violation|0|||
30603676|NCT01021852|58615011|FG000|Washout Period-No Drug|Adverse Event|1|||
30603677|NCT01021852|58615012|FG001|Washout Period-No Drug|Adverse Event|0|||
30603678|NCT01021852|58615013|FG002|Washout Period-No Drug|Adverse Event|0|||
30603679|NCT01021852|58615014|FG003|Washout Period-No Drug|Adverse Event|0|||
30603680|NCT01021852|58615015|FG004|Washout Period-No Drug|Adverse Event|0|||
30603681|NCT01021852|58615016|FG005|Washout Period-No Drug|Adverse Event|1|||
30603682|NCT01021852|58615017|FG006|Washout Period-No Drug|Adverse Event|0|||
30603683|NCT01021852|58615018|FG007|Washout Period-No Drug|Adverse Event|0|||
30603684|NCT01021852|58615011|FG000|Treatment Period 2|Adverse Event|0|||
30603685|NCT01021852|58615012|FG001|Treatment Period 2|Adverse Event|1|||
30603686|NCT01021852|58615013|FG002|Treatment Period 2|Adverse Event|0|||
30603687|NCT01021852|58615014|FG003|Treatment Period 2|Adverse Event|0|||
30603688|NCT01021852|58615015|FG004|Treatment Period 2|Adverse Event|1|||
30603689|NCT01021852|58615016|FG005|Treatment Period 2|Adverse Event|0|||
30603690|NCT01021852|58615017|FG006|Treatment Period 2|Adverse Event|1|||
30603691|NCT01021852|58615018|FG007|Treatment Period 2|Adverse Event|0|||
30603692|NCT01021852|58615011|FG000|Treatment Period 2|Lack of Efficacy|0|||
30603693|NCT01021852|58615012|FG001|Treatment Period 2|Lack of Efficacy|0|||
30603694|NCT01021852|58615013|FG002|Treatment Period 2|Lack of Efficacy|0|||
30603695|NCT01021852|58615014|FG003|Treatment Period 2|Lack of Efficacy|0|||
30603696|NCT01021852|58615015|FG004|Treatment Period 2|Lack of Efficacy|0|||
30603697|NCT01021852|58615016|FG005|Treatment Period 2|Lack of Efficacy|1|||
30603698|NCT01021852|58615017|FG006|Treatment Period 2|Lack of Efficacy|0|||
30603699|NCT01021852|58615018|FG007|Treatment Period 2|Lack of Efficacy|0|||
30603700|NCT01021852|58615011|FG000|Treatment Period 2|Physician Decision|0|||
30603701|NCT01021852|58615012|FG001|Treatment Period 2|Physician Decision|0|||
30603702|NCT01021852|58615013|FG002|Treatment Period 2|Physician Decision|1|||
30603703|NCT01021852|58615014|FG003|Treatment Period 2|Physician Decision|0|||
30603704|NCT01021852|58615015|FG004|Treatment Period 2|Physician Decision|0|||
30603705|NCT01021852|58615016|FG005|Treatment Period 2|Physician Decision|0|||
30603706|NCT01021852|58615017|FG006|Treatment Period 2|Physician Decision|0|||
30603707|NCT01021852|58615018|FG007|Treatment Period 2|Physician Decision|0|||
30603708|NCT01021852|58615011|FG000|Treatment Period 2|Protocol Violation|0|||
30603709|NCT01021852|58615012|FG001|Treatment Period 2|Protocol Violation|0|||
30603710|NCT01021852|58615013|FG002|Treatment Period 2|Protocol Violation|0|||
30603711|NCT01021852|58615014|FG003|Treatment Period 2|Protocol Violation|0|||
30603712|NCT01021852|58615015|FG004|Treatment Period 2|Protocol Violation|1|||
30603713|NCT01021852|58615016|FG005|Treatment Period 2|Protocol Violation|0|||
30603714|NCT01021852|58615017|FG006|Treatment Period 2|Protocol Violation|1|||
30603715|NCT01021852|58615018|FG007|Treatment Period 2|Protocol Violation|0|||
30603716|NCT01021852|58615011|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30603717|NCT01021852|58615012|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30603718|NCT01021852|58615013|FG002|Treatment Period 2|Withdrawal by Subject|0|||
30603719|NCT01021852|58615014|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30603720|NCT01021852|58615015|FG004|Treatment Period 2|Withdrawal by Subject|0|||
30603721|NCT01021852|58615016|FG005|Treatment Period 2|Withdrawal by Subject|0|||
30603722|NCT01021852|58615017|FG006|Treatment Period 2|Withdrawal by Subject|1|||
30603723|NCT01021852|58615018|FG007|Treatment Period 2|Withdrawal by Subject|2|||
30603724|NCT01056718|58615032|FG000|Overall Study|Withdrawal by Subject|2|||
30603725|NCT01056718|58615032|FG000|Overall Study|Ischemia on baseline stress test|1|||
30603726|NCT01298570|58615039|FG000|Overall Study|Disease progression, relapse during acti|64|||
30603727|NCT01298570|58615040|FG001|Overall Study|Disease progression, relapse during acti|40|||
30603728|NCT01298570|58615039|FG000|Overall Study|Adverse Event|20|||
30603729|NCT01298570|58615040|FG001|Overall Study|Adverse Event|2|||
30603730|NCT01298570|58615039|FG000|Overall Study|Withdrawal by Subject|21|||
30603731|NCT01298570|58615040|FG001|Overall Study|Withdrawal by Subject|6|||
30603732|NCT01298570|58615039|FG000|Overall Study|Treatment delay > 4 weeks|4|||
30603733|NCT01298570|58615040|FG001|Overall Study|Treatment delay > 4 weeks|5|||
30603734|NCT01298570|58615039|FG000|Overall Study|Physician Decision|4|||
30603735|NCT01298570|58615040|FG001|Overall Study|Physician Decision|2|||
30603736|NCT01298570|58615039|FG000|Overall Study|Other complicating disease|2|||
30603737|NCT01298570|58615040|FG001|Overall Study|Other complicating disease|1|||
30603738|NCT01298570|58615039|FG000|Overall Study|Surgery|2|||
30603739|NCT01298570|58615040|FG001|Overall Study|Surgery|1|||
30603740|NCT01298570|58615039|FG000|Overall Study|Symptomatic progression/deterioration|3|||
30603741|NCT01298570|58615040|FG001|Overall Study|Symptomatic progression/deterioration|2|||
30603742|NCT01298570|58615039|FG000|Overall Study|Death|0|||
30603743|NCT01298570|58615040|FG001|Overall Study|Death|1|||
30603744|NCT01298570|58615039|FG000|Overall Study|Ineligibility|0|||
30603745|NCT01298570|58615040|FG001|Overall Study|Ineligibility|1|||
30603746|NCT01259856|58615048|FG000|Overall Study|Adverse Event|12|||
30603747|NCT01259856|58615049|FG001|Overall Study|Adverse Event|9|||
30603748|NCT01259856|58615048|FG000|Overall Study|Death|0|||
30603749|NCT01259856|58615049|FG001|Overall Study|Death|1|||
30603750|NCT01259856|58615048|FG000|Overall Study|Lack of Efficacy|3|||
30603751|NCT01259856|58615049|FG001|Overall Study|Lack of Efficacy|1|||
30603752|NCT01259856|58615048|FG000|Overall Study|Lost to Follow-up|1|||
30603753|NCT01259856|58615049|FG001|Overall Study|Lost to Follow-up|1|||
30603754|NCT01259856|58615048|FG000|Overall Study|Physician Decision|2|||
30603755|NCT01259856|58615049|FG001|Overall Study|Physician Decision|1|||
30603756|NCT01259856|58615048|FG000|Overall Study|Withdrawal by Subject|9|||
30694775|NCT00348283|58709017|FG001|Open Label|Pregnancy|1|||
30603757|NCT01259856|58615049|FG001|Overall Study|Withdrawal by Subject|10|||
30603758|NCT01259856|58615048|FG000|Overall Study|Treatment never started|0|||
30603759|NCT01259856|58615049|FG001|Overall Study|Treatment never started|6|||
30603760|NCT01259856|58615048|FG000|Overall Study|Study closure by sponsor|40|||
30603761|NCT01259856|58615049|FG001|Overall Study|Study closure by sponsor|41|||
30603762|NCT01259856|58615048|FG000|Overall Study|Patient developed other disease|0|||
30603763|NCT01259856|58615049|FG001|Overall Study|Patient developed other disease|1|||
30603764|NCT01259856|58615048|FG000|Overall Study|Transfer to another study|0|||
30603765|NCT01259856|58615049|FG001|Overall Study|Transfer to another study|1|||
30603766|NCT01259856|58615048|FG000|Overall Study|Unknown/missing|2|||
30603767|NCT01259856|58615049|FG001|Overall Study|Unknown/missing|2|||
30603768|NCT01020838|58615055|FG000|Overall Study|Death|90|||
30603769|NCT01020838|58615055|FG000|Overall Study|Adverse Event|1|||
30603770|NCT01020838|58615055|FG000|Overall Study|Withdrawal by Subject|9|||
30603771|NCT01020838|58615055|FG000|Overall Study|Lost to Follow-up|6|||
30603772|NCT01020838|58615055|FG000|Overall Study|Most common: Study ended by sponsor|77|||
30603773|NCT01259466|58615070|FG000|Overall Study|Withdrawal by Subject|1|||
30603774|NCT01259466|58615071|FG001|Overall Study|Withdrawal by Subject|9|||
30603775|NCT01259388|58615079|FG000|Overall Study|Adverse Event|3|||
30603776|NCT01259388|58615080|FG001|Overall Study|Adverse Event|0|||
30603777|NCT01259388|58615079|FG000|Overall Study|Withdrawal by Subject|1|||
30603778|NCT01259388|58615080|FG001|Overall Study|Withdrawal by Subject|1|||
30603779|NCT01259388|58615079|FG000|Overall Study|Physician Decision|1|||
30603780|NCT01259388|58615080|FG001|Overall Study|Physician Decision|0|||
30603781|NCT01298492|58615086|FG000|Overall Study|Death|2|||
30603782|NCT01298492|58615086|FG000|Overall Study|Insufficient Clinical Response|22|||
30603783|NCT01298492|58615086|FG000|Overall Study|Lost to Follow-up|12|||
30603784|NCT01298492|58615086|FG000|Overall Study|Withdrawal by Subject|47|||
30603785|NCT01298492|58615086|FG000|Overall Study|Other (Unspecified)|7|||
30603786|NCT01298492|58615086|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
30603787|NCT01298492|58615086|FG000|Overall Study|Protocol Violation|2|||
30603788|NCT01298492|58615086|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
30603789|NCT01298492|58615086|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
30603790|NCT01297322|58615092|FG000|Overall Study|Lost to Follow-up|1|||
30603791|NCT01297322|58615093|FG001|Overall Study|Lost to Follow-up|0|||
30603792|NCT01297322|58615092|FG000|Overall Study|Withdrawal by Subject|0|||
30603793|NCT01297322|58615093|FG001|Overall Study|Withdrawal by Subject|1|||
30603794|NCT01297322|58615092|FG000|Overall Study|Protocol Violation|0|||
30603795|NCT01297322|58615093|FG001|Overall Study|Protocol Violation|3|||
30603796|NCT01297244|58615102|FG000|Overall Study|Progressive disease|22|||
30603797|NCT01297244|58615103|FG001|Overall Study|Progressive disease|3|||
30603798|NCT01297244|58615102|FG000|Overall Study|Adverse Event|9|||
30603799|NCT01297244|58615103|FG001|Overall Study|Adverse Event|1|||
30603800|NCT01297244|58615102|FG000|Overall Study|Death|1|||
30603801|NCT01297244|58615103|FG001|Overall Study|Death|1|||
30603802|NCT01297244|58615102|FG000|Overall Study|Clinical progression|1|||
30603803|NCT01297244|58615103|FG001|Overall Study|Clinical progression|1|||
30603804|NCT01297244|58615102|FG000|Overall Study|Withdrawal by Subject|2|||
30603805|NCT01297244|58615103|FG001|Overall Study|Withdrawal by Subject|0|||
30603806|NCT03456726|58615116|FG000|Overall Study|Disease Progression|6|||
30603807|NCT03456726|58615117|FG001|Overall Study|Disease Progression|1|||
30603808|NCT03456726|58615116|FG000|Overall Study|Adverse Event|4|||
30603809|NCT03456726|58615117|FG001|Overall Study|Adverse Event|2|||
30603810|NCT03456726|58615116|FG000|Overall Study|Withdrawal by Subject|1|||
30603811|NCT03456726|58615117|FG001|Overall Study|Withdrawal by Subject|0|||
30603812|NCT03456726|58615116|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
30603813|NCT03456726|58615117|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
30603814|NCT03181932|58615125|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
30603815|NCT03181932|58615126|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
30603816|NCT03181932|58615125|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
30603817|NCT03181932|58615126|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
30603818|NCT03181932|58615125|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
30603819|NCT03181932|58615126|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
30603820|NCT03181932|58615125|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
30603821|NCT03181932|58615126|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
30603822|NCT03181932|58615125|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
30694776|NCT00348283|58709016|FG000|Open Label|Sponsor decision|0|||
30603823|NCT03181932|58615126|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
30694777|NCT00348283|58709017|FG001|Open Label|Sponsor decision|1|||
30694778|NCT00336895|58709023|FG000|Overall Study|diarrhea|1|||
30694779|NCT00336895|58709023|FG000|Overall Study|nausea and upset stomach|1|||
30603824|NCT03181932|58615125|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
30603825|NCT03181932|58615126|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
30603826|NCT03181932|58615125|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
30603827|NCT03181932|58615126|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
30603828|NCT03181932|58615125|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
30603829|NCT03181932|58615126|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
30603830|NCT03181932|58615125|FG000|Period 2 (Open-label Period)|Reason missing|2|||
30603831|NCT03181932|58615126|FG001|Period 2 (Open-label Period)|Reason missing|0|||
30603832|NCT02864862|58615136|FG000|Overall Study|Lost to Follow-up|1|||
30603833|NCT02864862|58615137|FG001|Overall Study|Lost to Follow-up|0|||
30603834|NCT02864862|58615138|FG002|Overall Study|Lost to Follow-up|1|||
30603835|NCT02864862|58615136|FG000|Overall Study|Protocol Violation|0|||
30603836|NCT02864862|58615137|FG001|Overall Study|Protocol Violation|0|||
30603837|NCT02864862|58615138|FG002|Overall Study|Protocol Violation|1|||
30603838|NCT01598298|58615150|FG000|Overall Study|Not eligible|5|||
30603839|NCT01598298|58615151|FG001|Overall Study|Not eligible|5|||
30603840|NCT01598298|58615150|FG000|Overall Study|Adverse Event|21|||
30603841|NCT01598298|58615151|FG001|Overall Study|Adverse Event|19|||
30603842|NCT01598298|58615150|FG000|Overall Study|Progression/relapse|0|||
30603843|NCT01598298|58615151|FG001|Overall Study|Progression/relapse|2|||
30603844|NCT01598298|58615150|FG000|Overall Study|Withdrawal by Subject|10|||
30603845|NCT01598298|58615151|FG001|Overall Study|Withdrawal by Subject|15|||
30603846|NCT01598298|58615150|FG000|Overall Study|Other reason (not protocol specified)|4|||
30603847|NCT01598298|58615151|FG001|Overall Study|Other reason (not protocol specified)|0|||
30603848|NCT01235949|58615175|FG000|Primary Phase|Migrated/moved from study area|1|||
30603849|NCT01235949|58615176|FG001|Primary Phase|Migrated/moved from study area|1|||
30603850|NCT01235949|58615177|FG002|Primary Phase|Migrated/moved from study area|0|||
30603851|NCT01235949|58615178|FG003|Primary Phase|Migrated/moved from study area|0|||
30603852|NCT01235949|58615179|FG004|Primary Phase|Migrated/moved from study area|1|||
30603853|NCT01235949|58615180|FG005|Primary Phase|Migrated/moved from study area|2|||
30603854|NCT01235949|58615181|FG006|Primary Phase|Migrated/moved from study area|0|||
30603855|NCT01235949|58615182|FG007|Primary Phase|Migrated/moved from study area|0|||
30603856|NCT01235949|58615183|FG008|Primary Phase|Migrated/moved from study area|0|||
30603857|NCT01235949|58615184|FG009|Primary Phase|Migrated/moved from study area|0|||
30603858|NCT01235949|58615185|FG010|Primary Phase|Migrated/moved from study area|0|||
30603859|NCT01235949|58615186|FG011|Primary Phase|Migrated/moved from study area|0|||
30603860|NCT01235949|58615187|FG012|Primary Phase|Migrated/moved from study area|0|||
30603861|NCT01235949|58615188|FG013|Primary Phase|Migrated/moved from study area|0|||
30603862|NCT01235949|58615189|FG014|Primary Phase|Migrated/moved from study area|0|||
30603863|NCT01235949|58615190|FG015|Primary Phase|Migrated/moved from study area|0|||
30603864|NCT01235949|58615191|FG016|Primary Phase|Migrated/moved from study area|0|||
30603865|NCT01235949|58615192|FG017|Primary Phase|Migrated/moved from study area|0|||
30603866|NCT01235949|58615175|FG000|Primary Phase|Adverse Event|0|||
30603867|NCT01235949|58615176|FG001|Primary Phase|Adverse Event|0|||
30603868|NCT01235949|58615177|FG002|Primary Phase|Adverse Event|0|||
30603869|NCT01235949|58615178|FG003|Primary Phase|Adverse Event|1|||
30603870|NCT01235949|58615179|FG004|Primary Phase|Adverse Event|0|||
30603871|NCT01235949|58615180|FG005|Primary Phase|Adverse Event|0|||
30603872|NCT01235949|58615181|FG006|Primary Phase|Adverse Event|0|||
30603873|NCT01235949|58615182|FG007|Primary Phase|Adverse Event|0|||
30603874|NCT01235949|58615183|FG008|Primary Phase|Adverse Event|0|||
30603875|NCT01235949|58615184|FG009|Primary Phase|Adverse Event|0|||
30603876|NCT01235949|58615185|FG010|Primary Phase|Adverse Event|0|||
30603877|NCT01235949|58615186|FG011|Primary Phase|Adverse Event|0|||
30603878|NCT01235949|58615187|FG012|Primary Phase|Adverse Event|0|||
30603879|NCT01235949|58615188|FG013|Primary Phase|Adverse Event|0|||
30603880|NCT01235949|58615189|FG014|Primary Phase|Adverse Event|0|||
30603881|NCT01235949|58615190|FG015|Primary Phase|Adverse Event|0|||
30603882|NCT01235949|58615191|FG016|Primary Phase|Adverse Event|0|||
30603883|NCT01235949|58615192|FG017|Primary Phase|Adverse Event|0|||
30603884|NCT01235949|58615175|FG000|Primary Phase|Withdrawal by Subject|3|||
30603885|NCT01235949|58615176|FG001|Primary Phase|Withdrawal by Subject|2|||
30603886|NCT01235949|58615177|FG002|Primary Phase|Withdrawal by Subject|2|||
30603887|NCT01235949|58615178|FG003|Primary Phase|Withdrawal by Subject|0|||
30603888|NCT01235949|58615179|FG004|Primary Phase|Withdrawal by Subject|0|||
30603889|NCT01235949|58615180|FG005|Primary Phase|Withdrawal by Subject|3|||
30603890|NCT01235949|58615181|FG006|Primary Phase|Withdrawal by Subject|0|||
30603891|NCT01235949|58615182|FG007|Primary Phase|Withdrawal by Subject|0|||
30603892|NCT01235949|58615183|FG008|Primary Phase|Withdrawal by Subject|0|||
30603893|NCT01235949|58615184|FG009|Primary Phase|Withdrawal by Subject|0|||
30694780|NCT00336895|58709023|FG000|Overall Study|Physician Decision|1|||
30694781|NCT00336895|58709023|FG000|Overall Study|screen failed|1|||
30694782|NCT00336583|58709027|FG000|Overall Study|Lost to Follow-up|1|||
30694783|NCT00336583|58709027|FG000|Overall Study|Death|1|||
30694784|NCT00336505|58709033|FG000|Overall Study|Adverse Event|10|||
30694785|NCT00336505|58709034|FG001|Overall Study|Adverse Event|9|||
30694786|NCT00336505|58709033|FG000|Overall Study|Lack of Efficacy|8|||
30694787|NCT00336505|58709034|FG001|Overall Study|Lack of Efficacy|4|||
30694788|NCT00336505|58709033|FG000|Overall Study|Lost to Follow-up|7|||
30694789|NCT00336505|58709034|FG001|Overall Study|Lost to Follow-up|4|||
30603894|NCT01235949|58615185|FG010|Primary Phase|Withdrawal by Subject|0|||
30603895|NCT01235949|58615186|FG011|Primary Phase|Withdrawal by Subject|0|||
30603896|NCT01235949|58615187|FG012|Primary Phase|Withdrawal by Subject|0|||
30603897|NCT01235949|58615188|FG013|Primary Phase|Withdrawal by Subject|0|||
30603898|NCT01235949|58615189|FG014|Primary Phase|Withdrawal by Subject|0|||
30603899|NCT01235949|58615190|FG015|Primary Phase|Withdrawal by Subject|0|||
30603900|NCT01235949|58615191|FG016|Primary Phase|Withdrawal by Subject|0|||
30603901|NCT01235949|58615192|FG017|Primary Phase|Withdrawal by Subject|0|||
30603902|NCT01235949|58615175|FG000|Primary Phase|Lost to Follow-up|0|||
30603903|NCT01235949|58615176|FG001|Primary Phase|Lost to Follow-up|0|||
30603904|NCT01235949|58615177|FG002|Primary Phase|Lost to Follow-up|1|||
30603905|NCT01235949|58615178|FG003|Primary Phase|Lost to Follow-up|1|||
30603906|NCT01235949|58615179|FG004|Primary Phase|Lost to Follow-up|0|||
30603907|NCT01235949|58615180|FG005|Primary Phase|Lost to Follow-up|2|||
30603908|NCT01235949|58615181|FG006|Primary Phase|Lost to Follow-up|0|||
30603909|NCT01235949|58615182|FG007|Primary Phase|Lost to Follow-up|0|||
30603910|NCT01235949|58615183|FG008|Primary Phase|Lost to Follow-up|0|||
30603911|NCT01235949|58615184|FG009|Primary Phase|Lost to Follow-up|0|||
30603912|NCT01235949|58615185|FG010|Primary Phase|Lost to Follow-up|0|||
30603913|NCT01235949|58615186|FG011|Primary Phase|Lost to Follow-up|0|||
30603914|NCT01235949|58615187|FG012|Primary Phase|Lost to Follow-up|0|||
30603915|NCT01235949|58615188|FG013|Primary Phase|Lost to Follow-up|0|||
30603916|NCT01235949|58615189|FG014|Primary Phase|Lost to Follow-up|0|||
30603917|NCT01235949|58615190|FG015|Primary Phase|Lost to Follow-up|0|||
30603918|NCT01235949|58615191|FG016|Primary Phase|Lost to Follow-up|0|||
30603919|NCT01235949|58615192|FG017|Primary Phase|Lost to Follow-up|0|||
30603920|NCT01235949|58615175|FG000|Booster Phase|Migrated/moved from study area|0|||
30603921|NCT01235949|58615176|FG001|Booster Phase|Migrated/moved from study area|0|||
30603922|NCT01235949|58615177|FG002|Booster Phase|Migrated/moved from study area|0|||
30603923|NCT01235949|58615178|FG003|Booster Phase|Migrated/moved from study area|0|||
30603924|NCT01235949|58615179|FG004|Booster Phase|Migrated/moved from study area|0|||
30603925|NCT01235949|58615180|FG005|Booster Phase|Migrated/moved from study area|0|||
30603926|NCT01235949|58615181|FG006|Booster Phase|Migrated/moved from study area|0|||
30603927|NCT01235949|58615182|FG007|Booster Phase|Migrated/moved from study area|0|||
30603928|NCT01235949|58615183|FG008|Booster Phase|Migrated/moved from study area|0|||
30603929|NCT01235949|58615184|FG009|Booster Phase|Migrated/moved from study area|0|||
30603930|NCT01235949|58615185|FG010|Booster Phase|Migrated/moved from study area|0|||
30603931|NCT01235949|58615186|FG011|Booster Phase|Migrated/moved from study area|1|||
30603932|NCT01235949|58615187|FG012|Booster Phase|Migrated/moved from study area|1|||
30603933|NCT01235949|58615188|FG013|Booster Phase|Migrated/moved from study area|0|||
30603934|NCT01235949|58615189|FG014|Booster Phase|Migrated/moved from study area|0|||
30603935|NCT01235949|58615190|FG015|Booster Phase|Migrated/moved from study area|0|||
30603936|NCT01235949|58615191|FG016|Booster Phase|Migrated/moved from study area|0|||
30603937|NCT01235949|58615192|FG017|Booster Phase|Migrated/moved from study area|1|||
30603938|NCT01235949|58615175|FG000|Booster Phase|Adverse Event|0|||
30603939|NCT01235949|58615176|FG001|Booster Phase|Adverse Event|0|||
30603940|NCT01235949|58615177|FG002|Booster Phase|Adverse Event|0|||
30603941|NCT01235949|58615178|FG003|Booster Phase|Adverse Event|0|||
30603942|NCT01235949|58615179|FG004|Booster Phase|Adverse Event|0|||
30603943|NCT01235949|58615180|FG005|Booster Phase|Adverse Event|0|||
30603944|NCT01235949|58615181|FG006|Booster Phase|Adverse Event|0|||
30603945|NCT01235949|58615182|FG007|Booster Phase|Adverse Event|0|||
30603946|NCT01235949|58615183|FG008|Booster Phase|Adverse Event|0|||
30603947|NCT01235949|58615184|FG009|Booster Phase|Adverse Event|0|||
30603948|NCT01235949|58615185|FG010|Booster Phase|Adverse Event|0|||
30603949|NCT01235949|58615186|FG011|Booster Phase|Adverse Event|0|||
30603950|NCT01235949|58615187|FG012|Booster Phase|Adverse Event|0|||
30603951|NCT01235949|58615188|FG013|Booster Phase|Adverse Event|0|||
30603952|NCT01235949|58615189|FG014|Booster Phase|Adverse Event|0|||
30603953|NCT01235949|58615190|FG015|Booster Phase|Adverse Event|1|||
30603954|NCT01235949|58615191|FG016|Booster Phase|Adverse Event|0|||
30603955|NCT01235949|58615192|FG017|Booster Phase|Adverse Event|0|||
30603956|NCT01235949|58615175|FG000|Booster Phase|Withdrawal by Subject|0|||
30603957|NCT01235949|58615176|FG001|Booster Phase|Withdrawal by Subject|0|||
30603958|NCT01235949|58615177|FG002|Booster Phase|Withdrawal by Subject|0|||
30603959|NCT01235949|58615178|FG003|Booster Phase|Withdrawal by Subject|0|||
30603960|NCT01235949|58615179|FG004|Booster Phase|Withdrawal by Subject|0|||
30603961|NCT01235949|58615180|FG005|Booster Phase|Withdrawal by Subject|0|||
30603962|NCT01235949|58615181|FG006|Booster Phase|Withdrawal by Subject|0|||
30603963|NCT01235949|58615182|FG007|Booster Phase|Withdrawal by Subject|1|||
30603964|NCT01235949|58615183|FG008|Booster Phase|Withdrawal by Subject|1|||
30603965|NCT01235949|58615184|FG009|Booster Phase|Withdrawal by Subject|0|||
30603966|NCT01235949|58615185|FG010|Booster Phase|Withdrawal by Subject|1|||
30603967|NCT01235949|58615186|FG011|Booster Phase|Withdrawal by Subject|1|||
30603968|NCT01235949|58615187|FG012|Booster Phase|Withdrawal by Subject|2|||
30603969|NCT01235949|58615188|FG013|Booster Phase|Withdrawal by Subject|0|||
30877505|NCT01998958|58909052|FG031|Open Label Phase (Optional)|Other|0|||
30603970|NCT01235949|58615189|FG014|Booster Phase|Withdrawal by Subject|2|||
30603971|NCT01235949|58615190|FG015|Booster Phase|Withdrawal by Subject|0|||
30603972|NCT01235949|58615191|FG016|Booster Phase|Withdrawal by Subject|0|||
30603973|NCT01235949|58615192|FG017|Booster Phase|Withdrawal by Subject|0|||
30603974|NCT01235949|58615175|FG000|Booster Phase|Lost to Follow-up|0|||
30603975|NCT01235949|58615176|FG001|Booster Phase|Lost to Follow-up|0|||
30603976|NCT01235949|58615177|FG002|Booster Phase|Lost to Follow-up|0|||
30603977|NCT01235949|58615178|FG003|Booster Phase|Lost to Follow-up|0|||
30603978|NCT01235949|58615179|FG004|Booster Phase|Lost to Follow-up|0|||
30603979|NCT01235949|58615180|FG005|Booster Phase|Lost to Follow-up|0|||
30603980|NCT01235949|58615181|FG006|Booster Phase|Lost to Follow-up|0|||
30603981|NCT01235949|58615182|FG007|Booster Phase|Lost to Follow-up|0|||
30603982|NCT01235949|58615183|FG008|Booster Phase|Lost to Follow-up|1|||
30603983|NCT01235949|58615184|FG009|Booster Phase|Lost to Follow-up|1|||
30603984|NCT01235949|58615185|FG010|Booster Phase|Lost to Follow-up|1|||
30603985|NCT01235949|58615186|FG011|Booster Phase|Lost to Follow-up|1|||
30603986|NCT01235949|58615187|FG012|Booster Phase|Lost to Follow-up|0|||
30603987|NCT01235949|58615188|FG013|Booster Phase|Lost to Follow-up|0|||
30603988|NCT01235949|58615189|FG014|Booster Phase|Lost to Follow-up|0|||
30603989|NCT01235949|58615190|FG015|Booster Phase|Lost to Follow-up|0|||
30603990|NCT01235949|58615191|FG016|Booster Phase|Lost to Follow-up|0|||
30603991|NCT01235949|58615192|FG017|Booster Phase|Lost to Follow-up|1|||
30603992|NCT01235793|58615230|FG000|Overall Study|Death|6|||
30603993|NCT01258998|58615235|FG000|Overall Study|Ineligible|1|||
30603994|NCT01235715|58615241|FG000|Overall Study|Physician Decision|0|||
30603995|NCT01235715|58615242|FG001|Overall Study|Physician Decision|2|||
30603996|NCT01235403|58615249|FG000|Overall Study|Adverse Event|14|||
30603997|NCT01235403|58615249|FG000|Overall Study|Lost to Follow-up|2|||
30603998|NCT01235403|58615249|FG000|Overall Study|Withdrawal by Subject|4|||
30603999|NCT01235403|58615249|FG000|Overall Study|Lack of Efficacy|2|||
30604000|NCT01235403|58615249|FG000|Overall Study|Other reasons for premature termination|4|||
30604001|NCT01024036|58615255|FG000|Blinded Treatment|Adverse Event|1|||
30604002|NCT01024036|58615256|FG001|Blinded Treatment|Adverse Event|1|||
30604003|NCT01024036|58615255|FG000|Blinded Treatment|Lack of Efficacy|16|||
30604004|NCT01024036|58615256|FG001|Blinded Treatment|Lack of Efficacy|14|||
30604005|NCT01024036|58615255|FG000|Blinded Treatment|Physician Decision|1|||
30604006|NCT01024036|58615256|FG001|Blinded Treatment|Physician Decision|0|||
30604007|NCT01024036|58615255|FG000|Blinded Treatment|Death|0|||
30604008|NCT01024036|58615256|FG001|Blinded Treatment|Death|2|||
30604009|NCT01024036|58615255|FG000|Blinded Treatment|Withdrawal by Subject|4|||
30604010|NCT01024036|58615256|FG001|Blinded Treatment|Withdrawal by Subject|3|||
30604011|NCT01024036|58615255|FG000|Unblinded Treatment|Adverse Event|0|||
30604012|NCT01024036|58615256|FG001|Unblinded Treatment|Adverse Event|1|||
30604013|NCT01024036|58615255|FG000|Unblinded Treatment|Lack of Efficacy|0|||
30604014|NCT01024036|58615256|FG001|Unblinded Treatment|Lack of Efficacy|2|||
30604015|NCT01024036|58615255|FG000|Follow-Up Period|Lost to Follow-up|1|||
30604016|NCT01024036|58615256|FG001|Follow-Up Period|Lost to Follow-up|1|||
30604017|NCT01024036|58615255|FG000|Follow-Up Period|Withdrawal by Subject|0|||
30604018|NCT01024036|58615256|FG001|Follow-Up Period|Withdrawal by Subject|1|||
30604019|NCT01024036|58615255|FG000|Follow-Up Period|Adverse Event|4|||
30604020|NCT01024036|58615256|FG001|Follow-Up Period|Adverse Event|1|||
30604021|NCT01234467|58615265|FG000|Overall Study|Adverse Event|3|||
30604022|NCT01234467|58615265|FG000|Overall Study|Death|2|||
30604023|NCT01234467|58615265|FG000|Overall Study|Withdrawal by Subject|2|||
30604024|NCT01234467|58615265|FG000|Overall Study|Disease Progression|2|||
30604025|NCT01234467|58615265|FG000|Overall Study|Clinical deterioration|1|||
30604026|NCT01234467|58615265|FG000|Overall Study|Physician Decision|1|||
30604027|NCT01234467|58615265|FG000|Overall Study|Other complicating disease (stroke)|1|||
30604028|NCT01233999|58615269|FG000|Overall Study|Withdrawal by Subject|1|||
30604029|NCT01233999|58615269|FG000|Overall Study|Lost to Follow-up|1|||
30604030|NCT01233687|58615273|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
30604031|NCT01233687|58615273|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
30604032|NCT01233687|58615273|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
30604033|NCT01023958|58615277|FG000|Overall Study|Progressive disease|48|||
30604034|NCT01023958|58615277|FG000|Overall Study|Other adverse event|1|||
30604035|NCT01023958|58615277|FG000|Overall Study|Refused to continue medication|1|||
30604036|NCT01233609|58615283|FG000|Overall Study|Death|1|||
30604037|NCT01233609|58615284|FG001|Overall Study|Death|0|||
30604038|NCT01233609|58615283|FG000|Overall Study|Lost to Follow-up|3|||
30604039|NCT01233609|58615284|FG001|Overall Study|Lost to Follow-up|1|||
30604040|NCT01233609|58615283|FG000|Overall Study|Adverse Event|2|||
30604041|NCT01233609|58615284|FG001|Overall Study|Adverse Event|1|||
30604042|NCT01233609|58615283|FG000|Overall Study|Withdrawal by Subject|3|||
30604043|NCT01233609|58615284|FG001|Overall Study|Withdrawal by Subject|0|||
30604044|NCT01232283|58615300|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
30604045|NCT01232283|58615301|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
30604046|NCT01232283|58615302|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
30604047|NCT01232283|58615303|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
30604048|NCT01232283|58615304|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
30604049|NCT01232283|58615305|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
30604050|NCT01232283|58615306|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
30604051|NCT01232283|58615307|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
30604052|NCT01232283|58615308|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
30604053|NCT01232283|58615309|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
30604054|NCT01232283|58615300|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
30604055|NCT01232283|58615301|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
30604056|NCT01232283|58615302|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30604057|NCT01232283|58615303|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30604058|NCT01232283|58615304|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30604059|NCT01232283|58615305|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30604060|NCT01232283|58615306|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30604061|NCT01232283|58615307|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30604062|NCT01232283|58615308|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30604063|NCT01232283|58615309|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
30604064|NCT01232283|58615300|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
30604065|NCT01232283|58615301|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
30604066|NCT01232283|58615302|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
30604067|NCT01232283|58615303|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
30604068|NCT01232283|58615304|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
30604069|NCT01232283|58615305|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
30604070|NCT01232283|58615306|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
30604071|NCT01232283|58615307|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
30604072|NCT01232283|58615308|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
30604073|NCT01232283|58615309|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
30604074|NCT01232283|58615300|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
30604075|NCT01232283|58615301|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
30604076|NCT01232283|58615302|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30604077|NCT01232283|58615303|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30604078|NCT01232283|58615304|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30604079|NCT01232283|58615305|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30604080|NCT01232283|58615306|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30604081|NCT01232283|58615307|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30604082|NCT01232283|58615308|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30604083|NCT01232283|58615309|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
30604084|NCT01232283|58615300|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
30604085|NCT01232283|58615301|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
30604086|NCT01232283|58615302|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
30604087|NCT01232283|58615303|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
30604088|NCT01232283|58615304|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
30604089|NCT01232283|58615305|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
30604090|NCT01232283|58615306|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
30604091|NCT01232283|58615307|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
30604092|NCT01232283|58615308|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
30604093|NCT01232283|58615309|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
30604094|NCT01232283|58615300|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
30604095|NCT01232283|58615301|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
30604096|NCT01232283|58615302|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
30604097|NCT01232283|58615303|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
30604098|NCT01232283|58615304|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
30604099|NCT01232283|58615305|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
30604100|NCT01232283|58615306|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
30604101|NCT01232283|58615307|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
30604102|NCT01232283|58615308|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
30604103|NCT01232283|58615309|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
30604104|NCT01232283|58615300|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
30604105|NCT01232283|58615301|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
30604106|NCT01232283|58615302|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
30604107|NCT01232283|58615303|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
30604108|NCT01232283|58615304|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
30604109|NCT01232283|58615305|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
30604110|NCT01232283|58615306|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
30604111|NCT01232283|58615307|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
30604112|NCT01232283|58615308|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
30604113|NCT01232283|58615309|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
30604114|NCT01232283|58615300|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
30604115|NCT01232283|58615301|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
30604116|NCT01232283|58615302|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
30604117|NCT01232283|58615303|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
30604118|NCT01232283|58615304|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
30604119|NCT01232283|58615305|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
30604120|NCT01232283|58615306|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
30604121|NCT01232283|58615307|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
30604122|NCT01232283|58615308|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
30604123|NCT01232283|58615309|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
30604124|NCT01232283|58615300|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
30604125|NCT01232283|58615301|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
30604126|NCT01232283|58615302|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
30604127|NCT01232283|58615303|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
30604128|NCT01232283|58615304|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
30604129|NCT01232283|58615305|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
30604130|NCT01232283|58615306|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
30604131|NCT01232283|58615307|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
30604132|NCT01232283|58615308|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
30604133|NCT01232283|58615309|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
30604134|NCT01232283|58615300|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
30604135|NCT01232283|58615301|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
30604136|NCT01232283|58615302|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
30604137|NCT01232283|58615303|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
30604138|NCT01232283|58615304|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
30604139|NCT01232283|58615305|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
30604140|NCT01232283|58615306|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
30604141|NCT01232283|58615307|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
30604142|NCT01232283|58615308|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
30604143|NCT01232283|58615309|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
30604144|NCT01232283|58615300|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
30694790|NCT00336505|58709033|FG000|Overall Study|Withdrawal by Subject|5|||
30694791|NCT00336505|58709034|FG001|Overall Study|Withdrawal by Subject|3|||
30694792|NCT00336505|58709033|FG000|Overall Study|Other|7|||
30694793|NCT00336505|58709034|FG001|Overall Study|Other|7|||
30694794|NCT00357877|58709042|FG000|Overall Study|Death|2|||
30694795|NCT00357877|58709043|FG001|Overall Study|Death|1|||
30694796|NCT00357877|58709042|FG000|Overall Study|Lost to Follow-up|20|||
30694797|NCT00357877|58709043|FG001|Overall Study|Lost to Follow-up|23|||
30694798|NCT00357877|58709042|FG000|Overall Study|Withdrawal by Subject|3|||
30694799|NCT00357877|58709043|FG001|Overall Study|Withdrawal by Subject|3|||
30694800|NCT00357877|58709042|FG000|Overall Study|Administrative withdrawal|1|||
30694801|NCT00357877|58709043|FG001|Overall Study|Administrative withdrawal|1|||
30694802|NCT00357877|58709042|FG000|Overall Study|Other|0|||
30694803|NCT00357877|58709043|FG001|Overall Study|Other|2|||
30694804|NCT00335959|58709051|FG000|Overall Study|Adverse Event|2|||
30694805|NCT00335959|58709051|FG000|Overall Study|Ineligible|1|||
30694806|NCT00670488|58709066|FG000|Overall Study|Adverse Event|0|||
30694807|NCT00670488|58709067|FG001|Overall Study|Adverse Event|7|||
30694808|NCT00670488|58709068|FG002|Overall Study|Adverse Event|0|||
30694809|NCT00670488|58709069|FG003|Overall Study|Adverse Event|3|||
30694810|NCT00670488|58709070|FG004|Overall Study|Adverse Event|1|||
30694811|NCT00670488|58709071|FG005|Overall Study|Adverse Event|1|||
30694812|NCT00670488|58709072|FG006|Overall Study|Adverse Event|5|||
30694813|NCT00670488|58709073|FG007|Overall Study|Adverse Event|1|||
30694814|NCT00670488|58709074|FG008|Overall Study|Adverse Event|0|||
30694815|NCT00670488|58709075|FG009|Overall Study|Adverse Event|1|||
30694816|NCT00670488|58709066|FG000|Overall Study|Physician Decision|1|||
30694817|NCT00670488|58709067|FG001|Overall Study|Physician Decision|9|||
30694818|NCT00670488|58709068|FG002|Overall Study|Physician Decision|0|||
30694819|NCT00670488|58709069|FG003|Overall Study|Physician Decision|1|||
30694820|NCT00670488|58709070|FG004|Overall Study|Physician Decision|0|||
30604145|NCT01232283|58615301|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
30604146|NCT01232283|58615302|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
30694821|NCT00670488|58709071|FG005|Overall Study|Physician Decision|0|||
30694822|NCT00670488|58709072|FG006|Overall Study|Physician Decision|0|||
30694823|NCT00670488|58709073|FG007|Overall Study|Physician Decision|0|||
30694824|NCT00670488|58709074|FG008|Overall Study|Physician Decision|0|||
30694825|NCT00670488|58709075|FG009|Overall Study|Physician Decision|0|||
30694826|NCT00670488|58709066|FG000|Overall Study|Progressive Disease|2|||
30694827|NCT00670488|58709067|FG001|Overall Study|Progressive Disease|41|||
30694828|NCT00670488|58709068|FG002|Overall Study|Progressive Disease|3|||
30694829|NCT00670488|58709069|FG003|Overall Study|Progressive Disease|2|||
30694830|NCT00670488|58709070|FG004|Overall Study|Progressive Disease|2|||
30694831|NCT00670488|58709071|FG005|Overall Study|Progressive Disease|4|||
30694832|NCT00670488|58709072|FG006|Overall Study|Progressive Disease|11|||
30694833|NCT00670488|58709073|FG007|Overall Study|Progressive Disease|2|||
30694834|NCT00670488|58709074|FG008|Overall Study|Progressive Disease|2|||
30694835|NCT00670488|58709075|FG009|Overall Study|Progressive Disease|1|||
30694836|NCT00670488|58709066|FG000|Overall Study|Withdrawal by Subject|0|||
30694837|NCT00670488|58709067|FG001|Overall Study|Withdrawal by Subject|1|||
30694838|NCT00670488|58709068|FG002|Overall Study|Withdrawal by Subject|0|||
30694839|NCT00670488|58709069|FG003|Overall Study|Withdrawal by Subject|1|||
30694840|NCT00670488|58709070|FG004|Overall Study|Withdrawal by Subject|0|||
30694841|NCT00670488|58709071|FG005|Overall Study|Withdrawal by Subject|0|||
30694842|NCT00670488|58709072|FG006|Overall Study|Withdrawal by Subject|1|||
30694843|NCT00670488|58709073|FG007|Overall Study|Withdrawal by Subject|0|||
30694844|NCT00670488|58709074|FG008|Overall Study|Withdrawal by Subject|1|||
30694845|NCT00670488|58709075|FG009|Overall Study|Withdrawal by Subject|0|||
30694846|NCT00671658|58709097|FG000|Overall Study|Physician Decision|5|||
30694847|NCT00542386|58709107|FG000|Overall Study|Adverse Event|1|||
30694848|NCT00542386|58709108|FG001|Overall Study|Adverse Event|7|||
30694849|NCT00542386|58709109|FG002|Overall Study|Adverse Event|7|||
30694850|NCT00542386|58709110|FG003|Overall Study|Adverse Event|8|||
30694851|NCT00542386|58709111|FG004|Overall Study|Adverse Event|13|||
30694852|NCT00542386|58709112|FG005|Overall Study|Adverse Event|4|||
30694853|NCT00542386|58709107|FG000|Overall Study|Death|0|||
30694854|NCT00542386|58709108|FG001|Overall Study|Death|0|||
30694855|NCT00542386|58709109|FG002|Overall Study|Death|1|||
30694856|NCT00542386|58709110|FG003|Overall Study|Death|2|||
30694857|NCT00542386|58709111|FG004|Overall Study|Death|1|||
30694858|NCT00542386|58709112|FG005|Overall Study|Death|2|||
30694859|NCT00542386|58709107|FG000|Overall Study|Lack of Efficacy|32|||
30694860|NCT00542386|58709108|FG001|Overall Study|Lack of Efficacy|12|||
30694861|NCT00542386|58709109|FG002|Overall Study|Lack of Efficacy|10|||
30694862|NCT00542386|58709110|FG003|Overall Study|Lack of Efficacy|13|||
30694863|NCT00542386|58709111|FG004|Overall Study|Lack of Efficacy|7|||
30694864|NCT00542386|58709112|FG005|Overall Study|Lack of Efficacy|31|||
30694865|NCT00542386|58709107|FG000|Overall Study|Physician Decision|1|||
30694866|NCT00542386|58709108|FG001|Overall Study|Physician Decision|0|||
30694867|NCT00542386|58709109|FG002|Overall Study|Physician Decision|0|||
30694868|NCT00542386|58709110|FG003|Overall Study|Physician Decision|1|||
30694869|NCT00542386|58709111|FG004|Overall Study|Physician Decision|0|||
30694870|NCT00542386|58709112|FG005|Overall Study|Physician Decision|0|||
30694871|NCT00542386|58709107|FG000|Overall Study|Protocol Violation|0|||
30694872|NCT00542386|58709108|FG001|Overall Study|Protocol Violation|0|||
30694873|NCT00542386|58709109|FG002|Overall Study|Protocol Violation|1|||
30694874|NCT00542386|58709110|FG003|Overall Study|Protocol Violation|0|||
30694875|NCT00542386|58709111|FG004|Overall Study|Protocol Violation|0|||
30694876|NCT00542386|58709112|FG005|Overall Study|Protocol Violation|4|||
30694877|NCT00542386|58709107|FG000|Overall Study|Withdrawal by Subject|5|||
30694878|NCT00542386|58709108|FG001|Overall Study|Withdrawal by Subject|8|||
30694879|NCT00542386|58709109|FG002|Overall Study|Withdrawal by Subject|10|||
30694880|NCT00542386|58709110|FG003|Overall Study|Withdrawal by Subject|11|||
30694881|NCT00542386|58709111|FG004|Overall Study|Withdrawal by Subject|15|||
30694882|NCT00542386|58709112|FG005|Overall Study|Withdrawal by Subject|7|||
30604147|NCT01232283|58615303|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
30604148|NCT01232283|58615304|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
30604149|NCT01232283|58615305|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
30604150|NCT01232283|58615306|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
30604151|NCT01232283|58615307|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
30604152|NCT01232283|58615308|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
30604153|NCT01232283|58615309|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
30604154|NCT01232283|58615300|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
30604155|NCT01232283|58615301|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
30604156|NCT01232283|58615302|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
30604157|NCT01232283|58615303|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
30604158|NCT01232283|58615304|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
30694883|NCT00542386|58709107|FG000|Overall Study|Other Reasons|4|||
30694884|NCT00542386|58709108|FG001|Overall Study|Other Reasons|1|||
30694885|NCT00542386|58709109|FG002|Overall Study|Other Reasons|4|||
30694886|NCT00542386|58709110|FG003|Overall Study|Other Reasons|3|||
30604159|NCT01232283|58615305|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
30694887|NCT00542386|58709111|FG004|Overall Study|Other Reasons|4|||
30694888|NCT00542386|58709112|FG005|Overall Study|Other Reasons|2|||
30694889|NCT00604383|58709128|FG000|Overall Study|Withdrawal by Subject|33|||
30694890|NCT00604383|58709129|FG001|Overall Study|Withdrawal by Subject|31|||
30694891|NCT00604383|58709128|FG000|Overall Study|Lost to Follow-up|24|||
30694892|NCT00604383|58709129|FG001|Overall Study|Lost to Follow-up|19|||
30694893|NCT00604383|58709128|FG000|Overall Study|Death|14|||
30694894|NCT00604383|58709129|FG001|Overall Study|Death|22|||
30694895|NCT00604383|58709128|FG000|Overall Study|Adverse Event|16|||
30694896|NCT00604383|58709129|FG001|Overall Study|Adverse Event|9|||
30694897|NCT00604383|58709128|FG000|Overall Study|Physician Decision|0|||
30694898|NCT00604383|58709129|FG001|Overall Study|Physician Decision|3|||
30694899|NCT00333775|58709138|FG000|Overall Study|Death|144|||
30694900|NCT00333775|58709139|FG001|Overall Study|Death|149|||
30694901|NCT00333775|58709140|FG002|Overall Study|Death|143|||
30694902|NCT00333775|58709138|FG000|Overall Study|In Follow-up When Study Stopped|87|||
30694903|NCT00333775|58709139|FG001|Overall Study|In Follow-up When Study Stopped|92|||
30694904|NCT00333775|58709140|FG002|Overall Study|In Follow-up When Study Stopped|96|||
30694905|NCT00333775|58709138|FG000|Overall Study|Lost to Follow-up|10|||
30694906|NCT00333775|58709139|FG001|Overall Study|Lost to Follow-up|7|||
30694907|NCT00333775|58709140|FG002|Overall Study|Lost to Follow-up|8|||
30694908|NCT00605475|58709158|FG000|Overall Study|Abnormal Laboratory Values|0|||
30694909|NCT00605475|58709159|FG001|Overall Study|Abnormal Laboratory Values|0|||
30694910|NCT00605475|58709160|FG002|Overall Study|Abnormal Laboratory Values|0|||
30694911|NCT00605475|58709161|FG003|Overall Study|Abnormal Laboratory Values|0|||
30694912|NCT00605475|58709162|FG004|Overall Study|Abnormal Laboratory Values|0|||
30694913|NCT00605475|58709163|FG005|Overall Study|Abnormal Laboratory Values|0|||
30694914|NCT00605475|58709164|FG006|Overall Study|Abnormal Laboratory Values|0|||
30694915|NCT00605475|58709165|FG007|Overall Study|Abnormal Laboratory Values|0|||
30694916|NCT00605475|58709166|FG008|Overall Study|Abnormal Laboratory Values|1|||
30694917|NCT00605475|58709167|FG009|Overall Study|Abnormal Laboratory Values|0|||
30694918|NCT00605475|58709158|FG000|Overall Study|Administrative problems|0|||
30694919|NCT00605475|58709159|FG001|Overall Study|Administrative problems|0|||
30694920|NCT00605475|58709160|FG002|Overall Study|Administrative problems|0|||
30694921|NCT00605475|58709161|FG003|Overall Study|Administrative problems|0|||
30694922|NCT00605475|58709162|FG004|Overall Study|Administrative problems|0|||
30694923|NCT00605475|58709163|FG005|Overall Study|Administrative problems|0|||
30694924|NCT00605475|58709164|FG006|Overall Study|Administrative problems|1|||
30694925|NCT00605475|58709165|FG007|Overall Study|Administrative problems|0|||
30694926|NCT00605475|58709166|FG008|Overall Study|Administrative problems|0|||
30694927|NCT00605475|58709167|FG009|Overall Study|Administrative problems|0|||
30694928|NCT00605475|58709158|FG000|Overall Study|Lost to Follow-up|0|||
30694929|NCT00605475|58709159|FG001|Overall Study|Lost to Follow-up|0|||
30694930|NCT00605475|58709160|FG002|Overall Study|Lost to Follow-up|0|||
30694931|NCT00605475|58709161|FG003|Overall Study|Lost to Follow-up|0|||
30694932|NCT00605475|58709162|FG004|Overall Study|Lost to Follow-up|0|||
30694933|NCT00605475|58709163|FG005|Overall Study|Lost to Follow-up|0|||
30694934|NCT00605475|58709164|FG006|Overall Study|Lost to Follow-up|0|||
30694935|NCT00605475|58709165|FG007|Overall Study|Lost to Follow-up|0|||
30694936|NCT00605475|58709166|FG008|Overall Study|Lost to Follow-up|1|||
30694937|NCT00605475|58709167|FG009|Overall Study|Lost to Follow-up|1|||
30694938|NCT00605475|58709158|FG000|Overall Study|Protocol Violation|0|||
30694939|NCT00605475|58709159|FG001|Overall Study|Protocol Violation|0|||
30604160|NCT01232283|58615306|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
30604161|NCT01232283|58615307|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
30604162|NCT01232283|58615308|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
30604163|NCT01232283|58615309|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
30604164|NCT01232283|58615300|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
30604165|NCT01232283|58615301|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
30604166|NCT01232283|58615302|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
30604167|NCT01232283|58615303|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
30604168|NCT01232283|58615304|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
30604169|NCT01232283|58615305|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
30604170|NCT01232283|58615306|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
30604171|NCT01232283|58615307|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
30604172|NCT01232283|58615308|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
30604173|NCT01232283|58615309|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
30604174|NCT01232283|58615300|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
30604175|NCT01232283|58615301|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
30604176|NCT01232283|58615302|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
30604177|NCT01232283|58615303|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
30604178|NCT01232283|58615304|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
30604179|NCT01232283|58615305|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
30604180|NCT01232283|58615306|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
30694940|NCT00605475|58709160|FG002|Overall Study|Protocol Violation|0|||
30694941|NCT00605475|58709161|FG003|Overall Study|Protocol Violation|0|||
30694942|NCT00605475|58709162|FG004|Overall Study|Protocol Violation|1|||
30694943|NCT00605475|58709163|FG005|Overall Study|Protocol Violation|0|||
30873867|NCT02146833|58904590|FG000|Overall Study|No longer consented to study treatment|1|||
30604181|NCT01232283|58615307|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
30694944|NCT00605475|58709164|FG006|Overall Study|Protocol Violation|0|||
30694945|NCT00605475|58709165|FG007|Overall Study|Protocol Violation|0|||
30694946|NCT00605475|58709166|FG008|Overall Study|Protocol Violation|0|||
30694947|NCT00605475|58709167|FG009|Overall Study|Protocol Violation|0|||
30694948|NCT00605475|58709158|FG000|Overall Study|Withdrawal by Subject|0|||
30694949|NCT00605475|58709159|FG001|Overall Study|Withdrawal by Subject|0|||
30694950|NCT00605475|58709160|FG002|Overall Study|Withdrawal by Subject|0|||
30694951|NCT00605475|58709161|FG003|Overall Study|Withdrawal by Subject|0|||
30694952|NCT00605475|58709162|FG004|Overall Study|Withdrawal by Subject|0|||
30694953|NCT00605475|58709163|FG005|Overall Study|Withdrawal by Subject|2|||
30694954|NCT00605475|58709164|FG006|Overall Study|Withdrawal by Subject|0|||
30694955|NCT00605475|58709165|FG007|Overall Study|Withdrawal by Subject|0|||
30694956|NCT00605475|58709166|FG008|Overall Study|Withdrawal by Subject|0|||
30694957|NCT00605475|58709167|FG009|Overall Study|Withdrawal by Subject|1|||
30694958|NCT00333619|58709212|FG000|Overall Study|Death|12|||
30694959|NCT00333619|58709213|FG001|Overall Study|Death|6|||
30694960|NCT00333619|58709212|FG000|Overall Study|Withdrawal by Subject|6|||
30694961|NCT00333619|58709213|FG001|Overall Study|Withdrawal by Subject|1|||
30694962|NCT00333619|58709212|FG000|Overall Study|Lost to Follow-up|3|||
30694963|NCT00333619|58709213|FG001|Overall Study|Lost to Follow-up|3|||
30694964|NCT00605319|58709221|FG000|Overall Study|Adverse Event|6|||
30694965|NCT00333229|58709233|FG000|Overall Study|Lack of Efficacy|0|||
30694966|NCT00333229|58709234|FG001|Overall Study|Lack of Efficacy|1|||
30694967|NCT00332839|58709242|FG000|Core (Months 0 - 12)|Administrative problems|1|||
30694968|NCT00332839|58709243|FG001|Core (Months 0 - 12)|Administrative problems|1|||
30694969|NCT00332839|58709242|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
30694970|NCT00332839|58709243|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
30694971|NCT00332839|58709242|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
30694972|NCT00332839|58709243|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
30694973|NCT00332839|58709242|FG000|Core (Months 0 - 12)|Adverse Event|5|||
30694974|NCT00332839|58709243|FG001|Core (Months 0 - 12)|Adverse Event|15|||
30694975|NCT00332839|58709242|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
30694976|NCT00332839|58709243|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
30694977|NCT00332839|58709242|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
30694978|NCT00332839|58709243|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
30694979|NCT00332839|58709242|FG000|Follow-up (Months 12 - 60)|Death|1|||
30694980|NCT00332839|58709243|FG001|Follow-up (Months 12 - 60)|Death|1|||
30694981|NCT00357097|58709251|FG000|Overall Study|Did not meet inclusion criteria|5|||
30694982|NCT00357097|58709252|FG001|Overall Study|Did not meet inclusion criteria|3|||
30694983|NCT00357097|58709251|FG000|Overall Study|Adverse Event|34|||
30694984|NCT00357097|58709252|FG001|Overall Study|Adverse Event|6|||
30694985|NCT00357097|58709251|FG000|Overall Study|Withdrawal by Subject|8|||
30694986|NCT00357097|58709252|FG001|Overall Study|Withdrawal by Subject|7|||
30694987|NCT00357097|58709251|FG000|Overall Study|Non-compliance|1|||
30694988|NCT00357097|58709252|FG001|Overall Study|Non-compliance|2|||
30694989|NCT00357097|58709251|FG000|Overall Study|Lack of Efficacy|2|||
30694990|NCT00357097|58709252|FG001|Overall Study|Lack of Efficacy|8|||
30694991|NCT00357097|58709251|FG000|Overall Study|Met Exclusion Criteria|3|||
30694992|NCT00357097|58709252|FG001|Overall Study|Met Exclusion Criteria|1|||
30694993|NCT00357097|58709251|FG000|Overall Study|Other|1|||
30694994|NCT00357097|58709252|FG001|Overall Study|Other|1|||
30694995|NCT00357097|58709251|FG000|Overall Study|Increase of RLS Symptoms|0|||
30873868|NCT02690207|58904594|FG000|Overall Study|Lost to Follow-up|48|||
30873869|NCT02690207|58904594|FG000|Overall Study|Withdrawal by Subject|46|||
30873870|NCT02690207|58904594|FG000|Overall Study|Protocol Violation|2|||
30873871|NCT02690207|58904594|FG000|Overall Study|Serious adverse event|110|||
30873872|NCT02690207|58904594|FG000|Overall Study|Non-serious Adverse Event|18|||
30873873|NCT02690207|58904594|FG000|Overall Study|Migrated/moved from study area|5|||
30873874|NCT02690207|58904594|FG000|Overall Study|Suspected HZ Episode|1|||
30873875|NCT02690207|58904594|FG000|Overall Study|Other reasons for withdrawal|23|||
30873876|NCT02689349|58904600|FG000|Overall Study|Not implanted|4|||
30873877|NCT02689349|58904601|FG001|Overall Study|Not implanted|0|||
30873878|NCT02689349|58904600|FG000|Overall Study|Withdrawal by Subject|9|||
30873879|NCT02689349|58904601|FG001|Overall Study|Withdrawal by Subject|0|||
30873880|NCT02679287|58904612|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
30873881|NCT02679287|58904613|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
30873882|NCT02679287|58904612|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
30873883|NCT02679287|58904613|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
30873884|NCT02679287|58904612|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
30873885|NCT02679287|58904613|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
30694996|NCT00357097|58709252|FG001|Overall Study|Increase of RLS Symptoms|1|||
30694997|NCT00356863|58709260|FG000|Overall Study|Death|16|||
30694998|NCT00356863|58709261|FG001|Overall Study|Death|32|||
30694999|NCT00356863|58709260|FG000|Overall Study|Lost to Follow-up|76|||
30695000|NCT00356863|58709261|FG001|Overall Study|Lost to Follow-up|43|||
30695001|NCT00355615|58709284|FG000|Randomized Double Blind Period|Adverse Event|1|||
30695002|NCT00355615|58709285|FG001|Randomized Double Blind Period|Adverse Event|0|||
30695003|NCT00355615|58709286|FG002|Randomized Double Blind Period|Adverse Event|0|||
30695004|NCT00355615|58709287|FG003|Randomized Double Blind Period|Adverse Event|0|||
30695005|NCT00355615|58709288|FG004|Randomized Double Blind Period|Adverse Event|0|||
30695006|NCT00355615|58709284|FG000|Randomized Double Blind Period|Protocol Violation|0|||
30695007|NCT00355615|58709285|FG001|Randomized Double Blind Period|Protocol Violation|0|||
30695008|NCT00355615|58709286|FG002|Randomized Double Blind Period|Protocol Violation|1|||
30695009|NCT00355615|58709287|FG003|Randomized Double Blind Period|Protocol Violation|1|||
30695010|NCT00355615|58709288|FG004|Randomized Double Blind Period|Protocol Violation|0|||
30695011|NCT00355615|58709284|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
30695012|NCT00355615|58709285|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
30695013|NCT00355615|58709286|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
30695014|NCT00355615|58709287|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
30695015|NCT00355615|58709288|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
30695016|NCT00355615|58709284|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
30695017|NCT00355615|58709285|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
30695018|NCT00355615|58709286|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
30695019|NCT00355615|58709287|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
30695020|NCT00355615|58709288|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
30695021|NCT00355615|58709284|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
30695022|NCT00355615|58709285|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
30695023|NCT00355615|58709286|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
30695024|NCT00355615|58709287|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
30695025|NCT00355615|58709288|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
30695026|NCT00355615|58709284|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
30695027|NCT00355615|58709285|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
30695028|NCT00355615|58709286|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
30695029|NCT00355615|58709287|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
30695030|NCT00355615|58709288|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
30695031|NCT00347269|58709301|FG000|Overall Study|Lost to Follow-up|74|||
30695032|NCT00347269|58709302|FG001|Overall Study|Lost to Follow-up|65|||
30695033|NCT00347269|58709301|FG000|Overall Study|Withdrawal by Subject|18|||
30695034|NCT00347269|58709302|FG001|Overall Study|Withdrawal by Subject|38|||
30695035|NCT00347269|58709301|FG000|Overall Study|Death|2|||
30695036|NCT00347269|58709302|FG001|Overall Study|Death|3|||
30695037|NCT00544648|58709310|FG000|Overall Study|Withdrawal by Subject|1|||
30695038|NCT00544648|58709311|FG001|Overall Study|Withdrawal by Subject|0|||
30695039|NCT00544648|58709310|FG000|Overall Study|Adverse Event|1|||
30695040|NCT00544648|58709311|FG001|Overall Study|Adverse Event|1|||
30695041|NCT00544648|58709310|FG000|Overall Study|progression of disease|1|||
30695042|NCT00544648|58709311|FG001|Overall Study|progression of disease|0|||
30695043|NCT00346333|58709321|FG000|Overall Study|Death|1|||
30695044|NCT00346333|58709322|FG001|Overall Study|Death|0|||
30695045|NCT00346333|58709321|FG000|Overall Study|unwilling or unable to continue|4|||
30695046|NCT00346333|58709322|FG001|Overall Study|unwilling or unable to continue|8|||
30695047|NCT00330967|58709332|FG000|Overall Study|Withdrawal by Subject|0|||
30695048|NCT00330967|58709333|FG001|Overall Study|Withdrawal by Subject|5|||
30695049|NCT00330967|58709332|FG000|Overall Study|Physician Decision|0|||
30695050|NCT00330967|58709333|FG001|Overall Study|Physician Decision|9|||
30695051|NCT00330343|58709339|FG000|Overall Study|Lost to Follow-up|5|||
30695052|NCT00330187|58709347|FG000|Overall Study|Lost to Follow-up|12|||
30695053|NCT00330187|58709348|FG001|Overall Study|Lost to Follow-up|13|||
30695054|NCT00330187|58709349|FG002|Overall Study|Lost to Follow-up|14|||
30695055|NCT00330187|58709350|FG003|Overall Study|Lost to Follow-up|10|||
30695056|NCT00330187|58709347|FG000|Overall Study|Withdrawal by Subject|8|||
30695057|NCT00330187|58709348|FG001|Overall Study|Withdrawal by Subject|5|||
30695058|NCT00330187|58709349|FG002|Overall Study|Withdrawal by Subject|4|||
30695059|NCT00330187|58709350|FG003|Overall Study|Withdrawal by Subject|4|||
30695060|NCT03914950|58709360|FG000|Overall Study|Physician Decision|54|||
30695061|NCT00329797|58709372|FG000|Overall Study|Protocol Violation|1|||
30695062|NCT00329797|58709373|FG001|Overall Study|Protocol Violation|0|||
30695063|NCT00329797|58709372|FG000|Overall Study|Withdrawal by Subject|6|||
30695064|NCT00329797|58709373|FG001|Overall Study|Withdrawal by Subject|6|||
30695065|NCT00541450|58709381|FG000|Phase A|Adverse Event|3|||
30695066|NCT00541450|58709382|FG001|Phase A|Adverse Event|0|||
30695067|NCT00541450|58709381|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
30695068|NCT00541450|58709382|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
30695069|NCT00541450|58709381|FG000|Phase A|Hyperglycemia|0|||
30695070|NCT00541450|58709382|FG001|Phase A|Hyperglycemia|1|||
30695071|NCT00541450|58709381|FG000|Phase A|Lost to Follow-up|6|||
30695072|NCT00541450|58709382|FG001|Phase A|Lost to Follow-up|4|||
30695073|NCT00541450|58709381|FG000|Phase A|Physician Decision|2|||
30695074|NCT00541450|58709382|FG001|Phase A|Physician Decision|0|||
30695075|NCT00541450|58709381|FG000|Phase A|Protocol Violation|2|||
30695076|NCT00541450|58709382|FG001|Phase A|Protocol Violation|3|||
30695077|NCT00541450|58709381|FG000|Phase A|Withdrawal by Subject|7|||
30695078|NCT00541450|58709382|FG001|Phase A|Withdrawal by Subject|7|||
30695079|NCT00541450|58709381|FG000|Phase B|Adverse Event|6|||
30695080|NCT00541450|58709382|FG001|Phase B|Adverse Event|6|||
30695081|NCT00541450|58709381|FG000|Phase B|Hyperglycemia|10|||
30695082|NCT00541450|58709382|FG001|Phase B|Hyperglycemia|9|||
30695083|NCT00541450|58709381|FG000|Phase B|Lost to Follow-up|6|||
30695084|NCT00541450|58709382|FG001|Phase B|Lost to Follow-up|4|||
30695085|NCT00541450|58709381|FG000|Phase B|Physician Decision|4|||
30695086|NCT00541450|58709382|FG001|Phase B|Physician Decision|2|||
30695087|NCT00541450|58709381|FG000|Phase B|Pregnancy|0|||
30695088|NCT00541450|58709382|FG001|Phase B|Pregnancy|1|||
30695089|NCT00541450|58709381|FG000|Phase B|Protocol Violation|3|||
30695090|NCT00541450|58709382|FG001|Phase B|Protocol Violation|3|||
30695091|NCT00541450|58709381|FG000|Phase B|Withdrawal by Subject|8|||
30695092|NCT00541450|58709382|FG001|Phase B|Withdrawal by Subject|6|||
30695093|NCT00355147|58709394|FG000|Overall Study|Lost to Follow-up|10|||
30695094|NCT00355147|58709395|FG001|Overall Study|Lost to Follow-up|8|||
30695095|NCT00355147|58709394|FG000|Overall Study|Withdrawal by Subject|8|||
30695096|NCT00355147|58709395|FG001|Overall Study|Withdrawal by Subject|12|||
30695097|NCT00540124|58709408|FG000|Overall Study|Adverse Event|0|||
30695098|NCT00540124|58709409|FG001|Overall Study|Adverse Event|2|||
30695099|NCT00540124|58709410|FG002|Overall Study|Adverse Event|1|||
30695100|NCT00540124|58709408|FG000|Overall Study|Entry Criteria Not Met|2|||
30695101|NCT00540124|58709409|FG001|Overall Study|Entry Criteria Not Met|0|||
30695102|NCT00540124|58709410|FG002|Overall Study|Entry Criteria Not Met|0|||
30695103|NCT00540124|58709408|FG000|Overall Study|Lack of Efficacy|1|||
30695104|NCT00540124|58709409|FG001|Overall Study|Lack of Efficacy|0|||
30695105|NCT00540124|58709410|FG002|Overall Study|Lack of Efficacy|0|||
30695106|NCT00540124|58709408|FG000|Overall Study|Withdrawal by Subject|1|||
30695107|NCT00540124|58709409|FG001|Overall Study|Withdrawal by Subject|1|||
30695108|NCT00540124|58709410|FG002|Overall Study|Withdrawal by Subject|0|||
30695109|NCT00540046|58709420|FG000|Overall Study|Lost to Follow-up|33|||
30695110|NCT00540046|58709421|FG001|Overall Study|Lost to Follow-up|23|||
30695111|NCT00689936|58709432|FG000|Active Treatment Phase|Adverse Event|68|||
30695112|NCT00689936|58709433|FG001|Active Treatment Phase|Adverse Event|71|||
30695113|NCT00689936|58709434|FG002|Active Treatment Phase|Adverse Event|76|||
30695114|NCT00689936|58709432|FG000|Active Treatment Phase|Disease Progression|273|||
30695115|NCT00689936|58709433|FG001|Active Treatment Phase|Disease Progression|362|||
30695116|NCT00689936|58709434|FG002|Active Treatment Phase|Disease Progression|339|||
30695117|NCT00689936|58709432|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
30695118|NCT00689936|58709433|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
30695119|NCT00689936|58709434|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
30695120|NCT00689936|58709432|FG000|Active Treatment Phase|Death|60|||
30695121|NCT00689936|58709433|FG001|Active Treatment Phase|Death|28|||
30695122|NCT00689936|58709434|FG002|Active Treatment Phase|Death|37|||
30695123|NCT00689936|58709432|FG000|Active Treatment Phase|Lost to Follow-up|0|||
30695124|NCT00689936|58709433|FG001|Active Treatment Phase|Lost to Follow-up|2|||
30695125|NCT00689936|58709434|FG002|Active Treatment Phase|Lost to Follow-up|2|||
30695126|NCT00689936|58709432|FG000|Active Treatment Phase|Protocol Violation|2|||
30695127|NCT00689936|58709433|FG001|Active Treatment Phase|Protocol Violation|2|||
30695128|NCT00689936|58709434|FG002|Active Treatment Phase|Protocol Violation|4|||
30695129|NCT00689936|58709432|FG000|Active Treatment Phase|Study Close Out|64|||
30695130|NCT00689936|58709433|FG001|Active Treatment Phase|Study Close Out|26|||
30695131|NCT00689936|58709434|FG002|Active Treatment Phase|Study Close Out|21|||
30695132|NCT00689936|58709432|FG000|Active Treatment Phase|Miscellaneous|52|||
30695133|NCT00689936|58709433|FG001|Active Treatment Phase|Miscellaneous|34|||
30695134|NCT00689936|58709434|FG002|Active Treatment Phase|Miscellaneous|47|||
30695135|NCT00689936|58709432|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
30695136|NCT00689936|58709433|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
30695137|NCT00689936|58709434|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
30695138|NCT00671034|58709445|FG000|Overall Study|Adverse Event|5|||
30695139|NCT00671034|58709446|FG001|Overall Study|Adverse Event|7|||
30695140|NCT00671034|58709447|FG002|Overall Study|Adverse Event|1|||
30695141|NCT00671034|58709445|FG000|Overall Study|Death|3|||
30695142|NCT00671034|58709446|FG001|Overall Study|Death|2|||
30695143|NCT00671034|58709447|FG002|Overall Study|Death|1|||
30695144|NCT00671034|58709445|FG000|Overall Study|Physician Decision|12|||
30695145|NCT00671034|58709446|FG001|Overall Study|Physician Decision|4|||
30695146|NCT00671034|58709447|FG002|Overall Study|Physician Decision|5|||
30695147|NCT00671034|58709445|FG000|Overall Study|VHR ALL feature|8|||
30695148|NCT00671034|58709446|FG001|Overall Study|VHR ALL feature|3|||
30695149|NCT00671034|58709447|FG002|Overall Study|VHR ALL feature|5|||
30695150|NCT00671034|58709445|FG000|Overall Study|Refusal|5|||
30695151|NCT00671034|58709446|FG001|Overall Study|Refusal|3|||
30695152|NCT00671034|58709447|FG002|Overall Study|Refusal|5|||
30695153|NCT00671034|58709445|FG000|Overall Study|includes Alternative therapy, etc.|6|||
30695154|NCT00671034|58709446|FG001|Overall Study|includes Alternative therapy, etc.|1|||
30695155|NCT00671034|58709447|FG002|Overall Study|includes Alternative therapy, etc.|7|||
30695156|NCT04404478|58709458|FG000|Overall Study|Withdrawal by Subject|1|||
30695157|NCT04404478|58709459|FG001|Overall Study|Withdrawal by Subject|3|||
30695158|NCT00539734|58709467|FG000|Overall Study|Protocol Violation|1|||
30695159|NCT03907072|58709474|FG000|Overall Study|Study Terminated by Sponsor|2|||
30695160|NCT03907072|58709475|FG001|Overall Study|Study Terminated by Sponsor|2|||
30695161|NCT03907072|58709476|FG002|Overall Study|Study Terminated by Sponsor|2|||
30695162|NCT00329719|58709501|FG000|Overall Study|Lost to Follow-up|0|||
30695163|NCT00329719|58709502|FG001|Overall Study|Lost to Follow-up|0|||
30695164|NCT00329719|58709503|FG002|Overall Study|Lost to Follow-up|0|||
30695165|NCT00329719|58709504|FG003|Overall Study|Lost to Follow-up|1|||
30695166|NCT00329641|58709514|FG000|Overall Study|Did not start treatment|1|||
30695167|NCT00329641|58709514|FG000|Overall Study|Not eligible|1|||
30695168|NCT00329641|58709514|FG000|Overall Study|Adverse Event|3|||
30695169|NCT00329641|58709514|FG000|Overall Study|Other reason, not protocol specified|1|||
30695170|NCT00329407|58709528|FG000|Overall Study|Withdrawal by Subject|1|||
30695171|NCT00328783|58709532|FG000|Overall Study|Could not tolerate ABC|21|||
30695172|NCT00328783|58709532|FG000|Overall Study|No heart in RT field|4|||
30695173|NCT00328783|58709532|FG000|Overall Study|Withdrawal by Subject|1|||
30695174|NCT00567489|58709540|FG000|Overall Study|Adverse Event|6|||
30695175|NCT00567489|58709541|FG001|Overall Study|Adverse Event|14|||
30695176|NCT00567489|58709540|FG000|Overall Study|Physician Decision|0|||
30695177|NCT00567489|58709541|FG001|Overall Study|Physician Decision|4|||
30695178|NCT00567489|58709540|FG000|Overall Study|Withdrawal by Subject|0|||
30695179|NCT00567489|58709541|FG001|Overall Study|Withdrawal by Subject|2|||
30695180|NCT00567489|58709540|FG000|Overall Study|Renal Transplantation|0|||
30695181|NCT00567489|58709541|FG001|Overall Study|Renal Transplantation|3|||
30695182|NCT00567489|58709540|FG000|Overall Study|Other|1|||
30695183|NCT00567489|58709541|FG001|Overall Study|Other|0|||
30695184|NCT00669942|58709559|FG000|Parts 2 and 3|Adverse Event|0|||
30695185|NCT00669942|58709560|FG001|Parts 2 and 3|Adverse Event|0|||
30695186|NCT00669942|58709561|FG002|Parts 2 and 3|Adverse Event|0|||
30695187|NCT00669942|58709562|FG003|Parts 2 and 3|Adverse Event|0|||
30695188|NCT00669942|58709563|FG004|Parts 2 and 3|Adverse Event|0|||
30695189|NCT00669942|58709564|FG005|Parts 2 and 3|Adverse Event|0|||
30695190|NCT00669942|58709565|FG006|Parts 2 and 3|Adverse Event|0|||
30695191|NCT00669942|58709566|FG007|Parts 2 and 3|Adverse Event|2|||
30695192|NCT00669942|58709567|FG008|Parts 2 and 3|Adverse Event|1|||
30695193|NCT00669942|58709568|FG009|Parts 2 and 3|Adverse Event|0|||
30695194|NCT00669942|58709569|FG010|Parts 2 and 3|Adverse Event|0|||
30695195|NCT00669942|58709570|FG011|Parts 2 and 3|Adverse Event|0|||
30695196|NCT00669942|58709559|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
30695197|NCT00669942|58709560|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
30695198|NCT00669942|58709561|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
30695199|NCT00669942|58709562|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
30695200|NCT00669942|58709563|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
30695201|NCT00669942|58709564|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
30695202|NCT00669942|58709565|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
30695203|NCT00669942|58709566|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
30695204|NCT00669942|58709567|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
30695205|NCT00669942|58709568|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
30695206|NCT00669942|58709569|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
30695207|NCT00669942|58709570|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
30695208|NCT00669942|58709559|FG000|Parts 2 and 3|Protocol Violation|0|||
30695209|NCT00669942|58709560|FG001|Parts 2 and 3|Protocol Violation|0|||
30695210|NCT00669942|58709561|FG002|Parts 2 and 3|Protocol Violation|0|||
30695211|NCT00669942|58709562|FG003|Parts 2 and 3|Protocol Violation|0|||
30695212|NCT00669942|58709563|FG004|Parts 2 and 3|Protocol Violation|0|||
30604182|NCT01232283|58615308|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
30604183|NCT01232283|58615309|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
30604184|NCT01232283|58615300|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
30604185|NCT01232283|58615301|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
30604186|NCT01232283|58615302|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
30604187|NCT01232283|58615303|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
30604188|NCT01232283|58615304|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
30604189|NCT01232283|58615305|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
30604190|NCT01232283|58615306|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
30604191|NCT01232283|58615307|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
30695213|NCT00669942|58709564|FG005|Parts 2 and 3|Protocol Violation|1|||
30695214|NCT00669942|58709565|FG006|Parts 2 and 3|Protocol Violation|0|||
30695215|NCT00669942|58709566|FG007|Parts 2 and 3|Protocol Violation|0|||
30695216|NCT00669942|58709567|FG008|Parts 2 and 3|Protocol Violation|0|||
30695217|NCT00669942|58709568|FG009|Parts 2 and 3|Protocol Violation|0|||
30695218|NCT00669942|58709569|FG010|Parts 2 and 3|Protocol Violation|0|||
30604192|NCT01232283|58615308|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
30695219|NCT00669942|58709570|FG011|Parts 2 and 3|Protocol Violation|0|||
30695220|NCT00669864|58709593|FG000|Overall Study|Lost to Follow-up|2|||
30695221|NCT00669864|58709593|FG000|Overall Study|Protocol Violation|2|||
30695222|NCT00669864|58709593|FG000|Overall Study|Withdrawal by Subject|3|||
30695223|NCT00669864|58709593|FG000|Overall Study|Other|2|||
30695224|NCT00668148|58709597|FG000|Overall Study|Adverse Event|5|||
30695225|NCT00668148|58709597|FG000|Overall Study|Subject Non-compliance|1|||
30695226|NCT00668148|58709597|FG000|Overall Study|Progressive Disease Before Treatment|2|||
30695227|NCT00668148|58709597|FG000|Overall Study|Withdrawal of Consent|2|||
30695228|NCT00667992|58709614|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
30695229|NCT00667992|58709615|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
30695230|NCT00667992|58709614|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
30695231|NCT00667992|58709615|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
30695232|NCT00667992|58709614|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
30695233|NCT00667992|58709615|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
30695234|NCT00667992|58709614|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
30695235|NCT00667992|58709615|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
30695236|NCT00667992|58709614|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
30695237|NCT00667992|58709615|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
30695238|NCT00667992|58709614|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
30695239|NCT00667992|58709615|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
30695240|NCT00667992|58709614|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
30695241|NCT00667992|58709615|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
30695242|NCT00667992|58709614|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
30695243|NCT00667992|58709615|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
30695244|NCT00667992|58709614|FG000|Wash-out|Not within one doubling dilution|4|||
30695245|NCT00667992|58709615|FG001|Wash-out|Not within one doubling dilution|3|||
30695246|NCT00667992|58709614|FG000|Wash-out|Failure to wash-out|2|||
30695247|NCT00667992|58709615|FG001|Wash-out|Failure to wash-out|2|||
30695248|NCT00667992|58709614|FG000|Wash-out|Withdrawal by Subject|1|||
30695249|NCT00667992|58709615|FG001|Wash-out|Withdrawal by Subject|0|||
30695250|NCT00667992|58709614|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
30695251|NCT00667992|58709615|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
30695252|NCT00667992|58709614|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
30695253|NCT00667992|58709615|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
30695254|NCT00669396|58709633|FG000|Overall Study|Lost to Follow-up|10|||
30695255|NCT00669396|58709634|FG001|Overall Study|Lost to Follow-up|12|||
30695256|NCT00669318|58709640|FG000|Overall Study|Withdrawal by Subject|2|||
30695257|NCT00669240|58709644|FG000|Overall Study|Lack of Efficacy|33|||
30695258|NCT00669240|58709644|FG000|Overall Study|Withdrawal by Subject|42|||
30695259|NCT00669240|58709644|FG000|Overall Study|Lost to Follow-up|34|||
30695260|NCT00669240|58709644|FG000|Overall Study|Adverse Event|21|||
30695261|NCT00669240|58709644|FG000|Overall Study|Other|19|||
30695262|NCT00669240|58709644|FG000|Overall Study|Enrolled but not treated|15|||
30695263|NCT00669240|58709644|FG000|Overall Study|Enrolled but no dosing record|1|||
30695264|NCT00669162|58709648|FG000|Overall Study|Withdrawal by Subject|1|||
30695265|NCT00400946|58709657|FG000|Overall Study|Ineligible|0|||
30695266|NCT00400946|58709658|FG001|Overall Study|Ineligible|0|||
30695267|NCT00400946|58709659|FG002|Overall Study|Ineligible|0|||
30695268|NCT00400946|58709660|FG003|Overall Study|Ineligible|5|||
30695269|NCT00400946|58709661|FG004|Overall Study|Ineligible|1|||
30695270|NCT00400946|58709657|FG000|Overall Study|Induction Failure|0|||
30695271|NCT00400946|58709658|FG001|Overall Study|Induction Failure|0|||
30695272|NCT00400946|58709659|FG002|Overall Study|Induction Failure|0|||
30695273|NCT00400946|58709660|FG003|Overall Study|Induction Failure|11|||
30695274|NCT00400946|58709661|FG004|Overall Study|Induction Failure|8|||
30695275|NCT00400946|58709657|FG000|Overall Study|Induction Death|0|||
30695276|NCT00400946|58709658|FG001|Overall Study|Induction Death|0|||
30695277|NCT00400946|58709659|FG002|Overall Study|Induction Death|0|||
30695278|NCT00400946|58709660|FG003|Overall Study|Induction Death|13|||
30695279|NCT00400946|58709661|FG004|Overall Study|Induction Death|3|||
30695280|NCT00400946|58709657|FG000|Overall Study|Lost to Follow-up|1|||
30695281|NCT00400946|58709658|FG001|Overall Study|Lost to Follow-up|1|||
30695282|NCT00400946|58709659|FG002|Overall Study|Lost to Follow-up|0|||
30695283|NCT00400946|58709660|FG003|Overall Study|Lost to Follow-up|0|||
30695284|NCT00400946|58709661|FG004|Overall Study|Lost to Follow-up|1|||
30695285|NCT00400946|58709657|FG000|Overall Study|Remission Death|1|||
30695286|NCT00400946|58709658|FG001|Overall Study|Remission Death|1|||
30695287|NCT00400946|58709659|FG002|Overall Study|Remission Death|0|||
30695288|NCT00400946|58709660|FG003|Overall Study|Remission Death|0|||
30695289|NCT00400946|58709661|FG004|Overall Study|Remission Death|1|||
30695290|NCT00400946|58709657|FG000|Overall Study|Relapse|9|||
30695291|NCT00400946|58709658|FG001|Overall Study|Relapse|2|||
30695292|NCT00400946|58709659|FG002|Overall Study|Relapse|1|||
30695293|NCT00400946|58709660|FG003|Overall Study|Relapse|1|||
30695294|NCT00400946|58709661|FG004|Overall Study|Relapse|5|||
30695295|NCT00400946|58709657|FG000|Overall Study|Transplant in CR1|0|||
30695296|NCT00400946|58709658|FG001|Overall Study|Transplant in CR1|0|||
30695297|NCT00400946|58709659|FG002|Overall Study|Transplant in CR1|0|||
30695298|NCT00400946|58709660|FG003|Overall Study|Transplant in CR1|10|||
30695299|NCT00400946|58709661|FG004|Overall Study|Transplant in CR1|1|||
30695300|NCT00400946|58709657|FG000|Overall Study|Withdrawal by Subject|2|||
30695301|NCT00400946|58709658|FG001|Overall Study|Withdrawal by Subject|5|||
30695302|NCT00400946|58709659|FG002|Overall Study|Withdrawal by Subject|1|||
30695303|NCT00400946|58709660|FG003|Overall Study|Withdrawal by Subject|5|||
30695304|NCT00400946|58709661|FG004|Overall Study|Withdrawal by Subject|8|||
30695305|NCT00400946|58709657|FG000|Overall Study|Clinical|1|||
30695306|NCT00400946|58709658|FG001|Overall Study|Clinical|2|||
30695307|NCT00400946|58709659|FG002|Overall Study|Clinical|0|||
30695308|NCT00400946|58709660|FG003|Overall Study|Clinical|2|||
30695309|NCT00400946|58709661|FG004|Overall Study|Clinical|9|||
30695310|NCT00400946|58709657|FG000|Overall Study|Other|0|||
30695311|NCT00400946|58709658|FG001|Overall Study|Other|0|||
30695312|NCT00400946|58709659|FG002|Overall Study|Other|0|||
30695313|NCT00400946|58709660|FG003|Overall Study|Other|0|||
30695314|NCT00400946|58709661|FG004|Overall Study|Other|1|||
30695315|NCT00666588|58709692|FG000|Overall Study|ineligible|2|||
30695316|NCT00666588|58709693|FG001|Overall Study|ineligible|0|||
30695317|NCT00666588|58709694|FG002|Overall Study|ineligible|0|||
30695318|NCT00666588|58709695|FG003|Overall Study|ineligible|2|||
30695319|NCT00666588|58709692|FG000|Overall Study|inevaluable|2|||
30695320|NCT00666588|58709693|FG001|Overall Study|inevaluable|0|||
30695321|NCT00666588|58709694|FG002|Overall Study|inevaluable|0|||
30695322|NCT00666588|58709695|FG003|Overall Study|inevaluable|0|||
30695323|NCT00689390|58709707|FG000|Overall Study|Adverse Event|19|||
30695324|NCT00689390|58709708|FG001|Overall Study|Adverse Event|0|||
30695325|NCT00689390|58709707|FG000|Overall Study|Lost to Follow-up|179|||
30695326|NCT00689390|58709708|FG001|Overall Study|Lost to Follow-up|7|||
30695327|NCT00689390|58709707|FG000|Overall Study|Withdrawal by Subject|117|||
30695328|NCT00689390|58709708|FG001|Overall Study|Withdrawal by Subject|3|||
30695329|NCT00689390|58709707|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
30695330|NCT00689390|58709708|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
30695331|NCT00689390|58709707|FG000|Overall Study|Non-Compliance With Protocol|21|||
30695332|NCT00689390|58709708|FG001|Overall Study|Non-Compliance With Protocol|0|||
30695333|NCT00689390|58709707|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
30695334|NCT00689390|58709708|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
30695335|NCT00689390|58709707|FG000|Overall Study|Administrative|37|||
30695336|NCT00689390|58709708|FG001|Overall Study|Administrative|0|||
30695337|NCT00567879|58709725|FG000|Overall Study|Adverse Event|2|||
30695338|NCT00567879|58709726|FG001|Overall Study|Adverse Event|0|||
30695339|NCT00567879|58709727|FG002|Overall Study|Adverse Event|1|||
30695340|NCT00567879|58709728|FG003|Overall Study|Adverse Event|0|||
30695341|NCT00567879|58709729|FG004|Overall Study|Adverse Event|1|||
30695342|NCT00567879|58709730|FG005|Overall Study|Adverse Event|0|||
30695343|NCT00567879|58709725|FG000|Overall Study|Abnormal test procedure(s)|0|||
30695344|NCT00567879|58709726|FG001|Overall Study|Abnormal test procedure(s)|0|||
30695345|NCT00567879|58709727|FG002|Overall Study|Abnormal test procedure(s)|1|||
30695346|NCT00567879|58709728|FG003|Overall Study|Abnormal test procedure(s)|0|||
30695347|NCT00567879|58709729|FG004|Overall Study|Abnormal test procedure(s)|0|||
30695348|NCT00567879|58709730|FG005|Overall Study|Abnormal test procedure(s)|0|||
30695349|NCT00567879|58709725|FG000|Overall Study|Withdrawal by Subject|0|||
30695350|NCT00567879|58709726|FG001|Overall Study|Withdrawal by Subject|0|||
30695351|NCT00567879|58709727|FG002|Overall Study|Withdrawal by Subject|3|||
30695352|NCT00567879|58709728|FG003|Overall Study|Withdrawal by Subject|1|||
30695353|NCT00567879|58709729|FG004|Overall Study|Withdrawal by Subject|0|||
30695354|NCT00567879|58709730|FG005|Overall Study|Withdrawal by Subject|0|||
30695355|NCT00567879|58709725|FG000|Overall Study|New cancer therapy|0|||
30695356|NCT00567879|58709726|FG001|Overall Study|New cancer therapy|0|||
30695357|NCT00567879|58709727|FG002|Overall Study|New cancer therapy|1|||
30695358|NCT00567879|58709728|FG003|Overall Study|New cancer therapy|0|||
30695359|NCT00567879|58709729|FG004|Overall Study|New cancer therapy|0|||
30695360|NCT00567879|58709730|FG005|Overall Study|New cancer therapy|0|||
30695361|NCT00567879|58709725|FG000|Overall Study|Disease progression|5|||
30695362|NCT00567879|58709726|FG001|Overall Study|Disease progression|7|||
30695363|NCT00567879|58709727|FG002|Overall Study|Disease progression|15|||
30695364|NCT00567879|58709728|FG003|Overall Study|Disease progression|5|||
30695365|NCT00567879|58709729|FG004|Overall Study|Disease progression|11|||
30695366|NCT00567879|58709730|FG005|Overall Study|Disease progression|3|||
30695367|NCT00603915|58709748|FG000|Overall Study|Physician Decision|1|||
30695368|NCT00603837|58709754|FG000|Overall Study|Physician Decision|3|||
30695369|NCT00603837|58709755|FG001|Overall Study|Physician Decision|0|||
30695370|NCT00667602|58709764|FG000|Overall Study|Withdrawal by Subject|4|||
30695371|NCT00667602|58709765|FG001|Overall Study|Withdrawal by Subject|9|||
30695372|NCT00667602|58709766|FG002|Overall Study|Withdrawal by Subject|10|||
30695373|NCT00667602|58709764|FG000|Overall Study|Lost to Follow-up|4|||
30695374|NCT00667602|58709765|FG001|Overall Study|Lost to Follow-up|5|||
30695375|NCT00667602|58709766|FG002|Overall Study|Lost to Follow-up|6|||
30695376|NCT00667602|58709764|FG000|Overall Study|Administrative reason|0|||
30873886|NCT02679287|58904612|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
30873887|NCT02679287|58904613|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
30873888|NCT02679287|58904612|FG000|Period 2|Work/Scheduling Conflict|1|||
30873889|NCT02679287|58904613|FG001|Period 2|Work/Scheduling Conflict|0|||
30873890|NCT02679287|58904612|FG000|Period 2|Disliked Mobile System|2|||
30873891|NCT02679287|58904613|FG001|Period 2|Disliked Mobile System|0|||
30873892|NCT02679287|58904612|FG000|Period 3|Work/Scheduling Conflict|0|||
30873893|NCT02679287|58904613|FG001|Period 3|Work/Scheduling Conflict|1|||
30873894|NCT02544633|58904629|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
30873895|NCT02544633|58904630|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
30873896|NCT02544633|58904631|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
30873897|NCT02544633|58904632|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
30873898|NCT02544633|58904629|FG000|Treatment Period|Adverse Event|7|||
30873899|NCT02544633|58904630|FG001|Treatment Period|Adverse Event|4|||
30873900|NCT02544633|58904631|FG002|Treatment Period|Adverse Event|0|||
30873901|NCT02544633|58904632|FG003|Treatment Period|Adverse Event|5|||
30873902|NCT02544633|58904629|FG000|Treatment Period|Lack of Efficacy|17|||
30873903|NCT02544633|58904630|FG001|Treatment Period|Lack of Efficacy|11|||
30873904|NCT02544633|58904631|FG002|Treatment Period|Lack of Efficacy|5|||
30873905|NCT02544633|58904632|FG003|Treatment Period|Lack of Efficacy|5|||
30873906|NCT02544633|58904629|FG000|Treatment Period|Global Deterioration of Health|3|||
30873907|NCT02544633|58904630|FG001|Treatment Period|Global Deterioration of Health|3|||
30873908|NCT02544633|58904631|FG002|Treatment Period|Global Deterioration of Health|0|||
30873909|NCT02544633|58904632|FG003|Treatment Period|Global Deterioration of Health|1|||
30873910|NCT02544633|58904629|FG000|Treatment Period|Withdrawal by Subject|1|||
30873911|NCT02544633|58904630|FG001|Treatment Period|Withdrawal by Subject|0|||
30873912|NCT02544633|58904631|FG002|Treatment Period|Withdrawal by Subject|0|||
30873913|NCT02544633|58904632|FG003|Treatment Period|Withdrawal by Subject|0|||
30873914|NCT02544633|58904629|FG000|Treatment Period|Lost to Follow-up|0|||
30873915|NCT02544633|58904630|FG001|Treatment Period|Lost to Follow-up|1|||
30873916|NCT02544633|58904631|FG002|Treatment Period|Lost to Follow-up|0|||
30873917|NCT02544633|58904632|FG003|Treatment Period|Lost to Follow-up|0|||
30873918|NCT02544633|58904629|FG000|Treatment Period|Death|0|||
30873919|NCT02544633|58904630|FG001|Treatment Period|Death|0|||
30873920|NCT02544633|58904631|FG002|Treatment Period|Death|1|||
30873921|NCT02544633|58904632|FG003|Treatment Period|Death|0|||
30873922|NCT02544633|58904629|FG000|Treatment Period|Non-compliance|0|||
30873923|NCT02544633|58904630|FG001|Treatment Period|Non-compliance|0|||
30695377|NCT00667602|58709765|FG001|Overall Study|Administrative reason|0|||
30695378|NCT00667602|58709766|FG002|Overall Study|Administrative reason|2|||
30695379|NCT00667602|58709764|FG000|Overall Study|Protocol Violation|0|||
30695380|NCT00667602|58709765|FG001|Overall Study|Protocol Violation|1|||
30695381|NCT00667602|58709766|FG002|Overall Study|Protocol Violation|0|||
30695382|NCT00691028|58709782|FG000|Open-label Period|Adverse Event|0|||
30695383|NCT00691028|58709783|FG001|Open-label Period|Adverse Event|0|||
30695384|NCT00691028|58709784|FG002|Open-label Period|Adverse Event|0|||
30695385|NCT00691028|58709785|FG003|Open-label Period|Adverse Event|16|||
30695386|NCT00691028|58709782|FG000|Open-label Period|Withdrawal by Subject|0|||
30695387|NCT00691028|58709783|FG001|Open-label Period|Withdrawal by Subject|0|||
30695388|NCT00691028|58709784|FG002|Open-label Period|Withdrawal by Subject|0|||
30695389|NCT00691028|58709785|FG003|Open-label Period|Withdrawal by Subject|3|||
30695390|NCT00691028|58709782|FG000|Open-label Period|not come to a hospital|0|||
30695391|NCT00691028|58709783|FG001|Open-label Period|not come to a hospital|0|||
30695392|NCT00691028|58709784|FG002|Open-label Period|not come to a hospital|0|||
30695393|NCT00691028|58709785|FG003|Open-label Period|not come to a hospital|1|||
30695394|NCT00691028|58709782|FG000|Double-blind Period|Adverse Event|8|||
30695395|NCT00691028|58709783|FG001|Double-blind Period|Adverse Event|9|||
30695396|NCT00691028|58709784|FG002|Double-blind Period|Adverse Event|6|||
30695397|NCT00691028|58709785|FG003|Double-blind Period|Adverse Event|0|||
30695398|NCT00691028|58709782|FG000|Double-blind Period|Lack of Efficacy|4|||
30695399|NCT00691028|58709783|FG001|Double-blind Period|Lack of Efficacy|3|||
30695400|NCT00691028|58709784|FG002|Double-blind Period|Lack of Efficacy|2|||
30695401|NCT00691028|58709785|FG003|Double-blind Period|Lack of Efficacy|0|||
30695402|NCT00691028|58709782|FG000|Double-blind Period|Withdrawal by Subject|1|||
30695403|NCT00691028|58709783|FG001|Double-blind Period|Withdrawal by Subject|0|||
30873924|NCT02544633|58904631|FG002|Treatment Period|Non-compliance|1|||
30695404|NCT00691028|58709784|FG002|Double-blind Period|Withdrawal by Subject|1|||
30695405|NCT00691028|58709785|FG003|Double-blind Period|Withdrawal by Subject|0|||
30695406|NCT00691028|58709782|FG000|Double-blind Period|not come to a hospital.|0|||
30695407|NCT00691028|58709783|FG001|Double-blind Period|not come to a hospital.|1|||
30695408|NCT00691028|58709784|FG002|Double-blind Period|not come to a hospital.|0|||
30873925|NCT02544633|58904632|FG003|Treatment Period|Non-compliance|0|||
30873926|NCT02544633|58904629|FG000|Treatment Period|Clinical Disease Progression|0|||
30873927|NCT02544633|58904630|FG001|Treatment Period|Clinical Disease Progression|0|||
30695409|NCT00691028|58709785|FG003|Double-blind Period|not come to a hospital.|0|||
30695410|NCT00690794|58709799|FG000|Overall Study|Adverse Event|12|||
30695411|NCT00690794|58709800|FG001|Overall Study|Adverse Event|10|||
30695412|NCT00690794|58709799|FG000|Overall Study|Lost to Follow-up|1|||
30695413|NCT00690794|58709800|FG001|Overall Study|Lost to Follow-up|4|||
30695414|NCT00690794|58709799|FG000|Overall Study|Withdrawal by Subject|0|||
30695415|NCT00690794|58709800|FG001|Overall Study|Withdrawal by Subject|9|||
30695416|NCT00690794|58709799|FG000|Overall Study|Protocol Violation|6|||
30695417|NCT00690794|58709800|FG001|Overall Study|Protocol Violation|7|||
30695418|NCT00690794|58709799|FG000|Overall Study|Noncompliance|1|||
30695419|NCT00690794|58709800|FG001|Overall Study|Noncompliance|2|||
30695420|NCT00690794|58709799|FG000|Overall Study|Other not specified|1|||
30695421|NCT00690794|58709800|FG001|Overall Study|Other not specified|3|||
30695422|NCT00666276|58709806|FG000|Overall Study|Protocol Violation|34|||
30695423|NCT00567255|58709831|FG000|Overall Study|Adverse Event|241|||
30695424|NCT00567255|58709832|FG001|Overall Study|Adverse Event|68|||
30695425|NCT00567255|58709831|FG000|Overall Study|Lost to Follow-up|77|||
30695426|NCT00567255|58709832|FG001|Overall Study|Lost to Follow-up|48|||
30695427|NCT00567255|58709831|FG000|Overall Study|Withdrawal by Subject|75|||
30695428|NCT00567255|58709832|FG001|Overall Study|Withdrawal by Subject|56|||
30695429|NCT00567255|58709831|FG000|Overall Study|Lack of Efficacy|19|||
30695430|NCT00567255|58709832|FG001|Overall Study|Lack of Efficacy|33|||
30695431|NCT00567255|58709831|FG000|Overall Study|Protocol Violation|20|||
30695432|NCT00567255|58709832|FG001|Overall Study|Protocol Violation|8|||
30695433|NCT00567255|58709831|FG000|Overall Study|Pregnancy|6|||
30695434|NCT00567255|58709832|FG001|Overall Study|Pregnancy|0|||
30695435|NCT00567255|58709831|FG000|Overall Study|Drug noncompliance,moved,other|25|||
30695436|NCT00567255|58709832|FG001|Overall Study|Drug noncompliance,moved,other|15|||
30695437|NCT00667446|58709840|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
30695438|NCT00667446|58709841|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
30695439|NCT00667446|58709840|FG000|Treatment Period (36 Months)|Other|2|||
30695440|NCT00667446|58709841|FG001|Treatment Period (36 Months)|Other|2|||
30695441|NCT00667446|58709840|FG000|Treatment Period (36 Months)|Personal reasons|2|||
30695442|NCT00667446|58709841|FG001|Treatment Period (36 Months)|Personal reasons|2|||
30695443|NCT00667446|58709840|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
30695444|NCT00667446|58709841|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
30695445|NCT00667446|58709840|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
30695446|NCT00667446|58709841|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
30695447|NCT00667446|58709840|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
30695448|NCT00667446|58709841|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
30695449|NCT00667446|58709840|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
30695450|NCT00667446|58709841|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
30695451|NCT00667446|58709840|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
30695452|NCT00667446|58709841|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
30695453|NCT00667446|58709840|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
30695454|NCT00667446|58709841|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
30695455|NCT00688844|58709847|FG000|Overall Study|Lost to Follow-up|10|||
30695456|NCT00667368|58709853|FG000|Overall Study|Lost to Follow-up|176|||
30695457|NCT00667368|58709854|FG001|Overall Study|Lost to Follow-up|155|||
30695458|NCT00667368|58709853|FG000|Overall Study|Discontinued early|24|||
30695459|NCT00667368|58709854|FG001|Overall Study|Discontinued early|17|||
30695460|NCT00567567|58709863|FG000|Overall Study|Adverse Event|0|||
30695461|NCT00567567|58709864|FG001|Overall Study|Adverse Event|2|||
30695462|NCT00567567|58709865|FG002|Overall Study|Adverse Event|5|||
30695463|NCT00567567|58709863|FG000|Overall Study|Death|8|||
30695464|NCT00567567|58709864|FG001|Overall Study|Death|1|||
30695465|NCT00567567|58709865|FG002|Overall Study|Death|5|||
30695466|NCT00567567|58709863|FG000|Overall Study|Lack of Efficacy|16|||
30695467|NCT00567567|58709864|FG001|Overall Study|Lack of Efficacy|17|||
30695468|NCT00567567|58709865|FG002|Overall Study|Lack of Efficacy|48|||
30695469|NCT00567567|58709863|FG000|Overall Study|Lost to Follow-up|0|||
30695470|NCT00567567|58709864|FG001|Overall Study|Lost to Follow-up|0|||
30695471|NCT00567567|58709865|FG002|Overall Study|Lost to Follow-up|1|||
30695472|NCT00567567|58709863|FG000|Overall Study|Physician Decision|16|||
30695473|NCT00567567|58709864|FG001|Overall Study|Physician Decision|18|||
30695474|NCT00567567|58709865|FG002|Overall Study|Physician Decision|84|||
30695475|NCT00567567|58709863|FG000|Overall Study|Withdrawal by Subject|0|||
30695476|NCT00567567|58709864|FG001|Overall Study|Withdrawal by Subject|0|||
30695477|NCT00567567|58709865|FG002|Overall Study|Withdrawal by Subject|2|||
30695478|NCT00567567|58709863|FG000|Overall Study|Ineligible|4|||
30695479|NCT00567567|58709864|FG001|Overall Study|Ineligible|0|||
30695480|NCT00567567|58709865|FG002|Overall Study|Ineligible|9|||
30695481|NCT00567567|58709863|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
30695482|NCT00567567|58709864|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
30695483|NCT00567567|58709865|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
30695484|NCT00567567|58709863|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
30695485|NCT00567567|58709864|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
30695486|NCT00567567|58709865|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
30695487|NCT00567567|58709863|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
30695488|NCT00567567|58709864|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
30695489|NCT00567567|58709865|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
30695490|NCT00666198|58709875|FG000|Overall Study|Protocol Violation|10|||
30695491|NCT00666198|58709875|FG000|Overall Study|No Visit After First Day of Treatment|13|||
30695492|NCT00666198|58709875|FG000|Overall Study|Safety Not Assessable|6|||
30695493|NCT00666198|58709875|FG000|Overall Study|No Drug Administration|4|||
30695494|NCT00664560|58709882|FG000|Overall Study|Adverse Event|19|||
30695495|NCT00664560|58709883|FG001|Overall Study|Adverse Event|16|||
30695496|NCT00664560|58709884|FG002|Overall Study|Adverse Event|7|||
30695497|NCT00664560|58709882|FG000|Overall Study|Withdrawal by Subject|9|||
30695498|NCT00664560|58709883|FG001|Overall Study|Withdrawal by Subject|13|||
30695499|NCT00664560|58709884|FG002|Overall Study|Withdrawal by Subject|7|||
30695500|NCT00664560|58709882|FG000|Overall Study|Lost to Follow-up|0|||
30695501|NCT00664560|58709883|FG001|Overall Study|Lost to Follow-up|2|||
30695502|NCT00664560|58709884|FG002|Overall Study|Lost to Follow-up|0|||
30695503|NCT00664560|58709882|FG000|Overall Study|Other|11|||
30695504|NCT00664560|58709883|FG001|Overall Study|Other|4|||
30695505|NCT00664560|58709884|FG002|Overall Study|Other|5|||
30695506|NCT00566709|58709894|FG000|Overall Study|Protocol Violation|5|||
30695507|NCT00566709|58709895|FG001|Overall Study|Protocol Violation|0|||
30695508|NCT00688688|58709904|FG000|Overall Study|Eligibility criterion not met|7|||
30695509|NCT00688688|58709905|FG001|Overall Study|Eligibility criterion not met|7|||
30695510|NCT00688688|58709906|FG002|Overall Study|Eligibility criterion not met|10|||
30695511|NCT00688688|58709904|FG000|Overall Study|Adverse Event|52|||
30695512|NCT00688688|58709905|FG001|Overall Study|Adverse Event|51|||
30695513|NCT00688688|58709906|FG002|Overall Study|Adverse Event|50|||
30695514|NCT00688688|58709904|FG000|Overall Study|Lack of Efficacy|34|||
30695515|NCT00688688|58709905|FG001|Overall Study|Lack of Efficacy|25|||
30695516|NCT00688688|58709906|FG002|Overall Study|Lack of Efficacy|45|||
30695517|NCT00688688|58709904|FG000|Overall Study|Withdrawal by Subject|66|||
30695518|NCT00688688|58709905|FG001|Overall Study|Withdrawal by Subject|75|||
30695519|NCT00688688|58709906|FG002|Overall Study|Withdrawal by Subject|65|||
30695520|NCT00688688|58709904|FG000|Overall Study|Lost to Follow-up|14|||
30695521|NCT00688688|58709905|FG001|Overall Study|Lost to Follow-up|7|||
30695522|NCT00688688|58709906|FG002|Overall Study|Lost to Follow-up|7|||
30695523|NCT00688688|58709904|FG000|Overall Study|Protocol Violation|6|||
30695524|NCT00688688|58709905|FG001|Overall Study|Protocol Violation|9|||
30695525|NCT00688688|58709906|FG002|Overall Study|Protocol Violation|11|||
30695526|NCT00688688|58709904|FG000|Overall Study|Randomized but never received study drug|1|||
30695527|NCT00688688|58709905|FG001|Overall Study|Randomized but never received study drug|0|||
30695528|NCT00688688|58709906|FG002|Overall Study|Randomized but never received study drug|0|||
30695529|NCT00688688|58709904|FG000|Overall Study|Non-compliance with study procedures|5|||
30695530|NCT00688688|58709905|FG001|Overall Study|Non-compliance with study procedures|3|||
30695531|NCT00688688|58709906|FG002|Overall Study|Non-compliance with study procedures|4|||
30695532|NCT00688688|58709904|FG000|Overall Study|Taking exclusionary medications|1|||
30695533|NCT00688688|58709905|FG001|Overall Study|Taking exclusionary medications|0|||
30695534|NCT00688688|58709906|FG002|Overall Study|Taking exclusionary medications|0|||
30695535|NCT00688688|58709904|FG000|Overall Study|Site closure|0|||
30695536|NCT00688688|58709905|FG001|Overall Study|Site closure|1|||
30695537|NCT00688688|58709906|FG002|Overall Study|Site closure|0|||
30695538|NCT00688688|58709904|FG000|Overall Study|Violation of exclusion criterion|0|||
30695539|NCT00688688|58709905|FG001|Overall Study|Violation of exclusion criterion|1|||
30695540|NCT00688688|58709906|FG002|Overall Study|Violation of exclusion criterion|0|||
30695541|NCT00664326|58709914|FG000|Overall Study|Adverse Event|14|||
30695542|NCT00664326|58709914|FG000|Overall Study|Noncompliance with study medication|3|||
30695543|NCT00664326|58709914|FG000|Overall Study|Withdrawal by Subject|1|||
30695544|NCT00664326|58709914|FG000|Overall Study|Physician Decision|1|||
30695545|NCT00664326|58709914|FG000|Overall Study|Other Reasons|3|||
30695546|NCT00664326|58709914|FG000|Overall Study|Death|2|||
30695547|NCT00664326|58709914|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
30695548|NCT00686972|58709918|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
30695549|NCT00665652|58709922|FG000|Overall Study|Adverse Event|4|||
30695550|NCT00665652|58709922|FG000|Overall Study|Death|1|||
30873928|NCT02544633|58904631|FG002|Treatment Period|Clinical Disease Progression|0|||
30695551|NCT00665652|58709922|FG000|Overall Study|No longer met inclusion criteria.|1|||
30695552|NCT00566631|58709926|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
30695553|NCT00566631|58709926|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
30695554|NCT00566631|58709926|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
30695555|NCT00566631|58709926|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
30695556|NCT00566631|58709926|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
30695557|NCT00566631|58709926|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
30695558|NCT00566631|58709926|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
30695559|NCT00566631|58709926|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
30695560|NCT00566631|58709926|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
30695561|NCT00566631|58709926|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
30695562|NCT00566631|58709926|FG000|Part 2: Extension Phase|Adverse Event|11|||
30695563|NCT00566631|58709926|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
30695564|NCT00566631|58709926|FG000|Part 2: Extension Phase|Death|1|||
30695565|NCT00566631|58709926|FG000|Part 2: Extension Phase|Other|5|||
30695566|NCT00661830|58709932|FG000|Overall Study|Death|37|||
30695567|NCT00661830|58709933|FG001|Overall Study|Death|33|||
30695568|NCT00661830|58709932|FG000|Overall Study|Lost to Follow-up|1|||
30695569|NCT00661830|58709933|FG001|Overall Study|Lost to Follow-up|3|||
30695570|NCT00661830|58709932|FG000|Overall Study|Withdrawal by Subject|1|||
30695571|NCT00661830|58709933|FG001|Overall Study|Withdrawal by Subject|1|||
30695572|NCT00661830|58709932|FG000|Overall Study|Other reason|1|||
30695573|NCT00661830|58709933|FG001|Overall Study|Other reason|5|||
30695574|NCT00540592|58709949|FG000|Overall Study|Adverse Event|0|||
30695575|NCT00540592|58709950|FG001|Overall Study|Adverse Event|1|||
30695576|NCT00540592|58709951|FG002|Overall Study|Adverse Event|0|||
30695577|NCT00540592|58709952|FG003|Overall Study|Adverse Event|0|||
30695578|NCT00540592|58709953|FG004|Overall Study|Adverse Event|1|||
30695579|NCT00540592|58709954|FG005|Overall Study|Adverse Event|0|||
30695580|NCT00540592|58709955|FG006|Overall Study|Adverse Event|0|||
30695581|NCT00540592|58709956|FG007|Overall Study|Adverse Event|1|||
30695582|NCT00540592|58709957|FG008|Overall Study|Adverse Event|1|||
30695583|NCT00540592|58709958|FG009|Overall Study|Adverse Event|2|||
30695584|NCT00540592|58709949|FG000|Overall Study|Lost to Follow-up|2|||
30695585|NCT00540592|58709950|FG001|Overall Study|Lost to Follow-up|0|||
30695586|NCT00540592|58709951|FG002|Overall Study|Lost to Follow-up|0|||
30695587|NCT00540592|58709952|FG003|Overall Study|Lost to Follow-up|0|||
30695588|NCT00540592|58709953|FG004|Overall Study|Lost to Follow-up|0|||
30695589|NCT00540592|58709954|FG005|Overall Study|Lost to Follow-up|0|||
30695590|NCT00540592|58709955|FG006|Overall Study|Lost to Follow-up|0|||
30695591|NCT00540592|58709956|FG007|Overall Study|Lost to Follow-up|0|||
30695592|NCT00540592|58709957|FG008|Overall Study|Lost to Follow-up|0|||
30695593|NCT00540592|58709958|FG009|Overall Study|Lost to Follow-up|0|||
30695594|NCT00540592|58709949|FG000|Overall Study|Withdrawal by Subject|0|||
30695595|NCT00540592|58709950|FG001|Overall Study|Withdrawal by Subject|0|||
30695596|NCT00540592|58709951|FG002|Overall Study|Withdrawal by Subject|1|||
30695597|NCT00540592|58709952|FG003|Overall Study|Withdrawal by Subject|1|||
30695598|NCT00540592|58709953|FG004|Overall Study|Withdrawal by Subject|0|||
30695599|NCT00540592|58709954|FG005|Overall Study|Withdrawal by Subject|0|||
30695600|NCT00540592|58709955|FG006|Overall Study|Withdrawal by Subject|0|||
30695601|NCT00540592|58709956|FG007|Overall Study|Withdrawal by Subject|0|||
30695602|NCT00540592|58709957|FG008|Overall Study|Withdrawal by Subject|0|||
30695603|NCT00540592|58709958|FG009|Overall Study|Withdrawal by Subject|0|||
30695604|NCT03970395|58709982|FG000|Overall Study|Withdrawal by Subject|3|||
30695605|NCT03970395|58709983|FG001|Overall Study|Withdrawal by Subject|4|||
30695606|NCT03970395|58709982|FG000|Overall Study|Lost to Follow-up|4|||
30695607|NCT03970395|58709983|FG001|Overall Study|Lost to Follow-up|8|||
30695608|NCT00565773|58709993|FG000|Overall Study|Withdrawal by Subject|1|||
30695609|NCT00565773|58709993|FG000|Overall Study|Physician Decision|1|||
30695610|NCT00570492|58709999|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
30695611|NCT00570492|58710000|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
30695612|NCT00570492|58710001|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
30695613|NCT00570492|58709999|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
30695614|NCT00570492|58710000|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
30695615|NCT00570492|58710001|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
30695616|NCT00570492|58709999|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
30695617|NCT00570492|58710000|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
30695618|NCT00570492|58710001|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
30695619|NCT00570492|58709999|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
30695620|NCT00570492|58710000|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
30695621|NCT00570492|58710001|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
30695622|NCT00570492|58709999|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
30695623|NCT00570492|58710000|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
30695624|NCT00570492|58710001|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
30695625|NCT00570492|58709999|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
30695626|NCT00570492|58710000|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
30695627|NCT00570492|58710001|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
30695628|NCT00570492|58709999|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
30695629|NCT00570492|58710000|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
30695630|NCT00570492|58710001|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
30695631|NCT00570492|58709999|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
30695632|NCT00570492|58710000|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
30695633|NCT00570492|58710001|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
30695634|NCT00570492|58709999|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
30695635|NCT00570492|58710000|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
30695636|NCT00570492|58710001|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
30695637|NCT00570492|58709999|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
30695638|NCT00570492|58710000|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
30695639|NCT00570492|58710001|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
30695640|NCT00570492|58709999|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
30695641|NCT00570492|58710000|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
30695642|NCT00570492|58710001|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
30695643|NCT00570492|58709999|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
30695644|NCT00570492|58710000|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
30695645|NCT00570492|58710001|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
30695646|NCT00570492|58709999|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
30695647|NCT00570492|58710000|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
30695648|NCT00570492|58710001|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
30695649|NCT00570492|58709999|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
30695650|NCT00570492|58710000|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
30695651|NCT00570492|58710001|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
30695652|NCT00571922|58710009|FG000|Overall Study|Completion unknown|36|||
30695653|NCT00571922|58710010|FG001|Overall Study|Completion unknown|36|||
30695654|NCT00686894|58710016|FG000|Overall Study|Relapse|2|||
30695655|NCT00686894|58710016|FG000|Overall Study|Protocol Violation|4|||
30695656|NCT00328627|58710032|FG000|Overall Study|Hyperglycemic Rescue|41|||
30695657|NCT00328627|58710033|FG001|Overall Study|Hyperglycemic Rescue|18|||
30695658|NCT00328627|58710034|FG002|Overall Study|Hyperglycemic Rescue|16|||
30695659|NCT00328627|58710035|FG003|Overall Study|Hyperglycemic Rescue|13|||
30695660|NCT00328627|58710036|FG004|Overall Study|Hyperglycemic Rescue|6|||
30695661|NCT00328627|58710037|FG005|Overall Study|Hyperglycemic Rescue|5|||
30695662|NCT00328627|58710038|FG006|Overall Study|Hyperglycemic Rescue|19|||
30695663|NCT00328627|58710039|FG007|Overall Study|Hyperglycemic Rescue|6|||
30695664|NCT00328627|58710040|FG008|Overall Study|Hyperglycemic Rescue|6|||
30695665|NCT00328627|58710041|FG009|Overall Study|Hyperglycemic Rescue|11|||
30695666|NCT00328627|58710042|FG010|Overall Study|Hyperglycemic Rescue|3|||
30695667|NCT00328627|58710043|FG011|Overall Study|Hyperglycemic Rescue|2|||
30873929|NCT02544633|58904632|FG003|Treatment Period|Clinical Disease Progression|1|||
30873930|NCT02544633|58904629|FG000|Survival Follow-up Period|Death|12|||
30873931|NCT02544633|58904630|FG001|Survival Follow-up Period|Death|14|||
30873932|NCT02544633|58904631|FG002|Survival Follow-up Period|Death|3|||
30873933|NCT02544633|58904632|FG003|Survival Follow-up Period|Death|9|||
30873934|NCT02544633|58904629|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
30873935|NCT02544633|58904630|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
30873936|NCT02544633|58904631|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
30873937|NCT02544633|58904632|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
30873938|NCT02544633|58904629|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
30873939|NCT02544633|58904630|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
30873940|NCT02544633|58904631|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
30873941|NCT02544633|58904632|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
30873942|NCT02544633|58904629|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
30873943|NCT02544633|58904630|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
30873944|NCT02544633|58904631|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
30873945|NCT02544633|58904632|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
30873946|NCT02678351|58904654|FG000|Overall Study|Withdrawal by Subject|1|||
30873947|NCT02683187|58904658|FG000|Overall Study|Failed IV access|3|||
30873948|NCT02683187|58904658|FG000|Overall Study|Withdrawal by Subject|5|||
30873949|NCT02683109|58904668|FG000|Overall Study|Adverse Event|1|||
30873950|NCT02683109|58904669|FG001|Overall Study|Adverse Event|0|||
30873951|NCT02544321|58904678|FG000|Overall Study|Withdrawal by Subject|1|||
30873952|NCT02544321|58904679|FG001|Overall Study|Withdrawal by Subject|2|||
30873953|NCT02544321|58904678|FG000|Overall Study|Adverse Event|1|||
30873954|NCT02544321|58904679|FG001|Overall Study|Adverse Event|1|||
30873955|NCT02544321|58904678|FG000|Overall Study|Protocol Violation|0|||
30873956|NCT02544321|58904679|FG001|Overall Study|Protocol Violation|1|||
30873957|NCT02533401|58904694|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
30873958|NCT02533401|58904694|FG000|Overall Study|Death|5|||
30873959|NCT02533401|58904694|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
30873960|NCT02533401|58904694|FG000|Overall Study|Lost to Follow-up|1|||
30873961|NCT02533401|58904694|FG000|Overall Study|Violation of Selection Criteria|1|||
30873962|NCT02536833|58904702|FG000|Overall Study|Discontinued Before Treatment|0|||
30873963|NCT02536833|58904703|FG001|Overall Study|Discontinued Before Treatment|0|||
30873964|NCT02536833|58904704|FG002|Overall Study|Discontinued Before Treatment|1|||
30873965|NCT02536833|58904705|FG003|Overall Study|Discontinued Before Treatment|2|||
30873966|NCT02536833|58904702|FG000|Overall Study|Adverse Event|1|||
30873967|NCT02536833|58904703|FG001|Overall Study|Adverse Event|3|||
30873968|NCT02536833|58904704|FG002|Overall Study|Adverse Event|4|||
30873969|NCT02536833|58904705|FG003|Overall Study|Adverse Event|1|||
30873970|NCT02536833|58904702|FG000|Overall Study|Lost to Follow-up|2|||
30873971|NCT02536833|58904703|FG001|Overall Study|Lost to Follow-up|1|||
30873972|NCT02536833|58904704|FG002|Overall Study|Lost to Follow-up|2|||
30873973|NCT02536833|58904705|FG003|Overall Study|Lost to Follow-up|2|||
30873974|NCT02536833|58904702|FG000|Overall Study|Physician Decision|0|||
30873975|NCT02536833|58904703|FG001|Overall Study|Physician Decision|0|||
30873976|NCT02536833|58904704|FG002|Overall Study|Physician Decision|0|||
30873977|NCT02536833|58904705|FG003|Overall Study|Physician Decision|1|||
30873978|NCT02536833|58904702|FG000|Overall Study|Site Terminated by Sponsor|2|||
30873979|NCT02536833|58904703|FG001|Overall Study|Site Terminated by Sponsor|2|||
30873980|NCT02536833|58904704|FG002|Overall Study|Site Terminated by Sponsor|2|||
30873981|NCT02536833|58904705|FG003|Overall Study|Site Terminated by Sponsor|2|||
30873982|NCT02536833|58904702|FG000|Overall Study|Subject Non-Compliance|0|||
30873983|NCT02536833|58904703|FG001|Overall Study|Subject Non-Compliance|1|||
30873984|NCT02536833|58904704|FG002|Overall Study|Subject Non-Compliance|1|||
30873985|NCT02536833|58904705|FG003|Overall Study|Subject Non-Compliance|0|||
30873986|NCT02536833|58904702|FG000|Overall Study|Withdrawal by Subject|4|||
30873987|NCT02536833|58904703|FG001|Overall Study|Withdrawal by Subject|3|||
30873988|NCT02536833|58904704|FG002|Overall Study|Withdrawal by Subject|5|||
30873989|NCT02536833|58904705|FG003|Overall Study|Withdrawal by Subject|11|||
30873990|NCT02680847|58904719|FG000|Overall Study|Other|2|||
30873991|NCT02680847|58904720|FG001|Overall Study|Other|0|||
30873992|NCT02680847|58904721|FG002|Overall Study|Other|0|||
30873993|NCT02680847|58904719|FG000|Overall Study|No longer met eligibility criteria|2|||
30873994|NCT02680847|58904720|FG001|Overall Study|No longer met eligibility criteria|2|||
30873995|NCT02680847|58904721|FG002|Overall Study|No longer met eligibility criteria|0|||
30873996|NCT02680847|58904719|FG000|Overall Study|Unwilling to participate in study|1|||
30873997|NCT02680847|58904720|FG001|Overall Study|Unwilling to participate in study|1|||
30873998|NCT02680847|58904721|FG002|Overall Study|Unwilling to participate in study|0|||
30873999|NCT02680847|58904719|FG000|Overall Study|Lack of Efficacy|0|||
30874000|NCT02680847|58904720|FG001|Overall Study|Lack of Efficacy|0|||
30874001|NCT02680847|58904721|FG002|Overall Study|Lack of Efficacy|2|||
30874002|NCT02680847|58904719|FG000|Overall Study|Adverse Event|0|||
30874003|NCT02680847|58904720|FG001|Overall Study|Adverse Event|0|||
30874004|NCT02680847|58904721|FG002|Overall Study|Adverse Event|1|||
30874005|NCT02532855|58904731|FG000|Overall Study|Lost to Follow-up|4|||
30874006|NCT02532855|58904732|FG001|Overall Study|Lost to Follow-up|3|||
30874007|NCT02532855|58904731|FG000|Overall Study|Withdrawal by Subject|4|||
30874008|NCT02532855|58904732|FG001|Overall Study|Withdrawal by Subject|8|||
30874009|NCT02530125|58904738|FG000|Completed Treatment|Early termination of study|1|||
30961593|NCT02660580|59028268|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
30961594|NCT02660580|59028269|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
30961595|NCT02660580|59028265|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
30961596|NCT02660580|59028266|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
30695668|NCT00328627|58710032|FG000|Overall Study|Adverse Event|3|||
30695669|NCT00328627|58710033|FG001|Overall Study|Adverse Event|1|||
30695670|NCT00328627|58710034|FG002|Overall Study|Adverse Event|2|||
30695671|NCT00328627|58710035|FG003|Overall Study|Adverse Event|3|||
30695672|NCT00328627|58710036|FG004|Overall Study|Adverse Event|1|||
30695673|NCT00328627|58710037|FG005|Overall Study|Adverse Event|2|||
30961597|NCT02660580|59028267|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
30961598|NCT02660580|59028268|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
30961599|NCT02660580|59028269|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
30961600|NCT02660580|59028265|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
30961601|NCT02660580|59028266|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
30874010|NCT02530125|58904738|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
30874011|NCT01661205|58904742|FG000|Overall Study|Physician Decision|2|||
30874012|NCT02055820|58904756|FG000|Phase I: Dose-Finding|Death|1|||
30695674|NCT00328627|58710038|FG006|Overall Study|Adverse Event|1|||
30695675|NCT00328627|58710039|FG007|Overall Study|Adverse Event|2|||
30874013|NCT02055820|58904757|FG001|Phase I: Dose-Finding|Death|0|||
30874014|NCT02055820|58904758|FG002|Phase I: Dose-Finding|Death|1|||
30874015|NCT02055820|58904759|FG003|Phase I: Dose-Finding|Death|2|||
30874016|NCT02055820|58904760|FG004|Phase I: Dose-Finding|Death|0|||
30874017|NCT02055820|58904761|FG005|Phase I: Dose-Finding|Death|1|||
30874018|NCT02055820|58904762|FG006|Phase I: Dose-Finding|Death|1|||
30874019|NCT02055820|58904763|FG007|Phase I: Dose-Finding|Death|0|||
30961602|NCT02660580|59028267|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
30961603|NCT02660580|59028268|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
30961604|NCT02660580|59028269|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
30961605|NCT02660580|59028265|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
30961606|NCT02660580|59028266|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
30961607|NCT02660580|59028267|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
30961608|NCT02660580|59028268|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
30961609|NCT02660580|59028269|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
30961610|NCT02660580|59028265|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
30961611|NCT02660580|59028266|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
30961612|NCT02660580|59028267|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
30961613|NCT02660580|59028268|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
30961614|NCT02660580|59028269|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
30961615|NCT02660580|59028265|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
30961616|NCT02660580|59028266|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
30961617|NCT02660580|59028267|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
30961618|NCT02660580|59028268|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
30961619|NCT02660580|59028269|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
30961620|NCT01524991|59028288|FG000|Overall Study|Adverse Event|12|||
30961621|NCT01524991|59028288|FG000|Overall Study|Death|1|||
30961622|NCT01524991|59028288|FG000|Overall Study|Disease ProgressionDu|17|||
30961623|NCT01524991|59028288|FG000|Overall Study|Other complicating disease|1|||
30961624|NCT01524991|59028288|FG000|Overall Study|Withdrawal by Subject|2|||
30961625|NCT01524991|59028288|FG000|Overall Study|Symptomatic Deterioration|1|||
30961626|NCT01524913|59028295|FG000|Overall Study|Lost to Follow-up|4|||
30961627|NCT01524913|59028296|FG001|Overall Study|Lost to Follow-up|0|||
30961628|NCT01524913|59028297|FG002|Overall Study|Lost to Follow-up|0|||
30961629|NCT01524679|59028307|FG000|Overall Study|Lost to Follow-up|1|||
30961630|NCT01524679|59028308|FG001|Overall Study|Lost to Follow-up|4|||
30961631|NCT01524679|59028307|FG000|Overall Study|Withdrawal by Subject|4|||
30961632|NCT01524679|59028308|FG001|Overall Study|Withdrawal by Subject|4|||
30961633|NCT01524679|59028307|FG000|Overall Study|Adverse Event|9|||
30961634|NCT01524679|59028308|FG001|Overall Study|Adverse Event|0|||
30961635|NCT01524679|59028307|FG000|Overall Study|Protocol Violation|1|||
30961636|NCT01524679|59028308|FG001|Overall Study|Protocol Violation|0|||
30961637|NCT01524679|59028307|FG000|Overall Study|Lack of Efficacy|2|||
30961638|NCT01524679|59028308|FG001|Overall Study|Lack of Efficacy|0|||
30961639|NCT01524679|59028307|FG000|Overall Study|e.g.wish for children, relocation|6|||
30961640|NCT01524679|59028308|FG001|Overall Study|e.g.wish for children, relocation|1|||
30961641|NCT01524289|59028325|FG000|Overall Study|Lost to Follow-up|0|||
30961642|NCT01524289|59028326|FG001|Overall Study|Lost to Follow-up|1|||
30961643|NCT01524289|59028325|FG000|Overall Study|Physician Decision|1|||
30961644|NCT01524289|59028326|FG001|Overall Study|Physician Decision|0|||
30961645|NCT01524289|59028325|FG000|Overall Study|Protocol Violation|5|||
30961646|NCT01524289|59028326|FG001|Overall Study|Protocol Violation|1|||
30961647|NCT01524289|59028325|FG000|Overall Study|Withdrawal by Subject|11|||
30961648|NCT01524289|59028326|FG001|Overall Study|Withdrawal by Subject|7|||
30961649|NCT01524289|59028325|FG000|Overall Study|Adverse Event|12|||
30961650|NCT01524289|59028326|FG001|Overall Study|Adverse Event|5|||
30961651|NCT01524289|59028325|FG000|Overall Study|Did not take study medication|1|||
30874020|NCT02055820|58904764|FG008|Phase I: Dose-Finding|Death|0|||
30874021|NCT02055820|58904765|FG009|Phase I: Dose-Finding|Death|0|||
30874022|NCT02055820|58904756|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
30874023|NCT02055820|58904757|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
30874024|NCT02055820|58904758|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
30874025|NCT02055820|58904759|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
30874026|NCT02055820|58904760|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
30874027|NCT02055820|58904761|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
30874028|NCT02055820|58904762|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
30874029|NCT02055820|58904763|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
30874030|NCT02055820|58904764|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
30874031|NCT02055820|58904765|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
30874032|NCT02055820|58904756|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
30874033|NCT02055820|58904757|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
30874034|NCT02055820|58904758|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
30874035|NCT02055820|58904759|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
30874036|NCT02055820|58904760|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
30874037|NCT02055820|58904761|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
30874038|NCT02055820|58904762|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
30874039|NCT02055820|58904763|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
30874040|NCT02055820|58904764|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
30874041|NCT02055820|58904765|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
30874042|NCT02055820|58904756|FG000|Phase II: Expansion|Death|0|||
30961652|NCT01524289|59028326|FG001|Overall Study|Did not take study medication|0|||
30961653|NCT01498289|59028336|FG000|Overall Study|Adverse Event|16|||
30961654|NCT01498289|59028337|FG001|Overall Study|Adverse Event|18|||
30961655|NCT01498289|59028336|FG000|Overall Study|Death|6|||
30961656|NCT01498289|59028337|FG001|Overall Study|Death|8|||
30961657|NCT01498289|59028336|FG000|Overall Study|Withdrawal unrelated to AE|16|||
30961658|NCT01498289|59028337|FG001|Overall Study|Withdrawal unrelated to AE|16|||
30961659|NCT01498289|59028336|FG000|Overall Study|Progression/relapse|53|||
30961660|NCT01498289|59028337|FG001|Overall Study|Progression/relapse|59|||
30961661|NCT01498289|59028336|FG000|Overall Study|Not protocol specified|7|||
30961662|NCT01498289|59028337|FG001|Overall Study|Not protocol specified|2|||
30961663|NCT01498289|59028336|FG000|Overall Study|Reason under review|0|||
30961664|NCT01498289|59028337|FG001|Overall Study|Reason under review|1|||
30961665|NCT01524133|59028350|FG000|Treatment Phase|Withdrawal by Subject|13|||
30961666|NCT01524133|59028351|FG001|Treatment Phase|Withdrawal by Subject|28|||
30961667|NCT01524133|59028352|FG002|Treatment Phase|Withdrawal by Subject|31|||
30961668|NCT01524133|59028350|FG000|Treatment Phase|Physician Decision|6|||
30961669|NCT01524133|59028351|FG001|Treatment Phase|Physician Decision|3|||
30961670|NCT01524133|59028352|FG002|Treatment Phase|Physician Decision|3|||
30961671|NCT01524133|59028350|FG000|Treatment Phase|Lost to Follow-up|0|||
30961672|NCT01524133|59028351|FG001|Treatment Phase|Lost to Follow-up|1|||
30961673|NCT01524133|59028352|FG002|Treatment Phase|Lost to Follow-up|2|||
30961674|NCT01524133|59028350|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
30961675|NCT01524133|59028351|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
30961676|NCT01524133|59028352|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
30961677|NCT01524133|59028350|FG000|Overall Study 52 Weeks|Physician Decision|1|||
30961678|NCT01524133|59028351|FG001|Overall Study 52 Weeks|Physician Decision|0|||
30961679|NCT01524133|59028352|FG002|Overall Study 52 Weeks|Physician Decision|2|||
30961680|NCT01524133|59028350|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
30961681|NCT01524133|59028351|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
30961682|NCT01524133|59028352|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
30961683|NCT04304534|59028386|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
30961684|NCT04304534|59028387|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
30961685|NCT04304534|59028388|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
30961686|NCT04304534|59028389|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
30961687|NCT04304534|59028386|FG000|Overall Study|Non-Compliance with study drug|0|||
30961688|NCT04304534|59028387|FG001|Overall Study|Non-Compliance with study drug|1|||
30961689|NCT04304534|59028388|FG002|Overall Study|Non-Compliance with study drug|1|||
30961690|NCT04304534|59028389|FG003|Overall Study|Non-Compliance with study drug|1|||
30961691|NCT04304534|59028386|FG000|Overall Study|Lost to Follow-up|0|||
30961692|NCT04304534|59028387|FG001|Overall Study|Lost to Follow-up|1|||
30961693|NCT04304534|59028388|FG002|Overall Study|Lost to Follow-up|2|||
30961694|NCT04304534|59028389|FG003|Overall Study|Lost to Follow-up|3|||
30961695|NCT04304534|59028386|FG000|Overall Study|Unspecific|4|||
30961696|NCT04304534|59028387|FG001|Overall Study|Unspecific|2|||
30961697|NCT04304534|59028388|FG002|Overall Study|Unspecific|2|||
30961698|NCT04304534|59028389|FG003|Overall Study|Unspecific|2|||
30961699|NCT04304534|59028386|FG000|Overall Study|Technical Problems|2|||
30961700|NCT04304534|59028387|FG001|Overall Study|Technical Problems|2|||
30961701|NCT04304534|59028388|FG002|Overall Study|Technical Problems|3|||
30961702|NCT04304534|59028389|FG003|Overall Study|Technical Problems|4|||
30961703|NCT04304534|59028386|FG000|Overall Study|Death|7|||
30961704|NCT04304534|59028387|FG001|Overall Study|Death|2|||
30961705|NCT04304534|59028388|FG002|Overall Study|Death|4|||
30961706|NCT04304534|59028389|FG003|Overall Study|Death|3|||
30961707|NCT04304534|59028386|FG000|Overall Study|Withdrawal by Subject|7|||
30961708|NCT04304534|59028387|FG001|Overall Study|Withdrawal by Subject|2|||
30961709|NCT04304534|59028388|FG002|Overall Study|Withdrawal by Subject|7|||
30961710|NCT04304534|59028389|FG003|Overall Study|Withdrawal by Subject|4|||
30961711|NCT04304534|59028386|FG000|Overall Study|Physician Decision|4|||
30961712|NCT04304534|59028387|FG001|Overall Study|Physician Decision|9|||
30961713|NCT04304534|59028388|FG002|Overall Study|Physician Decision|9|||
30961714|NCT04304534|59028389|FG003|Overall Study|Physician Decision|5|||
30961715|NCT04304534|59028386|FG000|Overall Study|Subject Decision|34|||
30961716|NCT04304534|59028387|FG001|Overall Study|Subject Decision|25|||
30961717|NCT04304534|59028388|FG002|Overall Study|Subject Decision|25|||
30961718|NCT04304534|59028389|FG003|Overall Study|Subject Decision|26|||
30961719|NCT04304534|59028386|FG000|Overall Study|Adverse Event|35|||
30961720|NCT04304534|59028387|FG001|Overall Study|Adverse Event|40|||
30961721|NCT04304534|59028388|FG002|Overall Study|Adverse Event|39|||
30961722|NCT04304534|59028389|FG003|Overall Study|Adverse Event|44|||
30961723|NCT04223609|59028402|FG000|Overall Study|Adverse Event|0|||
30961724|NCT04223609|59028403|FG001|Overall Study|Adverse Event|1|||
30961725|NCT04223609|59028402|FG000|Overall Study|Missed last visit|0|||
30961726|NCT04223609|59028403|FG001|Overall Study|Missed last visit|1|||
30961727|NCT04176458|59028409|FG000|Overall Study|Covid 19|4|||
30961728|NCT03941548|59028415|FG000|Overall Study|Adverse Event|0|||
30961729|NCT03941548|59028416|FG001|Overall Study|Adverse Event|1|||
30961730|NCT03941548|59028415|FG000|Overall Study|Lost to Follow-up|0|||
30961731|NCT03941548|59028416|FG001|Overall Study|Lost to Follow-up|1|||
30961732|NCT03941548|59028415|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
30961733|NCT03941548|59028416|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
30961734|NCT03925727|59028425|FG000|Overall Study|Adverse Event|4|||
30961735|NCT03925727|59028426|FG001|Overall Study|Adverse Event|0|||
30961736|NCT03925727|59028427|FG002|Overall Study|Adverse Event|3|||
30961737|NCT03925727|59028425|FG000|Overall Study|Protocol Violation|1|||
30961738|NCT03925727|59028426|FG001|Overall Study|Protocol Violation|2|||
30961739|NCT03925727|59028427|FG002|Overall Study|Protocol Violation|2|||
30961740|NCT03925727|59028425|FG000|Overall Study|Withdrawal by Subject|3|||
30961741|NCT03925727|59028426|FG001|Overall Study|Withdrawal by Subject|2|||
30961742|NCT03925727|59028427|FG002|Overall Study|Withdrawal by Subject|4|||
30961743|NCT03925727|59028425|FG000|Overall Study|Administrative Reasons|3|||
30961744|NCT03925727|59028426|FG001|Overall Study|Administrative Reasons|1|||
30961745|NCT03925727|59028427|FG002|Overall Study|Administrative Reasons|2|||
30961746|NCT03925727|59028425|FG000|Overall Study|Randomized in error or Disqualified|8|||
30961747|NCT03925727|59028426|FG001|Overall Study|Randomized in error or Disqualified|1|||
30961748|NCT03925727|59028427|FG002|Overall Study|Randomized in error or Disqualified|7|||
30961749|NCT03387150|59028444|FG000|Overall Study|Withdrawal by Subject|3|||
30961750|NCT03387150|59028445|FG001|Overall Study|Withdrawal by Subject|0|||
30961751|NCT03387150|59028446|FG002|Overall Study|Withdrawal by Subject|3|||
30961752|NCT03387150|59028447|FG003|Overall Study|Withdrawal by Subject|4|||
30961753|NCT03387150|59028448|FG004|Overall Study|Withdrawal by Subject|1|||
30961754|NCT03387150|59028449|FG005|Overall Study|Withdrawal by Subject|2|||
30961755|NCT03387150|59028450|FG006|Overall Study|Withdrawal by Subject|0|||
30961756|NCT03387150|59028444|FG000|Overall Study|Lost to Follow-up|3|||
30961757|NCT03387150|59028445|FG001|Overall Study|Lost to Follow-up|2|||
30961758|NCT03387150|59028446|FG002|Overall Study|Lost to Follow-up|2|||
30961759|NCT03387150|59028447|FG003|Overall Study|Lost to Follow-up|3|||
30961760|NCT03387150|59028448|FG004|Overall Study|Lost to Follow-up|3|||
30961761|NCT03387150|59028449|FG005|Overall Study|Lost to Follow-up|3|||
30961762|NCT03387150|59028450|FG006|Overall Study|Lost to Follow-up|0|||
30961763|NCT03387150|59028444|FG000|Overall Study|Participant unable to adhere to visit|0|||
30961764|NCT03387150|59028445|FG001|Overall Study|Participant unable to adhere to visit|1|||
30961765|NCT03387150|59028446|FG002|Overall Study|Participant unable to adhere to visit|0|||
30961766|NCT03387150|59028447|FG003|Overall Study|Participant unable to adhere to visit|0|||
30961767|NCT03387150|59028448|FG004|Overall Study|Participant unable to adhere to visit|2|||
30961768|NCT03387150|59028449|FG005|Overall Study|Participant unable to adhere to visit|2|||
30961769|NCT03387150|59028450|FG006|Overall Study|Participant unable to adhere to visit|0|||
30961770|NCT03289208|59028482|FG000|Overall Study|Adverse Event|1|||
30961771|NCT03289208|59028483|FG001|Overall Study|Adverse Event|0|||
30961772|NCT03289208|59028484|FG002|Overall Study|Adverse Event|0|||
30961773|NCT03244059|59028494|FG000|Specific Aim 1|Physician Decision|1|||
30961774|NCT03244059|59028495|FG001|Specific Aim 1|Physician Decision|0|||
30961775|NCT03244059|59028494|FG000|Specific Aim 2|Physician Decision|1|||
30961776|NCT03244059|59028495|FG001|Specific Aim 2|Physician Decision|0|||
30961777|NCT03036566|59028514|FG000|Overall Study|Lost to Follow-up|3|||
30961778|NCT02754141|59028545|FG000|Overall Study|Disease progression|11|||
30961779|NCT02754141|59028546|FG001|Overall Study|Disease progression|7|||
30961780|NCT02754141|59028547|FG002|Overall Study|Disease progression|8|||
30961781|NCT02754141|59028548|FG003|Overall Study|Disease progression|5|||
30961782|NCT02754141|59028549|FG004|Overall Study|Disease progression|7|||
30961783|NCT02754141|59028550|FG005|Overall Study|Disease progression|7|||
30961784|NCT02754141|59028551|FG006|Overall Study|Disease progression|7|||
30961785|NCT02754141|59028552|FG007|Overall Study|Disease progression|6|||
30961786|NCT02754141|59028553|FG008|Overall Study|Disease progression|11|||
30961787|NCT02754141|59028554|FG009|Overall Study|Disease progression|16|||
30961788|NCT02754141|59028555|FG010|Overall Study|Disease progression|18|||
30961789|NCT02754141|59028556|FG011|Overall Study|Disease progression|13|||
30961790|NCT02754141|59028557|FG012|Overall Study|Disease progression|10|||
30961791|NCT02754141|59028558|FG013|Overall Study|Disease progression|12|||
30961792|NCT02754141|59028559|FG014|Overall Study|Disease progression|12|||
30961793|NCT02754141|59028560|FG015|Overall Study|Disease progression|14|||
30961794|NCT02754141|59028561|FG016|Overall Study|Disease progression|0|||
30961795|NCT02754141|59028562|FG017|Overall Study|Disease progression|1|||
30961796|NCT02754141|59028545|FG000|Overall Study|Study drug toxicity|1|||
30961797|NCT02754141|59028546|FG001|Overall Study|Study drug toxicity|1|||
30961798|NCT02754141|59028547|FG002|Overall Study|Study drug toxicity|0|||
30961799|NCT02754141|59028548|FG003|Overall Study|Study drug toxicity|0|||
30961800|NCT02754141|59028549|FG004|Overall Study|Study drug toxicity|0|||
30961801|NCT02754141|59028550|FG005|Overall Study|Study drug toxicity|0|||
30961802|NCT02754141|59028551|FG006|Overall Study|Study drug toxicity|0|||
30961803|NCT02754141|59028552|FG007|Overall Study|Study drug toxicity|0|||
30961804|NCT02754141|59028553|FG008|Overall Study|Study drug toxicity|0|||
30961805|NCT02754141|59028554|FG009|Overall Study|Study drug toxicity|0|||
30961806|NCT02754141|59028555|FG010|Overall Study|Study drug toxicity|2|||
30961807|NCT02754141|59028556|FG011|Overall Study|Study drug toxicity|1|||
30961808|NCT02754141|59028557|FG012|Overall Study|Study drug toxicity|1|||
30961809|NCT02754141|59028558|FG013|Overall Study|Study drug toxicity|0|||
30961810|NCT02754141|59028559|FG014|Overall Study|Study drug toxicity|0|||
30961811|NCT02754141|59028560|FG015|Overall Study|Study drug toxicity|0|||
30961812|NCT02754141|59028561|FG016|Overall Study|Study drug toxicity|0|||
30961813|NCT02754141|59028562|FG017|Overall Study|Study drug toxicity|0|||
30961814|NCT02754141|59028545|FG000|Overall Study|AE unrelated to study drug|1|||
30961815|NCT02754141|59028546|FG001|Overall Study|AE unrelated to study drug|1|||
30604193|NCT01232283|58615309|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
30604194|NCT01232283|58615300|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
30604195|NCT01232283|58615301|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
30604196|NCT01232283|58615302|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
30604197|NCT01232283|58615303|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
30604198|NCT01232283|58615304|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
30604199|NCT01232283|58615305|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
30604200|NCT01232283|58615306|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
30604201|NCT01232283|58615307|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
30604202|NCT01232283|58615308|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
30604203|NCT01232283|58615309|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
30604204|NCT01232283|58615300|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
30604205|NCT01232283|58615301|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
30604206|NCT01232283|58615302|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
30604207|NCT01232283|58615303|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
30604208|NCT01232283|58615304|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
30604209|NCT01232283|58615305|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
30604210|NCT01232283|58615306|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
30604211|NCT01232283|58615307|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
30604212|NCT01232283|58615308|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
30604213|NCT01232283|58615309|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
30604214|NCT01232283|58615300|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
30604215|NCT01232283|58615301|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
30604216|NCT01232283|58615302|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
30604217|NCT01232283|58615303|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
30604218|NCT01232283|58615304|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
30604219|NCT01232283|58615305|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
30604220|NCT01232283|58615306|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
30604221|NCT01232283|58615307|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
30604222|NCT01232283|58615308|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
30604223|NCT01232283|58615309|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
30604224|NCT01232283|58615300|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
30604225|NCT01232283|58615301|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
30604226|NCT01232283|58615302|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
30604227|NCT01232283|58615303|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
30604228|NCT01232283|58615304|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
30604229|NCT01232283|58615305|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
30604230|NCT01232283|58615306|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
30604231|NCT01232283|58615307|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
30604232|NCT01232283|58615308|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
30604233|NCT01232283|58615309|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
30604234|NCT01232283|58615300|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
30604235|NCT01232283|58615301|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
30604236|NCT01232283|58615302|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
30604237|NCT01232283|58615303|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
30604238|NCT01232283|58615304|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
30604239|NCT01232283|58615305|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
30604240|NCT01232283|58615306|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
30604241|NCT01232283|58615307|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
30604242|NCT01232283|58615308|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
30604243|NCT01232283|58615309|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
30604244|NCT01232283|58615300|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
30604245|NCT01232283|58615301|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
30961816|NCT02754141|59028547|FG002|Overall Study|AE unrelated to study drug|0|||
30961817|NCT02754141|59028548|FG003|Overall Study|AE unrelated to study drug|1|||
30961818|NCT02754141|59028549|FG004|Overall Study|AE unrelated to study drug|3|||
30961819|NCT02754141|59028550|FG005|Overall Study|AE unrelated to study drug|2|||
30961820|NCT02754141|59028551|FG006|Overall Study|AE unrelated to study drug|1|||
30961821|NCT02754141|59028552|FG007|Overall Study|AE unrelated to study drug|0|||
30961822|NCT02754141|59028553|FG008|Overall Study|AE unrelated to study drug|0|||
30961823|NCT02754141|59028554|FG009|Overall Study|AE unrelated to study drug|0|||
30961824|NCT02754141|59028555|FG010|Overall Study|AE unrelated to study drug|0|||
30961825|NCT02754141|59028556|FG011|Overall Study|AE unrelated to study drug|0|||
30961826|NCT02754141|59028557|FG012|Overall Study|AE unrelated to study drug|0|||
30961827|NCT02754141|59028558|FG013|Overall Study|AE unrelated to study drug|0|||
30961828|NCT02754141|59028559|FG014|Overall Study|AE unrelated to study drug|0|||
30961829|NCT02754141|59028560|FG015|Overall Study|AE unrelated to study drug|0|||
30961830|NCT02754141|59028561|FG016|Overall Study|AE unrelated to study drug|0|||
30961831|NCT02754141|59028562|FG017|Overall Study|AE unrelated to study drug|0|||
30961832|NCT02754141|59028545|FG000|Overall Study|Request to discontinue|0|||
30961833|NCT02754141|59028546|FG001|Overall Study|Request to discontinue|0|||
30961834|NCT02754141|59028547|FG002|Overall Study|Request to discontinue|0|||
30961835|NCT02754141|59028548|FG003|Overall Study|Request to discontinue|0|||
30961836|NCT02754141|59028549|FG004|Overall Study|Request to discontinue|0|||
30961837|NCT02754141|59028550|FG005|Overall Study|Request to discontinue|0|||
30961838|NCT02754141|59028551|FG006|Overall Study|Request to discontinue|0|||
30961839|NCT02754141|59028552|FG007|Overall Study|Request to discontinue|0|||
30961840|NCT02754141|59028553|FG008|Overall Study|Request to discontinue|1|||
30961841|NCT02754141|59028554|FG009|Overall Study|Request to discontinue|0|||
30961842|NCT02754141|59028555|FG010|Overall Study|Request to discontinue|0|||
30961843|NCT02754141|59028556|FG011|Overall Study|Request to discontinue|0|||
30961844|NCT02754141|59028557|FG012|Overall Study|Request to discontinue|0|||
30961845|NCT02754141|59028558|FG013|Overall Study|Request to discontinue|1|||
30961846|NCT02754141|59028559|FG014|Overall Study|Request to discontinue|1|||
30961847|NCT02754141|59028560|FG015|Overall Study|Request to discontinue|0|||
30961848|NCT02754141|59028561|FG016|Overall Study|Request to discontinue|0|||
30961849|NCT02754141|59028562|FG017|Overall Study|Request to discontinue|0|||
30961850|NCT02754141|59028545|FG000|Overall Study|Withdrew consent|0|||
30961851|NCT02754141|59028546|FG001|Overall Study|Withdrew consent|0|||
30961852|NCT02754141|59028547|FG002|Overall Study|Withdrew consent|0|||
30961853|NCT02754141|59028548|FG003|Overall Study|Withdrew consent|0|||
30961854|NCT02754141|59028549|FG004|Overall Study|Withdrew consent|0|||
30961855|NCT02754141|59028550|FG005|Overall Study|Withdrew consent|0|||
30961856|NCT02754141|59028551|FG006|Overall Study|Withdrew consent|0|||
30961857|NCT02754141|59028552|FG007|Overall Study|Withdrew consent|0|||
30961858|NCT02754141|59028553|FG008|Overall Study|Withdrew consent|0|||
30961859|NCT02754141|59028554|FG009|Overall Study|Withdrew consent|1|||
30961860|NCT02754141|59028555|FG010|Overall Study|Withdrew consent|0|||
30961861|NCT02754141|59028556|FG011|Overall Study|Withdrew consent|0|||
30961862|NCT02754141|59028557|FG012|Overall Study|Withdrew consent|0|||
30961863|NCT02754141|59028558|FG013|Overall Study|Withdrew consent|0|||
30961864|NCT02754141|59028559|FG014|Overall Study|Withdrew consent|0|||
30961865|NCT02754141|59028560|FG015|Overall Study|Withdrew consent|0|||
30961866|NCT02754141|59028561|FG016|Overall Study|Withdrew consent|0|||
30961867|NCT02754141|59028562|FG017|Overall Study|Withdrew consent|0|||
30961868|NCT02754141|59028545|FG000|Overall Study|Maximum clinical benefit|0|||
30961869|NCT02754141|59028546|FG001|Overall Study|Maximum clinical benefit|0|||
30961870|NCT02754141|59028547|FG002|Overall Study|Maximum clinical benefit|0|||
30961871|NCT02754141|59028548|FG003|Overall Study|Maximum clinical benefit|1|||
30961872|NCT02754141|59028549|FG004|Overall Study|Maximum clinical benefit|0|||
30961873|NCT02754141|59028550|FG005|Overall Study|Maximum clinical benefit|0|||
30961874|NCT02754141|59028551|FG006|Overall Study|Maximum clinical benefit|0|||
30961875|NCT02754141|59028552|FG007|Overall Study|Maximum clinical benefit|0|||
30961876|NCT02754141|59028553|FG008|Overall Study|Maximum clinical benefit|0|||
30961877|NCT02754141|59028554|FG009|Overall Study|Maximum clinical benefit|0|||
30961878|NCT02754141|59028555|FG010|Overall Study|Maximum clinical benefit|0|||
30961879|NCT02754141|59028556|FG011|Overall Study|Maximum clinical benefit|0|||
30961880|NCT02754141|59028557|FG012|Overall Study|Maximum clinical benefit|0|||
30961881|NCT02754141|59028558|FG013|Overall Study|Maximum clinical benefit|0|||
30961882|NCT02754141|59028559|FG014|Overall Study|Maximum clinical benefit|0|||
30961883|NCT02754141|59028560|FG015|Overall Study|Maximum clinical benefit|0|||
30961884|NCT02754141|59028561|FG016|Overall Study|Maximum clinical benefit|0|||
30961885|NCT02754141|59028562|FG017|Overall Study|Maximum clinical benefit|0|||
30961886|NCT02754141|59028545|FG000|Overall Study|No longer meets study criteria|0|||
30961887|NCT02754141|59028546|FG001|Overall Study|No longer meets study criteria|0|||
30961888|NCT02754141|59028547|FG002|Overall Study|No longer meets study criteria|0|||
30961889|NCT02754141|59028548|FG003|Overall Study|No longer meets study criteria|1|||
30961890|NCT02754141|59028549|FG004|Overall Study|No longer meets study criteria|0|||
30961891|NCT02754141|59028550|FG005|Overall Study|No longer meets study criteria|0|||
30961892|NCT02754141|59028551|FG006|Overall Study|No longer meets study criteria|0|||
30604246|NCT01232283|58615302|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
30961893|NCT02754141|59028552|FG007|Overall Study|No longer meets study criteria|0|||
30961894|NCT02754141|59028553|FG008|Overall Study|No longer meets study criteria|0|||
30961895|NCT02754141|59028554|FG009|Overall Study|No longer meets study criteria|0|||
30961896|NCT02754141|59028555|FG010|Overall Study|No longer meets study criteria|0|||
30961897|NCT02754141|59028556|FG011|Overall Study|No longer meets study criteria|0|||
30961898|NCT02754141|59028557|FG012|Overall Study|No longer meets study criteria|0|||
30961899|NCT02754141|59028558|FG013|Overall Study|No longer meets study criteria|0|||
30961900|NCT02754141|59028559|FG014|Overall Study|No longer meets study criteria|0|||
30961901|NCT02754141|59028560|FG015|Overall Study|No longer meets study criteria|0|||
30961902|NCT02754141|59028561|FG016|Overall Study|No longer meets study criteria|0|||
30961903|NCT02754141|59028562|FG017|Overall Study|No longer meets study criteria|0|||
30961904|NCT02754141|59028545|FG000|Overall Study|Other reasons|0|||
30961905|NCT02754141|59028546|FG001|Overall Study|Other reasons|0|||
30961906|NCT02754141|59028547|FG002|Overall Study|Other reasons|0|||
30961907|NCT02754141|59028548|FG003|Overall Study|Other reasons|0|||
30961908|NCT02754141|59028549|FG004|Overall Study|Other reasons|0|||
30961909|NCT02754141|59028550|FG005|Overall Study|Other reasons|0|||
30961910|NCT02754141|59028551|FG006|Overall Study|Other reasons|0|||
30961911|NCT02754141|59028552|FG007|Overall Study|Other reasons|1|||
30961912|NCT02754141|59028553|FG008|Overall Study|Other reasons|0|||
30961913|NCT02754141|59028554|FG009|Overall Study|Other reasons|0|||
30961914|NCT02754141|59028555|FG010|Overall Study|Other reasons|0|||
30961915|NCT02754141|59028556|FG011|Overall Study|Other reasons|0|||
30961916|NCT02754141|59028557|FG012|Overall Study|Other reasons|2|||
30961917|NCT02754141|59028558|FG013|Overall Study|Other reasons|0|||
30961918|NCT02754141|59028559|FG014|Overall Study|Other reasons|0|||
30961919|NCT02754141|59028560|FG015|Overall Study|Other reasons|0|||
30961920|NCT02754141|59028561|FG016|Overall Study|Other reasons|0|||
30961921|NCT02754141|59028562|FG017|Overall Study|Other reasons|0|||
30961922|NCT02754141|59028545|FG000|Overall Study|Completed treatment as per protocol|0|||
30961923|NCT02754141|59028546|FG001|Overall Study|Completed treatment as per protocol|1|||
30961924|NCT02754141|59028547|FG002|Overall Study|Completed treatment as per protocol|0|||
30961925|NCT02754141|59028548|FG003|Overall Study|Completed treatment as per protocol|0|||
30961926|NCT02754141|59028549|FG004|Overall Study|Completed treatment as per protocol|0|||
30961927|NCT02754141|59028550|FG005|Overall Study|Completed treatment as per protocol|0|||
30961928|NCT02754141|59028551|FG006|Overall Study|Completed treatment as per protocol|0|||
30961929|NCT02754141|59028552|FG007|Overall Study|Completed treatment as per protocol|0|||
30961930|NCT02754141|59028553|FG008|Overall Study|Completed treatment as per protocol|0|||
30961931|NCT02754141|59028554|FG009|Overall Study|Completed treatment as per protocol|0|||
30961932|NCT02754141|59028555|FG010|Overall Study|Completed treatment as per protocol|0|||
30961933|NCT02754141|59028556|FG011|Overall Study|Completed treatment as per protocol|0|||
30961934|NCT02754141|59028557|FG012|Overall Study|Completed treatment as per protocol|1|||
30961935|NCT02754141|59028558|FG013|Overall Study|Completed treatment as per protocol|0|||
30961936|NCT02754141|59028559|FG014|Overall Study|Completed treatment as per protocol|0|||
30961937|NCT02754141|59028560|FG015|Overall Study|Completed treatment as per protocol|0|||
30961938|NCT02754141|59028561|FG016|Overall Study|Completed treatment as per protocol|0|||
30961939|NCT02754141|59028562|FG017|Overall Study|Completed treatment as per protocol|0|||
30961940|NCT02754141|59028545|FG000|Overall Study|Not completing monotherapy|0|||
30961941|NCT02754141|59028546|FG001|Overall Study|Not completing monotherapy|0|||
30961942|NCT02754141|59028547|FG002|Overall Study|Not completing monotherapy|0|||
30961943|NCT02754141|59028548|FG003|Overall Study|Not completing monotherapy|0|||
30961944|NCT02754141|59028549|FG004|Overall Study|Not completing monotherapy|0|||
30961945|NCT02754141|59028550|FG005|Overall Study|Not completing monotherapy|0|||
30961946|NCT02754141|59028551|FG006|Overall Study|Not completing monotherapy|0|||
30961947|NCT02754141|59028552|FG007|Overall Study|Not completing monotherapy|0|||
30961948|NCT02754141|59028553|FG008|Overall Study|Not completing monotherapy|0|||
30961949|NCT02754141|59028554|FG009|Overall Study|Not completing monotherapy|0|||
30961950|NCT02754141|59028555|FG010|Overall Study|Not completing monotherapy|0|||
30961951|NCT02754141|59028556|FG011|Overall Study|Not completing monotherapy|0|||
30961952|NCT02754141|59028557|FG012|Overall Study|Not completing monotherapy|0|||
30961953|NCT02754141|59028558|FG013|Overall Study|Not completing monotherapy|1|||
30961954|NCT02754141|59028559|FG014|Overall Study|Not completing monotherapy|0|||
30961955|NCT02754141|59028560|FG015|Overall Study|Not completing monotherapy|0|||
30961956|NCT02754141|59028561|FG016|Overall Study|Not completing monotherapy|0|||
30961957|NCT02754141|59028562|FG017|Overall Study|Not completing monotherapy|0|||
30961958|NCT02659059|59028641|FG000|Overall Study|Other reasons|6|||
30961959|NCT02659059|59028642|FG001|Overall Study|Other reasons|1|||
30961960|NCT02659059|59028641|FG000|Overall Study|Disease Progression|143|||
30695676|NCT00328627|58710040|FG008|Overall Study|Adverse Event|0|||
30695677|NCT00328627|58710041|FG009|Overall Study|Adverse Event|7|||
30695678|NCT00328627|58710042|FG010|Overall Study|Adverse Event|5|||
30961961|NCT02659059|59028642|FG001|Overall Study|Disease Progression|16|||
30961962|NCT02659059|59028641|FG000|Overall Study|Study Drug toxicity|56|||
30961963|NCT02659059|59028642|FG001|Overall Study|Study Drug toxicity|9|||
30961964|NCT02659059|59028641|FG000|Overall Study|Death|3|||
30961965|NCT02659059|59028642|FG001|Overall Study|Death|1|||
30695679|NCT00328627|58710043|FG011|Overall Study|Adverse Event|4|||
30961966|NCT02659059|59028641|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
30961967|NCT02659059|59028642|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
30961968|NCT02659059|59028641|FG000|Overall Study|Participant request to discontinue study treatment|5|||
30961969|NCT02659059|59028642|FG001|Overall Study|Participant request to discontinue study treatment|0|||
30961970|NCT02659059|59028641|FG000|Overall Study|Participant withdrew consent|6|||
30961971|NCT02659059|59028642|FG001|Overall Study|Participant withdrew consent|1|||
30961972|NCT01164891|59028657|FG000|Overall Study|Disease Progression|5|||
30961973|NCT01164891|59028657|FG000|Overall Study|Adverse Event|1|||
30961974|NCT01497899|59028666|FG000|Double-Blind Phase|Randomized but not Treated|1|||
30961975|NCT01497899|59028667|FG001|Double-Blind Phase|Randomized but not Treated|0|||
30961976|NCT01497899|59028668|FG002|Double-Blind Phase|Randomized but not Treated|0|||
30961977|NCT01497899|59028669|FG003|Double-Blind Phase|Randomized but not Treated|0|||
30961978|NCT01497899|59028666|FG000|Double-Blind Phase|Adverse Event|1|||
30961979|NCT01497899|59028667|FG001|Double-Blind Phase|Adverse Event|0|||
30961980|NCT01497899|59028668|FG002|Double-Blind Phase|Adverse Event|0|||
30961981|NCT01497899|59028669|FG003|Double-Blind Phase|Adverse Event|0|||
30961982|NCT01497899|59028666|FG000|Double-Blind Phase|Lack of Efficacy|0|||
30961983|NCT01497899|59028667|FG001|Double-Blind Phase|Lack of Efficacy|1|||
30961984|NCT01497899|59028668|FG002|Double-Blind Phase|Lack of Efficacy|0|||
30961985|NCT01497899|59028669|FG003|Double-Blind Phase|Lack of Efficacy|0|||
30961986|NCT01497899|59028666|FG000|Double-Blind Phase|Investigator's Discretion|1|||
30961987|NCT01497899|59028667|FG001|Double-Blind Phase|Investigator's Discretion|0|||
30961988|NCT01497899|59028668|FG002|Double-Blind Phase|Investigator's Discretion|0|||
30961989|NCT01497899|59028669|FG003|Double-Blind Phase|Investigator's Discretion|0|||
30961990|NCT01497899|59028666|FG000|Double-Blind Phase|Withdrew Consent|0|||
30961991|NCT01497899|59028667|FG001|Double-Blind Phase|Withdrew Consent|1|||
30961992|NCT01497899|59028668|FG002|Double-Blind Phase|Withdrew Consent|0|||
30961993|NCT01497899|59028669|FG003|Double-Blind Phase|Withdrew Consent|0|||
30961994|NCT01497899|59028666|FG000|Double-Blind Phase|Lost to Follow-up|3|||
30961995|NCT01497899|59028667|FG001|Double-Blind Phase|Lost to Follow-up|2|||
30961996|NCT01497899|59028668|FG002|Double-Blind Phase|Lost to Follow-up|0|||
30961997|NCT01497899|59028669|FG003|Double-Blind Phase|Lost to Follow-up|0|||
30961998|NCT01497899|59028666|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
30961999|NCT01497899|59028667|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
30962000|NCT01497899|59028668|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
30962001|NCT01497899|59028669|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
30962002|NCT01497899|59028666|FG000|Open-Label Extension Phase|Adverse Event|1|||
30962003|NCT01497899|59028667|FG001|Open-Label Extension Phase|Adverse Event|0|||
30962004|NCT01497899|59028668|FG002|Open-Label Extension Phase|Adverse Event|0|||
30962005|NCT01497899|59028669|FG003|Open-Label Extension Phase|Adverse Event|0|||
30962006|NCT01497899|59028666|FG000|Open-Label Extension Phase|Death|1|||
30962007|NCT01497899|59028667|FG001|Open-Label Extension Phase|Death|0|||
30962008|NCT01497899|59028668|FG002|Open-Label Extension Phase|Death|0|||
30962009|NCT01497899|59028669|FG003|Open-Label Extension Phase|Death|0|||
30962010|NCT01497899|59028666|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
30962011|NCT01497899|59028667|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
30962012|NCT01497899|59028668|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
30962013|NCT01497899|59028669|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
30962014|NCT01497899|59028666|FG000|Open-Label Extension Phase|Pregnancy|0|||
30962015|NCT01497899|59028667|FG001|Open-Label Extension Phase|Pregnancy|1|||
30962016|NCT01497899|59028668|FG002|Open-Label Extension Phase|Pregnancy|1|||
30962017|NCT01497899|59028669|FG003|Open-Label Extension Phase|Pregnancy|0|||
30962018|NCT01497899|59028666|FG000|Open-Label Extension Phase|Protocol Violation|0|||
30962019|NCT01497899|59028667|FG001|Open-Label Extension Phase|Protocol Violation|0|||
30962020|NCT01497899|59028668|FG002|Open-Label Extension Phase|Protocol Violation|1|||
30962021|NCT01497899|59028669|FG003|Open-Label Extension Phase|Protocol Violation|0|||
30962022|NCT01497899|59028666|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
30962023|NCT01497899|59028667|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
30962024|NCT01497899|59028668|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
30962025|NCT01497899|59028669|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
30962026|NCT01497275|59028676|FG000|Overall Study|Death|1|||
30962027|NCT01497275|59028676|FG000|Overall Study|Adverse Event|1|||
30962028|NCT01557517|59028682|FG000|Overall Study|Death|1|||
30962029|NCT01557517|59028683|FG001|Overall Study|Death|0|||
30962030|NCT01557517|59028682|FG000|Overall Study|Refused further treatment|0|||
30962031|NCT01557517|59028683|FG001|Overall Study|Refused further treatment|2|||
30695680|NCT00328627|58710032|FG000|Overall Study|Protocol Violation|2|||
30695681|NCT00328627|58710033|FG001|Overall Study|Protocol Violation|2|||
30874043|NCT02055820|58904757|FG001|Phase II: Expansion|Death|0|||
30874044|NCT02055820|58904758|FG002|Phase II: Expansion|Death|0|||
30874045|NCT02055820|58904759|FG003|Phase II: Expansion|Death|0|||
30874046|NCT02055820|58904760|FG004|Phase II: Expansion|Death|33|||
30874047|NCT02055820|58904761|FG005|Phase II: Expansion|Death|0|||
30874048|NCT02055820|58904762|FG006|Phase II: Expansion|Death|0|||
30874049|NCT02055820|58904763|FG007|Phase II: Expansion|Death|0|||
30874050|NCT02055820|58904764|FG008|Phase II: Expansion|Death|0|||
30874051|NCT02055820|58904765|FG009|Phase II: Expansion|Death|0|||
30962032|NCT01557517|59028682|FG000|Overall Study|Adverse Event|0|||
30962033|NCT01557517|59028683|FG001|Overall Study|Adverse Event|2|||
30962034|NCT01557517|59028682|FG000|Overall Study|Pt declined before treatment started|1|||
30962035|NCT01557517|59028683|FG001|Overall Study|Pt declined before treatment started|0|||
30962036|NCT01497197|59028698|FG000|Overall Study|Lost to Follow-up|1|||
30962037|NCT01497197|59028699|FG001|Overall Study|Lost to Follow-up|0|||
30962038|NCT01497197|59028698|FG000|Overall Study|Protocol Violation|0|||
30962039|NCT01497197|59028699|FG001|Overall Study|Protocol Violation|2|||
30962040|NCT01497197|59028698|FG000|Overall Study|Withdrawal by Subject|2|||
30962041|NCT01497197|59028699|FG001|Overall Study|Withdrawal by Subject|1|||
30962042|NCT01497197|59028698|FG000|Overall Study|Excessive/lack of response to treatment|1|||
30962043|NCT01497197|59028699|FG001|Overall Study|Excessive/lack of response to treatment|0|||
30962044|NCT01497197|59028698|FG000|Overall Study|Risk of OHSS|1|||
30962045|NCT01497197|59028699|FG001|Overall Study|Risk of OHSS|0|||
30962046|NCT01497197|59028698|FG000|Overall Study|No oocytes retrieved|3|||
30962047|NCT01497197|59028699|FG001|Overall Study|No oocytes retrieved|2|||
30962048|NCT01497197|59028698|FG000|Overall Study|No fertilisation|6|||
30962049|NCT01497197|59028699|FG001|Overall Study|No fertilisation|5|||
30962050|NCT01497197|59028698|FG000|Overall Study|Intention to freeze all embryos|0|||
30962051|NCT01497197|59028699|FG001|Overall Study|Intention to freeze all embryos|1|||
30962052|NCT01497197|59028698|FG000|Overall Study|All embryos discarded|0|||
30962053|NCT01497197|59028699|FG001|Overall Study|All embryos discarded|3|||
30962054|NCT01497197|59028698|FG000|Overall Study|Other|3|||
30962055|NCT01497197|59028699|FG001|Overall Study|Other|1|||
30962056|NCT01496885|59028705|FG000|Overall Study|Lost to Follow-up|13|||
30962057|NCT01496885|59028705|FG000|Overall Study|Withdrawal by Subject|7|||
30962058|NCT01496885|59028705|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
30962059|NCT01496885|59028705|FG000|Overall Study|Death|1|||
30962060|NCT01557283|59028709|FG000|Overall Study|Lost to Follow-up|7|||
30962061|NCT01557283|59028709|FG000|Overall Study|Non-responder|19|||
30962062|NCT01557283|59028709|FG000|Overall Study|Adverse Event|7|||
30962063|NCT01557283|59028709|FG000|Overall Study|Lack of Efficacy|1|||
30962064|NCT01557283|59028709|FG000|Overall Study|Non-compliance|1|||
30962065|NCT01557283|59028709|FG000|Overall Study|Withdrawal by Subject|1|||
30962066|NCT01557283|59028709|FG000|Overall Study|Participant's weight too high for dose|1|||
30962067|NCT01557283|59028709|FG000|Overall Study|Worsening of psoriasis|1|||
30962068|NCT01557283|59028709|FG000|Overall Study|Other|6|||
30962069|NCT01523743|59028726|FG000|Period 1|Adverse Event|1|||
30962070|NCT01523743|59028727|FG001|Period 1|Adverse Event|0|||
30962071|NCT01523743|59028726|FG000|Period 1|Withdrawal by Subject|6|||
30962072|NCT01523743|59028727|FG001|Period 1|Withdrawal by Subject|2|||
30962073|NCT01523743|59028726|FG000|Period 1|Lost to Follow-up|1|||
30962074|NCT01523743|59028727|FG001|Period 1|Lost to Follow-up|0|||
30962075|NCT01523743|59028726|FG000|Period 1|Lack of Efficacy|1|||
30962076|NCT01523743|59028727|FG001|Period 1|Lack of Efficacy|0|||
30962077|NCT01523743|59028726|FG000|Period 1|Felt unable to empty bladder|1|||
30962078|NCT01523743|59028727|FG001|Period 1|Felt unable to empty bladder|0|||
30962079|NCT01523743|59028726|FG000|Period 2|Withdrawal by Subject|0|||
30962080|NCT01523743|59028727|FG001|Period 2|Withdrawal by Subject|2|||
30962081|NCT01523743|59028726|FG000|Period 2|Adverse Event|1|||
30962082|NCT01523743|59028727|FG001|Period 2|Adverse Event|0|||
30962083|NCT01496807|59028742|FG000|Overall Study|Progressive Disease|21|||
30962084|NCT01496807|59028742|FG000|Overall Study|Participant preference/toxicity|8|||
30962085|NCT01496807|59028742|FG000|Overall Study|Change in diagnosis|1|||
30962086|NCT01496183|59028748|FG000|Overall Study|Physician Decision|3|||
30962087|NCT01496183|59028749|FG001|Overall Study|Physician Decision|1|||
30962088|NCT01496183|59028748|FG000|Overall Study|Withdrawal by Subject|0|||
30962089|NCT01496183|59028749|FG001|Overall Study|Withdrawal by Subject|1|||
30962090|NCT01495793|59028756|FG000|Overall Study|Lost to Follow-up|1|||
30962091|NCT01495793|59028756|FG000|Overall Study|Violation of inclusion criteria|1|||
30962092|NCT01494467|59028762|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
30962093|NCT01494467|59028763|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
30962094|NCT01494467|59028762|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
30962095|NCT01494467|59028763|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
30962096|NCT01494467|59028762|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
30962097|NCT01494467|59028763|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
30962098|NCT01494467|59028762|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
30962099|NCT01494467|59028763|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
30962100|NCT01494467|59028762|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
30962101|NCT01494467|59028763|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
30962102|NCT01494467|59028762|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
30962103|NCT01494467|59028763|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
30962104|NCT01494467|59028762|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
30962105|NCT01494467|59028763|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
30962106|NCT01494467|59028762|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
30962107|NCT01494467|59028763|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
30962108|NCT01494467|59028762|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
30962109|NCT01494467|59028763|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
30962110|NCT01494467|59028762|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
30962111|NCT01494467|59028763|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
30874052|NCT02055820|58904756|FG000|Phase II: Expansion|Lost to Follow-up|0|||
30874053|NCT02055820|58904757|FG001|Phase II: Expansion|Lost to Follow-up|0|||
30874054|NCT02055820|58904758|FG002|Phase II: Expansion|Lost to Follow-up|0|||
30874055|NCT02055820|58904759|FG003|Phase II: Expansion|Lost to Follow-up|0|||
30874056|NCT02055820|58904760|FG004|Phase II: Expansion|Lost to Follow-up|4|||
30874057|NCT02055820|58904761|FG005|Phase II: Expansion|Lost to Follow-up|0|||
30874058|NCT02055820|58904762|FG006|Phase II: Expansion|Lost to Follow-up|0|||
30874059|NCT02055820|58904763|FG007|Phase II: Expansion|Lost to Follow-up|0|||
30874060|NCT02055820|58904764|FG008|Phase II: Expansion|Lost to Follow-up|0|||
30874061|NCT02055820|58904765|FG009|Phase II: Expansion|Lost to Follow-up|0|||
30874062|NCT02055820|58904756|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
30874063|NCT02055820|58904757|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
30874064|NCT02055820|58904758|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
30874065|NCT02055820|58904759|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
30874066|NCT02055820|58904760|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
30874067|NCT02055820|58904761|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
30874068|NCT02055820|58904762|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
30874069|NCT02055820|58904763|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
30874070|NCT02055820|58904764|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
30874071|NCT02055820|58904765|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
30874072|NCT02055352|58904809|FG000|Overall Study|Adverse Event|0|||
30874073|NCT02055352|58904810|FG001|Overall Study|Adverse Event|1|||
30874074|NCT02055352|58904809|FG000|Overall Study|Non-eligible|0|||
30874075|NCT02055352|58904810|FG001|Overall Study|Non-eligible|1|||
30874076|NCT02055352|58904809|FG000|Overall Study|Poor compliance|1|||
30874077|NCT02055352|58904810|FG001|Overall Study|Poor compliance|1|||
30874078|NCT02055352|58904809|FG000|Overall Study|Death|1|||
30874079|NCT02055352|58904810|FG001|Overall Study|Death|2|||
30874080|NCT02055352|58904809|FG000|Overall Study|Patient decision|1|||
30874081|NCT02055352|58904810|FG001|Overall Study|Patient decision|1|||
30874082|NCT02055352|58904809|FG000|Overall Study|Use of prohibited treatment|0|||
30874083|NCT02055352|58904810|FG001|Overall Study|Use of prohibited treatment|3|||
30874084|NCT02055352|58904809|FG000|Overall Study|AE, study drug would be detrimental|1|||
30874085|NCT02055352|58904810|FG001|Overall Study|AE, study drug would be detrimental|3|||
30874086|NCT02055352|58904809|FG000|Overall Study|Withdrawal of informed consent|1|||
30874087|NCT02055352|58904810|FG001|Overall Study|Withdrawal of informed consent|0|||
30874088|NCT02055352|58904809|FG000|Overall Study|Reason unknown|1|||
30874089|NCT02055352|58904810|FG001|Overall Study|Reason unknown|5|||
30874090|NCT02034916|58904818|FG000|Overall Study|Death|39|||
30874091|NCT02034916|58904819|FG001|Overall Study|Death|28|||
30874092|NCT02034916|58904818|FG000|Overall Study|Withdrawal by Subject|2|||
30874093|NCT02034916|58904819|FG001|Overall Study|Withdrawal by Subject|1|||
30874094|NCT02034916|58904818|FG000|Overall Study|Lost to Follow-up|4|||
30874095|NCT02034916|58904819|FG001|Overall Study|Lost to Follow-up|1|||
30874096|NCT02034916|58904818|FG000|Overall Study|Study terminated by sponsor|4|||
30874097|NCT02034916|58904819|FG001|Overall Study|Study terminated by sponsor|5|||
30874098|NCT01374425|58904828|FG000|Overall Study|Radiographic Disease Progression|86|||
30874099|NCT01374425|58904829|FG001|Overall Study|Radiographic Disease Progression|81|||
30874100|NCT01374425|58904828|FG000|Overall Study|Clinical Disease Progression|9|||
30874101|NCT01374425|58904829|FG001|Overall Study|Clinical Disease Progression|6|||
30874102|NCT01374425|58904828|FG000|Overall Study|Adverse Event|29|||
30874103|NCT01374425|58904829|FG001|Overall Study|Adverse Event|18|||
30874104|NCT01374425|58904828|FG000|Overall Study|Death (Progression of Disease)|1|||
30874105|NCT01374425|58904829|FG001|Overall Study|Death (Progression of Disease)|0|||
30874106|NCT01374425|58904828|FG000|Overall Study|Death (Adverse Event)|2|||
30874107|NCT01374425|58904829|FG001|Overall Study|Death (Adverse Event)|4|||
30874108|NCT01374425|58904828|FG000|Overall Study|Withdrawal by Subject|6|||
30874109|NCT01374425|58904829|FG001|Overall Study|Withdrawal by Subject|7|||
30874110|NCT01374425|58904828|FG000|Overall Study|Refused Treatment|10|||
30874111|NCT01374425|58904829|FG001|Overall Study|Refused Treatment|24|||
30874112|NCT01374425|58904828|FG000|Overall Study|Protocol Violation|2|||
30874113|NCT01374425|58904829|FG001|Overall Study|Protocol Violation|3|||
30874114|NCT01374425|58904828|FG000|Overall Study|Sponsor Decision|0|||
30874115|NCT01374425|58904829|FG001|Overall Study|Sponsor Decision|1|||
30874116|NCT01374425|58904828|FG000|Overall Study|Lost to Follow-up|2|||
30874117|NCT01374425|58904829|FG001|Overall Study|Lost to Follow-up|1|||
30874118|NCT01374425|58904828|FG000|Overall Study|Other|41|||
30874119|NCT01374425|58904829|FG001|Overall Study|Other|43|||
30874120|NCT02085460|58904859|FG000|Overall Study|Adverse Event|2|||
30874121|NCT02085460|58904860|FG001|Overall Study|Adverse Event|2|||
30874122|NCT02085460|58904861|FG002|Overall Study|Adverse Event|1|||
30874123|NCT02085460|58904859|FG000|Overall Study|Physician Decision|1|||
30874124|NCT02085460|58904860|FG001|Overall Study|Physician Decision|1|||
30874125|NCT02085460|58904861|FG002|Overall Study|Physician Decision|2|||
30874126|NCT02085460|58904859|FG000|Overall Study|Withdrawal by Subject|11|||
30874127|NCT02085460|58904860|FG001|Overall Study|Withdrawal by Subject|5|||
30874128|NCT02085460|58904861|FG002|Overall Study|Withdrawal by Subject|7|||
30874129|NCT02084134|58904871|FG000|Overall Study|Protocol Violation|4|||
30874130|NCT02084134|58904872|FG001|Overall Study|Protocol Violation|2|||
30874131|NCT02084134|58904871|FG000|Overall Study|Death|0|||
30874132|NCT02084134|58904872|FG001|Overall Study|Death|1|||
30874133|NCT02034058|58904878|FG000|Overall Study|Death|3|||
30874134|NCT01374269|58904884|FG000|Overall Study|Withdrawal by Subject|4|||
30962112|NCT01494467|59028762|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
30962113|NCT01494467|59028763|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
30962114|NCT01494467|59028762|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
30962115|NCT01494467|59028763|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
30962116|NCT01494467|59028762|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
30962117|NCT01494467|59028763|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
30962118|NCT01494467|59028762|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
30962119|NCT01494467|59028763|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
30962120|NCT01493687|59028777|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
30962121|NCT01493687|59028778|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
30962122|NCT01493687|59028777|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
30962123|NCT01493687|59028778|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
30962124|NCT01493687|59028777|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
30962125|NCT01493687|59028778|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
30962126|NCT01493687|59028777|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
30962127|NCT01493687|59028778|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
30962128|NCT01493687|59028777|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
30962129|NCT01493687|59028778|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
30962130|NCT01493687|59028777|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
30962131|NCT01493687|59028778|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
30962132|NCT01493687|59028777|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
30962133|NCT01493687|59028778|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
30962134|NCT01493687|59028777|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
30962135|NCT01493687|59028778|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
30962136|NCT01493687|59028777|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
30962137|NCT01493687|59028778|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
30962138|NCT01493687|59028777|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
30962139|NCT01493687|59028778|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
30962140|NCT01493687|59028777|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
30962141|NCT01493687|59028778|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
30962142|NCT01493687|59028777|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
30962143|NCT01493687|59028778|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
30962144|NCT01493687|59028777|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
30962145|NCT01493687|59028778|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
30962146|NCT01493687|59028777|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
30962147|NCT01493687|59028778|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
30962148|NCT01493687|59028777|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
30962149|NCT01493687|59028778|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
30962150|NCT01523587|59028810|FG000|Overall Study|Other than listed|5|||
30962151|NCT01523587|59028811|FG001|Overall Study|Other than listed|5|||
30962152|NCT01523587|59028810|FG000|Overall Study|Worsening of underlying cancer disease|19|||
30962153|NCT01523587|59028811|FG001|Overall Study|Worsening of underlying cancer disease|34|||
30962154|NCT01523587|59028810|FG000|Overall Study|Adverse Event|68|||
30962155|NCT01523587|59028811|FG001|Overall Study|Adverse Event|52|||
30962156|NCT01523587|59028810|FG000|Overall Study|Protocol Violation|5|||
30962157|NCT01523587|59028811|FG001|Overall Study|Protocol Violation|3|||
30962158|NCT01523587|59028810|FG000|Overall Study|Lost to Follow-up|2|||
30962159|NCT01523587|59028811|FG001|Overall Study|Lost to Follow-up|2|||
30962160|NCT01523587|59028810|FG000|Overall Study|Withdrawal by Subject|28|||
30962161|NCT01523587|59028811|FG001|Overall Study|Withdrawal by Subject|20|||
30962162|NCT01523587|59028810|FG000|Overall Study|Withdrew due to Progressive disease|265|||
30962163|NCT01523587|59028811|FG001|Overall Study|Withdrew due to Progressive disease|279|||
30962164|NCT01523587|59028810|FG000|Overall Study|Randomised but bot treated|6|||
30874135|NCT01374269|58904885|FG001|Overall Study|Withdrawal by Subject|0|||
30874136|NCT01374269|58904884|FG000|Overall Study|Lost to Follow-up|1|||
30874137|NCT01374269|58904885|FG001|Overall Study|Lost to Follow-up|3|||
30874138|NCT01374269|58904884|FG000|Overall Study|closed research|1|||
30962165|NCT01523587|59028811|FG001|Overall Study|Randomised but bot treated|2|||
30962166|NCT01493531|59028840|FG000|Overall Study|Adverse Event|4|||
30962167|NCT01493531|59028841|FG001|Overall Study|Adverse Event|12|||
30962168|NCT01493531|59028842|FG002|Overall Study|Adverse Event|9|||
30962169|NCT01493531|59028840|FG000|Overall Study|Gout flare|3|||
30962170|NCT01493531|59028841|FG001|Overall Study|Gout flare|0|||
30962171|NCT01493531|59028842|FG002|Overall Study|Gout flare|2|||
30962172|NCT01493531|59028840|FG000|Overall Study|Protocol Violation|8|||
30962173|NCT01493531|59028841|FG001|Overall Study|Protocol Violation|15|||
30962174|NCT01493531|59028842|FG002|Overall Study|Protocol Violation|12|||
30962175|NCT01493531|59028840|FG000|Overall Study|Sponsor terminated study|5|||
30962176|NCT01493531|59028841|FG001|Overall Study|Sponsor terminated study|2|||
30962177|NCT01493531|59028842|FG002|Overall Study|Sponsor terminated study|3|||
30874139|NCT01374269|58904885|FG001|Overall Study|closed research|2|||
30874140|NCT02679755|58904893|FG000|Overall Study|Death|0|||
30874141|NCT02679755|58904894|FG001|Overall Study|Death|3|||
30874142|NCT02679755|58904893|FG000|Overall Study|Global deterioration of health status|1|||
30874143|NCT02679755|58904894|FG001|Overall Study|Global deterioration of health status|8|||
30874144|NCT02679755|58904893|FG000|Overall Study|Lost to Follow-up|1|||
30874145|NCT02679755|58904894|FG001|Overall Study|Lost to Follow-up|0|||
30962178|NCT01493531|59028840|FG000|Overall Study|Lost to Follow-up|5|||
30962179|NCT01493531|59028841|FG001|Overall Study|Lost to Follow-up|7|||
30962180|NCT01493531|59028842|FG002|Overall Study|Lost to Follow-up|11|||
30962181|NCT01493531|59028840|FG000|Overall Study|Withdrawal by Subject|16|||
30962182|NCT01493531|59028841|FG001|Overall Study|Withdrawal by Subject|13|||
30962183|NCT01493531|59028842|FG002|Overall Study|Withdrawal by Subject|11|||
30962184|NCT01493531|59028840|FG000|Overall Study|Death|0|||
30962185|NCT01493531|59028841|FG001|Overall Study|Death|1|||
30962186|NCT01493531|59028842|FG002|Overall Study|Death|0|||
30962187|NCT01523275|59028866|FG000|Overall Study|Lost to Follow-up|1|||
30962188|NCT01523275|59028867|FG001|Overall Study|Lost to Follow-up|2|||
30962189|NCT01523275|59028866|FG000|Overall Study|Withdrawal by Subject|1|||
30962190|NCT01523275|59028867|FG001|Overall Study|Withdrawal by Subject|0|||
30962191|NCT01492439|59028884|FG000|Overall Study|Withdrew from RTE|4|||
30962192|NCT01492439|59028885|FG001|Overall Study|Withdrew from RTE|9|||
30962193|NCT01572727|59028920|FG000|Overall Study|Adverse Event|43|||
30962194|NCT01572727|59028921|FG001|Overall Study|Adverse Event|15|||
30962195|NCT01572727|59028920|FG000|Overall Study|Lost to Follow-up|1|||
30962196|NCT01572727|59028921|FG001|Overall Study|Lost to Follow-up|1|||
30962197|NCT01572727|59028920|FG000|Overall Study|Physician Decision|23|||
30604247|NCT01232283|58615303|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
30604248|NCT01232283|58615304|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
30604249|NCT01232283|58615305|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
30604250|NCT01232283|58615306|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
30604251|NCT01232283|58615307|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
30604252|NCT01232283|58615308|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
30604253|NCT01232283|58615309|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
30604254|NCT01232283|58615300|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
30604255|NCT01232283|58615301|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
30604256|NCT01232283|58615302|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
30604257|NCT01232283|58615303|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
30604258|NCT01232283|58615304|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
30604259|NCT01232283|58615305|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
30604260|NCT01232283|58615306|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
30604261|NCT01232283|58615307|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
30604262|NCT01232283|58615308|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
30604263|NCT01232283|58615309|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
30604264|NCT01232283|58615300|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
30604265|NCT01232283|58615301|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
30604266|NCT01232283|58615302|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
30604267|NCT01232283|58615303|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
30604268|NCT01232283|58615304|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
30695682|NCT00328627|58710034|FG002|Overall Study|Protocol Violation|2|||
30874146|NCT02679755|58904893|FG000|Overall Study|Objective progression or relapse|24|||
30874147|NCT02679755|58904894|FG001|Overall Study|Objective progression or relapse|83|||
30874148|NCT02679755|58904893|FG000|Overall Study|Not defined|0|||
30874149|NCT02679755|58904894|FG001|Overall Study|Not defined|2|||
30962198|NCT01572727|59028921|FG001|Overall Study|Physician Decision|9|||
30962199|NCT01572727|59028920|FG000|Overall Study|Progressive disease|59|||
30962200|NCT01572727|59028921|FG001|Overall Study|Progressive disease|82|||
30962201|NCT01572727|59028920|FG000|Overall Study|Protocol Violation|0|||
30962202|NCT01572727|59028921|FG001|Overall Study|Protocol Violation|1|||
30962203|NCT01572727|59028920|FG000|Overall Study|Study terminated by sponsor|61|||
30962204|NCT01572727|59028921|FG001|Overall Study|Study terminated by sponsor|83|||
30962205|NCT01572727|59028920|FG000|Overall Study|Parent/guardian decision|14|||
30962206|NCT01572727|59028921|FG001|Overall Study|Parent/guardian decision|9|||
30604269|NCT01232283|58615305|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
30604270|NCT01232283|58615306|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
30604271|NCT01232283|58615307|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
30604272|NCT01232283|58615308|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
30604273|NCT01232283|58615309|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
30604274|NCT01232283|58615300|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
30604275|NCT01232283|58615301|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
30604276|NCT01232283|58615302|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
30604277|NCT01232283|58615303|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
30604278|NCT01232283|58615304|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
30604279|NCT01232283|58615305|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
30604280|NCT01232283|58615306|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
30604281|NCT01232283|58615307|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
30604282|NCT01232283|58615308|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
30604283|NCT01232283|58615309|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
30604284|NCT01232283|58615300|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
30604285|NCT01232283|58615301|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
30604286|NCT01232283|58615302|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
30604287|NCT01232283|58615303|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
30604288|NCT01232283|58615304|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
30604289|NCT01232283|58615305|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
30604290|NCT01232283|58615306|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
30604291|NCT01232283|58615307|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
30604292|NCT01232283|58615308|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
30604293|NCT01232283|58615309|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
30604294|NCT01232283|58615300|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
30604295|NCT01232283|58615301|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
30604296|NCT01232283|58615302|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
30604297|NCT01232283|58615303|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
30604298|NCT01232283|58615304|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
30604299|NCT01232283|58615305|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
30604300|NCT01232283|58615306|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
30604301|NCT01232283|58615307|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
30604302|NCT01232283|58615308|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
30604303|NCT01232283|58615309|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
30604304|NCT01232283|58615300|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
30604305|NCT01232283|58615301|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
30604306|NCT01232283|58615302|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
30604307|NCT01232283|58615303|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
30604308|NCT01232283|58615304|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
30604309|NCT01232283|58615305|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
30604310|NCT01232283|58615306|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
30604311|NCT01232283|58615307|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
30604312|NCT01232283|58615308|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
30604313|NCT01232283|58615309|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
30604314|NCT01232283|58615300|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
30604315|NCT01232283|58615301|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
30604316|NCT01232283|58615302|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
30604317|NCT01232283|58615303|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
30604318|NCT01232283|58615304|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
30604319|NCT01232283|58615305|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
30604320|NCT01232283|58615306|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
30604321|NCT01232283|58615307|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
30604322|NCT01232283|58615308|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
30604323|NCT01232283|58615309|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
30604324|NCT01232127|58615331|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
30604325|NCT01232127|58615332|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
30604326|NCT01232127|58615333|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
30604327|NCT01258608|58615347|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
30604328|NCT01258608|58615348|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
30604329|NCT01258608|58615347|FG000|Overall Study|Clinical progression|1|||
30604330|NCT01258608|58615348|FG001|Overall Study|Clinical progression|0|||
30604331|NCT01258608|58615347|FG000|Overall Study|Sponsor decision|0|||
30604332|NCT01258608|58615348|FG001|Overall Study|Sponsor decision|1|||
30962207|NCT01572727|59028920|FG000|Overall Study|Death|2|||
30604333|NCT01258608|58615347|FG000|Overall Study|Physician Decision|6|||
30604334|NCT01258608|58615348|FG001|Overall Study|Physician Decision|1|||
30604335|NCT01258608|58615347|FG000|Overall Study|Lost to Follow-up|0|||
30604336|NCT01258608|58615348|FG001|Overall Study|Lost to Follow-up|1|||
30604337|NCT01258608|58615347|FG000|Overall Study|Lack of compliance|1|||
30604338|NCT01258608|58615348|FG001|Overall Study|Lack of compliance|0|||
30604339|NCT01258608|58615347|FG000|Overall Study|Lack of Efficacy|0|||
30604340|NCT01258608|58615348|FG001|Overall Study|Lack of Efficacy|1|||
30604341|NCT01258608|58615347|FG000|Overall Study|Adverse Event|6|||
30604342|NCT01258608|58615348|FG001|Overall Study|Adverse Event|10|||
30604343|NCT01258608|58615347|FG000|Overall Study|Withdrawal by Subject|6|||
30604344|NCT01258608|58615348|FG001|Overall Study|Withdrawal by Subject|5|||
30604345|NCT01015612|58615355|FG000|Overall Study|Death|113|||
30604346|NCT01015612|58615355|FG000|Overall Study|Withdrawal by Subject|40|||
30604347|NCT01231659|58615359|FG000|Overall Study|Adverse Event|9|||
30604348|NCT01231659|58615359|FG000|Overall Study|Disease Progression|48|||
30604349|NCT01231659|58615359|FG000|Overall Study|Death|2|||
30604350|NCT01231659|58615359|FG000|Overall Study|Patient refused to complete study visit|1|||
30604351|NCT01231659|58615359|FG000|Overall Study|Other protocol defined criteria|12|||
30604352|NCT01054222|58615363|FG000|Overall Study|Lack of Efficacy|1|||
30604353|NCT01054222|58615363|FG000|Overall Study|Lost to Follow-up|4|||
30604354|NCT01054222|58615363|FG000|Overall Study|Withdrawal by Subject|6|||
30604355|NCT01052428|58615369|FG000|Overall Study|Death|1|||
30604356|NCT01052428|58615370|FG001|Overall Study|Death|0|||
30604357|NCT01052428|58615369|FG000|Overall Study|Withdrawal by Subject|0|||
30604358|NCT01052428|58615370|FG001|Overall Study|Withdrawal by Subject|1|||
30604359|NCT01052272|58615380|FG000|Overall Study|Death|0|||
30604360|NCT01052272|58615381|FG001|Overall Study|Death|0|||
30604361|NCT01052272|58615382|FG002|Overall Study|Death|1|||
30604362|NCT01052272|58615383|FG003|Overall Study|Death|1|||
30604363|NCT01052272|58615380|FG000|Overall Study|Physician Decision|0|||
30604364|NCT01052272|58615381|FG001|Overall Study|Physician Decision|1|||
30604365|NCT01052272|58615382|FG002|Overall Study|Physician Decision|0|||
30604366|NCT01052272|58615383|FG003|Overall Study|Physician Decision|0|||
30604367|NCT01052272|58615380|FG000|Overall Study|patient refuses follow-up|5|||
30604368|NCT01052272|58615381|FG001|Overall Study|patient refuses follow-up|4|||
30604369|NCT01052272|58615382|FG002|Overall Study|patient refuses follow-up|2|||
30604370|NCT01052272|58615383|FG003|Overall Study|patient refuses follow-up|4|||
30604371|NCT01052272|58615380|FG000|Overall Study|Withdrawal by Subject|0|||
30604372|NCT01052272|58615381|FG001|Overall Study|Withdrawal by Subject|2|||
30604373|NCT01052272|58615382|FG002|Overall Study|Withdrawal by Subject|3|||
30604374|NCT01052272|58615383|FG003|Overall Study|Withdrawal by Subject|2|||
30604375|NCT01052272|58615380|FG000|Overall Study|placed in long-term care|0|||
30604376|NCT01052272|58615381|FG001|Overall Study|placed in long-term care|0|||
30604377|NCT01052272|58615382|FG002|Overall Study|placed in long-term care|1|||
30604378|NCT01052272|58615383|FG003|Overall Study|placed in long-term care|0|||
30604379|NCT01052272|58615380|FG000|Overall Study|decline in health|0|||
30604380|NCT01052272|58615381|FG001|Overall Study|decline in health|0|||
30604381|NCT01052272|58615382|FG002|Overall Study|decline in health|1|||
30604382|NCT01052272|58615383|FG003|Overall Study|decline in health|0|||
30604383|NCT01257204|58615396|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
30604384|NCT01257204|58615397|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
30604385|NCT01257204|58615398|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
30604386|NCT01257204|58615396|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
30604387|NCT01257204|58615397|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
30604388|NCT01257204|58615398|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
30604389|NCT01257204|58615396|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
30604390|NCT01257204|58615397|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
30604391|NCT01257204|58615398|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
30604392|NCT01257204|58615396|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
30604393|NCT01257204|58615397|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
30604394|NCT01257204|58615398|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
30604395|NCT01257204|58615396|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
30604396|NCT01257204|58615397|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
30604397|NCT01257204|58615398|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
30695683|NCT00328627|58710035|FG003|Overall Study|Protocol Violation|8|||
30604398|NCT01257204|58615396|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
30604399|NCT01257204|58615397|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
30604400|NCT01257204|58615398|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
30604401|NCT01257204|58615396|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
30604402|NCT01257204|58615397|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
30604403|NCT01257204|58615398|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
30604404|NCT01257204|58615396|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
30604405|NCT01257204|58615397|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
30604406|NCT01257204|58615398|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
30604407|NCT01257204|58615396|FG000|Follow-up Period (up to Week 48)|Other|0|||
30604408|NCT01257204|58615397|FG001|Follow-up Period (up to Week 48)|Other|0|||
30604409|NCT01257204|58615398|FG002|Follow-up Period (up to Week 48)|Other|5|||
30604410|NCT01231581|58615420|FG000|Overall Study|Lost to Follow-up|2|||
30604411|NCT01231581|58615421|FG001|Overall Study|Lost to Follow-up|2|||
30604412|NCT01231581|58615420|FG000|Overall Study|Withdrawal by Subject|6|||
30604413|NCT01231581|58615421|FG001|Overall Study|Withdrawal by Subject|9|||
30604414|NCT01231581|58615420|FG000|Overall Study|Study Closed/Terminated|6|||
30604415|NCT01231581|58615421|FG001|Overall Study|Study Closed/Terminated|5|||
30604416|NCT01231581|58615420|FG000|Overall Study|Death|65|||
30604417|NCT01231581|58615421|FG001|Overall Study|Death|64|||
30604418|NCT01231581|58615420|FG000|Overall Study|Ongoing|1|||
30604419|NCT01231581|58615421|FG001|Overall Study|Ongoing|0|||
30604420|NCT01050634|58615427|FG000|Overall Study|Enrolled, but Not Treated|56|||
30604421|NCT01050634|58615427|FG000|Overall Study|Death|2|||
30604422|NCT01050634|58615427|FG000|Overall Study|Adverse Event|42|||
30604423|NCT01050634|58615427|FG000|Overall Study|Lost to Follow-up|2|||
30604424|NCT01050634|58615427|FG000|Overall Study|Other|21|||
30604425|NCT01050634|58615427|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
30604426|NCT01020526|58615431|FG000|Overall Study|Withdrawal by Subject|5|||
30604427|NCT01020526|58615431|FG000|Overall Study|Other reasons|3|||
30604428|NCT01020526|58615431|FG000|Overall Study|Insufficient clinical response|3|||
30604429|NCT01020526|58615431|FG000|Overall Study|Lost to Follow-up|1|||
30604430|NCT01020526|58615431|FG000|Overall Study|Adverse Event|2|||
30604431|NCT01020448|58615435|FG000|Pre-assignment|Adverse Event|6|||
30604432|NCT01020448|58615435|FG000|Pre-assignment|Withdrawal by Subject|5|||
30604433|NCT01020448|58615435|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
30604434|NCT01020448|58615435|FG000|Treatment|Adverse Event|11|||
30604435|NCT01020448|58615435|FG000|Treatment|Consent Withdrawn|3|||
30604436|NCT01020448|58615435|FG000|Treatment|Disease Progression|2|||
30604437|NCT01020448|58615435|FG000|Treatment|Lack of Efficacy|8|||
30604438|NCT01020448|58615435|FG000|Treatment|Lost to Follow-up|2|||
30604439|NCT01256658|58615442|FG000|Period 1|Lost to Follow-up|837|||
30604440|NCT01256658|58615443|FG001|Period 1|Lost to Follow-up|661|||
30604441|NCT01256658|58615442|FG000|Period 1|Withdrawal by Subject|35|||
30604442|NCT01256658|58615443|FG001|Period 1|Withdrawal by Subject|43|||
30604443|NCT01256658|58615442|FG000|Period 1|Death|48|||
30604444|NCT01256658|58615443|FG001|Period 1|Death|44|||
30604445|NCT01256502|58615452|FG000|Overall Study|Had scaffold removed|4|||
30604446|NCT01256502|58615452|FG000|Overall Study|Personal reasons|5|||
30604447|NCT01256502|58615452|FG000|Overall Study|Protocol deviation|1|||
30604448|NCT01256190|58615463|FG000|Overall Study|Lost to Follow-up|2|||
30604449|NCT01256190|58615464|FG001|Overall Study|Lost to Follow-up|0|||
30604450|NCT01255722|58615473|FG000|Overall Study|Adverse Event|0|||
30604451|NCT01255722|58615474|FG001|Overall Study|Adverse Event|1|||
30604452|NCT01255722|58615475|FG002|Overall Study|Adverse Event|1|||
30604453|NCT01255722|58615473|FG000|Overall Study|asymptomatic patient|1|||
30604454|NCT01255722|58615474|FG001|Overall Study|asymptomatic patient|0|||
30604455|NCT01255722|58615475|FG002|Overall Study|asymptomatic patient|0|||
30604456|NCT01255722|58615473|FG000|Overall Study|beta-blocker contraindicated|2|||
30604457|NCT01255722|58615474|FG001|Overall Study|beta-blocker contraindicated|0|||
30604458|NCT01255722|58615475|FG002|Overall Study|beta-blocker contraindicated|0|||
30604459|NCT01231503|58615492|FG000|Overall Study|Adverse Event|0|||
30604460|NCT01231503|58615493|FG001|Overall Study|Adverse Event|0|||
30604461|NCT01231503|58615494|FG002|Overall Study|Adverse Event|0|||
30604462|NCT01231503|58615495|FG003|Overall Study|Adverse Event|0|||
30604463|NCT01231503|58615496|FG004|Overall Study|Adverse Event|0|||
30604464|NCT01231503|58615497|FG005|Overall Study|Adverse Event|1|||
30604465|NCT01231503|58615498|FG006|Overall Study|Adverse Event|0|||
30604466|NCT01231503|58615499|FG007|Overall Study|Adverse Event|0|||
30604467|NCT01231503|58615492|FG000|Overall Study|Adverse event, serious fatal|0|||
30604468|NCT01231503|58615493|FG001|Overall Study|Adverse event, serious fatal|0|||
30604469|NCT01231503|58615494|FG002|Overall Study|Adverse event, serious fatal|1|||
30604470|NCT01231503|58615495|FG003|Overall Study|Adverse event, serious fatal|1|||
30604471|NCT01231503|58615496|FG004|Overall Study|Adverse event, serious fatal|0|||
30604472|NCT01231503|58615497|FG005|Overall Study|Adverse event, serious fatal|1|||
30604473|NCT01231503|58615498|FG006|Overall Study|Adverse event, serious fatal|0|||
30604474|NCT01231503|58615499|FG007|Overall Study|Adverse event, serious fatal|0|||
30604475|NCT01231503|58615492|FG000|Overall Study|Withdrawal by Subject|6|||
30604476|NCT01231503|58615493|FG001|Overall Study|Withdrawal by Subject|3|||
30604477|NCT01231503|58615494|FG002|Overall Study|Withdrawal by Subject|3|||
30604478|NCT01231503|58615495|FG003|Overall Study|Withdrawal by Subject|1|||
30604479|NCT01231503|58615496|FG004|Overall Study|Withdrawal by Subject|3|||
30604480|NCT01231503|58615497|FG005|Overall Study|Withdrawal by Subject|5|||
30604481|NCT01231503|58615498|FG006|Overall Study|Withdrawal by Subject|1|||
30604482|NCT01231503|58615499|FG007|Overall Study|Withdrawal by Subject|2|||
30604483|NCT01231503|58615492|FG000|Overall Study|Lost to Follow-up|8|||
30604484|NCT01231503|58615493|FG001|Overall Study|Lost to Follow-up|10|||
30604485|NCT01231503|58615494|FG002|Overall Study|Lost to Follow-up|8|||
30604486|NCT01231503|58615495|FG003|Overall Study|Lost to Follow-up|5|||
30604487|NCT01231503|58615496|FG004|Overall Study|Lost to Follow-up|7|||
30604488|NCT01231503|58615497|FG005|Overall Study|Lost to Follow-up|9|||
30604489|NCT01231503|58615498|FG006|Overall Study|Lost to Follow-up|6|||
30604490|NCT01231503|58615499|FG007|Overall Study|Lost to Follow-up|6|||
30604491|NCT01231503|58615492|FG000|Overall Study|Protocol Violation|0|||
30604492|NCT01231503|58615493|FG001|Overall Study|Protocol Violation|0|||
30604493|NCT01231503|58615494|FG002|Overall Study|Protocol Violation|0|||
30604494|NCT01231503|58615495|FG003|Overall Study|Protocol Violation|1|||
30604495|NCT01231503|58615496|FG004|Overall Study|Protocol Violation|0|||
30604496|NCT01231503|58615497|FG005|Overall Study|Protocol Violation|0|||
30604497|NCT01231503|58615498|FG006|Overall Study|Protocol Violation|0|||
30604498|NCT01231503|58615499|FG007|Overall Study|Protocol Violation|0|||
30604499|NCT01230489|58615527|FG000|Overall Study|Death|2|||
30604500|NCT01230489|58615527|FG000|Overall Study|Adverse Event|2|||
30604501|NCT01230489|58615527|FG000|Overall Study|Treatment modality changed|1|||
30604502|NCT01229397|58615533|FG000|Overall Study|Withdrawal by Subject|3|||
30604503|NCT01229397|58615534|FG001|Overall Study|Withdrawal by Subject|3|||
30604504|NCT01229397|58615533|FG000|Overall Study|Lost to Follow-up|7|||
30604505|NCT01229397|58615534|FG001|Overall Study|Lost to Follow-up|6|||
30604506|NCT01229397|58615533|FG000|Overall Study|Migrated/moved from study area|1|||
30604507|NCT01229397|58615534|FG001|Overall Study|Migrated/moved from study area|0|||
30604508|NCT01228071|58615544|FG000|Overall Study|Protocol Violation|1|||
30604509|NCT01228071|58615544|FG000|Overall Study|Withdrawal by Subject|1|||
30604510|NCT01008475|58615555|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
30604511|NCT01008475|58615556|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
30604512|NCT01008475|58615557|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
30604513|NCT01008475|58615558|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
30604514|NCT01008475|58615559|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
30604515|NCT01008475|58615560|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
30604516|NCT01008475|58615561|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
30604517|NCT01226745|58615583|FG000|Overall Study|Did not complete schedule of assessments|8|||
30604518|NCT01226745|58615584|FG001|Overall Study|Did not complete schedule of assessments|3|||
30604519|NCT01226745|58615585|FG002|Overall Study|Did not complete schedule of assessments|6|||
30604520|NCT01226745|58615586|FG003|Overall Study|Did not complete schedule of assessments|0|||
30604521|NCT01226745|58615587|FG004|Overall Study|Did not complete schedule of assessments|0|||
30604522|NCT01226745|58615588|FG005|Overall Study|Did not complete schedule of assessments|1|||
30604523|NCT01226745|58615583|FG000|Overall Study|Lost to Follow-up|2|||
30604524|NCT01226745|58615584|FG001|Overall Study|Lost to Follow-up|6|||
30604525|NCT01226745|58615585|FG002|Overall Study|Lost to Follow-up|6|||
30604526|NCT01226745|58615586|FG003|Overall Study|Lost to Follow-up|1|||
30604527|NCT01226745|58615587|FG004|Overall Study|Lost to Follow-up|1|||
30604528|NCT01226745|58615588|FG005|Overall Study|Lost to Follow-up|2|||
30604529|NCT01226745|58615583|FG000|Overall Study|Death|1|||
30604530|NCT01226745|58615584|FG001|Overall Study|Death|0|||
30604531|NCT01226745|58615585|FG002|Overall Study|Death|0|||
30604532|NCT01226745|58615586|FG003|Overall Study|Death|0|||
30604533|NCT01226745|58615587|FG004|Overall Study|Death|0|||
30604534|NCT01226745|58615588|FG005|Overall Study|Death|1|||
30604535|NCT01226745|58615583|FG000|Overall Study|Other|6|||
30604536|NCT01226745|58615584|FG001|Overall Study|Other|7|||
30604537|NCT01226745|58615585|FG002|Overall Study|Other|8|||
30604538|NCT01226745|58615586|FG003|Overall Study|Other|4|||
30604539|NCT01226745|58615587|FG004|Overall Study|Other|3|||
30604540|NCT01226745|58615588|FG005|Overall Study|Other|1|||
30604541|NCT01226511|58615605|FG000|Acute Treatment Period|Adverse Event|7|||
30604542|NCT01226511|58615606|FG001|Acute Treatment Period|Adverse Event|6|||
30604543|NCT01226511|58615605|FG000|Acute Treatment Period|Lack of Efficacy|2|||
30604544|NCT01226511|58615606|FG001|Acute Treatment Period|Lack of Efficacy|1|||
30604545|NCT01226511|58615605|FG000|Acute Treatment Period|Lost to Follow-up|3|||
30604546|NCT01226511|58615606|FG001|Acute Treatment Period|Lost to Follow-up|6|||
30604547|NCT01226511|58615605|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
30604548|NCT01226511|58615606|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
30604549|NCT01226511|58615605|FG000|Acute Treatment Period|Protocol Violation|5|||
30604550|NCT01226511|58615606|FG001|Acute Treatment Period|Protocol Violation|5|||
30604551|NCT01226511|58615605|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
30604552|NCT01226511|58615606|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
30604553|NCT01226511|58615605|FG000|Extension Treatment Period|Adverse Event|8|||
30604554|NCT01226511|58615606|FG001|Extension Treatment Period|Adverse Event|8|||
30604555|NCT01226511|58615605|FG000|Extension Treatment Period|Lack of Efficacy|3|||
30604556|NCT01226511|58615606|FG001|Extension Treatment Period|Lack of Efficacy|2|||
30695684|NCT00328627|58710036|FG004|Overall Study|Protocol Violation|5|||
30604557|NCT01226511|58615605|FG000|Extension Treatment Period|Lost to Follow-up|4|||
30604558|NCT01226511|58615606|FG001|Extension Treatment Period|Lost to Follow-up|3|||
30604559|NCT01226511|58615605|FG000|Extension Treatment Period|Protocol Violation|2|||
30604560|NCT01226511|58615606|FG001|Extension Treatment Period|Protocol Violation|2|||
30604561|NCT01226511|58615605|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
30604562|NCT01226511|58615606|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
30604563|NCT01226511|58615605|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
30604564|NCT01226511|58615606|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
30604565|NCT01226511|58615605|FG000|Extension Treatment Period|Sponsor Decision|1|||
30604566|NCT01226511|58615606|FG001|Extension Treatment Period|Sponsor Decision|1|||
30604567|NCT01226511|58615605|FG000|Taper Period|Adverse Event|1|||
30604568|NCT01226511|58615606|FG001|Taper Period|Adverse Event|0|||
30604569|NCT01226511|58615605|FG000|Taper Period|Lost to Follow-up|2|||
30604570|NCT01226511|58615606|FG001|Taper Period|Lost to Follow-up|2|||
30604571|NCT01226511|58615605|FG000|Taper Period|Protocol Violation|1|||
30604572|NCT01226511|58615606|FG001|Taper Period|Protocol Violation|0|||
30604573|NCT01226511|58615605|FG000|Taper Period|Parent/Caregiver Decision|1|||
30604574|NCT01226511|58615606|FG001|Taper Period|Parent/Caregiver Decision|1|||
30604575|NCT01226121|58615621|FG000|Overall Study|Lost to Follow-up|2|||
30604576|NCT01226121|58615622|FG001|Overall Study|Lost to Follow-up|0|||
30604577|NCT01226121|58615623|FG002|Overall Study|Lost to Follow-up|1|||
30604578|NCT01226043|58615633|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
30604579|NCT01226043|58615634|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
30604580|NCT01226043|58615635|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
30604581|NCT01226043|58615636|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
30604582|NCT01226043|58615633|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
30604583|NCT01226043|58615634|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
30604584|NCT01226043|58615635|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
30604585|NCT01226043|58615636|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
30604586|NCT01226043|58615633|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
30604587|NCT01226043|58615634|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
30604588|NCT01226043|58615635|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
30604589|NCT01226043|58615636|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
30604590|NCT01226043|58615633|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
30604591|NCT01226043|58615634|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
30604592|NCT01226043|58615635|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
30604593|NCT01226043|58615636|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
30604594|NCT01226043|58615633|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
30604595|NCT01226043|58615634|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
30604596|NCT01226043|58615635|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
30604597|NCT01226043|58615636|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
30604598|NCT01226043|58615633|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
30604599|NCT01226043|58615634|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
30604600|NCT01226043|58615635|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
30604601|NCT01226043|58615636|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
30604602|NCT01226043|58615633|FG000|6-week Re-randomization Phase|Adverse Event|0|||
30604603|NCT01226043|58615634|FG001|6-week Re-randomization Phase|Adverse Event|0|||
30604604|NCT01226043|58615635|FG002|6-week Re-randomization Phase|Adverse Event|1|||
30604605|NCT01226043|58615636|FG003|6-week Re-randomization Phase|Adverse Event|1|||
30604606|NCT01226043|58615633|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
30604607|NCT01226043|58615634|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
30604608|NCT01226043|58615635|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
30604609|NCT01226043|58615636|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
30604610|NCT01226043|58615633|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
30604611|NCT01226043|58615634|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
30604612|NCT01226043|58615635|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
30604613|NCT01226043|58615636|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
30604614|NCT01226043|58615633|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
30604615|NCT01226043|58615634|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
30604616|NCT01226043|58615635|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
30604617|NCT01226043|58615636|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
30604618|NCT01226043|58615633|FG000|6-week Re-randomization Phase|Physician Decision|0|||
30604619|NCT01226043|58615634|FG001|6-week Re-randomization Phase|Physician Decision|0|||
30604620|NCT01226043|58615635|FG002|6-week Re-randomization Phase|Physician Decision|3|||
30604621|NCT01226043|58615636|FG003|6-week Re-randomization Phase|Physician Decision|2|||
30604622|NCT01226043|58615633|FG000|6-week Re-randomization Phase|completed in error|0|||
30604623|NCT01226043|58615634|FG001|6-week Re-randomization Phase|completed in error|0|||
30604624|NCT01226043|58615635|FG002|6-week Re-randomization Phase|completed in error|0|||
30604625|NCT01226043|58615636|FG003|6-week Re-randomization Phase|completed in error|1|||
30962208|NCT01572727|59028921|FG001|Overall Study|Death|2|||
30962209|NCT01572727|59028920|FG000|Overall Study|Untreated|4|||
30962210|NCT01572727|59028921|FG001|Overall Study|Untreated|7|||
30604626|NCT01226043|58615633|FG000|30-week Observational Phase|Adverse Event|0|||
30604627|NCT01226043|58615634|FG001|30-week Observational Phase|Adverse Event|0|||
30604628|NCT01226043|58615635|FG002|30-week Observational Phase|Adverse Event|1|||
30604629|NCT01226043|58615636|FG003|30-week Observational Phase|Adverse Event|1|||
30604630|NCT01226043|58615633|FG000|30-week Observational Phase|Protocol Violation|0|||
30604631|NCT01226043|58615634|FG001|30-week Observational Phase|Protocol Violation|0|||
30604632|NCT01226043|58615635|FG002|30-week Observational Phase|Protocol Violation|0|||
30604633|NCT01226043|58615636|FG003|30-week Observational Phase|Protocol Violation|1|||
30604634|NCT01226043|58615633|FG000|30-week Observational Phase|Lost to Follow-up|0|||
30604635|NCT01226043|58615634|FG001|30-week Observational Phase|Lost to Follow-up|0|||
30604636|NCT01226043|58615635|FG002|30-week Observational Phase|Lost to Follow-up|2|||
30604637|NCT01226043|58615636|FG003|30-week Observational Phase|Lost to Follow-up|2|||
30604638|NCT01226043|58615633|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
30604639|NCT01226043|58615634|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
30604640|NCT01226043|58615635|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
30604641|NCT01226043|58615636|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
30604642|NCT01226043|58615633|FG000|30-week Observational Phase|Physician Decision|0|||
30604643|NCT01226043|58615634|FG001|30-week Observational Phase|Physician Decision|0|||
30604644|NCT01226043|58615635|FG002|30-week Observational Phase|Physician Decision|2|||
30604645|NCT01226043|58615636|FG003|30-week Observational Phase|Physician Decision|2|||
30604646|NCT01001377|58615668|FG000|Overall Study|Ineligibility determined|2|||
30604647|NCT01001377|58615669|FG001|Overall Study|Ineligibility determined|0|||
30604648|NCT01001377|58615668|FG000|Overall Study|Withdrawal by Subject|19|||
30604649|NCT01001377|58615669|FG001|Overall Study|Withdrawal by Subject|20|||
30604650|NCT01001377|58615668|FG000|Overall Study|Lost to Follow-up|14|||
30604651|NCT01001377|58615669|FG001|Overall Study|Lost to Follow-up|17|||
30604652|NCT01001377|58615668|FG000|Overall Study|Death|391|||
30604653|NCT01001377|58615669|FG001|Overall Study|Death|384|||
30604654|NCT01225887|58615675|FG000|Overall Study|Ineligible:required test not done|2|||
30604655|NCT01225887|58615675|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
30604656|NCT01225887|58615675|FG000|Overall Study|Ineligible:inadequate pathology|2|||
30604657|NCT01001299|58615679|FG000|Overall Study|Insufficient Therapeutic Response|20|||
30604658|NCT01001299|58615679|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
30604659|NCT01001299|58615679|FG000|Overall Study|Death|1|||
30604660|NCT01001299|58615679|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
30604661|NCT01001299|58615679|FG000|Overall Study|Withdrew Consent|1|||
30604662|NCT01296932|58615692|FG000|Overall Study|Dose limiting toxicity|0|||
30604663|NCT01296932|58615693|FG001|Overall Study|Dose limiting toxicity|0|||
30604664|NCT01296932|58615694|FG002|Overall Study|Dose limiting toxicity|0|||
30604665|NCT01296932|58615695|FG003|Overall Study|Dose limiting toxicity|0|||
30604666|NCT01296932|58615696|FG004|Overall Study|Dose limiting toxicity|0|||
30604667|NCT01296932|58615697|FG005|Overall Study|Dose limiting toxicity|0|||
30604668|NCT01296932|58615698|FG006|Overall Study|Dose limiting toxicity|1|||
30604669|NCT01296932|58615699|FG007|Overall Study|Dose limiting toxicity|0|||
30604670|NCT01296932|58615700|FG008|Overall Study|Dose limiting toxicity|1|||
30604671|NCT01296932|58615692|FG000|Overall Study|Progressive disease|2|||
30604672|NCT01296932|58615693|FG001|Overall Study|Progressive disease|0|||
30604673|NCT01296932|58615694|FG002|Overall Study|Progressive disease|1|||
30604674|NCT01296932|58615695|FG003|Overall Study|Progressive disease|1|||
30604675|NCT01296932|58615696|FG004|Overall Study|Progressive disease|2|||
30604676|NCT01296932|58615697|FG005|Overall Study|Progressive disease|3|||
30604677|NCT01296932|58615698|FG006|Overall Study|Progressive disease|1|||
30604678|NCT01296932|58615699|FG007|Overall Study|Progressive disease|0|||
30604679|NCT01296932|58615700|FG008|Overall Study|Progressive disease|0|||
30604680|NCT01296932|58615692|FG000|Overall Study|Withdrawal by Subject|0|||
30604681|NCT01296932|58615693|FG001|Overall Study|Withdrawal by Subject|0|||
30604682|NCT01296932|58615694|FG002|Overall Study|Withdrawal by Subject|1|||
30604683|NCT01296932|58615695|FG003|Overall Study|Withdrawal by Subject|1|||
30604684|NCT01296932|58615696|FG004|Overall Study|Withdrawal by Subject|0|||
30604685|NCT01296932|58615697|FG005|Overall Study|Withdrawal by Subject|0|||
30604686|NCT01296932|58615698|FG006|Overall Study|Withdrawal by Subject|3|||
30604687|NCT01296932|58615699|FG007|Overall Study|Withdrawal by Subject|0|||
30604688|NCT01296932|58615700|FG008|Overall Study|Withdrawal by Subject|0|||
30604689|NCT01296932|58615692|FG000|Overall Study|Adverse Event|1|||
30604690|NCT01296932|58615693|FG001|Overall Study|Adverse Event|1|||
30604691|NCT01296932|58615694|FG002|Overall Study|Adverse Event|1|||
30604692|NCT01296932|58615695|FG003|Overall Study|Adverse Event|2|||
30604693|NCT01296932|58615696|FG004|Overall Study|Adverse Event|1|||
30604694|NCT01296932|58615697|FG005|Overall Study|Adverse Event|0|||
30604695|NCT01296932|58615698|FG006|Overall Study|Adverse Event|0|||
30604696|NCT01296932|58615699|FG007|Overall Study|Adverse Event|0|||
30604697|NCT01296932|58615700|FG008|Overall Study|Adverse Event|1|||
30604698|NCT01296932|58615692|FG000|Overall Study|Investigator decision|0|||
30604699|NCT01296932|58615693|FG001|Overall Study|Investigator decision|1|||
30604700|NCT01296932|58615694|FG002|Overall Study|Investigator decision|0|||
30604701|NCT01296932|58615695|FG003|Overall Study|Investigator decision|1|||
30604702|NCT01296932|58615696|FG004|Overall Study|Investigator decision|0|||
30604703|NCT01296932|58615697|FG005|Overall Study|Investigator decision|0|||
30604704|NCT01296932|58615698|FG006|Overall Study|Investigator decision|1|||
30604705|NCT01296932|58615699|FG007|Overall Study|Investigator decision|0|||
30604706|NCT01296932|58615700|FG008|Overall Study|Investigator decision|1|||
30604707|NCT01296932|58615692|FG000|Overall Study|No clinical benefit anymore|0|||
30604708|NCT01296932|58615693|FG001|Overall Study|No clinical benefit anymore|1|||
30604709|NCT01296932|58615694|FG002|Overall Study|No clinical benefit anymore|0|||
30604710|NCT01296932|58615695|FG003|Overall Study|No clinical benefit anymore|0|||
30604711|NCT01296932|58615696|FG004|Overall Study|No clinical benefit anymore|0|||
30604712|NCT01296932|58615697|FG005|Overall Study|No clinical benefit anymore|0|||
30604713|NCT01296932|58615698|FG006|Overall Study|No clinical benefit anymore|0|||
30604714|NCT01296932|58615699|FG007|Overall Study|No clinical benefit anymore|0|||
30604715|NCT01296932|58615700|FG008|Overall Study|No clinical benefit anymore|0|||
30604716|NCT01296932|58615692|FG000|Overall Study|Physician Decision|0|||
30604717|NCT01296932|58615693|FG001|Overall Study|Physician Decision|0|||
30604718|NCT01296932|58615694|FG002|Overall Study|Physician Decision|1|||
30604719|NCT01296932|58615695|FG003|Overall Study|Physician Decision|0|||
30604720|NCT01296932|58615696|FG004|Overall Study|Physician Decision|0|||
30604721|NCT01296932|58615697|FG005|Overall Study|Physician Decision|0|||
30604722|NCT01296932|58615698|FG006|Overall Study|Physician Decision|0|||
30604723|NCT01296932|58615699|FG007|Overall Study|Physician Decision|0|||
30604724|NCT01296932|58615700|FG008|Overall Study|Physician Decision|0|||
30604725|NCT01296932|58615692|FG000|Overall Study|IV problems, administration not possible|0|||
30604726|NCT01296932|58615693|FG001|Overall Study|IV problems, administration not possible|0|||
30604727|NCT01296932|58615694|FG002|Overall Study|IV problems, administration not possible|1|||
30604728|NCT01296932|58615695|FG003|Overall Study|IV problems, administration not possible|0|||
30604729|NCT01296932|58615696|FG004|Overall Study|IV problems, administration not possible|0|||
30604730|NCT01296932|58615697|FG005|Overall Study|IV problems, administration not possible|0|||
30604731|NCT01296932|58615698|FG006|Overall Study|IV problems, administration not possible|0|||
30604732|NCT01296932|58615699|FG007|Overall Study|IV problems, administration not possible|0|||
30604733|NCT01296932|58615700|FG008|Overall Study|IV problems, administration not possible|0|||
30604734|NCT01296932|58615692|FG000|Overall Study|per protocol|0|||
30604735|NCT01296932|58615693|FG001|Overall Study|per protocol|0|||
30604736|NCT01296932|58615694|FG002|Overall Study|per protocol|1|||
30604737|NCT01296932|58615695|FG003|Overall Study|per protocol|1|||
30604738|NCT01296932|58615696|FG004|Overall Study|per protocol|0|||
30604739|NCT01296932|58615697|FG005|Overall Study|per protocol|0|||
30604740|NCT01296932|58615698|FG006|Overall Study|per protocol|0|||
30604741|NCT01296932|58615699|FG007|Overall Study|per protocol|0|||
30604742|NCT01296932|58615700|FG008|Overall Study|per protocol|0|||
30604743|NCT01296932|58615692|FG000|Overall Study|Low benefit and too many side effects|0|||
30604744|NCT01296932|58615693|FG001|Overall Study|Low benefit and too many side effects|0|||
30604745|NCT01296932|58615694|FG002|Overall Study|Low benefit and too many side effects|0|||
30604746|NCT01296932|58615695|FG003|Overall Study|Low benefit and too many side effects|0|||
30604747|NCT01296932|58615696|FG004|Overall Study|Low benefit and too many side effects|0|||
30604748|NCT01296932|58615697|FG005|Overall Study|Low benefit and too many side effects|0|||
30604749|NCT01296932|58615698|FG006|Overall Study|Low benefit and too many side effects|0|||
30604750|NCT01296932|58615699|FG007|Overall Study|Low benefit and too many side effects|1|||
30604751|NCT01296932|58615700|FG008|Overall Study|Low benefit and too many side effects|0|||
30604752|NCT01296932|58615692|FG000|Overall Study|No adequate treatment response|0|||
30962211|NCT01522651|59028968|FG000|Overall Study|Adverse Event|3|||
30604753|NCT01296932|58615693|FG001|Overall Study|No adequate treatment response|0|||
30604754|NCT01296932|58615694|FG002|Overall Study|No adequate treatment response|0|||
30604755|NCT01296932|58615695|FG003|Overall Study|No adequate treatment response|0|||
30604756|NCT01296932|58615696|FG004|Overall Study|No adequate treatment response|0|||
30604757|NCT01296932|58615697|FG005|Overall Study|No adequate treatment response|0|||
30604758|NCT01296932|58615698|FG006|Overall Study|No adequate treatment response|0|||
30604759|NCT01296932|58615699|FG007|Overall Study|No adequate treatment response|1|||
30604760|NCT01296932|58615700|FG008|Overall Study|No adequate treatment response|0|||
30604761|NCT01296932|58615692|FG000|Overall Study|Dosage already reduced, AE still present|0|||
30604762|NCT01296932|58615693|FG001|Overall Study|Dosage already reduced, AE still present|0|||
30604763|NCT01296932|58615694|FG002|Overall Study|Dosage already reduced, AE still present|0|||
30604764|NCT01296932|58615695|FG003|Overall Study|Dosage already reduced, AE still present|0|||
30604765|NCT01296932|58615696|FG004|Overall Study|Dosage already reduced, AE still present|0|||
30604766|NCT01296932|58615697|FG005|Overall Study|Dosage already reduced, AE still present|0|||
30604767|NCT01296932|58615698|FG006|Overall Study|Dosage already reduced, AE still present|0|||
30604768|NCT01296932|58615699|FG007|Overall Study|Dosage already reduced, AE still present|0|||
30604769|NCT01296932|58615700|FG008|Overall Study|Dosage already reduced, AE still present|1|||
30604770|NCT01296698|58615723|FG000|Overall Study|Adverse Event|1|||
30604771|NCT01296698|58615724|FG001|Overall Study|Adverse Event|0|||
30604772|NCT01296698|58615723|FG000|Overall Study|Death|1|||
30604773|NCT01296698|58615724|FG001|Overall Study|Death|0|||
30604774|NCT01296698|58615723|FG000|Overall Study|Lost to Follow-up|19|||
30604775|NCT01296698|58615724|FG001|Overall Study|Lost to Follow-up|1|||
30604776|NCT01296698|58615723|FG000|Overall Study|Withdrawal by Subject|12|||
30604777|NCT01296698|58615724|FG001|Overall Study|Withdrawal by Subject|0|||
30604778|NCT01296698|58615723|FG000|Overall Study|Difficulty Contacting Subject|2|||
30604779|NCT01296698|58615724|FG001|Overall Study|Difficulty Contacting Subject|0|||
30604780|NCT01296698|58615723|FG000|Overall Study|Study Terminated by Sponsor|209|||
30604781|NCT01296698|58615724|FG001|Overall Study|Study Terminated by Sponsor|12|||
30604782|NCT01001221|58615734|FG000|Overall Study|Adverse Event|1|||
30604783|NCT01001221|58615735|FG001|Overall Study|Adverse Event|2|||
30604784|NCT01001221|58615736|FG002|Overall Study|Adverse Event|0|||
30604785|NCT01001221|58615737|FG003|Overall Study|Adverse Event|2|||
30604786|NCT01001221|58615738|FG004|Overall Study|Adverse Event|0|||
30604787|NCT01001221|58615734|FG000|Overall Study|Disease progression|3|||
30695685|NCT00328627|58710037|FG005|Overall Study|Protocol Violation|5|||
30695686|NCT00328627|58710038|FG006|Overall Study|Protocol Violation|6|||
30695687|NCT00328627|58710039|FG007|Overall Study|Protocol Violation|2|||
30695688|NCT00328627|58710040|FG008|Overall Study|Protocol Violation|1|||
30695689|NCT00328627|58710041|FG009|Overall Study|Protocol Violation|4|||
30695690|NCT00328627|58710042|FG010|Overall Study|Protocol Violation|6|||
30695691|NCT00328627|58710043|FG011|Overall Study|Protocol Violation|2|||
30695692|NCT00328627|58710032|FG000|Overall Study|Lost to Follow-up|4|||
30695693|NCT00328627|58710033|FG001|Overall Study|Lost to Follow-up|2|||
30695694|NCT00328627|58710034|FG002|Overall Study|Lost to Follow-up|2|||
30695695|NCT00328627|58710035|FG003|Overall Study|Lost to Follow-up|4|||
30695696|NCT00328627|58710036|FG004|Overall Study|Lost to Follow-up|0|||
30695697|NCT00328627|58710037|FG005|Overall Study|Lost to Follow-up|2|||
30695698|NCT00328627|58710038|FG006|Overall Study|Lost to Follow-up|3|||
30695699|NCT00328627|58710039|FG007|Overall Study|Lost to Follow-up|0|||
30695700|NCT00328627|58710040|FG008|Overall Study|Lost to Follow-up|3|||
30695701|NCT00328627|58710041|FG009|Overall Study|Lost to Follow-up|2|||
30695702|NCT00328627|58710042|FG010|Overall Study|Lost to Follow-up|0|||
30695703|NCT00328627|58710043|FG011|Overall Study|Lost to Follow-up|1|||
30695704|NCT00328627|58710032|FG000|Overall Study|Withdrawal by Subject|5|||
30695705|NCT00328627|58710033|FG001|Overall Study|Withdrawal by Subject|4|||
30695706|NCT00328627|58710034|FG002|Overall Study|Withdrawal by Subject|5|||
30695707|NCT00328627|58710035|FG003|Overall Study|Withdrawal by Subject|6|||
30695708|NCT00328627|58710036|FG004|Overall Study|Withdrawal by Subject|2|||
30695709|NCT00328627|58710037|FG005|Overall Study|Withdrawal by Subject|5|||
30695710|NCT00328627|58710038|FG006|Overall Study|Withdrawal by Subject|4|||
30695711|NCT00328627|58710039|FG007|Overall Study|Withdrawal by Subject|4|||
30695712|NCT00328627|58710040|FG008|Overall Study|Withdrawal by Subject|4|||
30695713|NCT00328627|58710041|FG009|Overall Study|Withdrawal by Subject|5|||
30695714|NCT00328627|58710042|FG010|Overall Study|Withdrawal by Subject|2|||
30695715|NCT00328627|58710043|FG011|Overall Study|Withdrawal by Subject|7|||
30695716|NCT00328627|58710032|FG000|Overall Study|Pregnancy|0|||
30695717|NCT00328627|58710033|FG001|Overall Study|Pregnancy|1|||
30695718|NCT00328627|58710034|FG002|Overall Study|Pregnancy|0|||
30695719|NCT00328627|58710035|FG003|Overall Study|Pregnancy|0|||
30695720|NCT00328627|58710036|FG004|Overall Study|Pregnancy|0|||
30695721|NCT00328627|58710037|FG005|Overall Study|Pregnancy|0|||
30695722|NCT00328627|58710038|FG006|Overall Study|Pregnancy|0|||
30695723|NCT00328627|58710039|FG007|Overall Study|Pregnancy|0|||
30695724|NCT00328627|58710040|FG008|Overall Study|Pregnancy|0|||
30695725|NCT00328627|58710041|FG009|Overall Study|Pregnancy|0|||
30695726|NCT00328627|58710042|FG010|Overall Study|Pregnancy|0|||
30695727|NCT00328627|58710043|FG011|Overall Study|Pregnancy|0|||
30695728|NCT00328627|58710032|FG000|Overall Study|Physician Decision|4|||
30695729|NCT00328627|58710033|FG001|Overall Study|Physician Decision|3|||
30962212|NCT01522651|59028969|FG001|Overall Study|Adverse Event|4|||
30604788|NCT01001221|58615735|FG001|Overall Study|Disease progression|2|||
30604789|NCT01001221|58615736|FG002|Overall Study|Disease progression|2|||
30604790|NCT01001221|58615737|FG003|Overall Study|Disease progression|4|||
30604791|NCT01001221|58615738|FG004|Overall Study|Disease progression|0|||
30604792|NCT01001221|58615734|FG000|Overall Study|Other|1|||
30604793|NCT01001221|58615735|FG001|Overall Study|Other|1|||
30604794|NCT01001221|58615736|FG002|Overall Study|Other|0|||
30604795|NCT01001221|58615737|FG003|Overall Study|Other|0|||
30695730|NCT00328627|58710034|FG002|Overall Study|Physician Decision|1|||
30695731|NCT00328627|58710035|FG003|Overall Study|Physician Decision|2|||
30695732|NCT00328627|58710036|FG004|Overall Study|Physician Decision|1|||
30695733|NCT00328627|58710037|FG005|Overall Study|Physician Decision|1|||
30695734|NCT00328627|58710038|FG006|Overall Study|Physician Decision|1|||
30695735|NCT00328627|58710039|FG007|Overall Study|Physician Decision|0|||
30695736|NCT00328627|58710040|FG008|Overall Study|Physician Decision|3|||
30695737|NCT00328627|58710041|FG009|Overall Study|Physician Decision|2|||
30695738|NCT00328627|58710042|FG010|Overall Study|Physician Decision|1|||
30695739|NCT00328627|58710043|FG011|Overall Study|Physician Decision|0|||
30695740|NCT00328627|58710032|FG000|Overall Study|Other|0|||
30695741|NCT00328627|58710033|FG001|Overall Study|Other|0|||
30695742|NCT00328627|58710034|FG002|Overall Study|Other|0|||
30695743|NCT00328627|58710035|FG003|Overall Study|Other|1|||
30695744|NCT00328627|58710036|FG004|Overall Study|Other|0|||
30695745|NCT00328627|58710037|FG005|Overall Study|Other|0|||
30695746|NCT00328627|58710038|FG006|Overall Study|Other|1|||
30695747|NCT00328627|58710039|FG007|Overall Study|Other|0|||
30695748|NCT00328627|58710040|FG008|Overall Study|Other|0|||
30695749|NCT00328627|58710041|FG009|Overall Study|Other|1|||
30695750|NCT00328627|58710042|FG010|Overall Study|Other|1|||
30695751|NCT00328627|58710043|FG011|Overall Study|Other|0|||
30695752|NCT03977727|58710079|FG000|Second Treatment|Lost to Follow-up|0|||
30695753|NCT03977727|58710080|FG001|Second Treatment|Lost to Follow-up|3|||
30695754|NCT00663858|58710089|FG000|Overall Study|Adverse Event|9|||
30695755|NCT00663858|58710090|FG001|Overall Study|Adverse Event|1|||
30695756|NCT00663858|58710091|FG002|Overall Study|Adverse Event|6|||
30695757|NCT00663858|58710089|FG000|Overall Study|Lack of Efficacy|5|||
30695758|NCT00663858|58710090|FG001|Overall Study|Lack of Efficacy|1|||
30695759|NCT00663858|58710091|FG002|Overall Study|Lack of Efficacy|3|||
30695760|NCT00663858|58710089|FG000|Overall Study|Withdrawal by Subject|7|||
30695761|NCT00663858|58710090|FG001|Overall Study|Withdrawal by Subject|3|||
30695762|NCT00663858|58710091|FG002|Overall Study|Withdrawal by Subject|3|||
30695763|NCT00663858|58710089|FG000|Overall Study|Protocol Violation|5|||
30695764|NCT00663858|58710090|FG001|Overall Study|Protocol Violation|3|||
30695765|NCT00663858|58710091|FG002|Overall Study|Protocol Violation|4|||
30695766|NCT00663858|58710089|FG000|Overall Study|Other|8|||
30695767|NCT00663858|58710090|FG001|Overall Study|Other|2|||
30695768|NCT00663858|58710091|FG002|Overall Study|Other|4|||
30695769|NCT00659880|58710099|FG000|Overall Study|Lost to Follow-up|5|||
30695770|NCT00683774|58710106|FG000|Overall Study|Withdrawal by Subject|0|||
30695771|NCT00683774|58710107|FG001|Overall Study|Withdrawal by Subject|1|||
30695772|NCT00683774|58710106|FG000|Overall Study|Physician Decision|3|||
30695773|NCT00683774|58710107|FG001|Overall Study|Physician Decision|0|||
30695774|NCT00354679|58710113|FG000|Overall Study|Patient Not Treated|1|||
30695775|NCT00683696|58710119|FG000|Overall Study|Withdrawn due to study closure|337|||
30695776|NCT00683696|58710120|FG001|Overall Study|Withdrawn due to study closure|338|||
30695777|NCT00683696|58710119|FG000|Overall Study|Withdrawn prior to study closure|13|||
30695778|NCT00683696|58710120|FG001|Overall Study|Withdrawn prior to study closure|28|||
30695779|NCT00683696|58710119|FG000|Overall Study|Lost to Follow-up|5|||
30695780|NCT00683696|58710120|FG001|Overall Study|Lost to Follow-up|6|||
30695781|NCT00683696|58710119|FG000|Overall Study|Vital status follow-up only|3|||
30695782|NCT00683696|58710120|FG001|Overall Study|Vital status follow-up only|3|||
30695783|NCT00683696|58710119|FG000|Overall Study|Death|46|||
30695784|NCT00683696|58710120|FG001|Overall Study|Death|30|||
30695785|NCT00345631|58710130|FG000|Overall Study|Withdrawal by Subject|1|||
30695786|NCT00345631|58710131|FG001|Overall Study|Withdrawal by Subject|0|||
30695787|NCT00345631|58710132|FG002|Overall Study|Withdrawal by Subject|1|||
30695788|NCT00345631|58710130|FG000|Overall Study|Adverse Event|0|||
30695789|NCT00345631|58710131|FG001|Overall Study|Adverse Event|1|||
30695790|NCT00345631|58710132|FG002|Overall Study|Adverse Event|0|||
30695791|NCT00345631|58710130|FG000|Overall Study|Lost to Follow-up|3|||
30695792|NCT00345631|58710131|FG001|Overall Study|Lost to Follow-up|7|||
30695793|NCT00345631|58710132|FG002|Overall Study|Lost to Follow-up|4|||
30695794|NCT00345631|58710130|FG000|Overall Study|Other reasons|0|||
30695795|NCT00345631|58710131|FG001|Overall Study|Other reasons|0|||
30695796|NCT00345631|58710132|FG002|Overall Study|Other reasons|1|||
30695797|NCT00540514|58710144|FG000|Overall Study|Still on treatment|3|||
30695798|NCT00540514|58710145|FG001|Overall Study|Still on treatment|0|||
30695799|NCT00540514|58710144|FG000|Overall Study|Unacceptable Toxicity|61|||
30695800|NCT00540514|58710145|FG001|Overall Study|Unacceptable Toxicity|62|||
30695801|NCT00540514|58710144|FG000|Overall Study|Adverse Event|20|||
30695802|NCT00540514|58710145|FG001|Overall Study|Adverse Event|24|||
30695803|NCT00540514|58710144|FG000|Overall Study|Physician Decision|86|||
30695804|NCT00540514|58710145|FG001|Overall Study|Physician Decision|99|||
30695805|NCT00540514|58710144|FG000|Overall Study|Protocol Deviation|3|||
30695806|NCT00540514|58710145|FG001|Overall Study|Protocol Deviation|4|||
30695807|NCT00540514|58710144|FG000|Overall Study|Lost to Follow-up|1|||
30695808|NCT00540514|58710145|FG001|Overall Study|Lost to Follow-up|1|||
30695809|NCT00540514|58710144|FG000|Overall Study|Withdrawal by Subject|65|||
30695810|NCT00540514|58710145|FG001|Overall Study|Withdrawal by Subject|67|||
30695811|NCT00540514|58710144|FG000|Overall Study|Excluded prior to treatment|7|||
30695812|NCT00540514|58710145|FG001|Overall Study|Excluded prior to treatment|7|||
30695813|NCT00540514|58710144|FG000|Overall Study|Paclitaxel not available|0|||
30695814|NCT00540514|58710145|FG001|Overall Study|Paclitaxel not available|2|||
30695815|NCT00663702|58710154|FG000|Overall Study|Adverse Event|8|||
30695816|NCT00663702|58710155|FG001|Overall Study|Adverse Event|4|||
30695817|NCT00663702|58710154|FG000|Overall Study|Withdrawal by Subject|3|||
30695818|NCT00663702|58710155|FG001|Overall Study|Withdrawal by Subject|1|||
30695819|NCT00663702|58710154|FG000|Overall Study|Pregnancy|0|||
30695820|NCT00663702|58710155|FG001|Overall Study|Pregnancy|1|||
30695821|NCT00663702|58710154|FG000|Overall Study|Lost to Follow-up|3|||
30695822|NCT00663702|58710155|FG001|Overall Study|Lost to Follow-up|0|||
30695823|NCT00663702|58710154|FG000|Overall Study|Death|1|||
30695824|NCT00663702|58710155|FG001|Overall Study|Death|1|||
30695825|NCT00663702|58710154|FG000|Overall Study|Lack of Efficacy|3|||
30695826|NCT00663702|58710155|FG001|Overall Study|Lack of Efficacy|3|||
30695827|NCT00683618|58710164|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
30695828|NCT00683618|58710165|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
30695829|NCT00683618|58710166|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
30695830|NCT00683618|58710164|FG000|Randomised Treatment Period|Protocol Violation|0|||
30695831|NCT00683618|58710165|FG001|Randomised Treatment Period|Protocol Violation|1|||
30695832|NCT00683618|58710166|FG002|Randomised Treatment Period|Protocol Violation|0|||
30695833|NCT00683618|58710164|FG000|Randomised Treatment Period|Adverse Event|2|||
30695834|NCT00683618|58710165|FG001|Randomised Treatment Period|Adverse Event|0|||
30695835|NCT00683618|58710166|FG002|Randomised Treatment Period|Adverse Event|2|||
30695836|NCT00683618|58710164|FG000|Randomised Treatment Period|Reason not provided|0|||
30695837|NCT00683618|58710165|FG001|Randomised Treatment Period|Reason not provided|0|||
30695838|NCT00683618|58710166|FG002|Randomised Treatment Period|Reason not provided|2|||
30695839|NCT00683618|58710164|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
30695840|NCT00683618|58710165|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
30695841|NCT00683618|58710166|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
30695842|NCT00683618|58710164|FG000|Extension Treatment Period|Adverse Event|1|||
30695843|NCT00683618|58710165|FG001|Extension Treatment Period|Adverse Event|0|||
30695844|NCT00683618|58710166|FG002|Extension Treatment Period|Adverse Event|0|||
30695845|NCT00683618|58710164|FG000|Extension Treatment Period|Protocol Violation|1|||
30695846|NCT00683618|58710165|FG001|Extension Treatment Period|Protocol Violation|0|||
30695847|NCT00683618|58710166|FG002|Extension Treatment Period|Protocol Violation|0|||
30695848|NCT00688064|58710178|FG000|Overall Study|Protocol Violation|0|||
30695849|NCT00688064|58710179|FG001|Overall Study|Protocol Violation|1|||
30695850|NCT00688064|58710178|FG000|Overall Study|Adverse Event|2|||
30695851|NCT00688064|58710179|FG001|Overall Study|Adverse Event|4|||
30695852|NCT00688064|58710178|FG000|Overall Study|Withdrawal by Subject|7|||
30695853|NCT00688064|58710179|FG001|Overall Study|Withdrawal by Subject|7|||
30695854|NCT00688064|58710178|FG000|Overall Study|Lost to Follow-up|10|||
30695855|NCT00688064|58710179|FG001|Overall Study|Lost to Follow-up|10|||
30695856|NCT00688064|58710178|FG000|Overall Study|Lack of Efficacy|0|||
30695857|NCT00688064|58710179|FG001|Overall Study|Lack of Efficacy|1|||
30695858|NCT00688064|58710178|FG000|Overall Study|Pregnancy|1|||
30695859|NCT00688064|58710179|FG001|Overall Study|Pregnancy|0|||
30695860|NCT00688064|58710178|FG000|Overall Study|Any other reasons|1|||
30695861|NCT00688064|58710179|FG001|Overall Study|Any other reasons|3|||
30695862|NCT00663234|58710185|FG000|Overall Study|Not willing to adhere to requirements|1|||
30695863|NCT00683384|58710193|FG000|Overall Study|Death|1|||
30695864|NCT00683384|58710193|FG000|Overall Study|Adverse Event|1|||
30695865|NCT00326911|58710199|FG000|Overall Study|Hospitalization prior to treatment|0|||
30695866|NCT00326911|58710200|FG001|Overall Study|Hospitalization prior to treatment|1|||
30695867|NCT00326911|58710199|FG000|Overall Study|Physician decision prior to treatment|1|||
30695868|NCT00326911|58710200|FG001|Overall Study|Physician decision prior to treatment|0|||
30695869|NCT00326911|58710199|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
30695870|NCT00326911|58710200|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
30695871|NCT00540436|58710206|FG000|First 12-Week Treatment Period|Adverse Event|1|||
30695872|NCT00540436|58710206|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
30695873|NCT00540436|58710206|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
30695874|NCT00540436|58710206|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
30695875|NCT00687440|58710210|FG000|Overall Study|Adverse Event|3|||
30695876|NCT00687440|58710210|FG000|Overall Study|Lost to Follow-up|3|||
30695877|NCT00687440|58710210|FG000|Overall Study|Lack of Efficacy|2|||
30695878|NCT00687440|58710210|FG000|Overall Study|Death|2|||
30695879|NCT00687440|58710210|FG000|Overall Study|Other|1|||
30695880|NCT00687440|58710210|FG000|Overall Study|Missing|1|||
30695881|NCT00659490|58710217|FG000|Overall Study|Lost to Follow-up|2|||
30695882|NCT00659490|58710218|FG001|Overall Study|Lost to Follow-up|0|||
30695883|NCT00659490|58710219|FG002|Overall Study|Lost to Follow-up|1|||
30695884|NCT00539500|58710227|FG000|Overall Study|Disease Progression|1|||
30695885|NCT00539500|58710227|FG000|Overall Study|Lost to Follow-up|2|||
30695886|NCT00662532|58710233|FG000|Overall Study|Adverse Event|0|||
30695887|NCT00662532|58710234|FG001|Overall Study|Adverse Event|1|||
30695888|NCT00662532|58710233|FG000|Overall Study|Lost to Follow-up|0|||
30695889|NCT00662532|58710234|FG001|Overall Study|Lost to Follow-up|1|||
30695890|NCT00686036|58710242|FG000|Overall Study|Adverse Event|3|||
30695891|NCT00686036|58710243|FG001|Overall Study|Adverse Event|0|||
30695892|NCT00686036|58710242|FG000|Overall Study|Withdrawal by Subject|3|||
30695893|NCT00686036|58710243|FG001|Overall Study|Withdrawal by Subject|1|||
30962213|NCT01522651|59028970|FG002|Overall Study|Adverse Event|4|||
30962214|NCT01522651|59028971|FG003|Overall Study|Adverse Event|5|||
30695894|NCT00686036|58710242|FG000|Overall Study|Study terminated by AstraZeneca|2|||
30695895|NCT00686036|58710243|FG001|Overall Study|Study terminated by AstraZeneca|1|||
30695896|NCT00686036|58710242|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
30695897|NCT00686036|58710243|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
30695898|NCT00686036|58710242|FG000|Overall Study|Other reasons not identified|0|||
30695899|NCT00686036|58710243|FG001|Overall Study|Other reasons not identified|4|||
30695900|NCT00682448|58710251|FG000|Overall Study|Adverse Event|1|||
30695901|NCT00682448|58710252|FG001|Overall Study|Adverse Event|2|||
30695902|NCT00682448|58710251|FG000|Overall Study|Lack of Efficacy|1|||
30695903|NCT00682448|58710252|FG001|Overall Study|Lack of Efficacy|0|||
30695904|NCT00682448|58710251|FG000|Overall Study|Lost to Follow-up|1|||
30874150|NCT02679755|58904893|FG000|Overall Study|Withdrawal by participant|6|||
30874151|NCT02679755|58904894|FG001|Overall Study|Withdrawal by participant|3|||
30874152|NCT02679755|58904893|FG000|Overall Study|Adverse Event|1|||
30874153|NCT02679755|58904894|FG001|Overall Study|Adverse Event|4|||
30874154|NCT02679755|58904893|FG000|Overall Study|Adverse events not related to study drug|1|||
30874155|NCT02679755|58904894|FG001|Overall Study|Adverse events not related to study drug|2|||
30874156|NCT02675231|58904906|FG000|Overall Study|Withdrawal by Subject|1|||
30874157|NCT02675231|58904907|FG001|Overall Study|Withdrawal by Subject|3|||
30874158|NCT02675231|58904908|FG002|Overall Study|Withdrawal by Subject|1|||
30874159|NCT02675231|58904906|FG000|Overall Study|Lost to Follow-up|2|||
30874160|NCT02675231|58904907|FG001|Overall Study|Lost to Follow-up|2|||
30874161|NCT02675231|58904908|FG002|Overall Study|Lost to Follow-up|2|||
30874162|NCT02675231|58904906|FG000|Overall Study|On study treatment/follow up|23|||
30874163|NCT02675231|58904907|FG001|Overall Study|On study treatment/follow up|31|||
30874164|NCT02675231|58904908|FG002|Overall Study|On study treatment/follow up|23|||
30874165|NCT02675075|58904919|FG000|Overall Study|Lost to Follow-up|3|||
30874166|NCT02675075|58904920|FG001|Overall Study|Lost to Follow-up|0|||
30874167|NCT02673515|58904930|FG000|Overall Study|Lack of motivation|2|||
30874168|NCT02673515|58904931|FG001|Overall Study|Lack of motivation|1|||
30874169|NCT02667275|58904939|FG000|Overall Study|Protocol Violation|11|||
30874170|NCT02667275|58904940|FG001|Overall Study|Protocol Violation|7|||
30874171|NCT02667275|58904939|FG000|Overall Study|Lost to Follow-up|0|||
30874172|NCT02667275|58904940|FG001|Overall Study|Lost to Follow-up|2|||
30874173|NCT02667275|58904939|FG000|Overall Study|Withdrawal by Subject|0|||
30874174|NCT02667275|58904940|FG001|Overall Study|Withdrawal by Subject|5|||
30874175|NCT02667275|58904939|FG000|Overall Study|Discontinued early without completing|0|||
30874176|NCT02667275|58904940|FG001|Overall Study|Discontinued early without completing|1|||
30874177|NCT02672423|58904949|FG000|Period 1|Adverse Event|0|||
30874178|NCT02672423|58904950|FG001|Period 1|Adverse Event|0|||
30874179|NCT02672423|58904951|FG002|Period 1|Adverse Event|0|||
30874180|NCT02672423|58904952|FG003|Period 1|Adverse Event|0|||
30874181|NCT02672423|58904953|FG004|Period 1|Adverse Event|1|||
30874182|NCT02672423|58904954|FG005|Period 1|Adverse Event|0|||
30874183|NCT02672423|58904955|FG006|Period 1|Adverse Event|0|||
30874184|NCT02672423|58904956|FG007|Period 1|Adverse Event|0|||
30874185|NCT02672423|58904957|FG008|Period 1|Adverse Event|0|||
30874186|NCT02672423|58904958|FG009|Period 1|Adverse Event|0|||
30604796|NCT01001221|58615738|FG004|Overall Study|Other|0|||
30604797|NCT01001221|58615734|FG000|Overall Study|Not treated; protocol exclusion|0|||
30604798|NCT01001221|58615735|FG001|Overall Study|Not treated; protocol exclusion|0|||
30604799|NCT01001221|58615736|FG002|Overall Study|Not treated; protocol exclusion|1|||
30604800|NCT01001221|58615737|FG003|Overall Study|Not treated; protocol exclusion|0|||
30604801|NCT01001221|58615738|FG004|Overall Study|Not treated; protocol exclusion|0|||
30604802|NCT01296152|58615749|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
30604803|NCT01002547|58615756|FG000|Overall Study|Withdrawal by Subject|4|||
30604804|NCT01002547|58615757|FG001|Overall Study|Withdrawal by Subject|0|||
30604805|NCT01002547|58615758|FG002|Overall Study|Withdrawal by Subject|5|||
30604806|NCT01002547|58615756|FG000|Overall Study|Lost to Follow-up|2|||
30604807|NCT01002547|58615757|FG001|Overall Study|Lost to Follow-up|1|||
30604808|NCT01002547|58615758|FG002|Overall Study|Lost to Follow-up|1|||
30874187|NCT02672423|58904949|FG000|Period 2|Withdrawal by Subject|0|||
30604809|NCT01002547|58615756|FG000|Overall Study|Physician Decision|1|||
30604810|NCT01002547|58615757|FG001|Overall Study|Physician Decision|0|||
30604811|NCT01002547|58615758|FG002|Overall Study|Physician Decision|0|||
30604812|NCT01002547|58615756|FG000|Overall Study|Death|0|||
30604813|NCT01002547|58615757|FG001|Overall Study|Death|2|||
30604814|NCT01002547|58615758|FG002|Overall Study|Death|2|||
30604815|NCT01002547|58615756|FG000|Overall Study|Adverse Event|1|||
30604816|NCT01002547|58615757|FG001|Overall Study|Adverse Event|0|||
30695905|NCT00682448|58710252|FG001|Overall Study|Lost to Follow-up|3|||
30695906|NCT00682448|58710251|FG000|Overall Study|Pregnancy|0|||
30695907|NCT00682448|58710252|FG001|Overall Study|Pregnancy|1|||
30874188|NCT02672423|58904950|FG001|Period 2|Withdrawal by Subject|0|||
30874189|NCT02672423|58904951|FG002|Period 2|Withdrawal by Subject|1|||
30874190|NCT02672423|58904952|FG003|Period 2|Withdrawal by Subject|0|||
30874191|NCT02672423|58904953|FG004|Period 2|Withdrawal by Subject|0|||
30874192|NCT02672423|58904954|FG005|Period 2|Withdrawal by Subject|0|||
30874193|NCT02672423|58904955|FG006|Period 2|Withdrawal by Subject|0|||
30874194|NCT02672423|58904956|FG007|Period 2|Withdrawal by Subject|0|||
30874195|NCT02672423|58904957|FG008|Period 2|Withdrawal by Subject|0|||
30874196|NCT02672423|58904958|FG009|Period 2|Withdrawal by Subject|0|||
30874197|NCT02672423|58904949|FG000|Period 3|Withdrawal by Subject|0|||
30874198|NCT02672423|58904950|FG001|Period 3|Withdrawal by Subject|0|||
30874199|NCT02672423|58904951|FG002|Period 3|Withdrawal by Subject|0|||
30874200|NCT02672423|58904952|FG003|Period 3|Withdrawal by Subject|0|||
30874201|NCT02672423|58904953|FG004|Period 3|Withdrawal by Subject|0|||
30874202|NCT02672423|58904954|FG005|Period 3|Withdrawal by Subject|0|||
30874203|NCT02672423|58904955|FG006|Period 3|Withdrawal by Subject|0|||
30874204|NCT02672423|58904956|FG007|Period 3|Withdrawal by Subject|1|||
30874205|NCT02672423|58904957|FG008|Period 3|Withdrawal by Subject|0|||
30874206|NCT02672423|58904958|FG009|Period 3|Withdrawal by Subject|0|||
30874207|NCT02672423|58904949|FG000|Period 3|Physician Decision|0|||
30874208|NCT02672423|58904950|FG001|Period 3|Physician Decision|0|||
30874209|NCT02672423|58904951|FG002|Period 3|Physician Decision|0|||
30874210|NCT02672423|58904952|FG003|Period 3|Physician Decision|0|||
30874211|NCT02672423|58904953|FG004|Period 3|Physician Decision|0|||
30874212|NCT02672423|58904954|FG005|Period 3|Physician Decision|1|||
30874213|NCT02672423|58904955|FG006|Period 3|Physician Decision|0|||
30874214|NCT02672423|58904956|FG007|Period 3|Physician Decision|0|||
30874215|NCT02672423|58904957|FG008|Period 3|Physician Decision|0|||
30874216|NCT02672423|58904958|FG009|Period 3|Physician Decision|0|||
30874217|NCT02670551|58904982|FG000|Overall Study|Adverse Event|4|||
30874218|NCT02670551|58904983|FG001|Overall Study|Adverse Event|7|||
30874219|NCT02670551|58904984|FG002|Overall Study|Adverse Event|9|||
30874220|NCT02670551|58904982|FG000|Overall Study|Lack of Efficacy|2|||
30874221|NCT02670551|58904983|FG001|Overall Study|Lack of Efficacy|0|||
30874222|NCT02670551|58904984|FG002|Overall Study|Lack of Efficacy|3|||
30874223|NCT02670551|58904982|FG000|Overall Study|Withdrawal of Consent|6|||
30874224|NCT02670551|58904983|FG001|Overall Study|Withdrawal of Consent|3|||
30874225|NCT02670551|58904984|FG002|Overall Study|Withdrawal of Consent|8|||
30874226|NCT02670551|58904982|FG000|Overall Study|Lost to Follow-up|5|||
30874227|NCT02670551|58904983|FG001|Overall Study|Lost to Follow-up|7|||
30874228|NCT02670551|58904984|FG002|Overall Study|Lost to Follow-up|6|||
30874229|NCT02670551|58904982|FG000|Overall Study|Protocol Violation|1|||
30874230|NCT02670551|58904983|FG001|Overall Study|Protocol Violation|0|||
30874231|NCT02670551|58904984|FG002|Overall Study|Protocol Violation|0|||
30874232|NCT02670551|58904982|FG000|Overall Study|Noncompliance with study drug|3|||
30874233|NCT02670551|58904983|FG001|Overall Study|Noncompliance with study drug|3|||
30874234|NCT02670551|58904984|FG002|Overall Study|Noncompliance with study drug|2|||
30874235|NCT02670551|58904982|FG000|Overall Study|Other Miscellaneous Reasons|2|||
30874236|NCT02670551|58904983|FG001|Overall Study|Other Miscellaneous Reasons|3|||
30874237|NCT02670551|58904984|FG002|Overall Study|Other Miscellaneous Reasons|3|||
30874238|NCT02670551|58904982|FG000|Overall Study|Did Not Receive Treatment|5|||
30874239|NCT02670551|58904983|FG001|Overall Study|Did Not Receive Treatment|3|||
30874240|NCT02670551|58904984|FG002|Overall Study|Did Not Receive Treatment|0|||
30874241|NCT02670473|58904992|FG000|Overall Study|Withdrawal by Subject|1|||
30874242|NCT02667119|58905007|FG000|Overall Study|Lost to Follow-up|3|||
30874243|NCT02667119|58905008|FG001|Overall Study|Lost to Follow-up|0|||
30874244|NCT02670083|58905016|FG000|Overall Study|Adverse Event|16|||
30874245|NCT02670083|58905017|FG001|Overall Study|Adverse Event|13|||
30874246|NCT02670083|58905016|FG000|Overall Study|Death|4|||
30874247|NCT02670083|58905017|FG001|Overall Study|Death|6|||
30874248|NCT02670083|58905016|FG000|Overall Study|Lost to Follow-up|2|||
30874249|NCT02670083|58905017|FG001|Overall Study|Lost to Follow-up|2|||
30874250|NCT02670083|58905016|FG000|Overall Study|Multiple Reasons|9|||
30874251|NCT02670083|58905017|FG001|Overall Study|Multiple Reasons|9|||
30874252|NCT02670083|58905016|FG000|Overall Study|Physician Decision|0|||
30874253|NCT02670083|58905017|FG001|Overall Study|Physician Decision|2|||
30874254|NCT02670083|58905016|FG000|Overall Study|Study Terminated By Sponsor|257|||
30874255|NCT02670083|58905017|FG001|Overall Study|Study Terminated By Sponsor|254|||
30874256|NCT02670083|58905016|FG000|Overall Study|Symptomatic Deterioration|0|||
30874257|NCT02670083|58905017|FG001|Overall Study|Symptomatic Deterioration|2|||
30874258|NCT02670083|58905016|FG000|Overall Study|Withdrawal by Subject|32|||
30874259|NCT02670083|58905017|FG001|Overall Study|Withdrawal by Subject|31|||
30874260|NCT02670083|58905016|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30874261|NCT02670083|58905017|FG001|Overall Study|Non-Compliance With Study Drug|0|||
30874262|NCT02669849|58905027|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
30874263|NCT02669849|58905028|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
30874264|NCT02669849|58905029|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
30874265|NCT02669849|58905027|FG000|Overall Study|Lost to Follow-up|1|||
30874266|NCT02669849|58905028|FG001|Overall Study|Lost to Follow-up|0|||
30874267|NCT02669849|58905029|FG002|Overall Study|Lost to Follow-up|3|||
30874268|NCT02669849|58905027|FG000|Overall Study|Death|1|||
30874269|NCT02669849|58905028|FG001|Overall Study|Death|1|||
30874270|NCT02669849|58905029|FG002|Overall Study|Death|2|||
30874271|NCT02669849|58905027|FG000|Overall Study|Study terminated by sponsor|16|||
30874272|NCT02669849|58905028|FG001|Overall Study|Study terminated by sponsor|1|||
30874273|NCT02669849|58905029|FG002|Overall Study|Study terminated by sponsor|14|||
30874274|NCT02669849|58905027|FG000|Overall Study|Other|0|||
30874275|NCT02669849|58905028|FG001|Overall Study|Other|0|||
30874276|NCT02669849|58905029|FG002|Overall Study|Other|2|||
30874277|NCT03625895|58905037|FG000|Overall Study|Protocol Violation|585|||
30874278|NCT02663687|58905046|FG000|Overall Study|Adverse Event|1|||
30874279|NCT02663687|58905047|FG001|Overall Study|Adverse Event|0|||
30874280|NCT02663687|58905048|FG002|Overall Study|Adverse Event|0|||
30874281|NCT02663687|58905049|FG003|Overall Study|Adverse Event|0|||
30874282|NCT02663687|58905050|FG004|Overall Study|Adverse Event|0|||
30874283|NCT02663687|58905046|FG000|Overall Study|Other|1|||
30874284|NCT02663687|58905047|FG001|Overall Study|Other|0|||
30874285|NCT02663687|58905048|FG002|Overall Study|Other|1|||
30874286|NCT02663687|58905049|FG003|Overall Study|Other|0|||
30874287|NCT02663687|58905050|FG004|Overall Study|Other|0|||
30874288|NCT02663453|58905081|FG000|Overall Study|Death|4|||
30874289|NCT02663453|58905082|FG001|Overall Study|Death|4|||
30874290|NCT02663453|58905081|FG000|Overall Study|Withdrawal by Subject|1|||
30874291|NCT02663453|58905082|FG001|Overall Study|Withdrawal by Subject|0|||
30874292|NCT02055118|58905091|FG000|Overall Study|Withdrawal by Subject|0|||
30874293|NCT02055118|58905092|FG001|Overall Study|Withdrawal by Subject|2|||
30874294|NCT02055118|58905093|FG002|Overall Study|Withdrawal by Subject|0|||
30874295|NCT02084056|58905104|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
30874296|NCT02084056|58905105|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
30874297|NCT02084056|58905106|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
30874298|NCT02084056|58905107|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
30874299|NCT02084056|58905104|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
30874300|NCT02084056|58905105|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
30874301|NCT02084056|58905106|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
30874302|NCT02084056|58905107|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
30874303|NCT01625182|58905119|FG000|Overall Study|Administrative problems|1|||
30874304|NCT01625182|58905120|FG001|Overall Study|Administrative problems|0|||
30874305|NCT01625182|58905119|FG000|Overall Study|Protocol deviation|0|||
30874306|NCT01625182|58905120|FG001|Overall Study|Protocol deviation|2|||
30874307|NCT01625182|58905119|FG000|Overall Study|Adverse Event|2|||
30874308|NCT01625182|58905120|FG001|Overall Study|Adverse Event|0|||
30874309|NCT01625182|58905119|FG000|Overall Study|Withdrawal by Subject|5|||
30874310|NCT01625182|58905120|FG001|Overall Study|Withdrawal by Subject|1|||
30874311|NCT01625182|58905119|FG000|Overall Study|Lack of Efficacy|12|||
30874312|NCT01625182|58905120|FG001|Overall Study|Lack of Efficacy|8|||
30874313|NCT02661815|58905131|FG000|Overall Study|Withdrawal by Subject|1|||
30874314|NCT02661815|58905132|FG001|Overall Study|Withdrawal by Subject|0|||
30874315|NCT02661815|58905133|FG002|Overall Study|Withdrawal by Subject|0|||
30874316|NCT02661815|58905134|FG003|Overall Study|Withdrawal by Subject|0|||
30874317|NCT02053792|58905150|FG000|Overall Study|Physician Decision|0|||
30874318|NCT02053792|58905151|FG001|Overall Study|Physician Decision|1|||
30874319|NCT02053792|58905150|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
30874320|NCT02053792|58905151|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
30874321|NCT02053792|58905150|FG000|Overall Study|Lack of Efficacy|1|||
30874322|NCT02053792|58905151|FG001|Overall Study|Lack of Efficacy|0|||
30874323|NCT02053792|58905150|FG000|Overall Study|Adverse Event|1|||
30874324|NCT02053792|58905151|FG001|Overall Study|Adverse Event|0|||
30874325|NCT02053792|58905150|FG000|Overall Study|Withdrawal by Subject|2|||
30874326|NCT02053792|58905151|FG001|Overall Study|Withdrawal by Subject|2|||
30874327|NCT02053792|58905150|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
30962215|NCT01522651|59028972|FG004|Overall Study|Adverse Event|4|||
30962216|NCT01522651|59028968|FG000|Overall Study|Cardioversion|1|||
30962217|NCT01522651|59028969|FG001|Overall Study|Cardioversion|0|||
30962218|NCT01522651|59028970|FG002|Overall Study|Cardioversion|0|||
30962219|NCT01522651|59028971|FG003|Overall Study|Cardioversion|0|||
30962220|NCT01522651|59028972|FG004|Overall Study|Cardioversion|0|||
30962221|NCT01522651|59028968|FG000|Overall Study|Device Malfunction|0|||
30962222|NCT01522651|59028969|FG001|Overall Study|Device Malfunction|1|||
30962223|NCT01522651|59028970|FG002|Overall Study|Device Malfunction|0|||
30962224|NCT01522651|59028971|FG003|Overall Study|Device Malfunction|0|||
30962225|NCT01522651|59028972|FG004|Overall Study|Device Malfunction|0|||
30874328|NCT02053792|58905151|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
30874329|NCT02053792|58905150|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
30874330|NCT02053792|58905151|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
30874331|NCT02082340|58905159|FG000|Overall Study|Lost to Follow-up|1|||
30874332|NCT02082340|58905160|FG001|Overall Study|Lost to Follow-up|1|||
30874333|NCT02053246|58905166|FG000|Overall Study|Withdrawal by Subject|3|||
30874334|NCT02053246|58905166|FG000|Overall Study|Physician Decision|1|||
30874335|NCT02053168|58905170|FG000|Overall Study|Withdrawal by Subject|1|||
30874336|NCT02053168|58905170|FG000|Overall Study|Physician Decision|1|||
30874337|NCT02053168|58905170|FG000|Overall Study|Lost to Follow-up|1|||
30874338|NCT02052466|58905174|FG000|Overall Study|Withdrawal by Subject|1|||
30962226|NCT01522651|59028968|FG000|Overall Study|Investigator's Discretion|0|||
30962227|NCT01522651|59028969|FG001|Overall Study|Investigator's Discretion|1|||
30962228|NCT01522651|59028970|FG002|Overall Study|Investigator's Discretion|0|||
30962229|NCT01522651|59028971|FG003|Overall Study|Investigator's Discretion|0|||
30962230|NCT01522651|59028972|FG004|Overall Study|Investigator's Discretion|0|||
30962231|NCT01522651|59028968|FG000|Overall Study|Protocol Violation|3|||
30962232|NCT01522651|59028969|FG001|Overall Study|Protocol Violation|0|||
30962233|NCT01522651|59028970|FG002|Overall Study|Protocol Violation|0|||
30962234|NCT01522651|59028971|FG003|Overall Study|Protocol Violation|0|||
30962235|NCT01522651|59028972|FG004|Overall Study|Protocol Violation|0|||
30962236|NCT01522651|59028968|FG000|Overall Study|Reason Not Specified|0|||
30962237|NCT01522651|59028969|FG001|Overall Study|Reason Not Specified|0|||
30962238|NCT01522651|59028970|FG002|Overall Study|Reason Not Specified|0|||
30962239|NCT01522651|59028971|FG003|Overall Study|Reason Not Specified|1|||
30962240|NCT01522651|59028972|FG004|Overall Study|Reason Not Specified|0|||
30962241|NCT01522651|59028968|FG000|Overall Study|Participant Non-Compliance|1|||
30962242|NCT01522651|59028969|FG001|Overall Study|Participant Non-Compliance|0|||
30962243|NCT01522651|59028970|FG002|Overall Study|Participant Non-Compliance|0|||
30962244|NCT01522651|59028971|FG003|Overall Study|Participant Non-Compliance|0|||
30962245|NCT01522651|59028972|FG004|Overall Study|Participant Non-Compliance|0|||
30962246|NCT01522651|59028968|FG000|Overall Study|Withdrew Consent|1|||
30962247|NCT01522651|59028969|FG001|Overall Study|Withdrew Consent|1|||
30962248|NCT01522651|59028970|FG002|Overall Study|Withdrew Consent|0|||
30962249|NCT01522651|59028971|FG003|Overall Study|Withdrew Consent|1|||
30962250|NCT01522651|59028972|FG004|Overall Study|Withdrew Consent|1|||
30962251|NCT01522651|59028968|FG000|Overall Study|Randomized but Never Treated|0|||
30962252|NCT01522651|59028969|FG001|Overall Study|Randomized but Never Treated|1|||
30962253|NCT01522651|59028970|FG002|Overall Study|Randomized but Never Treated|0|||
30962254|NCT01522651|59028971|FG003|Overall Study|Randomized but Never Treated|1|||
30962255|NCT01522651|59028972|FG004|Overall Study|Randomized but Never Treated|1|||
30962256|NCT01554241|59028999|FG000|Overall Study|Death|3|||
30962257|NCT01554241|59029000|FG001|Overall Study|Death|1|||
30962258|NCT01554241|59029001|FG002|Overall Study|Death|1|||
30962259|NCT01554241|59029002|FG003|Overall Study|Death|0|||
30962260|NCT01554241|59028999|FG000|Overall Study|protocol specified renal stone|0|||
30962261|NCT01554241|59029000|FG001|Overall Study|protocol specified renal stone|0|||
30962262|NCT01554241|59029001|FG002|Overall Study|protocol specified renal stone|0|||
30962263|NCT01554241|59029002|FG003|Overall Study|protocol specified renal stone|1|||
30962264|NCT01554241|59028999|FG000|Overall Study|protocol specified change in eGFR|0|||
30962265|NCT01554241|59029000|FG001|Overall Study|protocol specified change in eGFR|0|||
30962266|NCT01554241|59029001|FG002|Overall Study|protocol specified change in eGFR|1|||
30962267|NCT01554241|59029002|FG003|Overall Study|protocol specified change in eGFR|0|||
30962268|NCT01554241|59028999|FG000|Overall Study|Withdrawal by Subject|0|||
30962269|NCT01554241|59029000|FG001|Overall Study|Withdrawal by Subject|0|||
30962270|NCT01554241|59029001|FG002|Overall Study|Withdrawal by Subject|2|||
30962271|NCT01554241|59029002|FG003|Overall Study|Withdrawal by Subject|0|||
30962272|NCT01521559|59029014|FG000|Overall Study|Adverse Event|0|||
30962273|NCT01521559|59029015|FG001|Overall Study|Adverse Event|4|||
30962274|NCT01521559|59029014|FG000|Overall Study|Death|1|||
30962275|NCT01521559|59029015|FG001|Overall Study|Death|0|||
30962276|NCT01521559|59029014|FG000|Overall Study|Withdrawal by Subject|9|||
30962277|NCT01521559|59029015|FG001|Overall Study|Withdrawal by Subject|11|||
30962278|NCT01521559|59029014|FG000|Overall Study|Lost to Follow-up|3|||
30962279|NCT01521559|59029015|FG001|Overall Study|Lost to Follow-up|1|||
30962280|NCT01521559|59029014|FG000|Overall Study|Protocol Violation|1|||
30962281|NCT01521559|59029015|FG001|Overall Study|Protocol Violation|0|||
30962282|NCT01521559|59029014|FG000|Overall Study|Other|1|||
30962283|NCT01521559|59029015|FG001|Overall Study|Other|2|||
30962284|NCT01554163|59029024|FG000|Overall Study|Adverse Event|3|||
30962285|NCT01554163|59029025|FG001|Overall Study|Adverse Event|0|||
30962286|NCT01554163|59029024|FG000|Overall Study|Lack of Efficacy|1|||
30962287|NCT01554163|59029025|FG001|Overall Study|Lack of Efficacy|0|||
30962288|NCT01554163|59029024|FG000|Overall Study|Lost to Follow-up|1|||
30962289|NCT01554163|59029025|FG001|Overall Study|Lost to Follow-up|0|||
30962290|NCT01554163|59029024|FG000|Overall Study|Non-Compliance With Study Drug|1|||
30962291|NCT01554163|59029025|FG001|Overall Study|Non-Compliance With Study Drug|1|||
30962292|NCT01554163|59029024|FG000|Overall Study|Protocol Violation|0|||
30962293|NCT01554163|59029025|FG001|Overall Study|Protocol Violation|4|||
30962294|NCT01554163|59029024|FG000|Overall Study|Withdrawal by Subject|1|||
30962295|NCT01554163|59029025|FG001|Overall Study|Withdrawal by Subject|5|||
30962296|NCT01554163|59029024|FG000|Overall Study|Not Treated|1|||
30962297|NCT01554163|59029025|FG001|Overall Study|Not Treated|0|||
30962298|NCT01553851|59029031|FG000|Overall Study|Adverse Event|2|||
30962299|NCT01553851|59029031|FG000|Overall Study|constipation|1|||
30962300|NCT01552915|59029051|FG000|Overall Study|Adverse Event|3|||
30962301|NCT01552915|59029052|FG001|Overall Study|Adverse Event|14|||
30962302|NCT01552915|59029053|FG002|Overall Study|Adverse Event|3|||
30962303|NCT01552915|59029051|FG000|Overall Study|Lost to Follow-up|4|||
30962304|NCT01552915|59029052|FG001|Overall Study|Lost to Follow-up|6|||
30962305|NCT01552915|59029053|FG002|Overall Study|Lost to Follow-up|5|||
30962306|NCT01552915|59029051|FG000|Overall Study|Withdrawal by Subject|6|||
30962307|NCT01552915|59029052|FG001|Overall Study|Withdrawal by Subject|4|||
30962308|NCT01552915|59029053|FG002|Overall Study|Withdrawal by Subject|5|||
30962309|NCT01552915|59029051|FG000|Overall Study|Protocol Violation|0|||
30962310|NCT01552915|59029052|FG001|Overall Study|Protocol Violation|4|||
30962311|NCT01552915|59029053|FG002|Overall Study|Protocol Violation|4|||
30962312|NCT01552915|59029051|FG000|Overall Study|Lack of Efficacy|8|||
30962313|NCT01552915|59029052|FG001|Overall Study|Lack of Efficacy|1|||
30962314|NCT01552915|59029053|FG002|Overall Study|Lack of Efficacy|4|||
30962315|NCT01552915|59029051|FG000|Overall Study|Other|2|||
30962316|NCT01552915|59029052|FG001|Overall Study|Other|0|||
30962317|NCT01552915|59029053|FG002|Overall Study|Other|6|||
30962318|NCT01552681|59029082|FG000|Overall Study|Withdrawal by Subject|4|||
30962319|NCT01552681|59029083|FG001|Overall Study|Withdrawal by Subject|0|||
30962320|NCT01552681|59029082|FG000|Overall Study|Physician Decision|1|||
30962321|NCT01552681|59029083|FG001|Overall Study|Physician Decision|0|||
30962322|NCT01552681|59029082|FG000|Overall Study|Subject moved away|0|||
30962323|NCT01552681|59029083|FG001|Overall Study|Subject moved away|1|||
30962324|NCT01570387|59029115|FG000|Overall Study|Adverse Event|1|||
30962325|NCT01570387|59029116|FG001|Overall Study|Adverse Event|0|||
30962326|NCT01570387|59029117|FG002|Overall Study|Adverse Event|0|||
30962327|NCT01570387|59029118|FG003|Overall Study|Adverse Event|0|||
30962328|NCT01570387|59029115|FG000|Overall Study|Death|0|||
30962329|NCT01570387|59029116|FG001|Overall Study|Death|0|||
30962330|NCT01570387|59029117|FG002|Overall Study|Death|0|||
30962331|NCT01570387|59029118|FG003|Overall Study|Death|1|||
30962332|NCT01570387|59029115|FG000|Overall Study|Withdrawal by Subject|0|||
30962333|NCT01570387|59029116|FG001|Overall Study|Withdrawal by Subject|0|||
30962334|NCT01570387|59029117|FG002|Overall Study|Withdrawal by Subject|0|||
30962335|NCT01570387|59029118|FG003|Overall Study|Withdrawal by Subject|1|||
30962336|NCT01570309|59029127|FG000|Overall Study|Withdrawal by Subject|3|||
30962337|NCT01570309|59029128|FG001|Overall Study|Withdrawal by Subject|3|||
30962338|NCT01519921|59029140|FG000|Overall Study|Adverse Event|10|||
30962339|NCT01519921|59029141|FG001|Overall Study|Adverse Event|9|||
30962340|NCT01519921|59029140|FG000|Overall Study|Lack of Efficacy|4|||
30962341|NCT01519921|59029141|FG001|Overall Study|Lack of Efficacy|3|||
30962342|NCT01519921|59029140|FG000|Overall Study|Withdrawal by Subject|3|||
30962343|NCT01519921|59029141|FG001|Overall Study|Withdrawal by Subject|0|||
30962344|NCT01519921|59029140|FG000|Overall Study|Lost to Follow-up|2|||
30962345|NCT01519921|59029141|FG001|Overall Study|Lost to Follow-up|1|||
30962346|NCT01519921|59029140|FG000|Overall Study|Treatment refusal|2|||
30962347|NCT01519921|59029141|FG001|Overall Study|Treatment refusal|1|||
30962348|NCT01519921|59029140|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
30962349|NCT01519921|59029141|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
30962350|NCT01519765|59029149|FG000|Overall Study|Adverse Event|0|||
30962351|NCT01519765|59029150|FG001|Overall Study|Adverse Event|1|||
30962352|NCT01519765|59029149|FG000|Overall Study|Lack of Efficacy|2|||
30962353|NCT01519765|59029150|FG001|Overall Study|Lack of Efficacy|0|||
30962354|NCT01519765|59029149|FG000|Overall Study|Protocol Violation|1|||
30962355|NCT01519765|59029150|FG001|Overall Study|Protocol Violation|0|||
30962356|NCT01519765|59029149|FG000|Overall Study|Withdrawal by Subject|0|||
30962357|NCT01519765|59029150|FG001|Overall Study|Withdrawal by Subject|1|||
30962358|NCT01552603|59029157|FG000|Overall Study|Physician Decision|1|||
30962359|NCT01552369|59029163|FG000|Overall Study|Did not consent to extended follow up|8|||
30962360|NCT01552369|59029164|FG001|Overall Study|Did not consent to extended follow up|9|||
30962361|NCT01552057|59029174|FG000|Overall Study|Adverse Event|14|||
30874339|NCT02052466|58905174|FG000|Overall Study|Acromial fracture|1|||
30874340|NCT02032888|58905181|FG000|Treatment Period|Poor compliance/noncompliance|1|||
30874341|NCT02032888|58905182|FG001|Treatment Period|Poor compliance/noncompliance|1|||
30874342|NCT02032888|58905183|FG002|Treatment Period|Poor compliance/noncompliance|0|||
30874343|NCT02032888|58905181|FG000|Treatment Period|Other|1|||
30874344|NCT02032888|58905182|FG001|Treatment Period|Other|1|||
30874345|NCT02032888|58905183|FG002|Treatment Period|Other|0|||
30874346|NCT02032888|58905181|FG000|Follow-up Period|Lost to Follow-up|1|||
30874347|NCT02032888|58905182|FG001|Follow-up Period|Lost to Follow-up|1|||
30874348|NCT02032888|58905183|FG002|Follow-up Period|Lost to Follow-up|0|||
30874349|NCT02032888|58905181|FG000|Follow-up Period|Death|1|||
30962362|NCT01552057|59029175|FG001|Overall Study|Adverse Event|15|||
30962363|NCT01552057|59029174|FG000|Overall Study|Lack of Efficacy|8|||
30874350|NCT02032888|58905182|FG001|Follow-up Period|Death|1|||
30874351|NCT02032888|58905183|FG002|Follow-up Period|Death|0|||
30874352|NCT02032888|58905181|FG000|Follow-up Period|Other|1|||
30962364|NCT01552057|59029175|FG001|Overall Study|Lack of Efficacy|23|||
30962365|NCT01552057|59029174|FG000|Overall Study|Withdrawal by Subject|5|||
30962366|NCT01552057|59029175|FG001|Overall Study|Withdrawal by Subject|8|||
30962367|NCT01552057|59029174|FG000|Overall Study|Entry Criteria Not Met|2|||
30962368|NCT01552057|59029175|FG001|Overall Study|Entry Criteria Not Met|2|||
30962369|NCT01552057|59029174|FG000|Overall Study|Physician Decision|1|||
30962370|NCT01552057|59029175|FG001|Overall Study|Physician Decision|0|||
30962371|NCT01551745|59029181|FG000|Overall Study|Withdrawal by Subject|1|||
30962372|NCT01551745|59029181|FG000|Overall Study|Disease Progression|2|||
30962373|NCT01551355|59029191|FG000|Overall Study|Lost to Follow-up|51|||
30962374|NCT01551355|59029192|FG001|Overall Study|Lost to Follow-up|49|||
30962375|NCT01551355|59029193|FG002|Overall Study|Lost to Follow-up|34|||
30962376|NCT01551355|59029194|FG003|Overall Study|Lost to Follow-up|24|||
30962377|NCT01551355|59029195|FG004|Overall Study|Lost to Follow-up|9|||
30962378|NCT01551355|59029196|FG005|Overall Study|Lost to Follow-up|6|||
30962379|NCT01569841|59029204|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
30962380|NCT01569841|59029205|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
30962381|NCT01569763|59029215|FG000|Overall Study|Lack of Efficacy|2|||
30962382|NCT01569763|59029216|FG001|Overall Study|Lack of Efficacy|7|||
30962383|NCT01569763|59029215|FG000|Overall Study|Adverse Event|1|||
30962384|NCT01569763|59029216|FG001|Overall Study|Adverse Event|0|||
30962385|NCT01550965|59029222|FG000|Overall Study|Adverse Event|26|||
30962386|NCT01550965|59029222|FG000|Overall Study|Withdrawal by Subject|10|||
30962387|NCT01550965|59029222|FG000|Overall Study|Lost to Follow-up|2|||
30962388|NCT01550965|59029222|FG000|Overall Study|Lack of Efficacy|59|||
30962389|NCT01550965|59029222|FG000|Overall Study|Other|13|||
30962390|NCT01569295|59029343|FG000|Overall Study|Progressive Disease|75|||
30962391|NCT01569295|59029344|FG001|Overall Study|Progressive Disease|139|||
30962392|NCT01569295|59029343|FG000|Overall Study|Adverse Event|39|||
30962393|NCT01569295|59029344|FG001|Overall Study|Adverse Event|14|||
30962394|NCT01569295|59029343|FG000|Overall Study|Withdrawal by Subject|25|||
30962395|NCT01569295|59029344|FG001|Overall Study|Withdrawal by Subject|12|||
30962396|NCT01569295|59029343|FG000|Overall Study|Death|19|||
30962397|NCT01569295|59029344|FG001|Overall Study|Death|15|||
30962398|NCT01569295|59029343|FG000|Overall Study|Physician Decision|13|||
30962399|NCT01569295|59029344|FG001|Overall Study|Physician Decision|18|||
30962400|NCT01569295|59029343|FG000|Overall Study|Study Terminated by Sponsor|24|||
30962401|NCT01569295|59029344|FG001|Overall Study|Study Terminated by Sponsor|2|||
30962402|NCT01569295|59029343|FG000|Overall Study|Other Reason not Specified|3|||
30962403|NCT01569295|59029344|FG001|Overall Study|Other Reason not Specified|5|||
30962404|NCT01569295|59029343|FG000|Overall Study|Non-Compliance with Study Drug|6|||
30962405|NCT01569295|59029344|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30962406|NCT01569295|59029343|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
30874353|NCT02032888|58905182|FG001|Follow-up Period|Other|0|||
30874354|NCT02032888|58905183|FG002|Follow-up Period|Other|0|||
30874355|NCT02082262|58905200|FG000|Overall Study|Withdrawal by Subject|3|||
30874356|NCT02082262|58905200|FG000|Overall Study|Adverse Event|48|||
30874357|NCT04697069|58905206|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
30874358|NCT04697069|58905207|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
30874359|NCT04697069|58905206|FG000|Overall Study|Study termination|2|||
30874360|NCT04697069|58905207|FG001|Overall Study|Study termination|1|||
30874361|NCT02082184|58905215|FG000|Overall Study|Adverse Event|1|||
30874362|NCT02082184|58905216|FG001|Overall Study|Adverse Event|0|||
30874363|NCT02082184|58905215|FG000|Overall Study|Medical diagnosis|1|||
30874364|NCT02082184|58905216|FG001|Overall Study|Medical diagnosis|2|||
30874365|NCT02082184|58905215|FG000|Overall Study|Device associated symptoms|5|||
30874366|NCT02082184|58905216|FG001|Overall Study|Device associated symptoms|0|||
30874367|NCT02082184|58905215|FG000|Overall Study|Withdrawal by Subject|3|||
30874368|NCT02082184|58905216|FG001|Overall Study|Withdrawal by Subject|2|||
30874369|NCT02082184|58905215|FG000|Overall Study|Protocol Violation|0|||
30874370|NCT02082184|58905216|FG001|Overall Study|Protocol Violation|6|||
30874371|NCT02082184|58905215|FG000|Overall Study|Lost to Follow-up|0|||
30962407|NCT01569295|59029344|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
30962408|NCT01569295|59029343|FG000|Overall Study|Lost to Follow-up|1|||
30604817|NCT01002547|58615758|FG002|Overall Study|Adverse Event|0|||
30604818|NCT01225731|58615771|FG000|Part 1|Did not meet eligibility criteria|1|||
30604819|NCT01225731|58615772|FG001|Part 1|Did not meet eligibility criteria|0|||
30604820|NCT01225731|58615773|FG002|Part 1|Did not meet eligibility criteria|0|||
30604821|NCT01225731|58615774|FG003|Part 1|Did not meet eligibility criteria|0|||
30604822|NCT01225731|58615775|FG004|Part 1|Did not meet eligibility criteria|1|||
30962409|NCT01569295|59029344|FG001|Overall Study|Lost to Follow-up|1|||
30604823|NCT01225731|58615776|FG005|Part 1|Did not meet eligibility criteria|0|||
30604824|NCT01225731|58615777|FG006|Part 1|Did not meet eligibility criteria|0|||
30604825|NCT01225731|58615778|FG007|Part 1|Did not meet eligibility criteria|0|||
30962410|NCT01549951|59029401|FG000|Overall Study|Adverse Event|15|||
30962411|NCT01549951|59029401|FG000|Overall Study|Withdrawal by Subject|2|||
30962412|NCT01549951|59029401|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
30962413|NCT01549951|59029401|FG000|Overall Study|Progressive disease|29|||
30962414|NCT01549951|59029401|FG000|Overall Study|Symptomatic deterioration|1|||
30874372|NCT02082184|58905216|FG001|Overall Study|Lost to Follow-up|2|||
30874373|NCT02082184|58905215|FG000|Overall Study|Subject non-compliance|0|||
30874374|NCT02082184|58905216|FG001|Overall Study|Subject non-compliance|1|||
30874375|NCT01624870|58905222|FG000|Overall Study|Death|19|||
30962415|NCT01549951|59029401|FG000|Overall Study|Other|2|||
30874376|NCT01624870|58905222|FG000|Overall Study|Withdrawal by Subject|1|||
30874377|NCT01624870|58905222|FG000|Overall Study|CoreValve not implanted|6|||
30874378|NCT01624870|58905222|FG000|Overall Study|Lost to follow up|1|||
30874379|NCT02031640|58905233|FG000|Screening Period|Adverse Event|1|||
30874380|NCT02031640|58905234|FG001|Screening Period|Adverse Event|0|||
30874381|NCT02031640|58905235|FG002|Screening Period|Adverse Event|0|||
30874382|NCT02031640|58905236|FG003|Screening Period|Adverse Event|0|||
30874383|NCT02031640|58905237|FG004|Screening Period|Adverse Event|0|||
30874384|NCT02031640|58905238|FG005|Screening Period|Adverse Event|0|||
30874385|NCT02031640|58905233|FG000|Screening Period|Withdrawal by Subject|29|||
30874386|NCT02031640|58905234|FG001|Screening Period|Withdrawal by Subject|0|||
30874387|NCT02031640|58905235|FG002|Screening Period|Withdrawal by Subject|0|||
30874388|NCT02031640|58905236|FG003|Screening Period|Withdrawal by Subject|0|||
30874389|NCT02031640|58905237|FG004|Screening Period|Withdrawal by Subject|0|||
30874390|NCT02031640|58905238|FG005|Screening Period|Withdrawal by Subject|0|||
30874391|NCT02031640|58905233|FG000|Screening Period|Inclusion criteria not met|312|||
30874392|NCT02031640|58905234|FG001|Screening Period|Inclusion criteria not met|0|||
30874393|NCT02031640|58905235|FG002|Screening Period|Inclusion criteria not met|0|||
30874394|NCT02031640|58905236|FG003|Screening Period|Inclusion criteria not met|0|||
30874395|NCT02031640|58905237|FG004|Screening Period|Inclusion criteria not met|0|||
30874396|NCT02031640|58905238|FG005|Screening Period|Inclusion criteria not met|0|||
30874397|NCT02031640|58905233|FG000|Screening Period|Exclusion criteria met|30|||
30874398|NCT02031640|58905234|FG001|Screening Period|Exclusion criteria met|0|||
30874399|NCT02031640|58905235|FG002|Screening Period|Exclusion criteria met|0|||
30874400|NCT02031640|58905236|FG003|Screening Period|Exclusion criteria met|0|||
30874401|NCT02031640|58905237|FG004|Screening Period|Exclusion criteria met|0|||
30874402|NCT02031640|58905238|FG005|Screening Period|Exclusion criteria met|0|||
30874403|NCT02031640|58905233|FG000|Screening Period|Lost to Follow-up|14|||
30874404|NCT02031640|58905234|FG001|Screening Period|Lost to Follow-up|0|||
30874405|NCT02031640|58905235|FG002|Screening Period|Lost to Follow-up|0|||
30874406|NCT02031640|58905236|FG003|Screening Period|Lost to Follow-up|0|||
30874407|NCT02031640|58905237|FG004|Screening Period|Lost to Follow-up|0|||
30874408|NCT02031640|58905238|FG005|Screening Period|Lost to Follow-up|0|||
30874409|NCT02031640|58905233|FG000|Screening Period|Enrollment closed|26|||
30874410|NCT02031640|58905234|FG001|Screening Period|Enrollment closed|0|||
30874411|NCT02031640|58905235|FG002|Screening Period|Enrollment closed|0|||
30874412|NCT02031640|58905236|FG003|Screening Period|Enrollment closed|0|||
30874413|NCT02031640|58905237|FG004|Screening Period|Enrollment closed|0|||
30874414|NCT02031640|58905238|FG005|Screening Period|Enrollment closed|0|||
30874415|NCT02031640|58905233|FG000|Run-In Period|Adverse Event|4|||
30874416|NCT02031640|58905234|FG001|Run-In Period|Adverse Event|0|||
30874417|NCT02031640|58905235|FG002|Run-In Period|Adverse Event|0|||
30874418|NCT02031640|58905236|FG003|Run-In Period|Adverse Event|0|||
30874419|NCT02031640|58905237|FG004|Run-In Period|Adverse Event|0|||
30874420|NCT02031640|58905238|FG005|Run-In Period|Adverse Event|0|||
30874421|NCT02031640|58905233|FG000|Run-In Period|Withdrawal by Subject|17|||
30874422|NCT02031640|58905234|FG001|Run-In Period|Withdrawal by Subject|0|||
30874423|NCT02031640|58905235|FG002|Run-In Period|Withdrawal by Subject|0|||
30874424|NCT02031640|58905236|FG003|Run-In Period|Withdrawal by Subject|0|||
30874425|NCT02031640|58905237|FG004|Run-In Period|Withdrawal by Subject|0|||
30874426|NCT02031640|58905238|FG005|Run-In Period|Withdrawal by Subject|0|||
30874427|NCT02031640|58905233|FG000|Run-In Period|Inclusion criteria not met|38|||
30962416|NCT01517893|59029407|FG000|Overall Study|Withdrawal by Subject|3|||
30962417|NCT01517893|59029408|FG001|Overall Study|Withdrawal by Subject|0|||
30962418|NCT01489891|59029416|FG000|Overall Study|Endoscopy failure|1|||
30962419|NCT01489891|59029417|FG001|Overall Study|Endoscopy failure|0|||
30962420|NCT04062240|59029499|FG000|Overall Study|equipment malfunction|1|||
30962421|NCT02790138|59029505|FG000|Overall Study|Adverse Event|5|||
30962422|NCT02790138|59029506|FG001|Overall Study|Adverse Event|2|||
30962423|NCT02790138|59029505|FG000|Overall Study|Significant Protocol Deviation|0|||
30874428|NCT02031640|58905234|FG001|Run-In Period|Inclusion criteria not met|0|||
30874429|NCT02031640|58905235|FG002|Run-In Period|Inclusion criteria not met|0|||
30874430|NCT02031640|58905236|FG003|Run-In Period|Inclusion criteria not met|0|||
30874431|NCT02031640|58905237|FG004|Run-In Period|Inclusion criteria not met|0|||
30874432|NCT02031640|58905238|FG005|Run-In Period|Inclusion criteria not met|0|||
30962424|NCT02790138|59029506|FG001|Overall Study|Significant Protocol Deviation|1|||
30962425|NCT02790138|59029505|FG000|Overall Study|Lost to Follow-up|1|||
30962426|NCT02790138|59029506|FG001|Overall Study|Lost to Follow-up|0|||
30962427|NCT02790138|59029505|FG000|Overall Study|Voluntary Withdrawal|8|||
30962428|NCT02790138|59029506|FG001|Overall Study|Voluntary Withdrawal|9|||
30874433|NCT02031640|58905233|FG000|Run-In Period|Exclusion criteria met|8|||
30874434|NCT02031640|58905234|FG001|Run-In Period|Exclusion criteria met|0|||
30874435|NCT02031640|58905235|FG002|Run-In Period|Exclusion criteria met|0|||
30874436|NCT02031640|58905236|FG003|Run-In Period|Exclusion criteria met|0|||
30874437|NCT02031640|58905237|FG004|Run-In Period|Exclusion criteria met|0|||
30874438|NCT02031640|58905238|FG005|Run-In Period|Exclusion criteria met|0|||
30962429|NCT02790138|59029505|FG000|Overall Study|Lack of Efficacy|6|||
30962430|NCT02790138|59029506|FG001|Overall Study|Lack of Efficacy|7|||
30962431|NCT02790138|59029505|FG000|Overall Study|Reason not Specified|1|||
30962432|NCT02790138|59029506|FG001|Overall Study|Reason not Specified|0|||
30962433|NCT01489189|59029661|FG000|Overall Study|Withdrawal by Subject|20|||
30962434|NCT01489189|59029662|FG001|Overall Study|Withdrawal by Subject|23|||
30962435|NCT01489189|59029661|FG000|Overall Study|Death|10|||
30962436|NCT01489189|59029662|FG001|Overall Study|Death|8|||
30962437|NCT01489189|59029661|FG000|Overall Study|Missed Visit|1|||
30962438|NCT01489189|59029662|FG001|Overall Study|Missed Visit|4|||
30962439|NCT01549873|59029671|FG000|Overall Study|Physician Decision|0|||
30962440|NCT01549873|59029672|FG001|Overall Study|Physician Decision|1|||
30962441|NCT01489111|59029678|FG000|Overall Study|Withdrawal criterion|1|||
30962442|NCT01488487|59029682|FG000|Overall Study|Adverse Event|6|||
30962443|NCT01488487|59029682|FG000|Overall Study|Death|1|||
30962444|NCT01488487|59029682|FG000|Overall Study|Withdrawal by Subject|2|||
30962445|NCT01488097|59029686|FG000|Overall Study|Lost to Follow-up|1|||
30962446|NCT01516879|59029692|FG000|Overall Study|Withdrawal by Subject|9|||
30962447|NCT01516879|59029693|FG001|Overall Study|Withdrawal by Subject|11|||
30962448|NCT01516879|59029692|FG000|Overall Study|Death|0|||
30962449|NCT01516879|59029693|FG001|Overall Study|Death|2|||
30962450|NCT01516879|59029692|FG000|Overall Study|Lost to Follow-up|2|||
30962451|NCT01516879|59029693|FG001|Overall Study|Lost to Follow-up|11|||
30962452|NCT01516879|59029692|FG000|Overall Study|Other|5|||
30962453|NCT01516879|59029693|FG001|Overall Study|Other|10|||
30962454|NCT01515865|59029699|FG000|Part A (Open-label)|Other|3|||
30962455|NCT01515865|59029700|FG001|Part A (Open-label)|Other|0|||
30962456|NCT01515865|59029701|FG002|Part A (Open-label)|Other|0|||
30962457|NCT01515865|59029699|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
30962458|NCT01515865|59029700|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
30962459|NCT01515865|59029701|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
30962460|NCT01515865|59029699|FG000|Part B (Open-label)|Other|1|||
30962461|NCT01515865|59029700|FG001|Part B (Open-label)|Other|0|||
30962462|NCT01515865|59029701|FG002|Part B (Open-label)|Other|0|||
30962463|NCT01547299|59029711|FG000|Overall Study|Withdrawal by Subject|2|||
30962464|NCT01547299|59029712|FG001|Overall Study|Withdrawal by Subject|2|||
30962465|NCT01515475|59029722|FG000|Overall Study|Lost to Follow-up|20|||
30962466|NCT01515475|59029723|FG001|Overall Study|Lost to Follow-up|15|||
30962467|NCT01515475|59029724|FG002|Overall Study|Lost to Follow-up|12|||
30962468|NCT01515475|59029725|FG003|Overall Study|Lost to Follow-up|12|||
30962469|NCT01515319|59029811|FG000|Overall Study|Withdrawal by Subject|0|||
30962470|NCT01515319|59029812|FG001|Overall Study|Withdrawal by Subject|0|||
30962471|NCT01515319|59029813|FG002|Overall Study|Withdrawal by Subject|0|||
30962472|NCT01515319|59029814|FG003|Overall Study|Withdrawal by Subject|0|||
30962473|NCT01515319|59029815|FG004|Overall Study|Withdrawal by Subject|0|||
30962474|NCT01515319|59029816|FG005|Overall Study|Withdrawal by Subject|0|||
30962475|NCT01515319|59029817|FG006|Overall Study|Withdrawal by Subject|1|||
30962476|NCT01515319|59029818|FG007|Overall Study|Withdrawal by Subject|0|||
30962477|NCT01515319|59029819|FG008|Overall Study|Withdrawal by Subject|0|||
30962478|NCT01515319|59029820|FG009|Overall Study|Withdrawal by Subject|0|||
30962479|NCT01515319|59029811|FG000|Overall Study|Adverse Event|0|||
30962480|NCT01515319|59029812|FG001|Overall Study|Adverse Event|0|||
30962481|NCT01515319|59029813|FG002|Overall Study|Adverse Event|0|||
30962482|NCT01515319|59029814|FG003|Overall Study|Adverse Event|0|||
30962483|NCT01515319|59029815|FG004|Overall Study|Adverse Event|0|||
30962484|NCT01515319|59029816|FG005|Overall Study|Adverse Event|0|||
30962485|NCT01515319|59029817|FG006|Overall Study|Adverse Event|0|||
30962486|NCT01515319|59029818|FG007|Overall Study|Adverse Event|0|||
30962487|NCT01515319|59029819|FG008|Overall Study|Adverse Event|3|||
30962488|NCT01515319|59029820|FG009|Overall Study|Adverse Event|0|||
30962489|NCT01515319|59029811|FG000|Overall Study|Protocol Violation|0|||
30962490|NCT01515319|59029812|FG001|Overall Study|Protocol Violation|0|||
30962491|NCT01515319|59029813|FG002|Overall Study|Protocol Violation|0|||
30962492|NCT01515319|59029814|FG003|Overall Study|Protocol Violation|0|||
30962493|NCT01515319|59029815|FG004|Overall Study|Protocol Violation|0|||
30962494|NCT01515319|59029816|FG005|Overall Study|Protocol Violation|0|||
30962495|NCT01515319|59029817|FG006|Overall Study|Protocol Violation|0|||
30962496|NCT01515319|59029818|FG007|Overall Study|Protocol Violation|0|||
30962497|NCT01515319|59029819|FG008|Overall Study|Protocol Violation|2|||
30962498|NCT01515319|59029820|FG009|Overall Study|Protocol Violation|0|||
30962499|NCT01492361|59029857|FG000|Overall Study|Withdrawal by Subject|281|||
30962500|NCT01492361|59029858|FG001|Overall Study|Withdrawal by Subject|297|||
30962501|NCT01492361|59029857|FG000|Overall Study|Physician Decision|12|||
30962502|NCT01492361|59029858|FG001|Overall Study|Physician Decision|12|||
30962503|NCT01492361|59029857|FG000|Overall Study|Lost to Follow-up|6|||
30962504|NCT01492361|59029858|FG001|Overall Study|Lost to Follow-up|13|||
30962505|NCT01492361|59029857|FG000|Overall Study|Other than specified above|106|||
30962506|NCT01492361|59029858|FG001|Overall Study|Other than specified above|138|||
30962507|NCT01514461|59029937|FG000|Overall Study|Adverse Event|2|||
30962508|NCT01514461|59029938|FG001|Overall Study|Adverse Event|1|||
30962509|NCT01514461|59029939|FG002|Overall Study|Adverse Event|3|||
30962510|NCT01514461|59029937|FG000|Overall Study|Physician Decision|1|||
30962511|NCT01514461|59029938|FG001|Overall Study|Physician Decision|1|||
30962512|NCT01514461|59029939|FG002|Overall Study|Physician Decision|0|||
30962513|NCT01514461|59029937|FG000|Overall Study|Patient/guardian decision|1|||
30962514|NCT01514461|59029938|FG001|Overall Study|Patient/guardian decision|1|||
30962515|NCT01514461|59029939|FG002|Overall Study|Patient/guardian decision|1|||
30962516|NCT01514461|59029937|FG000|Overall Study|Death|1|||
30962517|NCT01514461|59029938|FG001|Overall Study|Death|0|||
30962518|NCT01514461|59029939|FG002|Overall Study|Death|0|||
30962519|NCT01491737|59029985|FG000|Overall Study|Withdrawal by Subject|20|||
30962520|NCT01491737|59029986|FG001|Overall Study|Withdrawal by Subject|17|||
30962521|NCT01491737|59029985|FG000|Overall Study|Lost to Follow-up|2|||
30962522|NCT01491737|59029986|FG001|Overall Study|Lost to Follow-up|10|||
30962523|NCT01491737|59029985|FG000|Overall Study|Death|63|||
30962524|NCT01491737|59029986|FG001|Overall Study|Death|57|||
30962525|NCT01491737|59029985|FG000|Overall Study|Study Termination by Sponsor|36|||
30962526|NCT01491737|59029986|FG001|Overall Study|Study Termination by Sponsor|36|||
30962527|NCT01491737|59029985|FG000|Overall Study|Reason Not Specified|8|||
30962528|NCT01491737|59029986|FG001|Overall Study|Reason Not Specified|9|||
30962529|NCT01487863|59029998|FG000|Overall Study|Death|19|||
30962530|NCT01487863|59029999|FG001|Overall Study|Death|19|||
30962531|NCT01487161|59030018|FG000|Overall Study|Adverse Event|1|||
30962532|NCT01487161|59030019|FG001|Overall Study|Adverse Event|0|||
30962533|NCT01487161|59030020|FG002|Overall Study|Adverse Event|0|||
30962534|NCT01487161|59030021|FG003|Overall Study|Adverse Event|0|||
30962535|NCT01487161|59030018|FG000|Overall Study|Withdrawal by Subject|1|||
30962536|NCT01487161|59030019|FG001|Overall Study|Withdrawal by Subject|1|||
30962537|NCT01487161|59030020|FG002|Overall Study|Withdrawal by Subject|1|||
30962538|NCT01487161|59030021|FG003|Overall Study|Withdrawal by Subject|2|||
30962539|NCT01487161|59030018|FG000|Overall Study|missing data|0|||
30962540|NCT01487161|59030019|FG001|Overall Study|missing data|1|||
30962541|NCT01487161|59030020|FG002|Overall Study|missing data|0|||
30962542|NCT01487161|59030021|FG003|Overall Study|missing data|0|||
30962543|NCT01491035|59030076|FG000|Overall Study|Lost to Follow-up|0|||
30962544|NCT01491035|59030077|FG001|Overall Study|Lost to Follow-up|0|||
30962545|NCT01491035|59030078|FG002|Overall Study|Lost to Follow-up|0|||
30962546|NCT01491035|59030079|FG003|Overall Study|Lost to Follow-up|0|||
30962547|NCT01491035|59030080|FG004|Overall Study|Lost to Follow-up|1|||
30962548|NCT01491035|59030081|FG005|Overall Study|Lost to Follow-up|0|||
30962549|NCT01491035|59030082|FG006|Overall Study|Lost to Follow-up|0|||
30962550|NCT01491035|59030083|FG007|Overall Study|Lost to Follow-up|0|||
30962551|NCT01488071|59030107|FG000|Overall Study|Adverse Event|15|||
30962552|NCT01488071|59030108|FG001|Overall Study|Adverse Event|23|||
30962553|NCT01488071|59030107|FG000|Overall Study|Lack of Efficacy|11|||
30962554|NCT01488071|59030108|FG001|Overall Study|Lack of Efficacy|17|||
30962555|NCT01488071|59030107|FG000|Overall Study|Non-compliance with study drug|2|||
30962556|NCT01488071|59030108|FG001|Overall Study|Non-compliance with study drug|0|||
30962557|NCT01488071|59030107|FG000|Overall Study|Protocol Violation|5|||
30874439|NCT02031640|58905233|FG000|Run-In Period|Randomization criteria not met|85|||
30874440|NCT02031640|58905234|FG001|Run-In Period|Randomization criteria not met|0|||
30874441|NCT02031640|58905235|FG002|Run-In Period|Randomization criteria not met|0|||
30874442|NCT02031640|58905236|FG003|Run-In Period|Randomization criteria not met|0|||
30874443|NCT02031640|58905237|FG004|Run-In Period|Randomization criteria not met|0|||
30874444|NCT02031640|58905238|FG005|Run-In Period|Randomization criteria not met|0|||
30874445|NCT02031640|58905233|FG000|Run-In Period|Various administrative reasons|17|||
30962558|NCT01488071|59030108|FG001|Overall Study|Protocol Violation|7|||
30962559|NCT01488071|59030107|FG000|Overall Study|Withdrawal of Consent|14|||
30962560|NCT01488071|59030108|FG001|Overall Study|Withdrawal of Consent|12|||
30962561|NCT01488071|59030107|FG000|Overall Study|Lost to Follow-up|1|||
30962562|NCT01488071|59030108|FG001|Overall Study|Lost to Follow-up|0|||
30962563|NCT01488071|59030107|FG000|Overall Study|Administrative or Other Reason(s)|5|||
30962564|NCT01488071|59030108|FG001|Overall Study|Administrative or Other Reason(s)|4|||
30962565|NCT01487525|59030116|FG000|Overall Study|Withdrawal by Subject|0|||
30962566|NCT01487525|59030117|FG001|Overall Study|Withdrawal by Subject|1|||
30874446|NCT02031640|58905234|FG001|Run-In Period|Various administrative reasons|0|||
30962567|NCT01486199|59030125|FG000|Two Year Period Between Study Days|Physician Decision|1|||
30962568|NCT01486199|59030126|FG001|Two Year Period Between Study Days|Physician Decision|0|||
30962569|NCT01485887|59030132|FG000|Overall Study|Withdrawal by Subject|2|||
30962570|NCT01485887|59030132|FG000|Overall Study|Adverse Event|8|||
30962571|NCT01485887|59030132|FG000|Overall Study|Deterioration of primary disease|1|||
30962572|NCT01485887|59030132|FG000|Overall Study|Primary disease markedly improved|1|||
30962573|NCT01546519|59030140|FG000|Overall Study|Adverse Event|0|||
30962574|NCT01546519|59030141|FG001|Overall Study|Adverse Event|0|||
30962575|NCT01546519|59030142|FG002|Overall Study|Adverse Event|1|||
30962576|NCT01546519|59030143|FG003|Overall Study|Adverse Event|1|||
30962577|NCT01546519|59030140|FG000|Overall Study|Death|0|||
30962578|NCT01546519|59030141|FG001|Overall Study|Death|1|||
30874447|NCT02031640|58905235|FG002|Run-In Period|Various administrative reasons|0|||
30874448|NCT02031640|58905236|FG003|Run-In Period|Various administrative reasons|0|||
30874449|NCT02031640|58905237|FG004|Run-In Period|Various administrative reasons|0|||
30874450|NCT02031640|58905238|FG005|Run-In Period|Various administrative reasons|0|||
30874451|NCT02031640|58905233|FG000|Double-blind Treatment Period|Protocol deviation|0|||
30874452|NCT02031640|58905234|FG001|Double-blind Treatment Period|Protocol deviation|2|||
30874453|NCT02031640|58905235|FG002|Double-blind Treatment Period|Protocol deviation|0|||
30874454|NCT02031640|58905236|FG003|Double-blind Treatment Period|Protocol deviation|1|||
30874455|NCT02031640|58905237|FG004|Double-blind Treatment Period|Protocol deviation|3|||
30874456|NCT02031640|58905238|FG005|Double-blind Treatment Period|Protocol deviation|1|||
30874457|NCT02031640|58905233|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
30874458|NCT02031640|58905234|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
30874459|NCT02031640|58905235|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
30874460|NCT02031640|58905236|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
30874461|NCT02031640|58905237|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
30874462|NCT02031640|58905238|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
30874463|NCT02031640|58905233|FG000|Double-blind Treatment Period|Non-compliance|0|||
30874464|NCT02031640|58905234|FG001|Double-blind Treatment Period|Non-compliance|1|||
30874465|NCT02031640|58905235|FG002|Double-blind Treatment Period|Non-compliance|0|||
30874466|NCT02031640|58905236|FG003|Double-blind Treatment Period|Non-compliance|1|||
30874467|NCT02031640|58905237|FG004|Double-blind Treatment Period|Non-compliance|1|||
30874468|NCT02031640|58905238|FG005|Double-blind Treatment Period|Non-compliance|0|||
30874469|NCT02031640|58905233|FG000|Double-blind Treatment Period|Adverse Event|0|||
30874470|NCT02031640|58905234|FG001|Double-blind Treatment Period|Adverse Event|0|||
30874471|NCT02031640|58905235|FG002|Double-blind Treatment Period|Adverse Event|0|||
30874472|NCT02031640|58905236|FG003|Double-blind Treatment Period|Adverse Event|2|||
30874473|NCT02031640|58905237|FG004|Double-blind Treatment Period|Adverse Event|0|||
30874474|NCT02031640|58905238|FG005|Double-blind Treatment Period|Adverse Event|0|||
30874475|NCT02031640|58905233|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
30874476|NCT02031640|58905234|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
30874477|NCT02031640|58905235|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
30874478|NCT02031640|58905236|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
30874479|NCT02031640|58905237|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
30874480|NCT02031640|58905238|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
30874481|NCT02031640|58905233|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
30874482|NCT02031640|58905234|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
30874483|NCT02031640|58905235|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
30874484|NCT02031640|58905236|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
30874485|NCT02031640|58905237|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
30874486|NCT02031640|58905238|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
30874487|NCT02370173|58905259|FG000|Overall Study|Protocol Violation|1|||
30874488|NCT02370173|58905260|FG001|Overall Study|Protocol Violation|1|||
30874489|NCT02370173|58905259|FG000|Overall Study|Withdrawal by Subject|2|||
30874490|NCT02370173|58905260|FG001|Overall Study|Withdrawal by Subject|2|||
30874491|NCT02660489|58905270|FG000|Overall Study|Lost to Follow-up|1|||
30874492|NCT02660489|58905271|FG001|Overall Study|Lost to Follow-up|1|||
30874493|NCT02660489|58905270|FG000|Overall Study|Adverse Event|1|||
30874494|NCT02660489|58905271|FG001|Overall Study|Adverse Event|3|||
30874495|NCT02660489|58905270|FG000|Overall Study|no rhinovirus infection|4|||
30874496|NCT02660489|58905271|FG001|Overall Study|no rhinovirus infection|4|||
30874497|NCT02052310|58905279|FG000|Overall Study|Death|64|||
30874498|NCT02052310|58905280|FG001|Overall Study|Death|54|||
30874499|NCT02052310|58905279|FG000|Overall Study|Withdrawal by Subject|37|||
30874500|NCT02052310|58905280|FG001|Overall Study|Withdrawal by Subject|49|||
30874501|NCT02052310|58905279|FG000|Overall Study|Other than specified|32|||
30874502|NCT02052310|58905280|FG001|Overall Study|Other than specified|29|||
30874503|NCT02052310|58905279|FG000|Overall Study|Adverse Event|29|||
30874504|NCT02052310|58905280|FG001|Overall Study|Adverse Event|22|||
30874505|NCT02052310|58905279|FG000|Overall Study|Kidney Transplant|23|||
30874506|NCT02052310|58905280|FG001|Overall Study|Kidney Transplant|29|||
30874507|NCT02052310|58905279|FG000|Overall Study|Physician Decision|14|||
30874508|NCT02052310|58905280|FG001|Overall Study|Physician Decision|7|||
30874509|NCT02052310|58905279|FG000|Overall Study|Lack of Efficacy|6|||
30874510|NCT02052310|58905280|FG001|Overall Study|Lack of Efficacy|1|||
30874511|NCT02052310|58905279|FG000|Overall Study|Site Terminated by Sponsor|5|||
30874512|NCT02052310|58905280|FG001|Overall Study|Site Terminated by Sponsor|13|||
30874513|NCT02052310|58905279|FG000|Overall Study|Lost to Follow-up|4|||
30874514|NCT02052310|58905280|FG001|Overall Study|Lost to Follow-up|2|||
30874515|NCT02052310|58905279|FG000|Overall Study|Protocol Violation|1|||
30874516|NCT02052310|58905280|FG001|Overall Study|Protocol Violation|6|||
30874517|NCT02051764|58905288|FG000|Overall Study|Study terminated by sponsor|0|||
30874518|NCT02051764|58905289|FG001|Overall Study|Study terminated by sponsor|7|||
30874519|NCT02051296|58905297|FG000|Overall Study|Lost to Follow-up|1|||
30874520|NCT02051296|58905298|FG001|Overall Study|Lost to Follow-up|2|||
30874521|NCT02051296|58905297|FG000|Overall Study|withdraw prior to treatment|7|||
30874522|NCT02051296|58905298|FG001|Overall Study|withdraw prior to treatment|7|||
30874523|NCT02050048|58905306|FG000|Overall Study|Lost to Follow-up|0|||
30874524|NCT02050048|58905307|FG001|Overall Study|Lost to Follow-up|1|||
30874525|NCT02050048|58905306|FG000|Overall Study|Death|1|||
30874526|NCT02050048|58905307|FG001|Overall Study|Death|0|||
30874527|NCT02050048|58905306|FG000|Overall Study|Ineligible after ERCP|4|||
30874528|NCT02050048|58905307|FG001|Overall Study|Ineligible after ERCP|1|||
30874529|NCT02049814|58905315|FG000|Overall Study|Reason not Specified|4|||
30874530|NCT02049814|58905316|FG001|Overall Study|Reason not Specified|3|||
30874531|NCT02049814|58905315|FG000|Overall Study|Pregnancy|1|||
30874532|NCT02049814|58905316|FG001|Overall Study|Pregnancy|0|||
30874533|NCT02049814|58905315|FG000|Overall Study|Lost to Follow-up|2|||
30874534|NCT02049814|58905316|FG001|Overall Study|Lost to Follow-up|3|||
30874535|NCT02049814|58905315|FG000|Overall Study|Serious Protocol Violation|5|||
30874536|NCT02049814|58905316|FG001|Overall Study|Serious Protocol Violation|7|||
30874537|NCT02049814|58905315|FG000|Overall Study|Study Termination|0|||
30874538|NCT02049814|58905316|FG001|Overall Study|Study Termination|1|||
30874539|NCT02049814|58905315|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
30874540|NCT02049814|58905316|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
30874541|NCT02049814|58905315|FG000|Overall Study|Voluntary withdrawal|9|||
30874542|NCT02049814|58905316|FG001|Overall Study|Voluntary withdrawal|8|||
30874543|NCT02079844|58905334|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
30874544|NCT02079844|58905335|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
30874545|NCT02079844|58905336|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
30874546|NCT02079844|58905334|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
30874547|NCT02079844|58905335|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
30874548|NCT02079844|58905336|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
30874549|NCT02048722|58905356|FG000|2 Cycles of Treatment|Adverse Event|2|||
30874550|NCT02048722|58905356|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
30874551|NCT02048722|58905356|FG000|2 Cycles of Treatment|Progressive Disease|2|||
30874552|NCT02048722|58905356|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
30874553|NCT02048722|58905356|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
30874554|NCT02048722|58905356|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
30874555|NCT02030002|58905360|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
30874556|NCT02030002|58905360|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
30874557|NCT02030002|58905360|FG000|Follow-up|Lost to Follow-up|2|||
30874558|NCT02079610|58905368|FG000|Overall Study|Withdrawal by Subject|1|||
30874559|NCT02079610|58905369|FG001|Overall Study|Withdrawal by Subject|1|||
30874560|NCT02079532|58905375|FG000|Overall Study|Adverse Event|7|||
30874561|NCT02079532|58905375|FG000|Overall Study|Additional or changed therapy|2|||
30874562|NCT02079532|58905375|FG000|Overall Study|Lack of Efficacy|9|||
30874563|NCT02079532|58905375|FG000|Overall Study|Protocol Violation|3|||
30874564|NCT02079532|58905375|FG000|Overall Study|Withdrawal by Subject|1|||
30874565|NCT02079532|58905375|FG000|Overall Study|Administrative problems|1|||
30874566|NCT02079532|58905375|FG000|Overall Study|Inclusion into ReFIRST|3|||
30874567|NCT02079532|58905375|FG000|Overall Study|Other|3|||
30874568|NCT02709889|58905428|FG000|Overall Study|Withdrawal by Subject|11|||
30874569|NCT02709889|58905429|FG001|Overall Study|Withdrawal by Subject|10|||
30874570|NCT02709889|58905430|FG002|Overall Study|Withdrawal by Subject|2|||
30874571|NCT02709889|58905431|FG003|Overall Study|Withdrawal by Subject|12|||
30874572|NCT02709889|58905428|FG000|Overall Study|Death|25|||
30874573|NCT02709889|58905429|FG001|Overall Study|Death|38|||
30874574|NCT02709889|58905430|FG002|Overall Study|Death|4|||
30874575|NCT02709889|58905431|FG003|Overall Study|Death|44|||
30874576|NCT02709889|58905428|FG000|Overall Study|Physician Decision|1|||
30874577|NCT02709889|58905429|FG001|Overall Study|Physician Decision|2|||
30874578|NCT02709889|58905430|FG002|Overall Study|Physician Decision|3|||
30874579|NCT02709889|58905431|FG003|Overall Study|Physician Decision|5|||
30874580|NCT02709889|58905428|FG000|Overall Study|Lost to Follow-up|2|||
30874581|NCT02709889|58905429|FG001|Overall Study|Lost to Follow-up|0|||
30874582|NCT02709889|58905430|FG002|Overall Study|Lost to Follow-up|0|||
30874583|NCT02709889|58905431|FG003|Overall Study|Lost to Follow-up|4|||
30874584|NCT02709889|58905428|FG000|Overall Study|Study Terminated by Sponsor|4|||
30874585|NCT02709889|58905429|FG001|Overall Study|Study Terminated by Sponsor|6|||
30874586|NCT02709889|58905430|FG002|Overall Study|Study Terminated by Sponsor|2|||
30874587|NCT02709889|58905431|FG003|Overall Study|Study Terminated by Sponsor|17|||
30874588|NCT02709889|58905428|FG000|Overall Study|Other, Not Specified|0|||
30874589|NCT02709889|58905429|FG001|Overall Study|Other, Not Specified|1|||
30874590|NCT02709889|58905430|FG002|Overall Study|Other, Not Specified|1|||
30874591|NCT02709889|58905431|FG003|Overall Study|Other, Not Specified|6|||
30874592|NCT02711995|58905476|FG000|Washout (90 Days)|Conflicting medication|1|||
30874593|NCT02514239|58905514|FG000|Overall Study|Refused to continue trial medication|0|||
30874594|NCT02514239|58905515|FG001|Overall Study|Refused to continue trial medication|0|||
30874595|NCT02514239|58905516|FG002|Overall Study|Refused to continue trial medication|0|||
30874596|NCT02514239|58905517|FG003|Overall Study|Refused to continue trial medication|0|||
30874597|NCT02514239|58905518|FG004|Overall Study|Refused to continue trial medication|0|||
30874598|NCT02514239|58905519|FG005|Overall Study|Refused to continue trial medication|0|||
30874599|NCT02514239|58905520|FG006|Overall Study|Refused to continue trial medication|0|||
30874600|NCT02514239|58905521|FG007|Overall Study|Refused to continue trial medication|0|||
30874601|NCT02514239|58905522|FG008|Overall Study|Refused to continue trial medication|0|||
30874602|NCT02514239|58905523|FG009|Overall Study|Refused to continue trial medication|1|||
30874603|NCT02514239|58905514|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
30874604|NCT02514239|58905515|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
30874605|NCT02514239|58905516|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
30874606|NCT02514239|58905517|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
30874607|NCT02514239|58905518|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
30874608|NCT02514239|58905519|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
30874609|NCT02514239|58905520|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
30874610|NCT02514239|58905521|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
30874611|NCT02514239|58905522|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
30874612|NCT02514239|58905523|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
30874613|NCT02514239|58905514|FG000|Overall Study|Not treated|0|||
30874614|NCT02514239|58905515|FG001|Overall Study|Not treated|1|||
30874615|NCT02514239|58905516|FG002|Overall Study|Not treated|0|||
30874616|NCT02514239|58905517|FG003|Overall Study|Not treated|0|||
30874617|NCT02514239|58905518|FG004|Overall Study|Not treated|0|||
30874618|NCT02514239|58905519|FG005|Overall Study|Not treated|0|||
30874619|NCT02514239|58905520|FG006|Overall Study|Not treated|0|||
30874620|NCT02514239|58905521|FG007|Overall Study|Not treated|0|||
30874621|NCT02514239|58905522|FG008|Overall Study|Not treated|0|||
30874622|NCT02514239|58905523|FG009|Overall Study|Not treated|0|||
30874623|NCT02514239|58905514|FG000|Overall Study|Other Adverse Events|2|||
30874624|NCT02514239|58905515|FG001|Overall Study|Other Adverse Events|0|||
30874625|NCT02514239|58905516|FG002|Overall Study|Other Adverse Events|0|||
30874626|NCT02514239|58905517|FG003|Overall Study|Other Adverse Events|1|||
30874627|NCT02514239|58905518|FG004|Overall Study|Other Adverse Events|0|||
30874628|NCT02514239|58905519|FG005|Overall Study|Other Adverse Events|1|||
30874629|NCT02514239|58905520|FG006|Overall Study|Other Adverse Events|0|||
30874630|NCT02514239|58905521|FG007|Overall Study|Other Adverse Events|1|||
30874631|NCT02514239|58905522|FG008|Overall Study|Other Adverse Events|2|||
30874632|NCT02514239|58905523|FG009|Overall Study|Other Adverse Events|0|||
30874633|NCT02514239|58905514|FG000|Overall Study|Progressive disease|3|||
30874634|NCT02514239|58905515|FG001|Overall Study|Progressive disease|3|||
30874635|NCT02514239|58905516|FG002|Overall Study|Progressive disease|2|||
30874636|NCT02514239|58905517|FG003|Overall Study|Progressive disease|2|||
30874637|NCT02514239|58905518|FG004|Overall Study|Progressive disease|3|||
30874638|NCT02514239|58905519|FG005|Overall Study|Progressive disease|3|||
30874639|NCT02514239|58905520|FG006|Overall Study|Progressive disease|4|||
30874640|NCT02514239|58905521|FG007|Overall Study|Progressive disease|2|||
30874641|NCT02514239|58905522|FG008|Overall Study|Progressive disease|5|||
30874642|NCT02514239|58905523|FG009|Overall Study|Progressive disease|0|||
30874643|NCT02709109|58905567|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
30874644|NCT02709109|58905568|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
30874645|NCT02709109|58905569|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
30874646|NCT02709109|58905570|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
30874647|NCT02709109|58905567|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
30874648|NCT02709109|58905568|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
30874649|NCT02709109|58905569|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
30874650|NCT02709109|58905570|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
30874651|NCT02709109|58905567|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
30874652|NCT02709109|58905568|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
30874653|NCT02709109|58905569|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
30874654|NCT02709109|58905570|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
30874655|NCT02709109|58905567|FG000|Washout Period (28 Days)|Other|2|||
30874656|NCT02709109|58905568|FG001|Washout Period (28 Days)|Other|2|||
30874657|NCT02709109|58905569|FG002|Washout Period (28 Days)|Other|3|||
30874658|NCT02709109|58905570|FG003|Washout Period (28 Days)|Other|0|||
30874659|NCT02709109|58905567|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
30874660|NCT02709109|58905568|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
30874661|NCT02709109|58905569|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
30874662|NCT02709109|58905570|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
30874663|NCT02709109|58905567|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
30874664|NCT02709109|58905568|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
30874665|NCT02709109|58905569|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
30874666|NCT02709109|58905570|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
30874667|NCT02709109|58905567|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
30874668|NCT02709109|58905568|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
30874669|NCT02709109|58905569|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
30874670|NCT02709109|58905570|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
30874671|NCT02709109|58905567|FG000|Treatment Period 2 (28 Days)|Other|0|||
30874672|NCT02709109|58905568|FG001|Treatment Period 2 (28 Days)|Other|0|||
30874673|NCT02709109|58905569|FG002|Treatment Period 2 (28 Days)|Other|1|||
30874674|NCT02709109|58905570|FG003|Treatment Period 2 (28 Days)|Other|0|||
30874675|NCT04289051|58905585|FG000|Overall Study|Lost to Follow-up|0|||
30874676|NCT04289051|58905586|FG001|Overall Study|Lost to Follow-up|0|||
30874677|NCT04289051|58905587|FG002|Overall Study|Lost to Follow-up|2|||
30874678|NCT02709655|58905595|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
30874679|NCT02709655|58905596|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
30874680|NCT02709655|58905597|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
30874681|NCT02709655|58905598|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
30874682|NCT02709655|58905599|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
30874683|NCT02709655|58905595|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
30874684|NCT02709655|58905596|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
30874685|NCT02709655|58905597|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
30874686|NCT02709655|58905598|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
30874687|NCT02709655|58905599|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
30874688|NCT02709655|58905595|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
30874689|NCT02709655|58905596|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
30874690|NCT02709655|58905597|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
30874691|NCT02709655|58905598|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
30874692|NCT02709655|58905599|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
30874693|NCT02709655|58905595|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
30874694|NCT02709655|58905596|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
30874695|NCT02709655|58905597|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
30874696|NCT02709655|58905598|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
30874697|NCT02709655|58905599|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
30874698|NCT02709655|58905595|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
30874699|NCT02709655|58905596|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
30874700|NCT02709655|58905597|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
30874701|NCT02709655|58905598|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
30874702|NCT02709655|58905599|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
30874703|NCT02709655|58905595|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
30874704|NCT02709655|58905596|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
30874705|NCT02709655|58905597|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
30874706|NCT02709655|58905598|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
30874707|NCT02709655|58905599|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
30874708|NCT02709655|58905595|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
30874709|NCT02709655|58905596|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
30874710|NCT02709655|58905597|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
30874711|NCT02709655|58905598|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
30874712|NCT02709655|58905599|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
30874713|NCT02709655|58905595|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
30874714|NCT02709655|58905596|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
30874715|NCT02709655|58905597|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
30874716|NCT02709655|58905598|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
30874717|NCT02709655|58905599|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
30874718|NCT02709655|58905595|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
30874719|NCT02709655|58905596|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
30874720|NCT02709655|58905597|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
30874721|NCT02709655|58905598|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
30874722|NCT02709655|58905599|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
30874723|NCT02709655|58905595|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
30874724|NCT02709655|58905596|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
30874725|NCT02709655|58905597|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
30874726|NCT02709655|58905598|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
30874727|NCT02709655|58905599|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
30874728|NCT02709655|58905595|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
30874729|NCT02709655|58905596|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
30874730|NCT02709655|58905597|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
30874731|NCT02709655|58905598|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
30874732|NCT02709655|58905599|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
30874733|NCT02709655|58905595|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
30874734|NCT02709655|58905596|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
30874735|NCT02709655|58905597|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
30962579|NCT01546519|59030142|FG002|Overall Study|Death|3|||
30874736|NCT02709655|58905598|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
30874737|NCT02709655|58905599|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
30874738|NCT02709655|58905595|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
30874739|NCT02709655|58905596|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
30874740|NCT02709655|58905597|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
30874741|NCT02709655|58905598|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
30874742|NCT02709655|58905599|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
30874743|NCT02709655|58905595|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
30874744|NCT02709655|58905596|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
30874745|NCT02709655|58905597|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
30874746|NCT02709655|58905598|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
30874747|NCT02709655|58905599|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
30874748|NCT02709655|58905595|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
30874749|NCT02709655|58905596|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
30874750|NCT02709655|58905597|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
30874751|NCT02709655|58905598|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
30874752|NCT02709655|58905599|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
30874753|NCT02709655|58905595|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
30874754|NCT02709655|58905596|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
30874755|NCT02709655|58905597|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
30874756|NCT02709655|58905598|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
30874757|NCT02709655|58905599|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
30874758|NCT02708485|58905613|FG000|Overall Study|Withdrawal by Subject|3|||
30874759|NCT02708485|58905614|FG001|Overall Study|Withdrawal by Subject|2|||
30874760|NCT02709577|58905626|FG000|Overall Study|non-accommodating anatomy|0|||
30874761|NCT02709577|58905627|FG001|Overall Study|non-accommodating anatomy|1|||
30874762|NCT02709577|58905628|FG002|Overall Study|non-accommodating anatomy|0|||
30874763|NCT02709577|58905629|FG003|Overall Study|non-accommodating anatomy|0|||
30874764|NCT02709577|58905626|FG000|Overall Study|procedural complication|0|||
30874765|NCT02709577|58905627|FG001|Overall Study|procedural complication|1|||
30874766|NCT02709577|58905628|FG002|Overall Study|procedural complication|0|||
30874767|NCT02709577|58905629|FG003|Overall Study|procedural complication|0|||
30874768|NCT02709577|58905626|FG000|Overall Study|Withdrawal by Subject|2|||
30874769|NCT02709577|58905627|FG001|Overall Study|Withdrawal by Subject|3|||
30874770|NCT02709577|58905628|FG002|Overall Study|Withdrawal by Subject|2|||
30874771|NCT02709577|58905629|FG003|Overall Study|Withdrawal by Subject|0|||
30874772|NCT02078752|58905650|FG000|Overall Study|Death|0|||
30874773|NCT02078752|58905651|FG001|Overall Study|Death|3|||
30874774|NCT02078752|58905652|FG002|Overall Study|Death|0|||
30874775|NCT02078752|58905653|FG003|Overall Study|Death|0|||
30874776|NCT02078752|58905654|FG004|Overall Study|Death|0|||
30874777|NCT02078752|58905655|FG005|Overall Study|Death|1|||
30874778|NCT02078752|58905656|FG006|Overall Study|Death|0|||
30874779|NCT02078752|58905657|FG007|Overall Study|Death|1|||
30874780|NCT02078752|58905658|FG008|Overall Study|Death|0|||
30874781|NCT02078752|58905659|FG009|Overall Study|Death|4|||
30874782|NCT02078752|58905650|FG000|Overall Study|Lost to Follow-up|1|||
30874783|NCT02078752|58905651|FG001|Overall Study|Lost to Follow-up|0|||
30874784|NCT02078752|58905652|FG002|Overall Study|Lost to Follow-up|0|||
30874785|NCT02078752|58905653|FG003|Overall Study|Lost to Follow-up|1|||
30874786|NCT02078752|58905654|FG004|Overall Study|Lost to Follow-up|0|||
30874787|NCT02078752|58905655|FG005|Overall Study|Lost to Follow-up|0|||
30874788|NCT02078752|58905656|FG006|Overall Study|Lost to Follow-up|0|||
30874789|NCT02078752|58905657|FG007|Overall Study|Lost to Follow-up|0|||
30874790|NCT02078752|58905658|FG008|Overall Study|Lost to Follow-up|0|||
30874791|NCT02078752|58905659|FG009|Overall Study|Lost to Follow-up|0|||
30874792|NCT02078752|58905650|FG000|Overall Study|Withdrawal by Subject|1|||
30874793|NCT02078752|58905651|FG001|Overall Study|Withdrawal by Subject|1|||
30874794|NCT02078752|58905652|FG002|Overall Study|Withdrawal by Subject|1|||
30874795|NCT02078752|58905653|FG003|Overall Study|Withdrawal by Subject|1|||
30874796|NCT02078752|58905654|FG004|Overall Study|Withdrawal by Subject|0|||
30874797|NCT02078752|58905655|FG005|Overall Study|Withdrawal by Subject|3|||
30874798|NCT02078752|58905656|FG006|Overall Study|Withdrawal by Subject|2|||
30874799|NCT02078752|58905657|FG007|Overall Study|Withdrawal by Subject|1|||
30874800|NCT02078752|58905658|FG008|Overall Study|Withdrawal by Subject|0|||
30874801|NCT02078752|58905659|FG009|Overall Study|Withdrawal by Subject|1|||
30874802|NCT02078752|58905650|FG000|Overall Study|Other|0|||
30874803|NCT02078752|58905651|FG001|Overall Study|Other|3|||
30874804|NCT02078752|58905652|FG002|Overall Study|Other|0|||
30874805|NCT02078752|58905653|FG003|Overall Study|Other|0|||
30874806|NCT02078752|58905654|FG004|Overall Study|Other|1|||
30874807|NCT02078752|58905655|FG005|Overall Study|Other|0|||
30874808|NCT02078752|58905656|FG006|Overall Study|Other|0|||
30874809|NCT02078752|58905657|FG007|Overall Study|Other|1|||
30874810|NCT02078752|58905658|FG008|Overall Study|Other|0|||
30874811|NCT02078752|58905659|FG009|Overall Study|Other|0|||
30874812|NCT02078752|58905650|FG000|Overall Study|Study terminated by sponsor|0|||
30874813|NCT02078752|58905651|FG001|Overall Study|Study terminated by sponsor|0|||
30874814|NCT02078752|58905652|FG002|Overall Study|Study terminated by sponsor|0|||
30874815|NCT02078752|58905653|FG003|Overall Study|Study terminated by sponsor|0|||
30874816|NCT02078752|58905654|FG004|Overall Study|Study terminated by sponsor|0|||
30874817|NCT02078752|58905655|FG005|Overall Study|Study terminated by sponsor|0|||
30874818|NCT02078752|58905656|FG006|Overall Study|Study terminated by sponsor|0|||
30874819|NCT02078752|58905657|FG007|Overall Study|Study terminated by sponsor|0|||
30874820|NCT02078752|58905658|FG008|Overall Study|Study terminated by sponsor|0|||
30874821|NCT02078752|58905659|FG009|Overall Study|Study terminated by sponsor|5|||
30874822|NCT02022748|58905692|FG000|Overall Study|Adverse Event|1|||
30874823|NCT02022748|58905693|FG001|Overall Study|Adverse Event|1|||
30874824|NCT02022748|58905694|FG002|Overall Study|Adverse Event|0|||
30874825|NCT02022748|58905692|FG000|Overall Study|Withdrawal by Subject|0|||
30874826|NCT02022748|58905693|FG001|Overall Study|Withdrawal by Subject|1|||
30874827|NCT02022748|58905694|FG002|Overall Study|Withdrawal by Subject|0|||
30874828|NCT02022670|58905705|FG000|Overall Study|Adverse Event|1|||
30874829|NCT02022670|58905706|FG001|Overall Study|Adverse Event|0|||
30874830|NCT02022670|58905707|FG002|Overall Study|Adverse Event|1|||
30874831|NCT02076334|58905720|FG000|Overall Study|Protocol Violation|1|||
30874832|NCT02076334|58905721|FG001|Overall Study|Protocol Violation|0|||
30874833|NCT02076334|58905722|FG002|Overall Study|Protocol Violation|0|||
30874834|NCT02076334|58905723|FG003|Overall Study|Protocol Violation|0|||
30874835|NCT02076334|58905720|FG000|Overall Study|Lost to Follow-up|0|||
30874836|NCT02076334|58905721|FG001|Overall Study|Lost to Follow-up|1|||
30874837|NCT02076334|58905722|FG002|Overall Study|Lost to Follow-up|1|||
30874838|NCT02076334|58905723|FG003|Overall Study|Lost to Follow-up|0|||
30874839|NCT02076334|58905720|FG000|Overall Study|muscle soreness|0|||
30874840|NCT02076334|58905721|FG001|Overall Study|muscle soreness|0|||
30874841|NCT02076334|58905722|FG002|Overall Study|muscle soreness|0|||
30874842|NCT02076334|58905723|FG003|Overall Study|muscle soreness|1|||
30874843|NCT02021812|58905733|FG000|Overall Study|Death|8|||
30874844|NCT02021812|58905733|FG000|Overall Study|Withdrawal by Subject|3|||
30874845|NCT02021812|58905733|FG000|Overall Study|Lost to Follow-up|2|||
30874846|NCT02021812|58905733|FG000|Overall Study|Refuse to return, COVD 19|2|||
30874847|NCT02021656|58905737|FG000|Overall Study|Adverse Event|1|||
30874848|NCT02021656|58905737|FG000|Overall Study|Lack of Efficacy|2|||
30874849|NCT02021656|58905737|FG000|Overall Study|Lost to Follow-up|1|||
30874850|NCT02021656|58905737|FG000|Overall Study|Withdrew Consent|2|||
30874851|NCT02076022|58905747|FG000|Overall Study|Withdrawal by Subject|2|||
30874852|NCT02076022|58905748|FG001|Overall Study|Withdrawal by Subject|0|||
30874853|NCT02075632|58905756|FG000|Overall Study|Adverse Event|1|||
30874854|NCT02075632|58905757|FG001|Overall Study|Adverse Event|1|||
30874855|NCT02075632|58905756|FG000|Overall Study|Lost to Follow-up|0|||
30874856|NCT02075632|58905757|FG001|Overall Study|Lost to Follow-up|3|||
30874857|NCT02075632|58905756|FG000|Overall Study|Withdrawal by Subject|0|||
30874858|NCT02075632|58905757|FG001|Overall Study|Withdrawal by Subject|1|||
30874859|NCT02075554|58905763|FG000|Overall Study|Lost to Follow-up|7|||
30874860|NCT02075554|58905763|FG000|Overall Study|Withdrawal by Subject|5|||
30874861|NCT02075554|58905763|FG000|Overall Study|Physician Decision|3|||
30874862|NCT02075476|58905769|FG000|Overall Study|Death|2|||
30874863|NCT02075476|58905770|FG001|Overall Study|Death|2|||
30874864|NCT02075476|58905769|FG000|Overall Study|Lost to Follow-up|1|||
30874865|NCT02075476|58905770|FG001|Overall Study|Lost to Follow-up|3|||
30874866|NCT02075320|58905776|FG000|Overall Study|Withdrawal by Subject|2|||
30874867|NCT02708095|58905783|FG000|Overall Study|Adverse Event|4|||
30874868|NCT02708095|58905784|FG001|Overall Study|Adverse Event|10|||
30874869|NCT02708095|58905785|FG002|Overall Study|Adverse Event|11|||
30874870|NCT02708095|58905783|FG000|Overall Study|Lack of Efficacy|9|||
30874871|NCT02708095|58905784|FG001|Overall Study|Lack of Efficacy|3|||
30874872|NCT02708095|58905785|FG002|Overall Study|Lack of Efficacy|0|||
30874873|NCT02708095|58905783|FG000|Overall Study|Lost to Follow-up|2|||
30874874|NCT02708095|58905784|FG001|Overall Study|Lost to Follow-up|0|||
30874875|NCT02708095|58905785|FG002|Overall Study|Lost to Follow-up|0|||
30874876|NCT02708095|58905783|FG000|Overall Study|Physician Decision|2|||
30874877|NCT02708095|58905784|FG001|Overall Study|Physician Decision|3|||
30874878|NCT02708095|58905785|FG002|Overall Study|Physician Decision|2|||
30874879|NCT02708095|58905783|FG000|Overall Study|Protocol Violation|0|||
30874880|NCT02708095|58905784|FG001|Overall Study|Protocol Violation|0|||
30874881|NCT02708095|58905785|FG002|Overall Study|Protocol Violation|1|||
30874882|NCT02708095|58905783|FG000|Overall Study|Withdrawal by Subject|5|||
30874883|NCT02708095|58905784|FG001|Overall Study|Withdrawal by Subject|3|||
30874884|NCT02708095|58905785|FG002|Overall Study|Withdrawal by Subject|4|||
30874885|NCT02707861|58905797|FG000|Overall Study|Went onto commercial drug|30|||
30874886|NCT02707861|58905798|FG001|Overall Study|Went onto commercial drug|23|||
30874887|NCT02707861|58905797|FG000|Overall Study|Adverse Event|2|||
30874888|NCT02707861|58905798|FG001|Overall Study|Adverse Event|3|||
30874889|NCT02707861|58905797|FG000|Overall Study|Death|5|||
30874890|NCT02707861|58905798|FG001|Overall Study|Death|2|||
30874891|NCT02707861|58905797|FG000|Overall Study|Lack of Efficacy|0|||
30874892|NCT02707861|58905798|FG001|Overall Study|Lack of Efficacy|2|||
30874893|NCT02707861|58905797|FG000|Overall Study|Physician Decision|1|||
30874894|NCT02707861|58905798|FG001|Overall Study|Physician Decision|4|||
30874895|NCT02707861|58905797|FG000|Overall Study|Withdrawal by Subject|2|||
30874896|NCT02707861|58905798|FG001|Overall Study|Withdrawal by Subject|1|||
30874897|NCT02707861|58905797|FG000|Overall Study|Lost to Follow-up|1|||
30874898|NCT02707861|58905798|FG001|Overall Study|Lost to Follow-up|3|||
30874899|NCT02027428|58905806|FG000|Induction|Never treated|7|||
30874900|NCT02027428|58905807|FG001|Induction|Never treated|0|||
30874901|NCT02027428|58905808|FG002|Induction|Never treated|0|||
30874902|NCT02027428|58905806|FG000|Induction|Progressive disease|77|||
30874903|NCT02027428|58905807|FG001|Induction|Progressive disease|0|||
30874904|NCT02027428|58905808|FG002|Induction|Progressive disease|0|||
30874905|NCT02027428|58905806|FG000|Induction|Adverse Event|51|||
30874906|NCT02027428|58905807|FG001|Induction|Adverse Event|0|||
30874907|NCT02027428|58905808|FG002|Induction|Adverse Event|0|||
30874908|NCT02027428|58905806|FG000|Induction|Withdrawal by Subject|22|||
30874909|NCT02027428|58905807|FG001|Induction|Withdrawal by Subject|0|||
30874910|NCT02027428|58905808|FG002|Induction|Withdrawal by Subject|0|||
30874911|NCT02027428|58905806|FG000|Induction|Death|21|||
30874912|NCT02027428|58905807|FG001|Induction|Death|0|||
30874913|NCT02027428|58905808|FG002|Induction|Death|0|||
30874914|NCT02027428|58905806|FG000|Induction|Symptomatic deterioration|16|||
30874915|NCT02027428|58905807|FG001|Induction|Symptomatic deterioration|0|||
30874916|NCT02027428|58905808|FG002|Induction|Symptomatic deterioration|0|||
30874917|NCT02027428|58905806|FG000|Induction|Study terminated by sponsor|12|||
30874918|NCT02027428|58905807|FG001|Induction|Study terminated by sponsor|0|||
30874919|NCT02027428|58905808|FG002|Induction|Study terminated by sponsor|0|||
30874920|NCT02027428|58905806|FG000|Induction|Protocol Violation|1|||
30874921|NCT02027428|58905807|FG001|Induction|Protocol Violation|0|||
30874922|NCT02027428|58905808|FG002|Induction|Protocol Violation|0|||
30874923|NCT02027428|58905806|FG000|Induction|Miscellaneous|14|||
30874924|NCT02027428|58905807|FG001|Induction|Miscellaneous|0|||
30874925|NCT02027428|58905808|FG002|Induction|Miscellaneous|0|||
30874926|NCT02027428|58905806|FG000|Induction|Induction Treatment Ongoing|4|||
30874927|NCT02027428|58905807|FG001|Induction|Induction Treatment Ongoing|0|||
30874928|NCT02027428|58905808|FG002|Induction|Induction Treatment Ongoing|0|||
30874929|NCT02027428|58905806|FG000|Maintenance|Death|0|||
30874930|NCT02027428|58905807|FG001|Maintenance|Death|3|||
30874931|NCT02027428|58905808|FG002|Maintenance|Death|2|||
30874932|NCT02027428|58905806|FG000|Maintenance|Adverse Event|0|||
30874933|NCT02027428|58905807|FG001|Maintenance|Adverse Event|21|||
30874934|NCT02027428|58905808|FG002|Maintenance|Adverse Event|1|||
30874935|NCT02027428|58905806|FG000|Maintenance|Progressive disease|0|||
30874936|NCT02027428|58905807|FG001|Maintenance|Progressive disease|84|||
30874937|NCT02027428|58905808|FG002|Maintenance|Progressive disease|47|||
30874938|NCT02027428|58905806|FG000|Maintenance|Symptomatic deterioration|0|||
30874939|NCT02027428|58905807|FG001|Maintenance|Symptomatic deterioration|4|||
30874940|NCT02027428|58905808|FG002|Maintenance|Symptomatic deterioration|1|||
30874941|NCT02027428|58905806|FG000|Maintenance|Withdrawal by Subject|0|||
30874942|NCT02027428|58905807|FG001|Maintenance|Withdrawal by Subject|6|||
30874943|NCT02027428|58905808|FG002|Maintenance|Withdrawal by Subject|5|||
30874944|NCT02027428|58905806|FG000|Maintenance|Protocol Violation|0|||
30874945|NCT02027428|58905807|FG001|Maintenance|Protocol Violation|0|||
30874946|NCT02027428|58905808|FG002|Maintenance|Protocol Violation|1|||
30874947|NCT02027428|58905806|FG000|Maintenance|Other|0|||
30874948|NCT02027428|58905807|FG001|Maintenance|Other|6|||
30874949|NCT02027428|58905808|FG002|Maintenance|Other|3|||
30874950|NCT02027428|58905806|FG000|Survival Follow-up|Death|0|||
30874951|NCT02027428|58905807|FG001|Survival Follow-up|Death|78|||
30874952|NCT02027428|58905808|FG002|Survival Follow-up|Death|45|||
30874953|NCT02027428|58905806|FG000|Survival Follow-up|Lost to Follow-up|0|||
30874954|NCT02027428|58905807|FG001|Survival Follow-up|Lost to Follow-up|1|||
30874955|NCT02027428|58905808|FG002|Survival Follow-up|Lost to Follow-up|1|||
30874956|NCT01995136|58905831|FG000|Overall Study|Change in residence|1|||
30874957|NCT01994902|58905835|FG000|Test Period 1|Withdrawal by Subject|3|||
30874958|NCT01994902|58905836|FG001|Test Period 1|Withdrawal by Subject|0|||
30874959|NCT01994902|58905835|FG000|Test Period 1|device deficiency with adverse event|0|||
30874960|NCT01994902|58905836|FG001|Test Period 1|device deficiency with adverse event|1|||
30874961|NCT01994902|58905835|FG000|Test Period 1|Adverse Event|2|||
30874962|NCT01994902|58905836|FG001|Test Period 1|Adverse Event|1|||
30874963|NCT01994902|58905835|FG000|Test Period 1|Lack of Efficacy|0|||
30874964|NCT01994902|58905836|FG001|Test Period 1|Lack of Efficacy|1|||
30874965|NCT01994902|58905835|FG000|Test Period 1|bag too small|1|||
30874966|NCT01994902|58905836|FG001|Test Period 1|bag too small|0|||
30874967|NCT01994902|58905835|FG000|Test Period 2|Withdrawal by Subject|0|||
30874968|NCT01994902|58905836|FG001|Test Period 2|Withdrawal by Subject|2|||
30874969|NCT01994902|58905835|FG000|Test Period 2|Lack of Efficacy|0|||
30874970|NCT01994902|58905836|FG001|Test Period 2|Lack of Efficacy|1|||
30874971|NCT01994902|58905835|FG000|Test Period 2|Other|0|||
30874972|NCT01994902|58905836|FG001|Test Period 2|Other|3|||
30874973|NCT02026258|58905844|FG000|Randomized|Did not start treatment|2|||
30874974|NCT02026258|58905845|FG001|Randomized|Did not start treatment|1|||
30874975|NCT02026258|58905844|FG000|Randomized|Change in treatment plan|1|||
30874976|NCT02026258|58905845|FG001|Randomized|Change in treatment plan|0|||
30874977|NCT02026258|58905844|FG000|Randomized|Presence of periodontal disease|1|||
30874978|NCT02026258|58905845|FG001|Randomized|Presence of periodontal disease|1|||
30874979|NCT02026258|58905844|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
30874980|NCT02026258|58905845|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
30874981|NCT02026258|58905844|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
30874982|NCT02026258|58905845|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
30874983|NCT01994590|58905852|FG000|Overall Study|Adverse Event|1|||
30874984|NCT01994590|58905852|FG000|Overall Study|Trial Terminated|1|||
30874985|NCT02019550|58905858|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
30874986|NCT02019550|58905859|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
30874987|NCT02019472|58905870|FG000|Overall Study|Adverse Event|14|||
30874988|NCT02019472|58905871|FG001|Overall Study|Adverse Event|23|||
30874989|NCT02019472|58905872|FG002|Overall Study|Adverse Event|17|||
30874990|NCT02019472|58905870|FG000|Overall Study|Death|0|||
30874991|NCT02019472|58905871|FG001|Overall Study|Death|1|||
30874992|NCT02019472|58905872|FG002|Overall Study|Death|1|||
30874993|NCT02019472|58905870|FG000|Overall Study|Lack of Efficacy|7|||
30874994|NCT02019472|58905871|FG001|Overall Study|Lack of Efficacy|4|||
30874995|NCT02019472|58905872|FG002|Overall Study|Lack of Efficacy|4|||
30874996|NCT02019472|58905870|FG000|Overall Study|Lost to Follow-up|0|||
30874997|NCT02019472|58905871|FG001|Overall Study|Lost to Follow-up|2|||
30874998|NCT02019472|58905872|FG002|Overall Study|Lost to Follow-up|1|||
30874999|NCT02019472|58905870|FG000|Overall Study|Physician Decision|1|||
30875000|NCT02019472|58905871|FG001|Overall Study|Physician Decision|2|||
30875001|NCT02019472|58905872|FG002|Overall Study|Physician Decision|0|||
30875002|NCT02019472|58905870|FG000|Overall Study|Pregnancy|1|||
30875003|NCT02019472|58905871|FG001|Overall Study|Pregnancy|2|||
30875004|NCT02019472|58905872|FG002|Overall Study|Pregnancy|2|||
30875005|NCT02019472|58905870|FG000|Overall Study|Withdrawal by Subject|11|||
30875006|NCT02019472|58905871|FG001|Overall Study|Withdrawal by Subject|10|||
30875007|NCT02019472|58905872|FG002|Overall Study|Withdrawal by Subject|11|||
30875008|NCT02019472|58905870|FG000|Overall Study|Other|3|||
30875009|NCT02019472|58905871|FG001|Overall Study|Other|8|||
30875010|NCT02019472|58905872|FG002|Overall Study|Other|6|||
30875011|NCT02705755|58905884|FG000|Part A (6 Days)|Adverse Event|1|||
30875012|NCT02705755|58905885|FG001|Part A (6 Days)|Adverse Event|0|||
30875013|NCT02705755|58905886|FG002|Part A (6 Days)|Adverse Event|0|||
30875014|NCT02705755|58905887|FG003|Part A (6 Days)|Adverse Event|0|||
30875015|NCT02705755|58905884|FG000|Part A (6 Days)|Physician Decision|3|||
30875016|NCT02705755|58905885|FG001|Part A (6 Days)|Physician Decision|0|||
30875017|NCT02705755|58905886|FG002|Part A (6 Days)|Physician Decision|0|||
30875018|NCT02705755|58905887|FG003|Part A (6 Days)|Physician Decision|0|||
30875019|NCT02705755|58905884|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
30875020|NCT02705755|58905885|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
30875021|NCT02705755|58905886|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
30875022|NCT02705755|58905887|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
30875023|NCT02705755|58905884|FG000|Part C (20 Weeks)|Physician Decision|0|||
30875024|NCT02705755|58905885|FG001|Part C (20 Weeks)|Physician Decision|0|||
30875025|NCT02705755|58905886|FG002|Part C (20 Weeks)|Physician Decision|0|||
30875026|NCT02705755|58905887|FG003|Part C (20 Weeks)|Physician Decision|2|||
30875027|NCT02705755|58905884|FG000|Part C (20 Weeks)|Adverse Event|0|||
30875028|NCT02705755|58905885|FG001|Part C (20 Weeks)|Adverse Event|0|||
30875029|NCT02705755|58905886|FG002|Part C (20 Weeks)|Adverse Event|0|||
30875030|NCT02705755|58905887|FG003|Part C (20 Weeks)|Adverse Event|6|||
30875031|NCT02705755|58905884|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
30875032|NCT02705755|58905885|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
30875033|NCT02705755|58905886|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
30875034|NCT02705755|58905887|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
30875035|NCT02024932|58905920|FG000|Overall Study|Adverse Event|2|||
30875036|NCT02024932|58905921|FG001|Overall Study|Adverse Event|3|||
30875037|NCT02024932|58905922|FG002|Overall Study|Adverse Event|0|||
30875038|NCT02024932|58905923|FG003|Overall Study|Adverse Event|0|||
30875039|NCT02024932|58905924|FG004|Overall Study|Adverse Event|2|||
30875040|NCT02024932|58905925|FG005|Overall Study|Adverse Event|0|||
30875041|NCT02024932|58905920|FG000|Overall Study|Abnormal laboratory value|0|||
30875042|NCT02024932|58905921|FG001|Overall Study|Abnormal laboratory value|0|||
30875043|NCT02024932|58905922|FG002|Overall Study|Abnormal laboratory value|0|||
30875044|NCT02024932|58905923|FG003|Overall Study|Abnormal laboratory value|2|||
30875045|NCT02024932|58905924|FG004|Overall Study|Abnormal laboratory value|0|||
30875046|NCT02024932|58905925|FG005|Overall Study|Abnormal laboratory value|0|||
30875047|NCT01993888|58905956|FG000|Overall Study|Death|1|||
30875048|NCT01993888|58905957|FG001|Overall Study|Death|1|||
30875049|NCT01993888|58905956|FG000|Overall Study|Lost to Follow-up|1|||
30875050|NCT01993888|58905957|FG001|Overall Study|Lost to Follow-up|1|||
30875051|NCT01993888|58905956|FG000|Overall Study|Withdrawal by Subject|0|||
30875052|NCT01993888|58905957|FG001|Overall Study|Withdrawal by Subject|1|||
30875053|NCT02024698|58905963|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
30875054|NCT02024698|58905964|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
30875055|NCT02018458|58905970|FG000|Overall Study|Death|4|||
30875056|NCT02017522|58905974|FG000|Overall Study|Withdrawal by Subject|1|||
30875057|NCT02017444|58905981|FG000|Overall Study|Physician Decision|1|||
30875058|NCT02017444|58905982|FG001|Overall Study|Physician Decision|0|||
30875059|NCT02017444|58905981|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
30875060|NCT02017444|58905982|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
30875061|NCT01993186|58905990|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
30875062|NCT01993186|58905991|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
30875063|NCT01993186|58905990|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
30875064|NCT01993186|58905991|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
30875065|NCT01993186|58905990|FG000|Open-Label Extension Period|Other, Not Specified|0|||
30875066|NCT01993186|58905991|FG001|Open-Label Extension Period|Other, Not Specified|1|||
30875067|NCT01993186|58905990|FG000|Open-Label Extension Period|Adverse Event|1|||
30875068|NCT01993186|58905991|FG001|Open-Label Extension Period|Adverse Event|0|||
30875069|NCT01993186|58905990|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
30875070|NCT01993186|58905991|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
30875071|NCT01993186|58905990|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
30875072|NCT01993186|58905991|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
30875073|NCT01993186|58905990|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
30875074|NCT01993186|58905991|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
30875075|NCT02016898|58906000|FG000|Overall Study|Death|1|||
30875076|NCT02016898|58906001|FG001|Overall Study|Death|1|||
30875077|NCT02016898|58906000|FG000|Overall Study|Lost to Follow-up|4|||
30875078|NCT02016898|58906001|FG001|Overall Study|Lost to Follow-up|4|||
30875079|NCT01993030|58906009|FG000|Overall Study|Adverse Event|0|||
30875080|NCT01993030|58906010|FG001|Overall Study|Adverse Event|4|||
30875081|NCT01992094|58906019|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
30875082|NCT01992094|58906020|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
30875083|NCT01992094|58906021|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
30875084|NCT01992094|58906019|FG000|Overall Study|Adverse Event|1|||
30875085|NCT01992094|58906020|FG001|Overall Study|Adverse Event|0|||
30875086|NCT01992094|58906021|FG002|Overall Study|Adverse Event|0|||
30875087|NCT01992094|58906019|FG000|Overall Study|Death|5|||
30875088|NCT01992094|58906020|FG001|Overall Study|Death|5|||
30875089|NCT01992094|58906021|FG002|Overall Study|Death|2|||
30875090|NCT01992094|58906019|FG000|Overall Study|Lost to Follow-up|26|||
30875091|NCT01992094|58906020|FG001|Overall Study|Lost to Follow-up|9|||
30875092|NCT01992094|58906021|FG002|Overall Study|Lost to Follow-up|13|||
30875093|NCT01992094|58906019|FG000|Overall Study|OTHER|4|||
30875094|NCT01992094|58906020|FG001|Overall Study|OTHER|0|||
30875095|NCT01992094|58906021|FG002|Overall Study|OTHER|0|||
30875096|NCT01992094|58906019|FG000|Overall Study|Protocol Violation|1|||
30875097|NCT01992094|58906020|FG001|Overall Study|Protocol Violation|0|||
30875098|NCT01992094|58906021|FG002|Overall Study|Protocol Violation|1|||
30875099|NCT01992094|58906019|FG000|Overall Study|Withdrawal by Subject|7|||
30875100|NCT01992094|58906020|FG001|Overall Study|Withdrawal by Subject|3|||
30875101|NCT01992094|58906021|FG002|Overall Study|Withdrawal by Subject|4|||
30875102|NCT02706691|58906045|FG000|Overall Study|Adverse Event|1|||
30875103|NCT01991470|58906050|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
30875104|NCT01991470|58906050|FG000|Enlite 1 Period|Adverse Event|1|||
30875105|NCT01991470|58906050|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
30875106|NCT01991470|58906050|FG000|Enlite 3 Period|Lost to Follow-up|1|||
30875107|NCT01991470|58906050|FG000|Enlite 3 Period|Physician Decision|2|||
30875108|NCT01991470|58906050|FG000|Enlite 3 Period|Physician Decision|8|||
30875109|NCT01991470|58906050|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
30875110|NCT01991314|58906064|FG000|Overall Study|Adverse Event|5|||
30875111|NCT01991314|58906065|FG001|Overall Study|Adverse Event|1|||
30875112|NCT01991314|58906064|FG000|Overall Study|Lost to Follow-up|6|||
30875113|NCT01991314|58906065|FG001|Overall Study|Lost to Follow-up|10|||
30875114|NCT01990768|58906074|FG000|Intervention Started|Found to be ineligible|14|||
30875115|NCT01990768|58906075|FG001|Intervention Started|Found to be ineligible|13|||
30875116|NCT01990768|58906076|FG002|Intervention Started|Found to be ineligible|11|||
30875117|NCT01990768|58906074|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
30875118|NCT01990768|58906075|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
30875119|NCT01990768|58906076|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
30875120|NCT01990768|58906074|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
30875121|NCT01990768|58906075|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
30875122|NCT01990768|58906076|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
30875123|NCT01990768|58906074|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
30875124|NCT01990768|58906075|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
30875125|NCT01990768|58906076|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
30875126|NCT01990768|58906074|FG000|Intervention Started|Patient care priority|1|||
30875127|NCT01990768|58906075|FG001|Intervention Started|Patient care priority|2|||
30875128|NCT01990768|58906076|FG002|Intervention Started|Patient care priority|3|||
30875129|NCT01990768|58906074|FG000|Intervention Started|IV lost|2|||
30875130|NCT01990768|58906075|FG001|Intervention Started|IV lost|2|||
30875131|NCT01990768|58906076|FG002|Intervention Started|IV lost|2|||
30875132|NCT01990768|58906074|FG000|Intervention Started|Required CPR|1|||
30875133|NCT01990768|58906075|FG001|Intervention Started|Required CPR|1|||
30875134|NCT01990768|58906076|FG002|Intervention Started|Required CPR|0|||
30875135|NCT01990768|58906074|FG000|Intervention Started|Seizure or hx of seizure|0|||
30875136|NCT01990768|58906075|FG001|Intervention Started|Seizure or hx of seizure|0|||
30875137|NCT01990768|58906076|FG002|Intervention Started|Seizure or hx of seizure|2|||
30875138|NCT01990768|58906074|FG000|Intervention Started|Discovered to be pregnant|0|||
30875139|NCT01990768|58906075|FG001|Intervention Started|Discovered to be pregnant|1|||
30875140|NCT01990768|58906076|FG002|Intervention Started|Discovered to be pregnant|0|||
30875141|NCT01990768|58906074|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
30875142|NCT01990768|58906075|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
30875143|NCT01990768|58906076|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
30875144|NCT01990768|58906074|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
30875145|NCT01990768|58906075|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
30875146|NCT01990768|58906076|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
30875147|NCT01990768|58906074|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
30875148|NCT01990768|58906075|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
30875149|NCT01990768|58906076|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
30875150|NCT01990768|58906074|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
30875151|NCT01990768|58906075|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
30875152|NCT01990768|58906076|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
30875153|NCT01990768|58906074|FG000|Prehospital Study Drug Infusion|Death|3|||
30875154|NCT01990768|58906075|FG001|Prehospital Study Drug Infusion|Death|1|||
30875155|NCT01990768|58906076|FG002|Prehospital Study Drug Infusion|Death|1|||
30875156|NCT01990768|58906074|FG000|Prehospital Study Drug Infusion|Discharged|2|||
30875157|NCT01990768|58906075|FG001|Prehospital Study Drug Infusion|Discharged|1|||
30875158|NCT01990768|58906076|FG002|Prehospital Study Drug Infusion|Discharged|0|||
30875159|NCT01990768|58906074|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
30875160|NCT01990768|58906075|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
30875161|NCT01990768|58906076|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
30875162|NCT01990768|58906074|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
30875163|NCT01990768|58906075|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
30875164|NCT01990768|58906076|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
30875165|NCT01990768|58906074|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
30875166|NCT01990768|58906075|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
30875167|NCT01990768|58906076|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
30875168|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
30875169|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
30875170|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
30875171|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
30875172|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
30875173|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
30875174|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
30875175|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
30875176|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
30875177|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
30875178|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
30875179|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
30875180|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
30875181|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
30875182|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
30875183|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
30875184|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
30875185|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
30875186|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
30875187|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
30875188|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
30875189|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
30875190|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
30875191|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
30875192|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
30875193|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
30875194|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
30875195|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
30875196|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
30875197|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
30875198|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
30875199|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
30875200|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
30875201|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
30875202|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
30875203|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
30875204|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
30875205|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
30875206|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
30875207|NCT01990768|58906074|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
30875208|NCT01990768|58906075|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
30875209|NCT01990768|58906076|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
30875210|NCT01990768|58906074|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
30875211|NCT01990768|58906075|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
30875212|NCT01990768|58906076|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
30875213|NCT01990768|58906074|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
30875214|NCT01990768|58906075|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
30875215|NCT01990768|58906076|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
30875216|NCT01990768|58906074|FG000|6-Month Follow-up|No contact information|5|||
30875217|NCT01990768|58906075|FG001|6-Month Follow-up|No contact information|6|||
30875218|NCT01990768|58906076|FG002|6-Month Follow-up|No contact information|5|||
30875219|NCT01990768|58906074|FG000|6-Month Follow-up|Homeless|4|||
30875220|NCT01990768|58906075|FG001|6-Month Follow-up|Homeless|3|||
30875221|NCT01990768|58906076|FG002|6-Month Follow-up|Homeless|6|||
30875222|NCT01990768|58906074|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
30875223|NCT01990768|58906075|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
30875224|NCT01990768|58906076|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
30875225|NCT01990768|58906074|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
30875226|NCT01990768|58906075|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
30875227|NCT01990768|58906076|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
30875228|NCT01990768|58906074|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
30875229|NCT01990768|58906075|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
30962580|NCT01546519|59030143|FG003|Overall Study|Death|1|||
30962581|NCT01546519|59030140|FG000|Overall Study|related to disease progression|2|||
30962582|NCT01546519|59030141|FG001|Overall Study|related to disease progression|2|||
30962583|NCT01546519|59030142|FG002|Overall Study|related to disease progression|2|||
30962584|NCT01546519|59030143|FG003|Overall Study|related to disease progression|1|||
30962585|NCT01546519|59030140|FG000|Overall Study|Physician Decision|6|||
30962586|NCT01546519|59030141|FG001|Overall Study|Physician Decision|5|||
30962587|NCT01546519|59030142|FG002|Overall Study|Physician Decision|2|||
30604826|NCT01225731|58615779|FG008|Part 1|Did not meet eligibility criteria|0|||
30604827|NCT01225731|58615780|FG009|Part 1|Did not meet eligibility criteria|0|||
30604828|NCT01225731|58615781|FG010|Part 1|Did not meet eligibility criteria|0|||
30604829|NCT01225731|58615782|FG011|Part 1|Did not meet eligibility criteria|0|||
30604830|NCT01225731|58615783|FG012|Part 1|Did not meet eligibility criteria|0|||
30604831|NCT01225731|58615771|FG000|Part 1|Adverse Event|1|||
30604832|NCT01225731|58615772|FG001|Part 1|Adverse Event|2|||
30604833|NCT01225731|58615773|FG002|Part 1|Adverse Event|1|||
30604834|NCT01225731|58615774|FG003|Part 1|Adverse Event|1|||
30604835|NCT01225731|58615775|FG004|Part 1|Adverse Event|1|||
30604836|NCT01225731|58615776|FG005|Part 1|Adverse Event|0|||
30604837|NCT01225731|58615777|FG006|Part 1|Adverse Event|0|||
30604838|NCT01225731|58615778|FG007|Part 1|Adverse Event|0|||
30604839|NCT01225731|58615779|FG008|Part 1|Adverse Event|0|||
30604840|NCT01225731|58615780|FG009|Part 1|Adverse Event|0|||
30875230|NCT01990768|58906076|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
30875231|NCT01990612|58906087|FG000|Overall Study|Lost to Follow-up|2|||
30875232|NCT01990612|58906088|FG001|Overall Study|Lost to Follow-up|1|||
30875233|NCT01990612|58906087|FG000|Overall Study|Withdrawal by Subject|5|||
30875234|NCT01990612|58906088|FG001|Overall Study|Withdrawal by Subject|2|||
30875235|NCT01990534|58906094|FG000|Overall Study|Death|22|||
30875236|NCT01990534|58906094|FG000|Overall Study|Progressive disease|3|||
30875237|NCT01990534|58906094|FG000|Overall Study|Protocol Violation|1|||
30875238|NCT01990534|58906094|FG000|Overall Study|Withdrawal of Informed Consent|2|||
30875239|NCT01990534|58906094|FG000|Overall Study|Symptomatic Deterioration|1|||
30875240|NCT01990534|58906094|FG000|Overall Study|Withdrawal by Subject|3|||
30604841|NCT01225731|58615781|FG010|Part 1|Adverse Event|0|||
30604842|NCT01225731|58615782|FG011|Part 1|Adverse Event|0|||
30604843|NCT01225731|58615783|FG012|Part 1|Adverse Event|0|||
30962588|NCT01546519|59030143|FG003|Overall Study|Physician Decision|3|||
30962589|NCT01546519|59030140|FG000|Overall Study|Withdrawal by Subject|1|||
30962590|NCT01546519|59030141|FG001|Overall Study|Withdrawal by Subject|0|||
30962591|NCT01546519|59030142|FG002|Overall Study|Withdrawal by Subject|0|||
30962592|NCT01546519|59030143|FG003|Overall Study|Withdrawal by Subject|0|||
30962593|NCT01484951|59030157|FG000|Overall Study|Adverse Event|3|||
30875241|NCT01990534|58906094|FG000|Overall Study|Reason not Specified|2|||
30875242|NCT01990534|58906094|FG000|Overall Study|Lost to Follow-up|1|||
30875243|NCT01967134|58906101|FG000|Overall Study|Lost to Follow-up|0|||
30875244|NCT01967134|58906102|FG001|Overall Study|Lost to Follow-up|1|||
30875245|NCT01967134|58906103|FG002|Overall Study|Lost to Follow-up|0|||
30875246|NCT01990300|58906111|FG000|Overall Study|Case Report Forms Uncollected|89|||
30875247|NCT01990300|58906111|FG000|Overall Study|Protocol Deviation|53|||
30875248|NCT01966432|58906118|FG000|Overall Study|Lost to Follow-up|3|||
30875249|NCT01966432|58906119|FG001|Overall Study|Lost to Follow-up|2|||
30875250|NCT01966432|58906120|FG002|Overall Study|Lost to Follow-up|5|||
30875251|NCT01966432|58906118|FG000|Overall Study|Withdrawal by Subject|1|||
30875252|NCT01966432|58906119|FG001|Overall Study|Withdrawal by Subject|3|||
30875253|NCT01966432|58906120|FG002|Overall Study|Withdrawal by Subject|0|||
30875254|NCT01966432|58906118|FG000|Overall Study|Subject Incarcerated|0|||
30875255|NCT01966432|58906119|FG001|Overall Study|Subject Incarcerated|0|||
30875256|NCT01966432|58906120|FG002|Overall Study|Subject Incarcerated|1|||
30875257|NCT01966432|58906118|FG000|Overall Study|SBIRT program ended|1|||
30875258|NCT01966432|58906119|FG001|Overall Study|SBIRT program ended|8|||
30875259|NCT01966432|58906120|FG002|Overall Study|SBIRT program ended|20|||
30875260|NCT02702401|58906132|FG000|Overall Study|Death|242|||
30875261|NCT02702401|58906133|FG001|Overall Study|Death|125|||
30875262|NCT02702401|58906132|FG000|Overall Study|Withdrawal by Subject|15|||
30875263|NCT02702401|58906133|FG001|Overall Study|Withdrawal by Subject|5|||
30875264|NCT02702401|58906132|FG000|Overall Study|Sponsor Decision|19|||
30962594|NCT01484951|59030157|FG000|Overall Study|Personal Reasons|1|||
30962595|NCT01484951|59030157|FG000|Overall Study|Non-Compliance|1|||
30962596|NCT01484873|59030161|FG000|Overall Study|Withdrawal by Subject|2|||
30962597|NCT01486927|59030166|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
30962598|NCT01486927|59030166|FG000|Overall Study|Physician Decision|1|||
30962599|NCT01486927|59030166|FG000|Overall Study|50 Exposure days not reached|2|||
30962600|NCT01486927|59030166|FG000|Overall Study|Withdrawal by Subject|8|||
30962601|NCT01486927|59030166|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
30962602|NCT01513759|59030199|FG000|Overall Study|Protocol Violation|4|||
30962603|NCT01513759|59030199|FG000|Overall Study|Death during catheter placement|1|||
30962604|NCT01484561|59030205|FG000|Overall Study|Lack of Efficacy|3|||
30962605|NCT01484561|59030206|FG001|Overall Study|Lack of Efficacy|1|||
30962606|NCT01484561|59030205|FG000|Overall Study|Lost to Follow-up|1|||
30962607|NCT01484561|59030206|FG001|Overall Study|Lost to Follow-up|0|||
30962608|NCT01484561|59030205|FG000|Overall Study|Withdrawal by Subject|3|||
30962609|NCT01484561|59030206|FG001|Overall Study|Withdrawal by Subject|0|||
30962610|NCT01484561|59030205|FG000|Overall Study|Other|1|||
30962611|NCT01484561|59030206|FG001|Overall Study|Other|1|||
30962612|NCT01484561|59030205|FG000|Overall Study|Adverse Event|1|||
30962613|NCT01484561|59030206|FG001|Overall Study|Adverse Event|4|||
30962614|NCT01546207|59030212|FG000|Overall Study|Death|1|||
30962615|NCT01513291|59030218|FG000|Treatment Period|Adverse Event|8|||
30962616|NCT01513291|59030219|FG001|Treatment Period|Adverse Event|4|||
30962617|NCT01513291|59030220|FG002|Treatment Period|Adverse Event|0|||
30962618|NCT01513291|59030221|FG003|Treatment Period|Adverse Event|0|||
30962619|NCT01513291|59030222|FG004|Treatment Period|Adverse Event|0|||
30962620|NCT01513291|59030218|FG000|Treatment Period|Lack of Efficacy|3|||
30962621|NCT01513291|59030219|FG001|Treatment Period|Lack of Efficacy|0|||
30962622|NCT01513291|59030220|FG002|Treatment Period|Lack of Efficacy|0|||
30962623|NCT01513291|59030221|FG003|Treatment Period|Lack of Efficacy|0|||
30962624|NCT01513291|59030222|FG004|Treatment Period|Lack of Efficacy|0|||
30962625|NCT01513291|59030218|FG000|Treatment Period|Lost to Follow-up|2|||
30962626|NCT01513291|59030219|FG001|Treatment Period|Lost to Follow-up|3|||
30962627|NCT01513291|59030220|FG002|Treatment Period|Lost to Follow-up|0|||
30962628|NCT01513291|59030221|FG003|Treatment Period|Lost to Follow-up|0|||
30962629|NCT01513291|59030222|FG004|Treatment Period|Lost to Follow-up|0|||
30875265|NCT02702401|58906133|FG001|Overall Study|Sponsor Decision|3|||
30875266|NCT02702401|58906132|FG000|Overall Study|Physician Decision|1|||
30875267|NCT02702401|58906133|FG001|Overall Study|Physician Decision|2|||
30875268|NCT02702401|58906132|FG000|Overall Study|Lost to Follow-up|1|||
30875269|NCT02702401|58906133|FG001|Overall Study|Lost to Follow-up|0|||
30962630|NCT01513291|59030218|FG000|Treatment Period|Physician Decision|1|||
30962631|NCT01513291|59030219|FG001|Treatment Period|Physician Decision|0|||
30962632|NCT01513291|59030220|FG002|Treatment Period|Physician Decision|0|||
30962633|NCT01513291|59030221|FG003|Treatment Period|Physician Decision|0|||
30962634|NCT01513291|59030222|FG004|Treatment Period|Physician Decision|0|||
30962635|NCT01513291|59030218|FG000|Treatment Period|Protocol Violation|1|||
30962636|NCT01513291|59030219|FG001|Treatment Period|Protocol Violation|2|||
30875270|NCT02703337|58906140|FG000|Period One (Part A)|Withdrawal by Subject|0|||
30875271|NCT02703337|58906141|FG001|Period One (Part A)|Withdrawal by Subject|0|||
30875272|NCT02703337|58906142|FG002|Period One (Part A)|Withdrawal by Subject|0|||
30875273|NCT02703337|58906143|FG003|Period One (Part A)|Withdrawal by Subject|0|||
30875274|NCT02703337|58906144|FG004|Period One (Part A)|Withdrawal by Subject|1|||
30875275|NCT02703337|58906145|FG005|Period One (Part A)|Withdrawal by Subject|0|||
30875276|NCT02703337|58906146|FG006|Period One (Part A)|Withdrawal by Subject|0|||
30875277|NCT02703337|58906147|FG007|Period One (Part A)|Withdrawal by Subject|0|||
30875278|NCT01680497|58906165|FG000|Overall Study|Lost to Follow-up|2|||
30875279|NCT01680341|58906171|FG000|Overall Study|Adverse Event|3|||
30875280|NCT01680341|58906172|FG001|Overall Study|Adverse Event|2|||
30875281|NCT01680341|58906171|FG000|Overall Study|Unclassified|18|||
30875282|NCT01680341|58906172|FG001|Overall Study|Unclassified|15|||
30875283|NCT01679405|58906180|FG000|Overall Study|Death|2|||
30875284|NCT01679405|58906181|FG001|Overall Study|Death|5|||
30875285|NCT01603355|58906187|FG000|Overall Study|Lack of Efficacy|2|||
30875286|NCT02703259|58906193|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
30875287|NCT02703259|58906194|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
30875288|NCT02703259|58906193|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
30875289|NCT02703259|58906194|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
30875290|NCT02703259|58906193|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
30875291|NCT02703259|58906194|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
30875292|NCT00701701|58906202|FG000|Overall Study|Withdrawal by Subject|0|||
30875293|NCT00701701|58906203|FG001|Overall Study|Withdrawal by Subject|1|||
30875294|NCT00701701|58906202|FG000|Overall Study|Adverse Event|0|||
30875295|NCT00701701|58906203|FG001|Overall Study|Adverse Event|1|||
30875296|NCT01989754|58906212|FG000|Overall Study|Withdrawal by Subject|10|||
30875297|NCT01989754|58906213|FG001|Overall Study|Withdrawal by Subject|14|||
30875298|NCT01989754|58906212|FG000|Overall Study|Lost to Follow-up|28|||
30875299|NCT01989754|58906213|FG001|Overall Study|Lost to Follow-up|20|||
30875300|NCT01989754|58906212|FG000|Overall Study|Closed Site|1|||
30875301|NCT01989754|58906213|FG001|Overall Study|Closed Site|1|||
30875302|NCT01619878|58906219|FG000|6 Week Follow-up Phase|Adverse Event|1|||
30875303|NCT01619878|58906219|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
30875304|NCT01619878|58906219|FG000|Follow-up at 12 Months of Age|Death|2|||
30875305|NCT02015104|58906225|FG000|Overall Study|Withdrew consent after first dose drug|1|||
30875306|NCT02015104|58906226|FG001|Overall Study|Withdrew consent after first dose drug|0|||
30875307|NCT02015104|58906225|FG000|Overall Study|Withdrew consent prior to treatment|0|||
30875308|NCT02015104|58906226|FG001|Overall Study|Withdrew consent prior to treatment|1|||
30875309|NCT01619800|58906237|FG000|Overall Study|study terminated|2|||
30875310|NCT01619800|58906238|FG001|Overall Study|study terminated|0|||
30875311|NCT01989208|58906246|FG000|200 mg (7 Days)|Protocol Violation|0|||
30875312|NCT01989208|58906247|FG001|200 mg (7 Days)|Protocol Violation|1|||
30875313|NCT01619410|58906267|FG000|Overall Study|Lost to Follow-up|7|||
30875314|NCT01619410|58906268|FG001|Overall Study|Lost to Follow-up|4|||
30875315|NCT01966042|58906274|FG000|Overall Study|Death|2|||
30875316|NCT02014480|58906278|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
30875317|NCT02014480|58906279|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
30875318|NCT02014480|58906280|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
30875319|NCT02014480|58906281|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
30875320|NCT02014480|58906282|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
30875321|NCT02014480|58906283|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
30875322|NCT02014480|58906278|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30875323|NCT02014480|58906279|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
30875324|NCT02014480|58906280|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30875325|NCT02014480|58906281|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
30875326|NCT02014480|58906282|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
30875327|NCT02014480|58906283|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
30875328|NCT02014480|58906278|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
30875329|NCT02014480|58906279|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
30875330|NCT02014480|58906280|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
30875331|NCT02014480|58906281|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
30875332|NCT02014480|58906282|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
30875333|NCT02014480|58906283|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
30875334|NCT02014480|58906278|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
30875335|NCT02014480|58906279|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
30875336|NCT02014480|58906280|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
30875337|NCT02014480|58906281|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
30875338|NCT02014480|58906282|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
30875339|NCT02014480|58906283|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
30875340|NCT02014480|58906278|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
30875341|NCT02014480|58906279|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
30875342|NCT02014480|58906280|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
30875343|NCT02014480|58906281|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
30875344|NCT02014480|58906282|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
30875345|NCT02014480|58906283|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
30875346|NCT02014480|58906278|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
30875347|NCT02014480|58906279|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
30875348|NCT02014480|58906280|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
30875349|NCT02014480|58906281|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
30875350|NCT02014480|58906282|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
30875351|NCT02014480|58906283|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
30875352|NCT02014480|58906278|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30875353|NCT02014480|58906279|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30875354|NCT02014480|58906280|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30875355|NCT02014480|58906281|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30875356|NCT02014480|58906282|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
30875357|NCT02014480|58906283|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
30875358|NCT01261247|58906291|FG000|Overall Study|Ineligible|2|||
30875359|NCT01677767|58906295|FG000|Overall Study|Adverse Event|1|||
30875360|NCT01677767|58906295|FG000|Overall Study|Death|4|||
30875361|NCT01677767|58906295|FG000|Overall Study|Protocol Violation|4|||
30875362|NCT01677767|58906295|FG000|Overall Study|Withdrawal by Subject|10|||
30875363|NCT01677767|58906295|FG000|Overall Study|Non-compliance by the participants|3|||
30875364|NCT01603277|58906316|FG000|Overall Study|Adverse Event|1|||
30875365|NCT01603277|58906317|FG001|Overall Study|Adverse Event|2|||
30875366|NCT01603277|58906316|FG000|Overall Study|Physician Decision|0|||
30875367|NCT01603277|58906317|FG001|Overall Study|Physician Decision|1|||
30875368|NCT01603277|58906316|FG000|Overall Study|Protocol Violation|6|||
30875369|NCT01603277|58906317|FG001|Overall Study|Protocol Violation|10|||
30875370|NCT01603277|58906316|FG000|Overall Study|Withdrawal by Subject|5|||
30875371|NCT01603277|58906317|FG001|Overall Study|Withdrawal by Subject|4|||
30875372|NCT01603277|58906316|FG000|Overall Study|Non-Compliance|2|||
30875373|NCT01603277|58906317|FG001|Overall Study|Non-Compliance|1|||
30875374|NCT01678313|58906325|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
30875375|NCT01678313|58906326|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
30875376|NCT01678313|58906325|FG000|Completed the 3-month Therapy|Physician Decision|3|||
30875377|NCT01678313|58906326|FG001|Completed the 3-month Therapy|Physician Decision|4|||
30875378|NCT01678313|58906325|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
30875379|NCT01678313|58906326|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
30875380|NCT01678313|58906325|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
30875381|NCT01678313|58906326|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
30875382|NCT01603121|58906332|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
30875383|NCT01603121|58906333|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
30875384|NCT01603043|58906341|FG000|Overall Study|Study Futility|7|||
30875385|NCT01603043|58906342|FG001|Overall Study|Study Futility|3|||
30875386|NCT02014402|58906352|FG000|Overall Study|Adverse Event|1|||
30875387|NCT02014402|58906353|FG001|Overall Study|Adverse Event|0|||
30875388|NCT02014402|58906354|FG002|Overall Study|Adverse Event|0|||
30875389|NCT02014402|58906355|FG003|Overall Study|Adverse Event|0|||
30875390|NCT02014402|58906352|FG000|Overall Study|Withdrawal by Subject|1|||
30875391|NCT02014402|58906353|FG001|Overall Study|Withdrawal by Subject|2|||
30875392|NCT02014402|58906354|FG002|Overall Study|Withdrawal by Subject|2|||
30875393|NCT02014402|58906355|FG003|Overall Study|Withdrawal by Subject|1|||
30875394|NCT02014402|58906352|FG000|Overall Study|Subject did not have transportation|0|||
30875395|NCT02014402|58906353|FG001|Overall Study|Subject did not have transportation|1|||
30875396|NCT02014402|58906354|FG002|Overall Study|Subject did not have transportation|0|||
30875397|NCT02014402|58906355|FG003|Overall Study|Subject did not have transportation|0|||
30875398|NCT02014402|58906352|FG000|Overall Study|Lost to Follow-up|0|||
30875399|NCT02014402|58906353|FG001|Overall Study|Lost to Follow-up|0|||
30875400|NCT02014402|58906354|FG002|Overall Study|Lost to Follow-up|1|||
30875401|NCT02014402|58906355|FG003|Overall Study|Lost to Follow-up|2|||
30875402|NCT01988662|58906374|FG000|Overall Study|Subject/guardian decision|1|||
30875403|NCT01988662|58906375|FG001|Overall Study|Subject/guardian decision|1|||
30875404|NCT01988662|58906374|FG000|Overall Study|Adverse Event|3|||
30875405|NCT01988662|58906375|FG001|Overall Study|Adverse Event|1|||
30875406|NCT02839343|58906384|FG000|Overall Study|Withdrawal by Subject|3|||
30875407|NCT02839343|58906385|FG001|Overall Study|Withdrawal by Subject|1|||
30875408|NCT02839343|58906384|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
30875409|NCT02839343|58906385|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
30875410|NCT02839343|58906384|FG000|Overall Study|Adverse Event|1|||
30875411|NCT02839343|58906385|FG001|Overall Study|Adverse Event|0|||
30875412|NCT01965652|58906414|FG000|Overall Study|Adverse Event|40|||
30875413|NCT01965652|58906415|FG001|Overall Study|Adverse Event|37|||
30875414|NCT01965652|58906414|FG000|Overall Study|Withdrawal by Subject|62|||
30875415|NCT01965652|58906415|FG001|Overall Study|Withdrawal by Subject|69|||
30875416|NCT01965652|58906414|FG000|Overall Study|Lost to Follow-up|53|||
30875417|NCT01965652|58906415|FG001|Overall Study|Lost to Follow-up|40|||
30875418|NCT01965652|58906414|FG000|Overall Study|Protocol Violation|34|||
30875419|NCT01965652|58906415|FG001|Overall Study|Protocol Violation|38|||
30875420|NCT01965652|58906414|FG000|Overall Study|Death|3|||
30875421|NCT01965652|58906415|FG001|Overall Study|Death|4|||
30875422|NCT01965652|58906414|FG000|Overall Study|Other - Miscellaneous|18|||
30875423|NCT01965652|58906415|FG001|Overall Study|Other - Miscellaneous|21|||
30875424|NCT01965652|58906414|FG000|Overall Study|Pregnancy|0|||
30875425|NCT01965652|58906415|FG001|Overall Study|Pregnancy|1|||
30875426|NCT01602965|58906423|FG000|Overall Study|Lost to Follow-up|4|||
30875427|NCT01602965|58906424|FG001|Overall Study|Lost to Follow-up|2|||
30875428|NCT01987960|58906432|FG000|Period 1|Adverse Event|24|||
30875429|NCT01987960|58906433|FG001|Period 1|Adverse Event|0|||
30875430|NCT01987960|58906434|FG002|Period 1|Adverse Event|0|||
30875431|NCT01987960|58906435|FG003|Period 1|Adverse Event|0|||
30875432|NCT01987960|58906432|FG000|Period 1|Lack of Efficacy|4|||
30875433|NCT01987960|58906433|FG001|Period 1|Lack of Efficacy|0|||
30875434|NCT01987960|58906434|FG002|Period 1|Lack of Efficacy|0|||
30875435|NCT01987960|58906435|FG003|Period 1|Lack of Efficacy|0|||
30875436|NCT01987960|58906432|FG000|Period 1|Non-compliance with IMP|6|||
30875437|NCT01987960|58906433|FG001|Period 1|Non-compliance with IMP|0|||
30875438|NCT01987960|58906434|FG002|Period 1|Non-compliance with IMP|0|||
30875439|NCT01987960|58906435|FG003|Period 1|Non-compliance with IMP|0|||
30875440|NCT01987960|58906432|FG000|Period 1|Protocol Violation|12|||
30875441|NCT01987960|58906433|FG001|Period 1|Protocol Violation|0|||
30875442|NCT01987960|58906434|FG002|Period 1|Protocol Violation|0|||
30875443|NCT01987960|58906435|FG003|Period 1|Protocol Violation|0|||
30875444|NCT01987960|58906432|FG000|Period 1|Withdrawal by Subject|21|||
30875445|NCT01987960|58906433|FG001|Period 1|Withdrawal by Subject|0|||
30875446|NCT01987960|58906434|FG002|Period 1|Withdrawal by Subject|0|||
30875447|NCT01987960|58906435|FG003|Period 1|Withdrawal by Subject|0|||
30875448|NCT01987960|58906432|FG000|Period 1|Lost to Follow-up|40|||
30875449|NCT01987960|58906433|FG001|Period 1|Lost to Follow-up|0|||
30875450|NCT01987960|58906434|FG002|Period 1|Lost to Follow-up|0|||
30875451|NCT01987960|58906435|FG003|Period 1|Lost to Follow-up|0|||
30875452|NCT01987960|58906432|FG000|Period 1|administrative or other reason|75|||
30875453|NCT01987960|58906433|FG001|Period 1|administrative or other reason|0|||
30875454|NCT01987960|58906434|FG002|Period 1|administrative or other reason|0|||
30875455|NCT01987960|58906435|FG003|Period 1|administrative or other reason|0|||
30875456|NCT01987960|58906432|FG000|Period 1|Withdrawal of consent before treatment|4|||
30875457|NCT01987960|58906433|FG001|Period 1|Withdrawal of consent before treatment|0|||
30875458|NCT01987960|58906434|FG002|Period 1|Withdrawal of consent before treatment|0|||
30875459|NCT01987960|58906435|FG003|Period 1|Withdrawal of consent before treatment|0|||
30875460|NCT01987960|58906432|FG000|Period 2|Adverse Event|0|||
30875461|NCT01987960|58906433|FG001|Period 2|Adverse Event|0|||
30875462|NCT01987960|58906434|FG002|Period 2|Adverse Event|1|||
30875463|NCT01987960|58906435|FG003|Period 2|Adverse Event|0|||
30875464|NCT01987960|58906432|FG000|Period 2|Withdrawal by Subject|0|||
30875465|NCT01987960|58906433|FG001|Period 2|Withdrawal by Subject|0|||
30875466|NCT01987960|58906434|FG002|Period 2|Withdrawal by Subject|1|||
30875467|NCT01987960|58906435|FG003|Period 2|Withdrawal by Subject|0|||
30875468|NCT01987960|58906432|FG000|Period 2|Administrative or other reason|0|||
30875469|NCT01987960|58906433|FG001|Period 2|Administrative or other reason|5|||
30875470|NCT01987960|58906434|FG002|Period 2|Administrative or other reason|7|||
30875471|NCT01987960|58906435|FG003|Period 2|Administrative or other reason|0|||
30875472|NCT01987960|58906432|FG000|Period 3|Adverse Event|0|||
30875473|NCT01987960|58906433|FG001|Period 3|Adverse Event|0|||
30875474|NCT01987960|58906434|FG002|Period 3|Adverse Event|0|||
30875475|NCT01987960|58906435|FG003|Period 3|Adverse Event|7|||
30875476|NCT01987960|58906432|FG000|Period 3|Non-compliance with IMP|0|||
30875477|NCT01987960|58906433|FG001|Period 3|Non-compliance with IMP|0|||
30875478|NCT01987960|58906434|FG002|Period 3|Non-compliance with IMP|0|||
30875479|NCT01987960|58906435|FG003|Period 3|Non-compliance with IMP|1|||
30875480|NCT01987960|58906432|FG000|Period 3|Protocol Violation|0|||
30875481|NCT01987960|58906433|FG001|Period 3|Protocol Violation|0|||
30875482|NCT01987960|58906434|FG002|Period 3|Protocol Violation|0|||
30875483|NCT01987960|58906435|FG003|Period 3|Protocol Violation|6|||
30875484|NCT01987960|58906432|FG000|Period 3|Withdrawal by Subject|0|||
30875485|NCT01987960|58906433|FG001|Period 3|Withdrawal by Subject|0|||
30875486|NCT01987960|58906434|FG002|Period 3|Withdrawal by Subject|0|||
30875487|NCT01987960|58906435|FG003|Period 3|Withdrawal by Subject|9|||
30875488|NCT01987960|58906432|FG000|Period 3|Lost to Follow-up|0|||
30875489|NCT01987960|58906433|FG001|Period 3|Lost to Follow-up|0|||
30875490|NCT01987960|58906434|FG002|Period 3|Lost to Follow-up|0|||
30875491|NCT01987960|58906435|FG003|Period 3|Lost to Follow-up|5|||
30875492|NCT01987960|58906432|FG000|Period 3|Administrative or other reason|0|||
30875493|NCT01987960|58906433|FG001|Period 3|Administrative or other reason|0|||
30875494|NCT01987960|58906434|FG002|Period 3|Administrative or other reason|0|||
30875495|NCT01987960|58906435|FG003|Period 3|Administrative or other reason|43|||
30875496|NCT02013778|58906445|FG000|Overall Study|Death|4|||
30875497|NCT02013778|58906445|FG000|Overall Study|Withdrawal by Subject|1|||
30875498|NCT02013778|58906445|FG000|Overall Study|Physician Decision|1|||
30875499|NCT02013778|58906445|FG000|Overall Study|Adverse Event|1|||
30875500|NCT02013622|58906449|FG000|Overall Study|Lost to Follow-up|10|||
30875501|NCT02013622|58906449|FG000|Overall Study|Adverse Event|3|||
30875502|NCT02013622|58906449|FG000|Overall Study|Met Withdrawal Criteria|3|||
30875503|NCT02013622|58906449|FG000|Overall Study|Withdrawal by Subject|6|||
30875504|NCT02013622|58906449|FG000|Overall Study|Protocol Deviation|1|||
30875505|NCT02013622|58906449|FG000|Overall Study|Lack of Efficacy|1|||
30875506|NCT01987102|58906455|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
30875507|NCT01987102|58906456|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
30875508|NCT01987102|58906455|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
30875509|NCT01987102|58906456|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
30875510|NCT01987102|58906455|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
30875511|NCT01987102|58906456|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
30875512|NCT01987102|58906455|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
30875513|NCT01987102|58906456|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
30875514|NCT01987102|58906455|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
30875515|NCT01987102|58906456|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
30875516|NCT01987102|58906455|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
30875517|NCT01987102|58906456|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
30875518|NCT02013544|58906465|FG000|Overall Study|Adverse Event|5|||
30875519|NCT02013544|58906466|FG001|Overall Study|Adverse Event|5|||
30875520|NCT02013544|58906465|FG000|Overall Study|Lost to Follow-up|2|||
30875521|NCT02013544|58906466|FG001|Overall Study|Lost to Follow-up|3|||
30875522|NCT02013544|58906465|FG000|Overall Study|Withdrawal by Subject|2|||
30875523|NCT02013544|58906466|FG001|Overall Study|Withdrawal by Subject|8|||
30875524|NCT02013544|58906465|FG000|Overall Study|Physician Decision|0|||
30875525|NCT02013544|58906466|FG001|Overall Study|Physician Decision|1|||
30875526|NCT02013544|58906465|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
30875527|NCT02013544|58906466|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
30875528|NCT02013388|58906480|FG000|Overall Study|work emergency|1|||
30875529|NCT02013388|58906481|FG001|Overall Study|work emergency|0|||
30875530|NCT02013388|58906482|FG002|Overall Study|work emergency|0|||
30875531|NCT02013388|58906483|FG003|Overall Study|work emergency|0|||
30875532|NCT02013388|58906484|FG004|Overall Study|work emergency|1|||
30875533|NCT02013388|58906485|FG005|Overall Study|work emergency|0|||
30875534|NCT02013388|58906486|FG006|Overall Study|work emergency|0|||
30875535|NCT02013388|58906487|FG007|Overall Study|work emergency|0|||
30875536|NCT02012686|58906511|FG000|Overall Study|muscle contraction|0|||
30875537|NCT02012686|58906512|FG001|Overall Study|muscle contraction|1|||
30875538|NCT02012686|58906511|FG000|Overall Study|electrocardiography monitoring noise|0|||
30875539|NCT02012686|58906512|FG001|Overall Study|electrocardiography monitoring noise|1|||
30875540|NCT02012452|58906520|FG000|Overall Study|Lost to Follow-up|2|||
30875541|NCT02012452|58906521|FG001|Overall Study|Lost to Follow-up|1|||
30875542|NCT02012452|58906520|FG000|Overall Study|Withdrawal by Subject|4|||
30875543|NCT02012452|58906521|FG001|Overall Study|Withdrawal by Subject|0|||
30875544|NCT01676909|58906529|FG000|Overall Study|Withdrawal by Subject|3|||
30875545|NCT01676909|58906530|FG001|Overall Study|Withdrawal by Subject|5|||
30875546|NCT01676909|58906529|FG000|Overall Study|Lost to Follow-up|15|||
30875547|NCT01676909|58906530|FG001|Overall Study|Lost to Follow-up|9|||
30875548|NCT02012296|58906541|FG000|Overall Study|Lack of Efficacy|0|||
30875549|NCT02012296|58906542|FG001|Overall Study|Lack of Efficacy|0|||
30875550|NCT02012296|58906543|FG002|Overall Study|Lack of Efficacy|15|||
30875551|NCT02012296|58906541|FG000|Overall Study|Adverse Event|0|||
30875552|NCT02012296|58906542|FG001|Overall Study|Adverse Event|0|||
30875553|NCT02012296|58906543|FG002|Overall Study|Adverse Event|2|||
30875554|NCT02012296|58906541|FG000|Overall Study|Early study closure|0|||
30875555|NCT02012296|58906542|FG001|Overall Study|Early study closure|0|||
30875556|NCT02012296|58906543|FG002|Overall Study|Early study closure|5|||
30875557|NCT02012296|58906541|FG000|Overall Study|Protocol Violation|0|||
30875558|NCT02012296|58906542|FG001|Overall Study|Protocol Violation|1|||
30875559|NCT02012296|58906543|FG002|Overall Study|Protocol Violation|0|||
30962637|NCT01513291|59030220|FG002|Treatment Period|Protocol Violation|0|||
30962638|NCT01513291|59030221|FG003|Treatment Period|Protocol Violation|0|||
30962639|NCT01513291|59030222|FG004|Treatment Period|Protocol Violation|0|||
30962640|NCT01513291|59030218|FG000|Treatment Period|Withdrawal by Subject|8|||
30962641|NCT01513291|59030219|FG001|Treatment Period|Withdrawal by Subject|5|||
30875560|NCT02012218|58906560|FG000|Overall Study|Withdrawal by Subject|1|||
30875561|NCT02012218|58906561|FG001|Overall Study|Withdrawal by Subject|0|||
30875562|NCT02012218|58906562|FG002|Overall Study|Withdrawal by Subject|1|||
30875563|NCT02012218|58906563|FG003|Overall Study|Withdrawal by Subject|1|||
30875564|NCT02012218|58906564|FG004|Overall Study|Withdrawal by Subject|1|||
30875565|NCT02012218|58906560|FG000|Overall Study|Adverse Event|1|||
30875566|NCT02012218|58906561|FG001|Overall Study|Adverse Event|0|||
30962642|NCT01513291|59030220|FG002|Treatment Period|Withdrawal by Subject|0|||
30875567|NCT02012218|58906562|FG002|Overall Study|Adverse Event|0|||
30875568|NCT02012218|58906563|FG003|Overall Study|Adverse Event|1|||
30962643|NCT01513291|59030221|FG003|Treatment Period|Withdrawal by Subject|0|||
30962644|NCT01513291|59030222|FG004|Treatment Period|Withdrawal by Subject|0|||
30962645|NCT01513291|59030218|FG000|Treatment Period|Randomized not treated|0|||
30962646|NCT01513291|59030219|FG001|Treatment Period|Randomized not treated|2|||
30962647|NCT01513291|59030220|FG002|Treatment Period|Randomized not treated|0|||
30875569|NCT02012218|58906564|FG004|Overall Study|Adverse Event|0|||
30875570|NCT02012218|58906560|FG000|Overall Study|Lost to Follow-up|0|||
30875571|NCT02012218|58906561|FG001|Overall Study|Lost to Follow-up|1|||
30875572|NCT02012218|58906562|FG002|Overall Study|Lost to Follow-up|1|||
30875573|NCT02012218|58906563|FG003|Overall Study|Lost to Follow-up|0|||
30875574|NCT02012218|58906564|FG004|Overall Study|Lost to Follow-up|0|||
30875575|NCT02012218|58906560|FG000|Overall Study|Protocol Specified|1|||
30875576|NCT02012218|58906561|FG001|Overall Study|Protocol Specified|0|||
30875577|NCT02012218|58906562|FG002|Overall Study|Protocol Specified|0|||
30875578|NCT02012218|58906563|FG003|Overall Study|Protocol Specified|0|||
30875579|NCT02012218|58906564|FG004|Overall Study|Protocol Specified|0|||
30875580|NCT02012218|58906560|FG000|Overall Study|Protocol Deviation|1|||
30875581|NCT02012218|58906561|FG001|Overall Study|Protocol Deviation|0|||
30875582|NCT02012218|58906562|FG002|Overall Study|Protocol Deviation|0|||
30875583|NCT02012218|58906563|FG003|Overall Study|Protocol Deviation|0|||
30875584|NCT02012218|58906564|FG004|Overall Study|Protocol Deviation|0|||
30875585|NCT01965262|58906576|FG000|Second Intervention (7 Days)|Discontinued|0|||
30875586|NCT01965262|58906577|FG001|Second Intervention (7 Days)|Discontinued|1|||
30875587|NCT01965262|58906576|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
30875588|NCT01965262|58906577|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
30875589|NCT01965262|58906576|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
30875590|NCT01965262|58906577|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
30875591|NCT01677377|58906586|FG000|Overall Study|Protocol Violation|1|||
30875592|NCT01677377|58906587|FG001|Overall Study|Protocol Violation|0|||
30875593|NCT01677377|58906588|FG002|Overall Study|Protocol Violation|0|||
30962648|NCT01513291|59030221|FG003|Treatment Period|Randomized not treated|0|||
30962649|NCT01513291|59030222|FG004|Treatment Period|Randomized not treated|0|||
30962650|NCT01513291|59030218|FG000|Run-out Period|Lost to Follow-up|0|||
30962651|NCT01513291|59030219|FG001|Run-out Period|Lost to Follow-up|0|||
30962652|NCT01513291|59030220|FG002|Run-out Period|Lost to Follow-up|0|||
30962653|NCT01513291|59030221|FG003|Run-out Period|Lost to Follow-up|1|||
30962654|NCT01513291|59030222|FG004|Run-out Period|Lost to Follow-up|0|||
30962655|NCT01513291|59030218|FG000|Run-out Period|Withdrawal by Subject|0|||
30962656|NCT01513291|59030219|FG001|Run-out Period|Withdrawal by Subject|0|||
30962657|NCT01513291|59030220|FG002|Run-out Period|Withdrawal by Subject|0|||
30962658|NCT01513291|59030221|FG003|Run-out Period|Withdrawal by Subject|1|||
30962659|NCT01513291|59030222|FG004|Run-out Period|Withdrawal by Subject|0|||
30962660|NCT01483937|59030236|FG000|Overall Study|Withdrawal by Subject|4|||
30962661|NCT01483937|59030237|FG001|Overall Study|Withdrawal by Subject|3|||
30962662|NCT01483625|59030248|FG000|Overall Study|Adverse Event|1|||
30962663|NCT01483625|59030249|FG001|Overall Study|Adverse Event|1|||
30962664|NCT01483625|59030248|FG000|Overall Study|Refused to continue medication|2|||
30962665|NCT01483625|59030249|FG001|Overall Study|Refused to continue medication|1|||
30962666|NCT01483625|59030248|FG000|Overall Study|Due to other reason|1|||
30962667|NCT01483625|59030249|FG001|Overall Study|Due to other reason|0|||
30962668|NCT01485991|59030257|FG000|Overall Study|Adverse Event|0|||
30962669|NCT01485991|59030258|FG001|Overall Study|Adverse Event|4|||
30962670|NCT01485991|59030257|FG000|Overall Study|Lost to Follow-up|13|||
30962671|NCT01485991|59030258|FG001|Overall Study|Lost to Follow-up|10|||
30962672|NCT01485991|59030257|FG000|Overall Study|Withdrawal by Subject|13|||
30962673|NCT01485991|59030258|FG001|Overall Study|Withdrawal by Subject|20|||
30962674|NCT01485991|59030257|FG000|Overall Study|randomized but not treated|6|||
30875594|NCT01677377|58906586|FG000|Overall Study|Lost to Follow-up|0|||
30875595|NCT01677377|58906587|FG001|Overall Study|Lost to Follow-up|1|||
30875596|NCT01677377|58906588|FG002|Overall Study|Lost to Follow-up|1|||
30875597|NCT01677377|58906586|FG000|Overall Study|Withdrawal by Subject|0|||
30875598|NCT01677377|58906587|FG001|Overall Study|Withdrawal by Subject|0|||
30875599|NCT01677377|58906588|FG002|Overall Study|Withdrawal by Subject|3|||
30962675|NCT01485991|59030258|FG001|Overall Study|randomized but not treated|2|||
30962676|NCT01482767|59030290|FG000|Overall Study|Death|1|||
30962677|NCT01482767|59030291|FG001|Overall Study|Death|1|||
30962678|NCT01482767|59030290|FG000|Overall Study|Withdrawal by Subject|7|||
30962679|NCT01482767|59030291|FG001|Overall Study|Withdrawal by Subject|5|||
30962680|NCT01482767|59030290|FG000|Overall Study|Lost to Follow-up|12|||
30962681|NCT01482767|59030291|FG001|Overall Study|Lost to Follow-up|6|||
30962682|NCT01482767|59030290|FG000|Overall Study|Adverse Event|0|||
30962683|NCT01482767|59030291|FG001|Overall Study|Adverse Event|3|||
30962684|NCT01482767|59030290|FG000|Overall Study|Site closure|22|||
30962685|NCT01482767|59030291|FG001|Overall Study|Site closure|14|||
30962686|NCT01482767|59030290|FG000|Overall Study|Non-adherence to study requirements|4|||
30875600|NCT01677377|58906586|FG000|Overall Study|Lack of Efficacy|0|||
30962687|NCT01482767|59030291|FG001|Overall Study|Non-adherence to study requirements|7|||
30962688|NCT01482767|59030290|FG000|Overall Study|Alternate HCV treatment|7|||
30875601|NCT01677377|58906587|FG001|Overall Study|Lack of Efficacy|0|||
30875602|NCT01677377|58906588|FG002|Overall Study|Lack of Efficacy|1|||
30875603|NCT01677377|58906586|FG000|Overall Study|Pregnancy|0|||
30875604|NCT01677377|58906587|FG001|Overall Study|Pregnancy|0|||
30875605|NCT01677377|58906588|FG002|Overall Study|Pregnancy|1|||
30875606|NCT01964950|58906598|FG000|Overall Study|Protocol Violation|25|||
30875607|NCT01964716|58906607|FG000|Overall Study|Withdrawal by Subject|2|||
30875608|NCT01964716|58906608|FG001|Overall Study|Withdrawal by Subject|3|||
30875609|NCT01964716|58906607|FG000|Overall Study|Lost to Follow-up|1|||
30875610|NCT01964716|58906608|FG001|Overall Study|Lost to Follow-up|2|||
30875611|NCT01964716|58906607|FG000|Overall Study|No longer met eligibility criteria|1|||
30875612|NCT01964716|58906608|FG001|Overall Study|No longer met eligibility criteria|1|||
30875613|NCT01964716|58906607|FG000|Overall Study|Death|1|||
30875614|NCT01964716|58906608|FG001|Overall Study|Death|0|||
30875615|NCT01964560|58906622|FG000|Overall Study|Adverse Event|23|||
30875616|NCT01964560|58906622|FG000|Overall Study|Lack of Efficacy|46|||
30875617|NCT01964560|58906622|FG000|Overall Study|Protocol deviation|2|||
30875618|NCT01964560|58906622|FG000|Overall Study|Lost to Follow-up|4|||
30875619|NCT01964560|58906622|FG000|Overall Study|Withdrawal by Subject|64|||
30875620|NCT01964560|58906622|FG000|Overall Study|Surgery-hemispherotomy|1|||
30875621|NCT01964560|58906622|FG000|Overall Study|Surgery|1|||
30875622|NCT01964560|58906622|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
30875623|NCT01964560|58906622|FG000|Overall Study|Patient and Investigator choice|1|||
30875624|NCT01964560|58906622|FG000|Overall Study|Patient was prescribed CBD|1|||
30875625|NCT01964560|58906622|FG000|Overall Study|Participant moved to another country|1|||
30875626|NCT02659943|58906633|FG000|Overall Study|Switched to alternative treatment|1|||
30875627|NCT02659943|58906634|FG001|Overall Study|Switched to alternative treatment|1|||
30875628|NCT02659943|58906635|FG002|Overall Study|Switched to alternative treatment|0|||
30875629|NCT02659943|58906636|FG003|Overall Study|Switched to alternative treatment|2|||
30875630|NCT02659943|58906637|FG004|Overall Study|Switched to alternative treatment|1|||
30875631|NCT02659943|58906638|FG005|Overall Study|Switched to alternative treatment|0|||
30875632|NCT02659943|58906639|FG006|Overall Study|Switched to alternative treatment|1|||
30875633|NCT02659943|58906633|FG000|Overall Study|Disease progression on study|0|||
30875634|NCT02659943|58906634|FG001|Overall Study|Disease progression on study|1|||
30875635|NCT02659943|58906635|FG002|Overall Study|Disease progression on study|1|||
30875636|NCT02659943|58906636|FG003|Overall Study|Disease progression on study|1|||
30875637|NCT02659943|58906637|FG004|Overall Study|Disease progression on study|1|||
30875638|NCT02659943|58906638|FG005|Overall Study|Disease progression on study|4|||
30875639|NCT02659943|58906639|FG006|Overall Study|Disease progression on study|0|||
30875640|NCT02659943|58906633|FG000|Overall Study|Patient's condition per principal investigator|0|||
30875641|NCT02659943|58906634|FG001|Overall Study|Patient's condition per principal investigator|0|||
30875642|NCT02659943|58906635|FG002|Overall Study|Patient's condition per principal investigator|0|||
30875643|NCT02659943|58906636|FG003|Overall Study|Patient's condition per principal investigator|0|||
30875644|NCT02659943|58906637|FG004|Overall Study|Patient's condition per principal investigator|0|||
30875645|NCT02659943|58906638|FG005|Overall Study|Patient's condition per principal investigator|1|||
30875646|NCT02659943|58906639|FG006|Overall Study|Patient's condition per principal investigator|0|||
30875647|NCT02659943|58906633|FG000|Overall Study|Ineligible|0|||
30875648|NCT02659943|58906634|FG001|Overall Study|Ineligible|0|||
30875649|NCT02659943|58906635|FG002|Overall Study|Ineligible|0|||
30875650|NCT02659943|58906636|FG003|Overall Study|Ineligible|0|||
30875651|NCT02659943|58906637|FG004|Overall Study|Ineligible|0|||
30875652|NCT02659943|58906638|FG005|Overall Study|Ineligible|0|||
30875653|NCT02659943|58906639|FG006|Overall Study|Ineligible|1|||
30875654|NCT02659943|58906633|FG000|Overall Study|No longer meets eligibility|0|||
30875655|NCT02659943|58906634|FG001|Overall Study|No longer meets eligibility|0|||
30875656|NCT02659943|58906635|FG002|Overall Study|No longer meets eligibility|0|||
30875657|NCT02659943|58906636|FG003|Overall Study|No longer meets eligibility|0|||
30875658|NCT02659943|58906637|FG004|Overall Study|No longer meets eligibility|0|||
30875659|NCT02659943|58906638|FG005|Overall Study|No longer meets eligibility|0|||
30875660|NCT02659943|58906639|FG006|Overall Study|No longer meets eligibility|1|||
30875661|NCT02659943|58906633|FG000|Overall Study|No treatment, per protocol|0|||
30875662|NCT02659943|58906634|FG001|Overall Study|No treatment, per protocol|0|||
30875663|NCT02659943|58906635|FG002|Overall Study|No treatment, per protocol|0|||
30875664|NCT02659943|58906636|FG003|Overall Study|No treatment, per protocol|0|||
30875665|NCT02659943|58906637|FG004|Overall Study|No treatment, per protocol|0|||
30875666|NCT02659943|58906638|FG005|Overall Study|No treatment, per protocol|0|||
30875667|NCT02659943|58906639|FG006|Overall Study|No treatment, per protocol|3|||
30875668|NCT01677299|58906664|FG000|Overall Study|Adverse Event|0|||
30875669|NCT01677299|58906665|FG001|Overall Study|Adverse Event|2|||
30875670|NCT01677299|58906666|FG002|Overall Study|Adverse Event|1|||
30875671|NCT01677299|58906667|FG003|Overall Study|Adverse Event|0|||
30875672|NCT01677299|58906664|FG000|Overall Study|Withdrawal by Subject|0|||
30875673|NCT01677299|58906665|FG001|Overall Study|Withdrawal by Subject|1|||
30875674|NCT01677299|58906666|FG002|Overall Study|Withdrawal by Subject|0|||
30875675|NCT01677299|58906667|FG003|Overall Study|Withdrawal by Subject|1|||
30875676|NCT01964326|58906681|FG000|Overall Study|Adverse Event|48|||
30875677|NCT01964326|58906681|FG000|Overall Study|Death|2|||
30875678|NCT01964326|58906681|FG000|Overall Study|Protocol Violation|4|||
30875679|NCT01964326|58906681|FG000|Overall Study|Lost to Follow-up|88|||
30875680|NCT01964326|58906681|FG000|Overall Study|Withdrawal by Subject|87|||
30875681|NCT01964326|58906681|FG000|Overall Study|Pregnancy|1|||
30875682|NCT01964326|58906681|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
30875683|NCT01964326|58906681|FG000|Overall Study|Physician Decision|55|||
30875684|NCT01964326|58906681|FG000|Overall Study|Investigator Discretion|1|||
30875685|NCT01964326|58906681|FG000|Overall Study|Other|9|||
30875686|NCT01964326|58906681|FG000|Overall Study|Did not meet eligibility criteria|1|||
30875687|NCT02699749|58906699|FG000|Overall Study|Other|0|||
30875688|NCT02699749|58906700|FG001|Overall Study|Other|0|||
30875689|NCT02699749|58906701|FG002|Overall Study|Other|2|||
30875690|NCT02699749|58906702|FG003|Overall Study|Other|0|||
30875691|NCT02699749|58906703|FG004|Overall Study|Other|0|||
30875692|NCT02699749|58906704|FG005|Overall Study|Other|1|||
30875693|NCT02699749|58906705|FG006|Overall Study|Other|1|||
30875694|NCT02699749|58906706|FG007|Overall Study|Other|0|||
30875695|NCT02699749|58906707|FG008|Overall Study|Other|0|||
30875696|NCT02699749|58906708|FG009|Overall Study|Other|0|||
30875697|NCT02699749|58906709|FG010|Overall Study|Other|1|||
30875698|NCT02699749|58906710|FG011|Overall Study|Other|0|||
30875699|NCT02699749|58906711|FG012|Overall Study|Other|0|||
30875700|NCT02699749|58906712|FG013|Overall Study|Other|0|||
30875701|NCT02699749|58906699|FG000|Overall Study|Progressive Disease|3|||
30875702|NCT02699749|58906700|FG001|Overall Study|Progressive Disease|3|||
30875703|NCT02699749|58906701|FG002|Overall Study|Progressive Disease|14|||
30875704|NCT02699749|58906702|FG003|Overall Study|Progressive Disease|3|||
30875705|NCT02699749|58906703|FG004|Overall Study|Progressive Disease|3|||
30875706|NCT02699749|58906704|FG005|Overall Study|Progressive Disease|7|||
30875707|NCT02699749|58906705|FG006|Overall Study|Progressive Disease|5|||
30875708|NCT02699749|58906706|FG007|Overall Study|Progressive Disease|5|||
30875709|NCT02699749|58906707|FG008|Overall Study|Progressive Disease|6|||
30875710|NCT02699749|58906708|FG009|Overall Study|Progressive Disease|6|||
30875711|NCT02699749|58906709|FG010|Overall Study|Progressive Disease|5|||
30875712|NCT02699749|58906710|FG011|Overall Study|Progressive Disease|4|||
30875713|NCT02699749|58906711|FG012|Overall Study|Progressive Disease|3|||
30875714|NCT02699749|58906712|FG013|Overall Study|Progressive Disease|5|||
30875715|NCT02699749|58906699|FG000|Overall Study|Death|0|||
30875716|NCT02699749|58906700|FG001|Overall Study|Death|0|||
30875717|NCT02699749|58906701|FG002|Overall Study|Death|0|||
30875718|NCT02699749|58906702|FG003|Overall Study|Death|0|||
30875719|NCT02699749|58906703|FG004|Overall Study|Death|0|||
30875720|NCT02699749|58906704|FG005|Overall Study|Death|0|||
30875721|NCT02699749|58906705|FG006|Overall Study|Death|0|||
30875722|NCT02699749|58906706|FG007|Overall Study|Death|0|||
30875723|NCT02699749|58906707|FG008|Overall Study|Death|0|||
30875724|NCT02699749|58906708|FG009|Overall Study|Death|0|||
30875725|NCT02699749|58906709|FG010|Overall Study|Death|0|||
30875726|NCT02699749|58906710|FG011|Overall Study|Death|0|||
30875727|NCT02699749|58906711|FG012|Overall Study|Death|0|||
30875728|NCT02699749|58906712|FG013|Overall Study|Death|1|||
30875729|NCT02699749|58906699|FG000|Overall Study|Lost to Follow-up|0|||
30875730|NCT02699749|58906700|FG001|Overall Study|Lost to Follow-up|0|||
30875731|NCT02699749|58906701|FG002|Overall Study|Lost to Follow-up|0|||
30875732|NCT02699749|58906702|FG003|Overall Study|Lost to Follow-up|0|||
30875733|NCT02699749|58906703|FG004|Overall Study|Lost to Follow-up|0|||
30875734|NCT02699749|58906704|FG005|Overall Study|Lost to Follow-up|1|||
30875735|NCT02699749|58906705|FG006|Overall Study|Lost to Follow-up|0|||
30875736|NCT02699749|58906706|FG007|Overall Study|Lost to Follow-up|1|||
30875737|NCT02699749|58906707|FG008|Overall Study|Lost to Follow-up|0|||
30875738|NCT02699749|58906708|FG009|Overall Study|Lost to Follow-up|0|||
30875739|NCT02699749|58906709|FG010|Overall Study|Lost to Follow-up|0|||
30875740|NCT02699749|58906710|FG011|Overall Study|Lost to Follow-up|0|||
30875741|NCT02699749|58906711|FG012|Overall Study|Lost to Follow-up|0|||
30875742|NCT02699749|58906712|FG013|Overall Study|Lost to Follow-up|0|||
30875743|NCT02699593|58906742|FG000|Period 1|Unsatisfactory Visual Response|0|||
30875744|NCT02699593|58906743|FG001|Period 1|Unsatisfactory Visual Response|1|||
30875745|NCT02699593|58906742|FG000|Period 1|Torn Contact Len|4|||
30875746|NCT02699593|58906743|FG001|Period 1|Torn Contact Len|3|||
30875747|NCT02699593|58906742|FG000|Period 1|Protocol Violation|0|||
30875748|NCT02699593|58906743|FG001|Period 1|Protocol Violation|1|||
30875749|NCT02699593|58906742|FG000|Period 1|Withdrawal by Subject|0|||
30875750|NCT02699593|58906743|FG001|Period 1|Withdrawal by Subject|1|||
30875751|NCT02699593|58906742|FG000|Period 1|Adverse Event|1|||
30875752|NCT02699593|58906743|FG001|Period 1|Adverse Event|1|||
30875753|NCT02699593|58906742|FG000|Period 2|Adverse Event|1|||
30875754|NCT02699593|58906743|FG001|Period 2|Adverse Event|1|||
30875755|NCT02699593|58906742|FG000|Period 2|Lost Contact Lens|0|||
30875756|NCT02699593|58906743|FG001|Period 2|Lost Contact Lens|1|||
30875757|NCT02699593|58906742|FG000|Period 2|Torn Contact Lens|1|||
30875758|NCT02699593|58906743|FG001|Period 2|Torn Contact Lens|0|||
30875759|NCT00708097|58906749|FG000|Period 1|Protocol Violation|0|||
30875760|NCT00708097|58906750|FG001|Period 1|Protocol Violation|1|||
30875761|NCT00708097|58906751|FG002|Period 1|Protocol Violation|0|||
30875762|NCT00708097|58906752|FG003|Period 1|Protocol Violation|2|||
30875763|NCT00708097|58906753|FG004|Period 1|Protocol Violation|0|||
30875764|NCT00708097|58906749|FG000|Period 1|Other Reason|0|||
30875765|NCT00708097|58906750|FG001|Period 1|Other Reason|0|||
30875766|NCT00708097|58906751|FG002|Period 1|Other Reason|0|||
30875767|NCT00708097|58906752|FG003|Period 1|Other Reason|0|||
30875768|NCT00708097|58906753|FG004|Period 1|Other Reason|1|||
30875769|NCT00708097|58906749|FG000|Period 2|Protocol Violation|0|||
30875770|NCT00708097|58906750|FG001|Period 2|Protocol Violation|1|||
30875771|NCT00708097|58906751|FG002|Period 2|Protocol Violation|1|||
30875772|NCT00708097|58906752|FG003|Period 2|Protocol Violation|1|||
30875773|NCT00708097|58906753|FG004|Period 2|Protocol Violation|0|||
30875774|NCT02659631|58906780|FG000|Overall Study|Lost to Follow-up|0|||
30875775|NCT02659631|58906781|FG001|Overall Study|Lost to Follow-up|0|||
30875776|NCT02659631|58906782|FG002|Overall Study|Lost to Follow-up|2|||
30875777|NCT02659631|58906783|FG003|Overall Study|Lost to Follow-up|0|||
30875778|NCT02659631|58906784|FG004|Overall Study|Lost to Follow-up|0|||
30875779|NCT02659631|58906785|FG005|Overall Study|Lost to Follow-up|1|||
30875780|NCT02659631|58906786|FG006|Overall Study|Lost to Follow-up|0|||
30875781|NCT02659631|58906787|FG007|Overall Study|Lost to Follow-up|0|||
30875782|NCT02659631|58906788|FG008|Overall Study|Lost to Follow-up|0|||
30875783|NCT02659631|58906789|FG009|Overall Study|Lost to Follow-up|0|||
30875784|NCT02659631|58906780|FG000|Overall Study|Withdrawal prior to treatment|0|||
30875785|NCT02659631|58906781|FG001|Overall Study|Withdrawal prior to treatment|0|||
30875786|NCT02659631|58906782|FG002|Overall Study|Withdrawal prior to treatment|0|||
30875787|NCT02659631|58906783|FG003|Overall Study|Withdrawal prior to treatment|0|||
30875788|NCT02659631|58906784|FG004|Overall Study|Withdrawal prior to treatment|1|||
30875789|NCT02659631|58906785|FG005|Overall Study|Withdrawal prior to treatment|0|||
30875790|NCT02659631|58906786|FG006|Overall Study|Withdrawal prior to treatment|0|||
30875791|NCT02659631|58906787|FG007|Overall Study|Withdrawal prior to treatment|0|||
30875792|NCT02659631|58906788|FG008|Overall Study|Withdrawal prior to treatment|0|||
30875793|NCT02659631|58906789|FG009|Overall Study|Withdrawal prior to treatment|0|||
30875794|NCT02659631|58906780|FG000|Overall Study|Participant refused further follow-up|0|||
30875795|NCT02659631|58906781|FG001|Overall Study|Participant refused further follow-up|0|||
30875796|NCT02659631|58906782|FG002|Overall Study|Participant refused further follow-up|0|||
30875797|NCT02659631|58906783|FG003|Overall Study|Participant refused further follow-up|1|||
30875798|NCT02659631|58906784|FG004|Overall Study|Participant refused further follow-up|0|||
30875799|NCT02659631|58906785|FG005|Overall Study|Participant refused further follow-up|0|||
30875800|NCT02659631|58906786|FG006|Overall Study|Participant refused further follow-up|0|||
30875801|NCT02659631|58906787|FG007|Overall Study|Participant refused further follow-up|0|||
30875802|NCT02659631|58906788|FG008|Overall Study|Participant refused further follow-up|1|||
30875803|NCT02659631|58906789|FG009|Overall Study|Participant refused further follow-up|0|||
30875804|NCT02659631|58906780|FG000|Overall Study|Death (follow-up phase)|1|||
30875805|NCT02659631|58906781|FG001|Overall Study|Death (follow-up phase)|2|||
30875806|NCT02659631|58906782|FG002|Overall Study|Death (follow-up phase)|1|||
30875807|NCT02659631|58906783|FG003|Overall Study|Death (follow-up phase)|1|||
30875808|NCT02659631|58906784|FG004|Overall Study|Death (follow-up phase)|3|||
30875809|NCT02659631|58906785|FG005|Overall Study|Death (follow-up phase)|2|||
30875810|NCT02659631|58906786|FG006|Overall Study|Death (follow-up phase)|0|||
30875811|NCT02659631|58906787|FG007|Overall Study|Death (follow-up phase)|3|||
30875812|NCT02659631|58906788|FG008|Overall Study|Death (follow-up phase)|1|||
30875813|NCT02659631|58906789|FG009|Overall Study|Death (follow-up phase)|0|||
30875814|NCT02659631|58906780|FG000|Overall Study|Death (treatment phase)|0|||
30875815|NCT02659631|58906781|FG001|Overall Study|Death (treatment phase)|0|||
30875816|NCT02659631|58906782|FG002|Overall Study|Death (treatment phase)|0|||
30875817|NCT02659631|58906783|FG003|Overall Study|Death (treatment phase)|0|||
30875818|NCT02659631|58906784|FG004|Overall Study|Death (treatment phase)|1|||
30875819|NCT02659631|58906785|FG005|Overall Study|Death (treatment phase)|0|||
30875820|NCT02659631|58906786|FG006|Overall Study|Death (treatment phase)|1|||
30875821|NCT02659631|58906787|FG007|Overall Study|Death (treatment phase)|0|||
30875822|NCT02659631|58906788|FG008|Overall Study|Death (treatment phase)|0|||
30875823|NCT02659631|58906789|FG009|Overall Study|Death (treatment phase)|0|||
30875824|NCT02699125|58906813|FG000|Placebo|Lost to Follow-up|2|||
30875825|NCT02699125|58906814|FG001|Placebo|Lost to Follow-up|0|||
30875826|NCT02699125|58906813|FG000|Placebo|Protocol Violation|1|||
30875827|NCT02699125|58906814|FG001|Placebo|Protocol Violation|0|||
30875828|NCT02699125|58906813|FG000|Placebo|Withdrawal by Subject|0|||
30875829|NCT02699125|58906814|FG001|Placebo|Withdrawal by Subject|4|||
30875830|NCT02699125|58906813|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
30875831|NCT02699125|58906814|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
30875832|NCT02698891|58906824|FG000|Overall Study|Withdrawal by Subject|2|||
30875833|NCT02698891|58906824|FG000|Overall Study|deemed ineligible|1|||
30875834|NCT02698891|58906824|FG000|Overall Study|Adverse Event|9|||
30875835|NCT02698423|58906830|FG000|Overall Study|Lost to Follow-up|19|||
30875836|NCT02698423|58906831|FG001|Overall Study|Lost to Follow-up|24|||
30875837|NCT02700997|58906839|FG000|Overall Study|Did not undergo CT imaging|1|||
30875838|NCT02700997|58906839|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
30875839|NCT02658149|58906845|FG000|Overall Study|Physician Decision|1|||
30875840|NCT02658149|58906846|FG001|Overall Study|Physician Decision|0|||
30875841|NCT02698189|58906854|FG000|Overall Study|Physician Decision|3|||
30875842|NCT02698189|58906855|FG001|Overall Study|Physician Decision|0|||
30875843|NCT02698189|58906854|FG000|Overall Study|Progressive disease|0|||
30875844|NCT02698189|58906855|FG001|Overall Study|Progressive disease|5|||
30875845|NCT02698189|58906854|FG000|Overall Study|Study terminated by sponsor|0|||
30875846|NCT02698189|58906855|FG001|Overall Study|Study terminated by sponsor|1|||
30875847|NCT02702011|58906867|FG000|Overall Study|Withdrawal by Subject|0|||
30875848|NCT02702011|58906868|FG001|Overall Study|Withdrawal by Subject|1|||
30875849|NCT02702011|58906869|FG002|Overall Study|Withdrawal by Subject|0|||
30875850|NCT02702011|58906870|FG003|Overall Study|Withdrawal by Subject|0|||
30875851|NCT02657369|58906880|FG000|Overall Study|Death|27|||
30875852|NCT02657369|58906880|FG000|Overall Study|Study terminated by sponsor|7|||
30875853|NCT02701777|58906888|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
30875854|NCT02701777|58906889|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
30875855|NCT02701777|58906890|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
30875856|NCT02701777|58906891|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
30875857|NCT02701777|58906888|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
30875858|NCT02701777|58906889|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
30875859|NCT02701777|58906890|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
30875860|NCT02701777|58906891|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
30875861|NCT01675661|58906916|FG000|Overall Study|Lost to Follow-up|22|||
30875862|NCT01675661|58906917|FG001|Overall Study|Lost to Follow-up|23|||
30875863|NCT01675661|58906916|FG000|Overall Study|Practical problems|9|||
30875864|NCT01675661|58906917|FG001|Overall Study|Practical problems|5|||
30875865|NCT01675661|58906916|FG000|Overall Study|Moved away|5|||
30875866|NCT01675661|58906917|FG001|Overall Study|Moved away|6|||
30875867|NCT01675661|58906916|FG000|Overall Study|Withdrawal by Subject|3|||
30875868|NCT01675661|58906917|FG001|Overall Study|Withdrawal by Subject|7|||
30875869|NCT01675661|58906916|FG000|Overall Study|Physician Decision|0|||
30875870|NCT01675661|58906917|FG001|Overall Study|Physician Decision|2|||
30875871|NCT01675661|58906916|FG000|Overall Study|Death|0|||
30875872|NCT01675661|58906917|FG001|Overall Study|Death|1|||
30875873|NCT01675661|58906916|FG000|Overall Study|Other reason|1|||
30875874|NCT01675661|58906917|FG001|Overall Study|Other reason|2|||
30875875|NCT01602341|58906925|FG000|Overall Study|Adverse Event|0|||
30875876|NCT01602341|58906926|FG001|Overall Study|Adverse Event|1|||
30875877|NCT02700919|58906939|FG000|Overall Study|Physician Decision|1|||
30875878|NCT02700919|58906940|FG001|Overall Study|Physician Decision|0|||
30875879|NCT02700919|58906941|FG002|Overall Study|Physician Decision|0|||
30875880|NCT02700919|58906939|FG000|Overall Study|Protocol Violation|1|||
30875881|NCT02700919|58906940|FG001|Overall Study|Protocol Violation|0|||
30875882|NCT02700919|58906941|FG002|Overall Study|Protocol Violation|0|||
30875883|NCT02700919|58906939|FG000|Overall Study|Adverse Event|1|||
30875884|NCT02700919|58906940|FG001|Overall Study|Adverse Event|3|||
30875885|NCT02700919|58906941|FG002|Overall Study|Adverse Event|1|||
30875886|NCT02700919|58906939|FG000|Overall Study|Withdrawal by Subject|5|||
30875887|NCT02700919|58906940|FG001|Overall Study|Withdrawal by Subject|8|||
30875888|NCT02700919|58906941|FG002|Overall Study|Withdrawal by Subject|2|||
30875889|NCT02700919|58906939|FG000|Overall Study|Lost to Follow-up|2|||
30875890|NCT02700919|58906940|FG001|Overall Study|Lost to Follow-up|0|||
30875891|NCT02700919|58906941|FG002|Overall Study|Lost to Follow-up|0|||
30875892|NCT02700919|58906939|FG000|Overall Study|Other|2|||
30875893|NCT02700919|58906940|FG001|Overall Study|Other|1|||
30875894|NCT02700919|58906941|FG002|Overall Study|Other|1|||
30875895|NCT01986010|58906966|FG000|Overall Study|Adverse Event|0|||
30875896|NCT01986010|58906967|FG001|Overall Study|Adverse Event|1|||
30875897|NCT01986010|58906968|FG002|Overall Study|Adverse Event|0|||
30875898|NCT01986010|58906969|FG003|Overall Study|Adverse Event|0|||
30875899|NCT01986010|58906970|FG004|Overall Study|Adverse Event|0|||
30875900|NCT01986010|58906971|FG005|Overall Study|Adverse Event|0|||
30875901|NCT01986010|58906972|FG006|Overall Study|Adverse Event|0|||
30875902|NCT01986010|58906973|FG007|Overall Study|Adverse Event|0|||
30875903|NCT01986010|58906974|FG008|Overall Study|Adverse Event|0|||
30875904|NCT01986010|58906975|FG009|Overall Study|Adverse Event|0|||
30875905|NCT01986010|58906976|FG010|Overall Study|Adverse Event|0|||
30875906|NCT01986010|58906977|FG011|Overall Study|Adverse Event|0|||
30875907|NCT01986010|58906978|FG012|Overall Study|Adverse Event|0|||
30875908|NCT01986010|58906979|FG013|Overall Study|Adverse Event|0|||
30875909|NCT01986010|58906980|FG014|Overall Study|Adverse Event|0|||
30875910|NCT01986010|58906981|FG015|Overall Study|Adverse Event|1|||
30875911|NCT01986010|58906982|FG016|Overall Study|Adverse Event|0|||
30875912|NCT01986010|58906966|FG000|Overall Study|Lost to Follow-up|2|||
30875913|NCT01986010|58906967|FG001|Overall Study|Lost to Follow-up|1|||
30875914|NCT01986010|58906968|FG002|Overall Study|Lost to Follow-up|2|||
30875915|NCT01986010|58906969|FG003|Overall Study|Lost to Follow-up|2|||
30875916|NCT01986010|58906970|FG004|Overall Study|Lost to Follow-up|2|||
30875917|NCT01986010|58906971|FG005|Overall Study|Lost to Follow-up|2|||
30875918|NCT01986010|58906972|FG006|Overall Study|Lost to Follow-up|0|||
30875919|NCT01986010|58906973|FG007|Overall Study|Lost to Follow-up|0|||
30875920|NCT01986010|58906974|FG008|Overall Study|Lost to Follow-up|4|||
30875921|NCT01986010|58906975|FG009|Overall Study|Lost to Follow-up|2|||
30875922|NCT01986010|58906976|FG010|Overall Study|Lost to Follow-up|0|||
30875923|NCT01986010|58906977|FG011|Overall Study|Lost to Follow-up|1|||
30875924|NCT01986010|58906978|FG012|Overall Study|Lost to Follow-up|1|||
30875925|NCT01986010|58906979|FG013|Overall Study|Lost to Follow-up|1|||
30875926|NCT01986010|58906980|FG014|Overall Study|Lost to Follow-up|2|||
30875927|NCT01986010|58906981|FG015|Overall Study|Lost to Follow-up|0|||
30875928|NCT01986010|58906982|FG016|Overall Study|Lost to Follow-up|0|||
30875929|NCT01986010|58906966|FG000|Overall Study|Physician Decision|0|||
30875930|NCT01986010|58906967|FG001|Overall Study|Physician Decision|0|||
30875931|NCT01986010|58906968|FG002|Overall Study|Physician Decision|0|||
30875932|NCT01986010|58906969|FG003|Overall Study|Physician Decision|0|||
30875933|NCT01986010|58906970|FG004|Overall Study|Physician Decision|0|||
30875934|NCT01986010|58906971|FG005|Overall Study|Physician Decision|0|||
30875935|NCT01986010|58906972|FG006|Overall Study|Physician Decision|0|||
30875936|NCT01986010|58906973|FG007|Overall Study|Physician Decision|0|||
30875937|NCT01986010|58906974|FG008|Overall Study|Physician Decision|0|||
30875938|NCT01986010|58906975|FG009|Overall Study|Physician Decision|0|||
30875939|NCT01986010|58906976|FG010|Overall Study|Physician Decision|0|||
30875940|NCT01986010|58906977|FG011|Overall Study|Physician Decision|0|||
30875941|NCT01986010|58906978|FG012|Overall Study|Physician Decision|0|||
30875942|NCT01986010|58906979|FG013|Overall Study|Physician Decision|0|||
30875943|NCT01986010|58906980|FG014|Overall Study|Physician Decision|1|||
30875944|NCT01986010|58906981|FG015|Overall Study|Physician Decision|0|||
30875945|NCT01986010|58906982|FG016|Overall Study|Physician Decision|0|||
30875946|NCT01986010|58906966|FG000|Overall Study|Withdrawal by Subject|2|||
30875947|NCT01986010|58906967|FG001|Overall Study|Withdrawal by Subject|2|||
30875948|NCT01986010|58906968|FG002|Overall Study|Withdrawal by Subject|3|||
30875949|NCT01986010|58906969|FG003|Overall Study|Withdrawal by Subject|0|||
30875950|NCT01986010|58906970|FG004|Overall Study|Withdrawal by Subject|2|||
30875951|NCT01986010|58906971|FG005|Overall Study|Withdrawal by Subject|4|||
30875952|NCT01986010|58906972|FG006|Overall Study|Withdrawal by Subject|0|||
30875953|NCT01986010|58906973|FG007|Overall Study|Withdrawal by Subject|0|||
30875954|NCT01986010|58906974|FG008|Overall Study|Withdrawal by Subject|0|||
30875955|NCT01986010|58906975|FG009|Overall Study|Withdrawal by Subject|0|||
30875956|NCT01986010|58906976|FG010|Overall Study|Withdrawal by Subject|0|||
30875957|NCT01986010|58906977|FG011|Overall Study|Withdrawal by Subject|2|||
30875958|NCT01986010|58906978|FG012|Overall Study|Withdrawal by Subject|0|||
30875959|NCT01986010|58906979|FG013|Overall Study|Withdrawal by Subject|1|||
30875960|NCT01986010|58906980|FG014|Overall Study|Withdrawal by Subject|2|||
30875961|NCT01986010|58906981|FG015|Overall Study|Withdrawal by Subject|0|||
30875962|NCT01986010|58906982|FG016|Overall Study|Withdrawal by Subject|0|||
30875963|NCT01986010|58906966|FG000|Overall Study|Status Not Recorded|2|||
30875964|NCT01986010|58906967|FG001|Overall Study|Status Not Recorded|4|||
30875965|NCT01986010|58906968|FG002|Overall Study|Status Not Recorded|2|||
30875966|NCT01986010|58906969|FG003|Overall Study|Status Not Recorded|0|||
30875967|NCT01986010|58906970|FG004|Overall Study|Status Not Recorded|1|||
30875968|NCT01986010|58906971|FG005|Overall Study|Status Not Recorded|2|||
30875969|NCT01986010|58906972|FG006|Overall Study|Status Not Recorded|0|||
30875970|NCT01986010|58906973|FG007|Overall Study|Status Not Recorded|0|||
30875971|NCT01986010|58906974|FG008|Overall Study|Status Not Recorded|2|||
30875972|NCT01986010|58906975|FG009|Overall Study|Status Not Recorded|1|||
30875973|NCT01986010|58906976|FG010|Overall Study|Status Not Recorded|7|||
30875974|NCT01986010|58906977|FG011|Overall Study|Status Not Recorded|7|||
30875975|NCT01986010|58906978|FG012|Overall Study|Status Not Recorded|9|||
30875976|NCT01986010|58906979|FG013|Overall Study|Status Not Recorded|9|||
30875977|NCT01986010|58906980|FG014|Overall Study|Status Not Recorded|5|||
30875978|NCT01986010|58906981|FG015|Overall Study|Status Not Recorded|10|||
30875979|NCT01986010|58906982|FG016|Overall Study|Status Not Recorded|4|||
30875980|NCT01963780|58907028|FG000|Overall Study|Death|7|||
30875981|NCT02009878|58907035|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
30875982|NCT02009878|58907036|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
30875983|NCT02009878|58907037|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
30875984|NCT02009722|58907047|FG000|Overall Study|Protocol Violation|1|||
30875985|NCT02009722|58907048|FG001|Overall Study|Protocol Violation|2|||
30875986|NCT02009722|58907047|FG000|Overall Study|Did not receive intervention|0|||
30875987|NCT02009722|58907048|FG001|Overall Study|Did not receive intervention|1|||
30875988|NCT02655419|58907056|FG000|Overall Study|Enrolled but not treated|1|||
30875989|NCT02655419|58907057|FG001|Overall Study|Enrolled but not treated|5|||
30875990|NCT02655419|58907056|FG000|Overall Study|Withdrawal by Subject|4|||
30875991|NCT02655419|58907057|FG001|Overall Study|Withdrawal by Subject|1|||
30875992|NCT02655419|58907056|FG000|Overall Study|Other|0|||
30875993|NCT02655419|58907057|FG001|Overall Study|Other|1|||
30875994|NCT01962922|58907069|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
30875995|NCT01962922|58907070|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
30875996|NCT01962922|58907069|FG000|PK Portion Day 7|non-compliance|1|||
30875997|NCT01962922|58907070|FG001|PK Portion Day 7|non-compliance|0|||
30875998|NCT01962922|58907069|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
30875999|NCT01962922|58907070|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
30876000|NCT01962922|58907069|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
30876001|NCT01962922|58907070|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
30876002|NCT01984684|58907078|FG000|Overall Study|Lost to Follow-up|25|||
30876003|NCT01984684|58907079|FG001|Overall Study|Lost to Follow-up|24|||
30876004|NCT01984684|58907078|FG000|Overall Study|Adverse Event|8|||
30876005|NCT01984684|58907079|FG001|Overall Study|Adverse Event|12|||
30876006|NCT01984684|58907078|FG000|Overall Study|Withdrawal by Subject|9|||
30876007|NCT01984684|58907079|FG001|Overall Study|Withdrawal by Subject|9|||
30876008|NCT01984684|58907078|FG000|Overall Study|Lack of Efficacy|3|||
30876009|NCT01984684|58907079|FG001|Overall Study|Lack of Efficacy|6|||
30876010|NCT01984684|58907078|FG000|Overall Study|Physician Decision|4|||
30876011|NCT01984684|58907079|FG001|Overall Study|Physician Decision|2|||
30876012|NCT01984684|58907078|FG000|Overall Study|Protocol Violation|4|||
30876013|NCT01984684|58907079|FG001|Overall Study|Protocol Violation|2|||
30876014|NCT01984684|58907078|FG000|Overall Study|Death|0|||
30876015|NCT01984684|58907079|FG001|Overall Study|Death|1|||
30876016|NCT01984684|58907078|FG000|Overall Study|Noncompliance with study drug|2|||
30876017|NCT01984684|58907079|FG001|Overall Study|Noncompliance with study drug|1|||
30876018|NCT01984684|58907078|FG000|Overall Study|Subject incarcerated|1|||
30876019|NCT01984684|58907079|FG001|Overall Study|Subject incarcerated|0|||
30876020|NCT01984684|58907078|FG000|Overall Study|Study drug not available at site|1|||
30876021|NCT01984684|58907079|FG001|Overall Study|Study drug not available at site|1|||
30876022|NCT01984684|58907078|FG000|Overall Study|Subject had inadequate IV access|0|||
30876023|NCT01984684|58907079|FG001|Overall Study|Subject had inadequate IV access|1|||
30876024|NCT02694523|58907087|FG000|Part A|Adverse Event|7|||
30876025|NCT02694523|58907088|FG001|Part A|Adverse Event|3|||
30876026|NCT02694523|58907089|FG002|Part A|Adverse Event|0|||
30876027|NCT02694523|58907090|FG003|Part A|Adverse Event|0|||
30962689|NCT01482767|59030291|FG001|Overall Study|Alternate HCV treatment|8|||
30962690|NCT01482767|59030290|FG000|Overall Study|Ineligible|0|||
30962691|NCT01482767|59030291|FG001|Overall Study|Ineligible|5|||
30962692|NCT01482767|59030290|FG000|Overall Study|Nurse error|1|||
30962693|NCT01482767|59030291|FG001|Overall Study|Nurse error|0|||
30962694|NCT01482221|59030320|FG000|Overall Study|Lack of Efficacy|1|||
30962695|NCT01482221|59030321|FG001|Overall Study|Lack of Efficacy|0|||
30962696|NCT01482221|59030322|FG002|Overall Study|Lack of Efficacy|1|||
30876028|NCT02694523|58907091|FG004|Part A|Adverse Event|0|||
30876029|NCT02694523|58907092|FG005|Part A|Adverse Event|0|||
30876030|NCT02694523|58907093|FG006|Part A|Adverse Event|0|||
30876031|NCT02694523|58907087|FG000|Part A|Protocol Violation|1|||
30876032|NCT02694523|58907088|FG001|Part A|Protocol Violation|0|||
30876033|NCT02694523|58907089|FG002|Part A|Protocol Violation|0|||
30876034|NCT02694523|58907090|FG003|Part A|Protocol Violation|0|||
30876035|NCT02694523|58907091|FG004|Part A|Protocol Violation|0|||
30876036|NCT02694523|58907092|FG005|Part A|Protocol Violation|0|||
30876037|NCT02694523|58907093|FG006|Part A|Protocol Violation|0|||
30876038|NCT02694523|58907087|FG000|Part A|Lost to Follow-up|1|||
30876039|NCT02694523|58907088|FG001|Part A|Lost to Follow-up|2|||
30876040|NCT02694523|58907089|FG002|Part A|Lost to Follow-up|0|||
30876041|NCT02694523|58907090|FG003|Part A|Lost to Follow-up|0|||
30876042|NCT02694523|58907091|FG004|Part A|Lost to Follow-up|0|||
30876043|NCT02694523|58907092|FG005|Part A|Lost to Follow-up|0|||
30876044|NCT02694523|58907093|FG006|Part A|Lost to Follow-up|0|||
30876045|NCT02694523|58907087|FG000|Part A|Withdrawal by Subject|3|||
30876046|NCT02694523|58907088|FG001|Part A|Withdrawal by Subject|1|||
30962697|NCT01482221|59030320|FG000|Overall Study|Lost to Follow-up|3|||
30962698|NCT01482221|59030321|FG001|Overall Study|Lost to Follow-up|2|||
30962699|NCT01482221|59030322|FG002|Overall Study|Lost to Follow-up|1|||
30876047|NCT02694523|58907089|FG002|Part A|Withdrawal by Subject|0|||
30876048|NCT02694523|58907090|FG003|Part A|Withdrawal by Subject|0|||
30876049|NCT02694523|58907091|FG004|Part A|Withdrawal by Subject|0|||
30876050|NCT02694523|58907092|FG005|Part A|Withdrawal by Subject|0|||
30876051|NCT02694523|58907093|FG006|Part A|Withdrawal by Subject|0|||
30876052|NCT02694523|58907087|FG000|Part A|Other|1|||
30876053|NCT02694523|58907088|FG001|Part A|Other|1|||
30876054|NCT02694523|58907089|FG002|Part A|Other|0|||
30876055|NCT02694523|58907090|FG003|Part A|Other|0|||
30876056|NCT02694523|58907091|FG004|Part A|Other|0|||
30876057|NCT02694523|58907092|FG005|Part A|Other|0|||
30876058|NCT02694523|58907093|FG006|Part A|Other|0|||
30876059|NCT02694523|58907087|FG000|Part B|Adverse Event|0|||
30876060|NCT02694523|58907088|FG001|Part B|Adverse Event|0|||
30876061|NCT02694523|58907089|FG002|Part B|Adverse Event|7|||
30876062|NCT02694523|58907090|FG003|Part B|Adverse Event|1|||
30962700|NCT01482221|59030320|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
30962701|NCT01482221|59030321|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
30962702|NCT01482221|59030322|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
30962703|NCT01482221|59030320|FG000|Overall Study|Condition under Investigation Worsened|3|||
30962704|NCT01482221|59030321|FG001|Overall Study|Condition under Investigation Worsened|2|||
30962705|NCT01482221|59030322|FG002|Overall Study|Condition under Investigation Worsened|4|||
30962706|NCT01482221|59030320|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
30962707|NCT01482221|59030321|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
30962708|NCT01482221|59030322|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
30962709|NCT01482221|59030320|FG000|Overall Study|Adverse Event|1|||
30962710|NCT01482221|59030321|FG001|Overall Study|Adverse Event|7|||
30962711|NCT01482221|59030322|FG002|Overall Study|Adverse Event|3|||
30962712|NCT01482221|59030320|FG000|Overall Study|Withdrawal by Subject|10|||
30962713|NCT01482221|59030321|FG001|Overall Study|Withdrawal by Subject|7|||
30962714|NCT01482221|59030322|FG002|Overall Study|Withdrawal by Subject|12|||
30962715|NCT01482221|59030320|FG000|Overall Study|Incorrect randomization|0|||
30962716|NCT01482221|59030321|FG001|Overall Study|Incorrect randomization|1|||
30962717|NCT01482221|59030322|FG002|Overall Study|Incorrect randomization|0|||
30962718|NCT01482221|59030320|FG000|Overall Study|Physician Decision|0|||
30962719|NCT01482221|59030321|FG001|Overall Study|Physician Decision|1|||
30962720|NCT01482221|59030322|FG002|Overall Study|Physician Decision|0|||
30962721|NCT01482065|59030332|FG000|Overall Study|Withdrawal by Subject|0|||
30962722|NCT01482065|59030333|FG001|Overall Study|Withdrawal by Subject|1|||
30962723|NCT01545817|59030348|FG000|Pazopanib|Disease progression|51|||
30962724|NCT01545817|59030349|FG001|Pazopanib|Disease progression|0|||
30962725|NCT01545817|59030348|FG000|Pazopanib|Adverse Event|19|||
30962726|NCT01545817|59030349|FG001|Pazopanib|Adverse Event|0|||
30962727|NCT01545817|59030348|FG000|Pazopanib|Other reason|4|||
30962728|NCT01545817|59030349|FG001|Pazopanib|Other reason|0|||
30962729|NCT01545817|59030348|FG000|Everolimus|Other reason|0|||
30962730|NCT01545817|59030349|FG001|Everolimus|Other reason|7|||
30962731|NCT01545817|59030348|FG000|Everolimus|Disease progression|0|||
30962732|NCT01545817|59030349|FG001|Everolimus|Disease progression|25|||
30962733|NCT01545817|59030348|FG000|Everolimus|Adverse Event|0|||
30962734|NCT01545817|59030349|FG001|Everolimus|Adverse Event|6|||
30962735|NCT01512979|59030368|FG000|Overall Study|Adverse Event|2|||
30962736|NCT01512979|59030369|FG001|Overall Study|Adverse Event|2|||
30962737|NCT01512979|59030368|FG000|Overall Study|Protocol Violation|1|||
30962738|NCT01512979|59030369|FG001|Overall Study|Protocol Violation|4|||
30962739|NCT01512979|59030368|FG000|Overall Study|Lost to Follow-up|2|||
30962740|NCT01512979|59030369|FG001|Overall Study|Lost to Follow-up|5|||
30962741|NCT01512979|59030368|FG000|Overall Study|Withdrawal by Subject|1|||
30962742|NCT01512979|59030369|FG001|Overall Study|Withdrawal by Subject|2|||
30962743|NCT01512979|59030368|FG000|Overall Study|Reason other than stated above|13|||
30962744|NCT01512979|59030369|FG001|Overall Study|Reason other than stated above|9|||
30962745|NCT01512745|59030381|FG000|Overall Study|Adverse Event|22|||
30962746|NCT01512745|59030382|FG001|Overall Study|Adverse Event|3|||
30962747|NCT01512745|59030381|FG000|Overall Study|Death|9|||
30962748|NCT01512745|59030382|FG001|Overall Study|Death|13|||
30962749|NCT01512745|59030381|FG000|Overall Study|Withdrawal by Subject|2|||
30962750|NCT01512745|59030382|FG001|Overall Study|Withdrawal by Subject|2|||
30962751|NCT01512745|59030381|FG000|Overall Study|Lost to Follow-up|4|||
30962752|NCT01512745|59030382|FG001|Overall Study|Lost to Follow-up|0|||
30962753|NCT01512745|59030381|FG000|Overall Study|Lack of Efficacy|2|||
30962754|NCT01512745|59030382|FG001|Overall Study|Lack of Efficacy|2|||
30962755|NCT01512745|59030381|FG000|Overall Study|Protocol Violation|1|||
30962756|NCT01512745|59030382|FG001|Overall Study|Protocol Violation|0|||
30962757|NCT01478321|59030388|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
30962758|NCT01478321|59030388|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
30962759|NCT01478321|59030388|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
30962760|NCT01478321|59030388|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
30962761|NCT01478321|59030388|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
30962762|NCT01478321|59030388|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
30962763|NCT01478321|59030388|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
30962764|NCT01478321|59030388|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
30962765|NCT01544491|59030394|FG000|Overall Study|Withdrawal by Subject|3|||
30962766|NCT01544491|59030395|FG001|Overall Study|Withdrawal by Subject|2|||
30962767|NCT01544491|59030394|FG000|Overall Study|Lost to Follow-up|0|||
30962768|NCT01544491|59030395|FG001|Overall Study|Lost to Follow-up|1|||
30962769|NCT01544491|59030394|FG000|Overall Study|administrative problems|2|||
30962770|NCT01544491|59030395|FG001|Overall Study|administrative problems|0|||
30962771|NCT01478087|59030414|FG000|Overall Study|due to sponsor closing study|1|||
30962772|NCT01477853|59030432|FG000|Phase A|Adverse Event|1|||
30962773|NCT01477853|59030433|FG001|Phase A|Adverse Event|2|||
30962774|NCT01477853|59030434|FG002|Phase A|Adverse Event|2|||
30962775|NCT01477853|59030432|FG000|Phase A|Lost to Follow-up|4|||
30962776|NCT01477853|59030433|FG001|Phase A|Lost to Follow-up|3|||
30962777|NCT01477853|59030434|FG002|Phase A|Lost to Follow-up|2|||
30962778|NCT01477853|59030432|FG000|Phase A|Physician Decision|1|||
30962779|NCT01477853|59030433|FG001|Phase A|Physician Decision|0|||
30962780|NCT01477853|59030434|FG002|Phase A|Physician Decision|1|||
30962781|NCT01477853|59030432|FG000|Phase A|Study terminated by sponsor|37|||
30962782|NCT01477853|59030433|FG001|Phase A|Study terminated by sponsor|40|||
30962783|NCT01477853|59030434|FG002|Phase A|Study terminated by sponsor|39|||
30962784|NCT01477853|59030432|FG000|Phase B|Lost to Follow-up|0|||
30962785|NCT01477853|59030433|FG001|Phase B|Lost to Follow-up|1|||
30962786|NCT01477853|59030434|FG002|Phase B|Lost to Follow-up|0|||
30962787|NCT01477853|59030432|FG000|Phase B|Study terminated by sponsor|12|||
30962788|NCT01477853|59030433|FG001|Phase B|Study terminated by sponsor|10|||
30962789|NCT01477853|59030434|FG002|Phase B|Study terminated by sponsor|11|||
30962790|NCT01511419|59030466|FG000|Dose 2|Physician Decision|1|||
30962791|NCT01511419|59030467|FG001|Dose 2|Physician Decision|0|||
30962792|NCT01511107|59030529|FG000|Overall Study|Ineligible|3|||
30962793|NCT01511107|59030530|FG001|Overall Study|Ineligible|2|||
30962794|NCT01511107|59030529|FG000|Overall Study|Lost to Follow-up|10|||
30962795|NCT01511107|59030530|FG001|Overall Study|Lost to Follow-up|19|||
30962796|NCT01511107|59030529|FG000|Overall Study|Withdrawal by Subject|9|||
30962797|NCT01511107|59030530|FG001|Overall Study|Withdrawal by Subject|20|||
30962798|NCT01484977|59030565|FG000|Overall Study|Adverse Event|8|||
30962799|NCT01484977|59030565|FG000|Overall Study|Lack of Efficacy|4|||
30962800|NCT01484977|59030565|FG000|Overall Study|Protocol Violation|6|||
30962801|NCT01484977|59030565|FG000|Overall Study|Lost to Follow-up|1|||
30962802|NCT01484977|59030565|FG000|Overall Study|Withdrawal by Subject|4|||
30962803|NCT01484977|59030565|FG000|Overall Study|Subject Protocol Non-compliant|1|||
30962804|NCT01484977|59030565|FG000|Overall Study|Moving Overseas|1|||
30962805|NCT01484977|59030565|FG000|Overall Study|Low White Blood Cell Count|1|||
30962806|NCT01484977|59030565|FG000|Overall Study|Lack of Compliance|1|||
30962807|NCT01475825|59030645|FG000|Overall Study|Adverse Event|41|||
30962808|NCT01475825|59030646|FG001|Overall Study|Adverse Event|15|||
30962809|NCT01475825|59030647|FG002|Overall Study|Adverse Event|27|||
30962810|NCT01475825|59030648|FG003|Overall Study|Adverse Event|11|||
30962811|NCT01475825|59030645|FG000|Overall Study|Death|1|||
30962812|NCT01475825|59030646|FG001|Overall Study|Death|0|||
30962813|NCT01475825|59030647|FG002|Overall Study|Death|1|||
30962814|NCT01475825|59030648|FG003|Overall Study|Death|0|||
30962815|NCT01475825|59030645|FG000|Overall Study|Lack of Efficacy|0|||
30962816|NCT01475825|59030646|FG001|Overall Study|Lack of Efficacy|0|||
30962817|NCT01475825|59030647|FG002|Overall Study|Lack of Efficacy|1|||
30962818|NCT01475825|59030648|FG003|Overall Study|Lack of Efficacy|0|||
30962819|NCT01475825|59030645|FG000|Overall Study|Lost to Follow-up|0|||
30962820|NCT01475825|59030646|FG001|Overall Study|Lost to Follow-up|0|||
30962821|NCT01475825|59030647|FG002|Overall Study|Lost to Follow-up|3|||
30962822|NCT01475825|59030648|FG003|Overall Study|Lost to Follow-up|1|||
30962823|NCT01475825|59030645|FG000|Overall Study|Non-compliance with Study Drug|1|||
30962824|NCT01475825|59030646|FG001|Overall Study|Non-compliance with Study Drug|2|||
30962825|NCT01475825|59030647|FG002|Overall Study|Non-compliance with Study Drug|4|||
30962826|NCT01475825|59030648|FG003|Overall Study|Non-compliance with Study Drug|0|||
30962827|NCT01475825|59030645|FG000|Overall Study|Other: Not available|0|||
30962828|NCT01475825|59030646|FG001|Overall Study|Other: Not available|0|||
30962829|NCT01475825|59030647|FG002|Overall Study|Other: Not available|2|||
30962830|NCT01475825|59030648|FG003|Overall Study|Other: Not available|0|||
30962831|NCT01475825|59030645|FG000|Overall Study|Protocol Violation|1|||
30962832|NCT01475825|59030646|FG001|Overall Study|Protocol Violation|0|||
30962833|NCT01475825|59030647|FG002|Overall Study|Protocol Violation|0|||
30962834|NCT01475825|59030648|FG003|Overall Study|Protocol Violation|0|||
30962835|NCT01475825|59030645|FG000|Overall Study|Physician Decision|0|||
30962836|NCT01475825|59030646|FG001|Overall Study|Physician Decision|1|||
30962837|NCT01475825|59030647|FG002|Overall Study|Physician Decision|0|||
30962838|NCT01475825|59030648|FG003|Overall Study|Physician Decision|0|||
30962839|NCT01475825|59030645|FG000|Overall Study|Withdrawal by Subject|8|||
30962840|NCT01475825|59030646|FG001|Overall Study|Withdrawal by Subject|3|||
30962841|NCT01475825|59030647|FG002|Overall Study|Withdrawal by Subject|11|||
30962842|NCT01475825|59030648|FG003|Overall Study|Withdrawal by Subject|7|||
30962843|NCT01475825|59030645|FG000|Overall Study|Did not enter OLC|15|||
30962844|NCT01475825|59030646|FG001|Overall Study|Did not enter OLC|11|||
30962845|NCT01475825|59030647|FG002|Overall Study|Did not enter OLC|15|||
30962846|NCT01475825|59030648|FG003|Overall Study|Did not enter OLC|11|||
30962847|NCT01484431|59030670|FG000|Period 1: High Dose|Physician Decision|0|||
30962848|NCT01484431|59030671|FG001|Period 1: High Dose|Physician Decision|1|||
30962849|NCT01484431|59030672|FG002|Period 1: High Dose|Physician Decision|0|||
30962850|NCT01484431|59030670|FG000|Period 2|Death|0|||
30962851|NCT01484431|59030671|FG001|Period 2|Death|1|||
30962852|NCT01484431|59030672|FG002|Period 2|Death|1|||
30962853|NCT01484431|59030670|FG000|Period 2|Physician Decision|0|||
30962854|NCT01484431|59030671|FG001|Period 2|Physician Decision|0|||
30962855|NCT01484431|59030672|FG002|Period 2|Physician Decision|1|||
30962856|NCT01484431|59030670|FG000|Period 2|Non-Compliance with Study Drug|1|||
30962857|NCT01484431|59030671|FG001|Period 2|Non-Compliance with Study Drug|0|||
30604844|NCT01225731|58615771|FG000|Part 1|Withdrawal by Subject|0|||
30876063|NCT02694523|58907091|FG004|Part B|Adverse Event|1|||
30876064|NCT02694523|58907092|FG005|Part B|Adverse Event|2|||
30876065|NCT02694523|58907093|FG006|Part B|Adverse Event|0|||
30876066|NCT02694523|58907087|FG000|Part B|Protocol Violation|0|||
30876067|NCT02694523|58907088|FG001|Part B|Protocol Violation|0|||
30876068|NCT02694523|58907089|FG002|Part B|Protocol Violation|1|||
30876069|NCT02694523|58907090|FG003|Part B|Protocol Violation|0|||
30876070|NCT02694523|58907091|FG004|Part B|Protocol Violation|0|||
30876071|NCT02694523|58907092|FG005|Part B|Protocol Violation|0|||
30876072|NCT02694523|58907093|FG006|Part B|Protocol Violation|0|||
30876073|NCT02694523|58907087|FG000|Part B|Lost to Follow-up|0|||
30876074|NCT02694523|58907088|FG001|Part B|Lost to Follow-up|0|||
30876075|NCT02694523|58907089|FG002|Part B|Lost to Follow-up|2|||
30876076|NCT02694523|58907090|FG003|Part B|Lost to Follow-up|3|||
30876077|NCT02694523|58907091|FG004|Part B|Lost to Follow-up|2|||
30876078|NCT02694523|58907092|FG005|Part B|Lost to Follow-up|0|||
30876079|NCT02694523|58907093|FG006|Part B|Lost to Follow-up|1|||
30876080|NCT02694523|58907087|FG000|Part B|Withdrawal by Subject|0|||
30876081|NCT02694523|58907088|FG001|Part B|Withdrawal by Subject|0|||
30876082|NCT02694523|58907089|FG002|Part B|Withdrawal by Subject|9|||
30876083|NCT02694523|58907090|FG003|Part B|Withdrawal by Subject|0|||
30876084|NCT02694523|58907091|FG004|Part B|Withdrawal by Subject|1|||
30876085|NCT02694523|58907092|FG005|Part B|Withdrawal by Subject|3|||
30876086|NCT02694523|58907093|FG006|Part B|Withdrawal by Subject|0|||
30876087|NCT02694523|58907087|FG000|Part B|Other|0|||
30876088|NCT02694523|58907088|FG001|Part B|Other|0|||
30876089|NCT02694523|58907089|FG002|Part B|Other|1|||
30876090|NCT02694523|58907090|FG003|Part B|Other|0|||
30876091|NCT02694523|58907091|FG004|Part B|Other|0|||
30876092|NCT02694523|58907092|FG005|Part B|Other|0|||
30876093|NCT02694523|58907093|FG006|Part B|Other|1|||
30876094|NCT01353703|58907107|FG000|Overall Study|Migrated/moved from study area|1|||
30876095|NCT01353703|58907108|FG001|Overall Study|Migrated/moved from study area|0|||
30876096|NCT02009332|58907122|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
30876097|NCT02009332|58907123|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
30876098|NCT02009332|58907124|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
30876099|NCT02009332|58907125|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
30876100|NCT02009332|58907126|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
30876101|NCT02009332|58907127|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
30876102|NCT02009332|58907122|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
30876103|NCT02009332|58907123|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
30876104|NCT02009332|58907124|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
30876105|NCT02009332|58907125|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
30876106|NCT02009332|58907126|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
30876107|NCT02009332|58907127|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
30876108|NCT02009332|58907122|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
30876109|NCT02009332|58907123|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
30876110|NCT02009332|58907124|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
30876111|NCT02009332|58907125|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
30876112|NCT02009332|58907126|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
30876113|NCT02009332|58907127|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
30876114|NCT01984294|58907144|FG000|Overall Study|Randomized but Never Treated|0|||
30876115|NCT01984294|58907145|FG001|Overall Study|Randomized but Never Treated|0|||
30876116|NCT01984294|58907146|FG002|Overall Study|Randomized but Never Treated|1|||
30876117|NCT01984294|58907144|FG000|Overall Study|Lack of Efficacy|4|||
30876118|NCT01984294|58907145|FG001|Overall Study|Lack of Efficacy|2|||
30876119|NCT01984294|58907146|FG002|Overall Study|Lack of Efficacy|6|||
30876120|NCT01984294|58907144|FG000|Overall Study|Adverse Event|0|||
30876121|NCT01984294|58907145|FG001|Overall Study|Adverse Event|1|||
30876122|NCT01984294|58907146|FG002|Overall Study|Adverse Event|0|||
30876123|NCT01962298|58907159|FG000|Overall Study|Protocol Violation|1|||
30876124|NCT01962298|58907160|FG001|Overall Study|Protocol Violation|0|||
30876125|NCT01962298|58907161|FG002|Overall Study|Protocol Violation|1|||
30876126|NCT01962298|58907162|FG003|Overall Study|Protocol Violation|1|||
30876127|NCT01962298|58907163|FG004|Overall Study|Protocol Violation|0|||
30876128|NCT01962298|58907159|FG000|Overall Study|Data quality insufficient|2|||
30876129|NCT01962298|58907160|FG001|Overall Study|Data quality insufficient|0|||
30876130|NCT01962298|58907161|FG002|Overall Study|Data quality insufficient|3|||
30876131|NCT01962298|58907162|FG003|Overall Study|Data quality insufficient|1|||
30876132|NCT01962298|58907163|FG004|Overall Study|Data quality insufficient|4|||
30876133|NCT01962298|58907159|FG000|Overall Study|Insufficient data|0|||
30876134|NCT01962298|58907160|FG001|Overall Study|Insufficient data|2|||
30876135|NCT01962298|58907161|FG002|Overall Study|Insufficient data|1|||
30876136|NCT01962298|58907162|FG003|Overall Study|Insufficient data|0|||
30876137|NCT01962298|58907163|FG004|Overall Study|Insufficient data|1|||
30876138|NCT01962298|58907159|FG000|Overall Study|Incorrect data recorded|0|||
30876139|NCT01962298|58907160|FG001|Overall Study|Incorrect data recorded|1|||
30962858|NCT01484431|59030672|FG002|Period 2|Non-Compliance with Study Drug|0|||
30962859|NCT01473953|59030720|FG000|Overall Study|Other|1|||
30962860|NCT01473953|59030721|FG001|Overall Study|Other|0|||
30962861|NCT01473953|59030722|FG002|Overall Study|Other|0|||
30962862|NCT01473953|59030723|FG003|Overall Study|Other|0|||
30962863|NCT01473953|59030724|FG004|Overall Study|Other|0|||
30962864|NCT01510717|59030738|FG000|Overall Study|Adverse Event|1|||
30962865|NCT01510717|59030739|FG001|Overall Study|Adverse Event|2|||
30962866|NCT01510717|59030738|FG000|Overall Study|Death|1|||
30962867|NCT01510717|59030739|FG001|Overall Study|Death|0|||
30962868|NCT01510717|59030738|FG000|Overall Study|Lost to Follow-up|0|||
30962869|NCT01510717|59030739|FG001|Overall Study|Lost to Follow-up|1|||
30962870|NCT01510717|59030738|FG000|Overall Study|Withdrawal by Subject|0|||
30962871|NCT01510717|59030739|FG001|Overall Study|Withdrawal by Subject|2|||
30962872|NCT01473563|59030755|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
30962873|NCT01484275|59030773|FG000|Overall Study|Study terminated by sponsor|28|||
30962874|NCT01484275|59030774|FG001|Overall Study|Study terminated by sponsor|32|||
30962875|NCT01484275|59030773|FG000|Overall Study|Other|10|||
30962876|NCT01484275|59030774|FG001|Overall Study|Other|0|||
30962877|NCT01484275|59030773|FG000|Overall Study|Death|3|||
30962878|NCT01484275|59030774|FG001|Overall Study|Death|4|||
30962879|NCT01484275|59030773|FG000|Overall Study|Withdrawal by Subject|1|||
30962880|NCT01484275|59030774|FG001|Overall Study|Withdrawal by Subject|5|||
30962881|NCT01484275|59030773|FG000|Overall Study|Lost to Follow-up|1|||
30962882|NCT01484275|59030774|FG001|Overall Study|Lost to Follow-up|1|||
30962883|NCT01544335|59030780|FG000|Overall Study|Lost to Follow-up|27|||
30962884|NCT01544335|59030780|FG000|Overall Study|Death|4|||
30962885|NCT01544335|59030780|FG000|Overall Study|Disease progression|3|||
30962886|NCT01544335|59030780|FG000|Overall Study|Baseline Measurements not Available|19|||
30962887|NCT01484197|59030784|FG000|Treatment Period 1|Adverse Event|1|||
30962888|NCT01484197|59030785|FG001|Treatment Period 1|Adverse Event|0|||
30962889|NCT01484197|59030786|FG002|Treatment Period 1|Adverse Event|0|||
30962890|NCT01484197|59030787|FG003|Treatment Period 1|Adverse Event|0|||
30962891|NCT01484197|59030784|FG000|Treatment Period 2|Subject withdrew consent|0|||
30962892|NCT01484197|59030785|FG001|Treatment Period 2|Subject withdrew consent|0|||
30962893|NCT01484197|59030786|FG002|Treatment Period 2|Subject withdrew consent|0|||
30962894|NCT01484197|59030787|FG003|Treatment Period 2|Subject withdrew consent|1|||
30962895|NCT01473407|59030799|FG000|Overall Study|Physician Decision|1|||
30962896|NCT01473407|59030800|FG001|Overall Study|Physician Decision|4|||
30962897|NCT01473407|59030799|FG000|Overall Study|Lost to Follow-up|10|||
30962898|NCT01473407|59030800|FG001|Overall Study|Lost to Follow-up|4|||
30962899|NCT01473407|59030799|FG000|Overall Study|Adverse Event|8|||
30962900|NCT01473407|59030800|FG001|Overall Study|Adverse Event|8|||
30962901|NCT01473407|59030799|FG000|Overall Study|Randomization Error|3|||
30962902|NCT01473407|59030800|FG001|Overall Study|Randomization Error|1|||
30962903|NCT01473407|59030799|FG000|Overall Study|Withdrawal by Subject|4|||
30962904|NCT01473407|59030800|FG001|Overall Study|Withdrawal by Subject|7|||
30962905|NCT01473407|59030799|FG000|Overall Study|Kidney Transplant|7|||
30962906|NCT01473407|59030800|FG001|Overall Study|Kidney Transplant|6|||
30962907|NCT01473407|59030799|FG000|Overall Study|Vacation/Travel|1|||
30962908|NCT01473407|59030800|FG001|Overall Study|Vacation/Travel|1|||
30962909|NCT01473407|59030799|FG000|Overall Study|Elevated Hemoglobin|1|||
30604845|NCT01225731|58615772|FG001|Part 1|Withdrawal by Subject|3|||
30876140|NCT01962298|58907161|FG002|Overall Study|Incorrect data recorded|0|||
30876141|NCT01962298|58907162|FG003|Overall Study|Incorrect data recorded|0|||
30876142|NCT01962298|58907163|FG004|Overall Study|Incorrect data recorded|0|||
30876143|NCT01962298|58907159|FG000|Overall Study|Physician Decision|0|||
30876144|NCT01962298|58907160|FG001|Overall Study|Physician Decision|1|||
30876145|NCT01962298|58907161|FG002|Overall Study|Physician Decision|0|||
30876146|NCT01962298|58907162|FG003|Overall Study|Physician Decision|0|||
30876147|NCT01962298|58907163|FG004|Overall Study|Physician Decision|1|||
30876148|NCT02693743|58907177|FG000|Overall Study|Physician Decision|1|||
30876149|NCT02693743|58907178|FG001|Overall Study|Physician Decision|0|||
30876150|NCT02655887|58907184|FG000|Overall Study|Lost to Follow-up|3|||
30876151|NCT02655887|58907184|FG000|Overall Study|Death|4|||
30876152|NCT02655887|58907184|FG000|Overall Study|Withdrawal by Subject|3|||
30876153|NCT02655887|58907184|FG000|Overall Study|Missed 12-month follow-up visit|4|||
30876154|NCT02008318|58907190|FG000|Overall Study|Adverse Event|4|||
30876155|NCT02008318|58907191|FG001|Overall Study|Adverse Event|0|||
30876156|NCT02008318|58907190|FG000|Overall Study|Physician Decision|2|||
30876157|NCT02008318|58907191|FG001|Overall Study|Physician Decision|0|||
30876158|NCT02008318|58907190|FG000|Overall Study|Progressive Disease|2|||
30876159|NCT02008318|58907191|FG001|Overall Study|Progressive Disease|0|||
30876160|NCT02008318|58907190|FG000|Overall Study|Protocol Violation|1|||
30876161|NCT02008318|58907191|FG001|Overall Study|Protocol Violation|1|||
30876162|NCT02008318|58907190|FG000|Overall Study|Withdrawal by Subject|3|||
30876163|NCT02008318|58907191|FG001|Overall Study|Withdrawal by Subject|0|||
30876164|NCT01982812|58907202|FG000|Overall Study|Death|1|||
30876165|NCT01982812|58907203|FG001|Overall Study|Death|5|||
30962910|NCT01473407|59030800|FG001|Overall Study|Elevated Hemoglobin|0|||
30962911|NCT01473407|59030799|FG000|Overall Study|Patient Received Aranesp|1|||
30962912|NCT01473407|59030800|FG001|Overall Study|Patient Received Aranesp|0|||
30962913|NCT01473407|59030799|FG000|Overall Study|Patient Lost Green Card Status|1|||
30962914|NCT01473407|59030800|FG001|Overall Study|Patient Lost Green Card Status|0|||
30962915|NCT01473407|59030799|FG000|Overall Study|Temperature Excursion|2|||
30962916|NCT01473407|59030800|FG001|Overall Study|Temperature Excursion|3|||
30962917|NCT01473407|59030799|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
30962918|NCT01473407|59030800|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
30962919|NCT01473407|59030799|FG000|Overall Study|Sponsor's Decision|10|||
30962920|NCT01473407|59030800|FG001|Overall Study|Sponsor's Decision|10|||
30962921|NCT01473407|59030799|FG000|Overall Study|Site Closure|1|||
30962922|NCT01473407|59030800|FG001|Overall Study|Site Closure|0|||
30962923|NCT01472939|59030810|FG000|Overall Study|Adverse Event|3|||
30962924|NCT01472939|59030811|FG001|Overall Study|Adverse Event|7|||
30962925|NCT01472939|59030812|FG002|Overall Study|Adverse Event|7|||
30962926|NCT01472939|59030813|FG003|Overall Study|Adverse Event|14|||
30962927|NCT01472939|59030810|FG000|Overall Study|Lack of Efficacy|1|||
30962928|NCT01472939|59030811|FG001|Overall Study|Lack of Efficacy|0|||
30962929|NCT01472939|59030812|FG002|Overall Study|Lack of Efficacy|0|||
30962930|NCT01472939|59030813|FG003|Overall Study|Lack of Efficacy|1|||
30962931|NCT01472939|59030810|FG000|Overall Study|Lost to Follow-up|3|||
30962932|NCT01472939|59030811|FG001|Overall Study|Lost to Follow-up|0|||
30962933|NCT01472939|59030812|FG002|Overall Study|Lost to Follow-up|2|||
30962934|NCT01472939|59030813|FG003|Overall Study|Lost to Follow-up|0|||
30962935|NCT01472939|59030810|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
30962936|NCT01472939|59030811|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
30962937|NCT01472939|59030812|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
30962938|NCT01472939|59030813|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
30962939|NCT01472939|59030810|FG000|Overall Study|Prohibited Medication|0|||
30962940|NCT01472939|59030811|FG001|Overall Study|Prohibited Medication|1|||
30962941|NCT01472939|59030812|FG002|Overall Study|Prohibited Medication|0|||
30962942|NCT01472939|59030813|FG003|Overall Study|Prohibited Medication|0|||
30962943|NCT01472939|59030810|FG000|Overall Study|Withdrawal By PI|1|||
30962944|NCT01472939|59030811|FG001|Overall Study|Withdrawal By PI|0|||
30962945|NCT01472939|59030812|FG002|Overall Study|Withdrawal By PI|0|||
30962946|NCT01472939|59030813|FG003|Overall Study|Withdrawal By PI|0|||
30962947|NCT01472939|59030810|FG000|Overall Study|Protocol Violation|3|||
30962948|NCT01472939|59030811|FG001|Overall Study|Protocol Violation|3|||
30962949|NCT01472939|59030812|FG002|Overall Study|Protocol Violation|0|||
30962950|NCT01472939|59030813|FG003|Overall Study|Protocol Violation|1|||
30962951|NCT01472939|59030810|FG000|Overall Study|Withdrawal by Subject|9|||
30962952|NCT01472939|59030811|FG001|Overall Study|Withdrawal by Subject|3|||
30962953|NCT01472939|59030812|FG002|Overall Study|Withdrawal by Subject|1|||
30962954|NCT01472939|59030813|FG003|Overall Study|Withdrawal by Subject|4|||
30962955|NCT01544179|59030828|FG000|Overall Study|Death|50|||
30962956|NCT01544179|59030829|FG001|Overall Study|Death|37|||
30962957|NCT01544179|59030828|FG000|Overall Study|Lost to Follow-up|0|||
30962958|NCT01544179|59030829|FG001|Overall Study|Lost to Follow-up|1|||
30962959|NCT01544179|59030828|FG000|Overall Study|Adverse Event|0|||
30962960|NCT01544179|59030829|FG001|Overall Study|Adverse Event|1|||
30962961|NCT01544179|59030828|FG000|Overall Study|Withdrawal by Subject|12|||
30962962|NCT01544179|59030829|FG001|Overall Study|Withdrawal by Subject|7|||
30962963|NCT01544179|59030828|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
30962964|NCT01544179|59030829|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
30962965|NCT01483651|59030835|FG000|Overall Study|Withdrawal by Subject|0|||
30962966|NCT01483651|59030836|FG001|Overall Study|Withdrawal by Subject|1|||
30962967|NCT01483651|59030837|FG002|Overall Study|Withdrawal by Subject|1|||
30962968|NCT01483651|59030838|FG003|Overall Study|Withdrawal by Subject|0|||
30962969|NCT01483651|59030839|FG004|Overall Study|Withdrawal by Subject|0|||
30962970|NCT01483651|59030840|FG005|Overall Study|Withdrawal by Subject|1|||
30962971|NCT01464307|59030850|FG000|Main Period|Death|0|||
30962972|NCT01464307|59030851|FG001|Main Period|Death|1|||
30962973|NCT01464307|59030850|FG000|Main Period|Adverse Event|6|||
30962974|NCT01464307|59030851|FG001|Main Period|Adverse Event|1|||
30604846|NCT01225731|58615773|FG002|Part 1|Withdrawal by Subject|0|||
30876166|NCT01982812|58907202|FG000|Overall Study|Adverse Event|0|||
30876167|NCT01982812|58907203|FG001|Overall Study|Adverse Event|5|||
30876168|NCT02007070|58907209|FG000|Overall Study|Adverse Event|4|||
30876169|NCT02007070|58907209|FG000|Overall Study|Clinical Progression|4|||
30876170|NCT02007070|58907209|FG000|Overall Study|Death|1|||
30876171|NCT02007070|58907209|FG000|Overall Study|Protocol Violation|2|||
30876172|NCT02007070|58907209|FG000|Overall Study|Physician Decision|1|||
30876173|NCT02007070|58907209|FG000|Overall Study|Progressive Disease|21|||
30876174|NCT02006758|58907213|FG000|Overall Study|Protocol Violation|1|||
30876175|NCT02006758|58907213|FG000|Overall Study|Death|1|||
30962975|NCT01464307|59030850|FG000|Main Period|Lack of Efficacy|2|||
30962976|NCT01464307|59030851|FG001|Main Period|Lack of Efficacy|0|||
30962977|NCT01464307|59030850|FG000|Main Period|Withdrawal by Subject|5|||
30962978|NCT01464307|59030851|FG001|Main Period|Withdrawal by Subject|2|||
30962979|NCT01464307|59030850|FG000|Main Period|Predefined discontinuation criteria|2|||
30962980|NCT01464307|59030851|FG001|Main Period|Predefined discontinuation criteria|1|||
30962981|NCT01464307|59030850|FG000|Open-Label Extension Period|Adverse Event|15|||
30962982|NCT01464307|59030851|FG001|Open-Label Extension Period|Adverse Event|0|||
30962983|NCT01464307|59030850|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
30962984|NCT01464307|59030851|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
30962985|NCT01464307|59030850|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
30962986|NCT01464307|59030851|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
30962987|NCT01464307|59030850|FG000|Open-Label Extension Period|Death|1|||
30962988|NCT01464307|59030851|FG001|Open-Label Extension Period|Death|0|||
30962989|NCT01464307|59030850|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
30962990|NCT01464307|59030851|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
30962991|NCT01464307|59030850|FG000|Open-Label Extension Period|Non-compliance|9|||
30962992|NCT01464307|59030851|FG001|Open-Label Extension Period|Non-compliance|0|||
30962993|NCT01464307|59030850|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
30962994|NCT01464307|59030851|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
30962995|NCT01483183|59030868|FG000|Overall Study|Physician Decision|0|||
30962996|NCT01483183|59030869|FG001|Overall Study|Physician Decision|0|||
30962997|NCT01483183|59030870|FG002|Overall Study|Physician Decision|0|||
30962998|NCT01483183|59030871|FG003|Overall Study|Physician Decision|0|||
30962999|NCT01483183|59030872|FG004|Overall Study|Physician Decision|0|||
30963000|NCT01483183|59030873|FG005|Overall Study|Physician Decision|0|||
30963001|NCT01483183|59030874|FG006|Overall Study|Physician Decision|2|||
30963002|NCT01483183|59030875|FG007|Overall Study|Physician Decision|0|||
30963003|NCT01483183|59030876|FG008|Overall Study|Physician Decision|0|||
30963004|NCT01483183|59030877|FG009|Overall Study|Physician Decision|0|||
30963005|NCT01483183|59030868|FG000|Overall Study|Withdrawal by Subject|0|||
30963006|NCT01483183|59030869|FG001|Overall Study|Withdrawal by Subject|0|||
30963007|NCT01483183|59030870|FG002|Overall Study|Withdrawal by Subject|0|||
30963008|NCT01483183|59030871|FG003|Overall Study|Withdrawal by Subject|0|||
30963009|NCT01483183|59030872|FG004|Overall Study|Withdrawal by Subject|0|||
30963010|NCT01483183|59030873|FG005|Overall Study|Withdrawal by Subject|0|||
30963011|NCT01483183|59030874|FG006|Overall Study|Withdrawal by Subject|0|||
30963012|NCT01483183|59030875|FG007|Overall Study|Withdrawal by Subject|0|||
30963013|NCT01483183|59030876|FG008|Overall Study|Withdrawal by Subject|0|||
30963014|NCT01483183|59030877|FG009|Overall Study|Withdrawal by Subject|1|||
30963015|NCT01483027|59030907|FG000|Overall Study|Administrative Reasons|2|||
30963016|NCT01483027|59030908|FG001|Overall Study|Administrative Reasons|1|||
30963017|NCT01483027|59030907|FG000|Overall Study|Withdrawal by Subject|21|||
30963018|NCT01483027|59030908|FG001|Overall Study|Withdrawal by Subject|32|||
30963019|NCT01483027|59030907|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
30963020|NCT01483027|59030908|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
30963021|NCT01483027|59030907|FG000|Overall Study|Lost to Follow-up|1|||
30963022|NCT01483027|59030908|FG001|Overall Study|Lost to Follow-up|1|||
30963023|NCT01483027|59030907|FG000|Overall Study|Adverse Event|0|||
30963024|NCT01483027|59030908|FG001|Overall Study|Adverse Event|1|||
30963025|NCT01483027|59030907|FG000|Overall Study|Withdrawal by Subject|0|||
30963026|NCT01483027|59030908|FG001|Overall Study|Withdrawal by Subject|1|||
30963027|NCT01463683|59030917|FG000|Overall Study|Adverse Event|2|||
30963028|NCT01463683|59030918|FG001|Overall Study|Adverse Event|0|||
30963029|NCT01463683|59030919|FG002|Overall Study|Adverse Event|0|||
30963030|NCT01463683|59030917|FG000|Overall Study|Lost to Follow-up|10|||
30963031|NCT01463683|59030918|FG001|Overall Study|Lost to Follow-up|9|||
30963032|NCT01463683|59030919|FG002|Overall Study|Lost to Follow-up|7|||
30963033|NCT01463683|59030917|FG000|Overall Study|Physician Decision|0|||
30963034|NCT01463683|59030918|FG001|Overall Study|Physician Decision|3|||
30963035|NCT01463683|59030919|FG002|Overall Study|Physician Decision|1|||
30963036|NCT01463683|59030917|FG000|Overall Study|Pregnancy|2|||
30963037|NCT01463683|59030918|FG001|Overall Study|Pregnancy|2|||
30963038|NCT01463683|59030919|FG002|Overall Study|Pregnancy|1|||
30963039|NCT01463683|59030917|FG000|Overall Study|Withdrawal by Subject|5|||
30963040|NCT01463683|59030918|FG001|Overall Study|Withdrawal by Subject|17|||
30963041|NCT01463683|59030919|FG002|Overall Study|Withdrawal by Subject|2|||
30963042|NCT01482169|59030927|FG000|Overall Study|Physician Decision|2|||
30963043|NCT01481779|59030936|FG000|Overall Study|Adverse Event|23|||
30963044|NCT01481779|59030937|FG001|Overall Study|Adverse Event|5|||
30963045|NCT01481779|59030936|FG000|Overall Study|Lost to Follow-up|3|||
30963046|NCT01481779|59030937|FG001|Overall Study|Lost to Follow-up|2|||
30963047|NCT01481779|59030936|FG000|Overall Study|Protocol Violation|2|||
30963048|NCT01481779|59030937|FG001|Overall Study|Protocol Violation|3|||
30963049|NCT01481779|59030936|FG000|Overall Study|Withdrawal by Subject|26|||
30963050|NCT01481779|59030937|FG001|Overall Study|Withdrawal by Subject|13|||
30963051|NCT01481779|59030936|FG000|Overall Study|Physician Decision|13|||
30963052|NCT01481779|59030937|FG001|Overall Study|Physician Decision|4|||
30963053|NCT01481779|59030936|FG000|Overall Study|Sponsor Decision|3|||
30963054|NCT01481779|59030937|FG001|Overall Study|Sponsor Decision|1|||
30963055|NCT01463527|59030945|FG000|Overall Study|Protocol Violation|1|||
30963056|NCT01463527|59030946|FG001|Overall Study|Protocol Violation|1|||
30963057|NCT01463527|59030945|FG000|Overall Study|Crying >20% of sedation|5|||
30963058|NCT01463527|59030946|FG001|Overall Study|Crying >20% of sedation|6|||
30963059|NCT01509547|59030954|FG000|Overall Study|Lost to Follow-up|24|||
30963060|NCT01509547|59030955|FG001|Overall Study|Lost to Follow-up|14|||
30963061|NCT01509547|59030954|FG000|Overall Study|Withdrawal by Subject|11|||
30963062|NCT01509547|59030955|FG001|Overall Study|Withdrawal by Subject|24|||
30963063|NCT01509547|59030954|FG000|Overall Study|Physician Decision|0|||
30963064|NCT01509547|59030955|FG001|Overall Study|Physician Decision|1|||
30963065|NCT01509079|59030963|FG000|Overall Study|Lack of Efficacy|0|||
30963066|NCT01509079|59030964|FG001|Overall Study|Lack of Efficacy|2|||
30963067|NCT01509079|59030963|FG000|Overall Study|started an excluded medication|0|||
30963068|NCT01509079|59030964|FG001|Overall Study|started an excluded medication|1|||
30963069|NCT01463293|59030973|FG000|Overall Study|Lost to Follow-up|1|||
30963070|NCT01463293|59030974|FG001|Overall Study|Lost to Follow-up|4|||
30963071|NCT01463293|59030975|FG002|Overall Study|Lost to Follow-up|5|||
30963072|NCT01463293|59030973|FG000|Overall Study|Adverse Event|1|||
30963073|NCT01463293|59030974|FG001|Overall Study|Adverse Event|2|||
30963074|NCT01463293|59030975|FG002|Overall Study|Adverse Event|0|||
30963075|NCT01463293|59030973|FG000|Overall Study|Withdrawal by Subject|4|||
30963076|NCT01463293|59030974|FG001|Overall Study|Withdrawal by Subject|10|||
30963077|NCT01463293|59030975|FG002|Overall Study|Withdrawal by Subject|5|||
30963078|NCT01463293|59030973|FG000|Overall Study|Other|0|||
30963079|NCT01463293|59030974|FG001|Overall Study|Other|0|||
30963080|NCT01463293|59030975|FG002|Overall Study|Other|2|||
30963081|NCT01479985|59031006|FG000|Overall Study|Tablet malfunction, no data saved|1|||
30963082|NCT01479985|59031007|FG001|Overall Study|Tablet malfunction, no data saved|1|||
30963083|NCT01479985|59031006|FG000|Overall Study|No decisional conflict scale responses|0|||
30963084|NCT01479985|59031007|FG001|Overall Study|No decisional conflict scale responses|2|||
30963085|NCT01479985|59031006|FG000|Overall Study|No post-visit survey|5|||
30963086|NCT01479985|59031007|FG001|Overall Study|No post-visit survey|3|||
30963087|NCT01462435|59031021|FG000|Overall Study|Lack of Efficacy|1|||
30963088|NCT01462435|59031022|FG001|Overall Study|Lack of Efficacy|0|||
30963089|NCT01462435|59031023|FG002|Overall Study|Lack of Efficacy|0|||
30963090|NCT01462435|59031024|FG003|Overall Study|Lack of Efficacy|3|||
30963091|NCT01462435|59031021|FG000|Overall Study|Physician Decision|0|||
30963092|NCT01462435|59031022|FG001|Overall Study|Physician Decision|0|||
30963093|NCT01462435|59031023|FG002|Overall Study|Physician Decision|1|||
30963094|NCT01462435|59031024|FG003|Overall Study|Physician Decision|0|||
30963095|NCT01462435|59031021|FG000|Overall Study|Withdrawal by Subject|0|||
30963096|NCT01462435|59031022|FG001|Overall Study|Withdrawal by Subject|0|||
30963097|NCT01462435|59031023|FG002|Overall Study|Withdrawal by Subject|0|||
30963098|NCT01462435|59031024|FG003|Overall Study|Withdrawal by Subject|1|||
30963099|NCT01462435|59031021|FG000|Overall Study|Lost to Follow-up|0|||
30963100|NCT01462435|59031022|FG001|Overall Study|Lost to Follow-up|0|||
30963101|NCT01462435|59031023|FG002|Overall Study|Lost to Follow-up|0|||
30963102|NCT01462435|59031024|FG003|Overall Study|Lost to Follow-up|1|||
30963103|NCT01472081|59031040|FG000|Overall Study|Continuing treatment at time of analysis|1|||
30963104|NCT01472081|59031041|FG001|Overall Study|Continuing treatment at time of analysis|4|||
30963105|NCT01472081|59031042|FG002|Overall Study|Continuing treatment at time of analysis|1|||
30963106|NCT01472081|59031043|FG003|Overall Study|Continuing treatment at time of analysis|8|||
30963107|NCT01472081|59031044|FG004|Overall Study|Continuing treatment at time of analysis|9|||
30963108|NCT01472081|59031045|FG005|Overall Study|Continuing treatment at time of analysis|0|||
30963109|NCT01472081|59031040|FG000|Overall Study|Disease Progression|4|||
30963110|NCT01472081|59031041|FG001|Overall Study|Disease Progression|10|||
30963111|NCT01472081|59031042|FG002|Overall Study|Disease Progression|12|||
30963112|NCT01472081|59031043|FG003|Overall Study|Disease Progression|31|||
30963113|NCT01472081|59031044|FG004|Overall Study|Disease Progression|22|||
30963114|NCT01472081|59031045|FG005|Overall Study|Disease Progression|3|||
30963115|NCT01472081|59031040|FG000|Overall Study|Study drug toxicity|2|||
30963116|NCT01472081|59031041|FG001|Overall Study|Study drug toxicity|9|||
30963117|NCT01472081|59031042|FG002|Overall Study|Study drug toxicity|4|||
30963118|NCT01472081|59031043|FG003|Overall Study|Study drug toxicity|6|||
30963119|NCT01472081|59031044|FG004|Overall Study|Study drug toxicity|13|||
30963120|NCT01472081|59031045|FG005|Overall Study|Study drug toxicity|2|||
30963121|NCT01472081|59031040|FG000|Overall Study|Death|0|||
30963122|NCT01472081|59031041|FG001|Overall Study|Death|0|||
30963123|NCT01472081|59031042|FG002|Overall Study|Death|0|||
30963124|NCT01472081|59031043|FG003|Overall Study|Death|0|||
30963125|NCT01472081|59031044|FG004|Overall Study|Death|1|||
30963126|NCT01472081|59031045|FG005|Overall Study|Death|0|||
30963127|NCT01472081|59031040|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
30963128|NCT01472081|59031041|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
30963129|NCT01472081|59031042|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
30963130|NCT01472081|59031043|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
30963131|NCT01472081|59031044|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
30963132|NCT01472081|59031045|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
30963133|NCT01472081|59031040|FG000|Overall Study|Withdrawal by Subject|0|||
30963134|NCT01472081|59031041|FG001|Overall Study|Withdrawal by Subject|0|||
30963135|NCT01472081|59031042|FG002|Overall Study|Withdrawal by Subject|0|||
30963136|NCT01472081|59031043|FG003|Overall Study|Withdrawal by Subject|0|||
30963137|NCT01472081|59031044|FG004|Overall Study|Withdrawal by Subject|0|||
30963138|NCT01472081|59031045|FG005|Overall Study|Withdrawal by Subject|1|||
30963139|NCT01472081|59031040|FG000|Overall Study|Poor/non-compliance|0|||
30963140|NCT01472081|59031041|FG001|Overall Study|Poor/non-compliance|0|||
30963141|NCT01472081|59031042|FG002|Overall Study|Poor/non-compliance|1|||
30963142|NCT01472081|59031043|FG003|Overall Study|Poor/non-compliance|0|||
30963143|NCT01472081|59031044|FG004|Overall Study|Poor/non-compliance|1|||
30963144|NCT01472081|59031045|FG005|Overall Study|Poor/non-compliance|0|||
30963145|NCT01472081|59031040|FG000|Overall Study|No longer meets study criteria|0|||
30963146|NCT01472081|59031041|FG001|Overall Study|No longer meets study criteria|0|||
30963147|NCT01472081|59031042|FG002|Overall Study|No longer meets study criteria|1|||
30963148|NCT01472081|59031043|FG003|Overall Study|No longer meets study criteria|0|||
30963149|NCT01472081|59031044|FG004|Overall Study|No longer meets study criteria|0|||
30963150|NCT01472081|59031045|FG005|Overall Study|No longer meets study criteria|0|||
30963151|NCT01472081|59031040|FG000|Overall Study|Subject request to discontinue treatment|0|||
30963152|NCT01472081|59031041|FG001|Overall Study|Subject request to discontinue treatment|3|||
30963153|NCT01472081|59031042|FG002|Overall Study|Subject request to discontinue treatment|1|||
30963154|NCT01472081|59031043|FG003|Overall Study|Subject request to discontinue treatment|1|||
30963155|NCT01472081|59031044|FG004|Overall Study|Subject request to discontinue treatment|0|||
30963156|NCT01472081|59031045|FG005|Overall Study|Subject request to discontinue treatment|0|||
30963157|NCT01471691|59031060|FG000|Overall Study|Lack of Efficacy|0|||
30963158|NCT01471691|59031061|FG001|Overall Study|Lack of Efficacy|1|||
30963159|NCT01471379|59031070|FG000|Overall Study|Adverse Event|1|||
30963160|NCT01471379|59031071|FG001|Overall Study|Adverse Event|0|||
30963161|NCT01471379|59031072|FG002|Overall Study|Adverse Event|0|||
30963162|NCT01471379|59031070|FG000|Overall Study|Study terminated|0|||
30963163|NCT01471379|59031071|FG001|Overall Study|Study terminated|1|||
30963164|NCT01471379|59031072|FG002|Overall Study|Study terminated|0|||
30963165|NCT01470989|59031083|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
30963166|NCT01470989|59031084|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
30963167|NCT01470989|59031083|FG000|Overall Study|Adverse Event|2|||
30963168|NCT01470989|59031084|FG001|Overall Study|Adverse Event|5|||
30963169|NCT01470989|59031083|FG000|Overall Study|Abnormal laboratory value|1|||
30963170|NCT01470989|59031084|FG001|Overall Study|Abnormal laboratory value|1|||
30963171|NCT01470989|59031083|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
30963172|NCT01470989|59031084|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
30963173|NCT01470989|59031083|FG000|Overall Study|Withdrawal by Subject|19|||
30963174|NCT01470989|59031084|FG001|Overall Study|Withdrawal by Subject|17|||
30963175|NCT01470989|59031083|FG000|Overall Study|Lost to Follow-up|18|||
30963176|NCT01470989|59031084|FG001|Overall Study|Lost to Follow-up|13|||
30963177|NCT01470989|59031083|FG000|Overall Study|Administrative problems|2|||
30963178|NCT01470989|59031084|FG001|Overall Study|Administrative problems|4|||
30963179|NCT01470989|59031083|FG000|Overall Study|Death|2|||
30963180|NCT01470989|59031084|FG001|Overall Study|Death|2|||
30963181|NCT01470989|59031083|FG000|Overall Study|Protocol deviation|1|||
30963182|NCT01470989|59031084|FG001|Overall Study|Protocol deviation|2|||
30963183|NCT01470599|59031094|FG000|Overall Study|Did not meet entrance criteria|1|||
30963184|NCT01470599|59031095|FG001|Overall Study|Did not meet entrance criteria|0|||
30963185|NCT01470599|59031094|FG000|Overall Study|Lost to Follow-up|2|||
30963186|NCT01470599|59031095|FG001|Overall Study|Lost to Follow-up|1|||
30963187|NCT01470599|59031094|FG000|Overall Study|Withdrawal by Subject|3|||
30963188|NCT01470599|59031095|FG001|Overall Study|Withdrawal by Subject|4|||
30963189|NCT01470599|59031094|FG000|Overall Study|Other|1|||
30963190|NCT01470599|59031095|FG001|Overall Study|Other|0|||
30963191|NCT01470599|59031094|FG000|Overall Study|Protocol Violation|3|||
30963192|NCT01470599|59031095|FG001|Overall Study|Protocol Violation|1|||
30963193|NCT01470599|59031094|FG000|Overall Study|Adverse event related to study drug|2|||
30963194|NCT01470599|59031095|FG001|Overall Study|Adverse event related to study drug|5|||
30963195|NCT01470599|59031094|FG000|Overall Study|Insufficient clinical response|6|||
30963196|NCT01470599|59031095|FG001|Overall Study|Insufficient clinical response|27|||
30963197|NCT01470599|59031094|FG000|Overall Study|Adverse event not related to study drug|1|||
30963198|NCT01470599|59031095|FG001|Overall Study|Adverse event not related to study drug|5|||
30963199|NCT01469819|59031101|FG000|Overall Study|Withdrawal by Subject|1|||
30963200|NCT01469819|59031101|FG000|Overall Study|Did not meet inclusionary criteria|2|||
30963201|NCT01469819|59031101|FG000|Overall Study|Could not swallow SmartPill|2|||
30963202|NCT01469819|59031101|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
30963203|NCT01507831|59031113|FG000|Overall Study|Randomized but not treated|0|||
30963204|NCT01507831|59031114|FG001|Overall Study|Randomized but not treated|3|||
30963205|NCT01507831|59031113|FG000|Overall Study|Adverse Event|48|||
30963206|NCT01507831|59031114|FG001|Overall Study|Adverse Event|113|||
30963207|NCT01507831|59031113|FG000|Overall Study|Death|6|||
30963208|NCT01507831|59031114|FG001|Overall Study|Death|2|||
30963209|NCT01507831|59031113|FG000|Overall Study|Poor compliance to protocol|38|||
30963210|NCT01507831|59031114|FG001|Overall Study|Poor compliance to protocol|60|||
30963211|NCT01507831|59031113|FG000|Overall Study|Physician Decision|0|||
30963212|NCT01507831|59031114|FG001|Overall Study|Physician Decision|4|||
30963213|NCT01507831|59031113|FG000|Overall Study|Participant moved|5|||
30963214|NCT01507831|59031114|FG001|Overall Study|Participant moved|19|||
30963215|NCT01507831|59031113|FG000|Overall Study|Consent withdrawn by participant|34|||
30963216|NCT01507831|59031114|FG001|Overall Study|Consent withdrawn by participant|72|||
30963217|NCT01507831|59031113|FG000|Overall Study|Related to study drug administration|5|||
30963218|NCT01507831|59031114|FG001|Overall Study|Related to study drug administration|14|||
30963219|NCT01507831|59031113|FG000|Overall Study|Last visit outside protocol visit window|51|||
30963220|NCT01507831|59031114|FG001|Overall Study|Last visit outside protocol visit window|143|||
30963221|NCT01507831|59031113|FG000|Overall Study|Selection criteria finally not met|0|||
30963222|NCT01507831|59031114|FG001|Overall Study|Selection criteria finally not met|1|||
30963223|NCT01507831|59031113|FG000|Overall Study|Site closure|0|||
30963224|NCT01507831|59031114|FG001|Overall Study|Site closure|3|||
30963225|NCT01507831|59031113|FG000|Overall Study|Potential lost to follow-up|3|||
30963226|NCT01507831|59031114|FG001|Overall Study|Potential lost to follow-up|0|||
30963227|NCT01507831|59031113|FG000|Overall Study|Other|3|||
30963228|NCT01507831|59031114|FG001|Overall Study|Other|6|||
30963229|NCT01479595|59031122|FG000|Overall Study|Protocol deviation|0|||
30963230|NCT01479595|59031123|FG001|Overall Study|Protocol deviation|1|||
30963231|NCT01479595|59031122|FG000|Overall Study|Adverse Event|2|||
30963232|NCT01479595|59031123|FG001|Overall Study|Adverse Event|1|||
30963233|NCT01462357|59031132|FG000|Overall Study|Death|0|||
30963234|NCT01462357|59031133|FG001|Overall Study|Death|0|||
30963235|NCT01462357|59031134|FG002|Overall Study|Death|1|||
30963236|NCT01462357|59031132|FG000|Overall Study|Withdrawal by Subject|3|||
30963237|NCT01462357|59031133|FG001|Overall Study|Withdrawal by Subject|11|||
30963238|NCT01462357|59031134|FG002|Overall Study|Withdrawal by Subject|3|||
30963239|NCT01462357|59031132|FG000|Overall Study|Migrated/moved from study area|2|||
30963240|NCT01462357|59031133|FG001|Overall Study|Migrated/moved from study area|3|||
30963241|NCT01462357|59031134|FG002|Overall Study|Migrated/moved from study area|1|||
30963242|NCT01462357|59031132|FG000|Overall Study|Lost to Follow-up|3|||
30963243|NCT01462357|59031133|FG001|Overall Study|Lost to Follow-up|5|||
30963244|NCT01462357|59031134|FG002|Overall Study|Lost to Follow-up|7|||
30963245|NCT01479439|59031145|FG000|Overall Study|Adverse Event|1|||
30963246|NCT01479439|59031146|FG001|Overall Study|Adverse Event|0|||
30963247|NCT01479439|59031147|FG002|Overall Study|Adverse Event|0|||
30963248|NCT01479439|59031145|FG000|Overall Study|Lost to Follow-up|0|||
30963249|NCT01479439|59031146|FG001|Overall Study|Lost to Follow-up|1|||
30963250|NCT01479439|59031147|FG002|Overall Study|Lost to Follow-up|0|||
30963251|NCT01479439|59031145|FG000|Overall Study|Protocol Violation|0|||
30963252|NCT01479439|59031146|FG001|Overall Study|Protocol Violation|0|||
30963253|NCT01479439|59031147|FG002|Overall Study|Protocol Violation|2|||
30963254|NCT01478971|59031158|FG000|Standard of Care Period|Adverse Event|1|||
30963255|NCT01478971|59031158|FG000|Standard of Care Period|Withdrawal by Subject|3|||
30963256|NCT01478971|59031158|FG000|Standard of Care Period|Death|8|||
30963257|NCT01478971|59031158|FG000|Standard of Care Period|Lost to Follow-up|9|||
30963258|NCT01478971|59031158|FG000|Standard of Care Period|Other|4|||
30963259|NCT01478971|59031158|FG000|Peginesatide Treatment Period|Adverse Event|1|||
30963260|NCT01478971|59031158|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
30963261|NCT01478971|59031158|FG000|Peginesatide Treatment Period|Death|4|||
30963262|NCT01478971|59031158|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
30963263|NCT01478971|59031158|FG000|Peginesatide Treatment Period|Other|4|||
30963264|NCT01507051|59031170|FG000|Overall Study|Withdrawal by Subject|1|||
30963265|NCT01507051|59031171|FG001|Overall Study|Withdrawal by Subject|3|||
30963266|NCT01507051|59031172|FG002|Overall Study|Withdrawal by Subject|1|||
30963267|NCT01507051|59031173|FG003|Overall Study|Withdrawal by Subject|6|||
30963268|NCT01507051|59031170|FG000|Overall Study|Physician Decision|0|||
30963269|NCT01507051|59031171|FG001|Overall Study|Physician Decision|0|||
30963270|NCT01507051|59031172|FG002|Overall Study|Physician Decision|0|||
30963271|NCT01507051|59031173|FG003|Overall Study|Physician Decision|1|||
30963272|NCT01507051|59031170|FG000|Overall Study|Adverse Event|1|||
30963273|NCT01507051|59031171|FG001|Overall Study|Adverse Event|0|||
30963274|NCT01507051|59031172|FG002|Overall Study|Adverse Event|0|||
30963275|NCT01507051|59031173|FG003|Overall Study|Adverse Event|0|||
30963276|NCT01478347|59031183|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
30963277|NCT01478347|59031183|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
30963278|NCT01478347|59031183|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
30963279|NCT01478113|59031189|FG000|Overall Study|Withdrawal by Subject|0|||
30963280|NCT01478113|59031190|FG001|Overall Study|Withdrawal by Subject|1|||
30963281|NCT01478113|59031189|FG000|Overall Study|Physician Decision|1|||
30963282|NCT01478113|59031190|FG001|Overall Study|Physician Decision|0|||
30963283|NCT01506271|59031201|FG000|Overall Study|Progressive disease|0|||
30963284|NCT01506271|59031202|FG001|Overall Study|Progressive disease|1|||
30963285|NCT01506271|59031203|FG002|Overall Study|Progressive disease|0|||
30963286|NCT01506271|59031201|FG000|Overall Study|Protocol Violation|3|||
30963287|NCT01506271|59031202|FG001|Overall Study|Protocol Violation|1|||
30963288|NCT01506271|59031203|FG002|Overall Study|Protocol Violation|0|||
30963289|NCT01506271|59031201|FG000|Overall Study|Death|0|||
30963290|NCT01506271|59031202|FG001|Overall Study|Death|1|||
30963291|NCT01506271|59031203|FG002|Overall Study|Death|0|||
30963292|NCT01506271|59031201|FG000|Overall Study|Adverse Event|0|||
30963293|NCT01506271|59031202|FG001|Overall Study|Adverse Event|2|||
30963294|NCT01506271|59031203|FG002|Overall Study|Adverse Event|0|||
30963295|NCT01506271|59031201|FG000|Overall Study|Insufficient supply of study drug|1|||
30963296|NCT01506271|59031202|FG001|Overall Study|Insufficient supply of study drug|0|||
30963297|NCT01506271|59031203|FG002|Overall Study|Insufficient supply of study drug|0|||
30963298|NCT01506271|59031201|FG000|Overall Study|Withdrawal by Subject|0|||
30963299|NCT01506271|59031202|FG001|Overall Study|Withdrawal by Subject|1|||
30963300|NCT01506271|59031203|FG002|Overall Study|Withdrawal by Subject|1|||
30963301|NCT01506271|59031201|FG000|Overall Study|Lost to Follow-up|0|||
30963302|NCT01506271|59031202|FG001|Overall Study|Lost to Follow-up|1|||
30963303|NCT01506271|59031203|FG002|Overall Study|Lost to Follow-up|2|||
30963304|NCT01506193|59031214|FG000|Overall Study|Protocol Violation|1|||
30963305|NCT01506193|59031215|FG001|Overall Study|Protocol Violation|0|||
30963306|NCT01506193|59031216|FG002|Overall Study|Protocol Violation|1|||
30963307|NCT01506193|59031214|FG000|Overall Study|Migrated/moved from study area|0|||
30963308|NCT01506193|59031215|FG001|Overall Study|Migrated/moved from study area|0|||
30963309|NCT01506193|59031216|FG002|Overall Study|Migrated/moved from study area|1|||
30963310|NCT01506193|59031214|FG000|Overall Study|Adverse event, non-fatal|0|||
30963311|NCT01506193|59031215|FG001|Overall Study|Adverse event, non-fatal|0|||
30963312|NCT01506193|59031216|FG002|Overall Study|Adverse event, non-fatal|1|||
30963313|NCT01506193|59031214|FG000|Overall Study|Withdrawal by Subject|5|||
30963314|NCT01506193|59031215|FG001|Overall Study|Withdrawal by Subject|1|||
30963315|NCT01506193|59031216|FG002|Overall Study|Withdrawal by Subject|8|||
30963316|NCT01506193|59031214|FG000|Overall Study|Lost to Follow-up|8|||
30963317|NCT01506193|59031215|FG001|Overall Study|Lost to Follow-up|3|||
30963318|NCT01506193|59031216|FG002|Overall Study|Lost to Follow-up|3|||
30963319|NCT01505881|59031227|FG000|Overall Study|Adverse Event|0|||
30963320|NCT01505881|59031228|FG001|Overall Study|Adverse Event|1|||
30963321|NCT01505881|59031227|FG000|Overall Study|Lost to Follow-up|2|||
30963322|NCT01505881|59031228|FG001|Overall Study|Lost to Follow-up|0|||
30963323|NCT01505881|59031227|FG000|Overall Study|Withdrawal by Subject|2|||
30963324|NCT01505881|59031228|FG001|Overall Study|Withdrawal by Subject|0|||
30963325|NCT01462045|59031238|FG000|Overall Study|Family matter|0|||
30963326|NCT01462045|59031239|FG001|Overall Study|Family matter|1|||
30963327|NCT01462045|59031240|FG002|Overall Study|Family matter|0|||
30963328|NCT01505647|59031250|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
30963329|NCT01505647|59031251|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
30963330|NCT01505647|59031250|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
30963331|NCT01505647|59031251|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
30963332|NCT01505647|59031250|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
30963333|NCT01505647|59031251|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
30963334|NCT01505647|59031250|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
30963335|NCT01505647|59031251|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
30963336|NCT01505647|59031250|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
30963337|NCT01505647|59031251|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
30963338|NCT01477333|59031257|FG000|Overall Study|Adverse Event|1|||
30963339|NCT01477333|59031257|FG000|Overall Study|Withdrawal by Subject|1|||
30963340|NCT01477333|59031257|FG000|Overall Study|Clinical Deterioration|1|||
30963341|NCT01461811|59031267|FG000|Overall Study|Adverse Event|2|||
30963342|NCT01461811|59031268|FG001|Overall Study|Adverse Event|1|||
30963343|NCT01461811|59031267|FG000|Overall Study|Subject decision unrelated to an AE|1|||
30963344|NCT01461811|59031268|FG001|Overall Study|Subject decision unrelated to an AE|1|||
30963345|NCT01461811|59031267|FG000|Overall Study|Noncompliance|1|||
30963346|NCT01461811|59031268|FG001|Overall Study|Noncompliance|1|||
30963347|NCT01505491|59031277|FG000|Overall Study|Other reason not listed|1|||
30963348|NCT01505491|59031278|FG001|Overall Study|Other reason not listed|0|||
30963349|NCT01505491|59031279|FG002|Overall Study|Other reason not listed|0|||
30963350|NCT01505491|59031277|FG000|Overall Study|Withdrawal by Subject|1|||
30963351|NCT01505491|59031278|FG001|Overall Study|Withdrawal by Subject|1|||
30963352|NCT01505491|59031279|FG002|Overall Study|Withdrawal by Subject|4|||
30963353|NCT01505491|59031277|FG000|Overall Study|Lost to Follow-up|0|||
30963354|NCT01505491|59031278|FG001|Overall Study|Lost to Follow-up|0|||
30963355|NCT01505491|59031279|FG002|Overall Study|Lost to Follow-up|1|||
30963356|NCT01504867|59031289|FG000|Overall Study|Inclusion criteria not met|2|||
30963357|NCT01504867|59031290|FG001|Overall Study|Inclusion criteria not met|2|||
30963358|NCT01504867|59031289|FG000|Overall Study|Consent revoked|5|||
30963359|NCT01504867|59031290|FG001|Overall Study|Consent revoked|1|||
30963360|NCT01476475|59031298|FG000|Overall Study|Adverse Event|6|||
30963361|NCT01476475|59031299|FG001|Overall Study|Adverse Event|0|||
30963362|NCT01476475|59031298|FG000|Overall Study|Poor compliance to protocol|1|||
30963363|NCT01476475|59031299|FG001|Overall Study|Poor compliance to protocol|1|||
30963364|NCT01476475|59031298|FG000|Overall Study|Other reasons|4|||
30963365|NCT01476475|59031299|FG001|Overall Study|Other reasons|2|||
30963366|NCT01475851|59031308|FG000|Overall Study|Protocol defined stopping criteria|1|||
30963367|NCT01475851|59031309|FG001|Overall Study|Protocol defined stopping criteria|0|||
30963368|NCT01460719|59031315|FG000|Overall Study|Adverse Event|1|||
30963369|NCT01460719|59031315|FG000|Overall Study|Withdrawal by Subject|1|||
30963370|NCT01468181|59031385|FG000|Overall Study|Adverse Event|8|||
30963371|NCT01468181|59031386|FG001|Overall Study|Adverse Event|1|||
30963372|NCT01468181|59031387|FG002|Overall Study|Adverse Event|6|||
30963373|NCT01468181|59031388|FG003|Overall Study|Adverse Event|2|||
30963374|NCT01468181|59031389|FG004|Overall Study|Adverse Event|2|||
30963375|NCT01468181|59031385|FG000|Overall Study|Protocol Violation|2|||
30963376|NCT01468181|59031386|FG001|Overall Study|Protocol Violation|0|||
30963377|NCT01468181|59031387|FG002|Overall Study|Protocol Violation|1|||
30963378|NCT01468181|59031388|FG003|Overall Study|Protocol Violation|0|||
30963379|NCT01468181|59031389|FG004|Overall Study|Protocol Violation|1|||
30963380|NCT01468181|59031385|FG000|Overall Study|Physician Decision|0|||
30963381|NCT01468181|59031386|FG001|Overall Study|Physician Decision|0|||
30963382|NCT01468181|59031387|FG002|Overall Study|Physician Decision|0|||
30963383|NCT01468181|59031388|FG003|Overall Study|Physician Decision|1|||
30963384|NCT01468181|59031389|FG004|Overall Study|Physician Decision|1|||
30963385|NCT01468181|59031385|FG000|Overall Study|Lost to Follow-up|0|||
30963386|NCT01468181|59031386|FG001|Overall Study|Lost to Follow-up|0|||
30963387|NCT01468181|59031387|FG002|Overall Study|Lost to Follow-up|1|||
30963388|NCT01468181|59031388|FG003|Overall Study|Lost to Follow-up|0|||
30963389|NCT01468181|59031389|FG004|Overall Study|Lost to Follow-up|1|||
30963390|NCT01468181|59031385|FG000|Overall Study|Withdrawal by Subject|0|||
30963391|NCT01468181|59031386|FG001|Overall Study|Withdrawal by Subject|1|||
30963392|NCT01468181|59031387|FG002|Overall Study|Withdrawal by Subject|0|||
30963393|NCT01468181|59031388|FG003|Overall Study|Withdrawal by Subject|0|||
30963394|NCT01468181|59031389|FG004|Overall Study|Withdrawal by Subject|0|||
30963395|NCT01693562|59031424|FG000|Escalation Phase|Withdrawal by Subject|0|||
30963396|NCT01693562|59031425|FG001|Escalation Phase|Withdrawal by Subject|1|||
30963397|NCT01693562|59031426|FG002|Escalation Phase|Withdrawal by Subject|0|||
30963398|NCT01693562|59031427|FG003|Escalation Phase|Withdrawal by Subject|0|||
30963399|NCT01693562|59031428|FG004|Escalation Phase|Withdrawal by Subject|0|||
30963400|NCT01693562|59031429|FG005|Escalation Phase|Withdrawal by Subject|2|||
30963401|NCT01693562|59031430|FG006|Escalation Phase|Withdrawal by Subject|0|||
30963402|NCT01693562|59031431|FG007|Escalation Phase|Withdrawal by Subject|0|||
30963403|NCT01693562|59031432|FG008|Escalation Phase|Withdrawal by Subject|0|||
30963404|NCT01693562|59031433|FG009|Escalation Phase|Withdrawal by Subject|0|||
30963405|NCT01693562|59031434|FG010|Escalation Phase|Withdrawal by Subject|0|||
30963406|NCT01693562|59031435|FG011|Escalation Phase|Withdrawal by Subject|0|||
30963407|NCT01693562|59031436|FG012|Escalation Phase|Withdrawal by Subject|0|||
30963408|NCT01693562|59031437|FG013|Escalation Phase|Withdrawal by Subject|0|||
30963409|NCT01693562|59031438|FG014|Escalation Phase|Withdrawal by Subject|0|||
30876176|NCT02006758|58907213|FG000|Overall Study|Lost to Follow-up|4|||
30876177|NCT02006758|58907213|FG000|Overall Study|Withdrawal by Subject|4|||
30876178|NCT02006758|58907213|FG000|Overall Study|Procedurally excluded|1|||
30876179|NCT02006758|58907213|FG000|Overall Study|Other|2|||
30876180|NCT01960816|58907218|FG000|Overall Study|Lost to Follow-up|1|||
30876181|NCT01602419|58907222|FG000|Overall Study|Not treated with Wilate|9|||
30876182|NCT01602419|58907222|FG000|Overall Study|Adverse Drug Reaction|4|||
30876183|NCT01602419|58907222|FG000|Overall Study|Insurance issues|3|||
30876184|NCT01602419|58907222|FG000|Overall Study|Changed treatment centre|1|||
30876185|NCT01602419|58907222|FG000|Overall Study|Treatment centre closed|1|||
30876186|NCT01602419|58907222|FG000|Overall Study|Withdrawal by Subject|5|||
30876187|NCT01602419|58907222|FG000|Overall Study|Lost to Follow-up|6|||
30876188|NCT01981954|58907267|FG000|Titration Period|Protocol Deviation|1|||
30876189|NCT01981954|58907267|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
30876190|NCT02693119|58907273|FG000|Open-Label Period|Withdrawal by Subject|0|||
30876191|NCT02693119|58907274|FG001|Open-Label Period|Withdrawal by Subject|1|||
30876192|NCT01960348|58907312|FG000|Overall Study|Adverse event, not serious|2|||
30876193|NCT01960348|58907313|FG001|Overall Study|Adverse event, not serious|2|||
30876194|NCT01960348|58907312|FG000|Overall Study|Adverse event, serious fatal|6|||
30876195|NCT01960348|58907313|FG001|Overall Study|Adverse event, serious fatal|5|||
30876196|NCT01960348|58907312|FG000|Overall Study|Adverse event, serious non-fatal|0|||
30876197|NCT01960348|58907313|FG001|Overall Study|Adverse event, serious non-fatal|3|||
30876198|NCT01960348|58907312|FG000|Overall Study|Withdrawal by Subject|1|||
30876199|NCT01960348|58907313|FG001|Overall Study|Withdrawal by Subject|11|||
30876200|NCT01960348|58907312|FG000|Overall Study|Physician Decision|0|||
30876201|NCT01960348|58907313|FG001|Overall Study|Physician Decision|1|||
30876202|NCT01960348|58907312|FG000|Overall Study|Protocol Violation|1|||
30876203|NCT01960348|58907313|FG001|Overall Study|Protocol Violation|0|||
30876204|NCT02653625|58907319|FG000|Overall Study|Adverse Event|1|||
30963410|NCT01693562|59031439|FG015|Escalation Phase|Withdrawal by Subject|0|||
30963411|NCT01693562|59031440|FG016|Escalation Phase|Withdrawal by Subject|0|||
30963412|NCT01693562|59031441|FG017|Escalation Phase|Withdrawal by Subject|0|||
30963413|NCT01693562|59031442|FG018|Escalation Phase|Withdrawal by Subject|0|||
30963414|NCT01693562|59031443|FG019|Escalation Phase|Withdrawal by Subject|0|||
30963415|NCT01693562|59031444|FG020|Escalation Phase|Withdrawal by Subject|0|||
30963416|NCT01693562|59031445|FG021|Escalation Phase|Withdrawal by Subject|0|||
30963417|NCT01693562|59031446|FG022|Escalation Phase|Withdrawal by Subject|0|||
30963418|NCT01693562|59031424|FG000|Escalation Phase|Death|4|||
30963419|NCT01693562|59031425|FG001|Escalation Phase|Death|2|||
30963420|NCT01693562|59031426|FG002|Escalation Phase|Death|0|||
30963421|NCT01693562|59031427|FG003|Escalation Phase|Death|3|||
30963422|NCT01693562|59031428|FG004|Escalation Phase|Death|6|||
30963423|NCT01693562|59031429|FG005|Escalation Phase|Death|4|||
30963424|NCT01693562|59031430|FG006|Escalation Phase|Death|0|||
30963425|NCT01693562|59031431|FG007|Escalation Phase|Death|0|||
30963426|NCT01693562|59031432|FG008|Escalation Phase|Death|0|||
30963427|NCT01693562|59031433|FG009|Escalation Phase|Death|0|||
30963428|NCT01693562|59031434|FG010|Escalation Phase|Death|0|||
30963429|NCT01693562|59031435|FG011|Escalation Phase|Death|0|||
30963430|NCT01693562|59031436|FG012|Escalation Phase|Death|0|||
30963431|NCT01693562|59031437|FG013|Escalation Phase|Death|0|||
30963432|NCT01693562|59031438|FG014|Escalation Phase|Death|0|||
30963433|NCT01693562|59031439|FG015|Escalation Phase|Death|0|||
30963434|NCT01693562|59031440|FG016|Escalation Phase|Death|0|||
30963435|NCT01693562|59031441|FG017|Escalation Phase|Death|0|||
30963436|NCT01693562|59031442|FG018|Escalation Phase|Death|0|||
30963437|NCT01693562|59031443|FG019|Escalation Phase|Death|0|||
30963438|NCT01693562|59031444|FG020|Escalation Phase|Death|0|||
30963439|NCT01693562|59031445|FG021|Escalation Phase|Death|0|||
30963440|NCT01693562|59031446|FG022|Escalation Phase|Death|0|||
30963441|NCT01693562|59031424|FG000|Escalation Phase|Lost to Follow-up|0|||
30963442|NCT01693562|59031425|FG001|Escalation Phase|Lost to Follow-up|1|||
30963443|NCT01693562|59031426|FG002|Escalation Phase|Lost to Follow-up|1|||
30963444|NCT01693562|59031427|FG003|Escalation Phase|Lost to Follow-up|0|||
30963445|NCT01693562|59031428|FG004|Escalation Phase|Lost to Follow-up|0|||
30963446|NCT01693562|59031429|FG005|Escalation Phase|Lost to Follow-up|0|||
30963447|NCT01693562|59031430|FG006|Escalation Phase|Lost to Follow-up|0|||
30963448|NCT01693562|59031431|FG007|Escalation Phase|Lost to Follow-up|0|||
30963449|NCT01693562|59031432|FG008|Escalation Phase|Lost to Follow-up|0|||
30963450|NCT01693562|59031433|FG009|Escalation Phase|Lost to Follow-up|0|||
30963451|NCT01693562|59031434|FG010|Escalation Phase|Lost to Follow-up|0|||
30963452|NCT01693562|59031435|FG011|Escalation Phase|Lost to Follow-up|0|||
30963453|NCT01693562|59031436|FG012|Escalation Phase|Lost to Follow-up|0|||
30963454|NCT01693562|59031437|FG013|Escalation Phase|Lost to Follow-up|0|||
30963455|NCT01693562|59031438|FG014|Escalation Phase|Lost to Follow-up|0|||
30963456|NCT01693562|59031439|FG015|Escalation Phase|Lost to Follow-up|0|||
30963457|NCT01693562|59031440|FG016|Escalation Phase|Lost to Follow-up|0|||
30963458|NCT01693562|59031441|FG017|Escalation Phase|Lost to Follow-up|0|||
30963459|NCT01693562|59031442|FG018|Escalation Phase|Lost to Follow-up|0|||
30963460|NCT01693562|59031443|FG019|Escalation Phase|Lost to Follow-up|0|||
30963461|NCT01693562|59031444|FG020|Escalation Phase|Lost to Follow-up|0|||
30963462|NCT01693562|59031445|FG021|Escalation Phase|Lost to Follow-up|0|||
30963463|NCT01693562|59031446|FG022|Escalation Phase|Lost to Follow-up|0|||
30963464|NCT01693562|59031424|FG000|Escalation Phase|Other|0|||
30963465|NCT01693562|59031425|FG001|Escalation Phase|Other|0|||
30963466|NCT01693562|59031426|FG002|Escalation Phase|Other|2|||
30963467|NCT01693562|59031427|FG003|Escalation Phase|Other|0|||
30963468|NCT01693562|59031428|FG004|Escalation Phase|Other|0|||
30963469|NCT01693562|59031429|FG005|Escalation Phase|Other|1|||
30963470|NCT01693562|59031430|FG006|Escalation Phase|Other|0|||
30963471|NCT01693562|59031431|FG007|Escalation Phase|Other|0|||
30963472|NCT01693562|59031432|FG008|Escalation Phase|Other|0|||
30963473|NCT01693562|59031433|FG009|Escalation Phase|Other|0|||
30963474|NCT01693562|59031434|FG010|Escalation Phase|Other|0|||
30963475|NCT01693562|59031435|FG011|Escalation Phase|Other|0|||
30963476|NCT01693562|59031436|FG012|Escalation Phase|Other|0|||
30963477|NCT01693562|59031437|FG013|Escalation Phase|Other|0|||
30963478|NCT01693562|59031438|FG014|Escalation Phase|Other|0|||
30963479|NCT01693562|59031439|FG015|Escalation Phase|Other|0|||
30963480|NCT01693562|59031440|FG016|Escalation Phase|Other|0|||
30963481|NCT01693562|59031441|FG017|Escalation Phase|Other|0|||
30963482|NCT01693562|59031442|FG018|Escalation Phase|Other|0|||
30963483|NCT01693562|59031443|FG019|Escalation Phase|Other|0|||
30963484|NCT01693562|59031444|FG020|Escalation Phase|Other|0|||
30963485|NCT01693562|59031445|FG021|Escalation Phase|Other|0|||
30963486|NCT01693562|59031446|FG022|Escalation Phase|Other|0|||
30963487|NCT01693562|59031424|FG000|Exploration Phase|Withdrawal by Subject|0|||
30963488|NCT01693562|59031425|FG001|Exploration Phase|Withdrawal by Subject|0|||
30963489|NCT01693562|59031426|FG002|Exploration Phase|Withdrawal by Subject|0|||
30963490|NCT01693562|59031427|FG003|Exploration Phase|Withdrawal by Subject|0|||
30963491|NCT01693562|59031428|FG004|Exploration Phase|Withdrawal by Subject|0|||
30963492|NCT01693562|59031429|FG005|Exploration Phase|Withdrawal by Subject|0|||
30963493|NCT01693562|59031430|FG006|Exploration Phase|Withdrawal by Subject|2|||
30963494|NCT01693562|59031431|FG007|Exploration Phase|Withdrawal by Subject|0|||
30963495|NCT01693562|59031432|FG008|Exploration Phase|Withdrawal by Subject|0|||
30963496|NCT01693562|59031433|FG009|Exploration Phase|Withdrawal by Subject|0|||
30963497|NCT01693562|59031434|FG010|Exploration Phase|Withdrawal by Subject|0|||
30963498|NCT01693562|59031435|FG011|Exploration Phase|Withdrawal by Subject|0|||
30963499|NCT01693562|59031436|FG012|Exploration Phase|Withdrawal by Subject|0|||
30963500|NCT01693562|59031437|FG013|Exploration Phase|Withdrawal by Subject|0|||
30963501|NCT01693562|59031438|FG014|Exploration Phase|Withdrawal by Subject|0|||
30963502|NCT01693562|59031439|FG015|Exploration Phase|Withdrawal by Subject|0|||
30963503|NCT01693562|59031440|FG016|Exploration Phase|Withdrawal by Subject|0|||
30963504|NCT01693562|59031441|FG017|Exploration Phase|Withdrawal by Subject|0|||
30963505|NCT01693562|59031442|FG018|Exploration Phase|Withdrawal by Subject|0|||
30963506|NCT01693562|59031443|FG019|Exploration Phase|Withdrawal by Subject|0|||
30963507|NCT01693562|59031444|FG020|Exploration Phase|Withdrawal by Subject|0|||
30963508|NCT01693562|59031445|FG021|Exploration Phase|Withdrawal by Subject|0|||
30963509|NCT01693562|59031446|FG022|Exploration Phase|Withdrawal by Subject|0|||
30963510|NCT01693562|59031424|FG000|Exploration Phase|Death|0|||
30963511|NCT01693562|59031425|FG001|Exploration Phase|Death|0|||
30963512|NCT01693562|59031426|FG002|Exploration Phase|Death|0|||
30963513|NCT01693562|59031427|FG003|Exploration Phase|Death|0|||
30963514|NCT01693562|59031428|FG004|Exploration Phase|Death|0|||
30963515|NCT01693562|59031429|FG005|Exploration Phase|Death|0|||
30963516|NCT01693562|59031430|FG006|Exploration Phase|Death|17|||
30963517|NCT01693562|59031431|FG007|Exploration Phase|Death|0|||
30963518|NCT01693562|59031432|FG008|Exploration Phase|Death|0|||
30963519|NCT01693562|59031433|FG009|Exploration Phase|Death|0|||
30963520|NCT01693562|59031434|FG010|Exploration Phase|Death|0|||
30963521|NCT01693562|59031435|FG011|Exploration Phase|Death|0|||
30963522|NCT01693562|59031436|FG012|Exploration Phase|Death|0|||
30963523|NCT01693562|59031437|FG013|Exploration Phase|Death|0|||
30963524|NCT01693562|59031438|FG014|Exploration Phase|Death|0|||
30963525|NCT01693562|59031439|FG015|Exploration Phase|Death|0|||
30963526|NCT01693562|59031440|FG016|Exploration Phase|Death|0|||
30963527|NCT01693562|59031441|FG017|Exploration Phase|Death|0|||
30963528|NCT01693562|59031442|FG018|Exploration Phase|Death|0|||
30963529|NCT01693562|59031443|FG019|Exploration Phase|Death|0|||
30963530|NCT01693562|59031444|FG020|Exploration Phase|Death|0|||
30963531|NCT01693562|59031445|FG021|Exploration Phase|Death|0|||
30963532|NCT01693562|59031446|FG022|Exploration Phase|Death|0|||
30963533|NCT01693562|59031424|FG000|Exploration Phase|Other|0|||
30963534|NCT01693562|59031425|FG001|Exploration Phase|Other|0|||
30963535|NCT01693562|59031426|FG002|Exploration Phase|Other|0|||
30963536|NCT01693562|59031427|FG003|Exploration Phase|Other|0|||
30963537|NCT01693562|59031428|FG004|Exploration Phase|Other|0|||
30963538|NCT01693562|59031429|FG005|Exploration Phase|Other|0|||
30963539|NCT01693562|59031430|FG006|Exploration Phase|Other|2|||
30963540|NCT01693562|59031431|FG007|Exploration Phase|Other|0|||
30963541|NCT01693562|59031432|FG008|Exploration Phase|Other|0|||
30963542|NCT01693562|59031433|FG009|Exploration Phase|Other|0|||
30963543|NCT01693562|59031434|FG010|Exploration Phase|Other|0|||
30963544|NCT01693562|59031435|FG011|Exploration Phase|Other|0|||
30963545|NCT01693562|59031436|FG012|Exploration Phase|Other|0|||
30963546|NCT01693562|59031437|FG013|Exploration Phase|Other|0|||
30963547|NCT01693562|59031438|FG014|Exploration Phase|Other|0|||
30963548|NCT01693562|59031439|FG015|Exploration Phase|Other|0|||
30963549|NCT01693562|59031440|FG016|Exploration Phase|Other|0|||
30963550|NCT01693562|59031441|FG017|Exploration Phase|Other|0|||
30963551|NCT01693562|59031442|FG018|Exploration Phase|Other|0|||
30963552|NCT01693562|59031443|FG019|Exploration Phase|Other|0|||
30963553|NCT01693562|59031444|FG020|Exploration Phase|Other|0|||
30963554|NCT01693562|59031445|FG021|Exploration Phase|Other|0|||
30963555|NCT01693562|59031446|FG022|Exploration Phase|Other|0|||
30963556|NCT01693562|59031424|FG000|Expansion Phase|Withdrawal by Subject|0|||
30963557|NCT01693562|59031425|FG001|Expansion Phase|Withdrawal by Subject|0|||
30963558|NCT01693562|59031426|FG002|Expansion Phase|Withdrawal by Subject|0|||
30963559|NCT01693562|59031427|FG003|Expansion Phase|Withdrawal by Subject|0|||
30963560|NCT01693562|59031428|FG004|Expansion Phase|Withdrawal by Subject|0|||
30963561|NCT01693562|59031429|FG005|Expansion Phase|Withdrawal by Subject|0|||
30963562|NCT01693562|59031430|FG006|Expansion Phase|Withdrawal by Subject|0|||
30963563|NCT01693562|59031431|FG007|Expansion Phase|Withdrawal by Subject|16|||
30963564|NCT01693562|59031432|FG008|Expansion Phase|Withdrawal by Subject|2|||
30963565|NCT01693562|59031433|FG009|Expansion Phase|Withdrawal by Subject|54|||
30963566|NCT01693562|59031434|FG010|Expansion Phase|Withdrawal by Subject|2|||
30963567|NCT01693562|59031435|FG011|Expansion Phase|Withdrawal by Subject|2|||
30963568|NCT01693562|59031436|FG012|Expansion Phase|Withdrawal by Subject|3|||
30963569|NCT01693562|59031437|FG013|Expansion Phase|Withdrawal by Subject|5|||
30963570|NCT01693562|59031438|FG014|Expansion Phase|Withdrawal by Subject|16|||
30963571|NCT01693562|59031439|FG015|Expansion Phase|Withdrawal by Subject|7|||
30963572|NCT01693562|59031440|FG016|Expansion Phase|Withdrawal by Subject|40|||
30963573|NCT01693562|59031441|FG017|Expansion Phase|Withdrawal by Subject|4|||
30963574|NCT01693562|59031442|FG018|Expansion Phase|Withdrawal by Subject|8|||
30963575|NCT01693562|59031443|FG019|Expansion Phase|Withdrawal by Subject|3|||
30963576|NCT01693562|59031444|FG020|Expansion Phase|Withdrawal by Subject|1|||
30963577|NCT01693562|59031445|FG021|Expansion Phase|Withdrawal by Subject|8|||
30963578|NCT01693562|59031446|FG022|Expansion Phase|Withdrawal by Subject|1|||
30963579|NCT01693562|59031424|FG000|Expansion Phase|Death|0|||
30963580|NCT01693562|59031425|FG001|Expansion Phase|Death|0|||
30963581|NCT01693562|59031426|FG002|Expansion Phase|Death|0|||
30963582|NCT01693562|59031427|FG003|Expansion Phase|Death|0|||
30963583|NCT01693562|59031428|FG004|Expansion Phase|Death|0|||
30963584|NCT01693562|59031429|FG005|Expansion Phase|Death|0|||
30963585|NCT01693562|59031430|FG006|Expansion Phase|Death|0|||
30963586|NCT01693562|59031431|FG007|Expansion Phase|Death|42|||
30963587|NCT01693562|59031432|FG008|Expansion Phase|Death|17|||
30963588|NCT01693562|59031433|FG009|Expansion Phase|Death|208|||
30963589|NCT01693562|59031434|FG010|Expansion Phase|Death|30|||
30963590|NCT01693562|59031435|FG011|Expansion Phase|Death|8|||
30963591|NCT01693562|59031436|FG012|Expansion Phase|Death|19|||
30963592|NCT01693562|59031437|FG013|Expansion Phase|Death|42|||
30963593|NCT01693562|59031438|FG014|Expansion Phase|Death|23|||
30963594|NCT01693562|59031439|FG015|Expansion Phase|Death|23|||
30963595|NCT01693562|59031440|FG016|Expansion Phase|Death|128|||
30963596|NCT01693562|59031441|FG017|Expansion Phase|Death|16|||
30963597|NCT01693562|59031442|FG018|Expansion Phase|Death|36|||
30963598|NCT01693562|59031443|FG019|Expansion Phase|Death|16|||
30963599|NCT01693562|59031444|FG020|Expansion Phase|Death|17|||
30963600|NCT01693562|59031445|FG021|Expansion Phase|Death|35|||
30963601|NCT01693562|59031446|FG022|Expansion Phase|Death|7|||
30963602|NCT01693562|59031424|FG000|Expansion Phase|Lost to Follow-up|0|||
30963603|NCT01693562|59031425|FG001|Expansion Phase|Lost to Follow-up|0|||
30963604|NCT01693562|59031426|FG002|Expansion Phase|Lost to Follow-up|0|||
30963605|NCT01693562|59031427|FG003|Expansion Phase|Lost to Follow-up|0|||
30963606|NCT01693562|59031428|FG004|Expansion Phase|Lost to Follow-up|0|||
30963607|NCT01693562|59031429|FG005|Expansion Phase|Lost to Follow-up|0|||
30963608|NCT01693562|59031430|FG006|Expansion Phase|Lost to Follow-up|0|||
30963609|NCT01693562|59031431|FG007|Expansion Phase|Lost to Follow-up|1|||
30963610|NCT01693562|59031432|FG008|Expansion Phase|Lost to Follow-up|2|||
30963611|NCT01693562|59031433|FG009|Expansion Phase|Lost to Follow-up|10|||
30963612|NCT01693562|59031434|FG010|Expansion Phase|Lost to Follow-up|4|||
30963613|NCT01693562|59031435|FG011|Expansion Phase|Lost to Follow-up|4|||
30963614|NCT01693562|59031436|FG012|Expansion Phase|Lost to Follow-up|1|||
30963615|NCT01693562|59031437|FG013|Expansion Phase|Lost to Follow-up|3|||
30963616|NCT01693562|59031438|FG014|Expansion Phase|Lost to Follow-up|0|||
30963617|NCT01693562|59031439|FG015|Expansion Phase|Lost to Follow-up|1|||
30963618|NCT01693562|59031440|FG016|Expansion Phase|Lost to Follow-up|1|||
30963619|NCT01693562|59031441|FG017|Expansion Phase|Lost to Follow-up|0|||
30963620|NCT01693562|59031442|FG018|Expansion Phase|Lost to Follow-up|2|||
30963621|NCT01693562|59031443|FG019|Expansion Phase|Lost to Follow-up|1|||
30963622|NCT01693562|59031444|FG020|Expansion Phase|Lost to Follow-up|2|||
30963623|NCT01693562|59031445|FG021|Expansion Phase|Lost to Follow-up|2|||
30963624|NCT01693562|59031446|FG022|Expansion Phase|Lost to Follow-up|1|||
30963625|NCT01693562|59031424|FG000|Expansion Phase|Other|0|||
30963626|NCT01693562|59031425|FG001|Expansion Phase|Other|0|||
30963627|NCT01693562|59031426|FG002|Expansion Phase|Other|0|||
30963628|NCT01693562|59031427|FG003|Expansion Phase|Other|0|||
30963629|NCT01693562|59031428|FG004|Expansion Phase|Other|0|||
30963630|NCT01693562|59031429|FG005|Expansion Phase|Other|0|||
30963631|NCT01693562|59031430|FG006|Expansion Phase|Other|0|||
30963632|NCT01693562|59031431|FG007|Expansion Phase|Other|3|||
30963633|NCT01693562|59031432|FG008|Expansion Phase|Other|1|||
30963634|NCT01693562|59031433|FG009|Expansion Phase|Other|28|||
30963635|NCT01693562|59031434|FG010|Expansion Phase|Other|4|||
30963636|NCT01693562|59031435|FG011|Expansion Phase|Other|7|||
30963637|NCT01693562|59031436|FG012|Expansion Phase|Other|0|||
30963638|NCT01693562|59031437|FG013|Expansion Phase|Other|1|||
30963639|NCT01693562|59031438|FG014|Expansion Phase|Other|1|||
30963640|NCT01693562|59031439|FG015|Expansion Phase|Other|0|||
30963641|NCT01693562|59031440|FG016|Expansion Phase|Other|28|||
30963642|NCT01693562|59031441|FG017|Expansion Phase|Other|0|||
30963643|NCT01693562|59031442|FG018|Expansion Phase|Other|1|||
30963644|NCT01693562|59031443|FG019|Expansion Phase|Other|0|||
30963645|NCT01693562|59031444|FG020|Expansion Phase|Other|1|||
30963646|NCT01693562|59031445|FG021|Expansion Phase|Other|17|||
30963647|NCT01693562|59031446|FG022|Expansion Phase|Other|1|||
30963648|NCT01467713|59031543|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
30963649|NCT01467713|59031544|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
30963650|NCT01467713|59031545|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
30963651|NCT01467713|59031546|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
30963652|NCT01467713|59031543|FG000|Overall Study|Major Protocol Deviation|2|||
30963653|NCT01467713|59031544|FG001|Overall Study|Major Protocol Deviation|4|||
30963654|NCT01467713|59031545|FG002|Overall Study|Major Protocol Deviation|4|||
30963655|NCT01467713|59031546|FG003|Overall Study|Major Protocol Deviation|1|||
30963656|NCT01467713|59031543|FG000|Overall Study|Lost to Follow-up|9|||
30963657|NCT01467713|59031544|FG001|Overall Study|Lost to Follow-up|12|||
30963658|NCT01467713|59031545|FG002|Overall Study|Lost to Follow-up|6|||
30963659|NCT01467713|59031546|FG003|Overall Study|Lost to Follow-up|9|||
30963660|NCT01467713|59031543|FG000|Overall Study|Voluntary Withdrawal|18|||
30963661|NCT01467713|59031544|FG001|Overall Study|Voluntary Withdrawal|14|||
30963662|NCT01467713|59031545|FG002|Overall Study|Voluntary Withdrawal|21|||
30963663|NCT01467713|59031546|FG003|Overall Study|Voluntary Withdrawal|20|||
30963664|NCT01467713|59031543|FG000|Overall Study|Study Termination|23|||
30963665|NCT01467713|59031544|FG001|Overall Study|Study Termination|33|||
30963666|NCT01467713|59031545|FG002|Overall Study|Study Termination|28|||
30963667|NCT01467713|59031546|FG003|Overall Study|Study Termination|29|||
30963668|NCT01467713|59031543|FG000|Overall Study|Pregnancy|0|||
30963669|NCT01467713|59031544|FG001|Overall Study|Pregnancy|1|||
30963670|NCT01467713|59031545|FG002|Overall Study|Pregnancy|1|||
30963671|NCT01467713|59031546|FG003|Overall Study|Pregnancy|3|||
30963672|NCT01467713|59031543|FG000|Overall Study|Relapse|35|||
30963673|NCT01467713|59031544|FG001|Overall Study|Relapse|25|||
30963674|NCT01467713|59031545|FG002|Overall Study|Relapse|28|||
30963675|NCT01467713|59031546|FG003|Overall Study|Relapse|35|||
30963676|NCT01467713|59031543|FG000|Overall Study|Reason not Specified|6|||
30963677|NCT01467713|59031544|FG001|Overall Study|Reason not Specified|11|||
30963678|NCT01467713|59031545|FG002|Overall Study|Reason not Specified|8|||
30963679|NCT01467713|59031546|FG003|Overall Study|Reason not Specified|7|||
30963680|NCT01693250|59031576|FG000|Overall Study|Lost to Follow-up|2|||
30963681|NCT01693250|59031577|FG001|Overall Study|Lost to Follow-up|2|||
30963682|NCT01590758|59031600|FG000|Overall Study|Withdrawal by Subject|0|||
30963683|NCT01590758|59031601|FG001|Overall Study|Withdrawal by Subject|3|||
30963684|NCT01590758|59031600|FG000|Overall Study|Physician Decision|1|||
30963685|NCT01590758|59031601|FG001|Overall Study|Physician Decision|2|||
30963686|NCT01590758|59031600|FG000|Overall Study|Lost to Follow-up|4|||
30963687|NCT01590758|59031601|FG001|Overall Study|Lost to Follow-up|2|||
30963688|NCT01590212|59031610|FG000|Overall Study|Withdrawal by Subject|2|||
30963689|NCT01590212|59031611|FG001|Overall Study|Withdrawal by Subject|2|||
30963690|NCT01590212|59031612|FG002|Overall Study|Withdrawal by Subject|2|||
30963691|NCT01590212|59031610|FG000|Overall Study|Lost to Follow-up|1|||
30963692|NCT01590212|59031611|FG001|Overall Study|Lost to Follow-up|2|||
30963693|NCT01590212|59031612|FG002|Overall Study|Lost to Follow-up|3|||
30963694|NCT01692938|59031623|FG000|Overall Study|Protocol Deviation|1|||
30963695|NCT01692938|59031624|FG001|Overall Study|Protocol Deviation|1|||
30963696|NCT01692938|59031623|FG000|Overall Study|Study completed prior to site completion|3|||
30963697|NCT01692938|59031624|FG001|Overall Study|Study completed prior to site completion|3|||
30963698|NCT01692782|59031637|FG000|Overall Study|Adverse Event|12|||
30963699|NCT01692782|59031638|FG001|Overall Study|Adverse Event|32|||
30963700|NCT01692782|59031639|FG002|Overall Study|Adverse Event|2|||
30963701|NCT01692782|59031637|FG000|Overall Study|Lack of Efficacy|1|||
30963702|NCT01692782|59031638|FG001|Overall Study|Lack of Efficacy|2|||
30963703|NCT01692782|59031639|FG002|Overall Study|Lack of Efficacy|0|||
30963704|NCT01692782|59031637|FG000|Overall Study|Lost to Follow-up|2|||
30963705|NCT01692782|59031638|FG001|Overall Study|Lost to Follow-up|7|||
30963706|NCT01692782|59031639|FG002|Overall Study|Lost to Follow-up|1|||
30963707|NCT01692782|59031637|FG000|Overall Study|Pregnancy|1|||
30963708|NCT01692782|59031638|FG001|Overall Study|Pregnancy|0|||
30963709|NCT01692782|59031639|FG002|Overall Study|Pregnancy|0|||
30963710|NCT01692782|59031637|FG000|Overall Study|Protocol Violation|1|||
30963711|NCT01692782|59031638|FG001|Overall Study|Protocol Violation|0|||
30963712|NCT01692782|59031639|FG002|Overall Study|Protocol Violation|2|||
30963713|NCT01692782|59031637|FG000|Overall Study|Non-complance with study drug|0|||
30963714|NCT01692782|59031638|FG001|Overall Study|Non-complance with study drug|4|||
30963715|NCT01692782|59031639|FG002|Overall Study|Non-complance with study drug|1|||
30963716|NCT01692782|59031637|FG000|Overall Study|Non-compliant with study visits|0|||
30963717|NCT01692782|59031638|FG001|Overall Study|Non-compliant with study visits|0|||
30963718|NCT01692782|59031639|FG002|Overall Study|Non-compliant with study visits|1|||
30963719|NCT01692782|59031637|FG000|Overall Study|SAE not related to study drug|0|||
30963720|NCT01692782|59031638|FG001|Overall Study|SAE not related to study drug|1|||
30963721|NCT01692782|59031639|FG002|Overall Study|SAE not related to study drug|0|||
30963722|NCT01692782|59031637|FG000|Overall Study|Withdrawal by Subject|3|||
30963723|NCT01692782|59031638|FG001|Overall Study|Withdrawal by Subject|10|||
30963724|NCT01692782|59031639|FG002|Overall Study|Withdrawal by Subject|3|||
30963725|NCT01692626|59031647|FG000|Overall Study|Death|0|||
30963726|NCT01692626|59031648|FG001|Overall Study|Death|1|||
30963727|NCT01692626|59031647|FG000|Overall Study|Adverse Event|2|||
30963728|NCT01692626|59031648|FG001|Overall Study|Adverse Event|3|||
30963729|NCT01692626|59031647|FG000|Overall Study|Protocol Violation|1|||
30963730|NCT01692626|59031648|FG001|Overall Study|Protocol Violation|2|||
30963731|NCT01692626|59031647|FG000|Overall Study|Withdrawal by Subject|1|||
30963732|NCT01692626|59031648|FG001|Overall Study|Withdrawal by Subject|0|||
30963733|NCT01475461|59031674|FG000|Run-in Period|Not meet eligibility criteria|16|||
30963734|NCT01475461|59031675|FG001|Run-in Period|Not meet eligibility criteria|0|||
30963735|NCT01475461|59031676|FG002|Run-in Period|Not meet eligibility criteria|0|||
30963736|NCT01475461|59031677|FG003|Run-in Period|Not meet eligibility criteria|0|||
30963737|NCT01475461|59031678|FG004|Run-in Period|Not meet eligibility criteria|0|||
30963738|NCT01475461|59031679|FG005|Run-in Period|Not meet eligibility criteria|0|||
30963739|NCT01475461|59031680|FG006|Run-in Period|Not meet eligibility criteria|0|||
30963740|NCT01475461|59031674|FG000|Run-in Period|Lost to Follow-up|7|||
30963741|NCT01475461|59031675|FG001|Run-in Period|Lost to Follow-up|0|||
30963742|NCT01475461|59031676|FG002|Run-in Period|Lost to Follow-up|0|||
30963743|NCT01475461|59031677|FG003|Run-in Period|Lost to Follow-up|0|||
30963744|NCT01475461|59031678|FG004|Run-in Period|Lost to Follow-up|0|||
30963745|NCT01475461|59031679|FG005|Run-in Period|Lost to Follow-up|0|||
30963746|NCT01475461|59031680|FG006|Run-in Period|Lost to Follow-up|0|||
30963747|NCT01475461|59031674|FG000|Run-in Period|Withdrawal by Subject|11|||
30963748|NCT01475461|59031675|FG001|Run-in Period|Withdrawal by Subject|0|||
30963749|NCT01475461|59031676|FG002|Run-in Period|Withdrawal by Subject|0|||
30963750|NCT01475461|59031677|FG003|Run-in Period|Withdrawal by Subject|0|||
30963751|NCT01475461|59031678|FG004|Run-in Period|Withdrawal by Subject|0|||
30963752|NCT01475461|59031679|FG005|Run-in Period|Withdrawal by Subject|0|||
30963753|NCT01475461|59031680|FG006|Run-in Period|Withdrawal by Subject|0|||
30963754|NCT01475461|59031674|FG000|Run-in Period|Other|3|||
30963755|NCT01475461|59031675|FG001|Run-in Period|Other|0|||
30963756|NCT01475461|59031676|FG002|Run-in Period|Other|0|||
30963757|NCT01475461|59031677|FG003|Run-in Period|Other|0|||
30963758|NCT01475461|59031678|FG004|Run-in Period|Other|0|||
30963759|NCT01475461|59031679|FG005|Run-in Period|Other|0|||
30963760|NCT01475461|59031680|FG006|Run-in Period|Other|0|||
30963761|NCT01475461|59031674|FG000|Run-in Period|Protocol Violation|4|||
30963762|NCT01475461|59031675|FG001|Run-in Period|Protocol Violation|0|||
30963763|NCT01475461|59031676|FG002|Run-in Period|Protocol Violation|0|||
30963764|NCT01475461|59031677|FG003|Run-in Period|Protocol Violation|0|||
30963765|NCT01475461|59031678|FG004|Run-in Period|Protocol Violation|0|||
30963766|NCT01475461|59031679|FG005|Run-in Period|Protocol Violation|0|||
30963767|NCT01475461|59031680|FG006|Run-in Period|Protocol Violation|0|||
30963768|NCT01475461|59031674|FG000|Treatment Period|Death|0|||
30963769|NCT01475461|59031675|FG001|Treatment Period|Death|0|||
30963770|NCT01475461|59031676|FG002|Treatment Period|Death|0|||
30963771|NCT01475461|59031677|FG003|Treatment Period|Death|1|||
30963772|NCT01475461|59031678|FG004|Treatment Period|Death|0|||
30963773|NCT01475461|59031679|FG005|Treatment Period|Death|0|||
30963774|NCT01475461|59031680|FG006|Treatment Period|Death|0|||
30963775|NCT01475461|59031674|FG000|Treatment Period|Lost to Follow-up|0|||
30963776|NCT01475461|59031675|FG001|Treatment Period|Lost to Follow-up|3|||
30963777|NCT01475461|59031676|FG002|Treatment Period|Lost to Follow-up|2|||
30963778|NCT01475461|59031677|FG003|Treatment Period|Lost to Follow-up|3|||
30963779|NCT01475461|59031678|FG004|Treatment Period|Lost to Follow-up|1|||
30963780|NCT01475461|59031679|FG005|Treatment Period|Lost to Follow-up|2|||
30963781|NCT01475461|59031680|FG006|Treatment Period|Lost to Follow-up|1|||
30963782|NCT01475461|59031674|FG000|Treatment Period|Withdrawal by Subject|0|||
30963783|NCT01475461|59031675|FG001|Treatment Period|Withdrawal by Subject|2|||
30963784|NCT01475461|59031676|FG002|Treatment Period|Withdrawal by Subject|2|||
30963785|NCT01475461|59031677|FG003|Treatment Period|Withdrawal by Subject|0|||
30963786|NCT01475461|59031678|FG004|Treatment Period|Withdrawal by Subject|2|||
30963787|NCT01475461|59031679|FG005|Treatment Period|Withdrawal by Subject|2|||
30963788|NCT01475461|59031680|FG006|Treatment Period|Withdrawal by Subject|0|||
30963789|NCT01475461|59031674|FG000|Treatment Period|Other|0|||
30963790|NCT01475461|59031675|FG001|Treatment Period|Other|1|||
30963791|NCT01475461|59031676|FG002|Treatment Period|Other|0|||
30963792|NCT01475461|59031677|FG003|Treatment Period|Other|0|||
30963793|NCT01475461|59031678|FG004|Treatment Period|Other|0|||
30963794|NCT01475461|59031679|FG005|Treatment Period|Other|0|||
30963795|NCT01475461|59031680|FG006|Treatment Period|Other|0|||
30963796|NCT01475461|59031674|FG000|Treatment Period|Protocol Violation|0|||
30963797|NCT01475461|59031675|FG001|Treatment Period|Protocol Violation|1|||
30963798|NCT01475461|59031676|FG002|Treatment Period|Protocol Violation|0|||
30604847|NCT01225731|58615774|FG003|Part 1|Withdrawal by Subject|0|||
30604848|NCT01225731|58615775|FG004|Part 1|Withdrawal by Subject|4|||
30963799|NCT01475461|59031677|FG003|Treatment Period|Protocol Violation|0|||
30963800|NCT01475461|59031678|FG004|Treatment Period|Protocol Violation|0|||
30963801|NCT01475461|59031679|FG005|Treatment Period|Protocol Violation|0|||
30963802|NCT01475461|59031680|FG006|Treatment Period|Protocol Violation|1|||
30963803|NCT01475461|59031674|FG000|Treatment Period|Lack of Efficacy|0|||
30963804|NCT01475461|59031675|FG001|Treatment Period|Lack of Efficacy|2|||
30963805|NCT01475461|59031676|FG002|Treatment Period|Lack of Efficacy|0|||
30963806|NCT01475461|59031677|FG003|Treatment Period|Lack of Efficacy|2|||
30963807|NCT01475461|59031678|FG004|Treatment Period|Lack of Efficacy|1|||
30963808|NCT01475461|59031679|FG005|Treatment Period|Lack of Efficacy|1|||
30963809|NCT01475461|59031680|FG006|Treatment Period|Lack of Efficacy|0|||
30963810|NCT01475461|59031674|FG000|Treatment Period|Medication Error|0|||
30963811|NCT01475461|59031675|FG001|Treatment Period|Medication Error|0|||
30604849|NCT01225731|58615776|FG005|Part 1|Withdrawal by Subject|0|||
30963812|NCT01475461|59031676|FG002|Treatment Period|Medication Error|0|||
30963813|NCT01475461|59031677|FG003|Treatment Period|Medication Error|1|||
30963814|NCT01475461|59031678|FG004|Treatment Period|Medication Error|0|||
30963815|NCT01475461|59031679|FG005|Treatment Period|Medication Error|0|||
30963816|NCT01475461|59031680|FG006|Treatment Period|Medication Error|0|||
30963817|NCT01475461|59031674|FG000|Treatment Period|Adverse Event|0|||
30963818|NCT01475461|59031675|FG001|Treatment Period|Adverse Event|0|||
30963819|NCT01475461|59031676|FG002|Treatment Period|Adverse Event|0|||
30963820|NCT01475461|59031677|FG003|Treatment Period|Adverse Event|1|||
30963821|NCT01475461|59031678|FG004|Treatment Period|Adverse Event|0|||
30963822|NCT01475461|59031679|FG005|Treatment Period|Adverse Event|0|||
30963823|NCT01475461|59031680|FG006|Treatment Period|Adverse Event|0|||
30963824|NCT01589822|59031716|FG000|Overall Study|Withdrawal by Subject|1|||
30963825|NCT01589822|59031717|FG001|Overall Study|Withdrawal by Subject|2|||
30963826|NCT01589822|59031718|FG002|Overall Study|Withdrawal by Subject|0|||
30963827|NCT01589822|59031716|FG000|Overall Study|Death|1|||
30963828|NCT01589822|59031717|FG001|Overall Study|Death|0|||
30963829|NCT01589822|59031718|FG002|Overall Study|Death|0|||
30963830|NCT01589822|59031716|FG000|Overall Study|Missed 90 day visit|2|||
30963831|NCT01589822|59031717|FG001|Overall Study|Missed 90 day visit|1|||
30963832|NCT01589822|59031718|FG002|Overall Study|Missed 90 day visit|1|||
30963833|NCT01565642|59031730|FG000|Overall Study|Withdrawal by Subject|2|||
30963834|NCT01565642|59031731|FG001|Overall Study|Withdrawal by Subject|1|||
30963835|NCT01475071|59031737|FG000|Overall Study|Physician Decision|1|||
30963836|NCT01475071|59031737|FG000|Overall Study|Withdrawal by Subject|6|||
30963837|NCT01475071|59031737|FG000|Overall Study|Lost to Follow-up|1|||
30963838|NCT01474993|59031745|FG000|Overall Study|Lost to Follow-up|1|||
30963839|NCT01474993|59031746|FG001|Overall Study|Lost to Follow-up|2|||
30963840|NCT01474993|59031745|FG000|Overall Study|Adverse Event|0|||
30963841|NCT01474993|59031746|FG001|Overall Study|Adverse Event|1|||
30963842|NCT01691768|59031756|FG000|Overall Study|Death|0|||
30963843|NCT01691768|59031757|FG001|Overall Study|Death|2|||
30963844|NCT01691768|59031756|FG000|Overall Study|Lost to Follow-up|4|||
30963845|NCT01691768|59031757|FG001|Overall Study|Lost to Follow-up|3|||
30963846|NCT01691768|59031756|FG000|Overall Study|Withdrawal by Subject|10|||
30963847|NCT01691768|59031757|FG001|Overall Study|Withdrawal by Subject|9|||
30963848|NCT01691768|59031756|FG000|Overall Study|Relocated|0|||
30963849|NCT01691768|59031757|FG001|Overall Study|Relocated|1|||
30963850|NCT01691768|59031756|FG000|Overall Study|Investigator decision|1|||
30963851|NCT01691768|59031757|FG001|Overall Study|Investigator decision|1|||
30963852|NCT01503229|59031764|FG000|Overall Study|Withdrew consent|1|||
30963853|NCT01691612|59031768|FG000|Overall Study|deemed ineligible after 1st visit|6|||
30963854|NCT01691612|59031768|FG000|Overall Study|Adverse Event|1|||
30963855|NCT01565564|59031774|FG000|Overall Study|Lost to Follow-up|5|||
30963856|NCT01565564|59031775|FG001|Overall Study|Lost to Follow-up|1|||
30963857|NCT01460407|59031781|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
30963858|NCT01460407|59031782|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
30963859|NCT01502371|59031794|FG000|Overall Study|Withdrawal by Subject|1|||
30963860|NCT01502371|59031795|FG001|Overall Study|Withdrawal by Subject|2|||
30963861|NCT01502371|59031796|FG002|Overall Study|Withdrawal by Subject|1|||
30963862|NCT01502371|59031797|FG003|Overall Study|Withdrawal by Subject|1|||
30963863|NCT01502371|59031798|FG004|Overall Study|Withdrawal by Subject|1|||
30963864|NCT01502371|59031794|FG000|Overall Study|Adverse Event|2|||
30963865|NCT01502371|59031795|FG001|Overall Study|Adverse Event|1|||
30963866|NCT01502371|59031796|FG002|Overall Study|Adverse Event|0|||
30963867|NCT01502371|59031797|FG003|Overall Study|Adverse Event|4|||
30963868|NCT01502371|59031798|FG004|Overall Study|Adverse Event|3|||
30963869|NCT01502371|59031794|FG000|Overall Study|Treatment Failure|22|||
30963870|NCT01502371|59031795|FG001|Overall Study|Treatment Failure|20|||
30963871|NCT01502371|59031796|FG002|Overall Study|Treatment Failure|12|||
30963872|NCT01502371|59031797|FG003|Overall Study|Treatment Failure|19|||
30963873|NCT01502371|59031798|FG004|Overall Study|Treatment Failure|30|||
30604850|NCT01225731|58615777|FG006|Part 1|Withdrawal by Subject|0|||
30963874|NCT01502371|59031794|FG000|Overall Study|Lack of Efficacy|3|||
30963875|NCT01502371|59031795|FG001|Overall Study|Lack of Efficacy|3|||
30963876|NCT01502371|59031796|FG002|Overall Study|Lack of Efficacy|2|||
30963877|NCT01502371|59031797|FG003|Overall Study|Lack of Efficacy|2|||
30963878|NCT01502371|59031798|FG004|Overall Study|Lack of Efficacy|4|||
30963879|NCT01502371|59031794|FG000|Overall Study|Physician Decision|3|||
30963880|NCT01502371|59031795|FG001|Overall Study|Physician Decision|0|||
30963881|NCT01502371|59031796|FG002|Overall Study|Physician Decision|0|||
30604851|NCT01225731|58615778|FG007|Part 1|Withdrawal by Subject|0|||
30963882|NCT01502371|59031797|FG003|Overall Study|Physician Decision|0|||
30963883|NCT01502371|59031798|FG004|Overall Study|Physician Decision|1|||
30963884|NCT01502371|59031794|FG000|Overall Study|Noncompliance with Study Drug|0|||
30963885|NCT01502371|59031795|FG001|Overall Study|Noncompliance with Study Drug|0|||
30963886|NCT01502371|59031796|FG002|Overall Study|Noncompliance with Study Drug|1|||
30963887|NCT01502371|59031797|FG003|Overall Study|Noncompliance with Study Drug|2|||
30963888|NCT01502371|59031798|FG004|Overall Study|Noncompliance with Study Drug|1|||
30963889|NCT01502371|59031794|FG000|Overall Study|Technical Problems|1|||
30963890|NCT01502371|59031795|FG001|Overall Study|Technical Problems|0|||
30963891|NCT01502371|59031796|FG002|Overall Study|Technical Problems|2|||
30963892|NCT01502371|59031797|FG003|Overall Study|Technical Problems|4|||
30963893|NCT01502371|59031798|FG004|Overall Study|Technical Problems|1|||
30963894|NCT01502371|59031794|FG000|Overall Study|Protocol Violation|9|||
30963895|NCT01502371|59031795|FG001|Overall Study|Protocol Violation|5|||
30963896|NCT01502371|59031796|FG002|Overall Study|Protocol Violation|6|||
30963897|NCT01502371|59031797|FG003|Overall Study|Protocol Violation|5|||
30963898|NCT01502371|59031798|FG004|Overall Study|Protocol Violation|10|||
30963899|NCT01502371|59031794|FG000|Overall Study|Excluded Medication|0|||
30963900|NCT01502371|59031795|FG001|Overall Study|Excluded Medication|1|||
30963901|NCT01502371|59031796|FG002|Overall Study|Excluded Medication|1|||
30963902|NCT01502371|59031797|FG003|Overall Study|Excluded Medication|0|||
30963903|NCT01502371|59031798|FG004|Overall Study|Excluded Medication|1|||
30963904|NCT01588496|59031814|FG000|Overall Study|Withdrawal by Subject|0|||
30963905|NCT01588496|59031815|FG001|Overall Study|Withdrawal by Subject|1|||
30963906|NCT01588496|59031816|FG002|Overall Study|Withdrawal by Subject|0|||
30963907|NCT01502293|59031827|FG000|Overall Study|Progressive Disease|20|||
30963908|NCT01502293|59031828|FG001|Overall Study|Progressive Disease|12|||
30963909|NCT01502293|59031829|FG002|Overall Study|Progressive Disease|2|||
30963910|NCT01502293|59031827|FG000|Overall Study|Withdrawal by Subject|3|||
30963911|NCT01502293|59031828|FG001|Overall Study|Withdrawal by Subject|3|||
30963912|NCT01502293|59031829|FG002|Overall Study|Withdrawal by Subject|1|||
30963913|NCT01502293|59031827|FG000|Overall Study|Adverse Event|0|||
30963914|NCT01502293|59031828|FG001|Overall Study|Adverse Event|2|||
30963915|NCT01502293|59031829|FG002|Overall Study|Adverse Event|0|||
30963916|NCT01502293|59031827|FG000|Overall Study|Reason Not Specified|2|||
30963917|NCT01502293|59031828|FG001|Overall Study|Reason Not Specified|0|||
30963918|NCT01502293|59031829|FG002|Overall Study|Reason Not Specified|0|||
30963919|NCT01502293|59031827|FG000|Overall Study|Physician Decision|0|||
30963920|NCT01502293|59031828|FG001|Overall Study|Physician Decision|0|||
30963921|NCT01502293|59031829|FG002|Overall Study|Physician Decision|1|||
30963922|NCT01474681|59031842|FG000|Overall Study|Death|0|||
30963923|NCT01474681|59031843|FG001|Overall Study|Death|3|||
30963924|NCT01474681|59031844|FG002|Overall Study|Death|2|||
30963925|NCT01474681|59031845|FG003|Overall Study|Death|6|||
30963926|NCT01459783|59031861|FG000|Baseline to 6 Months|Death|1|||
30963927|NCT01459783|59031862|FG001|Baseline to 6 Months|Death|0|||
30963928|NCT01459783|59031861|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
30963929|NCT01459783|59031862|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
30963930|NCT01459783|59031861|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
30963931|NCT01459783|59031862|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
30963932|NCT01459783|59031861|FG000|6 Months to 12 Months|Death|0|||
30963933|NCT01459783|59031862|FG001|6 Months to 12 Months|Death|1|||
30963934|NCT01459783|59031861|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
30963935|NCT01459783|59031862|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
30963936|NCT01459783|59031861|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
30963937|NCT01459783|59031862|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
30963938|NCT01459783|59031861|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
30963939|NCT01459783|59031862|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
30963940|NCT01588184|59031874|FG000|Overall Study|Death|1|||
30963941|NCT01588184|59031875|FG001|Overall Study|Death|0|||
30963942|NCT01588184|59031876|FG002|Overall Study|Death|0|||
30963943|NCT01588184|59031877|FG003|Overall Study|Death|1|||
30963944|NCT01588184|59031878|FG004|Overall Study|Death|1|||
30963945|NCT01588184|59031879|FG005|Overall Study|Death|1|||
30963946|NCT01588184|59031874|FG000|Overall Study|Withdrawal by Subject|2|||
30963947|NCT01588184|59031875|FG001|Overall Study|Withdrawal by Subject|4|||
30963948|NCT01588184|59031876|FG002|Overall Study|Withdrawal by Subject|0|||
30963949|NCT01588184|59031877|FG003|Overall Study|Withdrawal by Subject|1|||
30963950|NCT01588184|59031878|FG004|Overall Study|Withdrawal by Subject|0|||
30963951|NCT01588184|59031879|FG005|Overall Study|Withdrawal by Subject|0|||
30963952|NCT01588184|59031874|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
30963953|NCT01588184|59031875|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
30963954|NCT01588184|59031876|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
30963955|NCT01588184|59031877|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
30963956|NCT01588184|59031878|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
30963957|NCT01588184|59031879|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
30963958|NCT01588184|59031874|FG000|Overall Study|multiple reasons|0|||
30963959|NCT01588184|59031875|FG001|Overall Study|multiple reasons|3|||
30963960|NCT01588184|59031876|FG002|Overall Study|multiple reasons|0|||
30963961|NCT01588184|59031877|FG003|Overall Study|multiple reasons|1|||
30963962|NCT01588184|59031878|FG004|Overall Study|multiple reasons|0|||
30963963|NCT01588184|59031879|FG005|Overall Study|multiple reasons|0|||
30963964|NCT01588106|59031895|FG000|Overall Study|Withdrawal by Subject|5|||
30963965|NCT01588106|59031896|FG001|Overall Study|Withdrawal by Subject|4|||
30963966|NCT01564862|59031905|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
30963967|NCT01564862|59031906|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
30963968|NCT01564862|59031907|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
30963969|NCT01564862|59031905|FG000|Overall Study|Major Protocol Deviation|3|||
30963970|NCT01564862|59031906|FG001|Overall Study|Major Protocol Deviation|3|||
30963971|NCT01564862|59031907|FG002|Overall Study|Major Protocol Deviation|4|||
30963972|NCT01564862|59031905|FG000|Overall Study|Lost to Follow-up|10|||
30963973|NCT01564862|59031906|FG001|Overall Study|Lost to Follow-up|8|||
30963974|NCT01564862|59031907|FG002|Overall Study|Lost to Follow-up|6|||
30963975|NCT01564862|59031905|FG000|Overall Study|Voluntary Withdrawal|9|||
30963976|NCT01564862|59031906|FG001|Overall Study|Voluntary Withdrawal|6|||
30963977|NCT01564862|59031907|FG002|Overall Study|Voluntary Withdrawal|8|||
30963978|NCT01564862|59031905|FG000|Overall Study|Lack of Efficacy|1|||
30963979|NCT01564862|59031906|FG001|Overall Study|Lack of Efficacy|5|||
30963980|NCT01564862|59031907|FG002|Overall Study|Lack of Efficacy|6|||
30963981|NCT01564862|59031905|FG000|Overall Study|Other reason(s)|1|||
30963982|NCT01564862|59031906|FG001|Overall Study|Other reason(s)|0|||
30963983|NCT01564862|59031907|FG002|Overall Study|Other reason(s)|0|||
30963984|NCT01691378|59031917|FG000|Overall Study|Withdrawal by Subject|2|||
30963985|NCT01691378|59031918|FG001|Overall Study|Withdrawal by Subject|0|||
30963986|NCT01691378|59031917|FG000|Overall Study|Lost to Follow-up|5|||
30963987|NCT01691378|59031918|FG001|Overall Study|Lost to Follow-up|2|||
30963988|NCT01467479|59031927|FG000|Overall Study|No Study Medication|1|||
30963989|NCT01467479|59031928|FG001|Overall Study|No Study Medication|0|||
30963990|NCT01467479|59031929|FG002|Overall Study|No Study Medication|2|||
30963991|NCT01467479|59031927|FG000|Overall Study|Adverse Event|1|||
30963992|NCT01467479|59031928|FG001|Overall Study|Adverse Event|2|||
30963993|NCT01467479|59031929|FG002|Overall Study|Adverse Event|0|||
30963994|NCT01467479|59031927|FG000|Overall Study|Death|0|||
30963995|NCT01467479|59031928|FG001|Overall Study|Death|0|||
30963996|NCT01467479|59031929|FG002|Overall Study|Death|1|||
30963997|NCT01467479|59031927|FG000|Overall Study|Lost to Follow-up|2|||
30963998|NCT01467479|59031928|FG001|Overall Study|Lost to Follow-up|5|||
30963999|NCT01467479|59031929|FG002|Overall Study|Lost to Follow-up|3|||
30964000|NCT01467479|59031927|FG000|Overall Study|Withdrawal of Consent|3|||
30964001|NCT01467479|59031928|FG001|Overall Study|Withdrawal of Consent|7|||
30964002|NCT01467479|59031929|FG002|Overall Study|Withdrawal of Consent|7|||
30964003|NCT01467479|59031927|FG000|Overall Study|Study Terminated by Sponsor|1|||
30964004|NCT01467479|59031928|FG001|Overall Study|Study Terminated by Sponsor|3|||
30964005|NCT01467479|59031929|FG002|Overall Study|Study Terminated by Sponsor|3|||
30964006|NCT01467479|59031927|FG000|Overall Study|Other|1|||
30964007|NCT01467479|59031928|FG001|Overall Study|Other|0|||
30964008|NCT01467479|59031929|FG002|Overall Study|Other|0|||
30964009|NCT01466387|59031944|FG000|Overall Study|Adverse Event|0|||
30964010|NCT01466387|59031945|FG001|Overall Study|Adverse Event|0|||
30964011|NCT01466387|59031946|FG002|Overall Study|Adverse Event|1|||
30964012|NCT01466387|59031947|FG003|Overall Study|Adverse Event|1|||
30964013|NCT01466387|59031948|FG004|Overall Study|Adverse Event|0|||
30964014|NCT01466387|59031949|FG005|Overall Study|Adverse Event|0|||
30964015|NCT01466387|59031944|FG000|Overall Study|Lost to Follow-up|0|||
30964016|NCT01466387|59031945|FG001|Overall Study|Lost to Follow-up|0|||
30964017|NCT01466387|59031946|FG002|Overall Study|Lost to Follow-up|0|||
30964018|NCT01466387|59031947|FG003|Overall Study|Lost to Follow-up|0|||
30964019|NCT01466387|59031948|FG004|Overall Study|Lost to Follow-up|0|||
30964020|NCT01466387|59031949|FG005|Overall Study|Lost to Follow-up|1|||
30964021|NCT01466387|59031944|FG000|Overall Study|Protocol Violation|1|||
30964022|NCT01466387|59031945|FG001|Overall Study|Protocol Violation|0|||
30964023|NCT01466387|59031946|FG002|Overall Study|Protocol Violation|0|||
30964024|NCT01466387|59031947|FG003|Overall Study|Protocol Violation|1|||
30964025|NCT01466387|59031948|FG004|Overall Study|Protocol Violation|0|||
30964026|NCT01466387|59031949|FG005|Overall Study|Protocol Violation|0|||
30964027|NCT01564784|59032080|FG000|Overall Study|Other|1|||
30964028|NCT01564784|59032081|FG001|Overall Study|Other|0|||
30964029|NCT01564784|59032080|FG000|Overall Study|Subject refused further follow-up|1|||
30964030|NCT01564784|59032081|FG001|Overall Study|Subject refused further follow-up|6|||
30964031|NCT01564784|59032080|FG000|Overall Study|Lost to Follow-up|1|||
30964032|NCT01564784|59032081|FG001|Overall Study|Lost to Follow-up|1|||
30964033|NCT01564784|59032080|FG000|Overall Study|Death|131|||
30964034|NCT01564784|59032081|FG001|Overall Study|Death|126|||
30964035|NCT01564394|59032132|FG000|Overall Study|Withdrawal by Subject|6|||
30964036|NCT01564394|59032133|FG001|Overall Study|Withdrawal by Subject|10|||
30964037|NCT01690988|59032147|FG000|Overall Study|Withdrawal by Subject|2|||
30964038|NCT01690988|59032148|FG001|Overall Study|Withdrawal by Subject|2|||
30964039|NCT01690988|59032149|FG002|Overall Study|Withdrawal by Subject|3|||
30964040|NCT01690988|59032147|FG000|Overall Study|Physician Decision|0|||
30964041|NCT01690988|59032148|FG001|Overall Study|Physician Decision|0|||
30964042|NCT01690988|59032149|FG002|Overall Study|Physician Decision|1|||
30964043|NCT01690988|59032147|FG000|Overall Study|Operation Cancelled|1|||
30964044|NCT01690988|59032148|FG001|Overall Study|Operation Cancelled|1|||
30964045|NCT01690988|59032149|FG002|Overall Study|Operation Cancelled|0|||
30964046|NCT01690988|59032147|FG000|Overall Study|Determined ineligible|1|||
30964047|NCT01690988|59032148|FG001|Overall Study|Determined ineligible|0|||
30964048|NCT01690988|59032149|FG002|Overall Study|Determined ineligible|0|||
30964049|NCT01690988|59032147|FG000|Overall Study|Death|1|||
30964050|NCT01690988|59032148|FG001|Overall Study|Death|1|||
30964051|NCT01690988|59032149|FG002|Overall Study|Death|1|||
30964052|NCT01690988|59032147|FG000|Overall Study|Sedated|1|||
30964053|NCT01690988|59032148|FG001|Overall Study|Sedated|1|||
30964054|NCT01690988|59032149|FG002|Overall Study|Sedated|2|||
30964055|NCT01466153|59032180|FG000|Overall Study|Disease Progression|2|||
30964056|NCT01466153|59032181|FG001|Overall Study|Disease Progression|2|||
30964057|NCT01466153|59032182|FG002|Overall Study|Disease Progression|0|||
30964058|NCT01466153|59032180|FG000|Overall Study|Adverse Event|14|||
30964059|NCT01466153|59032181|FG001|Overall Study|Adverse Event|13|||
30964060|NCT01466153|59032182|FG002|Overall Study|Adverse Event|17|||
30964061|NCT01466153|59032180|FG000|Overall Study|Withdrawal of Consent|2|||
30964062|NCT01466153|59032181|FG001|Overall Study|Withdrawal of Consent|0|||
30964063|NCT01466153|59032182|FG002|Overall Study|Withdrawal of Consent|0|||
30964064|NCT01466153|59032180|FG000|Overall Study|Investigator Discretion|3|||
30964065|NCT01466153|59032181|FG001|Overall Study|Investigator Discretion|2|||
30964066|NCT01466153|59032182|FG002|Overall Study|Investigator Discretion|2|||
30964067|NCT01466153|59032180|FG000|Overall Study|Randomized-Not Treated|2|||
30964068|NCT01466153|59032181|FG001|Overall Study|Randomized-Not Treated|3|||
30964069|NCT01466153|59032182|FG002|Overall Study|Randomized-Not Treated|4|||
30964070|NCT01466153|59032180|FG000|Overall Study|Other-Unspecified|6|||
30604852|NCT01225731|58615779|FG008|Part 1|Withdrawal by Subject|0|||
30604853|NCT01225731|58615780|FG009|Part 1|Withdrawal by Subject|0|||
30604854|NCT01225731|58615781|FG010|Part 1|Withdrawal by Subject|0|||
30604855|NCT01225731|58615782|FG011|Part 1|Withdrawal by Subject|0|||
30604856|NCT01225731|58615783|FG012|Part 1|Withdrawal by Subject|0|||
30604857|NCT01225731|58615771|FG000|Part 1|Protocol Violation|0|||
30604858|NCT01225731|58615772|FG001|Part 1|Protocol Violation|0|||
30604859|NCT01225731|58615773|FG002|Part 1|Protocol Violation|0|||
30604860|NCT01225731|58615774|FG003|Part 1|Protocol Violation|1|||
30604861|NCT01225731|58615775|FG004|Part 1|Protocol Violation|0|||
30604862|NCT01225731|58615776|FG005|Part 1|Protocol Violation|0|||
30604863|NCT01225731|58615777|FG006|Part 1|Protocol Violation|0|||
30604864|NCT01225731|58615778|FG007|Part 1|Protocol Violation|0|||
30604865|NCT01225731|58615779|FG008|Part 1|Protocol Violation|0|||
30604866|NCT01225731|58615780|FG009|Part 1|Protocol Violation|0|||
30604867|NCT01225731|58615781|FG010|Part 1|Protocol Violation|0|||
30604868|NCT01225731|58615782|FG011|Part 1|Protocol Violation|0|||
30604869|NCT01225731|58615783|FG012|Part 1|Protocol Violation|0|||
30604870|NCT01225731|58615771|FG000|Part 2|Protocol Violation|0|||
30604871|NCT01225731|58615772|FG001|Part 2|Protocol Violation|0|||
30604872|NCT01225731|58615773|FG002|Part 2|Protocol Violation|0|||
30604873|NCT01225731|58615774|FG003|Part 2|Protocol Violation|0|||
30604874|NCT01225731|58615775|FG004|Part 2|Protocol Violation|0|||
30604875|NCT01225731|58615776|FG005|Part 2|Protocol Violation|1|||
30604876|NCT01225731|58615777|FG006|Part 2|Protocol Violation|0|||
30604877|NCT01225731|58615778|FG007|Part 2|Protocol Violation|0|||
30604878|NCT01225731|58615779|FG008|Part 2|Protocol Violation|1|||
30604879|NCT01225731|58615780|FG009|Part 2|Protocol Violation|0|||
30604880|NCT01225731|58615781|FG010|Part 2|Protocol Violation|0|||
30604881|NCT01225731|58615782|FG011|Part 2|Protocol Violation|0|||
30604882|NCT01225731|58615783|FG012|Part 2|Protocol Violation|0|||
30604883|NCT01225731|58615771|FG000|Part 2|Adverse Event|0|||
30604884|NCT01225731|58615772|FG001|Part 2|Adverse Event|0|||
30604885|NCT01225731|58615773|FG002|Part 2|Adverse Event|0|||
30604886|NCT01225731|58615774|FG003|Part 2|Adverse Event|0|||
30604887|NCT01225731|58615775|FG004|Part 2|Adverse Event|0|||
30604888|NCT01225731|58615776|FG005|Part 2|Adverse Event|0|||
30604889|NCT01225731|58615777|FG006|Part 2|Adverse Event|4|||
30604890|NCT01225731|58615778|FG007|Part 2|Adverse Event|4|||
30604891|NCT01225731|58615779|FG008|Part 2|Adverse Event|2|||
30604892|NCT01225731|58615780|FG009|Part 2|Adverse Event|0|||
30604893|NCT01225731|58615781|FG010|Part 2|Adverse Event|0|||
30604894|NCT01225731|58615782|FG011|Part 2|Adverse Event|0|||
30964071|NCT01466153|59032181|FG001|Overall Study|Other-Unspecified|4|||
30964072|NCT01466153|59032182|FG002|Overall Study|Other-Unspecified|2|||
30964073|NCT01474291|59032203|FG000|Overall Study|Not Evaluable for Efficacy|26|||
30604895|NCT01225731|58615783|FG012|Part 2|Adverse Event|0|||
30604896|NCT01225731|58615771|FG000|Part 2|Lack of Efficacy|0|||
30964074|NCT01474291|59032203|FG000|Overall Study|Lack of Treatment Efficacy|88|||
30604897|NCT01225731|58615772|FG001|Part 2|Lack of Efficacy|0|||
30604898|NCT01225731|58615773|FG002|Part 2|Lack of Efficacy|0|||
30604899|NCT01225731|58615774|FG003|Part 2|Lack of Efficacy|0|||
30604900|NCT01225731|58615775|FG004|Part 2|Lack of Efficacy|0|||
30604901|NCT01225731|58615776|FG005|Part 2|Lack of Efficacy|1|||
30604902|NCT01225731|58615777|FG006|Part 2|Lack of Efficacy|0|||
30604903|NCT01225731|58615778|FG007|Part 2|Lack of Efficacy|12|||
30604904|NCT01225731|58615779|FG008|Part 2|Lack of Efficacy|3|||
30604905|NCT01225731|58615780|FG009|Part 2|Lack of Efficacy|0|||
30964075|NCT01474291|59032203|FG000|Overall Study|Adverse Event|53|||
30964076|NCT01474291|59032203|FG000|Overall Study|Lost to Follow-up|29|||
30964077|NCT01474291|59032203|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
30964078|NCT01474291|59032203|FG000|Overall Study|No Reason Reported|10|||
30964079|NCT01474291|59032203|FG000|Overall Study|Death|2|||
30964080|NCT01465997|59032212|FG000|Overall Study|Adverse Event|12|||
30964081|NCT01465997|59032213|FG001|Overall Study|Adverse Event|22|||
30964082|NCT01465997|59032212|FG000|Overall Study|Lack of Efficacy|13|||
30964083|NCT01465997|59032213|FG001|Overall Study|Lack of Efficacy|1|||
30964084|NCT01465997|59032212|FG000|Overall Study|Protocol Violation|1|||
30964085|NCT01465997|59032213|FG001|Overall Study|Protocol Violation|4|||
30964086|NCT01465997|59032212|FG000|Overall Study|Lost to Follow-up|6|||
30964087|NCT01465997|59032213|FG001|Overall Study|Lost to Follow-up|9|||
30964088|NCT01465997|59032212|FG000|Overall Study|Withdrawal by Subject|32|||
30964089|NCT01465997|59032213|FG001|Overall Study|Withdrawal by Subject|35|||
30964090|NCT01465997|59032212|FG000|Overall Study|investigator's decision|1|||
30964091|NCT01465997|59032213|FG001|Overall Study|investigator's decision|1|||
30964092|NCT01465997|59032212|FG000|Overall Study|Death|0|||
30964093|NCT01465997|59032213|FG001|Overall Study|Death|1|||
30964094|NCT01465997|59032212|FG000|Overall Study|sponsor's decision|1|||
30964095|NCT01465997|59032213|FG001|Overall Study|sponsor's decision|1|||
30964096|NCT01465997|59032212|FG000|Overall Study|subject withdrew consent|1|||
30964097|NCT01465997|59032213|FG001|Overall Study|subject withdrew consent|0|||
30964098|NCT01465997|59032212|FG000|Overall Study|local lab unblinded site|1|||
30964099|NCT01465997|59032213|FG001|Overall Study|local lab unblinded site|0|||
30964100|NCT01465997|59032212|FG000|Overall Study|withdrew before follow-up|0|||
30964101|NCT01465997|59032213|FG001|Overall Study|withdrew before follow-up|13|||
30964102|NCT01465997|59032212|FG000|Overall Study|decision by site staff|0|||
30964103|NCT01465997|59032213|FG001|Overall Study|decision by site staff|1|||
30964104|NCT01465997|59032212|FG000|Overall Study|subject left participation SP0993|0|||
30964105|NCT01465997|59032213|FG001|Overall Study|subject left participation SP0993|1|||
30964106|NCT01465763|59032234|FG000|Overall Study|Withdrawal by Subject|4|||
30964107|NCT01465763|59032235|FG001|Overall Study|Withdrawal by Subject|0|||
30964108|NCT01465763|59032236|FG002|Overall Study|Withdrawal by Subject|1|||
30964109|NCT01465763|59032234|FG000|Overall Study|Insufficient Clinical Response|11|||
30964110|NCT01465763|59032235|FG001|Overall Study|Insufficient Clinical Response|0|||
30964111|NCT01465763|59032236|FG002|Overall Study|Insufficient Clinical Response|1|||
30964112|NCT01465763|59032234|FG000|Overall Study|Adverse Event|9|||
30964113|NCT01465763|59032235|FG001|Overall Study|Adverse Event|0|||
30964114|NCT01465763|59032236|FG002|Overall Study|Adverse Event|1|||
30964115|NCT01465763|59032234|FG000|Overall Study|Other|2|||
30964116|NCT01465763|59032235|FG001|Overall Study|Other|0|||
30964117|NCT01465763|59032236|FG002|Overall Study|Other|0|||
30964118|NCT01465763|59032234|FG000|Overall Study|Protocol Violation|4|||
30964119|NCT01465763|59032235|FG001|Overall Study|Protocol Violation|1|||
30964120|NCT01465763|59032236|FG002|Overall Study|Protocol Violation|1|||
30964121|NCT01465763|59032234|FG000|Overall Study|Death|1|||
30964122|NCT01465763|59032235|FG001|Overall Study|Death|0|||
30964123|NCT01465763|59032236|FG002|Overall Study|Death|0|||
30964124|NCT01690520|59032269|FG000|Overall Study|Death|25|||
30964125|NCT01690520|59032270|FG001|Overall Study|Death|21|||
30964126|NCT01690520|59032269|FG000|Overall Study|Lost to Follow-up|2|||
30964127|NCT01690520|59032270|FG001|Overall Study|Lost to Follow-up|3|||
30964128|NCT01690520|59032269|FG000|Overall Study|Withdrawal by Subject|2|||
30964129|NCT01690520|59032270|FG001|Overall Study|Withdrawal by Subject|0|||
30964130|NCT01690520|59032269|FG000|Overall Study|Relapse|0|||
30964131|NCT01690520|59032270|FG001|Overall Study|Relapse|1|||
30964132|NCT01690520|59032269|FG000|Overall Study|Other|0|||
30964133|NCT01690520|59032270|FG001|Overall Study|Other|1|||
30964134|NCT01690520|59032269|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
30964135|NCT01690520|59032270|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
30964136|NCT01563536|59032291|FG000|Overall Study|Withdrawal by Subject|0|||
30964137|NCT01563536|59032292|FG001|Overall Study|Withdrawal by Subject|2|||
30964138|NCT01563536|59032291|FG000|Overall Study|Lost to Follow-up|1|||
30964139|NCT01563536|59032292|FG001|Overall Study|Lost to Follow-up|0|||
30964140|NCT01690130|59032300|FG000|Overall Study|Subject have cancelled visit.|1|||
30964141|NCT01690130|59032301|FG001|Overall Study|Subject have cancelled visit.|0|||
30964142|NCT01690052|59032307|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
30964143|NCT01690052|59032308|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
30964144|NCT01689974|59032335|FG000|Overall Study|Termination of Study|5|||
30964145|NCT01689974|59032336|FG001|Overall Study|Termination of Study|5|||
30964146|NCT01587014|59032342|FG000|Overall Study|Death|2|||
30964147|NCT01458535|59032454|FG000|Overall Study|Other|0|||
30964148|NCT01458535|59032455|FG001|Overall Study|Other|0|||
30964149|NCT01458535|59032456|FG002|Overall Study|Other|0|||
30964150|NCT01458535|59032457|FG003|Overall Study|Other|0|||
30964151|NCT01458535|59032458|FG004|Overall Study|Other|1|||
30964152|NCT01458535|59032459|FG005|Overall Study|Other|1|||
30964153|NCT01458535|59032454|FG000|Overall Study|Withdrawal by Subject|0|||
30964154|NCT01458535|59032455|FG001|Overall Study|Withdrawal by Subject|0|||
30964155|NCT01458535|59032456|FG002|Overall Study|Withdrawal by Subject|2|||
30964156|NCT01458535|59032457|FG003|Overall Study|Withdrawal by Subject|0|||
30964157|NCT01458535|59032458|FG004|Overall Study|Withdrawal by Subject|1|||
30964158|NCT01458535|59032459|FG005|Overall Study|Withdrawal by Subject|1|||
30964159|NCT01458535|59032454|FG000|Overall Study|Lost to Follow-up|0|||
30964160|NCT01458535|59032455|FG001|Overall Study|Lost to Follow-up|2|||
30964161|NCT01458535|59032456|FG002|Overall Study|Lost to Follow-up|0|||
30964162|NCT01458535|59032457|FG003|Overall Study|Lost to Follow-up|3|||
30964163|NCT01458535|59032458|FG004|Overall Study|Lost to Follow-up|2|||
30964164|NCT01458535|59032459|FG005|Overall Study|Lost to Follow-up|2|||
30964165|NCT01458535|59032454|FG000|Overall Study|Adverse Event|0|||
30964166|NCT01458535|59032455|FG001|Overall Study|Adverse Event|0|||
30964167|NCT01458535|59032456|FG002|Overall Study|Adverse Event|0|||
30964168|NCT01458535|59032457|FG003|Overall Study|Adverse Event|1|||
30964169|NCT01458535|59032458|FG004|Overall Study|Adverse Event|0|||
30964170|NCT01458535|59032459|FG005|Overall Study|Adverse Event|0|||
30964171|NCT01464827|59032487|FG000|Overall Study|Adverse Event|0|||
30964172|NCT01464827|59032488|FG001|Overall Study|Adverse Event|0|||
30964173|NCT01464827|59032489|FG002|Overall Study|Adverse Event|0|||
30964174|NCT01464827|59032490|FG003|Overall Study|Adverse Event|0|||
30964175|NCT01464827|59032491|FG004|Overall Study|Adverse Event|0|||
30964176|NCT01464827|59032492|FG005|Overall Study|Adverse Event|0|||
30964177|NCT01464827|59032493|FG006|Overall Study|Adverse Event|0|||
30964178|NCT01464827|59032494|FG007|Overall Study|Adverse Event|0|||
30964179|NCT01464827|59032495|FG008|Overall Study|Adverse Event|0|||
30964180|NCT01464827|59032496|FG009|Overall Study|Adverse Event|0|||
30964181|NCT01464827|59032497|FG010|Overall Study|Adverse Event|0|||
30964182|NCT01464827|59032498|FG011|Overall Study|Adverse Event|0|||
30964183|NCT01464827|59032499|FG012|Overall Study|Adverse Event|1|||
30964184|NCT01464827|59032500|FG013|Overall Study|Adverse Event|0|||
30964185|NCT01464827|59032487|FG000|Overall Study|Withdrawal by Subject|1|||
30964186|NCT01464827|59032488|FG001|Overall Study|Withdrawal by Subject|0|||
30964187|NCT01464827|59032489|FG002|Overall Study|Withdrawal by Subject|0|||
30964188|NCT01464827|59032490|FG003|Overall Study|Withdrawal by Subject|0|||
30964189|NCT01464827|59032491|FG004|Overall Study|Withdrawal by Subject|1|||
30964190|NCT01464827|59032492|FG005|Overall Study|Withdrawal by Subject|0|||
30964191|NCT01464827|59032493|FG006|Overall Study|Withdrawal by Subject|0|||
30964192|NCT01464827|59032494|FG007|Overall Study|Withdrawal by Subject|1|||
30964193|NCT01464827|59032495|FG008|Overall Study|Withdrawal by Subject|0|||
30964194|NCT01464827|59032496|FG009|Overall Study|Withdrawal by Subject|0|||
30964195|NCT01464827|59032497|FG010|Overall Study|Withdrawal by Subject|0|||
30964196|NCT01464827|59032498|FG011|Overall Study|Withdrawal by Subject|0|||
30964197|NCT01464827|59032499|FG012|Overall Study|Withdrawal by Subject|0|||
30964198|NCT01464827|59032500|FG013|Overall Study|Withdrawal by Subject|0|||
30964199|NCT01464827|59032487|FG000|Overall Study|Lost to Follow-up|0|||
30964200|NCT01464827|59032488|FG001|Overall Study|Lost to Follow-up|2|||
30964201|NCT01464827|59032489|FG002|Overall Study|Lost to Follow-up|0|||
30964202|NCT01464827|59032490|FG003|Overall Study|Lost to Follow-up|2|||
30964203|NCT01464827|59032491|FG004|Overall Study|Lost to Follow-up|3|||
30964204|NCT01464827|59032492|FG005|Overall Study|Lost to Follow-up|1|||
30964205|NCT01464827|59032493|FG006|Overall Study|Lost to Follow-up|2|||
30964206|NCT01464827|59032494|FG007|Overall Study|Lost to Follow-up|2|||
30964207|NCT01464827|59032495|FG008|Overall Study|Lost to Follow-up|0|||
30964208|NCT01464827|59032496|FG009|Overall Study|Lost to Follow-up|0|||
30964209|NCT01464827|59032497|FG010|Overall Study|Lost to Follow-up|0|||
30964210|NCT01464827|59032498|FG011|Overall Study|Lost to Follow-up|1|||
30964211|NCT01464827|59032499|FG012|Overall Study|Lost to Follow-up|0|||
30964212|NCT01464827|59032500|FG013|Overall Study|Lost to Follow-up|1|||
30964213|NCT01464827|59032487|FG000|Overall Study|Other|2|||
30964214|NCT01464827|59032488|FG001|Overall Study|Other|3|||
30964215|NCT01464827|59032489|FG002|Overall Study|Other|0|||
30964216|NCT01464827|59032490|FG003|Overall Study|Other|2|||
30964217|NCT01464827|59032491|FG004|Overall Study|Other|3|||
30964218|NCT01464827|59032492|FG005|Overall Study|Other|0|||
30964219|NCT01464827|59032493|FG006|Overall Study|Other|1|||
30964220|NCT01464827|59032494|FG007|Overall Study|Other|0|||
30964221|NCT01464827|59032495|FG008|Overall Study|Other|3|||
30964222|NCT01464827|59032496|FG009|Overall Study|Other|1|||
30964223|NCT01464827|59032497|FG010|Overall Study|Other|2|||
30964224|NCT01464827|59032498|FG011|Overall Study|Other|0|||
30964225|NCT01464827|59032499|FG012|Overall Study|Other|1|||
30964226|NCT01464827|59032500|FG013|Overall Study|Other|0|||
30964227|NCT01464827|59032487|FG000|Overall Study|Not Treated|0|||
30964228|NCT01464827|59032488|FG001|Overall Study|Not Treated|2|||
30964229|NCT01464827|59032489|FG002|Overall Study|Not Treated|0|||
30964230|NCT01464827|59032490|FG003|Overall Study|Not Treated|0|||
30964231|NCT01464827|59032491|FG004|Overall Study|Not Treated|1|||
30964232|NCT01464827|59032492|FG005|Overall Study|Not Treated|0|||
30964233|NCT01464827|59032493|FG006|Overall Study|Not Treated|1|||
30964234|NCT01464827|59032494|FG007|Overall Study|Not Treated|0|||
30964235|NCT01464827|59032495|FG008|Overall Study|Not Treated|0|||
30964236|NCT01464827|59032496|FG009|Overall Study|Not Treated|2|||
30964237|NCT01464827|59032497|FG010|Overall Study|Not Treated|0|||
30964238|NCT01464827|59032498|FG011|Overall Study|Not Treated|1|||
30964239|NCT01464827|59032499|FG012|Overall Study|Not Treated|0|||
30964240|NCT01464827|59032500|FG013|Overall Study|Not Treated|2|||
30964241|NCT01463111|59032541|FG000|Overall Study|Withdrawal by Subject|2|||
30964242|NCT01463111|59032541|FG000|Overall Study|Lost to Follow-up|5|||
30964243|NCT01463111|59032541|FG000|Overall Study|Physician Decision|2|||
30964244|NCT01463033|59032547|FG000|Overall Study|Lost to Follow-up|4|||
30964245|NCT01463033|59032548|FG001|Overall Study|Lost to Follow-up|4|||
30964246|NCT01463033|59032547|FG000|Overall Study|Death|3|||
30964247|NCT01463033|59032548|FG001|Overall Study|Death|2|||
30964248|NCT01461707|59032557|FG000|Overall Study|Withdrawal by Subject|1|||
30964249|NCT01461707|59032558|FG001|Overall Study|Withdrawal by Subject|0|||
30964250|NCT01461551|59032567|FG000|Overall Study|Physician Decision|2|||
30964251|NCT01461551|59032568|FG001|Overall Study|Physician Decision|1|||
30964252|NCT01461551|59032569|FG002|Overall Study|Physician Decision|2|||
30964253|NCT01461005|59032577|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
30964254|NCT01460381|59032584|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
30964255|NCT01460381|59032585|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
30964256|NCT01473589|59032669|FG000|Overall Study|Adverse Event|1|||
30964257|NCT01473589|59032670|FG001|Overall Study|Adverse Event|1|||
30964258|NCT01473589|59032669|FG000|Overall Study|Death|2|||
30964259|NCT01473589|59032670|FG001|Overall Study|Death|0|||
30964260|NCT01473589|59032669|FG000|Overall Study|Lost to Follow-up|2|||
30964261|NCT01473589|59032670|FG001|Overall Study|Lost to Follow-up|2|||
30964262|NCT01473589|59032669|FG000|Overall Study|Protocol Violation|1|||
30964263|NCT01473589|59032670|FG001|Overall Study|Protocol Violation|0|||
30964264|NCT01473589|59032669|FG000|Overall Study|Withdrawal by Subject|5|||
30964265|NCT01473589|59032670|FG001|Overall Study|Withdrawal by Subject|11|||
30964266|NCT01473589|59032669|FG000|Overall Study|Physician Decision|0|||
30964267|NCT01473589|59032670|FG001|Overall Study|Physician Decision|1|||
30964268|NCT01473589|59032669|FG000|Overall Study|Entry criteria not met|0|||
30964269|NCT01473589|59032670|FG001|Overall Study|Entry criteria not met|1|||
30964270|NCT01500187|59032689|FG000|Overall Study|Lost to Follow-up|6|||
30964271|NCT01500187|59032690|FG001|Overall Study|Lost to Follow-up|0|||
30964272|NCT01500031|59032708|FG000|Overall Study|Death|1|||
30964273|NCT01500031|59032708|FG000|Overall Study|Withdrawal by Subject|4|||
30964274|NCT01473355|59032721|FG000|Overall Study|Protocol Violation|2|||
30964275|NCT01473355|59032721|FG000|Overall Study|Adverse Event|2|||
30964276|NCT01473355|59032721|FG000|Overall Study|Lost to Follow-up|2|||
30964277|NCT01472965|59032731|FG000|Overall Study|Withdrawal by Subject|1|||
30964278|NCT01472965|59032732|FG001|Overall Study|Withdrawal by Subject|0|||
30964279|NCT01457053|59032742|FG000|Overall Study|Unable to undergo selected treatment|1|||
30964280|NCT01457053|59032743|FG001|Overall Study|Unable to undergo selected treatment|1|||
30964281|NCT01472341|59032758|FG000|Overall Study|Started insulin therapy|55|||
30964282|NCT01472341|59032758|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
30964283|NCT01472341|59032758|FG000|Overall Study|Withdrawal by Subject|39|||
30964284|NCT01472341|59032758|FG000|Overall Study|Lost to Follow-up|52|||
30964285|NCT01472341|59032758|FG000|Overall Study|Laboratory parameters unavailable|25|||
30964286|NCT01472341|59032758|FG000|Overall Study|Death|9|||
30964287|NCT01472185|59032764|FG000|Overall Study|Randomized but Not Treated|0|||
30964288|NCT01472185|59032765|FG001|Overall Study|Randomized but Not Treated|1|||
30964289|NCT01472185|59032764|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
30876205|NCT02653625|58907319|FG000|Overall Study|Non-compliance with Study Drug|1|||
30876206|NCT02653625|58907319|FG000|Overall Study|Protocol Violation|1|||
30876207|NCT02653625|58907319|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
30876208|NCT01981096|58907325|FG000|Overall Study|Parent illness|1|||
30876209|NCT01981096|58907326|FG001|Overall Study|Parent illness|0|||
30876210|NCT01981096|58907325|FG000|Overall Study|Withdrawal by Subject|0|||
30876211|NCT01981096|58907326|FG001|Overall Study|Withdrawal by Subject|1|||
30876212|NCT01981096|58907325|FG000|Overall Study|Lost to Follow-up|2|||
30876213|NCT01981096|58907326|FG001|Overall Study|Lost to Follow-up|0|||
30876214|NCT02652767|58907332|FG000|Overall Study|Death|2|||
30876215|NCT02652767|58907332|FG000|Overall Study|Lost to Follow-up|1|||
30876216|NCT02652767|58907332|FG000|Overall Study|Withdrawal by Subject|1|||
30876217|NCT01980940|58907346|FG000|Overall Study|Protocol Violation|0|||
30876218|NCT01980940|58907347|FG001|Overall Study|Protocol Violation|0|||
30876219|NCT01980940|58907348|FG002|Overall Study|Protocol Violation|0|||
30876220|NCT01980940|58907349|FG003|Overall Study|Protocol Violation|0|||
30876221|NCT01980940|58907350|FG004|Overall Study|Protocol Violation|0|||
30876222|NCT01980940|58907351|FG005|Overall Study|Protocol Violation|2|||
30876223|NCT01980940|58907352|FG006|Overall Study|Protocol Violation|0|||
30964290|NCT01472185|59032765|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
30876224|NCT01980940|58907353|FG007|Overall Study|Protocol Violation|0|||
30876225|NCT02699983|58907379|FG000|Overall Study|Withdrawal by Subject|1|||
30876226|NCT02699983|58907380|FG001|Overall Study|Withdrawal by Subject|0|||
30876227|NCT01960114|58907392|FG000|Overall Study|Adverse Event|1|||
30876228|NCT01960114|58907393|FG001|Overall Study|Adverse Event|0|||
30964291|NCT01472185|59032764|FG000|Overall Study|Hyperglycemia|5|||
30964292|NCT01472185|59032765|FG001|Overall Study|Hyperglycemia|2|||
30964293|NCT01472185|59032764|FG000|Overall Study|Investigator's Discretion|3|||
30964294|NCT01472185|59032765|FG001|Overall Study|Investigator's Discretion|1|||
30964295|NCT01472185|59032764|FG000|Overall Study|Lost to Follow-up|4|||
30964296|NCT01472185|59032765|FG001|Overall Study|Lost to Follow-up|1|||
30964297|NCT01472185|59032764|FG000|Overall Study|Protocol Violation|5|||
30964298|NCT01472185|59032765|FG001|Overall Study|Protocol Violation|1|||
30964299|NCT01472185|59032764|FG000|Overall Study|Subject Noncompliance|8|||
30964300|NCT01472185|59032765|FG001|Overall Study|Subject Noncompliance|15|||
30964301|NCT01472185|59032764|FG000|Overall Study|Subject Withdrew Consent|6|||
30964302|NCT01472185|59032765|FG001|Overall Study|Subject Withdrew Consent|3|||
30964303|NCT01456897|59032786|FG000|Overall Study|Adverse Event|19|||
30964304|NCT01456897|59032787|FG001|Overall Study|Adverse Event|22|||
30964305|NCT01456897|59032786|FG000|Overall Study|Protocol Violation|3|||
30964306|NCT01456897|59032787|FG001|Overall Study|Protocol Violation|4|||
30964307|NCT01456897|59032786|FG000|Overall Study|Physician Decision|5|||
30964308|NCT01456897|59032787|FG001|Overall Study|Physician Decision|3|||
30964309|NCT01456897|59032786|FG000|Overall Study|Withdrawal by Subject|44|||
30964310|NCT01456897|59032787|FG001|Overall Study|Withdrawal by Subject|17|||
30964311|NCT01456897|59032786|FG000|Overall Study|Lack of Efficacy|4|||
30964312|NCT01456897|59032787|FG001|Overall Study|Lack of Efficacy|11|||
30964313|NCT01456195|59032800|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
30964314|NCT01456195|59032801|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
30964315|NCT01456195|59032802|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
30964316|NCT01456195|59032800|FG000|Overall Study|Lost to Follow-up|3|||
30964317|NCT01456195|59032801|FG001|Overall Study|Lost to Follow-up|1|||
30964318|NCT01456195|59032802|FG002|Overall Study|Lost to Follow-up|3|||
30964319|NCT01456195|59032800|FG000|Overall Study|Voluntary Withdrawal|5|||
30964320|NCT01456195|59032801|FG001|Overall Study|Voluntary Withdrawal|3|||
30964321|NCT01456195|59032802|FG002|Overall Study|Voluntary Withdrawal|7|||
30964322|NCT01456195|59032800|FG000|Overall Study|Lack of Efficacy|0|||
30964323|NCT01456195|59032801|FG001|Overall Study|Lack of Efficacy|1|||
30964324|NCT01456195|59032802|FG002|Overall Study|Lack of Efficacy|0|||
30964325|NCT01456195|59032800|FG000|Overall Study|Other Reasons|2|||
30964326|NCT01456195|59032801|FG001|Overall Study|Other Reasons|1|||
30964327|NCT01456195|59032802|FG002|Overall Study|Other Reasons|3|||
30964328|NCT01456039|59032870|FG000|Phase 1 (First Step)|Disease Progression|1|||
30964329|NCT01456039|59032871|FG001|Phase 1 (First Step)|Disease Progression|1|||
30964330|NCT01456039|59032872|FG002|Phase 1 (First Step)|Disease Progression|0|||
30964331|NCT01456039|59032870|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
30964332|NCT01456039|59032871|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
30964333|NCT01456039|59032872|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
30964334|NCT01456039|59032870|FG000|Phase 1 (First Step)|Adverse Event|0|||
30964335|NCT01456039|59032871|FG001|Phase 1 (First Step)|Adverse Event|3|||
30604906|NCT01225731|58615781|FG010|Part 2|Lack of Efficacy|0|||
30695908|NCT00682448|58710251|FG000|Overall Study|Withdrawal by Subject|2|||
30695909|NCT00682448|58710252|FG001|Overall Study|Withdrawal by Subject|0|||
30695910|NCT00681824|58710261|FG000|Overall Study|withdrawn by investigator|0|||
30695911|NCT00681824|58710262|FG001|Overall Study|withdrawn by investigator|0|||
30695912|NCT00681824|58710263|FG002|Overall Study|withdrawn by investigator|1|||
30964336|NCT01456039|59032872|FG002|Phase 1 (First Step)|Adverse Event|0|||
30964337|NCT01456039|59032870|FG000|Phase 1 (First Step)|Other|0|||
30964338|NCT01456039|59032871|FG001|Phase 1 (First Step)|Other|1|||
30964339|NCT01456039|59032872|FG002|Phase 1 (First Step)|Other|0|||
30964340|NCT01456039|59032870|FG000|Phase 2 (Second Step)|Disease Progression|0|||
30964341|NCT01456039|59032871|FG001|Phase 2 (Second Step)|Disease Progression|0|||
30964342|NCT01456039|59032872|FG002|Phase 2 (Second Step)|Disease Progression|17|||
30964343|NCT01456039|59032870|FG000|Phase 2 (Second Step)|Adverse Event|0|||
30964344|NCT01456039|59032871|FG001|Phase 2 (Second Step)|Adverse Event|0|||
30964345|NCT01456039|59032872|FG002|Phase 2 (Second Step)|Adverse Event|10|||
30604907|NCT01225731|58615782|FG011|Part 2|Lack of Efficacy|0|||
30604908|NCT01225731|58615783|FG012|Part 2|Lack of Efficacy|0|||
30604909|NCT01225731|58615771|FG000|Part 2|Pregnancy|0|||
30604910|NCT01225731|58615772|FG001|Part 2|Pregnancy|0|||
30604911|NCT01225731|58615773|FG002|Part 2|Pregnancy|0|||
30604912|NCT01225731|58615774|FG003|Part 2|Pregnancy|0|||
30604913|NCT01225731|58615775|FG004|Part 2|Pregnancy|0|||
30604914|NCT01225731|58615776|FG005|Part 2|Pregnancy|0|||
30604915|NCT01225731|58615777|FG006|Part 2|Pregnancy|1|||
30604916|NCT01225731|58615778|FG007|Part 2|Pregnancy|0|||
30604917|NCT01225731|58615779|FG008|Part 2|Pregnancy|1|||
30604918|NCT01225731|58615780|FG009|Part 2|Pregnancy|0|||
30604919|NCT01225731|58615781|FG010|Part 2|Pregnancy|0|||
30604920|NCT01225731|58615782|FG011|Part 2|Pregnancy|0|||
30604921|NCT01225731|58615783|FG012|Part 2|Pregnancy|0|||
30604922|NCT01225731|58615771|FG000|Part 2|Lost to Follow-up|0|||
30604923|NCT01225731|58615772|FG001|Part 2|Lost to Follow-up|0|||
30604924|NCT01225731|58615773|FG002|Part 2|Lost to Follow-up|0|||
30964346|NCT01456039|59032870|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
30964347|NCT01456039|59032871|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
30964348|NCT01456039|59032872|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
30964349|NCT01456039|59032870|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
30964350|NCT01456039|59032871|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
30964351|NCT01456039|59032872|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
30964352|NCT01456039|59032870|FG000|Phase 2 (Second Step)|Other|0|||
30964353|NCT01456039|59032871|FG001|Phase 2 (Second Step)|Other|0|||
30964354|NCT01456039|59032872|FG002|Phase 2 (Second Step)|Other|1|||
30964355|NCT01455415|59032890|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
30964356|NCT01455415|59032891|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
30964357|NCT01455415|59032890|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
30964358|NCT01455415|59032891|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
30964359|NCT01455415|59032890|FG000|Period 1|Drug Error not Associated to AE|0|||
30964360|NCT01455415|59032891|FG001|Period 1|Drug Error not Associated to AE|1|||
30964361|NCT01455415|59032890|FG000|Period 1|AE Not Related to Study Drug|2|||
30964362|NCT01455415|59032891|FG001|Period 1|AE Not Related to Study Drug|6|||
30964363|NCT01455415|59032890|FG000|Period 1|Withdrawal by Subject|4|||
30964364|NCT01455415|59032891|FG001|Period 1|Withdrawal by Subject|5|||
30964365|NCT01455415|59032890|FG000|Period 1|Unspecified Reason|1|||
30964366|NCT01455415|59032891|FG001|Period 1|Unspecified Reason|1|||
30964367|NCT01455415|59032890|FG000|Period 1|Protocol Violation|0|||
30964368|NCT01455415|59032891|FG001|Period 1|Protocol Violation|2|||
30964369|NCT01455415|59032890|FG000|Washout|AE Related to Study Drug|2|||
30964370|NCT01455415|59032891|FG001|Washout|AE Related to Study Drug|0|||
30964371|NCT01455415|59032890|FG000|Washout|Lost to Follow-up|1|||
30964372|NCT01455415|59032891|FG001|Washout|Lost to Follow-up|0|||
30964373|NCT01455415|59032890|FG000|Washout|Drug Error not Associated to AE|2|||
30964374|NCT01455415|59032891|FG001|Washout|Drug Error not Associated to AE|1|||
30964375|NCT01455415|59032890|FG000|Washout|AE Not Related to Study Drug|2|||
30964376|NCT01455415|59032891|FG001|Washout|AE Not Related to Study Drug|3|||
30964377|NCT01455415|59032890|FG000|Washout|Unspecified Reason|1|||
30964378|NCT01455415|59032891|FG001|Washout|Unspecified Reason|2|||
30964379|NCT01455415|59032890|FG000|Washout|Protocol Violation|0|||
30964380|NCT01455415|59032891|FG001|Washout|Protocol Violation|1|||
30964381|NCT01455415|59032890|FG000|Period 2|AE Related to Study Drug|1|||
30964382|NCT01455415|59032891|FG001|Period 2|AE Related to Study Drug|2|||
30964383|NCT01455415|59032890|FG000|Period 2|Lost to Follow-up|2|||
30964384|NCT01455415|59032891|FG001|Period 2|Lost to Follow-up|1|||
30964385|NCT01455415|59032890|FG000|Period 2|AE Not Related to Study Drug|2|||
30964386|NCT01455415|59032891|FG001|Period 2|AE Not Related to Study Drug|1|||
30964387|NCT01455415|59032890|FG000|Period 2|Lack of Efficacy|2|||
30964388|NCT01455415|59032891|FG001|Period 2|Lack of Efficacy|0|||
30964389|NCT01455415|59032890|FG000|Period 2|Withdrawal by Subject|2|||
30964390|NCT01455415|59032891|FG001|Period 2|Withdrawal by Subject|3|||
30964391|NCT01455415|59032890|FG000|Period 2|Unspecified Reason|2|||
30964392|NCT01455415|59032891|FG001|Period 2|Unspecified Reason|3|||
30964393|NCT01455415|59032890|FG000|Period 2|Protocol Violation|2|||
30964394|NCT01455415|59032891|FG001|Period 2|Protocol Violation|0|||
30964395|NCT01455415|59032890|FG000|Follow-up|AE Related to Study Drug|0|||
30964396|NCT01455415|59032891|FG001|Follow-up|AE Related to Study Drug|1|||
30964397|NCT01455415|59032890|FG000|Follow-up|Lack of Efficacy|0|||
30964398|NCT01455415|59032891|FG001|Follow-up|Lack of Efficacy|1|||
30964399|NCT01455415|59032890|FG000|Follow-up|Withdrawal by Subject|2|||
30964400|NCT01455415|59032891|FG001|Follow-up|Withdrawal by Subject|0|||
30964401|NCT01455415|59032890|FG000|Follow-up|Unspecified Reason|1|||
30964402|NCT01455415|59032891|FG001|Follow-up|Unspecified Reason|0|||
30964403|NCT01471171|59032897|FG000|Treatment Period 1|Adverse Event|4|||
30964404|NCT01471171|59032898|FG001|Treatment Period 1|Adverse Event|1|||
30964405|NCT01471171|59032897|FG000|Treatment Period 2|Adverse Event|1|||
30964406|NCT01471171|59032898|FG001|Treatment Period 2|Adverse Event|0|||
30964407|NCT01471093|59032906|FG000|Overall Study|Adverse Event|1|||
30964408|NCT01471093|59032907|FG001|Overall Study|Adverse Event|0|||
30964409|NCT01471093|59032908|FG002|Overall Study|Adverse Event|0|||
30964410|NCT01471093|59032909|FG003|Overall Study|Adverse Event|0|||
30964411|NCT01471015|59032918|FG000|Overall Study|Death|0|||
30964412|NCT01471015|59032919|FG001|Overall Study|Death|1|||
30964413|NCT01471015|59032920|FG002|Overall Study|Death|1|||
30964414|NCT01497067|59032928|FG000|Overall Study|Lost to Follow-up|56|||
30964415|NCT01497067|59032928|FG000|Overall Study|Adverse Event|3|||
30964416|NCT01497067|59032928|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
30964417|NCT01497067|59032928|FG000|Overall Study|Other|13|||
30964418|NCT01470469|59032958|FG000|Overall Study|Withdrawal by Subject|4|||
30964419|NCT01470469|59032959|FG001|Overall Study|Withdrawal by Subject|6|||
30964420|NCT01470469|59032958|FG000|Overall Study|Lack of Efficacy|1|||
30964421|NCT01470469|59032959|FG001|Overall Study|Lack of Efficacy|7|||
30964422|NCT01470469|59032958|FG000|Overall Study|Adverse Event|0|||
30964423|NCT01470469|59032959|FG001|Overall Study|Adverse Event|7|||
30964424|NCT01470469|59032958|FG000|Overall Study|Lost to Follow-up|2|||
30964425|NCT01470469|59032959|FG001|Overall Study|Lost to Follow-up|2|||
30964426|NCT01470469|59032958|FG000|Overall Study|Protocol Violation|1|||
30964427|NCT01470469|59032959|FG001|Overall Study|Protocol Violation|1|||
30964428|NCT01470469|59032958|FG000|Overall Study|Other|2|||
30964429|NCT01470469|59032959|FG001|Overall Study|Other|1|||
30964430|NCT01470001|59032967|FG000|Overall Study|Lost to Follow-up|1|||
30964431|NCT01470001|59032968|FG001|Overall Study|Lost to Follow-up|1|||
30964432|NCT01470001|59032967|FG000|Overall Study|Physician Decision|2|||
30964433|NCT01470001|59032968|FG001|Overall Study|Physician Decision|0|||
30964434|NCT01470001|59032967|FG000|Overall Study|Withdrawal by Subject|2|||
30964435|NCT01470001|59032968|FG001|Overall Study|Withdrawal by Subject|1|||
30964436|NCT01469377|59032977|FG000|Overall Study|Protocol Deviation|7|||
30964437|NCT01469377|59032978|FG001|Overall Study|Protocol Deviation|10|||
30964438|NCT01469377|59032979|FG002|Overall Study|Protocol Deviation|10|||
30964439|NCT01469377|59032977|FG000|Overall Study|Lost to Follow-up|3|||
30964440|NCT01469377|59032978|FG001|Overall Study|Lost to Follow-up|2|||
30964441|NCT01469377|59032979|FG002|Overall Study|Lost to Follow-up|5|||
30964442|NCT01469377|59032977|FG000|Overall Study|Withdrawal of Consent|12|||
30964443|NCT01469377|59032978|FG001|Overall Study|Withdrawal of Consent|14|||
30964444|NCT01469377|59032979|FG002|Overall Study|Withdrawal of Consent|15|||
30964445|NCT01469377|59032977|FG000|Overall Study|Adverse Event|8|||
30964446|NCT01469377|59032978|FG001|Overall Study|Adverse Event|18|||
30964447|NCT01469377|59032979|FG002|Overall Study|Adverse Event|36|||
30964448|NCT01469377|59032977|FG000|Overall Study|Insufficient Therapeutic Response|3|||
30964449|NCT01469377|59032978|FG001|Overall Study|Insufficient Therapeutic Response|4|||
30964450|NCT01469377|59032979|FG002|Overall Study|Insufficient Therapeutic Response|0|||
30964451|NCT01469377|59032977|FG000|Overall Study|Other Miscellaneous Reasons|2|||
30964452|NCT01469377|59032978|FG001|Overall Study|Other Miscellaneous Reasons|0|||
30964453|NCT01469377|59032979|FG002|Overall Study|Other Miscellaneous Reasons|0|||
30964454|NCT01469221|59032989|FG000|Double Blind Phase|Protocol Violation|1|||
30964455|NCT01469221|59032990|FG001|Double Blind Phase|Protocol Violation|0|||
30964456|NCT01469221|59032991|FG002|Double Blind Phase|Protocol Violation|0|||
30964457|NCT01469221|59032989|FG000|Double Blind Phase|Physician Decision|1|||
30964458|NCT01469221|59032990|FG001|Double Blind Phase|Physician Decision|1|||
30964459|NCT01469221|59032991|FG002|Double Blind Phase|Physician Decision|0|||
30964460|NCT01469221|59032989|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
30964461|NCT01469221|59032990|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
30964462|NCT01469221|59032991|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
30964463|NCT01453855|59033000|FG000|Overall Study|Adverse Event|3|||
30964464|NCT01453855|59033001|FG001|Overall Study|Adverse Event|4|||
30964465|NCT01453855|59033000|FG000|Overall Study|Lost to Follow-up|2|||
30964466|NCT01453855|59033001|FG001|Overall Study|Lost to Follow-up|1|||
30964467|NCT01453855|59033000|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
30964468|NCT01453855|59033001|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
30964469|NCT01453855|59033000|FG000|Overall Study|Noncompliance|1|||
30964470|NCT01453855|59033001|FG001|Overall Study|Noncompliance|0|||
30964471|NCT01453855|59033000|FG000|Overall Study|Inadequate Control of IOP|1|||
30964472|NCT01453855|59033001|FG001|Overall Study|Inadequate Control of IOP|5|||
30964473|NCT01453855|59033000|FG000|Overall Study|Other|0|||
30964474|NCT01453855|59033001|FG001|Overall Study|Other|1|||
30964475|NCT01469065|59033012|FG000|Overall Study|Lack of Efficacy|0|||
30964476|NCT01469065|59033013|FG001|Overall Study|Lack of Efficacy|0|||
30964477|NCT01469065|59033014|FG002|Overall Study|Lack of Efficacy|0|||
30964478|NCT01469065|59033015|FG003|Overall Study|Lack of Efficacy|0|||
30964479|NCT01469065|59033016|FG004|Overall Study|Lack of Efficacy|1|||
30964480|NCT01469065|59033012|FG000|Overall Study|Other|0|||
30964481|NCT01469065|59033013|FG001|Overall Study|Other|1|||
30964482|NCT01469065|59033014|FG002|Overall Study|Other|0|||
30964483|NCT01469065|59033015|FG003|Overall Study|Other|0|||
30964484|NCT01469065|59033016|FG004|Overall Study|Other|0|||
30964485|NCT01586624|59033040|FG000|Overall Study|Adverse Event|3|||
30964486|NCT01586624|59033041|FG001|Overall Study|Adverse Event|0|||
30964487|NCT01586624|59033042|FG002|Overall Study|Adverse Event|2|||
30964488|NCT01586624|59033043|FG003|Overall Study|Adverse Event|1|||
30964489|NCT01586624|59033044|FG004|Overall Study|Adverse Event|3|||
30964490|NCT01586624|59033045|FG005|Overall Study|Adverse Event|3|||
30964491|NCT01586624|59033046|FG006|Overall Study|Adverse Event|2|||
30964492|NCT01586624|59033047|FG007|Overall Study|Adverse Event|3|||
30964493|NCT01586624|59033040|FG000|Overall Study|Physician Decision|0|||
30964494|NCT01586624|59033041|FG001|Overall Study|Physician Decision|1|||
30964495|NCT01586624|59033042|FG002|Overall Study|Physician Decision|1|||
30964496|NCT01586624|59033043|FG003|Overall Study|Physician Decision|0|||
30964497|NCT01586624|59033044|FG004|Overall Study|Physician Decision|2|||
30964498|NCT01586624|59033045|FG005|Overall Study|Physician Decision|0|||
30964499|NCT01586624|59033046|FG006|Overall Study|Physician Decision|1|||
30964500|NCT01586624|59033047|FG007|Overall Study|Physician Decision|1|||
30964501|NCT01586624|59033040|FG000|Overall Study|Withdrawal by Subject|0|||
30964502|NCT01586624|59033041|FG001|Overall Study|Withdrawal by Subject|0|||
30964503|NCT01586624|59033042|FG002|Overall Study|Withdrawal by Subject|0|||
30964504|NCT01586624|59033043|FG003|Overall Study|Withdrawal by Subject|1|||
30964505|NCT01586624|59033044|FG004|Overall Study|Withdrawal by Subject|0|||
30964506|NCT01586624|59033045|FG005|Overall Study|Withdrawal by Subject|0|||
30964507|NCT01586624|59033046|FG006|Overall Study|Withdrawal by Subject|0|||
30964508|NCT01586624|59033047|FG007|Overall Study|Withdrawal by Subject|0|||
30964509|NCT01586624|59033040|FG000|Overall Study|Evidence of disease progression|1|||
30964510|NCT01586624|59033041|FG001|Overall Study|Evidence of disease progression|3|||
30964511|NCT01586624|59033042|FG002|Overall Study|Evidence of disease progression|2|||
30964512|NCT01586624|59033043|FG003|Overall Study|Evidence of disease progression|5|||
30964513|NCT01586624|59033044|FG004|Overall Study|Evidence of disease progression|3|||
30964514|NCT01586624|59033045|FG005|Overall Study|Evidence of disease progression|5|||
30964515|NCT01586624|59033046|FG006|Overall Study|Evidence of disease progression|4|||
30964516|NCT01586624|59033047|FG007|Overall Study|Evidence of disease progression|6|||
30964517|NCT01586624|59033040|FG000|Overall Study|Screen failure (no treatment received)|0|||
30964518|NCT01586624|59033041|FG001|Overall Study|Screen failure (no treatment received)|0|||
30964519|NCT01586624|59033042|FG002|Overall Study|Screen failure (no treatment received)|0|||
30964520|NCT01586624|59033043|FG003|Overall Study|Screen failure (no treatment received)|0|||
30964521|NCT01586624|59033044|FG004|Overall Study|Screen failure (no treatment received)|0|||
30964522|NCT01586624|59033045|FG005|Overall Study|Screen failure (no treatment received)|0|||
30964523|NCT01586624|59033046|FG006|Overall Study|Screen failure (no treatment received)|1|||
30964524|NCT01586624|59033047|FG007|Overall Study|Screen failure (no treatment received)|0|||
30964525|NCT01586156|59033069|FG000|Overall Study|Pregnancy|0|||
30964526|NCT01586156|59033070|FG001|Overall Study|Pregnancy|1|||
30964527|NCT01586156|59033071|FG002|Overall Study|Pregnancy|0|||
30964528|NCT01459913|59033083|FG000|Overall Study|Adverse Event|0|||
30964529|NCT01459913|59033084|FG001|Overall Study|Adverse Event|0|||
30964530|NCT01459913|59033085|FG002|Overall Study|Adverse Event|0|||
30964531|NCT01459913|59033086|FG003|Overall Study|Adverse Event|3|||
30964532|NCT01459913|59033083|FG000|Overall Study|Withdrawal by Subject|4|||
30964533|NCT01459913|59033084|FG001|Overall Study|Withdrawal by Subject|0|||
30964534|NCT01459913|59033085|FG002|Overall Study|Withdrawal by Subject|0|||
30964535|NCT01459913|59033086|FG003|Overall Study|Withdrawal by Subject|5|||
30964536|NCT01459913|59033083|FG000|Overall Study|Lost to Follow-up|7|||
30964537|NCT01459913|59033084|FG001|Overall Study|Lost to Follow-up|4|||
30964538|NCT01459913|59033085|FG002|Overall Study|Lost to Follow-up|1|||
30964539|NCT01459913|59033086|FG003|Overall Study|Lost to Follow-up|8|||
30964540|NCT01459913|59033083|FG000|Overall Study|Death|0|||
30964541|NCT01459913|59033084|FG001|Overall Study|Death|0|||
30964542|NCT01459913|59033085|FG002|Overall Study|Death|0|||
30964543|NCT01459913|59033086|FG003|Overall Study|Death|1|||
30964544|NCT01459913|59033083|FG000|Overall Study|Non- Compliance|0|||
30964545|NCT01459913|59033084|FG001|Overall Study|Non- Compliance|0|||
30964546|NCT01459913|59033085|FG002|Overall Study|Non- Compliance|0|||
30964547|NCT01459913|59033086|FG003|Overall Study|Non- Compliance|3|||
30964548|NCT01459913|59033083|FG000|Overall Study|Physician Decision|0|||
30964549|NCT01459913|59033084|FG001|Overall Study|Physician Decision|1|||
30964550|NCT01459913|59033085|FG002|Overall Study|Physician Decision|0|||
30964551|NCT01459913|59033086|FG003|Overall Study|Physician Decision|0|||
30964552|NCT01459913|59033083|FG000|Overall Study|Study Terminated by Sponsor|30|||
30964553|NCT01459913|59033084|FG001|Overall Study|Study Terminated by Sponsor|15|||
30964554|NCT01459913|59033085|FG002|Overall Study|Study Terminated by Sponsor|9|||
30964555|NCT01459913|59033086|FG003|Overall Study|Study Terminated by Sponsor|11|||
30964556|NCT01459913|59033083|FG000|Overall Study|Other|0|||
30964557|NCT01459913|59033084|FG001|Overall Study|Other|0|||
30964558|NCT01459913|59033085|FG002|Overall Study|Other|3|||
30964559|NCT01459913|59033086|FG003|Overall Study|Other|1|||
30964560|NCT01459913|59033083|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
30964561|NCT01459913|59033084|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
30964562|NCT01459913|59033085|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
30964563|NCT01459913|59033086|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
30964564|NCT01458587|59033100|FG000|Overall Study|Withdrawal by Subject|1|||
30964565|NCT01458587|59033101|FG001|Overall Study|Withdrawal by Subject|0|||
30964566|NCT01458275|59033112|FG000|Overall Study|Adverse Event|3|||
30964567|NCT01458275|59033113|FG001|Overall Study|Adverse Event|4|||
30964568|NCT01458275|59033114|FG002|Overall Study|Adverse Event|1|||
30964569|NCT01458275|59033112|FG000|Overall Study|Lost to Follow-up|3|||
30964570|NCT01458275|59033113|FG001|Overall Study|Lost to Follow-up|2|||
30964571|NCT01458275|59033114|FG002|Overall Study|Lost to Follow-up|5|||
30964572|NCT01458275|59033112|FG000|Overall Study|Protocol Violation|5|||
30964573|NCT01458275|59033113|FG001|Overall Study|Protocol Violation|5|||
30964574|NCT01458275|59033114|FG002|Overall Study|Protocol Violation|2|||
30964575|NCT01458275|59033112|FG000|Overall Study|Withdrawal by Subject|3|||
30964576|NCT01458275|59033113|FG001|Overall Study|Withdrawal by Subject|2|||
30964577|NCT01458275|59033114|FG002|Overall Study|Withdrawal by Subject|1|||
30964578|NCT01458119|59033124|FG000|Overall Study|Physician Decision|4|||
30964579|NCT01458119|59033124|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
30964580|NCT01458119|59033124|FG000|Overall Study|Pregnancy|1|||
30964581|NCT01458119|59033124|FG000|Overall Study|Death|2|||
30964582|NCT01458119|59033124|FG000|Overall Study|Adverse Event|1|||
30964583|NCT01458119|59033124|FG000|Overall Study|Consent Withdrawn by Participant|8|||
30964584|NCT01458119|59033124|FG000|Overall Study|Non-compliance With Study Drug|3|||
30964585|NCT01688882|59033139|FG000|Overall Study|Adverse Event|1|||
30964586|NCT01688882|59033140|FG001|Overall Study|Adverse Event|0|||
30604925|NCT01225731|58615774|FG003|Part 2|Lost to Follow-up|0|||
30604926|NCT01225731|58615775|FG004|Part 2|Lost to Follow-up|0|||
30604927|NCT01225731|58615776|FG005|Part 2|Lost to Follow-up|0|||
30604928|NCT01225731|58615777|FG006|Part 2|Lost to Follow-up|0|||
30604929|NCT01225731|58615778|FG007|Part 2|Lost to Follow-up|3|||
30604930|NCT01225731|58615779|FG008|Part 2|Lost to Follow-up|1|||
30604931|NCT01225731|58615780|FG009|Part 2|Lost to Follow-up|0|||
30604932|NCT01225731|58615781|FG010|Part 2|Lost to Follow-up|0|||
30604933|NCT01225731|58615782|FG011|Part 2|Lost to Follow-up|0|||
30604934|NCT01225731|58615783|FG012|Part 2|Lost to Follow-up|0|||
30604935|NCT01225731|58615771|FG000|Part 2|Physician Decision|0|||
30604936|NCT01225731|58615772|FG001|Part 2|Physician Decision|0|||
30604937|NCT01225731|58615773|FG002|Part 2|Physician Decision|0|||
30604938|NCT01225731|58615774|FG003|Part 2|Physician Decision|0|||
30604939|NCT01225731|58615775|FG004|Part 2|Physician Decision|0|||
30604940|NCT01225731|58615776|FG005|Part 2|Physician Decision|0|||
30604941|NCT01225731|58615777|FG006|Part 2|Physician Decision|0|||
30604942|NCT01225731|58615778|FG007|Part 2|Physician Decision|2|||
30604943|NCT01225731|58615779|FG008|Part 2|Physician Decision|2|||
30604944|NCT01225731|58615780|FG009|Part 2|Physician Decision|0|||
30604945|NCT01225731|58615781|FG010|Part 2|Physician Decision|0|||
30604946|NCT01225731|58615782|FG011|Part 2|Physician Decision|0|||
30604947|NCT01225731|58615783|FG012|Part 2|Physician Decision|0|||
30604948|NCT01225731|58615771|FG000|Part 2|Withdrawal by Subject|0|||
30604949|NCT01225731|58615772|FG001|Part 2|Withdrawal by Subject|0|||
30604950|NCT01225731|58615773|FG002|Part 2|Withdrawal by Subject|0|||
30604951|NCT01225731|58615774|FG003|Part 2|Withdrawal by Subject|0|||
30604952|NCT01225731|58615775|FG004|Part 2|Withdrawal by Subject|0|||
30604953|NCT01225731|58615776|FG005|Part 2|Withdrawal by Subject|1|||
30604954|NCT01225731|58615777|FG006|Part 2|Withdrawal by Subject|3|||
30604955|NCT01225731|58615778|FG007|Part 2|Withdrawal by Subject|4|||
30604956|NCT01225731|58615779|FG008|Part 2|Withdrawal by Subject|1|||
30604957|NCT01225731|58615780|FG009|Part 2|Withdrawal by Subject|0|||
30604958|NCT01225731|58615781|FG010|Part 2|Withdrawal by Subject|0|||
30604959|NCT01225731|58615782|FG011|Part 2|Withdrawal by Subject|0|||
30604960|NCT01225731|58615783|FG012|Part 2|Withdrawal by Subject|0|||
30604961|NCT01225731|58615771|FG000|Part 3|Adverse Event|0|||
30604962|NCT01225731|58615772|FG001|Part 3|Adverse Event|0|||
30604963|NCT01225731|58615773|FG002|Part 3|Adverse Event|0|||
30604964|NCT01225731|58615774|FG003|Part 3|Adverse Event|0|||
30604965|NCT01225731|58615775|FG004|Part 3|Adverse Event|0|||
30604966|NCT01225731|58615776|FG005|Part 3|Adverse Event|0|||
30604967|NCT01225731|58615777|FG006|Part 3|Adverse Event|0|||
30604968|NCT01225731|58615778|FG007|Part 3|Adverse Event|0|||
30604969|NCT01225731|58615779|FG008|Part 3|Adverse Event|0|||
30604970|NCT01225731|58615780|FG009|Part 3|Adverse Event|0|||
30604971|NCT01225731|58615781|FG010|Part 3|Adverse Event|1|||
30604972|NCT01225731|58615782|FG011|Part 3|Adverse Event|1|||
30695913|NCT00681824|58710261|FG000|Overall Study|scheduling conflict|1|||
30964587|NCT01688882|59033139|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
30964588|NCT01688882|59033140|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
30604973|NCT01225731|58615783|FG012|Part 3|Adverse Event|0|||
30604974|NCT01225731|58615771|FG000|Part 3|Lost to Follow-up|0|||
30604975|NCT01225731|58615772|FG001|Part 3|Lost to Follow-up|0|||
30604976|NCT01225731|58615773|FG002|Part 3|Lost to Follow-up|0|||
30604977|NCT01225731|58615774|FG003|Part 3|Lost to Follow-up|0|||
30604978|NCT01225731|58615775|FG004|Part 3|Lost to Follow-up|0|||
30604979|NCT01225731|58615776|FG005|Part 3|Lost to Follow-up|0|||
30604980|NCT01225731|58615777|FG006|Part 3|Lost to Follow-up|0|||
30604981|NCT01225731|58615778|FG007|Part 3|Lost to Follow-up|0|||
30604982|NCT01225731|58615779|FG008|Part 3|Lost to Follow-up|0|||
30604983|NCT01225731|58615780|FG009|Part 3|Lost to Follow-up|0|||
30604984|NCT01225731|58615781|FG010|Part 3|Lost to Follow-up|1|||
30604985|NCT01225731|58615782|FG011|Part 3|Lost to Follow-up|2|||
30604986|NCT01225731|58615783|FG012|Part 3|Lost to Follow-up|1|||
30604987|NCT01225731|58615771|FG000|Part 3|Physician Decision|0|||
30604988|NCT01225731|58615772|FG001|Part 3|Physician Decision|0|||
30604989|NCT01225731|58615773|FG002|Part 3|Physician Decision|0|||
30604990|NCT01225731|58615774|FG003|Part 3|Physician Decision|0|||
30604991|NCT01225731|58615775|FG004|Part 3|Physician Decision|0|||
30604992|NCT01225731|58615776|FG005|Part 3|Physician Decision|0|||
30695914|NCT00681824|58710262|FG001|Overall Study|scheduling conflict|0|||
30604993|NCT01225731|58615777|FG006|Part 3|Physician Decision|0|||
30604994|NCT01225731|58615778|FG007|Part 3|Physician Decision|0|||
30604995|NCT01225731|58615779|FG008|Part 3|Physician Decision|0|||
30604996|NCT01225731|58615780|FG009|Part 3|Physician Decision|0|||
30604997|NCT01225731|58615781|FG010|Part 3|Physician Decision|0|||
30604998|NCT01225731|58615782|FG011|Part 3|Physician Decision|1|||
30604999|NCT01225731|58615783|FG012|Part 3|Physician Decision|2|||
30964589|NCT01688882|59033139|FG000|Overall Study|Administrative problems|1|||
30964590|NCT01688882|59033140|FG001|Overall Study|Administrative problems|0|||
30964591|NCT01688726|59033152|FG000|Overall Study|Adverse Event|1|||
30964592|NCT01688726|59033153|FG001|Overall Study|Adverse Event|0|||
30964593|NCT01688726|59033152|FG000|Overall Study|Relocated abroad|0|||
30964594|NCT01688726|59033153|FG001|Overall Study|Relocated abroad|1|||
30964595|NCT01585766|59033169|FG000|Overall Study|Withdrawal by Subject|0|||
30964596|NCT01585766|59033170|FG001|Overall Study|Withdrawal by Subject|1|||
30964597|NCT01585766|59033171|FG002|Overall Study|Withdrawal by Subject|1|||
30964598|NCT01585766|59033172|FG003|Overall Study|Withdrawal by Subject|0|||
30964599|NCT01585766|59033173|FG004|Overall Study|Withdrawal by Subject|0|||
30964600|NCT01585766|59033174|FG005|Overall Study|Withdrawal by Subject|0|||
30964601|NCT01585766|59033169|FG000|Overall Study|Death|0|||
30964602|NCT01585766|59033170|FG001|Overall Study|Death|1|||
30964603|NCT01585766|59033171|FG002|Overall Study|Death|0|||
30964604|NCT01585766|59033172|FG003|Overall Study|Death|0|||
30964605|NCT01585766|59033173|FG004|Overall Study|Death|0|||
30964606|NCT01585766|59033174|FG005|Overall Study|Death|0|||
30964607|NCT01585766|59033169|FG000|Overall Study|Physician Decision|0|||
30964608|NCT01585766|59033170|FG001|Overall Study|Physician Decision|0|||
30964609|NCT01585766|59033171|FG002|Overall Study|Physician Decision|1|||
30964610|NCT01585766|59033172|FG003|Overall Study|Physician Decision|0|||
30964611|NCT01585766|59033173|FG004|Overall Study|Physician Decision|0|||
30964612|NCT01585766|59033174|FG005|Overall Study|Physician Decision|0|||
30964613|NCT01562444|59033198|FG000|Overall Study|Did not meet entry criteria|2|||
30964614|NCT01562444|59033199|FG001|Overall Study|Did not meet entry criteria|0|||
30964615|NCT01562444|59033200|FG002|Overall Study|Did not meet entry criteria|3|||
30964616|NCT01562444|59033198|FG000|Overall Study|Did not comply with blood draw schedule|1|||
30964617|NCT01562444|59033199|FG001|Overall Study|Did not comply with blood draw schedule|0|||
30964618|NCT01562444|59033200|FG002|Overall Study|Did not comply with blood draw schedule|1|||
30964619|NCT01562444|59033198|FG000|Overall Study|Unavailable serological results|0|||
30964620|NCT01562444|59033199|FG001|Overall Study|Unavailable serological results|2|||
30964621|NCT01562444|59033200|FG002|Overall Study|Unavailable serological results|2|||
30964622|NCT01562444|59033198|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
30964623|NCT01562444|59033199|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
30964624|NCT01562444|59033200|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
30964625|NCT01562444|59033198|FG000|Overall Study|Protocol forbidden medication|1|||
30964626|NCT01562444|59033199|FG001|Overall Study|Protocol forbidden medication|0|||
30964627|NCT01562444|59033200|FG002|Overall Study|Protocol forbidden medication|0|||
30964628|NCT01457339|59033210|FG000|Period 3 (100 mg)|Adverse Event|0|||
30964629|NCT01457339|59033211|FG001|Period 3 (100 mg)|Adverse Event|1|||
30964630|NCT01457339|59033210|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
30964631|NCT01457339|59033211|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
30964632|NCT01457339|59033210|FG000|Period 6 (250 mg)|Family Emergency|1|||
30964633|NCT01457339|59033211|FG001|Period 6 (250 mg)|Family Emergency|0|||
30964634|NCT01457339|59033210|FG000|Period 6 (250 mg)|Personal appointment|0|||
30964635|NCT01457339|59033211|FG001|Period 6 (250 mg)|Personal appointment|1|||
30964636|NCT01456949|59033234|FG000|Enrollment|PI death- incomplete data|6|||
30964637|NCT01456949|59033234|FG000|Enrollment|Death|1|||
30964638|NCT01456949|59033234|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
30964639|NCT01456949|59033234|FG000|Enrollment|Physician Decision|10|||
30964640|NCT01456949|59033234|FG000|Enrollment|Withdrawal by Subject|7|||
30964641|NCT01456949|59033234|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
30964642|NCT01456949|59033234|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
30964643|NCT01456949|59033234|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
30964644|NCT01456949|59033234|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
30964645|NCT01456949|59033234|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
30964646|NCT01456949|59033234|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
30964647|NCT01456949|59033234|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
30964648|NCT01456949|59033234|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
30964649|NCT01456169|59033241|FG000|Overall Study|Adverse Event|1|||
30964650|NCT01456169|59033242|FG001|Overall Study|Adverse Event|2|||
30964651|NCT01456169|59033243|FG002|Overall Study|Adverse Event|7|||
30964652|NCT01456169|59033241|FG000|Overall Study|Major Protocol Deviation|3|||
30964653|NCT01456169|59033242|FG001|Overall Study|Major Protocol Deviation|2|||
30964654|NCT01456169|59033243|FG002|Overall Study|Major Protocol Deviation|3|||
30964655|NCT01456169|59033241|FG000|Overall Study|Voluntary Withdrawal|3|||
30964656|NCT01456169|59033242|FG001|Overall Study|Voluntary Withdrawal|0|||
30964657|NCT01456169|59033243|FG002|Overall Study|Voluntary Withdrawal|2|||
30964658|NCT01456169|59033241|FG000|Overall Study|Lack of Efficacy|2|||
30964659|NCT01456169|59033242|FG001|Overall Study|Lack of Efficacy|0|||
30964660|NCT01456169|59033243|FG002|Overall Study|Lack of Efficacy|0|||
30964661|NCT01456169|59033241|FG000|Overall Study|Other|1|||
30964662|NCT01456169|59033242|FG001|Overall Study|Other|1|||
30964663|NCT01456169|59033243|FG002|Overall Study|Other|0|||
30964664|NCT01454531|59033252|FG000|Overall Study|Adverse Event|14|||
30964665|NCT01454531|59033252|FG000|Overall Study|Withdrawal by Subject|5|||
30964666|NCT01454531|59033252|FG000|Overall Study|Lost to Follow-up|1|||
30964667|NCT01454531|59033252|FG000|Overall Study|Physician Decision|1|||
30964668|NCT01454531|59033252|FG000|Overall Study|Delay in IMP administration|1|||
30964669|NCT01454531|59033252|FG000|Overall Study|Other|1|||
30964670|NCT01454063|59033258|FG000|Randomized|Adverse Event|1|||
30964671|NCT01454063|59033259|FG001|Randomized|Adverse Event|1|||
30964672|NCT01454063|59033258|FG000|Randomized|Protocol Violation|0|||
30964673|NCT01454063|59033259|FG001|Randomized|Protocol Violation|1|||
30964674|NCT01453595|59033268|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
30964675|NCT01453595|59033269|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
30964676|NCT01453595|59033270|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
30964677|NCT01453439|59033278|FG000|Treatment Phase|Withdrawal by Subject|13|||
30964678|NCT01453439|59033279|FG001|Treatment Phase|Withdrawal by Subject|10|||
30964679|NCT01453439|59033278|FG000|Treatment Phase|Suicidal Ideation|2|||
30964680|NCT01453439|59033279|FG001|Treatment Phase|Suicidal Ideation|0|||
30964681|NCT01453439|59033278|FG000|Treatment Phase|Need for higher level of care|1|||
30964682|NCT01453439|59033279|FG001|Treatment Phase|Need for higher level of care|1|||
30964683|NCT01453439|59033278|FG000|Treatment Phase|Therapist conflict of interest|1|||
30964684|NCT01453439|59033279|FG001|Treatment Phase|Therapist conflict of interest|0|||
30964685|NCT01453439|59033278|FG000|Follow-up|Withdrawal by Subject|0|||
30964686|NCT01453439|59033279|FG001|Follow-up|Withdrawal by Subject|1|||
30964687|NCT01453439|59033278|FG000|Follow-up|Lost to Follow-up|5|||
30964688|NCT01453439|59033279|FG001|Follow-up|Lost to Follow-up|10|||
30964689|NCT01453361|59033285|FG000|Overall Study|Disease Progression|6|||
30964690|NCT01453361|59033285|FG000|Overall Study|Screen-Failures|10|||
30964691|NCT01585298|59033289|FG000|Overall Study|Study completion was not documented.|1|||
30964692|NCT01585298|59033289|FG000|Overall Study|Protocol deviation|1|||
30964693|NCT01585298|59033289|FG000|Overall Study|Administrative problems|4|||
30964694|NCT01585298|59033289|FG000|Overall Study|Lost to Follow-up|2|||
30964695|NCT01585298|59033289|FG000|Overall Study|Withdrawal by Subject|4|||
30964696|NCT01585298|59033289|FG000|Overall Study|Abnormal test procedure results|1|||
30964697|NCT01585298|59033289|FG000|Overall Study|Adverse Event|24|||
30964698|NCT01453205|59033296|FG000|Overall Study|Lost to Follow-up|3|||
30964699|NCT01453205|59033297|FG001|Overall Study|Lost to Follow-up|0|||
30964700|NCT01453205|59033298|FG002|Overall Study|Lost to Follow-up|1|||
30964701|NCT01453205|59033296|FG000|Overall Study|Withdrawal by Subject|8|||
30964702|NCT01453205|59033297|FG001|Overall Study|Withdrawal by Subject|3|||
30964703|NCT01453205|59033298|FG002|Overall Study|Withdrawal by Subject|0|||
30964704|NCT01453205|59033296|FG000|Overall Study|Death|24|||
30964705|NCT01453205|59033297|FG001|Overall Study|Death|22|||
30964706|NCT01453205|59033298|FG002|Overall Study|Death|18|||
30964707|NCT01453205|59033296|FG000|Overall Study|Other|45|||
30964708|NCT01453205|59033297|FG001|Overall Study|Other|27|||
30964709|NCT01453205|59033298|FG002|Overall Study|Other|35|||
30964710|NCT01453049|59033311|FG000|Overall Study|Protocol Violation|2|||
30964711|NCT01453049|59033312|FG001|Overall Study|Protocol Violation|5|||
30964712|NCT01453049|59033311|FG000|Overall Study|Lost to Follow-up|2|||
30964713|NCT01453049|59033312|FG001|Overall Study|Lost to Follow-up|1|||
30964714|NCT01453049|59033311|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
30964715|NCT01453049|59033312|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
30964716|NCT01453049|59033311|FG000|Overall Study|Withdrawal by Subject|1|||
30964717|NCT01453049|59033312|FG001|Overall Study|Withdrawal by Subject|0|||
30964718|NCT01453049|59033311|FG000|Overall Study|Randomized in Error|1|||
30964719|NCT01453049|59033312|FG001|Overall Study|Randomized in Error|0|||
30964720|NCT01452347|59033320|FG000|Overall Study|Adverse Event|2|||
30964721|NCT01452347|59033321|FG001|Overall Study|Adverse Event|1|||
30964722|NCT01452347|59033320|FG000|Overall Study|Non compliance protocol|2|||
30964723|NCT01452347|59033321|FG001|Overall Study|Non compliance protocol|0|||
30964724|NCT01452347|59033320|FG000|Overall Study|Lost to Follow-up|2|||
30964725|NCT01452347|59033321|FG001|Overall Study|Lost to Follow-up|0|||
30964726|NCT01452347|59033320|FG000|Overall Study|Withdrawal by Subject|3|||
30964727|NCT01452347|59033321|FG001|Overall Study|Withdrawal by Subject|3|||
30964728|NCT01452347|59033320|FG000|Overall Study|Not treated|6|||
30964729|NCT01452347|59033321|FG001|Overall Study|Not treated|3|||
30964730|NCT01452347|59033320|FG000|Overall Study|Other reason not defined above|2|||
30964731|NCT01452347|59033321|FG001|Overall Study|Other reason not defined above|0|||
30964732|NCT01451723|59033331|FG000|Overall Study|study halted|6|||
30964733|NCT01451723|59033332|FG001|Overall Study|study halted|5|||
30964734|NCT01451645|59033340|FG000|Overall Study|Protocol Violation|1|||
30964735|NCT01451645|59033341|FG001|Overall Study|Protocol Violation|0|||
30605000|NCT01225731|58615771|FG000|Part 3|Withdrawal by Subject|0|||
30964736|NCT01451645|59033340|FG000|Overall Study|Adverse Event|0|||
30605001|NCT01225731|58615772|FG001|Part 3|Withdrawal by Subject|0|||
30605002|NCT01225731|58615773|FG002|Part 3|Withdrawal by Subject|0|||
30964737|NCT01451645|59033341|FG001|Overall Study|Adverse Event|3|||
30964738|NCT01451645|59033340|FG000|Overall Study|Withdrawal by Subject|4|||
30964739|NCT01451645|59033341|FG001|Overall Study|Withdrawal by Subject|2|||
30964740|NCT01451645|59033340|FG000|Overall Study|Lost to Follow-up|4|||
30964741|NCT01451645|59033341|FG001|Overall Study|Lost to Follow-up|3|||
30964742|NCT01450943|59033350|FG000|Overall Study|Screen failure, loss to follow-up|2|||
30964743|NCT01450943|59033351|FG001|Overall Study|Screen failure, loss to follow-up|7|||
30964744|NCT01450943|59033352|FG002|Overall Study|Screen failure, loss to follow-up|6|||
30964745|NCT01450631|59033366|FG000|Overall Study|Lost to Follow-up|2|||
30964746|NCT01450631|59033367|FG001|Overall Study|Lost to Follow-up|4|||
30964747|NCT01450631|59033366|FG000|Overall Study|Withdrawal by Subject|1|||
30964748|NCT01450631|59033367|FG001|Overall Study|Withdrawal by Subject|0|||
30964749|NCT01450007|59033376|FG000|Overall Study|Late exclusion before treatment|2|||
30964750|NCT01450007|59033377|FG001|Overall Study|Late exclusion before treatment|3|||
30964751|NCT01450007|59033378|FG002|Overall Study|Late exclusion before treatment|2|||
30964752|NCT01450007|59033376|FG000|Overall Study|Protocol Violation|0|||
30964753|NCT01450007|59033377|FG001|Overall Study|Protocol Violation|1|||
30964754|NCT01450007|59033378|FG002|Overall Study|Protocol Violation|1|||
30964755|NCT01450007|59033376|FG000|Overall Study|Adverse Event|0|||
30964756|NCT01450007|59033377|FG001|Overall Study|Adverse Event|1|||
30964757|NCT01450007|59033378|FG002|Overall Study|Adverse Event|0|||
30964758|NCT01496365|59033393|FG000|Overall Study|Adverse Event|2|||
30964759|NCT01496365|59033394|FG001|Overall Study|Adverse Event|3|||
30964760|NCT01496365|59033395|FG002|Overall Study|Adverse Event|3|||
30964761|NCT01496365|59033396|FG003|Overall Study|Adverse Event|2|||
30964762|NCT01496365|59033397|FG004|Overall Study|Adverse Event|5|||
30964763|NCT01496365|59033398|FG005|Overall Study|Adverse Event|6|||
30964764|NCT01496365|59033399|FG006|Overall Study|Adverse Event|4|||
30964765|NCT01496365|59033393|FG000|Overall Study|Withdrawal by Subject|6|||
30964766|NCT01496365|59033394|FG001|Overall Study|Withdrawal by Subject|6|||
30964767|NCT01496365|59033395|FG002|Overall Study|Withdrawal by Subject|0|||
30964768|NCT01496365|59033396|FG003|Overall Study|Withdrawal by Subject|1|||
30964769|NCT01496365|59033397|FG004|Overall Study|Withdrawal by Subject|3|||
30964770|NCT01496365|59033398|FG005|Overall Study|Withdrawal by Subject|2|||
30964771|NCT01496365|59033399|FG006|Overall Study|Withdrawal by Subject|1|||
30964772|NCT01496365|59033393|FG000|Overall Study|Protocol Violation|2|||
30964773|NCT01496365|59033394|FG001|Overall Study|Protocol Violation|1|||
30964774|NCT01496365|59033395|FG002|Overall Study|Protocol Violation|1|||
30964775|NCT01496365|59033396|FG003|Overall Study|Protocol Violation|0|||
30964776|NCT01496365|59033397|FG004|Overall Study|Protocol Violation|0|||
30964777|NCT01496365|59033398|FG005|Overall Study|Protocol Violation|1|||
30964778|NCT01496365|59033399|FG006|Overall Study|Protocol Violation|0|||
30964779|NCT01496365|59033393|FG000|Overall Study|Lack of Efficacy|1|||
30964780|NCT01496365|59033394|FG001|Overall Study|Lack of Efficacy|0|||
30964781|NCT01496365|59033395|FG002|Overall Study|Lack of Efficacy|0|||
30964782|NCT01496365|59033396|FG003|Overall Study|Lack of Efficacy|0|||
30964783|NCT01496365|59033397|FG004|Overall Study|Lack of Efficacy|0|||
30964784|NCT01496365|59033398|FG005|Overall Study|Lack of Efficacy|1|||
30964785|NCT01496365|59033399|FG006|Overall Study|Lack of Efficacy|0|||
30964786|NCT01496365|59033393|FG000|Overall Study|Lost to Follow-up|0|||
30964787|NCT01496365|59033394|FG001|Overall Study|Lost to Follow-up|1|||
30964788|NCT01496365|59033395|FG002|Overall Study|Lost to Follow-up|0|||
30964789|NCT01496365|59033396|FG003|Overall Study|Lost to Follow-up|0|||
30964790|NCT01496365|59033397|FG004|Overall Study|Lost to Follow-up|2|||
30964791|NCT01496365|59033398|FG005|Overall Study|Lost to Follow-up|0|||
30964792|NCT01496365|59033399|FG006|Overall Study|Lost to Follow-up|0|||
30964793|NCT01496365|59033393|FG000|Overall Study|Other|4|||
30964794|NCT01496365|59033394|FG001|Overall Study|Other|4|||
30964795|NCT01496365|59033395|FG002|Overall Study|Other|2|||
30964796|NCT01496365|59033396|FG003|Overall Study|Other|1|||
30964797|NCT01496365|59033397|FG004|Overall Study|Other|3|||
30964798|NCT01496365|59033398|FG005|Overall Study|Other|0|||
30964799|NCT01496365|59033399|FG006|Overall Study|Other|1|||
30964800|NCT01496287|59033415|FG000|Overall Study|Lost to Follow-up|1|||
30964801|NCT01496287|59033415|FG000|Overall Study|Incomplete anesthesia|5|||
30964802|NCT01495975|59033422|FG000|Overall Study|Lost to Follow-up|1|||
30964803|NCT01495975|59033423|FG001|Overall Study|Lost to Follow-up|0|||
30964804|NCT01468987|59033431|FG000|Overall Study|Adverse Event|12|||
30964805|NCT01468987|59033432|FG001|Overall Study|Adverse Event|9|||
30964806|NCT01468987|59033431|FG000|Overall Study|Death|4|||
30695915|NCT00681824|58710263|FG002|Overall Study|scheduling conflict|0|||
30964807|NCT01468987|59033432|FG001|Overall Study|Death|1|||
30964808|NCT01468987|59033431|FG000|Overall Study|Lost to Follow-up|10|||
30964809|NCT01468987|59033432|FG001|Overall Study|Lost to Follow-up|5|||
30964810|NCT01468987|59033431|FG000|Overall Study|Protocol Violation|8|||
30964811|NCT01468987|59033432|FG001|Overall Study|Protocol Violation|2|||
30964812|NCT01468987|59033431|FG000|Overall Study|Withdrawal by Subject|28|||
30964813|NCT01468987|59033432|FG001|Overall Study|Withdrawal by Subject|28|||
30964814|NCT01468987|59033431|FG000|Overall Study|Physician Decision|8|||
30964815|NCT01468987|59033432|FG001|Overall Study|Physician Decision|15|||
30964816|NCT01468987|59033431|FG000|Overall Study|Sponsor Decision|1|||
30964817|NCT01468987|59033432|FG001|Overall Study|Sponsor Decision|0|||
30964818|NCT01687712|59033442|FG000|Cycle 1|Not Biochemically Pregnant|386|||
30964819|NCT01687712|59033443|FG001|Cycle 1|Not Biochemically Pregnant|348|||
30964820|NCT01687712|59033442|FG000|Cycle 1|Early Pregnancy Loss|43|||
30964821|NCT01687712|59033443|FG001|Cycle 1|Early Pregnancy Loss|60|||
30964822|NCT01687712|59033442|FG000|Cycle 1|Ectopic Pregnancy|5|||
30964823|NCT01687712|59033443|FG001|Cycle 1|Ectopic Pregnancy|5|||
30964824|NCT01687712|59033442|FG000|Cycle 1|Heterotropic Pregnancy|1|||
30964825|NCT01687712|59033443|FG001|Cycle 1|Heterotropic Pregnancy|0|||
30964826|NCT01687712|59033442|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
30964827|NCT01687712|59033443|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
30964828|NCT01687712|59033442|FG000|Cycle 1|Abortion|3|||
30964829|NCT01687712|59033443|FG001|Cycle 1|Abortion|0|||
30964830|NCT01687712|59033442|FG000|Cycle 1|Intrauterine Fetal Death|0|||
30964831|NCT01687712|59033443|FG001|Cycle 1|Intrauterine Fetal Death|1|||
30964832|NCT01687712|59033442|FG000|Cycle 1|Lost to Follow-up|1|||
30964833|NCT01687712|59033443|FG001|Cycle 1|Lost to Follow-up|1|||
30964834|NCT01687712|59033442|FG000|Cycle 2|Not Biochemically Pregnant|74|||
30964835|NCT01687712|59033443|FG001|Cycle 2|Not Biochemically Pregnant|77|||
30964836|NCT01687712|59033442|FG000|Cycle 2|Early Pregnancy Loss|18|||
30964837|NCT01687712|59033443|FG001|Cycle 2|Early Pregnancy Loss|16|||
30964838|NCT01687712|59033442|FG000|Cycle 2|Ectopic Pregnancy|0|||
30964839|NCT01687712|59033443|FG001|Cycle 2|Ectopic Pregnancy|1|||
30964840|NCT01687712|59033442|FG000|Cycle 2|Still Birth|1|||
30964841|NCT01687712|59033443|FG001|Cycle 2|Still Birth|0|||
30964842|NCT01687712|59033442|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
30964843|NCT01687712|59033443|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
30964844|NCT01687712|59033442|FG000|Cycle 3|Not Biochemically Pregnant|21|||
30964845|NCT01687712|59033443|FG001|Cycle 3|Not Biochemically Pregnant|22|||
30964846|NCT01687712|59033442|FG000|Cycle 3|Early Pregnancy Loss|1|||
30964847|NCT01687712|59033443|FG001|Cycle 3|Early Pregnancy Loss|2|||
30964848|NCT01687712|59033442|FG000|Cycle 3|Ectopic Pregnancy|1|||
30964849|NCT01687712|59033443|FG001|Cycle 3|Ectopic Pregnancy|0|||
30964850|NCT01687712|59033442|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
30964851|NCT01687712|59033443|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
30964852|NCT01603628|59033456|FG000|Overall Study|Personal Reasons|1|||
30964853|NCT01603628|59033457|FG001|Overall Study|Personal Reasons|1|||
30964854|NCT01603628|59033458|FG002|Overall Study|Personal Reasons|2|||
30964855|NCT01603628|59033456|FG000|Overall Study|Protocol Violation|1|||
30964856|NCT01603628|59033457|FG001|Overall Study|Protocol Violation|1|||
30964857|NCT01603628|59033458|FG002|Overall Study|Protocol Violation|0|||
30964858|NCT01603628|59033456|FG000|Overall Study|Lost to Follow-up|0|||
30964859|NCT01603628|59033457|FG001|Overall Study|Lost to Follow-up|1|||
30964860|NCT01603628|59033458|FG002|Overall Study|Lost to Follow-up|0|||
30964861|NCT01603628|59033456|FG000|Overall Study|Other Miscellaneous Reason|1|||
30964862|NCT01603628|59033457|FG001|Overall Study|Other Miscellaneous Reason|0|||
30964863|NCT01603628|59033458|FG002|Overall Study|Other Miscellaneous Reason|0|||
30964864|NCT01453153|59033469|FG000|Overall Study|Physician Decision|0|||
30964865|NCT01453153|59033470|FG001|Overall Study|Physician Decision|0|||
30964866|NCT01453153|59033471|FG002|Overall Study|Physician Decision|1|||
30964867|NCT01453153|59033469|FG000|Overall Study|Progressive Disease|3|||
30964868|NCT01453153|59033470|FG001|Overall Study|Progressive Disease|2|||
30964869|NCT01453153|59033471|FG002|Overall Study|Progressive Disease|16|||
30964870|NCT01453153|59033469|FG000|Overall Study|Withdrawal by Subject|0|||
30964871|NCT01453153|59033470|FG001|Overall Study|Withdrawal by Subject|1|||
30964872|NCT01453153|59033471|FG002|Overall Study|Withdrawal by Subject|2|||
30964873|NCT01453153|59033469|FG000|Overall Study|Adverse Event|1|||
30964874|NCT01453153|59033470|FG001|Overall Study|Adverse Event|1|||
30964875|NCT01453153|59033471|FG002|Overall Study|Adverse Event|1|||
30964876|NCT01584440|59033485|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
30964877|NCT01584440|59033486|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
30964878|NCT01584440|59033487|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
30964879|NCT01584440|59033488|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
30964880|NCT01584440|59033489|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
30964881|NCT01584440|59033485|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
30964882|NCT01584440|59033486|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
30964883|NCT01584440|59033487|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
30964884|NCT01584440|59033488|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
30964885|NCT01584440|59033489|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
30964886|NCT01584440|59033485|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
30964887|NCT01584440|59033486|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
30964888|NCT01584440|59033487|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
30964889|NCT01584440|59033488|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
30964890|NCT01584440|59033489|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
30964891|NCT01584440|59033485|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
30964892|NCT01584440|59033486|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
30964893|NCT01584440|59033487|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
30964894|NCT01584440|59033488|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
30964895|NCT01584440|59033489|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
30964896|NCT01584440|59033485|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
30964897|NCT01584440|59033486|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
30964898|NCT01584440|59033487|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
30964899|NCT01584440|59033488|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
30964900|NCT01584440|59033489|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
30964901|NCT01584440|59033485|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
30964902|NCT01584440|59033486|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
30964903|NCT01584440|59033487|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
30964904|NCT01584440|59033488|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
30964905|NCT01584440|59033489|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
30964906|NCT01584440|59033485|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
30964907|NCT01584440|59033486|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
30964908|NCT01584440|59033487|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
30605003|NCT01225731|58615774|FG003|Part 3|Withdrawal by Subject|0|||
30605004|NCT01225731|58615775|FG004|Part 3|Withdrawal by Subject|0|||
30605005|NCT01225731|58615776|FG005|Part 3|Withdrawal by Subject|0|||
30605006|NCT01225731|58615777|FG006|Part 3|Withdrawal by Subject|0|||
30605007|NCT01225731|58615778|FG007|Part 3|Withdrawal by Subject|0|||
30605008|NCT01225731|58615779|FG008|Part 3|Withdrawal by Subject|0|||
30605009|NCT01225731|58615780|FG009|Part 3|Withdrawal by Subject|0|||
30605010|NCT01225731|58615781|FG010|Part 3|Withdrawal by Subject|4|||
30605011|NCT01225731|58615782|FG011|Part 3|Withdrawal by Subject|6|||
30605012|NCT01225731|58615783|FG012|Part 3|Withdrawal by Subject|4|||
30605013|NCT01007149|58615814|FG000|Overall Study|Administrative problems|0|||
30605014|NCT01007149|58615815|FG001|Overall Study|Administrative problems|1|||
30605015|NCT00998335|58615823|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
30605016|NCT00998335|58615824|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
30605017|NCT01294670|58615841|FG000|Overall Study|Not treated|1|||
30605018|NCT01294670|58615842|FG001|Overall Study|Not treated|0|||
30605019|NCT01294670|58615843|FG002|Overall Study|Not treated|0|||
30605020|NCT01294670|58615844|FG003|Overall Study|Not treated|0|||
30605021|NCT01294670|58615845|FG004|Overall Study|Not treated|0|||
30605022|NCT01006603|58615859|FG000|Overall Study|Withdrawal by Subject|17|||
30605023|NCT01006603|58615860|FG001|Overall Study|Withdrawal by Subject|19|||
30605024|NCT01006603|58615859|FG000|Overall Study|Lost to Follow-up|0|||
30605025|NCT01006603|58615860|FG001|Overall Study|Lost to Follow-up|1|||
30605026|NCT01006603|58615859|FG000|Overall Study|Safety reason|1|||
30605027|NCT01006603|58615860|FG001|Overall Study|Safety reason|1|||
30605028|NCT01006603|58615859|FG000|Overall Study|Protocol Violation|1|||
30605029|NCT01006603|58615860|FG001|Overall Study|Protocol Violation|3|||
30605030|NCT01006603|58615859|FG000|Overall Study|Incorrect enrolment|0|||
30605031|NCT01006603|58615860|FG001|Overall Study|Incorrect enrolment|2|||
30605032|NCT01006603|58615859|FG000|Overall Study|Adverse Event|15|||
30605033|NCT01006603|58615860|FG001|Overall Study|Adverse Event|7|||
30605034|NCT01006603|58615859|FG000|Overall Study|Death|1|||
30605035|NCT01006603|58615860|FG001|Overall Study|Death|1|||
30605036|NCT01006603|58615859|FG000|Overall Study|Study specific discontinuation criteria|33|||
30605037|NCT01006603|58615860|FG001|Overall Study|Study specific discontinuation criteria|34|||
30605038|NCT01006603|58615859|FG000|Overall Study|Other|3|||
30605039|NCT01006603|58615860|FG001|Overall Study|Other|7|||
30605040|NCT00997321|58615868|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
30605041|NCT00997321|58615869|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
30605042|NCT01294592|58615883|FG000|Overall Study|Adverse Event|28|||
30605043|NCT01294592|58615884|FG001|Overall Study|Adverse Event|13|||
30605044|NCT01294592|58615883|FG000|Overall Study|Lack of Efficacy|7|||
30605045|NCT01294592|58615884|FG001|Overall Study|Lack of Efficacy|5|||
30964909|NCT01584440|59033488|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
30605046|NCT01294592|58615883|FG000|Overall Study|Protocol Violation|1|||
30605047|NCT01294592|58615884|FG001|Overall Study|Protocol Violation|7|||
30605048|NCT01294592|58615883|FG000|Overall Study|Lost to Follow-up|7|||
30605049|NCT01294592|58615884|FG001|Overall Study|Lost to Follow-up|9|||
30605050|NCT01294592|58615883|FG000|Overall Study|Physician Decision|6|||
30605051|NCT01294592|58615884|FG001|Overall Study|Physician Decision|11|||
30605052|NCT01294592|58615883|FG000|Overall Study|Withdrawal by Subject|28|||
30605053|NCT01294592|58615884|FG001|Overall Study|Withdrawal by Subject|28|||
30605054|NCT00997243|58615893|FG000|Overall Study|Early termination of study by sponsor|7|||
30605055|NCT01294514|58615897|FG000|Overall Study|Excluded due to Arrhythmia|1|||
30605056|NCT00999661|58615905|FG000|Overall Study|Lost to Follow-up|59|||
30605057|NCT00999661|58615905|FG000|Overall Study|Adverse Event|1|||
30605058|NCT00999661|58615905|FG000|Overall Study|Withdrawal by Subject|1|||
30605059|NCT00999661|58615905|FG000|Overall Study|Not meeting eligibility criteria|9|||
30605060|NCT01294436|58615911|FG000|Overall Study|Adverse Event|10|||
30605061|NCT01294436|58615912|FG001|Overall Study|Adverse Event|17|||
30605062|NCT01294436|58615911|FG000|Overall Study|Withdrawal by Subject|11|||
30605063|NCT01294436|58615912|FG001|Overall Study|Withdrawal by Subject|28|||
30605064|NCT01294436|58615911|FG000|Overall Study|subject no longer meets study criteria|5|||
30605065|NCT01294436|58615912|FG001|Overall Study|subject no longer meets study criteria|20|||
30605066|NCT01294436|58615911|FG000|Overall Study|poor/non-compliance|2|||
30605067|NCT01294436|58615912|FG001|Overall Study|poor/non-compliance|5|||
30605068|NCT00995371|58615920|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
30605069|NCT00995371|58615921|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
30605070|NCT01294358|58615929|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
30605071|NCT01294358|58615930|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
30605072|NCT01294358|58615931|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
30605073|NCT01294358|58615932|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
30605074|NCT01294358|58615933|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
30605075|NCT01294358|58615929|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
30605076|NCT01294358|58615930|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
30605077|NCT01294358|58615931|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
30605078|NCT01294358|58615932|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
30605079|NCT01294358|58615933|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
30605080|NCT01294358|58615929|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
30605081|NCT01294358|58615930|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
30605082|NCT01294358|58615931|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
30605083|NCT01294358|58615932|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
30605084|NCT01294358|58615933|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
30605085|NCT01294358|58615929|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
30605086|NCT01294358|58615930|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
30605087|NCT01294358|58615931|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
30605088|NCT01294358|58615932|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
30605089|NCT01294358|58615933|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
30605090|NCT00994279|58615952|FG000|Overall Study|Withdrawal by Subject|2|||
30605091|NCT00994279|58615953|FG001|Overall Study|Withdrawal by Subject|2|||
30605092|NCT00994279|58615952|FG000|Overall Study|Toxicity|1|||
30605093|NCT00994279|58615953|FG001|Overall Study|Toxicity|0|||
30605094|NCT00994279|58615952|FG000|Overall Study|Multiple reasons|1|||
30605095|NCT00994279|58615953|FG001|Overall Study|Multiple reasons|3|||
30605096|NCT01294046|58615959|FG000|Overall Study|Infection and surgical explant|1|||
30605097|NCT01294046|58615959|FG000|Overall Study|Eligibility criteria expanded|1|||
30605098|NCT01294046|58615959|FG000|Overall Study|Stimulation response inadqequate|1|||
30605099|NCT01224639|58615974|FG000|Overall Study|Withdrawal by Subject|0|||
30605100|NCT01224639|58615975|FG001|Overall Study|Withdrawal by Subject|0|||
30605101|NCT01224639|58615976|FG002|Overall Study|Withdrawal by Subject|0|||
30605102|NCT01224639|58615977|FG003|Overall Study|Withdrawal by Subject|0|||
30605103|NCT01224639|58615978|FG004|Overall Study|Withdrawal by Subject|2|||
30605104|NCT01224639|58615979|FG005|Overall Study|Withdrawal by Subject|0|||
30605105|NCT01224639|58615980|FG006|Overall Study|Withdrawal by Subject|1|||
30605106|NCT01224639|58615981|FG007|Overall Study|Withdrawal by Subject|1|||
30605107|NCT01224639|58615974|FG000|Overall Study|Adverse Event|0|||
30605108|NCT01224639|58615975|FG001|Overall Study|Adverse Event|0|||
30605109|NCT01224639|58615976|FG002|Overall Study|Adverse Event|0|||
30605110|NCT01224639|58615977|FG003|Overall Study|Adverse Event|0|||
30605111|NCT01224639|58615978|FG004|Overall Study|Adverse Event|0|||
30605112|NCT01224639|58615979|FG005|Overall Study|Adverse Event|0|||
30605113|NCT01224639|58615980|FG006|Overall Study|Adverse Event|0|||
30605114|NCT01224639|58615981|FG007|Overall Study|Adverse Event|1|||
30605115|NCT01293968|58616001|FG000|Overall Study|non-cooperation|3|||
30605116|NCT01293968|58616002|FG001|Overall Study|non-cooperation|3|||
30605117|NCT01293032|58616012|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
30605118|NCT01293032|58616013|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
30605119|NCT01293032|58616014|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
30605120|NCT01293032|58616015|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
30605121|NCT01293032|58616012|FG000|Treatment|Adverse Event|0|||
30605122|NCT01293032|58616013|FG001|Treatment|Adverse Event|0|||
30605123|NCT01293032|58616014|FG002|Treatment|Adverse Event|1|||
30605124|NCT01293032|58616015|FG003|Treatment|Adverse Event|1|||
30605125|NCT01293032|58616012|FG000|Treatment|Withdrawal by Subject|2|||
30605126|NCT01293032|58616013|FG001|Treatment|Withdrawal by Subject|4|||
30605127|NCT01293032|58616014|FG002|Treatment|Withdrawal by Subject|0|||
30605128|NCT01293032|58616015|FG003|Treatment|Withdrawal by Subject|0|||
30605129|NCT01293032|58616012|FG000|Treatment|Disease Progression, relapse|0|||
30605130|NCT01293032|58616013|FG001|Treatment|Disease Progression, relapse|1|||
30605131|NCT01293032|58616014|FG002|Treatment|Disease Progression, relapse|0|||
30605132|NCT01293032|58616015|FG003|Treatment|Disease Progression, relapse|0|||
30605133|NCT01292876|58616022|FG000|Overall Study|Physician Decision|4|||
30605134|NCT01224171|58616030|FG000|Overall Study|Adverse Event|8|||
30605135|NCT01224171|58616031|FG001|Overall Study|Adverse Event|4|||
30605136|NCT01224171|58616030|FG000|Overall Study|Protocol Violation|0|||
30605137|NCT01224171|58616031|FG001|Overall Study|Protocol Violation|1|||
30605138|NCT01224171|58616030|FG000|Overall Study|Lack of Efficacy|5|||
30605139|NCT01224171|58616031|FG001|Overall Study|Lack of Efficacy|1|||
30605140|NCT01224171|58616030|FG000|Overall Study|Withdrawal of Consent|2|||
30605141|NCT01224171|58616031|FG001|Overall Study|Withdrawal of Consent|4|||
30605142|NCT01224171|58616030|FG000|Overall Study|Lost to Follow-up|0|||
30605143|NCT01224171|58616031|FG001|Overall Study|Lost to Follow-up|3|||
30605144|NCT01292486|58616037|FG000|Overall Study|Protocol Violation|2|||
30605145|NCT01292486|58616037|FG000|Overall Study|Did not meet screening criteria|2|||
30605146|NCT01292486|58616037|FG000|Overall Study|Adverse Event|1|||
30605147|NCT01292486|58616037|FG000|Overall Study|Physician Decision|1|||
30605148|NCT01223937|58616044|FG000|Overall Study|Withdrawal by Subject|3|||
30605149|NCT01223937|58616045|FG001|Overall Study|Withdrawal by Subject|2|||
30605150|NCT01223937|58616044|FG000|Overall Study|Lost to Follow-up|1|||
30605151|NCT01223937|58616045|FG001|Overall Study|Lost to Follow-up|4|||
30605152|NCT01223937|58616044|FG000|Overall Study|Adverse Event|1|||
30605153|NCT01223937|58616045|FG001|Overall Study|Adverse Event|4|||
30605154|NCT01223937|58616044|FG000|Overall Study|Protocol Violation|8|||
30605155|NCT01223937|58616045|FG001|Overall Study|Protocol Violation|7|||
30605156|NCT01223937|58616044|FG000|Overall Study|Other|4|||
30605157|NCT01223937|58616045|FG001|Overall Study|Other|1|||
30605158|NCT01290224|58616051|FG000|Overall Study|Adverse Event|1|||
30605159|NCT01290224|58616051|FG000|Overall Study|Refused Further Treatment|4|||
30605160|NCT01223235|58616057|FG000|Overall Study|Withdrawal by Subject|1|||
30605161|NCT01290068|58616063|FG000|Overall Study|Adverse Event|1|||
30605162|NCT01290068|58616064|FG001|Overall Study|Adverse Event|3|||
30605163|NCT01290068|58616063|FG000|Overall Study|Lost to Follow-up|3|||
30605164|NCT01290068|58616064|FG001|Overall Study|Lost to Follow-up|0|||
30605165|NCT01290068|58616063|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
30605166|NCT01290068|58616064|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
30605167|NCT01290068|58616063|FG000|Overall Study|Other|3|||
30605168|NCT01290068|58616064|FG001|Overall Study|Other|1|||
30605169|NCT00998881|58616072|FG000|Overall Study|Adverse Event|2|||
30605170|NCT00998881|58616073|FG001|Overall Study|Adverse Event|2|||
30605171|NCT00998881|58616072|FG000|Overall Study|Lack of Efficacy|1|||
30605172|NCT00998881|58616073|FG001|Overall Study|Lack of Efficacy|0|||
30605173|NCT00998881|58616072|FG000|Overall Study|Physician Decision|3|||
30605174|NCT00998881|58616073|FG001|Overall Study|Physician Decision|0|||
30605175|NCT00998881|58616072|FG000|Overall Study|Withdrawal by Subject|1|||
30605176|NCT00998881|58616073|FG001|Overall Study|Withdrawal by Subject|0|||
30605177|NCT00998881|58616072|FG000|Overall Study|Personal matter|1|||
30605178|NCT00998881|58616073|FG001|Overall Study|Personal matter|0|||
30605179|NCT01222767|58616079|FG000|Overall Study|Progressive disease|13|||
30605180|NCT01222767|58616079|FG000|Overall Study|Adverse Event|2|||
30605181|NCT01222767|58616079|FG000|Overall Study|Surgical resection|1|||
30605182|NCT01222767|58616079|FG000|Overall Study|Never treated|1|||
30605183|NCT00993967|58616083|FG000|Overall Study|Adverse Event|8|||
30605184|NCT00993967|58616083|FG000|Overall Study|Death|1|||
30605185|NCT00993967|58616083|FG000|Overall Study|Lost to Follow-up|14|||
30605186|NCT00993967|58616083|FG000|Overall Study|Withdrawal by Subject|36|||
30605187|NCT00993967|58616083|FG000|Overall Study|Protocol Violation|2|||
30605188|NCT01222533|58616087|FG000|Overall Study|Adverse Event|5|||
30605189|NCT01222533|58616087|FG000|Overall Study|Withdrawal by Subject|5|||
30605190|NCT01222533|58616087|FG000|Overall Study|Other|4|||
30605191|NCT01221753|58616099|FG000|Overall Study|Adverse Event|1|||
30605192|NCT01221597|58616105|FG000|Overall Study|Adverse Event|4|||
30605193|NCT01221597|58616106|FG001|Overall Study|Adverse Event|1|||
30605194|NCT01221597|58616105|FG000|Overall Study|Withdrawal by Subject|20|||
30605195|NCT01221597|58616106|FG001|Overall Study|Withdrawal by Subject|6|||
30605196|NCT01221597|58616105|FG000|Overall Study|Lost to Follow-up|6|||
30605197|NCT01221597|58616106|FG001|Overall Study|Lost to Follow-up|5|||
30605198|NCT01221597|58616105|FG000|Overall Study|Protocol Violation|1|||
30605199|NCT01221597|58616106|FG001|Overall Study|Protocol Violation|0|||
30605200|NCT01221597|58616105|FG000|Overall Study|Other|3|||
30605201|NCT01221597|58616106|FG001|Overall Study|Other|4|||
30605202|NCT01221597|58616105|FG000|Overall Study|Death|2|||
30605203|NCT01221597|58616106|FG001|Overall Study|Death|0|||
30605204|NCT01221363|58616115|FG000|Overall Study|Pregnancy|1|||
30605205|NCT01221363|58616116|FG001|Overall Study|Pregnancy|0|||
30605206|NCT01221363|58616115|FG000|Overall Study|Withdrawal by Subject|11|||
30605207|NCT01221363|58616116|FG001|Overall Study|Withdrawal by Subject|5|||
30605208|NCT01221285|58616122|FG000|Overall Study|Withdrawal by Subject|1|||
30605209|NCT01014988|58616132|FG000|Overall Study|Adverse Event|20|||
30605210|NCT01014988|58616133|FG001|Overall Study|Adverse Event|0|||
30605211|NCT01014988|58616134|FG002|Overall Study|Adverse Event|1|||
30605212|NCT01014988|58616135|FG003|Overall Study|Adverse Event|0|||
30605213|NCT01014988|58616136|FG004|Overall Study|Adverse Event|1|||
30605214|NCT01014988|58616137|FG005|Overall Study|Adverse Event|3|||
30605215|NCT01014988|58616132|FG000|Overall Study|Lost to Follow-up|1|||
30605216|NCT01014988|58616133|FG001|Overall Study|Lost to Follow-up|0|||
30605217|NCT01014988|58616134|FG002|Overall Study|Lost to Follow-up|1|||
30605218|NCT01014988|58616135|FG003|Overall Study|Lost to Follow-up|0|||
30605219|NCT01014988|58616136|FG004|Overall Study|Lost to Follow-up|0|||
30605220|NCT01014988|58616137|FG005|Overall Study|Lost to Follow-up|0|||
30605221|NCT01014988|58616132|FG000|Overall Study|Physician Decision|1|||
30605222|NCT01014988|58616133|FG001|Overall Study|Physician Decision|0|||
30605223|NCT01014988|58616134|FG002|Overall Study|Physician Decision|0|||
30605224|NCT01014988|58616135|FG003|Overall Study|Physician Decision|0|||
30605225|NCT01014988|58616136|FG004|Overall Study|Physician Decision|0|||
30605226|NCT01014988|58616137|FG005|Overall Study|Physician Decision|0|||
30605227|NCT01014988|58616132|FG000|Overall Study|Withdrawal by Subject|1|||
30605228|NCT01014988|58616133|FG001|Overall Study|Withdrawal by Subject|0|||
30605229|NCT01014988|58616134|FG002|Overall Study|Withdrawal by Subject|0|||
30605230|NCT01014988|58616135|FG003|Overall Study|Withdrawal by Subject|0|||
30605231|NCT01014988|58616136|FG004|Overall Study|Withdrawal by Subject|0|||
30605232|NCT01014988|58616137|FG005|Overall Study|Withdrawal by Subject|0|||
30605233|NCT01014910|58616161|FG000|Overall Study|Withdrawal by Subject|0|||
30605234|NCT01014910|58616162|FG001|Overall Study|Withdrawal by Subject|2|||
30605235|NCT01019980|58616170|FG000|Overall Study|Drug not available.|2|||
30605236|NCT01019980|58616171|FG001|Overall Study|Drug not available.|0|||
30605237|NCT00993499|58616183|FG000|Run-in Period (8 Days)|Adverse Event|0|||
30605238|NCT00993499|58616184|FG001|Run-in Period (8 Days)|Adverse Event|1|||
30605239|NCT00993499|58616185|FG002|Run-in Period (8 Days)|Adverse Event|0|||
30605240|NCT00993499|58616186|FG003|Run-in Period (8 Days)|Adverse Event|0|||
30605241|NCT00993499|58616187|FG004|Run-in Period (8 Days)|Adverse Event|0|||
30605242|NCT00993499|58616188|FG005|Run-in Period (8 Days)|Adverse Event|0|||
30605243|NCT00993499|58616183|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
30605244|NCT00993499|58616184|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
30605245|NCT00993499|58616185|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
30605246|NCT00993499|58616186|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
30605247|NCT00993499|58616187|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
30605248|NCT00993499|58616188|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
30605249|NCT00993499|58616183|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
30605250|NCT00993499|58616184|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
30605251|NCT00993499|58616185|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
30605252|NCT00993499|58616186|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
30605253|NCT00993499|58616187|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
30605254|NCT00993499|58616188|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
30605255|NCT00993499|58616183|FG000|Run-in Period (8 Days)|Progressive disease|0|||
30605256|NCT00993499|58616184|FG001|Run-in Period (8 Days)|Progressive disease|1|||
30605257|NCT00993499|58616185|FG002|Run-in Period (8 Days)|Progressive disease|1|||
30605258|NCT00993499|58616186|FG003|Run-in Period (8 Days)|Progressive disease|0|||
30605259|NCT00993499|58616187|FG004|Run-in Period (8 Days)|Progressive disease|0|||
30605260|NCT00993499|58616188|FG005|Run-in Period (8 Days)|Progressive disease|0|||
30605261|NCT00993499|58616183|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
30605262|NCT00993499|58616184|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
30605263|NCT00993499|58616185|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
30605264|NCT00993499|58616186|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
30605265|NCT00993499|58616187|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
30605266|NCT00993499|58616188|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
30605267|NCT00993499|58616183|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
30605268|NCT00993499|58616184|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
30605269|NCT00993499|58616185|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
30605270|NCT00993499|58616186|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
30605271|NCT00993499|58616187|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
30605272|NCT00993499|58616188|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
30605273|NCT00993499|58616183|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
30605274|NCT00993499|58616184|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
30605275|NCT00993499|58616185|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
30605276|NCT00993499|58616186|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
30605277|NCT00993499|58616187|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
30605278|NCT00993499|58616188|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
30605279|NCT00993499|58616183|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
30605280|NCT00993499|58616184|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
30605281|NCT00993499|58616185|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
30605282|NCT00993499|58616186|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
30605283|NCT00993499|58616187|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
30605284|NCT00993499|58616188|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
30605285|NCT00993499|58616183|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
30605286|NCT00993499|58616184|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
30605287|NCT00993499|58616185|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
30605288|NCT00993499|58616186|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
30605289|NCT00993499|58616187|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
30605290|NCT00993499|58616188|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
30605291|NCT00993499|58616183|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
30605292|NCT00993499|58616184|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
30605293|NCT00993499|58616185|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
30605294|NCT00993499|58616186|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
30605295|NCT00993499|58616187|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
30605296|NCT00993499|58616188|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
30605297|NCT00993499|58616183|FG000|Discontinued After Starting Course 3|DLT|1|||
30605298|NCT00993499|58616184|FG001|Discontinued After Starting Course 3|DLT|0|||
30605299|NCT00993499|58616185|FG002|Discontinued After Starting Course 3|DLT|2|||
30605300|NCT00993499|58616186|FG003|Discontinued After Starting Course 3|DLT|1|||
30605301|NCT00993499|58616187|FG004|Discontinued After Starting Course 3|DLT|0|||
30605302|NCT00993499|58616188|FG005|Discontinued After Starting Course 3|DLT|0|||
30605303|NCT00993499|58616183|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
30605304|NCT00993499|58616184|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
30605305|NCT00993499|58616185|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
30605306|NCT00993499|58616186|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
30605307|NCT00993499|58616187|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
30605308|NCT00993499|58616188|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
30605309|NCT01014442|58616204|FG000|Overall Study|Adverse Event|0|||
30605310|NCT01014442|58616205|FG001|Overall Study|Adverse Event|8|||
30605311|NCT01014442|58616204|FG000|Overall Study|Withdrawal by Subject|4|||
30605312|NCT01014442|58616205|FG001|Overall Study|Withdrawal by Subject|4|||
30605313|NCT01014442|58616204|FG000|Overall Study|Protocol Violation|2|||
30605314|NCT01014442|58616205|FG001|Overall Study|Protocol Violation|5|||
30605315|NCT01014442|58616204|FG000|Overall Study|Lack of Compliance|0|||
30605316|NCT01014442|58616205|FG001|Overall Study|Lack of Compliance|1|||
30605317|NCT01014442|58616204|FG000|Overall Study|Unspecified Reason|1|||
30605318|NCT01014442|58616205|FG001|Overall Study|Unspecified Reason|1|||
30605319|NCT00996307|58616219|FG000|Overall Study|Adverse Event|0|||
30605320|NCT00996307|58616220|FG001|Overall Study|Adverse Event|1|||
30605321|NCT00996307|58616221|FG002|Overall Study|Adverse Event|0|||
30605322|NCT00996307|58616222|FG003|Overall Study|Adverse Event|0|||
30605323|NCT00996307|58616219|FG000|Overall Study|Withdrawal by Subject|3|||
30605324|NCT00996307|58616220|FG001|Overall Study|Withdrawal by Subject|2|||
30605325|NCT00996307|58616221|FG002|Overall Study|Withdrawal by Subject|5|||
30605326|NCT00996307|58616222|FG003|Overall Study|Withdrawal by Subject|5|||
30605327|NCT00996307|58616219|FG000|Overall Study|Lost to Follow-up|13|||
30605328|NCT00996307|58616220|FG001|Overall Study|Lost to Follow-up|13|||
30605329|NCT00996307|58616221|FG002|Overall Study|Lost to Follow-up|7|||
30605330|NCT00996307|58616222|FG003|Overall Study|Lost to Follow-up|15|||
30605331|NCT00996307|58616219|FG000|Overall Study|Administrative reason|0|||
30605332|NCT00996307|58616220|FG001|Overall Study|Administrative reason|1|||
30605333|NCT00996307|58616221|FG002|Overall Study|Administrative reason|0|||
30605334|NCT00996307|58616222|FG003|Overall Study|Administrative reason|0|||
30605335|NCT00996307|58616219|FG000|Overall Study|Unable to classify|4|||
30605336|NCT00996307|58616220|FG001|Overall Study|Unable to classify|0|||
30605337|NCT00996307|58616221|FG002|Overall Study|Unable to classify|2|||
30605338|NCT00996307|58616222|FG003|Overall Study|Unable to classify|1|||
30605339|NCT01219959|58616252|FG000|Overall Study|Adverse Event|6|||
30605340|NCT01219959|58616253|FG001|Overall Study|Adverse Event|14|||
30605341|NCT01219959|58616252|FG000|Overall Study|Physician Decision|0|||
30605342|NCT01219959|58616253|FG001|Overall Study|Physician Decision|4|||
30605343|NCT01219959|58616252|FG000|Overall Study|Withdrawal by Subject|0|||
30605344|NCT01219959|58616253|FG001|Overall Study|Withdrawal by Subject|2|||
30605345|NCT01219959|58616252|FG000|Overall Study|Renal Transplantation|0|||
30605346|NCT01219959|58616253|FG001|Overall Study|Renal Transplantation|3|||
30605347|NCT01219959|58616252|FG000|Overall Study|Other|1|||
30605348|NCT01219959|58616253|FG001|Overall Study|Other|0|||
30605349|NCT00993421|58616266|FG000|Overall Study|Adverse Event|2|||
30605350|NCT00993421|58616267|FG001|Overall Study|Adverse Event|7|||
30605351|NCT00993421|58616268|FG002|Overall Study|Adverse Event|6|||
30605352|NCT00993421|58616269|FG003|Overall Study|Adverse Event|9|||
30605353|NCT00993421|58616270|FG004|Overall Study|Adverse Event|5|||
30605354|NCT00993421|58616271|FG005|Overall Study|Adverse Event|7|||
30605355|NCT00993421|58616272|FG006|Overall Study|Adverse Event|1|||
30605356|NCT00993421|58616266|FG000|Overall Study|Sponsor Decision|36|||
30605357|NCT00993421|58616267|FG001|Overall Study|Sponsor Decision|31|||
30605358|NCT00993421|58616268|FG002|Overall Study|Sponsor Decision|28|||
30605359|NCT00993421|58616269|FG003|Overall Study|Sponsor Decision|30|||
30605360|NCT00993421|58616270|FG004|Overall Study|Sponsor Decision|38|||
30605361|NCT00993421|58616271|FG005|Overall Study|Sponsor Decision|30|||
30605362|NCT00993421|58616272|FG006|Overall Study|Sponsor Decision|29|||
30605363|NCT00993421|58616266|FG000|Overall Study|Lost to Follow-up|3|||
30605364|NCT00993421|58616267|FG001|Overall Study|Lost to Follow-up|5|||
30605365|NCT00993421|58616268|FG002|Overall Study|Lost to Follow-up|5|||
30605366|NCT00993421|58616269|FG003|Overall Study|Lost to Follow-up|0|||
30605367|NCT00993421|58616270|FG004|Overall Study|Lost to Follow-up|0|||
30605368|NCT00993421|58616271|FG005|Overall Study|Lost to Follow-up|0|||
30605369|NCT00993421|58616272|FG006|Overall Study|Lost to Follow-up|6|||
30605370|NCT00993421|58616266|FG000|Overall Study|Withdrawal by Subject|3|||
30605371|NCT00993421|58616267|FG001|Overall Study|Withdrawal by Subject|2|||
30605372|NCT00993421|58616268|FG002|Overall Study|Withdrawal by Subject|3|||
30605373|NCT00993421|58616269|FG003|Overall Study|Withdrawal by Subject|3|||
30605374|NCT00993421|58616270|FG004|Overall Study|Withdrawal by Subject|3|||
30605375|NCT00993421|58616271|FG005|Overall Study|Withdrawal by Subject|5|||
30605376|NCT00993421|58616272|FG006|Overall Study|Withdrawal by Subject|3|||
30605377|NCT00993421|58616266|FG000|Overall Study|Death|0|||
30605378|NCT00993421|58616267|FG001|Overall Study|Death|0|||
30605379|NCT00993421|58616268|FG002|Overall Study|Death|0|||
30605380|NCT00993421|58616269|FG003|Overall Study|Death|0|||
30605381|NCT00993421|58616270|FG004|Overall Study|Death|0|||
30605382|NCT00993421|58616271|FG005|Overall Study|Death|0|||
30605383|NCT00993421|58616272|FG006|Overall Study|Death|1|||
30605384|NCT00993421|58616266|FG000|Overall Study|Entry Criteria Exclusion|0|||
30605385|NCT00993421|58616267|FG001|Overall Study|Entry Criteria Exclusion|0|||
30605386|NCT00993421|58616268|FG002|Overall Study|Entry Criteria Exclusion|1|||
30605387|NCT00993421|58616269|FG003|Overall Study|Entry Criteria Exclusion|3|||
30605388|NCT00993421|58616270|FG004|Overall Study|Entry Criteria Exclusion|0|||
30605389|NCT00993421|58616271|FG005|Overall Study|Entry Criteria Exclusion|1|||
30605390|NCT00993421|58616272|FG006|Overall Study|Entry Criteria Exclusion|0|||
30605391|NCT00993421|58616266|FG000|Overall Study|Physician Decision|0|||
30605392|NCT00993421|58616267|FG001|Overall Study|Physician Decision|0|||
30605393|NCT00993421|58616268|FG002|Overall Study|Physician Decision|0|||
30605394|NCT00993421|58616269|FG003|Overall Study|Physician Decision|0|||
30605395|NCT00993421|58616270|FG004|Overall Study|Physician Decision|0|||
30605396|NCT00993421|58616271|FG005|Overall Study|Physician Decision|1|||
30605397|NCT00993421|58616272|FG006|Overall Study|Physician Decision|1|||
30605398|NCT00993421|58616266|FG000|Overall Study|Protocol Violation|0|||
30605399|NCT00993421|58616267|FG001|Overall Study|Protocol Violation|0|||
30605400|NCT00993421|58616268|FG002|Overall Study|Protocol Violation|0|||
30605401|NCT00993421|58616269|FG003|Overall Study|Protocol Violation|0|||
30605402|NCT00993421|58616270|FG004|Overall Study|Protocol Violation|0|||
30605403|NCT00993421|58616271|FG005|Overall Study|Protocol Violation|2|||
30605404|NCT00993421|58616272|FG006|Overall Study|Protocol Violation|1|||
30605405|NCT01014208|58616290|FG000|Overall Study|Lost to Follow-up|2|||
30605406|NCT01014208|58616291|FG001|Overall Study|Lost to Follow-up|5|||
30605407|NCT01014208|58616290|FG000|Overall Study|Participant Withdrew Consent|12|||
30605408|NCT01014208|58616291|FG001|Overall Study|Participant Withdrew Consent|12|||
30605409|NCT01014208|58616290|FG000|Overall Study|Did Not Receive Study Drug|2|||
30605410|NCT01014208|58616291|FG001|Overall Study|Did Not Receive Study Drug|0|||
30605411|NCT01014208|58616290|FG000|Overall Study|Study Closed/terminated|78|||
30605412|NCT01014208|58616291|FG001|Overall Study|Study Closed/terminated|83|||
30605413|NCT00991939|58616299|FG000|Overall Study|Lost to Follow-up|0|||
30964910|NCT01584440|59033489|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
30964911|NCT01584440|59033485|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
30964912|NCT01584440|59033486|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
30605414|NCT00991939|58616300|FG001|Overall Study|Lost to Follow-up|1|||
30605415|NCT00991939|58616299|FG000|Overall Study|Withdrawal by Subject|1|||
30605416|NCT00991939|58616300|FG001|Overall Study|Withdrawal by Subject|0|||
30605417|NCT00991939|58616299|FG000|Overall Study|Entire study terminated|4|||
30964913|NCT01584440|59033487|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
30605418|NCT00991939|58616300|FG001|Overall Study|Entire study terminated|1|||
30605419|NCT00993265|58616310|FG000|Overall Study|Adverse Event|1|||
30605420|NCT00993265|58616311|FG001|Overall Study|Adverse Event|0|||
30605421|NCT00993265|58616310|FG000|Overall Study|Changed dose of concomitant drug|2|||
30605422|NCT00993265|58616311|FG001|Overall Study|Changed dose of concomitant drug|0|||
30605423|NCT00993265|58616310|FG000|Overall Study|Non-compliant with study medication|1|||
30605424|NCT00993265|58616311|FG001|Overall Study|Non-compliant with study medication|0|||
30605425|NCT04211389|58616319|FG000|Overall Study|Adverse Event|1|||
30605426|NCT04211389|58616320|FG001|Overall Study|Adverse Event|2|||
30605427|NCT04211389|58616319|FG000|Overall Study|Lost to Follow-up|15|||
30605428|NCT04211389|58616320|FG001|Overall Study|Lost to Follow-up|7|||
30605429|NCT04211389|58616319|FG000|Overall Study|Protocol Violation|0|||
30605430|NCT04211389|58616320|FG001|Overall Study|Protocol Violation|1|||
30605431|NCT04211389|58616319|FG000|Overall Study|Withdrawal by Subject|10|||
30605432|NCT04211389|58616320|FG001|Overall Study|Withdrawal by Subject|11|||
30605433|NCT00993031|58616328|FG000|Overall Study|Death|0|||
30605434|NCT00993031|58616329|FG001|Overall Study|Death|1|||
30605435|NCT00993031|58616328|FG000|Overall Study|Physician Decision|0|||
30605436|NCT00993031|58616329|FG001|Overall Study|Physician Decision|2|||
30605437|NCT00993031|58616328|FG000|Overall Study|Withdrawal by Subject|3|||
30605438|NCT00993031|58616329|FG001|Overall Study|Withdrawal by Subject|3|||
30605439|NCT00993031|58616328|FG000|Overall Study|Lost to Follow-up|19|||
30605440|NCT00993031|58616329|FG001|Overall Study|Lost to Follow-up|13|||
30605441|NCT01010776|58616339|FG000|Main Phase|Withdrawal by Subject|14|||
30605442|NCT01010776|58616339|FG000|Main Phase|Lack of Efficacy|8|||
30605443|NCT01010776|58616339|FG000|Main Phase|Adverse Event|7|||
30605444|NCT01010776|58616339|FG000|Main Phase|Lost to Follow-up|6|||
30605445|NCT01010776|58616339|FG000|Main Phase|Non-compliance to study medication|5|||
30605446|NCT01010776|58616339|FG000|Main Phase|Selection failure|2|||
30605447|NCT01010776|58616339|FG000|Main Phase|Inform consent withdrawal|1|||
30605448|NCT01010776|58616339|FG000|Main Phase|Other|1|||
30605449|NCT01010776|58616339|FG000|Main Phase|Did not received study medication|5|||
30605450|NCT01010776|58616339|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
30605451|NCT01010776|58616339|FG000|Extension Phase|Other|3|||
30605452|NCT01018810|58616359|FG000|Overall Study|Withdrawal by Subject|0|||
30605453|NCT01018810|58616360|FG001|Overall Study|Withdrawal by Subject|1|||
30605454|NCT01018810|58616361|FG002|Overall Study|Withdrawal by Subject|0|||
30605455|NCT01018810|58616362|FG003|Overall Study|Withdrawal by Subject|0|||
30605456|NCT01018810|58616363|FG004|Overall Study|Withdrawal by Subject|0|||
30605457|NCT01018810|58616359|FG000|Overall Study|Sponsor Decision|2|||
30605458|NCT01018810|58616360|FG001|Overall Study|Sponsor Decision|0|||
30605459|NCT01018810|58616361|FG002|Overall Study|Sponsor Decision|1|||
30605460|NCT01018810|58616362|FG003|Overall Study|Sponsor Decision|1|||
30605461|NCT01018810|58616363|FG004|Overall Study|Sponsor Decision|1|||
30605462|NCT01018732|58616378|FG000|Overall Study|Lost to Follow-up|0|||
30605463|NCT01018732|58616379|FG001|Overall Study|Lost to Follow-up|0|||
30605464|NCT01018732|58616380|FG002|Overall Study|Lost to Follow-up|3|||
30605465|NCT01018732|58616378|FG000|Overall Study|Protocol Violation|1|||
30605466|NCT01018732|58616379|FG001|Overall Study|Protocol Violation|1|||
30605467|NCT01018732|58616380|FG002|Overall Study|Protocol Violation|0|||
30605468|NCT01018732|58616378|FG000|Overall Study|Inappropriate Enrollment|0|||
30605469|NCT01018732|58616379|FG001|Overall Study|Inappropriate Enrollment|1|||
30605470|NCT01018732|58616380|FG002|Overall Study|Inappropriate Enrollment|0|||
30605471|NCT01018732|58616378|FG000|Overall Study|Unable to Classify|0|||
30605472|NCT01018732|58616379|FG001|Overall Study|Unable to Classify|0|||
30605473|NCT01018732|58616380|FG002|Overall Study|Unable to Classify|1|||
30605474|NCT01218867|58616399|FG000|Overall Study|Death during treatment|0|||
30605475|NCT01218867|58616400|FG001|Overall Study|Death during treatment|0|||
30605476|NCT01218867|58616401|FG002|Overall Study|Death during treatment|0|||
30605477|NCT01218867|58616402|FG003|Overall Study|Death during treatment|0|||
30605478|NCT01218867|58616403|FG004|Overall Study|Death during treatment|0|||
30605479|NCT01218867|58616404|FG005|Overall Study|Death during treatment|0|||
30605480|NCT01218867|58616405|FG006|Overall Study|Death during treatment|1|||
30605481|NCT01218867|58616406|FG007|Overall Study|Death during treatment|0|||
30605482|NCT01218867|58616407|FG008|Overall Study|Death during treatment|0|||
30605483|NCT01218867|58616408|FG009|Overall Study|Death during treatment|0|||
30605484|NCT01218867|58616409|FG010|Overall Study|Death during treatment|0|||
30605485|NCT01018264|58616446|FG000|Overall Study|Withdrawal by Subject|1|||
30605486|NCT01018264|58616447|FG001|Overall Study|Withdrawal by Subject|0|||
30605487|NCT01018264|58616446|FG000|Overall Study|Lost to Follow-up|0|||
30605488|NCT01018264|58616447|FG001|Overall Study|Lost to Follow-up|1|||
30605489|NCT01018186|58616456|FG000|2-week Run-in Period|Protocol Violation|1|||
30605490|NCT01018186|58616457|FG001|2-week Run-in Period|Protocol Violation|0|||
30605491|NCT01018186|58616458|FG002|2-week Run-in Period|Protocol Violation|0|||
30605492|NCT01018186|58616459|FG003|2-week Run-in Period|Protocol Violation|0|||
30605493|NCT01018186|58616456|FG000|2-week Run-in Period|Lost to Follow-up|2|||
30605494|NCT01018186|58616457|FG001|2-week Run-in Period|Lost to Follow-up|0|||
30605495|NCT01018186|58616458|FG002|2-week Run-in Period|Lost to Follow-up|0|||
30605496|NCT01018186|58616459|FG003|2-week Run-in Period|Lost to Follow-up|0|||
30605497|NCT01018186|58616456|FG000|2-week Run-in Period|Physician Decision|3|||
30605498|NCT01018186|58616457|FG001|2-week Run-in Period|Physician Decision|0|||
30605499|NCT01018186|58616458|FG002|2-week Run-in Period|Physician Decision|0|||
30605500|NCT01018186|58616459|FG003|2-week Run-in Period|Physician Decision|0|||
30605501|NCT01018186|58616456|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
30605502|NCT01018186|58616457|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
30605503|NCT01018186|58616458|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
30605504|NCT01018186|58616459|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
30605505|NCT01018186|58616456|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
30605506|NCT01018186|58616457|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
30605507|NCT01018186|58616458|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
30605508|NCT01018186|58616459|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
30605509|NCT01018186|58616456|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
30605510|NCT01018186|58616457|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
30605511|NCT01018186|58616458|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
30605512|NCT01018186|58616459|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
30605513|NCT01018186|58616456|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
30605514|NCT01018186|58616457|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
30605515|NCT01018186|58616458|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
30605516|NCT01018186|58616459|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
30605517|NCT01018186|58616456|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
30605518|NCT01018186|58616457|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
30605519|NCT01018186|58616458|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
30605520|NCT01018186|58616459|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
30605521|NCT01018186|58616456|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
30605522|NCT01018186|58616457|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
30605523|NCT01018186|58616458|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
30605524|NCT01018186|58616459|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
30605525|NCT01018186|58616456|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
30605526|NCT01018186|58616457|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
30605527|NCT01018186|58616458|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
30605528|NCT01018186|58616459|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
30605529|NCT01018186|58616456|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
30605530|NCT01018186|58616457|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
30605531|NCT01018186|58616458|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
30605532|NCT01018186|58616459|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
30605533|NCT01018186|58616456|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
30605534|NCT01018186|58616457|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
30605535|NCT01018186|58616458|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
30605536|NCT01018186|58616459|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
30605537|NCT00987337|58616474|FG000|Overall Study|Adverse Event|10|||
30605538|NCT00987337|58616475|FG001|Overall Study|Adverse Event|9|||
30605539|NCT00987337|58616476|FG002|Overall Study|Adverse Event|8|||
30605540|NCT00987337|58616474|FG000|Overall Study|Insufficient Virologic Response|10|||
30605541|NCT00987337|58616475|FG001|Overall Study|Insufficient Virologic Response|7|||
30605542|NCT00987337|58616476|FG002|Overall Study|Insufficient Virologic Response|12|||
30605543|NCT00987337|58616474|FG000|Overall Study|Virologic Breakthrough|2|||
30605544|NCT00987337|58616475|FG001|Overall Study|Virologic Breakthrough|2|||
30605545|NCT00987337|58616476|FG002|Overall Study|Virologic Breakthrough|8|||
30605546|NCT00987337|58616474|FG000|Overall Study|Lost to Follow-up|10|||
30605547|NCT00987337|58616475|FG001|Overall Study|Lost to Follow-up|6|||
30605548|NCT00987337|58616476|FG002|Overall Study|Lost to Follow-up|2|||
30605549|NCT00987337|58616474|FG000|Overall Study|Withdrawal by Subject|6|||
30605550|NCT00987337|58616475|FG001|Overall Study|Withdrawal by Subject|9|||
30605551|NCT00987337|58616476|FG002|Overall Study|Withdrawal by Subject|9|||
30605552|NCT00987337|58616474|FG000|Overall Study|Other|0|||
30605553|NCT00987337|58616475|FG001|Overall Study|Other|2|||
30605554|NCT00987337|58616476|FG002|Overall Study|Other|5|||
30605555|NCT00987337|58616474|FG000|Overall Study|Protocol Violation|1|||
30605556|NCT00987337|58616475|FG001|Overall Study|Protocol Violation|0|||
30605557|NCT00987337|58616476|FG002|Overall Study|Protocol Violation|2|||
30605558|NCT00987337|58616474|FG000|Overall Study|Participant Relapsed|18|||
30605559|NCT00987337|58616475|FG001|Overall Study|Participant Relapsed|20|||
30605560|NCT00987337|58616476|FG002|Overall Study|Participant Relapsed|5|||
30605561|NCT00992407|58616488|FG000|Overall Study|Protocol Violation|2|||
30605562|NCT00992407|58616489|FG001|Overall Study|Protocol Violation|1|||
30605563|NCT00992407|58616488|FG000|Overall Study|Lost to Follow-up|3|||
30605564|NCT00992407|58616489|FG001|Overall Study|Lost to Follow-up|3|||
30605565|NCT00992407|58616488|FG000|Overall Study|Adverse Event|3|||
30605566|NCT00992407|58616489|FG001|Overall Study|Adverse Event|2|||
30605567|NCT00992407|58616488|FG000|Overall Study|protocol Violation & Adverse events|2|||
30605568|NCT00992407|58616489|FG001|Overall Study|protocol Violation & Adverse events|4|||
30605569|NCT00992407|58616488|FG000|Overall Study|Other|2|||
30605570|NCT00992407|58616489|FG001|Overall Study|Other|0|||
30605571|NCT00992407|58616488|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
30605572|NCT00992407|58616489|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
30605573|NCT00992407|58616488|FG000|Overall Study|Study medication not administered|17|||
30605574|NCT00992407|58616489|FG001|Overall Study|Study medication not administered|13|||
30605575|NCT00986479|58616500|FG000|Period 1|Improved mood|1|||
30605576|NCT00986479|58616501|FG001|Period 1|Improved mood|0|||
30605577|NCT00986479|58616500|FG000|Period 1|Administrative reasons|1|||
30605578|NCT00986479|58616501|FG001|Period 1|Administrative reasons|0|||
30605579|NCT00986245|58616507|FG000|First Intervention|Poor compliance|8|||
30605580|NCT00986245|58616508|FG001|First Intervention|Poor compliance|4|||
30605581|NCT00986245|58616507|FG000|First Intervention|Lack of Efficacy|1|||
30605582|NCT00986245|58616508|FG001|First Intervention|Lack of Efficacy|2|||
30605583|NCT00986245|58616507|FG000|First Intervention|Withdrawal by Subject|0|||
30605584|NCT00986245|58616508|FG001|First Intervention|Withdrawal by Subject|1|||
30605585|NCT00986245|58616507|FG000|First Intervention|Protocol Violation|0|||
30605586|NCT00986245|58616508|FG001|First Intervention|Protocol Violation|1|||
30605587|NCT00986245|58616507|FG000|First Intervention|Out of indication|1|||
30605588|NCT00986245|58616508|FG001|First Intervention|Out of indication|0|||
30605589|NCT00986245|58616507|FG000|Second Intervention|Poor compliance|1|||
30605590|NCT00986245|58616508|FG001|Second Intervention|Poor compliance|0|||
30605591|NCT00986245|58616507|FG000|Second Intervention|Lost to Follow-up|1|||
30605592|NCT00986245|58616508|FG001|Second Intervention|Lost to Follow-up|0|||
30605593|NCT00986245|58616507|FG000|Second Intervention|Protocol Violation|0|||
30605594|NCT00986245|58616508|FG001|Second Intervention|Protocol Violation|1|||
30605595|NCT00989833|58616522|FG000|Overall Study|Lost to Follow-up|0|||
30605596|NCT00989833|58616523|FG001|Overall Study|Lost to Follow-up|1|||
30605597|NCT00989833|58616524|FG002|Overall Study|Lost to Follow-up|0|||
30605598|NCT00989833|58616522|FG000|Overall Study|Protocol Violation|1|||
30605599|NCT00989833|58616523|FG001|Overall Study|Protocol Violation|2|||
30605600|NCT00989833|58616524|FG002|Overall Study|Protocol Violation|1|||
30605601|NCT00989833|58616522|FG000|Overall Study|Withdrawal by Subject|0|||
30605602|NCT00989833|58616523|FG001|Overall Study|Withdrawal by Subject|0|||
30605603|NCT00989833|58616524|FG002|Overall Study|Withdrawal by Subject|1|||
30605604|NCT00989833|58616522|FG000|Overall Study|Incorrectly randomized|1|||
30605605|NCT00989833|58616523|FG001|Overall Study|Incorrectly randomized|0|||
30605606|NCT00989833|58616524|FG002|Overall Study|Incorrectly randomized|0|||
30605607|NCT01218477|58616536|FG000|Overall Study|Disease progression|2|||
30605608|NCT01218477|58616537|FG001|Overall Study|Disease progression|3|||
30605609|NCT01218477|58616538|FG002|Overall Study|Disease progression|6|||
30605610|NCT01218477|58616539|FG003|Overall Study|Disease progression|2|||
30605611|NCT01218477|58616536|FG000|Overall Study|Study drug toxicity|0|||
30605612|NCT01218477|58616537|FG001|Overall Study|Study drug toxicity|2|||
30605613|NCT01218477|58616538|FG002|Overall Study|Study drug toxicity|5|||
30605614|NCT01218477|58616539|FG003|Overall Study|Study drug toxicity|0|||
30605615|NCT01218477|58616536|FG000|Overall Study|No longer meets study criteria|1|||
30605616|NCT01218477|58616537|FG001|Overall Study|No longer meets study criteria|0|||
30605617|NCT01218477|58616538|FG002|Overall Study|No longer meets study criteria|0|||
30605618|NCT01218477|58616539|FG003|Overall Study|No longer meets study criteria|0|||
30964914|NCT01584440|59033488|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
30964915|NCT01584440|59033489|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
30964916|NCT01584440|59033485|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
30964917|NCT01584440|59033486|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
30964918|NCT01584440|59033487|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
30964919|NCT01584440|59033488|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
30964920|NCT01584440|59033489|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
30964921|NCT01687478|59033504|FG000|Overall Study|Adverse Event|3|||
30964922|NCT01687478|59033505|FG001|Overall Study|Adverse Event|10|||
30964923|NCT01687478|59033504|FG000|Overall Study|Lost to Follow-up|1|||
30964924|NCT01687478|59033505|FG001|Overall Study|Lost to Follow-up|3|||
30964925|NCT01687478|59033504|FG000|Overall Study|Protocol Violation|0|||
30964926|NCT01687478|59033505|FG001|Overall Study|Protocol Violation|2|||
30964927|NCT01687478|59033504|FG000|Overall Study|Withdrawal by Subject|21|||
30964928|NCT01687478|59033505|FG001|Overall Study|Withdrawal by Subject|19|||
30964929|NCT01687478|59033504|FG000|Overall Study|Physician Decision|1|||
30605619|NCT01218477|58616536|FG000|Overall Study|Withdrawal by Subject|0|||
30605620|NCT01218477|58616537|FG001|Overall Study|Withdrawal by Subject|0|||
30605621|NCT01218477|58616538|FG002|Overall Study|Withdrawal by Subject|1|||
30964930|NCT01687478|59033505|FG001|Overall Study|Physician Decision|3|||
30964931|NCT01687478|59033504|FG000|Overall Study|Entry Criteria Not Met|6|||
30605622|NCT01218477|58616539|FG003|Overall Study|Withdrawal by Subject|0|||
30964932|NCT01687478|59033505|FG001|Overall Study|Entry Criteria Not Met|2|||
30964933|NCT01468909|59033513|FG000|Overall Study|Never Treated|2|||
30964934|NCT01468909|59033514|FG001|Overall Study|Never Treated|2|||
30964935|NCT01468597|59033520|FG000|Overall Study|Found ineligible|17|||
30964936|NCT01468597|59033520|FG000|Overall Study|concomitant valves|12|||
30964937|NCT01468597|59033520|FG000|Overall Study|off-pump CABG|1|||
30964938|NCT01468597|59033520|FG000|Overall Study|no platelet function data|5|||
30964939|NCT01687166|59033528|FG000|Overall Study|Attempt subject|2|||
30964940|NCT01687166|59033529|FG001|Overall Study|Attempt subject|3|||
30964941|NCT01687166|59033530|FG002|Overall Study|Attempt subject|2|||
30964942|NCT01687166|59033531|FG003|Overall Study|Attempt subject|0|||
30964943|NCT01687166|59033528|FG000|Overall Study|Did not meet eligibility criteria|4|||
30964944|NCT01687166|59033529|FG001|Overall Study|Did not meet eligibility criteria|6|||
30964945|NCT01687166|59033530|FG002|Overall Study|Did not meet eligibility criteria|1|||
30964946|NCT01687166|59033531|FG003|Overall Study|Did not meet eligibility criteria|1|||
30964947|NCT01687166|59033528|FG000|Overall Study|Adverse Event|2|||
30964948|NCT01687166|59033529|FG001|Overall Study|Adverse Event|1|||
30964949|NCT01687166|59033530|FG002|Overall Study|Adverse Event|0|||
30964950|NCT01687166|59033531|FG003|Overall Study|Adverse Event|0|||
30964951|NCT01687166|59033528|FG000|Overall Study|Physician Decision|3|||
30964952|NCT01687166|59033529|FG001|Overall Study|Physician Decision|2|||
30964953|NCT01687166|59033530|FG002|Overall Study|Physician Decision|1|||
30964954|NCT01687166|59033531|FG003|Overall Study|Physician Decision|0|||
30964955|NCT01687166|59033528|FG000|Overall Study|Withdrawal by Subject|11|||
30964956|NCT01687166|59033529|FG001|Overall Study|Withdrawal by Subject|4|||
30964957|NCT01687166|59033530|FG002|Overall Study|Withdrawal by Subject|3|||
30964958|NCT01687166|59033531|FG003|Overall Study|Withdrawal by Subject|0|||
30964959|NCT01687166|59033528|FG000|Overall Study|Lost to Follow-up|2|||
30964960|NCT01687166|59033529|FG001|Overall Study|Lost to Follow-up|5|||
30964961|NCT01687166|59033530|FG002|Overall Study|Lost to Follow-up|1|||
30964962|NCT01687166|59033531|FG003|Overall Study|Lost to Follow-up|0|||
30964963|NCT01687166|59033528|FG000|Overall Study|Equipment/Device Availability|0|||
30964964|NCT01687166|59033529|FG001|Overall Study|Equipment/Device Availability|1|||
30964965|NCT01687166|59033530|FG002|Overall Study|Equipment/Device Availability|0|||
30964966|NCT01687166|59033531|FG003|Overall Study|Equipment/Device Availability|0|||
30964967|NCT01687166|59033528|FG000|Overall Study|Death|1|||
30964968|NCT01687166|59033529|FG001|Overall Study|Death|1|||
30964969|NCT01687166|59033530|FG002|Overall Study|Death|0|||
30964970|NCT01687166|59033531|FG003|Overall Study|Death|0|||
30964971|NCT01687166|59033528|FG000|Overall Study|Protocol Violation|1|||
30964972|NCT01687166|59033529|FG001|Overall Study|Protocol Violation|1|||
30964973|NCT01687166|59033530|FG002|Overall Study|Protocol Violation|1|||
30964974|NCT01687166|59033531|FG003|Overall Study|Protocol Violation|0|||
30964975|NCT01687166|59033528|FG000|Overall Study|Subject moved out of state|0|||
30964976|NCT01687166|59033529|FG001|Overall Study|Subject moved out of state|1|||
30964977|NCT01687166|59033530|FG002|Overall Study|Subject moved out of state|0|||
30964978|NCT01687166|59033531|FG003|Overall Study|Subject moved out of state|0|||
30964979|NCT01687166|59033528|FG000|Overall Study|Patient unable to be compliant|1|||
30964980|NCT01687166|59033529|FG001|Overall Study|Patient unable to be compliant|0|||
30964981|NCT01687166|59033530|FG002|Overall Study|Patient unable to be compliant|0|||
30964982|NCT01687166|59033531|FG003|Overall Study|Patient unable to be compliant|0|||
30964983|NCT01687166|59033528|FG000|Overall Study|Physician choice to use different device|1|||
30964984|NCT01687166|59033529|FG001|Overall Study|Physician choice to use different device|2|||
30964985|NCT01687166|59033530|FG002|Overall Study|Physician choice to use different device|4|||
30964986|NCT01687166|59033531|FG003|Overall Study|Physician choice to use different device|0|||
30605623|NCT01218477|58616536|FG000|Overall Study|Prepared for cell transplantation|0|||
30605624|NCT01218477|58616537|FG001|Overall Study|Prepared for cell transplantation|1|||
30605625|NCT01218477|58616538|FG002|Overall Study|Prepared for cell transplantation|1|||
30605626|NCT01218477|58616539|FG003|Overall Study|Prepared for cell transplantation|0|||
30605627|NCT01218477|58616536|FG000|Overall Study|Administrative reason by sponsor|0|||
30605628|NCT01218477|58616537|FG001|Overall Study|Administrative reason by sponsor|0|||
30605629|NCT01218477|58616538|FG002|Overall Study|Administrative reason by sponsor|1|||
30605630|NCT01218477|58616539|FG003|Overall Study|Administrative reason by sponsor|0|||
30605631|NCT01218477|58616536|FG000|Overall Study|Maximum clinical benefit|0|||
30605632|NCT01218477|58616537|FG001|Overall Study|Maximum clinical benefit|2|||
30605633|NCT01218477|58616538|FG002|Overall Study|Maximum clinical benefit|0|||
30605634|NCT01218477|58616539|FG003|Overall Study|Maximum clinical benefit|0|||
30605635|NCT01218243|58616555|FG000|Overall Study|Lack of Efficacy|1|||
30605636|NCT01218243|58616556|FG001|Overall Study|Lack of Efficacy|1|||
30964987|NCT01687166|59033528|FG000|Overall Study|Insurance|0|||
30964988|NCT01687166|59033529|FG001|Overall Study|Insurance|0|||
30964989|NCT01687166|59033530|FG002|Overall Study|Insurance|1|||
30964990|NCT01687166|59033531|FG003|Overall Study|Insurance|1|||
30964991|NCT01561976|59033545|FG000|Period 1|Adverse Event|0|||
30964992|NCT01561976|59033546|FG001|Period 1|Adverse Event|0|||
30964993|NCT01561976|59033547|FG002|Period 1|Adverse Event|1|||
30964994|NCT01561976|59033548|FG003|Period 1|Adverse Event|0|||
30964995|NCT01561976|59033549|FG004|Period 1|Adverse Event|0|||
30964996|NCT01561976|59033550|FG005|Period 1|Adverse Event|0|||
30605637|NCT01218243|58616555|FG000|Overall Study|Lost to Follow-up|3|||
30605638|NCT01218243|58616556|FG001|Overall Study|Lost to Follow-up|3|||
30605639|NCT01218243|58616555|FG000|Overall Study|Protocol Violation|5|||
30605640|NCT01218243|58616556|FG001|Overall Study|Protocol Violation|10|||
30605641|NCT00989287|58616564|FG000|Overall Study|Adverse Event|1|||
30605642|NCT00989287|58616565|FG001|Overall Study|Adverse Event|0|||
30605643|NCT00989287|58616564|FG000|Overall Study|Lost to Follow-up|0|||
30605644|NCT00989287|58616565|FG001|Overall Study|Lost to Follow-up|1|||
30605645|NCT01218087|58616586|FG000|Overall Study|Death|2|||
30605646|NCT01218087|58616587|FG001|Overall Study|Death|1|||
30605647|NCT01218087|58616586|FG000|Overall Study|Withdrawal by Subject|5|||
30605648|NCT01218087|58616587|FG001|Overall Study|Withdrawal by Subject|0|||
30605649|NCT01218087|58616586|FG000|Overall Study|Transferred|8|||
30605650|NCT01218087|58616587|FG001|Overall Study|Transferred|5|||
30605651|NCT01218009|58616595|FG000|Overall Study|Protocol Violation|2|||
30605652|NCT01218009|58616596|FG001|Overall Study|Protocol Violation|1|||
30605653|NCT01218009|58616595|FG000|Overall Study|Withdrawal by Subject|3|||
30605654|NCT01218009|58616596|FG001|Overall Study|Withdrawal by Subject|1|||
30605655|NCT01218009|58616595|FG000|Overall Study|Sponsor terminated study|161|||
30605656|NCT01218009|58616596|FG001|Overall Study|Sponsor terminated study|163|||
30605657|NCT00992017|58616602|FG000|Overall Study|Lost to Follow-up|2|||
30605658|NCT00992017|58616602|FG000|Overall Study|Withdrawal by Subject|2|||
30605659|NCT00992017|58616602|FG000|Overall Study|Unable to get to clinic|5|||
30605660|NCT00992017|58616602|FG000|Overall Study|Not adhere to study requirements|1|||
30605661|NCT01217463|58616613|FG000|Overall Study|Adverse Event|8|||
30605662|NCT01217463|58616614|FG001|Overall Study|Adverse Event|5|||
30605663|NCT01217463|58616613|FG000|Overall Study|Physician Decision|0|||
30605664|NCT01217463|58616614|FG001|Overall Study|Physician Decision|1|||
30605665|NCT01217463|58616613|FG000|Overall Study|Withdrawal by Subject|3|||
30605666|NCT01217463|58616614|FG001|Overall Study|Withdrawal by Subject|0|||
30605667|NCT01217463|58616613|FG000|Overall Study|Surgery on the Target Limb|0|||
30605668|NCT01217463|58616614|FG001|Overall Study|Surgery on the Target Limb|1|||
30605669|NCT01217463|58616613|FG000|Overall Study|Patient Non-compliant|1|||
30605670|NCT01217463|58616614|FG001|Overall Study|Patient Non-compliant|0|||
30605671|NCT01217463|58616613|FG000|Overall Study|Other|1|||
30605672|NCT01217463|58616614|FG001|Overall Study|Other|1|||
30605673|NCT01217307|58616624|FG000|Overall Study|Withdrawal by Subject|0|||
30605674|NCT01217307|58616625|FG001|Overall Study|Withdrawal by Subject|1|||
30605675|NCT01217229|58616631|FG000|Overall Study|Adverse Event|1|||
30605676|NCT01217229|58616631|FG000|Overall Study|Disease progression, deterioration|2|||
30605677|NCT01217229|58616631|FG000|Overall Study|Disease progression, Cheson criteria|14|||
30605678|NCT01217229|58616631|FG000|Overall Study|Protocol Violation|1|||
30605679|NCT01217229|58616631|FG000|Overall Study|Disease progression not confirmed|2|||
30605680|NCT01013740|58616637|FG000|Overall Study|Lost to Follow-up|3|||
30605681|NCT01013740|58616638|FG001|Overall Study|Lost to Follow-up|5|||
30605682|NCT01013740|58616637|FG000|Overall Study|Physician Decision|2|||
30605683|NCT01013740|58616638|FG001|Overall Study|Physician Decision|0|||
30605684|NCT01013740|58616637|FG000|Overall Study|Withdrawal by Subject|2|||
30605685|NCT01013740|58616638|FG001|Overall Study|Withdrawal by Subject|10|||
30605686|NCT01013740|58616637|FG000|Overall Study|study close / terminated : done in error|2|||
30605687|NCT01013740|58616638|FG001|Overall Study|study close / terminated : done in error|1|||
30605688|NCT01013740|58616637|FG000|Overall Study|Missing|2|||
30605689|NCT01013740|58616638|FG001|Overall Study|Missing|1|||
30605690|NCT01013740|58616637|FG000|Overall Study|Ongoing: Study records not completed|0|||
30605691|NCT01013740|58616638|FG001|Overall Study|Ongoing: Study records not completed|2|||
30605692|NCT01013350|58616648|FG000|Overall Study|Lost to Follow-up|15|||
30605693|NCT01013350|58616649|FG001|Overall Study|Lost to Follow-up|95|||
30605694|NCT01013350|58616648|FG000|Overall Study|Adverse Event|0|||
30605695|NCT01013350|58616649|FG001|Overall Study|Adverse Event|1|||
30605696|NCT01013350|58616648|FG000|Overall Study|Physician Decision|4|||
30605697|NCT01013350|58616649|FG001|Overall Study|Physician Decision|20|||
30605698|NCT01013350|58616648|FG000|Overall Study|Withdrawal by Subject|15|||
30605699|NCT01013350|58616649|FG001|Overall Study|Withdrawal by Subject|38|||
30605700|NCT01013350|58616648|FG000|Overall Study|Death|3|||
30605701|NCT01013350|58616649|FG001|Overall Study|Death|5|||
30605702|NCT01013350|58616648|FG000|Overall Study|Participant entered interventional study|0|||
30605703|NCT01013350|58616649|FG001|Overall Study|Participant entered interventional study|8|||
30605704|NCT01013350|58616648|FG000|Overall Study|Other|1|||
30605705|NCT01013350|58616649|FG001|Overall Study|Other|25|||
30605706|NCT01018030|58616659|FG000|Overall Study|Adverse Event|10|||
30605707|NCT01018030|58616660|FG001|Overall Study|Adverse Event|5|||
30605708|NCT01018030|58616661|FG002|Overall Study|Adverse Event|5|||
30605709|NCT01018030|58616659|FG000|Overall Study|Withdrawal by Subject|2|||
30605710|NCT01018030|58616660|FG001|Overall Study|Withdrawal by Subject|2|||
30605711|NCT01018030|58616661|FG002|Overall Study|Withdrawal by Subject|4|||
30605712|NCT01018030|58616659|FG000|Overall Study|Lost to Follow-up|2|||
30605713|NCT01018030|58616660|FG001|Overall Study|Lost to Follow-up|0|||
30605714|NCT01018030|58616661|FG002|Overall Study|Lost to Follow-up|3|||
30605715|NCT01018030|58616659|FG000|Overall Study|Protocol Violation|2|||
30605716|NCT01018030|58616660|FG001|Overall Study|Protocol Violation|1|||
30605717|NCT01018030|58616661|FG002|Overall Study|Protocol Violation|0|||
30605718|NCT01018030|58616659|FG000|Overall Study|Physician Decision|1|||
30605719|NCT01018030|58616660|FG001|Overall Study|Physician Decision|0|||
30605720|NCT01018030|58616661|FG002|Overall Study|Physician Decision|1|||
30605721|NCT01018030|58616659|FG000|Overall Study|Lack of Efficacy|1|||
30605722|NCT01018030|58616660|FG001|Overall Study|Lack of Efficacy|0|||
30605723|NCT01018030|58616661|FG002|Overall Study|Lack of Efficacy|0|||
30605724|NCT01018030|58616659|FG000|Overall Study|Did Not Receive Study Drug|1|||
30605725|NCT01018030|58616660|FG001|Overall Study|Did Not Receive Study Drug|3|||
30605726|NCT01018030|58616661|FG002|Overall Study|Did Not Receive Study Drug|0|||
30605727|NCT01217073|58616677|FG000|Base Period|Adverse Event|1|||
30605728|NCT01217073|58616678|FG001|Base Period|Adverse Event|0|||
30605729|NCT01217073|58616679|FG002|Base Period|Adverse Event|1|||
30605730|NCT01217073|58616680|FG003|Base Period|Adverse Event|0|||
30605731|NCT01217073|58616681|FG004|Base Period|Adverse Event|4|||
30605732|NCT01217073|58616682|FG005|Base Period|Adverse Event|1|||
30605733|NCT01217073|58616683|FG006|Base Period|Adverse Event|0|||
30605734|NCT01217073|58616684|FG007|Base Period|Adverse Event|0|||
30605735|NCT01217073|58616677|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
30605736|NCT01217073|58616678|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
30605737|NCT01217073|58616679|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
30605738|NCT01217073|58616680|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
30605739|NCT01217073|58616681|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
30605740|NCT01217073|58616682|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
30605741|NCT01217073|58616683|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
30605742|NCT01217073|58616684|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
30605743|NCT01217073|58616677|FG000|Base Period|Excluded medication|0|||
30605744|NCT01217073|58616678|FG001|Base Period|Excluded medication|0|||
30605745|NCT01217073|58616679|FG002|Base Period|Excluded medication|0|||
30605746|NCT01217073|58616680|FG003|Base Period|Excluded medication|0|||
30605747|NCT01217073|58616681|FG004|Base Period|Excluded medication|1|||
30605748|NCT01217073|58616682|FG005|Base Period|Excluded medication|0|||
30605749|NCT01217073|58616683|FG006|Base Period|Excluded medication|0|||
30605750|NCT01217073|58616684|FG007|Base Period|Excluded medication|0|||
30605751|NCT01217073|58616677|FG000|Base Period|Lack of Efficacy|0|||
30605752|NCT01217073|58616678|FG001|Base Period|Lack of Efficacy|0|||
30605753|NCT01217073|58616679|FG002|Base Period|Lack of Efficacy|0|||
30605754|NCT01217073|58616680|FG003|Base Period|Lack of Efficacy|0|||
30605755|NCT01217073|58616681|FG004|Base Period|Lack of Efficacy|0|||
30605756|NCT01217073|58616682|FG005|Base Period|Lack of Efficacy|1|||
30605757|NCT01217073|58616683|FG006|Base Period|Lack of Efficacy|0|||
30605758|NCT01217073|58616684|FG007|Base Period|Lack of Efficacy|0|||
30605759|NCT01217073|58616677|FG000|Base Period|Lost to Follow-up|0|||
30605760|NCT01217073|58616678|FG001|Base Period|Lost to Follow-up|0|||
30605761|NCT01217073|58616679|FG002|Base Period|Lost to Follow-up|1|||
30605762|NCT01217073|58616680|FG003|Base Period|Lost to Follow-up|1|||
30605763|NCT01217073|58616681|FG004|Base Period|Lost to Follow-up|3|||
30605764|NCT01217073|58616682|FG005|Base Period|Lost to Follow-up|0|||
30605765|NCT01217073|58616683|FG006|Base Period|Lost to Follow-up|0|||
30605766|NCT01217073|58616684|FG007|Base Period|Lost to Follow-up|0|||
30605767|NCT01217073|58616677|FG000|Base Period|Physician Decision|0|||
30605768|NCT01217073|58616678|FG001|Base Period|Physician Decision|0|||
30605769|NCT01217073|58616679|FG002|Base Period|Physician Decision|0|||
30605770|NCT01217073|58616680|FG003|Base Period|Physician Decision|0|||
30605771|NCT01217073|58616681|FG004|Base Period|Physician Decision|1|||
30605772|NCT01217073|58616682|FG005|Base Period|Physician Decision|0|||
30605773|NCT01217073|58616683|FG006|Base Period|Physician Decision|0|||
30605774|NCT01217073|58616684|FG007|Base Period|Physician Decision|0|||
30605775|NCT01217073|58616677|FG000|Base Period|Protocol Violation|1|||
30605776|NCT01217073|58616678|FG001|Base Period|Protocol Violation|0|||
30605777|NCT01217073|58616679|FG002|Base Period|Protocol Violation|0|||
30605778|NCT01217073|58616680|FG003|Base Period|Protocol Violation|0|||
30876229|NCT01960114|58907392|FG000|Overall Study|Could not swallow study medication|0|||
30876230|NCT01960114|58907393|FG001|Overall Study|Could not swallow study medication|1|||
30876231|NCT02005276|58907403|FG000|Overall Study|No longer interested|5|||
30876232|NCT02005276|58907404|FG001|Overall Study|No longer interested|2|||
30876233|NCT02005276|58907405|FG002|Overall Study|No longer interested|3|||
30876234|NCT02005276|58907406|FG003|Overall Study|No longer interested|3|||
30876235|NCT01980706|58907421|FG000|Overall Study|Withdrawal by Subject|9|||
30876236|NCT01980706|58907422|FG001|Overall Study|Withdrawal by Subject|6|||
30876237|NCT01980706|58907423|FG002|Overall Study|Withdrawal by Subject|2|||
30876238|NCT01980706|58907421|FG000|Overall Study|Adverse Event|1|||
30876239|NCT01980706|58907422|FG001|Overall Study|Adverse Event|2|||
30605779|NCT01217073|58616681|FG004|Base Period|Protocol Violation|1|||
30605780|NCT01217073|58616682|FG005|Base Period|Protocol Violation|2|||
30605781|NCT01217073|58616683|FG006|Base Period|Protocol Violation|0|||
30605782|NCT01217073|58616684|FG007|Base Period|Protocol Violation|0|||
30876240|NCT01980706|58907423|FG002|Overall Study|Adverse Event|5|||
30876241|NCT01980706|58907421|FG000|Overall Study|Lost to Follow-up|3|||
30876242|NCT01980706|58907422|FG001|Overall Study|Lost to Follow-up|4|||
30876243|NCT01980706|58907423|FG002|Overall Study|Lost to Follow-up|3|||
30876244|NCT01980706|58907421|FG000|Overall Study|miscellaneous|4|||
30876245|NCT01980706|58907422|FG001|Overall Study|miscellaneous|5|||
30876246|NCT01980706|58907423|FG002|Overall Study|miscellaneous|3|||
30876247|NCT02692417|58907433|FG000|Overall Study|Withdrawal by Subject|5|||
30876248|NCT02692417|58907434|FG001|Overall Study|Withdrawal by Subject|1|||
30876249|NCT02692417|58907433|FG000|Overall Study|Adverse Event|1|||
30876250|NCT02692417|58907434|FG001|Overall Study|Adverse Event|0|||
30876251|NCT02004886|58907444|FG000|Overall Study|Adverse Event|0|||
30876252|NCT02004886|58907445|FG001|Overall Study|Adverse Event|1|||
30876253|NCT02004886|58907446|FG002|Overall Study|Adverse Event|0|||
30876254|NCT02004886|58907447|FG003|Overall Study|Adverse Event|0|||
30876255|NCT02004886|58907444|FG000|Overall Study|Unable to attend future visits|1|||
30876256|NCT02004886|58907445|FG001|Overall Study|Unable to attend future visits|0|||
30876257|NCT02004886|58907446|FG002|Overall Study|Unable to attend future visits|0|||
30876258|NCT02004886|58907447|FG003|Overall Study|Unable to attend future visits|0|||
30876259|NCT01959880|58907461|FG000|Overall Study|Withdrawal by Subject|11|||
30876260|NCT01959880|58907462|FG001|Overall Study|Withdrawal by Subject|13|||
30876261|NCT01959880|58907463|FG002|Overall Study|Withdrawal by Subject|8|||
30876262|NCT01959880|58907464|FG003|Overall Study|Withdrawal by Subject|7|||
30876263|NCT01959880|58907461|FG000|Overall Study|Death|1|||
30876264|NCT01959880|58907462|FG001|Overall Study|Death|10|||
30876265|NCT01959880|58907463|FG002|Overall Study|Death|1|||
30876266|NCT01959880|58907464|FG003|Overall Study|Death|2|||
30876267|NCT01959880|58907461|FG000|Overall Study|Lost to Follow-up|95|||
30876268|NCT01959880|58907462|FG001|Overall Study|Lost to Follow-up|18|||
30876269|NCT01959880|58907463|FG002|Overall Study|Lost to Follow-up|15|||
30605783|NCT01217073|58616677|FG000|Base Period|Withdrawal by Subject|4|||
30605784|NCT01217073|58616678|FG001|Base Period|Withdrawal by Subject|5|||
30605785|NCT01217073|58616679|FG002|Base Period|Withdrawal by Subject|5|||
30605786|NCT01217073|58616680|FG003|Base Period|Withdrawal by Subject|1|||
30605787|NCT01217073|58616681|FG004|Base Period|Withdrawal by Subject|5|||
30605788|NCT01217073|58616682|FG005|Base Period|Withdrawal by Subject|5|||
30605789|NCT01217073|58616683|FG006|Base Period|Withdrawal by Subject|0|||
30605790|NCT01217073|58616684|FG007|Base Period|Withdrawal by Subject|0|||
30605791|NCT01217073|58616677|FG000|Extension Period|Adverse Event|0|||
30605792|NCT01217073|58616678|FG001|Extension Period|Adverse Event|0|||
30605793|NCT01217073|58616679|FG002|Extension Period|Adverse Event|0|||
30605794|NCT01217073|58616680|FG003|Extension Period|Adverse Event|0|||
30876270|NCT01959880|58907464|FG003|Overall Study|Lost to Follow-up|8|||
30876271|NCT01959880|58907461|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
30964997|NCT01561976|59033545|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
30964998|NCT01561976|59033546|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
30964999|NCT01561976|59033547|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
30965000|NCT01561976|59033548|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
30965001|NCT01561976|59033549|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
30965002|NCT01561976|59033550|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
30965003|NCT01561976|59033545|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30965004|NCT01561976|59033546|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30965005|NCT01561976|59033547|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30965006|NCT01561976|59033548|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30965007|NCT01561976|59033549|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
30876272|NCT01959880|58907462|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
30876273|NCT01959880|58907463|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
30876274|NCT01959880|58907464|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
30605795|NCT01217073|58616681|FG004|Extension Period|Adverse Event|0|||
30605796|NCT01217073|58616682|FG005|Extension Period|Adverse Event|0|||
30605797|NCT01217073|58616683|FG006|Extension Period|Adverse Event|19|||
30605798|NCT01217073|58616684|FG007|Extension Period|Adverse Event|5|||
30605799|NCT01217073|58616677|FG000|Extension Period|ALT/AST|0|||
30605800|NCT01217073|58616678|FG001|Extension Period|ALT/AST|0|||
30605801|NCT01217073|58616679|FG002|Extension Period|ALT/AST|0|||
30605802|NCT01217073|58616680|FG003|Extension Period|ALT/AST|0|||
30605803|NCT01217073|58616681|FG004|Extension Period|ALT/AST|0|||
30605804|NCT01217073|58616682|FG005|Extension Period|ALT/AST|0|||
30605805|NCT01217073|58616683|FG006|Extension Period|ALT/AST|2|||
30605806|NCT01217073|58616684|FG007|Extension Period|ALT/AST|0|||
30605807|NCT01217073|58616677|FG000|Extension Period|Contraindication to study medication|0|||
30605808|NCT01217073|58616678|FG001|Extension Period|Contraindication to study medication|0|||
30605809|NCT01217073|58616679|FG002|Extension Period|Contraindication to study medication|0|||
30605810|NCT01217073|58616680|FG003|Extension Period|Contraindication to study medication|0|||
30605811|NCT01217073|58616681|FG004|Extension Period|Contraindication to study medication|0|||
30605812|NCT01217073|58616682|FG005|Extension Period|Contraindication to study medication|0|||
30605813|NCT01217073|58616683|FG006|Extension Period|Contraindication to study medication|1|||
30605814|NCT01217073|58616684|FG007|Extension Period|Contraindication to study medication|0|||
30605815|NCT01217073|58616677|FG000|Extension Period|Creatinine/eGFR|0|||
30605816|NCT01217073|58616678|FG001|Extension Period|Creatinine/eGFR|0|||
30605817|NCT01217073|58616679|FG002|Extension Period|Creatinine/eGFR|0|||
30605818|NCT01217073|58616680|FG003|Extension Period|Creatinine/eGFR|0|||
30605819|NCT01217073|58616681|FG004|Extension Period|Creatinine/eGFR|0|||
30605820|NCT01217073|58616682|FG005|Extension Period|Creatinine/eGFR|0|||
30605821|NCT01217073|58616683|FG006|Extension Period|Creatinine/eGFR|11|||
30605822|NCT01217073|58616684|FG007|Extension Period|Creatinine/eGFR|1|||
30605823|NCT01217073|58616677|FG000|Extension Period|Death|0|||
30605824|NCT01217073|58616678|FG001|Extension Period|Death|0|||
30605825|NCT01217073|58616679|FG002|Extension Period|Death|0|||
30605826|NCT01217073|58616680|FG003|Extension Period|Death|0|||
30605827|NCT01217073|58616681|FG004|Extension Period|Death|0|||
30605828|NCT01217073|58616682|FG005|Extension Period|Death|0|||
30605829|NCT01217073|58616683|FG006|Extension Period|Death|1|||
30605830|NCT01217073|58616684|FG007|Extension Period|Death|0|||
30605831|NCT01217073|58616677|FG000|Extension Period|Excluded medication|0|||
30605832|NCT01217073|58616678|FG001|Extension Period|Excluded medication|0|||
30605833|NCT01217073|58616679|FG002|Extension Period|Excluded medication|0|||
30605834|NCT01217073|58616680|FG003|Extension Period|Excluded medication|0|||
30605835|NCT01217073|58616681|FG004|Extension Period|Excluded medication|0|||
30605836|NCT01217073|58616682|FG005|Extension Period|Excluded medication|0|||
30605837|NCT01217073|58616683|FG006|Extension Period|Excluded medication|2|||
30605838|NCT01217073|58616684|FG007|Extension Period|Excluded medication|0|||
30605839|NCT01217073|58616677|FG000|Extension Period|Lack of Efficacy|0|||
30605840|NCT01217073|58616678|FG001|Extension Period|Lack of Efficacy|0|||
30605841|NCT01217073|58616679|FG002|Extension Period|Lack of Efficacy|0|||
30605842|NCT01217073|58616680|FG003|Extension Period|Lack of Efficacy|0|||
30605843|NCT01217073|58616681|FG004|Extension Period|Lack of Efficacy|0|||
30605844|NCT01217073|58616682|FG005|Extension Period|Lack of Efficacy|0|||
30605845|NCT01217073|58616683|FG006|Extension Period|Lack of Efficacy|3|||
30605846|NCT01217073|58616684|FG007|Extension Period|Lack of Efficacy|0|||
30605847|NCT01217073|58616677|FG000|Extension Period|Lost to Follow-up|0|||
30605848|NCT01217073|58616678|FG001|Extension Period|Lost to Follow-up|0|||
30605849|NCT01217073|58616679|FG002|Extension Period|Lost to Follow-up|0|||
30605850|NCT01217073|58616680|FG003|Extension Period|Lost to Follow-up|0|||
30605851|NCT01217073|58616681|FG004|Extension Period|Lost to Follow-up|0|||
30605852|NCT01217073|58616682|FG005|Extension Period|Lost to Follow-up|0|||
30605853|NCT01217073|58616683|FG006|Extension Period|Lost to Follow-up|9|||
30605854|NCT01217073|58616684|FG007|Extension Period|Lost to Follow-up|1|||
30605855|NCT01217073|58616677|FG000|Extension Period|Non-compliance with study drug|0|||
30605856|NCT01217073|58616678|FG001|Extension Period|Non-compliance with study drug|0|||
30605857|NCT01217073|58616679|FG002|Extension Period|Non-compliance with study drug|0|||
30605858|NCT01217073|58616680|FG003|Extension Period|Non-compliance with study drug|0|||
30605859|NCT01217073|58616681|FG004|Extension Period|Non-compliance with study drug|0|||
30605860|NCT01217073|58616682|FG005|Extension Period|Non-compliance with study drug|0|||
30605861|NCT01217073|58616683|FG006|Extension Period|Non-compliance with study drug|0|||
30605862|NCT01217073|58616684|FG007|Extension Period|Non-compliance with study drug|1|||
30605863|NCT01217073|58616677|FG000|Extension Period|Physician Decision|0|||
30605864|NCT01217073|58616678|FG001|Extension Period|Physician Decision|0|||
30605865|NCT01217073|58616679|FG002|Extension Period|Physician Decision|0|||
30605866|NCT01217073|58616680|FG003|Extension Period|Physician Decision|0|||
30605867|NCT01217073|58616681|FG004|Extension Period|Physician Decision|0|||
30605868|NCT01217073|58616682|FG005|Extension Period|Physician Decision|0|||
30605869|NCT01217073|58616683|FG006|Extension Period|Physician Decision|4|||
30605870|NCT01217073|58616684|FG007|Extension Period|Physician Decision|1|||
30605871|NCT01217073|58616677|FG000|Extension Period|Protocol Violation|0|||
30605872|NCT01217073|58616678|FG001|Extension Period|Protocol Violation|0|||
30605873|NCT01217073|58616679|FG002|Extension Period|Protocol Violation|0|||
30605874|NCT01217073|58616680|FG003|Extension Period|Protocol Violation|0|||
30605875|NCT01217073|58616681|FG004|Extension Period|Protocol Violation|0|||
30605876|NCT01217073|58616682|FG005|Extension Period|Protocol Violation|0|||
30605877|NCT01217073|58616683|FG006|Extension Period|Protocol Violation|2|||
30605878|NCT01217073|58616684|FG007|Extension Period|Protocol Violation|1|||
30605879|NCT01217073|58616677|FG000|Extension Period|Site discontinued study participation|0|||
30605880|NCT01217073|58616678|FG001|Extension Period|Site discontinued study participation|0|||
30605881|NCT01217073|58616679|FG002|Extension Period|Site discontinued study participation|0|||
30605882|NCT01217073|58616680|FG003|Extension Period|Site discontinued study participation|0|||
30605883|NCT01217073|58616681|FG004|Extension Period|Site discontinued study participation|0|||
30605884|NCT01217073|58616682|FG005|Extension Period|Site discontinued study participation|0|||
30605885|NCT01217073|58616683|FG006|Extension Period|Site discontinued study participation|7|||
30605886|NCT01217073|58616684|FG007|Extension Period|Site discontinued study participation|2|||
30605887|NCT01217073|58616677|FG000|Extension Period|Withdrawal by Subject|0|||
30605888|NCT01217073|58616678|FG001|Extension Period|Withdrawal by Subject|0|||
30605889|NCT01217073|58616679|FG002|Extension Period|Withdrawal by Subject|0|||
30605890|NCT01217073|58616680|FG003|Extension Period|Withdrawal by Subject|0|||
30605891|NCT01217073|58616681|FG004|Extension Period|Withdrawal by Subject|0|||
30605892|NCT01217073|58616682|FG005|Extension Period|Withdrawal by Subject|0|||
30605893|NCT01217073|58616683|FG006|Extension Period|Withdrawal by Subject|30|||
30605894|NCT01217073|58616684|FG007|Extension Period|Withdrawal by Subject|8|||
30695916|NCT00681824|58710261|FG000|Overall Study|Death|0|||
30695917|NCT00681824|58710262|FG001|Overall Study|Death|1|||
30695918|NCT00681824|58710263|FG002|Overall Study|Death|0|||
30695919|NCT00681668|58710271|FG000|Overall Study|Protocol Violation|1|||
30695920|NCT00681668|58710271|FG000|Overall Study|Withdrawal by Subject|1|||
30695921|NCT00539188|58710277|FG000|Overall Study|Withdrawal by Subject|1|||
30695922|NCT00539188|58710278|FG001|Overall Study|Withdrawal by Subject|0|||
30695923|NCT00539188|58710277|FG000|Overall Study|Lost to Follow-up|2|||
30695924|NCT00539188|58710278|FG001|Overall Study|Lost to Follow-up|1|||
30695925|NCT00681590|58710286|FG000|Overall Study|Withdrawal by Subject|2|||
30695926|NCT00681590|58710287|FG001|Overall Study|Withdrawal by Subject|12|||
30695927|NCT04980456|58710295|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
30695928|NCT04980456|58710296|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
30695929|NCT04980456|58710295|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
30695930|NCT04980456|58710296|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
30695931|NCT04980456|58710295|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
30695932|NCT04980456|58710296|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
30695933|NCT04980456|58710295|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
30695934|NCT04980456|58710296|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
30695935|NCT00326599|58710309|FG000|Overall Study|Withdrawal by Subject|1|||
30695936|NCT00326599|58710310|FG001|Overall Study|Withdrawal by Subject|0|||
30695937|NCT00326599|58710311|FG002|Overall Study|Withdrawal by Subject|5|||
30695938|NCT00326599|58710312|FG003|Overall Study|Withdrawal by Subject|2|||
30695939|NCT00326599|58710309|FG000|Overall Study|Adverse Event|1|||
30695940|NCT00326599|58710310|FG001|Overall Study|Adverse Event|0|||
30695941|NCT00326599|58710311|FG002|Overall Study|Adverse Event|32|||
30695942|NCT00326599|58710312|FG003|Overall Study|Adverse Event|3|||
30695943|NCT00326599|58710309|FG000|Overall Study|Disease Progression|3|||
30695944|NCT00326599|58710310|FG001|Overall Study|Disease Progression|1|||
30695945|NCT00326599|58710311|FG002|Overall Study|Disease Progression|13|||
30695946|NCT00326599|58710312|FG003|Overall Study|Disease Progression|11|||
30695947|NCT00326599|58710309|FG000|Overall Study|Alternate Treatment|1|||
30695948|NCT00326599|58710310|FG001|Overall Study|Alternate Treatment|0|||
30695949|NCT00326599|58710311|FG002|Overall Study|Alternate Treatment|0|||
30695950|NCT00326599|58710312|FG003|Overall Study|Alternate Treatment|0|||
30695951|NCT00326599|58710309|FG000|Overall Study|Death|0|||
30695952|NCT00326599|58710310|FG001|Overall Study|Death|0|||
30695953|NCT00326599|58710311|FG002|Overall Study|Death|1|||
30695954|NCT00326599|58710312|FG003|Overall Study|Death|2|||
30695955|NCT00326599|58710309|FG000|Overall Study|Other Unspecified Reason|0|||
30605895|NCT00985621|58616712|FG000|Overall Study|Adverse Event|2|||
30695956|NCT00326599|58710310|FG001|Overall Study|Other Unspecified Reason|0|||
30605896|NCT00985621|58616713|FG001|Overall Study|Adverse Event|3|||
30605897|NCT00985621|58616714|FG002|Overall Study|Adverse Event|4|||
30605898|NCT00985621|58616715|FG003|Overall Study|Adverse Event|16|||
30605899|NCT00985621|58616712|FG000|Overall Study|Lack of Efficacy|10|||
30605900|NCT00985621|58616713|FG001|Overall Study|Lack of Efficacy|6|||
30605901|NCT00985621|58616714|FG002|Overall Study|Lack of Efficacy|5|||
30605902|NCT00985621|58616715|FG003|Overall Study|Lack of Efficacy|12|||
30605903|NCT00985621|58616712|FG000|Overall Study|Lost to Follow-up|2|||
30695957|NCT00326599|58710311|FG002|Overall Study|Other Unspecified Reason|2|||
30695958|NCT00326599|58710312|FG003|Overall Study|Other Unspecified Reason|1|||
30695959|NCT00539032|58710323|FG000|Overall Study|Withdrawal by Subject|2|||
30695960|NCT00539032|58710324|FG001|Overall Study|Withdrawal by Subject|1|||
30695961|NCT00685802|58710330|FG000|Washout Period of 7 Days|Protocol Violation|2|||
30695962|NCT00685802|58710331|FG001|Washout Period of 7 Days|Protocol Violation|0|||
30695963|NCT00685802|58710330|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
30695964|NCT00685802|58710331|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
30695965|NCT00354601|58710337|FG000|Overall Study|Protocol Violation|1|||
30695966|NCT00354601|58710337|FG000|Overall Study|progression|1|||
30695967|NCT03827473|58710343|FG000|Overall Study|Withdrawal by Subject|1|||
30695968|NCT03827473|58710344|FG001|Overall Study|Withdrawal by Subject|0|||
30695969|NCT00345397|58710350|FG000|Overall Study|Death|1|||
30695970|NCT00326209|58710355|FG000|Overall Study|Adverse Event|28|||
30695971|NCT00326209|58710355|FG000|Overall Study|Withdrawal by Subject|22|||
30695972|NCT00326209|58710355|FG000|Overall Study|Lack of Efficacy|31|||
30695973|NCT00326209|58710355|FG000|Overall Study|Lost to Follow-up|18|||
30695974|NCT00326209|58710355|FG000|Overall Study|Participant non-compliant|6|||
30695975|NCT00326209|58710355|FG000|Overall Study|Sponsor closed study|173|||
30695976|NCT00326209|58710355|FG000|Overall Study|Prohibited medication use|1|||
30695977|NCT00326209|58710355|FG000|Overall Study|Violation of entry criteria|1|||
30695978|NCT00326209|58710355|FG000|Overall Study|Withdrawn in error|1|||
30695979|NCT00326209|58710355|FG000|Overall Study|Pregnancy|1|||
30695980|NCT00537940|58710361|FG000|Overall Study|Adverse Event|20|||
30695981|NCT00537940|58710362|FG001|Overall Study|Adverse Event|19|||
30695982|NCT00537940|58710361|FG000|Overall Study|Lack of Efficacy|8|||
30695983|NCT00537940|58710362|FG001|Overall Study|Lack of Efficacy|16|||
30695984|NCT00537940|58710361|FG000|Overall Study|Lost to Follow-up|23|||
30695985|NCT00537940|58710362|FG001|Overall Study|Lost to Follow-up|29|||
30695986|NCT00537940|58710361|FG000|Overall Study|Withdrawal by Subject|113|||
30695987|NCT00537940|58710362|FG001|Overall Study|Withdrawal by Subject|95|||
30695988|NCT00537940|58710361|FG000|Overall Study|Protocol Violation|6|||
30695989|NCT00537940|58710362|FG001|Overall Study|Protocol Violation|4|||
30695990|NCT00537940|58710361|FG000|Overall Study|Pregnancy|1|||
30695991|NCT00537940|58710362|FG001|Overall Study|Pregnancy|1|||
30695992|NCT00537940|58710361|FG000|Overall Study|Study terminated by sponsor|2|||
30695993|NCT00537940|58710362|FG001|Overall Study|Study terminated by sponsor|3|||
30695994|NCT00537940|58710361|FG000|Overall Study|Other|10|||
30695995|NCT00537940|58710362|FG001|Overall Study|Other|12|||
30695996|NCT00661362|58710370|FG000|Overall Study|Adverse Event|5|||
30695997|NCT00661362|58710371|FG001|Overall Study|Adverse Event|4|||
30695998|NCT00661362|58710370|FG000|Overall Study|Incorrect enrollment|2|||
30695999|NCT00661362|58710371|FG001|Overall Study|Incorrect enrollment|0|||
30696000|NCT00661362|58710370|FG000|Overall Study|Study specific discontinuation criteria|4|||
30696001|NCT00661362|58710371|FG001|Overall Study|Study specific discontinuation criteria|11|||
30696002|NCT00661362|58710370|FG000|Overall Study|Withdrawal by Subject|13|||
30696003|NCT00661362|58710371|FG001|Overall Study|Withdrawal by Subject|23|||
30696004|NCT00661362|58710370|FG000|Overall Study|Lost to Follow-up|3|||
30696005|NCT00661362|58710371|FG001|Overall Study|Lost to Follow-up|1|||
30696006|NCT00661362|58710370|FG000|Overall Study|Severe non-compliance to protocol|0|||
30696007|NCT00661362|58710371|FG001|Overall Study|Severe non-compliance to protocol|1|||
30696008|NCT00661362|58710370|FG000|Overall Study|Safety reasons|1|||
30696009|NCT00661362|58710371|FG001|Overall Study|Safety reasons|0|||
30696010|NCT00661362|58710370|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
30696011|NCT00661362|58710371|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
30696012|NCT00325897|58710379|FG000|Overall Study|Lost to Follow-up|12|||
30696013|NCT00325897|58710380|FG001|Overall Study|Lost to Follow-up|13|||
30696014|NCT00344773|58710389|FG000|Overall Study|Adverse Event|2|||
30696015|NCT00344773|58710389|FG000|Overall Study|Objective Disease Progression|16|||
30696016|NCT00344773|58710389|FG000|Overall Study|Withdrawal by Subject|1|||
30696017|NCT00344773|58710389|FG000|Overall Study|Not Eligible for the study|2|||
30696018|NCT00325819|58710395|FG000|Overall Study|Study product lost in mail|2|||
30696019|NCT00325819|58710396|FG001|Overall Study|Study product lost in mail|1|||
30696020|NCT00325819|58710395|FG000|Overall Study|Did not take a dose of study product|4|||
30696021|NCT00325819|58710396|FG001|Overall Study|Did not take a dose of study product|9|||
30696022|NCT00325819|58710395|FG000|Overall Study|Lost to Follow-up|3|||
30696023|NCT00325819|58710396|FG001|Overall Study|Lost to Follow-up|3|||
30696024|NCT00687362|58710404|FG000|Overall Study|Protocol Violation|2|||
30696025|NCT00687362|58710404|FG000|Overall Study|Withdrawal by Subject|1|||
30696026|NCT00325195|58710411|FG000|Randomized|Not dosed|5|||
30696027|NCT00325195|58710412|FG001|Randomized|Not dosed|5|||
30696028|NCT00325195|58710413|FG002|Randomized|Not dosed|3|||
30696029|NCT00325195|58710411|FG000|Received Intervention: ITT Population|Adverse Event|15|||
30696030|NCT00325195|58710412|FG001|Received Intervention: ITT Population|Adverse Event|17|||
30696031|NCT00325195|58710413|FG002|Received Intervention: ITT Population|Adverse Event|1|||
30696032|NCT00325195|58710411|FG000|Received Intervention: ITT Population|Death|3|||
30696033|NCT00325195|58710412|FG001|Received Intervention: ITT Population|Death|1|||
30696034|NCT00325195|58710413|FG002|Received Intervention: ITT Population|Death|0|||
30696035|NCT00325195|58710411|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
30696036|NCT00325195|58710412|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
30696037|NCT00325195|58710413|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
30696038|NCT00325195|58710411|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
30696039|NCT00325195|58710412|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
30696040|NCT00325195|58710413|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
30696041|NCT00325195|58710411|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
30696042|NCT00325195|58710412|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
30696043|NCT00325195|58710413|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
30696044|NCT03976401|58710427|FG000|Overall Study|Adverse Event|2|||
30696045|NCT03976401|58710428|FG001|Overall Study|Adverse Event|0|||
30696046|NCT03976401|58710429|FG002|Overall Study|Adverse Event|4|||
30696047|NCT03976401|58710430|FG003|Overall Study|Adverse Event|1|||
30696048|NCT03976401|58710431|FG004|Overall Study|Adverse Event|1|||
30696049|NCT03976401|58710432|FG005|Overall Study|Adverse Event|0|||
30696050|NCT03976401|58710427|FG000|Overall Study|Withdrawal by Subject|0|||
30696051|NCT03976401|58710428|FG001|Overall Study|Withdrawal by Subject|1|||
30696052|NCT03976401|58710429|FG002|Overall Study|Withdrawal by Subject|0|||
30696053|NCT03976401|58710430|FG003|Overall Study|Withdrawal by Subject|0|||
30696054|NCT03976401|58710431|FG004|Overall Study|Withdrawal by Subject|0|||
30696055|NCT03976401|58710432|FG005|Overall Study|Withdrawal by Subject|1|||
30696056|NCT03976401|58710427|FG000|Overall Study|Physician Decision|0|||
30696057|NCT03976401|58710428|FG001|Overall Study|Physician Decision|0|||
30696058|NCT03976401|58710429|FG002|Overall Study|Physician Decision|1|||
30696059|NCT03976401|58710430|FG003|Overall Study|Physician Decision|0|||
30696060|NCT03976401|58710431|FG004|Overall Study|Physician Decision|0|||
30696061|NCT03976401|58710432|FG005|Overall Study|Physician Decision|0|||
30696062|NCT03976401|58710427|FG000|Overall Study|Lost to Follow-up|1|||
30696063|NCT03976401|58710428|FG001|Overall Study|Lost to Follow-up|2|||
30696064|NCT03976401|58710429|FG002|Overall Study|Lost to Follow-up|0|||
30696065|NCT03976401|58710430|FG003|Overall Study|Lost to Follow-up|0|||
30696066|NCT03976401|58710431|FG004|Overall Study|Lost to Follow-up|0|||
30696067|NCT03976401|58710432|FG005|Overall Study|Lost to Follow-up|0|||
30696068|NCT03976401|58710427|FG000|Overall Study|Protocol Violation|0|||
30696069|NCT03976401|58710428|FG001|Overall Study|Protocol Violation|1|||
30696070|NCT03976401|58710429|FG002|Overall Study|Protocol Violation|0|||
30696071|NCT03976401|58710430|FG003|Overall Study|Protocol Violation|0|||
30696072|NCT03976401|58710431|FG004|Overall Study|Protocol Violation|0|||
30696073|NCT03976401|58710432|FG005|Overall Study|Protocol Violation|0|||
30696074|NCT03976401|58710427|FG000|Overall Study|Withdrew Consent|0|||
30696075|NCT03976401|58710428|FG001|Overall Study|Withdrew Consent|0|||
30696076|NCT03976401|58710429|FG002|Overall Study|Withdrew Consent|0|||
30696077|NCT03976401|58710430|FG003|Overall Study|Withdrew Consent|1|||
30696078|NCT03976401|58710431|FG004|Overall Study|Withdrew Consent|0|||
30696079|NCT03976401|58710432|FG005|Overall Study|Withdrew Consent|0|||
30696080|NCT00685334|58710448|FG000|Overall Study|Withdrawal by Subject|5|||
30696081|NCT00685334|58710449|FG001|Overall Study|Withdrawal by Subject|6|||
30696082|NCT00685334|58710448|FG000|Overall Study|Lost to Follow-up|4|||
30696083|NCT00685334|58710449|FG001|Overall Study|Lost to Follow-up|0|||
30696084|NCT00685334|58710448|FG000|Overall Study|Chose to enter hospital|1|||
30696085|NCT00685334|58710449|FG001|Overall Study|Chose to enter hospital|1|||
30696086|NCT00325039|58710457|FG000|Overall Study|Lost to Follow-up|18|||
30696087|NCT00325039|58710458|FG001|Overall Study|Lost to Follow-up|14|||
30696088|NCT00344461|58710464|FG000|Overall Study|Adverse Event|6|||
30696089|NCT00344461|58710464|FG000|Overall Study|Death|1|||
30696090|NCT00344461|58710464|FG000|Overall Study|Lack of Efficacy|2|||
30696091|NCT00344461|58710464|FG000|Overall Study|Lost to Follow-up|2|||
30696092|NCT00344461|58710464|FG000|Overall Study|Physician Decision|2|||
30696093|NCT00344461|58710464|FG000|Overall Study|Protocol Violation|6|||
30696094|NCT00344461|58710464|FG000|Overall Study|Withdrawal by Subject|2|||
30696095|NCT00685178|58710473|FG000|Overall Study|Adverse Event|1|||
30696096|NCT00685178|58710474|FG001|Overall Study|Adverse Event|5|||
30696097|NCT00685178|58710475|FG002|Overall Study|Adverse Event|2|||
30696098|NCT00685178|58710476|FG003|Overall Study|Adverse Event|4|||
30696099|NCT00685178|58710473|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
30696100|NCT00685178|58710474|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
30696101|NCT00685178|58710475|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
30696102|NCT00685178|58710476|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
30696103|NCT00685178|58710473|FG000|Overall Study|voluntary study discharge|4|||
30696104|NCT00685178|58710474|FG001|Overall Study|voluntary study discharge|5|||
30696105|NCT00685178|58710475|FG002|Overall Study|voluntary study discharge|1|||
30696106|NCT00685178|58710476|FG003|Overall Study|voluntary study discharge|1|||
30696107|NCT00685178|58710473|FG000|Overall Study|incarcerated|1|||
30696108|NCT00685178|58710474|FG001|Overall Study|incarcerated|3|||
30696109|NCT00685178|58710475|FG002|Overall Study|incarcerated|7|||
30696110|NCT00685178|58710476|FG003|Overall Study|incarcerated|0|||
30696111|NCT00685178|58710473|FG000|Overall Study|administrative (disciplinary) discharge|0|||
30696112|NCT00685178|58710474|FG001|Overall Study|administrative (disciplinary) discharge|1|||
30696113|NCT00685178|58710475|FG002|Overall Study|administrative (disciplinary) discharge|0|||
30696114|NCT00685178|58710476|FG003|Overall Study|administrative (disciplinary) discharge|2|||
30696115|NCT00685178|58710473|FG000|Overall Study|Pregnancy|0|||
30696116|NCT00685178|58710474|FG001|Overall Study|Pregnancy|0|||
30696117|NCT00685178|58710475|FG002|Overall Study|Pregnancy|0|||
30696118|NCT00685178|58710476|FG003|Overall Study|Pregnancy|1|||
30696119|NCT00537394|58710489|FG000|First Year of Follow-up|Death|7|||
30696120|NCT00537394|58710490|FG001|First Year of Follow-up|Death|0|||
30696121|NCT00537394|58710491|FG002|First Year of Follow-up|Death|0|||
30696122|NCT00537394|58710489|FG000|First Year of Follow-up|Severe debilitation|1|||
30696123|NCT00537394|58710490|FG001|First Year of Follow-up|Severe debilitation|0|||
30696124|NCT00537394|58710491|FG002|First Year of Follow-up|Severe debilitation|1|||
30696125|NCT00537394|58710489|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
30696126|NCT00537394|58710490|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
30696127|NCT00537394|58710491|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
30696128|NCT00537394|58710489|FG000|First Year of Follow-up|Lost to Follow-up|1|||
30696129|NCT00537394|58710490|FG001|First Year of Follow-up|Lost to Follow-up|5|||
30696130|NCT00537394|58710491|FG002|First Year of Follow-up|Lost to Follow-up|1|||
30696131|NCT00537394|58710489|FG000|2nd Year of Follow-up|Death|4|||
30696132|NCT00537394|58710490|FG001|2nd Year of Follow-up|Death|1|||
30696133|NCT00537394|58710491|FG002|2nd Year of Follow-up|Death|2|||
30696134|NCT00537394|58710489|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
30696135|NCT00537394|58710490|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
30696136|NCT00537394|58710491|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
30696137|NCT00537394|58710489|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
30696138|NCT00537394|58710490|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
30696139|NCT00537394|58710491|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
30696140|NCT00537394|58710489|FG000|2nd Year of Follow-up|Clinic site closure|1|||
30696141|NCT00537394|58710490|FG001|2nd Year of Follow-up|Clinic site closure|0|||
30696142|NCT00537394|58710491|FG002|2nd Year of Follow-up|Clinic site closure|0|||
30696143|NCT00352885|58710499|FG000|Overall Study|Withdrawal by Subject|0|||
30696144|NCT00352885|58710500|FG001|Overall Study|Withdrawal by Subject|3|||
30696145|NCT00352885|58710499|FG000|Overall Study|Development of major depression|0|||
30696146|NCT00352885|58710500|FG001|Overall Study|Development of major depression|1|||
30696147|NCT00352885|58710499|FG000|Overall Study|Progression of metastatic melanoma|5|||
30696148|NCT00352885|58710500|FG001|Overall Study|Progression of metastatic melanoma|3|||
30696149|NCT00352885|58710499|FG000|Overall Study|Side effects of IL-2 administration|1|||
30696150|NCT00352885|58710500|FG001|Overall Study|Side effects of IL-2 administration|0|||
30696151|NCT00660660|58710508|FG000|Overall Study|Adverse Event|1|||
30696152|NCT00660660|58710509|FG001|Overall Study|Adverse Event|0|||
30696153|NCT00660660|58710508|FG000|Overall Study|Lost to Follow-up|0|||
30696154|NCT00660660|58710509|FG001|Overall Study|Lost to Follow-up|6|||
30696155|NCT00660660|58710508|FG000|Overall Study|Lack of Efficacy|0|||
30696156|NCT00660660|58710509|FG001|Overall Study|Lack of Efficacy|2|||
30696157|NCT00660660|58710508|FG000|Overall Study|Withdrawal by Subject|3|||
30696158|NCT00660660|58710509|FG001|Overall Study|Withdrawal by Subject|0|||
30696159|NCT00660660|58710508|FG000|Overall Study|Incorrect enrollment and other|0|||
30696160|NCT00660660|58710509|FG001|Overall Study|Incorrect enrollment and other|1|||
30696161|NCT00660660|58710508|FG000|Overall Study|New medication after randomization|1|||
30696162|NCT00660660|58710509|FG001|Overall Study|New medication after randomization|0|||
30696163|NCT00344305|58710517|FG000|Overall Study|Lost to Follow-up|2|||
30696164|NCT00344305|58710518|FG001|Overall Study|Lost to Follow-up|0|||
30696165|NCT00344305|58710517|FG000|Overall Study|Participant was not contacted in window|0|||
30696166|NCT00344305|58710518|FG001|Overall Study|Participant was not contacted in window|1|||
30696167|NCT00660816|58710527|FG000|Overall Study|Adverse Event|1|||
30696168|NCT00660816|58710528|FG001|Overall Study|Adverse Event|2|||
30696169|NCT00660816|58710527|FG000|Overall Study|Withdrawal by Subject|1|||
30696170|NCT00660816|58710528|FG001|Overall Study|Withdrawal by Subject|0|||
30696171|NCT00660816|58710527|FG000|Overall Study|Death|0|||
30696172|NCT00660816|58710528|FG001|Overall Study|Death|2|||
30696173|NCT00660816|58710527|FG000|Overall Study|Lack of Efficacy|1|||
30696174|NCT00660816|58710528|FG001|Overall Study|Lack of Efficacy|0|||
30696175|NCT00660816|58710527|FG000|Overall Study|Physician Decision|0|||
30696176|NCT00660816|58710528|FG001|Overall Study|Physician Decision|2|||
30696177|NCT00660816|58710527|FG000|Overall Study|Protocol Violation|1|||
30696178|NCT00660816|58710528|FG001|Overall Study|Protocol Violation|0|||
30696179|NCT00660816|58710527|FG000|Overall Study|Disease Progression|16|||
30696180|NCT00660816|58710528|FG001|Overall Study|Disease Progression|12|||
30696181|NCT00660816|58710527|FG000|Overall Study|Complicating Disease|0|||
30696182|NCT00660816|58710528|FG001|Overall Study|Complicating Disease|1|||
30696183|NCT00576056|58710534|FG000|Overall Study|Adverse Event|1|||
30696184|NCT00576056|58710534|FG000|Overall Study|Death|1|||
30696185|NCT00576056|58710534|FG000|Overall Study|Lack of Efficacy|1|||
30696186|NCT00576056|58710534|FG000|Overall Study|Withdrawal by Subject|2|||
30696187|NCT00576056|58710534|FG000|Overall Study|did not meet eligibility criteria|8|||
30696188|NCT00576056|58710534|FG000|Overall Study|Physician Decision|1|||
30696189|NCT00575510|58710541|FG000|Overall Study|Lost to Follow-up|4|||
30696190|NCT00575510|58710542|FG001|Overall Study|Lost to Follow-up|6|||
30696191|NCT00575510|58710543|FG002|Overall Study|Lost to Follow-up|9|||
30696192|NCT00575510|58710541|FG000|Overall Study|Withdrawal by Subject|1|||
30696193|NCT00575510|58710542|FG001|Overall Study|Withdrawal by Subject|0|||
30696194|NCT00575510|58710543|FG002|Overall Study|Withdrawal by Subject|0|||
30696195|NCT00575510|58710541|FG000|Overall Study|Clinic Called Patient|7|||
30696196|NCT00575510|58710542|FG001|Overall Study|Clinic Called Patient|7|||
30696197|NCT00575510|58710543|FG002|Overall Study|Clinic Called Patient|7|||
30696198|NCT00575510|58710541|FG000|Overall Study|Pregnancy|0|||
30696199|NCT00575510|58710542|FG001|Overall Study|Pregnancy|0|||
30696200|NCT00575510|58710543|FG002|Overall Study|Pregnancy|1|||
30696201|NCT02636439|58710554|FG000|Overall Study|Adverse Event|2|||
30696202|NCT02636439|58710555|FG001|Overall Study|Adverse Event|2|||
30696203|NCT02636439|58710554|FG000|Overall Study|Lost to Follow-up|1|||
30696204|NCT02636439|58710555|FG001|Overall Study|Lost to Follow-up|0|||
30696205|NCT02636439|58710554|FG000|Overall Study|Non-compliance|1|||
30696206|NCT02636439|58710555|FG001|Overall Study|Non-compliance|1|||
30696207|NCT02636439|58710554|FG000|Overall Study|Personal reasons|2|||
30696208|NCT02636439|58710555|FG001|Overall Study|Personal reasons|0|||
30696209|NCT00343915|58710563|FG000|Primary Study|Withdrawal by Subject|1|||
30696210|NCT00343915|58710564|FG001|Primary Study|Withdrawal by Subject|0|||
30696211|NCT00343915|58710563|FG000|Primary Study|Lost to Follow-up|2|||
30696212|NCT00343915|58710564|FG001|Primary Study|Lost to Follow-up|3|||
30696213|NCT00343915|58710563|FG000|Primary Study|Other|1|||
30696214|NCT00343915|58710564|FG001|Primary Study|Other|0|||
30696215|NCT00575666|58710575|FG000|Overall Study|Withdrawal by Subject|3|||
30696216|NCT00575666|58710576|FG001|Overall Study|Withdrawal by Subject|2|||
30696217|NCT00575666|58710575|FG000|Overall Study|Physician Decision|1|||
30696218|NCT00575666|58710576|FG001|Overall Study|Physician Decision|1|||
30696219|NCT00658632|58710584|FG000|Overall Study|Adverse Event|13|||
30696220|NCT00658632|58710585|FG001|Overall Study|Adverse Event|11|||
30696221|NCT00658632|58710584|FG000|Overall Study|Lost to Follow-up|25|||
30696222|NCT00658632|58710585|FG001|Overall Study|Lost to Follow-up|23|||
30696223|NCT00658632|58710584|FG000|Overall Study|Withdrawal by Subject|10|||
30696224|NCT00658632|58710585|FG001|Overall Study|Withdrawal by Subject|7|||
30696225|NCT00658632|58710584|FG000|Overall Study|Lack of Efficacy|0|||
30696226|NCT00658632|58710585|FG001|Overall Study|Lack of Efficacy|1|||
30696227|NCT00658632|58710584|FG000|Overall Study|Withdrawal of consent|8|||
30696228|NCT00658632|58710585|FG001|Overall Study|Withdrawal of consent|14|||
30696229|NCT00658632|58710584|FG000|Overall Study|Pregnancy|1|||
30696230|NCT00658632|58710585|FG001|Overall Study|Pregnancy|1|||
30696231|NCT00658632|58710584|FG000|Overall Study|Other|7|||
30696232|NCT00658632|58710585|FG001|Overall Study|Other|8|||
30696233|NCT00677534|58710591|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
30696234|NCT00677534|58710591|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
30696235|NCT00677534|58710591|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
30696236|NCT00660348|58710597|FG000|Overall Study|Withdrawal by Subject|1|||
30696237|NCT00660348|58710598|FG001|Overall Study|Withdrawal by Subject|0|||
30696238|NCT00660192|58710606|FG000|Overall Study|Lost to Follow-up|2|||
30696239|NCT00660192|58710607|FG001|Overall Study|Lost to Follow-up|3|||
30696240|NCT00571688|58710615|FG000|Overall Study|Lost to Follow-up|3|||
30696241|NCT00571688|58710616|FG001|Overall Study|Lost to Follow-up|6|||
30696242|NCT00571688|58710615|FG000|Overall Study|subject did not tolerate Consta|1|||
30696243|NCT00571688|58710616|FG001|Overall Study|subject did not tolerate Consta|0|||
30696244|NCT00571688|58710615|FG000|Overall Study|subject moved out of the area|1|||
30696245|NCT00571688|58710616|FG001|Overall Study|subject moved out of the area|0|||
30696246|NCT00343291|58710624|FG000|Overall Study|Adverse Event|13|||
30605904|NCT00985621|58616713|FG001|Overall Study|Lost to Follow-up|3|||
30605905|NCT00985621|58616714|FG002|Overall Study|Lost to Follow-up|4|||
30605906|NCT00985621|58616715|FG003|Overall Study|Lost to Follow-up|4|||
30605907|NCT00985621|58616712|FG000|Overall Study|Study Terminated by Sponsor|89|||
30605908|NCT00985621|58616713|FG001|Overall Study|Study Terminated by Sponsor|108|||
30605909|NCT00985621|58616714|FG002|Overall Study|Study Terminated by Sponsor|99|||
30605910|NCT00985621|58616715|FG003|Overall Study|Study Terminated by Sponsor|92|||
30605911|NCT00985621|58616712|FG000|Overall Study|Protocol Violation|1|||
30605912|NCT00985621|58616713|FG001|Overall Study|Protocol Violation|1|||
30696247|NCT00343291|58710625|FG001|Overall Study|Adverse Event|13|||
30696248|NCT00343291|58710624|FG000|Overall Study|Death|3|||
30696249|NCT00343291|58710625|FG001|Overall Study|Death|2|||
30696250|NCT00343291|58710624|FG000|Overall Study|Progressive disease|33|||
30696251|NCT00343291|58710625|FG001|Overall Study|Progressive disease|34|||
30605913|NCT00985621|58616714|FG002|Overall Study|Protocol Violation|1|||
30605914|NCT00985621|58616715|FG003|Overall Study|Protocol Violation|0|||
30605915|NCT00985621|58616712|FG000|Overall Study|Withdrawal by Subject|8|||
30696252|NCT00343291|58710624|FG000|Overall Study|Withdrawal by Subject|0|||
30696253|NCT00343291|58710625|FG001|Overall Study|Withdrawal by Subject|2|||
30696254|NCT00343291|58710624|FG000|Overall Study|Other|8|||
30696255|NCT00343291|58710625|FG001|Overall Study|Other|5|||
30696256|NCT00658788|58710631|FG000|Overall Study|Adverse Event|11|||
30696257|NCT00658788|58710631|FG000|Overall Study|Withdrawal by Subject|13|||
30696258|NCT00658788|58710631|FG000|Overall Study|Lost to Follow-up|18|||
30696259|NCT00658788|58710631|FG000|Overall Study|Treatment Discontinuation|32|||
30696260|NCT04829214|58710646|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
30696261|NCT04829214|58710647|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
30696262|NCT04829214|58710646|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
30696263|NCT04829214|58710647|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
30696264|NCT00562965|58710657|FG000|Overall Study|Withdrawal by Subject|0|||
30696265|NCT00562965|58710658|FG001|Overall Study|Withdrawal by Subject|1|||
30696266|NCT00562965|58710657|FG000|Overall Study|Death|2|||
30696267|NCT00562965|58710658|FG001|Overall Study|Death|4|||
30696268|NCT00562965|58710657|FG000|Overall Study|Lost to Follow-up|1|||
30696269|NCT00562965|58710658|FG001|Overall Study|Lost to Follow-up|0|||
30696270|NCT00562965|58710657|FG000|Overall Study|Other|0|||
30696271|NCT00562965|58710658|FG001|Overall Study|Other|1|||
30696272|NCT00537082|58710667|FG000|Overall Study|Adverse Event|6|||
30696273|NCT00537082|58710668|FG001|Overall Study|Adverse Event|6|||
30696274|NCT00537082|58710669|FG002|Overall Study|Adverse Event|3|||
30696275|NCT00537082|58710667|FG000|Overall Study|Protocol Violation|0|||
30696276|NCT00537082|58710668|FG001|Overall Study|Protocol Violation|2|||
30696277|NCT00537082|58710669|FG002|Overall Study|Protocol Violation|1|||
30696278|NCT00537082|58710667|FG000|Overall Study|Lack of Efficacy|0|||
30696279|NCT00537082|58710668|FG001|Overall Study|Lack of Efficacy|0|||
30696280|NCT00537082|58710669|FG002|Overall Study|Lack of Efficacy|2|||
30696281|NCT00537082|58710667|FG000|Overall Study|Withdrawal by Subject|0|||
30696282|NCT00537082|58710668|FG001|Overall Study|Withdrawal by Subject|1|||
30696283|NCT00537082|58710669|FG002|Overall Study|Withdrawal by Subject|0|||
30696284|NCT00537082|58710667|FG000|Overall Study|Discontinued before initiating treatment|3|||
30696285|NCT00537082|58710668|FG001|Overall Study|Discontinued before initiating treatment|0|||
30605916|NCT00985621|58616713|FG001|Overall Study|Withdrawal by Subject|10|||
30605917|NCT00985621|58616714|FG002|Overall Study|Withdrawal by Subject|8|||
30605918|NCT00985621|58616715|FG003|Overall Study|Withdrawal by Subject|12|||
30605919|NCT00985621|58616712|FG000|Overall Study|Other|1|||
30605920|NCT00985621|58616713|FG001|Overall Study|Other|0|||
30605921|NCT00985621|58616714|FG002|Overall Study|Other|0|||
30605922|NCT00985621|58616715|FG003|Overall Study|Other|0|||
30605923|NCT00985621|58616712|FG000|Overall Study|Randomized but not Treated|1|||
30605924|NCT00985621|58616713|FG001|Overall Study|Randomized but not Treated|0|||
30605925|NCT00985621|58616714|FG002|Overall Study|Randomized but not Treated|2|||
30605926|NCT00985621|58616715|FG003|Overall Study|Randomized but not Treated|1|||
30605927|NCT01215981|58616729|FG000|Overall Study|Physician Decision|0|||
30605928|NCT01215981|58616730|FG001|Overall Study|Physician Decision|1|||
30605929|NCT01215981|58616729|FG000|Overall Study|Protocol Violation|1|||
30605930|NCT01215981|58616730|FG001|Overall Study|Protocol Violation|0|||
30605931|NCT01215981|58616729|FG000|Overall Study|Withdrawal by Subject|1|||
30605932|NCT01215981|58616730|FG001|Overall Study|Withdrawal by Subject|0|||
30605933|NCT01215513|58616736|FG000|Overall Study|Not completed CS42|9|||
30605934|NCT01215513|58616736|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
30605935|NCT01215513|58616736|FG000|Overall Study|Adverse event (CS42A)|2|||
30605936|NCT01215513|58616736|FG000|Overall Study|Physician decision (CS42A)|6|||
30605937|NCT01215513|58616736|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
30605938|NCT01215513|58616736|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
30605939|NCT01215435|58616743|FG000|Overall Study|Adverse Event|1|||
30605940|NCT01215435|58616744|FG001|Overall Study|Adverse Event|0|||
30605941|NCT01215435|58616743|FG000|Overall Study|Protocol Violation|2|||
30605942|NCT01215435|58616744|FG001|Overall Study|Protocol Violation|0|||
30605943|NCT01215435|58616743|FG000|Overall Study|Withdrawal Criteria|8|||
30605944|NCT01215435|58616744|FG001|Overall Study|Withdrawal Criteria|11|||
30605945|NCT01215435|58616743|FG000|Overall Study|Lost to Follow-up|3|||
30605946|NCT01215435|58616744|FG001|Overall Study|Lost to Follow-up|0|||
30605947|NCT01215435|58616743|FG000|Overall Study|Unclassified|5|||
30605948|NCT01215435|58616744|FG001|Overall Study|Unclassified|5|||
30605949|NCT01215357|58616750|FG000|Overall Study|Withdrawal by Subject|3|||
30605950|NCT01215357|58616750|FG000|Overall Study|Protocol Violation|9|||
30696286|NCT00537082|58710669|FG002|Overall Study|Discontinued before initiating treatment|0|||
30696287|NCT03828487|58710677|FG000|Overall Study|Physician Decision|1|||
30965008|NCT01561976|59033550|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
30605951|NCT00984295|58616757|FG000|Overall Study|Lost to Follow-up|31|||
30605952|NCT00984295|58616758|FG001|Overall Study|Lost to Follow-up|12|||
30605953|NCT00984295|58616759|FG002|Overall Study|Lost to Follow-up|13|||
30605954|NCT00984295|58616757|FG000|Overall Study|Protocol Violation|2|||
30605955|NCT00984295|58616758|FG001|Overall Study|Protocol Violation|1|||
30605956|NCT00984295|58616759|FG002|Overall Study|Protocol Violation|4|||
30696288|NCT00324961|58710681|FG000|Overall Study|Adverse Event|5|||
30696289|NCT00324961|58710681|FG000|Overall Study|Consent Withdrawn|11|||
30696290|NCT00324961|58710681|FG000|Overall Study|Lost to Follow-up|22|||
30696291|NCT00324961|58710681|FG000|Overall Study|Protocol Violation|3|||
30696292|NCT00324961|58710681|FG000|Overall Study|Other|2|||
30696293|NCT00324649|58710689|FG000|Overall Study|Adverse Event|1|||
30696294|NCT00324649|58710690|FG001|Overall Study|Adverse Event|4|||
30696295|NCT00324649|58710689|FG000|Overall Study|Withdrawal by Subject|0|||
30696296|NCT00324649|58710690|FG001|Overall Study|Withdrawal by Subject|1|||
30696297|NCT00324649|58710689|FG000|Overall Study|Noncompliance|1|||
30696298|NCT00324649|58710690|FG001|Overall Study|Noncompliance|0|||
30696299|NCT00656370|58710696|FG000|Overall Study|Screen Failures|7|||
30696300|NCT00656370|58710696|FG000|Overall Study|Alternates|3|||
30696301|NCT00680186|58710704|FG000|Overall Study|Adverse Event|47|||
30696302|NCT00680186|58710705|FG001|Overall Study|Adverse Event|44|||
30696303|NCT00680186|58710704|FG000|Overall Study|Protocol Violation|31|||
30696304|NCT00680186|58710705|FG001|Overall Study|Protocol Violation|26|||
30696305|NCT00680186|58710704|FG000|Overall Study|Lost to Follow-up|11|||
30696306|NCT00680186|58710705|FG001|Overall Study|Lost to Follow-up|6|||
30696307|NCT00680186|58710704|FG000|Overall Study|Withdrawal by Subject|32|||
30696308|NCT00680186|58710705|FG001|Overall Study|Withdrawal by Subject|39|||
30696309|NCT00680186|58710704|FG000|Overall Study|Other|4|||
30696310|NCT00680186|58710705|FG001|Overall Study|Other|1|||
30696311|NCT00656292|58710713|FG000|Overall Study|Withdrawal by Subject|2|||
30696312|NCT00656292|58710714|FG001|Overall Study|Withdrawal by Subject|3|||
30696313|NCT00656292|58710713|FG000|Overall Study|Screen failure|1|||
30696314|NCT00656292|58710714|FG001|Overall Study|Screen failure|2|||
30696315|NCT00352417|58710722|FG000|Overall Study|Adverse Event|1|||
30696316|NCT00352417|58710723|FG001|Overall Study|Adverse Event|0|||
30696317|NCT00352417|58710722|FG000|Overall Study|Protocol Violation|0|||
30696318|NCT00352417|58710723|FG001|Overall Study|Protocol Violation|2|||
30696319|NCT00352417|58710722|FG000|Overall Study|Withdrawal by Subject|1|||
30696320|NCT00352417|58710723|FG001|Overall Study|Withdrawal by Subject|2|||
30696321|NCT00352417|58710722|FG000|Overall Study|Lost to Follow-up|1|||
30696322|NCT00352417|58710723|FG001|Overall Study|Lost to Follow-up|0|||
30696323|NCT00352417|58710722|FG000|Overall Study|Schedule Change|2|||
30696324|NCT00352417|58710723|FG001|Overall Study|Schedule Change|1|||
30696325|NCT00323869|58710729|FG000|Overall Study|Death|1|||
30696326|NCT00323557|58710735|FG000|Overall Study|Physician Decision|1|||
30696327|NCT00323557|58710736|FG001|Overall Study|Physician Decision|0|||
30696328|NCT00558363|58710745|FG000|Overall Study|Physician Decision|18|||
30696329|NCT00558363|58710746|FG001|Overall Study|Physician Decision|4|||
30696330|NCT00558363|58710745|FG000|Overall Study|Withdrawal by Subject|11|||
30696331|NCT00558363|58710746|FG001|Overall Study|Withdrawal by Subject|4|||
30696332|NCT00558363|58710745|FG000|Overall Study|Adverse Event|5|||
30696333|NCT00558363|58710746|FG001|Overall Study|Adverse Event|5|||
30696334|NCT00558363|58710745|FG000|Overall Study|Lack of Efficacy|2|||
30696335|NCT00558363|58710746|FG001|Overall Study|Lack of Efficacy|2|||
30696336|NCT00558363|58710745|FG000|Overall Study|Protocol Violation|2|||
30696337|NCT00558363|58710746|FG001|Overall Study|Protocol Violation|1|||
30696338|NCT00558363|58710745|FG000|Overall Study|Lost to Follow-up|0|||
30696339|NCT00558363|58710746|FG001|Overall Study|Lost to Follow-up|1|||
30696340|NCT00558363|58710745|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
30696341|NCT00558363|58710746|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
30696342|NCT00558363|58710745|FG000|Overall Study|Randomized in Error|1|||
30696343|NCT00558363|58710746|FG001|Overall Study|Randomized in Error|2|||
30696344|NCT00558363|58710745|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
30696345|NCT00558363|58710746|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
30696346|NCT00323479|58710752|FG000|Overall Study|Adverse Event|2|||
30696347|NCT00323479|58710752|FG000|Overall Study|Withdrawal by Subject|2|||
30696348|NCT00323479|58710752|FG000|Overall Study|Protocol Violation|3|||
30696349|NCT00323479|58710752|FG000|Overall Study|house moving|1|||
30696350|NCT00352105|58710756|FG000|Overall Study|Death|5|||
30696351|NCT00352105|58710756|FG000|Overall Study|Withdrawal by Subject|5|||
30696352|NCT00352105|58710756|FG000|Overall Study|Lack of Efficacy|9|||
30696353|NCT00352105|58710756|FG000|Overall Study|Adverse Event|19|||
30696354|NCT00352105|58710756|FG000|Overall Study|Protocol Violation|2|||
30696355|NCT00350779|58710762|FG000|Overall Study|Adverse Event|4|||
30696356|NCT00350779|58710763|FG001|Overall Study|Adverse Event|2|||
30696357|NCT00350779|58710762|FG000|Overall Study|Lack of Efficacy|0|||
30696358|NCT00350779|58710763|FG001|Overall Study|Lack of Efficacy|4|||
30696359|NCT00350779|58710762|FG000|Overall Study|Lost to Follow-up|2|||
30696360|NCT00350779|58710763|FG001|Overall Study|Lost to Follow-up|0|||
30696361|NCT00350779|58710762|FG000|Overall Study|Physician Decision|2|||
30696362|NCT00350779|58710763|FG001|Overall Study|Physician Decision|4|||
30696363|NCT00350779|58710762|FG000|Overall Study|Protocol Violation|3|||
30696364|NCT00350779|58710763|FG001|Overall Study|Protocol Violation|1|||
30696365|NCT00350779|58710762|FG000|Overall Study|Withdrawal by Subject|9|||
30696366|NCT00350779|58710763|FG001|Overall Study|Withdrawal by Subject|8|||
30696367|NCT00350779|58710762|FG000|Overall Study|Patient Moved|2|||
30696368|NCT00350779|58710763|FG001|Overall Study|Patient Moved|1|||
30696369|NCT00350779|58710762|FG000|Overall Study|Non-compliance with study procedures|0|||
30696370|NCT00350779|58710763|FG001|Overall Study|Non-compliance with study procedures|1|||
30696371|NCT00350623|58710774|FG000|Overall Study|Lost to Follow-up|8|||
30696372|NCT00350623|58710775|FG001|Overall Study|Lost to Follow-up|3|||
30696373|NCT00350623|58710776|FG002|Overall Study|Lost to Follow-up|4|||
30696374|NCT00350623|58710774|FG000|Overall Study|Withdrawal by Subject|0|||
30696375|NCT00350623|58710775|FG001|Overall Study|Withdrawal by Subject|1|||
30696376|NCT00350623|58710776|FG002|Overall Study|Withdrawal by Subject|1|||
30965009|NCT01561976|59033545|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
30605957|NCT00984295|58616757|FG000|Overall Study|Withdrawal by Subject|18|||
30605958|NCT00984295|58616758|FG001|Overall Study|Withdrawal by Subject|9|||
30605959|NCT00984295|58616759|FG002|Overall Study|Withdrawal by Subject|12|||
30605960|NCT00984295|58616757|FG000|Overall Study|CAE - discontinued test vaccine|0|||
30605961|NCT00984295|58616758|FG001|Overall Study|CAE - discontinued test vaccine|1|||
30605962|NCT00984295|58616759|FG002|Overall Study|CAE - discontinued test vaccine|3|||
30605963|NCT00984295|58616757|FG000|Overall Study|Missed one or more blood samplings|3|||
30605964|NCT00984295|58616758|FG001|Overall Study|Missed one or more blood samplings|7|||
30605965|NCT00984295|58616759|FG002|Overall Study|Missed one or more blood samplings|2|||
30605966|NCT00984295|58616757|FG000|Overall Study|Incomplete safety follow-up|11|||
30605967|NCT00984295|58616758|FG001|Overall Study|Incomplete safety follow-up|2|||
30605968|NCT00984295|58616759|FG002|Overall Study|Incomplete safety follow-up|3|||
30605969|NCT01017952|58616771|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
30605970|NCT01017952|58616772|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
30605971|NCT01017952|58616773|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
30605972|NCT01017952|58616774|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
30605973|NCT01017952|58616775|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
30605974|NCT01017952|58616771|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
30605975|NCT01017952|58616772|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
30605976|NCT01017952|58616773|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
30605977|NCT01017952|58616774|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
30605978|NCT01017952|58616775|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
30605979|NCT01017952|58616771|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
30605980|NCT01017952|58616772|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
30605981|NCT01017952|58616773|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
30605982|NCT01017952|58616774|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
30605983|NCT01017952|58616775|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
30605984|NCT01017952|58616771|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
30605985|NCT01017952|58616772|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
30605986|NCT01017952|58616773|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
30605987|NCT01017952|58616774|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
30605988|NCT01017952|58616775|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
30605989|NCT01017952|58616771|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
30605990|NCT01017952|58616772|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
30605991|NCT01017952|58616773|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
30605992|NCT01017952|58616774|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
30605993|NCT01017952|58616775|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
30605994|NCT01017952|58616771|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
30605995|NCT01017952|58616772|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
30605996|NCT01017952|58616773|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
30605997|NCT01017952|58616774|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
30605998|NCT01017952|58616775|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
30605999|NCT01017952|58616771|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
30606000|NCT01017952|58616772|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
30606001|NCT01017952|58616773|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
30606002|NCT01017952|58616774|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
30606003|NCT01017952|58616775|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
30606004|NCT01017952|58616771|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
30606005|NCT01017952|58616772|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
30606006|NCT01017952|58616773|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
30606007|NCT01017952|58616774|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
30606008|NCT01017952|58616775|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
30606009|NCT01017952|58616771|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
30606010|NCT01017952|58616772|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
30606011|NCT01017952|58616773|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
30606012|NCT01017952|58616774|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
30606013|NCT01017952|58616775|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
30696377|NCT00350623|58710774|FG000|Overall Study|patient traveling outside the country|0|||
30696378|NCT00350623|58710775|FG001|Overall Study|patient traveling outside the country|0|||
30606014|NCT01017952|58616771|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
30606015|NCT01017952|58616772|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
30606016|NCT01017952|58616773|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
30606017|NCT01017952|58616774|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
30606018|NCT01017952|58616775|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
30606019|NCT01017952|58616771|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
30606020|NCT01017952|58616772|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
30606021|NCT01017952|58616773|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
30606022|NCT01017952|58616774|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
30606023|NCT01017952|58616775|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
30606024|NCT01017952|58616771|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
30606025|NCT01017952|58616772|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
30606026|NCT01017952|58616773|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
30606027|NCT01017952|58616774|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
30606028|NCT01017952|58616775|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
30606029|NCT01017952|58616771|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
30606030|NCT01017952|58616772|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
30606031|NCT01017952|58616773|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
30606032|NCT01017952|58616774|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
30606033|NCT01017952|58616775|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
30606034|NCT01017952|58616771|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
30606035|NCT01017952|58616772|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
30606036|NCT01017952|58616773|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
30606037|NCT01017952|58616774|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
30606038|NCT01017952|58616775|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
30606039|NCT01214655|58616788|FG000|Part A|Progressive Disease|7|||
30606040|NCT01214655|58616789|FG001|Part A|Progressive Disease|0|||
30606041|NCT01214655|58616790|FG002|Part A|Progressive Disease|0|||
30606042|NCT01214655|58616788|FG000|Part A|Physician Decision|1|||
30606043|NCT01214655|58616789|FG001|Part A|Physician Decision|0|||
30606044|NCT01214655|58616790|FG002|Part A|Physician Decision|0|||
30606045|NCT01214655|58616788|FG000|Part B|Progressive disease|0|||
30606046|NCT01214655|58616789|FG001|Part B|Progressive disease|10|||
30606047|NCT01214655|58616790|FG002|Part B|Progressive disease|0|||
30606048|NCT01214655|58616788|FG000|Part B|Death|0|||
30606049|NCT01214655|58616789|FG001|Part B|Death|1|||
30606050|NCT01214655|58616790|FG002|Part B|Death|0|||
30606051|NCT01214655|58616788|FG000|Part B|Withdrawal by Subject|0|||
30606052|NCT01214655|58616789|FG001|Part B|Withdrawal by Subject|2|||
30606053|NCT01214655|58616790|FG002|Part B|Withdrawal by Subject|0|||
30606054|NCT01214655|58616788|FG000|Part C|Progressive Disease|0|||
30606055|NCT01214655|58616789|FG001|Part C|Progressive Disease|0|||
30606056|NCT01214655|58616790|FG002|Part C|Progressive Disease|5|||
30606057|NCT01214655|58616788|FG000|Part C|Death|0|||
30606058|NCT01214655|58616789|FG001|Part C|Death|0|||
30606059|NCT01214655|58616790|FG002|Part C|Death|1|||
30606060|NCT01214655|58616788|FG000|Part C|Physician Decision|0|||
30606061|NCT01214655|58616789|FG001|Part C|Physician Decision|0|||
30606062|NCT01214655|58616790|FG002|Part C|Physician Decision|1|||
30606063|NCT01017874|58616838|FG000|Overall Study|Withdrawal by Subject|23|||
30606064|NCT01017874|58616839|FG001|Overall Study|Withdrawal by Subject|20|||
30606065|NCT01017874|58616838|FG000|Overall Study|Sponsor decision|3|||
30606066|NCT01017874|58616839|FG001|Overall Study|Sponsor decision|1|||
30606067|NCT01017874|58616838|FG000|Overall Study|Lost to Follow-up|3|||
30606068|NCT01017874|58616839|FG001|Overall Study|Lost to Follow-up|2|||
30606069|NCT01017874|58616838|FG000|Overall Study|Physician Decision|1|||
30606070|NCT01017874|58616839|FG001|Overall Study|Physician Decision|3|||
30606071|NCT01015768|58616845|FG000|Overall Study|Some subject data unuseable|4|||
30606072|NCT01015768|58616846|FG001|Overall Study|Some subject data unuseable|4|||
30606073|NCT04426630|58616854|FG000|Overall Study|Death|4|||
30606074|NCT04426630|58616854|FG000|Overall Study|Lost to Follow-up|2|||
30965010|NCT01561976|59033546|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
30606075|NCT01010230|58616860|FG000|Overall Study|Withdrawal by Subject|6|||
30606076|NCT01010230|58616861|FG001|Overall Study|Withdrawal by Subject|5|||
30606077|NCT01010230|58616860|FG000|Overall Study|Lost to Follow-up|4|||
30606078|NCT01010230|58616861|FG001|Overall Study|Lost to Follow-up|2|||
30606079|NCT01009840|58616867|FG000|Overall Study|Lost to Follow-up|1|||
30606080|NCT01009840|58616867|FG000|Overall Study|Adverse Event|4|||
30606081|NCT01009840|58616867|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
30606082|NCT01009840|58616867|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
30606083|NCT01009840|58616867|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
30606084|NCT00982657|58616875|FG000|Overall Study|Death|1|||
30606085|NCT00982657|58616876|FG001|Overall Study|Death|0|||
30606086|NCT00982657|58616877|FG002|Overall Study|Death|1|||
30606087|NCT00982657|58616878|FG003|Overall Study|Death|1|||
30606088|NCT00982657|58616875|FG000|Overall Study|Withdrawal by Subject|0|||
30606089|NCT00982657|58616876|FG001|Overall Study|Withdrawal by Subject|0|||
30606090|NCT00982657|58616877|FG002|Overall Study|Withdrawal by Subject|1|||
30606091|NCT00982657|58616878|FG003|Overall Study|Withdrawal by Subject|3|||
30606092|NCT00982657|58616875|FG000|Overall Study|Other|0|||
30606093|NCT00982657|58616876|FG001|Overall Study|Other|0|||
30606094|NCT00982657|58616877|FG002|Overall Study|Other|0|||
30606095|NCT00982657|58616878|FG003|Overall Study|Other|4|||
30606096|NCT00982657|58616875|FG000|Overall Study|On going at date of cut-off|0|||
30606097|NCT00982657|58616876|FG001|Overall Study|On going at date of cut-off|0|||
30606098|NCT00982657|58616877|FG002|Overall Study|On going at date of cut-off|0|||
30606099|NCT00982657|58616878|FG003|Overall Study|On going at date of cut-off|1|||
30606100|NCT01005316|58616901|FG000|Overall Study|Adverse Event|0|||
30606101|NCT01005316|58616902|FG001|Overall Study|Adverse Event|0|||
30606102|NCT01005316|58616903|FG002|Overall Study|Adverse Event|0|||
30606103|NCT01005316|58616904|FG003|Overall Study|Adverse Event|1|||
30606104|NCT01005316|58616901|FG000|Overall Study|Death|20|||
30606105|NCT01005316|58616902|FG001|Overall Study|Death|5|||
30606106|NCT01005316|58616903|FG002|Overall Study|Death|1|||
30606107|NCT01005316|58616904|FG003|Overall Study|Death|15|||
30606108|NCT01005316|58616901|FG000|Overall Study|Study Termination|5|||
30606109|NCT01005316|58616902|FG001|Overall Study|Study Termination|63|||
30606110|NCT01005316|58616903|FG002|Overall Study|Study Termination|9|||
30606111|NCT01005316|58616904|FG003|Overall Study|Study Termination|85|||
30606112|NCT01005316|58616901|FG000|Overall Study|Lost to Follow-up|1|||
30606113|NCT01005316|58616902|FG001|Overall Study|Lost to Follow-up|3|||
30606114|NCT01005316|58616903|FG002|Overall Study|Lost to Follow-up|0|||
30606115|NCT01005316|58616904|FG003|Overall Study|Lost to Follow-up|2|||
30606116|NCT01005316|58616901|FG000|Overall Study|Physician Decision|6|||
30606117|NCT01005316|58616902|FG001|Overall Study|Physician Decision|0|||
30606118|NCT01005316|58616903|FG002|Overall Study|Physician Decision|0|||
30606119|NCT01005316|58616904|FG003|Overall Study|Physician Decision|0|||
30606120|NCT01005316|58616901|FG000|Overall Study|Sponsor Decision|6|||
30606121|NCT01005316|58616902|FG001|Overall Study|Sponsor Decision|3|||
30606122|NCT01005316|58616903|FG002|Overall Study|Sponsor Decision|0|||
30606123|NCT01005316|58616904|FG003|Overall Study|Sponsor Decision|0|||
30606124|NCT01005316|58616901|FG000|Overall Study|Withdrawal by Subject|1|||
30606125|NCT01005316|58616902|FG001|Overall Study|Withdrawal by Subject|1|||
30606126|NCT01005316|58616903|FG002|Overall Study|Withdrawal by Subject|0|||
30606127|NCT01005316|58616904|FG003|Overall Study|Withdrawal by Subject|2|||
30606128|NCT01005316|58616901|FG000|Overall Study|Consented to Another Study|2|||
30606129|NCT01005316|58616902|FG001|Overall Study|Consented to Another Study|0|||
30606130|NCT01005316|58616903|FG002|Overall Study|Consented to Another Study|0|||
30606131|NCT01005316|58616904|FG003|Overall Study|Consented to Another Study|0|||
30606132|NCT01005316|58616901|FG000|Overall Study|Delisted|8|||
30606133|NCT01005316|58616902|FG001|Overall Study|Delisted|0|||
30606134|NCT01005316|58616903|FG002|Overall Study|Delisted|0|||
30606135|NCT01005316|58616904|FG003|Overall Study|Delisted|0|||
30606136|NCT01005316|58616901|FG000|Overall Study|Transferred Care|1|||
30606137|NCT01005316|58616902|FG001|Overall Study|Transferred Care|0|||
30606138|NCT01005316|58616903|FG002|Overall Study|Transferred Care|1|||
30606139|NCT01005316|58616904|FG003|Overall Study|Transferred Care|3|||
30606140|NCT01005316|58616901|FG000|Overall Study|Retransplanted|0|||
30606141|NCT01005316|58616902|FG001|Overall Study|Retransplanted|1|||
30606142|NCT01005316|58616903|FG002|Overall Study|Retransplanted|0|||
30606143|NCT01005316|58616904|FG003|Overall Study|Retransplanted|0|||
30606144|NCT01004848|58616917|FG000|Overall Study|Lost to Follow-up|55|||
30606145|NCT01004848|58616918|FG001|Overall Study|Lost to Follow-up|45|||
30606146|NCT01009294|58616926|FG000|Overall Study|Study discontinued by Sponsor|6|||
30606147|NCT01009060|58616932|FG000|Overall Study|Adverse Event|1|||
30606148|NCT01009060|58616933|FG001|Overall Study|Adverse Event|2|||
30606149|NCT01009060|58616932|FG000|Overall Study|Protocol Violation|0|||
30606150|NCT01009060|58616933|FG001|Overall Study|Protocol Violation|1|||
30606151|NCT01009060|58616932|FG000|Overall Study|Lost to Follow-up|1|||
30696379|NCT00350623|58710776|FG002|Overall Study|patient traveling outside the country|1|||
30606152|NCT01009060|58616933|FG001|Overall Study|Lost to Follow-up|0|||
30606153|NCT01009060|58616932|FG000|Overall Study|Physician Decision|1|||
30606154|NCT01009060|58616933|FG001|Overall Study|Physician Decision|1|||
30606155|NCT01009060|58616932|FG000|Overall Study|Withdrawal by Subject|1|||
30606156|NCT01009060|58616933|FG001|Overall Study|Withdrawal by Subject|1|||
30606157|NCT00988429|58616946|FG000|Overall Study|Adverse Event|9|||
30606158|NCT00988429|58616947|FG001|Overall Study|Adverse Event|21|||
30606159|NCT00988429|58616948|FG002|Overall Study|Adverse Event|45|||
30606160|NCT00988429|58616946|FG000|Overall Study|Lack of Efficacy|0|||
30606161|NCT00988429|58616947|FG001|Overall Study|Lack of Efficacy|0|||
30606162|NCT00988429|58616948|FG002|Overall Study|Lack of Efficacy|1|||
30606163|NCT00988429|58616946|FG000|Overall Study|Non-Compliance with Study Drug|5|||
30606164|NCT00988429|58616947|FG001|Overall Study|Non-Compliance with Study Drug|1|||
30606165|NCT00988429|58616948|FG002|Overall Study|Non-Compliance with Study Drug|3|||
30606166|NCT00988429|58616946|FG000|Overall Study|Physician Decision|1|||
30606167|NCT00988429|58616947|FG001|Overall Study|Physician Decision|0|||
30606168|NCT00988429|58616948|FG002|Overall Study|Physician Decision|3|||
30606169|NCT00988429|58616946|FG000|Overall Study|Pregnancy|2|||
30606170|NCT00988429|58616947|FG001|Overall Study|Pregnancy|1|||
30606171|NCT00988429|58616948|FG002|Overall Study|Pregnancy|0|||
30606172|NCT00988429|58616946|FG000|Overall Study|Protocol Violation|4|||
30606173|NCT00988429|58616947|FG001|Overall Study|Protocol Violation|3|||
30606174|NCT00988429|58616948|FG002|Overall Study|Protocol Violation|3|||
30606175|NCT00988429|58616946|FG000|Overall Study|Withdrawal by Subject|7|||
30606176|NCT00988429|58616947|FG001|Overall Study|Withdrawal by Subject|7|||
30606177|NCT00988429|58616948|FG002|Overall Study|Withdrawal by Subject|12|||
30606178|NCT00988429|58616946|FG000|Overall Study|Administrative Reasons|1|||
30606179|NCT00988429|58616947|FG001|Overall Study|Administrative Reasons|2|||
30606180|NCT00988429|58616948|FG002|Overall Study|Administrative Reasons|1|||
30606181|NCT00988429|58616946|FG000|Overall Study|other reasons|8|||
30606182|NCT00988429|58616947|FG001|Overall Study|other reasons|8|||
30606183|NCT00988429|58616948|FG002|Overall Study|other reasons|1|||
30606184|NCT01008904|58616957|FG000|Overall Study|Lost to Follow-up|1|||
30606185|NCT01008904|58616957|FG000|Overall Study|Adverse Event|2|||
30606186|NCT01008904|58616957|FG000|Overall Study|unexpected unrelated surgery|1|||
30606187|NCT01004614|58616965|FG000|Washout|Withdrawal by Subject|0|||
30606188|NCT01004614|58616966|FG001|Washout|Withdrawal by Subject|1|||
30606189|NCT01004614|58616967|FG002|Washout|Withdrawal by Subject|0|||
30606190|NCT01004614|58616968|FG003|Washout|Withdrawal by Subject|0|||
30606191|NCT00981409|58616980|FG000|Overall Study|Adverse Event|4|||
30606192|NCT00981409|58616981|FG001|Overall Study|Adverse Event|0|||
30606193|NCT00981409|58616980|FG000|Overall Study|Protocol Violation|0|||
30606194|NCT00981409|58616981|FG001|Overall Study|Protocol Violation|1|||
30606195|NCT00981409|58616980|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
30606196|NCT00981409|58616981|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
30606197|NCT01008748|58616987|FG000|Overall Study|Lost to Follow-up|80|||
30606198|NCT01008748|58616987|FG000|Overall Study|Other|1|||
30606199|NCT01004146|58616993|FG000|Overall Study|Withdrawal by Subject|4|||
30606200|NCT01004146|58616994|FG001|Overall Study|Withdrawal by Subject|5|||
30606201|NCT01012414|58617000|FG000|Overall Study|Withdrawal by Subject|2|||
30606202|NCT01012414|58617000|FG000|Overall Study|Lost to Follow-up|1|||
30606203|NCT01012414|58617000|FG000|Overall Study|Trial was stopped before completed|7|||
30606204|NCT00975715|58617008|FG000|Titration Period|Adverse Event|6|||
30606205|NCT00975715|58617009|FG001|Titration Period|Adverse Event|0|||
30606206|NCT00975715|58617008|FG000|Titration Period|Protocol Violation|1|||
30606207|NCT00975715|58617009|FG001|Titration Period|Protocol Violation|0|||
30606208|NCT00975715|58617008|FG000|Maintenance Period|Adverse Event|2|||
30606209|NCT00975715|58617009|FG001|Maintenance Period|Adverse Event|1|||
30606210|NCT03962491|58617017|FG000|Overall Study|Lost to Follow-up|4|||
30606211|NCT03962491|58617018|FG001|Overall Study|Lost to Follow-up|5|||
30606212|NCT00978757|58617026|FG000|Overall Study|Physician Decision|1|||
30606213|NCT00978757|58617027|FG001|Overall Study|Physician Decision|3|||
30606214|NCT01214421|58617037|FG000|Overall Study|Lost to Follow-up|7|||
30606215|NCT01214421|58617038|FG001|Overall Study|Lost to Follow-up|3|||
30606216|NCT01214421|58617039|FG002|Overall Study|Lost to Follow-up|7|||
30606217|NCT01214421|58617040|FG003|Overall Study|Lost to Follow-up|3|||
30606218|NCT01214421|58617037|FG000|Overall Study|Adverse Event|16|||
30606219|NCT01214421|58617038|FG001|Overall Study|Adverse Event|35|||
30606220|NCT01214421|58617039|FG002|Overall Study|Adverse Event|14|||
30606221|NCT01214421|58617040|FG003|Overall Study|Adverse Event|3|||
30606222|NCT01214421|58617037|FG000|Overall Study|Sponsor Discontinued Site|1|||
30606223|NCT01214421|58617038|FG001|Overall Study|Sponsor Discontinued Site|2|||
30606224|NCT01214421|58617039|FG002|Overall Study|Sponsor Discontinued Site|0|||
30606225|NCT01214421|58617040|FG003|Overall Study|Sponsor Discontinued Site|0|||
30606226|NCT01214421|58617037|FG000|Overall Study|Withdrawal Criteria Met|3|||
30606227|NCT01214421|58617038|FG001|Overall Study|Withdrawal Criteria Met|0|||
30606228|NCT01214421|58617039|FG002|Overall Study|Withdrawal Criteria Met|2|||
30606229|NCT01214421|58617040|FG003|Overall Study|Withdrawal Criteria Met|1|||
30606230|NCT01214421|58617037|FG000|Overall Study|Physician Decision|2|||
30606231|NCT01214421|58617038|FG001|Overall Study|Physician Decision|0|||
30606232|NCT01214421|58617039|FG002|Overall Study|Physician Decision|4|||
30606233|NCT01214421|58617040|FG003|Overall Study|Physician Decision|0|||
30606234|NCT01214421|58617037|FG000|Overall Study|Withdrawal by Subject|21|||
30606235|NCT01214421|58617038|FG001|Overall Study|Withdrawal by Subject|18|||
30606236|NCT01214421|58617039|FG002|Overall Study|Withdrawal by Subject|11|||
30606237|NCT01214421|58617040|FG003|Overall Study|Withdrawal by Subject|2|||
30606238|NCT04102111|58617052|FG000|Overall Study|Withdrawal by Subject|2|||
30606239|NCT04102111|58617053|FG001|Overall Study|Withdrawal by Subject|3|||
30696380|NCT00656136|58710786|FG000|Overall Study|Progressive disease|177|||
30606240|NCT04102111|58617052|FG000|Overall Study|Adverse Event|1|||
30606241|NCT04102111|58617053|FG001|Overall Study|Adverse Event|1|||
30606242|NCT04102111|58617052|FG000|Overall Study|Study terminated by sponsor|1|||
30606243|NCT04102111|58617053|FG001|Overall Study|Study terminated by sponsor|3|||
30606244|NCT01214187|58617061|FG000|Overall Study|Adverse Event|6|||
30606245|NCT01214187|58617062|FG001|Overall Study|Adverse Event|2|||
30606246|NCT01214187|58617061|FG000|Overall Study|Death|1|||
30606247|NCT01214187|58617062|FG001|Overall Study|Death|1|||
30606248|NCT01214187|58617061|FG000|Overall Study|Withdrawal by Subject|0|||
30606249|NCT01214187|58617062|FG001|Overall Study|Withdrawal by Subject|3|||
30606250|NCT01003990|58617071|FG000|Overall Study|Adverse Event|8|||
30606251|NCT01003990|58617072|FG001|Overall Study|Adverse Event|5|||
30606252|NCT01003990|58617073|FG002|Overall Study|Adverse Event|11|||
30606253|NCT01003990|58617071|FG000|Overall Study|Death|0|||
30606254|NCT01003990|58617072|FG001|Overall Study|Death|8|||
30606255|NCT01003990|58617073|FG002|Overall Study|Death|1|||
30606256|NCT01003990|58617071|FG000|Overall Study|Lack of Efficacy|10|||
30606257|NCT01003990|58617072|FG001|Overall Study|Lack of Efficacy|2|||
30606258|NCT01003990|58617073|FG002|Overall Study|Lack of Efficacy|3|||
30606259|NCT01003990|58617071|FG000|Overall Study|Lost to Follow-up|30|||
30606260|NCT01003990|58617072|FG001|Overall Study|Lost to Follow-up|12|||
30606261|NCT01003990|58617073|FG002|Overall Study|Lost to Follow-up|7|||
30606262|NCT01003990|58617071|FG000|Overall Study|Reasons Not Identified|14|||
30606263|NCT01003990|58617072|FG001|Overall Study|Reasons Not Identified|13|||
30606264|NCT01003990|58617073|FG002|Overall Study|Reasons Not Identified|8|||
30606265|NCT01003990|58617071|FG000|Overall Study|Poor/Non-compliance|4|||
30606266|NCT01003990|58617072|FG001|Overall Study|Poor/Non-compliance|3|||
30606267|NCT01003990|58617073|FG002|Overall Study|Poor/Non-compliance|2|||
30606268|NCT01003990|58617071|FG000|Overall Study|Pregnancy|10|||
30606269|NCT01003990|58617072|FG001|Overall Study|Pregnancy|2|||
30606270|NCT01003990|58617073|FG002|Overall Study|Pregnancy|4|||
30606271|NCT01003990|58617071|FG000|Overall Study|No Longer Met Study Criteria|4|||
30606272|NCT01003990|58617072|FG001|Overall Study|No Longer Met Study Criteria|1|||
30606273|NCT01003990|58617073|FG002|Overall Study|No Longer Met Study Criteria|0|||
30606274|NCT01003990|58617071|FG000|Overall Study|Subject Withdrew Consent|12|||
30606275|NCT01003990|58617072|FG001|Overall Study|Subject Withdrew Consent|5|||
30606276|NCT01003990|58617073|FG002|Overall Study|Subject Withdrew Consent|7|||
30606277|NCT01003210|58617083|FG000|Overall Study|Lost to Follow-up|1|||
30606278|NCT01003210|58617084|FG001|Overall Study|Lost to Follow-up|3|||
30606279|NCT01002820|58617090|FG000|Overall Study|Adverse Event|1|||
30606280|NCT01002820|58617090|FG000|Overall Study|Withdrawal by Subject|2|||
30606281|NCT01002820|58617090|FG000|Overall Study|Lack of Efficacy|1|||
30606282|NCT01012258|58617094|FG000|Overall Study|Death|14|||
30606283|NCT01012258|58617094|FG000|Overall Study|Lost to Follow-up|1|||
30606284|NCT01012258|58617094|FG000|Overall Study|Adverse Event|1|||
30606285|NCT01012258|58617094|FG000|Overall Study|Progressive Disease (PD)|18|||
30606286|NCT01012258|58617094|FG000|Overall Study|Symptomatic Deterioration|1|||
30606287|NCT01012258|58617094|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
30606288|NCT01012258|58617094|FG000|Overall Study|Another Tumor Discovered|1|||
30606289|NCT01012258|58617094|FG000|Overall Study|Ongoing|29|||
30606290|NCT01011946|58617099|FG000|Overall Study|Transferred to another hospital|2|||
30606291|NCT01011946|58617099|FG000|Overall Study|No pathological lab value|1|||
30606292|NCT00975481|58617103|FG000|Second Intervention Period|Adverse Event|2|||
30606293|NCT00975481|58617104|FG001|Second Intervention Period|Adverse Event|1|||
30606294|NCT00975481|58617105|FG002|Second Intervention Period|Adverse Event|0|||
30606295|NCT00975481|58617106|FG003|Second Intervention Period|Adverse Event|0|||
30606296|NCT00975481|58617107|FG004|Second Intervention Period|Adverse Event|0|||
30606297|NCT00975481|58617108|FG005|Second Intervention Period|Adverse Event|0|||
30606298|NCT00975481|58617103|FG000|Second Intervention Period|Withdrawal by Subject|0|||
30606299|NCT00975481|58617104|FG001|Second Intervention Period|Withdrawal by Subject|0|||
30606300|NCT00975481|58617105|FG002|Second Intervention Period|Withdrawal by Subject|1|||
30606301|NCT00975481|58617106|FG003|Second Intervention Period|Withdrawal by Subject|0|||
30606302|NCT00975481|58617107|FG004|Second Intervention Period|Withdrawal by Subject|0|||
30606303|NCT00975481|58617108|FG005|Second Intervention Period|Withdrawal by Subject|0|||
30606304|NCT00975481|58617103|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
30606305|NCT00975481|58617104|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
30606306|NCT00975481|58617105|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
30606307|NCT00975481|58617106|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
30606308|NCT00975481|58617107|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
30606309|NCT00975481|58617108|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
30965011|NCT01561976|59033547|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
30606310|NCT00975481|58617103|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
30606311|NCT00975481|58617104|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
30606312|NCT00975481|58617105|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
30606313|NCT00975481|58617106|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
30606314|NCT00975481|58617107|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
30606315|NCT00975481|58617108|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
30606316|NCT01011868|58617129|FG000|After Week 18 Follow-up|Adverse Event|8|||
30606317|NCT01011868|58617130|FG001|After Week 18 Follow-up|Adverse Event|6|||
30606318|NCT01011868|58617131|FG002|After Week 18 Follow-up|Adverse Event|13|||
30606319|NCT01011868|58617129|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
30606320|NCT01011868|58617130|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
30606321|NCT01011868|58617131|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
30606322|NCT01011868|58617129|FG000|After Week 18 Follow-up|Protocol Violation|1|||
30606323|NCT01011868|58617130|FG001|After Week 18 Follow-up|Protocol Violation|1|||
30606324|NCT01011868|58617131|FG002|After Week 18 Follow-up|Protocol Violation|1|||
30606325|NCT01011868|58617129|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
30606326|NCT01011868|58617130|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
30606327|NCT01011868|58617131|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
30606328|NCT01011868|58617129|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
30606329|NCT01011868|58617130|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
30606330|NCT01011868|58617131|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
30606331|NCT01011868|58617129|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
30606332|NCT01011868|58617130|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
30606333|NCT01011868|58617131|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
30606334|NCT01011868|58617129|FG000|After Week 78 Follow-up|Adverse Event|14|||
30606335|NCT01011868|58617130|FG001|After Week 78 Follow-up|Adverse Event|18|||
30606336|NCT01011868|58617131|FG002|After Week 78 Follow-up|Adverse Event|21|||
30606337|NCT01011868|58617129|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
30606338|NCT01011868|58617130|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
30606339|NCT01011868|58617131|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
30606340|NCT01011868|58617129|FG000|After Week 78 Follow-up|Protocol Violation|9|||
30606341|NCT01011868|58617130|FG001|After Week 78 Follow-up|Protocol Violation|1|||
30606342|NCT01011868|58617131|FG002|After Week 78 Follow-up|Protocol Violation|2|||
30606343|NCT01011868|58617129|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
30606344|NCT01011868|58617130|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
30606345|NCT01011868|58617131|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
30606346|NCT01011868|58617129|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
30606347|NCT01011868|58617130|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
30606348|NCT01011868|58617131|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
30606349|NCT01011868|58617129|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
30606350|NCT01011868|58617130|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
30606351|NCT01011868|58617131|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
30606352|NCT01213251|58617142|FG000|Overall Study|Death|2|||
30606353|NCT01213251|58617143|FG001|Overall Study|Death|1|||
30606354|NCT01213251|58617144|FG002|Overall Study|Death|2|||
30606355|NCT01213251|58617142|FG000|Overall Study|Exit|3|||
30606356|NCT01213251|58617143|FG001|Overall Study|Exit|2|||
30606357|NCT01213251|58617144|FG002|Overall Study|Exit|8|||
30606358|NCT01213251|58617142|FG000|Overall Study|Protocol Violation|1|||
30606359|NCT01213251|58617143|FG001|Overall Study|Protocol Violation|1|||
30606360|NCT01213251|58617144|FG002|Overall Study|Protocol Violation|0|||
30606361|NCT01213251|58617142|FG000|Overall Study|Missed 18-Month Follow-up|0|||
30606362|NCT01213251|58617143|FG001|Overall Study|Missed 18-Month Follow-up|0|||
30606363|NCT01213251|58617144|FG002|Overall Study|Missed 18-Month Follow-up|1|||
30606364|NCT01213173|58617159|FG000|Overall Study|Protocol Violation|2|||
30606365|NCT01213173|58617160|FG001|Overall Study|Protocol Violation|0|||
30606366|NCT01213173|58617159|FG000|Overall Study|Adverse Event|4|||
30606367|NCT01213173|58617160|FG001|Overall Study|Adverse Event|8|||
30606368|NCT01213173|58617159|FG000|Overall Study|Withdrawal by Subject|5|||
30606369|NCT01213173|58617160|FG001|Overall Study|Withdrawal by Subject|5|||
30606370|NCT01213173|58617159|FG000|Overall Study|Incorrect Enrollment|1|||
30606371|NCT01213173|58617160|FG001|Overall Study|Incorrect Enrollment|3|||
30606372|NCT01212159|58617168|FG000|Overall Study|Withdrawal by Subject|12|||
30606373|NCT01212159|58617169|FG001|Overall Study|Withdrawal by Subject|12|||
30606374|NCT00973765|58617177|FG000|Overall Study|Lost to Follow-up|8|||
30606375|NCT00973765|58617178|FG001|Overall Study|Lost to Follow-up|14|||
30606376|NCT01211769|58617188|FG000|Overall Study|Lost to Follow-up|7|||
30606377|NCT01211769|58617189|FG001|Overall Study|Lost to Follow-up|9|||
30606378|NCT01211769|58617190|FG002|Overall Study|Lost to Follow-up|5|||
30606379|NCT01211769|58617191|FG003|Overall Study|Lost to Follow-up|9|||
30606380|NCT01211769|58617188|FG000|Overall Study|Physician Decision|2|||
30606381|NCT01211769|58617189|FG001|Overall Study|Physician Decision|0|||
30606382|NCT01211769|58617190|FG002|Overall Study|Physician Decision|2|||
30606383|NCT01211769|58617191|FG003|Overall Study|Physician Decision|1|||
30606384|NCT01211769|58617188|FG000|Overall Study|Adverse Event|0|||
30606385|NCT01211769|58617189|FG001|Overall Study|Adverse Event|1|||
30606386|NCT01211769|58617190|FG002|Overall Study|Adverse Event|1|||
30606387|NCT01211769|58617191|FG003|Overall Study|Adverse Event|1|||
30606388|NCT01211613|58617204|FG000|Overall Study|Lost to Follow-up|2|||
30696381|NCT00656136|58710787|FG001|Overall Study|Progressive disease|322|||
30606389|NCT01211613|58617205|FG001|Overall Study|Lost to Follow-up|2|||
30606390|NCT01211613|58617206|FG002|Overall Study|Lost to Follow-up|2|||
30606391|NCT01211613|58617204|FG000|Overall Study|Withdrawal by Subject|1|||
30606392|NCT01211613|58617205|FG001|Overall Study|Withdrawal by Subject|0|||
30606393|NCT01211613|58617206|FG002|Overall Study|Withdrawal by Subject|0|||
30606394|NCT01211535|58617216|FG000|Overall Study|Adverse Event|0|||
30606395|NCT01211535|58617217|FG001|Overall Study|Adverse Event|1|||
30606396|NCT01011556|58617227|FG000|Overall Study|Adverse Event|1|||
30606397|NCT01011556|58617228|FG001|Overall Study|Adverse Event|3|||
30606398|NCT01011556|58617229|FG002|Overall Study|Adverse Event|2|||
30606399|NCT01011556|58617230|FG003|Overall Study|Adverse Event|1|||
30606400|NCT01011556|58617227|FG000|Overall Study|Lost to Follow-up|1|||
30606401|NCT01011556|58617228|FG001|Overall Study|Lost to Follow-up|0|||
30606402|NCT01011556|58617229|FG002|Overall Study|Lost to Follow-up|0|||
30606403|NCT01011556|58617230|FG003|Overall Study|Lost to Follow-up|0|||
30606404|NCT01011556|58617227|FG000|Overall Study|Physician Decision|1|||
30606405|NCT01011556|58617228|FG001|Overall Study|Physician Decision|0|||
30606406|NCT01011556|58617229|FG002|Overall Study|Physician Decision|0|||
30606407|NCT01011556|58617230|FG003|Overall Study|Physician Decision|1|||
30606408|NCT01011556|58617227|FG000|Overall Study|Protocol Violation|0|||
30606409|NCT01011556|58617228|FG001|Overall Study|Protocol Violation|1|||
30606410|NCT01011556|58617229|FG002|Overall Study|Protocol Violation|0|||
30606411|NCT01011556|58617230|FG003|Overall Study|Protocol Violation|0|||
30606412|NCT01011556|58617227|FG000|Overall Study|Withdrawal by Subject|1|||
30606413|NCT01011556|58617228|FG001|Overall Study|Withdrawal by Subject|2|||
30606414|NCT01011556|58617229|FG002|Overall Study|Withdrawal by Subject|4|||
30606415|NCT01011556|58617230|FG003|Overall Study|Withdrawal by Subject|4|||
30606416|NCT01011556|58617227|FG000|Overall Study|Sponsor decision|0|||
30606417|NCT01011556|58617228|FG001|Overall Study|Sponsor decision|1|||
30606418|NCT01011556|58617229|FG002|Overall Study|Sponsor decision|1|||
30606419|NCT01011556|58617230|FG003|Overall Study|Sponsor decision|2|||
30606420|NCT01011556|58617227|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
30606421|NCT01011556|58617228|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
30606422|NCT01011556|58617229|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
30606423|NCT01011556|58617230|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
30606424|NCT01211145|58617247|FG000|Overall Study|Reason not specified|3|||
30606425|NCT01211145|58617248|FG001|Overall Study|Reason not specified|2|||
30606426|NCT01211145|58617249|FG002|Overall Study|Reason not specified|2|||
30606427|NCT01211145|58617250|FG003|Overall Study|Reason not specified|1|||
30606428|NCT01211145|58617247|FG000|Overall Study|Lost to Follow-up|3|||
30606429|NCT01211145|58617248|FG001|Overall Study|Lost to Follow-up|2|||
30606430|NCT01211145|58617249|FG002|Overall Study|Lost to Follow-up|1|||
30606431|NCT01211145|58617250|FG003|Overall Study|Lost to Follow-up|2|||
30606432|NCT01211145|58617247|FG000|Overall Study|Study-specific withdrawal criteria|1|||
30606433|NCT01211145|58617248|FG001|Overall Study|Study-specific withdrawal criteria|0|||
30606434|NCT01211145|58617249|FG002|Overall Study|Study-specific withdrawal criteria|0|||
30606435|NCT01211145|58617250|FG003|Overall Study|Study-specific withdrawal criteria|0|||
30606436|NCT01211145|58617247|FG000|Overall Study|Severe noncompliance to protocol|1|||
30696382|NCT00656136|58710786|FG000|Overall Study|Other Adverse Event|5|||
30696383|NCT00656136|58710787|FG001|Overall Study|Other Adverse Event|51|||
30696384|NCT00656136|58710786|FG000|Overall Study|Protocol Violation|2|||
30696385|NCT00656136|58710787|FG001|Overall Study|Protocol Violation|3|||
30696386|NCT00656136|58710786|FG000|Overall Study|Patient refused to take study medication|7|||
30696387|NCT00656136|58710787|FG001|Overall Study|Patient refused to take study medication|10|||
30696388|NCT00656136|58710786|FG000|Overall Study|Unknown and others|4|||
30696389|NCT00656136|58710787|FG001|Overall Study|Unknown and others|4|||
30696390|NCT00676520|58710793|FG000|Overall Study|Withdrawal by Subject|163|||
30696391|NCT00676520|58710793|FG000|Overall Study|Lost to Follow-up|162|||
30696392|NCT00676520|58710793|FG000|Overall Study|Death|159|||
30696393|NCT00676520|58710793|FG000|Overall Study|Physician Decision|20|||
30696394|NCT00676520|58710793|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
30696395|NCT00676520|58710793|FG000|Overall Study|Other Reason|18|||
30696396|NCT00652938|58710805|FG000|Overall Study|Adverse Event|1|||
30696397|NCT00652938|58710806|FG001|Overall Study|Adverse Event|0|||
30606437|NCT01211145|58617248|FG001|Overall Study|Severe noncompliance to protocol|0|||
30606438|NCT01211145|58617249|FG002|Overall Study|Severe noncompliance to protocol|0|||
30606439|NCT01211145|58617250|FG003|Overall Study|Severe noncompliance to protocol|0|||
30606440|NCT01211145|58617247|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
30606441|NCT01211145|58617248|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
30606442|NCT01211145|58617249|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
30606443|NCT01211145|58617250|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
30606444|NCT01211145|58617247|FG000|Overall Study|Patient decision|2|||
30696398|NCT00652938|58710807|FG002|Overall Study|Adverse Event|2|||
30696399|NCT00652938|58710805|FG000|Overall Study|Withdrawal by Subject|0|||
30696400|NCT00652938|58710806|FG001|Overall Study|Withdrawal by Subject|6|||
30696401|NCT00652938|58710807|FG002|Overall Study|Withdrawal by Subject|1|||
30696402|NCT00652938|58710805|FG000|Overall Study|Lost to Follow-up|0|||
30696403|NCT00652938|58710806|FG001|Overall Study|Lost to Follow-up|0|||
30696404|NCT00652938|58710807|FG002|Overall Study|Lost to Follow-up|2|||
30696405|NCT00652938|58710805|FG000|Overall Study|fear of blood sampling|0|||
30696406|NCT00652938|58710806|FG001|Overall Study|fear of blood sampling|1|||
30696407|NCT00652938|58710807|FG002|Overall Study|fear of blood sampling|0|||
30696408|NCT00322621|58710815|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
30696409|NCT00322621|58710816|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
30696410|NCT00322621|58710817|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
30696411|NCT00322621|58710815|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
30696412|NCT00322621|58710816|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
30696413|NCT00322621|58710817|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
30696414|NCT00322621|58710815|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
30696415|NCT00322621|58710816|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
30696416|NCT00322621|58710817|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
30696417|NCT00322621|58710815|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
30696418|NCT00322621|58710816|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
30696419|NCT00322621|58710817|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
30696420|NCT00322621|58710815|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
30696421|NCT00322621|58710816|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
30696422|NCT00322621|58710817|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
30696423|NCT00322621|58710815|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
30696424|NCT00322621|58710816|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
30696425|NCT00322621|58710817|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
30696426|NCT00322621|58710815|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
30696427|NCT00322621|58710816|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
30696428|NCT00322621|58710817|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
30696429|NCT00322621|58710815|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
30696430|NCT00322621|58710816|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
30696431|NCT00322621|58710817|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
30696432|NCT00322621|58710815|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
30696433|NCT00322621|58710816|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
30696434|NCT00322621|58710817|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
30696435|NCT00322621|58710815|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
30696436|NCT00322621|58710816|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
30696437|NCT00322621|58710817|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
30696438|NCT00322621|58710815|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
30696439|NCT00322621|58710816|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
30696440|NCT00322621|58710817|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
30696441|NCT00575042|58710830|FG000|Overall Study|Adverse Event|2|||
30696442|NCT00575042|58710830|FG000|Overall Study|Lost to Follow-up|1|||
30696443|NCT00676208|58710837|FG000|Overall Study|Lost to Follow-up|0|||
30696444|NCT00676208|58710838|FG001|Overall Study|Lost to Follow-up|2|||
30696445|NCT00676208|58710837|FG000|Overall Study|Incomplete data|2|||
30696446|NCT00676208|58710838|FG001|Overall Study|Incomplete data|4|||
30696447|NCT00656058|58710846|FG000|Overall Study|Withdrawal by Subject|2|||
30696448|NCT00656058|58710846|FG000|Overall Study|Withdrawal by Subject|4|||
30696449|NCT00537316|58710856|FG000|Part 1|Adverse Event|7|||
30696450|NCT00537316|58710857|FG001|Part 1|Adverse Event|11|||
30696451|NCT00537316|58710858|FG002|Part 1|Adverse Event|8|||
30696452|NCT00537316|58710859|FG003|Part 1|Adverse Event|0|||
30606445|NCT01211145|58617248|FG001|Overall Study|Patient decision|1|||
30606446|NCT01211145|58617249|FG002|Overall Study|Patient decision|0|||
30696453|NCT00537316|58710860|FG004|Part 1|Adverse Event|0|||
30696454|NCT00537316|58710861|FG005|Part 1|Adverse Event|0|||
30696455|NCT00537316|58710862|FG006|Part 1|Adverse Event|0|||
30696456|NCT00537316|58710856|FG000|Part 1|Protocol defined clinical event|1|||
30606447|NCT01211145|58617250|FG003|Overall Study|Patient decision|2|||
30606448|NCT00977665|58617262|FG000|Overall Study|Withdrawal by Subject|1|||
30606449|NCT00977665|58617263|FG001|Overall Study|Withdrawal by Subject|3|||
30606450|NCT00977665|58617262|FG000|Overall Study|Physician Decision|2|||
30606451|NCT00977665|58617263|FG001|Overall Study|Physician Decision|1|||
30606452|NCT00977665|58617262|FG000|Overall Study|Sponsor requested withdrawal|0|||
30606453|NCT00977665|58617263|FG001|Overall Study|Sponsor requested withdrawal|1|||
30606454|NCT00977665|58617262|FG000|Overall Study|Lost to Follow-up|1|||
30606455|NCT00977665|58617263|FG001|Overall Study|Lost to Follow-up|0|||
30606456|NCT00977665|58617262|FG000|Overall Study|Death|3|||
30606457|NCT00977665|58617263|FG001|Overall Study|Death|2|||
30606458|NCT00977665|58617262|FG000|Overall Study|Adverse Event|14|||
30606459|NCT00977665|58617263|FG001|Overall Study|Adverse Event|7|||
30606460|NCT00977665|58617262|FG000|Overall Study|Treatment failure|0|||
30606461|NCT00977665|58617263|FG001|Overall Study|Treatment failure|1|||
30606462|NCT01210443|58617269|FG000|Overall Study|Study terminated by sponsor|2|||
30606463|NCT01007812|58617273|FG000|Period 1, One Week|Lost to Follow-up|0|||
30606464|NCT01007812|58617274|FG001|Period 1, One Week|Lost to Follow-up|1|||
30606465|NCT01007812|58617273|FG000|Period 1, One Week|Discomfort|1|||
30606466|NCT01007812|58617274|FG001|Period 1, One Week|Discomfort|0|||
30606467|NCT01208961|58617280|FG000|High-Fat Period III|Protocol Violation|1|||
30696457|NCT00537316|58710857|FG001|Part 1|Protocol defined clinical event|0|||
30696458|NCT00537316|58710858|FG002|Part 1|Protocol defined clinical event|0|||
30696459|NCT00537316|58710859|FG003|Part 1|Protocol defined clinical event|0|||
30696460|NCT00537316|58710860|FG004|Part 1|Protocol defined clinical event|0|||
30696461|NCT00537316|58710861|FG005|Part 1|Protocol defined clinical event|0|||
30696462|NCT00537316|58710862|FG006|Part 1|Protocol defined clinical event|0|||
30696463|NCT00537316|58710856|FG000|Part 1|Lost to Follow-up|1|||
30696464|NCT00537316|58710857|FG001|Part 1|Lost to Follow-up|0|||
30696465|NCT00537316|58710858|FG002|Part 1|Lost to Follow-up|0|||
30696466|NCT00537316|58710859|FG003|Part 1|Lost to Follow-up|0|||
30696467|NCT00537316|58710860|FG004|Part 1|Lost to Follow-up|0|||
30696468|NCT00537316|58710861|FG005|Part 1|Lost to Follow-up|0|||
30696469|NCT00537316|58710862|FG006|Part 1|Lost to Follow-up|0|||
30696470|NCT00537316|58710856|FG000|Part 1|Withdrawal by Subject|3|||
30696471|NCT00537316|58710857|FG001|Part 1|Withdrawal by Subject|8|||
30696472|NCT00537316|58710858|FG002|Part 1|Withdrawal by Subject|4|||
30696473|NCT00537316|58710859|FG003|Part 1|Withdrawal by Subject|0|||
30696474|NCT00537316|58710860|FG004|Part 1|Withdrawal by Subject|0|||
30696475|NCT00537316|58710861|FG005|Part 1|Withdrawal by Subject|0|||
30696476|NCT00537316|58710862|FG006|Part 1|Withdrawal by Subject|0|||
30696477|NCT00537316|58710856|FG000|Part 1|Protocol Violation|1|||
30696478|NCT00537316|58710857|FG001|Part 1|Protocol Violation|5|||
30696479|NCT00537316|58710858|FG002|Part 1|Protocol Violation|1|||
30696480|NCT00537316|58710859|FG003|Part 1|Protocol Violation|0|||
30696481|NCT00537316|58710860|FG004|Part 1|Protocol Violation|0|||
30696482|NCT00537316|58710861|FG005|Part 1|Protocol Violation|0|||
30696483|NCT00537316|58710862|FG006|Part 1|Protocol Violation|0|||
30696484|NCT00537316|58710856|FG000|Part 1|Did not meet protocol eligibility|1|||
30696485|NCT00537316|58710857|FG001|Part 1|Did not meet protocol eligibility|3|||
30696486|NCT00537316|58710858|FG002|Part 1|Did not meet protocol eligibility|2|||
30696487|NCT00537316|58710859|FG003|Part 1|Did not meet protocol eligibility|0|||
30696488|NCT00537316|58710860|FG004|Part 1|Did not meet protocol eligibility|0|||
30696489|NCT00537316|58710861|FG005|Part 1|Did not meet protocol eligibility|0|||
30696490|NCT00537316|58710862|FG006|Part 1|Did not meet protocol eligibility|0|||
30696491|NCT00537316|58710856|FG000|Part 1|Administrative|0|||
30696492|NCT00537316|58710857|FG001|Part 1|Administrative|0|||
30696493|NCT00537316|58710858|FG002|Part 1|Administrative|2|||
30696494|NCT00537316|58710859|FG003|Part 1|Administrative|0|||
30696495|NCT00537316|58710860|FG004|Part 1|Administrative|0|||
30696496|NCT00537316|58710861|FG005|Part 1|Administrative|0|||
30696497|NCT00537316|58710862|FG006|Part 1|Administrative|0|||
30696498|NCT00537316|58710856|FG000|Part 2|Never entered follow-up|0|||
30696499|NCT00537316|58710857|FG001|Part 2|Never entered follow-up|0|||
30696500|NCT00537316|58710858|FG002|Part 2|Never entered follow-up|0|||
30696501|NCT00537316|58710859|FG003|Part 2|Never entered follow-up|0|||
30696502|NCT00537316|58710860|FG004|Part 2|Never entered follow-up|0|||
30696503|NCT00537316|58710861|FG005|Part 2|Never entered follow-up|0|||
30696504|NCT00537316|58710862|FG006|Part 2|Never entered follow-up|1|||
30696505|NCT00537316|58710856|FG000|Part 2|Adverse Event|4|||
30696506|NCT00537316|58710857|FG001|Part 2|Adverse Event|0|||
30696507|NCT00537316|58710858|FG002|Part 2|Adverse Event|2|||
30696508|NCT00537316|58710859|FG003|Part 2|Adverse Event|0|||
30696509|NCT00537316|58710860|FG004|Part 2|Adverse Event|0|||
30696510|NCT00537316|58710861|FG005|Part 2|Adverse Event|0|||
30696511|NCT00537316|58710862|FG006|Part 2|Adverse Event|0|||
30696512|NCT00537316|58710856|FG000|Part 2|Lost to Follow-up|1|||
30696513|NCT00537316|58710857|FG001|Part 2|Lost to Follow-up|0|||
30696514|NCT00537316|58710858|FG002|Part 2|Lost to Follow-up|2|||
30696515|NCT00537316|58710859|FG003|Part 2|Lost to Follow-up|0|||
30696516|NCT00537316|58710860|FG004|Part 2|Lost to Follow-up|0|||
30696517|NCT00537316|58710861|FG005|Part 2|Lost to Follow-up|0|||
30696518|NCT00537316|58710862|FG006|Part 2|Lost to Follow-up|0|||
30696519|NCT00537316|58710856|FG000|Part 2|Withdrawal by Subject|5|||
30696520|NCT00537316|58710857|FG001|Part 2|Withdrawal by Subject|1|||
30696521|NCT00537316|58710858|FG002|Part 2|Withdrawal by Subject|4|||
30696522|NCT00537316|58710859|FG003|Part 2|Withdrawal by Subject|0|||
30696523|NCT00537316|58710860|FG004|Part 2|Withdrawal by Subject|0|||
30696524|NCT00537316|58710861|FG005|Part 2|Withdrawal by Subject|0|||
30696525|NCT00537316|58710862|FG006|Part 2|Withdrawal by Subject|0|||
30696526|NCT00537316|58710856|FG000|Part 2|Administrative|16|||
30696527|NCT00537316|58710857|FG001|Part 2|Administrative|8|||
30696528|NCT00537316|58710858|FG002|Part 2|Administrative|24|||
30696529|NCT00537316|58710859|FG003|Part 2|Administrative|3|||
30696530|NCT00537316|58710860|FG004|Part 2|Administrative|1|||
30696531|NCT00537316|58710861|FG005|Part 2|Administrative|4|||
30696532|NCT00537316|58710862|FG006|Part 2|Administrative|1|||
30696533|NCT03827395|58710883|FG000|Overall Study|Lost to Follow-up|1|||
30696534|NCT03827395|58710884|FG001|Overall Study|Lost to Follow-up|0|||
30696535|NCT03827395|58710883|FG000|Overall Study|Protocol Violation|1|||
30696536|NCT03827395|58710884|FG001|Overall Study|Protocol Violation|0|||
30696537|NCT03827395|58710883|FG000|Overall Study|Became ineligible after enrollment|1|||
30696538|NCT03827395|58710884|FG001|Overall Study|Became ineligible after enrollment|2|||
30696539|NCT00655980|58710893|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
30696540|NCT00655980|58710894|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
30696541|NCT00655980|58710895|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
30696542|NCT00679172|58710911|FG000|Overall Study|Non-compliance|1|||
30696543|NCT00679172|58710912|FG001|Overall Study|Non-compliance|1|||
30696544|NCT00679172|58710913|FG002|Overall Study|Non-compliance|0|||
30696545|NCT00679172|58710914|FG003|Overall Study|Non-compliance|1|||
30696546|NCT00679172|58710915|FG004|Overall Study|Non-compliance|0|||
30696547|NCT00679172|58710911|FG000|Overall Study|Other not specified|0|||
30696548|NCT00679172|58710912|FG001|Overall Study|Other not specified|0|||
30696549|NCT00679172|58710913|FG002|Overall Study|Other not specified|1|||
30696550|NCT00679172|58710914|FG003|Overall Study|Other not specified|0|||
30696551|NCT00679172|58710915|FG004|Overall Study|Other not specified|0|||
30696552|NCT00676130|58710932|FG000|Overall Study|Lost to Follow-up|0|||
30696553|NCT00676130|58710933|FG001|Overall Study|Lost to Follow-up|1|||
30696554|NCT00676130|58710932|FG000|Overall Study|Found ineligible|3|||
30696555|NCT00676130|58710933|FG001|Overall Study|Found ineligible|2|||
30696556|NCT00676130|58710932|FG000|Overall Study|Withdrawal by Subject|0|||
30696557|NCT00676130|58710933|FG001|Overall Study|Withdrawal by Subject|1|||
30696558|NCT00676052|58710945|FG000|Overall Study|Adverse Event|0|||
30696559|NCT00676052|58710946|FG001|Overall Study|Adverse Event|1|||
30696560|NCT00676052|58710947|FG002|Overall Study|Adverse Event|1|||
30696561|NCT00676052|58710948|FG003|Overall Study|Adverse Event|2|||
30696562|NCT00676052|58710949|FG004|Overall Study|Adverse Event|2|||
30696563|NCT00676052|58710950|FG005|Overall Study|Adverse Event|2|||
30696564|NCT00676052|58710945|FG000|Overall Study|Lack of Efficacy|2|||
30696565|NCT00676052|58710946|FG001|Overall Study|Lack of Efficacy|2|||
30696566|NCT00676052|58710947|FG002|Overall Study|Lack of Efficacy|1|||
30696567|NCT00676052|58710948|FG003|Overall Study|Lack of Efficacy|1|||
30696568|NCT00676052|58710949|FG004|Overall Study|Lack of Efficacy|2|||
30696569|NCT00676052|58710950|FG005|Overall Study|Lack of Efficacy|1|||
30696570|NCT00676052|58710945|FG000|Overall Study|Protocol Violation|5|||
30696571|NCT00676052|58710946|FG001|Overall Study|Protocol Violation|3|||
30696572|NCT00676052|58710947|FG002|Overall Study|Protocol Violation|2|||
30696573|NCT00676052|58710948|FG003|Overall Study|Protocol Violation|2|||
30696574|NCT00676052|58710949|FG004|Overall Study|Protocol Violation|1|||
30696575|NCT00676052|58710950|FG005|Overall Study|Protocol Violation|2|||
30696576|NCT00676052|58710945|FG000|Overall Study|Lost to Follow-up|0|||
30696577|NCT00676052|58710946|FG001|Overall Study|Lost to Follow-up|0|||
30696578|NCT00676052|58710947|FG002|Overall Study|Lost to Follow-up|0|||
30696579|NCT00676052|58710948|FG003|Overall Study|Lost to Follow-up|0|||
30696580|NCT00676052|58710949|FG004|Overall Study|Lost to Follow-up|1|||
30696581|NCT00676052|58710950|FG005|Overall Study|Lost to Follow-up|0|||
30696582|NCT00676052|58710945|FG000|Overall Study|Physician Decision|1|||
30696583|NCT00676052|58710946|FG001|Overall Study|Physician Decision|1|||
30696584|NCT00676052|58710947|FG002|Overall Study|Physician Decision|1|||
30696585|NCT00676052|58710948|FG003|Overall Study|Physician Decision|0|||
30696586|NCT00676052|58710949|FG004|Overall Study|Physician Decision|0|||
30696587|NCT00676052|58710950|FG005|Overall Study|Physician Decision|1|||
30696588|NCT00676052|58710945|FG000|Overall Study|Withdrawal by Subject|1|||
30696589|NCT00676052|58710946|FG001|Overall Study|Withdrawal by Subject|0|||
30696590|NCT00676052|58710947|FG002|Overall Study|Withdrawal by Subject|1|||
30696591|NCT00676052|58710948|FG003|Overall Study|Withdrawal by Subject|0|||
30696592|NCT00676052|58710949|FG004|Overall Study|Withdrawal by Subject|0|||
30696593|NCT00676052|58710950|FG005|Overall Study|Withdrawal by Subject|0|||
30696594|NCT00535288|58710969|FG000|Overall Study|Adverse Event|20|||
30696595|NCT00535288|58710970|FG001|Overall Study|Adverse Event|19|||
30696596|NCT00535288|58710971|FG002|Overall Study|Adverse Event|25|||
30696597|NCT00535288|58710972|FG003|Overall Study|Adverse Event|20|||
30696598|NCT00535288|58710973|FG004|Overall Study|Adverse Event|30|||
30696599|NCT00535288|58710969|FG000|Overall Study|Lost to Follow-up|0|||
30696600|NCT00535288|58710970|FG001|Overall Study|Lost to Follow-up|3|||
30696601|NCT00535288|58710971|FG002|Overall Study|Lost to Follow-up|0|||
30696602|NCT00535288|58710972|FG003|Overall Study|Lost to Follow-up|0|||
30696603|NCT00535288|58710973|FG004|Overall Study|Lost to Follow-up|0|||
30696604|NCT00535288|58710969|FG000|Overall Study|Lack of Efficacy|26|||
30696605|NCT00535288|58710970|FG001|Overall Study|Lack of Efficacy|3|||
30696606|NCT00535288|58710971|FG002|Overall Study|Lack of Efficacy|4|||
30696607|NCT00535288|58710972|FG003|Overall Study|Lack of Efficacy|4|||
30696608|NCT00535288|58710973|FG004|Overall Study|Lack of Efficacy|7|||
30696609|NCT00535288|58710969|FG000|Overall Study|Unwilling to cooperate|6|||
30696610|NCT00535288|58710970|FG001|Overall Study|Unwilling to cooperate|6|||
30696611|NCT00535288|58710971|FG002|Overall Study|Unwilling to cooperate|3|||
30696612|NCT00535288|58710972|FG003|Overall Study|Unwilling to cooperate|3|||
30696613|NCT00535288|58710973|FG004|Overall Study|Unwilling to cooperate|4|||
30696614|NCT00535288|58710969|FG000|Overall Study|Other|2|||
30696615|NCT00535288|58710970|FG001|Overall Study|Other|1|||
30696616|NCT00535288|58710971|FG002|Overall Study|Other|1|||
30696617|NCT00535288|58710972|FG003|Overall Study|Other|2|||
30696618|NCT00535288|58710973|FG004|Overall Study|Other|1|||
30696619|NCT03904420|58710992|FG000|Overall Study|Study terminated|2|||
30696620|NCT03904420|58710993|FG001|Overall Study|Study terminated|2|||
30696621|NCT00675506|58711001|FG000|Overall Study|Lost to Follow-up|1|||
30696622|NCT00675506|58711002|FG001|Overall Study|Lost to Follow-up|5|||
30696623|NCT00675506|58711001|FG000|Overall Study|Lost interest|3|||
30696624|NCT00675506|58711002|FG001|Overall Study|Lost interest|5|||
30696625|NCT00675506|58711001|FG000|Overall Study|Elevated fasting glucose|2|||
30696626|NCT00675506|58711002|FG001|Overall Study|Elevated fasting glucose|1|||
30696627|NCT00675506|58711001|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
30696628|NCT00675506|58711002|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
30696629|NCT00675506|58711001|FG000|Overall Study|Elevated IGF-1|2|||
30696630|NCT00675506|58711002|FG001|Overall Study|Elevated IGF-1|0|||
30696631|NCT00675506|58711001|FG000|Overall Study|Hypersensitivity Reaction|1|||
30696632|NCT00675506|58711002|FG001|Overall Study|Hypersensitivity Reaction|0|||
30696633|NCT00675506|58711001|FG000|Overall Study|Disclosed history of cancer|1|||
30696634|NCT00675506|58711002|FG001|Overall Study|Disclosed history of cancer|0|||
30696635|NCT00675506|58711001|FG000|Overall Study|Declined participation|1|||
30696636|NCT00675506|58711002|FG001|Overall Study|Declined participation|0|||
30696637|NCT00675506|58711001|FG000|Overall Study|Schedule conflict|0|||
30696638|NCT00675506|58711002|FG001|Overall Study|Schedule conflict|1|||
30696639|NCT03895840|58711009|FG000|Overall Study|Withdrawal by Subject|21|||
30696640|NCT00310375|58711015|FG000|Primary Reporting Phase|Adverse Event|28|||
30696641|NCT00310375|58711016|FG001|Primary Reporting Phase|Adverse Event|22|||
30696642|NCT00310375|58711017|FG002|Primary Reporting Phase|Adverse Event|0|||
30696643|NCT00310375|58711015|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
30696644|NCT00310375|58711016|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
30696645|NCT00310375|58711017|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
30696646|NCT00310375|58711015|FG000|Primary Reporting Phase|Pregnancy|2|||
30696647|NCT00310375|58711016|FG001|Primary Reporting Phase|Pregnancy|2|||
30696648|NCT00310375|58711017|FG002|Primary Reporting Phase|Pregnancy|0|||
30696649|NCT00310375|58711015|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
30696650|NCT00310375|58711016|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
30696651|NCT00310375|58711017|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
30696652|NCT00310375|58711015|FG000|Primary Reporting Phase|Protocol Violation|8|||
30696653|NCT00310375|58711016|FG001|Primary Reporting Phase|Protocol Violation|5|||
30696654|NCT00310375|58711017|FG002|Primary Reporting Phase|Protocol Violation|0|||
30696655|NCT00310375|58711015|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
30696656|NCT00310375|58711016|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
30696657|NCT00310375|58711017|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
30696658|NCT00310375|58711015|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
30696659|NCT00310375|58711016|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
30696660|NCT00310375|58711017|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
30696661|NCT00310375|58711015|FG000|Primary Reporting Phase|Physician Decision|5|||
30696662|NCT00310375|58711016|FG001|Primary Reporting Phase|Physician Decision|3|||
30696663|NCT00310375|58711017|FG002|Primary Reporting Phase|Physician Decision|0|||
30696664|NCT00310375|58711015|FG000|Primary Reporting Phase|Request of the sponsor|2|||
30696665|NCT00310375|58711016|FG001|Primary Reporting Phase|Request of the sponsor|2|||
30696666|NCT00310375|58711017|FG002|Primary Reporting Phase|Request of the sponsor|0|||
30696667|NCT00310375|58711015|FG000|Primary Reporting Phase|Failed to return|1|||
30696668|NCT00310375|58711016|FG001|Primary Reporting Phase|Failed to return|3|||
30696669|NCT00310375|58711017|FG002|Primary Reporting Phase|Failed to return|0|||
30696670|NCT00310375|58711015|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
30696671|NCT00310375|58711016|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
30696672|NCT00310375|58711017|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
30696673|NCT00310375|58711015|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
30696674|NCT00310375|58711016|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
30696675|NCT00310375|58711017|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
30696676|NCT00310375|58711015|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
30696677|NCT00310375|58711016|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
30696678|NCT00310375|58711017|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
30696679|NCT00310375|58711015|FG000|Primary Reporting Phase|Site closure|3|||
30696680|NCT00310375|58711016|FG001|Primary Reporting Phase|Site closure|0|||
30696681|NCT00310375|58711017|FG002|Primary Reporting Phase|Site closure|0|||
30696682|NCT00310375|58711015|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
30696683|NCT00310375|58711016|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
30696684|NCT00310375|58711017|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
30696685|NCT00310375|58711015|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
30696686|NCT00310375|58711016|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
30696687|NCT00310375|58711017|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
30696688|NCT00310375|58711015|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
30696689|NCT00310375|58711016|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
30965012|NCT01561976|59033548|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
30696690|NCT00310375|58711017|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
30696691|NCT00310375|58711015|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
30696692|NCT00310375|58711016|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
30696693|NCT00310375|58711017|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
30696694|NCT00309907|58711026|FG000|Overall Study|Death|4|||
30696695|NCT00309907|58711026|FG000|Overall Study|Physician Decision|1|||
30696696|NCT00309907|58711026|FG000|Overall Study|Ineligible|11|||
30696697|NCT00309907|58711026|FG000|Overall Study|Major infectious event|4|||
30696698|NCT00655824|58711031|FG000|Overall Study|Adverse Event|3|||
30696699|NCT00655824|58711031|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
30696700|NCT00655824|58711031|FG000|Overall Study|Protocol Violation|1|||
30696701|NCT00655824|58711031|FG000|Overall Study|Withdrawal by Subject|4|||
30696702|NCT00655824|58711031|FG000|Overall Study|Deterioration of Trial Disease|2|||
30696703|NCT00575588|58711037|FG000|Overall Study|Adverse Event|11|||
30696704|NCT00575588|58711038|FG001|Overall Study|Adverse Event|13|||
30696705|NCT00575588|58711037|FG000|Overall Study|Withdrawal by Subject|27|||
30696706|NCT00575588|58711038|FG001|Overall Study|Withdrawal by Subject|31|||
30696707|NCT00575588|58711037|FG000|Overall Study|Lost to Follow-up|1|||
30696708|NCT00575588|58711038|FG001|Overall Study|Lost to Follow-up|3|||
30696709|NCT00575588|58711037|FG000|Overall Study|Death|4|||
30696710|NCT00575588|58711038|FG001|Overall Study|Death|2|||
30696711|NCT00575588|58711037|FG000|Overall Study|Incorrect enrollment|8|||
30696712|NCT00575588|58711038|FG001|Overall Study|Incorrect enrollment|4|||
30696713|NCT00575588|58711037|FG000|Overall Study|Study specific discontinuation criteria|203|||
30696714|NCT00575588|58711038|FG001|Overall Study|Study specific discontinuation criteria|218|||
30696715|NCT00575588|58711037|FG000|Overall Study|Severe non-compliance to protocol|5|||
30696716|NCT00575588|58711038|FG001|Overall Study|Severe non-compliance to protocol|7|||
30696717|NCT00575588|58711037|FG000|Overall Study|Safety reasons|2|||
30696718|NCT00575588|58711038|FG001|Overall Study|Safety reasons|1|||
30696719|NCT00575588|58711037|FG000|Overall Study|Elevated triglyceride|1|||
30696720|NCT00575588|58711038|FG001|Overall Study|Elevated triglyceride|0|||
30696721|NCT00575588|58711037|FG000|Overall Study|Patient moved|1|||
30696722|NCT00575588|58711038|FG001|Overall Study|Patient moved|3|||
30696723|NCT00575588|58711037|FG000|Overall Study|Impossible to determine HbA1c|0|||
30696724|NCT00575588|58711038|FG001|Overall Study|Impossible to determine HbA1c|1|||
30696725|NCT00675428|58711046|FG000|Overall Study|Disease Progression|2|||
30696726|NCT00675428|58711047|FG001|Overall Study|Disease Progression|2|||
30696727|NCT00675428|58711046|FG000|Overall Study|No Disease Response After Cycle 6|0|||
30696728|NCT00675428|58711047|FG001|Overall Study|No Disease Response After Cycle 6|1|||
30696729|NCT00675428|58711046|FG000|Overall Study|Physician Decision|1|||
30696730|NCT00675428|58711047|FG001|Overall Study|Physician Decision|0|||
30696731|NCT00557505|58711071|FG000|Overall Study|Death|0|||
30696732|NCT00557505|58711072|FG001|Overall Study|Death|0|||
30696733|NCT00557505|58711073|FG002|Overall Study|Death|0|||
30696734|NCT00557505|58711074|FG003|Overall Study|Death|0|||
30696735|NCT00557505|58711075|FG004|Overall Study|Death|0|||
30696736|NCT00557505|58711076|FG005|Overall Study|Death|0|||
30696737|NCT00557505|58711077|FG006|Overall Study|Death|0|||
30696738|NCT00557505|58711078|FG007|Overall Study|Death|0|||
30696739|NCT00557505|58711079|FG008|Overall Study|Death|1|||
30696740|NCT00557505|58711071|FG000|Overall Study|Adverse Event|0|||
30696741|NCT00557505|58711072|FG001|Overall Study|Adverse Event|0|||
30696742|NCT00557505|58711073|FG002|Overall Study|Adverse Event|1|||
30696743|NCT00557505|58711074|FG003|Overall Study|Adverse Event|0|||
30696744|NCT00557505|58711075|FG004|Overall Study|Adverse Event|0|||
30696745|NCT00557505|58711076|FG005|Overall Study|Adverse Event|0|||
30696746|NCT00557505|58711077|FG006|Overall Study|Adverse Event|1|||
30696747|NCT00557505|58711078|FG007|Overall Study|Adverse Event|0|||
30696748|NCT00557505|58711079|FG008|Overall Study|Adverse Event|0|||
30696749|NCT00557505|58711071|FG000|Overall Study|Global deterioration of health|1|||
30696750|NCT00557505|58711072|FG001|Overall Study|Global deterioration of health|0|||
30696751|NCT00557505|58711073|FG002|Overall Study|Global deterioration of health|0|||
30696752|NCT00557505|58711074|FG003|Overall Study|Global deterioration of health|0|||
30696753|NCT00557505|58711075|FG004|Overall Study|Global deterioration of health|0|||
30696754|NCT00557505|58711076|FG005|Overall Study|Global deterioration of health|0|||
30696755|NCT00557505|58711077|FG006|Overall Study|Global deterioration of health|0|||
30696756|NCT00557505|58711078|FG007|Overall Study|Global deterioration of health|0|||
30696757|NCT00557505|58711079|FG008|Overall Study|Global deterioration of health|0|||
30696758|NCT00557505|58711071|FG000|Overall Study|Objective progression or relapse|2|||
30696759|NCT00557505|58711072|FG001|Overall Study|Objective progression or relapse|3|||
30696760|NCT00557505|58711073|FG002|Overall Study|Objective progression or relapse|3|||
30696761|NCT00557505|58711074|FG003|Overall Study|Objective progression or relapse|2|||
30696762|NCT00557505|58711075|FG004|Overall Study|Objective progression or relapse|2|||
30696763|NCT00557505|58711076|FG005|Overall Study|Objective progression or relapse|3|||
30696764|NCT00557505|58711077|FG006|Overall Study|Objective progression or relapse|2|||
30696765|NCT00557505|58711078|FG007|Overall Study|Objective progression or relapse|5|||
30696766|NCT00557505|58711079|FG008|Overall Study|Objective progression or relapse|15|||
30696767|NCT00557505|58711071|FG000|Overall Study|Withdrawal by Subject|0|||
30696768|NCT00557505|58711072|FG001|Overall Study|Withdrawal by Subject|0|||
30696769|NCT00557505|58711073|FG002|Overall Study|Withdrawal by Subject|0|||
30696770|NCT00557505|58711074|FG003|Overall Study|Withdrawal by Subject|1|||
30696771|NCT00557505|58711075|FG004|Overall Study|Withdrawal by Subject|0|||
30696772|NCT00557505|58711076|FG005|Overall Study|Withdrawal by Subject|0|||
30696773|NCT00557505|58711077|FG006|Overall Study|Withdrawal by Subject|0|||
30696774|NCT00557505|58711078|FG007|Overall Study|Withdrawal by Subject|0|||
30696775|NCT00557505|58711079|FG008|Overall Study|Withdrawal by Subject|1|||
30696776|NCT00674570|58711105|FG000|Overall Study|Withdrawal by Subject|0|||
30876275|NCT01959880|58907461|FG000|Overall Study|Study completed early-FDA approved|1003|||
30876276|NCT01959880|58907462|FG001|Overall Study|Study completed early-FDA approved|311|||
30876277|NCT01959880|58907463|FG002|Overall Study|Study completed early-FDA approved|179|||
30876278|NCT01959880|58907464|FG003|Overall Study|Study completed early-FDA approved|152|||
30876279|NCT01980628|58907474|FG000|Overall Study|Adverse Event|12|||
30876280|NCT01980628|58907474|FG000|Overall Study|Physician Decision|5|||
30876281|NCT01980628|58907474|FG000|Overall Study|Withdrawal by Subject|4|||
30876282|NCT01980628|58907474|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
30876283|NCT01979614|58907481|FG000|Overall Study|Adverse Event|1|||
30876284|NCT01979614|58907482|FG001|Overall Study|Adverse Event|1|||
30876285|NCT02654717|58907490|FG000|Overall Study|Adverse Event|2|||
30876286|NCT02654717|58907491|FG001|Overall Study|Adverse Event|2|||
30876287|NCT02654717|58907490|FG000|Overall Study|Protocol Violation|1|||
30876288|NCT02654717|58907491|FG001|Overall Study|Protocol Violation|2|||
30876289|NCT02654717|58907490|FG000|Overall Study|Withdrawal by Subject|0|||
30876290|NCT02654717|58907491|FG001|Overall Study|Withdrawal by Subject|1|||
30876291|NCT02654717|58907490|FG000|Overall Study|Non-permitted medication|3|||
30876292|NCT02654717|58907491|FG001|Overall Study|Non-permitted medication|0|||
30876293|NCT03343301|58907499|FG000|Overall Study|Withdrawal by Subject|1|||
30876294|NCT03343301|58907500|FG001|Overall Study|Withdrawal by Subject|1|||
30876295|NCT03343301|58907499|FG000|Overall Study|Death|0|||
30876296|NCT03343301|58907500|FG001|Overall Study|Death|2|||
30876297|NCT03343301|58907499|FG000|Overall Study|Other|0|||
30876298|NCT03343301|58907500|FG001|Overall Study|Other|6|||
30876299|NCT03343301|58907499|FG000|Overall Study|Missing|2|||
30876300|NCT03343301|58907500|FG001|Overall Study|Missing|0|||
30876301|NCT02696785|58907510|FG000|Blinded Treatment Period|Adverse Event|0|||
30876302|NCT02696785|58907511|FG001|Blinded Treatment Period|Adverse Event|1|||
30876303|NCT02696785|58907512|FG002|Blinded Treatment Period|Adverse Event|3|||
30876304|NCT02696785|58907513|FG003|Blinded Treatment Period|Adverse Event|0|||
30876305|NCT02696785|58907510|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
30876306|NCT02696785|58907511|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
30876307|NCT02696785|58907512|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
30876308|NCT02696785|58907513|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
30876309|NCT02696785|58907510|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
30876310|NCT02696785|58907511|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
30876311|NCT02696785|58907512|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
30876312|NCT02696785|58907513|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
30876313|NCT02696785|58907510|FG000|Blinded Treatment Period|Screen Failure|1|||
30876314|NCT02696785|58907511|FG001|Blinded Treatment Period|Screen Failure|0|||
30876315|NCT02696785|58907512|FG002|Blinded Treatment Period|Screen Failure|0|||
30876316|NCT02696785|58907513|FG003|Blinded Treatment Period|Screen Failure|0|||
30876317|NCT02696785|58907510|FG000|Washout Period|Withdrawal by Subject|0|||
30876318|NCT02696785|58907511|FG001|Washout Period|Withdrawal by Subject|1|||
30876319|NCT02696785|58907512|FG002|Washout Period|Withdrawal by Subject|0|||
30876320|NCT02696785|58907513|FG003|Washout Period|Withdrawal by Subject|0|||
30876321|NCT02696785|58907510|FG000|Washout Period|Lack of Efficacy|0|||
30876322|NCT02696785|58907511|FG001|Washout Period|Lack of Efficacy|1|||
30876323|NCT02696785|58907512|FG002|Washout Period|Lack of Efficacy|0|||
30876324|NCT02696785|58907513|FG003|Washout Period|Lack of Efficacy|0|||
30876325|NCT02696785|58907510|FG000|Extended Treatment Period|Adverse Event|2|||
30876326|NCT02696785|58907511|FG001|Extended Treatment Period|Adverse Event|3|||
30876327|NCT02696785|58907512|FG002|Extended Treatment Period|Adverse Event|2|||
30876328|NCT02696785|58907513|FG003|Extended Treatment Period|Adverse Event|1|||
30876329|NCT02696785|58907510|FG000|Extended Treatment Period|Lack of Efficacy|0|||
30876330|NCT02696785|58907511|FG001|Extended Treatment Period|Lack of Efficacy|1|||
30876331|NCT02696785|58907512|FG002|Extended Treatment Period|Lack of Efficacy|0|||
30876332|NCT02696785|58907513|FG003|Extended Treatment Period|Lack of Efficacy|0|||
30876333|NCT02696785|58907510|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
30876334|NCT02696785|58907511|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
30696777|NCT00674570|58711106|FG001|Overall Study|Withdrawal by Subject|2|||
30696778|NCT00674570|58711107|FG002|Overall Study|Withdrawal by Subject|0|||
30696779|NCT00561951|58711118|FG000|Overall Study|Adverse Event|11|||
30876335|NCT02696785|58907512|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
30965013|NCT01561976|59033549|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
30965014|NCT01561976|59033550|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
30965015|NCT01686932|59033560|FG000|Period 1|Adverse Event|1|||
30965016|NCT01686932|59033561|FG001|Period 1|Adverse Event|1|||
30965017|NCT01468207|59033569|FG000|Treatment Period 1|Adverse Event|1|||
30965018|NCT01468207|59033570|FG001|Treatment Period 1|Adverse Event|0|||
30965019|NCT01468207|59033571|FG002|Treatment Period 1|Adverse Event|0|||
30965020|NCT01468207|59033572|FG003|Treatment Period 1|Adverse Event|0|||
30965021|NCT01468207|59033573|FG004|Treatment Period 1|Adverse Event|0|||
30965022|NCT01468207|59033574|FG005|Treatment Period 1|Adverse Event|0|||
30965023|NCT01468207|59033569|FG000|Treatment Period 1|Protocol Violation|1|||
30965024|NCT01468207|59033570|FG001|Treatment Period 1|Protocol Violation|1|||
30965025|NCT01468207|59033571|FG002|Treatment Period 1|Protocol Violation|0|||
30965026|NCT01468207|59033572|FG003|Treatment Period 1|Protocol Violation|0|||
30965027|NCT01468207|59033573|FG004|Treatment Period 1|Protocol Violation|0|||
30965028|NCT01468207|59033574|FG005|Treatment Period 1|Protocol Violation|0|||
30965029|NCT01468207|59033569|FG000|Treatment Period 1|Withdrawal by Subject|5|||
30965030|NCT01468207|59033570|FG001|Treatment Period 1|Withdrawal by Subject|4|||
30965031|NCT01468207|59033571|FG002|Treatment Period 1|Withdrawal by Subject|0|||
30965032|NCT01468207|59033572|FG003|Treatment Period 1|Withdrawal by Subject|0|||
30965033|NCT01468207|59033573|FG004|Treatment Period 1|Withdrawal by Subject|0|||
30606468|NCT01208961|58617281|FG001|High-Fat Period III|Protocol Violation|0|||
30606469|NCT01001572|58617288|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
30606470|NCT01001572|58617289|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
30606471|NCT01001572|58617290|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
30606472|NCT01001572|58617288|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
30606473|NCT01001572|58617289|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
30606474|NCT01001572|58617290|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
30606475|NCT01001572|58617288|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
30606476|NCT01001572|58617289|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
30606477|NCT01001572|58617290|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
30606478|NCT01001572|58617288|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
30606479|NCT01001572|58617289|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
30606480|NCT01001572|58617290|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
30606481|NCT01001572|58617288|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
30606482|NCT01001572|58617289|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
30606483|NCT01001572|58617290|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
30606484|NCT01001572|58617288|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
30606485|NCT01001572|58617289|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
30606486|NCT01001572|58617290|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
30606487|NCT01001572|58617288|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
30606488|NCT01001572|58617289|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
30606489|NCT01001572|58617290|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
30606490|NCT01001572|58617288|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
30606491|NCT01001572|58617289|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
30606492|NCT01001572|58617290|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
30876336|NCT02696785|58907513|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
30876337|NCT02696785|58907510|FG000|Follow-up Period|Adverse Event|0|||
30876338|NCT02696785|58907511|FG001|Follow-up Period|Adverse Event|0|||
30876339|NCT02696785|58907512|FG002|Follow-up Period|Adverse Event|8|||
30876340|NCT02696785|58907513|FG003|Follow-up Period|Adverse Event|2|||
30876341|NCT02696785|58907510|FG000|Follow-up Period|Lost to Follow-up|0|||
30876342|NCT02696785|58907511|FG001|Follow-up Period|Lost to Follow-up|0|||
30876343|NCT02696785|58907512|FG002|Follow-up Period|Lost to Follow-up|0|||
30876344|NCT02696785|58907513|FG003|Follow-up Period|Lost to Follow-up|1|||
30876345|NCT02696785|58907510|FG000|Follow-up Period|Lack of Efficacy|0|||
30876346|NCT02696785|58907511|FG001|Follow-up Period|Lack of Efficacy|0|||
30876347|NCT02696785|58907512|FG002|Follow-up Period|Lack of Efficacy|0|||
30876348|NCT02696785|58907513|FG003|Follow-up Period|Lack of Efficacy|1|||
30876349|NCT02696785|58907510|FG000|Follow-up Period|Withdrawal by Subject|1|||
30876350|NCT02696785|58907511|FG001|Follow-up Period|Withdrawal by Subject|0|||
30876351|NCT02696785|58907512|FG002|Follow-up Period|Withdrawal by Subject|5|||
30876352|NCT02696785|58907513|FG003|Follow-up Period|Withdrawal by Subject|4|||
30965034|NCT01468207|59033574|FG005|Treatment Period 1|Withdrawal by Subject|0|||
30965035|NCT01468207|59033569|FG000|Treatment Period 1|Lost to Follow-up|2|||
30606493|NCT01001572|58617288|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
30606494|NCT01001572|58617289|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
30876353|NCT02004262|58907547|FG000|Overall Study|Death|67|||
30876354|NCT02004262|58907548|FG001|Overall Study|Death|64|||
30876355|NCT02004262|58907549|FG002|Overall Study|Death|66|||
30876356|NCT02004262|58907550|FG003|Overall Study|Death|28|||
30876357|NCT02004262|58907551|FG004|Overall Study|Death|29|||
30965036|NCT01468207|59033570|FG001|Treatment Period 1|Lost to Follow-up|1|||
30876358|NCT02004262|58907552|FG005|Overall Study|Death|22|||
30876359|NCT02004262|58907547|FG000|Overall Study|Withdrawal by Subject|1|||
30876360|NCT02004262|58907548|FG001|Overall Study|Withdrawal by Subject|0|||
30876361|NCT02004262|58907549|FG002|Overall Study|Withdrawal by Subject|4|||
30876362|NCT02004262|58907550|FG003|Overall Study|Withdrawal by Subject|0|||
30876363|NCT02004262|58907551|FG004|Overall Study|Withdrawal by Subject|1|||
30876364|NCT02004262|58907552|FG005|Overall Study|Withdrawal by Subject|3|||
30876365|NCT02004262|58907547|FG000|Overall Study|Lost to Follow-up|1|||
30876366|NCT02004262|58907548|FG001|Overall Study|Lost to Follow-up|1|||
30876367|NCT02004262|58907549|FG002|Overall Study|Lost to Follow-up|0|||
30876368|NCT02004262|58907550|FG003|Overall Study|Lost to Follow-up|0|||
30876369|NCT02004262|58907551|FG004|Overall Study|Lost to Follow-up|0|||
30876370|NCT02004262|58907552|FG005|Overall Study|Lost to Follow-up|0|||
30876371|NCT02004262|58907547|FG000|Overall Study|Study Terminated by Sponsor|4|||
30876372|NCT02004262|58907548|FG001|Overall Study|Study Terminated by Sponsor|3|||
30876373|NCT02004262|58907549|FG002|Overall Study|Study Terminated by Sponsor|2|||
30876374|NCT02004262|58907550|FG003|Overall Study|Study Terminated by Sponsor|1|||
30876375|NCT02004262|58907551|FG004|Overall Study|Study Terminated by Sponsor|1|||
30876376|NCT02004262|58907552|FG005|Overall Study|Study Terminated by Sponsor|5|||
30876377|NCT01675427|58907566|FG000|Overall Study|Withdrawal by Subject|7|||
30876378|NCT01675427|58907566|FG000|Overall Study|Participant Refused Sample Collection|18|||
30876379|NCT01675427|58907566|FG000|Overall Study|Sample not Collected by Mistake|2|||
30876380|NCT01675427|58907566|FG000|Overall Study|Lost to Follow-up|5|||
30876381|NCT01675427|58907566|FG000|Overall Study|Other|2|||
30876382|NCT01978912|58907604|FG000|Overall Study|Adverse Event|0|||
30876383|NCT01978912|58907605|FG001|Overall Study|Adverse Event|1|||
30876384|NCT01978912|58907606|FG002|Overall Study|Adverse Event|0|||
30876385|NCT01978912|58907607|FG003|Overall Study|Adverse Event|0|||
30876386|NCT01978912|58907604|FG000|Overall Study|Lost to Follow-up|1|||
30876387|NCT01978912|58907605|FG001|Overall Study|Lost to Follow-up|1|||
30876388|NCT01978912|58907606|FG002|Overall Study|Lost to Follow-up|0|||
30876389|NCT01978912|58907607|FG003|Overall Study|Lost to Follow-up|1|||
30876390|NCT01978912|58907604|FG000|Overall Study|Withdrawal by Subject|1|||
30876391|NCT01978912|58907605|FG001|Overall Study|Withdrawal by Subject|0|||
30876392|NCT01978912|58907606|FG002|Overall Study|Withdrawal by Subject|2|||
30876393|NCT01978912|58907607|FG003|Overall Study|Withdrawal by Subject|2|||
30876394|NCT01978912|58907604|FG000|Overall Study|Lumbar Surgery|1|||
30876395|NCT01978912|58907605|FG001|Overall Study|Lumbar Surgery|0|||
30876396|NCT01978912|58907606|FG002|Overall Study|Lumbar Surgery|1|||
30876397|NCT01978912|58907607|FG003|Overall Study|Lumbar Surgery|0|||
30876398|NCT01978912|58907604|FG000|Overall Study|Intradiscal Steroid Injection|0|||
30876399|NCT01978912|58907605|FG001|Overall Study|Intradiscal Steroid Injection|1|||
30876400|NCT01978912|58907606|FG002|Overall Study|Intradiscal Steroid Injection|0|||
30876401|NCT01978912|58907607|FG003|Overall Study|Intradiscal Steroid Injection|0|||
30876402|NCT01977898|58907619|FG000|Overall Study|Non functioning catheter|1|||
30876403|NCT01977898|58907620|FG001|Overall Study|Non functioning catheter|1|||
30876404|NCT02003638|58907628|FG000|Overall Study|Withdrawal by Subject|1|||
30876405|NCT02003638|58907629|FG001|Overall Study|Withdrawal by Subject|0|||
30876406|NCT02696317|58907635|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
30876407|NCT02696317|58907636|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
30876408|NCT02696317|58907635|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
30876409|NCT02696317|58907636|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
30876410|NCT01959412|58907644|FG000|Overall Study|Protocol deviation|1|||
30876411|NCT01959412|58907645|FG001|Overall Study|Protocol deviation|1|||
30876412|NCT01959412|58907646|FG002|Overall Study|Protocol deviation|0|||
30876413|NCT01959412|58907647|FG003|Overall Study|Protocol deviation|1|||
30876414|NCT01959412|58907648|FG004|Overall Study|Protocol deviation|3|||
30876415|NCT01959412|58907649|FG005|Overall Study|Protocol deviation|0|||
30876416|NCT01959412|58907644|FG000|Overall Study|Adverse Event|0|||
30876417|NCT01959412|58907645|FG001|Overall Study|Adverse Event|0|||
30876418|NCT01959412|58907646|FG002|Overall Study|Adverse Event|0|||
30876419|NCT01959412|58907647|FG003|Overall Study|Adverse Event|1|||
30876420|NCT01959412|58907648|FG004|Overall Study|Adverse Event|0|||
30965037|NCT01468207|59033571|FG002|Treatment Period 1|Lost to Follow-up|0|||
30965038|NCT01468207|59033572|FG003|Treatment Period 1|Lost to Follow-up|0|||
30876421|NCT01959412|58907649|FG005|Overall Study|Adverse Event|0|||
30876422|NCT01977820|58907665|FG000|Overall Study|Sponsor terminated the study|1|||
30876423|NCT01977820|58907666|FG001|Overall Study|Sponsor terminated the study|1|||
30876424|NCT02003014|58907672|FG000|Overall Study|Case report forms uncollected|9|||
30876425|NCT02003014|58907672|FG000|Overall Study|Treatment started after contract period|1|||
30876426|NCT02003014|58907672|FG000|Overall Study|Patient did not visit the study site|5|||
30876427|NCT02003014|58907672|FG000|Overall Study|Investigator's transfer|4|||
30876428|NCT01977352|58907678|FG000|Overall Study|Lost to Follow-up|1|||
30876429|NCT01977352|58907679|FG001|Overall Study|Lost to Follow-up|2|||
30876430|NCT02001688|58907688|FG000|Overall Study|Withdrawal by Subject|0|||
30876431|NCT02001688|58907689|FG001|Overall Study|Withdrawal by Subject|0|||
30876432|NCT02001688|58907690|FG002|Overall Study|Withdrawal by Subject|1|||
30876433|NCT02001688|58907688|FG000|Overall Study|Adverse Event|0|||
30876434|NCT02001688|58907689|FG001|Overall Study|Adverse Event|1|||
30876435|NCT02001688|58907690|FG002|Overall Study|Adverse Event|0|||
30876436|NCT02001064|58907701|FG000|Overall Study|Withdrawal by Subject|2|||
30876437|NCT02001064|58907702|FG001|Overall Study|Withdrawal by Subject|1|||
30876438|NCT02000752|58907710|FG000|Overall Study|Dystocic delivery|19|||
30876439|NCT02000752|58907711|FG001|Overall Study|Dystocic delivery|8|||
30876440|NCT02000752|58907710|FG000|Overall Study|Shift Changes|12|||
30876441|NCT02000752|58907711|FG001|Overall Study|Shift Changes|5|||
30876442|NCT02000440|58907717|FG000|Overall Study|Adverse Event|3|||
30876443|NCT02000440|58907717|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
30876444|NCT02687815|58907723|FG000|Overall Study|Lost to Follow-up|2|||
30876445|NCT02687815|58907724|FG001|Overall Study|Lost to Follow-up|4|||
30876446|NCT02687815|58907723|FG000|Overall Study|Withdrawal by Subject|2|||
30876447|NCT02687815|58907724|FG001|Overall Study|Withdrawal by Subject|4|||
30876448|NCT01959334|58907732|FG000|Second Dose|Adverse Event|1|||
30876449|NCT01959334|58907733|FG001|Second Dose|Adverse Event|0|||
30876450|NCT01959334|58907732|FG000|Third Dose|Adverse Event|0|||
30876451|NCT01959334|58907733|FG001|Third Dose|Adverse Event|1|||
30876452|NCT02687581|58907743|FG000|Overall Study|Withdrawal by Subject|1|||
30876453|NCT02687581|58907744|FG001|Overall Study|Withdrawal by Subject|0|||
30876454|NCT02687581|58907745|FG002|Overall Study|Withdrawal by Subject|0|||
30876455|NCT02687581|58907746|FG003|Overall Study|Withdrawal by Subject|1|||
30876456|NCT02687581|58907743|FG000|Overall Study|Lost to Follow-up|2|||
30876457|NCT02687581|58907744|FG001|Overall Study|Lost to Follow-up|2|||
30876458|NCT02687581|58907745|FG002|Overall Study|Lost to Follow-up|0|||
30876459|NCT02687581|58907746|FG003|Overall Study|Lost to Follow-up|0|||
30876460|NCT02687581|58907743|FG000|Overall Study|the device is too small for the patient.|1|||
30876461|NCT02687581|58907744|FG001|Overall Study|the device is too small for the patient.|0|||
30876462|NCT02687581|58907745|FG002|Overall Study|the device is too small for the patient.|0|||
30876463|NCT02687581|58907746|FG003|Overall Study|the device is too small for the patient.|0|||
30876464|NCT01977040|58907756|FG000|Overall Study|Vasa previa not confirmed|2|||
30876465|NCT01958476|58907766|FG000|Overall Study|Parent requested exclusion from analysis|1|||
30876466|NCT01958476|58907767|FG001|Overall Study|Parent requested exclusion from analysis|0|||
30876467|NCT02695537|58907803|FG000|Overall Study|Adverse Event|3|||
30876468|NCT02695537|58907803|FG000|Overall Study|Lack of Efficacy|28|||
30876469|NCT02695537|58907803|FG000|Overall Study|Withdrawal by Subject|4|||
30876470|NCT02695537|58907803|FG000|Overall Study|Protocol Violation|3|||
30876471|NCT01353313|58907809|FG000|Overall Study|Lost to Follow-up|22|||
30876472|NCT01353313|58907810|FG001|Overall Study|Lost to Follow-up|23|||
30876473|NCT01353313|58907809|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
30876474|NCT01353313|58907810|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
30876475|NCT02691247|58907819|FG000|Overall Study|Withdrawal by Subject|1|||
30876476|NCT02691247|58907820|FG001|Overall Study|Withdrawal by Subject|2|||
30876477|NCT02691247|58907821|FG002|Overall Study|Withdrawal by Subject|2|||
30876478|NCT02691247|58907819|FG000|Overall Study|Lost to Follow-up|2|||
30876479|NCT02691247|58907820|FG001|Overall Study|Lost to Follow-up|0|||
30876480|NCT02691247|58907821|FG002|Overall Study|Lost to Follow-up|1|||
30876481|NCT01362491|58907832|FG000|Overall Study|Ineligible|1|||
30876482|NCT01362491|58907833|FG001|Overall Study|Ineligible|0|||
30876483|NCT01362491|58907834|FG002|Overall Study|Ineligible|0|||
30876484|NCT02687191|58907849|FG000|Overall Study|Death|0|||
30876485|NCT02687191|58907850|FG001|Overall Study|Death|1|||
30876486|NCT02687191|58907851|FG002|Overall Study|Death|1|||
30876487|NCT02687191|58907852|FG003|Overall Study|Death|0|||
30876488|NCT02687191|58907853|FG004|Overall Study|Death|1|||
30876489|NCT02687191|58907854|FG005|Overall Study|Death|1|||
30876490|NCT02687191|58907849|FG000|Overall Study|Withdrawal by Subject|0|||
30876491|NCT02687191|58907850|FG001|Overall Study|Withdrawal by Subject|0|||
30876492|NCT02687191|58907851|FG002|Overall Study|Withdrawal by Subject|0|||
30876493|NCT02687191|58907852|FG003|Overall Study|Withdrawal by Subject|1|||
30876494|NCT02687191|58907853|FG004|Overall Study|Withdrawal by Subject|0|||
30876495|NCT02687191|58907854|FG005|Overall Study|Withdrawal by Subject|0|||
30876496|NCT02687035|58907868|FG000|Overall Study|Withdrawal by Subject|1|||
30876497|NCT02687035|58907868|FG000|Overall Study|Death|87|||
30876498|NCT02687035|58907868|FG000|Overall Study|Lost to Follow-up|1|||
30876499|NCT02687035|58907868|FG000|Overall Study|Missed Visit|87|||
30876500|NCT02687035|58907868|FG000|Overall Study|Did not receive Study Device|8|||
30876501|NCT02691013|58907874|FG000|Overall Study|Withdrawal by Subject|3|||
30876502|NCT02691013|58907875|FG001|Overall Study|Withdrawal by Subject|0|||
30876503|NCT02690701|58907885|FG000|Treatment Period 1|Adverse Event|2|||
30876504|NCT02690701|58907886|FG001|Treatment Period 1|Adverse Event|2|||
30876505|NCT02690701|58907885|FG000|Treatment Period 1|Withdrawal by Subject|0|||
30876506|NCT02690701|58907886|FG001|Treatment Period 1|Withdrawal by Subject|1|||
30876507|NCT02690701|58907885|FG000|Treatment Period 2|Adverse Event|2|||
30876508|NCT02690701|58907886|FG001|Treatment Period 2|Adverse Event|0|||
30876509|NCT02690701|58907885|FG000|Treatment Period 2|Lack of Efficacy|1|||
30876510|NCT02690701|58907886|FG001|Treatment Period 2|Lack of Efficacy|0|||
30876511|NCT02690701|58907885|FG000|Treatment Period 2|Lost to Follow-up|0|||
30876512|NCT02690701|58907886|FG001|Treatment Period 2|Lost to Follow-up|2|||
30876513|NCT02690701|58907885|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30876514|NCT02690701|58907886|FG001|Treatment Period 2|Withdrawal by Subject|2|||
30876515|NCT02690701|58907885|FG000|Treatment Period 2|Protocol Violation|0|||
30876516|NCT02690701|58907886|FG001|Treatment Period 2|Protocol Violation|1|||
30876517|NCT02694757|58907893|FG000|Overall Study|Lack of Efficacy|3|||
30876518|NCT03805841|58907900|FG000|Overall Study|Clinical Progression|2|||
30876519|NCT03805841|58907901|FG001|Overall Study|Clinical Progression|0|||
30876520|NCT03805841|58907902|FG002|Overall Study|Clinical Progression|0|||
30876521|NCT03805841|58907900|FG000|Overall Study|Death|0|||
30876522|NCT03805841|58907901|FG001|Overall Study|Death|3|||
30876523|NCT03805841|58907902|FG002|Overall Study|Death|1|||
30876524|NCT03805841|58907900|FG000|Overall Study|Lost to Follow-up|0|||
30876525|NCT03805841|58907901|FG001|Overall Study|Lost to Follow-up|0|||
30876526|NCT03805841|58907902|FG002|Overall Study|Lost to Follow-up|1|||
30876527|NCT03805841|58907900|FG000|Overall Study|Withdrawal by Subject|2|||
30876528|NCT03805841|58907901|FG001|Overall Study|Withdrawal by Subject|3|||
30876529|NCT03805841|58907902|FG002|Overall Study|Withdrawal by Subject|0|||
30876530|NCT03805841|58907900|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
30876531|NCT03805841|58907901|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
30876532|NCT03805841|58907902|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
30876533|NCT02684617|58907913|FG000|Overall Study|Adverse Event|1|||
30876534|NCT02684617|58907914|FG001|Overall Study|Adverse Event|0|||
30876535|NCT02684617|58907915|FG002|Overall Study|Adverse Event|1|||
30876536|NCT02684617|58907913|FG000|Overall Study|Death|8|||
30876537|NCT02684617|58907914|FG001|Overall Study|Death|16|||
30876538|NCT02684617|58907915|FG002|Overall Study|Death|28|||
30876539|NCT02684617|58907913|FG000|Overall Study|Withdrawal by Subject|2|||
30876540|NCT02684617|58907914|FG001|Overall Study|Withdrawal by Subject|0|||
30876541|NCT02684617|58907915|FG002|Overall Study|Withdrawal by Subject|4|||
30876542|NCT02684617|58907913|FG000|Overall Study|Screen Failure|1|||
30876543|NCT02684617|58907914|FG001|Overall Study|Screen Failure|0|||
30876544|NCT02684617|58907915|FG002|Overall Study|Screen Failure|2|||
30876545|NCT02684617|58907913|FG000|Overall Study|Study Terminated by Sponsor|6|||
30876546|NCT02684617|58907914|FG001|Overall Study|Study Terminated by Sponsor|1|||
30876547|NCT02684617|58907915|FG002|Overall Study|Study Terminated by Sponsor|5|||
30876548|NCT01999972|58907929|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
30876549|NCT01999972|58907930|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
30876550|NCT01999972|58907931|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
30876551|NCT01999972|58907932|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
30876552|NCT01999972|58907933|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
30876553|NCT01999972|58907934|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
30876554|NCT01999972|58907929|FG000|Dose Escalation Part|Death|0|||
30876555|NCT01999972|58907930|FG001|Dose Escalation Part|Death|1|||
30876556|NCT01999972|58907931|FG002|Dose Escalation Part|Death|0|||
30876557|NCT01999972|58907932|FG003|Dose Escalation Part|Death|0|||
30876558|NCT01999972|58907933|FG004|Dose Escalation Part|Death|0|||
30876559|NCT01999972|58907934|FG005|Dose Escalation Part|Death|0|||
30876560|NCT01999972|58907929|FG000|Dose Escalation Part|Enrolled but not treated|0|||
30876561|NCT01999972|58907930|FG001|Dose Escalation Part|Enrolled but not treated|0|||
30876562|NCT01999972|58907931|FG002|Dose Escalation Part|Enrolled but not treated|1|||
30876563|NCT01999972|58907932|FG003|Dose Escalation Part|Enrolled but not treated|1|||
30876564|NCT01999972|58907933|FG004|Dose Escalation Part|Enrolled but not treated|0|||
30876565|NCT01999972|58907934|FG005|Dose Escalation Part|Enrolled but not treated|0|||
30876566|NCT01999972|58907929|FG000|Dose Escalation Part|Disease progression|3|||
30876567|NCT01999972|58907930|FG001|Dose Escalation Part|Disease progression|2|||
30876568|NCT01999972|58907931|FG002|Dose Escalation Part|Disease progression|3|||
30876569|NCT01999972|58907932|FG003|Dose Escalation Part|Disease progression|6|||
30876570|NCT01999972|58907933|FG004|Dose Escalation Part|Disease progression|0|||
30876571|NCT01999972|58907934|FG005|Dose Escalation Part|Disease progression|0|||
30876572|NCT01999972|58907929|FG000|Dose Escalation Part|Adverse Event|0|||
30876573|NCT01999972|58907930|FG001|Dose Escalation Part|Adverse Event|0|||
30876574|NCT01999972|58907931|FG002|Dose Escalation Part|Adverse Event|0|||
30876575|NCT01999972|58907932|FG003|Dose Escalation Part|Adverse Event|2|||
30876576|NCT01999972|58907933|FG004|Dose Escalation Part|Adverse Event|0|||
30876577|NCT01999972|58907934|FG005|Dose Escalation Part|Adverse Event|0|||
30876578|NCT01999972|58907929|FG000|Dose Escalation Part|Global deterioration of health status|1|||
30876579|NCT01999972|58907930|FG001|Dose Escalation Part|Global deterioration of health status|0|||
30876580|NCT01999972|58907931|FG002|Dose Escalation Part|Global deterioration of health status|0|||
30876581|NCT01999972|58907932|FG003|Dose Escalation Part|Global deterioration of health status|1|||
30876582|NCT01999972|58907933|FG004|Dose Escalation Part|Global deterioration of health status|0|||
30876583|NCT01999972|58907934|FG005|Dose Escalation Part|Global deterioration of health status|0|||
30876584|NCT01999972|58907929|FG000|Dose Expansion Part|Death|0|||
30876585|NCT01999972|58907930|FG001|Dose Expansion Part|Death|0|||
30876586|NCT01999972|58907931|FG002|Dose Expansion Part|Death|0|||
30876587|NCT01999972|58907932|FG003|Dose Expansion Part|Death|0|||
30876588|NCT01999972|58907933|FG004|Dose Expansion Part|Death|2|||
30876589|NCT01999972|58907934|FG005|Dose Expansion Part|Death|1|||
30876590|NCT01999972|58907929|FG000|Dose Expansion Part|Disease progression|0|||
30876591|NCT01999972|58907930|FG001|Dose Expansion Part|Disease progression|0|||
30876592|NCT01999972|58907931|FG002|Dose Expansion Part|Disease progression|0|||
30876593|NCT01999972|58907932|FG003|Dose Expansion Part|Disease progression|0|||
30876594|NCT01999972|58907933|FG004|Dose Expansion Part|Disease progression|9|||
30876595|NCT01999972|58907934|FG005|Dose Expansion Part|Disease progression|3|||
30876596|NCT01999972|58907929|FG000|Dose Expansion Part|Sponsor decision|0|||
30876597|NCT01999972|58907930|FG001|Dose Expansion Part|Sponsor decision|0|||
30876598|NCT01999972|58907931|FG002|Dose Expansion Part|Sponsor decision|0|||
30876599|NCT01999972|58907932|FG003|Dose Expansion Part|Sponsor decision|0|||
30876600|NCT01999972|58907933|FG004|Dose Expansion Part|Sponsor decision|1|||
30876601|NCT01999972|58907934|FG005|Dose Expansion Part|Sponsor decision|0|||
30876602|NCT01999972|58907929|FG000|Dose Expansion Part|Adverse Event|0|||
30876603|NCT01999972|58907930|FG001|Dose Expansion Part|Adverse Event|0|||
30876604|NCT01999972|58907931|FG002|Dose Expansion Part|Adverse Event|0|||
30876605|NCT01999972|58907932|FG003|Dose Expansion Part|Adverse Event|0|||
30876606|NCT01999972|58907933|FG004|Dose Expansion Part|Adverse Event|4|||
30876607|NCT01999972|58907934|FG005|Dose Expansion Part|Adverse Event|2|||
30876608|NCT01999972|58907929|FG000|Dose Expansion Part|Participant's non-compliance|0|||
30876609|NCT01999972|58907930|FG001|Dose Expansion Part|Participant's non-compliance|0|||
30876610|NCT01999972|58907931|FG002|Dose Expansion Part|Participant's non-compliance|0|||
30876611|NCT01999972|58907932|FG003|Dose Expansion Part|Participant's non-compliance|0|||
30876612|NCT01999972|58907933|FG004|Dose Expansion Part|Participant's non-compliance|0|||
30876613|NCT01999972|58907934|FG005|Dose Expansion Part|Participant's non-compliance|1|||
30876614|NCT01999972|58907929|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
30876615|NCT01999972|58907930|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
30876616|NCT01999972|58907931|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
30876617|NCT01999972|58907932|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
30876618|NCT01999972|58907933|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
30876619|NCT01999972|58907934|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
30876620|NCT01999972|58907929|FG000|Dose Expansion Part|Changed to standard of care|0|||
30876621|NCT01999972|58907930|FG001|Dose Expansion Part|Changed to standard of care|0|||
30876622|NCT01999972|58907931|FG002|Dose Expansion Part|Changed to standard of care|0|||
30876623|NCT01999972|58907932|FG003|Dose Expansion Part|Changed to standard of care|0|||
30876624|NCT01999972|58907933|FG004|Dose Expansion Part|Changed to standard of care|1|||
30876625|NCT01999972|58907934|FG005|Dose Expansion Part|Changed to standard of care|0|||
30876626|NCT01999894|58907950|FG000|Overall Study|Adverse Event|9|||
30876627|NCT01999894|58907950|FG000|Overall Study|Lack of Efficacy|5|||
30876628|NCT01999894|58907950|FG000|Overall Study|Protocol Violation|1|||
30876629|NCT01999894|58907950|FG000|Overall Study|Withdrawal by Subject|7|||
30876630|NCT01999894|58907950|FG000|Overall Study|Lost to Follow-up|10|||
30876631|NCT01999894|58907950|FG000|Overall Study|Other Reason|3|||
30876632|NCT01999894|58907950|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
30876633|NCT02679235|58907955|FG000|Overall Study|Withdrawal by Subject|3|||
30876634|NCT02679235|58907955|FG000|Overall Study|Adverse Event|1|||
30876635|NCT01976806|58907961|FG000|Overall Study|Lost to Follow-up|1|||
30876636|NCT01976806|58907962|FG001|Overall Study|Lost to Follow-up|4|||
30876637|NCT01976806|58907961|FG000|Overall Study|Adverse Event|1|||
30876638|NCT01976806|58907962|FG001|Overall Study|Adverse Event|1|||
30876639|NCT01976806|58907961|FG000|Overall Study|Withdrawal by Subject|1|||
30876640|NCT01976806|58907962|FG001|Overall Study|Withdrawal by Subject|1|||
30876641|NCT02679079|58907971|FG000|Overall Study|Adverse Event|2|||
30876642|NCT02679079|58907972|FG001|Overall Study|Adverse Event|0|||
30876643|NCT02679079|58907973|FG002|Overall Study|Adverse Event|2|||
30876644|NCT02679079|58907971|FG000|Overall Study|Protocol Violation|0|||
30876645|NCT02679079|58907972|FG001|Overall Study|Protocol Violation|1|||
30876646|NCT02679079|58907973|FG002|Overall Study|Protocol Violation|0|||
30876647|NCT02679079|58907971|FG000|Overall Study|Withdrawal by Subject|2|||
30876648|NCT02679079|58907972|FG001|Overall Study|Withdrawal by Subject|1|||
30876649|NCT02679079|58907973|FG002|Overall Study|Withdrawal by Subject|0|||
30876650|NCT02678923|58907983|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
30876651|NCT02678923|58907984|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
30876652|NCT02678923|58907983|FG000|Overall Study|Withdrawal by Subject|3|||
30876653|NCT02678923|58907984|FG001|Overall Study|Withdrawal by Subject|2|||
30876654|NCT02678923|58907983|FG000|Overall Study|Lost to Follow-up|1|||
30876655|NCT02678923|58907984|FG001|Overall Study|Lost to Follow-up|0|||
30876656|NCT02678923|58907983|FG000|Overall Study|Did Not Return for Study Visits|1|||
30876657|NCT02678923|58907984|FG001|Overall Study|Did Not Return for Study Visits|0|||
30876658|NCT01976728|58907994|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
30876659|NCT01976728|58907995|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
30876660|NCT01976728|58907996|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
30876661|NCT01976728|58907997|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
30876662|NCT02689219|58908025|FG000|Overall Study|Death|1|||
30876663|NCT02689219|58908026|FG001|Overall Study|Death|1|||
30876664|NCT02689219|58908025|FG000|Overall Study|Disease Progression|10|||
30876665|NCT02689219|58908026|FG001|Overall Study|Disease Progression|6|||
30876666|NCT02683525|58908032|FG000|Overall Study|Lost to Follow-up|1|||
30876667|NCT02683525|58908032|FG000|Overall Study|Physician Decision|1|||
30876668|NCT02683525|58908032|FG000|Overall Study|Disease Progression|6|||
30876669|NCT01976338|58908038|FG000|Overall Study|Physician Decision|0|||
30876670|NCT01976338|58908039|FG001|Overall Study|Physician Decision|1|||
30876671|NCT01976338|58908038|FG000|Overall Study|Lost to Follow-up|3|||
30876672|NCT01976338|58908039|FG001|Overall Study|Lost to Follow-up|0|||
30876673|NCT01976338|58908038|FG000|Overall Study|Withdrawal by Subject|5|||
30876674|NCT01976338|58908039|FG001|Overall Study|Withdrawal by Subject|2|||
30876675|NCT01976338|58908038|FG000|Overall Study|Adverse Event|5|||
30876676|NCT01976338|58908039|FG001|Overall Study|Adverse Event|1|||
30876677|NCT02674633|58908048|FG000|Overall Study|Lost to Follow-up|3|||
30876678|NCT02674633|58908049|FG001|Overall Study|Lost to Follow-up|2|||
30876679|NCT02674633|58908048|FG000|Overall Study|Physician Decision|1|||
30876680|NCT02674633|58908049|FG001|Overall Study|Physician Decision|0|||
30876681|NCT02674633|58908048|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
30876682|NCT02674633|58908049|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
30876683|NCT02651987|58908057|FG000|Overall Study|Adverse Event|2|||
30876684|NCT02651987|58908058|FG001|Overall Study|Adverse Event|2|||
30876685|NCT02651987|58908057|FG000|Overall Study|Consent Withdrawn|2|||
30876686|NCT02651987|58908058|FG001|Overall Study|Consent Withdrawn|0|||
30876687|NCT02651987|58908057|FG000|Overall Study|Local PD|0|||
30876688|NCT02651987|58908058|FG001|Overall Study|Local PD|2|||
30876689|NCT02651987|58908057|FG000|Overall Study|Investigator Decision|1|||
30876690|NCT02651987|58908058|FG001|Overall Study|Investigator Decision|1|||
30876691|NCT02677987|58908069|FG000|Overall Study|Withdrawal by Subject|3|||
30876692|NCT02677987|58908070|FG001|Overall Study|Withdrawal by Subject|0|||
30876693|NCT02677987|58908069|FG000|Overall Study|Lost to Follow-up|1|||
30876694|NCT02677987|58908070|FG001|Overall Study|Lost to Follow-up|0|||
30876695|NCT01999114|58908089|FG000|Overall Study|Adverse Event|8|||
30876696|NCT01999114|58908090|FG001|Overall Study|Adverse Event|7|||
30876697|NCT01999114|58908091|FG002|Overall Study|Adverse Event|2|||
30876698|NCT01999114|58908092|FG003|Overall Study|Adverse Event|2|||
30876699|NCT01999114|58908093|FG004|Overall Study|Adverse Event|1|||
30876700|NCT01999114|58908089|FG000|Overall Study|Withdrawal by Subject|0|||
30876701|NCT01999114|58908090|FG001|Overall Study|Withdrawal by Subject|0|||
30876702|NCT01999114|58908091|FG002|Overall Study|Withdrawal by Subject|1|||
30876703|NCT01999114|58908092|FG003|Overall Study|Withdrawal by Subject|0|||
30876704|NCT01999114|58908093|FG004|Overall Study|Withdrawal by Subject|1|||
30876705|NCT01999114|58908089|FG000|Overall Study|Lost to Follow-up|0|||
30876706|NCT01999114|58908090|FG001|Overall Study|Lost to Follow-up|0|||
30876707|NCT01999114|58908091|FG002|Overall Study|Lost to Follow-up|1|||
30876708|NCT01999114|58908092|FG003|Overall Study|Lost to Follow-up|0|||
30876709|NCT01999114|58908093|FG004|Overall Study|Lost to Follow-up|0|||
30876710|NCT01999114|58908089|FG000|Overall Study|Administrative|0|||
30876711|NCT01999114|58908090|FG001|Overall Study|Administrative|0|||
30876712|NCT01999114|58908091|FG002|Overall Study|Administrative|1|||
30876713|NCT01999114|58908092|FG003|Overall Study|Administrative|1|||
30876714|NCT01999114|58908093|FG004|Overall Study|Administrative|2|||
30876715|NCT02682823|58908124|FG000|Overall Study|Withdrawal by Subject|0|||
30876716|NCT02682823|58908125|FG001|Overall Study|Withdrawal by Subject|0|||
30876717|NCT02682823|58908126|FG002|Overall Study|Withdrawal by Subject|1|||
30876718|NCT02682823|58908127|FG003|Overall Study|Withdrawal by Subject|0|||
30876719|NCT02682823|58908128|FG004|Overall Study|Withdrawal by Subject|1|||
30876720|NCT02682823|58908124|FG000|Overall Study|Protocol Deviation|0|||
30876721|NCT02682823|58908125|FG001|Overall Study|Protocol Deviation|1|||
30876722|NCT02682823|58908126|FG002|Overall Study|Protocol Deviation|0|||
30876723|NCT02682823|58908127|FG003|Overall Study|Protocol Deviation|0|||
30876724|NCT02682823|58908128|FG004|Overall Study|Protocol Deviation|0|||
30876725|NCT02682823|58908124|FG000|Overall Study|Adverse Event|0|||
30876726|NCT02682823|58908125|FG001|Overall Study|Adverse Event|0|||
30876727|NCT02682823|58908126|FG002|Overall Study|Adverse Event|0|||
30876728|NCT02682823|58908127|FG003|Overall Study|Adverse Event|1|||
30876729|NCT02682823|58908128|FG004|Overall Study|Adverse Event|0|||
30876730|NCT01374451|58908142|FG000|Overall Study|Administrative problems|1|||
30876731|NCT01374451|58908143|FG001|Overall Study|Administrative problems|0|||
30876732|NCT02674477|58908151|FG000|Overall Study|Protocol Violation|8|||
30876733|NCT02674477|58908152|FG001|Overall Study|Protocol Violation|2|||
30876734|NCT01352845|58908160|FG000|Overall Study|Lost to Follow-up|313|||
30876735|NCT01352845|58908161|FG001|Overall Study|Lost to Follow-up|92|||
30876736|NCT01352845|58908160|FG000|Overall Study|No Longer Willing to Participate|205|||
30876737|NCT01352845|58908161|FG001|Overall Study|No Longer Willing to Participate|58|||
30876738|NCT01352845|58908160|FG000|Overall Study|Withdrawal by Subject|48|||
30876739|NCT01352845|58908161|FG001|Overall Study|Withdrawal by Subject|16|||
30876740|NCT01352845|58908160|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
30876741|NCT01352845|58908161|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
30876742|NCT01352845|58908160|FG000|Overall Study|Pregnancy|27|||
30876743|NCT01352845|58908161|FG001|Overall Study|Pregnancy|7|||
30876744|NCT01352845|58908160|FG000|Overall Study|Adverse Event|22|||
30876745|NCT01352845|58908161|FG001|Overall Study|Adverse Event|6|||
30876746|NCT01352845|58908160|FG000|Overall Study|Other|17|||
30876747|NCT01352845|58908161|FG001|Overall Study|Other|7|||
30876748|NCT01352845|58908160|FG000|Overall Study|Protocol Violation|12|||
30876749|NCT01352845|58908161|FG001|Overall Study|Protocol Violation|6|||
30876750|NCT01352845|58908160|FG000|Overall Study|Death|3|||
30876751|NCT01352845|58908161|FG001|Overall Study|Death|0|||
30876752|NCT02674399|58908169|FG000|Overall Study|Lost to Follow-up|2|||
30876753|NCT02674399|58908170|FG001|Overall Study|Lost to Follow-up|0|||
30876754|NCT02676895|58908179|FG000|Overall Study|Administrative reason|1|||
30876755|NCT02676895|58908180|FG001|Overall Study|Administrative reason|0|||
30876756|NCT02676895|58908181|FG002|Overall Study|Administrative reason|0|||
30876757|NCT02676895|58908179|FG000|Overall Study|Protocol Violation|1|||
30876758|NCT02676895|58908180|FG001|Overall Study|Protocol Violation|0|||
30876759|NCT02676895|58908181|FG002|Overall Study|Protocol Violation|0|||
30876760|NCT02676895|58908179|FG000|Overall Study|Adverse Event|0|||
30876761|NCT02676895|58908180|FG001|Overall Study|Adverse Event|3|||
30876762|NCT02676895|58908181|FG002|Overall Study|Adverse Event|1|||
30876763|NCT02676895|58908179|FG000|Overall Study|Lost to Follow-up|0|||
30876764|NCT02676895|58908180|FG001|Overall Study|Lost to Follow-up|0|||
30876765|NCT02676895|58908181|FG002|Overall Study|Lost to Follow-up|1|||
30876766|NCT02676895|58908179|FG000|Overall Study|Withdrawal by Subject|0|||
30876767|NCT02676895|58908180|FG001|Overall Study|Withdrawal by Subject|0|||
30876768|NCT02676895|58908181|FG002|Overall Study|Withdrawal by Subject|1|||
30876769|NCT02673697|58908192|FG000|Overall Study|Adverse Event|2|||
30876770|NCT02673697|58908193|FG001|Overall Study|Adverse Event|0|||
30876771|NCT02673697|58908192|FG000|Overall Study|Death|32|||
30876772|NCT02673697|58908193|FG001|Overall Study|Death|24|||
30876773|NCT02673697|58908192|FG000|Overall Study|Lost to Follow-up|5|||
30876774|NCT02673697|58908193|FG001|Overall Study|Lost to Follow-up|2|||
30876775|NCT02673697|58908192|FG000|Overall Study|Physician Decision|2|||
30876776|NCT02673697|58908193|FG001|Overall Study|Physician Decision|1|||
30876777|NCT02673697|58908192|FG000|Overall Study|Withdrawal by Subject|10|||
30876778|NCT02673697|58908193|FG001|Overall Study|Withdrawal by Subject|7|||
30876779|NCT02673697|58908192|FG000|Overall Study|Change subj medical status|1|||
30965039|NCT01468207|59033573|FG004|Treatment Period 1|Lost to Follow-up|0|||
30965040|NCT01468207|59033574|FG005|Treatment Period 1|Lost to Follow-up|0|||
30965041|NCT01468207|59033569|FG000|Treatment Period 1|Other|0|||
30965042|NCT01468207|59033570|FG001|Treatment Period 1|Other|2|||
30965043|NCT01468207|59033571|FG002|Treatment Period 1|Other|0|||
30965044|NCT01468207|59033572|FG003|Treatment Period 1|Other|0|||
30965045|NCT01468207|59033573|FG004|Treatment Period 1|Other|0|||
30965046|NCT01468207|59033574|FG005|Treatment Period 1|Other|0|||
30965047|NCT01468207|59033569|FG000|Treatment Period 2|Adverse Event|0|||
30965048|NCT01468207|59033570|FG001|Treatment Period 2|Adverse Event|0|||
30965049|NCT01468207|59033571|FG002|Treatment Period 2|Adverse Event|6|||
30965050|NCT01468207|59033572|FG003|Treatment Period 2|Adverse Event|1|||
30965051|NCT01468207|59033573|FG004|Treatment Period 2|Adverse Event|2|||
30965052|NCT01468207|59033574|FG005|Treatment Period 2|Adverse Event|1|||
30965053|NCT01468207|59033569|FG000|Treatment Period 2|Lack of Efficacy|0|||
30965054|NCT01468207|59033570|FG001|Treatment Period 2|Lack of Efficacy|0|||
30965055|NCT01468207|59033571|FG002|Treatment Period 2|Lack of Efficacy|1|||
30965056|NCT01468207|59033572|FG003|Treatment Period 2|Lack of Efficacy|1|||
30965057|NCT01468207|59033573|FG004|Treatment Period 2|Lack of Efficacy|0|||
30965058|NCT01468207|59033574|FG005|Treatment Period 2|Lack of Efficacy|2|||
30965059|NCT01468207|59033569|FG000|Treatment Period 2|Withdrawal by Subject|0|||
30965060|NCT01468207|59033570|FG001|Treatment Period 2|Withdrawal by Subject|0|||
30965061|NCT01468207|59033571|FG002|Treatment Period 2|Withdrawal by Subject|5|||
30965062|NCT01468207|59033572|FG003|Treatment Period 2|Withdrawal by Subject|0|||
30965063|NCT01468207|59033573|FG004|Treatment Period 2|Withdrawal by Subject|0|||
30965064|NCT01468207|59033574|FG005|Treatment Period 2|Withdrawal by Subject|2|||
30965065|NCT01468207|59033569|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
30965066|NCT01468207|59033570|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
30965067|NCT01468207|59033571|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
30876780|NCT02673697|58908193|FG001|Overall Study|Change subj medical status|2|||
30876781|NCT02673697|58908192|FG000|Overall Study|Explant|10|||
30876782|NCT02673697|58908193|FG001|Overall Study|Explant|5|||
30965068|NCT01468207|59033572|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
30965069|NCT01468207|59033573|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
30965070|NCT01468207|59033574|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
30965071|NCT01468207|59033569|FG000|Treatment Period 2|Lost to Follow-up|0|||
30965072|NCT01468207|59033570|FG001|Treatment Period 2|Lost to Follow-up|0|||
30965073|NCT01468207|59033571|FG002|Treatment Period 2|Lost to Follow-up|5|||
30965074|NCT01468207|59033572|FG003|Treatment Period 2|Lost to Follow-up|1|||
30965075|NCT01468207|59033573|FG004|Treatment Period 2|Lost to Follow-up|0|||
30965076|NCT01468207|59033574|FG005|Treatment Period 2|Lost to Follow-up|0|||
30965077|NCT01468207|59033569|FG000|Treatment Period 2|Other|0|||
30965078|NCT01468207|59033570|FG001|Treatment Period 2|Other|0|||
30965079|NCT01468207|59033571|FG002|Treatment Period 2|Other|5|||
30965080|NCT01468207|59033572|FG003|Treatment Period 2|Other|1|||
30965081|NCT01468207|59033573|FG004|Treatment Period 2|Other|1|||
30965082|NCT01468207|59033574|FG005|Treatment Period 2|Other|2|||
30965083|NCT01494649|59033594|FG000|Overall Study|Lost to Follow-up|0|||
30965084|NCT01494649|59033595|FG001|Overall Study|Lost to Follow-up|1|||
30965085|NCT01686152|59033606|FG000|Overall Study|Withdrawal by Subject|11|||
30965086|NCT01686152|59033607|FG001|Overall Study|Withdrawal by Subject|11|||
30965087|NCT01686152|59033608|FG002|Overall Study|Withdrawal by Subject|3|||
30965088|NCT01686152|59033606|FG000|Overall Study|Drug Code Unblinded|0|||
30965089|NCT01686152|59033607|FG001|Overall Study|Drug Code Unblinded|1|||
30965090|NCT01686152|59033608|FG002|Overall Study|Drug Code Unblinded|0|||
30965091|NCT01686152|59033606|FG000|Overall Study|Protocol Violation|6|||
30965092|NCT01686152|59033607|FG001|Overall Study|Protocol Violation|1|||
30965093|NCT01686152|59033608|FG002|Overall Study|Protocol Violation|0|||
30965094|NCT01686152|59033606|FG000|Overall Study|Adverse Event|12|||
30965095|NCT01686152|59033607|FG001|Overall Study|Adverse Event|11|||
30965096|NCT01686152|59033608|FG002|Overall Study|Adverse Event|0|||
30965097|NCT01686152|59033606|FG000|Overall Study|Lack of Efficacy|0|||
30965098|NCT01686152|59033607|FG001|Overall Study|Lack of Efficacy|0|||
30965099|NCT01686152|59033608|FG002|Overall Study|Lack of Efficacy|1|||
30965100|NCT01686152|59033606|FG000|Overall Study|IP Non-compliance|5|||
30965101|NCT01686152|59033607|FG001|Overall Study|IP Non-compliance|5|||
30965102|NCT01686152|59033608|FG002|Overall Study|IP Non-compliance|0|||
30965103|NCT01686152|59033606|FG000|Overall Study|Lost to Follow-up|7|||
30965104|NCT01686152|59033607|FG001|Overall Study|Lost to Follow-up|6|||
30965105|NCT01686152|59033608|FG002|Overall Study|Lost to Follow-up|5|||
30965106|NCT01452919|59033616|FG000|Open-Label Treatment|Adverse Event|5|||
30965107|NCT01452919|59033617|FG001|Open-Label Treatment|Adverse Event|0|||
30965108|NCT01452919|59033618|FG002|Open-Label Treatment|Adverse Event|0|||
30965109|NCT01452919|59033616|FG000|Open-Label Treatment|Lost to Follow-up|4|||
30965110|NCT01452919|59033617|FG001|Open-Label Treatment|Lost to Follow-up|0|||
30965111|NCT01452919|59033618|FG002|Open-Label Treatment|Lost to Follow-up|0|||
30965112|NCT01452919|59033616|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
30965113|NCT01452919|59033617|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
30965114|NCT01452919|59033618|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
30965115|NCT01452919|59033616|FG000|Open-Label Treatment|Protocol Violation|4|||
30965116|NCT01452919|59033617|FG001|Open-Label Treatment|Protocol Violation|0|||
30965117|NCT01452919|59033618|FG002|Open-Label Treatment|Protocol Violation|0|||
30965118|NCT01452919|59033616|FG000|Open-Label Treatment|Sponsor Decision|1|||
30965119|NCT01452919|59033617|FG001|Open-Label Treatment|Sponsor Decision|0|||
30965120|NCT01452919|59033618|FG002|Open-Label Treatment|Sponsor Decision|0|||
30965121|NCT01452919|59033616|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
30965122|NCT01452919|59033617|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
30965123|NCT01452919|59033618|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
30965124|NCT01452919|59033616|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
30965125|NCT01452919|59033617|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
30965126|NCT01452919|59033618|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
30965127|NCT01452919|59033616|FG000|Randomization Treatment|Adverse Event|0|||
30965128|NCT01452919|59033617|FG001|Randomization Treatment|Adverse Event|0|||
30965129|NCT01452919|59033618|FG002|Randomization Treatment|Adverse Event|2|||
30965130|NCT01452919|59033616|FG000|Randomization Treatment|Sponsor Decision|0|||
30965131|NCT01452919|59033617|FG001|Randomization Treatment|Sponsor Decision|1|||
30965132|NCT01452919|59033618|FG002|Randomization Treatment|Sponsor Decision|0|||
30965133|NCT01452919|59033616|FG000|Randomization Treatment|Withdrawal by Subject|0|||
30965134|NCT01452919|59033617|FG001|Randomization Treatment|Withdrawal by Subject|1|||
30965135|NCT01452919|59033618|FG002|Randomization Treatment|Withdrawal by Subject|0|||
30965136|NCT01452919|59033616|FG000|Randomization Treatment|Subject is moving or has moved|0|||
30965137|NCT01452919|59033617|FG001|Randomization Treatment|Subject is moving or has moved|1|||
30965138|NCT01452919|59033618|FG002|Randomization Treatment|Subject is moving or has moved|0|||
30965139|NCT01582178|59033630|FG000|Overall Study|Physician Decision|6|||
30965140|NCT01582178|59033631|FG001|Overall Study|Physician Decision|5|||
30965141|NCT01561898|59033641|FG000|Overall Study|Withdrawal by Subject|0|||
30965142|NCT01561898|59033642|FG001|Overall Study|Withdrawal by Subject|8|||
30965143|NCT01561898|59033643|FG002|Overall Study|Withdrawal by Subject|12|||
30965144|NCT01561898|59033644|FG003|Overall Study|Withdrawal by Subject|5|||
30965145|NCT01561898|59033641|FG000|Overall Study|Lack of Efficacy|0|||
30965146|NCT01561898|59033642|FG001|Overall Study|Lack of Efficacy|8|||
30965147|NCT01561898|59033643|FG002|Overall Study|Lack of Efficacy|10|||
30965148|NCT01561898|59033644|FG003|Overall Study|Lack of Efficacy|5|||
30965149|NCT01561898|59033641|FG000|Overall Study|Worsening of complications|0|||
30965150|NCT01561898|59033642|FG001|Overall Study|Worsening of complications|1|||
30965151|NCT01561898|59033643|FG002|Overall Study|Worsening of complications|0|||
30965152|NCT01561898|59033644|FG003|Overall Study|Worsening of complications|0|||
30965153|NCT01561898|59033641|FG000|Overall Study|Lost to Follow-up|0|||
30965154|NCT01561898|59033642|FG001|Overall Study|Lost to Follow-up|0|||
30965155|NCT01561898|59033643|FG002|Overall Study|Lost to Follow-up|1|||
30965156|NCT01561898|59033644|FG003|Overall Study|Lost to Follow-up|0|||
30965157|NCT01561898|59033641|FG000|Overall Study|Adverse Event|1|||
30965158|NCT01561898|59033642|FG001|Overall Study|Adverse Event|19|||
30965159|NCT01561898|59033643|FG002|Overall Study|Adverse Event|14|||
30965160|NCT01561898|59033644|FG003|Overall Study|Adverse Event|9|||
30965161|NCT01561898|59033641|FG000|Overall Study|Physician Decision|1|||
30965162|NCT01561898|59033642|FG001|Overall Study|Physician Decision|5|||
30965163|NCT01561898|59033643|FG002|Overall Study|Physician Decision|7|||
30965164|NCT01561898|59033644|FG003|Overall Study|Physician Decision|1|||
30965165|NCT01685840|59033654|FG000|Overall Study|Death|77|||
30965166|NCT01685840|59033655|FG001|Overall Study|Death|66|||
30965167|NCT01685840|59033654|FG000|Overall Study|Lost to Follow-up|27|||
30965168|NCT01685840|59033655|FG001|Overall Study|Lost to Follow-up|25|||
30965169|NCT01685840|59033654|FG000|Overall Study|Physician Decision|3|||
30965170|NCT01685840|59033655|FG001|Overall Study|Physician Decision|7|||
30965171|NCT01685840|59033654|FG000|Overall Study|Withdrawal by Subject|14|||
30965172|NCT01685840|59033655|FG001|Overall Study|Withdrawal by Subject|17|||
30965173|NCT01685840|59033654|FG000|Overall Study|Futility|197|||
30965174|NCT01685840|59033655|FG001|Overall Study|Futility|200|||
30965175|NCT01685840|59033654|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
30965176|NCT01685840|59033655|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
30965177|NCT01452529|59033665|FG000|Run-in Period|Adverse Event|96|||
30965178|NCT01452529|59033666|FG001|Run-in Period|Adverse Event|0|||
30965179|NCT01452529|59033667|FG002|Run-in Period|Adverse Event|0|||
30965180|NCT01452529|59033665|FG000|Run-in Period|Withdrawal by Subject|49|||
30965181|NCT01452529|59033666|FG001|Run-in Period|Withdrawal by Subject|0|||
30965182|NCT01452529|59033667|FG002|Run-in Period|Withdrawal by Subject|0|||
30965183|NCT01452529|59033665|FG000|Run-in Period|Lost to Follow-up|19|||
30965184|NCT01452529|59033666|FG001|Run-in Period|Lost to Follow-up|0|||
30965185|NCT01452529|59033667|FG002|Run-in Period|Lost to Follow-up|0|||
30965186|NCT01452529|59033665|FG000|Run-in Period|Lack of Efficacy|46|||
30965187|NCT01452529|59033666|FG001|Run-in Period|Lack of Efficacy|0|||
30965188|NCT01452529|59033667|FG002|Run-in Period|Lack of Efficacy|0|||
30965189|NCT01452529|59033665|FG000|Run-in Period|Confirmed or suspected diversion|23|||
30965190|NCT01452529|59033666|FG001|Run-in Period|Confirmed or suspected diversion|0|||
30965191|NCT01452529|59033667|FG002|Run-in Period|Confirmed or suspected diversion|0|||
30965192|NCT01452529|59033665|FG000|Run-in Period|Administrative|21|||
30606495|NCT01001572|58617290|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
30606496|NCT01001572|58617288|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
30606497|NCT01001572|58617289|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
30606498|NCT01001572|58617290|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
30606499|NCT01001572|58617288|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
30606500|NCT01001572|58617289|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
30606501|NCT01001572|58617290|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
30606502|NCT01001572|58617288|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
30606503|NCT01001572|58617289|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
30606504|NCT01001572|58617290|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
30606505|NCT01001572|58617288|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
30606506|NCT01001572|58617289|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
30606507|NCT01001572|58617290|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
30606508|NCT01001572|58617288|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
30606509|NCT01001572|58617289|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
30606510|NCT01001572|58617290|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
30606511|NCT01208415|58617296|FG000|Overall Study|Death|1|||
30606512|NCT01208415|58617296|FG000|Overall Study|Lost to Follow-up|2|||
30606513|NCT01208415|58617296|FG000|Overall Study|Withdrawal by Subject|3|||
30606514|NCT01208415|58617296|FG000|Overall Study|Device not placed|1|||
30606515|NCT01208415|58617296|FG000|Overall Study|Still be eligible for follow-up|33|||
30606516|NCT01208337|58617300|FG000|Overall Study|Death|3|||
30606517|NCT01208181|58617316|FG000|Part 1|Withdrawal by Subject|11|||
30606518|NCT01208181|58617317|FG001|Part 1|Withdrawal by Subject|10|||
30606519|NCT01208181|58617318|FG002|Part 1|Withdrawal by Subject|0|||
30606520|NCT01208181|58617319|FG003|Part 1|Withdrawal by Subject|0|||
30606521|NCT01208181|58617320|FG004|Part 1|Withdrawal by Subject|0|||
30965193|NCT01452529|59033666|FG001|Run-in Period|Administrative|0|||
30965194|NCT01452529|59033667|FG002|Run-in Period|Administrative|0|||
30606522|NCT01208181|58617316|FG000|Part 1|Technical problem|5|||
30606523|NCT01208181|58617317|FG001|Part 1|Technical problem|0|||
30606524|NCT01208181|58617318|FG002|Part 1|Technical problem|0|||
30606525|NCT01208181|58617319|FG003|Part 1|Technical problem|0|||
30606526|NCT01208181|58617320|FG004|Part 1|Technical problem|0|||
30606527|NCT01208181|58617316|FG000|Part 1|Protocol Violation|10|||
30606528|NCT01208181|58617317|FG001|Part 1|Protocol Violation|5|||
30606529|NCT01208181|58617318|FG002|Part 1|Protocol Violation|0|||
30606530|NCT01208181|58617319|FG003|Part 1|Protocol Violation|0|||
30606531|NCT01208181|58617320|FG004|Part 1|Protocol Violation|0|||
30606532|NCT01208181|58617316|FG000|Part 1|Physician Decision|4|||
30606533|NCT01208181|58617317|FG001|Part 1|Physician Decision|0|||
30606534|NCT01208181|58617318|FG002|Part 1|Physician Decision|0|||
30606535|NCT01208181|58617319|FG003|Part 1|Physician Decision|0|||
30606536|NCT01208181|58617320|FG004|Part 1|Physician Decision|0|||
30606537|NCT01208181|58617316|FG000|Part 1|Non-compliance with study drug|1|||
30606538|NCT01208181|58617317|FG001|Part 1|Non-compliance with study drug|1|||
30606539|NCT01208181|58617318|FG002|Part 1|Non-compliance with study drug|0|||
30606540|NCT01208181|58617319|FG003|Part 1|Non-compliance with study drug|0|||
30606541|NCT01208181|58617320|FG004|Part 1|Non-compliance with study drug|0|||
30606542|NCT01208181|58617316|FG000|Part 1|Lost to Follow-up|5|||
30606543|NCT01208181|58617317|FG001|Part 1|Lost to Follow-up|3|||
30606544|NCT01208181|58617318|FG002|Part 1|Lost to Follow-up|0|||
30606545|NCT01208181|58617319|FG003|Part 1|Lost to Follow-up|0|||
30606546|NCT01208181|58617320|FG004|Part 1|Lost to Follow-up|1|||
30606547|NCT01208181|58617316|FG000|Part 1|Lack of Efficacy|37|||
30606548|NCT01208181|58617317|FG001|Part 1|Lack of Efficacy|12|||
30606549|NCT01208181|58617318|FG002|Part 1|Lack of Efficacy|0|||
30606550|NCT01208181|58617319|FG003|Part 1|Lack of Efficacy|0|||
30606551|NCT01208181|58617320|FG004|Part 1|Lack of Efficacy|17|||
30606552|NCT01208181|58617316|FG000|Part 1|Adverse Event|26|||
30606553|NCT01208181|58617317|FG001|Part 1|Adverse Event|24|||
30606554|NCT01208181|58617318|FG002|Part 1|Adverse Event|0|||
30606555|NCT01208181|58617319|FG003|Part 1|Adverse Event|0|||
30606556|NCT01208181|58617320|FG004|Part 1|Adverse Event|4|||
30606557|NCT01208181|58617316|FG000|Part 2|Adverse Event|0|||
30606558|NCT01208181|58617317|FG001|Part 2|Adverse Event|0|||
30606559|NCT01208181|58617318|FG002|Part 2|Adverse Event|6|||
30606560|NCT01208181|58617319|FG003|Part 2|Adverse Event|7|||
30606561|NCT01208181|58617320|FG004|Part 2|Adverse Event|0|||
30606562|NCT01208181|58617316|FG000|Part 2|Withdrawal by Subject|0|||
30606563|NCT01208181|58617317|FG001|Part 2|Withdrawal by Subject|0|||
30606564|NCT01208181|58617318|FG002|Part 2|Withdrawal by Subject|1|||
30606565|NCT01208181|58617319|FG003|Part 2|Withdrawal by Subject|1|||
30606566|NCT01208181|58617320|FG004|Part 2|Withdrawal by Subject|0|||
30606567|NCT01208181|58617316|FG000|Part 2|Protocol Violation|0|||
30606568|NCT01208181|58617317|FG001|Part 2|Protocol Violation|0|||
30606569|NCT01208181|58617318|FG002|Part 2|Protocol Violation|1|||
30606570|NCT01208181|58617319|FG003|Part 2|Protocol Violation|0|||
30606571|NCT01208181|58617320|FG004|Part 2|Protocol Violation|0|||
30606572|NCT01208181|58617316|FG000|Part 2|Physician Decision|0|||
30606573|NCT01208181|58617317|FG001|Part 2|Physician Decision|0|||
30606574|NCT01208181|58617318|FG002|Part 2|Physician Decision|1|||
30606575|NCT01208181|58617319|FG003|Part 2|Physician Decision|2|||
30606576|NCT01208181|58617320|FG004|Part 2|Physician Decision|0|||
30606577|NCT01208181|58617316|FG000|Part 2|Non-compliance with study drug|0|||
30606578|NCT01208181|58617317|FG001|Part 2|Non-compliance with study drug|0|||
30606579|NCT01208181|58617318|FG002|Part 2|Non-compliance with study drug|1|||
30606580|NCT01208181|58617319|FG003|Part 2|Non-compliance with study drug|1|||
30606581|NCT01208181|58617320|FG004|Part 2|Non-compliance with study drug|0|||
30606582|NCT01208181|58617316|FG000|Part 2|Lost to Follow-up|0|||
30606583|NCT01208181|58617317|FG001|Part 2|Lost to Follow-up|0|||
30606584|NCT01208181|58617318|FG002|Part 2|Lost to Follow-up|1|||
30606585|NCT01208181|58617319|FG003|Part 2|Lost to Follow-up|2|||
30606586|NCT01208181|58617320|FG004|Part 2|Lost to Follow-up|0|||
30606587|NCT01208181|58617316|FG000|Part 2|Lack of Efficacy|0|||
30606588|NCT01208181|58617317|FG001|Part 2|Lack of Efficacy|0|||
30606589|NCT01208181|58617318|FG002|Part 2|Lack of Efficacy|5|||
30606590|NCT01208181|58617319|FG003|Part 2|Lack of Efficacy|7|||
30606591|NCT01208181|58617320|FG004|Part 2|Lack of Efficacy|0|||
30606592|NCT01208103|58617337|FG000|Overall Study|Adverse Event|1|||
30606593|NCT01208103|58617337|FG000|Overall Study|Withdrawal by Subject|1|||
30606594|NCT01206777|58617342|FG000|Overall Study|Death|1|||
30606595|NCT01206777|58617342|FG000|Overall Study|Adverse Event|1|||
30606596|NCT01001494|58617349|FG000|Overall Study|Adverse Event|8|||
30606597|NCT01001494|58617350|FG001|Overall Study|Adverse Event|4|||
30606598|NCT01001494|58617351|FG002|Overall Study|Adverse Event|6|||
30606599|NCT01001494|58617349|FG000|Overall Study|Protocol Violation|0|||
30606600|NCT01001494|58617350|FG001|Overall Study|Protocol Violation|1|||
30606601|NCT01001494|58617351|FG002|Overall Study|Protocol Violation|1|||
30606602|NCT01001494|58617349|FG000|Overall Study|Lost to Follow-up|2|||
30606603|NCT01001494|58617350|FG001|Overall Study|Lost to Follow-up|0|||
30606604|NCT01001494|58617351|FG002|Overall Study|Lost to Follow-up|1|||
30606605|NCT01001494|58617349|FG000|Overall Study|Withdrawal by Subject|9|||
30606606|NCT01001494|58617350|FG001|Overall Study|Withdrawal by Subject|7|||
30606607|NCT01001494|58617351|FG002|Overall Study|Withdrawal by Subject|17|||
30606608|NCT01001494|58617349|FG000|Overall Study|COPD exacerbation|3|||
30606609|NCT01001494|58617350|FG001|Overall Study|COPD exacerbation|4|||
30606610|NCT01001494|58617351|FG002|Overall Study|COPD exacerbation|5|||
30606611|NCT01001494|58617349|FG000|Overall Study|Lack of Efficacy|2|||
30606612|NCT01001494|58617350|FG001|Overall Study|Lack of Efficacy|0|||
30606613|NCT01001494|58617351|FG002|Overall Study|Lack of Efficacy|8|||
30606614|NCT01001494|58617349|FG000|Overall Study|Other|0|||
30606615|NCT01001494|58617350|FG001|Overall Study|Other|1|||
30606616|NCT01001494|58617351|FG002|Overall Study|Other|3|||
30606617|NCT01205685|58617359|FG000|Overall Study|Disease Progression|10|||
30606618|NCT01205685|58617359|FG000|Overall Study|Withdrawal by Subject|1|||
30606619|NCT01205529|58617363|FG000|Overall Study|Procedure Cancelled|4|||
30606620|NCT01205529|58617363|FG000|Overall Study|Withdrawal by Subject|2|||
30606621|NCT01205529|58617363|FG000|Overall Study|Physician Decision|4|||
30606622|NCT01205529|58617363|FG000|Overall Study|Unstable post op|15|||
30606623|NCT01205529|58617363|FG000|Overall Study|No longer met criteria|30|||
30606624|NCT01205451|58617369|FG000|Overall Study|Lost to Follow-up|1|||
30606625|NCT01205451|58617370|FG001|Overall Study|Lost to Follow-up|1|||
30606626|NCT01205451|58617369|FG000|Overall Study|Withdrawal by Subject|5|||
30606627|NCT01205451|58617370|FG001|Overall Study|Withdrawal by Subject|9|||
30606628|NCT01001104|58617380|FG000|Overall Study|Adverse Event|2|||
30606629|NCT01001104|58617381|FG001|Overall Study|Adverse Event|1|||
30606630|NCT01001104|58617382|FG002|Overall Study|Adverse Event|0|||
30606631|NCT01001104|58617383|FG003|Overall Study|Adverse Event|0|||
30606632|NCT01001104|58617380|FG000|Overall Study|Lost to Follow-up|0|||
30606633|NCT01001104|58617381|FG001|Overall Study|Lost to Follow-up|0|||
30606634|NCT01001104|58617382|FG002|Overall Study|Lost to Follow-up|1|||
30606635|NCT01001104|58617383|FG003|Overall Study|Lost to Follow-up|0|||
30606636|NCT01001104|58617380|FG000|Overall Study|Entry Criteria Not Met|0|||
30606637|NCT01001104|58617381|FG001|Overall Study|Entry Criteria Not Met|0|||
30606638|NCT01001104|58617382|FG002|Overall Study|Entry Criteria Not Met|0|||
30606639|NCT01001104|58617383|FG003|Overall Study|Entry Criteria Not Met|1|||
30606640|NCT01001104|58617380|FG000|Overall Study|Withdrawal by Subject|0|||
30606641|NCT01001104|58617381|FG001|Overall Study|Withdrawal by Subject|0|||
30606642|NCT01001104|58617382|FG002|Overall Study|Withdrawal by Subject|0|||
30606643|NCT01001104|58617383|FG003|Overall Study|Withdrawal by Subject|2|||
30606644|NCT00998764|58617398|FG000|Overall Study|Lack of Efficacy|3|||
30606645|NCT00998764|58617399|FG001|Overall Study|Lack of Efficacy|6|||
30606646|NCT00998764|58617398|FG000|Overall Study|Adverse Event|17|||
30606647|NCT00998764|58617399|FG001|Overall Study|Adverse Event|12|||
30606648|NCT00998764|58617398|FG000|Overall Study|Withdrawal by Subject|19|||
30606649|NCT00998764|58617399|FG001|Overall Study|Withdrawal by Subject|25|||
30606650|NCT00998764|58617398|FG000|Overall Study|Physician Decision|3|||
30606651|NCT00998764|58617399|FG001|Overall Study|Physician Decision|3|||
30606652|NCT00998764|58617398|FG000|Overall Study|Death|3|||
30606653|NCT00998764|58617399|FG001|Overall Study|Death|1|||
30606654|NCT00998764|58617398|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
30606655|NCT00998764|58617399|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
30606656|NCT00998764|58617398|FG000|Overall Study|Protocol Violation|0|||
30606657|NCT00998764|58617399|FG001|Overall Study|Protocol Violation|1|||
30606658|NCT00998764|58617398|FG000|Overall Study|Failed to Return|1|||
30606659|NCT00998764|58617399|FG001|Overall Study|Failed to Return|1|||
30606660|NCT00998764|58617398|FG000|Overall Study|Lost to Follow-up|1|||
30606661|NCT00998764|58617399|FG001|Overall Study|Lost to Follow-up|1|||
30606662|NCT00998764|58617398|FG000|Overall Study|Loss of Caregiver|0|||
30606663|NCT00998764|58617399|FG001|Overall Study|Loss of Caregiver|3|||
30606664|NCT00998764|58617398|FG000|Overall Study|Other|4|||
30606665|NCT00998764|58617399|FG001|Overall Study|Other|4|||
30606666|NCT00998764|58617398|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
30606667|NCT00998764|58617399|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
30606668|NCT01204671|58617412|FG000|Overall Study|Adverse Event|4|||
30606669|NCT01204671|58617413|FG001|Overall Study|Adverse Event|3|||
30606670|NCT01204671|58617414|FG002|Overall Study|Adverse Event|3|||
30606671|NCT01204671|58617415|FG003|Overall Study|Adverse Event|3|||
30606672|NCT01204671|58617416|FG004|Overall Study|Adverse Event|1|||
30606673|NCT01204671|58617412|FG000|Overall Study|Withdrawal by Subject|2|||
30606674|NCT01204671|58617413|FG001|Overall Study|Withdrawal by Subject|3|||
30606675|NCT01204671|58617414|FG002|Overall Study|Withdrawal by Subject|4|||
30606676|NCT01204671|58617415|FG003|Overall Study|Withdrawal by Subject|5|||
30606677|NCT01204671|58617416|FG004|Overall Study|Withdrawal by Subject|3|||
30606678|NCT01204671|58617412|FG000|Overall Study|Lost to Follow-up|7|||
30606679|NCT01204671|58617413|FG001|Overall Study|Lost to Follow-up|8|||
30606680|NCT01204671|58617414|FG002|Overall Study|Lost to Follow-up|6|||
30606681|NCT01204671|58617415|FG003|Overall Study|Lost to Follow-up|4|||
30606682|NCT01204671|58617416|FG004|Overall Study|Lost to Follow-up|0|||
30606683|NCT01204671|58617412|FG000|Overall Study|Unknown Completion Status|1|||
30606684|NCT01204671|58617413|FG001|Overall Study|Unknown Completion Status|1|||
30606685|NCT01204671|58617414|FG002|Overall Study|Unknown Completion Status|0|||
30606686|NCT01204671|58617415|FG003|Overall Study|Unknown Completion Status|0|||
30606687|NCT01204671|58617416|FG004|Overall Study|Unknown Completion Status|0|||
30606688|NCT01204671|58617412|FG000|Overall Study|Physician Decision|0|||
30606689|NCT01204671|58617413|FG001|Overall Study|Physician Decision|0|||
30606690|NCT01204671|58617414|FG002|Overall Study|Physician Decision|0|||
30606691|NCT01204671|58617415|FG003|Overall Study|Physician Decision|1|||
30606692|NCT01204671|58617416|FG004|Overall Study|Physician Decision|0|||
30606693|NCT01202955|58617434|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
30606694|NCT01202955|58617435|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
30606695|NCT01202877|58617444|FG000|Overall Study|Disease Progression|0|||
30606696|NCT01202877|58617445|FG001|Overall Study|Disease Progression|1|||
30606697|NCT01202877|58617446|FG002|Overall Study|Disease Progression|2|||
30606698|NCT01202877|58617444|FG000|Overall Study|Adverse Event|0|||
30606699|NCT01202877|58617445|FG001|Overall Study|Adverse Event|0|||
30606700|NCT01202877|58617446|FG002|Overall Study|Adverse Event|2|||
30606701|NCT01202877|58617444|FG000|Overall Study|Withdrawal by Subject|0|||
30606702|NCT01202877|58617445|FG001|Overall Study|Withdrawal by Subject|0|||
30606703|NCT01202877|58617446|FG002|Overall Study|Withdrawal by Subject|1|||
30606704|NCT01202877|58617444|FG000|Overall Study|Death|0|||
30606705|NCT01202877|58617445|FG001|Overall Study|Death|0|||
30606706|NCT01202877|58617446|FG002|Overall Study|Death|1|||
30606707|NCT01202409|58617454|FG000|Overall Study|Adverse Event|1|||
30606708|NCT01202409|58617454|FG000|Overall Study|Ineligible - KRAS mutants|7|||
30606709|NCT01202175|58617460|FG000|Overall Study|Lost to Follow-up|2|||
30606710|NCT01202175|58617460|FG000|Overall Study|Withdrawal by Subject|1|||
30606711|NCT01202175|58617460|FG000|Overall Study|Adverse Event|2|||
30606712|NCT01201785|58617465|FG000|Overall Study|Lost to Follow-up|16|||
30606713|NCT01201317|58617472|FG000|Overall Study|Withdrawal by Subject|5|||
30606714|NCT01201317|58617473|FG001|Overall Study|Withdrawal by Subject|0|||
30606715|NCT01201317|58617474|FG002|Overall Study|Withdrawal by Subject|3|||
30606716|NCT01201317|58617472|FG000|Overall Study|Adverse Event|2|||
30606717|NCT01201317|58617473|FG001|Overall Study|Adverse Event|2|||
30606718|NCT01201317|58617474|FG002|Overall Study|Adverse Event|2|||
30606719|NCT01201317|58617472|FG000|Overall Study|Screen failure|1|||
30606720|NCT01201317|58617473|FG001|Overall Study|Screen failure|1|||
30606721|NCT01201317|58617474|FG002|Overall Study|Screen failure|0|||
30606722|NCT01201317|58617472|FG000|Overall Study|Protocol Violation|0|||
30606723|NCT01201317|58617473|FG001|Overall Study|Protocol Violation|1|||
30606724|NCT01201317|58617474|FG002|Overall Study|Protocol Violation|1|||
30606725|NCT01201317|58617472|FG000|Overall Study|Death|0|||
30606726|NCT01201317|58617473|FG001|Overall Study|Death|1|||
30606727|NCT01201317|58617474|FG002|Overall Study|Death|0|||
30606728|NCT01201317|58617472|FG000|Overall Study|Study-specific withdrawal criteria|0|||
30606729|NCT01201317|58617473|FG001|Overall Study|Study-specific withdrawal criteria|0|||
30606730|NCT01201317|58617474|FG002|Overall Study|Study-specific withdrawal criteria|1|||
30606731|NCT01201317|58617472|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
30606732|NCT01201317|58617473|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
30606733|NCT01201317|58617474|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
30606734|NCT01201317|58617472|FG000|Overall Study|Decrease in renal function|0|||
30606735|NCT01201317|58617473|FG001|Overall Study|Decrease in renal function|1|||
30606736|NCT01201317|58617474|FG002|Overall Study|Decrease in renal function|0|||
30606737|NCT01201317|58617472|FG000|Overall Study|Lack of Efficacy|1|||
30606738|NCT01201317|58617473|FG001|Overall Study|Lack of Efficacy|0|||
30606739|NCT01201317|58617474|FG002|Overall Study|Lack of Efficacy|0|||
30606740|NCT01201317|58617472|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
30606741|NCT01201317|58617473|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
30606742|NCT01201317|58617474|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
30606743|NCT01200069|58617484|FG000|Overall Study|Withdrawal by Subject|0|||
30606744|NCT01200069|58617485|FG001|Overall Study|Withdrawal by Subject|1|||
30606745|NCT01199601|58617536|FG000|Overall Study|Lost to Follow-up|47|||
30606746|NCT01199601|58617537|FG001|Overall Study|Lost to Follow-up|66|||
30606747|NCT01199601|58617536|FG000|Overall Study|Withdrawal by Subject|15|||
30606748|NCT01199601|58617537|FG001|Overall Study|Withdrawal by Subject|3|||
30606749|NCT01199601|58617536|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
30606750|NCT01199601|58617537|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
30606751|NCT01199289|58617547|FG000|Overall Study|Ineligibility determined|2|||
30606752|NCT01199289|58617548|FG001|Overall Study|Ineligibility determined|1|||
30606753|NCT01199289|58617549|FG002|Overall Study|Ineligibility determined|0|||
30606754|NCT01199289|58617550|FG003|Overall Study|Ineligibility determined|0|||
30696780|NCT00561951|58711119|FG001|Overall Study|Adverse Event|14|||
30606755|NCT01199289|58617547|FG000|Overall Study|Protocol Violation|1|||
30606756|NCT01199289|58617548|FG001|Overall Study|Protocol Violation|0|||
30606757|NCT01199289|58617549|FG002|Overall Study|Protocol Violation|0|||
30606758|NCT01199289|58617550|FG003|Overall Study|Protocol Violation|1|||
30606759|NCT01199289|58617547|FG000|Overall Study|Noncompliance|1|||
30606760|NCT01199289|58617548|FG001|Overall Study|Noncompliance|0|||
30606761|NCT01199289|58617549|FG002|Overall Study|Noncompliance|2|||
30606762|NCT01199289|58617550|FG003|Overall Study|Noncompliance|0|||
30606763|NCT01199289|58617547|FG000|Overall Study|Adverse Event|0|||
30606764|NCT01199289|58617548|FG001|Overall Study|Adverse Event|3|||
30606765|NCT01199289|58617549|FG002|Overall Study|Adverse Event|1|||
30606766|NCT01199289|58617550|FG003|Overall Study|Adverse Event|4|||
30606767|NCT01199289|58617547|FG000|Overall Study|Full consent withdrawn|2|||
30606768|NCT01199289|58617548|FG001|Overall Study|Full consent withdrawn|2|||
30606769|NCT01199289|58617549|FG002|Overall Study|Full consent withdrawn|2|||
30606770|NCT01199289|58617550|FG003|Overall Study|Full consent withdrawn|3|||
30606771|NCT01199289|58617547|FG000|Overall Study|Administrative decision|0|||
30606772|NCT01199289|58617548|FG001|Overall Study|Administrative decision|0|||
30606773|NCT01199289|58617549|FG002|Overall Study|Administrative decision|0|||
30606774|NCT01199289|58617550|FG003|Overall Study|Administrative decision|1|||
30606775|NCT01199289|58617547|FG000|Overall Study|Lost to Follow-up|0|||
30606776|NCT01199289|58617548|FG001|Overall Study|Lost to Follow-up|0|||
30606777|NCT01199289|58617549|FG002|Overall Study|Lost to Follow-up|0|||
30606778|NCT01199289|58617550|FG003|Overall Study|Lost to Follow-up|1|||
30606779|NCT01199289|58617547|FG000|Overall Study|Protocol-specified criteria|3|||
30606780|NCT01199289|58617548|FG001|Overall Study|Protocol-specified criteria|0|||
30606781|NCT01199289|58617549|FG002|Overall Study|Protocol-specified criteria|0|||
30606782|NCT01199289|58617550|FG003|Overall Study|Protocol-specified criteria|1|||
30606783|NCT01199289|58617547|FG000|Overall Study|Pregnancy|0|||
30606784|NCT01199289|58617548|FG001|Overall Study|Pregnancy|1|||
30606785|NCT01199289|58617549|FG002|Overall Study|Pregnancy|0|||
30606786|NCT01199289|58617550|FG003|Overall Study|Pregnancy|1|||
30606787|NCT01199055|58617566|FG000|Overall Study|Death|0|||
30606788|NCT01199055|58617567|FG001|Overall Study|Death|1|||
30606789|NCT01199055|58617568|FG002|Overall Study|Death|0|||
30606790|NCT01199055|58617566|FG000|Overall Study|Physician Decision|0|||
30606791|NCT01199055|58617567|FG001|Overall Study|Physician Decision|1|||
30606792|NCT01199055|58617568|FG002|Overall Study|Physician Decision|1|||
30606793|NCT01199055|58617566|FG000|Overall Study|Progressive disease|2|||
30606794|NCT01199055|58617567|FG001|Overall Study|Progressive disease|1|||
30606795|NCT01199055|58617568|FG002|Overall Study|Progressive disease|2|||
30606796|NCT01199055|58617566|FG000|Overall Study|Withdrawal by Subject|0|||
30606797|NCT01199055|58617567|FG001|Overall Study|Withdrawal by Subject|0|||
30606798|NCT01199055|58617568|FG002|Overall Study|Withdrawal by Subject|1|||
30606799|NCT01198977|58617580|FG000|Overall Study|Lost to Follow-up|1|||
30606800|NCT01198977|58617581|FG001|Overall Study|Lost to Follow-up|0|||
30606801|NCT01198587|58617593|FG000|Overall Study|Lost to Follow-up|8|||
30606802|NCT01198587|58617594|FG001|Overall Study|Lost to Follow-up|0|||
30606803|NCT01198587|58617595|FG002|Overall Study|Lost to Follow-up|9|||
30606804|NCT01198587|58617596|FG003|Overall Study|Lost to Follow-up|0|||
30606805|NCT01198509|58617617|FG000|Overall Study|Withdrawal by Subject|1|||
30606806|NCT01198509|58617618|FG001|Overall Study|Withdrawal by Subject|0|||
30606807|NCT01198509|58617619|FG002|Overall Study|Withdrawal by Subject|0|||
30606808|NCT01198509|58617620|FG003|Overall Study|Withdrawal by Subject|0|||
30606809|NCT01198509|58617621|FG004|Overall Study|Withdrawal by Subject|0|||
30606810|NCT01198509|58617622|FG005|Overall Study|Withdrawal by Subject|0|||
30606811|NCT01198275|58617636|FG000|Overall Study|Adverse Event|2|||
30606812|NCT01198275|58617637|FG001|Overall Study|Adverse Event|3|||
30606813|NCT01198275|58617636|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
30606814|NCT01198275|58617637|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
30606815|NCT01197417|58617645|FG000|Overall Study|Physician Decision|3|||
30606816|NCT01197417|58617646|FG001|Overall Study|Physician Decision|2|||
30606817|NCT01197417|58617645|FG000|Overall Study|Withdrawal by Subject|2|||
30606818|NCT01197417|58617646|FG001|Overall Study|Withdrawal by Subject|4|||
30606819|NCT01197417|58617645|FG000|Overall Study|Site miscommunication|0|||
30606820|NCT01197417|58617646|FG001|Overall Study|Site miscommunication|1|||
30606821|NCT01197417|58617645|FG000|Overall Study|Subject transferred to intensive care|0|||
30606822|NCT01197417|58617646|FG001|Overall Study|Subject transferred to intensive care|1|||
30606823|NCT01197417|58617645|FG000|Overall Study|Not consented in time to receive drug|0|||
30606824|NCT01197417|58617646|FG001|Overall Study|Not consented in time to receive drug|1|||
30606825|NCT01197417|58617645|FG000|Overall Study|Hypotension|1|||
30606826|NCT01197417|58617646|FG001|Overall Study|Hypotension|2|||
30606827|NCT01197417|58617645|FG000|Overall Study|Found to be ineligible|2|||
30606828|NCT01197417|58617646|FG001|Overall Study|Found to be ineligible|5|||
30606829|NCT01197417|58617645|FG000|Overall Study|No 25-hour magnesium level|0|||
30606830|NCT01197417|58617646|FG001|Overall Study|No 25-hour magnesium level|2|||
30606831|NCT00977431|58617657|FG000|Overall Study|Other than listed|1|||
30606832|NCT00977431|58617658|FG001|Overall Study|Other than listed|0|||
30606833|NCT00977431|58617659|FG002|Overall Study|Other than listed|0|||
30606834|NCT00977431|58617660|FG003|Overall Study|Other than listed|0|||
30606835|NCT00977431|58617661|FG004|Overall Study|Other than listed|2|||
30606836|NCT00977431|58617657|FG000|Overall Study|Protocol Violation|0|||
30606837|NCT00977431|58617658|FG001|Overall Study|Protocol Violation|0|||
30606838|NCT00977431|58617659|FG002|Overall Study|Protocol Violation|1|||
30606839|NCT00977431|58617660|FG003|Overall Study|Protocol Violation|0|||
30606840|NCT00977431|58617661|FG004|Overall Study|Protocol Violation|0|||
30606841|NCT00977431|58617657|FG000|Overall Study|Adverse Event|3|||
30606842|NCT00977431|58617658|FG001|Overall Study|Adverse Event|0|||
30606843|NCT00977431|58617659|FG002|Overall Study|Adverse Event|4|||
30606844|NCT00977431|58617660|FG003|Overall Study|Adverse Event|0|||
30606845|NCT00977431|58617661|FG004|Overall Study|Adverse Event|6|||
30606846|NCT00977431|58617657|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
30606847|NCT00977431|58617658|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
30606848|NCT00977431|58617659|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
30606849|NCT00977431|58617660|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
30606850|NCT00977431|58617661|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
30606851|NCT00977431|58617657|FG000|Overall Study|Progressive disease|2|||
30606852|NCT00977431|58617658|FG001|Overall Study|Progressive disease|6|||
30606853|NCT00977431|58617659|FG002|Overall Study|Progressive disease|1|||
30606854|NCT00977431|58617660|FG003|Overall Study|Progressive disease|3|||
30606855|NCT00977431|58617661|FG004|Overall Study|Progressive disease|5|||
30606856|NCT00977197|58617679|FG000|Overall Study|Withdrawal by Subject|3|||
30606857|NCT00977197|58617680|FG001|Overall Study|Withdrawal by Subject|4|||
30606858|NCT00977197|58617679|FG000|Overall Study|Adverse Event|3|||
30606859|NCT00977197|58617680|FG001|Overall Study|Adverse Event|1|||
30606860|NCT00977197|58617679|FG000|Overall Study|Lack of Efficacy|1|||
30606861|NCT00977197|58617680|FG001|Overall Study|Lack of Efficacy|0|||
30606862|NCT00977197|58617679|FG000|Overall Study|Lost to Follow-up|1|||
30606863|NCT00977197|58617680|FG001|Overall Study|Lost to Follow-up|3|||
30606864|NCT00977197|58617679|FG000|Overall Study|Nonadherence|1|||
30606865|NCT00977197|58617680|FG001|Overall Study|Nonadherence|1|||
30606866|NCT00974311|58617688|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
30606867|NCT00974311|58617689|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
30606868|NCT00974311|58617688|FG000|DB Phase (up to 24 Months)|Death|561|||
30606869|NCT00974311|58617689|FG001|DB Phase (up to 24 Months)|Death|298|||
30606870|NCT00974311|58617688|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
30606871|NCT00974311|58617689|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
30606872|NCT00974311|58617688|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
30606873|NCT00974311|58617689|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
30606874|NCT00974311|58617688|FG000|DB Phase (up to 24 Months)|Other|1|||
30606875|NCT00974311|58617689|FG001|DB Phase (up to 24 Months)|Other|0|||
30606876|NCT00974311|58617688|FG000|OLE Phase (up to 77 Months)|Death|14|||
30606877|NCT00974311|58617689|FG001|OLE Phase (up to 77 Months)|Death|21|||
30606878|NCT00974311|58617688|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
30606879|NCT00974311|58617689|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
30606880|NCT00974311|58617688|FG000|OLE Phase (up to 77 Months)|Other|15|||
30606881|NCT00974311|58617689|FG001|OLE Phase (up to 77 Months)|Other|2|||
30606882|NCT00974311|58617688|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
30606883|NCT00974311|58617689|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
30606884|NCT00974233|58617698|FG000|Induction Chemoimmunotherapy|Death|2|||
30606885|NCT00974233|58617698|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
30606886|NCT00974233|58617698|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
30606887|NCT00974233|58617698|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
30606888|NCT00974233|58617698|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
30606889|NCT00974233|58617698|FG000|Maintenance Lenalidomide|Adverse Event|8|||
30606890|NCT00973921|58617710|FG000|Overall Study|IVUS results were not available|9|||
30606891|NCT00972595|58617714|FG000|Period 1|Adverse Event|1|||
30606892|NCT00972595|58617715|FG001|Period 1|Adverse Event|0|||
30606893|NCT01196091|58617724|FG000|Overall Study|Adverse Event|22|||
30606894|NCT01196091|58617725|FG001|Overall Study|Adverse Event|27|||
30606895|NCT01196091|58617726|FG002|Overall Study|Adverse Event|26|||
30606896|NCT01196091|58617724|FG000|Overall Study|Death|3|||
30606897|NCT01196091|58617725|FG001|Overall Study|Death|2|||
30606898|NCT01196091|58617726|FG002|Overall Study|Death|2|||
30606899|NCT01196091|58617724|FG000|Overall Study|Entry Criteria Not Met|11|||
30606900|NCT01196091|58617725|FG001|Overall Study|Entry Criteria Not Met|11|||
30606901|NCT01196091|58617726|FG002|Overall Study|Entry Criteria Not Met|10|||
30606902|NCT01196091|58617724|FG000|Overall Study|Lack of Efficacy|15|||
30606903|NCT01196091|58617725|FG001|Overall Study|Lack of Efficacy|12|||
30606904|NCT01196091|58617726|FG002|Overall Study|Lack of Efficacy|17|||
30606905|NCT01196091|58617724|FG000|Overall Study|Lost to Follow-up|5|||
30606906|NCT01196091|58617725|FG001|Overall Study|Lost to Follow-up|5|||
30606907|NCT01196091|58617726|FG002|Overall Study|Lost to Follow-up|6|||
30606908|NCT01196091|58617724|FG000|Overall Study|Parent/Caregiver Decision|0|||
30606909|NCT01196091|58617725|FG001|Overall Study|Parent/Caregiver Decision|0|||
30606910|NCT01196091|58617726|FG002|Overall Study|Parent/Caregiver Decision|1|||
30606911|NCT01196091|58617724|FG000|Overall Study|Withdrawal by Subject|16|||
30606912|NCT01196091|58617725|FG001|Overall Study|Withdrawal by Subject|19|||
30606913|NCT01196091|58617726|FG002|Overall Study|Withdrawal by Subject|22|||
30606914|NCT01196091|58617724|FG000|Overall Study|Physician Decision|3|||
30606915|NCT01196091|58617725|FG001|Overall Study|Physician Decision|3|||
30606916|NCT01196091|58617726|FG002|Overall Study|Physician Decision|4|||
30606917|NCT01196091|58617724|FG000|Overall Study|Protocol Violation|1|||
30606918|NCT01196091|58617725|FG001|Overall Study|Protocol Violation|3|||
30606919|NCT01196091|58617726|FG002|Overall Study|Protocol Violation|3|||
30606920|NCT01196091|58617724|FG000|Overall Study|Sponsor Decision|6|||
30606921|NCT01196091|58617725|FG001|Overall Study|Sponsor Decision|5|||
30606922|NCT01196091|58617726|FG002|Overall Study|Sponsor Decision|4|||
30606923|NCT01196091|58617724|FG000|Overall Study|Excluded Site|5|||
30606924|NCT01196091|58617725|FG001|Overall Study|Excluded Site|11|||
30606925|NCT01196091|58617726|FG002|Overall Study|Excluded Site|8|||
30606926|NCT01196091|58617724|FG000|Overall Study|Randomized, No Study Drug Received|1|||
30606927|NCT01196091|58617725|FG001|Overall Study|Randomized, No Study Drug Received|0|||
30606928|NCT01196091|58617726|FG002|Overall Study|Randomized, No Study Drug Received|1|||
30606929|NCT01195623|58617741|FG000|Overall Study|Lost to Follow-up|35|||
30606930|NCT01195623|58617742|FG001|Overall Study|Lost to Follow-up|37|||
30606931|NCT01195545|58617748|FG000|Overall Study|Protocol Violation|4|||
30606932|NCT01194999|58617752|FG000|Overall Study|Lost to Follow-up|17|||
30606933|NCT01194531|58617758|FG000|Overall Study|Withdrawal by Subject|1|||
30606934|NCT01194531|58617759|FG001|Overall Study|Withdrawal by Subject|0|||
30606935|NCT01194531|58617758|FG000|Overall Study|Protocol Violation|4|||
30606936|NCT01194531|58617759|FG001|Overall Study|Protocol Violation|1|||
30606937|NCT01194531|58617758|FG000|Overall Study|Physician Decision|0|||
30606938|NCT01194531|58617759|FG001|Overall Study|Physician Decision|2|||
30606939|NCT00972517|58617765|FG000|Overall Study|Adverse Event|0|||
30606940|NCT00972517|58617766|FG001|Overall Study|Adverse Event|0|||
30606941|NCT00972517|58617767|FG002|Overall Study|Adverse Event|0|||
30606942|NCT00972517|58617768|FG003|Overall Study|Adverse Event|1|||
30606943|NCT00972517|58617769|FG004|Overall Study|Adverse Event|0|||
30606944|NCT00972517|58617770|FG005|Overall Study|Adverse Event|0|||
30606945|NCT00972517|58617765|FG000|Overall Study|Withdrawal by Subject|0|||
30606946|NCT00972517|58617766|FG001|Overall Study|Withdrawal by Subject|1|||
30606947|NCT00972517|58617767|FG002|Overall Study|Withdrawal by Subject|0|||
30606948|NCT00972517|58617768|FG003|Overall Study|Withdrawal by Subject|2|||
30606949|NCT00972517|58617769|FG004|Overall Study|Withdrawal by Subject|1|||
30606950|NCT00972517|58617770|FG005|Overall Study|Withdrawal by Subject|0|||
30606951|NCT00972283|58617792|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
30606952|NCT00972283|58617793|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
30606953|NCT00972283|58617792|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
30606954|NCT00972283|58617793|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
30606955|NCT00972283|58617792|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
30606956|NCT00972283|58617793|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
30606957|NCT00972283|58617792|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
30606958|NCT00972283|58617793|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
30606959|NCT00972283|58617792|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
30606960|NCT00972283|58617793|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
30606961|NCT00972283|58617792|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
30606962|NCT00972283|58617793|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
30606963|NCT00972283|58617792|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
30606964|NCT00972283|58617793|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
30606965|NCT00972283|58617792|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
30606966|NCT00972283|58617793|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
30606967|NCT00972283|58617792|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
30606968|NCT00972283|58617793|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
30606969|NCT00972283|58617792|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
30606970|NCT00972283|58617793|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
30606971|NCT00969709|58617803|FG000|Overall Study|Adverse Event|3|||
30606972|NCT00969709|58617804|FG001|Overall Study|Adverse Event|13|||
30606973|NCT00969709|58617805|FG002|Overall Study|Adverse Event|26|||
30606974|NCT00969709|58617806|FG003|Overall Study|Adverse Event|12|||
30606975|NCT00969709|58617803|FG000|Overall Study|Lack of Efficacy|7|||
30606976|NCT00969709|58617804|FG001|Overall Study|Lack of Efficacy|4|||
30606977|NCT00969709|58617805|FG002|Overall Study|Lack of Efficacy|1|||
30606978|NCT00969709|58617806|FG003|Overall Study|Lack of Efficacy|3|||
30606979|NCT00969709|58617803|FG000|Overall Study|Protocol Violation|9|||
30606980|NCT00969709|58617804|FG001|Overall Study|Protocol Violation|5|||
30606981|NCT00969709|58617805|FG002|Overall Study|Protocol Violation|9|||
30876783|NCT02673697|58908192|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
30606982|NCT00969709|58617806|FG003|Overall Study|Protocol Violation|10|||
30606983|NCT00969709|58617803|FG000|Overall Study|Withdrawal by Subject|9|||
30606984|NCT00969709|58617804|FG001|Overall Study|Withdrawal by Subject|12|||
30606985|NCT00969709|58617805|FG002|Overall Study|Withdrawal by Subject|11|||
30606986|NCT00969709|58617806|FG003|Overall Study|Withdrawal by Subject|23|||
30606987|NCT00969709|58617803|FG000|Overall Study|Lost to Follow-up|10|||
30606988|NCT00969709|58617804|FG001|Overall Study|Lost to Follow-up|14|||
30606989|NCT00969709|58617805|FG002|Overall Study|Lost to Follow-up|8|||
30606990|NCT00969709|58617806|FG003|Overall Study|Lost to Follow-up|15|||
30606991|NCT00969709|58617803|FG000|Overall Study|Other reasons|0|||
30606992|NCT00969709|58617804|FG001|Overall Study|Other reasons|0|||
30606993|NCT00969709|58617805|FG002|Overall Study|Other reasons|3|||
30606994|NCT00969709|58617806|FG003|Overall Study|Other reasons|0|||
30606995|NCT01193517|58617823|FG000|Overall Study|Early Progression|1|||
30606996|NCT01193517|58617824|FG001|Overall Study|Early Progression|0|||
30606997|NCT01193517|58617825|FG002|Overall Study|Early Progression|0|||
30606998|NCT01193283|58617834|FG000|Overall Study|Death|1|||
30606999|NCT00971425|58617840|FG000|Overall Study|Adverse Event|1|||
30607000|NCT00971425|58617841|FG001|Overall Study|Adverse Event|1|||
30607001|NCT00971425|58617840|FG000|Overall Study|Withdrawal by Subject|0|||
30607002|NCT00971425|58617841|FG001|Overall Study|Withdrawal by Subject|1|||
30607003|NCT01193127|58617851|FG000|Randomized|Surgery Cancelled|0|||
30607004|NCT01193127|58617852|FG001|Randomized|Surgery Cancelled|0|||
30607005|NCT01193127|58617853|FG002|Randomized|Surgery Cancelled|0|||
30607006|NCT01193127|58617854|FG003|Randomized|Surgery Cancelled|1|||
30607007|NCT01193127|58617851|FG000|Treated|Withdrawal by Subject|0|||
30607008|NCT01193127|58617852|FG001|Treated|Withdrawal by Subject|0|||
30607009|NCT01193127|58617853|FG002|Treated|Withdrawal by Subject|0|||
30607010|NCT01193127|58617854|FG003|Treated|Withdrawal by Subject|1|||
30607011|NCT01192815|58617866|FG000|Overall Study|Withdrawal by Subject|1|||
30607012|NCT01192815|58617866|FG000|Overall Study|Lack of Efficacy|1|||
30607013|NCT01192347|58617870|FG000|Overall Study|Death|3|||
30607014|NCT01192347|58617870|FG000|Overall Study|Lost to Follow-up|3|||
30607015|NCT01192347|58617870|FG000|Overall Study|Withdrawal by Subject|1|||
30607016|NCT01192347|58617870|FG000|Overall Study|Adverse Event|1|||
30607017|NCT01192347|58617870|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
30607018|NCT01192347|58617870|FG000|Overall Study|Patient seen in different hospital|1|||
30607019|NCT01192347|58617870|FG000|Overall Study|Patient not visiting hospital regularly|1|||
30607020|NCT01192347|58617870|FG000|Overall Study|Patient did not show up for visits|1|||
30607021|NCT01192191|58617876|FG000|Overall Study|Adverse Event|7|||
30607022|NCT01192191|58617877|FG001|Overall Study|Adverse Event|12|||
30607023|NCT01192191|58617876|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
30607024|NCT01192191|58617877|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
30607025|NCT01192191|58617876|FG000|Overall Study|Lost to Follow-up|0|||
30607026|NCT01192191|58617877|FG001|Overall Study|Lost to Follow-up|1|||
30607027|NCT01192191|58617876|FG000|Overall Study|Withdrawal by Subject|1|||
30607028|NCT01192191|58617877|FG001|Overall Study|Withdrawal by Subject|6|||
30607029|NCT01307267|58617906|FG000|Overall Study|Death|4|||
30607030|NCT01307267|58617907|FG001|Overall Study|Death|3|||
30607031|NCT01307267|58617908|FG002|Overall Study|Death|5|||
30607032|NCT01307267|58617909|FG003|Overall Study|Death|3|||
30607033|NCT01307267|58617910|FG004|Overall Study|Death|1|||
30607034|NCT01307267|58617911|FG005|Overall Study|Death|26|||
30607035|NCT01307267|58617912|FG006|Overall Study|Death|2|||
30607036|NCT01307267|58617913|FG007|Overall Study|Death|2|||
30607037|NCT01307267|58617914|FG008|Overall Study|Death|21|||
30607038|NCT01307267|58617915|FG009|Overall Study|Death|2|||
30607039|NCT01307267|58617916|FG010|Overall Study|Death|3|||
30607040|NCT01307267|58617917|FG011|Overall Study|Death|9|||
30607041|NCT01307267|58617918|FG012|Overall Study|Death|0|||
30607042|NCT01307267|58617919|FG013|Overall Study|Death|0|||
30607043|NCT01307267|58617920|FG014|Overall Study|Death|0|||
30607044|NCT01307267|58617921|FG015|Overall Study|Death|0|||
30607045|NCT01307267|58617922|FG016|Overall Study|Death|1|||
30607046|NCT01307267|58617923|FG017|Overall Study|Death|1|||
30607047|NCT01307267|58617924|FG018|Overall Study|Death|2|||
30607048|NCT01307267|58617925|FG019|Overall Study|Death|8|||
30607049|NCT01307267|58617926|FG020|Overall Study|Death|1|||
30607050|NCT01307267|58617927|FG021|Overall Study|Death|2|||
30607051|NCT01307267|58617928|FG022|Overall Study|Death|2|||
30607052|NCT01307267|58617906|FG000|Overall Study|Lost to Follow-up|0|||
30607053|NCT01307267|58617907|FG001|Overall Study|Lost to Follow-up|0|||
30607054|NCT01307267|58617908|FG002|Overall Study|Lost to Follow-up|0|||
30607055|NCT01307267|58617909|FG003|Overall Study|Lost to Follow-up|0|||
30607056|NCT01307267|58617910|FG004|Overall Study|Lost to Follow-up|0|||
30607057|NCT01307267|58617911|FG005|Overall Study|Lost to Follow-up|7|||
30607058|NCT01307267|58617912|FG006|Overall Study|Lost to Follow-up|0|||
30607059|NCT01307267|58617913|FG007|Overall Study|Lost to Follow-up|0|||
30607060|NCT01307267|58617914|FG008|Overall Study|Lost to Follow-up|1|||
30607061|NCT01307267|58617915|FG009|Overall Study|Lost to Follow-up|2|||
30607062|NCT01307267|58617916|FG010|Overall Study|Lost to Follow-up|1|||
30876784|NCT02673697|58908193|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
30607063|NCT01307267|58617917|FG011|Overall Study|Lost to Follow-up|0|||
30607064|NCT01307267|58617918|FG012|Overall Study|Lost to Follow-up|0|||
30607065|NCT01307267|58617919|FG013|Overall Study|Lost to Follow-up|0|||
30607066|NCT01307267|58617920|FG014|Overall Study|Lost to Follow-up|0|||
30607067|NCT01307267|58617921|FG015|Overall Study|Lost to Follow-up|0|||
30607068|NCT01307267|58617922|FG016|Overall Study|Lost to Follow-up|0|||
30607069|NCT01307267|58617923|FG017|Overall Study|Lost to Follow-up|0|||
30607070|NCT01307267|58617924|FG018|Overall Study|Lost to Follow-up|0|||
30607071|NCT01307267|58617925|FG019|Overall Study|Lost to Follow-up|2|||
30607072|NCT01307267|58617926|FG020|Overall Study|Lost to Follow-up|0|||
30607073|NCT01307267|58617927|FG021|Overall Study|Lost to Follow-up|0|||
30607074|NCT01307267|58617928|FG022|Overall Study|Lost to Follow-up|0|||
30607075|NCT01307267|58617906|FG000|Overall Study|Withdrawal by Subject|0|||
30607076|NCT01307267|58617907|FG001|Overall Study|Withdrawal by Subject|0|||
30607077|NCT01307267|58617908|FG002|Overall Study|Withdrawal by Subject|0|||
30607078|NCT01307267|58617909|FG003|Overall Study|Withdrawal by Subject|0|||
30607079|NCT01307267|58617910|FG004|Overall Study|Withdrawal by Subject|0|||
30607080|NCT01307267|58617911|FG005|Overall Study|Withdrawal by Subject|1|||
30607081|NCT01307267|58617912|FG006|Overall Study|Withdrawal by Subject|0|||
30607082|NCT01307267|58617913|FG007|Overall Study|Withdrawal by Subject|1|||
30607083|NCT01307267|58617914|FG008|Overall Study|Withdrawal by Subject|5|||
30607084|NCT01307267|58617915|FG009|Overall Study|Withdrawal by Subject|1|||
30607085|NCT01307267|58617916|FG010|Overall Study|Withdrawal by Subject|1|||
30607086|NCT01307267|58617917|FG011|Overall Study|Withdrawal by Subject|1|||
30607087|NCT01307267|58617918|FG012|Overall Study|Withdrawal by Subject|0|||
30607088|NCT01307267|58617919|FG013|Overall Study|Withdrawal by Subject|0|||
30607089|NCT01307267|58617920|FG014|Overall Study|Withdrawal by Subject|0|||
30607090|NCT01307267|58617921|FG015|Overall Study|Withdrawal by Subject|0|||
30607091|NCT01307267|58617922|FG016|Overall Study|Withdrawal by Subject|0|||
30607092|NCT01307267|58617923|FG017|Overall Study|Withdrawal by Subject|0|||
30607093|NCT01307267|58617924|FG018|Overall Study|Withdrawal by Subject|0|||
30607094|NCT01307267|58617925|FG019|Overall Study|Withdrawal by Subject|3|||
30607095|NCT01307267|58617926|FG020|Overall Study|Withdrawal by Subject|0|||
30607096|NCT01307267|58617927|FG021|Overall Study|Withdrawal by Subject|0|||
30607097|NCT01307267|58617928|FG022|Overall Study|Withdrawal by Subject|0|||
30607098|NCT01307267|58617906|FG000|Overall Study|Other|0|||
30607099|NCT01307267|58617907|FG001|Overall Study|Other|0|||
30607100|NCT01307267|58617908|FG002|Overall Study|Other|0|||
30607101|NCT01307267|58617909|FG003|Overall Study|Other|0|||
30607102|NCT01307267|58617910|FG004|Overall Study|Other|0|||
30607103|NCT01307267|58617911|FG005|Overall Study|Other|7|||
30607104|NCT01307267|58617912|FG006|Overall Study|Other|0|||
30607105|NCT01307267|58617913|FG007|Overall Study|Other|1|||
30607106|NCT01307267|58617914|FG008|Overall Study|Other|3|||
30607107|NCT01307267|58617915|FG009|Overall Study|Other|0|||
30607108|NCT01307267|58617916|FG010|Overall Study|Other|1|||
30607109|NCT01307267|58617917|FG011|Overall Study|Other|1|||
30607110|NCT01307267|58617918|FG012|Overall Study|Other|1|||
30607111|NCT01307267|58617919|FG013|Overall Study|Other|0|||
30607112|NCT01307267|58617920|FG014|Overall Study|Other|2|||
30607113|NCT01307267|58617921|FG015|Overall Study|Other|1|||
30607114|NCT01307267|58617922|FG016|Overall Study|Other|0|||
30607115|NCT01307267|58617923|FG017|Overall Study|Other|0|||
30607116|NCT01307267|58617924|FG018|Overall Study|Other|0|||
30607117|NCT01307267|58617925|FG019|Overall Study|Other|19|||
30607118|NCT01307267|58617926|FG020|Overall Study|Other|2|||
30607119|NCT01307267|58617927|FG021|Overall Study|Other|3|||
30607120|NCT01307267|58617928|FG022|Overall Study|Other|2|||
30607121|NCT01307111|58617990|FG000|IUD Insertion|Lost to Follow-up|2|||
30607122|NCT01307111|58617991|FG001|IUD Insertion|Lost to Follow-up|0|||
30607123|NCT01307111|58617990|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
30607124|NCT01307111|58617991|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
30607125|NCT01306877|58617999|FG000|Overall Study|Lost to Follow-up|3|||
30607126|NCT01306877|58618000|FG001|Overall Study|Lost to Follow-up|3|||
30607127|NCT01306877|58617999|FG000|Overall Study|Physician Decision|0|||
30607128|NCT01306877|58618000|FG001|Overall Study|Physician Decision|1|||
30607129|NCT01191801|58618008|FG000|Overall Study|Death|36|||
30607130|NCT01191801|58618009|FG001|Overall Study|Death|12|||
30607131|NCT01191801|58618008|FG000|Overall Study|Lack of Efficacy|176|||
30607132|NCT01191801|58618009|FG001|Overall Study|Lack of Efficacy|258|||
30607133|NCT01191801|58618008|FG000|Overall Study|Adverse Event|9|||
30607134|NCT01191801|58618009|FG001|Overall Study|Adverse Event|8|||
30607135|NCT01191801|58618008|FG000|Overall Study|Protocol Violation|2|||
30607136|NCT01191801|58618009|FG001|Overall Study|Protocol Violation|4|||
30607137|NCT01191801|58618008|FG000|Overall Study|Physician Decision|47|||
30607138|NCT01191801|58618009|FG001|Overall Study|Physician Decision|24|||
30607139|NCT01191801|58618008|FG000|Overall Study|Withdrawal by Subject|1|||
30607140|NCT01191801|58618009|FG001|Overall Study|Withdrawal by Subject|4|||
30607141|NCT01191801|58618008|FG000|Overall Study|Not Provided|45|||
30607142|NCT01191801|58618009|FG001|Overall Study|Not Provided|27|||
30607143|NCT01306643|58618015|FG000|Overall Study|Adverse Event|5|||
30607144|NCT01306643|58618015|FG000|Overall Study|Disease Progression|7|||
30607145|NCT01306643|58618015|FG000|Overall Study|Other: Change in Eligibility Status|1|||
30607146|NCT01306331|58618021|FG000|Overall Study|Adverse Event|28|||
30607147|NCT01306331|58618022|FG001|Overall Study|Adverse Event|25|||
30607148|NCT01306331|58618021|FG000|Overall Study|Lost to Follow-up|321|||
30607149|NCT01306331|58618022|FG001|Overall Study|Lost to Follow-up|323|||
30607150|NCT01306331|58618021|FG000|Overall Study|Physician Decision|26|||
30607151|NCT01306331|58618022|FG001|Overall Study|Physician Decision|22|||
30607152|NCT01306331|58618021|FG000|Overall Study|Pregnancy|136|||
30607153|NCT01306331|58618022|FG001|Overall Study|Pregnancy|151|||
30607154|NCT01306331|58618021|FG000|Overall Study|Protocol Violation|154|||
30607155|NCT01306331|58618022|FG001|Overall Study|Protocol Violation|124|||
30607156|NCT01306331|58618021|FG000|Overall Study|Withdrawal by Subject|163|||
30607157|NCT01306331|58618022|FG001|Overall Study|Withdrawal by Subject|152|||
30607158|NCT01306331|58618021|FG000|Overall Study|Not sexually active|29|||
30607159|NCT01306331|58618022|FG001|Overall Study|Not sexually active|28|||
30607160|NCT01306331|58618021|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
30607161|NCT01306331|58618022|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
30607162|NCT01306331|58618021|FG000|Overall Study|Other|34|||
30607163|NCT01306331|58618022|FG001|Overall Study|Other|32|||
30607164|NCT01306253|58618030|FG000|Overall Study|Lost to Follow-up|1|||
30607165|NCT01306253|58618031|FG001|Overall Study|Lost to Follow-up|1|||
30607166|NCT01305941|58618037|FG000|Overall Study|Adverse Event|6|||
30607167|NCT01305941|58618037|FG000|Overall Study|Clinical decline|2|||
30607168|NCT01305941|58618037|FG000|Overall Study|Withdrawal by Subject|1|||
30607169|NCT01305941|58618037|FG000|Overall Study|Death|1|||
30607170|NCT01305239|58618041|FG000|Overall Study|Adverse Event|22|||
30607171|NCT01305239|58618041|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
30607172|NCT01194219|58618047|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
30607173|NCT01194219|58618048|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
30607174|NCT01194219|58618049|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
30607175|NCT01194219|58618050|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
30607176|NCT01194219|58618051|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
30607177|NCT01194219|58618052|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
30607178|NCT01194219|58618053|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
30607179|NCT01194219|58618054|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
30607180|NCT01194219|58618055|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
30607181|NCT01194219|58618056|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
30607182|NCT01194219|58618047|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
30607183|NCT01194219|58618048|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
30607184|NCT01194219|58618049|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
30607185|NCT01194219|58618050|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
30607186|NCT01194219|58618051|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
30607187|NCT01194219|58618052|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
30607188|NCT01194219|58618053|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
30607189|NCT01194219|58618054|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
30607190|NCT01194219|58618055|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
30607191|NCT01194219|58618056|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
30607192|NCT01194219|58618047|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
30607193|NCT01194219|58618048|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
30607194|NCT01194219|58618049|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
30607195|NCT01194219|58618050|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
30607196|NCT01194219|58618051|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
30607197|NCT01194219|58618052|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
30607198|NCT01194219|58618053|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
30607199|NCT01194219|58618054|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
30607200|NCT01194219|58618055|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
30607201|NCT01194219|58618056|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
30607202|NCT01194219|58618047|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
30607203|NCT01194219|58618048|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
30607204|NCT01194219|58618049|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
30607205|NCT01194219|58618050|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
30607206|NCT01194219|58618051|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
30607207|NCT01194219|58618052|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
30607208|NCT01194219|58618053|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
30607209|NCT01194219|58618054|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
30607210|NCT01194219|58618055|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
30607211|NCT01194219|58618056|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
30607212|NCT01194219|58618047|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
30876785|NCT05168579|58908201|FG000|Overall Study|Lack of Consent|1|||
30876786|NCT05168579|58908202|FG001|Overall Study|Lack of Consent|0|||
30876787|NCT05168579|58908201|FG000|Overall Study|Conflicts with time|2|||
30876788|NCT05168579|58908202|FG001|Overall Study|Conflicts with time|0|||
30876789|NCT05168579|58908201|FG000|Overall Study|Time slots were full|3|||
30876790|NCT05168579|58908202|FG001|Overall Study|Time slots were full|0|||
30876791|NCT05168579|58908201|FG000|Overall Study|Lost to Follow-up|0|||
30876792|NCT05168579|58908202|FG001|Overall Study|Lost to Follow-up|15|||
30876793|NCT02673619|58908215|FG000|Overall Study|Lost to Follow-up|1|||
30876794|NCT02673619|58908216|FG001|Overall Study|Lost to Follow-up|0|||
30876795|NCT02673619|58908217|FG002|Overall Study|Lost to Follow-up|0|||
30876796|NCT02673619|58908218|FG003|Overall Study|Lost to Follow-up|0|||
30965195|NCT01452529|59033665|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
30965196|NCT01452529|59033666|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
30965197|NCT01452529|59033667|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
30965198|NCT01452529|59033665|FG000|Double-blind (DB) Period|Adverse Event|0|||
30965199|NCT01452529|59033666|FG001|Double-blind (DB) Period|Adverse Event|18|||
30965200|NCT01452529|59033667|FG002|Double-blind (DB) Period|Adverse Event|11|||
30965201|NCT01452529|59033665|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
30965202|NCT01452529|59033666|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
30965203|NCT01452529|59033667|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
30965204|NCT01452529|59033665|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
30965205|NCT01452529|59033666|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
30965206|NCT01452529|59033667|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
30965207|NCT01452529|59033665|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
30965208|NCT01452529|59033666|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
30965209|NCT01452529|59033667|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
30965210|NCT01452529|59033665|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
30965211|NCT01452529|59033666|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
30965212|NCT01452529|59033667|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
30965213|NCT01452529|59033665|FG000|Double-blind (DB) Period|Administrative|0|||
30965214|NCT01452529|59033666|FG001|Double-blind (DB) Period|Administrative|11|||
30965215|NCT01452529|59033667|FG002|Double-blind (DB) Period|Administrative|7|||
30965216|NCT01560416|59033676|FG000|Randomized Phase|Crossover Participants|7|||
30965217|NCT01560416|59033677|FG001|Randomized Phase|Crossover Participants|0|||
30965218|NCT01685606|59033685|FG000|Overall Study|Withdrawal by Subject|1|||
30965219|NCT01685372|59033691|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
30965220|NCT01685372|59033692|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
30965221|NCT01685216|59033698|FG000|Overall Study|Did not receive study drug|1|||
30965222|NCT01685138|59033702|FG000|Overall Study|Lost to Follow-up|1|||
30965223|NCT01685138|59033702|FG000|Overall Study|Protocol Violation|1|||
30965224|NCT01685138|59033702|FG000|Overall Study|No longer requires treatment|1|||
30965225|NCT01685138|59033702|FG000|Overall Study|Subject/guardian decision|2|||
30965226|NCT01685138|59033702|FG000|Overall Study|Physician Decision|6|||
30965227|NCT01685138|59033702|FG000|Overall Study|Death|10|||
30965228|NCT01685138|59033702|FG000|Overall Study|Adverse Event|18|||
30965229|NCT01685138|59033702|FG000|Overall Study|Progressive disease|53|||
30965230|NCT01685060|59033706|FG000|Overall Study|Rollover patients|16|||
30965231|NCT01685060|59033706|FG000|Overall Study|Adverse Event|12|||
30965232|NCT01685060|59033706|FG000|Overall Study|Progressive disease|69|||
30965233|NCT01685060|59033706|FG000|Overall Study|Physician Decision|14|||
30965234|NCT01685060|59033706|FG000|Overall Study|Subject/guardian decision|20|||
30965235|NCT01685060|59033706|FG000|Overall Study|Lost to Follow-up|1|||
30965236|NCT01685060|59033706|FG000|Overall Study|Death|8|||
30965237|NCT01582100|59033710|FG000|Overall Study|Adverse Event|1|||
30965238|NCT01582100|59033710|FG000|Overall Study|Withdrawal by Subject|1|||
30965239|NCT01579916|59033716|FG000|Overall Study|Lost to Follow-up|6|||
30965240|NCT01579916|59033717|FG001|Overall Study|Lost to Follow-up|1|||
30965241|NCT01579916|59033716|FG000|Overall Study|Withdrawal by Subject|1|||
30965242|NCT01579916|59033717|FG001|Overall Study|Withdrawal by Subject|1|||
30965243|NCT01579916|59033716|FG000|Overall Study|Death|1|||
30965244|NCT01579916|59033717|FG001|Overall Study|Death|0|||
30965245|NCT01684202|59033727|FG000|Dose-escalation Period|Adverse Event|0|||
30965246|NCT01684202|59033728|FG001|Dose-escalation Period|Adverse Event|1|||
30965247|NCT01684202|59033729|FG002|Dose-escalation Period|Adverse Event|0|||
30965248|NCT01684202|59033730|FG003|Dose-escalation Period|Adverse Event|0|||
30965249|NCT01684202|59033727|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
30965250|NCT01684202|59033728|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
30965251|NCT01684202|59033729|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
30965252|NCT01684202|59033730|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
30965253|NCT01684202|59033727|FG000|Maintenance Period|Adverse Event|1|||
30965254|NCT01684202|59033728|FG001|Maintenance Period|Adverse Event|1|||
30876797|NCT02673619|58908215|FG000|Overall Study|Withdrawal by Subject|1|||
30876798|NCT02673619|58908216|FG001|Overall Study|Withdrawal by Subject|1|||
30876799|NCT02673619|58908217|FG002|Overall Study|Withdrawal by Subject|1|||
30876800|NCT02673619|58908218|FG003|Overall Study|Withdrawal by Subject|0|||
30876801|NCT02673619|58908215|FG000|Overall Study|Adverse Event|0|||
30876802|NCT02673619|58908216|FG001|Overall Study|Adverse Event|0|||
30876803|NCT02673619|58908217|FG002|Overall Study|Adverse Event|1|||
30876804|NCT02673619|58908218|FG003|Overall Study|Adverse Event|0|||
30876805|NCT02673619|58908215|FG000|Overall Study|Lack of Efficacy|0|||
30876806|NCT02673619|58908216|FG001|Overall Study|Lack of Efficacy|0|||
30876807|NCT02673619|58908217|FG002|Overall Study|Lack of Efficacy|1|||
30876808|NCT02673619|58908218|FG003|Overall Study|Lack of Efficacy|0|||
30876809|NCT02680639|58908240|FG000|Screening Period|Screen Failure|7|||
30965255|NCT01684202|59033729|FG002|Maintenance Period|Adverse Event|1|||
30965256|NCT01684202|59033730|FG003|Maintenance Period|Adverse Event|1|||
30965257|NCT01684202|59033727|FG000|Maintenance Period|Physician Decision|0|||
30965258|NCT01684202|59033728|FG001|Maintenance Period|Physician Decision|1|||
30965259|NCT01684202|59033729|FG002|Maintenance Period|Physician Decision|0|||
30965260|NCT01684202|59033730|FG003|Maintenance Period|Physician Decision|0|||
30965261|NCT01684202|59033727|FG000|Maintenance Period|Withdrawal by Subject|0|||
30965262|NCT01684202|59033728|FG001|Maintenance Period|Withdrawal by Subject|1|||
30965263|NCT01684202|59033729|FG002|Maintenance Period|Withdrawal by Subject|0|||
30965264|NCT01684202|59033730|FG003|Maintenance Period|Withdrawal by Subject|0|||
30965265|NCT01684046|59033740|FG000|Period 1, First 30 Days|Adverse Event|0|||
30965266|NCT01684046|59033741|FG001|Period 1, First 30 Days|Adverse Event|2|||
30965267|NCT01559090|59033750|FG000|Stage I|Withdrawal by Subject|2|||
30965268|NCT01559090|59033751|FG001|Stage I|Withdrawal by Subject|2|||
30965269|NCT01559090|59033752|FG002|Stage I|Withdrawal by Subject|3|||
30965270|NCT01559090|59033750|FG000|Stage II|Withdrawal by Subject|1|||
30965271|NCT01559090|59033751|FG001|Stage II|Withdrawal by Subject|0|||
30965272|NCT01559090|59033752|FG002|Stage II|Withdrawal by Subject|0|||
30965273|NCT01683266|59033762|FG000|Overall Study|Adverse Event|5|||
30965274|NCT01683266|59033763|FG001|Overall Study|Adverse Event|4|||
30965275|NCT01683266|59033762|FG000|Overall Study|Lack of Efficacy|5|||
30965276|NCT01683266|59033763|FG001|Overall Study|Lack of Efficacy|2|||
30965277|NCT01683266|59033762|FG000|Overall Study|Protocol Violation|13|||
30965278|NCT01683266|59033763|FG001|Overall Study|Protocol Violation|6|||
30965279|NCT01683266|59033762|FG000|Overall Study|Personal Reason|17|||
30965280|NCT01683266|59033763|FG001|Overall Study|Personal Reason|25|||
30965281|NCT01683266|59033762|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
30965282|NCT01683266|59033763|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
30965283|NCT01683266|59033762|FG000|Overall Study|Lost to Follow-up|5|||
30965284|NCT01683266|59033763|FG001|Overall Study|Lost to Follow-up|0|||
30965285|NCT01683266|59033762|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
30965286|NCT01683266|59033763|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
30965287|NCT01683266|59033762|FG000|Overall Study|Nonserious Hypoglycemia|0|||
30965288|NCT01683266|59033763|FG001|Overall Study|Nonserious Hypoglycemia|3|||
30965289|NCT01683266|59033762|FG000|Overall Study|Perceived Lack of Efficacy|1|||
30965290|NCT01683266|59033763|FG001|Overall Study|Perceived Lack of Efficacy|1|||
30965291|NCT01683266|59033762|FG000|Overall Study|Possibly Hypoglycemia|1|||
30965292|NCT01683266|59033763|FG001|Overall Study|Possibly Hypoglycemia|0|||
30965293|NCT01683266|59033762|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
30965294|NCT01683266|59033763|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
30965295|NCT01467661|59033769|FG000|Overall Study|Adverse Event|16|||
30965296|NCT01467661|59033769|FG000|Overall Study|Withdrawal by Subject|1|||
30965297|NCT01467661|59033769|FG000|Overall Study|Lack of Efficacy|3|||
30965298|NCT01467661|59033769|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
30965299|NCT01577186|59033775|FG000|Overall Study|Adverse Event|23|||
30965300|NCT01577186|59033775|FG000|Overall Study|Death|1|||
30965301|NCT01577186|59033775|FG000|Overall Study|Lost to Follow-up|28|||
30965302|NCT01577186|59033775|FG000|Overall Study|Withdrawal by Subject|35|||
30965303|NCT01577186|59033775|FG000|Overall Study|Insufficient Response|18|||
30965304|NCT01577186|59033775|FG000|Overall Study|Ineligible to Continue|15|||
30965305|NCT01577186|59033775|FG000|Overall Study|Non-Compliant|8|||
30965306|NCT01577186|59033775|FG000|Overall Study|Other|2|||
30965307|NCT01559012|59033781|FG000|Overall Study|Withdrawal by Subject|0|||
30965308|NCT01559012|59033782|FG001|Overall Study|Withdrawal by Subject|1|||
30965309|NCT01451827|59033807|FG000|Overall Study|Adverse Event|2|||
30965310|NCT01451827|59033808|FG001|Overall Study|Adverse Event|0|||
30965311|NCT01451827|59033809|FG002|Overall Study|Adverse Event|1|||
30965312|NCT01451827|59033810|FG003|Overall Study|Adverse Event|1|||
30965313|NCT01451827|59033807|FG000|Overall Study|Protocol deviation|1|||
30965314|NCT01451827|59033808|FG001|Overall Study|Protocol deviation|0|||
30965315|NCT01451827|59033809|FG002|Overall Study|Protocol deviation|0|||
30965316|NCT01451827|59033810|FG003|Overall Study|Protocol deviation|0|||
30965317|NCT01451827|59033807|FG000|Overall Study|Lost to Follow-up|0|||
30965318|NCT01451827|59033808|FG001|Overall Study|Lost to Follow-up|3|||
30965319|NCT01451827|59033809|FG002|Overall Study|Lost to Follow-up|0|||
30965320|NCT01451827|59033810|FG003|Overall Study|Lost to Follow-up|2|||
30965321|NCT01451827|59033807|FG000|Overall Study|Participant met withdrawal criteria|0|||
30876810|NCT02680639|58908241|FG001|Screening Period|Screen Failure|0|||
30876811|NCT02680639|58908242|FG002|Screening Period|Screen Failure|0|||
30876812|NCT01674725|58908254|FG000|Overall Study|Adverse Event|1|||
30876813|NCT01674725|58908255|FG001|Overall Study|Adverse Event|0|||
30876814|NCT01674725|58908254|FG000|Overall Study|Did not receive study drug|1|||
30876815|NCT01674725|58908255|FG001|Overall Study|Did not receive study drug|0|||
30876816|NCT01674725|58908254|FG000|Overall Study|Withdrawal by Subject|1|||
30876817|NCT01674725|58908255|FG001|Overall Study|Withdrawal by Subject|0|||
30876818|NCT01674725|58908254|FG000|Overall Study|Lost to Follow-up|0|||
30965322|NCT01451827|59033808|FG001|Overall Study|Participant met withdrawal criteria|2|||
30965323|NCT01451827|59033809|FG002|Overall Study|Participant met withdrawal criteria|0|||
30965324|NCT01451827|59033810|FG003|Overall Study|Participant met withdrawal criteria|0|||
30965325|NCT01451827|59033807|FG000|Overall Study|Withdrawal by Subject|0|||
30965326|NCT01451827|59033808|FG001|Overall Study|Withdrawal by Subject|0|||
30965327|NCT01451827|59033809|FG002|Overall Study|Withdrawal by Subject|1|||
30607213|NCT01194219|58618048|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
30607214|NCT01194219|58618049|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
30607215|NCT01194219|58618050|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
30607216|NCT01194219|58618051|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
30607217|NCT01194219|58618052|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
30607218|NCT01194219|58618053|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
30607219|NCT01194219|58618054|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
30607220|NCT01194219|58618055|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
30607221|NCT01194219|58618056|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
30607222|NCT01194219|58618047|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
30607223|NCT01194219|58618048|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
30607224|NCT01194219|58618049|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
30607225|NCT01194219|58618050|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
30607226|NCT01194219|58618051|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
30607227|NCT01194219|58618052|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
30607228|NCT01194219|58618053|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
30607229|NCT01194219|58618054|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
30607230|NCT01194219|58618055|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
30607231|NCT01194219|58618056|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
30607232|NCT01194219|58618047|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
30607233|NCT01194219|58618048|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
30607234|NCT01194219|58618049|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
30607235|NCT01194219|58618050|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
30607236|NCT01194219|58618051|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
30607237|NCT01194219|58618052|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
30607238|NCT01194219|58618053|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
30607239|NCT01194219|58618054|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
30607240|NCT01194219|58618055|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
30607241|NCT01194219|58618056|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
30607242|NCT01194219|58618047|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
30607243|NCT01194219|58618048|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
30607244|NCT01194219|58618049|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
30607245|NCT01194219|58618050|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
30607246|NCT01194219|58618051|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
30607247|NCT01194219|58618052|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
30607248|NCT01194219|58618053|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
30607249|NCT01194219|58618054|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
30607250|NCT01194219|58618055|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
30607251|NCT01194219|58618056|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
30607252|NCT01194219|58618047|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
30607253|NCT01194219|58618048|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
30607254|NCT01194219|58618049|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
30965328|NCT01451827|59033810|FG003|Overall Study|Withdrawal by Subject|1|||
30965329|NCT01557920|59033820|FG000|Overall Study|Withdrawal by Subject|2|||
30965330|NCT01557920|59033821|FG001|Overall Study|Withdrawal by Subject|3|||
30965331|NCT01557920|59033820|FG000|Overall Study|Lack of Efficacy|1|||
30965332|NCT01557920|59033821|FG001|Overall Study|Lack of Efficacy|0|||
30965333|NCT01467583|59033857|FG000|Overall Study|Death|1|||
30965334|NCT01467583|59033858|FG001|Overall Study|Death|1|||
30965335|NCT01467583|59033859|FG002|Overall Study|Death|0|||
30965336|NCT01467583|59033857|FG000|Overall Study|Withdrawal by Subject|1|||
30965337|NCT01467583|59033858|FG001|Overall Study|Withdrawal by Subject|0|||
30965338|NCT01467583|59033859|FG002|Overall Study|Withdrawal by Subject|0|||
30965339|NCT01467583|59033857|FG000|Overall Study|Protocol Violation|0|||
30965340|NCT01467583|59033858|FG001|Overall Study|Protocol Violation|0|||
30965341|NCT01467583|59033859|FG002|Overall Study|Protocol Violation|2|||
30965342|NCT01576718|59033876|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
30965343|NCT01576718|59033877|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30965344|NCT01576718|59033878|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30965345|NCT01576718|59033879|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30965346|NCT01576718|59033880|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30965347|NCT01576718|59033881|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30607255|NCT01194219|58618050|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
30607256|NCT01194219|58618051|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
30607257|NCT01194219|58618052|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
30607258|NCT01194219|58618053|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
30607259|NCT01194219|58618054|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
30607260|NCT01194219|58618055|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
30607261|NCT01194219|58618056|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
30607262|NCT01194219|58618047|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
30607263|NCT01194219|58618048|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
30607264|NCT01194219|58618049|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
30607265|NCT01194219|58618050|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
30607266|NCT01194219|58618051|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
30607267|NCT01194219|58618052|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
30607268|NCT01194219|58618053|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
30607269|NCT01194219|58618054|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
30607270|NCT01194219|58618055|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
30607271|NCT01194219|58618056|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
30607272|NCT01194219|58618047|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
30607273|NCT01194219|58618048|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
30607274|NCT01194219|58618049|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
30607275|NCT01194219|58618050|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
30607276|NCT01194219|58618051|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
30607277|NCT01194219|58618052|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
30607278|NCT01194219|58618053|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
30607279|NCT01194219|58618054|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
30607280|NCT01194219|58618055|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
30607281|NCT01194219|58618056|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
30607282|NCT01194219|58618047|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
30607283|NCT01194219|58618048|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
30607284|NCT01194219|58618049|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
30607285|NCT01194219|58618050|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
30607286|NCT01194219|58618051|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
30607287|NCT01194219|58618052|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
30607288|NCT01194219|58618053|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
30607289|NCT01194219|58618054|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
30607290|NCT01194219|58618055|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
30607291|NCT01194219|58618056|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
30607292|NCT01194219|58618047|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
30607293|NCT01194219|58618048|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
30607294|NCT01194219|58618049|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
30607295|NCT01194219|58618050|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
30607296|NCT01194219|58618051|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
30607297|NCT01194219|58618052|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
30607298|NCT01194219|58618053|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
30607299|NCT01194219|58618054|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
30607300|NCT01194219|58618055|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
30607301|NCT01194219|58618056|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
30607302|NCT01194219|58618047|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
30607303|NCT01194219|58618048|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
30607304|NCT01194219|58618049|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
30607305|NCT01194219|58618050|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
30607306|NCT01194219|58618051|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
30607307|NCT01194219|58618052|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
30607308|NCT01194219|58618053|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
30607309|NCT01194219|58618054|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
30607310|NCT01194219|58618055|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
30607311|NCT01194219|58618056|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
30607312|NCT01194219|58618047|FG000|Maintenance Phase Weeks16-32|Other|0|||
30607313|NCT01194219|58618048|FG001|Maintenance Phase Weeks16-32|Other|0|||
30607314|NCT01194219|58618049|FG002|Maintenance Phase Weeks16-32|Other|2|||
30607315|NCT01194219|58618050|FG003|Maintenance Phase Weeks16-32|Other|1|||
30607316|NCT01194219|58618051|FG004|Maintenance Phase Weeks16-32|Other|0|||
30607317|NCT01194219|58618052|FG005|Maintenance Phase Weeks16-32|Other|0|||
30607318|NCT01194219|58618053|FG006|Maintenance Phase Weeks16-32|Other|0|||
30607319|NCT01194219|58618054|FG007|Maintenance Phase Weeks16-32|Other|0|||
30607320|NCT01194219|58618055|FG008|Maintenance Phase Weeks16-32|Other|0|||
30607321|NCT01194219|58618056|FG009|Maintenance Phase Weeks16-32|Other|0|||
30607322|NCT01194219|58618047|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
30607323|NCT01194219|58618048|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
30607324|NCT01194219|58618049|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
30607325|NCT01194219|58618050|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
30607326|NCT01194219|58618051|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
30607327|NCT01194219|58618052|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
30607328|NCT01194219|58618053|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
30607329|NCT01194219|58618054|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
30607330|NCT01194219|58618055|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
30607331|NCT01194219|58618056|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
30607332|NCT01194219|58618047|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
30607333|NCT01194219|58618048|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
30607334|NCT01194219|58618049|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
30607335|NCT01194219|58618050|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
30607336|NCT01194219|58618051|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
30607337|NCT01194219|58618052|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
30607338|NCT01194219|58618053|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
30607339|NCT01194219|58618054|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
30607340|NCT01194219|58618055|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
30607341|NCT01194219|58618056|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
30607342|NCT01194219|58618047|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
30607343|NCT01194219|58618048|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
30607344|NCT01194219|58618049|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
30607345|NCT01194219|58618050|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
30607346|NCT01194219|58618051|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
30607347|NCT01194219|58618052|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
30607348|NCT01194219|58618053|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
30607349|NCT01194219|58618054|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
30607350|NCT01194219|58618055|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
30607351|NCT01194219|58618056|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
30607352|NCT01194219|58618047|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
30607353|NCT01194219|58618048|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
30607354|NCT01194219|58618049|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
30607355|NCT01194219|58618050|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
30607356|NCT01194219|58618051|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
30607357|NCT01194219|58618052|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
30607358|NCT01194219|58618053|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
30607359|NCT01194219|58618054|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
30607360|NCT01194219|58618055|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
30607361|NCT01194219|58618056|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
30607362|NCT01194219|58618047|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
30607363|NCT01194219|58618048|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
30607364|NCT01194219|58618049|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
30607365|NCT01194219|58618050|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
30607366|NCT01194219|58618051|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
30607367|NCT01194219|58618052|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
30607368|NCT01194219|58618053|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
30607369|NCT01194219|58618054|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
30607370|NCT01194219|58618055|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
30607371|NCT01194219|58618056|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
30607372|NCT01194219|58618047|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
30607373|NCT01194219|58618048|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
30607374|NCT01194219|58618049|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
30607375|NCT01194219|58618050|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
30607376|NCT01194219|58618051|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
30607377|NCT01194219|58618052|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
30607378|NCT01194219|58618053|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
30607379|NCT01194219|58618054|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
30607380|NCT01194219|58618055|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
30607381|NCT01194219|58618056|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
30607382|NCT01194219|58618047|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
30607383|NCT01194219|58618048|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
30607384|NCT01194219|58618049|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
30607385|NCT01194219|58618050|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
30607386|NCT01194219|58618051|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
30607387|NCT01194219|58618052|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
30607388|NCT01194219|58618053|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
30607389|NCT01194219|58618054|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
30607390|NCT01194219|58618055|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
30607391|NCT01194219|58618056|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
30607392|NCT01194219|58618047|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
30607393|NCT01194219|58618048|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
30607394|NCT01194219|58618049|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
30607395|NCT01194219|58618050|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
30607396|NCT01194219|58618051|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
30607397|NCT01194219|58618052|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
30607398|NCT01194219|58618053|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
30607399|NCT01194219|58618054|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
30607400|NCT01194219|58618055|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
30607401|NCT01194219|58618056|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
30607402|NCT01194219|58618047|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
30607403|NCT01194219|58618048|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
30607404|NCT01194219|58618049|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
30607405|NCT01194219|58618050|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
30607406|NCT01194219|58618051|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
30607407|NCT01194219|58618052|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
30607408|NCT01194219|58618053|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
30607409|NCT01194219|58618054|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
30607410|NCT01194219|58618055|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
30607411|NCT01194219|58618056|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
30607412|NCT01194219|58618047|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
30607413|NCT01194219|58618048|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
30965348|NCT01576718|59033882|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
30965349|NCT01576718|59033876|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
30965350|NCT01576718|59033877|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30965351|NCT01576718|59033878|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30965352|NCT01576718|59033879|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30965353|NCT01576718|59033880|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30965354|NCT01576718|59033881|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30965355|NCT01576718|59033882|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
30965356|NCT01576718|59033876|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
30965357|NCT01576718|59033877|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30965358|NCT01576718|59033878|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30965359|NCT01576718|59033879|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30965360|NCT01576718|59033880|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30965361|NCT01576718|59033881|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30965362|NCT01576718|59033882|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
30965363|NCT01576718|59033876|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
30965364|NCT01576718|59033877|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30965365|NCT01576718|59033878|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30965366|NCT01576718|59033879|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30965367|NCT01576718|59033880|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30965368|NCT01576718|59033881|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30965369|NCT01576718|59033882|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
30965370|NCT01576718|59033876|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
30965371|NCT01576718|59033877|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30965372|NCT01576718|59033878|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30965373|NCT01576718|59033879|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30965374|NCT01576718|59033880|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30965375|NCT01576718|59033881|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30965376|NCT01576718|59033882|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
30965377|NCT01576718|59033876|FG000|Treatment Period|Adverse Event|0|||
30965378|NCT01576718|59033877|FG001|Treatment Period|Adverse Event|1|||
30965379|NCT01576718|59033878|FG002|Treatment Period|Adverse Event|1|||
30965380|NCT01576718|59033879|FG003|Treatment Period|Adverse Event|1|||
30965381|NCT01576718|59033880|FG004|Treatment Period|Adverse Event|1|||
30965382|NCT01576718|59033881|FG005|Treatment Period|Adverse Event|1|||
30965383|NCT01576718|59033882|FG006|Treatment Period|Adverse Event|0|||
30965384|NCT01576718|59033876|FG000|Treatment Period|Withdrawal by Subject|0|||
30965385|NCT01576718|59033877|FG001|Treatment Period|Withdrawal by Subject|1|||
30965386|NCT01576718|59033878|FG002|Treatment Period|Withdrawal by Subject|1|||
30965387|NCT01576718|59033879|FG003|Treatment Period|Withdrawal by Subject|0|||
30965388|NCT01576718|59033880|FG004|Treatment Period|Withdrawal by Subject|2|||
30965389|NCT01576718|59033881|FG005|Treatment Period|Withdrawal by Subject|4|||
30965390|NCT01576718|59033882|FG006|Treatment Period|Withdrawal by Subject|2|||
30965391|NCT01576718|59033876|FG000|Treatment Period|Physician Decision|0|||
30965392|NCT01576718|59033877|FG001|Treatment Period|Physician Decision|1|||
30965393|NCT01576718|59033878|FG002|Treatment Period|Physician Decision|1|||
30965394|NCT01576718|59033879|FG003|Treatment Period|Physician Decision|1|||
30965395|NCT01576718|59033880|FG004|Treatment Period|Physician Decision|1|||
30965396|NCT01576718|59033881|FG005|Treatment Period|Physician Decision|0|||
30965397|NCT01576718|59033882|FG006|Treatment Period|Physician Decision|0|||
30965398|NCT01576718|59033876|FG000|Treatment Period|Protocol Violation|0|||
30965399|NCT01576718|59033877|FG001|Treatment Period|Protocol Violation|5|||
30965400|NCT01576718|59033878|FG002|Treatment Period|Protocol Violation|4|||
30965401|NCT01576718|59033879|FG003|Treatment Period|Protocol Violation|10|||
30965402|NCT01576718|59033880|FG004|Treatment Period|Protocol Violation|6|||
30965403|NCT01576718|59033881|FG005|Treatment Period|Protocol Violation|8|||
30965404|NCT01576718|59033882|FG006|Treatment Period|Protocol Violation|12|||
30965405|NCT01576718|59033876|FG000|Treatment Period|Sponsor request|0|||
30965406|NCT01576718|59033877|FG001|Treatment Period|Sponsor request|1|||
30965407|NCT01576718|59033878|FG002|Treatment Period|Sponsor request|0|||
30965408|NCT01576718|59033879|FG003|Treatment Period|Sponsor request|0|||
30965409|NCT01576718|59033880|FG004|Treatment Period|Sponsor request|0|||
30965410|NCT01576718|59033881|FG005|Treatment Period|Sponsor request|1|||
30965411|NCT01576718|59033882|FG006|Treatment Period|Sponsor request|0|||
30965412|NCT01576718|59033876|FG000|Treatment Period|Met stopping criteria|0|||
30965413|NCT01576718|59033877|FG001|Treatment Period|Met stopping criteria|16|||
30965414|NCT01576718|59033878|FG002|Treatment Period|Met stopping criteria|13|||
30965415|NCT01576718|59033879|FG003|Treatment Period|Met stopping criteria|19|||
30965416|NCT01576718|59033880|FG004|Treatment Period|Met stopping criteria|16|||
30965417|NCT01576718|59033881|FG005|Treatment Period|Met stopping criteria|33|||
30965418|NCT01576718|59033882|FG006|Treatment Period|Met stopping criteria|15|||
30965419|NCT01576718|59033876|FG000|Treatment Period|Lost to Follow-up|0|||
30965420|NCT01576718|59033877|FG001|Treatment Period|Lost to Follow-up|0|||
30965421|NCT01576718|59033878|FG002|Treatment Period|Lost to Follow-up|0|||
30965422|NCT01576718|59033879|FG003|Treatment Period|Lost to Follow-up|0|||
30965423|NCT01576718|59033880|FG004|Treatment Period|Lost to Follow-up|1|||
30965424|NCT01576718|59033881|FG005|Treatment Period|Lost to Follow-up|0|||
30965425|NCT01576718|59033882|FG006|Treatment Period|Lost to Follow-up|0|||
30965426|NCT01576718|59033876|FG000|Treatment Period|Noncompliance to study medication|0|||
30965427|NCT01576718|59033877|FG001|Treatment Period|Noncompliance to study medication|0|||
30965428|NCT01576718|59033878|FG002|Treatment Period|Noncompliance to study medication|0|||
30965429|NCT01576718|59033879|FG003|Treatment Period|Noncompliance to study medication|0|||
30965430|NCT01576718|59033880|FG004|Treatment Period|Noncompliance to study medication|0|||
30965431|NCT01576718|59033881|FG005|Treatment Period|Noncompliance to study medication|1|||
30965432|NCT01576718|59033882|FG006|Treatment Period|Noncompliance to study medication|1|||
30965433|NCT01493557|59033899|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
30965434|NCT01493557|59033900|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
30965435|NCT01493557|59033901|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
30965436|NCT01493557|59033899|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
30965437|NCT01493557|59033900|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
30965438|NCT01493557|59033901|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
30965439|NCT01493557|59033899|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
30965440|NCT01493557|59033900|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
30965441|NCT01493557|59033901|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
30965442|NCT01493557|59033899|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
30965443|NCT01493557|59033900|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
30965444|NCT01493557|59033901|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
30965445|NCT01493557|59033899|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
30965446|NCT01493557|59033900|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
30965447|NCT01493557|59033901|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
30965448|NCT01493557|59033899|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
30965449|NCT01493557|59033900|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
30965450|NCT01493557|59033901|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
30965451|NCT01493557|59033899|FG000|Not Randomized to Management Strategies|Early termination|0|||
30965452|NCT01493557|59033900|FG001|Not Randomized to Management Strategies|Early termination|0|||
30965453|NCT01493557|59033901|FG002|Not Randomized to Management Strategies|Early termination|34|||
30965454|NCT01493557|59033899|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
30965455|NCT01493557|59033900|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
30965456|NCT01493557|59033901|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
30965457|NCT01493557|59033899|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
30965458|NCT01493557|59033900|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
30965459|NCT01493557|59033901|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
30965460|NCT01493557|59033899|FG000|Randomized to Management Strategies|Other adverse event|8|||
30965461|NCT01493557|59033900|FG001|Randomized to Management Strategies|Other adverse event|5|||
30965462|NCT01493557|59033901|FG002|Randomized to Management Strategies|Other adverse event|0|||
30965463|NCT01493557|59033899|FG000|Randomized to Management Strategies|Protocol Violation|3|||
30965464|NCT01493557|59033900|FG001|Randomized to Management Strategies|Protocol Violation|0|||
30965465|NCT01493557|59033901|FG002|Randomized to Management Strategies|Protocol Violation|0|||
30965466|NCT01493557|59033899|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
30965467|NCT01493557|59033900|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
30965468|NCT01493557|59033901|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
30965469|NCT01493557|59033899|FG000|Randomized to Management Strategies|Other than stated above|1|||
30965470|NCT01493557|59033900|FG001|Randomized to Management Strategies|Other than stated above|3|||
30965471|NCT01493557|59033901|FG002|Randomized to Management Strategies|Other than stated above|0|||
30965472|NCT01493557|59033899|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
30965473|NCT01493557|59033900|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
30965474|NCT01493557|59033901|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
30965475|NCT01493557|59033899|FG000|Adding the Second Strategy|Other adverse event|1|||
30965476|NCT01493557|59033900|FG001|Adding the Second Strategy|Other adverse event|2|||
30965477|NCT01493557|59033901|FG002|Adding the Second Strategy|Other adverse event|0|||
30965478|NCT01493557|59033899|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
30965479|NCT01493557|59033900|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
30965480|NCT01493557|59033901|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
30965481|NCT01451749|59033910|FG000|Overall Study|Protocol Violation|14|||
30965482|NCT01451749|59033911|FG001|Overall Study|Protocol Violation|7|||
30965483|NCT01451749|59033910|FG000|Overall Study|Lost to Follow-up|15|||
30965484|NCT01451749|59033911|FG001|Overall Study|Lost to Follow-up|5|||
30965485|NCT01451749|59033910|FG000|Overall Study|Meet the exclusion criteria,and|1|||
30965486|NCT01451749|59033911|FG001|Overall Study|Meet the exclusion criteria,and|1|||
30965487|NCT01451749|59033910|FG000|Overall Study|Adverse Event|2|||
30965488|NCT01451749|59033911|FG001|Overall Study|Adverse Event|0|||
30965489|NCT01451749|59033910|FG000|Overall Study|Withdrawal by Subject|0|||
30965490|NCT01451749|59033911|FG001|Overall Study|Withdrawal by Subject|1|||
30965491|NCT01576484|59033921|FG000|Overall Study|Adverse Event|1|||
30965492|NCT01576484|59033922|FG001|Overall Study|Adverse Event|1|||
30965493|NCT01576484|59033921|FG000|Overall Study|Protocol Violation|0|||
30965494|NCT01576484|59033922|FG001|Overall Study|Protocol Violation|2|||
30965495|NCT01576484|59033921|FG000|Overall Study|Sponsor Decision|2|||
30965496|NCT01576484|59033922|FG001|Overall Study|Sponsor Decision|8|||
30965497|NCT01576484|59033921|FG000|Overall Study|Withdrawal by Subject|0|||
30965498|NCT01576484|59033922|FG001|Overall Study|Withdrawal by Subject|3|||
30965499|NCT01576484|59033921|FG000|Overall Study|Other|2|||
30965500|NCT01576484|59033922|FG001|Overall Study|Other|5|||
30965501|NCT01467505|59033932|FG000|Overall Study|Adverse Event|1|||
30965502|NCT01467505|59033933|FG001|Overall Study|Adverse Event|0|||
30965503|NCT01467505|59033932|FG000|Overall Study|Withdrawal by Subject|4|||
30965504|NCT01467505|59033933|FG001|Overall Study|Withdrawal by Subject|0|||
30965505|NCT01467505|59033932|FG000|Overall Study|Study Terminated by Sponsor|28|||
30965506|NCT01467505|59033933|FG001|Overall Study|Study Terminated by Sponsor|3|||
30965507|NCT01467271|59033939|FG000|Overall Study|Death|84|||
30965508|NCT01467271|59033939|FG000|Overall Study|Lost to Follow-up|83|||
30965509|NCT01467271|59033939|FG000|Overall Study|Retraction of patient's consent|21|||
30965510|NCT01467271|59033939|FG000|Overall Study|Other reason|14|||
30965511|NCT01449929|59033945|FG000|Randomization Phase 96 Week|Adverse Event|5|||
30965512|NCT01449929|59033946|FG001|Randomization Phase 96 Week|Adverse Event|13|||
30965513|NCT01449929|59033947|FG002|Randomization Phase 96 Week|Adverse Event|0|||
30965514|NCT01449929|59033945|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
30965515|NCT01449929|59033946|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
30965516|NCT01449929|59033947|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
30965517|NCT01449929|59033945|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
30965518|NCT01449929|59033946|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
30965519|NCT01449929|59033947|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
30965520|NCT01449929|59033945|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
30965521|NCT01449929|59033946|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
30965522|NCT01449929|59033947|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
30965523|NCT01449929|59033945|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
30965524|NCT01449929|59033946|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
30965525|NCT01449929|59033947|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
30696781|NCT00561951|58711120|FG002|Overall Study|Adverse Event|14|||
30965526|NCT01449929|59033945|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
30965527|NCT01449929|59033946|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
30965528|NCT01449929|59033947|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
30965529|NCT01449929|59033945|FG000|Randomization Phase 96 Week|Physician Decision|2|||
30965530|NCT01449929|59033946|FG001|Randomization Phase 96 Week|Physician Decision|3|||
30965531|NCT01449929|59033947|FG002|Randomization Phase 96 Week|Physician Decision|0|||
30965532|NCT01449929|59033945|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
30965533|NCT01449929|59033946|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
30965534|NCT01449929|59033947|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
30965535|NCT01449929|59033945|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
30965536|NCT01449929|59033946|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
30965537|NCT01449929|59033947|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
30965538|NCT01449929|59033945|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
30965539|NCT01449929|59033946|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
30965540|NCT01449929|59033947|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
30965541|NCT01449929|59033945|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
30965542|NCT01449929|59033946|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
30965543|NCT01449929|59033947|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
30965544|NCT01449539|59033957|FG000|Overall Study|Withdrawal by Subject|3|||
30965545|NCT01449539|59033957|FG000|Overall Study|Toxicity not study related|1|||
30965546|NCT01451515|59033964|FG000|Overall Study|Death|0|||
30965547|NCT01451515|59033965|FG001|Overall Study|Death|1|||
30965548|NCT01451515|59033966|FG002|Overall Study|Death|0|||
30965549|NCT01451515|59033964|FG000|Overall Study|Withdrawal by Subject|0|||
30965550|NCT01451515|59033965|FG001|Overall Study|Withdrawal by Subject|1|||
30965551|NCT01451515|59033966|FG002|Overall Study|Withdrawal by Subject|0|||
30965552|NCT01451515|59033964|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
30965553|NCT01451515|59033965|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
30965554|NCT01451515|59033966|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
30965555|NCT01451515|59033964|FG000|Overall Study|Relapse (except CNS)|1|||
30965556|NCT01451515|59033965|FG001|Overall Study|Relapse (except CNS)|1|||
30965557|NCT01451515|59033966|FG002|Overall Study|Relapse (except CNS)|0|||
30965558|NCT01466881|59033977|FG000|Overall Study|Ineligible|5|||
30965559|NCT01466881|59033977|FG000|Overall Study|Adverse Event|6|||
30965560|NCT01466881|59033977|FG000|Overall Study|Progression/relapse|20|||
30965561|NCT01466881|59033977|FG000|Overall Study|Death|4|||
30965562|NCT01466881|59033977|FG000|Overall Study|Other reason not protocol specified|5|||
30965563|NCT01576406|59033989|FG000|Overall Study|Lost to Follow-up|1|||
30965564|NCT01576406|59033990|FG001|Overall Study|Lost to Follow-up|2|||
30965565|NCT01576406|59033991|FG002|Overall Study|Lost to Follow-up|0|||
30965566|NCT01576406|59033992|FG003|Overall Study|Lost to Follow-up|0|||
30965567|NCT01576406|59033993|FG004|Overall Study|Lost to Follow-up|0|||
30965568|NCT01576406|59033994|FG005|Overall Study|Lost to Follow-up|0|||
30965569|NCT01576406|59033989|FG000|Overall Study|Death|3|||
30965570|NCT01576406|59033990|FG001|Overall Study|Death|4|||
30965571|NCT01576406|59033991|FG002|Overall Study|Death|8|||
30965572|NCT01576406|59033992|FG003|Overall Study|Death|5|||
30965573|NCT01576406|59033993|FG004|Overall Study|Death|7|||
30965574|NCT01576406|59033994|FG005|Overall Study|Death|9|||
30965575|NCT01576406|59033989|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
30965576|NCT01576406|59033990|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
30965577|NCT01576406|59033991|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
30965578|NCT01576406|59033992|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
30965579|NCT01576406|59033993|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
30965580|NCT01576406|59033994|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
30965581|NCT01576406|59033989|FG000|Overall Study|Withdrawal the consent|2|||
30965582|NCT01576406|59033990|FG001|Overall Study|Withdrawal the consent|2|||
30965583|NCT01576406|59033991|FG002|Overall Study|Withdrawal the consent|5|||
30965584|NCT01576406|59033992|FG003|Overall Study|Withdrawal the consent|1|||
30965585|NCT01576406|59033993|FG004|Overall Study|Withdrawal the consent|1|||
30965586|NCT01576406|59033994|FG005|Overall Study|Withdrawal the consent|3|||
30965587|NCT01576406|59033989|FG000|Overall Study|Other|0|||
30965588|NCT01576406|59033990|FG001|Overall Study|Other|0|||
30965589|NCT01576406|59033991|FG002|Overall Study|Other|2|||
30965590|NCT01576406|59033992|FG003|Overall Study|Other|2|||
30965591|NCT01576406|59033993|FG004|Overall Study|Other|0|||
30965592|NCT01576406|59033994|FG005|Overall Study|Other|0|||
30965593|NCT01576172|59034010|FG000|Overall Study|Ineligible|2|||
30965594|NCT01576172|59034011|FG001|Overall Study|Ineligible|1|||
30965595|NCT01576172|59034010|FG000|Overall Study|Withdrawal by Subject|2|||
30965596|NCT01576172|59034011|FG001|Overall Study|Withdrawal by Subject|0|||
30965597|NCT01576172|59034010|FG000|Overall Study|Insurance issue|1|||
30965598|NCT01576172|59034011|FG001|Overall Study|Insurance issue|0|||
30965599|NCT01542788|59034021|FG000|Overall Study|Randomized but Not Treated|2|||
30965600|NCT01542788|59034022|FG001|Overall Study|Randomized but Not Treated|0|||
30965601|NCT01542788|59034021|FG000|Overall Study|Lack of Efficacy|41|||
30965602|NCT01542788|59034022|FG001|Overall Study|Lack of Efficacy|71|||
30965603|NCT01542788|59034021|FG000|Overall Study|Lost to Follow-up|5|||
30965604|NCT01542788|59034022|FG001|Overall Study|Lost to Follow-up|0|||
30965605|NCT01542788|59034021|FG000|Overall Study|Death|3|||
30965606|NCT01542788|59034022|FG001|Overall Study|Death|0|||
30965607|NCT01542788|59034021|FG000|Overall Study|Protocol Violation|2|||
30965608|NCT01542788|59034022|FG001|Overall Study|Protocol Violation|0|||
30965609|NCT01542788|59034021|FG000|Overall Study|Physician Decision|1|||
30965610|NCT01542788|59034022|FG001|Overall Study|Physician Decision|0|||
30965611|NCT01542788|59034021|FG000|Overall Study|Withdrawal by Subject|1|||
30965612|NCT01542788|59034022|FG001|Overall Study|Withdrawal by Subject|0|||
30965613|NCT01542632|59034034|FG000|Overall Study|Withdrawal of Consent|0|||
30965614|NCT01542632|59034035|FG001|Overall Study|Withdrawal of Consent|0|||
30965615|NCT01542632|59034036|FG002|Overall Study|Withdrawal of Consent|0|||
30965616|NCT01542632|59034037|FG003|Overall Study|Withdrawal of Consent|2|||
30965617|NCT01542632|59034038|FG004|Overall Study|Withdrawal of Consent|3|||
30965618|NCT01542632|59034039|FG005|Overall Study|Withdrawal of Consent|0|||
30965619|NCT01542632|59034034|FG000|Overall Study|Adverse Event|0|||
30965620|NCT01542632|59034035|FG001|Overall Study|Adverse Event|0|||
30965621|NCT01542632|59034036|FG002|Overall Study|Adverse Event|1|||
30965622|NCT01542632|59034037|FG003|Overall Study|Adverse Event|0|||
30965623|NCT01542632|59034038|FG004|Overall Study|Adverse Event|0|||
30965624|NCT01542632|59034039|FG005|Overall Study|Adverse Event|0|||
30965625|NCT01542632|59034034|FG000|Overall Study|Lost to Follow-up|0|||
30965626|NCT01542632|59034035|FG001|Overall Study|Lost to Follow-up|1|||
30607414|NCT01194219|58618049|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
30607415|NCT01194219|58618050|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
30607416|NCT01194219|58618051|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
30607417|NCT01194219|58618052|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
30607418|NCT01194219|58618053|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
30607419|NCT01194219|58618054|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
30607420|NCT01194219|58618055|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
30607421|NCT01194219|58618056|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
30607422|NCT01194219|58618047|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
30607423|NCT01194219|58618048|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
30607424|NCT01194219|58618049|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
30607425|NCT01194219|58618050|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
30607426|NCT01194219|58618051|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
30607427|NCT01194219|58618052|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
30607428|NCT01194219|58618053|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
30607429|NCT01194219|58618054|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
30607430|NCT01194219|58618055|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
30607431|NCT01194219|58618056|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
30607432|NCT01194219|58618047|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
30607433|NCT01194219|58618048|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
30607434|NCT01194219|58618049|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
30607435|NCT01194219|58618050|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
30607436|NCT01194219|58618051|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
30607437|NCT01194219|58618052|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
30607438|NCT01194219|58618053|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
30607439|NCT01194219|58618054|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
30607440|NCT01194219|58618055|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
30607441|NCT01194219|58618056|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
30607442|NCT01194219|58618047|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
30607443|NCT01194219|58618048|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
30607444|NCT01194219|58618049|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
30607445|NCT01194219|58618050|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
30607446|NCT01194219|58618051|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
30607447|NCT01194219|58618052|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
30607448|NCT01194219|58618053|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
30607449|NCT01194219|58618054|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
30607450|NCT01194219|58618055|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
30607451|NCT01194219|58618056|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
30607452|NCT01194219|58618047|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
30607453|NCT01194219|58618048|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
30607454|NCT01194219|58618049|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
30696782|NCT00561951|58711118|FG000|Overall Study|Lack of Efficacy|5|||
30965627|NCT01542632|59034036|FG002|Overall Study|Lost to Follow-up|0|||
30965628|NCT01542632|59034037|FG003|Overall Study|Lost to Follow-up|0|||
30965629|NCT01542632|59034038|FG004|Overall Study|Lost to Follow-up|0|||
30965630|NCT01542632|59034039|FG005|Overall Study|Lost to Follow-up|0|||
30965631|NCT01542632|59034034|FG000|Overall Study|Sponsor/Investigator Decision|0|||
30965632|NCT01542632|59034035|FG001|Overall Study|Sponsor/Investigator Decision|0|||
30607455|NCT01194219|58618050|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
30607456|NCT01194219|58618051|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
30607457|NCT01194219|58618052|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
30607458|NCT01194219|58618053|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
30607459|NCT01194219|58618054|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
30607460|NCT01194219|58618055|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
30607461|NCT01194219|58618056|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
30607462|NCT01194219|58618047|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
30607463|NCT01194219|58618048|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
30607464|NCT01194219|58618049|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
30607465|NCT01194219|58618050|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
30607466|NCT01194219|58618051|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
30607467|NCT01194219|58618052|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
30607468|NCT01194219|58618053|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
30607469|NCT01194219|58618054|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
30607470|NCT01194219|58618055|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
30696783|NCT00561951|58711119|FG001|Overall Study|Lack of Efficacy|3|||
30696784|NCT00561951|58711120|FG002|Overall Study|Lack of Efficacy|2|||
30696785|NCT00561951|58711118|FG000|Overall Study|Lost to Follow-up|1|||
30696786|NCT00561951|58711119|FG001|Overall Study|Lost to Follow-up|1|||
30696787|NCT00561951|58711120|FG002|Overall Study|Lost to Follow-up|0|||
30696788|NCT00561951|58711118|FG000|Overall Study|Withdrawal by Subject|10|||
30696789|NCT00561951|58711119|FG001|Overall Study|Withdrawal by Subject|9|||
30696790|NCT00561951|58711120|FG002|Overall Study|Withdrawal by Subject|10|||
30696791|NCT00561951|58711118|FG000|Overall Study|Protocol Violation|4|||
30696792|NCT00561951|58711119|FG001|Overall Study|Protocol Violation|3|||
30696793|NCT00561951|58711120|FG002|Overall Study|Protocol Violation|4|||
30696794|NCT00561951|58711118|FG000|Overall Study|Physician Decision|1|||
30696795|NCT00561951|58711119|FG001|Overall Study|Physician Decision|0|||
30696796|NCT00561951|58711120|FG002|Overall Study|Physician Decision|0|||
30696797|NCT00561951|58711118|FG000|Overall Study|Pregnancy|0|||
30696798|NCT00561951|58711119|FG001|Overall Study|Pregnancy|1|||
30696799|NCT00561951|58711120|FG002|Overall Study|Pregnancy|0|||
30696800|NCT00561951|58711118|FG000|Overall Study|Meet Withdrawal Criterion|0|||
30696801|NCT00561951|58711119|FG001|Overall Study|Meet Withdrawal Criterion|1|||
30696802|NCT00561951|58711120|FG002|Overall Study|Meet Withdrawal Criterion|1|||
30696803|NCT00561951|58711118|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
30696804|NCT00561951|58711119|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
30696805|NCT00561951|58711120|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
30696806|NCT00322387|58711130|FG000|Treatment Period|Adverse Event|0|||
30696807|NCT00322387|58711131|FG001|Treatment Period|Adverse Event|1|||
30696808|NCT00322387|58711130|FG000|Follow-up Period|Final assessment not done|1|||
30696809|NCT00322387|58711131|FG001|Follow-up Period|Final assessment not done|3|||
30696810|NCT00322387|58711130|FG000|Follow-up Period|Death|1|||
30696811|NCT00322387|58711131|FG001|Follow-up Period|Death|0|||
30696812|NCT00561015|58711154|FG000|Overall Study|Adverse Event|0|||
30696813|NCT00561015|58711155|FG001|Overall Study|Adverse Event|0|||
30696814|NCT00561015|58711156|FG002|Overall Study|Adverse Event|0|||
30696815|NCT00561015|58711157|FG003|Overall Study|Adverse Event|0|||
30696816|NCT00561015|58711158|FG004|Overall Study|Adverse Event|1|||
30696817|NCT00561015|58711159|FG005|Overall Study|Adverse Event|0|||
30696818|NCT00561015|58711154|FG000|Overall Study|Lost to Follow-up|2|||
30696819|NCT00561015|58711155|FG001|Overall Study|Lost to Follow-up|0|||
30696820|NCT00561015|58711156|FG002|Overall Study|Lost to Follow-up|0|||
30696821|NCT00561015|58711157|FG003|Overall Study|Lost to Follow-up|1|||
30696822|NCT00561015|58711158|FG004|Overall Study|Lost to Follow-up|0|||
30696823|NCT00561015|58711159|FG005|Overall Study|Lost to Follow-up|3|||
30696824|NCT00561015|58711154|FG000|Overall Study|Participant non-compliance|2|||
30696825|NCT00561015|58711155|FG001|Overall Study|Participant non-compliance|0|||
30696826|NCT00561015|58711156|FG002|Overall Study|Participant non-compliance|0|||
30696827|NCT00561015|58711157|FG003|Overall Study|Participant non-compliance|0|||
30696828|NCT00561015|58711158|FG004|Overall Study|Participant non-compliance|0|||
30696829|NCT00561015|58711159|FG005|Overall Study|Participant non-compliance|0|||
30696830|NCT00560937|58711179|FG000|Overall Study|Withdrawal by Subject|0|||
30696831|NCT00560937|58711180|FG001|Overall Study|Withdrawal by Subject|1|||
30696832|NCT00560937|58711179|FG000|Overall Study|Physician Decision|1|||
30696833|NCT00560937|58711180|FG001|Overall Study|Physician Decision|1|||
30696834|NCT00561795|58711188|FG000|Overall Study|Adverse Event|3|||
30696835|NCT00561795|58711189|FG001|Overall Study|Adverse Event|3|||
30696836|NCT00561795|58711190|FG002|Overall Study|Adverse Event|0|||
30696837|NCT00561795|58711191|FG003|Overall Study|Adverse Event|0|||
30696838|NCT00561795|58711188|FG000|Overall Study|Study Closed/Terminated|0|||
30696839|NCT00561795|58711189|FG001|Overall Study|Study Closed/Terminated|3|||
30696840|NCT00561795|58711190|FG002|Overall Study|Study Closed/Terminated|0|||
30696841|NCT00561795|58711191|FG003|Overall Study|Study Closed/Terminated|0|||
30696842|NCT00561795|58711188|FG000|Overall Study|Physician Decision|1|||
30696843|NCT00561795|58711189|FG001|Overall Study|Physician Decision|0|||
30696844|NCT00561795|58711190|FG002|Overall Study|Physician Decision|0|||
30696845|NCT00561795|58711191|FG003|Overall Study|Physician Decision|0|||
30696846|NCT00652626|58711206|FG000|Initial Treatment Phase|Adverse Event|0|||
30696847|NCT00652626|58711207|FG001|Initial Treatment Phase|Adverse Event|0|||
30696848|NCT00652626|58711208|FG002|Initial Treatment Phase|Adverse Event|0|||
30696849|NCT00652626|58711209|FG003|Initial Treatment Phase|Adverse Event|0|||
30696850|NCT00652626|58711210|FG004|Initial Treatment Phase|Adverse Event|1|||
30696851|NCT00652626|58711211|FG005|Initial Treatment Phase|Adverse Event|0|||
30696852|NCT00652626|58711212|FG006|Initial Treatment Phase|Adverse Event|0|||
30696853|NCT00652626|58711206|FG000|Initial Treatment Phase|Protocol Violation|0|||
30696854|NCT00652626|58711207|FG001|Initial Treatment Phase|Protocol Violation|0|||
30696855|NCT00652626|58711208|FG002|Initial Treatment Phase|Protocol Violation|0|||
30696856|NCT00652626|58711209|FG003|Initial Treatment Phase|Protocol Violation|1|||
30696857|NCT00652626|58711210|FG004|Initial Treatment Phase|Protocol Violation|0|||
30696858|NCT00652626|58711211|FG005|Initial Treatment Phase|Protocol Violation|0|||
30696859|NCT00652626|58711212|FG006|Initial Treatment Phase|Protocol Violation|0|||
30696860|NCT00652626|58711206|FG000|Initial Treatment Phase|Physician Decision|0|||
30696861|NCT00652626|58711207|FG001|Initial Treatment Phase|Physician Decision|0|||
30696862|NCT00652626|58711208|FG002|Initial Treatment Phase|Physician Decision|0|||
30696863|NCT00652626|58711209|FG003|Initial Treatment Phase|Physician Decision|0|||
30696864|NCT00652626|58711210|FG004|Initial Treatment Phase|Physician Decision|1|||
30696865|NCT00652626|58711211|FG005|Initial Treatment Phase|Physician Decision|0|||
30696866|NCT00652626|58711212|FG006|Initial Treatment Phase|Physician Decision|0|||
30696867|NCT00652626|58711206|FG000|Initial Treatment Phase|Sponsor Request|0|||
30696868|NCT00652626|58711207|FG001|Initial Treatment Phase|Sponsor Request|0|||
30696869|NCT00652626|58711208|FG002|Initial Treatment Phase|Sponsor Request|1|||
30696870|NCT00652626|58711209|FG003|Initial Treatment Phase|Sponsor Request|0|||
30696871|NCT00652626|58711210|FG004|Initial Treatment Phase|Sponsor Request|0|||
30696872|NCT00652626|58711211|FG005|Initial Treatment Phase|Sponsor Request|0|||
30696873|NCT00652626|58711212|FG006|Initial Treatment Phase|Sponsor Request|0|||
30696874|NCT00652626|58711206|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
30696875|NCT00652626|58711207|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
30696876|NCT00652626|58711208|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
30696877|NCT00652626|58711209|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
30696878|NCT00652626|58711210|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
30696879|NCT00652626|58711211|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
30696880|NCT00652626|58711212|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
30696881|NCT00652626|58711206|FG000|Extension Phase|Withdrawal by Subject|0|||
30696882|NCT00652626|58711207|FG001|Extension Phase|Withdrawal by Subject|0|||
30696883|NCT00652626|58711208|FG002|Extension Phase|Withdrawal by Subject|0|||
30696884|NCT00652626|58711209|FG003|Extension Phase|Withdrawal by Subject|0|||
30696885|NCT00652626|58711210|FG004|Extension Phase|Withdrawal by Subject|0|||
30696886|NCT00652626|58711211|FG005|Extension Phase|Withdrawal by Subject|2|||
30696887|NCT00652626|58711212|FG006|Extension Phase|Withdrawal by Subject|0|||
30696888|NCT00652626|58711206|FG000|Extension Phase|Adverse Event|0|||
30696889|NCT00652626|58711207|FG001|Extension Phase|Adverse Event|0|||
30696890|NCT00652626|58711208|FG002|Extension Phase|Adverse Event|0|||
30696891|NCT00652626|58711209|FG003|Extension Phase|Adverse Event|0|||
30696892|NCT00652626|58711210|FG004|Extension Phase|Adverse Event|0|||
30696893|NCT00652626|58711211|FG005|Extension Phase|Adverse Event|2|||
30696894|NCT00652626|58711212|FG006|Extension Phase|Adverse Event|1|||
30696895|NCT00652626|58711206|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
30696896|NCT00652626|58711207|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
30696897|NCT00652626|58711208|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
30696898|NCT00652626|58711209|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
30696899|NCT00652626|58711210|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
30696900|NCT00652626|58711211|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
30696901|NCT00652626|58711212|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
30696902|NCT00652626|58711206|FG000|Extension Phase|Physician Decision|0|||
30696903|NCT00652626|58711207|FG001|Extension Phase|Physician Decision|0|||
30696904|NCT00652626|58711208|FG002|Extension Phase|Physician Decision|0|||
30696905|NCT00652626|58711209|FG003|Extension Phase|Physician Decision|0|||
30696906|NCT00652626|58711210|FG004|Extension Phase|Physician Decision|0|||
30696907|NCT00652626|58711211|FG005|Extension Phase|Physician Decision|1|||
30696908|NCT00652626|58711212|FG006|Extension Phase|Physician Decision|1|||
30696909|NCT00652626|58711206|FG000|Extension Phase|Death|0|||
30696910|NCT00652626|58711207|FG001|Extension Phase|Death|0|||
30696911|NCT00652626|58711208|FG002|Extension Phase|Death|0|||
30696912|NCT00652626|58711209|FG003|Extension Phase|Death|0|||
30696913|NCT00652626|58711210|FG004|Extension Phase|Death|0|||
30696914|NCT00652626|58711211|FG005|Extension Phase|Death|1|||
30696915|NCT00652626|58711212|FG006|Extension Phase|Death|1|||
30696916|NCT00560703|58711232|FG000|Overall Study|Adverse Event|0|||
30696917|NCT00560703|58711233|FG001|Overall Study|Adverse Event|2|||
30696918|NCT00560703|58711232|FG000|Overall Study|Protocol Violation|0|||
30696919|NCT00560703|58711233|FG001|Overall Study|Protocol Violation|2|||
30696920|NCT00560703|58711232|FG000|Overall Study|Withdrawal by Subject|0|||
30696921|NCT00560703|58711233|FG001|Overall Study|Withdrawal by Subject|1|||
30696922|NCT00560703|58711232|FG000|Overall Study|non-compliance|0|||
30696923|NCT00560703|58711233|FG001|Overall Study|non-compliance|1|||
30696924|NCT00308737|58711242|FG000|Overall Study|Adverse Event|104|||
30696925|NCT00308737|58711243|FG001|Overall Study|Adverse Event|9|||
30696926|NCT00308737|58711244|FG002|Overall Study|Adverse Event|0|||
30696927|NCT00308737|58711242|FG000|Overall Study|Death|4|||
30696928|NCT00308737|58711243|FG001|Overall Study|Death|3|||
30696929|NCT00308737|58711244|FG002|Overall Study|Death|0|||
30696930|NCT00308737|58711242|FG000|Overall Study|Lost to Follow-up|56|||
30696931|NCT00308737|58711243|FG001|Overall Study|Lost to Follow-up|80|||
30696932|NCT00308737|58711244|FG002|Overall Study|Lost to Follow-up|5|||
30696933|NCT00308737|58711242|FG000|Overall Study|Physician Decision|15|||
30696934|NCT00308737|58711243|FG001|Overall Study|Physician Decision|2|||
30696935|NCT00308737|58711244|FG002|Overall Study|Physician Decision|1|||
30696936|NCT00308737|58711242|FG000|Overall Study|Protocol Violation|34|||
30696937|NCT00308737|58711243|FG001|Overall Study|Protocol Violation|9|||
30696938|NCT00308737|58711244|FG002|Overall Study|Protocol Violation|5|||
30696939|NCT00308737|58711242|FG000|Overall Study|Withdrawal by Subject|218|||
30696940|NCT00308737|58711243|FG001|Overall Study|Withdrawal by Subject|166|||
30696941|NCT00308737|58711244|FG002|Overall Study|Withdrawal by Subject|18|||
30696942|NCT00308737|58711242|FG000|Overall Study|Various|32|||
30696943|NCT00308737|58711243|FG001|Overall Study|Various|20|||
30696944|NCT00308737|58711244|FG002|Overall Study|Various|8|||
30696945|NCT00655746|58711252|FG000|Overall Study|Withdrawal by Subject|1|||
30696946|NCT00338455|58711262|FG000|Overall Study|Death|2|||
30696947|NCT00338455|58711263|FG001|Overall Study|Death|1|||
30696948|NCT00338455|58711262|FG000|Overall Study|Physician Decision|1|||
30696949|NCT00338455|58711263|FG001|Overall Study|Physician Decision|0|||
30696950|NCT00651924|58711271|FG000|Overall Study|Withdrawal by PI|0|||
30696951|NCT00651924|58711272|FG001|Overall Study|Withdrawal by PI|2|||
30696952|NCT00651924|58711271|FG000|Overall Study|Withdrawal by Subject|0|||
30696953|NCT00651924|58711272|FG001|Overall Study|Withdrawal by Subject|5|||
30696954|NCT00678392|58711280|FG000|Overall Study|Adverse Event|0|||
30696955|NCT00678392|58711281|FG001|Overall Study|Adverse Event|6|||
30696956|NCT00678392|58711280|FG000|Overall Study|Death|280|||
30696957|NCT00678392|58711281|FG001|Overall Study|Death|269|||
30696958|NCT00678392|58711280|FG000|Overall Study|Lost to Follow-up|15|||
30696959|NCT00678392|58711281|FG001|Overall Study|Lost to Follow-up|13|||
30696960|NCT00678392|58711280|FG000|Overall Study|Objective Progression or Relapse|3|||
30696961|NCT00678392|58711281|FG001|Overall Study|Objective Progression or Relapse|8|||
30696962|NCT00678392|58711280|FG000|Overall Study|Sponsor's Decision|1|||
30696963|NCT00678392|58711281|FG001|Overall Study|Sponsor's Decision|2|||
30696964|NCT00678392|58711280|FG000|Overall Study|Withdrawal by Subject|4|||
30696965|NCT00678392|58711281|FG001|Overall Study|Withdrawal by Subject|4|||
30696966|NCT00678392|58711280|FG000|Overall Study|Randomized But Not Treated|2|||
30696967|NCT00678392|58711281|FG001|Overall Study|Randomized But Not Treated|7|||
30696968|NCT00678392|58711280|FG000|Overall Study|Other|56|||
30696969|NCT00678392|58711281|FG001|Overall Study|Other|53|||
30696970|NCT00308581|58711287|FG000|Induction Phase|Adverse Event|0|||
30696971|NCT00308581|58711288|FG001|Induction Phase|Adverse Event|0|||
30696972|NCT00308581|58711289|FG002|Induction Phase|Adverse Event|37|||
30696973|NCT00308581|58711287|FG000|Induction Phase|Lack of Efficacy|0|||
30696974|NCT00308581|58711288|FG001|Induction Phase|Lack of Efficacy|0|||
30696975|NCT00308581|58711289|FG002|Induction Phase|Lack of Efficacy|121|||
30696976|NCT00308581|58711287|FG000|Induction Phase|Withdrawal by Subject|0|||
30696977|NCT00308581|58711288|FG001|Induction Phase|Withdrawal by Subject|0|||
30696978|NCT00308581|58711289|FG002|Induction Phase|Withdrawal by Subject|5|||
30696979|NCT00308581|58711287|FG000|Induction Phase|Unknown reason|0|||
30696980|NCT00308581|58711288|FG001|Induction Phase|Unknown reason|0|||
30696981|NCT00308581|58711289|FG002|Induction Phase|Unknown reason|3|||
30696982|NCT00308581|58711287|FG000|Randomized Maintenance Phase|Adverse Event|10|||
30696983|NCT00308581|58711288|FG001|Randomized Maintenance Phase|Adverse Event|17|||
30696984|NCT00308581|58711289|FG002|Randomized Maintenance Phase|Adverse Event|0|||
30696985|NCT00308581|58711287|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
30696986|NCT00308581|58711288|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
30696987|NCT00308581|58711289|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
30696988|NCT00308581|58711287|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
30696989|NCT00308581|58711288|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
30696990|NCT00308581|58711289|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
30696991|NCT00308581|58711287|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
30696992|NCT00308581|58711288|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
30696993|NCT00308581|58711289|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
30696994|NCT00308581|58711287|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
30696995|NCT00308581|58711288|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
30696996|NCT00308581|58711289|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
30696997|NCT00308581|58711287|FG000|Randomized Maintenance Phase|Unknown reason|3|||
30696998|NCT00308581|58711288|FG001|Randomized Maintenance Phase|Unknown reason|0|||
30696999|NCT00308581|58711289|FG002|Randomized Maintenance Phase|Unknown reason|0|||
30697000|NCT00678080|58711299|FG000|Overall Study|Physician Decision|2|||
30697001|NCT00678080|58711300|FG001|Overall Study|Physician Decision|0|||
30697002|NCT00678080|58711299|FG000|Overall Study|Lost to Follow-up|1|||
30697003|NCT00678080|58711300|FG001|Overall Study|Lost to Follow-up|0|||
30697004|NCT00678080|58711299|FG000|Overall Study|Withdrawal by Subject|0|||
30697005|NCT00678080|58711300|FG001|Overall Study|Withdrawal by Subject|1|||
30697006|NCT00658320|58711308|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
30697007|NCT00658320|58711309|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
30697008|NCT00658320|58711308|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
30697009|NCT00658320|58711309|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
30697010|NCT00658320|58711308|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
30697011|NCT00658320|58711309|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
30697012|NCT00658320|58711308|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
30697013|NCT00658320|58711309|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
30697014|NCT00322153|58711319|FG000|Overall Study|Adverse Event|21|||
30697015|NCT00322153|58711320|FG001|Overall Study|Adverse Event|34|||
30697016|NCT00322153|58711319|FG000|Overall Study|Protocol Violation|6|||
30697017|NCT00322153|58711320|FG001|Overall Study|Protocol Violation|14|||
30697018|NCT00322153|58711319|FG000|Overall Study|Withdrawal by Subject|18|||
30697019|NCT00322153|58711320|FG001|Overall Study|Withdrawal by Subject|10|||
30697020|NCT00322153|58711319|FG000|Overall Study|Lack of Efficacy|8|||
30697021|NCT00322153|58711320|FG001|Overall Study|Lack of Efficacy|3|||
30697022|NCT00322153|58711319|FG000|Overall Study|Lost to Follow-up|5|||
30697023|NCT00322153|58711320|FG001|Overall Study|Lost to Follow-up|4|||
30697024|NCT00322153|58711319|FG000|Overall Study|Withdrawn for other reasons|5|||
30697025|NCT00322153|58711320|FG001|Overall Study|Withdrawn for other reasons|4|||
30697026|NCT00657618|58711326|FG000|Overall Study|Adverse Event|32|||
30697027|NCT00657618|58711326|FG000|Overall Study|Withdrawal by Subject|8|||
30697028|NCT00657618|58711326|FG000|Overall Study|negative for leishmaniasis|2|||
30697029|NCT00657618|58711326|FG000|Overall Study|didn't start due to schedule conflicts|1|||
30697030|NCT00657540|58711332|FG000|Overall Study|Lost to Follow-up|1|||
30697031|NCT00657540|58711333|FG001|Overall Study|Lost to Follow-up|4|||
30697032|NCT00672620|58711343|FG000|Overall Study|Adverse Event|7|||
30697033|NCT00672620|58711344|FG001|Overall Study|Adverse Event|7|||
30697034|NCT00672620|58711345|FG002|Overall Study|Adverse Event|12|||
30697035|NCT00672620|58711346|FG003|Overall Study|Adverse Event|17|||
30697036|NCT00672620|58711343|FG000|Overall Study|Lack of Efficacy|1|||
30697037|NCT00672620|58711344|FG001|Overall Study|Lack of Efficacy|2|||
30697038|NCT00672620|58711345|FG002|Overall Study|Lack of Efficacy|2|||
30697039|NCT00672620|58711346|FG003|Overall Study|Lack of Efficacy|0|||
30697040|NCT00672620|58711343|FG000|Overall Study|Noncompliance with Study Drug|3|||
30697041|NCT00672620|58711344|FG001|Overall Study|Noncompliance with Study Drug|4|||
30697042|NCT00672620|58711345|FG002|Overall Study|Noncompliance with Study Drug|0|||
30697043|NCT00672620|58711346|FG003|Overall Study|Noncompliance with Study Drug|2|||
30697044|NCT00672620|58711343|FG000|Overall Study|Protocol Deviations|5|||
30697045|NCT00672620|58711344|FG001|Overall Study|Protocol Deviations|7|||
30697046|NCT00672620|58711345|FG002|Overall Study|Protocol Deviations|2|||
30697047|NCT00672620|58711346|FG003|Overall Study|Protocol Deviations|5|||
30697048|NCT00672620|58711343|FG000|Overall Study|Withdrawal of Consent|6|||
30697049|NCT00672620|58711344|FG001|Overall Study|Withdrawal of Consent|12|||
30697050|NCT00672620|58711345|FG002|Overall Study|Withdrawal of Consent|5|||
30697051|NCT00672620|58711346|FG003|Overall Study|Withdrawal of Consent|6|||
30697052|NCT00672620|58711343|FG000|Overall Study|Lost to Follow-up|8|||
30697053|NCT00672620|58711344|FG001|Overall Study|Lost to Follow-up|19|||
30697054|NCT00672620|58711345|FG002|Overall Study|Lost to Follow-up|8|||
30697055|NCT00672620|58711346|FG003|Overall Study|Lost to Follow-up|11|||
30697056|NCT00672620|58711343|FG000|Overall Study|Reason not Specified|3|||
30697057|NCT00672620|58711344|FG001|Overall Study|Reason not Specified|3|||
30697058|NCT00672620|58711345|FG002|Overall Study|Reason not Specified|2|||
30697059|NCT00672620|58711346|FG003|Overall Study|Reason not Specified|1|||
30697060|NCT00673790|58711359|FG000|Overall Study|Adverse Event|23|||
30697061|NCT00673790|58711360|FG001|Overall Study|Adverse Event|14|||
30697062|NCT00673790|58711361|FG002|Overall Study|Adverse Event|2|||
30697063|NCT00673790|58711359|FG000|Overall Study|Lack of Efficacy|2|||
30697064|NCT00673790|58711360|FG001|Overall Study|Lack of Efficacy|2|||
30697065|NCT00673790|58711361|FG002|Overall Study|Lack of Efficacy|2|||
30697066|NCT00673790|58711359|FG000|Overall Study|Protocol Violation|6|||
30697067|NCT00673790|58711360|FG001|Overall Study|Protocol Violation|9|||
30697068|NCT00673790|58711361|FG002|Overall Study|Protocol Violation|1|||
30697069|NCT00673790|58711359|FG000|Overall Study|Withdrawal by Subject|7|||
30697070|NCT00673790|58711360|FG001|Overall Study|Withdrawal by Subject|4|||
30697071|NCT00673790|58711361|FG002|Overall Study|Withdrawal by Subject|1|||
30965633|NCT01542632|59034036|FG002|Overall Study|Sponsor/Investigator Decision|0|||
30965634|NCT01542632|59034037|FG003|Overall Study|Sponsor/Investigator Decision|0|||
30965635|NCT01542632|59034038|FG004|Overall Study|Sponsor/Investigator Decision|1|||
30965636|NCT01542632|59034039|FG005|Overall Study|Sponsor/Investigator Decision|0|||
30965637|NCT01557842|59034060|FG000|Overall Study|Lost to Follow-up|0|||
30965638|NCT01557842|59034061|FG001|Overall Study|Lost to Follow-up|1|||
30965639|NCT01557842|59034060|FG000|Overall Study|Death|1|||
30965640|NCT01557842|59034061|FG001|Overall Study|Death|0|||
30965641|NCT01557842|59034060|FG000|Overall Study|Lack of Efficacy|0|||
30965642|NCT01557842|59034061|FG001|Overall Study|Lack of Efficacy|1|||
30965643|NCT01557842|59034060|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
30965644|NCT01557842|59034061|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
30965645|NCT01557842|59034060|FG000|Overall Study|Study Terminated by Sponsor|3|||
30965646|NCT01557842|59034061|FG001|Overall Study|Study Terminated by Sponsor|4|||
30965647|NCT01557842|59034060|FG000|Overall Study|Not Ablated|2|||
30965648|NCT01557842|59034061|FG001|Overall Study|Not Ablated|0|||
30965649|NCT01541930|59034067|FG000|Overall Study|Withdrawal by Subject|1|||
30965650|NCT01576016|59034084|FG000|Lead Safety|Death|132|||
30965651|NCT01576016|59034085|FG001|Lead Safety|Death|0|||
30965652|NCT01576016|59034084|FG000|Lead Safety|Withdrawal by Subject|81|||
30965653|NCT01576016|59034085|FG001|Lead Safety|Withdrawal by Subject|0|||
30965654|NCT01576016|59034084|FG000|Lead Safety|System Explanted without Replacement|24|||
30965655|NCT01576016|59034085|FG001|Lead Safety|System Explanted without Replacement|0|||
30965656|NCT01576016|59034084|FG000|Lead Safety|Physician Decision|14|||
30965657|NCT01576016|59034085|FG001|Lead Safety|Physician Decision|0|||
30965658|NCT01576016|59034084|FG000|Lead Safety|Lost to Follow-up|13|||
30965659|NCT01576016|59034085|FG001|Lead Safety|Lost to Follow-up|0|||
30965660|NCT01576016|59034084|FG000|Lead Safety|Unsuccessful implant|2|||
30965661|NCT01576016|59034085|FG001|Lead Safety|Unsuccessful implant|0|||
30965662|NCT01576016|59034084|FG000|Lead Safety|Sponsor request|1|||
30965663|NCT01576016|59034085|FG001|Lead Safety|Sponsor request|0|||
30965664|NCT01576016|59034084|FG000|Lead Safety|Device replaced with CRT-D|1|||
30965665|NCT01576016|59034085|FG001|Lead Safety|Device replaced with CRT-D|0|||
30965666|NCT01576016|59034084|FG000|Lead Safety|Patient on Palliative Care|1|||
30965667|NCT01576016|59034085|FG001|Lead Safety|Patient on Palliative Care|0|||
30965668|NCT01576016|59034084|FG000|Lead Safety|Patient noncompliance|1|||
30965669|NCT01576016|59034085|FG001|Lead Safety|Patient noncompliance|0|||
30965670|NCT01576016|59034084|FG000|Lead Safety|Too far from study site|1|||
30965671|NCT01576016|59034085|FG001|Lead Safety|Too far from study site|0|||
30965672|NCT01576016|59034084|FG000|Lead Safety|System deactivated|1|||
30965673|NCT01576016|59034085|FG001|Lead Safety|System deactivated|0|||
30965674|NCT01576016|59034084|FG000|Lead Safety|Patient no longer followed by study PI|1|||
30965675|NCT01576016|59034085|FG001|Lead Safety|Patient no longer followed by study PI|0|||
30965676|NCT01576016|59034084|FG000|MRI Safety|Withdrawal by Subject|0|||
30965677|NCT01576016|59034085|FG001|MRI Safety|Withdrawal by Subject|10|||
30965678|NCT01576016|59034084|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
30965679|NCT01576016|59034085|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
30965680|NCT01576016|59034084|FG000|MRI Safety|Has not yet completed MRI scan|0|||
30965681|NCT01576016|59034085|FG001|MRI Safety|Has not yet completed MRI scan|56|||
30965682|NCT01576016|59034084|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
30965683|NCT01576016|59034085|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
30965684|NCT01540838|59034095|FG000|Overall Study|Open nasogastric tube|9|||
30965685|NCT01540838|59034096|FG001|Overall Study|Open nasogastric tube|7|||
30965686|NCT01540838|59034095|FG000|Overall Study|Treatment doses missing|8|||
30965687|NCT01540838|59034096|FG001|Overall Study|Treatment doses missing|12|||
30965688|NCT01540838|59034095|FG000|Overall Study|Additional antibiotic treatment|1|||
30965689|NCT01540838|59034096|FG001|Overall Study|Additional antibiotic treatment|2|||
30965690|NCT01540838|59034095|FG000|Overall Study|Died before treatment initiation|1|||
30965691|NCT01540838|59034096|FG001|Overall Study|Died before treatment initiation|1|||
30965692|NCT01540838|59034095|FG000|Overall Study|Not BM. Other treatment|3|||
30965693|NCT01540838|59034096|FG001|Overall Study|Not BM. Other treatment|1|||
30965694|NCT01451437|59034111|FG000|Overall Study|Adverse Event|0|||
30965695|NCT01451437|59034112|FG001|Overall Study|Adverse Event|0|||
30965696|NCT01451437|59034113|FG002|Overall Study|Adverse Event|0|||
30965697|NCT01451437|59034114|FG003|Overall Study|Adverse Event|0|||
30965698|NCT01451437|59034115|FG004|Overall Study|Adverse Event|0|||
30965699|NCT01451437|59034116|FG005|Overall Study|Adverse Event|1|||
30965700|NCT01451437|59034117|FG006|Overall Study|Adverse Event|1|||
30965701|NCT01451437|59034118|FG007|Overall Study|Adverse Event|2|||
30965702|NCT01451437|59034119|FG008|Overall Study|Adverse Event|1|||
30965703|NCT01451437|59034111|FG000|Overall Study|Physician Decision|1|||
30965704|NCT01451437|59034112|FG001|Overall Study|Physician Decision|1|||
30965705|NCT01451437|59034113|FG002|Overall Study|Physician Decision|2|||
30965706|NCT01451437|59034114|FG003|Overall Study|Physician Decision|0|||
30965707|NCT01451437|59034115|FG004|Overall Study|Physician Decision|0|||
30965708|NCT01451437|59034116|FG005|Overall Study|Physician Decision|0|||
30965709|NCT01451437|59034117|FG006|Overall Study|Physician Decision|0|||
30965710|NCT01451437|59034118|FG007|Overall Study|Physician Decision|0|||
30965711|NCT01451437|59034119|FG008|Overall Study|Physician Decision|0|||
30965712|NCT01451437|59034111|FG000|Overall Study|Disease Progression|0|||
30965713|NCT01451437|59034112|FG001|Overall Study|Disease Progression|0|||
30965714|NCT01451437|59034113|FG002|Overall Study|Disease Progression|1|||
30965715|NCT01451437|59034114|FG003|Overall Study|Disease Progression|1|||
30965716|NCT01451437|59034115|FG004|Overall Study|Disease Progression|3|||
30965717|NCT01451437|59034116|FG005|Overall Study|Disease Progression|2|||
30965718|NCT01451437|59034117|FG006|Overall Study|Disease Progression|3|||
30965719|NCT01451437|59034118|FG007|Overall Study|Disease Progression|1|||
30965720|NCT01451437|59034119|FG008|Overall Study|Disease Progression|3|||
30965721|NCT01451437|59034111|FG000|Overall Study|Protocol Violation|0|||
30965722|NCT01451437|59034112|FG001|Overall Study|Protocol Violation|0|||
30965723|NCT01451437|59034113|FG002|Overall Study|Protocol Violation|0|||
30965724|NCT01451437|59034114|FG003|Overall Study|Protocol Violation|0|||
30965725|NCT01451437|59034115|FG004|Overall Study|Protocol Violation|0|||
30965726|NCT01451437|59034116|FG005|Overall Study|Protocol Violation|0|||
30965727|NCT01451437|59034117|FG006|Overall Study|Protocol Violation|1|||
30965728|NCT01451437|59034118|FG007|Overall Study|Protocol Violation|0|||
30965729|NCT01451437|59034119|FG008|Overall Study|Protocol Violation|0|||
30965730|NCT01451437|59034111|FG000|Overall Study|Withdrawal by Subject|0|||
30965731|NCT01451437|59034112|FG001|Overall Study|Withdrawal by Subject|0|||
30965732|NCT01451437|59034113|FG002|Overall Study|Withdrawal by Subject|0|||
30965733|NCT01451437|59034114|FG003|Overall Study|Withdrawal by Subject|0|||
30965734|NCT01451437|59034115|FG004|Overall Study|Withdrawal by Subject|1|||
30965735|NCT01451437|59034116|FG005|Overall Study|Withdrawal by Subject|0|||
30965736|NCT01451437|59034117|FG006|Overall Study|Withdrawal by Subject|1|||
30965737|NCT01451437|59034118|FG007|Overall Study|Withdrawal by Subject|0|||
30965738|NCT01451437|59034119|FG008|Overall Study|Withdrawal by Subject|0|||
30965739|NCT01451203|59034150|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
30965740|NCT01451203|59034151|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
30965741|NCT01451203|59034150|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
30965742|NCT01451203|59034151|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
30965743|NCT01451203|59034150|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
30965744|NCT01451203|59034151|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
30965745|NCT01451203|59034150|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
30965746|NCT01451203|59034151|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
30965747|NCT01451203|59034150|FG000|Double-blind Treatment Period|Adverse Event|6|||
30965748|NCT01451203|59034151|FG001|Double-blind Treatment Period|Adverse Event|9|||
30965749|NCT01451203|59034150|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
30965750|NCT01451203|59034151|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
30965751|NCT01451203|59034150|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
30965752|NCT01451203|59034151|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
30965753|NCT01451203|59034150|FG000|Double-blind Treatment Period|Investigator decision|2|||
30965754|NCT01451203|59034151|FG001|Double-blind Treatment Period|Investigator decision|0|||
30965755|NCT01451203|59034150|FG000|Post-treatment Period|Consent withdrawn|2|||
30965756|NCT01451203|59034151|FG001|Post-treatment Period|Consent withdrawn|4|||
30965757|NCT01451203|59034150|FG000|Post-treatment Period|Lack of Efficacy|12|||
30965758|NCT01451203|59034151|FG001|Post-treatment Period|Lack of Efficacy|28|||
30965759|NCT01451203|59034150|FG000|Post-treatment Period|Adverse Event|0|||
30965760|NCT01451203|59034151|FG001|Post-treatment Period|Adverse Event|1|||
30965761|NCT01451203|59034150|FG000|Post-treatment Period|Investigator decision|0|||
30965762|NCT01451203|59034151|FG001|Post-treatment Period|Investigator decision|1|||
30965763|NCT01556438|59034159|FG000|Overall Study|Adverse Event|4|||
30965764|NCT01556438|59034160|FG001|Overall Study|Adverse Event|2|||
30965765|NCT01556438|59034159|FG000|Overall Study|Sponsor Decision|0|||
30965766|NCT01556438|59034160|FG001|Overall Study|Sponsor Decision|2|||
30965767|NCT01556438|59034159|FG000|Overall Study|Progressive Disease|0|||
30965768|NCT01556438|59034160|FG001|Overall Study|Progressive Disease|6|||
30965769|NCT01556438|59034159|FG000|Overall Study|Death|0|||
30965770|NCT01556438|59034160|FG001|Overall Study|Death|1|||
30965771|NCT01554176|59034186|FG000|Treatment Phase|Protocol Violation|1|||
30965772|NCT01554176|59034187|FG001|Treatment Phase|Protocol Violation|2|||
30965773|NCT01554176|59034188|FG002|Treatment Phase|Protocol Violation|0|||
30965774|NCT01554176|59034189|FG003|Treatment Phase|Protocol Violation|0|||
30965775|NCT01554176|59034190|FG004|Treatment Phase|Protocol Violation|0|||
30697072|NCT00673790|58711359|FG000|Overall Study|Lost to Follow-up|6|||
30697073|NCT00673790|58711360|FG001|Overall Study|Lost to Follow-up|6|||
30697074|NCT00673790|58711361|FG002|Overall Study|Lost to Follow-up|5|||
30697075|NCT00673790|58711359|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
30697076|NCT00673790|58711360|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
30697077|NCT00673790|58711361|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
30697078|NCT00673790|58711359|FG000|Overall Study|Poor compliance|1|||
30697079|NCT00673790|58711360|FG001|Overall Study|Poor compliance|0|||
30697080|NCT00673790|58711361|FG002|Overall Study|Poor compliance|0|||
30697081|NCT00673790|58711359|FG000|Overall Study|Participated in two Nebivolol studies|0|||
30697082|NCT00673790|58711360|FG001|Overall Study|Participated in two Nebivolol studies|0|||
30697083|NCT00673790|58711361|FG002|Overall Study|Participated in two Nebivolol studies|1|||
30697084|NCT00673790|58711359|FG000|Overall Study|Unconfirmed pregnancy|0|||
30697085|NCT00673790|58711360|FG001|Overall Study|Unconfirmed pregnancy|1|||
30697086|NCT00673790|58711361|FG002|Overall Study|Unconfirmed pregnancy|0|||
30965776|NCT01554176|59034186|FG000|Treatment Phase|Physician Decision|1|||
30965777|NCT01554176|59034187|FG001|Treatment Phase|Physician Decision|1|||
30697087|NCT00673790|58711359|FG000|Overall Study|Randomization criteria not met|0|||
30697088|NCT00673790|58711360|FG001|Overall Study|Randomization criteria not met|1|||
30697089|NCT00673790|58711361|FG002|Overall Study|Randomization criteria not met|0|||
30697090|NCT00657150|58711372|FG000|Overall Study|Adverse Event|19|||
30697091|NCT00657150|58711373|FG001|Overall Study|Adverse Event|10|||
30697092|NCT00657150|58711372|FG000|Overall Study|Non-compliant with protocol|5|||
30697093|NCT00657150|58711373|FG001|Overall Study|Non-compliant with protocol|9|||
30697094|NCT00657150|58711372|FG000|Overall Study|Lost to Follow-up|2|||
30697095|NCT00657150|58711373|FG001|Overall Study|Lost to Follow-up|0|||
30697096|NCT00657150|58711372|FG000|Overall Study|Withdrawal by Subject|51|||
30697097|NCT00657150|58711373|FG001|Overall Study|Withdrawal by Subject|36|||
30697098|NCT00657150|58711372|FG000|Overall Study|Other|38|||
30697099|NCT00657150|58711373|FG001|Overall Study|Other|38|||
30697100|NCT00657150|58711372|FG000|Treatment|Adverse Event|60|||
30697101|NCT00657150|58711373|FG001|Treatment|Adverse Event|53|||
30697102|NCT00657150|58711372|FG000|Treatment|Non-compliant with protocol|10|||
30697103|NCT00657150|58711373|FG001|Treatment|Non-compliant with protocol|9|||
30697104|NCT00657150|58711372|FG000|Treatment|Lost to Follow-up|1|||
30697105|NCT00657150|58711373|FG001|Treatment|Lost to Follow-up|0|||
30697106|NCT00657150|58711372|FG000|Treatment|Withdrawal by Subject|23|||
30697107|NCT00657150|58711373|FG001|Treatment|Withdrawal by Subject|20|||
30697108|NCT00657150|58711372|FG000|Treatment|Other|13|||
30697109|NCT00657150|58711373|FG001|Treatment|Other|15|||
30697110|NCT00670748|58711383|FG000|Overall Study|Death during treatment|1|||
30697111|NCT00670748|58711384|FG001|Overall Study|Death during treatment|1|||
30697112|NCT00670748|58711385|FG002|Overall Study|Death during treatment|1|||
30697113|NCT00670748|58711386|FG003|Overall Study|Death during treatment|0|||
30697114|NCT00670748|58711383|FG000|Overall Study|Not off study|2|||
30697115|NCT00670748|58711384|FG001|Overall Study|Not off study|1|||
30697116|NCT00670748|58711385|FG002|Overall Study|Not off study|1|||
30697117|NCT00670748|58711386|FG003|Overall Study|Not off study|1|||
30697118|NCT00646776|58711398|FG000|Overall Study|Adverse Event|1|||
30697119|NCT00646776|58711399|FG001|Overall Study|Adverse Event|9|||
30697120|NCT00646776|58711398|FG000|Overall Study|Investigator discretion|0|||
30697121|NCT00646776|58711399|FG001|Overall Study|Investigator discretion|4|||
30697122|NCT00655668|58711408|FG000|Overall Study|Adverse Event|6|||
30697123|NCT00655668|58711408|FG000|Overall Study|Death|5|||
30697124|NCT00655668|58711408|FG000|Overall Study|Disease Progression|27|||
30697125|NCT00655668|58711408|FG000|Overall Study|Study Terminated|9|||
30697126|NCT00655668|58711408|FG000|Overall Study|Other|1|||
30697127|NCT00655668|58711408|FG000|Overall Study|New Lymphoma Treatment Started|4|||
30697128|NCT00655668|58711408|FG000|Overall Study|Withdrawal by Subject|2|||
30697129|NCT00569166|58711415|FG000|Overall Study|Withdrawal by Subject|7|||
30697130|NCT00569166|58711416|FG001|Overall Study|Withdrawal by Subject|5|||
30697131|NCT00569166|58711417|FG002|Overall Study|Withdrawal by Subject|3|||
30697132|NCT00569166|58711415|FG000|Overall Study|Lost to Follow-up|2|||
30697133|NCT00569166|58711416|FG001|Overall Study|Lost to Follow-up|1|||
30697134|NCT00569166|58711417|FG002|Overall Study|Lost to Follow-up|1|||
30697135|NCT00655356|58711427|FG000|Overall Study|Withdrawal by Subject|3|||
30697136|NCT00655356|58711428|FG001|Overall Study|Withdrawal by Subject|4|||
30697137|NCT00655356|58711427|FG000|Overall Study|Sponsor Request|10|||
30697138|NCT00655356|58711428|FG001|Overall Study|Sponsor Request|4|||
30697139|NCT00655356|58711427|FG000|Overall Study|Adverse Event|1|||
30697140|NCT00655356|58711428|FG001|Overall Study|Adverse Event|1|||
30697141|NCT00655356|58711427|FG000|Overall Study|Protocol Violation|2|||
30697142|NCT00655356|58711428|FG001|Overall Study|Protocol Violation|1|||
30697143|NCT00655356|58711427|FG000|Overall Study|Other Reason|1|||
30697144|NCT00655356|58711428|FG001|Overall Study|Other Reason|0|||
30697145|NCT00571064|58711434|FG000|Overall Study|Adverse Event|13|||
30697146|NCT00571064|58711434|FG000|Overall Study|Protocol Violation|4|||
30697147|NCT00571064|58711434|FG000|Overall Study|Withdrawal by Subject|2|||
30697148|NCT00571064|58711434|FG000|Overall Study|Other|2|||
30697149|NCT03895372|58711447|FG000|Investigational Treatment Period|Adverse Event|1|||
30697150|NCT03895372|58711448|FG001|Investigational Treatment Period|Adverse Event|0|||
30697151|NCT03895372|58711449|FG002|Investigational Treatment Period|Adverse Event|0|||
30697152|NCT03895372|58711450|FG003|Investigational Treatment Period|Adverse Event|0|||
30697153|NCT03895372|58711451|FG004|Investigational Treatment Period|Adverse Event|0|||
30697154|NCT03895372|58711452|FG005|Investigational Treatment Period|Adverse Event|0|||
30697155|NCT03895372|58711453|FG006|Investigational Treatment Period|Adverse Event|4|||
30697156|NCT03895372|58711454|FG007|Investigational Treatment Period|Adverse Event|3|||
30697157|NCT03895372|58711447|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
30697158|NCT03895372|58711448|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
30697159|NCT03895372|58711449|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
30697160|NCT03895372|58711450|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
30697161|NCT03895372|58711451|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
30697162|NCT03895372|58711452|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
30697163|NCT03895372|58711453|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
30697164|NCT03895372|58711454|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
30697165|NCT03895372|58711447|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
30697166|NCT03895372|58711448|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
30697167|NCT03895372|58711449|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
30697168|NCT03895372|58711450|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
30697169|NCT03895372|58711451|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
30697170|NCT03895372|58711452|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
30697171|NCT03895372|58711453|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
30697172|NCT03895372|58711454|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
30697173|NCT03895372|58711447|FG000|Investigational Treatment Period|Other|0|||
30697174|NCT03895372|58711448|FG001|Investigational Treatment Period|Other|0|||
30697175|NCT03895372|58711449|FG002|Investigational Treatment Period|Other|0|||
30697176|NCT03895372|58711450|FG003|Investigational Treatment Period|Other|0|||
30697177|NCT03895372|58711451|FG004|Investigational Treatment Period|Other|0|||
30697178|NCT03895372|58711452|FG005|Investigational Treatment Period|Other|1|||
30697179|NCT03895372|58711453|FG006|Investigational Treatment Period|Other|0|||
30697180|NCT03895372|58711454|FG007|Investigational Treatment Period|Other|2|||
30697181|NCT03895372|58711447|FG000|Investigational Treatment Period|Protocol Violation|0|||
30697182|NCT03895372|58711448|FG001|Investigational Treatment Period|Protocol Violation|0|||
30697183|NCT03895372|58711449|FG002|Investigational Treatment Period|Protocol Violation|0|||
30697184|NCT03895372|58711450|FG003|Investigational Treatment Period|Protocol Violation|1|||
30697185|NCT03895372|58711451|FG004|Investigational Treatment Period|Protocol Violation|0|||
30697186|NCT03895372|58711452|FG005|Investigational Treatment Period|Protocol Violation|0|||
30697187|NCT03895372|58711453|FG006|Investigational Treatment Period|Protocol Violation|0|||
30697188|NCT03895372|58711454|FG007|Investigational Treatment Period|Protocol Violation|0|||
30697189|NCT03895372|58711447|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
30697190|NCT03895372|58711448|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
30697191|NCT03895372|58711449|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
30697192|NCT03895372|58711450|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
30697193|NCT03895372|58711451|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
30697194|NCT03895372|58711452|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
30697195|NCT03895372|58711453|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
30697196|NCT03895372|58711454|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
30697197|NCT03895372|58711447|FG000|Extension Treatment Period|Adverse Event|0|||
30697198|NCT03895372|58711448|FG001|Extension Treatment Period|Adverse Event|1|||
30697199|NCT03895372|58711449|FG002|Extension Treatment Period|Adverse Event|0|||
30697200|NCT03895372|58711450|FG003|Extension Treatment Period|Adverse Event|1|||
30697201|NCT03895372|58711451|FG004|Extension Treatment Period|Adverse Event|0|||
30697202|NCT03895372|58711452|FG005|Extension Treatment Period|Adverse Event|0|||
30697203|NCT03895372|58711453|FG006|Extension Treatment Period|Adverse Event|3|||
30697204|NCT03895372|58711454|FG007|Extension Treatment Period|Adverse Event|3|||
30697205|NCT03895372|58711447|FG000|Extension Treatment Period|Other|1|||
30697206|NCT03895372|58711448|FG001|Extension Treatment Period|Other|3|||
30697207|NCT03895372|58711449|FG002|Extension Treatment Period|Other|0|||
30697208|NCT03895372|58711450|FG003|Extension Treatment Period|Other|0|||
30697209|NCT03895372|58711451|FG004|Extension Treatment Period|Other|1|||
30697210|NCT03895372|58711452|FG005|Extension Treatment Period|Other|0|||
30697211|NCT03895372|58711453|FG006|Extension Treatment Period|Other|0|||
30697212|NCT03895372|58711454|FG007|Extension Treatment Period|Other|2|||
30697213|NCT03895372|58711447|FG000|Extension Treatment Period|Pregnancy|0|||
30697214|NCT03895372|58711448|FG001|Extension Treatment Period|Pregnancy|0|||
30697215|NCT03895372|58711449|FG002|Extension Treatment Period|Pregnancy|0|||
30697216|NCT03895372|58711450|FG003|Extension Treatment Period|Pregnancy|0|||
30697217|NCT03895372|58711451|FG004|Extension Treatment Period|Pregnancy|1|||
30697218|NCT03895372|58711452|FG005|Extension Treatment Period|Pregnancy|0|||
30697219|NCT03895372|58711453|FG006|Extension Treatment Period|Pregnancy|0|||
30697220|NCT03895372|58711454|FG007|Extension Treatment Period|Pregnancy|0|||
30697221|NCT03895372|58711447|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
30697222|NCT03895372|58711448|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
30697223|NCT03895372|58711449|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
30697224|NCT03895372|58711450|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
30697225|NCT03895372|58711451|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
30697226|NCT03895372|58711452|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
30697227|NCT03895372|58711453|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
30697228|NCT03895372|58711454|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
30697229|NCT00669110|58711479|FG000|Overall Study|Adverse Event|4|||
30697230|NCT00669110|58711480|FG001|Overall Study|Adverse Event|3|||
30697231|NCT00669110|58711479|FG000|Overall Study|Caregiver request|3|||
30697232|NCT00669110|58711480|FG001|Overall Study|Caregiver request|2|||
30697233|NCT00669110|58711479|FG000|Overall Study|Physician Decision|0|||
30697234|NCT00669110|58711480|FG001|Overall Study|Physician Decision|1|||
30697235|NCT00669110|58711479|FG000|Overall Study|Lost to Follow-up|1|||
30697236|NCT00669110|58711480|FG001|Overall Study|Lost to Follow-up|0|||
30697237|NCT00669110|58711479|FG000|Overall Study|Protocol Violation|0|||
30697238|NCT00669110|58711480|FG001|Overall Study|Protocol Violation|5|||
30697239|NCT00669110|58711479|FG000|Overall Study|Withdrawal by Subject|0|||
30697240|NCT00669110|58711480|FG001|Overall Study|Withdrawal by Subject|2|||
30697241|NCT00654732|58711488|FG000|Overall Study|Adverse Event|4|||
30697242|NCT00654732|58711489|FG001|Overall Study|Adverse Event|6|||
30697243|NCT00649428|58711497|FG000|Overall Study|Adverse Event|2|||
30697244|NCT00649428|58711498|FG001|Overall Study|Adverse Event|2|||
30697245|NCT00649428|58711497|FG000|Overall Study|Withdrawal by Subject|6|||
30697246|NCT00649428|58711498|FG001|Overall Study|Withdrawal by Subject|6|||
30697247|NCT00649428|58711497|FG000|Overall Study|Lost to Follow-up|1|||
30697248|NCT00649428|58711498|FG001|Overall Study|Lost to Follow-up|3|||
30697249|NCT00649428|58711497|FG000|Overall Study|Insufficient manufacturing yield|5|||
30697250|NCT00649428|58711498|FG001|Overall Study|Insufficient manufacturing yield|1|||
30697251|NCT00649428|58711497|FG000|Overall Study|Protocol Violation|6|||
30697252|NCT00649428|58711498|FG001|Overall Study|Protocol Violation|2|||
30697253|NCT00649428|58711497|FG000|Overall Study|Physician Decision|0|||
30697254|NCT00649428|58711498|FG001|Overall Study|Physician Decision|1|||
30697255|NCT00669032|58711507|FG000|Overall Study|Lost to Follow-up|6|||
30697256|NCT00669032|58711508|FG001|Overall Study|Lost to Follow-up|5|||
30697257|NCT00669032|58711507|FG000|Overall Study|Lack of Efficacy|8|||
30697258|NCT00669032|58711508|FG001|Overall Study|Lack of Efficacy|19|||
30697259|NCT00669032|58711507|FG000|Overall Study|Withdrawal by Subject|12|||
30697260|NCT00669032|58711508|FG001|Overall Study|Withdrawal by Subject|13|||
30697261|NCT00669032|58711507|FG000|Overall Study|Adverse Event|12|||
30697262|NCT00669032|58711508|FG001|Overall Study|Adverse Event|16|||
30697263|NCT00669032|58711507|FG000|Overall Study|Physician Decision|1|||
30697264|NCT00669032|58711508|FG001|Overall Study|Physician Decision|1|||
30697265|NCT00669032|58711507|FG000|Overall Study|No fulfilment of the selection criteria|5|||
30697266|NCT00669032|58711508|FG001|Overall Study|No fulfilment of the selection criteria|5|||
30697267|NCT00654498|58711516|FG000|Overall Study|Not Treated|1|||
30697268|NCT00654498|58711517|FG001|Overall Study|Not Treated|0|||
30697269|NCT00654498|58711516|FG000|Overall Study|Adverse Event|6|||
30697270|NCT00654498|58711517|FG001|Overall Study|Adverse Event|1|||
30697271|NCT00654498|58711516|FG000|Overall Study|Protocol Violation|1|||
30697272|NCT00654498|58711517|FG001|Overall Study|Protocol Violation|1|||
30697273|NCT00654498|58711516|FG000|Overall Study|Lost to Follow-up|1|||
30697274|NCT00654498|58711517|FG001|Overall Study|Lost to Follow-up|5|||
30697275|NCT00654498|58711516|FG000|Overall Study|Withdrawal by Subject|1|||
30697276|NCT00654498|58711517|FG001|Overall Study|Withdrawal by Subject|0|||
30697277|NCT00654498|58711516|FG000|Overall Study|Other reason not defined above|4|||
30697278|NCT00654498|58711517|FG001|Overall Study|Other reason not defined above|5|||
30697279|NCT00670046|58711525|FG000|Overall Study|Lost to Follow-up|1|||
30697280|NCT00670046|58711526|FG001|Overall Study|Lost to Follow-up|1|||
30697281|NCT00670046|58711525|FG000|Overall Study|Withdrawal by Subject|0|||
30697282|NCT00670046|58711526|FG001|Overall Study|Withdrawal by Subject|1|||
30697283|NCT00560391|58711537|FG000|Overall Study|Still on treatment|0|||
30697284|NCT00560391|58711538|FG001|Overall Study|Still on treatment|0|||
30697285|NCT00560391|58711539|FG002|Overall Study|Still on treatment|0|||
30697286|NCT00560391|58711540|FG003|Overall Study|Still on treatment|1|||
30697287|NCT00560391|58711541|FG004|Overall Study|Still on treatment|2|||
30697288|NCT00537238|58711556|FG000|Overall Study|Death|1|||
30697289|NCT00537238|58711557|FG001|Overall Study|Death|2|||
30697290|NCT00537238|58711556|FG000|Overall Study|Adverse Event|31|||
30697291|NCT00537238|58711557|FG001|Overall Study|Adverse Event|22|||
30697292|NCT00537238|58711556|FG000|Overall Study|Lack of Efficacy|20|||
30697293|NCT00537238|58711557|FG001|Overall Study|Lack of Efficacy|21|||
30697294|NCT00537238|58711556|FG000|Overall Study|Lost to Follow-up|12|||
30697295|NCT00537238|58711557|FG001|Overall Study|Lost to Follow-up|8|||
30697296|NCT00537238|58711556|FG000|Overall Study|Withdrawal by Subject|51|||
30697297|NCT00537238|58711557|FG001|Overall Study|Withdrawal by Subject|47|||
30697298|NCT00537238|58711556|FG000|Overall Study|Protocol Violation|15|||
30697299|NCT00537238|58711557|FG001|Overall Study|Protocol Violation|19|||
30697300|NCT00537238|58711556|FG000|Overall Study|Does not meet entrance criteria|0|||
30697301|NCT00537238|58711557|FG001|Overall Study|Does not meet entrance criteria|2|||
30697302|NCT00537238|58711556|FG000|Overall Study|Other|44|||
30697303|NCT00537238|58711557|FG001|Overall Study|Other|52|||
30697304|NCT03966885|58711565|FG000|Overall Study|Death|1|||
30697305|NCT03966885|58711566|FG001|Overall Study|Death|0|||
30697306|NCT03966885|58711565|FG000|Overall Study|Lost to Follow-up|1|||
30697307|NCT03966885|58711566|FG001|Overall Study|Lost to Follow-up|2|||
30697308|NCT03966885|58711565|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
30697309|NCT03966885|58711566|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
30697310|NCT03966885|58711565|FG000|Overall Study|Moved from study area.|0|||
30697311|NCT03966885|58711566|FG001|Overall Study|Moved from study area.|2|||
30697312|NCT03965403|58711573|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
30697313|NCT00552669|58711579|FG000|Overall Study|Death|3|||
30697314|NCT00552669|58711580|FG001|Overall Study|Death|7|||
30697315|NCT00552513|58711588|FG000|Overall Study|Lost to Follow-up|5|||
30697316|NCT00552513|58711589|FG001|Overall Study|Lost to Follow-up|1|||
30697317|NCT00560313|58711597|FG000|Overall Study|Adverse Events or Death|2|||
30697318|NCT00560313|58711597|FG000|Overall Study|Withdrawal by Subject|2|||
30697319|NCT00560313|58711597|FG000|Overall Study|Lost to Follow-up|1|||
30697320|NCT00560313|58711597|FG000|Overall Study|Protocol Violation|1|||
30697321|NCT00667862|58711616|FG000|Overall Study|Adverse Event|9|||
30697322|NCT00667862|58711616|FG000|Overall Study|Death|1|||
30697323|NCT00667862|58711616|FG000|Overall Study|Disease Progression|22|||
30697324|NCT00667862|58711616|FG000|Overall Study|Withdrawal by Subject|3|||
30697325|NCT00535132|58711622|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
30697326|NCT00535132|58711623|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
30697327|NCT00535132|58711622|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
30697328|NCT00535132|58711623|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
30697329|NCT00570908|58711631|FG000|Overall Study|Adverse Event|5|||
30697330|NCT00570908|58711631|FG000|Overall Study|Withdrawal by Subject|2|||
30697331|NCT00321919|58711637|FG000|Overall Study|Adverse Event|17|||
30697332|NCT00321919|58711638|FG001|Overall Study|Adverse Event|10|||
30697333|NCT00321919|58711637|FG000|Overall Study|Death|21|||
30697334|NCT00321919|58711638|FG001|Overall Study|Death|17|||
30697335|NCT00321919|58711637|FG000|Overall Study|Insufficient Therapeutic Response|1|||
30697336|NCT00321919|58711638|FG001|Overall Study|Insufficient Therapeutic Response|0|||
30697337|NCT00321919|58711637|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
30697338|NCT00321919|58711638|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
30697339|NCT00321919|58711637|FG000|Overall Study|Refused Treatment|23|||
30697340|NCT00321919|58711638|FG001|Overall Study|Refused Treatment|14|||
30697341|NCT00321919|58711637|FG000|Overall Study|Other Protocol Violation|2|||
30697342|NCT00321919|58711638|FG001|Overall Study|Other Protocol Violation|3|||
30697343|NCT00321919|58711637|FG000|Overall Study|Failure to Return|3|||
30697344|NCT00321919|58711638|FG001|Overall Study|Failure to Return|1|||
30697345|NCT00321919|58711637|FG000|Overall Study|Other withdrawal reason|7|||
30697346|NCT00321919|58711638|FG001|Overall Study|Other withdrawal reason|6|||
30697347|NCT00781391|58711648|FG000|Overall Study|never received study drug|24|||
30697348|NCT00781391|58711649|FG001|Overall Study|never received study drug|23|||
30697349|NCT00781391|58711650|FG002|Overall Study|never received study drug|32|||
30697350|NCT00781391|58711648|FG000|Overall Study|Protocol Violation|19|||
30697351|NCT00781391|58711649|FG001|Overall Study|Protocol Violation|17|||
30697352|NCT00781391|58711650|FG002|Overall Study|Protocol Violation|20|||
30697353|NCT00781391|58711648|FG000|Overall Study|Death|789|||
30697354|NCT00781391|58711649|FG001|Overall Study|Death|730|||
30697355|NCT00781391|58711650|FG002|Overall Study|Death|706|||
30697356|NCT00781391|58711648|FG000|Overall Study|Withdrawal by Subject|47|||
30697357|NCT00781391|58711649|FG001|Overall Study|Withdrawal by Subject|37|||
30697358|NCT00781391|58711650|FG002|Overall Study|Withdrawal by Subject|25|||
30697359|NCT00781391|58711648|FG000|Overall Study|Lost to Follow-up|0|||
30697360|NCT00781391|58711649|FG001|Overall Study|Lost to Follow-up|0|||
30697361|NCT00781391|58711650|FG002|Overall Study|Lost to Follow-up|1|||
30697362|NCT00534976|58711660|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
30697363|NCT00534976|58711661|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
30697364|NCT00534976|58711660|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
30697365|NCT00534976|58711661|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
30697366|NCT00534976|58711660|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
30697367|NCT00534976|58711661|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
30697368|NCT00321763|58711671|FG000|Overall Study|Adverse Event|1|||
30697369|NCT00321763|58711672|FG001|Overall Study|Adverse Event|1|||
30697370|NCT00321763|58711673|FG002|Overall Study|Adverse Event|0|||
30697371|NCT00321763|58711674|FG003|Overall Study|Adverse Event|1|||
30697372|NCT00321763|58711671|FG000|Overall Study|Withdrawal by Subject|2|||
30697373|NCT00321763|58711672|FG001|Overall Study|Withdrawal by Subject|0|||
30697374|NCT00321763|58711673|FG002|Overall Study|Withdrawal by Subject|1|||
30697375|NCT00321763|58711674|FG003|Overall Study|Withdrawal by Subject|0|||
30697376|NCT00321763|58711671|FG000|Overall Study|Lost to Follow-up|3|||
30697377|NCT00321763|58711672|FG001|Overall Study|Lost to Follow-up|1|||
30697378|NCT00321763|58711673|FG002|Overall Study|Lost to Follow-up|5|||
30697379|NCT00321763|58711674|FG003|Overall Study|Lost to Follow-up|4|||
30697380|NCT00308113|58711690|FG000|Overall Study|Protocol closure|0|||
30697381|NCT00308113|58711691|FG001|Overall Study|Protocol closure|0|||
30697382|NCT00308113|58711692|FG002|Overall Study|Protocol closure|0|||
30697383|NCT00308113|58711693|FG003|Overall Study|Protocol closure|1|||
30697384|NCT00307801|58711709|FG000|Overall Study|Adverse Event|12|||
30697385|NCT00307801|58711710|FG001|Overall Study|Adverse Event|4|||
30697386|NCT00307801|58711709|FG000|Overall Study|Withdrawal by Subject|9|||
30697387|NCT00307801|58711710|FG001|Overall Study|Withdrawal by Subject|4|||
30697388|NCT00307801|58711709|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
30697389|NCT00307801|58711710|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
30697390|NCT00307801|58711709|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
30697391|NCT00307801|58711710|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
30697392|NCT00307801|58711709|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
30697393|NCT00307801|58711710|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
30697394|NCT00307801|58711709|FG000|Overall Study|Wrong Randomization|1|||
30697395|NCT00307801|58711710|FG001|Overall Study|Wrong Randomization|0|||
30697396|NCT00307801|58711709|FG000|Overall Study|Lack of Efficacy|0|||
30697397|NCT00307801|58711710|FG001|Overall Study|Lack of Efficacy|2|||
30697398|NCT00307801|58711709|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
30697399|NCT00307801|58711710|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
30697400|NCT00307801|58711709|FG000|Overall Study|Frustration with e-diary|1|||
30697401|NCT00307801|58711710|FG001|Overall Study|Frustration with e-diary|0|||
30697402|NCT00307801|58711709|FG000|Overall Study|Protocol Violation|3|||
30697403|NCT00307801|58711710|FG001|Overall Study|Protocol Violation|2|||
30697404|NCT00307801|58711709|FG000|Overall Study|No reason specified|2|||
30697405|NCT00307801|58711710|FG001|Overall Study|No reason specified|0|||
30697406|NCT00307801|58711709|FG000|Overall Study|Pregnancy|0|||
30697407|NCT00307801|58711710|FG001|Overall Study|Pregnancy|1|||
30697408|NCT00671060|58711719|FG000|Overall Study|Protocol Violation|1|||
30697409|NCT00671060|58711720|FG001|Overall Study|Protocol Violation|0|||
30697410|NCT00671060|58711719|FG000|Overall Study|Physician Decision|0|||
30697411|NCT00671060|58711720|FG001|Overall Study|Physician Decision|1|||
30697412|NCT00654420|58711730|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
30697413|NCT00654420|58711731|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
30697414|NCT00654420|58711732|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
30697415|NCT00654420|58711733|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
30697416|NCT00654420|58711730|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
30697417|NCT00654420|58711731|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
30697418|NCT00654420|58711732|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
30697419|NCT00654420|58711733|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
30697420|NCT00654420|58711730|FG000|Phase II|Adverse Event|0|||
30697421|NCT00654420|58711731|FG001|Phase II|Adverse Event|0|||
30697422|NCT00654420|58711732|FG002|Phase II|Adverse Event|3|||
30697423|NCT00654420|58711733|FG003|Phase II|Adverse Event|3|||
30697424|NCT00654420|58711730|FG000|Phase II|Lost to Follow-up|0|||
30697425|NCT00654420|58711731|FG001|Phase II|Lost to Follow-up|0|||
30697426|NCT00654420|58711732|FG002|Phase II|Lost to Follow-up|0|||
30697427|NCT00654420|58711733|FG003|Phase II|Lost to Follow-up|1|||
30697428|NCT00654420|58711730|FG000|Phase II|Physician Decision|0|||
30697429|NCT00654420|58711731|FG001|Phase II|Physician Decision|0|||
30697430|NCT00654420|58711732|FG002|Phase II|Physician Decision|0|||
30697431|NCT00654420|58711733|FG003|Phase II|Physician Decision|4|||
30697432|NCT00654420|58711730|FG000|Phase II|Progressive Disease|0|||
30697433|NCT00654420|58711731|FG001|Phase II|Progressive Disease|0|||
30697434|NCT00654420|58711732|FG002|Phase II|Progressive Disease|29|||
30697435|NCT00654420|58711733|FG003|Phase II|Progressive Disease|29|||
30697436|NCT00654420|58711730|FG000|Phase II|Withdrawal by Subject|0|||
30697437|NCT00654420|58711731|FG001|Phase II|Withdrawal by Subject|0|||
30697438|NCT00654420|58711732|FG002|Phase II|Withdrawal by Subject|4|||
30697439|NCT00654420|58711733|FG003|Phase II|Withdrawal by Subject|1|||
30697440|NCT00654420|58711730|FG000|Phase II|Missing Disposition Record|0|||
30697441|NCT00654420|58711731|FG001|Phase II|Missing Disposition Record|0|||
30697442|NCT00654420|58711732|FG002|Phase II|Missing Disposition Record|1|||
30697443|NCT00654420|58711733|FG003|Phase II|Missing Disposition Record|0|||
30697444|NCT00307489|58711745|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
30697445|NCT00307489|58711746|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
30697446|NCT00307489|58711745|FG000|Baseline Through Week 48|Physician Decision|1|||
30697447|NCT00307489|58711746|FG001|Baseline Through Week 48|Physician Decision|0|||
30697448|NCT00307489|58711745|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
30697449|NCT00307489|58711746|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
30697450|NCT00307489|58711745|FG000|Week 48 Through Week 168|Adverse Event|1|||
30697451|NCT00307489|58711746|FG001|Week 48 Through Week 168|Adverse Event|0|||
30697452|NCT00307489|58711745|FG000|Week 48 Through Week 168|Physician Decision|1|||
30697453|NCT00307489|58711746|FG001|Week 48 Through Week 168|Physician Decision|0|||
30697454|NCT00307489|58711745|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
30697455|NCT00307489|58711746|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
30697456|NCT00307489|58711745|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
30697457|NCT00307489|58711746|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
30697458|NCT00307489|58711745|FG000|Week 48 Through Week 168|Death|0|||
30965778|NCT01554176|59034188|FG002|Treatment Phase|Physician Decision|0|||
30697459|NCT00307489|58711746|FG001|Week 48 Through Week 168|Death|1|||
30697460|NCT00307489|58711745|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
30697461|NCT00307489|58711746|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
30697462|NCT00307489|58711745|FG000|Week 48 Through Week 168|Seroconversion|1|||
30697463|NCT00307489|58711746|FG001|Week 48 Through Week 168|Seroconversion|0|||
30697464|NCT00645840|58711752|FG000|Overall Study|Protocol Violation|3|||
30697465|NCT00307333|58711758|FG000|Overall Study|Lost to Follow-up|11|||
30697466|NCT00307333|58711759|FG001|Overall Study|Lost to Follow-up|3|||
30697467|NCT00762359|58711767|FG000|Overall Study|Adverse Event|20|||
30697468|NCT00762359|58711768|FG001|Overall Study|Adverse Event|23|||
30697469|NCT00762359|58711767|FG000|Overall Study|Protocol Violation|21|||
30697470|NCT00762359|58711768|FG001|Overall Study|Protocol Violation|13|||
30697471|NCT00762359|58711767|FG000|Overall Study|Withdrawal by Subject|13|||
30697472|NCT00762359|58711768|FG001|Overall Study|Withdrawal by Subject|10|||
30697473|NCT00762359|58711767|FG000|Overall Study|Lack of Efficacy|0|||
30697474|NCT00762359|58711768|FG001|Overall Study|Lack of Efficacy|4|||
30697475|NCT00762359|58711767|FG000|Overall Study|Institution closed|2|||
30697476|NCT00762359|58711768|FG001|Overall Study|Institution closed|3|||
30697477|NCT00762359|58711767|FG000|Overall Study|Physician Decision|2|||
30697478|NCT00762359|58711768|FG001|Overall Study|Physician Decision|3|||
30697479|NCT00762359|58711767|FG000|Overall Study|Removal|0|||
30697480|NCT00762359|58711768|FG001|Overall Study|Removal|1|||
30697481|NCT00762359|58711767|FG000|Overall Study|Withdrew consent|1|||
30697482|NCT00762359|58711768|FG001|Overall Study|Withdrew consent|0|||
30697483|NCT00654186|58711774|FG000|Overall Study|Withdrawal by Subject|5|||
30697484|NCT00761969|58711780|FG000|Overall Study|Death|112|||
30697485|NCT00761969|58711781|FG001|Overall Study|Death|47|||
30697486|NCT00761969|58711780|FG000|Overall Study|Lost to Follow-up|88|||
30697487|NCT00761969|58711781|FG001|Overall Study|Lost to Follow-up|93|||
30697488|NCT00761891|58711792|FG000|Overall Study|Withdrawal by Subject|10|||
30697489|NCT00321685|58711797|FG000|Overall Study|Adverse Event|18|||
30697490|NCT00321685|58711797|FG000|Overall Study|Death|2|||
30697491|NCT00321685|58711797|FG000|Overall Study|Withdrawal by Subject|8|||
30697492|NCT00321685|58711797|FG000|Overall Study|Alternative therapy|1|||
30697493|NCT00321685|58711797|FG000|Overall Study|Complicating disese|1|||
30697494|NCT00321685|58711797|FG000|Overall Study|Other|5|||
30697495|NCT00321685|58711797|FG000|Overall Study|Not start protocol therapy|2|||
30697496|NCT00321685|58711797|FG000|Overall Study|Ineligible|2|||
30697497|NCT03902392|58711803|FG000|Overall Study|Lost to Follow-up|7|||
30697498|NCT03902392|58711804|FG001|Overall Study|Lost to Follow-up|7|||
30697499|NCT00306787|58711812|FG000|Overall Study|Discontinued without taking study drug|208|||
30697500|NCT00306787|58711813|FG001|Overall Study|Discontinued without taking study drug|215|||
30697501|NCT00306787|58711812|FG000|Overall Study|Adverse Event|1|||
30697502|NCT00306787|58711813|FG001|Overall Study|Adverse Event|1|||
30965779|NCT01554176|59034189|FG003|Treatment Phase|Physician Decision|0|||
30965780|NCT01554176|59034190|FG004|Treatment Phase|Physician Decision|0|||
30965781|NCT01554176|59034186|FG000|Treatment Phase|Lack of Efficacy|0|||
30965782|NCT01554176|59034187|FG001|Treatment Phase|Lack of Efficacy|1|||
30965783|NCT01554176|59034188|FG002|Treatment Phase|Lack of Efficacy|0|||
30965784|NCT01554176|59034189|FG003|Treatment Phase|Lack of Efficacy|0|||
30965785|NCT01554176|59034190|FG004|Treatment Phase|Lack of Efficacy|0|||
30965786|NCT01554176|59034186|FG000|Treatment Phase|Adverse event, non-fatal|1|||
30965787|NCT01554176|59034187|FG001|Treatment Phase|Adverse event, non-fatal|1|||
30965788|NCT01554176|59034188|FG002|Treatment Phase|Adverse event, non-fatal|0|||
30965789|NCT01554176|59034189|FG003|Treatment Phase|Adverse event, non-fatal|0|||
30965790|NCT01554176|59034190|FG004|Treatment Phase|Adverse event, non-fatal|0|||
30965791|NCT01554176|59034186|FG000|Treatment Phase|Non-compliance with study drug|1|||
30965792|NCT01554176|59034187|FG001|Treatment Phase|Non-compliance with study drug|0|||
30965793|NCT01554176|59034188|FG002|Treatment Phase|Non-compliance with study drug|0|||
30965794|NCT01554176|59034189|FG003|Treatment Phase|Non-compliance with study drug|0|||
30965795|NCT01554176|59034190|FG004|Treatment Phase|Non-compliance with study drug|0|||
30965796|NCT01554176|59034186|FG000|Treatment Phase|Withdrawal by Subject|1|||
30965797|NCT01554176|59034187|FG001|Treatment Phase|Withdrawal by Subject|0|||
30965798|NCT01554176|59034188|FG002|Treatment Phase|Withdrawal by Subject|0|||
30965799|NCT01554176|59034189|FG003|Treatment Phase|Withdrawal by Subject|0|||
30965800|NCT01554176|59034190|FG004|Treatment Phase|Withdrawal by Subject|0|||
30965801|NCT01554176|59034186|FG000|Treatment Phase|Lost to Follow-up|3|||
30965802|NCT01554176|59034187|FG001|Treatment Phase|Lost to Follow-up|0|||
30965803|NCT01554176|59034188|FG002|Treatment Phase|Lost to Follow-up|0|||
30965804|NCT01554176|59034189|FG003|Treatment Phase|Lost to Follow-up|0|||
30697503|NCT00306787|58711812|FG000|Overall Study|Lack of Efficacy|1|||
30965805|NCT01554176|59034190|FG004|Treatment Phase|Lost to Follow-up|0|||
30965806|NCT01554176|59034186|FG000|Run-out Phase|Protocol Violation|0|||
30965807|NCT01554176|59034187|FG001|Run-out Phase|Protocol Violation|0|||
30965808|NCT01554176|59034188|FG002|Run-out Phase|Protocol Violation|0|||
30965809|NCT01554176|59034189|FG003|Run-out Phase|Protocol Violation|1|||
30697504|NCT00306787|58711813|FG001|Overall Study|Lack of Efficacy|0|||
30697505|NCT00306787|58711812|FG000|Overall Study|Protocol Violation|8|||
30697506|NCT00306787|58711813|FG001|Overall Study|Protocol Violation|10|||
30697507|NCT00306787|58711812|FG000|Overall Study|Withdrawal by Subject|2|||
30697508|NCT00306787|58711813|FG001|Overall Study|Withdrawal by Subject|9|||
30697509|NCT00306787|58711812|FG000|Overall Study|Lost to Follow-up|9|||
30697510|NCT00306787|58711813|FG001|Overall Study|Lost to Follow-up|6|||
30697511|NCT00306787|58711812|FG000|Overall Study|Administrative problems|4|||
30697512|NCT00306787|58711813|FG001|Overall Study|Administrative problems|0|||
30965810|NCT01554176|59034190|FG004|Run-out Phase|Protocol Violation|0|||
30965811|NCT01466491|59034206|FG000|Overall Study|Protocol Violation|0|||
30965812|NCT01466491|59034207|FG001|Overall Study|Protocol Violation|3|||
30965813|NCT01466491|59034208|FG002|Overall Study|Protocol Violation|2|||
30965814|NCT01466491|59034209|FG003|Overall Study|Protocol Violation|0|||
30965815|NCT01466491|59034206|FG000|Overall Study|Missing Data|0|||
30965816|NCT01466491|59034207|FG001|Overall Study|Missing Data|0|||
30965817|NCT01466491|59034208|FG002|Overall Study|Missing Data|1|||
30965818|NCT01466491|59034209|FG003|Overall Study|Missing Data|0|||
30965819|NCT01466179|59034219|FG000|Overall Study|Ongoing in core study|2|||
30965820|NCT01466179|59034219|FG000|Overall Study|Physician Decision|46|||
30965821|NCT01466179|59034219|FG000|Overall Study|Progressive disease|43|||
30965822|NCT01466179|59034219|FG000|Overall Study|Adverse Event|32|||
30965823|NCT01466179|59034219|FG000|Overall Study|Disease relapse|23|||
30965824|NCT01466179|59034219|FG000|Overall Study|Lack of Efficacy|14|||
30965825|NCT01466179|59034219|FG000|Overall Study|Death|7|||
30965826|NCT01466179|59034219|FG000|Overall Study|Withdrawal by Subject|7|||
30965827|NCT01466179|59034219|FG000|Overall Study|Protocol Violation|2|||
30965828|NCT01466179|59034219|FG000|Overall Study|Other|3|||
30965829|NCT01493089|59034228|FG000|Overall Study|Protocol Violation|2|||
30965830|NCT01493089|59034229|FG001|Overall Study|Protocol Violation|2|||
30965831|NCT01493089|59034228|FG000|Overall Study|Withdrawal by Subject|1|||
30965832|NCT01493089|59034229|FG001|Overall Study|Withdrawal by Subject|0|||
30965833|NCT01493089|59034228|FG000|Overall Study|Physician Decision|0|||
30965834|NCT01493089|59034229|FG001|Overall Study|Physician Decision|1|||
30965835|NCT01450813|59034241|FG000|Overall Study|Physician Decision|1|||
30965836|NCT01450813|59034242|FG001|Overall Study|Physician Decision|1|||
30965837|NCT01450813|59034243|FG002|Overall Study|Physician Decision|0|||
30965838|NCT01450813|59034244|FG003|Overall Study|Physician Decision|3|||
30965839|NCT01539512|59034258|FG000|Overall Study|Adverse Event|9|||
30965840|NCT01539512|59034259|FG001|Overall Study|Adverse Event|7|||
30965841|NCT01539512|59034258|FG000|Overall Study|Physician Decision|1|||
30965842|NCT01539512|59034259|FG001|Overall Study|Physician Decision|1|||
30965843|NCT01539512|59034258|FG000|Overall Study|Withdrawal by Subject|12|||
30965844|NCT01539512|59034259|FG001|Overall Study|Withdrawal by Subject|5|||
30965845|NCT01539512|59034258|FG000|Overall Study|Richter's Transformation|1|||
30965846|NCT01539512|59034259|FG001|Overall Study|Richter's Transformation|0|||
30965847|NCT01449955|59034267|FG000|Overall Study|Withdrawal by Subject|1|||
30965848|NCT01449955|59034268|FG001|Overall Study|Withdrawal by Subject|2|||
30965849|NCT01574612|59034281|FG000|Overall Study|Adverse Event|3|||
30965850|NCT01574612|59034281|FG000|Overall Study|non compliant with drug|2|||
30965851|NCT01574612|59034281|FG000|Overall Study|Withdrawal by Subject|1|||
30965852|NCT01574612|59034281|FG000|Overall Study|Lost to Follow-up|2|||
30965853|NCT01573910|59034287|FG000|Overall Study|Adverse Event|4|||
30965854|NCT01573910|59034288|FG001|Overall Study|Adverse Event|4|||
30965855|NCT01573910|59034287|FG000|Overall Study|Lost to Follow-up|2|||
30965856|NCT01573910|59034288|FG001|Overall Study|Lost to Follow-up|1|||
30965857|NCT01573910|59034287|FG000|Overall Study|Withdrawal by Subject|0|||
30965858|NCT01573910|59034288|FG001|Overall Study|Withdrawal by Subject|1|||
30965859|NCT01573910|59034287|FG000|Overall Study|Protocol Violation|3|||
30965860|NCT01573910|59034288|FG001|Overall Study|Protocol Violation|0|||
30965861|NCT01573910|59034287|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
30965862|NCT01573910|59034288|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
30965863|NCT01491919|59034297|FG000|Overall Study|Insufficient PK sampling|1|||
30965864|NCT01491919|59034298|FG001|Overall Study|Insufficient PK sampling|2|||
30965865|NCT01491919|59034299|FG002|Overall Study|Insufficient PK sampling|1|||
30965866|NCT01573442|59034311|FG000|Overall Study|Cancels|9|||
30965867|NCT01573442|59034312|FG001|Overall Study|Cancels|10|||
30965868|NCT01491841|59034381|FG000|Overall Study|Screen Failure|10|||
30965869|NCT01491841|59034381|FG000|Overall Study|Withdrawal by Subject|1|||
30965870|NCT01553318|59034400|FG000|Overall Study|Protocol Violation|3|||
30965871|NCT01553318|59034401|FG001|Overall Study|Protocol Violation|2|||
30965872|NCT01572740|59034420|FG000|Overall Study|Adverse Event|1|||
30965873|NCT01572740|59034421|FG001|Overall Study|Adverse Event|1|||
30965874|NCT01572740|59034420|FG000|Overall Study|Withdrawal by Subject|1|||
30965875|NCT01572740|59034421|FG001|Overall Study|Withdrawal by Subject|1|||
30965876|NCT01572740|59034420|FG000|Overall Study|unclassified|4|||
30965877|NCT01572740|59034421|FG001|Overall Study|unclassified|3|||
30965878|NCT01491607|59034431|FG000|Overall Study|Lost to Follow-up|7|||
30965879|NCT01491607|59034431|FG000|Overall Study|Withdrawal by Subject|3|||
30965880|NCT01449721|59034514|FG000|Overall Study|Physician Decision|0|||
30965881|NCT01449721|59034515|FG001|Overall Study|Physician Decision|1|||
30965882|NCT01449721|59034514|FG000|Overall Study|Physician Decision|0|||
30965883|NCT01449721|59034515|FG001|Overall Study|Physician Decision|1|||
30965884|NCT01553084|59034524|FG000|Overall Study|Withdrawal by Subject|15|||
30965885|NCT01553084|59034525|FG001|Overall Study|Withdrawal by Subject|13|||
30965886|NCT01553084|59034526|FG002|Overall Study|Withdrawal by Subject|35|||
30965887|NCT01536860|59034536|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
30965888|NCT01536860|59034537|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
30965889|NCT01536860|59034538|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
30965890|NCT01552928|59034550|FG000|Period 3|Adverse Event|0|||
30965891|NCT01552928|59034551|FG001|Period 3|Adverse Event|0|||
30965892|NCT01552928|59034552|FG002|Period 3|Adverse Event|1|||
30965893|NCT01552928|59034553|FG003|Period 3|Adverse Event|0|||
30965894|NCT01448707|59034572|FG000|Overall Study|Adverse Event|3|||
30965895|NCT01448707|59034573|FG001|Overall Study|Adverse Event|1|||
30965896|NCT01448707|59034572|FG000|Overall Study|Lost to Follow-up|2|||
30965897|NCT01448707|59034573|FG001|Overall Study|Lost to Follow-up|6|||
30965898|NCT01448707|59034572|FG000|Overall Study|Withdrawal by Subject|6|||
30965899|NCT01448707|59034573|FG001|Overall Study|Withdrawal by Subject|7|||
30965900|NCT01448707|59034572|FG000|Overall Study|Other|7|||
30965901|NCT01448707|59034573|FG001|Overall Study|Other|4|||
30965902|NCT01536704|59034579|FG000|Washout Period 1|Withdrawal by Subject|1|||
30965903|NCT01536704|59034580|FG001|Washout Period 1|Withdrawal by Subject|2|||
30965904|NCT01536704|59034581|FG002|Washout Period 1|Withdrawal by Subject|0|||
30965905|NCT01536704|59034582|FG003|Washout Period 1|Withdrawal by Subject|0|||
30965906|NCT01536704|59034579|FG000|Washout Period 2|Adverse Event|1|||
30965907|NCT01536704|59034580|FG001|Washout Period 2|Adverse Event|0|||
30965908|NCT01536704|59034581|FG002|Washout Period 2|Adverse Event|0|||
30965909|NCT01536704|59034582|FG003|Washout Period 2|Adverse Event|0|||
30965910|NCT01536704|59034579|FG000|Washout Period 2|Withdrawal by Subject|0|||
30965911|NCT01536704|59034580|FG001|Washout Period 2|Withdrawal by Subject|0|||
30965912|NCT01536704|59034581|FG002|Washout Period 2|Withdrawal by Subject|0|||
30965913|NCT01536704|59034582|FG003|Washout Period 2|Withdrawal by Subject|1|||
30965914|NCT01536704|59034579|FG000|Period 3|Adverse Event|0|||
30965915|NCT01536704|59034580|FG001|Period 3|Adverse Event|0|||
30965916|NCT01536704|59034581|FG002|Period 3|Adverse Event|0|||
30965917|NCT01536704|59034582|FG003|Period 3|Adverse Event|1|||
30965918|NCT01536704|59034579|FG000|Washout Period 3|Adverse Event|0|||
30965919|NCT01536704|59034580|FG001|Washout Period 3|Adverse Event|0|||
30965920|NCT01536704|59034581|FG002|Washout Period 3|Adverse Event|1|||
30965921|NCT01536704|59034582|FG003|Washout Period 3|Adverse Event|0|||
30965922|NCT01552772|59034596|FG000|Overall Study|Lost to Follow-up|2|||
30965923|NCT01552772|59034596|FG000|Overall Study|Adverse Event|1|||
30965924|NCT01552772|59034596|FG000|Overall Study|Protocol Deviation|1|||
30965925|NCT01552694|59034603|FG000|Overall Study|Lost to Follow-up|0|||
30965926|NCT01552694|59034604|FG001|Overall Study|Lost to Follow-up|1|||
30965927|NCT01552694|59034603|FG000|Overall Study|Protocol Violation|0|||
30965928|NCT01552694|59034604|FG001|Overall Study|Protocol Violation|1|||
30965929|NCT01464931|59034612|FG000|Overall Study|Withdrawal by Subject|1|||
30965930|NCT01464931|59034613|FG001|Overall Study|Withdrawal by Subject|0|||
30965931|NCT01536392|59034638|FG000|Overall Study|Adverse Event|2|||
30965932|NCT01536392|59034639|FG001|Overall Study|Adverse Event|2|||
30965933|NCT01536392|59034638|FG000|Overall Study|Physician Decision|2|||
30965934|NCT01536392|59034639|FG001|Overall Study|Physician Decision|3|||
30607471|NCT01194219|58618056|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
30607472|NCT01304693|58618084|FG000|Overall Study|Adverse Event|0|||
30607473|NCT01304693|58618085|FG001|Overall Study|Adverse Event|0|||
30607474|NCT01304693|58618086|FG002|Overall Study|Adverse Event|0|||
30607475|NCT01304693|58618087|FG003|Overall Study|Adverse Event|0|||
30607476|NCT01304693|58618088|FG004|Overall Study|Adverse Event|1|||
30607477|NCT01304693|58618084|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
30607478|NCT01304693|58618085|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
30607479|NCT01304693|58618086|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
30607480|NCT01304693|58618087|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
30607481|NCT01304693|58618088|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
30607482|NCT01304147|58618100|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
30607483|NCT01304147|58618101|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
30607484|NCT01303445|58618107|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
30607485|NCT01303445|58618108|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
30607486|NCT01303445|58618107|FG000|Second Intervention (7 Days)|Adverse Event|0|||
30607487|NCT01303445|58618108|FG001|Second Intervention (7 Days)|Adverse Event|2|||
30607488|NCT01303445|58618107|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
30607489|NCT01303445|58618108|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
30607490|NCT01303445|58618107|FG000|Washout (14 Days)|Protocol Violation|1|||
30607491|NCT01303445|58618108|FG001|Washout (14 Days)|Protocol Violation|0|||
30607492|NCT01303445|58618107|FG000|Washout (14 Days)|Lost to Follow-up|0|||
30965935|NCT01536392|59034638|FG000|Overall Study|Withdrawal by Subject|3|||
30965936|NCT01536392|59034639|FG001|Overall Study|Withdrawal by Subject|6|||
30965937|NCT01536392|59034638|FG000|Overall Study|Non Compliance|3|||
30965938|NCT01536392|59034639|FG001|Overall Study|Non Compliance|4|||
30965939|NCT01536392|59034638|FG000|Overall Study|Completed therapy early|3|||
30965940|NCT01536392|59034639|FG001|Overall Study|Completed therapy early|0|||
30965941|NCT01464619|59034647|FG000|Overall Study|Lost to Follow-up|3|||
30965942|NCT01464619|59034648|FG001|Overall Study|Lost to Follow-up|4|||
30965943|NCT01490125|59034714|FG000|Period I|Adverse Event|4|||
30965944|NCT01490125|59034715|FG001|Period I|Adverse Event|1|||
30965945|NCT01490125|59034716|FG002|Period I|Adverse Event|1|||
30965946|NCT01490125|59034717|FG003|Period I|Adverse Event|3|||
30965947|NCT01490125|59034718|FG004|Period I|Adverse Event|2|||
30965948|NCT01490125|59034719|FG005|Period I|Adverse Event|4|||
30965949|NCT01490125|59034714|FG000|Period I|Protocol Violation|1|||
30965950|NCT01490125|59034715|FG001|Period I|Protocol Violation|1|||
30965951|NCT01490125|59034716|FG002|Period I|Protocol Violation|1|||
30965952|NCT01490125|59034717|FG003|Period I|Protocol Violation|1|||
30965953|NCT01490125|59034718|FG004|Period I|Protocol Violation|0|||
30965954|NCT01490125|59034719|FG005|Period I|Protocol Violation|0|||
30965955|NCT01490125|59034714|FG000|Period I|Withdrawal by Subject|1|||
30965956|NCT01490125|59034715|FG001|Period I|Withdrawal by Subject|3|||
30965957|NCT01490125|59034716|FG002|Period I|Withdrawal by Subject|2|||
30965958|NCT01490125|59034717|FG003|Period I|Withdrawal by Subject|1|||
30965959|NCT01490125|59034718|FG004|Period I|Withdrawal by Subject|2|||
30965960|NCT01490125|59034719|FG005|Period I|Withdrawal by Subject|1|||
30965961|NCT01490125|59034714|FG000|Period II|Adverse Event|2|||
30965962|NCT01490125|59034715|FG001|Period II|Adverse Event|3|||
30965963|NCT01490125|59034716|FG002|Period II|Adverse Event|2|||
30965964|NCT01490125|59034717|FG003|Period II|Adverse Event|2|||
30965965|NCT01490125|59034718|FG004|Period II|Adverse Event|4|||
30965966|NCT01490125|59034719|FG005|Period II|Adverse Event|2|||
30965967|NCT01490125|59034714|FG000|Period II|Protocol Violation|0|||
30965968|NCT01490125|59034715|FG001|Period II|Protocol Violation|0|||
30965969|NCT01490125|59034716|FG002|Period II|Protocol Violation|1|||
30965970|NCT01490125|59034717|FG003|Period II|Protocol Violation|1|||
30965971|NCT01490125|59034718|FG004|Period II|Protocol Violation|0|||
30965972|NCT01490125|59034719|FG005|Period II|Protocol Violation|0|||
30965973|NCT01490125|59034714|FG000|Period II|Lost to Follow-up|0|||
30607493|NCT01303445|58618108|FG001|Washout (14 Days)|Lost to Follow-up|2|||
30607494|NCT01303445|58618107|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
30607495|NCT01303445|58618108|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
30607496|NCT01303445|58618107|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
30607497|NCT01303445|58618108|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
30607498|NCT01188681|58618122|FG000|Overall Study|bladder cancer|0|||
30607499|NCT01188681|58618123|FG001|Overall Study|bladder cancer|0|||
30607500|NCT01188681|58618124|FG002|Overall Study|bladder cancer|1|||
30607501|NCT01188681|58618125|FG003|Overall Study|bladder cancer|0|||
30607502|NCT01188681|58618122|FG000|Overall Study|Withdrawal by Subject|0|||
30607503|NCT01188681|58618123|FG001|Overall Study|Withdrawal by Subject|0|||
30607504|NCT01188681|58618124|FG002|Overall Study|Withdrawal by Subject|0|||
30607505|NCT01188681|58618125|FG003|Overall Study|Withdrawal by Subject|1|||
30607506|NCT01302899|58618141|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
30607507|NCT01302899|58618142|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
30607508|NCT01302899|58618141|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
30607509|NCT01302899|58618142|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
30607510|NCT01187901|58618154|FG000|Overall Study|Protocol Violation|1|||
30607511|NCT01187901|58618155|FG001|Overall Study|Protocol Violation|0|||
30607512|NCT01187901|58618154|FG000|Overall Study|Lost to Follow-up|1|||
30607513|NCT01187901|58618155|FG001|Overall Study|Lost to Follow-up|2|||
30607514|NCT01187901|58618154|FG000|Overall Study|Unrelated Health Reasons|1|||
30607515|NCT01187901|58618155|FG001|Overall Study|Unrelated Health Reasons|2|||
30607516|NCT01187901|58618154|FG000|Overall Study|Suspected Allergic Reaction|1|||
30607517|NCT01187901|58618155|FG001|Overall Study|Suspected Allergic Reaction|1|||
30607518|NCT01187901|58618154|FG000|Overall Study|Adverse Event|3|||
30607519|NCT01187901|58618155|FG001|Overall Study|Adverse Event|0|||
30607520|NCT01187901|58618154|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
30607521|NCT01187901|58618155|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
30607522|NCT01187901|58618154|FG000|Overall Study|Pregnancy|0|||
30607523|NCT01187901|58618155|FG001|Overall Study|Pregnancy|2|||
30607524|NCT01302119|58618163|FG000|Overall Study|Withdrawal by Subject|30|||
30607525|NCT01302119|58618164|FG001|Overall Study|Withdrawal by Subject|20|||
30607526|NCT01302119|58618163|FG000|Overall Study|Lost to Follow-up|10|||
30607527|NCT01302119|58618164|FG001|Overall Study|Lost to Follow-up|4|||
30607528|NCT01302119|58618163|FG000|Overall Study|Adverse Event|2|||
30607529|NCT01302119|58618164|FG001|Overall Study|Adverse Event|1|||
30607530|NCT01302119|58618163|FG000|Overall Study|Non-compliance|4|||
30607531|NCT01302119|58618164|FG001|Overall Study|Non-compliance|2|||
30607532|NCT01302119|58618163|FG000|Overall Study|Non-specific|4|||
30607533|NCT01302119|58618164|FG001|Overall Study|Non-specific|1|||
30607534|NCT05038982|58618172|FG000|Overall Study|Withdrawal by Subject|0|||
30607535|NCT05038982|58618173|FG001|Overall Study|Withdrawal by Subject|2|||
30607536|NCT04964128|58618184|FG000|Phase 1|Withdrawal by Subject|1|||
30607537|NCT04964128|58618184|FG000|Phase 2|Physician Decision|1|||
30607538|NCT04867785|58618200|FG000|Overall Study|Adverse Event|1|||
30607539|NCT04867785|58618201|FG001|Overall Study|Adverse Event|0|||
30607540|NCT04867785|58618202|FG002|Overall Study|Adverse Event|1|||
30607541|NCT04867785|58618203|FG003|Overall Study|Adverse Event|0|||
30607542|NCT04867785|58618204|FG004|Overall Study|Adverse Event|0|||
30607543|NCT04867785|58618205|FG005|Overall Study|Adverse Event|0|||
30607544|NCT04867785|58618206|FG006|Overall Study|Adverse Event|0|||
30607545|NCT04867785|58618207|FG007|Overall Study|Adverse Event|2|||
30607546|NCT04867785|58618200|FG000|Overall Study|Lost to Follow-up|4|||
30607547|NCT04867785|58618201|FG001|Overall Study|Lost to Follow-up|4|||
30607548|NCT04867785|58618202|FG002|Overall Study|Lost to Follow-up|3|||
30607549|NCT04867785|58618203|FG003|Overall Study|Lost to Follow-up|2|||
30607550|NCT04867785|58618204|FG004|Overall Study|Lost to Follow-up|0|||
30607551|NCT04867785|58618205|FG005|Overall Study|Lost to Follow-up|1|||
30607552|NCT04867785|58618206|FG006|Overall Study|Lost to Follow-up|0|||
30607553|NCT04867785|58618207|FG007|Overall Study|Lost to Follow-up|1|||
30607554|NCT04867785|58618200|FG000|Overall Study|Withdrawal by Subject|6|||
30607555|NCT04867785|58618201|FG001|Overall Study|Withdrawal by Subject|2|||
30607556|NCT04867785|58618202|FG002|Overall Study|Withdrawal by Subject|2|||
30607557|NCT04867785|58618203|FG003|Overall Study|Withdrawal by Subject|1|||
30607558|NCT04867785|58618204|FG004|Overall Study|Withdrawal by Subject|2|||
30607559|NCT04867785|58618205|FG005|Overall Study|Withdrawal by Subject|0|||
30607560|NCT04867785|58618206|FG006|Overall Study|Withdrawal by Subject|2|||
30607561|NCT04867785|58618207|FG007|Overall Study|Withdrawal by Subject|5|||
30607562|NCT04867785|58618200|FG000|Overall Study|Physician Decision|0|||
30607563|NCT04867785|58618201|FG001|Overall Study|Physician Decision|0|||
30607564|NCT04867785|58618202|FG002|Overall Study|Physician Decision|0|||
30607565|NCT04867785|58618203|FG003|Overall Study|Physician Decision|0|||
30607566|NCT04867785|58618204|FG004|Overall Study|Physician Decision|0|||
30607567|NCT04867785|58618205|FG005|Overall Study|Physician Decision|0|||
30607568|NCT04867785|58618206|FG006|Overall Study|Physician Decision|0|||
30607569|NCT04867785|58618207|FG007|Overall Study|Physician Decision|1|||
30607570|NCT04867785|58618200|FG000|Overall Study|Inadvertent Enrollment|0|||
30607571|NCT04867785|58618201|FG001|Overall Study|Inadvertent Enrollment|0|||
30607572|NCT04867785|58618202|FG002|Overall Study|Inadvertent Enrollment|0|||
30607573|NCT04867785|58618203|FG003|Overall Study|Inadvertent Enrollment|1|||
30607574|NCT04867785|58618204|FG004|Overall Study|Inadvertent Enrollment|1|||
30607575|NCT04867785|58618205|FG005|Overall Study|Inadvertent Enrollment|0|||
30607576|NCT04867785|58618206|FG006|Overall Study|Inadvertent Enrollment|0|||
30607577|NCT04867785|58618207|FG007|Overall Study|Inadvertent Enrollment|1|||
30607578|NCT04867785|58618200|FG000|Overall Study|Eligibility Criteria Not Met|0|||
30607579|NCT04867785|58618201|FG001|Overall Study|Eligibility Criteria Not Met|0|||
30607580|NCT04867785|58618202|FG002|Overall Study|Eligibility Criteria Not Met|0|||
30607581|NCT04867785|58618203|FG003|Overall Study|Eligibility Criteria Not Met|0|||
30607582|NCT04867785|58618204|FG004|Overall Study|Eligibility Criteria Not Met|0|||
30607583|NCT04867785|58618205|FG005|Overall Study|Eligibility Criteria Not Met|0|||
30607584|NCT04867785|58618206|FG006|Overall Study|Eligibility Criteria Not Met|0|||
30607585|NCT04867785|58618207|FG007|Overall Study|Eligibility Criteria Not Met|1|||
30607586|NCT04541004|58618244|FG000|Overall Study|Adverse Event|2|||
30607587|NCT04295499|58618251|FG000|Overall Study|moving out of state|1|||
30607588|NCT04295499|58618252|FG001|Overall Study|moving out of state|0|||
30607589|NCT04295499|58618251|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
30607590|NCT04295499|58618252|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
30607591|NCT04091646|58618260|FG000|Overall Study|Adverse Event|2|||
30607592|NCT04091646|58618261|FG001|Overall Study|Adverse Event|1|||
30607593|NCT04091646|58618260|FG000|Overall Study|Lost to Follow-up|6|||
30607594|NCT04091646|58618261|FG001|Overall Study|Lost to Follow-up|2|||
30607595|NCT04091646|58618260|FG000|Overall Study|Protocol Violation|0|||
30607596|NCT04091646|58618261|FG001|Overall Study|Protocol Violation|1|||
30607597|NCT04091646|58618260|FG000|Overall Study|Withdrawal by Subject|4|||
30607598|NCT04091646|58618261|FG001|Overall Study|Withdrawal by Subject|1|||
30607599|NCT04091646|58618260|FG000|Overall Study|Participant Incarcerated|1|||
30607600|NCT04091646|58618261|FG001|Overall Study|Participant Incarcerated|0|||
30607601|NCT04040933|58618273|FG000|Overall Study|Protocol Violation|1|||
30607602|NCT04040933|58618273|FG000|Overall Study|Withdrawal by Subject|2|||
30607603|NCT03995355|58618286|FG000|Overall Study|Adverse Event|1|||
30607604|NCT03995355|58618287|FG001|Overall Study|Adverse Event|0|||
30607605|NCT03995355|58618286|FG000|Overall Study|Withdrawal by Subject|1|||
30607606|NCT03995355|58618287|FG001|Overall Study|Withdrawal by Subject|0|||
30607607|NCT03995355|58618286|FG000|Overall Study|Scheduling Issues|0|||
30607608|NCT03995355|58618287|FG001|Overall Study|Scheduling Issues|1|||
30607609|NCT03933397|58618295|FG000|Overall Study|No emergency department visit|65|||
30607610|NCT03933397|58618296|FG001|Overall Study|No emergency department visit|71|||
30607611|NCT03933397|58618295|FG000|Overall Study|Missed emergency department visit|25|||
30607612|NCT03933397|58618296|FG001|Overall Study|Missed emergency department visit|30|||
30607613|NCT03933397|58618295|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
30697513|NCT00306787|58711812|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30697514|NCT00306787|58711813|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30697515|NCT00769067|58711821|FG000|Overall Study|Death|89|||
30697516|NCT00769067|58711822|FG001|Overall Study|Death|86|||
30697517|NCT00769067|58711821|FG000|Overall Study|Lost to Follow-up|3|||
30697518|NCT00769067|58711822|FG001|Overall Study|Lost to Follow-up|1|||
30697519|NCT00769067|58711821|FG000|Overall Study|Study terminated by sponsor|1|||
30697520|NCT00769067|58711822|FG001|Overall Study|Study terminated by sponsor|3|||
30697521|NCT00769067|58711821|FG000|Overall Study|Other|1|||
30697522|NCT00769067|58711822|FG001|Overall Study|Other|3|||
30697523|NCT00769067|58711821|FG000|Overall Study|Withdrawal by Subject|0|||
30697524|NCT00769067|58711822|FG001|Overall Study|Withdrawal by Subject|1|||
30697525|NCT00321373|58711832|FG000|Overall Study|Adverse Event|0|||
30697526|NCT00321373|58711833|FG001|Overall Study|Adverse Event|0|||
30697527|NCT00321373|58711834|FG002|Overall Study|Adverse Event|1|||
30697528|NCT00321373|58711832|FG000|Overall Study|Lost to Follow-up|1|||
30697529|NCT00321373|58711833|FG001|Overall Study|Lost to Follow-up|0|||
30697530|NCT00321373|58711834|FG002|Overall Study|Lost to Follow-up|1|||
30697531|NCT00321373|58711832|FG000|Overall Study|Withdrawal by Subject|1|||
30697532|NCT00321373|58711833|FG001|Overall Study|Withdrawal by Subject|0|||
30697533|NCT00321373|58711834|FG002|Overall Study|Withdrawal by Subject|0|||
30697534|NCT00321373|58711832|FG000|Overall Study|Other|0|||
30697535|NCT00321373|58711833|FG001|Overall Study|Other|0|||
30697536|NCT00321373|58711834|FG002|Overall Study|Other|1|||
30607614|NCT03933397|58618296|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
30607615|NCT03933397|58618295|FG000|Overall Study|Withdrawal by Subject|1|||
30697537|NCT00667394|58711844|FG000|Overall Study|Adverse Event|3|||
30697538|NCT00667394|58711845|FG001|Overall Study|Adverse Event|0|||
30697539|NCT00667394|58711844|FG000|Overall Study|Progressive disease|1|||
30697540|NCT00667394|58711845|FG001|Overall Study|Progressive disease|0|||
30697541|NCT00761735|58711851|FG000|Overall Study|Lost to Follow-up|6|||
30697542|NCT00761735|58711851|FG000|Overall Study|Withdrawal by Subject|6|||
30697543|NCT00761735|58711851|FG000|Overall Study|Non-compliance with protocol|1|||
30697544|NCT00761735|58711851|FG000|Overall Study|Administrative|1|||
30697545|NCT00569946|58711859|FG000|Overall Study|Adverse Event|16|||
30697546|NCT00569946|58711859|FG000|Overall Study|Objective Progression or Relapse|42|||
30697547|NCT00569946|58711859|FG000|Overall Study|Global Deterioration of Health Status|1|||
30697548|NCT00645528|58711863|FG000|Overall Study|Did not show up for Visit 2|7|||
30697549|NCT00295633|58711870|FG000|Overall Study|Lack of Efficacy|19|||
30697550|NCT00295633|58711871|FG001|Overall Study|Lack of Efficacy|7|||
30697551|NCT00295633|58711872|FG002|Overall Study|Lack of Efficacy|16|||
30697552|NCT00295633|58711870|FG000|Overall Study|Withdrawal of consent by subject|16|||
30697553|NCT00295633|58711871|FG001|Overall Study|Withdrawal of consent by subject|16|||
30697554|NCT00295633|58711872|FG002|Overall Study|Withdrawal of consent by subject|26|||
30697555|NCT00295633|58711870|FG000|Overall Study|Adverse Event|9|||
30697556|NCT00295633|58711871|FG001|Overall Study|Adverse Event|17|||
30697557|NCT00295633|58711872|FG002|Overall Study|Adverse Event|9|||
30697558|NCT00295633|58711870|FG000|Overall Study|Lost to Follow-up|6|||
30697559|NCT00295633|58711871|FG001|Overall Study|Lost to Follow-up|11|||
30697560|NCT00295633|58711872|FG002|Overall Study|Lost to Follow-up|7|||
30697561|NCT00295633|58711870|FG000|Overall Study|Physician Decision|9|||
30697562|NCT00295633|58711871|FG001|Overall Study|Physician Decision|10|||
30697563|NCT00295633|58711872|FG002|Overall Study|Physician Decision|8|||
30697564|NCT00295633|58711870|FG000|Overall Study|Poor/Noncompliance|2|||
30697565|NCT00295633|58711871|FG001|Overall Study|Poor/Noncompliance|2|||
30697566|NCT00295633|58711872|FG002|Overall Study|Poor/Noncompliance|6|||
30697567|NCT00295633|58711870|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
30697568|NCT00295633|58711871|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
30697569|NCT00295633|58711872|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
30697570|NCT00295633|58711870|FG000|Overall Study|Death|1|||
30697571|NCT00295633|58711871|FG001|Overall Study|Death|1|||
30697572|NCT00295633|58711872|FG002|Overall Study|Death|0|||
30697573|NCT00295633|58711870|FG000|Overall Study|Administrative reason by sponsor|0|||
30697574|NCT00295633|58711871|FG001|Overall Study|Administrative reason by sponsor|0|||
30697575|NCT00295633|58711872|FG002|Overall Study|Administrative reason by sponsor|1|||
30697576|NCT00570674|58711880|FG000|Overall Study|Withdrawal by Subject|0|||
30697577|NCT00570674|58711881|FG001|Overall Study|Withdrawal by Subject|0|||
30697578|NCT00570674|58711882|FG002|Overall Study|Withdrawal by Subject|1|||
30697579|NCT00570674|58711883|FG003|Overall Study|Withdrawal by Subject|0|||
30697580|NCT00570674|58711884|FG004|Overall Study|Withdrawal by Subject|0|||
30697581|NCT00570674|58711885|FG005|Overall Study|Withdrawal by Subject|0|||
30697582|NCT00570674|58711886|FG006|Overall Study|Withdrawal by Subject|0|||
30786584|NCT03679767|58799810|FG002|Overall Study|Withdrawal by Subject|0|||
30786585|NCT03679767|58799811|FG003|Overall Study|Withdrawal by Subject|1|||
30786586|NCT03679767|58799808|FG000|Overall Study|Follow-up Completed|18|||
30786587|NCT03679767|58799809|FG001|Overall Study|Follow-up Completed|11|||
30786588|NCT03679767|58799810|FG002|Overall Study|Follow-up Completed|11|||
30786589|NCT03679767|58799811|FG003|Overall Study|Follow-up Completed|20|||
30786590|NCT03679767|58799808|FG000|Overall Study|Entered Hospice Care|0|||
30786591|NCT03679767|58799809|FG001|Overall Study|Entered Hospice Care|0|||
30786592|NCT03679767|58799810|FG002|Overall Study|Entered Hospice Care|0|||
30786593|NCT03679767|58799811|FG003|Overall Study|Entered Hospice Care|1|||
30786594|NCT03679767|58799808|FG000|Overall Study|Progressive Disease|0|||
30786595|NCT03679767|58799809|FG001|Overall Study|Progressive Disease|0|||
30786596|NCT03679767|58799810|FG002|Overall Study|Progressive Disease|0|||
30786597|NCT03679767|58799811|FG003|Overall Study|Progressive Disease|1|||
30786598|NCT00130247|58799825|FG000|Overall Study|Pregnancy|1|||
30786599|NCT00130247|58799826|FG001|Overall Study|Pregnancy|0|||
30786600|NCT00130247|58799825|FG000|Overall Study|Post-randomization exclusion|1|||
30786601|NCT00130247|58799826|FG001|Overall Study|Post-randomization exclusion|2|||
30786602|NCT00130247|58799825|FG000|Overall Study|Not compliant with DOT|0|||
30786603|NCT00130247|58799826|FG001|Overall Study|Not compliant with DOT|2|||
30786604|NCT03678285|58799832|FG000|Overall Study|Adverse Event|2|||
30786605|NCT03678285|58799832|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
30965974|NCT01490125|59034715|FG001|Period II|Lost to Follow-up|1|||
30965975|NCT01490125|59034716|FG002|Period II|Lost to Follow-up|0|||
30965976|NCT01490125|59034717|FG003|Period II|Lost to Follow-up|0|||
30965977|NCT01490125|59034718|FG004|Period II|Lost to Follow-up|0|||
30965978|NCT01490125|59034719|FG005|Period II|Lost to Follow-up|0|||
30965979|NCT01490125|59034714|FG000|Period II|Withdrawal by Subject|1|||
30965980|NCT01490125|59034715|FG001|Period II|Withdrawal by Subject|0|||
30965981|NCT01490125|59034716|FG002|Period II|Withdrawal by Subject|0|||
30786606|NCT03678285|58799832|FG000|Overall Study|Dehydrated prior to start of workout|1|||
30786607|NCT04032171|58799838|FG000|Overall Study|Study Termination|1|||
30786608|NCT04032171|58799839|FG001|Overall Study|Study Termination|0|||
30786609|NCT00137423|58799847|FG000|Overall Study|Adverse Event|7|||
30786610|NCT00137423|58799848|FG001|Overall Study|Adverse Event|9|||
30786611|NCT00137423|58799847|FG000|Overall Study|consent withdrawn|1|||
30786612|NCT00137423|58799848|FG001|Overall Study|consent withdrawn|1|||
30965982|NCT01490125|59034717|FG003|Period II|Withdrawal by Subject|0|||
30965983|NCT01490125|59034718|FG004|Period II|Withdrawal by Subject|0|||
30965984|NCT01490125|59034719|FG005|Period II|Withdrawal by Subject|0|||
30965985|NCT01490125|59034714|FG000|Period III|Adverse Event|3|||
30965986|NCT01490125|59034715|FG001|Period III|Adverse Event|1|||
30965987|NCT01490125|59034716|FG002|Period III|Adverse Event|0|||
30965988|NCT01490125|59034717|FG003|Period III|Adverse Event|1|||
30965989|NCT01490125|59034718|FG004|Period III|Adverse Event|0|||
30965990|NCT01490125|59034719|FG005|Period III|Adverse Event|0|||
30965991|NCT01490125|59034714|FG000|Period III|Death|0|||
30965992|NCT01490125|59034715|FG001|Period III|Death|0|||
30965993|NCT01490125|59034716|FG002|Period III|Death|0|||
30965994|NCT01490125|59034717|FG003|Period III|Death|1|||
30965995|NCT01490125|59034718|FG004|Period III|Death|0|||
30965996|NCT01490125|59034719|FG005|Period III|Death|0|||
30965997|NCT01490125|59034714|FG000|Period III|Lack of Efficacy|0|||
30965998|NCT01490125|59034715|FG001|Period III|Lack of Efficacy|0|||
30965999|NCT01490125|59034716|FG002|Period III|Lack of Efficacy|0|||
30966000|NCT01490125|59034717|FG003|Period III|Lack of Efficacy|0|||
30966001|NCT01490125|59034718|FG004|Period III|Lack of Efficacy|1|||
30966002|NCT01490125|59034719|FG005|Period III|Lack of Efficacy|0|||
30966003|NCT01446913|59034730|FG000|Overall Study|Significant illness|1|||
30966004|NCT01446913|59034731|FG001|Overall Study|Significant illness|1|||
30966005|NCT01446913|59034732|FG002|Overall Study|Significant illness|1|||
30966006|NCT01446913|59034730|FG000|Overall Study|Withdrawal by Subject|5|||
30966007|NCT01446913|59034731|FG001|Overall Study|Withdrawal by Subject|3|||
30966008|NCT01446913|59034732|FG002|Overall Study|Withdrawal by Subject|5|||
30966009|NCT01446913|59034730|FG000|Overall Study|Physician Decision|0|||
30966010|NCT01446913|59034731|FG001|Overall Study|Physician Decision|0|||
30966011|NCT01446913|59034732|FG002|Overall Study|Physician Decision|2|||
30966012|NCT01446913|59034730|FG000|Overall Study|Lost to Follow-up|3|||
30966013|NCT01446913|59034731|FG001|Overall Study|Lost to Follow-up|5|||
30966014|NCT01446913|59034732|FG002|Overall Study|Lost to Follow-up|3|||
30966015|NCT01420549|59034763|FG000|Overall Study|Adverse Event|1|||
30966016|NCT01420549|59034764|FG001|Overall Study|Adverse Event|1|||
30966017|NCT01420549|59034763|FG000|Overall Study|Lost to Follow-up|2|||
30966018|NCT01420549|59034764|FG001|Overall Study|Lost to Follow-up|2|||
30966019|NCT01420549|59034763|FG000|Overall Study|Protocol Violation|0|||
30966020|NCT01420549|59034764|FG001|Overall Study|Protocol Violation|1|||
30966021|NCT01420549|59034763|FG000|Overall Study|Non-adherence to medication|4|||
30966022|NCT01420549|59034764|FG001|Overall Study|Non-adherence to medication|1|||
30966023|NCT01440595|59034785|FG000|Overall Study|Lost to Follow-up|0|||
30966024|NCT01440595|59034786|FG001|Overall Study|Lost to Follow-up|1|||
30966025|NCT01440595|59034787|FG002|Overall Study|Lost to Follow-up|0|||
30966026|NCT01440595|59034785|FG000|Overall Study|Study terminated by sponsor.|1|||
30966027|NCT01440595|59034786|FG001|Overall Study|Study terminated by sponsor.|2|||
30966028|NCT01440595|59034787|FG002|Overall Study|Study terminated by sponsor.|1|||
30966029|NCT01440517|59034793|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
30966030|NCT01440283|59034797|FG000|Overall Study|Death|3|||
30966031|NCT01440283|59034797|FG000|Overall Study|Withdrawal by Subject|4|||
30966032|NCT01440283|59034797|FG000|Overall Study|Physician Decision|3|||
30966033|NCT01440049|59034807|FG000|Overall Study|Adverse Event|5|||
30966034|NCT01439971|59034868|FG000|Overall Study|Required number in cohort dosed|0|||
30966035|NCT01439971|59034869|FG001|Overall Study|Required number in cohort dosed|1|||
30966036|NCT01439971|59034870|FG002|Overall Study|Required number in cohort dosed|2|||
30966037|NCT01439971|59034871|FG003|Overall Study|Required number in cohort dosed|0|||
30966038|NCT01439971|59034872|FG004|Overall Study|Required number in cohort dosed|1|||
30966039|NCT01447927|59034935|FG000|Overall Study|Adverse Event|4|||
30966040|NCT01447927|59034936|FG001|Overall Study|Adverse Event|3|||
30966041|NCT01447927|59034935|FG000|Overall Study|Withdrawal by Subject|1|||
30966042|NCT01447927|59034936|FG001|Overall Study|Withdrawal by Subject|0|||
30966043|NCT01551758|59034958|FG000|Overall Study|Adverse Event|29|||
30966044|NCT01551758|59034959|FG001|Overall Study|Adverse Event|43|||
30966045|NCT01551758|59034958|FG000|Overall Study|Lack of Efficacy|0|||
30966046|NCT01551758|59034959|FG001|Overall Study|Lack of Efficacy|1|||
30966047|NCT01551758|59034958|FG000|Overall Study|Protocol Violation|5|||
30966048|NCT01551758|59034959|FG001|Overall Study|Protocol Violation|6|||
30966049|NCT01551758|59034958|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
30786613|NCT00137423|58799847|FG000|Overall Study|Lack of Efficacy|31|||
30966050|NCT01551758|59034959|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
30966051|NCT01551758|59034958|FG000|Overall Study|Lost to Follow-up|29|||
30966052|NCT01551758|59034959|FG001|Overall Study|Lost to Follow-up|25|||
30966053|NCT01551758|59034958|FG000|Overall Study|Physician Decision|9|||
30966054|NCT01551758|59034959|FG001|Overall Study|Physician Decision|3|||
30966055|NCT01551758|59034958|FG000|Overall Study|Withdrawal by Subject|14|||
30966056|NCT01551758|59034959|FG001|Overall Study|Withdrawal by Subject|17|||
30966057|NCT01449461|59035162|FG000|Overall Study|Adverse Event|0|||
30966058|NCT01449461|59035163|FG001|Overall Study|Adverse Event|3|||
30966059|NCT01449461|59035164|FG002|Overall Study|Adverse Event|2|||
30966060|NCT01449461|59035165|FG003|Overall Study|Adverse Event|3|||
30966061|NCT01449461|59035166|FG004|Overall Study|Adverse Event|4|||
30966062|NCT01449461|59035167|FG005|Overall Study|Adverse Event|4|||
30966063|NCT01449461|59035162|FG000|Overall Study|Death|0|||
30966064|NCT01449461|59035163|FG001|Overall Study|Death|2|||
30966065|NCT01449461|59035164|FG002|Overall Study|Death|0|||
30966066|NCT01449461|59035165|FG003|Overall Study|Death|0|||
30966067|NCT01449461|59035166|FG004|Overall Study|Death|7|||
30966068|NCT01449461|59035167|FG005|Overall Study|Death|1|||
30966069|NCT01449461|59035162|FG000|Overall Study|Physician Decision|0|||
30966070|NCT01449461|59035163|FG001|Overall Study|Physician Decision|1|||
30966071|NCT01449461|59035164|FG002|Overall Study|Physician Decision|0|||
30966072|NCT01449461|59035165|FG003|Overall Study|Physician Decision|4|||
30966073|NCT01449461|59035166|FG004|Overall Study|Physician Decision|1|||
30966074|NCT01449461|59035167|FG005|Overall Study|Physician Decision|0|||
30966075|NCT01449461|59035162|FG000|Overall Study|Documented Progressive Disease|4|||
30966076|NCT01449461|59035163|FG001|Overall Study|Documented Progressive Disease|7|||
30966077|NCT01449461|59035164|FG002|Overall Study|Documented Progressive Disease|14|||
30966078|NCT01449461|59035165|FG003|Overall Study|Documented Progressive Disease|15|||
30966079|NCT01449461|59035166|FG004|Overall Study|Documented Progressive Disease|24|||
30966080|NCT01449461|59035167|FG005|Overall Study|Documented Progressive Disease|5|||
30966081|NCT01449461|59035162|FG000|Overall Study|Clinical Progressive Disease|2|||
30966082|NCT01449461|59035163|FG001|Overall Study|Clinical Progressive Disease|2|||
30966083|NCT01449461|59035164|FG002|Overall Study|Clinical Progressive Disease|0|||
30966084|NCT01449461|59035165|FG003|Overall Study|Clinical Progressive Disease|3|||
30966085|NCT01449461|59035166|FG004|Overall Study|Clinical Progressive Disease|4|||
30966086|NCT01449461|59035167|FG005|Overall Study|Clinical Progressive Disease|2|||
30966087|NCT01449461|59035162|FG000|Overall Study|Protocol Violation|0|||
30966088|NCT01449461|59035163|FG001|Overall Study|Protocol Violation|0|||
30966089|NCT01449461|59035164|FG002|Overall Study|Protocol Violation|0|||
30966090|NCT01449461|59035165|FG003|Overall Study|Protocol Violation|1|||
30966091|NCT01449461|59035166|FG004|Overall Study|Protocol Violation|0|||
30966092|NCT01449461|59035167|FG005|Overall Study|Protocol Violation|0|||
30966093|NCT01449461|59035162|FG000|Overall Study|Site Terminated by Sponsor|0|||
30966094|NCT01449461|59035163|FG001|Overall Study|Site Terminated by Sponsor|1|||
30966095|NCT01449461|59035164|FG002|Overall Study|Site Terminated by Sponsor|2|||
30966096|NCT01449461|59035165|FG003|Overall Study|Site Terminated by Sponsor|3|||
30966097|NCT01449461|59035166|FG004|Overall Study|Site Terminated by Sponsor|4|||
30966098|NCT01449461|59035167|FG005|Overall Study|Site Terminated by Sponsor|1|||
30966099|NCT01449461|59035162|FG000|Overall Study|Withdrawal by Subject|0|||
30966100|NCT01449461|59035163|FG001|Overall Study|Withdrawal by Subject|1|||
30966101|NCT01449461|59035164|FG002|Overall Study|Withdrawal by Subject|0|||
30966102|NCT01449461|59035165|FG003|Overall Study|Withdrawal by Subject|0|||
30966103|NCT01449461|59035166|FG004|Overall Study|Withdrawal by Subject|2|||
30966104|NCT01449461|59035167|FG005|Overall Study|Withdrawal by Subject|1|||
30966105|NCT01449461|59035162|FG000|Overall Study|Reason not Specified|0|||
30966106|NCT01449461|59035163|FG001|Overall Study|Reason not Specified|1|||
30966107|NCT01449461|59035164|FG002|Overall Study|Reason not Specified|0|||
30966108|NCT01449461|59035165|FG003|Overall Study|Reason not Specified|3|||
30966109|NCT01449461|59035166|FG004|Overall Study|Reason not Specified|2|||
30966110|NCT01449461|59035167|FG005|Overall Study|Reason not Specified|1|||
30966111|NCT01572038|59035203|FG000|Overall Study|Death|648|||
30966112|NCT01572038|59035203|FG000|Overall Study|Withdrawal by Subject|204|||
30966113|NCT01572038|59035203|FG000|Overall Study|Lost to Follow-up|81|||
30966114|NCT01572038|59035203|FG000|Overall Study|Physician Decision|20|||
30966115|NCT01572038|59035203|FG000|Overall Study|Patient Decision|14|||
30966116|NCT01572038|59035203|FG000|Overall Study|Progressive Disease|8|||
30966117|NCT01572038|59035203|FG000|Overall Study|Site Closed Before Completing Form|6|||
30966118|NCT01572038|59035203|FG000|Overall Study|Enrolled into Another Trial|3|||
30966119|NCT01572038|59035203|FG000|Overall Study|Participated in Another Trial|3|||
30966120|NCT01572038|59035203|FG000|Overall Study|Termination by Sponsor|2|||
30966121|NCT01572038|59035203|FG000|Overall Study|Patient Deterioration|1|||
30966122|NCT01572038|59035203|FG000|Overall Study|Sponsor Decision|1|||
30966123|NCT01448213|59035231|FG000|Overall Study|Lost to Follow-up|12|||
30966124|NCT01448213|59035232|FG001|Overall Study|Lost to Follow-up|10|||
30966125|NCT01448213|59035231|FG000|Overall Study|Adverse Event|4|||
30966126|NCT01448213|59035232|FG001|Overall Study|Adverse Event|10|||
30966127|NCT01448213|59035231|FG000|Overall Study|Protocol Violation|1|||
30966128|NCT01448213|59035232|FG001|Overall Study|Protocol Violation|2|||
30966129|NCT01448057|59035249|FG000|Overall Study|Protocol Violation|3|||
30966130|NCT01448057|59035250|FG001|Overall Study|Protocol Violation|2|||
30966131|NCT01448057|59035249|FG000|Overall Study|Lost to Follow-up|3|||
30966132|NCT01448057|59035250|FG001|Overall Study|Lost to Follow-up|0|||
30966133|NCT01448057|59035249|FG000|Overall Study|Adverse Event|0|||
30966134|NCT01448057|59035250|FG001|Overall Study|Adverse Event|2|||
30966135|NCT01448057|59035249|FG000|Overall Study|Withdrawal by Subject|2|||
30966136|NCT01448057|59035250|FG001|Overall Study|Withdrawal by Subject|0|||
30966137|NCT01447433|59035258|FG000|Overall Study|Lost to Follow-up|0|||
30966138|NCT01447433|59035259|FG001|Overall Study|Lost to Follow-up|2|||
30966139|NCT01447433|59035258|FG000|Overall Study|Withdrawal by Subject|3|||
30966140|NCT01447433|59035259|FG001|Overall Study|Withdrawal by Subject|3|||
30966141|NCT01447433|59035258|FG000|Overall Study|Protocol Violation|1|||
30966142|NCT01447433|59035259|FG001|Overall Study|Protocol Violation|1|||
30966143|NCT01446965|59035267|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
30966144|NCT01446965|59035268|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
30966145|NCT01446965|59035267|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
30966146|NCT01446965|59035268|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
30966147|NCT01446809|59035276|FG000|Overall Study|Adverse Event|0|||
30966148|NCT01446809|59035277|FG001|Overall Study|Adverse Event|0|||
30966149|NCT01446809|59035278|FG002|Overall Study|Adverse Event|1|||
30966150|NCT01446809|59035276|FG000|Overall Study|Failure to complete study procedures|0|||
30966151|NCT01446809|59035277|FG001|Overall Study|Failure to complete study procedures|0|||
30966152|NCT01446809|59035278|FG002|Overall Study|Failure to complete study procedures|1|||
30966153|NCT01446419|59035289|FG000|Overall Study|Death|1|||
30966154|NCT01446419|59035290|FG001|Overall Study|Death|0|||
30966155|NCT01446419|59035289|FG000|Overall Study|Withdrawal by Subject|1|||
30966156|NCT01446419|59035290|FG001|Overall Study|Withdrawal by Subject|1|||
30966157|NCT01446419|59035289|FG000|Overall Study|Terminated per protocol|3|||
30966158|NCT01446419|59035290|FG001|Overall Study|Terminated per protocol|0|||
30966159|NCT01445951|59035299|FG000|Overall Study|Adverse Event|16|||
30966160|NCT01445951|59035300|FG001|Overall Study|Adverse Event|9|||
30966161|NCT01445951|59035301|FG002|Overall Study|Adverse Event|0|||
30966162|NCT01445951|59035299|FG000|Overall Study|Protocol Violation|2|||
30966163|NCT01445951|59035300|FG001|Overall Study|Protocol Violation|2|||
30966164|NCT01445951|59035301|FG002|Overall Study|Protocol Violation|2|||
30966165|NCT01445951|59035299|FG000|Overall Study|Withdrawal by Subject|21|||
30966166|NCT01445951|59035300|FG001|Overall Study|Withdrawal by Subject|16|||
30966167|NCT01445951|59035301|FG002|Overall Study|Withdrawal by Subject|8|||
30966168|NCT01445951|59035299|FG000|Overall Study|Physician Decision|3|||
30966169|NCT01445951|59035300|FG001|Overall Study|Physician Decision|1|||
30966170|NCT01445951|59035301|FG002|Overall Study|Physician Decision|0|||
30966171|NCT01445951|59035299|FG000|Overall Study|Lost to Follow-up|1|||
30966172|NCT01445951|59035300|FG001|Overall Study|Lost to Follow-up|2|||
30966173|NCT01445951|59035301|FG002|Overall Study|Lost to Follow-up|4|||
30966174|NCT01445951|59035299|FG000|Overall Study|Pregnancy|0|||
30966175|NCT01445951|59035300|FG001|Overall Study|Pregnancy|1|||
30966176|NCT01445951|59035301|FG002|Overall Study|Pregnancy|4|||
30966177|NCT01445951|59035299|FG000|Overall Study|Death|0|||
30966178|NCT01445951|59035300|FG001|Overall Study|Death|0|||
30966179|NCT01445951|59035301|FG002|Overall Study|Death|1|||
30966180|NCT01445951|59035299|FG000|Overall Study|Non-compliance with study drug|1|||
30966181|NCT01445951|59035300|FG001|Overall Study|Non-compliance with study drug|2|||
30966182|NCT01445951|59035301|FG002|Overall Study|Non-compliance with study drug|0|||
30966183|NCT01445951|59035299|FG000|Overall Study|Non-compliance with protocol|0|||
30966184|NCT01445951|59035300|FG001|Overall Study|Non-compliance with protocol|1|||
30966185|NCT01445951|59035301|FG002|Overall Study|Non-compliance with protocol|0|||
30966186|NCT01445951|59035299|FG000|Overall Study|Sponsor decision - subject travel|0|||
30966187|NCT01445951|59035300|FG001|Overall Study|Sponsor decision - subject travel|1|||
30966188|NCT01445951|59035301|FG002|Overall Study|Sponsor decision - subject travel|0|||
30966189|NCT01445951|59035299|FG000|Overall Study|Cough|0|||
30966190|NCT01445951|59035300|FG001|Overall Study|Cough|1|||
30966191|NCT01445951|59035301|FG002|Overall Study|Cough|0|||
30966192|NCT01445171|59035313|FG000|Overall Study|Lost to Follow-up|11|||
30966193|NCT01445171|59035313|FG000|Overall Study|Withdrawal by Subject|16|||
30966194|NCT01445171|59035313|FG000|Overall Study|Death|51|||
30966195|NCT01445171|59035313|FG000|Overall Study|Subjects declined to return for followup|9|||
30966196|NCT01445171|59035313|FG000|Overall Study|Consented but did not receive device|8|||
30966197|NCT01444781|59035322|FG000|Overall Study|Lost to Follow-up|0|||
30966198|NCT01444781|59035323|FG001|Overall Study|Lost to Follow-up|3|||
30966199|NCT01444781|59035324|FG002|Overall Study|Lost to Follow-up|1|||
30966200|NCT01444781|59035322|FG000|Overall Study|Withdrawal by Subject|3|||
30966201|NCT01444781|59035323|FG001|Overall Study|Withdrawal by Subject|1|||
30966202|NCT01444781|59035324|FG002|Overall Study|Withdrawal by Subject|2|||
30966203|NCT01444391|59035339|FG000|Overall Study|Death|1|||
30966204|NCT01443923|59035345|FG000|Overall Study|Adverse Event|1|||
30966205|NCT01443923|59035346|FG001|Overall Study|Adverse Event|0|||
30966206|NCT01551212|59035358|FG000|Overall Study|Graft loss/Retransplantation|0|||
30966207|NCT01551212|59035359|FG001|Overall Study|Graft loss/Retransplantation|1|||
30966208|NCT01551212|59035358|FG000|Overall Study|Administrative problems|1|||
30966209|NCT01551212|59035359|FG001|Overall Study|Administrative problems|2|||
30966210|NCT01551212|59035358|FG000|Overall Study|Lost to Follow-up|0|||
30966211|NCT01551212|59035359|FG001|Overall Study|Lost to Follow-up|1|||
30966212|NCT01551212|59035358|FG000|Overall Study|Protocol Violation|0|||
30966213|NCT01551212|59035359|FG001|Overall Study|Protocol Violation|1|||
30966214|NCT01551212|59035358|FG000|Overall Study|Withdrawal by Subject|0|||
30966215|NCT01551212|59035359|FG001|Overall Study|Withdrawal by Subject|7|||
30966216|NCT01551212|59035358|FG000|Overall Study|Death|2|||
30966217|NCT01551212|59035359|FG001|Overall Study|Death|4|||
30966218|NCT01551212|59035358|FG000|Overall Study|Never Received Study Treatment|2|||
30966219|NCT01551212|59035359|FG001|Overall Study|Never Received Study Treatment|4|||
30966220|NCT01550744|59035419|FG000|Open-Label|Lost to Follow-up|7|||
30966221|NCT01550744|59035420|FG001|Open-Label|Lost to Follow-up|0|||
30966222|NCT01550744|59035421|FG002|Open-Label|Lost to Follow-up|0|||
30966223|NCT01550744|59035419|FG000|Open-Label|Withdrawal by Subject|13|||
30966224|NCT01550744|59035420|FG001|Open-Label|Withdrawal by Subject|0|||
30966225|NCT01550744|59035421|FG002|Open-Label|Withdrawal by Subject|0|||
30966226|NCT01550744|59035419|FG000|Open-Label|Adverse Event|11|||
30966227|NCT01550744|59035420|FG001|Open-Label|Adverse Event|0|||
30966228|NCT01550744|59035421|FG002|Open-Label|Adverse Event|0|||
30966229|NCT01550744|59035419|FG000|Open-Label|Lack of Efficacy|4|||
30966230|NCT01550744|59035420|FG001|Open-Label|Lack of Efficacy|0|||
30966231|NCT01550744|59035421|FG002|Open-Label|Lack of Efficacy|0|||
30966232|NCT01550744|59035419|FG000|Open-Label|Protocol Violation|4|||
30966233|NCT01550744|59035420|FG001|Open-Label|Protocol Violation|0|||
30607616|NCT03933397|58618296|FG001|Overall Study|Withdrawal by Subject|0|||
30607617|NCT03933397|58618295|FG000|Overall Study|Physician Decision|1|||
30607618|NCT03933397|58618296|FG001|Overall Study|Physician Decision|1|||
30607619|NCT03933397|58618295|FG000|Overall Study|missing pain score|1|||
30607620|NCT03933397|58618296|FG001|Overall Study|missing pain score|1|||
30607621|NCT03933397|58618295|FG000|Overall Study|Confirmed COVID-19|1|||
30607622|NCT03933397|58618296|FG001|Overall Study|Confirmed COVID-19|2|||
30607623|NCT03775486|58618328|FG000|Initial Therapy Phase|Other reason provided|0|||
30607624|NCT03775486|58618329|FG001|Initial Therapy Phase|Other reason provided|15|||
30607625|NCT03775486|58618328|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
30607626|NCT03775486|58618329|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
30607627|NCT03775486|58618328|FG000|Initial Therapy Phase|Protocol Violation|0|||
30607628|NCT03775486|58618329|FG001|Initial Therapy Phase|Protocol Violation|2|||
30607629|NCT03775486|58618328|FG000|Initial Therapy Phase|Adverse Event|0|||
30607630|NCT03775486|58618329|FG001|Initial Therapy Phase|Adverse Event|34|||
30607631|NCT03775486|58618328|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
30607632|NCT03775486|58618329|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
30607633|NCT03775486|58618328|FG000|Maintenance Phase|Withdrawal by Subject|13|||
30607634|NCT03775486|58618329|FG001|Maintenance Phase|Withdrawal by Subject|12|||
30607635|NCT03775486|58618328|FG000|Maintenance Phase|Death|44|||
30607636|NCT03775486|58618329|FG001|Maintenance Phase|Death|45|||
30607637|NCT03624881|58618347|FG000|Overall Study|Screen Failure|14|||
30607638|NCT03624881|58618348|FG001|Overall Study|Screen Failure|0|||
30607639|NCT03624881|58618347|FG000|Overall Study|No Catheter Inserted|6|||
30607640|NCT03624881|58618348|FG001|Overall Study|No Catheter Inserted|1|||
30607641|NCT03624881|58618347|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
30607642|NCT03624881|58618348|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
30607643|NCT03624881|58618347|FG000|Overall Study|Death|2|||
30607644|NCT03624881|58618348|FG001|Overall Study|Death|0|||
30607645|NCT03624881|58618347|FG000|Overall Study|Lost to Follow-up|10|||
30607646|NCT03624881|58618348|FG001|Overall Study|Lost to Follow-up|4|||
30607647|NCT03624881|58618347|FG000|Overall Study|Withdrawal by Subject|12|||
30607648|NCT03624881|58618348|FG001|Overall Study|Withdrawal by Subject|1|||
30607653|NCT03428997|58618380|FG000|Overall Study|Sponsor decision.|1|||
30607654|NCT03428997|58618380|FG000|Overall Study|Withdrawal by Subject|3|||
30607655|NCT03428997|58618380|FG000|Overall Study|Lost to Follow-up|4|||
30607656|NCT03118674|58618413|FG000|Overall Study|Lost to Follow-up|2|||
30607657|NCT03118674|58618413|FG000|Overall Study|Screen Faliure|8|||
30607658|NCT03118674|58618413|FG000|Overall Study|Withdrawal by Subject|5|||
30607659|NCT03069352|58618419|FG000|Overall Study|Ongoing|12|||
30607660|NCT03069352|58618420|FG001|Overall Study|Ongoing|40|||
30607661|NCT02993523|58618431|FG000|Overall Study|Withdrew Consent|0|||
30607662|NCT02993523|58618432|FG001|Overall Study|Withdrew Consent|0|||
30607663|NCT02993523|58618433|FG002|Overall Study|Withdrew Consent|2|||
30607664|NCT02993523|58618434|FG003|Overall Study|Withdrew Consent|9|||
30607665|NCT02993523|58618435|FG004|Overall Study|Withdrew Consent|0|||
30607666|NCT02993523|58618431|FG000|Overall Study|Lost to Follow-up|0|||
30607667|NCT02993523|58618432|FG001|Overall Study|Lost to Follow-up|0|||
30607668|NCT02993523|58618433|FG002|Overall Study|Lost to Follow-up|3|||
30607669|NCT02993523|58618434|FG003|Overall Study|Lost to Follow-up|6|||
30607670|NCT02993523|58618435|FG004|Overall Study|Lost to Follow-up|0|||
30607671|NCT02993523|58618431|FG000|Overall Study|Death|1|||
30966234|NCT01550744|59035421|FG002|Open-Label|Protocol Violation|0|||
30607672|NCT02993523|58618432|FG001|Overall Study|Death|1|||
30607673|NCT02993523|58618433|FG002|Overall Study|Death|138|||
30607674|NCT02993523|58618434|FG003|Overall Study|Death|222|||
30607675|NCT02993523|58618435|FG004|Overall Study|Death|6|||
30607676|NCT02993523|58618431|FG000|Overall Study|Reason not Specified|0|||
30607677|NCT02993523|58618432|FG001|Overall Study|Reason not Specified|0|||
30607678|NCT02993523|58618433|FG002|Overall Study|Reason not Specified|1|||
30607679|NCT02993523|58618434|FG003|Overall Study|Reason not Specified|1|||
30607680|NCT02993523|58618435|FG004|Overall Study|Reason not Specified|0|||
30607681|NCT02795429|58618448|FG000|Overall Study|Adverse Event|1|||
30607682|NCT02795429|58618449|FG001|Overall Study|Adverse Event|2|||
30607683|NCT02795429|58618450|FG002|Overall Study|Adverse Event|1|||
30607684|NCT02795429|58618451|FG003|Overall Study|Adverse Event|2|||
30607685|NCT02795429|58618452|FG004|Overall Study|Adverse Event|1|||
30607686|NCT02795429|58618448|FG000|Overall Study|Death|1|||
30607687|NCT02795429|58618449|FG001|Overall Study|Death|0|||
30607688|NCT02795429|58618450|FG002|Overall Study|Death|1|||
30607689|NCT02795429|58618451|FG003|Overall Study|Death|2|||
30607690|NCT02795429|58618452|FG004|Overall Study|Death|1|||
30607691|NCT02795429|58618448|FG000|Overall Study|Physician Decision|0|||
30607692|NCT02795429|58618449|FG001|Overall Study|Physician Decision|0|||
30607693|NCT02795429|58618450|FG002|Overall Study|Physician Decision|2|||
30607694|NCT02795429|58618451|FG003|Overall Study|Physician Decision|1|||
30607695|NCT02795429|58618452|FG004|Overall Study|Physician Decision|5|||
30607696|NCT02795429|58618448|FG000|Overall Study|Progressive disease|3|||
30607697|NCT02795429|58618449|FG001|Overall Study|Progressive disease|7|||
30607698|NCT02795429|58618450|FG002|Overall Study|Progressive disease|6|||
30607699|NCT02795429|58618451|FG003|Overall Study|Progressive disease|26|||
30607700|NCT02795429|58618452|FG004|Overall Study|Progressive disease|20|||
30607701|NCT02795429|58618448|FG000|Overall Study|Subject/guardian decision|1|||
30607702|NCT02795429|58618449|FG001|Overall Study|Subject/guardian decision|1|||
30607703|NCT02795429|58618450|FG002|Overall Study|Subject/guardian decision|1|||
30607704|NCT02795429|58618451|FG003|Overall Study|Subject/guardian decision|1|||
30607705|NCT02795429|58618452|FG004|Overall Study|Subject/guardian decision|3|||
30607706|NCT02652949|58618475|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
30607707|NCT02652949|58618475|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
30607708|NCT02652949|58618475|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
30607709|NCT02652949|58618475|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
30607710|NCT02652949|58618475|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
30607711|NCT02652949|58618475|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
30607712|NCT02652949|58618475|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
30607713|NCT02652949|58618475|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
30607714|NCT02652949|58618475|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
30607715|NCT02652949|58618475|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
30607716|NCT02652949|58618475|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
30607717|NCT02652949|58618475|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
30607718|NCT02652949|58618475|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
30607719|NCT02652949|58618475|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
30607720|NCT02652949|58618475|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
30607721|NCT02632344|58618486|FG000|Overall Study|Adverse Event|3|||
30607722|NCT02632344|58618486|FG000|Overall Study|Lack of Efficacy|3|||
30607723|NCT02632344|58618486|FG000|Overall Study|Withdrawal by Subject|2|||
30607724|NCT02625324|58618490|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
30607725|NCT02625324|58618490|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
30607726|NCT02625324|58618490|FG000|6-Month Follow-up Subject Accountability|Death|5|||
30607727|NCT02625324|58618490|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
30607728|NCT02625324|58618490|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
30607729|NCT02625324|58618490|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
30607730|NCT02625324|58618490|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
30607731|NCT02625324|58618490|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
30607732|NCT02625324|58618490|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
30607733|NCT02625324|58618490|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
30607734|NCT02625324|58618490|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
30607735|NCT02625324|58618490|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
30607736|NCT02625324|58618490|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
30607737|NCT02625324|58618490|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
30607738|NCT02625324|58618490|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
30607739|NCT02576509|58618504|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
30607740|NCT02576509|58618505|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
30607741|NCT02576509|58618504|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
30607742|NCT02576509|58618505|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
30607743|NCT02576509|58618504|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
30607744|NCT02576509|58618505|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
30607745|NCT02576509|58618504|FG000|Treatment Period|Disease progression|245|||
30607746|NCT02576509|58618505|FG001|Treatment Period|Disease progression|240|||
30786614|NCT00137423|58799848|FG001|Overall Study|Lack of Efficacy|33|||
30607747|NCT02576509|58618504|FG000|Treatment Period|Study drug toxicity|32|||
30607748|NCT02576509|58618505|FG001|Treatment Period|Study drug toxicity|41|||
30607749|NCT02576509|58618504|FG000|Treatment Period|Death|1|||
30607750|NCT02576509|58618505|FG001|Treatment Period|Death|1|||
30607751|NCT02576509|58618504|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
30607752|NCT02576509|58618505|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
30607753|NCT02576509|58618504|FG000|Treatment Period|Participant request to stop treatment|8|||
30607754|NCT02576509|58618505|FG001|Treatment Period|Participant request to stop treatment|17|||
30607755|NCT02576509|58618504|FG000|Treatment Period|Participant withdrew consent|2|||
30607756|NCT02576509|58618505|FG001|Treatment Period|Participant withdrew consent|7|||
30607757|NCT02576509|58618504|FG000|Treatment Period|Lost to Follow-up|0|||
30607758|NCT02576509|58618505|FG001|Treatment Period|Lost to Follow-up|1|||
30607759|NCT02576509|58618504|FG000|Treatment Period|Maximum clinical benefit|1|||
30607760|NCT02576509|58618505|FG001|Treatment Period|Maximum clinical benefit|0|||
30607761|NCT02576509|58618504|FG000|Treatment Period|Poor/non-compliance|0|||
30607762|NCT02576509|58618505|FG001|Treatment Period|Poor/non-compliance|1|||
30607763|NCT02576509|58618504|FG000|Treatment Period|Participant no longer meets criteria|1|||
30607764|NCT02576509|58618505|FG001|Treatment Period|Participant no longer meets criteria|0|||
30607765|NCT02576509|58618504|FG000|Treatment Period|Other reason|2|||
30607766|NCT02576509|58618505|FG001|Treatment Period|Other reason|7|||
30607767|NCT02576509|58618504|FG000|Follow-up Period|Death|41|||
30607768|NCT02576509|58618505|FG001|Follow-up Period|Death|35|||
30607769|NCT02576509|58618504|FG000|Follow-up Period|Participant withdrew consent|7|||
30607770|NCT02576509|58618505|FG001|Follow-up Period|Participant withdrew consent|14|||
30607771|NCT02576509|58618504|FG000|Follow-up Period|Lost to Follow-up|0|||
30607772|NCT02576509|58618505|FG001|Follow-up Period|Lost to Follow-up|1|||
30607773|NCT02576509|58618504|FG000|Follow-up Period|Other reason|1|||
30607774|NCT02576509|58618505|FG001|Follow-up Period|Other reason|2|||
30607775|NCT02477696|58618528|FG000|Overall Study|Adverse Event|40|||
30607776|NCT02477696|58618529|FG001|Overall Study|Adverse Event|59|||
30607777|NCT02477696|58618528|FG000|Overall Study|CLL Disease Progression|82|||
30607778|NCT02477696|58618529|FG001|Overall Study|CLL Disease Progression|68|||
30607779|NCT02477696|58618528|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2|||
30607780|NCT02477696|58618529|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10|||
30607781|NCT02477696|58618528|FG000|Overall Study|Death|5|||
30607782|NCT02477696|58618529|FG001|Overall Study|Death|6|||
30607783|NCT02477696|58618528|FG000|Overall Study|Withdrawal by Subject|7|||
30607784|NCT02477696|58618529|FG001|Overall Study|Withdrawal by Subject|7|||
30607785|NCT02477696|58618528|FG000|Overall Study|Physician Decision|5|||
30607786|NCT02477696|58618529|FG001|Overall Study|Physician Decision|5|||
30607787|NCT02471144|58618539|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
30607788|NCT02471144|58618540|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
30607789|NCT02471144|58618541|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
30607790|NCT02471144|58618542|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
30607791|NCT02471144|58618543|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
30607792|NCT02471144|58618544|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
30607793|NCT02471144|58618545|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
30607794|NCT02471144|58618546|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
30607795|NCT02471144|58618547|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
30607796|NCT02471144|58618548|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
30607797|NCT02471144|58618549|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
30607798|NCT02471144|58618539|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
30607799|NCT02471144|58618540|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
30607800|NCT02471144|58618541|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
30607801|NCT02471144|58618542|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
30607802|NCT02471144|58618543|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
30607803|NCT02471144|58618544|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
30607804|NCT02471144|58618545|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
30607805|NCT02471144|58618546|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
30607806|NCT02471144|58618547|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
30607807|NCT02471144|58618548|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
30607808|NCT02471144|58618549|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
30607809|NCT02471144|58618539|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
30607810|NCT02471144|58618540|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
30607811|NCT02471144|58618541|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
30607812|NCT02471144|58618542|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
30607813|NCT02471144|58618543|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
30607814|NCT02471144|58618544|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
30607815|NCT02471144|58618545|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
30607816|NCT02471144|58618546|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
30607817|NCT02471144|58618547|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
30607818|NCT02471144|58618548|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
30607819|NCT02471144|58618549|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
30607820|NCT02471144|58618539|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
30607821|NCT02471144|58618540|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
30607822|NCT02471144|58618541|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
30607823|NCT02471144|58618542|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
30607824|NCT02471144|58618543|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
30607825|NCT02471144|58618544|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
30607826|NCT02471144|58618545|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
30607827|NCT02471144|58618546|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
30607828|NCT02471144|58618547|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
30607829|NCT02471144|58618548|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
30607830|NCT02471144|58618549|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
30607831|NCT02471144|58618539|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
30607832|NCT02471144|58618540|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
30607833|NCT02471144|58618541|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
30607834|NCT02471144|58618542|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
30607835|NCT02471144|58618543|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
30607836|NCT02471144|58618544|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
30607837|NCT02471144|58618545|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
30607838|NCT02471144|58618546|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
30607839|NCT02471144|58618547|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
30607840|NCT02471144|58618548|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
30607841|NCT02471144|58618549|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
30607842|NCT02471144|58618539|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
30607843|NCT02471144|58618540|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
30607844|NCT02471144|58618541|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
30607845|NCT02471144|58618542|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
30607846|NCT02471144|58618543|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
30607847|NCT02471144|58618544|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
30607848|NCT02471144|58618545|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
30607849|NCT02471144|58618546|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
30607850|NCT02471144|58618547|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
30607851|NCT02471144|58618548|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
30607852|NCT02471144|58618549|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
30607853|NCT02471144|58618539|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
30607854|NCT02471144|58618540|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
30607855|NCT02471144|58618541|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
30607856|NCT02471144|58618542|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
30607857|NCT02471144|58618543|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
30607858|NCT02471144|58618544|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
30607859|NCT02471144|58618545|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
30607860|NCT02471144|58618546|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
30607861|NCT02471144|58618547|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
30607862|NCT02471144|58618548|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
30607863|NCT02471144|58618549|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
30607864|NCT02471144|58618539|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
30607865|NCT02471144|58618540|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
30607866|NCT02471144|58618541|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
30607867|NCT02471144|58618542|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
30607868|NCT02471144|58618543|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
30607869|NCT02471144|58618544|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
30607870|NCT02471144|58618545|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
30607871|NCT02471144|58618546|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
30607872|NCT02471144|58618547|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
30607873|NCT02471144|58618548|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
30607874|NCT02471144|58618549|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
30607875|NCT02471144|58618539|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
30607876|NCT02471144|58618540|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
30607877|NCT02471144|58618541|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
30607878|NCT02471144|58618542|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
30607879|NCT02471144|58618543|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
30607880|NCT02471144|58618544|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
30607881|NCT02471144|58618545|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
30607882|NCT02471144|58618546|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
30607883|NCT02471144|58618547|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
30607884|NCT02471144|58618548|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5|||
30607885|NCT02471144|58618549|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2|||
30607886|NCT02471144|58618539|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
30607887|NCT02471144|58618540|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
30607888|NCT02471144|58618541|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
30607889|NCT02471144|58618542|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
30607890|NCT02471144|58618543|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
30607891|NCT02471144|58618544|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
30607892|NCT02471144|58618545|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
30607893|NCT02471144|58618546|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
30607894|NCT02471144|58618547|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
30607895|NCT02471144|58618548|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
30607896|NCT02471144|58618549|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
30607897|NCT02471144|58618539|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
30607898|NCT02471144|58618540|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
30607899|NCT02471144|58618541|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
30607900|NCT02471144|58618542|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
30607901|NCT02471144|58618543|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
30607902|NCT02471144|58618544|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
30607903|NCT02471144|58618545|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
30607904|NCT02471144|58618546|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
30607905|NCT02471144|58618547|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
30607906|NCT02471144|58618548|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
30607907|NCT02471144|58618549|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
30607908|NCT02470585|58618568|FG000|Overall Study|Death|82|||
30607909|NCT02470585|58618569|FG001|Overall Study|Death|87|||
30607910|NCT02470585|58618570|FG002|Overall Study|Death|86|||
30607911|NCT02470585|58618568|FG000|Overall Study|Withdrawal by Subject|19|||
30607912|NCT02470585|58618569|FG001|Overall Study|Withdrawal by Subject|21|||
30607913|NCT02470585|58618570|FG002|Overall Study|Withdrawal by Subject|29|||
30607914|NCT02470585|58618568|FG000|Overall Study|Lost to Follow-up|2|||
30607915|NCT02470585|58618569|FG001|Overall Study|Lost to Follow-up|5|||
30607916|NCT02470585|58618570|FG002|Overall Study|Lost to Follow-up|4|||
30607917|NCT02470585|58618568|FG000|Overall Study|Other|4|||
30607918|NCT02470585|58618569|FG001|Overall Study|Other|4|||
30607919|NCT02470585|58618570|FG002|Overall Study|Other|6|||
30607920|NCT02213328|58618587|FG000|Overall Study|Withdrawal by Subject|10|||
30607921|NCT02213328|58618587|FG000|Overall Study|Physician Decision|2|||
30607922|NCT02213328|58618587|FG000|Overall Study|Lost to Follow-up|16|||
30966235|NCT01550744|59035419|FG000|Open-Label|Not all 3 study drug injections received|2|||
30966236|NCT01550744|59035420|FG001|Open-Label|Not all 3 study drug injections received|0|||
30966237|NCT01550744|59035421|FG002|Open-Label|Not all 3 study drug injections received|0|||
30966238|NCT01550744|59035419|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
30966239|NCT01550744|59035420|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
30966240|NCT01550744|59035421|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
30966241|NCT01550744|59035419|FG000|Open-Label|Other|1|||
30966242|NCT01550744|59035420|FG001|Open-Label|Other|0|||
30966243|NCT01550744|59035421|FG002|Open-Label|Other|0|||
30966244|NCT01550744|59035419|FG000|Double-Blind|Lost to Follow-up|0|||
30607935|NCT02085408|58618625|FG000|Step 1: Induction|Disease Progression|19|||
30607936|NCT02085408|58618626|FG001|Step 1: Induction|Disease Progression|19|||
30607937|NCT02085408|58618625|FG000|Step 1: Induction|Adverse Event|18|||
30607938|NCT02085408|58618626|FG001|Step 1: Induction|Adverse Event|17|||
30607939|NCT02085408|58618625|FG000|Step 1: Induction|Death|33|||
30607940|NCT02085408|58618626|FG001|Step 1: Induction|Death|30|||
30607941|NCT02085408|58618625|FG000|Step 1: Induction|Withdrawal by Subject|16|||
30607942|NCT02085408|58618626|FG001|Step 1: Induction|Withdrawal by Subject|8|||
30607943|NCT02085408|58618625|FG000|Step 1: Induction|Alternative Therapy|15|||
30607944|NCT02085408|58618626|FG001|Step 1: Induction|Alternative Therapy|19|||
30607945|NCT02085408|58618625|FG000|Step 1: Induction|Complicating Disease|2|||
30607946|NCT02085408|58618626|FG001|Step 1: Induction|Complicating Disease|3|||
30607947|NCT02085408|58618625|FG000|Step 1: Induction|Other|27|||
30607948|NCT02085408|58618626|FG001|Step 1: Induction|Other|39|||
30607949|NCT02085408|58618625|FG000|Step 1: Induction|Never started treatment|6|||
30607950|NCT02085408|58618626|FG001|Step 1: Induction|Never started treatment|4|||
30607951|NCT02085408|58618625|FG000|Step 2: Consolidation|Disease Progression|5|||
30607952|NCT02085408|58618626|FG001|Step 2: Consolidation|Disease Progression|20|||
30607953|NCT02085408|58618625|FG000|Step 2: Consolidation|Adverse Event|9|||
30607954|NCT02085408|58618626|FG001|Step 2: Consolidation|Adverse Event|8|||
30607955|NCT02085408|58618625|FG000|Step 2: Consolidation|Death|4|||
30607956|NCT02085408|58618626|FG001|Step 2: Consolidation|Death|3|||
30607957|NCT02085408|58618625|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
30786615|NCT00137423|58799847|FG000|Overall Study|Death|0|||
30607958|NCT02085408|58618626|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
30607959|NCT02085408|58618625|FG000|Step 2: Consolidation|Alternative Therapy|9|||
30607960|NCT02085408|58618626|FG001|Step 2: Consolidation|Alternative Therapy|3|||
30607961|NCT02085408|58618625|FG000|Step 2: Consolidation|Complicating Disease|0|||
30607962|NCT02085408|58618626|FG001|Step 2: Consolidation|Complicating Disease|2|||
30607963|NCT02085408|58618625|FG000|Step 2: Consolidation|Other|6|||
30607964|NCT02085408|58618626|FG001|Step 2: Consolidation|Other|6|||
30607965|NCT02085408|58618625|FG000|Step 2: Consolidation|Never started treatment|4|||
30607966|NCT02085408|58618626|FG001|Step 2: Consolidation|Never started treatment|3|||
30607967|NCT02085408|58618625|FG000|Step 3: Maintenance|Disease Progression|13|||
30607968|NCT02085408|58618626|FG001|Step 3: Maintenance|Disease Progression|11|||
30607969|NCT02085408|58618625|FG000|Step 3: Maintenance|Adverse Event|2|||
30607970|NCT02085408|58618626|FG001|Step 3: Maintenance|Adverse Event|4|||
30607971|NCT02085408|58618625|FG000|Step 3: Maintenance|Death|1|||
30607972|NCT02085408|58618626|FG001|Step 3: Maintenance|Death|2|||
30607973|NCT02085408|58618625|FG000|Step 3: Maintenance|Alternative Therapy|1|||
30607974|NCT02085408|58618626|FG001|Step 3: Maintenance|Alternative Therapy|1|||
30607975|NCT02085408|58618625|FG000|Step 3: Maintenance|Complicating Disease|0|||
30607976|NCT02085408|58618626|FG001|Step 3: Maintenance|Complicating Disease|1|||
30607977|NCT02085408|58618625|FG000|Step 3: Maintenance|Other|3|||
30607978|NCT02085408|58618626|FG001|Step 3: Maintenance|Other|2|||
30607979|NCT02085408|58618625|FG000|Step 3: Maintenance|Never started treatment|5|||
30607980|NCT02085408|58618626|FG001|Step 3: Maintenance|Never started treatment|1|||
30607981|NCT01867606|58618643|FG000|Overall Study|Withdrawal by Subject|10|||
30607982|NCT01867606|58618644|FG001|Overall Study|Withdrawal by Subject|14|||
30607983|NCT01867606|58618643|FG000|Overall Study|Protocol Violation|0|||
30607984|NCT01867606|58618644|FG001|Overall Study|Protocol Violation|1|||
30607985|NCT01730937|58618658|FG000|Overall Study|Protocol Violation|5|||
30607986|NCT01730937|58618659|FG001|Overall Study|Protocol Violation|11|||
30607987|NCT01496976|58618665|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
30607988|NCT01475786|58618672|FG000|Overall Study|Adverse Event|0|||
30607989|NCT01475786|58618673|FG001|Overall Study|Adverse Event|1|||
30607990|NCT01475786|58618674|FG002|Overall Study|Adverse Event|0|||
30607991|NCT01475786|58618672|FG000|Overall Study|Lost to Follow-up|1|||
30607992|NCT01475786|58618673|FG001|Overall Study|Lost to Follow-up|2|||
30607993|NCT01475786|58618674|FG002|Overall Study|Lost to Follow-up|1|||
30607994|NCT01475786|58618672|FG000|Overall Study|Withdrawal by Subject|0|||
30607995|NCT01475786|58618673|FG001|Overall Study|Withdrawal by Subject|1|||
30607996|NCT01475786|58618674|FG002|Overall Study|Withdrawal by Subject|1|||
30607997|NCT01475786|58618672|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
30607998|NCT01475786|58618673|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
30607999|NCT01475786|58618674|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
30786616|NCT00137423|58799848|FG001|Overall Study|Death|1|||
30786617|NCT02786836|58799858|FG000|Overall Study|Death|1|||
30786618|NCT02786836|58799858|FG000|Overall Study|Lack of Efficacy|2|||
30786619|NCT02786836|58799858|FG000|Overall Study|Protocol Violation|3|||
30786620|NCT02786836|58799858|FG000|Overall Study|Withdrawal by Subject|3|||
30786621|NCT02786836|58799858|FG000|Overall Study|Liver Transplantation|2|||
30786622|NCT02786836|58799858|FG000|Overall Study|Device or Pharmacy Issues|3|||
30786623|NCT00137267|58799865|FG000|Overall Study|Lost to Follow-up|15|||
30786624|NCT00137267|58799866|FG001|Overall Study|Lost to Follow-up|21|||
30786625|NCT00137111|58799876|FG000|Total Therapy|Death|35|||
30786626|NCT00137111|58799877|FG001|Total Therapy|Death|0|||
30786627|NCT00137111|58799878|FG002|Total Therapy|Death|0|||
30786628|NCT00137111|58799879|FG003|Total Therapy|Death|0|||
30786629|NCT00137111|58799876|FG000|Total Therapy|Non Compliance|5|||
30786630|NCT00137111|58799877|FG001|Total Therapy|Non Compliance|0|||
30786631|NCT00137111|58799878|FG002|Total Therapy|Non Compliance|0|||
30786632|NCT00137111|58799879|FG003|Total Therapy|Non Compliance|0|||
30786633|NCT00136955|58799886|FG000|Overall Study|Adverse Event|8|||
30786634|NCT00136955|58799886|FG000|Overall Study|Lost to Follow-up|1|||
30786635|NCT00136955|58799886|FG000|Overall Study|Withdrawal by Subject|2|||
30786636|NCT00136955|58799886|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
30786637|NCT00135707|58799892|FG000|Overall Study|Lost to Follow-up|94|||
30786638|NCT00135707|58799893|FG001|Overall Study|Lost to Follow-up|89|||
30786639|NCT00135707|58799892|FG000|Overall Study|Withdrawal by Subject|0|||
30786640|NCT00135707|58799893|FG001|Overall Study|Withdrawal by Subject|1|||
30786641|NCT00135707|58799892|FG000|Overall Study|Institutional review board request|1|||
30786642|NCT00135707|58799893|FG001|Overall Study|Institutional review board request|0|||
30786643|NCT00129701|58799903|FG000|Overall Study|Withdrawal by Subject|33|||
30786644|NCT00129623|58799912|FG000|Overall Study|Adverse Event|3|||
30786645|NCT00129623|58799913|FG001|Overall Study|Adverse Event|7|||
30786646|NCT00129623|58799912|FG000|Overall Study|Refused Treatment|5|||
30786647|NCT00129623|58799913|FG001|Overall Study|Refused Treatment|3|||
30786648|NCT00129623|58799912|FG000|Overall Study|Failure to Return|1|||
30786649|NCT00129623|58799913|FG001|Overall Study|Failure to Return|1|||
30786650|NCT00129623|58799912|FG000|Overall Study|Relocated job out of state|1|||
30786651|NCT00129623|58799913|FG001|Overall Study|Relocated job out of state|0|||
30786652|NCT00129623|58799912|FG000|Overall Study|Uncertainty to return|0|||
30786653|NCT00129623|58799913|FG001|Overall Study|Uncertainty to return|1|||
30786654|NCT00129545|58799924|FG000|Overall Study|Death|5|||
30786655|NCT00129545|58799925|FG001|Overall Study|Death|60|||
30786656|NCT00129545|58799926|FG002|Overall Study|Death|44|||
30786657|NCT00129545|58799924|FG000|Overall Study|Withdrawal by Subject|3|||
30786658|NCT00129545|58799925|FG001|Overall Study|Withdrawal by Subject|18|||
30786659|NCT00129545|58799926|FG002|Overall Study|Withdrawal by Subject|44|||
30786660|NCT00129545|58799924|FG000|Overall Study|Lost to Follow-up|2|||
30786661|NCT00129545|58799925|FG001|Overall Study|Lost to Follow-up|22|||
30786662|NCT00129545|58799926|FG002|Overall Study|Lost to Follow-up|13|||
30786663|NCT00129545|58799924|FG000|Overall Study|Physician Decision|0|||
30786664|NCT00129545|58799925|FG001|Overall Study|Physician Decision|3|||
30786665|NCT00129545|58799926|FG002|Overall Study|Physician Decision|10|||
30786666|NCT00129545|58799924|FG000|Overall Study|Device not implanted|16|||
30786667|NCT00129545|58799925|FG001|Overall Study|Device not implanted|61|||
30786668|NCT00129545|58799926|FG002|Overall Study|Device not implanted|0|||
30786669|NCT00129467|58799936|FG000|Received Intervention|Death|1|||
30786670|NCT00129467|58799937|FG001|Received Intervention|Death|1|||
30786671|NCT00129467|58799936|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
30786672|NCT00129467|58799937|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
30786673|NCT00129467|58799936|FG000|Received Intervention|Delirium|2|||
30786674|NCT00129467|58799937|FG001|Received Intervention|Delirium|0|||
30786675|NCT00129467|58799936|FG000|Received Intervention|Withdrawal by Subject|1|||
30786676|NCT00129467|58799937|FG001|Received Intervention|Withdrawal by Subject|0|||
30786677|NCT00129467|58799936|FG000|Received Intervention|Nausea|1|||
30786678|NCT00129467|58799937|FG001|Received Intervention|Nausea|0|||
30786679|NCT00129467|58799936|FG000|Received Intervention|Intolerance to citalopram|0|||
30786680|NCT00129467|58799937|FG001|Received Intervention|Intolerance to citalopram|1|||
30786681|NCT00129467|58799936|FG000|Received Intervention|Dizzyness, fatigue|0|||
30786682|NCT00129467|58799937|FG001|Received Intervention|Dizzyness, fatigue|1|||
30786683|NCT00129467|58799936|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
30786684|NCT00129467|58799937|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
30786685|NCT00129467|58799936|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
30786686|NCT00129467|58799937|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
30786687|NCT00129311|58799945|FG000|Overall Study|Withdrawal by Subject|12|||
30786688|NCT00129311|58799946|FG001|Overall Study|Withdrawal by Subject|19|||
30786689|NCT00133991|58799952|FG000|Overall Study|Death|4|||
30786690|NCT02784106|58799958|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
30786691|NCT02784106|58799959|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
30786692|NCT02784106|58799960|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
30786693|NCT02784106|58799961|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
30786694|NCT02784106|58799958|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
30786695|NCT02784106|58799959|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
30786696|NCT02784106|58799960|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
30786697|NCT02784106|58799961|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
30786698|NCT02784106|58799958|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
30786699|NCT02784106|58799959|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
30786700|NCT02784106|58799960|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
30786701|NCT02784106|58799961|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
30786702|NCT02784106|58799958|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
30786703|NCT02784106|58799959|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
30786704|NCT02784106|58799960|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
30786705|NCT02784106|58799961|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
30786706|NCT02784106|58799958|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
30786707|NCT02784106|58799959|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
30786708|NCT02784106|58799960|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
30786709|NCT02784106|58799961|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
30786710|NCT02784106|58799958|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
30786711|NCT02784106|58799959|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
30786712|NCT02784106|58799960|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
30786713|NCT02784106|58799961|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
30786714|NCT02785900|58799972|FG000|Overall Study|Study Termination by Sponsor|64|||
30786715|NCT02785900|58799973|FG001|Overall Study|Study Termination by Sponsor|81|||
30786716|NCT02785900|58799972|FG000|Overall Study|Death|46|||
30786717|NCT02785900|58799973|FG001|Overall Study|Death|32|||
30786718|NCT02785900|58799972|FG000|Overall Study|Withdrawal by Subject|4|||
30786719|NCT02785900|58799973|FG001|Overall Study|Withdrawal by Subject|8|||
30786720|NCT02785900|58799972|FG000|Overall Study|Physician Decision|3|||
30786721|NCT02785900|58799973|FG001|Overall Study|Physician Decision|2|||
30786722|NCT00127205|58799982|FG000|Overall Study|Adverse Event|228|||
30786723|NCT00127205|58799983|FG001|Overall Study|Adverse Event|387|||
30786724|NCT00127205|58799984|FG002|Overall Study|Adverse Event|273|||
30786725|NCT00127205|58799982|FG000|Overall Study|Death|8|||
30786726|NCT00127205|58799983|FG001|Overall Study|Death|6|||
30786727|NCT00127205|58799984|FG002|Overall Study|Death|5|||
30786728|NCT00127205|58799982|FG000|Overall Study|Withdrawal by Subject|318|||
30786729|NCT00127205|58799983|FG001|Overall Study|Withdrawal by Subject|310|||
30786730|NCT00127205|58799984|FG002|Overall Study|Withdrawal by Subject|172|||
30786731|NCT00127205|58799982|FG000|Overall Study|Other-non protocol specified|142|||
30786732|NCT00127205|58799983|FG001|Overall Study|Other-non protocol specified|129|||
30786733|NCT00127205|58799984|FG002|Overall Study|Other-non protocol specified|77|||
30786734|NCT00127205|58799982|FG000|Overall Study|Data not reported|6|||
30786735|NCT00127205|58799983|FG001|Overall Study|Data not reported|10|||
30786736|NCT00127205|58799984|FG002|Overall Study|Data not reported|1|||
30786737|NCT00127205|58799982|FG000|Overall Study|Progression|127|||
30786738|NCT00127205|58799983|FG001|Overall Study|Progression|131|||
30786739|NCT00127205|58799984|FG002|Overall Study|Progression|84|||
30786740|NCT02785588|58799994|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
30786741|NCT02785588|58799994|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
30786742|NCT03670641|58799998|FG000|Overall Study|Lost to Follow-up|3|||
30786743|NCT04029519|58800005|FG000|Overall Study|Protocol Violation|1|||
30786744|NCT04029519|58800005|FG000|Overall Study|Withdrawal by Subject|3|||
30786745|NCT04029519|58800005|FG000|Overall Study|Lost to Follow-up|1|||
30786746|NCT03669861|58800009|FG000|Overall Study|Disease Flare|5|||
30786747|NCT03669861|58800009|FG000|Overall Study|Lack of Efficacy|2|||
30786748|NCT00127127|58800017|FG000|Overall Study|Adverse Event|0|||
30786749|NCT00127127|58800018|FG001|Overall Study|Adverse Event|2|||
30786750|NCT00127127|58800019|FG002|Overall Study|Adverse Event|0|||
30786751|NCT00127127|58800020|FG003|Overall Study|Adverse Event|1|||
30786752|NCT00127127|58800017|FG000|Overall Study|Lack of Efficacy|1|||
30786753|NCT00127127|58800018|FG001|Overall Study|Lack of Efficacy|3|||
30786754|NCT00127127|58800019|FG002|Overall Study|Lack of Efficacy|0|||
30786755|NCT00127127|58800020|FG003|Overall Study|Lack of Efficacy|2|||
30786756|NCT03669549|58800057|FG000|Overall Study|Adverse Event|4|||
30786757|NCT03669549|58800057|FG000|Overall Study|Withdrawal by Subject|1|||
30786758|NCT03669549|58800057|FG000|Overall Study|Study terminated by the Sponsor|1|||
30786759|NCT00126659|58800068|FG000|Overall Study|Adverse Event|0|||
30786760|NCT00126659|58800069|FG001|Overall Study|Adverse Event|0|||
30786761|NCT00126659|58800070|FG002|Overall Study|Adverse Event|2|||
30786762|NCT04022733|58800078|FG000|Overall Study|conversion to open surgery|3|||
30786763|NCT04022733|58800079|FG001|Overall Study|conversion to open surgery|2|||
30786764|NCT04022733|58800078|FG000|Overall Study|bradycardia|0|||
30786765|NCT04022733|58800079|FG001|Overall Study|bradycardia|1|||
30786766|NCT03669081|58800087|FG000|Overall Study|Data could not be validated|1|||
30786767|NCT03669081|58800088|FG001|Overall Study|Data could not be validated|1|||
30786768|NCT03667053|58800097|FG000|Overall Study|Withdrawal by Subject|1|||
30786769|NCT03667053|58800098|FG001|Overall Study|Withdrawal by Subject|0|||
30786770|NCT03667053|58800099|FG002|Overall Study|Withdrawal by Subject|0|||
30786771|NCT03631407|58800116|FG000|Overall Study|Withdrawal by Subject|3|||
30786772|NCT03631407|58800117|FG001|Overall Study|Withdrawal by Subject|2|||
30786773|NCT03631407|58800116|FG000|Overall Study|Sponsor Decision|0|||
30786774|NCT03631407|58800117|FG001|Overall Study|Sponsor Decision|2|||
30786775|NCT03631407|58800116|FG000|Overall Study|Death|16|||
30786776|NCT03631407|58800117|FG001|Overall Study|Death|16|||
30786777|NCT03631407|58800116|FG000|Overall Study|Randomized by mistake without study treatment|1|||
30786778|NCT03631407|58800117|FG001|Overall Study|Randomized by mistake without study treatment|0|||
30786779|NCT03630393|58800134|FG000|Overall Study|Death|1|||
30786780|NCT03630393|58800135|FG001|Overall Study|Death|0|||
30786781|NCT03628599|58800152|FG000|Overall Study|Adverse Event|0|||
30786782|NCT03628599|58800153|FG001|Overall Study|Adverse Event|1|||
30786783|NCT03627195|58800179|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
30786784|NCT03627195|58800180|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
30786785|NCT03627195|58800181|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
30786786|NCT03627195|58800182|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
30786787|NCT03627195|58800183|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
30786788|NCT03627195|58800184|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
30786789|NCT00126581|58800200|FG000|Overall Study|Adverse Event|3|||
30786790|NCT00126581|58800201|FG001|Overall Study|Adverse Event|7|||
30786791|NCT00126581|58800200|FG000|Overall Study|Death|3|||
30786792|NCT00126581|58800201|FG001|Overall Study|Death|2|||
30786793|NCT00126581|58800200|FG000|Overall Study|Withdrawal by Subject|1|||
30786794|NCT00126581|58800201|FG001|Overall Study|Withdrawal by Subject|4|||
30786795|NCT00126581|58800200|FG000|Overall Study|Alternative therapy|3|||
30786796|NCT00126581|58800201|FG001|Overall Study|Alternative therapy|3|||
30786797|NCT00126581|58800200|FG000|Overall Study|Other illness/MD discretion|3|||
30786798|NCT00126581|58800201|FG001|Overall Study|Other illness/MD discretion|4|||
30786799|NCT03704584|58800211|FG000|Overall Study|Withdrawal by Subject|1|||
30786800|NCT03704584|58800212|FG001|Overall Study|Withdrawal by Subject|0|||
30786801|NCT03662997|58800222|FG000|Overall Study|Adverse Event|0|||
30786802|NCT03662997|58800223|FG001|Overall Study|Adverse Event|2|||
30786803|NCT03662997|58800224|FG002|Overall Study|Adverse Event|0|||
30786804|NCT03662997|58800225|FG003|Overall Study|Adverse Event|0|||
30786805|NCT03648879|58800237|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
30786806|NCT03647709|58800241|FG000|Overall Study|Lost to Follow-up|5|||
30786807|NCT03647709|58800241|FG000|Overall Study|Physician Decision|6|||
30786808|NCT03647709|58800241|FG000|Overall Study|Withdrawal by Subject|3|||
30786809|NCT03661983|58800247|FG000|Open Label Stabilization Phase|Adverse Event|5|||
30786810|NCT03661983|58800248|FG001|Open Label Stabilization Phase|Adverse Event|0|||
30786811|NCT03661983|58800249|FG002|Open Label Stabilization Phase|Adverse Event|0|||
30786812|NCT03661983|58800250|FG003|Open Label Stabilization Phase|Adverse Event|0|||
30786813|NCT03661983|58800247|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
30786814|NCT03661983|58800248|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
30786815|NCT03661983|58800249|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
30786816|NCT03661983|58800250|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
30786817|NCT03661983|58800247|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
30786818|NCT03661983|58800248|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
30786819|NCT03661983|58800249|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
30786820|NCT03661983|58800250|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
30786821|NCT03661983|58800247|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
30786822|NCT03661983|58800248|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
30786823|NCT03661983|58800249|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
30786824|NCT03661983|58800250|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
30786825|NCT03661983|58800247|FG000|Double-blind Randomized Phase|Adverse Event|0|||
30786826|NCT03661983|58800248|FG001|Double-blind Randomized Phase|Adverse Event|1|||
30786827|NCT03661983|58800249|FG002|Double-blind Randomized Phase|Adverse Event|0|||
30786828|NCT03661983|58800250|FG003|Double-blind Randomized Phase|Adverse Event|0|||
30786829|NCT03661983|58800247|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
30786830|NCT03661983|58800248|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
30786831|NCT03661983|58800249|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
30786832|NCT03661983|58800250|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
30786833|NCT03661983|58800247|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
30786834|NCT03661983|58800248|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
30786835|NCT03661983|58800249|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
30786836|NCT03661983|58800250|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
30786837|NCT03661983|58800247|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
30786838|NCT03661983|58800248|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
30786839|NCT03661983|58800249|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
30786840|NCT03661983|58800250|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
30786841|NCT02783170|58800261|FG000|Overall Study|Randomized but not Vaccinated|1|||
30786842|NCT02783170|58800262|FG001|Overall Study|Randomized but not Vaccinated|0|||
30786843|NCT03646305|58800273|FG000|Overall Study|Lost to Follow-up|4|||
30786844|NCT03646305|58800274|FG001|Overall Study|Lost to Follow-up|2|||
30786845|NCT03646305|58800275|FG002|Overall Study|Lost to Follow-up|2|||
30786846|NCT03646305|58800276|FG003|Overall Study|Lost to Follow-up|1|||
30786847|NCT03646305|58800273|FG000|Overall Study|Withdrawal by Subject|1|||
30786848|NCT03646305|58800274|FG001|Overall Study|Withdrawal by Subject|0|||
30786849|NCT03646305|58800275|FG002|Overall Study|Withdrawal by Subject|0|||
30786850|NCT03646305|58800276|FG003|Overall Study|Withdrawal by Subject|1|||
30786851|NCT02782780|58800292|FG000|Overall Study|dropped out after randomization.|7|||
30786852|NCT02782780|58800293|FG001|Overall Study|dropped out after randomization.|5|||
30786853|NCT02782780|58800292|FG000|Overall Study|Protocol Violation|0|||
30786854|NCT02782780|58800293|FG001|Overall Study|Protocol Violation|2|||
30786855|NCT00126503|58800305|FG000|Overall Study|disease progression|23|||
30786856|NCT00126503|58800306|FG001|Overall Study|disease progression|14|||
30786857|NCT00126503|58800305|FG000|Overall Study|Withdrawal by Subject|0|||
30786858|NCT00126503|58800306|FG001|Overall Study|Withdrawal by Subject|1|||
30786859|NCT00126503|58800305|FG000|Overall Study|alternative therapy|1|||
30786860|NCT00126503|58800306|FG001|Overall Study|alternative therapy|1|||
30786861|NCT00126503|58800305|FG000|Overall Study|other complicating disease|4|||
30786862|NCT00126503|58800306|FG001|Overall Study|other complicating disease|1|||
30786863|NCT00126503|58800305|FG000|Overall Study|Death|3|||
30786864|NCT00126503|58800306|FG001|Overall Study|Death|0|||
30786865|NCT00126503|58800305|FG000|Overall Study|Adverse Event|13|||
30786866|NCT00126503|58800306|FG001|Overall Study|Adverse Event|3|||
30786867|NCT00126503|58800305|FG000|Overall Study|non-compliant|1|||
30786868|NCT00126503|58800306|FG001|Overall Study|non-compliant|0|||
30786869|NCT00126503|58800305|FG000|Overall Study|Physician Decision|2|||
30786870|NCT00126503|58800306|FG001|Overall Study|Physician Decision|1|||
30786871|NCT00126425|58800318|FG000|Overall Study|Withdrawal by Subject|17|||
30786872|NCT00126425|58800319|FG001|Overall Study|Withdrawal by Subject|1|||
30786873|NCT00126425|58800318|FG000|Overall Study|Lost to Follow-up|8|||
30786874|NCT00126425|58800319|FG001|Overall Study|Lost to Follow-up|4|||
30786875|NCT00126425|58800318|FG000|Overall Study|Protocol Violation|9|||
30786876|NCT00126425|58800319|FG001|Overall Study|Protocol Violation|6|||
30786877|NCT00126425|58800318|FG000|Overall Study|Adverse Event|1|||
30786878|NCT00126425|58800319|FG001|Overall Study|Adverse Event|0|||
30786879|NCT00126425|58800318|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
30786880|NCT00126425|58800319|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
30786881|NCT00126425|58800318|FG000|Overall Study|Other|5|||
30786882|NCT00126425|58800319|FG001|Overall Study|Other|0|||
30786883|NCT00126191|58800327|FG000|Overall Study|Physician Decision|0|||
30786884|NCT00126191|58800328|FG001|Overall Study|Physician Decision|1|||
30786885|NCT00126191|58800327|FG000|Overall Study|Death|0|||
30786886|NCT00126191|58800328|FG001|Overall Study|Death|1|||
30786887|NCT00124943|58800338|FG000|Phase II|Adverse Event|0|||
30786888|NCT00124943|58800339|FG001|Phase II|Adverse Event|2|||
30786889|NCT00124943|58800340|FG002|Phase II|Adverse Event|0|||
30786890|NCT00124943|58800341|FG003|Phase II|Adverse Event|1|||
30786891|NCT00124943|58800338|FG000|Phase II|Protocol Violation|0|||
30786892|NCT00124943|58800339|FG001|Phase II|Protocol Violation|0|||
30786893|NCT00124943|58800340|FG002|Phase II|Protocol Violation|0|||
30786894|NCT00124943|58800341|FG003|Phase II|Protocol Violation|1|||
30786895|NCT00124943|58800338|FG000|Phase II|Lost to Follow-up|0|||
30786896|NCT00124943|58800339|FG001|Phase II|Lost to Follow-up|0|||
30786897|NCT00124943|58800340|FG002|Phase II|Lost to Follow-up|0|||
30786898|NCT00124943|58800341|FG003|Phase II|Lost to Follow-up|1|||
30786899|NCT00124943|58800338|FG000|Phase II|Withdrawal by Subject|0|||
30786900|NCT00124943|58800339|FG001|Phase II|Withdrawal by Subject|0|||
30786901|NCT00124943|58800340|FG002|Phase II|Withdrawal by Subject|0|||
30786902|NCT00124943|58800341|FG003|Phase II|Withdrawal by Subject|2|||
30786903|NCT00124709|58800353|FG000|Overall Study|Randomized but did not take medication|3|||
30786904|NCT00124709|58800354|FG001|Overall Study|Randomized but did not take medication|1|||
30786905|NCT00124709|58800353|FG000|Overall Study|Adverse Event|3|||
30786906|NCT00124709|58800354|FG001|Overall Study|Adverse Event|0|||
30786907|NCT00124709|58800353|FG000|Overall Study|Lack of Efficacy|5|||
30786908|NCT00124709|58800354|FG001|Overall Study|Lack of Efficacy|10|||
30786909|NCT00124709|58800353|FG000|Overall Study|Protocol Violation|3|||
30786910|NCT00124709|58800354|FG001|Overall Study|Protocol Violation|5|||
30786911|NCT00124709|58800353|FG000|Overall Study|Withdrawal by Subject|127|||
30786912|NCT00124709|58800354|FG001|Overall Study|Withdrawal by Subject|136|||
30786913|NCT00124709|58800353|FG000|Overall Study|Lost to Follow-up|114|||
30786914|NCT00124709|58800354|FG001|Overall Study|Lost to Follow-up|120|||
30786915|NCT00108862|58800362|FG000|Overall Study|Death|31|||
30786916|NCT00108862|58800363|FG001|Overall Study|Death|37|||
30786917|NCT00108862|58800362|FG000|Overall Study|Withdrawal by Subject|10|||
30786918|NCT00108862|58800363|FG001|Overall Study|Withdrawal by Subject|6|||
30786919|NCT00108862|58800362|FG000|Overall Study|Lost to Follow-up|27|||
30786920|NCT00108862|58800363|FG001|Overall Study|Lost to Follow-up|19|||
30786921|NCT00564850|58800369|FG000|Overall Study|Protocol Violation|2|||
30786922|NCT00561340|58800375|FG000|Overall Study|refused to drink pediasure|6|||
30786923|NCT00561340|58800376|FG001|Overall Study|refused to drink pediasure|0|||
30786924|NCT00108628|58800384|FG000|Overall Study|Withdrawal by Subject|17|||
30786925|NCT00108628|58800385|FG001|Overall Study|Withdrawal by Subject|9|||
30786926|NCT00108628|58800384|FG000|Overall Study|Lack of Efficacy|2|||
30786927|NCT00108628|58800385|FG001|Overall Study|Lack of Efficacy|1|||
30786928|NCT00108628|58800384|FG000|Overall Study|Death|1|||
30786929|NCT00108628|58800385|FG001|Overall Study|Death|0|||
30786930|NCT02715856|58800393|FG000|Overall Study|Software Issues|12|||
30786931|NCT02715856|58800394|FG001|Overall Study|Software Issues|7|||
30786932|NCT02715856|58800393|FG000|Overall Study|Death|6|||
30786933|NCT02715856|58800394|FG001|Overall Study|Death|5|||
30786934|NCT02715856|58800393|FG000|Overall Study|Non- Compliant|0|||
30786935|NCT02715856|58800394|FG001|Overall Study|Non- Compliant|40|||
30786936|NCT00108160|58800402|FG000|Overall Study|Lost to Follow-up|25|||
30786937|NCT00108160|58800403|FG001|Overall Study|Lost to Follow-up|12|||
30786938|NCT00108160|58800402|FG000|Overall Study|Death|1|||
30786939|NCT00108160|58800403|FG001|Overall Study|Death|2|||
30786940|NCT00108160|58800402|FG000|Overall Study|Withdrawal by Subject|4|||
30786941|NCT00108160|58800403|FG001|Overall Study|Withdrawal by Subject|2|||
30786942|NCT00108160|58800402|FG000|Overall Study|Protocol Violation|9|||
30786943|NCT00108160|58800403|FG001|Overall Study|Protocol Violation|5|||
30786944|NCT01366846|58800415|FG000|Overall Study|Withdrawal by Subject|2|||
30786945|NCT01366846|58800416|FG001|Overall Study|Withdrawal by Subject|0|||
30786946|NCT01366846|58800417|FG002|Overall Study|Withdrawal by Subject|0|||
30786947|NCT01366846|58800418|FG003|Overall Study|Withdrawal by Subject|0|||
30786948|NCT01366846|58800415|FG000|Overall Study|Communication Difficulties|1|||
30786949|NCT01366846|58800416|FG001|Overall Study|Communication Difficulties|4|||
30786950|NCT01366846|58800417|FG002|Overall Study|Communication Difficulties|0|||
30786951|NCT01366846|58800418|FG003|Overall Study|Communication Difficulties|1|||
30786952|NCT01366846|58800415|FG000|Overall Study|Scheduling Conflicts|0|||
30786953|NCT01366846|58800416|FG001|Overall Study|Scheduling Conflicts|0|||
30786954|NCT01366846|58800417|FG002|Overall Study|Scheduling Conflicts|1|||
30786955|NCT01366846|58800418|FG003|Overall Study|Scheduling Conflicts|0|||
30786956|NCT00108082|58800434|FG000|Overall Study|Adverse Event|14|||
30786957|NCT00108082|58800435|FG001|Overall Study|Adverse Event|12|||
30786958|NCT00108082|58800436|FG002|Overall Study|Adverse Event|17|||
30786959|NCT00108082|58800434|FG000|Overall Study|Lost to Follow-up|6|||
30786960|NCT00108082|58800435|FG001|Overall Study|Lost to Follow-up|3|||
30786961|NCT00108082|58800436|FG002|Overall Study|Lost to Follow-up|7|||
30786962|NCT00108082|58800434|FG000|Overall Study|Consent Withdrawn|3|||
30786963|NCT00108082|58800435|FG001|Overall Study|Consent Withdrawn|3|||
30786964|NCT00108082|58800436|FG002|Overall Study|Consent Withdrawn|5|||
30786965|NCT00108082|58800434|FG000|Overall Study|Protocol Violation|1|||
30786966|NCT00108082|58800435|FG001|Overall Study|Protocol Violation|2|||
30786967|NCT00108082|58800436|FG002|Overall Study|Protocol Violation|0|||
30786968|NCT00108082|58800434|FG000|Overall Study|Lack of Efficacy|3|||
30786969|NCT00108082|58800435|FG001|Overall Study|Lack of Efficacy|1|||
30786970|NCT00108082|58800436|FG002|Overall Study|Lack of Efficacy|2|||
30786971|NCT00108082|58800434|FG000|Overall Study|Amendment 4: > Month 12|5|||
30786972|NCT00108082|58800435|FG001|Overall Study|Amendment 4: > Month 12|7|||
30786973|NCT00108082|58800436|FG002|Overall Study|Amendment 4: > Month 12|5|||
30786974|NCT00108082|58800434|FG000|Overall Study|Woman of Child-bearing Potential|2|||
30786975|NCT00108082|58800435|FG001|Overall Study|Woman of Child-bearing Potential|0|||
30786976|NCT00108082|58800436|FG002|Overall Study|Woman of Child-bearing Potential|2|||
30786977|NCT00108082|58800434|FG000|Overall Study|Incorrectly Randomized|0|||
30786978|NCT00108082|58800435|FG001|Overall Study|Incorrectly Randomized|0|||
30786979|NCT00108082|58800436|FG002|Overall Study|Incorrectly Randomized|2|||
30786980|NCT00108082|58800434|FG000|Overall Study|Non-compliance|1|||
30786981|NCT00108082|58800435|FG001|Overall Study|Non-compliance|0|||
30786982|NCT00108082|58800436|FG002|Overall Study|Non-compliance|2|||
30786983|NCT00108082|58800434|FG000|Overall Study|Stopped Study Medication|0|||
30786984|NCT00108082|58800435|FG001|Overall Study|Stopped Study Medication|0|||
30786985|NCT00108082|58800436|FG002|Overall Study|Stopped Study Medication|1|||
30786986|NCT00108082|58800434|FG000|Overall Study|Site Closed Study|0|||
30786987|NCT00108082|58800435|FG001|Overall Study|Site Closed Study|2|||
30786988|NCT00108082|58800436|FG002|Overall Study|Site Closed Study|0|||
30786989|NCT00108082|58800434|FG000|Overall Study|Protocol Amendment|0|||
30786990|NCT00108082|58800435|FG001|Overall Study|Protocol Amendment|1|||
30786991|NCT00108082|58800436|FG002|Overall Study|Protocol Amendment|0|||
30786992|NCT00108082|58800434|FG000|Overall Study|Study Medication Not Tapered|0|||
30786993|NCT00108082|58800435|FG001|Overall Study|Study Medication Not Tapered|1|||
30786994|NCT00108082|58800436|FG002|Overall Study|Study Medication Not Tapered|0|||
30786995|NCT00108082|58800434|FG000|Overall Study|Subject Left Site Location|1|||
30786996|NCT00108082|58800435|FG001|Overall Study|Subject Left Site Location|0|||
30786997|NCT00108082|58800436|FG002|Overall Study|Subject Left Site Location|0|||
30786998|NCT00108082|58800434|FG000|Overall Study|Investigator Not at Site|1|||
30786999|NCT00108082|58800435|FG001|Overall Study|Investigator Not at Site|0|||
30787000|NCT00108082|58800436|FG002|Overall Study|Investigator Not at Site|0|||
30787001|NCT00108082|58800434|FG000|Overall Study|Blood Pressure Not Controlled|1|||
30787002|NCT00108082|58800435|FG001|Overall Study|Blood Pressure Not Controlled|0|||
30787003|NCT00108082|58800436|FG002|Overall Study|Blood Pressure Not Controlled|0|||
30787004|NCT00104728|58800448|FG000|Overall Study|screen failures|19|||
30787005|NCT02781844|58800456|FG000|Treatment Period 1|Adverse Event|0|||
30787006|NCT02781844|58800457|FG001|Treatment Period 1|Adverse Event|0|||
30787007|NCT02781844|58800458|FG002|Treatment Period 1|Adverse Event|0|||
30787008|NCT02781844|58800459|FG003|Treatment Period 1|Adverse Event|0|||
30787009|NCT02781844|58800460|FG004|Treatment Period 1|Adverse Event|0|||
30787010|NCT02781844|58800461|FG005|Treatment Period 1|Adverse Event|1|||
30787011|NCT02781844|58800462|FG006|Treatment Period 1|Adverse Event|0|||
30787012|NCT02781844|58800463|FG007|Treatment Period 1|Adverse Event|0|||
30787013|NCT02775916|58800481|FG000|Overall Study|Adverse Event|1|||
30787014|NCT02775916|58800482|FG001|Overall Study|Adverse Event|0|||
30787015|NCT02775916|58800481|FG000|Overall Study|Subject/Guardian Decision|2|||
30787016|NCT02775916|58800482|FG001|Overall Study|Subject/Guardian Decision|0|||
30787017|NCT00122681|58800490|FG000|Overall Study|Adverse Event|20|||
30787018|NCT00122681|58800491|FG001|Overall Study|Adverse Event|16|||
30787019|NCT00122681|58800490|FG000|Overall Study|Lost to Follow-up|1080|||
30787020|NCT00122681|58800491|FG001|Overall Study|Lost to Follow-up|1097|||
30787021|NCT00122681|58800490|FG000|Overall Study|Protocol Violation|7|||
30787022|NCT00122681|58800491|FG001|Overall Study|Protocol Violation|10|||
30787023|NCT00122681|58800490|FG000|Overall Study|Withdrawal by Subject|257|||
30787024|NCT00122681|58800491|FG001|Overall Study|Withdrawal by Subject|251|||
30787025|NCT00122681|58800490|FG000|Overall Study|Personal reasons|150|||
30787026|NCT00122681|58800491|FG001|Overall Study|Personal reasons|147|||
30787027|NCT02774278|58800505|FG000|Overall Study|Lack of Efficacy|199|||
30787028|NCT02774278|58800505|FG000|Overall Study|Death|29|||
30787029|NCT02774278|58800505|FG000|Overall Study|Adverse event/intercurrent illness|16|||
30787030|NCT02774278|58800505|FG000|Overall Study|Refused treatment/did not cooperate|9|||
30787031|NCT02774278|58800505|FG000|Overall Study|Administrative reasons|6|||
30787032|NCT02774278|58800505|FG000|Overall Study|Withdrawal by Subject|3|||
30787033|NCT02774278|58800505|FG000|Overall Study|Protocol Violation|2|||
30787034|NCT03621189|58800511|FG000|Overall Study|Withdrawal by Subject|0|||
30787035|NCT03621189|58800512|FG001|Overall Study|Withdrawal by Subject|3|||
30787036|NCT03621189|58800511|FG000|Overall Study|Physician Decision|0|||
30787037|NCT03621189|58800512|FG001|Overall Study|Physician Decision|2|||
30787038|NCT00122135|58800521|FG000|Overall Study|Withdrawal by Subject|3|||
30787039|NCT00122135|58800522|FG001|Overall Study|Withdrawal by Subject|0|||
30787040|NCT03645057|58800532|FG000|Randomization to Baseline|Lost to Follow-up|1|||
30787041|NCT03645057|58800533|FG001|Randomization to Baseline|Lost to Follow-up|0|||
30787042|NCT03645057|58800534|FG002|Randomization to Baseline|Lost to Follow-up|1|||
30787043|NCT03645057|58800535|FG003|Randomization to Baseline|Lost to Follow-up|0|||
30787044|NCT03645057|58800532|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
30787045|NCT03645057|58800533|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
30787046|NCT03645057|58800534|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
30787047|NCT03645057|58800535|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
30787048|NCT03645057|58800532|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
30787049|NCT03645057|58800533|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
30787050|NCT03645057|58800534|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
30787051|NCT03645057|58800535|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
30787052|NCT03645057|58800532|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
30787053|NCT03645057|58800533|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
30787054|NCT03645057|58800534|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
30787055|NCT03645057|58800535|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
30787056|NCT00132041|58800541|FG000|Baseline|Ineligible|6|||
30787057|NCT00132041|58800541|FG000|3 Months Post Ablation|Transplant|1|||
30787058|NCT00132041|58800541|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
30787059|NCT00132041|58800541|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
30787060|NCT00132041|58800541|FG000|6 Months Post Ablation|Death|2|||
30787061|NCT00132041|58800541|FG000|6 Months Post Ablation|Transplant|6|||
30787062|NCT00132041|58800541|FG000|9 Months Post Ablation|Death|1|||
30787063|NCT00132041|58800541|FG000|9 Months Post Ablation|Transplant|1|||
30787064|NCT00132041|58800541|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
30787065|NCT00132041|58800541|FG000|12 Months Post Ablation|Death|1|||
30787066|NCT00132041|58800541|FG000|12 Months Post Ablation|Transplant|1|||
30787067|NCT00132041|58800541|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
30787068|NCT00132041|58800541|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
30787069|NCT00132041|58800541|FG000|15 Months Post Ablation|Death|1|||
30787070|NCT00132041|58800541|FG000|15 Months Post Ablation|Transplant|5|||
30787071|NCT00132041|58800541|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
30787072|NCT00132041|58800541|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
30787073|NCT00132041|58800541|FG000|18 Months Post Ablation|Transplant|1|||
30787074|NCT00132041|58800541|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
30787075|NCT00132041|58800541|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
30787076|NCT03643575|58800551|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
30787077|NCT03643575|58800552|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
30787078|NCT03643575|58800553|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
30787079|NCT03643575|58800554|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
30787080|NCT03643575|58800555|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
30787081|NCT03643575|58800556|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
30787082|NCT03643575|58800551|FG000|Washout: 7 Days|Adverse Event|1|||
30787083|NCT03643575|58800552|FG001|Washout: 7 Days|Adverse Event|0|||
30787084|NCT03643575|58800553|FG002|Washout: 7 Days|Adverse Event|0|||
30787085|NCT03643575|58800554|FG003|Washout: 7 Days|Adverse Event|0|||
30787086|NCT03643575|58800555|FG004|Washout: 7 Days|Adverse Event|0|||
30787087|NCT03643575|58800556|FG005|Washout: 7 Days|Adverse Event|0|||
30787088|NCT03643575|58800551|FG000|Washout: 7 Days|Non compliance check in|0|||
30787089|NCT03643575|58800552|FG001|Washout: 7 Days|Non compliance check in|1|||
30787090|NCT03643575|58800553|FG002|Washout: 7 Days|Non compliance check in|0|||
30787091|NCT03643575|58800554|FG003|Washout: 7 Days|Non compliance check in|0|||
30787092|NCT03643575|58800555|FG004|Washout: 7 Days|Non compliance check in|0|||
30787093|NCT03643575|58800556|FG005|Washout: 7 Days|Non compliance check in|0|||
30787094|NCT02768194|58800564|FG000|Period 1|Adverse Event|0|||
30787095|NCT02768194|58800565|FG001|Period 1|Adverse Event|0|||
30787096|NCT02768194|58800566|FG002|Period 1|Adverse Event|0|||
30787097|NCT02768194|58800567|FG003|Period 1|Adverse Event|1|||
30787098|NCT02768194|58800568|FG004|Period 1|Adverse Event|0|||
30787099|NCT02768194|58800569|FG005|Period 1|Adverse Event|0|||
30787100|NCT02768194|58800564|FG000|Period 2|Other (Reason not specified)|1|||
30787101|NCT02768194|58800565|FG001|Period 2|Other (Reason not specified)|0|||
30787102|NCT02768194|58800566|FG002|Period 2|Other (Reason not specified)|0|||
30787103|NCT02768194|58800567|FG003|Period 2|Other (Reason not specified)|0|||
30787104|NCT02768194|58800568|FG004|Period 2|Other (Reason not specified)|0|||
30787105|NCT02768194|58800569|FG005|Period 2|Other (Reason not specified)|0|||
30787106|NCT02768194|58800564|FG000|Period 3|Other (Reason not specified)|0|||
30787107|NCT02768194|58800565|FG001|Period 3|Other (Reason not specified)|1|||
30787108|NCT02768194|58800566|FG002|Period 3|Other (Reason not specified)|0|||
30787109|NCT02768194|58800567|FG003|Period 3|Other (Reason not specified)|0|||
30787110|NCT02768194|58800568|FG004|Period 3|Other (Reason not specified)|0|||
30787111|NCT02768194|58800569|FG005|Period 3|Other (Reason not specified)|0|||
30787112|NCT00130793|58800579|FG000|Overall Study|Lost to Follow-up|1|||
30787113|NCT00130793|58800580|FG001|Overall Study|Lost to Follow-up|4|||
30787114|NCT00130793|58800579|FG000|Overall Study|Withdrew consent|2|||
30787115|NCT00130793|58800580|FG001|Overall Study|Withdrew consent|0|||
30787116|NCT03818399|58800587|FG000|Overall Study|Lost to Follow-up|11|||
30787117|NCT03818399|58800587|FG000|Overall Study|Withdrawal by Subject|1|||
30787118|NCT03818399|58800587|FG000|Overall Study|Protocol Violation|2|||
30787119|NCT03642873|58800591|FG000|Third Intervention (1 Day)|Screen failure|0|||
30787120|NCT03642873|58800592|FG001|Third Intervention (1 Day)|Screen failure|0|||
30787121|NCT03642873|58800593|FG002|Third Intervention (1 Day)|Screen failure|0|||
30787122|NCT03642873|58800594|FG003|Third Intervention (1 Day)|Screen failure|0|||
30787123|NCT03642873|58800595|FG004|Third Intervention (1 Day)|Screen failure|1|||
30787124|NCT03642873|58800596|FG005|Third Intervention (1 Day)|Screen failure|0|||
30787125|NCT03818321|58800610|FG000|Overall Study|Withdrawal by Subject|1|||
30787126|NCT03818321|58800611|FG001|Overall Study|Withdrawal by Subject|2|||
30787127|NCT03616977|58800617|FG000|Period 1|Physician Decision|0|||
30787128|NCT03616977|58800618|FG001|Period 1|Physician Decision|1|||
30787129|NCT03616977|58800617|FG000|Period 3|Adverse Event|1|||
30787130|NCT03616977|58800618|FG001|Period 3|Adverse Event|1|||
30787131|NCT02767570|58800627|FG000|Overall Study|Lost to Follow-up|3|||
30787132|NCT02767570|58800628|FG001|Overall Study|Lost to Follow-up|0|||
30787133|NCT02767570|58800627|FG000|Overall Study|COVID shutdown|2|||
30787134|NCT02767570|58800628|FG001|Overall Study|COVID shutdown|5|||
30787135|NCT02767570|58800627|FG000|Overall Study|Increased pain|2|||
30787136|NCT02767570|58800628|FG001|Overall Study|Increased pain|0|||
30787137|NCT02767570|58800627|FG000|Overall Study|Withdrawal by Subject|1|||
30787138|NCT02767570|58800628|FG001|Overall Study|Withdrawal by Subject|3|||
30787139|NCT02767570|58800627|FG000|Overall Study|Unrelated medical issue|1|||
30787140|NCT02767570|58800628|FG001|Overall Study|Unrelated medical issue|1|||
30787141|NCT02767570|58800627|FG000|Overall Study|Received intra-articular injection|0|||
30787142|NCT02767570|58800628|FG001|Overall Study|Received intra-articular injection|1|||
30787143|NCT03816761|58800637|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
30787144|NCT03816761|58800638|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
30787145|NCT03816761|58800639|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
30787146|NCT03816761|58800640|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
30787147|NCT03816761|58800641|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
30787148|NCT03816761|58800642|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
30787149|NCT03816761|58800637|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
30787150|NCT03816761|58800638|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
30787151|NCT03816761|58800639|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
30787152|NCT03816761|58800640|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
30787153|NCT03816761|58800641|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
30787154|NCT03816761|58800642|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
30787155|NCT02770612|58800664|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
30787156|NCT03575871|58800671|FG000|Overall Study|Adverse Event|5|||
30787157|NCT03575871|58800672|FG001|Overall Study|Adverse Event|5|||
30787158|NCT03575871|58800673|FG002|Overall Study|Adverse Event|8|||
30787159|NCT03575871|58800671|FG000|Overall Study|Death|1|||
30787160|NCT03575871|58800672|FG001|Overall Study|Death|0|||
30787161|NCT03575871|58800673|FG002|Overall Study|Death|0|||
30787162|NCT03575871|58800671|FG000|Overall Study|Lack of Efficacy|5|||
30787163|NCT03575871|58800672|FG001|Overall Study|Lack of Efficacy|4|||
30787164|NCT03575871|58800673|FG002|Overall Study|Lack of Efficacy|7|||
30787165|NCT03575871|58800671|FG000|Overall Study|Lost to Follow-up|1|||
30787166|NCT03575871|58800672|FG001|Overall Study|Lost to Follow-up|1|||
30787167|NCT03575871|58800673|FG002|Overall Study|Lost to Follow-up|1|||
30787168|NCT03575871|58800671|FG000|Overall Study|Protocol Deviation|1|||
30787169|NCT03575871|58800672|FG001|Overall Study|Protocol Deviation|1|||
30787170|NCT03575871|58800673|FG002|Overall Study|Protocol Deviation|1|||
30787171|NCT03575871|58800671|FG000|Overall Study|Withdrawal by Subject|6|||
30787172|NCT03575871|58800672|FG001|Overall Study|Withdrawal by Subject|1|||
30787173|NCT03575871|58800673|FG002|Overall Study|Withdrawal by Subject|9|||
30787174|NCT03575871|58800671|FG000|Overall Study|Other than specified|2|||
30787175|NCT03575871|58800672|FG001|Overall Study|Other than specified|2|||
30787176|NCT03575871|58800673|FG002|Overall Study|Other than specified|0|||
30787177|NCT03642717|58800681|FG000|Overall Study|Lost to Follow-up|2|||
30787178|NCT03642717|58800681|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
30787179|NCT03642717|58800681|FG000|Overall Study|Taken study drug prior to contract date|3|||
30787180|NCT02766478|58800688|FG000|Overall Study|Withdrawal by Subject|1|||
30787181|NCT02766478|58800689|FG001|Overall Study|Withdrawal by Subject|1|||
30787182|NCT02766400|58800697|FG000|Overall Study|Death|1|||
30787183|NCT02766400|58800698|FG001|Overall Study|Death|2|||
30787184|NCT02766400|58800697|FG000|Overall Study|Withdrawal by Subject|1|||
30787185|NCT02766400|58800698|FG001|Overall Study|Withdrawal by Subject|0|||
30787186|NCT00104650|58800707|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
30787187|NCT00104650|58800708|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
30787188|NCT00104650|58800709|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
30787189|NCT00104650|58800707|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
30787190|NCT00104650|58800708|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
30787191|NCT00104650|58800709|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
30787192|NCT00104650|58800707|FG000|Treatment Period (25 Weeks)|Death|7|||
30787193|NCT00104650|58800708|FG001|Treatment Period (25 Weeks)|Death|5|||
30787194|NCT00104650|58800709|FG002|Treatment Period (25 Weeks)|Death|6|||
30787195|NCT00104650|58800707|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
30787196|NCT00104650|58800708|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
30787197|NCT00104650|58800709|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
30787198|NCT00104650|58800707|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
30787199|NCT00104650|58800708|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
30787200|NCT00104650|58800709|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
30787201|NCT00104650|58800707|FG000|Treatment Period (25 Weeks)|Other|1|||
30787202|NCT00104650|58800708|FG001|Treatment Period (25 Weeks)|Other|0|||
30787203|NCT00104650|58800709|FG002|Treatment Period (25 Weeks)|Other|0|||
30787204|NCT00104650|58800707|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
30787205|NCT00104650|58800708|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
30787206|NCT00104650|58800709|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
30787207|NCT00104650|58800707|FG000|Follow-up Period|Physician Decision|1|||
30787208|NCT00104650|58800708|FG001|Follow-up Period|Physician Decision|1|||
30787209|NCT00104650|58800709|FG002|Follow-up Period|Physician Decision|0|||
30787210|NCT00104650|58800707|FG000|Follow-up Period|Adverse Event|1|||
30787211|NCT00104650|58800708|FG001|Follow-up Period|Adverse Event|0|||
30787212|NCT00104650|58800709|FG002|Follow-up Period|Adverse Event|1|||
30787213|NCT00104650|58800707|FG000|Follow-up Period|Withdrawal by Subject|0|||
30787214|NCT00104650|58800708|FG001|Follow-up Period|Withdrawal by Subject|3|||
30787215|NCT00104650|58800709|FG002|Follow-up Period|Withdrawal by Subject|3|||
30787216|NCT00104650|58800707|FG000|Follow-up Period|Death|6|||
30787217|NCT00104650|58800708|FG001|Follow-up Period|Death|6|||
30787218|NCT00104650|58800709|FG002|Follow-up Period|Death|4|||
30787219|NCT00104650|58800707|FG000|Follow-up Period|Disease progression|3|||
30787220|NCT00104650|58800708|FG001|Follow-up Period|Disease progression|1|||
30787221|NCT00104650|58800709|FG002|Follow-up Period|Disease progression|0|||
30787222|NCT00104650|58800707|FG000|Follow-up Period|Lost to Follow-up|0|||
30787223|NCT00104650|58800708|FG001|Follow-up Period|Lost to Follow-up|1|||
30787224|NCT00104650|58800709|FG002|Follow-up Period|Lost to Follow-up|2|||
30787225|NCT00104650|58800707|FG000|Follow-up Period|Other|0|||
30787226|NCT00104650|58800708|FG001|Follow-up Period|Other|1|||
30787227|NCT00104650|58800709|FG002|Follow-up Period|Other|0|||
30787228|NCT03732807|58800724|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
30787229|NCT03732807|58800725|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
30787230|NCT03732807|58800726|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
30787231|NCT03732807|58800727|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
30787232|NCT03732807|58800728|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
30787233|NCT03732807|58800729|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
30787234|NCT03732807|58800730|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
30787235|NCT03732807|58800724|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
30787236|NCT03732807|58800725|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
30787237|NCT03732807|58800726|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
30787238|NCT03732807|58800727|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
30787239|NCT03732807|58800728|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
30787240|NCT03732807|58800729|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
30787241|NCT03732807|58800730|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
30787242|NCT03732807|58800724|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
30787243|NCT03732807|58800725|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
30787244|NCT03732807|58800726|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
30787245|NCT03732807|58800727|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
30787246|NCT03732807|58800728|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
30787247|NCT03732807|58800729|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
30787248|NCT03732807|58800730|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
30787249|NCT03732807|58800724|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
30787250|NCT03732807|58800725|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
30787251|NCT03732807|58800726|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
30787252|NCT03732807|58800727|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
30787253|NCT03732807|58800728|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
30787254|NCT03732807|58800729|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
30787255|NCT03732807|58800730|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
30966245|NCT01550744|59035420|FG001|Double-Blind|Lost to Follow-up|6|||
30966246|NCT01550744|59035421|FG002|Double-Blind|Lost to Follow-up|12|||
30966247|NCT01550744|59035419|FG000|Double-Blind|Withdrawal by Subject|0|||
30966248|NCT01550744|59035420|FG001|Double-Blind|Withdrawal by Subject|2|||
30966249|NCT01550744|59035421|FG002|Double-Blind|Withdrawal by Subject|15|||
30966250|NCT01550744|59035419|FG000|Double-Blind|Adverse Event|0|||
30966251|NCT01550744|59035420|FG001|Double-Blind|Adverse Event|4|||
30966252|NCT01550744|59035421|FG002|Double-Blind|Adverse Event|15|||
30966253|NCT01550744|59035419|FG000|Double-Blind|Death|0|||
30966254|NCT01550744|59035420|FG001|Double-Blind|Death|1|||
30966255|NCT01550744|59035421|FG002|Double-Blind|Death|0|||
30966256|NCT01550744|59035419|FG000|Double-Blind|Lack of Efficacy|0|||
30966257|NCT01550744|59035420|FG001|Double-Blind|Lack of Efficacy|2|||
30966258|NCT01550744|59035421|FG002|Double-Blind|Lack of Efficacy|8|||
30966259|NCT01550744|59035419|FG000|Double-Blind|Protocol Violation|0|||
30966260|NCT01550744|59035420|FG001|Double-Blind|Protocol Violation|0|||
30966261|NCT01550744|59035421|FG002|Double-Blind|Protocol Violation|4|||
30966262|NCT01550744|59035419|FG000|Double-Blind|Pregnancy|0|||
30966263|NCT01550744|59035420|FG001|Double-Blind|Pregnancy|0|||
30966264|NCT01550744|59035421|FG002|Double-Blind|Pregnancy|3|||
30966265|NCT01550744|59035419|FG000|Double-Blind|Other|0|||
30966266|NCT01550744|59035420|FG001|Double-Blind|Other|2|||
30966267|NCT01550744|59035421|FG002|Double-Blind|Other|10|||
30966268|NCT01549964|59035482|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
30966269|NCT01549964|59035483|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
30966270|NCT01549964|59035484|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
30966271|NCT01549964|59035485|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
30966272|NCT01549964|59035482|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
30966273|NCT01549964|59035483|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
30966274|NCT01549964|59035484|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
30966275|NCT01549964|59035485|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
30966276|NCT01549964|59035482|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
30966277|NCT01549964|59035483|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
30966278|NCT01549964|59035484|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
30966279|NCT01549964|59035485|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
30966280|NCT01549964|59035482|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
30966281|NCT01549964|59035483|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
30966282|NCT01549964|59035484|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
30966283|NCT01549964|59035485|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
30966284|NCT01549964|59035482|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
30966285|NCT01549964|59035483|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
30966286|NCT01549964|59035484|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
30966287|NCT01549964|59035485|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
30966288|NCT01549964|59035482|FG000|24-Week Treatment Period|Other|1|||
30966289|NCT01549964|59035483|FG001|24-Week Treatment Period|Other|0|||
30966290|NCT01549964|59035484|FG002|24-Week Treatment Period|Other|1|||
30966291|NCT01549964|59035485|FG003|24-Week Treatment Period|Other|0|||
30966292|NCT01549964|59035482|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
30966293|NCT01549964|59035483|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
30966294|NCT01549964|59035484|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
30966295|NCT01549964|59035485|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
30966296|NCT01549964|59035482|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
30966297|NCT01549964|59035483|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
30966298|NCT01549964|59035484|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
30966299|NCT01549964|59035485|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
30966300|NCT01549964|59035482|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
30966301|NCT01549964|59035483|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
30966302|NCT01549964|59035484|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
30966303|NCT01549964|59035485|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
30966304|NCT01549964|59035482|FG000|80-Week Extension Period|Pregnancy|0|||
30966305|NCT01549964|59035483|FG001|80-Week Extension Period|Pregnancy|0|||
30966306|NCT01549964|59035484|FG002|80-Week Extension Period|Pregnancy|1|||
30966307|NCT01549964|59035485|FG003|80-Week Extension Period|Pregnancy|0|||
30966308|NCT01549964|59035482|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
30966309|NCT01549964|59035483|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
30966310|NCT01549964|59035484|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
30966311|NCT01549964|59035485|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
30966312|NCT01549964|59035482|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
30966313|NCT01549964|59035483|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
30966314|NCT01549964|59035484|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
30966315|NCT01549964|59035485|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
30966316|NCT01549964|59035482|FG000|80-Week Extension Period|Lost to Follow-up|1|||
30966317|NCT01549964|59035483|FG001|80-Week Extension Period|Lost to Follow-up|0|||
30966318|NCT01549964|59035484|FG002|80-Week Extension Period|Lost to Follow-up|2|||
30966319|NCT01549964|59035485|FG003|80-Week Extension Period|Lost to Follow-up|1|||
30966320|NCT01549964|59035482|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
30966321|NCT01549964|59035483|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
30966322|NCT01549964|59035484|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
30966323|NCT01549964|59035485|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
30966324|NCT01570244|59035567|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
30966325|NCT01535222|59035602|FG000|Overall Study|Inclusion/exclusion|0|||
30966326|NCT01535222|59035603|FG001|Overall Study|Inclusion/exclusion|0|||
30966327|NCT01535222|59035604|FG002|Overall Study|Inclusion/exclusion|1|||
30966328|NCT01535222|59035605|FG003|Overall Study|Inclusion/exclusion|0|||
30966329|NCT01535222|59035606|FG004|Overall Study|Inclusion/exclusion|0|||
30966330|NCT01535222|59035607|FG005|Overall Study|Inclusion/exclusion|0|||
30966331|NCT01549886|59035623|FG000|Overall Study|Sponsor's decision|2|||
30966332|NCT01549886|59035624|FG001|Overall Study|Sponsor's decision|3|||
30966333|NCT01443845|59035653|FG000|Overall Study|Protocol Violation|43|||
30966334|NCT01443845|59035654|FG001|Overall Study|Protocol Violation|45|||
30966335|NCT01443845|59035653|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
30966336|NCT01443845|59035654|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
30966337|NCT01443845|59035653|FG000|Overall Study|Deterioration in pulmonary function|1|||
30966338|NCT01443845|59035654|FG001|Overall Study|Deterioration in pulmonary function|4|||
30966339|NCT01443845|59035653|FG000|Overall Study|Lack of Efficacy|10|||
30966340|NCT01443845|59035654|FG001|Overall Study|Lack of Efficacy|5|||
30966341|NCT01443845|59035653|FG000|Overall Study|Adverse Event|64|||
30966342|NCT01443845|59035654|FG001|Overall Study|Adverse Event|138|||
30966343|NCT01443845|59035653|FG000|Overall Study|Withdrawal by Subject|63|||
30966344|NCT01443845|59035654|FG001|Overall Study|Withdrawal by Subject|67|||
30966345|NCT01443845|59035653|FG000|Overall Study|Military Conflict - Site Terminated|20|||
30966346|NCT01443845|59035654|FG001|Overall Study|Military Conflict - Site Terminated|21|||
30966347|NCT01443845|59035653|FG000|Overall Study|Lost to Follow-up|9|||
30966348|NCT01443845|59035654|FG001|Overall Study|Lost to Follow-up|13|||
30966349|NCT01549652|59035663|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
30966350|NCT01549652|59035664|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
30966351|NCT01549652|59035665|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
30966352|NCT01549652|59035666|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
30966353|NCT01549652|59035663|FG000|Overall Study|Study Drug Titration Failure|5|||
30966354|NCT01549652|59035664|FG001|Overall Study|Study Drug Titration Failure|6|||
30966355|NCT01549652|59035665|FG002|Overall Study|Study Drug Titration Failure|0|||
30966356|NCT01549652|59035666|FG003|Overall Study|Study Drug Titration Failure|0|||
30966357|NCT01549652|59035663|FG000|Overall Study|Withdrawal Effect|0|||
30966358|NCT01549652|59035664|FG001|Overall Study|Withdrawal Effect|2|||
30966359|NCT01549652|59035665|FG002|Overall Study|Withdrawal Effect|0|||
30966360|NCT01549652|59035666|FG003|Overall Study|Withdrawal Effect|0|||
30966361|NCT01549652|59035663|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
30966362|NCT01549652|59035664|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
30966363|NCT01549652|59035665|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
30966364|NCT01549652|59035666|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
30966365|NCT01549652|59035663|FG000|Overall Study|Problem with Infusion|1|||
30966366|NCT01549652|59035664|FG001|Overall Study|Problem with Infusion|0|||
30966367|NCT01549652|59035665|FG002|Overall Study|Problem with Infusion|0|||
30966368|NCT01549652|59035666|FG003|Overall Study|Problem with Infusion|0|||
30966369|NCT01549652|59035663|FG000|Overall Study|Titration Non-Compliance|1|||
30966370|NCT01549652|59035664|FG001|Overall Study|Titration Non-Compliance|3|||
30966371|NCT01549652|59035665|FG002|Overall Study|Titration Non-Compliance|4|||
30966372|NCT01549652|59035666|FG003|Overall Study|Titration Non-Compliance|5|||
30966373|NCT01549652|59035663|FG000|Overall Study|Titration Side Effects|0|||
30966374|NCT01549652|59035664|FG001|Overall Study|Titration Side Effects|0|||
30966375|NCT01549652|59035665|FG002|Overall Study|Titration Side Effects|6|||
30966376|NCT01549652|59035666|FG003|Overall Study|Titration Side Effects|3|||
30966377|NCT01549652|59035663|FG000|Overall Study|Withdrawal by Subject|0|||
30966378|NCT01549652|59035664|FG001|Overall Study|Withdrawal by Subject|0|||
30966379|NCT01549652|59035665|FG002|Overall Study|Withdrawal by Subject|5|||
30966380|NCT01549652|59035666|FG003|Overall Study|Withdrawal by Subject|3|||
30966381|NCT01569464|59035674|FG000|Overall Study|Adverse Event|4|||
30966382|NCT01569464|59035675|FG001|Overall Study|Adverse Event|0|||
30966383|NCT01569464|59035674|FG000|Overall Study|Lack of Efficacy|1|||
30966384|NCT01569464|59035675|FG001|Overall Study|Lack of Efficacy|0|||
30966385|NCT01569464|59035674|FG000|Overall Study|Protocol Violation|1|||
30966386|NCT01569464|59035675|FG001|Overall Study|Protocol Violation|0|||
30966387|NCT01569464|59035674|FG000|Overall Study|Lost to Follow-up|2|||
30966388|NCT01569464|59035675|FG001|Overall Study|Lost to Follow-up|3|||
30966389|NCT01569464|59035674|FG000|Overall Study|Withdrawal by Subject|1|||
30966390|NCT01569464|59035675|FG001|Overall Study|Withdrawal by Subject|1|||
30966391|NCT01569464|59035674|FG000|Overall Study|Other|1|||
30966392|NCT01569464|59035675|FG001|Overall Study|Other|1|||
30966393|NCT01534676|59035685|FG000|Overall Study|Study closed due to poor enrollment|2|||
30966394|NCT01534676|59035686|FG001|Overall Study|Study closed due to poor enrollment|1|||
30966395|NCT01442675|59035692|FG000|Overall Study|Protocol Violation|6|||
30966396|NCT01442675|59035692|FG000|Overall Study|Lost to Follow-up|2|||
30966397|NCT01442675|59035692|FG000|Overall Study|Withdrawal by Subject|4|||
30966398|NCT01534520|59035699|FG000|Overall Study|Adverse Event|0|||
30966399|NCT01534520|59035700|FG001|Overall Study|Adverse Event|1|||
30966400|NCT01534208|59035730|FG000|Overall Study|Lost to Follow-up|19|||
30966401|NCT01534208|59035731|FG001|Overall Study|Lost to Follow-up|14|||
30966402|NCT01534208|59035730|FG000|Overall Study|Withdrawal by Subject|6|||
30966403|NCT01534208|59035731|FG001|Overall Study|Withdrawal by Subject|20|||
30966404|NCT01534208|59035730|FG000|Overall Study|Adverse Event|15|||
30966405|NCT01534208|59035731|FG001|Overall Study|Adverse Event|8|||
30966406|NCT01534208|59035730|FG000|Overall Study|Physician Decision|2|||
30966407|NCT01534208|59035731|FG001|Overall Study|Physician Decision|0|||
30966408|NCT01534208|59035730|FG000|Overall Study|Lack of Efficacy|0|||
30966409|NCT01534208|59035731|FG001|Overall Study|Lack of Efficacy|3|||
30966410|NCT01534208|59035730|FG000|Overall Study|Protocol Violation|2|||
30966411|NCT01534208|59035731|FG001|Overall Study|Protocol Violation|2|||
30966412|NCT01534208|59035730|FG000|Overall Study|Sponsor decision|4|||
30966413|NCT01534208|59035731|FG001|Overall Study|Sponsor decision|1|||
30966414|NCT01534208|59035730|FG000|Overall Study|Subject relocation|2|||
30966415|NCT01534208|59035731|FG001|Overall Study|Subject relocation|0|||
30966416|NCT01534208|59035730|FG000|Overall Study|Lab assessment|2|||
30966417|NCT01534208|59035731|FG001|Overall Study|Lab assessment|1|||
30966418|NCT01534208|59035730|FG000|Overall Study|Eligibility error|3|||
30966419|NCT01534208|59035731|FG001|Overall Study|Eligibility error|0|||
30966420|NCT01534208|59035730|FG000|Overall Study|PCP decision|1|||
30966421|NCT01534208|59035731|FG001|Overall Study|PCP decision|0|||
30966422|NCT01534208|59035730|FG000|Overall Study|Needed prohibited meds|1|||
30966423|NCT01534208|59035731|FG001|Overall Study|Needed prohibited meds|0|||
30966424|NCT01548638|59035737|FG000|Overall Study|Protocol Violation|3|||
30966425|NCT01548638|59035737|FG000|Overall Study|Withdrawal by Subject|1|||
30966426|NCT01533428|59035761|FG000|Overall Study|Adverse Event|0|||
30966427|NCT01533428|59035762|FG001|Overall Study|Adverse Event|1|||
30966428|NCT01533428|59035761|FG000|Overall Study|Lost to Follow-up|2|||
30966429|NCT01533428|59035762|FG001|Overall Study|Lost to Follow-up|1|||
30966430|NCT01533428|59035761|FG000|Overall Study|Withdrawal by Subject|7|||
30966431|NCT01533428|59035762|FG001|Overall Study|Withdrawal by Subject|6|||
30966432|NCT01517984|59035771|FG000|Overall Study|Lost to Follow-up|0|||
30966433|NCT01517984|59035772|FG001|Overall Study|Lost to Follow-up|1|||
30966434|NCT01517984|59035773|FG002|Overall Study|Lost to Follow-up|0|||
30966435|NCT01517984|59035774|FG003|Overall Study|Lost to Follow-up|0|||
30966436|NCT01517984|59035771|FG000|Overall Study|Withdrawal by Subject|1|||
30966437|NCT01517984|59035772|FG001|Overall Study|Withdrawal by Subject|8|||
30966438|NCT01517984|59035773|FG002|Overall Study|Withdrawal by Subject|4|||
30966439|NCT01517984|59035774|FG003|Overall Study|Withdrawal by Subject|1|||
30966440|NCT01517984|59035771|FG000|Overall Study|Screen Failure|4|||
30966441|NCT01517984|59035772|FG001|Overall Study|Screen Failure|0|||
30966442|NCT01517984|59035773|FG002|Overall Study|Screen Failure|0|||
30966443|NCT01517984|59035774|FG003|Overall Study|Screen Failure|0|||
30966444|NCT01517984|59035771|FG000|Overall Study|Ineligible for randomization|0|||
30966445|NCT01517984|59035772|FG001|Overall Study|Ineligible for randomization|14|||
30966446|NCT01517984|59035773|FG002|Overall Study|Ineligible for randomization|0|||
30966447|NCT01517984|59035774|FG003|Overall Study|Ineligible for randomization|0|||
30966448|NCT01517750|59035802|FG000|Overall Study|Lost to Follow-up|1|||
30966449|NCT01517750|59035803|FG001|Overall Study|Lost to Follow-up|2|||
30966450|NCT01517750|59035804|FG002|Overall Study|Lost to Follow-up|4|||
30966451|NCT01517750|59035805|FG003|Overall Study|Lost to Follow-up|1|||
30966452|NCT01548404|59035830|FG000|Overall Study|Adverse Event|3|||
30966453|NCT01548404|59035831|FG001|Overall Study|Adverse Event|1|||
30966454|NCT01548404|59035830|FG000|Overall Study|Physician Decision|2|||
30966455|NCT01548404|59035831|FG001|Overall Study|Physician Decision|1|||
30966456|NCT01548404|59035830|FG000|Overall Study|Inadequate response to study treatment|23|||
30966457|NCT01548404|59035831|FG001|Overall Study|Inadequate response to study treatment|7|||
30966458|NCT01548404|59035830|FG000|Overall Study|Lost to Follow-up|2|||
30966459|NCT01548404|59035831|FG001|Overall Study|Lost to Follow-up|0|||
30966460|NCT01548404|59035830|FG000|Overall Study|Withdrawal by Subject|0|||
30876819|NCT01674725|58908255|FG001|Overall Study|Lost to Follow-up|1|||
30876820|NCT01674569|58908261|FG000|Overall Study|Adverse Event|0|||
30876821|NCT01674569|58908262|FG001|Overall Study|Adverse Event|2|||
30876822|NCT01674569|58908263|FG002|Overall Study|Adverse Event|0|||
30876823|NCT01674569|58908264|FG003|Overall Study|Adverse Event|1|||
30876824|NCT01674569|58908265|FG004|Overall Study|Adverse Event|2|||
30876825|NCT01674569|58908266|FG005|Overall Study|Adverse Event|2|||
30876826|NCT01674569|58908261|FG000|Overall Study|Protocol Violation|0|||
30876827|NCT01674569|58908262|FG001|Overall Study|Protocol Violation|1|||
30876828|NCT01674569|58908263|FG002|Overall Study|Protocol Violation|1|||
30966461|NCT01548404|59035831|FG001|Overall Study|Withdrawal by Subject|3|||
30966462|NCT01548404|59035830|FG000|Overall Study|Other than specified above|0|||
30966463|NCT01548404|59035831|FG001|Overall Study|Other than specified above|2|||
30966464|NCT01547780|59035845|FG000|Baseline PET Scan|Physician Decision|1|||
30966465|NCT01547780|59035846|FG001|Baseline PET Scan|Physician Decision|0|||
30966466|NCT01547780|59035847|FG002|Baseline PET Scan|Physician Decision|1|||
30966467|NCT01547780|59035848|FG003|Baseline PET Scan|Physician Decision|0|||
30966468|NCT01547780|59035845|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
30966469|NCT01547780|59035846|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
30966470|NCT01547780|59035847|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
30966471|NCT01547780|59035848|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
30966472|NCT01547390|59035870|FG000|Overall Study|Withdrawal by Subject|10|||
30966473|NCT01547390|59035871|FG001|Overall Study|Withdrawal by Subject|7|||
30966474|NCT01547390|59035870|FG000|Overall Study|termination of pregnancy|0|||
30966475|NCT01547390|59035871|FG001|Overall Study|termination of pregnancy|1|||
30966476|NCT01547390|59035870|FG000|Overall Study|Lost to Follow-up|0|||
30966477|NCT01547390|59035871|FG001|Overall Study|Lost to Follow-up|2|||
30966478|NCT01547390|59035870|FG000|Overall Study|Adverse Event|3|||
30966479|NCT01547390|59035871|FG001|Overall Study|Adverse Event|0|||
30966480|NCT01546922|59035877|FG000|First Period of 10 Weeks|Protocol Violation|3|||
30966481|NCT01546922|59035878|FG001|First Period of 10 Weeks|Protocol Violation|1|||
30966482|NCT01546922|59035877|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
30966483|NCT01546922|59035878|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
30966484|NCT01546922|59035877|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
30966485|NCT01546922|59035878|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
30966486|NCT01546922|59035877|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
30966487|NCT01546922|59035878|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
30966488|NCT01546922|59035877|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
30966489|NCT01546922|59035878|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
30966490|NCT01532648|59035895|FG000|Overall Study|Lost to Follow-up|3|||
30966491|NCT01532648|59035896|FG001|Overall Study|Lost to Follow-up|4|||
30966492|NCT01532648|59035895|FG000|Overall Study|Lack of Efficacy|4|||
30966493|NCT01532648|59035896|FG001|Overall Study|Lack of Efficacy|1|||
30966494|NCT01532648|59035895|FG000|Overall Study|Protocol Violation|1|||
30966495|NCT01532648|59035896|FG001|Overall Study|Protocol Violation|1|||
30966496|NCT01532648|59035895|FG000|Overall Study|Adverse Event|12|||
30966497|NCT01532648|59035896|FG001|Overall Study|Adverse Event|9|||
30966498|NCT01532648|59035895|FG000|Overall Study|Withdrawal by Subject|16|||
30966499|NCT01532648|59035896|FG001|Overall Study|Withdrawal by Subject|2|||
30966500|NCT01532570|59035926|FG000|Overall Study|Lack of Efficacy|1|||
30966501|NCT01532570|59035927|FG001|Overall Study|Lack of Efficacy|0|||
30966502|NCT01532570|59035928|FG002|Overall Study|Lack of Efficacy|0|||
30966503|NCT01532570|59035929|FG003|Overall Study|Lack of Efficacy|0|||
30966504|NCT01532570|59035926|FG000|Overall Study|Withdrawal by Subject|0|||
30966505|NCT01532570|59035927|FG001|Overall Study|Withdrawal by Subject|1|||
30966506|NCT01532570|59035928|FG002|Overall Study|Withdrawal by Subject|0|||
30966507|NCT01532570|59035929|FG003|Overall Study|Withdrawal by Subject|0|||
30966508|NCT01532414|59035962|FG000|Overall Study|Lost to Follow-up|3|||
30966509|NCT01532414|59035963|FG001|Overall Study|Lost to Follow-up|0|||
30966510|NCT01532414|59035964|FG002|Overall Study|Lost to Follow-up|1|||
30966511|NCT01532414|59035962|FG000|Overall Study|Withdrawal by Subject|3|||
30966512|NCT01532414|59035963|FG001|Overall Study|Withdrawal by Subject|0|||
30966513|NCT01532414|59035964|FG002|Overall Study|Withdrawal by Subject|0|||
30966514|NCT01532414|59035962|FG000|Overall Study|No V6 semen sample|0|||
30966515|NCT01532414|59035963|FG001|Overall Study|No V6 semen sample|1|||
30966516|NCT01532414|59035964|FG002|Overall Study|No V6 semen sample|0|||
30966517|NCT01532414|59035962|FG000|Overall Study|Adverse Event|0|||
30966518|NCT01532414|59035963|FG001|Overall Study|Adverse Event|1|||
30966519|NCT01532414|59035964|FG002|Overall Study|Adverse Event|1|||
30966520|NCT01532414|59035962|FG000|Overall Study|Unable to complete 24 hour PK|0|||
30966521|NCT01532414|59035963|FG001|Overall Study|Unable to complete 24 hour PK|0|||
30966522|NCT01532414|59035964|FG002|Overall Study|Unable to complete 24 hour PK|1|||
30966523|NCT01532414|59035962|FG000|Overall Study|Withdrawn by sponsor|1|||
30966524|NCT01532414|59035963|FG001|Overall Study|Withdrawn by sponsor|0|||
30966525|NCT01532414|59035964|FG002|Overall Study|Withdrawn by sponsor|0|||
30966526|NCT01441973|59035974|FG000|Overall Study|Disease progression|8|||
30966527|NCT01441973|59035975|FG001|Overall Study|Disease progression|6|||
30966528|NCT01441973|59035974|FG000|Overall Study|Adverse event unrelated to study drug|3|||
30966529|NCT01441973|59035975|FG001|Overall Study|Adverse event unrelated to study drug|2|||
30966530|NCT01441973|59035974|FG000|Overall Study|Participant request to discontinue|1|||
30966531|NCT01441973|59035975|FG001|Overall Study|Participant request to discontinue|1|||
30966532|NCT01441973|59035974|FG000|Overall Study|Poor compliance/noncompliance|0|||
30966533|NCT01441973|59035975|FG001|Overall Study|Poor compliance/noncompliance|1|||
30966534|NCT01441973|59035974|FG000|Overall Study|Administrative reason by sponsor|3|||
30966535|NCT01441973|59035975|FG001|Overall Study|Administrative reason by sponsor|5|||
30966536|NCT01441973|59035974|FG000|Overall Study|Participant withdrew consent|0|||
30966537|NCT01441973|59035975|FG001|Overall Study|Participant withdrew consent|1|||
30966538|NCT01575899|59035994|FG000|Overall Study|Lost to Follow-up|3|||
30966539|NCT01575899|59035995|FG001|Overall Study|Lost to Follow-up|4|||
30966540|NCT01575899|59035996|FG002|Overall Study|Lost to Follow-up|2|||
30966541|NCT01575899|59035994|FG000|Overall Study|Protocol Violation|2|||
30966542|NCT01575899|59035995|FG001|Overall Study|Protocol Violation|1|||
30966543|NCT01575899|59035996|FG002|Overall Study|Protocol Violation|0|||
30966544|NCT01440881|59036008|FG000|Overall Study|Death|0|||
30966545|NCT01440881|59036009|FG001|Overall Study|Death|1|||
30966546|NCT01575197|59036024|FG000|Overall Study|Migration out of study area|1|||
30966547|NCT01575197|59036025|FG001|Overall Study|Migration out of study area|5|||
30966548|NCT01575197|59036026|FG002|Overall Study|Migration out of study area|4|||
30966549|NCT01575197|59036024|FG000|Overall Study|SAE|0|||
30966550|NCT01575197|59036025|FG001|Overall Study|SAE|1|||
30966551|NCT01575197|59036026|FG002|Overall Study|SAE|0|||
30966552|NCT01575197|59036024|FG000|Overall Study|Lost to Follow-up|0|||
30966553|NCT01575197|59036025|FG001|Overall Study|Lost to Follow-up|1|||
30966554|NCT01575197|59036026|FG002|Overall Study|Lost to Follow-up|0|||
30966555|NCT01575197|59036024|FG000|Overall Study|Withdrawal by Subject|0|||
30966556|NCT01575197|59036025|FG001|Overall Study|Withdrawal by Subject|1|||
30966557|NCT01575197|59036026|FG002|Overall Study|Withdrawal by Subject|1|||
30966558|NCT01575197|59036024|FG000|Overall Study|Protocol Violation|2|||
30966559|NCT01575197|59036025|FG001|Overall Study|Protocol Violation|1|||
30966560|NCT01575197|59036026|FG002|Overall Study|Protocol Violation|1|||
30966561|NCT01574651|59036057|FG000|Overall Study|Lost to Follow-up|2|||
30966562|NCT01574651|59036058|FG001|Overall Study|Lost to Follow-up|4|||
30966563|NCT01574651|59036057|FG000|Overall Study|Administrative problems|0|||
30966564|NCT01574651|59036058|FG001|Overall Study|Administrative problems|1|||
30966565|NCT01574651|59036057|FG000|Overall Study|Death|3|||
30966566|NCT01574651|59036058|FG001|Overall Study|Death|3|||
30966567|NCT01574651|59036057|FG000|Overall Study|Patient's inability to use the device|0|||
30966568|NCT01574651|59036058|FG001|Overall Study|Patient's inability to use the device|1|||
30966569|NCT01574651|59036057|FG000|Overall Study|Adverse Event|36|||
30966570|NCT01574651|59036058|FG001|Overall Study|Adverse Event|27|||
30966571|NCT01574651|59036057|FG000|Overall Study|Abnormal laboratory value(s)|1|||
30966572|NCT01574651|59036058|FG001|Overall Study|Abnormal laboratory value(s)|0|||
30966573|NCT01574651|59036057|FG000|Overall Study|Abnormal test procedure result(s)|1|||
30966574|NCT01574651|59036058|FG001|Overall Study|Abnormal test procedure result(s)|1|||
30966575|NCT01574651|59036057|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
30966576|NCT01574651|59036058|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
30966577|NCT01574651|59036057|FG000|Overall Study|Protocol Violation|3|||
30966578|NCT01574651|59036058|FG001|Overall Study|Protocol Violation|5|||
30966579|NCT01574651|59036057|FG000|Overall Study|Withdrawal by Subject|9|||
30966580|NCT01574651|59036058|FG001|Overall Study|Withdrawal by Subject|10|||
30966581|NCT01440803|59036070|FG000|Overall Study|Met study stopping rule|2|||
30966582|NCT01440803|59036071|FG001|Overall Study|Met study stopping rule|1|||
30966583|NCT01440803|59036070|FG000|Overall Study|Lost to Follow-up|0|||
30966584|NCT01440803|59036071|FG001|Overall Study|Lost to Follow-up|2|||
30966585|NCT01440803|59036070|FG000|Overall Study|Withdrawal by Subject|0|||
30966586|NCT01440803|59036071|FG001|Overall Study|Withdrawal by Subject|1|||
30966587|NCT01517282|59036082|FG000|Overall Study|Consent withdrawn|0|||
30966588|NCT01517282|59036083|FG001|Overall Study|Consent withdrawn|1|||
30966589|NCT01517282|59036084|FG002|Overall Study|Consent withdrawn|1|||
30966590|NCT01517282|59036085|FG003|Overall Study|Consent withdrawn|1|||
30966591|NCT01517282|59036082|FG000|Overall Study|Physician Decision|1|||
30966592|NCT01517282|59036083|FG001|Overall Study|Physician Decision|0|||
30966593|NCT01517282|59036084|FG002|Overall Study|Physician Decision|0|||
30966594|NCT01517282|59036085|FG003|Overall Study|Physician Decision|0|||
30966595|NCT01440647|59036106|FG000|Overall Study|Death|2|||
30966596|NCT01440647|59036107|FG001|Overall Study|Death|3|||
30966597|NCT01516970|59036115|FG000|Overall Study|Lost to Follow-up|7|||
30966598|NCT01516970|59036116|FG001|Overall Study|Lost to Follow-up|8|||
30966599|NCT01516970|59036115|FG000|Overall Study|Adverse Event|1|||
30966600|NCT01516970|59036116|FG001|Overall Study|Adverse Event|5|||
30966601|NCT01516970|59036115|FG000|Overall Study|Withdrawal by Subject|1|||
30966602|NCT01516970|59036116|FG001|Overall Study|Withdrawal by Subject|1|||
30966603|NCT01516970|59036115|FG000|Overall Study|Other|9|||
30966604|NCT01516970|59036116|FG001|Overall Study|Other|7|||
30966605|NCT01516892|59036137|FG000|Overall Study|Adverse Event|25|||
30966606|NCT01516892|59036137|FG000|Overall Study|Lack of Efficacy|35|||
30966607|NCT01516892|59036137|FG000|Overall Study|Pregnancy|5|||
30966608|NCT01516892|59036137|FG000|Overall Study|Lost to Follow-up|82|||
30966609|NCT01516892|59036137|FG000|Overall Study|Subject Withdrew Consent|92|||
30966610|NCT01516892|59036137|FG000|Overall Study|Protocol Violation|60|||
30966611|NCT01516892|59036137|FG000|Overall Study|Other Miscellaneous Reasons|43|||
30966612|NCT01516892|59036137|FG000|Overall Study|Missing|1|||
30966613|NCT01516736|59036162|FG000|Overall Study|Withdrawal by Subject|10|||
30966614|NCT01516736|59036163|FG001|Overall Study|Withdrawal by Subject|4|||
30966615|NCT01516736|59036162|FG000|Overall Study|Adverse Event|4|||
30966616|NCT01516736|59036163|FG001|Overall Study|Adverse Event|5|||
30966617|NCT01516736|59036162|FG000|Overall Study|Death|3|||
30966618|NCT01516736|59036163|FG001|Overall Study|Death|1|||
30966619|NCT01516736|59036162|FG000|Overall Study|Physician Decision|2|||
30966620|NCT01516736|59036163|FG001|Overall Study|Physician Decision|1|||
30966621|NCT01516736|59036162|FG000|Overall Study|Lack of Efficacy|1|||
30966622|NCT01516736|59036163|FG001|Overall Study|Lack of Efficacy|0|||
30966623|NCT01516736|59036162|FG000|Overall Study|Protocol Violation|0|||
30966624|NCT01516736|59036163|FG001|Overall Study|Protocol Violation|1|||
30966625|NCT01516736|59036162|FG000|Overall Study|Other (not specified)|0|||
30966626|NCT01516736|59036163|FG001|Overall Study|Other (not specified)|1|||
30966627|NCT01546688|59036175|FG000|Overall Study|Adverse Event|0|||
30966628|NCT01546688|59036176|FG001|Overall Study|Adverse Event|4|||
30966629|NCT01546688|59036175|FG000|Overall Study|Withdrawal by Subject|2|||
30966630|NCT01546688|59036176|FG001|Overall Study|Withdrawal by Subject|1|||
30787256|NCT03732807|58800724|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
30787257|NCT03732807|58800725|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
30787258|NCT03732807|58800726|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
30787259|NCT03732807|58800727|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
30787260|NCT03732807|58800728|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
30787261|NCT03732807|58800729|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
30787262|NCT03732807|58800730|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
30787263|NCT03732807|58800724|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
30787264|NCT03732807|58800725|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
30787265|NCT03732807|58800726|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
30787266|NCT03732807|58800727|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
30787267|NCT03732807|58800728|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
30787268|NCT03732807|58800729|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
30787269|NCT03732807|58800730|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
30787270|NCT03732807|58800724|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
30787271|NCT03732807|58800725|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
30787272|NCT03732807|58800726|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
30787273|NCT03732807|58800727|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
30787274|NCT03732807|58800728|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
30787275|NCT03732807|58800729|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
30787276|NCT03732807|58800730|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
30787277|NCT03732807|58800724|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
30787278|NCT03732807|58800725|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
30787279|NCT03732807|58800726|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
30787280|NCT03732807|58800727|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
30787281|NCT03732807|58800728|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
30787282|NCT03732807|58800729|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
30787283|NCT03732807|58800730|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
30787284|NCT03732807|58800724|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
30787285|NCT03732807|58800725|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
30787286|NCT03732807|58800726|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
30787287|NCT03732807|58800727|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
30787288|NCT03732807|58800728|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
30787289|NCT03732807|58800729|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
30787290|NCT03732807|58800730|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
30787291|NCT03732807|58800724|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
30787292|NCT03732807|58800725|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
30787293|NCT03732807|58800726|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
30787294|NCT03732807|58800727|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
30787295|NCT03732807|58800728|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
30787296|NCT03732807|58800729|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
30787297|NCT03732807|58800730|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
30787298|NCT03732807|58800724|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
30787299|NCT03732807|58800725|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
30787300|NCT03732807|58800726|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
30787301|NCT03732807|58800727|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
30787302|NCT03732807|58800728|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
30787303|NCT03732807|58800729|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
30787304|NCT03732807|58800730|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
30966631|NCT01546688|59036175|FG000|Overall Study|Lack of Efficacy|1|||
30966632|NCT01546688|59036176|FG001|Overall Study|Lack of Efficacy|0|||
30966633|NCT01516034|59036182|FG000|Overall Study|Physician Decision|1|||
30966634|NCT01516034|59036182|FG000|Overall Study|Lack of Efficacy|7|||
30787305|NCT03732807|58800724|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
30787306|NCT03732807|58800725|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
30787307|NCT03732807|58800726|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
30787308|NCT03732807|58800727|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
30787309|NCT03732807|58800728|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
30787310|NCT03732807|58800729|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
30787311|NCT03732807|58800730|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
30787312|NCT03732807|58800724|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
30787313|NCT03732807|58800725|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
30787314|NCT03732807|58800726|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
30787315|NCT03732807|58800727|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
30787316|NCT03732807|58800728|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
30787317|NCT03732807|58800729|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
30787318|NCT03732807|58800730|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
30787319|NCT03732807|58800724|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
30787320|NCT03732807|58800725|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
30787321|NCT03732807|58800726|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
30787322|NCT03732807|58800727|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
30787323|NCT03732807|58800728|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
30787324|NCT03732807|58800729|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
30787325|NCT03732807|58800730|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
30787326|NCT00104416|58800749|FG000|Double-Blind Phase|Adverse Event|2|||
30787327|NCT00104416|58800750|FG001|Double-Blind Phase|Adverse Event|1|||
30787328|NCT00104416|58800751|FG002|Double-Blind Phase|Adverse Event|0|||
30787329|NCT00104416|58800752|FG003|Double-Blind Phase|Adverse Event|0|||
30787330|NCT00104416|58800753|FG004|Double-Blind Phase|Adverse Event|0|||
30787331|NCT00104416|58800749|FG000|Double-Blind Phase|Lost to Follow-up|0|||
30787332|NCT00104416|58800750|FG001|Double-Blind Phase|Lost to Follow-up|1|||
30787333|NCT00104416|58800751|FG002|Double-Blind Phase|Lost to Follow-up|0|||
30787334|NCT00104416|58800752|FG003|Double-Blind Phase|Lost to Follow-up|0|||
30787335|NCT00104416|58800753|FG004|Double-Blind Phase|Lost to Follow-up|0|||
30787336|NCT00104416|58800749|FG000|Double-Blind Phase|Protocol Violation|0|||
30787337|NCT00104416|58800750|FG001|Double-Blind Phase|Protocol Violation|1|||
30787338|NCT00104416|58800751|FG002|Double-Blind Phase|Protocol Violation|0|||
30787339|NCT00104416|58800752|FG003|Double-Blind Phase|Protocol Violation|0|||
30787340|NCT00104416|58800753|FG004|Double-Blind Phase|Protocol Violation|0|||
30787341|NCT00104416|58800749|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
30787342|NCT00104416|58800750|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
30787343|NCT00104416|58800751|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
30787344|NCT00104416|58800752|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
30787345|NCT00104416|58800753|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
30787346|NCT00104416|58800749|FG000|Double-Blind Phase|Pregnancy|1|||
30787347|NCT00104416|58800750|FG001|Double-Blind Phase|Pregnancy|0|||
30787348|NCT00104416|58800751|FG002|Double-Blind Phase|Pregnancy|0|||
30787349|NCT00104416|58800752|FG003|Double-Blind Phase|Pregnancy|0|||
30787350|NCT00104416|58800753|FG004|Double-Blind Phase|Pregnancy|0|||
30787351|NCT00104416|58800749|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
30787352|NCT00104416|58800750|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
30787353|NCT00104416|58800751|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
30787354|NCT00104416|58800752|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
30787355|NCT00104416|58800753|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
30787356|NCT00104416|58800749|FG000|Continuation Phase|Adverse Event|0|||
30787357|NCT00104416|58800750|FG001|Continuation Phase|Adverse Event|0|||
30787358|NCT00104416|58800751|FG002|Continuation Phase|Adverse Event|2|||
30787359|NCT00104416|58800752|FG003|Continuation Phase|Adverse Event|0|||
30787360|NCT00104416|58800753|FG004|Continuation Phase|Adverse Event|2|||
30787361|NCT00104416|58800749|FG000|Continuation Phase|Lost to Follow-up|0|||
30787362|NCT00104416|58800750|FG001|Continuation Phase|Lost to Follow-up|0|||
30787363|NCT00104416|58800751|FG002|Continuation Phase|Lost to Follow-up|1|||
30787364|NCT00104416|58800752|FG003|Continuation Phase|Lost to Follow-up|0|||
30787365|NCT00104416|58800753|FG004|Continuation Phase|Lost to Follow-up|1|||
30787366|NCT00104416|58800749|FG000|Continuation Phase|Withdrawal by Subject|0|||
30787367|NCT00104416|58800750|FG001|Continuation Phase|Withdrawal by Subject|0|||
30787368|NCT00104416|58800751|FG002|Continuation Phase|Withdrawal by Subject|2|||
30787369|NCT00104416|58800752|FG003|Continuation Phase|Withdrawal by Subject|1|||
30787370|NCT00104416|58800753|FG004|Continuation Phase|Withdrawal by Subject|1|||
30787371|NCT00104416|58800749|FG000|Continuation Phase|Pregnancy|0|||
30787372|NCT00104416|58800750|FG001|Continuation Phase|Pregnancy|0|||
30787373|NCT00104416|58800751|FG002|Continuation Phase|Pregnancy|1|||
30787374|NCT00104416|58800752|FG003|Continuation Phase|Pregnancy|1|||
30787375|NCT00104416|58800753|FG004|Continuation Phase|Pregnancy|0|||
30787376|NCT00104416|58800749|FG000|Continuation Phase|Non-compliance|0|||
30787377|NCT00104416|58800750|FG001|Continuation Phase|Non-compliance|0|||
30787378|NCT00104416|58800751|FG002|Continuation Phase|Non-compliance|0|||
30787379|NCT00104416|58800752|FG003|Continuation Phase|Non-compliance|0|||
30787380|NCT00104416|58800753|FG004|Continuation Phase|Non-compliance|1|||
30787381|NCT03639987|58800767|FG000|Overall Study|Study terminated by sponsor|26|||
30787382|NCT03639987|58800768|FG001|Overall Study|Study terminated by sponsor|25|||
30787383|NCT03639987|58800767|FG000|Overall Study|Lost to Follow-up|0|||
30787384|NCT03639987|58800768|FG001|Overall Study|Lost to Follow-up|1|||
30787385|NCT02766088|58800774|FG000|Overall Study|Sponsor study termination|498|||
30787386|NCT02766088|58800774|FG000|Overall Study|Migrated/moved from the study area|1|||
30787387|NCT02766088|58800774|FG000|Overall Study|Lost to Follow-up|5|||
30787388|NCT02766088|58800774|FG000|Overall Study|Other|1|||
30787389|NCT02766088|58800774|FG000|Overall Study|Death|1|||
30787390|NCT03639675|58800778|FG000|Overall Study|Withdrawal by Subject|1|||
30787391|NCT03635775|58800786|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
30787392|NCT03635775|58800787|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
30787393|NCT03635775|58800788|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
30787394|NCT03635775|58800789|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
30787395|NCT03610581|58800801|FG000|Overall Study|Study terminated by sponsor|2|||
30787396|NCT03610581|58800802|FG001|Overall Study|Study terminated by sponsor|0|||
30787397|NCT03610581|58800801|FG000|Overall Study|Other|0|||
30787398|NCT03610581|58800802|FG001|Overall Study|Other|1|||
30787399|NCT03610581|58800801|FG000|Overall Study|Withdrawal by Subject|1|||
30787400|NCT03610581|58800802|FG001|Overall Study|Withdrawal by Subject|0|||
30787401|NCT03610269|58800808|FG000|Overall Study|Physician Decision|10|||
30787402|NCT03610269|58800808|FG000|Overall Study|Protocol Violation|1|||
30787403|NCT03610269|58800808|FG000|Overall Study|Unable to draw blood|1|||
30787404|NCT03610269|58800808|FG000|Overall Study|Screen fail|4|||
30787405|NCT00121667|58800816|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
30787406|NCT00121667|58800817|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
30787407|NCT00121667|58800818|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
30787408|NCT00121667|58800819|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
30787409|NCT00121667|58800816|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
30787410|NCT00121667|58800817|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
30787411|NCT00121667|58800818|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
30787412|NCT00121667|58800819|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
30787413|NCT00121667|58800816|FG000|Short Term (ST) Period|Adverse Event|5|||
30787414|NCT00121667|58800817|FG001|Short Term (ST) Period|Adverse Event|6|||
30787415|NCT00121667|58800818|FG002|Short Term (ST) Period|Adverse Event|5|||
30787416|NCT00121667|58800819|FG003|Short Term (ST) Period|Adverse Event|3|||
30787417|NCT00121667|58800816|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
30787418|NCT00121667|58800817|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
30787419|NCT00121667|58800818|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
30787420|NCT00121667|58800819|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
30787421|NCT00121667|58800816|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
30787422|NCT00121667|58800817|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
30787423|NCT00121667|58800818|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
30787424|NCT00121667|58800819|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
30787425|NCT00121667|58800816|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
30787426|NCT00121667|58800817|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
30787427|NCT00121667|58800818|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
30787428|NCT00121667|58800819|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
30787429|NCT00121667|58800816|FG000|Short Term (ST) Period|Other Reason|3|||
30787430|NCT00121667|58800817|FG001|Short Term (ST) Period|Other Reason|0|||
30787431|NCT00121667|58800818|FG002|Short Term (ST) Period|Other Reason|0|||
30787432|NCT00121667|58800819|FG003|Short Term (ST) Period|Other Reason|0|||
30787433|NCT00121667|58800816|FG000|Short Term (ST) Period|Death|0|||
30787434|NCT00121667|58800817|FG001|Short Term (ST) Period|Death|0|||
30787435|NCT00121667|58800818|FG002|Short Term (ST) Period|Death|0|||
30787436|NCT00121667|58800819|FG003|Short Term (ST) Period|Death|1|||
30787437|NCT00121667|58800816|FG000|Short Term (ST) Period|Pregnancy|0|||
30787438|NCT00121667|58800817|FG001|Short Term (ST) Period|Pregnancy|0|||
30787439|NCT00121667|58800818|FG002|Short Term (ST) Period|Pregnancy|0|||
30787440|NCT00121667|58800819|FG003|Short Term (ST) Period|Pregnancy|1|||
30787441|NCT00121667|58800816|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
30787442|NCT00121667|58800817|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
30787443|NCT00121667|58800818|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
30787444|NCT00121667|58800819|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
30787445|NCT00121667|58800816|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
30787446|NCT00121667|58800817|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
30787447|NCT00121667|58800818|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
30787448|NCT00121667|58800819|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
30787449|NCT00121667|58800816|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
30787450|NCT00121667|58800817|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
30787451|NCT00121667|58800818|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
30787452|NCT00121667|58800819|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
30787453|NCT00121667|58800816|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
30787454|NCT00121667|58800817|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
30787455|NCT00121667|58800818|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
30787456|NCT00121667|58800819|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
30787457|NCT00121667|58800816|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
30787458|NCT00121667|58800817|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
30787459|NCT00121667|58800818|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
30787460|NCT00121667|58800819|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
30787461|NCT00121667|58800816|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
30787462|NCT00121667|58800817|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
30787463|NCT00121667|58800818|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
30787464|NCT00121667|58800819|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
30787465|NCT00121667|58800816|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
30787466|NCT00121667|58800817|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
30787467|NCT00121667|58800818|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
30787468|NCT00121667|58800819|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
30787469|NCT00121667|58800816|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
30787470|NCT00121667|58800817|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
30787471|NCT00121667|58800818|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
30787472|NCT00121667|58800819|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
30787473|NCT00121667|58800816|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
30787474|NCT00121667|58800817|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
30787475|NCT00121667|58800818|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
30787476|NCT00121667|58800819|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
30787477|NCT02954601|58800833|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
30787478|NCT02954601|58800834|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
30787479|NCT02954601|58800835|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
30787480|NCT02954601|58800836|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
30787481|NCT03633903|58800848|FG000|Overall Study|Withdrawal by Subject|1|||
30787482|NCT03633903|58800849|FG001|Overall Study|Withdrawal by Subject|2|||
30787483|NCT03633903|58800848|FG000|Overall Study|Lost to Follow-up|5|||
30787484|NCT03633903|58800849|FG001|Overall Study|Lost to Follow-up|5|||
30787485|NCT03607695|58800855|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
30787486|NCT03607695|58800855|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
30787487|NCT03557775|58800862|FG000|Overall Study|Withdrawal by Subject|1|||
30787488|NCT03557775|58800863|FG001|Overall Study|Withdrawal by Subject|2|||
30787489|NCT03557775|58800864|FG002|Overall Study|Withdrawal by Subject|4|||
30787490|NCT03557775|58800862|FG000|Overall Study|Physician Decision|0|||
30787491|NCT03557775|58800863|FG001|Overall Study|Physician Decision|1|||
30787492|NCT03557775|58800864|FG002|Overall Study|Physician Decision|0|||
30787493|NCT00121199|58800872|FG000|Overall Study|Adverse Event|11|||
30787494|NCT00121199|58800872|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
30787495|NCT00121199|58800872|FG000|Overall Study|Progression/Relapse|1|||
30787496|NCT00121199|58800872|FG000|Overall Study|Death|3|||
30787497|NCT00121199|58800872|FG000|Overall Study|Other - Not Protocol Specified|3|||
30787498|NCT00121199|58800872|FG000|Overall Study|Ineligible|9|||
30787499|NCT00119405|58800876|FG000|Overall Study|Withdrawal by Subject|1|||
30787500|NCT00119015|58800882|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
30787501|NCT00119015|58800883|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
30787502|NCT00119015|58800884|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
30787503|NCT01981850|58800897|FG000|Main Phase Stage 1|Death|2|||
30787504|NCT01981850|58800898|FG001|Main Phase Stage 1|Death|0|||
30787505|NCT01981850|58800899|FG002|Main Phase Stage 1|Death|0|||
30787506|NCT01981850|58800900|FG003|Main Phase Stage 1|Death|0|||
30787507|NCT01981850|58800901|FG004|Main Phase Stage 1|Death|0|||
30787508|NCT01981850|58800902|FG005|Main Phase Stage 1|Death|0|||
30787509|NCT01981850|58800903|FG006|Main Phase Stage 1|Death|0|||
30787510|NCT01981850|58800904|FG007|Main Phase Stage 1|Death|0|||
30787511|NCT01981850|58800905|FG008|Main Phase Stage 1|Death|0|||
30787512|NCT01981850|58800906|FG009|Main Phase Stage 1|Death|0|||
30787513|NCT01981850|58800897|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
30787514|NCT01981850|58800898|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
30787515|NCT01981850|58800899|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
30787516|NCT01981850|58800900|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
30787517|NCT01981850|58800901|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
30787518|NCT01981850|58800902|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
30787519|NCT01981850|58800903|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
30787520|NCT01981850|58800904|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
30787521|NCT01981850|58800905|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
30787522|NCT01981850|58800906|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
30787523|NCT01981850|58800897|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
30787524|NCT01981850|58800898|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
30787525|NCT01981850|58800899|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
30787526|NCT01981850|58800900|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
30787527|NCT01981850|58800901|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
30787528|NCT01981850|58800902|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
30787529|NCT01981850|58800903|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
30787530|NCT01981850|58800904|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
30787531|NCT01981850|58800905|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
30787532|NCT01981850|58800906|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
30787533|NCT01981850|58800897|FG000|Main Phase Stage 1|Various reasons|0|||
30787534|NCT01981850|58800898|FG001|Main Phase Stage 1|Various reasons|0|||
30787535|NCT01981850|58800899|FG002|Main Phase Stage 1|Various reasons|2|||
30787536|NCT01981850|58800900|FG003|Main Phase Stage 1|Various reasons|0|||
30787537|NCT01981850|58800901|FG004|Main Phase Stage 1|Various reasons|0|||
30787538|NCT01981850|58800902|FG005|Main Phase Stage 1|Various reasons|0|||
30787539|NCT01981850|58800903|FG006|Main Phase Stage 1|Various reasons|0|||
30787540|NCT01981850|58800904|FG007|Main Phase Stage 1|Various reasons|0|||
30787541|NCT01981850|58800905|FG008|Main Phase Stage 1|Various reasons|0|||
30787542|NCT01981850|58800906|FG009|Main Phase Stage 1|Various reasons|0|||
30787543|NCT01981850|58800897|FG000|Main Phase Stage 2|Adverse Event|0|||
30787544|NCT01981850|58800898|FG001|Main Phase Stage 2|Adverse Event|0|||
30787545|NCT01981850|58800899|FG002|Main Phase Stage 2|Adverse Event|0|||
30787546|NCT01981850|58800900|FG003|Main Phase Stage 2|Adverse Event|0|||
30787547|NCT01981850|58800901|FG004|Main Phase Stage 2|Adverse Event|6|||
30787548|NCT01981850|58800902|FG005|Main Phase Stage 2|Adverse Event|5|||
30787549|NCT01981850|58800903|FG006|Main Phase Stage 2|Adverse Event|7|||
30787550|NCT01981850|58800904|FG007|Main Phase Stage 2|Adverse Event|0|||
30787551|NCT01981850|58800905|FG008|Main Phase Stage 2|Adverse Event|0|||
30787552|NCT01981850|58800906|FG009|Main Phase Stage 2|Adverse Event|0|||
30787553|NCT01981850|58800897|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
30787554|NCT01981850|58800898|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
30787555|NCT01981850|58800899|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
30787556|NCT01981850|58800900|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
30787557|NCT01981850|58800901|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
30787558|NCT01981850|58800902|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
30787559|NCT01981850|58800903|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
30787560|NCT01981850|58800904|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
30787561|NCT01981850|58800905|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
30787562|NCT01981850|58800906|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
30787563|NCT01981850|58800897|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
30787564|NCT01981850|58800898|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
30787565|NCT01981850|58800899|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
30787566|NCT01981850|58800900|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
30787567|NCT01981850|58800901|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
30787568|NCT01981850|58800902|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
30787569|NCT01981850|58800903|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
30787570|NCT01981850|58800904|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
30787571|NCT01981850|58800905|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
30787572|NCT01981850|58800906|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
30787573|NCT01981850|58800897|FG000|Main Phase Stage 2|Various reasons|0|||
30787574|NCT01981850|58800898|FG001|Main Phase Stage 2|Various reasons|0|||
30787575|NCT01981850|58800899|FG002|Main Phase Stage 2|Various reasons|0|||
30787576|NCT01981850|58800900|FG003|Main Phase Stage 2|Various reasons|0|||
30787577|NCT01981850|58800901|FG004|Main Phase Stage 2|Various reasons|2|||
30787578|NCT01981850|58800902|FG005|Main Phase Stage 2|Various reasons|0|||
30787579|NCT01981850|58800903|FG006|Main Phase Stage 2|Various reasons|1|||
30787580|NCT01981850|58800904|FG007|Main Phase Stage 2|Various reasons|0|||
30787581|NCT01981850|58800905|FG008|Main Phase Stage 2|Various reasons|0|||
30787582|NCT01981850|58800906|FG009|Main Phase Stage 2|Various reasons|0|||
30787583|NCT01981850|58800897|FG000|Main Phase Stage 2|Progressive Disease|0|||
30787584|NCT01981850|58800898|FG001|Main Phase Stage 2|Progressive Disease|0|||
30787585|NCT01981850|58800899|FG002|Main Phase Stage 2|Progressive Disease|0|||
30787586|NCT01981850|58800900|FG003|Main Phase Stage 2|Progressive Disease|0|||
30787587|NCT01981850|58800901|FG004|Main Phase Stage 2|Progressive Disease|0|||
30787588|NCT01981850|58800902|FG005|Main Phase Stage 2|Progressive Disease|6|||
30787589|NCT01981850|58800903|FG006|Main Phase Stage 2|Progressive Disease|6|||
30787590|NCT01981850|58800904|FG007|Main Phase Stage 2|Progressive Disease|0|||
30787591|NCT01981850|58800905|FG008|Main Phase Stage 2|Progressive Disease|0|||
30787592|NCT01981850|58800906|FG009|Main Phase Stage 2|Progressive Disease|0|||
30787593|NCT01981850|58800897|FG000|Open Label Extension (OLE)|Adverse Event|0|||
30787594|NCT01981850|58800898|FG001|Open Label Extension (OLE)|Adverse Event|0|||
30787595|NCT01981850|58800899|FG002|Open Label Extension (OLE)|Adverse Event|0|||
30787596|NCT01981850|58800900|FG003|Open Label Extension (OLE)|Adverse Event|0|||
30787597|NCT01981850|58800901|FG004|Open Label Extension (OLE)|Adverse Event|0|||
30787598|NCT01981850|58800902|FG005|Open Label Extension (OLE)|Adverse Event|0|||
30787599|NCT01981850|58800903|FG006|Open Label Extension (OLE)|Adverse Event|0|||
30787600|NCT01981850|58800904|FG007|Open Label Extension (OLE)|Adverse Event|2|||
30787601|NCT01981850|58800905|FG008|Open Label Extension (OLE)|Adverse Event|1|||
30787602|NCT01981850|58800906|FG009|Open Label Extension (OLE)|Adverse Event|8|||
30787603|NCT01981850|58800897|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
30787604|NCT01981850|58800898|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
30787605|NCT01981850|58800899|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
30787606|NCT01981850|58800900|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
30787607|NCT01981850|58800901|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
30787608|NCT01981850|58800902|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
30787609|NCT01981850|58800903|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
30787610|NCT01981850|58800904|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
30787611|NCT01981850|58800905|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
30787612|NCT01981850|58800906|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
30787613|NCT01981850|58800897|FG000|Open Label Extension (OLE)|Various reasons|0|||
30787614|NCT01981850|58800898|FG001|Open Label Extension (OLE)|Various reasons|0|||
30787615|NCT01981850|58800899|FG002|Open Label Extension (OLE)|Various reasons|0|||
30787616|NCT01981850|58800900|FG003|Open Label Extension (OLE)|Various reasons|0|||
30787617|NCT01981850|58800901|FG004|Open Label Extension (OLE)|Various reasons|0|||
30787618|NCT01981850|58800902|FG005|Open Label Extension (OLE)|Various reasons|0|||
30787619|NCT01981850|58800903|FG006|Open Label Extension (OLE)|Various reasons|0|||
30787620|NCT01981850|58800904|FG007|Open Label Extension (OLE)|Various reasons|3|||
30787621|NCT01981850|58800905|FG008|Open Label Extension (OLE)|Various reasons|1|||
30787622|NCT01981850|58800906|FG009|Open Label Extension (OLE)|Various reasons|3|||
30787623|NCT01981850|58800897|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
30787624|NCT01981850|58800898|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
30787625|NCT01981850|58800899|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
30787626|NCT01981850|58800900|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
30787627|NCT01981850|58800901|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
30787628|NCT01981850|58800902|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
30787629|NCT01981850|58800903|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
30787630|NCT01981850|58800904|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
30787631|NCT01981850|58800905|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
30787632|NCT01981850|58800906|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
30787633|NCT01981850|58800897|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
30787634|NCT01981850|58800898|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
30787635|NCT01981850|58800899|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
30787636|NCT01981850|58800900|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
30787637|NCT01981850|58800901|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
30787638|NCT01981850|58800902|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
30787639|NCT01981850|58800903|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
30787640|NCT01981850|58800904|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
30787641|NCT01981850|58800905|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
30787642|NCT01981850|58800906|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
30787643|NCT01981850|58800897|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
30787644|NCT01981850|58800898|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
30787645|NCT01981850|58800899|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
30787646|NCT01981850|58800900|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
30787647|NCT01981850|58800901|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
30787648|NCT01981850|58800902|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
30787649|NCT01981850|58800903|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
30787650|NCT01981850|58800904|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
30787651|NCT01981850|58800905|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
30787652|NCT01981850|58800906|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
30787653|NCT03557307|58800938|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
30787654|NCT03557307|58800938|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
30787655|NCT03557307|58800938|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
30787656|NCT03557307|58800938|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
30787657|NCT03557307|58800938|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
30787658|NCT03557307|58800938|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
30787659|NCT03557307|58800938|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
30787660|NCT03557307|58800938|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
30787661|NCT03557307|58800938|FG000|Period 2: Maintenance Phase|Death|3|||
30787662|NCT03557307|58800938|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
30787663|NCT03557307|58800938|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
30787664|NCT03557307|58800938|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
30787665|NCT03557307|58800938|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
30787666|NCT03557307|58800938|FG000|Period 2: Maintenance Phase|other|3|||
30787667|NCT00118703|58800950|FG000|Overall Study|Protocol Violation|1|||
30787668|NCT00118703|58800951|FG001|Overall Study|Protocol Violation|0|||
30787669|NCT00118703|58800950|FG000|Overall Study|Adverse Event|1|||
30787670|NCT00118703|58800951|FG001|Overall Study|Adverse Event|1|||
30787671|NCT00118703|58800950|FG000|Overall Study|Participant took two different treatment|0|||
30787672|NCT00118703|58800951|FG001|Overall Study|Participant took two different treatment|1|||
30787673|NCT00118703|58800950|FG000|Overall Study|Withdrawal by Subject|2|||
30787674|NCT00118703|58800951|FG001|Overall Study|Withdrawal by Subject|5|||
30787675|NCT00118703|58800950|FG000|Overall Study|Lost to Follow-up|1|||
30787676|NCT00118703|58800951|FG001|Overall Study|Lost to Follow-up|2|||
30876829|NCT01674569|58908264|FG003|Overall Study|Protocol Violation|0|||
30876830|NCT01674569|58908265|FG004|Overall Study|Protocol Violation|0|||
30876831|NCT01674569|58908266|FG005|Overall Study|Protocol Violation|0|||
30876832|NCT01674569|58908261|FG000|Overall Study|Withdrawal by Subject|0|||
30876833|NCT01674569|58908262|FG001|Overall Study|Withdrawal by Subject|0|||
30876834|NCT01674569|58908263|FG002|Overall Study|Withdrawal by Subject|1|||
30876835|NCT01674569|58908264|FG003|Overall Study|Withdrawal by Subject|0|||
30876836|NCT01674569|58908265|FG004|Overall Study|Withdrawal by Subject|0|||
30876837|NCT01674569|58908266|FG005|Overall Study|Withdrawal by Subject|0|||
30876838|NCT01374217|58908270|FG000|Overall Study|Lack of Efficacy|13|||
30876839|NCT01674647|58908276|FG000|Treatment Period|Death|4|||
30876840|NCT01674647|58908277|FG001|Treatment Period|Death|1|||
30876841|NCT01674647|58908276|FG000|Treatment Period|Efficacy outcome reached|0|||
30876842|NCT01674647|58908277|FG001|Treatment Period|Efficacy outcome reached|1|||
30876843|NCT01674647|58908276|FG000|Treatment Period|Physician Decision|3|||
30876844|NCT01674647|58908277|FG001|Treatment Period|Physician Decision|1|||
30876845|NCT01674647|58908276|FG000|Treatment Period|Adverse Event|60|||
30876846|NCT01674647|58908277|FG001|Treatment Period|Adverse Event|22|||
30876847|NCT01674647|58908276|FG000|Treatment Period|Non-compliance with study drug|3|||
30876848|NCT01674647|58908277|FG001|Treatment Period|Non-compliance with study drug|0|||
30876849|NCT01674647|58908276|FG000|Treatment Period|Lost to Follow-up|1|||
30876850|NCT01674647|58908277|FG001|Treatment Period|Lost to Follow-up|1|||
30876851|NCT01674647|58908276|FG000|Treatment Period|Withdrawal by Subject|19|||
30876852|NCT01674647|58908277|FG001|Treatment Period|Withdrawal by Subject|16|||
30876853|NCT01674647|58908276|FG000|Treatment Period|Switching to other therapy|5|||
30876854|NCT01674647|58908277|FG001|Treatment Period|Switching to other therapy|2|||
30876855|NCT01674647|58908276|FG000|Treatment Period|Logistical difficulties|5|||
30876856|NCT01674647|58908277|FG001|Treatment Period|Logistical difficulties|8|||
30876857|NCT01674647|58908276|FG000|Treatment Period|Treatment failure|0|||
30876858|NCT01674647|58908277|FG001|Treatment Period|Treatment failure|14|||
30876859|NCT01674647|58908276|FG000|Treatment Period|Protocol Violation|56|||
30876860|NCT01674647|58908277|FG001|Treatment Period|Protocol Violation|36|||
30876861|NCT01674647|58908276|FG000|30-day Safety Follow-up Period|Death|3|||
30876862|NCT01674647|58908277|FG001|30-day Safety Follow-up Period|Death|2|||
30876863|NCT01674647|58908276|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
30876864|NCT01674647|58908277|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
30876865|NCT01674647|58908276|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
30876866|NCT01674647|58908277|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
30876867|NCT01674647|58908276|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
30876868|NCT01674647|58908277|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
30876869|NCT01674647|58908276|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
30876870|NCT01674647|58908277|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
30876871|NCT01674647|58908276|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
30876872|NCT01674647|58908277|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
30876873|NCT02669407|58908283|FG000|Overall Study|Physician Decision|3|||
30876874|NCT02667457|58908289|FG000|Overall Study|Withdrawal by Subject|1|||
30876875|NCT02667457|58908290|FG001|Overall Study|Withdrawal by Subject|0|||
30876876|NCT02667457|58908289|FG000|Overall Study|Other Reason|0|||
30876877|NCT02667457|58908290|FG001|Overall Study|Other Reason|2|||
30876878|NCT02669095|58908299|FG000|Overall Study|Adverse Event|1|||
30876879|NCT02669095|58908300|FG001|Overall Study|Adverse Event|0|||
30876880|NCT02669095|58908299|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
30876881|NCT02669095|58908300|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
30876882|NCT02669095|58908299|FG000|Overall Study|Torn Lens|0|||
30876883|NCT02669095|58908300|FG001|Overall Study|Torn Lens|1|||
30876884|NCT02669095|58908299|FG000|Overall Study|Visit 5 assessments not completed|0|||
30876885|NCT02669095|58908300|FG001|Overall Study|Visit 5 assessments not completed|1|||
30876886|NCT02667301|58908306|FG000|Overall Study|Adverse Event|1|||
30876887|NCT02667301|58908306|FG000|Overall Study|Lack of Efficacy|1|||
30876888|NCT05274165|58908314|FG000|Overall Study|Withdrawal by Subject|3|||
30876889|NCT05274165|58908315|FG001|Overall Study|Withdrawal by Subject|3|||
30876890|NCT04510090|58908357|FG000|FE-HS|Withdrawal by Subject|0|||
30876891|NCT04510090|58908358|FG001|FE-HS|Withdrawal by Subject|0|||
30876892|NCT04510090|58908359|FG002|FE-HS|Withdrawal by Subject|0|||
30876893|NCT04510090|58908360|FG003|FE-HS|Withdrawal by Subject|0|||
30876894|NCT04510090|58908361|FG004|FE-HS|Withdrawal by Subject|1|||
30876895|NCT04510090|58908362|FG005|FE-HS|Withdrawal by Subject|0|||
30876896|NCT04510090|58908363|FG006|FE-HS|Withdrawal by Subject|0|||
30876897|NCT04510090|58908364|FG007|FE-HS|Withdrawal by Subject|0|||
30876898|NCT04491006|58908394|FG000|Overall Study|Adverse Event|0|||
30876899|NCT04491006|58908395|FG001|Overall Study|Adverse Event|3|||
30876900|NCT04491006|58908396|FG002|Overall Study|Adverse Event|5|||
30876901|NCT04491006|58908394|FG000|Overall Study|Withdrawal by Subject|1|||
30876902|NCT04491006|58908395|FG001|Overall Study|Withdrawal by Subject|0|||
30876903|NCT04491006|58908396|FG002|Overall Study|Withdrawal by Subject|2|||
30876904|NCT04162470|58908439|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
30876905|NCT04122625|58908449|FG000|Part A (up to 2.92 Years)|Death|2|||
30876906|NCT04122625|58908450|FG001|Part A (up to 2.92 Years)|Death|4|||
30876907|NCT04122625|58908451|FG002|Part A (up to 2.92 Years)|Death|0|||
30876908|NCT04122625|58908452|FG003|Part A (up to 2.92 Years)|Death|0|||
30876909|NCT04122625|58908453|FG004|Part A (up to 2.92 Years)|Death|0|||
30876910|NCT04122625|58908454|FG005|Part A (up to 2.92 Years)|Death|0|||
30876911|NCT04122625|58908449|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
30876912|NCT04122625|58908450|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
30876913|NCT04122625|58908451|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
30876914|NCT04122625|58908452|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
30876915|NCT04122625|58908453|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
30876916|NCT04122625|58908454|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
30876917|NCT04122625|58908449|FG000|Part B (up to 2.33 Years)|Death|0|||
30876918|NCT04122625|58908450|FG001|Part B (up to 2.33 Years)|Death|0|||
30876919|NCT04122625|58908451|FG002|Part B (up to 2.33 Years)|Death|5|||
30876920|NCT04122625|58908452|FG003|Part B (up to 2.33 Years)|Death|7|||
30876921|NCT04122625|58908453|FG004|Part B (up to 2.33 Years)|Death|6|||
30876922|NCT04122625|58908454|FG005|Part B (up to 2.33 Years)|Death|7|||
30876923|NCT03824704|58908472|FG000|Overall Study|Study Terminated by Sponsor|1|||
30876924|NCT03766581|58908488|FG000|Randomization|Other reasons|2|||
30876925|NCT03766581|58908489|FG001|Randomization|Other reasons|1|||
30876926|NCT03766581|58908490|FG002|Randomization|Other reasons|0|||
30876927|NCT03766581|58908491|FG003|Randomization|Other reasons|1|||
30876928|NCT03766581|58908492|FG004|Randomization|Other reasons|0|||
30876929|NCT03766581|58908493|FG005|Randomization|Other reasons|0|||
30876930|NCT03766581|58908494|FG006|Randomization|Other reasons|0|||
30876931|NCT03766581|58908495|FG007|Randomization|Other reasons|0|||
30876932|NCT03766581|58908488|FG000|Randomization|Participant no longer meets study criteria|5|||
30876933|NCT03766581|58908489|FG001|Randomization|Participant no longer meets study criteria|3|||
30876934|NCT03766581|58908490|FG002|Randomization|Participant no longer meets study criteria|4|||
30876935|NCT03766581|58908491|FG003|Randomization|Participant no longer meets study criteria|0|||
30876936|NCT03766581|58908492|FG004|Randomization|Participant no longer meets study criteria|2|||
30876937|NCT03766581|58908493|FG005|Randomization|Participant no longer meets study criteria|3|||
30876938|NCT03766581|58908494|FG006|Randomization|Participant no longer meets study criteria|0|||
30876939|NCT03766581|58908495|FG007|Randomization|Participant no longer meets study criteria|1|||
30876940|NCT03766581|58908488|FG000|Randomization|Participant request to discontinue study treatment|1|||
30876941|NCT03766581|58908489|FG001|Randomization|Participant request to discontinue study treatment|0|||
30876942|NCT03766581|58908490|FG002|Randomization|Participant request to discontinue study treatment|0|||
30876943|NCT03766581|58908491|FG003|Randomization|Participant request to discontinue study treatment|0|||
30876944|NCT03766581|58908492|FG004|Randomization|Participant request to discontinue study treatment|1|||
30876945|NCT03766581|58908493|FG005|Randomization|Participant request to discontinue study treatment|2|||
30876946|NCT03766581|58908494|FG006|Randomization|Participant request to discontinue study treatment|0|||
30876947|NCT03766581|58908495|FG007|Randomization|Participant request to discontinue study treatment|0|||
30876948|NCT03766581|58908488|FG000|Randomization|Participant withdrew consent|1|||
30876949|NCT03766581|58908489|FG001|Randomization|Participant withdrew consent|0|||
30876950|NCT03766581|58908490|FG002|Randomization|Participant withdrew consent|1|||
30876951|NCT03766581|58908491|FG003|Randomization|Participant withdrew consent|2|||
30876952|NCT03766581|58908492|FG004|Randomization|Participant withdrew consent|1|||
30876953|NCT03766581|58908493|FG005|Randomization|Participant withdrew consent|1|||
30876954|NCT03766581|58908494|FG006|Randomization|Participant withdrew consent|0|||
30876955|NCT03766581|58908495|FG007|Randomization|Participant withdrew consent|0|||
30876956|NCT03766581|58908488|FG000|Treatment|Adverse Event|82|||
30876957|NCT03766581|58908489|FG001|Treatment|Adverse Event|44|||
30876958|NCT03766581|58908490|FG002|Treatment|Adverse Event|47|||
30876959|NCT03766581|58908491|FG003|Treatment|Adverse Event|46|||
30876960|NCT03766581|58908492|FG004|Treatment|Adverse Event|50|||
30876961|NCT03766581|58908493|FG005|Treatment|Adverse Event|77|||
30876962|NCT03766581|58908494|FG006|Treatment|Adverse Event|5|||
30876963|NCT03766581|58908495|FG007|Treatment|Adverse Event|2|||
30876964|NCT03766581|58908488|FG000|Treatment|Participant request to discontinue treatment|34|||
30876965|NCT03766581|58908489|FG001|Treatment|Participant request to discontinue treatment|6|||
30876966|NCT03766581|58908490|FG002|Treatment|Participant request to discontinue treatment|10|||
30876967|NCT03766581|58908491|FG003|Treatment|Participant request to discontinue treatment|10|||
30876968|NCT03766581|58908492|FG004|Treatment|Participant request to discontinue treatment|14|||
30876969|NCT03766581|58908493|FG005|Treatment|Participant request to discontinue treatment|15|||
30876970|NCT03766581|58908494|FG006|Treatment|Participant request to discontinue treatment|0|||
30876971|NCT03766581|58908495|FG007|Treatment|Participant request to discontinue treatment|1|||
30876972|NCT03766581|58908488|FG000|Treatment|Participant withdrew consent|11|||
30876973|NCT03766581|58908489|FG001|Treatment|Participant withdrew consent|4|||
30876974|NCT03766581|58908490|FG002|Treatment|Participant withdrew consent|5|||
30876975|NCT03766581|58908491|FG003|Treatment|Participant withdrew consent|5|||
30876976|NCT03766581|58908492|FG004|Treatment|Participant withdrew consent|4|||
30876977|NCT03766581|58908493|FG005|Treatment|Participant withdrew consent|4|||
30876978|NCT03766581|58908494|FG006|Treatment|Participant withdrew consent|0|||
30876979|NCT03766581|58908495|FG007|Treatment|Participant withdrew consent|0|||
30876980|NCT03766581|58908488|FG000|Treatment|Death|1|||
30876981|NCT03766581|58908489|FG001|Treatment|Death|0|||
30876982|NCT03766581|58908490|FG002|Treatment|Death|0|||
30876983|NCT03766581|58908491|FG003|Treatment|Death|0|||
30876984|NCT03766581|58908492|FG004|Treatment|Death|0|||
30876985|NCT03766581|58908493|FG005|Treatment|Death|0|||
30876986|NCT03766581|58908494|FG006|Treatment|Death|0|||
30876987|NCT03766581|58908495|FG007|Treatment|Death|0|||
30876988|NCT03766581|58908488|FG000|Treatment|Lost to Follow-up|1|||
30876989|NCT03766581|58908489|FG001|Treatment|Lost to Follow-up|0|||
30876990|NCT03766581|58908490|FG002|Treatment|Lost to Follow-up|0|||
30876991|NCT03766581|58908491|FG003|Treatment|Lost to Follow-up|1|||
30876992|NCT03766581|58908492|FG004|Treatment|Lost to Follow-up|0|||
30876993|NCT03766581|58908493|FG005|Treatment|Lost to Follow-up|0|||
30876994|NCT03766581|58908494|FG006|Treatment|Lost to Follow-up|0|||
30876995|NCT03766581|58908495|FG007|Treatment|Lost to Follow-up|0|||
30876996|NCT03766581|58908488|FG000|Treatment|Poor/Non compliance|2|||
30876997|NCT03766581|58908489|FG001|Treatment|Poor/Non compliance|2|||
30876998|NCT03766581|58908490|FG002|Treatment|Poor/Non compliance|1|||
30876999|NCT03766581|58908491|FG003|Treatment|Poor/Non compliance|1|||
30877000|NCT03766581|58908492|FG004|Treatment|Poor/Non compliance|1|||
30877001|NCT03766581|58908493|FG005|Treatment|Poor/Non compliance|1|||
30877002|NCT03766581|58908494|FG006|Treatment|Poor/Non compliance|0|||
30877003|NCT03766581|58908495|FG007|Treatment|Poor/Non compliance|0|||
30877004|NCT03766581|58908488|FG000|Treatment|Participant no longer meets study criteria|9|||
30877005|NCT03766581|58908489|FG001|Treatment|Participant no longer meets study criteria|1|||
30877006|NCT03766581|58908490|FG002|Treatment|Participant no longer meets study criteria|5|||
30877007|NCT03766581|58908491|FG003|Treatment|Participant no longer meets study criteria|4|||
30877008|NCT03766581|58908492|FG004|Treatment|Participant no longer meets study criteria|4|||
30877009|NCT03766581|58908493|FG005|Treatment|Participant no longer meets study criteria|4|||
30877010|NCT03766581|58908494|FG006|Treatment|Participant no longer meets study criteria|2|||
30877011|NCT03766581|58908495|FG007|Treatment|Participant no longer meets study criteria|0|||
30877012|NCT03766581|58908488|FG000|Treatment|Other reasons|13|||
30877013|NCT03766581|58908489|FG001|Treatment|Other reasons|8|||
30877014|NCT03766581|58908490|FG002|Treatment|Other reasons|3|||
30877015|NCT03766581|58908491|FG003|Treatment|Other reasons|7|||
30877016|NCT03766581|58908492|FG004|Treatment|Other reasons|3|||
30877017|NCT03766581|58908493|FG005|Treatment|Other reasons|3|||
30877018|NCT03766581|58908494|FG006|Treatment|Other reasons|0|||
30877019|NCT03766581|58908495|FG007|Treatment|Other reasons|0|||
30877020|NCT03675321|58908520|FG000|Overall Study|Lack of Efficacy|2|||
30877021|NCT03675321|58908521|FG001|Overall Study|Lack of Efficacy|2|||
30877022|NCT03675321|58908520|FG000|Overall Study|Withdrawal by Subject|1|||
30877023|NCT03675321|58908521|FG001|Overall Study|Withdrawal by Subject|3|||
30877024|NCT03527745|58908567|FG000|Overall Study|Lost to Follow-up|3|||
30877025|NCT03527745|58908568|FG001|Overall Study|Lost to Follow-up|6|||
30877026|NCT03527745|58908569|FG002|Overall Study|Lost to Follow-up|7|||
30877027|NCT03527745|58908570|FG003|Overall Study|Lost to Follow-up|9|||
30877028|NCT03527745|58908571|FG004|Overall Study|Lost to Follow-up|0|||
30877029|NCT03527745|58908572|FG005|Overall Study|Lost to Follow-up|2|||
30877030|NCT03527745|58908573|FG006|Overall Study|Lost to Follow-up|3|||
30877031|NCT03527745|58908574|FG007|Overall Study|Lost to Follow-up|2|||
30877032|NCT03527745|58908575|FG008|Overall Study|Lost to Follow-up|3|||
30877033|NCT03527745|58908576|FG009|Overall Study|Lost to Follow-up|2|||
30877034|NCT03527745|58908577|FG010|Overall Study|Lost to Follow-up|1|||
30877035|NCT03527745|58908578|FG011|Overall Study|Lost to Follow-up|1|||
30877036|NCT03527745|58908579|FG012|Overall Study|Lost to Follow-up|0|||
30877037|NCT03527745|58908580|FG013|Overall Study|Lost to Follow-up|0|||
30877038|NCT03527745|58908581|FG014|Overall Study|Lost to Follow-up|0|||
30877039|NCT03527745|58908582|FG015|Overall Study|Lost to Follow-up|0|||
30877040|NCT03527745|58908583|FG016|Overall Study|Lost to Follow-up|1|||
30877041|NCT03527745|58908584|FG017|Overall Study|Lost to Follow-up|0|||
30877042|NCT03527745|58908585|FG018|Overall Study|Lost to Follow-up|0|||
30877043|NCT03527745|58908586|FG019|Overall Study|Lost to Follow-up|1|||
30966635|NCT01440569|59036193|FG000|Main Study|Enrolled but not treated|1|||
30966636|NCT01440569|59036194|FG001|Main Study|Enrolled but not treated|0|||
30966637|NCT01440569|59036193|FG000|Main Study|Adverse Event|9|||
30966638|NCT01440569|59036194|FG001|Main Study|Adverse Event|0|||
30966639|NCT01440569|59036193|FG000|Main Study|Pregnancy|1|||
30966640|NCT01440569|59036194|FG001|Main Study|Pregnancy|0|||
30966641|NCT01440569|59036193|FG000|Main Study|Investigator's Discretion|1|||
30966642|NCT01440569|59036194|FG001|Main Study|Investigator's Discretion|1|||
30966643|NCT01440569|59036193|FG000|Main Study|Withdrew Consent|7|||
30966644|NCT01440569|59036194|FG001|Main Study|Withdrew Consent|1|||
30966645|NCT01440569|59036193|FG000|Main Study|Lost to Follow-up|13|||
30966646|NCT01440569|59036194|FG001|Main Study|Lost to Follow-up|2|||
30966647|NCT01440569|59036193|FG000|Main Study|Subject Non-Compliance|3|||
30966648|NCT01440569|59036194|FG001|Main Study|Subject Non-Compliance|0|||
30966649|NCT01440569|59036193|FG000|Main Study|Protocol Violation|1|||
30966650|NCT01440569|59036194|FG001|Main Study|Protocol Violation|0|||
30966651|NCT01440569|59036193|FG000|Open-Label Rollover Phase|Adverse Event|3|||
30966652|NCT01440569|59036194|FG001|Open-Label Rollover Phase|Adverse Event|0|||
30966653|NCT01440569|59036193|FG000|Open-Label Rollover Phase|Pregnancy|1|||
30966654|NCT01440569|59036194|FG001|Open-Label Rollover Phase|Pregnancy|0|||
30966655|NCT01440569|59036193|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
30966656|NCT01440569|59036194|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
30966657|NCT01440569|59036193|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
30966658|NCT01440569|59036194|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
30966659|NCT01440569|59036193|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
30966660|NCT01440569|59036194|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
30966661|NCT01440569|59036193|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
30966662|NCT01440569|59036194|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
30966663|NCT01440569|59036193|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
30966664|NCT01440569|59036194|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
30966665|NCT01546142|59036217|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
30966666|NCT01546142|59036218|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
30966667|NCT01546142|59036217|FG000|Overall Study|Subject Noncompliance|1|||
30966668|NCT01546142|59036218|FG001|Overall Study|Subject Noncompliance|1|||
30966669|NCT01546142|59036217|FG000|Overall Study|Adverse Event|6|||
30966670|NCT01546142|59036218|FG001|Overall Study|Adverse Event|3|||
30966671|NCT01546142|59036217|FG000|Overall Study|Lost to Follow-up|20|||
30966672|NCT01546142|59036218|FG001|Overall Study|Lost to Follow-up|15|||
30966673|NCT01546142|59036217|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
30966674|NCT01546142|59036218|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
30966675|NCT01546142|59036217|FG000|Overall Study|Subject Randomized but Not Treated|1|||
30966676|NCT01546142|59036218|FG001|Overall Study|Subject Randomized but Not Treated|0|||
30966677|NCT01440101|59036252|FG000|Overall Study|Adverse Event|2|||
30966678|NCT01440101|59036253|FG001|Overall Study|Adverse Event|0|||
30966679|NCT01440101|59036254|FG002|Overall Study|Adverse Event|0|||
30966680|NCT01440101|59036252|FG000|Overall Study|Withdrawal by Subject|0|||
30966681|NCT01440101|59036253|FG001|Overall Study|Withdrawal by Subject|3|||
30966682|NCT01440101|59036254|FG002|Overall Study|Withdrawal by Subject|1|||
30966683|NCT01440101|59036252|FG000|Overall Study|Other|0|||
30966684|NCT01440101|59036253|FG001|Overall Study|Other|1|||
30966685|NCT01440101|59036254|FG002|Overall Study|Other|0|||
30966686|NCT01530464|59036265|FG000|Washout (24h)|Withdrawal by Subject|1|||
30966687|NCT01530464|59036266|FG001|Washout (24h)|Withdrawal by Subject|0|||
30966688|NCT01530464|59036265|FG000|Washout (24h)|Withdrawal by Subject|0|||
30966689|NCT01530464|59036266|FG001|Washout (24h)|Withdrawal by Subject|1|||
30966690|NCT01439945|59036333|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
30966691|NCT01439945|59036334|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
30966692|NCT01439945|59036335|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
30966693|NCT01439945|59036336|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
30966694|NCT01439945|59036333|FG000|Double-Blind Treatment Phase|Ineligible|1|||
30966695|NCT01439945|59036334|FG001|Double-Blind Treatment Phase|Ineligible|2|||
30966696|NCT01439945|59036335|FG002|Double-Blind Treatment Phase|Ineligible|0|||
30966697|NCT01439945|59036336|FG003|Double-Blind Treatment Phase|Ineligible|1|||
30966698|NCT01420081|59036441|FG000|Overall Study|Death|1|||
30966699|NCT01420081|59036442|FG001|Overall Study|Death|0|||
30966700|NCT01420081|59036443|FG002|Overall Study|Death|8|||
30966701|NCT01420081|59036444|FG003|Overall Study|Death|0|||
30966702|NCT01420081|59036445|FG004|Overall Study|Death|7|||
30966703|NCT01420081|59036446|FG005|Overall Study|Death|12|||
30966704|NCT01420081|59036447|FG006|Overall Study|Death|0|||
30966705|NCT01420081|59036448|FG007|Overall Study|Death|1|||
30966706|NCT01420081|59036449|FG008|Overall Study|Death|1|||
30966707|NCT01420081|59036441|FG000|Overall Study|Lost to Follow-up|0|||
30966708|NCT01420081|59036442|FG001|Overall Study|Lost to Follow-up|0|||
30966709|NCT01420081|59036443|FG002|Overall Study|Lost to Follow-up|0|||
30966710|NCT01420081|59036444|FG003|Overall Study|Lost to Follow-up|0|||
30966711|NCT01420081|59036445|FG004|Overall Study|Lost to Follow-up|1|||
30966712|NCT01420081|59036446|FG005|Overall Study|Lost to Follow-up|1|||
30966713|NCT01420081|59036447|FG006|Overall Study|Lost to Follow-up|0|||
30966714|NCT01420081|59036448|FG007|Overall Study|Lost to Follow-up|0|||
30966715|NCT01420081|59036449|FG008|Overall Study|Lost to Follow-up|0|||
30966716|NCT01420081|59036441|FG000|Overall Study|Study Terminated by Sponsor|2|||
30966717|NCT01420081|59036442|FG001|Overall Study|Study Terminated by Sponsor|1|||
30966718|NCT01420081|59036443|FG002|Overall Study|Study Terminated by Sponsor|1|||
30966719|NCT01420081|59036444|FG003|Overall Study|Study Terminated by Sponsor|3|||
30966720|NCT01420081|59036445|FG004|Overall Study|Study Terminated by Sponsor|11|||
30966721|NCT01420081|59036446|FG005|Overall Study|Study Terminated by Sponsor|7|||
30966722|NCT01420081|59036447|FG006|Overall Study|Study Terminated by Sponsor|3|||
30966723|NCT01420081|59036448|FG007|Overall Study|Study Terminated by Sponsor|2|||
30966724|NCT01420081|59036449|FG008|Overall Study|Study Terminated by Sponsor|2|||
30966725|NCT01420081|59036441|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
30966726|NCT01420081|59036442|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
30966727|NCT01420081|59036443|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
30966728|NCT01420081|59036444|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
30966729|NCT01420081|59036445|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
30966730|NCT01420081|59036446|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
30966731|NCT01420081|59036447|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
30966732|NCT01420081|59036448|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
30966733|NCT01420081|59036449|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
30966734|NCT01420081|59036441|FG000|Overall Study|Other Reasons|0|||
30966735|NCT01420081|59036442|FG001|Overall Study|Other Reasons|0|||
30966736|NCT01420081|59036443|FG002|Overall Study|Other Reasons|1|||
30966737|NCT01420081|59036444|FG003|Overall Study|Other Reasons|0|||
30966738|NCT01420081|59036445|FG004|Overall Study|Other Reasons|0|||
30966739|NCT01420081|59036446|FG005|Overall Study|Other Reasons|0|||
30966740|NCT01420081|59036447|FG006|Overall Study|Other Reasons|0|||
30966741|NCT01420081|59036448|FG007|Overall Study|Other Reasons|0|||
30966742|NCT01420081|59036449|FG008|Overall Study|Other Reasons|0|||
30966743|NCT01439867|59036467|FG000|Overall Study|Non-compliance|0|||
30966744|NCT01439867|59036468|FG001|Overall Study|Non-compliance|1|||
30966745|NCT01439867|59036467|FG000|Overall Study|Withdrawal by Subject|1|||
30966746|NCT01439867|59036468|FG001|Overall Study|Withdrawal by Subject|2|||
30966747|NCT01439867|59036467|FG000|Overall Study|Administrative Decision|4|||
30966748|NCT01439867|59036468|FG001|Overall Study|Administrative Decision|5|||
30966749|NCT01439867|59036467|FG000|Overall Study|Protocol-specified Criteria|1|||
30966750|NCT01439867|59036468|FG001|Overall Study|Protocol-specified Criteria|0|||
30966751|NCT01439711|59036485|FG000|Overall Study|Ineligible|13|||
30966752|NCT01439711|59036485|FG000|Overall Study|Cancel|3|||
30966753|NCT01439711|59036485|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
30966754|NCT01439711|59036485|FG000|Overall Study|Adverse Event|5|||
30966755|NCT01439711|59036485|FG000|Overall Study|Withdrawal by Subject|3|||
30966756|NCT01439711|59036485|FG000|Overall Study|Progression During Active Tx|3|||
30966757|NCT01439711|59036485|FG000|Overall Study|Noncompliance|3|||
30966758|NCT01439711|59036485|FG000|Overall Study|No MRI|9|||
30966759|NCT01439555|59036489|FG000|Overall Study|Protocol Violation|1|||
30966760|NCT01544582|59036509|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
30966761|NCT01544582|59036510|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
30966762|NCT01544582|59036511|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
30966763|NCT01544582|59036512|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
30966764|NCT01544582|59036509|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
30966765|NCT01544582|59036510|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
30966766|NCT01544582|59036511|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
30966767|NCT01544582|59036512|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
30966768|NCT01544582|59036509|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
30966769|NCT01544582|59036510|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
30966770|NCT01544582|59036511|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
30966771|NCT01544582|59036512|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
30966772|NCT01544582|59036509|FG000|Analysis Population|Physician Decision|0|||
30966773|NCT01544582|59036510|FG001|Analysis Population|Physician Decision|13|||
30966774|NCT01544582|59036511|FG002|Analysis Population|Physician Decision|10|||
30966775|NCT01544582|59036512|FG003|Analysis Population|Physician Decision|9|||
30966776|NCT01544582|59036509|FG000|Analysis Population|Safety Reason|0|||
30966777|NCT01544582|59036510|FG001|Analysis Population|Safety Reason|33|||
30966778|NCT01544582|59036511|FG002|Analysis Population|Safety Reason|31|||
30966779|NCT01544582|59036512|FG003|Analysis Population|Safety Reason|8|||
30966780|NCT01544582|59036509|FG000|Analysis Population|Effectiveness Reason|0|||
30966781|NCT01544582|59036510|FG001|Analysis Population|Effectiveness Reason|48|||
30966782|NCT01544582|59036511|FG002|Analysis Population|Effectiveness Reason|29|||
30966783|NCT01544582|59036512|FG003|Analysis Population|Effectiveness Reason|12|||
30966784|NCT01544582|59036509|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
30966785|NCT01544582|59036510|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
30966786|NCT01544582|59036511|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
30966787|NCT01544582|59036512|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
30966788|NCT01544582|59036509|FG000|Analysis Population|Lost to Follow-up|0|||
30966789|NCT01544582|59036510|FG001|Analysis Population|Lost to Follow-up|6|||
30966790|NCT01544582|59036511|FG002|Analysis Population|Lost to Follow-up|6|||
30966791|NCT01544582|59036512|FG003|Analysis Population|Lost to Follow-up|5|||
30966792|NCT01544582|59036509|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
30966793|NCT01544582|59036510|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
30966794|NCT01544582|59036511|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
30966795|NCT01544582|59036512|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
30966796|NCT01544582|59036509|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
30966797|NCT01544582|59036510|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
30966798|NCT01544582|59036511|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
30966799|NCT01544582|59036512|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
30966800|NCT01544582|59036509|FG000|Analysis Population|Intolerance|0|||
30966801|NCT01544582|59036510|FG001|Analysis Population|Intolerance|1|||
30966802|NCT01544582|59036511|FG002|Analysis Population|Intolerance|0|||
30966803|NCT01544582|59036512|FG003|Analysis Population|Intolerance|0|||
30966804|NCT01544582|59036509|FG000|Analysis Population|Liver Transplantation|0|||
30966805|NCT01544582|59036510|FG001|Analysis Population|Liver Transplantation|0|||
30966806|NCT01544582|59036511|FG002|Analysis Population|Liver Transplantation|1|||
30966807|NCT01544582|59036512|FG003|Analysis Population|Liver Transplantation|0|||
30966808|NCT01544582|59036509|FG000|Analysis Population|No Social Insurance|0|||
30966809|NCT01544582|59036510|FG001|Analysis Population|No Social Insurance|0|||
30966810|NCT01544582|59036511|FG002|Analysis Population|No Social Insurance|1|||
30966811|NCT01544582|59036512|FG003|Analysis Population|No Social Insurance|0|||
30966812|NCT01544582|59036509|FG000|Analysis Population|Poor Adherence|0|||
30966813|NCT01544582|59036510|FG001|Analysis Population|Poor Adherence|0|||
30966814|NCT01544582|59036511|FG002|Analysis Population|Poor Adherence|1|||
30966815|NCT01544582|59036512|FG003|Analysis Population|Poor Adherence|0|||
30966816|NCT01544582|59036509|FG000|Analysis Population|Poor Participant Compliance|0|||
30966817|NCT01544582|59036510|FG001|Analysis Population|Poor Participant Compliance|1|||
30966818|NCT01544582|59036511|FG002|Analysis Population|Poor Participant Compliance|0|||
30966819|NCT01544582|59036512|FG003|Analysis Population|Poor Participant Compliance|0|||
30966820|NCT01544582|59036509|FG000|Analysis Population|Programmed Surgery|0|||
30966821|NCT01544582|59036510|FG001|Analysis Population|Programmed Surgery|1|||
30966822|NCT01544582|59036511|FG002|Analysis Population|Programmed Surgery|0|||
30966823|NCT01544582|59036512|FG003|Analysis Population|Programmed Surgery|0|||
30966824|NCT01544582|59036509|FG000|Analysis Population|Participant in Jail|0|||
30966825|NCT01544582|59036510|FG001|Analysis Population|Participant in Jail|0|||
30966826|NCT01544582|59036511|FG002|Analysis Population|Participant in Jail|1|||
30966827|NCT01544582|59036512|FG003|Analysis Population|Participant in Jail|0|||
30966828|NCT01439165|59036540|FG000|Overall Study|Protocol Violation|3|||
30966829|NCT01439165|59036541|FG001|Overall Study|Protocol Violation|0|||
30966830|NCT01439165|59036540|FG000|Overall Study|Lost to Follow-up|11|||
30966831|NCT01439165|59036541|FG001|Overall Study|Lost to Follow-up|1|||
30966832|NCT01439165|59036540|FG000|Overall Study|Withdrawal by Subject|7|||
30966833|NCT01439165|59036541|FG001|Overall Study|Withdrawal by Subject|1|||
30966834|NCT01529606|59036555|FG000|Overall Study|Lost to Follow-up|21|||
30966835|NCT01529606|59036556|FG001|Overall Study|Lost to Follow-up|18|||
30966836|NCT01439009|59036573|FG000|Overall Study|Physician Decision|5|||
30966837|NCT01439009|59036574|FG001|Overall Study|Physician Decision|3|||
30966838|NCT01439009|59036573|FG000|Overall Study|Protocol Violation|2|||
30966839|NCT01439009|59036574|FG001|Overall Study|Protocol Violation|0|||
30966840|NCT01439009|59036573|FG000|Overall Study|Deviation of exclusion criteria|1|||
30966841|NCT01439009|59036574|FG001|Overall Study|Deviation of exclusion criteria|0|||
30966842|NCT01572389|59036593|FG000|Overall Study|Death|1|||
30966843|NCT01572389|59036594|FG001|Overall Study|Death|3|||
30966844|NCT01572389|59036593|FG000|Overall Study|Withdrawal by Subject|14|||
30966845|NCT01572389|59036594|FG001|Overall Study|Withdrawal by Subject|2|||
30966846|NCT01572389|59036593|FG000|Overall Study|Lost to Follow-up|25|||
30966847|NCT01572389|59036594|FG001|Overall Study|Lost to Follow-up|14|||
30966848|NCT01572389|59036593|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
30966849|NCT01572389|59036594|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
30966850|NCT01571453|59036606|FG000|Overall Study|Adverse Event|14|||
30966851|NCT01571453|59036607|FG001|Overall Study|Adverse Event|32|||
30966852|NCT01571453|59036606|FG000|Overall Study|Lack of Efficacy|8|||
30966853|NCT01571453|59036607|FG001|Overall Study|Lack of Efficacy|3|||
30966854|NCT01571453|59036606|FG000|Overall Study|Non-compliance|2|||
30966855|NCT01571453|59036607|FG001|Overall Study|Non-compliance|4|||
30966856|NCT01571453|59036606|FG000|Overall Study|Protocol Violation|1|||
30966857|NCT01571453|59036607|FG001|Overall Study|Protocol Violation|5|||
30966858|NCT01571453|59036606|FG000|Overall Study|Withdrawal of consent|5|||
30966859|NCT01571453|59036607|FG001|Overall Study|Withdrawal of consent|13|||
30966860|NCT01571453|59036606|FG000|Overall Study|Lost to Follow-up|4|||
30966861|NCT01571453|59036607|FG001|Overall Study|Lost to Follow-up|2|||
30966862|NCT01571453|59036606|FG000|Overall Study|Administrative or other reason(s)|4|||
30966863|NCT01571453|59036607|FG001|Overall Study|Administrative or other reason(s)|3|||
30966864|NCT01446289|59036617|FG000|Overall Study|Withdrawal by Subject|1|||
30966865|NCT01446289|59036618|FG001|Overall Study|Withdrawal by Subject|0|||
30966866|NCT01446289|59036619|FG002|Overall Study|Withdrawal by Subject|1|||
30966867|NCT01446289|59036620|FG003|Overall Study|Withdrawal by Subject|0|||
30966868|NCT01438541|59036632|FG000|Overall Study|Physician Decision|1|||
30966869|NCT01438541|59036632|FG000|Overall Study|Withdrawal by Subject|1|||
30966870|NCT01438541|59036632|FG000|Overall Study|discharge from the hospital|5|||
30966871|NCT01419769|59036636|FG000|Overall Study|Did not receive the AXIOS stent|3|||
30966872|NCT01419769|59036636|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
30966873|NCT01438307|59036642|FG000|Overall Study|Death|1|||
30966874|NCT01438307|59036643|FG001|Overall Study|Death|1|||
30966875|NCT01444651|59036651|FG000|Overall Study|Adverse Event|3|||
30966876|NCT01444651|59036652|FG001|Overall Study|Adverse Event|2|||
30966877|NCT01444651|59036651|FG000|Overall Study|Lost to Follow-up|5|||
30966878|NCT01444651|59036652|FG001|Overall Study|Lost to Follow-up|5|||
30966879|NCT01444651|59036651|FG000|Overall Study|Non-fasting|2|||
30966880|NCT01444651|59036652|FG001|Overall Study|Non-fasting|1|||
30966881|NCT01444651|59036651|FG000|Overall Study|Missing data|1|||
30966882|NCT01444651|59036652|FG001|Overall Study|Missing data|1|||
30966883|NCT01570751|59036660|FG000|Period A (16 Weeks)|Protocol Violation|1|||
30966884|NCT01570751|59036661|FG001|Period A (16 Weeks)|Protocol Violation|1|||
30966885|NCT01570751|59036660|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
30966886|NCT01570751|59036661|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
30966887|NCT01570751|59036660|FG000|Period A (16 Weeks)|Unclassified|2|||
30966888|NCT01570751|59036661|FG001|Period A (16 Weeks)|Unclassified|3|||
30966889|NCT01570751|59036660|FG000|Period B (16 Weeks)|Adverse Event|1|||
30966890|NCT01570751|59036661|FG001|Period B (16 Weeks)|Adverse Event|0|||
30966891|NCT01570751|59036660|FG000|Period B (16 Weeks)|Protocol Violation|0|||
30966892|NCT01570751|59036661|FG001|Period B (16 Weeks)|Protocol Violation|1|||
30966893|NCT01419535|59036671|FG000|Overall Study|could not maintain iv line|1|||
30966894|NCT01419535|59036672|FG001|Overall Study|could not maintain iv line|1|||
30966895|NCT01419535|59036671|FG000|Overall Study|Withdrawal by Subject|0|||
30966896|NCT01419535|59036672|FG001|Overall Study|Withdrawal by Subject|1|||
30966897|NCT01438151|59036678|FG000|Overall Study|study terminated|8|||
30966898|NCT01418365|59036704|FG000|First Intervention|Withdrawal by Subject|0|||
30966899|NCT01418365|59036705|FG001|First Intervention|Withdrawal by Subject|1|||
30966900|NCT01418365|59036704|FG000|First Intervention|Non-compliance|1|||
30966901|NCT01418365|59036705|FG001|First Intervention|Non-compliance|0|||
30966902|NCT01418365|59036704|FG000|Second Intervention|Withdrawal by Subject|0|||
30966903|NCT01418365|59036705|FG001|Second Intervention|Withdrawal by Subject|1|||
30966904|NCT01437995|59036740|FG000|Overall Study|Lost to Follow-up|11|||
30966905|NCT01437995|59036741|FG001|Overall Study|Lost to Follow-up|18|||
30966906|NCT01437995|59036742|FG002|Overall Study|Lost to Follow-up|20|||
30966907|NCT01439347|59036791|FG000|Overall Study|Death|10|||
30966908|NCT01439347|59036792|FG001|Overall Study|Death|9|||
30966909|NCT01439347|59036791|FG000|Overall Study|Withdrawal by Subject|0|||
30966910|NCT01439347|59036792|FG001|Overall Study|Withdrawal by Subject|1|||
30966911|NCT01439347|59036791|FG000|Overall Study|Physician Decision|1|||
30966912|NCT01439347|59036792|FG001|Overall Study|Physician Decision|0|||
30966913|NCT01439347|59036791|FG000|Overall Study|Sponsor Terminated Study|2|||
30966914|NCT01439347|59036792|FG001|Overall Study|Sponsor Terminated Study|3|||
30966915|NCT01438957|59036839|FG000|Overall Study|Physician Decision|1|||
30966916|NCT01438957|59036840|FG001|Overall Study|Physician Decision|1|||
30966917|NCT01438957|59036841|FG002|Overall Study|Physician Decision|0|||
30966918|NCT01438957|59036842|FG003|Overall Study|Physician Decision|1|||
30966919|NCT01438957|59036843|FG004|Overall Study|Physician Decision|0|||
30966920|NCT01444417|59036892|FG000|Overall Study|Ineligibility Determined|0|||
30966921|NCT01444417|59036893|FG001|Overall Study|Ineligibility Determined|1|||
30966922|NCT01444417|59036892|FG000|Overall Study|Withdrawal by Subject|2|||
30966923|NCT01444417|59036893|FG001|Overall Study|Withdrawal by Subject|0|||
30966924|NCT01444027|59036920|FG000|Overall Study|Withdrawal by Subject|4|||
30966925|NCT01444027|59036921|FG001|Overall Study|Withdrawal by Subject|10|||
30966926|NCT01444027|59036922|FG002|Overall Study|Withdrawal by Subject|24|||
30966927|NCT01444027|59036920|FG000|Overall Study|Lost to Follow-up|26|||
30966928|NCT01444027|59036921|FG001|Overall Study|Lost to Follow-up|20|||
30966929|NCT01444027|59036922|FG002|Overall Study|Lost to Follow-up|14|||
30966930|NCT01438489|59036964|FG000|Overall Study|Lost to Follow-up|4|||
30966931|NCT01438489|59036965|FG001|Overall Study|Lost to Follow-up|2|||
30966932|NCT01438489|59036966|FG002|Overall Study|Lost to Follow-up|2|||
30966933|NCT01438489|59036964|FG000|Overall Study|Withdrawal by Subject|11|||
30966934|NCT01438489|59036965|FG001|Overall Study|Withdrawal by Subject|3|||
30966935|NCT01438489|59036966|FG002|Overall Study|Withdrawal by Subject|8|||
30966936|NCT01438489|59036964|FG000|Overall Study|Death|0|||
30966937|NCT01438489|59036965|FG001|Overall Study|Death|0|||
30966938|NCT01438489|59036966|FG002|Overall Study|Death|1|||
30966939|NCT01438489|59036964|FG000|Overall Study|Sponsor decision|4|||
30966940|NCT01438489|59036965|FG001|Overall Study|Sponsor decision|1|||
30966941|NCT01438489|59036966|FG002|Overall Study|Sponsor decision|4|||
30966942|NCT01438489|59036964|FG000|Overall Study|Subject choice/Subject moved|2|||
30966943|NCT01438489|59036965|FG001|Overall Study|Subject choice/Subject moved|1|||
30966944|NCT01438489|59036966|FG002|Overall Study|Subject choice/Subject moved|1|||
30966945|NCT01438489|59036964|FG000|Overall Study|Investigator decision|0|||
30966946|NCT01438489|59036965|FG001|Overall Study|Investigator decision|1|||
30966947|NCT01438489|59036966|FG002|Overall Study|Investigator decision|0|||
30966948|NCT01438489|59036964|FG000|Overall Study|AE/SAEs|2|||
30966949|NCT01438489|59036965|FG001|Overall Study|AE/SAEs|1|||
30966950|NCT01438489|59036966|FG002|Overall Study|AE/SAEs|1|||
30966951|NCT01438489|59036964|FG000|Overall Study|Received prohibited medication|1|||
30966952|NCT01438489|59036965|FG001|Overall Study|Received prohibited medication|0|||
30966953|NCT01438489|59036966|FG002|Overall Study|Received prohibited medication|0|||
30966954|NCT01438489|59036964|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
30966955|NCT01438489|59036965|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
30966956|NCT01438489|59036966|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
30966957|NCT01438489|59036964|FG000|Overall Study|Inadequate venous access|0|||
30966958|NCT01438489|59036965|FG001|Overall Study|Inadequate venous access|2|||
30966959|NCT01438489|59036966|FG002|Overall Study|Inadequate venous access|0|||
30966960|NCT01418209|59036992|FG000|Overall Study|Withdrawal by Subject|1|||
30966961|NCT01418209|59036993|FG001|Overall Study|Withdrawal by Subject|0|||
30966962|NCT01418209|59036994|FG002|Overall Study|Withdrawal by Subject|1|||
30966963|NCT01418209|59036992|FG000|Overall Study|Did not provide hot flash diary data|1|||
30966964|NCT01418209|59036993|FG001|Overall Study|Did not provide hot flash diary data|3|||
30966965|NCT01418209|59036994|FG002|Overall Study|Did not provide hot flash diary data|3|||
30966966|NCT01570361|59037013|FG000|Overall Study|Subject discontinued|1|||
30966967|NCT01570361|59037014|FG001|Overall Study|Subject discontinued|2|||
30966968|NCT01570361|59037013|FG000|Overall Study|Sponsor closing the study|51|||
30966969|NCT01570361|59037014|FG001|Overall Study|Sponsor closing the study|50|||
30966970|NCT01570361|59037013|FG000|Overall Study|Subject excluded|5|||
30966971|NCT01570361|59037014|FG001|Overall Study|Subject excluded|3|||
30966972|NCT01570361|59037013|FG000|Overall Study|Subject withdrew consent|14|||
30966973|NCT01570361|59037014|FG001|Overall Study|Subject withdrew consent|9|||
30966974|NCT01570361|59037013|FG000|Overall Study|Adverse Event|2|||
30966975|NCT01570361|59037014|FG001|Overall Study|Adverse Event|1|||
30966976|NCT01570361|59037013|FG000|Overall Study|Lost to Follow-up|4|||
30966977|NCT01570361|59037014|FG001|Overall Study|Lost to Follow-up|4|||
30966978|NCT01570361|59037013|FG000|Overall Study|Death|5|||
30966979|NCT01570361|59037014|FG001|Overall Study|Death|4|||
30966980|NCT01570361|59037013|FG000|Overall Study|Other|0|||
30966981|NCT01570361|59037014|FG001|Overall Study|Other|2|||
30966982|NCT01417195|59037025|FG000|Overall Study|Stimulation failure|1|||
30966983|NCT01417195|59037026|FG001|Overall Study|Stimulation failure|0|||
30966984|NCT01417195|59037025|FG000|Overall Study|No embryos for transfer|0|||
30966985|NCT01417195|59037026|FG001|Overall Study|No embryos for transfer|1|||
30966986|NCT01417195|59037025|FG000|Overall Study|No transfer due to risk of OHSS|1|||
30966987|NCT01417195|59037026|FG001|Overall Study|No transfer due to risk of OHSS|0|||
30966988|NCT01417195|59037025|FG000|Overall Study|No transfer due to elevated progesterone|1|||
30966989|NCT01417195|59037026|FG001|Overall Study|No transfer due to elevated progesterone|0|||
30966990|NCT01438411|59037051|FG000|Overall Study|Adverse Event|8|||
30966991|NCT01438411|59037051|FG000|Overall Study|Lost to Follow-up|1|||
30966992|NCT01438411|59037051|FG000|Overall Study|Lack of Efficacy|1|||
30966993|NCT01438411|59037051|FG000|Overall Study|Withdrawal by Subject|3|||
30966994|NCT01443403|59037063|FG000|Overall Study|Adverse Event|1|||
30966995|NCT01443403|59037064|FG001|Overall Study|Adverse Event|1|||
30966996|NCT01443403|59037065|FG002|Overall Study|Adverse Event|4|||
30966997|NCT01443403|59037066|FG003|Overall Study|Adverse Event|5|||
30966998|NCT01443403|59037063|FG000|Overall Study|Withdrawal by Subject|0|||
30966999|NCT01443403|59037064|FG001|Overall Study|Withdrawal by Subject|1|||
30967000|NCT01443403|59037065|FG002|Overall Study|Withdrawal by Subject|2|||
30967001|NCT01443403|59037066|FG003|Overall Study|Withdrawal by Subject|1|||
30967002|NCT01443403|59037063|FG000|Overall Study|Lost to Follow-up|0|||
30967003|NCT01443403|59037064|FG001|Overall Study|Lost to Follow-up|0|||
30967004|NCT01443403|59037065|FG002|Overall Study|Lost to Follow-up|0|||
30967005|NCT01443403|59037066|FG003|Overall Study|Lost to Follow-up|1|||
30967006|NCT01443403|59037063|FG000|Overall Study|Protocol Violation|2|||
30967007|NCT01443403|59037064|FG001|Overall Study|Protocol Violation|1|||
30967008|NCT01443403|59037065|FG002|Overall Study|Protocol Violation|1|||
30967009|NCT01443403|59037066|FG003|Overall Study|Protocol Violation|1|||
30967010|NCT01443403|59037063|FG000|Overall Study|Use of Prohibited Treatment|2|||
30967011|NCT01443403|59037064|FG001|Overall Study|Use of Prohibited Treatment|3|||
30967012|NCT01443403|59037065|FG002|Overall Study|Use of Prohibited Treatment|0|||
30967013|NCT01443403|59037066|FG003|Overall Study|Use of Prohibited Treatment|0|||
30967014|NCT01443403|59037063|FG000|Overall Study|Other - Miscellaneous|1|||
30967015|NCT01443403|59037064|FG001|Overall Study|Other - Miscellaneous|0|||
30967016|NCT01443403|59037065|FG002|Overall Study|Other - Miscellaneous|0|||
30967017|NCT01443403|59037066|FG003|Overall Study|Other - Miscellaneous|1|||
30967018|NCT01438177|59037079|FG000|Overall Study|Withdrawal by Subject|1|||
30967019|NCT01438177|59037079|FG000|Overall Study|Initiation of new therapy|1|||
30967020|NCT01442779|59037083|FG000|Overall Study|Withdrawal by Subject|3|||
30967021|NCT01442779|59037083|FG000|Overall Study|Death|3|||
30967022|NCT01442779|59037083|FG000|Overall Study|Non-compliance|1|||
30967023|NCT01416805|59037089|FG000|Overall Study|Lost to Follow-up|4|||
30967024|NCT01416805|59037090|FG001|Overall Study|Lost to Follow-up|4|||
30967025|NCT01437943|59037098|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
30967026|NCT01437943|59037099|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
30967027|NCT01437943|59037098|FG000|Overall Study|Subject expressed pregnancy plans|1|||
30967028|NCT01437943|59037099|FG001|Overall Study|Subject expressed pregnancy plans|0|||
30967029|NCT01437943|59037098|FG000|Overall Study|Adverse Event|2|||
30967030|NCT01437943|59037099|FG001|Overall Study|Adverse Event|0|||
30967031|NCT01570283|59037108|FG000|Cohort 1: Dose Level 1|Death|0|||
30967032|NCT01570283|59037109|FG001|Cohort 1: Dose Level 1|Death|1|||
30967033|NCT01570283|59037110|FG002|Cohort 1: Dose Level 1|Death|0|||
30967034|NCT01570283|59037111|FG003|Cohort 1: Dose Level 1|Death|0|||
30967035|NCT01570283|59037112|FG004|Cohort 1: Dose Level 1|Death|0|||
30967036|NCT01570283|59037113|FG005|Cohort 1: Dose Level 1|Death|0|||
30967037|NCT01570283|59037108|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
30967038|NCT01570283|59037109|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
30967039|NCT01570283|59037110|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
30967040|NCT01570283|59037111|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
30967041|NCT01570283|59037112|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
30967042|NCT01570283|59037113|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
30967043|NCT01570283|59037108|FG000|Cohort 2: Dose Level 2|Death|0|||
30967044|NCT01570283|59037109|FG001|Cohort 2: Dose Level 2|Death|0|||
30967045|NCT01570283|59037110|FG002|Cohort 2: Dose Level 2|Death|1|||
30967046|NCT01570283|59037111|FG003|Cohort 2: Dose Level 2|Death|0|||
30967047|NCT01570283|59037112|FG004|Cohort 2: Dose Level 2|Death|0|||
30967048|NCT01570283|59037113|FG005|Cohort 2: Dose Level 2|Death|0|||
30967049|NCT01570283|59037108|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
30967050|NCT01570283|59037109|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
30967051|NCT01570283|59037110|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
30967052|NCT01570283|59037111|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
30967053|NCT01570283|59037112|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
30967054|NCT01570283|59037113|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
30967055|NCT01570283|59037108|FG000|Cohort 3: Dose Level 3|Death|0|||
30967056|NCT01570283|59037109|FG001|Cohort 3: Dose Level 3|Death|0|||
30967057|NCT01570283|59037110|FG002|Cohort 3: Dose Level 3|Death|0|||
30967058|NCT01570283|59037111|FG003|Cohort 3: Dose Level 3|Death|0|||
30967059|NCT01570283|59037112|FG004|Cohort 3: Dose Level 3|Death|0|||
30967060|NCT01570283|59037113|FG005|Cohort 3: Dose Level 3|Death|1|||
30967061|NCT01570283|59037108|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
30967062|NCT01570283|59037109|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
30967063|NCT01570283|59037110|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
30967064|NCT01570283|59037111|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
30967065|NCT01570283|59037112|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
30967066|NCT01570283|59037113|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
30967067|NCT01436357|59037129|FG000|Overall Study|Death|5|||
30967068|NCT01436357|59037130|FG001|Overall Study|Death|1|||
30967069|NCT01436357|59037129|FG000|Overall Study|Enrolled but not vaccinated|1|||
30967070|NCT01436357|59037130|FG001|Overall Study|Enrolled but not vaccinated|1|||
30967071|NCT01436357|59037129|FG000|Overall Study|Incarceration|18|||
30967072|NCT01436357|59037130|FG001|Overall Study|Incarceration|20|||
30967073|NCT01436357|59037129|FG000|Overall Study|Lost to Follow-up|67|||
30967074|NCT01436357|59037130|FG001|Overall Study|Lost to Follow-up|61|||
30967075|NCT01436357|59037129|FG000|Overall Study|Protocol Violation|1|||
30967076|NCT01436357|59037130|FG001|Overall Study|Protocol Violation|0|||
30967077|NCT01436357|59037129|FG000|Overall Study|Withdrawal by Subject|26|||
30967078|NCT01436357|59037130|FG001|Overall Study|Withdrawal by Subject|38|||
30967079|NCT01436357|59037129|FG000|Overall Study|Physician Decision|3|||
30967080|NCT01436357|59037130|FG001|Overall Study|Physician Decision|4|||
30967081|NCT01436357|59037129|FG000|Overall Study|Moved out of area|1|||
30967082|NCT01436357|59037130|FG001|Overall Study|Moved out of area|2|||
30967083|NCT01436357|59037129|FG000|Overall Study|Subject in rehab|0|||
30967084|NCT01436357|59037130|FG001|Overall Study|Subject in rehab|1|||
30967085|NCT01436201|59037136|FG000|Overall Study|Adverse Event|2|||
30967086|NCT01436201|59037136|FG000|Overall Study|Withdrawal by Subject|1|||
30967087|NCT01436201|59037136|FG000|Overall Study|Protocol Violation|1|||
30967088|NCT01437397|59037147|FG000|Overall Study|Lost to Follow-up|9|||
30967089|NCT01437397|59037148|FG001|Overall Study|Lost to Follow-up|4|||
30967090|NCT01437397|59037149|FG002|Overall Study|Lost to Follow-up|2|||
30967091|NCT01437397|59037150|FG003|Overall Study|Lost to Follow-up|4|||
30967092|NCT01437397|59037151|FG004|Overall Study|Lost to Follow-up|5|||
30967093|NCT01437397|59037147|FG000|Overall Study|Withdrawal by Subject|11|||
30967094|NCT01437397|59037148|FG001|Overall Study|Withdrawal by Subject|12|||
30967095|NCT01437397|59037149|FG002|Overall Study|Withdrawal by Subject|24|||
30967096|NCT01437397|59037150|FG003|Overall Study|Withdrawal by Subject|11|||
30967097|NCT01437397|59037151|FG004|Overall Study|Withdrawal by Subject|22|||
30967098|NCT01437397|59037147|FG000|Overall Study|Protocol Violation|10|||
30967099|NCT01437397|59037148|FG001|Overall Study|Protocol Violation|12|||
30967100|NCT01437397|59037149|FG002|Overall Study|Protocol Violation|13|||
30967101|NCT01437397|59037150|FG003|Overall Study|Protocol Violation|21|||
30967102|NCT01437397|59037151|FG004|Overall Study|Protocol Violation|19|||
30967103|NCT01437397|59037147|FG000|Overall Study|Lack of Efficacy|5|||
30967104|NCT01437397|59037148|FG001|Overall Study|Lack of Efficacy|4|||
30967105|NCT01437397|59037149|FG002|Overall Study|Lack of Efficacy|8|||
30967106|NCT01437397|59037150|FG003|Overall Study|Lack of Efficacy|10|||
30967107|NCT01437397|59037151|FG004|Overall Study|Lack of Efficacy|20|||
30967108|NCT01437397|59037147|FG000|Overall Study|Adverse Event|21|||
30967109|NCT01437397|59037148|FG001|Overall Study|Adverse Event|22|||
30967110|NCT01437397|59037149|FG002|Overall Study|Adverse Event|16|||
30967111|NCT01437397|59037150|FG003|Overall Study|Adverse Event|14|||
30967112|NCT01437397|59037151|FG004|Overall Study|Adverse Event|21|||
30967113|NCT01437397|59037147|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
30967114|NCT01437397|59037148|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
30967115|NCT01437397|59037149|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
30967116|NCT01437397|59037150|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
30967117|NCT01437397|59037151|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
30967118|NCT01437319|59037163|FG000|Phase I|Lost to Follow-up|2|||
30967119|NCT01437319|59037164|FG001|Phase I|Lost to Follow-up|0|||
30967120|NCT01437319|59037165|FG002|Phase I|Lost to Follow-up|0|||
30967121|NCT01437319|59037163|FG000|Phase I|Protocol Violation|1|||
30967122|NCT01437319|59037164|FG001|Phase I|Protocol Violation|0|||
30967123|NCT01437319|59037165|FG002|Phase I|Protocol Violation|0|||
30967124|NCT01437319|59037163|FG000|Phase I|Study related symptoms/complaints|27|||
30967125|NCT01437319|59037164|FG001|Phase I|Study related symptoms/complaints|0|||
30967126|NCT01437319|59037165|FG002|Phase I|Study related symptoms/complaints|0|||
30967127|NCT01437319|59037163|FG000|Phase I|Withdrawal by Subject|25|||
30967128|NCT01437319|59037164|FG001|Phase I|Withdrawal by Subject|0|||
30967129|NCT01437319|59037165|FG002|Phase I|Withdrawal by Subject|0|||
30967130|NCT01437319|59037163|FG000|Phase II|Withdrawal by Subject|0|||
30967131|NCT01437319|59037164|FG001|Phase II|Withdrawal by Subject|8|||
30967132|NCT01437319|59037165|FG002|Phase II|Withdrawal by Subject|16|||
30967133|NCT01437319|59037163|FG000|Phase II|Lost to Follow-up|0|||
30967134|NCT01437319|59037164|FG001|Phase II|Lost to Follow-up|7|||
30967135|NCT01437319|59037165|FG002|Phase II|Lost to Follow-up|2|||
30967136|NCT01437319|59037163|FG000|Phase II|Study related symptoms/complaints|0|||
30967137|NCT01437319|59037164|FG001|Phase II|Study related symptoms/complaints|28|||
30967138|NCT01437319|59037165|FG002|Phase II|Study related symptoms/complaints|19|||
30967139|NCT01437319|59037163|FG000|Phase II|Protocol Violation|0|||
30967140|NCT01437319|59037164|FG001|Phase II|Protocol Violation|1|||
30967141|NCT01437319|59037165|FG002|Phase II|Protocol Violation|0|||
30967142|NCT01416571|59037174|FG000|Overall Study|Lost to Follow-up|2|||
30967143|NCT01442155|59037195|FG000|Overall Study|Complete remission|35|||
30967144|NCT01442155|59037195|FG000|Overall Study|Recurrence|26|||
30967145|NCT01442155|59037195|FG000|Overall Study|Adverse Event|2|||
30967146|NCT01442155|59037195|FG000|Overall Study|Lost to Follow-up|2|||
30967147|NCT01416181|59037201|FG000|Part 1|Other|10|||
30967148|NCT01416181|59037202|FG001|Part 1|Other|24|||
30967149|NCT01416181|59037201|FG000|Part 1|Death|0|||
30967150|NCT01416181|59037202|FG001|Part 1|Death|1|||
30967151|NCT01416181|59037201|FG000|Part 1|Investigator Decision|7|||
30967152|NCT01416181|59037202|FG001|Part 1|Investigator Decision|6|||
30967153|NCT01416181|59037201|FG000|Part 1|Withdrawal by Subject|74|||
30967154|NCT01416181|59037202|FG001|Part 1|Withdrawal by Subject|48|||
30967155|NCT01416181|59037201|FG000|Part 1|Lack of Efficacy|16|||
30967156|NCT01416181|59037202|FG001|Part 1|Lack of Efficacy|8|||
30967157|NCT01416181|59037201|FG000|Part 1|Lost to Follow-up|1|||
30967158|NCT01416181|59037202|FG001|Part 1|Lost to Follow-up|1|||
30967159|NCT01416181|59037201|FG000|Part 1|Adverse Event|15|||
30967160|NCT01416181|59037202|FG001|Part 1|Adverse Event|18|||
30967161|NCT01416181|59037201|FG000|Part 1|Ongoing in Follow-Up|14|||
30967162|NCT01416181|59037202|FG001|Part 1|Ongoing in Follow-Up|8|||
30967163|NCT01416181|59037201|FG000|Part 2|Adverse Event|11|||
30967164|NCT01416181|59037202|FG001|Part 2|Adverse Event|4|||
30967165|NCT01416181|59037201|FG000|Part 2|Other|234|||
30967166|NCT01416181|59037202|FG001|Part 2|Other|267|||
30967167|NCT01416181|59037201|FG000|Part 2|Investigator Decision|6|||
30967168|NCT01416181|59037202|FG001|Part 2|Investigator Decision|7|||
30967169|NCT01416181|59037201|FG000|Part 2|Withdrawal by Subject|14|||
30967170|NCT01416181|59037202|FG001|Part 2|Withdrawal by Subject|5|||
30967171|NCT01416181|59037201|FG000|Part 2|Lack of Efficacy|4|||
30967172|NCT01416181|59037202|FG001|Part 2|Lack of Efficacy|1|||
30967173|NCT01416181|59037201|FG000|Part 2|Lost to Follow-up|2|||
30967174|NCT01416181|59037202|FG001|Part 2|Lost to Follow-up|2|||
30967175|NCT01441765|59037210|FG000|Overall Study|Death|1|||
30967176|NCT01441765|59037211|FG001|Overall Study|Death|0|||
30967177|NCT01419665|59037219|FG000|Combination Treatment|Adverse Event|7|||
30967178|NCT01419665|59037220|FG001|Combination Treatment|Adverse Event|10|||
30967179|NCT01419665|59037219|FG000|Combination Treatment|Physician Decision|5|||
30967180|NCT01419665|59037220|FG001|Combination Treatment|Physician Decision|8|||
30967181|NCT01419665|59037219|FG000|Combination Treatment|Protocol Violation|6|||
30967182|NCT01419665|59037220|FG001|Combination Treatment|Protocol Violation|2|||
30967183|NCT01419665|59037219|FG000|Combination Treatment|disease progression|10|||
30967184|NCT01419665|59037220|FG001|Combination Treatment|disease progression|9|||
30967185|NCT01419665|59037219|FG000|Combination Treatment|Death|5|||
30967186|NCT01419665|59037220|FG001|Combination Treatment|Death|7|||
30967187|NCT01419665|59037219|FG000|Combination Treatment|administrative problems|0|||
30967188|NCT01419665|59037220|FG001|Combination Treatment|administrative problems|1|||
30967189|NCT01419665|59037219|FG000|Combination Treatment|Withdrawal by Subject|5|||
30967190|NCT01419665|59037220|FG001|Combination Treatment|Withdrawal by Subject|4|||
30967191|NCT01419665|59037219|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
30967192|NCT01419665|59037220|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
30967193|NCT01419665|59037219|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
30967194|NCT01419665|59037220|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
30967195|NCT01419665|59037219|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
30967196|NCT01419665|59037220|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
30967197|NCT01419665|59037219|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
30967198|NCT01419665|59037220|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
30967199|NCT01419665|59037219|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
30967200|NCT01419665|59037220|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
30967201|NCT01419665|59037219|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
30967202|NCT01419665|59037220|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
30967203|NCT01419665|59037219|FG000|Maintenance Treatment and/or Follow up|Death|1|||
30967204|NCT01419665|59037220|FG001|Maintenance Treatment and/or Follow up|Death|2|||
30967205|NCT01419665|59037219|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
30967206|NCT01419665|59037220|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
30967207|NCT01419665|59037219|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
30967208|NCT01419665|59037220|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
30967209|NCT01419665|59037219|FG000|Open Label Phase|Death|1|||
30967210|NCT01419665|59037220|FG001|Open Label Phase|Death|0|||
30967211|NCT01419665|59037219|FG000|Open Label Phase|disease progression|0|||
30967212|NCT01419665|59037220|FG001|Open Label Phase|disease progression|1|||
30877044|NCT03527745|58908587|FG020|Overall Study|Lost to Follow-up|1|||
30877045|NCT03527745|58908588|FG021|Overall Study|Lost to Follow-up|5|||
30877046|NCT03527745|58908589|FG022|Overall Study|Lost to Follow-up|6|||
30877047|NCT03527745|58908590|FG023|Overall Study|Lost to Follow-up|8|||
30877048|NCT03527745|58908591|FG024|Overall Study|Lost to Follow-up|1|||
30877049|NCT03527745|58908592|FG025|Overall Study|Lost to Follow-up|3|||
30877050|NCT03330405|58908683|FG000|Overall Study|Other|0|||
30877051|NCT03330405|58908684|FG001|Overall Study|Other|1|||
30877052|NCT03330405|58908685|FG002|Overall Study|Other|0|||
30877053|NCT03330405|58908686|FG003|Overall Study|Other|0|||
30877054|NCT03330405|58908687|FG004|Overall Study|Other|0|||
30877055|NCT03330405|58908688|FG005|Overall Study|Other|0|||
30877056|NCT03330405|58908689|FG006|Overall Study|Other|1|||
30877057|NCT03330405|58908690|FG007|Overall Study|Other|0|||
30877058|NCT03330405|58908691|FG008|Overall Study|Other|0|||
30877059|NCT03330405|58908692|FG009|Overall Study|Other|0|||
30877060|NCT03330405|58908693|FG010|Overall Study|Other|0|||
30877061|NCT03330405|58908683|FG000|Overall Study|Ongoing|1|||
30877062|NCT03330405|58908684|FG001|Overall Study|Ongoing|4|||
30877063|NCT03330405|58908685|FG002|Overall Study|Ongoing|1|||
30877064|NCT03330405|58908686|FG003|Overall Study|Ongoing|0|||
30877065|NCT03330405|58908687|FG004|Overall Study|Ongoing|2|||
30877066|NCT03330405|58908688|FG005|Overall Study|Ongoing|0|||
30877067|NCT03330405|58908689|FG006|Overall Study|Ongoing|0|||
30877068|NCT03330405|58908690|FG007|Overall Study|Ongoing|2|||
30877069|NCT03330405|58908691|FG008|Overall Study|Ongoing|0|||
30877070|NCT03330405|58908692|FG009|Overall Study|Ongoing|0|||
30877071|NCT03330405|58908693|FG010|Overall Study|Ongoing|0|||
30877072|NCT03330405|58908683|FG000|Overall Study|Progressive disease|8|||
30877073|NCT03330405|58908684|FG001|Overall Study|Progressive disease|26|||
30877074|NCT03330405|58908685|FG002|Overall Study|Progressive disease|4|||
30877075|NCT03330405|58908686|FG003|Overall Study|Progressive disease|18|||
30877076|NCT03330405|58908687|FG004|Overall Study|Progressive disease|16|||
30877077|NCT03330405|58908688|FG005|Overall Study|Progressive disease|14|||
30877078|NCT03330405|58908689|FG006|Overall Study|Progressive disease|7|||
30877079|NCT03330405|58908690|FG007|Overall Study|Progressive disease|29|||
30967213|NCT01436305|59037231|FG000|Overall Study|Death|1|||
30967214|NCT01436305|59037232|FG001|Overall Study|Death|0|||
30967215|NCT01436305|59037233|FG002|Overall Study|Death|0|||
30967216|NCT01436305|59037231|FG000|Overall Study|Lost to Follow-up|0|||
30967217|NCT01436305|59037232|FG001|Overall Study|Lost to Follow-up|1|||
30967218|NCT01436305|59037233|FG002|Overall Study|Lost to Follow-up|0|||
30967219|NCT01436305|59037231|FG000|Overall Study|Withdrawal by Subject|1|||
30967220|NCT01436305|59037232|FG001|Overall Study|Withdrawal by Subject|3|||
30967221|NCT01436305|59037233|FG002|Overall Study|Withdrawal by Subject|0|||
30967222|NCT01436149|59037243|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
30967223|NCT01436149|59037244|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
30967224|NCT01436149|59037245|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
30967225|NCT01436149|59037243|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
30967226|NCT01436149|59037244|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
30967227|NCT01436149|59037245|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
30967228|NCT01436149|59037243|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
30967229|NCT01436149|59037244|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
30967230|NCT01436149|59037245|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
30967231|NCT01436149|59037243|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
30967232|NCT01436149|59037244|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
30967233|NCT01436149|59037245|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
30967234|NCT01436149|59037243|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
30967235|NCT01436149|59037244|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
30967236|NCT01436149|59037245|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
30967237|NCT01436149|59037243|FG000|Antidepressant Lead-in Phase|Other|119|||
30967238|NCT01436149|59037244|FG001|Antidepressant Lead-in Phase|Other|0|||
30967239|NCT01436149|59037245|FG002|Antidepressant Lead-in Phase|Other|0|||
30967240|NCT01436149|59037243|FG000|Randomized Phase|Adverse Event|9|||
30967241|NCT01436149|59037244|FG001|Randomized Phase|Adverse Event|10|||
30967242|NCT01436149|59037245|FG002|Randomized Phase|Adverse Event|11|||
30967243|NCT01436149|59037243|FG000|Randomized Phase|Protocol Violation|4|||
30967244|NCT01436149|59037244|FG001|Randomized Phase|Protocol Violation|5|||
30967245|NCT01436149|59037245|FG002|Randomized Phase|Protocol Violation|0|||
30967246|NCT01436149|59037243|FG000|Randomized Phase|Withdrawal by Subject|16|||
30967247|NCT01436149|59037244|FG001|Randomized Phase|Withdrawal by Subject|10|||
30967248|NCT01436149|59037245|FG002|Randomized Phase|Withdrawal by Subject|10|||
30967249|NCT01436149|59037243|FG000|Randomized Phase|Lost to Follow-up|34|||
30967250|NCT01436149|59037244|FG001|Randomized Phase|Lost to Follow-up|5|||
30967251|NCT01436149|59037245|FG002|Randomized Phase|Lost to Follow-up|6|||
30967252|NCT01436149|59037243|FG000|Randomized Phase|Lack of Efficacy|0|||
30967253|NCT01436149|59037244|FG001|Randomized Phase|Lack of Efficacy|0|||
30967254|NCT01436149|59037245|FG002|Randomized Phase|Lack of Efficacy|1|||
30967255|NCT01436149|59037243|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
30967256|NCT01436149|59037244|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
30967257|NCT01436149|59037245|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
30967258|NCT01436149|59037243|FG000|Randomized Phase|Other|12|||
30967259|NCT01436149|59037244|FG001|Randomized Phase|Other|5|||
30967260|NCT01436149|59037245|FG002|Randomized Phase|Other|11|||
30967261|NCT01415401|59037251|FG000|Overall Study|Adverse Event|5|||
30967262|NCT01415401|59037251|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
30967263|NCT01415401|59037251|FG000|Overall Study|Terminated by Sponsor|1|||
30967264|NCT01414855|59037255|FG000|Overall Study|Death|17|||
30967265|NCT01414855|59037255|FG000|Overall Study|Lost to Follow-up|5|||
30967266|NCT01414855|59037255|FG000|Overall Study|Withdrawal by Subject|7|||
30967267|NCT01527500|59037263|FG000|Part A|Administrative|11|||
30967268|NCT01527500|59037264|FG001|Part A|Administrative|7|||
30967269|NCT01527500|59037263|FG000|Part A|Adverse Event|4|||
30967270|NCT01527500|59037264|FG001|Part A|Adverse Event|2|||
30967271|NCT01527500|59037263|FG000|Part A|Death|4|||
30967272|NCT01527500|59037264|FG001|Part A|Death|1|||
30967273|NCT01527500|59037263|FG000|Part A|Lost to Follow-up|0|||
30967274|NCT01527500|59037264|FG001|Part A|Lost to Follow-up|1|||
30967275|NCT01527500|59037263|FG000|Part A|Protocol Deviation|9|||
30967276|NCT01527500|59037264|FG001|Part A|Protocol Deviation|2|||
30967277|NCT01527500|59037263|FG000|Part A|Withdrawal by Subject|2|||
30967278|NCT01527500|59037264|FG001|Part A|Withdrawal by Subject|0|||
30967279|NCT01527500|59037263|FG000|Part B|Adverse Event|1|||
30967280|NCT01527500|59037264|FG001|Part B|Adverse Event|0|||
30967281|NCT01527110|59037289|FG000|Overall Study|Adverse Event|1|||
30967282|NCT01441063|59037293|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
30967283|NCT01441063|59037293|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
30967284|NCT01436071|59037302|FG000|Overall Study|Adverse Event|1|||
30967285|NCT01436071|59037303|FG001|Overall Study|Adverse Event|0|||
30967286|NCT01436071|59037302|FG000|Overall Study|Lack of Efficacy|16|||
30967287|NCT01436071|59037303|FG001|Overall Study|Lack of Efficacy|7|||
30967288|NCT01436071|59037302|FG000|Overall Study|Protocol Violation|0|||
30967289|NCT01436071|59037303|FG001|Overall Study|Protocol Violation|1|||
30967290|NCT01436071|59037302|FG000|Overall Study|Lost to Follow-up|3|||
30967291|NCT01436071|59037303|FG001|Overall Study|Lost to Follow-up|1|||
30967292|NCT01436071|59037302|FG000|Overall Study|Physician Decision|1|||
30967293|NCT01436071|59037303|FG001|Overall Study|Physician Decision|0|||
30967294|NCT01436071|59037302|FG000|Overall Study|Withdrawal by Subject|2|||
30967295|NCT01436071|59037303|FG001|Overall Study|Withdrawal by Subject|2|||
30967296|NCT01436071|59037302|FG000|Overall Study|Did Not Receive Trial Medication|3|||
30967297|NCT01436071|59037303|FG001|Overall Study|Did Not Receive Trial Medication|3|||
30967298|NCT01514864|59037311|FG000|Overall Study|Disease progression|7|||
30967299|NCT01514864|59037312|FG001|Overall Study|Disease progression|5|||
30967300|NCT01514864|59037311|FG000|Overall Study|Study drug toxicity|2|||
30967301|NCT01514864|59037312|FG001|Overall Study|Study drug toxicity|0|||
30967302|NCT01514240|59037321|FG000|Overall Study|Adverse Event|4|||
30967303|NCT01514240|59037322|FG001|Overall Study|Adverse Event|4|||
30967304|NCT01514240|59037321|FG000|Overall Study|Subject Decision|2|||
30967305|NCT01514240|59037322|FG001|Overall Study|Subject Decision|7|||
30967306|NCT01435759|59037333|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
30967307|NCT01435759|59037334|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
30967308|NCT01435759|59037335|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
30967309|NCT01435759|59037336|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
30967310|NCT01435759|59037337|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
30967311|NCT01435759|59037338|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
30967312|NCT01435759|59037333|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
30967313|NCT01435759|59037334|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
30967314|NCT01435759|59037335|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
30967315|NCT01435759|59037336|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
30967316|NCT01435759|59037337|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
30967317|NCT01435759|59037338|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
30967318|NCT01435759|59037333|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
30967319|NCT01435759|59037334|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
30967320|NCT01435759|59037335|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
30967321|NCT01435759|59037336|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
30967322|NCT01435759|59037337|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
30967323|NCT01435759|59037338|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
30967324|NCT01435759|59037333|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
30967325|NCT01435759|59037334|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
30967326|NCT01435759|59037335|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
30967327|NCT01435759|59037336|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
30967328|NCT01435759|59037337|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
30967329|NCT01435759|59037338|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
30967330|NCT01435759|59037333|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
30967331|NCT01435759|59037334|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
30967332|NCT01435759|59037335|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
30967333|NCT01435759|59037336|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
30967334|NCT01435759|59037337|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
30967335|NCT01435759|59037338|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
30967336|NCT01435759|59037333|FG000|Antidepressant Lead-in Phase|Other|119|||
30967337|NCT01435759|59037334|FG001|Antidepressant Lead-in Phase|Other|0|||
30967338|NCT01435759|59037335|FG002|Antidepressant Lead-in Phase|Other|0|||
30967339|NCT01435759|59037336|FG003|Antidepressant Lead-in Phase|Other|0|||
30967340|NCT01435759|59037337|FG004|Antidepressant Lead-in Phase|Other|0|||
30967341|NCT01435759|59037338|FG005|Antidepressant Lead-in Phase|Other|0|||
30967342|NCT01435759|59037333|FG000|Double-blind Phase|Adverse Event|7|||
30967343|NCT01435759|59037334|FG001|Double-blind Phase|Adverse Event|0|||
30967344|NCT01435759|59037335|FG002|Double-blind Phase|Adverse Event|1|||
30967345|NCT01435759|59037336|FG003|Double-blind Phase|Adverse Event|1|||
30967346|NCT01435759|59037337|FG004|Double-blind Phase|Adverse Event|1|||
30967347|NCT01435759|59037338|FG005|Double-blind Phase|Adverse Event|3|||
30967348|NCT01435759|59037333|FG000|Double-blind Phase|Protocol Violation|2|||
30967349|NCT01435759|59037334|FG001|Double-blind Phase|Protocol Violation|0|||
30967350|NCT01435759|59037335|FG002|Double-blind Phase|Protocol Violation|1|||
30967351|NCT01435759|59037336|FG003|Double-blind Phase|Protocol Violation|2|||
30967352|NCT01435759|59037337|FG004|Double-blind Phase|Protocol Violation|0|||
30967353|NCT01435759|59037338|FG005|Double-blind Phase|Protocol Violation|1|||
30967354|NCT01435759|59037333|FG000|Double-blind Phase|Withdrawal by Subject|17|||
30967355|NCT01435759|59037334|FG001|Double-blind Phase|Withdrawal by Subject|4|||
30967356|NCT01435759|59037335|FG002|Double-blind Phase|Withdrawal by Subject|3|||
30967357|NCT01435759|59037336|FG003|Double-blind Phase|Withdrawal by Subject|4|||
30967358|NCT01435759|59037337|FG004|Double-blind Phase|Withdrawal by Subject|2|||
30967359|NCT01435759|59037338|FG005|Double-blind Phase|Withdrawal by Subject|2|||
30967360|NCT01435759|59037333|FG000|Double-blind Phase|Lost to Follow-up|31|||
30967361|NCT01435759|59037334|FG001|Double-blind Phase|Lost to Follow-up|1|||
30967362|NCT01435759|59037335|FG002|Double-blind Phase|Lost to Follow-up|2|||
30967363|NCT01435759|59037336|FG003|Double-blind Phase|Lost to Follow-up|0|||
30967364|NCT01435759|59037337|FG004|Double-blind Phase|Lost to Follow-up|3|||
30967365|NCT01435759|59037338|FG005|Double-blind Phase|Lost to Follow-up|3|||
30967366|NCT01435759|59037333|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
30967367|NCT01435759|59037334|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
30967368|NCT01435759|59037335|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
30967369|NCT01435759|59037336|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
30967370|NCT01435759|59037337|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
30967371|NCT01435759|59037338|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
30967372|NCT01435759|59037333|FG000|Double-blind Phase|Other|8|||
30967373|NCT01435759|59037334|FG001|Double-blind Phase|Other|2|||
30967374|NCT01435759|59037335|FG002|Double-blind Phase|Other|0|||
30967375|NCT01435759|59037336|FG003|Double-blind Phase|Other|2|||
30967376|NCT01435759|59037337|FG004|Double-blind Phase|Other|0|||
30967377|NCT01435759|59037338|FG005|Double-blind Phase|Other|0|||
30877080|NCT03330405|58908691|FG008|Overall Study|Progressive disease|9|||
30877081|NCT03330405|58908692|FG009|Overall Study|Progressive disease|11|||
30877082|NCT03330405|58908693|FG010|Overall Study|Progressive disease|5|||
30877083|NCT03330405|58908683|FG000|Overall Study|Withdrawal by Subject|1|||
30877084|NCT03330405|58908684|FG001|Overall Study|Withdrawal by Subject|4|||
30877085|NCT03330405|58908685|FG002|Overall Study|Withdrawal by Subject|0|||
30877086|NCT03330405|58908686|FG003|Overall Study|Withdrawal by Subject|1|||
30877087|NCT03330405|58908687|FG004|Overall Study|Withdrawal by Subject|1|||
30877088|NCT03330405|58908688|FG005|Overall Study|Withdrawal by Subject|1|||
30877089|NCT03330405|58908689|FG006|Overall Study|Withdrawal by Subject|0|||
30877090|NCT03330405|58908690|FG007|Overall Study|Withdrawal by Subject|1|||
30877091|NCT03330405|58908691|FG008|Overall Study|Withdrawal by Subject|2|||
30877092|NCT03330405|58908692|FG009|Overall Study|Withdrawal by Subject|1|||
30877093|NCT03330405|58908693|FG010|Overall Study|Withdrawal by Subject|1|||
30877094|NCT03330405|58908683|FG000|Overall Study|Global deterioration of health status|2|||
30877095|NCT03330405|58908684|FG001|Overall Study|Global deterioration of health status|3|||
30877096|NCT03330405|58908685|FG002|Overall Study|Global deterioration of health status|0|||
30877097|NCT03330405|58908686|FG003|Overall Study|Global deterioration of health status|2|||
30877098|NCT03330405|58908687|FG004|Overall Study|Global deterioration of health status|3|||
30877099|NCT03330405|58908688|FG005|Overall Study|Global deterioration of health status|3|||
30877100|NCT03330405|58908689|FG006|Overall Study|Global deterioration of health status|0|||
30877101|NCT03330405|58908690|FG007|Overall Study|Global deterioration of health status|2|||
30877102|NCT03330405|58908691|FG008|Overall Study|Global deterioration of health status|8|||
30877103|NCT03330405|58908692|FG009|Overall Study|Global deterioration of health status|4|||
30877104|NCT03330405|58908693|FG010|Overall Study|Global deterioration of health status|1|||
30877105|NCT03330405|58908683|FG000|Overall Study|Adverse Event|0|||
30877106|NCT03330405|58908684|FG001|Overall Study|Adverse Event|0|||
30877107|NCT03330405|58908685|FG002|Overall Study|Adverse Event|0|||
30877108|NCT03330405|58908686|FG003|Overall Study|Adverse Event|1|||
30877109|NCT03330405|58908687|FG004|Overall Study|Adverse Event|1|||
30877110|NCT03330405|58908688|FG005|Overall Study|Adverse Event|1|||
30877111|NCT03330405|58908689|FG006|Overall Study|Adverse Event|3|||
30877112|NCT03330405|58908690|FG007|Overall Study|Adverse Event|3|||
30877113|NCT03330405|58908691|FG008|Overall Study|Adverse Event|2|||
30877114|NCT03330405|58908692|FG009|Overall Study|Adverse Event|2|||
30877115|NCT03330405|58908693|FG010|Overall Study|Adverse Event|2|||
30877116|NCT03330405|58908683|FG000|Overall Study|Death|0|||
30877117|NCT03330405|58908684|FG001|Overall Study|Death|4|||
30877118|NCT03330405|58908685|FG002|Overall Study|Death|0|||
30877119|NCT03330405|58908686|FG003|Overall Study|Death|0|||
30877120|NCT03330405|58908687|FG004|Overall Study|Death|0|||
30877121|NCT03330405|58908688|FG005|Overall Study|Death|1|||
30877122|NCT03330405|58908689|FG006|Overall Study|Death|0|||
30877123|NCT03330405|58908690|FG007|Overall Study|Death|2|||
30877124|NCT03330405|58908691|FG008|Overall Study|Death|0|||
30877125|NCT03330405|58908692|FG009|Overall Study|Death|0|||
30877126|NCT03330405|58908693|FG010|Overall Study|Death|0|||
30877127|NCT03330405|58908683|FG000|Overall Study|Physician Decision|0|||
30877128|NCT03330405|58908684|FG001|Overall Study|Physician Decision|0|||
30877129|NCT03330405|58908685|FG002|Overall Study|Physician Decision|0|||
30877130|NCT03330405|58908686|FG003|Overall Study|Physician Decision|0|||
30877131|NCT03330405|58908687|FG004|Overall Study|Physician Decision|0|||
30877132|NCT03330405|58908688|FG005|Overall Study|Physician Decision|0|||
30877133|NCT03330405|58908689|FG006|Overall Study|Physician Decision|0|||
30877134|NCT03330405|58908690|FG007|Overall Study|Physician Decision|1|||
30877135|NCT03330405|58908691|FG008|Overall Study|Physician Decision|0|||
30877192|NCT02644967|58908932|FG000|Overall Study|Study Terminated by Sponsor|4|||
30877193|NCT02644343|58908936|FG000|Overall Study|Withdrawal by Subject|1|||
30877194|NCT02644109|58908942|FG000|Overall Study|Adverse Event|0|||
30877195|NCT02644109|58908943|FG001|Overall Study|Adverse Event|4|||
30877196|NCT02642159|58908951|FG000|Overall Study|Randomized but not treated|1|||
30877197|NCT02642159|58908952|FG001|Overall Study|Randomized but not treated|0|||
30877198|NCT02642159|58908951|FG000|Overall Study|Adverse Event|10|||
30877199|NCT02642159|58908952|FG001|Overall Study|Adverse Event|4|||
30877200|NCT02642159|58908951|FG000|Overall Study|Withdrawal by Subject|9|||
30877201|NCT02642159|58908952|FG001|Overall Study|Withdrawal by Subject|1|||
30877202|NCT02642159|58908951|FG000|Overall Study|Poor compliance to study protocol|1|||
30877203|NCT02642159|58908952|FG001|Overall Study|Poor compliance to study protocol|0|||
30877204|NCT02642159|58908951|FG000|Overall Study|Other than specified above|10|||
30877205|NCT02642159|58908952|FG001|Overall Study|Other than specified above|3|||
30877206|NCT02669017|58908968|FG000|Overall Study|Death|1|||
30877207|NCT02669017|58908969|FG001|Overall Study|Death|2|||
30877208|NCT02669017|58908970|FG002|Overall Study|Death|2|||
30877209|NCT02669017|58908971|FG003|Overall Study|Death|3|||
30877210|NCT02669017|58908972|FG004|Overall Study|Death|8|||
30877211|NCT02669017|58908973|FG005|Overall Study|Death|18|||
30877212|NCT02669017|58908974|FG006|Overall Study|Death|10|||
30877213|NCT02669017|58908975|FG007|Overall Study|Death|47|||
30877214|NCT02669017|58908976|FG008|Overall Study|Death|20|||
30877215|NCT02669017|58908968|FG000|Overall Study|Withdrawal by Subject|0|||
30877216|NCT02669017|58908969|FG001|Overall Study|Withdrawal by Subject|0|||
30877217|NCT02669017|58908970|FG002|Overall Study|Withdrawal by Subject|0|||
30877218|NCT02669017|58908971|FG003|Overall Study|Withdrawal by Subject|1|||
30877219|NCT02669017|58908972|FG004|Overall Study|Withdrawal by Subject|2|||
30877220|NCT02669017|58908973|FG005|Overall Study|Withdrawal by Subject|0|||
30877221|NCT02669017|58908974|FG006|Overall Study|Withdrawal by Subject|0|||
30877222|NCT02669017|58908975|FG007|Overall Study|Withdrawal by Subject|2|||
30877223|NCT02669017|58908976|FG008|Overall Study|Withdrawal by Subject|2|||
30877224|NCT02669017|58908968|FG000|Overall Study|Lost to Follow-up|0|||
30877225|NCT02669017|58908969|FG001|Overall Study|Lost to Follow-up|0|||
30877226|NCT02669017|58908970|FG002|Overall Study|Lost to Follow-up|0|||
30877227|NCT02669017|58908971|FG003|Overall Study|Lost to Follow-up|0|||
30877228|NCT02669017|58908972|FG004|Overall Study|Lost to Follow-up|0|||
30877229|NCT02669017|58908973|FG005|Overall Study|Lost to Follow-up|0|||
30877230|NCT02669017|58908974|FG006|Overall Study|Lost to Follow-up|0|||
30877231|NCT02669017|58908975|FG007|Overall Study|Lost to Follow-up|0|||
30877232|NCT02669017|58908976|FG008|Overall Study|Lost to Follow-up|1|||
30877233|NCT02669017|58908968|FG000|Overall Study|Miscellaneous|0|||
30877234|NCT02669017|58908969|FG001|Overall Study|Miscellaneous|0|||
30877235|NCT02669017|58908970|FG002|Overall Study|Miscellaneous|0|||
30877236|NCT02669017|58908971|FG003|Overall Study|Miscellaneous|0|||
30877237|NCT02669017|58908972|FG004|Overall Study|Miscellaneous|2|||
30877238|NCT02669017|58908973|FG005|Overall Study|Miscellaneous|1|||
30877239|NCT02669017|58908974|FG006|Overall Study|Miscellaneous|1|||
30877240|NCT02669017|58908975|FG007|Overall Study|Miscellaneous|13|||
30877241|NCT02669017|58908976|FG008|Overall Study|Miscellaneous|2|||
30877242|NCT02668393|58909006|FG000|Overall Study|Progressive disease|6|||
30877243|NCT02668393|58909007|FG001|Overall Study|Progressive disease|3|||
30877244|NCT02668393|58909006|FG000|Overall Study|Adverse Event|0|||
30877245|NCT02668393|58909007|FG001|Overall Study|Adverse Event|2|||
30877246|NCT02668393|58909006|FG000|Overall Study|Withdrawal from the trial|0|||
30877247|NCT02668393|58909007|FG001|Overall Study|Withdrawal from the trial|1|||
30877248|NCT02668393|58909006|FG000|Overall Study|Lack of benefit and side effects|1|||
30877249|NCT02668393|58909007|FG001|Overall Study|Lack of benefit and side effects|0|||
30877250|NCT01998958|58909021|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877251|NCT01998958|58909022|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
30877252|NCT01998958|58909023|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877253|NCT01998958|58909024|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877254|NCT01998958|58909025|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877255|NCT01998958|58909026|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877256|NCT01998958|58909027|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877257|NCT01998958|58909028|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877258|NCT01998958|58909029|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877259|NCT01998958|58909030|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877260|NCT01998958|58909031|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877261|NCT01998958|58909032|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877262|NCT01998958|58909033|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877263|NCT01998958|58909034|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877264|NCT01998958|58909035|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877265|NCT01998958|58909036|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877266|NCT01998958|58909037|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877267|NCT01998958|58909038|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877268|NCT01998958|58909039|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877269|NCT01998958|58909040|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877270|NCT01998958|58909041|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877271|NCT01998958|58909042|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877272|NCT01998958|58909043|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877273|NCT01998958|58909044|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877274|NCT01998958|58909045|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877275|NCT01998958|58909046|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877276|NCT01998958|58909047|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877277|NCT01998958|58909048|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877278|NCT01998958|58909049|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877279|NCT01998958|58909050|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877280|NCT01998958|58909051|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877281|NCT01998958|58909052|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
30877282|NCT01998958|58909021|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877283|NCT01998958|58909022|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
30877284|NCT01998958|58909023|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877285|NCT01998958|58909024|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877286|NCT01998958|58909025|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877287|NCT01998958|58909026|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877288|NCT01998958|58909027|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877289|NCT01998958|58909028|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877290|NCT01998958|58909029|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877291|NCT01998958|58909030|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877292|NCT01998958|58909031|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877293|NCT01998958|58909032|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877294|NCT01998958|58909033|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877295|NCT01998958|58909034|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877296|NCT01998958|58909035|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877297|NCT01998958|58909036|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877298|NCT01998958|58909037|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877299|NCT01998958|58909038|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877300|NCT01998958|58909039|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877301|NCT01998958|58909040|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877302|NCT01998958|58909041|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877303|NCT01998958|58909042|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877304|NCT01998958|58909043|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877305|NCT01998958|58909044|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877306|NCT01998958|58909045|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877307|NCT01998958|58909046|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877308|NCT01998958|58909047|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877309|NCT01998958|58909048|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877310|NCT01998958|58909049|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877311|NCT01998958|58909050|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877312|NCT01998958|58909051|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877313|NCT01998958|58909052|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
30877314|NCT01998958|58909021|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
30877315|NCT01998958|58909022|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
30877316|NCT01998958|58909023|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
30877317|NCT01998958|58909024|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
30877318|NCT01998958|58909025|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
30877319|NCT01998958|58909026|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
30877320|NCT01998958|58909027|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
30877321|NCT01998958|58909028|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
30877322|NCT01998958|58909029|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
30877323|NCT01998958|58909030|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
30877324|NCT01998958|58909031|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
30877325|NCT01998958|58909032|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
30877326|NCT01998958|58909033|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
30877327|NCT01998958|58909034|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
30877328|NCT01998958|58909035|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
30877329|NCT01998958|58909036|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
30877330|NCT01998958|58909037|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
30877331|NCT01998958|58909038|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
30877332|NCT01998958|58909039|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
30877333|NCT01998958|58909040|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
30877334|NCT01998958|58909041|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
30877335|NCT01998958|58909042|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
30877336|NCT01998958|58909043|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
30877337|NCT01998958|58909044|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
30877338|NCT01998958|58909045|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
30877339|NCT01998958|58909046|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
30877340|NCT01998958|58909047|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
30877341|NCT01998958|58909048|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
30877342|NCT01998958|58909049|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
30877343|NCT01998958|58909050|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
30877344|NCT01998958|58909051|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
30877345|NCT01998958|58909052|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
30877346|NCT01998958|58909021|FG000|Period 1 (Panel A and B)|Other|1|||
30877347|NCT01998958|58909022|FG001|Period 1 (Panel A and B)|Other|0|||
30877348|NCT01998958|58909023|FG002|Period 1 (Panel A and B)|Other|0|||
30877349|NCT01998958|58909024|FG003|Period 1 (Panel A and B)|Other|0|||
30877350|NCT01998958|58909025|FG004|Period 1 (Panel A and B)|Other|0|||
30877351|NCT01998958|58909026|FG005|Period 1 (Panel A and B)|Other|0|||
30877352|NCT01998958|58909027|FG006|Period 1 (Panel A and B)|Other|0|||
30877353|NCT01998958|58909028|FG007|Period 1 (Panel A and B)|Other|0|||
30877354|NCT01998958|58909029|FG008|Period 1 (Panel A and B)|Other|0|||
30877355|NCT01998958|58909030|FG009|Period 1 (Panel A and B)|Other|0|||
30877356|NCT01998958|58909031|FG010|Period 1 (Panel A and B)|Other|0|||
30877357|NCT01998958|58909032|FG011|Period 1 (Panel A and B)|Other|0|||
30877358|NCT01998958|58909033|FG012|Period 1 (Panel A and B)|Other|0|||
30877359|NCT01998958|58909034|FG013|Period 1 (Panel A and B)|Other|0|||
30877360|NCT01998958|58909035|FG014|Period 1 (Panel A and B)|Other|0|||
30877361|NCT01998958|58909036|FG015|Period 1 (Panel A and B)|Other|0|||
30877362|NCT01998958|58909037|FG016|Period 1 (Panel A and B)|Other|0|||
30877363|NCT01998958|58909038|FG017|Period 1 (Panel A and B)|Other|0|||
30877364|NCT01998958|58909039|FG018|Period 1 (Panel A and B)|Other|0|||
30877365|NCT01998958|58909040|FG019|Period 1 (Panel A and B)|Other|0|||
30877366|NCT01998958|58909041|FG020|Period 1 (Panel A and B)|Other|0|||
30877367|NCT01998958|58909042|FG021|Period 1 (Panel A and B)|Other|0|||
30877368|NCT01998958|58909043|FG022|Period 1 (Panel A and B)|Other|0|||
30877369|NCT01998958|58909044|FG023|Period 1 (Panel A and B)|Other|0|||
30877370|NCT01998958|58909045|FG024|Period 1 (Panel A and B)|Other|0|||
30877371|NCT01998958|58909046|FG025|Period 1 (Panel A and B)|Other|0|||
30877372|NCT01998958|58909047|FG026|Period 1 (Panel A and B)|Other|0|||
30877373|NCT01998958|58909048|FG027|Period 1 (Panel A and B)|Other|0|||
30877374|NCT01998958|58909049|FG028|Period 1 (Panel A and B)|Other|0|||
30877375|NCT01998958|58909050|FG029|Period 1 (Panel A and B)|Other|0|||
30877376|NCT01998958|58909051|FG030|Period 1 (Panel A and B)|Other|0|||
30877377|NCT01998958|58909052|FG031|Period 1 (Panel A and B)|Other|0|||
30877378|NCT01998958|58909021|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
30877379|NCT01998958|58909022|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
30877380|NCT01998958|58909023|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
30877381|NCT01998958|58909024|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
30877382|NCT01998958|58909025|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
30877383|NCT01998958|58909026|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
30877384|NCT01998958|58909027|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
30877385|NCT01998958|58909028|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
30877386|NCT01998958|58909029|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
30877387|NCT01998958|58909030|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
30877388|NCT01998958|58909031|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
30877389|NCT01998958|58909032|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
30877390|NCT01998958|58909033|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
30877391|NCT01998958|58909034|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
30877392|NCT01998958|58909035|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
30877393|NCT01998958|58909036|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
30877394|NCT01998958|58909037|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
30877395|NCT01998958|58909038|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
30877396|NCT01998958|58909039|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
30877397|NCT01998958|58909040|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
30877398|NCT01998958|58909041|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
30877399|NCT01998958|58909042|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
30877400|NCT01998958|58909043|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
30877401|NCT01998958|58909044|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
30877402|NCT01998958|58909045|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
30877403|NCT01998958|58909046|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
30877404|NCT01998958|58909047|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
30877405|NCT01998958|58909048|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
30877406|NCT01998958|58909049|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
30877407|NCT01998958|58909050|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
30877408|NCT01998958|58909051|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
30877409|NCT01998958|58909052|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
30877410|NCT01998958|58909021|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877411|NCT01998958|58909022|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877412|NCT01998958|58909023|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877413|NCT01998958|58909024|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877414|NCT01998958|58909025|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877415|NCT01998958|58909026|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877416|NCT01998958|58909027|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877417|NCT01998958|58909028|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877418|NCT01998958|58909029|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877419|NCT01998958|58909030|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877420|NCT01998958|58909031|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877421|NCT01998958|58909032|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877422|NCT01998958|58909033|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877423|NCT01998958|58909034|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877424|NCT01998958|58909035|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
30877425|NCT01998958|58909036|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877426|NCT01998958|58909037|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877427|NCT01998958|58909038|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877428|NCT01998958|58909039|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
30877429|NCT01998958|58909040|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877430|NCT01998958|58909041|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877431|NCT01998958|58909042|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877432|NCT01998958|58909043|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877433|NCT01998958|58909044|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877434|NCT01998958|58909045|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877435|NCT01998958|58909046|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877436|NCT01998958|58909047|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877437|NCT01998958|58909048|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877438|NCT01998958|58909049|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877439|NCT01998958|58909050|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877440|NCT01998958|58909051|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877441|NCT01998958|58909052|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
30877442|NCT01998958|58909021|FG000|Open Label Phase (Optional)|Adverse Event|0|||
30877443|NCT01998958|58909022|FG001|Open Label Phase (Optional)|Adverse Event|0|||
30877444|NCT01998958|58909023|FG002|Open Label Phase (Optional)|Adverse Event|0|||
30877445|NCT01998958|58909024|FG003|Open Label Phase (Optional)|Adverse Event|0|||
30877446|NCT01998958|58909025|FG004|Open Label Phase (Optional)|Adverse Event|0|||
30877447|NCT01998958|58909026|FG005|Open Label Phase (Optional)|Adverse Event|0|||
30877448|NCT01998958|58909027|FG006|Open Label Phase (Optional)|Adverse Event|0|||
30877449|NCT01998958|58909028|FG007|Open Label Phase (Optional)|Adverse Event|0|||
30877450|NCT01998958|58909029|FG008|Open Label Phase (Optional)|Adverse Event|0|||
30877451|NCT01998958|58909030|FG009|Open Label Phase (Optional)|Adverse Event|0|||
30877452|NCT01998958|58909031|FG010|Open Label Phase (Optional)|Adverse Event|0|||
30877453|NCT01998958|58909032|FG011|Open Label Phase (Optional)|Adverse Event|0|||
30877454|NCT01998958|58909033|FG012|Open Label Phase (Optional)|Adverse Event|0|||
30877455|NCT01998958|58909034|FG013|Open Label Phase (Optional)|Adverse Event|0|||
30877456|NCT01998958|58909035|FG014|Open Label Phase (Optional)|Adverse Event|0|||
30877457|NCT01998958|58909036|FG015|Open Label Phase (Optional)|Adverse Event|0|||
30877458|NCT01998958|58909037|FG016|Open Label Phase (Optional)|Adverse Event|0|||
30877459|NCT01998958|58909038|FG017|Open Label Phase (Optional)|Adverse Event|0|||
30877460|NCT01998958|58909039|FG018|Open Label Phase (Optional)|Adverse Event|0|||
30877461|NCT01998958|58909040|FG019|Open Label Phase (Optional)|Adverse Event|0|||
30877462|NCT01998958|58909041|FG020|Open Label Phase (Optional)|Adverse Event|0|||
30877463|NCT01998958|58909042|FG021|Open Label Phase (Optional)|Adverse Event|0|||
30877464|NCT01998958|58909043|FG022|Open Label Phase (Optional)|Adverse Event|0|||
30877465|NCT01998958|58909044|FG023|Open Label Phase (Optional)|Adverse Event|1|||
30877466|NCT01998958|58909045|FG024|Open Label Phase (Optional)|Adverse Event|0|||
30877467|NCT01998958|58909046|FG025|Open Label Phase (Optional)|Adverse Event|0|||
30877468|NCT01998958|58909047|FG026|Open Label Phase (Optional)|Adverse Event|0|||
30877469|NCT01998958|58909048|FG027|Open Label Phase (Optional)|Adverse Event|0|||
30877470|NCT01998958|58909049|FG028|Open Label Phase (Optional)|Adverse Event|0|||
30877471|NCT01998958|58909050|FG029|Open Label Phase (Optional)|Adverse Event|0|||
30877472|NCT01998958|58909051|FG030|Open Label Phase (Optional)|Adverse Event|0|||
30877473|NCT01998958|58909052|FG031|Open Label Phase (Optional)|Adverse Event|0|||
30877474|NCT01998958|58909021|FG000|Open Label Phase (Optional)|Other|0|||
30877475|NCT01998958|58909022|FG001|Open Label Phase (Optional)|Other|0|||
30877476|NCT01998958|58909023|FG002|Open Label Phase (Optional)|Other|0|||
30877477|NCT01998958|58909024|FG003|Open Label Phase (Optional)|Other|0|||
30877478|NCT01998958|58909025|FG004|Open Label Phase (Optional)|Other|0|||
30877479|NCT01998958|58909026|FG005|Open Label Phase (Optional)|Other|0|||
30877480|NCT01998958|58909027|FG006|Open Label Phase (Optional)|Other|0|||
30877481|NCT01998958|58909028|FG007|Open Label Phase (Optional)|Other|0|||
30877482|NCT01998958|58909029|FG008|Open Label Phase (Optional)|Other|0|||
30877483|NCT01998958|58909030|FG009|Open Label Phase (Optional)|Other|0|||
30877484|NCT01998958|58909031|FG010|Open Label Phase (Optional)|Other|0|||
30877485|NCT01998958|58909032|FG011|Open Label Phase (Optional)|Other|0|||
30877486|NCT01998958|58909033|FG012|Open Label Phase (Optional)|Other|0|||
30877487|NCT01998958|58909034|FG013|Open Label Phase (Optional)|Other|0|||
30877488|NCT01998958|58909035|FG014|Open Label Phase (Optional)|Other|0|||
30877489|NCT01998958|58909036|FG015|Open Label Phase (Optional)|Other|0|||
30877490|NCT01998958|58909037|FG016|Open Label Phase (Optional)|Other|0|||
30877491|NCT01998958|58909038|FG017|Open Label Phase (Optional)|Other|0|||
30877492|NCT01998958|58909039|FG018|Open Label Phase (Optional)|Other|0|||
30877493|NCT01998958|58909040|FG019|Open Label Phase (Optional)|Other|0|||
30877494|NCT01998958|58909041|FG020|Open Label Phase (Optional)|Other|0|||
30877506|NCT01998958|58909021|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877507|NCT01998958|58909022|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877508|NCT01998958|58909023|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877509|NCT01998958|58909024|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877510|NCT01998958|58909025|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877511|NCT01998958|58909026|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877512|NCT01998958|58909027|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877513|NCT01998958|58909028|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877514|NCT01998958|58909029|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877515|NCT01998958|58909030|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877516|NCT01998958|58909031|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877517|NCT01998958|58909032|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877518|NCT01998958|58909033|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877519|NCT01998958|58909034|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877520|NCT01998958|58909035|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877521|NCT01998958|58909036|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877522|NCT01998958|58909037|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877523|NCT01998958|58909038|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877524|NCT01998958|58909039|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877525|NCT01998958|58909040|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877526|NCT01998958|58909041|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877527|NCT01998958|58909042|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877528|NCT01998958|58909043|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
30877529|NCT01998958|58909044|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877530|NCT01998958|58909045|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877531|NCT01998958|58909046|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877532|NCT01998958|58909047|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877533|NCT01998958|58909048|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877534|NCT01998958|58909049|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877535|NCT01998958|58909050|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877536|NCT01998958|58909051|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877537|NCT01998958|58909052|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
30877538|NCT01998958|58909021|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877539|NCT01998958|58909022|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877540|NCT01998958|58909023|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877541|NCT01998958|58909024|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877542|NCT01998958|58909025|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877543|NCT01998958|58909026|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877544|NCT01998958|58909027|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877545|NCT01998958|58909028|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877546|NCT01998958|58909029|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877547|NCT01998958|58909030|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877548|NCT01998958|58909031|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877549|NCT01998958|58909032|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877550|NCT01998958|58909033|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877551|NCT01998958|58909034|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877552|NCT01998958|58909035|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877553|NCT01998958|58909036|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877554|NCT01998958|58909037|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877555|NCT01998958|58909038|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877556|NCT01998958|58909039|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877557|NCT01998958|58909040|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877558|NCT01998958|58909041|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877559|NCT01998958|58909042|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
30877560|NCT01998958|58909043|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
30877561|NCT01998958|58909044|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877562|NCT01998958|58909045|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877563|NCT01998958|58909046|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877564|NCT01998958|58909047|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877565|NCT01998958|58909048|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877566|NCT01998958|58909049|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877567|NCT01998958|58909050|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877568|NCT01998958|58909051|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877569|NCT01998958|58909052|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
30877570|NCT01998958|58909021|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877571|NCT01998958|58909022|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877572|NCT01998958|58909023|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877573|NCT01998958|58909024|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877574|NCT01998958|58909025|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877575|NCT01998958|58909026|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877576|NCT01998958|58909027|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877577|NCT01998958|58909028|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877578|NCT01998958|58909029|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877579|NCT01998958|58909030|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877580|NCT01998958|58909031|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877581|NCT01998958|58909032|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877582|NCT01998958|58909033|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877583|NCT01998958|58909034|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877584|NCT01998958|58909035|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877585|NCT01998958|58909036|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877586|NCT01998958|58909037|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877587|NCT01998958|58909038|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877588|NCT01998958|58909039|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877589|NCT01998958|58909040|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877590|NCT01998958|58909041|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877591|NCT01998958|58909042|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
30877592|NCT01998958|58909043|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
30877593|NCT01998958|58909044|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
30877594|NCT01998958|58909045|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877595|NCT01998958|58909046|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877596|NCT01998958|58909047|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877597|NCT01998958|58909048|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877598|NCT01998958|58909049|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877599|NCT01998958|58909050|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877600|NCT01998958|58909051|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
30877601|NCT01998958|58909052|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
